PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Fauroux, B; Hascoet, JM; Jarreau, PH; Magny, JF; Roze, JC; Saliba, E; Schwarzinger, M				Fauroux, Brigitte; Hascoet, Jean-Michel; Jarreau, Pierre-Henri; Magny, Jean-Francois; Roze, Jean-Christophe; Saliba, Elie; Schwarzinger, Michael			Risk factors for bronchiolitis hospitalization in infants: A French nationwide retrospective cohort study over four consecutive seasons (2009-2013)	PLOS ONE			English	Article							RESPIRATORY SYNCYTIAL VIRUS; MORBIDITY; INFECTION; CHILDREN; MORTALITY; FRANCE; EPIDEMIOLOGY; DISEASE; BURDEN	Objectives Large studies are needed to update risk factors of bronchiolitis hospitalization. We performed a nationwide analysis of hospitalization rates for bronchiolitis over four consecutive bronchiolitis seasons to identify underlying medical disorders at risk of bronchiolitis hospitalization and assess their frequency. Methods Data were retrieved from the French National Hospital Discharge database. Of all infants discharged alive from maternity wards from January 2008 to December 2013 in France (N = 3,884,791), we identified four consecutive cohorts at risk of bronchiolitis during the seasons of 2009-2010 to 2012-2013. The main outcome was bronchiolitis hospitalization during a season. Individual risk factors were collected. Results Among infants, 6.0% were preterm and 2.0% had >= 1 chronic condition including 0.2% bronchopulmonary dysplasia (BPD) and 0.2% hemodynamically significant congenital heart disease (HS-CHD). Bronchiolitis hospitalization rates varied between seasons (min: 1.26% in 2010-2011; max: 1.48% in 2012-2013; p< 0.001). Except omphalocele, the following conditions were associated with an increased risk for bronchiolitis hospitalization: solid organ (9.052; 95% CI, 4.664-17.567) and stem cell transplants (6.012; 95% CI, 3.441-10.503), muscular dystrophy (4.002; 95% CI, 3.1095-5.152), cardiomyopathy (3.407; 95% CI, 2.613-4.442), HS-CHD (3.404; 95% CI, 3.153-3.675), congenital lung disease and/or bronchial abnormalities, Down syndrome, congenital tracheoesophageal fistula, diaphragmatic hernia, pulmonary hypertension, chromosomal abnormalities other than Down syndrome, hemodynamically non-significant CHD, congenital abnormalities of nervous system, cystic fibrosis, cleft palate, cardiovascular disease occurring during perinatal period, and BPD. Conclusion Besides prematurity, BPD, and HS-CHD, eighteen underlying conditions were associated with a significant increased risk for bronchiolitis hospitalization in a nationwide population.	[Fauroux, Brigitte] Necker Enfants Malad Hosp, Pediat Noninvas Ventilat & Sleep Unit, Paris, France; [Fauroux, Brigitte] Univ Paris, VIFASOM, Paris, France; [Hascoet, Jean-Michel] Univ Lorraine, Reg Matern CHRU, Nancy, Meurthe Moselle, France; [Jarreau, Pierre-Henri] Univ Paris, Paris, France; [Jarreau, Pierre-Henri] Cochin Hosp, AP HP, Dept Neonatal Med, Paris, France; [Jarreau, Pierre-Henri] Cochin Hosp, AP HP, Intens Care Unit, Paris, France; [Magny, Jean-Francois] Necker Enfants Malad Univ Hosp, Dept Neonatol, Paris, France; [Roze, Jean-Christophe] Univ Hosp, Dept Neonatol, Nantes, France; [Saliba, Elie] Clocheville Univ Hosp, Dept Neonatol, Tours, Indre & Loire, France; [Schwarzinger, Michael] Translat Hlth Econ Network THEN, Paris, France; [Schwarzinger, Michael] Inst Natl Sante & Rech Med INSERM, Infect Antimicrobials Modeling & Evolut IAME, UMR 1137, Paris, France; [Schwarzinger, Michael] Univ Paris Diderot, Sorbonne Paris Cite, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Universite de Lorraine; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Nantes Universite; CHU de Nantes; CHU Tours; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite	Fauroux, B (corresponding author), Necker Enfants Malad Hosp, Pediat Noninvas Ventilat & Sleep Unit, Paris, France.; Fauroux, B (corresponding author), Univ Paris, VIFASOM, Paris, France.	brigitte.fauroux@aphp.fr	Rozé, Jean-Christophe/AAS-1314-2021; Schwarzinger, Michael/F-7367-2011	Schwarzinger, Michael/0000-0002-0573-6856; Fauroux, Brigitte/0000-0001-6092-2662	AbbVie France	AbbVie France(AbbVie)	The present study was supported by AbbVie France. Translational Health Economics (THEN) was responsible for data collection, preparation, and validation with external sources of information. THEN received payment from AbbVie for these activities. Writing charges were funded by AbbVie France, and AbbVie approved the decision to submit the paper for publication, but the corresponding author was ultimately responsible for submitting the manuscript for publication. The sponsor had no additional role in study design, collection, analysis, and interpretation of data.	ANAES, 2000, C CONS PRIS CHARG BR; Ancel PY, 2015, JAMA PEDIATR, V169, P230, DOI 10.1001/jamapediatrics.2014.3351; Bont L, 2016, INFECT DIS THER, V5, P271, DOI 10.1007/s40121-016-0123-0; Brady MT, 2014, PEDIATRICS, V134, pE620, DOI [10.1542/peds.2014-1665, 10.1542/peds.2014-1666]; Charkaluk ML, 2012, J PEDIATR-US, V161, P1053, DOI 10.1016/j.jpeds.2012.05.037; Che D, 2012, ARCH PEDIATRIE, V19, P700, DOI 10.1016/j.arcped.2012.04.015; Checchia PA, 2017, INFECT DIS THER, V6, P37, DOI 10.1007/s40121-016-0142-x; Figueras-Aloy J, 2016, INFECT DIS THER, V5, P417, DOI 10.1007/s40121-016-0130-1; Florin TA, 2017, LANCET, V389, P211, DOI 10.1016/S0140-6736(16)30951-5; Green CA, 2016, ARCH DIS CHILD, V101, P140, DOI 10.1136/archdischild-2015-308723; Houyel L, 2011, ORPHANET J RARE DIS, V6, DOI 10.1186/1750-1172-6-64; Iacobelli S, 2017, BMC PEDIATR, V17, DOI 10.1186/s12887-017-0787-y; Khirani S, 2018, EUR J CARDIO-THORAC, V53, P740, DOI 10.1093/ejcts/ezx391; Kristensen K, 2012, CLIN INFECT DIS, V54, P810, DOI 10.1093/cid/cir928; Lal C, 2015, CHEST, V147, P570, DOI 10.1378/chest.14-0266; Manzoni P, 2012, EARLY HUM DEV, V88, pS34, DOI 10.1016/S0378-3782(12)70012-9; Manzoni P, 2017, INFECT DIS THER, V6, P383, DOI 10.1007/s40121-017-0160-3; Meissner HC, 2016, NEW ENGL J MED, V374, P62, DOI 10.1056/NEJMra1413456; NICE guideline, 2015, BRONCHIOLITIS CHILDR; Paes B, 2016, INFECT DIS THER, V5, P453, DOI 10.1007/s40121-016-0137-7; Pierron A, 2015, REV EPIDEMIOL SANTE, V63, P237, DOI 10.1016/j.respe.2015.05.001; Pignotti MS, 2016, PEDIATR PULM, V51, P1088, DOI 10.1002/ppul.23561; Ralston SL, 2014, PEDIATRICS, V134, pE1474, DOI 10.1542/peds.2014-2742; Shi T, 2017, LANCET, V390, P946, DOI [10.1016/s0140-6736(17)30938-8, 10.1016/S0140-6736(17)30938-8]; Soilly AL, 2012, EPIDEMIOL INFECT, V140, P608, DOI 10.1017/S0950268811001208; Stranak Z, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157446; Verhoeven D, 2019, VIRAL IMMUNOL, V32, P76, DOI 10.1089/vim.2018.0121; Welliver RC, 2003, PEDIATR INFECT DIS J, V22, pS6, DOI 10.1097/00006454-200302001-00002	28	9	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2020	15	3							e0229766	10.1371/journal.pone.0229766	http://dx.doi.org/10.1371/journal.pone.0229766			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8TR	32142528	Green Published, gold			2022-12-26	WOS:000535271600017
J	Orimaye, SO; Goodkin, K; Riaz, OA; Salcedo, JMM; Al-Khateeb, T; Awujoola, AO; Sodeke, PO				Orimaye, Sylvester Olubolu; Goodkin, Karl; Riaz, Ossama Abid; Salcedo, Jean-Maurice Miranda; Al-Khateeb, Thabit; Awujoola, Adeola Olubukola; Sodeke, Patrick Olumuyiwa			A machine learning-based linguistic battery for diagnosing mild cognitive impairment due to Alzheimer's disease	PLOS ONE			English	Article							MENTAL-STATE-EXAMINATION; NEUROPSYCHOLOGICAL ASSESSMENT; DEMENTIA; CERAD; PERFORMANCE	There is a limited evaluation of an independent linguistic battery for early diagnosis of Mild Cognitive Impairment due to Alzheimer's disease (MCI-AD). We hypothesized that an independent linguistic battery comprising of only the language components or subtests of popular test batteries could give a better clinical diagnosis for MCI-AD compared to using an exhaustive battery of tests. As such, we combined multiple clinical datasets and performed Exploratory Factor Analysis (EFA) to extract the underlying linguistic constructs from a combination of the Consortium to Establish a Registry for Alzheimer's disease (CERAD), Wechsler Memory Scale (WMS) Logical Memory (LM) I and II, and the Boston Naming Test. Furthermore, we trained a machine-learning algorithm that validates the clinical relevance of the independent linguistic battery for differentiating between patients with MCI-AD and cognitive healthy control individuals. Our EFA identified ten linguistic variables with distinct underlying linguistic constructs that show Cronbach's alpha of 0.74 on the MCI-AD group and 0.87 on the healthy control group. Our machine learning evaluation showed a robust AUC of 0.97 when controlled for age, sex, race, and education, and a clinically reliable AUC of 0.88 without controlling for age, sex, race, and education. Overall, the linguistic battery showed a better diagnostic result compared to the Mini-Mental State Examination (MMSE), Clinical Dementia Rating Scale (CDR), and a combination of MMSE and CDR.	[Orimaye, Sylvester Olubolu] East Tennessee State Univ, Coll Publ Hlth, Dept Hlth Serv Management & Policy, Johnson City, TN 37614 USA; [Orimaye, Sylvester Olubolu; Goodkin, Karl; Riaz, Ossama Abid; Salcedo, Jean-Maurice Miranda; Al-Khateeb, Thabit; Awujoola, Adeola Olubukola; Sodeke, Patrick Olumuyiwa] East Tennessee State Univ, Quillen Coll Med, Dept Psychiat & Behav Sci, Psychiat Res Div, Johnson City, TN 37614 USA	East Tennessee State University; East Tennessee State University	Orimaye, SO (corresponding author), East Tennessee State Univ, Coll Publ Hlth, Dept Hlth Serv Management & Policy, Johnson City, TN 37614 USA.; Orimaye, SO (corresponding author), East Tennessee State Univ, Quillen Coll Med, Dept Psychiat & Behav Sci, Psychiat Res Div, Johnson City, TN 37614 USA.	orimaye@etsu.edu	Awujoola, Adeola/AAK-7306-2021; Orimaye, Sylvester/ABB-9920-2021	Awujoola, Adeola/0000-0003-1729-9443; Orimaye, Sylvester/0000-0001-7678-8680	Department of Psychiatry and Behavioral Sciences, James H. Quillen College of Medicine, East Tennessee State University	Department of Psychiatry and Behavioral Sciences, James H. Quillen College of Medicine, East Tennessee State University	This study was funded in part by the Department of Psychiatry and Behavioral Sciences, James H. Quillen College of Medicine, East Tennessee State University. No additional external funding was received for this study.	Abbott A, 2011, NATURE, V475, pS2, DOI 10.1038/475S2a; Ahmed S, 2013, BRAIN, V136, P3727, DOI 10.1093/brain/awt269; Albert MS, 2011, ALZHEIMERS DEMENT, V7, P270, DOI 10.1016/j.jalz.2011.03.008; Andel R, 2003, INT J GERIATR PSYCH, V18, P733, DOI 10.1002/gps.913; Bandalos D.L., 2019, REVIEWERS GUIDE QUAN, P98, DOI [10.4324/9781315755649, DOI 10.4324/9781315755649, 10.4324/9781315755649-8.]; Benson J, 2018, CROSS CULTURAL ANXIE, P149; Bouman Z, 2016, J CLIN EXP NEUROPSYC, V38, P455, DOI 10.1080/13803395.2015.1123226; Damian AM, 2011, DEMENT GERIATR COGN, V31, P126, DOI 10.1159/000323867; Fan Jerome, 2006, CJEM, V8, P19; Fergadiotis G, 2016, APHASIOLOGY, V30, P364, DOI 10.1080/02687038.2015.1067288; Fraser KC, 2016, J ALZHEIMERS DIS, V49, P407, DOI 10.3233/JAD-150520; Geda YE, 2013, ALZHEIMERS DEMENT, V9, P602, DOI 10.1016/j.jalz.2012.12.001; Guruje O, 1995, West Afr J Med, V14, P29; Hajian-Tilaki K, 2013, CASP J INTERN MED, V4, P627; Handels RLH, 2014, ALZHEIMERS DEMENT, V10, P225, DOI 10.1016/j.jalz.2013.02.005; Hogarty KY, 2005, EDUC PSYCHOL MEAS, V65, P202, DOI 10.1177/0013164404267287; Jordan MI, 2015, SCIENCE, V349, P255, DOI 10.1126/science.aaa8415; Kaplan E, 2001, BOSTON NAMING TEST; Kim SY, 2014, UTILITY LIMITS MINI; Lee J. H., 2011, UK STAT US GROUP M 2, V23; Lehr M, 2012, 13TH ANNUAL CONFERENCE OF THE INTERNATIONAL SPEECH COMMUNICATION ASSOCIATION 2012 (INTERSPEECH 2012), VOLS 1-3, P1038; Madley-Dowd P, 2019, J CLIN EPIDEMIOL, V110, P63, DOI 10.1016/j.jclinepi.2019.02.016; Mathews M, 2013, INT PSYCHOGERIATR, V25, P1115, DOI 10.1017/S1041610213000367; Meyer D., 2019, R J; Mickes L, 2015, J APPL RES MEM COGN, V4, P93, DOI 10.1016/j.jarmac.2015.01.003; Mitchell AJ, 2009, J PSYCHIATR RES, V43, P411, DOI 10.1016/j.jpsychires.2008.04.014; Morris J C, 1997, Int Psychogeriatr, V9 Suppl 1, P173, DOI 10.1017/S1041610297004870; MORRIS JC, 1989, NEUROLOGY, V39, P1159, DOI 10.1212/wnl.43.12.2457; Orimaye S. O., 2015, ARXIV151102436; Orimaye S.O., 2014, P WORKSHOP COMPUTATI, P78; Orimaye SO, 2017, BMC BIOINFORMATICS, V18, DOI 10.1186/s12859-016-1456-0; Orimaye SO, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0205636; Osborne, 2015, PRACT ASSESS RES EVA, V20, P1, DOI DOI 10.7275/HB2G-M060; Pedersen AB, 2017, CLIN EPIDEMIOL, V9, P157, DOI 10.2147/CLEP.S129785; Pozueta A, 2011, BMC NEUROL, V11, DOI 10.1186/1471-2377-11-78; Prud'hommeaux E, 2015, COMPUTATIONAL LINGUI; Rezvan PH, 2015, BMC MED RES METHODOL, V15, DOI 10.1186/s12874-015-0022-1; Roark B, 2011, IEEE T AUDIO SPEECH, V19, P2081, DOI 10.1109/TASL.2011.2112351; Robin X, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-77; Rojas-Dominguez A, 2018, IEEE ACCESS, V6, P7164, DOI 10.1109/ACCESS.2017.2779794; Sterne JAC, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2393; Tavakol M, 2011, INT J MED EDUC, V2, P53, DOI 10.5116/ijme.4dfb.8dfd; Venneri A, 2016, PARADIGM SHIFT SEMAN; Warnes M.G.R., 2016, PACKAGEGPLOTSVARIOUS; Wechsler D., 1997, WECHSLER MEMORY SCAL, Vthird; Wolfsgruber S, 2014, AM J GERIAT PSYCHIAT, V22, P1017, DOI 10.1016/j.jagp.2012.08.021; Zou KH, 2007, CIRCULATION, V115, P654, DOI 10.1161/CIRCULATIONAHA.105.594929	48	4	5	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2020	15	3							e0229460	10.1371/journal.pone.0229460	http://dx.doi.org/10.1371/journal.pone.0229460			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LQ8RK	32134942	gold, Green Published			2022-12-26	WOS:000535265600024
J	Barthold, D; Joyce, G; Brinton, RD; Wharton, W; Kehoe, PG; Zissimopoulos, J				Barthold, Douglas; Joyce, Geoffrey; Brinton, Roberta Diaz; Wharton, Whitney; Kehoe, Patrick Gavin; Zissimopoulos, Julie			Association of combination statin and antihypertensive therapy with reduced Alzheimer's disease and related dementia risk	PLOS ONE			English	Article							MILD COGNITIVE IMPAIRMENT; RENIN-ANGIOTENSIN SYSTEM; CHOLESTEROL; BRAIN; METABOLISM; DECLINE; IMPACT; TRIALS; ACE	Background Hyperlipidemia and hypertension are modifiable risk factors for Alzheimer's disease and related dementias (ADRD). Approximately 25% of adults over age 65 use both antihypertensives (AHTs) and statins for these conditions. While a growing body of evidence found statins and AHTs are independently associated with lower ADRD risk, no evidence exists on simultaneous use for different drug class combinations and ADRD risk. Our primary objective was to compare ADRD risk associated with concurrent use of different combinations of statins and antihypertensives. Methods In a retrospective cohort study (2007-2014), we analyzed 694,672 Medicare beneficiaries in the United States (2,017,786 person-years) who concurrently used both statins and AHTs. Using logistic regression adjusting for age, socioeconomic status and comorbidities, we quantified incident ADRD diagnosis associated with concurrent use of different statin molecules (atorvastatin, pravastatin, rosuvastatin, and simvastatin) and AHT drug classes (two renin-angiotensin system (RAS)-acting AHTs, angiotensin converting enzyme inhibitors (ACEIs) or angiotensin-II receptor blockers (ARBs), vs non-RAS-acting AHTs). Findings Pravastatin or rosuvastatin combined with RAS-acting AHTs reduce risk of ADRD relative to any statin combined with non-RAS-acting AHTs: ACEI+pravastatin odds ratio (OR) = 0.942 (CI: 0.899-0.986, p = 0.011), ACEI+rosuvastatin OR = 0.841 (CI: 0.794-0.892, p< 0.001), ARB+pravastatin OR = 0.794 (CI: 0.748-0.843, p< 0.001), ARB+rosuvastatin OR = 0.818 (CI: 0.765-0.874, p< 0.001). ARBs combined with atorvastatin and simvastatin are associated with smaller reductions in risk, and ACEI with no risk reduction, compared to when combined with pravastatin or rosuvastatin. Among Hispanics, no combination of statins and RAS-acting AHTs reduces risk relative to combinations of statins and non-RAS-acting AHTs. Among blacks using ACEI+rosuvastatin, ADRD odds were 33% lower compared to blacks using other statins combined with non-RAS-acting AHTs (OR = 0.672 (CI: 0.5480.825, p<0.001)). Conclusion Among older Americans, use of pravastatin and rosuvastatin to treat hyperlipidemia is less common than use of simvastatin and atorvastatin, however, in combination with RAS-acting AHTs, particularly ARBs, they may be more effective at reducing risk of ADRD. The number of Americans with ADRD may be reduced with drug treatments for vascular health that also confer effects on ADRD.	[Barthold, Douglas] Univ Washington, Dept Pharm, Comparat Hlth Outcomes Policy & Econ CHOICE Inst, Seattle, WA 98195 USA; [Joyce, Geoffrey] Univ Southern Calif, Schaeffer Ctr Hlth Policy & Econ, Sch Pharm, Los Angeles, CA 90007 USA; [Brinton, Roberta Diaz] Univ Arizona Hlth Sci, Ctr Innovat Brain Sci, Tucson, AZ USA; [Wharton, Whitney] Emory Univ, Sch Nursing, Atlanta, GA 30322 USA; [Wharton, Whitney] Emory Univ, Sch Med, Dept Neurol, Atlanta, GA 30322 USA; [Kehoe, Patrick Gavin] Univ Bristol, Bristol Med Sch, Translat Hlth Sci, Bristol, Avon, England; [Zissimopoulos, Julie] Univ Southern Calif, Price Sch Publ Policy, Schaeffer Ctr Hlth Policy & Econ, Los Angeles, CA 90007 USA	University of Washington; University of Washington Seattle; University of Southern California; University of Arizona; University of Arizona Health Sciences; Emory University; Emory University; University of Bristol; University of Southern California	Barthold, D (corresponding author), Univ Washington, Dept Pharm, Comparat Hlth Outcomes Policy & Econ CHOICE Inst, Seattle, WA 98195 USA.	barthold@uw.edu	; Kehoe, Patrick/P-8760-2018	Brinton, Roberta/0000-0001-8450-772X; Kehoe, Patrick/0000-0002-7542-1139	National Institutes of Health (NIH) [R01AG055401, P30AG043073, K01AG042498, P01AG026572, R01HL126804, R01HL130462]; University of Southern California Zumberge Research Fund [1R34AG049652]; Schaeffer-Amgen Fellowship Program - Amgen; Sigmund Gestetner Foundation; NIHR-EME; Alzheimer's Society; Alzheimer's Research UK; BRACE; Medical Research Council; British Heart Foundation; MRC [MC_PC_13088] Funding Source: UKRI	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Southern California Zumberge Research Fund; Schaeffer-Amgen Fellowship Program - Amgen(Amgen); Sigmund Gestetner Foundation; NIHR-EME; Alzheimer's Society; Alzheimer's Research UK(Alzheimer's Research UK (ARUK)); BRACE; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This research was supported by National Institutes of Health (NIH), awards R01AG055401, P30AG043073, K01AG042498, P01AG026572, R01HL126804, and R01HL130462, and the University of Southern California Zumberge Research Fund, 1R34AG049652. Douglas Barthold was supported through the Schaeffer-Amgen Fellowship Program funded by Amgen. Patrick Kehoe was supported by a Fellowship from the Sigmund Gestetner Foundation, and NIHR-EME, Alzheimer's Society, Alzheimer's Research UK, BRACE, the Medical Research Council, and the British Heart Foundation. Sponsors' role: The sponsors had no role in the design, methods, analysis, interpretation, or preparation of the paper.	Aitken M., 2016, MED USE SPENDING US; ALZGENE, 2019, CHROM 10 LOC PUBL AD; Benedet AL, 2018, NEUROL-GENET, V4, DOI 10.1212/NXG.0000000000000216; Berthold D, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0206705; Bonito AJ, 2008, CREATION NEW RACE ET; Chen Cynthia, 2018, Alzheimers Dement (N Y), V4, P510, DOI 10.1016/j.trci.2018.08.009; Chong PH, 2001, AM J MED, V111, P390, DOI 10.1016/S0002-9343(01)00870-1; Deane R, 2009, CNS NEUROL DISORD-DR, V8, P16, DOI 10.2174/187152709787601867; Evans C.E., 2018, ALZHEIMERS DEMENT, V14, pP1659; Ferdinand KC, 2006, AM J CARDIOL, V97, P229, DOI 10.1016/j.amjcard.2005.08.026; Flockhart D.A., 2007, DRUG INTERACTIONS CY; Geifman N, 2018, ALZHEIMERS RES THER, V10, DOI 10.1186/s13195-017-0332-0; Geifman N, 2017, ALZHEIMERS RES THER, V9, DOI 10.1186/s13195-017-0237-y; Haag MDM, 2009, J NEUROL NEUROSUR PS, V80, P13, DOI 10.1136/jnnp.2008.150433; Hajar I, 2013, J AM GERIATR SOC, V61, P194, DOI 10.1111/jgs.12100; Hajjar I, 2012, ARCH NEUROL-CHICAGO, V69, P1632, DOI 10.1001/archneurol.2012.1010; Jacobsen W, 1999, DRUG METAB DISPOS, V27, P173; Jick H, 2000, LANCET, V356, P1627, DOI 10.1016/S0140-6736(00)03155-X; Kandiah N, 2009, J NEUROL SCI, V283, P230, DOI 10.1016/j.jns.2009.02.352; Kehoe PG, 2007, LANCET NEUROL, V6, P373, DOI 10.1016/S1474-4422(07)70077-7; Kehoe PG, 2009, TRENDS NEUROSCI, V32, P619, DOI 10.1016/j.tins.2009.07.006; Kehoe PG, 2018, J ALZHEIMERS DIS, V62, P1443, DOI 10.3233/JAD-171119; Kehoe PG, 2016, ALZHEIMERS RES THER, V8, DOI 10.1186/s13195-016-0217-7; Lesser GT, 2011, CURR ALZHEIMER RES, V8, P303; Li G, 2007, NEUROLOGY, V69, P878, DOI 10.1212/01.wnl.0000277657.95487.1c; Li G, 2017, NEUROLOGY, V89, P1251, DOI 10.1212/WNL.0000000000004392; Li G, 2010, J AM GERIATR SOC, V58, P1311, DOI 10.1111/j.1532-5415.2010.02906.x; Li NC, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.b5465; Li P., 2010, BMC HEALTH SERV RES, V10, P1, DOI DOI 10.1186/1472-6963-10-245; LIN FC, 2015, MEDICINE, V94, DOI DOI 10.1097/MD; Livingston G, 2017, LANCET, V390, P2673, DOI 10.1016/S0140-6736(17)31363-6; Long D., 2018, GLOBAL GENERIC BIOSI; Lourida I., 2019, JAMA; Luvai A, 2012, CLIN MED INSIGHTS-CA, V6, P17, DOI 10.4137/CMC.S4324; Marpillat NL, 2013, J HYPERTENS, V31, P1073, DOI 10.1097/HJH.0b013e3283603f53; McGraw J, 2012, EXPERT OPIN DRUG MET, V8, P371, DOI 10.1517/17425255.2012.657626; Miners JS, 2008, NEUROPATH APPL NEURO, V34, P181, DOI 10.1111/j.1365-2990.2007.00885.x; Miners JS, 2011, J NEUROPATH EXP NEUR, V70, P944, DOI 10.1097/NEN.0b013e3182345e46; Miners S, 2009, AM J TRANSL RES, V1, P163; Nasrallah IM, 2019, JAMA-J AM MED ASSOC, V322, P524, DOI 10.1001/jama.2019.10551; Neuman P, 2018, NEW ENGL J MED, V379, P2163, DOI 10.1056/NEJMhpr1804089; Petanceska SS, 2002, J MOL NEUROSCI, V19, P155, DOI 10.1007/s12031-002-0026-2; Peters R, 2008, LANCET NEUROL, V7, P683, DOI 10.1016/S1474-4422(08)70143-1; Redelmeier D.A., 2019, JAMA NEUROLOGY; Reed B, 2014, JAMA NEUROL, V71, P195, DOI 10.1001/jamaneurol.2013.5390; Refolo LM, 2001, NEUROBIOL DIS, V8, P890, DOI 10.1006/nbdi.2001.0422; Richardson K, 2013, ANN INTERN MED, V159, P688, DOI 10.7326/0003-4819-159-10-201311190-00007; Rouch L, 2015, CNS DRUGS, V29, P113, DOI 10.1007/s40263-015-0230-6; Schultz BG, 2018, TRANSL NEURODEGENER, V7, DOI 10.1186/s40035-018-0110-3; Shepardson NE, 2011, ARCH NEUROL-CHICAGO, V68, P1385, DOI 10.1001/archneurol.2011.242; van Charante EPM, 2016, LANCET, V388, P797, DOI 10.1016/S0140-6736(16)30950-3; Vaughan CJ, 2004, CIRCULATION, V110, P886, DOI 10.1161/01.CIR.0000139312.10076.BA; Wang D, 2011, PHARMACOGENOMICS J, V11, P274, DOI 10.1038/tpj.2010.28; Wharton W., 2019, J ALZHEIMERS DIS, P1; Wharton W, 2015, J AM GERIATR SOC, V63, P1749, DOI 10.1111/jgs.13627; White CM, 2002, J CLIN PHARMACOL, V42, P963; Wolozin B, 2007, BMC MED, V5, DOI 10.1186/1741-7015-5-20; World Health Organization, 2019, RISK RED COGN DECL D, DOI [10.1177/1471301217699675, DOI 10.1177/1471301217699675]; Xu JS, 2016, BBA-MOL BASIS DIS, V1862, P1084, DOI 10.1016/j.bbadis.2016.03.001; Zissimopoulos Julie, 2014, Forum Health Econ Policy, V18, P25; Zissimopoulos JM, 2018, J GERONTOL B-PSYCHOL, V73, pS38, DOI 10.1093/geronb/gbx147; Zissimopoulos JM, 2017, JAMA NEUROL, V74, P225, DOI [10.1001/jamaneurol.2016.3783, 10.1001/ja]	62	22	22	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2020	15	3							e0229541	10.1371/journal.pone.0229541	http://dx.doi.org/10.1371/journal.pone.0229541			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LQ8QU	32130251	Green Published, gold			2022-12-26	WOS:000535264000030
J	Power, J; Dowsett, GW; Westle, A; Tucker, JD; Hill, S; Sugarman, J; Lewin, SR; Brown, G; Lucke, J				Power, Jennifer; Dowsett, Gary W.; Westle, Andrew; Tucker, Joseph D.; Hill, Sophie; Sugarman, Jeremy; Lewin, Sharon R.; Brown, Graham; Lucke, Jayne			The significance and expectations of HIV cure research among people living with HIV in Australia	PLOS ONE			English	Article							QUALITY-OF-LIFE; PERCEPTIONS; PREVENTION; STIGMA	Most people living with HIV (PLHIV) with reliable access to antiretroviral treatment (ART) have a life expectancy similar to uninfected populations. Despite this, HIV can negatively affect their social and psychological wellbeing. This study aimed to enhance understanding of the expectations PLHIV hold for HIV cure research and the implications this has for HIV cure research trials. We interviewed 20 Australian PLHIV about their expectations for HIV cure research outcomes and the impact a potential cure for HIV may have on their everyday lives. Data were analysed thematically, using both inductive and deductive approaches. The significance of a cure for HIV was expressed by participants as something that would offer relief from their sense of vigilance or uncertainty about their health into the future. A cure was also defined in social terms, as alleviation from worry about potential for onward HIV transmission, concerns for friends and family, and the negative impact of HIV-related stigma. Participants did not consider sustained medication-free viral suppression (or remission) as a cure for HIV because this did not offer certainty in remaining virus free in a way that would alleviate these fears and concerns. A cure was seen as complete elimination of HIV from the body. There is an ethical need to consider the expectations of PLHIV in design of, and recruitment for, HIV cure-related research. The language used to describe HIV cure research should differentiate the long-term aspiration of achieving complete elimination of HIV from the body and possible shorter-term therapeutic advances, such as achieving medication free viral suppression.	[Power, Jennifer; Dowsett, Gary W.; Westle, Andrew; Brown, Graham; Lucke, Jayne] La Trobe Univ, Australian Res Ctr Sex Hlth & Soc, Melbourne, Vic, Australia; [Dowsett, Gary W.; Brown, Graham] UNSW Australia, Ctr Social Res Hlth, Sydney, NSW, Australia; [Tucker, Joseph D.] Univ North Carolina Chapel Hill, Inst Global Hlth & Infect Dis, Chapel Hill, NC USA; [Tucker, Joseph D.] London Sch Hyg & Trop Med, Fac Infect & Trop Dis, London, England; [Hill, Sophie] La Trobe Univ, Ctr Hlth Commun & Participat, Sch Psychol & Publ Hlth, Melbourne, Vic, Australia; [Sugarman, Jeremy] Johns Hopkins Univ, Berman Inst Bioeth, Baltimore, MD USA; [Sugarman, Jeremy] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA; [Lewin, Sharon R.] Univ Melbourne, Peter Doherty Inst Infect & Immun, Melbourne, Vic, Australia; [Lewin, Sharon R.] Royal Melbourne Hosp, Melbourne, Vic, Australia; [Lewin, Sharon R.] Alfred Hlth, Dept Infect Dis, Melbourne, Vic, Australia; [Lewin, Sharon R.] Monash Univ, Melbourne, Vic, Australia; [Lucke, Jayne] Univ Queensland, Sch Publ Hlth, Brisbane, Qld, Australia	La Trobe University; University of New South Wales Sydney; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of London; London School of Hygiene & Tropical Medicine; La Trobe University; Johns Hopkins University; Johns Hopkins University; University of Melbourne; Royal Melbourne Hospital; Monash University; University of Queensland	Power, J (corresponding author), La Trobe Univ, Australian Res Ctr Sex Hlth & Soc, Melbourne, Vic, Australia.	jennifer.power@latrobe.edu.au		Power, Jennifer/0000-0002-6566-3214; Tucker, Joseph/0000-0003-2804-1181; Lewin, Sharon Ruth/0000-0002-0330-8241; Sugarman, Jeremy/0000-0001-7022-8332	Building Healthy Communities, Research Focus Area Grant, La Trobe University; Australian Federation of AIDS Organisations; National Association of People with HIV Australia	Building Healthy Communities, Research Focus Area Grant, La Trobe University; Australian Federation of AIDS Organisations; National Association of People with HIV Australia	Dowsett, G, Lucke, J, Power, J, Wallace, J, Ellard, J, Richmond, J, Lewin, S, Hill, S, Tucker, J, Slavin, S and Cogle, A. 'An HIV Cure: ethical and social consequences of cure-focused research', Building Healthy Communities, Research Focus Area Grant, La Trobe University ($29,730); We are grateful to all people living with HIV who took time to participate in this study. This project was endorsed and supported by the Australian Federation of AIDS Organisations and the National Association of People with HIV Australia. This paper was produced with assistance from Henry von Doussa. Other collaborators on the project were Jack Wallace, Jacquie Richmond and Sean Slavin.	Aldiabat KM, 2018, QUAL REP, V23, P245; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [DOI 10.1191/1478088706QP063OA, 10.1191/1478088706qp063oa]; Brett J, 2014, PATIENT, V7, P387, DOI 10.1007/s40271-014-0065-0; Brown G, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-5433-6; Brown G, 2017, SEX HEALTH, V14, P111, DOI 10.1071/SH16052; Burt RS, 2005, BROKERAGE CLOSURE IN; Charmaz K., 2012, SAGE HDB INTERVIEW R, P347, DOI [10.4135/, 10.4135/9781452218403.n25]; Chu CE, 2015, AIDS RES HUM RETROV, V31, P78, DOI [10.1089/aid.2014.0200, 10.1089/AID.2014.0200]; Cohen MS, 2016, NEW ENGL J MED, V375, P830, DOI [10.1056/NEJMoa1600693, 10.1056/NEJMoa1105243]; Deeks SG, 2016, NAT MED, V22, P839, DOI 10.1038/nm.4108; Deeks SG, 2013, LANCET, V382, P1525, DOI 10.1016/S0140-6736(13)61809-7; Dube K, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-5141-2; Dube K, 2018, AIDS RES HUM RETROV, V34, P67, DOI [10.1089/aid.2017.0067, 10.1089/AID.2017.0067]; Dube K, 2017, J VIRUS ERAD, V3, P40; Dube K, 2015, J VIRUS ERAD, V1, P250; Dube K, 2014, TRENDS MICROBIOL, V22, P547, DOI 10.1016/j.tim.2014.08.003; Eisinger RW, 2019, JAMA-J AM MED ASSOC, V321, P451, DOI 10.1001/jama.2018.21167; Elliott JH, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004473; Epstein Steven., 1996, IMPURE SCI; Garner SA, 2017, J VIRUS ERAD, V3, P82; Henderson GE, 2017, J MED ETHICS; Holton JA, 2010, GROUNDED THEORY REV, V9, P21; Hsieh HF, 2005, QUAL HEALTH RES, V15, P1277, DOI 10.1177/1049732305276687; Jenkins N, 2010, QUAL RES, V10, P175, DOI 10.1177/1468794109356737; Joint United Nations Programme on HIV/ AIDS (UNAIDS), 2016, GLOB AIDS UPD 2016; Julg B, 2019, LANCET HIV, V6, pE259, DOI 10.1016/S2352-3018(19)30052-9; Kirby Institute, 2017, VIR HEP MAPP PROJ NA; Lazarus JV, 2016, BMC MED, V14, DOI 10.1186/s12916-016-0640-4; Lelievre J-D, 2019, J INFECT DIS; Lewin SR, 2011, J INT AIDS SOC, V14, DOI 10.1186/1758-2652-14-4; McIntosh MJ, 2015, GLOB QUALIT NURS RES, V2, DOI 10.1177/2333393615597674; McMahon JH, 2015, AIDS, V29, P248, DOI 10.1097/QAD.0000000000000534; Park CL, 2013, PSYCHO-ONCOLOGY, V22, P1630, DOI 10.1002/pon.3195; Power J, 2016, HIV AUSTR, V14, P32; Power J, 2011, MOVEMENT KNOWLEDGE E; Power J, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0202647; Rennie S, 2015, BMC MED ETHICS, V16, DOI 10.1186/s12910-015-0013-0; Simmons R, 2017, HIV MED, V18, P73, DOI 10.1111/hiv.12391; Spinner CD, 2016, INFECTION, V44, P151, DOI 10.1007/s15010-015-0850-2; Sugarman J, 2013, ANN INTERN MED, V159, P490, DOI 10.7326/00030003-4819-159-7-201310010-00694; Sylla L, 2018, AIDS RES HUM RETROV, V34, P56, DOI [10.1089/aid.2017.0178, 10.1089/AID.2017.0178]; Tucker J, 2014, J AQUIR IMMUNE DEFIC, V67; Turan B, 2017, AM J PUBLIC HEALTH, V107, P863, DOI 10.2105/AJPH.2017.303744; Ugarte A, 2019, J INFECT DIS; Verdult F., 2012, EUR COMM SURV HIV CU; Vincent W, 2017, J BEHAV MED, V40, P434, DOI 10.1007/s10865-016-9812-0; Wu F, 2018, ARCH SEX BEHAV, V47, P2061, DOI 10.1007/s10508-017-1062-x; Young I, 2016, SOCIOL HEALTH ILL, V38, P411, DOI 10.1111/1467-9566.12372	48	14	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2020	15	3							e0229733	10.1371/journal.pone.0229733	http://dx.doi.org/10.1371/journal.pone.0229733			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LQ8QU	32130262	Green Published, gold			2022-12-26	WOS:000535264000048
J	Wang, Y; Cheng, P; Jiao, BY; Song, X; Wang, HY; Wang, HF; Wang, HW; Huang, XD; Liu, HM; Gong, MQ				Wang, Yang; Cheng, Peng; Jiao, Boyan; Song, Xiao; Wang, Haiyang; Wang, Haifang; Wang, Huaiwei; Huang, Xiaodan; Liu, Hongmei; Gong, Maoqing			Investigation of mosquito larval habitats and insecticide resistance in an area with a high incidence of mosquito-borne diseases in Jining, Shandong Province	PLOS ONE			English	Article							WEST NILE VIRUS; DIPTERA-CULICIDAE; HUMAN MOVEMENT; INFECTION; VECTOR; TRANSMISSION; PREVALENCE; XINJIANG; CHINA	Background To investigate mosquito larval habitats and resistance to common insecticides in areas with high incidence rates of mosquito-borne diseases in Jining, Shandong Province, and to provide a scientific basis for the future prevention and control of mosquito-borne diseases and the rational use of insecticides. Methods and results From June to September 2018, mosquito habitat characteristics and species compositions in Jintun town were studied through a cross-sectional survey. Larvae and pupae were collected in different habitats using the standard dipping technique. A total of 7,815 mosquitoes, comprising 7 species from 4 genera, were collected. Among them, Culex pipiens pallens (n = 5,336, 68.28%) was the local dominant species and found in all four habitats (rice paddies, irrigation channels, water containers, drainage ditches). There were 1,708 Cx. tritaeniorhynchus (21.85%), 399 Anopheles sinensis (5.11%), 213 Armigeres subalbatus (2.72%), 124 Aedes albopictus (1.59%), and 35 other (Cx. bitaeniorhynchus and Cx. halifaxii) (0.45%) mosquito samples collected. Spearman correlation analysis was employed to evaluate the relationship between larval density and the physicochemical characteristics of the breeding habitat. It was found that the larval density of Cx. tritaeniorhynchus correlated positively with water depth (r = 0.927 p = 0.003), the larval density of An. sinensis correlated positively with dissolved oxygen (DO) (r = 0.775 p = 0.041) and the larval density of Cx. p. pallens correlated positively with ammonia nitrogen (r = 0.527 p = 0.002). Resistance bioassays were carried out on the dominant populations of Cx. p. pallens: mosquitoes presented very high resistance to cypermethrin and deltamethrin, moderate resistance to dichlorvos (DDVP), and low resistance to Bacillus thuringiensis israelensis (Bti), with decreased susceptibility to propoxur. Conclusion We showed that mosquito species vary across habitat type and that the mosquito larval density correlated positively with certain physicochemical characteristics in different habitats. In addition, Cx. p. pallens developed different levels of resistance to five insecticides. Vector monitoring should be strengthened after an epidemic, and further research should be conducted to scientifically prevent and kill mosquitoes.	[Wang, Yang; Cheng, Peng; Song, Xiao; Wang, Haiyang; Wang, Haifang; Wang, Huaiwei; Huang, Xiaodan; Liu, Hongmei; Gong, Maoqing] Shandong First Med Univ & Shandong Acad Med Sci, Shandong Inst Parasit Dis, Jining, Shandong, Peoples R China; [Wang, Yang; Song, Xiao; Wang, Haiyang] Univ Jinan, Sch Med & Life Sci, Shandong Acad Med Sci, Jinan, Shandong, Peoples R China; [Jiao, Boyan] Jining Ctr Dis Control & Prevent, Jining, Shandong, Peoples R China	Shandong First Medical University & Shandong Academy of Medical Sciences; Shandong First Medical University & Shandong Academy of Medical Sciences; University of Jinan	Liu, HM; Gong, MQ (corresponding author), Shandong First Med Univ & Shandong Acad Med Sci, Shandong Inst Parasit Dis, Jining, Shandong, Peoples R China.	liuhmm163@163.com; mqgong@sdfmu.edu.cn			National Natural Science Foundation of China [81702034, 81672059, 81871685]; Innovation Project of Shandong Academy of Medical Sciences; China Postdoctoral Science Foundation [2017M622733]; Key Research and Development Projects in Shandong Province [2018GSF118040]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Innovation Project of Shandong Academy of Medical Sciences; China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Key Research and Development Projects in Shandong Province	This work was supported by grants from the National Natural Science Foundation of China [(81702034 (HML), 81672059 (MQG), 81871685 (MQG)], the Innovation Project of Shandong Academy of Medical Sciences (MQG), China Postdoctoral Science Foundation funded project [(2017M622733 (HML)], Key Research and Development Projects in Shandong Province [2018GSF118040 (MQG)]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006763; AhbiRami R, 2014, J INSECT SCI, V14, DOI 10.1093/jisesa/ieu042; Alout H, 2016, SCI REP-UK, V6, DOI 10.1038/srep29755; Amerasinghe F.P., 1996, Ceylon Journal of Science Biological Sciences, V24, P13; [Anonymous], 2012, Wkly Epidemiol Rec, V87, P345; Arifin SMN, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-290; Bashar K, 2016, PATHOG GLOB HEALTH, V110, P48, DOI 10.1080/20477724.2016.1179862; Das MK, 2018, J VECTOR DIS, V55, P34, DOI 10.4103/0972-9062.234624; DEALWIS RE, 1971, B WORLD HEALTH ORGAN, V45, P853; Deng X, 2002, J PATHOG BIOL, V15, P82; Fillinger U, 2009, B WORLD HEALTH ORGAN, V87, P655, DOI 10.2471/BLT.08.055632; Geissbuhler Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005107; Gopalakrishnan R, 2013, J VECTOR DIS, V50, P215; Grillet ME, 2000, J MED ENTOMOL, V37, P231, DOI 10.1603/0022-2585-37.2.231; Gu WD, 2006, P NATL ACAD SCI USA, V103, P17560, DOI 10.1073/pnas.0608452103; Gu WD, 2009, T ROY SOC TROP MED H, V103, P1105, DOI 10.1016/j.trstmh.2009.01.006; Gui JianJun, 2008, Zhongguo Bingyuan Shengwuxue Zazhi / Journal of Pathogen Biology, V3, P638; Guo Yun-hai, 2016, Zhongguo Xuexichongbing Fangzhi Zazhi, V28, P258, DOI 10.16250/j.32.1374.2016096; Hancock PA, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-98; Jiang HongTao, 2005, China Tropical Medicine, V5, P17; Jiang SF, 2014, J VECTOR ECOL, V39, P78, DOI 10.1111/j.1948-7134.2014.12073.x; Kawada H, 2012, NEW MOSQUITO CONTROL, P658; KEIDING J, 1976, PESTIC SCI, V7, P283, DOI 10.1002/ps.2780070313; Kou Jing-xuan, 2015, Zhongguo Meijieshengwuxue Ji Kongzhi Zazhi, V26, P279; Kristan M, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1384-x; Lai TC, 2011, PESTIC BIOCHEM PHYS, V101, P198, DOI 10.1016/j.pestbp.2011.09.006; Li XL, 2013, VECTOR-BORNE ZOONOT, V13, P131, DOI 10.1089/vbz.2012.0995; Li YJ, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003301; Lin XiaoJuan, 2013, Modern Preventive Medicine, V40, P2389; Liu BY, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15091848; Liu Hong-Mei, 2015, Int J Insect Sci, V7, P47, DOI 10.4137/IJIS.S24232; Liu HM, 2019, PARASITE VECTOR, V12, DOI 10.1186/s13071-019-3416-9; Liu Qi-yong, 2011, Zhongguo Meijieshengwuxue Ji Kongzhi Zazhi, V22, P201; Liu XB, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-58; Lu BL., 1997, FAUNA SINICA INSECTA; Lu Z, 2014, EMERG INFECT DIS, V20, P1421, DOI 10.3201/eid2008.131433; Marshall JM, 2016, TRENDS PARASITOL, V32, P752, DOI 10.1016/j.pt.2016.07.004; McCann RS, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2749-2; Meng Feng-xia, 2011, Zhongguo Meijieshengwuxue Ji Kongzhi Zazhi, V22, P517; Miller RH, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001678; Norris DE, 2004, ECOHEALTH, V1, P19, DOI DOI 10.1007/S10393-004-0008-7; Odero Joel, 2018, Wellcome Open Res, V3, P26, DOI 10.12688/wellcomeopenres.14193.1; Ohba S, 2015, ACTA TROP, V142, P89, DOI 10.1016/j.actatropica.2014.11.002; OMORI N, 1962, B WORLD HEALTH ORGAN, V27, P585; Paaijmans K, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0217860; Petric D, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-187; Rajavel A. R., 1992, Southeast Asian Journal of Tropical Medicine and Public Health, V23, P470; Rao BB, 2011, SE ASIAN J TROP MED, V42, P1077; Rozendaal JA, 1997, VECTOR CONTROL METHO, P411; Scott JG, 2015, PESTIC BIOCHEM PHYS, V120, P68, DOI 10.1016/j.pestbp.2014.12.018; Shi QQ, 2019, VECTOR-BORNE ZOONOT, V19, P640, DOI 10.1089/vbz.2018.2416; Siegert PY, 2009, J ECON ENTOMOL, V102, P2061, DOI 10.1603/029.102.0607; Sinka ME, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-89; Song Xiao, 2019, Zhonghua Weisheng Shachong Yaoxie, V25, P13, DOI 10.19821/j.1671-2781.2019.01.004; Tusting LS, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008923.pub2; Umar A., 2008, INT J PURE APPL SCI, V2, P58; van den Berg H, 2018, MALARIA J, V17, DOI 10.1186/s12936-018-2415-1; Vazquez-Prokopec GM, 2010, ENVIRON HEALTH PERSP, V118, P1382, DOI 10.1289/ehp.1001939; Viana M, 2016, P NATL ACAD SCI USA, V113, P8975, DOI 10.1073/pnas.1603431113; Wang HaiFang, 2009, China Tropical Medicine, V9, P1199; WHO, 1980, VBCEC807 WHO; WHO, 2005, GUID LAB FELD TEST M; Worrall E, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-338; Yibin Z., 2003, MODERN AGROCHEMICALS, V2, P9; Zhang Xi-Zeng, 1992, Chinese Journal of Parasitology & Parasitic Diseases, V10, P48	65	5	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2020	15	3							e0229764	10.1371/journal.pone.0229764	http://dx.doi.org/10.1371/journal.pone.0229764			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8QU	32130263	Green Published, gold			2022-12-26	WOS:000535264000050
J	Lacchini, E; Kiegle, E; Castellani, M; Adam, H; Jouannic, S; Gregis, V; Kater, MM				Lacchini, Elia; Kiegle, Edward; Castellani, Marco; Adam, Helene; Jouannic, Stefan; Gregis, Veronica; Kater, Martin M.			CRISPR-mediated accelerated domestication of African rice landraces	PLOS ONE			English	Article							ORYZA-GLABERRIMA; GENOMIC DNA; GRAIN WIDTH; DIVERSITY; SATIVA; IMPROVEMENT; ENCODES; HISTORY; WEIGHT; BASE	African Oryza glaberrima and Oryza sativa landraces are considered valuable resources for breeding traits due to their adaptation to local environmental and soil conditions. They often possess superior resistance to endemic pests and tolerance to drought and nutrient deficiencies when compared to the "imported" high production Asian rice varieties. In contrast, "domestication traits" such as seed shattering, lodging, and seed yield are not well established in these African landraces. Therefore, the use of these African varieties for high production agriculture is limited by unpredictable yield and grain quality. We are addressing this shortcoming by developing protocols for genetically transforming African landraces to allow the use of CRISPR-Cas mediated breeding approaches. Here we use as proof of concept the cultivated African landrace Kabre to target selected known "domestication loci" and improve the agronomic potential of Kabre rice. Stable genetic transformation with CRISPR-Cas9-based vectors generated single and simultaneous multiple gene knockouts. Plants with reduced stature to diminish lodging were generated by disrupting the HTD1 gene. Furthermore, three loci shown to control seed size and/or yield (GS3, GW2 and GN1A) were targeted using a multiplex CRISPR-Cas9 construct. This resulted in mutants with significantly improved seed yield. Our study provides an example of how new breeding technologies can accelerate the development of highly productive African landrace rice varieties, an important advancement considering that Africa is a hotspot for worldwide population growth and therefore prone to food shortage.	[Lacchini, Elia; Kiegle, Edward; Castellani, Marco; Gregis, Veronica; Kater, Martin M.] Univ Milan, Dept Biosci, Milan, Italy; [Adam, Helene; Jouannic, Stefan] Univ Montpellier, DIADE, IRD, Montpellier, France; [Lacchini, Elia] VIB Ctr Plant Syst Biol, Technol Pk, Ghent, Belgium; [Kiegle, Edward] Vital Vio, Troy, NY USA	University of Milan; Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; Flanders Institute for Biotechnology (VIB); Ghent University	Kater, MM (corresponding author), Univ Milan, Dept Biosci, Milan, Italy.	martin.kater@unimi.it	adam, helene/GLU-1655-2022; gregis, veronica/B-7902-2017; Kater, Martin/M-9381-2017	gregis, veronica/0000-0003-1876-9849; Lacchini, Elia/0000-0002-1598-8950; Kater, Martin/0000-0003-1155-2575	Agropolis Foundation ("Investissements d'avenir" programme) [ANR-10-LABX-0001-01]; Fondazione Cariplo [EVOREPRICE 1201-004]; Doctorate School in Molecular and Cellular Biology, University of Milan	Agropolis Foundation ("Investissements d'avenir" programme)(French National Research Agency (ANR)); Fondazione Cariplo(Fondazione Cariplo); Doctorate School in Molecular and Cellular Biology, University of Milan	SJ and MMK joined funding by Agropolis Foundation ("Investissements d'avenir" programme (ANR-10-LABX-0001-01)) and Fondazione Cariplo under the reference ID EVOREPRICE 1201-004. EL PhD fellowship: Doctorate School in Molecular and Cellular Biology, University of Milan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agnoun Y., 2012, International Journal of Biology, V4, P158; Ashikari M, 2005, SCIENCE, V309, P741, DOI 10.1126/science.1113373; Bortesi L, 2015, BIOTECHNOL ADV, V33, P41, DOI 10.1016/j.biotechadv.2014.12.006; Chen CJ, 2017, ELECTRON J BIOTECHN, V30, P48, DOI 10.1016/j.ejbt.2017.08.001; Cubry P, 2018, CURR BIOL, V28, P2274, DOI 10.1016/j.cub.2018.05.066; Fan CH, 2006, THEOR APPL GENET, V112, P1164, DOI 10.1007/s00122-006-0218-1; Gaudelli NM, 2017, NATURE, V551, P464, DOI 10.1038/nature24644; Goff SA, 2002, SCIENCE, V296, P92, DOI 10.1126/science.1068275; Guyot R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017726; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Khush GS, 1997, PLANT MOL BIOL, V35, P25, DOI 10.1023/A:1005810616885; Klauer AA, 2012, WIRES RNA, V3, P649, DOI 10.1002/wrna.1124; Komor AC, 2016, NATURE, V533, P420, DOI 10.1038/nature17946; LI XQ, 1992, PLANT MOL BIOL, V20, P1037, DOI 10.1007/BF00028891; Linares OF, 2002, P NATL ACAD SCI USA, V99, P16360, DOI 10.1073/pnas.252604599; Londo JP, 2006, P NATL ACAD SCI USA, V103, P9578, DOI 10.1073/pnas.0603152103; Miao J, 2013, CELL RES, V23, P1233, DOI 10.1038/cr.2013.123; Sanni KA, 2008, EUPHYTICA, V160, P389, DOI 10.1007/s10681-007-9549-5; Sarla N, 2005, CURR SCI INDIA, V89, P955; Song XJ, 2007, NAT GENET, V39, P623, DOI 10.1038/ng2014; Sweeney M, 2007, ANN BOT-LONDON, V100, P951, DOI 10.1093/aob/mcm128; Takeda S, 2008, NAT REV GENET, V9, P444, DOI 10.1038/nrg2342; Tanabata T, 2012, PLANT PHYSIOL, V160, P1871, DOI 10.1104/pp.112.205120; Toki S, 1997, PLANT MOL BIOL REP, V15, P16, DOI 10.1007/BF02772109; Van Andel T, 2010, ECON BOT, V64, P1, DOI 10.1007/s12231-010-9111-6; Vaughan DA, 2003, CURR OPIN PLANT BIOL, V6, P139, DOI 10.1016/S1369-5266(03)00009-8; Wu YZ, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06509-2; Xie KB, 2015, P NATL ACAD SCI USA, V112, P3570, DOI 10.1073/pnas.1420294112; Zhou JP, 2019, PLANT CELL REP, V38, P475, DOI 10.1007/s00299-018-2340-3; Zou JH, 2006, PLANT J, V48, P687, DOI 10.1111/j.1365-313X.2006.02916.x	30	24	25	4	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2020	15	3							e0229782	10.1371/journal.pone.0229782	http://dx.doi.org/10.1371/journal.pone.0229782			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8MS	32126126	Green Submitted, Green Published, gold			2022-12-26	WOS:000535253100050
J	Yang, W; Cai, LL; Wu, F				Yang, Wei; Cai, Lulu; Wu, Fei			Image segmentation based on gray level and local relative entropy two dimensional histogram	PLOS ONE			English	Article								Though traditional thresholding methods are simple and efficient, they may result in poor segmentation results because only image's brightness information is taken into account in the procedure of threshold selection. Considering the contextual information between pixels can improve segmentation accuracy. To to this, a new thresholding method is proposed in this paper. The proposed method constructs a new two dimensional histogram using brightness of a pixel and local relative entropy of it's neighbor pixels. The local relative entropy (LRE) measures the brightness difference between a pixel and it's neighbor pixels. The two dimensional histogram, consisting of gray level and LRE, can reflect the contextual information between pixels to a certain extent. The optimal thresholding vector is obtained via minimizing cross entropy criteria. Experimental results show that the proposed method can achieve more accurate segmentation results than other thresholding methods.	[Yang, Wei] State GRID Quzhou Power Supply Co, 6 Xinhe Rd, Quzhou 324000, Zhejiang, Peoples R China; [Cai, Lulu; Wu, Fei] Quzhou Univ, Coll Elect & Informat Engn, Quzhou 324000, Zhejiang, Peoples R China	Quzhou University	Wu, F (corresponding author), Quzhou Univ, Coll Elect & Informat Engn, Quzhou 324000, Zhejiang, Peoples R China.	wufei_qzu@126.com			Public Welfare Project of Zhejiang Province of China [LGG19F050003]	Public Welfare Project of Zhejiang Province of China	This work was sponsored in part by Public Welfare Project of Zhejiang Province of China (LGG19F050003) to LC. The commercial affiliation State GRID Quzhou Power Supply Company provided support in the form of salaries for author Wei Yang, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the `author contributions' section.	ABUTALEB AS, 1989, COMPUT VISION GRAPH, V47, P22, DOI 10.1016/0734-189X(89)90051-0; Chen HY, 2019, OPT LASER ENG, V118, P22, DOI 10.1016/j.optlaseng.2019.01.016; KAPUR JN, 1985, COMPUT VISION GRAPH, V29, P273, DOI 10.1016/0734-189X(85)90125-2; KITTLER J, 1986, PATTERN RECOGN, V19, P41, DOI 10.1016/0031-3203(86)90030-0; LI CH, 1993, PATTERN RECOGN, V26, P617, DOI 10.1016/0031-3203(93)90115-D; Ma JunCheng, 2019, Information Processing in Agriculture, V6, P216; Mabrouk E, 2019, J COMPUT SCI-NETH, V31, P111, DOI 10.1016/j.jocs.2019.01.002; Mohan A, 2018, ALEX ENG J, V57, P787, DOI 10.1016/j.aej.2017.01.020; OTSU N, 1979, IEEE T SYST MAN CYB, V9, P62, DOI 10.1109/TSMC.1979.4310076; Parida P, 2018, ENG SCI TECHNOL, V21, P547, DOI 10.1016/j.jestch.2018.05.012; Peng SH, 2018, 2018 IEEE 3RD INTERNATIONAL CONFERENCE ON IMAGE, VISION AND COMPUTING (ICIVC), P305; Qureshia M.N., 2018, PROCEDIA COMPUT SCI, V132, P534, DOI [10.1016/j.procs.2018.05.006, DOI 10.1016/j.procs.2018.05.006]; Ronneberger O., 2015, INT C MED IM COMP CO, P234; Sahoo PK, 2006, PATTERN RECOGN LETT, V27, P520, DOI 10.1016/j.patrec.2005.09.017; Schlittgen R, 2016, J BUS RES, V69, P4583, DOI 10.1016/j.jbusres.2016.04.009; SHANNON CE, 1949, BELL SYST TECH J, V28, P656, DOI 10.1002/j.1538-7305.1949.tb00928.x; Shelhamer E, 2017, IEEE T PATTERN ANAL, V39, P640, DOI 10.1109/TPAMI.2016.2572683; Ubaid Muhammad, INT J BIOL MACROMOL, V114, P1174, DOI [10.1016/j.ijbiomac.2018.04.023, DOI 10.1016/J.IJBIOMAC.2018.04.023, DOI 10.HTTPS://D0I.0RG/10.1016/J.ENGAPPAI.2018.04.023]; Wang WW, 2017, NEUROCOMPUTING, V267, P426, DOI 10.1016/j.neucom.2017.06.046; Wenqing L, 1993, ACTA AUTOM SIN, V19, P101, DOI DOI 10.16383/J.AAS.1993.01.015; Xiao Y, 2008, PROC INT CONF ANTI, P1, DOI 10.1109/IWASID.2008.4688353; Yimit A, 2013, NEUROCOMPUTING, V120, P287, DOI 10.1016/j.neucom.2012.10.031; Yuan XC, 2015, APPL SURF SCI, V349, P472, DOI 10.1016/j.apsusc.2015.05.033; Zhang L, 2019, NEUROCOMPUTING, V334, P59, DOI 10.1016/j.neucom.2019.01.003; Zheng XL, 2017, ENTROPY-SWITZ, V19, DOI 10.3390/e19050191	25	14	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2020	15	3							e0229651	10.1371/journal.pone.0229651	http://dx.doi.org/10.1371/journal.pone.0229651			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8MS	32126113	Green Published, gold			2022-12-26	WOS:000535253100042
J	Molkenthin, N; Muhle, S; Mey, ASJS; Timme, M				Molkenthin, Nora; Muehle, Steffen; Mey, Antonia S. J. S.; Timme, Marc			Self-organized emergence of folded protein-like network structures from geometric constraints	PLOS ONE			English	Article							STRUCTURE PREDICTION; COMPLEX NETWORKS; DYNAMICS; MACHINE	The intricate three-dimensional geometries of protein tertiary structures underlie protein function and emerge through a folding process from one-dimensional chains of amino acids. The exact spatial sequence and configuration of amino acids, the biochemical environment and the temporal sequence of distinct interactions yield a complex folding process that cannot yet be easily tracked for all proteins. To gain qualitative insights into the fundamental mechanisms behind the folding dynamics and generic features of the folded structure, we propose a simple model of structure formation that takes into account only fundamental geometric constraints and otherwise assumes randomly paired connections. We find that despite its simplicity, the model results in a network ensemble consistent with key overall features of the ensemble of Protein Residue Networks we obtained from more than 1000 biological protein geometries as available through the Protein Data Base. Specifically, the distribution of the number of interaction neighbors a unit (amino acid) has, the scaling of the structure's spatial extent with chain length, the eigenvalue spectrum and the scaling of the smallest relaxation time with chain length are all consistent between model and real proteins. These results indicate that geometric constraints alone may already account for a number of generic features of protein tertiary structures.	[Molkenthin, Nora; Timme, Marc] Tech Univ Dresden, Inst Theoret Phys, Chair Network Dyna, Gottingen, Germany; [Molkenthin, Nora; Timme, Marc] Tech Univ Dresden, Ctr Adv Elect Dresden Cfaed, Gottingen, Germany; [Molkenthin, Nora; Timme, Marc] Max Planck Inst Dynam & Self Org MPIDS, Network Dynam, Gottingen, Germany; [Muehle, Steffen] Univ Gottingen, Inst Phys Biophys 3, Gottingen, Germany; [Mey, Antonia S. J. S.] Univ Edinburgh, EaStCHEM Sch Chem, Edinburgh, Midlothian, Scotland	Technische Universitat Dresden; Technische Universitat Dresden; Max Planck Society; University of Gottingen; University of Edinburgh	Molkenthin, N (corresponding author), Tech Univ Dresden, Inst Theoret Phys, Chair Network Dyna, Gottingen, Germany.; Molkenthin, N (corresponding author), Tech Univ Dresden, Ctr Adv Elect Dresden Cfaed, Gottingen, Germany.; Molkenthin, N (corresponding author), Max Planck Inst Dynam & Self Org MPIDS, Network Dynam, Gottingen, Germany.	molkenthin@nld.ds.mpg.de	Mey, Antonia/AEY-5191-2022	Mey, Antonia/0000-0001-7512-5252; Molkenthin, Nora/0000-0002-7190-0714	Max Planck Society; Deutsche Forschungsgemeinschaft (DFG) [SFB 755]; Engineering and Physical Sciences Research Council (EPSRC) UK [EP/P022138/1]; DFG	Max Planck Society(Max Planck SocietyFoundation CELLEX); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Engineering and Physical Sciences Research Council (EPSRC) UK(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); DFG(German Research Foundation (DFG))	We acknowledge partial support by the Max Planck Society [NM, MT], the Deutsche Forschungsgemeinschaft (DFG) through SFB 755 (project A05) [SM], the Engineering and Physical Sciences Research Council (EPSRC) UK under grant no. EP/P022138/1 [AM], and the DFG through funding the Clusters of Excellence Center for Advancing Electronics Dresden (cfaed) and Physics of Life (PoL) [MT] The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert R, 2002, REV MOD PHYS, V74, P47, DOI 10.1103/RevModPhys.74.47; Berman H, 2003, NAT STRUCT BIOL, V10, P980, DOI 10.1038/nsb1203-980; Boccaletti S, 2006, PHYS REP, V424, P175, DOI 10.1016/j.physrep.2005.10.009; Bradley P, 2005, SCIENCE, V309, P1868, DOI 10.1126/science.1113801; Cheng JL, 2006, BIOINFORMATICS, V22, P1456, DOI 10.1093/bioinformatics/btl102; Clementi C, 2008, CURR OPIN STRUC BIOL, V18, P10, DOI 10.1016/j.sbi.2007.10.005; Danielsson Ulf H., 2010, PHYS REV E, V82, P1, DOI [10.1103/PhysRevE.82.021910, DOI 10.1103/PHYSREVE.82.021910]; Di Paola L, 2013, CHEM REV, V113, P1598, DOI 10.1021/cr3002356; DILL KA, 1995, PROTEIN SCI, V4, P561; Dill KA, 2012, SCIENCE, V338, P1042, DOI 10.1126/science.1219021; Dokholyan NV, 2002, P NATL ACAD SCI USA, V99, P8637, DOI 10.1073/pnas.122076099; Donges JF, 2009, EUR PHYS J-SPEC TOP, V174, P157, DOI 10.1140/epjst/e2009-01098-2; Ernesto Estrada, 2011, STRUCTURE COMPLEX NE; Estrada E, 2010, NETWORK SCIENCE: COMPLEXITY IN NATURE AND TECHNOLOGY, P13, DOI 10.1007/978-1-84996-396-1_2; Girvan M, 2002, P NATL ACAD SCI USA, V99, P7821, DOI 10.1073/pnas.122653799; Hagberg A, 2008, 7 PYTH SCI C SCIPY20, V7, P11, DOI DOI 10.25080/ISSN.2575-9752; Hong L, 2009, J POLYM SCI POL PHYS, V47, P207, DOI 10.1002/polb.21634; Hubner IA, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.022901; Mey Antonia SJS, 2014, PHYS REV E, V89; Mirny L, 2001, ANNU REV BIOPH BIOM, V30, P361, DOI 10.1146/annurev.biophys.30.1.361; Molkenthin N, 2018, PHYS REV LETT, V121, DOI 10.1103/PhysRevLett.121.138301; Molkenthin N, 2016, PHYS REV LETT, V117, DOI 10.1103/PhysRevLett.117.168301; Molkenthin N, 2014, SCI REP-UK, V4, DOI 10.1038/srep04119; Molkenthin N, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.078102; Monastyrskyy B, 2016, PROTEINS, V84, P131, DOI 10.1002/prot.24943; Moult J, 2007, PROTEINS, V69, P3, DOI 10.1002/prot.21767; Newman MEJ, 2003, SIAM REV, V45, P167, DOI 10.1137/S003614450342480; Ogorzalek TL, 2018, PROTEINS, V86, P202, DOI 10.1002/prot.25452; Saunders MG, 2013, ANNU REV BIOPHYS, V42, P73, DOI 10.1146/annurev-biophys-083012-130348; Scheraga HA, 2007, ANNU REV PHYS CHEM, V58, P57, DOI 10.1146/annurev.physchem.58.032806.104614; Shakhnovich E, 2006, CHEM REV, V106, P1559, DOI 10.1021/cr040425u; Shaw DE, 2008, COMMUN ACM, V51, P91, DOI 10.1145/1364782.1364802; Shirts M, 2000, SCIENCE, V290, P1903, DOI 10.1126/science.290.5498.1903; Snow CD, 2002, NATURE, V420, P102, DOI 10.1038/nature01160; Trombach L, 2018, PHYS REV E, V97, DOI 10.1103/PhysRevE.97.043309; TYSON TA, 2009, PHYS REV E, V79, DOI DOI 10.1103/PHYSREVE.79.051922; UPPENBRINK J, 1991, J CHEM SOC FARADAY T, V87, P215, DOI 10.1039/ft9918700215; Vendruscolo M, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.061910; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Xu JB, 2019, P NATL ACAD SCI USA, V116, P16856, DOI 10.1073/pnas.1821309116; Yang JY, 2015, NAT METHODS, V12, P7, DOI 10.1038/nmeth.3213	42	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2020	15	2							e0229230	10.1371/journal.pone.0229230	http://dx.doi.org/10.1371/journal.pone.0229230			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8GQ	32106258	gold, Green Published, Green Submitted			2022-12-26	WOS:000535237000022
J	Niemczynowicz, A; Budziak, I; Kulesza, S; Gorecki, A; Makowski, M; Karcz, D; Starzak, K; Gladyszewska, B; Podlesny, J; Piotrowicz-Cieslak, AI; Matwijczuk, A				Niemczynowicz, Agnieszka; Budziak, Iwona; Kulesza, Slawomir; Gorecki, Andrzej; Makowski, Marcin; Karcz, Dariusz; Starzak, Karolina; Gladyszewska, Bozena; Podlesny, Janusz; Piotrowicz-Cieslak, Agnieszka, I; Matwijczuk, Arkadiusz			Spectroscopic and theoretical studies of fluorescence effects induced by the ESIPT process in a new derivative 2-Hydroxy-N-(2-phenylethyl)benzamide - Study on the effects of pH and medium polarity changes	PLOS ONE			English	Article							INTRAMOLECULAR PROTON-TRANSFER; AGGREGATION-INDUCED EMISSION; RESONANCE LIGHT-SCATTERING; STATE DIPOLE-MOMENTS; DUAL FLUORESCENCE; SALICYLIC-ACID; DYES	The paper presents the results of studies conducted with the use of stationary and timeresolved fluorescence spectroscopy for the new derivative 2-Hydroxy-N-(2-phenylethyl) benzamide (SAL-3) in aqueous solutions with various concentrations of hydrogen ions as well as in solvent mixtures (i.e. media with changing polarity/polarizability). For the compound selected for the study placed in aqueous solutions with varying concentrations of hydrogen ions, the fluorescence emission spectra revealed a single emission band within most of the pH range, however, at low pH (pH<3) a significant broadening (noticeable effect of dual fluorescence) and shifting of the band was observed. Whereas, for water and polar (protic) solvents, we observed a very interesting phenomenon of dual fluorescence never before reported for this particular group of analogues (with the specific substituent system). Based on the results of the experiments, it was observed that the presented effects may be related both with conformational effects (related to the possible positioning of the-OH group on the side of the carbonyl system, which facilitates the possibility of proton transfer) as well as, most importantly, the effects of excited state intramolecular proton transfer (ESIPT-Excited State Intramolecular Proton Transfer) related in this case with the necessary (new/previously unobserved in published literature) presence of ionic and non-ionic forms of the compound). Both the conducted quantum-mechanical [TD]DFT-Time-Dependent Density Functional Theory) calculations and excited state dipole moment change calculations for the analyzed molecule in solvents with varying pH confirmed the association between the observed fluorescence phenomena and the two aforementioned effects.	[Niemczynowicz, Agnieszka] Univ Warmia & Mazury, Fac Math & Comp Sci, Dept Anal & Differential Equat, Olsztyn, Poland; [Budziak, Iwona] Univ Life Sci Lublin, Dept Chem, Lublin, Poland; [Kulesza, Slawomir] Univ Warmia & Mazury, Fac Math & Informat, Chair Relativist Phys, Olsztyn, Poland; [Gorecki, Andrzej] Jagiellonian Univ, Fac Biochem Biophys & Biotechnol, Dept Phys Biochem, Krakow, Poland; [Makowski, Marcin] Jagiellonian Univ, Fac Chem, Dept Theoret Chem, Krakow, Poland; [Karcz, Dariusz; Starzak, Karolina] Cracow Univ Technol, Fac Chem Engn & Technol, Dept Analyt Chem C1, Krakow, Poland; [Gladyszewska, Bozena; Matwijczuk, Arkadiusz] Univ Life Sci Lublin, Dept BioPhys, Lublin, Poland; [Podlesny, Janusz] Inst Soil Sci & Plant Cultivat, State Res Inst, Pulawy, Poland; [Piotrowicz-Cieslak, Agnieszka, I] Univ Warmia & Mazury, Fac Biol & Biotechnol, Dept Plant Physiol Genet & Biotechnol, Olsztyn, Poland	University of Warmia & Mazury; University of Life Sciences in Lublin; University of Warmia & Mazury; Jagiellonian University; Jagiellonian University; Cracow University of Technology; University of Life Sciences in Lublin; Institute of Soil Science & Plant Cultivation; University of Warmia & Mazury	Matwijczuk, A (corresponding author), Univ Life Sci Lublin, Dept BioPhys, Lublin, Poland.	arkadiusz.matwijczuk@up.lublin.pl	Matwijczuk, Arkadiusz/AAU-8881-2021; Niemczynowicz, Agnieszka/K-3481-2019; Sławomir, Kulesza/J-1178-2019; , Piotrowicz-Cieslak/AAA-8413-2021; Niemczynowicz, Agnieszka/W-4957-2017	Matwijczuk, Arkadiusz/0000-0003-2630-120X; Niemczynowicz, Agnieszka/0000-0002-4370-3326; Sławomir, Kulesza/0000-0003-2889-5611; , Piotrowicz-Cieslak/0000-0001-8356-6373; Niemczynowicz, Agnieszka/0000-0002-4370-3326; Gladyszewska, Bozena/0000-0002-8473-1403; Starzak, Karolina/0000-0002-0343-5363; Budziak-Wieczorek, Iwona/0000-0002-5834-555X; PODLESNY, JANUSZ/0000-0001-6757-8331	PL-Grid Infrastructure; European Regional Development Fund [POIG.02.01.00-12-023/08]; Cost project [CA 15126]	PL-Grid Infrastructure; European Regional Development Fund(European Commission); Cost project	This research was supported in part by PL-Grid Infrastructure. The research was carried out with the equipment purchased thanks to the financial support of the European Regional Development Fund in the framework of the Polish Innovation Economy Operational Program (contract no. POIG.02.01.00-12-023/08). The author Arkadiusz Matwijczuk acknowledges the Cost project CA 15126.	Abdolmohammad-Zadeh H, 2019, ANAL CHIM ACTA, V1061, P152, DOI 10.1016/j.aca.2019.02.007; BECKE AD, 1993, J CHEM PHYS, V98, P5648, DOI 10.1063/1.464913; Bi XM, 2017, J PHYS CHEM B, V121, P4981, DOI 10.1021/acs.jpcb.7b01885; Bramowicz M, 2016, APPL SURF SCI, V379, P338, DOI 10.1016/j.apsusc.2016.04.077; Brancato G, 2015, J PHYS CHEM B, V119, P6144, DOI 10.1021/acs.jpcb.5b01119; Budziak I, 2019, J MOL LIQ, V291, DOI 10.1016/j.molliq.2019.111261; Casida ME, 1998, J CHEM PHYS, V108, P4439, DOI 10.1063/1.475855; Chen Y, 2020, SPECTROCHIM ACTA A, V224, DOI 10.1016/j.saa.2019.117416; Czernel G, 2018, MOLECULES, V23, DOI 10.3390/molecules23112861; DUNNING TH, 1989, J CHEM PHYS, V90, P1007, DOI 10.1063/1.456153; Feng X, 2018, CHEM SCI, V9, P5679, DOI 10.1039/c8sc01709c; Frisch M.J., 2009, GAUSSIAN 09 D 01; Gagos M, 2011, J FLUORESC, V21, P1, DOI 10.1007/s10895-010-0682-5; Ghoneim MM, 2015, SPECTROCHIM ACTA A, V137, P1039, DOI 10.1016/j.saa.2014.08.122; Grimme S, 2011, J COMPUT CHEM, V32, P1456, DOI 10.1002/jcc.21759; Imramovsky A, 2009, BIOORG MED CHEM LETT, V19, P348, DOI 10.1016/j.bmcl.2008.11.080; Imramovsky A, 2013, EUR J MED CHEM, V68, P253, DOI 10.1016/j.ejmech.2013.08.009; Kumar A, 2015, RSC ADV, V5, P23613, DOI 10.1039/c5ra00565e; Kumar V, 2015, SENSOR ACTUAT B-CHEM, V207, P650, DOI 10.1016/j.snb.2014.10.068; Kwok RTK, 2015, CHEM SOC REV, V44, P4228, DOI 10.1039/c4cs00325j; Lahmani F, 1997, J PHYS CHEM A, V101, P6141, DOI 10.1021/jp9712516; Maity A, 2015, CHEM COMMUN, V51, P2130, DOI 10.1039/c4cc09211b; Matwijczuk A, 2017, J FLUORESC, V27, P1201, DOI 10.1007/s10895-017-2053-y; Matwijczuk A, 2015, J PHYS CHEM A, V119, P10791, DOI 10.1021/acs.jpca.5b06475; Mei J, 2015, CHEM REV, V115, P11718, DOI 10.1021/acs.chemrev.5b00263; Moussart A, 1998, EUR J PLANT PATHOL, V104, P93, DOI 10.1023/A:1008673914537; NUNBERG JH, 1984, MOL CELL BIOL, V4, P2306, DOI 10.1128/MCB.4.11.2306; Padalkar VS, 2016, CHEM SOC REV, V45, P169, DOI 10.1039/c5cs00543d; PANT DD, 1994, CHEM PHYS, V185, P137, DOI 10.1016/0301-0104(94)00090-5; Parkash J, 1998, BIOPHYS J, V74, P2089, DOI 10.1016/S0006-3495(98)77916-0; PASTERNACK RF, 1995, SCIENCE, V269, P935, DOI 10.1126/science.7638615; Patil SK, 2014, SPECTROCHIM ACTA A, V123, P117, DOI 10.1016/j.saa.2013.12.031; Pistolis G, 1999, CHEM PHYS LETT, V304, P371, DOI 10.1016/S0009-2614(99)00307-3; Raeker T, 2017, J PHYS CHEM A, V121, P5967, DOI 10.1021/acs.jpca.7b03261; Rawls H.R., 1965, PURE APPL CHEM, V11, P371, DOI [10.1351/pac196511030371, 10.1002/anie.201002307]; Samundeeswari S, 2017, J FLUORESC, V27, P1247, DOI 10.1007/s10895-017-2052-z; Sasaki S, 2016, J MATER CHEM C, V4, P2731, DOI 10.1039/c5tc03933a; Sedgwick AC, 2018, CHEM SOC REV, V47, P8842, DOI 10.1039/c8cs00185e; Shen Q, 2018, CURR OPIN MICROBIOL, V46, P1, DOI 10.1016/j.mib.2018.01.006; Talu S, 2016, ELECTRON MATER LETT, V12, P580, DOI 10.1007/s13391-016-6036-y; Thiare DD, 2015, J MOL LIQ, V211, P640, DOI 10.1016/j.molliq.2015.07.071; TODESCO RV, 1986, MACROMOLECULES, V19, P2390, DOI 10.1021/ma00163a010; Tomasi J, 2005, CHEM REV, V105, P2999, DOI 10.1021/cr9904009; Vicente MRS, 2011, J EXP BOT, V62, P3321, DOI 10.1093/jxb/err031; Wei CX, 2019, TALANTA, V195, P339, DOI 10.1016/j.talanta.2018.11.075; Zhang MX, 2016, RSC ADV, V6, P59389, DOI 10.1039/c6ra11140h; Zhao GJ, 2010, PHYS CHEM CHEM PHYS, V12, P8914, DOI 10.1039/b924549a	47	3	3	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2020	15	2							e0229149	10.1371/journal.pone.0229149	http://dx.doi.org/10.1371/journal.pone.0229149			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8EV	32097423	gold, Green Submitted, Green Published			2022-12-26	WOS:000535232000019
J	Toyoda, A; Kozaki, T; Ishii, K; Taniishi, M; Hattori, M; Matsuda, H; Yoshida, T				Toyoda, Ayano; Kozaki, Toshinori; Ishii, Kazuo; Taniishi, Momoka; Hattori, Makoto; Matsuda, Hiroshi; Yoshida, Tadashi			Comprehensive analysis of DNA methylation and gene expression in orally tolerized T cells	PLOS ONE			English	Article							E3 UBIQUITIN LIGASE; TRANSCRIPTION FACTOR; FOXP3 EXPRESSION; ANERGY; DIFFERENTIATION; INDUCTION	T cell anergy is known to be a crucial mechanism for various types of immune tolerance, including oral tolerance. The expression of several anergy-specific genes was reportedly up-regulated in anergic T cells, and played important roles in the cells. However, how the genes were up-regulated has not been understood. In this study, we comprehensively analyzed the altered gene expression and DNA methylation status in T cells tolerized by oral antigen in vivo. Our results showed that many genes were significantly up-regulated in the orally tolerized T cells, and most of the genes found in this study have not been reported previously as anergy related genes; for example, ribosomal protein L41 (FC = 3.54E06, p = 3.70E-09: Fisher's exact test; the same applies hereinafter) and CD52 (FC = 2.18E05, p = 3.44E-06). Furthermore, we showed that the DNA methylation statuses of many genes; for example, enoyl-coenzyme A delta isomerase 3 (FC = 3.62E-01, p = 3.01E-02) and leucine zipper protein 1 (FC = 4.80E-01, p = 3.25E-02), including the ones distinctly expressed in tolerized T cells; for example, latexin (FC = 3.85E03, p = 4.06E-02 for expression; FC = 7.75E-01, p = 4.13E-01 for DNA methylation) and small nuclear ribonucleoprotein polypeptide F (FC = 3.12E04, p = 4.46E-04 for expression; FC = 8.56E-01, p = 5.15E-01 for DNA methylation), changed during tolerization, suggesting that the distinct expression of some genes was epigenetically regulated in the tolerized T cells. This study would contribute to providing a novel clue to the fine understanding of the mechanism for T cell anergy and oral tolerance.	[Toyoda, Ayano; Kozaki, Toshinori; Ishii, Kazuo; Taniishi, Momoka; Hattori, Makoto; Yoshida, Tadashi] Tokyo Univ Agr & Technol, Dept Appl Biol Sci, Fuchu, Tokyo, Japan; [Ishii, Kazuo] Kurume Univ, Biostat Ctr, Kurume, Fukuoka, Japan; [Matsuda, Hiroshi] Tokyo Univ Agr & Technol, Div Anim Life Sci, Fuchu, Tokyo, Japan	Tokyo University of Agriculture & Technology; Kurume University; Tokyo University of Agriculture & Technology	Yoshida, T (corresponding author), Tokyo Univ Agr & Technol, Dept Appl Biol Sci, Fuchu, Tokyo, Japan.	tyoshi@cc.tuat.ac.jp	Ishii, Kazuo/N-9946-2019; HATTORI, Makoto/H-6598-2013; YOSHIDA, Tadashi/G-1124-2013	Ishii, Kazuo/0000-0002-8363-8266	KAKENHI [26450151, 16H06383]; Japan Society for the Promotion of Science [16H06383]; (Human Resource Development Program in Agricultural Genome Sciences), Ministry of Education, Culture, Sports, Science and Technology	KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); (Human Resource Development Program in Agricultural Genome Sciences), Ministry of Education, Culture, Sports, Science and Technology	TY (KAKENHI; 26450151, 16H06383), Japan Society for the Promotion of Science, https://www.jsps.go.jp HM (KAKENHI; 16H06383), Japan Society for the Promotion of Science, https://www.jsps.go.jp The funding bodies had no involvement in the study design, collection, analysis and interpretation of data, writing of the manuscript, or decision to publish the work. KI Human Resource Development Program in Agricultural Genome Sciences), Ministry of Education, Culture, Sports, Science and Technology, http://www.mext.go.jp TK (Human Resource Development Program in Agricultural Genome Sciences), Ministry of Education, Culture, Sports, Science and Technology, http://www.mext.go.jp The funding bodies had no involvement in the study design, collection, analysis and interpretation of data, writing of the manuscript, or decision to publish the work.	Aagaard A, 2005, STRUCTURE, V13, P309, DOI 10.1016/j.str.2004.12.013; Ait-Lounis A, 2007, DIABETES, V56, P950, DOI 10.2337/db06-1187; Anandasabapathy N, 2003, IMMUNITY, V18, P535, DOI 10.1016/S1074-7613(03)00084-0; Bandala-Sanchez E, 2013, NAT IMMUNOL, V14, P741, DOI 10.1038/ni.2610; Bandyopadhyay S, 2007, BLOOD, V109, P2878, DOI 10.1182/blood-2006-07-037754; Beer S, 2005, MOL CELL BIOL, V25, P9646, DOI 10.1128/MCB.25.21.9646-9660.2005; Bruniquel D, 2003, NAT IMMUNOL, V4, P235, DOI 10.1038/ni887; Castor T, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191927; Han Jeong A., 2014, Genomics & Informatics, V12, P247, DOI 10.5808/GI.2014.12.4.247; Harris JE, 2004, J IMMUNOL, V173, P7331, DOI 10.4049/jimmunol.173.12.7331; Hatt L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128918; Heissmeyer V, 2004, NAT IMMUNOL, V5, P255, DOI 10.1038/ni1047; Hing B, 2015, EPIGENETICS-US, V10, P581, DOI 10.1080/15592294.2015.1045179; Huehn J, 2009, NAT REV IMMUNOL, V9, P83, DOI 10.1038/nri2474; Ise W, 2005, J IMMUNOL, V175, P829, DOI 10.4049/jimmunol.175.2.829; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Janik David K, 2015, J Clin Cell Immunol, V6, P1; Krueger F, 2011, BIOINFORMATICS, V27, P1571, DOI 10.1093/bioinformatics/btr167; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Malik S, 2010, NAT REV GENET, V11, P761, DOI 10.1038/nrg2901; Mendiratta S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159370; Miyao T, 2012, IMMUNITY, V36, P262, DOI 10.1016/j.immuni.2011.12.012; Mueller DL, 2004, NAT IMMUNOL, V5, P883, DOI 10.1038/ni1106; MuhChyi C, 2013, INT J DEV NEUROSCI, V31, P424, DOI 10.1016/j.ijdevneu.2013.02.006; Safford M, 2005, NAT IMMUNOL, V6, P472, DOI 10.1038/ni1193; Saunders A, 2010, BLOOD, V115, P3249, DOI 10.1182/blood-2009-08-237586; Seroogy CM, 2004, J IMMUNOL, V173, P79, DOI 10.4049/jimmunol.173.1.79; Sprent J, 1995, Int Rev Immunol, V13, P95, DOI 10.3109/08830189509061740; Tordesillas L, 2018, CLIN REV ALLERG IMMU, V55, P107, DOI 10.1007/s12016-018-8680-5; Yates A, 2004, J THEOR BIOL, V231, P181, DOI 10.1016/j.jtbi.2004.06.013; Yokoyama C, 1996, GENOMICS, V36, P296, DOI 10.1006/geno.1996.0465; Yoshioka Y, 2017, CELL IMMUNOL, V311, P71, DOI 10.1016/j.cellimm.2016.10.006; Zha YY, 2006, NAT IMMUNOL, V7, P1166, DOI 10.1038/ni1394; Zheng Y, 2013, MOL IMMUNOL, V55, P283, DOI 10.1016/j.molimm.2013.03.006; Zhi L, 2012, J IMMUNOL, V189, P1639, DOI 10.4049/jimmunol.1200528	35	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2020	15	2							e0229042	10.1371/journal.pone.0229042	http://dx.doi.org/10.1371/journal.pone.0229042			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8EV	32097442	Green Published, gold			2022-12-26	WOS:000535232000017
J	Mardjuki, RE; Carozza, JA; Li, LY				Mardjuki, Rachel E.; Carozza, Jacqueline A.; Li, Lingyin			Development of cGAMP-Luc, a sensitive and precise coupled enzyme assay to measure cGAMP in complex biological samples	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cyclic nucleotide; enzyme; mass spectrometry (MS); analytical chemistry; drug discovery; ATP; assay development; cancer; coupled-enzyme assay; extracellular cGAMP; STING; cyclic nucleotide	CYCLIC GMP-AMP; ATP REGENERATION; DNA SENSOR; PHOSPHOTRANSFERASE; MINERALIZATION; POLYPHOSPHATE; 2ND-MESSENGER; DINUCLEOTIDE; ADAPTER; ENPP1	2?,5?/3?,5?-cGMP-AMP (cGAMP) is a second messenger produced in response to cytosolic dsDNA that activates the stimulator of interferon genes (STING) pathway. We recently discovered that cGAMP is exported by cancer cells and that this extracellular signal is an immunotransmitter key to tumor detection and elimination by the innate immune system. The enhancement of extracellular cGAMP levels therefore holds great promise for managing cancer. However, there is still much more to understand about the basic biology of cGAMP before its full therapeutic potential can be realized. To answer these questions, we must be able to detect and quantitate cGAMP with an assay that is high-throughput, sensitive, and precise. Existing assays fall short of these needs. Here, we describe the development of cGAMP-Luc, a coupled enzyme assay that relies on the degradation of cGAMP to AMP by ectonucleotide pyrophosphatase phosphodiesterase 1 (ENPP1) and an optimized assay for the detection of AMP by luciferase. We also developed STING-CAP, a STING-mediated method to concentrate and purify cGAMP from any type of biological sample. We conclude that cGAMP-Luc is an economical high-throughput assay that matches the accuracy of and surpasses the detection limit of MS, the current gold standard of cGAMP quantitation. We propose that cGAMP-Luc is a powerful tool that may enable discoveries that advance insights into extracellular cGAMP levels in healthy and diseased tissues, such as cancer.	[Mardjuki, Rachel E.; Carozza, Jacqueline A.] Stanford Univ, Sch Med, Dept Chem, Stanford, CA 94306 USA; [Carozza, Jacqueline A.; Li, Lingyin] Stanford Univ, Sch Med, Stanford ChEM H, Stanford, CA 94306 USA; [Li, Lingyin] Stanford Univ, Sch Med, Dept Biochem, Stanford, CA 94306 USA	Stanford University; Stanford University; Stanford University	Li, LY (corresponding author), Stanford Univ, Dept Biochem, Stanford, CA 94306 USA.	lingyinl@stanford.edu		Li, Lingyin/0000-0003-4386-7926	National Science Foundation Graduate Research Fellowship Program [1656518]; National Institutes of Health [DP2CA228044]	National Science Foundation Graduate Research Fellowship Program(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the National Science Foundation Graduate Research Fellowship Program Grant 1656518 (to R. E. M.) and National Institutes of Health Grant DP2CA228044 (to L. L.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ablasser A, 2013, NATURE, V503, P530, DOI 10.1038/nature12640; Ablasser A, 2013, NATURE, V498, P380, DOI 10.1038/nature12306; [Anonymous], HDB STABILITY TESTIN; [Anonymous], GUIDANCE IND Q2B VAL; [Anonymous], REGARDING CGAMP UPTA; Apelbaum A, 2013, MOL CELL BIOL, V33, P800, DOI 10.1128/MCB.01430-12; Bakhoum SF, 2018, NATURE, V553, P467, DOI 10.1038/nature25432; Bose D, 2016, CELL CHEM BIOL, V23, P1539, DOI 10.1016/j.chembiol.2016.10.014; Burdette DL, 2011, NATURE, V478, P515, DOI 10.1038/nature10429; Carozza JA, 2020, NAT CANCER, V1, P184, DOI 10.1038/s43018-020-0028-4; Corrales L., 2013, J IMMUNOTHER CANC S1, V1, P015, DOI DOI 10.1186/2051-1426-1-S1-O15; Diner EJ, 2013, CELL REP, V3, P1355, DOI 10.1016/j.celrep.2013.05.009; Eaglesham JB, 2019, NATURE, V566, P259, DOI 10.1038/s41586-019-0928-6; FDA, 2018, BIOAN METH VAL GUID; Gu HD, 2014, ANAL CHEM, V86, P8959, DOI 10.1021/ac5018265; Harding SM, 2017, NATURE, V548, P466, DOI 10.1038/nature23470; Ishikawa H, 2008, NATURE, V455, P674, DOI 10.1038/nature07317; Jin L, 2008, MOL CELL BIOL, V28, P5014, DOI 10.1128/MCB.00640-08; Kameda A, 2001, J BIOSCI BIOENG, V91, P557, DOI 10.1263/jbb.91.557; Kato K, 2012, P NATL ACAD SCI USA, V109, P16876, DOI 10.1073/pnas.1208017109; Kato K, 2012, ACTA CRYSTALLOGR F, V68, P778, DOI 10.1107/S1744309112019306; Li LY, 2014, NAT CHEM BIOL, V10, P1043, DOI [10.1038/NChemBio.1661, 10.1038/nchembio.1661]; Luteijn RD, 2019, NATURE, V573, P434, DOI 10.1038/s41586-019-1553-0; Mackenzie KJ, 2017, NATURE, V548, P461, DOI 10.1038/nature23449; Muranaka LS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072937; NODA L, 1957, J BIOL CHEM, V226, P541; Resnick SM, 2000, APPL ENVIRON MICROB, V66, P2045, DOI 10.1128/AEM.66.5.2045-2051.2000; Ritchie C, 2019, MOL CELL, V75, P372, DOI 10.1016/j.molcel.2019.05.006; Shayhidin EE, 2015, BRIT J PHARMACOL, V172, P4189, DOI 10.1111/bph.13204; Shrivastava A., 2011, CHRONICLES YOUNG SCI, V2, P21, DOI [DOI 10.4103/2229-5186.79345, 10.4103/2229-5186.79345]; Sun LJ, 2013, SCIENCE, V339, P786, DOI 10.1126/science.1232458; Sun WX, 2009, P NATL ACAD SCI USA, V106, P8653, DOI 10.1073/pnas.0900850106; Woo SR, 2014, IMMUNITY, V41, P830, DOI 10.1016/j.immuni.2014.10.017; Wu JX, 2013, SCIENCE, V339, P826, DOI 10.1126/science.1229963; Zhang X, 2013, MOL CELL, V51, P226, DOI 10.1016/j.molcel.2013.05.022; Zhong B, 2008, IMMUNITY, V29, P538, DOI 10.1016/j.immuni.2008.09.003	36	13	13	4	14	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 10	2020	295	15					4881	4892		10.1074/jbc.RA119.012170	http://dx.doi.org/10.1074/jbc.RA119.012170			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LE7FC	32127400	Green Published, hybrid			2022-12-26	WOS:000526887000012
J	Wen, YT; Yang, S; Wakabayashi, K; Svensson, MND; Stanford, SM; Santelli, E; Bottini, N				Wen, Yutao; Yang, Shen; Wakabayashi, Kuninobu; Svensson, Mattias N. D.; Stanford, Stephanie M.; Santelli, Eugenio; Bottini, Nunzio			RPTP? phosphatase activity is allosterically regulated by the membrane-distal catalytic domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						protein phosphatase; tyrosine-protein phosphatase (tyrosine phosphatase); protein structure; allosteric regulation; crystal structure; cell signaling; cancer; signal transduction; cancer	PROTEIN-TYROSINE-PHOSPHATASE; KINETIC-ANALYSIS; STRUCTURAL BASIS; PTP-ALPHA; INHIBITION; CD45; VISUALIZATION; MOTIONS; BINDS; SIGMA	Receptor-type protein tyrosine phosphatase ? (RPTP?) is an important positive regulator of SRC kinase activation and a known promoter of cancer growth, fibrosis, and arthritis. The domain structure of RPTPs comprises an extracellular region, a transmembrane helix, and two tandem intracellular catalytic domains referred to as D1 and D2. The D2 domain of RPTPs is believed to mostly play a regulatory function; however, no regulatory model has been established for RPTP?-D2 or other RPTP-D2 domains. Here, we solved the 1.8 ? resolution crystal structure of the cytoplasmic region of RPTP?, encompassing D1 and D2, trapped in a conformation that revealed a possible mechanism through which D2 can allosterically inhibit D1 activity. Using a D2-truncation RPTP? variant and mutational analysis of the D1/D2 interfaces, we show that D2 inhibits RPTP? phosphatase activity and identified a (PFTP408)-P-405 motif in D1 that mediates the inhibitory effect of D2. Expression of the gain-of-function F406A/T407A RPTP? variant in HEK293T cells enhanced SRC activation, supporting the relevance of our proposed D2-mediated regulation mechanism in cell signaling. There is emerging interest in the development of allosteric inhibitors of RPTPs but a scarcity of validated allosteric sites for RPTPs. The results of our study not only shed light on the regulatory role of RPTP-D2 domains, but also provide a potentially useful tool for the discovery of chemical probes targeting RPTP? and other RPTPs.	[Wen, Yutao; Yang, Shen; Wakabayashi, Kuninobu; Svensson, Mattias N. D.; Stanford, Stephanie M.; Santelli, Eugenio; Bottini, Nunzio] Univ Calif San Diego, Dept Med, La Jolla, CA 92037 USA; [Wen, Yutao] Univ Calif San Diego, Dept Biol Sci, La Jolla, CA 92037 USA; [Wakabayashi, Kuninobu; Stanford, Stephanie M.; Santelli, Eugenio; Bottini, Nunzio] La Jolla Inst Immunol, Div Cellular Biol, La Jolla, CA 92037 USA; [Wakabayashi, Kuninobu] Showa Univ, Sch Med, Dept Med, Div Rheumatol, Tokyo 1428555, Japan; [Svensson, Mattias N. D.] Univ Gothenburg, Sahlgrenska Acad, Dept Rheumatol & Inflammat Res, S-40530 Gothenburg, Sweden	University of California System; University of California San Diego; University of California System; University of California San Diego; La Jolla Institute for Immunology; Showa University; University of Gothenburg	Bottini, N (corresponding author), Univ Calif San Diego, Dept Med, La Jolla, CA 92037 USA.	esantelli@health.ucsd.edu; nbottini@health.ucsd.edu	Svensson, Mattias N.D./A-9827-2012	Svensson, Mattias N.D./0000-0001-8077-9824	National Institutes of Health [AR066053]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by National Institutes of Health Grant AR066053 (to N. B.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Almo Steven C., 2007, Journal of Structural and Functional Genomics, V8, P121, DOI 10.1007/s10969-007-9036-1; Alonso A, 2004, CELL, V117, P699, DOI 10.1016/j.cell.2004.05.018; Aschner Y, 2014, AM J PATHOL, V184, P1489, DOI 10.1016/j.ajpath.2014.01.016; Barr AJ, 2009, CELL, V136, P352, DOI 10.1016/j.cell.2008.11.038; Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675; Bilwes AM, 1996, NATURE, V382, P555, DOI 10.1038/382555a0; Blanchetot C, 2002, EMBO J, V21, P493, DOI 10.1093/emboj/21.4.493; Chen YNP, 2016, NATURE, V535, P148, DOI 10.1038/nature18621; Choy MS, 2017, MOL CELL, V65, P644, DOI 10.1016/j.molcel.2017.01.014; Cowtan K, 2006, ACTA CRYSTALLOGR D, V62, P1002, DOI 10.1107/S0907444906022116; Cui DS, 2017, J MOL BIOL, V429, P2360, DOI 10.1016/j.jmb.2017.06.009; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Felberg J, 2004, J BIOL CHEM, V279, P3455, DOI 10.1074/jbc.M309537200; Fujikawa A, 2019, J BIOL CHEM, V294, P14953, DOI 10.1074/jbc.RA119.007878; Gu ZD, 2017, INT J ONCOL, V51, P489, DOI 10.3892/ijo.2017.4055; Hao Q, 2006, FREE RADICAL BIO MED, V41, P302, DOI 10.1016/j.freeradbiomed.2006.04.011; Hayward S, 1998, PROTEINS, V30, P144, DOI 10.1002/(SICI)1097-0134(19980201)30:2<144::AID-PROT4>3.0.CO;2-N; He RJ, 2014, ACTA PHARMACOL SIN, V35, P1227, DOI 10.1038/aps.2014.80; Hou L, 2011, ACTA BIOCH BIOPH SIN, V43, P977, DOI 10.1093/abbs/gmr095; Jeon TJ, 2013, MOL CELLS, V36, P55, DOI 10.1007/s10059-013-0033-x; Jiang GL, 1999, NATURE, V401, P606, DOI 10.1038/44170; Kashio N, 1998, J BIOL CHEM, V273, P33856, DOI 10.1074/jbc.273.50.33856; Keedy DA, 2018, ELIFE, V7, DOI 10.7554/eLife.36307; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; LAWRENCE MC, 1993, J MOL BIOL, V234, P946, DOI 10.1006/jmbi.1993.1648; Lim KL, 1997, EUR J BIOCHEM, V245, P693, DOI 10.1111/j.1432-1033.1997.00693.x; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nam HJ, 2005, J EXP MED, V201, P441, DOI 10.1084/jem.20041890; Nam HJ, 1999, CELL, V97, P449, DOI 10.1016/S0092-8674(00)80755-2; Pannifer ADB, 1998, J BIOL CHEM, V273, P10454, DOI 10.1074/jbc.273.17.10454; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Sonnenburg ED, 2003, BIOCHEMISTRY-US, V42, P7904, DOI 10.1021/bi0340503; Stanford SM, 2017, TRENDS PHARMACOL SCI, V38, P524, DOI 10.1016/j.tips.2017.03.004; Stanford SM, 2016, ARTHRITIS RHEUMATOL, V68, P359, DOI 10.1002/art.39442; STREULI M, 1990, EMBO J, V9, P2399, DOI 10.1002/j.1460-2075.1990.tb07415.x; Su J, 1999, CURR BIOL, V9, P505, DOI 10.1016/S0960-9822(99)80234-6; Sun WC, 1998, BIOORG MED CHEM LETT, V8, P3107, DOI 10.1016/S0960-894X(98)00578-2; Toledano-Katchalski H, 2003, MOL CELL BIOL, V23, P5460, DOI 10.1128/MCB.23.15.5460-5471.2003; Tonks NK, 2006, NAT REV MOL CELL BIO, V7, P833, DOI 10.1038/nrm2039; Tsujikawa K, 2001, MOL ENDOCRINOL, V15, P271, DOI 10.1210/me.15.2.271; Wallace MJ, 1998, MOL CELL BIOL, V18, P2608, DOI 10.1128/MCB.18.5.2608; Wang Y, 1999, J BIOL CHEM, V274, P7454, DOI 10.1074/jbc.274.11.7454; Whittier SK, 2013, SCIENCE, V341, P899, DOI 10.1126/science.1241735; Wiesmann C, 2004, NAT STRUCT MOL BIOL, V11, P730, DOI 10.1038/nsmb803; Wu L, 1997, J BIOL CHEM, V272, P6994, DOI 10.1074/jbc.272.11.6994; Zeng L, 1999, J CELL BIOL, V147, P707, DOI 10.1083/jcb.147.4.707; Zhang YR, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11490-5; Zhang ZY, 2017, ACCOUNTS CHEM RES, V50, P122, DOI 10.1021/acs.accounts.6b00537; Zhang ZY, 2003, PROG NUCLEIC ACID RE, V73, P171, DOI 10.1016/S0079-6603(03)01006-7; ZHENG XM, 1992, NATURE, V359, P336, DOI 10.1038/359336a0	52	5	5	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 10	2020	295	15					4923	4936		10.1074/jbc.RA119.011808	http://dx.doi.org/10.1074/jbc.RA119.011808			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LE7FC	32139509	Green Published, hybrid			2022-12-26	WOS:000526887000016
J	Ostmeyer, J; Lucas, E; Christley, S; Lea, J; Monson, N; Tiro, J; Cowell, LG				Ostmeyer, Jared; Lucas, Elena; Christley, Scott; Lea, Jayanthi; Monson, Nancy; Tiro, Jasmin; Cowell, Lindsay G.			Biophysicochemical motifs in T cell receptor sequences as a potential biomarker for high-grade serous ovarian carcinoma	PLOS ONE			English	Article							TUMOR-INFILTRATING LYMPHOCYTES; BETA-CHAIN REPERTOIRE; ANTIGEN; CANCER; IDENTIFICATION; REVEALS; REGRESSION	We previously showed, in a pilot study with publicly available data, that T cell receptor (TCR) repertoires from tumor infiltrating lymphocytes (TILs) could be distinguished from adjacent healthy tissue repertoires by the presence of TCRs bearing specific, biophysicochemical motifs in their antigen binding regions. We hypothesized that such motifs might allow development of a novel approach to cancer detection. The motifs were cancer specific and achieved high classification accuracy: we found distinct motifs for breast versus colorectal cancer-associated repertoires, and the colorectal cancer motif achieved 93% accuracy, while the breast cancer motif achieved 94% accuracy. In the current study, we sought to determine whether such motifs exist for ovarian cancer, a cancer type for which detection methods are urgently needed. We made two significant advances over the prior work. First, the prior study used patient-matched TILs and healthy repertoires, collecting healthy tissue adjacent to the tumors. The current study collected TILs from patients with high-grade serous ovarian carcinoma (HGSOC) and healthy ovary repertoires from cancer-free women undergoing hysterectomy/salpingo-oophorectomy for benign disease. Thus, the classification task is distinguishing women with cancer from women without cancer. Second, in the prior study, classification accuracy was measured by patient-hold-out cross-validation on the training data. In the current study, classification accuracy was additionally assessed on an independent cohort not used during model development to establish the generalizability of the motif to unseen data. Classification accuracy was 95% by patient-hold-out cross-validation on the training set and 80% when the model was applied to the blinded test set. The results on the blinded test set demonstrate a biophysicochemical TCR motif found overwhelmingly in women with HGSOC but rarely in women with healthy ovaries, strengthening the proposal that cancer detection approaches might benefit from incorporation of TCR motif-based biomarkers. Furthermore, these results call for studies on large cohorts to establish higher classification accuracies, as well as for studies in other cancer types.	[Ostmeyer, Jared; Christley, Scott; Tiro, Jasmin] UT Southwestern Med Ctr, Dept Populat & Data Sci, Dallas, TX USA; [Lucas, Elena] UT Southwestern Med Ctr, Dept Pathol, Dallas, TX USA; [Lea, Jayanthi] UT Southwestern Med Ctr, Dept Obstet & Gynecol, Dallas, TX USA; [Monson, Nancy] UT Southwestern Med Ctr, Dept Neurol & Neurotherapeut, Dept Immunol, Dallas, TX USA; [Cowell, Lindsay G.] UT Southwestern Med Ctr, Dept Populat & Data Sci, Dept Immunol, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Cowell, LG (corresponding author), UT Southwestern Med Ctr, Dept Populat & Data Sci, Dept Immunol, Dallas, TX 75390 USA.	lindsay.cowell@utsouthwestern.edu		Cowell, Lindsay/0000-0003-1617-8244; Lea, Jayanthi/0000-0002-8657-4309	UT Southwestern Medical Center; Be the Difference Foundation; Commercial Real Estate Women of Dallas (CREW Dallas)	UT Southwestern Medical Center; Be the Difference Foundation; Commercial Real Estate Women of Dallas (CREW Dallas)	This project was supported by funding to LGC from UT Southwestern Medical Center, Be the Difference Foundation, Commercial Real Estate Women of Dallas (CREW Dallas), and an anonymous donor. CREW Dallas is NOT a commercial entity. It is a 501c3. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atchley WR, 2005, P NATL ACAD SCI USA, V102, P6395, DOI 10.1073/pnas.0408677102; Bai XL, 2015, SCI REP-UK, V5, DOI 10.1038/srep13664; Carbonneau MA, 2018, PATTERN RECOGN, V77, P329, DOI 10.1016/j.patcog.2017.10.009; Carlson CS, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3680; Carrick DM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127353; Chen ZC, 2016, J PATHOL, V239, P450, DOI 10.1002/path.4742; Christley S, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00976; Dhodapkar KM, 2013, ONCOIMMUNOLOGY, V2, DOI 10.4161/onci.25205; Dhodapkar MV, 2015, BLOOD, V126, P2475, DOI 10.1182/blood-2015-03-632919; Dhodapkar MV, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008068; Disis ML, 2009, J CLIN ONCOL, V27, P4685, DOI 10.1200/JCO.2008.20.6789; Emerson RO, 2017, NAT GENET, V49, P659, DOI 10.1038/ng.3822; Emerson RO, 2013, J PATHOL, V231, P433, DOI 10.1002/path.4260; Gee MH, 2018, CELL, V172, P549, DOI 10.1016/j.cell.2017.11.043; Gros A, 2016, NAT MED, V22, P433, DOI 10.1038/nm.4051; Jang M., 2015, ONCOIMMUNOLOGY, V4, DOI DOI 10.1080/2162402X.2015.1030561; Kenter GG, 2009, NEW ENGL J MED, V361, P1838, DOI 10.1056/NEJMoa0810097; Kingma DP., 2014, ADAM METHOD STOCHAST; Koh S, 2016, DISEASES, V4, P1; Krishnadas DK, 2013, IMMUNOTARGETS THER, V2, P11, DOI 10.2147/ITT.S35570; Kvistborg P, 2013, CURR OPIN IMMUNOL, V25, P284, DOI 10.1016/j.coi.2013.03.005; Lee PP, 1999, NAT MED, V5, P677, DOI 10.1038/9525; Louis CU, 2010, J IMMUNOTHER, V33, P983, DOI 10.1097/CJI.0b013e3181f3cbf4; Markert S, 2008, ANTICANCER RES, V28, P3567; Massa C, 2017, ONCOTARGET, V8, P21212, DOI 10.18632/oncotarget.15064; Munson DJ, 2016, P NATL ACAD SCI USA, V113, P8272, DOI 10.1073/pnas.1606994113; Nakanishi K, 2016, CANCER MED-US, V5, P2513, DOI 10.1002/cam4.828; Ostmeyer J, 2019, CANCER RES, V79, P1671, DOI 10.1158/0008-5472.CAN-18-2292; Ostmeyer J, 2017, BMC BIOINFORMATICS, V18, DOI 10.1186/s12859-017-1814-6; Page DB, 2016, CANCER IMMUNOL RES, V4, P835, DOI 10.1158/2326-6066.CIR-16-0013; Robins HS, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3007247; Romero P, 1998, J EXP MED, V188, P1641, DOI 10.1084/jem.188.9.1641; Romero P, 2002, IMMUNOL REV, V188, P81, DOI 10.1034/j.1600-065X.2002.18808.x; Savage PA, 2014, IMMUNOL REV, V259, P245, DOI 10.1111/imr.12166; Shima K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025062; Sims J.S., 2016, P NATL ACAD SCI USA; Stevanovic S, 2015, J CLIN ONCOL, V33, P1543, DOI 10.1200/JCO.2014.58.9093; Vander Heiden JA, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02206; Want MY, 2018, IMMUNOLOGY, V155, P202, DOI 10.1111/imm.12951; Ye J, 2013, NUCLEIC ACIDS RES, V41, pW34, DOI 10.1093/nar/gkt382	40	11	12	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2020	15	3							e0229569	10.1371/journal.pone.0229569	http://dx.doi.org/10.1371/journal.pone.0229569			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8RK	32134923	gold, Green Published			2022-12-26	WOS:000535265600030
J	Prieto-Ramirez, AM; Rohler, L; Cord, AF; Pe'er, G; Rodder, D; Henle, K				Prieto-Ramirez, Ana Maria; Roehler, Leonie; Cord, Anna F.; Pe'er, Guy; Roedder, Dennis; Henle, Klaus			Differential effects of habitat loss on occupancy patterns of the eastern green lizard Lacerta viridis at the core and periphery of its distribution range	PLOS ONE			English	Article							FRANKLINS GROUND-SQUIRREL; NICHE BREADTH; SPECIES SENSITIVITY; PATCH OCCUPANCY; NATAL DISPERSAL; R-PACKAGE; FRAGMENTATION; RESPONSES; SPECIALIST; MANAGEMENT	The effects of habitat loss on the distribution of populations are often linked with species specialization degree. Specialist species can be more affected by changes in landscape structure and local patch characteristics compared to generalist species. Moreover, the spatial scale at which different land covers (eg. habitat, cropland, urban areas) affect specialist species can be smaller. Specialization is usually assumed as a constant trait along the distribution range of species. However, for several taxa, there is evidence of higher specialization degree in peripheral populations compared with populations in the core. Hence, peripheral populations should have a higher sensitivity to habitat loss, and strongest effects should be found at a smaller spatial scale. To test these expectations, we implemented a patch-landscape approach at different spatial scales, and compared effects of landscape structure and patch characteristics on occupancy probability among northern peripheral, more specialized populations (Czech Republic) and core populations (Bulgaria) of the eastern green lizard Lacerta viridis. We found that landscape structure and patch characteristics affect differently the occupancy probability of Lacerta viridis in each region. Strongest effects of habitat loss were found at a spatial scale of 150m around patches in the periphery, but at a scale of 500m in the core. In the periphery occupancy probability of populations was principally affected by landscape composition, and the effect of habitat quality was stronger compared to core populations. In the core, persistence of populations was mainly explained by characteristics of the spatial configuration of habitat patches. We discuss possible ecological mechanisms behind the relationship between sensitivity to habitat loss, populations' specialization degree and position in the distribution range, and suggest conservation measures for L. viridis.	[Prieto-Ramirez, Ana Maria; Henle, Klaus] UFZ Helmholtz Ctr Environm Res, Dept Conservat Biol, Leipzig, Germany; [Roehler, Leonie; Cord, Anna F.] UFZ Helmholtz Ctr Environm Res, Dept Landscape Ecol, Leipzig, Germany; [Pe'er, Guy] German Ctr Integrat Biodivers Res iDiv Jena Halle, Leipzig, Germany; [Pe'er, Guy] UFZ Helmholtz Ctr Environm Res, Dept Econ, Leipzig, Germany; [Pe'er, Guy] UFZ Helmholtz Ctr Environm Res, Dept Ecosyst Serv, Leipzig, Germany; [Pe'er, Guy] Univ Leipzig, Leipzig, Germany; [Roedder, Dennis] Zool Res Museum Alexander Koenig ZFMK, Dept Herpetol, Bonn, Germany	Helmholtz Association; Helmholtz Center for Environmental Research (UFZ); Helmholtz Association; Helmholtz Center for Environmental Research (UFZ); Helmholtz Association; Helmholtz Center for Environmental Research (UFZ); Helmholtz Association; Helmholtz Center for Environmental Research (UFZ); Leipzig University; Zoologisches Forschungsmuseum Alexander Koenig (ZFMK)	Prieto-Ramirez, AM (corresponding author), UFZ Helmholtz Ctr Environm Res, Dept Conservat Biol, Leipzig, Germany.	ana-maria.prieto-ramire@ufz.de	Rödder, Dennis/AAT-8644-2021; Prieto, Ana María/AAE-3249-2021; Cord, Anna/AAE-8327-2022	Rödder, Dennis/0000-0002-6108-1639; Prieto Ramirez, Ana Maria/0000-0001-7633-3192	German Society for Herpetology and Herpetoculture DGHT Hans-Schiemen-Fonds; Heinrich Boll Foundation HBS Scholarship [P113742]	German Society for Herpetology and Herpetoculture DGHT Hans-Schiemen-Fonds; Heinrich Boll Foundation HBS Scholarship	A.M.P.R. German Society for Herpetology and Herpetoculture DGHT Hans-Schiemen-Fonds https://www.dght.de/startseite Heinrich Boll Foundation HBS Scholarship number P113742 https://www.boell.de/de/stiftung/heinrich-boell The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDREN H, 1994, OIKOS, V71, P355, DOI 10.2307/3545823; Augustin NH, 1996, J APPL ECOL, V33, P339, DOI 10.2307/2404755; Baguette M, 2014, MOV ECOL, V2, DOI 10.1186/s40462-014-0013-6; Banner KM, 2017, ECOL APPL, V27, P78, DOI 10.1002/eap.1419; Barton K., 2015, MUMIN MULTIMODEL INF; Bender DJ, 1998, ECOLOGY, V79, P517, DOI 10.2307/176950; Biedermann R, 2004, J BIOGEOGR, V31, P1179, DOI 10.1111/j.1365-2699.2004.01108.x; Blanchet S, 2010, EVOL APPL, V3, P291, DOI 10.1111/j.1752-4571.2009.00110.x; Blanco-Fontao B, 2010, J ORNITHOL, V151, P269, DOI 10.1007/s10336-009-0452-9; Bo hme W, 2014, WARNSIGNAL KLIMA GEF, P77; Boakes EH, 2018, CONSERV BIOL, V32, P229, DOI 10.1111/cobi.12979; Brachet S, 1999, J THEOR BIOL, V198, P479, DOI 10.1006/jtbi.1999.0926; Brito JC, 1998, HERPETOL J, V8, P187; BROWN JH, 1984, AM NAT, V124, P255, DOI 10.1086/284267; Burnham K.P., 2002, PRACTICAL INFORM THE, V2nd ed., DOI [DOI 10.1007/B97636, 10.1007/b97636]; Carrara E, 2015, BIOL CONSERV, V184, P117, DOI 10.1016/j.biocon.2015.01.014; CONRAD O., 1991, GEOSCI MODEL DEV, V8; Cote J, 2007, P R SOC B, V274, P383, DOI 10.1098/rspb.2006.3734; Cozzi G, 2008, LANDSCAPE ECOL, V23, P269, DOI 10.1007/s10980-007-9178-3; Cushman S.A., 2013, KEY TOPICS CONSERVAT, P384, DOI DOI 10.1002/9781118520178.CH21; Gomez MD, 2018, AUSTRAL ECOL, V43, P828, DOI 10.1111/aec.12625; Davies KF, 2004, ECOLOGY, V85, P265, DOI 10.1890/03-0110; Devictor V, 2008, OIKOS, V117, P507, DOI 10.1111/j.2008.0030-1299.16215.x; Donald PF, 2001, IBIS, V143, P593, DOI 10.1111/j.1474-919X.2001.tb04887.x; Duggan JM, 2011, LANDSCAPE ECOL, V26, P1477, DOI 10.1007/s10980-011-9652-9; ESRI, 2018, ARCGIS DESKT VERS 10; ESRI, 2015, ARCGIS DESKT REL 10; Fahrig L, 2001, BIOL CONSERV, V100, P65, DOI 10.1016/S0006-3207(00)00208-1; Fahrig L, 2003, ANNU REV ECOL EVOL S, V34, P487, DOI 10.1146/annurev.ecolsys.34.011802.132419; Fahrig L, 2013, J BIOGEOGR, V40, P1649, DOI 10.1111/jbi.12130; Fielding AH, 1997, ENVIRON CONSERV, V24, P38, DOI 10.1017/S0376892997000088; Fiske IJ, 2011, J STAT SOFTW, V43, P1; Fletcher RJ, 2007, CAN J ZOOL, V85, P1017, DOI 10.1139/Z07-100; Freeman EA, 2008, J STAT SOFTW, V23, P1; Fynn I. E. M., 2019, Journal of Landscape Ecology, V12, P1, DOI 10.2478/jlecol-2019-0001; Gardiner R, 2018, LANDSCAPE ECOL, V33, P1837, DOI 10.1007/s10980-018-0722-0; Grimm A, 2014, NAT CONSERV-BULGARIA, P45, DOI 10.3897/natureconservation.9.8908; Hampe A, 2005, ECOL LETT, V8, P461, DOI 10.1111/j.1461-0248.2005.00739.x; Hanski I, 1998, NATURE, V396, P41, DOI 10.1038/23876; Helzer CJ, 1999, ECOL APPL, V9, P1448; Henle K, 2004, BIODIVERS CONSERV, V13, P207, DOI 10.1023/B:BIOC.0000004319.91643.9e; Henle K, 2017, LANDSCAPE ECOL, V32, P131, DOI 10.1007/s10980-016-0418-2; Hoehn M, 2007, MOL ECOL, V16, P3299, DOI 10.1111/j.1365-294X.2007.03352.x; IPR, 2010, PLAN VYUZ FUNKCN PLO; Jackson HB, 2012, LANDSCAPE ECOL, V27, P929, DOI 10.1007/s10980-012-9757-9; Janssen I, 2006, MONITORING NETWORK R; Jauker B, 2013, LANDSCAPE ECOL, V28, P107, DOI 10.1007/s10980-012-9820-6; Keinath DA, 2017, GLOBAL ECOL BIOGEOGR, V26, P115, DOI 10.1111/geb.12509; Korsos Z., 1983, VERTEBRATA HUNGARICA, V22, P5; Krauss J, 2003, J BIOGEOGR, V30, P889, DOI 10.1046/j.1365-2699.2003.00878.x; Lappalainen J, 2006, NATURWISSENSCHAFTEN, V93, P246, DOI 10.1007/s00114-006-0093-2; Lucas PM, 2016, ECOGRAPHY, V39, P1100, DOI 10.1111/ecog.01819; MACARTHUR R, 1961, ECOLOGY, V42, P594, DOI 10.2307/1932254; MacArthur R.H., 1967, THEORY ISLAND BIOGEO, DOI DOI 10.1080/00379271.2014.984955; Mackenzie DI, 2005, J APPL ECOL, V42, P1105, DOI 10.1111/j.1365-2664.2005.01098.x; MacKenzie DI, 2004, J AGR BIOL ENVIR ST, V9, P300, DOI 10.1198/108571104X3361; MacKenzie DI, 2002, ECOLOGY, V83, P2248, DOI 10.1890/0012-9658(2002)083[2248:ESORWD]2.0.CO;2; Mangiacotti M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067573; Martin JM, 2005, AM MIDL NAT, V153, P444, DOI 10.1674/0003-0031(2005)153[0444:JDOFGS]2.0.CO;2; Mazerolle M.J., 2019, **DATA OBJECT**; McGarigal K., 2012, FRAGSTATS V4 SPATIAL; Melo GL, 2017, BIOL CONSERV, V209, P304, DOI 10.1016/j.biocon.2017.02.031; Michaelides G, 2009, J BIOL RES-THESSALON, V12, P211; Miguet P, 2016, LANDSCAPE ECOL, V31, P1177, DOI 10.1007/s10980-015-0314-1; Mollov Ivelin A., 2011, Biharean Biologist, V5, P25; Morris DW, 1996, ECOLOGY, V77, P2352, DOI 10.2307/2265737; Moser J., 1998, Beitraege zur Naturkunde Oberoesterreichs, V6, P391; Munsch T, 2019, J INSECT CONSERV, V23, P247, DOI 10.1007/s10841-018-0109-1; Ockinger E, 2010, ECOL LETT, V13, P969, DOI 10.1111/j.1461-0248.2010.01487.x; Olsson M., 1988, Mertensiella, P86; Peterman WE, 2013, BIOL CONSERV, V158, P351, DOI 10.1016/j.biocon.2012.07.028; Prieto-Ramirez AM, 2018, ECOL EVOL, V8, P11322, DOI 10.1002/ece3.4612; Puttker T, 2013, J MAMMAL, V94, P714, DOI 10.1644/12-MAMM-A-119.1; R Core Team, 2013, R LANG ENV STAT COMP; Ries L, 2004, ANNU REV ECOL EVOL S, V35, P491, DOI 10.1146/annurev.ecolsys.35.112202.130148; Ronce O, 1998, P NATL ACAD SCI USA, V95, P600, DOI 10.1073/pnas.95.2.600; SAINTGIRONS H, 1989, BIJDR DIERKD, V59, P63, DOI 10.1163/26660644-05902001; Sewell D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043387; Soga M, 2013, J FOREST RES-JPN, V18, P270, DOI 10.1007/s10310-012-0349-y; SVENSSON BW, 1992, OIKOS, V63, P147, DOI 10.2307/3545524; Swihart RK, 2003, DIVERS DISTRIB, V9, P1, DOI 10.1046/j.1472-4642.2003.00158.x; Thomas JA, 1999, FUNCT ECOL, V13, P55, DOI 10.1046/j.1365-2435.1999.00008.x; Thompson ME, 2018, J THERM BIOL, V75, P54, DOI 10.1016/j.jtherbio.2018.05.007; Vasudev D, 2015, ECOGRAPHY, V38, P967, DOI 10.1111/ecog.01306; Vergara PM, 2009, LANDSCAPE ECOL, V24, P25, DOI 10.1007/s10980-008-9275-y; Villard MA, 2014, J APPL ECOL, V51, P309, DOI 10.1111/1365-2664.12190; Waitzmann M., 1990, Herpetozoa, V3, P25; Yackulic CB, 2011, P NATL ACAD SCI USA, V108, P4024, DOI 10.1073/pnas.1015097108; Ye XP, 2013, LANDSCAPE ECOL, V28, P135, DOI 10.1007/s10980-012-9826-0; Yurkowski DJ, 2016, ECOL EVOL, V6, P1666, DOI 10.1002/ece3.1980	90	2	3	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2020	15	3							e0229600	10.1371/journal.pone.0229600	http://dx.doi.org/10.1371/journal.pone.0229600			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8RK	32134932	Green Published, gold			2022-12-26	WOS:000535265600033
J	Sadakata, M; Weidema, JL; Honing, H				Sadakata, Makiko; Weidema, Joey L.; Honing, Henkjan			Parallel pitch processing in speech and melody: A study of the interference of musical melody on lexical pitch perception in speakers of Mandarin	PLOS ONE			English	Article							TIME-COURSE	Music and language have long been considered two distinct cognitive faculties governed by domain-specific cognitive and neural mechanisms. Recent work into the domain-specificity of pitch processing in both domains appears to suggest pitch processing to be governed by shared neural mechanisms. The current study aimed to explore the domain-specificity of pitch processing by simultaneously presenting pitch contours in speech and music to speakers of a tonal language, and measuring behavioral response and event-related potentials (ERPs). Native speakers of Mandarin were exposed to concurrent pitch contours in melody and speech. Contours in melody emulated those in speech were either congruent or incongruent with the pitch contour of the lexical tone (i.e., rising or falling). Component magnitudes of the N2b and N400 were used as indices of lexical processing. We found that the N2b was modulated by melodic pitch; incongruent item evoked significantly stronger amplitude. There was a trend of N400 to be modulated in the same way. Interestingly, these effects were present only on rising tones. Amplitude and time-course of the N2b and N400 may suggest an interference of melodic pitch contours with both early and late stages of phonological and semantic processing.	[Sadakata, Makiko; Weidema, Joey L.; Honing, Henkjan] Univ Amsterdam, Amsterdam Brain & Cognit, Inst Log Language & Computat, Amsterdam, Netherlands; [Sadakata, Makiko; Honing, Henkjan] Univ Amsterdam, Musicol Dept, Amsterdam, Netherlands	University of Amsterdam; University of Amsterdam	Sadakata, M (corresponding author), Univ Amsterdam, Amsterdam Brain & Cognit, Inst Log Language & Computat, Amsterdam, Netherlands.; Sadakata, M (corresponding author), Univ Amsterdam, Musicol Dept, Amsterdam, Netherlands.	m.sadakata@uva.nl	; Honing, Henkjan/A-1362-2012	Sadakata, Makiko/0000-0002-3931-0642; Honing, Henkjan/0000-0001-7046-7923	Horizon grant of the Netherlands Organization for Scientific Research (NWO) [317-70-010]; Distinguished Lorentz fellowship - Lorentz Center for the Sciences; Netherlands Institute for Advanced Study in the Humanities and Social Sciences (NIAS)	Horizon grant of the Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Distinguished Lorentz fellowship - Lorentz Center for the Sciences; Netherlands Institute for Advanced Study in the Humanities and Social Sciences (NIAS)	JW and HH are supported by a Horizon grant (317-70-010) of the Netherlands Organization for Scientific Research (NWO). HH was supported by a Distinguished Lorentz fellowship granted by the Lorentz Center for the Sciences and the Netherlands Institute for Advanced Study in the Humanities and Social Sciences (NIAS).	Abrams DA, 2011, CEREB CORTEX; Asaridou SS, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00321; Baumann S, 2008, J COGN NEUROSCI; Bent T, 2006, J EXP PSYCHOL HUM PE; Bidelman GM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060676; Bidelman GM, 2011, NEUROSCI LETT; Bidelman GM, 2011, BRAIN COGN; Boersma P., 2014, MESQUITE MODULAR SYS, V5, P84; Cai Q, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010729; Chandrasekaran B, 2007, RESTOR NEUROL NEUROS; Chandrasekaran B, 2009, BRAIN LANG; D'Arcy RCN, 2000, CLIN NEUROPHYSIOL; DEACON D, 1991, PSYCHOPHYSIOLOGY, V28, P185, DOI 10.1111/j.1469-8986.1991.tb00411.x; Delogu F, 2010, EUR J COGN PSYCHOL, DOI [10.1080/09541440903155658, DOI 10.1080/09541440903155658]; Delorme A., 2004, J NEUROSCI METHODS; Dumay N, 2001, J COGN NEUROSCI; Erlbeck H, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00654; Folstein JR, 2008, PSYCHOPHYSIOLOGY; Gagnon L, 2003, COGNITION EMOTION; Gerardi GM, 1995, DEV AFFECTIVE RESPON; Honing H., 2019, ORIGINS MUSICALITY; Huang X, 2016, SCI REP; Huang XJ, 2014, NEUROPSYCHOLOGIA, V63, P165, DOI 10.1016/j.neuropsychologia.2014.08.015; Hutka S, 2015, NEUROPSYCHOLOGIA; Koelsch S, 2005, J COGN NEUROSCI; Koelsch S, 2004, NAT NEUROSCI; Kolinsky R, 2009, COGNITION; Krishnan A, 2009, NEUROREPORT; Kuhnis J, 2013, NEUROPSYCHOLOGIA; KUTAS M, 1980, SCIENCE, V207, P203, DOI 10.1126/science.7350657; Kutas M, 1984, NATURE; Kutas M, 2011, ANN REV PSYCHOL; Lidji P P, 2010, CLIN NEUROPHYSIOL; Lopez-Calderon J, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00213; Luck S.J., 2005, INTRO EVENT RELATED; Marie C, 2011, J COGN NEUROSCI; Nguyen S, 2009, ANN NEW YORK ACAD SC; Nieuwland MS, 2006, J COGN NEUROSCI; Norman-Haignere S, 2015, NEURON; Oechslin MS, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/neuro.09.076.2009; Oechslin MS, 2010, CEREB CORTEX; Ott CGM, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00195; Paavilainen P., 2007, CLIN NEUROPHYSIOLOGY; Patel A. D., 2012, LANGUAGE MUSIC COGNI; Patel AD, 2015, LANGUAGE MUSIC BRAIN; Patel AD, 2008, MUSIC PERCEPT, DOI [10.1525/MP.2008.25.4.315, DOI 10.1525/MP.2008.25.4.315]; Patel SH, 2005, INT J MED SCI; Peretz I, 2003, TRENDS COGN SCI, V7, P362, DOI 10.1016/S1364-6613(03)00150-5; Peretz I., 2016, TRENDS COGNITIVE SCI; Peretz I., 2009, MUSIC LANGUAGE MODUL; Peretz I, 2015, PHILOS T ROYAL SOC B; Peretz I, 2015, PHILOS T R SOC B, V370, P68, DOI 10.1098/rstb.2014.0090; Peretz I, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00145; Perrin F, 2003, COGN BRAIN RES; Polich J., 2007, CLIN NEUROPHYSIOLOGY; Praamstra P, 1994, J COGN NEUROSCI; Rogalsky C, 2011, J NEUROSCI; Sams M, 1983, BIOL PSYCHOL; Schirmer A, 2005, J COGNITIVE NEUROSCI, V17, P1, DOI 10.1162/0898929052880057; Schmitt BM, 2000, PSYCHOPHYSIOLOGY, V37, P473, DOI 10.1017/S0048577200981782; Steinbeis N., 2008, PLOS ONE, V3, P1, DOI [10.1371/journal.pone, DOI 10.1371/JOURNAL.PONE]; Sutton S, 1965, SCIENCE; Tervaniemi M, 2009, EUR J NEUROSCI; Tierney A, 2013, CEREB CORTEX, V23, P249, DOI 10.1093/cercor/bhs003; Tillmann B, 2011, FRONT PSYCHOL; Tillmann B, 2011, J ACOUST SOC AM; Van Den Brink D, 2001, J COGN NEUROSCI; Weidema JL, 2016, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.00817; Wong PCM, 2007, NAT NEUROSCI, V10, P420, DOI 10.1038/nn1872; Xu Y, 2006, NEUROREPORT; Yip M., 2002, TONE; Zatorre RJ, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001372	72	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2020	15	3							e0229109	10.1371/journal.pone.0229109	http://dx.doi.org/10.1371/journal.pone.0229109			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LQ8QU	32130244	Green Published, gold			2022-12-26	WOS:000535264000015
J	Tsukumo, Y; Naito, M; Suzuki, T				Tsukumo, Yoshinori; Naito, Mikihiko; Suzuki, Takayoshi			Influence of EGFR-activating mutations on sensitivity to tyrosine kinase inhibitors in a KRAS mutant non-small cell lung cancer cell line	PLOS ONE			English	Article							CLINICAL-PRACTICE GUIDELINES; FACTOR RECEPTOR GENE; ADENOCARCINOMA; RESISTANCE; RESPONSIVENESS; STATISTICS; EVOLUTION; IMPACT	In non-small cell lung cancer (NSCLC), oncogenic driver mutations including those in KRAS and EGFR are typically mutually exclusive. However, recent reports indicate that multiple driver mutations are found in a certain percentage of cancers, and that the therapeutic responses of such cases with co-mutations of driver genes are largely unclear. Here, using CRISPR-Cas9-mediated genome editing, we generated isogenic cell lines harboring one or two copies of an EGFR-activating mutation from the human NSCLC cell line A549, which is known to harbor a homozygous KRAS gene mutation. In comparison with parent cells with KRAS mutation alone, cells with concomitant EGFR mutation exhibited higher sensitivity to EGFR-tyrosine kinase inhibitors (TKIs) but not to conventional anti-cancer drugs. In particular, cells with two copies of EGFR mutation were markedly more sensitive to EGFR-TKIs compared with parent cells. Thus, the presence of concomitant EGFR mutation can affect the TKI response of KRAS-mutated cells, implying that EGFR-TKI may represent an effective treatment option against NSCLC with EGFR/KRAS co-mutation.	[Tsukumo, Yoshinori; Naito, Mikihiko; Suzuki, Takayoshi] Natl Inst Hlth Sci, Div Mol Target & Gene Therapy Prod, Kawasaki, Kanagawa, Japan	National Institute of Health Sciences - Japan	Tsukumo, Y (corresponding author), Natl Inst Hlth Sci, Div Mol Target & Gene Therapy Prod, Kawasaki, Kanagawa, Japan.	tsukumo@nihs.go.jp	SUZUKI, TAKAYOSHI/ABA-2386-2020	SUZUKI, TAKAYOSHI/0000-0002-2261-5263	MEXT/JSPS KAKENHI [JP19K07724, JP16K18444, JP16H05090, JP18H05502]; AMED [JP19ak0101073j0603, JP19im0210616j0002, JP18mk0102093j0202]; Takeda Science Foundation	MEXT/JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); AMED; Takeda Science Foundation(Takeda Science Foundation (TSF))	This study was supported by MEXT/JSPS KAKENHI (Grant Numbers JP19K07724, JP16K18444 to Y.T., JP16H05090, JP18H05502 to M.N.), by AMED (Grant Numbers JP19ak0101073j0603, JP19im0210616j0002 to M. N., JP18mk0102093j0202 to T.S), and by the Takeda Science Foundation (to Y.T.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adderley H, 2019, EBIOMEDICINE, V41, P711, DOI 10.1016/j.ebiom.2019.02.049; Baldi L, 2014, LUNG CANCER, V86, P291, DOI 10.1016/j.lungcan.2014.09.011; Blakely CM, 2017, NAT GENET, V49, P1693, DOI 10.1038/ng.3990; Cancer Genome Atlas Research Network, 2014, Nature, V511, P543, DOI [10.1038/s41586-018-0228-6, 10.1038/nature13385]; Chiang TWW, 2016, SCI REP-UK, V6, DOI 10.1038/srep24356; Chong CR, 2013, NAT MED, V19, P1389, DOI 10.1038/nm.3388; Dearden S, 2013, ANN ONCOL, V24, P2371, DOI 10.1093/annonc/mdt205; Engelman JA, 2006, J CLIN INVEST, V116, P2695, DOI 10.1172/JCI28656; Ettinger DS, 2017, J NATL COMPR CANC NE, V15, P504, DOI 10.6004/jnccn.2017.0050; Gandhi J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004576; Guibert N, 2017, J THORAC ONCOL, V12, P963, DOI 10.1016/j.jtho.2017.02.001; Hu WT, 2017, ONCOTARGET, V8, P25046, DOI 10.18632/oncotarget.15337; Ikediobi ON, 2006, MOL CANCER THER, V5, P2606, DOI 10.1158/1535-7163.MCT-06-0433; Jakobsen Jan Nyrop, 2018, Oncotarget, V9, P26195, DOI 10.18632/oncotarget.25490; Jamal-Hanjani M, 2017, NEW ENGL J MED, V376, P2109, DOI 10.1056/NEJMoa1616288; Jordan EJ, 2017, CANCER DISCOV, V7, P596, DOI 10.1158/2159-8290.CD-16-1337; Kondo Y, 2017, BMC CANCER, V17, DOI 10.1186/s12885-017-3305-6; Kruspig B, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aao2565; Lauand C, 2013, CANCER CELL INT, V13, DOI 10.1186/1475-2867-13-38; Lee T, 2016, J PATHOL TRANSL MED, V50, P197, DOI 10.4132/jptm.2016.03.09; Linardou H, 2008, LANCET ONCOL, V9, P962, DOI 10.1016/S1470-2045(08)70206-7; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Mao C, 2010, LUNG CANCER, V69, P272, DOI 10.1016/j.lungcan.2009.11.020; Mitsudomi T, 2007, CANCER SCI, V98, P1817, DOI 10.1111/j.1349-7006.2007.00607.x; Moll HP, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aao2301; Papadimitrakopoulou V, 2016, J CLIN ONCOL, V34, P3638, DOI 10.1200/JCO.2015.66.0084; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Raimbourg J, 2017, MOL CANCER THER, V16, P1634, DOI 10.1158/1535-7163.MCT-17-0075; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Ran FA, 2013, CELL, V154, P1380, DOI 10.1016/j.cell.2013.08.021; Reck M, 2014, ANN ONCOL, V25, P27, DOI 10.1093/annonc/mdu199; Rulli E, 2015, ANN ONCOL, V26, P2079, DOI 10.1093/annonc/mdv318; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Sholl LM, 2015, J THORAC ONCOL, V10, P768, DOI 10.1097/JTO.0000000000000516; Siegel RL, 2017, CA-CANCER J CLIN, V67, P7, DOI 10.3322/caac.21387; Tracy S, 2004, CANCER RES, V64, P7241, DOI 10.1158/0008-5472.CAN-04-1905; Won JK, 2015, ANN ONCOL, V26, P348, DOI 10.1093/annonc/mdu530; Yang JCH, 2015, LANCET ONCOL, V16, P141, DOI 10.1016/S1470-2045(14)71173-8; Yang JJ, 2014, CLIN CANCER RES, V20, P1383, DOI 10.1158/1078-0432.CCR-13-0699; Zhang H, 2016, THORAC CANCER, V7, P24, DOI 10.1111/1759-7714.12266; Zheng G, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1811-y	41	5	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2020	15	3							e0229712	10.1371/journal.pone.0229712	http://dx.doi.org/10.1371/journal.pone.0229712			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8QU	32130260	Green Published, Green Submitted, gold			2022-12-26	WOS:000535264000045
J	Parola, A; Salvini, R; Gabbatore, I; Colle, L; Berardinelli, L; Bosco, FM				Parola, Alberto; Salvini, Rogerio; Gabbatore, Ilaria; Colle, Livia; Berardinelli, Laura; Bosco, Francesca M.			Pragmatics, Theory of Mind and executive functions in schizophrenia: Disentangling the puzzle using machine learning	PLOS ONE			English	Article							LANGUAGE; COMPREHENSION; DEFICITS; AUTISM; COMMUNICATION; DISTURBANCES; IMPAIRMENT; ABILITIES; DISORDER; PEOPLE	Objective Schizophrenia is associated with a severe impairment in the communicative-pragmatic domain. Recent research has tried to disentangle the relationship between communicative impairment and other domains usually impaired in schizophrenia, i.e. Theory of Mind (ToM) and cognitive functions. However, the results are inconclusive and this relationship is still unclear. Machine learning (ML) provides novel opportunities for studying complex relationships among phenomena and representing causality among multiple variables. The present research explored the potential of applying ML, specifically Bayesian network (BNs) analysis, to characterize the relationship between cognitive, ToM and pragmatic abilities in individuals with schizophrenia and healthy controls, and to identify the cognitive and pragmatic abilities that are most informative in discriminating between schizophrenia and controls. Methods We provided a comprehensive assessment of different aspects of pragmatic performance, i.e. linguistic, extralinguistic, paralinguistic, contextual and conversational, ToM and cognitive functions, i.e. Executive Functions (EF)-selective attention, planning, inhibition, cognitive flexibility, working memory and speed processing-and general intelligence, in a sample of 32 individuals with schizophrenia and 35 controls. Results The results showed that the BNs classifier discriminated well between patients with schizophrenia and healthy controls. The network structure revealed that only pragmatic Linguistic ability directly influenced the classification of patients and controls, while diagnosis determined performance on ToM, Extralinguistic, Paralinguistic, Selective Attention, Planning, Inhibition and Cognitive Flexibility tasks. The model identified pragmatic, ToM and cognitive abilities as three distinct domains independent of one another. Conclusion Taken together, our results confirmed the importance of considering pragmatic linguistic impairment as a core dysfunction in schizophrenia, and demonstrated the potential of applying BNs in investigating the relationship between pragmatic ability and cognition.	[Parola, Alberto; Gabbatore, Ilaria; Colle, Livia; Bosco, Francesca M.] Univ Turin, Dept Psychol, Turin, Italy; [Salvini, Rogerio] Univ Fed Goias, Inst Informat, Goiania, Go, Brazil; [Berardinelli, Laura] ASL Citta Torino, Dept Mental Hlth, Turin, Italy; [Bosco, Francesca M.] Inst Neurosci Turin, Turin, Italy	University of Turin; Universidade Federal de Goias	Gabbatore, I (corresponding author), Univ Turin, Dept Psychol, Turin, Italy.	ilaria.gabbatore@unito.it	Parola, alberto/AAK-3748-2020; Gabbatore, Ilaria/AAC-1925-2019; BOSCO, Francesca Marina/B-6746-2013; Salvini, Rogerio/B-2141-2017	Gabbatore, Ilaria/0000-0002-9724-8066; BOSCO, Francesca Marina/0000-0001-6101-8587; Salvini, Rogerio/0000-0001-8889-6654; PAROLA, ALBERTO/0000-0002-6039-0907	Compagnia di San Paolo: Bando Ex-post University of Turin [D11G19000220007]; FAPEG (Fundacao de Amparo a Pesquisa do Estado de Goias) Mobility Confap-Italy MCI 2018 fellowship; Marie Sklodowska-Curie Actions (MSCA) -Individuals Fellowship H2020-MSCA-IF-2018 [832518]	Compagnia di San Paolo: Bando Ex-post University of Turin(Compagnia di San Paolo); FAPEG (Fundacao de Amparo a Pesquisa do Estado de Goias) Mobility Confap-Italy MCI 2018 fellowship; Marie Sklodowska-Curie Actions (MSCA) -Individuals Fellowship H2020-MSCA-IF-2018	This work was supported by Compagnia di San Paolo: Bando Ex-post University of Turin. Grant Number: D11G19000220007. RS was supported by FAPEG (Fundacao de Amparo a Pesquisa do Estado de Goias) Mobility Confap-Italy MCI 2018 fellowship. AP was supported by Marie Sklodowska-Curie Actions (MSCA) -Individuals Fellowship H2020-MSCA-IF-2018 (Grant agreement ID: 832518, Project: MOVES) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Akel A., 1999, PRAGMAT COGN, V7, P247, DOI DOI 10.1075/PC.7.2.02ABU; Angeleri R., 2015, BATTERIA ASSESSMENT; Angeleri R, 2012, BEHAV RES METHODS, V44, P845, DOI 10.3758/s13428-011-0174-9; [Anonymous], 1919, DEMENTIA PRECOX PARA; Ashby D, 1991, STATISTIC MED, V10, P1635, DOI [10.1002/sim.4780101015, DOI 10.1002/SIM.4780101015]; Bambini V, 2016, COMPR PSYCHIAT, V71, P106, DOI 10.1016/j.comppsych.2016.08.012; Bara B. G., 2010, COGNITIVE PRAGMATCIS; Belizario GO, 2019, J AFFECT DISORDERS, V245, P279, DOI 10.1016/j.jad.2018.11.051; Bleuler E., 1911, DEMENTIA PRAECOX GRO; Bone D, 2017, IEEE SIGNAL PROCESS, V34; Bone D, 2016, J CHILD PSYCHOL PSYC, V57, P927, DOI 10.1111/jcpp.12559; Bone D, 2015, J AUTISM DEV DISORD, V45, P1121, DOI 10.1007/s10803-014-2268-6; Bosco FM, 2016, PSYCHOL CLIN SETTING, V7, P1, DOI DOI 10.3389/FPSYG.2016.00566; Bosco FM, 2019, FRONT PSYCHOL, V10, DOI 10.3389/fpsyg.2019.00827; Bosco FM, 2018, FRONT PSYCHOL, V9, DOI 10.3389/fpsyg.2018.01453; Bosco FM, 2012, J COMMUN DISORD, V45, P290, DOI 10.1016/j.jcomdis.2012.03.002; Bosco FM, 2012, J COMMUN DISORD, V45, P181, DOI 10.1016/j.jcomdis.2012.01.005; Bouckaert R.R., 2004, BAYESIAN NETWORK CLA; Bowie CR, 2008, SCHIZOPHR RES, V103, P240, DOI 10.1016/j.schres.2008.05.006; Brune M, 2005, SCHIZOPHR RES, V75, P233, DOI 10.1016/j.schres.2004.11.006; Bzdok Danilo, 2018, Nat Methods, V15, P233, DOI 10.1038/nmeth.4642; Bzdok D, 2018, BIOL PSYCHIAT-COGN N, V3, P223, DOI 10.1016/j.bpsc.2017.11.007; Champagne-Lavau M, 2010, J NEUROLINGUIST, V23, P285, DOI 10.1016/j.jneuroling.2009.08.009; Colle L, 2013, J COMMUN DISORD, V46, P294, DOI 10.1016/j.jcomdis.2013.01.003; Conway ARA, 2003, TRENDS COGN SCI, V7, P547, DOI 10.1016/j.tics.2003.10.005; Cummings L., 2014, PRAGMATIC DISORDERS, P177; DERENZI E, 1962, BRAIN, V85, P665, DOI 10.1093/brain/85.4.665; Duering M, 2013, NEUROIMAGE, V66, P177, DOI 10.1016/j.neuroimage.2012.10.084; Fayyad UM, 1993, P 13 INT JT C ART IN; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Frank Eibe, 2016, ONLINE APPENDIX DATA; FRITH C. D., 1992, COGNITIVE NEUROPSYCH; Frith CD, 1996, PSYCHOL MED, V26, P521, DOI 10.1017/S0033291700035601; Fusaroli R, 2017, AUTISM RES, V10, P384, DOI 10.1002/aur.1678; Gabbatore I, 2017, NEURAL PLAST, V2017, DOI 10.1155/2017/1612078; Gabbatore I, 2015, J HEAD TRAUMA REHAB, V30, pE14, DOI 10.1097/HTR.0000000000000087; Ibanez JMG, 2013, PSICOTHEMA, V25, P440, DOI 10.7334/psicothema2012.357; Gazzaley A, 2012, TRENDS COGN SCI, V16, P129, DOI 10.1016/j.tics.2011.11.014; Green MF, 2015, NAT REV NEUROSCI, V16, P620, DOI 10.1038/nrn4005; Haas MH, 2015, J PSYCHOLINGUIST RES, V44, P469, DOI 10.1007/s10936-014-9298-2; Han K, 2012, COMPUT BIOL MED, DOI [10.1016/compbiomed.2012.06.007, DOI 10.1016/COMPBIOMED.2012.06.007]; Happe F, 2002, MIND LANG, V17, P24, DOI 10.1111/1468-0017.00187; HAPPE FGE, 1993, COGNITION, V48, P101, DOI 10.1016/0010-0277(93)90026-R; HAPPE FGE, 1994, J AUTISM DEV DISORD, V24, P129, DOI 10.1007/BF02172093; Huber W, 1984, Adv Neurol, V42, P291; Kay S., 1987, SCHIZOPHR B, P13; Kerns JG, 2008, BIOL PSYCHIAT, V64, P26, DOI 10.1016/j.biopsych.2008.04.027; Kluwe-Schiavon B, 2013, J PSYCHIATR RES, V47, P91, DOI 10.1016/j.jpsychires.2012.10.001; Koul A, 2018, BEHAV RES METHODS, V50, P1657, DOI 10.3758/s13428-017-0987-2; Langdon R, 2002, MIND LANG, V17, P68, DOI 10.1111/1468-0017.00189; Langdon R, 2002, PSYCHOL MED, V32, P1273, DOI 10.1017/S0033291702006396; Langdon R., 2001, COGNITIVE NEUROPSYCH, V6, P81, DOI DOI 10.1080/13546800042000061; Levinson S. C., 1983, PRAGMATICS; Marini A, 2008, SCHIZOPHR RES, V105, P144, DOI 10.1016/j.schres.2008.07.011; Martin I, 2003, BRAIN LANG, V85, P451, DOI 10.1016/S0093-934X(03)00070-1; Maylor EA, 2002, DOES PERFORMANCE THE, P465; Mazza M, 2008, PSYCHOPATHOLOGY, V41, P254, DOI 10.1159/000128324; McNally RJ, 2017, EUR J PSYCHOTRAUMATO, V8, DOI 10.1080/20008198.2017.1341276; Miyake A, 2000, COGNITIVE PSYCHOL, V41, P49, DOI 10.1006/cogp.1999.0734; Mo SL, 2008, PSYCHIAT RES, V157, P21, DOI 10.1016/j.psychres.2006.04.002; Montemurro S, 2019, FRONT PSYCHOL, V10, DOI 10.3389/fpsyg.2019.01220; Mossaheb N, 2014, COMPR PSYCHIAT, V55, P928, DOI 10.1016/j.comppsych.2013.12.021; NELSON HE, 1976, CORTEX, V12, P313, DOI 10.1016/S0010-9452(76)80035-4; Park E, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00699; Parola A., 2018, REHABILITATION MED E, P357, DOI [10.1007/978-3-319-57406-6_36, DOI 10.1007/978-3-319-57406-6_36]; Parola A, 2020, SCHIZOPHR RES, V216, P24, DOI 10.1016/j.schres.2019.11.031; Parola A, 2018, PSYCHIAT RES, V260, P144, DOI 10.1016/j.psychres.2017.11.051; Parola A, 2016, J NEUROLINGUIST, V39, P10, DOI 10.1016/j.jneuroling.2015.12.003; Pawelczyk A, 2018, PSYCHIAT RES, V267, P63, DOI 10.1016/j.psychres.2018.05.070; Pearl J, 1988, PROBABILISTIC REASON; PERNER J, 1989, CHILD DEV, V60, P689, DOI 10.2307/1130734; Peterson CC, 2000, MIND LANG, V15, P123, DOI 10.1111/1468-0017.00126; Pinheiro AP, 2017, PSYCHOPHYSIOLOGY, V54, P1252, DOI 10.1111/psyp.12880; PREMACK D, 1978, BEHAV BRAIN SCI, V1, P515, DOI 10.1017/S0140525X00076512; Raven J., 2003, RAVEN PROGR MATRICES, DOI [10.1007/978-1-4615-0153-4_11, DOI 10.1007/978-1-4615-0153-4_11]; REITAN R. M., 1958, PERCEPT MOT SKILLS, V8, P271; Schettino A, 2010, NEUROPSYCHOLOGIA, V48, P1032, DOI 10.1016/j.neuropsychologia.2009.11.030; Seixas FL, 2014, COMPUT BIOL MED, V51, P140, DOI 10.1016/j.compbiomed.2014.04.010; Sperber D, 2002, MIND LANG, V17, P3, DOI 10.1111/1468-0017.00186; Spinnler H., 1987, ITAL J NEUROL SCI, V6, P21; Sponheim SR, 2003, SCHIZOPHR RES, V65, P117, DOI 10.1016/S0920-9964(02)00525-X; Tan EJ, 2014, COMPR PSYCHIAT, V55, P693, DOI 10.1016/j.comppsych.2013.10.016; Tavano A, 2008, SCHIZOPHR RES, V102, P53, DOI 10.1016/j.schres.2008.02.008; Thoma P, 2009, PSYCHIAT RES, V170, P132, DOI 10.1016/j.psychres.2009.01.026; WIMMER H, 1983, COGNITION, V13, P103, DOI 10.1016/0010-0277(83)90004-5; Winner E, 1998, BRAIN LANG, V62, P89, DOI 10.1006/brln.1997.1889	86	16	16	4	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2020	15	3							e0229603	10.1371/journal.pone.0229603	http://dx.doi.org/10.1371/journal.pone.0229603			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LQ8MS	32126068	Green Published, gold			2022-12-26	WOS:000535253100036
J	Yoo, YJ; Kang, CM; Choi, M; Rho, SY; Hwang, HK; Lee, WJ; Kim, EW; Lee, JA				Yoo, Young Jin; Kang, Chang Moo; Choi, Munseok; Rho, Seung Yoon; Hwang, Ho Kyung; Lee, Woo Jung; Kim, Eun Wha; Lee, Jin Ae			Preoperative prognostic nutritional index as an independent prognostic factor for resected ampulla of Vater cancer	PLOS ONE			English	Article							HEPATOCELLULAR-CARCINOMA; SURGICAL-TREATMENT; PREDICTS SURVIVAL; GASTRIC-CANCER; PNI PREDICTS; TUMOR; COMPLICATIONS; TRANSFERRIN; RECURRENCE; OUTCOMES	Introduction Prognostic nutritional index (PNI) reflects the nutritional and immunologic status of the patients. The clinical application of PNI is already well-known in various kinds of solid tumors. However, there is no study investigating the relationship between PNI and oncological outcome of the resected ampulla of Vater (AoV) cancer. Materials and methods From January 2005 to December 2012, the medical records of patients who underwent pancreaticoduodenectomy for pathologically confirmed AoV cancer were retrospectively reviewed. Long-term oncological outcomes were compared according to the preoperative PNI value. Result A total of 118 patients were enrolled in this study. The preoperative PNI was 46.13 +/- 6.63, while the mean disease-free survival was 43.88 months and the mean disease-specific survival was 55.3 months. In the multivariate Cox analysis, initial CA19-9 (p = 0.0399), lymphovascular invasion (p = 0.0031), AJCC 8th N-stage (p = 0.0018), and preoperative PNI (p = 0.0081) were identified as significant prognostic factors for resected AoV cancer. The disease-specific survival was better in the high preoperative PNI group (<= 48.85: 40.77 months vs. >48.85: 68.05 months, p = 0.0015). A highly accurate nomogram was developed based on four clinical components to predict the 1, 3, and 5-year disease-specific survival probability (C-index 0.8169, 0.8426, and 0.8233, respectively). Conclusion In resected AoV cancer, preoperative PNI can play a significant role as an independent prognostic factor for predicting disease-specific survival.	[Yoo, Young Jin; Kang, Chang Moo; Choi, Munseok; Rho, Seung Yoon; Hwang, Ho Kyung; Lee, Woo Jung] Yonsei Univ, Coll Med, Dept Hepatobiliary & Pancreat Surg, Seoul, South Korea; [Kang, Chang Moo; Rho, Seung Yoon; Hwang, Ho Kyung; Lee, Woo Jung] Severance Hosp, Yonsei Canc Ctr, Pancreaticobiliary Canc Clin, Seoul, South Korea; [Kim, Eun Wha; Lee, Jin Ae] Yonsei Univ, Coll Med, Biostat Collaborat Unit, Seoul, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System	Kang, CM (corresponding author), Yonsei Univ, Coll Med, Dept Hepatobiliary & Pancreat Surg, Seoul, South Korea.; Kang, CM (corresponding author), Severance Hosp, Yonsei Canc Ctr, Pancreaticobiliary Canc Clin, Seoul, South Korea.	cmkang@yuhs.ac		Kang, Chang Moo/0000-0002-5382-4658; Yoo, Young Jin/0000-0002-1391-048X; Lee, Woo jung/0000-0001-9273-261X; Choi, Munseok/0000-0002-9844-4747; Rho, Seoung Yoon/0000-0002-1265-826X; Hwang, Ho Kyoung/0000-0003-4064-7776				Albores-Saavedra J, 2009, J SURG ONCOL, V100, P598, DOI 10.1002/jso.21374; Aydin Y, 2011, TURK GOGUS KALP DAMA, V19, P384, DOI 10.5606/tgkdc.dergisi.2011.049; Bassi C, 2005, SURGERY, V138, P8, DOI 10.1016/j.surg.2005.05.001; Beger HG, 1999, ARCH SURG-CHICAGO, V134, P526, DOI 10.1001/archsurg.134.5.526; Chan AWH, 2015, ANN SURG ONCOL, V22, P4138, DOI 10.1245/s10434-015-4516-1; Cheung K, 2012, CLIN GASTROENTEROL H, V10, P117, DOI 10.1016/j.cgh.2011.08.016; Choi SB, 2011, SCAND J SURG, V100, P92, DOI 10.1177/145749691110000205; Crumley ABC, 2010, WORLD J SURG, V34, P2393, DOI 10.1007/s00268-010-0641-y; Demler OV, 2015, STAT MED, V34, P1659, DOI 10.1002/sim.6428; Dindo D, 2004, ANN SURG, V240, P205, DOI 10.1097/01.sla.0000133083.54934.ae; Feng JF, 2014, THER CLIN RISK MANAG, V10, P1, DOI 10.2147/TCRM.S56159; Gao YY, 2014, J CANCER RES THER, V10, P799, DOI 10.4103/0973-1482.146054; Geng Y, 2015, EJSO-EUR J SURG ONC, V41, P1508, DOI 10.1016/j.ejso.2015.07.022; Gonzalez-Trejo S, 2017, MEDICINE, V96, DOI 10.1097/MD.0000000000006610; Gupta D, 2010, NUTR J, V9, DOI 10.1186/1475-2891-9-69; HOFBAUER SL, 2015, UROL ONCOL, V33, DOI DOI 10.1097/01.SLA.0000133083.54934.AE; Hong SD, 2015, TUMOR BIOL, V36, P3389, DOI 10.1007/s13277-014-2973-y; Junrungsee Sunhawit, 2017, Asian Pac J Cancer Prev, V18, P225; Kanda M, 2011, BRIT J SURG, V98, P268, DOI 10.1002/bjs.7305; Kang CM, 2007, J SURG RES, V140, P31, DOI 10.1016/j.jss.2006.10.007; Kaya V, 2013, ASIAN PAC J CANCER P, V14, P5473, DOI 10.7314/APJCP.2013.14.9.5473; Klein JP, 2004, HANDB STAT, V23, P27; Kohl M, 2015, COMPUT METH PROG BIO, V118, P218, DOI 10.1016/j.cmpb.2014.11.009; Lillemoe KD, 1999, ANN SURG, V230, P143, DOI 10.1097/00000658-199908000-00002; Luchini C, 2019, PANCREAS, V48, P70, DOI 10.1097/MPA.0000000000001194; Luchini C, 2016, EUR J GASTROEN HEPAT, V28, P205, DOI 10.1097/MEG.0000000000000520; Mandrekar JN, 2003, P 28 SAS US GROUP IN; Marrelli D, 2009, AM J SURG, V198, P333, DOI 10.1016/j.amjsurg.2008.12.031; Meyers, 2003, 28 SAS USERS GROUP I; Migita K, 2013, ANN SURG ONCOL, V20, P2647, DOI 10.1245/s10434-013-2926-5; MILANO G, 1978, J NATL CANCER I, V61, P687; Mohri T, 2016, WORLD J SURG ONCOL, V14, DOI 10.1186/s12957-016-0920-7; Mohri Y, 2013, WORLD J SURG, V37, P2688, DOI 10.1007/s00268-013-2156-9; Mori S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136897; Ni XC, 2019, INT J CLIN ONCOL, V24, P825, DOI 10.1007/s10147-019-01402-4; Nozoe T, 2002, EUR J SURG ONCOL, V28, P396, DOI 10.1053/ejso.2002.1257; Nunez E, 2011, REV ESP CARDIOL, V64, P501, DOI [10.1016/j.recesp.2011.01.019, 10.1016/j.rec.2011.01.017]; Ohike N, 2010, AM J SURG PATHOL, V34, P1417, DOI 10.1097/PAS.0b013e3181f0b05a; Okamura Y, 2015, WORLD J SURG, V39, P1501, DOI 10.1007/s00268-015-2982-z; Onodera T, 1984, Nihon Geka Gakkai Zasshi, V85, P1001; Palazzo L, 1998, Endoscopy, V30 Suppl 1, pA128, DOI 10.1055/s-2007-1001493; Pinato DJ, 2012, BRIT J CANCER, V106, P1439, DOI 10.1038/bjc.2012.92; SIMON R, 1994, BRIT J CANCER, V69, P979, DOI 10.1038/bjc.1994.192; Song JM, 2015, BMC SURG, V15, DOI 10.1186/s12893-015-0019-z; Steyerberg EW, 2001, MED DECIS MAKING, V21, P45, DOI 10.1177/0272989X0102100106; Sugiura T, 2012, J GASTROINTEST SURG, V16, P977, DOI 10.1007/s11605-012-1859-9; Sun KY, 2014, J CANCER RES CLIN, V140, P1537, DOI 10.1007/s00432-014-1714-3; Tomiyasu S, 2015, J CLIN ONCOL, V33, DOI 10.1200/jco.2015.33.3_suppl.270; Zhou YM, 2017, PANCREATOLOGY, V17, P273, DOI 10.1016/j.pan.2017.01.007	49	8	8	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2020	15	3							e0229597	10.1371/journal.pone.0229597	http://dx.doi.org/10.1371/journal.pone.0229597			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8MS	32126069	Green Published, gold			2022-12-26	WOS:000535253100034
J	Mobli, A; Rinwa, A; Sahil; Chauhan, BS				Mobli, Ahmadreza; Rinwa, Abhimanyu; Sahil; Chauhan, Bhagirath Singh			Effects of sorghum residue in presence of pre-emergence herbicides on emergence and biomass of Echinochloa colona and Chloris virgata	PLOS ONE			English	Article							SEED-GERMINATION ECOLOGY; MICROBIAL-DEGRADATION; WEED; TILLAGE; MANAGEMENT; TEMPERATURE; RESISTANT; METOLACHLOR; IMAZETHAPYR; YIELD	In conservation agriculture systems, farmers gain many advantages from retaining crop residue on the soil surface, but crop residue retention in these systems may intervene with the activity of pre-emergence herbicides. A pot study was conducted to evaluate the effect of different rates of pre-emergence herbicides [imazethapyr (100 and 150 g a. i. ha(-1)), isoxaflutole (100 and 200 g a. i. ha(-1)), metolachlor (1.5 and 2.25 kg a. i. ha(-1)), pendimethalin (2.25 and 3.38 kg a. i. ha(-1)) and prosulfocarb + metolachlor (2.5 and 3.75 kg a. i. ha(-1))] on seedling emergence and biomass of Echinochloa colona and Chloris virgata when applied in the presence of sorghum residue at rates equivalent to (0, 3 and 6 t ha(-1)). When seeds of E. colona and C. virgata were not covered with sorghum residue, the seedling emergence and biomass of both weeds was inhibited by 93-100% and 56-100%, respectively, with the application (both rates) of isoxaflutole, metolachlor, pendimethalin and prosulfocarb + metolachlor. Using sorghum residue resulted in lower herbicide efficacy on both weeds. At 3 t ha(-1) sorghum residue, E. colona emergence and biomass reduced by 38-100% and 30-100%, respectively, with application of isoxaflutole, metolachlor and pendimethalin (both rates) in comparison with the no-herbicide treatment. Similarly, the emergence and biomass of C. virgata was also reduced by 92-100% and 25-100%, respectively. The results of this study suggest that crop residue may influence efficacy of commonly used pre-emergence herbicides and that the amount of crop residue on the soil surface should be adjusted according to the nature of the pre-emergence herbicides to achieve adequate weed control.	[Mobli, Ahmadreza] Ferdowsi Univ Mashhad, Fac Agr, Dept Agrotechnol, Mashhad, Razavi Khorasan, Iran; [Mobli, Ahmadreza; Rinwa, Abhimanyu; Sahil; Chauhan, Bhagirath Singh] Univ Queensland, Queensland Alliance Agr & Food Innovat QAAFI, Ctr Crop Sci, Gatton, Qld, Australia; [Rinwa, Abhimanyu] Punjab Agr Univ, Dept Agron, Ludhiana, Punjab, India; [Sahil] Punjabi Univ Patiala, Mata Gujri Coll, Fatehgarh Sahib, Punjab, India	Ferdowsi University Mashhad; University of Queensland; Punjab Agricultural University; Punjabi University	Mobli, A (corresponding author), Ferdowsi Univ Mashhad, Fac Agr, Dept Agrotechnol, Mashhad, Razavi Khorasan, Iran.; Mobli, A (corresponding author), Univ Queensland, Queensland Alliance Agr & Food Innovat QAAFI, Ctr Crop Sci, Gatton, Qld, Australia.	a.mobli@uq.edu.au		Mobli, Ahmadreza/0000-0002-9332-1879; , Sahil/0000-0002-3546-5217				[Anonymous], 2019, SYNGENTA AUSTR BOXER; Avila LA, 2006, J AGR FOOD CHEM, V54, P2635, DOI 10.1021/jf052214b; BANKS PA, 1986, WEED SCI, V34, P607, DOI 10.1017/S0043174500067527; Baskin CC, 1998, SEEDS ECOLOGY BIOGEO; Beckie HJ, 2006, WEED TECHNOL, V20, P793, DOI 10.1614/WT-05-084R1.1; Boydston RA, 2010, WEED TECHNOL, V24, P336, DOI 10.1614/WT-D-09-00053.1; Chauhan BS, 2006, AUST J EXP AGR, V46, P1557, DOI 10.1071/EA05291; Chauhan BS, 2011, CROP PROT, V30, P1385, DOI 10.1016/j.cropro.2011.07.013; Chauhan BS, 2012, WEED TECHNOL, V26, P627, DOI 10.1614/WT-D-12-00067.1; Chauhan BS, 2009, WEED SCI, V57, P235, DOI 10.1614/WS-08-141.1; Dalazen G., 2018, Journal of Agricultural Science (Toronto), V10, P389, DOI 10.5539/jas.v10n9p389; DICK RP, 1992, AGR ECOSYST ENVIRON, V40, P25, DOI 10.1016/0167-8809(92)90081-L; DORAN JW, 1980, SOIL SCI SOC AM J, V44, P765, DOI 10.2136/sssaj1980.03615995004400040022x; Espy R, 2011, J AGR FOOD CHEM, V59, P7277, DOI 10.1021/jf200573g; Fernando N, 2016, WEED SCI, V64, P605, DOI 10.1614/WS-D-15-00212.1; Flint JL, 1997, WEED SCI, V45, P586, DOI 10.1017/S004317450008886X; Grundy AC, 2007, NON CHEMICAL WEED MANAGEMENT: PRINCIPLES, CONCEPTS AND TECHNOLOGY, P135, DOI 10.1079/9781845932909.0135; Hatfield JL, 2011, AGRON J, V103, P351, DOI 10.2134/agronj2010.0303; Hatfield JL, 2015, WEATHER CLIM EXTREME, V10, P4, DOI 10.1016/j.wace.2015.08.001; Heap I, 2019, INT SURVEY HERBICIDE; Heap I, 2018, PEST MANAG SCI, V74, P1040, DOI 10.1002/ps.4760; HENDERSON CWL, 1993, AUST J EXP AGR, V33, P645, DOI 10.1071/EA9930645; HEUVELINK E, 1995, PHYSIOL PLANTARUM, V94, P447, DOI [10.1111/j.1399-3054.1995.tb00952.x, 10.1034/j.1399-3054.1995.940311.x]; HOUSE GJ, 1989, AGR ECOSYST ENVIRON, V27, P331, DOI 10.1016/0167-8809(89)90096-0; JOHNSON MD, 1989, WEED SCI, V37, P239, DOI 10.1017/S004317450007185X; Khalil Y, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0210219; Khalil Y, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0208274; KULSHRESTHA G, 1992, B ENVIRON CONTAM TOX, V48, P269, DOI 10.1007/BF00194383; Kumar K, 2000, ADV AGRON, V68, P197; Lin J, 2016, GRASS FORAGE SCI, V71, P507, DOI 10.1111/gfs.12218; Llewellyn Rick., 2016, IMPACT WEEDS AUSTR G; Marble SC, 2015, WEED TECHNOL, V29, P341, DOI 10.1614/WT-D-14-00165.1; McGillion T., 2006, INTEGRATED WEED MANA, P28; Meyers SL, 2010, WEED TECHNOL, V24, P495, DOI 10.1614/WT-D-09-00057.1; MOHLER CL, 1993, ECOL APPL, V3, P53, DOI 10.2307/1941792; Mutti NK, 2019, CROP PASTURE SCI, V70, P367, DOI 10.1071/CP18444; OSTEN V, 2012, FEATHERTOP RHODES GR; Owen MDK, 2005, PEST MANAG SCI, V61, P301, DOI 10.1002/ps.1015; Prihar SS, 1996, SOIL USE MANAGE, V12, P150, DOI 10.1111/j.1475-2743.1996.tb00536.x; Sarkar S, 2007, SOIL TILL RES, V92, P79, DOI 10.1016/j.still.2006.01.014; SINGH SB, 1991, J ENVIRON SCI HEAL B, V26, P309, DOI 10.1080/03601239109372737; Soulas G, 2001, BIOL FERT SOILS, V33, P551, DOI 10.1007/s003740100363; van Acker RC, 2005, SOIL RESIDUAL HERBIC; Varanasi A, 2016, ADV AGRON, V135, P107, DOI 10.1016/bs.agron.2015.09.002; Webster EP, 2018, WEED TECHNOL, V32, P45, DOI 10.1017/wet.2017.83; Wilen CA, 2007, WEED MANAGEMENT LAND; Zhao N, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-12696-7	47	5	5	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2020	15	3							e0229817	10.1371/journal.pone.0229817	http://dx.doi.org/10.1371/journal.pone.0229817			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8JT	32119693	gold, Green Published, Green Accepted			2022-12-26	WOS:000535245300042
J	Tan, L; Harper, L; McNulty, MA; Carlson, CS; Yammani, RR				Tan, Li; Harper, Lindsey; McNulty, Margaret A.; Carlson, Cathy S.; Yammani, Raghunatha R.			High-fat diet induces endoplasmic reticulum stress to promote chondrocyte apoptosis in mouse knee joints	FASEB JOURNAL			English	Article						apoptosis; endoplasmic reticulum stress; obesity; osteoarthritis; PBA	UNFOLDED PROTEIN RESPONSE; SUBCHONDRAL BONE; ER STRESS; OSTEOARTHRITIS; PATHWAY; INSULIN; OBESITY; TRB3; INFLAMMATION; PREVALENCE	Mice fed a high-fat diet (HFD) become obese and develop osteoarthritis (OA)-like lesions, including chondrocyte apoptosis, in the knee joints. However, the mechanism by which HFD/obesity induces chondrocyte apoptosis is not clearly understood. In the present study, male mice were fed a low-fat diet (LFD, 10% kcal), HFD (45% kcal), or a HFD administered with 0.5 g/kg bodyweight of 4-phenyl butyric acid (PBA, a small chaperone known to ease endoplasmic reticulum [ER] stress), via the drinking water. At the end of the 18-week study, stifle (knee) joints from all animals were collected, fixed, paraffin embedded, and sectioned. Immunostaining of joints from the HFD group showed increased expression of ER stress and apoptotic markers and increased expression of nuclear protein 1 and tribbles related protein-3 compared to the LFD group. Mice on HFD also showed higher percentage of chondrocyte death, lower chondrocyte numbers per cartilage area, and thickening of subchondral bone. Administration of PBA alleviated all of the HFD-induced symptoms. Our study demonstrated that HFD induces ER stress to promote chondrocyte death and subchondral bone thickening, which could be relieved by alleviating ER stress via PBA administration, suggesting that ER stress could play an important role in obesity-linked OA and could be targeted for OA therapeutics.	[Tan, Li; Yammani, Raghunatha R.] Wake Forest Sch Med, Dept Internal Med, Sect Mol Med, Winston Salem, NC 27157 USA; [Harper, Lindsey; Carlson, Cathy S.] Univ Minnesota, Coll Vet Med, Dept Vet Clin Sci, St Paul, MN 55108 USA; [McNulty, Margaret A.] Indiana Univ Sch Med, Dept Anat Cell Biol & Physiol, Indianapolis, IN 46202 USA	Wake Forest University; University of Minnesota System; University of Minnesota Twin Cities; Indiana University System; Indiana University Bloomington	Yammani, RR (corresponding author), Wake Forest Sch Med, Dept Internal Med, Sect Mol Med, Winston Salem, NC 27157 USA.	ryammani@wakehealth.edu		McNulty, Margaret/0000-0001-6638-253X	HHS \ NIH \ National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) [AR066105]	HHS \ NIH \ National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)	HHS vertical bar NIH vertical bar National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), Grant/Award Number: AR066105	Asou Y, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162794; Basseri S, 2009, J LIPID RES, V50, P2486, DOI 10.1194/jlr.M900216-JLR200; Berenbaum F, 2013, CURR OPIN RHEUMATOL, V25, P114, DOI 10.1097/BOR.0b013e32835a9414; Blanco FJ, 1998, ARTHRITIS RHEUM, V41, P284, DOI 10.1002/1529-0131(199802)41:2<284::AID-ART12>3.0.CO;2-T; Boden G, 2008, ENDOCRIN METAB CLIN, V37, P635, DOI 10.1016/j.ecl.2008.06.007; Cano CE, 2011, J CELL PHYSIOL, V226, P1439, DOI 10.1002/jcp.22324; Carracedo A, 2006, CANCER CELL, V9, P301, DOI 10.1016/j.ccr.2006.03.005; Castaneda S, 2012, BIOCHEM PHARMACOL, V83, P315, DOI 10.1016/j.bcp.2011.09.018; Choi JY, 2016, INT J OBESITY, V40, P1452, DOI 10.1038/ijo.2016.70; Cravero JD, 2009, ARTHRITIS RHEUM-US, V60, P492, DOI 10.1002/art.24225; Darzynkiewicz Z, 2008, METHODS, V44, P250, DOI 10.1016/j.ymeth.2007.11.008; Du KY, 2003, SCIENCE, V300, P1574, DOI 10.1126/science.1079817; Felson DT, 2000, ANN INTERN MED, V133, P635, DOI 10.7326/0003-4819-133-8-200010170-00016; Goldring SR, 2016, NAT REV RHEUMATOL, V12, P632, DOI 10.1038/nrrheum.2016.148; Goruppi S, 2010, J BIOL CHEM, V285, P1577, DOI 10.1074/jbc.R109.080887; Griffin TM, 2012, ARTHRITIS RHEUM-US, V64, P443, DOI 10.1002/art.33332; Griffin TM, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3068; Griffin TM, 2005, EXERC SPORT SCI REV, V33, P195, DOI 10.1097/00003677-200510000-00008; Haywood J, 2016, OSTEOARTHR CARTILAGE, V24, P942, DOI 10.1016/j.joca.2015.11.020; Hootman JM, 2006, ARTHRITIS RHEUM-US, V54, P226, DOI 10.1002/art.21562; Husa M, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4415; Kawasaki N, 2012, SCI REP-UK, V2, DOI 10.1038/srep00799; Lawrence RC, 2008, ARTHRITIS RHEUM, V58, P26, DOI 10.1002/art.23176; Lee AH, 2003, MOL CELL BIOL, V23, P7448, DOI 10.1128/MCB.23.21.7448-7459.2003; Li GY, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4405; Loeser RF, 2012, ARTHRITIS RHEUM-US, V64, P1697, DOI 10.1002/art.34453; McNulty MA, 2011, CARTILAGE, V2, P354, DOI 10.1177/1947603511402665; Mistry D, 2004, OSTEOARTHR CARTILAGE, V12, P131, DOI 10.1016/j.joca.2003.10.006; Nazli SA, 2017, OSTEOARTHR CARTILAGE, V25, P1516, DOI 10.1016/j.joca.2017.05.011; Ozcan U, 2006, SCIENCE, V313, P1137, DOI 10.1126/science.1128294; Ohoka N, 2005, EMBO J, V24, P1243, DOI 10.1038/sj.emboj.7600596; Oliveria SA, 1999, EPIDEMIOLOGY, V10, P161, DOI 10.1097/00001648-199903000-00013; Ozcan U, 2004, SCIENCE, V306, P457, DOI 10.1126/science.1103160; Presle N, 2006, OSTEOARTHR CARTILAGE, V14, P690, DOI 10.1016/j.joca.2006.01.009; Qian B, 2008, J ENDOCRINOL, V199, P407, DOI 10.1677/JOE-08-0331; Schonthal AH, 2012, SCIENTIFICA, V2012, DOI 10.6064/2012/857516; Szegezdi E, 2006, EMBO REP, V7, P880, DOI 10.1038/sj.embor.7400779; Takada K, 2011, INT J EXP PATHOL, V92, P232, DOI 10.1111/j.1365-2613.2010.00758.x; Tan L, 2019, BIOSCIENCE REP, V39, DOI 10.1042/BSR20181473; Todd DJ, 2008, NAT REV IMMUNOL, V8, P663, DOI 10.1038/nri2359; Uehara Y, 2014, OSTEOARTHR CARTILAGE, V22, P1007, DOI 10.1016/j.joca.2014.04.025; Walter P, 2011, SCIENCE, V334, P1081, DOI 10.1126/science.1209038; Wang XZ, 1998, EMBO J, V17, P3619, DOI 10.1093/emboj/17.13.3619; Wang YY, 2010, RHEUMATOLOGY, V49, P997, DOI 10.1093/rheumatology/keq034; Xu X, 2017, FRONT MOL NEUROSCI, V10, DOI 10.3389/fnmol.2017.00203; Yammani RR, 2014, ARTHRITIS RHEUMATOL, V66, P1266, DOI 10.1002/art.38391; Yammani RR, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3705	47	11	11	0	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2020	34	4					5818	5826		10.1096/fj.201902746R	http://dx.doi.org/10.1096/fj.201902746R		MAR 2020	9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	LJ5ZA	32124494	Bronze			2022-12-26	WOS:000517934700001
J	Adeniyi, OV; Ajayi, AI				Adeniyi, Oladele Vincent; Ajayi, Anthony Idowu			Level and determinants of postpartum adherence to antiretroviral therapy in the Eastern Cape, South Africa	PLOS ONE			English	Article							SELF-REPORT; VIRAL LOAD; WOMEN; HIV; PERIPARTUM; DRUGS	Background Adherence to antiretroviral therapy (ART), especially during the postpartum period, remains a major challenge in the efforts towards eliminating mother-to-child transmission of HIV. This study examined the levels and determinants of postpartum adherence to ART among mothers with HIV in the Eastern Cape, South Africa. Methods In this cross-sectional analytical study, we interviewed 495 postpartum women with HIV between January and May 2018. We measured postpartum adherence using six questions probing participants' adherence behaviours since child birth. We categorised the adherence behaviours into complete adherence (mothers who reported no missed episode(s) of ART since child birth) and suboptimal adherence (mothers with any missed episode(s) of ART). Adjusted and unadjusted logistic regression models were used to examine the determinants of postpartum adherence to ART. Results Overall, 63.9% reported complete adherence during the postpartum period but the rates varied by socio-demographic and behavioural characteristics. The adjusted logistic regression analysis showed that younger mothers were 70% less likely to report complete adherence to ART compared to mothers aged 40 and above. Likewise, mothers who currently use alcohol were 53% less likely to report complete postpartum adherence to ART compared to those who did not use alcohol. However, mothers who knew their partner's status were twice more likely to report complete postpartum adherence compared to those who did not. There was no statistically significant relationship between ART adherence and breastfeeding durations. Conclusion Postpartum adherence to ART is suboptimal in the study setting, and younger mothers and those who use alcohol have a lower odds of complete adherence. Knowing a partner's status improves adherence, but infant feeding practices did not influence postpartum adherence behaviours. It is critical to design and strengthen interventions which target young mothers and alcohol users. Also, HIV sero-status disclosure should be encouraged among mothers to facilitate partner support.	[Adeniyi, Oladele Vincent] Walter Sisulu Univ, Cecilia Makiwane Hosp, Fac Hlth Sci, Dept Family Med & Rural Hlth, Mthatha East London Hosp Complex, East London, South Africa; [Ajayi, Anthony Idowu] African Populat & Hlth Res Ctr, Populat Dynam & Sexual & Reprod Hlth & Rights Uni, APHRC Campus, Nairobi, Kenya	Walter Sisulu University; African Population & Health Research Centre	Ajayi, AI (corresponding author), African Populat & Hlth Res Ctr, Populat Dynam & Sexual & Reprod Hlth & Rights Uni, APHRC Campus, Nairobi, Kenya.	ajayianthony@gmail.com	Ajayi, Anthony Idowu/N-4272-2016	Ajayi, Anthony Idowu/0000-0002-6004-3972	South African Medical Research Council Pilot Grant; South African AIDS Vaccine Initiative under South African Medical Research Council; South African National Department of Health	South African Medical Research Council Pilot Grant; South African AIDS Vaccine Initiative under South African Medical Research Council; South African National Department of Health	OVA is a receipient of the South African Medical Research Council Pilot Grant awarded to Walter Sisulu University. Research reported in this publication was supported by the South African AIDS Vaccine Initiative under the auspices of the South African Medical Research Council with funds received from the South African National Department of Health.	Abuogi LL, 2018, J VIRUS ERAD, V4, P33; Adeniyi OV, 2019, INT BREASTFEED J, V14, DOI 10.1186/s13006-019-0201-5; Adeniyi OV, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181730; Ajayi AI, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-5522-6; Bardeguez AD, 2008, JAIDS-J ACQ IMM DEF, V48, P408, DOI 10.1097/QAI.0b013e31817bbe80; Davis NL, 2016, JAIDS-J ACQ IMM DEF, V73, P572, DOI 10.1097/QAI.0000000000001145; Davis NL, 2014, AIDS, V28, P2739, DOI 10.1097/QAD.0000000000000492; Decker S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179448; Gill MM, 2017, AIDS PATIENT CARE ST, V31, P153, DOI 10.1089/apc.2016.0234; Joint United Nations Programme on HIV/ AIDS (UNAIDS), 2016, GLOB AIDS UPD 2016; Kader R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125088; Kreitchmann R, 2016, INT J STD AIDS, V27, P377, DOI 10.1177/0956462415584483; Mekuria LA, 2016, TROP MED INT HEALTH, V21, P856, DOI 10.1111/tmi.12709; Morisky DE, 2008, PREDICTIVE VALIDITY; Nachega JB, 2012, AIDS, V26, P2039, DOI 10.1097/QAD.0b013e328359590f; Okawa S, 2015, BMC PREGNANCY CHILDB, V15, DOI 10.1186/s12884-015-0697-7; Owolabi EO, 2018, S AFR FAM PRACT, V60, P46, DOI 10.1080/20786190.2017.1382970; Phillips T, 2017, AIDS BEHAV, V21, P450, DOI 10.1007/s10461-016-1448-0; Vaz MJR, 2007, INT J STD AIDS, V18, P28, DOI 10.1258/095646207779949808; Rollins N, 2012, SEX TRANSM INFECT, V88, pI44, DOI 10.1136/sextrans-2012-050709; Sileo KM, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0216892; Sileo KM, 2016, DRUG ALCOHOL DEPEN, V167, P103, DOI 10.1016/j.drugalcdep.2016.07.028; Stirratt MJ, 2015, TRANSL BEHAV MED, V5, P470, DOI 10.1007/s13142-015-0315-2; UNAIDS, 2017, GLOB HIV STAT FACT S; UNAIDS, 2018, GLOB AIDS UPD MIL GO; UNAIDS, 2020, COUNTR FACTSH S AFR; Wilson IB, 2016, AIDS BEHAV, V20, P2700, DOI 10.1007/s10461-016-1406-x; World Health Organization, 2016, GUID UPD HIV INF FEE; Zacharius KM, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0212587	29	2	2	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2020	15	2							e0229592	10.1371/journal.pone.0229592	http://dx.doi.org/10.1371/journal.pone.0229592			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8GQ	32106255	Green Published, gold			2022-12-26	WOS:000535237000048
J	Chaharborj, SS; Amin, N				Chaharborj, Sarkhosh S.; Amin, Norsarahaida			Controlling the pressure of hydrogen-natural gas mixture in an inclined pipeline	PLOS ONE			English	Article							TRANSIENT FLOW; LEAK DETECTION; OPTIMIZATION; SENSITIVITY	This paper discusses the optimal control of pressure using the zero-gradient control (ZGC) approach. It is applied for the first time in the study to control the optimal pressure of hydrogen natural gas mixture in an inclined pipeline. The solution to the flow problem is first validated with existing results using the Taylor series approximation, regression analysis and the Runge-Kutta method combined. The optimal pressure is then determined using ZGC where the optimal set points are calculated without having to solve the non-linear system of equations associated with the standard optimization problem. It is shown that the mass ratio is the more effective parameter compared to the initial pressure in controlling the maximum variation of pressure in a gas pipeline.	[Chaharborj, Sarkhosh S.; Amin, Norsarahaida] Univ Teknol Malaysia, Fac Sci, Dept Math Sci, Johor Baharu, Malaysia; [Amin, Norsarahaida] Univ Airlangga, Dept Math, Fak Sains & Teknol, Surabaya City, East Java, Indonesia	Universiti Teknologi Malaysia; Airlangga University	Amin, N (corresponding author), Univ Teknol Malaysia, Fac Sci, Dept Math Sci, Johor Baharu, Malaysia.; Amin, N (corresponding author), Univ Airlangga, Dept Math, Fak Sains & Teknol, Surabaya City, East Java, Indonesia.	norsarahaida@utm.my	Chaharborj, Sarkhosh Seddighi/AAF-4933-2021	Chaharborj, Sarkhosh Seddighi/0000-0001-5894-6622	Research and Innovation University Grant Scheme, Universiti Teknologi Malaysia	Research and Innovation University Grant Scheme, Universiti Teknologi Malaysia	Financial support provided by Research and Innovation University Grant Scheme, Universiti Teknologi Malaysia, is gratefully acknowledged.	Cavenagh NJ, 2019, J COMB DES, V27, P522, DOI 10.1002/jcd.21660; Chaczykowski M, 2010, APPL MATH MODEL, V34, P1051, DOI 10.1016/j.apm.2009.07.017; Chaharborj SS, 2012, INT J MASS SPECTROM, V309, P63, DOI 10.1016/j.ijms.2011.08.027; Chaharborj SS, 2018, HEAT TRANSF RES, V49, P761, DOI 10.1615/HeatTransRes.2018019795; Elaoud S, 2008, INT J HYDROGEN ENERG, V33, P4824, DOI 10.1016/j.ijhydene.2008.06.032; Elaoud S, 2017, J PETROL SCI ENG, V159, P532, DOI 10.1016/j.petrol.2017.09.063; Elaoud S, 2010, J LOSS PREVENT PROC, V23, P637, DOI 10.1016/j.jlp.2010.06.015; Fouladirad M, 2018, EUR J OPER RES, V266, P963, DOI 10.1016/j.ejor.2017.10.055; Hennings F., 2019, CONTROLLING TRANSIEN; Hu L, 2019, APPL ENERG, V248, P567, DOI 10.1016/j.apenergy.2019.04.073; Jalving J, 2018, IND ENG CHEM RES, V57, P5966, DOI 10.1021/acs.iecr.7b04124; KARNEY BW, 1985, CAN J CIVIL ENG, V12, P241, DOI 10.1139/l85-027; Kim H, 2018, J PRESS VESS-T ASME, V140, DOI 10.1115/1.4040361; Kim M. S., 2012, P 10 IIR GUST LOR C; Larsen LFS, 2004, IEEE DECIS CONTR P, P4708, DOI 10.1109/CDC.2004.1429534; LARSEN LFS, 2006, MODEL BASED CONTROL; Lee WR, 2019, BRACHYTHERAPY, V18, P426, DOI 10.1016/j.brachy.2019.01.009; Liu B, 2019, INT J HYDROGEN ENERG, V44, P7428, DOI 10.1016/j.ijhydene.2019.01.221; Noeding M, 2019, INT J REFRIG, V106, P283, DOI 10.1016/j.ijrefrig.2019.05.041; Osiadacz A. J., PSIG ANN M PIP SIM I; Subani N., 2015, ABSTR APPL ANAL, P1, DOI 10.1155/2015/510675; Subani N., 2012, APPL COMPUT MATH, V4, P135; Subani N, 2017, J LOSS PREVENT PROC, V48, P244, DOI 10.1016/j.jlp.2017.05.003; Tomazic S, 2019, IEEE T IND ELECTRON, V66, P2015, DOI 10.1109/TIE.2018.2840525; Uilhoorn FE, 2009, INT J HYDROGEN ENERG, V34, P6722, DOI 10.1016/j.ijhydene.2009.06.062; Wang YC, 2018, IEEE T IND ELECTRON, V65, P211, DOI 10.1109/TIE.2017.2719620; Yu MZ, 2018, REV CHEM ENG, V34, P561, DOI 10.1515/revce-2016-0061; Yu TC, 2019, WATER SCI TECHNOL, V79, P114, DOI 10.2166/wst.2019.014; Zaki K., J WATER SUPPLY RES T; Zhang WJ, 2011, INT J REFRIG, V34, P844, DOI 10.1016/j.ijrefrig.2011.01.014	30	1	1	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2020	15	2							e0228955	10.1371/journal.pone.0228955	http://dx.doi.org/10.1371/journal.pone.0228955			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8GQ	32106248	Green Published, Green Submitted, gold			2022-12-26	WOS:000535237000016
J	Rippon, D; McDonnell, A; Smith, M; McCreadie, M; Wetherell, M				Rippon, Daniel; McDonnell, Andrew; Smith, Michael; McCreadie, Michael; Wetherell, Mark			A grounded theory study on work related stress in professionals who provide health & social care for people who exhibit behaviours that challenge	PLOS ONE			English	Article							INTELLECTUAL DISABILITY SERVICES; BURNOUT; SUPPORT; NURSES; STAFF; PERCEPTIONS; DEPRESSION; DISORDER; CHILDREN; ENGLAND	Providing direct health and social care services for people who exhibit behaviours that challenge can be a highly stressful occupation. Existing literature has suggested that there is a need to develop further theoretical understanding of how work related stress can be reduced in professions that consist of providing care for people who exhibit behaviours that challenge. The aim for this study was to use a Classic Grounded Theory approach to develop a theoretical framework to illustrate a common issue that could influence work related stress levels experienced when managing behaviours that challenge in health and social care settings. A series of focus groups and 1:1 semi-structured interviews were conducted to explore the articulated experiences of 47 health/social care professionals who provide care for people who exhibit behaviours that challenge. This led to the development of Therapeutic Engagement Stress Theory (TEST), which illustrates that the perceived capacity to therapeutically engage with people who exhibit behaviours that challenge is an issue that can influence the levels of stress experienced by health/social care professionals. TEST provides a framework that could be applied to identify specific factors that inhibit staff to successfully deliver caring interventions for people who exhibit behaviours that challenge, and also inform bespoke support mechanisms to reduce stress in health/social care professionals.	[Rippon, Daniel; Smith, Michael; Wetherell, Mark] Univ Northumbria Newcastle, Newcastle Upon Tyne, Tyne & Wear, England; [McDonnell, Andrew; McCreadie, Michael] Studio III Training Syst & Clin Support, Warwick, England	Northumbria University	Rippon, D (corresponding author), Univ Northumbria Newcastle, Newcastle Upon Tyne, Tyne & Wear, England.	daniel.rippon@northumbria.ac.uk		Smith, Michael/0000-0001-5107-6441; Wetherell, Mark/0000-0002-1026-2798; Rippon, Daniel/0000-0002-7170-5644				Abbott D., 2004, J INTEGRATED CARE, V12, P24, DOI DOI 10.1108/14769018200400013; ADAMS JS, 1965, ADV EXP SOC PSYCHOL, V2, P267; Baghdadli A, 2003, J INTELL DISABIL RES, V47, P622, DOI 10.1046/j.1365-2788.2003.00507.x; Breckenridge J, 2009, GROUNDED THEORY REV, V8, P112; Centre NNSSC-o, 2017, NHS STAFF SURV ENGL; Cohen S, 2004, AM PSYCHOL, V59, P676, DOI 10.1037/0003-066X.59.8.676; COHEN S, 1983, J HEALTH SOC BEHAV, V24, P385, DOI 10.2307/2136404; Collins A., 2014, COHERENT MEASUREMENT, P1; Council NHSS, 2012, GUID PREV MAN SICKN; Devereux J, 2009, J APPL RES INTELLECT, V22, P561, DOI 10.1111/j.1468-3148.2009.00509.x; Emerson E., 1995, CHALLENGING BEHAV AN; Executive HaS, 2016, VIOL WORK 2015 16; Executive HaS, 2018, WORK REL STRESS DEPR; FRENCH JRP, 1962, J SOC ISSUES, V18, P1, DOI 10.1111/j.1540-4560.1962.tb00415.x; Gallagher S, 2013, J HEALTH PSYCHOL, V18, P1220, DOI 10.1177/1359105312464672; GEORGE JM, 1992, ACAD MANAGE J, V35, P191, DOI 10.2307/256478; Gilbreath B, 2004, WORK STRESS, V18, P255, DOI 10.1080/02678370412331317499; Glaser B.G., 1968, DISCOV GROUNDED THEO; Glaser BG, 1978, THEORETICAL SENSITIV; Hastings RP, 2010, J INTELLECT DEV DIS, V35, P207, DOI 10.3109/13668250.2010.492710; Hollander JA, 2004, J CONTEMP ETHNOGR, V33, P602, DOI 10.1177/0891241604266988; Huckshorn Kevin Ann, 2004, J Psychosoc Nurs Ment Health Serv, V42, P22; Humphries R, 2015, HEALTH POLICY, V119, P856, DOI 10.1016/j.healthpol.2015.04.010; Hunt Geoffrey, 2002, J Interprof Care, V16, P211, DOI 10.1080/13561820220146658; Hurley AD, 2008, J INTELL DISABIL RES, V52, P905, DOI 10.1111/j.1365-2788.2008.01113.x; Jenkins R, 2004, J ADV NURS, V48, P622, DOI 10.1111/j.1365-2648.2004.03240.x; Joyce S, 2016, PSYCHOL MED, V46, P683, DOI 10.1017/S0033291715002408; Karasek R., 1990, HLTH WORK STRESS PRO; Khamisa N, 2015, INT J ENV RES PUB HE, V12, P652, DOI 10.3390/ijerph120100652; Kitwood T., 1997, DEMENTIA RECONSIDERE; Lazarus R.S., 1984, HDB BEHAV MED; Lewis Maureen, 2009, Issues Ment Health Nurs, V30, P159, DOI 10.1080/01612840802694171; Liden RC, 2004, J MANAGE, V30, P285, DOI 10.1016/j.jm.2003.02.002; Litz BT, 2008, J TRAUMA STRESS, V21, P503, DOI 10.1002/jts.20373; Mackenzie Corey S, 2003, Am J Alzheimers Dis Other Demen, V18, P291, DOI 10.1177/153331750301800507; Matson J, 2008, J INTELLECT DEV DIS, V33, P323, DOI 10.1080/13668250802492600; McDonnell AA, 2011, MANAGING AGGRESSIVE; McElfatrick S, 2000, PERS INDIV DIFFER, V28, P965, DOI 10.1016/S0191-8869(99)00152-X; Miyamoto Y, 2010, GERIATR NURS, V31, P246, DOI 10.1016/j.gerinurse.2010.01.002; Moniz-Cook E, 2003, CLIN PSYCHOL PSYCHOT, V10, P197, DOI 10.1002/cpp.370; Moustaka L., 2010, HLTH SCI J, V4, P210; Mutkins E, 2011, J INTELL DISABIL RES, V55, P500, DOI 10.1111/j.1365-2788.2011.01406.x; Naylor C, 2015, ACUTE HOSP INTEGRATE; Needham H, 2010, PERSPECT PSYCHIATR C, V46, P221, DOI 10.1111/j.1744-6163.2010.00256.x; NOLENHOEKSEMA S, 1991, J ABNORM PSYCHOL, V100, P569, DOI 10.1037/0021-843X.100.4.569; Peterson U, 2008, J ADV NURS, V63, P506, DOI 10.1111/j.1365-2648.2008.04743.x; Pinkney L, 2008, J ADULT PROT, V10, P12, DOI 10.1108/14668203200800022; Roemer L, 1993, WORRY UNWANTED COGNI; ROGERS CR, 1958, PERS GUID J, V37, P6, DOI 10.1002/j.2164-4918.1958.tb01147.x; Schablon A, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001420; Schmidt SG, 2012, J CLIN NURS, V21, P3134, DOI 10.1111/jocn.12066; Sobral DT, 2000, MED TEACH, V22, P59, DOI 10.1080/01421590078832; Sparks K., 2013, STRESS WELLBEING, V1, P315; Valli L., 1997, PEABODY J EDUC, V72, P67, DOI [DOI 10.1207/S15327930PJE7201_4, 10.1207/s15327930pje7201_4]; Weinberg A, 2000, LANCET, V355, P533, DOI 10.1016/S0140-6736(99)07366-3; Winstanley S, 2004, AGGRESSIVE BEHAV, V30, P534, DOI 10.1002/ab.20052; Wu TY, 2012, NURS EDUC TODAY, V32, P669, DOI 10.1016/j.nedt.2011.09.002; Zeisel J, 2003, GERONTOLOGIST, V43, P697, DOI 10.1093/geront/43.5.697	58	6	6	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2020	15	2							e0229706	10.1371/journal.pone.0229706	http://dx.doi.org/10.1371/journal.pone.0229706			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LQ8GQ	32108179	Green Published, Green Accepted, gold			2022-12-26	WOS:000535237000062
J	Yoe, J; Kim, D; Kim, S; Lee, Y				Yoe, Jeehyun; Kim, Donghyo; Kim, Sanguk; Lee, Yoontae			Capicua restricts cancer stem cell-like properties in breast cancer cells	ONCOGENE			English	Article							TRANSCRIPTION FACTORS; EXTRACELLULAR-MATRIX; GENE-EXPRESSION; MICE; ASSOCIATION; RESISTANCE; MUTATIONS; FUSION; FAMILY; LINKS	Cancer stem cells (CSCs) play a central role in cancer initiation, progression, therapeutic resistance, and recurrence in patients. Here we present Capicua (CIC), a developmental transcriptional repressor, as a suppressor of CSC properties in breast cancer cells. CIC deficiency critically enhances CSC self-renewal and multiple CSC subpopulations of breast cancer cells without altering their growth rate or invasiveness. Loss of CIC relieves repression of ETV4 and ETV5 expression, consequently promoting self-renewal capability, EpCAM(+)/CD44(+)/CD24(low/-) expression, and ALDH activity. In xenograft models, CIC deficiency significantly increases CSC frequency and drives tumor initiation through derepression of ETV4. Consistent with the experimental data, the CD44(high)/CD24(low) CSC-like feature is inversely correlated with CIC levels in breast cancer patients. We also identify SOX2 as a downstream target gene of CIC that partly promotes CSC properties. Taken together, our study demonstrates that CIC suppresses breast cancer formation via restricting cancer stemness and proposes CIC as a potential regulator of stem cell maintenance.	[Yoe, Jeehyun; Kim, Donghyo; Kim, Sanguk; Lee, Yoontae] Pohang Univ Sci & Technol POSTECH, Dept Life Sci, Pohang 37673, Gyeongbuk, South Korea; [Kim, Sanguk; Lee, Yoontae] Pohang Univ Sci & Technol POSTECH, Div Integrat Biosci & Biotechnol, Pohang 37673, Gyeongbuk, South Korea	Pohang University of Science & Technology (POSTECH); Pohang University of Science & Technology (POSTECH)	Lee, Y (corresponding author), Pohang Univ Sci & Technol POSTECH, Dept Life Sci, Pohang 37673, Gyeongbuk, South Korea.; Lee, Y (corresponding author), Pohang Univ Sci & Technol POSTECH, Div Integrat Biosci & Biotechnol, Pohang 37673, Gyeongbuk, South Korea.	yoontael@postech.ac.kr		Kim, Sanguk/0000-0002-3449-3814	National Research Foundation (NRF) of Korea [2017R1A5A1015366, 2018R1A2B2004416]; BK21 Plus Program (Program of Bio-Molecular Function, POSTECH)	National Research Foundation (NRF) of Korea(National Research Foundation of Korea); BK21 Plus Program (Program of Bio-Molecular Function, POSTECH)	We thank the Lee lab members for helpful discussions on this study as well as helping to conduct the experiments. This work was supported by grants from the National Research Foundation (NRF) of Korea (2017R1A5A1015366 and 2018R1A2B2004416 to YL). JY and DK were supported by the BK21 Plus Program (Program of Bio-Molecular Function, POSTECH).	Ahmad ST, 2018, REGULATION NEURAL ST, DOI [10.1101/335984, DOI 10.1101/335984]; Akagi T, 2015, J BIOL CHEM, V290, P22460, DOI 10.1074/jbc.M115.675595; Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Ben-Porath I, 2008, NAT GENET, V40, P499, DOI 10.1038/ng.127; Bieche I, 2004, CARCINOGENESIS, V25, P405, DOI 10.1093/carcin/bgh024; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Charafe-Jauffret E, 2010, CLIN CANCER RES, V16, P45, DOI 10.1158/1078-0432.CCR-09-1630; Choi N, 2015, ONCOTARGET, V6, P23533, DOI 10.18632/oncotarget.4372; Chotteau-Lelievre A, 2004, CLIN CANCER RES, V10, P7297, DOI 10.1158/1078-0432.CCR-04-0593; Clarke Michael F, 2006, Cancer Res, V66, P9339, DOI 10.1158/0008-5472.CAN-06-3126; Colacino JA, 2018, STEM CELL REP, V10, P1596, DOI 10.1016/j.stemcr.2018.03.001; Dean M, 2005, NAT REV CANCER, V5, P275, DOI 10.1038/nrc1590; Desgrosellier JS, 2010, NAT REV CANCER, V10, P9, DOI 10.1038/nrc2748; Diehn M, 2009, NATURE, V458, P780, DOI 10.1038/nature07733; Eleveld TF, 2018, CANCER RES, V78, P6297, DOI 10.1158/0008-5472.CAN-18-1045; Firlej V, 2008, J CELL SCI, V121, P3393, DOI 10.1242/jcs.027201; Fores M, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1006622; Gattazzo F, 2014, BBA-GEN SUBJECTS, V1840, P2506, DOI 10.1016/j.bbagen.2014.01.010; Ginestier C, 2007, CELL STEM CELL, V1, P555, DOI 10.1016/j.stem.2007.08.014; Graham C, 2012, HUM PATHOL, V43, P180, DOI 10.1016/j.humpath.2011.04.023; Han SK, 2016, ONCOTARGET, V7, P56147, DOI 10.18632/oncotarget.11269; Hess DA, 2006, BLOOD, V107, P2162, DOI 10.1182/blood-2005-06-2284; Hu YF, 2009, J IMMUNOL METHODS, V347, P70, DOI 10.1016/j.jim.2009.06.008; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Hyun KA, 2016, ONCOTARGET, V7, P24677, DOI 10.18632/oncotarget.8250; Jimenez G, 2012, J CELL SCI, V125, P1383, DOI 10.1242/jcs.092965; Kan ZY, 2010, NATURE, V466, P869, DOI 10.1038/nature09208; Kawamura-Saito M, 2006, HUM MOL GENET, V15, P2125, DOI 10.1093/hmg/ddl136; Kim E, 2018, HEPATOLOGY, V67, P2287, DOI 10.1002/hep.29738; Kim E, 2015, SCI REP-UK, V5, DOI 10.1038/srep08272; Kurpios NA, 2003, J MAMMARY GLAND BIOL, V8, P177, DOI 10.1023/A:1025948823955; LeBlanc VG, 2017, J PATHOL, V242, P206, DOI 10.1002/path.4894; Lee JS, 2020, CANCER CELL INT, V20, DOI 10.1186/s12935-020-1111-8; Lee Y, 2011, DEV CELL, V21, P746, DOI 10.1016/j.devcel.2011.08.017; Leis O, 2012, ONCOGENE, V31, P1354, DOI 10.1038/onc.2011.338; Li XX, 2008, JNCI-J NATL CANCER I, V100, P672, DOI 10.1093/jnci/djn123; Liu SL, 2014, STEM CELL REP, V2, P78, DOI 10.1016/j.stemcr.2013.11.009; Lobo NA, 2007, ANNU REV CELL DEV BI, V23, P675, DOI 10.1146/annurev.cellbio.22.010305.104154; Lu HC, 2017, NAT GENET, V49, P527, DOI 10.1038/ng.3808; Masui S, 2007, NAT CELL BIOL, V9, P625, DOI 10.1038/ncb1589; Nik-Zainal S, 2016, NATURE, V534, P47, DOI 10.1038/nature17676; Oh S, 2012, BBA-REV CANCER, V1826, P1, DOI 10.1016/j.bbcan.2012.02.002; Okimoto RA, 2017, NAT GENET, V49, P87, DOI 10.1038/ng.3728; Park S, 2019, HEPATOLOGY, V70, P358, DOI 10.1002/hep.30594; Park S, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms16037; Patel M, 2008, LUNG CANCER, V59, P340, DOI 10.1016/j.lungcan.2007.08.033; Ponti D, 2005, CANCER RES, V65, P5506, DOI 10.1158/0008-5472.CAN-05-0626; Simon-Carrasco L, 2017, GENE DEV, V31, P1456, DOI 10.1101/gad.300244.117; Tan QM, 2018, P NATL ACAD SCI USA, V115, pE1511, DOI 10.1073/pnas.1716452115; Tanei T, 2009, CLIN CANCER RES, V15, P4234, DOI 10.1158/1078-0432.CCR-08-1479; Wong D, 2019, ONCOGENE, V38, P273, DOI 10.1038/s41388-018-0427-5; Yip S, 2012, J PATHOL, V226, P7, DOI 10.1002/path.2995; Yuan ZY, 2014, ONCOTARGETS THER, V7, P1733, DOI 10.2147/OTT.S66692	53	14	15	1	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR	2020	39	17					3489	3506		10.1038/s41388-020-1230-7	http://dx.doi.org/10.1038/s41388-020-1230-7		FEB 2020	18	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	LH1YK	32108163				2022-12-26	WOS:000516891300001
J	Yorzinski, JL; Miller, J				Yorzinski, Jessica L.; Miller, Jacob			Sclera color enhances gaze perception in humans	PLOS ONE			English	Article							EYE; DIRECTION; DISCRIMINATION; ATTENTION; CHILDREN; ANIMALS; CUES	Gaze perception is an essential behavior that allows individuals to determine where others are directing their attention but we know relatively little about the ways in which eye morphology influences it. We therefore tested whether eyes with conspicuous morphology have evolved to facilitate gaze perception. During a visual search task, we recorded the eye movements of human participants (Homo sapiens) as they searched for faces with directed gaze within arrays of faces with averted gaze or the reverse; the faces were large and upright, small and upright, or large and inverted. The faces had sclera that were conspicuous (white or colored lighter than the iris color) or inconspicuous (colored the same or darker than the iris color). We found that participants were fastest and most accurate in finding the faces with conspicuous sclera versus inconspicuous sclera. Our results demonstrate that eyes with conspicuous morphology facilitate gaze perception in humans.	[Yorzinski, Jessica L.] Texas A&M Univ, Dept Ecol & Conservat Biol, College Stn, TX 77843 USA; [Miller, Jacob] Texas A&M Univ, Dept Anthropol, College Stn, TX 77843 USA	Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station	Yorzinski, JL (corresponding author), Texas A&M Univ, Dept Ecol & Conservat Biol, College Stn, TX 77843 USA.	jyorzinski@tamu.edu			National Science Foundation [1926327]; College of Agriculture and Life Sciences at Texas AM University; Texas A&M AgriLife Research; Texas A&M University Open Access to Knowledge Fund (OAKFund); University Libraries; Office of the Vice President for Research	National Science Foundation(National Science Foundation (NSF)); College of Agriculture and Life Sciences at Texas AM University; Texas A&M AgriLife Research; Texas A&M University Open Access to Knowledge Fund (OAKFund); University Libraries; Office of the Vice President for Research	This study was funded by the National Science Foundation (BCS #1926327), the College of Agriculture and Life Sciences at Texas A&M University and Texas A&M AgriLife Research. In addition, the open access publishing fees for this article have been partially covered by the Texas A&M University Open Access to Knowledge Fund (OAKFund), supported by the University Libraries and the Office of the Vice President for Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson NC, 2016, PSYCHON B REV, V23, P817, DOI 10.3758/s13423-015-0971-8; Ando S, 2004, PERCEPTION, V33, P1173, DOI 10.1068/p5297; Ando S, 2002, PERCEPTION, V31, P657, DOI 10.1068/p3332; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Chelnokova O, 2014, MOL PSYCHIATR, V19, P746, DOI 10.1038/mp.2014.1; Cooper RM, 2013, J VISION, V13, DOI 10.1167/13.6.10; Coss RG, 2002, PRIMATES, V43, P217, DOI 10.1007/BF02629649; Emery NJ, 2000, NEUROSCI BIOBEHAV R, V24, P581, DOI 10.1016/S0149-7634(00)00025-7; Grossmann T, 2017, PERSPECT PSYCHOL SCI, V12, P107, DOI 10.1177/1745691616654457; Itti L, 2001, NAT REV NEUROSCI, V2, P194, DOI 10.1038/35058500; Jenkins R, 2007, PERCEPTION, V36, P1266, DOI 10.1068/p5745; Jessen S, 2014, P NATL ACAD SCI USA, V111, P16208, DOI 10.1073/pnas.1411333111; Kawai N, 2016, ANIM COGN, V19, P655, DOI 10.1007/s10071-015-0949-y; Kobayashi H, 2001, J HUM EVOL, V40, P419, DOI 10.1006/jhev.2001.0468; Langton SRH, 2000, TRENDS COGN SCI, V4, P50, DOI 10.1016/S1364-6613(99)01436-9; LoBue V, 2010, J EXP CHILD PSYCHOL, V107, P59, DOI 10.1016/j.jecp.2010.04.005; MARTIN WW, 1982, BRIT J SOC PSYCHOL, V21, P293, DOI 10.1111/j.2044-8309.1982.tb00551.x; Nasanen R, 2001, VISION RES, V41, P1817, DOI 10.1016/S0042-6989(01)00056-6; Ohman A, 2001, J EXP PSYCHOL GEN, V130, P466, DOI 10.1037/0096-3445.130.3.466; Pazda AD, 2016, PERCEPTION, V45, P739, DOI 10.1177/0301006616633386; Penkunas MJ, 2013, J EXP CHILD PSYCHOL, V114, P522, DOI 10.1016/j.jecp.2012.10.001; Ricciardelli P, 2000, COGNITION, V77, pB1, DOI 10.1016/S0010-0277(00)00092-5; Sato T., 2000, HUM INTERFACE SOC, V2, P127; Segal NL, 2015, EVOL HUM BEHAV, V37, P35; Taglialatela JP, 2015, AM J PRIMATOL, V77, P1143, DOI 10.1002/ajp.22449; Tanaka JW, 2016, Q J EXP PSYCHOL, V69, P1876, DOI 10.1080/17470218.2016.1146780; Tomasello M, 2007, J HUM EVOL, V52, P314, DOI 10.1016/j.jhevol.2006.10.001; Ueda S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098217; Watt R, 2007, Q J EXP PSYCHOL, V60, P1169, DOI 10.1080/17470210701396798; Yokoyama T, 2014, SCI REP-UK, V4, DOI 10.1038/srep03858; Yorzinski JL, 2014, EVOL PSYCHOL-US, V12, P534, DOI 10.1177/147470491401200304	31	7	7	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2020	15	2							e0228275	10.1371/journal.pone.0228275	http://dx.doi.org/10.1371/journal.pone.0228275			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LQ8GQ	32107490	Green Published, gold			2022-12-26	WOS:000535237000011
J	Uhlmann, SS; Yochum, N; Ampe, B				Uhlmann, Sven Sebastian; Yochum, Norlle; Ampe, Bart			Repeatability of flatfish reflex impairment assessments based on video recordings	PLOS ONE			English	Article							CRAB CHIONOECETES-BAIRDI; ANIMAL BEHAVIOR RESEARCH; DISCARD MORTALITY; OBSERVER BIAS; FISH; SURVIVAL; VALIDITY; VITALITY; INJURY; SCORE	Using measures of reflex impairment and injury to quantify an aquatic organism's vitality have gained popularity as survival predictors of discarded non-target fisheries catch. To evaluate the robustness of this method with respect to 'rater' subjectivity, we tested inter- and intra-rater repeatability and the role of 'expectation bias'. From video clips, multiple raters determined impairment levels of four reflexes of beam-trawled common sole (Solea solea) intended for discard. Raters had a range of technical experience, including veterinary students, practicing veterinarians, and fisheries scientists. Expectation bias was evaluated by first assessing a rater's assumption about the effect of air exposure on vitality, then comparing their reflex ratings of the same fish, once when the true air exposure duration was indicated and once when the time was exaggerated (by either 15 or 30 min). Inter-rater repeatability was assessed by having multiple raters evaluate those clips with true air exposure information; and intra- and inter-rater repeatability was determined by having individual raters evaluate a series of duplicated clips, all with true air exposure. Results indicate that inter- and intra-rater repeatability were high (intra-class correlation coefficients of 74% for both), and were not significantly affected by background type nor expectation bias related to assumed impact from prolonged air exposure. This suggests that reflex impairment as a metric for predicting fish survival is robust to involving multiple raters with diverse backgrounds. Bias is potentially more likely to be introduced through subjective reflexes than raters, given that consistency in scoring differed for some reflexes based on rater experience type. This study highlights the need to provide ample training for raters, and that no prior experience is needed to become a reliable rater. Moreover, before implementing reflexes in a vitality study, it is important to evaluate whether the determination of presence/absence is subjective.	[Uhlmann, Sven Sebastian; Ampe, Bart] Flanders Res Inst Agr Fisheries & Food, Anim Sci Unit, Oostende, Belgium; [Yochum, Norlle] NOAA, Alaska Fisheries Sci Ctr, Seattle, WA USA	Institute For Agricultural & Fisheries Research; National Oceanic Atmospheric Admin (NOAA) - USA	Uhlmann, SS (corresponding author), Flanders Res Inst Agr Fisheries & Food, Anim Sci Unit, Oostende, Belgium.	sven.uhlmann@gmx.net		Uhlmann, Sven Sebastian/0000-0003-2830-5845	European Maritime and Fisheries Fund [VIS/14/B/01/DIV, 17/UP1/01/Div, 18/UP1/30/Div]	European Maritime and Fisheries Fund	The work was supported by the European Maritime and Fisheries Fund (Grant Numbers: VIS/14/B/01/DIV, 17/UP1/01/Div, and 18/UP1/30/Div). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Benoit HP, 2012, FISH RES, V125, P318, DOI 10.1016/j.fishres.2011.12.004; Benoit HP, 2010, FISH RES, V106, P436, DOI 10.1016/j.fishres.2010.09.018; Brownscombe JW, 2017, FISH RES, V186, P693, DOI 10.1016/j.fishres.2016.04.018; Burghardt GM, 2012, ETHOLOGY, V118, P511, DOI 10.1111/j.1439-0310.2012.02040.x; Chilton E. A., 2011, N PACIFIC RES BOARD, V917, P16; Davis MW, 2006, FISH RES, V82, P1, DOI 10.1016/j.fishres.2006.09.004; Desender M, 2016, FISH RES, V179, P90, DOI 10.1016/j.fishres.2016.02.018; Eliasziw M, 1994, PHYS THERAPY; Fischer K, 2010, WASSERWIRTSCHAFT, V100, P64; Gamer M., 2012, PACKAGE IRR VARIOUS; Gibbons J, 2012, ANIM WELFARE, V21, P379, DOI 10.7120/09627286.21.3.379; HARTMANN DP, 1977, J APPL BEHAV ANAL, V10, P103, DOI 10.1901/jaba.1977.10-103; Holman L, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002190; International Council for the Exploration of the Sea (ICES), 2016, WORKSH AG EST WHIT M; Iyer VN, 2009, MAYO CLIN PROC, V84, P694, DOI 10.1016/S0025-6196(11)60519-3; KAZDIN AE, 1977, J APPL BEHAV ANAL, V10, P141, DOI 10.1901/jaba.1977.10-141; Kestin SC, 2002, VET REC, V150, P302, DOI 10.1136/vr.150.10.302; Marsh DM, 2004, ANIM BEHAV, V68, P1425, DOI 10.1016/j.anbehav.2004.02.017; Meagher RK, 2009, APPL ANIM BEHAV SCI, V119, P1, DOI 10.1016/j.applanim.2009.02.026; Meeremans P, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179092; Morfin M, 2019, ECOL INDIC, V98, P310, DOI 10.1016/j.ecolind.2018.10.060; Mullan Siobhan, 2011, Vet J, V190, pe100, DOI 10.1016/j.tvjl.2011.01.012; Raby GD, 2012, J APPL ECOL, V49, P90, DOI 10.1111/j.1365-2664.2011.02073.x; Revelle W., 2012, INTRO PSYCHOMETRIC T; Roberts MBV., 1986, BIOL FUNCTIONAL APPR; SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037/0033-2909.86.2.420; Soetaert M, 2016, ICES J MAR SCI, V73, P2370, DOI 10.1093/icesjms/fsw096; Stoner AW, 2008, FISH B-NOAA, V106, P337; Stoner AW, 2012, FISH RES, V119, P108, DOI 10.1016/j.fishres.2011.12.014; Tuyttens FAM, 2014, ANIM BEHAV, V90, P273, DOI 10.1016/j.anbehav.2014.02.007; Tuyttens FAM, 2016, APPL ANIM BEHAV SCI, V181, P27, DOI 10.1016/j.applanim.2016.04.019; Uhlmann SS, 2016, ICES J MAR SCI, V73, P1244, DOI 10.1093/icesjms/fsv252; Williams JB., 2012, EUR PSYCHIAT, V27, P1, DOI 10.1016/S0924-9338(12)74807-1; Yochum N, 2017, CAN J FISH AQUAT SCI, V74, P739, DOI 10.1139/cjfas-2016-0029; Yochum N, 2015, FISH RES, V161, P226, DOI 10.1016/j.fishres.2014.07.012	36	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2020	15	2							e0229456	10.1371/journal.pone.0229456	http://dx.doi.org/10.1371/journal.pone.0229456			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LQ8FM	32101577	Green Published, gold			2022-12-26	WOS:000535233700035
J	Viswasam, N; Lyons, CE; MacAllister, J; Millett, G; Sherwood, J; Rao, A; Baral, SD				Viswasam, Nikita; Lyons, Carrie E.; MacAllister, Jack; Millett, Greg; Sherwood, Jennifer; Rao, Amrita; Baral, Stefan D.		Global HIV Res Grp	The uptake of population size estimation studies for key populations in guiding HIV responses on the African continent	PLOS ONE			English	Article							FEMALE SEX WORKERS; GLOBAL EPIDEMIOLOGY; MEN; INFECTION; COUNTRIES; COVERAGE	Background There has been a heightened emphasis on prioritizing data to inform evidence-based HIV responses, including data focused on both defining the content and scale of HIV programs in response to evidence-based need. Consequently, population size estimation (PSE) studies for key populations have become increasingly common to define the necessary scale of specific programs for key populations. This study aims to assess the research utilization of these size estimates in informing HIV policy and program documents across the African continent. Methods This study included two phases; Phase 1 was a review of all PSE for key populations, including men who have sex with men (MSM), female sex workers (FSW), people who use drugs (PWUD), and transgender persons in the 54 countries across Africa published from January 2009-December 2017. Phase 2 was a review of 23 different types of documents released between January 2009-January 2019, with a focus on the US President's Emergency Plan for AIDS Relief (PEPFAR) and The Global Fund to Fight AIDS, Tuberculosis and Malaria investments, for evidence of stakeholder engagement in PSE studies, as well as key population PSE research utilization to inform HIV programming and international HIV investments. Results Of 118 size estimates identified in 39 studies, less than 15% were utilized in PEPFAR Country Operational Plans or national strategic health plan documents, and less than 2% in Global Fund Concept Notes. Of 39 PSE studies, over 50% engaged stakeholders in study implementation and identified target population stakeholders, a third of studies identified policy or program stakeholders, and 15% involved stakeholders in study design. Conclusion The past decade has seen an increase in PSE studies conducted for key populations in more generalized HIV epidemic settings which involve significant investments of finances and human resources. However, there remains limited evidence of sustained uptake of these data to guide the HIV responses. Increasing uptake necessitates effective stakeholder engagement and data-oriented capacity building to optimize research utilization and facilitate data-driven and human rights-affirming HIV responses.	[Viswasam, Nikita; Lyons, Carrie E.; Rao, Amrita; Baral, Stefan D.] Johns Hopkins Bloomberg Sch Publ Hlth, Ctr Publ Hlth & Human Rights, Key Populat Program, Dept Epidemiol, Baltimore, MD 21205 USA; [MacAllister, Jack] JWM Consulting LLC, Washington, DC USA; [Millett, Greg; Sherwood, Jennifer] amfAR, Fdn AIDS Res, Washington, DC USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Viswasam, N (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Ctr Publ Hlth & Human Rights, Key Populat Program, Dept Epidemiol, Baltimore, MD 21205 USA.	nviswas1@jhu.edu	Rao, Amrita/I-5863-2019; Baral, Stefan/AAG-4818-2020	Rao, Amrita/0000-0002-9596-2418; Baral, Stefan/0000-0002-5482-2419; Viswasam, Nikita/0000-0003-2387-5056	Project SOAR [AID-OAA-A-1400060]; American people through the United States President's Emergency Plan for AIDS Relief (PEPFAR); United States Agency for International Development (USAID); non-profit foundation amfAR; NIAID [R01 AI136664]	Project SOAR; American people through the United States President's Emergency Plan for AIDS Relief (PEPFAR); United States Agency for International Development (USAID)(United States Agency for International Development (USAID)); non-profit foundation amfAR; NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by Project SOAR (Cooperative Agreement AID-OAA-A-1400060) (http://www.projsoar.org/), made possible by the generous support of the American people through the United States President's Emergency Plan for AIDS Relief (PEPFAR) and United States Agency for International Development (USAID). The contents of this paper are the sole responsibility of the authors and do not necessarily reflect the views of PEPFAR, USAID, or the United States Government. Funding for this work was also partially provided by the non-profit foundation amfAR. This funding was awarded to Johns Hopkins University, and no personal awards were received. Authors GM and JS are also affiliated with amfAR, and amfAR provided support in the form of salaries for GM and JS, but did not play a role in study design, secondary data collection, analyses, decision to publish, or preparation of the manuscript. Author JM declares a commercial affiliation to JWM Consulting, LLC, which provided support in the form of salary for author JM, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the `author contributions' section. Additionally, SB and NV's effort was, in part, supported by NIAID Grant R01 AI136664.	Abdul-Quader AS, 2015, AIDS BEHAV, V19, pS1, DOI 10.1007/s10461-014-0963-0; Abdul-Quader AS, 2014, CURR OPIN HIV AIDS, V9, P107, DOI 10.1097/COH.0000000000000041; Adebajo Sylvia B, 2013, Afr J Reprod Health, V17, P83; [Anonymous], 2018, MIL TO GO GLOB AIDS; [Anonymous], 2014, BURUNDI PLACE REPORT; Baral S, 2018, JMIR PUBLIC HLTH SUR, V4, P289, DOI 10.2196/publichealth.9321; Baral S, 2012, LANCET INFECT DIS, V12, P538, DOI 10.1016/S1473-3099(12)70066-X; Baral SD, 2014, CURR OPIN HIV AIDS, V9, P156, DOI 10.1097/COH.0000000000000037; Bergenstrom AM, 2010, AIDS, V1; Beyrer C, 2012, LANCET, V380, P367, DOI 10.1016/S0140-6736(12)60821-6; Bugssa G, 2015, INT J PHARM SCI RES, V6, P135, DOI 10.13040/IJPSR.0975-8232.6(1).135-46; Concannon TW, 2014, J GEN INTERN MED, V29, P1692, DOI 10.1007/s11606-014-2878-x; Conseil National de Lutte contre le Sida, 2013, PLAN STRAT NAT SIDA; Datta A, 2019, STAT PUBLIC POLICY, V6, P1, DOI 10.1080/2330443X.2018.1546634; Davis SLM, 2017, J INT AIDS SOC, V20, DOI 10.7448/IAS.20.1.21386; Fraser N, 2014, NIGERS HIV RESPONSE; Fraser N, 2015, JAIDS-J ACQ IMM DEF, V68, pS213, DOI 10.1097/QAI.0000000000000456; Ghana AIDS commission, 2016, GHAN NAT HIV AIDS ST; Githuka G, 2014, JAIDS-J ACQ IMM DEF, V66, pS46, DOI 10.1097/QAI.0000000000000137; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Health Communication Capacity Collaborative, 2015, CHAR HIV PREV TREATM; Holland CE, 2016, PUBLIC HEALTH REP, V131, P773, DOI 10.1177/0033354916677237; Holland CE, 2015, JAIDS-J ACQ IMM DEF, V68, pS232, DOI 10.1097/QAI.0000000000000443; Ikpeazu A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103619; Jacobsen JO ST, 2015, ESTIMATING SIZE KEY; Johnston LG, 2015, EPIDEMIOLOGY, V26, P846, DOI 10.1097/EDE.0000000000000362; Joint United Nations Programme on HIV/ AIDS, 2015, FAST TRACK END AIDS; Joint United Nations Programme on HIV/AIDS, 2014, GAP REP; Kendall C, 2014, JAIDS-J ACQ IMM DEF, V66, P544, DOI 10.1097/QAI.0000000000000213; Kenya Ministry of Health, 2016, MARPS BOOK REP; Khalid FJ, 2014, AIDS BEHAV, V18, pS25, DOI 10.1007/s10461-013-0517-x; Lafort Y, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-144; Lemma D, 2012, ETHIOP J HLTH BIOMED, V1, P1; Lepretre A, 2015, J INT AIDS SOC, V18, DOI 10.7448/IAS.18.1.19888; MacAllister J, 2015, JAIDS-J ACQ IMM DEF, V68, pS83, DOI 10.1097/QAI.0000000000000457; Ministry of Health & Quality of Life, 2012, INT BIOL SURV SURV F; Ministry of Health & Quality of Life, 2010, INT BEH BIOL SURV SU; Mumtaz G, 2010, HIV MODES TRANSMISSI; Mumtaz GR, 2013, SEX TRANSM INFECT, V89, P49, DOI 10.1136/sextrans-2012-050844; Mutagoma M, 2015, INT J STD AIDS, V26, P810, DOI 10.1177/0956462414555931; Nascop, 2014, 2010 2011 INT BIOL B; National Agency for the Control of AIDS, 2014, NAT GUID IMPL HIV PR; Nieburg P, 2011, HIV PREVENTION INJEC; Office of the US Global AIDS Coordinator, 2014, PEPFAR 3 0 CONTR EP; Papworth E, 2014, EXAMINING RISK FACTO; Papworth E, 2013, J INT AIDS SOC, V16, DOI 10.7448/IAS.16.4.18751; Population Council, 2015, PROJ SOARS RES UT PR; Poteat TSA, 2016, J ACQUIRED IMMUNE S2, V72; Rao A, 2018, SYST REV-LONDON, V7, DOI 10.1186/s13643-018-0894-3; Ray KN, 2017, J COMP EFFECT RES, V6, P375, DOI 10.2217/cer-2016-0096; Sabin K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155150; Shannon K., 2018, LANCET; Shannon K, 2015, LANCET, V385, P55, DOI 10.1016/S0140-6736(14)60931-4; South A, 2019, TRIALS, V20; The Global Fund, 2016, GLOB FUND STRAT 2017; The Global Fund, 2015, TB HIV CONC NOT; The Global Fund, 2014, HIV CONC NOT; Ucsf AHIW, 2015, S AFR HLTH MON STUD; UNAIDS/WHO Working Group on Global HIV/AIDS and STI Surveillance, 2011, GUID EST SIZ POP MOS; US President's Emergency Plan for AIDS Relief, 2012, S AFR COUNTR OP PLAN; US President's Emergency Plan for AIDS Relief, 2015, CAM COUNTR OP PLAN C; US President's Emergency Plan for AIDS Relief, 2015, ANG COUNTR OP PLAN F; US President's Emergency Plan for AIDS Relief, 2015, GHAN COUNTR OP PLAN; US President's Emergency Plan for AIDS Relief, 2015, KEN COUNTR OP PLAN 2; Vuylsteke B, 2010, TROP MED INT HEALTH, V15, P1537, DOI 10.1111/j.1365-3156.2010.02654.x	65	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2020	15	2							e0228634	10.1371/journal.pone.0228634	http://dx.doi.org/10.1371/journal.pone.0228634			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8FM	32101551	gold, Green Published			2022-12-26	WOS:000535233700011
J	Damsteegt, EL; Thomson-Laine, G; Wylie, MJ; Lokman, PM				Damsteegt, Erin L.; Thomson-Laine, Georgia; Wylie, Matthew J.; Lokman, P. Mark			Effects of estradiol and 11-ketotestosterone pre-treatment on artificial induction of maturation in silver female shortfinned eels (Anguilla australis)	PLOS ONE			English	Article							FRESH-WATER EELS; MATURED JAPANESE EEL; SEXUAL-MATURATION; EUROPEAN EEL; VITELLOGENIN SYNTHESIS; BROODSTOCK MANAGEMENT; OVARIAN DEVELOPMENT; OOCYTE DEVELOPMENT; PRIMARY CULTURE; EGG-PRODUCTION	Our previous work documented significant advancements in steroid-induced progression of oogenesis, demonstrating that co-treatment of female eels with 11-ketotestosterone (11KT) and estradiol-17 beta (E-2) successfully induced uptake of vitellogenin by oocytes. Here we evaluate the effects of this steroid co-treatment on subsequent time to ovulation and egg quality in shortfinned eels artificially matured by hypophysation. Co-treatment with 11KT (1 mg) and E-2 (0.2 or 2 mg) significantly reduced time to ovulation and therefore, the amount of pituitary homogenate required, without any detrimental effects on gonadosomatic index, oocyte diameter or the total weight of stripped eggs. E-2 treatment resulted in promising increases in fertilization rates. These indicators suggest that co-treatment with 11KT and E-2 holds promise for future artificial maturation practices in terms of minimising fish handling and stress, and of reducing the need for expensive pituitary preparations.	[Damsteegt, Erin L.; Thomson-Laine, Georgia; Wylie, Matthew J.; Lokman, P. Mark] Univ Otago, Dept Zool, Dunedin, New Zealand; [Thomson-Laine, Georgia] Cawthron Inst, Nelson, New Zealand; [Wylie, Matthew J.] New Zealand Inst Plant & Food Res Ltd, Nelson, New Zealand	University of Otago; Cawthron Institute; New Zealand Institute for Plant & Food Research Ltd	Damsteegt, EL (corresponding author), Univ Otago, Dept Zool, Dunedin, New Zealand.	erin.damsteegt@otago.ac.nz	Damsteegt, Erin/C-4113-2018; Damsteegt, Erin/AAF-1978-2021	Damsteegt, Erin/0000-0001-8972-9313; Thomson-Laing, Georgia/0000-0001-8337-5489	University of Otago; 2018 PBRF Research Enhancement Grant	University of Otago; 2018 PBRF Research Enhancement Grant	This work was supported by a 2016 University of Otago Research grant and a 2018 PBRF Research Enhancement Grant (both PML). Publication fees were covered by a 2019 PBRF Research Enhancement Grant (ELD).	[Anonymous], 2012, ISR J AQUAC; Bobe J., 2015, Animal Frontiers, V5, P66, DOI 10.2527/af.2015-0010; BROMAGE N, 1992, AQUACULTURE, V100, P141, DOI 10.1016/0044-8486(92)90355-O; Burgerhout E, 2011, BMC DEV BIOL, V11, DOI 10.1186/1471-213X-11-16; Chow S, 2010, MAR ECOL PROG SER, V402, P233, DOI 10.3354/meps08448; CLEARWATER SJ, 1994, AUST J MAR FRESH RES, V45, P131; Damsteegt EL, 2015, GEN COMP ENDOCR, V221, P94, DOI 10.1016/j.ygcen.2014.12.019; Di Biase A, 2017, AQUACULTURE, V479, P508, DOI 10.1016/j.aquaculture.2017.06.030; Di Biase A, 2016, AQUAC RES, V47, P3052, DOI 10.1111/are.12755; Dou SZ, 2008, ENVIRON BIOL FISH, V82, P151, DOI 10.1007/s10641-007-9268-8; Endo T, 2011, BIOL REPROD, V84, P816, DOI 10.1095/biolreprod.110.087163; HOP H, 1995, CAN J FISH AQUAT SCI, V52, P541, DOI 10.1139/f95-055; Ijiri S, 1998, FISHERIES SCI, V64, P531, DOI 10.2331/fishsci.64.531; Kagawa H, 1997, FISHERIES SCI, V63, P365, DOI 10.2331/fishsci.63.365; Kagawa H., 2001, SUISANZOSHOKU, V49, P127; Kumagai A, 2005, COMP BIOCHEM PHYS B, V140, P543, DOI 10.1016/j.cbpc.2004.12.004; Kwon HC, 2005, J STEROID BIOCHEM, V96, P175, DOI 10.1016/j.jsbmb.2005.02.010; Lin HR, 1998, B FR PECHE PISCIC, P163, DOI 10.1051/kmae:1998041; LIN HR, 1991, AQUACULTURE, V96, P87, DOI 10.1016/0044-8486(91)90141-S; Lokman PM, 2015, AQUACULTURE, V437, P111, DOI 10.1016/j.aquaculture.2014.11.026; Lokman PM, 2007, REPRODUCTION, V133, P955, DOI 10.1530/REP-06-0229; Lokman PM, 1998, FISH PHYSIOL BIOCHEM, V19, P325, DOI 10.1023/A:1007719414295; Lokman PM, 2000, NEW ZEAL J MAR FRESH, V34, P135, DOI 10.1080/00288330.2000.9516921; Luizi F, 1997, FISH PHYSIOL BIOCHEM, V16, P273, DOI 10.1023/A:1007746912113; MEDFORD BA, 1978, J FISH RES BOARD CAN, V35, P213, DOI 10.1139/f78-035; Mes D, 2016, AQUACULTURE, V452, P367, DOI 10.1016/j.aquaculture.2015.11.020; Migaud H, 2013, REV AQUACULT, V5, pS194, DOI 10.1111/raq.12025; Miller MJ, 2002, MAR BIOL, V140, P809, DOI 10.1007/s00227-001-0754-9; Mordenti O, 2018, AQUAC RES, V49, P442, DOI 10.1111/are.13475; Mordenti O, 2013, AQUACULT INT, V21, P1045, DOI 10.1007/s10499-012-9611-8; Ohta H, 1997, FISH PHYSIOL BIOCHEM, V17, P163, DOI 10.1023/A:1007720600588; Okamura A, 2014, ECOL FRESHW FISH, V23, P95, DOI 10.1111/eff.12086; Oliveira K, 2010, CAN J ZOOL, V88, P1121, DOI 10.1139/Z10-081; Palstra AP, 2005, AQUACULTURE, V249, P533, DOI 10.1016/j.aquaculture.2005.04.031; PANKHURST NW, 1982, J FISH BIOL, V21, P127, DOI 10.1111/j.1095-8649.1982.tb03994.x; Perez L, 2000, J FISH BIOL, V57, P1488, DOI 10.1111/j.1095-8649.2000.tb02227.x; Peyon P, 1996, GEN COMP ENDOCR, V102, P263, DOI 10.1006/gcen.1996.0068; PEYON P, 1993, GEN COMP ENDOCR, V91, P318, DOI 10.1006/gcen.1993.1132; Reading BJ, 2018, FISHES-BASEL, V3, DOI 10.3390/fishes3040045; Schmidt J, 1923, PHILOS T R SOC LON B, V211, P179, DOI 10.1098/rstb.1923.0004; SHERWOOD NM, 1988, AQUACULTURE, V74, P75, DOI 10.1016/0044-8486(88)90088-9; Sudo R, 2012, ZOOL SCI, V29, P254, DOI 10.2108/zsj.29.254; Tanaka H, 2003, FISH PHYSIOL BIOCHEM, V28, P493, DOI 10.1023/B:FISH.0000030638.56031.ed; Thomson-Laing G, 2019, BIOL REPROD, V100, P1319, DOI 10.1093/biolre/ioz007; Tsukamoto K, 2009, J FISH BIOL, V74, P1833, DOI 10.1111/j.1095-8649.2009.02242.x; TSUKAMOTO K, 1992, NATURE, V356, P789, DOI 10.1038/356789a0; Tsukamoto K, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1174; Unuma T, 2011, AQUACULTURE, V322, P142, DOI 10.1016/j.aquaculture.2011.10.001; Vazirzadeh A, 2014, J ANIM PHYSIOL AN N, V98, P1060, DOI 10.1111/jpn.12171; Wang YS, 2006, J STEROID BIOCHEM, V100, P193, DOI 10.1016/j.jsbmb.2006.04.011; WENNER CA, 1974, J FISH RES BOARD CAN, V31, P1387, DOI 10.1139/f74-164; YAMAMOTO K, 1974, NATURE, V251, P220, DOI 10.1038/251220a0	52	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2020	15	2							e0229391	10.1371/journal.pone.0229391	http://dx.doi.org/10.1371/journal.pone.0229391			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8DW	32092110	Green Published, gold			2022-12-26	WOS:000535229300053
J	Mandelli, F; de Morais, MAB; de Lima, EA; Oliveira, L; Persinoti, GF; Murakami, MT				Mandelli, Fernanda; de Morais, Mariana Abrahao Bueno; de Lima, Evandro Antonio; Oliveira, Leane; Persinoti, Gabriela Felix; Murakami, Mario Tyago			Spatially remote motifs cooperatively affect substrate preference of a ruminal GH26-type endo-?-1,4-mannanase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						glycoside hydrolase; crystal structure; glycobiology; enzyme mechanism; substrate specificity	GLYCOSIDE HYDROLASE; BIOLOGICAL MACROMOLECULES; BIOCHEMICAL ANALYSES; SOLUTION SCATTERING; BETA-MANNANASE; RESOLUTION; PROGRAM; GENOMES; PROTEIN; TOOLS	?-Mannanases from the glycoside hydrolase 26 (GH26) family are retaining hydrolases that are active on complex heteromannans and whose genes are abundant in rumen metagenomes and metatranscriptomes. These enzymes can exhibit distinct modes of substrate recognition and are often fused to carbohydrate-binding modules (CBMs), resulting in a molecular puzzle of mechanisms governing substrate preference and mode of action that has not yet been pieced together. In this study, we recovered a novel GH26 enzyme with a CBM35 module linked to its N terminus (CrMan26) from a cattle rumen metatranscriptome. CrMan26 exhibited a preference for galactomannan as substrate and the crystal structure of the full-length protein at 1.85 ? resolution revealed a unique orientation of the ancillary domain relative to the catalytic interface, strategically positioning a surface aromatic cluster of the ancillary domain as an extension of the substrate-binding cleft, contributing to galactomannan preference. Moreover, systematic investigation of nonconserved residues in the catalytic interface unveiled that residues Tyr(195) (?3 subsite) and Trp(234) (?5 subsite) from distal negative subsites have a key role in galactomannan preference. These results indicate a novel and complex mechanism for substrate recognition involving spatially remote motifs, distal negative subsites from the catalytic domain, and a surface-associated aromatic cluster from the ancillary domain. These findings expand our molecular understanding of the mechanisms of substrate binding and recognition in the GH26 family and shed light on how some CBMs and their respective orientation can contribute to substrate preference.	[Mandelli, Fernanda; de Morais, Mariana Abrahao Bueno; de Lima, Evandro Antonio; Persinoti, Gabriela Felix; Murakami, Mario Tyago] Brazilian Ctr Res Energy & Mat CNPEM, Brazilian Biorenewables Natl Lab LNBR, BR-13083970 Campinas, SP, Brazil; [Oliveira, Leane] Elanco Anim Hlth, Greenfield, IN 46140 USA		Murakami, MT (corresponding author), Brazilian Ctr Res Energy & Mat, Brazilian Biorenewables Natl Lab, BR-13083970 Campinas, SP, Brazil.	mario.murakami@lnbr.cnpem.br	Persinoti, Gabriela/C-5933-2016; Murakami, Mario T/F-5640-2016; Lima, Evandro/E-4574-2017	Persinoti, Gabriela/0000-0002-0975-7283; Murakami, Mario T/0000-0002-0405-8010; Lima, Evandro/0000-0002-7412-2655; Mandelli, Fernanda/0000-0003-0891-9241	Financiadora de Estudos e Projetos (FINEP) [01.13.0225.00]; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2015/26982-0, 2016/19995-0]	Financiadora de Estudos e Projetos (FINEP)(Financiadora de Inovacao e Pesquisa (Finep)); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work was supported by Financiadora de Estudos e Projetos (FINEP) Grant 01.13.0225.00 and Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) Grants 2015/26982-0 (to M. T. M.) and 2016/19995-0 (to M. A. B. M.). The authors declare that they have no conflicts of interest with the contents of this article.	Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Bagenholm V, 2019, J BIOL CHEM, V294, P9100, DOI 10.1074/jbc.RA118.007171; Bagenholm V, 2017, J BIOL CHEM, V292, P229, DOI 10.1074/jbc.M116.746438; BIELY P, 1981, EUR J BIOCHEM, V119, P559, DOI 10.1111/j.1432-1033.1981.tb05644.x; Cartmell A, 2008, J BIOL CHEM, V283, P34403, DOI 10.1074/jbc.M804053200; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Correia MAS, 2010, BIOCHEMISTRY-US, V49, P6193, DOI 10.1021/bi1006139; Couturier M, 2013, J BIOL CHEM, V288, P14624, DOI 10.1074/jbc.M113.459438; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Hess M, 2011, SCIENCE, V331, P463, DOI 10.1126/science.1200387; Holm L, 2016, NUCLEIC ACIDS RES, V44, pW351, DOI 10.1093/nar/gkw357; Hornung B., 2018, RUMEN METATRANSCRIPT, DOI [10.1101/275883, DOI 10.1101/275883]; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Karplus PA, 2012, SCIENCE, V336, P1030, DOI [10.1126/science.121823, 10.1126/science.1218231]; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Kozin MB, 2001, J APPL CRYSTALLOGR, V34, P33, DOI 10.1107/S0021889800014126; Laskowski RA, 2018, PROTEIN SCI, V27, P129, DOI 10.1002/pro.3289; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Lombard V, 2014, NUCLEIC ACIDS RES, V42, pD490, DOI 10.1093/nar/gkt1178; Madeira F, 2019, NUCLEIC ACIDS RES, V47, pW636, DOI 10.1093/nar/gkz268; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; MILLER GL, 1959, ANAL CHEM, V31, P426, DOI 10.1021/ac60147a030; Morais S, 2019, FEMS MICROBIOL REV, V43, P362, DOI 10.1093/femsre/fuz007; Nursimulu N, 2018, BIOINFORMATICS, V34, P3393, DOI 10.1093/bioinformatics/bty368; Patel AB, 2016, BIOTECHNOL APPL BIOC, V63, P257, DOI 10.1002/bab.1358; Petkun S, 2015, PEERJ, V3, DOI 10.7717/peerj.1126; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; Svartstrom O, 2017, ISME J, V11, P2538, DOI 10.1038/ismej.2017.108; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; Svergun DI, 1999, BIOPHYS J, V76, P2879, DOI 10.1016/S0006-3495(99)77443-6; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Tailford LE, 2009, BIOCHEMISTRY-US, V48, P7009, DOI 10.1021/bi900515d; Tsukagoshi H, 2014, J BIOL CHEM, V289, P10843, DOI 10.1074/jbc.M114.555383; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; von Freiesleben P, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-38602-x; von Freiesleben P, 2018, BIOTECHNOL BIOFUELS, V11, DOI 10.1186/s13068-018-1184-y; Zhang H, 2018, NUCLEIC ACIDS RES, V46, pW95, DOI 10.1093/nar/gky418	38	4	5	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 10	2020	295	15					5012	5021		10.1074/jbc.RA120.012583	http://dx.doi.org/10.1074/jbc.RA120.012583			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LE7FC	32139511	hybrid, Green Published			2022-12-26	WOS:000526887000023
J	Archer, S; de Villiers, CB; Scheibl, F; Carver, T; Hartley, S; Lee, A; Cunningham, AP; Easton, DF; McIntosh, JG; Emery, J; Tischkowitz, M; Antoniou, AC; Walter, FM				Archer, Stephanie; de Villiers, Chantal Babb; Scheibl, Fiona; Carver, Tim; Hartley, Simon; Lee, Andrew; Cunningham, Alex P.; Easton, Douglas F.; McIntosh, Jennifer G.; Emery, Jon; Tischkowitz, Marc; Antoniou, Antonis C.; Walter, Fiona M.			Evaluating clinician acceptability of the prototype CanRisk tool for predicting risk of breast and ovarian cancer: A multi-methods study	PLOS ONE			English	Article							GENETIC SUSCEPTIBILITY; GENERAL-PRACTICE; BOADICEA MODEL; SUPPORT	Background There is a growing focus on the development of multi-factorial cancer risk prediction algorithms alongside tools that operationalise them for clinical use. BOADICEA is a breast and ovarian cancer risk prediction model incorporating genetic and other risk factors. A new user-friendly Web-based tool (CanRisk.org) has been developed to apply BOADICEA. This study aimed to explore the acceptability of the prototype CanRisk tool among two healthcare professional groups to inform further development, evaluation and implementation. Method A multi-methods approach was used. Clinicians from primary care and specialist genetics clinics in England, France and Germany were invited to use the CanRisk prototype with two test cases (either face-to-face with a simulated patient or via a written vignette). Their views about the tool were examined via a semi-structured interview or equivalent open-ended questionnaire. Qualitative data were subjected to thematic analysis and organised around Sekhon's Theoretical Framework of Acceptability. Results Seventy-five clinicians participated, 21 from primary care and 54 from specialist genetics clinics. Participants were from England (n = 37), France (n = 23) and Germany (n = 15). The prototype CanRisk tool was generally acceptable to most participants due to its intuitive design. Primary care clinicians were concerned about the amount of time needed to complete, interpret and communicate risk information. Clinicians from both settings were apprehensive about the impact of the CanRisk tool on their consultations and lack of opportunities to interpret risk scores before sharing them with their patients. Conclusions The findings highlight the challenges associated with developing a complex tool for use in different clinical settings; they also helped refine the tool. This prototype may not have been versatile enough for clinical use in both primary care and specialist genetics clinics where the needs of clinicians are different, emphasising the importance of understanding the clinical context when developing cancer risk assessment tools.	[Archer, Stephanie; de Villiers, Chantal Babb; Scheibl, Fiona; Emery, Jon; Walter, Fiona M.] Univ Cambridge, Dept Publ Hlth & Primary Care, Primary Care Unit, Cambridge, England; [Carver, Tim; Lee, Andrew; Cunningham, Alex P.; Easton, Douglas F.; Antoniou, Antonis C.] Univ Cambridge, Ctr Canc Genet Epidemiol, Dept Publ Hlth & Primary Care, Cambridge, England; [Hartley, Simon] Univ Birmingham, Ctr Computat Biol, Birmingham, W Midlands, England; [McIntosh, Jennifer G.; Emery, Jon; Walter, Fiona M.] Univ Melbourne, Ctr Canc Res, Melbourne, Vic, Australia; [McIntosh, Jennifer G.; Emery, Jon; Walter, Fiona M.] Univ Melbourne, Dept Gen Practice, Melbourne, Vic, Australia; [Tischkowitz, Marc] Univ Cambridge, Acad Dept Med Genet, Cambridge, England	University of Cambridge; University of Cambridge; University of Birmingham; University of Melbourne; University of Melbourne; University of Cambridge	Archer, S (corresponding author), Univ Cambridge, Dept Publ Hlth & Primary Care, Primary Care Unit, Cambridge, England.	saa71@medschl.cam.ac.uk	de Villiers, Chantal Babb/AAL-3787-2021; Walter, Fiona/GYR-1347-2022; Walter, Fiona/F-3054-2014	de Villiers, Chantal Babb/0000-0003-1334-1819; Lee, Andrew/0000-0003-0677-0252; hartley, simon/0000-0001-7991-0581; McIntosh, Jennifer/0000-0002-6655-0940; Archer, Stephanie/0000-0003-1349-7178; Walter, Fiona/0000-0002-7191-6476; Scheibl, Fiona/0000-0002-9115-1247	Cancer Research UK [C12292/A20861, C8640/A23385]; European Union's Horizon 2020 research and innovation programme [633784, 634935]; Wellcome Trust Collaborative Award [203477/B/16/Z]; PERSPECTIVE programme: The Government of Canada through Genome Canada; Canadian Institutes of Health Research [GPH-129344]; Australian National Health Medical Research Council; European Research Council; Cambridge NIHR Biomedical Research Centre	Cancer Research UK(Cancer Research UK); European Union's Horizon 2020 research and innovation programme; Wellcome Trust Collaborative Award(Wellcome Trust); PERSPECTIVE programme: The Government of Canada through Genome Canada; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Australian National Health Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); European Research Council(European Research Council (ERC)European Commission); Cambridge NIHR Biomedical Research Centre(National Institute for Health Research (NIHR))	This work was supported by Cancer Research UK grants C12292/A20861; the European Union's Horizon 2020 research and innovation programme under grant agreement numbers 633784 (B-CAST) and 634935 (BRIDGES); a Wellcome Trust Collaborative Award (203477/B/16/Z); and the PERSPECTIVE programme: The Government of Canada through Genome Canada and the Canadian Institutes of Health Research (grant GPH-129344). Jon Emery is funded by an Australian National Health Medical Research Council practitioner fellowship. Marc Tischkowitz acknowledges funding from the European Research Council and Cambridge NIHR Biomedical Research Centre. Fiona Walter is Director of the multi-institutional CanTest Collaborative which is funded by Cancer Research UK (C8640/A23385).	[Anonymous], 2018, QSR INT; Antoniou AC, 2008, BRIT J CANCER, V98, P1457, DOI 10.1038/sj.bjc.6604305; Antoniou AC, 2004, BRIT J CANCER, V91, P1580, DOI 10.1038/sj.bjc.6602175; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [DOI 10.1191/1478088706QP063OA, 10.1191/1478088706qp063oa]; Carver T, 2018, BIOINFORMATICS, V34, P1069, DOI 10.1093/bioinformatics/btx705; Craig P, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a1655; Deveugele M, 2002, BRIT MED J, V325, P472, DOI 10.1136/bmj.325.7362.472; Domchek SM, 2003, J CLIN ONCOL, V21, P593, DOI 10.1200/JCO.2003.07.007; Eccles SA, 2013, BREAST CANCER RES, V15, DOI 10.1186/bcr3493; Edwards AGK, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001865.pub3; Emery J, 1999, BRIT MED J, V319, P32, DOI 10.1136/bmj.319.7201.32; Fischer C, 2013, J MED GENET, V50, P360, DOI 10.1136/jmedgenet-2012-101415; Howell A, 2014, BREAST CANCER RES, V16, DOI 10.1186/s13058-014-0446-2; Johnson CM, 2005, J BIOMED INFORM, V38, P75, DOI 10.1016/j.jbi.2004.11.005; Lee A, 2019, GENET MED, V21, P1708, DOI 10.1038/s41436-018-0406-9; Lee AJ, 2016, GENET MED, V18, P1190, DOI 10.1038/gim.2016.31; MacInnis RJ, 2013, BRIT J CANCER, V109, P1296, DOI 10.1038/bjc.2013.382; Moore GF, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h1258; NICE, 2013, EXC NIFHAC; Qualitrics, 2018, QUALTRICS XM; Sekhon M, 2017, BMC HEALTH SERV RES, V17, DOI 10.1186/s12913-017-2031-8; Shah N, 2019, INT J MED INFORM, V125, P96, DOI 10.1016/j.ijmedinf.2019.03.003; Short D, 2004, INT J MED INFORM, V73, P357, DOI 10.1016/j.ijmedinf.2004.02.001; Spiegelhalter D, 2011, SCIENCE, V333, P1393, DOI 10.1126/science.1191181; Terry MB, 2019, LANCET ONCOL, V20, P504, DOI 10.1016/S1470-2045(18)30902-1; Trivedi MH, 2009, BMC MED INFORM DECIS, V9, DOI 10.1186/1472-6947-9-6; Usher-Smith J, 2015, BRIT J CANCER, V113, P1645, DOI 10.1038/bjc.2015.409	27	21	21	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2020	15	3							e0229999	10.1371/journal.pone.0229999	http://dx.doi.org/10.1371/journal.pone.0229999			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8TR	32142536	Green Published, gold, Green Accepted			2022-12-26	WOS:000535271600030
J	Wynne, SJ; Duarte, R; de Wildt, G; Meza, G; Merriel, A				Wynne, Sara Jabeen; Duarte, Rui; de Wildt, Gilles; Meza, Graciela; Merriel, Abi			The timing and quality of antenatal care received by women attending a primary care centre in Iquitos, Peru: A facility exit survey	PLOS ONE			English	Article							EARLY-PREGNANCY; PRENATAL-CARE; FOLIC-ACID; SERVICES; HEALTH; SATISFACTION; MALARIA	Background Maternal mortality is high in Loreto, Peru, but can be reduced by high quality antenatal care. Indicators for the quality of antenatal care received include the timing (with respect to gestational age) and number of antenatal appointments attended, the delivery of antenatal services and health information, and women's perceptions about their care. This study investigated these indicators amongst women receiving antenatal care in predominantly the San Juan Bautista district of Iquitos, Loreto. This was to identify areas for improvement through comparison with antenatal guidelines published by the Ministry of Health, Peru, and the World Health Organization. Methods A total of 134 women were recruited at the Centro de Salud, San Juan-a primary care centre in Iquitos. Information about the delivery of antenatal services and the number of and gestational ages at appointments attended was collected from 121/134 women's hand-held antenatal cards. The delivery of health information and women's perceptions about their antenatal care were investigated through questionnaires (133/134 completed). Descriptive statistics, such as frequencies and valid percentages, were determined. Results Hand-held antenatal cards revealed that 52.9% of participants began their antenatal care in the first trimester. Compared to national guidelines, 42.1% attended appointments at recommended gestational ages and no women received all recommended antenatal services. Most women received information about identifying complications in pregnancy and health and lifestyle topics. Over 85% of women reported satisfaction with their antenatal care. Conclusions Timely antenatal attendance and delivery of services should be encouraged to meet national and global standards. Although all services were not delivered in a combined manner according to national guidelines, individual services were mostly delivered to a high standard and therefore a high proportion of women were satisfied with their antenatal care.	[Wynne, Sara Jabeen] Univ Birmingham, Coll Med & Dent Sci, Med Sch, Birmingham, W Midlands, England; [Duarte, Rui] Univ Liverpool, Liverpool Reviews & Implementat Grp, Liverpool, Merseyside, England; [de Wildt, Gilles] Univ Birmingham, Coll Med & Dent Sci, Inst Clin Sci, Birmingham, W Midlands, England; [Meza, Graciela] Natl Univ Peruvian Amazon, Fac Med, Punchana, Peru; [Merriel, Abi] Univ Bristol, Southmead Hosp, Bristol Med Sch, Bristol, Avon, England	University of Birmingham; University of Liverpool; University of Birmingham; Universidad Nacional de la Amazonia Peruana; Southmead Hospital; University of Bristol	Wynne, SJ (corresponding author), Univ Birmingham, Coll Med & Dent Sci, Med Sch, Birmingham, W Midlands, England.	sarajwynne@gmail.com	Meza, Graciela/AAK-8386-2021; Duarte, Rui/C-9635-2012	Duarte, Rui/0000-0001-6485-7415; Meza sanchez, Graciela Rocio/0000-0001-5752-8824	Population Sciences and Humanities department [FIN 7N]; Sir Arthur Thomson Trust [FIN 42]	Population Sciences and Humanities department; Sir Arthur Thomson Trust	The corresponding author received awards from the Population Sciences and Humanities department (grant number FIN 7N, https://www.birmingham.ac.uk/undergraduate/courses/med/InternationalHealthBMedScIntercalatedDegree.aspx) and the Sir Arthur Thomson Trust (grant number FIN 42, https://www.birmingham.ac.uk/research/activity/mds/icat/undergraduate/index.aspx), both at the University of Birmingham (United Kingdom). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Airoldi J, 2007, OBSTET GYNECOL SURV, V62, P117, DOI 10.1097/01.ogx.0000253301.55009.ac; Allen DR, 2009, MANAGING MOTHERHOOD; Alwan NA, 2011, HUM REPROD, V26, P911, DOI 10.1093/humrep/der005; American Diabetes Association, 2004, DIABETES CARE S1, V27, pS88, DOI [10.2337/diacare.27.2007.S88, DOI 10.2337/DIACARE.27.2007.S88]; Amooti-Kaguna B, 2000, SOC SCI MED, V50, P203, DOI 10.1016/S0277-9536(99)00275-0; Arispe Claudia, 2011, Rev Med Hered, V22, P159; Arsenault C, 2018, LANCET GLOB HEALTH, V6, pE1186, DOI 10.1016/S2214-109X(18)30389-9; Ayala LSH, 2013, MATERN CHILD HLTH J, V17, P1112, DOI 10.1007/s10995-012-1113-9; Bassani DG, 2009, INT PERSPECT SEX R H, V35, P15, DOI [10.1363/3501509, 10.1363/ifpp.35.015.09]; Bleich SN, 2009, B WORLD HEALTH ORGAN, V87, P271, DOI 10.2471/BLT.07.050401; Blencowe H, 2010, INT J EPIDEMIOL, V39, P102, DOI 10.1093/ije/dyq027; Brown HC, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002856.pub3; del Carpio Ancaya Lucy, 2013, Rev. perú. med. exp. salud publica, V30, P461; Department of Making Pregnancy Safer, 2002, MAT IMM TET; Diaz JJ, 2019, HEALTH ECON, V28, P1099, DOI 10.1002/hec.3919; Doskoch P, 2014, INT PERSPECT SEX R H, V40, P102; Doubova SV, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-168; Edie GEHE, 2015, PAN AFR MED J, V21, DOI 10.11604/pamj.2015.21.45.4858; Eggleston E, 2000, SOC SCI MED, V51, P1011, DOI 10.1016/S0277-9536(00)00010-1; Fagbamigbe AF, 2015, REPROD HEALTH, V12, DOI 10.1186/s12978-015-0081-0; Fawole AO, 2008, J NATL MED ASSOC, V100, P1052, DOI 10.1016/S0027-9684(15)31443-7; Galle A, 2015, BMC WOMENS HEALTH, V15, DOI 10.1186/s12905-015-0266-2; Gross K, 2012, BMC PREGNANCY CHILDB, V12, DOI 10.1186/1471-2393-12-16; Gross K, 2011, BMC PREGNANCY CHILDB, V11, DOI 10.1186/1471-2393-11-36; Gudayu TW, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-287; Hildingsson I, 2013, WOMEN BIRTH, V26, pE9, DOI 10.1016/j.wombi.2012.06.002; INEI UNFPA PNUD, 2009, PERF SOC DEP LOR; Instituto Nacional de Estadistica e Informatic, 2016, PER ENC DEM SAL FAM; Jallow IK, 2012, INT J QUAL HEALTH C, V24, P595, DOI 10.1093/intqhc/mzs033; Kruk ME, 2018, LANCET GLOB HEALTH, V6, pE1196, DOI 10.1016/S2214-109X(18)30386-3; Kyei NNA, 2012, BMC PREGNANCY CHILDB, V12, DOI 10.1186/1471-2393-12-151; Langer Ana, 2002, BMC Womens Health, V2, P7, DOI 10.1186/1472-6874-2-7; Launiala A, 2007, T ROY SOC TROP MED H, V101, P980, DOI 10.1016/j.trstmh.2007.04.005; Leeman L, 2008, AM FAM PHYSICIAN, V78, P93; Marsland H, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0209736; Mera KC, 2014, IDENTIFICACION PRIOR; MILUNSKY A, 1989, JAMA-J AM MED ASSOC, V262, P2847, DOI 10.1001/jama.262.20.2847; Ministerio de Salud del Peru, 2013, NORM TECN SAL AT INT; Ministerio de Salud del Peru United Nations Population Fund Peru: Progresso Para Todos, 2013, PER PROGR TOD MORT M; Montasser N, 2014, INT J TROP DIS HLTH, V2, P145; Moore N, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171136; Mrisho M, 2009, BMC PREGNANCY CHILDB, V9, DOI 10.1186/1471-2393-9-10; Myer L, 2003, J MIDWIFERY WOM HEAL, V48, P268, DOI 10.1016/S1526-9523(02)00421-X; Ndyomugyenyi R, 1998, HEALTH POLICY PLANN, V13, P94, DOI 10.1093/heapol/13.1.94; Nwaeze I L, 2013, Ann Ib Postgrad Med, V11, P22; Obican SG, 2010, FASEB J, V24, P4167, DOI 10.1096/fj.10-165084; Oladapo Olufemi T, 2008, Afr J Reprod Health, V12, P71; Osungbade KO, 2011, HEALTH CARE WOMEN IN, V32, P441, DOI 10.1080/07399332.2010.517878; Pan American Health Organization/World Health Organization The Partnership for Maternal Newborn & Child Health World Bank Group Alliance for Health Policy and Systems Research, 2015, SUCC FACTS WOM CHILD; Paredes I, 2005, INT J GYNECOL OBSTET, V88, P168, DOI 10.1016/j.ijgo.2004.09.024; Ryan JA, 2009, INT J GYNECOL OBSTET, V107, P162, DOI 10.1016/j.ijgo.2009.06.014; SCHOLL TO, 1994, AM J CLIN NUTR, V59, p492S, DOI 10.1093/ajcn/59.2.492S; Scholl TO, 2005, AM J CLIN NUTR, V81, p1218S; Schwarzler P, 1999, ULTRASOUND OBST GYN, V14, P92, DOI 10.1046/j.1469-0705.1999.14020092.x; Sholeye O. O., 2013, World Journal of Medical Sciences, V8, P359; Sibai BM, 2009, AM J OBSTET GYNECOL, V200, DOI 10.1016/j.ajog.2008.07.048; SIBAI BM, 1993, NEW ENGL J MED, V329, P1213, DOI 10.1056/NEJM199310213291701; Soliman FE, 2015, IJSRP, V5, P3; Tann Carolyn J, 2007, BMC Pregnancy Childbirth, V7, P23, DOI 10.1186/1471-2393-7-23; van Eijk Anna M, 2006, Reprod Health, V3, P2, DOI 10.1186/1742-4755-3-2; Victora CG, 2016, LANCET, V387, P2049, DOI 10.1016/S0140-6736(15)00519-X; WHO, 2022, WHO RECOMMENDATIONS; Williamson J, 2015, AM J TROP MED HYG, V92, P857, DOI 10.4269/ajtmh.14-0536; World Health Organization, 2011, WHO REC PREV TREATM; World Health Organization UNICEF UNFPA Wolrd Bank Group United Nations Population Division Maternal Mortality Estimation Inter-Agency Group, 2016, MAT MORT 1990 2015	65	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2020	15	3							e0229852	10.1371/journal.pone.0229852	http://dx.doi.org/10.1371/journal.pone.0229852			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LQ8RK	32134987	Green Published, gold			2022-12-26	WOS:000535265600051
J	Abdollahnia, M; Makhdoumi, A; Mashreghi, M; Eshghi, H				Abdollahnia, Maryam; Makhdoumi, Ali; Mashreghi, Mansour; Eshghi, Hossein			Exploring the potentials of halophilic prokaryotes from a solar saltern for synthesizing nanoparticles: The case of silver and selenium	PLOS ONE			English	Article							BIOGENIC SYNTHESIS; GREEN SYNTHESIS; BIOSYNTHESIS; ARCHAEA	Halophiles are the organisms that thrive in extreme high salt environments. Despite the extensive studies on their biotechnological potentials, the ability of halophilic prokaryotes for the synthesis of nanoparticles has remained understudied. In this study, the archaeal and bacterial halophiles from a solar saltern were investigated for the intracellular/extracellular synthesis of silver and selenium nanoparticles. Silver nanoparticles were produced by the archaeal Haloferax sp. (AgNP-A, intracellular) and the bacterial Halomonas sp. (AgNP-B, extracellular), while the intracellular selenium nanoparticles were produced by the archaeal Halogeometricum sp. (SeNP-A) and the bacterial Bacillus sp. (SeNP-B). The nanoparticles were characterized by various techniques including UV-Vis spectroscopy, XRD, DLS, ICP-OES, Zeta potentials, FTIR, EDX, SEM, and TEM. The average particle size of AgNP-A and AgNP-B was 26.34 nm and 22 nm based on TEM analysis. Also, the characteristic Bragg peaks of face-centered cubic with crystallite domain sizes of 13.01 nm and 6.13 nm were observed in XRD analysis, respectively. Crystallographic characterization of SeNP-A and SeNP-B strains showed a hexagonal crystallite structure with domain sizes of 30.63 nm and 29.48 nm and average sizes of 111.6 nm and 141.6 nm according to TEM analysis, respectively. The polydispersity index of AgNP-A, AgNP-B, SeNP-A, and SeNP-B was determined as 0.26, 0.28, 0.27, and 0.36 and revealed high uniformity of the nanoparticles. All of the synthesized nanoparticles were stable and their zeta potentials were calculated as (mV): -33.12, -35.9, -31.2, and -29.34 for AgNP-A, AgNP-B, SeNP-A, and SeNP-B, respectively. The nanoparticles showed the antibacterial activity against various bacterial pathogens. The results of this study suggested that the (extremely) halophilic prokaryotes have great potentials for the green synthesis of nanoparticles.	[Abdollahnia, Maryam; Makhdoumi, Ali; Mashreghi, Mansour] Ferdowsi Univ Mashhad, Fac Sci, Dept Biol, Mashhad, Razavi Khorasan, Iran; [Mashreghi, Mansour] Ferdowsi Univ Mashhad, Ctr Nano Res, Mashhad, Razavi Khorasan, Iran; [Eshghi, Hossein] Ferdowsi Univ Mashhad, Fac Sci, Dept Chem, Mashhad, Razavi Khorasan, Iran	Ferdowsi University Mashhad; Ferdowsi University Mashhad; Ferdowsi University Mashhad	Makhdoumi, A (corresponding author), Ferdowsi Univ Mashhad, Fac Sci, Dept Biol, Mashhad, Razavi Khorasan, Iran.	a.makhdomi@um.ac.ir	Makhdoumi, Ali/L-3627-2017; Eshghi, Hossein/E-6942-2015; Mashreghi, Mansour/AAB-1370-2020	Makhdoumi, Ali/0000-0003-1412-1121; Eshghi, Hossein/0000-0002-8417-220X; Mashreghi, Mansour/0000-0003-1479-676X	Ferdowsi University of Mashhad [41316/3]	Ferdowsi University of Mashhad	This work was supported by grant from Ferdowsi University of Mashhad to A. Makhdoumi (41316/3).	Anandalakshmi K, 2016, APPL NANOSCI, V6, P399, DOI 10.1007/s13204-015-0449-z; Avendano R, 2016, SCI REP-UK, V6, DOI 10.1038/srep37155; Desai PP, 2016, J NANOSTRUCTURE CHEM, V6, P235, DOI 10.1007/s40097-016-0197-y; Duran N, 2011, APPL MICROBIOL BIOT, V90, P1609, DOI 10.1007/s00253-011-3249-8; Elbeshehy EKF, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00453; Fesharaki PJ, 2010, BRAZ J MICROBIOL, V41, P461, DOI [10.1590/S1517-83822010000200028, 10.1590/S1517-838220100002000028]; Grobelny J, 2011, METHODS MOL BIOL, V697, P71, DOI 10.1007/978-1-60327-198-1_7; Huang NM, 2010, COLLOID SURFACE A, V353, P69, DOI 10.1016/j.colsurfa.2009.10.023; Jeevanandam J, 2018, BEILSTEIN J NANOTECH, V9, P1050, DOI 10.3762/bjnano.9.98; Kalimuthu K, 2008, COLLOID SURFACE B, V65, P150, DOI 10.1016/j.colsurfb.2008.02.018; Maturrano L, 2006, APPL ENVIRON MICROB, V72, P3887, DOI 10.1128/AEM.02214-05; Mishra RR, 2011, CHEMOSPHERE, V84, P1231, DOI 10.1016/j.chemosphere.2011.05.025; Nercessian D, 2015, EXTREMOPHILES, V19, P1133, DOI 10.1007/s00792-015-0785-7; Oren A, 2002, FEMS MICROBIOL ECOL, V39, P1, DOI 10.1111/j.1574-6941.2002.tb00900.x; Oren A, 2010, ENVIRON TECHNOL, V31, P825, DOI 10.1080/09593330903370026; Oren Aharon, 2008, Saline Syst, V4, P2, DOI 10.1186/1746-1448-4-2; Panacek A, 2009, BIOMATERIALS, V30, P6333, DOI 10.1016/j.biomaterials.2009.07.065; Patil S, 2014, J CLUST SCI, V25, P423, DOI 10.1007/s10876-013-0621-0; Patra J. K., 2014, J NANOMATER, V2014, P219; Phanjom P., 2015, NANOSCIENCE NANOTECH, V5, P14, DOI [10.5923/j.nn.20150501.03, DOI 10.5923/J.NN.20150501.03]; Prasad KS, 2013, COLLOID SURFACE B, V103, P261, DOI 10.1016/j.colsurfb.2012.10.029; Rachel R, 2010, METHOD CELL BIOL, V96, P47, DOI 10.1016/S0091-679X(10)96003-2; Ramamurthy C, 2013, BIOPROC BIOSYST ENG, V36, P1131, DOI 10.1007/s00449-012-0867-1; Sarangadharan S., 2015, INT J PHARMA MED BIO, V4, P236; Shah R., 2012, J MICROBIOL BIOTECH, V2, P485; Shahverdi AR, 2007, NANOMED-NANOTECHNOL, V3, P168, DOI 10.1016/j.nano.2007.02.001; Shahverdi AR, 2007, PROCESS BIOCHEM, V42, P919, DOI 10.1016/j.procbio.2007.02.005; Singh J, 2018, J NANOBIOTECHNOL, V16, DOI 10.1186/s12951-018-0408-4; Singh R, 2011, J BIOMED NANOTECHNOL, V7, P489, DOI 10.1166/jbn.2011.1324; Sonkusre P., 2014, J NANOMEDICINE NANOT, V5, P194, DOI [10.4172/2157-7439.1000194, DOI 10.4172/2157-7439.1000194]; Srivastava N, 2013, POWDER TECHNOL, V244, P26, DOI 10.1016/j.powtec.2013.03.050; Srivastava P, 2014, ADV MAT RES, V938, P236; Srivastava P, 2015, SUSTAIN DEV BIODIVER, V6, P145, DOI 10.1007/978-3-319-14595-2_4; Srivastava P, 2014, BIOTECHNOL PROGR, V30, P1480, DOI 10.1002/btpr.1992; Srivastava P, 2013, EXTREMOPHILES, V17, P821, DOI 10.1007/s00792-013-0563-3; Suman J., 2014, AM J PHYTOMED CLIN T, V2, P1016; Suvith VS, 2014, SPECTROCHIM ACTA A, V118, P526, DOI 10.1016/j.saa.2013.09.016; Ventosa A, 2014, EXTREMOPHILES, V18, P811, DOI 10.1007/s00792-014-0681-6; Voica DM, 2016, FEMS MICROBIOL LETT, V363, DOI 10.1093/femsle/fnw146; Wrotniak-Drzewiecka W., 2014, AUSTIN J BIOTECHNOLO, V1, P7	40	22	24	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2020	15	3							e0229886	10.1371/journal.pone.0229886	http://dx.doi.org/10.1371/journal.pone.0229886			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8QU	32130283	gold, Green Published			2022-12-26	WOS:000535264000055
J	Hao, SY; You, J; Chen, L; Zhao, H; Huang, YJ; Zheng, L; Tian, L; Maric, I; Liu, X; Li, T; Bianco, YK; Winn, VD; Aghaeepour, N; Gaudilliere, B; Angst, MS; Zhou, X; Li, YM; Mo, LH; Wong, RJ; Shaw, GM; Stevenson, DK; Cohen, HJ; Mcelhinney, DB; Sylvester, KG; Ling, XFB				Hao, Shiying; You, Jin; Chen, Lin; Zhao, Hui; Huang, Yujuan; Zheng, Le; Tian, Lu; Maric, Ivana; Liu, Xin; Li, Tian; Bianco, Ylayaly K.; Winn, Virginia D.; Aghaeepour, Nima; Gaudilliere, Brice; Angst, Martin S.; Zhou, Xin; Li, Yu-Ming; Mo, Lihong; Wong, Ronald J.; Shaw, Gary M.; Stevenson, David K.; Cohen, Harvey J.; Mcelhinney, Doff B.; Sylvester, Karl G.; Ling, Xuefeng B.			Changes in pregnancy-related serum biomarkers early in gestation are associated with later development of preeclampsia	PLOS ONE			English	Article							PLACENTA GROWTH-FACTOR; CORD BLOOD LEPTIN; ANGIOGENIC FACTORS; TYROSINE KINASE-1; ACTIVIN-A; LONGITUDINAL ANALYSIS; MOLECULAR-MECHANISMS; HEME OXYGENASE-1; GENE-EXPRESSION; MENSTRUAL-CYCLE	Background Placental protein expression plays a crucial role during pregnancy. We hypothesized that: (1) circulating levels of pregnancy-associated, placenta-related proteins throughout gestation reflect the temporal progression of the uncomplicated, full-term pregnancy, and can effectively estimate gestational ages (GAs); and (2) preeclampsia (PE) is associated with disruptions in these protein levels early in gestation; and can identify impending PE. We also compared gestational profiles of proteins in the human and mouse, using pregnant heme oxygenase-1 (HO-1) heterozygote (Het) mice, a mouse model reflecting PE-like symptoms. Methods Serum levels of placenta-related proteins-leptin (LEP), chorionic somatomammotropin hormone like 1 (CSHL1), elabela (ELA), activin A, soluble fms-like tyrosine kinase 1 (sFlt-1), and placental growth factor (PlGF)-were quantified by ELISA in blood serially collected throughout human pregnancies (20 normal subjects with 66 samples, and 20 subjects who developed PE with 61 samples). Multivariate analysis was performed to estimate the GA in normal pregnancy. Mean-squared errors of GA estimations were used to identify impending PE. The human protein profiles were then compared with those in the pregnant HO-1 Het mice. Results An elastic net-based gestational dating model was developed (R-2 = 0.76) and validated (R2 = 0.61) using serum levels of the 6 proteins measured at various GAs from women with normal uncomplicated pregnancies. In women who developed PE, the model was not (R-2 = -0.17) associated with GA. Deviations from the model estimations were observed in women who developed PE (P = 0.01). The model developed with 5 proteins (ELA excluded) performed similarly from sera from normal human (R-2 = 0.68) and WT mouse (R-2 = 0.85) pregnancies. Disruptions of this model were observed in both human PE-associated (R-2 = 0.27) and mouse HO-1 Het (R-2 = 0.30) pregnancies. LEP outperformed sFlt-1 and PlGF in differentiating impending PE at early human and late mouse GAs. Conclusions Serum placenta-related protein profiles are temporally regulated throughout normal pregnancies and significantly disrupted in women who develop PE. LEP changes earlier than the well-established biomarkers (sFlt-1 and PlGF). There may be evidence of a causative action of HO-1 deficiency in LEP upregulation in a PE-like murine model.	[Hao, Shiying; Zheng, Le; Mcelhinney, Doff B.] Stanford Univ, Sch Med, Dept Cardiothorac Surg, Stanford, CA 94305 USA; [Hao, Shiying; Zheng, Le; Mcelhinney, Doff B.; Ling, Xuefeng B.] Lucile Packard Childrens Hosp, Betty Irene Moore Childrens Heart Ctr, Clin & Translat Res Program, Palo Alto, CA 94304 USA; [You, Jin; Chen, Lin; Liu, Xin; Li, Tian; Sylvester, Karl G.; Ling, Xuefeng B.] Stanford Univ, Sch Med, Dept Surg, Stanford, CA 94305 USA; [Zhao, Hui; Maric, Ivana; Wong, Ronald J.; Shaw, Gary M.; Stevenson, David K.; Cohen, Harvey J.] Stanford Univ, Sch Med, Dept Pediat, Stanford, CA 94305 USA; [Huang, Yujuan] Shanghai Jiao Tong Univ, Sch Med, Shanghai Childrens Hosp, Dept Emergency, Shanghai, Peoples R China; [Tian, Lu] Stanford Univ, Dept Hlth Res & Policy, Stanford, CA 94305 USA; [Bianco, Ylayaly K.; Winn, Virginia D.] Stanford Univ, Sch Med, Dept Obstet & Gynecol, Stanford, CA 94305 USA; [Aghaeepour, Nima; Gaudilliere, Brice; Angst, Martin S.] Stanford Univ, Sch Med, Dept Anesthesiol Perioperat & Pain Med, Stanford, CA USA; [Zhou, Xin; Li, Yu-Ming] Pingjin Hosp Heart Ctr, Tianjin Key Lab Cardiovasc Remodeling & Target Or, Tianjin, Peoples R China; [Mo, Lihong] Univ Calif San Francisco, Dept Obstet & Gynecol, Fresno, CA USA; [Ling, Xuefeng B.] Stanford Univ, Dept Surg, Stanford, CA 94305 USA	Stanford University; Lucile Packard Children's Hospital (LPCH); Stanford University; Stanford University; Shanghai Jiao Tong University; Stanford University; Stanford University; Stanford University; University of California System; University of California San Francisco; University of California San Francisco at Fresno; Stanford University	Ling, XFB (corresponding author), Lucile Packard Childrens Hosp, Betty Irene Moore Childrens Heart Ctr, Clin & Translat Res Program, Palo Alto, CA 94304 USA.; Ling, XFB (corresponding author), Stanford Univ, Sch Med, Dept Surg, Stanford, CA 94305 USA.; Ling, XFB (corresponding author), Stanford Univ, Dept Surg, Stanford, CA 94305 USA.	bxling@stanford.edu	Zhou, Xin/AAH-7351-2019	Zhou, Xin/0000-0003-1395-7103; Hao, Shiying/0000-0002-7527-2460; Winn, Virginia/0000-0003-1136-2907; Sylvester, Karl G./0000-0002-8559-0155; McElhinney, Doff/0000-0001-7242-0934; Shaw, Gary/0000-0001-7438-4914; Angst, Martin/0000-0002-1550-8136; Mo, Lihong/0000-0001-6701-0594; Ling, Bruce/0000-0002-5386-3884; tian, lu/0000-0002-5893-0169	Stanford University Spark Spectrum Pilot Program; March of the Dimes Prematurity Research Center at Stanford University; Stanford Child Health Research Institute	Stanford University Spark Spectrum Pilot Program; March of the Dimes Prematurity Research Center at Stanford University; Stanford Child Health Research Institute	This work was supported in part by the Stanford University Spark Spectrum Pilot Program and the March of the Dimes Prematurity Research Center at Stanford University, and Stanford Child Health Research Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACOG Committee on Practice Bulletins--Obstetrics, 2002, Obstet Gynecol, V99, P159; Aghaeepour N, 2018, AM J OBSTET GYNECOL, V218, DOI 10.1016/j.ajog.2017.12.208; Aghaeepour N, 2017, SCI IMMUNOL, V2, DOI 10.1126/sciimmunol.aan2946; Anim-Nyame N, 2000, HUM REPROD, V15, P2033, DOI 10.1093/humrep/15.9.2033; [Anonymous], 2002, OBSTET GYNECOL, V99, P159, DOI [10.1016/s0029-7844(01)01747-1, DOI 10.1016/S0029-7844(01)01747-1]; Bainbridge SA, 2005, FREE RADICAL BIO MED, V38, P979, DOI 10.1016/j.freeradbiomed.2004.11.002; Berg CJ, 2009, OBSTET GYNECOL, V113, P1075, DOI 10.1097/AOG.0b013e3181a09fc0; Burton GJ, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0066; Bytautiene E, 2010, AM J PHYSIOL-HEART C, V298, pH189, DOI 10.1152/ajpheart.00792.2009; Carty DM, 2011, HYPERTENSION, V57, P561, DOI 10.1161/HYPERTENSIONAHA.110.164285; Cox B, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.37; Das J, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1465-9; Davisson RL, 2002, HYPERTENSION, V39, P337, DOI 10.1161/hy02t2.102904; Dugoff L, 2005, OBSTET GYNECOL, V106, P260, DOI 10.1097/01.AOG.0000172419.37410.eb; Erez O, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181468; Hardie L, 1997, CLIN ENDOCRINOL, V47, P101, DOI 10.1046/j.1365-2265.1997.2441017.x; Hendler I, 2005, AM J OBSTET GYNECOL, V193, P979, DOI 10.1016/j.ajog.2005.06.041; Hirashima C, 2005, HYPERTENS RES, V28, P727, DOI 10.1291/hypres.28.727; Ho LN, 2017, SCIENCE, V357, P707, DOI 10.1126/science.aam6607; Hoggard N, 2001, BIOCHEM SOC T, V29, P57, DOI 10.1042/0300-5127:0290057; Johansson A, 2011, HUM GENET, V129, P25, DOI 10.1007/s00439-010-0893-5; Karakosta P, 2013, PAEDIATR PERINAT EP, V27, P461, DOI 10.1111/ppe.12074; Kocyigit Y, 2004, GYNECOL ENDOCRINOL, V18, P341, DOI 10.1080/09513590410001704975; Kolla V, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/305964; Krauss T, 2004, HYPERTENS PREGNANCY, V23, P101, DOI 10.1081/PRG-120028286; Lage M, 1999, CLIN ENDOCRINOL, V50, P211, DOI 10.1046/j.1365-2265.1999.00637.x; Laing EE, 2019, SLEEP, V42, DOI 10.1093/sleep/zsy186; Landek-Salgado MA, 2010, AUTOIMMUN REV, V9, P153, DOI 10.1016/j.autrev.2009.06.001; Lapaire O, 2012, FETAL DIAGN THER, V31, P147, DOI 10.1159/000337325; Levine RJ, 2004, NEW ENGL J MED, V350, P672, DOI 10.1056/NEJMoa031884; Liu LY, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-236; Loboda A, 2008, ANTIOXID REDOX SIGN, V10, P1767, DOI 10.1089/ars.2008.2043; Loset M, 2011, AM J OBSTET GYNECOL, V204, DOI 10.1016/j.ajog.2010.08.043; MacKay AP, 2001, OBSTET GYNECOL, V97, P533, DOI 10.1016/S0029-7844(00)01223-0; Mannik J, 2012, MOL CELL ENDOCRINOL, V355, P180, DOI 10.1016/j.mce.2012.02.009; Magarinos MP, 2007, BIOL REPROD, V76, P203, DOI 10.1095/biolreprod.106.051391; Malassine A, 2003, HUM REPROD UPDATE, V9, P531, DOI 10.1093/humupd/dmg043; Mary S, 2012, PROTEOM CLIN APPL, V6, P79, DOI 10.1002/prca.201100089; Maynard SE, 2003, J CLIN INVEST, V111, P649, DOI 10.1172/JCI200317189; Mise H, 1998, J CLIN ENDOCR METAB, V83, P3225, DOI 10.1210/jc.83.9.3225; Mosimann B, 2017, FETAL DIAGN THER, V42, P111, DOI 10.1159/000455946; Muttukrishna S, 1996, J CLIN ENDOCR METAB, V81, P3328, DOI 10.1210/jc.81.9.3328; Muttukrishna S, 2000, HUM REPROD, V15, P1640, DOI 10.1093/humrep/15.7.1640; Muy-Rivera M, 2005, PHYSIOL RES, V54, P167, DOI 10.33549/physiolres.930599; Mylonas I, 2006, J MOL HISTOL, V37, P43, DOI 10.1007/s10735-006-9029-6; Naruse K, 2005, J REPROD IMMUNOL, V65, P65, DOI 10.1016/j.jri.2004.09.004; Ning Y, 2004, J Matern Fetal Neonatal Med, V15, P186, DOI 10.1080/14767050410001668293; Nishizawa H, 2007, PLACENTA, V28, P487, DOI 10.1016/j.placenta.2006.05.010; Ouyang YQ, 2007, INT J GYNECOL OBSTET, V98, P110, DOI 10.1016/j.ijgo.2007.04.021; Ozkan S, 2005, EUR J OBSTET GYN R B, V120, P158, DOI 10.1016/j.ejogrb.2004.02.046; Palmer KR, 2017, MOL HUM REPROD, V23, P69, DOI 10.1093/molehr/gaw077; Pavlicev M, 2017, GENOME RES, V27, P349, DOI 10.1101/gr.207597.116; Perez-Perez A, 2008, ARCH BIOCHEM BIOPHYS, V477, P390, DOI 10.1016/j.abb.2008.06.015; Perez-Perez A, 2018, J CELL MOL MED, V22, P716, DOI 10.1111/jcmm.13369; Perez-Perez A, 2016, PLACENTA, V42, P106, DOI 10.1016/j.placenta.2016.03.009; Perez-Perez A, 2009, BIOL REPROD, V81, P826, DOI 10.1095/biolreprod.109.076513; Powe CE, 2011, CIRCULATION, V123, P2856, DOI 10.1161/CIRCULATIONAHA.109.853127; Rajakumar A, 2005, PLACENTA, V26, P563, DOI 10.1016/j.placenta.2004.09.001; Toro AR, 2015, PLACENTA, V36, P1266, DOI 10.1016/j.placenta.2015.08.017; Toro AR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099187; Raymond D, 2011, OBSTET GYNECOL SURV, V66, P497, DOI 10.1097/OGX.0b013e3182331028; Roberts JM, 2009, PLACENTA, V30, pS32, DOI 10.1016/j.placenta.2008.11.009; Robillard P-Y, 2017, PREGNANCY HYPERTENS, V7, P59, DOI [10.1016/j.preghy.2016.10.013, DOI 10.1016/J.PREGHY.2016.10.013]; Romero R, 2017, AM J OBSTET GYNECOL, V217, pe1, DOI DOI 10.1016/J.AJ0G.2017.02.037; Samano R, 2017, NUTRIENTS, V9, DOI 10.3390/nu9101067; Schubring C, 1998, HORM RES, V50, P276, DOI 10.1159/000023290; Shaarawy M, 1999, J SOC GYNECOL INVEST, V6, P70, DOI 10.1016/S1071-5576(99)00003-9; Shen L, 2011, LECT NOTES COMPUT SC, V7012, P27, DOI 10.1007/978-3-642-24446-9_4; Shibata E, 2005, J CLIN ENDOCR METAB, V90, P4895, DOI 10.1210/jc.2004-1955; Sitras V, 2009, PLACENTA, V30, P424, DOI 10.1016/j.placenta.2009.01.012; Soncin F, 2018, DEVELOPMENT, V145, DOI 10.1242/dev.156273; Spencer K, 2008, ULTRASOUND OBST GYN, V32, P622, DOI 10.1002/uog.6212; Stepan H, 2010, Z GEBURTSH NEONATOL, V214, P234, DOI 10.1055/s-0030-1262827; Tarca AL, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0217273; Taylor AP, 2003, INT J CANCER, V105, P158, DOI 10.1002/ijc.11059; Taylor BD, 2015, HYPERTENSION, V65, P594, DOI 10.1161/HYPERTENSIONAHA.114.03979; Teppa RJ, 2000, METABOLISM, V49, P1043, DOI 10.1053/meta.2000.7707; Tessier DR, 2013, PLACENTA, V34, P205, DOI 10.1016/j.placenta.2012.11.035; Tidwell SC, 2001, AM J OBSTET GYNECOL, V184, P1267, DOI 10.1067/mob.2001.113129; Tommaselli GA, 2004, GYNECOL ENDOCRINOL, V19, P160, DOI 10.1080/09513590400007267; Torry DS, 1998, AM J OBSTET GYNECOL, V179, P1539, DOI 10.1016/S0002-9378(98)70021-3; Tsai S, 2011, PLACENTA, V32, P175, DOI 10.1016/j.placenta.2010.11.014; Tsiakkas A, 2015, ULTRASOUND OBST GYN, V45, P584, DOI 10.1002/uog.14817; Tsur A, 2019, PLACENTA, V75, P1, DOI 10.1016/j.placenta.2018.11.001; Vaiman D, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-111; Verlohren S, 2010, AM J OBSTET GYNECOL, V202, DOI 10.1016/j.ajog.2009.09.016; Winn VD, 2009, ENDOCRINOLOGY, V150, P452, DOI 10.1210/en.2008-0990; Wolf M, 2005, AM J OBSTET GYNECOL, V193, P16, DOI 10.1016/j.ajog.2005.03.016; Wright D, 2019, AM J OBSTET GYNECOL, V220, DOI 10.1016/j.ajog.2018.11.1087; Yefet E, 2017, FETAL DIAGN THER, V42, P285, DOI 10.1159/000458409; Zhao H, 2009, PLACENTA, V30, P861, DOI 10.1016/j.placenta.2009.07.012; Zhao H, 2011, BIOL REPROD, V85, P1005, DOI 10.1095/biolreprod.111.093039; Zou H, 2005, J R STAT SOC B, V67, P301, DOI 10.1111/j.1467-9868.2005.00503.x	93	9	10	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2020	15	3							e0230000	10.1371/journal.pone.0230000	http://dx.doi.org/10.1371/journal.pone.0230000			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8MS	32126118	Green Published, Green Submitted, gold			2022-12-26	WOS:000535253100059
J	Rufiange, M; Leung, VSY; Simpson, K; Pang, DSJ				Rufiange, Maxime; Leung, Vivian S. Y.; Simpson, Keith; Pang, Daniel S. J.			Pre-warming before general anesthesia with isoflurane delays the onset of hypothermia in rats	PLOS ONE			English	Article							CORE-TEMPERATURE; POSTANESTHETIC HYPOTHERMIA; PREVENTION; RECOVERY; SURGERY; VASOCONSTRICTION; COMPLICATIONS; NORMOTHERMIA; PREVALENCE; EVOLUTION	General anesthesia causes hypothermia by impairing normal thermoregulatory mechanisms. When using inhalational anesthetic agents, Redistribution of warm blood from the core to the periphery is the primary mechanism in the development of hypothermia and begins following induction of anesthesia. Raising skin temperature before anesthesia reduces the temperature gradient between core and periphery, decreasing the transfer of heat. This prospective, crossover study (n = 17 adult male and female SD rats) compared three treatment groups: PW1% (pre-warming to increase core temperature 1% over baseline), PW40 (pre-warming to increase core temperature to 40 degrees C) and NW (no warming). The PW1% group was completed first to ensure tolerance of pre-warming. Treatment order was then randomized and alternated after a washout period. Once target temperature was achieved, anesthesia was induced and maintained with isoflurane in oxygen without further external temperature support. Pre-warming was effective at delaying the onset of hypothermia, with a significant difference between PW1% (12.4 minutes) and PW40 (19.3 minutes, p = 0.0044 (95%CI -12 to -2.2), PW40 and NW (7.1 minutes, p < 0.0001 (95%CI 8.1 to 16.0) and PW1% and NW (p = 0.003, 95%CI 1.8 to 8.7). The rate of heat loss in the pre-warmed groups exceed that of the NW group: PW1% versus NW (p = 0.005, 95%CI 0.004 to 0.027), PW40 versus NW (p < 0.0001, 95%CI 0.014 to 0.036) and PW1% versus PW40 (p = 0.07, 95%CI -0.021 to 0.00066). Pre-warming alone confers a protective effect against hypothermia during volatile anesthesia; however, longer duration procedures would require additional heating support.	[Rufiange, Maxime; Leung, Vivian S. Y.; Pang, Daniel S. J.] Univ Montreal, Dept Clin Sci, Fac Vet Med, St Hyacinthe, PQ, Canada; [Rufiange, Maxime; Leung, Vivian S. Y.; Pang, Daniel S. J.] Univ Montreal, Grp Rech Pharmacol Anim Que GREPAQ, Fac Vet Med, St Hyacinthe, PQ, Canada; [Simpson, Keith] Vetron Serv Ltd, Abbotskerswell, England	Universite de Montreal; Universite de Montreal	Pang, DSJ (corresponding author), Univ Montreal, Dept Clin Sci, Fac Vet Med, St Hyacinthe, PQ, Canada.; Pang, DSJ (corresponding author), Univ Montreal, Grp Rech Pharmacol Anim Que GREPAQ, Fac Vet Med, St Hyacinthe, PQ, Canada.	danielpang17@hotmail.com		Pang, Daniel/0000-0002-6420-477X	Natural Sciences and Engineering Research Council (NSERC) [424022-2013]; Fondation Levesque; Vetronic Services Ltd.	Natural Sciences and Engineering Research Council (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Fondation Levesque; Vetronic Services Ltd.	This work was supported by Natural Sciences and Engineering Research Council (NSERC) Discovery Grant (ID: 424022-2013; DSJP), Fondation Levesque (DSJP), and Vetronic Services Ltd. Author KS received support in the form of a salary from Vetronic Services Ltd. The specific role of this author is articulated in the `author contributions' section. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrecht M, 2014, BMC VET RES, V10, DOI 10.1186/s12917-014-0198-3; Andrzejowski J, 2008, BRIT J ANAESTH, V101, P627, DOI 10.1093/bja/aen272; [Anonymous], 2015, GUIDELINES PAIN DIST; [Anonymous], 2011, CCAC TRAINING MODULE; Armstrong T, 2018, J FELINE MED SURG, V20, P73, DOI 10.1177/1098612X17693517; Bindu Barkha, 2017, J Anaesthesiol Clin Pharmacol, V33, P306, DOI 10.4103/joacp.JOACP_334_16; Buisman M, 2017, VET ANAESTH ANALG, V44, P646, DOI 10.1016/j.vaa.2016.09.001; Caro AC, 2013, J AM ASSOC LAB ANIM, V52, P577; Clark-Price S, 2015, VET CLIN N AM-SMALL, V45, P983, DOI 10.1016/j.cvsm.2015.04.005; DILSAVER SC, 1992, PHARMACOL BIOCHEM BE, V42, P549, DOI 10.1016/0091-3057(92)90154-8; GLOSTEN B, 1993, ANESTH ANALG, V77, P488; Hasiuk MMM, 2015, JAVMA-J AM VET MED A, V246, P645, DOI 10.2460/javma.246.6.645; Hershey J., 2016, LAB ANIM SCI PROF, V4, P40; Hildebrand F, 2004, AM J SURG, V187, P363, DOI 10.1016/j.amjsurg.2003.12.016; Horn EP, 2012, ANAESTHESIA, V67, P612, DOI 10.1111/j.1365-2044.2012.07073.x; Hynson J M, 1992, J Clin Anesth, V4, P194, DOI 10.1016/0952-8180(92)90064-8; HYNSON JM, 1993, ANESTHESIOLOGY, V79, P219, DOI 10.1097/00000542-199308000-00005; JUST B, 1993, ANESTHESIOLOGY, V79, P214, DOI 10.1097/00000542-199308000-00004; Kehlet H, 1997, BRIT J ANAESTH, V78, P606, DOI 10.1093/bja/78.5.606; Kehlet H, 2008, ANN SURG, V248, P189, DOI 10.1097/SLA.0b013e31817f2c1a; Kleimeyer JP, 2018, J AM ACAD ORTHOP SUR, V26, pE497, DOI 10.5435/JAAOS-D-16-00742; Kurz A, 1996, NEW ENGL J MED, V334, P1209, DOI 10.1056/NEJM199605093341901; KURZ A, 1995, J CLIN ANESTH, V7, P359, DOI 10.1016/0952-8180(95)00028-G; KURZ A, 1995, ANESTHESIOLOGY, V83, P491, DOI 10.1097/00000542-199509000-00007; Kurz A, 2008, BEST PRACT RES-CLIN, V22, P627, DOI 10.1016/j.bpa.2008.06.004; LOMAX P, 1966, NATURE, V210, P854, DOI 10.1038/210854a0; Marschner JA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149489; MATSUKAWA T, 1995, ANESTHESIOLOGY, V82, P662, DOI 10.1097/00000542-199503000-00008; MATSUKAWA T, 1995, ANESTHESIOLOGY, V82, P1169, DOI 10.1097/00000542-199505000-00012; Monzon CG, 2013, REV COLOMB ANESTESIO, V41, P97, DOI [10.1016/j.rca.2013.03.002, DOI 10.1016/J.RCA.2013.03.002, 10.1016/j.rcae.2013.03.002, DOI 10.1016/J.RCAE.2013.03.002]; Pottie RG, 2007, AUST VET J, V85, P158, DOI 10.1111/j.1751-0813.2007.00128.x; Redondo JI, 2012, VET REC, V171, P374, DOI 10.1136/vr.100476; Redondo JI, 2012, VET REC, V170, P206, DOI 10.1136/vr.100184; Reynolds L, 2008, BEST PRACT RES-CLIN, V22, P645, DOI 10.1016/j.bpa.2008.07.005; Roehl AB, 2011, LAB ANIM-UK, V45, P45, DOI 10.1258/la.2010.010076; Rose N, 2016, J SMALL ANIM PRACT, V57, P447, DOI 10.1111/jsap.12547; SAKAGUCHI Y, 1995, CANCER RES, V55, P5459; SATINOFF E, 1978, SCIENCE, V201, P16, DOI 10.1126/science.351802; Schmied H, 1996, LANCET, V347, P289, DOI 10.1016/S0140-6736(96)90466-3; Schuster CJ, 2018, LAB ANIM-UK, V52, P142, DOI 10.1177/0023677217712539; Scott Eileen M, 2006, AORN J, V83, P1090, DOI 10.1016/S0001-2092(06)60120-8; Sessler DI, 2001, ANESTHESIOLOGY, V95, P531, DOI 10.1097/00000542-200108000-00040; SESSLER DI, 1995, ANESTHESIOLOGY, V82, P674, DOI 10.1097/00000542-199503000-00009; Sessler DI, 2000, ANESTHESIOLOGY, V92, P578, DOI 10.1097/00000542-200002000-00042; Sun Z, 2015, ANESTHESIOLOGY, V122, P276, DOI 10.1097/ALN.0000000000000551; Taylor DK, 2007, J AM ASSOC LAB ANIM, V46, P37; Torossian A, 2008, BEST PRACT RES-CLIN, V22, P659, DOI 10.1016/j.bpa.2008.07.006; Xiong JY, 1996, ANESTHESIOLOGY, V85, P240, DOI 10.1097/00000542-199608000-00003; Zhang EQ, 2017, J AM ASSOC LAB ANIM, V56, P786	49	13	13	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2020	15	3							e0219722	10.1371/journal.pone.0219722	http://dx.doi.org/10.1371/journal.pone.0219722			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8MS	32126085	Green Submitted, Green Published, gold			2022-12-26	WOS:000535253100001
J	Hardt, F; Becker, M; Brandenburg, V; Grebe, J; Dirrichs, T; Gohmann, RF; Fehrenbacher, K; Schmoee, J; Reinartz, SD				Hardt, F.; Becker, M.; Brandenburg, V; Grebe, J.; Dirrichs, T.; Gohmann, R. F.; Fehrenbacher, K.; Schmoee, J.; Reinartz, S. D.			Impact of epicardial adipose tissue volume upon left ventricular dysfunction in patients with mild-to-moderate aortic stenosis: A post-hoc analysis	PLOS ONE			English	Article							HEART-FAILURE; EJECTION FRACTION; DIASTOLIC FUNCTION; CONSENSUS STATEMENT; METABOLIC SYNDROME; AMERICAN SOCIETY; VALVE DISEASE; ECHOCARDIOGRAPHY; ASSOCIATION; DIAGNOSIS	Background Aortic stenosis (AS) may lead to diastolic dysfunction and later on heart failure (HF) with preserved left ventricular ejection fraction (HFpEF) via increased afterload and left-ventricular (LV) hypertrophy. Since epicardial adipose tissue (EAT) is a metabolically active fat depot that is adjacent to the myocardium and can influence cardiomyocytes and LV function via secretion of proinflammatory cytokines, we hypothesized that high amounts of EAT, as assessed by computed tomography (CT), may aggravate the development and severity of LV hypertrophy and diastolic dysfunction in the context of AS. Methods We studied 50 patients (mean age 71 +/- 9 years; 9 women) in this preliminary study with mild or moderate AS and mild to severe LV diastolic dysfunction (LVDD), diagnosed by echocardiography, who underwent non-contrast cardiac CT and echocardiography. EAT parameters were measured on 2nd generation dual source CT. Conventional two-dimensional echocardiography and Tissue Doppler Imaging (TDI) was performed to assess LV function and to derive myocardial straining parameter. All patients had a preserved LV ejection fraction > 50%. Data was analysed using Pearson's correlation. Results Only weak correlation was found between EAT volume or density and E/e' ratio as LVDD marker (r = -.113 p = .433 and r = .260, p = .068 respectively). Also, EAT volume or density were independent from Global Strain Parameters (r = 0.058 p = .688 and r = -0.207 p =.239). E/e' ratio was strongly associated with LVDD (r = .761 p <= 0.0001) and Strain Parameters were moderately associated with LV Ejection Fraction (r = -.669 p <= 0.001 and r = -.454 P <= 0.005). Conclusions In this preliminary study in patients with AS, the EAT volume and density as assessed by CT correlated only weakly with LVDD, as expressed by the commonly used E/e' ratio, and with LV strain function. Hence, measuring EAT volume and density may neither contribute to the prediction nor upon the severity of LVDD, respectively.	[Hardt, F.; Dirrichs, T.; Gohmann, R. F.; Fehrenbacher, K.; Schmoee, J.; Reinartz, S. D.] Univ Hosp RWTH Aachen, Dept Diagnost & Intervent Radiol, Aachen, Germany; [Becker, M.; Brandenburg, V; Grebe, J.] Univ Hosp RWTH Aachen, Dept Cardiol Angiol & Intens Care, Aachen, Germany	RWTH Aachen University; RWTH Aachen University Hospital; RWTH Aachen University; RWTH Aachen University Hospital	Hardt, F (corresponding author), Univ Hosp RWTH Aachen, Dept Diagnost & Intervent Radiol, Aachen, Germany.	fhardt@ukaachen.de	Gohmann, Robin/AAT-8991-2021					Abhayaratna WP, 2006, HEART, V92, P1259, DOI 10.1136/hrt.2005.080150; Baker AR, 2006, CARDIOVASC DIABETOL, V5, DOI 10.1186/1475-2840-5-1; Brandenburg VM, 2017, CIRCULATION, V135, P2081, DOI 10.1161/CIRCULATIONAHA.116.027011; Brouwers FP, 2013, EUR HEART J, V34, P1424, DOI 10.1093/eurheartj/eht066; Cavalcante JL, 2012, AM J CARDIOL, V110, P1793, DOI 10.1016/j.amjcard.2012.07.045; Chapman CB, 2013, ECHOCARDIOGR-J CARD, V30, P1022, DOI 10.1111/echo.12185; Cherian S, 2012, AM J PHYSIOL-ENDOC M, V303, pE937, DOI 10.1152/ajpendo.00061.2012; DeVore AD, 2017, EUR J HEART FAIL, V19, P893, DOI 10.1002/ejhf.754; Doesch C, 2013, OBESITY, V21, pE253, DOI 10.1002/oby.20149; Doesch C, 2012, CIRC J, V76, P2426, DOI 10.1253/circj.CJ-12-0301; HESS OM, 1984, CIRCULATION, V69, P855, DOI 10.1161/01.CIR.69.5.855; Iacobellis G, 2011, TRENDS ENDOCRIN MET, V22, P450, DOI 10.1016/j.tem.2011.07.003; Iung B, 2003, EUR HEART J, V24, P1231, DOI 10.1016/S0195-668X(03)00201-X; Kraigher-Krainer E, 2014, J AM COLL CARDIOL, V63, P447, DOI 10.1016/j.jacc.2013.09.052; Kremen J, 2006, J CLIN ENDOCR METAB, V91, P4620, DOI 10.1210/jc.2006-1044; Lam CSP, 2011, EUR J HEART FAIL, V13, P18, DOI 10.1093/eurjhf/hfq121; Leonardi B, 2014, CARDIOL YOUNG, V24, P105, DOI 10.1017/S1047951112002326; Lindman BR, 2017, J CARDIAC SURG, V32, P454, DOI 10.1111/jocs.13183; Mahabadi Amir A, 2017, J Heart Valve Dis, V26, P262; Mazurek T, 2003, CIRCULATION, V108, P2460, DOI 10.1161/01.CIR.0000099542.57313.C5; Miljkovik Lidija Veterovska, 2015, Open Access Maced J Med Sci, V3, P521, DOI 10.3889/oamjms.2015.087; Mor-Avi V, 2011, EUR J ECHOCARDIOGR, V12, P167, DOI 10.1093/ejechocard/jer021; Nagueh SF, 2016, J AM SOC ECHOCARDIOG, V29, P277, DOI 10.1016/j.echo.2016.01.011; Nakanishi K, 2017, CAN J CARDIOL, V33, P1489, DOI 10.1016/j.cjca.2017.08.001; Owan TE, 2006, NEW ENGL J MED, V355, P251, DOI 10.1056/NEJMoa052256; Paulus WJ, 2007, EUR HEART J, V28, P2539, DOI 10.1093/eurheartj/ehm037; Perez-Belmonte LM, 2017, INT J MED SCI, V14, P891, DOI 10.7150/ijms.19854; Ponikowski P, 2016, EUR HEART J, V37, P2129, DOI 10.1093/eurheartj/ehw128; Salazar J, 2016, CARDIOL RES PRACT, V2016, DOI 10.1155/2016/1291537; Serrano-Ferrer J, 2016, METABOLISM, V65, P1350, DOI 10.1016/j.metabol.2016.05.006; Smiseth OA, 2016, EUR HEART J, V37, P1196, DOI 10.1093/eurheartj/ehv529; van Woerden G, 2018, EUR J HEART FAIL; Wu CK, 2017, J CLIN LIPIDOL, V11, P1421, DOI 10.1016/j.jacl.2017.08.018; Yancy CW, 2013, J AM COLL CARDIOL, V62, pE147, DOI 10.1016/j.jacc.2013.05.019; Yingchoncharoen T, 2013, J AM SOC ECHOCARDIOG, V26, P185, DOI 10.1016/j.echo.2012.10.008; Zile MR, 2001, CIRCULATION, V104, P779, DOI 10.1161/hc3201.094226	36	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2020	15	3							e0229636	10.1371/journal.pone.0229636	http://dx.doi.org/10.1371/journal.pone.0229636			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8JT	32119694	Green Submitted, Green Published, gold			2022-12-26	WOS:000535245300032
J	Ke, XR; Qiu, JD; Wang, XJ; Yang, XY; Shen, JH; Ye, S; Yang, GJ; Xu, SZ; Bi, Q; Gou, ZR; Jia, XF; Zhang, L				Ke, Xiurong; Qiu, Jiandi; Wang, Xijuan; Yang, Xianyan; Shen, Jianhua; Ye, Shuo; Yang, Guojing; Xu, Sanzhong; Bi, Qing; Gou, Zhongru; Jia, Xiaofeng; Zhang, Lei			Modification of pore-wall in direct ink writing wollastonite scaffolds favorable for tuning biodegradation and mechanical stability and enhancing osteogenic capability	FASEB JOURNAL			English	Article						additive manufacture; bioceramic scaffold; electrostatic interaction; foreign-ion doping; pore-wall modification	BONE REGENERATION CAPACITY; BIOCERAMIC SCAFFOLDS; CERAMIC SCAFFOLDS; MAGNESIUM; PHOSPHATE; IMPLANTS; STRENGTH; SUBSTITUTES; FABRICATION; FRACTURES	Surface chemistry and mechanical stability determine the osteogenic capability of bone implants. The development of high-strength bioactive scaffolds for in-situ repair of large bone defects is challenging because of the lack of satisfying biomaterials. In this study, highly bioactive Ca-silicate (CSi) bioceramic scaffolds were fabricated by additive manufacturing and then modified for pore-wall reinforcement. Pure CSi scaffolds were fabricated using a direct ink writing technique, and the pore-wall was modified with 0%, 6%, or 10% Mg-doped CSi slurry (CSi, CSi-Mg6, or CSi-Mg10) through electrostatic interaction. Modified CSi@CSi-Mg6 and CSi@CSi-Mg10 scaffolds with over 60% porosity demonstrated an appreciable compressive strength beyond 20 MPa, which was 2-fold higher than that of pure CSi scaffolds. CSi-Mg6 and CSi-Mg10 coating layers were specifically favorable for retarding bio-dissolution and mechanical decay of scaffolds in vitro. In-vivo investigation of critical-size femoral bone defects repair revealed that CSi@CSi-Mg6 and CSi@CSi-Mg10 scaffolds displayed limited biodegradation, accelerated new bone ingrowth (4-12 weeks), and elicited a suitable mechanical response. In contrast, CSi scaffolds exhibited fast biodegradation and retarded new bone regeneration after 8 weeks. Thus, tailoring of the chemical composition of pore-wall struts of CSi scaffolds is beneficial for enhancing the biomechanical properties and bone repair efficacy.	[Ke, Xiurong; Qiu, Jiandi; Ye, Shuo; Yang, Guojing; Zhang, Lei] Wenzhou Med Univ, Hosp Affiliated 3, Dept Orthopaed Surg, Ruian, Peoples R China; [Wang, Xijuan] Zhejiang Univ, Affiliated Hosp 2, Sch Med, Key Lab Mol Biol Med Sci, Hangzhou, Peoples R China; [Yang, Xianyan; Shen, Jianhua; Gou, Zhongru] Zhejiang Univ, Zhejiang California Int Nanosyst Inst, Bionanomat & Regenerat Med Res Div, Yuhangtang Rd 866, Hangzhou 310058, Peoples R China; [Xu, Sanzhong] Zhejiang Univ, Affiliated Hosp 1, Sch Med, Dept Orthopaed Surg, Hangzhou, Peoples R China; [Bi, Qing] Zhejiang Prov Peoples Hosp, Hangzhou Med Coll, Peoples Hosp, Dept Orthoped Surg, Hangzhou, Peoples R China; [Jia, Xiaofeng] Univ Maryland, Sch Med, Dept Neurosurg, 10 South Pine St,MSTF Bldg 823, Baltimore, MD 21201 USA; [Jia, Xiaofeng] Univ Maryland, Sch Med, Dept Orthoped, Baltimore, MD 21201 USA; [Jia, Xiaofeng] Univ Maryland, Sch Med, Dept Anat & Neurobiol, Baltimore, MD 21201 USA; [Jia, Xiaofeng] Johns Hopkins Univ, Sch Med, Dept Biomed Engn, Baltimore, MD 21205 USA; [Jia, Xiaofeng] Johns Hopkins Univ, Sch Med, Dept Anesthesiol & Crit Care Med, Baltimore, MD 21205 USA	Wenzhou Medical University; Zhejiang University; Zhejiang University; Zhejiang University; Hangzhou Medical College; Zhejiang Provincial People's Hospital; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; Johns Hopkins University; Johns Hopkins University	Gou, ZR (corresponding author), Zhejiang Univ, Zhejiang California Int Nanosyst Inst, Bionanomat & Regenerat Med Res Div, Yuhangtang Rd 866, Hangzhou 310058, Peoples R China.; Jia, XF (corresponding author), Univ Maryland, Sch Med, Dept Neurosurg, 10 South Pine St,MSTF Bldg 823, Baltimore, MD 21201 USA.; Zhang, L (corresponding author), Wenzhou Med Univ, Affiliated Hosp 3, Dept Orthoped, Wansong Rd 108, Ruian 325200, Peoples R China.	zhrgou@zju.edu.cn; xjia@som.umaryland.edu; zhanglei@wmu.edu.cn	Yang, Xian/GVU-9087-2022; Jia, Xiaofeng/B-2145-2008	Jia, Xiaofeng/0000-0003-1445-8525; Zhang, Lei/0000-0001-6302-8383; Xu, Sanzhong/0000-0002-1881-2723	National Key Research and Development Program of China [2017YFE0117700]; National Natural Science Foundation of China [81601881, 81871775, 81772311]; Basic Public Welfare Research Project of Zhejiang Province [LGF19H180007]; Medical and Health Research Project of Zhejiang Province [2018KY768]; Zhejiang Province Bureau of Health [WKJ-ZJ-1711]; Basic Medical Technology Project of Wenzhou [2018Y1347]	National Key Research and Development Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Basic Public Welfare Research Project of Zhejiang Province; Medical and Health Research Project of Zhejiang Province; Zhejiang Province Bureau of Health; Basic Medical Technology Project of Wenzhou	The National Key Research and Development Program of China, Grant/Award Number: 2017YFE0117700; the National Natural Science Foundation of China, Grant/Award Number: 81601881, 81871775 and 81772311; The Basic Public Welfare Research Project of Zhejiang Province, Grant/Award Number: LGF19H180007; The Medical and Health Research Project of Zhejiang Province, Grant/Award Number: 2018KY768; The Zhejiang Province Bureau of Health, Grant/Award Number: WKJ-ZJ-1711; The Basic Medical Technology Project of Wenzhou, Grant/Award Number: 2018Y1347	Barinov S. M., 2015, Inorganic Materials: Applied Research, V6, P316, DOI 10.1134/S207511331504005X; Bhandari Mohit, 2012, J Bone Joint Surg Am, V94, pe1091, DOI 10.2106/JBJS.K.01344; BONFIELD W, 1981, BIOMATERIALS, V2, P185, DOI 10.1016/0142-9612(81)90050-8; Braem A, 2012, MAT SCI ENG C-MATER, V32, P2267, DOI 10.1016/j.msec.2012.06.013; Campana V, 2014, J MATER SCI-MATER M, V25, P2445, DOI 10.1007/s10856-014-5240-2; Chen IW, 2000, NATURE, V404, P168, DOI 10.1038/35004548; Chia HN, 2015, J BIOL ENG, V9, DOI 10.1186/s13036-015-0001-4; Dadhich P, 2016, ACS APPL MATER INTER, V8, P11910, DOI 10.1021/acsami.5b11981; Daskalova A, 2018, APPL PHYS A-MATER, V124, DOI 10.1007/s00339-018-1831-y; Descamps M, 2008, J EUR CERAM SOC, V28, P149, DOI 10.1016/j.jeurceramsoc.2007.05.025; Diba M, 2014, CURR OPIN SOLID ST M, V18, P147, DOI 10.1016/j.cossms.2014.02.004; Du J, 2018, BIOMATERIALS, V181, P347, DOI 10.1016/j.biomaterials.2018.07.015; Flierl MA, 2013, J ORTHOP SURG RES, V8, DOI 10.1186/1749-799X-8-33; Ginebra MP, 2018, EFORT OPEN REV, V3, P173, DOI 10.1302/2058-5241.3.170056; Gou ZR, 2006, J CONTROL RELEASE, V116, P360, DOI 10.1016/j.jconrel.2006.09.003; He DS, 2016, ACS BIOMATER SCI ENG, V2, P1519, DOI 10.1021/acsbiomaterials.6b00282; Hench LL, 2002, SCIENCE, V295, P1014, DOI 10.1126/science.1067404; HENCH LL, 1973, J BIOMED MATER RES, V7, P25, DOI 10.1002/jbm.820070304; Jell G, 2006, J MATER SCI-MATER M, V17, P997, DOI 10.1007/s10856-006-0435-9; Jones AC, 2009, BIOMATERIALS, V30, P1440, DOI 10.1016/j.biomaterials.2008.10.056; Jones N, 2012, NATURE, V487, P22, DOI 10.1038/487022a; Keating JF, 2005, J BONE JOINT SURG BR, V87B, P142, DOI 10.1302/0301-620X.87B2.15874; Kim HD, 2017, ADV HEALTHC MATER, V6, DOI 10.1002/adhm.201700612; Lee WH, 2013, RSC ADV, V3, P4040, DOI 10.1039/c3ra22966a; LeGeros RZ, 2008, CHEM REV, V108, P4742, DOI 10.1021/cr800427g; Li R, 2018, BIOMATERIALS, V168, P24, DOI 10.1016/j.biomaterials.2018.03.044; Lin KL, 2015, J MATER SCI-MATER M, V26, DOI 10.1007/s10856-015-5523-2; Liu A, 2016, J MATER CHEM B, V4, P3945, DOI 10.1039/c6tb00449k; Liu A, 2016, SCI REP-UK, V6, DOI 10.1038/srep21704; Liu S, 2017, BIOMED RES INT, V2017, DOI 10.1155/2017/1038476; Luo YX, 2015, ACS APPL MATER INTER, V7, P24377, DOI 10.1021/acsami.5b08911; Marcacci M, 2007, TISSUE ENG, V13, P947, DOI 10.1089/ten.2006.0271; Meininger S, 2016, ACTA BIOMATER, V31, P401, DOI 10.1016/j.actbio.2015.11.050; Mroz W, 2015, J BIOMED MATER RES B, V103, P151, DOI 10.1002/jbm.b.33170; Neufurth M, 2017, ACTA BIOMATER, V64, P377, DOI 10.1016/j.actbio.2017.09.031; Ni S, 2010, J BIOMED MATER RES A, V76, P196; Otsuki B, 2006, BIOMATERIALS, V27, P5892, DOI 10.1016/j.biomaterials.2006.08.013; Penney DP, 2002, BIOTECH HISTOCHEM, V77, P237, DOI 10.1080/714028210; Reffitt DM, 2003, BONE, V32, P127, DOI 10.1016/S8756-3282(02)00950-X; Shao HF, 2017, J MATER CHEM B, V5, P2941, DOI 10.1039/c7tb00217c; Shao HF, 2017, BIOFABRICATION, V9, DOI 10.1088/1758-5090/aa663c; Shao HF, 2016, J EUR CERAM SOC, V36, P1495, DOI 10.1016/j.jeurceramsoc.2016.01.010; Shao HF, 2015, BIOFABRICATION, V7, DOI 10.1088/1758-5090/7/3/035010; Tarafder S, 2014, ACS APPL MATER INTER, V6, P9955, DOI 10.1021/am501048n; Travitzky N, 2014, ADV ENG MATER, V16, P729, DOI 10.1002/adem.201400097; Turner BN, 2014, RAPID PROTOTYPING J, V20, P192, DOI 10.1108/RPJ-01-2013-0012; van der Stok J., 2015, NED TIJDSCHR TRAUMAC, V23, P84, DOI DOI 10.1007/S12506-015-0024-Y; Van Lieshout EMM, 2016, INJURY, V47, pS43, DOI 10.1016/S0020-1383(16)30011-0; Wang C, 2012, ACTA BIOMATER, V8, P350, DOI 10.1016/j.actbio.2011.08.019; Wu CT, 2012, J MATER CHEM, V22, P12288, DOI 10.1039/c2jm30566f; Xie JJ, 2015, MRS COMMUN, V5, P631, DOI 10.1557/mrc.2015.74; Xie JJ, 2016, J MECH BEHAV BIOMED, V54, P60, DOI 10.1016/j.jmbbm.2015.09.012; Xu S, 2008, BIOMATERIALS, V29, P2588, DOI 10.1016/j.biomaterials.2008.03.013; Yi DL, 2014, J BIOMATER APPL, V28, P1343, DOI 10.1177/0885328213508165; You F, 2015, ACS BIOMATER SCI ENG, V1, P825, DOI 10.1021/acsbiomaterials.5b00199; Yu W, 2017, BIOMATER SCI-UK, V5, P1690, DOI 10.1039/c7bm00315c; Zhang L, 2019, ACTA BIOMATER, V84, P16, DOI 10.1016/j.actbio.2018.11.039; Zhang YL, 2015, NANOSCALE, V7, P19207, DOI 10.1039/c5nr05421d; Zhu HY, 2016, J MATER CHEM B, V4, P6200, DOI 10.1039/c6tb01692h	60	4	4	5	32	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2020	34	4					5673	5687		10.1096/fj.201903044R	http://dx.doi.org/10.1096/fj.201903044R		MAR 2020	15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	LJ5ZA	32115776				2022-12-26	WOS:000517977500001
J	Kirchner, B; Buschmann, D; Paul, V; Pfaffl, MW				Kirchner, Benedikt; Buschmann, Dominik; Paul, Vijay; Pfaffl, Michael W.			Postprandial transfer of colostral extracellular vesicles and their protein and miRNA cargo in neonatal calves	PLOS ONE			English	Article							MILK-DERIVED EXOSOMES; IMMUNE-RELATED MICRORNAS; QUANTITATIVE CHANGES; PLANT MIRNAS; CELL-GROWTH; COWS MILK; BOVINE; BLOOD; TARGETS; IDENTIFICATION	Extracellular vesicles (EVs) such as exosomes are key regulators of intercellular communication that can be found in almost all bio fluids. Although studies in the last decade have made great headway in discerning the role of EVs in many physiological and pathophysiological processes, the bioavailability and impact of dietary EVs and their cargo still remain to be elucidated. Due to its widespread consumption and high content of EV-associated microRNAs and proteins, a major focus in this field has been set on EVs in bovine milk and colostrum. Despite promising in vitro studies in recent years that show high resiliency of milk EVs to degradation and uptake of milk EV cargo in a variety of intestinal and blood cell types, in vivo experiments continue to be inconclusive and sometimes outright contradictive. To resolve this discrepancy, we assessed the potential postprandial transfer of colostral EVs to the circulation of newborn calves by analysing colostrum-specific protein and miRNAs, including specific isoforms (isomiRs) in cells, EV isolations and unfractionated samples from blood and colostrum. Our findings reveal distinct populations of EVs in colostrum and blood from cows that can be clearly separated by density, particle concentration and protein content (BTN1A1, MFGE8). Postprandial blood samples of calves show a time-dependent increase in EVs that share morphological and protein characteristics of colostral EVs. Analysis of miRNA expression profiles by Next-Generation Sequencing gave a different picture however. Although significant postprandial expression changes could only be detected for calf EV samples, expression profiles show very limited overlap with highly expressed miRNAs in colostral EVs or colostrum in general. Taken together our results indicate a selective uptake of membrane-associated protein cargo but not luminal miRNAs from colostral EVs into the circulation of neonatal calves.	[Kirchner, Benedikt; Buschmann, Dominik; Pfaffl, Michael W.] Tech Univ Munich, TUM Sch Life Sci Weihenstephan, Div Anim Physiol & Immunol, Munich, Germany; [Buschmann, Dominik] Univ Hosp, Inst Human Genet, LMU Munich, Munich, Germany; [Paul, Vijay] ICAR Res Complex, Natl Res Ctr Yak, Dirang, India	Technical University of Munich; University of Munich; Indian Council of Agricultural Research (ICAR); ICAR - National Research Centre on Yak	Kirchner, B (corresponding author), Tech Univ Munich, TUM Sch Life Sci Weihenstephan, Div Anim Physiol & Immunol, Munich, Germany.	benedikt.kirchner@wzw.tum.de	Pfaffl, Michael/G-6622-2013	Pfaffl, Michael/0000-0002-3192-1019; Kirchner, Benedikt/0000-0003-3878-0148				Admyre C, 2007, J IMMUNOL, V179, P1969, DOI 10.4049/jimmunol.179.3.1969; Agrawal AK, 2017, NANOMED-NANOTECHNOL, V13, P1627, DOI 10.1016/j.nano.2017.03.001; Alsaweed M, 2016, SCI REP-UK, V6, DOI 10.1038/srep20680; Ameres SL, 2013, NAT REV MOL CELL BIO, V14, P475, DOI 10.1038/nrm3611; Andrews S, FASTQC QUALITY CONTR; Arntz OJ, 2015, MOL NUTR FOOD RES, V59, P1701, DOI 10.1002/mnfr.201500222; Auerbach Amanda, 2016, F1000Res, V5, P721, DOI 10.12688/f1000research.8548.1; Baier SR, 2014, J NUTR, V144, P1495, DOI 10.3945/jn.114.196436; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Benmoussa A, 2019, J PROTEOMICS, V192, P78, DOI 10.1016/j.jprot.2018.08.010; Benmoussa A, 2016, J NUTR, V146, P2206, DOI 10.3945/jn.116.237651; Betker JL, 2019, J PHARM SCI-US, V108, P1496, DOI 10.1016/j.xphs.2018.11.022; Buschmann D, 2018, J EXTRACELL VESICLES, V7, DOI 10.1080/20013078.2018.1481321; Buschow SI, 2010, IMMUNOL CELL BIOL, V88, P851, DOI 10.1038/icb.2010.64; Chen X, 2010, CELL RES, V20, P1128, DOI 10.1038/cr.2010.80; Chou CH, 2018, NUCLEIC ACIDS RES, V46, pD296, DOI 10.1093/nar/gkx1067; Cloonan N, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-12-r126; Dickinson B, 2013, NAT BIOTECHNOL, V31, P965, DOI 10.1038/nbt.2737; EL Andaloussi S, 2013, NAT REV DRUG DISCOV, V12, P348, DOI 10.1038/nrd3978; Feng XL, 2014, CANCER LETT, V344, P166, DOI 10.1016/j.canlet.2013.11.004; Fernandez-Valverde SL, 2010, RNA, V16, P1881, DOI 10.1261/rna.2379610; Friedman JM, 2009, SWISS MED WKLY, V139, P466, DOI smw-12794; Galili T, 2015, BIOINFORMATICS, V31, P3718, DOI 10.1093/bioinformatics/btv428; Gardiner C, 2013, J EXTRACELL VESICLES, V2, DOI 10.3402/jev.v2i0.19671; Godard P, 2015, NUCLEIC ACIDS RES, V43, P3490, DOI 10.1093/nar/gkv249; Golan-Gerstl R, 2017, MOL NUTR FOOD RES, V61, DOI 10.1002/mnfr.201700009; Guo E, 2016, EUR REV MED PHARMACO, V20, P3385; Guo L, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154955; Gyorgy B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049726; Hata T, 2010, BIOCHEM BIOPH RES CO, V396, P528, DOI 10.1016/j.bbrc.2010.04.135; Howard KM, 2015, J AGR FOOD CHEM, V63, P588, DOI 10.1021/jf505526w; Hyun S, 2009, CELL, V139, P1096, DOI 10.1016/j.cell.2009.11.020; Izumi H, 2015, J DAIRY SCI, V98, P2920, DOI 10.3168/jds.2014-9076; JOCHIMS K, 1994, RES VET SCI, V57, P75, DOI 10.1016/0034-5288(94)90085-X; Kalra H, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001450; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Keerthikumar S, 2016, J MOL BIOL, V428, P688, DOI 10.1016/j.jmb.2015.09.019; Kirchner B, 2016, J ALLERGY CLIN IMMUN, V137, P1893, DOI 10.1016/j.jaci.2015.10.028; Koh YQ, 2017, J ANIM SCI, V95, P3893, DOI [10.2527/jas.2017.1727, 10.2527/jas2017.1727]; Kong Y, 2011, GENOMICS, V98, P152, DOI 10.1016/j.ygeno.2011.05.009; Kozomara A, 2014, NUCLEIC ACIDS RES, V42, pD68, DOI 10.1093/nar/gkt1181; Kusuma RJ, 2016, AM J PHYSIOL-CELL PH, V310, pC800, DOI 10.1152/ajpcell.00169.2015; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Liao YL, 2017, MOL NUTR FOOD RES, V61, DOI 10.1002/mnfr.201700082; Linares R, 2015, J EXTRACELL VESICLES, V4, DOI 10.3402/jev.v4.29509; Lotvall J, 2014, J EXTRACELL VESICLES, V3, DOI 10.3402/jev.v3.26913; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Manca S, 2016, FASEB J, V30; Manca S, 2017, FASEB J, V31; Mestdagh P, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-6-r64; Mjelle R, 2017, ONCOTARGET, V8, P90077, DOI 10.18632/oncotarget.21412; Mork M, 2017, J EXTRACELL VESICLES, V6, DOI 10.1080/20013078.2017.1308779; Muller L, 2014, J IMMUNOL METHODS, V411, P55, DOI 10.1016/j.jim.2014.06.007; Munagala R, 2016, CANCER LETT, V371, P48, DOI 10.1016/j.canlet.2015.10.020; Neilsen CT, 2012, TRENDS GENET, V28, P544, DOI 10.1016/j.tig.2012.07.005; Pandey P., 2014, NONCODING RNAS ENDOC, V1, P45, DOI [10.2478/micrnado-2014-0003, DOI 10.2478/MICRNADO-2014-0003]; Petrov AI, 2017, NUCLEIC ACIDS RES, V45, pD128, DOI 10.1093/nar/gkw1008; Pienimaeki-Roemer A, 2015, TRANSFUSION, V55, P507, DOI 10.1111/trf.12874; R Core Team, 2018, R LANG ENV STAT COMP; Reinhardt TA, 2013, J PROTEOMICS, V82, P141, DOI 10.1016/j.jprot.2013.02.013; Reinhardt TA, 2012, J PROTEOMICS, V75, P1486, DOI 10.1016/j.jprot.2011.11.017; Reithmair M, 2017, J CELL MOL MED, V21, P2403, DOI 10.1111/jcmm.13162; Rubio M, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0193527; Samuel M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-06288-8; Snow JW, 2013, RNA BIOL, V10, P1107, DOI 10.4161/rna.24909; Spornraft M, 2015, BIOTECHNOL LETT, V37, P1165, DOI 10.1007/s10529-015-1788-2; Spornraft M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107259; Starega-Roslan J, 2015, INT J MOL SCI, V16, P8110, DOI 10.3390/ijms16048110; Sun Q, 2013, PROTEIN CELL, V4, P197, DOI 10.1007/s13238-013-2119-9; Tan GC, 2014, NUCLEIC ACIDS RES, V42, P9424, DOI 10.1093/nar/gku656; Thery C, 2002, NAT REV IMMUNOL, V2, P569, DOI 10.1038/nri855; Thery C, 2009, NAT REV IMMUNOL, V9, P581, DOI 10.1038/nri2567; Thery Clotilde, 2006, Curr Protoc Cell Biol, VChapter 3, DOI 10.1002/0471143030.cb0322s30; Title AC, 2015, J BIOL CHEM, V290, P23680, DOI 10.1074/jbc.M115.676734; Tosar JP, 2014, RNA, V20, P754, DOI 10.1261/rna.044263.114; Vilella F, 2015, DEVELOPMENT, V142, P3210, DOI 10.1242/dev.124289; Wickham H., 2016, GGPLOT2 ELEGANT GRAP; Witwer KW, 2017, J EXTRACELL VESICLES, V6, DOI 10.1080/20013078.2017.1396823; Witwer KW, 2015, J NUTR BIOCHEM, V26, P1685, DOI 10.1016/j.jnutbio.2015.09.004; Witwer KW, 2013, RNA BIOL, V10, P1080, DOI 10.4161/rna.25246; Witwer KW, 2012, RNA BIOL, V9, P1147, DOI 10.4161/rna.21619; Wolf T, 2015, J NUTR, V145, P2201, DOI 10.3945/jn.115.218586; Yanez-Mo M, 2015, J EXTRACELL VESICLES, V4, DOI 10.3402/jev.v4.27066; Yu GC, 2012, OMICS, V16, P284, DOI 10.1089/omi.2011.0118; Yu SR, 2017, J AGR FOOD CHEM, V65, P1220, DOI 10.1021/acs.jafc.6b05002; Zempleni J, 2017, J NUTR, V147, P3, DOI 10.3945/jn.116.238949; Zhang L, 2012, CELL RES, V22, P107, DOI 10.1038/cr.2011.158; Zhou Q, 2012, INT J BIOL SCI, V8, P118, DOI 10.7150/ijbs.8.118; Zhou Z, 2015, CELL RES, V25, P39, DOI 10.1038/cr.2014.130	89	11	11	3	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2020	15	2							e0229606	10.1371/journal.pone.0229606	http://dx.doi.org/10.1371/journal.pone.0229606			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8HR	32109241	Green Submitted, Green Published, gold			2022-12-26	WOS:000535239800017
J	Nakamoto, S; Ito, Y; Nishizawa, N; Goto, T; Kojo, K; Kumamoto, Y; Watanabe, M; Narumiya, S; Majima, M				Nakamoto, Shuji; Ito, Yoshiya; Nishizawa, Nobuyuki; Goto, Takuya; Kojo, Ken; Kumamoto, Yusuke; Watanabe, Masahiko; Narumiya, Shuh; Majima, Masataka			EP3 signaling in dendritic cells promotes liver repair by inducing IL-13-mediated macrophage differentiation in mice	FASEB JOURNAL			English	Article						crosstalk; immune cells; ischemia; prostaglandin; reperfusion	E RECEPTOR SUBTYPE; ISCHEMIA/REPERFUSION INJURY; MONOCYTES; INFLAMMATION; HOMEOSTASIS; INDUCTION; SITE	Macrophage plasticity is essential for liver wound healing; however, the mechanisms underlying macrophage phenotype switching are largely unknown. Dendritic cells (DCs) are critical initiators of innate immune responses; as such, they orchestrate inflammation following hepatic injury. Here, we subjected EP3-deficient (Ptger3(-/-)) and wild-type (WT) mice to hepatic ischemia-reperfusion (I/R) and demonstrate that signaling via the prostaglandin E (PGE) receptor EP3 in DCs regulates macrophage plasticity during liver repair. Compared with WT mice, Ptger3(-/-) mice showed delayed liver repair accompanied by reduced expression of hepatic growth factors and accumulation of Ly6C(low) reparative macrophages and monocyte-derived DCs (moDCs). MoDCs were recruited to the boundary between damaged and undamaged liver tissue in an EP3-dependent manner. Adoptive transfer of moDCs from Ptger3(-/-) mice resulted in impaired repair, along with increased numbers of Ly6C(high) inflammatory macrophages. Bone marrow macrophages (BMMs) up-regulated expression of genes related to a reparative macrophage phenotype when co-cultured with moDCs; this phenomenon was dependent on EP3 signaling. In the presence of an EP3 agonist, interleukin (IL)-13 derived from moDCs drove BMMs to increase expression of genes characteristic of a reparative macrophage phenotype. The results suggest that EP3 signaling in moDCs facilitates liver repair by inducing IL-13-mediated switching of macrophage phenotype from pro-inflammatory to pro-reparative.	[Nakamoto, Shuji; Ito, Yoshiya; Goto, Takuya; Majima, Masataka] Kitasato Univ, Grad Sch Med Sci, Dept Mol Pharmacol, Sagamihara, Kanagawa, Japan; [Nakamoto, Shuji; Ito, Yoshiya; Nishizawa, Nobuyuki; Goto, Takuya; Majima, Masataka] Kitasato Univ, Dept Pharmacol, Sch Med, Sagamihara, Kanagawa, Japan; [Nakamoto, Shuji; Nishizawa, Nobuyuki; Goto, Takuya; Kojo, Ken; Kumamoto, Yusuke; Watanabe, Masahiko] Kitasato Univ, Dept Surg, Sch Med, Sagamihara, Kanagawa, Japan; [Narumiya, Shuh] Kyoto Univ, Grad Sch Med, Ctr Innovat Immunoregulat Technol & Therapeut, Kyoto, Japan	Kitasato University; Kitasato University; Kitasato University; Kyoto University	Majima, M (corresponding author), Kitasato Univ, Sch Med, Dept Pharmacol, Minami Ku, 1-15-1 Kitasato, Sagamihara, Kanagawa 2520374, Japan.	mmajima@med.kitasato-u.ac.jp	Majima, Masataka/ABH-3063-2021	Nakamoto, Shuji/0000-0002-6225-9355	Ministry of Education, Culture, Sports, Science and Technology (MEXT) [16K10581, 18K16373, 18H02605]; Takeda Foundation; Kitasato University Research Grant for Young Researchers	Ministry of Education, Culture, Sports, Science and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Takeda Foundation(Takeda Science Foundation (TSF)); Kitasato University Research Grant for Young Researchers	Ministry of Education, Culture, Sports, Science and Technology (MEXT), Grant/Award Number: 16K10581, 18K16373 and 18H02605; Takeda Foundation; Kitasato University Research Grant for Young Researchers	Anzai A, 2012, CIRCULATION, V125, P1234, DOI 10.1161/CIRCULATIONAHA.111.052126; Bamboat ZM, 2010, J CLIN INVEST, V120, P559, DOI 10.1172/JCI40008; Bonnardel J, 2019, IMMUNITY, V51, P638, DOI 10.1016/j.immuni.2019.08.017; Brempelis KJ, 2016, CLIN TRANSL IMMUNOL, V5, DOI 10.1038/cti.2016.62; Castellaneta A, 2014, HEPATOLOGY, V60, P267, DOI 10.1002/hep.27037; Choo EH, 2017, CIRCULATION, V135, P1444, DOI 10.1161/CIRCULATIONAHA.116.023106; Clavien P, 2007, NEW ENGL J MED, V356, P1545, DOI 10.1056/NEJMra065156; Connolly MK, 2009, J CLIN INVEST, V119, P3213, DOI 10.1172/JCI37581; Dal-Secco D, 2015, J EXP MED, V212, P447, DOI 10.1084/jem.20141539; Ginhoux F, 2014, NAT REV IMMUNOL, V14, P392, DOI 10.1038/nri3671; Heier EC, 2017, J HEPATOL, V66, P1241, DOI 10.1016/j.jhep.2017.01.008; Heymann F, 2016, NAT REV GASTRO HEPAT, V13, P88, DOI 10.1038/nrgastro.2015.200; Hosono K, 2011, ARTERIOSCL THROM VAS, V31, P1049, DOI 10.1161/ATVBAHA.110.222356; Jenne CN, 2013, NAT IMMUNOL, V14, P996, DOI 10.1038/ni.2691; Jiao JJ, 2012, HEPATOLOGY, V55, P243, DOI 10.1002/hep.24621; Kamoshita E, 2006, AM J PATHOL, V169, P1458, DOI 10.2353/ajpath.2006.051358; Kato A, 2003, HEPATOLOGY, V37, P304, DOI 10.1053/jhep.2003.50075; Kawai S, 2011, EXP ANIM TOKYO, V60, P481, DOI 10.1538/expanim.60.481; Kojo K, 2016, SCI REP-UK, V6, DOI 10.1038/srep29650; Krenkel O, 2017, NAT REV IMMUNOL, V17, P306, DOI 10.1038/nri.2017.11; Kubes P, 2012, GASTROENTEROLOGY, V143, P1158, DOI 10.1053/j.gastro.2012.09.008; Kuzumoto Y, 2005, HEPATOLOGY, V42, P608, DOI 10.1002/hep.20827; Lentsch AB, 2012, SCIENTIFICA, V2012, DOI 10.6064/2012/513192; Leon B, 2007, IMMUNITY, V26, P519, DOI 10.1016/j.immuni.2007.01.017; Liew PX, 2017, IMMUNITY, V47, P752, DOI 10.1016/j.immuni.2017.09.016; Mildner A, 2013, ADV IMMUNOL, V120, P69, DOI 10.1016/B978-0-12-417028-5.00003-X; Motino O, 2019, HEPATOLOGY, V70, P650, DOI 10.1002/hep.30241; Nakao T, 2019, HEPATOLOGY, V70, P696, DOI 10.1002/hep.30334; Nishizawa N, 2018, J HEPATOL, V69, P110, DOI 10.1016/j.jhep.2018.02.009; Noll J, 2016, J HEPATOL, V64, P1147, DOI 10.1016/j.jhep.2016.01.013; Ogawa F, 2014, J CLIN INVEST, V124, P4882, DOI 10.1172/JCI73530; Ohkubo H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105533; Proto JD, 2018, IMMUNITY, V49, P666, DOI 10.1016/j.immuni.2018.07.015; Scandella E, 2002, BLOOD, V100, P1354, DOI 10.1182/blood-2001-11-0017; Sugimoto Y, 2007, J BIOL CHEM, V282, P11613, DOI 10.1074/jbc.R600038200; Tang JA, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms13724; Ushikubi F, 1998, NATURE, V395, P281, DOI 10.1038/26233; Zhang M, 2013, HEPATOLOGY, V57, P1585, DOI 10.1002/hep.26129	38	8	8	1	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2020	34	4					5610	5627		10.1096/fj.201901955R	http://dx.doi.org/10.1096/fj.201901955R		FEB 2020	18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	LJ5ZA	32112485	Bronze			2022-12-26	WOS:000517912100001
J	Ayturk, UM; Sieker, JT; Haslauer, CM; Proffen, BL; Weissenberger, MH; Warman, ML; Fleming, BC; Murray, MM				Ayturk, Ugur M.; Sieker, Jakob T.; Haslauer, Carla M.; Proffen, Benedikt L.; Weissenberger, Manuela H.; Warman, Matthew L.; Fleming, Braden C.; Murray, Martha M.			Proteolysis and cartilage development are activated in the synovium after surgical induction of post traumatic osteoarthritis	PLOS ONE			English	Article							CRUCIATE LIGAMENT RECONSTRUCTION; KNEE OSTEOARTHRITIS; ARTICULAR-CARTILAGE; LUBRICIN TRIBOSUPPLEMENTATION; POSTTRAUMATIC OSTEOARTHRITIS; EXPRESSION CHANGES; ANTERIOR; FLUID; JOINT; DEGENERATION	Anterior cruciate ligament (ACL) transection surgery in the minipig induces post-traumatic osteoarthritis (PTOA) in a pattern similar to that seen in human patients after ACL injury. Prior studies have reported the presence of cartilage matrix-degrading proteases, such as Matrix metalloproteinase-1 (MMP-1) and A disintegrin and metalloproteinase with thrombospondin motifs 4 (ADAMTS-4), in the synovial fluid of injured or arthritic joints; however, the tissue origin of these proteases is unknown. The objective of this study was to identify transcriptional processes activated in the synovium after surgical induction of PTOA with ACL transection, and to determine if processes associated with proteolysis were enriched in the synovium after ACL transection. Unilateral ACL transection was performed in adolescent Yucatan minipigs and synovium samples were collected at 1, 5, 9, and 14 days post-injury. Transcriptome-wide gene expression levels were determined using bulk RNA-Sequencing in the surgical animals and control animals with healthy knees. The greatest number of transcripts with significant changes was observed 1 day after injury. These changes were primarily associated with cellular proliferation, consistent with measurements of increased cellularity of the synovium at the two-week time point. At five to 14 days, the expression of transcripts relating to proteolysis and cartilage development was significantly enriched. While protease inhibitor-encoding transcripts (TIMP2, TIMP3) represented the largest fraction of protease-associated transcripts in the uninjured synovium, protease-encoding transcripts (including MMP1, MMP2, ADAMTS4) predominated after surgery. Cartilage development-associated transcripts that are typically not expressed by synovial cells, such as ACAN and COMP, were enriched in the synovium following ACL-transection. The upregulation in both catabolic processes (proteolysis) and anabolic processes (cartilage development) suggests that the synovium plays a complex, balancing role in the early response to PTOA induction.	[Ayturk, Ugur M.; Sieker, Jakob T.; Haslauer, Carla M.; Proffen, Benedikt L.; Warman, Matthew L.; Murray, Martha M.] Harvard Med Sch, Boston Childrens Hosp, Dept Orthopaed Surg, Boston, MA 02115 USA; [Ayturk, Ugur M.; Warman, Matthew L.] Harvard Med Sch, Dept Genet, Boston, MA 02115 USA; [Weissenberger, Manuela H.] Caritas Hosp Bad Mergentheim, Dept Pathol, Bad Mergentheim, Germany; [Fleming, Braden C.] Brown Univ, Rhode Isl Hosp, Dept Orthopaed, Warren Alpert Med Sch, Providence, RI 02903 USA	Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Harvard Medical School; Caritas Hospital Bad Mergentheim; Brown University; Lifespan Health Rhode Island; Rhode Island Hospital	Murray, MM (corresponding author), Harvard Med Sch, Boston Childrens Hosp, Dept Orthopaed Surg, Boston, MA 02115 USA.	Martha.Murray@childrens.harvard.edu		Murray, Martha/0000-0001-5086-9511; Fleming, Braden C./0000-0002-7841-425X	National Institutes of Health under NIAMS [AR054099, AR056834]; Ruth L. Kirschstein National Research Service Award [F32 AR061186]	National Institutes of Health under NIAMS; Ruth L. Kirschstein National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This investigation was supported by National Institutes of Health under NIAMS AR054099 (MMM) https://www.niams.nih.gov/, AR056834 (BCF/MMM), and the Ruth L. Kirschstein National Research Service Award (F32 AR061186) (CMH) https://www.nlm.nih.gov/ep/NRSAFellowshipGrants.html The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alliston T, 2018, J ORTHOP RES, V36, P1818, DOI 10.1002/jor.23844; Amano K, 2018, AM J SPORT MED, V46, P890, DOI 10.1177/0363546517749834; Ayral X, 2005, OSTEOARTHR CARTILAGE, V13, P361, DOI 10.1016/j.joca.2005.01.005; Ayturk UM, 2013, J BONE MINER RES, V28, P2081, DOI 10.1002/jbmr.1946; Beynnon BD, 2005, AM J SPORT MED, V33, P347, DOI 10.1177/0363546504268406; Bigoni M, 2013, J ORTHOP RES, V31, P315, DOI 10.1002/jor.22208; Cameron M L, 1994, Knee Surg Sports Traumatol Arthrosc, V2, P38, DOI 10.1007/BF01552652; Candela ME, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156783; Catterall JB, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3216; Elsaid KA, 2008, ARTHRITIS RHEUM-US, V58, P1707, DOI 10.1002/art.23495; FELL HB, 1977, ARTHRITIS RHEUM, V20, P1359, DOI 10.1002/art.1780200710; Ferretti A, 2019, ORTHOP J SPORTS MED, V7, DOI 10.1177/2325967119852916; Garciadiego-Cazares D, 2004, DEVELOPMENT, V131, P4735, DOI 10.1242/dev.01345; Grant GR, 2011, BIOINFORMATICS, V27, P2518, DOI 10.1093/bioinformatics/btr427; Haslauer CM, 2013, OSTEOARTHRITIS CARTI; Higuchi H, 2006, INT ORTHOP, V30, P43, DOI 10.1007/s00264-005-0023-5; HOCHBERG Y, 1990, STAT MED, V9, P811, DOI 10.1002/sim.4780090710; Intema F, 2010, OSTEOARTHR CARTILAGE, V18, P691, DOI 10.1016/j.joca.2010.01.004; Irie K, 2003, KNEE, V10, P93, DOI 10.1016/S0968-0160(02)00083-2; Jay GD, 2012, ARTHRITIS RHEUM-US, V64, P1162, DOI 10.1002/art.33461; Jay GD, 2010, ARTHRITIS RHEUM-US, V62, P2382, DOI 10.1002/art.27550; King J, 2018, AUST NZ J PSYCHIAT, V52, P806, DOI 10.1177/0004867418763528; Koyama E, 2008, DEV BIOL, V316, P62, DOI 10.1016/j.ydbio.2008.01.012; Krenn V, 2006, HISTOPATHOLOGY, V49, P358, DOI 10.1111/j.1365-2559.2006.02508.x; Kwapisz A, 2014, INT ORTHOP, V38, P649, DOI 10.1007/s00264-013-2195-8; Lambert C, 2014, ARTHRITIS RHEUMATOL, V66, P960, DOI 10.1002/art.38315; Lattermann C, 2017, AM J SPORT MED, V45, P325, DOI 10.1177/0363546516666818; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Little CB, 2013, NAT REV RHEUMATOL, V9, P485, DOI 10.1038/nrrheum.2013.72; Lohmander LS, 2004, ARTHRITIS RHEUM-US, V50, P3145, DOI 10.1002/art.20589; Monaco E, 2019, AM J SPORT MED, V47, P1186, DOI 10.1177/0363546519831686; Murray MM, 2013, AM J SPORT MED, V41, P1762, DOI 10.1177/0363546513483446; Murray MM, 2010, J BONE JOINT SURG AM, V92A, P2039, DOI 10.2106/JBJS.I.01368; Murray MM, 2007, J ORTHOP RES, V25, P81, DOI 10.1002/jor.20282; Oiestad BE, 2010, AM J SPORT MED, V38, P2201, DOI 10.1177/0363546510373876; Proffen BL, 2012, KNEE, V19, P493, DOI 10.1016/j.knee.2011.07.005; Roberts S, 2015, OSTEOARTHR CARTILAGE, V23, P1622, DOI 10.1016/j.joca.2015.05.006; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Sieker JT, 2018, J ORTHOP RES, V36, P2128, DOI 10.1002/jor.23876; Sieker JT, 2018, J ORTHOP RES, V36, P318, DOI 10.1002/jor.23644; Sieker JT, 2016, ARTHRITIS RHEUMATOL, V68, P1637, DOI 10.1002/art.39631; VONPORAT A, 2004, BRIT J SPORT MED, V38, P263	42	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2020	15	2							e0229449	10.1371/journal.pone.0229449	http://dx.doi.org/10.1371/journal.pone.0229449			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8GQ	32107493	Green Published, gold			2022-12-26	WOS:000535237000033
J	Vieira, SCF; Santos, VS; Franco, JM; Nascimento, HM; Barbosa, KDESS; de Lyra, DP; Bastos, KD; Cipolotti, R; Wayhs, MLC; Vieira, MC; Sole, D; de Morais, MB; Gurgel, RQ				Fontes Vieira, Sarah Cristina; Santos, Victor Santana; Franco, Jackeline Motta; Nascimento-Filho, Hiram Menezes; Solis Barbosa, Kamilla de Oliveira e Silva; de Lyra-Junior, Divaldo Pereira; Bastos, Kleyton de Andrade; Cipolotti, Rosana; Chang Wayhs, Monica Lisboa; Vieira, Mario Cesar; Sole, Dirceu; de Morais, Mauro Batista; Gurgel, Ricardo Queiroz			Brazilian pediatricians' adherence to food allergy guidelines-A cross-sectional study	PLOS ONE			English	Article							AMERICAN ACADEMY; DIAGNOSIS; MANAGEMENT; QUALITY; HEALTH; NUTRITIONISTS; PREVENTION; PHYSICIANS; KNOWLEDGE; ASTHMA	Food allergy is an emerging clinical condition in pediatrics, so recommendations on its management have been widely published. Studying pediatricians' adherence to these clinical practice guidelines (CPG) and understanding the reasons for their non-compliance can help to promote better management of this condition. A cross-sectional study was conducted by a survey among Brazilian pediatricians, randomly selected during the 38th Brazilian Congress of Pediatrics, which took place in October, 2017. A validated questionnaire with 16 questions addressing knowledge and practice on food allergy, as well as self-reported adherence to international guidelines was applied. Of the total of 415 pediatricians from all regions of the country who were surveyed, only 69 (16.7%) had a satisfactory adherence rate (>= 80%). Adequate adherence to the guidelines was associated with the variables: `evaluating more than 10 children with suspected cow's milk allergy (CMA) per month'; 'having read the Brazilian consensus'; or 'being aware of any international food allergy guideline'. In 8 of the 10 questions that assessed conscious adherence, a minority of those surveyed (20.3-42.3% variation) stated that they knew that their response was in line with the guidelines. This finding was statistically significant (p<0.05) in 7 of these 8 questions. The self-reported adherence of Brazilian pediatricians to international food allergy guidelines was low. Pediatricians who evaluated a higher number of children with suspected CMA or who were aware of the recommendations, had a higher rate of adherence. The results of the survey found that lack of resource was the major reported barrier to guideline adherence but lack of awareness must be a relevant non perceived barrier. This study shows the pediatricians ' self-reported adherence to food allergy guidelines in a widely overview for the first time in Brazil. More studies are necessary to investigate adherence to guidelines by pediatricians in other countries and to develop strategies to improve adherence.	[Fontes Vieira, Sarah Cristina; de Lyra-Junior, Divaldo Pereira; Bastos, Kleyton de Andrade; Cipolotti, Rosana; Gurgel, Ricardo Queiroz] Univ Fed Sergipe, Grad Program Hlth Sci, Aracaju, Sergipe, Brazil; [Fontes Vieira, Sarah Cristina; Franco, Jackeline Motta] Univ Fed Sergipe, Reference Ctr Food Allergy Sergipe, Aracaju, Sergipe, Brazil; [Fontes Vieira, Sarah Cristina; Nascimento-Filho, Hiram Menezes; Solis Barbosa, Kamilla de Oliveira e Silva; Bastos, Kleyton de Andrade; Cipolotti, Rosana; Gurgel, Ricardo Queiroz] Univ Fed Sergipe, Dept Med, Aracaju, Sergipe, Brazil; [Santos, Victor Santana] Univ Fed Alagoas, Dept Nursing, Arapiraca, Alagoas, Brazil; [Chang Wayhs, Monica Lisboa] Univ Fed Santa Catarina, Dept Pediat, Florianopolis, SC, Brazil; [Vieira, Mario Cesar] Hosp Pequeno Principe, Ctr Pediat Gastroenterol, Curitiba, Parana, Brazil; [Vieira, Mario Cesar] Pontificia Univ Catolica Parana, Dept Pediat, Curitiba, Parana, Brazil; [Sole, Dirceu; de Morais, Mauro Batista] Univ Fed Sao Paulo, Dept Pediat, Sao Paulo, SP, Brazil	Universidade Federal de Sergipe; Universidade Federal de Sergipe; Universidade Federal de Sergipe; Universidade Federal de Alagoas; Universidade Federal de Santa Catarina (UFSC); Hospital Pequeno Principe; Pontificia Universidade Catolica do Parana; Universidade Federal de Sao Paulo (UNIFESP)	Vieira, SCF (corresponding author), Univ Fed Sergipe, Grad Program Hlth Sci, Aracaju, Sergipe, Brazil.; Vieira, SCF (corresponding author), Univ Fed Sergipe, Reference Ctr Food Allergy Sergipe, Aracaju, Sergipe, Brazil.	sarahcfv@yahoo.com.br	Solé, Dirceu/D-7789-2013; Junior, Divaldo Lyra/AAU-9987-2020; Santos, Victor Santana/B-8738-2014	Junior, Divaldo Lyra/0000-0002-0266-0702; Santos, Victor Santana/0000-0003-0194-7397; Vieira, Sarah Cristina Fontes/0000-0002-0830-9657; Franco, Jackeline/0000-0003-3088-492X	CAPES (PROAP budget) from Graduate Program in Health Sciences-Federal University of Sergipe (UFS), Brazil; Federal University of Sergipe institutional funds (PROAP) from CAPES - Graduate Studies Coordination, a Brazilian Government Institution [23113.063993/2019-77]	CAPES (PROAP budget) from Graduate Program in Health Sciences-Federal University of Sergipe (UFS), Brazil; Federal University of Sergipe institutional funds (PROAP) from CAPES - Graduate Studies Coordination, a Brazilian Government Institution	This publication was partly funded by CAPES (PROAP budget) from Graduate Program in Health Sciences-Federal University of Sergipe (UFS), Brazil. We also declare that our study received no funding from any company or institution for the field work and development, all costs for this were due to the authors. Publication fee was in part supported by Federal University of Sergipe institutional funds (PROAP) received from CAPES - Graduate Studies Coordination, a Brazilian Government Institution - award number 23113.063993/2019-77. All methods decisions, paper preparation and decision to publish were taken by the authors, with no interference from funders.	Arts DL, 2016, INT J MED INFORM, V89, P55, DOI 10.1016/j.ijmedinf.2016.02.009; Bacal L, 2013, PEDIATR ANN, V42, P151; de Faria DPB, 2018, REV NUTR, V31, P535, DOI 10.1590/1678-98652018000600003; Bilaver LA, 2019, ANN ALLERG ASTHMA IM, V122, P373, DOI 10.1016/j.anai.2019.01.014; Cabana MD, 1999, JAMA-J AM MED ASSOC, V282, P1458, DOI 10.1001/jama.282.15.1458; Centre for Clinical Practice at NICE (UK), 2011, FOOD ALL CHILDR YOUN, V116; Cortez Ana Paula B., 2007, Rev. paul. pediatr., V25, P106; Cosgrove L, 2013, J EVAL CLIN PRACT, V19, P674, DOI 10.1111/jep.12016; de Albuquerque MV, 2017, CIENC SAUDE COLETIVA, V22, P1055, DOI 10.1590/1413-81232017224.26862016; Fiocchi A, 2016, WORLD ALLERGY ORGAN, V9, DOI 10.1186/s40413-016-0125-0; Fiocchi A, 2010, PEDIAT ALLERG IMM-UK, V21, P1, DOI [10.1097/WOX.0b013e3181defeb9, 10.1111/j.1399-3038.2010.01068.x]; Fischer F, 2016, HEALTHCARE-BASEL, V4, DOI 10.3390/healthcare4030036; Vieira SCF, 2018, J PEDIATR GASTR NUTR, V67, pE1, DOI 10.1097/MPG.0000000000001902; Gold Jessica, 2019, Hosp Pediatr, V9, P87, DOI 10.1542/hpeds.2018-0211; Goncalves LCP, 2016, ALLERGOL IMMUNOPATH, V44, P497, DOI 10.1016/j.aller.2016.04.009; Gupta M, 2018, IMMUNOL ALLERGY CLIN, V38, P39, DOI 10.1016/j.iac.2017.09.004; Gupta RS, 2014, CLIN PEDIATR, V53, P524, DOI 10.1177/0009922813518425; Kissoon N, 2015, J INFECTION, V71, pS36, DOI 10.1016/j.jinf.2015.04.017; Koletzko S, 2012, J PEDIATR GASTR NUTR, V55, P221, DOI 10.1097/MPG.0b013e31825c9482; Lee JY, 2015, EJSO-EUR J SURG ONC, V41, P585, DOI 10.1016/j.ejso.2015.01.006; Lugtenberg M, 2011, BMC FAM PRACT, V12, DOI 10.1186/1471-2296-12-98; Luyt D, 2014, CLIN EXP ALLERGY, V44, P642, DOI 10.1111/cea.12302; McGlynn EA, 2003, NEW ENGL J MED, V348, P2635, DOI 10.1056/NEJMsa022615; Meyer R, 2018, PEDIAT ALLERG IMM-UK, V29, P689, DOI 10.1111/pai.12960; Mittman B S, 1992, QRB Qual Rev Bull, V18, P413; Muraro A, 2014, ALLERGY, V69, P1008, DOI 10.1111/all.12429; Nowak-Wegrzyn A, 2017, J ALLERGY CLIN IMMUN, V139, P1111, DOI 10.1016/j.jaci.2016.12.966; O'Sullivan JW, 2018, J CLIN EPIDEMIOL, V103, P40, DOI 10.1016/j.jclinepi.2018.06.013; Patel N, 2017, ALLERGY ASTHMA PROC, V38, P88, DOI 10.2500/aap.2017.38.4028; Pedone C, 2003, BMC PUBLIC HEALTH, V3, DOI 10.1186/1471-2458-3-24; Powell BJ, 2012, MED CARE RES REV, V69, P123, DOI 10.1177/1077558711430690; Ribeiro CC, 2013, CLIN NUTR, V32, P624, DOI 10.1016/j.clnu.2012.10.014; Ruszczynski M, 2016, CLIN EXP ALLERGY, V46, P1236, DOI 10.1111/cea.12784; Sampson HA, 2014, J ALLERGY CLIN IMMUN, V134, P1016, DOI 10.1016/j.jaci.2014.05.013; Sampson HA, 2012, J ALLERGY CLIN IMMUN, V130, P1260, DOI 10.1016/j.jaci.2012.10.017; Shanbhag D, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2017-017765; Sicherer SH, 2018, J ALLERGY CLIN IMMUN, V141, P41, DOI 10.1016/j.jaci.2017.11.003; Sole D., 2008, REV BRAS ALERG IMUNO, V31, P64; SOLE D., 2018, ARQ ASMA ALERG IMUNO, V2, P39; Sole D, 2012, REV BRAS ALERG IMUNO, V35, P203; Sole Dirceu, 2007, Rev. paul. pediatr., V25, P311; Thangaratinam S, 2005, OBSTET GYNAECOL, V7, P120, DOI 10.1576/toag.7.2.120.27071; Vandenplas Y, 2017, BMC PEDIATR, V17, DOI 10.1186/s12887-017-0871-3; Vieira MC, 2010, BMC PEDIATR, V10, DOI 10.1186/1471-2431-10-25	44	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2020	15	2							e0229356	10.1371/journal.pone.0229356	http://dx.doi.org/10.1371/journal.pone.0229356			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8DW	32092100	Green Published, gold, Green Submitted			2022-12-26	WOS:000535229300049
J	Bouillet, S; Wu, T; Chen, SX; Stock, AM; Gao, R				Bouillet, Sophie; Wu, Ti; Chen, Shaoxing; Stock, Ann M.; Gao, Rong			Structural asymmetry does not indicate hemiphosphorylation in the bacterial histidine kinase CpxA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						bacterial signal transduction; histidine kinase; autophosphorylation; cooperativity; kinetics; asymmetric phosphorylation; environmental sensing; heterodimer; kinetic equilibrium modeling; two-component system; negative cooperativity; environmental sensing; histidine phosphotransfer	ESCHERICHIA-COLI; SIGNAL-TRANSDUCTION; SUBUNIT EXCHANGE; ATP-BINDING; AUTOPHOSPHORYLATION; INSIGHTS; CHEA; DEPHOSPHORYLATION; INHIBITION; ACTIVATION	Histidine protein kinases (HKs) are prevalent prokaryotic sensor kinases that are central to phosphotransfer in two-component signal transduction systems, regulating phosphorylation of response regulator proteins that determine the output responses. HKs typically exist as dimers and can potentially autophosphorylate at each conserved histidine residue in the individual protomers, leading to diphosphorylation. However, analyses of HK phosphorylation in biochemical assays in vitro suggest negative cooperativity, whereby phosphorylation in one protomer of the dimer inhibits phosphorylation in the second protomer, leading to ?50% phosphorylation of the available sites in dimers. This negative cooperativity is often correlated with an asymmetric domain arrangement, a common structural characteristic of autophosphorylation states in many HK structures. In this study, we engineered covalent dimers of the cytoplasmic domains of Escherichia coli CpxA, enabling us to quantify individual species: unphosphorylated, monophosphorylated, and diphosphorylated dimers. Together with mathematical modeling, we unambiguously demonstrate no cooperativity in autophosphorylation of CpxA despite its asymmetric structures, indicating that these asymmetric domain arrangements are not linked to negative cooperativity and hemiphosphorylation. Furthermore, the modeling indicated that many parameters, most notably minor amounts of ADP generated during autophosphorylation reactions or present in ATP preparations, can produce ?50% total phosphorylation that may be mistakenly attributed to negative cooperativity. This study also establishes that the engineered covalent heterodimer provides a robust experimental system for investigating cooperativity in HK autophosphorylation and offers a useful tool for testing how symmetric or asymmetric structural features influence HK functions.	[Bouillet, Sophie; Wu, Ti; Chen, Shaoxing; Stock, Ann M.; Gao, Rong] Rutgers State Univ, Robert Wood Johnson Med Sch, Ctr Adv Biotechnol & Med, Dept Biochem & Mol Biol, Piscataway, NJ 08854 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center	Gao, R (corresponding author), Rutgers State Univ, Ctr Adv Biotechnol & Med, Piscataway, NJ 08854 USA.	rgao@cabm.rutgers.edu		Gao, Rong/0000-0002-9245-4952; Stock, Ann/0000-0002-0446-8079	National Institutes of Health [R35GM131727]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by National Institutes of Health Grant R35GM131727 (to A. M. S.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Albanesi D, 2004, J BACTERIOL, V186, P2655, DOI 10.1128/JB.186.9.2655-2663.2004; Albanesi D, 2009, P NATL ACAD SCI USA, V106, P16185, DOI 10.1073/pnas.0906699106; Barbieri CM, 2008, ANAL BIOCHEM, V376, P73, DOI 10.1016/j.ab.2008.02.004; Berntsson O, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00300-5; Bhate MP, 2015, STRUCTURE, V23, P981, DOI 10.1016/j.str.2015.04.002; Buschiazzo A, 2019, ANNU REV MICROBIOL, V73, P507, DOI 10.1146/annurev-micro-091018-054627; Cai SJ, 2003, J MOL BIOL, V329, P495, DOI 10.1016/S0022-2836(03)00446-7; Cai YF, 2017, ACTA CRYSTALLOGR D, V73, P793, DOI 10.1107/S2059798317013043; Casino P, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4258; Casino P, 2010, CURR OPIN STRUC BIOL, V20, P763, DOI 10.1016/j.sbi.2010.09.010; Cheung J, 2009, STRUCTURE, V17, P190, DOI 10.1016/j.str.2008.12.013; Diensthuber RP, 2013, STRUCTURE, V21, P1127, DOI 10.1016/j.str.2013.04.024; Dikiy I, 2019, P NATL ACAD SCI USA, V116, P4963, DOI 10.1073/pnas.1813586116; Dubey BN, 2020, P NATL ACAD SCI USA, V117, P1000, DOI 10.1073/pnas.1911427117; Engler C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003647; Fisher SL, 1996, BIOCHEMISTRY-US, V35, P4732, DOI 10.1021/bi9525435; Gao R, 2009, ANNU REV MICROBIOL, V63, P133, DOI 10.1146/annurev.micro.091208.073214; Grimshaw CE, 1998, BIOCHEMISTRY-US, V37, P1365, DOI 10.1021/bi971917m; Gushchin I, 2017, SCIENCE, V356, DOI 10.1126/science.aah6345; Hazra S, 2015, J BIOL CHEM, V290, P24222, DOI 10.1074/jbc.M115.651745; Janiak-Spens F, 2005, BIOCHEMISTRY-US, V44, P377, DOI 10.1021/bi048433s; Jiang P, 2000, BIOCHEMISTRY-US, V39, P5057, DOI 10.1021/bi992921w; Keeble AH, 2017, ANGEW CHEM INT EDIT, V56, P16521, DOI 10.1002/anie.201707623; Mechaly AE, 2017, STRUCTURE, V25, P939, DOI 10.1016/j.str.2017.04.011; Mechaly AE, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001776; Moglich A, 2019, PROTEIN SCI, V28, P1923, DOI 10.1002/pro.3705; Moore JO, 2012, STRUCTURE, V20, P729, DOI 10.1016/j.str.2012.02.021; Neiditch MB, 2006, CELL, V126, P1095, DOI 10.1016/j.cell.2006.07.032; Noriega CE, 2008, J BACTERIOL, V190, P3869, DOI 10.1128/JB.00092-08; Park SY, 2004, BIOCHEMISTRY-US, V43, P2228, DOI 10.1021/bi0352419; Plesniak L, 2002, BIOCHEMISTRY-US, V41, P13876, DOI 10.1021/bi020331j; Potter CA, 2002, J MOL BIOL, V320, P201, DOI 10.1016/S0022-2836(02)00424-2; Surette MG, 1996, J BIOL CHEM, V271, P939, DOI 10.1074/jbc.271.2.939; TAWA P, 1994, BIOCHEMISTRY-US, V33, P7917, DOI 10.1021/bi00191a019; Trajtenberg F, 2016, ELIFE, V5, DOI 10.7554/eLife.21422; Trajtenberg F, 2010, J BIOL CHEM, V285, P24892, DOI 10.1074/jbc.M110.147843; Tran QH, 1998, EUR J BIOCHEM, V251, P538, DOI 10.1046/j.1432-1327.1998.2510538.x; Ueno TB, 2015, BIOCHEM BIOPH RES CO, V465, P331, DOI 10.1016/j.bbrc.2015.07.121; Wang BY, 2014, MOL CELL, V53, P929, DOI 10.1016/j.molcel.2014.02.029; Wang C, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001493; Wilke KE, 2015, ACS CHEM BIOL, V10, P328, DOI 10.1021/cb5008019; Willett JW, 2017, MOL MICROBIOL, V103, P197, DOI 10.1111/mmi.13525; Willett JW, 2015, P NATL ACAD SCI USA, V112, pE3709, DOI 10.1073/pnas.1503118112; Wojnowska M, 2013, CHEM BIOL, V20, P1411, DOI 10.1016/j.chembiol.2013.09.008; Yaginuma H, 2014, SCI REP-UK, V4, DOI 10.1038/srep06522; Yeo WS, 2012, MOL CELL, V45, P409, DOI 10.1016/j.molcel.2011.12.027; Young C, 2012, METHOD ENZYMOL, V511, P213, DOI 10.1016/B978-0-12-396546-2.00010-3; Zschiedrich CP, 2016, J MOL BIOL, V428, P3752, DOI 10.1016/j.jmb.2016.08.003	48	3	3	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 5	2020	295	23					8106	8117		10.1074/jbc.RA120.012757	http://dx.doi.org/10.1074/jbc.RA120.012757			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LZ0QD	32094228	hybrid, Green Published			2022-12-26	WOS:000540935400022
J	Dally, M; Butler-Dawson, J; Cruz, A; Krisher, L; Johnson, RJ; Asensio, C; Pilloni, WD; Asturias, EJ; Newman, LS				Dally, Miranda; Butler-Dawson, Jaime; Cruz, Alex; Krisher, Lyndsay; Johnson, Richard J.; Asensio, Claudia; Pilloni, W. Daniel; Asturias, Edwin J.; Newman, Lee S.			Longitudinal trends in renal function among first time sugarcane harvesters in Guatemala	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; RISK-FACTORS; AMERICA; MODELS; ADULTS; CKD	Introduction Chronic kidney disease of unknown origin (CKDu) is an epidemic concentrated in agricultural communities in Central and South America, including young, male sugarcane harvesters. The purpose of this analysis is to understand early changes in kidney function among a cohort of first-time sugarcane harvesters and to determine risk factors for kidney function decline. Methods Joint latent class mixed models were used to model sub-population kidney function trajectory over the course of 4 years (2012-2016). Probability weighted logistic regression was used to determine personal health, community, and individual behavior risk factors associated with sub-population assignment. Data analysis occurred in 2019. Results Of 181 new workers median age 19 years old (IQR: 4), 39 (22%) were identified as having non-stable kidney function with an annual age-adjusted decline of estimated glomerular filtration rate (eGFR) of -1.0 ml/min per 1.73 m(2) (95% CI: -3.4, 1.3). Kidney function (OR: 0.96; 95% CI: 0.93, 0.98), mild hypertension (OR: 5.21; 95% CI: 2.14, 13.94), and having a local home of residence (OR: 7.12; 95% CI: 2.41, 26.02) prior to employment in sugarcane were associated with non-stable eGFR sub-population assignment. Conclusions Mild hypertension may be an early indicator of the development of CKDu. A better understanding of preexisting risk factors is needed to determine why individuals are entering the workforce with reduced kidney function and elevated blood pressure and increased risk of renal function decline.	[Dally, Miranda; Butler-Dawson, Jaime; Krisher, Lyndsay; Newman, Lee S.] Univ Colorado, Ctr Hlth Work & Environm, Colorado Sch Publ Hlth, Anschutz Med Campus, Aurora, CO 80045 USA; [Dally, Miranda; Butler-Dawson, Jaime; Newman, Lee S.] Univ Colorado, Dept Environm & Occupat Hlth, Colorado Sch Publ Hlth, Anschutz Med Campus, Aurora, CO 80045 USA; [Cruz, Alex; Asensio, Claudia; Pilloni, W. Daniel] Pantaleon, Guatemala City, Guatemala; [Johnson, Richard J.] Univ Colorado, Div Renal Dis & Hypertens, Sch Med, Anschutz Med Campus, Aurora, CO USA; [Asturias, Edwin J.] Univ Colorado, Div Pediat Infect Dis, Sch Med, Anschutz Med Campus, Aurora, CO USA; [Asturias, Edwin J.] Univ Colorado, Ctr Global Hlth, Colorado Sch Publ Hlth, Anschutz Med Campus, Aurora, CO USA; [Asturias, Edwin J.; Newman, Lee S.] Univ Colorado, Dept Epidemiol, Colorado Sch Publ Hlth, Anschutz Med Campus, Aurora, CO USA; [Newman, Lee S.] Univ Colorado, Div Pulm Sci & Crit Care Med, Sch Med, Anschutz Med Campus, Aurora, CO USA	Colorado School of Public Health; University of Colorado System; University of Colorado Anschutz Medical Campus; Colorado School of Public Health; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; Colorado School of Public Health; University of Colorado System; University of Colorado Anschutz Medical Campus; Colorado School of Public Health; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus	Dally, M (corresponding author), Univ Colorado, Ctr Hlth Work & Environm, Colorado Sch Publ Hlth, Anschutz Med Campus, Aurora, CO 80045 USA.; Dally, M (corresponding author), Univ Colorado, Dept Environm & Occupat Hlth, Colorado Sch Publ Hlth, Anschutz Med Campus, Aurora, CO 80045 USA.	miranda.dally@cuanschutz.edu	Dally, Miranda/GXV-9250-2022		Pantaleon; Centers for Disease Control and Prevention [U19 OH01127]; National Institutes of Health [R21 ES028826]	Pantaleon; Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This evaluation was supported in part by Pantaleon; the Chancellor, CU Anschutz; Centers for Disease Control and Prevention (CDC.gov) (U19 OH01127 to LSN) and National Institutes of Health (NIH.gov) (R21 ES028826 to LSN). Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the Centers for Disease Control and Prevention, the National Institutes of Health, or the Department of Health and Human Services. The funders had no role in the evaluation design, data analysis, or data interpretation. Co-authors employed by the company (AC, CA, WDP) participated on the writing team. They provided details regarding work practices, but did not modify the results or conclusions of this report. The corresponding author had full access to all the raw data and had final responsibility for the decision to submit for publication. University of Colorado and Pantaleon are separate, independent organizations. University of Colorado employed appropriate research methods in keeping with academic freedom, based conclusions on critical analysis of the evidence and reported findings fully and objectively. The terms of this arrangement have been reviewed and approved by the University of Colorado in accordance with its conflict of interest policies.	Agampodi SB, 2018, BMC NEPHROL, V19, DOI 10.1186/s12882-018-0911-8; [Anonymous], R LANG ENV STAT COMP, DOI DOI 10.1080/02705060.2017.1422558; Burkner PC, 2017, J STAT SOFTW, V80, P1, DOI 10.18637/jss.v080.i01; Butler-Dawson J, 2018, J OCCUP ENVIRON MED, V60, P548, DOI [10.1097/JOM.0000000000001284, 10.1097/jom.0000000000001284]; Correa-Rotter R, 2014, AM J KIDNEY DIS, V63, P506, DOI 10.1053/j.ajkd.2013.10.062; Dally M, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0205181; Glaser J, 2016, CLIN J AM SOC NEPHRO, V11, P1472, DOI 10.2215/CJN.13841215; Gonzalez-Quiroz M, 2018, J AM SOC NEPHROL, V29, P2200, DOI 10.1681/ASN.2018020151; Gonzalez-Quiroz M, 2018, CLIN KIDNEY J, V11, P496, DOI 10.1093/ckj/sfx136; Griffin BR, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0204614; Valdes RH, 2015, CLIN NEPHROL, V83, pS56, DOI 10.5414/CNP83S056; International Labour Organization, STAT DAT; Jayalal TBA, 2019, BMC NEPHROL, V20, DOI 10.1186/s12882-019-1371-5; Jayasumana C, 2015, ENVIRON HEALTH-GLOB, V14, DOI 10.1186/1476-069X-14-6; Jayasumana C, 2014, BMC NEPHROL, V15, DOI 10.1186/1471-2369-15-124; Johnson RJ, 2019, NEW ENGL J MED, V380, P1843, DOI 10.1056/NEJMra1813869; Johnson RJ, 2002, NEW ENGL J MED, V346, P913, DOI 10.1056/NEJMra011078; Kupferman J, 2016, AM J KIDNEY DIS, V68, P716, DOI 10.1053/j.ajkd.2016.06.012; Laws RL, 2015, INT J OCCUP ENV HEAL, V21, P241, DOI 10.1179/2049396714Y.0000000102; Le Blond JS, 2017, ATMOS ENVIRON, V149, P34, DOI 10.1016/j.atmosenv.2016.11.012; Lebov Jill F, 2015, Can J Kidney Health Dis, V2, P6, DOI 10.1186/s40697-015-0041-1; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; O'Donnell JK, 2011, NEPHROL DIAL TRANSPL, V26, P2798, DOI 10.1093/ndt/gfq385; Navarro CMO, 2015, CLIN NEPHROL, V83, pS24, DOI 10.5414/CNP83S024; Proust-Lima C, 2014, STAT METHODS MED RES, V23, P74, DOI 10.1177/0962280212445839; PROUSTLIMA C, 2015, ESTIMATION EXTENDED, V78, P1473, DOI DOI 10.18637/JSS.V078.I02; Raines N, 2014, MEDICC REV, V16, P16, DOI 10.37757/MR2014.V16.N2.4; Ramirez-Rubio O, 2016, NEPHROL DIAL TRANSPL, V31, P424, DOI 10.1093/ndt/gfv292; Scammell MK, 2019, SEMIN NEPHROL, V39, P230, DOI 10.1016/j.semnephrol.2019.02.001; Sorensen C, 2019, NEW ENGL J MED, V381, P693, DOI 10.1056/NEJMp1907859; Sorensen CJ, 2019, J OCCUP ENVIRON MED, V61, P239, DOI 10.1097/JOM.0000000000001529; Torres C, 2010, AM J KIDNEY DIS, V55, P485, DOI 10.1053/j.ajkd.2009.12.012; Trabanino Ramón García, 2002, Rev Panam Salud Publica, V12, P202, DOI 10.1590/S1020-49892002000900009; Valcke M, 2017, ENVIRON HEALTH-GLOB, V16, DOI 10.1186/s12940-017-0254-0; Wesseling C, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-011034; Whelton PK, 2018, J AM COLL CARDIOL, V71, pE127, DOI 10.1016/j.jacc.2017.11.006; Wijkstrom J, 2017, AM J KIDNEY DIS, V69, P626, DOI 10.1053/j.ajkd.2016.10.036	37	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2020	15	3							e0229413	10.1371/journal.pone.0229413	http://dx.doi.org/10.1371/journal.pone.0229413			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8TR	32142520	Green Published, gold			2022-12-26	WOS:000535271600014
J	Gayrard, N; Muyor, K; Notarnicola, C; Duranton, F; Jover, B; Argiles, A				Gayrard, Nathalie; Muyor, Karen; Notarnicola, Cecile; Duranton, Flore; Jover, Bernard; Argiles, Angel			Optimisation of cell and ex vivo culture conditions to study vascular calcification	PLOS ONE			English	Article							CORONARY-ARTERY CALCIFICATION; DIALYSIS PATIENTS; MORTALITY RISK; UP-REGULATION; RAT MODEL; CALCIUM; PYROPHOSPHATE; PHOSPHORUS	Medial vascular calcification (MVC) is a highly prevalent disease associated with a high risk of severe, potentially lethal, complications. While animal studies may not systematically be circumvented, in vitro systems have been proven useful to study disease physiopathology. In the context of MVC, the absence of a clinically relevant standardized in vitro method prevents the appropriate comparison and overall interpretation of results originating from different experiments. The aim of our study is to establish in vitro models mimicking in vivo vascular calcification and to select the best methods to unravel the mechanisms involved in MVC. Human aortic smooth muscle cells and rat aortic rings were cultured in different conditions. The influence of fetal calf serum (FCS), alkaline phosphatase, phosphate and calcium concentrations in the medium were evaluated. We identified culture conditions, including the herein reported Aorta Calcifying Medium (ACM), which allowed a reproducible and specific medial calcification of aortic explants. Studying cells and aortic explants cultured, the involvement of bone morphogenetic protein 2 (BMP2) pathway, fibrosis and apoptosis processes in in vitro MVC were demonstrated. Expression of osteoblastic markers was also observed suggesting the occurrence of transdifferentiation of smooth muscle cells to osteoblasts in our models. The use of these models will help researchers in the field of vascular calcification to achieve reproducible results and allow result comparison in a more consistent way.	[Gayrard, Nathalie; Muyor, Karen; Duranton, Flore; Argiles, Angel] RD Nephrol, 2 Rue Muriers, Montpellier, France; [Gayrard, Nathalie; Muyor, Karen; Duranton, Flore; Argiles, Angel] EA 7288 BC2M BatD RDC UFR Pharm, RD Nephrol, Montpellier, France; [Notarnicola, Cecile; Jover, Bernard] Univ Montpellier, INSERM, CNRS, PhyMedExp Physiol & Med Expt Cur Muscles, Montpellier, France; [Argiles, Angel] Nephrol Dialyse St Guilhem NDSG, CS 40 339, Sete, France	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier	Gayrard, N (corresponding author), RD Nephrol, 2 Rue Muriers, Montpellier, France.; Gayrard, N (corresponding author), EA 7288 BC2M BatD RDC UFR Pharm, RD Nephrol, Montpellier, France.	Nathalie.gayrard@umontpellier.fr	Duranton, Flore/ABB-6225-2021; gayrard, nathalie/AAO-2888-2020	Duranton, Flore/0000-0003-3202-0551; gayrard, nathalie/0000-0001-8283-8429; JOVER, Bernard/0000-0001-5826-5755; Notarnicola, Cecile/0000-0001-8363-1614; Argiles, Angel/0000-0001-7029-4532	French Languedoc Roussillon region's ARPE program [2014-005987]	French Languedoc Roussillon region's ARPE program	This project has received funding from French Languedoc Roussillon region's ARPE program under number 2014-005987 (BJ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balls M, 2009, ATLA-ALTERN LAB ANIM, V37, P1; Block GA, 1998, AM J KIDNEY DIS, V31, P607, DOI 10.1053/ajkd.1998.v31.pm9531176; Bouvet C, 2007, CARDIOVASC RES, V73, P504, DOI 10.1016/j.cardiores.2006.11.001; Ciceri P, 2015, MOL CELL BIOCHEM, V410, P197, DOI 10.1007/s11010-015-2552-6; Gaillard V, 2008, AM J PHYSIOL-RENAL, V295, pF1222, DOI 10.1152/ajprenal.00081.2008; Goodman WG, 2000, NEW ENGL J MED, V342, P1478, DOI 10.1056/NEJM200005183422003; Hortells L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141751; Hosen MJ, 2014, ORPHANET J RARE DIS, V9, DOI 10.1186/1750-1172-9-66; Jahnen-Dechent W, 2011, CIRC RES, V108, P1494, DOI 10.1161/CIRCRESAHA.110.234260; Johnson RC, 2006, CIRC RES, V99, P1044, DOI 10.1161/01.RES.0000249379.55535.21; Jono S, 2000, CIRC RES, V87, pE10, DOI 10.1161/01.RES.87.7.e10; Lehto S, 1996, ARTERIOSCL THROM VAS, V16, P978, DOI 10.1161/01.ATV.16.8.978; Li XW, 2008, ATHEROSCLEROSIS, V199, P271, DOI 10.1016/j.atherosclerosis.2007.11.031; Lomashvili KA, 2008, KIDNEY INT, V73, P1024, DOI 10.1038/ki.2008.26; Lomashvili KA, 2004, J AM SOC NEPHROL, V15, P1392, DOI 10.1097/01.ASN.0000128955.83129.9C; Mizobuchi M, 2009, J AM SOC NEPHROL, V20, P1453, DOI 10.1681/ASN.2008070692; de Oca AM, 2010, J BONE MINER RES, V25, P1996, DOI 10.1002/jbmr.93; Ostric M, 2019, J BIOL REG HOMEOS AG, V33, P29; Reslerova M, 2003, AM J KIDNEY DIS, V41, pS96, DOI 10.1053/ajkd.2003.50094; RUSSELL WMS, 1995, ATLA-ALTERN LAB ANIM, V23, P298; Schuchardt M, 2012, KIDNEY INT, V81, P256, DOI 10.1038/ki.2011.326; SHIOI A, 1995, ARTERIOSCL THROM VAS, V15, P2003, DOI 10.1161/01.ATV.15.11.2003; Shobeiri N, 2010, AM J NEPHROL, V31, P471, DOI 10.1159/000299794; Shroff R, 2013, J AM SOC NEPHROL, V24, P179, DOI 10.1681/ASN.2011121191; Steitz SA, 2001, CIRC RES, V89, P1147, DOI 10.1161/hh2401.101070; Tentori F, 2008, AM J KIDNEY DIS, V52, P519, DOI 10.1053/j.ajkd.2008.03.020; Villa-Bellosta R, 2011, CIRC J, V75, P2705, DOI 10.1253/circj.CJ-11-0477; Zhou Y, 2014, ARTERIOSCL THROM VAS, V34, P1002, DOI 10.1161/ATVBAHA.114.303301	28	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2020	15	3							e0230201	10.1371/journal.pone.0230201	http://dx.doi.org/10.1371/journal.pone.0230201			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8TR	32143215	Green Published, gold			2022-12-26	WOS:000535271600041
J	Moghaddam, M; Kazempour-Osaloo, S				Moghaddam, Mahtab; Kazempour-Osaloo, Shahrokh			Extensive survey of the ycf4 plastid gene throughout the IRLC legumes: Robust evidence of its locus and lineage specific accelerated rate of evolution, pseudogenization and gene loss in the tribe Fabeae	PLOS ONE			English	Article							COMPLETE CHLOROPLAST GENOME; PHOTOSYSTEM-I; INVERTED REPEAT; SEQUENCE ALIGNMENT; SELECTION; MULTIPLE; DNA; CLASSIFICATION; REARRANGEMENTS; INVERSIONS	The genome organization and gene content of plastome (plastid genome) are highly conserved among most flowering plant species. Plastome variation (in size and gene order) is rare in photosynthetic species but size variation, rearrangements and gene/intron losses is attributed to groups of seed plants. Fabaceae (legume family), in particular the subfamily Papilionoideae and the inverted repeat lacking clade (IRLC), a largest legume lineage, display the most dramatic and structural change which providing an excellent model for understanding of mechanisms of genomic evolution. The IRLC comprises 52 genera and ca 4000 species divided into seven tribes. In present study, we have sampled several representatives from each tribe across the IRLC from various herbaria and field. The ycf4 gene, which plays a role in regulating and assembly of photosystem I, is more variable in the tribe Fabeae than in other tribes. In certain species of Lathyrus, Pisum and Vavilovia, all belonging to Fabeae, the gene is either absent or a pseudogene. Our study suggests that ycf4 gene has undergone positive selection. Furthermore, the rapid evolution of the gene is locus and lineage specific and is not a shared character of the IRLC in legumes.	[Moghaddam, Mahtab; Kazempour-Osaloo, Shahrokh] Tarbiat Modares Univ, Fac Biol Sci, Dept Plant Biol, Tehran, Iran	Tarbiat Modares University	Kazempour-Osaloo, S (corresponding author), Tarbiat Modares Univ, Fac Biol Sci, Dept Plant Biol, Tehran, Iran.	skosaloo@modares.ac.ir	Kazempour-Osaloo, Shahrokh/AAJ-7357-2021	Kazempour-Osaloo, Shahrokh/0000-0002-6275-1673				Azani N, 2017, TAXON, V66, P44, DOI 10.12705/661.3; Bock R, 2012, GENOMICS CHLOROPLAST; Bock Ralph, 2007, V19, P29, DOI 10.1007/4735_2007_0223; Boudreau E, 1997, EMBO J, V16, P6095, DOI 10.1093/emboj/16.20.6095; Brandvain Y, 2009, GENETICS, V182, P1129, DOI 10.1534/genetics.108.100024; Cai ZQ, 2008, J MOL EVOL, V67, P696, DOI 10.1007/s00239-008-9180-7; Chumley TW, 2006, MOL BIOL EVOL, V23, P2175, DOI 10.1093/molbev/msl089; Compton JA, 2019, PHYTOKEYS, P1, DOI 10.3897/phytokeys.125.34877; Crispell J, 2019, MICROB GENOMICS, V5, DOI 10.1099/mgen.0.000245; Doyle J. J., 1987, PHYTOCHEM B, P11; Drummond A.J, 2014, TRACER VERSION 1 6, DOI DOI 10.1073/pnas.1007407107; Duan Lei, 2016, PhytoKeys, P111; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Funk HT, 2007, BMC PLANT BIOL, V7, DOI 10.1186/1471-2229-7-45; Gao FL, 2019, ECOL EVOL, V9, P3891, DOI 10.1002/ece3.5015; Guisinger MM, 2011, MOL BIOL EVOL, V28, P583, DOI 10.1093/molbev/msq229; Guo XW, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-228; Huson D. H, 2010, USER MANUAL DENDROSC; Jansen RK, 2012, ADV PHOTOSYNTHESIS R, P103, DOI DOI 10.1007/978-94-007-2920-9_5; Jansen RK, 2008, MOL PHYLOGENET EVOL, V48, P1204, DOI 10.1016/j.ympev.2008.06.013; Jansen RK, 2007, P NATL ACAD SCI USA, V104, P19369, DOI 10.1073/pnas.0709121104; Jiang M, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19051419; Jin DP, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0218743; Keller J, 2017, DNA RES, V24, P343, DOI 10.1093/dnares/dsx006; Kenicer GJ, 2005, AM J BOT, V92, P1199, DOI 10.3732/ajb.92.7.1199; Kim Y, 2017, J EXP BOT, V68, P2065, DOI 10.1093/jxb/erw500; Koonin EV, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-8-331; Krech K, 2012, PLANT PHYSIOL, V159, P579, DOI 10.1104/pp.112.196642; LAVIN M, 1990, EVOLUTION, V44, P390, DOI 10.1111/j.1558-5646.1990.tb05207.x; Lee HL, 2007, MOL BIOL EVOL, V24, P1161, DOI 10.1093/molbev/msm036; Loytynoja A, 2005, P NATL ACAD SCI USA, V102, P10557, DOI 10.1073/pnas.0409137102; Loytynoja A, 2008, SCIENCE, V320, P1632, DOI 10.1126/science.1158395; Macas J, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-427; Macas J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143424; Magee AM, 2010, GENOME RES, V20, P1700, DOI 10.1101/gr.111955.110; McNeal JR, 2007, BMC PLANT BIOL, V7, DOI 10.1186/1471-2229-7-57; Miller M.A., 2010, P GAT COMP ENV WORKS; Moghaddam M, 2017, PLANT BIOSYST, V151, P1082, DOI 10.1080/11263504.2016.1244120; Nellaepalli S, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04823-3; Nelson N, 2006, ANNU REV PLANT BIOL, V57, P521, DOI 10.1146/annurev.arplant.57.032905.105350; Neumann P, 2006, GENETICS, V173, P1047, DOI 10.1534/genetics.106.056259; Nylander J. A. A., 2004, MRMODELTEST V2; Oskoueiyan R, 2014, IRAN J BIOTECHNOL, V12, DOI 10.5812/ijb.10315; Ozawa S, 2009, PLANT CELL, V21, P2424, DOI 10.1105/tpc.108.063313; PALMER JD, 1988, CURR GENET, V14, P65, DOI 10.1007/BF00405856; PALMER JD, 1981, P NATL ACAD SCI-BIOL, V78, P5533, DOI 10.1073/pnas.78.9.5533; PALMER JD, 1987, CURR GENET, V11, P275, DOI 10.1007/BF00355401; Posada D, 2004, SYST BIOL, V53, P793, DOI 10.1080/10635150490522304; Ren T, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19041050; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Ruf S, 1997, J CELL BIOL, V139, P95, DOI 10.1083/jcb.139.1.95; Sabir J, 2014, PLANT BIOTECHNOL J, V12, P743, DOI 10.1111/pbi.12179; Sanderson MJ, 1996, AM J BOT, V83, P1488, DOI 10.2307/2446103; Schaefer H, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-250; Schwarz EN, 2015, J SYST EVOL, V53, P458, DOI 10.1111/jse.12179; Sobotka R, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-13575-x; Steinway SN, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-284; Suzuki Y, 1999, MOL BIOL EVOL, V16, P1315, DOI 10.1093/oxfordjournals.molbev.a026042; Sveinsson S, 2016, BIORXIV, DOI [10.1101/040188, DOI 10.1101/040188]; Sveinsson S, 2014, BMC EVOL BIOL, V14, DOI 10.1186/s12862-014-0228-6; Tao XL, 2017, GENE REP, V6, P67, DOI 10.1016/j.genrep.2016.12.006; TSUDZUKI J, 1992, MOL GEN GENET, V232, P206, DOI 10.1007/BF00279998; Vasil IK, 1991, CELL CULTURE SOMAT A, V7a, P5, DOI DOI 10.1016/B978-0-12-715007-9.50009-8; Wicke S, 2011, PLANT MOL BIOL, V76, P273, DOI 10.1007/s11103-011-9762-4; Wojciechowski MF, 2013, S AFR J BOT, V89, P85, DOI 10.1016/j.sajb.2013.06.017; Wojciechowski MF, 2004, AM J BOT, V91, P1846, DOI 10.3732/ajb.91.11.1846; WOLFE KH, 1992, P NATL ACAD SCI USA, V89, P10648, DOI 10.1073/pnas.89.22.10648; Wyman SK, 2004, BIOINFORMATICS, V20, P3252, DOI 10.1093/bioinformatics/bth352; Yang Y, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000264; Yang ZH, 2005, MOL BIOL EVOL, V22, P1107, DOI 10.1093/molbev/msi097; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088	71	7	7	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2020	15	3							e0229846	10.1371/journal.pone.0229846	http://dx.doi.org/10.1371/journal.pone.0229846			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8RK	32134967	Green Published, gold			2022-12-26	WOS:000535265600050
J	Ronquist, F; Forshage, M; Haggqvist, S; Karlsson, D; Hovmolle, R; Bergsten, J; Holston, K; Britton, T; Abenius, J; Andersson, B; Buhl, PN; Coulianos, CC; Fjellberg, A; Gertsson, CA; Hellqvist, S; Jaschhof, M; Kjaerandsen, J; Klopfstein, S; Kobro, S; Liston, A; Meier, R; Pollet, M; Riedel, M; Rohacek, J; Schuppenhauer, M; Stigenberg, J; Struwe, I; Taeger, A; Ulefors, SO; Varga, O; Withers, P; Gardenfors, U				Ronquist, Fredrik; Forshage, Mattias; Haggqvist, Sibylle; Karlsson, Dave; Hovmolle, Rasmus; Bergsten, Johannes; Holston, Kevin; Britton, Tom; Abenius, Johan; Andersson, Bengt; Buhl, Peter Neerup; Coulianos, Carl-Cedric; Fjellberg, Arne; Gertsson, Carl-Axel; Hellqvist, Sven; Jaschhof, Mathias; Kjaerandsen, Jostein; Klopfstein, Seraina; Kobro, Sverre; Liston, Andrew; Meier, Rudolf; Pollet, Marc; Riedel, Matthias; Rohacek, Jindrich; Schuppenhauer, Meike; Stigenberg, Julia; Struwe, Ingemar; Taeger, Andreas; Ulefors, Sven-Olof; Varga, Oleksandr; Withers, Phil; Gardenfors, Ulf			Completing Linnaeus's inventory of the Swedish insect fauna: Only 5,000 species left?	PLOS ONE			English	Article							DIVERSITY; BIODIVERSITY; HYMENOPTERA; TAXONOMY; DIPTERA	Despite more than 250 years of taxonomic research, we still have only a vague idea about the true size and composition of the faunas and floras of the planet. Many biodiversity inventories provide limited insight because they focus on a small taxonomic subsample or a tiny geographic area. Here, we report on the size and composition of the Swedish insect fauna, thought to represent roughly half of the diversity of multicellular life in one of the largest European countries. Our results are based on more than a decade of data from the Swedish Taxonomy Initiative and its massive inventory of the country's insect fauna, the Swedish Malaise Trap Project The fauna is considered one of the best known in the world, but the initiative has nevertheless revealed a surprising amount of hidden diversity: more than 3,000 new species (301 new to science) have been documented so far. Here, we use three independent methods to analyze the true size and composition of the fauna at the family or subfamily level: (1) assessments by experts who have been working on the most poorly known groups in the fauna; (2) estimates based on the proportion of new species discovered in the Malaise trap inventory; and (3) extrapolations based on species abundance and incidence data from the inventory. For the last method, we develop a new estimator, the combined non-parametric estimator, which we show is less sensitive to poor coverage of the species pool than other popular estimators. The three methods converge on similar estimates of the size and composition of the fauna, suggesting that it comprises around 33,000 species. Of those, 8,600 (26%) were unknown at the start of the inventory and 5,000 (15%) still await discovery. We analyze the taxonomic and ecological composition of the estimated fauna, and show that most of the new species belong to Hymenoptera and Diptera groups that are decomposers or parasitoids. Thus, current knowledge of the Swedish insect fauna is strongly biased taxonomically and ecologically, and we show that similar but even stronger biases have distorted our understanding of the fauna in the past. We analyze latitudinal gradients in the size and composition of known European insect faunas and show that several of the patterns contradict the Swedish data, presumably due to similar knowledge biases. Addressing these biases is critical in understanding insect biomes and the ecosystem services they provide. Our results emphasize the need to broaden the taxonomic scope of current insect monitoring efforts, a task that is all the more urgent as recent studies indicate a possible worldwide decline in insect faunas.	[Ronquist, Fredrik; Holston, Kevin] Swedish Museum Nat Hist, Dept Bioinformat & Genet, Stockholm, Sweden; [Forshage, Mattias; Haggqvist, Sibylle; Hovmolle, Rasmus; Bergsten, Johannes; Stigenberg, Julia] Swedish Museum Nat Hist, Dept Zool, Stockholm, Sweden; [Karlsson, Dave; Abenius, Johan; Andersson, Bengt; Buhl, Peter Neerup; Coulianos, Carl-Cedric; Fjellberg, Arne; Gertsson, Carl-Axel; Hellqvist, Sven; Jaschhof, Mathias; Kobro, Sverre; Struwe, Ingemar; Ulefors, Sven-Olof; Withers, Phil] Stn Linne, Olands Skogsby, Farjestaden, Sweden; [Britton, Tom] Stockholm Univ, Dept Math, Stockholm, Sweden; [Kjaerandsen, Jostein] UiT Arctic Univ Norway, Tromso Univ Museum, Tromso, Norway; [Klopfstein, Seraina] Nat Hist Museum Basel, Basel, Switzerland; [Liston, Andrew; Taeger, Andreas] Senckenberg German Entomol Inst, Muncheberg, Germany; [Meier, Rudolf] Natl Univ Singapore, Lee Kong Chian Nat Hist Museum, Singapore, Singapore; [Meier, Rudolf] Natl Univ Singapore, Dept Biol Sci, Singapore, Singapore; [Pollet, Marc] Res Inst Nat & Forest, Brussels, Belgium; [Pollet, Marc] Univ Ghent, Res Grp Terr Ecol, Ghent, Belgium; [Pollet, Marc] Royal Belgian Inst Nat Sci, Entomol Unit, Brussels, Belgium; [Riedel, Matthias] Bavarian State Collect Zool, Munich, Germany; [Rohacek, Jindrich] Silesian Museum, Dept Entomol, Opava, Czech Republic; [Schuppenhauer, Meike] Senckenberg Museum Nat Hist Gorlitz, Dept Soil Zool, Gorlitz, Germany; [Varga, Oleksandr] Natl Acad Sci Ukraine, Schmalhausen Inst Zool, Kiev, Ukraine; [Gardenfors, Ulf] Swedish Univ Agr Sci, Swedish Species Informat Ctr, Uppsala, Sweden	Swedish Museum of Natural History; Swedish Museum of Natural History; Stockholm University; UiT The Arctic University of Tromso; Senckenberg Gesellschaft fur Naturforschung (SGN); National University of Singapore; National University of Singapore; Research Institute for Nature & Forest; Ghent University; Royal Belgian Institute of Natural Sciences; Silesian Museum; Senckenberg Gesellschaft fur Naturforschung (SGN); National Academy of Sciences Ukraine; Schmalhausen Institute of Zoology of NASU; Swedish University of Agricultural Sciences	Ronquist, F (corresponding author), Swedish Museum Nat Hist, Dept Bioinformat & Genet, Stockholm, Sweden.	fredrik.ronquist@nrm.se	Varga, Oleksandr/K-7722-2019; Riedel, Matthias/ABA-2098-2021; Meier, Rudolf/AAB-3848-2021; Meier, Rudolf/A-7099-2011; Ronquist, Fredrik/Q-2013-2015	Meier, Rudolf/0000-0002-4452-2885; Meier, Rudolf/0000-0002-4452-2885; Varga, Oleksandr/0000-0002-6285-7830; Ronquist, Fredrik/0000-0002-3929-251X; Holston, Kevin/0000-0002-0786-4069	Swedish Research Council [2014-05901]; FORMAS, a Swedish research council for sustainable development [217-2004-2101]; Ministry of Culture of the Czech Republic [MK000100595]; Swedish Taxonomy Initiative	Swedish Research Council(Swedish Research CouncilEuropean Commission); FORMAS, a Swedish research council for sustainable development; Ministry of Culture of the Czech Republic; Swedish Taxonomy Initiative	FR was supported by grant 2014-05901 from the Swedish Research Council (https://vr.se), DK by grant 217-2004-2101 from FORMAS, a Swedish research council for sustainable development (https://formas.se) and JR by grant MK000100595 from the Ministry of Culture of the Czech Republic (https://mkcr.cz).The Swedish Taxonomy Initiative (https://www.artdatabanken.se/en/the-swedish-taxonomy-initiative) funded the Malaise trap inventory and many of the taxonomic research projects contributing to the charting of the Swedish insect fauna since 2003. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Basset Y, 2012, SCIENCE, V338, P1481, DOI 10.1126/science.1226727; Borkent A, 2018, ZOOTAXA, V4402, P53, DOI 10.11646/zootaxa.4402.1.3; Cardoso P, 2015, METHODS ECOL EVOL, V6, P232, DOI 10.1111/2041-210X.12310; CHAO A, 1984, SCAND J STAT, V11, P265; CHAO A, 1987, BIOMETRICS, V43, P783, DOI 10.2307/2531532; Chao A, 2012, ECOLOGY, V93, P2533, DOI 10.1890/11-1952.1; Chapman DG, 1951, SOME PROPERTIES HYPE, V1; COLWELL RK, 1994, PHILOS T R SOC B, V345, P101, DOI 10.1098/rstb.1994.0091; de Jong Yde, 2014, Biodivers Data J, pe4034, DOI 10.3897/BDJ.2.e4034; Fontaine B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036881; Forbes AA, 2018, BMC ECOL, V18, DOI 10.1186/s12898-018-0176-x; Gardenfors U, 2003, DJUR SVAMPAR VAXTER; GAULD ID, 1987, BIOL J LINN SOC, V30, P299, DOI 10.1111/j.1095-8312.1987.tb00304.x; Goulet H, 1993, HYMENOPTERA WORLD ID; Haggqvist S, 2015, ZOOKEYS, P89, DOI 10.3897/zookeys.512.9494; Hallmann CA, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185809; Hamilton AJ, 2010, AM NAT, V176, P90, DOI 10.1086/652998; Hausmann A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084518; Hebert PDN, 2018, BMC GENOMICS, V19, DOI 10.1186/s12864-018-4611-3; Hebert PDN, 2016, PHILOS T R SOC B, V371, DOI 10.1098/rstb.2015.0333; Hendrich L, 2015, MOL ECOL RESOUR, V15, P795, DOI 10.1111/1755-0998.12354; JANZEN DH, 1981, ECOLOGY, V62, P532, DOI 10.2307/1937717; Jaschhof M., 2017, STUDIA DIPTEROLOGICA, V23, P51; Jones OR, 2012, ECOGRAPHY, V35, P333, DOI 10.1111/j.1600-0587.2011.06956.x; Karlsson D, BIODIVERSITY DATA J; Karlsson Dave, 2005, Entomologisk Tidskrift, V126, P43; Kjaerandsen J, 2017, GENOME, V60, P74, DOI [10.1139/gen-2015-0179, DOI 10.1139/GEN-2015-0179]; Landin B-O., 1970, FALTFAUNA INSEKTER 2, P1; Landin B-O., 1971, FALTFAUNA 2 2, P381; Landin B-O., 1967, FALTFAUNA INSEKTER 1; Langor DW, 2019, ZOOKEYS, P9, DOI 10.3897/zookeys.819.31947; Linnaeus C., 1761, FAUNA SVECICA; Lister B, 2019, P NATL ACAD SCI USA, V116, P12145, DOI 10.1073/pnas.1904582116; Lister BC, 2018, P NATL ACAD SCI USA, V115, pE10397, DOI 10.1073/pnas.1722477115; MAGURRAN A. E., 2004, MEASURING BIOLOGICAL; Marquina D, 2019, MOL ECOL RESOUR, V19, P1516, DOI 10.1111/1755-0998.13071; Meier R, 2016, CLADISTICS, V32, P100, DOI 10.1111/cla.12115; Miller G, 2005, SCIENCE, V307, P1038; Mora C, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000606; Moriniere J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155497; Novotny V, 2002, NATURE, V416, P841, DOI 10.1038/416841a; NOYES JS, 1989, ECOL ENTOMOL, V14, P197, DOI 10.1111/j.1365-2311.1989.tb00770.x; Oksanen J., 2020, VEGAN COMMUNITY ECOL; Oosterbroek P., 2006, EUROPEAN FAMILIES DI; Pentinsaari M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108651; Quicke DLJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032101; R Core Team, 2021, R LANGUAGE ENV STAT; Rodriguez JJ, 2013, INSECT CONSERV DIVER, V6, P530, DOI 10.1111/icad.12003; Ronquist F, 2003, TRENDS ECOL EVOL, V18, P269, DOI 10.1016/S0169-5347(03)00098-3; Schmidt S, 2015, MOL ECOL RESOUR, V15, P985, DOI 10.1111/1755-0998.12363; Seber G.A.F., 1982, P1; Seibold S, 2019, NATURE, V574, P671, DOI 10.1038/s41586-019-1684-3; Lopez LCS, 2012, ECOL INDIC, V14, P164, DOI 10.1016/j.ecolind.2011.07.012; Southwood TRE, 2000, ECOLOGICAL METHODS; Srivathsan A, 2019, BMC BIOL, V17, DOI 10.1186/s12915-019-0706-9; Srivathsan A, 2018, MOL ECOL RESOUR, V18, P1035, DOI 10.1111/1755-0998.12890; Stigenberg J, 2011, ZOOTAXA, P1; Stork NE, 2015, P NATL ACAD SCI USA, V112, P7519, DOI 10.1073/pnas.1502408112; TOWNES H, 1972, Entomological News, V83, P239; Troudet J, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09084-6; Tullgren A, 1922, SVENSKA INSEKTER ORI; Veijalainen A, 2012, P ROY SOC B-BIOL SCI, V279, P4694, DOI 10.1098/rspb.2012.1664; Wang WY, 2018, MOL ECOL RESOUR, V18, P490, DOI 10.1111/1755-0998.12751; Willig MR, 2019, P NATL ACAD SCI USA, V116, P12143, DOI 10.1073/pnas.1820456116; Wirta H, 2016, MOL ECOL RESOUR, V16, P809, DOI 10.1111/1755-0998.12489	65	16	22	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2020	15	3							e0228561	10.1371/journal.pone.0228561	http://dx.doi.org/10.1371/journal.pone.0228561			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8QU	32130216	Green Published, gold			2022-12-26	WOS:000535264000008
J	Marconi, KP; Bharathi, B; Venis, AM; Raj, R; Amirtham, SM; Subramani, S				Marconi, Kawin Padmaja; Bharathi, Bhavithra; Venis, Alen Major; Raj, Renu; Amirtham, Soosai Manickam; Subramani, Sathya			Phenylephrine induces relaxation of longitudinal strips from small arteries of goat legs	PLOS ONE			English	Article							MUSCLE; PHOSPHATASE; ARGININE; PROTEIN	Alpha adrenergic stimulation is known to produce vasoconstriction. We have earlier shown that, in spiral strips of small arteries Phenylephrine (PE) caused vasorelaxation under high nitric oxide (NO) environment. However, on further experimentation it was realized that the PE-induced vasorelaxant response occurred only with longitudinal strips of small arteries even under normal NO environment while circular strips showed contraction with PE even under high NO environment. Such PE-induced vasorelaxation of longitudinal strips was blocked by Phentolamine, an alpha-adrenergic receptor blocker. On delineation of specific receptor subtype, PE-induced relaxation was found to be mediated through alpha 1D receptor. However, this phenomenon is specific to small artery, as longitudinal smooth muscle of aorta showed only contractile response to adrenergic stimulation. There is no prior report of longitudinal smooth muscle in small artery up to our knowledge. The results of this study and histological examination of vessel sections suggest the presence of longitudinal smooth muscle in small artery and their relaxant response to alpha adrenergic stimulation is a novel phenomenon.	[Marconi, Kawin Padmaja; Bharathi, Bhavithra; Venis, Alen Major; Raj, Renu; Amirtham, Soosai Manickam; Subramani, Sathya] Christian Med Coll & Hosp, Dept Physiol, Vellore, Tamil Nadu, India; [Bharathi, Bhavithra] Jawaharlal Inst Postgrad Med Educ & Res, Dept Physiol, Pondicherry, India; [Venis, Alen Major] Govt Primary Hlth Ctr, Kanyakumari, Tamil Nadu, India; [Raj, Renu] PK Das Inst Med Sci, Dept Physiol, Palakkad, Kerala, India	Christian Medical College & Hospital (CMCH) Vellore; Jawaharlal Institute of Postgraduate Medical Education & Research	Subramani, S (corresponding author), Christian Med Coll & Hosp, Dept Physiol, Vellore, Tamil Nadu, India.	sathya@cmcvellore.ac.in	RAJ, RENU/AAH-7456-2021	Subramani, Sathya/0000-0002-4415-6774; Venis, Alen Major/0000-0002-0609-0452	Christian Medical College, Vellore [10959]	Christian Medical College, Vellore	KPM and SS received an institutional grant (IRB No.10959 dated 07.11.2017). Name of institution: Christian Medical College, Vellore. https://www.cmch-vellore.edu/.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Basu S, 2016, J BIOL CHEM, V291, P2988, DOI 10.1074/jbc.M115.679803; Cleary L., 2005, Autonomic & Autacoid Pharmacology, V25, P135, DOI 10.1111/j.1474-8673.2005.00342.x; COHEN ML, 1977, AM J PHYSIOL, V232, pH131, DOI 10.1152/ajpheart.1977.232.2.H131; Davis MJ, 2011, LOCAL REGULATION MIC, P161; EXTON JH, 1985, AM J PHYSIOL, V248, pE633, DOI 10.1152/ajpendo.1985.248.6.E633; Grassie ME, 2011, ARCH BIOCHEM BIOPHYS, V510, P147, DOI 10.1016/j.abb.2011.01.018; GUO TZ, 1991, ANESTHESIOLOGY, V75, P252, DOI 10.1097/00000542-199108000-00013; INSEL PA, 1989, AM J MED, V87, pS12, DOI 10.1016/0002-9343(89)90108-3; Kim JI, 2012, AM J PHYSIOL-CELL PH, V303, pC58, DOI 10.1152/ajpcell.00118.2012; KIOWSKI W, 1981, CLIN SCI, V60, P483, DOI 10.1042/cs0600483; Liu Y, 2018, MICROCIRCULATION, V25, DOI 10.1111/micc.12465; MOLINOFF PB, 1984, DRUGS, V28, P1, DOI 10.2165/00003495-198400282-00002; Perez DM, 2005, ADRENERGIC RECEPTORS, P416; Raj RR, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158551; SAKUMA I, 1988, P NATL ACAD SCI USA, V85, P8664, DOI 10.1073/pnas.85.22.8664; Strosberg A D, 1998, Adv Pharmacol, V42, P511; TARRY WC, 1994, ARTERIOSCLER THROMB, V14, P938, DOI 10.1161/01.ATV.14.6.938; TENNANT M, 1990, AUST NZ J SURG, V60, P747, DOI 10.1111/j.1445-2197.1990.tb07468.x; Tykocki NR, 2017, COMPR PHYSIOL, V7, P485, DOI 10.1002/cphy.c160011; VANBRUMMELEN P, 1986, BRIT J CLIN PHARMACO, V21, pS33	20	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2020	15	3							e0227316	10.1371/journal.pone.0227316	http://dx.doi.org/10.1371/journal.pone.0227316			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8MS	32126062	gold, Green Submitted, Green Published			2022-12-26	WOS:000535253100008
J	Vidiri, A; Gangemi, E; Ruberto, E; Pasqualoni, R; Sciuto, R; Sanguineti, G; Farneti, A; Benevolo, M; Rollo, F; Sperati, F; Spasiano, F; Pellini, R; Marzi, S				Vidiri, Antonello; Gangemi, Emma; Ruberto, Emanuela; Pasqualoni, Rosella; Sciuto, Rosa; Sanguineti, Giuseppe; Farneti, Alessia; Benevolo, Maria; Rollo, Francesca; Sperati, Francesca; Spasiano, Filomena; Pellini, Raul; Marzi, Simona			Correlation between histogram-based DCE-MRI parameters and F-18-FDG PET values in oropharyngeal squamous cell carcinoma: Evaluation in primary tumors and metastatic nodes	PLOS ONE			English	Article							IMAGING PARAMETERS; RISK HPV; HEAD; CANCER; EXPRESSION; BIOMARKER	Objectives To investigate the correlation between histogram-based Dynamic Contrast-Enhanced magnetic resonance imaging (DCE-MRI) parameters and positron emission tomography with F-18-fluorodeoxyglucose (F-18-FDG-PET) values in oropharyngeal squamous cell carcinoma (OPSCC), both in primary tumors (PTs) and in metastatic lymph nodes (LNs). Methods 52 patients with a new pathologically-confirmed OPSCC were included in the present retrospective cohort study. Imaging including DCE-MRI and F-18-FDG PET/CT scans were acquired in all patients. Both PTs and the largest LN, if present, were volumetrically contoured. Quantitative parameters, including the transfer constants, K-trans and K-ep, and the volume of extravascular extracellular space, v(e), were calculated from DCE-MRI. The percentiles (P), P10, P25, P50, P75, P90, and skewness, kurtosis and entropy were obtained from the histogram-based analysis of each perfusion parameter. Standardized uptake values (SUV), SUVmax, SUVpeak, SUVmean, metabolic tumor volume (MTV) and total lesion glycolysis (TLG) were calculated applying a SUV threshold of 40%. The correlations between all variables were investigated with the Spearman-rank correlation test. To exclude false positive results under multiple testing, the Benjamini-Hockberg procedure was applied. Results No significant correlations were found between any parameters in PTs, while significant associations emerged between K-trans and F-18-FDG PET parameters in LNs. Conclusions Evident relationships emerged between DCE-MRI and F-18-FDG PET parameters in OPSCC LNs, while no association was found in PTs. The complex relationships between perfusion and metabolic biomarkers should be interpreted separately for primary tumors and lymph-nodes. A multiparametric approach to analyze PTs and LNs before treatment is advisable in head and neck squamous cell carcinoma (HNSCC).	[Vidiri, Antonello; Gangemi, Emma; Ruberto, Emanuela] IRCCS Regina Elena Natl Canc Inst, Radiol & Diagnost Imaging Dept, Rome, Italy; [Gangemi, Emma] Univ Campus Biomed Rome, Ctr Integrated Res, Dept Fac Med & Surg, Rome, Italy; [Pasqualoni, Rosella; Sciuto, Rosa] IRCCS Regina Elena Natl Canc Inst, Dept Nucl Med, Rome, Italy; [Sanguineti, Giuseppe; Farneti, Alessia; Spasiano, Filomena] IRCCS Regina Elena Natl Canc Inst, Dept Radiotherapy, Rome, Italy; [Benevolo, Maria; Rollo, Francesca] IRCCS Regina Elena Natl Canc Inst, Dept Pathol, Rome, Italy; [Sperati, Francesca] IRCCS Regina Elena Natl Canc Inst, Biostat Sci Direct, Rome, Italy; [Pellini, Raul] IRCCS Regina Elena Natl Canc Inst, Dept Otolaryngol & Head & Neck Surg, Rome, Italy; [Marzi, Simona] IRCCS Regina Elena Natl Canc Inst, Med Phys Lab, Rome, Italy	University Campus Bio-Medico - Rome Italy	Gangemi, E (corresponding author), IRCCS Regina Elena Natl Canc Inst, Radiol & Diagnost Imaging Dept, Rome, Italy.; Gangemi, E (corresponding author), Univ Campus Biomed Rome, Ctr Integrated Res, Dept Fac Med & Surg, Rome, Italy.	emma_gan86@yahoo.it	Rollo, Francesca/I-5249-2018; Sperati, Francesca/K-5843-2016; Rollo, Francesca/AAC-2775-2021; pellini, raul/ABH-6664-2020; Benevolo, Maria/J-8491-2018; Vidiri, Antonello/AAB-3370-2021; Marzi, Simona/B-9346-2017	Rollo, Francesca/0000-0003-2724-872X; Sperati, Francesca/0000-0002-6038-2798; Rollo, Francesca/0000-0003-2724-872X; pellini, raul/0000-0001-6051-3041; Benevolo, Maria/0000-0003-1994-0935; Vidiri, Antonello/0000-0001-6203-4642; Marzi, Simona/0000-0002-9845-4400; Gangemi, Emma/0000-0003-1041-2888	Italian Association for Cancer Research (AIRC) [17028]	Italian Association for Cancer Research (AIRC)(Fondazione AIRC per la ricerca sul cancro)	This work was supported by the Italian Association for Cancer Research (AIRC, project No.17028).	Abraham J, 2015, SURG ONCOL CLIN N AM, V24, P455, DOI 10.1016/j.soc.2015.03.012; Bekaert L, 2017, EUR J NUCL MED MOL I, V44, P1383, DOI 10.1007/s00259-017-3677-5; Bisdas S, 2010, EUR RADIOL, V20, P2358, DOI 10.1007/s00330-010-1803-x; Bonomo P, 2018, EUR J NUCL MED MOL I, V45, P2122, DOI 10.1007/s00259-018-4065-5; Cacicedo J, 2016, BRIT J RADIOL, V89, DOI 10.1259/bjr.20160217; Cao Y, 2019, FRONT ONCOL, V9, DOI 10.3389/fonc.2019.01118; Chotchutipan T, 2019, HEAD NECK-J SCI SPEC, V41, P366, DOI 10.1002/hed.25505; Covello M, 2015, EUR J RADIOL, V84, P1269, DOI 10.1016/j.ejrad.2015.04.010; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Fischbein NJ, 2003, AM J NEURORADIOL, V24, P301; Gawlitza M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134749; Gong L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075094; Han M, 2018, CLIN RADIOL, V73; Han M, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000002141; Incoronato M, 2018, EUR J NUCL MED MOL I, V45, P1680, DOI 10.1007/s00259-018-4010-7; Jacob R, 2001, ORL J OTO-RHINO-LARY, V63, P307, DOI 10.1159/000055764; Jansen JFA, 2016, MAGN RESON IMAGING C, V24, P123, DOI 10.1016/j.mric.2015.08.011; Jansen JFA, 2012, INT J RADIAT ONCOL, V82, P299, DOI 10.1016/j.ijrobp.2010.11.022; Jansen JFA, 2010, INT J RADIAT ONCOL, V77, P1403, DOI 10.1016/j.ijrobp.2009.07.009; Joo YH, 2014, HEAD NECK-J SCI SPEC, V36, P323, DOI 10.1002/hed.23296; Khalid MB, 2019, LARYNGOSCOPE, V129, P877, DOI 10.1002/lary.27296; Kim SG, 2016, AM J ROENTGENOL, V207, P248, DOI 10.2214/AJR.16.16265; Kroenke M, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0213111; Lee N, 2016, INT J RADIAT ONCOL, V96, P9, DOI 10.1016/j.ijrobp.2016.04.027; Leifels L, 2017, CONTRAST MEDIA MOL I, DOI 10.1155/2017/5369625; Marcu LG, 2016, CRIT REV ONCOL HEMAT, V103, P27, DOI 10.1016/j.critrevonc.2016.05.002; Mena M, 2018, ORAL ONCOL, V78, P137, DOI 10.1016/j.oraloncology.2018.01.010; Meyer HJ, 2019, CONTRAST MEDIA MOL I, DOI 10.1155/2019/5081909; Meyer HJ, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0202897; Norikane T, 2014, NUCL MED COMMUN, V35, P30, DOI 10.1097/MNM.0000000000000010; O'Sullivan B, 2017, AM JOINT COMMITTEE C; Rasmussen GB, 2015, ACTA ONCOL, V54, P1408, DOI 10.3109/0284186X.2015.1062539; Schouten CS, 2016, HEAD NECK-J SCI SPEC, V38, P529, DOI 10.1002/hed.23920; Shen GH, 2017, NUCL MED COMMUN, V38, P1076, DOI 10.1097/MNM.0000000000000746; Solomon MC, 2016, MED ONCOL, V33, DOI 10.1007/s12032-016-0851-8; Surov A, 2019, CANCERS, V11, DOI 10.3390/cancers11040543; Surov A, 2019, TRANSL ONCOL, V12, P8, DOI 10.1016/j.tranon.2018.08.018; Surov A, 2018, TRANSL ONCOL, V11, P498, DOI 10.1016/j.tranon.2018.02.004; Surov A, 2018, ANTICANCER RES, V38, P1637, DOI 10.21873/anticanres.12395; Surov A, 2017, TRANSL ONCOL, V10, P17, DOI 10.1016/j.tranon.2016.10.001; Swartz JE, 2015, CANCER MED-US, V4, P1101, DOI 10.1002/cam4.460; Szafarowski T, 2018, EUR ARCH OTO-RHINO-L, V275, P1845, DOI 10.1007/s00405-018-4996-2; Tahari AK, 2014, CLIN NUCL MED, V39, P225, DOI 10.1097/RLU.0000000000000255; Teng FF, 2018, INT J RADIAT ONCOL, V102, P969, DOI 10.1016/j.ijrobp.2017.12.269; Tofts PS, 1999, J MAGN RESON IMAGING, V10, P223, DOI 10.1002/(SICI)1522-2586(199909)10:3<223::AID-JMRI2>3.0.CO;2-S; Zheng HN, 2019, CLIN LUNG CANCER, V20, P420, DOI 10.1016/j.cllc.2019.04.002	46	3	4	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2020	15	3							e0229611	10.1371/journal.pone.0229611	http://dx.doi.org/10.1371/journal.pone.0229611			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8JT	32119697	Green Published, gold			2022-12-26	WOS:000535245300031
J	Okamoto, K; Koda, M; Okamoto, T; Onoyama, T; Miyoshi, K; Kishina, M; Matono, T; Kato, J; Tokunaga, S; Sugihara, T; Hiramatsu, A; Hyogo, H; Tobita, H; Sato, S; Kawanaka, M; Hara, Y; Hino, K; Chayama, K; Murawaki, Y; Isomoto, H				Okamoto, Kinya; Koda, Masahiko; Okamoto, Toshiaki; Onoyama, Takumi; Miyoshi, Kenichi; Kishina, Manabu; Matono, Tomomitsu; Kato, Jun; Tokunaga, Shiho; Sugihara, Takaaki; Hiramatsu, Akira; Hyogo, Hideyuki; Tobita, Hiroshi; Sato, Shuichi; Kawanaka, Miwa; Hara, Yuichi; Hino, Keisuke; Chayama, Kazuaki; Murawaki, Yoshikazu; Isomoto, Hajime			Serum miR-379 expression is related to the development and progression of hypercholesterolemia in non-alcoholic fatty liver disease	PLOS ONE			English	Article							ALKALINE-PHOSPHATASE; FREE-CHOLESTEROL; OXIDATIVE STRESS; GROWTH-FACTOR; INSULIN-RESISTANCE; BILE-ACID; STEATOHEPATITIS; FIBROSIS; NAFLD; PATHOGENESIS	Introduction Non-alcoholic fatty liver disease (NAFLD) has a wide spectrum, eventually leading to cirrhosis and hepatic carcinogenesis. We previously reported that a series of microRNAs (miRNAs) mapped in the 14q32.2 maternally imprinted gene region (Dlk1-Dio3 mat) are related to NAFLD development and progression in a mouse model. We examined the suitability of miR-379, a circulating Dlk1-Dio3 mat miRNA, as a human NAFLD biomarker. Methods Eighty NAFLD patients were recruited for this study. miR-379 was selected from the putative Dlk1-Dio3 mat miRNA cluster because it exhibited the greatest expression difference between NAFLD and non-alcoholic steatohepatitis in our preliminary study. Real-time PCR was used to examine the expression levels of miR-379 and miR-16 as an internal control. One patient was excluded due to low RT-PCR signal. Results Compared to normal controls, serum miR-379 expression was significantly up-regulated in NAFLD patients. Receiver operating characteristic curve analysis suggested that miR-379 is a suitable marker for discriminating NAFLD patients from controls, with an area under the curve value of 0.72. Serum miR-379 exhibited positive correlations with alkaline phosphatase, total cholesterol, low-density-lipoprotein cholesterol and non-high-density-lipoprotein cholesterol levels in patients with early stage NAFLD (Brunt fibrosis stage 0 to 1). The correlation between serum miR-379 and cholesterol levels was lost in early stage NAFLD patients treated with statins. Software-based predictions indicated that various energy metabolism-related genes, including insulin-like growth factor-1 (IGF-1) and IGF-1 receptor, are potential targets of miR-379. Conclusions Serum miR-379 exhibits high potential as a biomarker for NAFLD. miR-379 appears to increase cholesterol lipotoxicity, leading to the development and progression of NAFLD, via interference with the expression of target genes, including those related to the IGF-1 signaling pathway. Our results could facilitate future research into the pathogenesis, diagnosis, and treatment of NAFLD.	[Okamoto, Kinya; Koda, Masahiko; Okamoto, Toshiaki; Onoyama, Takumi; Miyoshi, Kenichi; Kishina, Manabu; Matono, Tomomitsu; Kato, Jun; Tokunaga, Shiho; Sugihara, Takaaki; Murawaki, Yoshikazu; Isomoto, Hajime] Tottori Univ, Dept Internal Med 2, Sch Med, Yonago, Tottori, Japan; [Hiramatsu, Akira; Chayama, Kazuaki] Hiroshima Univ, Grad Sch Biomed & Hlth Sci, Dept Gastroenterol & Metab, Hiroshima, Hiroshima, Japan; [Hyogo, Hideyuki] JA Hiroshima Gen Hosp, Dept Gastroenterol & Hepatol, Hiroshima, Japan; [Tobita, Hiroshi; Sato, Shuichi] Shimane Univ, Dept Gastroenterol & Hepatol, Sch Med, Izumo, Shimane, Japan; [Kawanaka, Miwa] Kawasaki Med Sch, Gen Med Ctr, Dept Gen Internal Med 2, Okayama, Okayama, Japan; [Hara, Yuichi; Hino, Keisuke] Kawasaki Med Sch, Dept Hepatol & Pancreatol, Kurashiki, Okayama, Japan	Tottori University; Hiroshima University; Shimane University; Kawasaki Medical School; Kawasaki Medical School	Okamoto, K (corresponding author), Tottori Univ, Dept Internal Med 2, Sch Med, Yonago, Tottori, Japan.	kinya.okamoto@kje.biglobe.ne.jp		Okamoto, Kinya/0000-0001-9087-8965; Chayama, Kazuaki/0000-0002-5530-5341	Japan Society for the Promotion of Science [26461005]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	Initials of the authors who received award: MK Grant number: 26461005 The full name of funder: A grant-in-aid for scientific research category C from the Japan Society for the Promotion of Science URL of funder: websitehttp://www.jsps.go.jp/english/e-grants/index.html Did the sponsors or funders play any role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript?: NO	Abderrahmani A, 2018, DIABETES, V67, P1310, DOI 10.2337/db17-1539; Adamek A, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19051308; Adams LA, 2005, GASTROENTEROLOGY, V129, P113, DOI 10.1053/j.gastro.2005.04.014; Alisi A, 2011, LAB INVEST, V91, P283, DOI 10.1038/labinvest.2010.166; Angulo P, 2007, HEPATOLOGY, V45, P846, DOI 10.1002/hep.21496; Angulo P, 2015, GASTROENTEROLOGY, V149, P389, DOI 10.1053/j.gastro.2015.04.043; Anstee QM, 2013, NAT REV GASTRO HEPAT, V10, P330, DOI 10.1038/nrgastro.2013.41; Arturi F, 2011, J CLIN ENDOCR METAB, V96, pE1640, DOI 10.1210/jc.2011-1227; Asaga S, 2011, CLIN CHEM, V57, P84, DOI 10.1373/clinchem.2010.151845; Ballestri S, 2017, ADV THER, V34, P1291, DOI 10.1007/s12325-017-0556-1; Barshop NJ, 2008, ALIMENT PHARM THER, V28, P13, DOI 10.1111/j.1365-2036.2008.03703.x; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Basaranoglu M, 2013, WORLD J GASTROENTERO, V19, P1166, DOI 10.3748/wjg.v19.i8.1166; BEG ZH, 1985, J BIOL CHEM, V260, P1682; Begriche K, 2013, HEPATOLOGY, V58, P1497, DOI 10.1002/hep.26226; Brunt EM, 1999, AM J GASTROENTEROL, V94, P2467, DOI 10.1111/j.1572-0241.1999.01377.x; Caballero F, 2009, J HEPATOL, V50, P789, DOI 10.1016/j.jhep.2008.12.016; Chartoumpekis DV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034872; Chen JS, 2016, CANCER LETT, V375, P73, DOI 10.1016/j.canlet.2016.02.043; Chen P, 2018, HEPATOL INT, V12, P26, DOI 10.1007/s12072-017-9841-y; Chen X, 2008, CELL RES, V18, P997, DOI 10.1038/cr.2008.282; Cheung O, 2008, HEPATOLOGY, V48, P1810, DOI 10.1002/hep.22569; Cicognani C, 1997, ARCH INTERN MED, V157, P792, DOI 10.1001/archinte.157.7.792; Cintra DE, 2008, J HEPATOL, V48, P628, DOI 10.1016/j.jhep.2007.12.017; Colak Y, 2012, DIS MARKERS, V33, P77, DOI [10.1155/2012/283726, 10.3233/DMA-2012-0907]; Csiszar A, 2008, AM J PHYSIOL-HEART C, V295, pH1882, DOI 10.1152/ajpheart.412.2008; Da Rocha ST, 2008, TRENDS GENET, V24, P306, DOI 10.1016/j.tig.2008.03.011; Dai RJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153509; de Guia RM, 2015, EMBO J, V34, P344, DOI 10.15252/embj.201490464; Dongiovanni P, 2015, J HEPATOL, V63, P705, DOI 10.1016/j.jhep.2015.05.006; Ekstedt M, 2015, HEPATOLOGY, V61, P1547, DOI 10.1002/hep.27368; Eslami L, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008623.pub2; Gan LT, 2014, J HEPATOL, V61, P1376, DOI 10.1016/j.jhep.2014.07.024; Garcia D, 2019, CELL REP, V26, P192, DOI 10.1016/j.celrep.2018.12.036; Garcia-Galiano D, 2007, OBES SURG, V17, P493, DOI 10.1007/s11695-007-9087-1; Gentric G, 2015, J CLIN INVEST, V125, P981, DOI 10.1172/JCI73957; Go GW, 2014, CELL METAB, V19, P209, DOI 10.1016/j.cmet.2013.11.023; Gregory RI, 2005, CELL, V123, P631, DOI 10.1016/j.cell.2005.10.022; Hamaguchi M, 2005, ANN INTERN MED, V143, P722, DOI 10.7326/0003-4819-143-10-200511150-00009; HARDIE DG, 1992, BIOCHIM BIOPHYS ACTA, V1123, P231, DOI 10.1016/0005-2760(92)90001-C; Hardy T, 2017, GUT, V66, P1321, DOI 10.1136/gutjnl-2016-311526; HATOFF DE, 1982, HEPATOLOGY, V2, P433; Hauff P, 2015, EXPERT OPIN INV DRUG, V24, P309, DOI 10.1517/13543784.2015.997874; Huang DJ, 2016, EUR REV MED PHARMACO, V20, P5098; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Ichikawa T, 2007, HEPATOL INT, V1, P287, DOI 10.1007/s12072-007-9007-4; Jegatheesan P, 2017, NUTRIENTS, V9, DOI 10.3390/nu9030230; KAPLAN MM, 1972, GASTROENTEROLOGY, V62, P452; KIM KH, 1983, CURR TOP CELL REGUL, V22, P143; Kocabay G, 2011, BRATISL MED J, V112, P626; Kolodziejczyk AA, 2019, EMBO MOL MED, V11, DOI 10.15252/emmm.201809302; Kosone T, 2007, AM J PHYSIOL-GASTR L, V293, pG204, DOI 10.1152/ajpgi.00021.2007; Kumar A, 2013, J CLIN EXP HEPATOL, V3, P12, DOI 10.1016/j.jceh.2012.10.009; Kung CP, 2016, CELL REP, V14, P2413, DOI 10.1016/j.celrep.2016.02.037; Kuo TR, 2017, BIOMARK RES, V5, DOI 10.1186/s40364-017-0097-4; Lagos-Quintana M, 2001, SCIENCE, V294, P853, DOI 10.1126/science.1064921; Lam CSP, 2010, ARTERIOSCL THROM VAS, V30, P1479, DOI 10.1161/ATVBAHA.110.203943; Leclercq IA, 2000, J CLIN INVEST, V105, P1067, DOI 10.1172/JCI8814; Leroux A, 2012, J HEPATOL, V57, P141, DOI 10.1016/j.jhep.2012.02.028; Li K, 2017, YONSEI MED J, V58, P234, DOI 10.3349/ymj.2017.58.1.234; Li YZ, 2017, HEPATOL RES, V47, P186, DOI 10.1111/hepr.12787; Liang Y, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-166; Liu WJ, 2019, GENOME BIOL, V20, DOI 10.1186/s13059-019-1629-z; Liu Y, 2017, BIOMED RES INT, V2017, DOI 10.1155/2017/8234507; Mari M, 2006, CELL METAB, V4, P185, DOI 10.1016/j.cmet.2006.07.006; Matsubara T, 2012, J LIPID RES, V53, P2698, DOI 10.1194/jlr.M031773; Matsuda Satoru, 2013, ISRN Endocrinol, V2013, P472432, DOI 10.1155/2013/472432; Min HK, 2012, CELL METAB, V15, P665, DOI 10.1016/j.cmet.2012.04.004; Mitter D, 2006, AM J MED GENET A, V140A, P2039, DOI 10.1002/ajmg.a.31414; Miura K, 2014, WORLD J GASTROENTERO, V20, P7381, DOI 10.3748/wjg.v20.i23.7381; Molitch ME, 2011, J CLIN ENDOCR METAB, V96, P1587, DOI 10.1210/jc.2011-0179; Musso G, 2009, AM J CLIN NUTR, V89, P558, DOI 10.3945/ajcn.2008.26720; Ng EKO, 2009, GUT, V58, P1375, DOI 10.1136/gut.2008.167817; Nishizawa H, 2016, SCI REP-UK, V6, DOI 10.1038/srep34605; Nishizawa H, 2012, BIOCHEM BIOPH RES CO, V423, P295, DOI 10.1016/j.bbrc.2012.05.115; Oh KJ, 2013, BMB REP, V46, P567, DOI 10.5483/BMBRep.2013.46.12.248; Okamoto K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154676; Ouyang X, 2008, J HEPATOL, V48, P993, DOI 10.1016/j.jhep.2008.02.011; Pan X, 2017, SCI REP-UK, V7, DOI 10.1038/srep44597; Panasiuk A, 2006, WORLD J GASTROENTERO, V12, P6198, DOI 10.3748/wjg.v12.i38.6198; Pantsari MW, 2006, J CLIN GASTROENTEROL, V40, P633, DOI 10.1097/00004836-200608000-00015; Pearce SG, 2013, BIOMARK RES, V1, DOI 10.1186/2050-7771-1-7; Pogribny IP, 2010, LAB INVEST, V90, P1437, DOI 10.1038/labinvest.2010.113; Poupon R, 2015, HEPATOLOGY, V61, P2080, DOI 10.1002/hep.27715; Qin G, 2018, J DIGEST DIS, V19, P301, DOI 10.1111/1751-2980.12599; Romeo S, 2008, NAT GENET, V40, P1461, DOI 10.1038/ng.257; Saito Y, 2006, CANCER CELL, V9, P435, DOI 10.1016/j.ccr.2006.04.020; Sanyal Arun J, 2011, Hepatology, V54, P344, DOI 10.1002/hep.24376; Shi X, 2018, ONCOL RES, V26, P987, DOI 10.3727/096504017X15140534417184; Simonen P, 2011, J HEPATOL, V54, P153, DOI 10.1016/j.jhep.2010.05.037; Song Z, 2007, AM J PHYSIOL-GASTR L, V293, pG894, DOI 10.1152/ajpgi.00133.2007; Stancu C, 2001, J CELL MOL MED, V5, P378, DOI 10.1111/j.1582-4934.2001.tb00172.x; Stojsavljevic S, 2014, WORLD J GASTROENTERO, V20, P18070, DOI 10.3748/wjg.v20.i48.18070; Sumida Y, 2018, J GASTROENTEROL, V53, P362, DOI 10.1007/s00535-017-1415-1; Sydor S, 2017, MOL METAB, V6, P416, DOI 10.1016/j.molmet.2017.03.002; Szabo G, 2013, NAT REV GASTRO HEPAT, V10, P542, DOI 10.1038/nrgastro.2013.87; Takada S, 2002, HUM MOL GENET, V11, P77, DOI 10.1093/hmg/11.1.77; Teratani T, 2012, GASTROENTEROLOGY, V142, P152, DOI 10.1053/j.gastro.2011.09.049; Thery C, 2002, NAT REV IMMUNOL, V2, P569, DOI 10.1038/nri855; Tilg H, 2010, HEPATOLOGY, V52, P1836, DOI 10.1002/hep.24001; Tomizawa M, 2014, BIOMED REP, V2, P633, DOI [10.3892/br.2014.309, 10.3892/br.2015.487]; Turan S, 2011, J CLIN RES PEDIATR E, V3, P7, DOI 10.4274/jcrpe.v3i1.02; UEASILAMONGKOL P, 2019, HEPATOLOGY, P10925, DOI DOI 10.1002/HEP.29588; Wang C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103071; Wang HL, 2017, BIOMED RES INT, V2017, DOI 10.1155/2017/2503847; Wei YR, 2006, AM J PHYSIOL-ENDOC M, V291, pE275, DOI 10.1152/ajpendo.00644.2005; Willner IR, 2001, AM J GASTROENTEROL, V96, P2957; Wu DY, 2017, ONCOL REP, V37, P3502, DOI 10.3892/or.2017.5607; Wu H, 2017, J HEPATOL, V66, P816, DOI 10.1016/j.jhep.2016.12.016; Xie X, 2017, BIOSCIENCE REP, V37, DOI 10.1042/BSR20160542; Xu MZ, 2017, INT J ONCOL, V51, P867, DOI 10.3892/ijo.2017.4072; Yang M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131664; Younossi Z, 2018, NAT REV GASTRO HEPAT, V15, P11, DOI 10.1038/nrgastro.2017.109; Younossi ZM, 2016, HEPATOLOGY, V64, P73, DOI 10.1002/hep.28431; Zaki SM, 2019, FOLIA MORPHOL, V78, P124, DOI 10.5603/FM.a2018.0063; Zhang J, 2015, GENOM PROTEOM BIOINF, V13, P17, DOI 10.1016/j.gpb.2015.02.001; Zhao XJ, 2018, EXP THER MED, V16, P1232, DOI 10.3892/etm.2018.6302	117	13	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2020	15	2							e0219412	10.1371/journal.pone.0219412	http://dx.doi.org/10.1371/journal.pone.0219412			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8GQ	32106257	Green Published, Green Submitted, gold			2022-12-26	WOS:000535237000004
J	Ragupathi, NKD; Veeraraghavan, B; Sethuvel, DPM; Anandan, S; Vasudevan, K; Neeravi, AR; Daniel, JLK; Sathyendra, S; Iyadurai, R; Mutreja, A				Ragupathi, Naveen Kumar Devanga; Veeraraghavan, Balaji; Sethuvel, Dhiviya Prabaa Muthuirulandi; Anandan, Shalini; Vasudevan, Karthick; Neeravi, Ayyan Raj; Daniel, Jones Lionel Kumar; Sathyendra, Sowmya; Iyadurai, Ramya; Mutreja, Ankur			First Indian report on genome-wide comparison of multidrug-resistant Escherichia coli from blood stream infections	PLOS ONE			English	Article							KLEBSIELLA-PNEUMONIAE; BETA-LACTAMASE; CARBAPENEM RESISTANCE; KPC-2 CARBAPENEMASE; FIMBRIAL ADHESIN; GENE MCR-1; EMERGENCE; PLASMID; ISOLATE; HUMANS	Background Multidrug-resistant (MDR) E. coli with extended-spectrum beta-lactamases (ESBLs) is becoming endemic in health care settings around the world. Baseline data on virulence and antimicrobial resistance (AMR) of specific lineages of E. coli circulating in developing countries like India is currently lacking. Methods Whole-genome sequencing was performed for 60 MDR E. coli isolates. The analysis was performed at single nucleotide polymorphism (SNP) level resolution to identify the presence of their virulence and AMR genes. Results Genome comparison revealed the presence of ST-131 global MDR and ST410 as emerging-MDR clades of E. coli in India. AMR gene profile for cephalosporin and carbapenem resistance differed between the clades. Genotypes bla(CTX-M-15) and bla(NDM-5) were common among cephalosporinases and carbapenemases, respectively. For aminoglycoside resistance, rmtB was positive for 31.7% of the isolates, of which 95% were co-harboring carbapenemases. In addition, the FimH types and virulence gene profile positively correlated with the SNP based phylogeny, and also revealed the evolution of MDR clones among the study population with temporal accumulation of SNPs. The predominant clone was ST167 (bla(NDM) lineage) followed by ST405 (global clone ST131 equivalent) and ST410 (fast spreading high risk clone). Conclusions This is the first report on the whole genome analysis of MDR E. coli lineages circulating in India. Data from this study will provide public health agencies with baseline information on AMR and virulent genes in pathogenic E. coli in the region.	[Ragupathi, Naveen Kumar Devanga; Veeraraghavan, Balaji; Sethuvel, Dhiviya Prabaa Muthuirulandi; Anandan, Shalini; Vasudevan, Karthick; Neeravi, Ayyan Raj; Daniel, Jones Lionel Kumar] Christian Med Coll & Hosp, Dept Clin Microbiol, Vellore, Tamil Nadu, India; [Ragupathi, Naveen Kumar Devanga] Univ Sheffield, Dept Chem & Biol Engn, Sheffield, S Yorkshire, England; [Sathyendra, Sowmya; Iyadurai, Ramya] Christian Med Coll & Hosp, Dept Med, Vellore, Tamil Nadu, India; [Mutreja, Ankur] Univ Cambridge, Addenbrookes Hosp, Dept Med, Cambridge, England; [Mutreja, Ankur] Translat Hlth Sci & Technol Inst THSTI, Delhi, India	Christian Medical College & Hospital (CMCH) Vellore; University of Sheffield; Christian Medical College & Hospital (CMCH) Vellore; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Department of Biotechnology (DBT) India; Translational Health Science & Technology Institute (THSTI)	Veeraraghavan, B (corresponding author), Christian Med Coll & Hosp, Dept Clin Microbiol, Vellore, Tamil Nadu, India.	vbalaji@cmcvellore.ac.in	vasudevan, karthick/ABH-7205-2020	vasudevan, karthick/0000-0001-7471-2527; Veeraraghavan, Balaji/0000-0002-8662-4257	Global Challenges Research Fellowship, The University of Sheffield, UK; Department of Biotechnology in India; National Institute for Health Research [Cambridge Biomedical Research Centre at the Cambridge University Hospitals NHS Foundation Trust] in the UK	Global Challenges Research Fellowship, The University of Sheffield, UK; Department of Biotechnology in India; National Institute for Health Research [Cambridge Biomedical Research Centre at the Cambridge University Hospitals NHS Foundation Trust] in the UK	The author(s) received no specific funding for this research work. DRNK is funded by the Global Challenges Research Fellowship, The University of Sheffield, UK. AM is funded by the Department of Biotechnology in India and by the National Institute for Health Research [Cambridge Biomedical Research Centre at the Cambridge University Hospitals NHS Foundation Trust] in the UK. The views expressed are those of the authors and not necessarily those of the NHS, the NIHR or the Department of Health and Social Care.	Abbott SL, 2003, J CLIN MICROBIOL, V41, P2348, DOI 10.1128/JCM.41.6.2348-2357.2003; Aktas Z, 2012, AFR J MICROBIOL RES, V6, P3874, DOI 10.5897/AJMR12.036; Alhashash F, 2013, EMERG INFECT DIS, V19, P1699, DOI 10.3201/eid1910.130309; Bouckaert J, 2006, MOL MICROBIOL, V61, P1556, DOI 10.1111/j.1365-2958.2006.05352.x; Brolund A, 2014, CLIN MICROBIOL INFEC, V20, pO344, DOI 10.1111/1469-0691.12413; Budak S, 2014, SE ASIAN J TROP MED, V45, P113; Cai JC, 2014, ANTIMICROB AGENTS CH, V58, P1146, DOI 10.1128/AAC.00912-13; Candan ED, 2017, BRAZ ARCH BIOL TECHN, V60, DOI 10.1590/1678-4324-2017160416; Croucher NJ, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gku1196; Doi Y, 2016, INFECT DIS CLIN N AM, V30, P523, DOI 10.1016/j.idc.2016.02.011; Doi Y, 2015, SEMIN RESP CRIT CARE, V36, P74, DOI 10.1055/s-0035-1544208; Elnahriry SS, 2016, ANTIMICROB AGENTS CH, V60, P3249, DOI 10.1128/AAC.00269-16; Ewers C, 2010, J ANTIMICROB CHEMOTH, V65, P651, DOI 10.1093/jac/dkq004; Feng Y, 2015, SCI REP-UK, V5, DOI 10.1038/srep12275; Ghafur A, 2019, J GLOB ANTIMICROB RE, V16, P48, DOI 10.1016/j.jgar.2018.09.005; Ho PL, 2016, EUR J CLIN MICROBIOL, V35, P379, DOI 10.1007/s10096-015-2550-3; Ikram R, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-0974-0; Johnson JR, 2007, EMERG INFECT DIS, V13, P838, DOI 10.3201/eid1306.061576; Kaas RS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104984; Kanamori H, 2017, ANTIMICROB AGENTS CH, V61, DOI [10.1128/aac.00912-17, 10.1128/AAC.00912-17]; Kennedy KJ, 2008, MED J AUSTRALIA, V188, P209, DOI 10.5694/j.1326-5377.2008.tb01586.x; Lau SH, 2008, J ANTIMICROB CHEMOTH, V62, P1241, DOI 10.1093/jac/dkn380; Laupland KB, 2008, J INFECTION, V57, P441, DOI 10.1016/j.jinf.2008.09.034; Liang WJ, 2018, J INFECT PUBLIC HEAL, V11, P347, DOI [10.1016/j.jiph.2017.09.020, 10.1016/j.jiph.2017.00.020]; Lopez-Banda DA, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/959206; Matsumura Y, 2013, ANTIMICROB AGENTS CH, V57, P4736, DOI 10.1128/AAC.00641-13; Mesa RJ, 2006, J ANTIMICROB CHEMOTH, V58, P211, DOI 10.1093/jac/dkl211; Morris D, 2011, ANTIMICROB AGENTS CH, V55, P4935, DOI 10.1128/AAC.05127-11; Mushtaq S, 2011, J ANTIMICROB CHEMOTH, V66, P2002, DOI 10.1093/jac/dkr226; Nagaraj S, 2012, INDIAN J MED MICROBI, V30, P93, DOI 10.4103/0255-0857.93054; Nicolas-Chanoine MH, 2008, J ANTIMICROB CHEMOTH, V61, P273, DOI 10.1093/jac/dkm464; Page AJ, 2015, BIOINFORMATICS, V31, P3691, DOI 10.1093/bioinformatics/btv421; Poirel L, 2018, ANTIMICROB AGENTS CH, V62, DOI [10.1128/AAC.00021-18, 10.1128/aac.00021-18]; Ragupathi NKD, 2019, INDIAN J MED RES, V149, P222, DOI 10.4103/ijmr.IJMR_2098_17; Ravikant, 2016, INDIAN J EXP BIOL, V54, P108; Roer L, 2018, MSPHERE, V3, DOI 10.1128/mSphere.00337-18; Sharma A., 2016, J INFECT DIS THER, V4, P293, DOI [10.4172/2332-0877.1000293, DOI 10.4172/2332-0877.1000293]; Shen P, 2017, J CLIN MICROBIOL, V55, P199, DOI 10.1128/JCM.01581-16; Taylor E, 2018, INT J ANTIMICROB AG, V52, P278, DOI 10.1016/j.ijantimicag.2018.03.016; Tchesnokova V, 2011, INFECT IMMUN, V79, P3895, DOI 10.1128/IAI.05169-11; Veeraraghavan B, 2018, INDIAN J MED MICROBI, V36, P32, DOI 10.4103/ijmm.IJMM_17_415; Veeraraghavan B, 2017, PATHOG GLOB HEALTH, V111, P240, DOI 10.1080/20477724.2017.1340128; Yang F, 2019, INFECT DRUG RESIST, V12, P385, DOI 10.2147/IDR.S194635; Yang P, 2014, ANTIMICROB AGENTS CH, V58, P7548, DOI 10.1128/AAC.03911-14; Yu FY, 2009, DIAGN MICR INFEC DIS, V64, P57, DOI 10.1016/j.diagmicrobio.2009.01.020; Zhang XX, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-017-18910-w	46	17	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2020	15	2							e0220428	10.1371/journal.pone.0220428	http://dx.doi.org/10.1371/journal.pone.0220428			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8FM	32101543	Green Published, Green Submitted, gold, Green Accepted			2022-12-26	WOS:000535233700001
J	Resch, MD; Balogh, A; Deak, GG; Nagy, ZZ; Papp, A				Resch, Miklos D.; Balogh, Aniko; Deak, Gabor Gy; Nagy, Zoltan Z.; Papp, Andras			Vascular density in age-related macular degeneration after one year of antiVEGF treatment with treat-and-extend and fixed regimens	PLOS ONE			English	Article							VEGF TREATMENT; RANIBIZUMAB; THERAPY; AFLIBERCEPT; OUTCOMES; AMD; CNV	Treatment of neovascular age-related macular degeneration (nAMD) with VEGF can be performed with several posologies. The purpose of our cross-sectional study was to analyze retinal vessel density by quantitative OCT-angiography (OCT-A) and to compare treat-and-extend (T&E) and fixed treatment protocols to a control group with dry AMD. Altogether 48 patients were enrolled: 13 eyes with T&E protocol ranibizumab treatment (group A) and 17 eyes with fixed regimen aflibercept therapy (group B), the control group comprised 18 eyes with dry AMD (group C). One year after the start of the treatment, quantitative OCT-A (AngioVue-Optovue, Fermont, USA) was performed: superficial and deep retinal vessel densities were analyzed in the foveal and parafoveal regions. Our results show, that the density of retinal superficial vasculature in the fovea was not different between the treatment groups (A: 25.9 +/- 9.1%; B: 24.3%+/- 8.9), neither from group C (25.6 +/- 4.8%). Superficial parafoveal vascular density of the retina, however, was decreased in both treated groups (A: 46.7 +/- 9.1%, B: 42.9 +/- 6.1%, C: 49.7 +/- 4.9%). In the deep retinal plexus, vascular density was lower in both treatment groups compared to that of in controls in both the foveal and parafoveal area (A: 29.8 +/- 6.3%, B: 32.5 +/- 6.9%, C: 36.4 +/- 1.7% and A: 46.3 +/- 3.8%, B: 47.1 +/- 5.3%, C: 49.7 +/- 4.9%, foveal and parafoveal respectively). Our data suggest, that after one year of anti-VEGF treatment, reduced macular vessel density in three of the four examined vascular regions can be found independent of the treatment regimen.	[Resch, Miklos D.; Balogh, Aniko; Nagy, Zoltan Z.; Papp, Andras] Semmelweis Univ, Dept Ophthalmol, Budapest, Hungary; [Balogh, Aniko] Uzsoki Hosp, Dept Ophthalmol, Budapest, Hungary; [Deak, Gabor Gy] Med Univ Vienna, Dept Ophthalmol & Optometry, Vienna, Austria	Semmelweis University; Medical University of Vienna	Resch, MD (corresponding author), Semmelweis Univ, Dept Ophthalmol, Budapest, Hungary.	miklosresch@gmail.com		Resch, Miklos/0000-0002-8285-1153				Amoaku W, 2018, CLIN OPHTHALMOL, V12, P1731, DOI 10.2147/OPTH.S174560; Bakri SJ, 2019, OPHTHALMOLOGY, V126, P55, DOI 10.1016/j.ophtha.2018.07.028; Bressler Neil M, 2004, JAMA, V291, P1900, DOI 10.1001/jama.291.15.1900; Brown DM, 2009, OPHTHALMOLOGY, V116, P57, DOI 10.1016/j.ophtha.2008.10.018; Cennamo G, 2020, OPHTHALMOL THER, V9, P77, DOI 10.1007/s40123-019-00221-0; Coscas F, 2019, BRIT J OPHTHALMOL, V103, P1342, DOI 10.1136/bjophthalmol-2018-313065; Czako C, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-28994-7; Faatz H, 2019, EYE, V33, P1466, DOI 10.1038/s41433-019-0429-8; Hikichi T, 2020, RETINA-J RET VIT DIS, V40, P2158, DOI 10.1097/IAE.0000000000002745; Ho AC, 2018, OPHTHALMOL RETINA, V2, P676, DOI 10.1016/j.oret.2017.10.017; Lotery A, 2017, EYE, V31, P1697, DOI 10.1038/eye.2017.143; Martin DF, 2012, OPHTHALMOLOGY, V119, DOI 10.1016/j.ophtha.2012.03.053; Matsumoto H, 2018, OPHTHALMOL RETINA, V2, P462, DOI 10.1016/j.oret.2017.09.002; McClintic SM, 2018, OPHTHALMOL RETINA, V2, P931, DOI 10.1016/j.oret.2018.01.014; Miere A, 2018, J OPHTHALMOL, V2018, DOI 10.1155/2018/3751702; Mitchell P, 2012, CLIN EXP OPHTHALMOL, V40, P44; Muakkassa NW, 2015, RETINA-J RET VIT DIS, V35, P2252, DOI 10.1097/IAE.0000000000000836; Munk MR, 2016, ACTA OPHTHALMOL, V94, pE757, DOI 10.1111/aos.13157; Okada M, 2018, AM J OPHTHALMOL, V192, P184, DOI 10.1016/j.ajo.2018.05.026; Pilotto E, 2019, BRIT J OPHTHALMOL, V103, P67, DOI 10.1136/bjophthalmol-2017-311752; Rispoli M, 2018, OSLI RETINA, V49, P918, DOI 10.3928/23258160-20181203-02; Rosenfeld PJ, 2006, NEW ENGL J MED, V355, P1419, DOI 10.1056/NEJMoa054481; Sarwar S, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD011346.pub2; Schmidt-Erfurth U, 2014, BRIT J OPHTHALMOL, V98, P1144, DOI 10.1136/bjophthalmol-2014-305702; Silva R, 2018, OPHTHALMOLOGY, V125, P57, DOI 10.1016/j.ophtha.2017.07.014; Sorour OA, 2019, INT OPHTHALMOL, V39, P2361, DOI 10.1007/s10792-019-01076-x; Wylegala A, 2018, J HEALTHC ENG, V2018, DOI 10.1155/2018/8595278; You QS, 2020, AM J OPHTHALMOL, V209, P206, DOI 10.1016/j.ajo.2019.09.004	28	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2020	15	2							e0229388	10.1371/journal.pone.0229388	http://dx.doi.org/10.1371/journal.pone.0229388			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8FM	32101581	Green Published, gold, Green Submitted			2022-12-26	WOS:000535233700030
J	Yang, P; Zeng, H; Tan, W; Luo, XQ; Zheng, EZ; Zhao, L; Wei, L; Ruan, XZ; Chen, Y; Chen, YX				Yang, Ping; Zeng, Han; Tan, Wei; Luo, Xiaoqing; Zheng, Enze; Zhao, Lei; Wei, Li; Ruan, Xiong Z.; Chen, Yao; Chen, Yaxi			Loss of CD36 impairs hepatic insulin signaling by enhancing the interaction of PTP1B with IR	FASEB JOURNAL			English	Article						CD36; ER stress; insulin sensitivity; IR; PTP1B	ENDOPLASMIC-RETICULUM STRESS; TYROSINE-PHOSPHATASE 1B; FATTY-ACID TRANSPORT; RECEPTOR CD36; SOLUBLE CD36; RESISTANCE; INFLAMMATION; MUSCLE; LIVER; ATHEROSCLEROSIS	A contradictory role of CD36 in insulin resistance was found to be related to the nutrient state. Here, we examined that the physiological functions of CD36 in insulin signal transduction in mice fed a low-fat diet. CD36 deficiency led to hepatic insulin resistance and decreased insulin-stimulated tyrosine phosphorylation of insulin receptor beta (IR beta) in mice fed a low-fat diet. The ability of insulin to bind with IR did not differ between WT and CD36-deficient hepatocytes. CD36 formed a complex with IR beta and dissociation of CD36/Fyn complex or inhibition of Fyn only partially reversed the effects of CD36 on hepatic insulin signaling. Furthermore, we found that CD36 deficiency led to abnormally increased hepatic protein-tyrosine phosphatase 1B (PTP1B) expression and enhanced PTP1B and IR interactions, which contributed to the decreased insulin signaling and disordered glucose metabolism. In addition, increased endoplasmic reticulum (ER) stress was found in the livers of the CD36-deficient mice, while inhibited ER stress normalized the PTP1B expression and restored insulin signaling in the CD36-deficient mice. Our findings suggest that the loss of CD36 impairs hepatic insulin signaling by enhancing the PTP1B/IR interaction that is induced by ER stress, indicating a possible critical step in the progression of hepatic insulin resistance.	[Yang, Ping; Zeng, Han; Tan, Wei; Luo, Xiaoqing; Zheng, Enze; Zhao, Lei; Wei, Li; Ruan, Xiong Z.; Chen, Yaxi] Chongqing Med Univ, Key Lab Mol Biol Infect Dis, Affiliated Hosp 2,Inst Viral Hepatitis, Minist Educ,Dept Infect Dis,Ctr Lipid Res, Chongqing, Peoples R China; [Ruan, Xiong Z.] Fudan Univ, Huashan Hosp, Natl Clin Res Ctr Aging & Med, Shanghai, Peoples R China; [Ruan, Xiong Z.] UCL, Sch Med, Ctr Nephrol, John Moorhead Res Lab, Royal Free Campus, London, England; [Chen, Yao] Chongqing Med Univ, Affiliated Hosp 2, Med Examinat Ctr, Chongqing, Peoples R China	Chongqing Medical University; Fudan University; University of London; University College London; UCL Medical School; Chongqing Medical University	Ruan, XZ; Chen, YX (corresponding author), Chongqing Med Univ, Key Lab Mol Biol Infect Dis, Affiliated Hosp 2,Inst Viral Hepatitis, Minist Educ,Dept Infect Dis,Ctr Lipid Res, Chongqing, Peoples R China.; Chen, Y (corresponding author), Chongqing Med Univ, Affiliated Hosp 2, Med Examinat Ctr, Chongqing, Peoples R China.	x.ruan@ucl.ac.uk; chenyao@cqmu.edu.cn; chenyaxi@cqmu.edu.cn	Ruan, Xiong Zhong/GZA-5963-2022	Ruan, Xiong Zhong/0000-0001-5199-4971	National Natural Science Foundation of China [81873569, 31571210, 81400786]; National Key R&D Program of China [2018YFC1312700]; Science and Technology Research Program of Chongqing Municipal Education Commission [KJZD-K201800401]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key R&D Program of China; Science and Technology Research Program of Chongqing Municipal Education Commission	This research was supported by the National Natural Science Foundation of China (81873569, 31571210, 81400786), National Key R&D Program of China (2018YFC1312700), and the Science and Technology Research Program of Chongqing Municipal Education Commission (Grant No. KJZD-K201800401).	Aouadi M, 2014, AM J PHYSIOL-ENDOC M, V307, pE374, DOI 10.1152/ajpendo.00187.2014; Bakke J, 2015, SEMIN CELL DEV BIOL, V37, P58, DOI 10.1016/j.semcdb.2014.09.020; BERRY MN, 1969, J CELL BIOL, V43, P506, DOI 10.1083/jcb.43.3.506; Bonen A, 2015, DIABETOLOGIA, V58, P2381, DOI 10.1007/s00125-015-3691-8; Cai L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036785; Coburn CT, 2000, J BIOL CHEM, V275, P32523, DOI 10.1074/jbc.M003826200; Ekici M, 2018, BRIT J NUTR, V119, P153, DOI [10.1017/S0007114517003269, 10.1017/s0007114517003269]; Miquilena-Colina ME, 2011, GUT, V60, P1394, DOI 10.1136/gut.2010.222844; Febbraio M, 1999, J BIOL CHEM, V274, P19055, DOI 10.1074/jbc.274.27.19055; Febbraio M, 2001, J CLIN INVEST, V108, P785, DOI 10.1172/JCI200114006; Flamment M, 2012, TRENDS ENDOCRIN MET, V23, P381, DOI 10.1016/j.tem.2012.06.003; Garbacz WG, 2016, MOL CELL BIOL, V36, P2715, DOI 10.1128/MCB.00138-16; Goudriaan JR, 2003, J LIPID RES, V44, P2270, DOI 10.1194/jlr.M300143-JLR200; Hajri T, 2002, J CLIN INVEST, V109, P1381, DOI [10.1172/JCI200214596, 10.1172/JCI0214596]; Hajri T, 2007, DIABETES, V56, P1872, DOI 10.2337/db06-1699; Heron-Milhavet L, 2004, ENDOCRINOLOGY, V145, P4667, DOI 10.1210/en.2003-1543; Hetz C, 2011, PHYSIOL REV, V91, P1219, DOI 10.1152/physrev.00001.2011; Hirano K, 2003, TRENDS CARDIOVAS MED, V13, P136, DOI 10.1016/S1050-1738(03)00026-4; Iizuka Y, 2001, LANCET, V358, P243, DOI 10.1016/S0140-6736(01)05429-0; Kennedy DJ, 2011, METAB SYNDR RELAT D, V9, P239, DOI 10.1089/met.2011.0003; Kennedy DJ, 2011, CARDIOVASC RES, V89, P604, DOI 10.1093/cvr/cvq360; Klingmuller U, 2006, IEE P SYST BIOL, V153, P433, DOI 10.1049/ip-syb:20050067; Koonen Debby P. Y., 2011, Archives of Physiology and Biochemistry, V117, P57, DOI 10.3109/13813455.2010.543136; Kulkarni NB, 2018, INDIAN J MED RES, V147, P169, DOI 10.4103/ijmr.IJMR_852_16; Kuwasako T, 2003, DIABETES CARE, V26, P1647, DOI 10.2337/diacare.26.5.1647-a; Love-Gregory L, 2011, CURR OPIN CLIN NUTR, V14, P527, DOI 10.1097/MCO.0b013e32834bbac9; Nassir F, 2013, J LIPID RES, V54, P2988, DOI 10.1194/jlr.M037812; Panzhinskiy E, 2013, DIABETOLOGIA, V56, P598, DOI 10.1007/s00125-012-2782-z; Panzhinskiy E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077228; Park YM, 2014, EXP MOL MED, V46, DOI 10.1038/emm.2014.38; Popov D, 2012, BIOCHEM BIOPH RES CO, V422, P535, DOI 10.1016/j.bbrc.2012.05.048; Samovski D, 2018, DIABETES, V67, P1272, DOI 10.2337/db17-1226; Shiju TM, 2015, J DIABETES COMPLICAT, V29, P400, DOI 10.1016/j.jdiacomp.2014.12.012; Silverstein RL, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.272re3; Sun SS, 2018, J BIOL CHEM, V293, P2383, DOI 10.1074/jbc.M117.811471; Wang N, 2009, MOL CELL ENDOCRINOL, V307, P89, DOI 10.1016/j.mce.2009.03.001; Yamashita S, 2007, MOL CELL BIOCHEM, V299, P19, DOI 10.1007/s11010-005-9031-4; Yang P, 2017, J LIPID RES, V58, P1417, DOI 10.1194/jlr.M076216; Zhong S, 2017, ANTIOXID REDOX SIGN, V27, P201, DOI 10.1089/ars.2016.6808	39	8	11	3	12	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2020	34	4					5658	5672		10.1096/fj.201902777RR	http://dx.doi.org/10.1096/fj.201902777RR		FEB 2020	15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	LJ5ZA	32100381	Green Submitted, Bronze			2022-12-26	WOS:000518581700001
J	Koo, CZ; Harrison, N; Noy, PJ; Szyroka, J; Matthews, AL; Hsia, HE; Muller, SA; Tushaus, J; Goulding, J; Willis, K; Apicella, C; Cragoe, B; Davis, E; Keles, M; Malinova, A; McFarlane, TA; Morrison, PR; Nguyen, HTH; Sykes, MC; Ahmed, H; Di Maio, A; Seipold, L; Saftig, P; Cull, E; Pliotas, C; Rubinstein, E; Poulter, NS; Briddon, SJ; Holliday, ND; Lichtenthaler, SF; Tomlinson, MG				Koo, Chek Ziu; Harrison, Neale; Noy, Peter J.; Szyroka, Justyna; Matthews, Alexandra L.; Hsia, Hung-En; Mueller, Stephan A.; Tueshaus, Johanna; Goulding, Joelle; Willis, Katie; Apicella, Clara; Cragoe, Bethany; Davis, Edward; Keles, Murat; Malinova, Antonia; McFarlane, Thomas A.; Morrison, Philip R.; Nguyen, Hanh T. H.; Sykes, Michael C.; Ahmed, Haroon; Di Maio, Alessandro; Seipold, Lisa; Saftig, Paul; Cull, Eleanor; Pliotas, Christos; Rubinstein, Eric; Poulter, Natalie S.; Briddon, Stephen J.; Holliday, Nicholas D.; Lichtenthaler, Stefan F.; Tomlinson, Michael G.			The tetraspanin Tspan15 is an essential subunit of an ADAM10 scissor complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						tetraspanin; monoclonal antibody; shedding; membrane protein; ADAM; a disintegrin and metalloprotease; ADAM10; metalloproteinase; Tspan14; Tspan15; molecular cell biology	NOTCH ACTIVATION; CELL-ADHESION; TRAFFICKING; CLEAVAGE; ALPHA; COLOCALIZATION; CADHERIN; REVEALS; CD53	A disintegrin and metalloprotease 10 (ADAM10) is a transmembrane protein essential for embryonic development, and its dysregulation underlies disorders such as cancer, Alzheimer's disease, and inflammation. ADAM10 is a "molecular scissor" that proteolytically cleaves the extracellular region from >100 substrates, including Notch, amyloid precursor protein, cadherins, growth factors, and chemokines. ADAM10 has been recently proposed to function as six distinct scissors with different substrates, depending on its association with one of six regulatory tetraspanins, termed TspanC8s. However, it remains unclear to what degree ADAM10 function critically depends on a TspanC8 partner, and a lack of monoclonal antibodies specific for most TspanC8s has hindered investigation of this question. To address this knowledge gap, here we designed an immunogen to generate the first monoclonal antibodies targeting Tspan15, a model TspanC8. The immunogen was created in an ADAM10-knockout mouse cell line stably overexpressing human Tspan15, because we hypothesized that expression in this cell line would expose epitopes that are normally blocked by ADAM10. Following immunization of mice, this immunogen strategy generated four Tspan15 antibodies. Using these antibodies, we show that endogenous Tspan15 and ADAM10 co-localize on the cell surface, that ADAM10 is the principal Tspan15-interacting protein, that endogenous Tspan15 expression requires ADAM10 in cell lines and primary cells, and that a synthetic ADAM10/Tspan15 fusion protein is a functional scissor. Furthermore, two of the four antibodies impaired ADAM10/Tspan15 activity. These findings suggest that Tspan15 directly interacts with ADAM10 in a functional scissor complex.	[Koo, Chek Ziu; Harrison, Neale; Noy, Peter J.; Szyroka, Justyna; Matthews, Alexandra L.; Willis, Katie; Apicella, Clara; Cragoe, Bethany; Davis, Edward; Keles, Murat; Malinova, Antonia; McFarlane, Thomas A.; Morrison, Philip R.; Nguyen, Hanh T. H.; Sykes, Michael C.; Ahmed, Haroon; Di Maio, Alessandro; Cull, Eleanor; Tomlinson, Michael G.] Univ Birmingham, Sch Biosci, Birmingham B15 2TT, W Midlands, England; [Poulter, Natalie S.] Univ Birmingham, Inst Cardiovasc Sci, Birmingham B15 2TT, W Midlands, England; [Koo, Chek Ziu; Goulding, Joelle; Poulter, Natalie S.; Briddon, Stephen J.; Tomlinson, Michael G.] Univ Birmingham, Ctr Membrane Prot & Receptors COMPARE, Midlands B15 2TT, England; [Koo, Chek Ziu; Goulding, Joelle; Poulter, Natalie S.; Briddon, Stephen J.; Tomlinson, Michael G.] Univ Nottingham, Ctr Membrane Prot & Receptors COMPARE, Midlands B15 2TT, England; [Hsia, Hung-En; Mueller, Stephan A.; Tueshaus, Johanna; Lichtenthaler, Stefan F.] Tech Univ Munich, German Ctr Neurodegenerat Dis DZNE Munich, Neuroprote, Klinikum Rechts Isar, D-81377 Munich, Germany; [Hsia, Hung-En; Mueller, Stephan A.; Tueshaus, Johanna; Lichtenthaler, Stefan F.] Munich Cluster Syst Neurol SyNergy, D-81377 Munich, Germany; [Goulding, Joelle; Briddon, Stephen J.; Holliday, Nicholas D.] Univ Nottingham, Div Physiol Pharmacol & Neurosci, Sch Life Sci, Nottingham NG7 2UH, England; [Seipold, Lisa; Saftig, Paul] Christian Albrechts Univ Kiel, Inst Biochem, D-24118 Kiel, Germany; [Pliotas, Christos] Univ Leeds, Sch Biomed Sci, Fac Biol Sci, Leeds LS2 9JT, W Yorkshire, England; [Rubinstein, Eric] Sorbonne Univ, INSERM, CNRS, Ctr Immunol & Malad Infect,CIMI Paris, F-75013 Paris, France	University of Birmingham; University of Birmingham; University of Birmingham; University of Nottingham; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); Technical University of Munich; University of Munich; University of Nottingham; University of Kiel; University of Leeds; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite	Tomlinson, MG (corresponding author), Univ Birmingham, Sch Biosci, Coll Life & Environm Sci, Birmingham B15 2TT, W Midlands, England.	m.g.tomlinson@bham.ac.uk	Goulding, Joelle/AAI-1362-2021; Saftig, Paul/A-7966-2010; Rubinstein, Eric/B-4650-2019; Lichtenthaler, Stefan/B-6587-2016	Goulding, Joelle/0000-0002-6227-4483; Malinova, Antonia/0000-0003-0325-501X; KELES, MURAT/0000-0003-3420-3976; Rubinstein, Eric/0000-0001-7623-9665; Poulter, Natalie/0000-0002-3187-2130; Tomlinson, Michael/0000-0002-1189-0091; Pliotas, Christos/0000-0002-4309-4858; Muller, Stephan/0000-0003-3414-307X; Holliday, Nicholas/0000-0002-2900-828X; Koo, Chek Ziu/0000-0003-3770-2594; Lichtenthaler, Stefan/0000-0003-2211-2575; Harrison, Neale/0000-0001-6821-4089	BBSRC [BB/P00783X/1] Funding Source: UKRI	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		Arduise C, 2008, J IMMUNOL, V181, P7002, DOI 10.4049/jimmunol.181.10.7002; Ayling LJ, 2012, J CELL SCI, V125, P869, DOI 10.1242/jcs.091090; Brummer T, 2019, EMBO MOL MED, V11, DOI 10.15252/emmm.201809695; Brummer T, 2018, FASEB J, V32, P3560, DOI 10.1096/fj.201700823RR; Cox J, 2014, MOL CELL PROTEOMICS, V13, P2513, DOI 10.1074/mcp.M113.031591; Dahmane S, 2019, NANOSCALE, V11, P6036, DOI 10.1039/c8nr07269h; Dobos J, 2013, WEB3D 2013: 18TH INTERNATIONAL CONFERENCE ON 3D WEB TECHNOLOGY, P47; Dornier E, 2012, J CELL BIOL, V199, P481, DOI 10.1083/jcb.201201133; Ehrhardt C., 2006, SIGNAL TRANSDUCT BAN, V6, P179, DOI [10.1002/sita.200500073, DOI 10.1002/SITA.200500073]; Eschenbrenner E, 2020, LIFE SCI ALLIANCE, V3, DOI 10.26508/lsa.201900444; Haining EJ, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.416503; Hiroshima K, 2019, EXP CELL RES, V384, DOI 10.1016/j.yexcr.2019.111622; Hodgkins A, 2015, BIOINFORMATICS, V31, P3078, DOI 10.1093/bioinformatics/btv308; Hughes CS, 2019, NAT PROTOC, V14, P68, DOI 10.1038/s41596-018-0082-x; Jouannet S, 2016, CELL MOL LIFE SCI, V73, P1895, DOI 10.1007/s00018-015-2111-z; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; Kilpatrick LE, 2012, BBA-MOL CELL RES, V1823, P1068, DOI 10.1016/j.bbamcr.2012.03.002; Lichtenthaler SF, 2018, EMBO J, V37, DOI 10.15252/embj.201899456; Liu C, 2009, MOL CELL, V35, P26, DOI 10.1016/j.molcel.2009.06.018; MANDERS EMM, 1993, J MICROSC-OXFORD, V169, P375, DOI 10.1111/j.1365-2818.1993.tb03313.x; Maretzky T, 2005, MOL CELL BIOL, V25, P9040, DOI 10.1128/MCB.25.20.9040-9053.2005; Marjon KD, 2016, ONCOGENE, V35, P4132, DOI 10.1038/onc.2015.449; Matthews AL, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01451; Matthews AL, 2017, BIOCHEM SOC T, V45, P719, DOI 10.1042/BST20160290; Matthews AL, 2017, PLATELETS, V28, P333, DOI 10.1080/09537104.2016.1184751; McCarty OJT, 2006, J THROMB HAEMOST, V4, P1367, DOI 10.1111/j.1538-7836.2006.01966.x; Min GW, 2006, J CELL BIOL, V173, P975, DOI 10.1083/jcb.200602086; Noy PJ, 2016, J BIOL CHEM, V291, P3145, DOI 10.1074/jbc.M115.703058; OTSU N, 1979, IEEE T SYST MAN CYB, V9, P62, DOI 10.1109/TSMC.1979.4310076; Perez-Riverol Y, 2019, NUCLEIC ACIDS RES, V47, pD442, DOI 10.1093/nar/gky1106; Pike JA, 2017, METHODS, V115, P42, DOI 10.1016/j.ymeth.2017.01.005; Prox J, 2012, CELL MOL LIFE SCI, V69, P2919, DOI 10.1007/s00018-012-0960-2; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Reiss K, 2005, EMBO J, V24, P742, DOI 10.1038/sj.emboj.7600548; Reyat JS, 2017, J IMMUNOL, V199, P666, DOI 10.4049/jimmunol.1600713; Reyat JS, 2017, METHODS MOL BIOL, V1591, P155, DOI 10.1007/978-1-4939-6931-9_11; Sahin U, 2004, J CELL BIOL, V164, P769, DOI 10.1083/jcb.200307137; Saint-Pol J, 2017, BIOCHEM SOC T, V45, P937, DOI 10.1042/BST20160296; Saint-Pol J, 2017, J BIOL CHEM, V292, P9551, DOI 10.1074/jbc.M116.765669; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Seipold L, 2018, CELL MOL LIFE SCI, V75, P3251, DOI 10.1007/s00018-018-2791-2; Shah J, 2018, CELL REP, V25, P2132, DOI 10.1016/j.celrep.2018.10.088; Sidahmed-Adrar N, 2019, PROTEOMICS, V19, DOI 10.1002/pmic.201900025; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Sincock PM, 1997, J HISTOCHEM CYTOCHEM, V45, P515, DOI 10.1177/002215549704500404; Tang ZF, 2019, NUCLEIC ACIDS RES, V47, pW556, DOI 10.1093/nar/gkz430; Termini CM, 2017, FRONT CELL DEV BIOL, V5, DOI 10.3389/fcell.2017.00034; Thul PJ, 2017, SCIENCE, V356, DOI 10.1126/science.aal3321; Tomlinson MG, 2007, J THROMB HAEMOST, V5, P2274, DOI 10.1111/j.1538-7836.2007.02746.x; TOMLINSON MG, 1995, EUR J IMMUNOL, V25, P2201, DOI 10.1002/eji.1830250813; TOMLINSON MG, 1993, EUR J IMMUNOL, V23, P136, DOI 10.1002/eji.1830230122; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Uhlen M, 2017, SCIENCE, V357, P660, DOI 10.1126/science.aan2507; van Deventer SJ, 2017, BIOCHEM SOC T, V45, P741, DOI 10.1042/BST20160284; Virreira Winter S, 2016, SCI REP-UK, V6, DOI 10.1038/srep24242; Wetzel S, 2017, BBA-MOL CELL RES, V1864, P2071, DOI 10.1016/j.bbamcr.2017.06.005; Wilson E, 2014, J CELL SCI, V127, P3039, DOI 10.1242/jcs.140434; Zhang BZ, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03716-9; Zhou J, 2014, CALCIFIED TISSUE INT, V95, P209, DOI 10.1007/s00223-014-9883-2; Zimmerman B, 2016, CELL, V167, P1041, DOI 10.1016/j.cell.2016.09.056; Zuidscherwoude M, 2015, SCI REP-UK, V5, DOI 10.1038/srep12201	61	17	17	1	7	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 4	2020	295	36					12822	12839		10.1074/jbc.RA120.012601	http://dx.doi.org/10.1074/jbc.RA120.012601			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NQ9DL	32111735	Green Submitted, Green Published, Green Accepted, hybrid			2022-12-26	WOS:000571166700021
J	Geck, RC; Foley, JR; Stewart, TM; Asara, JM; Casero, RA; Toker, A				Geck, Renee C.; Foley, Jackson R.; Stewart, Tracy Murray; Asara, John M.; Casero, Robert A., Jr.; Toker, Alex			Inhibition of the polyamine synthesis enzyme ornithine decarboxylase sensitizes triple-negative breast cancer cells to cytotoxic chemotherapy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						amino acid; breast cancer; metabolomics; polyamine; DNA damage; antizyme; difluoromethylornithine; ornithine decarboxylase (ODC); triple-negative breast cancer (TNBC); cell metabolism	DNA-DAMAGE; ALPHA-DIFLUOROMETHYLORNITHINE; METABOLIC VULNERABILITY; L-ARGININE; PHASE; BIOSYNTHESIS; EXPRESSION; ARGINASE; GENE; CHEMOPREVENTION	Treatment of patients with triple-negative breast cancer (TNBC) is limited by a lack of effective molecular therapies targeting this disease. Recent studies have identified metabolic alterations in cancer cells that can be targeted to improve responses to standard-of-care chemotherapy regimens. Using MDA-MB-468 and SUM-159PT TNBC cells, along with LC-MS/MS and HPLC metabolomics profiling, we found here that exposure of TNBC cells to the cytotoxic chemotherapy drugs cisplatin and doxorubicin alter arginine and polyamine metabolites. This alteration was because of a reduction in the levels and activity of a rate-limiting polyamine biosynthetic enzyme, ornithine decarboxylase (ODC). Using gene silencing and inhibitor treatments, we determined that the reduction in ODC was mediated by its negative regulator antizyme, targeting ODC to the proteasome for degradation. Treatment with the ODC inhibitor difluoromethylornithine (DFMO) sensitized TNBC cells to chemotherapy, but this was not observed in receptor-positive breast cancer cells. Moreover, TNBC cell lines had greater sensitivity to single-agent DFMO, and ODC levels were elevated in TNBC patient samples. The alterations in polyamine metabolism in response to chemotherapy, as well as DFMO-induced preferential sensitization of TNBC cells to chemotherapy, reported here suggest that ODC may be a targetable metabolic vulnerability in TNBC.	[Geck, Renee C.; Asara, John M.; Toker, Alex] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA; [Geck, Renee C.; Toker, Alex] Harvard Med Sch, Boston, MA 02115 USA; [Foley, Jackson R.; Stewart, Tracy Murray; Casero, Robert A., Jr.] Johns Hopkins Univ, Sch Med, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD 21287 USA; [Toker, Alex] Ludwig Ctr Harvard, Boston, MA 02115 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; Johns Hopkins University; Johns Hopkins Medicine	Toker, A (corresponding author), 330 Brookline Ave,EC-CLS633A, Boston, MA 02215 USA.	atoker@bidmc.harvard.edu	Stewart, Tracy Murray/B-6137-2017	Stewart, Tracy Murray/0000-0001-8679-6414; Geck, Renee/0000-0001-7812-7675	BIDMC Research Capital Fund; Ruth L. Kirschstein Predoctoral Individual National Research Service Award [F31CA213460]	BIDMC Research Capital Fund; Ruth L. Kirschstein Predoctoral Individual National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank B. Manning (Harvard School of Public Health) for suggestions and critical reagents; J. Brugge (Harvard Medical School), N. Kalaany (Boston Children's Hospital), and members of the Toker lab (Beth Israel Deaconess Medical Center) for discussion; M. Yuan and C. Dibble (Beth Israel Deaconess Medical Center) for assistance with MS. The BIDMC Research Capital Fund provided funds for the mass spectrometry instrumentation (QTRAP 5500 and 6500).; Supported by the Ruth L. Kirschstein Predoctoral Individual National Research Service Award F31CA213460.	Agostinelli E, 2010, AMINO ACIDS, V38, P393, DOI 10.1007/s00726-009-0396-7; ANEHUS S, 1984, MOL CELL BIOL, V4, P915, DOI 10.1128/MCB.4.5.915; Bachmann AS, 2018, J BIOL CHEM, V293, P18757, DOI 10.1074/jbc.TM118.003336; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Battaglia V, 2014, AMINO ACIDS, V46, P511, DOI 10.1007/s00726-013-1529-6; BELLOFERNANDEZ C, 1993, P NATL ACAD SCI USA, V90, P7804, DOI 10.1073/pnas.90.16.7804; Bianchini G, 2016, NAT REV CLIN ONCOL, V13, P674, DOI 10.1038/nrclinonc.2016.66; Boyle P, 2012, ANN ONCOL, V23, P7, DOI 10.1093/annonc/mds187; Brown KK, 2017, CANCER DISCOV, V7, P391, DOI 10.1158/2159-8290.CD-16-0611; Burns MR, 2009, J MED CHEM, V52, P1983, DOI 10.1021/jm801580w; Casero RA, 2007, NAT REV DRUG DISCOV, V6, P373, DOI 10.1038/nrd2243; Casero RA, 2018, NAT REV CANCER, V18, P681, DOI 10.1038/s41568-018-0050-3; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Chong J, 2018, NUCLEIC ACIDS RES, V46, pW486, DOI 10.1093/nar/gky310; COURDI A, 1986, INT J CANCER, V38, P103, DOI 10.1002/ijc.2910380117; DeBerardinis RJ, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1600200; Denkert C, 2017, LANCET, V389, P2430, DOI 10.1016/S0140-6736(16)32454-0; Dillon BJ, 2004, CANCER-AM CANCER SOC, V100, P826, DOI 10.1002/cncr.20057; Do THT, 2013, AMINO ACIDS, V44, P869, DOI 10.1007/s00726-012-1413-9; Dulloo I, 2010, P NATL ACAD SCI USA, V107, P4902, DOI 10.1073/pnas.0906782107; Fabian CJ, 2002, CLIN CANCER RES, V8, P3105; Fahrmann JF, 2020, JNCI-J NATL CANCER I, V112, P607, DOI 10.1093/jnci/djz182; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Gross MI, 2014, MOL CANCER THER, V13, P890, DOI 10.1158/1535-7163.MCT-13-0870; Hayes CS, 2014, CANCER IMMUNOL RES, V2, P274, DOI 10.1158/2326-6066.CIR-13-0120-T; He W, 2017, NPJ PRECIS ONCOL, V1, DOI 10.1038/s41698-017-0014-1; Hoechst B, 2009, HEPATOLOGY, V50, P799, DOI 10.1002/hep.23054; Hu HY, 2005, WORLD J GASTROENTERO, V11, P2244, DOI 10.3748/wjg.v11.i15.2244; Jahani M, 2018, BIOMED PHARMACOTHER, V102, P594, DOI 10.1016/j.biopha.2018.02.109; Johansson VM, 2008, DNA CELL BIOL, V27, P511, DOI 10.1089/dna.2008.0750; KABRA PM, 1986, J CHROMATOGR, V380, P19, DOI 10.1016/S0378-4347(00)83621-X; Kahana C, 2018, J BIOL CHEM, V293, P18730, DOI 10.1074/jbc.TM118.003339; Keren-Paz A, 2007, BIOCHEM SOC T, V35, P311, DOI 10.1042/BST0350311; Kumar P, 2016, ARCH GYNECOL OBSTET, V293, P247, DOI 10.1007/s00404-015-3859-y; Lebert JM, 2018, CURR ONCOL, V25, pS142, DOI 10.3747/co.25.3954; Lee A, 2018, CANCER TREAT REV, V62, P110, DOI 10.1016/j.ctrv.2017.11.003; Lehmann BD, 2011, J CLIN INVEST, V121, P2750, DOI 10.1172/JCI45014; Lien EC, 2016, NAT CELL BIOL, V18, P572, DOI 10.1038/ncb3341; Ling YH, 1996, MOL PHARMACOL, V49, P832; Mayer IA, 2014, CLIN CANCER RES, V20, P782, DOI 10.1158/1078-0432.CCR-13-0583; Morris SM, 2009, BRIT J PHARMACOL, V157, P922, DOI 10.1111/j.1476-5381.2009.00278.x; Mueller S, 2006, INT J ONCOL, V29, P471; Murray-Stewart TR, 2016, BIOCHEM J, V473, P2937, DOI 10.1042/BCJ20160383; Nayvelt I, 2010, BIOMACROMOLECULES, V11, P97, DOI 10.1021/bm900958c; Nowotarski SL, 2013, EXPERT REV MOL MED, V15, DOI 10.1017/erm.2013.3; O'Shaughnessy JA, 1999, CLIN CANCER RES, V5, P3438; Oredsson SM, 2003, BIOCHEM SOC T, V31, P366, DOI 10.1042/BST0310366; Pereira B, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11479; Perez-Leal O, 2012, AMINO ACIDS, V42, P611, DOI 10.1007/s00726-011-1036-6; Potter AJ, 2002, CARCINOGENESIS, V23, P389, DOI 10.1093/carcin/23.3.389; Qiu FM, 2015, CANCER LETT, V364, P1, DOI 10.1016/j.canlet.2015.04.020; Reznik E, 2018, CELL SYST, V6, P301, DOI 10.1016/j.cels.2017.12.014; Roci I, 2019, CELL REP, V26, P1691, DOI 10.1016/j.celrep.2019.01.059; Saunders LR, 2006, MOL CANCER THER, V5, P2777, DOI 10.1158/1535-7163.MCT-06-0298; SEELY JE, 1983, METHOD ENZYMOL, V94, P158; SEIDENFELD J, 1986, CANCER RES, V46, P47; Silver DP, 2010, J CLIN ONCOL, V28, P1145, DOI 10.1200/JCO.2009.22.4725; Singh R, 2000, CANCER RES, V60, P3305; Singh R, 2001, CARCINOGENESIS, V22, P1863, DOI 10.1093/carcin/22.11.1863; Stewart TM, 2018, J BIOL CHEM, V293, P18736, DOI 10.1074/jbc.TM118.003337; Szefel J, 2019, ADV MED SCI-POLAND, V64, P104, DOI 10.1016/j.advms.2018.08.018; THOMAS T, 1991, BREAST CANCER RES TR, V19, P257, DOI 10.1007/BF01961162; Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596; Vander Heiden MG, 2017, CELL, V168, DOI 10.1016/j.cell.2016.12.039; Vichai V, 2006, NAT PROTOC, V1, P1112, DOI 10.1038/nprot.2006.179; Waks AG, 2019, JAMA-J AM MED ASSOC, V321, P288, DOI 10.1001/jama.2018.19323; Weicht Rebecca R, 2018, Med Sci (Basel), V6, DOI 10.3390/medsci6030065; Werner A, 2016, EUR J IMMUNOL, V46, P92, DOI 10.1002/eji.201546047; Witherspoon M, 2013, CANCER DISCOV, V3, P1072, DOI 10.1158/2159-8290.CD-12-0305; Yamashita T, 2013, INT J BIOCHEM CELL B, V45, P1042, DOI 10.1016/j.biocel.2013.02.021; Yang D, 1997, J BIOL CHEM, V272, P3376, DOI 10.1074/jbc.272.6.3376; Yao H, 2017, ONCOTARGET, V8, P1913, DOI 10.18632/oncotarget.12284; Young L, 2006, J HISTOCHEM CYTOCHEM, V54, P223, DOI 10.1369/jhc.5A6672.2005; Yuan M, 2019, NAT PROTOC, V14, P313, DOI 10.1038/s41596-018-0102-x; Yuan M, 2012, NAT PROTOC, V7, P872, DOI 10.1038/nprot.2012.024; Zahedi K, 2007, AM J PHYSIOL-CELL PH, V292, pC1204, DOI 10.1152/ajpcell.00451.2006; Zhang L, 1999, CANCER LETT, V142, P129, DOI 10.1016/S0304-3835(99)00107-X	77	23	23	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 8	2020	295	19					6263	6277		10.1074/jbc.RA119.012376	http://dx.doi.org/10.1074/jbc.RA119.012376			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LU3UT	32139506	Green Published, Green Submitted, hybrid			2022-12-26	WOS:000537685000002
J	Milton, AO; Wang, TZ; Li, WT; Guo, J; Zhang, ST				Milton, Alexandria O.; Wang, Tingzhong; Li, Wentao; Guo, Jun; Zhang, Shetuan			Mechanical stretch increases Kv1.5 current through an interaction between the S1?S2 linker and N-terminus of the channel	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Src kinase; potassium channel; electrophysiology; ion channel; molecular biology; patch clamp; structure-function; mechanotransduction; Kv1; 5; cell biology; voltage-gated potassium channel; mechanical stretch; Src	FOCAL ADHESION KINASE; ATRIAL-FIBRILLATION; TYROSINE KINASE; PROLINE; RECEPTORS; BINDING; HEART	The voltage-gated potassium channel Kv1.5 plays important roles in atrial repolarization and regulation of vascular tone. In the present study, we investigated the effects of mechanical stretch on Kv1.5 channels. We induced mechanical stretch by centrifuging or culturing Kv1.5-expressing HEK 293 cells and neonatal rat ventricular myocytes in low osmolarity (LO) medium and then recorded Kv1.5 current (I-Kv1.5) in a normal, isotonic solution. We observed that mechanical stretch increased I-Kv1.5, and this increase required the intact, long, proline-rich extracellular S1?S2 linker of the Kv1.5 channel. The low osmolarity?induced I-Kv1.5 increase also required an intact intracellular N terminus, which contains the binding motif for endogenous Src tyrosine kinase that constitutively inhibits I-Kv1.5. Disrupting the Src-binding motif of Kv1.5 through N-terminal truncation or mutagenesis abolished the mechanical stretch-mediated increase in I-Kv1.5. Our results further showed that the extracellular S1?S2 linker of Kv1.5 communicates with the intracellular N terminus. Although the S1?S2 linker of WT Kv1.5 could be cleaved by extracellularly applied proteinase K (PK), an N-terminal truncation up to amino acid residue 209 altered the conformation of the S1?S2 linker and made it no longer susceptible to proteinase K?mediated cleavage. In summary, the findings of our study indicate that the S1?S2 linker of Kv1.5 represents a mechanosensor that regulates the activity of this channel. By targeting the S1?S2 linker, mechanical stretch may induce a change in the N-terminal conformation of Kv1.5 that relieves Src-mediated tonic channel inhibition and results in an increase in I-Kv1.5.	[Milton, Alexandria O.; Wang, Tingzhong; Li, Wentao; Guo, Jun; Zhang, Shetuan] Queens Univ, Dept Biomed & Mol Sci, Kingston, ON K7L 3N6, Canada	Queens University - Canada	Zhang, ST (corresponding author), 18 Stuart St, Kingston, ON K7L 3N6, Canada.	shetuan.zhang@queensu.ca		Zhang, Shetuan/0000-0002-2297-0193	Natural Sciences and Engineering Research Council of Canada [RGPIN-2019-04878]	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This work was supported by Natural Sciences and Engineering Research Council of Canada Grant RGPIN-2019-04878 (to S. Z.). The authors declare that they have no conflicts of interest with the contents of this article.	Anter E, 2009, CIRCULATION, V119, P2516, DOI 10.1161/CIRCULATIONAHA.108.821306; Archer SL, 1998, J CLIN INVEST, V101, P2319, DOI 10.1172/JCI333; Bett GCL, 2012, BIOPHYS J, V103, P1440, DOI 10.1016/j.bpj.2012.08.036; Boycott HE, 2013, P NATL ACAD SCI USA, V110, pE3955, DOI 10.1073/pnas.1309896110; CHAN HC, 1992, SCIENCE, V257, P669, DOI 10.1126/science.1379742; Christophersen IE, 2013, EUR HEART J, V34, P1517, DOI 10.1093/eurheartj/ehs442; De Jong AM, 2011, CARDIOVASC RES, V89, P754, DOI 10.1093/cvr/cvq357; Dzeshka MS, 2017, HYPERTENSION, V70, P854, DOI 10.1161/HYPERTENSIONAHA.117.08934; FEDIDA D, 1993, CIRC RES, V73, P210, DOI 10.1161/01.RES.73.1.210; Fonseca PM, 2005, CIRC RES, V96, P73, DOI 10.1161/01.RES.0000152390.99806.A5; Go AS, 2001, JAMA-J AM MED ASSOC, V285, P2370, DOI 10.1001/jama.285.18.2370; Gomis A, 2008, J PHYSIOL-LONDON, V586, P5633, DOI 10.1113/jphysiol.2008.161257; Guo W, 1998, J MOL CELL CARDIOL, V30, P157, DOI 10.1006/jmcc.1997.0584; Han B, 2004, J BIOL CHEM, V279, P54793, DOI 10.1074/jbc.M406880200; Hanke JH, 1996, J BIOL CHEM, V271, P695, DOI 10.1074/jbc.271.2.695; Hogan-Cann A, 2016, BBA-BIOMEMBRANES, V1858, P1082, DOI 10.1016/j.bbamem.2016.02.012; Holmes TC, 1996, J NEUROSCI, V16, P1581; Holmes TC, 1996, SCIENCE, V274, P2089, DOI 10.1126/science.274.5295.2089; Hong SH, 1997, J BIOL CHEM, V272, P4166, DOI 10.1074/jbc.272.7.4166; Kaduk C, 1997, BIOPHYS J, V72, P2151, DOI 10.1016/S0006-3495(97)78858-1; Katsumi A, 2005, J BIOL CHEM, V280, P16546, DOI 10.1074/jbc.C400455200; Lamothe SM, 2018, J BIOL CHEM, V293, P15347, DOI 10.1074/jbc.RA118.004065; Linz P, 2002, AM J PHYSIOL-HEART C, V282, pH1828, DOI 10.1152/ajpheart.00708.2000; MONTROSERAFIZADEH C, 1990, ANNU REV PHYSIOL, V52, P761; Noubiap JJ, 2019, AM J CARDIOL, V124, P262, DOI 10.1016/j.amjcard.2019.04.028; Ohanyan V, 2015, CIRC RES, V117, P612, DOI 10.1161/CIRCRESAHA.115.306642; Peyronnet R, 2016, CIRC RES, V118, P311, DOI 10.1161/CIRCRESAHA.115.305043; Schmidt D, 2012, P NATL ACAD SCI USA, V109, P10352, DOI 10.1073/pnas.1204700109; Torsoni AS, 2003, CIRC RES, V93, P140, DOI 10.1161/01.RES.0000081595.25297.1B; Tschirhart JN, 2019, MOL PHARMACOL, V95, P386, DOI 10.1124/mol.118.114751; VOLK T, 1995, P NATL ACAD SCI USA, V92, P8478, DOI 10.1073/pnas.92.18.8478; WANG ZG, 1993, CIRC RES, V73, P1061, DOI 10.1161/01.RES.73.6.1061; WESS J, 1993, EMBO J, V12, P331, DOI 10.1002/j.1460-2075.1993.tb05661.x; Yang F, 2014, ELIFE, V3, DOI 10.7554/eLife.03255; Yang T, 2010, HEART RHYTHM, V7, P1246, DOI 10.1016/j.hrthm.2010.05.032; YU HT, 1994, CELL, V76, P933, DOI 10.1016/0092-8674(94)90367-0; Zhang ST, 1998, J MOL CELL CARDIOL, V30, P1955, DOI 10.1006/jmcc.1998.0758	37	0	0	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 3	2020	295	14					4723	4732		10.1074/jbc.RA119.011302	http://dx.doi.org/10.1074/jbc.RA119.011302			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LB2WZ	32122972	Green Published, hybrid			2022-12-26	WOS:000524499700029
J	Parker, BL; Kiens, B; Wojtaszewski, JFP; Richter, EA; James, DE				Parker, Benjamin L.; Kiens, Bente; Wojtaszewski, Jorgen F. P.; Richter, Erik A.; James, David E.			Quantification of exercise-regulated ubiquitin signaling in human skeletal muscle identifies protein modification cross talk via NEDDylation	FASEB JOURNAL			English	Article						exercise; human skeletal muscle; isotopic labeling; mass spectrometry; NEDD8; proteomics; ubiquitin	RESISTANCE EXERCISE; PHOSPHORYLATION; EXPRESSION; DEGRADATION; METABOLISM; TURNOVER; REVEALS	The maintenance of muscle function is extremely important for whole body health and exercise is essential to this process. The ubiquitin-proteasome system (UPS) is required for muscle adaptation following exercise but little is known about acute posttranslational regulation and proteome remodeling during and after high-intensity exercise. Here, we used quantitative proteomics to study ubiquitin signaling dynamics in human skeletal muscle biopsies from healthy males before, during, and after a single bout of high-intensity exercise. Exercise resulted in a marked depletion of protein ubiquitylation in the vastus lateralis muscle consistent with proteasome activation. This was also associated with acute posttranslational modification of protein abundance. Integration of these data with phosphoproteomics identified co-regulated proximal modifications suggesting a cross talk between phosphorylation and ubiquitylation. We also identified additional protein modification cross talk and showed acute activation of protein NEDDylation. In vitro experiments revealed that cAMP-dependent activation of the proteasome requires NEDD8, an ubiquitin-like protein involved in protein NEDDylation, to maintain cellular protein ubiquitylation levels. Our data reveal the complexity of ubiquitin signaling and proteome remodeling in muscle during and after high-intensity exercise. We propose a model whereby exercise and the resulting cAMP signaling activate both the proteasome and ubiquitylation via NEDDylation to rapidly remove potentially damaged proteins.	[Parker, Benjamin L.; James, David E.] Univ Sydney, Charles Perkins Ctr, Sch Life & Environm Sci, Sydney, NSW, Australia; [Parker, Benjamin L.] Univ Melbourne, Dept Physiol, Ctr Muscle Res, Melbourne, Vic, Australia; [Kiens, Bente; Wojtaszewski, Jorgen F. P.; Richter, Erik A.] Univ Copenhagen, Sect Mol Physiol, Fac Sci, Dept Nutr Exercise & Sports, DK-2100 Copenhagen, Denmark; [James, David E.] Univ Sydney, Sch Med, Sydney, NSW, Australia	University of Sydney; University of Melbourne; University of Copenhagen; University of Sydney	Richter, EA (corresponding author), Univ Copenhagen, Sect Mol Physiol, Fac Sci, Dept Nutr Exercise & Sports, DK-2100 Copenhagen, Denmark.; James, DE (corresponding author), Univ Sydney, Charles Perkins Ctr D17, Sch Life & Environm Sci, Sydney, NSW 2006, Australia.	erichter@nexs.ku.dk; david.james@sydney.edu.au	Kiens, Bente/B-1375-2015; Richter, Erik A./N-4189-2014	Kiens, Bente/0000-0001-5705-5625; James, David/0000-0001-5946-5257; wojtaszewski, jorgen/0000-0001-8185-3408; Richter, Erik A./0000-0002-6850-3056				Benjamini Y, 2001, BEHAV BRAIN RES, V125, P279, DOI 10.1016/S0166-4328(01)00297-2; Bilodeau PA, 2016, AM J PHYSIOL-CELL PH, V311, pC392, DOI 10.1152/ajpcell.00125.2016; BIOLO G, 1995, AM J PHYSIOL-ENDOC M, V268, pE514; Chen YW, 2010, THROMB HAEMOSTASIS, V104, P293, DOI 10.1160/TH09-09-0633; DOHM GL, 1985, FED PROC, V44, P348; DOHM GL, 1987, MED SCI SPORT EXER, V19, pS166; Enchev RI, 2015, NAT REV MOL CELL BIO, V16, P30, DOI 10.1038/nrm3919; Filipcik P, 2017, J MOL BIOL, V429, P1097, DOI 10.1016/j.jmb.2017.02.011; HARALAMBIE G, 1976, EUR J APPL PHYSIOL O, V36, P39, DOI 10.1007/BF00421632; Hoffman NJ, 2015, CELL METAB, V22, P922, DOI 10.1016/j.cmet.2015.09.001; Hutchins AP, 2013, MOL BIOL EVOL, V30, P1172, DOI 10.1093/molbev/mst022; Kall L, 2007, NAT METHODS, V4, P923, DOI 10.1038/NMETH1113; Kim W, 2011, MOL CELL, V44, P325, DOI 10.1016/j.molcel.2011.08.025; Lee JS, 2010, CELL, V142, P682, DOI 10.1016/j.cell.2010.08.011; Lokireddy S, 2015, P NATL ACAD SCI USA, V112, pE7176, DOI 10.1073/pnas.1522332112; Louis E, 2007, J APPL PHYSIOL, V103, P1744, DOI 10.1152/japplphysiol.00679.2007; Lydeard JR, 2013, EMBO REP, V14, P1050, DOI 10.1038/embor.2013.173; Malik ZA, 2013, PROTEOMES, V1, DOI 10.3390/proteomes1030290; Mansueto G, 2017, CELL METAB, V25, P182, DOI 10.1016/j.cmet.2016.11.003; Mir R, 2018, MOL CELL BIOL, V38, DOI 10.1128/MCB.00188-18; Nedergaard A, 2007, J APPL PHYSIOL, V103, P1513, DOI 10.1152/japplphysiol.01445.2006; Olsen LA, 2019, EUR J APPL PHYSIOL, V119, P333, DOI 10.1007/s00421-018-04061-x; Orlicky S, 2003, CELL, V112, P243, DOI 10.1016/S0092-8674(03)00034-5; Palmisano G, 2010, NAT PROTOC, V5, P1974, DOI 10.1038/nprot.2010.167; Parikh H, 2008, AM J PHYSIOL-ENDOC M, V294, pE1152, DOI 10.1152/ajpendo.90255.2008; Perez-Riverol Y, 2019, NUCLEIC ACIDS RES, V47, pD442, DOI 10.1093/nar/gky1106; Phillips SM, 2002, CAN J PHYSIOL PHARM, V80, P1045, DOI [10.1139/y02-134, 10.1139/Y02-134]; Phillips SM, 1997, AM J PHYSIOL-ENDOC M, V273, pE99, DOI 10.1152/ajpendo.1997.273.1.E99; Phillips SM, 1999, AM J PHYSIOL-ENDOC M, V276, pE118; Rose CM, 2016, CELL SYST, V3, P395, DOI 10.1016/j.cels.2016.08.009; Schafer MJ, 2016, DIABETES, V65, P1606, DOI 10.2337/db15-0291; Sheffield-Moore M, 2004, AM J PHYSIOL-ENDOC M, V287, pE513, DOI 10.1152/ajpendo.00334.2003; Shimizu K, 2017, SCI SIGNAL, V10, DOI 10.1126/scisignal.aah4117; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Swatek KN, 2016, CELL RES, V26, P399, DOI 10.1038/cr.2016.39; Taus T, 2011, J PROTEOME RES, V10, P5354, DOI 10.1021/pr200611n; THOMPSON HS, 1994, BIOCHEM BIOPH RES CO, V204, P1193, DOI 10.1006/bbrc.1994.2589; VerPlank JJS, 2019, P NATL ACAD SCI USA, V116, P4228, DOI 10.1073/pnas.1809254116; Werner C, 2009, CIRCULATION, V120, P2438, DOI 10.1161/CIRCULATIONAHA.109.861005; Wiley CD, 2019, CELL REP, V28, P3329, DOI 10.1016/j.celrep.2019.08.049; Willoughby DS, 2003, MED SCI SPORT EXER, V35, P2023, DOI 10.1249/01.MSS.0000099100.83796.77; Ye X, 2004, J BIOL CHEM, V279, P50110, DOI 10.1074/jbc.M409226200; Zhao B, 2010, GENE DEV, V24, P72, DOI 10.1101/gad.1843810; Zhou YY, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09234-6	44	13	13	0	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2020	34	4					5906	5916		10.1096/fj.202000075R	http://dx.doi.org/10.1096/fj.202000075R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	LJ5ZA	32141134				2022-12-26	WOS:000530242100073
J	Winskell, K; Singleton, R; Sabben, G; Tiendrebeogo, G; Obong'o, C; Dia, FL; Nkambule-Vilakati, S; Mbakwem, B; Stephenson, R				Winskell, Kate; Singleton, Robyn; Sabben, Gaelle; Tiendrebeogo, Georges; Obong'o, Chris; Dia, Fatim Louise; Nkambule-Vilakati, Siphiwe; Mbakwem, Benjamin; Stephenson, Rob			Social representations of the prevention of heterosexual transmission of HIV among young Africans from five countries, 1997-2014	PLOS ONE			English	Article							SOUTH-AFRICA; BEHAVIOR; PERCEPTIONS; HEALTH	HIV prevention has evolved dramatically since the 1990s. The ABC trilogy (abstinence, be faithful, use a condom) has expanded to incorporate a range of biomedical prevention strategies, including voluntary medical male circumcision, pre- and post-exposure prophylaxis, and treatment-as-prevention, and to accommodate structural and combination prevention approaches. This study examines how young Africans from five epidemiologically and socio-culturally diverse countries (Swaziland, Kenya, Nigeria, Burkina Faso and Senegal) made sense of the evolving prevention of sexual transmission of HIV between 1997 and 2014. It uses a distinctive data source: 1,343 creative narratives submitted to HIV-themed scriptwriting competitions by young people aged 10-24. The study triangulates between analysis of quantifiable characteristics of the narratives, thematic qualitative analysis, and narrative-based approaches. Over time, HIV prevention themes become less prominent. Condoms are represented less often from 2008, though representations become more favourable. Biomedical prevention is all but absent through 2014. While prevention strategies may be described as effective in narratorial commentary, they are rarely depicted as preventing HIV, but are evoked instead in moralistic cautionary tales or represented as ineffective. Over time, an increasing proportion of protagonists are female. One in five narratives acknowledge structural drivers of HIV, but these are generally either disempowering or condemn characters for failing to prevent HIV in the face of often overwhelming structural challenges. In the context of combination prevention, there is a need to disseminate an empowering cultural narrative that models successful use of HIV prevention strategies despite structural constraints and avoids blaming and stigma.	[Winskell, Kate; Singleton, Robyn; Sabben, Gaelle; Dia, Fatim Louise] Emory Univ, Rollins Sch Publ Hlth, Hubert Dept Global Hlth, Atlanta, GA 30322 USA; [Tiendrebeogo, Georges] Fdn Bouisson Bertrand, Inst Rech Dev, Montpellier, France; [Obong'o, Chris] Univ Memphis, Sch Publ Hlth, Memphis, TN 38152 USA; [Nkambule-Vilakati, Siphiwe] Super Buddies Club, Mbabane, Switzerland; [Mbakwem, Benjamin] Community & Youth Dev Initiatives, Owerri, Imo State, Nigeria; [Stephenson, Rob] Univ Michigan, Sch Nursing, Dept Hlth Behav & Biol Sci, Ann Arbor, MI 48109 USA	Emory University; Rollins School Public Health; Institut de Recherche pour le Developpement (IRD); University of Memphis; University of Michigan System; University of Michigan	Winskell, K (corresponding author), Emory Univ, Rollins Sch Publ Hlth, Hubert Dept Global Hlth, Atlanta, GA 30322 USA.	swinske@emory.edu	; Singleton, Robyn/U-6439-2018	Winskell, Kate/0000-0001-7772-3037; Singleton, Robyn/0000-0001-9749-6687	Eunice Kennedy Shriver National Institute of Child Health & Human Development of the National Institutes of Health [R01HD085877]; Emory Center for AIDS Research [P30 AI050409]; Mellon Foundation	Eunice Kennedy Shriver National Institute of Child Health & Human Development of the National Institutes of Health; Emory Center for AIDS Research; Mellon Foundation	Research reported in this publication was supported by the Eunice Kennedy Shriver National Institute of Child Health & Human Development of the National Institutes of Health under Award Number R01HD085877 (PI: Winskell). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. This research was also supported by the Emory Center for AIDS Research (P30 AI050409) and the Mellon Foundation.	Ahmed N, 2019, CURR OPIN INFECT DIS, V32, P24, DOI [10.1097/QCO.0000000000000511, 10.1097/qco.0000000000000511]; Allen S, 2003, AIDS, V17, P733, DOI 10.1097/00002030-200303280-00012; Bekker LG, 2018, LANCET, V392, P312, DOI [10.1016/s0140-6736(18)31070-5, 10.1016/S0140-6736(18)31070-5]; Bond V, 2016, AIDS PATIENT CARE ST, V30, P425, DOI 10.1089/apc.2016.0114; Cohen J., 2018, HIV PREVENTION STRAT; Cohen MS, 2016, NEW ENGL J MED, V375, P830, DOI [10.1056/NEJMoa1600693, 10.1056/NEJMoa1105243]; Corbin J., 2007, BASICS QUALITATIVE R, V3rd, DOI DOI 10.4135/9781452230153.N8; Davis SM, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2018-021835; Deacon H., 2005, UNDERSTANDING HIV AI; Dworkin SL, 2007, AM J PUBLIC HEALTH, V97, P13, DOI 10.2105/AJPH.2005.074591; Farmer P., 1991, MENTAL REPRESENTATIO, P132; Fonner VA, 2016, AIDS, V30, P1973, DOI 10.1097/QAD.0000000000001145; Gupta GR, 2008, LANCET, V372, P764, DOI 10.1016/S0140-6736(08)60887-9; HIV/AIDS. JUNPo, 2007, UNAIDS PRACT GUID IN; Hosek S, 2019, CURRENT HIV AIDS REP, P1, DOI [10.1007/s11904-019-00436-7, DOI 10.1007/S11904-019-00436-7]; Kurth Ann E, 2011, Curr HIV/AIDS Rep, V8, P62, DOI 10.1007/s11904-010-0063-3; Lazlo J., 1997, PAP SOC REPRESENT, V6, P155; Lo NC, 2016, HEALTH AFFAIR, V35, P856, DOI 10.1377/hlthaff.2015.0828; Mahajan AP, 2008, AIDS, V22, pS67, DOI 10.1097/01.aids.0000327438.13291.62; Measure DHS, 2019, STATCOMPILER 2019; Mooney AC, 2017, AIDS EDUC PREV, V29, P274, DOI 10.1521/aeap.2017.29.3.274; Moore SE, 2013, MORAL PANICS CONT WO; Morris BJ, 2016, POPUL HEALTH METR, V14, DOI 10.1186/s12963-016-0073-5; Moscovici S., 2008, PSYCHOANALYSIS ITS I; Murray M, 2002, SOC SCI INFORM, V41, P653, DOI 10.1177/0539018402041004008; Ncube NBQ, 2014, AFR J PRIM HEALTH CA, V6, DOI 10.4102/phcfm.v6i1.665; Piot P, 2015, LANCET, V386, P171, DOI 10.1016/S0140-6736(15)60658-4; Rabinow Paul, 1986, WRITING CULTURE POET, P234; Riessman C.K., 2008, NARRATIVE METHODS HU, P21; Rothman AJ, 1997, PSYCHOL BULL, V121, P3, DOI 10.1037/0033-2909.121.1.3; Saul J, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0208167; Slutkin G, 2006, AIDS BEHAV, V10, P351, DOI 10.1007/s10461-006-9118-2; Winskell K, 2018, SOC SCI MED, V211, P234, DOI 10.1016/j.socscimed.2018.06.006; Winskell K, 2018, QUAL HEALTH RES, V28, P1629, DOI 10.1177/1049732318759658; Winskell K, 2011, SOC SCI MED, V73, P1257, DOI 10.1016/j.socscimed.2011.07.007; Winskell K, 2011, SOC SCI MED, V72, P953, DOI 10.1016/j.socscimed.2011.01.014	36	5	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2020	15	3							e0227878	10.1371/journal.pone.0227878	http://dx.doi.org/10.1371/journal.pone.0227878			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LQ8TR	32142515	Green Published, gold			2022-12-26	WOS:000535271600004
J	Ikari, S; Lu, SL; Hao, FK; Imai, K; Araki, Y; Yamamoto, YH; Tsai, CY; Nishiyama, Y; Shitan, N; Yoshimori, T; Otomo, T; Noda, T				Ikari, Sumiko; Lu, Shiou-Ling; Hao, Feike; Imai, Kenta; Araki, Yasuhiro; Yamamoto, Yo-hei; Tsai, Chao-Yuan; Nishiyama, Yumi; Shitan, Nobukazu; Yoshimori, Tamotsu; Otomo, Takanobu; Noda, Takeshi			Starvation-induced autophagy via calcium-dependent TFEB dephosphorylation is suppressed by Shigyakusan	PLOS ONE			English	Article							TRADITIONAL CHINESE MEDICINE; CA2+; PROGRESSION; PROTEIN; RECRUITMENT; CALCINEURIN; DISSECTION; MATURATION; EFFECTORS; RECEPTOR	Kampo, a system of traditional Japanese therapy utilizing mixtures of herbal medicine, is widely accepted in the Japanese medical system. Kampo originated from traditional Chinese medicine, and was gradually adopted into a Japanese style. Although its effects on a variety of diseases are appreciated, the underlying mechanisms remain mostly unclear. Using a quantitative tf-LC3 system, we conducted a high-throughput screen of 128 kinds of Kampo to evaluate the effects on autophagy. The results revealed a suppressive effect of Shigyakusan/TJ-35 on autophagic activity. TJ-35 specifically suppressed dephosphorylation of ULK1 and TFEB, among several TORC1 substrates, in response to nutrient deprivation. TFEB was dephosphorylated by calcineurin in a Ca2+ dependent manner. Cytosolic Ca2+ concentration was increased in response to nutrient starvation, and TJ-35 suppressed this increase. Thus, TJ-35 prevents the starvation-induced Ca2+ increase, thereby suppressing induction of autophagy.	[Ikari, Sumiko; Noda, Takeshi] Osaka Univ, Ctr Frontier Oral Sci, Grad Sch Frontier Biosci, Suita, Osaka, Japan; [Lu, Shiou-Ling; Hao, Feike; Araki, Yasuhiro; Yamamoto, Yo-hei; Noda, Takeshi] Osaka Univ, Ctr Frontier Oral Sci, Grad Sch Dent, Suita, Osaka, Japan; [Hao, Feike] China Natl Res Inst Food & Fermentat Ind, Beijing, Peoples R China; [Imai, Kenta; Yoshimori, Tamotsu] Osaka Univ, Grad Sch Frontier Biosci, Dept Intracellular Membrane Dynam, Suita, Osaka, Japan; [Tsai, Chao-Yuan] Osaka Univ, Immunol Frontier Res Ctr, Lab Immune Regulat, Suita, Osaka, Japan; [Nishiyama, Yumi] Kobe Pharmaceut Univ, Med Bot Garden, Kobe, Hyogo, Japan; [Shitan, Nobukazu] Kobe Pharmaceut Univ, Lab Med Cell Biol, Kobe, Hyogo, Japan; [Otomo, Takanobu] Kawasaki Med Sch, Dept Mol & Genet Med, Ku Rashiki, Kurashiki, Okayama, Japan	Osaka University; Osaka University; Osaka University; Osaka University; Kobe Pharmaceutical University; Kobe Pharmaceutical University; Kawasaki Medical School	Noda, T (corresponding author), Osaka Univ, Ctr Frontier Oral Sci, Grad Sch Frontier Biosci, Suita, Osaka, Japan.; Noda, T (corresponding author), Osaka Univ, Ctr Frontier Oral Sci, Grad Sch Dent, Suita, Osaka, Japan.	takenoda@dent.osaka-u.ac.jp	Noda, Takeshi/B-7240-2008	Noda, Takeshi/0000-0003-3581-7961	Tsumura CO. LTD.; Tsumura CO LTD	Tsumura CO. LTD.; Tsumura CO LTD(Tsumura & Company)	Takeshi NODA has received research grant from Tsumura CO. LTD. Tsumura CO LTD has no role in the study design; collection, analysis, and interpretation of data; writing of the paper; and decision to submit for publication.	Aramburu J, 1999, SCIENCE, V285, P2129, DOI 10.1126/science.285.5436.2129; Bloor S, 2010, P NATL ACAD SCI USA, V107, P6970, DOI 10.1073/pnas.0908536107; Chan EY, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.284pe51; Chang CM, 2019, MOL CELL, V73, P339, DOI 10.1016/j.molcel.2018.10.035; Decuypere JP, 2011, AUTOPHAGY, V7, P1472, DOI 10.4161/auto.7.12.17909; Decuypere JP, 2011, CELL CALCIUM, V50, P242, DOI 10.1016/j.ceca.2011.04.001; Fingar DC, 2004, MOL CELL BIOL, V24, P200, DOI 10.1128/MCB.24.1.200-216.2004; Hagen BM, 2012, CELL CALCIUM, V52, P170, DOI 10.1016/j.ceca.2012.05.010; Hansen M, 2007, MOL CELL, V25, P193, DOI [10.1016/j.molcel.2006.12.009, DOI 10.1016/J.MOLCEL.2006.12.009]; Hao FK, 2018, J CELL SCI, V131, DOI 10.1242/jcs.208017; Hara T, 2007, J CELL BIOL, V9, P497; Hashimoto D, 2008, J CELL BIOL, V181, P1065, DOI 10.1083/jcb.200712156; Hosokawa N, 2009, MOL BIOL CELL, V20, P1981, DOI 10.1091/mbc.E08-12-1248; Kageyama S, 2011, MOL BIOL CELL, V22, P2290, DOI 10.1091/mbc.E10-11-0893; Kimura S, 2007, AUTOPHAGY, V3, P452, DOI 10.4161/auto.4451; Kimura S, 2009, METHOD ENZYMOL, V452, P1, DOI 10.1016/S0076-6879(08)03601-X; Kinsey CG, 2019, NAT MED, V25, P620, DOI 10.1038/s41591-019-0367-9; Kroemer G, 2015, J CLIN INVEST, V125, P1, DOI 10.1172/JCI78652; Lamark Trond, 2012, Int J Cell Biol, V2012, P736905, DOI 10.1155/2012/736905; Lippai M, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/832704; Liu MJ, 2018, CANCER SCI, V109, P3055, DOI 10.1111/cas.13746; Luo T, 2016, AUTOPHAGY, V12, P1355, DOI 10.1080/15548627.2015.1034405; Martina JA, 2013, J CELL BIOL, V200, P475, DOI 10.1083/jcb.201209135; MCKEON F, 1991, CELL, V66, P823, DOI 10.1016/0092-8674(91)90426-Y; Medina DL, 2015, NAT CELL BIOL, V17, P288, DOI 10.1038/ncb3114; Mizushima N, 2001, J CELL BIOL, V152, P657, DOI 10.1083/jcb.152.4.657; Mizushima N, 2018, NAT CELL BIOL, V20, P521, DOI 10.1038/s41556-018-0092-5; Mizushima N, 2010, CURR OPIN CELL BIOL, V22, P132, DOI 10.1016/j.ceb.2009.12.004; Nakai J, 2001, NAT BIOTECHNOL, V19, P137, DOI 10.1038/84397; Noda T, 2017, BIOMOLECULES, V7, DOI 10.3390/biom7030052; Ohta Y, 2006, PHYTOTHER RES, V20, P256, DOI 10.1002/ptr.1832; Oka T, 2002, BRIT J PHARMACOL, V135, P1959, DOI 10.1038/sj.bjp.0704662; Okubo Shinya, 2019, Medicines (Basel), V6, DOI 10.3390/medicines6020063; Pena-Llopis S, 2011, EMBO J, V30, P3242, DOI 10.1038/emboj.2011.257; Proikas-Cezanne T, 2015, J CELL SCI, V128, P207, DOI 10.1242/jcs.146258; Rubinsztein DC, 2012, NAT REV DRUG DISCOV, V11, P709, DOI 10.1038/nrd3802; Saitoh T, 2003, J BIOL CHEM, V278, P36005, DOI 10.1074/jbc.M304266200; Sardiello M, 2009, SCIENCE, V325, P473, DOI 10.1126/science.1174447; Schalm SS, 2002, CURR BIOL, V12, P632, DOI 10.1016/S0960-9822(02)00762-5; Settembre C, 2011, SCIENCE, V332, P1429, DOI 10.1126/science.1204592; STEWART AA, 1982, FEBS LETT, V137, P80, DOI 10.1016/0014-5793(82)80319-0; Takanashi K, 2019, PHAMACOLOGY, V99, P2017; Tanida I, 2005, AUTOPHAGY, V1, P84, DOI 10.4161/auto.1.2.1697; Thoreen CC, 2009, J BIOL CHEM, V284, P8023, DOI 10.1074/jbc.M900301200; Wang SF, 2016, J ETHNOPHARMACOL, V194, P861, DOI 10.1016/j.jep.2016.10.069; Yamamoto A, 1998, CELL STRUCT FUNCT, V23, P33, DOI 10.1247/csf.23.33; YOSHIKAWA T, 1991, J CLIN BIOCHEM NUTR, V10, P189; Yu R, 2006, J INT MED RES, V34, P231, DOI 10.1177/147323000603400301; Yusuf IH, 2017, EYE, V31, P828, DOI 10.1038/eye.2016.298; Zatloukal B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096690; Zhao YG, 2019, CURR OPIN CELL BIOL, V61, P117, DOI 10.1016/j.ceb.2019.08.003	51	7	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2020	15	3							e0230156	10.1371/journal.pone.0230156	http://dx.doi.org/10.1371/journal.pone.0230156			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8RK	32134989	Green Published, gold, Green Submitted			2022-12-26	WOS:000535265600069
J	Teramoto, A; Tsukamoto, T; Yamada, A; Kiriyama, Y; Imaizumi, K; Saito, K; Fujita, H				Teramoto, Atsushi; Tsukamoto, Tetsuya; Yamada, Ayumi; Kiriyama, Yuka; Imaizumi, Kazuyoshi; Saito, Kuniaki; Fujita, Hiroshi			Deep learning approach to classification of lung cytological images: Two-step training using actual and synthesized images by progressive growing of generative adversarial networks	PLOS ONE			English	Article								Cytology is the first pathological examination performed in the diagnosis of lung cancer. In our previous study, we introduced a deep convolutional neural network (DCNN) to automatically classify cytological images as images with benign or malignant features and achieved an accuracy of 81.0%. To further improve the DCNN's performance, it is necessary to train the network using more images. However, it is difficult to acquire cell images which contain a various cytological features with the use of many manual operations with a microscope. Therefore, in this study, we aim to improve the classification accuracy of a DCNN with the use of actual and synthesized cytological images with a generative adversarial network (GAN). Based on the proposed method, patch images were obtained from a microscopy image. Accordingly, these generated many additional similar images using a GAN. In this study, we introduce progressive growing of GANs (PGGAN), which enables the generation of high-resolution images. The use of these images allowed us to pretrain a DCNN. The DCNN was then fine-tuned using actual patch images. To confirm the effectiveness of the proposed method, we first evaluated the quality of the images which were generated by PGGAN and by a conventional deep convolutional GAN. We then evaluated the classification performance of benign and malignant cells, and confirmed that the generated images had characteristics similar to those of the actual images. Accordingly, we determined that the overall classification accuracy of lung cells was 85.3% which was improved by approximately 4.3% compared to a previously conducted study without pretraining using GAN-generated images. Based on these results, we confirmed that our proposed method will be effective for the classification of cytological images in cases at which only limited data are acquired.	[Teramoto, Atsushi; Yamada, Ayumi; Saito, Kuniaki] Fujita Hlth Univ, Fac Radiol Technol, Sch Med Sci, Toyoake, Aichi, Japan; [Teramoto, Atsushi; Tsukamoto, Tetsuya; Kiriyama, Yuka; Imaizumi, Kazuyoshi] Fujita Hlth Univ, Sch Med, Toyoake, Aichi, Japan; [Fujita, Hiroshi] Gifu Univ, Fac Engn, Dept Elect Elect & Comp Engn, Gifu, Japan	Fujita Health University; Fujita Health University; Gifu University	Teramoto, A (corresponding author), Fujita Hlth Univ, Fac Radiol Technol, Sch Med Sci, Toyoake, Aichi, Japan.; Teramoto, A (corresponding author), Fujita Hlth Univ, Sch Med, Toyoake, Aichi, Japan.	teramoto@fujita-hu.ac.jp	Tsukamoto, Tetsuya/ABD-4397-2020	Tsukamoto, Tetsuya/0000-0002-7502-8724	ministry of education, culture, sports, science and 271 technology, Japan [17K09070]	ministry of education, culture, sports, science and 271 technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This research was partially supported by a Grant-in270 Aid for scientific research (No. 17K09070) from the ministry of education, culture, sports, science and 271 technology, Japan. And there was no additional external funding received for this study.	American Cancer Society, 2015, CANC FACTS FIG 2015; Andrew Zisserman, 2015, Arxiv, DOI arXiv:1409.1556; Arjovsky M., 2017, ARXIV170107875; Frid-Adar M, 2018, NEUROCOMPUTING, V321, P321, DOI 10.1016/j.neucom.2018.09.013; Goodfellow IJ, 2014, ADV NEUR IN, V27, P2672, DOI 10.1145/3422622; Guibas JT., 2017, ARXIV PREPRINT ARXIV; Han CC, 2003, POLYMER CHARACTERIZATION TECHNIQUES AND THEIR APPLICATION TO BLENDS, P1; HE KM, 2016, PROC CVPR IEEE, P770, DOI DOI 10.1109/CVPR.2016.90; Huang G, 2017, PROC CVPR IEEE, P2261, DOI 10.1109/CVPR.2017.243; Inamura K, 2018, CANCERS, V10, DOI 10.3390/cancers10030072; JOHNSTON WW, 1986, PATHOL RES PRACT, V181, P1; Karras T., 2017, PROGR GROWING GANS I; Kingma DP., 2014, ADAM METHOD STOCHAST; Krizhevsky A., 2012, ADV NEURAL INF PROCE; LeCun Y, 2015, NATURE, V521, P436, DOI 10.1038/nature14539; Okazaki T, 2013, NAT IMMUNOL, V14, P1212, DOI 10.1038/ni.2762; Onishi Y, 2020, INT J COMPUT ASS RAD, V15, P173, DOI 10.1007/s11548-019-02092-z; Onishi Y, 2019, BIOMED RES INT, V2019, DOI 10.1155/2019/6051939; Radford A., 2015, ARXIV151106434, DOI DOI 10.1051/0004-6361/201527329; Russakovsky O, 2015, INT J COMPUT VISION, V115, P211, DOI 10.1007/s11263-015-0816-y; Song TH, 2019, IEEE J BIOMED HEALTH, V23, P1469, DOI 10.1109/JBHI.2018.2878945; Szegedy C, 2015, IEEE C COMPUTER VISI, DOI 10.1109/CVPR.2015.7298594; Teramoto A., 2019, INFORM MED UNLOCKED, V16, P100205, DOI [10.1016/j.imu.2019.100205, DOI 10.1016/J.IMU.2019.100205]; Teramoto Atsushi, 2019, Asia Ocean J Nucl Med Biol, V7, P29, DOI 10.22038/AOJNMB.2018.12014; Teramoto A, 2018, INTEL SYST REF LIBR, V140, P87, DOI 10.1007/978-3-319-68843-5_4; Teramoto A, 2017, BIOMED RES INT, V2017, DOI 10.1155/2017/4067832; Teramoto A, 2016, MED PHYS, V43, P2821, DOI 10.1118/1.4948498; Wang JN, 2018, LECT NOTES COMPUT SC, V11070, P3, DOI 10.1007/978-3-030-00928-1_1; Yan K, 2018, J MED IMAGING, V5, DOI 10.1117/1.JMI.5.3.036501; Yi X, 2019, MED IMAGE ANAL, V58, DOI 10.1016/j.media.2019.101552	30	20	21	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2020	15	3							e0229951	10.1371/journal.pone.0229951	http://dx.doi.org/10.1371/journal.pone.0229951			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8RK	32134949	gold, Green Published			2022-12-26	WOS:000535265600063
J	Patel, C; Vaishnav, A; Edwards, BFP; Evans, DR				Patel, Chandni; Vaishnav, Asmita; Edwards, Brian F. P.; Evans, David R.			Characterization and assembly of the Pseudomonas aeruginosa aspartate transcarbamoylase-pseudo dihydroorotase complex	PLOS ONE			English	Article							CARBAMOYL-PHOSPHATE; MULTIFUNCTIONAL PROTEIN; SUBUNIT STRUCTURE; PYRIMIDINE; PURIFICATION; SYNTHETASE; AEOLICUS; GENES; MODEL; CARBAMOYLTRANSFERASE	Pseudomonas aeruginosa is a virulent pathogen that has become more threatening with the emergence of multidrug resistance. The aspartate transcarbamoylase (ATCase) of this organism is a dodecamer comprised of six 37 kDa catalytic chains and six 45 kDa chains homologous to dihydroorotase (pDHO). The pDHO chain is inactive but is necessary for ATCase activity. A stoichiometric mixture of the subunits associates into a dodecamer with full ATCase activity. Unlike other known ATCases, the P. aeruginosa catalytic chain does not spontaneously assemble into a trimer. Chemical-crosslinking and size-exclusion chromatography showed that P. aeruginosa ATCase is monomeric which accounts for its lack of catalytic activity since the active site is a composite comprised of residues from adjacent monomers in the trimer. Circular dichroism spectroscopy indicated that the ATCase chain adopts a structure that contains secondary structure elements although neither the ATCase nor the pDHO subunits are very stable as determined by a thermal shift assay. Formation of the complex increases the melting temperature by about 30 degrees C. The ATCase is strongly inhibited by all nucleotide di- and triphosphates and exhibits extreme cooperativity. Previous studies suggested that the regulatory site is located in an 11-residue extension of the amino end of the catalytic chain. However, deletion of the extensions did not affect catalytic activity, nucleotide inhibition or the assembly of the dodecamer. Nucleotides destabilized the dodecamer which probably accounts for the inhibition and apparent cooperativity of the substrate saturation curves. Contrary to previous interpretations, these results suggest that P. aeruginosa ATCase is not allosterically regulated by nucleotides.	[Patel, Chandni; Vaishnav, Asmita; Edwards, Brian F. P.; Evans, David R.] Wayne State Univ, Sch Med, Dept Biochem Microbiol & Immunol, Detroit, MI 48202 USA	Wayne State University	Evans, DR (corresponding author), Wayne State Univ, Sch Med, Dept Biochem Microbiol & Immunol, Detroit, MI 48202 USA.	drevansplymoutn@gmail.com			American Heart Association [17PRE33660545/Chandni Patel/2017]	American Heart Association(American Heart Association)	CP is funded by American Heart Association Grant #17PRE33660545/Chandni Patel/2017. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABDELAL AT, 1983, EUR J BIOCHEM, V129, P697; ADAIR LB, 1972, J BIOL CHEM, V247, P2308; Ahuja A, 2004, J BIOL CHEM, V279, P53136, DOI 10.1074/jbc.M403009200; BAKER DP, 1995, PROTEIN SCI, V4, P258; BAKER DP, 1993, BIOCHEMISTRY-US, V32, P10150, DOI 10.1021/bi00089a034; BERGH ST, 1993, P NATL ACAD SCI USA, V90, P9818, DOI 10.1073/pnas.90.21.9818; BETHELL MR, 1969, ARCH BIOCHEM BIOPHYS, V134, P352, DOI 10.1016/0003-9861(69)90294-X; BRABSON JS, 1975, J BIOL CHEM, V250, P8664; COLEMAN PF, 1977, J BIOL CHEM, V252, P6379; DENISDUPHIL M, 1990, EUR J BIOCHEM, V193, P581, DOI 10.1111/j.1432-1033.1990.tb19376.x; Evans DR, 2004, J BIOL CHEM, V279, P33035, DOI 10.1074/jbc.R400007200; EVANS DR, 1973, SCIENCE, V179, P683, DOI 10.1126/science.179.4074.683; FAURE M, 1989, EUR J BIOCHEM, V179, P345, DOI 10.1111/j.1432-1033.1989.tb14560.x; FREUND JN, 1987, J MOL BIOL, V193, P1, DOI 10.1016/0022-2836(87)90621-8; GERHART JC, 1965, BIOCHEMISTRY-US, V4, P1054, DOI 10.1021/bi00882a012; HONZATKO RB, 1982, J MOL BIOL, V160, P219, DOI 10.1016/0022-2836(82)90175-9; Hughes LE, 1999, CURR MICROBIOL, V39, P175, DOI 10.1007/s002849900441; JONES ME, 1980, ANNU REV BIOCHEM, V49, P253, DOI 10.1146/annurev.bi.49.070180.001345; KRAUSE KL, 1985, P NATL ACAD SCI USA, V82, P1643, DOI 10.1073/pnas.82.6.1643; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MAKOFF AJ, 1978, MOL GEN GENET, V161, P297, DOI 10.1007/BF00331004; Moreno-Morcillo M, 2017, STRUCTURE, V25, P912, DOI 10.1016/j.str.2017.04.012; NEUMANN J, 1964, ARCH BIOCHEM BIOPHYS, V104, P438, DOI 10.1016/0003-9861(64)90487-4; PASTRALANDIS SC, 1981, ANAL BIOCHEM, V118, P358, DOI 10.1016/0003-2697(81)90594-7; PRESCOTT LM, 1969, ANAL BIOCHEM, V32, P408, DOI 10.1016/S0003-2697(69)80008-4; Purcarea C, 2003, J BIOL CHEM, V278, P52924, DOI 10.1074/jbc.M309383200; ROSENBUSCH JP, 1971, J BIOL CHEM, V246, P1644; SCHURR MJ, 1995, J BACTERIOL, V177, P1751, DOI 10.1128/jb.177.7.1751-1759.1995; STEVENS RC, 1991, P NATL ACAD SCI USA, V88, P6087, DOI 10.1073/pnas.88.14.6087; Vickrey JF, 2002, J BIOL CHEM, V277, P24490, DOI 10.1074/jbc.M200009200; WEBER K, 1968, NATURE, V218, P1116, DOI 10.1038/2181116a0; WILEY DC, 1968, NATURE, V218, P1119, DOI 10.1038/2181119a0; WILLIAMS LG, 1970, BIOCHEMISTRY-US, V9, P4329, DOI 10.1021/bi00824a013; WILLIAMSON CL, 1994, PLANT PHYSIOL, V105, P377, DOI 10.1104/pp.105.1.377; WILLIAMSON CL, 1993, PLANT PHYSIOL, V102, P1055, DOI 10.1104/pp.102.3.1055; Ye F, 2007, SPECTROSC SPECT ANAL, V27, P321; YON RJ, 1984, BIOCHEM J, V221, P281, DOI 10.1042/bj2210281; Zhang PF, 2009, BIOCHEMISTRY-US, V48, P766, DOI 10.1021/bi801831r	39	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2020	15	3							e0229494	10.1371/journal.pone.0229494	http://dx.doi.org/10.1371/journal.pone.0229494			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8MS	32126100	Green Published, gold			2022-12-26	WOS:000535253100026
J	Singh, M; Kumar, S; Basandrai, AK; Basandrai, D; Malhotra, N; Saxena, DR; Gupta, D; Sarker, A; Singh, K				Singh, Mohar; Kumar, Sandeep; Basandrai, Ashwani Kumar; Basandrai, Daisy; Malhotra, Nikhil; Saxena, Deep Rattan; Gupta, Dorin; Sarker, Ashutosh; Singh, Kuldeep			Evaluation and identification of wild lentil accessions for enhancing genetic gains of cultivated varieties	PLOS ONE			English	Article							L.; RESISTANCE; DIVERSITY; TRAITS; YIELD	Domesticated lentil has a relatively narrow genetic base globally and most released varieties are susceptible to severe biotic and abiotic stresses. The crop wild relatives could provide new traits of interest for tailoring novel germplasm and cultivated lentil improvement. The primary objective of this study was to evaluate wild lentil accessions for identification of economically viable agro-morphological traits and resistance against major biotic stresses. The study has revealed substantial variations in seed yield and its important component characters. Further, the diversity analysis of wild accessions showed two major clusters which were bifurcated into sub-clusters, thereby suggesting their wider genetic divergence. However, principal component analysis exhibited that seed yield plant(-1), number of seeds plant(-1), number of pods plant(-1), harvest index and biological yield plant(-1) contributed significantly to the total genetic variation assessed in wild lentil taxa. Moreover, some of the wild accessions collected from Syria and Turkey regions showed resistance against more than one disease indicating rich diversity of lentil genetic resources. The identification of most promising genotypes carrying resistance against major biotic stresses could be utilized in the cultivated or susceptible varieties of lentil for enhancing genetic gains. The study has also identified some trait specific accessions, which could also be taken into the consideration while planning distant hybridization in lentil.	[Singh, Mohar; Malhotra, Nikhil] Natl Bur Plant Genet Resources, Reg Stn, Shimla, India; [Kumar, Sandeep; Singh, Kuldeep] Natl Bur Plant Genet Resources, New Delhi, India; [Basandrai, Ashwani Kumar; Basandrai, Daisy] CSK Himachal Pradesh Agr Univ, Palampur, Himachal Prades, India; [Saxena, Deep Rattan] Rafi Ahmad Kidwai Coll Agr, Sehore, India; [Gupta, Dorin] Univ Melbourne, Fac Vet & Agr Sci, Melbourne, Vic, Australia; [Sarker, Ashutosh] Int Ctr Agr Res Dry Areas, South Asia & China Reg Programme, New Delhi, India	Indian Council of Agricultural Research (ICAR); ICAR - National Bureau of Plant Genetics Resources; Indian Council of Agricultural Research (ICAR); ICAR - National Bureau of Plant Genetics Resources; Ch. Sarwan Kumar Himachal Pradesh Krishi Vishvavidyalaya; University of Melbourne	Singh, M (corresponding author), Natl Bur Plant Genet Resources, Reg Stn, Shimla, India.	singhmohar_2003@yahoo.com	Malhotra, Nikhil/AAG-5968-2021	Malhotra, Nikhil/0000-0001-9517-1029; Singh, Kuldeep/0000-0001-5239-6586; singh, mohar/0000-0002-5644-9144; Gupta, Dorin/0000-0003-2375-0237	Regional Coordinator of South Asia and China Regional Programme	Regional Coordinator of South Asia and China Regional Programme	Authors thank the Regional Coordinator of South Asia and China Regional Programme for grant in aid to accomplish the proposed research.	Abo-Hegozy S R, 2012, EGYPTIAN J PLANT BRE, V16, P147; Arumuganathan K, 1991, PLANT MOL BIOL REP, V9, P208, DOI DOI 10.1007/BF02672069; Bayaa B, 1997, EUPHYTICA, V98, P69, DOI 10.1023/A:1003022830846; Bayaa B., 1990, Arab Journal of Plant Protection, V8, P30; BAYAA B, 1995, GENET RESOUR CROP EV, V42, P231, DOI 10.1007/BF02431257; Burton GW, 1952, P 454 INT GRASSL C; Duvick DN, 1984, ECO BOT, V38, P151, DOI DOI 10.1007/BF02858829; Eujayl I, 1998, PLANT BREEDING, V117, P497, DOI 10.1111/j.1439-0523.1998.tb01982.x; Ferguson ME, 2000, BOT J LINN SOC, V133, P41, DOI 10.1111/j.1095-8339.2000.tb01536.x; Food and Agriculture Organization (FAO), 2017, FAO STAT DAT UN; Ghulam Sarwar, 2013, Journal of Agricultural Research (Lahore), V51, P239; Gupta SK, 2018, CROP J, V6, P271, DOI 10.1016/j.cj.2017.09.008; JOHNSON HERBERT W., 1955, AGRON JOUR, V47, P314; Kumar S, 2003, INDIAN SOC PULSES RE; Kumar S, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191122; Kumar S, 2013, GENET RESOUR CROP EV, V60, P2017, DOI 10.1007/s10722-013-9970-7; Lane A, 2007, CLIMATE PROOFING INN; Lazaro A, 2001, GENET RESOUR CROP EV, V48, P239, DOI 10.1023/A:1011234126154; Lush J.L., 1940, P AM SOC ANIM PROD, P293; Luthra SK, 1990, LENS NEW LETT, V7, P5; Maxted N., 2008, CROP WILD RELATIVE C; Mayee C.D., 1986, USDA TECHNICAL B, V1; Naghavi MR, 2005, J INTEGR PLANT BIOL, V47, P375, DOI 10.1111/j.1744-7909.2005.00058.x; Perrier X, 2003, GENETIC DIVERSITY CU; Sharpley R, 2009, ASPEC TOUR, P1; Singh M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107781; Tiwari KR, 1997, CAN J PLANT PATHOL, V19, P267, DOI 10.1080/07060669709500522; Toklu F, 2017, J AGR SCI-TARIM BILI, V23, P213; Vieira EA, 2007, GENET MOL BIOL, V30, P392, DOI 10.1590/S1415-47572007000300016; Wong MML, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122025	30	10	10	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2020	15	3							e0229554	10.1371/journal.pone.0229554	http://dx.doi.org/10.1371/journal.pone.0229554			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8MS	32126106	gold, Green Published			2022-12-26	WOS:000535253100030
J	Smejkal, M; Barton, D; Ded, V; Souza, AT; Blabolil, P; Vejrik, L; Sajdlova, Z; Riha, M; Kubecka, J				Smejkal, Marek; Barton, Daniel; Ded, Vilem; Souza, Allan T.; Blabolil, Petr; Vejrik, Lukas; Sajdlova, Zuzana; Riha, Milan; Kubecka, Jan			Negative feedback concept in tagging: Ghost tags imperil the long-term monitoring of fishes	PLOS ONE			English	Article							INTEGRATED TRANSPONDER TAGS; PIT-TAGGED FISH; DETECTION EFFICIENCY; JUVENILE SALMONIDS; RETENTION RATES; TRACKING; SYSTEM; IDENTIFICATION; PERFORMANCE; MANAGEMENT	Wildlife monitoring using passive telemetry has become a robust method for investigating animal migration. With increased use, this method progressively pollutes the environment with technological waste represented by so called ghost tags (PIT tags ending in the environment due to reproductive expulsions, shedding or animal mortality). However, their presence in the environment may lead to failed detections of living individuals. We used tagging data from studies of the asp Leuciscus aspius and the bleak Alburnus alburnus collected from 2014 to 2018 and located ghost tag positions on the monitored spawning site using portable backpack reader for their detection. We modelled virtual river-wide flat-bed antennas (widths 0.2, 0.4, 0.6 and 0.8 m) representing monitoring effort and estimated the probability of the presence of ghost tags within the antenna field. Of 3724 PIT tags used in the study, we detected on the spawning ground 173 ghost tags originating from long-term monitoring. The ghost tags accumulated in the environment in time, suggesting insufficient degradation rate or shift downstream from the research site. Number of ghost tags present on the spawning ground led to high probability of disabled readings of tagged fish passing through the antenna electro-magnetic field. We demonstrate how accumulated ghost tags may cause detection failures for focal species and incomplete data acquisition. We infer that intensive long-term monitoring using PIT tag technology may encumber future data acquisition or entail additional costs for clean-up.	[Smejkal, Marek; Barton, Daniel; Ded, Vilem; Souza, Allan T.; Blabolil, Petr; Vejrik, Lukas; Sajdlova, Zuzana; Riha, Milan; Kubecka, Jan] Czech Acad Sci, Inst Hydrobiol, Biol Ctr, Ceske Budejovice, Czech Republic	Czech Academy of Sciences; Biology Centre of the Czech Academy of Sciences	Smejkal, M (corresponding author), Czech Acad Sci, Inst Hydrobiol, Biol Ctr, Ceske Budejovice, Czech Republic.	marek.smejkal@hbu.cas.cz	Souza, Allan T./I-8799-2012; Bartoň, Daniel/ABE-2952-2021; Riha, Milan/G-1065-2014; Šmejkal, Marek/E-1269-2017; Bartoň, Daniel/AAD-2407-2021; Vejřík, Lukáš/E-1607-2017; Kubecka, Jan/A-8230-2011; Blabolil, Petr/N-8719-2019	Souza, Allan T./0000-0002-1851-681X; Bartoň, Daniel/0000-0001-8042-4564; Riha, Milan/0000-0002-3930-420X; Šmejkal, Marek/0000-0002-7887-6411; Bartoň, Daniel/0000-0001-8042-4564; Vejřík, Lukáš/0000-0001-8911-9128; Kubecka, Jan/0000-0001-9203-4854; Blabolil, Petr/0000-0003-1344-9627; Ded, Vilem/0000-0001-9235-8496	NAZV" [QK1920326, QK1920011]; project "The enhancement of rheophilous fish reproduction in the artificial river environment" [TJ02000012]; project "Biomanipulation as a tool for improving water quality of dam reservoirs" [CZ.02.1.01/0.0/0.0/16_025/0007417]	NAZV"; project "The enhancement of rheophilous fish reproduction in the artificial river environment"; project "Biomanipulation as a tool for improving water quality of dam reservoirs"	This research was supported by NAZV project "Aquaculture of rheophilous fish" (No. QK1920326) and "Methodology of predatory fish quantification in drinking-water reservoirs to optimize the management of aquatic ecosystems" (QK1920011), by project "The enhancement of rheophilous fish reproduction in the artificial river environment"(No. TJ02000012) and by the project "Biomanipulation as a tool for improving water quality of dam reservoirs" (No. CZ.02.1.01/0.0/0.0/16_025/0007417). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarestrup K, 2009, SCIENCE, V325, P1660, DOI 10.1126/science.1178120; Bateman DS, 2009, N AM J FISH MANAGE, V29, P653, DOI 10.1577/M07-169.1; Baxter-Gilbert JH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120537; Bistulfi G, 2013, NATURE, V502, P170, DOI 10.1038/502170a; Boisvert MJ, 2000, PHYSIOL BEHAV, V71, P147, DOI 10.1016/S0031-9384(00)00317-6; Bond MH, 2007, T AM FISH SOC, V136, P562, DOI 10.1577/T06-084.1; Bond RM, 2019, CAN J FISH AQUAT SCI, V76, P286, DOI 10.1139/cjfas-2017-0409; Bonter DN, 2011, J FIELD ORNITHOL, V82, P1, DOI 10.1111/j.1557-9263.2010.00302.x; BRANNAS E, 1994, T AM FISH SOC, V123, P395, DOI 10.1577/1548-8659(1994)123<0395:UOTPIT>2.3.CO;2; Bronmark C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001957; Bubb DH, 2002, HYDROBIOLOGIA, V483, P225, DOI 10.1023/A:1021352217332; Burnett NJ, 2013, N AM J FISH MANAGE, V33, P7, DOI 10.1080/02755947.2012.734895; Castro-Santos T, 1996, FISH RES, V28, P253, DOI 10.1016/0165-7836(96)00514-0; Clay CA, 2009, P R SOC B, V276, P1305, DOI 10.1098/rspb.2008.1693; Cooke S.J., 2013, ANIMAL BIOTELEMETRY, V1, P1, DOI DOI 10.1186/2050-3385-1-5; Cooke SJ, 2011, REV FISH BIOL FISHER, V21, P127, DOI 10.1007/s11160-010-9193-3; Dieterman DJ, 2009, N AM J FISH MANAGE, V29, P109, DOI 10.1577/M07-223.1; Fetherman ER, 2014, N AM J FISH MANAGE, V34, P1065, DOI 10.1080/02755947.2014.943859; Geyer R, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1700782; Gianasi BL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127884; Gibbons JW, 2004, BIOSCIENCE, V54, P447, DOI 10.1641/0006-3568(2004)054[0447:PTSTAI]2.0.CO;2; Greenberg LA, 2000, ECOL FRESHW FISH, V9, P74, DOI 10.1034/j.1600-0633.2000.90108.x; Hewitt DA, 2010, FISHERIES, V35, P217, DOI 10.1577/1548-8446-35.5.217; Jambeck JR, 2015, SCIENCE, V347, P768, DOI 10.1126/science.1260352; JEMISON SC, 1995, J HERPETOL, V29, P129, DOI 10.2307/1565098; Johnston P, 2009, J FISH BIOL, V74, P1651, DOI 10.1111/j.1095-8649.2009.02211.x; Lindenmayer DB, 2009, TRENDS ECOL EVOL, V24, P482, DOI 10.1016/j.tree.2009.03.005; Lucas MC., 2001, MIGRATION FRESHWATER, DOI [10.1002/9780470999653, DOI 10.1002/9780470999653]; Mamer ERJM, 2016, N AM J FISH MANAGE, V36, P1119, DOI 10.1080/02755947.2016.1198288; Meyer KA, 2011, N AM J FISH MANAGE, V31, P236, DOI 10.1080/02755947.2011.572799; Musselman WC, 2017, J FISH WILDL MANAG, V8, P353, DOI 10.3996/122016-JFWM-091; Nguyen VM, 2018, CAN J FISH AQUAT SCI, V75, P1733, DOI 10.1139/cjfas-2017-0303; O'Donnell MJ, 2010, N AM J FISH MANAGE, V30, P323, DOI 10.1577/M09-008.1; Prchalova M, 2008, J FISH BIOL, V73, P54, DOI 10.1111/j.1095-8649.2008.01906.x; QGIS Development Team, 2016, OP SOURC GEOSP FDN P, DOI [10.1093/cid/cis430, DOI 10.1093/CID/CIS430]; R Core Team, 2013, R LANG ENV STAT COMP; Radinger J, 2019, FISH FISH, V20, P729, DOI 10.1111/faf.12373; Ragaert K, 2017, WASTE MANAGE, V69, P24, DOI 10.1016/j.wasman.2017.07.044; Roussel JM, 2000, CAN J FISH AQUAT SCI, V57, P1326, DOI 10.1139/cjfas-57-7-1326; Schmidt T, 2016, N AM J FISH MANAGE, V36, P951, DOI 10.1080/02755947.2016.1173143; Schneider J.M., 2010, RIVER FLOW 2010 P IN, P1723; Skalski JR, 1998, CAN J FISH AQUAT SCI, V55, P1484, DOI 10.1139/cjfas-55-6-1484; Skov C, 2005, J FISH BIOL, V67, P1195, DOI 10.1111/j.1095-8649.2005.00814.x; Sloat MR, 2011, N AM J FISH MANAGE, V31, P986, DOI 10.1080/02755947.2011.635486; Smejkal M., 2016, POPULATION SIZE AGE; Smejkal M, 2019, FISH RES, V219, DOI 10.1016/j.fishres.2019.105325; Smejkal M, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-33615-4; Smejkal M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-04827-x; Tsoar A, 2011, P NATL ACAD SCI USA, V108, pE718, DOI 10.1073/pnas.1107365108; Urbina MA, 2015, NATURE, V528, P479, DOI 10.1038/528479c; Weber L, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0219069; Windfeld ES, 2015, J ENVIRON MANAGE, V163, P98, DOI 10.1016/j.jenvman.2015.08.013; Wood SN, 2011, J R STAT SOC B, V73, P3, DOI 10.1111/j.1467-9868.2010.00749.x; Zakes Z, 2017, AQUAC RES, V48, P5791, DOI 10.1111/are.13402; Zydlewski GB, 2001, J FISH BIOL, V58, P1471, DOI 10.1006/jfbi.2000.1540	55	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2020	15	3							e0229350	10.1371/journal.pone.0229350	http://dx.doi.org/10.1371/journal.pone.0229350			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8JT	32119687	Green Published, gold			2022-12-26	WOS:000535245300022
J	Vaidya, JD; van Gastelen, S; Smidt, H; Plugge, CM; Edwards, JE				Vaidya, Jueeli D.; van Gastelen, Sanne; Smidt, Hauke; Plugge, Caroline M.; Edwards, Joan E.			Characterization of dairy cow rumen bacterial and archaeal communities associated with grass silage and maize silage based diets	PLOS ONE			English	Article							ENTERIC METHANE PRODUCTION; RIBOSOMAL-RNA GENES; CORN-SILAGE; RUMINAL FERMENTATION; DIVERSITY; PH; SUPPLEMENTATION; METHANOGENESIS; PERFORMANCE; MITIGATION	The objective of the present study was to characterize the rumen bacterial and archaeal communities in dairy cows fed different ratios of maize silage (MS) and grass silage (GS), and place the findings in the context of ruminal fermentation as well as previously reported methane (CH4) emissions. Rumen fluid from 12 rumen cannulated dairy cows was collected after 10 and 17 days of feeding one of four diets, all of which had the same roughage to concentrate ratio of 80:20 based on dry matter (DM). Roughage in the four diets (GS100, GS0, GS67, GS33) consisted of either 1000 g/kg DM GS (GS100), 1000 g/kg DM MS (GS0), or a mixture of both silages in different proportions [667 g/kg DM GS and 333 g/kg DM MS (GS67); 333 g/kg DM GS and 677 g/kg DM MS (GS33)]. Total volatile fatty acid (VFA) concentrations and the molar proportions of the ruminal VFA were not affected by diet. Only the molar proportion of isovalerate was affected by time, being lower on day 17 than on day 10. Bacterial and archaeal concentrations were not affected by diet but increased from day 10 to day 17. The bacterial community composition was affected by diet, time and diet x time, whereas the archaeal community composition was only affected by diet. Several bacterial and archaeal genus level groups were associated with diet, but not with time. Analysis indicated the increased use of hydrogen by succinate and lactate producing bacteria is likely to at least partially explain the previously reported lower CH4 emissions from MS fed dairy cows. Furthermore, time had a significant effect on both bacterial and archaeal concentrations, and also bacterial community composition. This indicates that the rumen microbiota had not stabilized after 10 days of feeding the experimental diets.	[Vaidya, Jueeli D.; van Gastelen, Sanne; Edwards, Joan E.] Top Inst Food & Nutr, Wageningen, Netherlands; [Vaidya, Jueeli D.; Smidt, Hauke; Plugge, Caroline M.; Edwards, Joan E.] Wageningen Univ & Res, Lab Microbiol, Wageningen, Netherlands; [van Gastelen, Sanne] Wageningen Univ & Res, Anim Nutr Grp, Wageningen, Netherlands; [Vaidya, Jueeli D.] DuPont Co Inc, Leiden, Netherlands; [van Gastelen, Sanne] Wageningen Livestock Res, Wageningen, Netherlands	Top Institute Food & Nutrition; Wageningen University & Research; Wageningen University & Research; Wageningen University & Research	Smidt, H (corresponding author), Wageningen Univ & Res, Lab Microbiol, Wageningen, Netherlands.	Hauke.Smidt@wur.nl	Smidt, Hauke/D-7054-2014; Edwards, Joan/I-5797-2015	Smidt, Hauke/0000-0002-6138-5026; van Gastelen, Sanne/0000-0003-4547-8449; Edwards, Joan/0000-0003-0759-633X	TI Food and Nutrition [ME001]	TI Food and Nutrition	This work was funded by the TI Food and Nutrition (https://www.tifn.nl/) program `Reduced methane emissions from dairy cows: towards sustainable dairy cattle production by increased understanding of genetic variation and rumen functioning' (ME001). The funder provided support in the form of salaries for authors JDV, JEE and SvG, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the `author contributions' section.	Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; Brask M, 2013, ANIM FEED SCI TECH, V184, P67, DOI 10.1016/j.anifeedsci.2013.06.006; Carberry CA, 2014, APPL ENVIRON MICROB, V80, P586, DOI 10.1128/AEM.03131-13; Clemmons BA, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-45995-2; Creevey CJ, 2014, MICROB BIOTECHNOL, V7, P467, DOI 10.1111/1751-7915.12141; Cunha CS, 2019, J SCI FOOD AGR, V99, P210, DOI 10.1002/jsfa.9162; Daims H, 1999, SYST APPL MICROBIOL, V22, P434, DOI 10.1016/S0723-2020(99)80053-8; Danielsson R, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00226; de Menezes AB, 2011, FEMS MICROBIOL ECOL, V78, P256, DOI 10.1111/j.1574-6941.2011.01151.x; Deckardt K, 2013, NUTRIENTS, V5, P1970, DOI 10.3390/nu5061970; Deusch S, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01605; FENNER H, 1970, J DAIRY SCI, V53, P1568, DOI 10.3168/jds.S0022-0302(70)86438-4; FREIER TA, 1994, INT J SYST BACTERIOL, V44, P137, DOI 10.1099/00207713-44-1-137; Hamady M, 2008, NAT METHODS, V5, P235, DOI 10.1038/NMETH.1184; Henderson G, 2015, SCI REP-UK, V5, DOI 10.1038/srep14567; Hook SE, 2010, ARCHAEA, V2010, DOI 10.1155/2010/945785; Hristov AN, 2013, J ANIM SCI, V91, P5095, DOI 10.2527/jas.2013-6585; Jami E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033306; Jiang SZ, 2015, J ANIM SCI, V93, P5378, DOI 10.2527/jas.2015-9547; Kembel SW, 2010, BIOINFORMATICS, V26, P1463, DOI 10.1093/bioinformatics/btq166; Kittelmann S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103171; Kozakai K, 2007, CAN J ANIM SCI, V87, P259, DOI 10.4141/A06-028; Kvist T, 2007, FEMS MICROBIOL ECOL, V59, P71, DOI 10.1111/j.1574-6941.2006.00209.x; Lahti L., TOOLS MICROBIOME ANA; Lettat A, 2013, J DAIRY SCI, V96, P5237, DOI 10.3168/jds.2012-6481; Liu Q, 2016, J AGR SCI-CAMBRIDGE, V154, P1499, DOI 10.1017/S0021859616000630; Madden UA, 1999, J FOOD SCI, V64, P903, DOI 10.1111/j.1365-2621.1999.tb15937.x; Mao SY, 2015, SCI REP-UK, V5, DOI 10.1038/srep16116; Masson-Delmotte V., 2018, GLOBAL WARMING 15 C; McCabe MS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133234; Morgavi DP, 2010, ANIMAL, V4, P1024, DOI 10.1017/S1751731110000546; Oksanen J., 2019, R PACKAGE VERSION; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Pitta DW, 2010, MICROB ECOL, V59, P511, DOI 10.1007/s00248-009-9609-6; Poncheewin W, 2020, FRONT GENET, V10, DOI 10.3389/fgene.2019.01366; Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219; R Core Team, 2021, R LANGUAGE ENV STAT; Ramiro-Garcia Javier, 2016, F1000Res, V5, P1791, DOI 10.12688/f1000research.9227.2; Suzuki MT, 2000, APPL ENVIRON MICROB, V66, P4605, DOI 10.1128/AEM.66.11.4605-4614.2000; Tapio I, 2017, J ANIM SCI BIOTECHNO, V8, DOI 10.1186/s40104-017-0141-0; Tian LM, 2016, MOL NUTR FOOD RES, V60, P2256, DOI 10.1002/mnfr.201600149; van den Bogert B, 2013, FEMS MICROBIOL ECOL, V85, P376, DOI 10.1111/1574-6941.12127; van den Bogert B, 2011, APPL ENVIRON MICROB, V77, P2071, DOI 10.1128/AEM.02477-10; van Gastelen S, 2017, J DAIRY SCI, V100, P8939, DOI 10.3168/jds.2016-12367; van Gastelen S, 2015, J DAIRY SCI, V98, P1915, DOI 10.3168/jds.2014-8552; van Lingen HJ, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00425; van Lingen HJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161362; van Zijderveld SM, 2010, J DAIRY SCI, V93, P5856, DOI 10.3168/jds.2010-3281; VanKessel JAS, 1996, FEMS MICROBIOL ECOL, V20, P205, DOI 10.1016/0168-6496(96)00030-X; Wallace RJ, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-2032-0; Wallace RJ, 2014, SCI REP-UK, V4, DOI 10.1038/srep05892; Wang YF, 2009, PLOS ONE, V4, DOI [10.1371/journal.pone.0005368, 10.1371/journal.pone.0007401]; Wu WT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033200; Yu Y, 2005, BIOTECHNOL BIOENG, V89, P670, DOI 10.1002/bit.20347	55	4	4	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2020	15	3							e0229887	10.1371/journal.pone.0229887	http://dx.doi.org/10.1371/journal.pone.0229887			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8JT	32119709	Green Published, gold			2022-12-26	WOS:000535245300044
J	Khan, O; Ahmed, I; Cottingham, J; Rahhal, M; Arvanitis, TN; Elliott, MT				Khan, Omar; Ahmed, Imran; Cottingham, Joshua; Rahhal, Musa; Arvanitis, Theodoros N.; Elliott, Mark T.			Timing and correction of stepping movements with a virtual reality avatar	PLOS ONE			English	Article							PHASE-CORRECTION; SENSORIMOTOR SYNCHRONIZATION; SHIFTS; PERCEPTION; METRONOME; VELOCITY; BEAT	Research into the ability to coordinate one's movements with external cues has focussed on the use of simple rhythmic, auditory and visual stimuli, or interpersonal coordination with another person. Coordinating movements with a virtual avatar has not been explored, in the context of responses to temporal cues. To determine whether cueing of movements using a virtual avatar is effective, people's ability to accurately coordinate with the stimuli needs to be investigated. Here we focus on temporal cues, as we know from timing studies that visual cues can be difficult to follow in the timing context. Real stepping movements were mapped onto an avatar using motion capture data. Healthy participants were then motion captured whilst stepping in time with the avatar's movements, as viewed through a virtual reality headset. The timing of one of the avatar step cycles was accelerated or decelerated by 15% to create a temporal perturbation, for which participants would need to correct to, in order to remain in time. Step onset times of participants relative to the corresponding step-onsets of the avatar were used to measure the timing errors (asynchronies) between them. Participants completed either a visual-only condition, or auditory-visual with footstep sounds included, at two stepping tempo conditions (Fast: 400ms interval, Slow: 800ms interval). Participants' asynchronies exhibited slow drift in the Visual-Only condition, but became stable in the Auditory-Visual condition. Moreover, we observed a clear corrective response to the phase perturbation in both the fast and slow tempo auditory-visual conditions. We conclude that an avatar's movements can be used to influence a person's own motion, but should include relevant auditory cues congruent with the movement to ensure a suitable level of entrainment is achieved. This approach has applications in physiotherapy, where virtual avatars present an opportunity to provide the guidance to assist patients in adhering to prescribed exercises.	[Khan, Omar; Arvanitis, Theodoros N.; Elliott, Mark T.] Univ Warwick, Inst Digital Healthcare, Warwick Mfg Grp, Coventry, W Midlands, England; [Ahmed, Imran] Univ Warwick, Warwick Med Sch, Coventry, W Midlands, England; [Cottingham, Joshua] Univ Warwick, Dept Comp Sci, Coventry, W Midlands, England; [Rahhal, Musa] Univ Warwick, Sch Engn, Coventry, W Midlands, England	University of Warwick; University of Warwick; University of Warwick; University of Warwick	Elliott, MT (corresponding author), Univ Warwick, Inst Digital Healthcare, Warwick Mfg Grp, Coventry, W Midlands, England.	m.t.elliott@warwick.ac.uk	Arvanitis, Theodoros N/C-9210-2009	Arvanitis, Theodoros N/0000-0001-5473-135X; Ahmed, Imran/0000-0003-2774-9954; Khan, Omar/0000-0001-6851-3804	Department of Health [DRF-2018-11-ST2-030] Funding Source: Medline	Department of Health		Alais D., 2010, SEEING PERCEIVING; Armstrong A, 2014, EXP BRAIN RES, V232, P3453, DOI 10.1007/s00221-014-4031-9; Armstrong A, 2013, NEUROSCI LETT, V548, P212, DOI 10.1016/j.neulet.2013.05.013; Bank PJM, 2011, EXP BRAIN RES, V209, P159, DOI 10.1007/s00221-010-2531-9; Booth AJ, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.00866; Bovend'Eerdt TJH, 2009, CLIN REHABIL, V23, P352, DOI 10.1177/0269215508101741; Campbell R, 2001, J EPIDEMIOL COMMUN H, V55, P132, DOI 10.1136/jech.55.2.132; Chen HY, 2006, GAIT POSTURE, V23, P307, DOI 10.1016/j.gaitpost.2005.04.001; Chen LH, 2013, ATTEN PERCEPT PSYCHO, V75, P244, DOI [10.3758/s13414-012-0395-8, 10.3758/s13414-013-0475-4]; DAVIS RB, 1991, HUM MOVEMENT SCI, V10, P575, DOI 10.1016/0167-9457(91)90046-Z; Elliott MT, 2010, EUR J NEUROSCI, V31, P1828, DOI 10.1111/j.1460-9568.2010.07205.x; Elliott MT, 2009, EXP BRAIN RES, V192, P731, DOI 10.1007/s00221-008-1646-8; Elliott M. T., 2014, P R SOC B; Haggard Patrick, 2008, SENSORIMOTOR FDN HIG; Hajnal A, 2012, EXP BRAIN RES, V221, P351, DOI 10.1007/s00221-009-1982-3; Hove MJ, 2010, J EXP PSYCHOL HUMAN, V36, P1525, DOI 10.1037/a0019059; Jacoby N., 2015, TIMING TIME PERCEPT, V3, P52, DOI DOI 10.1163/22134468-00002048; Jelic A, 2012, PHYS REV E, V86, DOI 10.1103/PhysRevE.86.046111; Johnson L, 2013, PHYS THER, V93, P957, DOI 10.2522/ptj.20120300; Kording KP, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000943; Kurgansky A. V., 2008, Human Physiology, V34, P289, DOI 10.1134/S0362119708030043; Meerhoff LA, 2014, NEUROSCI LETT, V582, P12, DOI 10.1016/j.neulet.2014.08.022; Mustapha NAC, 2016, C IND ELECT APPL, P323, DOI 10.1109/IEACON.2016.8067399; OBERG T, 1993, J REHABIL RES DEV, V30, P210; Pietraszewski B, 2012, ACTA BIOENG BIOMECH, V14, P9, DOI 10.5277/abb120302; Repp B. H., 1997, PSYCHON B REV; Repp BH, 2005, PSYCHON B REV, V12, P969, DOI 10.3758/BF03206433; Repp BH, 2002, J EXP PSYCHOL HUMAN, V28, P410, DOI 10.1037//0096-1523.28.2.410; Repp BH, 2001, J EXP PSYCHOL HUMAN, V27, P600, DOI 10.1037/0096-1523.27.3.600; Repp BH, 2012, ACTA PSYCHOL, V139, P281, DOI 10.1016/j.actpsy.2011.11.002; Repp BH, 2011, J MOTOR BEHAV, V43, P213, DOI 10.1080/00222895.2011.561377; Rio KW, 2014, J VISION, V14, DOI 10.1167/14.2.4; Rizzolatti G, 2001, NAT REV NEUROSCI, V2, P661, DOI 10.1038/35090060; Rizzolatti G, 2004, ANNU REV NEUROSCI, V27, P169, DOI 10.1146/annurev.neuro.27.070203.144230; Rodger MWM, 2011, EXP BRAIN RES, V214, P393, DOI 10.1007/s00221-011-2837-2; Sejdi E., 2012, PLOS ONE, V7; Su YH, 2016, FRONT HUM NEUROSCI, V10, DOI 10.3389/fnhum.2016.00186; Su YH, 2014, BRAIN COGNITION, V90, P19, DOI 10.1016/j.bandc.2014.05.003; Su YH, 2014, ACTA PSYCHOL, V151, P40, DOI 10.1016/j.actpsy.2014.05.016; Su YH, 2014, COGNITION, V131, P330, DOI 10.1016/j.cognition.2014.02.004; Varlet M, 2014, J EXP PSYCHOL HUMAN, V40, P1849, DOI 10.1037/a0037417; Vorberg D, 2002, J MATH PSYCHOL, V46, P56, DOI 10.1006/jmps.2001.1375; Vorberg D., 1996, HDB PERCEPTION ACTIO, V2nd; Wright RL, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00724; Young W., 2013, J EXP PSYCHOL HUM PE; Zivotofsky AZ, 2012, HUM MOVEMENT SCI, V31, P1268, DOI 10.1016/j.humov.2012.01.003	46	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2020	15	2							e0229641	10.1371/journal.pone.0229641	http://dx.doi.org/10.1371/journal.pone.0229641			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LQ8HR	32109252	Green Published, gold			2022-12-26	WOS:000535239800020
J	Egnell, M; Galan, P; Farpour-Lambert, NJ; Talati, Z; Pettigrew, S; Hercberg, S; Julia, C				Egnell, Manon; Galan, Pilar; Farpour-Lambert, Nathalie J.; Talati, Zenobia; Pettigrew, Simone; Hercberg, Serge; Julia, Chantal			Compared to other front-of-pack nutrition labels, the Nutri-Score emerged as the most efficient to inform Swiss consumers on the nutritional quality of food products	PLOS ONE			English	Article							HEALTHY FOOD; IMPACT; CHOICES; PURCHASES; SYSTEMS; PERCEPTIONS; PERFORMANCE; ATTENTION; SELECTION; WARNINGS	Background Switzerland, like other high-income countries, is facing a major public health challenge with the increasing burden of non-communicable diseases. Discussions are currently on-going in Switzerland regarding the implementation of a Front-of-Pack nutrition label (FoPL) as a public health measure to guide consumers towards healthier food choices, and the Nutri-Score represents an alternative supported by multiple actors. To date, no studies have investigated the performance of the Nutri-Score among Swiss consumers. This study aimed to compare the response of Swiss consumers to five FoPLs (Health Star Rating system, Multiple Traffic Lights, Nutri-Score, Reference Intakes and Warning symbol) in terms of perception and understanding of these labels and effects on food choices. Methods In 2019, 1,088 Swiss consumers were recruited and asked to select one product from among a set of three foods with different nutritional profiles and then classify the products within the sets according to their nutritional quality. Tasks were performed in situations without a label and then with one of the five FoPLs-depending on the group in which they were randomized-on the pack. Finally, participants were questioned on their perceptions regarding the label to which they were exposed. Results All FoPLs were favorably perceived, with marginal differences between FoPLs. The Nutri-Score demonstrated the highest percentage of improvement in food choices and the highest overall performance in helping consumers rank the products according to their nutritional quality. Conclusion Overall, the Nutri-Score was the most efficient FoPL in informing Swiss consumers of the nutritional quality of food products, and as such could be a useful tool to improve food choices and reduce the burden of chronic diseases in Switzerland.	[Egnell, Manon; Galan, Pilar; Hercberg, Serge; Julia, Chantal] Paris 13 Univ, Nutr Epidemiol Res Team EREN, Epidemiol & Stat Res Ctr CRESS, Sorbonne Paris Cite,U1153 Inserm,U1125,Inra,Cnam, Bobigny, France; [Farpour-Lambert, Nathalie J.] Univ Hosp Geneva, Dept Primary Care, Geneva, Switzerland; [Talati, Zenobia] Curtin Univ, Sch Psychol, Bentley, WA, Australia; [Pettigrew, Simone] Georges Inst, Sydney, Australia; [Hercberg, Serge; Julia, Chantal] Avicenne Hosp, AP HP, Publ Hlth Dept, Bobigny, France	heSam Universite; Conservatoire National Arts & Metiers (CNAM); INRAE; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; University of Geneva; Curtin University; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Avicenne - APHP	Egnell, M (corresponding author), Paris 13 Univ, Nutr Epidemiol Res Team EREN, Epidemiol & Stat Res Ctr CRESS, Sorbonne Paris Cite,U1153 Inserm,U1125,Inra,Cnam, Bobigny, France.	m.egnell@eren.smbh.univ-paris13.fr	Chantal, Julia/F-2805-2017; HERCBERG, SERGE/F-3038-2017	Chantal, Julia/0000-0003-2006-5269; Pettigrew, Simone/0000-0003-3921-1174; HERCBERG, SERGE/0000-0002-3168-1350				Acton RB, 2019, INT J BEHAV NUTR PHY, V16, DOI 10.1186/s12966-019-0799-0; Acton RB, 2018, PREV MED, V115, P83, DOI 10.1016/j.ypmed.2018.08.022; Acton RB, 2018, APPETITE, V121, P129, DOI 10.1016/j.appet.2017.11.089; Alevizos D, 1992, REV STATISTIQUE APPL, V40, P27; Ares G, 2018, FOOD QUAL PREFER, V68, P215, DOI 10.1016/j.foodqual.2018.03.007; Arrua A, 2017, APPETITE, V116, P139, DOI 10.1016/j.appet.2017.04.012; Aschemann-Witzel J, 2013, APPETITE, V71, P63, DOI 10.1016/j.appet.2013.07.004; Balcombe K, 2010, FOOD POLICY, V35, P211, DOI 10.1016/j.foodpol.2009.12.005; Becker MW, 2016, APPL ERGON, V54, P90, DOI 10.1016/j.apergo.2015.11.014; Bialkova S, 2014, APPETITE, V76, P66, DOI 10.1016/j.appet.2013.11.021; Bochud M., 2017, ANTHROPOMETRIC CHARA, P83; Campos S, 2011, PUBLIC HEALTH NUTR, V14, P1496, DOI 10.1017/S1368980010003290; Carrad AM, 2015, AUST NZ J PUBL HEAL, V39, P355, DOI 10.1111/1753-6405.12386; CARRENO I, 2015, EUR J RISK REGUL, V6, P622, DOI DOI 10.1017/S1867299X0000516X; Cecchini M, 2016, OBES REV, V17, P201, DOI 10.1111/obr.12364; Chantal J, 2017, PUBLIC HLTH PANORAMA, V3, P712, DOI DOI 10.1016/S2468-2667(18)30009-4; Cowburn G, 2005, PUBLIC HEALTH NUTR, V8, P21, DOI [10.1079/PHN2005666, 10.1079/PHN2004666]; Crosetto P, 2016, CAHIER NUTR DIETETIQ, P124; Crosetto P, 2017, CAH NUTR DIET, V52, P129, DOI 10.1016/j.cnd.2017.04.002; Dodds P, 2014, APPETITE, V73, P23, DOI 10.1016/j.appet.2013.10.013; Ducrot P, 2016, AM J PREV MED, V50, P627, DOI 10.1016/j.amepre.2015.10.020; Ducrot P, 2015, NUTRIENTS, V7, P7106, DOI 10.3390/nu7085325; Egnell M., 2019, Ernaehrungs-Umschau, V66, P76, DOI 10.4455/eu.2019.020; Egnell M, 2018, NUTRIENTS, V10, DOI 10.3390/nu10101542; Egnell M, 2019, NUTRIENTS, V11, DOI 10.3390/nu11081817; Egnell M, 2019, INT J BEHAV NUTR PHY, V16, DOI 10.1186/s12966-019-0817-2; Egnell M, 2019, AM J PUBLIC HEALTH, V109, P1122, DOI 10.2105/AJPH.2019.305115; Egnell M, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0202095; Food and Drink Federation, 2017, REF INT PREV GUID DI; Food Standards Agency, 2007, FRONT OF PACK TRAFF, P2; Goodman S, 2013, PUBLIC HEALTH NUTR, V16, P383, DOI 10.1017/S1368980012003485; Graham DJ, 2017, PUBLIC HEALTH NUTR, V20, P774, DOI [10.1017/S1368980016002676, 10.1017/s1368980016002676]; Grunert KG, 2007, J PUBLIC HEALTH-HEID, V15, P385, DOI 10.1007/s10389-007-0101-9; Hamlin R, 2016, NUTRIENTS, V8, DOI 10.3390/nu8060327; Hamlin RP, 2015, PUBLIC HEALTH NUTR, V18, P2126, DOI 10.1017/S1368980014002997; Hawley KL, 2013, PUBLIC HEALTH NUTR, V16, P430, DOI 10.1017/S1368980012000754; Hersey JC, 2013, NUTR REV, V71, P1, DOI 10.1111/nure.12000; Julia C, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2017-016108; Julia C, 2016, INT J BEHAV NUTR PHY, V13, DOI 10.1186/s12966-016-0416-4; Kanter R, 2018, PUBLIC HEALTH NUTR, V21, P1399, DOI 10.1017/S1368980018000010; Khandpur N, 2018, NUTRIENTS, V10, DOI 10.3390/nu10060688; Lachat C, 2005, PUBLIC HEALTH NUTR, V8, P266, DOI 10.1079/PHN2004691; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; Liu PJ, 2014, APPL ECON PERSPECT P, V36, P6, DOI 10.1093/aepp/ppt027; Machin L, 2018, APPETITE, V121, P55, DOI 10.1016/j.appet.2017.10.037; Mejean C, 2013, PUBLIC HEALTH NUTR, V16, P392, DOI 10.1017/S1368980012003515; Mhurchu CN, 2017, NUTRIENTS, V9, DOI 10.3390/nu9080918; Mhurchu CN, 2018, APPETITE, V121, P360, DOI 10.1016/j.appet.2017.11.105; Mhurchu CN, 2017, AM J CLIN NUTR, V105, P695, DOI 10.3945/ajcn.116.144956; Mora-Garcia CA, 2019, NUTRIENTS, V11, DOI 10.3390/nu11030491; Naghavi M, 2017, LANCET, V390, P1151, DOI 10.1016/S0140-6736(17)32152-9; Neal B, 2017, NUTRIENTS, V9, DOI 10.3390/nu9121284; Office federal de la securite alimentaire et des affaires veterinaires, 2017, STRAT SUISS NUTR 201; Onozaka Y, 2014, J INT FOOD AGRIBUS M, V26, P140, DOI 10.1080/08974438.2013.833570; Organisation for Economic Co-operation and Development, 2008, PROM SUST CONS GOOD; Ruffieux B, ETUDE INFLUENCE DIVE; Sacks G, 2011, AUST NZ J PUBL HEAL, V35, P122, DOI 10.1111/j.1753-6405.2011.00684.x; Sacks G, 2009, HEALTH PROMOT INT, V24, P344, DOI 10.1093/heapro/dap032; Sanjari SS, 2017, NUTR REV, V75, P871, DOI 10.1093/nutrit/nux043; Savoie N, 2013, CAN J PUBLIC HEALTH, V104, pE359, DOI 10.17269/cjph.104.4027; Scarborough P, 2015, INT J BEHAV NUTR PHY, V12, DOI 10.1186/s12966-015-0319-9; Seward MW, 2016, AM J PUBLIC HEALTH, V106, P1808, DOI 10.2105/AJPH.2016.303301; Smed S, 2019, PUBLIC HEALTH NUTR, V22, P2879, DOI 10.1017/S1368980019001423; Talati Z, 2019, NUTRIENTS; Talati Z, 2019, NUTRIENTS, V11, DOI 10.3390/nu11081934; Talati Z, 2017, INT J BEHAV NUTR PHY, V14, DOI 10.1186/s12966-017-0628-2; Thorndike AN, 2014, AM J PREV MED, V46, P143, DOI 10.1016/j.amepre.2013.10.002; van Herpen E, 2011, APPETITE, V57, P148, DOI 10.1016/j.appet.2011.04.011; Van Kleef E, 2015, CRIT REV FOOD SCI, V55, P291, DOI 10.1080/10408398.2011.653018; Vasiljevic M, 2015, APPETITE, V91, P56, DOI 10.1016/j.appet.2015.03.034; Vyth EL, 2010, PUBLIC HEALTH NUTR, V13, P1882, DOI 10.1017/S1368980010000637; Vyth EL, 2010, INT J BEHAV NUTR PHY, V7, DOI 10.1186/1479-5868-7-65; Wasowicz G, 2015, J HEALTH PSYCHOL, V20, P907, DOI 10.1177/1359105315580251; Waterlander WE, 2013, INT J BEHAV NUTR PHY, V10, DOI 10.1186/1479-5868-10-59; Watson WL, 2014, APPETITE, V72, P90, DOI 10.1016/j.appet.2013.09.027; World Health Organization, 2000, WHO TECHN REP SER, P894; World Health Organization, GLOB STRAT DIET PHYS, P2; World Health Organization, GLOB HLTH RISKS MORT; World Health Organization (WHO), WHO TECHN REP SER, V916	79	20	20	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2020	15	2							e0228179	10.1371/journal.pone.0228179	http://dx.doi.org/10.1371/journal.pone.0228179			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LQ8GQ	32107489	gold, Green Published			2022-12-26	WOS:000535237000009
J	Fernandez-Garcia, S; Represas-Represas, C; Ruano-Ravina, A; Mouronte-Roibas, C; Botana-Rial, M; Ramos-Hernandez, C; Fernandez-Villar, A				Fernandez-Garcia, Sara; Represas-Represas, Cristina; Ruano-Ravina, Alberto; Mouronte-Roibas, Cecilia; Botana-Rial, Maribel; Ramos-Hernandez, Cristina; Fernandez-Villar, Alberto			Social and clinical predictors of short- and long-term readmission after a severe exacerbation of copd	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; RISK-FACTORS; HOSPITAL READMISSIONS; BARTHEL INDEX; IMPACT; VALIDATION; DISABILITY; FAILURE; DYSPNEA; FRAILTY	Introduction and objectives The aim of this study was to evaluate the predictive ability of multiple social, and clinical factors for readmission after a severe acute exacerbation of COPD (AECOPD) during various time periods. Methods We performed a prospective cohort study in which recruited patients with AECOPD. We systematically collected numerous clinical (symptoms, pulmonary function, comorbidities, and treatment) and social (financial situation, housing situation, family support, caregiver overload, ability to perform activities, and risk of social exclusion) variables using several questionnaires and indices. The patients were followed closely for one year and readmissions at 30, 60, and 365 days were analysed. Results 253 patients were included, aged 68.9 +/- 9.8 years, FEV1 = 42.1%+/- 14.2%, and a Charlson's index = 1.8 +/- 0.9. Of these patients, 20.2%, 39.6%, and 63.7% were readmitted within the first 30, 90, and 365 days after discharge, respectively. In the multivariate model applied, the variables that were independently associated with readmission over all three periods of the analysis were dependence to perform basic activities of daily living (BADLs) (odds ratio [OR] = 2.10-4.10) and a history of two or more admissions within the previous year (OR = 2.78-3.78). At 90 days, a history of bacterial isolates in a previous sputum culture (OR = 2.39) and at 365 days, a high grade of dyspnoea (OR = 2.51) and obesity (OR = 2.38) were also identified as predictors of hospital readmission. Conclusions The patients' limitation to perform BADLs and their history of admissions for AECOPD were the best predictive variables for the likelihood of readmission when adjusted for many other social and clinical variables, regardless of the time period considered for such prediction.	[Fernandez-Garcia, Sara; Represas-Represas, Cristina; Mouronte-Roibas, Cecilia; Botana-Rial, Maribel; Ramos-Hernandez, Cristina; Fernandez-Villar, Alberto] Univ Hosp Complex Vigo, Dept Pneumonol, Pontevedra, Spain; [Fernandez-Garcia, Sara; Represas-Represas, Cristina; Mouronte-Roibas, Cecilia; Botana-Rial, Maribel; Ramos-Hernandez, Cristina; Fernandez-Villar, Alberto] Inst Invest Sanitaria Galicia Sur, Neumo Vigo I I Inst Hlth Res Galicia Sur, IISGS, Vigo, Pontevedra, Spain; [Ruano-Ravina, Alberto] Univ Santiago de Compostela, Dept Prevent Med & Publ Hlth, Santiago De Compostela, Spain; [Ruano-Ravina, Alberto] Consorcio Invest Biomed Red Epidemiol & Salud, Consortium Biomed Res Epidemiol & Publ Hlth, CIBERESP, Madrid, Spain	Universidade de Santiago de Compostela; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP	Fernandez-Villar, A (corresponding author), Univ Hosp Complex Vigo, Dept Pneumonol, Pontevedra, Spain.; Fernandez-Villar, A (corresponding author), Inst Invest Sanitaria Galicia Sur, Neumo Vigo I I Inst Hlth Res Galicia Sur, IISGS, Vigo, Pontevedra, Spain.	alberto.fernandez.villar@sergas.es	Ruano-Ravina, Alberto/M-5705-2018	Ruano-Ravina, Alberto/0000-0001-9927-7453; RAMOS HERNANDEZ, CRISTINA/0000-0001-5626-7810; , IIS Galicia Sur/0000-0003-3812-7413; Represas-Represas, Cristina/0000-0002-5908-6684; FERNANDEZ-VILLAR, ALBERTO/0000-0001-7407-5249	SEPAR [456/2017]; FIS-ISCII (FEDER) [PI18/01317]; Menarini company	SEPAR; FIS-ISCII (FEDER); Menarini company(Menarini Group)	This study was financed by funds obtained from the SEPAR 456/2017, FIS-ISCII PI18/01317 (FEDER) grants and the unconditional collaboration of the Menarini company. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aimo A, 2018, INT J CARDIOL, V254, P240, DOI 10.1016/j.ijcard.2017.11.010; Alarcon M. T., 1998, REV ESP GERIATR GERO, V33, P178; [Anonymous], 2005, REV ESP GERIATR GERO, DOI DOI 10.1016/S0211-139X(05)74881-2; [Anonymous], 2019, GLOBAL INITIATIVE CH; Bahadori Katayoon, 2007, Int J Chron Obstruct Pulmon Dis, V2, P241; Bernabeu-Mora R, 2017, THER ADV RESPIR DIS, V11, P383, DOI 10.1177/1753465817726314; Bestall JC, 1999, THORAX, V54, P581, DOI 10.1136/thx.54.7.581; Braido F, 2011, CURR MED RES OPIN, V27, P981, DOI 10.1185/03007995.2011.563285; CHARLSON M, 1994, J CLIN EPIDEMIOL, V47, P1245, DOI 10.1016/0895-4356(94)90129-5; Chatterjee P, 2019, HEALTH SERV RES, V54, P324, DOI 10.1111/1475-6773.13131; Coventry PA, 2011, BMC PULM MED, V11, DOI 10.1186/1471-2466-11-49; Echevarria C, 2017, THORAX, V72, P686, DOI 10.1136/thoraxjnl-2016-209298; Escarrabill J, 2015, ARCH BRONCONEUMOL, V51, P483, DOI 10.1016/j.arbres.2014.06.023; Fernandez-Garcia S, 2019, ARCH BRONCONEUMOL; Garcia-Aymerich J, 2003, THORAX, V58, P100, DOI 10.1136/thorax.58.2.100; GOLDBERG D, 1988, BRIT MED J, V297, P897, DOI 10.1136/bmj.297.6653.897; Gonzalez N, 2018, AGING CLIN EXP RES, V30, P489, DOI 10.1007/s40520-017-0809-5; Halpin DMG, 2017, INT J CHRONIC OBSTR, V12, P2891, DOI 10.2147/COPD.S139470; Hartl S, 2016, EUR RESPIR J, V47, P113, DOI 10.1183/13993003.01391-2014; Jacobs DM, 2018, ANN AM THORAC SOC, V15, P837, DOI 10.1513/AnnalsATS.201712-913OC; Jones PW, 2009, EUR RESPIR J, V34, P648, DOI 10.1183/09031936.00102509; Lambert AA, 2017, CHEST, V151, P68, DOI 10.1016/j.chest.2016.08.1432; Lindenauer PK, 2018, AM J RESP CRIT CARE, V197, P1009, DOI 10.1164/rccm.201709-1852OC; Mantero M, 2017, INT J CHRONIC OBSTR, V12, P2687, DOI 10.2147/COPD.S145253; Meddings J, 2017, J GEN INTERN MED, V32, P71, DOI 10.1007/s11606-016-3869-x; Miravitlles M, 2017, ARCH BRONCONEUMOL, V53, P1, DOI 10.1016/S0300-2896(17)30355-1; Mulpuru S, 2017, INT J CHRONIC OBSTR, V12, P989, DOI 10.2147/COPD.S126607; Owens JM, 2015, SOC WORK HEALTH CARE, V54, P234, DOI 10.1080/00981389.2015.1005269; Pedersen Mona Kyndi, 2017, JBI Database System Rev Implement Rep, V15, P454, DOI 10.11124/JBISRIR-2016-003267; Press VG, 2019, ANN AM THORAC SOC, V16, P161, DOI 10.1513/AnnalsATS.201811-755WS; Press VG, 2018, ANN AM THORAC SOC, V15, P801, DOI 10.1513/AnnalsATS.201804-246ED; Press VG, 2018, CURR OPIN PULM MED, V24, P138, DOI 10.1097/MCP.0000000000000454; Raghavan D, 2016, CURR OPIN PULM MED, V22, P106, DOI 10.1097/MCP.0000000000000245; Shah T, 2016, CHEST, V150, P916, DOI 10.1016/j.chest.2016.05.002; Sokoreli I, 2019, INT J CARDIOL, V278, P167, DOI 10.1016/j.ijcard.2018.12.030; Van Durme T, 2012, INT J NURS STUD, V49, P490, DOI 10.1016/j.ijnurstu.2011.10.011; Vandenbroucke JP, 2014, INT J SURG, V12, P1500, DOI 10.1016/j.ijsu.2014.07.014; Vergara I, 2012, HEALTH QUAL LIFE OUT, V10, DOI 10.1186/1477-7525-10-130; Vitacca M, 2016, INT J CHRONIC OBSTR, V11, P1199, DOI 10.2147/COPD.S104376; Wong AWM, 2008, CAN RESPIR J, V15, P361, DOI 10.1155/2008/569496; Zapatero A, 2013, J HUM NUTR DIET, V26, P16, DOI 10.1111/jhn.12088	41	5	5	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2020	15	2							e0229257	10.1371/journal.pone.0229257	http://dx.doi.org/10.1371/journal.pone.0229257			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LQ8GQ	32106226	Green Published, gold			2022-12-26	WOS:000535237000024
J	Sirinawasatien, A; Techasirioangkun, T				Sirinawasatien, Apichet; Techasirioangkun, Thanaya			Sofosbuvir-based regimens in the treatment of patients with chronic hepatitis C virus infection: Real-world efficacy in Thailand	PLOS ONE			English	Article							INTERFERON-FREE THERAPIES; GENOTYPE 3 INFECTION; TRANSIENT ELASTOGRAPHY; LIVER FIBROSIS; PLUS RIBAVIRIN; PEGINTERFERON-ALPHA; HCV; LEDIPASVIR; SAFETY; COMBINATION	Aims To analyze the efficacy and safety of sofosbuvir (SOF)-based regimens in Thai patients with chronic hepatitis C virus infection who had pre-existing significant liver fibrosis. Patients and methods This was a retrospective cohort study, conducted between 1 June 2018 and 31 May 2019 at Rajavithi Hospital, Bangkok, Thailand. All patients completed 12 weeks of SOF-based regimens and had follow-up for at least 12 weeks after therapy discontinuation. The primary outcome was sustained virological response (SVR) 12 weeks after the end of therapy. Result A total of 185 patients were included, with 52, 63 and 70 taking SOF+Ledipasvir (SOF +LDV), SOF+LDV+ribavirin (RBV) and SOF+Pegylated interferon (Peg-IFN)+RBV (SOF +Peg-IFN+RBV) respectively. Genotype (GT) 1 was predominant at 40.0%, followed by GT3 at 37.8%, and GT6 at 22.2%. Overall 95.1% of patients in this study achieved SVR (n = 176/185), and the only factor associated with SVR was HCV genotype (p = 0.001). GT6 patients had lower SVR rates compared to GT1 and GT3 patients (82.9%, 98.6%, and 98.6% respectively) while there was no association between SVR and other factors (p > 0.05) such as gender, age, BMI, underlying cirrhosis, baseline HCV viral load, or prior treatment history. No serious adverse events were reported in the present study. Conclusion Sofosbuvir-based regimens in the treatment of patients with chronic HCV infection were highly efficacious with excellent safety and tolerability profiles in a real-world setting; however, further research is required to establish whether or not such a regimen is an adequate treatment for all genotype 6 patients.	[Sirinawasatien, Apichet; Techasirioangkun, Thanaya] Rangsit Univ, Rajavithi Hosp, Coll Med, Div Gastroenterol,Dept Med, Bangkok, Thailand	Rajavithi Hospital; Rangsit University	Sirinawasatien, A (corresponding author), Rangsit Univ, Rajavithi Hosp, Coll Med, Div Gastroenterol,Dept Med, Bangkok, Thailand.	sui_apichet@hotmail.com		SIRINAWASATIEN, APICHET/0000-0001-6628-2977	Rajavithi Hospital [157/2562]	Rajavithi Hospital	This study was funded by Rajavithi Hospital (No. 157/2562).	Abergel A, 2016, HEPATOLOGY, V64, P1049, DOI 10.1002/hep.28706; Afdhal N, 2014, NEW ENGL J MED, V370, P1889, DOI 10.1056/NEJMoa1402454; Andriulli A, 2008, ALIMENT PHARM THER, V28, P397, DOI 10.1111/j.1365-2036.2008.03763.x; [Anonymous], 2015, J HEPATOL, V63, P237, DOI 10.1016/j.jhep.2015.04.006; Blach S, 2017, LANCET GASTROENTEROL, V2, P161, DOI 10.1016/S2468-1253(16)30181-9; Bourliere M, 2012, ANTIVIR THER, V17, P101, DOI 10.3851/IMP1935; Castera L, 2008, J HEPATOL, V48, P835, DOI 10.1016/j.jhep.2008.02.008; Cheng GF, 2016, ANTIMICROB AGENTS CH, V60, P1847, DOI 10.1128/AAC.02524-15; Chung RT, 2018, CLIN INFECT DIS, V67, P1477, DOI 10.1093/cid/ciy585; European Ass Study Liver, 2017, J HEPATOL, V66, P153, DOI 10.1016/j.jhep.2016.09.001; Feld JJ, 2015, NEW ENGL J MED, V373, P2599, DOI 10.1056/NEJMoa1512610; Ferreira VL, 2016, J CLIN PHARM THER, V41, P478, DOI 10.1111/jcpt.12426; Ferreira VL, 2017, CLIN DRUG INVEST, V37, P635, DOI 10.1007/s40261-017-0521-4; Ferreira VL, 2017, J GASTROEN HEPATOL, V32, P749, DOI 10.1111/jgh.13620; Foster GR, 2015, GASTROENTEROLOGY, V149, P1462, DOI 10.1053/j.gastro.2015.07.043; Friedrich-Rust M, 2008, GASTROENTEROLOGY, V134, P960, DOI 10.1053/j.gastro.2008.01.034; Gane EJ, 2015, GASTROENTEROLOGY, V149, P1454, DOI 10.1053/j.gastro.2015.07.063; Gower E, 2014, J HEPATOL, V61, pS45, DOI 10.1016/j.jhep.2014.07.027; Hlaing NKT, 2017, J VIRAL HEPATITIS, V24, P927, DOI 10.1111/jvh.12721; Kemp W, 2015, J GASTROEN HEPATOL, V30, P453, DOI 10.1111/jgh.12865; Kowdley KV, 2014, NEW ENGL J MED, V370, P1879, DOI 10.1056/NEJMoa1402355; Kumthip K, 2014, J MED VIROL, V86, P1360, DOI 10.1002/jmv.23962; Messina JP, 2015, HEPATOLOGY, V61, P77, DOI 10.1002/hep.27259; Mizokami M, 2015, LANCET INFECT DIS, V15, P645, DOI 10.1016/S1473-3099(15)70099-X; Omata M, 2016, HEPATOL INT, V10, P702, DOI 10.1007/s12072-016-9717-6; Pawlotsky JM, 2015, J HEPATOL, V62, pS87, DOI 10.1016/j.jhep.2015.02.006; Ridruejo E, 2010, ANN HEPATOL, V9, P46, DOI 10.1016/S1665-2681(19)31678-3; Seo YS, 2015, LIVER INT, V35, P2246, DOI 10.1111/liv.12808; Sirinawasatien Apichet, 2018, Journal of the Medical Association of Thailand, V101, pS87; Swain MG, 2010, GASTROENTEROLOGY, V139, P1593, DOI 10.1053/j.gastro.2010.07.009; Talwalkar JA, 2007, CLIN GASTROENTEROL H, V5, P1214, DOI 10.1016/j.cgh.2007.07.020; Tanwandee Tawesak, 2006, J Med Assoc Thai, V89 Suppl 5, pS79; Wasitthankasem R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126764; Wong RJ, 2017, J VIRAL HEPATITIS, V24, P17, DOI 10.1111/jvh.12609; Zeuzem S, 2014, NEW ENGL J MED, V370, P1993, DOI 10.1056/NEJMoa1316145; Ziol M, 2005, HEPATOLOGY, V41, P48, DOI 10.1002/hep.20506	36	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2020	15	2							e0229517	10.1371/journal.pone.0229517	http://dx.doi.org/10.1371/journal.pone.0229517			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8GQ	32106270	gold, Green Published			2022-12-26	WOS:000535237000038
J	Klein, NP; Fireman, B; Goddard, K; Zerbo, O; Asher, J; Zhou, J; King, J; Lewis, N				Klein, Nicola P.; Fireman, Bruce; Goddard, Kristin; Zerbo, Ousseny; Asher, Jason; Zhou, James; King, James; Lewis, Ned			Vaccine effectiveness of cell-culture relative to egg-based inactivated influenza vaccine during the 2017-18 influenza season	PLOS ONE			English	Article							UNITED-STATES; MAMMALIAN-CELLS; VIRUS; EFFICACY	There is concern that influenza vaccine effectiveness (VE) may be attenuated by passage in eggs during manufacture. We compared quadrivalent cell-culture vaccine with egg-based vaccines, most of which were trivalent, against influenza A and B during 2017-2018 when A (H3N2) and B/Yamagata (present only in quadrivalent vaccines) predominated. We retrospectively examined risk of PCR-confirmed influenza A and B in members of Kaiser Permanente Northern California aged 4-64 years. We estimated the relative VE (rVE) of cell-culture vaccine versus egg-based vaccines, and the absolute VE (aVE) of each vaccine comparing vaccinated to unvaccinated individuals. Analyses used Cox regression with a calendar timeline, stratified by birth year, and adjusted for demographics, co-morbidities and utilization. One-third (1,016,965/3,053,248) of the population was vaccinated; 932,545 (91.7% of vaccinees) received egg-based and 84,420 (8.3%) received cell-culture vaccines. The rVE against influenza A was 8.0% (95% CI: -10, 23); aVE was 31.7% (CI: 18.7, 42.6) for cell-culture and 20.1% (CI: 14.5, 25.4) for egg-based vaccines. The rVE against influenza B was 39.6% (CI: 27.9, 49.3); aVE was 40.9% (CI: 30, 50.1) for cell-culture and 9.7% (CI 3.5, 15.6) for egg-based trivalent vaccines. Inclusion of the B/Yamagata lineage in the quadrivalent cell-based vaccine provided better protection against influenza B but vaccine effectiveness against influenza A was low for both the cell-culture vaccine and the egg-based vaccines. Improving influenza vaccines requires ongoing comparative vaccine effectiveness monitoring.	[Klein, Nicola P.; Fireman, Bruce; Goddard, Kristin; Zerbo, Ousseny; Lewis, Ned] Kaiser Permanente Northern Calif Div Res, Kaiser Permanente Vaccine Study Ctr, Oakland, CA 94612 USA; [Asher, Jason; Zhou, James; King, James] US Dept HHS, US Biomed Adv Res & Dev Author BARDA, Off Assistant Secretary Preparedness & Response, Washington, DC 20201 USA	Kaiser Permanente	Klein, NP (corresponding author), Kaiser Permanente Northern Calif Div Res, Kaiser Permanente Vaccine Study Ctr, Oakland, CA 94612 USA.	nicola.klein@kp.org			Department of Health and Human Services; Office of the Assistant Secretary for Preparedness and Response; Biomedical Advanced Research and Development Authority;  [HHSO100201800011C]	Department of Health and Human Services; Office of the Assistant Secretary for Preparedness and Response; Biomedical Advanced Research and Development Authority; 	This work was supported by Department of Health and Human Services; Office of the Assistant Secretary for Preparedness and Response; Biomedical Advanced Research and Development Authority. Grant numbers awarded: Contract No. HHSO100201800011C to NPK. Website: www.phe.gov/about/barda.Listed authors associated with the federal funding agency were involved in study design, review and preparation of the manuscript as indicated in the author section.	Alymova IV, 1998, J VIROL, V72, P4472, DOI 10.1128/JVI.72.5.4472-4477.1998; [Anonymous], 2018, J INFECT DIS; Belongia EA, 2019, CLIN INFECT DIS; Belongia EA, 2016, LANCET INFECT DIS, V16, P942, DOI 10.1016/S1473-3099(16)00129-8; Bruxvoort KJ, 2019, VACCINE, V37, P5807, DOI 10.1016/j.vaccine.2019.08.024; California Department of Public Health, 2018, INFL ANN REP; Chambers C, 2015, EUROSURVEILLANCE, V20, P28, DOI 10.2807/1560-7917.ES.2015.20.36.30015; Chen H, 2018, CLIN INFECT DIS; De Serres G, 2013, Euro Surveill, V18; DeMarcus L, 2019, VACCINE, V37, P4015, DOI 10.1016/j.vaccine.2019.06.004; Flannery B, 2019, CLIN INFECT DIS, V68, P1798, DOI 10.1093/cid/ciy775; Garten R, 2018, MMWR-MORBID MORTAL W, V67, P634, DOI 10.15585/mmwr.mm6722a4; Gouma S, 2020, CLIN INFECT DIS, V71, P1447, DOI 10.1093/cid/ciz996; Grohskopf LA, 2016, MMWR RECOMM REP, V65, P1, DOI 10.15585/mmwr.rr6505a1; Jackson ML, 2017, NEW ENGL J MED, V377, P534, DOI [10.1056/NEJMoa1700153, 10.1056/nejmoa1700153]; Jackson ML, 2013, VACCINE, V31, P2165, DOI 10.1016/j.vaccine.2013.02.053; KATZ JM, 1988, VIROLOGY, V165, P446, DOI 10.1016/0042-6822(88)90588-0; KATZ JM, 1989, J INFECT DIS, V160, P191, DOI 10.1093/infdis/160.2.191; McLean HQ, 2015, J INFECT DIS, V211, P1529, DOI 10.1093/infdis/jiu647; Ohmit SE, 2013, CLIN INFECT DIS, V56, P1363, DOI 10.1093/cid/cit060; Pebody R, 2017, EUROSURVEILLANCE, V22, P10, DOI 10.2807/1560-7917.ES.2017.22.44.17-00306; ROBERTSON JS, 1987, VIROLOGY, V160, P31, DOI 10.1016/0042-6822(87)90040-7; Rolfes MA, 2019, CLIN INFECT DIS, DOI [10.1093/cid/ciw635, DOI 10.1093/CID/CIW635]; Skowronski DM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092153; Sullivan SG, 2016, AM J EPIDEMIOL, V184, P345, DOI 10.1093/aje/kww064; Wu NC, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006682; Zimmerman RK, 2016, CLIN INFECT DIS, V63, P1564, DOI 10.1093/cid/ciw635; Zost SJ, 2017, P NATL ACAD SCI USA, V114, P12578, DOI 10.1073/pnas.1712377114	28	19	20	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2020	15	2							e0229279	10.1371/journal.pone.0229279	http://dx.doi.org/10.1371/journal.pone.0229279			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8FM	32101582	Green Published, gold			2022-12-26	WOS:000535233700023
J	Matthews, I; Duong, M; Parsons, VL; Nozad, B; Qizilbash, N; Patel, Y; Guimicheva, B				Matthews, Ian; Duong, Mai; Parsons, Victoria L.; Nozad, Bayad; Qizilbash, Nawab; Patel, Yash; Guimicheva, Boriana			Burden of disease from shingles and post-herpetic neuralgia in the over 80 year olds in the UK	PLOS ONE			English	Article							HERPES-ZOSTER; LONG-TERM; VACCINE; COST	Background The current UK vaccination programme for herpes zoster (HZ) excludes people aged >= 80 years. This study aimed to quantify the number of individuals >= 80 years who missed HZ vaccination and the consequent epidemiological and economic burden of HZ and post-herpetic neuralgia (PHN). Methods Immunocompetent individuals aged >= 80 years between 1st September 2013 and 31st December 2017 in the Clinical Practice Research Datalink were selected and linked to Hospital Episodes Statistics, where available. Rates of HZ and PHN and healthcare resource utilisation were investigated for the overall study population and by age group (80-84, 85-89, >= 90 years old) and the burden of HZ and PHN was projected to the UK population. Results 4,858 HZ episodes and 464 PHN cases were identified in 255,165 individuals over 576,421 person-years (PY). Rates of HZ and PHN were 8.43 (95% confidence interval [CI] 8.19-8.66) and 0.80 (0.73-0.87) per 1,000 PY respectively and lowest in those aged.90 (HZ rate 7.37/1,000 PY; PHN rate 0.56/1,000 PY). Within HZ episodes, 10.27% of GP visits, 5.82% of prescribed medications and 21.65% of hospitalisations were related to HZ/PHN. Median length of hospitalisation increased from 7.0 days for all-cause to 10.5 days for HZ/PHN related hospitalisations. Individuals >= 90 stayed in hospital a median of 3-4 days longer than younger groups. Approximately 2.23 million individuals in the UK missed HZ vaccination since 2013 (1.86 million had never been eligible and 365,000 lost eligibility for HZ vaccination), resulting in an estimated 43,149 HZ episodes. Conclusion This study highlights the impact of the 80-year upper age limit policy on the health system. Our study estimates that 2.23 million individuals in the UK may have lost the opportunity to be vaccinated and that their burden of HZ and PHN remains high, especially among the very elderly.	[Matthews, Ian; Patel, Yash; Guimicheva, Boriana] Merck Sharp & Dohme Ltd, Hoddesdon, Herts, England; [Duong, Mai; Parsons, Victoria L.; Qizilbash, Nawab] OXON Epidemiol, London, England; [Nozad, Bayad] Imperial Coll London, Dept Primary Care & Publ Hlth, London, England; [Qizilbash, Nawab] London Sch Hyg & Trop Med, London, England	Merck & Company; Imperial College London; University of London; London School of Hygiene & Tropical Medicine	Matthews, I (corresponding author), Merck Sharp & Dohme Ltd, Hoddesdon, Herts, England.	ian.matthews@merck.com		Matthews, Ian/0000-0001-6175-6512	Merck Sharp Dohme Ltd, UK	Merck Sharp Dohme Ltd, UK	This work was sponsored and funded by Merck Sharp & Dohme Ltd, UK. IM, BG and YP were employees of Merck Sharp & Dohme Ltd. BN received consultancy fees from Merck Sharp & Dohme Ltd, UK. MD, NQ and VP were employed by OXON Epidemiology Ltd which received funds from Merck Sharp & Dohme Ltd, UK to conduct the study. The funder provided support in the form of salaries for authors IM, BQ and YP and approved the study design for scientific integrity but did not have any additional role in the data collection and analysis, decision to publish or preparation of the manuscript. The specific roles of these authors are articulated in the `author contributions' section.	Amirthalingam G, 2018, LANCET PUBLIC HEALTH, V3, pE82, DOI 10.1016/S2468-2667(17)30234-7; [Anonymous], 2010, STAT VAR HERP ZOST V; [Anonymous], 2017, GREAT BRIT MID POP E; Baxter R, 2018, AM J EPIDEMIOL, V187, P161, DOI 10.1093/aje/kwx245; Delgado-Rodriguez M, 2004, J EPIDEMIOL COMMUN H, V58, P635, DOI 10.1136/jech.2003.008466; Dworkin RH, 2007, CLIN INFECT DIS, V44, pS1, DOI 10.1086/510206; Gauthier A, 2009, EPIDEMIOL INFECT, V137, P38, DOI 10.1017/S0950268808000678; Harding DM., 2018, SHINGLES HERPES ZOST; Herrett E, 2015, INT J EPIDEMIOL, V44, P827, DOI 10.1093/ije/dyv098; HOPESIMPSON RE, 1965, P ROY SOC MED, V58, P9, DOI 10.1177/003591576505800106; Kawai K, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-004833; Lukas K, 2012, J PUBLIC HEALTH-HEID, V20, P441, DOI 10.1007/s10389-011-0481-8; Matthews I, 2018, VACCINE, V36, P7105, DOI 10.1016/j.vaccine.2018.08.037; National Institute for Health and Care Excellence (NICE), 2018, SHINGL; National Institute for Health and Care Excellence (NICE), 2017, POST NEUR; Oxman MN, 2005, NEW ENGL J MED, V352, P2271, DOI 10.1056/NEJMoa051016; Public Health England, 2018, HLTH PROTECTION REPO, V12; Sanah Y, 2017, UK TOWNSEND DEPRIVAT; Schmader K, 2007, CLIN GERIATR MED, V23, P615, DOI 10.1016/j.cger.2007.03.003; Schmidt-Ott R, 2018, J INFECTION, V76, P475, DOI 10.1016/j.jinf.2018.02.001; Serpell M, 2014, HEALTH QUAL LIFE OUT, V12, DOI 10.1186/1477-7525-12-92; Tseng HF, 2016, J INFECT DIS, V213, P1872, DOI 10.1093/infdis/jiw047; van Hoek AJ, 2009, VACCINE, V27, P1454, DOI 10.1016/j.vaccine.2008.12.024; Walker JL, 2018, VACCINE, V36, P2371, DOI 10.1016/j.vaccine.2018.02.021; WELLER TH, 1983, NEW ENGL J MED, V309, P1362, DOI 10.1056/NEJM198312013092205; Zorzoli E, 2018, AGING CLIN EXP RES, V30, P693, DOI 10.1007/s40520-018-0956-3	26	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2020	15	2							e0229224	10.1371/journal.pone.0229224	http://dx.doi.org/10.1371/journal.pone.0229224			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8EV	32097441	Green Submitted, gold, Green Published			2022-12-26	WOS:000535232000023
J	Bagley, BA; Bordelon, B; Moseley, B; Wessel, R				Bagley, Bryce Allen; Bordelon, Blake; Moseley, Benjamin; Wessel, Ralf			Pre-Synaptic Pool Modification (PSPM): A supervised learning procedure for recurrent spiking neural networks	PLOS ONE			English	Article							NEURONS; BACKPROPAGATION	Learning synaptic weights of spiking neural network (SNN) models that can reproduce target spike trains from provided neural firing data is a central problem in computational neuroscience and spike-based computing. The discovery of the optimal weight values can be posed as a supervised learning task wherein the weights of the model network are chosen to maximize the similarity between the target spike trains and the model outputs. It is still largely unknown whether optimizing spike train similarity of highly recurrent SNNs produces weight matrices similar to those of the ground truth model. To this end, we propose flexible heuristic supervised learning rules, termed Pre-Synaptic Pool Modification (PSPM), that rely on stochastic weight updates in order to produce spikes within a short window of the desired times and eliminate spikes outside of this window. PSPM improves spike train similarity for all-to-all SNNs and makes no assumption about the post-synaptic potential of the neurons or the structure of the network since no gradients are required. We test whether optimizing for spike train similarity entails the discovery of accurate weights and explore the relative contributions of local and homeostatic weight updates. Although PSPM improves similarity between spike trains, the learned weights often differ from the weights of the ground truth model, implying that connectome inference from spike data may require additional constraints on connectivity statistics. We also find that spike train similarity is sensitive to local updates, but other measures of network activity such as avalanche distributions, can be learned through synaptic homeostasis.	[Bagley, Bryce Allen; Bordelon, Blake] Washington Univ, Dept Elect & Syst Engn, St Louis, MO 63110 USA; [Bagley, Bryce Allen; Bordelon, Blake; Wessel, Ralf] Washington Univ, Dept Phys, St Louis, MO 63130 USA; [Bagley, Bryce Allen; Moseley, Benjamin] Washington Univ, Dept Comp Sci, St Louis, MO 63130 USA; [Bagley, Bryce Allen] Stanford Univ, Stanford Inst Theoret Phys, Stanford, CA 94305 USA; [Moseley, Benjamin] Carnegie Mellon Univ, Dept Operat Res, Pittsburgh, PA 15213 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Stanford University; Carnegie Mellon University	Bagley, BA (corresponding author), Washington Univ, Dept Elect & Syst Engn, St Louis, MO 63110 USA.; Bagley, BA (corresponding author), Washington Univ, Dept Phys, St Louis, MO 63130 USA.; Bagley, BA (corresponding author), Washington Univ, Dept Comp Sci, St Louis, MO 63130 USA.; Bagley, BA (corresponding author), Stanford Univ, Stanford Inst Theoret Phys, Stanford, CA 94305 USA.	bbagley@stanford.edu		Bagey, Bryce/0000-0001-9702-1681	Whitehall Foundation [20121221]; National Science Foundation Collaborative Research in Computational Neuroscience [1308159]	Whitehall Foundation; National Science Foundation Collaborative Research in Computational Neuroscience(National Science Foundation (NSF))	This research was supported by a Whitehall Foundation grant (no.20121221, awarded to R.W., http://www.whitehall.org/) and a National Science Foundation Collaborative Research in Computational Neuroscience grant no. 1308159, awarded to R.W., https://www.nsf.gov/).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abeles M., CORTICONICS NEURAL C; Asai Y, 2012, BRAIN RES, V1434, P17, DOI 10.1016/j.brainres.2011.10.012; Bohte SM, 2002, NEUROCOMPUTING, V48, P17, DOI 10.1016/S0925-2312(01)00658-0; Bryant HL, J PHYSL; Butts DA, 2007, NATURE, V449, P92, DOI [10.1038/nature06105, 10.1038/natureO6105]; Cabessa J., PLOS ONE; Cabessa J., CHAOS INTERDISCIPLIN; Caudill MS, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.051923; Dayhoff J. E., APPL J NEUROPHYSIOLO; de Abril IM, 2018, NEURAL NETWORKS, V102, P120, DOI 10.1016/j.neunet.2018.02.016; Delorme A, 2003, NETWORK-COMP NEURAL, V14, P613, DOI 10.1088/0954-898X/14/4/301; Florian RV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040233; Friston KJ, 2011, BRAIN CONNECT, V1, P13, DOI 10.1089/brain.2011.0008; Gardner B, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161335; Ghosh-Dastidar S, 2009, NEURAL NETWORKS, V22, P1419, DOI 10.1016/j.neunet.2009.04.003; Gupta A, 2007, IEEE IJCNN, P53, DOI 10.1109/IJCNN.2007.4370930; Herikstad R, 2011, J NEUROSCI, V31, P15844, DOI 10.1523/JNEUROSCI.5153-10.2011; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764; Izhikevich EM, 2003, IEEE T NEURAL NETWOR, V14, P1569, DOI 10.1109/TNN.2003.820440; Jin YC, 2007, LECT NOTES COMPUT SC, V4668, P370; Jolivet R, 2003, LECT NOTES COMPUT SC, V2714, P846; Karimipanah Y, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182501; Karimipanah Y, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177396; Keck T, 2017, PHILOS T R SOC B, V372, DOI 10.1098/rstb.2016.0158; Kobayashi R., FRONTIERS COMPUTATIO; Larremore DB, 2012, PHYS REV E, V85, DOI 10.1103/PhysRevE.85.066131; Liaw JS, 1998, IEEE WORLD CONGRESS ON COMPUTATIONAL INTELLIGENCE, P2175, DOI 10.1109/IJCNN.1998.687197; Maass W, 1997, NEURAL NETWORKS, V10, P1659, DOI 10.1016/S0893-6080(97)00011-7; MAINEN ZF, 1995, SCIENCE, V268, P1503, DOI 10.1126/science.7770778; Masquelier T, 2007, PLOS COMPUT BIOL, V3, P247, DOI 10.1371/journal.pcbi.0030031; MEAD C, 1990, P IEEE, V78, P1629, DOI 10.1109/5.58356; Merolla PA, 2014, SCIENCE, V345, P668, DOI 10.1126/science.1254642; Mohemmed A, 2011, LECT NOTES COMPUT SC, V7063, P718, DOI 10.1007/978-3-642-24958-7_83; Nahmias MA, 2013, IEEE J SEL TOP QUANT, V19, DOI 10.1109/JSTQE.2013.2257700; Pavlidis NG, 2005, IEEE IJCNN, P2190; Pehlevan Cengiz, 2019, ARXIV190201429; Pfister JP, 2006, NEURAL COMPUT, V18, P1318, DOI 10.1162/neco.2006.18.6.1318; Ponulak F, 2010, NEURAL COMPUT, V22, P467, DOI 10.1162/neco.2009.11-08-901; Russell A, 2010, IEEE T NEURAL NETWOR, V21, P1950, DOI 10.1109/TNN.2010.2083685; Schrauwen B, 2004, IEEE IJCNN, P471, DOI 10.1109/IJCNN.2004.1379954; Schrauwen B, 2006, IEEE IJCNN, P1797; Segundo J. P., J EXPT BIOL; Shreiber S, 2003, NEUROCOMPUTING, V52; Sporns O, 2005, PLOS COMPUT BIOL, V1, P245, DOI 10.1371/journal.pcbi.0010042; Tang Ping Tak Peter, 2017, ARXIV170505475; Tavanaei A., 2018, CORR; Turrigiano GG, 2017, PHILOS T R SOC B, V372, DOI 10.1098/rstb.2016.0258; van Rossum MCW, 2001, NEURAL COMPUT, V13, P751, DOI 10.1162/089976601300014321; Villa A. E., NEUROREPORT INT J RA; Wu Q, 2007, ICIC; Wysoski SG, 2010, NEURAL NETWORKS, V23, P819, DOI 10.1016/j.neunet.2010.04.009	52	0	0	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2020	15	2							e0229083	10.1371/journal.pone.0229083	http://dx.doi.org/10.1371/journal.pone.0229083			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8DW	32092107	Green Published, gold			2022-12-26	WOS:000535229300020
J	Huang, YS; Zhang, ZH; Hou, TC; Shi, JF; Huang, WJ; Bai, Z; Long, DF; Huang, XD; Yan, SJ				Huang, Yushan; Zhang, Zuhong; Hou, Tianchun; Shi, Jingfang; Huang, Wenjie; Bai, Zhao; Long, Danfeng; Huang, Xiaodan; Yan, Shijuan			Antibiotic burden of school children from Tibetan, Hui, and Han groups in the Qinghai-Tibetan Plateau	PLOS ONE			English	Article							VETERINARY ANTIBIOTICS; TETRACYCLINES ANTIBIOTICS; CHILDHOOD OVERWEIGHT; RESIDUES; MEAT; GUIDELINES; MICROBIOTA; EXPOSURE; URINE; MILK	Background Given their geographical proximity but differences in cultural and religious dietary customs, we hypothesize that children from the three main ethnic populations (Han, Hui, and Tibetan) residing in the Qinghai-Tibetan Plateau region differs in their non-iatrogenic antibiotic loads. Methods To determine the antibiotic burden of the school children unrelated to medical treatment, we quantified the antibiotic residues in morning urine samples from 92 Han, 72 Tibetan, and 85 Muslim Hui primary school children aged 8 to 12 years using high-performance liquid chromatography-tandem mass spectrometry, and performed correlation analysis between these data and concurrent dietary nutrition assessments. Results Sixteen of the 18 targeted antibiotics (4 macrolides, 3 beta-lactams, 2 tetracyclines, 4 quinolones, 3 sulfonamides, and 2 aminoanols) were identified in the urine samples with an overall detection frequency of 58.63%. The detection frequency of the six antibiotic classes ranged from 1.61% to 32.53% with ofloxacin showing the single highest frequency (18.47%). Paired comparison analysis revealed significant differences in antibiotic distribution frequency among groups, with Tibetans having higher enrofloxacin (P = 0.015) and oxytetracycline (P = 0.021) than Han children. Norfloxacin (a human/veterinary antibiotic) was significantly higher in the Hui children than in the Han children (P = 0.024). Dietary nutrient intake assessments were comparable among participants, showing adequate levels of essential vitamins and minerals across all three ethnic groups. However, significant differences in specific foods were observed among groups, notably in lower fat consumption in the Hui group. Conclusions The introduction and accumulation of antibiotic residues in school children through non-iatrogenic routes (food or environmental sources) poses a serious potential health risk and merits closer scrutiny to determine the sources. While the exact sources of misused or overused antibiotics remains unclear, further study can potentially correlate ethnicity-specific dietary practices with the sources of contamination.	[Huang, Yushan; Zhang, Zuhong; Hou, Tianchun; Bai, Zhao; Long, Danfeng; Huang, Xiaodan] Lanzhou Univ, Sch Publ Hlth, Lanzhou, Peoples R China; [Shi, Jingfang; Huang, Wenjie; Yan, Shijuan] Guangdong Acad Agr Sci, Agrobiol Gene Res Ctr, Guangzhou, Peoples R China	Lanzhou University; Guangdong Academy of Agricultural Sciences	Huang, XD (corresponding author), Lanzhou Univ, Sch Publ Hlth, Lanzhou, Peoples R China.; Yan, SJ (corresponding author), Guangdong Acad Agr Sci, Agrobiol Gene Res Ctr, Guangzhou, Peoples R China.	huangxiaodan@lzu.edu.cn; shijuan@agrogene.ac.cn		HUANG, XIAODAN/0000-0001-8741-2785	NSFC [31500101, 31500045]; Fundamental Research Funds for the Central Universities [lzujbky-2019-48]; Special fund for scientific innovation strategy-construction of high level Academy of Agriculture Science [R2017PY-QY005]; Science and Technology Program of Guangzhou City, China [201607020035]; National undergraduate innovation and entrepreneurship training program [20170730163]	NSFC(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Special fund for scientific innovation strategy-construction of high level Academy of Agriculture Science; Science and Technology Program of Guangzhou City, China; National undergraduate innovation and entrepreneurship training program	This work was supported by research grants from the NSFC (No. 31500101; No. 31500045),the Fundamental Research Funds for the Central Universities (lzujbky-2019-48, Special fund for scientific innovation strategy-construction of high level Academy of Agriculture Science (R2017PY-QY005), the Science and Technology Program of Guangzhou City, China (No. 201607020035), and the National undergraduate innovation and entrepreneurship training program (No. 20170730163). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acevedo-Garcia D, 2008, HEALTH AFFAIR, V27, P321, DOI 10.1377/hlthaff.27.2.321; Ajslev TA, 2011, INT J OBESITY, V35, P522, DOI 10.1038/ijo.2011.27; Al-Mustafa ZH, 2000, INT J ENVIRON HEAL R, V10, P291, DOI 10.1080/0960312002001483; [Anonymous], [No title captured]; Ayashoglu E, 2005, AUST DENT J, V50, P273, DOI 10.1111/j.1834-7819.2005.tb00373.x; Azad MB, 2014, INT J OBESITY, V38, P1290, DOI 10.1038/ijo.2014.119; Bailey LC, 2014, JAMA PEDIATR, V168, P1063, DOI 10.1001/jamapediatrics.2014.1539; Bhutta Z A, 2014, BMJ-BRIT MED J, P2655; Bianba BB, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000001516; Cai ZX, 2008, J CHROMATOGR A, V1200, P144, DOI 10.1016/j.chroma.2008.05.095; Clemens SL, 2008, ALCOHOL ALCOHOLISM, V43, P223, DOI 10.1093/alcalc/agm143; Conzuelo F, 2012, ANAL CHIM ACTA, V737, P29, DOI 10.1016/j.aca.2012.05.051; CRAWFORD PB, 1994, J AM DIET ASSOC, V94, P626, DOI 10.1016/0002-8223(94)90158-9; De Wasch K, 1998, ANALYST, V123, P2737, DOI 10.1039/a804909b; Harris NS, 2001, NEW ENGL J MED, V344, P341, DOI 10.1056/NEJM200102013440504; He S, 2011, J ANIM SCI, V89, P84, DOI 10.2527/jas.2010-3032; Huang WJ, 2019, J CHROMATOGR B, V1105, P176, DOI 10.1016/j.jchromb.2018.12.019; Jernberg C, 2007, ISME J, V1, P56, DOI 10.1038/ismej.2007.3; Karaoglan I, 2013, J INT MED RES, V41, P1830, DOI 10.1177/0300060513496172; Kemper N, 2008, ECOL INDIC, V8, P1, DOI 10.1016/j.ecolind.2007.06.002; Li YB, 2012, HEALTH AFFAIR, V31, P1075, DOI 10.1377/hlthaff.2010.0965; Liang XY, 2011, INT J CLIN PHARM-NET, V33, P750, DOI 10.1007/s11096-011-9535-9; Liu L, 2013, ECOL ENG, V53, P138, DOI 10.1016/j.ecoleng.2012.12.033; Ma Li, 2013, BEIJING REV, V56; Mei ZG, 2007, B WORLD HEALTH ORGAN, V85, P441, DOI 10.2471/BLT.06.034421; Niermeyer S, 2009, ARCH DIS CHILD, V94, P806, DOI 10.1136/adc.2008.141838; Rashid MU, 2015, CLIN INFECT DIS, V60, pS77, DOI 10.1093/cid/civ137; Reynolds L, 2009, HEALTH POLICY, V90, P32, DOI 10.1016/j.healthpol.2008.09.002; Roumelioti M, 2009, NUTR J, V8, DOI 10.1186/1475-2891-8-8; Sarahroodi S, 2012, Pak J Biol Sci, V15, P707; Sendzik J, 2009, INT J ANTIMICROB AG, V33, P194, DOI 10.1016/j.ijantimicag.2008.08.004; Tamma PD, 2012, CLIN MICROBIOL REV, V25, P450, DOI 10.1128/CMR.05041-11; Trasande L, 2013, INT J OBESITY, V37, P16, DOI 10.1038/ijo.2012.132; Wang HX, 2014, ANAL BIOANAL CHEM, V406, P8049, DOI 10.1007/s00216-014-8197-6; Wang HX, 2017, FOOD CONTROL, V80, P217, DOI 10.1016/j.foodcont.2017.04.034; Wang HX, 2015, ENVIRON SCI TECHNOL, V49, P5070, DOI 10.1021/es5059428; Wang N, 2014, J ENVIRON SCI HEAL B, V49, P468, DOI 10.1080/03601234.2014.896660; Wang SS, 2016, J ZHEJIANG UNIV-SC B, V17, P649, DOI 10.1631/jzus.B1600341; Yiruhan, 2010, ENVIRON POLLUT, V158, P2350, DOI 10.1016/j.envpol.2010.03.019; Yoshida E, 2009, J FOOD HYG SOC JPN, V50, P216, DOI 10.3358/shokueishi.50.216; Zhang W, 2008, PHARMACOEPIDEM DR S, V17, P821; Zhang WS, 2008, EUR J CLIN PHARMACOL, V64, P821, DOI 10.1007/s00228-008-0489-3; Zhao L, 2010, SCI TOTAL ENVIRON, V408, P1069, DOI 10.1016/j.scitotenv.2009.11.014	43	5	5	3	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2020	15	2							e0229205	10.1371/journal.pone.0229205	http://dx.doi.org/10.1371/journal.pone.0229205			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LQ8DW	32092096	gold, Green Published			2022-12-26	WOS:000535229300032
J	Pacheco-Fores, SI; Gordon, GW; Knudson, KJ				Pacheco-Fores, Sofia, I; Gordon, Gwyneth W.; Knudson, Kelly J.			Expanding radiogenic strontium isotope baseline data for central Mexican paleomobility studies	PLOS ONE			English	Article							RESIDENTIAL-MOBILITY; VOSGES MOUNTAINS; SR-87/SR-86; RATIOS; OXYGEN; SR; VARIABILITY; FRACTIONATION; IMMIGRATION; TEOTIHUACAN	Radiogenic strontium isotopes (Sr-87/Sr-86) have long been used in analyses of paleomobility within Mesoamerica. While considerable effort has been expended developing Sr-87/Sr-86 baseline values across the Maya region, work in central Mexico is primarily focused on the Classic period urban center of Teotihuacan. This study adds to this important dataset by presenting bioavailable Sr-87/Sr-86 values across central Mexico focusing on the Basin of Mexico. This study therefore serves to expand the utility of strontium isotopes across a wider geographic region. A total of 63 plant and water samples were collected from 13 central Mexican sites and analyzed for Sr-87/Sr-86 on a Thermo-Finnigan Neptune multi-collector inductively coupled plasma mass spectrometer (MC-ICP-MS). These data were analyzed alongside 16 published Sr-87/Sr-86 values from two additional sites within the region of interest. A five-cluster k-means model was then generated to determine which regions of the Basin of Mexico and greater central Mexico can and cannot be distinguished isotopically using Sr-87/Sr-86 values. Although the two clusters falling within the Basin of Mexico overlap in their local Sr-87/Sr-86 ranges, many locations within the Basin are distinguishable using Sr-87/Sr-86 values at the site-level. This study contributes to paleomobility studies within central Mexico by expanding knowledge of strontium isotope variability within the region, ultimately allowing researchers to detect intra-regional residential mobility and gain a greater understanding of the sociopolitical interactions between the Basin of Mexico and supporting outlying regions of central Mexico.	[Pacheco-Fores, Sofia, I; Knudson, Kelly J.] Arizona State Univ, Sch Human Evolut & Social Change, Ctr Bioarchael Res, Tempe, AZ 85281 USA; [Gordon, Gwyneth W.] Arizona State Univ, Sch Earth & Space Explorat, Tempe, AZ USA	Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe	Pacheco-Fores, SI (corresponding author), Arizona State Univ, Sch Human Evolut & Social Change, Ctr Bioarchael Res, Tempe, AZ 85281 USA.	sipachec@asu.edu		Pacheco-Fores, Sofia/0000-0001-7769-5806; Gordon, Gwyneth/0000-0002-5157-0068	National Science Foundation [2013155229, 1744335]; School of Human Evolution and Social Change grant award	National Science Foundation(National Science Foundation (NSF)); School of Human Evolution and Social Change grant award	Fieldwork and laboratory analyses were supported by National Science Foundation (https:// www.nsf.gov) grants 2013155229 and 1744335 awarded to SIPF as well as a School of Human Evolution and Social Change (https://shesc.asu.edu) grant awarded to SIPF. The funders had no role in study design, data collection and analysiss, decision to publish, or preparation of the manuscript.; We are thankful to Andres Mejia-Ramon, Dr. Christopher Morehart, Camila Pacheco-Fores, and Edgar Paredes for assistance with sample collection in Mexico. At the Archaeological Chemistry Laboratory, we are thankful to research apprentices Aimee Alvarado, Jorge Benavente, Sibella Campbell, Eric Flores, Zen Garcia, Kari Guilbault, Arman Gurule, Sparshee Naik, Elizabeth Rausch, Emily Steinberg, Alyssa Torres, Rebecca Ulloa, and Tajinder Virdee. At the W. M. Keck Foundation Laboratory for Environmental Biogeochemistry, we are grateful for the assistance of Dr. Stephen Romaniello, Dr. Trevor Martin, and Natasha Zolotova. We thank Dr. Christina Stantis and one anonymous reviewer for providing insightful comments that improved the clarity of the manuscript.	Aguirre-Samudio Ana J, 2017, Rev Arg Antrop Biol, V19, P7, DOI 10.17139/raab.2017.0019.01.02; [Anonymous], 2021, LANG ENV STAT COMP; Aubert D, 2002, APPL GEOCHEM, V17, P285, DOI 10.1016/S0883-2927(01)00080-4; Beekman CS, 2003, J ARCHAEOL METHOD TH, V10, P111, DOI 10.1023/A:1024519712257; BEGUN E. M., 2013, THESIS; Bentley RA, 2006, J ARCHAEOL METHOD TH, V13, P135, DOI 10.1007/s10816-006-9009-x; Bentley RA, 2004, J ARCHAEOL SCI, V31, P365, DOI 10.1016/j.jas.2003.09.003; Blum JD, 2000, BIOGEOCHEMISTRY, V49, P87, DOI 10.1023/A:1006390707989; Budd P, 2000, APPL GEOCHEM, V15, P687, DOI 10.1016/S0883-2927(99)00069-4; Burton JH, 2002, USE ABUSE TRACE ELEM, P159; Buzon MR, 2011, INT J OSTEOARCHAEOL, V21, P446, DOI 10.1002/oa.1151; Christensen A F, 1997, Anthropol Anz, V55, P15; Cowgill, 1973, URBANIZATION TEOTIHU; Cowgill George L., 2015, MIGRATION DISRUPTION, P97; DASCH EJ, 1969, GEOCHIM COSMOCHIM AC, V33, P1521, DOI 10.1016/0016-7037(69)90153-7; De Cserna Z., 1989, GEOLOGY N AM AN OVER, P233, DOI DOI 10.1130/DNAG-GNA-A.233; Demant A., 1981, REV I GEOLOGIA, V5, P217; Ehleringer JR, 2008, P NATL ACAD SCI USA, V105, P2788, DOI 10.1073/pnas.0712228105; ERICSON JE, 1985, J HUM EVOL, V14, P503, DOI 10.1016/S0047-2484(85)80029-4; Evans JA, 2004, UK FORENSIC GEOSCI, V232, P237, DOI DOI 10.1144/GSL.SP.2004.232.01.21.SPEC.PUBL; Faure G., 1972, STRONTIUM ISOTOPE GE; Ferrusquia-Villafranca I., 1993, BIOL DIVERSITY MEXIC, P3, DOI [DOI 10.1007/BF02908211, 10.1007/BF02908211]; Flockhart DTT, 2015, ISOT ENVIRON HEALT S, V51, P372, DOI 10.1080/10256016.2015.1021345; Fries Jr C., 1958, THESIS; Galler P, 2007, ANAL CHEM, V79, P5023, DOI 10.1021/ac070307h; Gonzalez-Jose R, 2007, P ROY SOC B-BIOL SCI, V274, P681, DOI 10.1098/rspb.2006.0151; Grimstead DN, 2017, ADV ARCHAEOL PRACT, V5, P184, DOI 10.1017/aap.2017.6; Gulson BL, 1997, J FORENSIC SCI, V42, P787; Hodell DA, 2004, J ARCHAEOL SCI, V31, P585, DOI 10.1016/j.jas.2003.10.009; Hoogewerff J, 2001, J ARCHAEOL SCI, V28, P983, DOI 10.1006/jasc.2001.0659; Kemp BM, 2005, BIOMOLECULAR ARCHAEO, P22; KINTIGH K, 1990, STUDIES MODEM ARCHAE, V3, P165; KINTIGH KW, 1982, AM ANTIQUITY, V47, P31, DOI 10.2307/280052; Knudson KJ, 2009, INT J OSTEOARCHAEOL, V19, P171, DOI 10.1002/oa.1042; Knudson KJ, 2007, AM J PHYS ANTHROPOL, V132, P25, DOI 10.1002/ajpa.20480; Knudson KJ, 2016, J ARCHAEOL SCI-REP, V5, P590, DOI 10.1016/j.jasrep.2016.01.016; Knudson KJ, 2014, ARCHAEOL ANTHROP SCI, V6, P205, DOI 10.1007/s12520-013-0148-1; LUZ B, 1984, GEOCHIM COSMOCHIM AC, V48, P1689, DOI 10.1016/0016-7037(84)90338-7; Ma JL, 2013, CHINESE SCI BULL, V58, P3111, DOI 10.1007/s11434-013-5803-5; Manzanilla LR, 2012, ESTUDIOS ARQUEOMETRI, P449; Meza-Penaloza A, 2019, J ARCHAEOL SCI-REP, V23, P559, DOI 10.1016/j.jasrep.2018.11.031; Miller Kristen Publicover, 2015, Bacterial communication and its role as a target for nanoparticle-based antimicrobial therapy; MOORBATH S, 1978, NATURE, V271, P437, DOI 10.1038/271437a0; Mooser F., 1975, MEMORIAS OBRAS SISTE, P7; Moran-Zenteno D., 1994, GEOLOGY MEXICAN REPU; Moreiras Reynaga D., 2019, THESIS; Nado K.L., 2017, THESIS; Negrel P, 2003, J HYDROL, V277, P248, DOI 10.1016/S0022-1694(03)00125-2; OHMOTO H, 1966, ECON GEOL, V61, P1205, DOI 10.2113/gsecongeo.61.7.1205; PALMER MR, 1992, GEOCHIM COSMOCHIM AC, V56, P2099, DOI 10.1016/0016-7037(92)90332-D; Pestle WJ, 2013, J ARCHAEOL SCI, V40, P2561, DOI 10.1016/j.jas.2013.01.020; Pichardo GS, 2017, MULTIETHNICITY AND MIGRATION AT TEOPANCAZCO, P143; Price T.D., 2015, ARCHAEOLOGY BIOARCHA, P119, DOI 10.1007/978-3-319-10858-2_11; Price TD, 2008, LAT AM ANTIQ, V19, P167, DOI 10.2307/25478222; Price TD, 2006, AM J PHYS ANTHROPOL, V130, P485, DOI 10.1002/ajpa.20390; Price TD, 2014, J ANTHROPOL ARCHAEOL, V36, P32, DOI 10.1016/j.jaa.2014.02.003; Price TD, 2012, CURR ANTHROPOL, V53, P396, DOI 10.1086/666492; Price TD, 2007, INTERD CONTRIB ARCH, P263, DOI 10.1007/978-0-387-48871-4_12; Price TD, 2002, ARCHAEOMETRY, V44, P117, DOI 10.1111/1475-4754.00047; PRICE TD, 1994, J ARCHAEOL SCI, V21, P315, DOI 10.1006/jasc.1994.1031; Price TD, 2000, J ARCHAEOL SCI, V27, P903, DOI 10.1006/jasc.1999.0504; Principles Faure G., 1998, APPL GEOCHEMISTRY CO; Ragsdale CS, 2018, BIOAR INTER HUM PAST, P37; Ragsdale CS, 2017, ANCIENT MESOAM, V28, P357, DOI 10.1017/S0956536117000013; Reynolds AC, 2012, GEODERMA, V189, P574, DOI 10.1016/j.geoderma.2012.06.029; Romaniello SJ, 2015, J ANAL ATOM SPECTROM, V30, P1906, DOI 10.1039/c5ja00205b; RUNIA LT, 1987, J ARCHAEOL SCI, V14, P599, DOI 10.1016/0305-4403(87)90078-1; Schwarcz H. P., 1991, SNAKE HILL INVESTIGA, P263; SEALY J, 1995, ANTIQUITY, V69, P290, DOI 10.1017/S0003598X00064693; SEALY JC, 1991, J ARCHAEOL SCI, V18, P399, DOI 10.1016/0305-4403(91)90074-Y; Servicio Geolo gico Mexicano, 2007, CART GEOL REP MEX; Servicio Geologico Mexicano, 2008, EST PUEBL TLAXC CART; Servicio Geologico Mexicano, 2009, DISTR FED EST MEX MO; Sharpe AE, 2018, P NATL ACAD SCI USA, V115, P3605, DOI 10.1073/pnas.1713880115; SILLEN A, 1989, AM ANTIQUITY, V54, P504, DOI 10.2307/280778; Solis-Pichardo G., 2012, ESTUDIOS ARQUEOMETRI, P425; Spence M., 1992, ART IDEOLOGY CITY TE, P59; Spence MW, 2009, ANCIENT MESOAM, V20, P233, DOI 10.1017/S0956536109990083; Thibodeau AM, 2018, SCI ADV, V4, DOI 10.1126/sciadv.aas9370; Thornton EK, 2011, J ARCHAEOL SCI, V38, P3254, DOI 10.1016/j.jas.2011.06.035; Torres-Alvarado IS, 2000, P INDIAN AS-EARTH, V109, P67, DOI 10.1007/BF02719150; Tricca A, 1999, CHEM GEOL, V160, P139, DOI 10.1016/S0009-2541(99)00065-0; TUREKIAN KK, 1956, SCIENCE, V124, P405, DOI 10.1126/science.124.3218.405-a; VuYzquez-SuYnchez E., 1989, GEOFISICA INT, V28, P133, DOI DOI 10.22201/IGEOF.00167169P.1989.28.2.1026; White CD, 2007, ANCIENT MESOAM, V18, P159, DOI 10.1017/S0956536107000119; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Wolf KAM, 2018, J ARCHAEOL SCI-REP, V20, P799, DOI 10.1016/j.jasrep.2018.04.023; Wright LE, 2005, J ARCHAEOL SCI, V32, P555, DOI 10.1016/j.jas.2004.11.011; Wright LE, 2012, J ANTHROPOL ARCHAEOL, V31, P334, DOI 10.1016/j.jaa.2012.02.001; Wrobel GD, 2017, J ANTHROPOL ARCHAEOL, V45, P98, DOI 10.1016/j.jaa.2016.11.004	90	13	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2020	15	2							e0229687	10.1371/journal.pone.0229687	http://dx.doi.org/10.1371/journal.pone.0229687			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LQ8DW	32092121	gold, Green Published			2022-12-26	WOS:000535229300065
J	Szibor, M; Gizatullina, Z; Gainutdinov, T; Endres, T; Debska-Vielhaber, G; Kunz, M; Karavasili, N; Hallmann, K; Schreiber, F; Bamberger, A; Schwarzer, M; Doenst, T; Heinze, HJ; Lemann, V; Vielhaber, S; Kunz, WS; Gellerich, FN				Szibor, Marten; Gizatullina, Zemfira; Gainutdinov, Timur; Endres, Thomas; Debska-Vielhaber, Grazyna; Kunz, Matthias; Karavasili, Niki; Hallmann, Kerstin; Schreiber, Frank; Bamberger, Alexandra; Schwarzer, Michael; Doenst, Torsten; Heinze, Hans-Jochen; Lemann, Volkmar; Vielhaber, Stephan; Kunz, Wolfram S.; Gellerich, Frank N.			Cytosolic, but not matrix, calcium is essential for adjustment of mitochondrial pyruvate supply	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						mouse; mitochondria; respiratory chain; calcium; bioenergetics; malate-aspartate shuttle; mitochondrial calcium uniporter; cytosolic calcium; OXPHOS control; synaptosomes; thymocytes; fibroblasts; isolated working rat heart	MALATE-ASPARTATE SHUTTLE; OXIDATIVE-PHOSPHORYLATION; BRAIN MITOCHONDRIA; MICE LACKING; RAT-HEART; RESPIRATION; DEFICIENCY; HOMEOSTASIS; STRESS; CA2+	Mitochondrial oxidative phosphorylation (OXPHOS) and cellular workload are tightly balanced by the key cellular regulator, calcium (Ca2+). Current models assume that cytosolic Ca2+ regulates workload and that mitochondrial Ca2+ uptake precedes activation of matrix dehydrogenases, thereby matching OXPHOS substrate supply to ATP demand. Surprisingly, knockout (KO) of the mitochondrial Ca2+ uniporter (MCU) in mice results in only minimal phenotypic changes and does not alter OXPHOS. This implies that adaptive activation of mitochondrial dehydrogenases by intramitochondrial Ca2+ cannot be the exclusive mechanism for OXPHOS control. We hypothesized that cytosolic Ca2+, but not mitochondrial matrix Ca2+, may adapt OXPHOS to workload by adjusting the rate of pyruvate supply from the cytosol to the mitochondria. Here, we studied the role of malate-aspartate shuttle (MAS)-dependent substrate supply in OXPHOS responses to changing Ca2+ concentrations in isolated brain and heart mitochondria, synaptosomes, fibroblasts, and thymocytes from WT and MCU KO mice and the isolated working rat heart. Our results indicate that extramitochondrial Ca2+ controls up to 85% of maximal pyruvate-driven OXPHOS rates, mediated by the activity of the complete MAS, and that intramitochondrial Ca2+ accounts for the remaining 15%. Of note, the complete MAS, as applied here, included besides its classical NADH oxidation reaction the generation of cytosolic pyruvate. Part of this largely neglected mechanism has previously been described as the ?mitochondrial gas pedal.? Its implementation into OXPHOS control models integrates seemingly contradictory results and warrants a critical reappraisal of metabolic control mechanisms in health and disease.	[Gizatullina, Zemfira; Gainutdinov, Timur; Debska-Vielhaber, Grazyna; Kunz, Matthias; Karavasili, Niki; Schreiber, Frank; Heinze, Hans-Jochen; Vielhaber, Stephan; Gellerich, Frank N.] Otto von Guericke Univ, Dept Neurol, D-39120 Magdeburg, Germany; [Gizatullina, Zemfira; Gainutdinov, Timur; Gellerich, Frank N.] Leibniz Inst Neurobiol, D-39120 Magdeburg, Germany; [Szibor, Marten] Tampere Univ, Fac Med & Hlth Technol, FI-33520 Tampere, Finland; [Szibor, Marten; Bamberger, Alexandra; Schwarzer, Michael; Doenst, Torsten] Jena Univ Hosp, Dept Cardiothorac Surg, D-07747 Jena, Germany; [Gainutdinov, Timur] Tatarstan Acad Sci, Res Inst Problems Ecol & Mineral Wealth Use, Kazan 420087, Russia; [Endres, Thomas; Lemann, Volkmar] Otto von Guericke Univ, Inst Physiol, D-39120 Magdeburg, Germany; [Hallmann, Kerstin; Kunz, Wolfram S.] Univ Bonn, Inst Expt Epileptol & Cognit Res, D-53127 Bonn, Germany; [Schreiber, Frank; Heinze, Hans-Jochen; Vielhaber, Stephan] German Ctr Neurodegenerat Dis, D-39120 Magdeburg, Germany; [Heinze, Hans-Jochen; Lemann, Volkmar] CBBS, D-39120 Magdeburg, Germany	Otto von Guericke University; Leibniz Institut fur Neurobiologie (LIN); Tampere University; Friedrich Schiller University of Jena; Otto von Guericke University; University of Bonn; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE)	Gellerich, FN (corresponding author), Otto von Guericke Univ, Dept Neurol, D-39120 Magdeburg, Germany.	Frank.Gellerich@med.ovgu.de	Schwarzer, Michael/E-4438-2013; Kunz, Wolfram/K-1232-2019; Endres, Thomas/J-9393-2012; Gainutdinov, Timur/ABC-2749-2020; Schreiber, Stefanie/S-3223-2019; Lessmann, Volkmar/E-8125-2013	Kunz, Wolfram/0000-0003-1113-3493; Endres, Thomas/0000-0003-4263-2922; Gainutdinov, Timur/0000-0003-1723-1780; Schreiber, Stefanie/0000-0003-4439-4374; Lessmann, Volkmar/0000-0002-6863-323X; Szibor, Marten/0000-0003-4029-160X	Stiftung fur Medizinische Wissenschaft (Frankfurt/M, Germany); Deutsche Forschungsgemeinschaft [KU 911/21-2]	Stiftung fur Medizinische Wissenschaft (Frankfurt/M, Germany); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by a grant from the Stiftung fur Medizinische Wissenschaft (Frankfurt/M, Germany) and Deutsche Forschungsgemeinschaft Grant KU 911/21-2. The authors declare that they have no conflicts of interest with the contents of this article.	Abbrescia DI, 2012, ARCH BIOCHEM BIOPHYS, V518, P157, DOI 10.1016/j.abb.2011.12.021; Amoedo ND, 2016, BBA-MOL CELL RES, V1863, P2394, DOI 10.1016/j.bbamcr.2016.04.011; Balaban RS, 2002, J MOL CELL CARDIOL, V34, P1259, DOI 10.1006/jmcc.2002.2082; Carafoli E, 2010, BBA-BIOENERGETICS, V1797, P595, DOI 10.1016/j.bbabio.2010.03.024; Colwell CS, 2000, EUR J NEUROSCI, V12, P571, DOI 10.1046/j.1460-9568.2000.00939.x; Contreras L, 2009, J BIOL CHEM, V284, P7091, DOI 10.1074/jbc.M808066200; DENTON RM, 1990, ANNU REV PHYSIOL, V52, P451, DOI 10.1146/annurev.ph.52.030190.002315; Doenst T, 1998, MOL CELL BIOCHEM, V180, P153, DOI 10.1023/A:1006863728395; Doenst Torsten, 1996, American Journal of Physiology, V270, pH1607; Falk MJ, 2014, JIMD REP, V14, P77, DOI 10.1007/8904_2013_287; Fiermonte G, 2002, J BIOL CHEM, V277, P19289, DOI 10.1074/jbc.M201572200; Frohlich C, 2016, MOL NEUROBIOL, V53, P4728, DOI 10.1007/s12035-015-9399-4; Gellerich FN, 2008, J BIOL CHEM, V283, P30715, DOI 10.1074/jbc.M709555200; Gellerich FN, 2010, BBA-BIOENERGETICS, V1797, P1018, DOI 10.1016/j.bbabio.2010.02.005; Gellerich FN, 2013, IUBMB LIFE, V65, P180, DOI 10.1002/iub.1131; Gellerich FN, 2012, BIOCHEM J, V443, P747, DOI 10.1042/BJ20110765; Gizatullina ZZ, 2003, BIOCHEM BIOPH RES CO, V304, P643, DOI 10.1016/S0006-291X(03)00654-5; Gnaiger E, 2001, RESP PHYSIOL, V128, P277, DOI 10.1016/S0034-5687(01)00307-3; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Hamilton J, 2018, J BIOL CHEM, V293, P15652, DOI 10.1074/jbc.RA118.002926; HEINRICH R, 1974, EUR J BIOCHEM, V42, P89, DOI 10.1111/j.1432-1033.1974.tb03318.x; Holmstrom KM, 2015, J MOL CELL CARDIOL, V85, P178, DOI 10.1016/j.yjmcc.2015.05.022; Ikeda M, 2003, NEURON, V38, P253, DOI 10.1016/S0896-6273(03)00164-8; Juaristi I, 2017, J NEUROCHEM, V142, P132, DOI 10.1111/jnc.14047; KAUPPINEN RA, 1986, FEBS LETT, V199, P222, DOI 10.1016/0014-5793(86)80484-7; KAUPPINEN RA, 1987, BIOCHIM BIOPHYS ACTA, V930, P173, DOI 10.1016/0167-4889(87)90029-2; Keira Sidney Mamoru, 2004, Acta Cir. Bras., V19, P11, DOI 10.1590/S0102-86502004000700004; Konig T, 2016, MOL CELL, V64, P148, DOI 10.1016/j.molcel.2016.08.020; Korzeniewski B, 2007, BIOPHYS CHEM, V129, P93, DOI 10.1016/j.bpc.2007.05.013; Korzeniewski B, 2017, PROG BIOPHYS MOL BIO, V125, P1, DOI 10.1016/j.pbiomolbio.2016.12.001; Koval OM, 2019, SCI SIGNAL, V12, DOI 10.1126/scisignal.aav1439; Kudin AP, 2004, J BIOL CHEM, V279, P4127, DOI 10.1074/jbc.M310341200; Kwong JQ, 2015, CELL REP, V12, P15, DOI 10.1016/j.celrep.2015.06.002; Llorente-Folch I, 2013, J NEUROSCI, V33, P13957, DOI 10.1523/JNEUROSCI.0929-13.2013; Logan CV, 2014, NAT GENET, V46, P188, DOI 10.1038/ng.2851; Luongo TS, 2015, CELL REP, V12, P23, DOI 10.1016/j.celrep.2015.06.017; Mazat JP, 1997, MOL CELL BIOCHEM, V174, P143, DOI 10.1023/A:1006875517267; MCCORMACK JG, 1990, PHYSIOL REV, V70, P391, DOI 10.1152/physrev.1990.70.2.391; McKenna MC, 2006, BIOCHEM PHARMACOL, V71, P399, DOI 10.1016/j.bcp.2005.10.011; Monne M, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20184456; Nichols M, 2017, J CEREBR BLOOD F MET, V37, P3027, DOI 10.1177/0271678X16682250; Palmieri L, 2001, EMBO J, V20, P5060, DOI 10.1093/emboj/20.18.5060; Pan X, 2013, NAT CELL BIOL, V15, P1464, DOI 10.1038/ncb2868; Petzold A, 2015, NEUROBIOL LEARN MEM, V120, P52, DOI 10.1016/j.nlm.2015.02.009; Psotta L, 2015, FRONT BEHAV NEUROSCI, V9, DOI 10.3389/fnbeh.2015.00058; Rasmussen TP, 2015, P NATL ACAD SCI USA, V112, P9129, DOI 10.1073/pnas.1504705112; ROSENTHAL RE, 1987, J CEREBR BLOOD F MET, V7, P752, DOI 10.1038/jcbfm.1987.130; Satrustegui J, 2007, PHYSIOL REV, V87, P29, DOI 10.1152/physrev.00005.2006; SCHOLZ TD, 1995, PEDIATR RES, V38, P221, DOI 10.1203/00006450-199508000-00015; Schwarzer M, 2009, BASIC RES CARDIOL, V104, P547, DOI 10.1007/s00395-009-0015-5; SIMS NR, 1990, J NEUROCHEM, V55, P698, DOI 10.1111/j.1471-4159.1990.tb04189.x; Tang L, 2008, AM J PHYSIOL-HEART C, V295, pH297, DOI 10.1152/ajpheart.00137.2008; Tsai CW, 2017, P NATL ACAD SCI USA, V114, P4388, DOI 10.1073/pnas.1702938114; Wang P, 2020, J PHYSIOL-LONDON, V598, P1307, DOI 10.1113/JP276636; Wibom R, 2009, NEW ENGL J MED, V361, P489, DOI 10.1056/NEJMoa0900591; Wu YJ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7081	56	28	28	0	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 3	2020	295	14					4383	4397		10.1074/jbc.RA119.011902	http://dx.doi.org/10.1074/jbc.RA119.011902			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LB2WZ	32094224	Green Published, hybrid			2022-12-26	WOS:000524499700003
J	Camp, A; Croxford, AE; Ford, CS; Baumann, U; Clements, PR; Hiendleder, S; Woolford, L; Netzel, G; Boardman, WSJ; Fletcher, MT; Wilkinson, MJ				Camp, Amanda; Croxford, Adam E.; Ford, Caroline S.; Baumann, Ute; Clements, Peter R.; Hiendleder, Stefan; Woolford, Lucy; Netzel, Gabrielle; Boardman, Wayne S. J.; Fletcher, Mary T.; Wilkinson, Mike J.			Dual-locus DNA metabarcoding reveals southern hairy-nosed wombats (Lasiorhinus latifrons Owen) have a summer diet dominated by toxic invasive plants	PLOS ONE			English	Article							POPULATION-DYNAMICS; ALIGNMENT; IMPACTS; NUMBER	Habitat degradation and summer droughts severely restrict feeding options for the endangered southern hairy-nosed wombat (SHNW; Lasiorhinus latifrons). We reconstructed SHNW summer diets by DNA metabarcoding from feces. We initially validated rbcL and ndhJ diet reconstructions using autopsied and captive animals. Subsequent diet reconstructions of wild wombats broadly reflected vegetative ground cover, implying local rather than long-range foraging. Diets were all dominated by alien invasives. Chemical analysis of alien food revealed Carrichtera annua contains high levels of glucosinolates. Clinical examination (7 animals) and autopsy (12 animals) revealed that the most degraded site also contained most individuals showing signs of glucosinolate poisoning. We infer that dietary poisoning through the ingestion of alien invasives may have contributed to the recent population crashes in the region. In floristically diverse sites, individuals appear to be able to manage glucosinolate intake by avoidance or episodic feeding but this strategy is less tractable in the most degraded sites. We conclude that recovery of the most affected populations may require effective Carrichtera management and interim supplementary feeding. More generally, we argue that protection against population decline by poisoning in territorial herbivores requires knowledge of their diet and of those food plants containing toxic principles.	[Camp, Amanda; Hiendleder, Stefan; Woolford, Lucy; Boardman, Wayne S. J.] Univ Adelaide, Sch Anim & Vet Sci, Adelaide, SA, Australia; [Camp, Amanda; Hiendleder, Stefan; Woolford, Lucy; Boardman, Wayne S. J.] Univ Adelaide, Davies Res Ctr, Adelaide, SA, Australia; [Croxford, Adam E.; Clements, Peter R.] Univ Adelaide, Sch Agr Food & Wine, Adelaide, SA, Australia; [Ford, Caroline S.] Wales Vet Sci Ctr, Aberystwyth, Dyfed, Wales; [Baumann, Ute] Univ Adelaide, Australian Ctr Plant Funct Genom, Adelaide, SA, Australia; [Netzel, Gabrielle; Fletcher, Mary T.] Univ Queensland, Ctr Anim Sci, Brisbane, Qld, Australia; [Wilkinson, Mike J.] Aberystwyth Univ, Inst Biol Environm & Rural Sci, Aberystwyth, Dyfed, Wales	University of Adelaide; University of Adelaide; University of Adelaide; University of Adelaide; University of Queensland; Aberystwyth University; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Institute of Biological, Environmental, Rural & Sciences (IBERS)	Wilkinson, MJ (corresponding author), Aberystwyth Univ, Inst Biol Environm & Rural Sci, Aberystwyth, Dyfed, Wales.	mjw19@aber.ac.uk	Boardman, Wayne/ABE-7528-2020; Netzel, Gabriele/M-3889-2013	Boardman, Wayne/0000-0002-1746-0682; Netzel, Gabriele/0000-0003-1581-4851; Woolford, Lucy/0000-0001-7271-2937	Adelaide University; Biotechnology and Biological Sciences Research Council (BBSRC) [BB CSP1730/1]; South Australian Government Department for Environment and Water [0001034583]; BBSRC [BBS/E/W/0012843C] Funding Source: UKRI	Adelaide University; Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); South Australian Government Department for Environment and Water; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by Adelaide University (MJW), the Biotechnology and Biological Sciences Research Council (BBSRC) strategic program grant (grant number BB CSP1730/1) (MJW) and the South Australian Government Department for Environment and Water (Grant number 0001034583) (LW).	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Awano T, 2009, P NATL ACAD SCI USA, V106, P2794, DOI [10.1073/pnas.0905845106, 10.1073/pnas.0812297106]; BARBOZA PS, 1993, AUST J ZOOL, V41, P527, DOI 10.1071/ZO9930527; BARBOZA PS, 1992, J COMP PHYSIOL B, V162, P561; Beche D., 2016, J PLANT BIOL SOIL HL, V3, P1, DOI [10.13188/2331-8996.1000008, DOI 10.13188/2331-8996.1000008]; Bischoff K.L., 2016, NUTRACEUTICALS, DOI [10. 1016/B978-0-12-802147- 7.00040-1., 10.1016/B978-0-12-802147-7.00040-1, DOI 10.1016/B978-0-12-802147-7.00040-1]; Coghlan Megan L, 2013, Investig Genet, V4, P27, DOI 10.1186/2041-2223-4-27; Collett M. G., 2014, International Journal of Poisonous Plant Research, V3, P7; Cooke J, 2012, RANGELAND J, V34, P375, DOI 10.1071/RJ12027; Craine JM, 2015, SCI REP-UK, V5, DOI 10.1038/srep08280; Cunningham G.M, 2002, PLANTS W NEW S WALES, DOI [10.1071/9780643104273, DOI 10.1071/9780643104273]; Davis NE, 2016, WILDLIFE RES, V43, P515, DOI 10.1071/WR16148; El-Fattah HA, 1997, INT J PHARMACOGN, V35, P274; Everist SL., 1974, POISONOUS PLANTAUS, P21; Ford CS, 2009, BOT J LINN SOC, V159, P1, DOI 10.1111/j.1095-8339.2008.00938.x; Garcia-Robledo C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052967; Green K, 2015, AUST MAMMAL, V37, P146, DOI 10.1071/AM14037; Heckenhauer J, 2016, APPL PLANT SCI, V4, DOI 10.3732/apps.1500137; Iwanowicz DD, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165366; Jakubaviciute E, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0186929; Jessop JP, 1986, FLORA S AUSTR, P4; Kartzinel TR, 2015, P NATL ACAD SCI USA, V112, P8019, DOI 10.1073/pnas.1503283112; Kress WJ, 2009, P NATL ACAD SCI USA, V106, P18621, DOI 10.1073/pnas.0909820106; Kusznierewicz B, 2013, J CHROMATOGR A, V1278, P108, DOI 10.1016/j.chroma.2012.12.075; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Leray M, 2015, PEERJ, V3, DOI 10.7717/peerj.1047; Levin RA, 2003, AM J BOT, V90, P107, DOI 10.3732/ajb.90.1.107; Lin LZ, 2014, J AGR FOOD CHEM, V62, P6118, DOI 10.1021/jf405538d; Liu YF, 2010, RAPID COMMUN MASS SP, V24, P667, DOI 10.1002/rcm.4436; Ma J, 2015, CURR GENET, V61, P591, DOI 10.1007/s00294-015-0482-1; Magoc T, 2011, BIOINFORMATICS, V27, P2957, DOI 10.1093/bioinformatics/btr507; McArthur C, 2014, OECOLOGIA, V176, P677, DOI 10.1007/s00442-014-3076-6; MCKENZIE RA, 1987, AUST VET J, V64, P298, DOI 10.1111/j.1751-0813.1987.tb07330.x; McKenzie RA., 2012, AUSTR POISONOUS PLAN, P195; Pedras MSC, 2014, CHEM BIODIVERS, V11, P910, DOI 10.1002/cbdv.201300260; POSSINGH.JV, 1969, PLANTA, V86, P186, DOI 10.1007/BF00379826; Pysek P, 2012, GLOBAL CHANGE BIOL, V18, P1725, DOI 10.1111/j.1365-2486.2011.02636.x; Ruykys L, 2009, AUST J ZOOL, V57, P129, DOI 10.1071/ZO09010; Samreen U, 2015, CURR OPIN AGR, V4, P1; Soininen EM, 2013, POLAR BIOL, V36, P1069, DOI 10.1007/s00300-013-1328-2; Swinbourne MJ, 2017, AUST MAMMAL, V39, P1, DOI 10.1071/AM15046; Swinbourne MJ, 2015, WILDLIFE RES, V42, P678, DOI 10.1071/WR15068; Taggart D., 2008, IUCN RED LIST THREAT; Wilkinson MJ, 2017, SCI REP-UK, V7, DOI 10.1038/srep46040; Woinarski J., 2016, IUCN RED LIST THREAT, DOI 10.2305/IUCN.UK.2016-1.RLTS.T40488A21964009.en; Woinarski JCZ, 2015, P NATL ACAD SCI USA, V112, P4531, DOI 10.1073/pnas.1417301112	46	7	7	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2020	15	3							e0229390	10.1371/journal.pone.0229390	http://dx.doi.org/10.1371/journal.pone.0229390			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8TR	32142513	Green Published, gold			2022-12-26	WOS:000535271600012
J	Mu, QX; Yu, J; Griffin, JI; Wu, Y; Zhu, LX; McConnachie, LA; Ho, RJY				Mu, Qingxin; Yu, Jesse; Griffin, James, I; Wu, Yan; Zhu, Linxi; McConnachie, Lisa A.; Ho, Rodney J. Y.			Novel drug combination nanoparticles exhibit enhanced plasma exposure and doseresponsive effects on eliminating breast cancer lung metastasis	PLOS ONE			English	Article							GEMCITABINE PLUS PACLITAXEL; ADVANCED PANCREATIC-CANCER; BLOOD-VESSELS; NODE; LIPOSOMES; EXIT	Early diagnosis along with new drugs targeted to cancer receptors and immunocheckpoints have improved breast cancer survival. However, full remission remains elusive for metastatic breast cancer due to dose-limiting toxicities of heavily used, highly potent drug combinations such as gemcitabine and paclitaxel. Therefore, novel strategies that lower the effective dose and improve safety margins could enhance the effect of these drug combinations. To this end, we developed and evaluated a novel drug combination of gemcitabine and paclitaxel (GT). Leveraging a simple and scalable drug-combination nanoparticle platform (DcNP), we successfully prepared an injectable GT combination in DcNP (GT DcNP). Compared to a Cremophor EL/ethanol assisted drug suspension in buffer (CrEL), GT DcNP exhibits about 56-fold and 8.6-fold increases in plasma drug exposure (area under the curve, AUC) and apparent half-life of gemcitabine respectively, and a 2.9-fold increase of AUC for paclitaxel. Using 4T1 as a syngeneic model for breast cancer metastasis, we found that a single GT (20/2 mg/kg) dose in DcNP nearly eliminated colonization in the lungs. This effect was not achievable by a CrEL drug combination at a 5-fold higher dose (i.e., 100/10 mg/kg GT). A dose-response study indicates that GT DcNP provided a therapeutic index of similar to 15.8. Collectively, these data suggest that GT DcNP could be effective against advancing metastatic breast cancer with a margin of safety. As the DcNP formulation is intentionally designed to be simple, scalable, and long-acting, it may be suitable for clinical development to find effective treatment against metastatic breast cancer.	[Mu, Qingxin; Yu, Jesse; Griffin, James, I; Wu, Yan; Zhu, Linxi; McConnachie, Lisa A.; Ho, Rodney J. Y.] Univ Washington, Dept Pharmaceut, Seattle, WA 98195 USA; [Ho, Rodney J. Y.] Univ Washington, Dept Bioengn, Seattle, WA 98195 USA; [Wu, Yan] Air Force Med Ctr PLA, Dept Pharm, Beijing, Peoples R China	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Ho, RJY (corresponding author), Univ Washington, Dept Pharmaceut, Seattle, WA 98195 USA.; Ho, RJY (corresponding author), Univ Washington, Dept Bioengn, Seattle, WA 98195 USA.	rodneyho@uw.edu	Mu, Qingxin/B-7250-2009	Mu, Qingxin/0000-0003-4952-6591	NIH [UM1AI120176, R61AI149665, 1S10OD010652-01]; UW Shared IVIS Core	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UW Shared IVIS Core	This work was supported in part by NIH grants UM1AI120176 and R61AI149665, the UW Shared IVIS Core, and NIH Shared Instrumentation Grant 1S10OD010652-01. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albain KS, 2008, J CLIN ONCOL, V26, P3950, DOI 10.1200/JCO.2007.11.9362; Beane JD, 2015, INVEST NEW DRUG, V33, P109, DOI 10.1007/s10637-014-0157-7; Brown M, 2018, SCIENCE, V359, P1408, DOI 10.1126/science.aal3662; Cao HQ, 2016, ACS NANO, V10, P7738, DOI 10.1021/acsnano.6b03148; Cao HQ, 2015, J CONTROL RELEASE, V205, P162, DOI 10.1016/j.jconrel.2015.01.015; Chen QY, 2012, NUTR CANCER, V64, P1219, DOI 10.1080/01635581.2012.718404; Dan ZL, 2016, THERANOSTICS, V6, P435, DOI 10.7150/thno.13896; Eckhardt BL, 2012, NAT REV DRUG DISCOV, V11, P479, DOI 10.1038/nrd2372; Frese KK, 2012, CANCER DISCOV, V2, P260, DOI 10.1158/2159-8290.CD-11-0242; He XY, 2017, NANO LETT, V17, P5546, DOI 10.1021/acs.nanolett.7b02330; Koehn J, 2018, AIDS, V32, P2463, DOI [10.1097/QAD.0000000000001969, 10.1097/qad.0000000000001969]; Kraft JC, 2018, J DRUG TARGET, V26, P494, DOI 10.1080/1061186X.2018.1433681; Kraft JC, 2017, AIDS, V31, P765, DOI 10.1097/QAD.0000000000001405; Lim B, 2016, CANCER METAST REV, V35, P495, DOI 10.1007/s10555-016-9636-y; Loehrer PJ, 2011, J CLIN ONCOL, V29, P4105, DOI 10.1200/JCO.2011.34.8904; McConnachie LA, 2018, J PHARM SCI-US, V107, P1787, DOI 10.1016/j.xphs.2018.03.005; Paolino D, 2010, J CONTROL RELEASE, V144, P144, DOI 10.1016/j.jconrel.2010.02.021; Perazzolo S, 2018, J PHARM SCI-US, V107, P3153, DOI 10.1016/j.xphs.2018.07.032; Pereira ER, 2018, SCIENCE, V359, P1403, DOI 10.1126/science.aal3622; Pulaski BA, 2000, CURR PROTOC IMMUNOL, V39, P20, DOI DOI 10.1002/0471142735.IM2002S39; Rashid OM, 2015, EXPERT OPIN DRUG MET, V11, P221, DOI 10.1517/17425255.2015.983073; Rashid OM, 2013, J THORAC DIS, V5, P385, DOI 10.3978/j.issn.2072-1439.2013.06.17; Siegel RL, 2016, CA-CANCER J CLIN, V66, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; Srivastava S, 2015, J IMMUNOL S, V194; Steeg PS, 2006, NAT MED, V12, P895, DOI 10.1038/nm1469; Tao K, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-228; Xu BH, 2010, ASIA-PAC J CLIN ONCO, V6, P320, DOI 10.1111/j.1743-7563.2010.01323.x; Zhang J, 2018, MOLECULES, V23, DOI 10.3390/molecules23112906	28	5	5	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2020	15	3							e0228557	10.1371/journal.pone.0228557	http://dx.doi.org/10.1371/journal.pone.0228557			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8TR	32142553	Green Published, gold			2022-12-26	WOS:000535271600006
J	Campanero, C; Munoz-Atienza, E; Diep, DB; Feito, J; Arbulu, S; del Campo, R; Nes, IF; Hernandez, PE; Herranz, C; Cintas, LM				Campanero, Cristina; Munoz-Atienza, Estefania; Diep, Dzung B.; Feito, Javier; Arbulu, Sara; del Campo, Rosa; Nes, Ingolf F.; Hernandez, Pablo E.; Herranz, Carmen; Cintas, Luis M.			Biochemical, genetic and transcriptional characterization of multibacteriocin production by the anti-pneumococcal dairy strain Streptococcus infantarius LP90	PLOS ONE			English	Article							LACTIC-ACID BACTERIA; IDENTIFICATION; RESISTANCE; FOOD; PCR; L50	Streptococcus pneumoniae infections are one of the major causes of morbility and mortality worldwide. Although vaccination and antibiotherapy constitute fundamental and complementary strategies against pneumococcal infections, they present some limitations including the increase in non-vaccine serotypes and the emergence of multidrug-resistances, respectively. Ribosomally-synthesized antimicrobial peptides (i.e. bacteriocins) produced by Lactic Acid Bacteria (LAB) may represent an alternative or complementary strategy to antibiotics for the control of pneumococal infections. We tested the antimicrobial activity of 37 bacteriocinogenic LAB, isolated from food and other sources, against clinical S. pneumoniae strains. Streptococcus infantarius subsp. infantarius LP90, isolated from Venezuelan water-buffalo milk, was selected because of its broad and strong anti-pneumococcal spectrum. The in vitro safety assessment of S. infantarius LP90 revealed that it may be considered avirulent. The analysis of a 19,539-bp cluster showed the presence of 29 putative open reading frames (ORFs), including the genes encoding 8 new class II-bacteriocins, as well as the proteins involved in their secretion, immunity and regulation. Transcriptional analyses evidenced that the induction factor (IF) structural gene, the bacteriocin/IF transporter genes, the bacteriocin structural genes and most of the bacteriocin immunity genes were transcribed. MALDI-TOF analyses of peptides purified using different multichromatographic procedures revealed that the dairy strain S. infantarius LP90 produces at least 6 bacteriocins, including infantaricin A(1), a novel anti-pneumococcal two-peptide bacteriocin.	[Campanero, Cristina; Munoz-Atienza, Estefania; Feito, Javier; Arbulu, Sara; Hernandez, Pablo E.; Herranz, Carmen; Cintas, Luis M.] Univ Complutense Madrid, Grp Seguridad & Calidad Alimentos Bacterias Lact, Secc Dept Nutr & Ciencia Alimentos Nutr Bromatol, Fac Vet, Madrid, Spain; [Diep, Dzung B.; Nes, Ingolf F.] Norwegian Univ Life Sci NMBU, Dept Chem Biotechnol & Food Sci, As, Norway; [del Campo, Rosa] Hosp Univ Ramon & Cajal, Serv Microbiol, Madrid, Spain; [del Campo, Rosa] Inst Ramon & Cajal Invest Sanitaria IRYCIS, Madrid, Spain; [Munoz-Atienza, Estefania] Inst Nacl Invest & Tecnol Agr & Alimentaria INIA, Ctr Invest Sanidad Anim CISA, Madrid, Spain	Complutense University of Madrid; Norwegian University of Life Sciences; Hospital Universitario Ramon y Cajal; Instituto Nacional Investigacion Tecnologia Agraria Alimentaria (INIA)	Cintas, LM (corresponding author), Univ Complutense Madrid, Grp Seguridad & Calidad Alimentos Bacterias Lact, Secc Dept Nutr & Ciencia Alimentos Nutr Bromatol, Fac Vet, Madrid, Spain.	lcintas@vet.ucm.es	Diep, Dzung B./AAK-1419-2021; Arbulu, Sara/Z-6308-2019; Diệp, Dzũng/ABG-9262-2020; Cintas, Luis M/C-7030-2017; Hernandez, Pablo E./P-8701-2014; Muñoz-Atienza, Estefanía/J-9481-2017; Feito, Javier/AAN-7273-2020; del Campo, Rosa/M-9628-2013	Arbulu, Sara/0000-0001-9889-3692; Hernandez, Pablo E./0000-0001-6259-8456; Muñoz-Atienza, Estefanía/0000-0001-6218-1511; Feito, Javier/0000-0003-1774-3372; Diep, Dzung/0000-0001-7661-5501; del Campo, Rosa/0000-0003-1147-7923	Ministerio de Ciencia, Innovacion y Universidades (MICINN, Madrid, Spain) [RTI2018-094907-B-I00]; Ministerio de Economia y Competitividad (MINECO, Madrid, Spain) [AGL2012-34829]; Consejeria de Educacion, Comunidad de Madrid, Madrid, Spain [S-2009/AGR-1489, S-2013/ABI2747]; UCM, Spain; UCM; MINECO; Junta de Galicia, Spain [07CSA007E]	Ministerio de Ciencia, Innovacion y Universidades (MICINN, Madrid, Spain); Ministerio de Economia y Competitividad (MINECO, Madrid, Spain)(Spanish Government); Consejeria de Educacion, Comunidad de Madrid, Madrid, Spain; UCM, Spain; UCM; MINECO(Spanish Government); Junta de Galicia, Spain	This work was supported by projects RTI2018-094907-B-I00 from Ministerio de Ciencia, Innovacion y Universidades (MICINN, Madrid, Spain), 07CSA007E from the Junta de Galicia, Spain, AGL2012-34829 from Ministerio de Economia y Competitividad (MINECO, Madrid, Spain), and S-2009/AGR-1489 and S-2013/ABI2747 from Consejeria de Educacion, Comunidad de Madrid, Madrid, Spain. C. Campanero and E. Munoz-Atienza were recipients of predoctoral fellowships (FPU) from UCM, Spain. J. Feito holds a contract from UCM. S. Arbulu held a predoctoral fellowship (FPI) from MINECO.	Abdelgadir W, 2008, INT J FOOD MICROBIOL, V127, P215, DOI 10.1016/j.ijfoodmicro.2008.07.008; Ahmad V, 2017, INT J ANTIMICROB AG, V49, P1, DOI 10.1016/j.ijantimicag.2016.08.016; Aquilina G, 2012, EFSA J, V10, DOI 10.2903/j.efsa.2012.2740; Bover-Cid S, 1999, INT J FOOD MICROBIOL, V53, P33, DOI 10.1016/S0168-1605(99)00152-X; Braido F, 2008, PULM PHARMACOL THER, V21, P608, DOI 10.1016/j.pupt.2008.04.001; Cintas LM, 2000, J BACTERIOL, V182, P6806, DOI 10.1128/JB.182.23.6806-6814.2000; CINTAS LM, 1995, APPL ENVIRON MICROB, V61, P2643, DOI 10.1128/AEM.61.7.2643-2648.1995; Citti R., 2005, THESIS; Coton M, 2004, FOOD MICROBIOL, V21, P125, DOI 10.1016/j.fm.2003.10.004; Cotter PD, 2013, NAT REV MICROBIOL, V11, P95, DOI 10.1038/nrmicro2937; Delorme C, 2008, INT J FOOD MICROBIOL, V126, P274, DOI 10.1016/j.ijfoodmicro.2007.08.014; Eaton TJ, 2001, APPL ENVIRON MICROB, V67, P1628, DOI 10.1128/AEM.67.4.1628-1635.2001; Fontaine L, 2007, J BACTERIOL, V189, P7195, DOI 10.1128/JB.00966-07; Hoshino T, 2005, J CLIN MICROBIOL, V43, P6073, DOI 10.1128/JCM.43.12.6073-6085.2005; Jans C, 2012, J BACTERIOL, V194, P2105, DOI 10.1128/JB.00160-12; Kjos M, 2010, J BACTERIOL, V192, P2068, DOI 10.1128/JB.01553-09; LEJEUNE C, 1995, J APPL BACTERIOL, V78, P316; Marcobal A, 2005, J FOOD PROTECT, V68, P874, DOI 10.4315/0362-028X-68.4.874; Munoz-Atienza E, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-15; Munoz-Atienza E, 2011, INT J FOOD MICROBIOL, V146, P212, DOI 10.1016/j.ijfoodmicro.2011.02.024; Noriega L, 2006, INT DAIRY J, V16, P850, DOI 10.1016/j.idairyj.2005.09.008; Poyart C, 1998, J CLIN MICROBIOL, V36, P41, DOI 10.1128/JCM.36.1.41-47.1998; Rodgers GL, 2009, VACCINE, V27, P3802, DOI 10.1016/j.vaccine.2009.04.021; Schlegel L, 2003, INT J SYST EVOL MICR, V53, P631, DOI 10.1099/ijs.0.02361-0; Skaugen M, GENETICS LACTIC ACID; Toda H, 2018, J INFECT CHEMOTHER, V24, P171, DOI 10.1016/j.jiac.2017.12.010; Zhou JS, 2001, INT J FOOD MICROBIOL, V63, P81, DOI 10.1016/S0168-1605(00)00398-6	27	4	4	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2020	15	3							e0229417	10.1371/journal.pone.0229417	http://dx.doi.org/10.1371/journal.pone.0229417			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8RK	32134941	Green Published, gold			2022-12-26	WOS:000535265600023
J	Garciaz, S; Sfumato, P; Granata, A; Imbert, AM; Fournel, C; Calmels, B; Lemarie, C; Chiaroni, J; Blaise, D; Boher, JM; Picard, C; Chabannon, C; di Cristofaro, J				Garciaz, Sylvain; Sfumato, Patrick; Granata, Angela; Imbert, Anne-Marie; Fournel, Claire; Calmels, Boris; Lemarie, Claude; Chiaroni, Jacques; Blaise, Didier; Boher, Jean-Marie; Picard, Christophe; Chabannon, Christian; di Cristofaro, Julie			Analysis of a large single institution cohort of related donors fails to detect a relation between SDF1/CXCR4 or VCAM/VLA4 genetic polymorphisms and the level of hematopoietic progenitor cell mobilization in response to G-CSF	PLOS ONE			English	Article							BLOOD STEM-CELL; COLONY-STIMULATING FACTOR; BONE-MARROW; ALLOGENEIC TRANSPLANTATION; ACUTE-LEUKEMIA; IMPACT; VCAM1; YIELD	We studied a cohort of 367 healthy related donors who volunteered to donate their hematopoietic stem cells for allogeneic transplantation. All donors were homogeneously cared for at a single institution, and received rhG-CSF as a mobilization treatment prior to undergoing apheresis. Peripheral blood CD34+ cell counts were used as the main surrogate marker for rhG-CSF induced mobilization. We searched whether inter-individual variations in known genetic polymorphisms located in genes whose products are functionally important for mobilization, could affect the extent of CD34+ mobilization, either individually or in combination. We found little or no influence of individual SNPs or haplotypes for the SDF1, CXCR4, VCAM and VLA4 genes, whether using CD34+ cell counts as a continuous or a categorical variable. Simple clinical characteristics describing donors such as body mass index, age and possibly sex are more potent predictors of stem cell mobilization. The size of our cohort remains relatively small for genetic analyses, however compares favorably with cohorts analyzed in previously published reports suggesting associations of genetic traits to response to rhG-CSF; notwithstanding this limitation, our data do not support the use of genetic analyses when the choice exists of several potential donors for a given patient.	[Garciaz, Sylvain; Sfumato, Patrick; Granata, Angela; Imbert, Anne-Marie; Fournel, Claire; Calmels, Boris; Lemarie, Claude; Blaise, Didier; Boher, Jean-Marie; Chabannon, Christian] Inst Paoli Calmettes, Comprehens Canc Ctr, Marseille, France; [Garciaz, Sylvain; Calmels, Boris; Lemarie, Claude; Blaise, Didier; Chabannon, Christian] Aix Marseille Univ, Inst Paoli Calmettes, CRCM, INSERM,CNRS, Marseille, France; [Calmels, Boris; Lemarie, Claude; Chabannon, Christian] Inserm CBT, Ctr Invest Clin Marseille, Module Biotherapies, Marseille, France; [Chiaroni, Jacques; Picard, Christophe; di Cristofaro, Julie] Biol Groupes Sanguins, Etab Francais Sang PACA Corse, Marseille, France; [Chiaroni, Jacques; Picard, Christophe; di Cristofaro, Julie] Aix Marseille Univ, ADES, EFS, CNRS, Marseille, France	UNICANCER; Institut Paoli-Calmette (IPC); Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; UNICANCER; Institut Paoli-Calmette (IPC); Centre National de la Recherche Scientifique (CNRS); Universite Bordeaux-Montaigne; UDICE-French Research Universities; Aix-Marseille Universite	Chabannon, C (corresponding author), Inst Paoli Calmettes, Comprehens Canc Ctr, Marseille, France.; Chabannon, C (corresponding author), Aix Marseille Univ, Inst Paoli Calmettes, CRCM, INSERM,CNRS, Marseille, France.; Chabannon, C (corresponding author), Inserm CBT, Ctr Invest Clin Marseille, Module Biotherapies, Marseille, France.	chabannonc@ipc.unicancer.fr	Garciaz, Sylvain/AGJ-6731-2022; Blaise, Didier/R-2483-2016; Chiaroni, Jacques/ABA-2944-2021	Garciaz, Sylvain/0000-0002-0081-1255; Blaise, Didier/0000-0002-5684-9447; Chiaroni, Jacques/0000-0002-3133-8990; calmels, boris/0000-0002-1684-6030; Di Cristofaro, Julie/0000-0001-7867-6455; Chabannon, Christian/0000-0002-3755-4889	Institut Paoli-Calmettes, Inserm; Etablissement Francais du Sang; CNRS	Institut Paoli-Calmettes, Inserm(Institut National de la Sante et de la Recherche Medicale (Inserm)); Etablissement Francais du Sang; CNRS(Centre National de la Recherche Scientifique (CNRS))	This work was supported by Institut Paoli-Calmettes, Inserm and by Etablissement Francais du Sang and CNRS.	Bonig H, 2009, STEM CELLS, V27, P836, DOI 10.1002/stem.9; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Buhler S, 2010, TISSUE ANTIGENS, V75, P500, DOI 10.1111/j.1399-0039.2010.01469.x; Byrne M, 2016, EXP HEMATOL, V44, P567, DOI 10.1016/j.exphem.2016.04.005; Carlini F, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163570; Chang HW, 2012, CURR DRUG METAB, V13, P991, DOI 10.2174/138920012802138679; Chaudhary R, 2015, DRUG METAB REV, V47, P281, DOI 10.3109/03602532.2015.1047027; Collignon A, 2017, AM J HEMATOL, V92, pE57, DOI 10.1002/ajh.24661; Craddock CF, 1997, BLOOD, V90, P4779, DOI 10.1182/blood.V90.12.4779.4779_4779_4788; Ishwaran H., 2013, RANDOM FORESTS SURVI; Jo DY, 2000, J CLIN INVEST, V105, P101, DOI 10.1172/JCI7954; Julie DC, 2011, TISSUE ANTIGENS, V77, P193, DOI 10.1111/j.1399-0039.2010.01599.x; Lenk J, 2013, BIOL BLOOD MARROW TR, V19, P1517, DOI 10.1016/j.bbmt.2013.07.018; Martin-Antonio B, 2011, HAEMATOL-HEMATOL J, V96, P102, DOI 10.3324/haematol.2010.026401; Mishima S, 2017, TRANSFUS APHER SCI, V56, P154, DOI 10.1016/j.transci.2016.10.011; Nunes JM, 2015, EVOL BIOINFORM, V11, P19, DOI 10.4137/EBO.S32415; Okano A, 2008, J CLIN APHERESIS, V23, P171, DOI 10.1002/jca.20179; Ponomaryov T, 2000, J CLIN INVEST, V106, P1331, DOI 10.1172/JCI10329; Savani BN, 2016, HAEMATOLOGICA, V101, P256, DOI 10.3324/haematol.2015.135699; Schulz M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121859; Suzuya H, 2005, VOX SANG, V89, P229, DOI 10.1111/j.1423-0410.2005.00701.x; Torlen J, 2014, BIOL BLOOD MARROW TR, V20, P1418, DOI 10.1016/j.bbmt.2014.05.021	22	1	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2020	15	3							e0228878	10.1371/journal.pone.0228878	http://dx.doi.org/10.1371/journal.pone.0228878			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8RK	32134938	Green Published, gold			2022-12-26	WOS:000535265600014
J	de Oliveira, RTM; Dias, ARN; Vieira, WB; Falcao, ASC; Falcao, LFM; Quaresma, JAS				Moraes de Oliveira, Robson Tadachi; Nazareth Dias, Apio Ricardo; Vieira, Waldonio Brito; Carreira Falcao, Aline Semblano; Magno Falcao, Luiz Fabio; Simoes Quaresma, Juarez Antonio			A protocol of hepatic volume measurement using magnetic resonance imaging in individuals from the Eastern Brazilian Amazon population	PLOS ONE			English	Article							DONOR LIVER-TRANSPLANTATION; BODY-WEIGHT; CT; IMPACT; GRAFT	Determination of hepatic volume is an important preoperative procedure and is done through imaging exams or standard liver volume (SLV) formulas developed based on the biotype of each population. In the absence of a specific SLV formula for the Brazilian Eastern Amazon population, the measurement of liver volume is made with reference values from other populations. The aim of study was to compare the hepatic volume in healthy residents from the Brazilian Eastern Amazon population obtained with magnetic resonance imaging (MRI) and recommended SLV formulas validated to other populations. This was a Observational, cross-sectional study. Anthropometric data of 42 healthy individuals aged 18-60 years of both sexes was collected to measure the liver volume through SLV formulas calculations and MRI. MRI shows similarity with the Western European SLV liver volume values and significant differences with the Japan SLV formula, mainly for women, with a moderate-to-weak correlation with the MRI measurements. There was a strong correlation between weight and body surface area in male patients analysed with measurements of the liver volume by the MRI and SLV formulas. The SLV formula based on the Western European population could be used in the absence of a specific formula for individuals living in the Amazon region. The results suggest that liver measurement formulas should take into consideration the sex of individuals, as well as the development of a specific SLV formula for the Eastern Amazon population and the conduction of similar studies in other Brazilian regions.	[Moraes de Oliveira, Robson Tadachi; Vieira, Waldonio Brito] Fundacao Santa Casa Misericordia, Belem, Para, Brazil; [Moraes de Oliveira, Robson Tadachi; Nazareth Dias, Apio Ricardo; Vieira, Waldonio Brito; Simoes Quaresma, Juarez Antonio] Univ Fed Para, Nucleo Med Trop, Belem, Para, Brazil; [Nazareth Dias, Apio Ricardo; Magno Falcao, Luiz Fabio; Simoes Quaresma, Juarez Antonio] Univ Estado Para, Ctr Ciencias Biol & Saude, Belem, Para, Brazil; [Carreira Falcao, Aline Semblano; Simoes Quaresma, Juarez Antonio] Inst Evandro Chagas, Ananindeua, PA, Brazil	Universidade Federal do Para; Universidade do Estado do Para (UEPA); Instituto Evandro Chagas	Quaresma, JAS (corresponding author), Univ Fed Para, Nucleo Med Trop, Belem, Para, Brazil.; Quaresma, JAS (corresponding author), Univ Estado Para, Ctr Ciencias Biol & Saude, Belem, Para, Brazil.; Quaresma, JAS (corresponding author), Inst Evandro Chagas, Ananindeua, PA, Brazil.	juarez.quaresma@gmail.com	Dias, Apio Ricardo Nazareth/AER-3005-2022; Quaresma, Juarez AS/M-4190-2014; Falcão, Luiz Fábio Magno/D-2063-2017	Dias, Apio Ricardo Nazareth/0000-0002-9535-5095; Quaresma, Juarez AS/0000-0002-6267-9966; Falcão, Luiz Fábio Magno/0000-0001-8391-2694				Brasil, 2011, CENS 2010 CAR POP DO; Carvalho Fabio Augusto de, 2009, Rev Col Bras Cir, V36, P49; Chan SC, 2006, WORLD J GASTROENTERO, V12, P2217, DOI 10.3748/wjg.v12.i4.2217; Farraher SW, 2005, RADIOLOGY, V237, P322, DOI 10.1148/radiol.2371041416; Frericks BBJ, 2004, ROFO-FORTSCHR RONTG, V176, P252, DOI 10.1055/s-2004-817636; Ishifuro M, 2002, EUR RADIOL, V12, P2477, DOI 10.1007/s00330-002-1431-1; Jaeck D, 1997, BRIT J SURG, V84, P977, DOI 10.1002/bjs.1800840719; Kamel IR, 2001, AM J ROENTGENOL, V176, P193, DOI 10.2214/ajr.176.1.1760193; Karlo C, 2010, EUR J RADIOL, V75, pE107, DOI 10.1016/j.ejrad.2009.09.005; Kiuchi T, 2003, LIVER TRANSPLANT, V9, pS29, DOI 10.1053/jlts.2003.50198; Kotler DP, 1996, AM J CLIN NUTR, V64, P489; Lobato C, 2006, J GASTROEN HEPATOL, V21, P863, DOI 10.1111/j.1440-1746.2006.04298.x; Lu Yi, 2004, Hepatobiliary Pancreat Dis Int, V3, P82; Nakayama Y, 2006, RADIOLOGY, V240, P743, DOI 10.1148/radiol.2403050850; Paes-Barbosa Fábio Colagrossi, 2010, Rev. Col. Bras. Cir., V37, P370; Sakamoto S, 2001, TRANSPLANTATION, V71, P1407, DOI 10.1097/00007890-200105270-00009; Schiano TD, 2000, TRANSPLANTATION, V69, P545, DOI 10.1097/00007890-200002270-00014; Silva Graziella Moraes, 2012, Rev. bras. Ci. Soc., V27, P117, DOI 10.1590/S0102-69092012000300007; Suzuki K, 2011, AM J ROENTGENOL, V197, pW706, DOI 10.2214/AJR.10.5958; URATA K, 1995, HEPATOLOGY, V21, P1317, DOI 10.1016/0270-9139(95)90053-5; Vauthey JN, 2002, LIVER TRANSPLANT, V8, P233, DOI 10.1053/jlts.2002.31654; Yonemura Y, 2005, LIVER TRANSPLANT, V11, P1556, DOI 10.1002/lt.20537	22	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2020	15	3							e0229525	10.1371/journal.pone.0229525	http://dx.doi.org/10.1371/journal.pone.0229525			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8RK	32134922	Green Published, gold			2022-12-26	WOS:000535265600028
J	Shaheen, H; Qureshi, R; Qaseem, MF; Bruschi, P				Shaheen, Humaira; Qureshi, Rahmatuallah; Qaseem, Mirza Faisal; Bruschi, Piero			The fodder grass resources for ruminants: A indigenous treasure of local communities of Thal desert Punjab, Pakistan	PLOS ONE			English	Article							TRADITIONAL KNOWLEDGE; MEDICINAL-PLANTS; RANGELANDS; LIVESTOCK; PROVINCE	Indigenous people have been using local grasses for rearing their animals for centuries. The present study is the first record of traditional knowledge of grasses and livestock feeding system from the Thal desert in Pakistan. A snowball sampling method was used to identify key participants. Information was collected from the respondents from six districts of Thal Desert through semi-structural questionnaire and site visits. The data was analyzed through Smith's salience index and Composite Salience using ANTHROPAC package in R software. On the whole 61 grasses were recorded from the study area: most of them belong to the Poaceae family (52 species). Based on palatability grasses were categorized into three major groups i.e. (A) High priority, (B) Medium priority and (C) Low priority. Species in Group A, abundantly present in the study area represent a source of highly palatable forage for all ruminants. 232 (141M +91W) local participants were interviewed. Participants were grouped into three major age categories: 20-35 (48 participants), 36-50 (116 participants) and 51-67 years old (68 participants). ANTHROPAC frequency analysis confirmed the Smith's salience index and Composite Salience; Cynodon dactylon was the favorite species (6.46 SI, 0.6460 CS) followed by Cymbopogon jwarancusa (5.133 SI, 0.5133 CS) and Sorghum sp. was the third most salient species (5.121 SI, 0.5121 CS). Grasses were mostly available during the months of August and October and had also ethnoveterinary importance. This document about the traditional feeding of livestock in Thal Desert can underline the importance of conserving a traditional knowledge, which was poorly documented before.	[Shaheen, Humaira] COMSATS Univ Islamabad, Islamabad, Pakistan; [Shaheen, Humaira] Chinese Acad Sci, Key Lab Digital Bot Garden Guangdong Prov, South China Bot Garden, Key Lab Plant Resources Conservat & Sustainable U, Guangzhou, Peoples R China; [Qureshi, Rahmatuallah] Pir Mehr Ali Shah Arid Agr Univ Rawalpindi, Rawalpindi, Pakistan; [Qaseem, Mirza Faisal] State Key Lab Conservat & Utilizat Subtrop Agrobi, Guangzhou, Peoples R China; [Qaseem, Mirza Faisal] South China Agr Univ, Coll Forestry & Landscape Architectures, Guangdong Key Lab Innovat Dev & Utilizat Forest P, Guangzhou, Peoples R China; [Bruschi, Piero] Univ Florence, Dept Agr Environm Food & Forestry Sci DAGRI, Florence, Italy	COMSATS University Islamabad (CUI); Chinese Academy of Sciences; South China Botanical Garden, CAS; Arid Agriculture University; South China Agricultural University; University of Florence	Shaheen, H (corresponding author), COMSATS Univ Islamabad, Islamabad, Pakistan.; Shaheen, H (corresponding author), Chinese Acad Sci, Key Lab Digital Bot Garden Guangdong Prov, South China Bot Garden, Key Lab Plant Resources Conservat & Sustainable U, Guangzhou, Peoples R China.	humaira.shaheen@comsats.edu.pk	Qaseem, Mirza Faisal/AAB-5797-2021	Qaseem, Mirza Faisal/0000-0001-7973-408X	Higher Education Commission (HEC), Pakistan; Chinese academy of sciences under the President's International Fellowship Initiative (PIFI) program	Higher Education Commission (HEC), Pakistan(Higher Education Commission of Pakistan); Chinese academy of sciences under the President's International Fellowship Initiative (PIFI) program	The author(s) received no specific funding for this work. The Higher Education Commission (HEC), Pakistan, for providing travel grant for visit to USA to improve the data analyzing skills.; Authors are highly thankful to Higher Education Commission (HEC) Pakistan and Key Laboratory of Plant Resources Conservation & Sustainable Utilization/Key Laboratory of Digital Botanical Garden of Guangdong Province, South China Botanical Garden, Chinese Academy of Sciences, Guangzhou, 510650, China for their help in statistical analysis and facilitation in manuscript writing. The first author is also thankful to Chinese academy of sciences for postdoctoral fellowship under the President's International Fellowship Initiative (PIFI) program.	Abbasi AM, 2013, J ETHNOBIOL ETHNOMED, V9, DOI 10.1186/1746-4269-9-84; Abbasi AM, 2013, J ETHNOBIOL ETHNOMED, V9, DOI 10.1186/1746-4269-9-66; Abdullah M, 2017, J ANIM PLANT SCI, V27, P1656; Ahmad Z, 2012, MOLECULES, V17, P9631, DOI 10.3390/molecules17089631; Bruschi P, 2017, J AGRIC ENVIRON INT, V111, P105, DOI 10.12895/jaeid.20171.559; de Melo Joabe Gomes, 2011, Evid Based Complement Alternat Med, V2011, P365359, DOI 10.1155/2011/365359; Faraz A, 2019, J FISHERIES LIVEST P, V7, P287, DOI [10.4172/2332-2608.1000287, DOI 10.4172/2332-2608.1000287]; Geng YF, 2017, J ETHNOBIOL ETHNOMED, V13, DOI 10.1186/s13002-017-0153-z; Ghazali A., 2010, INT RES J FINANCE EC, V47, P123; Haleem S., 2013, PAKISTAN CULTURE SMA, DOI [10.1007/s10549-017-4496-x, DOI 10.1007/S10549-017-4496-X]; Harun N, 2017, J ETHNOBIOL ETHNOMED, V13, DOI 10.1186/s13002-017-0184-5; Heinrich M, 1998, SOC SCI MED, V47, P1859, DOI 10.1016/S0277-9536(98)00181-6; Hussain F, 2009, PAKISTAN J BOT PAKIS; Hussain I., 2017, INT J ACAD RES BUSIN, V7, P480; ISo E, 2006, ISE COD ETH 2008 ADD; Khalil AT, 2014, PAK J BOT, V46, P1137; Khan MA, 2012, J ANIM PLANT SCI, V22, P493; Meissner HH, 1997, ANIM FEED SCI TECH, V69, P103, DOI 10.1016/S0377-8401(97)81626-4; Moreki JC, 2013, VET WORLD, V6, P18, DOI 10.5455/vetworld.2013.18-21; Nadaf M, 2019, AVICENNA J PHYTOMEDI, V9, P153; Nankaya J, 2019, ENVIRON DEV SUSTAIN, P1; Nautiyal S, 2017, ECOSYSTEM FUNCTIONS, P39; Nunes AT, 2015, J ETHNOBIOL ETHNOMED, V11, DOI 10.1186/1746-4269-11-12; Okoli IC, 2003, AGR ECOSYST ENVIRON, V96, P147, DOI 10.1016/S0167-8809(02)00172-X; de Lucena RFP, 2012, J ENVIRON MANAGE, V96, P106, DOI 10.1016/j.jenvman.2011.09.001; Parveen, 2007, J ETHNOPHARMACOL, V113, P387, DOI 10.1016/j.jep.2007.06.010; Provenza FD, 2003, SMALL RUMINANT RES, V49, P257, DOI 10.1016/S0921-4488(03)00143-3; Qaseem MF, 2019, APPL ECOL ENV RES, V17, P2799, DOI 10.15666/aeer/1702_27992829; s Role in Livestock Economy of Cholistan Desert Pakistan, 2015, GLOBAL J HUMAN SOCIA, DOI [10.1016/j.jep.2007.06.010, DOI 10.1016/J.JEP.2007.06.010]; Shaheen H., 2012, ARCH SCI, V65, P57; Shaheen H, 2017, EUR J INTEGR MED, V12, P27, DOI 10.1016/j.eujim.2017.04.003; Shaheen Humaira, 2017, PLoS One, V12, pe0183956, DOI 10.1371/journal.pone.0183956; Shaheen H, 2014, PAK J BOT, V46, P13; Singh V, 2008, J MT SCI-ENGL, V5, P265, DOI 10.1007/s11629-008-0170-4; Torres-Avilez W, 2016, EVID-BASED COMPL ALT, V2016, DOI 10.1155/2016/6592363; Tounekti T, 2019, EVID-BASED COMPL ALT, V2019, DOI 10.1155/2019/3190670; Umar Farooq, 2009, Pakistan Development Review, V48, P795; Voeks RA, 2004, ECON BOT, V58, pS294, DOI 10.1663/0013-0001(2004)58[S294:FTFAMP]2.0.CO;2; Waters J, 2015, INT J SOC RES METHOD, V18, P367, DOI 10.1080/13645579.2014.953316; Zereen A, 2013, BIOL PAKISTAN, V59, P139; Zubair M., 2019, INT J MULTIDISCIPLIN, V2, P40	42	10	10	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2020	15	3							e0224061	10.1371/journal.pone.0224061	http://dx.doi.org/10.1371/journal.pone.0224061			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8RK	32134935	Green Published, gold, Green Submitted			2022-12-26	WOS:000535265600007
J	Soteriades, ES; Economidou, SC; Tsivitanidou, A; Polyviou, P; Lorimer, A; Katodritis, N; Theophanous-Kitiri, S				Soteriades, Elpidoforos S.; Economidou, Sofia C.; Tsivitanidou, Artemis; Polyviou, Petros; Lorimer, Amanda; Katodritis, Nikos; Theophanous-Kitiri, Stavroula			Environmental assessment of cytotoxic drugs in the Oncology Center of Cyprus	PLOS ONE			English	Article							ANTINEOPLASTIC DRUGS; SURFACE CONTAMINATION; OCCUPATIONAL-EXPOSURE; CYCLOPHOSPHAMIDE; AGENTS; PHARMACY; DEVICE; RISKS; VIALS	Background Cytotoxic drugs constitute an important workplace hazard in the hospital environment. Our aim was to conduct an environmental assessment of hazardous drugs in the Oncology Center of Cyprus. Methods Wipe samples were obtained from 42 workplace areas of the Oncology Center including two pairs of gloves in an initial assessment, while 10 samples were obtained at follow-up 3 years later. Potential contamination with cyclophosphamide (CP), ifosphamide (IF) and 5-fluorouracil (5-FU) and other cytotoxic medications was examined using the GC-MSMS system (CP, IF) and the HPLC system with UV detection (5-FU) method, respectively. Results Wipe sample contamination was detected at 11.9% and 15% in the initial and follow-up assessment, respectively. Both pairs of gloves assessed were free from contamination. The results showed contamination with cyclophosphamide on the work space inside the isolator, on a day-care office phone and on the central pharmacy bench. Ifosphamide was only detected on the floor of a patient's room. Contamination with 5-fluorouracil was found only on the surface of a prepared IV infusion bag. The levels of contamination in the positive samples ranged from 0.05 to 10.12 ng/cm(2). Conclusions The overall percentage of sample contamination at the Oncology Center was very low compared to other centers around the world. In addition, the detected levels of contamination with cytotoxic drugs were relatively low with the exception of the workspace inside the biological safety cabinet. These results in both assessments may reflect the implementation of comprehensive control measures including employee training, technological equipment and effective cleaning procedures.	[Soteriades, Elpidoforos S.] United Arab Emirates Univ, Inst Publ Hlth, Coll Med & Hlth Sci, Al Ain, U Arab Emirates; [Soteriades, Elpidoforos S.] Harvard TH Chan Sch Publ Hlth, Dept Environm Hlth Environm & Occupat Med & Epide, Boston, MA 02115 USA; [Economidou, Sofia C.] Univ Cyprus, Med Sch, Nicosia, Cyprus; [Tsivitanidou, Artemis; Lorimer, Amanda] Bank Cyprus, Dept Nursing, Oncol Ctr, Nicosia, Cyprus; [Polyviou, Petros] Bank Cyprus, Dept Radiol, Oncol Ctr, Nicosia, Cyprus; [Katodritis, Nikos] Bank Cyprus, Dept Radiat Oncol, Oncol Ctr, Nicosia, Cyprus; [Theophanous-Kitiri, Stavroula] Bank Cyprus, Dept Pharm, Oncol Ctr, Nicosia, Cyprus	United Arab Emirates University; Harvard University; Harvard T.H. Chan School of Public Health; University of Cyprus	Soteriades, ES (corresponding author), United Arab Emirates Univ, Inst Publ Hlth, Coll Med & Hlth Sci, Al Ain, U Arab Emirates.; Soteriades, ES (corresponding author), Harvard TH Chan Sch Publ Hlth, Dept Environm Hlth Environm & Occupat Med & Epide, Boston, MA 02115 USA.	esoteria@uaeu.ac.ae		Economidou, Sofia/0000-0003-2590-7576				AHLBORG G, 1995, J OCCUP ENVIRON MED, V37, P957, DOI 10.1097/00043764-199508000-00012; Bartel SB, 2018, AM J HEALTH-SYST PH, V75, P201, DOI 10.2146/ajhp160948; Bigelow Susan, 2009, J Oncol Pharm Pract, V15, P157, DOI 10.1177/1078155208101097; Boiano JM, 2014, J OCCUP ENVIRON HYG, V11, P728, DOI 10.1080/15459624.2014.916809; Chu Winnie C, 2012, J Oncol Pharm Pract, V18, P46, DOI 10.1177/1078155211402106; Colombo M, 2017, ANN WORK EXPOS HEAL, V61, P1003, DOI 10.1093/annweh/wxx070; Connor TH, 1999, AM J HEALTH-SYST PH, V56, P1427, DOI 10.1093/ajhp/56.14.1427; Connor TH, 2006, CA-CANCER J CLIN, V56, P354, DOI 10.3322/canjclin.56.6.354; Connor TH, 2014, J OCCUP ENVIRON MED, V56, P901, DOI 10.1097/JOM.0000000000000249; Crauste-Manciet S, 2005, ANN OCCUP HYG, V49, P619, DOI 10.1093/annhyg/mei045; Department of Health and Human Services Centers for Disease Control and Prevention National Institute for Occupational Safety and Health, REPR RISKS ASS HAZ D; Fleury-Souverain S, 2014, J ONCOL PHARM PRACT, V20, P100, DOI 10.1177/1078155213482683; Hama Koji, 2012, J Oncol Pharm Pract, V18, P201, DOI 10.1177/1078155211419543; Hedmer M, 2005, ANN OCCUP HYG, V49, P629, DOI 10.1093/annhyg/mei042; Hon CY, 2014, J ONCOL PHARM PRACT, V20, P210, DOI 10.1177/1078155213497070; Jeronimo M, 2015, ANAL BIOANAL CHEM, V407, P7083, DOI 10.1007/s00216-015-8868-y; Kibby T, 2017, J OCCUP ENVIRON HYG, V14, P159, DOI 10.1080/15459624.2016.1237026; Maeda S, 2010, YAKUGAKU ZASSHI, V130, P903, DOI 10.1248/yakushi.130.903; Marie P, 2017, ENVIRON MONIT ASSESS, V189, DOI 10.1007/s10661-016-5762-9; NIOSH Alert, PREV OCC EXP ANT OTH; Pretty Jack R, 2012, J Oncol Pharm Pract, V18, P23, DOI 10.1177/1078155210389215; Sessink Paul J M, 2011, J Oncol Pharm Pract, V17, P39, DOI 10.1177/1078155210361431; SESSINK PJM, 1992, PHARM WEEKBLAD, V14, P16, DOI 10.1007/BF01989220; Siderov Jim, 2010, J Oncol Pharm Pract, V16, P19, DOI 10.1177/1078155209352543; Sugiura Shin-ichi, 2011, J Oncol Pharm Pract, V17, P14, DOI 10.1177/1078155209358632; Sugiura Shinichi, 2011, J Oncol Pharm Pract, V17, P20, DOI 10.1177/1078155210369851; Turci R, 2003, J CHROMATOGR B, V789, P169, DOI 10.1016/S1570-0232(03)00100-4; Viegas S, 2018, ARH HIG RADA TOKSIKO, V69, P238, DOI 10.2478/aiht-2018-69-3137; Villarini M, 2016, MUTAT RES-REV MUTAT, V770, P35, DOI 10.1016/j.mrrev.2016.05.001; WHO-IARC, 1982, FOOD NAHRUNG, V26, P206; Wick C, 2003, AM J HEALTH-SYST PH, V60, P2314, DOI 10.1093/ajhp/60.22.2314; Yoshida J, 2009, ANN OCCUP HYG, V53, P153, DOI 10.1093/annhyg/men081	32	0	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2020	15	3							e0216098	10.1371/journal.pone.0216098	http://dx.doi.org/10.1371/journal.pone.0216098			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8RK	32134912	Green Published, gold, Green Submitted			2022-12-26	WOS:000535265600001
J	Strike, C; Robinson, S; Guta, A; Tan, DH; O'Leary, B; Cooper, C; Upshur, R; Carusone, SC				Strike, Carol; Robinson, Samantha; Guta, Adrian; Tan, Darrell H.; O'Leary, Bill; Cooper, Curtis; Upshur, Ross; Carusone, Soo Chan			Illicit drug use while admitted to hospital: Patient and health care provider perspectives	PLOS ONE			English	Article							SUBSTANCE USE; CENTERED CARE; ADDICTION; PEOPLE; INTERVENTIONS; CONSULTATION; PERCEPTIONS; MANAGEMENT; MEDICINE; SERVICE	Background Across North America, the opioid overdose epidemic is leading to increasing hospitalizations of people who use drugs (PWUD). However, hospitals are ill-prepared to meet the needs of PWUD. We focus on illicit drug use while admitted to hospital and how PWUD and health care providers describe, respond, and attempt to manage its use. Methods and findings Using varied purposive methods in Toronto and Ottawa, we recruited n = 24 PWUD (who self-reported that they were living with HIV and/or HCV infection; currently or had previously used drugs or alcohol in ways that were harmful; had a hospital admission in the past five years) and n = 26 health care providers (who were: currently working in an academic hospital as a physician, nurse, social worker or other allied health professional; and 2) providing care to this patient group). All n = 50 participants completed a short, socio-demographic questionnaire and an audio-recorded semi-structured interview about receiving or providing acute care in a hospital between 04/2014 and 05/2015. Patient participants received $25 CAD and return transit fare; provider participants received a $50 CAD gift card for a bookseller. All participants provided informed consent. Audio-recordings were transcribed verbatim, corrected, and uploaded to NVivo 10. Using the seven-step framework method, transcripts were coded line-by-line and managed using NVvivo. An analytic framework was created by grouping and mapping the codes. Preliminary analyses were presented to advisory group members for comment and used to refine the interpretation. Questionnaire data were managed using SPSS version 22.0 and descriptive statistics were used to describe the participants. Many but not all patient participants spoke about using psycho-active substances not prescribed to them during a hospital admission. Attempts to avoid negative experiences (e.g., withdrawal, boredom, sadness, loneliness and/or untreated pain) were cited as reasons for illicit drug use. Most tried to conceal their illicit drug use from health care providers. Patients described how their self-reported level of pain was not always believed, tolerance to opioids was ignored, and requests for higher doses of pain medications denied. Some health care providers were unaware of on-site illicit drug use; others acknowledged it occurred. Few could identify a hospital policy specific to illicit drug use and most used their personal beliefs to guide their responses to it (e.g., ignore it, increase surveillance of patients, reprimands, loss of privileges/medications, threats of immediate discharge should it continue, and substitution dosing of medication). Conclusions Providers highlighted gaps in institutional guidance for how they ought to appropriately respond to in-hospital substance use. Patients attempted to conceal illicit drug use in environments with no institutional policies about such use, leading to varied responses that were inconsistent with the principles of patient centred care and reflected personal beliefs about illicit drug use. There are increasing calls for implementation of harm reduction approaches and interventions in hospitals but uptake has been slow. Our study contributes to this emerging body of literature and highlights areas for future research, the development of interventions, and changes to policy and practice.	[Strike, Carol; Robinson, Samantha; Tan, Darrell H.; Upshur, Ross] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada; [Guta, Adrian] Univ Windsor, Sch Social Work, Windsor, ON, Canada; [Tan, Darrell H.] St Michaels Hosp, Toronto, ON, Canada; [O'Leary, Bill; Carusone, Soo Chan] Casey House, Toronto, ON, Canada; [Cooper, Curtis] Univ Ottawa, Div Infect Dis, Ottawa, ON, Canada; [Carusone, Soo Chan] McMaster Univ, Hamilton, ON, Canada	University of Toronto; University of Windsor; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Ottawa; McMaster University	Strike, C (corresponding author), Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada.	carol.strike@utoronto.ca	Strike, Carol/U-8317-2018	Strike, Carol/0000-0002-2716-3681; Chan Carusone, Soo/0000-0003-3977-0523; O'Leary, William/0000-0001-9999-2318; Guta, Adrian/0000-0002-1380-2016; Upshur, Ross/0000-0003-1128-0557; Robinson, Samantha/0000-0002-9410-6900	Ontario HIV Treatment Network, Community Based Research Grant [1035]; Canadian Institutes of Health Research [129926]	Ontario HIV Treatment Network, Community Based Research Grant; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	We received funding for this project from two sources: the Ontario HIV Treatment Network, Community Based Research Grant #1035 and the Canadian Institutes of Health Research, Grant #129926. No funding bodies had any role in study design, data collection and analysis, decision to publish, or preparation of the manuscript'	[Anonymous], 2002, INT J DRUG POLICY, DOI [DOI 10.1016/S0955-3959(02)00075-0, DOI 10.1016/S0955-3959]; [Anonymous], 2019, NAT REP APP OP REL D; Australian Bureau of Statistics, 2018, 33030 ABS; Baldacchino A, 2010, ADDICT BEHAV, V35, P270, DOI 10.1016/j.addbeh.2009.10.008; Berg KM, 2009, J GEN INTERN MED, V24, P482, DOI 10.1007/s11606-009-0908-x; Bowen EA, 2016, AM J PUBLIC HEALTH, V106, P223, DOI 10.2105/AJPH.2015.302970; Canadian Institutes for Health Information (CIHI), 2018, OP REL HARMS CAN; Carusone SC, 2019, HARM REDUCT J, V16, DOI 10.1186/s12954-019-0285-7; Day C, 2003, DRUG ALCOHOL REV, V22, P317, DOI 10.1080/0959523031000154463; Duff C., 2014, ASSEMBLAGES HLTH DEL; Englander H, 2017, J HOSP MED, V12, P339, DOI 10.12788/jhm.2736; European Monitering Centre for Drugs and Drug Addiction, 2019, DRUG REL DEATHS MORT; Gale NK, 2013, BMC MED RES METHODOL, V13, DOI 10.1186/1471-2288-13-117; Grewal HK, 2015, DRUG ALCOHOL REV, V34, P499, DOI 10.1111/dar.12270; Haber PS, 2009, LANCET, V374, P1284, DOI 10.1016/S0140-6736(09)61036-9; Kalkman GA, 2019, LANCET PUBLIC HEALTH, V4, pE498, DOI 10.1016/S2468-2667(19)30128-8; Kirst M, 2017, INT J MENT HEALTH AD, V15, P514, DOI 10.1007/s11469-016-9693-z; Kitson A, 2013, J ADV NURS, V69, P4, DOI 10.1111/j.1365-2648.2012.06064.x; Kolind T, 2017, ADDICTION, V112, P465, DOI 10.1111/add.13673; McCall J., 2019, J MENT HLTH ADDICT N, V3, pe1, DOI [10.22374/jmhan.v3i1.33, DOI 10.22374/JMHAN.V3I1.33]; McNeil R, 2016, ADDICTION, V111, P685, DOI 10.1111/add.13214; McNeil R, 2014, SOC SCI MED, V105, P59, DOI 10.1016/j.socscimed.2014.01.010; Merrill J, 2002, J GEN INTERN MED, V17, P327, DOI 10.1046/j.1525-1497.2002.10625.x; Miller NS, 2001, ACAD MED, V76, P410, DOI 10.1097/00001888-200105000-00007; Miskovic M, 2018, AM J PUBLIC HEALTH, V108, P1363, DOI 10.2105/AJPH.2018.304600; Monks R, 2013, J ADV NURS, V69, P935, DOI 10.1111/j.1365-2648.2012.06088.x; Murphy MK, 2009, J CLIN PSYCHOL MED S, V16, P77, DOI 10.1007/s10880-009-9149-8; Orpana HM, 2019, HEALTH PROMOT CHRON, V39, P56, DOI 10.24095/hpcdp.39.2.03; Pauly B, 2015, ADV NURS SCI, V38, P121, DOI 10.1097/ANS.0000000000000070; Pecoraro A, 2013, AIDS CARE, V25, P1399, DOI 10.1080/09540121.2013.772273; Priest KC, 2019, J ADDICT MED, V13, P104, DOI 10.1097/ADM.0000000000000496; Raja S, 2015, FAM COMMUNITY HEALTH, V38, P216, DOI 10.1097/FCH.0000000000000071; Reeves E, 2015, ISSUES MENT HEALTH N, V36, P698, DOI 10.3109/01612840.2015.1025319; Rhodes T., 2002, INT J DRUG POLICY, V13, P85, DOI [10.1016/S0955-3959(02)00007-5, DOI 10.1016/S0955-3959(02)00007-5]; Rosenthal ES, 2016, AM J MED, V129, P481, DOI 10.1016/j.amjmed.2015.09.024; Roxburgh A, 2017, DRUG ALCOHOL DEPEN, V179, P291, DOI 10.1016/j.drugalcdep.2017.07.018; Rudasill SE, 2019, J AM COLL CARDIOL, V73, P559, DOI 10.1016/j.jacc.2018.10.082; Sharma M, 2017, HARM REDUCT J, V14, DOI 10.1186/s12954-017-0163-0; Stewart M., 2001, GLOBAL DEFINITION PA; Strike C, 2014, INT J DRUG POLICY, V25, P640, DOI 10.1016/j.drugpo.2014.02.012; Switzer S, 2015, SOC SCI MED, V133, P77, DOI 10.1016/j.socscimed.2015.03.040; Ti LP, 2015, J HOSP MED, V10, P301, DOI 10.1002/jhm.2344; Velez CM, 2017, J GEN INTERN MED, V32, P296, DOI 10.1007/s11606-016-3919-4; Wakeman SE, 2017, J GEN INTERN MED, V32, P909, DOI 10.1007/s11606-017-4077-z; Wakeman SE, 2016, SUBST ABUS, V37, P635, DOI 10.1080/08897077.2016.1187240; Weinstein ZM, 2018, MED CLIN N AM, V102, P587, DOI 10.1016/j.mcna.2018.03.001; Werb D, 2008, INT J DRUG POLICY, V19, P332, DOI 10.1016/j.drugpo.2007.08.004; Wood E, 2004, CAN MED ASSOC J, V170, P1551, DOI 10.1503/cmaj.1031928	48	22	22	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2020	15	3							e0229713	10.1371/journal.pone.0229713	http://dx.doi.org/10.1371/journal.pone.0229713			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LQ8RK	32134973	Green Published, gold			2022-12-26	WOS:000535265600039
J	Luo, ZJ; Han, SL; Sun, W; Wang, Y; Liu, SJ; Yang, L; Pang, BS; Jin, JW; Chen, H; Cao, ZX; Ma, YM				Luo, Zujin; Han, Silu; Sun, Wei; Wang, Yan; Liu, Sijie; Yang, Liu; Pang, Baosen; Jin, Jiawei; Chen, Hong; Cao, Zhixin; Ma, Yingmin			Maintenance of spontaneous breathing at an intensity of 60%-80% may effectively prevent mechanical ventilation-induced diaphragmatic dysfunction	PLOS ONE			English	Article							PHRENIC-NERVE STIMULATION; CONTRACTILE PROPERTIES; OXIDATIVE STRESS; SUPPORT VENTILATION; CROSS-TALK; ACTIVATION; CALPAIN; CASPASE-3; WEAKNESS; ATROPHY	Controlled mechanical ventilation (CMV) can cause diaphragmatic motionlessness to induce diaphragmatic dysfunction. Partial maintenance of spontaneous breathing (SB) can reduce ventilation-induced diaphragmatic dysfunction (VIDD). However, to what extent SB is maintained in CMV can attenuate or even prevent VIDD has been rarely reported. The current study aimed to investigate the relationship between SB intensity and VIDD and to identify what intensity of SB maintained in CMV can effectively avoid VIDD. Adult rats were randomly divided according to different SB intensities: SB (0% pressure controlled ventilation (PCV)), high-intensity SB (20% PCV), medium-intensity SB (40% PCV), medium-low intensity SB (60% PCV), low-intensity SB (80% PCV), and PCV (100% PCV). The animals underwent 24-h controlled mechanical ventilation (CMV). The transdiaphragmatic pressure (Pdi), the maximal Pdi (Pdi max) when phrenic nerves were stimulated, Pdi/Pdi max, and the diaphragmatic tonus under different frequencies of electric stimulations were determined. Calpain and caspase-3 were detected using ELISA and the cross-section areas (CSAs) of different types of muscle fibers were measured. The Pdi showed a significant decrease from 20% PCV and the Pdi max showed a significant decrease from 40% PCV (P<0.05). In vivo and vitro diaphragmatic tonus exhibited a significant decrease from 40% PCV and 20% PCV, respectively (P<0.05). From 20% PCV, the CSAs of types I, IIa, and IIb/x muscle fibers showed significant differences, which reached the lowest levels at 100% PCV. SB intensity is negatively associated with the development of VIDD. Maintenance of SB at an intensity of 60%-80% may effectively prevent the occurrence of VIDD.	[Luo, Zujin; Han, Silu; Sun, Wei; Wang, Yan; Liu, Sijie; Yang, Liu; Pang, Baosen; Jin, Jiawei; Cao, Zhixin; Ma, Yingmin] Capital Med Univ, Dept Resp & Crit Care Med, Beijing Engn Res Ctr Resp & Crit Care Med, Beijing Inst Resp Med,Beijing Chao Yang Hosp, Beijing, Peoples R China; [Chen, Hong] Capital Med Univ, Beijing Chao Yang Hosp, Dept Pathol, Beijing, Peoples R China	Capital Medical University; Capital Medical University	Cao, ZX; Ma, YM (corresponding author), Capital Med Univ, Dept Resp & Crit Care Med, Beijing Engn Res Ctr Resp & Crit Care Med, Beijing Inst Resp Med,Beijing Chao Yang Hosp, Beijing, Peoples R China.	caozhixinicu@126.com	jin, jiawei/AAJ-7378-2021	, Jiawei Jin/0000-0001-5598-6039	Beijing Natural Science Foundation [7173259]; Beijing Hospital Authority Youth Programme [QML20180303]	Beijing Natural Science Foundation(Beijing Natural Science Foundation); Beijing Hospital Authority Youth Programme	This study was supported by Beijing Natural Science Foundation (7173259) and Beijing Hospital Authority Youth Programme (QML20180303). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler D, 2014, AM J RESP CRIT CARE, V190, P347, DOI 10.1164/rccm.201404-0655LE; Ahn B, 2014, AM J RESP CRIT CARE, V190, P837, DOI 10.1164/rccm.201405-0993LE; Anzueto A, 1997, CRIT CARE MED, V25, P1187, DOI 10.1097/00003246-199707000-00021; Capdevila X, 2003, INTENS CARE MED, V29, P103, DOI 10.1007/s00134-002-1548-3; Du J, 2004, J CLIN INVEST, V113, P115, DOI 10.1172/JCI200418330; Futier E, 2008, CRIT CARE, V12, DOI 10.1186/cc7010; Gayan-Ramirez G, 2005, CRIT CARE MED, V33, P2804, DOI 10.1097/01.CCM.0000191250.32988.A3; Goligher EC, 2018, AM J RESP CRIT CARE, V197, P204, DOI 10.1164/rccm.201703-0536OC; Goll DE, 2003, PHYSIOL REV, V83, P731, DOI 10.1152/physrev.00029.2002; Grosu HB, 2017, RESP CARE, V62, P904, DOI 10.4187/respcare.05370; Hooijman PE, 2015, AM J RESP CRIT CARE, V191, P1126, DOI 10.1164/rccm.201412-2214OC; Hudson MB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137693; Hudson MB, 2012, CRIT CARE MED, V40, P1254, DOI 10.1097/CCM.0b013e31823c8cc9; Hussain SNA, 2016, THORAX, V71, P436, DOI 10.1136/thoraxjnl-2015-207559; Jaber S, 2011, CRIT CARE, V15, DOI 10.1186/cc10023; Jaber S, 2011, AM J RESP CRIT CARE, V183, P364, DOI 10.1164/rccm.201004-0670OC; Jung B, 2010, ANESTHESIOLOGY, V112, P1435, DOI 10.1097/ALN.0b013e3181d7b036; Kim WY, 2011, CRIT CARE MED, V39, P2627, DOI 10.1097/CCM.0b013e3182266408; LEBOURDELLES G, 1994, AM J RESP CRIT CARE, V149, P1539, DOI 10.1164/ajrccm.149.6.8004310; Levine S, 2008, NEW ENGL J MED, V358, P1327, DOI 10.1056/NEJMoa070447; Maes K, 2007, AM J RESP CRIT CARE, V175, P1134, DOI 10.1164/rccm.200609-1342OC; Mankowski RT, 2016, J TRANSL MED, V14, DOI 10.1186/s12967-016-1060-0; Martin AD, 2014, CRIT CARE MED, V42, pE152, DOI 10.1097/CCM.0b013e3182a63fdf; McClung JM, 2007, AM J RESP CRIT CARE, V175, P150, DOI 10.1164/rccm.200601-142OC; Medrinal C, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1418-y; Mrozek S, 2012, ANESTHESIOLOGY, V117, P560, DOI 10.1097/ALN.0b013e318261e7f8; Nakagawa T, 2000, J CELL BIOL, V150, P887, DOI 10.1083/jcb.150.4.887; Nelson WB, 2012, CRIT CARE MED, V40, P1857, DOI 10.1097/CCM.0b013e318246bb5d; Powers SK, 2013, J PHYSIOL-LONDON, V591, P5255, DOI 10.1113/jphysiol.2013.254680; Radel P, 2004, ACTA ANAESTH SCAND, V48, P430, DOI 10.1111/j.1399-6576.2004.00352.x; Sassoon CSH, 2002, J APPL PHYSIOL, V92, P2585, DOI 10.1152/japplphysiol.01213.2001; Sassoon CSH, 2004, AM J RESP CRIT CARE, V170, P626, DOI 10.1164/rccm.200401-042OC; Shanely RA, 2004, AM J RESP CRIT CARE, V170, P994, DOI 10.1164/rccm.200304-575OC; Shanely RA, 2003, CHEST, V123, P195, DOI 10.1378/chest.123.1.195; Smuder AJ, 2018, FREE RADICAL BIO MED, V115, P179, DOI 10.1016/j.freeradbiomed.2017.11.025; Smuder AJ, 2010, FREE RADICAL BIO MED, V49, P1152, DOI 10.1016/j.freeradbiomed.2010.06.025; Tan YF, 2006, J BIOL CHEM, V281, P16016, DOI 10.1074/jbc.M601299200; Tidball JG, 2002, J PHYSIOL-LONDON, V545, P819, DOI 10.1113/jphysiol.2002.024935; Whidden MA, 2010, J APPL PHYSIOL, V108, P1376, DOI 10.1152/japplphysiol.00098.2010	39	0	0	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2020	15	3							e0229944	10.1371/journal.pone.0229944	http://dx.doi.org/10.1371/journal.pone.0229944			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8QU	32131083	Green Published, gold			2022-12-26	WOS:000535264000057
J	Mitchell, RA; Rathi, S; Dahiya, M; Zhu, JL; Hussaini, T; Yoshida, EM				Mitchell, Robert A.; Rathi, Sahaj; Dahiya, Monica; Zhu, Julie; Hussaini, Trana; Yoshida, Eric M.			Public awareness of acetaminophen and risks of drug induced liver injury: Results of a large outpatient clinic survey	PLOS ONE			English	Article							HEPATOTOXICITY	Acetaminophen is one of the most commonly consumed analgesics world wide. Generally perceived as a safe medication, it is the most common cause of acute liver failure in the United States with inadvertent hepatotoxicity in half of all cases. We therefore conducted a survey on the public perceptions of acetaminophen in patients attending the outpatient clinic in Vancouver, Canada. Among 928 patients who were asked, 765 completed the survey questionnaire. The majority of respondents were female (59%), Caucasian (61%), and educated beyond the secondary school level (81%). 23% reported using acetaminophen at least once a week. A significant minority were unaware of the potential liver toxicity of acetaminophen (24%), and knowledge of hepatotoxicity did not vary with education status. In terms of the medicinal composition of acetaminophen products, over half of the respondents (58%) did not know that extra strength preparations of acetaminophen contained the same drug but in a different dose. This knowledge was more prevalent among those with higher level of education (49% in graduate school educated respondents), but was still low overall. The knowledge that alcohol use with acetaminophen was more harmful was low (43%), but improved with level of education (P for trend 0.03). Among respondents who consumed alcohol regularly, 21% were consuming over 1.5 grams of acetaminophen at a time. These patients had similar harm perception to liver as patients who consumed lower doses of acetaminophen. Overall, in a large, well-educated cohort of patients, knowledge about the adverse effects of acetaminophen, the additional risks with alcohol and composition of various retailed products was suboptimal. We speculate that consumer ignorance is a significant reason why acetaminophen is a leading cause of acute liver failure.	[Mitchell, Robert A.; Rathi, Sahaj; Yoshida, Eric M.] Univ British Columbia, Div Gastroenterol, Vancouver, BC, Canada; [Dahiya, Monica] Univ British Columbia, Undergrad Sch Med, Vancouver, BC, Canada; [Zhu, Julie] Dalhousie Univ, Div Digest Sci, Halifax, NS, Canada; [Hussaini, Trana] Univ British Columbia, Fac Pharmaceut Sci, Vancouver, BC, Canada	University of British Columbia; University of British Columbia; Dalhousie University; University of British Columbia	Yoshida, EM (corresponding author), Univ British Columbia, Div Gastroenterol, Vancouver, BC, Canada.	eric.yoshida@vch.ca	Zhu, Julie/AAJ-7334-2021; Zhu, Julie/AAK-1275-2021; Rathi, Sahaj/P-9277-2016	Zhu, Julie/0000-0001-6057-8275; Rathi, Sahaj/0000-0001-6529-9080				Bernal W, 2010, LANCET, V376, P190, DOI 10.1016/S0140-6736(10)60274-7; Bunchorntavakul C, 2013, CLIN LIVER DIS, V17, P587, DOI 10.1016/j.cld.2013.07.005; Herndon Christopher M, 2014, J Pain Palliat Care Pharmacother, V28, P109, DOI 10.3109/15360288.2014.908993; Lee WM, 2017, J HEPATOL, V67, P1324, DOI 10.1016/j.jhep.2017.07.005; MAKIN AJ, 1995, GASTROENTEROLOGY, V109, P1907, DOI 10.1016/0016-5085(95)90758-0; Reuben A, 2016, ANN INTERN MED, V164, P724, DOI 10.7326/M15-2211; Shakil AO, 2000, LIVER TRANSPLANT, V6, P163, DOI 10.1016/S1527-6465(00)80005-2; Temple AR, 2006, CLIN THER, V28, P222, DOI 10.1016/j.clinthera.2006.02.004; Wolf MS, 2012, J GEN INTERN MED, V27, P1587, DOI 10.1007/s11606-012-2096-3; ZIMMERMAN HJ, 1995, HEPATOLOGY, V22, P767, DOI 10.1002/hep.1840220312	10	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2020	15	3							e0229070	10.1371/journal.pone.0229070	http://dx.doi.org/10.1371/journal.pone.0229070			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8QU	32130228	gold, Green Published			2022-12-26	WOS:000535264000014
J	Yang, W; Khoury, E; Guo, QY; Prabhu, SA; Emond, A; Huang, F; Goncalves, C; Zhan, Y; Plourde, D; Nichol, JN; Dahabieh, MS; Miller, WH; del Rincon, SV				Yang, William; Khoury, Elie; Guo, Qianyu; Prabhu, Sathyen A.; Emond, Audrey; Huang, Fan; Goncalves, Christophe; Zhan, Yao; Plourde, Dany; Nichol, Jessica N.; Dahabieh, Michael S.; Miller Jr., Wilson H.; del Rincon, Sonia Victoria			MNK1 signaling induces an ANGPTL4-mediated gene signature to drive melanoma progression	ONCOGENE			English	Article							ACTIVATED RECEPTOR BETA/DELTA; MATRIX METALLOPROTEINASES; EIF4E; PHOSPHORYLATION; METASTASIS; INVASION; ANGPTL4; INHIBITION; RESISTANCE; CLUSTERIN	The BRAF(V600E) mutation occurs in more than 50% of cutaneous melanomas, and results in the constitutive activation of the mitogen-activated protein kinases (MAPK) pathway. MAP kinase-interacting serine/threonine-protein kinase 1 and 2 (MNK1/2) are downstream effectors of the activated MAPK pathway, and important molecular targets in invasive and metastatic cancer. Despite the well-known role of MNK1 in regulating mRNA translation, little is known concerning the impact of its aberrant activation on gene transcription. Here, we show that changes in the activity, or abundance, of MNK1 result in changes in the expression of pro-oncogenic and pro-invasive genes. Among the MNK1-upregulated genes, we identify Angiopoietin-like 4 (ANGPTL4), which in turn promotes an invasive phenotype via its ability to induce the expression of matrix metalloproteinases (MMPs). Using a pharmacologic inhibitor of MNK1/2, SEL201, we demonstrate that BRAF(V600E)-mutated cutaneous melanoma cells are reliant on MNK1/2 for invasion and lung metastasis.	[Yang, William; Khoury, Elie; Guo, Qianyu; Prabhu, Sathyen A.; Huang, Fan; Zhan, Yao; Dahabieh, Michael S.; Miller Jr., Wilson H.; del Rincon, Sonia Victoria] McGill Univ, Div Expt Med, Fac Med, Montreal, PQ, Canada; [Yang, William; Khoury, Elie; Guo, Qianyu; Prabhu, Sathyen A.; Emond, Audrey; Huang, Fan; Goncalves, Christophe; Zhan, Yao; Plourde, Dany; Nichol, Jessica N.; Dahabieh, Michael S.; Miller Jr., Wilson H.; del Rincon, Sonia Victoria] McGill Univ, Lady Davis Inst, Jewish Gen Hosp, Montreal, PQ, Canada; [Miller Jr., Wilson H.] McGill Univ, Rossy Canc Network, Montreal, PQ, Canada	McGill University; Lady Davis Institute; McGill University; McGill University	Miller, WH; del Rincon, SV (corresponding author), McGill Univ, Div Expt Med, Fac Med, Montreal, PQ, Canada.; Miller, WH; del Rincon, SV (corresponding author), McGill Univ, Lady Davis Inst, Jewish Gen Hosp, Montreal, PQ, Canada.; Miller, WH (corresponding author), McGill Univ, Rossy Canc Network, Montreal, PQ, Canada.	wmiller@ldi.jgh.mcgill.ca; sonia.delrincon@mcgill.ca	Yang, William/AAU-2275-2020	Huang, Fan/0000-0002-3850-5317; Emond, Audrey/0000-0001-8053-2784; Miller, Wilson H./0000-0002-7408-1574	Canadian Institutes for Health Research [MOP-142281 PJT-156269, PJT-162260]; Canadian Cancer Society [703811]; Rossy Cancer Network; National Centre for Research and Development, INNOTECH Program [INNOTECH-K1/HI1/I6/157438/NCBR/12]; Cole Foundation Ph.D. fellowship; MICRTP graduate studentships; McGill Integrated Cancer Research Training Program (MICRTP) graduate studentship; McGill Faculty of Medicine graduate studentship	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Cancer Society(Canadian Cancer Society (CCS)); Rossy Cancer Network; National Centre for Research and Development, INNOTECH Program; Cole Foundation Ph.D. fellowship; MICRTP graduate studentships; McGill Integrated Cancer Research Training Program (MICRTP) graduate studentship; McGill Faculty of Medicine graduate studentship	This research is funded by the Canadian Institutes for Health Research (grants MOP-142281 PJT-156269 to WHM and SVDR, and grant PJT-162260 to SVDR) and the Canadian Cancer Society (grant 703811 WHM and SVDR). The research was further supported by the Rossy Cancer Network. Development of MNK1/2 inhibitors by Selvita S.A. has been co-financed by the National Centre for Research and Development, INNOTECH Program (INNOTECH-K1/HI1/I6/157438/NCBR/12). WY was endowed by MICRTP graduate studentships. QG was financed by a Cole Foundation Ph.D. fellowship, McGill Integrated Cancer Research Training Program (MICRTP) graduate studentship and a McGill Faculty of Medicine graduate studentship. FH was sponsored by MICRTP graduate studentships. We thank Shalom Chaim Spira for editing this manuscript.	Akbani R, 2015, CELL, V161, P1681, DOI 10.1016/j.cell.2015.05.044; Ascierto PA, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-85; Baron V, 2006, CANCER GENE THER, V13, P115, DOI 10.1038/sj.cgt.7700896; Beyaz S, 2016, CLIN CANCER RES, V22, P5636, DOI 10.1158/1078-0432.CCR-16-0775; Dankort D, 2009, NAT GENET, V41, P544, DOI 10.1038/ng.356; Deryugina EI, 2006, CANCER METAST REV, V25, P9, DOI 10.1007/s10555-006-7886-9; Djeu JY, 2009, ADV CANCER RES, V105, P77, DOI 10.1016/S0065-230X(09)05005-2; Domingues B, 2018, IMMUNOTARGETS THER, V7, P35, DOI 10.2147/ITT.S134842; Fang L, 2016, PPAR RES, V2016, DOI 10.1155/2016/6042162; Geller Alan C, 2003, Semin Oncol Nurs, V19, P2, DOI 10.1053/sonu.2003.50000; Georgiadi A, 2010, CIRC RES, V106, P1712, DOI 10.1161/CIRCRESAHA.110.217380; Gialeli C, 2011, FEBS J, V278, P16, DOI 10.1111/j.1742-4658.2010.07919.x; Guo QY, 2019, CANCER RES, V79, P1646, DOI 10.1158/0008-5472.CAN-18-1602; Guo ZH, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10397-9; Hodi FS, 2010, NEW ENGL J MED, V363, P711, DOI 10.1056/NEJMoa1003466; Hu K, 2016, ONCOTARGET, V7, P7816, DOI 10.18632/oncotarget.6868; Joshi Sonali, 2014, World J Biol Chem, V5, P321, DOI 10.4331/wjbc.v5.i3.321; Kimura R, 2011, BBA-MOL CELL RES, V1813, P1543, DOI 10.1016/j.bbamcr.2011.04.008; Korneeva NL, 2010, MOL CANCER RES, V8, P1571, DOI 10.1158/1541-7786.MCR-10-0091; La Paglia L, 2017, PPAR RES, V2017, DOI 10.1155/2017/8187235; Larkin J, 2014, NEW ENGL J MED, V371, P1867, DOI 10.1056/NEJMoa1408868; Liao YH, 2017, ONCOGENE, V36, P2228, DOI 10.1038/onc.2016.371; Liu L, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.419; Naruhn S, 2011, MOL PHARMACOL, V80, P828, DOI 10.1124/mol.111.074039; O'Loghlen A, 2007, BBA-MOL CELL RES, V1773, P1416, DOI 10.1016/j.bbamcr.2007.05.009; Pettersson F, 2015, CANCER RES, V75, P1102, DOI 10.1158/0008-5472.CAN-14-1996; Ramalingam S, 2014, ONCOTARGET, V5, P530, DOI 10.18632/oncotarget.1528; Redondo M, 2009, ADV CANCER RES, V105, P21, DOI 10.1016/S0065-230X(09)05002-7; Robert C, 2015, NEW ENGL J MED, V372, P30, DOI 10.1056/NEJMoa1412690; Robichaud N, 2015, ONCOGENE, V34, P2032, DOI 10.1038/onc.2014.146; Valsecchi ME, 2015, NEW ENGL J MED, V373, P1270, DOI [10.1056/NEJMoa1504030, 10.1056/NEJMc1509660]; Vella V, 2017, FRONT ENDOCRINOL, V8, DOI 10.3389/fendo.2017.00031; Wang JH, 2010, WORLD J GASTROENTERO, V16, P5642, DOI 10.3748/wjg.v16.i44.5642; Zhan Y, 2017, J CLIN INVEST, V127, P4179, DOI 10.1172/JCI91258	34	10	10	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR	2020	39	18					3650	3665		10.1038/s41388-020-1240-5	http://dx.doi.org/10.1038/s41388-020-1240-5		MAR 2020	16	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	LI5XR	32132651				2022-12-26	WOS:000518095100001
J	Alexandre, D; Marino, L; Marta, A; Graziani, G; Piva, R				Alexandre, David; Marino, Luca; Marta, Andre; Graziani, Giorgio; Piva, Renzo			On the feasibility of the Rayleigh cycle for dynamic soaring trajectories	PLOS ONE			English	Article							ENERGY; ALBATROSSES; FLIGHT	Dynamic soaring is a flight technique used by albatrosses and other birds to cover large distances without the expenditure of energy, which is extracted from the available wind conditions, as brightly perceived five centuries ago by Leonardo da Vinci. Closed dynamic soaring trajectories use spatial variations of wind speed to travel, in principle, indefinitely over a prescribed area. The application of the concept of closed dynamic soaring trajectories to aerial vehicles, such as UAVs, may provide a solution to improve the endurance in certain missions. The main limitation of dynamic soaring is its dependence on the wind characteristics. More than one century ago, Lord Rayleigh proposed a very simple model, based on the repeated crossing of a step wind profile, presently known as Rayleigh cycle, that provides a clear explanation of the physical phenomenon. The present paper studies the feasibility of closed, single-loop, energy-neutral trajectories for a broad set of wind and vehicle conditions. Through the use of trajectory optimization methods, it was possible to see how the shape of the wind profile, the initial flight conditions and the vehicle constraints influence the required wind strength to perform dynamic soaring trajectories and consequently their feasibility. It was possible to conclude that there are optimal values for the initial airspeed and initial height of the vehicle, that minimize the required wind strength. In addition, it was seen how the structural and aerodynamic constraints of the vehicle affect dynamic soaring at high and low airspeeds respectively. Finally, some new trajectories that can be performed in conditions of excess wind are proposed. The purpose is to maximize the time spent aloft and the path length while maintaining the concept of single-loop, energy-neutral trajectories, making them especially useful for aerial vehicles surveillance applications.	[Alexandre, David; Marino, Luca; Graziani, Giorgio; Piva, Renzo] Sapienza Univ Roma, Dipartimento Ingn Meccan & Aerosp, Rome, Italy; [Alexandre, David; Marta, Andre] Univ Lisbon, Inst Super Tecn, IDMEC, Lisbon, Portugal	Sapienza University Rome; Universidade de Lisboa; Instituto Superior Tecnico	Alexandre, D (corresponding author), Sapienza Univ Roma, Dipartimento Ingn Meccan & Aerosp, Rome, Italy.; Alexandre, D (corresponding author), Univ Lisbon, Inst Super Tecn, IDMEC, Lisbon, Portugal.	david.v.alexandre@tecnico.ulisboa.pt	Marta, Andre/I-7990-2012; Graziani, Giorgio/S-5897-2016	Marta, Andre/0000-0002-9399-7967; Graziani, Giorgio/0000-0002-7522-6755; MARINO, Luca/0000-0001-7380-6222	ENAC (the Italian Civil Aviation Authority); Fundacao para a Ciencia e Tecnologia (FCT), Portugal, through the Institute of Mechanical Engineering (IDMEC), under the Associated Laboratory for Energy, Transports and Aeronautics (LAETA) [UID/EMS/50022/2019]	ENAC (the Italian Civil Aviation Authority); Fundacao para a Ciencia e Tecnologia (FCT), Portugal, through the Institute of Mechanical Engineering (IDMEC), under the Associated Laboratory for Energy, Transports and Aeronautics (LAETA)	The research of Prof. G. Graziani has been partially supported by ENAC (the Italian Civil Aviation Authority) through a research grant. The research work of Prof. AndreMarta has been partially supported by Fundacao para a Ciencia e Tecnologia (FCT), Portugal, through the Institute of Mechanical Engineering (IDMEC), under the Associated Laboratory for Energy, Transports and Aeronautics (LAETA) project UID/EMS/50022/2019.	[Anonymous], 2007, INT J OBES LOND S2, V31, pS8; Bonnin V, 2015, INT J MICRO AIR VEH, V7, P213, DOI 10.1260/1756-8293.7.3.213; Cone CD, 1964, MATH ANAL DYNAMIC SO; Deittert M, 2009, J GUID CONTROL DYNAM, V32, P1446, DOI 10.2514/1.43270; Kai JM, 2019, J GUID CONTROL DYNAM, V42, P1250, DOI 10.2514/1.G003866; Kelly M, 2017, SIAM REV, V59, P849, DOI 10.1137/16M1062569; Lissaman P, 2005, P 43 AIAA AER SCI M; Marta AC, 2019, AIRCRAFT OPTIMAL DES; Mir I, 2018, NONLINEAR DYNAM, V94, P3117, DOI 10.1007/s11071-018-4540-3; Nie Y, 2019, EURASIP J WIREL COMM, DOI 10.1186/s13638-018-1331-y; PENNYCUICK CJ, 1982, PHILOS T ROY SOC B, V300, P75, DOI 10.1098/rstb.1982.0158; Pennycuick CJ, 2008, THEOR ECOL SER, P1; Rayleigh L., 1883, NATURE, V27, P534, DOI [10.1038/027534a0, DOI 10.1038/027534A0]; Richardson PL, 2019, NOTES REC, V73, P285, DOI 10.1098/rsnr.2018.0024; Richardson PL, 2015, PROG OCEANOGR, V130, P146, DOI 10.1016/j.pocean.2014.11.002; Sachs G., 2017, AIAA Atmospheric Flight Mechanics Conference; Sachs G, 2005, IBIS, V147, P1, DOI 10.1111/j.1474-919x.2004.00295.x; SACHS G, 1994, APPL MATH AEROSPACE, P221; Sachs G, 2019, J GUID CONTROL DYNAM, V42, P1812, DOI 10.2514/1.G003407; Sachs GP, 2019, AIAA SCIT 2019 FOR S; Tennekes H., 2009, SIMPLE SCI FLIGHT IN; Videler JJ., 2005, AVIAN FLIGHT; Wachter A, 2006, MATH PROGRAM, V106, P25, DOI 10.1007/s10107-004-0559-y; Zhao YM, 2018, J GUID CONTROL DYNAM, V41, P488, DOI 10.2514/1.G003048; Zhao YYJ, 2004, OPTIM CONTR APPL MET, V25, P67, DOI 10.1002/oca.739	25	1	1	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2020	15	3							e0229746	10.1371/journal.pone.0229746	http://dx.doi.org/10.1371/journal.pone.0229746			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	KX8CM	32126133	gold, Green Published			2022-12-26	WOS:000522103000001
J	Punnatin, P; Chanchao, C; Chunsrivirot, S				Punnatin, Panachai; Chanchao, Chanpen; Chunsrivirot, Surasak			Molecular dynamics reveals insight into how N226P and H227Y mutations affect maltose binding in the active site of alpha-glucosidase II from European honeybee, Apis mellifera	PLOS ONE			English	Article							SUBSTRATE-SPECIFICITY; SIMULATIONS; SOFTWARE; MODEL; SPEED; AMBER; L.	European honeybee, Apis mellifera, produces alpha-glucosidase (HBGase) that catalyzes the cleavage of an alpha-glycosidic bond of the non-reducing end of polysaccharides and has potential applications for malt hydrolysis in brewing industry. Characterized by their substrate specificities, HBGases have three isoforms including HBGase II, which prefers maltose to sucrose as a substrate. Previous study found that the catalytic efficiency of maltose hydrolysis of N226P mutant of HBGase II was higher than that of the wild type (WT), and the catalytic efficiency of maltose hydrolysis of WT was higher than those of H227Y and N226P-H227Y mutants. We hypothesized that N226P mutation probably caused maltose to bind with better affinity and position/orientation for hydrolysis than WT, while H227Y and N226P-H227Y mutations caused maltose to bind with worse affinity and position/orientation for hydrolysis than WT. Using this hypothesis, we performed molecular dynamics on the catalytically competent binding conformations of maltose/WT, maltose/N226P, maltose/H227Y, and maltose/N226P-H227Y complexes to elucidate effects of N226P and H227Y mutations on maltose binding in HBGase II active site. Our results reasonably support this hypothesis because the N226P mutant had better binding affinity, higher number of important binding residues, strong and medium hydrogen bonds as well as shorter distance between atoms necessary for hydrolysis than WT, while the H227Y and N226P-H227Y mutants had worse binding affinities, lower number of important binding residues and strong hydrogen bonds as well as longer distances between atoms necessary for hydrolysis than WT. Moreover, results of binding free energy and hydrogen bond interaction of residue 227 support the role of H227 as a maltose preference residue, as proposed by previous studies. Our study provides important and novel insight into how N226P and H227Y mutations affect maltose binding in HBGase II active site. This knowledge could potentially be used to engineer HBGase II to improve its efficiency.	[Punnatin, Panachai; Chanchao, Chanpen] Chulalongkorn Univ, Dept Biol, Fac Sci, Bangkok, Thailand; [Punnatin, Panachai; Chunsrivirot, Surasak] Chulalongkorn Univ, Dept Biochem, Struct & Computat Biol Res Unit, Fac Sci, Bangkok, Thailand; [Chunsrivirot, Surasak] Chulalongkorn Univ, Dept Biochem, Fac Sci, Bangkok, Thailand	Chulalongkorn University; Chulalongkorn University; Chulalongkorn University	Chunsrivirot, S (corresponding author), Chulalongkorn Univ, Dept Biochem, Struct & Computat Biol Res Unit, Fac Sci, Bangkok, Thailand.; Chunsrivirot, S (corresponding author), Chulalongkorn Univ, Dept Biochem, Fac Sci, Bangkok, Thailand.	surasak.ch@chula.ac.th			Structural and Computational Biology Research Unit, Faculty of Science, Rachadaphiseksomphot Endowment Fund, Chulalongkorn University	Structural and Computational Biology Research Unit, Faculty of Science, Rachadaphiseksomphot Endowment Fund, Chulalongkorn University	This study is supported by Structural and Computational Biology Research Unit, Faculty of Science, Rachadaphiseksomphot Endowment Fund, Chulalongkorn University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anandakrishnan R, 2012, NUCLEIC ACIDS RES, V40, pW537, DOI 10.1093/nar/gks375; Andriotis VME, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151642; [Anonymous], 2019, R LANG ENV STAT COMP; Ayutthaya PPN, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0198484; Bathgate GN, 2016, J I BREWING, V122, P197, DOI 10.1002/jib.332; Benkert P, 2011, BIOINFORMATICS, V27, P343, DOI 10.1093/bioinformatics/btq662; Case D. A., 2018, AMBER 2019; Chiba S, 1997, BIOSCI BIOTECH BIOCH, V61, P1233, DOI 10.1271/bbb.61.1233; Feig M, 2004, J MOL GRAPH MODEL, V22, P377, DOI 10.1016/j.jmgm.2003.12.005; Gotz AW, 2012, J CHEM THEORY COMPUT, V8, P1542, DOI 10.1021/ct200909j; Gordon JC, 2005, NUCLEIC ACIDS RES, V33, pW368, DOI 10.1093/nar/gki464; Guex N, 2009, ELECTROPHORESIS, V30, pS162, DOI 10.1002/elps.200900140; Huang ZH, 2018, APPL BIOCHEM BIOTECH, V185, P1088, DOI 10.1007/s12010-018-2706-6; Kirschner KN, 2008, J COMPUT CHEM, V29, P622, DOI 10.1002/jcc.20820; Kubota M, 2004, BIOSCI BIOTECH BIOCH, V68, P2346, DOI 10.1271/bbb.68.2346; Le Grand S, 2013, COMPUT PHYS COMMUN, V184, P374, DOI 10.1016/j.cpc.2012.09.022; Letunic I, 2019, NUCLEIC ACIDS RES, V47, pW256, DOI 10.1093/nar/gkz239; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; Madsen LR, 2017, J FOOD SCI, V82, P401, DOI 10.1111/1750-3841.13623; Miller BR, 2012, J CHEM THEORY COMPUT, V8, P3314, DOI 10.1021/ct300418h; Myers J, 2006, PROTEINS, V63, P928, DOI 10.1002/prot.20922; Ngiwsara L, 2012, BIOSCI BIOTECH BIOCH, V76, P1967, DOI 10.1271/bbb.120473; Nishimoto M, 2007, BIOSCI BIOTECH BIOCH, V71, P1703, DOI 10.1271/bbb.70125; Roe DR, 2013, J CHEM THEORY COMPUT, V9, P3084, DOI 10.1021/ct400341p; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Salomon-Ferrer R, 2013, J CHEM THEORY COMPUT, V9, P3878, DOI 10.1021/ct400314y; Shen X, 2015, ACTA CRYSTALLOGR D, V71, P1382, DOI 10.1107/S139900471500721X; Sitthiyotha T, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0204915; Swanson JMJ, 2004, BIOPHYS J, V86, P67, DOI 10.1016/S0006-3495(04)74084-9; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Waterhouse A, 2018, NUCLEIC ACIDS RES, V46, pW296, DOI 10.1093/nar/gky427; Xu ZQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054174; Zhang F, 2019, MOLECULES, V24, DOI 10.3390/molecules24071413	33	11	11	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2020	15	3							e0229734	10.1371/journal.pone.0229734	http://dx.doi.org/10.1371/journal.pone.0229734			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8MS	32126122	gold, Green Published			2022-12-26	WOS:000535253100045
J	Mielke, D; Bleuel, K; Stadelmann, C; Rohde, V; Malinova, V				Mielke, Dorothee; Bleuel, Kim; Stadelmann, Christine; Rohde, Veit; Malinova, Vesna			The ESAS-score: A histological severity grading system of subarachnoid hemorrhage using the modified double hemorrhage model in rats	PLOS ONE			English	Article							CEREBRAL-BLOOD-FLOW; MRI CHARACTERIZATION; PERFUSION-PRESSURE; WORLD-FEDERATION; ACUTE-PHASE; SCALE; VASOSPASM	Objective The amount of extravasated blood is an established surrogate marker for subarachnoid hemorrhage (SAH) severity, which varies in different experimental SAH (eSAH) models. A comprehensive eSAH grading system would allow a more reliable correlation of outcome parameters with SAH severity. The aim of this study was to define a severity score for eSAH related to the Fisher-Score in humans. Material and methods SAH was induced in 135 male rats using the modified double hemorrhage model. A sham group included 8 rats, in which saline solution instead of blood was injected. Histological analysis with HE(hematoxylin-eosin)-staining for the visualization of blood was performed in all rats on day 5. The amount and distribution of blood within the subarachnoid space and ventricles (IVH) was analyzed. Results The mortality rate was 49.6% (71/143). In all except five SAH rats, blood was visible within the subarachnoid space. As expected, no blood was detected in the sham group. The following eSAH severity score was established (ESAS-score): grade I: no SAH visible; grade II: local or diffuse thin SAH, no IVH; grade III: diffuse / thick layers of blood, no IVH; grade IV: additional IVH. Grade I was seen in five rats (7.9%), grade II in 28.6% (18/63), grade III in 41.3% (26/63) and grade IV in 22.2% (14/63) of the rats with eSAH. Conclusion The double hemorrhage model allows the induction of a high grade SAH in more than 60% of the rats, making it suitable for the evaluation of outcome parameters in severe SAH.	[Mielke, Dorothee; Rohde, Veit; Malinova, Vesna] Georg August Univ Gottingen, Dept Neurosurg, Gottingen, Germany; [Bleuel, Kim; Stadelmann, Christine] Georg August Univ Gottingen, Dept Neuropathol, Gottingen, Germany	University of Gottingen; University of Gottingen	Malinova, V (corresponding author), Georg August Univ Gottingen, Dept Neurosurg, Gottingen, Germany.	vesna.malinova@med.uni-goettingen.de	Mielke, Dorothee/AAU-6776-2021	Stadelmann, Christine/0000-0003-1766-5458	Deutsche Forschungsgemeinschaft [MI 1894/11]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by MI 1894/11, Deutsche Forschungsgemeinschaft, www.dfg.de, to DM. The funder did not play a role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARRY KJ, 1979, STROKE, V10, P538, DOI 10.1161/01.STR.10.5.538; BEDERSON JB, 1995, STROKE, V26, P1086, DOI 10.1161/01.STR.26.6.1086; Claassen J, 2001, STROKE, V32, P2012, DOI 10.1161/hs0901.095677; Egashira Y, 2015, STROKE, V46, P582, DOI 10.1161/STROKEAHA.114.007834; Ehlert A, 2018, J NEUROL SURG PART A, V79, P424, DOI 10.1055/s-0038-1641561; FISHER CM, 1980, NEUROSURGERY, V6, P1, DOI 10.1227/00006123-198001000-00001; Frontera JA, 2006, NEUROSURGERY, V59, P21, DOI 10.1227/01.NEU.0000218821.34014.1B; Guresir E, 2015, TRANSL STROKE RES, V6, P242, DOI 10.1007/s12975-015-0392-z; Guresir E, 2012, ACTA NEUROCHIR, V154, P11, DOI 10.1007/s00701-011-1191-2; Gules I, 2002, AM J PHYSIOL-HEART C, V283, pH2551, DOI 10.1152/ajpheart.00616.2002; Guo DW, 2017, TRANSL STROKE RES, V8, P234, DOI 10.1007/s12975-016-0511-5; Guresir Erdem, 2015, Acta Neurochir Suppl, V120, P325, DOI 10.1007/978-3-319-04981-6_56; HIJDRA A, 1990, STROKE, V21, P1156, DOI 10.1161/01.STR.21.8.1156; Jeon H, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-103; Kilkenny C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000412; Lee JY, 2008, J NEUROSCI METH, V168, P358, DOI 10.1016/j.jneumeth.2007.10.029; Malinova V, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171121; Oshiro EM, 1997, NEUROSURGERY, V41, P140, DOI 10.1097/00006123-199707000-00029; Prunell GF, 2003, NEUROSURGERY, V52, P165, DOI 10.1097/00006123-200301000-00022; Prunell GF, 2004, NEUROSURGERY, V54, P426, DOI 10.1227/01.NEU.0000103670.09687.7A; Raslan Furat, 2012, Exp Transl Stroke Med, V4, P23, DOI 10.1186/2040-7378-4-23; Sehba FA, 2014, TRANSL STROKE RES, V5, P660, DOI 10.1007/s12975-014-0368-4; Shishido H, 2015, J NEUROSCI METH, V243, P115, DOI 10.1016/j.jneumeth.2015.01.035; Sugawara T, 2008, J NEUROSCI METH, V167, P327, DOI 10.1016/j.jneumeth.2007.08.004; Sun Y, 2016, NEUROSCIENCE, V316, P53, DOI 10.1016/j.neuroscience.2015.12.027; Szklener S, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-007795; TEASDALE GM, 1988, J NEUROL NEUROSUR PS, V51, P1457, DOI 10.1136/jnnp.51.11.1457; Vatter H, 2006, NEUROSURGERY, V58, P1190, DOI 10.1227/01.NEU.0000199346.74649.66	28	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2020	15	2							e0227349	10.1371/journal.pone.0227349	http://dx.doi.org/10.1371/journal.pone.0227349			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8EV	32097426	Green Published, gold			2022-12-26	WOS:000535232000007
J	Darche, M; Cossutta, M; Caruana, L; Houppe, C; Gilles, ME; Habert, D; Guilloneau, X; Vignaud, L; Paques, M; Courty, J; Cascone, I				Darche, Marie; Cossutta, Melissande; Caruana, Laure; Houppe, Claire; Gilles, Maud-Emmanuelle; Habert, Damien; Guilloneau, Xavier; Vignaud, Lucile; Paques, Michel; Courty, Jose; Cascone, Ilaria			Antagonist of nucleolin, N6L, inhibits neovascularization in mouse models of retinopathies	FASEB JOURNAL			English	Article						angiogenesis; choroidal neovascularization (CNV); oxygen-induced retinopathy (OIR); vascular endothelial growth factor (VEGF); nucleolin	OXYGEN-INDUCED RETINOPATHY; ENDOTHELIAL GROWTH-FACTOR; CELL-SURFACE; MULTIVALENT PSEUDOPEPTIDES; CANCER; BINDING; NEUTRALIZATION; PLEIOTROPHIN; PROGRESSION; DELIVERY	Retinal vascular diseases (RVD) have been identified as a major cause of blindness worldwide. These pathologies, including the wet form of age-related macular degeneration, retinopathy of prematurity, and diabetic retinopathy are currently treated by intravitreal delivery of anti-vascular endothelial growth factor (VEGF) agents. However, repeated intravitreal injections can lead to ocular complications and resistance to these treatments. Thus, there is a need to find new targeted therapies. Nucleolin regulates the endothelial cell (EC) activation and angiogenesis. In previous studies, we designed a pseudopeptide, N6L, that binds the nucleolin and blocks the tumor angiogenesis. In this study, the effect of N6L was investigated in two experimental models of retinopathies including oxygen-induced retinopathy (OIR) and choroidal neovascularization (CNV). We found that in mouse OIR, intraperitoneal injection of N6L is delivered to activated ECs and induced a 50% reduction of pathological neovascularization. The anti-angiogenic effect of N6L has been tested in CNV model in which the systemic injection of N6L induced a 33% reduction of angiogenesis. This effect is comparable to those obtained with VEGF-trap, a standard of care drug for RVD. Interestingly, with preventive and curative treatments, neoangiogenesis is inhibited by 59%. Our results have potential interest in the development of new therapies targeting other molecules than VEGF for RVD.	[Darche, Marie; Cossutta, Melissande; Caruana, Laure; Houppe, Claire; Gilles, Maud-Emmanuelle; Habert, Damien; Courty, Jose; Cascone, Ilaria] Univ Paris Est Creteil, CNRS, CRRET Lab, ERL 9215, 61 Ave Gen Gaulle, F-94010 Creteil, France; [Darche, Marie; Paques, Michel] Sorbonne Univ, Inst Hosp Univ ForeSight, Ctr Hosp Natl Quinze Vingts, Clin Invest Ctr 1423, Paris, France; [Guilloneau, Xavier; Vignaud, Lucile] Sorbonne Univ, Inst Vis, CNRS, INSERM, Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite Gustave-Eiffel; Universite Paris-Est-Creteil-Val-de-Marne (UPEC); CHNO des Quinze-Vingts; UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite	Cascone, I (corresponding author), Univ Paris Est Creteil, CNRS, CRRET Lab, ERL 9215, 61 Ave Gen Gaulle, F-94010 Creteil, France.	ilaria.cascone@u-pec.fr	Guillonneau, xavier/E-3995-2017; guillonneau, xavier/AAF-9495-2021	Guillonneau, xavier/0000-0001-7379-3935; guillonneau, xavier/0000-0001-7379-3935; COSSUTTA, Melissande/0000-0001-5460-8386				Al-Latayfeh M, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006411; Berger CM, 2015, BIOCHIMIE, V113, P78, DOI 10.1016/j.biochi.2015.03.023; Birmpas C, 2012, BMC CELL BIOL, V13, DOI 10.1186/1471-2121-13-32; Bishop P, 1996, EYE, V10, P664, DOI 10.1038/eye.1996.159; Campochiaro PA, 2014, OPHTHALMOLOGY, V121, P1783, DOI 10.1016/j.ophtha.2014.03.021; Campochiaro PA, 2010, OPHTHALMOLOGY, V117, P1102, DOI 10.1016/j.ophtha.2010.02.021; Christian S, 2003, J CELL BIOL, V163, P871, DOI 10.1083/jcb.200304132; Connor KM, 2009, NAT PROTOC, V4, P1565, DOI 10.1038/nprot.2009.187; Cossutta M, 2019, ARTERIOSCL THROM VAS, V39, P1843, DOI 10.1161/ATVBAHA.119.313021; De Cola A, 2018, CANCER LETT, V412, P272, DOI 10.1016/j.canlet.2017.10.038; Destouches D, 2012, J BIOL CHEM, V287, P43685, DOI 10.1074/jbc.M112.380402; Destouches D, 2011, CANCER RES, V71, P3296, DOI 10.1158/0008-5472.CAN-10-3459; Destouches D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002518; Dhez AC, 2018, J CELL PHYSIOL, V233, P4091, DOI 10.1002/jcp.26205; Diamantopoulou Z, 2017, ONCOTARGET, V8, P90108, DOI 10.18632/oncotarget.21441; Fuma S, 2017, SCI REP-UK, V7, DOI 10.1038/srep43509; Gilles ME, 2016, CANCER RES, V76, P7181, DOI 10.1158/0008-5472.CAN-16-0300; Gioelli N, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aah4807; Hovanessian AG, 2000, EXP CELL RES, V261, P312, DOI 10.1006/excr.2000.5071; Hovanessian AG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015787; Keane PA, 2012, J OPHTHALMOL, V2012, DOI 10.1155/2012/483034; Koutsioumpa M, 2013, J BIOL CHEM, V288, P343, DOI 10.1074/jbc.M112.387076; Leaderer D, 2016, EXP EYE RES, V145, P380, DOI 10.1016/j.exer.2016.02.009; Legrand D, 2004, EUR J BIOCHEM, V271, P303, DOI 10.1046/j.1432-1033.2003.03929.x; Montassar F, 2017, FASEB J, V31, P1107, DOI 10.1096/fj.201600351R; Ng DS, 2017, SCI REP-UK, V7, DOI 10.1038/srep45081; Olsen TW, 2017, OPHTHALMOLOGY, V124, pE68, DOI 10.1016/j.ophtha.2017.03.066; Peters S, 2007, CYTOKINE, V40, P144, DOI 10.1016/j.cyto.2007.09.001; Presta M, 2009, EUR CYTOKINE NETW, V20, P39, DOI 10.1684/ecn.2009.0155; Quiroz-Mercado J, 2016, GRAEF ARCH CLIN EXP, V254, P1753, DOI 10.1007/s00417-016-3409-8; Sader M., 2015, J NANOMEDICINE NANOT, V6, P310; Said EA, 2005, FEBS J, V272, P4646, DOI 10.1111/j.1742-4658.2005.04870.x; Sampat KM, 2010, CURR OPIN OPHTHALMOL, V21, P178, DOI 10.1097/ICU.0b013e328338679a; Sato T, 2015, OSLI RETINA, V46, P87, DOI 10.3928/23258160-20150101-16; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Shao Z, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069552; Shi HB, 2007, BLOOD, V110, P2899, DOI 10.1182/blood-2007-01-064428; SMITH LEH, 1994, INVEST OPHTH VIS SCI, V35, P101; Stahl A, 2010, INVEST OPHTH VIS SCI, V51, P2813, DOI 10.1167/iovs.10-5176; Storkebaum E, 2004, J CLIN INVEST, V113, P14, DOI 10.1172/JCI200420682; Storkebaum E, 2004, BIOESSAYS, V26, P943, DOI 10.1002/bies.20092; TAKE M, 1994, J BIOCHEM-TOKYO, V116, P1063, DOI 10.1093/oxfordjournals.jbchem.a124628; Tate A, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-197; Turck N, 2006, J CELL PHYSIOL, V206, P545, DOI 10.1002/jcp.20501; Van Bergen T, 2017, EXP EYE RES, V165, P136, DOI 10.1016/j.exer.2017.09.012; Wang WW, 2017, ANGIOGENESIS, V20, P479, DOI 10.1007/s10456-017-9557-6; Zhu XM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0115523	47	8	8	0	10	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2020	34	4					5851	5862		10.1096/fj.201901876R	http://dx.doi.org/10.1096/fj.201901876R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	LJ5ZA	32141122	Bronze			2022-12-26	WOS:000530242100069
J	Hemker, SL; Cerqueira, DM; Bodnar, AJ; Cargill, KR; Clugston, A; Anslow, MJ; Sims-Lucas, S; Kostka, D; Ho, J				Hemker, Shelby L.; Cerqueira, Debora M.; Bodnar, Andrew J.; Cargill, Kasey R.; Clugston, Andrew; Anslow, Melissa J.; Sims-Lucas, Sunder; Kostka, Dennis; Ho, Jacqueline			Deletion of hypoxia-responsive microRNA-210 results in a sex-specific decrease in nephron number	FASEB JOURNAL			English	Article						apoptosis; kidney development; microRNA-210	GENE-EXPRESSION; BRANCHING MORPHOGENESIS; PLACENTAL INSUFFICIENCY; KIDNEY DEVELOPMENT; MAMMALIAN KIDNEY; MIR-210 EXPRESSION; FLASH; MOUSE; INDUCTION; GROWTH	Low nephron number results in an increased risk of developing hypertension and chronic kidney disease. Intrauterine growth restriction is associated with a nephron deficit in humans, and is commonly caused by placental insufficiency, which results in fetal hypoxia. The underlying mechanisms by which hypoxia impacts kidney development are poorly understood. microRNA-210 is the most consistently induced microRNA in hypoxia and is known to promote cell survival in a hypoxic environment. In this study, the role of microRNA-210 in kidney development was evaluated using a global microRNA-210 knockout mouse. A male-specific 35% nephron deficit in microRNA-210 knockout mice was observed. Wnt/beta -catenin signaling, a pathway crucial for nephron differentiation, was misregulated in male kidneys with increased expression of the canonical Wnt target lymphoid enhancer binding factor 1. This coincided with increased expression of caspase-8-associated protein 2, a known microRNA-210 target and apoptosis signal transducer. Together, these data are consistent with a sex-specific requirement for microRNA-210 in kidney development.	[Hemker, Shelby L.; Cerqueira, Debora M.; Bodnar, Andrew J.; Cargill, Kasey R.; Clugston, Andrew; Anslow, Melissa J.; Sims-Lucas, Sunder; Ho, Jacqueline] Univ Pittsburgh, Sch Med, Dept Pediat, Div Nephrol, Pittsburgh, PA 15261 USA; [Hemker, Shelby L.; Cerqueira, Debora M.; Bodnar, Andrew J.; Cargill, Kasey R.; Clugston, Andrew; Anslow, Melissa J.; Sims-Lucas, Sunder; Kostka, Dennis; Ho, Jacqueline] UPMC Childrens Hosp Pittsburgh, Rangos Res Ctr, 4401 Penn Ave, Pittsburgh, PA 15224 USA; [Clugston, Andrew; Kostka, Dennis] Univ Pittsburgh, Sch Med, Dept Dev Biol, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Ho, J (corresponding author), UPMC Childrens Hosp Pittsburgh, Rangos Res Ctr, 4401 Penn Ave, Pittsburgh, PA 15224 USA.	jacqueline.ho2@chp.edu	Cerqueira, Debora Malta/AAB-6204-2020; Cerqueira, Debora Malta/CAF-4323-2022; Ho, Jackie/AAP-1531-2021	Ho, Jackie/0000-0001-7115-1381; Hemker, Shelby/0000-0002-9135-7042; Clugston, Andrew/0000-0002-8521-9452; Cargill, Kasey/0000-0003-3082-1937	NICHD NIH HHS [K12 HD052892] Funding Source: Medline; NIDDK NIH HHS [R44 DK116370, T32 DK061296, K01 DK096996, P30 DK079307, R03 DK110503, F31 DK116338, R01 DK103776] Funding Source: Medline; NIGMS NIH HHS [R01 GM115836] Funding Source: Medline	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Aisa MC, 2016, PEDIATR NEPHROL, V31, P2277, DOI 10.1007/s00467-016-3484-4; Alexander BT, 2003, HYPERTENSION, V41, P457, DOI 10.1161/01.HYP.0000053448.95913.3D; Alm-Kristiansen AH, 2008, ONCOGENE, V27, P4644, DOI 10.1038/onc.2008.105; Barcaroli D, 2006, P NATL ACAD SCI USA, V103, P14808, DOI 10.1073/pnas.0604227103; Bard JBL, 2002, BIOESSAYS, V24, P72, DOI 10.1002/bies.10024; Baschat AA, 2004, BJOG-INT J OBSTET GY, V111, P1031, DOI 10.1111/j.1471-0528.2004.00273.x; Basson MA, 2006, DEV BIOL, V299, P466, DOI 10.1016/j.ydbio.2006.08.051; Baum M, 2018, PEDIATR NEPHROL, V33, P409, DOI 10.1007/s00467-016-3359-8; Bavelloni A, 2017, ANTICANCER RES, V37, P6511, DOI 10.21873/anticanres.12107; Bernhardt WM, 2006, KIDNEY INT, V69, P114, DOI 10.1038/sj.ki.5000062; Bertram JF, 2011, PEDIATR NEPHROL, V26, P1529, DOI 10.1007/s00467-011-1843-8; Brown AC, 2015, DEV CELL, V34, P229, DOI 10.1016/j.devcel.2015.06.021; Cargill K, 2019, J AM SOC NEPHROL, V30, P1192, DOI 10.1681/ASN.2018111170; Cebrian C, 2014, CELL REP, V7, P127, DOI 10.1016/j.celrep.2014.02.033; Cerqueira DM, 2017, FASEB J, V31, P3540, DOI 10.1096/fj.201700010R; Chan YC, 2012, MICROCIRCULATION, V19, P215, DOI 10.1111/j.1549-8719.2011.00154.x; Charlton JR, 2014, PEDIATR NEPHROL, V29, P2299, DOI 10.1007/s00467-014-2758-y; Chung E, 2017, DEVELOPMENT, V144, P4530, DOI 10.1242/dev.156661; Chung E, 2016, DEVELOPMENT, V143, P3907, DOI 10.1242/dev.143503; Cosmi E, 2011, J PREGNANCY, V2011, DOI 10.1155/2011/364381; Costantini F, 2010, DEV CELL, V18, P698, DOI 10.1016/j.devcel.2010.04.008; Cullen-McEwen Luise A, 2012, Methods Mol Biol, V886, P109, DOI 10.1007/978-1-61779-851-1_10; Dotsch J, 2016, CURR OPIN PEDIATR, V28, P188, DOI 10.1097/MOP.0000000000000312; EKBLOM P, 1981, J CELL BIOL, V91, P1, DOI 10.1083/jcb.91.1.1; Freeburg PB, 2003, J AM SOC NEPHROL, V14, P927, DOI 10.1097/01.ASN.0000059308.82322.4F; Gagnon R, 2003, EUR J OBSTET GYN R B, V110, pS99, DOI 10.1016/S0301-2115(03)00179-9; Gan L, 2017, MEDICINE, V96, DOI [10.1097/MD.0000000000007515, 10.1097/md.0000000000007515]; Gao XB, 2005, DEVELOPMENT, V132, P5437, DOI 10.1242/dev.02095; Greijer AE, 2005, J PATHOL, V206, P291, DOI 10.1002/path.1778; Halt K, 2014, PEDIATR NEPHROL, V29, P737, DOI 10.1007/s00467-013-2733-z; Hartman HA, 2007, DEV BIOL, V310, P379, DOI 10.1016/j.ydbio.2007.08.021; Ho J, 2014, FRONT PEDIATR, V2, DOI 10.3389/fped.2014.00128; Ho J, 2012, J AM SOC NEPHROL, V23, P400, DOI 10.1681/ASN.2011080797; Ho J, 2011, J AM SOC NEPHROL, V22, P1053, DOI 10.1681/ASN.2010080841; Hodeify R, 2013, AM J PHYSIOL-RENAL, V304, pF875, DOI 10.1152/ajprenal.00590.2012; Hoy WE, 2005, J AM SOC NEPHROL, V16, P2557, DOI 10.1681/ASN.2005020172; Huang X, 2009, MOL CELL, V35, P856, DOI 10.1016/j.molcel.2009.09.006; Hughson M, 2006, KIDNEY INT, V69, P671, DOI 10.1038/sj.ki.5000041; Imai Y, 1999, NATURE, V398, P777, DOI 10.1038/19709; Ivan M, 2014, ADV EXP MED BIOL, V772, P205, DOI 10.1007/978-1-4614-5915-6_10; Karner CM, 2011, DEVELOPMENT, V138, P1247, DOI 10.1242/dev.057646; Kim HW, 2009, J BIOL CHEM, V284, P33161, DOI 10.1074/jbc.M109.020925; Kiriyama M, 2009, MOL CELL BIOL, V29, P4729, DOI 10.1128/MCB.00289-09; KLEIN G, 1988, DEVELOPMENT, V102, P749; Kobayashi A, 2005, DEVELOPMENT, V132, P2809, DOI 10.1242/dev.01858; Kobayashi A, 2008, CELL STEM CELL, V3, P169, DOI 10.1016/j.stem.2008.05.020; Krawczynski K, 2016, PLACENTA, V47, P113, DOI 10.1016/j.placenta.2016.09.007; Krieghoff E, 2007, CELL CYCLE, V6, P771, DOI 10.4161/cc.6.7.4046; Li TY, 2017, OXID MED CELL LONGEV, V2017, DOI 10.1155/2017/3565613; Lindstrom NO, 2018, J AM SOC NEPHROL, V29, P806, DOI 10.1681/ASN.2017080890; Little MH, 2007, GENE EXPR PATTERNS, V7, P680, DOI 10.1016/j.modgep.2007.03.002; Liu LL, 2017, MOL MED, V23, DOI 10.2119/molmed.2017.00013; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lorenzen JM, 2011, CLIN J AM SOC NEPHRO, V6, P1540, DOI 10.2215/CJN.00430111; Ma QY, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18071356; Marrone AK, 2014, J AM SOC NEPHROL, V25, P1440, DOI 10.1681/ASN.2013040390; McCormick RI, 2013, BRIT J CANCER, V108, P1133, DOI 10.1038/bjc.2013.56; Milovic-Holm K, 2007, EMBO J, V26, P391, DOI 10.1038/sj.emboj.7601504; Mugford JW, 2009, DEV BIOL, V333, P312, DOI 10.1016/j.ydbio.2009.06.043; Muralimanoharan S, 2015, INT J OBESITY, V39, P1274, DOI 10.1038/ijo.2015.45; Murawski IJ, 2010, ORGANOGENESIS, V6, P189, DOI 10.4161/org.6.3.12125; Nakagawa N, 2015, KIDNEY INT, V87, P1125, DOI 10.1038/ki.2014.406; Natoli TA, 2004, DEV BIOL, V268, P429, DOI 10.1016/j.ydbio.2003.12.033; Nyengaard JR, 1999, J AM SOC NEPHROL, V10, P1100; O'Brien LL, 2016, DEVELOPMENT, V143, P595, DOI 10.1242/dev.127175; O'Brien LL, 2014, SEMIN CELL DEV BIOL, V36, P31, DOI 10.1016/j.semcdb.2014.08.014; Park JS, 2007, DEVELOPMENT, V134, P2533, DOI 10.1242/dev.006155; Park KM, 2004, J BIOL CHEM, V279, P52282, DOI 10.1074/jbc.M407629200; Paterson MR, 2019, KIDNEY INT, V96, P1332, DOI 10.1016/j.kint.2019.07.017; Phua YL, 2019, AM J PHYSIOL-RENAL, V316, pF993, DOI 10.1152/ajprenal.00450.2018; Phua YL, 2018, SCI DATA, V5, DOI 10.1038/sdata.2018.218; Plisov S, 2005, J AM SOC NEPHROL, V16, P1632, DOI 10.1681/ASN.2004060476; Pulkkinen K, 2008, FEBS LETT, V582, P2397, DOI 10.1016/j.febslet.2008.05.048; Qin LM, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-320; Ransick A, 2019, DEV CELL, V51, P293; Ricardo AC, 2019, J AM SOC NEPHROL, V30, P137, DOI 10.1681/ASN.2018030296; Rutledge EA, 2017, DEVELOPMENT, V144, P3177, DOI 10.1242/dev.149112; Rymer C, 2014, AM J PHYSIOL-RENAL, V307, pF337, DOI 10.1152/ajprenal.00208.2014; Samaan S, 2015, J MOL DIAGN, V17, P136, DOI 10.1016/j.jmoldx.2014.10.005; Schmidt-Ott KM, 2008, KIDNEY INT, V74, P1004, DOI 10.1038/ki.2008.322; Short KM, 2014, DEV CELL, V29, P188, DOI 10.1016/j.devcel.2014.02.017; Simard M, 2006, REPROD BIOL ENDOCRIN, V4, DOI 10.1186/1477-7827-4-25; Steinhart Z, 2018, DEVELOPMENT, V145, DOI 10.1242/dev.146589; Walton SL, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08365-4; Walton SL, 2018, J PHYSIOL-LONDON, V596, P5873, DOI 10.1113/JP275918; Wilkinson LJ, 2015, KIDNEY INT, V87, P975, DOI 10.1038/ki.2014.394; Wu H, 2019, J AM SOC NEPHROL, V30, P2159; Yi CH, 2009, DEV CELL, V16, P21, DOI 10.1016/j.devcel.2008.12.012	88	4	4	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2020	34	4					5782	5799		10.1096/fj.201902767R	http://dx.doi.org/10.1096/fj.201902767R			18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	LJ5ZA	32141129	Green Accepted, Bronze			2022-12-26	WOS:000530242100064
J	de Oliveira, EJ; de Oliveira, SAS; Otto, C; Alicai, T; de Freitas, JPX; Cortes, DFM; Pariyo, A; Liri, C; Adiga, G; Balmer, A; Klauser, D; Robinson, M				de Oliveira, Eder Jorge; Santos de Oliveira, Saulo Alves; Otto, Caroline; Alicai, Titus; Xavier de Freitas, Juan Paulo; Marmolejo Cortes, Diego Fernando; Pariyo, Anthony; Liri, Charles; Adiga, Gerald; Balmer, Andrea; Klauser, Dominik; Robinson, Mike			A novel seed treatment-based multiplication approach for cassava planting material	PLOS ONE			English	Article							DISEASES; MANAGEMENT; CROPS	Cassava (Manihot esculenta Crantz) is an important food security crop in many parts of the developing world. The crop's high yield potential and multitude of uses-both for nutrition and processing-render cassava a promising driver for the development of rural value chains. It is traditionally propagated from stem cuttings of up to 30 cm in length, giving a multiplication rate as low as 1:10. Propagating cassava traditionally is very inefficient, which leads to challenges in the production and distribution of quality planting material and improved cultivars, greatly limiting the impact of investments in crop breeding. The work described in the present study aimed to develop a seed treatment approach to facilitate the use of shorter seed pieces, increasing the multiplication rate of cassava and thus making the crop's seed systems more efficient. After several tests, formulation was identified, consisting of thiamethoxam 21 g ha(-1), mefenoxam 1.0 g ha(-1), fludioxonil 1.3 g ha(-1), thiabendazole 7.5 g ha(-1) and Latex 2% as a binder. Plant growing from seed pieces treated with this formulation displayed increased crop establishment and early crop vigor, leading to an improved productivity throughout a full growing cycle. This allowed to reduce the cassava seed piece size to 8 cm with no negative effects on germination and crop establishment, leading to yields comparable to those from untreated 16 cm pieces. This, in turn, will allow to increase the multiplication ratio of cassava by a factor of up to 3. Notably, this was possible under regular field conditions and independently of any specialised treatment facilities. Compared with existing seed production protocols, the increased multiplication rates allowed for efficiency gains of between 1 to 1.9 years compared to conventional five-year cycles. We believe that the technology described here holds considerable promise for developing more reliable and remunerative delivery channels for quality cassava planting material and improved genetics.	[de Oliveira, Eder Jorge; Santos de Oliveira, Saulo Alves; Xavier de Freitas, Juan Paulo; Marmolejo Cortes, Diego Fernando] Embrapa Mandioca & Fruticultura, Cruz Das Almas, BA, Brazil; [Otto, Caroline; Balmer, Andrea; Klauser, Dominik; Robinson, Mike] Syngenta Fdn Sustainable Agr, Basel, Switzerland; [Alicai, Titus; Pariyo, Anthony; Liri, Charles; Adiga, Gerald] Natl Crops Resources Res Inst NaCRRI, Kampala, Uganda	Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); Syngenta	de Oliveira, EJ (corresponding author), Embrapa Mandioca & Fruticultura, Cruz Das Almas, BA, Brazil.	eder.oliveira@embrapa.br	Alicai, Titus/AEN-1873-2022; Cortes, Diego Marmolejo/W-9068-2018; Oliveira, Eder Jorge/N-2216-2017; Alves Santos de Oliveira, Saulo/M-7920-2017	Alicai, Titus/0000-0002-4489-3133; Cortes, Diego Marmolejo/0000-0003-1250-9376; Oliveira, Eder Jorge/0000-0001-8992-7459; Alves Santos de Oliveira, Saulo/0000-0002-2992-1570	Conselho Nacional de Desenvolvimento Cienti'fico e Tecnologico (CNPq); Bill and Melinda Gates Foundation, Seattle, WA [OPP1142113]	Conselho Nacional de Desenvolvimento Cienti'fico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Bill and Melinda Gates Foundation, Seattle, WA(Bill & Melinda Gates Foundation)	EJO was supported by research productivity scholarships from Conselho Nacional de Desenvolvimento Cienti ' fico e Tecnologico (CNPq) All authors received funding from the Bill and Melinda Gates Foundation, Seattle, WA [grant number OPP1142113].	Almekinders CJM, 2019, FOOD SECUR, V11, P23, DOI 10.1007/s12571-018-0874-4; Ayalew M., 2017, INT J RES STUDIES SC, V4, P23; Bellotti A, 2012, TROP PLANT BIOL, V5, P39, DOI 10.1007/s12042-011-9091-4; Carvajal-Yepes M, 2014, VIRUS RES, V186, P76, DOI 10.1016/j.virusres.2013.12.011; Carvalho MJS, 2017, GENET MOL RES, V16, DOI 10.4238/gmr16029556; Castro P.R.C, 2008, TIAMETOXAM REVOLUCAO, P118; Ceballos H, 2015, THEOR APPL GENET, V128, P1647, DOI 10.1007/s00122-015-2555-4; CGIAR Research Program on Roots T.A.B, 2018, ANN REP 2017 SCI SCA, P44; Cock J.H., 1976, SERIES EE CTR INT AG, V20; El-Sharkawy MA, 2012, OPEN J SOIL SCI, V2, P162, DOI [10.4236/ojss.2012.22022, DOI 10.4236/OJSS.2012.22022]; Elbert A, 2008, PEST MANAG SCI, V64, P1099, DOI 10.1002/ps.1616; Embrapa, 2016, BRS FORM VAR MAND RE; Fanou A.A., 2018, CASSAVA BACTERIAL BL, DOI [10.5772/intechopen.71527, DOI 10.5772/INTECHOPEN.71527]; FAOSTAT, 2021, FAOSTAT STAT DAT; Fermont AM, 2009, FIELD CROP RES, V112, P24, DOI 10.1016/j.fcr.2009.01.009; Kalyebi A, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0204862; KAWANO K, 1987, CROP SCI, V27, P69, DOI 10.2135/cropsci1987.0011183X002700010018x; Klauser D, 2018, J PLANT DIS PROTECT, V125, P235, DOI 10.1007/s41348-018-0145-9; Kuznetsova A, 2017, J STAT SOFTW, V82, P1, DOI 10.18637/jss.v082.i13; Lapidot M, 2014, ADV VIRUS RES, V90, P147, DOI 10.1016/B978-0-12-801246-8.00003-2; Lebot V., 2008, Tropical root and tuber crops: cassava, sweet potato, yams and aroids, pxv, DOI 10.1079/9781845934248.0000; Legg JP, 2015, ADV VIRUS RES, V91, P85, DOI 10.1016/bs.aivir.2014.10.001; Mapayi E. F., 2013, Journal of Agricultural Science (Toronto), V5, P261; McQuaid CF, 2016, PLANT PATHOL, V65, P299, DOI 10.1111/ppa.12453; Mohammed I. U., 2017, African Journal of Biotechnology, V16, P1551, DOI 10.5897/AJB2017.16022; Okogbenin E, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00093; Otsubo A.A., 2007, REV RAIZES AMIDOS TR, V3, P78; Otsubo AA, 2009, SEMIN-CIENC AGRAR, V30, P1155; R Core Team, 2017, R LANG ENV STAT COMP; Ramos Junior E.U., 2009, REV RAIZES AMIDOS TR, V5, P249; Rey C, 2017, ANNU REV VIROL, V4, P429, DOI 10.1146/annurev-virology-101416-041913; Schade M., 2007, P 12 INT RAP C 26 30, V3, P259; SILVA, 2009, SISCOB MANUAL UTILIZ; Sirchio K, 2007, CHIMIA, V61, P17, DOI 10.2533/chimia.2007.17; Souza LS, 2006, ASPECTOS SOCIOECON M; Srinivasan V.M., 2017, INT J CHEM STUDIES, V5, P291; Thomas-Sharma S, 2017, PHYTOPATHOLOGY, V107, P1123, DOI [10.1094/PHYTO-09-16-0340-R, 10.1094/phyto-09-16-0340-r]; Venturini MT, 2016, SCI AGR, V73, P520, DOI 10.1590/0103-9016-2015-0374; Vidigal Filho Pedro Soares, 2000, Bragantia, V59, P69, DOI 10.1590/S0006-87052000000100011	39	2	2	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2020	15	3							e0229943	10.1371/journal.pone.0229943	http://dx.doi.org/10.1371/journal.pone.0229943			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8TR	32142527	gold, Green Published			2022-12-26	WOS:000535271600028
J	Ye, L; Liu, P; Shi, TF; Wang, AR; Zhu, YJ; Li, L; Yu, LS				Ye, Liang; Liu, Peng; Shi, Tengfei; Wang, Anran; Zhu, Yujie; Li, Lai; Yu, Linsheng			Transcriptomic analysis to elucidate the response of honeybees (Hymenoptera: Apidae) to amitraz treatment	PLOS ONE			English	Article							APIS-MELLIFERA HYMENOPTERA; GENE-EXPRESSION; NOSEMA-CERANAE; INSECTICIDE THIAMETHOXAM; DETOXIFICATION ENZYMES; PESTICIDE-RESIDUES; BEES HYMENOPTERA; PROTEIN-KINASES; EXPOSURE; TRENDS	Amitraz is an acaricide that is widely used in apiculture. Several studies have reported that in honeybees (Apis mellifera Linnaeus; Hymenoptera: Apidae), amitraz affects learning, memory, behavior, immunity, and various other physiological processes. Despite this, few studies have explored the molecular mechanisms underlying the action of amitraz on honeybees. Here, we investigated the transcriptome of honeybees after exposure to 9.4 mg/L amitraz for 10 d, a subchronic dose. Overall, 279 differentially expressed genes (DEGs) were identified (237 upregulated, 42 downregulated). Several, including Pla2, LOC725381, LOC413324, LOC724386, LOC100577456, LOC551785, and P4504c3, were validated by quantitative PCR. According to gene ontology, DEGs were mainly involved in metabolism, biosynthesis, and translation. Kyoto Encyclopedia of Genes and Genomes pathway analyses revealed that amitraz treatment affected the relaxin signaling pathway, platelet activation, and protein digestion and absorption.	[Ye, Liang; Liu, Peng; Shi, Tengfei; Wang, Anran; Zhu, Yujie; Li, Lai; Yu, Linsheng] Anhui Agr Univ, Hefei, Peoples R China	Anhui Agricultural University	Yu, LS (corresponding author), Anhui Agr Univ, Hefei, Peoples R China.	yulinshengahau@163.com	shi, teng/GSE-5879-2022	Liu, Peng/0000-0003-2616-7223	Earmarked Fund for China Agriculture Research System [CARS-45-KXJ10]	Earmarked Fund for China Agriculture Research System	This work was supported by the Earmarked Fund for China Agriculture Research System (No. CARS-45-KXJ10). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aizen MA, 2008, CURR BIOL, V18, P1572, DOI 10.1016/j.cub.2008.08.066; Alburaki M, 2019, J EXP BIOL, V222, DOI 10.1242/jeb.207761; Andrikopoulos CJ, 2018, J ECON ENTOMOL, V111, P2513, DOI 10.1093/jee/toy226; Attencia VM, 2005, SOCIOBIOLOGY, V45, P587; Badiou-Beneteau A, 2012, ECOTOX ENVIRON SAFE, V82, P22, DOI 10.1016/j.ecoenv.2012.05.005; Bezabih G, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02192-3; BITONDI MMG, 1983, BIOCHEM GENET, V21, P985, DOI 10.1007/BF00483955; Brunet T, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3821; Calatayud-Vernich P, 2017, SCI TOTAL ENVIRON, V605, P745, DOI 10.1016/j.scitotenv.2017.06.174; Carvalho SM, 2013, ENVIRON TOXICOL CHEM, V32, P2117, DOI 10.1002/etc.2288; Catae AF, 2018, ECOTOXICOLOGY, V27, P109, DOI 10.1007/s10646-017-1874-4; Chaimanee V, 2019, APIDOLOGIE, V50, P304, DOI 10.1007/s13592-019-00645-4; Chauzat MP, 2011, ENVIRON TOXICOL CHEM, V30, P103, DOI 10.1002/etc.361; Chouquet B, 2010, CHEM SENSES, V35, P363, DOI 10.1093/chemse/bjq024; Christen V, 2017, ENVIRON POLLUT, V226, P48, DOI 10.1016/j.envpol.2017.04.003; Claudianos C, 2006, INSECT MOL BIOL, V15, P615, DOI 10.1111/j.1365-2583.2006.00672.x; Dauterman W.C., 1985, P713; Dubois AEJ, 2007, CURR OPIN ALLERGY CL, V7, P346, DOI 10.1097/ACI.0b013e3282638848; Evans JD, 2006, INSECT MOL BIOL, V15, P645, DOI 10.1111/j.1365-2583.2006.00682.x; Faucher SP, 2008, FEMS MICROBIOL LETT, V281, P160, DOI 10.1111/j.1574-6968.2008.01094.x; Feyereisen R, 2006, BIOCHEM SOC T, V34, P1252, DOI 10.1042/BST0341252; Fijen TPM, 2018, ECOL LETT, V21, P1704, DOI 10.1111/ele.13150; Garelli A, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9732; Giri J, 2011, NEW PHYTOL, V191, P721, DOI 10.1111/j.1469-8137.2011.03740.x; Gontijo AM, 2018, MECH DEVELOP, V154, P44, DOI 10.1016/j.mod.2018.04.005; Goulson D, 2015, SCIENCE, V347, DOI 10.1126/science.1255957; Gregorc A, 2000, CELL BIOL INT, V24, P319, DOI 10.1006/cbir.1999.0490; Gregorc A, 2016, CHEMOSPHERE, V147, P328, DOI 10.1016/j.chemosphere.2015.12.030; Gregorc A, 2011, PESTIC BIOCHEM PHYS, V99, P200, DOI 10.1016/j.pestbp.2010.12.005; Hammer M, 1998, LEARN MEMORY, V5, P146; Hashimoto JH, 2003, SOCIOBIOLOGY, V42, P693; Higes M, 2013, ENV MICROBIOL REP, V5, P17, DOI 10.1111/1758-2229.12024; Iwasa T, 2004, CROP PROT, V23, P371, DOI 10.1016/j.cropro.2003.08.018; Johnson RM, 2006, J ECON ENTOMOL, V99, P1046, DOI 10.1603/0022-0493-99.4.1046; Johnson RM, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0031051, 10.1371/journal.pone.0033479]; Johnson RM, 2009, J ECON ENTOMOL, V102, P474, DOI 10.1603/029.102.0202; Johnson RM, 2008, DISSERTATIONS THESES; Karrenberg S, 2002, PLANT SYST EVOL, V235, P181, DOI 10.1007/s00606-002-0231-z; Kasiotis KM, 2014, SCI TOTAL ENVIRON, V485, P633, DOI 10.1016/j.scitotenv.2014.03.042; Krupa A, 2004, J MOL BIOL, V339, P1025, DOI 10.1016/j.jmb.2004.04.043; Li JQ, 2019, MOL GENET GENOMICS, V294, P1463, DOI 10.1007/s00438-019-01589-1; Li Z, 2015, J INVERTEBR PATHOL, V132, P66, DOI 10.1016/j.jip.2015.08.008; LOUCIF-AYAD W, 2008, EUR J SCI RES, V21, P642; Lourenco AP, 2008, APIDOLOGIE, V39, P372, DOI 10.1051/apido:2008015; Ma HH, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20122953; Manjon C, 2018, CURR BIOL, V28, P1137, DOI 10.1016/j.cub.2018.02.045; Mao WF, 2011, P NATL ACAD SCI USA, V108, P12657, DOI 10.1073/pnas.1109535108; Martel AC, 2007, APIDOLOGIE, V38, P534, DOI 10.1051/apido:2007038; Matsunaga TM, 2002, INSECT BIOCHEM MOLEC, V32, P691, DOI 10.1016/S0965-1748(01)00148-5; Garrido PM, 2016, VET RES, V47, DOI 10.1186/s13567-016-0335-z; Morita A, 2006, FEBS J, V273, P2955, DOI 10.1111/j.1742-4658.2006.05306.x; Mullin CA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009754; Naeger NL, 2016, J EXP BIOL, V219, P3554, DOI 10.1242/jeb.144311; Neumann P, 2010, J APICULT RES, V49, P1, DOI 10.3896/IBRA.1.49.1.01; Lien NTK, 2019, AM J TROP MED HYG, V100, P1240, DOI 10.4269/ajtmh.18-0607; Niu GD, 2011, APIDOLOGIE, V42, P79, DOI 10.1051/apido/2010039; O'Neal ST, 2017, J INVERTEBR PATHOL, V149, P119, DOI 10.1016/j.jip.2017.08.005; Oren Z, 1998, BIOPOLYMERS, V47, P451; Perrot T, 2018, AGR ECOSYST ENVIRON, V266, P39, DOI 10.1016/j.agee.2018.07.020; PILLING ED, 1995, PESTIC BIOCHEM PHYS, V51, P1, DOI 10.1006/pest.1995.1001; Pohorecka K, 2018, J VET RES, V62, P297, DOI 10.2478/jvetres-2018-0043; Potts SG, 2010, TRENDS ECOL EVOL, V25, P345, DOI 10.1016/j.tree.2010.01.007; Ravoet J, 2015, B ENVIRON CONTAM TOX, V94, P543, DOI 10.1007/s00128-015-1511-y; Roeder T, 2005, ANNU REV ENTOMOL, V50, P447, DOI 10.1146/annurev.ento.50.071803.130404; Sawamoto K, 1999, ONCOGENE, V18, P1967, DOI 10.1038/sj.onc.1202522; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Schwaerzel M, 2003, J NEUROSCI, V23, P10495, DOI 10.1523/jneurosci.23-33-10495.2003; Shi TF, 2017, J ECON ENTOMOL, V110, P2283, DOI 10.1093/jee/tox262; Stone D, 2002, COMP BIOCHEM PHYS C, V132, P105, DOI 10.1016/S1532-0456(02)00052-2; Tesovnik T, 2020, ENVIRON POLLUT, V256, DOI 10.1016/j.envpol.2019.113443; Tesovnik T, 2019, J APICULT RES, V58, P730, DOI 10.1080/00218839.2019.1634463; vanEngelsdorp D, 2010, J ECON ENTOMOL, V103, P1517, DOI 10.1603/EC09429; Xu K, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179922; Yang Y, 2019, ENVIRON POLLUT, V249, P860, DOI 10.1016/j.envpol.2019.03.077; Yilmaz HL, 2003, ARCH DIS CHILD, V88, P130, DOI 10.1136/adc.88.2.130; YU SJ, 1984, PESTIC BIOCHEM PHYS, V22, P360, DOI 10.1016/0048-3575(84)90029-4; Zhan DZ, 2018, J AGR FOOD CHEM, V66, P2598, DOI 10.1021/acs.jafc.7b05074	77	1	1	6	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2020	15	3							e0228933	10.1371/journal.pone.0228933	http://dx.doi.org/10.1371/journal.pone.0228933			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8TR	32143212	Green Published, gold			2022-12-26	WOS:000535271600007
J	Brown, ME; Bedinger, D; Lilov, A; Rathanaswami, P; Vasquez, M; Durand, S; Wallace-Moyer, I; Zhong, LH; Nett, JH; Burnina, I; Caffry, I; Lynaugh, H; Sinclair, M; Sun, TW; Bukowski, J; Xu, YD; Abdiche, YN				Brown, Michael E.; Bedinger, Daniel; Lilov, Asparouh; Rathanaswami, Palaniswami; Vasquez, Maximiliano; Durand, Stephanie; Wallace-Moyer, Ian; Zhong, Lihui; Nett, Juergen H.; Burnina, Irina; Caffry, Isabelle; Lynaugh, Heather; Sinclair, Melanie; Sun, Tingwan; Bukowski, John; Xu, Yingda; Abdiche, Yasmina Noubia			Assessing the binding properties of the anti-PD-1 antibody landscape using label-free biosensors	PLOS ONE			English	Article							AFFINITY; EQUILIBRIUM; PD-1	Here we describe an industry-wide collaboration aimed at assessing the binding properties of a comprehensive panel of monoclonal antibodies (mAbs) against programmed cell death protein 1 (PD-1), an important checkpoint protein in cancer immunotherapy and validated therapeutic target, with well over thirty unique mAbs either in clinical development or market-approved in the United States, the European Union or China. The binding kinetics of the PD-1/mAb interactions were measured by surface plasmon resonance (SPR) using a Carterra LSA instrument and the results were compared to data collected on a Biacore 8K. The effect of chip type on the SPR-derived binding rate constants and affinities were explored and the results compared with solution affinities from Meso Scale Discovery (MSD) and Kinetic Exclusion Assay (KinExA) experiments. When using flat chip types, the LSA and 8K platforms yielded near-identical kinetic rate and affinity constants that matched solution phase values more closely than those produced on 3D-hydrogels. Of the anti-PD-1 mAbs tested, which included a portion of those known to be in clinical development or approved, the affinities spanned from single digit picomolar to nearly 425 nM, challenging the dynamic range of our methods. The LSA instrument was also used to perform epitope binning and ligand competition studies which revealed over ten unique competitive binding profiles within this group of mAbs.	[Brown, Michael E.; Lilov, Asparouh; Burnina, Irina; Caffry, Isabelle; Lynaugh, Heather; Sinclair, Melanie; Sun, Tingwan; Xu, Yingda] Adimab, Dept Prot Analyt, Lebanon, NH 03766 USA; [Bedinger, Daniel; Abdiche, Yasmina Noubia] Carterra, Salt Lake City, UT 84103 USA; [Rathanaswami, Palaniswami] Amgen Inc, Amgen Res, Dept Therapeut Discovery, Burnaby, BC, Canada; [Vasquez, Maximiliano] Adimab, Dept Computat Biol, Palo Alto, CA USA; [Durand, Stephanie; Wallace-Moyer, Ian; Zhong, Lihui; Nett, Juergen H.] Adimab, Dept High Throughput Express, Lebanon, NH USA; [Bukowski, John] Adimab, Dept Antibody Discovery, Lebanon, NH USA		Brown, ME (corresponding author), Adimab, Dept Prot Analyt, Lebanon, NH 03766 USA.; Abdiche, YN (corresponding author), Carterra, Salt Lake City, UT 84103 USA.	michael.brown@adimab.com; ynoubia@gmail.com	Rathanaswami, Palaniswami/AAL-3979-2021; Rathanaswami, Palaniswami/AAL-7192-2021	Brown, Michael/0000-0003-3292-2117; Bedinger, Daniel/0000-0001-5009-9369				Abdiche YN, 2011, ANAL BIOCHEM, V411, P139, DOI 10.1016/j.ab.2010.12.020; Abdiche YN, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169535; Abdiche YN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092451; [Anonymous], 2015, EMACHMP4444582015, P16; Assessment Report, 2015, EMACHMP766882015, P24; Bee C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036261; Carter PJ, 2018, NAT REV DRUG DISCOV, V17, P197, DOI 10.1038/nrd.2017.227; Day YSN, 2002, PROTEIN SCI, V11, P1017, DOI 10.1110/ps.4330102; Drake AW, 2012, ANAL BIOCHEM, V429, P58, DOI 10.1016/j.ab.2012.06.024; Drake AW, 2004, ANAL BIOCHEM, V328, P35, DOI 10.1016/j.ab.2003.12.025; Estep P, 2013, MABS-AUSTIN, V5, P270, DOI 10.4161/mabs.23049; Fenwick C, 2019, J EXP MED, V216, P1525, DOI 10.1084/jem.20182359; Fessas P, 2017, SEMIN ONCOL, V44, P136, DOI 10.1053/j.seminoncol.2017.06.002; Ganesan A, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-48826-6; Gjetting T, 2019, MABS-AUSTIN, V11, P666, DOI 10.1080/19420862.2019.1596514; Haenel C, 2005, ANAL BIOCHEM, V339, P182, DOI 10.1016/j.ab.2004.12.032; Hamid O, 2013, NEW ENGL J MED, V369, P134, DOI 10.1056/NEJMoa1305133; Jain T, 2017, P NATL ACAD SCI USA, V114, P944, DOI 10.1073/pnas.1616408114; Kaplon H, 2019, MABS-AUSTIN, V11, P219, DOI 10.1080/19420862.2018.1556465; Katsamba PS, 2006, ANAL BIOCHEM, V352, P208, DOI 10.1016/j.ab.2006.01.034; Kraft TE, 2020, MABS-AUSTIN, V12, DOI 10.1080/19420862.2019.1683432; Lee HT, 2019, MOLECULES, V24, DOI 10.3390/molecules24061190; Lu XJ, 2019, MABS-AUSTIN, V11, P45, DOI 10.1080/19420862.2018.1548233; Myszyka DG, 1999, J MOL RECOGNIT, V12, P279, DOI 10.1002/(SICI)1099-1352(199909/10)12:5<279::AID-JMR473>3.0.CO;2-3; Na ZK, 2017, CELL RES, V27, P147, DOI 10.1038/cr.2016.77; Rathanaswami P, 2005, BIOCHEM BIOPH RES CO, V334, P1004, DOI 10.1016/j.bbrc.2005.07.002; Stenner F, 2018, FRONT ONCOL, V8, DOI 10.3389/fonc.2018.00219; Sydow JF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100736; Tan SG, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14369; Walker LM, 2018, NAT REV IMMUNOL, V18, P297, DOI 10.1038/nri.2017.148; Walsh STR, 2003, PROTEIN SCI, V12, P1960, DOI 10.1110/ps.03133903; Xu YD, 2019, MABS-AUSTIN, V11, DOI 10.1080/19420862.2018.1553476; Yang R, 2017, MABS-AUSTIN, V9, P646, DOI 10.1080/19420862.2017.1290753; Zak KM, 2017, STRUCTURE, V25, P1163, DOI 10.1016/j.str.2017.06.011	34	11	13	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2020	15	3							e0229206	10.1371/journal.pone.0229206	http://dx.doi.org/10.1371/journal.pone.0229206			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8RK	32134960	gold, Green Published			2022-12-26	WOS:000535265600020
J	Gao, J; Dai, C; Yu, X; Yin, XB; Zhou, F				Gao, Jun; Dai, Chao; Yu, Xin; Yin, Xiang-Bao; Zhou, Fan			Long noncoding RNA LINC00324 exerts protumorigenic effects on liver cancer stem cells by upregulating fas ligand via PU box binding protein	FASEB JOURNAL			English	Article						fas ligand; hepatocellular carcinoma; liver cancer stem cells; long noncoding RNA LINC00324; PU box binding protein; transcription factor	HEPATOCELLULAR-CARCINOMA CELLS; PROMOTES PROLIFERATION; EXPRESSION; APOPTOSIS; ACTIVATION; PATHWAY; GROWTH; AXIS; HUR	Hepatocellular carcinoma (HCC) represents a major cause of cancer death, but the molecular mechanism for its development has not yet been well characterized. Long noncoding RNAs (lncRNAs) are involved in a wide range of biological processes via their roles as oncogenes or tumor suppressor genes. The present study aimed to elucidate the role of LINC00324 in HCC through its interaction with Fas ligand (FasL). Initially, microarray-based gene expression profiling of HCC was employed to identify differentially expressed genes. Next, the expression of LINC00324 in HCC tissues and liver cancer stem cell (LCSC) lines was examined using RT-qPCR. Then, the interaction among LINC00324, PU box binding protein (PU.1) and FasL was identified with RIP, ChIP and dual-luciferase reporter gene assays. The effect of LINC00324 on viability, proliferation, migration, invasion, and apoptosis as well as the tumorigenesis of transfected cells was examined with gain- and loss-of-function experiments. LINC00324 and FasL were highly expressed in HCC. LINC00324 regulated FasL expression via interaction with PU.1. Silencing of LINC00324 or FasL suppressed expression of stemness-related genes, cell viability, proliferation, migration, invasion, self-renewal, and tumorigenesis, but enhanced cell apoptosis. Taken together, LINC00324 promotes the expression of FasL through the recruitment of PU.1, which ultimately maintains the biological properties of LCSCs, thus, highlighting LINC00324 as a promising therapeutic candidate for HCC.	[Gao, Jun; Dai, Chao; Yu, Xin; Yin, Xiang-Bao; Zhou, Fan] Nanchang Univ, Affiliated Hosp 2, Dept Hepatobiliary & Pancreat Surg, 1 Mingde Rd, Nanchang 330006, Jiangxi, Peoples R China	Nanchang University	Zhou, F (corresponding author), Nanchang Univ, Affiliated Hosp 2, Dept Hepatobiliary & Pancreat Surg, 1 Mingde Rd, Nanchang 330006, Jiangxi, Peoples R China.	nczhoufan@hotmail.com			Key Foundation of Jiangxi Provincial Science and Technology Departement [20171ACB21064]; Youth Science Foundation of Jiangxi Provincial Science and Technology Department [20151BAB205105]; Jiangxi Provincial Science and Technology Planning Project [20141BBG70042]; Science Planning Project of Jiangxi Provincial Education Department [GJJ14049]	Key Foundation of Jiangxi Provincial Science and Technology Departement; Youth Science Foundation of Jiangxi Provincial Science and Technology Department; Jiangxi Provincial Science and Technology Planning Project; Science Planning Project of Jiangxi Provincial Education Department	Key Foundation of Jiangxi Provincial Science and Technology Departement, Grant/Award Number: 20171ACB21064; Youth Science Foundation of Jiangxi Provincial Science and Technology Department, Grant/Award Number: 20151BAB205105; Jiangxi Provincial Science and Technology Planning Project, Grant/Award Number: 20141BBG70042; Science Planning Project of Jiangxi Provincial Education Department, Grant/Award Number: GJJ14049	Aboelenein HR, 2017, GROWTH FACTORS, V35, P49, DOI 10.1080/08977194.2017.1345900; Braconi C, 2012, CURR CANCER DRUG TAR, V12, P1073; Bruix J, 2016, GASTROENTEROLOGY, V150, P835, DOI 10.1053/j.gastro.2015.12.041; Chandrashekar DS, 2017, NEOPLASIA, V19, P649, DOI 10.1016/j.neo.2017.05.002; Chen Y, 2019, J CELL PHYSIOL, V234, P606, DOI 10.1002/jcp.26803; Ding LJ, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17101617; Dong YY, 2016, J EXP CLIN CANC RES, V35, DOI 10.1186/s13046-016-0394-z; Dou CH, 2017, INT J ONCOL, V51, P1775, DOI 10.3892/ijo.2017.4159; Fang Jia-Ying, 2015, Asian Pac J Cancer Prev, V16, P1959; Feng YJ, 2019, BIOCHEM BIOPH RES CO, V513, P56, DOI 10.1016/j.bbrc.2019.03.079; Gao YZ, 2016, BIOCHEM BIOPH RES CO, V480, P348, DOI 10.1016/j.bbrc.2016.10.048; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; Gong J, 2018, CLIN LAB, V64, P1193, DOI 10.7754/Clin.Lab.2018.180136; Gu Y, 2016, SCI REP-UK, V6, DOI 10.1038/srep18587; Li HY, 2015, ONCOTARGET, V6, P27847, DOI 10.18632/oncotarget.4443; Li JJ, 2015, GENET MOL RES, V14, P4150, DOI 10.4238/2015.April.27.30; Liu Q, 2017, ICERI PROC, P300; Luo P, 2017, CANCER BIOMARK, V18, P285, DOI 10.3233/CBM-160305; Ma YJ, 2016, DNA CELL BIOL, V35, P296, DOI 10.1089/dna.2015.3203; Militello G, 2017, BRIEF BIOINFORM, V18, P780, DOI 10.1093/bib/bbw053; Mohankumar S, 2016, BRIEF FUNCT GENOMICS, V15, P249, DOI 10.1093/bfgp/elv058; Nio K, 2015, J HEPATOL, V63, P1164, DOI 10.1016/j.jhep.2015.06.009; Pang SHM, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01264; Parasramka Mansi A, 2016, Stem Cell Investig, V3, P1, DOI 10.3978/j.issn.2306-9759.2016.01.01; Rodriguez-Hernandez MA, 2019, J CELL PHYSIOL, V234, P692, DOI 10.1002/jcp.26855; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Song Li-Jie, 2015, Asian Pac J Cancer Prev, V16, P3667; Takahashi K, 2014, FEBS OPEN BIO, V4, P458, DOI 10.1016/j.fob.2014.04.007; Wang F, 2014, HEPATOLOGY, V60, P1278, DOI 10.1002/hep.27239; Wang MH, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-017-0013-8; Wang WZ, 2013, LIFE SCI, V92, P352, DOI 10.1016/j.lfs.2013.01.013; Wang YY, 2015, CELL STEM CELL, V16, P413, DOI 10.1016/j.stem.2015.03.003; Wang Yong, 2012, Zhonghua Yi Xue Za Zhi, V92, P3434; Xiao CH, 2016, BIOSCI TRENDS, V10, P378, DOI 10.5582/bst.2016.01123; Yamashita T, 2013, J CLIN INVEST, V123, P1911, DOI 10.1172/JCI66024; Zhang SJ, 2017, INT J ONCOL, V50, P805, DOI 10.3892/ijo.2017.3855; Zhang YP, 2015, INT J CLIN EXP PATHO, V8, P15677; Zhu HF, 2015, MOL CANCER RES, V13, P809, DOI 10.1158/1541-7786.MCR-14-0241; Zhuang JL, 2017, THERANOSTICS, V7, P3053, DOI 10.7150/thno.19542; Zou ZG, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0758-8	40	18	18	1	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2020	34	4					5800	5817		10.1096/fj.201902705RR	http://dx.doi.org/10.1096/fj.201902705RR		MAR 2020	18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	LJ5ZA	32128906	Bronze			2022-12-26	WOS:000517935600001
J	Owashi, KP; Hubert, A; Galli, E; Donal, E; Hernandez, AI; Le Rolle, V				Owashi, Kimi P.; Hubert, Arnaud; Galli, Elena; Donal, Erwan; Hernandez, Alfredo I.; Le Rolle, Virginie			Model-based estimation of left ventricular pressure and myocardial work in aortic stenosis	PLOS ONE			English	Article							GLOBAL LONGITUDINAL STRAIN; EJECTION FRACTION; DYSFUNCTION; SYSTEM; HEART	This paper proposes a model-based estimation of left ventricular (LV) pressure for the evaluation of constructive and wasted myocardial work of patients with aortic stenosis (AS). A model of the cardiovascular system is proposed, including descriptions of i) cardiac electrical activity, ii) elastance-based cardiac cavities, iii) systemic and pulmonary circulations and iv) heart valves. After a sensitivity analysis of model parameters, an identification strategy was implemented using a Monte-Carlo cross-validation approach. Parameter identification procedure consists in two steps for the estimation of LV pressures: step 1) from invasive, intraventricular measurements and step 2) from non-invasive data. The proposed approach was validated on data obtained from 12 patients with AS. The total relative errors between estimated and measured pressures were on average 11.9% and 12.27% and mean R-2 were equal to 0.96 and 0.91, respectively for steps 1 and 2 of parameter identification strategy. Using LV pressures obtained from non-invasive measurements (step 2) and patient-specific simulations, Global Constructive (GCW), Wasted (GWW) myocardial Work and Global Work Efficiency (GWE) parameters were calculated. Correlations between measures and model-based estimations were 0.88, 0.80, 0.91 respectively for GCW, GWW and GWE. The main contributions concern the proposal of the parameter identification procedure, applied on an integrated cardiovascular model, able to reproduce LV pressure specifically to each AS patient, by non-invasive procedures, as well as a new method for the non-invasive estimation of constructive, wasted myocardial work and work efficiency in AS.	[Owashi, Kimi P.; Hubert, Arnaud; Galli, Elena; Donal, Erwan; Hernandez, Alfredo I.; Le Rolle, Virginie] Univ Rennes, INSERM, LTSI, UMR 1099, Rennes, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Rennes	Hernandez, AI (corresponding author), Univ Rennes, INSERM, LTSI, UMR 1099, Rennes, France.	Alfredo.Hernandez@inserm.fr	Galli, Elena/AAP-7999-2020; Le Rolle, Virginie/AAQ-7010-2020; donal, erwan/ABC-9736-2020; Hernández, Alfredo I/K-4933-2015	Galli, Elena/0000-0001-9584-5505; Le Rolle, Virginie/0000-0003-1068-5587; Hernández, Alfredo I/0000-0003-0765-2311; Owashi, Kimi/0000-0002-8106-1950	French National Research Agency (ANR) [ANR-16-CE19-0008-01]; French Brittany council (ADvICE project)	French National Research Agency (ANR)(French National Research Agency (ANR)); French Brittany council (ADvICE project)	This work was supported by the French National Research Agency (ANR) (ANR-16-CE19-0008-01) (project MAESTRo) and the French Brittany council (ADvICE project).	Calvo M, 2019, ARTIF INTELL MED, V97, P98, DOI 10.1016/j.artmed.2018.11.006; Calvo M, 2018, COMPUT BIOL MED, V103, P82, DOI 10.1016/j.compbiomed.2018.10.007; Chung DC, 1997, AM J PHYSIOL-HEART C, V272, pH2942, DOI 10.1152/ajpheart.1997.272.6.H2942; Delgado V, 2009, EUR HEART J, V30, P3037, DOI 10.1093/eurheartj/ehp351; Donal E, 2009, EUR J ECHOCARDIOGR, V10, P914, DOI 10.1093/ejechocard/jep095; Eleid MF, 2013, CIRCULATION, V128, P1781, DOI 10.1161/CIRCULATIONAHA.113.003695; Galli E, 2019, ECHOCARDIOGR-J CARD, V36, P74, DOI 10.1111/echo.14210; Galli E, 2018, J AM SOC ECHOCARDIOG, V31, P220, DOI 10.1016/j.echo.2017.10.009; Galli E, 2018, EUR HEART J-CARD IMG, V19, P1010, DOI 10.1093/ehjci/jex191; Garcia D, 2005, AM J PHYSIOL-HEART C, V288, pH1874, DOI 10.1152/ajpheart.00754.2004; Goldberger AL, 2002, NEUROBIOL AGING, V23, P23, DOI 10.1016/S0197-4580(01)00266-4; Hein S, 2003, CIRCULATION, V107, P984, DOI 10.1161/01.CIR.0000051865.66123.B7; Hernandez AI, 2002, ARTIF INTELL MED, V26, P211, DOI 10.1016/S0933-3657(02)00078-7; Hubert A, 2018, EUR HEART J-CARD IMG, V19, P1372, DOI 10.1093/ehjci/jey024; Kang DH, 2020, NEW ENGL J MED, V382, P111, DOI 10.1056/NEJMoa1912846; Kearney LG, 2012, EUR HEART J-CARD IMG, V13, P827, DOI 10.1093/ehjci/jes115; Klaeboe LG, 2017, J AM SOC ECHOCARDIOG, V30, P727, DOI 10.1016/j.echo.2017.04.009; Korurek M, 2010, ANATOL J CARDIOL, V10, P471, DOI 10.5152/akd.2010.164; Le Rolle V, 2008, ARTIF INTELL MED, V44, P201, DOI 10.1016/j.artmed.2008.06.001; Magne J, 2019, JACC-CARDIOVASC IMAG, V12, P84, DOI 10.1016/j.jcmg.2018.11.005; MORRIS MD, 1991, TECHNOMETRICS, V33, P161, DOI 10.2307/1269043; Mynard JP, 2012, INT J NUMER METH BIO, V28, P626, DOI 10.1002/cnm.1466; Nishimura RA, 2014, J THORAC CARDIOV SUR, V148, pE1, DOI 10.1016/j.jtcvs.2014.05.014; Ojeda D, 2014, IEEE T BIO-MED ENG, V61, P1208, DOI 10.1109/TBME.2013.2296971; Rajappan K, 2002, CIRCULATION, V105, P470, DOI 10.1161/hc0402.102931; Romero-Ugalde HM, 2015, IEEE T BIOMED ENG, V63, P1551; Russell K, 2013, AM J PHYSIOL-HEART C, V305, pH996, DOI 10.1152/ajpheart.00191.2013; Russell K, 2012, EUR HEART J, V33, P724, DOI 10.1093/eurheartj/ehs016; Smith BW, 2004, MED ENG PHYS, V26, P131, DOI 10.1016/j.medengphy.2003.10.001; Stergiopulos N, 1996, AM J PHYSIOL-HEART C, V270, pH2050, DOI 10.1152/ajpheart.1996.270.6.H2050; Taniguchi T, 2018, JACC-CARDIOVASC INTE, V11, P145, DOI 10.1016/j.jcin.2017.08.036; Tanoue Yoshihisa, 2009, Interact Cardiovasc Thorac Surg, V9, P255, DOI 10.1510/icvts.2009.202309; TZIVONI D, 1993, EUR HEART J, V14, P2, DOI 10.1093/eurheartj/14.suppl_A.2; VILLARI B, 1995, CIRCULATION, V91, P2353, DOI 10.1161/01.CIR.91.9.2353	34	12	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2020	15	3							e0229609	10.1371/journal.pone.0229609	http://dx.doi.org/10.1371/journal.pone.0229609			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	KV5HN	32126071	Green Published, gold			2022-12-26	WOS:000520513900001
J	Outlaw, F; Nixon, M; Odeyemi, O; MacDonald, LW; Meek, J; Leung, TS				Outlaw, Felix; Nixon, Miranda; Odeyemi, Oluwatobiloba; MacDonald, Lindsay W.; Meek, Judith; Leung, Terence S.			Smartphone screening for neonatal jaundice via ambient-subtracted sclera chromaticity	PLOS ONE			English	Article							COLOR; RECOGNITION; SYSTEM	Jaundice is a major cause of mortality and morbidity in the newborn. Globally, early identification and home monitoring are significant challenges in reducing the incidence of jaundice-related neurological damage. Smartphone cameras are promising as colour-based screening tools as they are low-cost, objective and ubiquitous. We propose a novel smartphone method to screen for neonatal jaundice by imaging the sclera. It does not rely on colour calibration cards or accessories, which may facilitate its adoption at scale and in less economically developed regions. Our approach is to explicitly address three confounding factors in relating colour to jaundice: (1) skin pigmentation, (2) ambient light, and (3) camera spectral response. (1) The variation in skin pigmentation is avoided by imaging the sclera. (2) With the smartphone screen acting as an illuminating flash, a flash/no-flash image pair is captured using the front-facing camera. The contribution of ambient light is subtracted. (3) In principle, this permits a device- and ambient-independent measure of sclera chromaticity following a one-time calibration. We introduce the concept of Scleral-Conjunctival Bilirubin (SCB), in analogy with Transcutaneous Bilirubin (TcB). The scleral chromaticity is mapped to an SCB value. A pilot study was conducted in the UCL Hospital Neonatal Care Unit (n = 37). Neonates were imaged using a specially developed app concurrently with having a blood test for total serum bilirubin (TSB). The better of two models for SCB based on ambient-subtracted sclera chromaticity achieved r = 0.75 (p < 0.01) correlation with TSB. Ambient subtraction improved chromaticity estimates in proof-of-principle laboratory tests and screening performance within our study sample. Using an SCB decision threshold of 190 mu mol/L, the sensitivity was 100% (specificity 61%) in identifying newborns with TSB>250 mu mol/ L (area under receiver operating characteristic curve, AUROC, 0.86), and 92% (specificity 67%) in identifying newborns with TSB>205 mu mol/L (AUROC 0.85). These results are comparable to modern transcutaneous bilirubinometers.	[Outlaw, Felix; Nixon, Miranda; Odeyemi, Oluwatobiloba; Leung, Terence S.] UCL, Dept Med Phys & Biomed Engn, London, England; [MacDonald, Lindsay W.] UCL, Dept Civil Environm & Geomat Engn, London, England; [Meek, Judith] Univ Coll London Hosp Trust, Neonatal Care Unit, Elizabeth Garrett Anderson Wing, London, England; [Odeyemi, Oluwatobiloba] UCL, Fac Med Sci, UCL Med Sch, London, England	University of London; University College London; University of London; University College London; University of London; University College London; University of London; University College London	Outlaw, F (corresponding author), UCL, Dept Med Phys & Biomed Engn, London, England.	felix.outlaw.15@ucl.ac.uk		Outlaw, Felix/0000-0002-8595-5150	EPSRC [EP/L016478/1]; Department of Health's NIHR; UCL Grand Challenges Small Grants Scheme (Global Health)	EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Department of Health's NIHR(National Institute for Health Research (NIHR)); UCL Grand Challenges Small Grants Scheme (Global Health)	This work is supported by the EPSRC funded UCL Centre for Doctoral Training in Medical Imaging (EP/L016478/1) [https://gow.epsrc.ukri.org/NGBOViewGrant.aspx?GrantRef=EP/L016478/1] and the Department of Health's NIHR-funded Biomedical Research Centre at University College London Hospitals [https://www.uclhospitals.brc.nihr.ac.uk/] (FO), and the UCL Grand Challenges Small Grants Scheme (Global Health) [https://www.ucl.ac.uk/grand-challenges/small-grants] (TL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afanetti M, 2014, EARLY HUM DEV, V90, P417, DOI 10.1016/j.earlhumdev.2014.05.009; Agarwal V, 2006, J PATTERN RECOGNIT R, V1, P42, DOI 10.13176/11.9; Alkassar S, 2017, IEEE T SYST MAN CY-S, V47, P474, DOI 10.1109/TSMC.2015.2505649; Aydin M, 2016, J MED SYST, V40, DOI 10.1007/s10916-016-0523-4; Bhutani VK, 2013, PEDIATR RES, V74, P86, DOI 10.1038/pr.2013.208; Coffin D, 2008, DCRAW DECODING RAW D; Das A, 2013, P 2 IAPR AS C PATT R, DOI [10.1109/ACPR.2013.168, DOI 10.1109/ACPR.2013.168]; de Greef L, 2014, UBICOMP'14: PROCEEDINGS OF THE 2014 ACM INTERNATIONAL JOINT CONFERENCE ON PERVASIVE AND UBIQUITOUS COMPUTING, P331, DOI 10.1145/2632048.2632076; Fairman HS, 1997, COLOR RES APPL, DOI [10.1002/(SICI)1520-6378(199702)22:11::AID-COL4>3.0.CO;2-7, DOI 10.1002/(SICI)1520-6378(199702)22:11::AID-COL4>3.0.CO;2-7]; Gijsenij A, 2011, IEEE T IMAGE PROCESS, V20, P2475, DOI 10.1109/TIP.2011.2118224; Grunerbl A, 2015, IEEE J BIOMED HEALTH, V19, P140, DOI 10.1109/JBHI.2014.2343154; He Y., 2012, P 2012 IEEE EMBS INT, P184, DOI [10.1109/BHI.2012.6211540, DOI 10.1109/BHI.2012.6211540]; Hordley SD, 2006, COLOR RES APPL, V31, P303, DOI 10.1002/col.20226; Jiang J, 2013, P IEEE WORKSH APPL C, DOI [10.1109/WACV.2013.6475015, DOI 10.1109/WACV.2013.6475015]; Jonathan E, 2010, PHYSIOL MEAS, V31, pN79, DOI 10.1088/0967-3334/31/11/N01; Kirwan M, 2013, J MED INTERNET RES, V15, DOI 10.2196/jmir.2588; Larson EC, 2012, UBICOMP'12: PROCEEDINGS OF THE 2012 ACM INTERNATIONAL CONFERENCE ON UBIQUITOUS COMPUTING, P280, DOI 10.1145/2370216.2370261; Leung TS, 2019, BIOMED OPT EXPRESS, V10, P1250, DOI 10.1364/BOE.10.001250; Leung TS, 2015, BIOMED OPT EXPRESS, V6, P4529, DOI 10.1364/BOE.6.004529; Lu C, 2006, 14 COLOR IM C; Mariakakis Alex, 2017, Proceedings of the ACM on Interactive, Mobile, Wearable and Ubiquitous Technologies, V1, DOI 10.1145/3090085; Mariakakis Alex, 2017, Proceedings of the ACM on Interactive, Mobile, Wearable and Ubiquitous Technologies, V1, DOI 10.1145/3131896; Moyer VA, 2000, ARCH PEDIAT ADOL MED, V154, P391, DOI 10.1001/archpedi.154.4.391; Munkholm SB, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0197938; National Institute for Health and Care, 2010, JAUND NEWB BAB 28 DA; Nixon M, 2019, COLOR IMAGING C, V2019, P49; Outlaw F, 2017, PROCEEDINGS OF THE 2017 INTERNATIONAL CONFERENCE ON DIGITAL HEALTH (DH'17), P241, DOI 10.1145/3079452.3079488; Padidar P, 2019, IRAN J PEDIATR, V29, DOI 10.5812/ijp.84397; Petschnigg G, 2004, ACM T GRAPHIC, V23, P664, DOI 10.1145/1015706.1015777; Rennie J., 2012, RENNIE ROBERTSONS TX, V5; Riskin A, 2008, J PEDIATR-US, V152, P782, DOI 10.1016/j.jpeds.2007.11.003; Rizvi Moattar Raza, 2019, Oman Med J, V34, P26, DOI 10.5001/omj.2019.05; Romagnoli C, 2012, CLIN BIOCHEM, V45, P659, DOI 10.1016/j.clinbiochem.2012.03.014; Samiee-Zafarghandy S, 2014, ARCH DIS CHILD-FETAL, V99, pF480, DOI 10.1136/archdischild-2013-305699; Saxena A, 2007, IEEE I CONF COMP VIS, P1; Scully CG, 2012, IEEE T BIO-MED ENG, V59, P303, DOI 10.1109/TBME.2011.2163157; Slusher TM, 2004, PEDIATRICS, V113, P1636, DOI 10.1542/peds.113.6.1636; Tan KL, 2003, ACTA PAEDIAT INT J P, DOI [10.1080/08035250310009257, DOI 10.1080/08035250310009257]; Taylor JA, 2017, PEDIATRICS, V140, DOI 10.1542/peds.2017-0312; TRIPATHI RC, 1979, JAMA-J AM MED ASSOC, V242, P2558, DOI 10.1001/jama.1979.03300230014016; Wainer S, 2009, ACTA PAEDIATR, V98, P1909, DOI 10.1111/j.1651-2227.2009.01497.x; Wang L, 2015, IEEE T BIO-MED ENG, V62, P477, DOI 10.1109/TBME.2014.2358632; Ziegelberger G, 2013, HEALTH PHYS, V105, P74, DOI 10.1097/HP.0b013e318289a611	43	6	7	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2020	15	3							e0216970	10.1371/journal.pone.0216970	http://dx.doi.org/10.1371/journal.pone.0216970			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8JT	32119664	Green Submitted, gold, Green Published			2022-12-26	WOS:000535245300001
J	Zhuang, Y; Ma, QH; Pan, CW; Lu, J				Zhuang, Ye; Ma, Qing-Hua; Pan, Chen-Wei; Lu, Jun			Health-related quality of life in older Chinese patients with diabetes	PLOS ONE			English	Article							ADULTS; EQ-5D; PREVALENCE; MELLITUS; DEPRESSION; MORTALITY; GLUCOSE; EUROQOL	Background Although older diabetes patients with unique characteristics should be cared carefully to improve their health-related quality of life (HRQOL), the association between diabetes and HRQOL remain unclear, especially in Asians. We aimed to compare the HRQOL between older Chinese patients with type 2 diabetes (T2D) and their age-gender-matched controls. Methods Older patients with T2D were recruited from a community hospital in Suzhou located in the east part of China while controls were selected from a community-based health survey of older adults aged 60 years or older. HRQOL of cases and controls was assessed by the EQ-5D-3L. The impact of T2D on HRQOL was investigated using a liner regression model and the relationship between T2D and EQ-5D health problems was evaluated using logistic regression models. Results A total of 220 cases and 440 controls were included. The mean age of the participants was 68.8 years and women accounted for 69.1% of the study sample. The EQ-5D-3L index score was lower for older people with T2D (0.886) than their controls (0.955). After multivariable adjustment, the difference in ED-5D-3L index score between older people with and without T2D was 0.072. In logistic regression analyses, T2D was positively associated with reporting of problems in mobility (odds ratio [OR] = 5.00); pain/discomfort (OR = 1.66), and anxiety/depression (OR = 3.2). Conclusions T2D has a detrimental effect on HRQOL of older Chinese people.	[Zhuang, Ye; Lu, Jun] Fudan Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Shanghai, Peoples R China; [Ma, Qing-Hua] 3rd Peoples Hosp Xiangcheng Dist, Suzhou, Peoples R China; [Pan, Chen-Wei] Soochow Univ, Sch Publ Hlth, Med Coll, Suzhou, Peoples R China	Fudan University; Soochow University - China	Lu, J (corresponding author), Fudan Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Shanghai, Peoples R China.	lujun@shmu.edu.cn		Pan, Chen-Wei/0000-0003-3362-4613				ANDERSSON DKG, 1995, DIABETES CARE, V18, P1534, DOI 10.2337/diacare.18.12.1534; BourdelMarchasson I, 1997, J AM GERIATR SOC, V45, P295, DOI 10.1111/j.1532-5415.1997.tb00943.x; DAMSGAARD EM, 1989, DAN MED BULL, V36, P89; DORNAN TL, 1992, DIABETIC MED, V9, P860, DOI 10.1111/j.1464-5491.1992.tb01906.x; Egede LE, 2010, DIABETES RES CLIN PR, V87, P302, DOI 10.1016/j.diabres.2010.01.024; GAVARD JA, 1993, DIABETES CARE, V16, P1167, DOI 10.2337/diacare.16.8.1167; Golicki D, 2015, ADV CLIN EXP MED, V24, P139, DOI 10.17219/acem/38137; Hiltunen L, 1996, SCAND J PRIM HEALTH, V14, P229, DOI 10.3109/02813439608997090; Holmes J, 2000, Value Health, V3 Suppl 1, P47; Janssen MF, 2011, DIABETIC MED, V28, P395, DOI 10.1111/j.1464-5491.2010.03136.x; Lin CY, 2020, THER ADV ENDOCRINOL, V11, DOI 10.1177/2042018819897522; Lin CY, 2017, HLTH QUAL LIFE OUT, V15; Liu GG, 2014, VALUE HEALTH, V17, P597, DOI 10.1016/j.jval.2014.05.007; Ma RCW, 2013, ANN NY ACAD SCI, V1281, P64, DOI 10.1111/nyas.12098; MORLEY GK, 1984, AM J MED, V77, P79, DOI 10.1016/0002-9343(84)90439-X; Morley JE, 1998, DIABETIC MED, V15, pS41, DOI 10.1002/(SICI)1096-9136(1998120)15:4+<S41::AID-DIA747>3.3.CO;2-5; NALIBOFF BD, 1989, J AM GERIATR SOC, V37, P838, DOI 10.1111/j.1532-5415.1989.tb02263.x; Pan Changyu, 2005, World Hosp Health Serv, V41, P29; REAVEN GM, 1990, DIABETES CARE, V13, P16, DOI 10.2337/diacare.13.1.16; Saffari M, 2019, QUAL LIFE RES, V28, P2183, DOI 10.1007/s11136-019-02183-z; Saffari M, 2019, INT J DIABETES DEV C, V39, P218, DOI 10.1007/s13410-018-0648-8; Saito I, 2006, DIABETES RES CLIN PR, V73, P51, DOI 10.1016/j.diabres.2005.11.015; Sakamaki H, 2006, VALUE HEALTH, V9, P47, DOI 10.1111/j.1524-4733.2006.00080.x; Sinclair AJ, 1997, DIABETIC MED, V14, P639, DOI 10.1002/(SICI)1096-9136(199708)14:8<639::AID-DIA433>3.0.CO;2-C; Sun HP, 2016, OPHTHAL PHYSL OPT, V36, P191, DOI 10.1111/opo.12248; Trief PM, 2003, AGE AGEING, V32, P613, DOI 10.1093/ageing/afg105; Wandell PE, 2000, J DIABETES COMPLICAT, V14, P25, DOI 10.1016/S1056-8727(99)00066-5; Wang H, 2005, QUAL LIFE RES, V14, P119, DOI 10.1007/s11136-004-0612-6; Wang HM, 2012, QUAL LIFE RES, V21, P155, DOI 10.1007/s11136-011-9915-6; Wang WB, 2009, AM J MANAG CARE, V15, P593; Xu Y, 2013, JAMA-J AM MED ASSOC, V310, P948, DOI 10.1001/jama.2013.168118; Yang WY, 2010, NEW ENGL J MED, V362, P1090, DOI 10.1056/NEJMoa0908292; Zhang X, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/601869; Zhao FL, 2010, VALUE HEALTH, V13, P649, DOI 10.1111/j.1524-4733.2010.00728.x	34	10	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2020	15	2							e0229652	10.1371/journal.pone.0229652	http://dx.doi.org/10.1371/journal.pone.0229652			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LQ8GQ	32106232	gold, Green Published			2022-12-26	WOS:000535237000052
J	Ngo, D; Baumgartner, R; Mt-Isa, S; Feng, D; Chen, J; Schnell, P				Duy Ngo; Baumgartner, Richard; Mt-Isa, Shahrul; Feng, Dai; Chen, Jie; Schnell, Patrick			Bayesian credible subgroup identification for treatment effectiveness in time-to-event data	PLOS ONE			English	Article							BENEFIT; RISK; PRASUGREL; EFFICACY; TRIALS; SAFETY	Due to differential treatment responses of patients to pharmacotherapy, drug development and practice in medicine are concerned with personalized medicine, which includes identifying subgroups of population that exhibit differential treatment effect. For time-to-event data, available methods only focus on detecting and testing treatment-by-covariate interactions and may not consider multiplicity. In this work, we introduce the Bayesian credible subgroups approach for time-to-event endpoints. It provides two bounding subgroups for the true benefiting subgroup: one which is likely to be contained by the benefiting subgroup and one which is likely to contain the benefiting subgroup. A personalized treatment effect is estimated by two common measures of survival time: the hazard ratio and restricted mean survival time. We apply the method to identify benefiting subgroups in a case study of prostate carcinoma patients and a simulated large clinical dataset.	[Duy Ngo; Baumgartner, Richard; Feng, Dai; Chen, Jie] Merck & Co Inc, Kenilworth, NJ 07033 USA; [Mt-Isa, Shahrul] MSD, MSD Res Labs, London, England; [Duy Ngo] Western Michigan Univ, Dept Stat, Kalamazoo, MI 49008 USA; [Mt-Isa, Shahrul] Imperial Coll London, Sch Publ Hlth, London, England; [Schnell, Patrick] Ohio State Univ, Coll Publ Hlth, Columbus, OH 43210 USA	Merck & Company; Merck & Company; Western Michigan University; Imperial College London; University System of Ohio; Ohio State University	Baumgartner, R (corresponding author), Merck & Co Inc, Kenilworth, NJ 07033 USA.	richard_baumgartner@merck.com			Merck Company	Merck Company(Merck & Company)	This study was funded from a commercial source: Merck & Company. The funder provided support in the form of salaries for authors Duy Ngo, Richard Baumgartner, Shahrul Mt-Isa, Jie Chen and Dai Feng. The specific roles of these authors are articulated in the `author contributions' section. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2013, BAYESIAN ANAL; Assmann SF, 2000, LANCET, V355, P1064, DOI 10.1016/S0140-6736(00)02039-0; Ballarini NM, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0205971; Berger JO, 2014, J BIOPHARM STAT, V24, P110, DOI 10.1080/10543406.2013.856026; Berry DA., 1990, SUBGROUP ANAL; Carpenter B, 2017, J STAT SOFTW, V76, P1, DOI 10.18637/jss.v076.i01; Cui Lu, 2002, J Biopharm Stat, V12, P347, DOI 10.1081/BIP-120014565; Dabrowska A., 2018, PRESCRIPTION DRUG US; de Bekker-Grob EW, 2018, GIVING PATIENTS PREF; De Boor C, 1978, PRACTICAL GUIDE SPLI, V27; FDA, 2017, PLAN ISS PAT FOC DRU; GRAMBSCH PM, 1994, BIOMETRIKA, V81, P515; Henderson NC, 2017, ARXIV170606611; HJORT NL, 1990, ANN STAT, V18, P1259, DOI 10.1214/aos/1176347749; Hughes D, 2016, PHARMACOEPIDEM DR S, V25, P251, DOI 10.1002/pds.3958; KALBFLEISCH JD, 1978, J ROY STAT SOC B MET, V40, P214; Kapelner A, 2015, CAN J STAT, V43, P224, DOI 10.1002/cjs.11248; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Lagakos SW, 2006, NEW ENGL J MED, V354, P1667, DOI 10.1056/NEJMp068070; Laud P. W., 1998, LECT NOTES STAT, P213; Mahajan Akshay, 2015, 2015 IEEE Biomedical Circuits and Systems Conference (BioCAS), P1, DOI 10.1109/BioCAS.2015.7348355; Mahani AS, 2017, J STAT SOFTW, V78, P1, DOI 10.18637/jss.v078.c01; Mahani AS, 2016, J STAT SOFTW, V74, P1, DOI 10.18637/jss.v074.c02; MDIC MDA, 2015, PAT CTR BEN RISK; Mt-Isa S, 2014, PHARMACOEPIDEM DR S, V23, P667, DOI 10.1002/pds.3636; Neal Radford M, 2011, HDB MARKOV CHAIN MON, V2, P2, DOI DOI 10.1201/B10905-6; Neal RM, 2003, ANN STAT, V31, P705, DOI 10.1214/aos/1056562461; Negassa A, 2005, STAT COMPUT, V15, P231, DOI 10.1007/s11222-005-1311-z; Pocock SJ, 2002, STAT MED, V21, P2917, DOI 10.1002/sim.1296; Rosenkranz GK, 2016, BIOMETRICAL J, V58, P1217, DOI 10.1002/bimj.201500147; Royston P., 2008, MULTIVARIABLE MODEL; Royston P, 2013, BMC MED RES METHODOL, V13, DOI 10.1186/1471-2288-13-152; Ruberg SJ, 2010, CLIN TRIALS, V7, P574, DOI 10.1177/1740774510369350; Schnell P, 2017, ANN APPL STAT, V11, P949, DOI 10.1214/17-AOAS1024; Schnell PM, 2018, CLIN TRIALS, V15, P75, DOI 10.1177/1740774517729167; Schnell PM, 2016, BIOMETRICS, V72, P1026, DOI 10.1111/biom.12522; Scirica BM, 2012, LANCET, V380, P1317, DOI 10.1016/S0140-6736(12)61269-0; Soekhai V, 2019, DRUG DISCOVERY TODAY; Su Xiaogang, 2008, Int J Biostat, V4, P2, DOI 10.2202/1557-4679.1071; Temple R, 2000, ANN INTERN MED, V133, P455, DOI 10.7326/0003-4819-133-6-200009190-00014; Uno H, 2015, ANN INTERN MED, V163, P127, DOI 10.7326/M14-1741; Uno H, 2014, J CLIN ONCOL, V32, P2380, DOI 10.1200/JCO.2014.55.2208; Waddingham E, 2016, BIOMETRICAL J, V58, P28, DOI 10.1002/bimj.201300254; Wang R, 2007, NEW ENGL J MED, V357, P2189, DOI 10.1056/NEJMsr077003; Wiviott SD, 2007, NEW ENGL J MED, V357, P2001, DOI 10.1056/NEJMoa0706482; Wiviott SD, 2011, AM J CARDIOL, V108, P905, DOI 10.1016/j.amjcard.2011.05.020; Zhao LH, 2016, BIOMETRICS, V72, P215, DOI 10.1111/biom.12384; Zhou H., 2017, ARXIV170504584	50	1	1	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2020	15	2							e0229336	10.1371/journal.pone.0229336	http://dx.doi.org/10.1371/journal.pone.0229336			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8FM	32101562	gold, Green Published, Green Submitted			2022-12-26	WOS:000535233700026
J	Sehrawat, A; Shiota, C; Mohamed, N; DiNicola, J; Saleh, M; Kalsi, R; Zhang, T; Wang, Y; Prasadan, K; Gittes, GK				Sehrawat, Anuradha; Shiota, Chiyo; Mohamed, Nada; DiNicola, Julia; Saleh, Mohamed; Kalsi, Ranjeet; Zhang Ting; Wang Yan; Prasadan, Krishna; Gittes, George K.			SMAD7 enhances adult ?-cell proliferation without significantly affecting ?-cell function in mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						beta cell (B-cell); cell proliferation; glucose metabolism; SMAD transcription factor; diabetes; SMAD7; beta cell; glucose homeostasis; cell signaling; transforming growth factor beta (TGF-beta); pancreatic islet; gene regulation; endocrine development	TGF-BETA; TRANSGENIC MICE; ENDOCRINE; EXPRESSION; RECEPTOR; HEMIPANCREATECTOMY; DIFFERENTIATION; FOLLISTATIN; INHIBITION; PANCREAS	The interplay between the transforming growth factor ? (TGF-?) signaling proteins, SMAD family member 2 (SMAD2) and 3 (SMAD3), and the TGF-??inhibiting SMAD, SMAD7, seems to play a vital role in proper pancreatic endocrine development and also in normal ?-cell function in adult pancreatic islets. Here, we generated conditional SMAD7 knockout mice by crossing insulin1(Cre) mice with SMAD7(fx/fx) mice. We also created a ? cell?specific SMAD7-overexpressing mouse line by crossing insulin1(Dre) mice with HPRT-SMAD7/RosaGFP mice. We analyzed ?-cell function in adult islets when SMAD7 was either absent or overexpressed in ? cells. Loss of SMAD7 in ? cells inhibited proliferation, and SMAD7 overexpression enhanced cell proliferation. However, alterations in basic glucose homeostasis were not detectable following either SMAD7 deletion or overexpression in ? cells. Our results show that both the absence and overexpression of SMAD7 affect TGF-? signaling and modulates ?-cell proliferation but does not appear to alter ?-cell function. Reversible SMAD7 overexpression may represent an attractive therapeutic option to enhance ?-cell proliferation without negative effects on ?-cell function.	[Sehrawat, Anuradha; Shiota, Chiyo; Mohamed, Nada; DiNicola, Julia; Saleh, Mohamed; Kalsi, Ranjeet; Zhang Ting; Wang Yan; Prasadan, Krishna; Gittes, George K.] Univ Pittsburgh, Childrens Hosp, Dept Pediat Surg, 4401 Penn Ave, Pittsburgh, PA 15224 USA; [Shiota, Chiyo] Vanderbilt Univ, Dept Mol Physiol & Biophys, 221 Kirkland Hall, Nashville, TN 37235 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Vanderbilt University	Gittes, GK (corresponding author), Univ Pittsburgh, Childrens Hosp, Dept Pediat Surg, 4401 Penn Ave, Pittsburgh, PA 15224 USA.	gittesgk@upmc.edu	wang, yan/G-3715-2018	wang, yan/0000-0001-7816-6121	National Institutes of Health [RO1DK111460]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported in part by National Institutes of Health Grant RO1DK111460 (to G. G.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Anastassiadis K, 2009, DIS MODEL MECH, V2, P508, DOI 10.1242/dmm.003087; Bertera S, 2012, J TRANSPLANT, V2012, DOI 10.1155/2012/856386; BONNERWEIR S, 1983, J CLIN INVEST, V71, P1544, DOI 10.1172/JCI110910; Bottinger EP, 1997, CANCER RES, V57, P5564; Bottinger EP, 1997, EMBO J, V16, P2621, DOI 10.1093/emboj/16.10.2621; Brorson M, 2001, HISTOCHEM CELL BIOL, V116, P263, DOI 10.1007/s004180100316; Chen CD, 2019, DEVELOPMENT, V146, DOI 10.1242/dev.164913; Dor Y, 2004, NATURE, V429, P41, DOI 10.1038/nature02520; El-Gohary Y, 2014, DIABETES, V63, P224, DOI 10.2337/db13-0432; El-Gohary Y, 2013, DEV BIOL, V378, P83, DOI 10.1016/j.ydbio.2013.04.003; George SHL, 2007, P NATL ACAD SCI USA, V104, P4455, DOI 10.1073/pnas.0609277104; Gittes GK, 2009, DEV BIOL, V326, P4, DOI 10.1016/j.ydbio.2008.10.024; Han B, 2011, J IMMUNOL, V186, P5833, DOI 10.4049/jimmunol.1002303; Hang Y, 2011, TRENDS ENDOCRIN MET, V22, P364, DOI 10.1016/j.tem.2011.05.003; Hara M, 2003, AM J PHYSIOL-ENDOC M, V284, pE177, DOI 10.1152/ajpendo.00321.2002; Itkin-Ansari P, 2005, DEV DYNAM, V233, P946, DOI 10.1002/dvdy.20443; KAARTINEN V, 1995, NAT GENET, V11, P415, DOI 10.1038/ng1295-415; KENDALL DM, 1990, NEW ENGL J MED, V322, P898, DOI 10.1056/NEJM199003293221305; Kleeff J, 1999, ONCOGENE, V18, P5363, DOI 10.1038/sj.onc.1202909; Kuang CZ, 2006, P NATL ACAD SCI USA, V103, P1858, DOI 10.1073/pnas.0508977103; Linnemann AK, 2014, ADV NUTR, V5, P278, DOI 10.3945/an.113.005488; Maldonado TS, 2000, J GASTROINTEST SURG, V4, P269, DOI 10.1016/S1091-255X(00)80075-X; Massague J, 2006, FEBS LETT, V580, P2811, DOI 10.1016/j.febslet.2006.04.033; Matsuzaki K, 2013, CYTOKINE GROWTH F R, V24, P385, DOI 10.1016/j.cytogfr.2013.06.002; Meier JJ, 2012, DIABETOLOGIA, V55, P1346, DOI 10.1007/s00125-012-2466-8; Miralles F, 1998, DEVELOPMENT, V125, P1017; MOSES HL, 1990, CELL, V63, P245, DOI 10.1016/0092-8674(90)90155-8; MOSES HL, 1987, J CELL PHYSIOL, P1, DOI 10.1002/jcp.1041330403; MOSES HL, 1994, MOLECULAR AND CELLULAR BASIS FOR CELL TO CELL INTERACTION: ITS SIGNIFICANCE IN CANCER, P250; Park SH, 2005, J BIOCHEM MOL BIOL, V38, P9; Prasadan K, 2016, CELL MOL LIFE SCI, V73, P3623, DOI 10.1007/s00018-016-2231-0; Sanford LP, 1997, DEVELOPMENT, V124, P2659; SEAQUIST ER, 1992, J CLIN INVEST, V89, P1761, DOI 10.1172/JCI115779; Smart NG, 2006, PLOS BIOL, V4, P200, DOI 10.1371/journal.pbio.0040039; Szabat M, 2010, DIABETOLOGIA, V53, P1680, DOI 10.1007/s00125-010-1758-0; Tulachan SS, 2007, DEV BIOL, V305, P508, DOI 10.1016/j.ydbio.2007.02.033; Wang P, 2019, CELL METAB, V29, P638, DOI 10.1016/j.cmet.2018.12.005; WANG RN, 1994, DIABETOLOGIA, V37, P1088; Warming S, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni035; Wrighton KH, 2009, CELL RES, V19, P8, DOI 10.1038/cr.2008.327; Xiao XW, 2014, P NATL ACAD SCI USA, V111, pE1211, DOI 10.1073/pnas.1321347111; Xiao XW, 2013, DIABETES, V62, P1217, DOI 10.2337/db12-1428; Yan XH, 2009, ACTA BIOCH BIOPH SIN, V41, P263, DOI 10.1093/abbs/gmp018; Yang GS, 2009, GENOMICS, V93, P196, DOI 10.1016/j.ygeno.2008.09.014; Zhang YQ, 2004, DIABETES, V53, P2024, DOI 10.2337/diabetes.53.8.2024	45	7	11	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 10	2020	295	15					4858	4869		10.1074/jbc.RA119.011011	http://dx.doi.org/10.1074/jbc.RA119.011011			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LE7FC	32122971	hybrid, Green Published			2022-12-26	WOS:000526887000010
J	Tan, W; Liao, TH; Wang, J; Ye, Y; Wei, YC; Zhou, HK; Xiao, YL; Zhi, XY; Shao, ZH; Lyu, LD; Zhao, GP				Tan, Wei; Liao, Tian-Hua; Wang, Jin; Ye, Yu; Wei, Yu-Chen; Zhou, Hao-Kui; Xiao, Youli; Zhi, Xiao-Yang; Shao, Zhi-Hui; Lyu, Liang-Dong; Zhao, Guo-Ping			A recently evolved diflavin-containing monomeric nitrate reductase is responsible for highly efficient bacterial nitrate assimilation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						nitrogen metabolism; Mycobacterium smegmatis; mycobacteria; reductase; protein evolution; assimilatory nitrate reductase; diflavin reductase; Mycolicibacterium smegmatis; nitrate assimilation	MYCOBACTERIUM-TUBERCULOSIS; SP NOV.; BIOCHEMICAL-CHARACTERIZATION; STREPTOMYCES-COELICOLOR; PHYLOGENETIC ANALYSIS; NITROGEN-METABOLISM; REGULATOR GLNR; BOVIS BCG; PROTEIN; IDENTIFICATION	Nitrate is one of the major inorganic nitrogen sources for microbes. Many bacterial and archaeal lineages have the capacity to express assimilatory nitrate reductase (NAS), which catalyzes the rate-limiting reduction of nitrate to nitrite. Although a nitrate assimilatory pathway in mycobacteria has been proposed and validated physiologically and genetically, the putative NAS enzyme has yet to be identified. Here, we report the characterization of a novel NAS encoded by Mycolicibacterium smegmatis Msmeg_4206, designated NasN, which differs from the canonical NASs in its structure, electron transfer mechanism, enzymatic properties, and phylogenetic distribution. Using sequence analysis and biochemical characterization, we found that NasN is an NADPH-dependent, diflavin-containing monomeric enzyme composed of a canonical molybdopterin cofactor-binding catalytic domain and an FMN?FAD/NAD-binding, electron-receiving/transferring domain, making it unique among all previously reported hetero-oligomeric NASs. Genetic studies revealed that NasN is essential for aerobic M. smegmatis growth on nitrate as the sole nitrogen source and that the global transcriptional regulator GlnR regulates nasN expression. Moreover, unlike the NADH-dependent heterodimeric NAS enzyme, NasN efficiently supports bacterial growth under nitrate-limiting conditions, likely due to its significantly greater catalytic activity and oxygen tolerance. Results from a phylogenetic analysis suggested that the nasN gene is more recently evolved than those encoding other NASs and that its distribution is limited mainly to Actinobacteria and Proteobacteria. We observed that among mycobacterial species, most fast-growing environmental mycobacteria carry nasN, but that it is largely lacking in slow-growing pathogenic mycobacteria because of multiple independent genomic deletion events along their evolution.	[Tan, Wei; Ye, Yu; Wei, Yu-Chen; Zhao, Guo-Ping] Chinese Univ Hong Kong, Prince Wales Hosp, Dept Microbiol, Shatin, Hong Kong 999077, Peoples R China; [Tan, Wei; Ye, Yu; Wei, Yu-Chen; Zhao, Guo-Ping] Chinese Univ Hong Kong, Prince Wales Hosp, Li Ka Shing Inst Hlth Sci, Shatin, Hong Kong 999077, Peoples R China; [Tan, Wei; Lyu, Liang-Dong; Zhao, Guo-Ping] Fudan Univ, Sch Basic Med Sci, Key Lab Med Mol Virol MOE NHC CAMS, Shanghai 200032, Peoples R China; [Tan, Wei; Lyu, Liang-Dong; Zhao, Guo-Ping] Fudan Univ, Sch Life Sci, Dept Microbiol & Microbial Engn, Shanghai 200032, Peoples R China; [Liao, Tian-Hua; Zhou, Hao-Kui; Zhao, Guo-Ping] Chinese Acad Sci, Shenzhen Inst Adv Technol, Inst Synthet Biol, Shenzhen 518055, Peoples R China; [Wang, Jin] Shanghai Normal Univ, Coll Life Sci, Shanghai 200234, Peoples R China; [Xiao, Youli; Shao, Zhi-Hui; Zhao, Guo-Ping] Chinese Acad Sci, CAS Key Lab Synthet Biol, CAS Ctr Excellence Mol Plant Sci, Inst Plant Physiol & Ecol, Shanghai 200032, Peoples R China; [Zhi, Xiao-Yang] Yunnan Univ, Sch Life Sci, Yunnan Inst Microbiol, Kunming 650091, Yunnan, Peoples R China; [Zhao, Guo-Ping] Chinese Acad Sci, CAS MPG Partner Inst Computat Biol, Key Lab Computat Biol,Shanghai Inst Nutr & Hlth, Univ Chinese Acad Sci,Shanghai Inst Biol Sci,Bio, Shanghai 200031, Peoples R China; [Zhao, Guo-Ping] Chinese Natl Human Genome Ctr, Shanghai MOST Key Lab Hlth & Dis Genom, Shanghai 201203, Peoples R China	Chinese University of Hong Kong; Prince of Wales Hospital; Chinese University of Hong Kong; Prince of Wales Hospital; Fudan University; Fudan University; Chinese Academy of Sciences; Shenzhen Institute of Advanced Technology, CAS; Shanghai Normal University; Chinese Academy of Sciences; Yunnan University; Chinese Academy of Sciences; Shanghai Institute of Nutrition & Health, CAS; Shanghai Institutes for Biological Sciences, CAS; University of Chinese Academy of Sciences, CAS; Max Planck Society	Zhao, GP (corresponding author), Chinese Univ Hong Kong, Prince Wales Hosp, Dept Microbiol, Shatin, Hong Kong 999077, Peoples R China.; Zhao, GP (corresponding author), Chinese Univ Hong Kong, Prince Wales Hosp, Li Ka Shing Inst Hlth Sci, Shatin, Hong Kong 999077, Peoples R China.; Lyu, LD; Zhao, GP (corresponding author), Fudan Univ, Sch Basic Med Sci, Key Lab Med Mol Virol MOE NHC CAMS, Shanghai 200032, Peoples R China.; Lyu, LD; Zhao, GP (corresponding author), Fudan Univ, Sch Life Sci, Dept Microbiol & Microbial Engn, Shanghai 200032, Peoples R China.; Zhao, GP (corresponding author), Chinese Acad Sci, Shenzhen Inst Adv Technol, Inst Synthet Biol, Shenzhen 518055, Peoples R China.; Shao, ZH; Zhao, GP (corresponding author), Chinese Acad Sci, CAS Key Lab Synthet Biol, CAS Ctr Excellence Mol Plant Sci, Inst Plant Physiol & Ecol, Shanghai 200032, Peoples R China.; Zhi, XY (corresponding author), Yunnan Univ, Sch Life Sci, Yunnan Inst Microbiol, Kunming 650091, Yunnan, Peoples R China.; Zhao, GP (corresponding author), Chinese Acad Sci, CAS MPG Partner Inst Computat Biol, Key Lab Computat Biol,Shanghai Inst Nutr & Hlth, Univ Chinese Acad Sci,Shanghai Inst Biol Sci,Bio, Shanghai 200031, Peoples R China.; Zhao, GP (corresponding author), Chinese Natl Human Genome Ctr, Shanghai MOST Key Lab Hlth & Dis Genom, Shanghai 201203, Peoples R China.	xyzhi@ynu.edu.cn; zhshao@sibs.ac.cn; liangdong.lv@gmail.com; gpzhao@sibs.ac.cn	TAN, Wei/P-5814-2018; Lyu, Liangdong/C-6557-2014	TAN, Wei/0000-0002-7832-9338; Lyu, Liangdong/0000-0001-6391-6030; Zhao, Guo-Ping/0000-0002-7621-6620; Liao, Tianhua/0000-0002-4818-9346	National Natural Science Foundation of China [31430004, 31830002, 81671988, 91751000, 91951000, 91856112, 31970032, 81991532, 31800123]; Research Unit Fund of Li Ka Shing Institute of Health Sciences [7103506]; Hong Kong Health and Medical Research Fund [12110622]; National Key R&D Program of China [2019YFA0905100, 2018YFD0500900, 2017YFC1201200]; National Science and Technology Major Program of China [2018ZX10302301]; Strategic Priority Research Program of the Chinese Academy of Sciences [XDB19040200]; Key Research Program of the Chinese Academy of Sciences [KFZD-SW-219-5]; International Partnership Program of the Chinese Academy of Sciences [153D31KYSB20170121]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Research Unit Fund of Li Ka Shing Institute of Health Sciences; Hong Kong Health and Medical Research Fund; National Key R&D Program of China; National Science and Technology Major Program of China; Strategic Priority Research Program of the Chinese Academy of Sciences(Chinese Academy of Sciences); Key Research Program of the Chinese Academy of Sciences(Chinese Academy of Sciences); International Partnership Program of the Chinese Academy of Sciences	This work was supported by National Natural Science Foundation of China Grants 31430004, 31830002, 81671988, 91751000, and 91951000 (to G.-P. Z.), 91856112 (to Y. X.), 31970032 and 81991532 (to L.-D. L.), and 31800123; Research Unit Fund of Li Ka Shing Institute of Health Sciences Grant 7103506 (to G.-P. Z.); Hong Kong Health and Medical Research Fund Grant 12110622 (to G.-P. Z.); National Key R&D Program of China Grants 2019YFA0905100, 2018YFD0500900, and 2017YFC1201200; National Science and Technology Major Program of China Grant 2018ZX10302301 (to L.-D. L.); Strategic Priority Research Program of the Chinese Academy of Sciences Grant XDB19040200; Key Research Program of the Chinese Academy of Sciences Grant KFZD-SW-219-5; and International Partnership Program of the Chinese Academy of Sciences Grant 153D31KYSB20170121. The authors declare that they have no conflicts of interest with the contents of this article.	Aigrain L, 2012, INT J MOL SCI, V13, P15012, DOI 10.3390/ijms131115012; Amon J, 2010, FEMS MICROBIOL REV, V34, P588, DOI 10.1111/j.1574-6976.2010.00216.x; Anderson LJ, 2001, BIOCHEMISTRY-US, V40, P11294, DOI 10.1021/bi002706b; Asnicar F, 2015, PEERJ, V3, DOI 10.7717/peerj.1029; Bardarov S, 2002, MICROBIOL-SGM, V148, P3007, DOI 10.1099/00221287-148-10-3007; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Case ED, 2016, MICROBIOL SPECTR, V4, DOI 10.1128/microbiolspec.VMBF-0014-2015; Chen MH, 2017, P NATL ACAD SCI USA, V114, P4954, DOI 10.1073/pnas.1615585114; Chu SH, 2017, INT J BIOL MACROMOL, V101, P1019, DOI 10.1016/j.ijbiomac.2017.04.009; Crack JC, 2015, J BIOL CHEM, V290, P12689, DOI 10.1074/jbc.M115.643072; Devulder G, 2005, INT J SYST EVOL MICR, V55, P293, DOI 10.1099/ijs.0.63222-0; Eddy SR, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002195; Eichorst SA, 2018, ENVIRON MICROBIOL, V20, P1041, DOI 10.1111/1462-2920.14043; Flores E, 2005, PHOTOSYNTH RES, V83, P117, DOI 10.1007/s11120-004-5830-9; Fournier D, 2009, APPL ENVIRON MICROB, V75, P5088, DOI 10.1128/AEM.00418-09; Gangeswaran R, 1996, BIOCHEM J, V317, P103, DOI 10.1042/bj3170103; Gates AJ, 2008, BIOCHEM J, V409, P159, DOI 10.1042/BJ20071088; Gates AJ, 2011, BIOCHEM J, V435, P743, DOI 10.1042/BJ20101920; Gouzy A, 2014, NAT REV MICROBIOL, V12, P729, DOI 10.1038/nrmicro3349; Gray TA, 2013, GENOME ANNOUNCEMENTS, V1, DOI 10.1128/genomeA.00148-13; Gupta RS, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.00067; Hajjar C, 2017, MBIO, V8, DOI 10.1128/mBio.01487-17; HEDGECOCK LW, 1962, J BACTERIOL, V84, P195, DOI 10.1128/JB.84.2.195-205.1962; Huerta-Cepas J, 2016, MOL BIOL EVOL, V33, P1635, DOI 10.1093/molbev/msw046; Iino T, 2013, J BIOSCI BIOENG, V115, P600, DOI 10.1016/j.jbiosc.2012.12.005; Jenkins VA, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-301; Jessberger N., 2011, THESIS; JeSSberger Nadja, 2013, BMC Res Notes, V6, P482, DOI 10.1186/1756-0500-6-482; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Kawada Y, 2018, J BIOSCI BIOENG, V126, P301, DOI 10.1016/j.jbiosc.2018.03.018; Khan A, 2008, MICROB PATHOGENESIS, V44, P71, DOI 10.1016/j.micpath.2007.08.006; Khan A, 2006, MICROB PATHOGENESIS, V41, P90, DOI 10.1016/j.micpath.2006.04.006; Khoroshilova N, 1997, P NATL ACAD SCI USA, V94, P6087, DOI 10.1073/pnas.94.12.6087; Koppel N, 2018, ELIFE, V7, DOI [10.7554/eLife.33953, 10.7554/elife.33953]; Kuypers MMM, 2018, NAT REV MICROBIOL, V16, P263, DOI 10.1038/nrmicro.2018.9; Lessner FH, 2012, J BIOL CHEM, V287, P18510, DOI 10.1074/jbc.M111.331199; LIN JT, 1994, J BACTERIOL, V176, P2551, DOI 10.1128/JB.176.9.2551-2559.1994; Lin W, 2014, J BIOL CHEM, V289, P15413, DOI 10.1074/jbc.M113.543504; Lombard J, 2012, NAT REV MICROBIOL, V10, P507, DOI 10.1038/nrmicro2815; Mahillon J, 1998, MICROBIOL MOL BIOL R, V62, P725, DOI 10.1128/MMBR.62.3.725-774.1998; Maia LB, 2014, CHEM REV, V114, P5273, DOI 10.1021/cr400518y; Malm S, 2009, MICROBIOL-SGM, V155, P1332, DOI 10.1099/mic.0.023275-0; Mannisto MK, 2012, INT J SYST EVOL MICR, V62, P2097, DOI 10.1099/ijs.0.031864-0; McGoldrick HM, 2005, J BIOL CHEM, V280, P1086, DOI 10.1074/jbc.M411884200; Mignard S, 2008, INT J SYST EVOL MICR, V58, P1432, DOI 10.1099/ijs.0.65658-0; Moreno-Vivian C, 1999, J BACTERIOL, V181, P6573; Morozkina EV, 2007, BIOCHEMISTRY-MOSCOW+, V72, P1151, DOI 10.1134/S0006297907100124; Murataliev MB, 2004, BBA-PROTEINS PROTEOM, V1698, P1, DOI 10.1016/j.bbapap.2003.10.003; Myers MR, 2016, INT J SYST EVOL MICR, V66, P5328, DOI 10.1099/ijsem.0.001516; Narrandes N. C., 2013, THESIS; Netz DJA, 2010, NAT CHEM BIOL, V6, P758, DOI [10.1038/NCHEMBIO.432, 10.1038/nchembio.432]; Novoa EM, 2012, CELL, V149, P202, DOI 10.1016/j.cell.2012.01.050; OGAWA KI, 1995, J BACTERIOL, V177, P1409, DOI 10.1128/jb.177.5.1409-1413.1995; Olteanu H, 2003, J BIOL CHEM, V278, P38310, DOI 10.1074/jbc.M306282200; Parte AC, 2018, INT J SYST EVOL MICR, V68, P1825, DOI 10.1099/ijsem.0.002786; PIERIK AJ, 1992, EUR J BIOCHEM, V206, P697, DOI 10.1111/j.1432-1033.1992.tb16976.x; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Richardson DJ, 2001, CELL MOL LIFE SCI, V58, P165, DOI 10.1007/PL00000845; Sahraoui N, 2011, INT J SYST EVOL MICR, V61, P1870, DOI 10.1099/ijs.0.024851-0; Schulz S, 2016, FRONT BIOENG BIOTECH, V4, DOI 10.3389/fbioe.2016.00057; Shao ZH, 2011, ARCH MICROBIOL, V193, P463, DOI 10.1007/s00203-011-0690-0; Simtchouk S, 2013, FEBS J, V280, P6627, DOI 10.1111/febs.12567; Srivastava AP, 2017, BIOCHEMISTRY-US, V56, P5582, DOI 10.1021/acs.biochem.7b00025; Srivastava AP, 2013, BIOCHEMISTRY-US, V52, P4343, DOI 10.1021/bi400354n; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Stermann M, 2004, J BACTERIOL, V186, P2856, DOI 10.1128/JB.186.9.2856-2861.2004; Suy F, 2013, J CLIN MICROBIOL, V51, P3154, DOI 10.1128/JCM.00925-13; Tortoli E, 2012, INFECT GENET EVOL, V12, P827, DOI 10.1016/j.meegid.2011.05.025; Urlacher VB, 2019, TRENDS BIOTECHNOL, V37, P882, DOI 10.1016/j.tibtech.2019.01.001; Varghese B, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005288; Wang J, 2015, BIOCHEM BIOPH RES CO, V458, P605, DOI 10.1016/j.bbrc.2015.02.010; Wang Y, 2012, J BACTERIOL, V194, P5237, DOI 10.1128/JB.00989-12; Weber I, 2000, MOL MICROBIOL, V35, P1017, DOI 10.1046/j.1365-2958.2000.01794.x; Willistein M, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10078-3; Zhi XY, 2014, GENOME BIOL EVOL, V6, P149, DOI 10.1093/gbe/evu007	75	9	9	4	43	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 10	2020	295	15					5051	5066		10.1074/jbc.RA120.012859	http://dx.doi.org/10.1074/jbc.RA120.012859			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LE7FC	32111737	Green Published, hybrid			2022-12-26	WOS:000526887000026
J	Chen, JH				Chen, Jeng-Haur			Protein kinase A phosphorylation potentiates cystic fibrosis transmembrane conductance regulator gating by relieving autoinhibition on the stimulatory C terminus of the regulatory domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cystic fibrosis; cystic fibrosis transmembrane conductance regulator (CFTR); chloride channel; channel activation; phosphorylation	NUCLEOTIDE-BINDING DOMAIN; CFTR CHLORIDE CHANNEL; R-DOMAIN; CONFORMATIONAL-CHANGES; ACTIVATION; SITES; IDENTIFICATION; REGION; STATE	Cystic fibrosis transmembrane conductance regulator (CFTR) is a chloride channel activated by protein kinase A (PKA) phosphorylation on the regulatory (R) domain. Phosphorylation at several R domain residues stimulates ATP-dependent channel openings and closings, termed channel gating. To explore the protein segment responsible for channel potentiation and PKA-dependent activation, deletion mutations were constructed by removing one to three protein segments of the R domain including residues 708?759 (?R-708?759), R-760?783, and R-784?835, each of which contains one or two PKA phosphorylation sites. Deletion of R-708?759 or R-760?783 had little effect on CFTR gating, whereas all mutations lacking R-784?835 reduced CFTR activity by decreasing the mean burst duration and increasing the interburst interval (IBI). The data suggest that R-784?835 plays a major role in stimulating CFTR gating. For ATP-associated regulation, ?R-784?835 had minor impact on gating potentiation by 2?dATP, CaATP, and pyrophosphate. Interestingly, introducing a phosphorylated peptide matching R-809?835 shortened the IBI of ?R-708?835-CFTR. Consistently, ?R-815?835, but not ?R-784?814, enhanced IBI, whereas both reduced mean burst duration. These data suggest that the entirety of R-784?835 is required for stabilizing the open state of CFTR; however, R-815?835, through interactions with the channel, is dominant for enhancing the opening rate. Of note, PKA markedly decreased the IBI of ?R-708?783-CFTR. Conversely, the IBI of ?R-708?814?CFTR was short and PKA-independent. These data reveal that for stimulating CFTR gating, PKA phosphorylation may relieve R-784?814?mediated autoinhibition that prevents IBI shortening by R-815?835. This mechanism may elucidate how the R domain potentiates channel gating and may unveil CFTR stimulation by other protein kinases.	[Chen, Jeng-Haur] Zhejiang Normal Univ, Coll Chem & Life Sci, 688 Yingbin Rd, Jinhua 321004, Zhejiang, Peoples R China; [Chen, Jeng-Haur] Univ Hong Kong, Shenzhen Inst Res & Innovat, Shenzhen 518057, Peoples R China; [Chen, Jeng-Haur] Univ Iowa, Roy J & Lucille A Carver Coll Med, Dept Internal Med, Iowa City, IA 52242 USA; [Chen, Jeng-Haur] Univ Iowa, Roy J & Lucille A Carver Coll Med, Howard Hughes Med Inst, Iowa City, IA 52242 USA; [Chen, Jeng-Haur] Univ Iowa, Howard Hughes Med Inst, Prof Michael J Welshs Lab, Iowa City, IA 52242 USA	Zhejiang Normal University; University of Hong Kong; University of Iowa; Howard Hughes Medical Institute; University of Iowa; Howard Hughes Medical Institute; University of Iowa	Chen, JH (corresponding author), Zhejiang Normal Univ, Coll Chem & Life Sci, 688 Yingbin Rd, Jinhua 321004, Zhejiang, Peoples R China.	jeng-haur-chen@zjnu.edu.cn	Chen, Jeng-Haur/E-1483-2011	Chen, Jeng-Haur/0000-0001-6756-6939	Hong Kong Research Grant Council [ECS HKU789713M, GRF 17106315]; National Natural Science Foundation of China [31370765, 81570001]	Hong Kong Research Grant Council(Hong Kong Research Grants Council); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by Hong Kong Research Grant Council Grants ECS HKU789713M and GRF 17106315 and National Natural Science Foundation of China Grants 31370765 and 81570001. The author declares that he has no conflicts of interest with the contents of this article.	Aleksandrov AA, 2002, FEBS LETT, V518, P183, DOI 10.1016/S0014-5793(02)02698-4; Auerbach A, 2013, J MOL BIOL, V425, P1461, DOI 10.1016/j.jmb.2013.01.027; Baker JMR, 2007, NAT STRUCT MOL BIOL, V14, P738, DOI 10.1038/nsmb1278; Baldursson O, 2001, J BIOL CHEM, V276, P1904, DOI 10.1074/jbc.M006934200; Basso C, 2003, J GEN PHYSIOL, V122, P333, DOI 10.1085/jgp.200308798; Billet A, 2015, FASEB J, V29, P3945, DOI 10.1096/fj.15-273151; Bompadre SG, 2005, J GEN PHYSIOL, V125, P361, DOI 10.1085/jgp.200409227; Bozoky Z, 2013, P NATL ACAD SCI USA, V110, pE4427, DOI 10.1073/pnas.1315104110; Burgers PP, 2016, FEBS J, V283, P2132, DOI 10.1111/febs.13726; CARSON MR, 1995, J BIOL CHEM, V270, P1711, DOI 10.1074/jbc.270.4.1711; CHANG XB, 1993, J BIOL CHEM, V268, P11304; Chappe V, 2005, EMBO J, V24, P2730, DOI 10.1038/sj.emboj.7600747; Chappe V, 2004, P NATL ACAD SCI USA, V101, P390, DOI 10.1073/pnas.0303411101; Chen JH, 2017, J PHYSIOL-LONDON, V595, P1059, DOI 10.1113/JP273205; Chen JH, 2009, J BIOL CHEM, V284, P35495, DOI 10.1074/jbc.M109.072678; Cotten JF, 1997, J BIOL CHEM, V272, P25617, DOI 10.1074/jbc.272.41.25617; Csanady L, 2005, J GEN PHYSIOL, V125, P171, DOI 10.1085/jgp.200409076; Csanady L, 2000, J GEN PHYSIOL, V116, P477, DOI 10.1085/jgp.116.3.477; Csanady L, 2019, PHYSIOL REV, V99, P707, DOI 10.1152/physrev.00007.2018; FRENCH PJ, 1995, J BIOL CHEM, V270, P26626, DOI 10.1074/jbc.270.44.26626; Grimard V, 2004, J BIOL CHEM, V279, P5528, DOI 10.1074/jbc.M311014200; Hegedus T, 2009, BBA-BIOMEMBRANES, V1788, P1341, DOI 10.1016/j.bbamem.2009.03.015; Hwang TC, 2018, J GEN PHYSIOL, V150, P539, DOI 10.1085/jgp.201711946; Hwang TC, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a009498; Ikuma M, 2000, P NATL ACAD SCI USA, V97, P8675, DOI 10.1073/pnas.140220597; Jih KY, 2012, J GEN PHYSIOL, V139, P359, DOI 10.1085/jgp.201210789; Kitchen J, 2008, BMC STRUCT BIOL, V8, DOI 10.1186/1472-6807-8-19; Li CH, 1996, J BIOL CHEM, V271, P28463, DOI 10.1074/jbc.271.45.28463; Liu FY, 2017, CELL, V169, P85, DOI 10.1016/j.cell.2017.02.024; Mense M, 2006, EMBO J, V25, P4728, DOI 10.1038/sj.emboj.7601373; Ostedgaard LS, 2000, P NATL ACAD SCI USA, V97, P5657, DOI 10.1073/pnas.100588797; Ostedgaard LS, 2001, J BIOL CHEM, V276, P7689, DOI 10.1074/jbc.R100001200; RICH DP, 1991, SCIENCE, V253, P205, DOI 10.1126/science.1712985; RICH DP, 1993, J BIOL CHEM, V268, P20259; RIORDAN JR, 1989, SCIENCE, V245, P1066; Scott-Ward TS, 2007, P NATL ACAD SCI USA, V104, P16365, DOI 10.1073/pnas.0701562104; SEIBERT FS, 1995, J BIOL CHEM, V270, P2158, DOI 10.1074/jbc.270.5.2158; Vais H, 2004, AM J PHYSIOL-CELL PH, V287, pC737, DOI 10.1152/ajpcell.00504.2003; VENGLARIK CJ, 1994, J GEN PHYSIOL, V104, P123, DOI 10.1085/jgp.104.1.123; Vergani P, 2005, NATURE, V433, P876, DOI 10.1038/nature03313; Wang GY, 2010, J BIOL CHEM, V285, P40438, DOI 10.1074/jbc.M110.161497; Wang GY, 2011, J BIOL CHEM, V286, P2171, DOI 10.1074/jbc.M110.145540; Wilkinson DJ, 1997, AM J PHYSIOL-LUNG C, V273, pL127, DOI 10.1152/ajplung.1997.273.1.L127; Winter MC, 1997, NATURE, V389, P294, DOI 10.1038/38514; Xie JX, 2002, J BIOL CHEM, V277, P23019, DOI 10.1074/jbc.M201661200; Zhang Z, 2018, P NATL ACAD SCI USA, V115, P12757, DOI 10.1073/pnas.1815287115; Zhang Z, 2017, CELL, V170, P483, DOI 10.1016/j.cell.2017.06.041	47	2	2	2	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 3	2020	295	14					4577	4590		10.1074/jbc.RA119.008427	http://dx.doi.org/10.1074/jbc.RA119.008427			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LB2WZ	32102849	Green Published, hybrid			2022-12-26	WOS:000524499700018
J	He, J; Chua, EL; Qin, L				He, Jie; Chua, Ee Lyn; Qin, Lin			Drought does not induce crassulacean acid metabolism (CAM) but regulates photosynthesis and enhances nutritional quality of Mesembryanthemum crystallinum	PLOS ONE			English	Article							LACTUCA-SATIVA L.; COMMON ICE PLANT; CHLOROPHYLL FLUORESCENCE; IMPROVING PHOTOSYNTHESIS; ANTIOXIDANT ACTIVITY; STRESS; GROWTH; SALINITY; WATER; RESPONSES	Physiology and nutritional quality of a facultative CAM plant Mesembryanthemum crystallinum under drought stress alone are poorly understood. To induce drought, M. crystallinum was cultured aeroponically with different nutrient spraying intervals such as 5, 30, 60 and 240 min. The long spraying interval such as 240 min resulted in lower mass of root and shoot, shorter total root length with less tips and smaller surface area, compared to short interval of 5 min. Grown under the longest spraying interval of 240 min, M. crystallinumalso had significantly higher leaf dry matter content but lower leaf succulence. However, CAM acidity was undetectable for any plants. Although M. crystallinum grown under extended spraying intervals had higher photosynthetic pigments, they utilized lesser light energy and did not dissipate heat as effectively as those grown under 5 min. Compare to other shorter spraying intervals, photosynthetic gas exchange rates were significantly reduced under 240 min spraying interval, indicating signs of water deficit stress. Shoot nitrate, total reduced nitrogen, total soluble protein and Rubisco concentrations were similar for all plants. For phytochemicals and dietary minerals, plants grown under 240 min spraying interval had significantly higher values than the other plants. Therefore, drought does not result in the induction of CAM but regulates photosynthetic performance and enhances nutritional quality of M. crystallinum.	[He, Jie; Chua, Ee Lyn; Qin, Lin] Nanyang Technol Univ, Natl Inst Educ, Singapore, Singapore	Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; National Institute of Education (NIE) Singapore	He, J (corresponding author), Nanyang Technol Univ, Natl Inst Educ, Singapore, Singapore.	jie.he@nie.edu.sg	He, jie/AAB-1279-2020	He, Jie/0000-0002-7398-697X	Nanyang Technological University, the Academic Research Fund (NTU AcRF Tier 1), Singapore [RP 1/18 HJ]; National Institute of Education, Nanyang Technological University, Singapore	Nanyang Technological University, the Academic Research Fund (NTU AcRF Tier 1), Singapore; National Institute of Education, Nanyang Technological University, Singapore(Nanyang Technological University)	Jie HE and Lin Qin was funded by Nanyang Technological University, the Academic Research Fund (NTU AcRF Tier 1, RP 1/18 HJ), Singapore while Ee Lyn Chua was supported by teaching materials' vote of National Institute of Education, Nanyang Technological University, Singapore.	Adams P, 1998, NEW PHYTOL, V138, P171, DOI 10.1046/j.1469-8137.1998.00111.x; Agarie S, 2009, PLANT PROD SCI, V12, P37, DOI 10.1626/pps.12.37; Agarie S, 2007, J EXP BOT, V58, P1957, DOI 10.1093/jxb/erm057; Ahmad P, 2012, ENV ADAPTATIONS STRE, DOI [10.1007/978-1-4614-0815-4, DOI 10.1007/978-1-4614-0815-4]; Ashrafi M, 2018, PLANT PHYSIOL BIOCH, V132, P391, DOI 10.1016/j.plaphy.2018.09.009; Atzori G, 2017, AGR WATER MANAGE, V187, P37, DOI 10.1016/j.agwat.2017.03.020; Banks JM, 2018, ENVIRON EXP BOT, V155, P118, DOI 10.1016/j.envexpbot.2018.06.022; BATES LS, 1973, PLANT SOIL, V39, P205, DOI 10.1007/BF00018060; BLOOM AJ, 1979, PLANT PHYSIOL, V63, P749, DOI 10.1104/pp.63.4.749; Bocchini M, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00514; Bohnert HJ, 1999, SCI HORTIC-AMSTERDAM, V78, P237; Bohnert HJ, 2000, J PLANT GROWTH REGUL, V19, P334, DOI 10.1007/s003440000033; Borland AM, 1998, PLANTA, V205, P342, DOI 10.1007/s004250050329; Bose J, 2014, J EXP BOT, V65, P1241, DOI 10.1093/jxb/ert430; Bouftira I., 2012, International Journal of Research in Pharmaceutical and Biomedical Sciences, V3, P1038; Brandt K, 2004, TRENDS FOOD SCI TECH, V15, P384, DOI 10.1016/j.tifs.2003.12.003; Ciriaco da Silva E., 2010, PLANT STRESS, V5, P32; Comas LH, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00442; Cushman JC, 2001, PLANT PHYSIOL, V127, P1439, DOI 10.1104/pp.010818; da Silva JM, 2004, PHYSIOL PLANTARUM, V121, P409, DOI 10.1111/j.1399-3054.2004.00328.x; Douglas JM, 1979, ADV GUIDE HYDROPONIC, P172; DUBOIS M, 1956, ANAL CHEM, V28, P350, DOI 10.1021/ac60111a017; Epstein E, 1999, ANNU REV PLANT PHYS, V50, P641, DOI 10.1146/annurev.arplant.50.1.641; Farooq M, 2009, SUSTAINABLE AGRICULTURE, P153, DOI 10.1051/agro:2008021; Flowers TJ, 2004, J EXP BOT, V55, P307, DOI 10.1093/jxb/erh003; Garnier E, 2001, FUNCT ECOL, V15, P688, DOI 10.1046/j.0269-8463.2001.00563.x; Gharibi S, 2016, APPL BIOCHEM BIOTECH, V178, P796, DOI 10.1007/s12010-015-1909-3; Gomes Mara de Menezes de Assis, 2004, Braz. J. Plant Physiol., V16, P155, DOI 10.1590/S1677-04202004000300005; HAVAUX M, 1992, PLANT PHYSIOL, V100, P424, DOI 10.1104/pp.100.1.424; He J, 2011, PHOTOSYNTHETICA, V49, P209, DOI 10.1007/s11099-011-0023-1; He J, 2001, J EXP BOT, V52, P1323, DOI 10.1093/jexbot/52.359.1323; He J, 2010, PLANT STRESS, V4, P14; He J, 2009, THEORY APPL ENERGY B, P111; He J, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.00361; He Jie, 2016, American Journal of Plant Sciences, V7, P1993; Herppich WB, 2008, J APPL BOT FOOD QUAL, V82, P47; HERRERA A, 1991, J EXP BOT, V42, P493, DOI 10.1093/jxb/42.4.493; Hodgson JG, 2011, ANN BOT-LONDON, V108, P1337, DOI 10.1093/aob/mcr225; Hunt R, 2002, ANN BOT-LONDON, V90, P485, DOI 10.1093/aob/mcf214; Jaleel CA, 2009, INT J AGRIC BIOL, V11, P100; Jie H, 1998, J PLANT PHYSIOL, V152, P387, DOI 10.1016/S0176-1617(98)80252-6; 차미경, 2014, [Protected Horticulture and Plant Factory, 시설원예‧식물공장], V23, P371; Klepper B., 1990, Agronomy, P281; Kromdijk J, 2016, SCIENCE, V354, P857, DOI 10.1126/science.aai8878; Ksouri R, 2007, PLANT PHYSIOL BIOCH, V45, P244, DOI 10.1016/j.plaphy.2007.02.001; Kumari A, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00537; Leipner J, 1997, PLANT CELL ENVIRON, V20, P366, DOI 10.1046/j.1365-3040.1997.d01-76.x; Li YB, 2019, AGR WATER MANAGE, V211, P190, DOI 10.1016/j.agwat.2018.09.050; Lokhande V.H., 2012, ENV ADAPTATIONS STRE, P29, DOI DOI 10.1007/978-1-4614-0815-4_2; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Luttge U, 2004, ANN BOT-LONDON, V93, P629, DOI 10.1093/aob/mch087; Mathobo R, 2017, AGR WATER MANAGE, V180, P118, DOI 10.1016/j.agwat.2016.11.005; Millard P., 1998, PLANT CELL ENVIRON, V11, P1, DOI DOI 10.1111/J.1365-3040.1988.TB01769.X; Netto AT, 2005, SCI HORTIC-AMSTERDAM, V104, P199, DOI 10.1016/j.scienta.2004.08.013; Niu J, 2018, J PLANT PHYSIOL, V224, P30, DOI 10.1016/j.jplph.2018.03.001; Nouraei S, 2018, SCI HORTIC-AMSTERDAM, V233, P378, DOI 10.1016/j.scienta.2017.12.060; Oh DH, 2015, NEW PHYTOL, V207, P627, DOI 10.1111/nph.13414; OLIVARES E, 1984, OECOLOGIA, V61, P358, DOI 10.1007/BF00379635; Park KS, 2016, HORTIC ENVIRON BIOTE, V57, P259, DOI 10.1007/s13580-016-0027-7; Parry MAJ, 2013, J EXP BOT, V64, P717, DOI 10.1093/jxb/ers336; PAUL MJ, 1989, J EXP BOT, V40, P1093, DOI 10.1093/jxb/40.10.1093; Pottier M, 2018, TRENDS PLANT SCI, V23, P382, DOI 10.1016/j.tplants.2018.02.006; Qin L, 2007, J EXP BOT, V58, P3017, DOI 10.1093/jxb/erm156; Ragaee S, 2006, FOOD CHEM, V98, P32, DOI 10.1016/j.foodchem.2005.04.039; Rahbarian R, 2011, ACTA BIOL CRACOV BOT, V53, P47, DOI 10.2478/v10182-011-0007-2; Reddy AR, 2004, J PLANT PHYSIOL, V161, P1189, DOI 10.1016/j.jplph.2004.01.013; Slesak I, 2002, PLANT PHYSIOL BIOCH, V40, P669, DOI 10.1016/S0981-9428(02)01409-2; Smirnoff N, 1996, ANN BOT-LONDON, V78, P661, DOI 10.1006/anbo.1996.0175; Stephenson PG, 2011, TRENDS BIOTECHNOL, V29, P615, DOI 10.1016/j.tibtech.2011.06.005; Tan LP, 2002, J PLANT NUTR, V25, P297, DOI 10.1081/PLN-100108837; TAY S, 2019, BOT STUD, V60, P96253, DOI DOI 10.1186/S40529-018-0249-3; THOMAS JC, 1993, PLANT PHYSIOL, V103, P1299, DOI 10.1104/pp.103.4.1299; Wang BS, 2004, J PLANT PHYSIOL, V161, P285, DOI 10.1078/0176-1617-01123; WEBBER AN, 1994, PHOTOSYNTH RES, V39, P413, DOI 10.1007/BF00014595; WELLBURN AR, 1994, J PLANT PHYSIOL, V144, P307, DOI 10.1016/S0176-1617(11)81192-2; WINTER K, 1982, PLANT PHYSIOL, V69, P300, DOI 10.1104/pp.69.2.300; Winter K, 1972, Z PFLANZENPHYSIOL, V67, P66, DOI [10.1016/S0044-328X(72)80131-4, DOI 10.1016/S0044-328X(72)80131-4]; Winter K, 2014, J EXP BOT, V65, P3425, DOI 10.1093/jxb/eru063; Winter K, 2011, J EXP BOT, V62, P4037, DOI 10.1093/jxb/err106; Wullschleger S, 2005, CAN J FOREST RES, V35, P1779, DOI 10.1139/x05-101; Zhang MingCai, 2004, "New Directions for a Diverse Planet", 4th International Crop Science Congress in conjunction with the 12th Australian Agronomy Conference and the 5th Asian Crop Science Conference, 26 September - 1 October 2004, Brisbane, Australia, P575	81	7	7	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2020	15	3							e0229897	10.1371/journal.pone.0229897	http://dx.doi.org/10.1371/journal.pone.0229897			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8TR	32142525	Green Published, gold			2022-12-26	WOS:000535271600022
J	Tokuhara, T; Nakata, E; Tenjo, T; Kawai, I; Kondo, K; Hatabe, S				Tokuhara, Takaya; Nakata, Eiji; Tenjo, Toshiyuki; Kawai, Isao; Kondo, Keisaku; Hatabe, Shigeru			Modified delta-shaped gastroduodenostomy consisting of linear stapling and single-layer suturing with the operator positioned between the patient's legs: A technique preventing intraoperative duodenal injury and postoperative anastomotic stenosis	PLOS ONE			English	Article							LAPAROSCOPIC DISTAL GASTRECTOMY; GASTRIC-CANCER; SURGICAL OUTCOMES; Y RECONSTRUCTION; HAND-SEWN; OPTION	Background The drawback of the delta-shaped gastroduodenostomy (DSG) in totally laparoscopic distal gastrectomy (TLDG) is the presence of intraoperative duodenal injury and postoperative anastomotic stenosis, which can occur due to a relatively short duodenal bulb diameter. Materials and methods From June 2013 to June 2019, 35 patients with gastric cancer underwent TLDG with a modified DSG consisting of linear stapling and single-layer hand suturing in our institution. All anastomotic procedures were performed by the right hand of the operator positioned between the patient's legs. Linear stapling of the posterior walls of the remnant stomach and duodenum without creating a gap was performed using a 45-mm linear stapler, considering the prevention of intraoperative duodenal injury. The stapler entry hole was closed using a single-layer full-thickness hand suturing technique with knotted sutures and a knotless barbed suture. We described the clinical data and outcomes in the present retrospective patient series. Results No intraoperative duodenal injury occurred in any of the 35 patients. The median staple length at linear stapling of the posterior walls of the remnant stomach and duodenum was 41.7 +/- 4.2 (30-45) mm, and 2 patients (5.7%) had a staple length of 30 mm. There were no incidences of postoperative anastomotic stenosis. Conclusions We suggest that a modified DSG consisting of linear stapling and single-layer hand suturing performed by an operator positioned between the patient's legs can be one option for B-vertical bar reconstruction following TLDG because it can aid in preventing both intraoperative duodenal injury and postoperative anastomotic stenosis.	[Tokuhara, Takaya; Nakata, Eiji; Tenjo, Toshiyuki; Kawai, Isao; Kondo, Keisaku; Hatabe, Shigeru] Otori Stomach & Intestines Hosp, Dept Surg, Osaka, Japan		Tokuhara, T (corresponding author), Otori Stomach & Intestines Hosp, Dept Surg, Osaka, Japan.	sur123@osaka-med.ac.jp						Bendewald FP, 2011, OBES SURG, V21, P1671, DOI 10.1007/s11695-011-0470-6; Bouras G, 2011, SURG LAPARO ENDO PER, V21, P37, DOI 10.1097/SLE.0b013e3182073fdb; Dindo D, 2004, ANN SURG, V240, P205, DOI 10.1097/01.sla.0000133083.54934.ae; Ikeda O, 2009, SURG ENDOSC, V23, P2374, DOI 10.1007/s00464-009-0360-3; Japanese Gastr Canc Assoc, 2021, GASTRIC CANCER, V24, P1, DOI [10.1007/s10120-020-01042-y, 10.1007/s10120-016-0622-4]; Japanese Gastric Canc Assoc, 2011, GASTRIC CANCER, V14, P101, DOI 10.1007/s10120-011-0041-5; Jeong O, 2015, SURG ENDOSC, V29, P1522, DOI 10.1007/s00464-014-3836-8; Kanaya S, 2002, J AM COLL SURGEONS, V195, P284, DOI 10.1016/S1072-7515(02)01239-5; Kanaya S, 2011, GASTRIC CANCER, V14, P365, DOI 10.1007/s10120-011-0054-0; Kim DG, 2013, SURG ENDOSC, V27, P3153, DOI 10.1007/s00464-013-2869-8; Kim JJ, 2008, SURG ENDOSC, V22, P436, DOI 10.1007/s00464-007-9446-y; Kim MG, 2011, WORLD J SURG, V35, P1327, DOI 10.1007/s00268-011-1034-6; Kim MG, 2011, SURG ENDOSC, V25, P1076, DOI 10.1007/s00464-010-1319-0; Kinoshita T, 2011, SURG ENDOSC, V25, P1395, DOI 10.1007/s00464-010-1402-6; Lee HH, 2015, SURG ENDOSC, V29, P2545, DOI 10.1007/s00464-014-3966-z; Lee SW, 2012, WORLD J SURG ONCOL, V10, DOI 10.1186/1477-7819-10-267; Leyba JL, 2008, JSLS-J SOC LAPAROEND, V12, P385; Noshiro H, 2011, GASTRIC CANCER, V14, P385, DOI 10.1007/s10120-011-0082-9; Okabe H, 2014, ANN SURG, V259, P109, DOI 10.1097/SLA.0b013e31828dfa5d; Song KY, 2008, J GASTROINTEST SURG, V12, P1015, DOI 10.1007/s11605-008-0484-0; Takaori K, 2005, AM J SURG, V189, P178, DOI 10.1016/j.amjsurg.2004.09.008; Takiguchi S, 2003, SURG TODAY, V33, P371, DOI 10.1007/s005950300084; Tokuhara T, 2018, ONCOL LETT, V15, P229, DOI 10.3892/ol.2017.7306; Tokuhara T, 2017, MOL CLIN ONCOL, V6, P483, DOI 10.3892/mco.2017.1191	24	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2020	15	3							e0230113	10.1371/journal.pone.0230113	http://dx.doi.org/10.1371/journal.pone.0230113			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8TR	32142547	Green Published, gold			2022-12-26	WOS:000535271600039
J	Gstohl, U; Pfenninger, S				Gstohl, Ursin; Pfenninger, Stefan			Energy self-sufficient households with photovoltaics and electric vehicles are feasible in temperate climate	PLOS ONE			English	Article							BATTERY STORAGE; PV; SYSTEM; HYDROGEN; OPTIMIZATION; CONSUMPTION; MODELS; COSTS	The idea that households produce and consume their own energy, that is, energy self-sufficiency at a very local level, captures the popular imagination and commands political support across parts of Europe. This paper investigates the technical and economic feasibility of household energy self-sufficiency in Switzerland, which can be seen as representative for other regions with a temperate climate, by 2050. We compare sixteen cases that vary across four dimensions: household type, building type, electricity demand reduction, and passenger vehicle use patterns. We assume that photovoltaic (PV) electricity supplies all energy, which implies a complete shift away from fossil fuel based heating and internal combustion engine vehicles. Two energy storage technologies are considered: short-term storage in lithium-ion batteries and long-term storage with hydrogen, requiring an electrolyzer, storage tank, and a fuel cell for electricity conversion. We examine technological feasibility and total system costs for self-sufficient households compared to base cases that rely on fossil fuels and the existing power grid. PV efficiency and available rooftop/facade area are most critical with respect to the overall energy balance. Single-family dwellings with profound electricity demand reduction and urban mobility patterns achieve self-sufficiency most easily. Multi-family buildings with conventional electricity demand and rural mobility patterns can only be self-sufficient if PV efficiency increases, and all of the roof plus most of the facade can be covered with PV. All self-sufficient cases are technically feasible but more expensive than fully electrified grid-connected cases. Self-sufficiency may even become cost-competitive in some cases depending on storage and fossil fuel prices. Thus, if political measures improve their financial attractiveness or individuals decide to shoulder the necessary investments, self-sufficient buildings may start to become increasingly prevalent.	[Gstohl, Ursin; Pfenninger, Stefan] Swiss Fed Inst Technol, Inst Environm Decis, Climate Policy Grp, Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich	Gstohl, U; Pfenninger, S (corresponding author), Swiss Fed Inst Technol, Inst Environm Decis, Climate Policy Grp, Zurich, Switzerland.	ugstoehl@student.ethz.ch; stefan.pfenninger@usys.ethz.ch		Pfenninger, Stefan/0000-0002-8420-9498	Swiss Competence Center for Energy Research -Supply of Electricity (SCCER SoE) [1155002546]; Swiss Competence Center for Energy Research - Supply of Electricity (SCCER SoE) [1155002546]	Swiss Competence Center for Energy Research -Supply of Electricity (SCCER SoE); Swiss Competence Center for Energy Research - Supply of Electricity (SCCER SoE)	SP acknowledges funding from the Swiss Competence Center for Energy Research -Supply of Electricity (SCCER SoE), contract number 1155002546. http://sccer-soe.ch/.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Anthony Patt for helpful comments on developing the grid-connected cases. Stefan Pfenninger acknowledges funding from the Swiss Competence Center for Energy Research - Supply of Electricity (SCCER SoE), contract number 1155002546.	[Anonymous], 2018, ENERGIESCHWEIZ; [Anonymous], 2017, THESIS; ARE, 2006, ERG SOND MIKR 2000 Z; ARE, 2016, PERSP SCHWEIZ PERS G; Assouline D., 2016, SOLAR PHOTOVOLTAIC E; Bauer C., 2017, POTENTIALS COSTS ENV; Baumann T, 2017, STUDIE SOLARSPAR; Baumgartner F, 2017, WOODHEAD PUBL SER EN, P135, DOI 10.1016/B978-1-78242-336-2.00005-7; Beccali M, 2013, APPL ENERG, V102, P534, DOI 10.1016/j.apenergy.2012.08.037; Buffat R, 2018, APPL ENERG, V216, P389, DOI 10.1016/j.apenergy.2018.02.008; CH2014-Impacts, 2014, QUANTITATIVE SCENARI; Coady D, 2017, WORLD DEV, V91, P11, DOI 10.1016/j.worlddev.2016.10.004; Council Federal, 2019, FED COUNC CLIM REUTR; Council Federal, 2013, GEORD AUSST AT AT; Dijk M, 2013, ENERG POLICY, V52, P135, DOI 10.1016/j.enpol.2012.04.024; DWD, 2018, KLIM AUSG WETT; EBP, 2015, PREIS LUFT WASS WARM; EBP, 2018, SZEN EL SCHWEIZ UPD; EL-Shimy M., 2017, 5 INT C EL EL INF EN; Energieheld, 2018, GASH VORT NACHT PREI; Energieheld, 2018, KLIM PREIS GANG MOD; Erhorn H, 2014, CONCERTED ACTION ENE; FDFA, 2017, SWISS PLAT; FOEN, 2018, IMPL PAR AGR; FSO, 2017, FAM SCHWEIZ; FSO, 2017, POP TRANSP BEH 2015, P15; FSO, 2018, BAU WOHN 2016; Good C, 2015, SOL ENERGY, V122, P986, DOI 10.1016/j.solener.2015.10.013; Green MA, 2018, PROG PHOTOVOLTAICS, V26, P427, DOI 10.1002/pip.3040; Groger O, 2015, J ELECTROCHEM SOC, V162, pA2605, DOI 10.1149/2.0211514jes; Grosspietsch D, 2018, SUPPORTING INFORM; Grosspietsch D, 2018, ENVIRON SCI TECHNOL, V52, P2339, DOI 10.1021/acs.est.7b02686; GSEE, 2019, GSEE GLOB SOL EN EST; Guney MS, 2017, RENEW SUST ENERG REV, V75, P1187, DOI 10.1016/j.rser.2016.11.102; Hernandez-Moro J, 2013, RENEW SUST ENERG REV, V20, P119, DOI 10.1016/j.rser.2012.11.082; Hoval, 2018, WIE VIEL STROM BEN T; IEA, 2015, TRENDS 2015 PHOTOVOL; IEA, 2017, GLOBAL EV OUTLOOK 20; IEA, 2014, HYDR PROD DISTR; Janek J, 2016, NAT ENERGY, V1, DOI [10.1038/NENERGY.2016.141, 10.1038/nenergy.2016.141]; Kalinci Y, 2015, INT J HYDROGEN ENERG, V40, P7652, DOI 10.1016/j.ijhydene.2014.10.147; Klauser D., 2016, SOLARPOTENTIALANALYS; Laurischkat K, 2016, PROC CIRP, V47, P483, DOI 10.1016/j.procir.2016.03.042; Lorenzi G, 2016, APPL ENERG, V180, P524, DOI 10.1016/j.apenergy.2016.07.103; Luo J, 2015, GEOTHERMICS, V53, P57, DOI 10.1016/j.geothermics.2014.04.004; Marchenko OV, 2015, INT J HYDROGEN ENERG, V40, P3801, DOI 10.1016/j.ijhydene.2015.01.132; Margelou S., 2015, THESIS; Maroufmashat A, 2016, INT J HYDROGEN ENERG, V41, P7700, DOI 10.1016/j.ijhydene.2015.08.038; McKenna R, 2017, APPL ENERG, V189, P800, DOI 10.1016/j.apenergy.2016.03.062; Milan C, 2012, ENERGY, V48, P118, DOI 10.1016/j.energy.2012.05.034; Miotti M, 2017, INT J LIFE CYCLE ASS, V22, P94, DOI 10.1007/s11367-015-0986-4; Muller J, 2019, ENERGY, V171, P135, DOI 10.1016/j.energy.2018.12.139; Murray P, 2018, APPL ENERG, V231, P1285, DOI 10.1016/j.apenergy.2018.08.106; Nipkow J., 2013, TYPISCHER HAUSHALT S, P29; Nykvist B, 2015, NAT CLIM CHANGE, V5, P329, DOI 10.1038/nclimate2564; Patt A, 2019, TRANSPORT RES A-POL, V125, P1, DOI 10.1016/j.tra.2019.05.004; Phillips R., 2010, WARMEPUMPEN HAUFIG G; Prognos, 2012, EN SCHWEIZ BIS 2050; Sarbu I, 2014, ENERG BUILDINGS, V70, P441, DOI 10.1016/j.enbuild.2013.11.068; SFOE, 2018, SCHWEIZ EL 2017; SFOE, 2016, SONN BER POT GEM; SFOE, 2015, KOMB WP SONN THEOR P; Sharaf OZ, 2014, RENEW SUST ENERG REV, V32, P810, DOI 10.1016/j.rser.2014.01.012; Smolinka T, 2011, NOW STUDIE; Solarpreis, 2017, SCHWEIZ SOL; Solarpreis, 2018, SCHWEIZ SOL; Solarpreis, 2016, SCHWEIZ SOL; Swissolar, 2016, PV ANL BATT; Tesla, 2018, POW IHR STROMSP; Thomas D., 2016, POWER TO GAS ROADMAP; Trondle T, 2019, ENERGY STRATEG REV, V26, DOI 10.1016/j.esr.2019.100388; Umweltarena, 2018, THEM 8 WARM; Umweltarena, 2018, THEM 5 LANGZ STROM; Umweltarena, 2018, THEM 4 KURZZ STORM; Umweltarena, 2018, THEM 1 STROM PROD DA; Weniger J, 2014, ENRGY PROCED, V46, P78, DOI 10.1016/j.egypro.2014.01.160; Zhang Y, 2017, APPL ENERG, V201, P397, DOI 10.1016/j.apenergy.2017.03.123	78	7	7	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2020	15	3							e0227368	10.1371/journal.pone.0227368	http://dx.doi.org/10.1371/journal.pone.0227368			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8QU	32130215	gold, Green Published			2022-12-26	WOS:000535264000004
J	Wang, H; Cui, RF; Long, CQ				Wang, Hong; Cui, Ruifang; Long, Changquan			P3a amplitude is related to conclusion specificity during category-based induction	PLOS ONE			English	Article							EVENT-RELATED POTENTIALS; PRIOR PROBABILITIES; NEGATIVITY; MODULATION; MECHANISMS; REPETITION; ATTENTION; SURPRISE; INDEXES; NOVELTY	Category-based induction involves the generalization of a novel property (conclusion property) to a new category (conclusion category), based on the knowledge that a category exemplar (premise category) has the respective novel property. Previous studies have shown that conclusion specificity (i.e., specific [S] or generic categories [G]) influences category-based induction. However, the timing of brain activity underlying this effect is not well known, especially with controlling the similarities of premise and conclusion categories between S and G arguments. In this study, the event-related potential (ERP) responses to category-based induction between S and G arguments were compared under both congruent (+, premise and conclusion categories are related) and incongruent (-, premise and conclusion categories are unrelated) arguments; additionally, the similarities of premise and conclusion categories between S and G arguments were controlled. The results showed that replicating this effect, S+ arguments have increased "strong" response rates compared to G+ arguments, suggesting that category-based induction is contingent on factors beyond matched similarities. Moreover, S arguments have more liberal inductive decision thresholds than G arguments, which suggest that conclusion specificity affects the inductive decision reflected by inductive decision thresholds. Furthermore, G+ arguments elicit greater P3a amplitudes than S+ arguments, which suggest greater attention resources allocation to the review of decisions for G+ arguments than that for S+ arguments. Taken together, the conclusion specificity effect during semantic category-based induction can be revealed by "strong" response rates, inductive decision thresholds, and P3a component after controlling the premise-conclusion similarity, providing evidence that category-based induction rely on more than simple similarity judgment and conclusion specificity would affect category-based induction.	[Wang, Hong; Cui, Ruifang; Long, Changquan] Southwest Univ, Key Lab Cognit & Personal MOE, Chongqing, Peoples R China; [Wang, Hong] Chongqing Normal Univ, Ctr Teaching & Learning Dev, Chongqing, Peoples R China; [Cui, Ruifang] Univ Elect Sci & Technol China, Clin Hosp, MOE Key Lab Neuroinformat, Chengdu Brain Sci Inst, Chengdu, Peoples R China; [Cui, Ruifang] Univ Elect Sci & Technol China, Ctr Informat Med, Sch Life Sci & Technol, Chengdu, Peoples R China	Southwest University - China; Chongqing Normal University; University of Electronic Science & Technology of China; University of Electronic Science & Technology of China	Long, CQ (corresponding author), Southwest Univ, Key Lab Cognit & Personal MOE, Chongqing, Peoples R China.	lcq@swu.edu.cn		Long, Changquan/0000-0002-6074-2423	National Natural Science Foundation of China [31200780]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was partially supported by a grant from the National Natural Science Foundation of China (nsfc.gov.cn: grant number 31200780) to CL. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Albert J, 2010, NEUROIMAGE, V49, P914, DOI 10.1016/j.neuroimage.2009.08.045; Bekker EM, 2005, INT J PSYCHOPHYSIOL, V55, P191, DOI 10.1016/j.ijpsycho.2004.07.005; Bennett D, 2015, ENEURO, V2, DOI 10.1523/ENEURO.0076-15.2015; Broder A, 2007, Z PSYCHOL, V215, P52, DOI 10.1027/0044-3409.215.1.52; Coley JD, 2004, COGNITION, V90, P217, DOI 10.1016/S0010-0277(03)00159-8; Cui RF, 2018, INT J PSYCHOPHYSIOL, V134, P108, DOI 10.1016/j.ijpsycho.2018.10.011; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Eldar S, 2010, PSYCHOL MED, V40, P667, DOI 10.1017/S0033291709990766; Escera C, 1998, J COGNITIVE NEUROSCI, V10, P590, DOI 10.1162/089892998562997; Escera C, 2007, J PSYCHOPHYSIOL, V21, P251, DOI 10.1027/0269-8803.21.34.251; Feeney A, 2007, MEM COGNITION, V35, P1830, DOI 10.3758/BF03193513; Folstein JR, 2011, PSYCHOPHYSIOLOGY, V48, P825, DOI 10.1111/j.1469-8986.2010.01146.x; Friedman D, 2001, NEUROSCI BIOBEHAV R, V25, P355, DOI 10.1016/S0149-7634(01)00019-7; General Assembly of the World Medical Association, 2014, J Am Coll Dent, V81, P14; Hawkins GE, 2016, J EXP PSYCHOL GEN, V145, P155, DOI 10.1037/xge0000113; Heit E, 2011, J EXP PSYCHOL GEN, V140, P76, DOI 10.1037/a0021488; Holig C, 2010, BRAIN RES, V1345, P164, DOI 10.1016/j.brainres.2010.05.047; Jing JY, 2019, ACTA PSYCHOL, V199, DOI 10.1016/j.actpsy.2019.102922; JOINER C, 1998, J CONSUM PSYCHOL, V7, P101, DOI DOI 10.1207/S15327663JCP0702_; Kemp C, 2014, PSYCHON B REV, V21, P23, DOI 10.3758/s13423-013-0467-3; Kolossa A, 2015, NEUROIMAGE, V106, P222, DOI 10.1016/j.neuroimage.2014.11.007; Kopp B, 2016, COGN AFFECT BEHAV NE, V16, P911, DOI 10.3758/s13415-016-0442-3; Kopp B, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00300; KOUNIOS J, 1992, J EXP PSYCHOL GEN, V121, P459, DOI 10.1037/0096-3445.121.4.459; Large ME, 2004, COGNITIVE BRAIN RES, V20, P415, DOI 10.1016/j.cogbrainres.2004.03.013; Lei Y, 2019, PSYCHOPHYSIOLOGY, V56, DOI 10.1111/psyp.13337; Lei Y, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-11560-y; Liang PP, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00797; Liang PP, 2010, COGN SYST RES, V11, P67, DOI 10.1016/j.cogsys.2008.10.001; Liang XL, 2016, SCI REP-UK, V6, DOI 10.1038/srep37890; Long CQ, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-30684-3; [龙长权 Long Changquan], 2017, [中国科学. 生命科学, Scientia Sinica Vitae], V47, P325; Long CQ, 2015, INT J PSYCHOPHYSIOL, V96, P141, DOI 10.1016/j.ijpsycho.2015.04.005; Lopez-Calderon J, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00213; Luck SJ, 2014, INTRODUCTION TO THE EVENT-RELATED POTENTIAL TECHNIQUE, 2ND EDITION, P1; Luck SJ, 2017, PSYCHOPHYSIOLOGY, V54, P146, DOI 10.1111/psyp.12639; Macmillan NA, 2005, DETECTION THEORY USE; Morales J, 2015, NEUROPSYCHOLOGIA, V66, P157, DOI 10.1016/j.neuropsychologia.2014.11.014; OSHERSON DN, 1990, PSYCHOL REV, V97, P185, DOI 10.1037/0033-295X.97.2.185; Polich J., 2012, NEUROPSYCHOLOGY P300, DOI [10.1016/j.brainres.2010.05.047, DOI 10.1016/J.BRAINRES.2010.05.047]; Polich J, 2007, CLIN NEUROPHYSIOL, V118, P2128, DOI 10.1016/j.clinph.2007.04.019; RUGG MD, 1992, ELECTROEN CLIN NEURO, V84, P521, DOI 10.1016/0168-5597(92)90041-9; Sawaki R, 2009, J COGNITIVE NEUROSCI, V21, P359, DOI 10.1162/jocn.2008.21022; Seer C, 2016, BRAIN COGNITION, V106, P78, DOI 10.1016/j.bandc.2016.04.011; Strozak P, 2016, BRAIN RES, V1635, P41, DOI 10.1016/j.brainres.2016.01.015; VERLEGER R, 1994, PSYCHOPHYSIOLOGY, V31, P359, DOI 10.1111/j.1469-8986.1994.tb02444.x; Wang XX, 2016, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.00184; Wessel JR, 2015, PSYCHOPHYSIOLOGY, V52, P472, DOI 10.1111/psyp.12374; YOUNG MP, 1992, PSYCHOPHYSIOLOGY, V29, P664, DOI 10.1111/j.1469-8986.1992.tb02044.x; Zhao DM, 2019, PHYSIOL BEHAV, V206, P134, DOI 10.1016/j.physbeh.2019.04.005	50	0	0	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2020	15	3							e0229515	10.1371/journal.pone.0229515	http://dx.doi.org/10.1371/journal.pone.0229515			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LQ8QU	32130232	gold, Green Published			2022-12-26	WOS:000535264000028
J	Sovrano, VA; Baratti, G; Lee, SA				Sovrano, Valeria Anna; Baratti, Greta; Lee, Sang Ah			The role of learning and environmental geometry in landmark-based spatial reorientation of fish (Xenotoca eiseni)	PLOS ONE			English	Article							TELENCEPHALIC ABLATION; INFORMATION-CONTENT; GOLDFISH; NAVIGATION; PALLIUM; IMPAIRS; MEMORY; VIEWS; REPRESENTATION; LOCALIZATION	Disoriented animals and humans use both the environmental geometry and visual landmarks to guide their spatial behavior. Although there is a broad consensus on the use of environmental geometry across various species of vertebrates, the nature of disoriented landmark-use has been greatly debated in the field. In particular, the discrepancy in performance under spontaneous choice conditions (sometimes called "working memory" task) and training over time ("reference memory" task) has raised questions about the task-dependent dissociability of mechanisms underlying the use of landmarks. Until now, this issue has not been directly addressed, due to the inclusion of environmental geometry in most disoriented navigation paradigms. In the present study, therefore, we placed our focus on landmark-based navigation in fish (Xenotoca eiseni), an animal model that has provided fruitful research in spatial reorientation. We began with a test of spontaneous navigation by geometry and landmarks (Experiment 1), showing a preference for the correct corner, even in the absence of reinforced training. We then proceeded to test landmarks without the influence of informative geometry through the use of square environments (Experiment 2-4), varying the numerosity of present landmarks, the distance of landmarks from the target corner, and the type of task (i.e., spontaneous cued memory or reference memory). We found marked differences in landmark-use in the absence of environmental geometry. In the spontaneous memory task, visual landmarks acquired perceptive salience (and attracted the fish) but without serving as a spatial cue to location when they were distal from the target. Across learning in the reference memory task, the fish overcame these effects and gradually improved in their performance, although they were still biased to learn visual landmarks near the target (i.e., as beacons). We discuss these results in relation to the existing literature on dissociable mechanisms of spatial learning.	[Sovrano, Valeria Anna; Baratti, Greta] Univ Trento, Ctr Mind Brain Sci CIMeC, Rovereto, Italy; [Sovrano, Valeria Anna] Univ Trento, Dept Psychol & Cognit Sci, Rovereto, Italy; [Lee, Sang Ah] Korea Adv Inst Sci & Technol KAIST, Dept Bio & Brain Engn, Daejeon, South Korea	University of Trento; University of Trento; Korea Advanced Institute of Science & Technology (KAIST)	Sovrano, VA (corresponding author), Univ Trento, Ctr Mind Brain Sci CIMeC, Rovereto, Italy.; Sovrano, VA (corresponding author), Univ Trento, Dept Psychol & Cognit Sci, Rovereto, Italy.; Lee, SA (corresponding author), Korea Adv Inst Sci & Technol KAIST, Dept Bio & Brain Engn, Daejeon, South Korea.	valeriaanna.sovrano@unitn.it; sangah.lee@kaist.ac.kr	Lee, Sang Ah/O-8501-2017	Lee, Sang Ah/0000-0002-7887-6067	CIMeC; KAIST [G04170038]	CIMeC; KAIST	This work was funded by the start-up financing to VAS from CIMeC and by a research grant to SAL from KAIST (G04170038). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Broglio C, 2003, FISH FISH, V4, P247, DOI 10.1046/j.1467-2979.2003.00128.x; Broglio C, 2010, BEHAV BRAIN RES, V210, P191, DOI 10.1016/j.bbr.2010.02.031; Broglio C., 2015, J BEHAV BRAIN SCI, V5, P109, DOI [10.4236/jbbs.2015.53011, DOI 10.4236/JBBS.2015.53011, 10.4236/JBBS.2015.53011]; CARO TM, 1979, BEHAVIOUR, V69, P303, DOI 10.1163/156853979X00520; Cheng K., 1984, P409; Cheng K, 2005, PSYCHON B REV, V12, P1, DOI 10.3758/BF03196346; CHENG K, 1986, COGNITION, V23, P149, DOI 10.1016/0010-0277(86)90041-7; Cheng K, 2008, TRENDS COGN SCI, V12, P355, DOI 10.1016/j.tics.2008.06.004; Cheng K, 2013, PSYCHON B REV, V20, P1033, DOI 10.3758/s13423-013-0416-1; Cheung A, 2008, J EXP PSYCHOL ANIM B, V34, P15, DOI 10.1037/0097-7403.34.1.15; Doeller CF, 2008, P NATL ACAD SCI USA, V105, P5915, DOI 10.1073/pnas.0801489105; Duran E, 2010, BEHAV BRAIN RES, V214, P480, DOI 10.1016/j.bbr.2010.06.010; Duran E, 2008, ACTA NEUROBIOL EXP, V68, P519; Gallistel C. R., 1990, ORG LEARNING; Gomez Y, 2006, NEUROBIOL LEARN MEM, V85, P252, DOI 10.1016/j.nlm.2005.11.006; HERMER L, 1994, NATURE, V370, P57, DOI 10.1038/370057a0; Keinath AT, 2017, CURR BIOL, V27, P309, DOI 10.1016/j.cub.2016.11.046; Knapska E, 2004, PROG NEUROBIOL, V74, P183, DOI 10.1016/j.pneurobio.2004.05.007; Lee SA, 2006, PSYCHOL SCI, V17, P577, DOI 10.1111/j.1467-9280.2006.01747.x; Lee SA, 2018, J NEUROSCI, V38, P3265, DOI 10.1523/JNEUROSCI.3216-17.2018; Lee SA, 2017, CURR OPIN BEHAV SCI, V16, P58, DOI 10.1016/j.cobeha.2017.03.006; Lee SA, 2015, BEHAV PROCESS, V119, P116, DOI 10.1016/j.beproc.2015.07.012; Lee SA, 2015, J COMP PSYCHOL, V129, P189, DOI 10.1037/a0039129; Lee SA, 2013, J EXP BIOL, V216, P3693, DOI 10.1242/jeb.088625; Lee SA, 2012, ANIM COGN, V15, P861, DOI 10.1007/s10071-012-0512-z; Lee SA, 2010, COGNITIVE PSYCHOL, V61, P152, DOI 10.1016/j.cogpsych.2010.04.002; Lee SA, 2010, EXP BRAIN RES, V206, P179, DOI 10.1007/s00221-010-2349-5; Lever C, 2009, J NEUROSCI, V29, P9771, DOI 10.1523/JNEUROSCI.1319-09.2009; Lopez JC, 2000, BEHAV NEUROSCI, V114, P687, DOI 10.1037/0735-7044.114.4.687; MORRIS RGM, 1981, LEARN MOTIV, V12, P239, DOI 10.1016/0023-9690(81)90020-5; Newcombe N. S., 2007, HDB CHILD PSYCHOL, V2, P734; Portavella M, 2005, EUR J NEUROSCI, V21, P2800, DOI 10.1111/j.1460-9568.2005.04114.x; Rajan KE, 2011, FISH PHYSIOL BIOCHEM, V37, P153, DOI 10.1007/s10695-010-9425-4; Rodriguez F, 2002, BRAIN RES BULL, V57, P499, DOI 10.1016/S0361-9230(01)00682-7; Salas C, 1996, BEHAV NEUROSCI, V110, P965, DOI 10.1037/0735-7044.110.5.965; Salas C, 1996, BEHAV BRAIN RES, V79, P193, DOI 10.1016/0166-4328(96)00014-9; Smeets WJAJ, 2000, J ANAT, V196, P501, DOI 10.1046/j.1469-7580.2000.19640501.x; Solstad T, 2008, SCIENCE, V322, P1865, DOI 10.1126/science.1166466; Sovrano VA, 2005, COGNITION, V97, P121, DOI 10.1016/j.cognition.2004.08.003; Sovrano VA, 2003, J EXP PSYCHOL ANIM B, V29, P199, DOI 10.1037/0097-7403.29.3.199; Sovrano VA, 2002, COGNITION, V85, pB51, DOI 10.1016/S0010-0277(02)00110-5; Sovrano VA, 2007, ANIM COGN, V10, P47, DOI 10.1007/s10071-006-0029-4; Sovrano VA, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-36167-9; Sovrano VA, 2013, J COMP PSYCHOL, V127, P312, DOI 10.1037/a0032040; Sovrano VA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037449; Spelke E, 2010, COGNITIVE SCI, V34, P863, DOI 10.1111/j.1551-6709.2010.01110.x; Sturzl W, 2008, J EXP PSYCHOL ANIM B, V34, P1, DOI 10.1037/0097-7403.34.1.1; Sutherland NS., 1971, MECH ANIMAL DISCRIMI; TOLMAN EC, 1948, PSYCHOL REV, V55, P189, DOI 10.1037/h0061626; Twyman AD, 2010, COGNITIVE SCI, V34, P1315, DOI 10.1111/j.1551-6709.2009.01081.x; Vallortigara G, 2009, VIENNA SER THEOR BIO, P83; Vargas JP, 2004, J COMP PSYCHOL, V118, P206, DOI 10.1037/0735-7036.118.2.206; Vargas JP, 2006, EUR J NEUROSCI, V24, P2870, DOI 10.1111/j.1460-9568.2006.05174.x; Wang RXF, 1999, BEHAV NEUROSCI, V113, P475, DOI 10.1037/0735-7044.113.3.475; Wystrach A, 2011, J EXP PSYCHOL-ANIM B, V37, P420, DOI 10.1037/a0023886; Wystrach A, 2009, CURR BIOL, V19, P61, DOI 10.1016/j.cub.2008.11.054	56	8	8	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2020	15	3							e0229608	10.1371/journal.pone.0229608	http://dx.doi.org/10.1371/journal.pone.0229608			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LQ8MS	32126075	Green Published, gold			2022-12-26	WOS:000535253100038
J	Dahlin, A; Sordillo, JE; McGeachie, M; Kelly, RS; Tantisira, KG; Lutz, SM; Lasky-Su, J; Wu, AC				Dahlin, Amber; Sordillo, Joanne E.; McGeachie, Michael; Kelly, Rachel S.; Tantisira, Kelan G.; Lutz, Sharon M.; Lasky-Su, Jessica; Wu, Ann Chen			Genome-wide interaction study reveals age-dependent determinants of responsiveness to inhaled corticosteroids in individuals with asthma	PLOS ONE			English	Article							LARGE-SCALE; CHILDHOOD ASTHMA; ASSOCIATION; SCHNURRI-2; EXPRESSION; FCER2; EXACERBATIONS; INFLAMMATION; VARIANTS; SYMPTOMS	While genome-wide association studies have identified genes involved in differential treatment responses to inhaled corticosteroids (ICS) in asthma, few studies have evaluated the potential effects of age in this context. A significant proportion of asthmatics experience exacerbations (hospitalizations and emergency department visits) during ICS treatment. We evaluated the interaction of genetic variation and age on ICS response (measured by the occurrence of exacerbations) through a genome-wide interaction study (GWIS) of 1,321 adult and child asthmatic patients of European ancestry. We identified 107 genome-wide suggestive (P<10(-05)) age-by-genotype interactions, two of which also met genome-wide significance (P<5x10(-08)) (rs34631960 [OR 2.3 +/- 1.6-3.3] in thrombospondin type 1 domain-containing protein 4 (THSD4) and rs2328386 [OR 0.5 +/- 0.3-0.7] in human immunodeficiency virus type I enhancer binding protein 2 (HIVEP2)) by joint analysis of GWIS results from discovery and replication populations. In addition to THSD4 and HIVEP2, age-by-genotype interactions also prioritized genes previously identified as asthma candidate genes, including DPP10, HDAC9, TBXAS1, FBXL7, and GSDMB/ORMDL3, as pharmacogenomic loci as well. This study is the first to link these genes to a pharmacogenetic trait for asthma.	[Dahlin, Amber; McGeachie, Michael; Kelly, Rachel S.; Tantisira, Kelan G.; Lasky-Su, Jessica; Wu, Ann Chen] Brigham & Womens Hosp, Channing Div Network Med, 75 Francis St, Boston, MA 02115 USA; [Dahlin, Amber; McGeachie, Michael; Kelly, Rachel S.; Tantisira, Kelan G.; Lasky-Su, Jessica; Wu, Ann Chen] Harvard Med Sch, Boston, MA 02115 USA; [Sordillo, Joanne E.; Lutz, Sharon M.; Wu, Ann Chen] Harvard Med Sch, Dept Populat Med, PRecis Med Translat Res PROMoTeR Ctr, Boston, MA 02115 USA; [Sordillo, Joanne E.; Lutz, Sharon M.; Wu, Ann Chen] Harvard Pilgrim Hlth Care Inst, Boston, MA 02215 USA; [Tantisira, Kelan G.] Brigham & Womens Hosp, Div Pulm & Crit Care Med, 75 Francis St, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard Pilgrim Health Care; Harvard University; Brigham & Women's Hospital	Wu, AC (corresponding author), Brigham & Womens Hosp, Channing Div Network Med, 75 Francis St, Boston, MA 02115 USA.; Wu, AC (corresponding author), Harvard Med Sch, Boston, MA 02115 USA.; Wu, AC (corresponding author), Harvard Med Sch, Dept Populat Med, PRecis Med Translat Res PROMoTeR Ctr, Boston, MA 02115 USA.; Wu, AC (corresponding author), Harvard Pilgrim Hlth Care Inst, Boston, MA 02215 USA.	Ann.Wu@childrens.harvard.edu	Wu, Ann/AAY-4293-2020; kelly, rachel/H-4505-2017	Wu, Ann/0000-0003-0599-9063; kelly, rachel/0000-0003-3023-1822	NIH (National Institutes of Health);  [R01HD085993];  [K01 HL130629]	NIH (National Institutes of Health)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; 	Authors received funding from NIH (National Institutes of Health). A.C. Wu received an R01 grant (R01HD085993) and A.D. received grant K01 HL130629. Funders did not play a role in study design, analysis, data collection, decision to publish or manuscript prep. https://www.nih.gov/	Agrawal DK, 2010, CURR ALLERGY ASTHM R, V10, P39, DOI 10.1007/s11882-009-0081-7; American Lung Association, 2012, ASTHM AD FACT SHEET; [Anonymous], 2007, J ALLERGY CLIN IMMUN, V120, pS94, DOI 10.1016/j.jaci.2007.09.029; [Anonymous], [No title captured]; [Anonymous], 2001, COND ED; Berce V, 2013, PHARMACOGENOMICS J, V13, P523, DOI 10.1038/tpj.2012.36; Boushey HA, 2005, NEW ENGL J MED, V352, P1519, DOI 10.1056/NEJMoa042552; Chan MTS, 1998, J ALLERGY CLIN IMMUN, V101, P594, DOI 10.1016/S0091-6749(98)70165-4; Chang CC, 2015, GIGASCIENCE, V4, DOI 10.1186/s13742-015-0047-8; Chen H, 2000, MATRIX BIOL, V19, P597, DOI 10.1016/S0945-053X(00)00107-4; Cherniack R, 1999, CONTROL CLIN TRIALS, V20, P91; Delaneau O, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-540; Favre CJ, 2003, AM J PHYSIOL-HEART C, V285, pH1917, DOI 10.1152/ajpheart.00983.2002; Fukuda S, 2002, J BIOCHEM, V131, P349, DOI 10.1093/oxfordjournals.jbchem.a003109; Hancock DB, 2010, NAT GENET, V42, P45, DOI 10.1038/ng.500; Himes BE, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002824; Hou XX, 2016, CLIN RESPIR J, V10, P371, DOI 10.1111/crj.12227; Howie BN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000529; Iwamura C, 2007, INT IMMUNOL, V19, P755, DOI 10.1093/intimm/dxm042; Jubb AW, 2017, CELL REP, V21, P3022, DOI 10.1016/j.celrep.2017.11.053; Kaditis AG, 2007, PEDIATR PULM, V42, P407, DOI 10.1002/ppul.20591; KEHOE RF, 1990, AM J CARDIOL, V65, pA58; Koster ES, 2011, ALLERGY, V66, P1546, DOI 10.1111/j.1398-9995.2011.02701.x; Kvale MN, 2015, GENETICS, V200, P1051, DOI 10.1534/genetics.115.178905; Li XN, 2013, J ALLERGY CLIN IMMUN, V132, P313, DOI 10.1016/j.jaci.2013.01.051; Liptak T., 1958, MAGYAR TUD AKAD MAT, V3, P171; Litonjua AA, 2008, AM J RESP CRIT CARE, V178, P688, DOI 10.1164/rccm.200709-1363OC; McCarty Catherine A, 2005, Per Med, V2, P49, DOI 10.1517/17410541.2.1.49; Moffatt MF, 2010, NEW ENGL J MED, V363, P1211, DOI 10.1056/NEJMoa0906312; Nakayama T, 2010, ADV EXP MED BIOL, V684, P1; National Institute of Allergy and Infectious Disease, 2001, ASTHM CONC MIN POP; Park HW, 2014, J ALLERGY CLIN IMMUN, V133, P664, DOI 10.1016/j.jaci.2013.12.1042; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Repapi E, 2010, NAT GENET, V42, P36, DOI 10.1038/ng.501; Roden DM, 2008, CLIN PHARMACOL THER, V84, P362, DOI 10.1038/clpt.2008.89; Saita Y, 2007, J BIOL CHEM, V282, P12907, DOI 10.1074/jbc.M611203200; Soler Artigas M, 2011, NAT GENET, V43, P1082, DOI 10.1038/ng.941; Sorkness CA, 2007, J ALLERGY CLIN IMMUN, V119, P64, DOI 10.1016/j.jaci.2006.09.042; Srivastava S, 2016, EUR J HUM GENET, V24, P556, DOI 10.1038/ejhg.2015.151; Staton TL, 2011, NATURE, V472, P105, DOI 10.1038/nature09848; Szalai R, 2014, MOL BIOL REP, V41, P7665, DOI 10.1007/s11033-014-3659-7; Szefler SJ, 2005, J ALLERGY CLIN IMMUN, V115, P233, DOI 10.1016/j.jaci.2004.11.014; Takao K, 2013, NEUROPSYCHOPHARMACOL, V38, P1409, DOI 10.1038/npp.2013.38; Tantisira KG, 2007, J ALLERGY CLIN IMMUN, V120, P1285, DOI 10.1016/j.jaci.2007.09.005; Torgerson DG, 2012, AM J HUM GENET, V90, P273, DOI 10.1016/j.ajhg.2012.01.008; Wu AC, 2009, J ALLERGY CLIN IMMUN, V123, P385, DOI 10.1016/j.jaci.2008.10.015; Yamashita J, 2012, LEUKEMIA LYMPHOMA, V53, P479, DOI 10.3109/10428194.2011.625099; Yao TC, 2014, J ALLERGY CLIN IMMUN, V133, P248, DOI 10.1016/j.jaci.2013.06.018	48	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2020	15	3							e0229241	10.1371/journal.pone.0229241	http://dx.doi.org/10.1371/journal.pone.0229241			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8JT	32119686	Green Published, gold			2022-12-26	WOS:000535245300018
J	Tensaouti, Y; Yu, TS; Kernie, SG				Tensaouti, Yacine; Yu, Tzong-Shiue; Kernie, Steven G.			Apolipoprotein E regulates the maturation of injury-induced adult-born hippocampal neurons following traumatic brain injury	PLOS ONE			English	Article							E KNOCKOUT MICE; ABERRANT NEUROGENESIS; ALZHEIMERS-DISEASE; APOE; ALLELE; MEMORY; SYNAPTOGENESIS; PROLIFERATION; ABNORMALITIES; ASSOCIATION	Various brain injuries lead to the activation of adult neural stem/progenitor cells in the mammalian hippocampus. Subsequent injury-induced neurogenesis appears to be essential for at least some aspects of the innate recovery in cognitive function observed following traumatic brain injury (TBI). It has previously been established that Apolipoprotein E (ApoE) plays a regulatory role in adult hippocampal neurogenesis, which is of particular interest as the presence of the human ApoE isoform ApoE4 leads to significant risk for the development of late-onset Alzheimer's disease, where impaired neurogenesis has been linked with disease progression. Moreover, genetically modified mice lacking ApoE or expressing the ApoE4 human isoform have been shown to impair adult hippocampal neurogenesis under normal conditions. Here, we investigate how controlled cortical impact (CCI) injury affects dentate gyrus development using hippocampal stereotactic injections of GFP-expressing retroviruses in wild-type (WT), ApoE-deficient and humanized (ApoE3 and ApoE4) mice. Infected adult-born hippocampal neurons were morphologically analyzed once fully mature, revealing significant attenuation of dendritic complexity and spine density in mice lacking ApoE or expressing the human ApoE4 allele, which may help inform how ApoE influences neurological diseases where neurogenesis is defective.	[Tensaouti, Yacine; Yu, Tzong-Shiue; Kernie, Steven G.] Columbia Univ, Dept Pediat, Vagelos Coll Phys & Surg, New York, NY 10027 USA; [Kernie, Steven G.] Columbia Univ, Dept Neurol, Vagelos Coll Phys & Surg, New York, NY 10027 USA	Columbia University; Columbia University	Kernie, SG (corresponding author), Columbia Univ, Dept Pediat, Vagelos Coll Phys & Surg, New York, NY 10027 USA.; Kernie, SG (corresponding author), Columbia Univ, Dept Neurol, Vagelos Coll Phys & Surg, New York, NY 10027 USA.	sk3516@cumc.columbia.edu	Kernie, Steven/AAT-9912-2020	Yu, Tzong-Shiue/0000-0003-4277-6213; Tensaouti, Yacine/0000-0001-6475-3245; Kernie, Steven/0000-0003-1371-0549	National Institutes of Health [R01 NS095803, R56NS089523]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the National Institutes of Health grants R01 NS095803 (sgk) and R56NS089523 (sgk) who played no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar-Arredondo A, 2018, BRAIN STRUCT FUNCT, V223, P2859, DOI 10.1007/s00429-018-1664-7; Allen KM, 2016, AUST NZ J PSYCHIAT, V50, P473, DOI 10.1177/0004867415589793; Bell RD, 2012, NATURE, V485, P512, DOI 10.1038/nature11087; Blaiss CA, 2011, J NEUROSCI, V31, P4906, DOI 10.1523/JNEUROSCI.5265-10.2011; Cao JQ, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-11654-7; Ceanga M, 2019, J NEUROSCI, V39, P1755, DOI 10.1523/JNEUROSCI.3303-17.2018; Cho KO, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7606; Chung WS, 2016, P NATL ACAD SCI USA, V113, P10186, DOI 10.1073/pnas.1609896113; CORDER EH, 1994, NAT GENET, V7, P180, DOI 10.1038/ng0694-180; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; Danzer Steve C, 2018, Brain Plast, V3, P169, DOI 10.3233/BPL-170056; Dewan MC, 2019, J NEUROSURG, V130, P1055, DOI 10.3171/2017.11.JNS171500; Diaz-Arrastia R, 2003, ARCH NEUROL-CHICAGO, V60, P818, DOI 10.1001/archneur.60.6.818; Dickstein DL, 2016, CURR PROTOC NEUROSCI, V77; Dumitriu D, 2011, NAT PROTOC, V6, P1391, DOI 10.1038/nprot.2011.389; East BS, 2018, NEUROSCIENCE, V380, P103, DOI 10.1016/j.neuroscience.2018.04.009; Fuentes D, 2018, BEHAV SCI, V8, DOI 10.3390/bs8030033; Gao X, 2008, J NEUROSCI RES, V86, P2258, DOI 10.1002/jnr.21677; Gilley JA, 2011, HIPPOCAMPUS, V21, P33, DOI 10.1002/hipo.20719; Goritz C, 2005, MOL CELL NEUROSCI, V29, P190, DOI 10.1016/j.mcn.2005.02.006; Grootendorst J, 2001, NEUROSCIENCE, V108, P237, DOI 10.1016/S0306-4522(01)00412-2; Hartman RE, 2001, EXP NEUROL, V170, P326, DOI 10.1006/exnr.2001.7715; Hatten ME, 1999, ANNU REV NEUROSCI, V22, P511, DOI 10.1146/annurev.neuro.22.1.511; Hauser PS, 2011, PROG LIPID RES, V50, P62, DOI 10.1016/j.plipres.2010.09.001; Hollands C, 2016, FRONT NEUROSCI-SWITZ, V10, DOI 10.3389/fnins.2016.00178; Hong S, 2016, J NEUROTRAUM, V33, P362, DOI 10.1089/neu.2014.3860; Ibrahim S, 2016, SCI REP-UK, V6, DOI 10.1038/srep21793; Jain S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059478; Jessberger S, 2007, J NEUROSCI, V27, P9400, DOI 10.1523/JNEUROSCI.2002-07.2007; Jordan BD, 1997, JAMA-J AM MED ASSOC, V278, P136, DOI 10.1001/jama.278.2.136; Kernie SG, 2001, J NEUROSCI RES, V66, P317, DOI 10.1002/jnr.10013; Kernie SG, 2010, NEUROBIOL DIS, V37, P267, DOI 10.1016/j.nbd.2009.11.002; Kim Hae-Young, 2015, Restor Dent Endod, V40, P172, DOI 10.5395/rde.2015.40.2.172; Koizumi K, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06301-2; Li G, 2009, CELL STEM CELL, V5, P634, DOI 10.1016/j.stem.2009.10.015; Main BS, 2018, MOL NEURODEGENER, V13, DOI 10.1186/s13024-018-0249-5; Mamotte CDS, 1999, AM J PHYSIOL-ENDOC M, V276, pE553, DOI 10.1152/ajpendo.1999.276.3.E553; Masliah E, 1997, BRAIN RES, V751, P307, DOI 10.1016/S0006-8993(96)01420-5; Mauch DH, 2001, SCIENCE, V294, P1354, DOI 10.1126/science.294.5545.1354; Merritt VC, 2018, ARCH CLIN NEUROPSYCH, V33, P36, DOI 10.1093/arclin/acx051; Merritt VC, 2016, J INT NEUROPSYCH SOC, V22, P89, DOI 10.1017/S1355617715001022; Nathan BP, 2002, BRAIN RES, V928, P96, DOI 10.1016/S0006-8993(01)03367-4; Niv F, 2012, STROKE, V43, P2468, DOI 10.1161/STROKEAHA.112.660977; Oitzl MS, 1997, BRAIN RES, V752, P189, DOI 10.1016/S0006-8993(96)01448-5; Peister A, 2006, EXP NEUROL, V201, P266, DOI 10.1016/j.expneurol.2006.03.023; Peng KY, 2017, NEUROSCIENCE, V343, P364, DOI 10.1016/j.neuroscience.2016.12.004; Perederiy JV, 2013, J NEUROSCI, V33, P4754, DOI 10.1523/JNEUROSCI.4785-12.2013; Perez-Alvarez A, 2014, J NEUROSCI, V34, P12738, DOI 10.1523/JNEUROSCI.2401-14.2014; Perry EK, 2012, NEUROBIOL DIS, V47, P155, DOI 10.1016/j.nbd.2012.03.033; Pfrieger FW, 2002, CURR OPIN NEUROBIOL, V12, P486, DOI 10.1016/S0959-4388(02)00358-6; Pugh P, 2011, FRONT NEUROSCI-SWITZ, V5, DOI 10.3389/fnins.2011.00045; Richardson RM, 2007, NEUROSURG CLIN N AM, V18, P169, DOI 10.1016/j.nec.2006.10.007; Rodriguez GA, 2013, LEARN MEMORY, V20, P256, DOI 10.1101/lm.030031.112; Rola R, 2006, EXP NEUROL, V202, P189, DOI 10.1016/j.expneurol.2006.05.034; Rubiano AM, 2015, NATURE, V527, pS193, DOI 10.1038/nature16035; Sahay A, 2007, NAT NEUROSCI, V10, P1110, DOI 10.1038/nn1969; Salomon-Zimri Shiran, 2015, Alzheimers Dement (Amst), V1, P127, DOI 10.1016/j.dadm.2014.11.014; Scharfman HE, 2000, J NEUROSCI, V20, P6144, DOI 10.1523/JNEUROSCI.20-16-06144.2000; Smith C, 2006, J NEUROL NEUROSUR PS, V77, P363, DOI 10.1136/jnnp.2005.074617; Sultan S, 2015, NEURON, V88, DOI 10.1016/j.neuron.2015.10.037; Teasdale GM, 1997, LANCET, V350, P1069, DOI 10.1016/S0140-6736(97)04318-3; Tensaouti Y, 2018, ENEURO, V5, DOI 10.1523/ENEURO.0155-18.2018; Tobin MK, 2014, J CEREBR BLOOD F MET, V34, P1573, DOI 10.1038/jcbfm.2014.130; Toni N, 2015, COLD SPRING HARB PER, V8, DOI DOI 10.1101/CSHPERSPECT.A018903; Vance JE, 2000, BBA-MOL CELL BIOL L, V1486, P84, DOI 10.1016/S1388-1981(00)00050-0; Villasana LE, 2015, ENEURO, V2, DOI 10.1523/ENEURO.0056-15.2015; Wang SB, 2018, J NEUROSCI, V38, P137, DOI 10.1523/JNEUROSCI.0988-17.2017; Wang XT, 2016, J NEUROTRAUM, V33, P721, DOI 10.1089/neu.2015.4097; Yang CP, 2011, DEVELOPMENT, V138, P4351, DOI 10.1242/dev.065540; Yu TS, 2008, J NEUROSCI, V28, P12901, DOI 10.1523/JNEUROSCI.4629-08.2008; Zeiler FA, 2021, J NEUROTRAUM, V38, P1107, DOI 10.1089/neu.2017.5583	71	13	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2020	15	3							e0229240	10.1371/journal.pone.0229240	http://dx.doi.org/10.1371/journal.pone.0229240			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8JT	32119690	Green Published, gold			2022-12-26	WOS:000535245300017
J	Li, Y; Zhang, HB; Fan, L; Mou, JH; Yin, Y; Peng, C; Chen, YX; Lu, HL; Zhao, LT; Tao, ZT; Chen, J; Wang, YZ; Qi, XM; Huang, RM; Ren, J				Li, Yu; Zhang, Huibiao; Fan, Lei; Mou, Jiahui; Yin, Yue; Peng, Chao; Chen, Yuxiang; Lu, Henglei; Zhao, Liting; Tao, Zhouteng; Chen, Jing; Wang, Yizheng; Qi, Xinming; Huang, Ruimin; Ren, Jin			MiR-629-5p promotes the invasion of lung adenocarcinoma via increasing both tumor cell invasion and endothelial cell permeability	ONCOGENE			English	Article							UP-REGULATION; CANCER; METASTASIS; EXPRESSION; TARGETS; GROWTH; CELSR1; ANGIOGENESIS; SUPPRESSES; MIGRATION	Tumor invasion underlies further metastasis, the leading cause for cancer-related deaths. Deregulation of microRNAs has been identified associated with the malignant behavior of various cancers, including lung adenocarcinoma (LUAD), the major subtype of lung cancer. Here, we showed the significantly positive correlation between miR-629-5p level and tumor invasion in LUAD specimens (n = 49). In a human LUAD metastasis mouse model, H1650 cells (high level of miR-629-5p) were more aggressive than A549 cells (low level of miR-629-5p) in vivo, including higher incidence of vascular invasion and pulmonary colonization. Ectopic expression of miR-629-5p in A549 cells also increased their invasive capability. Then we identified that miR-629-5p promotes LUAD invasion in a mode of dual regulation via tumor cells invasion and endothelial cells permeability, respectively. In tumor cells, miR-629-5p enhanced motility and invasiveness of tumor cells by directly targeting PPWD1 (a cyclophilin), which clinically related to tumor invasion in LUAD specimens. Restoring PPWD1 protein significantly attenuated the invasion-promoting effects of miR-629-5p. Besides, exosomal-miR-629-5p secreted from tumor cells could be transferred to endothelial cells and increased endothelial monolayers permeability by suppressing CELSR1 (a nonclassic-type cadherin), which had a low level in the endothelial cells of invasive LUAD specimens. Activating the expression of CELSR1 in endothelial cells markedly blocked the effect of miR-629-5p. Our study suggests the dual roles of miR-629-5p in tumor cells and endothelial cells for LUAD invasion, implying a therapeutic option to targeting miR-629-5p using the "one stone, two birds" strategy in LUAD.	[Li, Yu; Fan, Lei; Mou, Jiahui; Chen, Yuxiang; Lu, Henglei; Tao, Zhouteng; Chen, Jing; Qi, Xinming; Ren, Jin] Chinese Acad Sci, Shanghai Inst Mat Med, Ctr Drug Safety Evaluat & Res, State Key Lab Drug Res, Shanghai 201203, Peoples R China; [Li, Yu; Fan, Lei; Mou, Jiahui; Tao, Zhouteng; Chen, Jing; Qi, Xinming; Huang, Ruimin; Ren, Jin] Univ Chinese Acad Sci, Beijing 100049, Peoples R China; [Zhang, Huibiao] Fudan Univ, Huadong Hosp, Dept Thorac Surg, Shanghai 200040, Peoples R China; [Yin, Yue] Natl Facil Prot Sci Shanghai, Zhangjiang Lab, Shanghai 201210, Peoples R China; [Peng, Chao] Chinese Acad Sci, Shanghai Sci Res Ctr, Shanghai 201204, Peoples R China; [Lu, Henglei] Shanghai Univ Chinese Med, Shanghai 201203, Peoples R China; [Zhao, Liting] Fudan Univ, Huadong Hosp, Dept Nursing, Shanghai 200040, Peoples R China; [Wang, Yizheng] Beijing Inst Basic Med Sci, Brain Sci Ctr, Beijing 100730, Peoples R China; [Huang, Ruimin] Chinese Acad Sci, Shanghai Inst Mat Med, Shanghai 201203, Peoples R China	Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Fudan University; Chinese Academy of Sciences; Shanghai University of Traditional Chinese Medicine; Fudan University; Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS	Ren, J (corresponding author), Chinese Acad Sci, Shanghai Inst Mat Med, Ctr Drug Safety Evaluat & Res, State Key Lab Drug Res, Shanghai 201203, Peoples R China.; Huang, RM; Ren, J (corresponding author), Univ Chinese Acad Sci, Beijing 100049, Peoples R China.; Huang, RM (corresponding author), Chinese Acad Sci, Shanghai Inst Mat Med, Shanghai 201203, Peoples R China.	rmhuang@simm.ac.cn; jren@cdser.simm.ac.cn		yin, yue/0000-0002-7693-3910	National Science & Technology Major Project "Key New Drug Creation and Manufacturing Program," China [2018ZX09101001-003-007, 2018ZX09711002-010-001]; National Natural Science Foundation of china [91859106]; One Hundred Talent Program of Chinese Academy of Sciences; State Key Laboratory of Drug Research; Shanghai Committee of Science and Technology, China [18DZ2290200]	National Science & Technology Major Project "Key New Drug Creation and Manufacturing Program," China; National Natural Science Foundation of china(National Natural Science Foundation of China (NSFC)); One Hundred Talent Program of Chinese Academy of Sciences(Chinese Academy of Sciences); State Key Laboratory of Drug Research; Shanghai Committee of Science and Technology, China(Shanghai Science & Technology Committee)	This work was supported by the National Science & Technology Major Project "Key New Drug Creation and Manufacturing Program," China (2018ZX09101001-003-007 and 2018ZX09711002-010-001), "the National Natural Science Foundation of china (91859106)," One Hundred Talent Program of Chinese Academy of Sciences, the Fundamental and Open Research Funds from the State Key Laboratory of Drug Research, and the grant from Shanghai Committee of Science and Technology, China (Grant No.: 18DZ2290200). We thank the Electron Microscopy System and Animal Facility at the National Facility for Protein Science in Shanghai (NFPS), Zhangjiang Lab, China, and the Institutional Technology Service Center of Shanghai Institute of Materia Medica, Chinese Academy of Sciences for technical supports.	Nieto MA, 2013, SCIENCE, V342, P708, DOI 10.1126/science.1234850; Asangani IA, 2008, ONCOGENE, V27, P2128, DOI 10.1038/sj.onc.1210856; Aurrand-Lions M, 2001, J BIOL CHEM, V276, P2733, DOI 10.1074/jbc.M005458200; Bica-Pop C, 2018, CELL MOL LIFE SCI, V75, P3539, DOI 10.1007/s00018-018-2877-x; Bielenberg DR, 2015, CANCER J, V21, P267, DOI 10.1097/PPO.0000000000000138; Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492; Brzoska HL, 2016, KIDNEY INT, V90, P1274, DOI 10.1016/j.kint.2016.07.011; Chang TH, 2017, CANCER LETT, V402, P190, DOI 10.1016/j.canlet.2017.06.002; Chen LM, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6241; Chorti Angeliki, 2018, Microrna, V7, P167, DOI 10.2174/2211536607666180525073302; Davis TL, 2008, FEBS J, V275, P2283, DOI 10.1111/j.1742-4658.2008.06381.x; Duncan JS, 2017, DEV BIOL, V423, P126, DOI 10.1016/j.ydbio.2017.01.020; Faict S, 2018, BLOOD CANCER J, V8, DOI 10.1038/s41408-018-0139-7; Goffinet AM, 2017, SEMIN CELL DEV BIOL, V69, P102, DOI 10.1016/j.semcdb.2017.07.014; Graner MW, 2018, SEMIN IMMUNOPATHOL, V40, P505, DOI 10.1007/s00281-018-0689-6; Han ML, 2016, ONCOL REP, V35, P73, DOI 10.3892/or.2015.4360; Ito M, 2014, BLOOD, V123, P1499, DOI 10.1182/blood-2013-09-527739; Jenkinson EM, 2018, CLIN GENET, V93, P228, DOI 10.1111/cge.13025; Jin K, 2017, J PATHOL, V241, P567, DOI 10.1002/path.4871; Jingushi K, 2015, MOL CANCER RES, V13, P565, DOI 10.1158/1541-7786.MCR-14-0300; Kaemmerer D, 2014, CLIN EXP METASTAS, V31, P817, DOI 10.1007/s10585-014-9672-3; Kang YY, 2018, NATURE, V558, P553, DOI 10.1038/s41586-018-0215-y; Lee SW, 2009, INT J MOL MED, V23, P279, DOI 10.3892/ijmm_00000128; Lin SB, 2015, NAT REV CANCER, V15, P321, DOI 10.1038/nrc3932; Liu K, 2016, CHINESE MED J-PEKING, V129, P442, DOI 10.4103/0366-6999.176076; Lu J, 2018, BIOSCIENCE REP, V38; Maishi N, 2017, CANCER SCI, V108, P1921, DOI 10.1111/cas.13336; Miao LL, 2016, BBA-GENE REGUL MECH, V1859, P650, DOI 10.1016/j.bbagrm.2016.02.016; Myers D. J., 2019, CANC LUNG ADENOCARCI; Nagao Y, 2012, MODERN PATHOL, V25, P112, DOI 10.1038/modpathol.2011.142; Naik MU, 2006, J CELL SCI, V119, P490, DOI 10.1242/jcs.02771; Paliouras AR, 2018, CANCER LETT, V421, P152, DOI 10.1016/j.canlet.2018.02.029; Poel D, 2018, EXP MOL MED, V50, DOI 10.1038/emm.2017.288; Posorski N, 2011, CLIN EXP METASTAS, V28, P637, DOI 10.1007/s10585-011-9397-5; Pu MF, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1006896; Qi LQ, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-163; Rajiv C, 2018, BIOMOLECULES, V8, DOI 10.3390/biom8040161; Riihimaki M, 2014, LUNG CANCER, V86, P78, DOI 10.1016/j.lungcan.2014.07.020; Shao LP, 2017, DNA CELL BIOL, V36, P1108, DOI 10.1089/dna.2017.3904; Singleton PA, 2014, ADV CANCER RES, V123, P191, DOI 10.1016/B978-0-12-800092-2.00007-1; Tan XH, 2014, J CUTAN PATHOL, V41, P630, DOI 10.1111/cup.12332; Thery Clotilde, 2006, Curr Protoc Cell Biol, VChapter 3, DOI 10.1002/0471143030.cb0322s30; Tornavaca O, 2015, J CELL BIOL, V208, P821, DOI 10.1083/jcb.201404140; Travis WD, 2015, J THORAC ONCOL, V10, P1243, DOI 10.1097/JTO.0000000000000630; van Zijl F, 2011, MUTAT RES-REV MUTAT, V728, P23, DOI 10.1016/j.mrrev.2011.05.002; Wang T, 2017, ONCOGENE, V36, P3240, DOI 10.1038/onc.2016.468; Wen J, 2017, TUMOR BIOL, V39, DOI 10.1177/1010428317705761; Yan HJ, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.525; Yan LX, 2016, INT J ONCOL, V48, P471, DOI 10.3892/ijo.2015.3287; Yang H, 2013, HEPATOLOGY, V58, P205, DOI 10.1002/hep.26315; Yang L, 2012, CARCINOGENESIS, V33, P338, DOI 10.1093/carcin/bgr272; Yang N, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.358; Yu SJ, 2018, BMC CANCER, V18, DOI 10.1186/s12885-017-3930-0; Zeng ZC, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07810-w; Zhan YH, 2016, BIOCHEMISTRY-MOSCOW+, V81, P591, DOI 10.1134/S0006297916060055; Zhang BG, 2012, ONCOL REP, V27, P1019, DOI 10.3892/or.2012.1645; Zhao YJ, 2015, CANCER METAST REV, V34, P265, DOI 10.1007/s10555-015-9553-5; Zhou WY, 2014, CANCER CELL, V25, P501, DOI 10.1016/j.ccr.2014.03.007; Zhu SM, 2008, CELL RES, V18, P350, DOI 10.1038/cr.2008.24; Zhuang BF, 2019, MOL MED REP, V19, P3933, DOI 10.3892/mmr.2019.9990	60	18	19	5	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR	2020	39	17					3473	3488		10.1038/s41388-020-1228-1	http://dx.doi.org/10.1038/s41388-020-1228-1		FEB 2020	16	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	LH1YK	32108166				2022-12-26	WOS:000516891300003
J	Aslam, M; Anwar, SM				Aslam, Muhammad; Anwar, Syed Masroor			An improved Bayesian Modified-EWMA location chart and its applications in mechanical and sport industry	PLOS ONE			English	Article							ECONOMIC DESIGN; CRASH RATES; VARIANCE; CUSUM; SEVERITY; MODEL	Control charts are popular tools in the statistical process control toolkit and the exponentially weighted moving average (EWMA) chart is one of its essential component for efficient process monitoring. In the present study, a new Bayesian Modified-EWMA chart is proposed for the monitoring of the location parameter in a process. Four various loss functions and a conjugate prior distribution are used in this study. The average run length is used as a performance evaluation tool for the proposed chart and its counterparts. The results advocate that the proposed chart performs very well for the monitoring of small to moderate shifts in the process and beats the existing counterparts. The significance of the proposed scheme has proved through two real-life examples: (1) For the monitoring of the reaming process which is used in the mechanical industry. (2) For the monitoring of golf ball performance in the sports industry.	[Aslam, Muhammad; Anwar, Syed Masroor] Riphah Int Univ, Dept Math & Stat, Muzaffarabad, Pakistan; [Anwar, Syed Masroor] Univ Azad Jammu & Kashmir, Dept Stat, Muzaffarabad, Pakistan	University of Azad Jammu & Kashmir	Anwar, SM (corresponding author), Riphah Int Univ, Dept Math & Stat, Muzaffarabad, Pakistan.; Anwar, SM (corresponding author), Univ Azad Jammu & Kashmir, Dept Stat, Muzaffarabad, Pakistan.	masroorstatistics@gmail.com	Anwar, Syed Masroor/ABB-2626-2021; Aslam, Muhammad/GRS-8220-2022	Anwar, Syed Masroor/0000-0001-7184-9579; Aslam, Muhammad/0000-0002-6071-5468				Abbas N, 2014, COMMUN STAT-THEOR M, V43, P3485, DOI 10.1080/03610926.2012.700368; Acosta-Mejia CA, 1999, IIE TRANS, V31, P569, DOI 10.1080/07408179908969859; Ajadi JO, 2017, COMMUN STAT-THEOR M, V46, P6980, DOI 10.1080/03610926.2016.1139132; Ali S, 2020, ARAB J SCI ENG, V45, P2093, DOI 10.1007/s13369-019-04036-w; [Anonymous], 1991, INTRO STAT QUALITY C; Antony J., 2000, WORK STUDY, V49, P242, DOI [10.1108/00438020010343417, DOI 10.1108/00438020010343417]; Anwar SM, 2020, QUAL TECHNOL QUANT M, V17, P561, DOI 10.1080/16843703.2019.1696011; Aslam M, 2017, J STAT COMPUT SIM, V87, P3491, DOI 10.1080/00949655.2017.1373114; Ben-Daya M., 2003, International Journal of Quality Reliability Management, V20, P607, DOI 10.1108/02656710310476552; Biswas S., 1975, STAT QUALITY CONTROL; Bolstad WM., 2007, INTRO BAYESIAN STAT; BRUSH GG, 1986, TECHNOMETRICS, V28, P69, DOI 10.2307/1269605; Chen F, 2019, INT J ENV RES PUB HE, V16, P1, DOI DOI 10.3390/ijerph16142632; Chen F, 2011, ACCIDENT ANAL PREV, V43, P1677, DOI 10.1016/j.aap.2011.03.026; Chen G., 2004, QUALITY TECHNOLOGY Q, V1, P217, DOI DOI 10.1080/16843703.2004.11673074; CROWDER SV, 1992, J QUAL TECHNOL, V24, P12, DOI 10.1080/00224065.1992.11979369; De Chiffre L, 2008, P SWED PROD S; GAN FF, 1995, TECHNOMETRICS, V37, P446, DOI 10.2307/1269736; GIRSHICK MA, 1952, ANN MATH STAT, V23, P114, DOI 10.1214/aoms/1177729489; Hawkins DM., 1998, STAT ENGN PHYS SCI, DOI 10.2307/2670188; Khan N, 2017, QUAL RELIAB ENG INT, V33, P1095, DOI 10.1002/qre.2102; Lavanya A., 2016, INT J SCI RES, V5, P736; Lee SH, 2014, J STAT COMPUT SIM, V84, P1830, DOI 10.1080/00949655.2013.769540; Lu SL, 2017, QUAL TECHNOL QUANT M, V14, P280, DOI 10.1080/16843703.2016.1208940; Menzefricke U, 2002, COMMUN STAT-THEOR M, V31, P1423, DOI 10.1081/STA-120006077; Menzefricke U, 2007, COMMUN STAT-THEOR M, V36, P1031, DOI 10.1080/03610920601036176; Menzefricke U, 2013, COMMUN STAT-THEOR M, V42, P4003, DOI 10.1080/03610926.2011.638429; Menzefricke U, 2013, COMMUN STAT-THEOR M, V42, P988, DOI 10.1080/03610926.2011.592252; Montgomery SL, 2009, J SPEC TRANSL, P6; Norstrom JG, 1996, IEEE T RELIAB, V45, P400, DOI 10.1109/24.536992; Osei-Aning R, 2017, QUAL TECHNOL QUANT M, V14, P429, DOI 10.1080/16843703.2017.1304038; Quinino RD, 2014, INT J ADV MANUF TECH, V72, P101, DOI 10.1007/s00170-013-5605-6; Reynolds MR, 2006, TECHNOMETRICS, V48, P550, DOI 10.1198/004017006000000255; Riaz M, 2015, T I MEAS CONTROL, V38, P1; Riaz S, 2017, QUAL RELIAB ENG INT, V33, P2653, DOI 10.1002/qre.2224; Riaz S, 2017, COMPUT IND ENG, V112, P426, DOI 10.1016/j.cie.2017.08.023; Roberts SW., 1959, TECHNOMETRICS, V1, P239, DOI [10.1080/00401706.1959.10489860, DOI 10.1080/00401706.1959.10489860]; Rodrigues J., 1994, TEST, V3, P237; Saghir A, 2020, QUAL RELIAB ENG INT, V36, P328, DOI 10.1002/qre.2576; Saghir A, 2015, COMMUN STAT-THEOR M, V44, P644, DOI 10.1080/03610926.2012.752846; Saghir A, 2013, QUAL RELIAB ENG INT, V29, P759, DOI 10.1002/qre.1426; Sameniego FJ., 2010, COMP BAYESIAN FREQUE; Savran A, 2002, GOLF BALL DETECTOR 2, P1; Schneider G., 2010, CUTTING TOOL APPL; Serel DA, 2009, MATH COMPUT MODEL, V49, P745, DOI 10.1016/j.mcm.2008.06.012; SHARMA KK, 1992, MICROELECTRON RELIAB, V32, P493, DOI 10.1016/0026-2714(92)90479-5; Stoumbos ZG, 2002, J AM STAT ASSOC, V95, P992; Tanaka K, 2006, P I MECH ENG L-J MAT, V220, P13, DOI 10.1243/14644207JMDA80; Tsui K-L., 1993, SEQUENTIAL ANAL, V12, P79, DOI DOI 10.1080/07474949308836270; Van Nostrand D., 1931, EC CONTROL QUALITY M; Varian H. R., 1975, J SAVAGE, P195; Wu Z, 2005, INT J PROD RES, V43, P3027, DOI 10.1080/00207540500057639; ZELLNER A, 1986, J AM STAT ASSOC, V81, P446, DOI 10.1080/01621459.1986.10478289; Zeng Q, 2019, TRANSPORTMETRICA A, V15, P1867, DOI 10.1080/23249935.2019.1652867; Zeng Q, 2019, ACCIDENT ANAL PREV, V127, P87, DOI 10.1016/j.aap.2019.02.029; Zeng Q, 2018, TRANSPORTMETRICA A, V14, P177, DOI 10.1080/23249935.2017.1353556; Zeng Q, 2017, ACCIDENT ANAL PREV, V100, P37, DOI 10.1016/j.aap.2016.12.023; Zhang GY, 2014, J APPL STAT, V41, P1260, DOI 10.1080/02664763.2013.864264	58	17	17	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2020	15	2							e0229422	10.1371/journal.pone.0229422	http://dx.doi.org/10.1371/journal.pone.0229422			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LQ8FM	32101566	gold, Green Published			2022-12-26	WOS:000535233700032
J	Barthel, HJ; Fougerouse, D; Geisler, T; Rust, J				Barthel, H. Jonas; Fougerouse, Denis; Geisler, Thorsten; Rust, Jes			Fluoridation of a lizard bone embedded in Dominican amber suggests open-system behavior	PLOS ONE			English	Article							RAMAN-SPECTROSCOPY; BALTIC AMBER; COLLAGEN; WATER; PRESERVATION; DIAGENESIS; EVOLUTION; PHOSPHATE; SPECTRUM; INSECTS	Vertebrate fossils embedded in amber represent a particularly valuable paleobiological record as amber is supposed to be a barrier to the environment, precluding significant alteration of the animals' body over geological time. The mode and processes of amber preservation are still under debate, and it is questionable to what extent original material may be preserved. Due to their high value, vertebrates in amber have never been examined with analytical methods, which means that the composition of bone tissue in amber is unknown. Here, we report our results of a study on a left forelimb from a fossil Anolis sp. indet. (Squamata) that was fully embedded in Miocene Dominican amber. Our results show a transformation of the bioapatite to fluorapatite associated with a severe alteration of the collagen phase and the formation of an unidentified carbonate. These findings argue for a poor survival potential of macromolecules in Dominican amber fossils.	[Barthel, H. Jonas; Rust, Jes] Rheinische Friedrich Wilhelms Univ Bonn, Inst Geosci, Paleontol Sect, Bonn, Germany; [Fougerouse, Denis] Curtin Univ, Sch Earth & Planetary Sci, Perth, WA, Australia; [Geisler, Thorsten] Rheinische Friedrich Wilhelms Univ Bonn, Inst Geosci, Geochem Petrol Sect, Bonn, Germany	University of Bonn; Curtin University; University of Bonn	Barthel, HJ (corresponding author), Rheinische Friedrich Wilhelms Univ Bonn, Inst Geosci, Paleontol Sect, Bonn, Germany.	jbarthel@uni-bonn.de	Fougerouse, Denis/AAV-4909-2021	Barthel, Jonas/0000-0001-9511-6732; Fougerouse, Denis/0000-0003-3346-1121	Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) [396704064]; Australian Research Council (ARC) [DE190101307]	Deutsche Forschungsgemeinschaft (DFG, German Research Foundation)(German Research Foundation (DFG)); Australian Research Council (ARC)(Australian Research Council)	JR obtained funding by the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation; url: https://www.dfg.de/) project number 396704064. DF obtained funding by the Australian Research Council (ARC; url: https://www.arc.gov.au/) grant number DE190101307. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold EN, 2008, ZOOTAXA, P62, DOI 10.11646/zootaxa.1847.1.5; Arnold EN, 2002, J ZOOL, V258, P7, DOI 10.1017/S0952836902001152; Awonusi A, 2007, CALCIFIED TISSUE INT, V81, P46, DOI 10.1007/s00223-007-9034-0; BADA JL, 1994, GEOCHIM COSMOCHIM AC, V58, P3131, DOI 10.1016/0016-7037(94)90185-6; Bauer AM, 2005, J ZOOL, V265, P327, DOI 10.1017/S0952836904006259; Berna F, 2004, J ARCHAEOL SCI, V31, P867, DOI 10.1016/j.jas.2003.12.003; Boanini E, 2010, ACTA BIOMATER, V6, P1882, DOI 10.1016/j.actbio.2009.12.041; Boehme Wolfgang, 2002, Faunistische Abhandlungen (Dresden), V23, P117; Borsuk-Bialynicka M, 1999, ACTA PALAEONTOL POL, V44, P349; Brody RH, 2001, SPECTROCHIM ACTA A, V57, P1325, DOI 10.1016/S1386-1425(01)00387-0; Cheng KK, 2007, BMJ-BRIT MED J, V335, P699, DOI 10.1136/bmj.39318.562951.BE; Collins MJ, 2002, ARCHAEOMETRY, V44, P383, DOI 10.1111/1475-4754.t01-1-00071; Daza JD, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1501080; Daza JD, 2013, J ZOOL SYST EVOL RES, V51, P55, DOI 10.1111/jzs.12001; Daza Juan D., 2012, Breviora, P1; deAza PN, 1997, CHEM MATER, V9, P912, DOI 10.1021/cm960425d; Dumont M, 2011, PALAEOGEOGR PALAEOCL, V310, P108, DOI 10.1016/j.palaeo.2011.06.021; Eckstein K, 1890, SCHR NATURF GES DANZ, V7, P90; Edwards HGM, 2007, SPECTROCHIM ACTA A, V68, P1089, DOI 10.1016/j.saa.2006.11.037; France CAM, 2014, J ARCHAEOL SCI, V42, P346, DOI 10.1016/j.jas.2013.11.020; Freeman JJ, 2001, CALCIFIED TISSUE INT, V68, P156, DOI 10.1007/s002230001206; Grimaldi David, 1994, American Museum Novitates, V3097, P1; Hedges REM, 2002, ARCHAEOMETRY, V44, P319, DOI 10.1111/1475-4754.00064; HENWOOD A, 1992, Palaios, V7, P203, DOI 10.2307/3514931; HENWOOD AA, 1992, PALAEONTOLOGY, V35, P901; HOPFENBERG HB, 1988, SCIENCE, V241, P717, DOI 10.1126/science.241.4866.717; Klebs R., 1910, SCHRIFTEN PHYSIKALIS, V51, P217; Koller B, 2005, P ROY SOC B-BIOL SCI, V272, P121, DOI 10.1098/rspb.2004.2939; Lafuente B., 2015, HIGHLIGHTS MINERALOG, P1, DOI DOI 10.1515/9783110417104-003; LAZELL JAMES D., 1965, J PALEONTOL, V39, P379; Lee YC, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14220; MacPhee RDE, 1996, NATURE, V380, P489, DOI 10.1038/380489b0; Marshall CP, 2010, PHILOS T R SOC A, V368, P3137, DOI 10.1098/rsta.2010.0016; Nemliher JG, 2004, LITHOL MINER RESOUR+, V39, P468, DOI 10.1023/B:LIMI.0000040736.62014.2d; Pasteris JD, 2014, AM MINERAL, V99, P16, DOI 10.2138/am.2014.4627; Pasteris JD, 2009, AM MINERAL, V94, P53, DOI 10.2138/am.2009.2926; PAWLICKI R, 1966, NATURE, V211, P655, DOI 10.1038/211655a0; Penalver E, 2005, T ROY SOC EDIN-EARTH, V96, P177, DOI 10.1017/S0263593300001292; Perrichot V, 2008, P ROY SOC B-BIOL SCI, V275, P1197, DOI 10.1098/rspb.2008.0003; Petrone P, 2013, J GEOCHEM EXPLOR, V131, P14, DOI 10.1016/j.gexplo.2012.11.012; Pfretzschner HU, 2004, CR PALEVOL, V3, P605, DOI 10.1016/j.crpv.2004.07.006; Piga G, 2009, J ARCHAEOL SCI, V36, P1857, DOI 10.1016/j.jas.2009.04.013; Polcyn M.J., 2002, PALAEONTOL ELECTRON, V5, P1; Puceat E, 2004, CHEM GEOL, V205, P83, DOI 10.1016/j.chemgeo.2003.12.014; RIEPPEL O, 1980, NATURE, V286, P486, DOI 10.1038/286486a0; Rosin-Grget K, 2001, COLLEGIUM ANTROPOL, V25, P703; SCHLEE D, 1973, Journal fuer Ornithologie, V114, P207, DOI 10.1007/BF01641171; Schlee D, 1984, STUTTGARTER BEITR C, V18, P1; Sherratt E, 2015, P NATL ACAD SCI USA, V112, P9961, DOI 10.1073/pnas.1506516112; Stankiewicz BA, 1998, P ROY SOC B-BIOL SCI, V265, P641, DOI 10.1098/rspb.1998.0342; Trueman CNG, 2004, J ARCHAEOL SCI, V31, P721, DOI 10.1016/j.jas.2003.11.003; Wilson EE, 2006, BIOPHYS J, V90, P3722, DOI 10.1529/biophysj.105.070243; Winkler W, 2001, J RAMAN SPECTROSC, V32, P59, DOI 10.1002/1097-4555(200101)32:1<59::AID-JRS670>3.0.CO;2-D; Wopenka B, 2005, MAT SCI ENG C-BIO S, V25, P131, DOI 10.1016/j.msec.2005.01.008; Xing LD, 2017, GONDWANA RES, V49, P264, DOI 10.1016/j.gr.2017.06.001; Xing LD, 2016, CURR BIOL, V26, P3352, DOI 10.1016/j.cub.2016.10.008; Xing LD, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12089	58	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2020	15	2							e0228843	10.1371/journal.pone.0228843	http://dx.doi.org/10.1371/journal.pone.0228843			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LQ8FM	32101553	Green Published, gold			2022-12-26	WOS:000535233700012
J	Zhang, A; Li, CY; Kelly, EJ; Sheppard, L; Cui, JY				Zhang, Angela; Li, Cindy Yanfei; Kelly, Edward J.; Sheppard, Lianne; Cui, Julia Yue			Transcriptomic profiling of PBDE-exposed HepaRG cells unveils critical lncRNA-PCG pairs involved in intermediary metabolism	PLOS ONE			English	Article							POLYBROMINATED DIPHENYL ETHERS; DEVELOPMENTAL EXPOSURE; OXIDATIVE STRESS; DRUG-METABOLISM; LIVER; GENE; PROTEIN; RECEPTOR; CAR; EXPRESSION	Polybrominated diphenyl ethers (PBDEs) were formally used as flame-retardants and are chemically stable, lipophlic persistent organic pollutants which are known to bioaccumulate in humans. Although its toxicities are well characterized, little is known about the changes in transcriptional regulation caused by PBDE exposure. Long non-coding RNAs (lncRNAs) are increasingly recognized as key regulators of transcriptional and translational processes. It is hypothesized that lncRNAs can regulate nearby protein-coding genes (PCGs) and changes in the transcription of lncRNAs may act in cis to perturb gene expression of its neighboring PCGs. The goals of this study were to 1) characterize PCGs and lncRNAs that are differentially regulated from exposure to PBDEs; 2) identify PCG-lncRNA pairs through genome annotation and predictive binding tools; and 3) determine enriched canonical pathways caused by differentially expressed lncRNA-PCGs pairs. HepaRG cells, which are human-derived hepatic cells that accurately represent gene expression profiles of human liver tissue, were exposed to BDE-47 and BDE-99 at a dose of 25 mu M for 24 hours. Differentially expressed lncRNA-PCG pairs were identified through DESeq2 and HOMER; significant canonical pathways were determined through Ingenuity Pathway Analysis (IPA). LncTar was used to predict the binding of 19 lncRNA-PCG pairs with known roles in drug-processing pathways. Genome annotation revealed that the majority of the differentially expressed lncRNAs map to PCG introns. PBDEs regulated overlapping pathways with PXR and CAR such as protein ubiqutination pathway and peroxisome proliferator-activated receptor alpharetinoid X receptor alpha (PPARa-RXRa) activation but also regulate distinctive pathways involved in intermediary metabolism. PBDEs uniquely down-regulated GDP-L-fucose biosynthesis, suggesting its role in modifying important pathways involved in intermediary metabolism such as carbohydrate and lipid metabolism. In conclusion, we provide strong evidence that PBDEs regulate both PCGs and lncRNAs in a PXR/CAR ligand-dependent and independent manner.	[Zhang, Angela; Sheppard, Lianne] Univ Washington, Dept Biostat, Seattle, WA 98195 USA; [Zhang, Angela; Li, Cindy Yanfei; Kelly, Edward J.; Cui, Julia Yue] Univ Washington, Dept Environm & Occupat Hlth Sci, Seattle, WA 98195 USA; [Kelly, Edward J.] Univ Washington, Dept Pharmaceut, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Cui, JY (corresponding author), Univ Washington, Dept Environm & Occupat Hlth Sci, Seattle, WA 98195 USA.	juliacui@uw.edu	Sheppard, Lianne/AAF-6304-2021; Sharma, Ashwani/AAK-3879-2020	Sheppard, Lianne/0000-0003-1622-508X; Sharma, Ashwani/0000-0001-9835-1973	National Institutes of Health [R01 GM111381, R01 ES025708, P30 ES0007033, T32 ES015459]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	National Institutes of Health R01 GM111381 Dr Julia Yue Cui National Institutes of Health R01 ES025708 Dr Julia Yue Cui University of Washington School of Public Health P30 ES0007033 Dr Julia Yue Cui University of Washington School of Public Health T32 ES015459 Lianne Sheppard	Agarwal AK, 2015, J CANCER RES CLIN, V141, P1563, DOI 10.1007/s00432-015-1917-2; Albina ML, 2010, TOXICOLOGY, V271, P51, DOI 10.1016/j.tox.2010.03.006; Andersson TB, 2012, EXPERT OPIN DRUG MET, V8, P909, DOI 10.1517/17425255.2012.685159; Attisano L, 1996, MOL CELL BIOL, V16, P1066; Barouki R, 2007, FEBS LETT, V581, P3608, DOI 10.1016/j.febslet.2007.03.046; Bonin CP, 1997, P NATL ACAD SCI USA, V94, P2085, DOI 10.1073/pnas.94.5.2085; Brandt U, 2006, ANNU REV BIOCHEM, V75, P69, DOI 10.1146/annurev.biochem.75.103004.142539; Brown KA, 2011, J STEROID BIOCHEM, V127, P439, DOI 10.1016/j.jsbmb.2011.06.005; Chai XJ, 2013, EXPERT OPIN DRUG MET, V9, P253, DOI 10.1517/17425255.2013.754010; Chau K, 2020, CLIN EXP PHARMACOL P, V47, P49, DOI 10.1111/1440-1681.13169; Chen T, 2014, BIOCHEM J, V458, P95, DOI 10.1042/BJ20130685; Cheung PCF, 2000, BIOCHEM J, V346, P659, DOI 10.1042/0264-6021:3460659; CHITTENDEN T, 1995, EMBO J, V14, P5589, DOI 10.1002/j.1460-2075.1995.tb00246.x; Chou HC, 2007, CANCER LETT, V253, P138, DOI 10.1016/j.canlet.2007.01.016; Cowens KR, 2015, J TOXICOL ENV HEAL A, V78, P1437, DOI 10.1080/15287394.2015.1098580; Cui JY, 2016, BBA-GENE REGUL MECH, V1859, P1198, DOI 10.1016/j.bbagrm.2016.04.010; Davit-Spraul A, 2010, SEMIN LIVER DIS, V30, P134, DOI 10.1055/s-0030-1253223; Dempsey JL, 2017, TOXICOL SCI, V155, P3, DOI 10.1093/toxsci/kfw203; Douglass JD, 2017, MOL METAB, V6, P366, DOI 10.1016/j.molmet.2017.01.010; Dowling RJO, 2010, BBA-PROTEINS PROTEOM, V1804, P433, DOI 10.1016/j.bbapap.2009.12.001; Durand M, 2007, BMC CELL BIOL, V8, DOI 10.1186/1471-2121-8-13; Eskenazi B, 2013, ENVIRON HEALTH PERSP, V121, P257, DOI 10.1289/ehp.1205597; Fernie KJ, 2005, TOXICOL SCI, V88, P375, DOI 10.1093/toxsci/kfi295; Ghim Jaewang, 2016, Advances in Biological Regulation, V61, P42, DOI 10.1016/j.jbior.2015.11.010; GIPP JJ, 1992, BIOCHEM BIOPH RES CO, V185, P29, DOI 10.1016/S0006-291X(05)80950-7; Hall A, 2012, BIOCHEM SOC T, V40, P1378, DOI 10.1042/BST20120103; Harada H, 1998, BIOCHIMIE, V80, P641, DOI 10.1016/S0300-9084(99)80017-0; Hart SN, 2010, DRUG METAB DISPOS, V38, P988, DOI 10.1124/dmd.109.031831; He J, 2015, CARDIOVASC DIABETOL, V14, DOI 10.1186/s12933-015-0252-x; He RZ, 2019, GENES DIS, V6, P6, DOI 10.1016/j.gendis.2019.01.003; Hood DA, 2003, MED SCI SPORT EXER, V35, P86, DOI 10.1097/00005768-200301000-00015; Hu MCT, 2004, CELL, V117, P225, DOI 10.1016/S0092-8674(04)00302-2; Jechorek D, 2014, PATHOL RES PRACT, V210, P822, DOI 10.1016/j.prp.2014.08.014; Jedlitschky G, 2006, EXPERT OPIN DRUG MET, V2, P351, DOI 10.1517/17425255.2.3.351; Jevnikar Z, 2013, J BIOL CHEM, V288, P2201, DOI 10.1074/jbc.M112.436394; Khalil A, 2018, FRONT ENDOCRINOL, V9, DOI 10.3389/fendo.2018.00548; Kleiger G, 2014, TRENDS CELL BIOL, V24, P352, DOI 10.1016/j.tcb.2013.12.003; Korkmaz G, 2012, AUTOPHAGY, V8, P165, DOI 10.4161/auto.8.2.18351; Kowalewska M, 2017, RES VET SCI, V113, P50, DOI 10.1016/j.rvsc.2017.09.003; Kwon MY, 2015, ONCOTARGET, V6, P24393, DOI 10.18632/oncotarget.5162; LaRocca J, 2014, ENVIRON RES, V133, P396, DOI 10.1016/j.envres.2014.04.032; Ledgerwood LG, 2016, ONCOTARGET, V7, P27185, DOI 10.18632/oncotarget.8448; Li CYF, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0201387; Li CY, 2018, DRUG METAB DISPOS, V46, P1226, DOI 10.1124/dmd.118.081547; Lilienthal H, 2006, ENVIRON HEALTH PERSP, V114, P194, DOI 10.1289/ehp.8391; Linares V, 2015, ARCH TOXICOL, V89, P335, DOI 10.1007/s00204-015-1457-1; Liss KHH, 2017, BIOCHIMIE, V136, P65, DOI 10.1016/j.biochi.2016.11.009; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Lu A, 2017, ONCOTARGET, V8, P17491, DOI 10.18632/oncotarget.15097; Lu SC, 2013, BBA-GEN SUBJECTS, V1830, P3143, DOI 10.1016/j.bbagen.2012.09.008; Matouk IJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000845; Noren NK, 2001, J BIOL CHEM, V276, P33305, DOI 10.1074/jbc.C100306200; Ou XJ, 2006, J MOL BIOL, V357, P858, DOI 10.1016/j.jmb.2005.12.074; Pacyniak EK, 2007, TOXICOL SCI, V97, P94, DOI 10.1093/toxsci/kfm025; Parent R, 2004, GASTROENTEROLOGY, V126, P1147, DOI 10.1053/j.gastro.2004.01.002; Patsouris D, 2004, J CLIN INVEST, V114, P94, DOI 10.1172/JC1200420468; Pawlak M, 2015, J HEPATOL, V62, P720, DOI 10.1016/j.jhep.2014.10.039; Pereira B, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11479; Pereira LC, 2017, TOXICOLOGY, V376, P59, DOI 10.1016/j.tox.2016.05.022; Qu LJ, 2016, BIOCHEM BIOPH RES CO, V470, P306, DOI 10.1016/j.bbrc.2016.01.059; Richardson VM, 2008, TOXICOL APPL PHARM, V226, P244, DOI 10.1016/j.taap.2007.09.015; Ridley AJ, 2006, TRENDS CELL BIOL, V16, P522, DOI 10.1016/j.tcb.2006.08.006; Rizner TL, 2001, STEROIDS, V66, P49, DOI 10.1016/S0039-128X(00)00138-0; Salhia B, 2008, CELL MOTIL CYTOSKEL, V65, P12, DOI 10.1002/cm.20240; Schwarz M, 2000, J CLIN INVEST, V106, P1175, DOI 10.1172/JCI10902; Scoville DK, 2019, DRUG METAB DISPOS, V47, P928, DOI 10.1124/dmd.119.086538; Skurk C, 2004, J BIOL CHEM, V279, P1513, DOI 10.1074/jbc.M304736200; Styles NA, 2016, J LIPID RES, V57, P1133, DOI 10.1194/jlr.M064428; Sueyoshi T, 2014, TOXICOL SCI, V137, P292, DOI 10.1093/toxsci/kft243; Timsit YE, 2007, STEROIDS, V72, P231, DOI 10.1016/j.steroids.2006.12.006; Tonetti M, 1996, J BIOL CHEM, V271, P27274, DOI 10.1074/jbc.271.44.27274; Tsigelny IF, 2016, ONCOTARGET, V7, P53074, DOI 10.18632/oncotarget.10628; Tyagi S, 2011, J ADV PHARM TECHNOL, V2, P236, DOI 10.4103/2231-4040.90879; Veiga-da-Cunha M, 2010, J BIOL CHEM, V285, P18888, DOI 10.1074/jbc.M110.110924; Vuong AM, 2018, HORM BEHAV, V101, P94, DOI 10.1016/j.yhbeh.2017.11.008; Wei CY, 2015, INT J CLIN EXP PATHO, V8, P14619; Willson TM, 2002, NAT REV DRUG DISCOV, V1, P259, DOI 10.1038/nrd753; Yang CX, 2019, J HAZARD MATER, V378, DOI 10.1016/j.jhazmat.2019.120766; Yousefi S, 2006, NAT CELL BIOL, V8, P1124, DOI 10.1038/ncb1482; Zanger UM, 2013, PHARMACOL THERAPEUT, V138, P103, DOI 10.1016/j.pharmthera.2012.12.007; Zauber P, 2016, INT J MOL EPIDEMIOL, V7, P24; Zhang JY, 2017, EPIDEMIOLOGY, V28, pS89, DOI [10.1097/ede.0000000000000714, 10.1097/EDE.0000000000000714]; Zhang Z, 2013, J BIOL CHEM, V288, P7769, DOI 10.1074/jbc.M112.419317; Zhang ZF, 2015, J HAZARD MATER, V283, P98, DOI 10.1016/j.jhazmat.2014.09.012; Zhao YS, 2014, AM J PHYSIOL-ENDOC M, V307, pE186, DOI 10.1152/ajpendo.00652.2013; Zhou J, 2018, MED CHEM, V14, P3, DOI 10.2174/1573406413666171020115539; Zota AR, 2018, ENVIRON INT, V115, P9, DOI 10.1016/j.envint.2018.02.044	87	6	6	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2020	15	2							e0224644	10.1371/journal.pone.0224644	http://dx.doi.org/10.1371/journal.pone.0224644			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8FM	32101552	Green Published, Green Submitted, gold			2022-12-26	WOS:000535233700003
J	Wu, H; Zhou, J; Zhu, TH; Cohen, I; Dictenberg, J				Wu, Hao; Zhou, Jing; Zhu, Tianhui; Cohen, Ivan; Dictenberg, Jason			A kinesin adapter directly mediates dendritic mRNA localization during neural development in mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						neuron; kinesin; brain-derived neurotrophic factor (BDNF); synapse; RNA interference (RNAi); BDNF; kinesin; mRNA localization; PAT1; ZBP1	MYELIN BASIC-PROTEIN; BETA-ACTIN SYNTHESIS; TUG-OF-WAR; BINDING-PROTEIN; LIGHT-CHAIN; HEAVY-CHAIN; IN-VIVO; RIBONUCLEOPROTEIN-PARTICLES; BIDIRECTIONAL TRANSPORT; SYNAPTIC PLASTICITY	Motor protein-based active transport is essential for mRNA localization and local translation in animal cells, yet how mRNA granules interact with motor proteins remains poorly understood. Using an unbiased yeast two?hybrid screen for interactions between murine RNA-binding proteins (RBPs) and motor proteins, here we identified protein interaction with APP tail-1 (PAT1) as a potential direct adapter between zipcode-binding protein 1 (ZBP1, a ?-actin RBP) and the kinesin-I motor complex. The amino acid sequence of mouse PAT1 is similar to that of the kinesin light chain (KLC), and we found that PAT1 binds to KLC directly. Studying PAT1 in mouse primary hippocampal neuronal cultures from both sexes and using structured illumination microscopic imaging of these neurons, we observed that brain-derived neurotrophic factor (BDNF) enhances co-localization of dendritic ZBP1 and PAT1 within granules that also contain kinesin-I. PAT1 is essential for BDNF-stimulated neuronal growth cone development and dendritic protrusion formation, and we noted that ZBP1 and PAT1 co-locate along with ?-actin mRNA in actively transported granules in living neurons. Acute disruption of the PAT1?ZBP1 interaction in neurons with PAT1 siRNA or a dominant-negative ZBP1 construct diminished localization of ?-actin mRNA but not of Ca2+/calmodulin-dependent protein kinase II? (CaMKII?) mRNA in dendrites. The aberrant ?-actin mRNA localization resulted in abnormal dendritic protrusions and growth cone dynamics. These results suggest a critical role for PAT1 in BDNF-induced ?-actin mRNA transport during postnatal development and reveal a new molecular mechanism for mRNA localization in vertebrates.	[Wu, Hao; Zhu, Tianhui; Cohen, Ivan] CUNY Hunter Coll, Dept Biol Sci, New York, NY 10065 USA; [Zhou, Jing] CUNY, Lehman Coll, Biol Dept, Bronx, NY 10468 USA; [Wu, Hao; Zhou, Jing; Zhu, Tianhui] CUNY, Grad Sch, Biol Program, New York, NY 10016 USA; [Wu, Hao; Zhou, Jing; Zhu, Tianhui] CUNY, Univ Ctr, New York, NY 10016 USA; [Dictenberg, Jason] SUNY Downstate, Cell Biol, Brooklyn, NY 11226 USA; [Dictenberg, Jason] AccelBio, Biotechnol Incubator, Brooklyn, NY 11226 USA	City University of New York (CUNY) System; Hunter College (CUNY); City University of New York (CUNY) System; Lehman College (CUNY); City University of New York (CUNY) System; City University of New York (CUNY) System; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center	Wu, H (corresponding author), CUNY Hunter Coll, Dept Biol Sci, New York, NY 10065 USA.; Wu, H (corresponding author), CUNY, Grad Sch, Biol Program, New York, NY 10016 USA.; Wu, H (corresponding author), CUNY, Univ Ctr, New York, NY 10016 USA.; Dictenberg, J (corresponding author), SUNY Downstate, Cell Biol, Brooklyn, NY 11226 USA.; Dictenberg, J (corresponding author), AccelBio, Biotechnol Incubator, Brooklyn, NY 11226 USA.	haowu@genectr.hunter.cuny.edu; jason@accelbio.com	Wu, Hao/V-1303-2019	Wu, Hao/0000-0001-5648-1024	National Institutes of Health [GM084805]; National Science Foundation (NSF) [0819022, 0960367]; Hunter College of the City University of New York; Lehman College of the City University of New York; Graduate Center of the City University of New York	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation (NSF)(National Science Foundation (NSF)); Hunter College of the City University of New York; Lehman College of the City University of New York; Graduate Center of the City University of New York	This work was supported by National Institutes of Health Grants GM084805 (to J. D.). Also supported by National Science Foundation (NSF) Grants 0819022 and 0960367 (to J. D.), and by Hunter College, Lehman College, and the Graduate Center of the City University of New York. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. This article contains Figs. S1-S4, Movies S1-S3, and supporting Video S1.	Antar LN, 2004, J NEUROSCI, V24, P2648, DOI 10.1523/JNEUROSCI.0099-04.2004; Bassell GJ, 1998, J NEUROSCI, V18, P251; Berezuk MA, 2007, TRAFFIC, V8, P124, DOI 10.1111/j.1600-0854.2006.00517.x; Bianco A, 2010, CURR BIOL, V20, P1487, DOI 10.1016/j.cub.2010.07.016; Blangy A, 1997, J BIOL CHEM, V272, P19418, DOI 10.1074/jbc.272.31.19418; Blower MD, 2013, INT REV CEL MOL BIO, V302, P1, DOI 10.1016/B978-0-12-407699-0.00001-7; BONNEAU AM, 1985, J CELL BIOL, V100, P1209, DOI 10.1083/jcb.100.4.1209; Bowman AB, 2000, CELL, V103, P583, DOI 10.1016/S0092-8674(00)00162-8; Boylan KLM, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040036; Bramham CR, 2007, NAT REV NEUROSCI, V8, P776, DOI 10.1038/nrn2150; Bramham CR, 2010, EXP BRAIN RES, V200, P125, DOI 10.1007/s00221-009-1959-2; Brechbiel JL, 2008, CURR BIOL, V18, P745, DOI 10.1016/j.cub.2008.04.033; Brendel C, 2004, BIOCHEM J, V384, P239, DOI 10.1042/BJ20040812; Brendza RP, 2000, SCIENCE, V289, P2120, DOI 10.1126/science.289.5487.2120; Bullock SL, 2011, BIOCHEM SOC T, V39, P1161, DOI 10.1042/BST0391161; Cajigas IJ, 2012, NEURON, V74, P453, DOI 10.1016/j.neuron.2012.02.036; Carson JH, 1997, CELL MOTIL CYTOSKEL, V38, P318, DOI 10.1002/(SICI)1097-0169(1997)38:4<318::AID-CM2>3.0.CO;2-#; Chua JJE, 2012, P NATL ACAD SCI USA, V109, P5862, DOI 10.1073/pnas.1113819109; Deacon SW, 2003, J CELL BIOL, V160, P297, DOI 10.1083/jcb.200210066; Dictenberg J, 2012, TRENDS BIOTECHNOL, V30, P621, DOI 10.1016/j.tibtech.2012.09.004; Dictenberg JB, 2008, DEV CELL, V14, P926, DOI 10.1016/j.devcel.2008.04.003; Dienstbier M, 2009, GENE DEV, V23, P1546, DOI 10.1101/gad.531009; Dunaevsky A, 1999, P NATL ACAD SCI USA, V96, P13438, DOI 10.1073/pnas.96.23.13438; Dynes JL, 2007, J COMP NEUROL, V500, P433, DOI 10.1002/cne.21189; Elvira G, 2006, MOL CELL PROTEOMICS, V5, P635, DOI 10.1074/mcp.M500255-MCP200; Eom T, 2003, J NEUROSCI, V23, P10433; Estes PS, 2008, MOL CELL NEUROSCI, V39, P170, DOI 10.1016/j.mcn.2008.06.012; Falley K, 2009, TRAFFIC, V10, P844, DOI 10.1111/j.1600-0854.2009.00912.x; Farina KL, 2003, J CELL BIOL, V160, P77, DOI 10.1083/jcb.200206003; Gagnon JA, 2011, CRIT REV BIOCHEM MOL, V46, P229, DOI 10.3109/10409238.2011.572861; Gao YZ, 2008, MOL BIOL CELL, V19, P2311, DOI 10.1091/mbc.E07-09-0914; Goetze B, 2006, J CELL BIOL, V172, P221, DOI 10.1083/jcb.200509035; Gross SP, 2007, CURR BIOL, V17, pR478, DOI 10.1016/j.cub.2007.04.025; Hendricks AG, 2010, CURR BIOL, V20, P697, DOI 10.1016/j.cub.2010.02.058; HESKETH J, 1994, MOL BIOL REP, V19, P233, DOI 10.1007/BF00986965; Hirokawa N, 2006, J NEUROSCI, V26, P7139, DOI 10.1523/JNEUROSCI.1821-06.2006; Hoogenraad CC, 2003, EMBO J, V22, P6004, DOI 10.1093/emboj/cdg592; Huang F, 2007, J NEUROSCI, V27, P9054, DOI 10.1523/JNEUROSCI.2410-07.2007; Huang YS, 2003, GENE DEV, V17, P638, DOI 10.1101/gad.1053003; Huttelmaier S, 2005, NATURE, V438, P512, DOI 10.1038/nature04115; Iacoangeli A, 2008, P NATL ACAD SCI USA, V105, P734, DOI 10.1073/pnas.0803737105; Jeong JH, 2007, J NEUROCHEM, V102, P2073, DOI 10.1111/j.1471-4159.2007.04697.x; Ji YY, 2010, NAT NEUROSCI, V13, P302, DOI 10.1038/nn.2505; Kamal A, 2001, NATURE, V414, P643, DOI 10.1038/414643a; Kanai Y, 2004, NEURON, V43, P513, DOI 10.1016/j.neuron.2004.07.022; Kanhema T, 2006, J NEUROCHEM, V99, P1328, DOI 10.1111/j.1471-4159.2006.04158.x; Kiebler MA, 2006, NEURON, V51, P685, DOI 10.1016/j.neuron.2006.08.021; Knowles RB, 1996, J NEUROSCI, V16, P7812; Kohrmann M, 1999, MOL BIOL CELL, V10, P2945, DOI 10.1091/mbc.10.9.2945; Krichevsky AM, 2001, NEURON, V32, P683, DOI 10.1016/S0896-6273(01)00508-6; Kural C, 2005, SCIENCE, V308, P1469, DOI 10.1126/science.1108408; Landers SM, 2009, EUKARYOT CELL, V8, P1072, DOI 10.1128/EC.00084-09; Liao L, 2007, J PROTEOME RES, V6, P1059, DOI 10.1021/pr060358f; Libersat F, 2004, MOL NEUROBIOL, V29, P303, DOI 10.1385/MN:29:3:303; Loiseau P, 2010, DEVELOPMENT, V137, P2763, DOI 10.1242/dev.048108; Long RM, 1997, SCIENCE, V277, P383, DOI 10.1126/science.277.5324.383; Luikart BW, 2005, J NEUROSCI, V25, P3774, DOI 10.1523/JNEUROSCI.0041-05.2005; Mallardo M, 2003, P NATL ACAD SCI USA, V100, P2100, DOI 10.1073/pnas.0334355100; Martin KC, 2009, CELL, V136, P719, DOI 10.1016/j.cell.2009.01.044; Messitt TJ, 2008, DEV CELL, V15, P426, DOI 10.1016/j.devcel.2008.06.014; Muddashetty RS, 2007, J NEUROSCI, V27, P5338, DOI 10.1523/JNEUROSCI.0937-07.2007; Muller M, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000611; Navarro C, 2004, NAT CELL BIOL, V6, P427, DOI 10.1038/ncb1122; Palacios IM, 2002, DEVELOPMENT, V129, P5473, DOI 10.1242/dev.00119; Paquin N, 2008, TRENDS CELL BIOL, V18, P105, DOI 10.1016/j.tcb.2007.12.004; Rahman A, 1999, J CELL BIOL, V146, P1277, DOI 10.1083/jcb.146.6.1277; Richter JD, 2009, GENE DEV, V23, P1, DOI 10.1101/gad.1735809; Rook MS, 2000, J NEUROSCI, V20, P6385, DOI 10.1523/JNEUROSCI.20-17-06385.2000; Sasaki Y, 2010, J NEUROSCI, V30, P9349, DOI 10.1523/JNEUROSCI.0499-10.2010; Severt WL, 1999, J CELL SCI, V112, P3691; Shan JG, 2000, J BIOL CHEM, V275, P38286, DOI 10.1074/jbc.M007642200; Shan JG, 2003, J NEUROSCI, V23, P8859; Smart FM, 2003, P NATL ACAD SCI USA, V100, P14403, DOI 10.1073/pnas.2436349100; St Johnston D, 2005, NAT REV MOL CELL BIO, V6, P363, DOI 10.1038/nrm1643; Subramanian M, 2011, EMBO REP, V12, P697, DOI 10.1038/embor.2011.76; Sutton MA, 2006, CELL, V127, P49, DOI 10.1016/j.cell.2006.09.014; Swanger SA, 2011, CURR OPIN GENET DEV, V21, P414, DOI 10.1016/j.gde.2011.04.002; Tanaka JI, 2008, SCIENCE, V319, P1683, DOI 10.1126/science.1152864; Tiruchinapalli DM, 2003, J NEUROSCI, V23, P3251; Tubing F, 2010, J NEUROSCI, V30, P4160, DOI 10.1523/JNEUROSCI.3537-09.2010; Verhey KJ, 1998, J CELL BIOL, V143, P1053, DOI 10.1083/jcb.143.4.1053; Verhey KJ, 2001, J CELL BIOL, V152, P959, DOI 10.1083/jcb.152.5.959; Vessey JP, 2008, P NATL ACAD SCI USA, V105, P16374, DOI 10.1073/pnas.0804583105; Welshhans K, 2011, J NEUROSCI, V31, P9800, DOI 10.1523/JNEUROSCI.0166-11.2011; Welte MA, 2004, CURR BIOL, V14, pR525, DOI 10.1016/j.cub.2004.06.045; Wu XQ, 2000, BIOL REPROD, V62, P720, DOI 10.1095/biolreprod62.3.720; Zalfa F, 2003, CELL, V112, P317, DOI 10.1016/S0092-8674(03)00079-5; Zhang HL, 2001, NEURON, V31, P261, DOI 10.1016/S0896-6273(01)00357-9; Zhang WD, 2001, J NEUROSCI, V21, P5169, DOI 10.1523/JNEUROSCI.21-14-05169.2001; Zimyanin VL, 2008, CELL, V134, P843, DOI 10.1016/j.cell.2008.06.053	90	12	13	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 8	2020	295	19					6605	6628		10.1074/jbc.RA118.005616	http://dx.doi.org/10.1074/jbc.RA118.005616			24	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LU3UT	32111743	Green Published, hybrid			2022-12-26	WOS:000537685000029
J	Free, CM; Mangin, T; Molinos, JG; Ojea, E; Burden, M; Costello, C; Gaines, SD				Free, Christopher M.; Mangin, Tracey; Molinos, Jorge Garcia; Ojea, Elena; Burden, Merrick; Costello, Christopher; Gaines, Steven D.			Realistic fisheries management reforms could mitigate the impacts of climate change in most countries	PLOS ONE			English	Article							ENVIRONMENTAL-CHANGE; MARINE FISHERIES; AQUACULTURE; GOVERNANCE; ADAPTATION; OCEAN; DIVERSIFICATION; VULNERABILITY; CONSERVATION; RESILIENCE	Although climate change is altering the productivity and distribution of marine fisheries, climate-adaptive fisheries management could mitigate many of the negative impacts on human society. We forecast global fisheries biomass, catch, and profits to 2100 under three climate scenarios (RCPs 4.5, 6.0, 8.5) and five levels of management reform to (1) determine the impact of climate change on national fisheries and (2) quantify the national-scale benefits of implementing climate-adaptive fisheries reforms. Management reforms accounting for shifting productivity and shifting distributions would yield higher catch and profits in the future relative to today for 60-65% of countries under the two least severe climate scenarios but for only 35% of countries under the most severe scenario. Furthermore, these management reforms would yield higher cumulative catch and profits than business-asusual management for nearly all countries under the two least severe climate scenarios but would yield lower cumulative catch for 40% of countries under the most severe scenario. Fortunately, perfect fisheries management is not necessary to achieve these benefits: transboundary cooperation with 5-year intervals between adaptive interventions would result in comparable outcomes. However, the ability for realistic management reforms to offset the negative impacts of climate change is bounded by changes in underlying biological productivity. Although realistic reforms could generate higher catch and profits for 23-50% of countries experiencing reductions in productivity, the remaining countries would need to develop, expand, and reform aquaculture and other food production sectors to offset losses in capture fisheries. Still, climate-adaptive management is more profitable than business-as-usual management in all countries and we provide guidance on implementing-and achieving the benefits of-climate-adaptive fisheries reform along a gradient of scientific, management, and enforcement capacities.	[Free, Christopher M.; Mangin, Tracey; Costello, Christopher; Gaines, Steven D.] Univ Calif Santa Barbara, Bren Sch Environm Sci & Management, Santa Barbara, CA 93106 USA; [Molinos, Jorge Garcia] Hokkaido Univ, Arctic Res Ctr, Sapporo, Hokkaido, Japan; [Molinos, Jorge Garcia] Hokkaido Univ, Global Inst Collaborat Res & Educ, Global Stn Arctic Res, Sapporo, Hokkaido, Japan; [Molinos, Jorge Garcia] Hokkaido Univ, Grad Sch Environm Sci, Sapporo, Hokkaido, Japan; [Ojea, Elena] Univ Vigo, Future Oceans Lab, CIM UVigo, Vigo, Spain; [Burden, Merrick] Environm Def Fund, New York, NY USA	University of California System; University of California Santa Barbara; Hokkaido University; Hokkaido University; Hokkaido University; Universidade de Vigo; Environmental Defense Fund	Free, CM (corresponding author), Univ Calif Santa Barbara, Bren Sch Environm Sci & Management, Santa Barbara, CA 93106 USA.	cfree14@gmail.com	Free, Christopher Michael/AAC-5103-2019; Garcia Molinos, Jorge/C-9252-2015; ojea, elena/D-3709-2018	Free, Christopher Michael/0000-0002-2557-8920; Garcia Molinos, Jorge/0000-0001-7516-1835; ojea, elena/0000-0003-4991-8077	Environmental Defense Fund; "Tenure-Track System Promotion Program" of the Japanese Ministry of Education, Culture, Sports, Science and Technology (MEXT); European Research Council project CLOCK [679812]; GAINXunta de Galicia Oportunius program	Environmental Defense Fund; "Tenure-Track System Promotion Program" of the Japanese Ministry of Education, Culture, Sports, Science and Technology (MEXT); European Research Council project CLOCK; GAINXunta de Galicia Oportunius program	This work was funded by the Environmental Defense Fund. J.G.M. was supported by the "Tenure-Track System Promotion Program" of the Japanese Ministry of Education, Culture, Sports, Science and Technology (MEXT). E.O. was supported by the European Research Council project CLOCK (GA. 679812) and GAINXunta de Galicia Oportunius program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abate TG, 2016, AQUACULT ECON MANAG, V20, P201, DOI 10.1080/13657305.2016.1156191; Allison EH, 2009, FISH FISH, V10, P173, DOI 10.1111/j.1467-2979.2008.00310.x; Andrea Moreno, 2014, SYSTEM TERRITORIAL U, P88; [Anonymous], 2019, IPCC SPECIAL REPORT; Aqorau T, 2018, SCIENCE, V361, P1208, DOI 10.1126/science.aav2051; Atkinson DB, 1997, DISTRIBUTION CHANGES, V54, P7; Barange M, 2019, ICES J MAR SCI, V76, P1390, DOI 10.1093/icesjms/fsz061; Blasiak R, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179632; Bundy A, 2017, FISH FISH, V18, P412, DOI 10.1111/faf.12184; Charles A, 2012, CURR OPIN ENV SUST, V4, P351, DOI 10.1016/j.cosust.2012.05.011; Cheung WWL, 2016, SCIENCE, V354, P1591, DOI 10.1126/science.aag2331; Cinner JE, 2009, CONSERV BIOL, V23, P124, DOI 10.1111/j.1523-1739.2008.01041.x; Cinner JE, 2018, NAT CLIM CHANGE, V8, P117, DOI 10.1038/s41558-017-0065-x; Cline TJ, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14042; Cochrane KL, 2011, FISH FISH, V12, P275, DOI 10.1111/j.1467-2979.2010.00392.x; Costello C, 2008, SCIENCE, V321, P1678, DOI 10.1126/science.1159478; Costello C, 2016, P NATL ACAD SCI USA, V113, P5125, DOI 10.1073/pnas.1520420113; Costello C, 2010, ANNU REV RESOUR ECON, V2, P299, DOI 10.1146/annurev.resource.012809.103923; Davies IP, 2019, MAR POLICY, V104, P29, DOI 10.1016/j.marpol.2019.02.054; Daw TM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031460; Diana JS, 2009, BIOSCIENCE, V59, P27, DOI 10.1525/bio.2009.59.1.7; emLab, 2019, ESTIMATING THE OCEAN; FAO, 2018, STAT WORLD FISH AQ 2, P1, DOI DOI 10.18356/EECA78E4-EN; Fedele G, 2019, ENVIRON SCI POLICY, V101, P116, DOI 10.1016/j.envsci.2019.07.001; Fisher JAD, 2004, MAR ECOL PROG SER, V279, P201, DOI 10.3354/meps279201; Free CM, 2019, SCIENCE, V363, P979, DOI 10.1126/science.aau1758; Froehlich HE, 2018, NAT ECOL EVOL, V2, P1745, DOI 10.1038/s41559-018-0669-1; Gaichas SK, 2016, FRONT MAR SCI, V3, DOI 10.3389/fmars.2016.00105; Gaines SD, 2018, SCI ADV, V4, DOI 10.1126/sciadv.aao1378; Gentry RR, 2019, NAT SUSTAIN, V2, P949, DOI 10.1038/s41893-019-0395-y; Gentry RR, 2017, NAT ECOL EVOL, V1, P1317, DOI 10.1038/s41559-017-0257-9; Golden C, 2016, NATURE, V534, P317, DOI 10.1038/534317a; Guillotreau P, 2012, CURR OPIN ENV SUST, V4, P287, DOI 10.1016/j.cosust.2012.06.003; Gutierrez NL, 2011, NATURE, V470, P386, DOI 10.1038/nature09689; Hare JA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146756; Havice E, 2013, MAR POLICY, V42, P259, DOI 10.1016/j.marpol.2013.03.003; Hazen EL, 2018, SCI ADV, V4, DOI 10.1126/sciadv.aar3001; Hixon MA, 2014, ICES J MAR SCI, V71, P2171, DOI 10.1093/icesjms/fst200; Hobday AJ, 2018, FRONT MAR SCI, V5, DOI 10.3389/fmars.2018.00137; Hobday AJ, 2016, FISH OCEANOGR, V25, P45, DOI 10.1111/fog.12083; Holsman K, 2017, ECOSYST HEALTH SUST, V3, DOI 10.1002/ehs2.1256; Holsman KK, 2019, ICES J MAR SCI, V76, P1368, DOI 10.1093/icesjms/fsz031; Hughes TP, 2005, TRENDS ECOL EVOL, V20, P380, DOI 10.1016/j.tree.2005.03.022; Karp MA, 2019, ICES J MAR SCI, V76, P1305, DOI 10.1093/icesjms/fsz048; Kaschner K., 2019, AQUAMAPS PREDICTED R; Kasperski S, 2013, P NATL ACAD SCI USA, V110, P2076, DOI 10.1073/pnas.1212278110; Klinger D, 2012, ANNU REV ENV RESOUR, V37, P247, DOI 10.1146/annurev-environ-021111-161531; Klinger DH, 2017, P ROY SOC B-BIOL SCI, V284, DOI 10.1098/rspb.2017.0834; Lam VWY, 2016, SCI REP-UK, V6, DOI 10.1038/srep32607; Lester SE, 2018, P NATL ACAD SCI USA, V115, P7162, DOI 10.1073/pnas.1808737115; Lotze HK, 2019, P NATL ACAD SCI USA, V116, P12907, DOI 10.1073/pnas.1900194116; MacCall AD., 1990, DYNAMIC GEOGRAPHY MA; Marshall KN, 2019, ICES J MAR SCI, V76, P1, DOI 10.1093/icesjms/fsy152; Martell S, 2013, FISH FISH, V14, P504, DOI 10.1111/j.1467-2979.2012.00485.x; Melnychuk MC, 2017, ICES J MAR SCI, V74, P121, DOI 10.1093/icesjms/fsw169; Melnychuk MC, 2017, P NATL ACAD SCI USA, V114, P178, DOI 10.1073/pnas.1609915114; Melnychuk MC, 2012, FISH FISH, V13, P267, DOI 10.1111/j.1467-2979.2011.00429.x; Metcalf SJ, 2015, ECOL SOC, V20, DOI 10.5751/ES-07509-200235; Miller K.A., 2004, MARINE RESOURCE EC, V19, P367, DOI DOI 10.1086/MRE.19.3.42629440; Miller K, 2010, PROG OCEANOGR, V87, P338, DOI 10.1016/j.pocean.2010.09.014; Miller TJ, 2018, FISHERIES, V43, P533, DOI 10.1002/fsh.10179; Molinos JG, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01309-y; Molinos JG, 2016, NAT CLIM CHANGE, V6, P83, DOI [10.1038/NCLIMATE2769, 10.1038/nclimate2769]; Moore SS, 2013, POINT BLUE CONSERVAT; Mora C, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000131; Neubauer P, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0196483; NOAA,, 2018, CAS DEF STON COR TIS, P1; Ojea E, 2017, AMBIO, V46, P399, DOI 10.1007/s13280-016-0850-1; Pella J. J., 1969, Bulletin Inter-American Tropical Tuna Commission, V13, P421; Pinsky ML, 2018, SCIENCE, V360, P1189, DOI 10.1126/science.aat2360; Pinsky ML, 2014, OCEANOGRAPHY, V27, P146, DOI 10.5670/oceanog.2014.93; Pinsky ML, 2013, SCIENCE, V341, P1239, DOI 10.1126/science.1239352; Poloczanska ES, 2016, FRONT MAR SCI, V3, DOI 10.3389/fmars.2016.00062; Poloczanska ES, 2013, NAT CLIM CHANGE, V3, P919, DOI [10.1038/nclimate1958, 10.1038/NCLIMATE1958]; Punt AE, 2016, FISH FISH, V17, P303, DOI 10.1111/faf.12104; Punt AE, 2014, ICES J MAR SCI, V71, P2208, DOI 10.1093/icesjms/fst057; Ricard D, 2012, FISH FISH, V13, P380, DOI 10.1111/j.1467-2979.2011.00435.x; Richards LJ, 1998, CAN J FISH AQUAT SCI, V55, P1545, DOI 10.1139/cjfas-55-6-1545; Rijnsdorp AD, 2009, ICES J MAR SCI, V66, P1570, DOI 10.1093/icesjms/fsp056; Robinson LM, 2019, ECOSYSTEMS, V22, P1573, DOI 10.1007/s10021-019-00358-w; Schatz VJ, 2019, INT J MAR COAST LAW, V34, P195, DOI 10.1163/15718085-23342015; Schlenker W, 2010, ENVIRON RES LETT, V5, DOI 10.1088/1748-9326/5/1/014010; Serdy A., 2016, CAMBRIDGE CORE; Simpson MR, 2004, J SEA RES, V51, P199, DOI 10.1016/j.seares.2003.08.007; Singh GG, 2019, PEOPLE NAT, V1, P317, DOI 10.1002/pan3.26; Skern-Mauritzen M, 2016, FISH FISH, V17, P165, DOI 10.1111/faf.12111; Soto D, 2018, IMPACTS CLIMATE CHAN, P26; SOUTHWARD AJ, 1995, J THERM BIOL, V20, P127, DOI 10.1016/0306-4565(94)00043-I; Spijkers J, 2019, GLOBAL ENVIRON CHANG, V57, DOI 10.1016/j.gloenvcha.2019.05.005; Spijkers J, 2017, REG ENVIRON CHANGE, V17, P1835, DOI 10.1007/s10113-017-1150-4; Sullivan MC, 2006, CONT SHELF RES, V26, P1551, DOI 10.1016/j.csr.2006.03.012; Sumaila UR, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aau3855; Szuwalski CS, 2016, ICES J MAR SCI, V73, P1297, DOI 10.1093/icesjms/fsv229; Thorson JT, 2012, CAN J FISH AQUAT SCI, V69, P1556, DOI 10.1139/F2012-077; Tommasi D, 2017, ECOL APPL, V27, P378, DOI 10.1002/eap.1458; Willett W, 2019, LANCET, V393, P447, DOI 10.1016/S0140-6736(18)31788-4; Zador S, 2011, MAR ECOL PROG SER, V438, P229, DOI 10.3354/meps09316	97	30	32	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2020	15	3							e0224347	10.1371/journal.pone.0224347	http://dx.doi.org/10.1371/journal.pone.0224347			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LQ8RK	32134926	Green Published, Green Submitted, gold			2022-12-26	WOS:000535265600009
J	Adelowo, OO; Ikhimiukor, OO; Knecht, C; Vollmers, J; Bhatia, M; Kaster, AK; Muller, JA				Adelowo, Olawale Olufemi; Ikhimiukor, Odion Osebhahiemen; Knecht, Camila; Vollmers, John; Bhatia, Mudit; Kaster, Anne-Kirstin; Mueller, Jochen A.			A survey of extended-spectrum beta-lactamase-producing Enterobacteriaceae in urban wetlands in southwestern Nigeria as a step towards generating prevalence maps of antimicrobial resistance	PLOS ONE			English	Article							ESCHERICHIA-COLI; ANTIBIOTIC-RESISTANCE; KLEBSIELLA-PNEUMONIAE; GENE-MUTATIONS; INCF PLASMIDS; DNA-SEQUENCE; DIVERSITY; TIME; IDENTIFICATION; WASTEWATERS	In many countries, emission of insufficiently treated wastewater into water bodies appears to be an important factor in spreading clinically relevant antimicrobial resistant bacteria. In this study, we looked for the presence of Enterobacteriaceae strains with resistance to 3rd generation cephalosporin antibiotics in four urban wetlands in southwestern Nigeria by isolation, whole genome sequencing and qPCR enumeration of marker genes. Genome analysis of multi-drug resistant and potentially pathogenic Escherichia coli isolates (members of the widely distributed ST10 complex) revealed the presence of the extended spectrum beta-lactamase gene bla(CTX-M-15) on self-transmissible IncF plasmids. The gene was also present together with a bla(TEM-1B) gene on self-transmissible IncH plasmids in multi-drug resistant Enterobacter cloacae isolates. A Citrobacter freundii isolate carried bla(TEM-1B) on an IncR-type plasmid without discernable conjugation apparatus. All strains were isolated from a wetland for which previous qPCR enumeration of marker genes, in particular the ratio of intI1 to 16S rRNA gene copy numbers, had indicated a strong anthropogenic impact. Consistent with the isolation origin, qPCR analysis in this study showed that the bla(CTX-M) gene was present at an abundance of 1x10(-4) relative to bacterial 16S rRNA gene copy numbers. The results indicate that contamination of these urban aquatic ecosystems with clinically relevant antibiotic resistant bacteria is substantial in some areas. Measures should therefore be put in place to mitigate the propagation of clinically relevant antimicrobial resistance within the Nigerian aquatic ecosystems.	[Adelowo, Olawale Olufemi; Ikhimiukor, Odion Osebhahiemen; Knecht, Camila; Bhatia, Mudit; Mueller, Jochen A.] UFZ Helmholtz Ctr Environm Res, Dept Environm Biotechnol, Leipzig, Germany; [Adelowo, Olawale Olufemi; Ikhimiukor, Odion Osebhahiemen] Univ Ibadan, Dept Microbiol, Environm Microbiol & Biotechnol Lab, Ibadan, Nigeria; [Knecht, Camila] Otto von Guericke Univ, Inst Apparat & Environm Technol, Magdeburg, Germany; [Vollmers, John; Kaster, Anne-Kirstin] Karlsruhe Inst Technol, Inst Biol Interfaces IBG5, Eggenstein Leopoldshafen, Germany	Helmholtz Association; Helmholtz Center for Environmental Research (UFZ); University of Ibadan; Otto von Guericke University; Helmholtz Association; Karlsruhe Institute of Technology	Adelowo, OO; Muller, JA (corresponding author), UFZ Helmholtz Ctr Environm Res, Dept Environm Biotechnol, Leipzig, Germany.; Adelowo, OO (corresponding author), Univ Ibadan, Dept Microbiol, Environm Microbiol & Biotechnol Lab, Ibadan, Nigeria.	onomewaleadelowo@yahoo.co.uk; jochen.mueller@ufz.de	ADELOWO, OLAWALE/ABC-5821-2020; Ikhimiukor, Odion O/Z-1168-2018; Vollmers, John/H-1075-2019; Muller, Jochen A./T-7318-2019	Vollmers, John/0000-0001-5980-5178; Knecht, Camila A./0000-0002-2908-6157; Muller, Jochen A./0000-0002-0935-1523; Odion, Ikhimiukor/0000-0002-3738-4584; ADELOWO, OLAWALE OLUFEMI/0000-0002-5235-8122	Georg Forster (HERMES) Postdoctoral Fellowship of the Alexander von Humboldt-Foundation; German Academic Exchange Service (DAAD)	Georg Forster (HERMES) Postdoctoral Fellowship of the Alexander von Humboldt-Foundation; German Academic Exchange Service (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD))	This work was supported by a Georg Forster (HERMES) Postdoctoral Fellowship of the Alexander von Humboldt-Foundation (https://www.humboldt-foundation.de) to OOA, an international fellowship by the Otto-Bayer-Foundation (http://www.bayer-foundations.com/en/internationalfellowship.aspx) to OOI, a doctoral stipend of the Henrich-Boll-Foundation (https://www.boell.de) to CK, and an internship fellowship by the German Academic Exchange Service (DAAD) (https://www.daad.de) to MB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adelowo OO, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-33535-3; Adelowo OO, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0208269; Adelowo OO, 2018, ENVIRON SCI POLLUT R, V25, P2744, DOI 10.1007/s11356-017-0686-7; Aibinu I, 2012, CLIN MICROBIOL INFEC, V18, pE49, DOI 10.1111/j.1469-0691.2011.03730.x; Anzai Y, 2000, INT J SYST EVOL MICR, V50, P1563, DOI 10.1099/00207713-50-4-1563; Arndt D, 2016, NUCLEIC ACIDS RES, V44, pW16, DOI 10.1093/nar/gkw387; Bankevich A, 2012, J COMPUT BIOL, V19, P455, DOI 10.1089/cmb.2012.0021; BARTOWSKY E, 1991, MOL MICROBIOL, V5, P1715, DOI 10.1111/j.1365-2958.1991.tb01920.x; Berendonk TU, 2015, NAT REV MICROBIOL, V13, P310, DOI 10.1038/nrmicro3439; Bergeron S, 2016, INT BIODETER BIODEGR, V113, P80, DOI 10.1016/j.ibiod.2016.02.008; Bevan ER, 2017, J ANTIMICROB CHEMOTH, V72, P2145, DOI 10.1093/jac/dkx146; Billard-Pomares T, 2019, ANTIMICROB AGENTS CH, V63, DOI 10.1128/AAC.00635-19; Blaak H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127752; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Bonnet R, 2004, ANTIMICROB AGENTS CH, V48, P1, DOI 10.1128/AAC.48.1.1-14.2004; Borgogna TR, 2016, MICROB DRUG RESIST, V22, P312, DOI 10.1089/mdr.2015.0197; Bortolaia V, 2011, APPL ENVIRON MICROB, V77, P5830, DOI 10.1128/AEM.02890-10; Branger C, 2018, MICROB GENOMICS, V4, DOI 10.1099/mgen.0.000203; Canton R, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00110; Carattoli A, 2014, ANTIMICROB AGENTS CH, V58, P3895, DOI 10.1128/AAC.02412-14; Carattoli A, 2009, ANTIMICROB AGENTS CH, V53, P2227, DOI 10.1128/AAC.01707-08; Chen YT, 2009, ANTIMICROB AGENTS CH, V53, P1235, DOI 10.1128/AAC.00970-08; CHUBA PJ, 1989, MOL GEN GENET, V216, P287, DOI 10.1007/BF00334367; Clinical and Laboratory Standards Institute, 2015, PERFORMANCE STANDARD, V27th; Collignon P, 2018, LANCET PLANET HEALTH, V2, pE398, DOI 10.1016/S2542-5196(18)30186-4; Colomer-Lluch M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017549; Czeczulin JR, 1999, INFECT IMMUN, V67, P2692, DOI 10.1128/IAI.67.6.2692-2699.1999; Darling AE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011147; Day MJ, 2016, J ANTIMICROB CHEMOTH, V71, P1178, DOI 10.1093/jac/dkv485; Devarajan N, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149211; Falgenhauer L, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.02779; Finley RL, 2013, CLIN INFECT DIS, V57, P704, DOI 10.1093/cid/cit355; Gillings MR, 2015, ISME J, V9, P1269, DOI 10.1038/ismej.2014.226; Gomi R, 2017, APPL ENVIRON MICROB, V83, DOI [10.1128/AEM.02703-16, 10.1128/aem.02703-16]; Gupta A, 2001, MICROBIOL-SGM, V147, P3393, DOI 10.1099/00221287-147-12-3393; Guyomard-Rabenirina S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173155; Hendriksen RS, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-08853-3; Ho PL, 2015, J MED MICROBIOL, V64, P185, DOI 10.1099/jmm.0.000001-0; Huang Z., 2019, ENVIRON SCI EUR, V31, P1, DOI DOI 10.1186/s12302-018-0176-7; Irrgang A, 2018, VET MICROBIOL, V221, P98, DOI 10.1016/j.vetmic.2018.06.003; Izdebski R, 2013, ANTIMICROB AGENTS CH, V57, P309, DOI 10.1128/AAC.01656-12; Joensen KG, 2014, J CLIN MICROBIOL, V52, P1501, DOI 10.1128/JCM.03617-13; Johnson TJ, 2006, ANTIMICROB AGENTS CH, V50, P3929, DOI 10.1128/AAC.00569-06; Kaas RS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104984; Kaneko K, 2005, J CLIN MICROBIOL, V43, P2955, DOI 10.1128/JCM.43.6.2955-2958.2005; Kaushik R, 2012, ATMOS ENVIRON, V46, P131, DOI 10.1016/j.atmosenv.2011.10.013; Kuga A, 2000, ANTIMICROB AGENTS CH, V44, P561, DOI 10.1128/AAC.44.3.561-567.2000; Laffite A, 2020, EXPOS HEALTH, V12, P187, DOI 10.1007/s12403-019-00304-0; Laffite A, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01128; Lane D.J., 1991, NUCLEIC ACID TECHNIQ; Larsen MV, 2012, J CLIN MICROBIOL, V50, P1355, DOI 10.1128/JCM.06094-11; Li JJ, 2015, ANTIMICROB AGENTS CH, V59, P3002, DOI 10.1128/AAC.04772-14; Lin JS, 1996, APPL ENVIRON MICROB, V62, P3094, DOI 10.1128/AEM.62.9.3094-3100.1996; Liu HX, 2018, BMC MICROBIOL, V18, DOI 10.1186/s12866-018-1270-0; MARTINEZ JL, 1994, J MOL BIOL, V238, P288, DOI 10.1006/jmbi.1994.1290; Mazel D, 2000, ANTIMICROB AGENTS CH, V44, P1568, DOI 10.1128/AAC.44.6.1568-1574.2000; Mohsin M, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.02476; Mulet M, 2000, ENVIRON MICROBIOL, V12, P1513; Trung NT, 2015, ANN CLIN MICROB ANTI, V14, DOI 10.1186/s12941-015-0079-z; Obasi A, 2017, MICROB DRUG RESIST, V23, P1013, DOI 10.1089/mdr.2016.0269; Okeke IN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014093; Orsini M, 2001, LETT APPL MICROBIOL, V33, P17, DOI 10.1046/j.1472-765X.2001.00938.x; Oyelade AA, 2018, ENVIRON SCI POLLUT R, V25, P33538, DOI 10.1007/s11356-018-3306-2; Papagiannitsis CC, 2013, J ANTIMICROB CHEMOTH, V68, P2259, DOI 10.1093/jac/dkt196; Parks DH, 2015, GENOME RES, V25, P1043, DOI 10.1101/gr.186072.114; Paterson DL, 2005, CLIN MICROBIOL REV, V18, P657, DOI 10.1128/CMR.18.4.657-686.2005; Pecor ND, 2015, MBIO, V6, DOI 10.1128/mBio.01030-15; Perry J, 2016, CSH PERSPECT MED, V6, DOI 10.1101/cshperspect.a025197; Petersen J, 2019, P NATL ACAD SCI USA, V116, P20568, DOI 10.1073/pnas.1905878116; Rodriguez-Bano J, 2018, CLIN MICROBIOL REV, V31, DOI 10.1128/CMR.00079-17; Rozwandowicz M, 2018, J ANTIMICROB CHEMOTH, V73, P1121, DOI 10.1093/jac/dkx488; Saeed DK, 2017, ANTIMICROB RESIST IN, V6, DOI 10.1186/s13756-017-0260-6; SAVARINO SJ, 1993, P NATL ACAD SCI USA, V90, P3093, DOI 10.1073/pnas.90.7.3093; Seemann T, 2014, BIOINFORMATICS, V30, P2068, DOI 10.1093/bioinformatics/btu153; Singh NS, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.00382; Ullah R, 2019, SCI TOTAL ENVIRON, V677, P474, DOI 10.1016/j.scitotenv.2019.04.283; United Nations Inter Agency Coordination Group on Antimicrobial Resistance (UN-IACG), 2019, REPORT TO THE SECRET; Villa L, 2010, J ANTIMICROB CHEMOTH, V65, P2518, DOI 10.1093/jac/dkq347; Voets GM, 2011, INT J ANTIMICROB AG, V37, P356, DOI 10.1016/j.ijantimicag.2011.01.005; Wang HY, 2019, INFORMATION, V10, DOI 10.3390/info10030099; Yang QE, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00964; Yang Y, 2012, APPL MICROBIOL BIOT, V95, P1351, DOI 10.1007/s00253-011-3810-5; Zankari E, 2012, J ANTIMICROB CHEMOTH, V67, P2640, DOI 10.1093/jac/dks261; Zarfel G, 2017, SCI TOTAL ENVIRON, V593, P399, DOI 10.1016/j.scitotenv.2017.03.138; Zhang HJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006108	85	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2020	15	3							e0229451	10.1371/journal.pone.0229451	http://dx.doi.org/10.1371/journal.pone.0229451			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8QU	32130234	gold, Green Published			2022-12-26	WOS:000535264000026
J	Aydin, OF; Gokasar, I; Kalan, O				Aydin, Omer Faruk; Gokasar, Ilgin; Kalan, Onur			Matching algorithm for improving ride-sharing by incorporating route splits and social factors	PLOS ONE			English	Article							TAXI; OPTIMIZATION	Increasing traffic congestion and the advancements in technology have fostered the growth of alternative transportation modes such as dynamic ride-sharing. Smartphone technologies have enabled dynamic ride-sharing to thrive, as this type of transportation aims to establish ride matches between people with similar routes and schedules on short notice. Many automated matching methods are designed to improve system performance; such methods include minimizing process time, minimizing total system cost or maximizing total distance savings. However, the results may not provide the maximum benefits for the participants. This paper intends to develop an algorithm for optimizing matches when considering participants' gender, age, employment status and social tendencies. The proposed matching algorithm also splits unmatched parts of drivers' routes and creates new travel requests to find additional matches using these unmatched parts. Accordingly, this paper performs an extensive simulation study to assess the performance of the proposed algorithm. The simulation results indicate that route splits may increase the number of matches significantly when there is a shortage of drivers. Furthermore, the paper demonstrates the effects and potential benefits of utilizing a social compatibility score in the objective function.	[Aydin, Omer Faruk; Gokasar, Ilgin] Bogazici Univ, Dept Civil Engn, Istanbul, Turkey; [Aydin, Omer Faruk] Turkish German Univ, Dept Civil Engn, Istanbul, Turkey; [Kalan, Onur] NYU, Dept Civil & Urban Engn, New York, NY USA	Bogazici University; Turkish German University; New York University; New York University Tandon School of Engineering	Gokasar, I (corresponding author), Bogazici Univ, Dept Civil Engn, Istanbul, Turkey.	ilgin.gokasar@boun.edu.tr	Aydın, Ömer Faruk/AAA-1635-2020; GOKASAR, ILGIN/N-7044-2016	Aydın, Ömer Faruk/0000-0001-9345-3997; GOKASAR, ILGIN/0000-0001-9896-9220				Agatz N., 2010, SUSTAINABLE PASSENGE; Agatz N, 2012, EUR J OPER RES, V223, P295, DOI 10.1016/j.ejor.2012.05.028; Agatz NAH, 2011, TRANSPORT RES B-METH, V45, P1450, DOI 10.1016/j.trb.2011.05.017; Baldacci R, 2004, OPER RES, V52, P422, DOI 10.1287/opre.1030.0106; Ben Cheikh S, 2016, EXPERT SYST APPL, V62, P161, DOI 10.1016/j.eswa.2016.06.001; Chan ND, 2012, TRANSPORT REV, V32, P93, DOI 10.1080/01441647.2011.621557; Chen P.-Y., 2010, VEH TECHN C FALL VTC, P1, DOI DOI 10.1109/VETECF.2010.5594422; Di Febbraro A, 2013, TRANSPORT RES REC, P44, DOI 10.3141/2359-06; Dijkstra E.W, 1959, NUMER MATH, V1, P269, DOI DOI 10.1007/BF01386390; Edrissi A, 2013, EUR J OPER RES, V229, P261, DOI 10.1016/j.ejor.2013.03.008; EEA (European Environment Agency), 2005, HOUSEHOLD CONSUMPTIO; European Environment Agency EEA, 2015, OCC RAT PASS VEH; Furuhata M, 2013, TRANSPORT RES B-METH, V57, P28, DOI 10.1016/j.trb.2013.08.012; Ghoseiri K., 2013, DYNAMIC RIDESHARE OP; Ghoseiri K., 2011, REAL TIME RIDESHARE; Gokasar I, 2014, TEK DERGI, V25, P6655; Gu QP, 2018, THEOR COMPUT SCI, V749, P36, DOI 10.1016/j.tcs.2017.08.019; Gunturu S., 2005, LOAD SCHEDULING BIOI; Herbawi W, 2012, PROCEEDINGS OF THE FOURTEENTH INTERNATIONAL CONFERENCE ON GENETIC AND EVOLUTIONARY COMPUTATION CONFERENCE, P385, DOI 10.1145/2330163.2330219; Jiang W., 2018, INT J TRANSPORTATION, V7, P45, DOI [10.1016/j.ijtst.2017.10.002, DOI 10.1016/J.IJTST.2017.10.002]; Kalan O., 2017, RELATIONSHIP EC GROW; Lee A, 2015, TRANSPORT RES B-METH, V81, P483, DOI 10.1016/j.trb.2015.02.013; Litman T., 2010, EVALUATING TRANSPORT; Ma S, 2013, PROC INT CONF DATA, P410, DOI 10.1109/ICDE.2013.6544843; Masoud N, 2017, TRANSPORT RES B-METH, V106, P218, DOI 10.1016/j.trb.2017.10.006; Masoud N, 2017, TRANSPORT RES B-METH, V99, P1, DOI 10.1016/j.trb.2017.01.004; Najmi A, 2017, TRANSPORT RES E-LOG, V108, P122, DOI 10.1016/j.tre.2017.10.009; NEEDLEMAN SB, 1970, J MOL BIOL, V48, P443, DOI 10.1016/0022-2836(70)90057-4; Nielsen JR, 2015, TRANSPORT RES A-POL, V78, P113, DOI 10.1016/j.tra.2015.04.033; Nourinejad M, 2016, TRANSPORT RES C-EMER, V64, P117, DOI 10.1016/j.trc.2015.07.016; Qian XW, 2017, TRANSPORT RES B-METH, V103, P208, DOI 10.1016/j.trb.2017.03.001; Santos D.O., 2013, P 23 INT JOINT C ART, P2885, DOI [10.5555/2540128.2540544, DOI 10.5555/2540128.2540544]; Santos DO, 2015, EXPERT SYST APPL, V42, P6728, DOI 10.1016/j.eswa.2015.04.060; Shaheen SA, 2016, TRANSPORT POLICY, V51, P165, DOI 10.1016/j.tranpol.2016.01.003; Stiglic M, 2015, TRANSPORT RES B-METH, V82, P36, DOI 10.1016/j.trb.2015.07.025; Wang X, 2014, ERIM REPORT SERIES R; WATSON SK, 2004, MOL BIOL GENE, V5, P6; Xing X, 2009, LECT NOTES ARTIF INT, V5774, P165, DOI 10.1007/978-3-642-04143-3_15; Yan SY, 2011, IEEE T INTELL TRANSP, V12, P1362, DOI 10.1109/TITS.2011.2158209	39	8	8	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2020	15	3							e0229674	10.1371/journal.pone.0229674	http://dx.doi.org/10.1371/journal.pone.0229674			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8QU	32130273	Green Published, gold			2022-12-26	WOS:000535264000042
J	Jushaj, A; Churgin, M; Yao, BW; De La Torre, M; Fang-Yen, C; Temmerman, L				Jushaj, Areta; Churgin, Matthew; Yao, Bowen; De La Torre, Miguel; Fang-Yen, Christopher; Temmerman, Liesbet			Optimized criteria for locomotion-based healthspan evaluation in C. elegans using the WorMotel system	PLOS ONE			English	Article							AGE-RELATED-CHANGES; LIFE-SPAN; CAENORHABDITIS-ELEGANS	Getting a grip on how we may age healthily is a central interest of biogerontological research. To this end, a number of academic teams developed platforms for life- and health-span assessment in Caenorhabditis elegans. These are very appealing for medium- to high throughput screens, but a broader implementation is lacking due to many systems relying on custom scripts for data analysis that others struggle to adopt. Hence, user-friendly recommendations would help to translate raw data into interpretable results. The aim of this communication is to streamline the analysis of data obtained by the WorMotel, an economically and practically appealing screening platform, in order to facilitate the use of this system by interested researchers. We here detail recommendations for the stepwise conversion of raw image data into activity values and explain criteria for assessment of health in C. elegans based on locomotion. Our analysis protocol can easily be adopted by researchers, and all needed scripts and a tutorial are available in S1 and S2 Files.	[Jushaj, Areta; Temmerman, Liesbet] Katholieke Univ Leuven, Dept Biol, Anim Physiol & Neurobiol, Leuven, Belgium; [Churgin, Matthew; Yao, Bowen; De La Torre, Miguel; Fang-Yen, Christopher] Univ Penn, Dept Bioengn, Philadelphia, PA 19104 USA	KU Leuven; University of Pennsylvania	Temmerman, L (corresponding author), Katholieke Univ Leuven, Dept Biol, Anim Physiol & Neurobiol, Leuven, Belgium.	Liesbet.Temmerman@kuleuven.be	Fang-Yen, Christopher/AAY-9017-2020	Temmerman, Liesbet/0000-0002-1249-3995; Churgin, Matthew/0000-0003-2299-0124	European Union [633589]; KU Leuven Research Council [C14/15/049]; FWO Flanders [V426816N, K218918N]; Junior Mobility Program at KU Leuven [JUMO/16/021, JUMO/18/009]; National Institutes of Health (Office of Research Infrastructure Programs) [P40 OD010440]	European Union(European Commission); KU Leuven Research Council(KU Leuven); FWO Flanders(FWO); Junior Mobility Program at KU Leuven; National Institutes of Health (Office of Research Infrastructure Programs)	All authors received project funding from the European Union's Horizon 2020 research and innovation programme (633589). This work was supported by the KU Leuven Research Council (C14/15/049) to LT. AJ received travel support from the FWO Flanders (V426816N and K218918N) and Junior Mobility Program at KU Leuven (JUMO/16/021 and JUMO/18/009). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Strains used in this study were provided by the Caenorhabditis Genetics Center (CGC), which is funded by National Institutes of Health (Office of Research Infrastructure Programs Grant P40 OD010440). European Union's Horizon 2020 research and innovation programme: https://ec.europa.eu/programmes/horizon2020/en).KULeuven Research Council: https://admin.kuleuven.be/raden/en/research-council FWO: https://www.fwo.be/.Junior Mobility Program at KU Leuven: https://www.kuleuven.be/personeel/careercenter/youreca-career-center/yourecaENG/youreca-internationalmobility.	Bansal A, 2015, P NATL ACAD SCI USA, V112, pE277, DOI 10.1073/pnas.1412192112; Churgin MA, 2017, ELIFE, V6, DOI [10.7554/elife.26652, 10.7554/eLife.26652]; Churgin MA, 2015, METHODS MOL BIOL, V1327, P199, DOI 10.1007/978-1-4939-2842-2_14; Gelino S, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006135; Hahm JH, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9919; Herndon LA, 2002, NATURE, V419, P808, DOI 10.1038/nature01135; Huang C, 2004, P NATL ACAD SCI USA, V101, P8084, DOI 10.1073/pnas.0400848101; Hulme SE, 2010, LAB CHIP, V10, P589, DOI 10.1039/b919265d; Ito T., 2017, CLIN PHYS THER, DOI [10.5772/67528, DOI 10.5772/67528]; Kaeberlein M, 2018, GEROSCIENCE, V40, P361, DOI 10.1007/s11357-018-0036-9; Kamath RS, 2003, METHODS, V30, P313, DOI 10.1016/S1046-2023(03)00050-1; Lee Kun He, 2016, Curr Protoc Toxicol, V67, DOI 10.1002/0471140856.tx1121s67; Leiser SF, 2016, AGE, V38, P419, DOI 10.1007/s11357-016-9936-8; Lemmink KAPM, 2001, J AGING PHYS ACTIV, V9, P194, DOI 10.1123/japa.9.2.194; Lucanic M, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14256; Luyten W, 2016, BIOGERONTOLOGY, V17, P771, DOI 10.1007/s10522-016-9644-x; Marck A, 2017, J GERONTOL A-BIOL, V72, P455, DOI 10.1093/gerona/glw136; Mathew MD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033483; Mathew MD, WORMSCAN TECHNIQUE H, DOI [10.1371/journal.pone.0033483, DOI 10.1371/JOURNAL.PONE.0033483]; Pincus Z, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002306; Pitt JN, 2019, GEROSCIENCE, V41, P961, DOI 10.1007/s11357-019-00124-9; Rahman M, 2018, LAB CHIP, V18, P2187, DOI 10.1039/c8lc00103k; Ross JL, 1992, FAM SYST MED, V10, P213, DOI [10.1037/h0089169, DOI 10.1037/H0089169]; Stamper BLN, 2018, AGING CELL, V17, DOI 10.1111/acel.12704; Stiernagle Theresa, 2006, WormBook, P1; Stroustrup N, 2013, NAT METHODS, V10, P665, DOI [10.1038/NMETH.2475, 10.1038/nmeth.2475]; Swierczek NA, 2011, NAT METHODS, V8, P592, DOI [10.1038/NMETH.1625, 10.1038/nmeth.1625]; Zhang WB, 2016, CELL SYST, V3, P333, DOI 10.1016/j.cels.2016.09.003	28	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2020	15	3							e0229583	10.1371/journal.pone.0229583	http://dx.doi.org/10.1371/journal.pone.0229583			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8MS	32126105	gold, Green Published			2022-12-26	WOS:000535253100033
J	Hagerty, SL; Hutchison, KE; Lowry, CA; Bryan, AD				Hagerty, Sarah L.; Hutchison, Kent E.; Lowry, Christopher A.; Bryan, Angela D.			An empirically derived method for measuring human gut microbiome alpha diversity: Demonstrated utility in predicting health-related outcomes among a human clinical sample	PLOS ONE			English	Article							IDENTIFICATION TEST AUDIT; INTESTINAL PERMEABILITY; ALCOHOL; BIODIVERSITY; INFLAMMATION; CHALLENGES; COMMUNITY; KURTOSIS; EVENNESS; SKEWNESS	The human gut microbiome has emerged as a potential key factor involved in the manifestation of physical and mental health. Despite an explosion of cross-disciplinary interest in researching the gut microbiome, there remains to be a gold-standard method for operationalizing gut microbiome alpha diversity. Given researchers' interest in examining the relationships among gut microbiome alpha diversity and health-related outcomes of interest, a way of operationalizing the microbiome that yields a numeric value, which could be used in common statistical approaches, is needed. Thus, the current study aims to provide methodological guidance for how to operationalize microbiome alpha diversity. Findings suggest that alpha diversity of the human gut microbiome is comprised of two sub-constructs (richness and evenness), and we propose a step-by-step method of creating alpha diversity composite measures based on this key insight. Finally, we demonstrate that our empirically derived richness and evenness composite measures are significantly associated with health-related variables of interest (alcohol use, symptoms of depression) among a human clinical sample.	[Hagerty, Sarah L.; Hutchison, Kent E.; Bryan, Angela D.] Univ Colorado, Dept Psychol & Neurosci, Boulder, CO 80309 USA; [Hagerty, Sarah L.] Vet Affairs Palo Alto Hlth Care Syst, Palo Alto, CA 94304 USA; [Lowry, Christopher A.] Univ Colorado, Dept Integrat Physiol, Boulder, CO 80309 USA; [Lowry, Christopher A.] Univ Colorado, Ctr Neurosci, Boulder, CO 80309 USA; [Lowry, Christopher A.] Univ Colorado, Ctr Microbial Explorat, Boulder, CO 80309 USA	University of Colorado System; University of Colorado Boulder; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder	Hagerty, SL (corresponding author), Univ Colorado, Dept Psychol & Neurosci, Boulder, CO 80309 USA.; Hagerty, SL (corresponding author), Vet Affairs Palo Alto Hlth Care Syst, Palo Alto, CA 94304 USA.	sarah.hagerty@colorado.edu	Facility, BioFrontiers Next Generation Sequencing/AAJ-8616-2020	HAGERTY, SARAH/0000-0002-1082-5511	National Science Foundation Graduate Research Fellowship Program [DGE 1144083]; National Institute on Alcohol Abuse and Alcoholism [R01 AA024632/AA/NIAAA]	National Science Foundation Graduate Research Fellowship Program(National Science Foundation (NSF)); National Institute on Alcohol Abuse and Alcoholism(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported by the National Science Foundation Graduate Research Fellowship Program under Grant No. DGE 1144083 awarded to Sarah Hagerty: https://www.nsfgrfp.org/ National Institute on Alcohol Abuse and Alcoholism under Grant No. R01 AA024632/AA/NIAAA awarded to Kent Hutchison. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdi H., 2003, ENCY RES METHODS SOC, P792; BECK AT, 1988, CLIN PSYCHOL REV, V8, P77, DOI 10.1016/0272-7358(88)90050-5; BERGER WH, 1970, SCIENCE, V168, P1345, DOI 10.1126/science.168.3937.1345; Blanca MJ, 2013, METHODOLOGY-EUR, V9, P78, DOI 10.1027/1614-2241/a000057; Cain MK, 2017, BEHAV RES METHODS, V49, P1716, DOI 10.3758/s13428-016-0814-1; Caporaso JG, 2012, ISME J, V6, P1621, DOI 10.1038/ismej.2012.8; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Carabotti M, 2015, ANN GASTROENTEROL, V28, P203; Caruso T., 2006, BIODIVERSITY CONSERV, P35; CHAO A, 1984, SCAND J STAT, V11, P265; Chase JM, 2013, ECOL LETT, V16, P17, DOI 10.1111/ele.12112; Chen X, 2013, PROTEIN CELL, V4, P403, DOI 10.1007/s13238-013-3017-x; Chiarucci A, 2011, PHILOS T R SOC B, V366, P2426, DOI 10.1098/rstb.2011.0065; Child D., 1990, ESSENTIALS FACTOR AN; David LA, 2014, NATURE, V505, P559, DOI 10.1038/nature12820; DeCarlo LT, 1997, PSYCHOL METHODS, V2, P292, DOI 10.1037/1082-989X.2.3.292; FAITH DP, 1992, BIOL CONSERV, V61, P1, DOI 10.1016/0006-3207(92)91201-3; Falony G, 2016, SCIENCE, V352, P560, DOI 10.1126/science.aad3503; Fisher RA, 1943, J ANIM ECOL, V12, P42, DOI 10.2307/1411; Gevers D, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001377; Grenham S, 2011, FRONT PHYSIOL, V2, DOI 10.3389/fphys.2011.00094; Hagerty SL, 2019, PERSPECT PSYCHOL SCI, V14, P633, DOI 10.1177/1745691619827010; Hagerty SL, 2018, ALCOHOL CLIN EXP RES, V42, P248, DOI 10.1111/acer.13570; HEIP C, 1974, J MAR BIOL ASSOC UK, V54, P555, DOI 10.1017/S0025315400022736; Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234; Jensen MP, 1999, PAIN, V83, P157, DOI 10.1016/S0304-3959(99)00101-3; Jiang HY, 2015, BRAIN BEHAV IMMUN, V48, P186, DOI 10.1016/j.bbi.2015.03.016; Jost L, 2007, ECOLOGY, V88, P2427, DOI 10.1890/06-1736.1; KAISER HF, 1958, PSYCHOMETRIKA, V23, P187, DOI 10.1007/BF02289233; Landis RS, 2000, ORGAN RES METHODS, V3, P186, DOI 10.1177/109442810032003; Leclercq S, 2014, P NATL ACAD SCI USA, V111, pE4485, DOI 10.1073/pnas.1415174111; Leclercq S, 2012, BRAIN BEHAV IMMUN, V26, P911, DOI 10.1016/j.bbi.2012.04.001; Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/4441022a; Lladser ME, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021105; Lozupone CA, 2012, NATURE, V489, P220, DOI 10.1038/nature11550; MAGURRAN A. E., 2004, MEASURING BIOLOGICAL; Magurran AE, 2013, MEASURING BIOL DIVER; Mason NWH, 2005, OIKOS, V111, P112, DOI 10.1111/j.0030-1299.2005.13886.x; McDonald D, 2012, ISME J, V6, P610, DOI 10.1038/ismej.2011.139; MICCERI T, 1989, PSYCHOL BULL, V105, P156, DOI 10.1037/0033-2909.105.1.156; Morris EK, 2014, ECOL EVOL, V4, P3514, DOI 10.1002/ece3.1155; Mouillot D, 2005, OECOLOGIA, V142, P353, DOI 10.1007/s00442-004-1744-7; Mouillot D, 2002, THEOR POPUL BIOL, V61, P141, DOI 10.1006/tpbi.2001.1565; Mutlu EA, 2012, AM J PHYSIOL-GASTR L, V302, pG966, DOI 10.1152/ajpgi.00380.2011; Onsman A., 2010, AUSTRALASIAN J PARAM, V8, P1, DOI DOI 10.33151/AJP.8.3.93; Osborne J., 2005, PRACTICAL ASSESSMENT, V10, P1, DOI [10.7275/jyj1-4868, DOI 10.7275/JYJ1-4868, 10.4135/9781412995627.d8, DOI 10.4135/9781412995627.D8]; Peet R.K., 1974, Annual Rev Ecol Syst, V5, P285, DOI 10.1146/annurev.es.05.110174.001441; PIELOU EC, 1966, J THEOR BIOL, V13, P131, DOI 10.1016/0022-5193(66)90013-0; Prehn-Kristensen A, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0200728; Purvis A, 2000, NATURE, V405, P212, DOI 10.1038/35012221; Rideout JR, 2016, GIGASCIENCE, V5, DOI 10.1186/s13742-016-0133-6; SAUNDERS JB, 1993, ADDICTION, V88, P791, DOI 10.1111/j.1360-0443.1993.tb02093.x; SIMPSON EH, 1949, NATURE, V163, P688, DOI 10.1038/163688a0; Sobel M.E., 1982, SOCIOL METHODOL, V13, P290, DOI [10.2307/270723, DOI 10.2307/270723]; SOBELL LC, 1992, MEASURING ALCOHOL CONSUMPTION, P41, DOI 10.1007/978-1-4612-0357-5_3; Strong WL, 2002, COMMUNITY ECOL, V3, P237, DOI 10.1556/ComEc.3.2002.2.9; Subar AF, 2001, AM J EPIDEMIOL, V154, P1089, DOI 10.1093/aje/154.12.1089; Tabachnick BG, 2012, PRINCIPAL COMPONENTS; Thompson B, 2004, EXPLORATORY CONFIRMA; Tsai MC, 2005, ALCOHOL CLIN EXP RES, V29, P53, DOI 10.1097/01.ALC.0000151986.96710.E0; Turnbaugh PJ, 2007, NATURE; Vogt NM, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-13601-y; Wang HJ, 2010, WORLD J GASTROENTERO, V16, P1304, DOI 10.3748/wjg.v16.i11.1304; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Weiss S, 2017, MICROBIOME, V5, DOI 10.1186/s40168-017-0237-y; Willis A., 2017, BIORXIV, DOI [10.1101/231878, DOI 10.1101/231878]; Yong AG, 2013, TUTOR QUANT METHODS, V9, P79, DOI 10.20982/tqmp.09.2.p079; Yuan K.H., 1997, BEHAVIORMETRIKA, V24, P71, DOI [10.2333/bhmk.24.71, DOI 10.2333/BHMK.24.71, https://doi.org/10.2333/bhmk.24.71]	68	25	25	3	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2020	15	3							e0229204	10.1371/journal.pone.0229204	http://dx.doi.org/10.1371/journal.pone.0229204			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LQ8JT	32119675	Green Published, gold			2022-12-26	WOS:000535245300015
J	Martins, APB; Heupel, MR; Bierwagen, SL; Chin, A; Simpfendorfer, C				Martins, A. P. B.; Heupel, M. R.; Bierwagen, S. L.; Chin, A.; Simpfendorfer, C.			Diurnal activity patterns and habitat use of juvenile Pastinachus ater in a coral reef flat environment	PLOS ONE			English	Article							REPRODUCTIVE-BIOLOGY; DASYATIS-CHRYSONOTA; MOVEMENT PATTERNS; NURSERY AREAS; NINGALOO REEF; BLUE STINGRAY; RAY; SHARKS; ELASMOBRANCHS; CONSERVATION	Stingrays are thought to play important ecological roles in coral reef ecosystems. However, little is known about juvenile stingray movement patterns and habitat use in coral reefs. This study used active acoustic telemetry to determine fine-scale diel movement patterns and habitat use of juvenile cowtail stingrays (Pastinachus ater) in a coral reef flat environment. Seven cowtail stingrays (4 males and 3 females) were manually tracked between April and December 2016. Each individual was tracked over 2 days, generating a total of 14 active tracks ranging from 4.91 to 9 h. Specimens moved at an average speed of 2.44 m min(-1) +/- 0.87 SE, with minimum distances travelled ranging from 546 to 1446 m. Tracking data showed that juvenile cowtail stingrays move in response to tidal cycles, moving faster and in straighter pathways during incoming and outgoing tides. Juvenile cowtail stingrays also showed a strong affinity to sand flat areas and mangrove edge areas. These areas provide food resources and potential refuges for juvenile rays to avoid predators. Coral reef flats were identified as secondary refuge for juveniles during the lowest tides. Future research is necessary to fully unveil the major drivers of juvenile cowtail stingray seasonal and ontogenetic movement patterns and habitat use within coral reef flat environments. This information is important to establish a full understanding of juvenile cowtail stingray ecology, but could also improve management and conservation policies.	[Martins, A. P. B.; Bierwagen, S. L.; Chin, A.; Simpfendorfer, C.] James Cook Univ, Coll Sci & Engn, Ctr Sustainable Trop Fisheries & Aquaculture, Townsville, Qld, Australia; [Martins, A. P. B.; Heupel, M. R.; Bierwagen, S. L.] Australian Inst Marine Sci, Townsville, Qld, Australia	James Cook University; Australian Institute of Marine Science	Martins, APB (corresponding author), James Cook Univ, Coll Sci & Engn, Ctr Sustainable Trop Fisheries & Aquaculture, Townsville, Qld, Australia.; Martins, APB (corresponding author), Australian Inst Marine Sci, Townsville, Qld, Australia.	ana.barbosamartins@my.jcu.edu.au	; Chin, Andrew/C-2254-2008	Bierwagen, Stacy L./0000-0002-5345-4466; Chin, Andrew/0000-0003-1813-4042	James Cook University; CAPES Foundation; AIMS@JCU; James Cook University's College of Science and Engineering	James Cook University; CAPES Foundation(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); AIMS@JCU; James Cook University's College of Science and Engineering	The authors gratefully acknowledge James Cook University and CAPES Foundation for their financial support. Additional funding was granted to A. Martins by AIMS@JCU and James Cook University's College of Science and Engineering. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguiar AA, 2009, J MAR BIOL ASSOC UK, V89, P1147, DOI 10.1017/S0025315409000058; Ajemian MJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040227; Brinton CP, 2017, MAR FRESHWATER RES, V68, P1716, DOI 10.1071/MF16073; Brooks ME, 2017, R J, V9, P378, DOI 10.32614/RJ-2017-066; Brownscombe JW, 2019, REV FISH BIOL FISHER; Calenge C, 2006, ECOL MODEL, V197, P516, DOI 10.1016/j.ecolmodel.2006.03.017; Cartamil DP, 2003, MAR BIOL, V142, P841, DOI 10.1007/s00227-003-1014-y; Cerutti-Pereyra F, 2014, ENVIRON BIOL FISH, V97, P371, DOI 10.1007/s10641-013-0158-y; Collins AB, 2007, J FISH BIOL, V71, P1159, DOI 10.1111/j.1095-8649.2007.01590.x; Dabruzzi T., 2012, HYDROBIOLOGIA, V701, P37, DOI DOI 10.1007/S10750-012-1249-Z; Dale JJ, 2011, MAR ECOL PROG SER, V433, P221, DOI 10.3354/meps09171; Davy LE, 2015, MAR FRESHWATER RES, V66, P481, DOI 10.1071/MF14028; Dewar H, 2008, MAR BIOL, V155, P121, DOI 10.1007/s00227-008-0988-x; Dulvy NK, 2008, AQUAT CONSERV, V18, P459, DOI 10.1002/aqc.975; Dulvy NK, 2017, CURR BIOL, V27, pR565, DOI 10.1016/j.cub.2017.04.038; Dulvy NK, 2014, ELIFE, V3, DOI 10.7554/eLife.00590; Ebert DA, 2003, MAR FRESHWATER RES, V54, P957, DOI 10.1071/MF03069; Ebert DA, 2009, J MAR BIOL ASSOC UK, V89, P809, DOI 10.1017/S0025315408002907; Elston C, 2017, J FISH BIOL, V91, P429, DOI 10.1111/jfb.13334; Espinoza M, 2015, CORAL REEFS, V34, P807, DOI 10.1007/s00338-015-1312-0; George LW, 2019, MAR ECOL PROG SER, V623, P85, DOI 10.3354/meps13010; Hayne Abigail H. P., 2018, Gulf and Caribbean Research, V29, pSC1, DOI 10.18785/gcr.2901.03; Heupel MR, 2007, MAR ECOL PROG SER, V337, P287, DOI 10.3354/meps337287; Heupel MR, 2019, MAR FRESHWATER RES, V70, P897, DOI 10.1071/MF18081; Heupel MR, 2006, MAR FRESHWATER RES, V57, P1, DOI 10.1071/MF05091; Jabado RW, 2018, FISH FISHERIES; Jacobsen IP, 2012, J FISH BIOL, V80, P1580, DOI 10.1111/j.1095-8649.2011.03169.x; Kanno S, 2019, MAR ECOL PROG SER, V621, P155, DOI 10.3354/meps12977; Kinney MJ, 2009, CONSERV LETT, V2, P53, DOI 10.1111/j.1755-263X.2008.00046.x; Last P. R., 2016, P1; Last PR, 2016, ZOOTAXA, V4139, P345, DOI 10.11646/zootaxa.4139.3.2; Marshall AD, 2008, J FISH BIOL, V72, P883, DOI 10.1111/j.1095-8649.2007.01762.x; Martins APB, 2018, MAR ECOL PROG SER, V595, P253, DOI 10.3354/meps12545; McInturf AG, 2019, ENVIRON BIOL FISH, V102, P1149, DOI 10.1007/s10641-019-00894-3; O'Shea OR, 2013, J FISH BIOL, V82, P1805, DOI 10.1111/jfb.12104; O'Shea OR, 2012, MAR FRESHWATER RES, V63, P189, DOI 10.1071/MF11180; Papastamatiou YP, 2009, ECOLOGY, V90, P996, DOI 10.1890/08-0491.1; Pardo SA, 2015, MAR ECOL PROG SER, V533, P205, DOI 10.3354/meps11358; Rastgoo AR, 2018, AQUAT BIOL, V27, P35, DOI 10.3354/ab00694; Saadaoui A, CAHIERS BIOL MARINE; Schlaff AM, 2014, REV FISH BIOL FISHER, V24, P1089, DOI 10.1007/s11160-014-9364-8; Semeniuk CAD, 2005, BEHAV ECOL, V16, P417, DOI 10.1093/beheco/ari005; Sheaves M, 2009, MAR ECOL PROG SER, V391, P107, DOI 10.3354/meps08121; Simpfendorfer CA, 2004, CRC MAR BIOL SER, P553; Speed CW, 2011, MAR ECOL PROG SER, V429, P261, DOI 10.3354/meps09080; Takeuchi S, 2014, CONT SHELF RES, V84, P139, DOI 10.1016/j.csr.2014.05.007; THRUSH SF, 1991, MAR ECOL PROG SER, V69, P245, DOI 10.3354/meps069245; Vaudo JJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061907; Veras DP, 2014, MAR FRESHWATER RES, V65, P1035, DOI 10.1071/MF13008; Yokota L, 2007, CAH BIOL MAR, V48, P249	50	9	9	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2020	15	2							e0228280	10.1371/journal.pone.0228280	http://dx.doi.org/10.1371/journal.pone.0228280			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8GQ	32107488	Green Published, Green Accepted, gold			2022-12-26	WOS:000535237000012
J	Milhau, N; Almouazen, E; Bouteille, S; Hellel-Bourtal, I; Azzouz-Maache, S; Benavides, U; Petavy, AF; Marchal, T				Milhau, Nadege; Almouazen, Eyad; Bouteille, Sylvie; Hellel-Bourtal, Imene; Azzouz-Maache, Samira; Benavides, Uruguaysito; Petavy, Anne-Francoise; Marchal, Thierry			In vitro evaluations on canine monocyte-derived dendritic cells of a nanoparticles delivery system for vaccine antigen against Echinococcus granulosus	PLOS ONE			English	Article							PLGA NANOPARTICLES; SIZE	Since dogs play a central role in the contamination of humans and livestock with Echinococcus granulosus, the development of an effective vaccine for dogs is essential to control the disease caused by this parasite. For this purpose, a formulation based on biodegradable polymeric nanoparticles (NPs) as delivery system of recombinant Echinococcus granulosus antigen (tropomyosin EgTrp) adjuved with monophosphoryl lipid A (MPLA) has been developed. The obtained nanoparticles had a size of approximately 200 nm in diameter into which the antigen was correctly preserved and encapsulated. The efficiency of this system to deliver the antigen was evaluated in vitro on canine monocyte-derived dendritic cells (cMoDCs) generated from peripheral blood monocytes. After 48 h of contact between the formulations and cMoDCs, we observed no toxic effect on the cells but a strong internalization of the NPs, probably through different pathways depending on the presence or not of MPLA. An evaluation of cMoDCs activation by flow cytometry showed a stronger expression of CD80, CD86, CD40 and MHCII by cells treated with any of the tested formulations or with LPS (positive control) in comparison to cells treated with PBS (negative control). A higher activation was observed for cells challenged with EgTrp-NPs-MPLA compared to EgTrp alone. Formulations with MPLA, even at low ratio of MPLA, give better results than formulations without MPLA, proving the importance of the adjuvant in the nanoparticles structure. Moreover, autologous T CD4+ cell proliferation observed in presence of cMoDCs challenged with EgTrp-NPs-MPLA was higher than those observed after challenged with EgTrp alone (p<0.05). These first results suggest that our formulation could be used as an antigen delivery system to targeting canine dendritic cells in the course of Echinococcus granulosus vaccine development.	[Milhau, Nadege; Marchal, Thierry] Univ Lyon, VetAgro Sup, UPSP ICE 2011 03 101, Marcy Letoile, France; [Almouazen, Eyad; Hellel-Bourtal, Imene] Univ Claude Bernard Lyon 1, Univ Lyon, CNRS, LAGEPP UMR 5007, Villeurbanne, France; [Almouazen, Eyad; Azzouz-Maache, Samira; Petavy, Anne-Francoise] Univ Claude Bernard Lyon 1, Fac Pharm, ISPB, Lyon, France; [Bouteille, Sylvie; Marchal, Thierry] Univ Lyon, VetAgro Sup, Lab Histopathol, Marcy Letoile, France; [Azzouz-Maache, Samira; Petavy, Anne-Francoise] Inst Rech Dev IRD, UMR InterTryp IRD CIRAD, Campus Int Baillarguet, Montpellier, France; [Benavides, Uruguaysito] Univ Republica, Fac Vet, Immunol Dept, Montevideo, Uruguay	VetAgro Sup; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; VetAgro Sup; CIRAD; Institut de Recherche pour le Developpement (IRD); Universidad de la Republica, Uruguay	Marchal, T (corresponding author), Univ Lyon, VetAgro Sup, UPSP ICE 2011 03 101, Marcy Letoile, France.; Marchal, T (corresponding author), Univ Lyon, VetAgro Sup, Lab Histopathol, Marcy Letoile, France.	thierry.marchal@vetagro-sup.fr	ALMOUAZEN, Eyad/O-7131-2019	ALMOUAZEN, Eyad/0000-0003-1999-6103	 [PARAVAC FP7-KBBE2010-4]		grant number: PARAVAC FP7-KBBE2010-4	Bilati U, 2005, J MICROENCAPSUL, V22, P205, DOI 10.1080/02652040400026442; Bonnefont-Rebeix C, 2006, VET IMMUNOL IMMUNOP, V109, P167, DOI 10.1016/j.vetimm.2005.08.027; Bund D, 2010, CELL IMMUNOL, V263, P88, DOI 10.1016/j.cellimm.2010.03.003; Calderon-Gonzalez R, 2015, HUM VACC IMMUNOTHER, V11, P2501, DOI 10.1080/21645515.2015.1063756; Craig PS, 2017, ADV PARASIT, V96, P55, DOI 10.1016/bs.apar.2016.09.002; Derman S, 2015, J BIOMED SCI, V22, DOI 10.1186/s12929-015-0195-2; Elamanchili P, 2004, VACCINE, V22, P2406, DOI 10.1016/j.vaccine.2003.12.032; Esteves A, 2003, PARASITOL RES, V89, P501, DOI 10.1007/s00436-002-0791-4; Foged C, 2005, INT J PHARMACEUT, V298, P315, DOI 10.1016/j.ijpharm.2005.03.035; Fraize M, 2005, PARASITOL RES, V96, P113, DOI 10.1007/s00436-005-1322-x; Grabowski N, 2013, INT J PHARMACEUT, V454, P686, DOI 10.1016/j.ijpharm.2013.05.025; Gregory AE, 2013, FRONT CELL INFECT MI, V3, DOI 10.3389/fcimb.2013.00013; Guldner D, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165477; Heath DD, 2012, VACCINE, V30, P3076, DOI 10.1016/j.vaccine.2012.02.073; Hunsawong T, 2015, VACCINE, V33, P1702, DOI 10.1016/j.vaccine.2015.02.016; Ibisch C, 2005, J IMMUNOL METHODS, V298, P175, DOI 10.1016/j.jim.2005.02.001; Ismaili J, 2002, J IMMUNOL, V168, P926, DOI 10.4049/jimmunol.168.2.926; Klippstein R, 2010, NANOMED-NANOTECHNOL, V6, P523, DOI 10.1016/j.nano.2010.01.001; Lightowlers MW, 1996, PARASITE IMMUNOL, V18, P457, DOI 10.1111/j.1365-3024.1996.tb01029.x; Margaroni M, 2016, EUR J PHARM BIOPHARM, V105, P18, DOI 10.1016/j.ejpb.2016.05.018; Moon JJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031472; Moro P, 2009, INT J INFECT DIS, V13, P125, DOI 10.1016/j.ijid.2008.03.037; Oh N, 2014, INT J NANOMED, V9, P51, DOI 10.2147/IJN.S26592; Pan W, 2017, ASIAN PAC J TROP MED, V10, P497, DOI 10.1016/j.apjtm.2017.05.011; Petavy AF, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000125; Pourseif MM, 2018, BIOLOGICALS, V51, P1, DOI 10.1016/j.biologicals.2017.10.003; Qeska V, 2013, VET IMMUNOL IMMUNOP, V151, P181, DOI 10.1016/j.vetimm.2012.12.003; Reddy ST, 2006, TRENDS IMMUNOL, V27, P573, DOI 10.1016/j.it.2006.10.005; Sarti F, 2011, BIOMATERIALS, V32, P4052, DOI 10.1016/j.biomaterials.2011.02.011; Sehgal K, 2014, IMMUNOL LETT, V162, P59, DOI 10.1016/j.imlet.2014.07.004; Silva JM, 2014, NANOMEDICINE-UK, V9, P2639, DOI [10.2217/NNM.14.135, 10.2217/nnm.14.135]; Smith DM, 2013, NAT REV IMMUNOL, V13, P592, DOI 10.1038/nri3488; Tyler B, 2016, ADV DRUG DELIVER REV, V107, P163, DOI 10.1016/j.addr.2016.06.018; Uto T, 2007, J IMMUNOL, V178, P2979, DOI 10.4049/jimmunol.178.5.2979; Wang YS, 2007, CAN J VET RES, V71, P165; Weilhammer DR, 2013, BIOMATERIALS, V34, P10305, DOI 10.1016/j.biomaterials.2013.09.038; Xiang SD, 2006, METHODS, V40, P1, DOI 10.1016/j.ymeth.2006.05.016; Zhang WB, 2006, J INFECT DIS, V194, P966, DOI 10.1086/506622; Zhang ZZ, 2018, INFECT DIS POVERTY, V7, DOI 10.1186/s40249-018-0425-4; Zhao L, 2014, VACCINE, V32, P327, DOI 10.1016/j.vaccine.2013.11.069	40	4	4	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2020	15	2							e0229121	10.1371/journal.pone.0229121	http://dx.doi.org/10.1371/journal.pone.0229121			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8FM	32101539	gold, Green Published, Green Submitted			2022-12-26	WOS:000535233700016
J	Gil-Munoz, F; Perez-Perez, JG; Quinones, A; Primo-Capella, A; Cebolla, J; Forner-Giner, MA; Badenes, ML; Naval, MD				Gil-Munoz, Francisco; Gabriel Perez-Perez, Juan; Quinones, Ana; Primo-Capella, Amparo; Cebolla, Jaime; Angeles Forner-Giner, Ma; Badenes, Maria L.; del Mar Naval, Ma			A cross population between D. kaki and D. virginiana shows high variability for saline tolerance and improved salt stress tolerance	PLOS ONE			English	Article							DIFFERENTIAL ION ACCUMULATION; ROOT HYDRAULIC CONDUCTANCE; PLASMA-MEMBRANE; ARABIDOPSIS-THALIANA; HKT TRANSPORTERS; DIOSPYROS-KAKI; PROTEIN-KINASE; NA+ TRANSPORT; PHOTOSYNTHETIC CAPACITY; STOMATAL CONDUCTANCE	Persimmon (Diospyros kaki Thunb.) production is facing important problems related to climate change in the Mediterranean areas. One of them is soil salinization caused by the decrease and change of the rainfall distribution. In this context, there is a need to develop cultivars adapted to the increasingly challenging soil conditions. In this study, a backcross between (D. kaki x D. virginiana) x D. kaki was conducted, to unravel the mechanism involved in salinity tolerance of persimmon. The backcross involved the two species most used as rootstock for persimmon production. Both species are clearly distinct in their level of tolerance to salinity. Variables related to growth, leaf gas exchange, leaf water relations and content of nutrients were significantly affected by saline stress in the backcross population. Water flow regulation appears as a mechanism of salt tolerance in persimmon via differences in water potential and transpiration rate, which reduces ion entrance in the plant. Genetic expression of eight putative orthologous genes involved in different mechanisms leading to salt tolerance was analyzed. Differences in expression levels among populations under saline or control treatment were found. The 'High affinity potassium transporter' (HKT1-like) reduced its expression levels in the roots in all studied populations. Results obtained allowed selection of tolerant rootstocks genotypes and describe the hypothesis about the mechanisms involved in salt tolerance in persimmon that will be useful for breeding salinity tolerant rootstocks.	[Gil-Munoz, Francisco; Gabriel Perez-Perez, Juan; Quinones, Ana; Primo-Capella, Amparo; Angeles Forner-Giner, Ma; Badenes, Maria L.; del Mar Naval, Ma] Inst Valenciano Invest Agr IVIA, Valencia, Spain; [Cebolla, Jaime] Inst Conservac & Mejora Agrodiversidad Valenciana, Valencia, Spain	Instituto Valenciano de Investigaciones Agrarias (IVIA)	Badenes, ML (corresponding author), Inst Valenciano Invest Agr IVIA, Valencia, Spain.	badenes_mlu@gva.es	Pérez-Pérez, Juan Gabriel/AAK-7597-2020; Muñoz, Francisco Gil/AAB-9331-2021; Badenes, Maria Luisa/C-6606-2014; Forner-Giner, Angeles/D-5306-2014; Cebolla-Cornejo, Jaime/K-7922-2014; Quinones, Ana/E-6229-2014	Pérez-Pérez, Juan Gabriel/0000-0002-8012-119X; Muñoz, Francisco Gil/0000-0001-8396-4101; Badenes, Maria Luisa/0000-0001-9722-6783; Forner-Giner, Angeles/0000-0003-3237-0893; Cebolla-Cornejo, Jaime/0000-0002-2607-9920; Quinones, Ana/0000-0002-6096-734X	IVIA; European Funds for Regional Development; Generalitat Valenciana [ACIF/2016/115]; European Social Fund	IVIA; European Funds for Regional Development(European Commission); Generalitat Valenciana(Center for Forestry Research & Experimentation (CIEF)European Commission); European Social Fund(European Social Fund (ESF))	This study was funded by the IVIA and the European Funds for Regional Development. F. G.M.was funded by a PhD fellowship from the European Social Fund and the Generalitat Valenciana (ACIF/2016/115). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Akagi T, 2016, PLANT CELL, V28, P2905, DOI 10.1105/tpc.16.00532; Akagi T, 2009, PLANT PHYSIOL, V151, P2028, DOI 10.1104/pp.109.146985; Almeida P, 2013, INT J MOL SCI, V14, P20359, DOI 10.3390/ijms141020359; Amtmann A, 1999, ADV BOT RES, V29, P75; An D, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1007086; Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Apse MP, 1999, SCIENCE, V285, P1256, DOI 10.1126/science.285.5431.1256; Badenes ML, 2015, CULTIVO CAQUI GEN VA, P58; Baetz U, 2016, PLANT PHYSIOL, V172, P1167, DOI 10.1104/pp.16.00183; Barbier-Brygoo H, 2011, ANNU REV PLANT BIOL, V62, P25, DOI 10.1146/annurev-arplant-042110-103741; Barragan V, 2012, PLANT CELL, V24, P1127, DOI 10.1105/tpc.111.095273; BATES LS, 1973, PLANT SOIL, V39, P205, DOI 10.1007/BF00018060; Bellini E, 2002, ACTA HORTIC, P35, DOI 10.17660/ActaHortic.2002.592.3; Berthomieu P, 2003, EMBO J, V22, P2004, DOI 10.1093/emboj/cdg207; Besada C, 2016, PLANT PHYSIOL BIOCH, V100, P105, DOI 10.1016/j.plaphy.2016.01.006; Boursiac Y, 2005, PLANT PHYSIOL, V139, P790, DOI 10.1104/pp.105.065029; Brini F, 2005, PLANT PHYSIOL BIOCH, V43, P347, DOI 10.1016/j.plaphy.2005.02.010; BRUGNOLI E, 1991, PLANT PHYSIOL, V95, P628, DOI 10.1104/pp.95.2.628; Byrt CS, 2007, PLANT PHYSIOL, V143, P1918, DOI 10.1104/pp.106.093476; Callister AN, 2006, PHYSIOL PLANTARUM, V127, P383, DOI 10.1111/j.1399-3054.2006.00652.x; Cellier F, 2004, PLANT J, V39, P834, DOI 10.1111/j.1365-313X.2004.02177.x; Chamberlain J. L., 2018, General Technical Report - Southern Research Station, USDA Forest Service, P1; Chaumont F, 2014, PLANT PHYSIOL, V164, P1600, DOI 10.1104/pp.113.233791; De Paz J, 2016, FITOTOXICIDAD CLORUR, V391, P91; Evans AR, 2012, J EXP BOT, V63, P59, DOI 10.1093/jxb/err271; Flowers TJ, 2008, NEW PHYTOL, V179, P945, DOI 10.1111/j.1469-8137.2008.02531.x; Fricke W, 2006, J EXP BOT, V57, P1079, DOI 10.1093/jxb/erj095; Gambino G, 2008, PHYTOCHEM ANALYSIS, V19, P520, DOI 10.1002/pca.1078; Garciadeblas B, 2003, PLANT J, V34, P788, DOI 10.1046/j.1365-313X.2003.01764.x; Gaxiola RA, 2001, P NATL ACAD SCI USA, V98, P11444, DOI 10.1073/pnas.191389398; Gil-Munoz F., 2018, Acta Horticulturae, P105, DOI 10.17660/ActaHortic.2018.1195.18; GILLIAM JW, 1971, SOIL SCI SOC AM PRO, V35, P512, DOI 10.2136/sssaj1971.03615995003500030051x; Gimenez C, 2004, ENCY SOILS ENV, P231; Halfter U, 2000, P NATL ACAD SCI USA, V97, P3735, DOI 10.1073/pnas.040577697; Han Y, 2018, PLANT CELL PHYSIOL, V59, P1976, DOI 10.1093/pcp/pcy116; Hazzouri KM, 2018, FRONT PLANT SCI, V9, DOI 10.3389/fpls.2018.00156; Henderson SW, 2014, BMC PLANT BIOL, V14, DOI 10.1186/s12870-014-0273-8; Horie T, 2007, EMBO J, V26, P3003, DOI 10.1038/sj.emboj.7601732; Horie T, 2008, PLANT BIOTECHNOL-NAR, V25, P233, DOI 10.5511/plantbiotechnology.25.233; Hrabak EM, 2003, PLANT PHYSIOL, V132, P666, DOI 10.1104/pp.102.011999; HUANG CX, 1989, PLANT PHYSIOL, V90, P1440, DOI 10.1104/pp.90.4.1440; Huang S, 2008, J EXP BOT, V59, P927, DOI 10.1093/jxb/ern033; Huang SB, 2006, PLANT PHYSIOL, V142, P1718, DOI 10.1104/pp.106.088864; Incesu M, 2014, NOT BOT HORTI AGROBO, V42, P386, DOI 10.15835/nbha4229471; Isayenkov SV, 2019, FRONT PLANT SCI, V10, DOI 10.3389/fpls.2019.00080; James RA, 2006, PLANT CELL ENVIRON, V29, P2185, DOI 10.1111/j.1365-3040.2006.01592.x; Ji HT, 2013, MOL PLANT, V6, P275, DOI 10.1093/mp/sst017; Jia BW, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09772-3; Johanson U, 2001, PLANT PHYSIOL, V126, P1358, DOI 10.1104/pp.126.4.1358; JOLY RJ, 1989, PLANT PHYSIOL, V91, P1262, DOI 10.1104/pp.91.4.1262; Karley AJ, 2000, PLANT PHYSIOL, V122, P835, DOI 10.1104/pp.122.3.835; Karley AJ, 2000, TRENDS PLANT SCI, V5, P465, DOI 10.1016/S1360-1385(00)01758-1; Koyro HW, 2006, ENVIRON EXP BOT, V56, P136, DOI 10.1016/j.envexpbot.2005.02.001; Liu JP, 2000, P NATL ACAD SCI USA, V97, P3730, DOI 10.1073/pnas.060034197; Liu JP, 1998, SCIENCE, V280, P1943, DOI 10.1126/science.280.5371.1943; Lopez-Perez L, 2009, PHYTOCHEMISTRY, V70, P492, DOI 10.1016/j.phytochem.2009.01.014; Martinez-Ballesta MC, 2003, J PLANT PHYSIOL, V160, P689, DOI 10.1078/0176-1617-00861; Maser P, 2002, FEBS LETT, V531, P157, DOI 10.1016/S0014-5793(02)03488-9; Maurel C, 2008, ANNU REV PLANT BIOL, V59, P595, DOI 10.1146/annurev.arplant.59.032607.092734; de Paz JM, 2016, ANAL BIOANAL CHEM, V408, P3537, DOI 10.1007/s00216-016-9430-2; Munns R, 2000, AUST J PLANT PHYSIOL, V27, P949; Munns R, 2002, PLANT CELL ENVIRON, V25, P239, DOI 10.1046/j.0016-8025.2001.00808.x; Munns R, 2008, ANNU REV PLANT BIOL, V59, P651, DOI 10.1146/annurev.arplant.59.032607.092911; Munns R, 2020, NEW PHYTOL, V225, P1091, DOI 10.1111/nph.15862; Padmanaban S, 2007, PLANT PHYSIOL, V144, P82, DOI 10.1104/pp.106.092155; Pardo JM, 2006, J EXP BOT, V57, P1181, DOI 10.1093/jxb/erj114; Perucho R., 2018, Acta Horticulturae, P1, DOI 10.17660/ActaHortic.2018.1195.1; Plett DC, 2010, PLANT CELL ENVIRON, V33, P612, DOI 10.1111/j.1365-3040.2009.02086.x; Qiu QS, 2003, PLANT PHYSIOL, V132, P1041, DOI 10.1104/pp.102.010421; Qiu QS, 2002, P NATL ACAD SCI USA, V99, P8436, DOI 10.1073/pnas.122224699; Quan RD, 2007, PLANT CELL, V19, P1415, DOI 10.1105/tpc.106.042291; Quintero FJ, 2002, P NATL ACAD SCI USA, V99, P9061, DOI 10.1073/pnas.132092099; Quintero FJ, 2011, P NATL ACAD SCI USA, V108, P2611, DOI 10.1073/pnas.1018921108; Rahnama A, 2010, FUNCT PLANT BIOL, V37, P255, DOI 10.1071/FP09148; Acosta-Motos JR, 2017, AGRONOMY-BASEL, V7, DOI 10.3390/agronomy7010018; Rodriguez-Gamir J, 2012, ENVIRON EXP BOT, V78, P163, DOI 10.1016/j.envexpbot.2011.12.027; Rus A, 2004, PLANT PHYSIOL, V136, P2500, DOI 10.1104/pp.104.042234; Shapira O, 2009, PLANT CELL ENVIRON, V32, P476, DOI 10.1111/j.1365-3040.2009.01941.x; Shi HZ, 2000, P NATL ACAD SCI USA, V97, P6896, DOI 10.1073/pnas.120170197; Shi HZ, 2002, PLANT CELL, V14, P465, DOI 10.1105/tpc.010371; Sibole JV, 2003, J PLANT PHYSIOL, V160, P1361, DOI 10.1078/0176-1617-00811; Song CP, 2004, P NATL ACAD SCI USA, V101, P10211, DOI 10.1073/pnas.0403709101; Sunarpi, 2005, PLANT J, V44, P928, DOI 10.1111/j.1365-313X.2005.02595.x; Szczerba MW, 2009, J PLANT PHYSIOL, V166, P447, DOI 10.1016/j.jplph.2008.12.009; Tester M, 2003, ANN BOT-LONDON, V91, P503, DOI 10.1093/aob/mcg058; Uozumi N, 2000, PLANT PHYSIOL, V122, P1249, DOI 10.1104/pp.122.4.1249; Visconti F, 2017, SCI HORTIC-AMSTERDAM, V214, P83, DOI [10.1016/j.scienta.2016.11.025, 10.1016/j.scienta.2016.11.]; Visconti F, 2015, SCI HORTIC-AMSTERDAM, V185, P129, DOI 10.1016/j.scienta.2015.01.028; Vitali V, 2015, AOB PLANTS, V7, DOI 10.1093/aobpla/plv136; Wang P, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0145521; ZEKRI M, 1989, PHYSIOL PLANTARUM, V77, P99, DOI 10.1111/j.1399-3054.1989.tb05984.x; Zhu JK, 1998, PLANT CELL, V10, P1181, DOI 10.1105/tpc.10.7.1181; Zhu XC, 2018, FRONT PLANT SCI, V9, DOI 10.3389/fpls.2018.01363	94	1	1	4	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2020	15	2							e0229023	10.1371/journal.pone.0229023	http://dx.doi.org/10.1371/journal.pone.0229023			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8EV	32097425	gold, Green Published			2022-12-26	WOS:000535232000016
J	Pagella, P; Miran, S; Neto, E; Martin, I; Lamghari, M; Mitsiadis, TA				Pagella, Pierfrancesco; Miran, Shayee; Neto, Estrela; Martin, Ivan; Lamghari, Meriem; Mitsiadis, Thimios A.			Human dental pulp stem cells exhibit enhanced properties in comparison to human bone marrow stem cells on neurites outgrowth	FASEB JOURNAL			English	Article						human bone marrow stem cells; human dental pulp stem cells; innervation; microfluidics; neurotrophins; organs-on-chips; trigeminal ganglion	IN-VITRO; TRIGEMINAL NEURONS; AXON REGENERATION; SENSORY NEURONS; NERVOUS-SYSTEM; SPINAL-CORD; HOX; INNERVATION; REPAIR; TISSUE	Mesenchymal stem cells (MSCs) have the capacity to self-renew and differentiate into specific cell types and are, therefore, key players during tissue repair and regeneration. The use of MSCs for the regeneration of tissues in vivo is increasingly being explored and already constitutes a promising alternative to existing clinical treatments. MSCs also exert paracrine and trophic functions, including the promotion of innervation that plays fundamental roles in regeneration and in restoration of the function of organs. Human bone marrow stem cells (hBMSCs) and human dental pulp stem cells (hDPSCs) have been used in studies that aimed at the repair and/or regeneration of bone or other tissues of the craniofacial complex. However, the capabilities of hBMSCs and hDPSCs to elicit the growth of specific axons in order to reestablish functional innervation of the healing tissues are not known. Here, we compared the neurotrophic effects of hDPSCs and hBMSCs on trigeminal and dorsal root ganglia neurons using microfluidic organs-on-chips devices. We found that hDPSCs express significantly higher levels of neurotrophins than hBMSCs and consequently neurons cocultured with hDPSCs develop longer axons in the microfluidic co-culture system when compared to neurons cocultured with hBMSCs. Moreover, hDPSCs elicited the formation of extensive axonal networks and established close contacts with neurons, a phenomenon not observed in presence of hBMSCs. Taken together, these findings indicate that hDPSCs constitute a superior option for restoring the functionality of damaged craniofacial tissues, as they are able to support and promote extensive trigeminal innervation.	[Pagella, Pierfrancesco; Miran, Shayee; Mitsiadis, Thimios A.] Univ Zurich, Inst Oral Biol, Orofacial Dev & Regenerat, Ctr Dent Med, Plattenstr 11, CH-8032 Zurich, Switzerland; [Neto, Estrela; Lamghari, Meriem] Univ Porto, i3S, Porto, Portugal; [Neto, Estrela; Lamghari, Meriem] Univ Porto, Inst Biomed Engn INEB, Porto, Portugal; [Martin, Ivan] Univ Basel, Univ Hosp Basel, Dept Biomed, Basel, Switzerland	University of Zurich; Universidade do Porto; i3S - Instituto de Investigacao e Inovacao em Saude, Universidade do Porto; Universidade do Porto; University of Basel	Pagella, P; Mitsiadis, TA (corresponding author), Univ Zurich, Inst Oral Biol, Orofacial Dev & Regenerat, Ctr Dent Med, Plattenstr 11, CH-8032 Zurich, Switzerland.	pierfrancesco.pagella@zzm.uzh.ch; thimios.mitsiadis@zzm.uzh.ch	Pagella, Pierfrancesco/ABA-3648-2020; Neto, Estrela C/M-2561-2013; Mitsiadis, Thimios/B-5564-2016; Lamghari, Meriem/K-2159-2013	Pagella, Pierfrancesco/0000-0001-6912-0957; Neto, Estrela C/0000-0003-2334-2292; Mitsiadis, Thimios/0000-0002-9812-9982; Lamghari, Meriem/0000-0002-2500-4548	Universitat Zurich (UZH)	Universitat Zurich (UZH)	Universitat Zurich (UZH)	Abbas OL, 2019, J INVEST SURG, V32, P477, DOI 10.1080/08941939.2018.1433254; Alge DL, 2010, J TISSUE ENG REGEN M, V4, P73, DOI 10.1002/term.220; BENEDETTI M, 1993, P NATL ACAD SCI USA, V90, P7859, DOI 10.1073/pnas.90.16.7859; BYERS MR, 1993, J DENT RES, V72, P613, DOI 10.1177/00220345930720031001; d'Aquino R, 2009, EUR CELLS MATER, V18, P75, DOI 10.22203/eCM.v018a07; Elsalanty ME, 2009, CRANIOMAX TRAUM REC, V2, P125, DOI 10.1055/s-0029-1215875; Fu Y, 2017, TISSUE ENG PART B-RE, V23, P515, DOI [10.1089/ten.TEB.2016.0365, 10.1089/ten.teb.2016.0365]; Giuliani A, 2013, STEM CELL TRANSL MED, V2, P316, DOI 10.5966/sctm.2012-0136; Gkiatas I, 2017, FRONT PHYS, V5, DOI 10.3389/fphy.2017.00044; Gonella MC, 2009, SEMIN NEUROL, V29, P36, DOI 10.1055/s-0028-1124021; Gronthos S, 2000, P NATL ACAD SCI USA, V97, P13625, DOI 10.1073/pnas.240309797; HILDEBRAND C, 1995, PROG NEUROBIOL, V45, P165, DOI 10.1016/0301-0082(94)00045-J; Huang GTJ, 2009, J DENT RES, V88, P792, DOI 10.1177/0022034509340867; Huh D, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004249; Ichikawa H, 2004, ACTA HISTOCHEM, V106, P337, DOI 10.1016/j.acthis.2004.07.003; Ichikawa H, 2012, JPN DENT SCI REV, V48, P48, DOI 10.1016/j.jdsr.2011.10.001; Ingber DE, 2018, DEVELOPMENT, V145, DOI 10.1242/dev.156125; Isobe Y, 2016, INT J ORAL MAX SURG, V45, P124, DOI 10.1016/j.ijom.2015.06.022; Jain A, 2018, CLIN PHARMACOL THER, V103, P332, DOI 10.1002/cpt.742; Jones RHB, 2010, AUST DENT J, V55, P112, DOI 10.1111/j.1834-7819.2010.01216.x; Knox SM, 2010, SCIENCE, V329, P1645, DOI 10.1126/science.1192046; Knox SM, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2493; Kumar A, 2012, TRENDS NEUROSCI, V35, P691, DOI 10.1016/j.tins.2012.08.003; Kunimatsu R, 2018, BIOCHEM BIOPH RES CO, V501, P193, DOI 10.1016/j.bbrc.2018.04.213; La Noce M, 2014, EUR CELLS MATER, V28, P348, DOI 10.22203/eCM.v028a24; Leucht P, 2008, DEVELOPMENT, V135, P2845, DOI 10.1242/dev.023788; Lucas D, 2013, NAT MED, V19, P695, DOI 10.1038/nm.3155; Mallo M, 2010, DEV BIOL, V344, P7, DOI 10.1016/j.ydbio.2010.04.024; Martin I, 2019, SCI TRANSL MED, V11, DOI 10.1126/scitranslmed.aat2189; Mead B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109305; Mead B, 2013, INVEST OPHTH VIS SCI, V54, P7544, DOI 10.1167/iovs.13-13045; Miran S, 2016, STEM CELLS INT, V2016, DOI 10.1155/2016/7231038; Mitsiadis TA, 2015, EUR CELLS MATER, V30, P248, DOI 10.22203/eCM.v030a17; Mitsiadis TA, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01455-3; Neto EC, 2012, BONE, V50, pS113, DOI 10.1016/j.bone.2012.02.347; Neto E, 2016, J NEUROSCI, V36, P11573, DOI 10.1523/JNEUROSCI.1748-16.2016; Neto E, 2014, INTEGR BIOL-UK, V6, P586, DOI 10.1039/c4ib00035h; Nosrat IV, 2001, DEV BIOL, V238, P120, DOI 10.1006/dbio.2001.0400; Orsini G, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.01102; Orsini G, 2018, AM J MED, V131, P1425, DOI 10.1016/j.amjmed.2018.05.042; Pagella P, 2015, EUR CELLS MATER, V29, P213, DOI 10.22203/eCM.v029a16; Pagella P, 2015, JOVE-J VIS EXP, DOI 10.3791/53114; Pagella P, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00326; Pagella P, 2014, CELL MOL LIFE SCI, V71, P2241, DOI 10.1007/s00018-013-1549-0; Pearson JC, 2005, NAT REV GENET, V6, P893, DOI 10.1038/nrg1726; Pediaditakis I, 2016, FRONT PHARMACOL, V7, DOI 10.3389/fphar.2016.00512; Picchi J, 2013, J CELL PHYSIOL, V228, P879, DOI 10.1002/jcp.24239; Prantil-Baun R., 2016, ANN REV PHARM TOXICO, V58, P37; Sacchetti B, 2016, STEM CELL REP, V6, P897, DOI 10.1016/j.stemcr.2016.05.011; Sakai K, 2012, J CLIN INVEST, V122, P80, DOI 10.1172/JCI59251; SANDSTEDT P, 1995, J ORAL MAXIL SURG, V53, P498, DOI 10.1016/0278-2391(95)90055-1; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Sfriso R, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-24273-7; Shibahara T, 2000, J ORAL MAXIL SURG, V58, P714, DOI 10.1053/joms.2000.7252; Smith GM, 2012, TRENDS NEUROSCI, V35, P156, DOI 10.1016/j.tins.2011.10.006; Song M, 2017, CELL TRANSPLANT, V26, P1001, DOI 10.3727/096368916X694391; Stone JB, 2016, NAT REV CLIN ONCOL, V13, P92, DOI 10.1038/nrclinonc.2015.152; Sullins JS, 2000, J ENDODONT, V26, P88, DOI 10.1097/00004770-200002000-00007; Susarla SM, 2005, J ORAL MAXIL SURG, V63, P1138, DOI 10.1016/j.joms.2005.04.021; Tamaki Y, 2013, ODONTOLOGY, V101, P121, DOI 10.1007/s10266-012-0075-0; Tollemar V, 2016, GENES DIS, V3, P56, DOI 10.1016/j.gendis.2015.09.004; Tomlinson RE, 2016, CELL REP, V16, P2723, DOI 10.1016/j.celrep.2016.08.002	62	19	19	2	9	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2020	34	4					5499	5511		10.1096/fj.201902482R	http://dx.doi.org/10.1096/fj.201902482R		FEB 2020	13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	LJ5ZA	32096581	Bronze, Green Accepted			2022-12-26	WOS:000517889200001
J	Boursier, ME; Levin, S; Zimmerman, K; Machleidt, T; Hurst, R; Butler, BL; Eggers, CT; Kirkland, TA; Wood, KV; Ohana, RF				Boursier, Michelle E.; Levin, Sergiy; Zimmerman, Kris; Machleidt, Thomas; Hurst, Robin; Butler, Braeden L.; Eggers, Christopher T.; Kirkland, Thomas A.; Wood, Keith V.; Ohana, Rachel Friedman			The luminescent HiBiT peptide enables selective quantitation of G protein?coupled receptor ligand engagement and internalization in living cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						G protein-coupled receptor (GPCR); bioluminescence resonance energy transfer (BRET); receptor internalization; kinetics; bioluminescence; adrenergic receptor; endogenous tagging; HiBiT; ligand engagement; NanoLuc	ALLOSTERIC MODULATOR; COUPLED RECEPTOR; AGONIST BINDING; KINETICS; TIME; VALIDATION; PROTEINS; ANALOGS; POTENT; ASSAY	G protein?coupled receptors (GPCRs) are prominent targets to new therapeutics for a range of diseases. Comprehensive assessments of their cellular interactions with bioactive compounds, particularly in a kinetic format, are imperative to the development of drugs with improved efficacy. Hence, we developed complementary cellular assays that enable equilibrium and real-time analyses of GPCR ligand engagement and consequent activation, measured as receptor internalization. These assays utilize GPCRs genetically fused to an N-terminal HiBiT peptide (1.3 kDa), which produces bright luminescence upon high-affinity complementation with LgBiT, an 18-kDa subunit derived from NanoLuc. The cell impermeability of LgBiT limits signal detection to the cell surface and enables measurements of ligand-induced internalization through changes in cell-surface receptor density. In addition, bioluminescent resonance energy transfer is used to quantify dynamic interactions between ligands and their cognate HiBiT-tagged GPCRs through competitive binding with fluorescent tracers. The sensitivity and dynamic range of these assays benefit from the specificity of bioluminescent resonance energy transfer and the high signal intensity of HiBiT/LgBiT without background luminescence from receptors present in intracellular compartments. These features allow analyses of challenging interactions having low selectivity or affinity and enable studies using endogenously tagged receptors. Using the ?-adrenergic receptor family as a model, we demonstrate the versatility of these assays by utilizing the same HiBiT construct in analyses of multiple aspects of GPCR pharmacology. We anticipate that this combination of target engagement and proximal functional readout will prove useful to the study of other GPCR families and the development of new therapeutics.	[Boursier, Michelle E.; Zimmerman, Kris; Machleidt, Thomas; Hurst, Robin; Butler, Braeden L.; Eggers, Christopher T.; Wood, Keith V.; Ohana, Rachel Friedman] Promega Corp, 2800 Woods Hollow, Fitchburg, WI 53711 USA; [Levin, Sergiy; Kirkland, Thomas A.] Promega Biosci LLC, San Luis Obispo, CA 93401 USA	Promega Corporation	Ohana, RF (corresponding author), Promega Corp, 2800 Woods Hollow, Fitchburg, WI 53711 USA.	rachel.ohana@promega.com		Boursier, Michelle/0000-0002-2642-1802				Ahn KH, 2012, J BIOL CHEM, V287, P12070, DOI 10.1074/jbc.M111.316463; Ahn S, 2018, MOL PHARMACOL, V94, P850, DOI 10.1124/mol.118.111948; Algar WR, 2019, NAT METHODS, V16, P815, DOI 10.1038/s41592-019-0530-8; Alikhani V, 2004, BIOORG MED CHEM LETT, V14, P4705, DOI 10.1016/j.bmcl.2004.06.086; Atwood Brady K, 2011, BMC Genomics, V12, P14, DOI 10.1186/1471-2164-12-14; Baker JG, 2005, BRIT J PHARMACOL, V144, P317, DOI 10.1038/sj.bjp.0706048; Basu D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070736; Beattie D, 2010, BIOORG MED CHEM LETT, V20, P5302, DOI 10.1016/j.bmcl.2010.06.136; Braadland PR, 2015, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00375; Calebiro D, 2018, BEST PRACT RES CL EN, V32, P83, DOI 10.1016/j.beem.2018.01.004; Candelore MR, 1999, J PHARMACOL EXP THER, V290, P649; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; Choo KH, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S15-S2; Conn PJ, 2009, NAT REV DRUG DISCOV, V8, P41, DOI 10.1038/nrd2760; Cooper SL, 2019, BRIT J PHARMACOL, V176, P864, DOI 10.1111/bph.14575; Copeland RA, 2016, NAT REV DRUG DISCOV, V15, P87, DOI 10.1038/nrd.2015.18; Dale NC, 2019, FRONT BIOENG BIOTECH, V7, DOI 10.3389/fbioe.2019.00056; Dixon AS, 2016, ACS CHEM BIOL, V11, P400, DOI 10.1021/acschembio.5b00753; Flanagan CA, 2016, METHOD CELL BIOL, V132, P191, DOI 10.1016/bs.mcb.2015.11.004; Green SA, 1996, J BIOL CHEM, V271, P24029, DOI 10.1074/jbc.271.39.24029; Hoare BL, 2019, PHARMACOL RES PERSPE, V7, DOI 10.1002/prp2.513; Hoffmann C, 2004, N-S ARCH PHARMACOL, V369, P151, DOI 10.1007/s00210-003-0860-y; Hulme EC, 2010, BRIT J PHARMACOL, V161, P1219, DOI 10.1111/j.1476-5381.2009.00604.x; Isogaya M, 1999, MOL PHARMACOL, V56, P875, DOI 10.1124/mol.56.5.875; Jiang LL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047016; Krushinski JH, 2007, BIOORG MED CHEM LETT, V17, P5600, DOI 10.1016/j.bmcl.2007.07.086; Laprairie RB, 2015, BRIT J PHARMACOL, V172, P4790, DOI 10.1111/bph.13250; Leach K, 2010, NEUROPSYCHOPHARMACOL, V35, P855, DOI 10.1038/npp.2009.194; Liu XY, 2019, SCIENCE, V364, P1283, DOI 10.1126/science.aaw8981; Machleidt T, 2015, ACS CHEM BIOL, V10, P1797, DOI 10.1021/acschembio.5b00143; Martikkala E, 2009, ANAL BIOCHEM, V392, P103, DOI 10.1016/j.ab.2009.05.022; Moore RH, 2007, AM J RESP CELL MOL, V36, P254, DOI 10.1165/rcmb.2006-0158OC; MOTULSKY HJ, 1984, MOL PHARMACOL, V25, P1; Nevins AM, 2018, METHODS MOL BIOL, V1722, P151, DOI 10.1007/978-1-4939-7553-2_10; Opekarova M, 2003, BBA-BIOMEMBRANES, V1610, P11, DOI 10.1016/S0005-2736(02)00708-3; Riching KM, 2018, ACS CHEM BIOL, V13, P2758, DOI 10.1021/acschembio.8b00692; Robers MB, 2015, ANAL BIOCHEM, V489, P1, DOI 10.1016/j.ab.2015.08.005; Santos R, 2017, NAT REV DRUG DISCOV, V16, P19, DOI 10.1038/nrd.2016.230; Sato Y, 1996, EUR J PHARMACOL, V315, P363, DOI 10.1016/S0014-2999(96)00648-6; Schuetz DA, 2017, DRUG DISCOV TODAY, V22, P896, DOI 10.1016/j.drudis.2017.02.002; Schwinn MK, 2018, ACS CHEM BIOL, V13, P467, DOI 10.1021/acschembio.7b00549; Soave M, 2020, SLAS DISCOV, V25, P186, DOI 10.1177/2472555219880475; Soave M, 2016, PHARMACOL RES PERSPE, V4, DOI 10.1002/prp2.250; Stoddart LA, 2016, BRIT J PHARMACOL, V173, P3028, DOI 10.1111/bph.13316; Stoddart LA, 2015, NAT METHODS, V12, P661, DOI [10.1038/NMETH.3398, 10.1038/nmeth.3398]; Sykes DA, 2019, MOL CELL ENDOCRINOL, V485, P9, DOI 10.1016/j.mce.2019.01.018; Sykes DA, 2012, BRIT J PHARMACOL, V165, P2672, DOI 10.1111/j.1476-5381.2011.01639.x; Tsien Roger Y., 1993, Trends in Cell Biology, V3, P242, DOI 10.1016/0962-8924(93)90124-J; Tummino PJ, 2008, BIOCHEMISTRY-US, V47, P5481, DOI 10.1021/bi8002023; Vauquelin G, 2016, BRIT J PHARMACOL, V173, P2319, DOI 10.1111/bph.13504; Walker JR, 2017, ACS CHEM BIOL, V12, P1028, DOI 10.1021/acschembio.6b01129; White CW, 2019, CELL SIGNAL, V54, P27, DOI 10.1016/j.cellsig.2018.11.018; Yeatman HR, 2014, J BIOL CHEM, V289, P15856, DOI 10.1074/jbc.M113.536672; Zhang R, 2012, ACTA PHARMACOL SIN, V33, P372, DOI 10.1038/aps.2011.173	54	16	16	2	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 10	2020	295	15					5124	5135		10.1074/jbc.RA119.011952	http://dx.doi.org/10.1074/jbc.RA119.011952			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LE7FC	32107310	hybrid, Green Published			2022-12-26	WOS:000526887000031
J	Adapa, D; Raj, ANJ; Alisetti, SN; Zhuang, Z; Ganesan, K; Naik, G				Adapa, Dharmateja; Raj, Alex Noel Joseph; Alisetti, Sai Nikhil; Zhuang, Zhemin; Ganesan, K.; Naik, Ganesh			A supervised blood vessel segmentation technique for digital Fundus images using Zernike Moment based features	PLOS ONE			English	Article							RETINAL IMAGES; MATCHED-FILTER; CLASSIFICATION; NETWORK	This paper proposes a new supervised method for blood vessel segmentation using Zernike moment-based shape descriptors. The method implements a pixel wise classification by computing a 11-D feature vector comprising of both statistical (gray-level) features and shape-based (Zernike moment) features. Also the feature set contains optimal coefficients of the Zernike Moments which were derived based on the maximum differentiability between the blood vessel and background pixels. A manually selected training points obtained from the training set of the DRIVE dataset, covering all possible manifestations were used for training the ANN-based binary classifier. The method was evaluated on unknown test samples of DRIVE and STARE databases and returned accuracies of 0.945 and 0.9486 respectively, outperforming other existing supervised learning methods. Further, the segmented outputs were able to cover thinner blood vessels better than previous methods, aiding in early detection of pathologies.	[Adapa, Dharmateja; Raj, Alex Noel Joseph; Alisetti, Sai Nikhil; Zhuang, Zhemin] Shantou Univ, Coll Engn, Dept Elect Engn, Key Lab Digital Signal & Image Proc Guangdong Pro, Shantou, Guangdong, Peoples R China; [Ganesan, K.] Vellore Inst Technol, Sch Elect, TIFAC Core, Vellore, Tamil Nadu, India; [Naik, Ganesh] Western Sydney Univ, MARCS Inst, Sydney, NSW, Australia	Shantou University; Vellore Institute of Technology; Western Sydney University	Raj, ANJ (corresponding author), Shantou Univ, Coll Engn, Dept Elect Engn, Key Lab Digital Signal & Image Proc Guangdong Pro, Shantou, Guangdong, Peoples R China.	jalexnoel@stu.edu.cn	noel, alex/V-6663-2019	noel, alex/0000-0003-1505-3159; zhuang, zhemin/0000-0002-7236-6859	Key Project of Guangdong Province Science & Technology Plan [2015B020233018]; Foundation of China [61471228]; Research Start-up Fund Subsidized Project of Shantou University, China [NTF17016]	Key Project of Guangdong Province Science & Technology Plan; Foundation of China; Research Start-up Fund Subsidized Project of Shantou University, China	This research was financially supported by the Key Project of Guangdong Province Science & Technology Plan (No.2015B020233018), the Foundation of China (No.61471228), and The Research Start-up Fund Subsidized Project of Shantou University, China, Grant No: NTF17016.	Al-Diri B, 2005, 3 EUR MED BIOL ENG C; Al-Rawi M, 2007, COMPUT BIOL MED, V37, P262, DOI 10.1016/j.compbiomed.2006.03.003; Almotiri J, 2018, APPL SCI-BASEL, V8, DOI 10.3390/app8020155; Chen SD, 2003, IEEE T CONSUM ELECTR, V49, P1310, DOI 10.1109/TCE.2003.1261234; Chutatape O, 1998, P ANN INT IEEE EMBS, V20, P3144, DOI 10.1109/IEMBS.1998.746160; Dash J, 2018, J DIGIT IMAGING, V31, P857, DOI 10.1007/s10278-018-0059-x; Dizdaroglu Bekir, 2012, IEEE Int Workshop Mach Learn Signal Process, P1; Emary E, 2014, IEEE IJCNN, P1792, DOI 10.1109/IJCNN.2014.6889932; Espona L, 2007, LECT NOTES COMPUT SC, V4478, P178; Faust O, 2012, J MED SYST, V36, P145, DOI 10.1007/s10916-010-9454-7; Fraz MM, 2012, COMPUT METH PROG BIO, V108, P407, DOI 10.1016/j.cmpb.2012.03.009; Frucci M, 2014, 10TH INTERNATIONAL CONFERENCE ON SIGNAL-IMAGE TECHNOLOGY AND INTERNET-BASED SYSTEMS SITIS 2014, P592, DOI 10.1109/SITIS.2014.18; Gardner GG, 1996, BRIT J OPHTHALMOL, V80, P940, DOI 10.1136/bjo.80.11.940; Gong HM, 2015, 2015 8TH INTERNATIONAL CONGRESS ON IMAGE AND SIGNAL PROCESSING (CISP), P413, DOI 10.1109/CISP.2015.7407915; Hoover A, 2000, IEEE T MED IMAGING, V19, P203, DOI 10.1109/42.845178; Jiang ZX, 2017, BIOCYBERN BIOMED ENG, V37, P412, DOI 10.1016/j.bbe.2017.04.001; Kelvin P, 2007, P 10 INT C MED IM CO; Kirbas C, 2004, ACM COMPUT SURV, V36, P81, DOI 10.1145/1031120.1031121; Kumar D, 2016, ADV EXP MED BIOL, V926, P1, DOI 10.1007/978-3-319-42316-6_1; Lahiri A, 2016, IEEE ENG MED BIO, P1340, DOI 10.1109/EMBC.2016.7590955; Lam BSY, 2010, IEEE T MED IMAGING, V29, P1369, DOI 10.1109/TMI.2010.2043259; Mabrouk M.S., 2006, ICGST INT J GRAPH VI, V6, P1; Maji D, 2016, ARXIV1603048330; Maji D, 2015, IEEE ENG MED BIO, P3029, DOI 10.1109/EMBC.2015.7319030; Marin D, 2011, IEEE T MED IMAGING, V30, P146, DOI 10.1109/TMI.2010.2064333; Martinez-Perez ME, 2007, P ANN INT IEEE EMBS, P892, DOI 10.1109/IEMBS.2007.4352434; Martinez-Perez ME, 2007, MED IMAGE ANAL, V11, P47, DOI 10.1016/j.media.2006.11.004; NEKOVEI R, 1995, IEEE T NEURAL NETWOR, V6, P64, DOI 10.1109/72.363449; Niemeijer M, 2004, PROC SPIE, V5370, P648, DOI 10.1117/12.535349; Raj ANJ, 2017, ADV COMPU INTELL ROB, P90, DOI 10.4018/978-1-5225-2053-5.ch004; Ricci E, 2007, IEEE T MED IMAGING, V26, P1357, DOI 10.1109/TMI.2007.898551; Roy AG, 2015, PROCEEDINGS 3RD IAPR ASIAN CONFERENCE ON PATTERN RECOGNITION ACPR 2015, P735, DOI 10.1109/ACPR.2015.7486600; Roychowdhury S, 2015, IEEE T BIO-MED ENG, V62, P1738, DOI 10.1109/TBME.2015.2403295; Singh NP, 2016, COMPUT METH PROG BIO, V129, P40, DOI 10.1016/j.cmpb.2016.03.001; Sinthanayothin C, 1999, BRIT J OPHTHALMOL, V83, P902, DOI 10.1136/bjo.83.8.902; Sofka M, 2006, IEEE T MED IMAGING, V25, P1531, DOI 10.1109/TMI.2006.884190; Soille P, 2004, APPL CORRECTION UNEV; Staal J, 2004, IEEE T MED IMAGING, V23, P501, DOI 10.1109/TMI.2004.825627; Strisciuglio N., 2015, VIPIMAGE, V1, P149; Tahmasbi A, 2011, COMPUT BIOL MED, V41, P726, DOI 10.1016/j.compbiomed.2011.06.009; Thangaraj S, 2018, IET IMAGE PROCESS, V12, P669, DOI 10.1049/iet-ipr.2017.0284; Vaidya YM, 2015, 2015 INTERNATIONAL CONFERENCE ON INDUSTRIAL INSTRUMENTATION AND CONTROL (ICIC), P1373, DOI 10.1109/IIC.2015.7150962; Wang XH, 2019, PATTERN RECOGN, V88, P331, DOI 10.1016/j.patcog.2018.11.030; Winder RJ, 2009, COMPUT MED IMAG GRAP, V33, P608, DOI 10.1016/j.compmedimag.2009.06.003; Wu SB, 2013, 2013 IEEE INTERNATIONAL CONFERENCE ON INFORMATION AND AUTOMATION (ICIA), P521, DOI 10.1109/ICInfA.2013.6720354; Zijdenbos AP, 2002, IEEE T MED IMAGING, V21, P1280, DOI 10.1109/TMI.2002.806283; Zuiderveld Karel J., 1994, GRAPHICS GEMS	47	25	25	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2020	15	3							e0229831	10.1371/journal.pone.0229831	http://dx.doi.org/10.1371/journal.pone.0229831			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8TR	32142540	Green Published, gold			2022-12-26	WOS:000535271600020
J	Wu, KW; Lu, TW; Lee, WC; Ho, YT; Wang, JH; Kuo, KN; Wang, TM				Wu, Kuan-Wen; Lu, Tung-Wu; Lee, Wei-Chun; Ho, Ya-Ting; Wang, Jyh-Horng; Kuo, Ken N.; Wang, Ting-Ming			Whole body balance control in Lenke 1 thoracic adolescent idiopathic scoliosis during level walking	PLOS ONE			English	Article							CENTER-OF-MASS; MOTION; STABILITY; PRESSURE; FUSION; CLASSIFICATION; SENSITIVITY; KINEMATICS; PARAMETERS; DEFORMITY	Introduction Altered trunk shape and body alignment in Lenke 1 thoracic adolescent idiopathic scoliosis (AIS) may affect the body's balance control during activities. The current study aimed to identify the effects of Lenke 1 thoracic AIS on the balance control during level walking in terms of the inclination angles (IA) of the center of mass (COM) relative to the center of pressure (COP), the rate of change of IA (RCIA), and the jerk index of IA. The association between the Cobb angle, IA and RCIA was also evaluated. Materials and methods Sixteen adolescents with AIS (age: 14.0 +/- 1.8 years, height: 154.8 +/- 4.7 cm, mass: 42.0 +/- 7.5 kg) and sixteen healthy controls (age: 14.4 +/- 2.0 years, height: 158.4 +/- 6.2 cm, body mass: 48.6 +/- 8.9 kg) performed level walking in a gait laboratory. The kinematic and ground reaction force data were measured for both concave-side and convex-side limb cycles, and used to calculate the IA and RCIA, the jerk index of IA, and the temporal-spatial parameters. Correlations between the Cobb angle, IA and RCIA were quantified using Pearson's correlation coefficients (r). Results The patients showed less smooth COM-COP motion with increased jerk index of IA in the sagittal plane during single limb support (SLS) of the concave-limb (p = 0.05) and in the frontal plane during double limb support (DLS) (p < 0.05). The patients also showed significantly increased posterior RCIA on both the concave and convex side during initial (p = 0.04, p = 0.03) and terminal (p = 0.04, p = 0.03) DLS when compared to healthy controls. In the frontal plane, the patients walking on the concave-side limb showed decreased IA over SLS (p = 0.01), and at contralateral toe-off (p< 0.01) and contralateral heel-strike (p = 0.02), but increased mean IA magnitude over terminal DLS (p = 0.01). The frontal IA at contralateral toe-off and SLS for AIS-A showed a moderate to strong correlation with Cobb angles (r = -0.46 and -0.61), and the sagittal RCIA over the initial DLS for AIS-A also showed a significant, strong correlation with Cobb angles (r = -0.50). Conclusions The patients with Lenke 1 thoracic scoliosis in the current study showed altered and jerkier COM-COP control during level walking when compared to healthy controls. During DLS, the patients increased the posterior RCIA in the sagittal plane with increased IA jerk index in the frontal plane for both the concave- and the convex-side limb, indicating their difficulty in maintaining a smooth transfer of the body weight. During SLS of the concave-side limb, the patients adopted a conservative COM-COP control strategy, as indicated by a decreased IA in the frontal plane, but showed a jerky COM-COP control in the sagittal plane. The COMCOP control of the patients was associated with the severity of the spinal deformity. The current results suggest that this patient group should be monitored for signs of an increased risk of loss of balance during weight transfer on the concave-side limb.	[Wu, Kuan-Wen; Lu, Tung-Wu; Lee, Wei-Chun; Ho, Ya-Ting] Natl Taiwan Univ, Dept Biomed Engn, Taipei, Taiwan; [Wu, Kuan-Wen; Lu, Tung-Wu; Wang, Jyh-Horng; Wang, Ting-Ming] Natl Taiwan Univ, Sch Med, Dept Orthopaed Surg, Taipei, Taiwan; [Wu, Kuan-Wen; Ho, Ya-Ting; Wang, Jyh-Horng; Kuo, Ken N.; Wang, Ting-Ming] Natl Taiwan Univ Hosp, Dept Orthopaed Surg, Taipei, Taiwan; [Lee, Wei-Chun] Chang Gung Mem Hosp, Dept Orthopaed Surg, Taipei, Taiwan	National Taiwan University; National Taiwan University; National Taiwan University; National Taiwan University Hospital; Chang Gung Memorial Hospital	Wang, TM (corresponding author), Natl Taiwan Univ, Sch Med, Dept Orthopaed Surg, Taipei, Taiwan.; Wang, TM (corresponding author), Natl Taiwan Univ Hosp, Dept Orthopaed Surg, Taipei, Taiwan.	dtorth76@gmail.com		Wang, Ting-Ming/0000-0002-2263-5993; Wang, Jyh- Horng/0000-0002-1531-5297; WU, KUAN-WEN/0000-0001-8170-9879				BARRACK RL, 1984, SPINE, V9, P681, DOI 10.1097/00007632-198410000-00005; Bruijn SM, 2009, J NEUROSCI METH, V178, P327, DOI 10.1016/j.jneumeth.2008.12.015; Carpentier M, 2008, EARTH PLANET SC LETT, V272, P199, DOI 10.1016/j.epsl.2008.04.036; Chen HL, 2006, GAIT POSTURE, V23, P69, DOI 10.1016/j.gaitpost.2004.12.001; Chen PQ, 1998, CLIN BIOMECH, V13, pS52, DOI 10.1016/S0268-0033(97)00075-2; Chen SC, 2011, GAIT POSTURE, V33, P695, DOI 10.1016/j.gaitpost.2011.03.004; Chien HL, 2013, GAIT POSTURE, V38, P391, DOI 10.1016/j.gaitpost.2012.12.015; Chockalingam N, 2008, SCOLIOSIS SPINAL DIS, V3, DOI 10.1186/1748-7161-3-10; Choudhry Muhammad Naghman, 2016, Open Orthop J, V10, P143, DOI 10.2174/1874325001610010143; Cromwell RL, 2001, J ORTHOP SPORT PHYS, V31, P255, DOI 10.2519/jospt.2001.31.5.255; Damavandi M, 2013, MED ENG PHYS, V35, P1607, DOI 10.1016/j.medengphy.2013.05.010; Danielsson AJ, 2006, SPINE, V31, P275, DOI 10.1097/01.brs.0000197652.52890.71; Doi T, 2011, J ORTHOP SURG RES, V6, DOI 10.1186/1749-799X-6-4; England SA, 2007, GAIT POSTURE, V25, P172, DOI 10.1016/j.gaitpost.2006.03.003; Erdfelder E, 1996, BEHAV RES METH INS C, V28, P1, DOI 10.3758/BF03203630; Hansen AH, 2002, J BIOMECH, V35, P135, DOI 10.1016/S0021-9290(01)00174-9; Hogan N, 2009, J MOTOR BEHAV, V41, P529, DOI 10.3200/35-09-004-RC; Hong SW, 2015, GAIT POSTURE, V42, P523, DOI 10.1016/j.gaitpost.2015.08.007; Hreljac A, 2000, J BIOMECH, V33, P783, DOI 10.1016/S0021-9290(00)00014-2; Hsu WC, 2010, J MECH, V26, P229, DOI 10.1017/S1727719100003087; Huang S-C, 2008, AGE HEIGHT EFFECTS C, P968; Karimi MT, 2016, J BACK MUSCULOSKELET, V29, P403, DOI 10.3233/BMR-150641; Konieczny MR, 2013, J CHILD ORTHOP, V7, P3, DOI 10.1007/s11832-012-0457-4; LEBLANC R, 1995, ANN CHIR, V49, P762; Lee HJ, 2006, ARCH PHYS MED REHAB, V87, P569, DOI 10.1016/j.apmr.2005.11.033; Lenke LG, 2002, SPINE, V27, P604, DOI 10.1097/00007632-200203150-00008; Lenke LG, 2001, SPINE, V26, P2347, DOI 10.1097/00007632-200111010-00011; Lu TW, 1999, J BIOMECH, V32, P129, DOI 10.1016/S0021-9290(98)00158-4; Magee D. J., 2020, ORTHOPEDIC PHYS ASSE, V7th; Masso PD, 2000, SPINE, V25, P457, DOI 10.1097/00007632-200002150-00011; Nault ML, 2002, SPINE, V27, P1911, DOI 10.1097/00007632-200209010-00018; Pai YC, 1997, J BIOMECH, V30, P347, DOI 10.1016/S0021-9290(96)00165-0; Pasha S, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-34261-6; Pasha S, 2019, SPINE, V44, P134, DOI 10.1097/BRS.0000000000002748; RIDDLE HFV, 1955, LANCET, V1, P1245, DOI 10.1016/S0140-6736(55)91020-5; Rohrer B, 2002, J NEUROSCI, V22, P8297; Sarwahi V, 2002, SPINE, V27, P2328, DOI 10.1097/00007632-200211010-00005; Syczewska M, 2012, GAIT POSTURE, V35, P209, DOI 10.1016/j.gaitpost.2011.09.008; Wang TM, 2007, J CHIN INST ENG, V30, P471, DOI 10.1080/02533839.2007.9671275; Wank V, 1998, INT J SPORTS MED, V19, P455, DOI 10.1055/s-2007-971944; Weinstein SL, 2008, LANCET, V371, P1527, DOI 10.1016/S0140-6736(08)60658-3; WOLTRING HJ, 1986, ADV ENG SOFTW WORKST, V8, P104, DOI 10.1016/0141-1195(86)90098-7; Wu KW, 2019, GAIT POSTURE, V71, P211, DOI 10.1016/j.gaitpost.2019.05.007; Wu KW, 2019, GAIT POSTURE, V68, P423, DOI 10.1016/j.gaitpost.2018.12.024; Young RP, 1997, HUM MOVEMENT SCI, V16, P677, DOI 10.1016/S0167-9457(97)00010-9	45	2	3	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2020	15	3							e0229775	10.1371/journal.pone.0229775	http://dx.doi.org/10.1371/journal.pone.0229775			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8TR	32142524	Green Published, gold			2022-12-26	WOS:000535271600018
J	Anton, C; Kleine, RT; Mayerhoff, E; Diz, MDE; de Freitas, D; Carvalho, HD; de Carvalho, JPM; Silva, ASE; Genta, MLND; Silva, ALDE; Salim, RC; Aranha, A; Lopez, RVM; Carvalho, FM; Baracat, EC; Carvalho, JP				Anton, Cristina; Kleine, Rodolpho Truffa; Mayerhoff, Eric; Esteves Diz, Maria del Pilar; de Freitas, Daniela; Carvalho, Heloisa de Andrade; Mancusi de Carvalho, Joao Paulo; Silva e Silva, Alexandre; Nogueira Dias Genta, Maria Luiza; de Faria e Silva, Andre Lopes; Salim, Rafael Calil; Aranha, Andrea; Mendoza Lopez, Rossana Veronica; Carvalho, Filomena Marino; Baracat, Edmund Chada; Carvalho, Jesus Paula			Ten years of experience with endometrial cancer treatment in a single Brazilian institution: Patient characteristics and outcomes	PLOS ONE			English	Article							UTERINE SEGMENT INVOLVEMENT; LYMPH-NODE METASTASIS; POOLED ANALYSIS; SPACE INVASION; OBESITY; RECURRENCE; RISK	Few reports have described the clinical and prognostic characteristics of endometrial cancer, which is increasing worldwide, in large patient series in Brazil. Our objective was to analyze the clinicopathological characteristics, prognostic factors, and outcomes of patients with endometrial cancer treated and followed at a tertiary Brazilian institution over a 10-year period. This retrospective study included 703 patients diagnosed with endometrial cancer who were treated at a public academic tertiary hospital between 2008 and 2018. The following parameters were analyzed: age at diagnosis, race, body mass index, serum CA125 level before treatment; histological type and grade, and surgical stage. Outcomes were reported relative to histological type, surgical staging, serum CA125, lymph-vascular space involvement (LVSI), and lymph-node metastasis. The median patient age at diagnosis was 63 (range, 27-93) years (6.4% were < 50 years). Minimally invasive surgeries were performed in 523 patients (74.4%). Regarding histological grade, 468 patients (66.5%) had low-grade endometrioid histology and 449 patients (63.9%) had stage I tumors. Tumors exceeded 2.0 cm in 601 patients (85.5%). Lymphadenectomy was performed in 551 cases (78.4%). LVSI was present in 208 of the patients' tumors (29.5%). Ninety-three patients (13.2%) had recurrent tumors and 97 (13.7%) died from their malignant disease. The robust prognostic value of FIGO stage and lymph node status were confirmed. Other important survival predictors were histological grade and LVSI [overall survival: hazard ratio (HR) = 3.75, p < 0.001 and HR = 2.01, p = 0.001; recurrence: HR = 2.49, p = 0.004 and HR = 3.22, p = 0.001, respectively). Disease-free (p = 0.087) and overall survival (p = 0.368) did not differ significantly between patients with stage II and III disease. These results indicate that prognostic role of cervical involvement should be explored further. This study reports the characteristics and outcomes of endometrial cancer in a large population from a single institution, with systematic surgical staging, a predominance of minimally invasive procedures, and well-documented outcomes. Prognostic factors in the present study population were generally similar to those in other countries, though our patients' tumors were larger than in studies elsewhere due to later diagnosis. Our unexpected finding of similar prognoses of stage II and III patients raises questions about the prognostic value of cervical involvement and possible differences between carcinomas originating in the lower uterine segment versus those originating in the body and fundus. The present findings can be used to guide public policies aimed at improving the diagnosis and treatment of endometrial cancer in Brazil and other similar countries.	[Anton, Cristina; Kleine, Rodolpho Truffa; Mayerhoff, Eric; Mancusi de Carvalho, Joao Paulo; Silva e Silva, Alexandre; Nogueira Dias Genta, Maria Luiza; Carvalho, Jesus Paula] Univ Sao Paulo, Fac Med, ICESP, Inst Canc Estado Sao Paulo,Gynecol Oncol Team, Sao Paulo, SP, Brazil; [Esteves Diz, Maria del Pilar; de Freitas, Daniela; Carvalho, Heloisa de Andrade; Aranha, Andrea] Univ Sao Paulo, Fac Med, Inst Canc Estado Sao Paulo ICESP, Dept Radiol & Oncol, Sao Paulo, SP, Brazil; [de Faria e Silva, Andre Lopes] Univ Sao Paulo, Fac Med, Inst Canc Estado Sao Paulo ICESP, Dept Digest Surg, Sao Paulo, SP, Brazil; [Salim, Rafael Calil] Univ Sao Paulo, Fac Med, Inst Canc Estado Sao Paulo ICESP, Lab Surg Pathol, Sao Paulo, SP, Brazil; [Mendoza Lopez, Rossana Veronica] Univ Sao Paulo, Fac Med, Inst Canc Estado Sao Paulo ICESP, Oncol Translat Res Ctr, Sao Paulo, SP, Brazil; [Carvalho, Filomena Marino] Univ Sao Paulo, Fac Med FMUSP, Dept Pathol, Sao Paulo, SP, Brazil; [Baracat, Edmund Chada; Carvalho, Jesus Paula] Univ Sao Paulo, Fac Med FMUSP, Div Gynecol, Sao Paulo, SP, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo	Anton, C (corresponding author), Univ Sao Paulo, Fac Med, ICESP, Inst Canc Estado Sao Paulo,Gynecol Oncol Team, Sao Paulo, SP, Brazil.	cristinaanton@terra.com.br	Carvalho, Jesus Paula/O-7464-2019; Anton, Cristina/ABB-9783-2020; Anton, Cristina/AAS-7697-2020; del pilar estevez diz, maria/W-1036-2019; CARVALHO, JESUS PAULA/G-8387-2018; Carvalho, Filomena Marino/D-3987-2012; Zhang, Zhi Jie/AAR-1686-2020; Mendoza Lopez, Rossana Veronica/ABA-2587-2021	Anton, Cristina/0000-0002-6259-2449; del pilar estevez diz, maria/0000-0003-3176-9747; CARVALHO, JESUS PAULA/0000-0003-4495-057X; Carvalho, Filomena Marino/0000-0002-5838-3636; Mayerhoff, Eric/0000-0002-4985-060X; Lopes, Andre/0000-0002-4986-8738				AlHilli MM, 2013, GYNECOL ONCOL, V128, P294, DOI 10.1016/j.ygyno.2012.10.009; Amant F, 2018, INT J GYNECOL OBSTET, V143, P37, DOI 10.1002/ijgo.12612; Amin M, 2016, AJCC CANC STAGING MA; Anton C, 2017, CLINICS, V72, P30, DOI 10.6061/clinics/2017(01)06; Anton C, 2015, CLINICS, V70, P470, DOI 10.6061/clinics/2015(07)02; Arthur RS, 2019, CANCER CAUSE CONTROL, V30, P355, DOI 10.1007/s10552-019-01139-5; Bosse T, 2015, EUR J CANCER, V51, P1742, DOI 10.1016/j.ejca.2015.05.015; Cokmez H, 2019, GINEKOL POL, V90, P314, DOI 10.5603/GP.2019.0057; Colombo N, 2016, INT J GYNECOL CANCER, V26, P2, DOI 10.1097/IGC.0000000000000609; Conde WL, 2014, AM J CLIN NUTR, V100, p1617S, DOI 10.3945/ajcn.114.084764; Creutzberg CL, 2015, INT J RADIAT ONCOL, V91, P530, DOI 10.1016/j.ijrobp.2014.11.022; de Freitas D, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0209294; Dobbins M, 2013, ISRN Prev Med, V2013, P680536, DOI 10.5402/2013/680536; Duong LM, 2011, J WOMENS HEALTH, V20, P1157, DOI 10.1089/jwh.2010.2529; Elit LM, 2014, J CLIN ONCOL, V32, P27, DOI 10.1200/JCO.2013.51.3671; Erkaya S, 2017, TURK J MED SCI, V47, P300, DOI 10.3906/sag-1602-137; Ferlay J, 2018, GLOBAL CANC OBSERVAT; Ferreira AP, 2019, ELLIPSIS, V4, P1; Francis SR, 2019, GYNECOL ONCOL, V154, P38, DOI 10.1016/j.ygyno.2019.04.676; IARC, 2018, GLOBOCAN 2018 INC MO; Jaime PC, 2013, OBES REV, V14, P88, DOI 10.1111/obr.12101; Kaaks R, 2002, CANCER EPIDEM BIOMAR, V11, P1531; Mang C, 2017, ARCH GYNECOL OBSTET, V295, P1435, DOI 10.1007/s00404-017-4370-4; Nadaraja Sambavy, 2018, Drugs Real World Outcomes, V5, P225, DOI 10.1007/s40801-018-0145-x; Paulino E, 2018, REV BRAS GINECOL OBS, V40, P577, DOI 10.1055/s-0038-1673644; Lay AAR, 2019, MENOPAUSE, V26, P211, DOI 10.1097/GME.0000000000001186; Saude SdVe, 2017, VIG FAT RISC PROT IN, P42; Shaw E, 2016, RECENT RESULTS CANC, V208, P107, DOI 10.1007/978-3-319-42542-9_7; Sheikh MA, 2014, FUTURE ONCOL, V10, P2561, DOI 10.2217/fon.14.192; SILVA AE, 2018, CLINICS S1, V73, P61696, DOI DOI 10.6061/clinics/2017/e522s; Swinburn BA, 2011, LANCET, V378, P804, DOI 10.1016/S0140-6736(11)60813-1; Zeimet AG, 2013, JNCI-J NATL CANCER I, V105, P1142, DOI 10.1093/jnci/djt144	32	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2020	15	3							e0229543	10.1371/journal.pone.0229543	http://dx.doi.org/10.1371/journal.pone.0229543			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8RK	32134921	gold, Green Published			2022-12-26	WOS:000535265600029
J	De Piano, M; Manuelli, V; Zadra, G; Otte, J; Edqvist, PHD; Ponten, F; Nowinski, S; Niaouris, A; Grigoriadis, A; Loda, M; Van Hemelrijck, M; Wells, CM				De Piano, Mario; Manuelli, Valeria; Zadra, Giorgia; Otte, Jonathan; Edqvist, Per-Henrik D.; Ponten, Fredrik; Nowinski, Salpie; Niaouris, Athanasios; Grigoriadis, Anita; Loda, Massimo; Van Hemelrijck, Mieke; Wells, Claire M.			Lipogenic signalling modulates prostate cancer cell adhesion and migration via modification of Rho GTPases	ONCOGENE			English	Article							FATTY-ACID SYNTHASE; CDC42; EXPRESSION	Fatty acid synthase (FASN) is commonly overexpressed in prostate cancer and associated with tumour progression. FASN is responsible for de novo synthesis of the fatty acid palmitate; the building block for protein palmitoylation. Recent work has suggested that alongside its established role in promoting cell proliferation FASN may also promote invasion. We now find depletion of FASN expression increases prostate cancer cell adhesiveness, impairs HGF-mediated cell migration and reduces 3D invasion. These changes in motility suggest that FASN can mediate actin cytoskeletal remodelling; a process known to be downstream of Rho family GTPases. Here, we demonstrate that modulation of FASN expression specifically impacts on the palmitoylation of the atypical GTPase RhoU. Impaired RhoU activity in FASN depleted cells leads to reduced adhesion turnover downstream of paxillin serine phosphorylation, which is rescued by addition of exogenous palmitate. Moreover, canonical Cdc42 expression is dependent on the palmitoylation status of RhoU. Thus we uncover a novel relationship between FASN, RhoU and Cdc42 that directly influences cell migration potential. These results provide compelling evidence that FASN activity directly promotes cell migration and supports FASN as a potential therapeutic target in metastatic prostate cancer.	[De Piano, Mario; Manuelli, Valeria; Nowinski, Salpie; Niaouris, Athanasios; Grigoriadis, Anita; Van Hemelrijck, Mieke; Wells, Claire M.] Kings Coll London, Sch Canc & Pharmaceut Sci, London SE1 1UL, England; [Zadra, Giorgia; Loda, Massimo] Harvard Med Sch, Dana Farber Canc Inst, Dept Oncol Pathol, Boston, MA 02215 USA; [Zadra, Giorgia; Loda, Massimo] Harvard Med Sch, Dana Farber Canc Inst, Dept Pathol, Boston, MA 02215 USA; [Zadra, Giorgia; Loda, Massimo] Harvard Med Sch, Brigham & Womens Hosp, Boston, MA 02215 USA; [Otte, Jonathan] Uppsala Univ, Dept Surg Sci, Uppsala, Sweden; [Edqvist, Per-Henrik D.; Ponten, Fredrik] Uppsala Univ, Dept Immunol Genet & Pathol, Uppsala, Sweden	University of London; King's College London; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Uppsala University; Uppsala University	Wells, CM (corresponding author), Kings Coll London, Sch Canc & Pharmaceut Sci, London SE1 1UL, England.	claire.wells@kcl.ac.uk		Van Hemelrijck, Mieke/0000-0002-7317-0858; Grigoriadis, Anita/0000-0003-3434-201X; Ponten, Fredrik/0000-0003-0703-3940; Wells, Claire/0000-0003-1926-6282	Prostate UK [S12-008]; Medical Research Council; U-CAN; DoD [PC150263]; Claudia Adams Barr Award in Innovative Basic Cancer Research	Prostate UK; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); U-CAN; DoD(United States Department of Defense); Claudia Adams Barr Award in Innovative Basic Cancer Research	MDP was supported by Prostate UK (S12-008). VM is supported by the Medical Research Council. This study was supported by U-CAN. GZ is a recipient of the DoD Idea Development Award for New Investigators (PC150263) and a Claudia Adams Barr Award in Innovative Basic Cancer Research.	Alinezhad S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155901; American Cancer Society, 2016, SURV RAT PROST CANC; Baenke F, 2013, DIS MODEL MECH, V6, P1353, DOI 10.1242/dmm.011338; Berzat AC, 2005, J BIOL CHEM, V280, P33055, DOI 10.1074/jbc.M507362200; Bright RK, 1997, CANCER RES, V57, P995; Coleman DT, 2009, MOL CANCER THER, V8, P214, DOI 10.1158/1535-7163.MCT-08-0722; Czuchra A, 2005, MOL BIOL CELL, V16, P4473, DOI 10.1091/mbc.E05-01-0061; Dart AE, 2015, J CELL BIOL, V211, P863, DOI 10.1083/jcb.201501072; Dasgupta Subhamoy, 2012, J Carcinog, V11, P4, DOI 10.4103/1477-3163.93001; De Piano M, 2017, STANDARD SUPER RESOL, P173; Flavin R, 2010, FUTURE ONCOL, V6, P551, DOI [10.2217/fon.10.11, 10.2217/FON.10.11]; Friedl P, 2003, NAT REV CANCER, V3, P362, DOI 10.1038/nrc1075; Glimelius B, 2018, ACTA ONCOL, V57, P187, DOI 10.1080/0284186X.2017.1337926; Hodge Richard G, 2020, Small GTPases, V11, P8, DOI 10.1080/21541248.2017.1362495; Kampf C, 2012, JOVE-J VIS EXP, V63; Lawson CD, 2017, J CELL BIOL, P2; Li N, 2012, NUTR CANCER, V64, P864, DOI 10.1080/01635581.2012.701704; NC I, CANC GEN ATL; Pascual G, 2017, NATURE, V541, P41, DOI 10.1038/nature20791; Reymond N, 2012, J CELL BIOL, V199, P653, DOI 10.1083/jcb.201205169; Swinnen JV, 2002, INT J CANCER, V98, P19, DOI 10.1002/ijc.10127; Team RC, 2015, LANG ENV STAT COMP; Uhlen M, 2015, SCIENCE, V347, DOI 10.1126/science.1260419; Van de Sande T, 2005, J PATHOL, V206, P214, DOI 10.1002/path.1760; Wen SM, 2016, MOL CARCINOGEN, V55, P2278, DOI 10.1002/mc.22468; Whale AD, 2013, ONCOGENE, V32, P2114, DOI 10.1038/onc.2012.233; Zadra G, 2019, P NATL ACAD SCI USA, V116, P631, DOI 10.1073/pnas.1808834116; Zhang BL, 1998, J BIOL CHEM, V273, P25728, DOI 10.1074/jbc.273.40.25728	29	20	20	5	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR	2020	39	18					3666	3679		10.1038/s41388-020-1243-2	http://dx.doi.org/10.1038/s41388-020-1243-2		MAR 2020	14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	LI5XR	32139877	Green Published, hybrid			2022-12-26	WOS:000518240300001
J	Edwards, M; Konar, B; Kim, JH; Gabara, S; Sullaway, G; McHugh, T; Spector, M; Small, S				Edwards, Matthew; Konar, Brenda; Kim, Ju-Hyoung; Gabara, Scott; Sullaway, Genoa; McHugh, Tristin; Spector, Michael; Small, Sadie			Marine deforestation leads to widespread loss of ecosystem function	PLOS ONE			English	Article							KELP FORESTS; SEA OTTERS; COMMUNITY STRUCTURE; URCHIN BARRENS; GIANT-KELP; RESPIRATION; PHOTOSYNTHESIS; RATES; PHYTOPLANKTON; BIODIVERSITY	Trophic interactions can result in changes to the abundance and distribution of habitat-forming species that dramatically reduce ecosystem functioning. In the coastal zone of the Aleutian Archipelago, overgrazing by herbivorous sea urchins that began in the 1990s resulted in widespread deforestation of the region's kelp forests, which led to lower macroalgal abundances and higher benthic irradiances. We examined how this deforestation impacted ecosystem function by comparing patterns of net ecosystem production (NEP), gross primary production (GPP), ecosystem respiration (Re), and the range between GPP and Re in remnant kelp forests, urchin barrens, and habitats that were in transition between the two habitat types at nine islands that spanned more than 1000 kilometers of the archipelago. Our results show that deforestation, on average, resulted in a 24% reduction in GPP, a 26% reduction in Re, and a 24% reduction in the range between GPP and Re. Further, the transition habitats were intermediate to the kelp forests and urchin barrens for these metrics. These opposing metabolic processes remained in balance; however, which resulted in little-to-no changes to NEP. These effects of deforestation on ecosystem productivity, however, were highly variable between years and among the study islands. In light of the worldwide declines in kelp forests observed in recent decades, our findings suggest that marine deforestation profoundly affects how coastal ecosystems function.	[Edwards, Matthew; Gabara, Scott; Sullaway, Genoa; McHugh, Tristin; Spector, Michael; Small, Sadie] San Diego State Univ, Dept Biol, San Diego, CA 92182 USA; [Konar, Brenda] Univ Alaska Fairbanks, Coll Fisheries & Ocean Sci, Fairbanks, AK USA; [Kim, Ju-Hyoung] Kunsan Natl Univ, Marine Appl Biosci, Gunsan, South Korea; [Gabara, Scott] Univ Calif Davis, Dept Environm Sci & Policy, Davis, CA 95616 USA	California State University System; San Diego State University; University of Alaska System; University of Alaska Fairbanks; Kunsan National University; University of California System; University of California Davis	Edwards, M (corresponding author), San Diego State Univ, Dept Biol, San Diego, CA 92182 USA.	medwards@sdsu.edu		Edwards, Matthew/0000-0002-0515-7723; Sullaway, Genoa/0000-0002-9794-2808; Small, Sadie/0000-0003-3874-5924; Kim, Ju-Hyoung/0000-0002-8908-0902; Gabara, Scott/0000-0002-8891-3984; Spector, Pike/0000-0001-5406-7727	National Science Foundation [OCE1435194, OCE1435205]; National Research Foundation [NRF-2018R1C1B6008523, NRF-2015R1C1A1A01054831]	National Science Foundation(National Science Foundation (NSF)); National Research Foundation	This research was funded by grants from the National Science Foundation (OCE1435194) to ME and (OCE1435205) to BK, and the National Research Foundation (NRF-2018R1C1B6008523 and NRF-2015R1C1A1A01054831) to JHK.	[Anonymous], 2012, INT J MODERN ENG RES, V2, p[854, 854]; [Anonymous], 2013, NAT CLIM CHANGE, DOI [10.1038/nclimate1627, DOI 10.1038/NCLIMATE1627]; [Anonymous], 2017, LANCET GLOBAL HLTH, V5, pe428; Beschta RL, 2010, RESTOR ECOL, V18, P380, DOI 10.1111/j.1526-100X.2008.00450.x; Bland A, 2019, CONT SHELF RES, V175, P12, DOI 10.1016/j.csr.2019.01.006; Bolton JJ, 2012, AFR J MAR SCI, V34, P147, DOI 10.2989/1814232X.2012.675125; Bracken MES, 2013, ECOLOGY, V94, P1944, DOI 10.1890/12-2182.1; Brook BW, 2003, NATURE, V424, P420, DOI 10.1038/nature01795; Burt JM, 2018, P ROY SOC B-BIOL SCI, V285, DOI 10.1098/rspb.2018.0553; Connell SD, 2008, MAR ECOL PROG SER, V360, P63, DOI 10.3354/meps07526; Costanza R, 2007, ECOL ECON, V61, P478, DOI 10.1016/j.ecolecon.2006.03.021; delGiorgio PA, 1997, NATURE, V385, P148, DOI 10.1038/385148a0; delGiorgio PA, 1997, NATURE, V388, P132, DOI 10.1038/40538; Doroff AM, 2003, J MAMMAL, V84, P55, DOI 10.1644/1545-1542(2003)084<0055:SOPDIT>2.0.CO;2; Duarte CM, 1998, SCIENCE, V281, P234, DOI 10.1126/science.281.5374.234; Edwards MS, 2012, J PHYCOL, V48, P897, DOI 10.1111/j.1529-8817.2012.01139.x; Edwards MS, 2005, MAR BIOL, V147, P273, DOI 10.1007/s00227-004-1548-7; Ellison AM, 2005, FRONT ECOL ENVIRON, V3, P479, DOI 10.1890/1540-9295(2005)003[0479:LOFSCF]2.0.CO;2; Estes JA, 1998, SCIENCE, V282, P473, DOI 10.1126/science.282.5388.473; Fagerli CW, 2013, MAR ECOL PROG SER, V488, P119, DOI 10.3354/meps10413; Filbee-Dexter K, 2016, MAR ECOL PROG SER, V543, P141, DOI 10.3354/meps11554; Haas AF, 2013, PEERJ, V1, DOI 10.7717/peerj.108; Harrison PA, 2014, ECOSYST SERV, V9, P191, DOI 10.1016/j.ecoser.2014.05.006; Hewson I, 2014, P NATL ACAD SCI USA, V111, P17278, DOI 10.1073/pnas.1416625111; Hondolero D, 2017, MAR BIOL, V164, DOI 10.1007/s00227-017-3111-3; Jeon BH, 2015, ALGAE-SEOUL, V30, P139, DOI 10.4490/algae.2015.30.2.139; Konar B, 2014, HYDROBIOLOGIA, V724, P91, DOI 10.1007/s10750-013-1727-y; Krause-Jensen D, 2014, FRONT MAR SCI, V1, DOI 10.3389/fmars.2014.00077; Krumhansl KA, 2016, P NATL ACAD SCI USA, V113, P13785, DOI 10.1073/pnas.1606102113; Ling SD, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2013.0269; Metzger JR, 2019, MAR BIOL, V166, DOI 10.1007/s00227-019-3606-1; Michelou VK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067480; Middelboe AL, 2006, OECOLOGIA, V150, P464, DOI 10.1007/s00442-006-0526-9; Miller RJ, 2012, OECOLOGIA, V168, P797, DOI 10.1007/s00442-011-2143-5; Miller RJ, 2011, LIMNOL OCEANOGR, V56, P119, DOI 10.4319/lo.2011.56.1.0119; Miller RJ, 2009, MAR ECOL PROG SER, V388, P1, DOI 10.3354/meps08131; Minich JJ, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0192772; Olive I, 2016, ESTUAR COAST, V39, P138, DOI 10.1007/s12237-015-9973-z; Pfister CA, 2019, ECOLOGY, V100, DOI 10.1002/ecy.2798; Pfister CA, 2018, J ECOL, V106, P1520, DOI 10.1111/1365-2745.12908; Reed D, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13757; Reisewitz SE, 2006, OECOLOGIA, V146, P623, DOI 10.1007/s00442-005-0230-1; Ripple WJ, 2004, BIOSCIENCE, V54, P755, DOI 10.1641/0006-3568(2004)054[0755:WATEOF]2.0.CO;2; Ripple WJ, 2004, FRONT ECOL ENVIRON, V5, P241; Rodgers KL, 2015, MAR ECOL PROG SER, V528, P101, DOI 10.3354/meps11273; Scheibling RE, 1999, CAN J FISH AQUAT SCI, V56, P2300, DOI 10.1139/cjfas-56-12-2300; SHUKLA J, 1990, SCIENCE, V247, P1322, DOI 10.1126/science.247.4948.1322; SK AZ, 2016, DIABETOLOGIE STOFFWE, V11, pS01; Smale DA, 2020, NEW PHYTOL, V225, P1447, DOI 10.1111/nph.16107; Staufenberger T, 2008, FEMS MICROBIOL ECOL, V64, P65, DOI 10.1111/j.1574-6941.2008.00445.x; Sullaway G, MAR ECOL PROG SER; Tait LW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026986; Teagle H, 2017, J EXP MAR BIOL ECOL, V492, P81, DOI 10.1016/j.jembe.2017.01.017; Terborgh J., 2010, TROPHIC CASCADES PRE; Weigel BL, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.00346; Wernberg T, 2019, WORLD SEAS: AN ENVIRONMENTAL EVALUATION, VOL III: ECOLOGICAL ISSUES AND ENVIRONMENTAL IMPACTS, 2ND EDITION, P57, DOI 10.1016/B978-0-12-805052-1.00003-6; Wernberg T, 2016, SCIENCE, V353, P169, DOI 10.1126/science.aad8745; Wessel P, 1996, J GEOPHYS RES-SOL EA, V101, P8741, DOI 10.1029/96JB00104; WILLIAMS PJB, 1991, DEEP-SEA RES, V38, P891, DOI 10.1016/0198-0149(91)90024-A; Williams PJL, 1998, NATURE, V394, P55; Williams SL, 1998, J EXP MAR BIOL ECOL, V226, P293, DOI 10.1016/S0022-0981(97)00252-9; Wilmers CC, 2012, FRONT ECOL ENVIRON, V10, P409, DOI 10.1890/110176	62	27	27	4	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2020	15	3							e0226173	10.1371/journal.pone.0226173	http://dx.doi.org/10.1371/journal.pone.0226173			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	KV5HZ	32130220	Green Submitted, Green Published, gold			2022-12-26	WOS:000520515100001
J	Inglis, PW; Mello, SCM; Martins, I; Silva, JBT; Macedo, K; Sifuentes, DN; Valadares-Inglis, MC				Inglis, Peter W.; Mello, Sueli C. M.; Martins, Irene; Silva, Joao B. T.; Macedo, Kamilla; Sifuentes, Daniel N.; Cleria Valadares-Inglis, M.			Trichoderma from Brazilian garlic and onion crop soils and description of two new species: Trichoderma azevedoi and Trichoderma peberdyi	PLOS ONE			English	Article							MALDI-TOF MS; BIOLOGICAL-CONTROL AGENTS; IDENTIFICATION; AFLP; SEQUENCE; FUNGI; PERFORMANCE; BIOCONTROL; PHYLOGENY; DIVERSITY	Fifty four Trichoderma strains were isolated from soil samples collected from garlic and onion crops in eight different sites in Brazil and were identified using phylogenetic analysis based on combined ITS region, tef1-alpha , cal, act and rpb2 sequences. The genetic variability of the recovered Trichoderma species was analysed by AFLP and their phenotypic variability determined using MALDI-TOF. The strain clusters from both typing techniques coincided with the taxonomic determinations made from phylogenetic analysis. The phylogenetic analysis showed the occurrence of Trichoderma asperellum, Trichoderma asperelloides, Trichoderma afroharzianum, Trichoderma hamatum, Trichoderma lentiforme, Trichoderma koningiopsis, Trichoderma longibrachiatum and Trichoderma erinaceum, in the soil samples. We also identified and describe two new Trichoderma species, both in the harzianum clade of section Pachybasium, which we have named Trichoderma azevedoi sp. nov. and Trichoderma peberdyi sp. nov. The examined strains of both T. azevedoi (three strains) and T. peberdyi (12 strains) display significant genotypic and phenotypic variability, but form monophyletic clades with strong bootstrap and posterior probability support and are morphologically distinct from their respective most closely related species.	[Inglis, Peter W.; Mello, Sueli C. M.; Martins, Irene; Silva, Joao B. T.; Macedo, Kamilla; Sifuentes, Daniel N.; Cleria Valadares-Inglis, M.] Embrapa Recursos Genet & Biotecnol, Brasilia, DF, Brazil	Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA)	Inglis, PW (corresponding author), Embrapa Recursos Genet & Biotecnol, Brasilia, DF, Brazil.	peterwinglis@gmail.com	Inglis, Peter/HGB-7460-2022	Inglis, Peter/0000-0002-5513-8918; Nogoceke Sifuentes, Daniel/0000-0001-5083-0086	Fundacao de Apoio a Pesquisa do Distrito Federal (FAPDF) [0193.000.992/2015]	Fundacao de Apoio a Pesquisa do Distrito Federal (FAPDF)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)Fundacao de Apoio a Pesquisa do Distrito Federal (FAPDF))	This work was funded by a grant to SCMM from Fundacao de Apoio a Pesquisa do Distrito Federal (FAPDF competitive grant 0193.000.992/2015). http://www.fap.df.gov.br.The funders had no role in study design, data collection and analysis, decision to publish,or preparation of the manuscript.	Al-Sadi AM, 2015, BMC MICROBIOL, V15, DOI 10.1186/s12866-015-0483-8; Althoff DM, 2007, SYST BIOL, V56, P477, DOI 10.1080/10635150701427077; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Alvarado-Marchena L, 2016, REV BRAS CIENC SOLO, V40, DOI 10.1590/18069657rbcs20150454; Arrigo N, 2012, AUTOMATED SCORING AF, P155, DOI [10.1007/978-1-61779-870-2_10, DOI 10.1007/978-1-61779-870-2_10]; Atanasova L, 2013, TRICHODERMA: BIOLOGY AND APPLICATIONS, P10, DOI 10.1079/9781780642475.0010; Ayres DL, 2012, SYST BIOL, V61, P170, DOI [10.1093/sysbio/syr100, 10.1093/sysbio/sys029]; Bae SJ, 2016, BIOL CONTROL, V92, P128, DOI 10.1016/j.biocontrol.2015.10.005; Bissett J, 2015, IMA FUNGUS, V6, P263, DOI 10.5598/imafungus.2015.06.02.02; Buhariwalla HK, 2005, J PHYTOPATHOL, V153, P389, DOI 10.1111/j.1439-0434.2005.00989.x; Carbone I, 1999, MYCOLOGIA, V91, P553, DOI 10.2307/3761358; Chalupova J, 2014, BIOTECHNOL ADV, V32, P230, DOI 10.1016/j.biotechadv.2013.11.002; Chaverri P, 2003, STUD MYCOL, P1; Chaverri P, 2003, MOL PHYLOGENET EVOL, V27, P302, DOI 10.1016/S1055-7903(02)00400-1; Chaverri P, 2015, MYCOLOGIA, V107, P558, DOI 10.3852/14-147; Chen K, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07807-3; Cheng T, 2016, MOL ECOL RESOUR, V16, P138, DOI 10.1111/1755-0998.12438; Clarkson JP, 2002, PLANT PATHOL, V51, P735, DOI 10.1046/j.1365-3059.2002.00787.x; de Resende JTV, 2013, HORTIC BRAS, V31, P157, DOI 10.1590/S0102-05362013000100025; De Respinis S, 2010, MYCOL PROG, V9, P79, DOI 10.1007/s11557-009-0621-5; Hoang DT, 2018, MOL BIOL EVOL, V35, P518, DOI 10.1093/molbev/msx281; Dilbo C., 2015, J PLANT PATHOL MICRO, V06, DOI [10.4172/2157-7471.1000251, DOI 10.4172/2157-7471.1000251]; Drissner D, 2017, CHEM BIOL TECHNOL AG, V4, DOI 10.1186/s40538-017-0095-7; Druzhinina Irina, 2005, J Zhejiang Univ Sci B, V6, P100, DOI 10.1631/jzus.2005.B0100; Druzhinina IS, 2012, FUNGAL GENET BIOL, V49, P358, DOI 10.1016/j.fgb.2012.02.004; Druzhinina IS, 2011, NAT REV MICROBIOL, V9, P749, DOI 10.1038/nrmicro2637; Druzhinina IS, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-94; Druzhinina IS, 2005, FUNGAL GENET BIOL, V42, P813, DOI 10.1016/j.fgb.2005.06.007; Entwistle AR., 1990, ONIONS ALLIED CROPS, P103, DOI DOI 10.1201/9781351075169; Garnica-Vergara A, 2016, NEW PHYTOL, V209, P1496, DOI 10.1111/nph.13725; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Harman GE, 2004, NAT REV MICROBIOL, V2, P43, DOI 10.1038/nrmicro797; Hendrickx M, 2017, CURR FUNGAL INFECT R, V11, P60, DOI 10.1007/s12281-017-0277-6; Hernandez Castillo F. D., 2011, American Journal of Agricultural and Biological Sciences, V6, P410, DOI 10.3844/ajabssp.2011.410.417; Hoyos-Carvajal L, 2011, DYNAMICAL PROCESSES OF BIODIVERSITY - CASE STUDIES OF EVOLUTION AND SPATIAL DISTRIBUTION, P303; Hoyos-Carvajal L, 2009, FUNGAL GENET BIOL, V46, P615, DOI 10.1016/j.fgb.2009.04.006; Inglis PW, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0206085; Kalyaanamoorthy S, 2017, NAT METHODS, V14, P587, DOI [10.1038/NMETH.4285, 10.1038/nmeth.4285]; Katoh Kazutaka, 2013, Mol Biol Evol, V30, P772, DOI 10.1093/molbev/mst010; Kullnig-Gradinger CM, 2002, MYCOL RES, V106, P757, DOI 10.1017/S0953756202006172; Nguyen LT, 2015, MOL BIOL EVOL, V32, P268, DOI 10.1093/molbev/msu300; Lanfear R, 2017, MOL BIOL EVOL, V34, P772, DOI 10.1093/molbev/msw260; Lopes RB, 2014, MYCOLOGIA, V106, P865, DOI 10.3852/13-401; Lopez-Quintero CA, 2013, ANTON LEEUW INT J G, V104, P657, DOI 10.1007/s10482-013-9975-4; Majer D, 1996, MYCOL RES, V100, P1107, DOI 10.1016/S0953-7562(96)80222-X; Miller M.A., 2010, P GAT COMP ENV WORKS; Nelson K., 2012, GENOMICS APPL DEV WO, P217, DOI [10.1007/978-1-4614-2182-5_13, DOI 10.1007/978-1-4614-2182-5_13]; Normand AC, 2017, BMC MICROBIOL, V17, DOI 10.1186/s12866-017-0937-2; Oliveira ML, 2014, TROP PLANT PATHOL, V39, P483, DOI 10.1590/S1982-56762014000600011; Pais FSM, 2014, ALGORITHM MOL BIOL, V9, DOI 10.1186/1748-7188-9-4; QUiroz Sarmiento VF, 2008, REV MEX MICOL, V26, P27; Rehner SA, 2005, MYCOLOGIA, V97, P84, DOI 10.3852/mycologia.97.1.84; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Samuels GJ, 2006, STUD MYCOL, P67, DOI 10.3114/sim.2006.56.03; Samuels GJ, 2009, MYCOLOGIA, V101, P142, DOI 10.3852/08-161; Swofford DL, 2012, PHYLOGENETIC ANAL US, P166, DOI [10.1159/000170955, DOI 10.1159/000170955]; Taylor JW, 2000, FUNGAL GENET BIOL, V31, P21, DOI 10.1006/fgbi.2000.1228; Vahabi K., 2009, Acta Phytopathologica et Entomologica Hungarica, V44, P239, DOI 10.1556/APhyt.44.2009.2.3; Vaidya G, 2011, CLADISTICS, V27, P171, DOI 10.1111/j.1096-0031.2010.00329.x; Verma M, 2007, BIOCHEM ENG J, V37, P1, DOI 10.1016/j.bej.2007.05.012; VOS P, 1995, NUCLEIC ACIDS RES, V23, P4407, DOI 10.1093/nar/23.21.4407; Xin Y, 2016, PLOS ONE, V11, DOI [10.1371/journal.pone.0145838, 10.1371/journal.pone.0160613]; Zachow C, 2016, J BIOTECHNOL, V235, P162, DOI 10.1016/j.jbiotec.2016.03.049	63	20	20	3	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2020	15	3							e0228485	10.1371/journal.pone.0228485	http://dx.doi.org/10.1371/journal.pone.0228485			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8QU	32130211	Green Submitted, Green Published, gold			2022-12-26	WOS:000535264000007
J	Pereira, GRC; Tavares, GDB; de Freitas, MC; De Mesquita, JF				Coutinho Pereira, Gabriel Rodrigues; Bocayuva Tavares, Gustavo Duarte; de Freitas, Marta Costa; De Mesquita, Joelma Freire			In silico analysis of the tryptophan hydroxylase 2 (TPH2) protein variants related to psychiatric disorders	PLOS ONE			English	Article							DYNAMICS	The tryptophan hydroxylase 2 (TPH2) enzyme catalyzes the first step of serotonin biosynthesis. Serotonin is known for its role in several homeostatic systems related to sleep, mood, and food intake. As the reaction catalyzed by TPH2 is the rate-limiting step of serotonin biosynthesis, mutations in TPH2 have been associated with several psychiatric disorders (PD). This work undertakes an in silico analysis of the effects of genetic mutations in the human TPH2 protein. Ten algorithms were used to predict the functional and stability effects of the TPH2 mutations. ConSurf was used to estimate the evolutionary conservation of TPH2 amino acids. GROMACS was used to perform molecular dynamics (MD) simulations of TPH2 WT and P260S, R303W, and R441H, which had already been associated with the development of PD. Forty-six TPH2 variants were compiled from the literature. Among the analyzed variants, those occurring at the catalytic domain were shown to be more damaging to protein structure and function. The ConSurf analysis indicated that the mutations affecting the catalytic domain were also more conserved throughout evolution. The variants S364K and S383F were predicted to be deleterious by all the functional algorithms used and occurred at conserved positions, suggesting that they might be deleterious. The MD analyses indicate that the mutations P206S, R303W, and R441H affect TPH2 flexibility and essential mobility at the catalytic and oligomerization domains. The variants P206S, R303W, and R441H also exhibited alterations in dimer binding affinity and stability throughout the simulations. Thus, these mutations may impair TPH2 functional interactions and, consequently, its function, leading to the development of PD. Furthermore, we developed a database, SNPMOL (http://www.snpmol.org/), containing the results presented in this paper. Understanding the effects of TPH2 mutations on protein structure and function may lead to improvements in existing treatments for PD and facilitate the design of further experiments.	[Coutinho Pereira, Gabriel Rodrigues; Bocayuva Tavares, Gustavo Duarte; de Freitas, Marta Costa; De Mesquita, Joelma Freire] Fed Univ State Rio de Janeiro UNIRIO, Dept Genet & Mol Biol, Bioinformat & Computat Biol Lab, Rio De Janeiro, RJ, Brazil	Universidade Federal do Estado do Rio de Janeiro	De Mesquita, JF (corresponding author), Fed Univ State Rio de Janeiro UNIRIO, Dept Genet & Mol Biol, Bioinformat & Computat Biol Lab, Rio De Janeiro, RJ, Brazil.	joelma.mesquita@unirio.br			Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Financiadora de Estudos e Projetos (FINEP); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Universidade Federal do Estado do Rio de Janeiro; NVIDIA Corporation	Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Financiadora de Estudos e Projetos (FINEP)(Financiadora de Inovacao e Pesquisa (Finep)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Universidade Federal do Estado do Rio de Janeiro; NVIDIA Corporation	This study was supported by Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ) (http://www.faperj.br/) to GRCP, Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) (http://www.capes.gov.br/) to GRCP, Financiadora de Estudos e Projetos (FINEP) (http://www.finep.gov.br/) to GRCP, Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) (http://cnpq.br/) to GRCP, Universidade Federal do Estado do Rio de Janeiro to GRCP, and NVIDIA Corporation to GRCP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We gratefully acknowledge the support provided by NVIDIA Corporation in donating the Titan X Pascal GPU used for this research.	Moreira LGA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081979; Ashkenazy H, 2016, NUCLEIC ACIDS RES, V44, pW344, DOI 10.1093/nar/gkw408; Bateman A, 2017, NUCLEIC ACIDS RES, V45, pD158, DOI 10.1093/nar/gkw1099; Burley SK, 2017, METHOD MOL BIOL, V11, P347; Cao J, 2010, FEBS LETT, V584, P4775, DOI 10.1016/j.febslet.2010.11.005; Carkaci-Salli N, 2006, J BIOL CHEM, V281, P28105, DOI 10.1074/jbc.M602817200; Chandrasekaran P, 2017, J CELL BIOCHEM, V118, P3318, DOI [10.1002/jcb.25984, DOI 10.1002/JCB.25984]; Choudhury AR, 2017, BIOINFORMATICS, V33, P1621, DOI 10.1093/bioinformatics/btx031; Cichon S, 2008, HUM MOL GENET, V17, P87, DOI 10.1093/hmg/ddm286; David CC, 2014, METHODS MOL BIOL, V1084, P193, DOI 10.1007/978-1-62703-658-0_11; De Baets G, 2012, NUCLEIC ACIDS RES, V40, pD935, DOI 10.1093/nar/gkr996; Forrey C, 2012, SOFT MATTER, V8, P6385, DOI 10.1039/c2sm25160d; Gao M, 2015, STRUCTURE, V23, P1362, DOI 10.1016/j.str.2015.03.028; Grant BJ, 2006, BIOINFORMATICS, V22, P2695, DOI 10.1093/bioinformatics/btl461; Hu RD, 2018, INT J MOL MED, V41, P195, DOI 10.3892/ijmm.2017.3195; Khan FI, 2016, INT J BIOL MACROMOL, V85, P48, DOI 10.1016/j.ijbiomac.2015.12.072; Knapp B, 2011, J COMPUT BIOL, V18, P997, DOI 10.1089/cmb.2010.0237; Krebs BB, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158939; Kucukkal TG, 2015, CURR OPIN STRUC BIOL, V32, P18, DOI 10.1016/j.sbi.2015.01.003; Kumari R, 2014, J CHEM INF MODEL, V54, P1951, DOI 10.1021/ci500020m; Liu JF, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-4-r69; Ma JS, 2015, J AFFECT DISORDERS, V188, P304, DOI 10.1016/j.jad.2015.07.041; McKinney JA, 2009, HUM MUTAT, V30, P787, DOI 10.1002/humu.20956; Mosienko V, 2015, BEHAV BRAIN RES, V277, P78, DOI 10.1016/j.bbr.2014.06.005; Pace CN, 2014, PROTEIN SCI, V23, P652, DOI 10.1002/pro.2449; Pappalardo M, 2014, NUCLEIC ACIDS RES, V42, pW331, DOI 10.1093/nar/gku483; Pereira GRC, 2019, J CELL BIOCHEM, V120, P3583, DOI 10.1002/jcb.27636; Pisanu C, 2016, DRUG DEVELOP RES, V77, P368, DOI 10.1002/ddr.21341; Da Silva ANR, 2019, J CELL BIOCHEM, V120, P17822, DOI 10.1002/jcb.29048; Ruller R, 2005, BIOCHIMIE, V87, P993, DOI 10.1016/j.biochi.2005.04.008; Sansone Randy A, 2010, Psychiatry (Edgmont), V7, P16; Shelton Richard C, 2019, Handb Exp Pharmacol, V250, P145, DOI 10.1007/164_2018_164; De Oliveira CCS, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0215508; Sodhi MSK, 2004, INT REV NEUROBIOL, V59, P111; Stein SAM, 2006, ANN REP COMP CHEM, V2, P233, DOI 10.1016/S1574-1400(06)02013-5; Thusberg J, 2009, HUM MUTAT, V30, P703, DOI 10.1002/humu.20938; Trautmann S, 2016, EMBO REP, V17, P1245, DOI 10.15252/embr.201642951; Walther DJ, 2003, BIOCHEM PHARMACOL, V66, P1673, DOI 10.1016/S0006-2952(03)00556-2; Wang CH, 2016, J COMPUT CHEM, V37, P2436, DOI 10.1002/jcc.24467; Zhang XD, 2005, NEURON, V45, P11, DOI 10.1016/j.neuron.2004.12.014	40	10	11	3	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2020	15	3							e0229730	10.1371/journal.pone.0229730	http://dx.doi.org/10.1371/journal.pone.0229730			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LQ8JT	32119710	Green Published, gold			2022-12-26	WOS:000535245300037
J	Gradzielewska, A; Milczarski, P; Molik, K; Pawlowska, E				Gradzielewska, Agnieszka; Milczarski, Pawel; Molik, Katarzyna; Pawlowska, Edyta			Identification and mapping of a new recessive dwarfing gene dw9 on the 6RL rye chromosome and its phenotypic effects	PLOS ONE			English	Article							SECALE-CEREALE L.; LOCALIZATION; FERTILITY; MARKERS; GENOME; WHEAT; RFLP	The introduction of high-yielding semi-dwarf varieties of wheat into cultivation has led to a "green revolution." This has required intensive research into various sources of dwarfism in wheat. However, there has been very little advancement in research on dwarfing genes in rye in comparison to wheat or barley. So far, three dominant dwarfing genes (Ddw1, Ddw3, and Ddw4) and three recessive genes (ct1, ct2, and np) have been characterized and precisely mapped in rye. There is no complete catalog of dwarfing genes available in rye. This paper presents an identification of the source of dwarfism and preliminary characterization of the new recessive gene dw9 from the BK-1 line. The gene was mapped on the long arm of the 6R chromosome and belongs to the GA-insensitive group. The initial characterization of the influence of this gene on morphological traits shows that it significantly affects the decrease of yielding trait parameters. A full evaluation can be performed after detailed breeding studies.	[Gradzielewska, Agnieszka] Univ Life Sci, Inst Plant Genet Breeding & Biotechnol, Lublin, Poland; [Milczarski, Pawel; Molik, Katarzyna; Pawlowska, Edyta] West Pomeranian Univ Technol, Dept Plant Genet Breeding & Biotechnol, Szczecin, Poland	West Pomeranian University of Technology	Milczarski, P (corresponding author), West Pomeranian Univ Technol, Dept Plant Genet Breeding & Biotechnol, Szczecin, Poland.	pmilczarski@zut.edu.pl		Gradzielewska, Agnieszka/0000-0003-3595-5651; Milczarski, Pawel/0000-0003-2622-8938	National Centre for Research and Development [PBS1/B8/5/2012]	National Centre for Research and Development(National Centre for Research & Development, Poland)	This work was financially supported by the National Centre for Research and Development, Project No. PBS1/B8/5/2012. http://www.ncbr.gov.pl/programykrajowe/program-badan-stosowanych/, Pawel Milczarski. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker CJ, 2014, J THEOR BIOL, V363, P1, DOI 10.1016/j.jtbi.2014.07.032; Baloch FS, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0167821; Bauer E, 2017, PLANT J, V89, P853, DOI 10.1111/tpj.13436; Berry PM, 2015, EUPHYTICA, V205, P671, DOI 10.1007/s10681-015-1387-2; Borner A, 1996, EUPHYTICA, V89, P69, DOI 10.1007/BF00015721; Borner A., 1988, Archiv fur Zuchtungsforschung, V18, P71; Braun EM, 2019, FRONT PLANT SCI, V10, DOI 10.3389/fpls.2019.00857; Cruz VMV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064062; DEVRIES JN, 1984, Z PFLANZENZUCHT, V92, P117; Grzebelus D, 2014, MOL BREEDING, V33, P625, DOI 10.1007/s11032-013-9979-9; Haque MA, 2011, CEREAL RES COMMUN, V39, P171, DOI 10.1556/CRC.39.2011.2.1; Jighly A, 2016, MOL BREEDING NEW STR, V36, P1301; Kantarek Z, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0199335; Kilian Andrzej, 2012, Methods Mol Biol, V888, P67, DOI 10.1007/978-1-61779-870-2_5; Kobylyanskii V. D., 1975, Hodowla Roslin, Aklimatyzacja i Nasiennictwo, V19, P439; KOBYLYANSKII VD, 1972, GENETIKA+, V8, P12; KONDRATENKO F T, 1975, Hodowla Roslin Aklimatyzacja i Nasiennictwo, V19, P527; KUBICKA H, 1990, Genetica Polonica, V31, P9; Malyshev S, 2001, THEOR APPL GENET, V103, P70, DOI 10.1007/s001220000504; Melz G., 1989, THESIS ADL BERLIN, P1; Milczarski P, 2016, J APPL GENET, V57, P439, DOI 10.1007/s13353-016-0347-4; Milczarski P, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0189912; Milczarski P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028495; Mwadzingeni L, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171692; Myskow B, 2012, MOL BREEDING, V30, P367, DOI 10.1007/s11032-011-9627-1; PLASCHKE J, 1995, PLANT BREEDING, V114, P113, DOI 10.1111/j.1439-0523.1995.tb00773.x; PLASCHKE J, 1993, THEOR APPL GENET, V85, P1049, DOI 10.1007/BF00215046; Sansaloni CP, 2011, BMC P S7, V5, P54, DOI [10.1186/1753-6561-5-S7-P54, DOI 10.1186/1753-6561-5-S7-P54]; Stojalowski S, 2015, EUPHYTICA, V201, P43, DOI 10.1007/s10681-014-1173-6; SYBENGA J, 1962, GENETICA, V33, P95; Van Ooijen JW, 2011, GENET RES, V93, P343, DOI 10.1017/S0016672311000279; Voorrips RE, 2002, J HERED, V93, P77, DOI 10.1093/jhered/93.1.77; Voylokov AV, 1998, THEOR APPL GENET, V97, P147, DOI 10.1007/s001220050879; WORLAND AJ, 1986, EUPHYTICA, V35, P857, DOI 10.1007/BF00028593	34	4	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2020	15	3							e0229564	10.1371/journal.pone.0229564	http://dx.doi.org/10.1371/journal.pone.0229564			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8JT	32119688	Green Published, gold			2022-12-26	WOS:000535245300028
J	Melendez, DM; Marti, S; Haley, DB; Schwinghamer, TD; Schwartzkopf-Genswein, KS				Melendez, Daniela M.; Marti, Sonia; Haley, Derek B.; Schwinghamer, Timothy D.; Schwartzkopf-Genswein, Karen S.			Effect of transport and rest stop duration on the welfare of conditioned cattle transported by road	PLOS ONE			English	Article							BOVINE RESPIRATORY-DISEASE; LONG-HAUL TRANSPORT; BEHAVIORAL-RESPONSES; BLOOD-CONSTITUENTS; STOCKING DENSITY; BEEF-CATTLE; CALVES; STRESS; EPIDEMIOLOGY; PERFORMANCE	The effects of providing rest on physiological and behavioural indicators of welfare of cattle being transported by road has not been well studied in North America. New revisions to Canada's Health of Animals Regulations Part XII: Transportation of Animals indicate unweaned and weaned calves can be transported a maximum of 12 and 36 h, respectively, before an 8 h rest is required. Therefore, the aim of this study was to assess the effects of rest duration, after 12 and 36 h of transport, on physiological and behavioural indicators of welfare in 7-8 mo-old beef calves. Three hundred and twenty conditioned calves (258 +/- 23.9 kg BW) were randomly assigned to a 2 x 4 factorial design where the main factors included transport duration: 12 h (12; n = 160) and 36 h (36; n = 160) and rest stop duration: 0 h (R0; n = 80), 4 h (R4; n = 80), 8 h (R8; n = 80) and 12 h (R12; n = 80). After the resting period, animals were transported for an additional 4 h. Blood and hair samples were taken from 12 animals per treatment prior to and after the first and the 4 h transport; and then 7 h, 2 d and 28 d after the 4 h transport. The concentrations of haptoglobin, creatine kinase, non-esterified fatty acids (NEFA), lactate, and serum and hair cortisol were determined. Standing and lying behaviour was assessed for 14 d after transport, while feeding behaviour of calves in one pen per treatment were assessed for 28 d after transportation using an electronic feed bunk monitoring system. Body weight (BW), average daily gain (ADG) and shrink (%) was assessed for all calves. The data was modeled using generalized linear mixed methods (SAS PROC GLIMMIX), where transport and time (nested in rest) were considered fixed effects and animal and pen were considered random effects. Statistically significant (p < 0.05) effects of transport were observed on BW and shrink, where 36 h-transported calves had lower (p < 0.01) BW and greater (p < 0.01) shrink than 12 h-transported calves. A transport x time (nested in rest) interaction (p < 0.01) was observed for lying percentage where, 36-R8 calves had greater (p < 0.01) lying percentage than 12-R8 calves on d 1 after transportation. The area under the curve (AUC) for NEFA was greater (p < 0.01) for 36-R0 calves than 12-R0, 36-R4, and 36-R8 calves, and greater (p < 0.01) in 36-R12 calves than 12-R12 calves. Haptoglobin AUC was greater (p = 0.05) in 36-R12 than 12-R12 calves. Overall, physiological indicators of reduced welfare were greater in calves transported for 36 than 12 h, while no clear differences were observed between rest stop groups with the exception of NEFA. Based on these results, conditioned calves benefit from shorter transport durations but there was no clear evidence that calves rested 4, 8, and 12 h following transportation experienced reduced transport related stress compared to those that were not rested (0h).	[Melendez, Daniela M.; Schwinghamer, Timothy D.; Schwartzkopf-Genswein, Karen S.] Lethbridge Res & Dev Ctr, Agr & Agri Food Canada, Lethbridge, AB, Canada; [Marti, Sonia] IRTA, Dept Ruminant Prod, Barcelona, Spain; [Haley, Derek B.] Univ Guelph, Dept Populat Med, Guelph, ON, Canada	Agriculture & Agri Food Canada; IRTA; University of Guelph	Schwartzkopf-Genswein, KS (corresponding author), Lethbridge Res & Dev Ctr, Agr & Agri Food Canada, Lethbridge, AB, Canada.	Karen.genswein@canada.ca	Meléndez, Daniela/AAT-9279-2020	Meléndez, Daniela/0000-0002-0153-9708; Schwinghamer, Timothy/0000-0001-7727-7284	Agriculture and Agri-Food Canada; Beef Cattle Research Council through the Canadian Beef Cattle Industry Science Cluster [ANH.06.17 AIP-CL01]; CERCA program from Generalitat de Catalunya	Agriculture and Agri-Food Canada(Agriculture & Agri Food Canada); Beef Cattle Research Council through the Canadian Beef Cattle Industry Science Cluster; CERCA program from Generalitat de Catalunya	Funding was provided by Agriculture and Agri-Food Canada (http://www.agr.gc.ca/eng/home/?id=1395690825741) and the Beef Cattle Research Council (http://www.beefresearch.ca/) through the Canadian Beef Cattle Industry Science Cluster (ANH.06.17 AIP-CL01). The co-author Sonia Marti was partly supported by the CERCA program from Generalitat de Catalunya. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALSEMGEEST SPM, 1995, VET QUART, V17, P9, DOI 10.1080/01652176.1995.9694521; Arthington JD, 2003, J ANIM SCI, V81, P1120; Bailey E. A., 2015, Professional Animal Scientist, V31, P20; Barnes K, 2007, MANAGING SHRINK WEIG; BAUMANN H, 1994, IMMUNOL TODAY, V15, P74, DOI 10.1016/0167-5699(94)90137-6; Booth-McLean ME, 2007, CAN J ANIM SCI, V87, P291, DOI 10.4141/A06-033; Burrow H.M., 1988, P AUST SOC ANIM PROD, V17, P154; Canfax, 2015, EC CONS PREC CALV; CCAC, 2009, CCAC GUID AN US PROT; Coffey K.P., 2001, PROF ANIM SCI, V17, P247, DOI [10.15232/S1080-7446(15)31636-3, DOI 10.15232/S1080-7446(15)31636-3, 10.15232/ s1080-7446(15)31636-3]; Cook NJ, 2009, CAN J ANIM SCI, V89, P335, DOI 10.4141/CJAS09006; Cooke RF, 2013, J ANIM SCI, V91, P5448, DOI 10.2527/jas.2013-6357; CROOKSHANK HR, 1979, J ANIM SCI, V48, P430; Dewell G., 2013, FEEDLOT HLTH MANAGEM; Duff GC, 2007, J ANIM SCI, V85, P823, DOI 10.2527/jas.2006-501; Earley B, 2006, IRISH J AGR FOOD RES, V45, P51; Earley B, 2017, ANIMAL, V11, P486, DOI 10.1017/S1751731116001622; Earley B, 2012, RES VET SCI, V92, P531, DOI 10.1016/j.rvsc.2011.04.002; Earley B, 2011, RES VET SCI, V91, P454, DOI 10.1016/j.rvsc.2010.09.020; Earley B, 2013, RES VET SCI, V95, P811, DOI 10.1016/j.rvsc.2013.04.027; European Council 2. European Council (EC), 2005, OFFICIAL J EUROPEAN, V48; Fisher AD, 2014, J DAIRY RES, V81, P297, DOI 10.1017/S0022029914000193; Gonzalez LA, 2012, J ANIM SCI, V90, P3630, DOI 10.2527/jas.2011-4786; Gonzalez LA, 2012, J ANIM SCI, V90, P3640, DOI 10.2527/jas.2011-4796; Grandin T, 1997, J ANIM SCI, V75, P249; Grandin T., 2001, J ANIM SCI, V79, pE201, DOI [10.2527/jas2001.79e-supple201x, DOI 10.2527/JAS2001.79E-SUPPLE201X]; Hickey MC, 2003, J ANIM SCI, V81, P2847; Holman DB, 2017, BMC MICROBIOL, V17, DOI 10.1186/s12866-017-0978-6; Jarvis AM, 1996, APPL ANIM BEHAV SCI, V50, P83, DOI 10.1016/0168-1591(96)01070-2; Kahn CM, 2010, MERCK VET MANUAL, DOI DOI 10.1071/RD9910501; KENT JE, 1986, BRIT VET J, V142, P131, DOI 10.1016/0007-1935(86)90088-6; Knowles TG, 1999, VET REC, V144, P197; Knowles TG, 1999, VET REC, V145, P575; Knowles TG, 2014, LIVESTOCK HANDLING AND TRANSPORT, 4TH EDITION, P399, DOI 10.1079/9781780643212.0399; Macartney JE, 2003, J AM VET MED ASSOC, V223, P677, DOI 10.2460/javma.2003.223.677; MacKenzie AM, 1997, RES VET SCI, V63, P227, DOI 10.1016/S0034-5288(97)90025-4; Marti S, 2017, J ANIM SCI, V95, P636, DOI 10.2527/jas.2016.0739; Moya D, 2013, LIVEST SCI, V158, P138, DOI 10.1016/j.livsci.2013.10.007; NAMI. North American Meat Institute, 2016, NN AM MEAT I MOB SCO; NRC (National Research Council), 2016, NUTR REQ BEEF CATTL; Ohmann R, 2014, PHYS REV B, V89, DOI 10.1103/PhysRevB.89.205433; Penicaud L, 2000, NUTRITION, V16, P903, DOI 10.1016/S0899-9007(00)00427-5; Petersen HH, 2004, VET RES, V35, P163, DOI 10.1051/vetres:2004002; Pettiford SG, 2008, AUST J EXP AGR, V48, P1028, DOI 10.1071/EA08051; Polkinghorne R, 2018, MEAT SCI, V140, P101, DOI 10.1016/j.meatsci.2018.02.017; PRITCHARD RH, 1990, J ANIM SCI, V68, P28; Radostits O., 2000, CONTROL PREVENTION D; Roland L, 2014, J VET DIAGN INVEST, V26, P592, DOI 10.1177/1040638714546490; Schwartzkopf-Genswein KS, 2012, MEAT SCI, V92, P227, DOI 10.1016/j.meatsci.2012.04.010; Schwartzkopf-Genswein K, 2014, LIVESTOCK HANDLING AND TRANSPORT, 4TH EDITION, P143, DOI 10.1079/9781780643212.0143; Schwartzkopf-Genswein KS, 2007, APPL ANIM BEHAV SCI, V108, P12, DOI 10.1016/j.applanim.2006.11.012; Schwartzkopf-Genswein KS, 2003, CAN J ANIM SCI, V83, P29, DOI 10.4141/A02-027; Sowell BF, 1998, APPL ANIM BEHAV SCI, V59, P277, DOI 10.1016/S0168-1591(98)00110-5; Sporer KRB, 2007, VET IMMUNOL IMMUNOP, V118, P19, DOI 10.1016/j.vetimm.2007.04.002; TARRANT PV, 1988, MEAT SCI, V24, P209, DOI 10.1016/0309-1740(88)90079-4; TARRANT PV, 1992, LIVEST PROD SCI, V30, P223, DOI 10.1016/0301-6226(92)90071-B; Tarrant V, 2000, LIVESTOCK HANDLING T, V2; Taylor JD, 2010, CAN VET J, V51, P1351; Taylor JD, 2010, CAN VET J, V51, P1095; Todd SE, 2000, RES VET SCI, V68, P125, DOI 10.1053/rvsc.1999.0345; Tucker CB, 2015, ANIM HEALTH RES REV, V16, P107, DOI 10.1017/S1466252315000171	61	10	10	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2020	15	3							e0228492	10.1371/journal.pone.0228492	http://dx.doi.org/10.1371/journal.pone.0228492			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8JT	32120382	Green Published, gold			2022-12-26	WOS:000535245300006
J	Tiruvayipati, S; Wolfgeher, D; Yue, M; Duan, FF; Andrade, J; Jiang, H; Schuger, L				Tiruvayipati, Suma; Wolfgeher, Don; Yue, Ming; Duan, FangFang; Andrade, Jorge; Jiang, Hui; Schuger, Lucia			Variability in protein cargo detection in technical and biological replicates of exosome-enriched extracellular vesicles	PLOS ONE			English	Article							LIQUID-CHROMATOGRAPHY; MESSENGER-RNAS	Exosomes are extracellular vesicles (EVs) of similar to 20-200 nm diameter that shuttle DNAs, RNAs, proteins and other biomolecules between cells. The large number of biomolecules present in exosomes demands the frequent use of high-throughput analysis. This, in turn, requires technical replicates (TRs), and biological replicates (BRs) to produce accurate results. As the number and abundance of identified biomolecules varies between replicates (Rs), establishing the replicate variability predicted for the event under study is essential in determining the number of Rs required. Although there have been few reports of replicate variability in high throughput biological data, none of them focused on exosomes. Herein, we determined the replicate variability in protein profiles found in exosomes released from 3 lung adenocarcinoma cell lines, H1993, A549 and H1975. Since exosome isolates are invariably contaminated by a small percentage of similar to 200-300 nm microvesicles, we refer to our samples as exosome-enriched EVs (EE-EVs). We generated BRs of EE-EVs from each cell line, and divided each group into 3 TRs. All Rs were analyzed by liquid chromatography/mass spectrometry (LC/MS/MS) and customized bioinformatics and biostatistical workflows (raw data available via ProteomeXchange: PXD012798). We found that the variability among TRs as well as BRs, was largely qualitative (protein present or absent) and higher among BRs. By contrast, the quantitative (protein abundance) variability was low, save for the H1975 cell line where the quantitative variability was significant. Importantly, our replicate strategy identified 90% of the most abundant proteins, thereby establishing the utility of our approach.	[Tiruvayipati, Suma; Yue, Ming; Duan, FangFang; Schuger, Lucia] Univ Chicago, Dept Pathol, Biol Sci Div, 5841 S Maryland Ave, Chicago, IL 60637 USA; [Wolfgeher, Don] Univ Chicago, Cummings Life Sci Ctr, Prote Core Lab, Chicago, IL 60637 USA; [Andrade, Jorge] Univ Chicago, Ctr Res Informat, Chicago, IL 60637 USA; [Jiang, Hui] Univ Michigan, Dept Biostat, Ann Arbor, MI 48109 USA	University of Chicago; University of Chicago; University of Chicago; University of Michigan System; University of Michigan	Schuger, L (corresponding author), Univ Chicago, Dept Pathol, Biol Sci Div, 5841 S Maryland Ave, Chicago, IL 60637 USA.	lschuger@bsd.uchicago.edu	Tiruvayipati, Suma/AAF-8331-2021	Tiruvayipati, Suma/0000-0003-0195-1097; Wolfgeher, Don/0000-0002-8960-338X; Jiang, Hui/0000-0003-2718-9811	National Institutes of Health [R01 HL132870, R01 HL128228]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This study was supported by the National Institutes of Health (https://www.nih.gov/) under the Grant R01 HL132870 (L.S.) and Grant R01 HL128228 (L.S.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akers JC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149866; Boriachek K, 2018, SMALL, V14, DOI 10.1002/smll.201702153; Braisted JC, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-529; Bullard JH, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-94; Cabin RJ., 2000, B ECOL SOC AM, V81, P246, DOI [DOI 10.2307/20168454, 10.2307/20168454]; Chavez-Servin JL, 2004, J CHROMATOGR A, V1043, P211, DOI 10.1016/j.chroma.2004.06.002; Cheng TM, 2019, CURR ISSUES TOUR, V22, P1764, DOI 10.1080/13683500.2017.1405383; Chiva C, 2014, J PROTEOME RES, V13, P3979, DOI 10.1021/pr500294d; Colombo M, 2014, ANNU REV CELL DEV BI, V30, P255, DOI 10.1146/annurev-cellbio-101512-122326; Cottrell JS, 2011, J PROTEOMICS, V74, P1842, DOI 10.1016/j.jprot.2011.05.014; De Rubis G, 2019, TRENDS PHARMACOL SCI, V40, P172, DOI 10.1016/j.tips.2019.01.006; Gho YS, 2017, MOL BIOSYST, V13, P1291, DOI 10.1039/c7mb00146k; Gomez CD, 2018, FRONT GENET, V9, DOI 10.3389/fgene.2018.00092; He ZQ, 2017, ONCOTARGET, V8, P92635, DOI 10.18632/oncotarget.21517; Humphrey SJ, 2018, NAT PROTOC, V13, DOI 10.1038/s41596-018-0014-9; Jelonek K, 2015, ACTA BIOCHIM POL, V62, P265, DOI 10.18388/abp.2015_970; Kim H, 2019, LAB CHIP, V19, P3917, DOI 10.1039/c9lc00796b; Konoshenko MY, 2018, BIOMED RES INT, V2018, DOI 10.1155/2018/8545347; Kowal J, 2016, P NATL ACAD SCI USA, V113, pE968, DOI 10.1073/pnas.1521230113; Lakhter AJ, 2018, DIABETOLOGIA, V61, P1124, DOI 10.1007/s00125-018-4559-5; Lane RE, 2015, SCI REP-UK, V5, DOI 10.1038/srep07639; Le H, 2015, BIOTECHNOL BIOENG, V112, P2276, DOI 10.1002/bit.25646; Levanen B, 2013, J ALLERGY CLIN IMMUN, V131, P894, DOI 10.1016/j.jaci.2012.11.039; Li P, 2017, THERANOSTICS, V7, P789, DOI 10.7150/thno.18133; Lobb RJ, 2017, PROTEOMICS, V17, DOI 10.1002/pmic.201600432; Lu P, 2007, NAT BIOTECHNOL, V25, P117, DOI 10.1038/nbt1270; Lucchetti D, 2019, BIOTECHNOL J, V14, DOI 10.1002/biot.201700716; Mathivanan S, 2009, PROTEOMICS, V9, P4997, DOI 10.1002/pmic.200900351; McIntyre LM, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-293; Meckes DG, 2013, P NATL ACAD SCI USA, V110, pE2925, DOI 10.1073/pnas.1303906110; Naegle K, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.aab1125; Nagaraj N, 2011, J PROTEOME RES, V10, P637, DOI 10.1021/pr100835s; Perez-Riverol Y, 2019, NUCLEIC ACIDS RES, V47, pD442, DOI 10.1093/nar/gky1106; Perneger TV, 1998, BRIT MED J, V316, P1236, DOI 10.1136/bmj.316.7139.1236; Piehowski PD, 2013, J PROTEOME RES, V12, P2128, DOI 10.1021/pr301146m; Richards KE, 2017, ONCOGENE, V36, P1770, DOI 10.1038/onc.2016.353; Searle BC, 2010, PROTEOMICS, V10, P1265, DOI 10.1002/pmic.200900437; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Tabb DL, 2010, J PROTEOME RES, V9, P761, DOI 10.1021/pr9006365; Tietje A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113116; Tyanova S, 2015, PROTEOMICS, V15, P1453, DOI 10.1002/pmic.201400449; Vagner T, 2018, J EXTRACELL VESICLES, V7, DOI 10.1080/20013078.2018.1505403; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; van Niel G, 2018, NAT REV MOL CELL BIO, V19, P213, DOI 10.1038/nrm.2017.125; Vogel R, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-14981-x; Wen SW, 2019, PROTEOMICS, V19, DOI 10.1002/pmic.201800180; Wu AYT, 2019, PROTEOMICS, V19, DOI 10.1002/pmic.201800162; Xu R, 2016, J CLIN INVEST, V126, P1152, DOI 10.1172/JCI81129; Yan ZB, 2019, ACS SENSORS, V4, P488, DOI 10.1021/acssensors.8b01564; Yukawa H, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-24563-0; Zhang HG, 2014, AM J PATHOL, V184, P28, DOI 10.1016/j.ajpath.2013.09.027; Zhou CF, 2019, ONCOGENE, V38, P1256, DOI 10.1038/s41388-018-0511-x	53	8	8	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2020	15	3							e0228871	10.1371/journal.pone.0228871	http://dx.doi.org/10.1371/journal.pone.0228871			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8JT	32119684	Green Published, gold			2022-12-26	WOS:000535245300009
J	Nogimura, D; Mizushige, T; Taga, Y; Nagai, A; Shoji, S; Azuma, N; Kusubata, M; Adachi, SI; Yoshizawa, F; Kabuyama, Y				Nogimura, Dai; Mizushige, Takafumi; Taga, Yuki; Nagai, Akitoshi; Shoji, Sayo; Azuma, Nao; Kusubata, Masashi; Adachi, Shin-ichi; Yoshizawa, Fumiaki; Kabuyama, Yukihito			Prolyl-hydroxyproline, a collagen-derived dipeptide, enhances hippocampal cell proliferation, which leads to antidepressant-like effects in mice	FASEB JOURNAL			English	Article						corticosterone; depression; mental stress; neural stem cell; peptide	HUMAN BLOOD; NEUROTROPHIC FACTOR; VI PROTECTS; NGF LEVELS; NEUROGENESIS; DEPRESSION; PEPTIDES; IDENTIFICATION; BDNF; QUANTIFICATION	Depression has been a mental health issue worldwide. We previously reported that ginger-degraded collagen hydrolysate (GDCH) suppressed depression-like behavior in mice. Furthermore, prolyl-hydroxyproline (PO) and hydroxyprolyl-glycine (OG) were detected in the circulating blood after the oral administration of GDCH. In the present study, PO, but not OG, was detected in the cerebrospinal fluid of rats after the oral administration of GDCH, suggesting that PO is transported from blood to the brain. We then investigated the effects of PO and OG on the depression-like behavior of mice. The oral administration of PO significantly decreased depression-like behavior in the forced swim test. OG had no antidepressant-like effect. In addition, proline and hydroxyproline, components of PO, also had no antidepressant-like effect after their oral administration. PO significantly increased the gene expression of brain-derived neurotrophic factor and nerve growth factor in the hippocampus, and promoted the proliferation of neural progenitor cells in vivo and in vitro. PO also increased the dopamine concentration in the prefrontal cortex. Thus, PO-dependent regulation of neurotrophic function and neurotransmitter may be the mechanism for antidepressant-like behavior. Together, these results demonstrate that PO is an antidepressant bioactive peptide accompanying the proliferation of hippocampal neural progenitor cells.	[Nogimura, Dai; Mizushige, Takafumi; Nagai, Akitoshi; Shoji, Sayo; Azuma, Nao; Yoshizawa, Fumiaki; Kabuyama, Yukihito] Utsunomiya Univ, Sch Agr, 350 Minemachi, Utsunomiya, Tochigi 3218505, Japan; [Taga, Yuki; Kusubata, Masashi] Nippi Res Inst Biomatrix, Toride, Ibaraki, Japan; [Adachi, Shin-ichi] Utsunomiya Univ, Ctr Biosci Res & Educ, Utsunomiya, Tochigi, Japan; [Adachi, Shin-ichi] Kagoshima Womens Coll, Dept Human Life & Sci, 6-9 Korai Cho, Kagoshima, Kagoshima 8908565, Japan	Utsunomiya University; Utsunomiya University	Mizushige, T (corresponding author), Utsunomiya Univ, Sch Agr, 350 Minemachi, Utsunomiya, Tochigi 3218505, Japan.	mizushige@cc.utsunomiya-u.ac.jp	Taga, Yuki/I-2781-2019	Taga, Yuki/0000-0001-9100-758X	MEXT | Japan Society for the Promotion of Science (JSPS) [16K07731, 19K05927]	MEXT | Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	MEXT | Japan Society for the Promotion of Science (JSPS), Grant/Award Number: 16K07731 and 19K05927	Abdanipour A, 2015, NEUROL RES, V37, P117, DOI 10.1179/1743132814Y.0000000431; Anacker C, 2013, NEUROPSYCHOPHARMACOL, V38, P872, DOI 10.1038/npp.2012.253; Anacker C, 2011, PSYCHONEUROENDOCRINO, V36, P415, DOI 10.1016/j.psyneuen.2010.03.007; Cescon M, 2016, AGING-US, V8, P1083, DOI 10.18632/aging.100924; Chen TJ, 2016, J PHOTOCH PHOTOBIO B, V165, P34, DOI 10.1016/j.jphotobiol.2016.10.015; Cheng IH, 2011, NEUROSCIENCE, V183, P178, DOI 10.1016/j.neuroscience.2011.03.057; Cheng JS, 2009, NAT NEUROSCI, V12, P119, DOI 10.1038/nn.2240; Dailly E, 2004, FUND CLIN PHARMACOL, V18, P601, DOI 10.1111/j.1472-8206.2004.00287.x; Deltheil T, 2008, NEUROPHARMACOLOGY, V55, P1006, DOI 10.1016/j.neuropharm.2008.08.001; Eisch AJ, 2012, SCIENCE, V338, P72, DOI 10.1126/science.1222941; Filho CB, 2015, NEUROSCIENCE, V289, P367, DOI 10.1016/j.neuroscience.2014.12.048; Furukawa-Hibi Y, 2011, BEHAV BRAIN RES, V220, P271, DOI 10.1016/j.bbr.2011.02.003; Hanson ND, 2011, NEUROPSYCHOPHARMACOL, V36, P2589, DOI 10.1038/npp.2011.220; Hashimoto K, 2004, BRAIN RES REV, V45, P104, DOI 10.1016/j.brainresrev.2004.02.003; Hill AS, 2015, NEUROPSYCHOPHARMACOL, V40, P2368, DOI 10.1038/npp.2015.85; Hung YY, 2019, CELLS, V2, P9; Ichikawa S, 2010, INT J FOOD SCI NUTR, V61, P52, DOI 10.3109/09637480903257711; Iwai K, 2005, J AGR FOOD CHEM, V53, P6531, DOI 10.1021/jf050206p; Lagace DC, 2010, P NATL ACAD SCI USA, V107, P4436, DOI 10.1073/pnas.0910072107; Li HW, 2017, INT IMMUNOPHARMACOL, V53, P24, DOI 10.1016/j.intimp.2017.10.001; MacQueen GM, 2003, P NATL ACAD SCI USA, V100, P1387, DOI 10.1073/pnas.0337481100; MAISONPIERRE PC, 1990, NEURON, V5, P501, DOI 10.1016/0896-6273(90)90089-X; Malberg JE, 2005, CURR PHARM DESIGN, V11, P145, DOI 10.2174/1381612053382223; Mizushige T, 2019, J NUTR SCI VITAMINOL, V65, P251, DOI 10.3177/jnsv.65.251; Nasser A, 2014, NEUROSCI RES, V89, P44, DOI 10.1016/j.neures.2014.08.015; Onouchi T, 2014, MOL BRAIN, V7, DOI 10.1186/1756-6606-7-21; Osawa Y, 2018, BIOMED RES-TOKYO, V39, P1, DOI 10.2220/biomedres.39.1; Park SC, 2019, CELL TISSUE RES, V377, P95, DOI 10.1007/s00441-019-03043-5; PORSOLT RD, 1977, NATURE, V266, P730, DOI 10.1038/266730a0; Ricard-Blum S, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004978; Sahay A, 2007, NAT NEUROSCI, V10, P1110, DOI 10.1038/nn1969; Shigemura Y, 2011, FOOD CHEM, V129, P1019, DOI 10.1016/j.foodchem.2011.05.066; Shinohara R, 2018, MOL PSYCHIATR, V23, P1717, DOI 10.1038/mp.2017.177; Snyder JS, 2011, NATURE, V476, P458, DOI 10.1038/nature10287; Sugihara F, 2012, J BIOSCI BIOENG, V113, P202, DOI 10.1016/j.jbiosc.2011.09.024; Taga Y, 2017, J AGR FOOD CHEM, V65, P9514, DOI 10.1021/acs.jafc.7b03714; Taga Y, 2016, J AGR FOOD CHEM, V64, P2962, DOI 10.1021/acs.jafc.6b00609; Taga Y, 2014, J AGR FOOD CHEM, V62, P12096, DOI 10.1021/jf5039597; Tanaka M, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-42099-9; Tanti A, 2010, BRIT J PHARMACOL, V159, P1187, DOI 10.1111/j.1476-5381.2009.00585.x; Tsutsui-Kimura I, 2017, J PHARMACOL SCI, V134, P181, DOI 10.1016/j.jphs.2017.06.004; Tunc-Ozcan E, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11641-8; Tzeng WY, 2013, PSYCHONEUROENDOCRINO, V38, P425, DOI 10.1016/j.psyneuen.2012.07.002; Uppal A, 2010, CURR PHARM DESIGN, V16, P4243, DOI 10.2174/138161210794519110; Xian YF, 2019, FASEB J, V33, P10393, DOI 10.1096/fj.201802743RR; Yamamoto Y, 2015, NEUROPEPTIDES, V51, P25, DOI 10.1016/j.npep.2015.04.002; Zague V, 2011, J MED FOOD, V14, P618, DOI 10.1089/jmf.2010.0085	47	10	10	1	11	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2020	34	4					5715	5723		10.1096/fj.201902871R	http://dx.doi.org/10.1096/fj.201902871R		MAR 2020	9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	LJ5ZA	32115749	hybrid			2022-12-26	WOS:000517933300001
J	de Oliveira, APJ; Rangel, MCV; Vidovszky, MZ; Rossi, JL; Vicentini, F; Harrach, B; Kajan, GL				Jejesky de Oliveira, Ana Paula; Valdetaro Rangel, Maria Cristina; Vidovszky, Marton Z.; Rossi Jr, Joao Luiz; Vicentini, Fernando; Harrach, Balazs; Kajan, Gyozo L.			Identification of two novel adenoviruses in smooth-billed ani and tropical screech owl	PLOS ONE			English	Article							SIADENOVIRUS INFECTION; GENOME SEQUENCE; AVIADENOVIRUS; PCR; POPULATIONS; VIRUS; BIRDS; LIVER; ROADS; PREY	Avian adenoviruses (AdVs) are a very diverse group of pathogens causing diseases in poultry and wild birds. Wild birds, endangered by habitat loss and habitat fragmentation in the tropical forests, are recognised to play a role in the transmission of various AdVs. In this study, two novel, hitherto unknown AdVs were described from faecal samples of smooth-billed ani and tropical screech owl. The former was classified into genus Aviadenovirus, the latter into genus Atadenovirus, and both viruses most probably represent new AdV species as well. These results show that there is very limited information about the biodiversity of AdVs in tropical wild birds, though viruses might have a major effect on the population of their hosts or endanger even domesticated animals. Surveys like this provide new insights into the diversity, evolution, host variety, and distribution of avian AdVs.	[Jejesky de Oliveira, Ana Paula; Valdetaro Rangel, Maria Cristina; Rossi Jr, Joao Luiz] Univ Vila Velha, Dept Ecosyst Ecol, Lab Wildlife Hlth, Vila Velha, ES, Brazil; [Vidovszky, Marton Z.; Harrach, Balazs; Kajan, Gyozo L.] Ctr Agr Res, Inst Vet Med Res, Budapest, Hungary; [Vicentini, Fernando] Univ Fed Reconcavo Bahia, Hlth Sci Ctr, Santo Antonio De Jesus, BA, Brazil	Centro Universitario Vila Velha; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Centre for Agricultural Research; Hungarian Veterinary Medical Research Institute; Universidade Federal do Reconcavo da Bahia	de Oliveira, APJ (corresponding author), Univ Vila Velha, Dept Ecosyst Ecol, Lab Wildlife Hlth, Vila Velha, ES, Brazil.	anapaulaoliveira799@yahoo.com.br	Harrach, Balazs/AAC-2154-2020; Kaján, Győző László/N-2117-2019; Harrach, Balazs/A-3680-2008	Kaján, Győző László/0000-0001-8213-8238; Harrach, Balazs/0000-0002-1410-6469	Espirito Santo Research and Innovation Support Foundation [438/2016]; University of Vila Velha [201672442]; OMA Foundation [101ou6]; Janos Bolyai Research Scholarship of the Hungarian Academy of Sciences; National Research, Development and Innovation Office [NN128309]	Espirito Santo Research and Innovation Support Foundation; University of Vila Velha; OMA Foundation; Janos Bolyai Research Scholarship of the Hungarian Academy of Sciences(Hungarian Academy of Sciences); National Research, Development and Innovation Office(National Research, Development & Innovation Office (NRDIO) - Hungary)	The research of APJO is supported by the Espirito Santo Research and Innovation Support Foundation (438/2016, fapes.es.gov.br) and University of Vila Velha (201672442, www.uvv.br).GLK is supported by the OMA Foundation (101ou6, omaa.hu), and he is also the recipient of the Janos Bolyai Research Scholarship of the Hungarian Academy of Sciences (https://mta.hu/english).The research of MZV and BH is supported by the National Research, Development and Innovation Office (NN128309, nkfih.gov.hu/english-nkfih).	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Ballmann MZ, 2016, ACTA VET HUNG, V64, P514, DOI 10.1556/004.2016.047; Ballmann MZ, 2013, MAGY ALLATORVOSOK, V135, P78; Benko M., 2014, REFERENCE MODULE BIO; Bodewes R, 2013, VIROLOGY, V440, P84, DOI 10.1016/j.virol.2013.02.011; BOOM R, 1990, J CLIN MICROBIOL, V28, P495, DOI 10.1128/JCM.28.3.495-503.1990; Cassmann E, 2019, VIRUS RES, V263, P164, DOI 10.1016/j.virusres.2019.01.018; Das S, 2017, VIROLOGY, V502, P188, DOI 10.1016/j.virol.2016.12.031; Doszpoly A, 2019, INFECT GENET EVOL, V75, DOI 10.1016/j.meegid.2019.103976; Estes JA, 2011, SCIENCE, V333, P301, DOI 10.1126/science.1205106; Forman RTT, 1998, ANNU REV ECOL SYST, V29, P207, DOI 10.1146/annurev.ecolsys.29.1.207; Forman RTT, 2000, CONSERV BIOL, V14, P36, DOI 10.1046/j.1523-1739.2000.99088.x; Gunson KE, 2011, J ENVIRON MANAGE, V92, P1074, DOI 10.1016/j.jenvman.2010.11.027; Harrach B, 2000, ACTA VET HUNG, V48, P485, DOI 10.1556/004.48.2000.4.11; Harrach B., 2012, VIRUS TAXONOMY, P125, DOI DOI 10.1016/8978-0-12-384684-6.00009-4; Harrach B., 2011, AVIADENOVIRIDAE, P13, DOI DOI 10.1007/978-0-387-95919-1_2; Harrach B, 2019, FEBS LETT, V593, P3660, DOI 10.1002/1873-3468.13687; Hess M, 1997, VIROLOGY, V238, P145, DOI 10.1006/viro.1997.8815; Joseph HM, 2014, VET MICROBIOL, V172, P35, DOI 10.1016/j.vetmic.2014.04.006; Kajan G. L., 2016, MOL DETECTION ANIMAL, P735; Kajan GL, 2020, J MOL EVOL, V88, P41, DOI 10.1007/s00239-019-09913-4; Kajan GL, 2019, HELIYON, V5, DOI 10.1016/j.heliyon.2019.e01732; Kajan GL, 2012, J GEN VIROL, V93, P2457, DOI 10.1099/vir.0.042028-0; Kajan GL, 2010, VIRUS RES, V153, P226, DOI 10.1016/j.virusres.2010.08.006; Katoh H, 2009, VIRUS RES, V144, P294, DOI 10.1016/j.virusres.2009.04.012; Katoh Kazutaka, 2013, Mol Biol Evol, V30, P772, DOI 10.1093/molbev/mst010; Kovacs ER, 2011, INFECT GENET EVOL, V11, P1058, DOI 10.1016/j.meegid.2011.03.021; Kovacs ER, 2010, J VIROL METHODS, V163, P262, DOI 10.1016/j.jviromet.2009.10.007; Kumar S., 2016, MOL BIOL EVOLUTION, V33, DOI [DOI 10.1093/M0LBEV/MSW054, https://doi.org/10.1093/molbev/msw054, 10.1093/molbev/msw054]; Lee SY, 2014, VIRUSES-BASEL, V6, P2052, DOI 10.3390/v6052052; Lewis JS, 2011, LANDSCAPE URBAN PLAN, V101, P99, DOI 10.1016/j.landurbplan.2011.01.008; Marek A, 2016, J GEN VIROL, V97, P2323, DOI 10.1099/jgv.0.000519; Marek A, 2014, VIROLOGY, V462, P107, DOI 10.1016/j.virol.2014.04.033; Marks JS, 1999, HDB BIRDS WORLD, V5, P76; Motta-Junior Jose Carlos, 2004, P763; Nathan R, 2008, P NATL ACAD SCI USA, V105, P19052, DOI 10.1073/pnas.0800375105; NORRDAHL K, 1995, OECOLOGIA, V103, P241, DOI 10.1007/BF00329086; Papp T, 2009, VET MICROBIOL, V134, P233, DOI 10.1016/j.vetmic.2008.08.003; Park YM, 2012, VIROLOGY, V422, P144, DOI 10.1016/j.virol.2011.10.008; Phalen DN, 2019, AVIAN PATHOL, V48, P437, DOI 10.1080/03079457.2019.1617835; Pinheiro B.F., 2013, NAT LINE, V11, P68; Rosa Andre Osorio, 2004, Caderno de Pesquisa Serie Biologia, V16, P35; Schachner A, 2018, AVIAN PATHOL, V47, P111, DOI 10.1080/03079457.2017.1385724; Schrenzel M, 2005, J CLIN MICROBIOL, V43, P3402, DOI 10.1128/JCM.43.7.3402-3413.2005; Sick H., 1997, ORNITOLOGIA BRASILEI, P383; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Teske L, 2017, VIRUS RES, V227, P15, DOI 10.1016/j.virusres.2016.09.024; To KKW, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003318; Trombulak SC, 2000, CONSERV BIOL, V14, P18, DOI 10.1046/j.1523-1739.2000.99084.x; Valkama J, 2005, BIOL REV, V80, P171, DOI 10.1017/S146479310400658X; Vibin J, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-26851-1; Wellehan JFX, 2009, AVIAN PATHOL, V38, P413, DOI 10.1080/03079450903183660; Wellehan JFX, 2004, J VIROL, V78, P13366, DOI 10.1128/JVI.78.23.13366-13369.2004; Yang N, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0208674; Zadravec M, 2011, SLOV VET RES, V48, P107	55	11	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2020	15	2							e0229415	10.1371/journal.pone.0229415	http://dx.doi.org/10.1371/journal.pone.0229415			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8HR	32109945	Green Published, Green Accepted, gold			2022-12-26	WOS:000535239800009
J	Lucia, K; Wu, YH; Garcia, JM; Barlier, A; Buchfelder, M; Saeger, W; Renner, U; Stalla, GK; Theodoropoulou, M				Lucia, Kristin; Wu, Yonghe; Garcia, Jose Monteserin; Barlier, Anne; Buchfelder, Michael; Saeger, Wolfgang; Renner, Ulrich; Stalla, Guenter K.; Theodoropoulou, Marily			Hypoxia and the hypoxia inducible factor 1 alpha activate protein kinase A by repressing RII beta subunit transcription	ONCOGENE			English	Article							REGULATORY SUBUNIT; CATALYTIC SUBUNIT; GENE-EXPRESSION; DNA-BINDING; DIFFERENTIAL EXPRESSION; GROWTH-HORMONE; LUNG-CANCER; CELL-GROWTH; I-ALPHA; PHOSPHORYLATION	Overactivation of the cAMP signal transduction pathway plays a central role in the pathogenesis of endocrine tumors. Genetic aberrations leading to increased intracellular cAMP or directly affecting PKA subunit expression have been identified in inherited and sporadic endocrine tumors, but are rare indicating the presence of nongenomic pathological PKA activation. In the present study, we examined the impact of hypoxia on PKA activation using human growth hormone (GH)-secreting pituitary tumors as a model of an endocrine disease displaying PKA-CREB overactivation. We show that hypoxia activates PKA and enhances CREB transcriptional activity and subsequently GH oversecretion. This is due to a previously uncharacterized ability of HIF-1 alpha to suppress the transcription of the PKA regulatory subunit 2B (PRKAR2B) by sequestering Sp1 from the PRKAR2B promoter. The present study reveals a novel mechanism through which the transcription factor HIF-1 alpha transduces environmental signals directly onto PKA activity, without affecting intracellular cAMP concentrations. By identifying a point of interaction between the cellular microenvironment and intracellular enzyme activation, neoplastic, and nonneoplastic diseases involving overactivated PKA pathway may be more efficiently targeted.	[Lucia, Kristin; Garcia, Jose Monteserin; Renner, Ulrich; Stalla, Guenter K.; Theodoropoulou, Marily] Max Planck Inst Psychiat, Dept Endocrinol, Munich, Germany; [Lucia, Kristin; Stalla, Guenter K.; Theodoropoulou, Marily] Ludwig Maximilians Univ Munchen, Med Klin & Poliklin 4, Munich, Germany; [Lucia, Kristin; Wu, Yonghe] Deutsch Krebsforschungszentrum, Div Mol Genet, Heidelberg, Germany; [Barlier, Anne] Ctr Rech Neurobiol & Neurophysiol Marseille, Marseille, France; [Buchfelder, Michael] Klinikum Univ Erlangen, Dept Neurosurg, Erlangen, Germany; [Saeger, Wolfgang] Univ Hamburg, Dept Neuropathol, Hamburg, Germany; [Lucia, Kristin] Charite, Dept Neurosurg, Berlin, Germany	Max Planck Society; University of Munich; Helmholtz Association; German Cancer Research Center (DKFZ); UDICE-French Research Universities; Aix-Marseille Universite; University of Erlangen Nuremberg; University of Hamburg; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Theodoropoulou, M (corresponding author), Max Planck Inst Psychiat, Dept Endocrinol, Munich, Germany.; Theodoropoulou, M (corresponding author), Ludwig Maximilians Univ Munchen, Med Klin & Poliklin 4, Munich, Germany.	marily.theodoropoulou@med.uni-muechen.de	Wu, Yonghe/N-2269-2019; Monteserin-Garcia, Jose Luis/AAC-7052-2020; Theodoropoulou, Marily/S-9546-2017; Barlier, Anne/G-2398-2015	Wu, Yonghe/0000-0001-9667-8198; Monteserin-Garcia, Jose Luis/0000-0002-4508-6771; Theodoropoulou, Marily/0000-0002-7378-4374; Barlier, Anne/0000-0002-3740-6173	Projekt DEAL	Projekt DEAL	Open access funding provided by Projekt DEAL.	ADAMS JA, 1992, BIOCHEMISTRY-US, V31, P8516, DOI 10.1021/bi00151a019; Amieux PS, 1997, J BIOL CHEM, V272, P3993, DOI 10.1074/jbc.272.7.3993; ARZT E, 1993, ENDOCRINOLOGY, V132, P459, DOI 10.1210/en.132.1.459; Barlier A, 1998, J CLIN ENDOCR METAB, V83, P1604, DOI 10.1210/jc.83.5.1604; Barry S, 2019, ONCOGENE, V38, P5381, DOI 10.1038/s41388-019-0779-5; Basso F, 2014, HORM METAB RES, V46, P883, DOI 10.1055/s-0034-1389951; BERTHERAT J, 1995, MOL ENDOCRINOL, V9, P777, DOI 10.1210/me.9.7.777; Bertout JA, 2008, NAT REV CANCER, V8, P967, DOI 10.1038/nrc2540; Beuschlein F, 2014, NEW ENGL J MED, V370, P1019, DOI 10.1056/NEJMoa1310359; BODNER M, 1988, CELL, V55, P505, DOI 10.1016/0092-8674(88)90037-2; Brandon EP, 1998, J NEUROSCI, V18, P3639; Bullen JW, 2016, SCI SIGNAL, V9, DOI 10.1126/scisignal.aaf0583; Canettieri G, 2003, NAT STRUCT BIOL, V10, P175, DOI 10.1038/nsb895; Carlucci A, 2008, EMBO J, V27, P1073, DOI 10.1038/emboj.2008.33; Cheong HI, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.90240; Elliott MR, 2003, J IMMUNOL, V171, P3636, DOI 10.4049/jimmunol.171.7.3636; Epstein ACR, 2001, CELL, V107, P43, DOI 10.1016/S0092-8674(01)00507-4; Ezzat S, 2005, MOL ENDOCRINOL, V19, P1004, DOI 10.1210/me.2004-0432; Finger EC, 2015, P NATL ACAD SCI USA, V112, P4441, DOI 10.1073/pnas.1418164112; GONZALEZ GA, 1989, CELL, V59, P675, DOI 10.1016/0092-8674(89)90013-5; HAGIWARA M, 1992, CELL, V70, P105, DOI 10.1016/0092-8674(92)90537-M; HANDSCHIN JC, 1979, FEBS LETT, V106, P301, DOI 10.1016/0014-5793(79)80519-0; Harris AL, 2002, NAT REV CANCER, V2, P38, DOI 10.1038/nrc704; Hayward BE, 2001, J CLIN INVEST, V107, pR31, DOI 10.1172/JCI11887; INGRAHAM HA, 1988, CELL, V55, P519, DOI 10.1016/0092-8674(88)90038-4; KADONAGA JT, 1987, CELL, V51, P1079, DOI 10.1016/0092-8674(87)90594-0; Katznelson L, 2014, J CLIN ENDOCR METAB, V99, P3933, DOI 10.1210/jc.2014-2700; Kietzmann T, 2016, FRONT CELL DEV BIOL, V4, DOI 10.3389/fcell.2016.00011; Kim C, 2007, CELL, V130, P1032, DOI 10.1016/j.cell.2007.07.018; Kirschner LS, 2000, NAT GENET, V26, P89, DOI 10.1038/79238; Kitagawa K, 2007, FEBS J, V274, P3210, DOI 10.1111/j.1742-4658.2007.05890.x; Koshiji M, 2005, MOL CELL, V17, P793, DOI 10.1016/j.molcel.2005.02.015; Krishnamachary B, 2006, CANCER RES, V66, P2725, DOI 10.1158/0008-5472.CAN-05-3719; KURTEN RC, 1992, MOL ENDOCRINOL, V6, P536, DOI 10.1210/me.6.4.536; MCCORMICK A, 1990, NATURE, V345, P829, DOI 10.1038/345829a0; MELLON PL, 1989, P NATL ACAD SCI USA, V86, P4887, DOI 10.1073/pnas.86.13.4887; Melmed S, 2009, J CLIN INVEST, V119, P3189, DOI 10.1172/JCI39375; Michael LF, 2000, MOL CELL BIOL, V20, P1596, DOI 10.1128/MCB.20.5.1596-1603.2000; Michel G, 2002, BBA-GENE STRUCT EXPR, V1578, P73, DOI 10.1016/S0167-4781(02)00484-0; Mole DR, 2009, J BIOL CHEM, V284, P16767, DOI 10.1074/jbc.M901790200; Nesterova M, 1996, EUR J BIOCHEM, V235, P486, DOI 10.1111/j.1432-1033.1996.00486.x; Pagotto U, 2000, CANCER RES, V60, P6794; Prabu SK, 2006, J BIOL CHEM, V281, P2061, DOI 10.1074/jbc.M507741200; Pullamsetti SS, 2013, ONCOGENE, V32, P1121, DOI 10.1038/onc.2012.136; Ronchi CL, 2016, EUR J ENDOCRINOL, V174, P363, DOI 10.1530/EJE-15-1064; Ryan HE, 2000, CANCER RES, V60, P4010; Sandrini F, 2002, GENE CHROMOSOME CANC, V35, P182, DOI 10.1002/gcc.10112; Sandrini F, 2002, J Med Genet, V39, pe78, DOI 10.1136/jmg.39.12.e78; Seagroves TN, 2001, MOL CELL BIOL, V21, P3436, DOI 10.1128/MCB.21.10.3436-3444.2001; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; Semenza GL, 2017, EMBO J, V36, P252, DOI 10.15252/embj.201695204; Semenza GL, 2013, J CLIN INVEST, V123, P3664, DOI 10.1172/JCI67230; Shaikh D, 2012, CELL SIGNAL, V24, P2396, DOI 10.1016/j.cellsig.2012.08.007; Skalhegg BS, 2000, FRONT BIOSCI-LANDMRK, V5, pD678, DOI 10.2741/Skalhegg; STALLA GK, 1989, ENDOCRINOLOGY, V125, P699, DOI 10.1210/endo-125-2-699; STRUTHERS RS, 1991, NATURE, V350, P622, DOI 10.1038/350622a0; Talks KL, 2000, AM J PATHOL, V157, P411, DOI 10.1016/S0002-9440(10)64554-3; Taylor SS, 2004, BBA-PROTEINS PROTEOM, V1697, P259, DOI 10.1016/j.bbapap.2003.11.029; Taylor SS, 2012, NAT REV MOL CELL BIO, V13, P646, DOI 10.1038/nrm3432; Theodoropoulou M, 2004, ENDOCR-RELAT CANCER, V11, P333, DOI 10.1677/erc.0.0110333; Theodoropoulou M, 2006, CANCER RES, V66, P1576, DOI 10.1158/0008-5472.CAN-05-1189; Toffoli S, 2007, BBA-MOL CELL RES, V1773, P1558, DOI 10.1016/j.bbamcr.2007.06.002; TORTORA G, 1994, ONCOGENE, V9, P3233; Tsigginou A, 2012, ENDOCR-RELAT CANCER, V19, P457, DOI 10.1530/ERC-11-0328; Turner HE, 2000, J CLIN ENDOCR METAB, V85, P1159, DOI 10.1210/jc.85.3.1159; Valimaki N, 2015, J CLIN ENDOCR METAB, V100, P3918, DOI 10.1210/jc.2015-3129; Vitali E, 2014, MOL CELL ENDOCRINOL, V383, P193, DOI 10.1016/j.mce.2013.12.006; WANG GL, 1995, P NATL ACAD SCI USA, V92, P5510, DOI 10.1073/pnas.92.12.5510; Wilson WR, 2011, NAT REV CANCER, V11, P393, DOI 10.1038/nrc3064; YAMAMOTO KK, 1988, NATURE, V334, P494, DOI 10.1038/334494a0; Zhong H, 1999, CANCER RES, V59, P5830	71	11	11	2	7	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 16	2020	39	16					3367	3380		10.1038/s41388-020-1223-6	http://dx.doi.org/10.1038/s41388-020-1223-6		FEB 2020	14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	QF9OJ	32111982	Green Published, hybrid			2022-12-26	WOS:000517049100001
J	Davies-Strickleton, H; Cook, J; Hannam, S; Bennett, R; Gibbs, A; Edwards, D; Ridden, C; Ridden, J; Cook, D				Davies-Strickleton, Heather; Cook, Julie; Hannam, Sally; Bennett, Rhys; Gibbs, Alan; Edwards, David; Ridden, Christine; Ridden, John; Cook, David			Assessment of the nail penetration of antifungal agents, with different physico-chemical properties	PLOS ONE			English	Article							DRUG-DELIVERY; ONYCHOMYCOSIS; TERBINAFINE; PERMEATION	Onychomycosis, or fungal nail infection, is a common fungal infection largely caused by dermatophyte fungi, such as Trichophyton rubrum or Trichophyton mentagrophytes, which affects a significant number of people. Treatment is either through oral antifungal medicines, which are efficacious but have significant safety concerns, or with topical antifungal treatments that require long treatment regimens and have only limited efficacy. Thus, an efficacious topical therapy remains an unmet medical need. Among the barriers to topical delivery through the nail are the physico-chemical properties of the antifungal drugs. Here, we explore the ability of a range of antifungal compounds with different hydrophilicities to penetrate the nail. Human nail discs were clamped within static diffusion (Franz) cells and dosed with equimolar concentrations of antifungal drugs. Using LC-MS/MS we quantified the amount of drug that passed through the nail disc and that which remained associated with the nail. Our data identified increased drug flux through the nail for the more hydrophilic compounds (caffeine as a hydrophilic control and fluconazole, with LogP -0.07 and 0.5, respectively), while less hydrophilic efinaconazole, amorolfine and terbinafine (LogP 2.7, 5.6 and 5.9 respectively) had much lower flux through the nail. On the other hand, hydrophilicity alone did not account for the amount of drug associated with/bound to the nail itself. While there are other factors that are likely to combine to dictate nail penetration, this work supports earlier studies that implicate compound hydrophilicity as a critical factor for nail penetration.	[Davies-Strickleton, Heather; Cook, Julie; Edwards, David; Ridden, Christine; Ridden, John; Cook, David] Blueberry Therapeut Ltd, Alderley Pk, Alderley Edge, Cheshire, England; [Hannam, Sally; Bennett, Rhys; Gibbs, Alan] Alderley Analyt Ltd, Alderley Pk, Alderley Edge, Cheshire, England		Cook, D (corresponding author), Blueberry Therapeut Ltd, Alderley Pk, Alderley Edge, Cheshire, England.	David.cook@blueberrytherapeutics.com			Blueberry Therapeutics Ltd.	Blueberry Therapeutics Ltd.	Heather Davies-Strickleton, Julie Cook, Christine Ridden, David Edwards, John Ridden and David Cook are employees of Blueberry Therapeutics Ltd. Sally Hannam, Alan Gibbs, Rhys Bennett are employees of Alderley Analytical Ltd. and responsible for the study design, analysis, and interpretation of data, writing the manuscript and decision to submit for publication. All research was funded by Blueberry Therapeutics Ltd.	Bu W, 2010, J PHARMACEUT BIOMED, V51, P230, DOI 10.1016/j.jpba.2009.08.019; Chouhan P, 2014, J DRUG DELIV, V2014, DOI 10.1155/2014/950358; Darkes MJM, 2003, AM J CLIN DERMATOL, V4, P39, DOI 10.2165/00128071-200304010-00005; Del Rosso James Q, 2014, J Clin Aesthet Dermatol, V7, P10; Dhamoon Rupinder K., 2019, Pharmaceutical Nanotechnology, V7, P24, DOI 10.2174/2211738507666190228104031; Elewski BE, 1998, CLIN MICROBIOL REV, V11, P415, DOI 10.1128/CMR.11.3.415; Elkeeb R, 2010, INT J PHARMACEUT, V384, P1, DOI 10.1016/j.ijpharm.2009.10.002; Gupta AK, 2005, MED MYCOL, V43, P179, DOI 10.1080/13693780410001731583; Health Research Authority, DO I NEED NHS REC AP; Kobayashi Y, 1999, J PHARM PHARMACOL, V51, P271, DOI 10.1211/0022357991772448; Kubota-Ishida N, 2018, ANTIMICROB AGENTS CH, V62, DOI 10.1128/AAC.00779-17; Lee BC, 2019, DRUG DELIV, V26, P1167, DOI 10.1080/10717544.2019.1687612; Matsuda Y, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159661; McAuley WJ, 2016, EUR J PHARM BIOPHARM, V102, P178, DOI 10.1016/j.ejpb.2016.03.008; Neubert RHH, 2006, PHARMAZIE, V61, P604; Shanbhag PP, 2017, NEW HORIZ TRANSL MED, V3, P252, DOI 10.1016/j.nhtm.2017.01.002; Thomas J, 2010, J CLIN PHARM THER, V35, P497, DOI 10.1111/j.1365-2710.2009.01107.x; WALTERS KA, 1983, J PHARM PHARMACOL, V35, P28, DOI 10.1111/j.2042-7158.1983.tb04258.x	18	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2020	15	2							e0229414	10.1371/journal.pone.0229414	http://dx.doi.org/10.1371/journal.pone.0229414			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8GQ	32107486	gold, Green Published			2022-12-26	WOS:000535237000030
J	Goto, K; Kojima, C; Kasai, N; Sumi, D; Hayashi, N; Hwang, H				Goto, Kazushige; Kojima, Chihiro; Kasai, Nobukazu; Sumi, Daichi; Hayashi, Nanako; Hwang, Hyejung			Resistance exercise causes greater serum hepcidin elevation than endurance (cycling) exercise	PLOS ONE			English	Article							IRON-METABOLISM; GROWTH-HORMONE; INFLAMMATION; ERYTHROPOIESIS; INTENSITY; RESPONSES; HEMOLYSIS; INCREASE; BALANCE	Background Hepcidin is an iron regulating hormone, and exercise-induced hepcidin elevation is suggested to increase the risk of iron deficiency among athletes. Objective We compared serum hepcidin responses to resistance exercise and endurance (cycling) exercise. Methods Ten males [mean +/- standard error: 172 +/- 2 cm, body weight: 70 +/- 2 kg] performed three trials: a resistance exercise trial (RE), an endurance exercise trial (END), and a rest trial (REST). The RE consisted of 60 min of resistance exercise (3-5 sets x 12 repetitions, 8 exercises) at 65% of one repetition maximum, while 60 min of cycling exercise at 65% of VO2max was performed in the END. Blood samples were collected before exercise and during a 6-h post-exercise (0h, 1h, 2h, 3h, 6h after exercise). Results Both RE and END significantly increased blood lactate levels, with significantly higher in the RE (P < 0.001). Serum iron levels were significantly elevated immediately after exercise (P < 0.001), with no significant difference between RE and END. Both the RE and END significantly increased serum growth hormone (GH), cortisol, and myoglobin levels (P < 0.01). However, exercise-induced elevations of GH and cortisol were significantly greater in the RE (trial x time: P < 0.001). Plasma interleukin-6 (IL-6) levels were significantly elevated after exercise (P = 0.003), with no significant difference between the trials. Plasma hepcidin levels were elevated after exercise (P < 0.001), with significantly greater in the RE (463 +/- 125%) than in the END (137 +/- 27%, P = 0.03). During the REST, serum hepcidin and plasma IL-6 levels did not change significantly. Conclusion Resistance exercise caused a greater exercise-induced elevation in hepcidin than did endurance (cycling) exercise. The present findings indicate that caution will be required to avoid iron deficiency even among athletes in strength (power) types of events who are regularly involved in resistance exercise.	[Goto, Kazushige; Sumi, Daichi; Hayashi, Nanako] Ritsumeikan Univ, Grad Sch Sports & Hlth Sci, Kusatsu, Shiga, Japan; [Kojima, Chihiro; Kasai, Nobukazu] Japan Inst Sports Sci, Tokyo, Japan; [Hwang, Hyejung] Konkuk Univ, Phys Act & Performance Inst, Seoul, South Korea	Ritsumeikan University; Konkuk University	Goto, K (corresponding author), Ritsumeikan Univ, Grad Sch Sports & Hlth Sci, Kusatsu, Shiga, Japan.	kagoto@fc.ritsumei.ac.jp	Sumi, Daichi/AAV-7107-2021		Japan Society for the Promotion of Science [23680063]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	Grant name: Grant-in-Aid for Scientific Research from Japan Society for the Promotion of Science. Grant number: 23680063 Recipient: Goto K URL:https://www.jsps.go.jp/english/index.html The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antosiewicz J, 2013, CELL IMMUNOL, V283, P12, DOI 10.1016/j.cellimm.2013.06.006; Badenhorst CE, 2015, EUR J APPL PHYSIOL, V115, P2521, DOI 10.1007/s00421-015-3252-3; Beard J, 2000, AM J CLIN NUTR, V72, p594S, DOI 10.1093/ajcn/72.2.594S; Diaz V, 2015, PHYSIOL REP, V3, DOI 10.14814/phy2.12475; Fujii T, 2014, BIOL TRACE ELEM RES, V161, P101, DOI 10.1007/s12011-014-0075-8; Gassmann M, 2015, J APPL PHYSIOL, V119, P1432, DOI 10.1152/japplphysiol.00248.2015; GOLDE DW, 1977, SCIENCE, V196, P1112, DOI 10.1126/science.870971; Goto K, 2018, APPL PHYSIOL NUTR ME, V43, P221, DOI 10.1139/apnm-2017-0418; Govus AD, 2014, EUR J APPL PHYSIOL, V114, P2183, DOI 10.1007/s00421-014-2938-2; Hinton PS, 2014, APPL PHYSIOL NUTR ME, V39, P1012, DOI 10.1139/apnm-2014-0147; Ishibashi A, 2017, NUTRIENTS, V9, DOI 10.3390/nu9080820; Ishibashi A, 2017, NUTRIENTS, V9, DOI 10.3390/nu9030277; KURTZ A, 1988, P NATL ACAD SCI USA, V85, P7825, DOI 10.1073/pnas.85.20.7825; Ma XY, 2013, INT J SPORT NUTR EXE, V23, P513, DOI 10.1123/ijsnem.23.5.513; McClung JP, 2013, NUTR J, V12, DOI 10.1186/1475-2891-12-141; McKay AKA, 2019, J SCI MED SPORT, V22, P635, DOI 10.1016/j.jsams.2018.12.015; Milic R, 2011, EUR J APPL PHYSIOL, V111, P449, DOI 10.1007/s00421-010-1656-7; MILLER BJ, 1988, INT J SPORTS MED, V9, P56, DOI 10.1055/s-2007-1024979; Nemeth E, 2004, SCIENCE, V306, P2090, DOI 10.1126/science.1104742; Nemeth E, 2004, J CLIN INVEST, V113, P1271, DOI 10.1172/JCI200420945; Nicolas G, 2002, BLOOD CELL MOL DIS, V29, P327, DOI 10.1006/bcmd.2002.0573; Pasiakos SM, 2016, PHYSIOL REP, V4, DOI 10.14814/phy2.12820; Peake JM, 2017, J PHYSIOL-LONDON, V595, P695, DOI 10.1113/JP272881; Peeling P, 2017, EUR J APPL PHYSIOL, V117, P1233, DOI 10.1007/s00421-017-3611-3; Peeling P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093002; Peeling P, 2010, EUR J APPL PHYSIOL, V110, P877, DOI 10.1007/s00421-010-1594-4; Peeling P, 2009, INT J SPORT NUTR EXE, V19, P583, DOI 10.1123/ijsnem.19.6.583; Peeling P, 2009, MED SCI SPORT EXER, V41, P1138, DOI 10.1249/MSS.0b013e318192ce58; Sim M, 2014, J INT SOC SPORT NUTR, V11, DOI 10.1186/1550-2783-11-14; Sim M, 2013, INT J SPORT NUTR EXE, V23, P178, DOI 10.1123/ijsnem.23.2.178; Steinberg GR, 2006, APPL PHYSIOL NUTR ME, V31, P302, DOI 10.1139/H06-003; Steinbicker AU, 2013, NUTRIENTS, V5, P3034, DOI 10.3390/nu5083034; Troutt JS, 2012, CLIN CHEM, V58, P1225, DOI 10.1373/clinchem.2012.186866; Zoller H, 2004, NUTRITION, V20, P615, DOI 10.1016/j.nut.2004.04.006	34	5	5	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2020	15	2							e0228766	10.1371/journal.pone.0228766	http://dx.doi.org/10.1371/journal.pone.0228766			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8GQ	32106271	gold, Green Published			2022-12-26	WOS:000535237000013
J	Watanabe, A; Yamaguchi, T; Murota, K; Ishii, N; Terao, J; Okada, S; Tanaka, N; Kimata, S; Abe, A; Suzuki, T; Uchino, M; Niimura, Y				Watanabe, Akio; Yamaguchi, Takuro; Murota, Kaeko; Ishii, Naoaki; Terao, Junji; Okada, Sanae; Tanaka, Naoto; Kimata, Shinya; Abe, Akira; Suzuki, Tomonori; Uchino, Masataka; Niimura, Youichi			Isolation of lactic acid bacteria capable of reducing environmental alkyl and fatty acid hydroperoxides, and the effect of their oral administration on oxidative-stressed nematodes and rats	PLOS ONE			English	Article							LIPID-PEROXIDATION; SENSITIVE MUTANT; COLONIC-MUCOSA; IN-VIVO; IRON; OXYGEN; MEV-1	Reinforcement of the hydroperoxide-eliminating activity in the small and large intestines should prevent associated diseases. We previously isolated a lactic acid bacterium, Pediococcus pentosaceus Be1 that facilitates a 2-electron reduction of hydrogen peroxide to water. In this study, we successfully isolated an alternative lactic acid bacterium, Lactobacillus plantarum P1-2, that can efficiently reduce environmental alkyl hydroperoxides and fatty acid hydroperoxides to their corresponding hydroxyl derivatives through a 2-electron reduction. Each strain exhibited a wide concentration range with regard to the environmental reducing activity for each hydroperoxide. Given this, the two lactic acid bacteria were orally administered to an oxygen-sensitive short-lived nematode mutant, and this resulted in a significant expansion of its lifespan. This observation suggests that P. pentosaceus Be1 and L. plantarum P1-2 inhibit internal oxidative stress. To determine the specific organs involved in this response, we performed a similar experiment in rats, involving induced lipid peroxidation by iron-overloading. We observed that only L. plantarum P1-2 inhibited colonic mucosa lipid peroxidation in rats with induced oxidative stress.	[Watanabe, Akio; Kimata, Shinya; Niimura, Youichi] Tokyo Univ Agr, Dept Biosci, Setagaya Ku, Tokyo, Japan; [Watanabe, Akio] TAIYO Corp, Higashiyodogawa Ku, Osaka, Japan; [Yamaguchi, Takuro; Ishii, Naoaki] Tokai Univ, Dept Mol Life Sci, Sch Med, Isehara, Kanagawa, Japan; [Murota, Kaeko; Terao, Junji] Univ Tokushima, Sch Med, Dept Nutr, Tokushima, Japan; [Okada, Sanae; Tanaka, Naoto] Tokyo Univ Agr, Nodai Culture Collect Ctr, Setagaya Ku, Tokyo, Japan; [Tanaka, Naoto; Abe, Akira; Suzuki, Tomonori; Uchino, Masataka; Niimura, Youichi] Tokyo Univ Agr, Dept Mol Sci Bacteria, Setagaya Ku, Tokyo, Japan; [Murota, Kaeko] Shimane Univ, Acad Assembly, Inst Agr & Life Sci, Matsue, Shimane, Japan; [Terao, Junji] Konan Womens Univ, Fac Clin Nutr & Dietet, Higashinada Ku, Kobe, Hyogo, Japan	Tokyo University of Agriculture; Tokai University; Tokushima University; Tokyo University of Agriculture; Tokyo University of Agriculture; Shimane University	Niimura, Y (corresponding author), Tokyo Univ Agr, Dept Biosci, Setagaya Ku, Tokyo, Japan.; Niimura, Y (corresponding author), Tokyo Univ Agr, Dept Mol Sci Bacteria, Setagaya Ku, Tokyo, Japan.	niimura@nodai.ac.jp	Murota, Kaeko/GRO-6464-2022		Japanese Ministry of Education, Culture, Sports, Science and Technology [24580125]	Japanese Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by grants from the Japanese Ministry of Education, Culture, Sports, Science and Technology 24580125 to Youichi Niimua. The fund had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.; We thank Satoru Furukawa of the FRC for his technical advice, and Kayo Yasuda of Tokai University, Youko Yasutomi of Tokushima University for their technical assistance of the animal tests. We also thank Kyoko Takada, Kaoru Yoshitaka, and Chiaki Kaneko of Tokyo University of Agriculture for their technical assistance of microbial screenings and the hydroperoxide-eliminating activities.	Adachi H, 1998, J GERONTOL A-BIOL, V53, pB240, DOI 10.1093/gerona/53A.4.B240; Al-Madboly LA, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00772; Alzoghaibi Mohammed A, 2007, Saudi J Gastroenterol, V13, P187, DOI 10.4103/1319-3767.36750; BACON BR, 1983, J CLIN INVEST, V71, P429, DOI 10.1172/JCI110787; BRENNER S, 1974, GENETICS, V77, P71; Das D, 2015, LWT-FOOD SCI TECHNOL, V61, P263, DOI 10.1016/j.lwt.2014.11.013; de LeBlanc AD, 2008, J MED MICROBIOL, V57, P100, DOI 10.1099/jmm.0.47403-0; Erichsen K, 2005, INFLAMM BOWEL DIS, V11, P744, DOI 10.1097/01.MIB.0000174374.83601.86; Fernandez MF, 2003, J APPL MICROBIOL, V94, P449, DOI 10.1046/j.1365-2672.2003.01850.x; FUNK MO, 1976, LIPIDS, V11, P113, DOI 10.1007/BF02532660; Hammes W.P., 2009, BERGEYS MANUAL SYSTE, VVolume 3, P465; HOSOKAWA H, 1994, MECH AGEING DEV, V74, P161, DOI 10.1016/0047-6374(94)90087-6; Ikeda T, 2007, APPL ENVIRON MICROB, V73, P6404, DOI 10.1128/AEM.00704-07; ISHII N, 1990, MUTAT RES, V237, P165, DOI 10.1016/0921-8734(90)90022-J; Ito M, 2003, J AGR FOOD CHEM, V51, P4456, DOI 10.1021/jf0261957; Ito M, 2001, J DAIRY SCI, V84, P1583, DOI 10.3168/jds.S0022-0302(01)74591-2; Korpela R, 1996, NUTR TODAY S, V31, P51, DOI DOI 10.1097/00017285-199611001-00018; Lin MY, 2000, DIGEST DIS SCI, V45, P1617, DOI 10.1023/A:1005577330695; Mihaljevic B, 1996, FREE RADICAL BIO MED, V21, P53, DOI 10.1016/0891-5849(95)02224-4; Miyamoto Sayuri, 2001, P103, DOI 10.1159/000062733; MULLER A, 1984, BIOCHEM PHARMACOL, V33, P3235, DOI 10.1016/0006-2952(84)90083-2; Murakami A., 1998, Nippon Eiyo Shokuryo Gakkaishi = Journal of the Japanese Society of Nutrition and Food Science, V51, P9; NAITO Y, 1995, FREE RADICAL BIO MED, V18, P117, DOI 10.1016/0891-5849(94)00110-6; Stiernagle T, 2006, MAINTENANCE C ELEGAN; Tang W, 2018, PROBIOTICS ANTIMICRO, V10, P523, DOI 10.1007/s12602-017-9349-8; Tang W, 2017, FOOD CHEM, V221, P1642, DOI 10.1016/j.foodchem.2016.10.124; Tang W, 2016, APPL MICROBIOL BIOT, V100, P7193, DOI 10.1007/s00253-016-7581-x; UCHIYAMA M, 1978, ANAL BIOCHEM, V86, P271, DOI 10.1016/0003-2697(78)90342-1; Watanabe A, 2016, J GEN APPL MICROBIOL, V62, P75, DOI 10.2323/jgam.62.75; Yamaguchi T, 2008, AATEX, V13, P1; Yoshikawa T, 1993, FREE RADICAL RES COM, V7, P285; YOUNES M, 1990, RES COMMUN CHEM PATH, V70, P349	32	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2020	15	2							e0215113	10.1371/journal.pone.0215113	http://dx.doi.org/10.1371/journal.pone.0215113			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8GQ	32107484	Green Published, Green Submitted, gold			2022-12-26	WOS:000535237000002
J	Ahmed, CM; Ildefonso, CJ; Johnson, HM; Lewin, AS				Ahmed, Chulbul M.; Ildefonso, Cristhian J.; Johnson, Howard M.; Lewin, Alfred S.			A C-terminal peptide from type I interferon protects the retina in a mouse model of autoimmune uveitis	PLOS ONE			English	Article							OCULAR INFLAMMATION; NLRP3 INFLAMMASOME; EXPRESSION; ALPHA; RECEPTOR; TRISTETRAPROLIN; SUPPRESSOR; INDUCTION; HISTORY; PATHWAY	Experimental autoimmune uveitis (EAU) in rodents recapitulates many features of the disease in humans and has served as a useful tool for the development of therapeutics. A peptide from C-terminus of interferon alpha 1, conjugated to palmitoyl-lysine for cell penetration, denoted as IFN alpha-C, was tested for its anti-inflammatory properties in ARPE-19 cells, followed by testing in a mouse model of EAU. Treatment with IFN alpha-C and evaluation by RT-qPCR showed the induction of anti-inflammatory cytokines and chemokine. Inflammatory markers induced by treatment with TNF alpha were suppressed when IFN alpha-C was simultaneously present. TNF-alpha mediated induction of NF-kappa B and signaling by IL-17A were attenuated by IFN alpha-C. Differentiated ARPE-19 cells were treated with TNF alpha in the presence or absence IFN alpha-C and analyzed by immmunhistochemistry. IFN alpha-C protected against the disruption integrity of tight junction proteins. Similarly, loss of transepithelial resistance caused by TNF alpha was prevented by IFN alpha-C. B10.RIII mice were immunized with a peptide from interphotoreceptor binding protein (IRBP) and treated by gavage with IFN alpha-C. Development of uveitis was monitored by histology, fundoscopy, SD-OCT, and ERG. Treatment with IFN alpha-C prevented uveitis in mice immunized with the IRBP peptide. Splenocytes isolated from mice with ongoing EAU exhibited antigen-specific T cell proliferation that was inhibited in the presence of IFN alpha-C. IFN alpha-C peptide exhibits anti-inflammatory properties and protects mice against damage to retinal structure and function suggesting that it has therapeutic potential for the treatment of autoimmune uveitis.	[Ahmed, Chulbul M.; Lewin, Alfred S.] Univ Florida, Dept Mol Genet & Microbiol, Gainesville, FL 32611 USA; [Ildefonso, Cristhian J.] Univ Florida, Dept Ophthalmol, Gainesville, FL USA; [Johnson, Howard M.] Univ Florida, Dept Microbiol & Cell Sci, Gainesville, FL 32611 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida	Lewin, AS (corresponding author), Univ Florida, Dept Mol Genet & Microbiol, Gainesville, FL 32611 USA.	lewin@ufl.edu	Ildefonso, Cristhian/AAC-3576-2021	Lewin, Alfred/0000-0002-4192-9727	ASL Shaler Richardson Endowment	ASL Shaler Richardson Endowment	ASL Shaler Richardson Endowment https://research.ufl.edu/ufrf.html.The sponsors played no role in the study design.	Abbasian J, 2012, AM J OPHTHALMOL, V154, P72, DOI 10.1016/j.ajo.2012.01.016; Ablonczy Z, 2011, INVEST OPHTH VIS SCI, V52, P8614, DOI 10.1167/iovs.11-8021; Agarwal Rajeev K, 2012, Methods Mol Biol, V900, P443, DOI 10.1007/978-1-60761-720-4_22; Ahmed CM, 2007, J IMMUNOL, V178, P4576, DOI 10.4049/jimmunol.178.7.4576; Ahmed CM, 2018, EXP EYE RES, V177, P12, DOI 10.1016/j.exer.2018.07.020; Ahmed CM, 2016, MOL VIS, V22, P294; Ahmed Chulbul M, 2013, JAKSTAT, V2, pe26227, DOI 10.4161/jkst.26227; Ahmed CM, 2014, J INTERF CYTOK RES, V34, P802, DOI 10.1089/jir.2014.0041; Ahmed CM, 2014, CLIN VACCINE IMMUNOL, V21, P1178, DOI 10.1128/CVI.00204-14; Ahmed CMI, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00183; Ahmed CMI, 2010, J IMMUNOL, V185, P1103, DOI 10.4049/jimmunol.0902895; Al-Gayyar MM, 2013, EUR CYTOKINE NETW, V24, P27, DOI 10.1684/ecn.2013.0334; [Anonymous], [No title captured]; Benveniste E. N., 2007, SCI STKE, V416, ppe70, DOI DOI 10.1126/STKE.4162007PE70; Biswal MR, 2015, EXP EYE RES, V140, P94, DOI 10.1016/j.exer.2015.07.022; Bittencourt MG, 2012, DEV OPHTHALMOL, V51, P134, DOI 10.1159/000336338; Chen J, 2019, METHODS MOL BIOL, V1899, P211, DOI 10.1007/978-1-4939-8938-6_15; Chong WP, 2014, J AUTOIMMUN, V50, P12, DOI 10.1016/j.jaut.2013.08.003; Drucker DJ, 2019, NAT REV DRUG DISCOV; Dumitrescu L, 2018, EXPERT OPIN BIOL TH, V18, P665, DOI 10.1080/14712598.2018.1462793; Dunn KC, 1996, EXP EYE RES, V62, P155, DOI 10.1006/exer.1996.0020; Elliott EI, 2015, IMMUNOL REV, V265, P35, DOI 10.1111/imr.12286; Forrester JV, 2013, INT REV IMMUNOL, V32, P76, DOI 10.3109/08830185.2012.747524; Frohman LP, 2014, J NEUROOPHTHALMOL; Ganesan R, 2017, MOL IMMUNOL, V91, P134, DOI 10.1016/j.molimm.2017.09.003; Gao WW, 2015, BRAIN RES, V1622, P230, DOI 10.1016/j.brainres.2015.04.035; Gonzalez-Navajas JM, 2012, NAT REV IMMUNOL, V12, P125, DOI 10.1038/nri3133; Greco A, 2013, AUTOIMMUN REV, V12, P1033, DOI 10.1016/j.autrev.2013.01.004; Gu L, 2013, J IMMUNOL, V191, P3922, DOI 10.4049/jimmunol.1300126; Guarda G, 2011, IMMUNITY, V34, P213, DOI 10.1016/j.immuni.2011.02.006; Guo BC, 2008, J CLIN INVEST, V118, P1680, DOI 10.1172/JCI33342; He C, 2016, MEDIAT INFLAMM, V2016, DOI 10.1155/2016/2939370; He C, 2015, J AUTOIMMUN, V62, P31, DOI 10.1016/j.jaut.2015.05.011; Heissigerova J, 2016, J IMMUNOL RES, V2016, DOI 10.1155/2016/5065703; Hile G.A., 2018, CYTOKINE; Horai R, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00232; Horai R, 2013, J AUTOIMMUN, V44, P21, DOI 10.1016/j.jaut.2013.06.003; Horai R, 2011, J INTERF CYTOK RES, V31, P733, DOI 10.1089/jir.2011.0042; Ildefonso CJ, 2016, ADV EXP MED BIOL, V854, P59, DOI 10.1007/978-3-319-17121-0_9; Inoue M, 2013, AUTOIMMUN DIS, V2013, DOI 10.1155/2013/859145; Jager LD, 2011, J NEUROIMMUNOL, V232, P108, DOI 10.1016/j.jneuroim.2010.10.018; Johnson HM, 2019, MEDIAT INFLAMM, V2019, DOI 10.1155/2019/4143604; Johnson HM, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00202; Kovarik P, 2015, CYTOKINE; Kristensen M, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17020185; Laver T, 2008, J INTERF CYTOK RES, V28, P13, DOI 10.1089/jir.2007.0062; Lee FF, 2010, EXPERT OPIN PHARMACO, V11, P1135, DOI 10.1517/14656561003713534; Lee SE, 2012, GASTROENTEROLOGY, V143, P145, DOI 10.1053/j.gastro.2012.03.042; Lewczuk N, 2019, J INTERF CYTOK RES, V39, P259, DOI 10.1089/jir.2018.0125; Liu YL, 2012, MOL MED, V18, P1387, DOI 10.2119/molmed.2012.00008; Mackensen F, 2013, AM J OPHTHALMOL, V156, P478, DOI 10.1016/j.ajo.2013.05.002; Mackensen F, 2009, CLIN OPHTHALMOL, V3, P559; Messenger W, 2015, BRIT J OPHTHALMOL, V99, P205, DOI 10.1136/bjophthalmol-2014-305518; Miserocchi E, 2013, EUR J OPHTHALMOL, V23, P705, DOI 10.5301/ejo.5000278; Moschen AR, 2008, IMMUNOBIOLOGY, V213, P779, DOI 10.1016/j.imbio.2008.07.022; Ogilvie RL, 2009, J BIOL CHEM, V284, P11216, DOI 10.1074/jbc.M901229200; Ogilvie RL, 2005, J IMMUNOL, V174, P953, DOI 10.4049/jimmunol.174.2.953; Palanisamy V, 2012, J DENT RES, V91, P651, DOI 10.1177/0022034512437372; Pan J, 2014, CURR ALLERGY ASTHM R, V14, DOI 10.1007/s11882-013-0409-1; Park H, 2005, NAT IMMUNOL, V6, P1133, DOI 10.1038/ni1261; Park UC, 2014, J IMMUNOL RES, V2014, DOI 10.1155/2014/653539; Perez VL, 2015, TRENDS IMMUNOL, V36, P354, DOI 10.1016/j.it.2015.04.003; Plskova J, 2007, AM J OPHTHALMOL, V144, P55, DOI 10.1016/j.ajo.2007.03.050; Pott J, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00258; Reder AT, 2014, J INTERF CYTOK RES, V34, P589, DOI 10.1089/jir.2013.0158; Rizzo LV, 1998, INT IMMUNOL, V10, P807, DOI 10.1093/intimm/10.6.807; Rowan S, 2018, ADV EXP MED BIOL, V1074, P429, DOI 10.1007/978-3-319-75402-4_53; Sauer I, 2006, BLOOD, V107, P4790, DOI 10.1182/blood-2005-07-3058; Shugaiv E, 2015, MULT SCLER J, V21, P105, DOI 10.1177/1352458514539782; Steinman L, 2007, NAT MED, V13, P139, DOI 10.1038/nm1551; Subramaniam PS, 1995, P NATL ACAD SCI USA, V92, P12270, DOI 10.1073/pnas.92.26.12270; Thomas AS, 2019, CURR OPIN OPHTHALMOL, V30, P138, DOI 10.1097/ICU.0000000000000562; Touhami S, 2019, EXPERT OPIN BIOL TH, V19, P477, DOI 10.1080/14712598.2019.1595578; Vigneswara V, 2015, MOL CELL NEUROSCI, V68, P212, DOI 10.1016/j.mcn.2015.08.001; Walscheid K, 2014, INVEST OPHTH VIS SCI, V55, P3447, DOI 10.1167/iovs.13-13444; Weinstein JE, 2018, CURR OPIN OPHTHALMOL, V29, P267, DOI 10.1097/ICU.0000000000000466; Xu YY, 2014, INT IMMUNOPHARMACOL, V19, P327, DOI 10.1016/j.intimp.2014.01.027; Zhang XK, 2015, BBA-GEN SUBJECTS, V1850, P1140, DOI 10.1016/j.bbagen.2015.01.019; Zhao WP, 2011, J INTERF CYTOK RES, V31, P629, DOI 10.1089/jir.2010.0154	79	2	2	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2020	15	2							e0227524	10.1371/journal.pone.0227524	http://dx.doi.org/10.1371/journal.pone.0227524			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8FM	32101556	Green Published, Green Submitted, gold			2022-12-26	WOS:000535233700006
J	Lo, CKF; Mertz, D; Yamamura, D; Loeb, M				Lo, Calvin Ka-Fung; Mertz, Dominik; Yamamura, Debbie; Loeb, Mark			Assessing impact of MALDI mass spectroscopy on reducing directed antibiotic coverage time for Gram-negative organisms	PLOS ONE			English	Article							IDENTIFICATION; TOF	The objective of this study was to assess whether use of matrix assisted laser desorption ionization-time of flight (MALDI-TOF), through improvements in identification time, reduces time to directed antibiotic coverage. We therefore conducted a retrospective review of 377 blood cultures from hospitalized patients with gram negative bacteremia that underwent testing by MALDI-TOF compared to standard identification methods (VITEK 2) for blood cultures from January 2016 to December 2017. We found that MALDI significantly reduced time between blood culture collection to reach pathogen identification and was associated with a significantly reduced time to initiate more specific therapy, with a mean difference of 16.37 hours, 95% CI 10.05 to 22.69 (mean time 50.34 hours (+/- 21.21) vs VITEK: 66.71 hrs (+/- 27.12), p<0.001 as well as a reduced time to discontinue previous therapy (p = 0.004). In conclusion, in reducing time to identification of gram negative bacteremia, MALDI-TOF led to improvements in antibiotic coverage.	[Lo, Calvin Ka-Fung; Yamamura, Debbie; Loeb, Mark] Hamilton Reg Lab Program, Hamilton, ON, Canada; [Lo, Calvin Ka-Fung] Univ British Columbia, Dept Med, Vancouver, BC, Canada; [Mertz, Dominik] McMaster Univ, Dept Med, Hamilton, ON, Canada; [Mertz, Dominik; Loeb, Mark] McMaster Univ, Dept Hlth Res Methods Evidence & Impact, Hamilton, ON, Canada; [Mertz, Dominik; Loeb, Mark] McMaster Univ, Michael G DeGroote Inst Infect Dis Res, Hamilton, ON, Canada	University of British Columbia; McMaster University; McMaster University; McMaster University	Loeb, M (corresponding author), Hamilton Reg Lab Program, Hamilton, ON, Canada.; Loeb, M (corresponding author), McMaster Univ, Dept Hlth Res Methods Evidence & Impact, Hamilton, ON, Canada.; Loeb, M (corresponding author), McMaster Univ, Michael G DeGroote Inst Infect Dis Res, Hamilton, ON, Canada.	loebmark@mcmaster.ca		Lo, Calvin/0000-0003-3664-736X				Bhavsar SM, 2018, DIAGN MICR INFEC DIS, V92, P220, DOI 10.1016/j.diagmicrobio.2018.05.021; Carbonnelle E, 2011, CLIN BIOCHEM, V44, P104, DOI 10.1016/j.clinbiochem.2010.06.017; Clerc O, 2013, CLIN INFECT DIS, V56, P1101, DOI 10.1093/cid/cis1204; Gaskin M, 2016, P 11 ANN M ASS MED M; Mitchell SL, 2017, EUR J CLIN MICROBIOL, V36, P2201, DOI 10.1007/s10096-017-3046-0; Patel R, 2015, CLIN CHEM, V61, P100, DOI 10.1373/clinchem.2014.221770; Romero-Gomez MP, 2012, J INFECTION, V65, P513, DOI 10.1016/j.jinf.2012.08.013; Vlek ALM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032589	8	2	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2020	15	2							e0228935	10.1371/journal.pone.0228935	http://dx.doi.org/10.1371/journal.pone.0228935			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8FM	32101540	Green Published, gold			2022-12-26	WOS:000535233700013
J	Mantovani, MD; de Carvalho, NC; Archangelo, TE; de Andrade, LGM; Ferreira, SP; Cavalcante, RD; Kawano, PR; Papini, SJ; Costa, NA; Almeida, RAMD				Mantovani, Milena dos Santos; de Carvalho, Nyara Coelho; Archangelo, Thomaz Eduardo; Modelli de Andrade, Luis Gustavo; Ferreira Filho, Sebastiao Pires; Cavalcante, Ricardo de Souza; Kawano, Paulo Roberto; Papini, Silvia Justina; Costa, Nara Aline; Monteiro de Barros Almeida, Ricardo Augusto			Frailty predicts surgical complications after kidney transplantation. A propensity score matched study	PLOS ONE			English	Article							MORTALITY; CLASSIFICATION; RECIPIENTS; OUTCOMES; DISEASE; COHORT; SCALE	Background and objective Surgical complications after kidney transplantation can lead to catastrophic outcomes. Frailty has been associated with important kidney transplantation outcomes; however, there are no studies assessing this measure of physiological reserve as a specific predictor of surgical complications in this population. Such an assessment was, therefore, the objective of the present study. Methods A total of 87 individuals aged. 18 years who underwent kidney transplantation between March 2017 and March 2018 were included. At the time of admission for kidney transplantation, demographic, clinical, and kidney transplantation data were collected, and the frailty score was calculated according to Fried et al., which comprises five components: shrinking, weakness, exhaustion, low activity, and slowed walking speed. Urological, vascular, and general surgical complications were assessed three months later, or until graft loss or death. The propensity score was used to achieve a better homogeneity of the sample, and new analyses were performed in this new, balanced sample. Results Of the 87 individuals included, 30 (34.5%) had surgical complications. After propensity score matching, the risk of surgical complications was significantly higher among the frail individuals (RR 2.14; 95% CI 1.01-4.54; p = 0.035); specifically, the risk of noninfectious surgical complications was significantly higher among these individuals (RR 2.50; 95% CI 1.11-5.62; p = 0.017). Conclusion The results showed that individuals with some degree of frailty before kidney transplantation were more subject to surgical complications. The calculation of the frailty score for transplant candidates and the implementations of measures to increase the physiological reserve of these patients at the time of kidney transplantation may possibly reduce the occurrence of surgical complications.	[Mantovani, Milena dos Santos; de Carvalho, Nyara Coelho; Archangelo, Thomaz Eduardo; Costa, Nara Aline] Univ Estadual Paulista Unesp, Fac Med Botucatu, Botucatu, SP, Brazil; [Modelli de Andrade, Luis Gustavo] Univ Estadual Paulista Unesp, Fac Med Botucatu, Dept Clin Med, Botucatu, SP, Brazil; [Ferreira Filho, Sebastiao Pires; Cavalcante, Ricardo de Souza; Monteiro de Barros Almeida, Ricardo Augusto] Univ Estadual Paulista Unesp, Fac Med Botucatu, Dept Doencas Trop & Diagnost Imagem, Botucatu, SP, Brazil; [Kawano, Paulo Roberto] Univ Estadual Paulista Unesp, Fac Med Botucatu, Dept Urol, Botucatu, SP, Brazil; [Papini, Silvia Justina] Univ Estadual Paulista Unesp, Fac Med Botucatu, Dept Enfermagem, Botucatu, SP, Brazil	Universidade Estadual Paulista; Universidade Estadual Paulista; Universidade Estadual Paulista; Universidade Estadual Paulista; Universidade Estadual Paulista	Almeida, RAMD (corresponding author), Univ Estadual Paulista Unesp, Fac Med Botucatu, Dept Doencas Trop & Diagnost Imagem, Botucatu, SP, Brazil.	almeidaramb@yahoo.com.br	de Andrade, Luis Gustavo Modelli/I-4146-2013; de Souza Cavalcante, Ricardo/D-2058-2013; KAWANO, PAULO/C-6288-2019; Monteiro de Barros Almeida, Ricardo Augusto/A-5952-2017	de Souza Cavalcante, Ricardo/0000-0001-6382-2675; KAWANO, PAULO/0000-0001-8411-5822; Monteiro de Barros Almeida, Ricardo Augusto/0000-0003-0567-6221; Modelli de Andrade, Luis Gustavo/0000-0002-0230-0766; Archangelo, Thomaz Eduardo/0000-0002-1122-1015	Sao Paulo Research Foundation (FAPESP) [2016/24745-3]; Coordenacao de Aperfeicoamento de Pessoal de Ni'vel Superior Brasil (CAPES) [001]; National Council for Scientific and Technological Development (CNPq), RT Bolsa Reitoria [42014]	Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Coordenacao de Aperfeicoamento de Pessoal de Ni'vel Superior Brasil (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); National Council for Scientific and Technological Development (CNPq), RT Bolsa Reitoria(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)Fundacao de Apoio a Pesquisa do Distrito Federal (FAPDF))	This study was supported by grant from Sao Paulo Research Foundation (FAPESP) #2016/24745-3 (http://www.fapesp.br/en/) and was also financed in part by the Coordenacao de Aperfeicoamento de Pessoal de Ni ' vel Superior Brasil (CAPES) -Finance Code 001 (https://www.capes.gov.br/).TEA received a scientific initiation scholarship from the National Council for Scientific and Technological Development (CNPq), RT Bolsa Reitoria, project 42014 (http://www.cnpq.br/).	Ammi M, 2016, ANN VASC SURG, V33, P23, DOI 10.1016/j.avsg.2016.03.002; Araujo JC, 2016, TRANSPL P, V48, P2301, DOI 10.1016/j.transproceed.2016.06.017; Buigues C, 2015, ARCH GERONTOL GERIAT, V61, P309, DOI 10.1016/j.archger.2015.08.002; Buttigieg Jesmar, 2018, World J Transplant, V8, P142, DOI 10.5500/wjt.v8.i5.142; Chapman JR, 2017, AM J KIDNEY DIS, V69, P287, DOI 10.1053/j.ajkd.2016.08.024; Chowdhury R, 2017, ARCH GERONTOL GERIAT, V68, P135, DOI 10.1016/j.archger.2016.10.007; Clavien PA, 2009, ANN SURG, V250, P187, DOI 10.1097/SLA.0b013e3181b13ca2; Cohen J.E., 1988, STAT POWER ANAL BEHA; Dindo D, 2004, ANN SURG, V240, P205, DOI 10.1097/01.sla.0000133083.54934.ae; Exterkate L, 2016, TRANSPLANTATION, V100, P727, DOI 10.1097/TP.0000000000001003; Fitzpatrick J, 2019, NEPHROL DIAL TRANSPL, V34, P346, DOI 10.1093/ndt/gfy124; Fried LP, 2001, J GERONTOL A-BIOL, V56, pM146, DOI 10.1093/gerona/56.3.M146; Garonzik-Wang JM, 2012, ARCH SURG-CHICAGO, V147, P190, DOI 10.1001/archsurg.2011.1229; Haugen CE, 2018, J AM SOC NEPHROL, V29, P1752, DOI 10.1681/ASN.2018010064; Humar A, 2005, SEMIN DIALYSIS, V18, P505, DOI 10.1111/j.1525-139X.2005.00097.x; Kawano PR, 2017, INT J SURG CASE REP, V36, P82, DOI 10.1016/j.ijscr.2017.04.022; Kobashigawa J, 2019, AM J TRANSPLANT, V19, P984, DOI 10.1111/ajt.15198; Kocak T, 2004, UROL INT, V72, P252, DOI 10.1159/000077125; Kojima G, 2017, INT UROL NEPHROL, V49, P1989, DOI 10.1007/s11255-017-1547-5; Lustosa L, 2011, GERIATR GERONTOL INT, V5, P57; Makary MA, 2010, J AM COLL SURGEONS, V210, P901, DOI 10.1016/j.jamcollsurg.2010.01.028; McAdams-DeMarco MA, 2015, AM J TRANSPLANT, V15, P149, DOI 10.1111/ajt.12992; McAdams-DeMarco MA, 2013, AM J TRANSPLANT, V13, P2091, DOI 10.1111/ajt.12300; McAdams-DeMarco MA, 2018, TRANSPLANTATION, V102, P1740, DOI 10.1097/TP.0000000000002213; McAdams-DeMarco MA, 2017, ANN SURG, V266, P1084, DOI 10.1097/SLA.0000000000002025; McAdams-DeMarco MA, 2017, TRANSPLANTATION, V101, P2126, DOI 10.1097/TP.0000000000001546; McAdams-DeMarco MA, 2013, BMC NEPHROL, V14, DOI 10.1186/1471-2369-14-224; McAdams-DeMarco MA, 2013, J AM GERIATR SOC, V61, P896, DOI 10.1111/jgs.12266; Ommundsen N, 2014, ONCOLOGIST, V19, P1268, DOI 10.1634/theoncologist.2014-0237; Pascual J, 2018, J AM SOC NEPHROL, V29, P1979, DOI 10.1681/ASN.2018010009; Revenig LM, 2013, J AM COLL SURGEONS, V217, P665, DOI 10.1016/j.jamcollsurg.2013.06.012; Robinson TN, 2013, AM J SURG, V206, P544, DOI 10.1016/j.amjsurg.2013.03.012; Ferreira FDR, 2017, J NEPHROL, V30, P601, DOI 10.1007/s40620-017-0379-9; Schold JD, 2008, TRANSPLANTATION, V85, P1, DOI 10.1097/01.tp.0000297372.51408.c2; Schopmeyer L, 2019, TRANSPL INT, V32, P66, DOI 10.1111/tri.13330; Slankamenac K, 2013, ANN SURG, V258, P1, DOI 10.1097/SLA.0b013e318296c732; Soy EHA, 2017, EXP CLIN TRANSPLANT, V15, P79, DOI 10.6002/ect.mesot2016.O65; Streeter EH, 2002, BJU INT, V90, P627, DOI 10.1046/j.1464-410X.2002.03004.x; Batistoni SST, 2007, REV SAUDE PUBL, V41, P598, DOI 10.1590/S0034-89102007000400014; Wolff T, 2014, J SURG EDUC, V71, P748, DOI 10.1016/j.jsurg.2014.03.007	40	7	7	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2020	15	2							e0229531	10.1371/journal.pone.0229531	http://dx.doi.org/10.1371/journal.pone.0229531			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8FM	32102091	Green Published, gold, Green Submitted			2022-12-26	WOS:000535233700040
J	Wilson, DL; Howard, ME; Fung, AM; O'Donoghue, FJ; Barnes, M; Lappas, M; Walker, SP				Wilson, Danielle L.; Howard, Mark E.; Fung, Alison M.; O'Donoghue, Fergal J.; Barnes, Maree; Lappas, Martha; Walker, Susan P.			The presence of coexisting sleep-disordered breathing among women with hypertensive disorders of pregnancy does not worsen perinatal outcome	PLOS ONE			English	Article							FOR-GESTATIONAL-AGE; FETAL OXYGENATION; APNEA; GROWTH; POLYSOMNOGRAPHY; CLASSIFICATION; HYPOXIA; INFANTS; RISK	Objective To determine whether the presence of co-existing sleep-disordered breathing (SDB) is associated with worse perinatal outcomes among women diagnosed with a hypertensive disorder of pregnancy (HDP), compared with normotensive controls. Study design Women diagnosed with HDP (gestational hypertension or preeclampsia) and BMI- and gestation-matched controls underwent polysomnography in late pregnancy to determine if they had coexisting SDB. Fetal heart rate (FHR) monitoring accompanied the sleep study, and third trimester fetal growth velocity was assessed using ultrasound. Cord blood was taken at delivery to measure key regulators of fetal growth. Results SDB was diagnosed in 52.5% of the HDP group (n = 40) and 38.1% of the control group (n = 42); p =.19. FHR decelerations were commonly observed during sleep, but the presence of SDB did not increase this risk in either the HDP or control group (HDP group-SDB = 35.3% vs. No SDB = 40.0%, p = 1.0; control group-SDB = 41.7% vs. No SDB = 25.0%, p =.44), nor did SDB affect the total number of decelerations overnight (HDP group-SDB = 2.7 +/- 1.0 vs. No SDB = 2.8 +/- 2.1, p =.94; control group-SDB = 2.0 +/- 0.8 vs. No SDB = 2.0 +/- 0.7, p = 1.0). Fetal growth restriction was the strongest predictor of fetal heart rate events during sleep (aOR 5.31 (95% CI 1.26-22.26), p =.02). The presence of SDB also did not adversely affect fetal growth; in fact among women with HDP, SDB was associated with significantly larger customised birthweight centiles (43.2% +/- 38.3 vs. 16.2% +/- 27.0, p =.015) and fewer growth restricted babies at birth (30% vs. 68.4%, p =.026) compared to HDP women without SDB. There was no impact of SDB on measures of fetal growth for the control group. Cord blood measures of fetal growth did not show any adverse effect among women with SDB, either in the HDP or control group. Conclusion We did not find that the presence of mild SDB worsened fetal acute or longitudinal outcomes, either among women with HDP or BMI-matched normotensive controls. Unexpectedly, we found the presence of SDB conferred a better prognosis in HDP in terms of fetal growth. The fetus has considerable adaptive capacity to withstand in utero hypoxia, which may explain our mostly negative findings. In addition, SDB in this cohort was mostly mild. It may be that fetal sequelae will only be unmasked in the setting of more severe degrees of SDB and/or underlying placental disease.	[Wilson, Danielle L.; Howard, Mark E.; O'Donoghue, Fergal J.; Barnes, Maree] Austin Hlth, Inst Breathing & Sleep, Heidelberg, Vic, Australia; [Wilson, Danielle L.; Fung, Alison M.; Walker, Susan P.] Mercy Hosp Women, Mercy Perinatal, Heidelberg, Vic, Australia; [Wilson, Danielle L.; Howard, Mark E.; O'Donoghue, Fergal J.; Barnes, Maree] Univ Melbourne, Dept Med, Parkville, Vic, Australia; [Lappas, Martha; Walker, Susan P.] Univ Melbourne, Dept Obstet & Gynaecol, Parkville, Vic, Australia	Austin Research Institute; Florey Institute of Neuroscience & Mental Health; Institute for Breathing & Sleep (IBAS); University of Melbourne; University of Melbourne	Wilson, DL (corresponding author), Austin Hlth, Inst Breathing & Sleep, Heidelberg, Vic, Australia.; Wilson, DL (corresponding author), Mercy Hosp Women, Mercy Perinatal, Heidelberg, Vic, Australia.; Wilson, DL (corresponding author), Univ Melbourne, Dept Med, Parkville, Vic, Australia.	danielle.wilson@austin.org.au		Howard, Mark/0000-0001-7772-1496	Institute for Breathing and Sleep; Austin Medical Research Foundation; Norman Beischer Medical Research Foundation; National Health and Medical Research Council Postgraduate Scholarship [APP1038747]; Department of Obstetrics and Gynaecology (University of Melbourne)	Institute for Breathing and Sleep; Austin Medical Research Foundation; Norman Beischer Medical Research Foundation; National Health and Medical Research Council Postgraduate Scholarship(National Health and Medical Research Council (NHMRC) of Australia); Department of Obstetrics and Gynaecology (University of Melbourne)	This research was supported by the following -Institute for Breathing and Sleep (DW, MH, SW, FO, MB, AF) - https://ibas.org.au/Austin Medical Research Foundation (MB, MH, DW) http://www.austinmrf.org.au/Medical Research Foundation for Women and Babies (now named Norman Beischer Medical Research Foundation) (DW, SW, AF) -http://www.nbmrf.org.au/National Health and Medical Research Council Postgraduate Scholarship (DW) -APP1038747 https://www.nhmrc.gov.au/Research Fellowship from the Department of Obstetrics and Gynaecology (University of Melbourne) (ML). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bardien N, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0142788; Bin YS, 2016, J CLIN SLEEP MED, V12, P871, DOI 10.5664/jcsm.5890; Blyton DM, 2013, SLEEP, V36, P15, DOI 10.5665/sleep.2292; Bobrow CS, 1999, ARCH DIS CHILD-FETAL, V80, pF246, DOI 10.1136/fn.80.3.F246; Bourjeily G, 2017, SLEEP MED, V38, P50, DOI 10.1016/j.sleep.2017.06.035; Bourjeily G, 2015, J MATERN-FETAL NEO M, V28, P262, DOI 10.3109/14767058.2014.913131; Bruyneel M, 2014, SLEEP MED REV, V18, P341, DOI 10.1016/j.smrv.2013.12.002; Campbell AJ, 2011, J SLEEP RES, V20, P207, DOI 10.1111/j.1365-2869.2010.00854.x; Chen YH, 2012, AM J OBSTET GYNECOL, V206, DOI 10.1016/j.ajog.2011.09.006; Cruz MO, 2011, AM J OBSTET GYNECOL, V205, DOI 10.1016/j.ajog.2011.06.033; DEGRAUW TJ, 1986, BIOL NEONATE, V49, P85, DOI 10.1159/000242515; Edwards N, 2002, THORAX, V57, P555, DOI 10.1136/thorax.57.6.555; Facco FL, 2017, OBSTET GYNECOL, V129, P31, DOI 10.1097/AOG.0000000000001805; Facco FL, 2014, AM J OBSTET GYNECOL, V210, DOI 10.1016/j.ajog.2013.12.035; Flemons WW, 1999, SLEEP, V22, P667, DOI 10.1093/sleep/22.5.667; Fung AM, 2012, J PERINATOL, V32, P399, DOI 10.1038/jp.2012.14; Fung AM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068057; Gamaldo CE, 2016, AASM MANUAL SCORING; Gardosi J, 2005, BMJ-BRIT MED J, V331, P1113, DOI 10.1136/bmj.38629.587639.7C; Gardosi J, 2013, CUSTOMISED WEIGHT CE; Gardosi J, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f108; Hamilton GS, 2013, MED J AUSTRALIA, V199, pS27, DOI 10.5694/mja13.10579; Izci B, 2006, EUR RESPIR J, V27, P321, DOI 10.1183/09031936.06.00148204; JOELCOHEN SJ, 1978, EUR J OBSTET GYN R B, V8, P77, DOI 10.1016/0028-2243(78)90131-4; Kidron D, 2019, SLEEP, V42, DOI 10.1093/sleep/zsz072; Kneitel AW, 2018, J PERINATOL, V38, P982, DOI 10.1038/s41372-018-0127-6; Knuist M, 1998, INT J GYNECOL OBSTET, V61, P127, DOI 10.1016/S0020-7292(98)00024-1; Lauring JR, 2016, J MATERN-FETAL NEO M, V29, P3570, DOI 10.3109/14767058.2016.1139568; Louis J, 2012, OBSTET GYNECOL, V120, P1085, DOI 10.1097/AOG.0b013e31826eb9d8; Louis JM, 2010, AM J OBSTET GYNECOL, V202, DOI 10.1016/j.ajog.2009.10.867; LUEDER FL, 1995, METABOLISM, V44, P532, DOI 10.1016/0026-0495(95)90063-2; MacDonald TM, 2017, BMC MED, V15, DOI 10.1186/s12916-017-0928-z; Martin CB, 2008, SEMIN PERINATOL, V32, P239, DOI 10.1053/j.semperi.2008.04.003; Melamed N, 2014, J OBSTET GYNAECOL CA, V36, P642, DOI 10.1016/S1701-2163(15)30545-4; Meschia G, 2011, CLIN CHEST MED, V32, P15, DOI 10.1016/j.ccm.2010.11.007; Olivarez SA, 2010, AM J OBSTET GYNECOL, V202, DOI 10.1016/j.ajog.2009.12.008; Pamidi S, 2016, THORAX, V71, P719, DOI 10.1136/thoraxjnl-2015-208038; Pien GW, 2014, THORAX, V69, P371, DOI 10.1136/thoraxjnl-2012-202718; Randolph DA, 2014, ARCH DIS CHILD-FETAL, V99, pF263, DOI 10.1136/archdischild-2013-304179; RANZCOG, 2014, INTR FET SURV CLIN G; Ravishankar S, 2015, PEDIATR DEVEL PATHOL, V18, P380, DOI 10.2350/15-06-1647-OA.1; Reid J, 2011, CLIN EXP OBSTET GYN, V38, P123; Reutrakul S, 2013, J CLIN ENDOCR METAB, V98, P4195, DOI 10.1210/jc.2013-2348; Roush SF, 2004, J AM BOARD FAM PRACT, V17, P292, DOI 10.3122/jabfm.17.4.292; Shahar E, 2001, AM J RESP CRIT CARE, V163, P19, DOI 10.1164/ajrccm.163.1.2001008; Shen MX, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175914; SOOTHILL PW, 1995, EUR J OBSTET GYN R B, V59, P21, DOI 10.1016/0028-2243(94)02013-5; Sovio U, 2018, AM J OBSTET GYNECOL, V218, pS738, DOI 10.1016/j.ajog.2017.11.563; Telerant A, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-29052-y; Tranquilli AL, 2014, PREGNANCY HYPERTENS, V4, P97, DOI [10.1016/j.preghy.2014.02.001, 10.1016/j.preghy.2014.04.007, 10.1016/j.preghy.2014.04.017]; Warland J, 2015, BMC PREGNANCY CHILDB, V15, DOI 10.1186/s12884-015-0602-4; Wilson DL, 2018, J SLEEP RES, V27, DOI 10.1111/jsr.12656; Young T, 2011, PRINCIPLES PRACTICE, P1381	53	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2020	15	2							e0229568	10.1371/journal.pone.0229568	http://dx.doi.org/10.1371/journal.pone.0229568			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8FM	32101584	Green Published, gold			2022-12-26	WOS:000535233700042
J	Ikeda, Y; Sonoda, N; Bachuluun, B; Kimura, S; Ogawa, Y; Inoguchi, T				Ikeda, Yosuke; Sonoda, Noriyuki; Bachuluun, Battsetseg; Kimura, Shinichiro; Ogawa, Yoshihiro; Inoguchi, Toyoshi			Aberrant activation of bone marrow Ly6C (high) monocytes in diabetic mice contributes to impaired glucose tolerance	PLOS ONE			English	Article							ADIPOSE-TISSUE; INSULIN-RESISTANCE; FATTY-ACID; INFLAMMATION; OBESITY; MYELOPOIESIS; ACCUMULATION	Accumulating evidence indicates that diabetes and obesity are associated with chronic low-grade inflammation and multiple organ failure. Tissue-infiltrated inflammatory M1 macrophages are aberrantly activated in these conditions and contribute to hyperglycemia and insulin resistance. However, it is unclear at which stage these cells become aberrantly activated: as precursor monocytes in the bone marrow or as differentiated macrophages in tissues. We examined the abundance, activation state, and function of bone marrow-derived Ly6C(high) monocytes in mice with diabetes and/or obesity. Ly6C(high) monocytes were FACS-purified from six groups of male mice consisting of type 2 diabetes model db/db mice, streptozotocin (STZ) induced insulin depletion mice, high fat diet (HFD) induced obesity mice and each control mice. Ly6C(high) monocytes were then analyzed for the expression of inflammation markers by qRT-PCR. In addition, bone marrow-derived Ly6C(high) monocytes from db/+ and db/db mice were fluorescently labeled and injected into groups of db/db recipient mice. Cell trafficking to tissues and levels of markers were examined in the recipient mice. The expression of many inflammation-related genes was significantly increased in Ly6C(high) monocytes from db/db mice, compared with the control. Bone marrow-derived Ly6C(high) monocytes isolated from db/db mice, but not from db/+ mice, displayed prominent infiltration into peripheral tissues at 1 week after transfer into db/db mice. The recipients of db/db Ly6C(high) monocytes also exhibited significantly increased serum glucose levels and worsening tolerance compared with mice receiving db/+ Ly6C(high) monocytes. These novel observations suggest that activated Ly6C(high) monocytes may contribute to the glucose intolerance observed in diabetes.	[Ikeda, Yosuke; Sonoda, Noriyuki; Bachuluun, Battsetseg; Ogawa, Yoshihiro; Inoguchi, Toyoshi] Kyushu Univ, Grad Sch Med Sci, Dept Med & Bioregulatory Sci, Fukuoka, Japan; [Kimura, Shinichiro] Nagoya Univ, Res Inst Environm Med, Dept Mol Med & Metab, Nagoya, Aichi, Japan; [Ogawa, Yoshihiro] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Mol & Cellular Metab, Tokyo, Japan; [Ogawa, Yoshihiro] Japan Agcy Med Res & Dev, CREST, Tokyo, Japan; [Inoguchi, Toyoshi] Fukuoka City Hlth Promot Support Ctr, Fukuoka, Japan	Kyushu University; Nagoya University; Tokyo Medical & Dental University (TMDU); Japan Science & Technology Agency (JST)	Inoguchi, T (corresponding author), Kyushu Univ, Grad Sch Med Sci, Dept Med & Bioregulatory Sci, Fukuoka, Japan.; Inoguchi, T (corresponding author), Fukuoka City Hlth Promot Support Ctr, Fukuoka, Japan.	toyoshi@med.kyushu-u.ac.jp		Inoguchi, Toyoshi/0000-0002-7344-6199; Ogawa, Yoshihiro/0000-0002-0834-2836	Eli Lilly Japan K.K.	Eli Lilly Japan K.K.(Eli Lilly)	This work was financially supported in part by research grants from Eli Lilly Japan K.K. The funder also provided support in the form of research materials for author TI, who is employed by the commercial company Fukuoka Health Promotion Support Center. The funders did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the `author contributions' section.	Anderson EK, 2010, CURR OPIN LIPIDOL, V21, P172, DOI 10.1097/MOL.0b013e3283393867; Baggiolini M, 1998, NATURE, V392, P565, DOI 10.1038/33340; Donath MY, 2011, NAT REV IMMUNOL, V11, P98, DOI 10.1038/nri2925; Eguchi K, 2012, CELL METAB, V15, P518, DOI 10.1016/j.cmet.2012.01.023; Ikeda N, 2011, DIABETOLOGIA, V54, P2183, DOI 10.1007/s00125-011-2197-2; Inoguchi T, 2000, DIABETES, V49, P1939, DOI 10.2337/diabetes.49.11.1939; Inoguchi T, 2003, J AM SOC NEPHROL, V14, pS227, DOI 10.1097/01.ASN.0000077407.90309.65; Inoue T, 2013, BIOCHEM BIOPH RES CO, V438, P224, DOI 10.1016/j.bbrc.2013.07.063; Italiani P, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00514; Itoh M, 2011, AM J PATHOL, V179, P2454, DOI 10.1016/j.ajpath.2011.07.014; Kakimoto M, 2002, DIABETES, V51, P1588, DOI 10.2337/diabetes.51.5.1588; Kim F, 2007, CIRC RES, V100, P1589, DOI 10.1161/CIRCRESAHA.106.142851; Komiya C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151511; Nagareddy PR, 2014, CELL METAB, V19, P821, DOI 10.1016/j.cmet.2014.03.029; Nagareddy PR, 2013, CELL METAB, V17, P695, DOI 10.1016/j.cmet.2013.04.001; Obata A, 2016, ENDOCRINOLOGY, V157, P1029, DOI 10.1210/en.2015-1588; Oh DY, 2012, DIABETES, V61, P346, DOI 10.2337/db11-0860; Sekimoto R, 2015, P NATL ACAD SCI USA, V112, pE2058, DOI 10.1073/pnas.1409480112; Sell H, 2009, P NUTR SOC, V68, P378, DOI 10.1017/S0029665109990218; Suganami T, 2012, ENDOCR J, V59, P849, DOI 10.1507/endocrj.EJ12-0271; Tacke F, 2007, J CLIN INVEST, V117, P185, DOI 10.1172/JCI28549; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451; Yang MX, 2012, INFLAMMATION, V35, P388, DOI 10.1007/s10753-011-9374-9; Yokomizo H, 2014, AM J PHYSIOL-ENDOC M, V306, pE1163, DOI 10.1152/ajpendo.00688.2013	25	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2020	15	2							e0229401	10.1371/journal.pone.0229401	http://dx.doi.org/10.1371/journal.pone.0229401			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8EV	32097444	gold, Green Published			2022-12-26	WOS:000535232000028
J	Tarita-Nistor, L; Samet, S; Trope, GE; Gonzalez, EG				Tarita-Nistor, Luminita; Samet, Saba; Trope, Graham E.; Gonzalez, Esther G.			Intra- and inter-hemispheric processing during binocular rivalry in mild glaucoma	PLOS ONE			English	Article							VISUAL PATHWAY; OPTIC-NERVE; NEURODEGENERATION; STEREOACUITY; RECEPTORS; HIERARCHY; DYNAMICS; NUCLEUS; NUMBER; DEATH	Glaucoma is considered a progressive optic neuropathy because of the damage and death of the retinal ganglion cells. It is also a neurodegenerative disease because it affects neural structures in the visual system and beyond, including the corpus callosum-the largest white matter structure involved in inter-hemispheric transfer of information. In this study we probed the dysfunction of the inter-hemispheric processing in patients with mild glaucoma using the phenomenon of binocular rivalry. Patients with mild glaucoma and no measurable visual field defects and age-matched controls underwent a thorough visual assessment. Then they participated in a series of psychophysical tests designed to examine the binocular rivalry derived from intra- and inter-hemispheric processing. Static horizontal and vertical sinewave gratings were presented dichoptically using a double-mirror stereoscope in 3 locations: centrally, to probe inter-hemispheric processing, and peripherally to the left or to the right, to probe intra-hemispheric processing. Although the two groups were matched in functional measures, rivalry rate of the glaucoma group was significantly lower than that of the control group for the central location, but not for the peripheral location. These results were driven mainly by the patients with normal tension glaucoma whose average rivalry rate for the central location (from which information reaches the two hemispheres) was almost half (46% lower) that of the controls. These results indicate a dysfunction in inter-hemispheric transfer in mild glaucoma that can be detected behaviourally before any changes in standard functional measures.	[Tarita-Nistor, Luminita; Samet, Saba; Trope, Graham E.; Gonzalez, Esther G.] Toronto Western Hosp, Krembil Res Inst, Toronto, ON, Canada; [Samet, Saba] Univ Toronto, Fac Med, Toronto, ON, Canada; [Trope, Graham E.; Gonzalez, Esther G.] Univ Toronto, Ophthalmol & Vis Sci, Toronto, ON, Canada	Krembil Research Institute; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University of Toronto	Tarita-Nistor, L (corresponding author), Toronto Western Hosp, Krembil Res Inst, Toronto, ON, Canada.	lumi.tarita-nistor@rogers.com		Gonzalez, Esther/0000-0002-6190-6880	BrightFocus Foundation [G2017093]; National Glaucoma Research, a program of BrightFocus Foundation	BrightFocus Foundation(BrightFocus Foundation); National Glaucoma Research, a program of BrightFocus Foundation	This work was supported by the BrightFocus Foundation to EGG (Grant #G2017093). https://www.brightfocus.org/Acknowledgement is made to the donors of National Glaucoma Research, a program of BrightFocus Foundation, for support of this research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alais D, 1999, VISION RES, V39, P4341, DOI 10.1016/S0042-6989(99)00146-7; Amador-Campos JA, 2015, J ATTEN DISORD, V19, P1064, DOI 10.1177/1087054713482686; Berlucchi G, 2014, CORTEX, V56, P1, DOI 10.1016/j.cortex.2013.02.001; BLAKE R, 1992, VISUAL NEUROSCI, V8, P469, DOI 10.1017/S0952523800004971; BLAKE R, 1985, PERCEPT PSYCHOPHYS, V37, P114, DOI 10.3758/BF03202845; Blake R, 2011, VISION RES, V51, P754, DOI 10.1016/j.visres.2010.10.009; Boucard CC, 2016, OPHTHAL PHYSL OPT, V36, P344, DOI 10.1111/opo.12297; Chen WW, 2013, INVEST OPHTH VIS SCI, V54, P545, DOI 10.1167/iovs.12-9893; Colenbrander August, 2018, Vision (Basel), V2, DOI 10.3390/vision2010004; El-Rafei A, 2013, MAGN RESON IMAGING, V31, P1081, DOI 10.1016/j.mri.2013.01.001; Garaci FG, 2009, RADIOLOGY, V252, P496, DOI 10.1148/radiol.2522081240; Gong JL, 2018, MOL VIS, V24, P574; Gupta N, 2006, BRIT J OPHTHALMOL, V90, P979, DOI 10.1136/bjo.2006.091025; Gupta N, 2006, BRIT J OPHTHALMOL, V90, P674, DOI 10.1136/bjo.2005.086769; Gupta N, 2007, CURR OPIN OPHTHALMOL, V18, P110, DOI 10.1097/ICU.0b013e3280895aea; HALPERN DL, 1987, AM J OPTOM PHYS OPT, V64, P41; Hernowo AT, 2011, INVEST OPHTH VIS SCI, V52, P2758, DOI 10.1167/iovs.10-5682; Jia T, 2015, PHYSIOL BEHAV, V151, P272, DOI 10.1016/j.physbeh.2015.08.007; Kerrigan-Baumrind LA, 2000, INVEST OPHTH VIS SCI, V41, P741; Lakshmanan Y, 2013, OPHTHAL PHYSL OPT, V33, P172, DOI 10.1111/opo.12021; Lee SH, 2007, NAT NEUROSCI, V10, P1048, DOI 10.1038/nn1939; Lee SH, 1999, VISION RES, V39, P1447, DOI 10.1016/S0042-6989(98)00269-7; Lewerenz J, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00469; Miller SM, 2000, CURR BIOL, V10, P383, DOI 10.1016/S0960-9822(00)00416-4; Miller SM, 2003, PSYCHOL MED, V33, P683, DOI 10.1017/S0033291703007475; Moreno MC, 2008, NEUROCHEM INT, V52, P675, DOI 10.1016/j.neuint.2007.08.014; Murphy MC, 2016, SCI REP-UK, V6, DOI 10.1038/srep31464; Nguyen D, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.117; Nuzzi R, 2018, FRONT NEUROSCI-SWITZ, V12, DOI 10.3389/fnins.2018.00363; O'Shea RP, 2005, VISION RES, V45, P247, DOI 10.1016/j.visres.2004.08.009; O'Shea RP, 2003, J VISION, V3, P610, DOI 10.1167/3.10.3; Okumichi H, 2008, EXP EYE RES, V86, P727, DOI 10.1016/j.exer.2008.01.019; Pettigrew JD, 1998, P ROY SOC B-BIOL SCI, V265, P2141, DOI 10.1098/rspb.1998.0551; Quigley HA, 2006, BRIT J OPHTHALMOL, V90, P262, DOI 10.1136/bjo.2005.081224; Quigley HA, 1999, PROG RETIN EYE RES, V18, P39, DOI 10.1016/S1350-9462(98)00014-7; Ritchie KL, 2013, VISION RES, V91, P102, DOI 10.1016/j.visres.2013.08.004; Robertson CE, 2016, CURR BIOL, V26, P80, DOI 10.1016/j.cub.2015.11.019; Robertson CE, 2013, J NEUROSCI, V 33, P16983, DOI 10.1523/JNEUROSCI.0448-13.2013; Tong F, 2006, TRENDS COGN SCI, V10, P502, DOI 10.1016/j.tics.2006.09.003; van Loon AM, 2013, CURR BIOL, V23, P823, DOI 10.1016/j.cub.2013.03.067; Werner P, 2001, ANN NEUROL, V50, P169, DOI 10.1002/ana.1077; Williams AL, 2013, INVEST OPHTH VIS SCI, V54, P5880, DOI 10.1167/iovs.13-11776; Wilson HR, 2003, P NATL ACAD SCI USA, V100, P14499, DOI 10.1073/pnas.2333622100; Wilson HR, 2001, NATURE, V412, P907, DOI 10.1038/35091066; Xiao GX, 2018, FRONT NEUROSCI-SWITZ, V12, DOI 10.3389/fnins.2018.00634; Zhang YQ, 2012, ACTA OPHTHALMOL, V90, pE295, DOI 10.1111/j.1755-3768.2011.02346.x	46	2	2	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2020	15	2							e0229168	10.1371/journal.pone.0229168	http://dx.doi.org/10.1371/journal.pone.0229168			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8EV	32097443	Green Published, gold			2022-12-26	WOS:000535232000020
J	Moilanen, A; Ruddock, LW				Moilanen, Antti; Ruddock, Lloyd W.			Non-native proteins inhibit the ER oxidoreductin 1 (Ero1)?protein disulfide-isomerase relay when protein folding capacity is exceeded	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						disulfide; unfolded protein response (UPR); protein disulfide-isomerase; protein misfolding; endoplasmic-reticulum-associated protein degradation (ERAD); ER oxidoreductin (Ero1); feedback inhibition; hyperoxidation; oxidative folding; regulation	DEGRADATION; ERO1-ALPHA; REDUCTASE; DOMAINS; PATHWAY; BINDING; PDI	Protein maturation in the endoplasmic reticulum (ER) depends on a fine balance between oxidative protein folding and quality control mechanisms, which together ensure high-capacity export of properly folded proteins from the ER. Oxidative protein folding needs to be regulated to avoid hyperoxidation. The folding capacity of the ER is regulated by the unfolded protein response (UPR) and ER-associated degradation (ERAD). The UPR is triggered by unfolded protein stress and leads to up-regulation of cellular components such as chaperones and folding catalysts. These components relieve stress by increasing folding capacity and up-regulating ERAD components that remove non-native proteins. Although oxidative protein folding and the UPR/ERAD pathways each are well-understood, very little is known about any direct cross-talk between them. In this study, we carried out comprehensivein vitroactivity and binding assays, indicating that the oxidative protein folding relay formed by ER oxidoreductin 1 (Ero1), and protein disulfide-isomerase can be inactivated by a feedback inhibition mechanism involving unfolded proteins and folding intermediates when their levels exceed the folding capacity of the system. This mechanism allows client proteins to remain mainly in the reduced state and thereby minimizes potential futile oxidation?reduction cycles and may also enhance ERAD, which requires reduced protein substrates. Relief from excess levels of non-native proteins by increasing the levels of folding factors removed the feedback inhibition. These results reveal regulatory cross-talk between the oxidative protein folding and UPR and ERAD pathways.	[Moilanen, Antti; Ruddock, Lloyd W.] Univ Oulu, Fac Biochem & Mol Med, Aapistie 7, Oulu 90220, Finland	University of Oulu	Ruddock, LW (corresponding author), Univ Oulu, Fac Biochem & Mol Med, Aapistie 7, Oulu 90220, Finland.	lloyd.ruddock@oulu.fi		Moilanen, Antti/0000-0002-7199-3068; Ruddock, Lloyd/0000-0002-6247-686X	Academy of Finland [272573]; Biocenter Oulu	Academy of Finland(Academy of Finland); Biocenter Oulu	This work was supported by Academy of Finland Grant 272573 and by Biocenter Oulu. A patent for the production system used to make the protein for structural studies using sulfhydryl oxidases in the cytoplasm of E. coli is held by the University of Oulu:Methodforproducingnativelyfolded proteins inaprokaryotic host (Patent 9238817, January 19, 2016, inventor L. W. Ruddock).	Alanen HI, 2003, J BIOL CHEM, V278, P28912, DOI 10.1074/jbc.M304598200; Appenzeller-Herzog C, 2008, EMBO J, V27, P2977, DOI 10.1038/emboj.2008.202; Appenzeller-Herzog C, 2008, ANTIOXID REDOX SIGN, V10, P55, DOI 10.1089/ars.2007.1837; Appenzeller-Herzog C, 2010, EMBO J, V29, P3318, DOI 10.1038/emboj.2010.203; Baker KM, 2008, EMBO J, V27, P2988, DOI 10.1038/emboj.2008.230; Byrne LJ, 2009, BIOCHEM J, V423, P209, DOI 10.1042/BJ20090565; Cabibbo A, 2000, J BIOL CHEM, V275, P4827, DOI 10.1074/jbc.275.7.4827; Ellgaard L, 2018, TRENDS BIOCHEM SCI, V43, P32, DOI 10.1016/j.tibs.2017.10.006; Fu XM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027185; Gaciarz A, 2017, MICROB CELL FACT, V16, DOI 10.1186/s12934-017-0721-x; Geoghegan KF, 1999, ANAL BIOCHEM, V267, P169, DOI 10.1006/abio.1998.2990; Guo PC, 2012, J BIOL CHEM, V287, P34961, DOI 10.1074/jbc.M112.394759; Hansen RE, 2009, P NATL ACAD SCI USA, V106, P422, DOI 10.1073/pnas.0812149106; Hatahet F, 2009, ANTIOXID REDOX SIGN, V11, P2807, DOI [10.1089/ars.2009.2466, 10.1089/ARS.2009.2466]; He KY, 2015, MOL BIOL CELL, V26, P3413, DOI 10.1091/mbc.E15-01-0034; Hetz C, 2018, MOL CELL, V69, P169, DOI 10.1016/j.molcel.2017.06.017; HILLSON DA, 1984, METHOD ENZYMOL, V107, P281; Hiroi T, 2006, ENDOCRINOLOGY, V147, P2773, DOI 10.1210/en.2005-1235; Karala AR, 2007, ANTIOXID REDOX SIGN, V9, P527, DOI 10.1089/ars.2006.1473; Kim S, 2012, J CELL BIOL, V196, P713, DOI 10.1083/jcb.201110090; Klappa P, 1998, EMBO J, V17, P927, DOI 10.1093/emboj/17.4.927; LYLES MM, 1991, BIOCHEMISTRY-US, V30, P613, DOI 10.1021/bi00217a004; Masui S, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M111.231357; Moilanen A, 2018, LIFE SCI ALLIANCE, V1, DOI 10.26508/lsa.201800090; Molinari M, 2002, J CELL BIOL, V158, P247, DOI 10.1083/jcb.200204122; Nguyen VD, 2011, MICROB CELL FACT, V10, DOI 10.1186/1475-2859-10-1; Okumura M, 2014, J BIOL CHEM, V289, P27004, DOI 10.1074/jbc.M114.564104; Pagani M, 2000, J BIOL CHEM, V275, P23685, DOI 10.1074/jbc.M003061200; Smith MH, 2011, SCIENCE, V334, P1086, DOI 10.1126/science.1209235; TSIBRIS JCM, 1989, J BIOL CHEM, V264, P13967; Ushioda R, 2008, SCIENCE, V321, P569, DOI 10.1126/science.1159293; Walter P, 2011, SCIENCE, V334, P1081, DOI 10.1126/science.1209038; Wang L, 2009, J BIOL CHEM, V284, P199, DOI 10.1074/jbc.M806645200; WEISSMAN JS, 1991, SCIENCE, V253, P1386, DOI 10.1126/science.1716783	34	8	8	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 26	2020	295	26					8647	8655		10.1074/jbc.RA119.011766	http://dx.doi.org/10.1074/jbc.RA119.011766			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MG8QK	32102847	Green Published, hybrid			2022-12-26	WOS:000546296800002
J	Muha, V; Fenckova, M; Ferenbach, AT; Catinozzi, M; Eidhof, I; Storkebaum, E; Schenck, A; van Aalten, DMF				Muha, Villo; Fenckova, Michaela; Ferenbach, Andrew T.; Catinozzi, Marica; Eidhof, Ilse; Storkebaum, Erik; Schenck, Annette; van Aalten, Daan M. F.			O-GlcNAcase contributes to cognitive function inDrosophila	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Drosophila; O-GlcNAcylation; neuroscience; O-linked N-acetylglucosamine (O-GlcNAc); synapse; habituation; learning; NMJ; O-GlcNAcase	BETA-N-ACETYLGLUCOSAMINE; INTELLECTUAL DISABILITY; MISSENSE MUTATION; GLCNACYLATION; GLYCOSYLATION; TRANSFERASE; IDENTIFICATION; NEURONS; GENE; OGT	O-GlcNAcylation is an abundant post-translational modification in neurons. In mice, an increase inO-GlcNAcylation leads to defects in hippocampal synaptic plasticity and learning.O-GlcNAcylation is established by two opposing enzymes:O-GlcNAc transferase (OGT) andO-GlcNAcase (OGA). To investigate the role of OGA in elementary learning, we generated catalytically inactive and precise knockoutOgaalleles (Oga(D133N)andOga(KO), respectively) inDrosophila melanogaster. AdultOga(D133N)andOga(KO)flies lackingO-GlcNAcase activity showed locomotor phenotypes. Importantly, bothOgalines exhibited deficits in habituation, an evolutionarily conserved form of learning, highlighting that the requirement forO-GlcNAcase activity for cognitive function is preserved across species. Loss ofO-GlcNAcase affected a number of synaptic boutons at the axon terminals of larval neuromuscular junction. Taken together, we report behavioral and neurodevelopmental phenotypes associated withOgaalleles and show that Oga contributes to cognition and synaptic morphology inDrosophila.	[Muha, Villo; Fenckova, Michaela; Ferenbach, Andrew T.; van Aalten, Daan M. F.] Univ Dundee, Sch Life Sci, Gene Regulat & Express, Dundee DD1 5EH, Scotland; [Fenckova, Michaela; Eidhof, Ilse; Schenck, Annette] Radboud Univ Nijmegen, Med Ctr, Donders Inst Brain Cognit & Behav, Dept Human Genet, NL-6525 GA Nijmegen, Netherlands; [Catinozzi, Marica; Storkebaum, Erik] Radboud Univ Nijmegen, Donders Inst Brain Cognit & Behav, Dept Mol Neurobiol, NL-6525 XZ Nijmegen, Netherlands; [Catinozzi, Marica; Storkebaum, Erik] Radboud Univ Nijmegen, Fac Sci, NL-6525 XZ Nijmegen, Netherlands	University of Dundee; Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen	van Aalten, DMF (corresponding author), Univ Dundee, Sch Life Sci, Gene Regulat & Express, Dundee DD1 5EH, Scotland.	dmfvanaalten@dundee.ac.uk	Storkebaum, Erik/B-5389-2017; Fenckova, Michaela/AGY-9276-2022; Schenck, Annette/E-4514-2012; Fenckova, Michaela/H-8622-2017	Storkebaum, Erik/0000-0002-9519-5642; Fenckova, Michaela/0000-0002-5716-1652; Schenck, Annette/0000-0002-6918-3314; Fenckova, Michaela/0000-0002-5716-1652; Catinozzi, Marica/0000-0002-9211-9951; Muha, Villo/0000-0003-4156-8463; van Aalten, Daan/0000-0002-1499-6908	Netherlands Organisation for Scientific Research [912-12-109]; Wellcome Trust Senior Research Fellowship [WT087590MA]; Donders Center for Neuroscience; Muscular Dystrophy Association; European Union Joint Programme-Neurodegenerative Disease Research Grants [ZonMW 733051075, ZonMW733051073]; European Research Council Consolidator Grant [ERC-2017-COG 770244]	Netherlands Organisation for Scientific Research(Netherlands Organization for Scientific Research (NWO)); Wellcome Trust Senior Research Fellowship(Wellcome Trust); Donders Center for Neuroscience; Muscular Dystrophy Association(Muscular Dystrophy Association); European Union Joint Programme-Neurodegenerative Disease Research Grants; European Research Council Consolidator Grant(European Research Council (ERC))	This work was supported in part by TOP Grant 912-12-109 from the Netherlands Organisation for Scientific Research (to A. S.) and by Wellcome Trust Senior Research Fellowship WT087590MA (to D. M. F. v. A.). This work was also supported by funds from the Donders Center for Neuroscience (to E. S.) and the Muscular Dystrophy Association (to E. S.), European Union Joint Programme-Neurodegenerative Disease Research Grants ZonMW 733051075 (TransNeuro) and ZonMW733051073 (LocalNMD) (to E. S.), and European Research Council Consolidator Grant ERC-2017-COG 770244 (to E. S.). The authors declare that they have no conflicts of interest with the contents of this article.	Akan I, 2016, J BIOL CHEM, V291, P9906, DOI 10.1074/jbc.M115.704783; Andres LM, 2017, ACS CHEM BIOL, V12, P2030, DOI 10.1021/acschembio.7b00232; Arnold CS, 1996, J BIOL CHEM, V271, P28741, DOI 10.1074/jbc.271.46.28741; Bouazzi H, 2015, CLIN CASE REP, V3, P604, DOI 10.1002/ccr3.301; Brent Jonathan, 2009, J Vis Exp, DOI 10.3791/1108; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Castells-Nobau A, 2017, JOVE-J VIS EXP, DOI 10.3791/55395; Cetinbas N, 2006, BIOCHEMISTRY-US, V45, P3835, DOI 10.1021/bi052370b; Chiu Joanna C, 2010, J Vis Exp, DOI 10.3791/2157; Chu CS, 2014, P NATL ACAD SCI USA, V111, P1355, DOI 10.1073/pnas.1323226111; Cole RN, 2001, J NEUROCHEM, V79, P1080, DOI 10.1046/j.1471-4159.2001.00655.x; Constable S, 2017, GLYCOBIOLOGY, V27, P927, DOI 10.1093/glycob/cwx055; Dennis RJ, 2006, NAT STRUCT MOL BIOL, V13, P365, DOI 10.1038/nsmb1079; Deplus R, 2013, EMBO J, V32, P645, DOI 10.1038/emboj.2012.357; Donelson N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037250; Eidhof I, 2018, BRAIN, V141, P2592, DOI 10.1093/brain/awy198; Eidhof I, 2017, JOVE-J VIS EXP, DOI 10.3791/55892; Fenckova M, 2019, BIOL PSYCHIAT, V86, P294, DOI 10.1016/j.biopsych.2019.04.029; Forsythe ME, 2006, P NATL ACAD SCI USA, V103, P11952, DOI 10.1073/pnas.0601931103; Francisco H, 2009, DEV NEUROBIOL, V69, P162, DOI 10.1002/dneu.20695; Gambetta MC, 2014, DEV CELL, V31, P629, DOI 10.1016/j.devcel.2014.10.020; Hart GW, 2007, NATURE, V446, P1017, DOI 10.1038/nature05815; Hwang H, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-43017-9; Jang H, 2012, CELL STEM CELL, V11, P62, DOI 10.1016/j.stem.2012.03.001; Keembiyehetty C, 2015, J BIOL CHEM, V290, P7097, DOI 10.1074/jbc.M114.617779; Kochinke K, 2016, AM J HUM GENET, V98, P149, DOI 10.1016/j.ajhg.2015.11.024; Kramer JM, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000569; Lagerlof O, 2016, SCIENCE, V351, P1293, DOI 10.1126/science.aad5494; Lagerlof O, 2017, P NATL ACAD SCI USA, V114, P1684, DOI 10.1073/pnas.1621367114; Lamarre-Vincent N, 2003, J AM CHEM SOC, V125, P6612, DOI 10.1021/ja028200t; Mallik M, 2018, J CELL BIOL, V217, P3947, DOI 10.1083/jcb.201802151; Mariappa D, 2018, J BIOL CHEM, V293, P7209, DOI 10.1074/jbc.RA118.002580; Mariappa D, 2015, BIOCHEM J, V470, P255, DOI 10.1042/BJ20150610; McDiarmid TA, 2017, NEUROSCI BIOBEHAV R, V80, P286, DOI 10.1016/j.neubiorev.2017.05.028; Menon KP, 2013, WIRES DEV BIOL, V2, P647, DOI 10.1002/wdev.108; Na JB, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003175; Niehues S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8520; Nijhof B, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1004823; O'Donnell N, 2004, MOL CELL BIOL, V24, P1680, DOI 10.1128/MCB.24.4.1680-1690.2004; Olivier-Van Stichelen S, 2017, J BIOL CHEM, V292, P6076, DOI 10.1074/jbc.M116.774042; Park S, 2011, CELL MOL LIFE SCI, V68, P3377, DOI 10.1007/s00018-011-0640-7; Peng CM, 2017, MOL CELL, V68, P591, DOI 10.1016/j.molcel.2017.10.010; Port F, 2014, P NATL ACAD SCI USA, V111, pE2967, DOI 10.1073/pnas.1405500111; Pravata VM, 2020, FEBS LETT, V594, P717, DOI 10.1002/1873-3468.13640; Pravata VM, 2019, P NATL ACAD SCI USA, V116, P14961, DOI 10.1073/pnas.1900065116; Radermacher PT, 2014, P NATL ACAD SCI USA, V111, P5592, DOI 10.1073/pnas.1322396111; Ranuncolo SM, 2012, J BIOL CHEM, V287, P23549, DOI 10.1074/jbc.M111.330910; Rao FV, 2013, OPEN BIOL, V3, DOI 10.1098/rsob.130021; Rao FV, 2006, EMBO J, V25, P1569, DOI 10.1038/sj.emboj.7601026; RC Team, 2008, R LANG ENV STAT COMP; Restivo L, 2005, P NATL ACAD SCI USA, V102, P11557, DOI 10.1073/pnas.0504984102; Rexach JE, 2012, NAT CHEM BIOL, V8, P253, DOI [10.1038/NCHEMBIO.770, 10.1038/nchembio.770]; Rigoulot S, 2017, INT J DEV NEUROSCI, V59, P52, DOI 10.1016/j.ijdevneu.2017.03.008; Savage JE, 2018, NAT GENET, V50, P912, DOI 10.1038/s41588-018-0152-6; Schimpl M, 2012, CHEM BIOL, V19, P173, DOI 10.1016/j.chembiol.2012.01.011; Schimpl M, 2010, BIOCHEM J, V432, P1, DOI 10.1042/BJ20101338; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Schmidt I, 2012, J NEUROSCI, V32, P7466, DOI 10.1523/JNEUROSCI.0349-12.2012; Sekine O, 2010, J BIOL CHEM, V285, P38684, DOI 10.1074/jbc.M110.155192; Selvan N, 2018, J BIOL CHEM, V293, P10810, DOI 10.1074/jbc.RA118.002583; Selvan N, 2017, NAT CHEM BIOL, V13, P882, DOI 10.1038/nchembio.2404; Skorobogatko Y, 2014, J BIOL CHEM, V289, P3602, DOI 10.1074/jbc.M113.512814; Taylor EW, 2014, J NEUROSCI, V34, P10, DOI 10.1523/JNEUROSCI.4761-12.2014; Trinidad JC, 2012, MOL CELL PROTEOMICS, V11, P215, DOI 10.1074/mcp.O112.018366; Vaidyanathan K, 2017, J BIOL CHEM, V292, P8948, DOI 10.1074/jbc.M116.771030; van Bon BWM, 2013, HUM MOL GENET, V22, P3138, DOI 10.1093/hmg/ddt170; Vosseller K, 2006, MOL CELL PROTEOMICS, V5, P923, DOI 10.1074/mcp.T500040-MCP200; Wang AC, 2016, P NATL ACAD SCI USA, V113, P15120, DOI 10.1073/pnas.1606899113; Willems AP, 2017, J BIOL CHEM, V292, P12621, DOI 10.1074/jbc.M117.790097; Willemsen MH, 2013, J MED GENET, V50, P507, DOI 10.1136/jmedgenet-2012-101490; Wolman MA, 2014, CELL REP, V8, P1265, DOI 10.1016/j.celrep.2014.07.054; Yang YR, 2017, SCI REP-UK, V7, DOI 10.1038/srep44921; Yang YR, 2012, AGING CELL, V11, P439, DOI 10.1111/j.1474-9726.2012.00801.x; Zhu YP, 2015, NAT CHEM BIOL, V11, P319, DOI [10.1038/NCHEMBIO.1774, 10.1038/nchembio.1774]	74	7	8	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 26	2020	295	26					8636	8646		10.1074/jbc.RA119.010312	http://dx.doi.org/10.1074/jbc.RA119.010312			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MG8QK	32094227	Green Published, hybrid			2022-12-26	WOS:000546296800001
J	Scaletti, ER; Vallin, KS; Brautigam, L; Sarno, A; Berglund, UW; Helleday, T; Stenmark, P; Jemth, AS				Scaletti, Emma Rose; Vallin, Karl S.; Brautigam, Lars; Sarno, Antonio; Berglund, Ulrika Warpman; Helleday, Thomas; Stenmark, Pal; Jemth, Ann-Sofie			MutT homologue 1 (MTH1) removes N6-methyl-dATP from the dNTP pool	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						crystal structure; X-ray crystallography; enzyme catalysis; substrate specificity; enzyme kinetics; nucleoside; nucleotide metabolism; hydrolase; epigenetics; methylation; MutT homologue 1 (MTH1); N6-methyl-dATP; nucleotide hydrolysis; Nudix hydrolase 1 (NUDT1)	PROTEIN HYDROLYZES; DNA METHYLATION; OXIDIZED FORMS; N-6-METHYLADENINE; N-6-ADENINE; EXPRESSION; INHIBITORS; DEAMINASE; CLONING; REVEAL	MutT homologue 1 (MTH1) removes oxidized nucleotides from the nucleotide pool and thereby prevents their incorporation into the genome and thereby reduces genotoxicity. We previously reported that MTH1 is an efficient catalyst of O6-methyl-dGTP hydrolysis suggesting that MTH1 may also sanitize the nucleotide pool from other methylated nucleotides. We here show that MTH1 efficiently catalyzes the hydrolysis of N6-methyl-dATP to N6-methyl-dAMP and further report that N6-methylation of dATP drastically increases the MTH1 activity. We also observed MTH1 activity with N6-methyl-ATP, albeit at a lower level. We show that N6-methyl-dATP is incorporated into DNA in vivo, as indicated by increased N6-methyl-dA DNA levels in embryos developed from MTH1 knock-out zebrafish eggs microinjected with N6-methyl-dATP compared with noninjected embryos. N6-methyl-dATP activity is present in MTH1 homologues from distantly related vertebrates, suggesting evolutionary conservation and indicating that this activity is important. Of note, N6-methyl-dATP activity is unique to MTH1 among related NUDIX hydrolases. Moreover, we present the structure of N6-methyl-dAMP?bound human MTH1, revealing that the N6-methyl group is accommodated within a hydrophobic active-site subpocket explaining why N6-methyl-dATP is a good MTH1 substrate. N6-methylation of DNA and RNA has been reported to have epigenetic roles and to affect mRNA metabolism. We propose that MTH1 acts in concert with adenosine deaminase-like protein isoform 1 (ADAL1) to prevent incorporation of N6-methyl-(d)ATP into DNA and RNA. This would hinder potential dysregulation of epigenetic control and RNA metabolism via conversion of N6-methyl-(d)ATP to N6-methyl-(d)AMP, followed by ADAL1-catalyzed deamination producing (d)IMP that can enter the nucleotide salvage pathway.	[Scaletti, Emma Rose; Stenmark, Pal] Stockholm Univ, Dept Biochem & Biophys, S-10691 Stockholm, Sweden; [Vallin, Karl S.; Brautigam, Lars; Berglund, Ulrika Warpman; Helleday, Thomas; Jemth, Ann-Sofie] Karolinska Inst, Dept Oncol Pathol, Sci Life Lab, S-17176 Stockholm, Sweden; [Sarno, Antonio] Norwegian Univ Sci & Technol, Dept Clin & Mol Med, N-7491 Trondheim, Norway; [Sarno, Antonio] St Olavs Hosp, Dept Pathol, N-7006 Trondheim, Norway; [Helleday, Thomas] Univ Sheffield, Dept Oncol & Metab, Weston Pk Canc Ctr, Sheffield S10 2RX, S Yorkshire, England; [Scaletti, Emma Rose; Stenmark, Pal] Lund Univ, Dept Expt Med Sci, S-22100 Lund, Sweden	Stockholm University; Karolinska Institutet; Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); University of Sheffield; Lund University	Stenmark, P (corresponding author), Stockholm Univ, Dept Biochem & Biophys, S-10691 Stockholm, Sweden.; Jemth, AS (corresponding author), Karolinska Inst, Dept Oncol Pathol, Sci Life Lab, S-17176 Stockholm, Sweden.; Stenmark, P (corresponding author), Lund Univ, Dept Expt Med Sci, S-22100 Lund, Sweden.	stenmark@dbb.su.se; annsofie.jemth@scilifelab.se		Scaletti, Emma Rose/0000-0002-8741-8981; Stenmark, Pal/0000-0003-4777-3417; Jemth, Ann-Sofie/0000-0002-7550-1833; Sarno, Antonio/0000-0002-9308-8018	Swedish Research Council [2015-00162, 2018-03406]; Knut and Alice Wallenberg Foundation NOCA; Swedish Foundation for Strategic Research [RB13-0224]; European Research Council (ERC) [TAROX-695376]; Swedish Children's Cancer Foundation [PR2018-0095]; Swedish Cancer Society [CAN 2018/0658, CAN 2017/716]; Central Norway Regional Health Authority [46056921]; Svanhild and Arne Must's Fund for Medical Research; ERC Grant [TAROX-695376]	Swedish Research Council(Swedish Research CouncilEuropean Commission); Knut and Alice Wallenberg Foundation NOCA(Knut & Alice Wallenberg Foundation); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); European Research Council (ERC)(European Research Council (ERC)European Commission); Swedish Children's Cancer Foundation; Swedish Cancer Society(Swedish Cancer Society); Central Norway Regional Health Authority; Svanhild and Arne Must's Fund for Medical Research; ERC Grant	This work was supported by Swedish Research Council Grants 2015-00162 (to T. H.) and 2018-03406 (to P. S.), a grant from Knut and Alice Wallenberg Foundation NOCA (to P. S.), Swedish Foundation for Strategic Research Grant RB13-0224 (to U. W. B.), European Research Council (ERC) Grant TAROX-695376 (to T. H.), Swedish Children's Cancer Foundation Grant PR2018-0095 (to T. H.), Swedish Cancer Society Grants CAN 2018/0658 (to T. H.) and CAN 2017/716 (to P. S.), Central Norway Regional Health Authority Grant 46056921 (to A. S.), Svanhild and Arne Must's Fund for Medical Research (to A.S.), and ERC Grant TAROX-695376 for open access funding. The authors declare that they have no conflicts of interest with the contents of this article.	BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Balacco DL, 2019, BIOCHEMISTRY-US, V58, P363, DOI 10.1021/acs.biochem.8b01166; BAYKOV AA, 1988, ANAL BIOCHEM, V171, P266, DOI 10.1016/0003-2697(88)90484-8; Berglund UW, 2016, ANN ONCOL, V27, P2275, DOI 10.1093/annonc/mdw429; Brautigam L, 2016, CANCER RES, V76, P2366, DOI 10.1158/0008-5472.CAN-15-2380; Brautigham, 2019, MTH1 PROMOTES MITOTI, P10, DOI [10.1101/575290, DOI 10.1101/575290]; Carreras-Puigvert J, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01642-w; Carter M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8871; Casadesus J, 2013, J BIOL CHEM, V288, P13929, DOI 10.1074/jbc.R113.472274; Chen MJ, 2018, PLANT CELL, V30, P1511, DOI 10.1105/tpc.18.00236; Choi JS, 2016, NUCLEIC ACIDS RES, V44, P1022, DOI 10.1093/nar/gkv1509; Chojnacki S, 2017, NUCLEIC ACIDS RES, V45, pW550, DOI 10.1093/nar/gkx273; De Luca G, 2013, AGING CELL, V12, P695, DOI 10.1111/acel.12094; Eid J, 2009, SCIENCE, V323, P133, DOI 10.1126/science.1162986; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Fujikawa K, 1999, J BIOL CHEM, V274, P18201, DOI 10.1074/jbc.274.26.18201; Fujikawa K, 2001, NUCLEIC ACIDS RES, V29, P449, DOI 10.1093/nar/29.2.449; Gad H, 2014, NATURE, V508, P215, DOI 10.1038/nature13181; Gasmi L, 1999, BIOCHEM J, V344, P331, DOI 10.1042/0264-6021:3440331; Greer EL, 2015, CELL, V161, P868, DOI 10.1016/j.cell.2015.04.005; Hashiguchi K, 2018, MUTAT RES-FUND MOL M, V808, P10, DOI 10.1016/j.mrfmmm.2018.01.002; Heyen CA, 2009, BIOCHEM BIOPH RES CO, V390, P1414, DOI 10.1016/j.bbrc.2009.11.007; Heyn H, 2015, CELL, V161, P710, DOI 10.1016/j.cell.2015.04.021; Jemth AS, 2019, BIOCHEMISTRY-US, V58, P887, DOI 10.1021/acs.biochem.8b00950; Jemth AS, 2018, NUCLEIC ACIDS RES, V46, P10888, DOI 10.1093/nar/gky896; Kettle JG, 2016, J MED CHEM, V59, P2346, DOI 10.1021/acs.jmedchem.5b01760; Kigar SL, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-18414-7; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Kumar S, 2018, FRONT GENET, V9, DOI 10.3389/fgene.2018.00640; Lan Q, 2019, CANCER RES, V79, P1285, DOI 10.1158/0008-5472.CAN-18-2965; Luo GZ, 2015, NAT REV MOL CELL BIO, V16, P705, DOI 10.1038/nrm4076; Maity A, 2016, FEBS J, V283, P1607, DOI 10.1111/febs.13614; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McLennan AG, 2006, CELL MOL LIFE SCI, V63, P123, DOI 10.1007/s00018-005-5386-7; Meyer KD, 2014, NAT REV MOL CELL BIO, V15, P313, DOI 10.1038/nrm3785; Murakami E, 2011, J MED CHEM, V54, P5902, DOI 10.1021/jm200650j; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nakabeppu Y, 2001, MUTAT RES-FUND MOL M, V477, P59, DOI 10.1016/S0027-5107(01)00096-3; Narwal M, 2018, BIOCHEMISTRY-US, V57, P593, DOI 10.1021/acs.biochem.7b01163; Pacini CE, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-41601-7; Parkhurst JM, 2016, J APPL CRYSTALLOGR, V49, P1912, DOI 10.1107/S1600576716013595; Postlethwait JH, 2007, J EXP ZOOL PART B, V308B, P563, DOI 10.1002/jez.b.21137; Schiffers S, 2017, ANGEW CHEM INT EDIT, V56, P11268, DOI 10.1002/anie.201700424; Schinkmanova M, 2006, BIOCHEM PHARMACOL, V71, P1370, DOI 10.1016/j.bcp.2006.01.013; Svensson LM, 2011, FEBS LETT, V585, P2617, DOI 10.1016/j.febslet.2011.07.017; Takagi Y, 2012, J BIOL CHEM, V287, P21541, DOI 10.1074/jbc.M112.363010; TRAUT TW, 1994, MOL CELL BIOCHEM, V140, P1, DOI 10.1007/BF00928361; Tsuzuki T, 2001, P NATL ACAD SCI USA, V98, P11456, DOI 10.1073/pnas.191086798; Waz S, 2017, J BIOL CHEM, V292, P2785, DOI 10.1074/jbc.M116.749713; Winter G, 2010, J APPL CRYSTALLOGR, V43, P186, DOI 10.1107/S0021889809045701; Wion D, 2006, NAT REV MICROBIOL, V4, P183, DOI 10.1038/nrmicro1350; Wu TP, 2016, NATURE, V532, P329, DOI 10.1038/nature17640; Wu X, 2018, AM J CANCER RES, V8, P1957; Wu YS, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06898-4; Xiao CL, 2018, MOL CELL, V71, P306, DOI 10.1016/j.molcel.2018.06.015; Xie Q, 2018, CELL, V175, P1228, DOI 10.1016/j.cell.2018.10.006; Xu P, 2003, J BIOL CHEM, V278, P48422, DOI 10.1074/jbc.M307888200; Yang HJ, 2000, J BIOL CHEM, V275, P8844, DOI 10.1074/jbc.275.12.8844; Yao B, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01195-y; Zhang GQ, 2015, CELL, V161, P893, DOI 10.1016/j.cell.2015.04.018	61	6	8	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 10	2020	295	15					4761	4772		10.1074/jbc.RA120.012636	http://dx.doi.org/10.1074/jbc.RA120.012636			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LE7FC	32144205	Green Published, Green Accepted, hybrid			2022-12-26	WOS:000526887000001
J	Tam, TH; Chan, KL; Boroumand, P; Liu, Z; Brozinick, JT; Bui, HH; Roth, K; Wakefield, CB; Penuela, S; Bilan, PJ; Klip, A				Tam, Theresa H.; Chan, Kenny L.; Boroumand, Parastoo; Liu, Zhi; Brozinick, Joseph T.; Bui, Hai Hoang; Roth, Kenneth; Wakefield, C. Brent; Penuela, Silvia; Bilan, Philip J.; Klip, Amira			Nucleotides released from palmitate-activated murine macrophages attract neutrophils	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						fatty acid; nucleotide; chemotaxis; macrophage; neutrophil; inflammation; obesity; high fat diet; metabolic disorder; pannexin-1	FIND-ME SIGNAL; ATP RELEASE; INNATE IMMUNITY; PANNEXIN 1; TNF-ALPHA; INFLAMMATION; OBESITY; CHANNELS; RECRUITMENT; PYROPTOSIS	Obesity and elevation of circulating free fatty acids are associated with an accumulation and proinflammatory polarization of macrophages within metabolically active tissues, such as adipose tissue, muscle, liver, and pancreas. Beyond macrophages, neutrophils also accumulate in adipose and muscle tissues during high-fat diets and contribute to a state of local inflammation and insulin resistance. However, the mechanisms by which neutrophils are recruited to these tissues are largely unknown. Here we used a cell culture system as proof of concept to show that, upon exposure to a saturated fatty acid, palmitate, macrophages release nucleotides that attract neutrophils. Moreover, we found that palmitate up-regulates pannexin-1 channels in macrophages that mediate the attraction of neutrophils, shown previously to allow transfer of nucleotides across membranes. These findings suggest that proinflammatory macrophages release nucleotides through pannexin-1, a process that may facilitate neutrophil recruitment into metabolic tissues during obesity.	[Tam, Theresa H.; Chan, Kenny L.; Boroumand, Parastoo; Liu, Zhi; Bilan, Philip J.; Klip, Amira] Hosp Sick Children, Cell Biol Program, Toronto, ON M5G 0A4, Canada; [Tam, Theresa H.; Chan, Kenny L.; Klip, Amira] Univ Toronto, Dept Physiol, Toronto, ON M5S 1A8, Canada; [Boroumand, Parastoo; Klip, Amira] Univ Toronto, Dept Biochem, Toronto, ON M5S 1A8, Canada; [Brozinick, Joseph T.; Bui, Hai Hoang; Roth, Kenneth] Eli Lilly & Co, Indianapolis, IN 46285 USA; [Wakefield, C. Brent; Penuela, Silvia] Western Univ, Schulich Sch Med & Dent, Dept Anat & Cell Biol, London, ON N6A 5C1, Canada; [Penuela, Silvia] Western Univ, Schulich Sch Med & Dent, Dept Oncol, London, ON N6A 5C1, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto; Eli Lilly; Western University (University of Western Ontario); Western University (University of Western Ontario)	Klip, A (corresponding author), Hosp Sick Children, Cell Biol Program, Toronto, ON M5G 0A4, Canada.; Klip, A (corresponding author), Univ Toronto, Dept Physiol, Toronto, ON M5S 1A8, Canada.; Klip, A (corresponding author), Univ Toronto, Dept Biochem, Toronto, ON M5S 1A8, Canada.	amira@sickkids.ca	; Penuela, Silvia/A-6961-2010	boroumand, parastoo/0000-0002-9520-9303; Penuela, Silvia/0000-0003-4829-5517	Canadian Institutes of Health Research [FND-143203]; Natural Sciences and Engineering Research Council of Canada [RGPIN-2015-06794]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This study was supported by Foundation Grant FND-143203 (to A. K.) from the Canadian Institutes of Health Research. Panx1<SUP>-/-</SUP> mouse studies were supported by Discovery Grant RGPIN-2015-06794 (to S. P.) from the Natural Sciences and Engineering Research Council of Canada. The authors declare that they have no conflicts of interest with the contents of this article.	Adamson SE, 2015, MOL METAB, V4, P610, DOI 10.1016/j.molmet.2015.06.009; Aglietti RA, 2016, P NATL ACAD SCI USA, V113, P7858, DOI 10.1073/pnas.1607769113; Ali M, 2018, MOL BIOL REP, V45, P1245, DOI 10.1007/s11033-018-4279-4; Beyrau M, 2012, OPEN BIOL, V2, DOI 10.1098/rsob.120134; Bijnen M, 2018, GUT, V67, P1317, DOI 10.1136/gutjnl-2016-313654; Boutens L, 2016, DIABETOLOGIA, V59, P879, DOI 10.1007/s00125-016-3904-9; Boyd-Tressler A, 2014, J BIOL CHEM, V289, P27246, DOI 10.1074/jbc.M114.590240; Chai WD, 2019, AM J PHYSIOL-ENDOC M, V317, pE1063, DOI 10.1152/ajpendo.00203.2019; Chan KL, 2017, CELL REP, V18, P2415, DOI 10.1016/j.celrep.2017.02.027; Chan KL, 2015, J BIOL CHEM, V290, P16979, DOI 10.1074/jbc.M115.646992; Chekeni FB, 2010, NATURE, V467, P863, DOI 10.1038/nature09413; Chen Y, 2006, SCIENCE, V314, P1792, DOI 10.1126/science.1132559; Chen Y, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000549; Corriden R, 2012, PURINERG SIGNAL, V8, P587, DOI 10.1007/s11302-012-9311-x; De Filippo K, 2013, BLOOD, V121, P4930, DOI 10.1182/blood-2013-02-486217; Deaglio S, 2011, ADV PHARMACOL, V61, P301, DOI 10.1016/B978-0-12-385526-8.00010-2; Elgazar-Carmon V, 2008, J LIPID RES, V49, P1894, DOI 10.1194/jlr.M800132-JLR200; Elliott MR, 2009, NATURE, V461, P282, DOI 10.1038/nature08296; Erlinge D, 2011, ADV PHARMACOL, V61, P417, DOI 10.1016/B978-0-12-385526-8.00013-8; Eugenin EA, 2003, J IMMUNOL, V170, P1320, DOI 10.4049/jimmunol.170.3.1320; Fink LN, 2014, OBESITY, V22, P747, DOI 10.1002/oby.20615; Hadad N, 2013, DIABETES, V62, P3053, DOI 10.2337/db12-1300; Hotamisligil GS, 1996, SCIENCE, V271, P665, DOI 10.1126/science.271.5249.665; Idzko M, 2014, NATURE, V509, P310, DOI 10.1038/nature13085; Kewalramani G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026947; Kolaczkowska E, 2013, NAT REV IMMUNOL, V13, P159, DOI 10.1038/nri3399; Kukulski F, 2009, CYTOKINE, V46, P166, DOI 10.1016/j.cyto.2009.02.011; Lee VR, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-34234-9; Lee YS, 2011, DIABETES, V60, P2474, DOI 10.2337/db11-0194; Li W, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-017-18452-1; Liu X, 2016, NATURE, V535, P153, DOI 10.1038/nature18629; Lumeng CN, 2007, J CLIN INVEST, V117, P175, DOI 10.1172/JCI29881; Makarenkova HP, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00063; Michalski K, 2016, J GEN PHYSIOL, V147, P165, DOI 10.1085/jgp.201511505; Miyatake S, 2016, AM J PHYSIOL-ENDOC M, V310, pE160, DOI 10.1152/ajpendo.00325.2015; Penuela S, 2007, J CELL SCI, V120, P3772, DOI 10.1242/jcs.009514; PETRONE WF, 1980, P NATL ACAD SCI-BIOL, V77, P1159, DOI 10.1073/pnas.77.2.1159; Pillon NJ, 2016, AM J PHYSIOL-ENDOC M, V311, pE825, DOI 10.1152/ajpendo.00296.2016; Pillon NJ, 2014, DIABETES, V63, P3815, DOI 10.2337/db14-0150; Qu Y, 2011, J IMMUNOL, V186, P6553, DOI 10.4049/jimmunol.1100478; Roberts HM, 2018, OBES SURG, V28, P1611, DOI 10.1007/s11695-017-3063-1; Russo L, 2018, IMMUNOLOGY, V155, P407, DOI 10.1111/imm.13002; Sahoo M, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004327; Saltiel AR, 2017, J CLIN INVEST, V127, P1, DOI [10.1172/JCI92035, 10.1172/jci92035]; Selders GS, 2017, REGEN BIOMATER, V4, P55, DOI 10.1093/rb/rbw041; Shi H, 2006, J CLIN INVEST, V116, P3015, DOI 10.1172/JCI28898; Talukdar S, 2012, NAT MED, V18, P1407, DOI 10.1038/nm.2885; Ubhayasekera SJKA, 2013, ANAL BIOANAL CHEM, V405, P1929, DOI 10.1007/s00216-012-6658-3; Velasquez S, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00096; Vong Linda, 2013, Methods Mol Biol, V1031, P41, DOI 10.1007/978-1-62703-481-4_5; Wang QL, 2014, DIABETES, V63, P4172, DOI 10.2337/db14-0026; Wang X, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00399; Watanabe Y, 2019, FASEB J, V33, P11821, DOI 10.1096/fj.201900477RR; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Wen HT, 2011, NAT IMMUNOL, V12, P408, DOI 10.1038/ni.2022	55	12	12	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 10	2020	295	15					4902	4911		10.1074/jbc.RA119.010868	http://dx.doi.org/10.1074/jbc.RA119.010868			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LE7FC	32132172	Green Published, hybrid			2022-12-26	WOS:000526887000014
J	Manenda, MS; Picard, ME; Zhang, LP; Cyr, N; Zhu, XJ; Barma, J; Pascal, JM; Couture, M; Zhang, CS; Shi, R				Manenda, Mahder S.; Picard, Marie-Eve; Zhang, Liping; Cyr, Normand; Zhu, Xiaojun; Barma, Julie; Pascal, John M.; Couture, Manon; Zhang, Changsheng; Shi, Rong			Structural analyses of the Group A flavin-dependent monooxygenase PieE reveal a sliding FAD cofactor conformation bridging OUT and IN conformations	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						flavin adenine dinucleotide (FAD); enzyme catalysis; enzyme mechanism; small-angle X-ray scattering (SAXS); crystal structure; flavin-dependent monooxygenase; hydroxylation; mobile flavin; piericidin; sliding conformation	CRYSTAL-STRUCTURE; 2-HYDROXYBIPHENYL 3-MONOOXYGENASE; HYDROXYBENZOATE HYDROXYLASE; SUBSTRATE; PIERICIDIN; DYNAMICS; PROTEIN; STEPS; INHIBITION; SCATTERING	Group A flavin-dependent monooxygenases catalyze the cleavage of the oxygen?oxygen bond of dioxygen, followed by the incorporation of one oxygen atom into the substrate molecule with the aid of NADPH and FAD. These flavoenzymes play an important role in many biological processes, and their most distinct structural feature is the choreographed motions of flavin, which typically adopts two distinct conformations (OUT and IN) to fulfill its function. Notably, these enzymes seem to have evolved a delicate control system to avoid the futile cycle of NADPH oxidation and FAD reduction in the absence of substrate, but the molecular basis of this system remains elusive. Using protein crystallography, size-exclusion chromatography coupled to multi-angle light scattering (SEC-MALS), and small-angle X-ray scattering (SEC-SAXS) and activity assay, we report here a structural and biochemical characterization of PieE, a member of the Group A flavin-dependent monooxygenases involved in the biosynthesis of the antibiotic piericidin A1. This analysis revealed that PieE forms a unique hexamer. Moreover, we found, to the best of our knowledge for the first time, that in addition to the classical OUT and IN conformations, FAD possesses a ?sliding? conformation that exists in between the OUT and IN conformations. This observation sheds light on the underlying mechanism of how the signal of substrate binding is transmitted to the FAD-binding site to efficiently initiate NADPH binding and FAD reduction. Our findings bridge a gap currently missing in the orchestrated order of chemical events catalyzed by this important class of enzymes.	[Manenda, Mahder S.; Picard, Marie-Eve; Zhu, Xiaojun; Barma, Julie; Couture, Manon; Shi, Rong] Univ Laval, Dept Biochim Microbiol & Bioinformat, PROTEO, Quebec City, PQ G1V 0A6, Canada; [Manenda, Mahder S.; Picard, Marie-Eve; Zhu, Xiaojun; Barma, Julie; Couture, Manon; Shi, Rong] Univ Laval, IBIS, Quebec City, PQ G1V 0A6, Canada; [Zhang, Liping; Zhang, Changsheng] Chinese Acad Sci, RNAM Ctr Marine Microbiol, South China Sea Inst Oceanol, CAS Key Lab Trop Marine Bioresources & Ecol,Guang, 164 West Xingang Rd, Guangzhou 510301, Peoples R China; [Cyr, Normand; Pascal, John M.] Univ Montreal, Dept Biochim & Med Mol, Montreal, PQ H3T 1J4, Canada	Laval University; Laval University; Chinese Academy of Sciences; South China Sea Institute of Oceanology, CAS; Universite de Montreal	Shi, R (corresponding author), Univ Laval, Dept Biochim Microbiol & Bioinformat, PROTEO, Quebec City, PQ G1V 0A6, Canada.	rong.shi@bcm.ulaval.ca	Zhang, Changsheng/B-5965-2012; Couture, Manon/F-8326-2015	Zhang, Changsheng/0000-0003-2349-3138; ZHU, XIAOJUN/0000-0002-5409-3973; Couture, Manon/0000-0001-8296-8055; Cyr, Normand/0000-0002-9024-525X	Canada Foundation for Innovation; Natural Sciences and Engineering Research Council of Canada; University of Saskatchewan; Government of Saskatchewan; National Research Council Canada; Canadian Institutes of Health Research; Canada Foundation for Innovation Award [30574]	Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); University of Saskatchewan; Government of Saskatchewan; National Research Council Canada; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canada Foundation for Innovation Award(Canada Foundation for Innovation)	We thank Dr. Bhushan Nagar and Dr. Albert Berghuis for access to the X-ray diffractometer at McGill University. We also thank Dr. Steve Charette at Universite Laval for access to scientific equipment. Part of the research described in this paper was performed using beamline 08ID-1 at the Canadian Light Source (CLS), which is supported by the Canada Foundation for Innovation, Natural Sciences and Engineering Research Council of Canada, the University of Saskatchewan, the Government of Saskatchewan, the National Research Council Canada, and the Canadian Institutes of Health Research. We thank Shaun Labiuk at CLS for X-ray data collection. SEC-MALS and SEC-SAXS data were acquired at the Structural Biology Platform of the Universite de Montreal. The Platform was funded and is currently supported by Canada Foundation for Innovation Award 30574.	Ballou DP, 2005, BIOCHEM BIOPH RES CO, V338, P590, DOI 10.1016/j.bbrc.2005.09.081; Benitez AR, 2019, ACS CATAL, V9, P3633, DOI 10.1021/acscatal.8b04575; Fenwick RB, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5070; Chaiyen P, 2010, ARCH BIOCHEM BIOPHYS, V493, P62, DOI 10.1016/j.abb.2009.08.021; Chen YL, 2014, ORG LETT, V16, P736, DOI 10.1021/ol4034176; Chenprakhon P, 2019, PROTEIN SCI, V28, P8, DOI 10.1002/pro.3525; Crozier-Reabe K, 2012, INT J MOL SCI, V13, P15601, DOI 10.3390/ijms131215601; Darrouzet E, 1998, FEBS LETT, V431, P34, DOI 10.1016/S0014-5793(98)00719-4; Ellis HR, 2010, ARCH BIOCHEM BIOPHYS, V497, P1, DOI 10.1016/j.abb.2010.02.007; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Enroth C, 2003, ACTA CRYSTALLOGR D, V59, P1597, DOI 10.1107/S0907444903014902; ENTSCH B, 1995, FASEB J, V9, P476, DOI 10.1096/fasebj.9.7.7737455; Fischer H, 2010, J APPL CRYSTALLOGR, V43, P101, DOI 10.1107/S0021889809043076; Franke D, 2017, J APPL CRYSTALLOGR, V50, P1212, DOI 10.1107/S1600576717007786; GATTI DL, 1994, SCIENCE, V266, P110, DOI 10.1126/science.7939628; Greenhagen BT, 2008, BIOCHEMISTRY-US, V47, P5281, DOI 10.1021/bi702480t; HALL C, 1966, BIOCHEM BIOPH RES CO, V25, P373, DOI 10.1016/0006-291X(66)90214-2; Hicks KA, 2013, BIOCHEMISTRY-US, V52, P477, DOI 10.1021/bi301262p; Hiromoto T, 2006, J MOL BIOL, V364, P878, DOI 10.1016/j.jmb.2006.09.031; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Huijbers MME, 2014, ARCH BIOCHEM BIOPHYS, V544, P2, DOI 10.1016/j.abb.2013.12.005; HUSAIN M, 1979, J BIOL CHEM, V254, P6657; Hutchinson JP, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15827; Jackson DR, 2016, ACS CHEM BIOL, V11, P1137, DOI 10.1021/acschembio.5b00913; Jensen CN, 2015, CHEMBIOCHEM, V16, P968, DOI 10.1002/cbic.201402701; Kallio P, 2013, BIOCHEMISTRY-US, V52, P4507, DOI 10.1021/bi400381s; Kanteev M, 2015, BBA-PROTEINS PROTEOM, V1854, P1906, DOI 10.1016/j.bbapap.2015.08.002; Kikhney AG, 2020, PROTEIN SCI, V29, P66, DOI 10.1002/pro.3731; Kobayashi J, 2017, J BIOSCI BIOENG, V123, P154, DOI 10.1016/j.jbiosc.2016.07.022; Korasick DA, 2018, PROTEIN SCI, V27, P814, DOI 10.1002/pro.3376; Koshland DE, 1998, NAT MED, V4, P1112, DOI 10.1038/2605; Koskiniemi H, 2007, J MOL BIOL, V372, P633, DOI 10.1016/j.jmb.2007.06.087; Koteva K, 2018, CELL CHEM BIOL, V25, P403, DOI 10.1016/j.chembiol.2018.01.009; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Leslie AGW, 2007, NATO SCI SER II-MATH, V245, P41, DOI 10.1007/978-1-4020-6316-9_4; Lindqvist Y, 2009, J MOL BIOL, V393, P966, DOI 10.1016/j.jmb.2009.09.003; Liu LK, 2016, J BIOL CHEM, V291, P21553, DOI 10.1074/jbc.M116.745315; Markley JL, 2019, ACS INFECT DIS, V5, P618, DOI 10.1021/acsinfecdis.8b00349; Montersino S, 2013, J BIOL CHEM, V288, P26235, DOI 10.1074/jbc.M113.479303; Montersino S, 2011, ADV SYNTH CATAL, V353, P2301, DOI 10.1002/adsc.201100384; Moriarty NW, 2017, ACTA CRYSTALLOGR D, V73, P123, DOI 10.1107/S2059798316016570; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Palfey BA, 2002, BIOCHEMISTRY-US, V41, P8438, DOI 10.1021/bi012073g; Park J, 2017, NAT CHEM BIOL, V13, P730, DOI 10.1038/nchembio.2376; Piiadov V, 2019, PROTEIN SCI, V28, P454, DOI 10.1002/pro.3528; Romero E, 2018, CHEM REV, V118, P1742, DOI 10.1021/acs.chemrev.7b00650; Ryan KS, 2007, P NATL ACAD SCI USA, V104, P15311, DOI 10.1073/pnas.0707190104; Ryan KS, 2008, BIOCHEMISTRY-US, V47, P13506, DOI 10.1021/bi801229w; Teufel R, 2016, CURR OPIN CHEM BIOL, V31, P31, DOI 10.1016/j.cbpa.2016.01.001; Treiber N, 2008, J MOL BIOL, V379, P94, DOI 10.1016/j.jmb.2008.03.032; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; van Berkel W. J., 2013, FLAVINS FLAVOPROTEIN, V2011, P277; Walsh CT, 2013, NAT PROD REP, V30, P175, DOI 10.1039/c2np20069d; Wang J, 2002, P NATL ACAD SCI USA, V99, P608, DOI 10.1073/pnas.022640199; Wang P, 2013, J AM CHEM SOC, V135, P7138, DOI 10.1021/ja403516u; Zheng QF, 2018, CELL CHEM BIOL, V25, P718, DOI 10.1016/j.chembiol.2018.03.007; Zhu YG, 2016, CHEM SCI, V7, P4867, DOI 10.1039/c6sc00771f	58	4	4	3	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 3	2020	295	14					4709	4722		10.1074/jbc.RA119.011212	http://dx.doi.org/10.1074/jbc.RA119.011212			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LB2WZ	32111738	Green Published, hybrid			2022-12-26	WOS:000524499700028
J	Okamoto, Y; Saito, T; Tani, Y; Toki, T; Hasebe, A; Koido, M; Tomida, A				Okamoto, Yuka; Saito, Takuya; Tani, Yuri; Toki, Tamami; Hasebe, Akiko; Koido, Masaru; Tomida, Akihiro			The kinase PERK represses translation of the G-protein?coupled receptor LGR5 and receptor tyrosine kinase ERBB3 during ER stress in cancer cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						endoplasmic reticulum stress (ER stress); protein synthesis; protein stability; eukaryotic initiation factor 2 (eIF2); unfolded protein response (UPR); colon cancer; kinase signaling; leucine-rich repeat-containing G-protein?coupled receptor 5(LGR5); protein kinase R-like ER kinase (PERK)	UNCHARGED TRANSFER-RNA; WNT/BETA-CATENIN; STEM-CELLS; SMALL-INTESTINE; GRP78 PROMOTER; SELF-RENEWAL; COLON; GENE; REINITIATION; ACTIVATION	As a branch of the unfolded protein response, protein kinase R-like endoplasmic reticulum kinase (PERK) represses global translation in response to endoplasmic reticulum (ER) stress. This pathophysiological condition is associated with the tumor microenvironment in cancer. Previous findings in our lab have suggested that PERK selectively represses translation of some mRNAs, but this possibility awaits additional investigation. In this study, we show that a stem-cell marker protein, leucine-rich repeat-containing G-protein?coupled receptor 5 (LGR5), is rapidly depleted in colon cancer cells during ER stress, an effect that depended on the PERK-mediated translational repression. Indeed, the PERK inhibition led to the accumulation of premature, underglycosylated forms of LGR5, which were produced only at low levels during proper PERK activation. Unlike the mature LGR5 form, which is constitutively degraded regardless of PERK activation, the underglycosylated LGR5 exhibited a prolonged half-life and accumulated inside the cells without being expressed on the cell surface. We also found that Erb-B2 receptor tyrosine kinase 3 (ERBB3) is subjected to a similarly-regulated depletion by PERK, whereas the epidermal growth factor receptor (EGFR), stress-inducible heat-shock protein family A (Hsp70) member 5 (HSPA5), and anterior gradient 2 protein-disulfide isomerase family member (AGR2) were relatively. insensitive to the PERK-mediated repression of translation. These results indicate that LGR5 and ERBB3 are targets for PERK-mediated translational repression during ER stress	[Okamoto, Yuka; Saito, Takuya; Tani, Yuri; Toki, Tamami; Hasebe, Akiko; Koido, Masaru; Tomida, Akihiro] Japanese Fdn Canc Res, Canc Chemotherapy Ctr, Genome Res, Koto Ku, 3-8-31 Ariake, Tokyo 1358550, Japan	Japanese Foundation for Cancer Research	Tomida, A (corresponding author), Japanese Fdn Canc Res, Canc Chemotherapy Ctr, Genome Res, Koto Ku, 3-8-31 Ariake, Tokyo 1358550, Japan.	akihiro.tomida@jfcr.or.jp	Koido, Masaru/I-2930-2019	Koido, Masaru/0000-0002-0348-0666	Ministry of Education, Culture, Sports, Science and Technology of Japan [18K15293, 16K18465, 19H03526, 16H04717]; Nippon Foundation	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Nippon Foundation(Nippon Foundation)	This work was supported in part by Grants-in-aid for Young Scientists 18K15293 and 16K18465 (to Y. O.), Grants-in-aid for Scientific Research (B) 19H03526 and 16H04717 (to A. T.) from the Ministry of Education, Culture, Sports, Science and Technology of Japan, and in part by the Nippon Foundation. The authors declare that they have no conflicts of interest with the contents of this article.	Atkins C, 2013, CANCER RES, V73, P1993, DOI 10.1158/0008-5472.CAN-12-3109; Barker N, 2008, COLD SH Q B, V73, P351, DOI 10.1101/sqb.2008.72.003; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Barker N, 2010, CELL STEM CELL, V6, P25, DOI 10.1016/j.stem.2009.11.013; Calfon M, 2002, NATURE, V415, P92, DOI 10.1038/415092a; Carmon KS, 2012, MOL CELL BIOL, V32, P2054, DOI 10.1128/MCB.00272-12; Carmon KS, 2011, P NATL ACAD SCI USA, V108, P11452, DOI 10.1073/pnas.1106083108; Chakrabarti A, 2011, BIOTECHNOL BIOENG, V108, P2777, DOI 10.1002/bit.23282; Dong JS, 2000, MOL CELL, V6, P269, DOI 10.1016/S1097-2765(00)00028-9; Donnelly N, 2013, CELL MOL LIFE SCI, V70, P3493, DOI 10.1007/s00018-012-1252-6; Dumartin L, 2017, ONCOGENE, V36, P3094, DOI 10.1038/onc.2016.459; Glinka A, 2011, EMBO REP, V12, P1055, DOI 10.1038/embor.2011.175; GONCHAR NA, 1981, VOP MED KHIM, V27, P815; Gonen N, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-38705-5; Hao SZ, 2005, SCIENCE, V307, P1776, DOI 10.1126/science.1104882; Harding HP, 1999, NATURE, V397, P271, DOI 10.1038/16729; Harding HP, 2000, MOL CELL, V5, P897, DOI 10.1016/S1097-2765(00)80330-5; Heijmans J, 2013, CELL REP, V3, P1128, DOI 10.1016/j.celrep.2013.02.031; Hetz C, 2012, NAT REV MOL CELL BIO, V13, P89, DOI 10.1038/nrm3270; Jaks V, 2008, NAT GENET, V40, P1291, DOI 10.1038/ng.239; Keller TL, 2012, NAT CHEM BIOL, V8, P311, DOI [10.1038/NCHEMBIO.790, 10.1038/nchembio.790]; Kraft CL, 2017, ONCOTARGET, V8, P102923, DOI 10.18632/oncotarget.22084; Kreso A, 2014, NAT MED, V20, P29, DOI 10.1038/nm.3418; Li MQ, 2000, MOL CELL BIOL, V20, P5096, DOI 10.1128/MCB.20.14.5096-5106.2000; Lu PD, 2004, J CELL BIOL, V167, P27, DOI 10.1083/jcb.200408003; Luo SZ, 2003, J BIOL CHEM, V278, P37375, DOI 10.1074/jbc.M303619200; Morgan RG, 2015, BRIT J CANCER, V112, P714, DOI 10.1038/bjc.2015.4; Reid DW, 2014, CELL, V158, P1362, DOI 10.1016/j.cell.2014.08.012; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Sato H, 2004, BIOCHEM BIOPH RES CO, V325, P109, DOI 10.1016/j.bbrc.2004.10.009; Sato T, 2011, NATURE, V469, P415, DOI 10.1038/nature09637; Schmidt EK, 2009, NAT METHODS, V6, P275, DOI [10.1038/NMETH.1314, 10.1038/nmeth.1314]; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schroder M, 2005, ANNU REV BIOCHEM, V74, P739, DOI 10.1146/annurev.biochem.73.011303.074134; Schuldt A, 2014, NAT REV MOL CELL BIO, V15, DOI 10.1038/nrm3725; Shimokawa M, 2017, NATURE, V545, P187, DOI 10.1038/nature22081; Snyder JC, 2013, J BIOL CHEM, V288, P10286, DOI 10.1074/jbc.M112.447540; Trejo CL, 2017, NPJ BREAST CANCER, V3, DOI 10.1038/s41523-017-0018-6; Tsukumo Y, 2009, J BIOL CHEM, V284, P27500, DOI 10.1074/jbc.M109.021592; Van Hoewyk D, 2016, PLANT METHODS, V12, DOI 10.1186/s13007-016-0120-z; Vattem KM, 2004, P NATL ACAD SCI USA, V101, P11269, DOI 10.1073/pnas.0400541101; Vembar SS, 2008, NAT REV MOL CELL BIO, V9, P944, DOI 10.1038/nrm2546; Wek RC, 2006, BIOCHEM SOC T, V34, P7, DOI 10.1042/BST0340007; WOODEN SK, 1991, MOL CELL BIOL, V11, P5612, DOI 10.1128/MCB.11.11.5612; Yan KS, 2017, NATURE, V545, P238, DOI 10.1038/nature22313; Ye J, 2000, MOL CELL, V6, P1355, DOI 10.1016/S1097-2765(00)00133-7; Ye P, 2014, MOL CELL BIOL, V34, P3421, DOI 10.1128/MCB.00221-14; Zhou XL, 2017, CANCER RES, V77, P6589, DOI 10.1158/0008-5472.CAN-17-0219	48	2	2	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 3	2020	295	14					4591	4603		10.1074/jbc.RA119.010655	http://dx.doi.org/10.1074/jbc.RA119.010655			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LB2WZ	32107308	hybrid, Green Published			2022-12-26	WOS:000524499700019
J	Weitzel, CS; Li, L; Changyi, Z; Eilts, KK; Bretz, NM; Gatten, AL; Whitaker, RJ; Martinis, SA				Weitzel, Christopher S.; Li, Li; Changyi, Zhang; Eilts, Kristen K.; Bretz, Nicholas M.; Gatten, Alex L.; Whitaker, Rachel J.; Martinis, Susan A.			Duplication of leucyl-tRNA synthetase in an archaeal extremophile may play a role in adaptation to variable environmental conditions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						aminoacyl tRNA synthetase; transfer RNA (tRNA); translation; archaea; enzyme catalysis; genetics; editing; fidelity; paralogs; Sulfolobaceae; Sulfolobus islandicus	NUCLEIC-ACID INTERACTIONS; ESCHERICHIA-COLI; SULFOLOBUS-ISLANDICUS; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; GENETIC-CODE; AMINO-ACIDS; MICROSCALE THERMOPHORESIS; SENSITIVE METHOD; MISTRANSLATION	Aminoacyl-tRNA synthetases (aaRSs) are ancient enzymes that play a fundamental role in protein synthesis. They catalyze the esterification of specific amino acids to the 3?-end of their cognate tRNAs and therefore play a pivotal role in protein synthesis. Although previous studies suggest that aaRS-dependent errors in protein synthesis can be beneficial to some microbial species, evidence that reduced aaRS fidelity can be adaptive is limited. Using bioinformatics analyses, we identified two distinct leucyl-tRNA synthetase (LeuRS) genes within all genomes of the archaeal family Sulfolobaceae. Remarkably, one copy, designated LeuRS-I, had key amino acid substitutions within its editing domain that would be expected to disrupt hydrolytic editing of mischarged tRNA(Leu) and to result in variation within the proteome of these extremophiles. We found that another copy, LeuRS-F, contains canonical active sites for aminoacylation and editing. Biochemical and genetic analyses of the paralogs within Sulfolobus islandicus supported the hypothesis that LeuRS-F, but not LeuRS-I, functions as an essential tRNA synthetase that accurately charges leucine to tRNA(Leu) for protein translation. Although LeuRS-I was not essential, its expression clearly supported optimal S. islandicus growth. We conclude that LeuRS-I may have evolved to confer a selective advantage under the extreme and fluctuating environmental conditions characteristic of the volcanic hot springs in which these archaeal extremophiles reside.	[Weitzel, Christopher S.; Eilts, Kristen K.; Bretz, Nicholas M.] Illinois State Univ, Dept Chem, Normal, IL 61761 USA; [Li, Li; Gatten, Alex L.; Martinis, Susan A.] Univ Illinois, Dept Biochem, Urbana, IL 61801 USA; [Li, Li; Martinis, Susan A.] Univ Illinois, Ctr Biophys & Quantitat Biol, Urbana, IL 61801 USA; [Changyi, Zhang; Whitaker, Rachel J.] Univ Illinois, Dept Microbiol, 131 Burrill Hall, Urbana, IL 61801 USA; [Changyi, Zhang; Whitaker, Rachel J.] Univ Illinois, Carl R Woese Inst Genom Biol, Urbana, IL 61801 USA; [Li, Li] Richard B Simches Res Ctr, Ctr Computat & Integrat Res, Boston, MA 02114 USA; [Gatten, Alex L.] Univ Louisville, Sch Dent, Louisville, KY 40202 USA	Illinois State University; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Louisville	Weitzel, CS (corresponding author), Illinois State Univ, Dept Chem, Normal, IL 61761 USA.	csweitz@ilstu.edu		Eilts, Kristen/0000-0001-9470-3863; Martinis, Susan/0000-0001-5730-8346; Bretz, Nicholas/0000-0003-4481-7381	Illinois State University; National Science Foundation [1205373]; NASA Exobiology Program [NNX14AK23G]	Illinois State University; National Science Foundation(National Science Foundation (NSF)); NASA Exobiology Program(National Aeronautics & Space Administration (NASA))	This work was supported by laboratory startup funds from the Illinois State University (to C. S. W.), National Science Foundation Grant 1205373 (to S. A. M.), and NASA Exobiology Program Grant NNX14AK23G (to R. J. W.). The authors declare that they have no conflicts of interest with the contents of this article.	An LL, 2005, LEUKEMIA RES, V29, P535, DOI 10.1016/j.leukres.2004.11.009; Andam CP, 2011, FEMS MICROBIOL REV, V35, P756, DOI 10.1111/j.1574-6976.2011.00274.x; ANEMULLER S, 1990, EUR J BIOCHEM, V191, P297, DOI 10.1111/j.1432-1033.1990.tb19123.x; Rubio MA, 2015, NUCLEIC ACIDS RES, V43, P9905, DOI 10.1093/nar/gkv1020; Arnez JG, 1997, TRENDS BIOCHEM SCI, V22, P211, DOI 10.1016/S0968-0004(97)01052-9; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BREVET A, 1995, J BIOL CHEM, V270, P14439, DOI 10.1074/jbc.270.24.14439; Campbell KM, 2017, ENVIRON MICROBIOL, V19, P2334, DOI 10.1111/1462-2920.13728; Chaliotis A, 2017, NUCLEIC ACIDS RES, V45, P1059, DOI 10.1093/nar/gkw1182; CHARLIER J, 1987, BIOCHEM J, V248, P43, DOI 10.1042/bj2480043; Colussi TM, 2014, NATURE, V511, P366, DOI 10.1038/nature13378; Deng L, 2009, EXTREMOPHILES, V13, P735, DOI 10.1007/s00792-009-0254-2; Duchene AM, 2009, CURR GENET, V55, P1, DOI 10.1007/s00294-008-0223-9; Fang ZP, 2014, NUCLEIC ACIDS RES, V42, P5109, DOI 10.1093/nar/gku108; FERSHT AR, 1988, BIOCHEMISTRY-US, V27, P1581, DOI 10.1021/bi00405a028; FERSHT AR, 1979, BIOCHEMISTRY-US, V18, P2627, DOI 10.1021/bi00579a030; FIRST EA, 1995, BIOCHEMISTRY-US, V34, P5030, DOI 10.1021/bi00015a014; Fukuda W, 2008, FEMS MICROBIOL LETT, V287, P113, DOI 10.1111/j.1574-6968.2008.01303.x; Fukunaga R, 2005, NAT STRUCT MOL BIOL, V12, P915, DOI 10.1038/nsmb985; Fukunaga R, 2005, J MOL BIOL, V346, P57, DOI 10.1016/j.jmb.2004.11.060; Fukunaga R, 2007, BIOCHEMISTRY-US, V46, P4985, DOI 10.1021/bi6024935; Giege R, 2012, WIRES RNA, V3, P37, DOI 10.1002/wrna.103; Gomes AC, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-10-r206; He XD, 2018, CELL METAB, V27, P151, DOI 10.1016/j.cmet.2017.10.015; Hendrickson TL, 2004, ANNU REV BIOCHEM, V73, P147, DOI 10.1146/annurev.biochem.73.012803.092429; HIRSHFIELD IN, 1984, J BACTERIOL, V158, P615, DOI 10.1128/JB.158.2.615-620.1984; HIRSHFIELD IN, 1981, J BACTERIOL, V146, P345, DOI 10.1128/JB.146.1.345-351.1981; Inskeep WP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009773; Jaffe JD, 2004, GENOME RES, V14, P1447, DOI 10.1101/gr.2674004; JAKUBOWSKI H, 1992, MICROBIOL REV, V56, P412, DOI 10.1128/MMBR.56.3.412-429.1992; Jaubert C, 2013, OPEN BIOL, V3, DOI 10.1098/rsob.130010; Karkhanis VA, 2007, J BACTERIOL, V189, P8765, DOI 10.1128/JB.01215-07; Katz A, 2016, MOL MICROBIOL, V101, P545, DOI 10.1111/mmi.13419; Kumar S, 2018, MOL BIOL EVOL, V35, P1547, DOI 10.1093/molbev/msy096; Lee JW, 2006, NATURE, V443, P50, DOI 10.1038/nature05096; Lee JY, 2014, J CELL SCI, V127, P4234, DOI 10.1242/jcs.152470; Levine RL, 1996, P NATL ACAD SCI USA, V93, P15036, DOI 10.1073/pnas.93.26.15036; Li L, 2011, P NATL ACAD SCI USA, V108, P9378, DOI 10.1073/pnas.1016460108; Lincecum TL, 2003, MOL CELL, V11, P951, DOI 10.1016/S1097-2765(03)00098-4; Martinis S A, 1997, Nucleic Acids Symp Ser, V36, P125; Martinis SA, 2007, CHEM BIOL, V14, P1307, DOI 10.1016/j.chembiol.2007.12.001; Martinis SA, 2010, FEBS LETT, V584, P455, DOI 10.1016/j.febslet.2009.11.071; Mascarenhas A. P., 2009, V22, P155; Miranda I, 2013, MBIO, V4, DOI 10.1128/mBio.00285-13; Mohler K, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2017.117; Mueller AM, 2017, METHODS MOL BIOL, V1654, P151, DOI 10.1007/978-1-4939-7231-9_10; Mursinna RS, 2002, J AM CHEM SOC, V124, P7286, DOI 10.1021/ja025879s; Mursinna RS, 2001, BIOCHEMISTRY-US, V40, P5376, DOI 10.1021/bi002915w; Nakama T, 2001, J BIOL CHEM, V276, P47387, DOI 10.1074/jbc.M109089200; Nangle LA, 2006, CHEM BIOL, V13, P1091, DOI 10.1016/j.chembiol.2006.08.011; Netzer N, 2009, NATURE, V462, P522, DOI 10.1038/nature08576; NORMANLY J, 1986, P NATL ACAD SCI USA, V83, P6548, DOI 10.1073/pnas.83.17.6548; Ochsner UA, 2007, EXPERT OPIN INV DRUG, V16, P573, DOI 10.1517/13543784.16.5.573; PERONA JJ, 1993, BIOCHEMISTRY-US, V32, P8758, DOI 10.1021/bi00085a006; RajBhandary UL, 1997, P NATL ACAD SCI USA, V94, P11761, DOI 10.1073/pnas.94.22.11761; Reader JS, 2005, SCIENCE, V309, P1533, DOI 10.1126/science.1116841; Reno ML, 2009, P NATL ACAD SCI USA, V106, P8605, DOI 10.1073/pnas.0808945106; Reynolds NM, 2010, P NATL ACAD SCI USA, V107, P4063, DOI 10.1073/pnas.0909640107; Sakofsky CJ, 2011, ARCHAEA, V2011, DOI 10.1155/2011/864015; Samson RY, 2013, CELL REP, V3, P485, DOI 10.1016/j.celrep.2013.01.002; Santangelo TJ, 2010, APPL ENVIRON MICROB, V76, P1044, DOI 10.1128/AEM.02497-09; SANTOS MAS, 1993, EMBO J, V12, P607, DOI 10.1002/j.1460-2075.1993.tb05693.x; Sarkany Zsuzsa, 2014, Front Mol Biosci, V1, P27, DOI 10.3389/fmolb.2014.00027; Schimmel P, 2008, PROTEIN SCI, V17, P1643, DOI 10.1110/ps.037242.108; Schimmel P, 2011, PHILOS T R SOC B, V366, P2965, DOI 10.1098/rstb.2011.0158; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schwartz MH, 2016, NUCLEIC ACIDS RES, V44, P294, DOI 10.1093/nar/gkv1379; She QX, 2009, BIOCHEM SOC T, V37, P92, DOI 10.1042/BST0370092; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Snyder JC, 2007, P NATL ACAD SCI USA, V104, P19102, DOI 10.1073/pnas.0709445104; Soma A, 1999, J MOL BIOL, V293, P1029, DOI 10.1006/jmbi.1999.3219; STUDIER FW, 1990, METHOD ENZYMOL, V185, P60; Tang Y, 2002, BIOCHEMISTRY-US, V41, P10635, DOI 10.1021/bi026130x; Tremblay LW, 2008, BIOCHEMISTRY-US, V47, P13326, DOI 10.1021/bi801708f; Tukalo M, 2005, NAT STRUCT MOL BIOL, V12, P923, DOI 10.1038/nsmb986; Wagner M, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00214; Wang XY, 2016, ADV NUTR, V7, p773S, DOI 10.3945/an.115.010991; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; WEBSTER T, 1984, SCIENCE, V226, P1315, DOI 10.1126/science.6390679; Wiltrout E, 2012, NUCLEIC ACIDS RES, V40, P10494, DOI 10.1093/nar/gks805; Woese CR, 2000, MICROBIOL MOL BIOL R, V64, P202, DOI 10.1128/MMBR.64.1.202-236.2000; Zhai YX, 2007, BIOCHEMISTRY-US, V46, P3331, DOI 10.1021/bi061778l; Zhai YX, 2005, BIOCHEMISTRY-US, V44, P15437, DOI 10.1021/bi0514461; Zhang CY, 2018, APPL ENVIRON MICROB, V84, DOI 10.1128/AEM.02167-17; Zhang CY, 2013, APPL ENVIRON MICROB, V79, P5539, DOI 10.1128/AEM.01608-13; Zhang CY, 2013, BIOCHEM SOC T, V41, P458, DOI 10.1042/BST20120338; Zhang CY, 2012, MICROBIOL-SGM, V158, P1513, DOI 10.1099/mic.0.058289-0; Zhang CY, 2010, MICROBIOL-SGM, V156, P3386, DOI 10.1099/mic.0.042523-0; Zheng T, 2012, APPL ENVIRON MICROB, V78, P568, DOI 10.1128/AEM.06095-11; Zillner K, 2012, METHODS MOL BIOL, V815, P241, DOI 10.1007/978-1-61779-424-7_18	90	3	3	0	6	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 3	2020	295	14					4563	4576		10.1074/jbc.RA118.006481	http://dx.doi.org/10.1074/jbc.RA118.006481			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LB2WZ	32102848	hybrid, Green Published			2022-12-26	WOS:000524499700017
J	Kwasek, K; Wojno, M; Iannini, F; McCracken, VJ; Molinari, GS; Terova, G				Kwasek, Karolina; Wojno, Michal; Iannini, Federica; McCracken, Vance J.; Molinari, Giovanni S.; Terova, Genciana			Nutritional programming improves dietary plant protein utilization in zebrafish Danio rerio	PLOS ONE			English	Article							SALMON SALMO-SALAR; NEUROPEPTIDE-Y NPY; REGULATED TRANSCRIPT CART; RNA EXPRESSION RESPONSES; MEAL-INDUCED ENTERITIS; ATLANTIC SALMON; SOYBEAN-MEAL; FOOD-INTAKE; CHOLECYSTOKININ CCK; TISSUE DISTRIBUTION	Nutritional Programming (NP) has been shown to counteract the negative effects of dietary plant protein (PP) by introducing PP at an early age towards enhancement of PP utilization during later life stages. This study explored the effect of NP and its induction time on growth, expression of appetite-stimulating hormones, and any morphological changes in the gut possibly responsible for improved dietary PP utilization. At 3 days post-hatch (dph) zebrafish were distributed into 12 (3 L) tanks, 100 larvae per tank. This study included four groups: 1) The control (NP-FM) group received fishmeal (FM)-based diet from 13-36 dph and was challenged with PP-based diet during 36-66 dph; 2) The NP-PP group received NP with dietary PP in larval stage via live food enrichment during 3-13 dph followed by FM diet during 13-36 dph and PP diet during 36-66 dph; 3) The T-NP group received NP between 13-23 dph through PP diet followed by FM diet during 23-36 dph and PP diet during 36-66 dph; and 4) The PP group received PP diet from 13-66 dph. During the PP challenge the T-NP group achieved the highest weight gain compared to control and PP. Ghrelin expression in the brain was higher in T-NP compared to NP-FM and NP-PP, while in the gut it was reduced in both NP-PP and T-NP groups. Cholecystokinin expression showed an opposite trend to ghrelin. The brain neuropeptide Y expression was lower in NP-PP compared to PP but not different with NP-FM and T-NP groups. The highest villus length to width ratio in the middle intestine was found in T-NP compared to all other groups. The study suggests that NP induced during juvenile stages improves zebrafish growth and affects digestive hormone regulation and morphology of the intestinal lining-possible mechanisms behind the improved PP utilization in pre-adult zebrafish stages.	[Kwasek, Karolina; Wojno, Michal; Molinari, Giovanni S.] Southern Illinois Univ Carbondale, Sch Biol Sci, Ctr Fisheries Aquaculture & Aquat Sci, Carbondale, IL 62901 USA; [Iannini, Federica; Terova, Genciana] Univ Insubria, Dept Biotechnol & Life Sci, Varese, Italy; [McCracken, Vance J.] Southern Illinois Univ Edwardsville, Dept Biol Sci, Edwardsville, IL USA	Southern Illinois University System; Southern Illinois University; University of Insubria; Southern Illinois University System; Southern Illinois University Edwardsville	Kwasek, K (corresponding author), Southern Illinois Univ Carbondale, Sch Biol Sci, Ctr Fisheries Aquaculture & Aquat Sci, Carbondale, IL 62901 USA.	Karolina.kwasek@siu.edu	Terova, Genciana/AAL-6412-2021	Terova, Genciana/0000-0002-7532-7951; McCracken, Vance/0000-0002-8533-5808				Amole N, 2009, GEN COMP ENDOCR, V161, P133, DOI 10.1016/j.ygcen.2008.11.002; Babaei S, 2017, GEN COMP ENDOCR, V240, P121, DOI 10.1016/j.ygcen.2016.10.003; Bakke-McKellep AM, 2000, J FISH DIS, V23, P115, DOI 10.1046/j.1365-2761.2000.00218.x; Balasubramanian MN, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2804-1; Booman M, 2018, AQUACULTURE, V483, P238, DOI 10.1016/j.aquaculture.2017.10.025; Buckley C, 2010, PEPTIDES, V31, P1737, DOI 10.1016/j.peptides.2010.05.017; Buddington RK, 2004, COMP BIOCHEM PHYS A, V139, P261, DOI 10.1016/j.cbpb.2004.09.007; Dalmolin C, 2015, FISH PHYSIOL BIOCHEM, V41, P1131, DOI 10.1007/s10695-015-0074-5; de Francesco M, 2004, AQUACULTURE, V236, P413, DOI 10.1016/j.aquaculture.2004.01.006; Eom J, 2013, BIOCHEM BIOPH RES CO, V439, P115, DOI 10.1016/j.bbrc.2013.08.017; Fontainhas-Fernandes A, 1999, AQUACULT INT, V7, P57, DOI 10.1023/A:1009296818443; Geurden I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083162; Hedrera MI, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069983; HIMICK BA, 1994, AM J PHYSIOL-REG I, V267, pR84; Huising MO, 2006, ENDOCRINOLOGY, V147, P5786, DOI 10.1210/en.2006-0824; Izquierdo MS, 2015, AQUACULTURE, V449, P18, DOI 10.1016/j.aquaculture.2015.03.032; Ji W, 2015, GEN COMP ENDOCR, V223, P108, DOI 10.1016/j.ygcen.2015.08.009; Karimi K, 2015, J APPL ANIM RES, V43, P324, DOI 10.1080/09712119.2014.978770; Kasper CS, 2007, AQUACULT NUTR, V13, P431, DOI 10.1111/j.1365-2095.2007.00494.x; Kemski M, 2018, AQUACULTURE, V497, P452, DOI 10.1016/j.aquaculture.2018.07.001; Kling P, 2009, GEN COMP ENDOCR, V162, P307, DOI 10.1016/j.ygcen.2009.04.003; Koven W, 2012, FISH PHYSIOL BIOCHEM, V38, P1565, DOI 10.1007/s10695-012-9649-6; Krogdahl A, 2000, AQUACULT NUTR, V6, P77; Krogdahl A, 2015, J AGR FOOD CHEM, V63, P3887, DOI 10.1021/jf506242t; Kurokawa T, 2008, GEN COMP ENDOCR, V158, P108, DOI 10.1016/j.ygcen.2008.06.003; Le HT, 2019, FRONTIERS NEUROSCIEN, V13; LONDON RM, 1979, PHYSIOL BEHAV, V22, P1149, DOI 10.1016/0031-9384(79)90270-1; MacDonald E, 2009, HORM BEHAV, V56, P58, DOI 10.1016/j.yhbeh.2009.03.002; MacDonald E, 2009, GEN COMP ENDOCR, V161, P252, DOI 10.1016/j.ygcen.2009.01.021; Marjara IS, 2012, CYTOKINE, V60, P186, DOI 10.1016/j.cyto.2012.05.027; Blanco AM, 2017, HORM BEHAV, V93, P62, DOI 10.1016/j.yhbeh.2017.05.004; Murashita K, 2006, GEN COMP ENDOCR, V145, P287, DOI 10.1016/j.ygcen.2005.09.008; Murashita K, 2011, COMP BIOCHEM PHYS A, V158, P79, DOI 10.1016/j.cbpa.2010.09.001; Nakamachi T, 2006, J NEUROENDOCRINOL, V18, P290, DOI 10.1111/j.1365-2826.2006.01415.x; Narnaware YK, 2001, PHYSIOL BEHAV, V74, P185, DOI 10.1016/S0031-9384(01)00556-X; Narnaware YK, 2000, AM J PHYSIOL-REG I, V279, pR1025, DOI 10.1152/ajpregu.2000.279.3.R1025; Ng ANY, 2005, DEV BIOL, V286, P114, DOI 10.1016/j.ydbio.2005.07.013; Novak CM, 2005, NEUROSCI LETT, V383, P99, DOI 10.1016/j.neulet.2005.03.048; Oka Takehiko, 2010, BMC Physiol, V10, P21, DOI 10.1186/1472-6793-10-21; Perera E, 2016, ZEBRAFISH, V13, P61, DOI 10.1089/zeb.2015.1131; Ronnestad I, 2017, FRONT ENDOCRINOL, V8, DOI 10.3389/fendo.2017.00073; Silverstein JT, 1998, GEN COMP ENDOCR, V110, P157, DOI 10.1006/gcen.1998.7058; Trombley S, 2012, GEN COMP ENDOCR, V175, P92, DOI 10.1016/j.ygcen.2011.10.001; Turkmen S, 2017, BRIT J NUTR, V118, P500, DOI [10.1017/s0007114517002434, 10.1017/S0007114517002434]; Ulloa PE, 2011, REV FISH BIOL FISHER, V21, P649, DOI 10.1007/s11160-011-9203-0; Uran PA, 2008, AQUACULT NUTR, V14, P324, DOI 10.1111/j.1365-2095.2007.00534.x; Uran PA, 2008, FISH SHELLFISH IMMUN, V25, P751, DOI 10.1016/j.fsi.2008.02.013; Vagner M, 2007, AQUACULTURE, V267, P165, DOI 10.1016/j.aquaculture.2007.01.031; Vagner M, 2009, BRIT J NUTR, V101, P1452, DOI 10.1017/S0007114508088053; Valen R, 2011, GEN COMP ENDOCR, V171, P359, DOI 10.1016/j.ygcen.2011.02.027; Volkoff H, 2003, BRAIN RES, V972, P90, DOI 10.1016/S0006-8993(03)02507-1; Wallace KN, 2003, DEV BIOL, V255, P12, DOI 10.1016/S0012-1606(02)00034-9; Wang YR, 2017, AQUACULT REP, V5, P52, DOI 10.1016/j.aqrep.2016.12.005; Xu MY, 2007, MOL CELL ENDOCRINOL, V271, P28, DOI 10.1016/j.mce.2007.03.003; Yokobori E, 2012, J NEUROENDOCRINOL, V24, P766, DOI 10.1111/j.1365-2826.2012.02281.x; Yuan DY, 2014, GEN COMP ENDOCR, V204, P13, DOI 10.1016/j.ygcen.2014.05.013; Zhang HX, 2013, GEN COMP ENDOCR, V181, P295, DOI 10.1016/j.ygcen.2012.09.008	57	16	16	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2020	15	3							e0225917	10.1371/journal.pone.0225917	http://dx.doi.org/10.1371/journal.pone.0225917			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8TR	32142555	Green Published, gold, Green Submitted			2022-12-26	WOS:000535271600001
J	Zhu, YJ; Cui, HW; Lv, J; Li, GJ; Li, XY; Ye, F; Zhong, LB				Zhu, Yongjun; Cui, Hongwang; Lv, Jie; Li, Guojun; Li, Xiaoyan; Ye, Feng; Zhong, Liangbao			Angiotensin II triggers RIPK3-MLKL-mediated necroptosis by activating the Fas/FasL signaling pathway in renal tubular cells	PLOS ONE			English	Article							MIXED LINEAGE KINASE; DOMAIN-LIKE PROTEIN; MEDIATES NECROPTOSIS; KIDNEY; FIBROSIS; SYSTEM; INJURY; TRANSCRIPTION; ACCUMULATION; HYPERTENSION	Our earlier studies proved that RIPK3-mediated necroptosis might be an important mode of renal tubular cell death in rats with chronic renal injury and the necroptotic cell death can be triggered by tumor necrosis factor-alpha (TNF-alpha) in vitro, but the triggering role of angiotensin II (AngII), which exerts notable effects on renal cells for the initiation and progression of renal tubulointerstitial fibrosis, is largely unknown. Here, we identified the presence of necroptotic cell death in the tubular cells of AngII-induced chronic renal injury and fibrosis mice and assessed the percentage of necroptotic renal tubular cell death with the disruption of this necroptosis by the addition of necrostatin-1 (Nec-1). Furthermore, the observation was further confirmed in HK-2 cells treated with AngII and RIPK1/3 or MLKL inhibitors. The detection of Fas and FasL proteins led us to investigate the contribution of the Fas/FasL signaling pathway to AngII-induced necroptosis. Disruption of FasL decreased the percentage of necroptotic cells, suggesting that Fas and FasL are likely key signal molecules in the necroptosis of HK-2 cells induced by AngII. Our data suggest that AngII exposure might trigger RIPK3-MLKL-mediated necroptosis in renal tubular epithelial cells by activating the Fas/FasL signaling pathway in vivo and in vitro.	[Zhu, Yongjun; Li, Xiaoyan; Ye, Feng; Zhong, Liangbao] Hainan Med Univ, Affiliated Hosp 1, Dept Nephrol, Haikou, Hainan, Peoples R China; [Cui, Hongwang; Li, Guojun] Hainan Med Univ, Affiliated Hosp 1, Dept Orthoped, Haikou, Hainan, Peoples R China; [Lv, Jie] Hainan Med Univ, Clin Coll 1, Haikou, Hainan, Peoples R China	Hainan Medical University; Hainan Medical University; Hainan Medical University	Zhu, YJ; Zhong, LB (corresponding author), Hainan Med Univ, Affiliated Hosp 1, Dept Nephrol, Haikou, Hainan, Peoples R China.	zyj418207195@yeah.net; zcxy200808080@163.com			National Natural Science Foundation of China [81660131]; Hainan Natural Science Foundation of Hainan Province [20168301]; Science and Technology Cooperation Project from Key Research and Development Program of Hainan Province [ZDYF2019215]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Hainan Natural Science Foundation of Hainan Province; Science and Technology Cooperation Project from Key Research and Development Program of Hainan Province	This study was supported by grants from the National Natural Science Foundation of China, 81660131 to Zhu Yongjun and the Hainan Natural Science Foundation of Hainan Province, 20168301 to Zhu Yongjun and Science and Technology Cooperation Project from Key Research and Development Program of Hainan Province, ZDYF2019215 to Zhu Yongjun.	Bader M, 2008, J MOL MED, V86, P615, DOI 10.1007/s00109-008-0336-0; Bhaskaran M, 2003, AM J PHYSIOL-RENAL, V284, pF955, DOI 10.1152/ajprenal.00246.2002; Ding G, 2007, AM J PHYSIOL-RENAL, V293, pF1889, DOI 10.1152/ajprenal.00112.2007; Feng WG, 2012, HYPERTENSION, V60, P1226, DOI 10.1161/HYPERTENSIONAHA.112.197871; Galluzzi L, 2008, CELL DEATH DIFFER, V15, P1113, DOI 10.1038/cdd.2008.28; Jha V, 2013, LANCET, V382, P260, DOI 10.1016/S0140-6736(13)60687-X; Jha V, 2012, NEPHROL DIAL TRANSPL, V27, P32, DOI 10.1093/ndt/gfs113; Kalivendi SV, 2005, BIOCHEM J, V389, P527, DOI 10.1042/BJ20050285; Kobori H, 2007, PHARMACOL REV, V59, P251, DOI 10.1124/pr.59.3.3; Konvalinka A, 2013, J BIOL CHEM, V288, P24834, DOI 10.1074/jbc.M113.485326; Kroon AA, 2013, AM J PHYSIOL-LUNG C, V305, pL795, DOI 10.1152/ajplung.00048.2013; Levey AS, 2012, LANCET, V379, P165, DOI 10.1016/S0140-6736(11)60178-5; Li XC, 2006, AM J PHYSIOL-RENAL, V291, pF375, DOI 10.1152/ajprenal.00405.2005; Linkermann A, 2014, NEW ENGL J MED, V370, P455, DOI 10.1056/NEJMra1310050; Linkermann A, 2012, KIDNEY INT, V81, P751, DOI 10.1038/ki.2011.450; Lusthaus M, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00306; Mervaala EMA, 1999, HYPERTENSION, V33, P389, DOI 10.1161/01.HYP.33.1.389; Mohammed-Ali Z, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/172302; Mulay SR, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10274; Murphy JM, 2013, IMMUNITY, V39, P443, DOI 10.1016/j.immuni.2013.06.018; Namsolleck P, 2014, CURR HYPERTENS REP, V16, DOI 10.1007/s11906-013-0416-6; Nangaku M, 2004, INTERNAL MED, V43, P9, DOI 10.2169/internalmedicine.43.9; Pang XF, 2015, DRUG DES DEV THER, V9, P6043, DOI 10.2147/DDDT.S95333; Podhorska-Okolow M, 2004, Rocz Akad Med Bialymst, V49 Suppl 1, P8; Rodriguez DA, 2016, CELL DEATH DIFFER, V23, P76, DOI 10.1038/cdd.2015.70; Sakai N, 2008, J HYPERTENS, V26, P780, DOI 10.1097/HJH.0b013e3282f3e9e6; Siragy HM, 2010, AM J NEPHROL, V31, P541, DOI 10.1159/000313363; Sun LM, 2012, CELL, V148, P213, DOI 10.1016/j.cell.2011.11.031; Tain YL, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18020381; Tammaro A, 2018, CLIN EXP IMMUNOL, V193, P361, DOI 10.1111/cei.13154; Wang M, 2017, PHYTOMEDICINE, V36, P243, DOI 10.1016/j.phymed.2017.10.008; Wolf G, 2005, KIDNEY INT, V67, P799, DOI 10.1111/j.1523-1755.2005.00145.x; Wu HJ, 2015, MOL CELL ENDOCRINOL, V417, P27, DOI 10.1016/j.mce.2015.09.008; Zhang YY, 2018, CELL RES, V28, P9, DOI 10.1038/cr.2017.133; Zhu YJ, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-55550-8; Zhu YJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156729; Zhu YJ, 2015, BIOCHEM BIOPH RES CO, V461, P575, DOI 10.1016/j.bbrc.2015.03.164; Zhuo JL, 2007, J RENIN-ANGIO-ALDO S, V8, P23, DOI 10.3317/jraas.2007.003; Zhuo JL, 2002, HYPERTENSION, V39, P116, DOI 10.1161/hy0102.100780; ZHUO JL, 2006, AM J PHYSIOL-RENAL, V290, pF138, DOI DOI 10.1152/AJPRENAL.00269	40	9	11	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2020	15	3							e0228385	10.1371/journal.pone.0228385	http://dx.doi.org/10.1371/journal.pone.0228385			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8RK	32134954	gold, Green Published			2022-12-26	WOS:000535265600012
J	Minamino, H; Katsushima, M; Yoshida, T; Hashimoto, M; Fujita, Y; Shirakashi, M; Yamamoto, W; Murakami, K; Murata, K; Nishitani, K; Tanaka, M; Ito, H; Inagaki, N; Matsuda, S				Minamino, Hiroto; Katsushima, Masao; Yoshida, Tamami; Hashimoto, Motomu; Fujita, Yoshihito; Shirakashi, Mirei; Yamamoto, Wataru; Murakami, Kosaku; Murata, Koichi; Nishitani, Kohei; Tanaka, Masao; Ito, Hiromu; Inagaki, Nobuya; Matsuda, Shuichi			Increased circulating adiponectin is an independent disease activity marker in patients with rheumatoid arthritis: A cross-sectional study using the KURAMA database	PLOS ONE			English	Article							BODY-MASS INDEX; RADIOGRAPHIC PROGRESSION; PLASMA ADIPONECTIN; INSULIN-RESISTANCE; RISK-FACTORS; ALL-CAUSE; ASSOCIATION; OBESITY; ADIPOSITY; DECREASE	Objective To clarify the relationship among serum adiponectin, body composition, current disease activity and therapeutics of rheumatoid arthritis (RA). Methods We conducted a cross-sectional study in RA patients under treatment with agents including biological disease-modifying antirheumatic drugs (bDMARDs) and Janus kinase (JAK) inhibitors. A total of 351 subjects from the Kyoto University RA Management Alliance cohort (KURAMA) were enrolled in the analysis. We classified the participants into five body composition groups according to the cut-off points for obesity and visceral fat used in Japan: body mass index (BMI), 18.5 kg/m(2) for underweight and 25.0 kg/m(2) for obesity, and visceral fat area (VFA), 100 cm(2) for visceral adiposity. Results Classification of body composition revealed that serum adiponectin levels and disease activity score (DAS28-ESR) in the low BMI group were significantly higher than those in the normal and overweight groups. Because both increased serum adiponectin and low BMI were previously reported as poor prognostic factors of RA, we performed multiple regression analysis to determine which factor was correlated with RA disease activity. Serum adiponectin level, but not BMI, was positively associated with DAS28-ESR (estimate = 0.0127, p = 0.0258). Subanalysis also showed that the use of bDMARD or JAK inhibitor did not have an obvious influence on circulating adiponectin. Conclusions Classification of body composition and multiple regression analysis revealed a positive and independent correlation between serum adiponectin and DAS28-ESR in Japanese RA patients. Thus, serum adiponectin may be an important marker reflecting high disease activity of RA regardless of current medications.	[Minamino, Hiroto; Fujita, Yoshihito; Inagaki, Nobuya] Kyoto Univ, Grad Sch Med, Dept Diabet Endocrinol & Nutr, Kyoto, Japan; [Minamino, Hiroto] Japan Soc Promot Sci, Tokyo, Japan; [Katsushima, Masao] Kyoto Univ, Grad Sch Med, Dept Rheumatol & Clin Immunol, Kyoto, Japan; [Yoshida, Tamami; Shirakashi, Mirei; Murakami, Kosaku] Kyoto Prefectural Univ Med, Dept Nursing, Kyoto, Japan; [Hashimoto, Motomu; Murata, Koichi; Nishitani, Kohei; Tanaka, Masao] Kyoto Univ, Grad Sch Med, Dept Adv Med Rheumat Dis, Kyoto, Japan; [Yamamoto, Wataru] Kurashiki Sweet Hosp, Dept Hlth Informat Management, Kurashiki, Okayama, Japan; [Ito, Hiromu; Matsuda, Shuichi] Kyoto Univ, Grad Sch Med, Dept Orthoped Surg, Kyoto, Japan	Kyoto University; Japan Society for the Promotion of Science; Kyoto University; Kyoto Prefectural University of Medicine; Kyoto University; Kyoto University	Fujita, Y (corresponding author), Kyoto Univ, Grad Sch Med, Dept Diabet Endocrinol & Nutr, Kyoto, Japan.; Hashimoto, M (corresponding author), Kyoto Univ, Grad Sch Med, Dept Adv Med Rheumat Dis, Kyoto, Japan.	mohashim@kuhp.kyoto-u.ac.jp; yfujita9@kuhp.kyoto-u.ac.jp	Nishitani, Kohei/ABB-1788-2021; Minamino, Hiroto/AGT-3680-2022; Minamino, Hiroto/AAY-6654-2021	Minamino, Hiroto/0000-0002-9113-4690; Minamino, Hiroto/0000-0002-9113-4690; Nishitani, Kohei/0000-0002-8327-3826; Inagaki, Nobuya/0000-0001-8261-2593; Yamamoto, Wataru/0000-0002-0810-4221; SHIRAKASHI, Mirei/0000-0003-1135-0463	Daiichi Sankyo Co. Ltd.	Daiichi Sankyo Co. Ltd.(Daiichi Sankyo Company Limited)	This study (KURAMA cohort study) is supported by a grant from Daiichi Sankyo Co. Ltd. The funder had no role in the design of the study, the collection or analysis of the data, the writing of the manuscript or the decision to submit the manuscript for publication.	Albrecht K, 2017, ARTHRITIS RES THER, V19, DOI 10.1186/s13075-017-1266-4; Aletaha D, 2010, ARTHRITIS RHEUM-US, V62, P2569, DOI 10.1002/art.27584; Arita Y, 1999, BIOCHEM BIOPH RES CO, V257, P79, DOI 10.1006/bbrc.1999.0255; Baker JF, 2015, ARTHRITIS RHEUMATOL, V67, P1711, DOI 10.1002/art.39136; Baker JF, 2014, ANN RHEUM DIS, V73, P1923, DOI 10.1136/annrheumdis-2014-205544; Ebina K, 2009, CLIN RHEUMATOL, V28, P445, DOI 10.1007/s10067-008-1074-y; Ehling A, 2006, J IMMUNOL, V176, P4468, DOI 10.4049/jimmunol.176.7.4468; Escalante A, 2005, ARCH INTERN MED, V165, P1624, DOI 10.1001/archinte.165.14.1624; Frommer KW, 2010, ARTHRITIS RHEUM-US, V62, P2886, DOI 10.1002/art.27616; Giles JT, 2009, ARTHRIT RHEUM-ARTHR, V61, P1248, DOI 10.1002/art.24789; Gonzalez-Gay MA, 2008, CLIN EXP RHEUMATOL, V26, P596; Harle P, 2006, ANN RHEUM DIS, V65, P970, DOI 10.1136/ard.2005.040857; Han SJ, 2017, J CLIN ENDOCR METAB, V102, P4626, DOI 10.1210/jc.2017-01703; Hashimoto M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098202; Kadowaki T, 2005, ENDOCR REV, V26, P439, DOI 10.1210/er.2005-0005; Kaufmann J, 2003, J RHEUMATOL, V30, P2350; Kershaw EE, 2004, J CLIN ENDOCR METAB, V89, P2548, DOI 10.1210/jc.2004-0395; Klein-Wieringa IR, 2011, ARTHRITIS RHEUM-US, V63, P2567, DOI 10.1002/art.30449; Lago R, 2008, OSTEOARTHR CARTILAGE, V16, P1101, DOI 10.1016/j.joca.2007.12.008; Laurberg TB, 2009, J RHEUMATOL, V36, P1885, DOI 10.3899/jrheum.080907; Matsuzawa Y, 2002, CIRC J, V66, P987, DOI 10.1253/circj.66.987; McInnes IB, 2017, LANCET, V389, P2328, DOI 10.1016/S0140-6736(17)31472-1; Menzaghi C, 2018, DIABETES, V67, P12, DOI 10.2337/dbi17-0016; Nagashima T, 2008, J RHEUMATOL, V35, P936; Neumann E, 2011, ARTHRITIS RHEUM-US, V63, P1159, DOI 10.1002/art.30291; Okauchi Y, 2007, DIABETES CARE, V30, P2392, DOI 10.2337/dc07-0218; Oshima Y, 2010, OBES RES CLIN PRACT, V4, pE1, DOI 10.1016/j.orcp.2009.06.001; Popa C, 2009, J RHEUMATOL, V36, P724, DOI 10.3899/jrheum.080626; Senolt L, 2006, CYTOKINE, V35, P247, DOI 10.1016/j.cyto.2006.09.002; Serelis J, 2008, CLIN RHEUMATOL, V27, P795, DOI 10.1007/s10067-008-0855-7; Siemons L, 2014, BMC MUSCULOSKEL DIS, V15, DOI 10.1186/1471-2474-15-368; Singh JA, 2016, ARTHRITIS RHEUMATOL, V68, P1, DOI 10.1002/art.39480; Smolen JS, 2017, ANN RHEUM DIS, V76, P960, DOI 10.1136/annrheumdis-2016-210715; Stahl EA, 2010, NAT GENET, V42, P508, DOI 10.1038/ng.582; Sukumaran S, 2012, VITAM HORM, V90, P163, DOI 10.1016/B978-0-12-398313-8.00007-5; Tong KM, 2011, J CELL BIOCHEM, V112, P1431, DOI 10.1002/jcb.23059; Uetani E, 2014, DIABETES CARE, V37, P396, DOI 10.2337/dc13-1658; Westhoff G, 2007, ARTHRITIS RHEUM-US, V56, P3575, DOI 10.1002/art.23033; Weyer C, 2001, J CLIN ENDOCR METAB, V86, P1930, DOI 10.1210/jc.86.5.1930; Yamauchi T, 2001, NAT MED, V7, P941, DOI 10.1038/90984; Yoshida T, 2018, RHEUMATOL INT, V38, P1679, DOI 10.1007/s00296-018-4095-0	41	15	15	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2020	15	3							e0229998	10.1371/journal.pone.0229998	http://dx.doi.org/10.1371/journal.pone.0229998			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8MS	32126127	gold, Green Published			2022-12-26	WOS:000535253100058
J	Peyrony, O; Gerlier, C; Barla, I; Ellouze, S; Legay, L; Azoulay, E; Chevret, S; Fontaine, JP				Peyrony, Olivier; Gerlier, Camille; Barla, Imola; Ellouze, Sami; Legay, Lea; Azoulay, Elie; Chevret, Sylvie; Fontaine, Jean-Paul			Antibiotic prescribing and outcomes in cancer patients with febrile neutropenia in the emergency department	PLOS ONE			English	Article							INFECTIOUS-DISEASES SOCIETY; CLINICAL-PRACTICE GUIDELINE; MASCC RISK-INDEX; MULTINATIONAL-ASSOCIATION; SUPPORTIVE-CARE; SEVERE SEPSIS; SHOCK INDEX; MANAGEMENT; TIME; MORTALITY	Introduction The benefit of reducing the time of antibiotic initiation in the emergency department (ED) for neutropenic patients is controversial and the research on the impact of antibiotic adherence to international guidelines in the ED is scarce. We aimed to investigate the effect of antibiotic timing and appropriateness on outcomes in patients with febrile neutropenia (FN) and to assess the performance of the MASCC risk-index to risk-stratify such patients in the ED. Methods We prospectively identified patients with FN who presented to our ED and assessed their Multinational Association of Supportive Care in Cancer (MASCC) risk-index. The time to parenteral antibiotic initiation and the appropriateness of the antibiotic regimen according to international guidelines were retrospectively abstracted. The performance of the MASCC risk-index in predicting the absence of complication was assessed with sensitivity, specificity and the area under the receiver operating characteristics curve (AUC). We investigated the effect of the time to antibiotic initiation and the appropriateness of the antibiotic regimen on the outcome (ICU admission or death) by logistic regression analyses. Results We included 249 patients. Median age was 60 years and 67.9% had hematological malignancies, 26 (10.4%) were admitted to the ICU and 23 (9.8%) died during hospital stay. Among the 173 patients at low risk according to the MASCC risk-index, 56 (32.4%) presented at least one complication including 11 deaths. The MASCC risk-index had a sensitivity and a specificity of 0.78% and 0.43%, respectively, in predicting the absence of complication and the AUC was 0.67. The time to antibiotic initiation in the ED was not associated with the outcome after adjusting for performance status and shock-index. Conversely, an inadequate ED antibiotic regimen was associated with higher ICU admission or death during hospital stay (OR = 3.50; 95% CI = 1.49 to 8.28). Conclusion An inadequate ED antibiotic regimen in patients with FN was significantly associated with higher ICU admission or death during hospital stay.	[Peyrony, Olivier; Barla, Imola; Ellouze, Sami; Legay, Lea; Fontaine, Jean-Paul] Hop St Louis, Emergency Dept, Paris, France; [Gerlier, Camille] Hop St Joseph, Emergency Dept, Paris, France; [Azoulay, Elie] Hop St Louis, Intens Care Unit, Paris, France; [Azoulay, Elie; Chevret, Sylvie] Univ Paris, Epidemiol & Clin Stat Tumor Resp & Resuscitat Ass, Ctr Rech Epiderniol & Stat, CRESS,INSERM,UMR1153, Paris, France; [Azoulay, Elie; Chevret, Sylvie] Univ Paris, Paris, France; [Chevret, Sylvie] Hop St Louis, Biostat & Med Informat Dept, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; Hopital Paris Saint-Joseph; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite	Peyrony, O (corresponding author), Hop St Louis, Emergency Dept, Paris, France.	o.peyrony@hotmail.fr	GERLIER, CAMILLE/AAZ-8984-2021; peyrony, olivier/D-6872-2017	peyrony, olivier/0000-0001-6831-0054				Averbuch D, 2013, HAEMATOLOGICA, V98, P1826, DOI 10.3324/haematol.2013.091025; Azoulay E, 2015, BLOOD REV, V29, P359, DOI 10.1016/j.blre.2015.04.002; Azoulay E, 2013, J CLIN ONCOL, V31, P2810, DOI 10.1200/JCO.2012.47.2365; Baskaran ND, 2008, ANN HEMATOL, V87, P563, DOI 10.1007/s00277-008-0487-7; Berger T, 2013, WEST J EMERG MED, V14, P168, DOI 10.5811/westjem.2012.8.11546; Brown J, 2016, ANN EMERG MED, V68, P706, DOI 10.1016/j.annemergmed.2016.01.021; Chevret S, 2015, INTENS CARE MED, V41, P348, DOI 10.1007/s00134-014-3624-x; Coyne CJ, 2017, ANN EMERG MED, V69, P755, DOI 10.1016/j.annemergmed.2016.11.007; Daniels LM, 2019, SUPPORT CARE CANC; Freifeld AG, 2011, CLIN INFECT DIS, V52, pE56, DOI 10.1093/cid/cir073; Freund Y, 2019, EUR J EMERG MED, V26, P232, DOI 10.1097/MEJ.0000000000000603; Innes H, 2008, SUPPORT CARE CANCER, V16, P485, DOI 10.1007/s00520-007-0334-8; Kalil AC, 2018, CLIN INFECT DIS, V66, P1631, DOI 10.1093/cid/cix997; Keng MK, 2015, J ONCOL PRACT, V11, P450, DOI 10.1200/JOP.2014.002733; Kim M, 2017, SUPPORT CARE CANCER, V25, P1557, DOI 10.1007/s00520-016-3567-6; Klastersky J, 2000, J CLIN ONCOL, V18, P3038, DOI 10.1200/JCO.2000.18.16.3038; Ko BS, 2015, SUPPORT CARE CANCER, V23, P2799, DOI 10.1007/s00520-015-2645-5; Kristensen AKB, 2016, ANN EMERG MED, V67, P106, DOI 10.1016/j.annemergmed.2015.05.020; Larche J, 2003, INTENS CARE MED, V29, P1688, DOI 10.1007/s00134-003-1957-y; Legrand M, 2012, CRIT CARE MED, V40, P43, DOI 10.1097/CCM.0b013e31822b50c2; Lilford Richard, 2007, J Health Serv Res Policy, V12, P173, DOI 10.1258/135581907781543012; Lynn JJ, 2013, HEMATOL ONCOL, V31, P189, DOI 10.1002/hon.2040; Martinez-Nadal G, 2019, CLIN INFECT DIS; Mokart D, 2014, INTENS CARE MED, V40, P1173, DOI 10.1007/s00134-014-3374-9; Perron T, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/1472-6963-14-162; Peyrony O, 2019, INTERN EMERG MED, V14, P281, DOI 10.1007/s11739-018-1966-z; Rhodes A, 2017, INTENS CARE MED, V43, P304, DOI 10.1007/s00134-017-4683-6; Rosa RG, 2014, ANTIMICROB AGENTS CH, V58, P3799, DOI 10.1128/AAC.02561-14; Sammut SJ, 2012, QJM-INT J MED, V105, P327, DOI 10.1093/qjmed/hcr217; Taplitz RA, 2018, J CLIN ONCOL, V36, P1443, DOI 10.1200/JCO.2017.77.6211; Uys A, 2004, SUPPORT CARE CANCER, V12, P555, DOI 10.1007/s00520-004-0614-5; Viana LD, 2008, SUPPORT CARE CANCER, V16, P841, DOI 10.1007/s00520-007-0347-3; White IR, 2011, STAT MED, V30, P377, DOI 10.1002/sim.4067; Wright JD, 2013, JAMA INTERN MED, V173, P559, DOI 10.1001/jamainternmed.2013.2921	34	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2020	15	2							e0229828	10.1371/journal.pone.0229828	http://dx.doi.org/10.1371/journal.pone.0229828			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8HR	32109264	Green Submitted, gold, Green Published			2022-12-26	WOS:000535239800027
J	Rodrigues, CFB; Serino-Silva, C; de Morais-Zani, K; Kavazoi, VK; Carvalho, MPN; Grego, KF; Chiarelli, T; Tashima, AK; Toyama, MH; Tanaka-Azevedo, AM				Bittencourt Rodrigues, Caroline Fabri; Serino-Silva, Caroline; de Morais-Zani, Karen; Kavazoi, Victor Koiti; Nogueira Carvalho, Marcelo Pires; Grego, Kathleen Fernandes; Chiarelli, Tassia; Tashima, Alexandre Keiji; Toyama, Marcos Hikari; Tanaka-Azevedo, Anita Mitico			Boa.PLI: Structural and functional characterization of the gamma phospholipase A2 plasma inhibitor from the non-venomous Brazilian snake Boa constrictor	PLOS ONE			English	Article							BIOCHEMICAL-CHARACTERIZATION; A(2) INHIBITOR; SERUM	Plasma in several organisms has components that promote resistance to envenomation by inhibiting specific proteins from snake venoms, such as phospholipases A(2) (PLA(2)s). The major hypothesis for inhibitor's presence would be the protection against self-envenomation in venomous snakes, but the occurrence of inhibitors in non-venomous snakes and other animals has opened new perspectives for this molecule. Thus, this study showed for the first time the structural and functional characterization of the PLA(2) inhibitor from the Boa constrictor serum (Boa.PLI), a non-venomous snake that dwells extensively the Brazilian territory. Therefore, the inhibitor was isolated from B. constrictor serum, with 0.63% of recovery. SDS-PAGE showed a band at similar to 25 kDa under reducing conditions and similar to 20 kDa under non-reducing conditions. Chromatographic analyses showed the presence of oligomers formed by Boa.PLI. Primary structure of Boa.PLI suggested an estimated molecular mass of 22 kDa. When Boa.PLI was incubated with Asp-49 and Lys-49 PLA(2) there was no severe change in its dichroism spectrum, suggesting a non-covalent interaction. The enzymatic assay showed a dose-dependent inhibition, up to 48.2%, when Boa.PLI was incubated with Asp-49 PLA(2), since Lys-49 PLA(2) has a lack of enzymatic activity. The edematogenic and myotoxic effects of PLA(2)s were also inhibited by Boa.PLI. In summary, the present work provides new insights into inhibitors from non-venomous snakes, which possess PLIs in their plasma, although the contact with venom is unlikely.	[Bittencourt Rodrigues, Caroline Fabri; Serino-Silva, Caroline; de Morais-Zani, Karen; Tanaka-Azevedo, Anita Mitico] Univ Sao Paulo, Inst Pesquisas Tecnol, Inst Butantan, Interunidades Biotecnol, Sao Paulo, SP, Brazil; [Bittencourt Rodrigues, Caroline Fabri; Serino-Silva, Caroline; de Morais-Zani, Karen; Kavazoi, Victor Koiti; Grego, Kathleen Fernandes; Tanaka-Azevedo, Anita Mitico] Inst Butantan, Lab Herpetol, Sao Paulo, SP, Brazil; [Nogueira Carvalho, Marcelo Pires] Univ Fed Minas Gerais, Belo Horizonte, MG, Brazil; [Chiarelli, Tassia; Tashima, Alexandre Keiji] Univ Fed Sao Paulo, Dept Bioquim, Sao Paulo, SP, Brazil; [Toyama, Marcos Hikari] Univ Estadual Paulista, Inst Biociencias Litoral Paulista, Sao Vicente, SP, Brazil	Instituto Butantan; Universidade de Sao Paulo; Instituto Butantan; Universidade Federal de Minas Gerais; Universidade Federal de Sao Paulo (UNIFESP); Universidade Estadual Paulista	Tanaka-Azevedo, AM (corresponding author), Univ Sao Paulo, Inst Pesquisas Tecnol, Inst Butantan, Interunidades Biotecnol, Sao Paulo, SP, Brazil.; Tanaka-Azevedo, AM (corresponding author), Inst Butantan, Lab Herpetol, Sao Paulo, SP, Brazil.	anita.azevedo@butantan.gov.br	Azevedo, Anita M Tanaka/B-3429-2014; Grego, Kathleen/GOV-3529-2022; de Carvalho, Marcelo/S-6552-2018; Morais-Zani, Karen/B-3821-2014; Grego, Kathleen F/A-6394-2014; Toyama, Marcos Hikari/P-4673-2017	Azevedo, Anita M Tanaka/0000-0002-4694-4475; Grego, Kathleen/0000-0003-4769-5818; de Carvalho, Marcelo/0000-0002-0210-8352; Morais-Zani, Karen/0000-0001-9900-8384; Grego, Kathleen F/0000-0003-4769-5818; Toyama, Marcos Hikari/0000-0001-6836-3084	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior Brasil (CAPES) [001]; Fundacao de Amparo a Pesquisa de Sao Paulo (FAPESP) [2017/16908-2, 2017/20106-9, 2018/25786-0]	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior Brasil (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundacao de Amparo a Pesquisa de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	Funded studies: C.F.B.R. - Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior Brasil (CAPES) - Finance Code 001 K.M.Z. Fundacao de Amparo a Pesquisa de Sao Paulo (FAPESP): 2017/16908-2 A.K.T. - Fundacao de Amparo a Pesquisa de Sao Paulo (FAPESP): 2017/20106-9 A.M.T.A. - Fundacao de Amparo a Pesquisa de Sao Paulo (FAPESP): 2018/25786-0. NO: The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arni RK, 1996, TOXICON, V34, P827, DOI 10.1016/0041-0101(96)00036-0; Belchor MN, 2017, MOLECULES, V22, DOI 10.3390/molecules22091441; Calvete JJ, 2017, BIOCHEM J, V474, P611, DOI 10.1042/BCJ20160577; Campos PC, 2016, J VENOM ANIM TOXINS, V22, DOI 10.1186/s40409-016-0092-5; Chinnasamy S, 2020, INT J BIOL MACROMOL, V144, P53, DOI 10.1016/j.ijbiomac.2019.12.091; Chippaux JP, 2017, J VENOM ANIM TOXINS, V23, DOI 10.1186/s40409-017-0127-6; Gimenes SNC, 2014, TOXICON, V81, P58, DOI 10.1016/j.toxicon.2014.01.012; Coa LL, 2019, BIOSCIENCE REP, V39, DOI 10.1042/BSR20181312; Costa MI, 2008, TOXICON, V52, P122, DOI [10.1016/j.toxicon.2008.04.167, DOI 10.1016/J.TOXICON.2008.04.167]; de Melo AT, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-48433-5; Donnini S, 2011, BIOCHEM J, V440, P251, DOI 10.1042/BJ20100739; Dunn RD, 2001, BBA-MOL CELL BIOL L, V1533, P29, DOI 10.1016/S1388-1981(01)00138-X; Estevo-Costa MI, 2008, TOXICON, V52, P122, DOI 10.1016/j.toxicon.2008.04.167; Fortes-Dias C.L., 2016, SNAKE VENOMS, P1, DOI [10.1007/978-94-007-6648-8_33- 1, DOI 10.1007/978-94-007-6648-8_33-1]; Gutierrez JM, 2008, TOXICON, V51, P80, DOI 10.1016/j.toxicon.2007.08.007; Gutierrez JM, 2017, NAT REV DIS PRIMERS, V3, DOI [10.1038/nrdp.2017.79, 10.1038/nrdp.2017.63]; HABERMANN E, 1978, Toxicon, V16, P19, DOI 10.1016/0041-0101(78)90056-9; Holzer M, 1996, TOXICON, V34, P1149, DOI 10.1016/0041-0101(96)00057-8; Kini RM, 2003, TOXICON, V42, P827, DOI 10.1016/j.toxicon.2003.11.002; Kinkawa K, 2010, BIOCHEM BIOPH RES CO, V395, P377, DOI 10.1016/j.bbrc.2010.04.024; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Macedo DHF, 2010, 11 C SOC BRAS TOX AN; Gutierrez JM, 2009, TOXICON, V54, P976, DOI 10.1016/j.toxicon.2009.01.039; Gutierrez JM, 2009, TOXICON, V53, P625, DOI 10.1016/j.toxicon.2009.01.020; Murakami M, 2015, ALLERGOL INT, V64, P4, DOI 10.1016/j.alit.2014.07.005; Murakami M, 2014, BIOCHIMIE, V107, P105, DOI 10.1016/j.biochi.2014.09.003; Ohkura N, 1997, BIOCHEM J, V325, P527, DOI 10.1042/bj3250527; Oliveira CZ, 2011, CURR TOP MED CHEM, V11, P2509; Oliveira DG, 2002, J PROTEIN CHEM, V21, P161, DOI 10.1023/A:1015320616206; Salvador GHM, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-53755-5; Samy RP, 2012, BIOINFORMATION, V8, P48; Santos-Filho N.A., 2015, TOXINS DRUG DISCOVER, P1, DOI [10.1007/978-94-007-6726-3_12-1, DOI 10.1007/978-94-007-6726-3_12-1]; Santos-Filho NA, 2017, J VENOM ANIM TOXINS, V23, DOI 10.1186/s40409-017-0110-2; Fusco LS, 2015, BIOLOGICALS, V43, P62, DOI 10.1016/j.biologicals.2014.09.001; Serino-Silva C, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0193105; Shirai R, 2009, TOXICON, V53, P685, DOI 10.1016/j.toxicon.2009.02.001; So S, 2008, J MOL EVOL, V66, P298, DOI 10.1007/s00239-008-9089-1; Soares AM, 1998, TOXICON, V36, P503, DOI 10.1016/S0041-0101(97)00133-5; Thwin MM, 2000, BIOCHEMISTRY-US, V39, P9604, DOI 10.1021/bi000395z; Thwin MM, 2002, EUR J BIOCHEM, V269, P719, DOI 10.1046/j.0014-2956.2001.02711.x; Toyama MH, 2000, BBA-GEN SUBJECTS, V1474, P56, DOI 10.1016/S0304-4165(99)00211-1; Williams D, 2010, LANCET, V375, P89, DOI 10.1016/S0140-6736(09)61159-4; Zhong LP, 2016, TOXICON, V122, P1, DOI 10.1016/j.toxicon.2016.09.011	43	6	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2020	15	2							e0229657	10.1371/journal.pone.0229657	http://dx.doi.org/10.1371/journal.pone.0229657			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8GQ	32106235	Green Published, gold			2022-12-26	WOS:000535237000056
J	Varnon, CA; Dinges, CW; Vest, AJ; Abramson, CI				Varnon, Christopher A.; Dinges, Christopher W.; Vest, Adam J.; Abramson, Charles, I			Conspecific and interspecific stimuli reduce initial performance in an aversive learning task in honey bees (Apis mellifera)	PLOS ONE			English	Article							DIVISION-OF-LABOR; PROBOSCIS EXTENSION; NESTMATE RECOGNITION; DECISION-MAKING; BUMBLE BEES; DISCRIMINATION; HABITUATION; DRONES; MEMORY; ODORS	The purpose of this experiment was to investigate whether honey bees (Apis mellifera) are able to use social discriminative stimuli in a spatial aversive conditioning paradigm. We tested bees' ability to avoid shock in a shuttle box apparatus across multiple groups when either shock, or the absence of shock, was associated with a live hive mate, a dead hive mate, a live Polistes exclamans wasp or a dead wasp. Additionally, we used several control groups common to bee shuttle box research where shock was only associated with spatial cues, or where shock was associated with a blue or yellow color. While bees were able to learn the aversive task in a simple spatial discrimination, the presence of any other stimuli (color, another bee, or a wasp) reduced initial performance. While the color biases we discovered are in line with other experiments, the finding that the presence of another animal reduces performance is novel. Generally, it appears that the use of bees or wasps as stimuli initially causes an increase in overall activity that interferes with early performance in the spatial task. During the course of the experiment, the bees habituate to the insect stimuli (bee or wasp), and begin learning the aversive task. Additionally, we found that experimental subject bees did not discriminate between bees or wasps used as stimulus animals, nor did they discriminate between live or dead stimulus animals. This may occur, in part, due to the specialized nature of the worker honey bee. Results are discussed with implications for continual research on honey bees as models of aversive learning, as well as research on insect social learning in general.	[Varnon, Christopher A.] Converse Coll, Dept Psychol, Lab Comparat Psychol & Behav Ecol, Spartanburg, SC 29302 USA; [Dinges, Christopher W.; Vest, Adam J.; Abramson, Charles, I] Oklahoma State Univ, Dept Psychol, Lab Comparat Psychol & Behav Biol, Stillwater, OK 74078 USA	Oklahoma State University System; Oklahoma State University - Stillwater	Varnon, CA (corresponding author), Converse Coll, Dept Psychol, Lab Comparat Psychol & Behav Ecol, Spartanburg, SC 29302 USA.	Christopher.Varnon@Converse.edu			National Science Foundation [DBI 0552717, DBI 1263327, OISE 1545803, GRF 1144467]; National Institutes of Health [P20GM103499]	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This material was based upon work which was supported in part by National Science Foundation grants DBI 0552717, DBI 1263327, OISE 1545803, GRF 1144467 (received by CIA), and by National Institutes of Health grant P20GM103499 (received by CV). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramson CI, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162347; Abramson CI, 2001, J ENTOMOL SCI, V36, P78, DOI 10.18474/0749-8004-36.1.78; ABRAMSON CI, 1986, J COMP PSYCHOL, V100, P108, DOI 10.1037/0735-7036.100.2.108; Agarwal M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025371; Amaya-Marquez M, 2017, J INSECT BEHAV, V30, P728, DOI 10.1007/s10905-017-9653-x; Anaconda, 2019, AN SOFTW DISTR VERS; Avalos A, 2017, BIOL OPEN, V6, P41, DOI 10.1242/bio.021543; Beghetto RA, 2014, PSYCHOL AESTHET CREA, V8, P18, DOI 10.1037/a0035848; BITTERMAN ME, 1983, J COMP PSYCHOL, V97, P107, DOI 10.1037/0735-7036.97.2.107; Black TE, 2018, APIDOLOGIE, V49, P647, DOI 10.1007/s13592-018-0592-0; Breed MD, 1998, BIOSCIENCE, V48, P463, DOI 10.2307/1313244; BREED MD, 1983, ANIM BEHAV, V31, P86, DOI 10.1016/S0003-3472(83)80176-6; Breed MD, 1998, ANIM BEHAV, V55, P13, DOI 10.1006/anbe.1997.0581; CLOGG CC, 1995, AM J SOCIOL, V100, P1261, DOI 10.1086/230638; Couvillon MJ, 2009, J APICULT RES, V48, P225, DOI 10.3896/IBRA.1.48.4.01; Craig DPA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101262; Craig DPA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046729; Craig DPA., 2018, INT J COMP PSYCHOL, V31, P1, DOI [10.46867/ijcp.2018.31.01.10, DOI 10.46867/IJCP.2018.31.01.10]; Dani FR, 2005, CHEM SENSES, V30, P477, DOI 10.1093/chemse/bji040; Dinges CW, 2017, J EXP PSYCHOL-ANIM L, V43, P147, DOI 10.1037/xan0000133; Dinges CW, 2013, J EXP BIOL, V216, P4124, DOI 10.1242/jeb.090100; Eisenhardt D, 2014, LEARN MEMORY, V21, P534, DOI 10.1101/lm.033118.113; Farina WM, 2005, P ROY SOC B-BIOL SCI, V272, P1923, DOI 10.1098/rspb.2005.3172; Fidler F, 2006, CONSERV BIOL, V20, P1539, DOI 10.1111/j.1523-1739.2006.00525.x; Gigerenzer G., 2004, J SOCIO-ECON, V33, P587, DOI DOI 10.1016/J.SOCEC.2004.09.033; Giurfa M, 2001, NATURE, V410, P930, DOI 10.1038/35073582; Giurfa M, 1996, NATURE, V382, P458, DOI 10.1038/382458a0; GOULD JL, 1975, SCIENCE, V189, P685, DOI 10.1126/science.1154023; Gricar J, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00730; Grice JW, 2011, OBSERVATION ORIENTED MODELING: ANALYSIS OF CAUSE IN THE BEHAVIORAL SCIENCES, P1; Grice JW, 2012, BEHAV SCI-BASEL, V2, P1, DOI 10.3390/bs2010001; Grice J, 2017, EDUC PSYCHOL MEAS, V77, P855, DOI 10.1177/0013164416667985; Gross HJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004263; GROVES P M, 1970, Psychological Review, V77, P419, DOI 10.1037/h0029810; HAMMER M, 1995, J NEUROSCI, V15, P1617, DOI 10.1523/JNEUROSCI.15-03-01617.1995; Hardin JW, 2012, GEN ESTIMATING EQUAT; Hori S, 2006, J COMP PHYSIOL A, V192, P691, DOI 10.1007/s00359-005-0091-4; Howard SR, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aav0961; Huang ZY, 1996, BEHAV ECOL SOCIOBIOL, V39, P147, DOI 10.1007/s002650050276; Ichikawa N, 2003, APPL ENTOMOL ZOOL, V38, P203, DOI 10.1303/aez.2003.203; Johnson BR, 2003, P ROY SOC B-BIOL SCI, V270, P147, DOI 10.1098/rspb.2002.2207; Kawaguchi LG, 2006, FUNCT ECOL, V20, P239, DOI 10.1111/j.1365-2435.2006.01086.x; Kawaguchi LG, 2007, P ROY SOC B-BIOL SCI, V274, P2661, DOI 10.1098/rspb.2007.0860; Kimura T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084656; Kirkerud N. H., 2017, FRONT BEHAV NEUROSCI, V11, P1; Leadbeater E, 2007, BEHAV ECOL SOCIOBIOL, V61, P1789, DOI 10.1007/s00265-007-0412-4; Marchal P, 2019, LEARN MEMORY, V26, P412, DOI 10.1101/lm.050120.119; MARKWELL TJ, 1993, NEW ZEAL J ECOL, V17, P85; Matsumoto Y, 2012, J NEUROSCI METH, V211, P159, DOI 10.1016/j.jneumeth.2012.08.018; McAfee A, 2018, SCI REP, V8, P1; Menzel R, 2001, TRENDS COGN SCI, V5, P62, DOI 10.1016/S1364-6613(00)01601-6; Morawetz L, 2013, J COMP PHYSIOL A, V199, P817, DOI 10.1007/s00359-013-0843-5; Muller U, 2012, APIDOLOGIE, V43, P322, DOI 10.1007/s13592-011-0115-8; Mustard JA, 2008, NEUROBIOL LEARN MEM, V90, P633, DOI 10.1016/j.nlm.2008.07.017; Nouvian M, 2019, FRONT PHYSIOL, V10, DOI 10.3389/fphys.2019.00678; Paternoster R, 1998, CRIMINOLOGY, V36, P859, DOI 10.1111/j.1745-9125.1998.tb01268.x; Perktold J, 2018, STATSMODELS VERSION; Plath JA, 2017, FRONT BEHAV NEUROSCI, V11, DOI 10.3389/fnbeh.2017.00098; Rankin CH, 2009, NEUROBIOL LEARN MEM, V92, P135, DOI 10.1016/j.nlm.2008.09.012; Riddell CE, 2006, BRAIN BEHAV IMMUN, V20, P135, DOI 10.1016/j.bbi.2005.06.008; Riveros AJ, 2012, ANIM COGN, V15, P1183, DOI 10.1007/s10071-012-0542-6; Rossi N, 2018, J EXP BIOL, V221, DOI 10.1242/jeb.172270; Schott M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128528; Schulz DJ, 2001, J COMP PHYSIOL A, V187, P53, DOI 10.1007/s003590000177; Scienza L, 2019, J EXP ANAL BEHAV, V112, P74, DOI 10.1002/jeab.531; Seeley TD, 2006, AM SCI, V94, P220, DOI 10.1511/2006.59.220; Seeley TD, 1997, AM NAT, V150, pS22, DOI 10.1086/286048; SEELEY TD, 1989, AM SCI, V77, P546; Skinner BF, 1972, CUMULATIVE RECORD AP; SOUTHWICK EE, 1983, COMP BIOCHEM PHYS A, V75, P641, DOI 10.1016/0300-9629(83)90434-6; Sun Q, 2013, INT J BIOL SCI, V9, P313, DOI 10.7150/ijbs.5781; TAKEDA K, 1961, J INSECT PHYSIOL, V6, P168, DOI 10.1016/0022-1910(61)90060-9; THOMPSON RF, 1966, PSYCHOL REV, V73, P16, DOI 10.1037/h0022681; Urlacher E, 2010, FRONT BEHAV NEUROSCI, V4, DOI 10.3389/fnbeh.2010.00157; Varnon CA, 2018, J MIND BEHAV, V39, P1; Varnon CA, 2013, COMPREHENSIVE PSYCHO, V2, P1; Varnon CA, 2018, ALCOHOL CLIN EXP RES, V42, P1260, DOI 10.1111/acer.13761; Vergoz V, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000288; VISSCHER PK, 1983, ANIM BEHAV, V31, P1070, DOI 10.1016/S0003-3472(83)80014-1; von Frisch K., 1967, DANCE LANGUAGE ORIEN; WITTHOFT W., 1967, Z MORPHOL TIERE, V61, P160, DOI 10.1007/BF00298776; Woodside AG, 2016, J BUS-BUS MARK, V23, P327, DOI 10.1080/1051712X.2016.1258191; Wright GA, 2009, BEHAV NEUROSCI, V123, P36, DOI 10.1037/a0014040	83	1	1	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2020	15	2							e0228161	10.1371/journal.pone.0228161	http://dx.doi.org/10.1371/journal.pone.0228161			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LQ8EV	32097420	gold, Green Published			2022-12-26	WOS:000535232000008
J	De Roos, AJ; Kondo, MC; Robinson, LF; Rai, A; Ryan, M; Haas, CN; Lojo, J; Fagliano, JA				De Roos, Anneclaire J.; Kondo, Michelle C.; Robinson, Lucy F.; Rai, Arjita; Ryan, Michael; Haas, Charles N.; Lojo, Jose; Fagliano, Jerald A.			Heavy precipitation, drinking water source, and acute gastrointestinal illness in Philadelphia, 2015-2017	PLOS ONE			English	Article							UNITED-STATES; EXTREME PRECIPITATION; CRYPTOSPORIDIUM; TURBIDITY; OUTBREAKS; GIARDIA	Runoff from heavy precipitation events can lead to microbiological contamination of source waters for public drinking water supplies. Philadelphia is a city of interest for a study of waterborne acute gastrointestinal illness (AGI) because of frequent heavy precipitation, extensive impervious landcover, and combined sewer systems that lead to overflows. We conducted a time-series analysis of the association between heavy precipitation and AGI incidence in Philadelphia, served by drinking water from Delaware River and Schuylkill River source waters. AGI cases on each day during the study period (2015-2017) were captured through syndromic surveillance of patients' chief complaint upon presentation at local emergency departments. Daily precipitation was represented by measurements at the Philadelphia International Airport and by modeled precipitation within the watershed boundaries, and we also evaluated stream flowrate as a proxy of precipitation. We estimated the association using distributed lag nonlinear models, assuming a quasi-Poisson distribution of the outcome variable and with adjustment for potential confounding by seasonal and long-term time trends, ambient temperature, day-of-week, and major holidays. We observed an association between heavy precipitation and AGI incidence in Philadelphia that was primarily limited to the spring season, with significant increases in AGI that peaked from 8 to 16 days following a heavy precipitation event. For example, the increase in AGI incidence related to airport precipitation above the 95th percentile (vs no precipitation) during spring reached statistical significance on lag day 7, peaked on day 16 (102% increase, 95% confidence interval: 16%, 252%), and declined while remaining significantly elevated through day 28. Similar associations were observed in analyses of watershed-specific precipitation in relation to AGI cases within the populations served by drinking water from each river. Our results suggest that heavy precipitation events in Philadelphia result in detectable local increases in waterborne AGI.	[De Roos, Anneclaire J.; Rai, Arjita; Fagliano, Jerald A.] Drexel Univ, Dept Environm & Occupat Hlth, Dornsife Sch Publ Hlth, Philadelphia, PA 19104 USA; [Kondo, Michelle C.] US Forest Serv, Northern Res Stn, USDA, Philadelphia, PA USA; [Robinson, Lucy F.] Drexel Univ, Dept Epidemiol & Biostat, Dornsife Sch Publ Hlth, Philadelphia, PA 19104 USA; [Ryan, Michael; Haas, Charles N.] Drexel Univ, Coll Engn, Dept Civil Architectural & Environm Engn, Philadelphia, PA 19104 USA; [Lojo, Jose] Philadelphia Dept Publ Hlth, Div Dis Control, Philadelphia, PA USA	Drexel University; United States Department of Agriculture (USDA); United States Forest Service; Drexel University; Drexel University	De Roos, AJ (corresponding author), Drexel Univ, Dept Environm & Occupat Hlth, Dornsife Sch Publ Hlth, Philadelphia, PA 19104 USA.	aderoos@drexel.edu		Kondo, Michelle/0000-0001-9152-1589	Drexel Watershed Consortium pilot award [DWC-16-101]; Academy of Natural Sciences of Drexel University	Drexel Watershed Consortium pilot award; Academy of Natural Sciences of Drexel University	This research was funded through a Drexel Watershed Consortium pilot award (DWC-16-101, Principal Investigator: Anneclaire J. De Roos) from the Academy of Natural Sciences of Drexel University. The funder did not play any role in the study design, data collection or analysis, the decision to publish, or in preparation of the manuscript.	Alfaro J, 2015, UNIV PSYCHOL, V14, P29, DOI 10.11144/Javeriana.upsy14-1.ppeb; Atherholt TB, 1998, J AM WATER WORKS ASS, V90, P66; Barros V.R., 2014, CLIM CHANG 2014 IMP, P688, DOI DOI 10.1017/CBO9781107415324; Betancourt WQ, 2004, VET PARASITOL, V126, P219, DOI 10.1016/j.vetpar.2004.09.002; Curriero FC, 2001, AM J PUBLIC HEALTH, V91, P1194, DOI 10.2105/AJPH.91.8.1194; De Roos AJ, 2017, ENVIRON HEALTH PERSP, V125, DOI 10.1289/EHP1090; Easterling DR, CLIMATE SCI SPECIAL, VI, P207; Gasparrini A, 2010, STAT MED, V29, P2224, DOI 10.1002/sim.3940; Gasparrini A, 2011, J STAT SOFTW, V43, P1, DOI 10.18637/jss.v043.i08; Graciaa DS, 2018, MMWR-MORBID MORTAL W, V67, P701, DOI 10.15585/mmwr.mm6725a1; Hsieh JL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125071; Jagai JS, 2015, ENVIRON HEALTH PERSP, V123, P873, DOI 10.1289/ehp.1408971; LECHEVALLIER MW, 1991, APPL ENVIRON MICROB, V57, P2617, DOI 10.1128/AEM.57.9.2617-2621.1991; Liyanage LRJ, 1997, ENVIRON SCI TECHNOL, V31, P1992, DOI 10.1021/es960801v; NOAA NCEI, CLIM DAT ONL; NOAA/OAR/ESRL PSD (National Oceanic and Atmospheric Administration Oceanic and Atmospheric Research Environmental Systems Research Laboratory Physical Sciences Division), CPC UN GAUG BAS AN D; Nowak DJ, 2012, URBAN FOR URBAN GREE, V11, P21, DOI 10.1016/j.ufug.2011.11.005; Peng RD, 2006, J R STAT SOC A STAT, V169, P179, DOI 10.1111/j.1467-985X.2006.00410.x; Pintar KDM, 2009, EPIDEMIOL INFECT, V137, P1789, DOI 10.1017/S0950268809990197; PWD, 2018, PHILL WAT; PWD, 2019, STORMW OUTF; PWD (Philadelphia Water Department), 2018, 2017 DRINK WAT QUAL; Rha B, 2013, EMERG INFECT DIS, V19, P1214, DOI 10.3201/eid1908.130483; Roy SL, 2004, J CLIN MICROBIOL, V42, P2944, DOI 10.1128/JCM.42.7.2944-2951.2004; Schwartz J, 2000, J EPIDEMIOL COMMUN H, V54, P45, DOI 10.1136/jech.54.1.45; Schwartz J, 1999, EPIDEMIOLOGY, V10, P86, DOI 10.1097/00001648-199901000-00017; USGS, NAT WAT INF SYST; Yoder JS, 2010, EXP PARASITOL, V124, P31, DOI 10.1016/j.exppara.2009.09.020	28	2	2	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2020	15	2							e0229258	10.1371/journal.pone.0229258	http://dx.doi.org/10.1371/journal.pone.0229258			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8DW	32092111	gold, Green Published			2022-12-26	WOS:000535229300037
J	Tamura, I; Takagi, H; Doi-Tanaka, Y; Shirafuta, Y; Mihara, Y; Shinagawa, M; Maekawa, R; Taketani, T; Sato, S; Tamura, H; Sugino, N				Tamura, Isao; Takagi, Haruka; Doi-Tanaka, Yumiko; Shirafuta, Yuichiro; Mihara, Yumiko; Shinagawa, Masahiro; Maekawa, Ryo; Taketani, Toshiaki; Sato, Shun; Tamura, Hiroshi; Sugino, Norihiro			Wilms tumor 1 regulates lipid accumulation in human endometrial stromal cells during decidualization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						lipid droplet; gene regulation; cyclic AMP (cAMP); cell differentiation; lipid metabolism; decidualization; endometrial stromal cells (ESCs); pregnancy; very low-density lipoprotein receptor (VLDLR); Wilms tumor 1 (WT1)	HISTONE ACETYLATION STATUS; PROMOTER REGION; DNA METHYLATION; GRANULOSA-CELLS; VLDL RECEPTOR; MN-SOD; EXPRESSION; WT1; PROGESTERONE; INDUCTION	We previously reported that the transcription factor Wilms tumor 1 (WT1) regulates the expression of insulin-like growth factor-binding protein-1 (IGFBP-1) and prolactin (PRL) during decidualization of human endometrial stromal cells (ESCs). However, other roles of WT1 in decidualization remain to be fully clarified. Here, we investigated how WT1 regulates the physiological functions of human ESCs during decidualization. We incubated ESCs isolated from proliferative-phase endometrium with cAMP to induce decidualization, knocked down WT1 with siRNA, and generated three types of treatments (nontreated cells, cAMP-treated cells, and cAMP-treated + WT1-knockdown cells). To identify WT1-regulated genes, we used gene microarrays and compared the transcriptome data obtained among these three treatments. We observed that WT1 up-regulates 121 genes during decidualization, including several genes involved in lipid transport. The WT1 knockdown inhibited lipid accumulation (LA) in the cAMP-induced ESCs. To examine the mechanisms by which WT1 regulates LA, we focused on very low-density lipoprotein receptor (VLDLR), which is involved in lipoprotein uptake. We found that cAMP up-regulates VLDLR and that the WT1 knockdown inhibits it. Results of ChIP assays revealed that cAMP increases the recruitment of WT1 to the promoter region of the VLDLR gene, indicating that WT1 regulates VLDLR expression. Moreover, VLDLR knockdown inhibited cAMP-induced LA, and VLDLR overexpression reverted the suppression of LA caused by the WT1 knockdown. Taken together, our results indicate that WT1 enhances lipid storage by up-regulating VLDLR expression in human ESCs during decidualization.	[Tamura, Isao; Takagi, Haruka; Doi-Tanaka, Yumiko; Shirafuta, Yuichiro; Mihara, Yumiko; Shinagawa, Masahiro; Maekawa, Ryo; Taketani, Toshiaki; Sato, Shun; Tamura, Hiroshi; Sugino, Norihiro] Yamaguchi Univ, Dept Obstet & Gynecol, Grad Sch Med, Minamikogushi 1-1-1, Ube, Yamaguchi 7558505, Japan	Yamaguchi University	Tamura, I (corresponding author), Minamikogushi 1-1-1, Ube, Yamaguchi 7558505, Japan.	isao@yamaguchi-u.ac.jp	Maekawa, Ryo/AAR-4233-2020	Maekawa, Ryo/0000-0003-0923-376X; Tamura, Isao/0000-0002-0737-5556	Japan Society for the Promotion of Science KAKENHI [16K11091, 16K20191, 16K11142, 17K11239, 18K09230, 18K16772, 18K09262, 19K09803]	Japan Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Japan Society for the Promotion of Science KAKENHI Grants 16K11091, 16K20191, 16K11142, 17K11239, 18K09230, 18K16772, 18K09262, and 19K09803. The authors declare that they have no conflicts of interest with the contents of this article.	Anthony FW, 2003, J SOC GYNECOL INVEST, V10, P509, DOI 10.1016/S1071-5576(03)00147-3; Bombail V, 2010, J CLIN ENDOCR METAB, V95, pE224, DOI 10.1210/jc.2010-0154; C elegans Sequencing Consortium, 1998, SCIENCE, V282, P2012, DOI 10.1126/science.282.5396.2012; Dean M, 2019, BIOL REPROD, V101, P297, DOI 10.1093/biolre/ioz102; Desarzens S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094127; Dourlen P, 2015, PROG LIPID RES, V60, P30, DOI 10.1016/j.plipres.2015.08.001; Du M, 2016, J AM HEART ASSOC, V5, DOI 10.1161/JAHA.116.004440; Fischbach BV, 2005, PEDIATRICS, V116, P984, DOI 10.1542/peds.2004-0467; Frolova AI, 2011, ENDOCRINOLOGY, V152, P2123, DOI 10.1210/en.2010-1266; Gellersen B, 2007, SEMIN REPROD MED, V25, P445, DOI 10.1055/s-2007-991042; Gellersen B, 2014, ENDOCR REV, V35, P851, DOI 10.1210/er.2014-1045; Jozaki K, 2019, REPRODUCTION, V157, P457, DOI 10.1530/REP-18-0393; Kajihara T, 2014, REPROD SCI, V21, P372, DOI 10.1177/1933719113497280; Klattig J, 2007, MOL CELL BIOL, V27, P4355, DOI 10.1128/MCB.01780-06; KREIDBERG JA, 1993, CELL, V74, P679, DOI 10.1016/0092-8674(93)90515-R; Lee Hong Jun, 2014, Ann Pediatr Endocrinol Metab, V19, P100, DOI 10.6065/apem.2014.19.2.100; Lee L, 2013, ENDOCRINOLOGY, V154, P458, DOI 10.1210/en.2012-1610; Li XL, 2013, MOL ENDOCRINOL, V27, P2041, DOI 10.1210/me.2013-1191; Maekawa R, 2019, BMC GENOMICS, V20, DOI 10.1186/s12864-019-5695-0; Maekawa R, 2016, MOL ENDOCRINOL, V30, P335, DOI 10.1210/me.2015-1058; Maekawa R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066632; Makrigiannakis A, 2001, J CLIN ENDOCR METAB, V86, P5964, DOI 10.1210/jc.86.12.5964; Martin S, 2006, NAT REV MOL CELL BIO, V7, P373, DOI 10.1038/nrm1912; Matsuoka A, 2010, J CLIN ENDOCR METAB, V95, pE291, DOI 10.1210/jc.2010-0619; McKillop LH, 2019, CELL SIGNAL, V62, DOI 10.1016/j.cellsig.2019.06.001; Mo H, 2016, BIOCHEM BIOPH RES CO, V478, P74, DOI 10.1016/j.bbrc.2016.07.090; Motamedi FJ, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5444; NAKAGAMA H, 1995, MOL CELL BIOL, V15, P1489; NOYES RW, 1950, FERTIL STERIL, V1, P3, DOI 10.1016/s0015-0282(16)30062-0; Okada M, 2016, ENDOCRINOLOGY, V157, P3344, DOI 10.1210/en.2016-1264; Perman JC, 2011, J CLIN INVEST, V121, P2625, DOI 10.1172/JCI43068; Perugorria MJ, 2009, CANCER RES, V69, P1358, DOI 10.1158/0008-5472.CAN-08-2545; Popovici RM, 2000, ENDOCRINOLOGY, V141, P3510, DOI 10.1210/en.141.9.3510; Rumman M, 2015, STEM CELLS, V33, P2903, DOI 10.1002/stem.2056; Shandilya J, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5903; Shinagawa M, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-018-36566-y; Spasic M, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002433; Sultana S, 2017, REPROD MED BIOL, V16, P170, DOI 10.1002/rmb2.12028; Takahashi S, 2017, J ATHEROSCLER THROMB, V24, P552, DOI 10.5551/jat.RV17004; Takazawa T, 2009, J BIOL CHEM, V284, P30049, DOI 10.1074/jbc.M109.047993; Tamura I, 2018, J BIOL CHEM, V293, P5270, DOI 10.1074/jbc.RA117.000234; Tamura I, 2017, ENDOCRINOLOGY, V158, P3696, DOI 10.1210/en.2017-00478; Tamura I, 2014, MOL ENDOCRINOL, V28, P1656, DOI 10.1210/me.2014-1117; Tamura I, 2014, ENDOCRINOLOGY, V155, P275, DOI 10.1210/en.2013-1569; Tamura I, 2012, ENDOCRINOLOGY, V153, P5612, DOI 10.1210/en.2012-1420; Tamura I, 2011, J CLIN ENDOCR METAB, V96, pE1073, DOI 10.1210/jc.2010-2489; Tatsumi T, 2018, DEVELOPMENT, V145, DOI 10.1242/dev.161893; Wei SJ, 2018, CELL PHYSIOL BIOCHEM, V48, P2528, DOI 10.1159/000492697; Yang D, 2014, FEBS LETT, V588, P4448, DOI 10.1016/j.febslet.2014.09.046; Yoshida T, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-14063-y	50	8	8	5	9	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 3	2020	295	14					4673	4683		10.1074/jbc.RA120.012841	http://dx.doi.org/10.1074/jbc.RA120.012841			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LB2WZ	32098869	hybrid, Green Published			2022-12-26	WOS:000524499700025
J	Davey, JR; Estevez, E; Thomson, RE; Whitham, M; Watt, KI; Hagg, A; Qian, HW; Henstridge, DC; Ludlow, H; Hedger, MP; McGee, SL; Coughlan, MT; Febbraio, MA; Gregorevic, P				Davey, Jonathan R.; Estevez, Emma; Thomson, Rachel E.; Whitham, Martin; Watt, Kevin I.; Hagg, Adam; Qian, Hongwei; Henstridge, Darren C.; Ludlow, Helen; Hedger, Mark P.; McGee, Sean L.; Coughlan, Melinda T.; Febbraio, Mark A.; Gregorevic, Paul			Intravascular Follistatin gene delivery improves glycemic control in a mouse model of type 2 diabetes	FASEB JOURNAL			English	Article						Activin; diabetes; Follistatin; gene therapy; skeletal muscle	BETA-CELL DEDIFFERENTIATION; ACTIVIN-A; INSULIN; EXPRESSION; APOPTOSIS; MASS; TRANSCRIPTION; MUTATION	Type 2 diabetes (T2D) manifests from inadequate glucose control due to insulin resistance, hypoinsulinemia, and deteriorating pancreatic beta -cell function. The pro-inflammatory factor Activin has been implicated as a positive correlate of severity in T2D patients, and as a negative regulator of glucose uptake by skeletal muscle, and of pancreatic beta -cell phenotype in mice. Accordingly, we sought to determine whether intervention with the Activin antagonist Follistatin can ameliorate the diabetic pathology. Here, we report that an intravenous Follistatin gene delivery intervention with tropism for striated muscle reduced the serum concentrations of Activin B and improved glycemic control in the db/db mouse model of T2D. Treatment reversed the hyperglycemic progression with a corresponding reduction in the percentage of glycated-hemoglobin to levels similar to lean, healthy mice. Follistatin gene delivery promoted insulinemia and abundance of insulin-positive pancreatic beta -cells, even when treatment was administered to mice with advanced diabetes, supporting a mechanism for improved glycemic control associated with maintenance of functional beta -cells. Our data demonstrate that single-dose intravascular Follistatin gene delivery can ameliorate the diabetic progression and improve prognostic markers of disease. These findings are consistent with other observations of Activin-mediated mechanisms exerting deleterious effects in models of obesity and diabetes, and suggest that interventions that attenuate Activin signaling could help further understanding of T2D and the development of novel T2D therapeutics.	[Davey, Jonathan R.; Thomson, Rachel E.; Watt, Kevin I.; Hagg, Adam; Qian, Hongwei; Gregorevic, Paul] Univ Melbourne, Dept Physiol, Ctr Muscle Res, Parkville, Vic 3010, Australia; [Davey, Jonathan R.; Estevez, Emma; Thomson, Rachel E.; Whitham, Martin; Watt, Kevin I.; Hagg, Adam; Qian, Hongwei; Gregorevic, Paul] Baker Heart & Diabet Inst, Melbourne, Vic, Australia; [Whitham, Martin] Univ Birmingham, Coll Life & Environm Sci, Edgbaston, England; [Watt, Kevin I.; Coughlan, Melinda T.] Monash Univ, Dept Diabet, Cent Clin Sch, Melbourne, Vic, Australia; [Hagg, Adam] Monash Univ, Dept Physiol, Clayton, Vic, Australia; [Henstridge, Darren C.] Univ Tasmania, Sch Hlth Sci, Launceston, Tas, Australia; [Ludlow, Helen] Oxford Brookes Univ, Sch Life Sci, Oxford, England; [Hedger, Mark P.] Hudson Inst Med Res, Clayton, Vic, Australia; [McGee, Sean L.] Deakin Univ, Sch Med, Waurn Ponds, Vic, Australia; [Febbraio, Mark A.] Monash Univ, Monash Inst Pharmaceut Sci, Parkville, Vic, Australia; [Gregorevic, Paul] Monash Univ, Dept Biochem & Mol Biol, Clayton, Vic, Australia; [Gregorevic, Paul] Univ Washington, Dept Neurol, Seattle, WA 98195 USA	University of Melbourne; Baker Heart and Diabetes Institute; University of Birmingham; Monash University; Monash University; University of Tasmania; Oxford Brookes University; Hudson Institute of Medical Research; Deakin University; Monash University; Monash University; University of Washington; University of Washington Seattle	Gregorevic, P (corresponding author), Univ Melbourne, Dept Physiol, Ctr Muscle Res, Parkville, Vic 3010, Australia.	pgre@unimelb.edu.au	Hedger, Mark P/C-3495-2008; Watt, Kevin I./AAF-6703-2021; Gregorevic, Paul/AAH-6040-2021	Watt, Kevin I./0000-0001-7475-4487; Gregorevic, Paul/0000-0002-7418-8945; Whitham, Martin/0000-0002-0254-762X; Febbraio, Mark/0000-0002-9296-4418; Estevez, Emma/0000-0002-5125-2190; Hagg, Adam/0000-0001-7951-743X				Ashcroft FM, 2012, CELL, V148, P1160, DOI 10.1016/j.cell.2012.02.010; BAETENS D, 1978, DIABETES, V27, P1, DOI 10.2337/diabetes.27.1.1; Bertolino P, 2008, P NATL ACAD SCI USA, V105, P7246, DOI 10.1073/pnas.0801285105; Blum B, 2014, ELIFE, V3, DOI 10.7554/eLife.02809; Butler AE, 2003, DIABETES, V52, P2304, DOI 10.2337/diabetes.52.9.2304; Butler AE, 2003, DIABETES, V52, P102, DOI 10.2337/diabetes.52.1.102; Chen H, 1996, CELL, V84, P491, DOI 10.1016/S0092-8674(00)81294-5; Chen JL, 2014, FASEB J, V28, P1711, DOI 10.1096/fj.13-245894; Cinti F, 2016, J CLIN ENDOCR METAB, V101, P1044, DOI 10.1210/jc.2015-2860; Davey JR, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.85477; de Kretser DM, 1999, J ENDOCRINOL, V161, P195, DOI 10.1677/joe.0.1610195; DEFRONZO RA, 1985, J CLIN INVEST, V76, P149, DOI 10.1172/JCI111938; Dor Y, 2013, NEW ENGL J MED, V368, P572, DOI 10.1056/NEJMcibr1214034; Gao T, 2014, CELL METAB, V19, P259, DOI 10.1016/j.cmet.2013.12.002; Gregorevic P, 2004, NAT MED, V10, P828, DOI 10.1038/nm1085; Guo SL, 2013, J CLIN INVEST, V123, P3305, DOI 10.1172/JCI65390; Guo TQ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004937; Han XQ, 2019, J CACHEXIA SARCOPENI, V10, P1241, DOI 10.1002/jcsm.12474; HUMMEL KP, 1966, SCIENCE, V153, P1127, DOI 10.1126/science.153.3740.1127; Ishida E, 2017, DIABETES, V66, P2092, DOI 10.2337/db16-1213; Izumiya Y, 2008, CELL METAB, V7, P159, DOI 10.1016/j.cmet.2007.11.003; Jha JC, 2014, J AM SOC NEPHROL, V25, P1237, DOI 10.1681/ASN.2013070810; Jones KL, 2007, P NATL ACAD SCI USA, V104, P16239, DOI 10.1073/pnas.0705971104; Kahn SE, 2014, LANCET, V383, P1068, DOI 10.1016/S0140-6736(13)62154-6; Kim-Muller JY, 2014, CELL METAB, V20, P593, DOI 10.1016/j.cmet.2014.08.012; Knight PG, 1996, J ENDOCRINOL, V148, P267, DOI 10.1677/joe.0.1480267; Kota J, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000112; Lassila M, 2004, J AM SOC NEPHROL, V15, P2125, DOI 10.1097/01.ASN.0000133025.23732.46; Lee SJ, 2001, P NATL ACAD SCI USA, V98, P9306, DOI 10.1073/pnas.151270098; Lin HM, 2009, J BIOL CHEM, V284, P12246, DOI 10.1074/jbc.M805379200; Ludlow H, 2009, CLIN ENDOCRINOL, V71, P867, DOI 10.1111/j.1365-2265.2009.03567.x; McPherron AC, 2012, DIABETES OBES METAB, V14, P279, DOI 10.1111/j.1463-1326.2011.01520.x; McPherron AC, 2002, J CLIN INVEST, V109, P595, DOI 10.1172/JCI200213562; Mendell JR, 2015, MOL THER, V23, P192, DOI 10.1038/mt.2014.200; Nakatani M, 2011, AM J PHYSIOL-ENDOC M, V300, pE543, DOI 10.1152/ajpendo.00430.2010; Page MM, 2018, FASEB J, V32, P1196, DOI [10.1096/fj.201700518R, 10.1096/fj.201700518r]; Ripoche D, 2016, MOL CELL BIOL, V36, P756, DOI 10.1128/MCB.00930-15; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Singh R, 2018, DIABET METAB SYND OB, V11, P65, DOI 10.2147/DMSO.S159315; Szabat M, 2010, DIABETOLOGIA, V53, P1680, DOI 10.1007/s00125-010-1758-0; Talchai C, 2012, CELL, V150, P1223, DOI 10.1016/j.cell.2012.07.029; Tao RY, 2018, NAT MED, V24, P1058, DOI 10.1038/s41591-018-0048-0; Tersey SA, 2018, FASEB J, V32, P6150, DOI 10.1096/fj.201800150RR; Thompson TB, 2005, DEV CELL, V9, P535, DOI 10.1016/j.devcel.2005.09.008; Wang ZY, 2014, CELL METAB, V19, P872, DOI 10.1016/j.cmet.2014.03.010; Weir GC, 2004, DIABETES, V53, pS16, DOI 10.2337/diabetes.53.suppl_3.S16; Winbanks CE, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aac4976; Winbanks CE, 2012, J CELL BIOL, V197, P997, DOI 10.1083/jcb.201109091; Wu H, 2012, EXP DIABETES RES, DOI 10.1155/2012/410579; Zhang N, 2006, DIABETOLOGIA, V49, P506, DOI 10.1007/s00125-005-0095-1; Zhao CX, 2015, MOL THER, V23, P866, DOI 10.1038/mt.2015.29	52	4	4	1	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2020	34	4					5697	5714		10.1096/fj.201802059RRR	http://dx.doi.org/10.1096/fj.201802059RRR			18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	LJ5ZA	32141144	Bronze			2022-12-26	WOS:000530242100058
J	Hassan, O; Chang, T; Hossain, A				Hassan, Oliul; Chang, Taehyun; Hossain, Abul			Changes in the secondary compounds of persimmon leaves as a defense against circular leaf spot caused by Plurivorosphaerella nawae	PLOS ONE			English	Article							PHENOLIC-COMPOUNDS; MYCOSPHAERELLA-NAWAE; ANTIOXIDANT ACTIVITY; TANNINS; RESISTANCE; FLAVAN-3-OLS; INFECTION; DYNAMICS; INOCULUM; PLANTS	Circular leaf spot, caused by the ascomycetous fungus Plurivorosphaerella nawae (= Mycosphaerella nawae), is the most problematic fungal disease of persimmon worldwide. In Korea, persimmon exposed to P. nawae inoculum (ascospores) from May to August shows visible circular leaf spot disease symptoms from the end of August to early September. It is important to identify factors affecting this long latent period. The objective of this study was to elucidate the relation between the development of symptom of circular leaf spot and the content of phenolics compounds and vitamin C as well as the antioxidant activities in leaves. Healthy leaves (both young and old) and infected leaves of circular leaf spot-susceptible persimmon cultivar were harvested in 2016. The content of phenolics (total phenols, flavonoids, and tannins) and vitamin C, and their antioxidant activities were analyzed in all types of leaves. Compared with the asymptomatic leaves (old) and the asymptomatic parts of the infected leaves, the symptomatic parts of the infected leaves, symptomatic leaves, and asymptomatic young leaves showed significantly higher content of phenolics and vitamin C, and higher antioxidant activities. Disease incidence and severity were estimated for older leaves (emerged in early May) and younger leaves (emerged at the end of June) in 2017 and 2018. The AUDPC was higher in old leaves than younger leaves. The disease progression was much faster and severe in the older than in the younger leaves. Similar results were found in field experiments. Higher content of phenolics and antioxidant activities in the younger leaves may contribute to circular leaf spot resistance in persimmon. Furthermore, accumulation of phenolics and antioxidant activity in the infected leaves is a post-infection response and the first stage of the defense mechanism.	[Hassan, Oliul; Chang, Taehyun] Kyungpook Natl Univ, Coll Ecol & Environm Sci, Dept Ecol & Environm Syst, Sangju Si, Gyeongsangbuk D, South Korea; [Hossain, Abul] Mem Univ Newfoundland, Dept Biochem, St John, NF, Canada	Kyungpook National University; Memorial University Newfoundland	Chang, T (corresponding author), Kyungpook Natl Univ, Coll Ecol & Environm Sci, Dept Ecol & Environm Syst, Sangju Si, Gyeongsangbuk D, South Korea.	thchang@knu.ac.kr	Hossain, Abul/AAQ-7524-2020; Hossain, Abul/AAE-4714-2020	Hossain, Abul/0000-0002-7519-8555; Chang, Taehyun/0000-0002-0213-7444; Hassan, Oliul/0000-0001-9514-4581	Cooperative Research Program for Correspondence Competitiveness Improvement Technology Development [PJ01169703]; Rural Development Administration, Korea	Cooperative Research Program for Correspondence Competitiveness Improvement Technology Development; Rural Development Administration, Korea(Rural Development Administration (RDA), Republic of Korea)	This study was supported by a grant from the Cooperative Research Program for Correspondence Competitiveness Improvement Technology Development (Project No. PJ01169703) of the Rural Development Administration, Korea. No authors received a salary from the funder.	Agrios NG, 2005, PLANT PATHOL, P93; Arici SE, 2014, PHARM BIOL, V52, P904, DOI 10.3109/13880209.2013.872674; Arun K., 2010, International Journal of Plant Physiology and Biochemistry, V2, P6; Aver'yanov A. A., 1985, BIOL BULL, V4, P352; Balasundram N, 2006, FOOD CHEM, V99, P191, DOI 10.1016/j.foodchem.2005.07.042; Barbehenn RV, 2011, PHYTOCHEMISTRY, V72, P1551, DOI 10.1016/j.phytochem.2011.01.040; Bassimba DDM, 2017, ANN APPL BIOL, V170, P391, DOI 10.1111/aab.12343; Bhattacharya A, 2010, MOL PLANT PATHOL, V11, P705, DOI [10.1111/J.1364-3703.2010.00625.X, 10.1111/j.1364-3703.2010.00625.x]; Boubakri H., 2017, ASCORBIC ACID PLANT, P255, DOI DOI 10.1007/978-3-319-74057-7_10; Boubakri H, 2016, PLANTA, V244, P529, DOI 10.1007/s00425-016-2552-0; BROADHURST RB, 1978, J SCI FOOD AGR, V29, P788, DOI 10.1002/jsfa.2740290908; Freeman BC., 2008, OVERVIEW PLANT DEFEN, DOI [10.1094/PHI-I-2008-0226-01, 10.1094/PHI-I-2008-0226-01%20, DOI 10.1094/PHI-I-2008-0226-01]; Hassan O, 2019, PLANT DIS, V103, P200, DOI [10.1094/PDIS-05-18-0857-RE, 10.1094/pdis-05-18-0857-re]; Hassan O, 2018, J PLANT PATHOL, V100, P543, DOI 10.1007/s42161-018-0122-y; Hossain A, 2018, FOOD SCI BIOTECHNOL, V27, P177, DOI 10.1007/s10068-017-0195-y; Hossain A, 2017, BIOSCI BIOTECH BIOCH, V81, P2079, DOI 10.1080/09168451.2017.1378088; Ikata S, 1929, SPECIAL B OKAYAMA PR, V33, P1; Islam FMA, 2003, PLANT FOOD HUM NUTR, V58, P285, DOI 10.1023/B:QUAL.0000040283.51023.c2; 정승일, 2010, [Korean Journal of Pharmacognosy, 생약학회지], V41, P255; Jia Z, 1999, FOOD CHEM, V64, P555, DOI 10.1016/S0308-8146(98)00102-2; Jo C, 2003, RADIAT PHYS CHEM, V67, P143, DOI 10.1016/S0969-806X(02)00443-7; Khan M. M. R., 2006, Journal of Biological Sciences, V6, P388; Kulbat K., 2016, BIOTECH FOOD SCI, V80, P97; Kwon J-H., 2004, RES PLANT DIS, V10, P209, DOI DOI 10.5423/RPD.2004.10.4.209; Kwon JinHyeuk, 1998, Korean Journal of Plant Pathology, V14, P393; Kwon JinHyeuk, 1995, Korean Journal of Plant Pathology, V11, P344; Kwon JinHyeuk, 1998, Korean Journal of Plant Pathology, V14, P397; Lin DR, 2016, MOLECULES, V21, DOI 10.3390/molecules21101374; Madden L.V., 2007, AM PHYTOPATHOLOGICAL, DOI [10.1094/9780890545058, DOI 10.1094/9780890545058]; Martinia S, 2009, INT J ANTIMICROB AG, V34, P50, DOI 10.1016/j.ijantimicag.2009.01.010; MATERN U, 1988, PHYTOPARASITICA, V16, P153, DOI 10.1007/BF02980469; MATSUO T, 1978, AGR BIOL CHEM TOKYO, V42, P1637, DOI 10.1080/00021369.1978.10863225; Mikulic-Petkovsek M, 2014, PLANT PATHOL, V63, P185, DOI 10.1111/ppa.12081; Mikulic-Petkovsek M, 2011, BIOL PLANTARUM, V55, P725, DOI 10.1007/s10535-011-0176-6; Mikulic-Petkovsek M, 2009, PHYSIOL MOL PLANT P, V74, P60, DOI 10.1016/j.pmpp.2009.09.003; Oszmianski J, 2015, MOLECULES, V20, P2176, DOI 10.3390/molecules20022176; Pereira DM, 2009, MOLECULES, V14, P2202, DOI 10.3390/molecules14062202; RCore Team, 2020, R LANG ENV STAT COMP; Schijlen EGW, 2004, PHYTOCHEMISTRY, V65, P2631, DOI 10.1016/j.phytochem.2004.07.028; Shahidi F, 2006, FOOD CHEM, V99, P478, DOI 10.1016/j.foodchem.2005.08.009; Shilpashree K., 2013, Karnataka Journal of Agricultural Sciences, V26, P318; Singleton VL., 1965, AM J ENOL VITICULT, V16, P144, DOI DOI 10.12691/IJEBB-2-1-5; SOMERS TC, 1967, AUST J BIOL SCI, V20, P475, DOI 10.1071/BI9670475; Thaipong K, 2006, J FOOD COMPOS ANAL, V19, P669, DOI 10.1016/j.jfca.2006.01.003; Townsend G. R., 1943, PLANT DIS REPORTER, V27, P340; TREUTTER D, 1990, J HORTIC SCI BIOTECH, V65, P511, DOI 10.1080/00221589.1990.11516087; TREUTTER D, 1990, Z PFLANZENK PFLANZEN, V97, P634; Vicent A, 2012, EUR J PLANT PATHOL, V134, P289, DOI 10.1007/s10658-012-9989-1; Wang LW, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01251; Xu BJ, 2007, J FOOD SCI, V72, pS159, DOI 10.1111/j.1750-3841.2006.00260.x; 정우영, 2012, [The Korea Journal of Herbology, 대한본초학회지], V27, P41	51	2	3	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2020	15	3							e0230286	10.1371/journal.pone.0230286	http://dx.doi.org/10.1371/journal.pone.0230286			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8TR	32142558	Green Published, gold			2022-12-26	WOS:000535271600043
J	Mittra, I; Pal, K; Pancholi, N; Tidke, P; Siddiqui, S; Rane, B; D'souza, J; Shaikh, A; Parab, S; Shinde, S; Jadhav, V; Shende, S; Raghuram, GV				Mittra, Indraneel; Pal, Kavita; Pancholi, Namrata; Tidke, Pritish; Siddiqui, Sophiya; Rane, Bhagyeshri; D'souza, Jenevieve; Shaikh, Alfina; Parab, Saili; Shinde, Sushma; Jadhav, Vishal; Shende, Soniya; Raghuram, Gorantla, V			Cell-free chromatin particles released from dying host cells are global instigators of endotoxin sepsis in mice	PLOS ONE			English	Article							EXTRACELLULAR HISTONES; NUCLEIC-ACIDS; HEALTHY CELLS; MEDIATORS; DEATH; DNA; RESVERATROL; COAGULOPATHY; INFLAMMATION; COAGULATION	We have earlier reported that cell-free chromatin (cfCh) particles that are released from dying cells, or those that circulate blood, can readily enter into healthy cells, illegitimately integrate into their genomes and induce dsDNA breaks, apoptosis and intense activation of inflammatory cytokines. We hypothesized that sepsis is caused by cfCh released from dying host cells following microbial infection leading to bystander host cell apoptosis and inflammation which are perpetuated in a vicious cycle with release of more cfCh from dying host cells. To test this hypothesis we used three cfCh inactivating agents namely 1) anti-histone antibody complexed nanoparticles which inactivate cfCh by binding to histones; 2) DNase I which inactivates cfCh by degrading its DNA component, and 3) a novel pro-oxidant combination of Resveratrol and Copper which, like DNase I, inactivates cfCh by degrading its DNA component. Female C57 BL/6 mice, 6-8 weeks old, were administered a single i.p. injection of LPS at a dose of 10 mg/Kg or 20 mg/Kg with or without concurrent treatment with the above cfCh inactivating agents. Administration of cfCh inactivating agents concurrently with LPS resulted in prevention of following pathological parameters: 1) release of cfCh in extra-cellular spaces of brain, lung and heart and in circulation; 2) release of inflammatory cytokines in circulation; 3) activation of DNA damage, apoptosis and inflammation in cells of thymus, spleen and in PBMCs; 4) DNA damage, apoptosis and inflammation in cells of lung, liver, heart, brain, kidney and small intestine; 5) liver and kidney dysfunction and elevation of serum lactate; 6) coagulopathy, fibrinolysis and thrombocytopenia; 7) lethality. We conclude that cfCh that are released from dying host cells in response to bacterial endotoxin represents a global instigator of sepsis. cfCh inactivation may provide a novel approach to management of sepsis in humans.	[Mittra, Indraneel; Pal, Kavita; Pancholi, Namrata; Tidke, Pritish; Siddiqui, Sophiya; Rane, Bhagyeshri; D'souza, Jenevieve; Shaikh, Alfina; Parab, Saili; Shinde, Sushma; Jadhav, Vishal; Shende, Soniya; Raghuram, Gorantla, V] Tata Mem Hosp, Adv Ctr Treatment Res & Educ Canc, Translat Res Lab, Navi Mumbai, India	Tata Memorial Centre (TMC); Advance Centre for Treatment, Research & Education in Cancer (ACTREC); Tata Memorial Hospital	Mittra, I (corresponding author), Tata Mem Hosp, Adv Ctr Treatment Res & Educ Canc, Translat Res Lab, Navi Mumbai, India.	imittra@actrec.gov.in	Raghuram, Gorantla Venkata/GNO-9391-2022	Shende, Soniya/0000-0002-6404-5318; Mittra, Indraneel/0000-0002-5768-3821; D'souza, Jenevieve/0000-0003-2323-7230	Department of Atomic Energy, Government of India, through its grant CTCTMC to Tata Memorial Centre	Department of Atomic Energy, Government of India, through its grant CTCTMC to Tata Memorial Centre	This study was supported by the Department of Atomic Energy, Government of India, through its grant CTCTMC to Tata Memorial Centre awarded to I.M. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrams ST, 2013, AM J RESP CRIT CARE, V187, P160, DOI 10.1164/rccm.201206-1037OC; de la Lastral CA, 2007, BIOCHEM SOC T, V35, P1156, DOI 10.1042/BST0351156; Angus DC, 2011, JAMA-J AM MED ASSOC, V306, P2614, DOI 10.1001/jama.2011.1853; AYALA A, 1995, SHOCK, V3, P259, DOI 10.1097/00024382-199504000-00003; Basak R, 2016, MUTAT RES-FUND MOL M, V793, P15, DOI 10.1016/j.mrfmmm.2016.10.002; Camicia G, 2014, SHOCK, V42, P286, DOI 10.1097/SHK.0000000000000221; Cecconi M, 2018, LANCET, V392, P75, DOI 10.1016/S0140-6736(18)30696-2; Chaudhary S, 2019, J BIOSCIENCES, V44, DOI 10.1007/s12038-019-9849-7; Chaudhary S, 2018, MUTAT RES-FUND MOL M, V808, P48, DOI 10.1016/j.mrfmmm.2018.02.002; Chen QX, 2012, INT J INFECT DIS, V16, pE558, DOI 10.1016/j.ijid.2012.03.007; Chertoff J, 2015, J INTENSIVE CARE, V3, DOI 10.1186/s40560-015-0105-4; Christopher J. C, 2011, MOL MED, V17, P2, DOI [10.2119/molmed.2010.00001.commentary, DOI 10.2119/MOLMED.2010.00001.COMMENTARY]; Cohen J, 2015, LANCET INFECT DIS, V15, P581, DOI 10.1016/S1473-3099(15)70112-X; Copeland S, 2005, CLIN DIAGN LAB IMMUN, V12, P60, DOI 10.1128/CDLI.12.1.60-67.2005; Dewitte A, 2017, ANN INTENSIVE CARE, V7, DOI 10.1186/s13613-017-0337-7; FENG L, 1995, J CLIN INVEST, V95, P1669, DOI 10.1172/JCI117842; Fleischmann C, 2016, AM J RESP CRIT CARE, V193, P259, DOI 10.1164/rccm.201504-0781OC; Fukuhara K, 1998, BIOORG MED CHEM LETT, V8, P3187, DOI 10.1016/S0960-894X(98)00585-X; Gorantla R. V., 2019, GENES, V10, P407; Gulcin I, 2010, INNOV FOOD SCI EMERG, V11, P210, DOI 10.1016/j.ifset.2009.07.002; Gustot T, 2011, CURR OPIN CRIT CARE, V17, P153, DOI 10.1097/MCC.0b013e328344b446; Hoppensteadt D, 2014, CLIN APPL THROMB-HEM, V20, P129, DOI 10.1177/1076029613492875; Hotchkiss RS, 2003, SCAND J INFECT DIS, V35, P585, DOI 10.1080/00365540310015692; Hotchkiss RS, 2003, NEW ENGL J MED, V348, P138, DOI 10.1056/NEJMra021333; Iba T, 2014, J INTENSIVE CARE, V2, DOI 10.1186/s40560-014-0051-6; Jadali Z, 2010, INDIAN J PATHOL MICR, V53, P646, DOI 10.4103/0377-4929.72013; Kirolikar S, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-1181-x; Kume M, 2003, J HEPATOL, V38, P9, DOI 10.1016/S0168-8278(02)00324-0; Levi M, 2017, THROMB RES, V149, P38, DOI 10.1016/j.thromres.2016.11.007; Levi M, 2008, CLIN CHEST MED, V29, P627, DOI 10.1016/j.ccm.2008.06.006; Looney Mark R, 2007, Curr Infect Dis Rep, V3, P413, DOI 10.1007/s11908-007-1008-x; LOPPNOW H, 1990, INFECT IMMUN, V58, P3743, DOI 10.1128/IAI.58.11.3743-3750.1990; Mittra I, 2017, ANN ONCOL, V28, P2119, DOI 10.1093/annonc/mdx318; Mittra I, 2017, CELL DEATH DISCOV, V3, DOI 10.1038/cddiscovery.2017.15; Mittra I, 2015, J BIOSCIENCES, V40, P91, DOI 10.1007/s12038-015-9508-6; Ogawa Y, 2016, ELIFE, V5, DOI 10.7554/eLife.21055; Papageorgiou C, 2018, CLIN APPL THROMB-HEM, V24, p8S, DOI 10.1177/1076029618806424; Rekha MR, 2013, BIOMATERIALS, V34, P6328, DOI 10.1016/j.biomaterials.2013.05.019; Ronald HLL, 2018, FRONT VET SCI, V5, P291, DOI [10.3389/fvets.2018.00291, DOI 10.3389/FVETS.2018.00291]; Spapen HD, 2017, J EMERG CRIT CARE ME, V1, P1, DOI DOI 10.21037/JECCM.2017.09.04; Subramaniam Siddharth, 2015, F1000Res, V4, P1145, DOI 10.12688/f1000research.7202.1; Vincent JL, 2014, LANCET RESP MED, V2, P380, DOI 10.1016/S2213-2600(14)70061-X; Vincent JL, 2005, CRIT CARE CLIN, V21, P469, DOI 10.1016/j.ccc.2005.04.002; Xu J, 2011, J IMMUNOL, V187, P2626, DOI 10.4049/jimmunol.1003930; Xu J, 2009, NAT MED, V15, P1318, DOI 10.1038/nm.2053; Zeerleder S, 2003, CRIT CARE MED, V31, P1947, DOI 10.1097/01.CCM.0000074719.40109.95	47	7	7	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2020	15	3							e0229017	10.1371/journal.pone.0229017	http://dx.doi.org/10.1371/journal.pone.0229017			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8QU	32130239	Green Published, gold			2022-12-26	WOS:000535264000013
J	Smirnov, E; Trosan, P; Cabral, JV; Studeny, P; Kereiche, S; Jirsova, K; Cmarko, D				Smirnov, Evgeny; Trosan, Peter; Cabral, Joao Victor; Studeny, Pavel; Kereiche, Sami; Jirsova, Katerina; Cmarko, Dusan			Discontinuous transcription of ribosomal DNA in human cells	PLOS ONE			English	Article							RNA; GENES; ORGANIZATION; DYNAMICS; UNITS; FLUCTUATIONS; FIBRILLARIN; NUCLEOLUS; CHROMATIN; ROLES	Numerous studies show that various genes in all kinds of organisms are transcribed discontinuously, i.e. in short bursts or pulses with periods of inactivity between them. But it remains unclear whether ribosomal DNA (rDNA), represented by multiple copies in every cell, is also expressed in such manner. In this work, we synchronized the pol I activity in the populations of tumour derived as well as normal human cells by cold block and release. Our experiments with 5-fluorouridine (FU) and BrUTP confirmed that the nucleolar transcription can be efficiently and reversibly arrested at +4 degrees C. Then using special software for analysis of the microscopic images, we measured the intensity of transcription signal (incorporated FU) in the nucleoli at different time points after the release. We found that the ribosomal genes in the human cells are transcribed discontinuously with periods ranging from 45 min to 75 min. Our data indicate that the dynamics of rDNA transcription follows the undulating pattern, in which the bursts are alternated by periods of rare transcription events.	[Smirnov, Evgeny; Kereiche, Sami; Cmarko, Dusan] Charles Univ Prague, Fac Med 1, Inst Biol & Med Genet, Cell Biol Lab, Prague, Czech Republic; [Smirnov, Evgeny; Trosan, Peter; Cabral, Joao Victor; Kereiche, Sami; Jirsova, Katerina; Cmarko, Dusan] Gen Univ Hosp Prague, Prague, Czech Republic; [Trosan, Peter; Cabral, Joao Victor; Jirsova, Katerina] Charles Univ Prague, Fac Med 1, Inst Biol & Med Genet, Lab Biol & Pathol Eye, Prague, Czech Republic; [Studeny, Pavel] Charles Univ Prague, Fac Med 3, Ophthalmol Dept, Prague, Czech Republic; [Studeny, Pavel] Univ Hosp Kralovske Vinohrady, Prague, Czech Republic	Charles University Prague; General University Hospital Prague; Charles University Prague; Charles University Prague; University Hospital Vinohrady	Smirnov, E (corresponding author), Charles Univ Prague, Fac Med 1, Inst Biol & Med Genet, Cell Biol Lab, Prague, Czech Republic.; Smirnov, E (corresponding author), Gen Univ Hosp Prague, Prague, Czech Republic.	esmir@lf1.cuni.cz	Studený, Pavel/AAK-5254-2021; Smirnov, Evgeny N./M-3532-2016; Cabral, Joao Victor/P-9816-2018; Cmarko, Dusan/G-3712-2017	Smirnov, Evgeny N./0000-0002-9325-7504; Cabral, Joao Victor/0000-0003-4898-5163; Cmarko, Dusan/0000-0002-7467-8565	Grant Agency of Czech Republic [19-21715S]; Charles University (Progres Q25); Charles University (Progres Q28); Czech Science Foundation [1825144Y]; European Regional Development Fund [EF16_013/0001674, BBMRI_CZ LM2018125]	Grant Agency of Czech Republic(Grant Agency of the Czech Republic); Charles University (Progres Q25); Charles University (Progres Q28); Czech Science Foundation(Grant Agency of the Czech Republic); European Regional Development Fund(European Commission)	The work was supported by research project BBMRI_CZ LM2018125, European Regional Development Fund, project EF16_013/0001674, by the Grant Agency of Czech Republic (19-21715S) and by Charles University (Progres Q25 and Q28). SK acknowledges the financial support from the Czech Science Foundation Grant No. 1825144Y. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The work was supported by research project BBMRI_CZ LM2018125, European Regional Development Fund, project EF16_013/0001674, by the Grant Agency of Czech Republic (19-21715S) and by Charles University (Progres Q25 and Q28). SK acknowledges the financial support from the Czech Science Foundation Grant No. 1825144Y. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartova E, 2010, J HISTOCHEM CYTOCHEM, V58, P391, DOI 10.1369/jhc.2009.955435; Bensidoun P, 2016, METHODS, V98, P104, DOI 10.1016/j.ymeth.2016.01.006; Bersaglieri C, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8060579; Bertrand E, 1998, MOL CELL, V2, P437, DOI 10.1016/S1097-2765(00)80143-4; Brejchova K, 2018, EXP EYE RES, V176, P20, DOI 10.1016/j.exer.2018.06.019; Casafont I, 2006, NEUROSCIENCE, V140, P453, DOI 10.1016/j.neuroscience.2006.02.030; Cheutin T, 2002, J CELL SCI, V115, P3297; Chubb JR, 2016, CURR BIOL, V26, pR61, DOI 10.1016/j.cub.2015.12.002; Chubb JR, 2006, CURR BIOL, V16, P1018, DOI 10.1016/j.cub.2006.03.092; Cmarko D, 2000, HISTOCHEM CELL BIOL, V113, P181, DOI 10.1007/s004180050437; Cmarko D, 2008, HISTOL HISTOPATHOL, V23, P1291, DOI 10.14670/HH-23.1291; Correll CC, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8080869; Coulon A, 2014, ELIFE, V3, DOI 10.7554/eLife.03939; Dar RD, 2012, P NATL ACAD SCI USA, V109, P17454, DOI 10.1073/pnas.1213530109; Dundr M, 2002, SCIENCE, V298, P1623, DOI 10.1126/science.1076164; Eldar A, 2010, NATURE, V467, P167, DOI 10.1038/nature09326; Femino A, 1998, SCIENCE, V280, P585, DOI 10.1126/science.280.5363.585; Golding I, 2005, CELL, V123, P1025, DOI 10.1016/j.cell.2005.09.031; Golding I, 2004, P NATL ACAD SCI USA, V101, P11310, DOI 10.1073/pnas.0404443101; Haaf T, 1996, EXP CELL RES, V224, P163, DOI 10.1006/excr.1996.0124; HAAF T, 1991, EXP CELL RES, V193, P78, DOI 10.1016/0014-4827(91)90540-B; Halpern KB, 2016, METHODS, V98, P134, DOI 10.1016/j.ymeth.2015.11.015; Halpern KB, 2015, MOL CELL, V58, P147, DOI 10.1016/j.molcel.2015.01.027; HENDERSON AS, 1972, P NATL ACAD SCI USA, V69, P3394, DOI 10.1073/pnas.69.11.3394; Hornacek M, 2017, NUCLEUS-PHILA, V8, P421, DOI 10.1080/19491034.2017.1306160; Iyer-Bierhoff A, 2019, EPIGENETICS INSIGHTS, V12, DOI 10.1177/2516865719849090; Koberna K, 2002, J CELL BIOL, V157, P743, DOI 10.1083/jcb.200202007; Lam Yun Wah, 2015, F1000Prime Rep, V7, P48, DOI 10.12703/P7-48; Larsson AJM, 2019, NATURE, V565, P251, DOI 10.1038/s41586-018-0836-1; Li CX, 2018, CELL SYST, V6, P409, DOI 10.1016/j.cels.2018.01.012; Lionnet T, 2011, NAT METHODS, V8, P165, DOI 10.1038/NMETH.1551; LONG EO, 1980, ANNU REV BIOCHEM, V49, P727, DOI 10.1146/annurev.bi.49.070180.003455; MCKNIGHT SL, 1979, CELL, V17, P551; Moss T, 2019, CHROMOSOME RES, V27, P31, DOI 10.1007/s10577-018-09603-9; Mueller F, 2013, NAT METHODS, V10, P277, DOI 10.1038/nmeth.2406; Nicolas D, 2018, P NATL ACAD SCI USA, V115, P7153, DOI 10.1073/pnas.1722330115; Nicolas D, 2017, MOL BIOSYST, V13, P1280, DOI 10.1039/c7mb00154a; Ochiai H, 2019, GENOME WIDE ANAL TRA, DOI [10.1101/736207, DOI 10.1101/736207]; Pliss A, 2015, INTEGR BIOL-UK, V7, P681, DOI 10.1039/c5ib00008d; PUVIONDUTILLEUL F, 1991, CHROMOSOMA, V100, P395, DOI 10.1007/BF00337518; Raj A, 2008, CELL, V135, P216, DOI 10.1016/j.cell.2008.09.050; Raj A, 2006, PLOS BIOL, V4, P1707, DOI 10.1371/journal.pbio.0040309; RASKA I, 1989, BIOL CELL, V65, P79, DOI 10.1016/0248-4900(89)90013-0; Raska I, 2006, INT REV CYTOL, V255, P177, DOI 10.1016/S0074-7696(06)55004-1; SCHEER U, 1990, BIOESSAYS, V12, P14, DOI 10.1002/bies.950120104; Schermelleh L, 2001, CHROMOSOME RES, V9, P77, DOI 10.1023/A:1026799818566; Sharifi S, 2018, ANNU REV BIOCHEM, V87, P51, DOI 10.1146/annurev-biochem-062917-012612; Shaw PJ, 2011, PROTEIN REV, V15, P43, DOI 10.1007/978-1-4614-0514-6_3; Sirri V, 2008, HISTOCHEM CELL BIOL, V129, P13, DOI 10.1007/s00418-007-0359-6; Smirnov E, 2014, J STRUCT BIOL, V188, P259, DOI 10.1016/j.jsb.2014.10.001; Smirnov E, 2018, NUCLEUS-PHILA, V9, P149, DOI 10.1080/19491034.2017.1419112; Smirnov E, 2016, NUCLEUS-PHILA, V7, P203, DOI 10.1080/19491034.2016.1157674; Stadnikova A, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0211861; Suter DM, 2011, CURR OPIN CELL BIOL, V23, P657, DOI 10.1016/j.ceb.2011.09.004; Suter DM, 2011, SCIENCE, V332, P472, DOI 10.1126/science.1198817; TOLLERVEY D, 1993, CELL, V72, P443, DOI 10.1016/0092-8674(93)90120-F; Tollervey D, 1997, CURR OPIN CELL BIOL, V9, P337, DOI 10.1016/S0955-0674(97)80005-1; Wang YL, 2019, BIOL REV, V94, P248, DOI 10.1111/brv.12452	58	0	0	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2020	15	3							e0223030	10.1371/journal.pone.0223030	http://dx.doi.org/10.1371/journal.pone.0223030			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	KZ9QY	32119673	Green Submitted, gold, Green Published			2022-12-26	WOS:000523595100001
J	Campos, JC; Baehr, LM; Ferreira, ND; Bozi, LHM; Andres, AM; Ribeiro, MAC; Gottlieb, RA; Bodine, SC; Ferreira, JCB				Campos, Juliane C.; Baehr, Leslie M.; Ferreira, Nikolas D.; Bozi, Luiz H. M.; Andres, Allen M.; Ribeiro, Marcio A. C.; Gottlieb, Roberta A.; Bodine, Sue C.; Ferreira, Julio C. B.			beta(2)-adrenoceptor activation improves skeletal muscle autophagy in neurogenic myopathy	FASEB JOURNAL			English	Article						G protein-coupled proteins; protein quality control; skeletal muscle diseases; therapy	UBIQUITIN-PROTEASOME; FORMOTEROL; RAT; HYPERTROPHY; DAMAGE; FLUX	beta(2)-adrenoceptor agonists improve autophagy and re-establish proteostasis in cardiac cells; therefore, suggesting autophagy as a downstream effector of beta(2)-adrenoceptor signaling pathway. Here, we used the pharmacological and genetic tools to determine the autophagy effect of sustained beta(2)-adrenoceptor activation in rodents with neurogenic myopathy, which display impaired skeletal muscle autophagic flux. Sustained beta(2)-adrenoceptor activation using Formoterol (10 mu g kg(-1) day(-1)), starting at the onset of neurogenic myopathy, prevents disruption of autophagic flux in skeletal muscle 14 days after sciatic nerve constriction. These changes are followed by reduction of the cytotoxic protein levels and increased skeletal muscle cross-sectional area and contractility properties. Of interest, sustained administration of Formoterol at lower concentration (1 mu g kg(-1) day(-1)) induces similar improvements in skeletal muscle autophagic flux and contractility properties in neurogenic myopathy, without affecting the cross-sectional area. Sustained pharmacological inhibition of autophagy using Chloroquine (50 mg kg(-1) day(-1)) abolishes the beneficial effects of beta(2)-adrenoceptor activation on the skeletal muscle proteostasis and contractility properties in neurogenic myopathy. Further supporting an autophagy mechanism for beta(2)-adrenoceptor activation, skeletal muscle-specific deletion of ATG7 blunts the beneficial effects of beta(2)-adrenoceptor on skeletal muscle proteostasis and contractility properties in neurogenic myopathy in mice. These findings suggest autophagy as a critical downstream effector of beta(2)-adrenoceptor signaling pathway in skeletal muscle.	[Campos, Juliane C.; Ferreira, Nikolas D.; Bozi, Luiz H. M.; Ribeiro, Marcio A. C.; Ferreira, Julio C. B.] Univ Sao Paulo, Inst Biomed Sci, Ave Prof Lineu Prestes 2415, BR-05508000 Sao Paulo, SP, Brazil; [Baehr, Leslie M.; Bodine, Sue C.] Univ Iowa, Dept Internal Med, Div Endocrinol & Metab, Iowa City, IA 52242 USA; [Andres, Allen M.; Gottlieb, Roberta A.] Cedars Sinai Heart Inst, Los Angeles, CA USA; [Andres, Allen M.; Gottlieb, Roberta A.] Cedars Sinai Med Ctr, Barbra Streisand Womens Heart Ctr, Los Angeles, CA 90048 USA; [Ferreira, Julio C. B.] Stanford Univ, Sch Med, Dept Chem & Syst Biol, Stanford, CA 94305 USA	Universidade de Sao Paulo; University of Iowa; Cedars Sinai Medical Center; Cedars Sinai Medical Center; Stanford University	Ferreira, JCB (corresponding author), Univ Sao Paulo, Inst Biomed Sci, Ave Prof Lineu Prestes 2415, BR-05508000 Sao Paulo, SP, Brazil.	juliof@stanford.edu	Bozi, Luiz H M/K-5259-2012; Campos, Juliane/G-5997-2014; Ferreira, Julio Cesar Batista/AEU-0494-2022; Ferreira, Julio Cesar Batista/I-3177-2012; Bozi, Luiz/AAT-6126-2020; Ferreira, Julio/L-4687-2019	Bozi, Luiz H M/0000-0002-5698-1181; Campos, Juliane/0000-0003-0075-7209; Ferreira, Julio Cesar Batista/0000-0003-2694-239X; Ferreira, Julio Cesar Batista/0000-0003-2694-239X; Ribeiro, Marcio/0000-0002-8431-4968	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2012/14416-1, 2016/01633-5, 2017/16540-5, 2015/207835, 2015/50429-9, 2017/16694-2, 2018/18627-3]; MCTI | Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [407743/2018-9, 307934/20187, 303281/2015-4, 407306/2013-7]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) [001]; Instituto Nacional de Ciencia e Tecnologia de Processos Redox em Biomedicina (INCT Redoxoma)	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); MCTI | Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)Fundacao de Apoio a Pesquisa do Distrito Federal (FAPDF)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Instituto Nacional de Ciencia e Tecnologia de Processos Redox em Biomedicina (INCT Redoxoma)	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP), Grant/Award Number: #2012/14416-1, #2016/01633-5 and #2017/16540-5 and #2015/207835, #2015/50429-9, #2017/16694-2 and #2018/18627-3; MCTI | Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Grant/Award Number: #407743/2018-9, #307934/20187, #303281/2015-4 and #407306/2013-7; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), Grant/Award Number: Finance Code 001; Instituto Nacional de Ciencia e Tecnologia de Processos Redox em Biomedicina (INCT Redoxoma)	[Anonymous], 2016, J PHYSIOL-LONDON, DOI DOI 10.1113/JPHYSIOL.2014.282665; Aranguiz-Urroz P, 2011, BBA-MOL BASIS DIS, V1812, P23, DOI 10.1016/j.bbadis.2010.07.003; Asai M, 2009, J MOL CELL CARDIOL, V46, P452, DOI 10.1016/j.yjmcc.2008.11.001; Gomez-SanMiguel AB, 2016, AM J PHYSIOL-ENDOC M, V310, pE925, DOI 10.1152/ajpendo.00503.2015; BENNETT GJ, 1988, PAIN, V33, P87, DOI 10.1016/0304-3959(88)90209-6; Bodine SC, 2001, NAT CELL BIOL, V3, P1014, DOI 10.1038/ncb1101-1014; Brum PC, 2011, BRAZ J MED BIOL RES, V44, P827, DOI 10.1590/S0100-879X2011000900002; Brundtland GH, 2003, WHO TECH REP SER, V919, P1; Campos JC, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-30365-1; Campos JC, 2017, AUTOPHAGY, V13, P1304, DOI 10.1080/15548627.2017.1325062; Cunha TF, 2017, J APPL PHYSIOL, V122, P817, DOI 10.1152/japplphysiol.00182.2016; Cunha TF, 2012, J APPL PHYSIOL, V112, P1839, DOI 10.1152/japplphysiol.00346.2011; Ferreira JCB, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-018-08276-6; Ferreira JCB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033175; Ferreira JCB, 2011, LIFE SCI, V88, P578, DOI 10.1016/j.lfs.2011.01.009; Ferreira JCB, 2010, EXP BIOL MED, V235, P497, DOI 10.1258/ebm.2009.009165; Glabe CG, 2004, TRENDS BIOCHEM SCI, V29, P542, DOI 10.1016/j.tibs.2004.08.009; Gomes KMS, 2014, CARDIOVASC RES, V103, P498, DOI 10.1093/cvr/cvu125; Goncalves DA, 2019, J CACHEXIA SARCOPENI, V10, P455, DOI 10.1002/jcsm.12395; Goodman CA, 2011, FASEB J, V25, P1028, DOI 10.1096/fj.10-168799; Grumati P, 2011, AUTOPHAGY, V7, P1415, DOI 10.4161/auto.7.12.17877; Hashem SI, 2017, J MOL CELL CARDIOL, V108, P86, DOI 10.1016/j.yjmcc.2017.05.007; Joassard OR, 2013, INT J BIOCHEM CELL B, V45, P2444, DOI 10.1016/j.biocel.2013.07.019; Ju JS, 2010, AUTOPHAGY, V6, P929, DOI 10.4161/auto.6.7.12785; Kadir R, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1005919; Kline WO, 2007, J APPL PHYSIOL, V102, P740, DOI 10.1152/japplphysiol.00873.2006; Klionsky DJ, 2012, AUTOPHAGY, V8, P445, DOI 10.4161/auto.19496; Lynch GS, 2008, PHYSIOL REV, V88, P729, DOI 10.1152/physrev.00028.2007; Ma XC, 2012, AUTOPHAGY, V8, P1394, DOI 10.4161/auto.21036; Masiero E, 2009, CELL METAB, V10, P507, DOI 10.1016/j.cmet.2009.10.008; Mauthe M, 2018, AUTOPHAGY, V14, P1435, DOI 10.1080/15548627.2018.1474314; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Montuschi P, 2016, DRUG DISCOV TODAY, V21, P1820, DOI 10.1016/j.drudis.2016.07.009; Nalbandian A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122888; Nath S, 2014, NAT CELL BIOL, V16, P415, DOI 10.1038/ncb2940; PREEDY VR, 1983, BRIT J NUTR, V49, P517, DOI 10.1079/BJN19830060; Ramesh M, 2019, FASEB J, V33, P11857, DOI 10.1096/fj.201900807RR; Ryall JG, 2006, BRIT J PHARMACOL, V147, P587, DOI 10.1038/sj.bjp.0706669; Ryall JG, 2004, J PHYSIOL-LONDON, V555, P175, DOI 10.1113/jphysiol.2003.056770; Salazar-Degracia A, 2018, BIOCHIMIE, V149, P79, DOI 10.1016/j.biochi.2018.04.009; Shen A, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03459-7; Sleeper MM, 2002, MED SCI SPORT EXER, V34, P643, DOI 10.1097/00005768-200204000-00013; SOLISCOHEN S, 1990, J ASTHMA, V27, P401, DOI 10.3109/02770909009073358; Souccar C, 2005, NEUROMUSCULAR DISORD, V15, P48, DOI 10.1016/j.nmd.2004.10.010; Sun YT, 2007, EMBO J, V26, P53, DOI 10.1038/sj.emboj.7601502; Ueta CB, 2018, CARDIOVASC RES, V114, P1006, DOI 10.1093/cvr/cvy070; Wang L, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.237; WATERLOW JC, 1984, Q J EXP PHYSIOL CMS, V69, P409, DOI 10.1113/expphysiol.1984.sp002829; Xiang Y, 2003, SCIENCE, V300, P1530, DOI 10.1126/science.1079206; Zhang FX, 2007, J BIOL CHEM, V282, P22460, DOI 10.1074/jbc.M702439200	50	7	7	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2020	34	4					5628	5641		10.1096/fj.201902305R	http://dx.doi.org/10.1096/fj.201902305R		FEB 2020	14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	LJ5ZA	32112488	Bronze			2022-12-26	WOS:000517910500001
J	Tefera, A; Belay, T; Bajiro, M				Tefera, Azalech; Belay, Tariku; Bajiro, Mitiku			Epidemiology of Schistosoma mansoni infection and associated risk factors among school children attending primary schools nearby rivers in Jimma town, an urban setting, Southwest Ethiopia	PLOS ONE			English	Article							SOIL-TRANSMITTED HELMINTHS; PREVALENCE; SCHOOLCHILDREN; TIGRAY; ZONE	Background Schistosomiasis is one of the most neglected tropical parasitic disease which is common in Ethiopia. It is disease of rural areas for decades but now days there are reports of schistosomiasis from urban settings. Therefore, this study aimed to determine epidemiology of Schistosoma mansoni (S. mansoni) infection and associated determinant factors among school children attending primary schools nearby rivers in Jimma town, an urban setting, southwest Ethiopia. Methodology A cross sectional study was conducted among 328 school children aged between 7-17 years in selected primary schools nearby rivers in Jimma town from March to April 2017. For the diagnosis of S. mansoni, a single stool sample was obtained from each child and processed using double Kato Katz thick smear for quantification of S. mansoni ova examined using light microscope. A questionnaire was used to collect socio demographic data and associated determinant factors for S. mansoni infection. Data were analyzed using SPSS version 20.0. Variables with P-value < 0.05 were significantly associated with S. mansoni infection. Results The overall prevalence of S. mansoni infection was found to be 28.7%. Majority of infection intensities were categorized as light with maximum egg per gram of stool (epg) was 1728. The geometric mean of infection intensity was 102.3epg. Schools distance from river (p = 0.001), swimming habit in rivers (p = 0.001) and crossing river on bare foot (p = 0.001) were independent risk factors for S. mansoni infection. Conclusions The study revealed S. mansoni infection is prevalent in Jimma town. The school children were at moderate risk of morbidity caused by S. mansoni (prevalence >= 10% and < 50% according to WHO threshold), hence a biannual mass drug administration with praziquantel is required once every two years in the study area and promote health information on prevention, control, transmission and risk factors for S. mansoni infection.	[Tefera, Azalech] Jimma Med Ctr, Lab Unit, Jimma, Ethiopia; [Belay, Tariku; Bajiro, Mitiku] Jimma Univ, Fac Hlth Sci, Sch Med Lab Sci, Inst Hlth, Jimma, Ethiopia	Jimma University	Bajiro, M (corresponding author), Jimma Univ, Fac Hlth Sci, Sch Med Lab Sci, Inst Hlth, Jimma, Ethiopia.	mitikubajiro2008@yahoo.com			Jimma University institute of health research and postgraduate	Jimma University institute of health research and postgraduate	The study is funded by organization Jimma University institute of health research and postgraduate. So there is no specific funder with this research. The funder had no role in study design, data collection and analysis decision to publish, or preparation of the manuscript.	Abebe G, 2010, EASTAFRICAN J PUBLIC, V1, P80; Abebe N, 2014, PARASITE VECTOR, V158, P1; Abera B, 2013, J INFECT DEV COUNTR, V7, P253, DOI 10.3855/jidc.2539; Abera Kumie, 2005, Ethiopian Journal of Health Development, V19, P89; Aemero M, 2014, ETHIOP J HEALTH SCI, V24, P189, DOI 10.4314/ejhs.v24i3.1; Alebie G, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-15; Alemayehu B, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4499-x; Alemayehu B, 2015, ASIAN PAC J TROP MED, V8, P458, DOI [10.1016/S1995-7645(14)60360-6, 10.1016/j.apjtm.2015.05.009]; Alemu A, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-2864-9; Alhassan A., 2013, INT J APPL BIOL RES, V5, P72; Ali A., 2006, EPIDEMIOLOGY ECOLOGY; Amsalu Gashaw, 2015, BMC Research Notes, V8, P22, DOI 10.1186/s13104-014-0965-z; [Anonymous], 2012, Wkly Epidemiol Rec, V87, P37; Anto F., 2013, J BACTERIOL PARASITO, V4, P177, DOI 10.4172/2155-9597.1000177; Assefa A, 2013, MOMONA ETHIOP J SCI, V5, P174; Bajiro M, 2017, J BACTERIOLOGY PARAS, V8, P329, DOI DOI 10.4172/2155-9597.1000329; Bajiro Mitiku, 2017, BMC Res Notes, V10, P677, DOI 10.1186/s13104-017-3023-9; Bajiro M, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1833-6; Banji B., 2012, J PHARM BIOMED SCI, V15, P1; Barbosa CS, 2006, MEM I OSWALDO CRUZ, V101, P55, DOI 10.1590/S0074-02762006000900009; Chitsulo L, 2000, ACTA TROP, V77, P41, DOI 10.1016/S0001-706X(00)00122-4; Dabo A, 2015, INFECT DIS POVERTY, V4, DOI 10.1186/2049-9957-4-4; Dejenie T, 2013, MOMONA ETHIOP J SCI, V5, P32; Dejenie T, 2010, MOMONA ETHIOP J SCI, V2, P3, DOI 10.4314/mejs.v2i2.57669; Dejenie T, 2010, MOMONA ETHIOP J SCI, V2, P49, DOI 10.4314/mejs.v2i1.49650; Elizabeth T, 2016, GLOBAL J BIOSCIENCE, V5, P55; Engels D, 2002, ACTA TROP, V82, P139, DOI 10.1016/S0001-706X(02)00045-1; Erko Berhanu, 2012, Asian Pacific Journal of Tropical Biomedicine, V2, P235, DOI 10.1016/S2221-1691(12)60049-5; Essawi Tamer, 2013, ISRN Gastroenterol, V2013, P606258, DOI 10.1155/2013/606258; Goselle NO., 2010, SCI WORLD J, V5, DOI [10.4314/swj.v5i1.61485, DOI 10.4314/SWJ.V5I1.61485]; Haile S., 2012, J PARASITOL VECTOR B, V4, P25, DOI [10.5897/JPVB12.013, DOI 10.5897/JPVB12.013]; Jemaneh L., 1997, ETHIOP J HEALTH DEV, V11, P289; Jemaneh L., 1998, ETHIOP J HEALTH DEV, V12, P237; John R, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-110; Joseph B, 2010, MALAYS ORTHOP J, V4, P1; Kabatereine NB, 2004, TROP MED INT HEALTH, V9, P372, DOI 10.1046/j.1365-3156.2003.01176.x; KLOOS H, 1988, SOC SCI MED, V26, P803, DOI 10.1016/0277-9536(88)90174-8; Kure A, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-1101-1; Legesse M, 2004, ETHIOP J HEALTH DEV, V18, P116; Leshem E, 2008, CLIN INFECT DIS, V47, P1499, DOI 10.1086/593191; Mathewos Biniam, 2014, BMC Res Notes, V7, P88, DOI 10.1186/1756-0500-7-88; Mazigo H. D., 2010, Journal of Rural and Tropical Public Health, V9, P53; Mengistu M, 2011, ETHIOP J HEALTH SCI, V21, P111; Munisi David Z, 2016, J Parasitol Res, V2016, P1859737; Odiere MR, 2011, S BRIT SOC PARASITOL, V138; Rashad SB, 2013, J ADV RES, V4, P433, DOI [10.1016/j.jare.2013.01.005, DOI 10.1016/J.JARE.2013.01.005]; Sackoa M, 2011, ACTA TROP, V120, P142; Sady H, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002377; Samuels AM, 2012, AM J TROP MED HYG, V87, P874, DOI 10.4269/ajtmh.2012.12-0397; Siza JE, 2015, KOREAN J PARASITOL, V53, P515, DOI 10.3347/kjp.2015.53.5.515; Steinmann P, 2006, LANCET INFECT DIS, V6, P411, DOI 10.1016/S1473-3099(06)70521-7; Tadege B, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181547; Terefe A, 2011, ETHIOP J HEALTH DEV, V25, P46; WHO, 2016, SCHISTOSOMIASIS WEEK, V91, P585; WHO Expert Comm, 1998, WHO TECH REP SER, V881, P1; Worku Awoke, 2013, Open Journal of Preventive Medicine, V3, P199, DOI 10.4236/ojpm.2013.32027; Worku Ligabaw, 2014, J Parasitol Res, V2014, P792536, DOI 10.1155/2014/792536; World Health Organization, 2004, GLOBAL BURDEN DIS; Yami A, 2011, ETHIOP J HEALTH SCI, V21, P167	59	11	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2020	15	2							e0228007	10.1371/journal.pone.0228007	http://dx.doi.org/10.1371/journal.pone.0228007			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8GQ	32107485	Green Published, gold			2022-12-26	WOS:000535237000008
J	Wang, CJ; Liu, QH; Huang, M; Zhou, QH; Zhang, XY; Zhang, JT; Xie, RH; Yu, YQ; Chen, S; Fan, JB; Chen, X				Wang, Chanjuan; Liu, Qinghua; Huang, Ming; Zhou, Qianghua; Zhang, Xiaoyu; Zhang, Jingtong; Xie, Ruihui; Yu, Yanqi; Chen, Shang; Fan, Jianbing; Chen, Xu			Loss of GATA6 expression promotes lymphatic metastasis in bladder cancer	FASEB JOURNAL			English	Article						bladder cancer; GATA6; lymphangiogenesis; metastasis; VEGF-C	GROWTH FACTOR-C; RADICAL CYSTECTOMY; VEGF-C; BREAST-CANCER; LYMPHANGIOGENESIS; METHYLATION; ANGIOGENESIS; CELLS; DNA	Lymph node metastasis is associated with tumor relapse and poor patient prognosis in bladder cancer. However, the mechanisms by which bladder carcinoma cells induce lymphangiogenesis and further promote metastasis in the lymphatic system remain unclear. Here, we show that the transcription factor GATA-binding factor 6 (GATA6) was substantially downregulated in bladder cancer via promoter hypermethylation. Low-level GATA6 expression significantly correlated with lymph node metastasis positivity and was able to predict earlier relapse and shorter survival of bladder cancer. Reconstitution of GATA6 inhibited lymphangiogenesis and lymph node metastasis in GATA6-low bladder cancer cells, while silencing of GATA6 rendered lymphatic metastasis in GATA6-high bladder cancer cells. Additionally, we demonstrated that GATA6 bound to the promoter of vascular endothelial growth factor (VEGF)-C, a lymphangiogenic factor, and acted as a transcriptional repressor. This GATA6/VEGF-C axis was essential for GATA6-mediated lymphatic metastasis. In bladder cancer patients, low GATA6 correlated with high VEGF-C and reduced overall survival. These findings indicate GATA6 as a pivotal regulator in the lymphatic dissemination of bladder cancer and suggest a new therapeutic target for the disease.	[Wang, Chanjuan; Zhang, Xiaoyu; Yu, Yanqi; Chen, Shang; Fan, Jianbing] Southern Med Univ, Sch Basic Med Sci, Dept Pathol, Guangzhou, Peoples R China; [Liu, Qinghua] Sun Yat Sen Univ, Dept Expt Res, Ctr Canc, Guangzhou, Peoples R China; [Huang, Ming; Zhou, Qianghua; Zhang, Jingtong; Xie, Ruihui; Chen, Xu] Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Dept Urol, Guangzhou 510120, Peoples R China; [Chen, Xu] Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Guangdong Prov Key Lab Malignant Tumor Epigenet &, Guangzhou, Peoples R China	Southern Medical University - China; Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University	Chen, X (corresponding author), Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Dept Urol, Guangzhou 510120, Peoples R China.; Fan, JB (corresponding author), Southern Med Univ, Dept Pathol, Guangzhou 510515, Peoples R China.	jianbingfan1115@smu.edu.cn; chenx457@mail.sysu.edu.cn	Zhang, xiaoyu/GXA-3206-2022	Chen, Xu/0000-0002-8425-036X	National Natural Science Foundation of China (NSFC) [81702523]; National Key Research and Development Program of China [2017YFC1309002]; Science and Technology Planning Project of Guangdong Province, China [2017B020226005]; Guangzhou Science and Technology Program key projects [201804010041]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); National Key Research and Development Program of China; Science and Technology Planning Project of Guangdong Province, China; Guangzhou Science and Technology Program key projects	National Natural Science Foundation of China (NSFC), Grant/Award Number: 81702523; National Key Research and Development Program of China, Grant/Award Number: 2017YFC1309002; Science and Technology Planning Project of Guangdong Province, China, Grant/Award Number: 2017B020226005; Guangzhou Science and Technology Program key projects, Grant/Award Number: 201804010041	Achen MG, 2006, BRIT J CANCER, V94, P1355, DOI 10.1038/sj.bjc.6603120; Achen MG, 1998, P NATL ACAD SCI USA, V95, P548, DOI 10.1073/pnas.95.2.548; Amioka T, 2002, EUR J CANCER, V38, P1413, DOI 10.1016/S0959-8049(02)00106-5; [Anonymous], 2017, BJU INT, V120, P755, DOI [10.1111/bju.14045, DOI 10.1111/BJU.14045]; Berdik C, 2017, NATURE, V551, pS34, DOI 10.1038/551S34a; Capo-Chichi CD, 2009, MOL CELL BIOL, V29, P4766, DOI 10.1128/MCB.00087-09; Carrasco M, 2012, J CLIN INVEST, V122, P3504, DOI 10.1172/JCI63240; Chen X, 2019, CLIN CANCER RES, V25, P1389, DOI 10.1158/1078-0432.CCR-18-1656; Chen ZY, 2019, MOL THER, V27, P326, DOI 10.1016/j.ymthe.2018.12.015; Cheung WKC, 2013, CANCER CELL, V23, P725, DOI 10.1016/j.ccr.2013.04.009; De Carvalho DD, 2012, CANCER CELL, V21, P655, DOI 10.1016/j.ccr.2012.03.045; Dorin RP, 2011, EUR UROL, V60, P946, DOI 10.1016/j.eururo.2011.07.012; Faleiro I, 2017, ONCOTARGET, V8, P12484, DOI 10.18632/oncotarget.14226; Gu P, 2019, MOL CANCER, V18, DOI 10.1186/s12943-019-1037-8; He W, 2018, J CLIN INVEST, V128, P861, DOI 10.1172/JCI96218; Hoque MO, 2006, JNCI-J NATL CANCER I, V98, P996, DOI 10.1093/jnci/djj265; Jeltsch M, 1997, SCIENCE, V276, P1423, DOI 10.1126/science.276.5317.1423; Jia YT, 2004, WORLD J GASTROENTERO, V10, P3261, DOI 10.3748/wjg.v10.i22.3261; Kandimalla R, 2012, EUR UROL, V61, P1245, DOI 10.1016/j.eururo.2012.01.011; Kluth LA, 2015, EUR UROL, V68, P238, DOI 10.1016/j.eururo.2015.01.032; Li QC, 2003, CHINESE MED J-PEKING, V116, P727; Liao CM, 2018, J CLIN INVEST, V128, P2944, DOI 10.1172/JCI96539; Liu H, 2019, CELL DEATH DIS, V10, DOI 10.1038/s41419-018-1270-x; Mandriota SJ, 2001, EMBO J, V20, P672, DOI 10.1093/emboj/20.4.672; Martinelli P, 2017, GUT, V66, P1665, DOI 10.1136/gutjnl-2015-311256; Martinelli P, 2016, GUT, V65, P476, DOI 10.1136/gutjnl-2014-308042; May M, 2011, EUR UROL, V59, P712, DOI 10.1016/j.eururo.2011.01.030; Ding MX, 2006, WORLD J GASTROENTERO, V12, P4582, DOI 10.3748/wjg.v12.i28.4582; Miyata Y, 2006, CLIN CANCER RES, V12, P800, DOI 10.1158/1078-0432.CCR-05-1284; Nebbioso A, 2012, MOL ONCOL, V6, P657, DOI 10.1016/j.molonc.2012.09.004; Perera M, 2018, NAT REV UROL, V15, P686, DOI 10.1038/s41585-018-0066-1; Skobe M, 2001, NAT MED, V7, P192, DOI 10.1038/84643; Song YC, 2015, EXP MOL PATHOL, V99, P617, DOI 10.1016/j.yexmp.2015.10.005; Stacker SA, 2001, NAT MED, V7, P186, DOI 10.1038/84635; Stacker SA, 2002, NAT REV CANCER, V2, P573, DOI 10.1038/nrc863; Stacker SA, 2014, NAT REV CANCER, V14, P159, DOI 10.1038/nrc3677; Stein JP, 2001, J CLIN ONCOL, V19, P666, DOI 10.1200/JCO.2001.19.3.666; Tan HW, 2019, INT J CANCER, V145, P1860, DOI 10.1002/ijc.32248; Tarin TV, 2012, EUR UROL, V61, P1025, DOI 10.1016/j.eururo.2012.01.049; Whissell G, 2014, NAT CELL BIOL, V16, P695, DOI 10.1038/ncb2992; Zhao XD, 2018, FUTURE ONCOL, V14, P1741, DOI 10.2217/fon-2018-0064	41	12	12	2	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2020	34	4					5754	5766		10.1096/fj.201903176R	http://dx.doi.org/10.1096/fj.201903176R		FEB 2020	13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	LJ5ZA	32103545	Bronze			2022-12-26	WOS:000517906700001
J	Rawlings, AE; Liravi, P; Corbett, S; Holehouse, AS; Staniland, SS				Rawlings, Andrea E.; Liravi, Panah; Corbett, Sybilla; Holehouse, Alex S.; Staniland, Sarah S.			Investigating the ferric ion binding site of magnetite biomineralisation protein Mms6	PLOS ONE			English	Article							BACTERIAL PROTEIN; NANOPARTICLES; MECHANISMS; DYNAMICS; PROMOTES; SIZE	The biomineralization protein Mms6 has been shown to be a major player in the formation of magnetic nanoparticles both within the magnetosomes of magnetotactic bacteria and as an additive in synthetic magnetite precipitation assays. Previous studies have highlighted the ferric iron binding capability of the protein and this activity is thought to be crucial to its mineralizing properties. To understand how this protein binds ferric ions we have prepared a series of single amino acid substitutions within the C-terminal binding region of Mms6 and have used a ferric binding assay to probe the binding site at the level of individual residues which has pinpointed the key residues of E44, E50 and R55 involved in Mms6 ferric binding. No aspartic residues bound ferric ions. A nanoplasmonic sensing experiment was used to investigate the unstable EER44, 50,55AAA triple mutant in comparison to native Mms6. This suggests a difference in interaction with iron ions between the two and potential changes to the surface precipitation of iron oxide when the pH is increased. All-atom simulations suggest that disruptive mutations do not fundamentally alter the conformational preferences of the ferric binding region. Instead, disruption of these residues appears to impede a sequence-specific motif in the C-terminus critical to ferric ion binding.	[Rawlings, Andrea E.; Staniland, Sarah S.] Univ Sheffield, Dept Chem, Sheffield, S Yorkshire, England; [Liravi, Panah; Corbett, Sybilla] Univ Leeds, Fac Biol Sci, Leeds, W Yorkshire, England; [Holehouse, Alex S.] Washington Univ, Sch Med, Dept Biochem & Mol Biophys, St Louis, MO 63110 USA	University of Sheffield; University of Leeds; Washington University (WUSTL)	Staniland, SS (corresponding author), Univ Sheffield, Dept Chem, Sheffield, S Yorkshire, England.	s.s.staniland@sheffield.ac.uk	Holehouse, Alex/ABE-8308-2020	Holehouse, Alex/0000-0002-4155-5729; Staniland, sarah/0000-0001-8995-7172; /0000-0002-1242-1481	Biotechnology and Biological Sciences Research Council [BB/H005412/1, BB/H005412/2]; Human Frontiers Science Program [RGP0034/2017]; BBSRC [BB/H005412/1, BB/H005412/2] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Human Frontiers Science Program(Human Frontier Science Program); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	A. Rawlings and S Staniland were funded by Biotechnology and Biological Sciences Research Council (Grant No. BB/H005412/1 & 2) https://bbsrc.ukri.org.Panah Liravi & Sybilla Corbett were project students at the time. Sybilla was then part of a EPSRC doctiral training centre, https://epsrc.ukri.org.Alex Holehouse was supported by the Human Frontiers Science Program (grant RGP0034/2017) https://www.hfsp.org.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amemiya Y, 2007, BIOMATERIALS, V28, P5381, DOI 10.1016/j.biomaterials.2007.07.051; Arakaki A, 2003, J BIOL CHEM, V278, P8745, DOI 10.1074/jbc.M211729200; BALKWILL DL, 1980, J BACTERIOL, V141, P1399, DOI 10.1128/JB.141.3.1399-1408.1980; Bauerlein E, 2003, ANGEW CHEM INT EDIT, V42, P614, DOI 10.1002/anie.200390176; Bazylinski DA, 1997, REV MINERAL, V35, P181; Bird SM, 2016, RSC ADV, V6, P7356, DOI 10.1039/c5ra16469a; Bird SM, 2015, NANOSCALE, V7, P7340, DOI 10.1039/c5nr00651a; Bird SM, 2016, J MAT CHEM C; BLAKEMORE R, 1975, SCIENCE, V190, P377, DOI 10.1126/science.170679; Borgia A, 2018, NATURE, V555, P61, DOI 10.1038/nature25762; Colombo M, 2012, CHEM SOC REV, V41, P4306, DOI 10.1039/c2cs15337h; Feng SR, 2013, INT J MOL SCI, V14, P14594, DOI 10.3390/ijms140714594; Fossat MJ, 2019, J PHYS CHEM B, V123, P6952, DOI 10.1021/acs.jpcb.9b05206; Franzmann TM, 2018, SCIENCE, V359, P47, DOI 10.1126/science.aao5654; Fuertes G, 2017, P NATL ACAD SCI USA, V114, pE6342, DOI 10.1073/pnas.1704692114; Galloway JM, 2011, J MATER CHEM, V21, P15244, DOI [10.1039/c1jm12003d/, 10.1039/c1jm12003d]; Gibbs EB, 2016, J PHYS CHEM B, V120, P8960, DOI 10.1021/acs.jpcb.6b06934; Hogbom M, 2005, MOL CELL PROTEOMICS, V4, P827, DOI 10.1074/mcp.T400023-MCP200; Kashyap S, 2014, ACS NANO, V8, P9097, DOI 10.1021/nn502551y; Komelli A, 2007, ANNU REV BIOCHEM, V76, P351, DOI 10.1146/annurev.biochem.74.082803.133444; Larsson EM, 2007, NANO LETT, V7, P1256, DOI 10.1021/nl0701612; LOWENSTAM HA, 1981, SCIENCE, V211, P1126, DOI 10.1126/science.7008198; Lyle N, 2013, J CHEM PHYS, V139, DOI 10.1063/1.4812791; Malhis N, 2016, NUCLEIC ACIDS RES, V44, pW488, DOI 10.1093/nar/gkw409; Mann S., 2001, BIOMINERALIZATION PR; Mann S, 2007, HDB BIOMINERALIZATIO; Mao AH, 2012, J CHEM PHYS, V137, DOI 10.1063/1.4742068; Martin EW, 2016, J AM CHEM SOC, V138, P15323, DOI 10.1021/jacs.6b10272; McGibbon RT, 2015, BIOPHYS J, V109, P1528, DOI 10.1016/j.bpj.2015.08.015; Metskas LA, 2015, J AM CHEM SOC, V137, P11962, DOI 10.1021/jacs.5b04471; Murat D, 2012, MOL MICROBIOL, V85, P684, DOI 10.1111/j.1365-2958.2012.08132.x; Murat D, 2010, P NATL ACAD SCI USA, V107, P5593, DOI 10.1073/pnas.0914439107; Nudelman H, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00009; Rawlings AE, 2016, CHEM-EUR J, V22, P7885, DOI 10.1002/chem.201600322; Rawlings AE, 2014, P NATL ACAD SCI USA, V111, P16094, DOI 10.1073/pnas.1409256111; RECORD MT, 1976, J MOL BIOL, V107, P145, DOI 10.1016/S0022-2836(76)80023-X; Rogers JM, 2013, J AM CHEM SOC, V135, P1415, DOI 10.1021/ja309527h; Ruby C, 2006, CR GEOSCI, V338, P420, DOI 10.1016/j.crte.2006.04.008; Schuler B, 2020, CURR OPIN STRUC BIOL, V60, P66, DOI 10.1016/j.sbi.2019.12.006; Shammas SL, 2016, J BIOL CHEM, V291, P6689, DOI 10.1074/jbc.R115.692715; Staniland SS, 2016, BIOCHEM SOC T, V44, P883, DOI 10.1042/BST20160057; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Tanaka M, 2011, J BIOL CHEM, V286, P6386, DOI 10.1074/jbc.M110.183434; van der Lee R, 2014, CHEM REV, V114, P6589, DOI 10.1021/cr400525m; Vitalis A, 2009, J COMPUT CHEM, V30, P673, DOI 10.1002/jcc.21005; Wang LJ, 2012, BIOMACROMOLECULES, V13, P98, DOI 10.1021/bm201278u; Wright PE, 2009, CURR OPIN STRUC BIOL, V19, P31, DOI 10.1016/j.sbi.2008.12.003; Yamagishi A, 2016, SCI REP-UK, V6, DOI 10.1038/srep29785; Zhang HH, 2015, LANGMUIR, V31, P2818, DOI 10.1021/la5044377	49	6	6	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2020	15	2							e0228708	10.1371/journal.pone.0228708	http://dx.doi.org/10.1371/journal.pone.0228708			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8EV	32097412	Green Published, gold, Green Accepted			2022-12-26	WOS:000535232000011
J	Tobey, E; Jain, A; Mozumdar, A				Tobey, Elizabeth; Jain, Aparna; Mozumdar, Arupendra			The relationship between attitudes towards pregnancy and contraceptive continuation: Results from a longitudinal study of married women in India	PLOS ONE			English	Article							UNINTENDED PREGNANCY; LONDON MEASURE; UNITED-STATES; UNMET NEED; AMBIVALENCE; CONSISTENCY; FERTILITY; INTENTIONS; CHILDBEARING; BEHAVIORS	To understand the relationship between pregnancy intentions and contraceptive use, a growing body of research has begun to examine various domains of women's attitudes towards pregnancy, acknowledging that these attitudes may contradict one another, and women may be ambivalent. This study examines pregnancy ambivalence and assesses the relationship between attitudes towards pregnancy and contraceptive continuation after nine months among a sample of women in Odisha and Haryana, India. Data come from a longitudinal study of married women age 15-49 who began using a modern reversible method of contraception at the time of study enrollment. To assess their cognitive attitudes (beliefs/knowledge) towards pregnancy, women were asked "how important is it you to avoid a pregnancy now?" To assess their affective attitudes (feelings/emotions), women were asked about their agreement with the statement: "If I found out I was pregnant in the next several weeks, I would be happy." A joint, 4-category measure combining these cognitive and affective attitudes towards pregnancy was created to measure concordance and ambivalence in attitudes towards pregnancy. Multivariate random-effects logistic regression models were employed to examine the relationship of these two measures with method-specific contraceptive continuation nine months later. Two models were conducted, one with the two attitude variables included independently and the second with the joint, 4-category measure included. Results showed that affective and cognitive attitudes were both significantly associated with continuation, but that there were no significant differences between those that were ambivalent and those whose attitudes were concordantly anti-pregnancy. This study suggests that attitudes towards pregnancy are multifaceted and both cognitive and affective attitudes towards pregnancy may play an important role in contraceptive use in India.	[Tobey, Elizabeth; Jain, Aparna] Populat Council, Washington, DC 20008 USA; [Mozumdar, Arupendra] Populat Council, New Delhi, India	Population Council	Tobey, E (corresponding author), Populat Council, Washington, DC 20008 USA.	etobey@popcouncil.org		Jain, Aparna/0000-0003-1683-3341; Tobey, Elizabeth/0000-0001-6219-2827	United States Agency for International Development (USAID) [AIDOAA-A-13-00087]	United States Agency for International Development (USAID)(United States Agency for International Development (USAID)CGIAR)	The Evidence Project is made possible by the generous support of the American people through the United States Agency for International Development (USAID, https://www.usaid.gov/) under the terms of cooperative agreement no. AIDOAA-A-13-00087. The contents of this manuscript are the sole responsibility of the Evidence Project and Population Council and do not necessarily reflect the views of USAID or the United States Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiken ARA, 2016, PERSPECT SEX REPRO H, V48, P139, DOI 10.1363/48e11316; Aiken ARA, 2015, SOC SCI MED, V132, P149, DOI 10.1016/j.socscimed.2015.03.038; Bankole A, 1998, J BIOSOC SCI, V30, P439, DOI 10.1017/S0021932098004398; Barden-O'Fallon JL, 2010, INT PERSPECT SEX R H, V36, P36, DOI 10.1363/ipsrh.36.036.10; Bearak J, 2018, LANCET GLOB HEALTH, V6, pE380, DOI 10.1016/S2214-109X(18)30029-9; Bhardwaj N, 2016, THESIS; Bruckner H, 2004, PERSPECT SEX REPRO H, V36, P248, DOI 10.1363/3624804; Casterline JB, 2003, INT FAM PLAN PERSPEC, V29, P158, DOI 10.2307/3181044; Epari Venkatarao, 2017, J Family Med Prim Care, V6, P21, DOI 10.4103/2249-4863.214991; Finer LB, 2016, NEW ENGL J MED, V374, P843, DOI 10.1056/NEJMsa1506575; Frost JJ, 2007, PERSPECT SEX REPRO H, V39, P90, DOI 10.1363/3909007; Gipson JD, 2008, STUD FAMILY PLANN, V39, P18, DOI 10.1111/j.1728-4465.2008.00148.x; Gomez AM, 2019, PERSPECT SEX REPRO H, V51, P7, DOI 10.1363/psrh.12088; Government of India International Institute for Population Sciences (IIPS) and ICF, 2022, NATL FAMILY HLTH SUR; Higgins JA, 2012, PERSPECT SEX REPRO H, V44, P236, DOI 10.1363/4423612; Huber S, 2017, INT PERSPECT SEX R H, V43, P13, DOI 10.1363/43e3417; Jain A, 2019, GLOB HEALTH-SCI PRAC, V7, P289, DOI 10.9745/GHSP-D-19-00028; Jones RK, 2017, CONTRACEPTION, V95, P485, DOI 10.1016/j.contraception.2017.01.009; Kavanaugh ML, 2009, PERSPECT SEX REPRO H, V41, P238, DOI 10.1363/4123809; Koenig MA, 2006, POP STUD-J DEMOG, V60, P243, DOI 10.1080/00324720600895819; Lawton R, 2009, HEALTH PSYCHOL, V28, P56, DOI 10.1037/a0013424; Machiyama K, 2017, REPROD HEALTH, V14, DOI 10.1186/s12978-016-0268-z; MEASURE Evaluation, 2017, FAM PLANN REPR HLTH; MILLER WB, 1986, FAM PLANN PERSPECT, V18, P27, DOI 10.2307/2135198; Ministry of Health and Family Welfare (MOHFW), 2014, IND VIS FP2020; Moreau C, 2013, HUM REPROD, V28, P642, DOI 10.1093/humrep/des421; Potter JE, 2019, CONTRACEPTION, V100, P1, DOI 10.1016/j.contraception.2019.02.005; Rocca CH, 2010, DEMOGR RES, V23, P293, DOI 10.4054/DemRes.2010.23.11; Roy TK, 2008, INT FAM PLAN PERSPEC, V34, P138, DOI [10.1363/3413808, 10.1363/ifpp.34.138.08]; Russell JA, 2003, PSYCHOL REV, V110, P145, DOI 10.1037/0033-295X.110.1.145; Santelli JS, 2009, STUD FAMILY PLANN, V40, P87, DOI 10.1111/j.1728-4465.2009.00192.x; Singh A, 2018, INT PERSPECT SEX R H, V44, P167, DOI 10.1363/44e7218; Singh S, 2018, LANCET GLOB HEALTH, V6, pE111, DOI [10.1016/S2214-109X(17)30453-9, 10.1016/s2214-109x(17)30453-9]; Speizer IS, 2006, INT FAM PLAN PERSPEC, V32, P185, DOI 10.1363/3218506; Speizer IS, 2013, CONTRACEPTION, V88, P553, DOI 10.1016/j.contraception.2013.04.006; Speizer Ilene S, 2009, Reprod Health, V6, P19, DOI 10.1186/1742-4755-6-19; Trussell J, 1999, FAM PLANN PERSPECT, V31, P246, DOI 10.2307/2991573; Yoo SH, 2014, BIODEMOGR SOC BIOL, V60, P49, DOI 10.1080/19485565.2014.905193; Zabin LS, 1999, FAM PLANN PERSPECT, V31, P250, DOI 10.2307/2991576	39	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2020	15	2							e0229333	10.1371/journal.pone.0229333	http://dx.doi.org/10.1371/journal.pone.0229333			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LQ8EV	32097433	Green Published, gold			2022-12-26	WOS:000535232000026
J	Akiyama, Y; Fukui, Y; Okamoto, S; Yamada, Y				Akiyama, Yasuhiro; Fukui, Yusuke; Okamoto, Shogo; Yamada, Yoji			Effects of exoskeletal gait assistance on the recovery motion following tripping	PLOS ONE			English	Article							SWING PHASE; KNEE; PERTURBATIONS; STRATEGIES; MECHANISMS; WALKING; BALANCE	Physical assistant robots improve the user's ability to walk. However, they also potentially affect recovery motion following tripping. The assist algorithm should not interfere with the recovery motion, and should enhance the ability of the user to recover after tripping. Thus, in this study, we investigated the recovery motion affected by the assist robot after tripping. We compared the recovery motion with different reaction algorithms. Principal component analysis revealed the effects of the reaction algorithm. Correspondingly, principal components were related to the recovery motion during two steps following tripping. Specifically, the effects of the reaction algorithm were related to a principal component that represented the motion of the second step after tripping and that increased the margin of stability. Furthermore, the margin of stability became significantly large when the assistive torque was applied during the recovery motion. The result of this study suggests that the assist robot can potentially enhances the recovery motion of its user following tripping.	[Akiyama, Yasuhiro; Fukui, Yusuke; Okamoto, Shogo; Yamada, Yoji] Nagoya Univ, Dept Mech Syst Engn, Nagoya, Aichi, Japan	Nagoya University	Akiyama, Y (corresponding author), Nagoya Univ, Dept Mech Syst Engn, Nagoya, Aichi, Japan.	akiyama-yasuhiro@mech.nagoya-u.ac.jp	Akiyama, Yasuhiro/AAV-6248-2021	Akiyama, Yasuhiro/0000-0002-4169-3734	KAKENHI of Japan Society for the Promotion of Science [17K01293]	KAKENHI of Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by KAKENHI of Japan Society for the Promotion of Science. The Grant Number is 17K01293.	Akiyama Y, 2014, 2014 IEEE INTERNATIONAL CONFERENCE ON ROBOTICS AND BIOMIMETICS IEEE-ROBIO 2014, P1493, DOI 10.1109/ROBIO.2014.7090545; Arnold AS, 2007, J BIOMECH, V40, P3314, DOI 10.1016/j.jbiomech.2007.05.006; Bruijn SM, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2012.0999; Chen B, 2016, J ORTHOP TRANSL, V5, P26, DOI 10.1016/j.jot.2015.09.007; de Leva P, 1996, J BIOMECH, V29, P1223, DOI 10.1016/0021-9290(95)00178-6; Duclos C, 2009, J BIOMECH, V42, P379, DOI 10.1016/j.jbiomech.2008.11.007; ENG JJ, 1994, EXP BRAIN RES, V102, P339; Hof AL, 2005, J BIOMECH, V38, P1, DOI 10.1016/j.jbiomech.2004.03.025; Hof AL, 2007, GAIT POSTURE, V25, P250, DOI 10.1016/j.gaitpost.2006.04.013; MANN HB, 1947, ANN MATH STAT, V18, P50, DOI 10.1214/aoms/1177730491; Millard M, 2012, J COMPUT NONLIN DYN, V7, DOI 10.1115/1.4005462; Muniz AMS, 2009, GAIT POSTURE, V29, P31, DOI 10.1016/j.gaitpost.2008.05.015; Myers RH, 1990, CLASSICAL MODERN REG, V2; Niino N., 2000, J EPIDEMIOL, V10, pS90, DOI [10.2188/jea.10.1sup_90, DOI 10.2188/JEA.10.1SUP_90]; Owings TM, 2001, CLIN BIOMECH, V16, P813, DOI 10.1016/S0268-0033(01)00077-8; Pavol MJ, 2001, J GERONTOL A-BIOL, V56, pM428, DOI 10.1093/gerona/56.7.M428; Piazza SJ, 1996, J BIOMECH, V29, P723, DOI 10.1016/0021-9290(95)00144-1; Pijnappels M, 2005, GAIT POSTURE, V21, P388, DOI 10.1016/j.gaitpost.2004.04.009; Pijnappels M, 2001, GAIT POSTURE, V14, P11, DOI 10.1016/S0966-6362(01)00110-2; Roos PE, 2010, CLIN BIOMECH, V25, P873, DOI 10.1016/j.clinbiomech.2010.06.016; Shirota C, 2014, J BIOMECH, V47, P2679, DOI 10.1016/j.jbiomech.2014.05.009; TATE DG, 1992, AM J PHYS MED REHAB, V71, P92, DOI 10.1097/00002060-199204000-00006; van Dieen JH, 2005, SAFETY SCI, V43, P437, DOI 10.1016/j.ssci.2005.08.008; Viteckova S, 2013, BIOCYBERN BIOMED ENG, V33, P96, DOI 10.1016/j.bbe.2013.03.005; WOLD S, 1987, CHEMOMETR INTELL LAB, V2, P37, DOI 10.1016/0169-7439(87)80084-9; Zanotto D, 2015, IEEE T ROBOT, V31, P978, DOI 10.1109/TRO.2015.2450414; Zhou ZN, 2008, IEEE T CIRC SYST VID, V18, P1489, DOI 10.1109/TCSVT.2008.2005612	27	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2020	15	2							e0229150	10.1371/journal.pone.0229150	http://dx.doi.org/10.1371/journal.pone.0229150			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8DW	32092091	Green Published, gold			2022-12-26	WOS:000535229300027
J	Almeida, MC; Branco, R; Morais, PV				Almeida, Mariana Cruz; Branco, Rita; Morais, Paula, V			Response to vanadate exposure in Ochrobactrum tritici strains	PLOS ONE			English	Article							PSEUDOMONAS-AERUGINOSA; CONFERS RESISTANCE; MEXGHI-OPMD; EFFLUX PUMP; VANADIUM; GROWTH; ACCUMULATION; RESPIRATION; REDUCTION; BACTERIA	Vanadium is a transition metal that has been added recently to the EU list of Raw Critical Metals. The growing needs of vanadium primarily in the steel industry justify its increasing economic value. However, because mining of vanadium sources (i. e. ores, concentrates and vanadiferous slags) is expanding, so is vanadium environmental contamination. Bioleaching comes forth as smart strategy to deal with supply demand and environmental contamination. It requires organisms that are able to mobilize the metal and at the same time are resistant to the leachate generated. Here, we investigated the molecular mechanisms underlying vanadium resistance in Ochrobactrum tritici strains. The highly resistant strain 5bvl1 was able to grow at concentrations > 30 mM vanadate, while the O. tritici type strain only tolerated < 3 mM vanadate concentrations. Screening of O. tritici single mutants (chrA, chrC, chrF and recA) growth during vanadate exposure revealed that vanadate resistance was associated with chromate resistance mechanisms (in particular ChrA, an efflux pump and ChrC, a superoxide dismutase). We also showed that sensitivity to vanadate was correlated with increased accumulation of vanadate intracellularly, while in resistant cells this was not found. Other up-regulated proteins found during vanadate exposure were ABC transporters for methionine and iron, suggesting that cellular responses to vanadate toxicity may also induce changes in unspecific transport and chelation of vanadate.	[Almeida, Mariana Cruz; Branco, Rita; Morais, Paula, V] Univ Coimbra, Ctr Mech Engn Mat & Proc, Dept Life Sci, CEMMPRE, Coimbra, Portugal	Universidade de Coimbra	Morais, PV (corresponding author), Univ Coimbra, Ctr Mech Engn Mat & Proc, Dept Life Sci, CEMMPRE, Coimbra, Portugal.	pvmorais@ci.uc.pt	Branco, Rita/AAQ-4007-2021; Morais, Paula Vasconcelos/C-9756-2014	Branco, Rita/0000-0003-0291-8029; Morais, Paula Vasconcelos/0000-0002-1939-6389; Cruz Almeida, Mariana/0000-0001-8902-1892	Fundacao para a Ciencia e a Tecnologia (FCT) [UID/EMS/00285/2013, PTW-PTDC/AAG-REC/3839/2014, ERA-MIN/0002/2015, POCI-01-0145FEDER-031820]; CEMMPRE; project Renature [Centro-01-0145FEDER-000007]	Fundacao para a Ciencia e a Tecnologia (FCT)(Portuguese Foundation for Science and TechnologyEuropean Commission); CEMMPRE; project Renature	This work was supported by CEMMPRE and by Fundacao para a Ciencia e a Tecnologia (FCT, https://www.fct.pt/) under the projects UID/EMS/00285/2013, PTW-PTDC/AAG-REC/3839/2014, ERA-MIN/0002/2015 and POCI-01-0145FEDER-031820. MCA has a postdoctoral grant within the project Renature -Centro-01-0145FEDER-000007. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aendekerk S, 2005, MICROBIOL-SGM, V151, P1113, DOI 10.1099/mic.0.27631-0; Aendekerk S, 2002, MICROBIOL-SGM, V148, P2371, DOI 10.1099/00221287-148-8-2371; Baysse C, 2000, MICROBIOL-UK, V146, P2425, DOI 10.1099/00221287-146-10-2425; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Branco R, 2004, CAN J MICROBIOL, V50, P697, DOI [10.1139/w04-048, 10.1139/W04-048]; Branco R, 2008, J BACTERIOL, V190, P6996, DOI 10.1128/JB.00289-08; Branco R, 2016, BMC MICROBIOL, V16, DOI 10.1186/s12866-016-0648-0; Branco R, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-95; Brettin T, 2015, SCI REP-UK, V5, DOI 10.1038/srep08365; Carpentier W, 2005, J BACTERIOL, V187, P3293, DOI 10.1128/JB.187.10.3293-3301.2005; Carpentier W, 2003, APPL ENVIRON MICROB, V69, P3636, DOI 10.1128/AEM.69.6.3636-3639.2003; Comission E, 2017, STUD REV LIST CRIT R; Costigan M, 2001, CONCISE INT CHEM ASS; Del Carpio E, COORD CHEM; Denayer S, 2006, FEMS MICROBIOL LETT, V264, P59, DOI 10.1111/j.1574-6968.2006.00435.x; Francisco R, 2002, J APPL MICROBIOL, V92, P837, DOI 10.1046/j.1365-2672.2002.01591.x; Hernandez A, 1998, APPL ENVIRON MICROB, V64, P4317; Imtiaz M, 2015, ENVIRON INT, V80, P79, DOI 10.1016/j.envint.2015.03.018; Klaus-Joerger T, 2001, TRENDS BIOTECHNOL, V19, P15, DOI 10.1016/S0167-7799(00)01514-6; Kreuzer KN, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a012674; Lazaridis NK, 2003, SEP SCI TECHNOL, V38, P2201, DOI 10.1081/SS-120021620; Lebuhn M, 2000, INT J SYST EVOL MICR, V50, P2207, DOI 10.1099/00207713-50-6-2207; Ledin M, 2000, EARTH-SCI REV, V51, P1, DOI 10.1016/S0012-8252(00)00008-8; Lu L, 2019, J SOIL WATER CONSERV, V74, P296, DOI 10.2489/jswc.74.3.296; Ortiz-Bernad I, 2004, APPL ENVIRON MICROB, V70, P3091, DOI 10.1128/AEM.70.5.3091-3095.2004; Pessoa JC, 2015, COORDIN CHEM REV, V301, P49, DOI 10.1016/j.ccr.2015.03.016; Rehder D, 2014, OCEANOGRAPHY, V2, P1; Rehder D, 2015, METALLOMICS, V7, P730, DOI 10.1039/c4mt00304g; Romaidi, 2016, MAR BIOTECHNOL, V18, P359, DOI 10.1007/s10126-016-9697-5; Roux M, 2002, FEMS MICROBIOL LETT, V210, P129, DOI 10.1111/j.1574-6968.2002.tb11171.x; Silver S, 1996, GENE, V179, P9, DOI 10.1016/S0378-1119(96)00323-X; Silver S, 1996, ANNU REV MICROBIOL, V50, P753, DOI 10.1146/annurev.micro.50.1.753; SINGH HN, 1993, J BASIC MICROB, V33, P201, DOI 10.1002/jobm.3620330312; Sippel D, 2017, NAT CHEM BIOL, V13, P956, DOI [10.1038/nchembio.2428, 10.1038/NCHEMBIO.2428]; van Marwijk J, 2009, BIOTECHNOL LETT, V31, P845, DOI 10.1007/s10529-009-9946-z; Wang L, 2018, J HAZARD MATER, V341, P1, DOI 10.1016/j.jhazmat.2017.07.036; Zhang TF, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-85	37	2	2	5	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2020	15	2							e0229359	10.1371/journal.pone.0229359	http://dx.doi.org/10.1371/journal.pone.0229359			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8DW	32092126	Green Published, gold			2022-12-26	WOS:000535229300050
J	Sandmark, J; Tigerstrom, A; Akerud, T; Althage, M; Antonsson, T; Blaho, S; Bodin, C; Bostrom, J; Chen, YT; Dahlen, A; Eriksson, PO; Evertsson, E; Fex, T; Fjellstrom, O; Gustafsson, D; Herslof, M; Hicks, R; Jarkvist, E; Johansson, C; Kalies, I; Svalstedt, BK; Kartberg, F; Legnehed, A; Martinsson, S; Moberg, A; Ridderstrom, M; Rosengren, B; Sabirsh, A; Thelin, A; Vinblad, J; Wellner, AU; Xu, BZ; Ostlund-Lindqvist, AM; Knecht, W				Sandmark, Jenny; Tigerstrom, Anna; Akerud, Tomas; Althage, Magnus; Antonsson, Thomas; Blaho, Stefan; Bodin, Cristian; Bostrom, Jonas; Chen, Yantao; Dahlen, Anders; Eriksson, Per-Olof; Evertsson, Emma; Fex, Tomas; Fjellstrom, Ola; Gustafsson, David; Herslof, Margareta; Hicks, Ryan; Jarkvist, Emelie; Johansson, Carina; Kalies, Inge; Svalstedt, Birgitta Karlsson; Kartberg, Fredrik; Legnehed, Anne; Martinsson, Sofia; Moberg, Andreas; Ridderstrom, Marianne; Rosengren, Birgitta; Sabirsh, Alan; Thelin, Anders; Vinblad, Johanna; Wellner, Annika U.; Xu, Bingze; Ostlund-Lindqvist, Ann-Margret; Knecht, Wolfgang			Identification and analyses of inhibitors targeting apolipoprotein(a) kringle domains KIV-7, KIV-10, and KV provide insight into kringle domain function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						X-ray crystallography; surface plasmon resonance (SPR); apolipoprotein; low-density lipoprotein (LDL); drug discovery; drug design; crystal structure; crystallography; cardiovascular disease; apo(a); apolipoprotein(a); Lp(a); small molecule inhibitor	LOW-DENSITY-LIPOPROTEIN; LYSINE-BINDING-SITE; INDUCED CONFORMATIONAL-CHANGE; ENHANCED MACROPHAGE UPTAKE; CRYSTAL-STRUCTURE; DOUBLE-BLIND; CARDIOVASCULAR-DISEASE; TRANEXAMIC ACID; RISK-FACTOR; IV TYPE-7	Increased plasma concentrations of lipoprotein(a) (Lp(a)) are associated with an increased risk for cardiovascular disease. Lp(a) is composed of apolipoprotein(a) (apo(a)) covalently bound to apolipoprotein B of low-density lipoprotein (LDL). Many of apo(a)'s potential pathological properties, such as inhibition of plasmin generation, have been attributed to its main structural domains, the kringles, and have been proposed to be mediated by their lysine-binding sites. However, available small-molecule inhibitors, such as lysine analogs, bind unselectively to kringle domains and are therefore unsuitable for functional characterization of specific kringle domains. Here, we discovered small molecules that specifically bind to the apo(a) kringle domains KIV-7, KIV-10, and KV. Chemical synthesis yielded compound AZ-05, which bound to KIV-10 with a K-d of 0.8 ?m and exhibited more than 100-fold selectivity for KIV-10, compared with the other kringle domains tested, including plasminogen kringle 1. To better understand and further improve ligand selectivity, we determined the crystal structures of KIV-7, KIV-10, and KV in complex with small-molecule ligands at 1.6?2.1 ? resolutions. Furthermore, we used these small molecules as chemical probes to characterize the roles of the different apo(a) kringle domains in in vitro assays. These assays revealed the assembly of Lp(a) from apo(a) and LDL, as well as potential pathophysiological mechanisms of Lp(a), including (i) binding to fibrin, (ii) stimulation of smooth-muscle cell proliferation, and (iii) stimulation of LDL uptake into differentiated monocytes. Our results indicate that a small-molecule inhibitor targeting the lysine-binding site of KIV-10 can combat the pathophysiological effects of Lp(a).	[Sandmark, Jenny; Akerud, Tomas; Bodin, Cristian; Eriksson, Per-Olof; Johansson, Carina; Moberg, Andreas] AstraZeneca, R&D, Discovery Sci, Struct Biophys & Fragment Based Lead Generat, S-43183 Molndal, Sweden; [Tigerstrom, Anna] AstraZeneca, R&D, Precis Med, Precis Med BioPharmaceut, S-43183 Molndal, Sweden; [Althage, Magnus] AstraZeneca, Early CVRM Biopharmaceut R&D, Translat Sci & Expt Med, S-43183 Molndal, Sweden; [Gustafsson, David; Jarkvist, Emelie; Kalies, Inge; Svalstedt, Birgitta Karlsson; Legnehed, Anne; Martinsson, Sofia; Rosengren, Birgitta; Thelin, Anders; Vinblad, Johanna; Ostlund-Lindqvist, Ann-Margret; Knecht, Wolfgang] AstraZeneca, BioPharmaceut R&D, Cardiovasc Renal & Metab, Biosci Cardiovasc, S-43183 Molndal, Sweden; [Antonsson, Thomas; Bostrom, Jonas; Chen, Yantao; Dahlen, Anders; Evertsson, Emma; Fex, Tomas; Herslof, Margareta; Wellner, Annika U.] AstraZeneca, BioPharmaceut R&D, Cardiovasc Renal & Metab, Med Chem, S-43183 Molndal, Sweden; [Blaho, Stefan; Hicks, Ryan; Kartberg, Fredrik; Xu, Bingze] AstraZeneca, R&D, Discovery Sci, Discovery Biol, S-43183 Molndal, Sweden; [Fjellstrom, Ola] AstraZeneca, Biopharmaceut R&D, Cardiovasc Renal & Metab, Res & Early Dev, S-43183 Molndal, Sweden; [Ridderstrom, Marianne] AstraZeneca, Biopharmaceut R&D, Cardiovasc Renal & Metab, Drug Metab & Pharmacokinet, S-43183 Molndal, Sweden; [Sabirsh, Alan] AstraZeneca, R&D, Pharmaceut Sci, Adv Drug Delivery, S-43183 Molndal, Sweden; [Knecht, Wolfgang] Lund Univ, Dept Biol & Lund Prot Prod Platform, Solvegatan 35, S-22362 Lund, Sweden	AstraZeneca; AstraZeneca; AstraZeneca; AstraZeneca; AstraZeneca; AstraZeneca; AstraZeneca; AstraZeneca; AstraZeneca; Lund University	Sandmark, J (corresponding author), AstraZeneca, R&D, Discovery Sci, Struct Biophys & Fragment Based Lead Generat, S-43183 Molndal, Sweden.; Knecht, W (corresponding author), AstraZeneca, BioPharmaceut R&D, Cardiovasc Renal & Metab, Biosci Cardiovasc, S-43183 Molndal, Sweden.; Knecht, W (corresponding author), Lund Univ, Dept Biol & Lund Prot Prod Platform, Solvegatan 35, S-22362 Lund, Sweden.	jenny.sandmark@astrazeneca.com; Wolfgang.Knecht@biol.lu.se	Boström, Jonas/A-3749-2009	Sabirsh, Alan/0000-0001-5310-0281; Hicks, Ryan/0000-0002-3367-6272; Bostrom, Jonas/0000-0002-9719-9137				Angelin B, 2013, J INTERN MED, V273, P3, DOI 10.1111/joim.12013; Angles-Cano E, 2001, ANN NY ACAD SCI, V936, P261; ANGLESCANO E, 1994, CHEM PHYS LIPIDS, V67-8, P369, DOI 10.1016/0009-3084(94)90159-7; Becker L, 2003, J BIOL CHEM, V278, P14074, DOI 10.1074/jbc.M212855200; BERG K, 1963, ACTA PATHOL MIC SC, V59, P369; Boonmark NW, 1997, J CLIN INVEST, V100, P558, DOI 10.1172/JCI119565; Bostrom J, 2013, J MED CHEM, V56, P3273, DOI 10.1021/jm301818g; BRUNNER C, 1993, P NATL ACAD SCI USA, V90, P11643, DOI 10.1073/pnas.90.24.11643; Burgess S, 2018, JAMA CARDIOL, V3, P619, DOI 10.1001/jamacardio.2018.1470; Chang Y, 1998, BIOCHEMISTRY-US, V37, P3258, DOI 10.1021/bi972284e; Cheng LF, 2014, ACS MED CHEM LETT, V5, P538, DOI 10.1021/ml400526d; Cho T, 2008, J BIOL CHEM, V283, P30503, DOI 10.1074/jbc.M802648200; CLAEYS H, 1976, FEBS LETT, V61, P20, DOI 10.1016/0014-5793(76)80161-5; Dalvit C, 2002, J MED CHEM, V45, P2610, DOI 10.1021/jm011122k; Dalvit C, 2008, CONCEPT MAGN RESON A, V32A, P341, DOI 10.1002/cmr.a.20121; Fitzgerald K, 2017, NEW ENGL J MED, V376, P41, DOI 10.1056/NEJMoa1609243; Fless GM, 1996, BIOCHEMISTRY-US, V35, P2289, DOI 10.1021/bi951792q; Frank S, 1997, PROTEIN ENG, V10, P291, DOI 10.1093/protein/10.3.291; Frank S, 1999, BBA-MOL CELL BIOL L, V1438, P99, DOI 10.1016/S1388-1981(99)00044-X; FRANK S, 1995, ARTERIOSCL THROM VAS, V15, P1774, DOI 10.1161/01.ATV.15.10.1774; Gabel BR, 1998, BIOCHEMISTRY-US, V37, P7892, DOI 10.1021/bi973186w; Helmhold M, 1996, Z Gastroenterol, V34 Suppl 3, P36; HWANG TL, 1995, J MAGN RESON SER A, V112, P275, DOI 10.1006/jmra.1995.1047; Jaeger BR, 2009, NAT CLIN PRACT CARD, V6, P229, DOI 10.1038/ncpcardio1456; Kamstrup PR, 2011, SCAND J CLIN LAB INV, V71, P87, DOI 10.3109/00365513.2010.550311; KARLSSON R, 1994, ANAL BIOCHEM, V221, P142, DOI 10.1006/abio.1994.1390; KHOO JC, 1988, ARTERIOSCLEROSIS, V8, P348, DOI 10.1161/01.ATV.8.4.348; Klezovitch O, 2001, J BIOL CHEM, V276, P46864, DOI 10.1074/jbc.M107943200; Kogej T, 2006, J CHEM INF MODEL, V46, P1201, DOI 10.1021/ci0504723; Koschinsky Marlys L., 2006, Cardiovascular & Hematological Disorders - Drug Targets, V6, P267; KOSCHINSKY ML, 1991, BIOCHEMISTRY-US, V30, P5044, DOI 10.1021/bi00234a029; Kostner KM, 2018, ATHEROSCLEROSIS, V274, P16, DOI 10.1016/j.atherosclerosis.2018.04.032; Kronenberg F, 2013, J INTERN MED, V273, P6, DOI 10.1111/j.1365-2796.2012.02592.x; Law RHP, 2012, CELL REP, V1, P185, DOI 10.1016/j.celrep.2012.02.012; Leibundgut G, 2013, J LIPID RES, V54, P2815, DOI 10.1194/jlr.M040733; Libby P, 2011, NATURE, V473, P317, DOI 10.1038/nature10146; LIU JN, 1994, BIOCHEMISTRY-US, V33, P2554, DOI 10.1021/bi00175a026; Mansson M, 2014, SCI REP-UK, V4, DOI 10.1038/srep05318; Marcovina SM, 2003, CURR OPIN LIPIDOL, V14, P361, DOI 10.1097/00041433-200308000-00004; Mathews II, 1996, BIOCHEMISTRY-US, V35, P2567, DOI 10.1021/bi9521351; MCLEAN JW, 1987, NATURE, V330, P132, DOI 10.1038/330132a0; Mochalkin I, 1999, BIOCHEMISTRY-US, V38, P1990, DOI 10.1021/bi9820558; Nikolajsen CL, 2014, J BIOL CHEM, V289, P6526, DOI 10.1074/jbc.M113.517904; Nordestgaard BG, 2011, CURR OPIN LIPIDOL, V22, P113, DOI 10.1097/MOL.0b013e32834477d2; Nordestgaard BG, 2010, EUR HEART J, V31, P2844, DOI 10.1093/eurheartj/ehq386; O'Neil CH, 2004, J BIOL CHEM, V279, P55187, DOI 10.1074/jbc.M409860200; PALABRICA TM, 1995, NAT MED, V1, P256, DOI 10.1038/nm0395-256; Pellegrino M, 2004, J BIOL CHEM, V279, P6526, DOI 10.1074/jbc.M309705200; PHILLIPS ML, 1993, BIOCHEMISTRY-US, V32, P3722, DOI 10.1021/bi00065a026; Qian LJ, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00316-3; Raal FJ, 2015, LANCET, V385, P341, DOI 10.1016/S0140-6736(14)61374-X; Rahman MN, 2002, BIOCHEMISTRY-US, V41, P1149, DOI 10.1021/bi010964i; Rahman MN, 2001, PROTEIN ENG, V14, P427, DOI 10.1093/protein/14.6.427; Ray KK, 2018, CIRCULATION, V138, P1304, DOI 10.1161/CIRCULATIONAHA.118.034710; REBLIN T, 1995, ATHEROSCLEROSIS, V113, P179, DOI 10.1016/0021-9150(94)05445-O; Roberts I, 2011, LANCET, V377, P1096, DOI 10.1016/S0140-6736(11)60278-X; Roeseler E, 2016, ARTERIOSCL THROM VAS, V36, P2019, DOI 10.1161/ATVBAHA.116.307983; Santos RD, 2015, ARTERIOSCL THROM VAS, V35, P689, DOI 10.1161/ATVBAHA.114.304549; Tanaka S, 1998, LIPIDS, V33, P385, DOI 10.1007/s11745-998-0219-5; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tsimikas S, 2015, LANCET, V386, P1472, DOI 10.1016/S0140-6736(15)61252-1; Tsimikas S, 2012, J AM COLL CARDIOL, V60, P716, DOI 10.1016/j.jacc.2012.04.038; Viney NJ, 2016, LANCET, V388, P2239, DOI 10.1016/S0140-6736(16)31009-1; Virani SS, 2012, CIRCULATION, V125, P241, DOI 10.1161/CIRCULATIONAHA.111.045120; Waldmann E, 2017, ATHEROSCLEROSIS, V259, P20, DOI 10.1016/j.atherosclerosis.2017.02.019; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Xu SH, 1998, BIOCHEMISTRY-US, V37, P9284, DOI 10.1021/bi9729662; Xue Y, 2012, J THROMB HAEMOST, V10, P1385, DOI 10.1111/j.1538-7836.2012.04765.x; Ye QL, 2001, PROTEIN SCI, V10, P1124, DOI 10.1110/ps.01701; Yu H, 2003, CHINESE MED J-PEKING, V116, P721	70	3	3	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 10	2020	295	15					5136	5151		10.1074/jbc.RA119.011251	http://dx.doi.org/10.1074/jbc.RA119.011251			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LE7FC	32132173	Green Published, hybrid			2022-12-26	WOS:000526887000032
J	Czepita, M				Czepita, Maciej			Near-infrared transillumination imaging combined with aperture photometry for the quantification of melanin in the iris pigment epithelium	PLOS ONE			English	Article							DISPERSION; GRANULES; RED	Near-infrared transillumination is used in the diagnosis and the management of different eye diseases. In particular, it enables the visualization of melanin in the pigment epithelium of the iris. This technique is valuable in such conditions as pigment dispersion syndrome and Adie's tonic pupil. Thus, objective quantification of the amount of melanin shedded from the iris pigment epithelium may help in the management of these conditions. By combining aperture photometry with near-infrared iris transillumination this can be achieved. A total of 4 patients (7 eyes) were examined. Three patients were diagnosed with pigment dispersion syndrome in both eyes. One patient had Adie's tonic pupil in one eye. Near-infrared iris transillumination was performed by using a prototype apparatus. Aperture photometry measurements were carried out through specially developed software. The signal-to-noise ratio of the prototype apparatus was 52 dB (399:1). Each pixel within the near-infrared transillumination image corresponded with an area size of the iris of 85 mu m x 83 mu m. Measurements were taken from several points of the iris in all patients. The average aperture photometry value of transillumination defects was 1321.53 (ADU) +/- 501.08 SD, while the average aperture photometry value of the papillary ruff was 90.83 (ADU) +/- 53.4. On average transillumination defects transmit 14.55 times more near-infrared light than the papillary ruff. A prototype apparatus for the capture of near-infrared iris transillumination images and custom software enabling aperture photometry measurements of the obtained images has been developed for the purpose of this study. This study demonstrates a potential application of this technique in the diagnosis and management of patients with such conditions as pigment dispersion syndrome and Adie's tonic pupil.	[Czepita, Maciej] Pomeranian Med Univ, Dept Ophthalmol 2, Szczecin, Poland	Pomeranian Medical University	Czepita, M (corresponding author), Pomeranian Med Univ, Dept Ophthalmol 2, Szczecin, Poland.	maciej@czepita.pl						ALWARD WLM, 1990, ARCH OPHTHALMOL-CHIC, V108, P748, DOI 10.1001/archopht.1990.01070070134052; ANDERSSONENGELS S, 1990, OPT LETT, V15, P1179, DOI 10.1364/OL.15.001179; CAMPBELL DG, 1979, ARCH OPHTHALMOL-CHIC, V97, P1667, DOI 10.1001/archopht.1979.01020020235011; Chacko S, 2000, IEEE T BIO-MED ENG, V47, P131, DOI 10.1109/10.817628; Collins KA, 2017, ASTRON J, V153, DOI 10.3847/1538-3881/153/2/77; Fingert JH, 2013, J GLAUCOMA, V22, P555, DOI 10.1097/IJG.0b013e318255da16; GEERAETS WJ, 1968, AM J OPHTHALMOL, V66, P15, DOI 10.1016/0002-9394(68)91780-7; Haynes W L, 1994, J Glaucoma, V3, P106; Kardon RH, 1998, OPHTHALMOLOGY, V105, P313, DOI 10.1016/S0161-6420(98)93328-0; Khaliduzzaman A, 2019, COMPUT ELECTRON AGR, V158, P326, DOI 10.1016/j.compag.2019.02.014; Kuchle M, 1998, AM J OPHTHALMOL, V126, P425, DOI 10.1016/S0002-9394(98)00098-1; Mardin CY, 2000, OPHTHALMOLOGY, V107, P435, DOI 10.1016/S0161-6420(99)00089-5; Merlo S, 2019, SENSORS-BASEL, V19, DOI 10.3390/s19040851; MILLER SA, 1992, APPL OPTICS, V31, P1631, DOI 10.1364/AO.31.001631; Ritch R, 1996, Trans Am Ophthalmol Soc, V94, P381; Roberts DK, 2009, OPHTHAL SURG LAS IM, V40, P207, DOI 10.3928/15428877-20090301-18; Saari JM, 2005, EUR J OPHTHALMOL, V15, P277, DOI 10.1177/112067210501500218; SAARI M, 1978, BRIT J OPHTHALMOL, V62, P110, DOI 10.1136/bjo.62.2.110; Skuta G, 2011, CLIN OPTICS, P103; Sliney D, 2005, APPL OPTICS, V44, P2162, DOI 10.1364/AO.44.002162; Srinivasan R, 2003, IEEE T BIO-MED ENG, V50, P724, DOI 10.1109/TBME.2003.812188; Trobe JD, 2008, RAPID DIAGNOSIS OPHT, P208; Youssef A, 2014, BIOSYST ENG, V125, P9, DOI 10.1016/j.biosystemseng.2014.06.014; Zadorozhnyy Oleg, 2016, Klin Oczna, V118, P184	24	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2020	15	3							e0230210	10.1371/journal.pone.0230210	http://dx.doi.org/10.1371/journal.pone.0230210			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8TR	32143214	Green Published, gold			2022-12-26	WOS:000535271600042
J	Sakai, M; Parajuli, RK; Kubota, Y; Kubo, N; Kikuchi, M; Arakawa, K; Nakano, T				Sakai, Makoto; Parajuli, Raj Kumar; Kubota, Yoshiki; Kubo, Nobuteru; Kikuchi, Mikiko; Arakawa, Kazuo; Nakano, Takashi			Improved iterative reconstruction method for Compton imaging using median filter	PLOS ONE			English	Article							PROJECTION; ALGORITHM	A Compton camera is a device for imaging a radio-source distribution without using a mechanical collimator. Ordered-subset expectation-maximization (OS-EM) is widely used to reconstruct Compton images. However, the OS-EM algorithm tends to over-concentrate and amplify noise in the reconstructed image. It is, thus, necessary to optimize the number of iterations to develop high-quality images, but this has not yet been achieved. In this paper, we apply a median filter to an OS-EM algorithm and introduce a median root prior expectation-maximization (MRP-EM) algorithm to overcome this problem. In MRP-EM, the median filter is used to update the image in each iteration. We evaluated the quality of images reconstructed by our proposed method and compared them with those reconstructed by conventional algorithms using mathematical phantoms. The spatial resolution was estimated using the images of two point sources. Reproducibility was evaluated on an ellipsoidal phantom by calculating the residual sum of squares, zero-mean normalized cross-correlation, and mutual information. In addition, we evaluated the semi-quantitative performance and uniformity on the ellipsoidal phantom. MRP-EM reduces the generated noise and is robust with respect to the number of iterations. An evaluation of the reconstructed image quality using some statistical indices shows that our proposed method delivers better results than conventional techniques.	[Sakai, Makoto; Parajuli, Raj Kumar; Kubota, Yoshiki; Kikuchi, Mikiko; Arakawa, Kazuo] Gunma Univ, Heavy Ion Med Ctr, Grad Sch Med, Showa Machi, Maebashi, Gunma, Japan; [Parajuli, Raj Kumar] Natl Inst Quantum & Radiol Sci & Technol, Dept Mol Imaging & Theranost, Inage Ku, Chiba, Japan; [Kubo, Nobuteru; Nakano, Takashi] Gunma Univ, Dept Radiat Oncol, Grad Sch Med, Showa Machi, Maebashi, Gunma, Japan	Gunma University; National Institutes for Quantum Science & Technology; Gunma University	Sakai, M (corresponding author), Gunma Univ, Heavy Ion Med Ctr, Grad Sch Med, Showa Machi, Maebashi, Gunma, Japan.	sakai-m@gunma-u.ac.jp	Sakai, Makoto/AAW-1902-2020; Kubota, Yoshiki/ABI-7675-2020	Sakai, Makoto/0000-0001-9928-2375; Parajuli, Raj Kumar/0000-0001-7776-6336	JSPS KAKENHI [JP17K1579800]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	M.S received JSPS KAKENHI [Grant Number JP17K1579800]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison J, 2016, NUCL INSTRUM METH A, V835, P186, DOI 10.1016/j.nima.2016.06.125; Andreyev A, 2016, MED PHYS, V43, P4866, DOI 10.1118/1.4959551; Andreyev A, 2009, 2009 IEEE NUCL SCI S; Andreyev A, 2011, MED PHYS, V38, P429, DOI 10.1118/1.3528170; Bruyant PP, 2002, J NUCL MED, V43, P1343; Fontana M, 2017, PHYS MED BIOL, V62, P8794, DOI 10.1088/1361-6560/aa926a; GEMAN S, 1984, IEEE T PATTERN ANAL, V6, P721, DOI 10.1109/TPAMI.1984.4767596; GREEN PJ, 1990, J ROY STAT SOC B MET, V52, P443; Hirasawa M, 2004, PHYS MED BIOL, V49, P2083, DOI 10.1088/0031-9155/49/10/017; Hirasawa M, 2003, PHYS MED BIOL, V48, P1009, DOI 10.1088/0031-9155/48/8/304; HUDSON HM, 1994, IEEE T MED IMAGING, V13, P601, DOI 10.1109/42.363108; Jiang JY, 2016, J NUCL SCI TECHNOL, V53, P1067, DOI 10.1080/00223131.2015.1089796; Kazantsev D, 2012, PHYS MED BIOL, V57, P3793, DOI 10.1088/0031-9155/57/12/3793; Kim SM, 2010, PHYS MED BIOL, V55, P5007, DOI 10.1088/0031-9155/55/17/009; Kolstein M, 2013, J INSTRUM, V8, DOI 10.1088/1748-0221/8/04/P04030; Liu Z, 2008, COMPUT VIS IMAGE UND, V109, P56, DOI 10.1016/j.cviu.2007.04.003; Nakano T, PHYS MED BIOL, DOI [10.1118/1.3528170, DOI 10.1118/1.3528170]; Odaka H, 2012, NUCL INSTRUM METH A, V695, P179, DOI 10.1016/j.nima.2011.12.061; Parajuli RK, 2019, PHYS MED BIOL, V64, DOI 10.1088/1361-6560/ab00b2; Sakai M, 2018, PHYS MED BIOL, V63, DOI 10.1088/1361-6560/aae1d1; Sakai M, 2018, PHYS MEDICA, V56, P1, DOI 10.1016/j.ejmp.2018.11.006; Schaar M., 2017, CURRENT DIRECTIONS B, V3, P549; SCHONFELDER V, 1993, ASTROPHYS J SUPPL S, V86, P657, DOI 10.1086/191794; SHEPP LA, 1974, IEEE T NUCL SCI, VNS21, P21, DOI 10.1109/TNS.1974.6499235; Sitek A, 2008, PHYS MED BIOL, V53, P3201, DOI 10.1088/0031-9155/53/12/009; Suzuki Y, 2013, RADIOLOGY, V267, P941, DOI 10.1148/radiol.13121194; Takahashi T, 2018, J ASTRON TELESC INST, V4, DOI 10.1117/1.JATIS.4.2.021402; Takeda S, 2012, IEEE T NUCL SCI, V59, P70, DOI 10.1109/TNS.2011.2178432; Takeda S, 2009, IEEE T NUCL SCI, V56, P783, DOI 10.1109/TNS.2008.2012059; TODD RW, 1974, NATURE, V251, P132, DOI 10.1038/251132a0; Tomitani T, 2002, PHYS MED BIOL, V47, P2129, DOI 10.1088/0031-9155/47/12/309; Vunckx K, 2010, IEEE NUCL SCI CONF R, P3262, DOI 10.1109/NSSMIC.2010.5874408; Wang Z, 2002, IEEE SIGNAL PROC LET, V9, P81, DOI 10.1109/97.995823; Watanabe S, 2005, IEEE T NUCL SCI, V52, P2045, DOI 10.1109/TNS.2005.856995; Xu D, 2006, IEEE T NUCL SCI, V53, P2787, DOI 10.1109/TNS.2006.880974	35	7	7	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2020	15	3							e0229366	10.1371/journal.pone.0229366	http://dx.doi.org/10.1371/journal.pone.0229366			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8TR	32142552	Green Published, Green Submitted, gold			2022-12-26	WOS:000535271600010
J	Mizuno-Matsumoto, Y; Inoguchi, Y; Carpels, SMA; Muramatsu, A; Yamamoto, Y				Mizuno-Matsumoto, Yuko; Inoguchi, Yuji; Carpels, Steven M. A.; Muramatsu, Ayumi; Yamamoto, Yusuke			Cerebral cortex and autonomic nervous system responses during emotional memory processing	PLOS ONE			English	Article							CROSS-CORRELATION ANALYSIS; PREFRONTAL CORTEX; HEART-RATE; STRESS	Psychiatric symptoms are often accompanied by somatic symptoms induced by the activity of the autonomic nervous system (ANS). The aim of this study was to calculate the time lag between electroencephalography (EEG) and electrocardiography (ECG) responses, to clarify the changes in the relationship between the cerebral cortex (CC) and the sympathetic nervous system (SNS) during emotional recall processing. Twenty-two healthy young adults were examined. Their EEG and ECG data were simultaneously recorded during emotional audiovisual recall tasks using pleasant and unpleasant stimuli for 180 s, with three repetitions (Epochs 1 & 2 and Epoch 3). The EEG data were analyzed using a fast Fourier transform (FFT) to obtain a time series of relative power spectra, X-E, in the theta 1, theta 2, alpha 1, alpha 2, alpha 3, beta 1, beta 2, and beta 3 bands. Time series of RR (inter-beat) intervals (time intervals between successive R waves) derived from the ECG spectral analysis using FFT was applied to the resampled time series of RR intervals over about 60 s to obtain a time series of power spectra for the ratio low frequency/high frequency (LH/HF), X-C, which reflects the activity of the sympathetic nervous function. The time lag between X-E and X-C was calculated using wavelet-crosscorrelation analysis. The results demonstrated that the brain responded to unfamiliar emotionally pleasant stimuli in Epochs 1 & 2 earlier than the SNS, whereas the brain and SNS responded to unfamiliar unpleasant stimuli nearly simultaneously. The brain was activated rapidly in response to familiar unpleasant stimuli, although SNS responded more rapidly to familiar pleasant stimuli than the brain in Epoch 3. Our results quantitatively describe the relationship between the CC and the ANS during emotional recall.	[Mizuno-Matsumoto, Yuko; Inoguchi, Yuji; Carpels, Steven M. A.; Muramatsu, Ayumi; Yamamoto, Yusuke] Univ Hyogo, Grad Sch Appl Informat, Kobe, Hyogo, Japan	University of Hyogo	Mizuno-Matsumoto, Y (corresponding author), Univ Hyogo, Grad Sch Appl Informat, Kobe, Hyogo, Japan.	yuko@ai.u-hyogo.ac.jp			JSPS KAKENHI [JP16K01367]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	YMM This work was supported by JSPS KAKENHI Grant Number JP16K01367. https://www.jsps.go.jp/english/index.html The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adolphs R, 2005, NAT NEUROSCI, V8, P512, DOI 10.1038/nn1413; Arnsten AFT, 2009, NAT REV NEUROSCI, V10, P410, DOI 10.1038/nrn2648; Camm AJ, 1996, EUR HEART J, V17, P354; Carpels SMA, 2016, INT J BIOELECTROMAGN, V18, P8; Damasio AR, 2000, NAT NEUROSCI, V3, P1049, DOI 10.1038/79871; Davidson RJ, 2002, BIOL PSYCHIAT, V51, P68, DOI 10.1016/S0006-3223(01)01328-2; Davidson RJ, 1999, TRENDS COGN SCI, V3, P11, DOI 10.1016/S1364-6613(98)01265-0; Harmon-Jones E, 2004, BIOL PSYCHOL, V67, P51, DOI 10.1016/j.biopsycho.2004.03.003; Hayashi T., 2009, INT J INTELL COMPUT, V3, P57, DOI [10.1080/1931308X.2009.10644171, DOI 10.1080/1931308X.2009.10644171]; Ikeda S, 2015, NEUROPSYCHOBIOLOGY, V71, P34, DOI 10.1159/000368119; Inoguchi Y, 2019, IEICE T, P350, DOI DOI 10.14923/TRANSINFJ.2018JDP7047; Kaplan HI., 1988, SYNOPSIS PSYCHIAT BE; Knyazev GG, 2007, NEUROSCI BIOBEHAV R, V31, P377, DOI 10.1016/j.neubiorev.2006.10.004; Kop WJ, 2011, BIOL PSYCHOL, V86, P230, DOI 10.1016/j.biopsycho.2010.12.003; Lane RD, 2009, PSYCHOSOM MED, V71, P117, DOI 10.1097/PSY.0b013e31819783be; Lin AJ, 2016, PHILOS T R SOC A, V374, DOI 10.1098/rsta.2015.0182; Mizuno-Matsumoto Y, 2005, BRAIN TOPOGR, V17, P237, DOI 10.1007/s10548-005-6032-2; Mizuno-Matsumoto Y, 2002, CLIN NEUROPHYSIOL, V113, P33, DOI 10.1016/S1388-2457(01)00712-X; Mizuno-Matsumoto Y, 2014, WORLD AUT C 2014 WAI, P60, DOI [DOI 10.1109/WAC.2014.6935661, 10.1109/WAC.2014.6935661]; Mizuno-Matsumoto Y., 2011, INT J INTELL COMPUT, V4, P39, DOI [10.1080/1931308X.2011.10644182, DOI 10.1080/1931308X.2011.10644182]; Mizuno-Matsumoto Y, 2019, IEEJ T ELECTR ELECTR, V14, P1082, DOI 10.1002/tee.22903; Rocher C, 2004, CEREB CORTEX, V14, P224, DOI 10.1093/cercor/bhg122; Roozendaal B, 2009, NAT REV NEUROSCI, V10, P423, DOI 10.1038/nrn2651; Sokhadze EM, 2007, APPL PSYCHOPHYS BIOF, V32, P31, DOI 10.1007/s10484-007-9033-y; Tanida K., 2011, J JPN SOC NURS RES, V34, P191, DOI [10.1007/s10548-005-6032-2, DOI 10.1007/S10548-005-6032-2]; Thayer JF, 2009, INT J PSYCHOPHYSIOL, V72, P81, DOI 10.1016/j.ijpsycho.2008.04.007; Thayer JF, 2009, NEUROSCI BIOBEHAV R, V33, P81, DOI 10.1016/j.neubiorev.2008.08.004; Wager TD, 2009, NEUROIMAGE, V47, P821, DOI 10.1016/j.neuroimage.2009.05.043	28	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2020	15	3							e0229890	10.1371/journal.pone.0229890	http://dx.doi.org/10.1371/journal.pone.0229890			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LQ8RK	32134986	gold, Green Published			2022-12-26	WOS:000535265600057
J	Purohit, M; Diwan, V; Parashar, V; Tamhankar, AJ; Lundborg, CS				Purohit, Manju; Diwan, Vishal; Parashar, Vivek; Tamhankar, Ashok J.; Lundborg, Cecilia Stalsby			Mass bathing events in River Kshipra, Central India- influence on the water quality and the antibiotic susceptibility pattern of commensal E.coli	PLOS ONE			English	Article							ESCHERICHIA-COLI	Background Antibiotic resistance is one of the major global health emergencies. One potential source of dissemination of resistant bacteria is mass gatherings, e.g. mass bathing events. We evaluated the physicochemical parameters of water quality and the antibiotic resistance pattern in commensal Escherichia coli from river-water and river-sediment in pre-, during- and postmass bathing events in river Kshipra, Central India. Method/Design Water and sediment samples were collected from three selected points during eight mass bathing events during 2014-2016. Water quality parameters (physical, chemical and microbiological) were analyzed using standard methods. In river water and sediment samples, antibiotic susceptibility patterns of isolated E. coli to 17 antibiotics were tested. Results pH, turbidity and dissolved oxygen were significantly lower and total dissolved solid, free carbon dioxide were higher during mass bathing, whilst TSS, BOD and COD were lowest in pre-bathing and highest in post-bathing period. E.coli with multi drug resistance (MDR) or extended spectrum beta-lactamase (ESBL) production were between 9-44% and 6-24%, respectively in river-water as well as river-sediment. Total coliform count/ml and E. coli count were higher during-and post-bathing in river water than in pre-bathing period. Thus, the percentage of resistance was significantly higher during and post-bathing period (p<. 05) than in pre-bathing. Colony forming unit (CFU)/ml in river-sediment was much higher than in river-water. Percentage of resistance was significantly higher in river-water (p<.05) than in river-sediment. Conclusions Antibiotic resistance in E.coli isolated from the Kshipra River showed significant variation during mass bathing events. Guidelines and regulatory standards are needed to control environmental dissemination of resistant bacteria.	[Purohit, Manju; Diwan, Vishal; Tamhankar, Ashok J.; Lundborg, Cecilia Stalsby] Karolinska Inst, Dept Publ Hlth Sci, Stockholm, Sweden; [Purohit, Manju] RD Gardi Med Coll, Dept Pathol, Ujjain, Madhya Pradesh, India; [Diwan, Vishal; Parashar, Vivek] ICMR Natl Inst Res Environm Hlth, Bhopal, Madhya Pradesh, India; [Diwan, Vishal] RD Gardi Med Coll, Dept Publ Hlth & Environm, Ujjain, Madhya Pradesh, India; [Tamhankar, Ashok J.] RD Gardi Med Coll, Indian Initiat Management Antibiot Resistance, Dept Environm Med, Ujjain, Madhya Pradesh, India	Karolinska Institutet; Indian Council of Medical Research (ICMR); ICMR - National Institute for Research in Environmental Health (NIREH)	Purohit, M (corresponding author), Karolinska Inst, Dept Publ Hlth Sci, Stockholm, Sweden.; Purohit, M (corresponding author), RD Gardi Med Coll, Dept Pathol, Ujjain, Madhya Pradesh, India.	manjuraj.purohit@ki.se		purohit, manju/0000-0001-5385-7305; Stalsby Lundborg, Cecilia/0000-0001-6525-1861	Swedish Research Council [521-2012-2889, 2017-01237]	Swedish Research Council(Swedish Research CouncilEuropean Commission)	The project was funded by Swedish Research Council (grant no 521-2012-2889) and 2017-01237. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahammad ZS, 2014, ENVIRON SCI TECHNOL, V48, P3014, DOI 10.1021/es405348h; Akiba M, 2016, ANTIMICROB AGENTS CH, V60, P2972, DOI 10.1128/AAC.01950-15; [Anonymous], 1998, INTEGRATED COASTEL A; [Anonymous], 1990, WORLD HLTH STAT, V43, P118; [Anonymous], 1993, J ANTIMICROB CHEMOTH, P31; [Anonymous], 2010, ORIGINS EVOLUTION AN, V74, P417; [Anonymous], 2014, PERF STAND ANT SUS S; Arora NK, 2013, J ENVIRON BIOL, V34, P799; Asma Akhter, 2013, AFRICAN J MICROBIOLO, V8, P619; Azam M, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00176; Bisht A., 2015, INT J INNOVATIVE RES, V1, P107; Cabral JPS, 2010, INT J ENV RES PUB HE, V7, P3657, DOI 10.3390/ijerph7103657; Chitanand MP, 2010, INDIAN J MICROBIOL, V50, P216, DOI 10.1007/s12088-010-0042-9; Clermont O, 2000, APPL ENVIRON MICROB, V66, P4555, DOI 10.1128/AEM.66.10.4555-4558.2000; Daphne L.H.X., 2011, J WATER SUSTAINABILI, V1, P313, DOI DOI 10.11912/JWS.1.3.313-322; Diwan V, 2018, INT J ENV RES PUBLIC, V15; Diwan V, 2017, INT J ENV RES PUB HE, V14, DOI 10.3390/ijerph14060574; Gonzales L, 2013, J MED MICROBIOL, V62, P1697, DOI 10.1099/jmm.0.060798-0; Gowd SS, 2008, ENVIRON MONIT ASSESS, V136, P197, DOI 10.1007/s10661-007-9675-5; Janzon A., 2012, ANTIMICROBIAL RESIST, P483; Khanna D. R, 2012, ENV CONSER JR, V13, P165; Liu YY, 2016, LANCET INFECT DIS, V16, P161, DOI 10.1016/S1473-3099(15)00424-7; Lundborg CS, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2632-2; MATSON EA, 1978, J WATER POLLUT CON F, V50, P13; Poonia Shubra, 2014, Indian J Community Med, V39, P156, DOI 10.4103/0970-0218.137152; Purohit MR, 2017, INT J ENV RES PUB HE, V14, DOI 10.3390/ijerph14040386; Shukla S, 2013, J RES ENG TECHNOLOGY, V4; Taylor NGH, 2011, TRENDS ECOL EVOL, V26, P278, DOI 10.1016/j.tree.2011.03.004; Tyagi Aditya, 2003, Indian J Environ Health, V45, P15; Zhang XX, 2009, APPL MICROBIOL BIOT, V82, P1169, DOI 10.1007/s00253-009-1886-y	30	7	7	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2020	15	3							e0229664	10.1371/journal.pone.0229664	http://dx.doi.org/10.1371/journal.pone.0229664			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8QU	32130236	gold, Green Published			2022-12-26	WOS:000535264000040
J	Ruiz, DM; Tallis, H; Tershy, BR; Croll, DA				Ruiz, Diana M.; Tallis, Heather; Tershy, Bernie R.; Croll, Donald A.			Turning off the tap: Common domestic water conservation actions insufficient to alleviate drought in the United States of America	PLOS ONE			English	Article							WITHDRAWALS; SUSTAINABILITY; MANAGEMENT; FOOTPRINT; IMPACTS	Climate change is exacerbating drought and water stress in several global regions, including some parts of the United States. During times of drought in the U.S., municipal governments, private water suppliers and non-profits commonly deploy advocacy campaigns and incentive programs targeting reductions in residential water use through actions including: repairing leaks, shutting off taps, and installing new water-saving appliances. We asked whether these campaigns have the potential to alleviate water stress during drought at the county scale by estimating the potential impact of full adoption of such actions. In 2010, we show that the maximum potential use reductions from these residential actions may only alleviate water stress in 6% (174) of U.S. counties. The potential impact of domestic programs is limited by the relative dominance of agriculture water withdrawal, the primary water user in 50% of U.S. counties. While residential actions do achieve some water demand savings, they are not sufficient to alter water stress in the majority of the continental U.S. We recommend redirecting advocacy efforts and incentives to individual behaviors that can influence agricultural water use.	[Ruiz, Diana M.; Tershy, Bernie R.; Croll, Donald A.] Univ Calif Santa Cruz, Dept Ecol & Evolutionary Biol, Santa Cruz, CA 95064 USA; [Tallis, Heather] Nature Conservancy, Santa Cruz, CA USA	University of California System; University of California Santa Cruz; Nature Conservancy	Ruiz, DM (corresponding author), Univ Calif Santa Cruz, Dept Ecol & Evolutionary Biol, Santa Cruz, CA 95064 USA.	dmadriga@ucsc.edu		, Diana/0000-0001-7913-4308				Alcamo J, 2003, HYDROLOG SCI J, V48, P339, DOI 10.1623/hysj.48.3.339.45278; Alliance for Water Efficiency, 2016, IND WAT US DISH WASH; [Anonymous], 2016, WAT SAV TIPS FOOD CH; [Anonymous], 2016, WAT CONS FACTS TIPS; Arizona Department OWR, 2011, STAT AR DEP WAT RES; Averyt K., 2011, FRESHWATER USE US PO; Bates B.C., 2008, TECHNICAL PAPER INTE, DOI DOI 10.1016/J.JMB.2010.08.039; Chen LM, 2013, J AM WATER RESOUR AS, V49, P231, DOI 10.1111/jawr.12013; Department of Natural Resources SC, 2014, WAT US; EnergyStar, 2003, CLOTH WASH; Environmental Protection Agency U, 2015, LEAK FACTS; EPA, 2013, WAT LAB IRR CONTR; EPA, 2013, BATHR FAUC FACT SHEE; EPA, 2016, GREEN BUILD; EPA, 2013, WAT LABL TOIL FACT S; EPA, 2016, FREQ ASK QUEST WAT L, DOI [10.1002/div.5469, DOI 10.1002/DIV.5469]; EPA, SAV WAT EN SHOW BETT; Georgakakos A., 2014, CLIMATE CHANGE IMPAC, P69, DOI [10.7930/J0G44N6T, DOI 10.7930/J0G44N6T]; Hoekstra AY, 2012, P NATL ACAD SCI USA, V109, P3232, DOI 10.1073/pnas.1109936109; Lofquist D, 2012, C2010BR14 US CENS BU; Lundqvist J., 2008, SAVING WATER FIELD F; Maupin M.A., 2014, ESTIMATED USE WATER, DOI DOI 10.3133/CIR1405; Mazdiyasni O, 2015, P NATL ACAD SCI USA, V112, P11484, DOI 10.1073/pnas.1422945112; Mekonnen MM, 2012, ECOSYSTEMS, V15, P401, DOI 10.1007/s10021-011-9517-8; Oki T, 2006, SCIENCE, V313, P1068, DOI 10.1126/science.1128845; Perlman H., 2015, DRIP CALCULATOR MUCH; Peterson TC, 2013, B AM METEOROL SOC, V94, P821, DOI 10.1175/BAMS-D-12-00066.1; Postel SL, 2000, ECOL APPL, V10, P941, DOI 10.1890/1051-0761(2000)010[0941:EAEOWS]2.0.CO;2; Postel SL, 1996, SCIENCE, V271, P785, DOI 10.1126/science.271.5250.785; Pulwarty RS, 2005, BOOK SOIL P, V86, P249; Pulwarty RS, 2001, J ENVIRON MANAGE, V63, P307, DOI 10.1006/jema.2001.0494; Pulwarty RS, 2005, DROUGHT WATER CRISES, DOI [10.1007/BF01543134, DOI 10.1007/BF01543134]; Roy SB, 2005, J AM WATER RESOUR AS, V41, P1091, DOI 10.1111/j.1752-1688.2005.tb03787.x; San Francisco Public Utilities Commission, 2016, WAT RES DIV ANN REP; South Staff Water, 2009, WAT US YOUR HOM TIPS; Stoutenborough JW, 2014, WATER RESOUR MANAG, V28, P697, DOI 10.1007/s11269-013-0509-7; Sun G., 2008, WATERSHED UPDATE, V6, P1; Sun G, 2008, J AM WATER RESOUR AS, V44, P1441, DOI 10.1111/j.1752-1688.2008.00250.x; Tilman D, 2002, NATURE, V418, P671, DOI 10.1038/nature01014; Tilman D, 1999, P NATL ACAD SCI USA, V96, P5995, DOI 10.1073/pnas.96.11.5995; Vorosmarty CJ, 2000, SCIENCE, V289, P284, DOI 10.1126/science.289.5477.284; Wehner M, 2011, J HYDROMETEOROL, V12, P1359, DOI 10.1175/2011JHM1351.1	42	1	1	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2020	15	3							e0229798	10.1371/journal.pone.0229798	http://dx.doi.org/10.1371/journal.pone.0229798			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8QU	32130277	gold, Green Published, Green Submitted			2022-12-26	WOS:000535264000052
J	Virnik, K; Rosati, M; Medvedev, A; Scanlan, A; Walsh, G; Dayton, F; Broderick, KE; Lewis, M; Bryson, Y; Lifson, JD; Ruprecht, RM; Felber, BK; Berkower, I				Virnik, Konstantin; Rosati, Margherita; Medvedev, Alexei; Scanlan, Aaron; Walsh, Gabrielle; Dayton, Frances; Broderick, Kate E.; Lewis, Mark; Bryson, Yvonne; Lifson, Jeffrey D.; Ruprecht, Ruth M.; Felber, Barbara K.; Berkower, Ira			Immunotherapy with DNA vaccine and live attenuated rubella/SIV gag vectors plus early ART can prevent SIVmac251 viral rebound in acutely infected rhesus macaques	PLOS ONE			English	Article							IMMUNE-RESPONSES; SIV; HIV; REPLICATION; CHALLENGE; VIREMIA; PROLIFERATION; EXPRESSION; THERAPY; BARRIER	Anti-retroviral therapy (ART) has been highly successful in controlling HIV replication, reducing viral burden, and preventing both progression to AIDS and viral transmission. Yet, ART alone cannot cure the infection. Even after years of successful therapy, ART withdrawal leads inevitably to viral rebound within a few weeks or months. Our hypothesis: effective therapy must control both the replicating virus pool and the reactivatable latent viral reservoir. To do this, we have combined ART and immunotherapy to attack both viral pools simultaneously. The vaccine regimen consisted of DNA vaccine expressing SIV Gag, followed by a boost with live attenuated rubella/gag vectors. The vectors grow well in rhesus macaques, and they are potent immunogens when used in a prime and boost strategy. We infected rhesus macaques by high dose mucosal challenge with virulent SIVmac251 and waited three days to allow viral dissemination and establishment of a reactivatable viral reservoir before starting ART. While on ART, the control group received control DNA and empty rubella vaccine, while the immunotherapy group received DNA/gag prime, followed by boosts with rubella vectors expressing SIV gag over 27 weeks. Both groups had a vaccine "take" to rubella, and the vaccine group developed antibodies and T cells specific for Gag. Five weeks after the last immunization, we stopped ART and monitored virus rebound. All four control animals eventually had a viral rebound, and two were euthanized for AIDS. One control macaque did not rebound until 2 years after ART release. In contrast, there was only one viral rebound in the vaccine group. Three out of four vaccinees had no viral rebound, even after CD8 depletion, and they remain in drug-free viral remission more than 2.5 years later. The strategy of early ART combined with immunotherapy can produce a sustained SIV remission in macaques and may be relevant for immunotherapy of HIV in humans.	[Virnik, Konstantin; Medvedev, Alexei; Scanlan, Aaron; Walsh, Gabrielle; Berkower, Ira] Ctr Biol Food & Drug Adm, Lab Immunoregulat, Div Viral Prod, Off Vaccines, Silver Spring, MD 20993 USA; [Rosati, Margherita; Dayton, Frances] NCI, Human Retrovirus Sect, Vaccine Branch, Ctr Canc Res, Frederick, MD 21701 USA; [Broderick, Kate E.] Inovio Pharmaceut Inc, Plymouth Meeting, PA USA; [Lewis, Mark] BioQual Inc, Rockville, MD USA; [Bryson, Yvonne] UCLA, Dept Pediat, Div Infect Dis, David Geffen Sch Med, Los Angeles, CA 90024 USA; [Lifson, Jeffrey D.] Frederick Natl Lab Canc Res, AIDS & Canc Virus Program, Frederick, MD USA; [Ruprecht, Ruth M.] Univ Louisiana Lafayette, New Iberia Res Ctr, New Iberia, LA USA; [Felber, Barbara K.] NCI, Human Retrovirus Pathogenesis Sect, Vaccine Branch, Ctr Canc Res, Frederick, MD 21701 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); BIOQUAL Inc.; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Louisiana Lafayette; New Iberia Research Center; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Berkower, I (corresponding author), Ctr Biol Food & Drug Adm, Lab Immunoregulat, Div Viral Prod, Off Vaccines, Silver Spring, MD 20993 USA.	ira.berkower@fda.hhs.gov		Scanlan, Aaron/0000-0002-0465-7072; Walsh, Gabrielle/0000-0002-0600-1034; Bryson MD, yvonne/0000-0003-1589-269X	FDA; Bio Qual; Intramural Research Program of the National Institutes of Health/National Cancer Institute; NCI [R01 AI118586]	FDA(United States Department of Health & Human Services); Bio Qual; Intramural Research Program of the National Institutes of Health/National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was funded by awards to: IB from internal FDA funds; ML at Bio Qual under contract with FDA; BKF, MR, and FD were supported by the Intramural Research Program of the National Institutes of Health/National Cancer Institute; YB and RR under R01 AI118586 from NCI. KEB was employed by a commercial company, Inovio Pharmaceuticals, Inc. and ML was employed by BioQual, Inc. The specific roles of these authors are articulated in the 'author contributions' section. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bixby JG, 2010, AIDS RES HUM RETROV, V26, P1115, DOI 10.1089/aid.2010.0029; Borducchi EN, 2018, NATURE, V563, P360, DOI 10.1038/s41586-018-0600-6; Bui JK, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006283; Del Prete GQ, 2013, J VIROL, V87, P4584, DOI 10.1128/JVI.03507-12; Fuchs JD, 2015, OPEN FORUM INFECT DI, V2, DOI 10.1093/ofid/ofv082; Fung HB, 2002, CLIN THER, V24, P1515, DOI 10.1016/S0149-2918(02)80058-3; Hansen SG, 2017, NATURE, V547, P123, DOI 10.1038/nature22984; Hansen SG, 2013, SCIENCE, V340, P940, DOI 10.1126/science.1237874; Hansen SG, 2011, NATURE, V473, P523, DOI 10.1038/nature10003; Ho YC, 2013, CELL, V155, P540, DOI 10.1016/j.cell.2013.09.020; Hosmane NN, 2017, J EXP MED, V214, P959, DOI 10.1084/jem.20170193; Jalah R, 2013, J BIOL CHEM, V288, P6763, DOI 10.1074/jbc.M112.436675; Kim M, 2016, P NATL ACAD SCI USA, V113, P1692, DOI 10.1073/pnas.1600097113; LEWIS MG, 1994, AIDS RES HUM RETROV, V10, P213, DOI 10.1089/aid.1994.10.213; Li H, 2016, P NATL ACAD SCI USA, V113, pE3413, DOI 10.1073/pnas.1606636113; Luckay A, 2007, J VIROL, V81, P5257, DOI 10.1128/JVI.00055-07; Luzuriaga K, 2015, NEW ENGL J MED, V372, P786, DOI 10.1056/NEJMc1413931; Nishimura Y, 2017, NATURE, V543, P559, DOI 10.1038/nature21435; PAREKH BS, 1991, AIDS, V5, P1009, DOI 10.1097/00002030-199108000-00013; PARKMAN PD, 1965, J IMMUNOL, V95, P743; Persaud D, 2013, NEW ENGL J MED, V369, P1828, DOI 10.1056/NEJMoa1302976; Pion M, 2001, VIROLOGY, V289, P103, DOI 10.1006/viro.2001.1079; Plotkin S.A., 2013, VACCINES-BASEL, P688; Pugachev KV, 2000, VIROLOGY, V273, P189, DOI 10.1006/viro.2000.0408; Rosati M, 2015, VACCINE, V33, P2167, DOI 10.1016/j.vaccine.2015.02.067; Rosati M, 2009, P NATL ACAD SCI USA, V106, P15831, DOI 10.1073/pnas.0902628106; Rose NF, 2001, CELL, V106, P539, DOI 10.1016/S0092-8674(01)00482-2; Rutsaert S, 2018, RETROVIROLOGY, V15, DOI 10.1186/s12977-018-0399-0; Saez-Cirion A, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003211; Schmitz JE, 2005, J VIROL, V79, P8131, DOI 10.1128/JVI.79.13.8131-8141.2005; Singh S, 2018, J VIROL, V92, DOI 10.1128/JVI.00281-18; Sneller MC, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aan8848; Tsai CC, 1998, J VIROL, V72, P4265, DOI 10.1128/JVI.72.5.4265-4273.1998; Virnik K, 2017, VACCINE, V35, P3272, DOI 10.1016/j.vaccine.2017.04.047; Virnik K, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-99; Virnik K, 2013, VACCINE, V31, P2119, DOI 10.1016/j.vaccine.2013.02.055; Volberding PA, 2010, LANCET, V376, P49, DOI 10.1016/S0140-6736(10)60676-9; Wang W, 2011, J VIROL, V85, P12929, DOI 10.1128/JVI.05391-11; Whitney JB, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07881-9; Whitney JB, 2014, NATURE, V512, P74, DOI 10.1038/nature13594	40	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2020	15	3							e0228163	10.1371/journal.pone.0228163	http://dx.doi.org/10.1371/journal.pone.0228163			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8QU	32130229	Green Submitted, Green Published, gold			2022-12-26	WOS:000535264000006
J	Ward, MD; King, MA; Gabrial, C; Kenefick, RW; Leon, LR				Ward, Matthew D.; King, Michelle A.; Gabrial, Charles; Kenefick, Robert W.; Leon, Lisa R.			Biochemical recovery from exertional heat stroke follows a 16-day time course	PLOS ONE			English	Article							HEATSTROKE; ENZYME; RHABDOMYOLYSIS; ILLNESS; RETURN; MODEL	Background The aim of this study was to characterize the time-resolved progression of clinical laboratory disturbances days-following an exertional heat stroke (EHS). Currently, normalization of organ injury clinical biomarker values is the primary indicator of EHS recovery. However, an archetypical biochemical recovery profile following EHS has not been established. Methods We performed a retrospective analysis of EHS patient records in US military personnel from 2008-2014 using the Military Health System Data Repository (MDR). We focused on commonly reported clinical laboratory analytes measured on the day of injury and all proceeding follow-up visits. Results Over the prescribed period, there were 2,529 EHS episodes treated at 250 unique treatment locations. Laboratory results, including a standardized set of blood, serum and urine assays, were analyzed from 0-340 days following the initial injury. Indicators of acute kidney injury, including serum electrolyte disturbances and abnormal urinalysis findings, were most prevalent on the day of the injury but normalized within 24-48hours (creatinine, blood urea nitrogen, and blood and protein in urine). Muscle damage and liver function-associated markers peaked 0-4 days after injury and persisted outside their respective reference ranges for 2-16 days (alanine aminotransferase, aspartate aminotransferase, creatine phosphokinase, myoglobin, prothrombin time). Conclusion Biochemical recovery from EHS spans a 16-day time course, and markers of end-organ damage exhibit distinct patterns over this period. This analysis underscores the prognostic value of each clinical laboratory analyte and will assist in evaluating EHS patient presentation, injury severity and physiological recovery.	[Ward, Matthew D.; King, Michelle A.; Kenefick, Robert W.; Leon, Lisa R.] US Army Res Inst Environm Med, Thermal & Mt Med Div, Natick, MA 01760 USA; [Gabrial, Charles] Def Hlth Agcy, Falls Church, VA USA	United States Department of Defense; United States Army	Leon, LR (corresponding author), US Army Res Inst Environm Med, Thermal & Mt Med Div, Natick, MA 01760 USA.	lisa.r.leon.civ@mail.mil		Ward, Matthew/0000-0002-9618-7441	United State Department of Defense, Defense Health Program [W81XWH-13-MOMJPC5IPPEHA]	United State Department of Defense, Defense Health Program	This work was supported by the United State Department of Defense, Defense Health Program, grant number W81XWH-13-MOMJPC5IPPEHA (authored by LRL; https://cdmrp.army.mil/dmrdp/default).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Abriat A, 2014, MIL MED, V179, P309, DOI 10.7205/MILMED-D-13-00315; Alzeer AH, 1999, SERUM ENZYMES HEAT S, V1187, P1; ARMSTRONG LE, 1990, MED SCI SPORT EXER, V22, P36; Asplund CA, 2016, SPORTS HEALTH, V8, P117, DOI 10.1177/1941738115617453; Carter R, 2005, MED SCI SPORT EXER, V37, P1338, DOI 10.1249/01.mss.0000174895.19639.ed; Casa DJ, 2015, J ATHL TRAINING, V50, P986, DOI 10.4085/1062-6050-50.9.07; Cho YS, 2007, EMERG MED J, V24, P276, DOI 10.1136/emj.2006.043265; COSTRINI AM, 1979, AM J MED, V66, P296, DOI 10.1016/0002-9343(79)90548-5; Demartini JK, 2015, MED SCI SPORT EXER, V47, P240, DOI 10.1249/MSS.0000000000000409; Department of the Army and Air Force USA, 2003, DEP ARM AIR FORC US; GABOW PA, 1982, MEDICINE, V61, P141, DOI 10.1097/00005792-198205000-00002; Gardner J., 2001, MED ASPECTS HARSH EN, P231; Hakre S, 2004, MIL MED, V169, P169, DOI 10.7205/MILMED.169.3.169; Hanson PG, 2011, JAMA-J AM MED ASSOC, V242, P154; HUBBARD RW, 1977, J APPL PHYSIOL, V42, P809, DOI 10.1152/jappl.1977.42.6.809; Jackson C, 2015, ANN FAM MED, V13, P115, DOI 10.1370/afm.1753; KEW M, 1971, T ROY SOC TROP MED H, V65, P325, DOI 10.1016/0035-9203(71)90007-1; KEW M, 1970, AM J MED, V49, P192, DOI 10.1016/S0002-9343(70)80075-4; KEW MC, 1967, Q J MED, V36, P277; KHOGALI M, 1980, LANCET, V2, P276; KIELBLOCK AJ, 1979, S AFR MED J, V55, P1061; King MA, 2015, J APPL PHYSIOL, V118, P1207, DOI 10.1152/japplphysiol.01051.2014; Lew HL, 2002, AM J PHYS MED REHAB, V81, P629, DOI 10.1097/00002060-200208000-00013; MALAMUD N, 1946, Mil Surg, V99, P397; McDermott BP, 2007, J SPORT REHABIL, V16, P163, DOI 10.1123/jsr.16.3.163; Nagami GT, 2016, NEFROLOGIA, V36, P347, DOI 10.1016/j.nefro.2016.04.001; NOAKES TD, 1983, EUR J APPL PHYSIOL, V52, P75, DOI 10.1007/BF00429029; O'Connor FG, 2010, CURR SPORT MED REP, V9, P314, DOI 10.1249/JSR.0b013e3181f1d183; ODONNELL TF, 1975, JAMA-J AM MED ASSOC, V234, P824, DOI 10.1001/jama.234.8.824; Phinney LT, 2001, MED SCI SPORT EXER, V33, P1443, DOI 10.1097/00005768-200109000-00004; Rao L., 2015, WALLACHS INTERPRETAT, P1; ROWELL LB, 1966, J CLIN INVEST, V45, P1801, DOI 10.1172/JCI105484; SHIBOLET S, 1967, Q J MED, V36, P525; Sithinamsuwan P, 2009, MIL MED, V174, P496, DOI 10.7205/MILMED-D-02-5908; Stearns RL, 2016, CURR SPORT MED REP, V15, P94, DOI 10.1249/JSR.0000000000000244; Tazmini K, 2017, TIDSSKR NOR LAEGEFOR, V137; US Navy Environmental Health Center B of M and S, TECHN MAN NEHC TM OE; VANDERLINDE A, 1992, INT J BIOCHEM, V24, P477, DOI 10.1016/0020-711X(92)90042-Y; YAQUB BA, 1986, Q J MED, V59, P523; Zeller L, 2011, EUR J INTERN MED, V22, P296, DOI 10.1016/j.ejim.2010.12.013	40	15	16	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2020	15	3							e0229616	10.1371/journal.pone.0229616	http://dx.doi.org/10.1371/journal.pone.0229616			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8QU	32130237	gold, Green Published, Green Submitted			2022-12-26	WOS:000535264000033
J	Zapata, U; Wang, Q				Zapata, Uriel; Wang, Qian			Material properties of the skull layers of the primate parietal bone: A single-subject study	PLOS ONE			English	Article							ELASTIC PROPERTIES; CORTICAL BONE; MECHANICAL-PROPERTIES; CRANIAL BONE; BIOMECHANICAL PROPERTIES; MICROSTRUCTURE; MODEL	The outer cortical table of the parietal bone has been commonly used as a calvarial bone graft site for the craniofacial reconstruction. However, little is known about how removing the outer table may affect the function and structure of the inner table, and how the knowledge of the biomechanics and material properties of cortical bones will help the calvarial graft to better integrate into the biological and mechanical functions of its surrounding native tissues. In this study, it was hypothesized that there were significant differences in both density and material properties between inner and outer cortical plates in cranial bones. Twelve cylindrical specimens, including inner-outer layers, of cortical parietal bone of a female baboon were collected. Cortical thicknesses and densities were measured, and elastic properties were assessed using an ultrasonic technique. Results demonstrated remarkable difference in both thickness (t = 8.248, p <= 0.05) and density (t = 4.926, p <= 0.05) between inner and outer cortical paired samples. Orthotropic characteristics of the cortical plates were detected as well, these findings suggest that there are differences in biomechanical properties between two surfaces of cranial bones at both tissue and organ levels. How these differences are linked to the stress environments of the inner and outer cranial cortical layers awaits further studies. Further study will greatly enhance our ability to address questions derived from both morphological and craniofacial medicine fields about the development and biomechanics of craniofacial skeletons.	[Zapata, Uriel] EAFIT Univ, Dept Mech Engn, Medellin, Colombia; [Wang, Qian] Texas A&M Univ, Coll Dent, Dept Biomed Sci, Dallas, TX USA	Universidad EAFIT; Texas A&M University System	Zapata, U (corresponding author), EAFIT Univ, Dept Mech Engn, Medellin, Colombia.	uzapata@eafit.edu.co	Zapata M, Uriel/G-5411-2011	Zapata M, Uriel/0000-0002-9309-7571	UZ Fulbright award QW NIH-NCRR [P51 RR013986 QW MEDCEN]	UZ Fulbright award QW NIH-NCRR	UZ Fulbright award QW NIH-NCRR grant P51 RR013986 QW MEDCEN The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asgharpour Z, 2014, J MECH BEHAV BIOMED, V33, P16, DOI 10.1016/j.jmbbm.2013.02.010; Ashman R B, 1987, Adv Dent Res, V1, P64; ASHMAN RB, 1984, J BIOMECH, V17, P349, DOI 10.1016/0021-9290(84)90029-0; Auperrin A, 2014, J BIOMECH, V47, P1180, DOI 10.1016/j.jbiomech.2013.10.060; Bastos AS, 2014, J ORAL IMPLANTOL, V40, P469, DOI 10.1563/AAID-JOI-D-11-00090; Baumer TG, 2009, J BIOMECH ENG-T ASME, V131, DOI 10.1115/1.4000081; Boruah S, 2017, J MECH BEHAV BIOMED, V65, P688, DOI 10.1016/j.jmbbm.2016.09.041; Dechow Paul C., 2008, P265, DOI 10.1007/978-0-387-76585-3_13; DEMPSTER WT, 1967, AM J ANAT, V120, P7, DOI 10.1002/aja.1001200103; EVANS FG, 1957, J APPL PHYSIOL, V10, P493, DOI 10.1152/jappl.1957.10.3.493; Gharpure P, 2016, ANAT REC, V299, P1718, DOI 10.1002/ar.23466; Herring SW, 2000, AM J PHYS ANTHROPOL, V112, P575, DOI 10.1002/1096-8644(200008)112:4&lt;575::AID-AJPA10&gt;3.0.CO;2-0; Horgan TJ, 2003, INT J CRASHWORTHINES, V8, P353, DOI 10.1533/cras.8.4.353.19278; HUBBARD RP, 1971, J BIOMECH, V4, P251, DOI 10.1016/0021-9290(71)90031-5; HUNTER D, 1990, OTOLARYNG HEAD NECK, V102, P345, DOI 10.1177/019459989010200408; Margulies SS, 2000, J BIOMECH ENG-T ASME, V122, P364, DOI 10.1115/1.1287160; MAVES MD, 1986, OTOLARYNG HEAD NECK, V95, P464, DOI 10.1177/019459988609500408; MCELHANEY JH, 1970, J BIOMECH, V3, P495, DOI 10.1016/0021-9290(70)90059-X; MCPHERSON GK, 1980, J BIOMECH, V13, P9, DOI 10.1016/0021-9290(80)90003-2; Melvin J.W., 1969, DEV MECH, V5, P811; MOSS ML, 1960, AM J PHYS ANTHROPOL, V18, P281, DOI 10.1002/ajpa.1330180406; Motherway JA, 2009, J BIOMECH, V42, P2129, DOI 10.1016/j.jbiomech.2009.05.030; Panzer MB, 2012, ANN BIOMED ENG, V40, P1530, DOI 10.1007/s10439-012-0519-2; Park HK, 2001, NEUROL RES, V23, P267, DOI 10.1179/016164101101198424; Peterson J, 2003, ANAT REC PART A, V274A, P785, DOI 10.1002/ar.a.10096; Peterson J, 2002, ANAT REC, V268, P7, DOI 10.1002/ar.10131; Rahmoun J, 2014, MECH RES COMMUN, V60, P7, DOI 10.1016/j.mechrescom.2014.04.001; Ravosa MJ, 2000, ANAT REC, V261, P173, DOI 10.1002/1097-0185(20001015)261:5<173::AID-AR6>3.0.CO;2-X; RIGGS BL, 1990, NEW ENGL J MED, V322, P802, DOI 10.1056/NEJM199003223221203; ROBBINS DH, 1969, EXP MECH, V9, P236, DOI 10.1007/BF02326542; Sharp AC, 2016, J ANAT, V228, P984, DOI 10.1111/joa.12456; Stefan U, 2010, BONE, V47, P1048, DOI 10.1016/j.bone.2010.08.012; Strait DS, 2005, ANAT REC PART A, V283A, P275, DOI 10.1002/ar.a.20172; Tubbs R S, 2005, Folia Morphol (Warsz), V64, P321; van den Bos T, 2008, BONE, V43, P459, DOI 10.1016/j.bone.2008.05.009; van Haaren EH, 2008, ACTA ORTHOP, V79, P708, DOI 10.1080/17453670810016759; Wang Q, 2006, J HUM EVOL, V51, P375, DOI 10.1016/j.jhevol.2006.04.010; Wang Q, 2006, AM J PHYS ANTHROPOL, V131, P402, DOI 10.1002/ajpa.20438; Wang Q, 2010, AM J PHYS ANTHROPOL, V141, P526, DOI 10.1002/ajpa.21170; WOOD JL, 1971, J BIOMECH, V4, P1, DOI 10.1016/0021-9290(71)90010-8; Yue XF, 2013, INT J BIOMED IMAGING, V2013, DOI 10.1155/2013/781603	41	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2020	15	3							e0229244	10.1371/journal.pone.0229244	http://dx.doi.org/10.1371/journal.pone.0229244			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LQ8MS	32126093	gold, Green Published			2022-12-26	WOS:000535253100020
J	Shah, N; Gislason, AS; Becker, M; Belmonte, MF; Fernando, WGD; de Kievit, TR				Shah, Nidhi; Gislason, April S.; Becker, Michael; Belmonte, Mark F.; Fernando, W. G. Dilantha; de Kievit, Teresa R.			Investigation of the quorum-sensing regulon of the biocontrol bacterium Pseudomonas chlororaphis strain PA23	PLOS ONE			English	Article							SCLEROTINIA-SCLEROTIORUM; GENE-EXPRESSION; PROMOTER SPECIFICITY; ERWINIA-CAROTOVORA; BIOLOGICAL-CONTROL; SWARMING MOTILITY; AERUGINOSA; SYSTEM; VIRULENCE; REGULATOR	Pseudomonas chlororaphis strain PA23 is a biocontrol agent capable of protecting canola from stem rot disease caused by the fungal pathogen Sclerotinia sclerotiorum. PA23 produces several inhibitory compounds that are under control of a complex regulatory network. Included in this cascade is the PhzRI quorum sensing (QS) system, which plays an essential role in PA23 biocontrol, as well as CsaRI and AurRI, which have not yet been characterized in PA23. The focus of the current study was to employ RNA sequencing to explore the spectrum of PA23 genes under QS control. In this work, we investigated genes under the control of the main QS transcriptional regulator, PhzR, as well as those differentially expressed in an AHL-deficient strain, PA23-6863, which constitutively expresses an AiiA lactonase, rendering the strain QS defective. Transcriptomic profiling revealed 545 differentially expressed genes (365 downregulated; 180 upregulated) in the phzR mutant and 534 genes (382 downregulated; 152 upregulated) in the AHL-deficient PA23-6863. In both strains, decreased expression of phenazine, pyrrolnitrin, and exoprotease biosynthetic genes was observed. We have previously reported that QS activates expression of these genes and their encoded products. In addition, elevated siderophore and decreased chitinase gene expression was observed in the QS-deficient stains, which was confirmed by phenotypic analysis. Inspection of the promoter regions revealed the presence of "phz-box" sequences in only 58 of the 807 differentially expressed genes, suggesting that much of the QS regulon is indirectly regulated. Consistent with this notion, 41 transcriptional regulators displayed altered expression in one or both of the QS-deficient strains. Collectively, our findings indicate that QS governs expression of approximately 13% of the PA23 genome affecting diverse functions ranging from secondary metabolite production to general metabolism.	[Shah, Nidhi; Gislason, April S.; de Kievit, Teresa R.] Univ Manitoba, Dept Microbiol, Winnipeg, MB, Canada; [Becker, Michael; Belmonte, Mark F.] Univ Manitoba, Dept Biol Sci, Winnipeg, MB, Canada; [Fernando, W. G. Dilantha] Univ Manitoba, Dept Plant Sci, Winnipeg, MB, Canada	University of Manitoba; University of Manitoba; University of Manitoba	de Kievit, TR (corresponding author), Univ Manitoba, Dept Microbiol, Winnipeg, MB, Canada.	Teresa.Dekievit@ad.umanitoba.ca			Natural Sciences and Engineering Research Council (NSERC) [RGPAS/507804-2017, RGPIN/4970-2017]; NSERC Vanier Scholarship	Natural Sciences and Engineering Research Council (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); NSERC Vanier Scholarship	This work was supported by research grants from the Natural Sciences and Engineering Research Council (NSERC) discovery grants program (grants RGPAS/507804-2017 and RGPIN/4970-2017 to TRdK and MFB). M. Becker was supported by an NSERC Vanier Scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baehler E, 2006, MOL PLANT MICROBE IN, V19, P313, DOI 10.1094/MPMI-19-0313; Bailey TL, 2015, NUCLEIC ACIDS RES, V43, pW39, DOI 10.1093/nar/gkv416; Bailey TL, 1998, BIOINFORMATICS, V14, P48, DOI 10.1093/bioinformatics/14.1.48; Bauer JS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167002; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Burr T, 2006, MOL MICROBIOL, V59, P113, DOI 10.1111/j.1365-2958.2005.04939.x; Chen F, 2013, INT J MOL SCI, V14, P17477, DOI 10.3390/ijms140917477; Chugani S, 2010, P NATL ACAD SCI USA, V107, P10673, DOI 10.1073/pnas.1005909107; Cui Y, 2006, J BACTERIOL, V188, P4715, DOI 10.1128/JB.00351-06; de Kievit TR, 2000, INFECT IMMUN, V68, P4839, DOI 10.1128/IAI.68.9.4839-4849.2000; Dong YH, 2001, NATURE, V411, P813, DOI 10.1038/35081101; Doyle TB, 2004, J BACTERIOL, V186, P6341, DOI 10.1128/JB.186.19.6341-6350.2004; Duke KA, 2017, BMC GENOMICS, V73, P1; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Fernando WGD, 2007, CROP PROT, V26, P100, DOI 10.1016/j.cropro.2006.04.007; Hentzer M, 2003, EMBO J, V22, P3803, DOI 10.1093/emboj/cdg366; Hoang HH, 2008, J BACTERIOL, V190, P861, DOI 10.1128/JB.01310-07; Hoang HH, 2004, J BACTERIOL, V186, P5460, DOI 10.1128/JB.186.16.5460-5472.2004; Juhas M, 2005, ENVIRON MICROBIOL, V7, P459, DOI 10.1111/j.1462-2920.2005.00769.x; Klaponski N, 2014, BMC MICROBIOL, V14, DOI 10.1186/1471-2180-14-94; Kuchma SL, 2015, J BACTERIOL, V197, P420, DOI 10.1128/JB.02130-14; Kumar R, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00202; Lapouge K, 2008, MOL MICROBIOL, V67, P241, DOI 10.1111/j.1365-2958.2007.06042.x; Licciardello G, 2007, FEMS MICROBIOL ECOL, V61, P222, DOI 10.1111/j.1574-6941.2007.00338.x; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Manuel J, 2012, MICROBIOL-SGM, V158, P207, DOI 10.1099/mic.0.053082-0; Marchler-Bauer A, 2004, NUCLEIC ACIDS RES, V32, pW327, DOI 10.1093/nar/gkh454; Marchler-Bauer A, 2011, NUCLEIC ACIDS RES, V39, pD225, DOI 10.1093/nar/gkq1189; McClure R, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt444; Mukherjee S, 2017, PHOTOSYNTH RES, V134, P1, DOI 10.1007/s11120-017-0411-x; Nandi M, 2016, MICROBIOL-SGM, V162, P2159, DOI 10.1099/mic.0.000391; Oliveros J.C., 2007, INTERACTIVE TOOL COM; Poritsanos N, 2006, CAN J MICROBIOL, V52, P1177, DOI 10.1139/W06-079; Quinones B, 2005, MOL PLANT MICROBE IN, V18, P682, DOI 10.1094/MPMI-18-0682; Reimmann C, 2002, MICROBIOL-SGM, V148, P923, DOI 10.1099/00221287-148-4-923; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Savchuk S, 2004, FEMS MICROBIOL ECOL, V49, P379, DOI 10.1016/j.femsec.2004.04.014; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schuster M, 2003, J BACTERIOL, V185, P2066, DOI 10.1128/JB.185.7.2066-2079.2003; Schuster M, 2004, P NATL ACAD SCI USA, V101, P15833, DOI 10.1073/pnas.0407229101; SCHWYN B, 1987, ANAL BIOCHEM, V160, P47, DOI 10.1016/0003-2697(87)90612-9; Selin C, 2014, BIOL CONTROL, V69, P24, DOI 10.1016/j.biocontrol.2013.10.015; Selin C, 2012, MICROBIOL-SGM, V158, P896, DOI 10.1099/mic.0.054254-0; Selin C, 2010, FEMS MICROBIOL ECOL, V71, P73, DOI 10.1111/j.1574-6941.2009.00792.x; Shah N, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01512; Shemesh M, 2007, MICROBIOL-SGM, V153, P1307, DOI 10.1099/mic.0.2006/002030-0; Sjobolm S, 2006, MOL MICROBIOL, V60, P1474, DOI 10.1111/j.1365-2958.2006.05210.x; Smith RS, 2003, J CLIN INVEST, V112, P1460, DOI 10.1172/JCI200320364; Soutourina OA, 2003, FEMS MICROBIOL REV, V27, P505, DOI 10.1016/S0168-6445(03)00064-0; Tatusov RL, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-41; Tatusov RL, 2000, NUCLEIC ACIDS RES, V28, P33, DOI 10.1093/nar/28.1.33; Uzelac G, 2017, MICROBIOL-SGM, V163, P765, DOI 10.1099/mic.0.000454; Vallet I, 2004, J BACTERIOL, V186, P2880, DOI 10.1128/JB.186.9.2880-2890.2004; Venturi V, 2006, FEMS MICROBIOL REV, V30, P274, DOI 10.1111/j.1574-6976.2005.00012.x; Wagner VE, 2003, J BACTERIOL, V185, P2080, DOI 10.1128/JB.185.7.2080-2095.2003; Wang LH, 2004, J BIOL CHEM, V279, P13645, DOI 10.1074/jbc.M311194200; Whiteley M, 2001, J BACTERIOL, V183, P5529, DOI 10.1128/JB.183.19.5529-5534.2001; WIRTH SJ, 1990, J MICROBIOL METH, V12, P197, DOI 10.1016/0167-7012(90)90031-Z; Yu X, 2014, MBIO, V5, P1; Zhang ZG, 2001, APPL ENVIRON MICROB, V67, P4305, DOI 10.1128/AEM.67.9.4305-4315.2001	61	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2020	15	2							e0226232	10.1371/journal.pone.0226232	http://dx.doi.org/10.1371/journal.pone.0226232			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8HR	32109244	Green Submitted, Green Published, gold			2022-12-26	WOS:000535239800003
J	Moon, AM; Jiang, Y; Rogal, SS; Becker, J; Barritt, AS				Moon, Andrew M.; Jiang, Yue; Rogal, Shari S.; Becker, Jasper; Barritt, A. Sidney			In inpatients with cirrhosis opioid use is common and associated with length of stay and persistent use post-discharge	PLOS ONE			English	Article							CHRONIC NONCANCER PAIN; PRESCRIPTION; OVERDOSE; EVENTS; MODEL	Background Previous studies have demonstrated that opioids are often prescribed and associated with complications in outpatients with cirrhosis. Less is known about opioids among hospitalized patients with cirrhosis. We aimed to describe the patterns and complications of opioid use among inpatients with cirrhosis. Methods This retrospective cohort study included adult patients with cirrhosis admitted to a single hospital system from 4/4/2014 to 9/30/2015. We excluded hospitalizations with a surgery, invasive procedure, or palliative care/hospice consult in order to understand opioid use that may be avoidable. We determined the frequency, dosage, and type of opioids given during hospitalization. Using bivariable and multivariable analyses, we assessed length of stay, intensive care unit transfer, and in-hospital mortality by opioid use. Results Of 217 inpatients with cirrhosis, 118 (54.4%) received opioids during hospitalization, including 41.7% of patients without prior outpatient opioid prescriptions. Benzodiazepines or hypnotic sleep aids were given to 28.8% of opioid recipients. In the multivariable model, younger age and outpatient opioid prescription were associated with inpatient opioids. Hospitalization was longer among opioid recipients (median 3.9 vs 3.0 days, p = 0.002) and this difference remained after adjusting for age, cirrhosis severity, and medical comorbidities. There was no difference in intensive care unit transfers and no deaths occurred. At discharge, 22 patients were newly started on opioids of whom 10 (45.5%) had opioid prescriptions at 90 days post-discharge. Conclusion In non-surgical inpatients with cirrhosis, opioid prescribing was common and associated with prolonged length of stay. A high proportion of patients newly discharged with opioid prescriptions had ongoing prescriptions at 90 days post-discharge.	[Moon, Andrew M.; Barritt, A. Sidney] Univ N Carolina, Div Gastroenterol & Hepatol, Chapel Hill, NC 27515 USA; [Jiang, Yue] Duke Univ, Dept Stat Sci, Durham, NC USA; [Rogal, Shari S.] Univ Pittsburgh, Div Gastroenterol Hepatol & Nutr, Pittsburgh, PA USA; [Becker, Jasper] Univ N Carolina, Sch Med, North Carolina Translat & Clin Sci Inst NC TraCS, Chapel Hill, NC 27515 USA	University of North Carolina; University of North Carolina Chapel Hill; Duke University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Moon, AM (corresponding author), Univ N Carolina, Div Gastroenterol & Hepatol, Chapel Hill, NC 27515 USA.	Andrew.Moon@unchealth.unc.edu	Moon, Andrew/GXV-9316-2022; Moon, Andrew/AAS-9615-2021	Moon, Andrew/0000-0001-7163-2062; Jiang, Yue/0000-0002-8334-0013; Barritt, Alfred/0000-0002-4200-3256	National Institutes of Health [T32 DK007634]; National Center for Advancing Translational Science/National Institutes of Health [UL1TR002489]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Advancing Translational Science/National Institutes of Health	This research was supported in part by National Institutes of Health grant T32 DK007634 (AM) and National Center for Advancing Translational Science/National Institutes of Health grant UL1TR002489 (AM). Funder URL: https://www.nih.gov/The funder played no role in study design, data colection and analysis, decision to publish or preparation of the manuscript.	Acharya C, 2017, ALIMENT PHARM THER, V45, P319, DOI [10.1111/apt.13858, 10.1111/apt.14585]; Bergasa NV, 2002, LIFE SCI, V70, P1701, DOI 10.1016/S0024-3205(02)01487-X; Busse JW, 2018, JAMA-J AM MED ASSOC, V320, P2448, DOI 10.1001/jama.2018.18472; Calcaterra SL, 2016, J GEN INTERN MED, V31, P478, DOI 10.1007/s11606-015-3539-4; Centers for Disease Control and Prevention, 2016, MORBIDITY MORTALITY, V65, pSS; Chandok N, 2010, MAYO CLIN PROC, V85, P451, DOI 10.4065/mcp.2009.0534; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Dogan S, 2011, EUR J GASTROEN HEPAT, V23, P628, DOI 10.1097/MEG.0b013e328346df7a; Edlund MJ, 2014, CLIN J PAIN, V30, P557, DOI 10.1097/AJP.0000000000000021; Herzig SJ, 2014, J HOSP MED, V9, P73, DOI 10.1002/jhm.2102; Ioannou GN, 2013, HEPATOLOGY, V57, P249, DOI 10.1002/hep.25800; Jena AB, 2016, JAMA INTERN MED, V176, P990, DOI 10.1001/jamainternmed.2016.2737; Jones CM, 2015, AM J PREV MED, V49, P493, DOI 10.1016/j.amepre.2015.03.040; Kanwal F, 2012, GASTROENTEROLOGY, V143, P70, DOI 10.1053/j.gastro.2012.03.038; Kramer JR, 2008, ALIMENT PHARM THERAP, V27, P274, DOI 10.1111/j.1365-2036.2007.03572.x; Krebs EE, 2018, JAMA-J AM MED ASSOC, V319, P872, DOI 10.1001/jama.2018.0899; Liu TL, 2016, DIGEST DIS SCI, V61, P3335, DOI 10.1007/s10620-016-4261-8; Madan A, 2012, PROG TRANSPLANT, V22, P379, DOI 10.7182/pit2012535; Moon AM, 2020, ALIMENT PHARM THER, V51, P652, DOI 10.1111/apt.15639; Mullen KD, 1996, SEMIN LIVER DIS, V16, P255, DOI 10.1055/s-2007-1007238; Nebsit SA., 2018, EQUIANALGESIA OPIOID; Nehra MS, 2013, J CLIN GASTROENTEROL, V47, pE50, DOI 10.1097/MCG.0b013e3182688d2f; RCore Team, 2020, R LANG ENV STAT COMP; Rogal S, 2016, CLIN TRANSPLANT, V30, P1222, DOI 10.1111/ctr.12806; Rogal SS, 2015, CLIN GASTROENTEROL H, V13, P1009, DOI 10.1016/j.cgh.2014.10.029; Rogal SS, 2013, LIVER INT, V33, P1497, DOI 10.1111/liv.12215; Rogal SS, 2013, DIGEST DIS SCI, V58, P2976, DOI 10.1007/s10620-013-2638-5; Tapper EB, 2019, HEPATOL COMMUN, V3, P1510, DOI 10.1002/hep4.1425; Tapper EB, 2019, HEPATOLOGY, V69, P1676, DOI 10.1002/hep.30336; Wiesner R, 2003, GASTROENTEROLOGY, V124, P91, DOI 10.1053/gast.2003.50016; Zedler B, 2015, PAIN MED, V16, P1566, DOI 10.1111/pme.12777	31	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2020	15	2							e0229497	10.1371/journal.pone.0229497	http://dx.doi.org/10.1371/journal.pone.0229497			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8FM	32101574	Green Published, gold			2022-12-26	WOS:000535233700039
J	Blocker, SJ; Holbrook, MD; Mowery, YM; Sullivan, DC; Badea, CT				Blocker, S. J.; Holbrook, M. D.; Mowery, Y. M.; Sullivan, D. C.; Badea, C. T.			The impact of respiratory gating on improving volume measurement of murine lung tumors in micro-CT imaging	PLOS ONE			English	Article							CANCER	Small animal imaging has become essential in evaluating new cancer therapies as they are translated from the preclinical to clinical domain. However, preclinical imaging faces unique challenges that emphasize the gap between mouse and man. One example is the difference in breathing patterns and breath-holding ability, which can dramatically affect tumor burden assessment in lung tissue. As part of a co-clinical trial studying immunotherapy and radiotherapy in sarcomas, we are using micro-CT of the lungs to detect and measure metastases as a metric of disease progression. To effectively utilize metastatic disease detection as a metric of progression, we have addressed the impact of respiratory gating during micro-CT acquisition on improving lung tumor detection and volume quantitation. Accuracy and precision of lung tumor measurements with and without respiratory gating were studied by performing experiments with in vivo images, simulations, and a pocket phantom. When performing test-retest studies in vivo, the variance in volume calculations was 5.9% in gated images and 15.8% in non-gated images, compared to 2.9% in post-mortem images. Sensitivity of detection was examined in images with simulated tumors, demonstrating that reliable sensitivity (true positive rate (TPR) >= 90%) was achievable down to 1.0 mm(3) lesions with respiratory gating, but was limited to >= 8.0 mm(3) in non-gated images. Finally, a clinically-inspired "pocket phantom" was used during in vivo mouse scanning to aid in refining and assessing the gating protocols. Application of respiratory gating techniques reduced variance of repeated volume measurements and significantly improved the accuracy of tumor volume quantitation in vivo.	[Blocker, S. J.; Holbrook, M. D.; Sullivan, D. C.; Badea, C. T.] Duke Univ, Med Ctr, Dept Radiol, Ctr Vivo Microscopy, Durham, NC 27710 USA; [Mowery, Y. M.] Duke Univ, Med Ctr, Dept Radiat Oncol, Durham, NC USA	Duke University; Duke University	Badea, CT (corresponding author), Duke Univ, Med Ctr, Dept Radiol, Ctr Vivo Microscopy, Durham, NC 27710 USA.	cristian.badea@duke.edu	Blocker, Stephanie J/GLU-4581-2022; Badea, Cristian T/M-3323-2019; Badea, Cristian/B-6681-2011	Blocker, Stephanie J/0000-0002-6665-7844; Badea, Cristian T/0000-0002-1850-2522; Badea, Cristian/0000-0002-1850-2522; Holbrook, Matthew/0000-0002-5832-8725	National Institutes of Health, National Cancer Institute [R01 CA196667, U24 CA220245]	National Institutes of Health, National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	All work was performed at the Duke Center for In Vivo Microscopy supported by National Institutes of Health, National Cancer Institute(R01 CA196667, U24 CA220245, awarded to C.T.B., https://www.cancer.gov/grants-training/grants-funding/funding-opportunities).The funders had no role in study design, data collection and analysis, decision the	Badea C, 2004, MED PHYS, V31, P3324, DOI 10.1118/1.1812604; Badea CT, 2008, PHYS MED BIOL, V53, pR319, DOI 10.1088/0031-9155/53/19/R01; Badea CT, 2008, P SOC PHOTO-OPT INS, V6913, P91342, DOI 10.1117/12.772303; Blocker SJ, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0207555; Chen Z, 2012, NATURE, V483, P613, DOI 10.1038/nature10937; Clark D, 2012, P SPIE INT SOC OPT E, V8314; Clark D, 2018, GPU BASED TOOLS MULT; DuPage M, 2009, NAT PROTOC, V4, P1064, DOI 10.1038/nprot.2009.95; FELDKAMP LA, 1984, J OPT SOC AM A, V1, P612, DOI 10.1364/JOSAA.1.000612; Henschke CI, 2016, J MED IMAGING, V3, DOI 10.1117/1.JMI.3.3.035505; Holbrook M, 2018, PHYS MED BIOL, V63, DOI 10.1088/1361-6560/aa9b45; Huang J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079709; Johnston SM, 2010, P SPIE INT SOC OPT E, V7622; Kessler LG, 2015, STAT METHODS MED RES, V24, P9, DOI 10.1177/0962280214537333; Kirsch DG, 2007, NAT MED, V13, P992, DOI 10.1038/nm1602; Ledford H, 2011, NATURE, V477, P526, DOI 10.1038/477526a; Mai W, 2005, MAGN RESON MED, V53, P858, DOI 10.1002/mrm.20400; Mulshine JL, 2015, J AM COLL RADIOL, V12, P390, DOI 10.1016/j.jacr.2014.12.003; Nishino M, 2017, EUR J RADIOL, V88, P15, DOI 10.1016/j.ejrad.2016.12.028; Obuchowski NA, 2015, STAT METHODS MED RES, V24, P107, DOI 10.1177/0962280214537392; Perez BA, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00072; SATO F, 1981, INT J RADIAT BIOL, V39, P607, DOI 10.1080/09553008114550731; Thirion J P, 1998, Med Image Anal, V2, P243, DOI 10.1016/S1361-8415(98)80022-4; Tomasi C, 1998, SIXTH INTERNATIONAL CONFERENCE ON COMPUTER VISION, P839, DOI 10.1109/ICCV.1998.710815; VANDERVORST HA, 1992, SIAM J SCI STAT COMP, V13, P631, DOI 10.1137/0913035; Vercauteren T, 2009, NEUROIMAGE, V45, pS61, DOI 10.1016/j.neuroimage.2008.10.040	26	8	8	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2020	15	2							e0225019	10.1371/journal.pone.0225019	http://dx.doi.org/10.1371/journal.pone.0225019			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8EV	32097413	Green Submitted, Green Published, gold			2022-12-26	WOS:000535232000006
J	Agwa, AJ; Tran, P; Mueller, A; Tran, HNT; Deuis, JR; Israel, MR; McMahon, KL; Craik, DJ; Vetter, I; Schroeder, CI				Agwa, Akello J.; Tran, Poanna; Mueller, Alexander; Tran, Hue N. T.; Deuis, Jennifer R.; Israel, Mathilde R.; McMahon, Kirsten L.; Craik, David J.; Vetter, Irina; Schroeder, Christina I.			Manipulation of a spider peptide toxin alters its affinity for lipid bilayers and potency and selectivity for voltage-gated sodium channel subtype 1.7	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						pain; toxin; drug design; ion channel; electrophysiology; peptide interaction; disulfide-rich peptides; peptide?lipid membrane; regioselective oxidation; tri-molecular complex	HUWENTOXIN-IV; MEMBRANE-BINDING; DOMAIN-II; PROTX-II; NA(V)1.7; INHIBITION; SENSOR; VENOM; MUTATIONS; ANTAGONIST	Huwentoxin-IV (HwTx-IV) is a gating modifier peptide toxin from spiders that has weak affinity for the lipid bilayer. As some gating modifier toxins have affinity for model lipid bilayers, a tripartite relationship among gating modifier toxins, voltage-gated ion channels, and the lipid membrane surrounding the channels has been proposed. We previously designed an HwTx-IV analogue (gHwTx-IV) with reduced negative charge and increased hydrophobic surface profile, which displays increased lipid bilayer affinity and in vitro activity at the voltage-gated sodium channel subtype 1.7 (Na(V)1.7), a channel targeted in pain management. Here, we show that replacements of the positively-charged residues that contribute to the activity of the peptide can improve gHwTx-IV's potency and selectivity for Na(V)1.7. Using HwTx-IV, gHwTx-IV, [R26A]gHwTx-IV, [K27A]gHwTx-IV, and [R29A]gHwTx-IV variants, we examined their potency and selectivity at human Na(V)1.7 and their affinity for the lipid bilayer. [R26A]gHwTx-IV consistently displayed the most improved potency and selectivity for Na(V)1.7, examined alongside off-target Na(V)s, compared with HwTx-IV and gHwTx-IV. The lipid affinity of each of the three novel analogues was weaker than that of gHwTx-IV, but stronger than that of HwTx-IV, suggesting a possible relationship between in vitro potency at Na(V)1.7 and affinity for lipid bilayers. In a murine Na(V)1.7 engagement model, [R26A]gHwTx-IV exhibited an efficacy comparable with that of native HwTx-IV. In summary, this study reports the development of an HwTx-IV analogue with improved in vitro selectivity for the pain target Na(V)1.7 and with an in vivo efficacy similar to that of native HwTx-IV.	[Agwa, Akello J.; Tran, Poanna; Mueller, Alexander; Tran, Hue N. T.; Deuis, Jennifer R.; Israel, Mathilde R.; McMahon, Kirsten L.; Craik, David J.; Vetter, Irina; Schroeder, Christina I.] Univ Queensland, Inst Mol Biosci, Ctr Pain Res, Brisbane, Qld 4072, Australia; [Vetter, Irina] Univ Queensland, Sch Pharm, Woolloongabba, Qld 4103, Australia; [Schroeder, Christina I.] NCI, NIH, Frederick, MD 21702 USA; [Agwa, Akello J.] Univ Bath, Dept Biol & Biochem, Bath BA2 7AY, Avon, England	University of Queensland; University of Queensland; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Bath	Schroeder, CI (corresponding author), Univ Queensland, Inst Mol Biosci, Ctr Pain Res, Brisbane, Qld 4072, Australia.; Schroeder, CI (corresponding author), NCI, NIH, Frederick, MD 21702 USA.	christina.schroeder@nih.gov	Tran, Hue/AAV-4760-2020; Craik, David/B-1695-2010; Mueller, Alexander/C-5995-2017; Vetter, Irina/A-6035-2010; Agwa, Akello/C-7999-2017; Schroeder, Christina/K-2042-2014; McMahon, Kirsten/M-8735-2017; Deuis, Jennifer/R-2440-2017; Israel, Mathilde/D-6675-2017	Tran, Hue/0000-0001-5181-1899; Craik, David/0000-0003-0007-6796; Mueller, Alexander/0000-0002-7447-1310; Vetter, Irina/0000-0002-3594-9588; Agwa, Akello/0000-0001-9295-5071; Schroeder, Christina/0000-0002-6737-6374; McMahon, Kirsten/0000-0001-8254-0235; Deuis, Jennifer/0000-0002-5107-8938; Israel, Mathilde/0000-0002-3760-6036	Australian National Health and Medical Research Council (NMHRC) [APP1080405]; ARC [FT160100055]; Australian Research Council [FL150100146]; NHMRC Early Career Fellowship [APP1139961]; University of Queensland International Research Scholarships; Australian Government Research Training Program Scholarships; NHMRC Career Development Fellowship [APP1162503]	Australian National Health and Medical Research Council (NMHRC)(National Health and Medical Research Council (NHMRC) of Australia); ARC(Australian Research Council); Australian Research Council(Australian Research Council); NHMRC Early Career Fellowship(National Health and Medical Research Council (NHMRC) of Australia); University of Queensland International Research Scholarships; Australian Government Research Training Program Scholarships(Australian Government); NHMRC Career Development Fellowship(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by Australian National Health and Medical Research Council (NMHRC) Project Grant APP1080405 (to C. I. S.), Australian Research Council Future Fellow supported by ARC Grant FT160100055, ARC Australian Laureate Fellow supported by Australian Research Council Grant FL150100146, NHMRC Early Career Fellowship Grant APP1139961 (to J. R. D.), University of Queensland International Research Scholarships (to A. J. A., P. T., and H. N. T. T.), Australian Government Research Training Program Scholarships (to K. L. M., A. M., and M. R. I.), and by NHMRC Career Development Fellowship APP1162503 (to I. V.) The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Agwa AJ, 2018, J BIOL CHEM, V293, P9041, DOI 10.1074/jbc.RA118.002553; Agwa AJ, 2017, NEUROPHARMACOLOGY, V127, P32, DOI 10.1016/j.neuropharm.2017.04.004; Agwa AJ, 2017, TOXINS, V9, DOI 10.3390/toxins9080248; Agwa AJ, 2017, BBA-BIOMEMBRANES, V1859, P835, DOI 10.1016/j.bbamem.2017.01.020; Amaya F, 2006, J NEUROSCI, V26, P12852, DOI 10.1523/JNEUROSCI.4015-06.2006; Blesneac I, 2018, PAIN, V159, P469, DOI 10.1097/j.pain.0000000000001116; Bosmans F, 2010, TRENDS PHARMACOL SCI, V31, P175, DOI 10.1016/j.tips.2009.12.007; BRAUNSCHWEILER L, 1983, J MAGN RESON, V53, P521, DOI 10.1016/0022-2364(83)90226-3; Cai TF, 2015, PEPTIDES, V68, P148, DOI 10.1016/j.peptides.2014.09.005; Cardoso FC, 2017, BRIT J PHARMACOL, V174, P2528, DOI 10.1111/bph.13865; Catterall WA, 2000, NEURON, V26, P13, DOI 10.1016/S0896-6273(00)81133-2; Chattopadhyay M, 2012, MOL PAIN, V8, DOI 10.1186/1744-8069-8-17; Cox JJ, 2006, NATURE, V444, P894, DOI 10.1038/nature05413; Deng MC, 2013, TOXICON, V71, P57, DOI 10.1016/j.toxicon.2013.05.015; Deplazes E, 2016, BBA-BIOMEMBRANES, V1858, P872, DOI 10.1016/j.bbamem.2016.02.002; Deuis JR, 2017, SCI REP-UK, V7, DOI 10.1038/srep40883; Deuis JR, 2016, TOXINS, V8, DOI 10.3390/toxins8030078; Deuis JR, 2016, J BIOL CHEM, V291, P11829, DOI 10.1074/jbc.M116.721662; Dib-Hajj SD, 2005, BRAIN, V128, P1847, DOI 10.1093/brain/awh514; Dib-Hajj SD, 2007, TRENDS NEUROSCI, V30, P555, DOI 10.1016/j.tins.2007.08.004; Dib-Hajj SD, 2015, NAT REV NEUROSCI, V16, P511, DOI 10.1038/nrn3977; Dib-Hajj SD, 2013, NAT REV NEUROSCI, V14, P49, DOI 10.1038/nrn3404; Durek T, 2013, ACS CHEM BIOL, V8, P1215, DOI 10.1021/cb400012k; Elia N, 2019, NEUROLOGY, V92, pE1405, DOI 10.1212/WNL.0000000000007185; Escayg A, 2000, NAT GENET, V24, P343, DOI 10.1038/74159; Faber CG, 2012, P NATL ACAD SCI USA, V109, P19444, DOI 10.1073/pnas.1216080109; Fischer TZ, 2009, ANN NEUROL, V65, P733, DOI 10.1002/ana.21678; Flinspach M, 2017, SCI REP-UK, V7, DOI 10.1038/srep39662; Goncalves TC, 2018, NEUROPHARMACOLOGY, V133, P404, DOI 10.1016/j.neuropharm.2018.02.016; Habbout K, 2016, NEUROLOGY, V86, P161, DOI 10.1212/WNL.0000000000002264; Han CY, 2018, MOL PHARMACOL, V94, P1256, DOI 10.1124/mol.118.113076; Henriques ST, 2017, ACS CHEM BIOL, V12, P2324, DOI 10.1021/acschembio.7b00459; Henriques ST, 2016, J BIOL CHEM, V291, P17049, DOI 10.1074/jbc.M116.729095; Henriques ST, 2011, J BIOL CHEM, V286, P24231, DOI 10.1074/jbc.M111.253393; Hockley JRF, 2014, PAIN, V155, P1962, DOI 10.1016/j.pain.2014.06.015; JEENER J, 1979, J CHEM PHYS, V71, P4546, DOI 10.1063/1.438208; King GF, 2002, J TOXICOL-TOXIN REV, V21, P359, DOI 10.1081/TXR-120014409; Krafte DS, 2008, CURR OPIN PHARMACOL, V8, P50, DOI 10.1016/j.coph.2007.09.007; Lau CHY, 2016, SCI REP-UK, V6, DOI 10.1038/srep34333; Lee SY, 2004, NATURE, V430, P232, DOI 10.1038/nature02632; Li H, 2019, J BIOL CHEM, V294, P11892, DOI 10.1074/jbc.RA118.005511; Lin ZX, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161450; Liu ZH, 2013, J BIOL CHEM, V288, P20392, DOI 10.1074/jbc.M112.426627; Mao YC, 2008, TOXICON, V51, P230, DOI 10.1016/j.toxicon.2007.09.008; Mihailescu M, 2014, P NATL ACAD SCI USA, V111, pE5463, DOI 10.1073/pnas.1415324111; Milescu M, 2007, J GEN PHYSIOL, V130, P497, DOI 10.1085/jgp.200709869; Milescu M, 2009, NAT STRUCT MOL BIOL, V16, P1080, DOI 10.1038/nsmb.1679; Minassian NA, 2013, J BIOL CHEM, V288, P22707, DOI 10.1074/jbc.M113.461392; Moyer BD, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0196791; Mueller A, 2020, ACS PHARMACOL TRANSL, V3, P535, DOI 10.1021/acsptsci.0c00002; Mueller A, 2019, PAIN, V160, P1766, DOI 10.1097/j.pain.0000000000001567; Murray JK, 2015, J MED CHEM, V58, P2299, DOI 10.1021/jm501765v; Neff RA, 2020, J BIOL CHEM, V295, P1315, DOI 10.1074/jbc.RA119.011318; Nishizawa K, 2015, BBA-BIOMEMBRANES, V1848, P2767, DOI 10.1016/j.bbamem.2015.09.003; Okuse K, 1997, MOL CELL NEUROSCI, V10, P196, DOI 10.1006/mcne.1997.0657; Osteen JD, 2016, NATURE, V534, P494, DOI 10.1038/nature17976; PALLAGHY PK, 1994, PROTEIN SCI, V3, P1833, DOI 10.1002/pro.5560031022; Rahnama S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173551; Remme CA, 2010, CARDIOVASC THER, V28, P287, DOI 10.1111/j.1755-5922.2010.00210.x; Revell JD, 2013, PEPTIDES, V44, P40, DOI 10.1016/j.peptides.2013.03.011; Ruiz MD, 2015, J MED CHEM, V58, P7093, DOI 10.1021/jm501981g; Schmalhofer WA, 2008, MOL PHARMACOL, V74, P1476, DOI 10.1124/mol.108.047670; Shen HZ, 2019, SCIENCE, V363, P1303, DOI 10.1126/science.aaw2493; Smith JJ, 2005, J BIOL CHEM, V280, P11127, DOI 10.1074/jbc.M412552200; Suchyna TM, 2004, NATURE, V430, P235, DOI 10.1038/nature02743; Sugawara T, 2002, NEUROLOGY, V58, P1122, DOI 10.1212/WNL.58.7.1122; Tzakoniati F, 2020, CELL CHEM BIOL, V27, P306, DOI 10.1016/j.chembiol.2019.10.011; van Meer G, 2011, J CELL SCI, V124, P5, DOI 10.1242/jcs.071233; Vetter I, 2017, PHARMACOL THERAPEUT, V172, P73, DOI 10.1016/j.pharmthera.2016.11.015; Wuthrich K, 1986, NMR PROTEINS NUCL AC; Xiao YC, 2008, J BIOL CHEM, V283, P27300, DOI 10.1074/jbc.M708447200; Xiao YC, 2011, J BIOL CHEM, V286, P27301, DOI 10.1074/jbc.M111.246876; Xu H, 2019, CELL, V176, P702, DOI 10.1016/j.cell.2018.12.018; Zhang AH, 2018, NEUROSCI LETT, V679, P35, DOI 10.1016/j.neulet.2018.04.030	74	10	10	2	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 10	2020	295	15					5067	5080		10.1074/jbc.RA119.012281	http://dx.doi.org/10.1074/jbc.RA119.012281			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LE7FC	32139508	Green Published, hybrid			2022-12-26	WOS:000526887000027
J	Nagheli, S; Samani, N; Barry, DA				Nagheli, Setareh; Samani, Nozar; Barry, D. A.			Multi-well capture zones in strip-shaped aquifers	PLOS ONE			English	Article							CLIMATE-CHANGE; WATER-RESOURCES; FLOW-FIELDS; GROUNDWATER; SURFACE; OPTIMIZATION; SYSTEM; MANAGEMENT; MODELS; IMPACT	Capture zone equations for a multi-well system in strip-shaped confined and unconfined aquifers with and without regional flow are presented. The aquifer is limited by two parallel boundaries that are either no flow (barrier) or inflow (variable head) so that aquifers with four possible boundary configurations are formed. The wellfield includes any number of extraction or injection wells or a combination of both types. The flow field in the strip-shaped aquifer was converted to its equivalent extensive aquifer using conformal mapping and image well methods. To delineate the capture envelope, the potential, streamline and stagnation point equations were derived using velocity potential theory. The solution permits rapid determination of the effect of number, position and extraction/injection rate of wells, boundary type and direction, and rate of regional flow on the size, shape and pattern of well capture zones. The derived equations are readily extended to water quality and quantity management simulations, as shown by embedding the equations within two optimization schemes, viz., Particle Swarm Optimization (PSO) and Genetic Algorithm (GA), to automatically determine the most efficient wellfield designs for pump-and-treat remediation, contaminant plume containment and pumping policy projects.	[Nagheli, Setareh; Samani, Nozar] Shiraz Univ, Dept Earth Sci, Shiraz, Iran; [Nagheli, Setareh; Barry, D. A.] Ecole Polytech Fed Lausanne, Lab Technol Ecol ECOL, Inst Sci & Technol Environm IIE, Fac Environm Nat Architectural & Construit ENAC, Lausanne, Switzerland	Shiraz University; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne	Samani, N (corresponding author), Shiraz Univ, Dept Earth Sci, Shiraz, Iran.	samanin@shirazu.ac.ir	Barry, D. Andrew/C-6077-2008	Barry, D. Andrew/0000-0002-8621-0425	Office of Vice Chancellor for Research, Shiraz University [95GCU1M1206]; Iranian Ministry of Research, Science and Technology [SN-Shirazu-2017]	Office of Vice Chancellor for Research, Shiraz University; Iranian Ministry of Research, Science and Technology	Financial support was provided by the Office of Vice Chancellor for Research, Shiraz University (grant no. 95GCU1M1206) to NS and the Iranian Ministry of Research, Science and Technology (grant no. SN-Shirazu-2017) to SN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson EI, 2003, WATER RESOUR RES, V39, DOI 10.1029/2002WR001536; Anderson EI, 2000, ADV WATER RESOUR, V23, P461, DOI 10.1016/S0309-1708(99)00044-5; Anderson EI, 2003, ADV WATER RESOUR, V26, P513, DOI 10.1016/S0309-1708(03)00002-2; Anderson EI, 2002, ADV WATER RESOUR, V25, P279, DOI 10.1016/S0309-1708(01)00060-4; Bear J., 1972, DYNAMICS FLUIDS PORO, P125; Brusseau ML, 2011, J CONTAM HYDROL, V126, P130, DOI 10.1016/j.jconhyd.2011.08.003; Chahar BR, 2006, WATER RESOUR RES, V42, DOI 10.1029/2005WR004140; Christ JA, 2002, J HYDROL, V262, P224, DOI 10.1016/S0022-1694(02)00026-4; Craster RV, 2001, SIAM J APPL MATH, V61, P1839, DOI 10.1137/S0036139900371825; Da Costa J., 1960, INT ASS SCI HYDROL P, V52, P524; Davis L., 1991, HDB GENETIC ALGORITH, DOI DOI 10.1.1.87.3586; Dyachenko AI, 1996, PLASMA PHYS REP, V22, P829; Eldho, 2015, 47 IWWA ANN CONV, P1, DOI DOI 10.13140/2.1.4793.4244; Ferris J.G., 1962, SGS WATER SUPPLY PAP, V1536, DOI 10.3133/wsp1536E; Fienen MN, 2005, J HYDROL, V312, P39, DOI 10.1016/j.jhydrol.2005.02.008; Fitts CR, 2006, GROUND WATER, V44, P99, DOI 10.1111/j.1745-6584.2005.00082.x; Frederick KD, 1997, CLIMATIC CHANGE, V37, P7, DOI 10.1023/A:1005336924908; FUKUO Y, 1988, WATER RESOUR RES, V24, P1949, DOI 10.1029/WR024i011p01949; Gen M., 2008, WILEY ENCY COMPUTER, DOI [10.1002/9780470050118.ecse169, DOI 10.1002/9780470050118.ECSE169]; GRUBB S, 1993, GROUND WATER, V31, P27, DOI 10.1111/j.1745-6584.1993.tb00824.x; Gu XF, 2004, IEEE T MED IMAGING, V23, P949, DOI 10.1109/TMI.2004.831226; Harbaugh A. W., 2000, US GEOL SURV OPEN FI, V92, P134, DOI DOI 10.3133/OFR200092; Holland J.H., 1975, ADAPTATION NATURAL A; Intaraprasong T, 2007, J HYDROL, V338, P297, DOI 10.1016/j.jhydrol.2007.03.005; Javandal I., 1984, LBL8014175; JAVANDEL I, 1986, GROUND WATER, V24, P616, DOI 10.1111/j.1745-6584.1986.tb03710.x; Kennedy J, 1995, 1995 IEEE INTERNATIONAL CONFERENCE ON NEURAL NETWORKS PROCEEDINGS, VOLS 1-6, P1942, DOI 10.1109/icnn.1995.488968; Klammler H, 2014, ADV WATER RESOUR, V69, P79, DOI 10.1016/j.advwatres.2014.03.010; Klammler H, 2010, GROUND WATER, V48, P427, DOI 10.1111/j.1745-6584.2009.00661.x; Lari KS, 2008, J ENVIRON INFORM, V12, P44, DOI 10.3808/jci.200800123; Lari KS, 2019, WATER RES, V157, P630, DOI 10.1016/j.watres.2019.04.001; Lari KS, 2019, WATER RESOUR RES, V55, P923, DOI 10.1029/2018WR023380; LAURA PA, 1972, J SOUND VIB, V20, P27, DOI 10.1016/0022-460X(72)90759-6; Lu CH, 2015, WATER RESOUR RES, V51, P8294, DOI 10.1002/2015WR017019; Lu CH, 2009, J HYDROL, V373, P442, DOI 10.1016/j.jhydrol.2009.05.002; Mantoglou A, 2003, WATER RESOUR RES, V39, DOI 10.1029/2002WR001891; Matott LS, 2006, ADV WATER RESOUR, V29, P760, DOI 10.1016/j.advwatres.2005.07.009; Medici G, 2019, ENVIRON SCI POLLUT R, V26, P24863, DOI 10.1007/s11356-019-05525-z; Michalewicz Z., 1994, GENETIC ALGORITHMS D; Middelkoop H, 2001, CLIMATIC CHANGE, V49, P105, DOI 10.1023/A:1010784727448; Murdoch PS, 2000, J AM WATER RESOUR AS, V36, P347, DOI 10.1111/j.1752-1688.2000.tb04273.x; Muskat M., 1938, SOIL SCI, V46, P169; Ni CF, 2011, J HYDROL, V407, P184, DOI 10.1016/j.jhydrol.2011.07.025; Parker BL, 2008, J CONTAM HYDROL, V102, P86, DOI 10.1016/j.jconhyd.2008.07.003; Pollock D.W., 1994, 94464 US GEOL SURV; Rice J.R., 1968, FRACTURE ADV TREATIS, V2, P191; Riva M, 2006, J CONTAM HYDROL, V88, P92, DOI 10.1016/j.jconhyd.2006.06.005; Samani N, 2012, ADV WATER RESOUR, V39, P71, DOI 10.1016/j.advwatres.2012.01.004; Schafer DC, 1996, GROUND WATER, V34, P628, DOI 10.1111/j.1745-6584.1996.tb02050.x; Seyedpour SM, 2019, SCI TOTAL ENVIRON, V669, P389, DOI 10.1016/j.scitotenv.2019.01.409; Shan C, 1999, J HYDROL, V222, P123, DOI 10.1016/S0022-1694(99)00101-8; Strack O.D.L., 1989, GROUNDWATER MECH; Sun N.-Z, 1994, INVERSE PROBLEMS GRO; Todd D.K., 2005, GROUNDWATER HYDROLOG; Tsai FTC, 2003, WATER RESOUR RES, V39, DOI 10.1029/2001WR001135; Vorosmarty CJ, 2000, SCIENCE, V289, P284, DOI 10.1126/science.289.5477.284; Zarei-Doudeji S, 2018, IRAN J SCI TECHNOL A, V42, P191, DOI 10.1007/s40995-016-0046-3; Zarei-Doudeji S, 2014, J CONTAM HYDROL, V164, P114, DOI 10.1016/j.jconhyd.2014.05.015; Zlotnik VA, 1997, GROUND WATER, V35, P842, DOI 10.1111/j.1745-6584.1997.tb00152.x	59	3	3	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2020	15	3							e0229767	10.1371/journal.pone.0229767	http://dx.doi.org/10.1371/journal.pone.0229767			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8RK	32134982	gold, Green Published			2022-12-26	WOS:000535265600044
J	Liu, XY; Ke, L; Ho, J; Abboud, M; Mpofu, E; Brennan-Speranza, TC; Mason, RS; Brock, KE				Liu, Xiaoying; Ke, Liang; Ho, Jacky; Abboud, Myriam; Mpofu, Elias; Brennan-Speranza, Tara C.; Mason, Rebecca S.; Brock, Kaye E.			Sleep duration is associated with vitamin D deficiency in older women living in Macao, China: A pilot cross-sectional study	PLOS ONE			English	Article							25-HYDROXYVITAMIN D CONCENTRATION; SELF-REPORTED SLEEP; BONE-MINERAL DENSITY; QUALITY-OF-LIFE; METABOLIC SYNDROME; RISK-FACTORS; PARATHYROID-HORMONE; REPRESENTATIVE POPULATION; APNEA; HYPERTENSION	Chinese women are known to have both a high prevalence of metabolic syndrome (MetS) and vitamin D deficiency (serum 25-hydroxyvitamin D (25OHD) < 50 nmol/l). Associations between sleep duration and circulating 25OHD have recently been reported but, to our knowledge, these associations have not been studied in older Chinese populations. We thus investigated whether sleep duration was associated with vitamin D status in a population from Macao, China, and whether sleep duration modified the association between MetS and vitamin D deficiency. In 207 older (>55 years) Macanese, anthropometry, blood samples and validated questionnaires, including sleep duration and cardiovascular risk factors, were simultaneously collected. On multivariable categorical analyses, those women, not men, who had short sleep duration (<= 6 hours (h)) were at a 2-fold risk for vitamin D deficiency (both <50 nmol/L and <37 nmol/L; OR = 1.94, 95%CI 1.29-2.92; OR = 2.05, 95%CI 1.06-3.98, respectively) and those who had longer sleep duration (> 8 h) were 3-fold more likely to have vitamin D deficiency (OR = 3.07, 95%CI 1.47-6.39; OR = 2.75, 95%CI 1.08-7.00, respectively) compared to those with normal sleep duration (6-8 h). Both women and men with MetS were 2-fold more likely to have vitamin D deficiency (women: OR = 2.04, 95%CI 1.31-3.17; OR = 2.15, 95%CI 1.11-4.17, respectively; men: OR = 2.01, 95%CI 1.23-3.28; OR = 2.04, 95%CI 1.00-4.29, respectively). Moreover, women with both short sleep duration and MetS had an increased risk of vitamin D deficiency (OR = 3.26, 95%CI 1.10-9.64). These associations were not found in those with longer sleep. Men with longer sleep and MetS had a 5-fold risk of vitamin D deficiency (OR = 5.22; 95%CI 2.70-10.12). This association was non-significant for men with shorter sleep. We conclude that both short and long sleep duration were associated with vitamin D deficiency in older Chinese women. Further research is needed in larger cohorts or with intervention studies to further examine the associations between reduced sleep, metabolic syndrome and vitamin D deficiency.	[Liu, Xiaoying; Brennan-Speranza, Tara C.; Mason, Rebecca S.; Brock, Kaye E.] Univ Sydney, Sch Med Sci, Bosch Inst, Dept Physiol, Sydney, NSW, Australia; [Ke, Liang; Ho, Jacky] Macao Hypertens League, Macau, Peoples R China; [Ho, Jacky] City Univ Macao, Macau, Peoples R China; [Abboud, Myriam] Zayed Univ, Dubai, U Arab Emirates; [Mpofu, Elias] Univ Sydney, Fac Hlth Sci, Clin & Rehabil Sci Res Grp, Sydney, NSW, Australia; [Mpofu, Elias] Univ North Texas, Rehabil & Hlth Serv, Denton, TX 76203 USA; [Mpofu, Elias] Univ Johannesburg, Educ Psychol, Johannesburg, South Africa; [Brennan-Speranza, Tara C.] Univ Sydney, Fac Med & Hlth, Sch Publ Hlth, Sydney, NSW, Australia	University of Sydney; City University of Macau; Zayed University; University of Sydney; University of North Texas System; University of North Texas Denton; University of Johannesburg; University of Sydney	Brock, KE (corresponding author), Univ Sydney, Sch Med Sci, Bosch Inst, Dept Physiol, Sydney, NSW, Australia.	Kaye.Brock@sydney.edu.au	Mason, Rebecca/AHB-5478-2022	Speranza, Tara/0000-0001-5472-4969	Macao Hypertension League; China Studies Center, University of Sydney	Macao Hypertension League; China Studies Center, University of Sydney	Funding for this project was obtained from The Macao Hypertension League (2011-14) and The China Studies Center, University of Sydney. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anglin RES, 2013, BRIT J PSYCHIAT, V202, P100, DOI 10.1192/bjp.bp.111.106666; Autier P, 2014, LANCET DIABETES ENDO, V2, P76, DOI 10.1016/S2213-8587(13)70165-7; Barcelo A, 2013, RESPIRATION, V86, P295, DOI 10.1159/000342748; Bertisch SM, 2015, SLEEP, V38, P1305, DOI 10.5665/sleep.4914; Beydoun MA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103490; Bouillon R, 2019, ENDOCR REV, V40, P1109, DOI 10.1210/er.2018-00126; Brennan-Speranza TC, 2017, J STEROID BIOCHEM, V173, P180, DOI 10.1016/j.jsbmb.2017.01.022; BRESLOW N, 1982, J OCCUP ENVIRON MED, V24, P255; Brock KE, 2013, J STEROID BIOCHEM, V136, P214, DOI 10.1016/j.jsbmb.2012.12.005; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Cappuccio FP, 2011, EUR HEART J, V32, P1484, DOI 10.1093/eurheartj/ehr007; Chen WR, 2015, J CARDIOVASC MED, V16, P59, DOI 10.2459/JCM.0000000000000094; Chowdhury R, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g1903; Craig CL, 2003, MED SCI SPORT EXER, V35, P1381, DOI 10.1249/01.MSS.0000078924.61453.FB; Darling A, 2018, 21 VIT D WORKSH BARC; Darling AL, 2011, P NUTR SOC, V70, pE88, DOI 10.1017/S0029665111001285; Dattilo M, 2019, MED SCI SPORTS EXERC, DOI [10.1249/mss.0000000000002137, DOI 10.1249/MSS.0000000000002137]; Dawson-Hughes B, 2005, OSTEOPOROSIS INT, V16, P713, DOI 10.1007/s00198-005-1867-7; de Oliveira DL, 2017, J ENDOCRINOL, V234, pR23, DOI 10.1530/JOE-16-0514; Dixon KM, 2005, J STEROID BIOCHEM, V97, P137, DOI 10.1016/j.jsbmb.2005.06.006; Doo M, 2018, NUTRIENTS, V10, DOI 10.3390/nu10050575; Dorjgochoo T, 2012, BRIT J NUTR, V108, P449, DOI 10.1017/S0007114511005745; Erden ES, 2014, ENDOCRINE, V45, P311, DOI 10.1007/s12020-013-0022-z; Fang F, 2018, ARCH OSTEOPOROS, V13, DOI 10.1007/s11657-018-0479-8; Full KM, 2017, CIRCULATION, V136; Gao Q, 2018, NUTRIENTS, V10, DOI 10.3390/nu10101395; Gominak SC, 2012, MED HYPOTHESES, V79, P132, DOI 10.1016/j.mehy.2012.03.031; Gong QH, 2018, NUTRIENTS, V10, DOI 10.3390/nu10081013; Goswami U, 2016, ANN AM THORAC SOC, V13, P712, DOI 10.1513/AnnalsATS.201507-440OC; Government of Macao Special Administrative Region Statistics and Census Service, 2013, MAC YB STAT 2013; Grandner MA, 2013, APPETITE, V64, P71, DOI 10.1016/j.appet.2013.01.004; Grundy SM, 2005, CIRCULATION, V112, P2735, DOI 10.1161/CIRCULATIONAHA.105.169404; Guan X, 2016, J DIABETES INVEST, V7, P601, DOI 10.1111/jdi.12442; Hall MH, 2008, SLEEP, V31, P635, DOI 10.1093/sleep/31.5.635; Hirshkowitz M, 2015, SLEEP HEALTH, V1, P40, DOI 10.1016/j.sleh.2014.12.010; Holick MF, 2008, AM J CLIN NUTR, V87, p1080S; Hu LH, 2020, J CLIN HYPERTENS, V22, P65, DOI 10.1111/jch.13756; Hu LH, 2018, SLEEP MED, V47, P36, DOI 10.1016/j.sleep.2017.11.1147; Huang W, 2013, CLIN J PAIN, V29, P341, DOI 10.1097/AJP.0b013e318255655d; Irwin MR, 2016, BIOL PSYCHIAT, V80, P40, DOI 10.1016/j.biopsych.2015.05.014; Jang H, 2013, CULTURE SUN EXPOSURE, P504; Jike M, 2018, SLEEP MED REV, V39, P25, DOI 10.1016/j.smrv.2017.06.011; Ke L, 2015, J STEROID BIOCHEM, V148, P261, DOI 10.1016/j.jsbmb.2015.01.019; Ke L, 2017, J STEROID BIOCHEM, V173, P286, DOI 10.1016/j.jsbmb.2016.11.011; Ke L, 2015, AM J HYPERTENS, V28, P159, DOI 10.1093/ajh/hpu121; Ke L, 2014, J STEROID BIOCHEM, V144, P152, DOI 10.1016/j.jsbmb.2013.10.019; Kerley CP, 2017, J CLIN SLEEP MED, V13, P19, DOI 10.5664/jcsm.6378; Kerley CP, 2016, SLEEP, V39, P293, DOI 10.5665/sleep.5430; Khan H, 2013, P NUTR SOC, V72, P89, DOI 10.1017/S0029665112002765; Kim JH, 2014, J AM GERIATR SOC, V62, P2327, DOI 10.1111/jgs.13148; Korn EL, 2011, ANAL HLTH SURVEYS; Li LH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043344; Liguori C, 2017, SLEEP MED, V29, P81, DOI 10.1016/j.sleep.2016.08.022; Liguori C, 2015, J CLIN SLEEP MED, V11, P603, DOI 10.5664/jcsm.4766; Lin SW, 2012, AM J EPIDEMIOL, V176, P1043, DOI 10.1093/aje/kws285; LINDQVIST PG, 2016, BMJ OPEN, V6, DOI DOI 10.1136/BMJOPEN-2015-008119; Liu Y, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-35; Lu HK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047264; Lu L, 2009, DIABETES CARE, V32, P1278, DOI 10.2337/dc09-0209; Mah CD, 2011, SLEEP, V34, P943, DOI 10.5665/SLEEP.1132; Mason C, 2016, PREV MED, V93, P166, DOI 10.1016/j.ypmed.2016.09.035; Mason C, 2016, J AM GERIATR SOC, V64, P769, DOI 10.1111/jgs.14049; Mason RS, 2019, CURR DEV NUTR, V3, DOI 10.1093/cdn/nzz087; Mason RS, 2013, ANTI-CANCER AGENT ME, V13, P83; Massa J, 2015, SLEEP, V38, P251, DOI 10.5665/sleep.4408; McCarter SJ, 2017, SLEEP MED, V33, P23, DOI 10.1016/j.sleep.2016.03.013; Meier C, 2004, J BONE MINER RES, V19, P1221, DOI 10.1359/JBMR.040511; Mete T, 2013, J ENDOCRINOL INVEST, V36, P681, DOI 10.3275/8923; Mithal A, 2009, OSTEOPOROSIS INT, V20, P1807, DOI 10.1007/s00198-009-0954-6; Monico-Neto M, 2017, GROWTH FACTORS, V35, P12, DOI 10.1080/08977194.2017.1314277; MUSIOL IM, 1992, NEUROSCIENCE, V48, P841, DOI 10.1016/0306-4522(92)90272-4; Neighbors CLP, 2018, SLEEP MED, V43, P100, DOI 10.1016/j.sleep.2017.10.016; Palacios C, 2014, J STEROID BIOCHEM, V144, P138, DOI 10.1016/j.jsbmb.2013.11.003; Piovezan RD, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180901; Qiao Z, 2013, INT J ENDOCRINOL, V2013, DOI [10.1155/2013/150461PMC3771443, DOI 10.1155/2013/150461PMC3771443]; Saw RPM, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-780; Song BM, 2016, J AFFECT DISORDERS, V189, P357, DOI 10.1016/j.jad.2015.09.043; Stone KL, 2009, J AM GERIATR SOC, V57, P604, DOI 10.1111/j.1532-5415.2008.02171.x; Tanner SB, 2015, THER ADV MUSCULOSKEL, V7, P152, DOI 10.1177/1759720X15588521; Terzi R, 2016, J BONE MINER METAB, V34, P475, DOI 10.1007/s00774-015-0691-1; Wang F, 2009, NUTR METAB CARDIOVAS, V19, P542, DOI 10.1016/j.numecd.2008.11.006; Woo J, 2008, BRIT J NUTR, V99, P1330, DOI 10.1017/S0007114507844382; Xi B, 2014, SLEEP MED REV, V18, P293, DOI 10.1016/j.smrv.2013.06.001; Yan L, 2000, EUR J CLIN NUTR, V54, P68, DOI 10.1038/sj.ejcn.1600895; Yang J, 2015, OPEN J ENDOCR METAB, V5, P163; Yang ZJ, 2012, EUR HEART J, V33, P213, DOI 10.1093/eurheartj/ehr205; Yin X, 2012, NUTR J, V11, DOI 10.1186/1475-2891-11-68; Yu SL, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000000585; Zhen DH, 2015, BONE, V71, P1, DOI 10.1016/j.bone.2014.09.024; Zhu W, 2018, DIABETES METAB SYND, V12, P727, DOI 10.1016/j.dsx.2018.04.010	90	0	0	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2020	15	3							e0229642	10.1371/journal.pone.0229642	http://dx.doi.org/10.1371/journal.pone.0229642			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LQ8QU	32130235	Green Published, gold			2022-12-26	WOS:000535264000036
J	Sher, Y; Olm, MR; Raveh-Sadka, T; Brown, CT; Sher, R; Firek, B; Baker, R; Morowitz, MJ; Banfield, JF				Sher, Yonatan; Olm, Matthew R.; Raveh-Sadka, Tali; Brown, Christopher T.; Sher, Ruth; Firek, Brian; Baker, Robyn; Morowitz, Michael J.; Banfield, Jillian F.			Combined analysis of microbial metagenomic and metatranscriptomic sequencing data to assess in situ physiological conditions in the premature infant gut	PLOS ONE			English	Article							ESCHERICHIA-COLI; NECROTIZING ENTEROCOLITIS; OXYGEN-AFFINITY; PATHOGENESIS; EXPRESSION; ROLES; COLONIZATION; ACTIVATION; ISCHEMIA; STRAINS	Microbes alter their transcriptomic profiles in response to the environment. The physiological conditions experienced by a microbial community can thus be inferred using meta-transcriptomic sequencing by comparing transcription levels of specifically chosen genes. However, this analysis requires accurate reference genomes to identify the specific genes from which RNA reads originate. In addition, such an analysis should avoid biases in transcript counts related to differences in organism abundance. In this study we describe an approach to address these difficulties. Sample-specific meta-genomic assembled genomes (MAGs) were used as reference genomes to accurately identify the origin of RNA reads, and transcript ratios of genes with opposite transcription responses were compared to eliminate biases related to differences in organismal abundance, an approach hereafter named the "diametric ratio" method. We used this approach to probe the environmental conditions experienced by Escherichia spp. in the gut of 4 premature infants, 2 of whom developed necrotizing enterocolitis (NEC), a severe inflammatory intestinal disease. We analyzed twenty fecal samples taken from four premature infants (4-6 time points from each infant), and found significantly higher diametric ratios of genes associated with low oxygen levels in samples of infants later diagnosed with NEC than in samples without NEC. We also show this method can be used for examining other physiological conditions, such as exposure to nitric oxide and osmotic pressure. These study results should be treated with caution, due to the presence of confounding factors that might also distinguish between NEC and control infants. Nevertheless, together with benchmarking analyses, we show here that the diametric ratio approach can be applied for evaluating the physiological conditions experienced by microbes in situ. Results from similar studies can be further applied for designing diagnostic methods to detect NEC in its early developmental stages.	[Sher, Yonatan; Banfield, Jillian F.] Univ Calif Berkeley, Dept Environm Sci Policy & Management, Berkeley, CA 94720 USA; [Olm, Matthew R.; Raveh-Sadka, Tali; Brown, Christopher T.; Banfield, Jillian F.] Univ Calif Berkeley, Dept Plant & Microbial Biol, Berkeley, CA 94720 USA; [Sher, Ruth] Enview Inc, San Francisco, CA USA; [Firek, Brian; Morowitz, Michael J.] Univ Pittsburgh, Sch Med, Dept Surg, Pittsburgh, PA USA; [Baker, Robyn; Morowitz, Michael J.] UPMC, Magee Womens Hosp, Pittsburgh, PA USA; [Sher, Yonatan] MIGAL Galilee Res Inst, Dept Biotechnol, Kiryat Shmona, Israel	University of California System; University of California Berkeley; University of California System; University of California Berkeley; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Sher, Y; Banfield, JF (corresponding author), Univ Calif Berkeley, Dept Environm Sci Policy & Management, Berkeley, CA 94720 USA.; Banfield, JF (corresponding author), Univ Calif Berkeley, Dept Plant & Microbial Biol, Berkeley, CA 94720 USA.; Sher, Y (corresponding author), MIGAL Galilee Res Inst, Dept Biotechnol, Kiryat Shmona, Israel.	sher.Yoni@gmail.com; jbanfield@berkeley.edu	Sher, Yonatan/AAZ-2756-2020	Sher, Yonatan/0000-0002-7923-949X	National Institutes of Health (NIH) [RAI092531A]; March of Dimes Foundation [5-FY10-103, 2016-67012-24717]; USDA National Institute of Food and Agriculture; Enview, inc.	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); March of Dimes Foundation(March of Dimes); USDA National Institute of Food and Agriculture(United States Department of Agriculture (USDA)); Enview, inc.	This research was supported by the National Institutes of Health (NIH) under award no. RAI092531A to JFB. This work was supported in part by the March of Dimes Foundation research Grant no. 5-FY10-103 (to MJM). YS work was supported by postdoctoral fellowship grant no. 2016-67012-24717 from the USDA National Institute of Food and Agriculture. The funder Enview, inc., provided support in the form of salaries for the author RS, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the `author contributions' section.	Abu-Ali GS, 2018, NAT MICROBIOL, V3, P356, DOI 10.1038/s41564-017-0084-4; Albenberg L, 2014, GASTROENTEROLOGY, V147, P1055, DOI 10.1053/j.gastro.2014.07.020; BALLANCE WA, 1990, J PEDIATR-US, V117, pS6, DOI 10.1016/S0022-3476(05)81124-2; Baptista JM, 2012, J BACTERIOL, V194, P3611, DOI 10.1128/JB.00140-12; Bogdan C., 2015, NITRIC OXIDE SYNTHAS, V36, P34; Bokulich NA, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aad7121; Brocker Chad, 2012, Biomol Concepts, V3, P345; Brooks B, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-02018-w; Brooks B, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00654; Brown CT, 2018, MBIO, V9, DOI [10.1128/mBio.00441-18, 10.1128/mbio.00441-18]; Brown CT, 2013, MICROBIOME, V1, DOI 10.1186/2049-2618-1-30; Chen Y, 2016, J PEDIATR SURG, V51, P1255, DOI 10.1016/j.jpedsurg.2015.12.015; COMPAN I, 1994, MOL MICROBIOL, V11, P955, DOI 10.1111/j.1365-2958.1994.tb00374.x; CRISSINGER K, 1994, ACTA PAEDIATR, V83, P8, DOI 10.1111/j.1651-2227.1994.tb13233.x; Diamond S, 2019, NAT MICROBIOL, V4, P1356, DOI 10.1038/s41564-019-0449-y; Dmello R, 1996, MICROBIOL-UK, V142, P755, DOI 10.1099/00221287-142-4-755; DMELLO R, 1995, J BACTERIOL, V177, P867, DOI 10.1128/jb.177.3.867-870.1995; Faith JJ, 2013, SCIENCE, V341, P44, DOI 10.1126/science.1237439; Hackam D, 2018, SEMIN PEDIATR SURG, V27, P11, DOI 10.1053/j.sempedsurg.2017.11.003; Hazen TH, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-03489-z; Hyatt D, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-119; Hyduke DR, 2007, P NATL ACAD SCI USA, V104, P8484, DOI 10.1073/pnas.0610888104; Jarboe LR, 2010, NITRIC OXIDE BIOL PA, P103, DOI [10.1016/B978-0-12-373866-0.00004-6, DOI 10.1016/B978-0-12-373866-0.00004-6]; Jilling T, 2006, J IMMUNOL, V177, P3273, DOI 10.4049/jimmunol.177.5.3273; La Rosa PS, 2014, P NATL ACAD SCI USA, V111, P17336, DOI 10.1073/pnas.1420817111; Lindqvist A, 2000, ANTON LEEUW INT J G, V78, P23, DOI 10.1023/A:1002779201379; Litvak Y, 2017, CURR OPIN MICROBIOL, V39, P1, DOI 10.1016/j.mib.2017.07.003; Martin M, 2011, EMBNET J, V17, P10, DOI [10.14806/ej.17.1.200, 10.10.14806/ej.17.1.200, DOI 10.14806/EJ.17.1.200]; Morowitz MJ, 2011, P NATL ACAD SCI USA, V108, P1128, DOI 10.1073/pnas.1010992108; Morowitz MJ, 2010, PEDIATRICS, V125, P777, DOI 10.1542/peds.2009-3149; Nankervis CA, 2001, MICROCIRCULATION, V8, P377; Neu J, 2005, BIOL NEONATE, V87, P97, DOI 10.1159/000081898; NOWICKI PT, 1994, CLIN PERINATOL, V21, P219, DOI 10.1016/S0095-5108(18)30342-7; Olm MR, 2017, ISME J, V11, P2864, DOI 10.1038/ismej.2017.126; PAMMI M, 2017, MICROBIOME, V5, DOI DOI 10.1186/S40168-016-0221-Y; Partridge JD, 2007, J BIOL CHEM, V282, P11230, DOI 10.1074/jbc.M700728200; Peng Y, 2012, BIOINFORMATICS, V28, P1420, DOI 10.1093/bioinformatics/bts174; Ramani M, 2013, CLIN PERINATOL, V40, P1, DOI 10.1016/j.clp.2012.12.001; Raveh-Sadka T, 2016, ISME J, V10, P2817, DOI 10.1038/ismej.2016.83; Raveh-Sadka T, 2015, ELIFE, V4, DOI 10.7554/eLife.05477; Rich BS, 2017, PEDIATR REV, V38, P552, DOI 10.1542/pir.2017-0002; Rivera-Chavez F, 2017, FREE RADICAL BIO MED, V105, P93, DOI 10.1016/j.freeradbiomed.2016.09.022; Robinson MA, 2011, FREE RADICAL BIO MED, V51, P1952, DOI 10.1016/j.freeradbiomed.2011.08.034; Rolhion N, 2007, MOL MICROBIOL, V63, P1684, DOI 10.1111/j.1365-2958.2007.05638.x; Schirmer M, 2019, NAT REV MICROBIOL, V17, P497, DOI 10.1038/s41579-019-0213-6; Schirmer M, 2018, NAT MICROBIOL, V3, P337, DOI 10.1038/s41564-017-0089-z; Sharon I, 2013, GENOME RES, V23, P111, DOI 10.1101/gr.142315.112; Sieber CMK, 2018, NAT MICROBIOL, V3, P836, DOI 10.1038/s41564-018-0171-1; SPIRO S, 1987, J GEN MICROBIOL, V133, P3279; Stewart CJ, 2018, NATURE, V562, P583, DOI 10.1038/s41586-018-0617-x; STEWART CJ, 2017, FRONT MICROBIOL, V8, DOI DOI 10.3389/FMICB.2017.00008; Tjaden B, 2002, NUCLEIC ACIDS RES, V30, P3732, DOI 10.1093/nar/gkf505; Torrents E, 2007, J BACTERIOL, V189, P5012, DOI 10.1128/JB.00440-07; Tseng CP, 1996, J BACTERIOL, V178, P1094, DOI 10.1128/jb.178.4.1094-1098.1996; Unden G, 2002, J MOL MICROB BIOTECH, V4, P6; Wickham H., 2016, GGPLOT2 ELEGANT GRAP; Yazji I, 2013, P NATL ACAD SCI USA, V110, P9451, DOI 10.1073/pnas.1219997110; Yoshida T, 2006, J BIOL CHEM, V281, P17114, DOI 10.1074/jbc.M602112200; Young Christopher M, 2011, J Pediatr, V158, pe25, DOI 10.1016/j.jpeds.2010.11.009	59	4	4	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2020	15	3							e0229537	10.1371/journal.pone.0229537	http://dx.doi.org/10.1371/journal.pone.0229537			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8QU	32130257	Green Submitted, Green Published, gold			2022-12-26	WOS:000535264000029
J	Chou, LY; Chen, CH; Lin, YH; Chuang, SC; Chou, HC; Lin, SY; Fu, YC; Chang, JK; Ho, ML; Wang, CZ				Chou, Liang-Yin; Chen, Chung-Hwan; Lin, Yi-Hsiung; Chuang, Shu-Chun; Chou, Hsin-Chiao; Lin, Sung-Yen; Fu, Yin-Chi; Chang, Je-Ken; Ho, Mei-Ling; Wang, Chau-Zen			Discoidin domain receptor 1 regulates endochondral ossification through terminal differentiation of chondrocytes	FASEB JOURNAL			English	Article						chondrocytes; DDR1; discoidin domain receptor 1; endochondral ossification; skeletal development	GROWTH-PLATE; RUNX2; BONE; CARTILAGE; PROLIFERATION; KINASE; MATRIX; OSTEOARTHRITIS; TRANSCRIPTION; EXPRESSION	Chondrocytes in growth plates are responsible for longitudinal growth in long bones during endochondral ossification. Discoidin domain receptor 1 (Ddr1) is expressed in chondrocytes, but the molecular mechanisms by which DDR1 regulates chondrocyte behaviors during the endochondral ossification process remain undefined. To elucidate Ddr1-mediate chondrocyte functions, we generated chondrocyte-specific Ddr1 knockout (CKO Delta Ddr1) mice in this study. The CKO Delta Ddr1 mice showed delayed development of the secondary ossification center and increased growth plate length in the hind limbs. In the tibial growth plate in CKO Delta Ddr1 mice, chondrocyte proliferation was reduced in the proliferation zone, and remarkable downregulation of Ihh, MMP13, and Col-X expression in chondrocytes resulted in decreased terminal differentiation in the hypertrophic zone. Furthermore, apoptotic chondrocytes were reduced in the growth plates of CKO Delta Ddr1 mice. We concluded that chondrocytes with Ddr1 knockout exhibit decreased proliferation, terminal differentiation, and apoptosis in growth plates, which delays endochondral ossification and results in short stature. We also demonstrated that Ddr1 regulates the Ihh/Gli1/Gli2/Col-X pathway to regulate chondrocyte terminal differentiation. These results indicate that Ddr1 is required for chondrocytes to regulate endochondral ossification in skeletal development.	[Chou, Liang-Yin; Chou, Hsin-Chiao; Lin, Sung-Yen; Fu, Yin-Chi; Ho, Mei-Ling; Wang, Chau-Zen] Kaohsiung Med Univ, Grad Inst Med, Coll Med, 100,Shih Chuan 1st Rd, Kaohsiung 807, Taiwan; [Chou, Liang-Yin; Chen, Chung-Hwan; Chuang, Shu-Chun; Chou, Hsin-Chiao; Lin, Sung-Yen; Fu, Yin-Chi; Chang, Je-Ken; Ho, Mei-Ling; Wang, Chau-Zen] Kaohsiung Med Univ, Orthopaed Res Ctr, Kaohsiung, Taiwan; [Chou, Liang-Yin; Chen, Chung-Hwan; Chuang, Shu-Chun; Chou, Hsin-Chiao; Lin, Sung-Yen; Fu, Yin-Chi; Chang, Je-Ken; Ho, Mei-Ling; Wang, Chau-Zen] Kaohsiung Med Univ, Regenerat Med & Cell Therapy Res Ctr, Kaohsiung, Taiwan; [Chen, Chung-Hwan; Lin, Sung-Yen; Fu, Yin-Chi; Ho, Mei-Ling] Kaohsiung Med Univ, Dept Orthoped, Coll Med, Kaohsiung, Taiwan; [Chen, Chung-Hwan; Lin, Sung-Yen; Chang, Je-Ken] Kaohsiung Med Univ, Kaohsiung Municipal Ta Tung Hosp, Dept Orthoped, Kaohsiung, Taiwan; [Chen, Chung-Hwan] Natl Sun Yat Sen Univ, Inst Med Sci & Technol, Kaohsiung, Taiwan; [Chen, Chung-Hwan; Chang, Je-Ken] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Div Adult Reconstruct Surg, Dept Orthoped, Kaohsiung, Taiwan; [Lin, Yi-Hsiung] Kaohsiung Med Univ, Dept Biotechnol, Kaohsiung, Taiwan; [Lin, Yi-Hsiung] Kaohsiung Med Univ Hosp, Dept Internal Med, Div Cardiol, Kaohsiung, Taiwan; [Lin, Yi-Hsiung] Kaohsiung Med Univ, Lipid Sci & Aging Res Ctr, Kaohsiung, Taiwan; [Ho, Mei-Ling; Wang, Chau-Zen] Kaohsiung Med Univ, Coll Med, Dept Physiol, 100,Shih Chuan 1st Rd, Kaohsiung 807, Taiwan; [Ho, Mei-Ling] Natl Sun Yat Sen Univ, Dept Marine Biotechnol & Resources, Kaohsiung, Taiwan; [Wang, Chau-Zen] Kaohsiung Med Univ Hosp, Dept Med Res, Kaohsiung, Taiwan	Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Municipal Ta-Tung Hospital; National Sun Yat Sen University; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University; National Sun Yat Sen University; Kaohsiung Medical University; Kaohsiung Medical University Hospital	Ho, ML; Wang, CZ (corresponding author), Kaohsiung Med Univ, Grad Inst Med, Coll Med, 100,Shih Chuan 1st Rd, Kaohsiung 807, Taiwan.; Ho, ML; Wang, CZ (corresponding author), Kaohsiung Med Univ, Coll Med, Dept Physiol, 100,Shih Chuan 1st Rd, Kaohsiung 807, Taiwan.	homelin@kmu.edu.tw; czwang@kmu.edu.tw	Chen, Chung-Hwan/D-4036-2009	Chen, Chung-Hwan/0000-0001-8941-4792; Ho, Mei-Ling/0000-0001-8064-8488; Chang, Je-Ken/0000-0001-8485-2574	Ministry of Science and Technology (MOST) [MOST108-2320-B-037-008, MOST108-2314-B-037-059-MY3]; Kaohsiung Medical University [KMU-TP-105B10, KMU-DK105009, KMU-TC108A02, KMU-TC108A02-1]	Ministry of Science and Technology (MOST)(Ministry of Science and Technology, China); Kaohsiung Medical University	Ministry of Science and Technology (MOST), Grant/Award Number: MOST108-2320-B-037-008 and MOST108-2314-B-037-059-MY3; Kaohsiung Medical University, Grant/Award Number: KMU-TP-105B10, KMU-DK105009, KMU-TC108A02 and KMU-TC108A02-1	Amano K, 2014, J BIOL CHEM, V289, P24898, DOI 10.1074/jbc.M114.570507; Borza CM, 2014, MATRIX BIOL, V34, P185, DOI 10.1016/j.matbio.2013.12.002; Bruderer M, 2014, EUR CELLS MATER, V28, P269, DOI 10.22203/eCM.v028a19; Chen HY, 2014, J BONE MINER RES, V29, P2653, DOI 10.1002/jbmr.2287; Chen L, 2001, HUM MOL GENET, V10, P457, DOI 10.1093/hmg/10.5.457; Chen S, 2015, GENES DIS, V2, P76, DOI 10.1016/j.gendis.2014.12.003; Dreier R, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3117; Harrington EK, 2010, ANAT REC, V293, P225, DOI 10.1002/ar.21072; Henry SP, 2012, J BONE MINER RES, V27, P2511, DOI 10.1002/jbmr.1696; Karp SJ, 2000, DEVELOPMENT, V127, P543; Kozhemyakina E, 2009, MOL CELL BIOL, V29, P5751, DOI 10.1128/MCB.00415-09; Kwon TG, 2011, J CELL BIOCHEM, V112, P3582, DOI 10.1002/jcb.23289; Labrador JP, 2001, EMBO REP, V2, P446, DOI 10.1093/embo-reports/kve094; Leitinger B, 2004, J MOL BIOL, V344, P993, DOI 10.1016/j.jmb.2004.09.089; Leitinger B, 2006, MATRIX BIOL, V25, P355, DOI 10.1016/j.matbio.2006.05.006; Leitinger B, 2014, INT REV CEL MOL BIO, V310, P39, DOI 10.1016/B978-0-12-800180-6.00002-5; Li YW, 2009, DEVELOPMENT, V136, P1083, DOI 10.1242/dev.023820; Loebel C, 2015, TISSUE ENG PT A, V21, P115, DOI [10.1089/ten.tea.2014.0096, 10.1089/ten.TEA.2014.0096]; Mackie EJ, 2008, INT J BIOCHEM CELL B, V40, P46, DOI 10.1016/j.biocel.2007.06.009; Mohan RR, 2001, EXP EYE RES, V72, P87, DOI 10.1006/exer.2000.0932; Nakamura E, 2006, DEV DYNAM, V235, P2603, DOI 10.1002/dvdy.20892; Ovchinnikov DA, 2000, GENESIS, V26, P145, DOI 10.1002/(SICI)1526-968X(200002)26:2<145::AID-GENE14>3.0.CO;2-C; PINES M, 1991, POULTRY SCI, V70, P1806, DOI 10.3382/ps.0701806; Pitsillides AA, 2011, NAT REV RHEUMATOL, V7, P654, DOI 10.1038/nrrheum.2011.129; Pratap J, 2005, MOL CELL BIOL, V25, P8581, DOI 10.1128/MCB.25.19.8581-8591.2005; Schminke B, 2014, CELL MOL LIFE SCI, V71, P1081, DOI 10.1007/s00018-013-1436-8; St-Jacques B, 1999, GENE DEV, V13, P2072, DOI 10.1101/gad.13.16.2072; Stanton LA, 2004, BIOCHEM J, V378, P53, DOI 10.1042/BJ20030874; Stickens D, 2004, DEVELOPMENT, V131, P5883, DOI 10.1242/dev.01461; Studer D, 2012, EUR CELLS MATER, V24, P118, DOI 10.22203/eCM.v024a09; Valiathan RR, 2012, CANCER METAST REV, V31, P295, DOI 10.1007/s10555-012-9346-z; Vogel WF, 2006, CELL SIGNAL, V18, P1108, DOI 10.1016/j.cellsig.2006.02.012; Whitaker AT, 2017, BIOL OPEN, V6, P358, DOI 10.1242/bio.021436; Yoshida CA, 2004, GENE DEV, V18, P952, DOI 10.1101/gad.1174704; Zhou G, 2006, P NATL ACAD SCI USA, V103, P19004, DOI 10.1073/pnas.0605170103	35	11	12	2	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2020	34	4					5767	5781		10.1096/fj.201901852RR	http://dx.doi.org/10.1096/fj.201901852RR		MAR 2020	15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	LJ5ZA	32128899	Bronze			2022-12-26	WOS:000517936400001
J	McMahon, C; Trevaskis, JL; Carter, C; Holsapple, K; White, K; Das, M; Collins, S; Martin, H; Burns-Naas, LA				McMahon, Carrie; Trevaskis, James L.; Carter, Christoph; Holsapple, Kevin; White, Kirsten; Das, Moupali; Collins, Sean; Martin, Hal; Burns-Naas, Leigh Ann			Lack of an association between clinical INSTI-related body weight gain and direct interference with MC4 receptor (MC4R), a key central regulator of body weight	PLOS ONE			English	Article							ANTIRETROVIRAL THERAPY; CEREBROSPINAL-FLUID; OBESITY; MUTATION	An increasing prevalence of overweight and obesity in people living with HIV has been associated with initiation of antiretroviral therapy with integrase strand transfer inhibitors (INSTIs). An off-target inhibition of the endogenous ligand binding to the human melanocortin 4 receptor (MC4R) has been suggested as a potential mechanism for clinical body weight gain following initiation of dolutegravir, an INSTI. In this study, we interrogated several INSTIs for their capacity for antagonism or agonism of MC4R in an in vitro cell-based assays including at concentrations far exceeding plasma concentrations reached at the recommended dosages. Our results indicate that while INSTIs do exhibit the capacity to antagonize MC4R, this occurs at concentrations well above predicted clinical exposure and is thus an implausible explanation for INSTI-associated weight gain.	[McMahon, Carrie; Trevaskis, James L.; Carter, Christoph; Holsapple, Kevin; White, Kirsten; Das, Moupali; Collins, Sean; Martin, Hal; Burns-Naas, Leigh Ann] Gilead Sci Inc, 353 Lakeside Dr, Foster City, CA 94404 USA	Gilead Sciences	McMahon, C (corresponding author), Gilead Sci Inc, 353 Lakeside Dr, Foster City, CA 94404 USA.	carrie.mcmahon@gilead.com			(Gilead Sciences)	(Gilead Sciences)(Gilead Sciences)	The funder (Gilead Sciences) provided support in the form of salaries for all authors, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the `author contributions' section.	Asakawa A, 2001, GASTROENTEROLOGY, V120, P337, DOI 10.1053/gast.2001.22158; Bakal DR, 2018, J ANTIMICROB CHEMOTH, V73, P2177, DOI 10.1093/jac/dky145; Bhagwat P, 2018, OPEN FORUM INFECT DI, V5, DOI 10.1093/ofid/ofy201; Bourgi K, 2019, C RETR OPP INF MAR 4; Butler AA, 2001, NAT NEUROSCI, V4, P605, DOI 10.1038/88423; Butler AA, 2000, ENDOCRINOLOGY, V141, P3518, DOI 10.1210/en.141.9.3518; Calcagno A, 2016, AIDS RES HUM RETROV, V32, P409, DOI 10.1089/aid.2015.0337; European Medicines Agency Committee for Medicinal Products for Human Use, 2015, TIV ASS REP; Fan W, 1997, NATURE, V385, P165, DOI 10.1038/385165a0; Koethe JR, 2016, AIDS RES HUM RETROV, V32, P50, DOI 10.1089/aid.2015.0147; Lakey W, 2013, AIDS RES HUM RETROV, V29, P435, DOI [10.1089/aid.2012.0234, 10.1089/AID.2012.0234]; Letendre SL, 2014, CLIN INFECT DIS, V59, P1032, DOI 10.1093/cid/ciu477; McCormick CL, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00507; MORLEY JE, 1987, AM J PHYSIOL, V253, pR516, DOI 10.1152/ajpregu.1987.253.3.R516; MORLEY JE, 1987, AM J PHYSIOL, V252, pR599, DOI 10.1152/ajpregu.1987.252.3.R599; Morton GJ, 2014, NAT REV NEUROSCI, V15, P367, DOI 10.1038/nrn3745; Ollmann MM, 1997, SCIENCE, V278, P135, DOI 10.1126/science.278.5335.135; Qu DQ, 1996, NATURE, V380, P243, DOI 10.1038/380243a0; Sax PE, 2019, CLIN INFECT DIS, Vpii; Scrocchi LA, 1996, NAT MED, V2, P1254, DOI 10.1038/nm1196-1254; Taramasso L, 2017, OPEN FORUM INFECT DI, V4, DOI 10.1093/ofid/ofx239; Venter WDF, 2019, NEW ENGL J MED, V381, P803, DOI 10.1056/NEJMoa1902824; Waters L, 2018, SWITCH DOLUTEGRAVIR; Wilding JPH, 2016, DIABETES OBES METAB, V18, P491, DOI 10.1111/dom.12639; Yeo GSH, 1998, NAT GENET, V20, P111, DOI 10.1038/2404; Yilmaz A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006877; Yuh B, 2015, CLIN INFECT DIS, V60, P1852, DOI 10.1093/cid/civ192	27	17	17	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2020	15	2							e0229617	10.1371/journal.pone.0229617	http://dx.doi.org/10.1371/journal.pone.0229617			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8HR	32109250	Green Published, gold			2022-12-26	WOS:000535239800019
J	Chi, TT; Kraus, BLH				Chi, Ting-Ting; Kraus, Bonnie L. Hay			The effect of intravenous maropitant on blood pressure in healthy awake and anesthetized dogs	PLOS ONE			English	Article							MINIMUM ALVEOLAR CONCENTRATION; RECEPTOR ANTAGONIST; GENERAL-ANESTHESIA; PERIOPERATIVE USE; SUBSTANCE-P; HYPOTENSION; EFFICACY; ACEPROMAZINE; DEXMEDETOMIDINE; NAUSEA	Objective To evaluate the effects of intravenous maropitant on arterial blood pressure in healthy dogs while awake and under general anesthesia. Design Experimental crossover study. Animals Eight healthy adult Beagle dogs. Procedure All dogs received maropitant (1 mg kg(-1)) intravenously under the following conditions: 1) awake with non-invasive blood pressure monitoring (AwNIBP), 2) awake with invasive blood pressure monitoring (AwIBP), 3) premedication with acepromazine (0.005 mg kg(-1)) and butorphanol (0.2 mg kg(-1)) intramuscularly followed by propofol induction and isoflurane anesthesia (GaAB), and 4) premedication with dexmedetomidine (0.005 mg kg(-1)) and butorphanol (0.2 mg kg(-1)) intramuscularly followed by propofol induction and isoflurane anesthesia (GaDB). Heart rate (HR), systolic (SAP), diastolic (DAP), and mean blood pressures (MAP) were recorded before injection of maropitant (baseline), during the first 60 seconds of injection, during the second 60 seconds of injection, at the completion of injection and every 2 minutes post injection for 18 minutes. The data were compared over time using a Generalized Linear Model with mixed effects and then with simple effect comparison with Bonferroni adjustments (p < 0.05). Results There were significant decreases from baseline in SAP in the GaAB group (p < 0.01) and in MAP and DAP in the AwIBP and GaAB (p < 0.001) groups during injection. A significant decrease in SAP (p < 0.05), DAP (p < 0.05), and MAP (p < 0.05) occurred at 16 minutes post injection in GaDB group. There was also a significant increase in HR in the AwIBP group (p < 0.01) during injection. Clinically significant hypotension occurred in the GaAB group with a mean MAP at 54 +/- 6 mmHg during injection. Conclusion Intravenous maropitant administration significantly decreases arterial blood pressure during inhalant anesthesia. Patients premedicated with acepromazine prior to isoflurane anesthesia may develop clinically significant hypotension.	[Chi, Ting-Ting; Kraus, Bonnie L. Hay] Iowa State Univ, Coll Vet Med, Dept Vet Clin Sci, Ames, IA 50011 USA	Iowa State University	Chi, TT; Kraus, BLH (corresponding author), Iowa State Univ, Coll Vet Med, Dept Vet Clin Sci, Ames, IA 50011 USA.	schi@iastate.edu; bhkraus@iastate.edu		Chi, Ting-Ting/0000-0001-8228-8308	Veterinary Clinical Science Research Incentive Grant by Iowa State University Lloyd Veterinary Medical Hospital	Veterinary Clinical Science Research Incentive Grant by Iowa State University Lloyd Veterinary Medical Hospital	This research is funded by Veterinary Clinical Science Research Incentive Grant by Iowa State University Lloyd Veterinary Medical Hospital. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarnes TK, 2011, SMALL ANIMAL PEDIAT, P220, DOI 10.1016/B978-1-4160-4889-3.00026-7; Aarnes TK, 2009, AM J VET RES, V70, P1345, DOI 10.2460/ajvr.70.11.1345; Acierno MJ, 2018, J VET INTERN MED, V32, P1803, DOI 10.1111/jvim.15331; Alvillar BM, 2012, VET ANAESTH ANALG, V39, P201, DOI 10.1111/j.1467-2995.2011.00670.x; [Anonymous], 2016, CERENIA; Bednarski R, 2011, J AM ANIM HOSP ASSOC, V47, P377, DOI 10.5326/JAAHA-MS-5846; Boscan P, 2011, AM J VET RES, V72, P1576, DOI 10.2460/ajvr.72.12.1576; Brand PH, 1988, AM J PHYSL HEAR CIRC, V255; Cellier E, 1996, EUR J PHARMACOL, V318, P377, DOI 10.1016/S0014-2999(96)00808-4; Claude AK, 2014, EFFECTS MAROPITANT C, P1414; Corboz MR, 1998, EUR J PHARMACOL, V350, P1; Correa Janaina M X, 2019, Vet Med Int, V2019, P9352528, DOI 10.1155/2019/9352528; COUTURE R, 1989, N-S ARCH PHARMACOL, V340, P547; Davis H, 2013, J AM ANIM HOSP ASSOC, V49, P149, DOI 10.5326/JAAHA-MS-5868; Division VM, 2014, EMEAVC0027460000 CVM, P44; Duke-Novakovski T, 2015, VET CLIN N AM-SMALL, V45, P965, DOI 10.1016/j.cvsm.2015.04.004; FDA Cder, 2014, EMEND FOS DIM INJ; Feetham CH, 2014, PHYSL REP, V2, P1; Food and Drug administration (FDA), 2015, LAB INF APR; Food and Drug administration (FDA), 2018, LAB INF FOS; Fujiyama M, 2017, NEW ZEAL VET J, V65, P185, DOI 10.1080/00480169.2017.1295000; Grasso SC, 2015, JAVMA-J AM VET MED A, V246, P754, DOI 10.2460/javma.246.7.754; Hunt JR, 2013, VET ANAESTH ANALG, V40, P297, DOI 10.1111/vaa.12003; Keogh TP, 2014, J AM DENT ASSOC, V130, P467; Ko JC, 2013, SMALL ANIMAL ANESTHE, P59; Kraus BLH, 2017, VET MED-RES REP, V8, P41, DOI 10.2147/VMRR.S126469; Kraus BLH, 2014, JAVMA-J AM VET MED A, V245, P1015, DOI 10.2460/javma.245.9.1015; Kraus BLH, 2014, JAVMA-J AM VET MED A, V244, P1164, DOI 10.2460/javma.244.10.1164; Kraus BLH, 2013, VET ANAESTH ANALG, V40, P28, DOI 10.1111/j.1467-2995.2012.00788.x; Lemke KA, 2004, CAN VET J, V45, P475; Lorenzutti AM, 2017, CAN VET J, V58, P35; Luke DR, 2010, J PHARM SCI-US, V99, P3291, DOI 10.1002/jps.22109; Marquez M., 2015, PLOS ONE, V10, P1; Martin-Flores M, 2016, J FELINE MED SURG, V18, P921, DOI 10.1177/1098612X15613389; Mazzaferro E, 2001, COMP CONT EDUC PRACT, V23, P728; Mets B, 2013, J CARDIOTHOR VASC AN, V27, P156, DOI 10.1053/j.jvca.2012.06.014; Modi KD., 2019, INT J BASIC CLIN PHA, V8, P821, DOI DOI 10.18203/2319-2003.IJBCP20191125; Muir WW, 2014, JAVMA-J AM VET MED A, V245, P1021, DOI 10.2460/javma.245.9.1021; Murrell JC, 2005, VET ANAESTH ANALG, V32, P117, DOI 10.1111/j.1467-2995.2005.00233.x; Niyom S, 2013, VET ANAESTH ANALG, V40, P425, DOI 10.1111/vaa.12017; Noel-Morgan J, 2018, FRONT VET SCI, V5, DOI 10.3389/fvets.2018.00053; Noszczyk-Nowak A, 2017, J VET RES, V61, P103, DOI 10.1515/jvetres-2017-0013; Ouyang XP, 2008, IEEE ASME INT C ADV, P49, DOI 10.1109/AIM.2008.4601633; Ramsey DS, 2008, J VET PHARMACOL THER, V31, P538, DOI 10.1111/j.1365-2885.2008.00992.x; Redondo JI, 2007, J VET MED A, V54, P470, DOI 10.1111/j.1439-0442.2007.00987.x; Rosseels MLA, 2013, REGUL TOXICOL PHARM, V67, P351, DOI 10.1016/j.yrtph.2013.08.013; Ruffato M, 2015, VET ANAESTH ANALG, V42, P55, DOI 10.1111/vaa.12169; Salati AS, 2016, J PAKISTAN ASS DERMA, V26, P138; Sano H, 2019, J VET EMERG CRIT CAR, V29, P391, DOI 10.1111/vec.12860; Silverstein DC, 2012, J VET EMERG CRIT CAR, V22, P666, DOI 10.1111/j.1476-4431.2012.00822.x; Sinclair MD, 2003, 2003 REV PHYSIOL EFF, P44; Sinclair MD, 2012, VET ANAESTH ANALG, V39, P563, DOI 10.1111/j.1467-2995.2012.00766.x; Strazar AR, 2013, PLAST RECONSTR SURG, V132, P675, DOI 10.1097/PRS.0b013e31829ad1e2; Swallow A, 2017, VET ANAESTH ANALG, V44, P785, DOI 10.1016/j.vaa.2016.10.006; Tobias KM, 2006, J AM ANIM HOSP ASSOC, V42, P283, DOI 10.5326/0420283; UNGER T, 1988, CIRC RES, V63, P812, DOI 10.1161/01.RES.63.4.812; Waddell LS, 2000, CLIN TECH SMALL AN P, V15, P111, DOI 10.1053/svms.2000.18292; Walsh SL, 2013, ADDICT BIOL, V18, P332, DOI 10.1111/j.1369-1600.2011.00419.x; Weerink MAS, 2017, CLIN PHARMACOKINET, V56, P893, DOI 10.1007/s40262-017-0507-7; Wheeler BJ, 2012, J MED CASE REP, V6, P2; WITHRINGTON PG, 1992, BRIT J PHARMACOL, V107, P296, DOI 10.1111/j.1476-5381.1992.tb12741.x; Yunes R, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/734367	62	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2020	15	2							e0229736	10.1371/journal.pone.0229736	http://dx.doi.org/10.1371/journal.pone.0229736			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8GQ	32108177	Green Published, gold			2022-12-26	WOS:000535237000065
J	Shanmugalingam, R; Mengesha, Z; Notaras, S; Liamputtong, P; Fulcher, I; Lee, G; Kumar, R; Hennessy, A; Makris, A				Shanmugalingam, Renuka; Mengesha, Zelalem; Notaras, Stephanie; Liamputtong, Pranee; Fulcher, Ian; Lee, Gaksoo; Kumar, Roshika; Hennessy, Annemarie; Makris, Angela			Factors that influence adherence to aspirin therapy in the prevention of preeclampsia amongst high-risk pregnant women: A mixed method analysis	PLOS ONE			English	Article							MEDICATION; CARE; DISORDERS; BARRIERS; IMPACT; TRUST	Background Non-adherence with medications in pregnancy is increasingly recognized and often results in a higher rate of preventable maternal and fetal morbidity and mortality. Non-adherence with prophylactic aspirin amongst high-risk pregnant women is associated with higher incidence of preeclampsia, preterm delivery and intrauterine growth restriction. Yet, the factors that influences adherence with aspirin in pregnancy, from the women's perspective, remains poorly understood. Objective The study is aimed at understanding the factors, from the women's perspective, that influenced adherence with prophylactic aspirin in their pregnancy. Study design A sequential-exploratory designed mixed methods quantitative (n = 122) and qualitative (n = 6) survey of women with recent high-risk pregnancy necessitating antenatal prophylactic aspirin was utilized. Women recruited underwent their antenatal care in one of three highrisk pregnancy clinics within the South Western Sydney Local Health District, Australia. The quantitative study was done through an electronic anonymous survey and the qualitative study was conducted through a face-to-face interview. Data obtained was analysed against women's adherence with aspirin utilizing phi correlation (f) with significance set at < 0.05. Results Two key themes, from the women's perspective, that influenced their adherence with aspirin in pregnancy were identified; (1) pill burden and non-intention omission (2) communication and relationship with health care provider (HCP). Pill burden and its associated non-intentional omission, both strongly corelated with reduced adherence (Phi = 0.8, p = 0.02, Phi = 0.8, p< 0.01) whilst the use of reminder strategies minimized accidental omission and improved adherence (Phi = 0.9, p< 0.01). Consistent communication between HCPs and a good patient-HCP relationship was strongly associated with improved adherence (Phi = 0.7, p = 0.04, F = 0.9, p = < 0.01) and more importantly was found to play an important role in alleviating factors that had potentials to negatively influence adherence with aspirin in pregnancy. Conclusion This study identified factors that both positively and negatively influenced adherence with aspirin amongst high-risk pregnant women. Is highlights the importance in recognizing the impact of pill burden in pregnancy and the need to counsel women on the utility of reminder strategies to minimize non-intentional omission. Importantly, it emphasizes on the importance of a positive patient-HCP relationship through effective and consistent communication to achieve the desired maternal and fetal outcomes.	[Shanmugalingam, Renuka; Hennessy, Annemarie; Makris, Angela] South Western Sydney Local Hlth Dist, Dept Renal Med, Liverpool, NSW, Australia; [Shanmugalingam, Renuka; Notaras, Stephanie; Hennessy, Annemarie; Makris, Angela] Western Sydney Univ, Sch Med, Penrith, NSW, Australia; [Shanmugalingam, Renuka; Hennessy, Annemarie; Makris, Angela] Univ Sydney, Heart Res Inst, Vasc Immunol Grp, Newtown, NSW, Australia; [Shanmugalingam, Renuka; Lee, Gaksoo; Hennessy, Annemarie; Makris, Angela] Ingham Inst Appl Med Res, Womens Hlth Initiat Translat Unit WHITU, Liverpool, NSW, Australia; [Shanmugalingam, Renuka; Lee, Gaksoo; Hennessy, Annemarie; Makris, Angela] South Western Sydney Local Hlth Dist, Liverpool, NSW, Australia; [Mengesha, Zelalem] Uniting Australia, Res & Social Policy Team, Sydney, NSW, Australia; [Liamputtong, Pranee] Western Sydney Univ, Sch Hlth Sci, Penrith, NSW, Australia; [Liamputtong, Pranee] Western Sydney Univ, Translat Hlth Res Inst, Penrith, NSW, Australia; [Fulcher, Ian; Lee, Gaksoo; Kumar, Roshika] Liverpool Hosp, Dept Obstet & Gynaecol, Liverpool, NSW, Australia; [Makris, Angela] Univ New South Wales, Sch Med, Sydney, NSW, Australia	Western Sydney University; University of Sydney; Heart Research Institute; Ingham Institute for Applied Medical Research; Western Sydney University; Western Sydney University; Liverpool Hospital; University of New South Wales Sydney	Shanmugalingam, R (corresponding author), South Western Sydney Local Hlth Dist, Dept Renal Med, Liverpool, NSW, Australia.; Shanmugalingam, R (corresponding author), Western Sydney Univ, Sch Med, Penrith, NSW, Australia.; Shanmugalingam, R (corresponding author), Univ Sydney, Heart Res Inst, Vasc Immunol Grp, Newtown, NSW, Australia.; Shanmugalingam, R (corresponding author), Ingham Inst Appl Med Res, Womens Hlth Initiat Translat Unit WHITU, Liverpool, NSW, Australia.; Shanmugalingam, R (corresponding author), South Western Sydney Local Hlth Dist, Liverpool, NSW, Australia.	Renuka.shanmugalingam@health.nsw.gov.au		Mengesha, Zelalem/0000-0003-1599-0951	PEARLS Foundation; WHITU; Women's Health Initiative Translational Unit (WHITU); Department of Renal Medicine SWSLHD; Department of Obstetrics and Gynaecology SWSLHD, NSW Australia	PEARLS Foundation; WHITU; Women's Health Initiative Translational Unit (WHITU); Department of Renal Medicine SWSLHD; Department of Obstetrics and Gynaecology SWSLHD, NSW Australia	Supportive funds were received from the PEARLS Foundation and WHITU. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript; The authors would like to thank the participants of this study, the PEARLS Foundation, the Women's Health Initiative Translational Unit (WHITU), the Department of Renal Medicine SWSLHD and the Department of Obstetrics and Gynaecology SWSLHD, NSW Australia for their support in conducting this study.	Abheiden CNH, 2016, PREGNANCY HYPERTENS, V6, P350, DOI 10.1016/j.preghy.2016.08.232; Adhikari K, 2018, CAN J PSYCHIAT; Akincigil A, 2008, J GEN INTERN MED, V23, P115, DOI 10.1007/s11606-007-0351-9; ANDERSON LA, 1990, PSYCHOL REP, V67, P1091, DOI 10.2466/pr0.1990.67.3f.1091; Andreae MH, 2017, PAIN MED, V18, P265, DOI 10.1093/pm/pnw161; [Anonymous], 2018, PREGNANCY HYPERTENSI; Ayala DE, 2013, CHRONOBIOL INT, V30, P260, DOI 10.3109/07420528.2012.717455; Belanger K, 2010, OBSTET GYNECOL, V115, P559, DOI 10.1097/AOG.0b013e3181d06945; Bertakis KD, 2011, J AM BOARD FAM MED, V24, P229, DOI 10.3122/jabfm.2011.03.100170; Burkhart PV, 2003, J NURS SCHOLARSHIP, V35, P207; Castro EM, 2016, PATIENT EDUC COUNS, V99, P1923, DOI 10.1016/j.pec.2016.07.026; Chan KL, 2019, JMIR MHEALTH UHEALTH, V7, DOI 10.2196/11836; Creswell JW KA, 2011, BEST PRACTICES MIXED; DONOVAN JL, 1995, INT J TECHNOL ASSESS, V11, P443, DOI 10.1017/S0266462300008667; Einarson A, 2001, J PSYCHIATR NEUROSCI, V26, P44; Fairgrieve SD, 2000, BRIT MED J, V321, P674, DOI 10.1136/bmj.321.7262.674; Gallinger ZR, 2016, J CROHNS COLITIS, V10, P892, DOI 10.1093/ecco-jcc/jjw052; Hsu C, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/s12913-014-0533-1; Kingdon C, 2009, BJOG-INT J OBSTET GY, V116, P886, DOI 10.1111/j.1471-0528.2009.02119.x; Lowe SA, 2015, AUST NZ J OBSTET GYN, V55, pe1, DOI 10.1111/ajo.12399; Lupattelli A, 2014, INT J CLIN PHARM-NET, V36, P145, DOI 10.1007/s11096-013-9864-y; Martin SL, 2017, J NUTR, V147, P688, DOI 10.3945/jn.116.242503; Mathes T, 2014, ARCH PUBLIC HEALTH, V72, DOI 10.1186/2049-3258-72-37; Mechanic D, 2000, SOC SCI MED, V51, P657, DOI 10.1016/S0277-9536(00)00014-9; Muller S, 2015, BMC HEALTH SERV RES, V15, DOI 10.1186/s12913-015-0809-0; Nachega Jean B., 2011, Infectious Disorders - Drug Targets, V11, P167; Navaratnam K, 2018, EUR J OBSTET GYN R B, V221, P144, DOI 10.1016/j.ejogrb.2017.12.052; Omonaiye O, 2018, INT J INFECT DIS, V74, P71, DOI 10.1016/j.ijid.2018.07.004; Osterberg L, 2005, NEW ENGL J MED, V353, P487, DOI 10.1056/NEJMra050100; Park F, 2015, ULTRASOUND OBST GYN, V46, P419, DOI 10.1002/uog.14819; Redman CWG, 2011, HEART, V97, P1967, DOI 10.1136/heartjnl-2011-300949; Roberge S, 2017, AM J OBSTET GYNECOL, V216, P110, DOI 10.1016/j.ajog.2016.09.076; Rolnik DL, 2017, NEW ENGL J MED, V377, P613, DOI 10.1056/NEJMoa1704559; Sawicki E, 2011, AUST NZ J OBSTET GYN, V51, P333, DOI 10.1111/j.1479-828X.2011.01312.x; Shanmugalingam R, 2019, HYPERTENSION; Tariq Shema, 2013, JRSM Short Rep, V4, p2042533313479197, DOI 10.1177/2042533313479197; Van den Assem B, 2014, J HEALTH ORGAN MANAG, V28, P532, DOI 10.1108/JHOM-12-2012-0238; Villalobos BT, 2016, PSYCHOL SERV, V13, P49, DOI 10.1037/ser0000051; World Health Organization, 2009, ADHERENCE LONG TERM; Wright D., 2017, AM J OBSTET GYNECOL, V217, P685; Wright D, 2015, AM J OBSTET GYNECOL, V213, DOI 10.1016/j.ajog.2015.02.018	42	9	9	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2020	15	2							e0229622	10.1371/journal.pone.0229622	http://dx.doi.org/10.1371/journal.pone.0229622			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LQ8GQ	32106237	Green Published, gold			2022-12-26	WOS:000535237000051
J	Nishimura, K; Okamoto, M; Shibue, R; Mizuta, T; Shibayama, T; Yoshino, T; Murakami, T; Yamaguchi, M; Tanaka, S; Toida, T; Igarashi, K				Nishimura, Kazuhiro; Okamoto, Moemi; Shibue, Rina; Mizuta, Toshio; Shibayama, Toru; Yoshino, Tetsuhiko; Murakami, Teruki; Yamaguchi, Masashi; Tanaka, Satoshi; Toida, Toshihiko; Igarashi, Kazuei			KLF4 is required for suppression of histamine synthesis by polyamines during bone marrow-derived mast cell differentiation	PLOS ONE			English	Article							S-ADENOSYLMETHIONINE DECARBOXYLASE; HISTIDINE-DECARBOXYLASE; FREEZE-SUBSTITUTION; MOUSE; SERGLYCIN; PROTEOGLYCAN; MODULATION; SEROTONIN; MODEL; GENE	Mast cells have secretory granules containing chemical mediators such as histamine and play important roles in the immune system. Polyamines are essential factors for cellular processes such as gene expression and translation. It has been reported that secretory granules contain both histamine and polyamines, which have similar chemical structures and are produced from the metabolism of cationic amino acids. We investigated the effect of polyamine depletion on mast cells using bone marrow-derived mast cells (BMMCs). Polyamine depletion was induced using a-difluoromethylornithine (DFMO), an irreversible inhibitor of ornithine decarboxylase. DFMO treatment resulted in a significant reduction of cell number and abnormal secretory granules in BMMCs. Moreover, the cells showed a 2.3-fold increase in intracellular histamine and up-regulation of histidine decarboxylase (HDC) at the transcriptional level during BMMC differentiation. Levels of the transcription factor kruppel-like factor 4 (KLF4) greatly decreased upon DFMO treatment; however, Klf4 mRNA was expressed at levels similar to controls. We determined the translational regulation of KLF4 using reporter genes encoding Klf4-luc2 fusion mRNA, for transfecting NIH3T3 cells, and performed in vitro translation. We found that the efficiency of KLF4 synthesis in response to DFMO treatment was enhanced by the existence of a GC-rich 50-untranslated region (50UTR) on Klf4 mRNA, regardless of the recognition of the initiation codon. Taken together, these results indicate that the enhancement of histamine synthesis by DFMO depends on the up-regulation of Hdc expression, achieved by removal of transcriptional suppression of KLF4, during differentiation.	[Nishimura, Kazuhiro; Okamoto, Moemi; Shibue, Rina; Mizuta, Toshio; Shibayama, Toru; Yoshino, Tetsuhiko; Murakami, Teruki; Toida, Toshihiko; Igarashi, Kazuei] Chiba Univ, Grad Sch Pharmaceut Sci, Chiba, Japan; [Yamaguchi, Masashi] Chiba Univ, Med Mycol Res Ctr, Chiba, Japan; [Tanaka, Satoshi] Kyoto Pharmaceut Univ, Dept Pharmacol, Div Pathol Sci, Kyoto, Japan; [Igarashi, Kazuei] Amine Pharma Res Inst, Chiba, Japan	Chiba University; Chiba University; Kyoto Pharmaceutical University	Nishimura, K (corresponding author), Chiba Univ, Grad Sch Pharmaceut Sci, Chiba, Japan.	kaznishi@faculty.chiba-u.jp	Tanaka, Satoshi/H-6800-2019	Tanaka, Satoshi/0000-0002-3468-7694; Nishimura, Kazuhiro/0000-0002-6209-5522	Ministry of Education, Culture, Sports, Science and Technology, Japan [15K07921]	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by a Grant-inAid for Scientific Research 15K07921 from the Ministry of Education, Culture, Sports, Science and Technology, Japan.	Abrink M, 2004, J BIOL CHEM, V279, P40897, DOI 10.1074/jbc.M405856200; Acosta-Andrade C, 2016, AMINO ACIDS, V48, P2411, DOI 10.1007/s00726-016-2230-3; Ai WD, 2004, J BIOL CHEM, V279, P8684, DOI 10.1074/jbc.M308278200; Belting M, 2002, P NATL ACAD SCI USA, V99, P371, DOI 10.1073/pnas.012346499; Cohen S.S., 1998, GUIDE POLYAMINES, V1st ed.; Fukumoto Y, 2010, CYTOTECHNOLOGY, V62, P73, DOI 10.1007/s10616-010-9259-z; Furuta K, 2007, J BIOL CHEM, V282, P13438, DOI 10.1074/jbc.M609943200; Galli SJ, 2005, NAT IMMUNOL, V6, P135, DOI 10.1038/ni1158; Garcia-Faroldi G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015071; Garcia-Faroldi G, 2009, J CELL BIOCHEM, V108, P261, DOI 10.1002/jcb.22246; Ghaleb AM, 2017, GENE, V611, P27, DOI 10.1016/j.gene.2017.02.025; Guo JU, 2016, SCIENCE, V353, DOI 10.1126/science.aaf5371; Henningsson F, 2006, FEBS J, V273, P4901, DOI 10.1111/j.1742-4658.2006.05489.x; Hinnebusch AG, 2016, SCIENCE, V352, P1413, DOI 10.1126/science.aad9868; Homma R, 2005, INT J BIOCHEM CELL B, V37, P1911, DOI 10.1016/j.biocel.2005.04.014; Igarashi K, 2015, IUBMB LIFE, V67, P160, DOI 10.1002/iub.1363; Igarashi K, 2011, METHODS MOL BIOL, V720, P51, DOI 10.1007/978-1-61779-034-8_3; Imamura M, 2016, SCI REP-UK, V6, DOI 10.1038/srep33549; Kim SI, 2015, STEM CELL REP, V4, P727, DOI 10.1016/j.stemcr.2015.02.004; MATSUFUJI S, 1995, CELL, V80, P51, DOI 10.1016/0092-8674(95)90450-6; Metcalfe DD, 1997, PHYSIOL REV, V77, P1033, DOI 10.1152/physrev.1997.77.4.1033; Nishimura K, 2006, J BIOCHEM, V139, P81, DOI 10.1093/jb/mvj003; Nishimura K, 2005, BIOCHEM J, V385, P779, DOI 10.1042/BJ20041477; Nishimura K, 2002, GENES CELLS, V7, P41, DOI 10.1046/j.1356-9597.2001.00494.x; Nishimura K, 2007, BIOCHEM BIOPH RES CO, V364, P124, DOI 10.1016/j.bbrc.2007.09.112; Nishimura K, 2012, AMINO ACIDS, V42, P703, DOI 10.1007/s00726-011-0986-z; Nishimura K, 2009, INT J BIOCHEM CELL B, V41, P2251, DOI 10.1016/j.biocel.2009.04.021; Park MH, 2010, AMINO ACIDS, V38, P491, DOI 10.1007/s00726-009-0408-7; Pegg AE, 2009, IUBMB LIFE, V61, P880, DOI 10.1002/iub.230; Pendeville H, 2001, MOL CELL BIOL, V21, P6549, DOI 10.1128/MCB.21.19.6549-6558.2001; Raney A, 2002, J BIOL CHEM, V277, P5988, DOI 10.1074/jbc.M108375200; Ringvall M, 2008, J ALLERGY CLIN IMMUN, V121, P1020, DOI 10.1016/j.jaci.2007.11.031; Ronnberg E, 2012, J HISTOCHEM CYTOCHEM, V60, P950, DOI 10.1369/0022155412458927; Sievert H, 2014, DIS MODEL MECH, V7, P963, DOI 10.1242/dmm.014449; Stevens RL, 2007, IMMUNOL REV, V217, P155, DOI 10.1111/j.1600-065X.2007.00525.x; TABOR CW, 1984, ANNU REV BIOCHEM, V53, P749, DOI 10.1146/annurev.bi.53.070184.003533; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Takano H, 2008, FEBS LETT, V582, P1444, DOI 10.1016/j.febslet.2008.03.033; Terui Y, 2015, AMINO ACIDS, V47, P345, DOI 10.1007/s00726-014-1867-z; Waldron JA, 2018, NUCLEIC ACIDS RES, V46, P3075, DOI 10.1093/nar/gky108; WATANABE S, 1991, J BIOL CHEM, V266, P20803; Yamaguchi K, 2018, BIOCHEM J, V475, P3797, DOI 10.1042/BCJ20180672; Yamaguchi M, 2011, J ELECTRON MICROSC, V60, P283, DOI 10.1093/jmicro/dfr032; Yamaguchi M, 2009, J ELECTRON MICROSC, V58, P261, DOI 10.1093/jmicro/dfp013; Yamashita T, 2013, INT J BIOCHEM CELL B, V45, P1042, DOI 10.1016/j.biocel.2013.02.021	45	6	6	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2020	15	2							e0229744	10.1371/journal.pone.0229744	http://dx.doi.org/10.1371/journal.pone.0229744			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8FM	32101568	Green Submitted, Green Published, gold			2022-12-26	WOS:000535233700051
J	Jablonska, MR; Zajdel, R				Jablonska, Marta R.; Zajdel, Radoslaw			Artificial neural networks for predicting social comparison effects among female Instagram users	PLOS ONE			English	Article							BODY-IMAGE CONCERNS; HOSPITAL ANXIETY; DEPRESSION SCALE; SELF-OBJECTIFICATION; MEDIATING ROLE; RBF NETWORK; FACEBOOK; ASSOCIATIONS; SYMPTOMS; NUMBER	Systematic exposure to social media causes social comparisons, especially among women who compare their image to others; they are particularly vulnerable to mood decrease, self-objectification, body concerns, and lower perception of themselves. This study first investigates the possible links between life satisfaction, self-esteem, anxiety, depression, and the intensity of Instagram use with a social comparison model. In the study, 974 women age 18-49 who were Instagram users voluntarily participated, completing a questionnaire. The results suggest associations between the analyzed psychological data and social comparison types. Then, artificial neural networks models were implemented to predict the type of such comparison (positive, negative, equal) based on the aforementioned psychological traits. The models were able to properly predict between 71% and 82% of cases. As human behavior analysis has been a subject of study in various fields of science, this paper contributes towards understanding the role of artificial intelligence methods for analyzing behavioral data in psychology.	[Jablonska, Marta R.; Zajdel, Radoslaw] Univ Lodz, Fac Econ & Sociol, Inst Logist & Informat, Dept Comp Sci Econ, Lodz, Poland	University of Lodz	Jablonska, MR (corresponding author), Univ Lodz, Fac Econ & Sociol, Inst Logist & Informat, Dept Comp Sci Econ, Lodz, Poland.	marta.jablonska@uni.lodz.pl	Zajdel, Radoslaw/AAD-2758-2022; Zajdel, Radoslaw/ABB-4634-2020; Jablonska, Marta/H-5780-2016	Zajdel, Radoslaw/0000-0002-1654-8957; Jablonska, Marta/0000-0001-6004-6228				Alberga AS, 2018, J EAT DISORD, V6, DOI 10.1186/s40337-018-0227-x; Annunziata MA, 2011, ANN ONCOL, V22, P2330, DOI 10.1093/annonc/mdq750; Bishop C.M., 1995, NEURAL NETWORKS PATT; Bjelland I, 2002, J PSYCHOSOM RES, V52, P69, DOI 10.1016/S0022-3999(01)00296-3; Bleidorn W, 2019, PERS SOC PSYCHOL REV, V23, P190, DOI 10.1177/1088868318772990; Boxley L, 2016, J REHABIL RES DEV, V53, P873, DOI 10.1682/JRRD.2015.05.0088; Chae J, 2018, TELEMAT INFORM, V35, P1656, DOI 10.1016/j.tele.2018.04.011; Chao JH, 2001, IEEE IJCNN, P1995, DOI 10.1109/IJCNN.2001.938470; Chen C., 2014, THE CITESPACE MANUAL; Chen CM, 2018, CHIIR'18: PROCEEDINGS OF THE 2018 CONFERENCE ON HUMAN INFORMATION INTERACTION & RETRIEVAL, P369, DOI 10.1145/3176349.3176897; Chow TS, 2017, PERS INDIV DIFFER, V119, P277, DOI 10.1016/j.paid.2017.07.032; Claveria O, 2018, SSRN ELECT J; Dawes J, 2008, INT J MARKET RES, V50, P61, DOI 10.1177/147078530805000106; Devillers L, 2005, NEURAL NETWORKS, V18, P407, DOI 10.1016/j.neunet.2005.03.007; DIENER E, 1985, J PERS ASSESS, V49, P71, DOI 10.1207/s15327752jpa4901_13; Djukanovic I, 2017, HEALTH QUAL LIFE OUT, V15, DOI 10.1186/s12955-017-0759-9; Drageset J, 2013, SCAND J CARING SCI, V27, P872, DOI 10.1111/j.1471-6712.2012.01095.x; Dwyer DB, 2018, ANNU REV CLIN PSYCHO, V14, P91, DOI [10.1146/annurev-clinpsy-032816045037, 10.1146/annurev-clinpsy-032816-045037]; Ellison NB, 2007, J COMPUT-MEDIAT COMM, V12, P1143, DOI 10.1111/j.1083-6101.2007.00367.x; Fardouly J, 2018, NEW MEDIA SOC, V20, P1380, DOI 10.1177/1461444817694499; Fardouly J, 2015, PSYCHOL WOMEN QUART, V39, P447, DOI 10.1177/0361684315581841; Fardouly J, 2015, BODY IMAGE, V13, P38, DOI 10.1016/j.bodyim.2014.12.002; Borja-Borja LF, 2017, LECT NOTES COMPUT SC, V10306, P294, DOI 10.1007/978-3-319-59147-6_26; Fu XJ, 2003, IEEE T SYST MAN CY B, V33, P399, DOI 10.1109/TSMCB.2003.810911; Gale CR, 2010, INT PSYCHOGERIATR, V22, P559, DOI 10.1017/S1041610210000256; Gerson J, 2016, COMPUT HUM BEHAV, V63, P813, DOI 10.1016/j.chb.2016.06.023; Gupta U, 2013, 2013 INTERNATIONAL SYMPOSIUM ON COMPUTATIONAL AND BUSINESS INTELLIGENCE (ISCBI), P182, DOI 10.1109/ISCBI.2013.44; Hagan M.T., 2014, NEURAL NETWORK DESIG, V2nd; Hashemi Fath Aref, 2020, Petroleum, V6, P80, DOI 10.1016/j.petlm.2018.12.002; Haykin S., 1994, NEURAL NETWORKS, DOI 10.5555/521706; Iani L., 2014, HEALTH QUAL LIFE OUT, V12, P1; Jin SV, 2018, COMPUT HUM BEHAV, V87, P224, DOI 10.1016/j.chb.2018.06.001; Joshi A., 2015, CURRENT J APPL SCI T, P396, DOI [10.9734/BJAST/2015/14975, DOI 10.9734/BJAST/2015/14975]; Kalogirou SA, 2000, APPL ENERG, V67, P17, DOI 10.1016/S0306-2619(00)00005-2; Kang S., 2013, ASIAN J INFORM COMMU, V5, P1; Karthiyayini R., 2016, INT J ADV RES COMPUT, V6, P241; Kim JW, 2015, COMPUT HUM BEHAV, V48, P331, DOI 10.1016/j.chb.2015.01.009; Koul A, 2018, BEHAV RES METHODS, V50, P1657, DOI 10.3758/s13428-017-0987-2; Kuzma M, 2016, APPL INTELL, V44, P526, DOI 10.1007/s10489-015-0717-3; Liang HG, 2007, MIS QUART, V31, P59; Lup K, 2015, CYBERPSYCH BEH SOC N, V18, P247, DOI 10.1089/cyber.2014.0560; Meier A, 2018, CYBERPSYCH BEH SOC N, V21, P411, DOI 10.1089/cyber.2017.0708; Mellor D, 2014, J PEDIATR PSYCHOL, V39, P369, DOI 10.1093/jpepsy/jst079; Mingoia J, 2017, FRONT PSYCHOL, V8, DOI 10.3389/fpsyg.2017.01351; Moody J, 1989, NEURAL COMPUT, V1, P281, DOI 10.1162/neco.1989.1.2.281; Nabney Ian T, 2004, Int J Neural Syst, V14, P201, DOI 10.1142/S0129065704001930; Orosz G, 2016, PERS INDIV DIFFER, V100, P95, DOI 10.1016/j.paid.2015.11.038; Panchal F. S., 2014, INT J COMPUT SCI MOB, V3, P455; Park JW, 2005, IEEE T IND ELECTRON, V52, P1685, DOI 10.1109/TIE.2005.858703; Paulhus DL, 1991, MEAS PERSONAL SOC PS; Pavot W., 2008, J POSIT PSYCHOL, V3, P137, DOI [10.1080/17439760701756946, DOI 10.1080/17439760701756946]; Podsakoff PM, 2003, J APPL PSYCHOL, V88, P879, DOI 10.1037/0021-9010.88.5.879; POECHMUELLER W, 1994, 1994 IEEE INTERNATIONAL CONFERENCE ON NEURAL NETWORKS, VOL 1-7, P407, DOI 10.1109/ICNN.1994.374197; Powell E, 2018, COMPUT HUM BEHAV, V83, P221, DOI 10.1016/j.chb.2018.01.039; Reio T.G., 2010, HUM RESOUR DEV REV, V9, P405; Robinson A, 2019, J APPL BIOBEHAV RES, V24, DOI 10.1111/jabr.12158; Rosenberg M., 1965, MEASUREMENT SELF EST, DOI [10.1515/9781400876136, DOI 10.1515/9781400876136]; Sommer M, 2004, INT J AVIAT PSYCHOL, V14, P103, DOI 10.1207/s15327108ijap1401_6; Srividya M, 2018, J MED SYST, V42, DOI 10.1007/s10916-018-0934-5; TAYLOR SE, 1989, PSYCHOL REV, V96, P569, DOI 10.1037/0033-295X.96.4.569; Tehseen S., 2017, J MANAGEMENT SCI, V4, P142, DOI [10.20547/jms.2014.1704202, DOI 10.20547/JMS.2014.1704202]; Thomas L, 2017, COMPUT HUM BEHAV, V76, P541, DOI 10.1016/j.chb.2017.08.021; Tiggemann M, 2015, BODY IMAGE, V15, P61, DOI 10.1016/j.bodyim.2015.06.003; Tsang K.K., 2012, HONG KONG TEACHERSCE, V11, P121; Turner PG, 2017, EAT WEIGHT DISORD-ST, V22, P277, DOI 10.1007/s40519-017-0364-2; Utz S, 2018, FRONT PSYCHOL, V9, DOI 10.3389/fpsyg.2018.00628; Van der Zee K, 2000, PERS INDIV DIFFER, V28, P17, DOI 10.1016/S0191-8869(99)00045-8; Verduyn P, 2017, SOC ISS POLICY REV, V11, P274, DOI 10.1111/sipr.12033; Wang LC, 2016, RENEW SUST ENERG REV, V61, P384, DOI 10.1016/j.rser.2016.04.024; Weinstein E, 2017, COMPUT HUM BEHAV, V76, P396, DOI 10.1016/j.chb.2017.07.038; Yang CC, 2018, J ADOLESCENCE, V69, P92, DOI 10.1016/j.adolescence.2018.09.007; Yang CC, 2018, J YOUTH ADOLESCENCE, V47, P2114, DOI 10.1007/s10964-017-0801-6; Yang CC, 2018, COMPUT HUM BEHAV, V84, P49, DOI 10.1016/j.chb.2018.02.020; Yang CC, 2016, CYBERPSYCH BEH SOC N, V19, P703, DOI 10.1089/cyber.2016.0201; Yarkoni T, 2017, PERSPECT PSYCHOL SCI, V12, P1100, DOI 10.1177/1745691617693393; Yu H, 2011, IEEE T IND ELECTRON, V58, P5438, DOI 10.1109/TIE.2011.2164773; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	78	4	4	2	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2020	15	2							e0229354	10.1371/journal.pone.0229354	http://dx.doi.org/10.1371/journal.pone.0229354			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LQ8EV	32097446	Green Published, gold			2022-12-26	WOS:000535232000027
J	Futamata, R; Ogasawara, F; Ichikawa, T; Kodan, A; Kimura, Y; Kioka, N; Ueda, K				Futamata, Ryota; Ogasawara, Fumihiko; Ichikawa, Takafumi; Kodan, Atsushi; Kimura, Yasuhisa; Kioka, Noriyuki; Ueda, Kazumitsu			In vivo FRET analyses reveal a role of ATP hydrolysis?associated conformational changes in human P-glycoprotein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ABC transporter; ATPase; multidrug transporter; membrane protein; fluorescence resonance energy transfer (FRET); conformational change; ABCB1; MDR1; P-glycoprotein	NUCLEOTIDE-BINDING DOMAINS; MULTIDRUG-RESISTANCE; ENERGY-TRANSFER; GENE; TRANSPORTER; SITE; MODULATION; MUTATIONS; MECHANISM; PROTEINS	P-glycoprotein (P-gp; also known as MDR1 or ABCB1) is an ATP-driven multidrug transporter that extrudes various hydrophobic toxic compounds to the extracellular space. P-gp consists of two transmembrane domains (TMDs) that form the substrate translocation pathway and two nucleotide-binding domains (NBDs) that bind and hydrolyze ATP. At least two P-gp states are required for transport. In the inward-facing (pre-drug transport) conformation, the two NBDs are separated, and the two TMDs are open to the intracellular side; in the outward-facing (post-drug transport) conformation, the NBDs are dimerized, and the TMDs are slightly open to the extracellular side. ATP binding and hydrolysis cause conformational changes between the inward-facing and the outward-facing conformations, and these changes help translocate substrates across the membrane. However, how ATP hydrolysis is coupled to these conformational changes remains unclear. In this study, we used a new FRET sensor that detects conformational changes in P-gp to investigate the role of ATP binding and hydrolysis during the conformational changes of human P-gp in living HEK293 cells. We show that ATP binding causes the conformational change to the outward-facing state and that ATP hydrolysis and subsequent release of ?-phosphate from both NBDs allow the outward-facing state to return to the original inward-facing state. The findings of our study underscore the utility of using FRET analysis in living cells to elucidate the function of membrane proteins such as multidrug transporters.	[Futamata, Ryota; Ichikawa, Takafumi; Kimura, Yasuhisa; Kioka, Noriyuki] Kyoto Univ, Grad Sch Agr, Kyoto 6068502, Japan; [Ogasawara, Fumihiko; Kodan, Atsushi; Ueda, Kazumitsu] Kyoto Univ, Inst Integrated Cell Mat Sci WPI iCeMS, KUIAS, Kyoto 6068501, Japan; [Ichikawa, Takafumi] EMBL, Dev Biol Unit, D-69117 Heidelberg, Germany	Kyoto University; Kyoto University; European Molecular Biology Laboratory (EMBL)	Ueda, K (corresponding author), Kyoto Univ, Inst Integrated Cell Mat Sci WPI iCeMS, KUIAS, Kyoto 6068501, Japan.	uedak@kais.kyoto-u.ac.jp		Ueda, Kazumitsu/0000-0003-2980-6078; Kioka, Noriyuki/0000-0002-2708-537X; Ichikawa, Takafumi/0000-0002-0490-4176; Ogasawara, Fumihiko/0000-0001-8127-1504; Kimura, Yasuhisa/0000-0001-6466-1324	JSPS KAKENHI [18H05269, 18K19176]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by JSPS KAKENHI Grants 18H05269 (to K. U.) and 18K19176 (to Y. K.). The authors declare that they have no conflicts of interest with the contents of this article.	Alam A, 2018, P NATL ACAD SCI USA, V115, pE1973, DOI 10.1073/pnas.1717044115; AZZARIA M, 1989, MOL CELL BIOL, V9, P5289, DOI 10.1128/MCB.9.12.5289; Barsony O, 2016, SCI REP-UK, V6, DOI 10.1038/srep24810; CHEN CJ, 1986, CELL, V47, P381, DOI 10.1016/0092-8674(86)90595-7; Dastvan R, 2019, SCIENCE, V364, P689, DOI 10.1126/science.aav9406; Druley TE, 2001, BIOCHEMISTRY-US, V40, P4312, DOI 10.1021/bi001371v; Gottesman MM, 2006, FEBS LETT, V580, P998, DOI 10.1016/j.febslet.2005.12.060; Hofmann S, 2019, NATURE, V571, P580, DOI 10.1038/s41586-019-1391-0; Iram SH, 2015, MOL PHARMACOL, V88, P84, DOI 10.1124/mol.114.096792; Ishigami M, 2013, BBA-MOL CELL BIOL L, V1831, P683, DOI 10.1016/j.bbalip.2012.12.016; JULIANO RL, 1976, BIOCHIM BIOPHYS ACTA, V455, P152, DOI 10.1016/0005-2736(76)90160-7; Kim Y, 2018, SCIENCE, V359, P915, DOI 10.1126/science.aar7389; Kimura Y, 2004, ANAL BIOCHEM, V326, P262, DOI 10.1016/j.ab.2003.12.012; Kimura Y, 2004, CURR DRUG METAB, V5, P1, DOI 10.2174/1389200043489090; Kimura Y, 2007, BIOCHEM J, V401, P597, DOI 10.1042/BJ20060632; Kodan A, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-018-08007-x; Kodan A, 2014, P NATL ACAD SCI USA, V111, P4049, DOI 10.1073/pnas.1321562111; Kremers GJ, 2006, BIOCHEMISTRY-US, V45, P6570, DOI 10.1021/bi0516273; Li JZ, 2014, PROTEIN SCI, V23, P34, DOI 10.1002/pro.2387; Liu RH, 1996, BIOCHEMISTRY-US, V35, P11865, DOI 10.1021/bi960823u; LOO TW, 1995, J BIOL CHEM, V270, P22957, DOI 10.1074/jbc.270.39.22957; Mechetner EB, 1997, P NATL ACAD SCI USA, V94, P12908, DOI 10.1073/pnas.94.24.12908; Moeller A, 2015, STRUCTURE, V23, P450, DOI 10.1016/j.str.2014.12.013; Muller M, 1996, J BIOL CHEM, V271, P1877; Ogasawara F, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-39973-x; Qu Q, 2001, BIOCHEMISTRY-US, V40, P1413, DOI 10.1021/bi002035h; SCHINKEL AH, 1994, CELL, V77, P491, DOI 10.1016/0092-8674(94)90212-7; Stewart SE, 2015, BBA-BIOMEMBRANES, V1848, P115, DOI 10.1016/j.bbamem.2014.10.012; Szabo K, 1998, J BIOL CHEM, V273, P10132, DOI 10.1074/jbc.273.17.10132; Tombline G, 2004, J BIOL CHEM, V279, P31212, DOI 10.1074/jbc.M404689200; UEDA K, 1987, P NATL ACAD SCI USA, V84, P3004, DOI 10.1073/pnas.84.9.3004; UEDA K, 1986, BIOCHEM BIOPH RES CO, V141, P956, DOI 10.1016/S0006-291X(86)80136-X; Urbatsch IL, 2003, J BIOL CHEM, V278, P23171, DOI 10.1074/jbc.M301957200; URBATSCH IL, 1995, J BIOL CHEM, V270, P19383, DOI 10.1074/jbc.270.33.19383; Urbatsch IL, 1998, BIOCHEMISTRY-US, V37, P4592, DOI 10.1021/bi9728001; Vanderklish PW, 2000, P NATL ACAD SCI USA, V97, P2253, DOI 10.1073/pnas.040565597; Verhalen B, 2017, NATURE, V543, P738, DOI 10.1038/nature21414; Verhalen B, 2012, J BIOL CHEM, V287, P1112, DOI 10.1074/jbc.M111.301192; Zoghbi ME, 2017, J BIOL CHEM, V292, P20412, DOI 10.1074/jbc.M117.814186	39	10	10	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 10	2020	295	15					5002	5011		10.1074/jbc.RA119.012042	http://dx.doi.org/10.1074/jbc.RA119.012042			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LE7FC	32111736	Green Submitted, Green Published, hybrid			2022-12-26	WOS:000526887000022
J	Murakami, K; Obata, Y; Sekikawa, A; Ueda, H; Izuo, N; Awano, T; Takabe, K; Shimizu, T; Irie, K				Murakami, Kazuma; Obata, Yayoi; Sekikawa, Asa; Ueda, Haruka; Izuo, Naotaka; Awano, Tatsuya; Takabe, Keiji; Shimizu, Takahiko; Irie, Kazuhiro			An RNA aptamer with potent affinity for a toxic dimer of amyloid?42 has potential utility for histochemical studies of Alzheimer's disease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Alzheimer disease; amyloid-beta (AB); aggregation; aptamer; circular dichroism (CD); immunohistochemistry; G-quadruplex; oligomer; transgenic mice; RNA	BETA-PROTEIN; SECONDARY STRUCTURE; OXIDATIVE STRESS; OLIGOMERS; NEUROTOXICITY; AGGREGATION; MECHANISM; SELECTION; SEQUENCE; ANTIBODY	Oligomers of ?-amyloid 42 (A?42), rather than fibrils, drive the pathogenesis of Alzheimer's disease (AD). In particular, toxic oligomeric species called protofibrils (PFs) have attracted significant attention. Herein, we report RNA aptamers with higher affinity toward PFs derived from a toxic A?42 dimer than toward fibrils produced from WT A?42 or from a toxic, conformationally constrained A?42 variant, E22P?A?42. We obtained these RNA aptamers by using the preincubated dimer model of E22P?A?42, which dimerized via a linker located at Val-40, as the target of in vitro selection. This dimer formed PFs during incubation. Several physicochemical characteristics of an identified aptamer, E22P?AbD43, suggested that preferential affinity of this aptamer toward PFs is due to its higher affinity for the toxic dimer unit (K-D = 20 ? 6.0 nm) of A?42 than for less-toxic A?40 aggregates. Comparison of CD data from the full-length and random regions of E22P?AbD43 suggested that the preferential binding of E22P?AbD43 toward the dimer might be related to the formation of a G-quadruplex structure. E22P?AbD43 significantly inhibited the nucleation phase of the dimer and its associated neurotoxicity in SH-SY5Y human neuroblastoma cells. Of note, E22P?AbD43 also significantly protected against the neurotoxicity of WT A?42 and E22P?A?42. Furthermore, in an AD mouse model, E22P?AbD43 preferentially recognized diffuse aggregates, which likely originated from PFs or higher-order oligomers with curvilinear structures, compared with senile plaques formed from fibrils. We conclude that the E22P?AbD43 aptamer is a promising research and diagnostic tool for further studies of AD etiology.	[Murakami, Kazuma; Obata, Yayoi; Sekikawa, Asa; Ueda, Haruka; Irie, Kazuhiro] Kyoto Univ, Grad Sch Agr, Div Food Sci & Biotechnol, Kyoto 6068502, Japan; [Awano, Tatsuya; Takabe, Keiji] Kyoto Univ, Grad Sch Agr, Div Forest & Biomat Sci, Kyoto 6068502, Japan; [Izuo, Naotaka; Shimizu, Takahiko] Chiba Univ, Grad Sch Med, Dept Endocrinol Hematol & Gerontol, Chiba 2608670, Japan; [Izuo, Naotaka] Univ Toyama, Fac Pharmaceut Sci, Lab Pharmaceut Therapy & Neuropharmacol, Toyama 9300194, Japan; [Shimizu, Takahiko] Natl Ctr Geriatr & Gerontol, Aging Stress Response Res Project Team, Obu 4748511, Japan	Kyoto University; Kyoto University; Chiba University; University of Toyama; National Center for Geriatrics & Gerontology	Murakami, K; Irie, K (corresponding author), Kitashirakawa Oiwake Cho,Sakyo Ku, Kyoto 6068502, Japan.	murakami.kazuma.4v@kyoto-u.ac.jp; irie.kazuhiro.2z@kyoto-u.ac.jp	Awano, Tatsuya/GSN-5165-2022; Irie, Kazuhiro/A-6121-2014; Murakami, Kazuma/GQA-7062-2022	Awano, Tatsuya/0000-0002-4735-4506; Irie, Kazuhiro/0000-0001-7109-8568; Murakami, Kazuma/0000-0003-3152-1784	Japan Society for the Promotion of Science KAKENHI [26221202, 16H06194, 22603006]	Japan Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Japan Society for the Promotion of Science KAKENHI Grants 26221202 (to K. I. and K. M.) 16H06194 (to K. M.), and 22603006 (to K. M.). The authors declare that they have no conflicts of interest with the contents of this article.	Ambrus A, 2006, NUCLEIC ACIDS RES, V34, P2723, DOI 10.1093/nar/gkl348; Andrushchenko V, 2011, J AM CHEM SOC, V133, P15055, DOI 10.1021/ja204630k; Bailey T L, 1994, Proc Int Conf Intell Syst Mol Biol, V2, P28; Burge S, 2006, NUCLEIC ACIDS RES, V34, P5402, DOI 10.1093/nar/gkl655; Chakravarthy M, 2018, CHEM COMMUN, V54, P4593, DOI 10.1039/c8cc02256a; Farrar CT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089901; Ginsberg SD, 1999, ANN NEUROL, V45, P174, DOI 10.1002/1531-8249(199902)45:2<174::AID-ANA7>3.0.CO;2-E; Ginsberg SD, 1998, ACTA NEUROPATHOL, V96, P487, DOI 10.1007/s004010050923; GLENNER GG, 1984, BIOCHEM BIOPH RES CO, V120, P885, DOI 10.1016/S0006-291X(84)80190-4; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; Hanaki M, 2016, BIOORGAN MED CHEM, V24, P304, DOI 10.1016/j.bmc.2015.12.021; Harper JD, 1997, CHEM BIOL, V4, P119, DOI 10.1016/S1074-5521(97)90255-6; Horikoshi Y, 2004, BIOCHEM BIOPH RES CO, V325, P384, DOI 10.1016/j.bbrc.2004.10.039; Hoshi M, 2003, P NATL ACAD SCI USA, V100, P6370, DOI 10.1073/pnas.1237107100; Irie K, 2007, MINI-REV MED CHEM, V7, P1001, DOI 10.2174/138955707782110187; Irie Y, 2017, ACS CHEM NEUROSCI, V8, P807, DOI 10.1021/acschemneuro.6b00390; Kageyama Y, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-35004-3; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; Koffie RM, 2009, P NATL ACAD SCI USA, V106, P4012, DOI 10.1073/pnas.0811698106; Lambert MP, 1998, P NATL ACAD SCI USA, V95, P6448, DOI 10.1073/pnas.95.11.6448; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; MASTERS CL, 1985, P NATL ACAD SCI USA, V82, P4245, DOI 10.1073/pnas.82.12.4245; Masuda Y, 2009, CHEMBIOCHEM, V10, P287, DOI 10.1002/cbic.200800411; Morimoto A, 2004, J BIOL CHEM, V279, P52781, DOI 10.1074/jbc.M406262200; Murakami K, 2005, J AM CHEM SOC, V127, P15168, DOI 10.1021/ja054041c; Murakami K, 2003, J BIOL CHEM, V278, P46179, DOI 10.1074/jbc.M301874200; Murakami K, 2016, SCI REP-UK, V6, DOI 10.1038/srep29038; Murakami K, 2010, ACS CHEM NEUROSCI, V1, P747, DOI 10.1021/cn100072e; Naiki H, 1999, METHOD ENZYMOL, V309, P305; Ono K, 2008, J BIOL CHEM, V283, P32176, DOI 10.1074/jbc.M806154200; Rahimi F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007694; Rossi AM, 2011, NAT PROTOC, V6, DOI 10.1038/nprot.2011.305; Roychaudhuri R, 2009, J BIOL CHEM, V284, P4749, DOI 10.1074/jbc.R800036200; Sato K, 2009, NUCLEIC ACIDS RES, V37, pW277, DOI 10.1093/nar/gkp367; Sato M, 2013, J BIOL CHEM, V288, P23212, DOI 10.1074/jbc.M113.464222; Serio TR, 2000, SCIENCE, V289, P1317, DOI 10.1126/science.289.5483.1317; Sugimoto S, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv338; Takahashi T, 2009, MOL BIOSYST, V5, P986, DOI 10.1039/b903391b; Toda T, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/617974; Tsukakoshi K, 2016, CHEM COMMUN, V52, P12646, DOI 10.1039/c6cc07552e; Tsukakoshi K, 2012, ANAL CHEM, V84, P5542, DOI 10.1021/ac300330g; Walsh DM, 1997, J BIOL CHEM, V272, P22364, DOI 10.1074/jbc.272.35.22364; Watanabe-Nakayama T, 2016, P NATL ACAD SCI USA, V113, P5835, DOI 10.1073/pnas.1524807113; Ylera F, 2002, BIOCHEM BIOPH RES CO, V290, P1583, DOI 10.1006/bbrc.2002.6354; Zhou JH, 2017, NAT REV DRUG DISCOV, V16, P181, DOI 10.1038/nrd.2016.199	45	12	13	1	23	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 10	2020	295	15					4870	4880		10.1074/jbc.RA119.010955	http://dx.doi.org/10.1074/jbc.RA119.010955			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LE7FC	32127399	Green Published, hybrid			2022-12-26	WOS:000526887000011
J	Moreira, AG; Siddiqui, SK; Macias, R; Johnson-Pais, TL; Wilson, D; Gelfond, JAL; Vasquez, MM; Seidner, SR; Mustafa, SB				Moreira, Alvaro G.; Siddiqui, Sartaj K.; Macias, Rolando; Johnson-Pais, Teresa L.; Wilson, Desiree; Gelfond, Jonathon A. L.; Vasquez, Margarita M.; Seidner, Steven R.; Mustafa, Shamimunisa B.			Oxygen and mechanical ventilation impede the functional properties of resident lung mesenchymal stromal cells	PLOS ONE			English	Article							GENE-EXPRESSION; STEM-CELLS; GROWTH-FACTOR; DISEASE; PROTECTS; ALVEOLAR; PRETERM	Resident/endogenous mesenchymal stromal cells function to promote the normal development, growth, and repair of tissues. Following premature birth, the effects of routine neonatal care (e.g. oxygen support and mechanical ventilation) on the biological properties of lung endogenous mesenchymal stromal cells is (L-MSCs) is poorly understood. New Zealand white preterm rabbits were randomized into the following groups: (i) sacrificed at birth (Fetal), (ii) spontaneously breathing with 50% O-2 for 4 hours (SB), or (iii) mechanical ventilation with 50% O-2 for 4h (MV). At time of necropsy, L-MSCs were isolated, characterized, and compared. L-MSCs isolated from the MV group had decreased differentiation capacity, ability to form stem cell colonies, and expressed less vascular endothelial growth factor mRNA. Compared to Fetal L-MSCs, 98 and 458 genes were differentially expressed in the L-MSCs derived from the SB and MV groups, respectively. Gene ontology analysis revealed these genes were involved in key regulatory processes including cell cycle, cell division, and angiogenesis. Furthermore, the L-MSCs from the SB and MV groups had smaller mitochondria, nuclear changes, and distended endoplasmic reticula. Short-term hyperoxia/mechanical ventilation after birth alters the biological properties of L-MSCs and stimulates genomic changes that may impact their reparative potential.	[Moreira, Alvaro G.; Siddiqui, Sartaj K.; Macias, Rolando; Vasquez, Margarita M.; Seidner, Steven R.; Mustafa, Shamimunisa B.] Univ Texas Hlth Sci Ctr San Antonio, Dept Pediat, Div Neonatol, San Antonio, TX 78229 USA; [Johnson-Pais, Teresa L.] Univ Texas Hlth Sci Ctr San Antonio, Dept Urol, San Antonio, TX 78229 USA; [Wilson, Desiree] Univ Texas Hlth Sci Ctr San Antonio, Dept Periodont, San Antonio, TX 78229 USA; [Gelfond, Jonathon A. L.] Univ Texas Hlth Sci Ctr San Antonio, Dept Epidemiol & Biostat, San Antonio, TX 78229 USA	University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio	Mustafa, SB (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Pediat, Div Neonatol, San Antonio, TX 78229 USA.	mustafa@uthscsa.edu			National Institutes of Health (NIH) [8UL1TR001120]; NIH (NCI) [P30 CA054174]; National Institutes of Health, National Center for Advancing Translational Sciences [KL2 TR001118]; Parker B. Francis Foundation	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health, National Center for Advancing Translational Sciences; Parker B. Francis Foundation	1. SM: National Institutes of Health (NIH) 8UL1TR001120, www.nih.gov, sponsor did not play a role in the study design, data collection, analysis, decision to publication, or preparation of the manuscript. Flow Cytometry Facility at UT Health San Antonio with funding from University and the NIH (NCI P30 CA054174), sponsor did not play a role in the study design, data collection, analysis, decision to publication, or preparation of the manuscript. 2. AM: National Institutes of Health, National Center for Advancing Translational Sciences KL2 TR001118, www.nih.gov, sponsor did not play a role in the study design, data collection, analysis, decision to publication, or preparation of the manuscript; Parker B. Francis Foundation, www.francisfellowships.org, sponsor did not play a role in the study design, data collection, analysis, decision to publication, or preparation of the manuscript.	Ahmad A, 2002, AM J PHYSIOL-LUNG C, V283, pL573, DOI 10.1152/ajplung.00410.2001; Ahmad T, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2012.213; Ahn SY, 2017, J PEDIATR-US, V185, P49, DOI 10.1016/j.jpeds.2017.02.061; Asikainen TM, 2005, PEDIATR PULM, V40, P538, DOI 10.1002/ppul.20321; Aslam M, 2009, AM J RESP CRIT CARE, V180, P1122, DOI 10.1164/rccm.200902-0242OC; Balgi-Agarwal S, 2018, CELLS TISSUES ORGANS, V205, P137, DOI 10.1159/000489256; Baraldi E, 2007, NEW ENGL J MED, V357, P1946, DOI 10.1056/NEJMra067279; Collins JJP, 2018, STEM CELLS DEV, V27, P1109, DOI 10.1089/scd.2017.0145; Collins JJP, 2017, FRONT MED-LAUSANNE, V4, DOI 10.3389/fmed.2017.00061; Collins JJP, 2014, ANTIOXID REDOX SIGN, V21, P1849, DOI 10.1089/ars.2013.5781; Collins JJP, 2014, BIRTH DEFECTS RES A, V100, P217, DOI 10.1002/bdra.23227; D'Angio CT, 2014, AM J PHYSIOL-LUNG C, V307, pL959, DOI 10.1152/ajplung.00228.2014; Digeronimo RJ, 2007, PEDIATR RES, V62, P277, DOI 10.1203/PDR.0b013e3181256aeb; Duggan N, 2010, NAT ED, V3, P5; Fung ME, 2014, PEDIATR RES, V75, P2, DOI 10.1038/pr.2013.176; Grier DG, 2005, J PATHOL, V205, P154, DOI 10.1002/path.1710; Hou A, 2015, AM J PHYSIOL-LUNG C, V308, pL861, DOI 10.1152/ajplung.00099.2014; Islam MN, 2012, NAT MED, V18, P759, DOI 10.1038/nm.2736; Jobe AH, 2011, CURR OPIN PEDIATR, V23, P167, DOI 10.1097/MOP.0b013e3283423e6b; Martinez-Lorenzo MJ, 2009, J ORTHOP RES, V27, P1499, DOI 10.1002/jor.20898; Kolf CM, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2116; Kowal J, 2016, P NATL ACAD SCI USA, V113, pE968, DOI 10.1073/pnas.1521230113; Lapi Simone, 2008, BMC Res Notes, V1, P53, DOI 10.1186/1756-0500-1-53; Lee TC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111390; Lee Tsung-Han, 2013, BMC Res Notes, V6, P528, DOI 10.1186/1756-0500-6-528; Mobius Marius A, 2016, Mol Cell Pediatr, V3, P18, DOI 10.1186/s40348-016-0046-6; Mobius MA, 2019, AM J RESP CELL MOL, V60, P592, DOI 10.1165/rcmb.2018-0358OC; O'Reilly M, 2017, CELL TISSUE RES, V367, P737, DOI 10.1007/s00441-016-2517-4; Ota C, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-31214-x; Pang JJ, 1998, GRAEF ARCH CLIN EXP, V236, P696, DOI 10.1007/s004170050143; Pierro M, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD011932.pub2; Pittenger MF, 1999, SCIENCE, P284; Popova AP, 2010, PEDIATRICS, V126, pE1127, DOI 10.1542/peds.2009-3445; Popova AP, 2010, AM J PHYSIOL-LUNG C, V298, pL735, DOI 10.1152/ajplung.00347.2009; PRINGLE KC, 1986, CLIN OBSTET GYNECOL, V29, P502, DOI 10.1097/00003081-198609000-00006; Schmalisch G, 2012, BMC PEDIATR, V12, DOI 10.1186/1471-2431-12-37; Shivanna B, 2016, TOXICOL SCI, V152, P155, DOI 10.1093/toxsci/kfw071; Stocks J, 2013, LANCET RESP MED, V1, P728, DOI 10.1016/S2213-2600(13)70118-8; Tan HL, 2013, THORAX, V68, P788, DOI 10.1136/thoraxjnl-2013-203307; Ten VS, 2017, PEDIATR RES, V81, P286, DOI 10.1038/pr.2016.216; Teng RJ, 2017, AM J PHYSIOL-LUNG C, V312, P1586, DOI 10.1152/ajplung.00405.2016; Teti G, 2012, MICROSC RES TECHNIQ, V75, P596, DOI 10.1002/jemt.21096; Thebaud B, 2007, AM J RESP CRIT CARE, V175, P978, DOI 10.1164/rccm.200611-1660PP; van Haaften T, 2009, AM J RESP CRIT CARE, V180, P1131, DOI 10.1164/rccm.200902-0179OC; Willis GR, 2018, PEDIATR RES, V83, P298, DOI 10.1038/pr.2017.256; Yick CY, 2013, AM J RESP CRIT CARE, V187, P1076, DOI 10.1164/rccm.201210-1886OC; Zaganescu R, 2015, MICROSC RES TECHNIQ, V78, P792, DOI 10.1002/jemt.22542	47	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2020	15	3							e0229521	10.1371/journal.pone.0229521	http://dx.doi.org/10.1371/journal.pone.0229521			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8TR	32142526	gold, Green Published			2022-12-26	WOS:000535271600015
J	Cui, P; Zhang, P; Zhang, YM; Sun, LH; Cui, GH; Guo, X; Wang, H; Zhang, XW; Shi, Y; Yu, ZD				Cui, Peng; Zhang, Ping; Zhang, Yanmin; Sun, Lihua; Cui, Guanghui; Guo, Xin; Wang, He; Zhang, Xiaowei; Shi, Yu; Yu, Zhendong			HIF-1 alpha/Actl6a/H3K9ac axis is critical for pluripotency and lineage differentiation of human induced pluripotent stem cells	FASEB JOURNAL			English	Article						differentiation potential; epigenetics; hypoxia-inducible factor 1 alpha; pluripotency maintenance; regenerative medicine	GLYCOLYTIC METABOLISM; SELF-RENEWAL; CHROMATIN; ROLES; ACETYLATION; MECHANISM; BAF53A; OXYGEN; ESBAF; STATE	Pluripotent stem cells (PSCs) are important models for analyzing cellular metabolism and individual development. As a hypoxia-inducible factor subunit, HIF-1 alpha plays an important role in maintaining the pluripotency of PSCs under hypoxic conditions. However, the mechanisms underlying the self-renewal and pluripotency maintenance of human induced pluripotent stem cells (hiPSCs) via regulating HIF-1 alpha largely remain elusive. In this study, we found that disrupting the expression of HIF-1 alpha reduced self-renewal and pluripotency of hiPSCs. Additionally, HIF-1 alpha-knockdown led to lower mitochondrial membrane potential (Delta psi(m)) and higher reactive oxygen species production in hiPSCs. However, HIF-1 alpha-overexpression increased ATP content in hiPSCs, while the role of HIF-1 alpha-knockdown was opposite. The embryoid body (EB) and teratoma formation assays showed that HIF-1 alpha-knockdown promoted endoderm differentiation and development in vitro and in vivo. In terms of the underlying molecular mechanisms, HIF-1 alpha-knockdown inhibited the expression of Actl6a and histone H3K9ac acetylation (H3K9ac). Actl6a knockdown reduced the expression of H3K9ac and the pluripotency of hiPSCs, and also affected endoderm differentiation. These data suggest that hindering HIF-1 alpha expression causes the changes in mitochondrial properties and metabolic disorders in hiPSCs. Furthermore, HIF-1 alpha affects hiPSC pluripotency, and germ layer differentiation via Actl6a and histone acetylation.	[Cui, Peng; Zhang, Yanmin; Cui, Guanghui; Guo, Xin; Yu, Zhendong] Peking Univ, Shenzhen Hosp, Shenzhen Peking Univ Hong Kong Univ Sci & Technol, Cent Lab, Shenzhen, Peoples R China; [Zhang, Ping; Sun, Lihua] Peking Univ, Shenzhen Hosp, Shenzhen Peking Univ Hong Kong Univ Sci & Technol, Dept Hematol, Shenzhen, Peoples R China; [Wang, He] Peking Univ, Shenzhen Hosp, Shenzhen Peking Univ Hong Kong Univ Sci & Technol, Dept Lab Med, Shenzhen, Peoples R China; [Zhang, Xiaowei] Peking Univ, Sch Basic Med Sci, Beijing, Peoples R China; [Shi, Yu] Peking Univ, Shenzhen Hosp, Shenzhen Peking Univ Hong Kong Univ Sci & Technol, Dept Res & Teaching, Shenzhen, Peoples R China	Hong Kong University of Science & Technology; Peking University; Hong Kong University of Science & Technology; Peking University; Hong Kong University of Science & Technology; Peking University; Peking University; Hong Kong University of Science & Technology; Peking University	Shi, Y; Yu, ZD (corresponding author), Peking Univ, Shenzhen Hosp, Shenzhen Peking Univ Hong Kong Univ Sci & Technol, Shenzhen 518000, Peoples R China.	shiyu@pkuszh.com; dongboyaa@pkuszh.com	zhang, xiaowei/GQH-5387-2022		China Postdoctoral Science Foundation [2019M652993]; Natural Science Foundation of Guangdong Province (Guangdong Natural Science Foundation) [2019A1515011432]; Shenzhen Science and Technology Innovation Commission [JCYJ20170816105345191]	China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Natural Science Foundation of Guangdong Province (Guangdong Natural Science Foundation)(National Natural Science Foundation of Guangdong Province); Shenzhen Science and Technology Innovation Commission	China Postdoctoral Science Foundation, Grant/Award Number: 2019M652993; Natural Science Foundation of Guangdong Province (Guangdong Natural Science Foundation), Grant/Award Number: 2019A1515011432; Shenzhen Science and Technology Innovation Commission, Grant/Award Number: JCYJ20170816105345191	Atlasi Y, 2017, NAT REV GENET, V18, DOI 10.1038/nrg.2017.57; Axelson H, 2005, SEMIN CELL DEV BIOL, V16, P554, DOI 10.1016/j.semcdb.2005.03.007; Bao XM, 2013, CELL STEM CELL, V12, P193, DOI 10.1016/j.stem.2012.12.014; Cabarcas SM, 2011, INT J CANCER, V129, P2315, DOI 10.1002/ijc.26312; Cliff TS, 2017, CELL STEM CELL, V21, P502, DOI 10.1016/j.stem.2017.08.018; Ding JJ, 2015, CELL STEM CELL, V16, P653, DOI 10.1016/j.stem.2015.04.001; Doege CA, 2012, NATURE, V488, P652, DOI 10.1038/nature11333; Edupuganti RR, 2017, STEM CELL REP, V9, P1291, DOI 10.1016/j.stemcr.2017.08.021; Ezashi T, 2005, P NATL ACAD SCI USA, V102, P4783, DOI 10.1073/pnas.0501283102; Fazzio TG, 2008, CELL, V134, P162, DOI 10.1016/j.cell.2008.05.031; Folmes CDL, 2011, CELL METAB, V14, P264, DOI 10.1016/j.cmet.2011.06.011; Gaspar-Maia A, 2009, NATURE, V460, P863, DOI 10.1038/nature08212; Gintant G, 2017, CELL STEM CELL, V21, P14, DOI 10.1016/j.stem.2017.06.005; Gu W, 2016, CELL STEM CELL, V19, P476, DOI 10.1016/j.stem.2016.08.008; Harvey A, 2019, STEM CELL REP, V13, P573, DOI 10.1016/j.stemcr.2019.09.003; Ho L, 2009, P NATL ACAD SCI USA, V106, P5181, DOI 10.1073/pnas.0812889106; Huan F, 2016, MOL CELL BIOL, V36, P1900, DOI 10.1128/MCB.00055-16; Keenen B, 2009, J CELL PHYSIOL, V219, P1, DOI 10.1002/jcp.21654; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Krasteva V, 2012, BLOOD, V120, P4720, DOI 10.1182/blood-2012-04-427047; Landry J, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000241; Lu WS, 2015, STEM CELLS, V33, P1782, DOI 10.1002/stem.2000; Mandal S, 2011, STEM CELLS, V29, P486, DOI 10.1002/stem.590; Mohyeldin A, 2010, CELL STEM CELL, V7, P150, DOI 10.1016/j.stem.2010.07.007; Morrison SJ, 2000, J NEUROSCI, V20, P7370; Moussaieff A, 2015, CELL METAB, V21, P392, DOI 10.1016/j.cmet.2015.02.002; Mu XP, 2015, CELL REPROGRAM, V17, P259, DOI 10.1089/cell.2014.0102; Nascimento CHV, 2019, FASEB J, V33, P13435, DOI 10.1096/fj.201900722R; Nichols J, 2009, CELL STEM CELL, V4, P487, DOI 10.1016/j.stem.2009.05.015; Novershtern N, 2011, NAT CELL BIOL, V13, P886, DOI 10.1038/ncb2311; Panopoulos AD, 2012, CELL RES, V22, P168, DOI 10.1038/cr.2011.177; Park SJ, 2017, STEM CELLS DEV, V26, P734, DOI 10.1089/scd.2016.0320; Prigione A, 2014, STEM CELLS, V32, P364, DOI 10.1002/stem.1552; Qiao YB, 2015, J BIOL CHEM, V290, P2508, DOI 10.1074/jbc.M114.603761; Ryall JG, 2015, CELL STEM CELL, V17, P651, DOI 10.1016/j.stem.2015.11.012; Saladi SV, 2010, STEM CELL REV REP, V6, P62, DOI 10.1007/s12015-010-9120-y; Simsek T, 2010, CELL STEM CELL, V7, P380, DOI 10.1016/j.stem.2010.07.011; Suda T, 2011, CELL STEM CELL, V9, P298, DOI 10.1016/j.stem.2011.09.010; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Takubo K, 2012, INT J HEMATOL, V95, P478, DOI 10.1007/s12185-012-1071-4; Takubo K, 2010, CELL STEM CELL, V7, P391, DOI 10.1016/j.stem.2010.06.020; Trisciuoglio D, 2018, STEM CELLS INT, V2018, DOI 10.1155/2018/8908751; Wan WB, 2015, STEM CELLS INT, V2015, DOI 10.1155/2015/382530; Wanet A, 2015, STEM CELLS DEV, V24, P1957, DOI 10.1089/scd.2015.0117; Wang L, 2014, CELL STEM CELL, V14, P575, DOI 10.1016/j.stem.2014.02.013; Wang Y, 2011, CELL STEM CELL, V8, P399, DOI 10.1016/j.stem.2011.02.006; Wang Y, 2019, FASEB J, V33, P13398, DOI 10.1096/fj.201901366R; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968; Yoo AS, 2011, NATURE, V476, P228, DOI 10.1038/nature10323; Yoshida Y, 2009, CELL STEM CELL, V5, P237, DOI 10.1016/j.stem.2009.08.001; Zhang Y, 2018, FASEB J, V32, P1891, DOI 10.1096/fj.201700626RR; Zhong XY, 2019, CELL METAB, V29, P979, DOI 10.1016/j.cmet.2018.11.007; Zhou WY, 2012, EMBO J, V31, P2103, DOI 10.1038/emboj.2012.71; Zhu B, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-14362-4; Zhu SY, 2010, CELL STEM CELL, V7, P651, DOI 10.1016/j.stem.2010.11.015	55	9	10	1	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2020	34	4					5740	5753		10.1096/fj.201902829RR	http://dx.doi.org/10.1096/fj.201902829RR		FEB 2020	14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	LJ5ZA	32112486	hybrid			2022-12-26	WOS:000517911700001
J	Djibo, DA; Goldstein, J; Ford, JG				Djibo, Djeneba Audrey; Goldstein, Jessica; Ford, Jean G.			Prevalence of disability among adults with chronic obstructive pulmonary disease, Behavioral Risk Factor Surveillance System 2016-2017	PLOS ONE			English	Article							UNITED-STATES; COMORBIDITIES; COPD; POPULATION; DIAGNOSIS; OUTCOMES; ASTHMA; IMPACT	Background The prevalence of disabilities is rising steadily, reflecting an aging population and an increasing burden of chronic conditions affecting quality of life. There are scant national data on the prevalence of disability among individuals with chronic obstructive pulmonary disease (COPD). The main objective was to estimate the prevalence of common disabilities among US-based individuals diagnosed with COPD. Methods Data from the BRFSS, a national telephone survey examining health-related behaviors in 2016-2017 were analyzed. The study population consisted of individuals with self-reported COPD (N = 38352 in 2016 and N = 35423 in 2017). The prevalence of disabilities in hearing, vision, cognition, mobility, and independent living were obtained and adjusted with sampling weights. Healthcare access measures were described by type of disability. Results Mobility disability had the highest prevalence of 45.9 (44.8-47.0) % in 2016 and 48.4 (47.3-49.5)% in 2017 among respondents with COPD. The prevalence of disabilities was highest among those 45-64 years old, except for hearing and cognition. Hearing disabilities were most prevalent among males with COPD while cognitive and mobility disabilities were most prevalent among females with COPD. While differences in the prevalence of disabilities were observed, access to health care was similar by disability type and age group among respondents. Conclusion Contrary to expectation, the highest prevalence of disabilities was found not to be among those 65 years old and above. Further research is needed to explain this age-specific shift in the burden of disability, as long-term care planning and prevention support systems should be informed by the demographical patterns of disabilities among individuals with COPD.	[Djibo, Djeneba Audrey; Goldstein, Jessica] Einstein Healthcare Network, Div Res, Dept Med, Philadelphia, PA 19141 USA; [Ford, Jean G.] Einstein Healthcare Network, Dept Med, Philadelphia, PA USA		Djibo, DA (corresponding author), Einstein Healthcare Network, Div Res, Dept Med, Philadelphia, PA 19141 USA.	djiboaud@einstein.edu						Barnes PJ, 2009, EUR RESPIR J, V33, P1165, DOI 10.1183/09031936.00128008; Barnett S, 1999, AM J PUBLIC HEALTH, V89, P1754, DOI 10.2105/AJPH.89.11.1754; Barnett S, 2011, AM J PUBLIC HEALTH, V101, P2235, DOI 10.2105/AJPH.2011.300247; Bourdin A, 2009, EUR RESPIR REV, V18, P198, DOI 10.1183/09059180.00005509; Cavailles A, 2013, EUR RESPIR REV, V22, P454, DOI 10.1183/09059180.00008612; Centers for Disease Control and Prevention (CDC), 2009, MMWR Morb Mortal Wkly Rep, V58, P421; Centers for Disease Control and Prevention National Center for Chronic Disease Prevention and Health Promotion Division of Population Health, 2015, BRFSS PREV TRENDS DA; Centers of Disease Control and Prevention, 2018, BEH RISK FACT SURV S; Cote CG, 2009, INT J CLIN PRACT, V63, P486, DOI 10.1111/j.1742-1241.2008.01987.x; Courtney-Long EA, 2015, MMWR-MORBID MORTAL W, V64, P777, DOI 10.15585/mmwr.MM6429a2; Croft JB, 2018, MMWR-MORBID MORTAL W, V67, P205, DOI 10.15585/mmwr.mm6707a1; Dunlop DD, 2007, AM J PUBLIC HEALTH, V97, P2209, DOI 10.2105/AJPH.2006.106047; Ford ES, 2013, CHEST, V144, P284, DOI 10.1378/chest.13-0809; Froehlich-Grobe K, 2016, DISABIL HEALTH J, V9, P600, DOI 10.1016/j.dhjo.2016.04.007; Gut-Gobert C, 2019, EUR RESPIR REV, V28, DOI 10.1183/16000617.0055-2018; Halldin CN, 2015, CHRON RESP DIS, V12, P47, DOI 10.1177/1479972314562409; Hwang K., 2009, J DISABIL POLICY STU, V20, P28, DOI [10.1177/1044207308315564, DOI 10.1177/1044207308315564]; Kaye HS, 2019, AM J PUBLIC HEALTH, V109, P1015, DOI 10.2105/AJPH.2019.305056; Kohansal R, 2009, AM J RESP CRIT CARE, V180, P3, DOI 10.1164/rccm.200901-0047OC; Krommidas G, 2010, RESP MED, V104, P40, DOI 10.1016/j.rmed.2009.08.012; Lambert AA, 2017, CHEST, V151, P68, DOI 10.1016/j.chest.2016.08.1432; Liu Y, 2015, RESP MED, V109, P851, DOI 10.1016/j.rmed.2015.05.006; Okoro CA, 2018, MMWR-MORBID MORTAL W, V67, P882, DOI 10.15585/mmwr.mm6732a3; Peacock G, 2015, NEW ENGL J MED, V373, P892, DOI 10.1056/NEJMp1508854; Pharr Jennifer R, 2012, Glob J Health Sci, V4, P99, DOI 10.5539/gjhs.v4n6p99; Putcha N, 2014, CHRON OBSTR PULM DIS, V1, P105, DOI 10.15326/jcopdf.1.1.2014.0112; Russell S, 2018, NPJ PRIM CARE RESP M, V28, DOI 10.1038/s41533-017-0069-z; Srivastava K, 2015, PHARMACOECONOMICS, V33, P467, DOI 10.1007/s40273-015-0252-4; Welte T, 2015, INT J CLIN PRACT, V69, P336, DOI 10.1111/ijcp.12522; Wheaton AG, 2015, J AGING HEALTH, V27, P480, DOI 10.1177/0898264314552419; Zajacova A, 2018, SOC SCI MED, V211, P1, DOI 10.1016/j.socscimed.2018.05.041; Zhang XY, 2014, AM J EPIDEMIOL, V179, P1025, DOI 10.1093/aje/kwu018	32	5	5	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2020	15	2							e0229404	10.1371/journal.pone.0229404	http://dx.doi.org/10.1371/journal.pone.0229404			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LQ8GQ	32106254	gold, Green Published			2022-12-26	WOS:000535237000029
J	Roig, E; Garza, LC; Alvarez-Maldonado, N; Maia, P; Costa, S; Roig, M; Espona, J				Roig, Elena; Garza, Luis Carlos; Alvarez-Maldonado, Natalia; Maia, Paulo; Costa, Santiago; Roig, Miguel; Espona, Jose			In vitro comparison of the accuracy of four intraoral scanners and three conventional impression methods for two neighboring implants	PLOS ONE			English	Article							3-DIMENSIONAL ACCURACY; ARCH IMPRESSIONS; TIME; EFFICIENCY; CROWNS; FIT	Purpose To determine whether the accuracy of two-implant model impressions taken with optical scanners was inferior to that of those taken with elastomeric materials. Materials and Methods Impressions of a resin reference model with two almost parallel implants were taken using three elastomeric impressions (closed tray technique, open tray nonsplinted technique and open tray splinted technique) and scanned with four optical scanners (CEREC Omnicam, 3M True Definition Scanner, 3Shape TRIOS3 and Carestream CS 3600). STL files of the different methods were superimposed and analyzed with control software (Geomagic Control X, 3D systems) to determine the mean deviation between scans. Results Compared to elastomeric impressions, optical impressions showed a significantly improved mean precision. TRIOS3 and CS3600 showed a significantly improved mean trueness compared to that of closed tray, CEREC Omnicam and TrueDefinition. All methods showed a certain degree of implant rotation over their axes, which was significantly higher in the closed tray and the open tray nonsplinted techniques. Conclusions Optical impressions, taken under these in vitro conditions, showed improved accuracy compared with that of elastomeric impressions.	[Roig, Elena; Garza, Luis Carlos; Alvarez-Maldonado, Natalia; Costa, Santiago; Roig, Miguel; Espona, Jose] Univ Int Catalunya, Dept Restorat Dent, Barcelona, Spain; [Maia, Paulo] Inst Super Ciencias Saude Egas Moniz, Caparica, Portugal	Universitat Internacional de Catalunya (UIC); Instituto Superior de Ciencias da Saude Egas Moniz	Espona, J (corresponding author), Univ Int Catalunya, Dept Restorat Dent, Barcelona, Spain.	joseespona@uic.es	Cayon, Miguel Roig/B-8071-2018	Cayon, Miguel Roig/0000-0002-4872-4118; Maia, Paulo/0000-0002-7127-8718				Ahlholm P, 2018, J PROSTHODONT, V27, P35, DOI 10.1111/jopr.12527; Al-Turki LEE, 2002, INT J PROSTHODONT, V15, P38; Alsharbaty MHM, 2019, J PROSTHODONT, V28, pE902, DOI 10.1111/jopr.12764; Amin Wala M, 2009, J Clin Med Res, V1, P81, DOI 10.4021/jocmr2009.04.1235; Baig MR, 2019, INT J PROSTHODONT, V32, P66, DOI 10.11607/ijp.6014; Baig MR, 2014, INT J ORAL MAX IMPL, V29, P869, DOI 10.11607/jomi.3233; Chang WG, 2012, INT J PROSTHODONT, V25, P44; Chia VA, 2017, INT J ORAL MAX IMPL, V32, P313, DOI 10.11607/jomi.5087; Ender A, 2015, QUINTESSENCE INT, V46, P9, DOI 10.3290/j.qi.a32244; Ender A, 2013, J PROSTHET DENT, V109, P121, DOI 10.1016/S0022-3913(13)60028-1; Fluegge T, 2017, J PROSTHODONT, V26, P34, DOI 10.1111/jopr.12362; Flugge TV, 2016, INT J PROSTHODONT, V29, P277, DOI 10.11607/ijp.4417; Gimenez-Gonzalez B, 2017, J PROSTHODONT, V26, P650, DOI 10.1111/jopr.12457; Goracci C, 2016, EUR J ORTHODONT, V38, P422, DOI 10.1093/ejo/cjv077; Gupta S, 2017, AIP CONF PROC, V1850, DOI 10.1063/1.4984573; Holst S, 2007, QUINTESSENCE INT, V38, P67; International Organization for Standardization, 1994, 57251 ISO; Izadi Alireza, 2018, J Contemp Dent Pract, V19, P974; Jansen VK, 1997, INT J ORAL MAX IMPL, V12, P527; JEMT T, 1991, International Journal of Oral and Maxillofacial Implants, V6, P270; Jemt T, 1996, J PROSTHET DENT, V75, P314, DOI 10.1016/S0022-3913(96)90491-6; Kapos T, 2014, INT J ORAL MAX IMPL, V29, P117, DOI 10.11607/jomi.2014suppl.g2.3; Kim JH, 2015, J PROSTHET DENT, V114, P185, DOI 10.1016/j.prosdent.2015.02.005; Kioleoglou Ioannis, 2018, J Clin Exp Dent, V10, pe252, DOI 10.4317/jced.54603; Klineberg I J, 1985, Swed Dent J Suppl, V28, P63; Malik J, 2018, INT J PROSTHODONT, V31, P107, DOI 10.11607/ijp.5643; Mangano FG, 2019, BMC ORAL HEALTH, V19, DOI 10.1186/s12903-019-0792-7; Marghalani A, 2018, J PROSTHET DENT, V119, P574, DOI 10.1016/j.prosdent.2017.07.002; Marti AM, 2017, EUR J DENT EDUC, V21, P200, DOI 10.1111/eje.12201; Matta RE, 2017, J PROSTHET DENT, V117, P507, DOI 10.1016/j.prosdent.2016.07.026; Menini M, 2018, CLIN ORAL INVEST, V22, P1253, DOI 10.1007/s00784-017-2217-9; Millington N D, 1995, Int J Prosthodont, V8, P511; Moreira AHJ, 2015, CLIN IMPLANT DENT R, V17, pE751, DOI 10.1111/cid.12310; Osman MS, 2019, INT J IMPLANT DENT, V5, DOI 10.1186/s40729-019-0159-5; Papaspyridakos P, 2014, INT J ORAL MAX IMPL, V29, P836, DOI 10.11607/jomi.3625; Patzelt SBM, 2014, J AM DENT ASSOC, V145, P542, DOI 10.14219/jada.2014.23; Roig E, 2019, J CLIN EXP DENT, V11, P6, DOI [10.4317/jced, DOI 10.4317/JCED]; Sahin S, 2001, Implant Dent, V10, P85; Schaefer O, 2012, J PROSTHET DENT, V108, P165, DOI 10.1016/S0022-3913(12)60141-3; Schepke U, 2015, J PROSTHET DENT, V114, P403, DOI 10.1016/j.prosdent.2015.04.003; Stimmelmayr M, 2012, CLIN ORAL INVEST, V16, P1137, DOI 10.1007/s00784-011-0622-z; Tan K. B. C., 1995, Annals Academy of Medicine Singapore, V24, P138; Tan MY, 2019, INT J ORAL MAX IMPL, V34, P366, DOI 10.11607/jomi.6855; Wismeijer D, 2014, CLIN ORAL IMPLAN RES, V25, P1113, DOI 10.1111/clr.12234; Yuzbasioglu E, 2014, BMC ORAL HEALTH, V14, DOI 10.1186/1472-6831-14-10; Zimmermann M, 2015, INT J COMPUT DENT, V18, P101	46	12	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2020	15	2							e0228266	10.1371/journal.pone.0228266	http://dx.doi.org/10.1371/journal.pone.0228266			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8GQ	32106275	Green Published, gold			2022-12-26	WOS:000535237000010
J	Li, XZ; Perotti, LE; Martinez, JA; Duarte-Vogel, SM; Ennis, DB; Wu, HH				Li, Xinzhou; Perotti, Luigi E.; Martinez, Jessica A.; Duarte-Vogel, Sandra M.; Ennis, Daniel B.; Wu, Holden H.			Real-time 3T MRI-guided cardiovascular catheterization in a porcine model using a glass-fiber epoxy-based guidewire	PLOS ONE			English	Article							RESONANCE; ADULTS	Purpose Real-time magnetic resonance imaging (MRI) is a promising alternative to X-ray fluoroscopy for guiding cardiovascular catheterization procedures. Major challenges, however, include the lack of guidewires that are compatible with the MRI environment, not susceptible to radiofrequency-induced heating, and reliably visualized. Preclinical evaluation of new guidewire designs has been conducted at 1.5T. Here we further evaluate the safety (device heating), device visualization, and procedural feasibility of 3T MRI-guided cardiovascular catheterization using a novel MRI-visible glass-fiber epoxy-based guidewire in phantoms and porcine models. Methods To evaluate device safety, guidewire tip heating (GTH) was measured in phantom experiments with different combinations of catheters and guidewires. In vivo cardiovascular catheterization procedures were performed in both healthy (N = 5) and infarcted (N = 5) porcine models under real-time 3T MRI guidance using a glass-fiber epoxy-based guidewire. The times for each procedural step were recorded separately. Guidewire visualization was assessed by measuring the dimensions of the guidewire-induced signal void and contrastto-noise ratio (CNR) between the guidewire tip signal void and the blood signal in real-time gradient-echo MRI (specific absorption rate [SAR] = 0.04 W/kg). Results In the phantom experiments, GTH did not exceed 0.35 degrees C when using the real-time gradientecho sequence (SAR = 0.04 W/kg), demonstrating the safety of the glass-fiber epoxy-based guidewire at 3T. The catheter was successfully placed in the left ventricle (LV) under real-time MRI for all five healthy subjects and three out of five infarcted subjects. Signal void dimensions and CNR values showed consistent visualization of the glass-fiber epoxy-based guidewire in real-time MRI. The average time (minutes:seconds) for the catheterization procedure in all subjects was 4:32, although the procedure time varied depending on the subject's specific anatomy (standard deviation = 4:41). Conclusions Real-time 3T MRI-guided cardiovascular catheterization using a new MRI-visible glass-fiber epoxy-based guidewire is feasible in terms of visualization and guidewire navigation, and safe in terms of radiofrequency-induced guidewire tip heating.	[Li, Xinzhou; Perotti, Luigi E.; Ennis, Daniel B.; Wu, Holden H.] Univ Calif Los Angeles, Dept Radiol Sci, Los Angeles, CA 90024 USA; [Li, Xinzhou; Ennis, Daniel B.; Wu, Holden H.] Univ Calif Los Angeles, Dept Bioengn, Los Angeles, CA 90095 USA; [Perotti, Luigi E.] Univ Cent Florida, Dept Mech & Aerosp Engn, Orlando, FL 32816 USA; [Martinez, Jessica A.; Ennis, Daniel B.] Stanford Univ, Dept Radiol, Stanford, CA 94305 USA; [Duarte-Vogel, Sandra M.] Univ Calif Los Angeles, Div Lab Anim Med, Los Angeles, CA USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; State University System of Florida; University of Central Florida; Stanford University; University of California System; University of California Los Angeles	Wu, HH (corresponding author), Univ Calif Los Angeles, Dept Radiol Sci, Los Angeles, CA 90024 USA.; Wu, HH (corresponding author), Univ Calif Los Angeles, Dept Bioengn, Los Angeles, CA 90095 USA.	HoldenWu@mednet.ucla.edu	Martinez, Jessica/ABC-3232-2021	Martinez, Jessica/0000-0002-3274-566X; Perotti, Luigi/0000-0002-9010-2144; Wu, Holden/0000-0002-2585-5916; Ennis, Daniel/0000-0001-7435-1311	NIH/NHLBI [K25-HL135408]; UCLA Department of Radiological Sciences	NIH/NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); UCLA Department of Radiological Sciences	This study was supported by NIH/NHLBI K25-HL135408 (LP) and the UCLA Department of Radiological Sciences (HW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aliotta E, 2017, MAGN RESON MED, V77, P717, DOI 10.1002/mrm.26166; [Anonymous], 2011, F21822011A ASTM INT; Bernstein MA, 2006, J MAGN RESON IMAGING, V24, P735, DOI 10.1002/jmri.20698; Buecker A, 2004, INVEST RADIOL, V39, P656, DOI 10.1097/00004424-200411000-00002; Campbell-Washburn AE, 2018, J CARDIOVASC MAGN R, V20, DOI 10.1186/s12968-018-0458-7; Campbell-Washburn AE, 2017, J MAGN RESON IMAGING, V46, P935, DOI 10.1002/jmri.25749; Campbell-Washburn AE, 2015, MAGN RESON IMAGING C, V23, P669, DOI 10.1016/j.mric.2015.05.006; Clogenson H, 2016, J IMAGING INTERVENTI, V2, P28; Grothoff M, 2014, RADIOLOGY, V271, P695, DOI 10.1148/radiol.13122671; Kuehne T, 2004, CIRCULATION, V110, P2010, DOI 10.1161/01.CIR.0000143138.02493.DD; Li XZ, 2020, IEEE T BIO-MED ENG, V67, P1727, DOI 10.1109/TBME.2019.2944803; Lichter J, 2019, EUROPACE, V21, P154, DOI 10.1093/europace/euy089; Lucano E, 2016, IEEE ENG MED BIO, P1256, DOI 10.1109/EMBC.2016.7590934; Massmann A, 2017, RADIOLOGY, V284, P541, DOI 10.1148/radiol.2017152742; Mattei E, 2006, Conf Proc IEEE Eng Med Biol Soc, V2006, P1889; Mekle R, 2006, J MAGN RESON IMAGING, V23, P145, DOI 10.1002/jmri.20486; Neizel M, 2010, INVEST RADIOL, V45, P502, DOI 10.1097/RLI.0b013e3181e45578; Nordbeck P, 2008, MAGN RESON MED, V60, P312, DOI 10.1002/mrm.21475; Perotti LE, 2017, INT J NUMER METH BIO, V33, DOI 10.1002/cnm.2866; Rajiah P, 2014, RADIOGRAPHICS, V34, P1612, DOI 10.1148/rg.346140048; Ratnayaka K, 2016, JACC-CARDIOVASC INTE, V9, P959, DOI 10.1016/j.jcin.2016.01.032; Ratnayaka K, 2013, EUR HEART J, V34, P380, DOI 10.1093/eurheartj/ehs189; Razavi R, 2003, LANCET, V362, P1877, DOI 10.1016/S0140-6736(03)14956-2; Rogers T, 2017, J CARDIOVASC MAGN R, V19, DOI 10.1186/s12968-017-0366-2; SELDINGER SI, 1953, ACTA RADIOL, V39, P368, DOI 10.3109/00016925309136722; Whiting N, 2015, SCI REP-UK, V5, DOI 10.1038/srep12842; Winkelmann S, 2007, IEEE T MED IMAGING, V26, P68, DOI 10.1109/TMI.2006.885337; Wormleighton J, 2015, J CARDIOVASC MAGN R, V17, pT10, DOI [10.1186/1532-429X-17-S1-T10, DOI 10.1186/1532-429X-17-S1-T10]; Yildirim KD, 2019, J CARDIOVASC MAGN R, V21, DOI 10.1186/s12968-019-0526-7; Zampi JD, 2018, TRANSL PEDIATR, V7, P104, DOI 10.21037/tp.2017.12.02; Zhong XD, 2010, MAGN RESON MED, V64, P1089, DOI 10.1002/mrm.22503	31	4	4	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2020	15	2							e0229711	10.1371/journal.pone.0229711	http://dx.doi.org/10.1371/journal.pone.0229711			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8FM	32102092	Green Published, gold, Green Submitted			2022-12-26	WOS:000535233700049
J	Wickersham, RH; Zaval, L; Pachana, NA; Smyer, MA				Wickersham, Robert H.; Zaval, Lisa; Pachana, Nancy A.; Smyer, Michael A.			The impact of place and legacy framing on climate action: A lifespan approach	PLOS ONE			English	Article							PUBLIC ENGAGEMENT; ATTACHMENT; FUTURE; BENEFITS; HEALTH; AGE	Despite several decades of research on more effectively communicating climate change to the general public, there is only limited knowledge about how older adults engage with an issue that will shape and define future generations. We focus on two key factors that may motivate younger and older adults to engage in climate change action, legacy concern and place attachment, and assess whether older adults differ in any appreciable way from the general population in this domain. We randomly exposed participants of different ages to either a Legacy, Place, or control writing induction task before they completed various self-report measures. Both induction conditions were associated with significantly greater pro-environmental behavioral intentions and donations for all age groups when compared to the control condition. Legacy motivation and biophilia were used as manipulation checks and found to partially mediate these effects. Findings suggest that legacy and place message framing may be useful in prompting adults of all ages to take action to help combat climate change.	[Wickersham, Robert H.] Univ Colorado, Dept Psychol, Colorado Springs, CO 80933 USA; [Zaval, Lisa] Columbia Univ, Dept Psychol, New York, NY 10027 USA; [Pachana, Nancy A.] Univ Queensland, Sch Psychol, Brisbane, Qld, Australia; [Smyer, Michael A.] Bucknell Univ, Dept Psychol, Lewisburg, PA 17837 USA	University of Colorado System; University of Colorado at Colorado Springs; Columbia University; University of Queensland; Bucknell University	Wickersham, RH (corresponding author), Univ Colorado, Dept Psychol, Colorado Springs, CO 80933 USA.	rwickers@uccs.edu	Pachana, Nancy A./C-6807-2016; Pachana, Nancy A./HCI-4798-2022; Pachana, Nancy A./AAB-9235-2022	Pachana, Nancy A./0000-0002-8927-4205; Wickersham, Robert/0000-0001-6266-2905				BARON RM, 1986, J PERS SOC PSYCHOL, V51, P1173, DOI 10.1037/0022-3514.51.6.1173; Burholt V, 2006, ENVIRON PLANN A, V38, P1095, DOI 10.1068/a3767; Capaldi CA, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00976; Capraro V, 2018, INCREASING ALTRUISTI; Ceballos G, 2017, P NATL ACAD SCI USA, V114, pE6089, DOI 10.1073/pnas.1704949114; Cohen G.D., 2005, MATURE MIND POSITIVE; Cook J, 2016, ENVIRON RES LETT, V11, DOI 10.1088/1748-9326/11/4/048002; Deller J, 2009, GENEVA PAP R I-ISS P, V34, P137, DOI 10.1057/gpp.2008.44; Devine-Wright P, 2013, GLOBAL ENVIRON CHANG, V23, P61, DOI 10.1016/j.gloenvcha.2012.08.003; Devine-Wright P, 2009, J COMMUNITY APPL SOC, V19, P426, DOI 10.1002/casp.1004; Ersner-Hershfield H, 2009, JUDGM DECIS MAK, V4, P280; Gifford R, 2011, AM PSYCHOL, V66, P290, DOI 10.1037/a0023566; Gilleard C, 2007, RES AGING, V29, P590, DOI 10.1177/0164027507305730; GREENBERG J, 1994, J PERS SOC PSYCHOL, V67, P627, DOI 10.1037/0022-3514.67.4.627; Groulx M, 2014, LANDSCAPE URBAN PLAN, V132, P136, DOI 10.1016/j.landurbplan.2014.09.002; Hauser DJ, 2016, BEHAV RES METHODS, V48, P400, DOI 10.3758/s13428-015-0578-z; Hayes AF, INTRO MEDIATION MODE; Hudson RB, 2018, J AGING SOC POLICY, V30, P357, DOI 10.1080/08959420.2018.1462676; Jones C, 2017, RISK ANAL, V37, P331, DOI 10.1111/risa.12601; Kellert S.R., 1993, BIOPHILIA HYPOTHESIS, P42; Kerr J, 2012, INT J ENV RES PUB HE, V9, P4615, DOI 10.3390/ijerph9124615; Lang FR, 2002, PSYCHOL AGING, V17, P125, DOI 10.1037//0882-7974.17.1.125; Masson-Delmotte V., 2018, IPCC 2018 GLOBAL WAR; Miceli R, 2008, J ENVIRON PSYCHOL, V28, P164, DOI 10.1016/j.jenvp.2007.10.006; Mostafa MM, 2016, SOC INDIC RES, V128, P1273, DOI 10.1007/s11205-015-1079-2; Musselwhite C, 2010, QUAL AGEING OLDER AD, V11, P25, DOI 10.5042/qiaoa.2010.0153; National Academies of Science Panel on Informing Effective Decision and Actions Related to Climate Change Board on Atmospheric Sciences and Climate D on E and LS, 2011, INF EFF RESP CLIM CH; Perkins HE, 2010, J ENVIRON PSYCHOL, V30, P455, DOI 10.1016/j.jenvp.2010.05.004; Roser-Renouf C., 2014, GLOBAL WARMINGS 6 AM; Rubinstein R.L., 1992, PLACE ATTACHMENT, P139, DOI DOI 10.1007/978-1-4684-8753-4_7; Scannell L, 2017, J ENVIRON PSYCHOL, V51, P256, DOI 10.1016/j.jenvp.2017.04.001; Schneider CR, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0188781; Scott TL, 2015, AGEING SOC, V35, P2176, DOI 10.1017/S0144686X14000865; Sibley, 2011, INT J HISPANIC PSYCH, V4, P21; Smyer M.A., 2017, PUBLIC POLICY AGING, V27, P4, DOI [10.1093/ppar/prw028, DOI 10.1093/PPAR/PRW028]; Spence A, 2010, GLOBAL ENVIRON CHANG, V20, P656, DOI 10.1016/j.gloenvcha.2010.07.002; Steinberg L, 2009, CHILD DEV, V80, P28, DOI 10.1111/j.1467-8624.2008.01244.x; United Nations Department of Economic and Social Affairs, 2015, WORLD POP PROSP 2015; van der Linden S, 2015, PERSPECT PSYCHOL SCI, V10, P758, DOI 10.1177/1745691615598516; Vose R.S., 2017, CLIMATE SCI SPECIAL, VI, P185, DOI [10.7930/J0N29V45, DOI 10.7930/J0N29V45]; Watts N, 2018, LANCET, V391, P581, DOI 10.1016/S0140-6736(17)32464-9; Zaval L, 2016, NAT CLIM CHANGE, V6, P1061, DOI 10.1038/nclimate3164; Zaval L, 2015, PSYCHOL SCI, V26, P231, DOI 10.1177/0956797614561266	43	2	2	3	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2020	15	2							e0228963	10.1371/journal.pone.0228963	http://dx.doi.org/10.1371/journal.pone.0228963			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LQ8EV	32097411	Green Published, gold			2022-12-26	WOS:000535232000013
J	Dai, GZ; He, W; Xu, L; Pazo, EE; Lin, TZ; Liu, SS; Zhang, CG				Dai, Guangzheng; He, Wei; Xu, Ling; Pazo, Eric E.; Lin, Tiezhu; Liu, Shasha; Zhang, Chenguang			Exploring the effect of hypertension on retinal microvasculature using deep learning on East Asian population	PLOS ONE			English	Article							CARDIOVASCULAR RISK-FACTORS; ELEVATED BLOOD-PRESSURE; VESSEL DIAMETERS; DIABETIC-RETINOPATHY; ATHEROSCLEROSIS RISK; ARTERIOLAR DIAMETER; VASCULAR CALIBER; MICROCIRCULATION; AGE; ABNORMALITIES	Hypertension is the leading risk factor of cardiovascular disease and has profound effects on both the structure and function of the microvasculature. Abnormalities of the retinal vasculature may reflect the degree of microvascular damage due to hypertension, and these changes can be detected with fundus photographs. This study aimed to use deep learning technique that can detect subclinical features appearing below the threshold of a human observer to explore the effect of hypertension on morphological features of retinal microvasculature. We collected 2012 retinal photographs which included 1007 from patients with a diagnosis of hypertension and 1005 from normotensive control. By method of vessel segmentation, we removed interference information other than retinal vasculature and contained only morphological information about blood vessels. Using these segmented images, we trained a small convolutional neural networks (CNN) classification model and used a deep learning technique called Gradient-weighted Class Activation Mapping (Grad-CAM) to generate heat maps for the class "hypertension". Our model achieved an accuracy of 60.94%, a specificity of 51.54%, a precision of 59.27%, and a recall of 70.48%. The AUC was 0.6506. In the heat maps for the class "hypertension", red patchy areas were mainly distributed on or around arterial/venous bifurcations. This indicated that the model has identified these regions as being the most important for predicting hypertension. Our study suggested that the effect of hypertension on retinal microvascular morphology mainly occurred at branching of vessels. The change of the branching pattern of retinal vessels was probably the most significant in response to elevated blood pressure.	[Dai, Guangzheng; He, Wei; Zhang, Chenguang] Dalian Med Univ, Clin Coll 2, Dalian, Liaoning, Peoples R China; [Dai, Guangzheng; He, Wei; Xu, Ling; Pazo, Eric E.; Lin, Tiezhu; Liu, Shasha; Zhang, Chenguang] He Eye Specialists Hosp, Clin Res Ctr, Shenyang, Liaoning, Peoples R China; [He, Wei; Xu, Ling; Pazo, Eric E.; Lin, Tiezhu] He Univ, Clin Coll, Shenyang, Liaoning, Peoples R China	Dalian Medical University	He, W (corresponding author), Dalian Med Univ, Clin Coll 2, Dalian, Liaoning, Peoples R China.; He, W (corresponding author), He Eye Specialists Hosp, Clin Res Ctr, Shenyang, Liaoning, Peoples R China.; He, W (corresponding author), He Univ, Clin Coll, Shenyang, Liaoning, Peoples R China.	hsyk2017@163.com	lin, Tiezhu/AAY-1971-2020; Pazo, Emmanuel Eric/AAZ-1050-2020	Pazo, Emmanuel Eric/0000-0002-0848-827X				Abbas Q, 2017, MED BIOL ENG COMPUT, V55, P1959, DOI 10.1007/s11517-017-1638-6; Abramoff MD, 2016, INVEST OPHTH VIS SCI, V57, P5200, DOI 10.1167/iovs.16-19964; Antiga L., 2016, RETINA BLOOD VESSEL; Burlina PM, 2017, JAMA OPHTHALMOL, V135, P1170, DOI 10.1001/jamaophthalmol.2017.3782; Cheung CY, 2012, AM J OPHTHALMOL, V154, P663, DOI 10.1016/j.ajo.2012.04.016; Cheung CY, 2011, J HYPERTENS, V29, P1380, DOI 10.1097/HJH.0b013e328347266c; Cheung CYL, 2011, OPHTHALMOLOGY, V118, P812, DOI 10.1016/j.ophtha.2010.08.045; Cuadros Jorge, 2009, J Diabetes Sci Technol, V3, P509; Feihl F, 2009, CURR HYPERTENS REP, V11, P182, DOI 10.1007/s11906-009-0033-6; Gargeya R, 2017, OPHTHALMOLOGY, V124, P962, DOI 10.1016/j.ophtha.2017.02.008; Gopinath B, 2013, J HUM HYPERTENS, V27, P523, DOI 10.1038/jhh.2013.15; Gopinath B, 2010, J HYPERTENS, V28, P1406, DOI 10.1097/HJH.0b013e3283395223; Gulshan V, 2016, JAMA-J AM MED ASSOC, V316, P2402, DOI 10.1001/jama.2016.17216; Hubbard LD, 1999, OPHTHALMOLOGY, V106, P2269, DOI 10.1016/S0161-6420(99)90525-0; Ikram MK, 2006, HYPERTENSION, V47, P189, DOI 10.1161/01.HYP.0000199104.61945.33; Kawasaki Ryo, 2009, J Hypertens, V27, P2386, DOI 10.1097/HJH.0b013e3283310f7e; KLEIN R, 1994, ARCH OPHTHALMOL-CHIC, V112, P92, DOI 10.1001/archopht.1994.01090130102026; Kurniawan ED, 2012, INVEST OPHTH VIS SCI, V53, P470, DOI 10.1167/iovs.11-8835; LeCun Y, 2015, NATURE, V521, P436, DOI 10.1038/nature14539; Leung H, 2004, J HYPERTENS, V22, P1543, DOI 10.1097/01.hjh.0000125455.28861.3f; Leung H, 2003, INVEST OPHTH VIS SCI, V44, P2900, DOI 10.1167/iovs.02-1114; Li LJ, 2017, BMC OPHTHALMOL, V17, DOI 10.1186/s12886-017-0449-8; Li LJ, 2011, OPHTHALMOLOGY, V118, P1459, DOI 10.1016/j.ophtha.2010.12.007; Liew G, 2008, OPHTHALMOLOGY, V115, P1951, DOI 10.1016/j.ophtha.2008.05.029; Liew G, 2008, ARCH OPHTHALMOL-CHIC, V126, P1404, DOI 10.1001/archopht.126.10.1404; Mitchell P, 2007, HYPERTENSION, V49, P1156, DOI 10.1161/HYPERTENSIONAHA.106.085910; PIZER SM, 1987, COMPUT VISION GRAPH, V39, P355, DOI 10.1016/S0734-189X(87)80186-X; Poplin R, 2018, NAT BIOMED ENG, V2, P158, DOI 10.1038/s41551-018-0195-0; Ronneberger O, 2015, LECT NOTES COMPUT SC, V9351, P234, DOI 10.1007/978-3-319-24574-4_28; Sasongko MB, 2010, DIABETES CARE, V33, P1331, DOI 10.2337/dc10-0055; Schiffrin EL, 2004, AM J HYPERTENS, V17, P1192, DOI 10.1016/j.amjhyper.2004.05.023; Schiffrin EL, 2000, CIRCULATION, V101, P1653; Selvaraju RR, 2020, INT J COMPUT VISION, V128, P336, DOI 10.1007/s11263-019-01228-7; Sharrett AR, 1999, AM J EPIDEMIOL, V150, P263; Siebert A., DIFFERENTIAL INVARIA; Smith W, 2004, HYPERTENSION, V44, P442, DOI 10.1161/01.HYP.0000140772.40322.ec; Sng CCA, 2013, J HYPERTENS, V31, P2036, DOI 10.1097/HJH.0b013e328362c201; Staal J, 2004, IEEE T MED IMAGING, V23, P501, DOI 10.1109/TMI.2004.825627; Strain WD, 2012, MICROCIRCULATION, V19, P37, DOI 10.1111/j.1549-8719.2011.00140.x; Struijker-Boudier HAJ, 2007, EUR HEART J, V28, P2834, DOI 10.1093/eurheartj/ehm448; Sudlow C, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001779; Sun C, 2008, INVEST OPHTH VIS SCI, V49, P1784, DOI 10.1167/iovs.07-1450; Takahashi H, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179790; Tanabe Y, 2010, MICROCIRCULATION, V17, P94, DOI 10.1111/j.1549-8719.2009.00006.x; Voets M, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0217541; Wang JJ, 2008, AM J EPIDEMIOL, V168, P80, DOI 10.1093/aje/kwn100; Wang JJ, 2003, HYPERTENSION, V42, P534, DOI 10.1161/01.HYP.0000090122.38230.41; Wang ZW, 2018, CIRCULATION, V137, P2344, DOI 10.1161/CIRCULATIONAHA.117.032380; Wong TY, 2004, BMJ-BRIT MED J, V329, P79, DOI 10.1136/bmj.38124.682523.55; Wong TY, 2004, ANN INTERN MED, V140, P248, DOI 10.7326/0003-4819-140-4-200402170-00006; Wong TY, 2003, INVEST OPHTH VIS SCI, V44, P4644, DOI 10.1167/iovs.03-0079; Wong TY, 2002, BRIT J OPHTHALMOL, V86, P1007, DOI 10.1136/bjo.86.9.1007; World Health Organization, TOP 10 CAUS DEATH 20; Yu T, 1998, ARCH OPHTHALMOL-CHIC, V116, P83, DOI 10.1001/archopht.116.1.83; ZAMIR M, 1979, J GEN PHYSIOL, V74, P537, DOI 10.1085/jgp.74.4.537; ZAMIR M, 1976, J THEOR BIOL, V62, P227, DOI 10.1016/0022-5193(76)90058-8	56	9	9	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2020	15	3							e0230111	10.1371/journal.pone.0230111	http://dx.doi.org/10.1371/journal.pone.0230111			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8RK	32134976	gold, Green Published			2022-12-26	WOS:000535265600068
J	Araujo, LS; da Silva, MV; da Silva, CA; Borges, MD; Palhares, HMD; Rocha, LP; Correa, RRM; Rodrigues, V; dos Reis, MA; Machado, JR				Araujo, Liliane Silvano; da Silva, Marcos Vinicius; da Silva, Crislaine Aparecida; Borges, Maria de Fatima; da Cunha Palhares, Heloisa Marcelina; Rocha, Laura Penna; Miranda Correa, Rosana Rosa; Rodrigues Junior, Virmondes; dos Reis, Marlene Antonia; Machado, Juliana Reis			Analysis of serum inflammatory mediators in type 2 diabetic patients and their influence on renal function	PLOS ONE			English	Article							NECROSIS-FACTOR RECEPTOR; ELEVATED RESISTIN LEVELS; CHRONIC KIDNEY-DISEASE; NF-KAPPA-B; PROINFLAMMATORY CYTOKINES; TNF-ALPHA; CHEMOTACTIC CYTOKINES; OXIDATIVE STRESS; GENE-EXPRESSION; INNATE IMMUNITY	Aim To evaluate the serum concentrations of inflammatory mediators in patients with type 2 diabetes mellitus (T2DM) with or without renal alteration (RA) function. Methods Serum samples from 76 patients with T2DM and 24 healthy individuals were selected. Patients with T2DM were divided into two groups according to eGFR (> or < 60mL/min/1.73m(2)). Cytokines, chemokines and adipokines levels were evaluated using the Multiplex immunoassay and ELISA. Results TNFR1 and leptin were higher in the T2DM group with RA than in the T2DM group without RA and control group. All patients with T2DM showed increased resistin, IL-8, and MIP-1 alpha compared to the control group. Adiponectin were higher and IL-4 decreased in the T2DM group with RA compared to the control group. eGFR positively correlated with IL-4 and negatively with TNFR1, TNFR2, and leptin in patients with T2DM. In the T2DM group with RA, eGFR was negatively correlated with TNFR1 and resistin. TNFR1 was positively correlated with resistin and leptin, as well as resistin with IL-8 and leptin. Conclusion Increased levels of TNFR1, adipokines, chemokines and decrease of IL-4 play important role in the inflammatory process developed in T2DM and decreased renal function. We also suggest that TNFR1 is a strong predictor of renal dysfunction in patients with T2DM.	[Araujo, Liliane Silvano; da Silva, Crislaine Aparecida; Rocha, Laura Penna; Miranda Correa, Rosana Rosa; dos Reis, Marlene Antonia; Machado, Juliana Reis] Univ Fed Triangulo Mineiro, Inst Biol & Nat Sci, Discipline Gen Pathol, Uberaba, MG, Brazil; [da Silva, Marcos Vinicius; Rodrigues Junior, Virmondes] Univ Fed Triangulo Mineiro, Dept Microbiol Immunol & Parasitol, Inst Biol & Nat Sci, Uberaba, MG, Brazil; [Borges, Maria de Fatima; da Cunha Palhares, Heloisa Marcelina] Univ Fed Triangulo Mineiro, Hlth Sci Inst, Discipline Endocrinol & Metab, Uberaba, MG, Brazil	Universidade Federal do Triangulo Mineiro; Universidade Federal do Triangulo Mineiro; Universidade Federal do Triangulo Mineiro	Machado, JR (corresponding author), Univ Fed Triangulo Mineiro, Inst Biol & Nat Sci, Discipline Gen Pathol, Uberaba, MG, Brazil.	juliana.patologiageral@gmail.com	Silva, Marcos Vinicius/AAY-1986-2020; Correa, Rosana/ABD-8210-2020; Machado, Juliana/AAY-1978-2020	Silva, Marcos Vinicius/0000-0002-2966-7621; Machado, Juliana/0000-0002-8673-7788	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG); Fundacao de Ensino e Pesquisa de Uberaba (FUNEPU)	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); Fundacao de Ensino e Pesquisa de Uberaba (FUNEPU)	The authors appreciate the financial support of Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG), and Fundacao de Ensino e Pesquisa de Uberaba (FUNEPU).	Adela R, 2019, J TRANSL MED, V17, DOI 10.1186/s12967-018-1755-5; Andrade-Oliveira V, 2015, J DIABETES RES, V2015, DOI 10.1155/2015/681612; Araujo LS, 2016, J DIABETES MELLITUS, V6, P230, DOI [10.4236/jdm.2016.64025, DOI 10.4236/JDM.2016.64025]; Asterholm IW, 2014, DIABETOLOGIA, V57, P1209, DOI 10.1007/s00125-014-3210-3; Axelsson J, 2006, KIDNEY INT, V69, P596, DOI 10.1038/sj.ki.5000089; BAGGIOLINI M, 1994, ADV IMMUNOL, V55, P97; Beige J, 2009, EXPERT OPIN THER TAR, V13, P163, DOI [10.1517/14728220802658481 , 10.1517/14728220802658481]; Bokarewa M, 2005, J IMMUNOL, V174, P5789, DOI 10.4049/jimmunol.174.9.5789; Brown MA, 2017, CRIT REV IMMUNOL, V37, P181, DOI 10.1615/CritRevImmunol.v37.i2-6.30; Calabro P, 2005, J AM COLL CARDIOL, V46, P1112, DOI 10.1016/j.jacc.2005.06.017; Cao L, 2019, J DIABETES RES, V2019, DOI 10.1155/2019/5359635; Cawthorn WP, 2008, FEBS LETT, V582, P117, DOI 10.1016/j.febslet.2007.11.051; Cebeci E, 2019, EXP CLIN ENDOCR DIAB, V127, P189, DOI 10.1055/s-0043-121262; Chawla Aastha, 2016, Indian J Endocrinol Metab, V20, P546, DOI 10.4103/2230-8210.183480; Chen CY, 2010, AM J PHYSIOL-HEART C, V299, pH193, DOI 10.1152/ajpheart.00431.2009; Chen FQ, 2013, J DIABETES RES, V2013, DOI 10.1155/2013/138969; Cherney DZI, 2010, DIABETES CARE, V33, P2068, DOI 10.2337/dc10-0767; Cho NH, 2018, DIABETES RES CLIN PR, V138, P271, DOI 10.1016/j.diabres.2018.02.023; Christou GA, 2014, J ENDOCRINOL, V221, pR49, DOI 10.1530/JOE-13-0578; Crook M, 2004, DIABETIC MED, V21, P203, DOI 10.1046/j.1464-5491.2003.01030.x; Doody A, 2018, J DIABETES COMPLICAT, V32, P95, DOI 10.1016/j.jdiacomp.2017.09.007; Fasshauer M, 2001, BIOCHEM BIOPH RES CO, V288, P1027, DOI 10.1006/bbrc.2001.5874; Feng YM, 2018, NEPHROL DIAL TRANSPL, V33, P426, DOI 10.1093/ndt/gfx256; Festa A, 2000, CIRCULATION, V102, P42, DOI 10.1161/01.CIR.102.1.42; Fioretto P, 2008, DIABETOLOGIA, V51, P1347, DOI 10.1007/s00125-008-1051-7; Fruehwald-Schultes B, 1999, METABOLISM, V48, P1290, DOI 10.1016/S0026-0495(99)90270-6; Galkina E, 2006, J AM SOC NEPHROL, V17, P368, DOI 10.1681/ASN.2005080859; Garcia C, 2010, DIABETES METAB, V36, P327, DOI 10.1016/j.diabet.2010.07.001; GarciaZepeda EA, 1996, NAT MED, V2, P449, DOI 10.1038/nm0496-449; Gerard C, 2001, NAT IMMUNOL, V2, P108, DOI 10.1038/84209; Gregg EW, 2014, NEW ENGL J MED, V370, P1514, DOI 10.1056/NEJMoa1310799; Guest CB, 2008, FRONT BIOSCI-LANDMRK, V13, P5187, DOI 10.2741/3074; Gupta S, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07230-8; Hanai K, 2011, DIABETES CARE, V34, P2557, DOI 10.2337/dc11-1039; Hotta K, 2000, ARTERIOSCL THROM VAS, V20, P1595, DOI 10.1161/01.ATV.20.6.1595; Johnson DR, 2005, P NATL ACAD SCI USA, V102, P15184, DOI 10.1073/pnas.0507191102; Kadowaki T, 2005, ENDOCR REV, V26, P439, DOI 10.1210/er.2005-0005; Kamei N, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-33590-w; Karmiris K, 2006, INFLAMM BOWEL DIS, V12, P100, DOI 10.1097/01.MIB.0000200345.38837.46; Kaser S, 2003, BIOCHEM BIOPH RES CO, V309, P286, DOI 10.1016/j.bbrc.2003.07.003; Katsiki N, 2018, ACTA PHARMACOL SIN, V39, P1176, DOI 10.1038/aps.2018.40; Kawamura R, 2010, NEPHROL DIAL TRANSPL, V25, P3236, DOI 10.1093/ndt/gfq155; Konenkov VI, 2015, TERAPEVT ARKH, V87, P45, DOI 10.17116/terarkh201587645-49; Lehrke M, 2004, PLOS MED, V1, P161, DOI 10.1371/journal.pmed.0010045; Levey AS, 2011, KIDNEY INT, V80, P17, DOI 10.1038/ki.2010.483; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Lim AKH, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/146154; Lim CC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122009; Liu G, 2016, ENDOCRINE, V52, P541, DOI 10.1007/s12020-015-0807-3; Liu JF, 2010, J IMMUNOASS IMMUNOCH, V31, P279, DOI 10.1080/15321819.2010.524860; Luster AD, 1998, NEW ENGL J MED, V338, P436, DOI 10.1056/NEJM199802123380706; Mackay CR, 2001, NAT IMMUNOL, V2, P95, DOI 10.1038/84298; Manna SK, 1998, J BIOL CHEM, V273, P33333, DOI 10.1074/jbc.273.50.33333; Marouga A, 2013, CLIN LAB, V59, P1121, DOI 10.7754/Clin.Lab.2012.121112; Matsuda M, 2014, REV ENDOCR METAB DIS, V15, P1, DOI 10.1007/s11154-013-9271-7; Menzaghi C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038414; Mills KT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076902; Min DQ, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/649083; MIOSSEC P, 1993, REV RHUM, V60, P119; Mokhtar Entsar R, 2018, Egypt J Immunol, V25, P57; Moreno LO, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140631; Moreno LO, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119529; Nagaev I, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000031; Navarro JF, 2003, AM J KIDNEY DIS, V42, P53, DOI 10.1016/S0272-6386(03)00408-6; Navarro JF, 2006, CYTOKINE GROWTH F R, V17, P441, DOI 10.1016/j.cytogfr.2006.09.011; Navarro JF, 2006, THESCIENTIFICWORLDJO, V6, P908, DOI 10.1100/tsw.2006.179; Niemir ZI, 2004, AM J KIDNEY DIS, V43, P983, DOI 10.1053/j.ajkd.2004.02.011; Niewczas MA, 2012, J AM SOC NEPHROL, V23, P507, DOI 10.1681/ASN.2011060627; Nowak N, 2018, KIDNEY INT, V93, P1198, DOI 10.1016/j.kint.2017.11.024; O'Connor JC, 2005, J IMMUNOL, V174, P4991, DOI 10.4049/jimmunol.174.8.4991; Otero M, 2006, RHEUMATOLOGY, V45, P944, DOI 10.1093/rheumatology/kel157; Papaetis GS, 2015, ARCH MED SCI, V11, P463, DOI 10.5114/aoms.2015.52350; Park HK, 2011, DIABETES, V60, P775, DOI 10.2337/db10-1416; Pedone C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117828; Pena MJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120995; Perlman AS, 2015, ANN CLIN LAB SCI, V45, P256; Pickup JC, 2004, DIABETES CARE, V27, P813, DOI 10.2337/diacare.27.3.813; Pousset F, 2001, J NEUROCHEM, V79, P726, DOI 10.1046/j.1471-4159.2001.00569.x; Ramos LF, 2009, J RENAL NUTR, V19, P197, DOI 10.1053/j.jrn.2009.01.028; Reilly MP, 2005, CIRCULATION, V111, P932, DOI 10.1161/01.CIR.0000155620.10387.43; Roy MS, 2015, KIDNEY INT, V87, P427, DOI 10.1038/ki.2014.212; Ruscitti P, 2018, J IMMUNOL RES, V2018, DOI 10.1155/2018/8410182; Salcedo R, 2001, J IMMUNOL, V166, P7571, DOI 10.4049/jimmunol.166.12.7571; Santos FMM, 2017, LUPUS, V26, P10, DOI 10.1177/0961203316646463; Senolt L, 2007, ANN RHEUM DIS, V66, P458, DOI 10.1136/ard.2006.054734; Shankar Anoop, 2012, J Environ Public Health, V2012, P481641, DOI 10.1155/2012/481641; Sharma K, 2014, KIDNEY INT SUPPL, V4, P113, DOI 10.1038/kisup.2014.21; Shen YY, 2007, NEPHROL DIAL TRANSPL, V22, P171, DOI 10.1093/ndt/gfl552; Silswal N, 2005, BIOCHEM BIOPH RES CO, V334, P1092, DOI 10.1016/j.bbrc.2005.06.202; Soetikno V, 2011, NUTR METAB, V8, DOI 10.1186/1743-7075-8-35; Spoto B, 2013, NEPHROL DIAL TRANSPL, V28, P181, DOI 10.1093/ndt/gft365; Steppan CM, 2001, NATURE, V409, P307, DOI 10.1038/35053000; Tashiro K, 2002, J CLIN LAB ANAL, V16, P1, DOI 10.1002/jcla.2057; Turer AT, 2012, DIABETOLOGIA, V55, P2319, DOI 10.1007/s00125-012-2598-x; VANNIER E, 1992, P NATL ACAD SCI USA, V89, P4076, DOI 10.1073/pnas.89.9.4076; Vasudevan AR, 2006, J CLIN ENDOCR METAB, V91, P256, DOI 10.1210/jc.2005-1280; Verhave JC, 2013, DIABETES RES CLIN PR, V101, P333, DOI 10.1016/j.diabres.2013.07.006; Vianna HR, 2013, PEDIATR NEPHROL, V28, P463, DOI 10.1007/s00467-012-2363-x; Wada T, 1999, NEPHROL DIAL TRANSPL, V14, P76, DOI 10.1093/ndt/14.1.76; Williams Michael D, 2007, Curr Diab Rep, V7, P242, DOI 10.1007/s11892-007-0038-y; Wolkow PP, 2008, J AM SOC NEPHROL, V19, P789, DOI 10.1681/ASN.2007050556; Wu CC, 2010, CLIN CHIM ACTA, V411, P700, DOI 10.1016/j.cca.2010.01.036; Yenicesu M, 2005, CLIN NEPHROL, V64, P12; Zhang CP, 2014, HUM IMMUNOL, V75, P289, DOI 10.1016/j.humimm.2014.02.007; Zoccali C, 2002, J AM SOC NEPHROL, V13, P134, DOI 10.1681/ASN.V131134; ZWAHLEN R, 1993, INT REV EXP PATHOL, V34, P27	106	6	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2020	15	3							e0229765	10.1371/journal.pone.0229765	http://dx.doi.org/10.1371/journal.pone.0229765			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8QU	32130282	Green Published, gold			2022-12-26	WOS:000535264000051
J	Bezamat, M; Cunha, EJ; Modesto, AM; Vieira, AR; Taboas, JM				Bezamat, Mariana; Cunha, Emanuelle J.; Modesto, Adriana M.; Vieira, Alexandre R.; Taboas, Juan M.			Aquaporin locus (12q13.12) might contribute to susceptibility of temporomandibular joint disorder associated with periodontitis	PLOS ONE			English	Article							POPULATION STRATIFICATION; ARTICULAR CHONDROCYTES; WATER CHANNELS; EXPRESSION; LINKAGE; AQP1; SYNOVIOCYTES; ARTHRITIS; DISEASE; RISK	Aquaporins (AQPs) are membrane channels that provide for transport of water and other small molecules across the lipid bilayer of cells. Their function is essential for physiologic processes such as cell volume regulation, chondrocyte hypertrophy during appendicular skeletal growth, water reabsorption in the kidney tubules, and water excretion by the salivary glands. The ten AQP isoforms show tissue specificity and are involved in different pathologies and inflammatory diseases. This study addresses the hypothesis that arthritis, periodontitis, and temporomandibular joint disorders (TMDs) can be influenced by variation in the AQP genes at 12q13.12 locus. Salivary samples of 688 individuals were obtained from the Dental Registry and DNA Repository project at the University of Pittsburgh. Ten polymorphisms in four AQP genes (AQP1, 2, 5, and 6) were genotyped and correlated to disease status as reported by patients. Associations were found between the single nucleotide polymorphism (SNP) rs467323 in AQP2 and TMD in both genotypic (p = 0.03) and recessive (p = 0.02) models, and between rs1996315 in AQP6 and periodontitis (p = 0.05). Combined analysis of TMD and periodontitis showed an association with rs3741559 in AQP2 (p = 0.02). When conducting haplotype analysis of rs467323 and rs10875989 in AQP2, the haplotype CT showed an association with the TMD phenotype (p = 0.007). Our results suggest that the aquaporin locus at 12q13.12 may contribute to the pathogenesis of inflammatory conditions such as periodontitis and TMD. Thus, oral and skeletal health are correlated and potential susceptibility screening strategies may be developed.	[Bezamat, Mariana; Cunha, Emanuelle J.; Vieira, Alexandre R.; Taboas, Juan M.] Univ Pittsburgh, Dept Oral Biol, Pittsburgh, PA 15260 USA; [Cunha, Emanuelle J.] Pontifice Univ Catolica Parana, Grad Program Dent, Curitiba, Parana, Brazil; [Modesto, Adriana M.; Vieira, Alexandre R.] Univ Pittsburgh, Dept Pediat Dent, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Taboas, JM (corresponding author), Univ Pittsburgh, Dept Oral Biol, Pittsburgh, PA 15260 USA.	jmt106@pitt.edu		Taboas, Juan/0000-0003-0523-3359; Bezamat Chappel, Mariana/0000-0001-9397-3167	Dental Registry and DNA Repository at the University of Pittsburgh; School of Dental Medicine at the University of Pittsburgh; National Institutes of Health [AR062598]	Dental Registry and DNA Repository at the University of Pittsburgh; School of Dental Medicine at the University of Pittsburgh; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the Dental Registry and DNA Repository and the School of Dental Medicine at the University of Pittsburgh. JMT was supported by the National Institutes of Health (https://www.nih.gov/) K01 training award AR062598. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aidar Marisi, 2007, Braz. Dent. J., V18, P148, DOI 10.1590/S0103-64402007000200012; Anjomshoaa I, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143068; [Anonymous], EUR J DENT; Ayed MS, 2018, SAUDI MED J, V39, P719, DOI 10.15537/smj.2018.7.22453; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Benjamin RM, 2010, PUBLIC HEALTH REP, V125, P158, DOI 10.1177/003335491012500202; Bezamat M, 2019, CARIES RES, V53, P235, DOI 10.1159/000492675; Buffoli B, 2014, ACTA HISTOCHEM, V116, P898, DOI 10.1016/j.acthis.2014.02.010; Cai L, 2017, J INFLAMM-LOND, V14, DOI 10.1186/s12950-017-0153-8; Chatzopoulos GS, 2018, SPEC CARE DENT; Compan V, 2012, IMMUNITY, V37, P487, DOI 10.1016/j.immuni.2012.06.013; Gao Hangfei, 2011, Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi, V25, P279; Golub LM, 2006, J DENT RES, V85, P102, DOI 10.1177/154405910608500201; Hara-Chikuma M, 2012, J EXP MED, V209, P1743, DOI 10.1084/jem.20112398; Heiman GA, 2004, HUM HERED, V58, P30, DOI 10.1159/000081454; Hennessy S, 1999, AM J EPIDEMIOL, V149, P195; Hinrichs AL, 2009, GENET EPIDEMIOL, V33, pS88, DOI 10.1002/gepi.20478; Ishibashi K, 1998, BIOCHEM BIOPH RES CO, V244, P268, DOI 10.1006/bbrc.1998.8252; Jeon HM, 2017, J PERIODONTAL IMPLAN, V47, P211, DOI 10.5051/jpis.2017.47.4.211; Lockhart PB, 2012, CIRCULATION, V125, P2520, DOI 10.1161/CIR.0b013e31825719f3; Loitto VM, 2002, J LEUKOCYTE BIOL, V71, P212; Ma TH, 2011, ACTA PHARMACOL SIN, V32, P711, DOI 10.1038/aps.2011.63; Meli R, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.00101; Meng JH, 2007, CHINESE MED J-PEKING, V120, P2191, DOI 10.1097/00029330-200712020-00006; Mobasheri A, 2004, VET J, V168, P143, DOI 10.1016/j.tvjl.2003.08.001; Moon C, 2004, AM J HEMATOL, V75, P128, DOI 10.1002/ajh.10476; Nagahara M, 2010, RHEUMATOLOGY, V49, P898, DOI 10.1093/rheumatology/keq028; Papadopoulos MC, 2008, PFLUG ARCH EUR J PHY, V456, P693, DOI 10.1007/s00424-007-0357-5; Pedersen AML, 2018, J ORAL REHABIL, V45, P730, DOI 10.1111/joor.12664; Prescott NJ, 2002, J MED GENET, V39, P368, DOI 10.1136/jmg.39.5.368; Purcell S, 2003, BIOINFORMATICS, V19, P149, DOI 10.1093/bioinformatics/19.1.149; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Ranade K, 2001, GENOME RES, V11, P1262; Richards S, 2015, GENET MED, V17, P405, DOI 10.1038/gim.2015.30; Stanko P, 2014, BIOMED PAP, V158, P35, DOI 10.5507/bp.2014.005; Takata K, 2004, PROG HISTOCHEM CYTO, V39, P1, DOI 10.1016/j.proghi.2004.03.001; Trujillo E, 2004, HISTOL HISTOPATHOL, V19, P435, DOI 10.14670/HH-19.435; Tyteca D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117398; Verkman A. S., 2008, Expert Reviews in Molecular Medicine, V10, P1, DOI 10.1017/S1462399408000690; Vieira AR, 2017, FRONT MED-LAUSANNE, V4, DOI 10.3389/fmed.2017.00186; Vieira AR, 2015, J PERS MED, V5, P30, DOI 10.3390/jpm5010030; Wang X, 2012, CARIES RES, V46, P177, DOI 10.1159/000337282; Wei M, 2019, ONCOTARGETS THER, V12, P2843, DOI 10.2147/OTT.S194650; Zhao XY, 2018, MED SCI MONITOR, V24, P5802, DOI 10.12659/MSM.909117; Zhu N, 2011, FASEB J, V25, P4233, DOI 10.1096/fj.11-182808	45	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2020	15	3							e0229245	10.1371/journal.pone.0229245	http://dx.doi.org/10.1371/journal.pone.0229245			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8QU	32130259	gold, Green Published			2022-12-26	WOS:000535264000019
J	Liu, XC; Cui, JF; Gong, L; Tian, F; Shen, YL; Chen, LP; Wang, Y; Xia, YY; Liu, L; Ye, X; Wang, ML; Liu, GY; Jiang, BC; Shao, CS; Zou, YX; Gong, YQ				Liu, Xiaochen; Cui, Jianfeng; Gong, Li; Tian, Fei; Shen, Yangli; Chen, Lipeng; Wang, Yong; Xia, Yangyang; Liu, Lei; Ye, Xiang; Wang, Molin; Liu, Guangyi; Jiang, Baichun; Shao, Changshun; Zou, Yongxin; Gong, Yaoqin			The CUL4B-miR-372/373-PIK3CA-AKT axis regulates metastasis in bladder cancer	ONCOGENE			English	Article							HEPATOCELLULAR-CARCINOMA; PI3K/AKT PATHWAY; CUL4B; MUTATIONS; CELLS; TUMORIGENESIS; EXPRESSION; RESTRICTS; ENCODES; COMPLEX	CUL4B, which acts as a scaffold protein in CUL4B-RING ubiquitin ligase (CRL4B) complexes, participates in a variety of biological processes. Previous studies have shown that CUL4B is often overexpressed and exhibits oncogenic activities in a variety of solid tumors. However, the roles and the underlying mechanisms of CUL4B in bladder cancer (BC) were poorly understood. Here, we showed that CUL4B levels were overexpressed and positively correlated with the malignancy of BC, and CUL4B could confer BC cells increased motility, invasiveness, stemness, and chemoresistance. The PIK3CA/AKT pathway was identified as a critical downstream mediator of CUL4B-driven oncogenicity in BC cells. Furthermore, we demonstrated that CRL4B epigenetically repressed the transcription of miR-372/373, via catalyzing monoubiquitination of H2AK119 at the gene cluster encoding miR-372/373, leading to upregulation of PIK3CA and activation of AKT. Our findings thus establish a critical role for the CUL4B-miR-372/373-PIK3CA/AKT axis in the pathogenesis of BC and have important prognostic and therapeutic implications in BC.	[Liu, Xiaochen; Gong, Li; Tian, Fei; Shen, Yangli; Ye, Xiang; Wang, Molin; Jiang, Baichun; Zou, Yongxin; Gong, Yaoqin] Shandong Univ, Sch Basic Med Sci, Minist Educ, Key Lab Expt Teratol, Jinan, Shandong, Peoples R China; [Liu, Xiaochen; Gong, Li; Tian, Fei; Shen, Yangli; Ye, Xiang; Wang, Molin; Jiang, Baichun; Zou, Yongxin; Gong, Yaoqin] Shandong Univ, Sch Basic Med Sci, Dept Mol Med & Genet, Jinan, Shandong, Peoples R China; [Cui, Jianfeng; Chen, Lipeng; Wang, Yong; Xia, Yangyang; Liu, Lei] Shandong Univ, Qilu Hosp, Dept Urol, Jinan, Shandong, Peoples R China; [Liu, Guangyi] Shandong Univ, Qilu Hosp, Dept Nephrol, Jinan, Shandong, Peoples R China; [Shao, Changshun] Soochow Univ, Inst Translat Med, State Key Lab Radiat Med & Protect, Suzhou, Jiangsu, Peoples R China	Shandong University; Shandong University; Shandong University; Shandong University; Soochow University - China	Zou, YX; Gong, YQ (corresponding author), Shandong Univ, Sch Basic Med Sci, Minist Educ, Key Lab Expt Teratol, Jinan, Shandong, Peoples R China.; Zou, YX; Gong, YQ (corresponding author), Shandong Univ, Sch Basic Med Sci, Dept Mol Med & Genet, Jinan, Shandong, Peoples R China.	zouyongxin@sdu.edu.cn; yxg8@sdu.edu.cn	Shao, Changshun/AAD-8977-2022	Shao, Changshun/0000-0003-2618-9342	National Natural Science Foundation of China [81330050, 81571523, 31671427, 81770660]; Natural Science Foundation of Shandong Province [ZR2016HZ01]; Key Research and Development Program of Shandong Province [2016ZDJS07A08]; Young Scholars Program of Shandong University	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Shandong Province(Natural Science Foundation of Shandong Province); Key Research and Development Program of Shandong Province; Young Scholars Program of Shandong University	The authors would like to thank Dr M. Oren for kindly providing psiCHECK2 reporter plasmids containing the 3UTR wide-type and mutant sequences of PIK3CA. This work was supported by the National Natural Science Foundation of China (81330050 and 81571523 to YG, 31671427 to YZ, 81770660 to GL); the Natural Science Foundation of Shandong Province (ZR2016HZ01 to YG); the Key Research and Development Program of Shandong Province (2016ZDJS07A08 to YG); and Young Scholars Program of Shandong University (to YZ).	Batlle E, 2017, NAT MED, V23, P1124, DOI 10.1038/nm.4409; Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492; BUBENIK J, 1973, INT J CANCER, V11, P765, DOI 10.1002/ijc.2910110327; Caino MC, 2015, P NATL ACAD SCI USA, V112, P8638, DOI 10.1073/pnas.1500722112; Carnero A, 2008, CURR CANCER DRUG TAR, V8, P187, DOI 10.2174/156800908784293659; Choi W, 2017, EUR UROL, V72, P354, DOI 10.1016/j.eururo.2017.03.010; Cicenas J, 2008, INT J BIOL MARKER, V23, P1, DOI 10.1177/172460080802300101; Earl J, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1450-3; El-Daly SM, 2016, SCI REP-UK, V6, DOI 10.1038/srep24720; Hannah J, 2015, GENE, V573, P33, DOI 10.1016/j.gene.2015.08.064; Harel SA, 2015, CELL DEATH DIFFER, V22, P1328, DOI 10.1038/cdd.2014.221; Hennessy BT, 2005, NAT REV DRUG DISCOV, V4, P988, DOI 10.1038/nrd1902; Hu HL, 2012, CANCER CELL, V22, P781, DOI 10.1016/j.ccr.2012.10.024; Ji QH, 2014, J CELL SCI, V127, P4679, DOI 10.1242/jcs.154245; Julien S, 2007, ONCOGENE, V26, P7445, DOI 10.1038/sj.onc.1210546; Knowles MA, 2015, NAT REV CANCER, V15, P25, DOI 10.1038/nrc3817; Kuwada M, 2015, CANCER LETT, V369, P212, DOI 10.1016/j.canlet.2015.08.019; Lang A, 2019, CANCERS, V11, DOI 10.3390/cancers11040481; Lang QB, 2012, BIOCHEM BIOPH RES CO, V426, P247, DOI 10.1016/j.bbrc.2012.08.075; Ler LD, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aai8312; Li PS, 2017, DIABETES, V66, P300, DOI 10.2337/db16-0743; Liu J, 2017, AM J CANCER RES, V7, P148; Manning BD, 2017, CELL, V169, P381, DOI 10.1016/j.cell.2017.04.001; Mao XW, 2017, ONCOTARGET, V8, P77241, DOI 10.18632/oncotarget.20455; Mayer IA, 2016, ANNU REV MED, V67, P11, DOI 10.1146/annurev-med-062913-051343; Mensah FA, 2018, ONCOTARGETS THER, V11, P4817, DOI 10.2147/OTT.S142264; Mi J, 2017, MOL ONCOL, V11, P305, DOI 10.1002/1878-0261.12038; Paplomata E, 2014, THER ADV MED ONCOL, V6, P154, DOI 10.1177/1758834014530023; Platt FM, 2009, CLIN CANCER RES, V15, P6008, DOI 10.1158/1078-0432.CCR-09-0898; Qi M, 2018, ONCOGENE, V37, P1075, DOI 10.1038/onc.2017.380; Qi M, 2019, ONCOGENESIS, V8, DOI 10.1038/s41389-019-0131-5; Qian YY, 2015, CANCER RES, V75, P5070, DOI 10.1158/0008-5472.CAN-15-0898; Qiao M, 2008, CELL CYCLE, V7, P2991, DOI 10.4161/cc.7.19.6784; Samuels Y, 2004, SCIENCE, V304, P554, DOI 10.1126/science.1096502; Sanli O, 2017, NAT REV DIS PRIMERS, V3, DOI 10.1038/nrdp.2017.22; See WA, 1997, J UROLOGY, V157, P1136, DOI 10.1016/S0022-5347(01)65156-5; Segovia C, 2017, ONCOTARGET, V8, P10531, DOI 10.18632/oncotarget.14453; Solomon DA, 2013, NAT GENET, V45, P1428, DOI 10.1038/ng.2800; Tarpey PS, 2007, AM J HUM GENET, V80, P345, DOI 10.1086/511134; Vasudevan KM, 2009, CANCER CELL, V16, P21, DOI 10.1016/j.ccr.2009.04.012; Vivanco I, 2002, NAT REV CANCER, V2, P489, DOI 10.1038/nrc839; Wei Z, 2015, FREE RADICAL BIO MED, V79, P1, DOI 10.1016/j.freeradbiomed.2014.11.010; Weinstein JN, 2014, NATURE, V507, P315, DOI 10.1038/nature12965; Xu ZL, 2019, ONCOGENE, V38, P5860, DOI 10.1038/s41388-019-0847-x; Yang Y, 2015, ONCOGENE, V34, P104, DOI 10.1038/onc.2013.522; Yu QQ, 2014, BIOMED PHARMACOTHER, V68, P155, DOI 10.1016/j.biopha.2014.01.005; Yuan JP, 2015, J PATHOL, V235, P784, DOI 10.1002/path.4492; Zhang Y, 1997, INT J CANCER, V71, P851; Zhao MF, 2019, PROSTATE, V79, DOI 10.1002/pros.23754; Zou YX, 2007, AM J HUM GENET, V80, P561, DOI 10.1086/512489; Zou YX, 2013, J CELL BIOL, V200, P743, DOI 10.1083/jcb.201206065; Zou YX, 2009, J BIOL CHEM, V284, P33320, DOI 10.1074/jbc.M109.050427	52	12	13	2	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR	2020	39	17					3588	3603		10.1038/s41388-020-1236-1	http://dx.doi.org/10.1038/s41388-020-1236-1		MAR 2020	16	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	LH1YK	32127645				2022-12-26	WOS:000517861800002
J	Stockigt, F; Eichhorn, L; Beiert, T; Knappe, V; Radecke, T; Steinmetz, M; Nickenig, G; Peeva, V; Kudin, AP; Kunz, WS; Berwanger, C; Kamm, L; Schultheis, D; Schlotzer-Schrehardt, U; Clemen, CS; Schroder, R; Schrickel, JW				Stoeckigt, Florian; Eichhorn, Lars; Beiert, Thomas; Knappe, Vincent; Radecke, Tobias; Steinmetz, Martin; Nickenig, Georg; Peeva, Viktoriya; Kudin, Alexei P.; Kunz, Wolfram S.; Berwanger, Carolin; Kamm, Lisa; Schultheis, Dorothea; Schloetzer-Schrehardt, Ursula; Clemen, Christoph S.; Schroeder, Rolf; Schrickel, Jan W.			Heart failure after pressure overload in autosomal-dominant desminopathies: Lessons from heterozygous DES-p.R349P knock-in mice	PLOS ONE			English	Article							DESMIN-MUTATION; MITOCHONDRIAL MORPHOLOGY; DILATED CARDIOMYOPATHY; CALCIUM HOMEOSTASIS; MUTANT DESMIN; MUSCLE; ONSET; VIVO	Background Mutations in the human desmin gene (DES) cause autosomal-dominant and -recessive cardiomyopathies, leading to heart failure, arrhythmias, and AV blocks. We analyzed the effects of vascular pressure overload in a patient-mimicking p.R349P desmin knock-in mouse model that harbors the orthologue of the frequent human DES missense mutation p. R350P. Methods and results Transverse aortic constriction (TAC) was performed on heterozygous (HET) DES-p.R349P mice and wild-type (WT) littermates. Echocardiography demonstrated reduced left ventricular ejection fraction in HET-TAC (WT-sham: 69.5 +/- 2.9%, HET-sham: 64.5 +/- 4.7%, WT-TAC: 63.5 +/- 4.9%, HET-TAC: 55.7 +/- 5.4%; p < 0.01). Cardiac output was significantly reduced in HET-TAC (WT sham: 13088 +/- 2385 mu l/min, HET sham: 10391 +/- 1349 mu l/min, WT-TAC: 8097 +/- 1903 mu l/min, HET-TAC: 5793 +/- 2517 mu l/min; p< 0.01). Incidence and duration of AV blocks as well as the probability to induce ventricular tachycardias was highest in HET-TAC. We observed reduced mtDNA copy numbers in HET-TAC (WT-sham: 12546 +/- 406, HET-sham: 13526 +/- 781, WT-TAC: 11155 +/- 3315, HET-TAC: 8649 +/- 1582; p = 0.025), but no mtDNA deletions. The activity of respiratory chain complexes I and IV showed the greatest reductions in HET-TAC. Conclusion Pressure overload in HET mice aggravated the clinical phenotype of cardiomyopathy and resulted in mitochondrial dysfunction. Preventive avoidance of pressure overload/arterial hypertension in desminopathy patients might represent a crucial therapeutic measure.	[Stoeckigt, Florian; Beiert, Thomas; Knappe, Vincent; Nickenig, Georg; Schrickel, Jan W.] Univ Hosp Bonn, Dept Cardiol, Bonn, Germany; [Stoeckigt, Florian] Krankenhaus Porz, Dept Cardiol, Urbacher Weg, Cologne, Germany; [Eichhorn, Lars] Univ Hosp Bonn, Dept Anesthesiol, Bonn, Germany; [Radecke, Tobias; Steinmetz, Martin] Univ Hosp Essen, Dept Cardiol, Hufelandstr, Essen, Germany; [Peeva, Viktoriya; Kudin, Alexei P.; Kunz, Wolfram S.] Inst Expt Epileptol & Cognit Res, Bonn, Germany; [Peeva, Viktoriya; Kudin, Alexei P.; Kunz, Wolfram S.] Univ Hosp Bonn, Dept Epileptol, Bonn, Germany; [Berwanger, Carolin; Clemen, Christoph S.] German Aerosp Ctr DLR, Inst Aerosp Med, Cologne, Germany; [Kamm, Lisa; Schultheis, Dorothea; Clemen, Christoph S.; Schroeder, Rolf] Friedrich Alexander Univ Erlangen Numberg, Univ Hosp Erlangen, Inst Neuropathol, Erlangen, Germany; [Schloetzer-Schrehardt, Ursula] Friedrich Alexander Univ Erlangen Numberg, Univ Hosp Erlangen, Dept Opthalmol, Erlangen, Germany; [Clemen, Christoph S.] Univ Cologne, Med Fac, Inst Biochem 1, Ctr Biochem, Cologne, Germany; [Clemen, Christoph S.] Univ Cologne, Med Fac, Inst Vegetat Physiol, Ctr Physiol & Pathophysiol, Cologne, Germany	University of Bonn; University of Bonn; University of Duisburg Essen; University of Bonn; Helmholtz Association; German Aerospace Centre (DLR); University of Erlangen Nuremberg; University of Erlangen Nuremberg; University of Cologne; University of Cologne	Stockigt, F (corresponding author), Univ Hosp Bonn, Dept Cardiol, Bonn, Germany.; Stockigt, F (corresponding author), Krankenhaus Porz, Dept Cardiol, Urbacher Weg, Cologne, Germany.	f.stoeckigt@khporz.de	Kunz, Wolfram/K-1232-2019; Eichhorn, Lars/I-5985-2015	Kunz, Wolfram/0000-0003-1113-3493; Eichhorn, Lars/0000-0002-9769-0639; Schroder, Rolf/0000-0002-2772-2615				Bar H, 2005, HUM MOL GENET, V14, P1251, DOI 10.1093/hmg/ddi136; Baris OR, 2015, CELL METAB, V21, P667, DOI 10.1016/j.cmet.2015.04.005; Barrick CJ, 2007, AM J PHYSIOL-HEART C, V292, pH2119, DOI 10.1152/ajpheart.00816.2006; Bowles NE, 2000, HERZ, V25, P168, DOI 10.1007/s000590050003; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Chaanine AH, 2017, J AM HEART ASSOC, V6, DOI 10.1161/JAHA.117.005869; Clemen CS, 2015, ACTA NEUROPATHOL, V129, P297, DOI 10.1007/s00401-014-1363-2; Clemen CS, 2013, ACTA NEUROPATHOL, V125, P47, DOI 10.1007/s00401-012-1057-6; Diermeier S, 2017, NEUROBIOL AGING, V58, P77, DOI 10.1016/j.neurobiolaging.2017.06.001; Diermeier S, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01485-x; Disertori M, 2017, TRENDS CARDIOVAS MED, V27, P363, DOI 10.1016/j.tcm.2017.01.011; Doenst T, 2010, CARDIOVASC RES, V86, P461, DOI 10.1093/cvr/cvp414; Eichhorn L, 2018, JOVE-J VIS EXP, DOI 10.3791/57397; Harada H, 2018, J HUM GENET, V63, P249, DOI 10.1038/s10038-017-0383-x; Herrmann H, 2009, J CLIN INVEST, V119, P1772, DOI 10.1172/JCI38214; Jefferies JL, 2010, LANCET, V375, P752, DOI 10.1016/S0140-6736(09)62023-7; Klauke B, 2010, HUM MOL GENET, V19, P4595, DOI 10.1093/hmg/ddq387; KUNZ WS, 1993, BIOCHIM BIOPHYS ACTA, V1144, P46, DOI 10.1016/0005-2728(93)90029-F; Li ZL, 1997, J CELL BIOL, V139, P129, DOI 10.1083/jcb.139.1.129; MITCHELL GF, 1998, AM J PHYSIOL, V274, pH74; Pruszczyk P, 2007, INT J CARDIOL, V117, P244, DOI 10.1016/j.ijcard.2006.05.019; Rowe GC, 2017, AM J PHYSIOL-HEART C, V312, pH662, DOI 10.1152/ajpheart.00446.2016; Stockigt F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049203; Strach K, 2008, NEUROMUSCULAR DISORD, V18, P475, DOI 10.1016/j.nmd.2008.03.012; Taylor MRG, 2007, CIRCULATION, V115, P1244, DOI 10.1161/CIRCULATIONAHA.106.646778; van Spaendonck-Zwarts KY, 2011, CLIN GENET, V80, P354, DOI 10.1111/j.1399-0004.2010.01512.x; van Tintelen JP, 2009, HEART RHYTHM, V6, P1574, DOI 10.1016/j.hrthm.2009.07.041; Walter MC, 2007, BRAIN, V130, P1485, DOI 10.1093/brain/awm039; Wiedemann FR, 2000, ANAL BIOCHEM, V279, P55, DOI 10.1006/abio.1999.4434; Winter L, 2016, ACTA NEUROPATHOL, V132, P453, DOI 10.1007/s00401-016-1592-7; Winter L, 2015, HUM MOL GENET, V24, P4530, DOI 10.1093/hmg/ddv184; Wyles SP, 2016, CTS-CLIN TRANSL SCI, V9, P158, DOI 10.1111/cts.12393; Zhao S, 2005, J COMPUT BIOL, V12, P1047, DOI 10.1089/cmb.2005.12.1047; Zsurka G, 2008, J NEUROPATH EXP NEUR, V67, P857, DOI 10.1097/NEN.0b013e3181839b2d	34	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2020	15	3							e0228913	10.1371/journal.pone.0228913	http://dx.doi.org/10.1371/journal.pone.0228913			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8MS	32126091	gold, Green Accepted, Green Published			2022-12-26	WOS:000535253100011
J	Kumar, N; Arakeri, JH; Bobji, MS				Kumar, Navneet; Arakeri, Jaywant H.; Bobji, Musuvathi S.			Formation of a hard surface layer during drying of a heated porous media	PLOS ONE			English	Article							SALINE WATER EVAPORATION; CRACKING; PRECIPITATION; TRANSITIONS; BRIDGES; RATES; SALT	We report surface hardening or crust formation, like caking, during evaporation when a porous medium was heated from above using IR radiation. These crusts had higher strength than their closest counterparts such as sandcastles and mud-peels which essentially are clusters of a partially wet porous medium. Observed higher strength of the crusts was mostly due to surface tension between the solid particles, which are connected by liquid bridges (connate water). Qualitative (FTIR) and quantitative (TGA) measurements confirmed the presence of trapped water within the crust. Based on the weight measurements, the amount of water trapped in the crusts was similar to 1.5%; trapped water was also seen as liquid bridges in the SEM images. Further, in the fixed particle sizes case, the crust thickness varied slightly (only 10-20 particle diameters for cases with external heating) while with the natural sand whole porous column was crusted; surprisingly, the crust was also found with the hydrophobic glass beads. Fluorescein dye visualization technique was used to determine the crust thickness. We give a power-law relation between the crust thickness and the incident heat flux for various particle sizes. The strength of the crust decreased drastically with increasing hydrophilic spheres diameter while it increased with higher surface temperature.	[Kumar, Navneet; Arakeri, Jaywant H.; Bobji, Musuvathi S.] Indian Inst Sci, Dept Mech Engn, Bangalore, Karnataka, India	Indian Institute of Science (IISC) - Bangalore	Kumar, N (corresponding author), Indian Inst Sci, Dept Mech Engn, Bangalore, Karnataka, India.	navneetkumar@iisc.ac.in	Bobji, Musuvathi/AIA-7543-2022; kumar, Navneet/B-1470-2019	kumar, Navneet/0000-0001-5790-3532	Robert Bosch Centre for Cyber-Physical Systems [RBCCPS/ME/JHA/PC-0013]	Robert Bosch Centre for Cyber-Physical Systems	JHA received funding from Robert Bosch Centre for Cyber-Physical Systems under the grant RBCCPS/ME/JHA/PC-0013. MSB was the coinvestigator. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bergstad M, 2017, WATER RESOUR RES, V53, P1702, DOI 10.1002/2016WR020060; Bobji MS, 2009, LANGMUIR, V25, P12120, DOI 10.1021/la902679c; Brinker C. J., 1990, SOL GEL SCI PHYS CHE, DOI DOI 10.1016/B978-0-08-057103-4.50001-5; Brown LA, 2002, AICHE J, V48, P492, DOI 10.1002/aic.690480308; Cejas CM, 2017, PHYS REV E, V96, DOI 10.1103/PhysRevE.96.062908; Dragnevski KI, 2010, LANGMUIR, V26, P7747, DOI 10.1021/la904512q; Dufresne ER, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.224501; Fenyvesi O., 2012, C JUN RES CIV ENG, P51; Fournier Z, 2005, J PHYS-CONDENS MAT, V17, pS477, DOI 10.1088/0953-8984/17/9/013; Ghatak A, 2004, P ROY SOC A-MATH PHY, V460, P2725, DOI 10.1098/rspa.2004.1313; GROISMAN A, 1994, EUROPHYS LETT, V25, P415, DOI 10.1209/0295-5075/25/6/004; Herminghaus S, 2005, ADV PHYS, V54, P221, DOI 10.1080/00018730500167855; Hornbaker DJ, 1997, NATURE, V387, P765, DOI 10.1038/42831; HOTTA K, 1974, POWDER TECHNOL, V10, P231, DOI 10.1016/0032-5910(74)85047-3; Kindle EM, 1917, J GEOL, V25, P135, DOI 10.1086/622446; Kohonen MM, 2004, PHYSICA A, V339, P7, DOI 10.1016/j.physa.2004.03.047; Kudrolli A, 2008, NAT MATER, V7, P174, DOI 10.1038/nmat2131; Kumar N., 2017, THESIS; Kumar N, 2020, DRY TECHNOL, V38, P1194, DOI 10.1080/07373937.2019.1626877; Kumar N, 2020, AGR WATER MANAGE, V227, DOI 10.1016/j.agwat.2019.105855; Kumar N, 2020, INT J THERM SCI, V148, DOI 10.1016/j.ijthermalsci.2019.106151; Kumar N, 2019, J HYDROL, V569, P795, DOI 10.1016/j.jhydrol.2019.01.001; Kumar N, 2018, WATER RESOUR RES, V54, P7670, DOI 10.1029/2017WR021954; Kumar N, 2018, INT J MULTIPHAS FLOW, V109, P114, DOI 10.1016/j.ijmultiphaseflow.2018.07.009; Kumar N, 2018, TRANSPORT POROUS MED, V125, P311, DOI 10.1007/s11242-018-1120-4; Kumar N, 2018, INT J THERM SCI, V133, P299, DOI 10.1016/j.ijthermalsci.2018.07.035; Lehmann P, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.056309; MASON G, 1965, CHEM ENG SCI, V20, P859, DOI 10.1016/0009-2509(65)80082-3; Mitarai N, 2006, ADV PHYS, V55, P1, DOI 10.1080/00018730600626065; Muller G, 1998, J GEOPHYS RES-SOL EA, V103, P15239, DOI 10.1029/98JB00389; Or D, 2013, VADOSE ZONE J, V12, DOI 10.2136/vzj2012.0163; Paquette E, 2002, PROC GRAPH INTERF, P59; Pauchard L, 2003, PHYS REV E, V67, DOI 10.1103/PhysRevE.67.027103; Routh AF, 1999, LANGMUIR, V15, P7762, DOI 10.1021/la9903090; Russel WB, 2011, AICHE J, V57, P1378, DOI 10.1002/aic.12651; Sadeghi M, 2015, J HYDROL, V529, P1277, DOI 10.1016/j.jhydrol.2015.09.019; Samadani A, 2000, PHYS REV LETT, V85, P5102, DOI 10.1103/PhysRevLett.85.5102; Scheel M, 2008, NAT MATER, V7, P189, DOI 10.1038/nmat2117; Shokri-Kuehni SMS, 2017, GEOPHYS RES LETT, V44, P5504, DOI 10.1002/2017GL073337; Shokri-Kuehni SMS, 2017, ADV WATER RESOUR, V105, P154, DOI 10.1016/j.advwatres.2017.05.004; Singh KB, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.218302; Slowik V, 2009, CEMENT CONCRETE COMP, V31, P461, DOI 10.1016/j.cemconcomp.2009.05.004; Slowik V, 2008, CEMENT CONCRETE COMP, V30, P557, DOI 10.1016/j.cemconcomp.2008.03.002; Style R. W., 2010, P R SOC A, V467, P174, DOI DOI 10.1098/RSPA.2010.0039; Style RW, 2011, J GEOPHYS RES-EARTH, V116, DOI 10.1029/2010JF001842; Thiery J, 2017, PHYS REV FLUIDS, V2, DOI 10.1103/PhysRevFluids.2.074201; Tirumkudulu MS, 2005, LANGMUIR, V21, P4938, DOI 10.1021/la048298k; Tirumkudulu MS, 2004, LANGMUIR, V20, P2947, DOI 10.1021/la0356250; WIELICZKA DM, 1989, APPL OPTICS, V28, P1714, DOI 10.1364/AO.28.001714; Xia ZC, 2000, J MECH PHYS SOLIDS, V48, P1107, DOI 10.1016/S0022-5096(99)00081-2; Yiotis AG, 2012, PHYS REV E, V85, DOI 10.1103/PhysRevE.85.046308	51	2	2	3	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2020	15	2							e0229723	10.1371/journal.pone.0229723	http://dx.doi.org/10.1371/journal.pone.0229723			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8GQ	32106267	Green Submitted, Green Accepted, Green Published, gold			2022-12-26	WOS:000535237000064
J	Mirchi, N; Bissonnette, V; Yilmaz, R; Ledwos, N; Winkler-Schwartz, A; Del Maestro, RF				Mirchi, Nykan; Bissonnette, Vincent; Yilmaz, Recai; Ledwos, Nicole; Winkler-Schwartz, Alexander; Del Maestro, Rolando F.			The Virtual Operative Assistant: An explainable artificial intelligence tool for simulation-based training in surgery and medicine	PLOS ONE			English	Article							FEATURE-SELECTION; FEEDBACK; CLASSIFICATION; MODEL	Simulation-based training is increasingly being used for assessment and training of psychomotor skills involved in medicine. The application of artificial intelligence and machine learning technologies has provided new methodologies to utilize large amounts of data for educational purposes. A significant criticism of the use of artificial intelligence in education has been a lack of transparency in the algorithms' decision-making processes. This study aims to 1) introduce a new framework using explainable artificial intelligence for simulation-based training in surgery, and 2) validate the framework by creating the Virtual Operative Assistant, an automated educational feedback platform. Twenty-eight skilled participants (14 staff neurosurgeons, 4 fellows, 10 PGY 4-6 residents) and 22 novice participants (10 PGY 1-3 residents, 12 medical students) took part in this study. Participants performed a virtual reality subpial brain tumor resection task on the NeuroVR simulator using a simulated ultrasonic aspirator and bipolar. Metrics of performance were developed, and leave-one-out cross validation was employed to train and validate a support vector machine in Matlab. The classifier was combined with a unique educational system to build the Virtual Operative Assistant which provides users with automated feedback on their metric performance with regards to expert proficiency performance benchmarks. The Virtual Operative Assistant successfully classified skilled and novice participants using 4 metrics with an accuracy, specificity and sensitivity of 92, 82 and 100%, respectively. A 2-step feedback system was developed to provide participants with an immediate visual representation of their standing related to expert proficiency performance benchmarks. The educational system outlined establishes a basis for the potential role of integrating artificial intelligence and virtual reality simulation into surgical educational teaching. The potential of linking expertise classification, objective feedback based on proficiency benchmarks, and instructor input creates a novel educational tool by integrating these three components into a formative educational paradigm.	[Mirchi, Nykan; Bissonnette, Vincent; Yilmaz, Recai; Ledwos, Nicole; Winkler-Schwartz, Alexander; Del Maestro, Rolando F.] McGill Univ, Dept Neurol & Neurosurg, Neurosurg Simulat & Artificial Intelligence Learn, Montreal Neurol Inst & Hosp, Montreal, PQ, Canada; [Bissonnette, Vincent] McGill Univ, Montreal Gen Hosp, Div Orthopaed Surg, Montreal, PQ, Canada	McGill University; McGill University	Mirchi, N (corresponding author), McGill Univ, Dept Neurol & Neurosurg, Neurosurg Simulat & Artificial Intelligence Learn, Montreal Neurol Inst & Hosp, Montreal, PQ, Canada.	nykan.mirchi@mail.mcgill.ca		Yilmaz, Recai/0000-0003-0521-3227; Mirchi, Nykan/0000-0002-3742-4611; Ledwos, Nicole/0000-0002-8604-3313	Di Giovanni Foundation; McGill Division of Orthopaedic Surgery; Montreal Neurological Institute	Di Giovanni Foundation; McGill Division of Orthopaedic Surgery; Montreal Neurological Institute	This work was supported by the Di Giovanni Foundation. The funders did not play any role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank all the neurosurgical residents, fellows and surgeons who participated in this study. We thank the McGill Division of Orthopaedic Surgery and the Montreal Neurological Institute for their internal support. We acknowledge Dr. Abdulrahman Sabbagh and thank Dr. Robert DiRaddo, group leader of Simulation, Life Sciences Division, National Research Council of Canada in Boucherville in developing the virtual reality scenario. We also thank Drs. Khalid Bajunaid, Abdulgadir Bugdadi and Ghusn Al Sideiri along with Robin Sawaya and Mina Khan for their help with the study. We acknowledge the support of Drs. Mahmoud Al-Yamany and Lahbib Soualmi from the National Neuroscience Institute, Department of Neurosurgery, King Fahad Medical City in Riyadh, and Dr. Saleh Baeesa from King Abdulaziz University, in Jeddah, Saudi Arabia.	ALOTAIBI F, 2015, SOJ NEUROL, V2, P1, DOI DOI 10.15226/2374-6858/2/1/00116; Azarnoush H, 2017, J NEUROSURG, V127, P171, DOI 10.3171/2016.7.JNS16322; Bissonnette V, 2019, J BONE JOINT SURG AM, V101, DOI 10.2106/JBJS.18.01197; Block JH., 1976, REV RES EDUC, V4, P3, DOI DOI 10.3102/0091732X004001003; Bottou L, 2010, COMPSTAT'2010: 19TH INTERNATIONAL CONFERENCE ON COMPUTATIONAL STATISTICS, P177, DOI 10.1007/978-3-7908-2604-3_16; Burbidge R, 2001, COMPUT CHEM, V26, P5, DOI 10.1016/S0097-8485(01)00094-8; Calvo RA, 2014, POSITIVE COMPUTING: TECHNOLOGY FOR WELLBEING AND HUMAN POTENTIAL, P1; Conati C., 2018, ARXIV180700154; Delorme S, 2012, NEUROSURGERY, V71, P32, DOI 10.1227/NEU.0b013e318249c744; Deo RC, 2015, CIRCULATION, V132, P1920, DOI 10.1161/CIRCULATIONAHA.115.001593; ENDE J, 1983, JAMA-J AM MED ASSOC, V250, P777, DOI 10.1001/jama.250.6.777; Esteva A, 2019, NAT MED, V25, P24, DOI 10.1038/s41591-018-0316-z; Gobet F, 2001, TRENDS COGN SCI, V5, P236, DOI 10.1016/S1364-6613(00)01662-4; Goff BA, 2002, AM J OBSTET GYNECOL, V186, P613, DOI 10.1067/mob.2002.122145; Grapov D, 2018, OMICS, V22, P630, DOI 10.1089/omi.2018.0097; Hajshirmohammadi I., 2006, USING FUZZY SET THEO; Jain A, 2005, PATTERN RECOGN, V38, P2270, DOI 10.1016/j.patcog.2005.01.012; Kotsiantis SB, 2007, INFORM-J COMPUT INFO, V31, P249; Ladha L., 2011, INT J COMPUTER SCI E, V3, P1787; Li JD, 2018, ACM COMPUT SURV, V50, DOI 10.1145/3136625; Liu H, 2005, IEEE T KNOWL DATA EN, V17, P491, DOI 10.1109/TKDE.2005.66; McArthur D., 2005, J ED TECHNOLOGY, V1, P42, DOI [DOI 10.26634/JET.1.4.972, 10.26634/jet.1.4.972]; McCarthy J, 2006, AI MAG, V27, P12; Mirchi N, 2019, OPERATIVE NEUROSURGE; Moulton CAE, 2007, ACAD MED, V82, pS109, DOI 10.1097/ACM.0b013e3181405a76; Norman D., 2013, DESIGN EVERYDAY THIN; Raskin JS, 2018, OPER NEUROSURG, V14, P178, DOI 10.1093/ons/opx072; ROSENBLATT F, 1958, PSYCHOL REV, V65, P386, DOI 10.1037/h0042519; Ruikar DD, 2018, J MED SYST, V42, DOI 10.1007/s10916-018-1019-1; Ryu WHA, 2017, CAN J NEUROL SCI, V44, P177, DOI 10.1017/cjn.2016.315; Saplacan D, 2018, STUD HEALTH TECHNOL, V256, P421, DOI 10.3233/978-1-61499-923-2-421; Sawaya R, 2019, J NEUROSURG, V131, P192, DOI 10.3171/2018.2.JNS172327; Sawaya R, 2018, OPER NEUROSURG, V14, P686, DOI 10.1093/ons/opx189; Schmidhuber J, 2015, NEURAL NETWORKS, V61, P85, DOI 10.1016/j.neunet.2014.09.003; Si W, 2018, 2018 IEEE C VIRT REA; Sweller J., 1994, LEARN INSTR, V4, P295, DOI DOI 10.1016/0959-4752(94)90003-5; Szasz P, 2015, ANN SURG, V261, P1046, DOI 10.1097/SLA.0000000000000866; ten Cate O, 2004, ACAD MED, V79, P219, DOI 10.1097/00001888-200403000-00005; Wagner CR, 2007, PRESENCE-VIRTUAL AUG, V16, P252, DOI 10.1162/pres.16.3.252; Wang XZ, 2004, PATTERN RECOGN LETT, V25, P1123, DOI 10.1016/j.patrec.2004.03.008; Williamson B, 2016, J EDUC POLICY, V31, P123, DOI 10.1080/02680939.2015.1035758; Winkler-Schwartz A, 2019, WORLD NEUROSURGERY; Winkler-Schwartz A, 2019, JAMA NETW OPEN, V2, DOI 10.1001/jamanetworkopen.2019.8363; Winkler-Schwartz A, 2019, J SURG EDUC, V76, P1681, DOI 10.1016/j.jsurg.2019.05.015; Yu L, 2004, J MACH LEARN RES, V5, P1205; Yuan Z-Y, 2007, 2007 INT C MACH LEAR	46	53	53	18	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2020	15	2							e0229596	10.1371/journal.pone.0229596	http://dx.doi.org/10.1371/journal.pone.0229596			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LQ8GQ	32106247	Green Published, gold			2022-12-26	WOS:000535237000049
J	Mutsaerts, HJMM; Petr, J; Bokkers, RPH; Lazar, RM; Marshall, RS; Asllani, I				Mutsaerts, Henri J. M. M.; Petr, Jan; Bokkers, Reinoud P. H.; Lazar, Ronald M.; Marshall, Randolph S.; Asllani, Iris			Spatial coefficient of variation of arterial spin labeling MRI as a cerebrovascular correlate of carotid occlusive disease	PLOS ONE			English	Article							CEREBRAL-BLOOD-FLOW; PERFUSION; ANGIOGRAPHY; STRATEGIES; STENOSIS; IDENTIFY; STROKE; RISK	Clinical interpretation of arterial spin labeling (ASL) perfusion MRI in cerebrovascular disease remains challenging mainly because of the method's sensitivity to concomitant contributions from both intravascular and tissue compartments. While acquisition of multi-delay images can differentiate between the two contributions, the prolonged acquisition is prone to artifacts and not practical for clinical applications. Here, the utility of the spatial coefficient of variation (sCoV) of a single-delay ASL image as a marker of the intravascular contribution was evaluated by testing the hypothesis that sCoV can detect the effects of differences in label arrival times between ipsi- and contra-lateral hemispheres even in the absence of a hemispheric difference in CBF. Hemispheric lateralization values for sCoV and CBF were computed from ASL images acquired on 28 patients (age 73.9 +/- 10.2 years, 8 women) with asymptomatic unilateral carotid occlusion. The results showed that sCoV lateralization predicted the occluded side with 96.4% sensitivity, missing only 1 patient. In contrast, the sensitivity of the CBF lateralization was 71.4%, with 8 patients showing no difference in CBF between hemispheres. The findings demonstrate the potential clinical utility of sCoV as a cerebrovascular correlate of large vessel disease. Using sCoV in tandem with CBF, vascular information can be obtained in image processing without the need for additional scan-time.	[Mutsaerts, Henri J. M. M.] Univ Amsterdam, Dept Radiol & Nucl Med, VUMC, Med Ctr, Amsterdam, Netherlands; [Mutsaerts, Henri J. M. M.; Petr, Jan; Asllani, Iris] Rochester Inst Technol RIT, Dept Biomed Engn, Inst Hall, Rochester, NY 14623 USA; [Petr, Jan] Helmholtz Zentrum Dresden Rossendorf, Inst Radiopharmaceut Canc Res, Dresden, Germany; [Bokkers, Reinoud P. H.] Univ Groningen, Univ Med Ctr Groningen, Med Imaging Ctr, Dept Radiol, Groningen, Netherlands; [Lazar, Ronald M.] Univ Alabama Birmingham, Dept Neurol, McKnight Brain Inst, UAB Stn, Birmingham, AL 35294 USA; [Lazar, Ronald M.; Marshall, Randolph S.] Columbia Univ, Dept Neurol, Irving Med Ctr, New York, NY USA; [Asllani, Iris] Univ Sussex, Clin Imaging Sci Ctr, Neurosci, Brighton, E Sussex, England	University of Amsterdam; Vrije Universiteit Amsterdam; Rochester Institute of Technology; Helmholtz Association; Helmholtz-Zentrum Dresden-Rossendorf (HZDR); University of Groningen; University of Alabama System; University of Alabama Birmingham; Columbia University; NewYork-Presbyterian Hospital; University of Sussex	Asllani, I (corresponding author), Rochester Inst Technol RIT, Dept Biomed Engn, Inst Hall, Rochester, NY 14623 USA.; Asllani, I (corresponding author), Univ Sussex, Clin Imaging Sci Ctr, Neurosci, Brighton, E Sussex, England.	I.Asllani@bsms.ac.uk	Bokkers, Reinoud P H/ABD-2928-2020; Petr, Jan/B-5309-2013; Mutsaerts, Henk JMM/T-8656-2017	Bokkers, Reinoud P H/0000-0001-6130-7311; Petr, Jan/0000-0002-3201-6002; Mutsaerts, Henk JMM/0000-0003-0894-0307	NINDS [R01NS076277]; Gleason Foundation; Richard and Jenny Levine Fund	NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Gleason Foundation; Richard and Jenny Levine Fund	This study was funded by NINDS R01NS076277 (RL, RM). Support was also provided by the Gleason Foundation and Richard and Jenny Levine Fund (IA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alsop DC, 2015, MAGN RESON MED, V73, P102, DOI 10.1002/mrm.25197; Alsop DC, 1996, J CEREBR BLOOD F MET, V16, P1236, DOI 10.1097/00004647-199611000-00019; Bokkers RPH, 2010, J CEREBR BLOOD F MET, V30, P222, DOI 10.1038/jcbfm.2009.204; Bond R, 2003, STROKE, V34, P2290, DOI 10.1161/01.STR.0000087785.01407.CC; Chen YF, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02094-4; Chen YF, 2012, MAGN RESON MATER PHY, V25, P135, DOI 10.1007/s10334-011-0276-5; de Havenon A, 2017, JAMA NEUROL, V74, P453, DOI 10.1001/jamaneurol.2016.4491; de Rooij SR, 2019, NEUROBIOL AGING, V82, P1, DOI 10.1016/j.neurobiolaging.2019.06.012; Ferro DA, 2019, J CEREB BLOOD FLOW M, V26; Franke K, 2010, NEUROIMAGE, V50, P883, DOI 10.1016/j.neuroimage.2010.01.005; Hartkamp NS, 2014, CURR OPIN NEUROL, V27, P42, DOI 10.1097/WCO.0000000000000051; Heijtel DFR, 2014, NEUROIMAGE, V92, P182, DOI 10.1016/j.neuroimage.2014.02.011; Hendrikse J, 2002, J VASC SURG, V36, P799, DOI 10.1067/mva.2002.127346; Hendrikse J, 2012, NEUROIMAG CLIN N AM, V22, P259, DOI 10.1016/j.nic.2012.02.003; Ingala S., 2018, ALZHEIMERS DEMENT, V14, pP456; Jezzard P, 2018, J CEREBR BLOOD F MET, V38, P603, DOI 10.1177/0271678X17743240; Kato A, 2017, J STROKE CEREBROVASC, V26, P1457, DOI 10.1016/j.jstrokecerebrovasdis.2017.03.015; Lou X, 2019, J CEREBR BLOOD F MET, V39, P108, DOI 10.1177/0271678X17725212; Lou X, 2017, ONCOTARGET, V8, P2437, DOI 10.18632/oncotarget.13898; Markus H, 2001, BRAIN, V124, P457, DOI 10.1093/brain/124.3.457; Marshall RS, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0189727; Mutsaerts HJMM, 2018, J MAGN RESON IMAGING, V47, P131, DOI 10.1002/jmri.25751; Mutsaerts HJMM, 2017, J CEREBR BLOOD F MET, V37, P3184, DOI 10.1177/0271678X16683690; Mutsaerts HJMM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104108; Mutsaerts HJMM, 2011, STROKE, V42, P3497, DOI 10.1161/STROKEAHA.111.614453; Naylor AR, 2009, EUR J VASC ENDOVASC, V37, P625, DOI 10.1016/j.ejvs.2009.01.026; Robertson AD, 2017, AM J NEURORADIOL, V38, P1555, DOI 10.3174/ajnr.A5257; Silvestrini M, 2000, JAMA-J AM MED ASSOC, V283, P2122, DOI 10.1001/jama.283.16.2122; Sogabe S, 2017, NEURORADIOLOGY, V59, P587, DOI 10.1007/s00234-017-1828-9; Tada Y, 2014, CEREBROVASC DIS, V38, P191, DOI 10.1159/000365653; Tatu L, 1998, NEUROLOGY, V50, P1699, DOI 10.1212/WNL.50.6.1699; Teeuwisse WM, 2014, MAGN RESON MED, V72, P1712, DOI 10.1002/mrm.25083; Vagal A, 2018, STROKE, V49, P2102, DOI 10.1161/STROKEAHA.118.021484; Warmuth C, 2005, AM J NEURORADIOL, V26, P1035; Wolf JJHB, 2016, J CEREBR BLOOD F MET, V36, P1570, DOI 10.1177/0271678X15626155; Zaharchuk G, 2011, STROKE, V42, P2485, DOI 10.1161/STROKEAHA.111.616466	36	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2020	15	2							e0229444	10.1371/journal.pone.0229444	http://dx.doi.org/10.1371/journal.pone.0229444			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8FM	32101567	Green Published, gold			2022-12-26	WOS:000535233700034
J	Reesink, AJH; Darby, SE; Sear, DA; Leyland, J; Morgan, PR; Richardson, K; Brasington, J				Reesink, Arnold Jan H.; Darby, Stephen E.; Sear, David A.; Leyland, Julian; Morgan, Peter R.; Richardson, Keith; Brasington, James			Mean flow and turbulence structure over exposed roots on a forested floodplain: Insights from a controlled laboratory experiment	PLOS ONE			English	Article							LARGE-EDDY SIMULATION; BED SHEAR-STRESS; NUMERICAL-SIMULATION; 2-DIMENSIONAL DUNES; 3-DIMENSIONAL DUNES; SEDIMENT TRANSPORT; QUADRANT ANALYSIS; CHANNEL FLOW; PLAIN FLOW; VELOCITY	The time-averaged and instantaneous flow velocity structures of flood waters are not well understood for irregular surfaces such as are created by the presence of roots and fallen branches on forested floodplains. Natural flow structures commonly depart systematically from those described for idealised roughness elements, and an important knowledge gap exists surrounding the effects of natural flow structures on vertical exchanges of fluid and momentum. An improved understanding of the flow structure is required to model flows over forested floodplains more accurately, and to distinguish their dynamics from non-vegetated floodplains or indeed floodplains with other vegetation types, such as reed or grass. Here we present a quantification of the three-dimensional structure of mean flow velocity and turbulence as measured under controlled conditions in an experimental flume using a physical reproduction of a patch of forested floodplain. The results conform in part to existing models of local flow structure over simple roughness elements in aspects such as flow separation downstream of protruding roots, flow reattachment, and the lowering of the velocity maximum further downstream. However, the irregular shape of the surface of the floodplain with exposed roots causes the three-dimensional flow structure to deviate from that anticipated based on previous studies of flows over idealised two-dimensional roughness elements. The results emphasise varied effects of inheritance of flow structures that are generated upstream-the local response of the flow to similar obstacles depends on their spatial organisation and larger-scale context. Key differences from idealised models include the absence of a fully-developed flow at any location in the test section, and various interactions of flow structures such as a reduction of flow separation due to cross-stream circulation and the diversion of the flow over and around the irregular shapes of the roots.	[Reesink, Arnold Jan H.] Lancing Coll, Lancing, England; [Reesink, Arnold Jan H.; Darby, Stephen E.; Sear, David A.; Leyland, Julian; Morgan, Peter R.; Richardson, Keith] Univ Southampton, Sch Geog & Environm Sci, Southampton, Hants, England; [Brasington, James] Univ Waikato, NIWA, Joint Inst Freshwater Management, Hamilton, New Zealand	University of Southampton; National Institute of Water & Atmospheric Research (NIWA) - New Zealand; University of Waikato	Reesink, AJH (corresponding author), Lancing Coll, Lancing, England.; Reesink, AJH (corresponding author), Univ Southampton, Sch Geog & Environm Sci, Southampton, Hants, England.	ajhr@lancing.org.uk	Darby, Stephen E/J-5799-2012	Darby, Stephen/0000-0001-8778-4394; Reesink, Arnold Jan Herman/0000-0001-9528-6205; Brasington, James/0000-0002-1383-7462	UK Natural Environment Research Council (NERC) [NE/E009832/1]; NERC [NE/E009832/1] Funding Source: UKRI	UK Natural Environment Research Council (NERC)(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This research was supported by award NE/E009832/1 (to S.E.D and D.A.S) from the UK Natural Environment Research Council (NERC). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aalto R., 2008, J GEOPHYS RES, V113, P1, DOI DOI 10.1029/2006JF000627; Aberle J, 2013, J HYDRAUL RES, V51, P33, DOI 10.1080/00221686.2012.754795; [Anonymous], 1993, WETLANDS WORLD; ARMALY BF, 1983, J FLUID MECH, V127, P473, DOI 10.1017/S0022112083002839; BAKER CJ, 1980, J WIND ENG IND AEROD, V6, P9, DOI 10.1016/0167-6105(80)90018-5; BAKER CJ, 1979, J FLUID MECH, V95, P347, DOI 10.1017/S0022112079001506; Beffa C, 2001, J HYDROL ENG, V6, P397, DOI 10.1061/(ASCE)1084-0699(2001)6:5(397); BENNETT SJ, 1995, SEDIMENTOLOGY, V42, P491, DOI 10.1111/j.1365-3091.1995.tb00386.x; BERGERON NE, 1992, WATER RESOUR RES, V28, P2155, DOI 10.1029/92WR00897; Best J, 2002, J GEOPHYS RES-OCEANS, V107, DOI 10.1029/2000JC000294; Biron PM, 2004, EARTH SURF PROC LAND, V29, P1403, DOI 10.1002/esp.1111; Blois G, 2014, GEOPHYS RES LETT, V41, P6435, DOI 10.1002/2014GL060906; BOGARD DG, 1986, J FLUID MECH, V162, P389, DOI 10.1017/S0022112086002094; Brasington J, 2012, WATER RESOUR RES, V48, DOI 10.1029/2012WR012223; BRIDGE JS, 1977, EARTH SURF PROC LAND, V2, P281, DOI 10.1002/esp.3290020402; Buffin-Belanger T, 2005, GEOMORPHOLOGY, V68, P77, DOI 10.1016/j.geomorph.2004.09.032; Buffin-Belanger T, 2003, EARTH SURF PROC LAND, V28, P787, DOI 10.1002/esp.490; Coceal O, 2007, J FLUID MECH, V589, P375, DOI 10.1017/S002211200700794X; Coleman SE, 2007, J ENG MECH, V133, P194, DOI 10.1061/(ASCE)0733-9399(2007)133:2(194); Connell RJ, 2001, J HYDROL ENG, V6, P406, DOI 10.1061/(ASCE)1084-0699(2001)6:5(406); Dixon SJ, 2016, EARTH SURF PROC LAND, V41, P997, DOI 10.1002/esp.3919; Einstein H.A., 1950, EOS T AM GEOPHYS UN, V31, P603, DOI [DOI 10.1029/TR031I004P00603, 10.1029/TR031i004p00603]; Einstein H.A., 1958, EOS T AM GEOPHYS UN, V39, P1085, DOI DOI 10.1029/TR039I006P01085; ENGEL P, 1981, J HYDR ENG DIV-ASCE, V107, P1133; Ewen J, 2013, Q J ROY METEOR SOC, V139, P350, DOI 10.1002/qj.2026; FARIVAR D, 1981, AIAA J, V19, P275, DOI 10.2514/3.7771; Fernandez R, 2006, WATER RESOUR RES, V42, DOI 10.1029/2005WR004330; Floryan JM, 2011, PHYS FLUIDS, V23, DOI 10.1063/1.3644694; Frankel KL, 2007, J GEOPHYS RES-EARTH, V112, DOI 10.1029/2006JB004350; Goring DG, 2002, J HYDRAUL ENG-ASCE, V128, P117, DOI 10.1061/(ASCE)0733-9429(2002)128:1(117); GREGORY KJ, 1985, HYDROLOG SCI J, V30, P371, DOI 10.1080/02626668509491000; Hardy RJ, 2007, WATER RESOUR RES, V43, DOI 10.1029/2006WR004936; Hardy RJ, 2009, J GEOPHYS RES-EARTH, V114, DOI 10.1029/2007JF000970; Heritage G, 2007, EARTH SURF PROC LAND, V32, P66, DOI 10.1002/esp.1375; Hodder KH, 2005, 648 NORTHM HOUS; Hughes FMR, 2003, FLOBAR2; Jeffiries R, 2003, GEOMORPHOLOGY, V51, P61, DOI 10.1016/S0169-555X(02)00325-2; Junk W.J., 1997, CENTRAL AMAZON FLOOD, P3, DOI DOI 10.1007/978-3-662-03416-3_1; Keylock CJ, 2014, J GEOPHYS RES-EARTH, V119, P264, DOI 10.1002/2012JF002698; KIM J, 1980, J FLUID ENG-T ASME, V102, P302, DOI 10.1115/1.3240686; Kitts D. R., 2010, THESIS; KNIGHT DW, 1983, J HYDRAUL ENG-ASCE, V109, P1073, DOI 10.1061/(ASCE)0733-9429(1983)109:8(1073); Le H, 1997, J FLUID MECH, V330, P349, DOI 10.1017/S0022112096003941; Lefebvre A, 2016, GEO-MAR LETT, V36, P121, DOI 10.1007/s00367-016-0436-8; LU SS, 1973, J FLUID MECH, V60, P481, DOI 10.1017/S0022112073000315; Marjoribanks TI, 2014, J HYDRAUL RES, V52, P775, DOI 10.1080/00221686.2014.948502; MCKAY MD, 1979, TECHNOMETRICS, V21, P239, DOI 10.2307/1268522; McLean SR, 2006, WATER RESOUR RES, V42, DOI 10.1029/2005WR004708; McLelland SJ, 2000, HYDROL PROCESS, V14, P351, DOI 10.1002/(SICI)1099-1085(20000215)14:2<351::AID-HYP963>3.0.CO;2-K; Millington CE, 2007, EARTH SURF PROC LAND, V32, P1204, DOI 10.1002/esp.1552; MULHEARN P J, 1978, Boundary-Layer Meteorology, V15, P109, DOI 10.1007/BF00165509; Nagihara S, 2004, EARTH SURF PROC LAND, V29, P391, DOI 10.1002/esp.1026; Nepf HM, 2012, ANNU REV FLUID MECH, V44, P123, DOI 10.1146/annurev-fluid-120710-101048; Nicholas AP, 1997, EARTH SURF PROC LAND, V22, P59, DOI 10.1002/(SICI)1096-9837(199701)22:1&lt;59::AID-ESP652&gt;3.0.CO;2-R; Nikora V, 2001, J HYDRAUL ENG-ASCE, V127, P123, DOI 10.1061/(ASCE)0733-9429(2001)127:2(123); Nikora V, 2007, J HYDRAUL ENG, V133, P873, DOI 10.1061/(ASCE)0733-9429(2007)133:8(873); NORBERG C, 1994, J FLUID MECH, V258, P287, DOI 10.1017/S0022112094003332; Omidyeganeh M, 2013, J FLUID MECH, V734, P509, DOI 10.1017/jfm.2013.499; Omidyeganeh M, 2013, J FLUID MECH, V721, P454, DOI 10.1017/jfm.2013.36; Omidyeganeh M, 2011, J TURBUL, V12, P1, DOI 10.1080/14685248.2011.609820; Pokrajac D, 2007, EXP FLUIDS, V42, P413, DOI 10.1007/s00348-006-0248-0; Raven PJ, 1998, PHYS CHARACTER RIVER; Robert A, 1996, GEOMORPHOLOGY, V16, P175, DOI 10.1016/0169-555X(95)00143-S; Schatz V, 2006, GEOMORPHOLOGY, V81, P207, DOI 10.1016/j.geomorph.2006.04.009; Schmeeckle MW, 2015, EARTH SURF DYNAM, V3, P105, DOI 10.5194/esurf-3-105-2015; Sear DA, 2010, GEOMORPHOLOGY, V116, P305, DOI 10.1016/j.geomorph.2009.11.022; Smith MW, 2014, EARTH-SCI REV, V136, P202, DOI 10.1016/j.earscirev.2014.05.016; Solid Terrain Modeling Inc, PHYS TERR MOD DESCR; Stoesser T, 2008, ACTA GEOPHYS, V56, P876, DOI 10.2478/s11600-008-0030-1; Sumner D, 1999, J FLUID STRUCT, V13, P309, DOI 10.1006/jfls.1999.0205; Thomas H, 2007, WATER ENVIRON J, V21, P114, DOI 10.1111/j.1747-6593.2006.00056.x; Thomas H, 2012, J FLOOD RISK MANAG, V5, P164, DOI 10.1111/j.1753-318X.2012.01137.x; Trigg MA, 2012, WATER RESOUR RES, V48, DOI 10.1029/2012WR011888; VANRIJN LC, 1984, J HYDRAUL ENG-ASCE, V110, P1733, DOI 10.1061/(ASCE)0733-9429(1984)110:12(1733); Vermaas DA, 2011, WATER RESOUR RES, V47, DOI 10.1029/2010WR010138; Wallace JM, 2016, ANNU REV FLUID MECH, V48, P131, DOI 10.1146/annurev-fluid-122414-034550; Wang C, 2016, COMPUT FLUIDS, V137, P70, DOI 10.1016/j.compfluid.2016.07.015; Zdravkovich MM, 1997, FUNDAMENTALS, V1	78	3	3	4	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2020	15	2							e0229306	10.1371/journal.pone.0229306	http://dx.doi.org/10.1371/journal.pone.0229306			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8FM	32101590	Green Published, gold, Green Accepted			2022-12-26	WOS:000535233700025
J	Contreras-Alonso, MR; Ezquerra-Canalejo, A; Perez-Martin, E; Herrero-Tejedor, TR; Medina, SLC				Rosario Contreras-Alonso, Ma; Ezquerra-Canalejo, Alejandra; Perez-Martin, Enrique; Herrero-Tejedor, Tomas R.; Lopez-Cuervo Medina, Serafin			Environmental assessment of Obstacle Limitation Surfaces (OLS) in airports using geographic information technologies	PLOS ONE			English	Article								A series of 3D obstacle limitation surfaces (OLS) define the limits to which objects may project in the airspace in order to configure the airspace around aerodromes that must be kept free from obstacles. The aim is to ensure that aircraft can safely carry out their scheduled operations, and to prevent the aerodromes from becoming unusable due to the proliferation of obstacles in the surrounding area. One such possible obstacle is the vegetation growing in the zone. This work consists of a study of the variation in the vegetation in the El Prat airport (Barcelona-El Prat Josep Tarradellas) and the surrounding area in the years 2011-2018, and of the way in which it has influenced the configuration of the OLS. Until 2010, obstacle studies were carried out every four years but the growth of plant obstacles during this period was not controlled. Although the rate of tree growth depends on several factors such as age, species, site quality and forestry treatment, the parameter analysed in this research is height, as this is what will interfere in the OLS. This study therefore focuses on measuring the height and geolocation of the obstacle in order to determine its influence on the OLS, and on determining the subsequent actions, if any, that need to be taken in regard to this vegetation element to avoid it becoming a risk to operational safety. As a result, the growth and vulnerability of 84 vegetation obstacles from 794 terrain elements have been detected. The result of this study is the design, using geographic information systems, of a tool to assist airport managers in the automated control and monitoring of the vegetation in the obstacle limitation surfaces to avoid compromising the safety of airport operations and mitigating environmental impacts.	[Rosario Contreras-Alonso, Ma; Ezquerra-Canalejo, Alejandra] Univ Politecn Madrid, Dept Ingn & Gest & Forestal & Ambiental, Madrid, Spain; [Perez-Martin, Enrique; Herrero-Tejedor, Tomas R.] Univ Politecn Madrid, Dept Ingn Agroforestal, Madrid, Spain; [Lopez-Cuervo Medina, Serafin] Univ Politecn Madrid, Dept Ingn Topog & Cartog, Madrid, Spain	Universidad Politecnica de Madrid; Universidad Politecnica de Madrid; Universidad Politecnica de Madrid	Perez-Martin, E (corresponding author), Univ Politecn Madrid, Dept Ingn Agroforestal, Madrid, Spain.	enrique.perez@upm.es	Perez-Martin, Enrique/A-8910-2012; Herrero-Tejedor, Tomas Ramon/A-9600-2012; Medina, Serafin Lopez-Cuervo/L-4082-2017	Perez-Martin, Enrique/0000-0002-3827-0570; Herrero-Tejedor, Tomas Ramon/0000-0002-4827-1403; Medina, Serafin Lopez-Cuervo/0000-0003-2396-7815				Dos Santos FAB, 2014, B CIENC GEOD, V20, P504, DOI 10.1590/S1982-21702014000300029; Chang S-W., 2016, J CIVIL ENG ARCHITEC, P553; Cuadra L, 2019, RENEW ENERG, V135, P566, DOI 10.1016/j.renene.2018.12.038; Do-Hyun Kim, 2016, [Journal of the Korean Society for Aeronautical Science and Flight operation, 한국항공운항학회지], V24, P24; Garrido-Villen N, 2015, J SURV ENG, V141, DOI 10.1061/(ASCE)SU.1943-5428.0000142; Gavran D, 2017, P AIIT INT C TRANSP; Gomez C, 2015, GEOMORPHOLOGY, V242, P11, DOI 10.1016/j.geomorph.2015.02.021; Huang B, 2004, J ENVIRON INFORM, V3, P42, DOI 10.3808/jei.200400026; 김무근, 2016, [Korean Journal of Ornithology, 한국조류학회지], V23, P21; ICAO, 2009, CONV INT CIV AV AER, VI; Kim Hui-yang, 2019, [The Korean Journal of Air & Space Law and Policy, 항공우주정책 Â·법학회지], V34, P159, DOI 10.31691/KASL34.1.5; [李鹏 Li Peng], 2011, [测绘科学, Science of Surveying and Mapping], V36, P198; Panayotov A, 2008, P 3 INT C SCI COMP C; Prado Molina Jorge, 2012, Invest. Geog, P75; Qiao X, 2016, INT ARCH PHOTOGRAMME, V41; RODRIGUES MAF, 2011, GOOGLE PATENTS; Sandaradura AS, 2015, QUANTITATIVE RISK AN; Uddin W, 2013, J AIRPORT MANAGEMENT, V7, P179; Uddin W, 2002, 2002 FAA TECHN TRANS; Uddin W, 2011, TRANSPORT RES REC, P117, DOI 10.3141/2214-15; [王建国 Wang Jianguo], 2012, [测绘科学, Science of Surveying and Mapping], V37, P179	21	0	2	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2020	15	2							e0229378	10.1371/journal.pone.0229378	http://dx.doi.org/10.1371/journal.pone.0229378			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8FM	32101589	Green Published, gold			2022-12-26	WOS:000535233700028
J	Tang, BY; Li, X; Maretzky, T; Perez-Aguilar, JM; McIlwain, D; Xie, YF; Zheng, YF; Mak, TW; Weinstein, H; Blobel, CP				Tang, Beiyu; Li, Xue; Maretzky, Thorsten; Perez-Aguilar, Jose Manuel; McIlwain, David; Xie, Yifang; Zheng, Yufang; Mak, Tak W.; Weinstein, Harel; Blobel, Carl P.			Substrate-selective protein ectodomain shedding by ADAM17 and iRhom2 depends on their juxtamembrane and transmembrane domains	FASEB JOURNAL			English	Article						ADAM17 (a disintegrin and metalloprotease 17); EGFR (epidermal growth factor receptor); iRhom1/2 (inactive Rhomboid like protein 1/2); Rhbdf1/2 (rhomboid family member 1/2); TGF alpha (transforming growth factor alpha); TNF alpha (tumor necrosis factor alpha)	NECROSIS-FACTOR-ALPHA; EGF-RECEPTOR; MOLECULAR SWITCH; DISINTEGRIN; PHOSPHORYLATION; ACTIVATION; ENZYME; METALLOPROTEINASE; INTERLEUKIN-6; INFLAMMATION	The metalloprotease ADAM17 (a disintegrin and metalloprotease 17) regulates EGF-receptor and TNF alpha signaling, thereby not only protecting the skin and intestinal barrier, but also contributing to autoimmunity. ADAM17 can be rapidly activated by many stimuli through its transmembrane domain (TMD), with the seven membrane-spanning inactive Rhomboids (iRhom) 1 and 2 implicated as candidate regulatory partners. However, several alternative models of ADAM17 regulation exist that do not involve the iRhoms, such as regulation through disulfide bond exchange or through interaction with charged phospholipids. Here, we report that a non-activatable mutant of ADAM17 with the TMD of betacellulin (BTC) can be rescued by restoring residues from the ADAM17 TMD, but only in Adam17(-/-) cells, which contain iRhoms, not in iRhom1/2(-/-) cells. We also provide the first evidence that the extracellular juxtamembrane domains (JMDs) of ADAM17 and iRhom2 regulate the stimulation and substrate selectivity of ADAM17. Interestingly, a point mutation in the ADAM17 JMD identified in a patient with Tetralogy of Fallot, a serious heart valve defect, affects the substrate selectivity of ADAM17 toward Heparin-binding epidermal growth factor like growth factor (HB-EGF), a crucial regulator of heart valve development in mice. These findings provide new insights into the regulation of ADAM17 through an essential interaction with the TMD1 and JMD1 of iRhom2.	[Tang, Beiyu; Li, Xue; Blobel, Carl P.] Hosp Special Surg, Arthrit & Tissue Degenerat Program, 535 E 70th St, New York, NY 10021 USA; [Tang, Beiyu] Weill Cornell Med, Dept Pharmacol, New York, NY USA; [Li, Xue] Weill Cornell Med, Dept Biochem Cellular & Mol Biol, New York, NY USA; [Maretzky, Thorsten] Univ Iowa, Inflammat Program, Iowa City, IA USA; [Maretzky, Thorsten] Univ Iowa, Dept Internal Med, Roy J & Lucille A Carver Coll Med, Iowa City, IA 52242 USA; [Perez-Aguilar, Jose Manuel; Weinstein, Harel; Blobel, Carl P.] Weill Cornell Med, Dept Physiol Biophys & Syst Biol, New York, NY USA; [Perez-Aguilar, Jose Manuel] Meritorious Autonomous Univ Puebla BUAP, Sch Chem Sci, Puebla, Mexico; [McIlwain, David] Stanford Univ, Dept Microbiol & Immunol, Baxter Lab Stem Cell Biol, Stanford, CA 94305 USA; [McIlwain, David; Mak, Tak W.] Univ Hlth Network, Campbell Family Inst Breast Canc Res, Princess Margaret Canc Ctr, Toronto, ON, Canada; [Xie, Yifang; Zheng, Yufang] Fudan Univ, Inst Reprod & Dev, State Key Lab Genet Engn, Obstet & Gynecol Hosp,Sch Life Sci, Shanghai, Peoples R China; [Xie, Yifang; Zheng, Yufang] Fudan Univ, Collaborat Innovat Ctr Genet & Dev, Key Lab Reprod Regulat NPFPC, Shanghai, Peoples R China; [Xie, Yifang; Zheng, Yufang] Fudan Univ, Inst Biomed Sci, Shanghai, Peoples R China; [Blobel, Carl P.] Tech Univ Munich, Inst Adv Study, Garching, Germany	Cornell University; Cornell University; University of Iowa; University of Iowa; Cornell University; Stanford University; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; Fudan University; Fudan University; Fudan University; Technical University of Munich	Blobel, CP (corresponding author), Weill Cornell Med, Hosp Special Surg, 535 East 70th, New York, NY 10021 USA.	blobelc@hss.edu	WEINSTEIN, HAREL/O-8245-2019; Maretzky, Thorsten/AEN-1915-2022; Zheng, Yufang/F-1091-2011; Maretzky, Thorsten/GSN-2981-2022	WEINSTEIN, HAREL/0000-0003-3473-9818; Maretzky, Thorsten/0000-0003-1282-6080; Zheng, Yufang/0000-0002-0488-2624; Xie, Yifang/0000-0002-5501-4018	HHS | National Institutes of Health (NIH) [R01 GM64750, R35 GM134907]	HHS | National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	HHS | National Institutes of Health (NIH), Grant/Award Number: R01 GM64750 and R35 GM134907	Adrain C, 2012, SCIENCE, V335, P225, DOI 10.1126/science.1214400; Ardito CM, 2012, CANCER CELL, V22, P304, DOI 10.1016/j.ccr.2012.07.024; Black RA, 1997, NATURE, V385, P729, DOI 10.1038/385729a0; Blaydon DC, 2011, NEW ENGL J MED, V365, P1502, DOI 10.1056/NEJMoa1100721; Blobel CP, 2005, NAT REV MOL CELL BIO, V6, P32, DOI 10.1038/nrm1548; Cavadas M, 2017, CELL REP, V21, P745, DOI 10.1016/j.celrep.2017.09.074; Chalaris A, 2010, J EXP MED, V207, P1617, DOI 10.1084/jem.20092366; Doedens JR, 2003, BIOCHEM BIOPH RES CO, V308, P331, DOI 10.1016/S0006-291X(03)01381-0; Dusterhoft S, 2015, BIOCHEMISTRY-US, V54, P5791, DOI 10.1021/acs.biochem.5b00497; Dusterhoft S, 2014, J BIOL CHEM, V289, P16336, DOI 10.1074/jbc.M114.557322; Dusterhoft S, 2013, J AM CHEM SOC, V135, P5776, DOI 10.1021/ja400340u; Franzke CW, 2012, J EXP MED, V209, P1105, DOI 10.1084/jem.20112258; Garbers C, 2018, NAT REV DRUG DISCOV, V17, P395, DOI 10.1038/nrd.2018.45; Gooz P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033350; Grieve AG, 2017, ELIFE, V6, DOI 10.7554/eLife.23968; Grotzinger J, 2017, BBA-MOL CELL RES, V1864, P2088, DOI 10.1016/j.bbamcr.2017.05.024; Gschwind A, 2003, EMBO J, V22, P2411, DOI 10.1093/emboj/cdg231; Horiuchi K, 2007, J IMMUNOL, V179, P2686, DOI 10.4049/jimmunol.179.5.2686; Horiuchi K, 2007, MOL BIOL CELL, V18, P176, DOI 10.1091/mbc.E06-01-0014; Inoue A, 2012, NAT METHODS, V9, P1021, DOI [10.1038/nmeth.2172, 10.1038/NMETH.2172]; Inoue A, 2011, EMBO J, V30, P4248, DOI 10.1038/emboj.2011.296; Issuree PDA, 2013, J CLIN INVEST, V123, P928, DOI 10.1172/JCI66168; Jackson LF, 2003, EMBO J, V22, P2704, DOI 10.1093/emboj/cdg264; Kawaguchi N, 2007, J CELL SCI, V120, P943, DOI 10.1242/jcs.03403; Krossa S, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-19429-4; Kunzel U, 2018, ELIFE, V7, DOI 10.7554/eLife.35012; Lambrecht BN, 2018, NAT REV IMMUNOL, V18, P745, DOI 10.1038/s41577-018-0068-5; Le Gall SM, 2010, J CELL SCI, V123, P3913, DOI 10.1242/jcs.069997; Le Gall SM, 2009, MOL BIOL CELL, V20, P1785, DOI 10.1091/mbc.E08-11-1135; Li X, 2017, J CELL SCI, V130, P868, DOI 10.1242/jcs.196436; Li X, 2015, P NATL ACAD SCI USA, V112, P6080, DOI 10.1073/pnas.1505649112; Maretzky T, 2013, P NATL ACAD SCI USA, V110, P11433, DOI 10.1073/pnas.1302553110; Maretzky T, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1232; McIlwain DR, 2012, SCIENCE, V335, P229, DOI 10.1126/science.1214448; Moss ML, 1997, NATURE, V385, P733, DOI 10.1038/385733a0; Murphy G, 2008, NAT REV CANCER, V8, P929, DOI 10.1038/nrc2459; Oikonomidi I, 2018, ELIFE, V7, DOI 10.7554/eLife.35032; Peschon JJ, 1998, SCIENCE, V282, P1281, DOI 10.1126/science.282.5392.1281; Reiss K, 2017, BBA-MOL CELL RES, V1864, P2082, DOI 10.1016/j.bbamcr.2017.06.006; Sahin U, 2004, J CELL BIOL, V164, P769, DOI 10.1083/jcb.200307137; Sahin U, 2007, FEBS LETT, V581, P41, DOI 10.1016/j.febslet.2006.11.074; Scheller J, 2014, SEMIN IMMUNOL, V26, P2, DOI 10.1016/j.smim.2013.11.002; Scheller J, 2011, TRENDS IMMUNOL, V32, P380, DOI 10.1016/j.it.2011.05.005; Schlondorff J, 2000, BIOCHEM J, V347, P131, DOI 10.1042/0264-6021:3470131; Schwarz J, 2013, BBA-MOL CELL RES, V1833, P3355, DOI 10.1016/j.bbamcr.2013.10.005; Seegar TCM, 2017, CELL, V171, P1638, DOI 10.1016/j.cell.2017.11.014; Siggs OM, 2012, BLOOD, V119, P5769, DOI 10.1182/blood-2012-03-417949; Sommer A, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11523; Soond SM, 2005, J CELL SCI, V118, P2371, DOI 10.1242/jcs.02357; Urban S, 2001, CELL, V107, P173, DOI 10.1016/S0092-8674(01)00525-6; Weber S, 2012, DEVELOPMENT, V139, P3693, DOI 10.1242/dev.076398; Willems SH, 2010, BIOCHEM J, V428, P439, DOI 10.1042/BJ20100179; Xie YF, 2019, CLIN SCI, V133, P225, DOI 10.1042/CS20180842; Xu PL, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002689; Xu PL, 2010, MOL CELL, V37, P551, DOI 10.1016/j.molcel.2010.01.034; Zunke F, 2017, BBA-MOL CELL RES, V1864, P2059, DOI 10.1016/j.bbamcr.2017.07.001	56	14	14	0	9	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2020	34	4					4956	4969		10.1096/fj.201902649R	http://dx.doi.org/10.1096/fj.201902649R		FEB 2020	14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	LJ5ZA	32103528	Green Accepted, Bronze			2022-12-26	WOS:000517907200001
J	Gaveikaite, V; Grundstrom, C; Lourida, K; Winter, S; Priori, R; Chouvarda, I; Maglaveras, N				Gaveikaite, Violeta; Grundstrom, Casandra; Lourida, Katerina; Winter, Stefan; Priori, Rita; Chouvarda, Ioanna; Maglaveras, Nicos			Developing a strategic understanding of telehealth service adoption for COPD care management: A causal loop analysis of healthcare professionals	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; UNMET NEEDS; EXPERIENCES; TELECARE; PATIENT; SEARCH	Background Telehealth services can improve the quality of health services for chronic obstructive pulmonary disease (COPD) management, but the clinical benefits for patients yet not clear. It is crucial to develop a strategy that supports the engagement of healthcare professionals to promote the sustainable adoption of telehealth services further. The aim of the study was to show how variables related to the perception of telehealth services for COPD by different healthcare professionals interact to influence its adoption and to generate advice for future telehealth service implementation. Methods Data was thematically synthesized from published qualitative studies to create causal loop diagrams, further validated by expert interviews. These diagrams visualize dependencies and their polarity between different variables. Results Adoption of telehealth services from the nurse's perspective is directly affected by change management and autonomous decision making. From the physician's perspective, perceived value is the most important variable. Physical activity management and positive user experience are considered affecting perceived value for physiotherapists. There is no consensus where self-management services should be positioned in the COPD care pathway. Conclusion Our results indicate how complex interactions between multiple variables influence the adoption of telehealth services. Consequently, there is a need for multidimensional interventions to achieve adoption. Moreover, key variables were identified that require attention to ensure success of telehealth services. Furthermore, it is necessary to explore where selfmanagement services are best positioned in the care pathway of COPD patients.	[Gaveikaite, Violeta; Lourida, Katerina; Chouvarda, Ioanna; Maglaveras, Nicos] Aristotle Univ Thessaloniki, Lab Comp Med Informat & Biomed Imaging Technol, Thessaloniki, Greece; [Gaveikaite, Violeta; Priori, Rita] Philips Res, Dept Chron Dis Management, Eindhoven, Netherlands; [Grundstrom, Casandra] Univ Oulu, Fac Informat Technol & Elect Engn, M3S, Oulu, Finland; [Winter, Stefan] Philips Res, Dept Chron Dis Management, Aachen, Germany; [Maglaveras, Nicos] Northwestern Univ, Dept IEMS, McCormick Sch Engn, Evanston, IL USA	Aristotle University of Thessaloniki; Philips; Philips Research; University of Oulu; Philips; Philips Research; Northwestern University	Gaveikaite, V (corresponding author), Aristotle Univ Thessaloniki, Lab Comp Med Informat & Biomed Imaging Technol, Thessaloniki, Greece.; Gaveikaite, V (corresponding author), Philips Res, Dept Chron Dis Management, Eindhoven, Netherlands.	gaveikaite@gmail.com	Chouvarda, Ioanna/AAV-1500-2020; Grundstrom, Casandra/AAF-5376-2021; Maglaveras, Nicos/ABI-2190-2020	Chouvarda, Ioanna/0000-0001-8915-6658; Grundstrom, Casandra/0000-0001-6410-144X; Maglaveras, Nicos/0000-0002-4919-0664	European Union [676201]	European Union(European Commission)	Authors VG and CG received funding from the European Union's Horizon 2020 research and innovation programme - Marie SklodowskaCurie Actions Grant Agreement No. 676201 - CHESS - Connected Health Early Stage Researcher Support System.	[Anonymous], 2017, DEPLOYMENT TELEHEALT, P41; Barken TL, 2017, BMC MED INFORM DECIS, V17, DOI 10.1186/s12911-017-0573-7; Bertoncello C, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0207332; Biener AI, 2019, JAMA-J AM MED ASSOC, V322, P602, DOI 10.1001/jama.2019.10241; Bolton CE, 2011, J EVAL CLIN PRACT, V17, P1216, DOI 10.1111/j.1365-2753.2010.01536.x; Booth A., 2016, GUIDANCE CHOOSING QU; Booth A, 2018, J CLIN EPIDEMIOL, V99, P41, DOI 10.1016/j.jclinepi.2018.03.003; Brewster L, 2014, J ADV NURS, V70, P21, DOI 10.1111/jan.12196; Brunton L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139561; Burns JR, 2001, ATL SD C FLOR, P1; Carroll C, 2017, BMJ-BRIT MED J, V356, DOI 10.1136/bmj.j80; Clari M, 2018, COPD, V15, P79, DOI 10.1080/15412555.2017.1417373; Craig Peter, 2008, BMJ, V337, pa1655, DOI 10.1136/bmj.a1655; Cruz J, 2014, INT J CLIN PRACT, V68, P369, DOI 10.1111/ijcp.12345; de Pinto H, 2015, GUIDE CREATING CAUSA, P20; Dinesen B, 2013, INT J ENV RES PUB HE, V10, P6184, DOI 10.3390/ijerph10116184; Donner CF, 2018, RESP MED, V143, P91, DOI 10.1016/j.rmed.2018.09.003; Fairbrother P, 2013, PATIENT EDUC COUNS, V93, P403, DOI 10.1016/j.pec.2013.04.003; Farre A, 2019, BMJ QUAL SAF, V28, P1021, DOI 10.1136/bmjqs-2018-009082; Fitzsimmons DA, 2016, BMC HEALTH SERV RES, V16, DOI 10.1186/s12913-016-1623-z; Flax VL, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178298; Flemming K, 2019, BMJ GLOB HEALTH, V4, DOI 10.1136/bmjgh-2018-000882; Gale NK, 2013, BMC MED RES METHODOL, V13, DOI 10.1186/1471-2288-13-117; Gardener AC, 2018, INT J CHRONIC OBSTR, V13, P1021, DOI 10.2147/COPD.S155622; Greenhalgh T, 2005, BRIT MED J, V331, P1064, DOI 10.1136/bmj.38636.593461.68; Grundstrom C, 2019, INT CONF PER COMP, P444, DOI 10.1145/3329189.3329243; Halding AG, 2018, INT J CHRONIC OBSTR, V13, P2075, DOI 10.2147/COPD.S158058; Hibbert D, 2004, J TELEMED TELECARE, V10, P226, DOI 10.1258/1357633041424386; Incalzi RA, 2014, EUR J INTERN MED, V25, P320, DOI 10.1016/j.ejim.2013.10.001; Joseph V, 2011, J TELEMED TELECARE, V17, P71, DOI 10.1258/jtt.2010.100315; Kim H, 2012, SYST DYNAM REV, V28, P311, DOI 10.1002/sdr.1480; Lee SI, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-16561-5; Lenzen SA, 2017, INT J NURS STUD, V80, P1, DOI 10.1016/j.ijnurstu.2017.12.005; Lilholt PH, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2016-014587; Lundell S, 2017, BMC HEALTH SERV RES, V17, P1; MacNeill V, 2014, BRIT J GEN PRACT, V64, pE401, DOI 10.3399/bjgp14X680485; Mair FS, 2008, CHRONIC ILLN, V4, P110, DOI 10.1177/1742395308092482; McLean Susannah, 2011, BMJ, V342, pd120, DOI 10.1136/bmj.d120; Minet LR, 2015, BMC MED INFORM DECIS, V15, DOI 10.1186/s12911-014-0124-4; Nickelsen NCM, 2019, SOCIOL HEALTH ILL, V41, P67, DOI 10.1111/1467-9566.12781; Nickelsen NCM, 2017, J WORKPLACE LEARN, V29, P588, DOI 10.1108/JWL-03-2017-0024; Odeh Bassel, 2014, Br J Nurs, V23, P1133, DOI 10.12968/bjon.2014.23.21.1133; Orme MW, 2018, JMIR MHEALTH UHEALTH, V6, DOI 10.2196/mhealth.9398; Owen B, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0195141; Ozawa S., 2016, BMC HEALTH SERV RES, V16, P131; Patalano F, 2014, EUR RESPIR REV, V23, P333, DOI 10.1183/09059180.00004014; Pedone Claudio, 2015, Pneumonol Alergol Pol, V83, P476, DOI 10.5603/PiAP.2015.0077; Pinnock H, 2012, THORAX, V67, pA145, DOI 10.1136/thoraxjnl-2012-202678.247; Roberts A, 2012, SCOT MED J, V57, P33, DOI 10.1258/smj.2011.011288; Ross Jamie, 2016, Implement Sci, V11, P146; Segato F, 2017, HEALTH POLICY TECHN, V6, P268, DOI 10.1016/j.hlpt.2017.07.003; Stallberg B, 2018, NPJ PRIM CARE RESP M, V28, DOI 10.1038/s41533-018-0101-y; Sterman JD, 2006, AM J PUBLIC HEALTH, V96, P505, DOI 10.2105/AJPH.2005.066043; Thomas J, 2008, BMC MED RES METHODOL, V8, DOI 10.1186/1471-2288-8-45; Udsen FW, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2016-014616; Ure J, 2012, PRIM CARE RESP J, V21, P57, DOI 10.4104/pcrj.2011.00065; VITACCA M, 2018, THER ADV RESPIR DIS, V12, P153, DOI DOI 10.1177/1753465818754778; Vorrink Sigrid, 2017, JMIR Hum Factors, V4, pe20, DOI 10.2196/humanfactors.7196; Willis CD, 2012, BMJ QUAL SAF, V21, P250, DOI 10.1136/bmjqs-2011-000482; Yourkavitch J, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0201870; Zanaboni P, 2012, BMC MED INFORM DECIS, V12, DOI 10.1186/1472-6947-12-1	61	7	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2020	15	3							e0229619	10.1371/journal.pone.0229619	http://dx.doi.org/10.1371/journal.pone.0229619			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LQ8RK	32134958	Green Published, gold			2022-12-26	WOS:000535265600034
J	McClintock, SD; Attili, D; Dame, MK; Richter, A; Silvestri, SS; Berner, MM; Bohm, MS; Karpoff, K; McCarthy, CL; Spence, JR; Varani, J; Aslam, MN				McClintock, Shannon D.; Attili, Durga; Dame, Michael K.; Richter, Aliah; Silvestri, Sabrina S.; Berner, Maliha M.; Bohm, Margaret S.; Karpoff, Kateryna; McCarthy, Caroline L.; Spence, Jason R.; Varani, James; Aslam, Muhammad N.			Differentiation of human colon tissue in culture: Effects of calcium on trans-epithelial electrical resistance and tissue cohesive properties	PLOS ONE			English	Article							CELL-CELL-ADHESION; VITAMIN-D; INTESTINAL BARRIER; TIGHT JUNCTIONS; IN-VITRO; SENSING RECEPTOR; CHRONIC DISEASES; PERMEABILITY; HEALTH; PROLIFERATION	Background and aims Human colonoid cultures maintained under low-calcium (0.25 mM) conditions undergo differentiation spontaneously and, concomitantly, express a high level of tight junction proteins, but not desmosomal proteins. When calcium is included to a final concentration of 1.5-3.0 mM (provided either as a single agent or as a combination of calcium and additional minerals), there is little change in tight junction protein expression but a strong up-regulation of desmosomal proteins and an increase in desmosome formation. The aim of this study was to assess the functional consequences of calcium-mediated differences in barrier protein expression. Methods Human colonoid-derived epithelial cells were interrogated in transwell culture under low- or high-calcium conditions for monolayer integrity and ion permeability by measuring trans-epithelial electrical resistance (TEER) across the confluent monolayer. Colonoid cohesiveness was assessed in parallel. Results TEER values were high in the low-calcium environment but increased in response to calcium. In addition, colonoid cohesiveness increased substantially with calcium supplementation. In both assays, the response to multi-mineral intervention was greater than the response to calcium alone. Consistent with these findings, several components of tight junctions were expressed at 0.25 mM calcium but these did not increase substantially with supplementation. Cadherin-17 and desmoglein-2, in contrast, were weakly-expressed under low calcium conditions but increased with intervention. Conclusions These findings indicate that low ambient calcium levels are sufficient to support the formation of a permeability barrier in the colonic epithelium. Higher calcium levels promote tissue cohesion and enhance barrier function. These findings may help explain how an adequate calcium intake contributes to colonic health by improving barrier function, even though there is little change in colonic histological features over a wide range of calcium intake levels.	[McClintock, Shannon D.; Richter, Aliah; Varani, James; Aslam, Muhammad N.] Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI 48109 USA; [Attili, Durga] Univ Michigan, Sch Med, Dept Cell & Dev Biol, Ann Arbor, MI USA; [Dame, Michael K.; Silvestri, Sabrina S.; Berner, Maliha M.; Bohm, Margaret S.; Karpoff, Kateryna; McCarthy, Caroline L.; Spence, Jason R.] Univ Michigan, Sch Med, Dept Internal Med, Div Gastroenterol, Ann Arbor, MI USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Aslam, MN (corresponding author), Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI 48109 USA.	mnaslam@med.umich.edu	Aslam, Muhammad Nadeem/I-7314-2012; Aslam, Muhammad/GRS-8220-2022	Aslam, Muhammad Nadeem/0000-0003-1361-5357; Aslam, Muhammad/0000-0002-6071-5468; McCarthy, Caroline/0000-0002-0990-3279; Bohm, Margaret/0000-0001-7409-7798; Dame, Michael K/0000-0003-3760-1654; Berner, Maliha/0000-0003-2392-3871	NIH (National Institutes of Health) [CA201782]; Office of Dietary Supplements; MCubed University of Michigan	NIH (National Institutes of Health)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Office of Dietary Supplements(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MCubed University of Michigan(University of Michigan System)	This work was supported by: i) CA201782 -NIH (National Institutes of Health), https://www.nih.gov/to JV; ii) Supplemental funding through the Office of Dietary Supplements, https://ods.od.nih.gov/to JV; iii) MCubed University of Michigan, https://mcubed.umich.edu/, to MNA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Marigot LTD (Cork, Ireland) for providing Aquamin1 as a gift. We thank the Microscopy and Imaging Laboratory (MIL) for help with confocal fluorescence microscopy. We thank the Translational Tissue Modeling Laboratory (TTML) for help with colonoid propagation and help with the TEER assay.	ADEY WH, 1970, BOT MAR, V13, P100, DOI 10.1515/botm.1970.13.2.100; Aijaz S, 2006, INT REV CYTOL, V248, P261, DOI 10.1016/S0074-7696(06)48005-0; ALBELDA SM, 1990, FASEB J, V4, P2868, DOI 10.1096/fasebj.4.11.2199285; Anghileri L. J., 1982, ROLE CALCIUM BIOL SY; Aslam M. N., 2016, Journal of Nutrition and Food Sciences, V6, P496; Aslam MN, 2020, CANCER PREV RES, V13, P101, DOI 10.1158/1940-6207.CAPR-19-0325; Aslam MN, 2010, INTEGR CANCER THER, V9, P93, DOI 10.1177/1534735409360360; Aslam MN, 2010, CALCIFIED TISSUE INT, V86, P313, DOI 10.1007/s00223-010-9340-9; Attili D, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0215122; Attili D, 2012, BIOL TRACE ELEM RES, V150, P467, DOI 10.1007/s12011-012-9503-9; Balk EM, 2017, OSTEOPOROSIS INT, V28, P3315, DOI 10.1007/s00198-017-4230-x; Baumgartner W, 2013, TISSUE BARRIERS, V1, DOI 10.4161/tisb.23815; BISSELL DM, 1987, J CLIN INVEST, V79, P801, DOI 10.1172/JCI112887; Moreira APB, 2012, BRIT J NUTR, V108, P801, DOI 10.1017/S0007114512001213; Bostick RM, 2015, J STEROID BIOCHEM, V148, P86, DOI 10.1016/j.jsbmb.2015.01.010; BUSET M, 1986, CANCER RES, V46, P5426; Camilleri M, 2012, NEUROGASTROENT MOTIL, V24, P503, DOI 10.1111/j.1365-2982.2012.01921.x; Carrillo-Lopez N, 2010, NEPHROL DIAL TRANSPL, V25, P2930, DOI 10.1093/ndt/gfq124; Cereijido M, 1998, ANNU REV PHYSIOL, V60, P161, DOI 10.1146/annurev.physiol.60.1.161; Clayburgh DR, 2004, LAB INVEST, V84, P282, DOI 10.1038/labinvest.3700050; Dame MK, 2018, DEVELOPMENT, V145, DOI 10.1242/dev.153049; Dame MK, 2014, LAB INVEST, V94, P222, DOI 10.1038/labinvest.2013.145; Dipolo R, 2006, PHYSIOL REV, V86, P155, DOI 10.1152/physrev.00018.2005; Dunlop SP, 2006, AM J GASTROENTEROL, V101, P1288, DOI 10.1111/j.1572-0241.2006.00672.x; Fedirko V, 2009, CANCER EPIDEM BIOMAR, V18, P2933, DOI 10.1158/1055-9965.EPI-09-0239; Ferrell N, 2011, AM J PHYSIOL-RENAL, V300, pF86, DOI 10.1152/ajprenal.00484.2010; Gao Y, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0208762; Golob JL, 2019, BLOOD ADV, V3, P2866, DOI 10.1182/bloodadvances.2019000362; Green KJ, 2007, J INVEST DERMATOL, V127, P2499, DOI 10.1038/sj.jid.5701015; GRINNELL F, 1984, J CELL SCI, V65, P61; Gumbiner BM, 2000, J CELL BIOL, V148, P399, DOI 10.1083/jcb.148.3.399; Halbleib JM, 2006, GENE DEV, V20, P3199, DOI 10.1101/gad.1486806; Heaney RP, 2003, AM J CLIN NUTR, V78, P912, DOI 10.1093/ajcn/78.5.912; Heller F, 2005, GASTROENTEROLOGY, V129, P550, DOI 10.1053/j.gastro.2005.05.002; HIRANO S, 1987, J CELL BIOL, V105, P2501, DOI 10.1083/jcb.105.6.2501; Hon KL, 2013, AM J CLIN DERMATOL, V14, P389, DOI 10.1007/s40257-013-0033-9; In JG, 2019, JOVE-J VIS EXP, DOI 10.3791/59357; Ivanov AI, 2013, INT REV CEL MOL BIO, V303, P27, DOI 10.1016/B978-0-12-407697-6.00002-7; Johansson MEV, 2009, J PROTEOME RES, V8, P3549, DOI 10.1021/pr9002504; Kemler R, 1989, CURR OPIN CELL BIOL, V1, P892, DOI 10.1016/0955-0674(89)90055-0; Kim Young S, 2010, Curr Gastroenterol Rep, V12, P319, DOI 10.1007/s11894-010-0131-2; Kowalczyk AP, 2013, PROG MOL BIOL TRANSL, V116, P95, DOI 10.1016/B978-0-12-394311-8.00005-4; LANSMAN JB, 1990, J GEN PHYSIOL, V95, P679, DOI 10.1085/jgp.95.4.679; Luissint AC, 2016, GASTROENTEROLOGY, V151, P616, DOI 10.1053/j.gastro.2016.07.008; McClintock SD, 2018, CANCER PREV RES, V11, P413, DOI 10.1158/1940-6207.CAPR-17-0308; Meddings JB, 2000, GASTROENTEROLOGY, V119, P1019, DOI 10.1053/gast.2000.18152; Miyoshi H, 2013, NAT PROTOC, V8, P2471, DOI 10.1038/nprot.2013.153; PEARSON ADJ, 1982, BMJ-BRIT MED J, V285, P20, DOI 10.1136/bmj.285.6334.20; Peterlik M, 2005, EUR J CLIN INVEST, V35, P290, DOI 10.1111/j.1365-2362.2005.01487.x; Peterlik M, 2009, EUR J CLIN NUTR, V63, P1377, DOI 10.1038/ejcn.2009.105; Peterlik M, 2009, INT J ENV RES PUB HE, V6, P2585, DOI 10.3390/ijerph6102585; Salim SY, 2011, INFLAMM BOWEL DIS, V17, P362, DOI 10.1002/ibd.21403; Schmitz H, 1999, GASTROENTEROLOGY, V116, P301, DOI 10.1016/S0016-5085(99)70126-5; SHAPIRO L, 1995, NATURE, V374, P327, DOI 10.1038/374327a0; Shapiro L, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a003053; Shen L, 2009, DIGEST DIS, V27, P443, DOI 10.1159/000233282; Singh N, 2015, MOL CARCINOGEN, V54, P543, DOI 10.1002/mc.22123; Srinivasan B, 2015, JALA-J LAB AUTOM, V20, P107, DOI 10.1177/2211068214561025; TAKEICHI M, 1972, EXP CELL RES, V74, P51, DOI 10.1016/0014-4827(72)90480-6; Taylor CT, 1998, GASTROENTEROLOGY, V114, P657, DOI 10.1016/S0016-5085(98)70579-7; Thaiss CA, 2018, SCIENCE, V359, P1376, DOI 10.1126/science.aar3318; Turner JR, 2006, AM J PATHOL, V169, P1901, DOI 10.2353/ajpath.2006.060681; Turner JR, 2009, NAT REV IMMUNOL, V9, P799, DOI 10.1038/nri2653; Ungewiss H, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-06713-y; US Department of Health and Human Services (US DHHS) and USDA, 2015, 2015 2020 DIET GUID, V8th; Vllasaliu D, 2014, EXP CELL RES, V323, P218, DOI 10.1016/j.yexcr.2014.02.022; Wadsworth SJ, 2004, AM J PHYSIOL-LUNG C, V286, pL596, DOI 10.1152/ajplung.00217.2003; Xiao C, 2011, J ALLERGY CLIN IMMUN, V128, P549, DOI 10.1016/j.jaci.2011.05.038; Zeissig S, 2007, GUT, V56, P61, DOI 10.1136/gut.2006.094375; Zou WY, 2019, METHODS MOL BIOL, V1576, P229, DOI 10.1007/7651_2017_1	70	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2020	15	3							e0222058	10.1371/journal.pone.0222058	http://dx.doi.org/10.1371/journal.pone.0222058			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8RK	32134920	Green Published, Green Submitted, gold			2022-12-26	WOS:000535265600005
J	Bruns, TD; Chung, JA; Carver, AA; Glassman, SI				Bruns, Thomas D.; Chung, Judy A.; Carver, Akiko A.; Glassman, Sydney, I			A simple pyrocosm for studying soil microbial response to fire reveals a rapid, massive response by Pyronema species	PLOS ONE			English	Article							FUNGAL COMMUNITIES; FOREST-FIRE; TEMPERATURE; RICHNESS; CARBON	We have designed a pyrocosm to enable fine-scale dissection of post-fire soil microbial communities. Using it we show that the peak soil temperature achieved at a given depth occurs hours after the fire is out, lingers near this peak for a significant time, and is accurately predicted by soil depth and the mass of charcoal burned. Flash fuels that produce no large coals were found to have a negligible soil heating effect. Coupling this system with Illumina MiSeq sequencing of the control and post-fire soil we show that we can stimulate a rapid, massive response by Pyronema, a well-known genus of pyrophilous fungus, within two weeks of a test fire. This specific stimulation occurs in a background of many other fungal taxa that do not change noticeably with the fire, although there is an overall reduction in richness and evenness. We introduce a thermo-chemical gradient model to summarize the way that heat, soil depth and altered soil chemistry interact to create a predictable, depthstructured habitat for microbes in post-fire soils. Coupling this model with the temperature relationships found in the pyrocosms, we predict that the width of a survivable "goldilocks zone", which achieves temperatures that select for postfire-adapted microbes, will stay relatively constant across a range of fuel loads. In addition we predict that a larger necromass zone, containing labile carbon and nutrients from recently heat-killed organisms, will increase in size rapidly with addition of fuel and then remain nearly constant in size over a broad range of fuel loads. The simplicity of this experimental system, coupled with the availability of a set of sequenced, assembled and annotated genomes of pyrophilous fungi, offers a powerful tool for dissecting the ecology of post-fire microbial communities.	[Bruns, Thomas D.; Carver, Akiko A.] Univ Calif Berkeley, Dept Plant & Microbial Biol, Berkeley, CA 94720 USA; [Chung, Judy A.; Glassman, Sydney, I] Univ Calif Riverside, Dept Microbiol & Plant Pathol, Riverside, CA 92521 USA	University of California System; University of California Berkeley; University of California System; University of California Riverside	Bruns, TD (corresponding author), Univ Calif Berkeley, Dept Plant & Microbial Biol, Berkeley, CA 94720 USA.	pogon@berkeley.edu	Glassman, Sydney I./G-8710-2013	Bruns, Thomas/0000-0002-2943-8669; Glassman, Sydney I./0000-0001-9115-3026	Department of Energy [DE-SC0016365, DE-SC0020351]	Department of Energy(United States Department of Energy (DOE))	The work was funded by the Department of Energy grants DE-SC0016365 and DE-SC0020351 to TDB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams RI, 2013, MICROB ECOL, V66, P735, DOI 10.1007/s00248-013-0266-4; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; [Anonymous], 2014, R LANG ENV STAT COMP; Bruns TD, 2019, MYCOLOGIA, V111, P936, DOI 10.1080/00275514.2019.1657354; Bruns TD, 2019, FUNGAL ECOL, V39, P393, DOI 10.1016/j.funeco.2018.12.009; CAMPBELL GS, 1994, SOIL SCI, V158, P307, DOI 10.1097/00010694-199411000-00001; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Carlsen T, 2012, FUNGAL ECOL, V5, P747, DOI 10.1016/j.funeco.2012.06.003; Certini G, 2005, OECOLOGIA, V143, P1, DOI 10.1007/s00442-004-1788-8; DeBano LF, 2000, J HYDROL, V231, P195, DOI 10.1016/S0022-1694(00)00194-3; Dove NC, 2017, FIRE ECOL, V13, P37, DOI 10.4996/fireecology.130237746; Edgar RC, 2013, NAT METHODS, V10, P996, DOI [10.1038/NMETH.2604, 10.1038/nmeth.2604]; Egidi E, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10373-z; ELABYAD MSH, 1968, T BRIT MYCOL SOC, V51, P353, DOI 10.1016/S0007-1536(68)80002-6; ELABYAD MSH, 1968, T BRIT MYCOL SOC, V51, P369, DOI 10.1016/S0007-1536(68)80003-8; EMERSON MR, 1948, J BACTERIOL, V55, P327, DOI 10.1128/JB.55.3.327-330.1948; Garcia-Chevesich P, 2010, J SOIL SCI PLANT NUT, V10, P399, DOI 10.4067/S0718-95162010000200001; Glassman SI, 2016, ISME J, V10, P1228, DOI 10.1038/ismej.2015.182; HARDISON JR, 1976, ANNU REV PHYTOPATHOL, V14, P355, DOI 10.1146/annurev.py.14.090176.002035; JALALUDDIN M, 1967, T BRIT MYCOL SOC, V50, P449, DOI 10.1016/S0007-1536(67)80014-7; Keeley JE, 2011, TRENDS PLANT SCI, V16, P406, DOI 10.1016/j.tplants.2011.04.002; Keiluweit M, 2010, ENVIRON SCI TECHNOL, V44, P1247, DOI 10.1021/es9031419; Kircher M, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gkr771; Koljalg U, 2013, MOL ECOL, V22, P5271, DOI 10.1111/mec.12481; Kraft NJB, 2015, FUNCT ECOL, V29, P592, DOI 10.1111/1365-2435.12345; Kuske CR, 2015, FUNGAL ECOL, V14, P133, DOI 10.1016/j.funeco.2014.12.005; Lisiewska M., 1992, FUNGI VEGETATION SCI, P151; Mainwaring K, 2013, EUR J SOIL SCI, V64, P667, DOI 10.1111/ejss.12078; Massman WJ, 2012, WATER RESOUR RES, V48, DOI 10.1029/2011WR011710; Massman WJ, 2004, INT J WILDLAND FIRE, V13, P427, DOI 10.1071/WF04018; Nordberg H, 2014, NUCLEIC ACIDS RES, V42, pD26, DOI 10.1093/nar/gkt1069; PETERSEN PM, 1970, DAN BOT ARK, V27, P1; Pingree MRA, 2019, FOREST ECOL MANAG, V432, P1022, DOI 10.1016/j.foreco.2018.10.032; Pressler Y, 2019, OIKOS, V128, P309, DOI 10.1111/oik.05738; Raudabaugh DB, 2020, FUNGAL ECOL, V43, DOI 10.1016/j.funeco.2019.100870; Reazin C, 2016, FOREST ECOL MANAG, V377, P118, DOI 10.1016/j.foreco.2016.07.002; Santin C, 2016, GEODERMA, V264, P71, DOI 10.1016/j.geoderma.2015.09.021; Schoch CL, 2012, P NATL ACAD SCI USA, V109, P6241, DOI 10.1073/pnas.1117018109; Seaver F. J, 1909, MYCOLOGIA, V1, P131; Shear CL, 1927, J AGRIC RES, V34, P1019; Singh N, 2012, BIOGEOSCIENCES, V9, P2847, DOI 10.5194/bg-9-2847-2012; Smith DP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090234; Smith JE, 2016, INT J WILDLAND FIRE, V25, P1202, DOI 10.1071/WF16016; Stoof CR, 2011, SOIL SCI SOC AM J, V75, P1133, DOI 10.2136/sssaj2010.0322; Thompson DK, 2015, INT J WILDLAND FIRE, V24, P120, DOI 10.1071/WF12121; Traeger S, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003820; Westerling AL, 2006, SCIENCE, V313, P940, DOI 10.1126/science.1128834; Widder S, 2016, ISME J, V10, P2557, DOI 10.1038/ismej.2016.45	48	17	17	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2020	15	3							e0222691	10.1371/journal.pone.0222691	http://dx.doi.org/10.1371/journal.pone.0222691			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8QU	32130222	gold, Green Published, Green Submitted			2022-12-26	WOS:000535264000002
J	Roman-Liu, D; Mockallo, Z				Roman-Liu, Danuta; Mockallo, Zofia			Effectiveness of bimanual coordination tasks performance in improving coordination skills and cognitive functions in elderly	PLOS ONE			English	Article							AGE-RELATED DIFFERENCES; OLDER-ADULTS; BRAIN; YOUNG; ACQUISITION; PRECISION; MOVEMENTS; CALLOSAL; FEEDBACK; DEMANDS	Background The purpose of the study was to determine the impact of the performance of bimanual coordination tasks with specific characteristics on the changes in quality of coordination, musculoskeletal load of the upper limbs and cognitive functions. Methods and findings A group of 26 people aged 60-67 years performed 6 sessions of bimanual coordination training. Each session included set of tasks that varied depending on the shape in which the cursor moved, the coordination mode (in-phase, anti-phase, complex) and the tracking mode (imposed or freely chosen speed). Performance was assessed by: Error, Variability and Execution. The load of upper limb muscles was expressed with the value of the normalized EMG amplitude. Cognitive functions were evaluated using the Vienna Test System. The Variability and Error values obtained during the sixth training session decreased by more than 50% of the initial values. Tasks with freely chosen speed showed changes from 15% to 34% for Error and from 45% to 50% for Variability. For tasks with imposed speed and coordination mode anti-phase or complex it was between 51% and 58% for Error and between 58% and 68% for Variability. Statistically significant differences between load during the sixth training session compared to the first session occurred in three out of four muscles and were between 9% to 39%. There were statistically significant differences in motor time and no differences in variables describing attention and working memory. Conclusions Coordination mode is meaningful for improving coordination skills; tasks in the anti-phase and complex are recommended. Tracking mode also plays a role, tasks with an imposed cursor movement speed have greater potential to improve coordination skills than tasks with freely chosen. Improved control skills resulted in the reduction of upper limb musculoskeletal load. It can be assumed that an increase in coordination skills with the use of appropriate training can help to reduce musculoskeletal load.	[Roman-Liu, Danuta; Mockallo, Zofia] Natl Res Inst CIOP PIB, Cent Inst Labour Protect, Dept Ergon, Warsaw, Poland	Central Institute for Labour Protection - National Research Institute	Roman-Liu, D (corresponding author), Natl Res Inst CIOP PIB, Cent Inst Labour Protect, Dept Ergon, Warsaw, Poland.	daliu@ciop.pl	Roman-Liu, Danuta/HGU-6076-2022	Roman-Liu, Danuta/0000-0001-7836-8516; Mockallo, Zofia/0000-0002-1756-9215	Ministry of Science and Higher Education/National Centre for Research and Development	Ministry of Science and Higher Education/National Centre for Research and Development	This paper is based on the results of a research task carried out within the scope of the fourth stage of the "Improvement of safety and working conditions" National Programme, supported partly in 2017-2019-within the scope of research and development-by the Ministry of Science and Higher Education/National Centre for Research and Development. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoki T, 2010, MED SCI SPORT EXER, V42, P449, DOI 10.1249/MSS.0b013e3181b7f3e1; Bangert AS, 2010, NEUROPSYCHOLOGIA, V48, P1165, DOI 10.1016/j.neuropsychologia.2009.11.013; Bowden JL, 2013, EXP GERONTOL, V48, P756, DOI 10.1016/j.exger.2013.03.011; Budde H, 2008, NEUROSCI LETT, V441, P219, DOI 10.1016/j.neulet.2008.06.024; Chen F, 2019, TUNN UNDERGR SP TECH, V92, DOI 10.1016/j.tust.2019.103034; Davis DHJ, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010775.pub2; Dounskaia N, 2010, J NEUROPHYSIOL, V103, P2027, DOI 10.1152/jn.00778.2009; Escorpizo RS, 2007, INT J IND ERGONOM, V37, P13, DOI 10.1016/j.ergon.2006.09.001; Fling BW, 2012, CEREB CORTEX, V22, P2643, DOI 10.1093/cercor/bhr349; Fujiyama H, 2016, CORTEX, V77, P141, DOI 10.1016/j.cortex.2016.02.007; Glisky E.L., 2007, BRAIN AGING MODELS M; Heuninckx S, 2008, J NEUROSCI, V28, P91, DOI 10.1523/JNEUROSCI.3300-07.2008; Hoff M, 2015, FRONT AGING NEUROSCI, V7, DOI 10.3389/fnagi.2015.00176; HORSTMANN V, 1995, STAT PROBABIL LETT, V23, P333, DOI 10.1016/0167-7152(94)00132-R; Howieson DB, 2015, CEREBRUM; Hoyer EH, 2013, EXP BRAIN RES, V226, P193, DOI 10.1007/s00221-013-3425-4; Hurley SR, 2006, HUM MOVEMENT SCI, V25, P339, DOI 10.1016/j.humov.2006.03.006; Johann VE, 2016, PSYCHOL SPORT EXERC, V24, P118, DOI 10.1016/j.psychsport.2016.01.008; Kennerley SW, 2002, NAT NEUROSCI, V5, P376, DOI 10.1038/nn822; Kourtis D, 2014, NEUROPSYCHOLOGIA, V58, P81, DOI 10.1016/j.neuropsychologia.2014.04.002; Krehbiel LM, 2017, EXP GERONTOL, V98, P199, DOI 10.1016/j.exger.2017.09.001; Lin CH, 2014, EXP GERONTOL, V53, P40, DOI 10.1016/j.exger.2014.02.005; Loehrer PA, 2016, NEUROIMAGE, V143, P325, DOI 10.1016/j.neuroimage.2016.09.014; Maes C, 2017, NEUROSCI BIOBEHAV R, V75, P234, DOI 10.1016/j.neubiorev.2017.01.052; Mahncke HW, 2006, PROG BRAIN RES, V157, P81, DOI 10.1016/S0079-6123(06)57006-2; Mechsner F, 2001, NATURE, V414, P69, DOI 10.1038/35102060; Monteiro TS, 2017, NEUROBIOL AGING, V58, P54, DOI 10.1016/j.neurobiolaging.2017.06.004; Neva JL, 2012, NEUROSCI LETT, V514, P147, DOI 10.1016/j.neulet.2012.02.075; Nieuwboer A, 2009, EUR J NEUROSCI, V29, P1422, DOI 10.1111/j.1460-9568.2009.06681.x; Pascual-Leone A, 2011, BRAIN TOPOGR, V24, P302, DOI 10.1007/s10548-011-0196-8; Pauwels L, 2015, FRONT AGING NEUROSCI, V7, DOI 10.3389/fnagi.2015.00157; Pauwels L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100906; Reinkensmeyer DJ, 2016, J NEUROENG REHABIL, V13, DOI 10.1186/s12984-016-0148-3; Ren J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121708; Sainburg Rl, 2013, J Neurol Transl Neurosci, V1; Seidler RD, 2010, NEUROSCI BIOBEHAV R, V34, P721, DOI 10.1016/j.neubiorev.2009.10.005; Shahidi B, 2013, J ELECTROMYOGR KINES, V23, P1082, DOI 10.1016/j.jelekin.2013.05.009; Sisti HM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023619; Smethurst CJ, 2001, HUM MOVEMENT SCI, V20, P499, DOI 10.1016/S0167-9457(01)00065-3; Solesio-Jofre E, 2014, HUM BRAIN MAPP, V35, P3945, DOI 10.1002/hbm.22450; Sullivan EV, 2002, CEREB CORTEX, V12, P438, DOI 10.1093/cercor/12.4.438; Tucker MG, 2008, HUM MOVEMENT SCI, V27, P728, DOI 10.1016/j.humov.2008.03.002; Uhrbrand A, 2015, J NEUROL SCI, V353, P9, DOI 10.1016/j.jns.2015.04.004; van Delden AEQ, 2012, STROKE RES TREAT, V2012, DOI 10.1155/2012/972069; Vercruysse S, 2014, CEREB CORTEX, V24, P3154, DOI 10.1093/cercor/bht170; Visser B, 2004, ERGONOMICS, V47, P202, DOI 10.1080/00140130310001617967; Voelcker-Rehage C, 2008, EUR REV AGING PHYS A, V5, P5, DOI 10.1007/s11556-008-0030-9; Waller SM, 2008, NEUROREHABILITATION, V23, P29; White O, 2010, CURR BIOL, V20, P1290, DOI 10.1016/j.cub.2010.05.069; Wilson TW, 2014, NEUROIMAGE, V85, P445, DOI 10.1016/j.neuroimage.2013.04.112; Wishart LR, 2000, J GERONTOL B-PSYCHOL, V55, pP85, DOI 10.1093/geronb/55.2.P85; Wishart LR, 2002, ACTA PSYCHOL, V110, P247, DOI 10.1016/S0001-6918(02)00036-7; Woytowicz E, 2016, CURR GERIATR REP, V5, P191, DOI 10.1007/s13670-016-0184-7	53	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2020	15	3							e0228599	10.1371/journal.pone.0228599	http://dx.doi.org/10.1371/journal.pone.0228599			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LQ8QU	32130219	Green Published, gold			2022-12-26	WOS:000535264000009
J	Ding, C; Hamann, A; Yang, RC; Brouard, JS				Ding, Chen; Hamann, Andreas; Yang, Rong-Cai; Brouard, Jean S.			Genetic parameters of growth and adaptive traits in aspen (Populus tremuloides): Implications for tree breeding in a warming world	PLOS ONE			English	Article							SHORT-ROTATION FORESTRY; PHENOTYPIC VARIATION; TREMBLING ASPEN; POPULATIONS; HETEROSIS; PHENOLOGY; HARDINESS; POPLAR; RISK; L.	Aspen (Populus tremuloides Michx) is a widespread commercial forest tree of high economic importance in western Canada and has been subject to tree improvement efforts over the past two decades. Such improvement programs rely on accurate estimates of the genetic gain in growth traits and correlated response in adaptive traits that are important for forest health. Here, we estimated genetic parameters in 10 progeny trials containing > 30,000 trees with pedigree structures based on a partial factorial mating design that includes 60 half-sibs, 100 full-sib families and 1,400 clonally replicated genotypes. Estimated narrow-sense and broad-sense heritabilities were low for height and diameter (similar to 0.2), but moderate for the dates of budbreak and leaf senescence (similar to 0.4). Furthermore, estimated genetic correlations between growth and phenology were moderate to strong with tall trees being associated with early budbreak (r = -0.3) and late leaf senescence (r = -0.7). Survival was not compromised, but was positively associated with early budbreak or late leaf senescence, indicating that utilizing the growing season was more important for survival and growth than avoiding early fall or late spring frosts. These result suggests that populations are adapted to colder climate conditions and lag behind environmental conditions to which they are optimally adapted due to substantial climate warming observed over the last several decades for the study area.	[Ding, Chen; Hamann, Andreas] Univ Alberta, Dept Renewable Resources, Edmonton, AB, Canada; [Yang, Rong-Cai] Univ Alberta, Dept Agr Food & Nutr Sci, Edmonton, AB, Canada; [Brouard, Jean S.] Isabella Point Forestry Ltd, Salt Spring Isl, BC, Canada; [Ding, Chen] Texas A&M Forest Serv, Western Gulf Forest Tree Improvement Program, College Stn, TX 77843 USA	University of Alberta; University of Alberta; Texas A&M University System; Texas A&M University College Station	Ding, C (corresponding author), Univ Alberta, Dept Renewable Resources, Edmonton, AB, Canada.; Ding, C (corresponding author), Texas A&M Forest Serv, Western Gulf Forest Tree Improvement Program, College Stn, TX 77843 USA.	cd2@ualberta.ca	DING, Chen/AAZ-7327-2020		NSERC/Industry Collaborative Development Grant [CRDPJ 349100-06]; NSERC through the Government of Canada [RGPIN-330527-13]; Alberta-Pacific Forest Industries; Norbord Inc.; Mercer Peace River Pulp; Western Boreal Aspen Corporation; Weyerhaeuser Company Ltd.	NSERC/Industry Collaborative Development Grant(Natural Sciences and Engineering Research Council of Canada (NSERC)); NSERC through the Government of Canada; Alberta-Pacific Forest Industries; Norbord Inc.; Mercer Peace River Pulp; Western Boreal Aspen Corporation; Weyerhaeuser Company Ltd.	Funding was provided by an NSERC/Industry Collaborative Development Grant CRDPJ 349100-06 to AH and an NSERC Discovery Grant RGPIN-330527-13 to AH through the Government of Canada. The contributing industry partners were Alberta-Pacific Forest Industries, Norbord Inc. (previously as Ainsworth Engineered Canada LP), Mercer Peace River Pulp (formerly DaishowaMarubeni International Ltd.), Western Boreal Aspen Corporation, and Weyerhaeuser Company Ltd. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Araujo JA, 2012, TREE GENET GENOMES, V8, P327, DOI 10.1007/s11295-011-0443-x; BARNES BV, 1975, FOREST SCI, V21, P319; Brouard JS, 2004, P JOINT CONV SOC AM; Butler D, 2009, R PACKAGE VERSION 3; D'Orangeville L, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05705-4; Ding C., 2015, ECOLOGICAL QUANTITAT; FOSTER GS, 1988, THEOR APPL GENET, V76, P788, DOI 10.1007/BF00303527; Fracheboud Y, 2009, PLANT PHYSIOL, V149, P1982, DOI 10.1104/pp.108.133249; Gilmour AR, 1995, BIOMETRICS, V51, P1440, DOI 10.2307/2533274; Gylander T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044303; Hanninen H, 2006, TREE PHYSIOL, V26, P889, DOI 10.1093/treephys/26.7.889; Hart JF, 2013, FORESTS, V4, P786, DOI 10.3390/f4040786; Hedrick PW, 1999, EVOLUTION, V53, P313, DOI 10.1111/j.1558-5646.1999.tb03767.x; Ibanez C, 2010, PLANT PHYSIOL, V153, P1823, DOI 10.1104/pp.110.158220; Ingvarsson PK, 2008, GENETICS, V178, P2217, DOI 10.1534/genetics.107.082354; Kanaga MK, 2008, CAN J FOREST RES, V38, P1690, DOI 10.1139/X08-012; Li B, 1996, THEOR APPL GENET, V93, P380, DOI 10.1007/BF00223180; Li BL, 1997, CAN J FOREST RES, V27, P1525, DOI 10.1139/cjfr-27-10-1525; Li BL, 1995, FOREST CHRON, V71, P720, DOI 10.5558/tfc71720-6; Li HT, 2010, CAN J FOREST RES, V40, P2082, DOI 10.1139/X10-153; Long JN, 2012, CAN J FOREST RES, V42, P2011, DOI 10.1139/x2012-143; Lynch M., 1998, GENETICS ANAL QUANTI; Mbogga MS, 2009, AGR FOREST METEOROL, V149, P881, DOI 10.1016/j.agrformet.2008.11.009; McKown AD, 2014, NEW PHYTOL, V203, P535, DOI 10.1111/nph.12815; McKown AD, 2014, NEW PHYTOL, V201, P1263, DOI 10.1111/nph.12601; Niemczyk M, 2019, FORESTS, V10, DOI 10.3390/f10050450; Olson MS, 2013, MOL ECOL, V22, P1214, DOI 10.1111/mec.12067; ONDRO WJ, 1991, FOREST CHRON, V67, P271, DOI 10.5558/tfc67271-3; Perala D.A., 1990, POPULUS TREMULOIDES; Peterson E.B., 1992, ECOLOGY MANAGEMENT U, V1, P1; R Development Core Team, 2013, R: A Language and Environment for Statistical Computing; Rogers PC, 2020, GLOB ECOL CONSERV, V21, DOI 10.1016/j.gecco.2019.e00828; Rohde A, 2011, NEW PHYTOL, V189, P106, DOI 10.1111/j.1469-8137.2010.03469.x; Schreiber SG, 2013, J APPL ECOL, V50, P939, DOI 10.1111/1365-2664.12102; Silva JCE, 2004, THEOR APPL GENET, V108, P1113, DOI 10.1007/s00122-003-1524-5; Soolanayakanahally RY, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00528; Soolanayakanahally RY, 2013, PLANT CELL ENVIRON, V36, P116, DOI 10.1111/j.1365-3040.2012.02560.x; St Clair SB, 2010, FOREST SCI, V56, P222; STIELL WM, 1986, FOREST CHRON, V62, P10, DOI 10.5558/tfc62010-1; Tullus A, 2012, SCAND J FOREST RES, V27, P10, DOI 10.1080/02827581.2011.628949; Weih M, 2004, CAN J FOREST RES, V34, P1369, DOI 10.1139/X04-090; Weih M, 2009, TREE PHYSIOL, V29, P1479, DOI 10.1093/treephys/tpp081; Williams E.R., 2002, EXPT DESIGN ANAL TRE; Wolken JM, 2009, ANN FOREST SCI, V66, DOI 10.1051/forest/2009072; Worrall JJ, 2013, FOREST ECOL MANAG, V299, P35, DOI 10.1016/j.foreco.2012.12.033	45	4	4	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2020	15	3							e0229225	10.1371/journal.pone.0229225	http://dx.doi.org/10.1371/journal.pone.0229225			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8MS	32126110	Green Published, gold			2022-12-26	WOS:000535253100017
J	Mannino, F; Wisotsky, S; Pond, SLK; Muse, SV				Mannino, Frank; Wisotsky, Sadie; Pond, Sergei L. Kosakovsky; Muse, Spencer, V			Equiprobable discrete models of site-specific substitution rates underestimate the extent of rate variability	PLOS ONE			English	Article							DNA-SEQUENCES	It is standard practice to model site-to-site variability of substitution rates by discretizing a continuous distribution into a small number, K, of equiprobable rate categories. We demonstrate that the variance of this discretized distribution has an upper bound determined solely by the choice of K and the mean of the distribution. This bound can introduce biases into statistical inference, especially when estimating parameters governing site-to-site variability of substitution rates. Applications to two large collections of sequence alignments demonstrate that this upper bound is often reached in analyses of real data. When parameter estimation is of primary interest, additional rate categories or more flexible modeling methods should be considered.	[Mannino, Frank; Wisotsky, Sadie; Muse, Spencer, V] North Carolina State Univ, Bioinformat Res Ctr, Raleigh, NC 27695 USA; [Wisotsky, Sadie; Pond, Sergei L. Kosakovsky] Temple Univ, Inst Genom & Evolutionary Med, Philadelphia, PA 19122 USA; [Muse, Spencer, V] North Carolina State Univ, Dept Stat, Raleigh, NC 27695 USA	University of North Carolina; North Carolina State University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; University of North Carolina; North Carolina State University	Muse, SV (corresponding author), North Carolina State Univ, Bioinformat Res Ctr, Raleigh, NC 27695 USA.; Muse, SV (corresponding author), North Carolina State Univ, Dept Stat, Raleigh, NC 27695 USA.	muse@ncsu.edu	Pond, Sergei LK/G-9830-2012	Pond, Sergei LK/0000-0003-4817-4029; Muse, Spencer/0000-0003-0104-0728	NIH [T32 ES007329, R01 GM093939]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by NIH grant R01 GM093939 to SVM and SLKP; SW was supported by a predoctoral fellowship from NIH T32 ES007329. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Excoffier L, 1999, MOL BIOL EVOL, V16, P1357, DOI 10.1093/oxfordjournals.molbev.a026046; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Kuck P, 2010, MOL PHYLOGENET EVOL, V56, P1115, DOI 10.1016/j.ympev.2010.04.024; Maddison D.R., 2007, MESQUITE 2 MODULAR S; Mannino FV, 2006, SITE TO SITE RATE VA; Moretti S, 2014, NUCLEIC ACIDS RES, V42, pD917, DOI 10.1093/nar/gkt1065; Ohta T, 1995, J MOL EVOL, V41, P717, DOI 10.1007/BF00173150; Pond SK, 2005, MOL BIOL EVOL, V22, P2375, DOI 10.1093/molbev/msi232; Pond SLK, 2005, MOL BIOL EVOL, V22, P223, DOI 10.1093/molbev/msi009; Pond SLK, 2005, BIOINFORMATICS, V21, P676, DOI 10.1093/bioinformatics/bti079; Yang ZH, 1996, TRENDS ECOL EVOL, V11, P367, DOI 10.1016/0169-5347(96)10041-0; YANG ZH, 1993, MOL BIOL EVOL, V10, P1396; YANG ZH, 1994, J MOL EVOL, V39, P306, DOI 10.1007/BF00160154; Yang ZH, 2002, MOL BIOL EVOL, V19, P49, DOI 10.1093/oxfordjournals.molbev.a003981	15	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2020	15	3							e0229493	10.1371/journal.pone.0229493	http://dx.doi.org/10.1371/journal.pone.0229493			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8JT	32119689	Green Published, gold			2022-12-26	WOS:000535245300025
J	Bega, D; Samocha, Y; Yitzhak, N; Saar, M; Subach, A; Scharf, I				Bega, Darar; Samocha, Yehonatan; Yitzhak, Nitzan; Saar, Maya; Subach, Aziz; Scharf, Inon			Non-spatial information on the presence of food elevates search intensity in ant workers, leading to faster maze solving in a process parallel to spatial learning	PLOS ONE			English	Article							FORAGING SUCCESS; POGONOMYRMEX-OWYHEEI; DESERT ANTS; ORIENTATION; PERFORMANCE; HYMENOPTERA; NAVIGATION; BEHAVIOR; MEMORY; DISCRIMINATION	Experience can lead to faster exploitation of food patches through spatial learning or other parallel processes. Past studies have indicated that hungry animals either search more intensively for food or learn better how to detect it. However, fewer studies have examined the contribution of non-spatial information on the presence of food nearby to maze solving, as a parallel process to spatial learning. We exposed Cataglyphis niger ant workers to a food reward and then let them search for food in a maze. The information that food existed nearby, even without spatial information, led to faster maze solving compared to a control group that was not exposed to the food prior to the experiment. Faster solving is probably achieved by a higher number of workers entering the maze, following the information that food is present nearby. In a second experiment, we allowed the ants to make successive searches in the maze, followed by removing them after they had returned to the nest and interacted with their naive nestmates. This procedure led to a maze-solving time in-between that displayed when removing the workers immediately after they had reached the food and preventing their return to the colony, and that of no removal. The workers that interacted upon returning to the nest might have transferred to naive workers information, unrelated to spatial learning, that food existed nearby, and driven them to commence searching. Spatial learning, or an increase in the correct movements leading to the food reward relative to those leading to dead-ends, was only evident when the same workers were allowed to search again in the same maze. However, both non-spatial information on the presence of food that elevated search intensity and spatial learning led to faster maze solving.	[Bega, Darar; Samocha, Yehonatan; Yitzhak, Nitzan; Saar, Maya; Subach, Aziz; Scharf, Inon] Tel Aviv Univ, Fac Life Sci, Sch Zool, Tel Aviv, Israel	Tel Aviv University	Scharf, I (corresponding author), Tel Aviv Univ, Fac Life Sci, Sch Zool, Tel Aviv, Israel.	scharfi@tauex.tau.ac.il	Scharf, Inon/AAF-2343-2020; Saar, Maya/AAJ-6973-2021	Scharf, Inon/0000-0002-8506-7161; Saar, Maya/0000-0002-2734-1871	Israel Science Foundation [442/16]; Humboldt Foundation	Israel Science Foundation(Israel Science Foundation); Humboldt Foundation(Alexander von Humboldt Foundation)	This work was supported by the Israel Science Foundation (grant no. 442/16) and a scholarship by the Humboldt Foundation to IS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adar S, 2016, BEHAV ECOL, V27, P1491, DOI 10.1093/beheco/arw071; ALLOWAY TM, 1972, ANNU REV ENTOMOL, V17, P43, DOI 10.1146/annurev.en.17.010172.000355; Avgar T, 2008, ECOL LETT, V11, P224, DOI 10.1111/j.1461-0248.2007.01140.x; Baader AP, 1996, INSECT SOC, V43, P435, DOI 10.1007/BF01258416; BAUMGAERTNER JU, 1981, CAN ENTOMOL, V113, P1007, DOI 10.4039/Ent1131007-11; BECKERS R, 1989, Psyche (Cambridge), V96, P239, DOI 10.1155/1989/94279; Bega D, 2019, BEHAV PROCESS, V166, DOI 10.1016/j.beproc.2019.103893; Brodbeck DR., 2012, ENCY SCI LEARNING, P3166; Brodetzki TR, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-45950-1; Capaldi EA, 1999, ANNU REV PSYCHOL, V50, P651, DOI 10.1146/annurev.psych.50.1.651; Capaldi EA, 1999, J EXP BIOL, V202, P1655; CERDA X, 1992, SOCIOBIOLOGY, V20, P315; Chameron S, 1998, P ROY SOC B-BIOL SCI, V265, P2309, DOI 10.1098/rspb.1998.0576; Cheng K, 2014, BEHAV PROCESS, V102, P51, DOI 10.1016/j.beproc.2013.10.001; CLIFTON KE, 1991, J EXP MAR BIOL ECOL, V145, P141, DOI 10.1016/0022-0981(91)90171-R; Cole EF, 2011, ANIM BEHAV, V81, P491, DOI 10.1016/j.anbehav.2010.11.025; COSENS D, 1986, PHYSIOL ENTOMOL, V11, P383, DOI 10.1111/j.1365-3032.1986.tb00429.x; CUNNINGHAM PN, 1984, MAR ECOL PROG SER, V16, P21, DOI 10.3354/meps016021; Czaczkes TJ, 2018, INSECT SOC, V65, P213, DOI 10.1007/s00040-018-0621-z; Czaczkes TJ, 2011, BIOL LETTERS, V7, P521, DOI 10.1098/rsbl.2011.0067; DEJEAN A, 1993, BEHAV PROCESS, V30, P233, DOI 10.1016/0376-6357(93)90135-E; Dixon P.M., 2001, DESIGN ANAL ECOLOGIC, P267; Dornhaus A, 2001, BEHAV ECOL SOCIOBIOL, V50, P570, DOI 10.1007/s002650100395; Dukas R, 2008, ANNU REV ENTOMOL, V53, P145, DOI 10.1146/annurev.ento.53.103106.093343; Dukas Reuven, 2009, P7; Ego-Stengel V, 2010, HIPPOCAMPUS, V20, P1, DOI 10.1002/hipo.20707; Evans S, 1932, J COMP PSYCHOL, V14, P183, DOI 10.1037/h0072177; Farris SM, 2013, BRAIN BEHAV EVOLUT, V82, P9, DOI 10.1159/000352057; FORMANOWICZ DR, 1987, ANIM BEHAV, V35, P453, DOI 10.1016/S0003-3472(87)80270-1; Gordon DM, 2008, BEHAV ECOL, V19, P217, DOI 10.1093/beheco/arm125; Graham P, 2009, J COMP PHYSIOL A, V195, P681, DOI 10.1007/s00359-009-0443-6; Guillette LM, 2009, BEHAV PROCESS, V80, P224, DOI 10.1016/j.beproc.2008.12.015; Healy SD, 2004, BRAIN BEHAV EVOLUT, V63, P211, DOI 10.1159/000076782; Hollis KL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017958; JAFFE K, 1990, INSECT SOC, V37, P101, DOI 10.1007/BF02224024; Jandt JM, 2014, BIOL REV, V89, P48, DOI 10.1111/brv.12042; Janson CH, 1997, BEHAV ECOL SOCIOBIOL, V41, P17, DOI 10.1007/s002650050359; Jones PL, 2015, ANIM BEHAV, V101, P11, DOI 10.1016/j.anbehav.2014.12.016; JORGENSEN CD, 1982, ENVIRON ENTOMOL, V11, P381, DOI 10.1093/ee/11.2.381; Knaden M, 2016, ANNU REV ENTOMOL, V61, P63, DOI 10.1146/annurev-ento-010715-023703; Knoppien P, 2000, J INSECT BEHAV, V13, P27, DOI 10.1023/A:1007759424777; KREBS JR, 1992, AM NAT, V140, pS63, DOI 10.1086/285397; Lahav S, 1998, BEHAV ECOL SOCIOBIOL, V43, P203, DOI 10.1007/s002650050482; Lanan M, 2014, MYRMECOL NEWS, V20, P53; Lenoir Alain, 2010, Israel Journal of Entomology, V39, P1; Li DQ, 2003, BEHAVIOUR, V140, P739, DOI 10.1163/156853903322370652; Lihoreau M, 2010, AM NAT, V176, P744, DOI 10.1086/657042; Macquart D, 2008, ANIM BEHAV, V75, P1693, DOI 10.1016/j.anbehav.2007.10.023; Mailleux AC, 2010, ETHOLOGY, V116, P248, DOI 10.1111/j.1439-0310.2009.01736.x; MAYADE S, 1993, BEHAV PROCESS, V30, P131, DOI 10.1016/0376-6357(93)90003-A; McFarland D, 1991, INT STUDIES PHILOS S, V5, P153, DOI DOI 10.1080/02698599108573387; MELLGREN RL, 1986, ANIM BEHAV, V34, P1129, DOI 10.1016/S0003-3472(86)80172-5; Mizunami M, 1998, J COMP NEUROL, V402, P520; Morand-Ferron J, 2016, BIOL REV, V91, P367, DOI 10.1111/brv.12174; O'Keefe J, 1993, Curr Opin Neurobiol, V3, P917, DOI 10.1016/0959-4388(93)90163-S; Odetti F, 2003, ANIM BEHAV, V66, P1093, DOI 10.1006/anbe.2003.2293; Pasquier G, 2016, BEHAV ECOL, V27, P1702, DOI 10.1093/beheco/arw079; PORTER SD, 1981, BEHAV ECOL SOCIOBIOL, V9, P247, DOI 10.1007/BF00299879; Pravosudov VV, 2006, P ROY SOC B-BIOL SCI, V273, P2641, DOI 10.1098/rspb.2006.3624; PROVENCHER L, 1991, OIKOS, V62, P160, DOI 10.2307/3545261; Radnan GN, 2018, ECOL ENTOMOL, V43, P379, DOI 10.1111/een.12510; Raine NE, 2008, P R SOC B, V275, P803, DOI 10.1098/rspb.2007.1652; RAMOND CK, 1954, J EXP PSYCHOL, V48, P265, DOI 10.1037/h0053643; Razin N, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2013.0079; RETANA J, 1990, ETHOLOGY, V84, P105, DOI 10.1111/j.1439-0310.1990.tb00788.x; REZNIKOVA Z, 2003, P 2 INT WORKSH MATH, P139; Reznikova Zhanna, 2008, Myrmecological News, V11, P201; Roth TC, 2008, P ROY SOC LOND B BIO, V276, P401; Rowe C, 2014, BEHAV ECOL, V25, P1287, DOI 10.1093/beheco/aru090; Saar M, 2018, CURR ZOOL, V64, P653, DOI 10.1093/cz/zox054; Saar M, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-32064-3; Saar M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183753; Scharf I, 2016, ANIM BEHAV, V119, P37, DOI 10.1016/j.anbehav.2016.06.019; Scharf I, 2012, AM NAT, V180, P671, DOI 10.1086/667894; Schatz B, 1999, NATURE, V399, P769, DOI 10.1038/21625; Schneirla TC, 1933, J COMP PSYCHOL, V15, P243, DOI 10.1037/h0072289; SEELEY TD, 1989, AM SCI, V77, P546; SENF GM, 1968, J COMP PHYSIOL PSYCH, V65, P140, DOI 10.1037/h0025408; Shaw RC, 2019, CURR BIOL, V29, P1498, DOI 10.1016/j.cub.2019.03.027; Shettleworth S. J., 2009, COGNITION EVOLUTION; Sison M, 2010, BEHAV BRAIN RES, V207, P99, DOI 10.1016/j.bbr.2009.09.043; Sommer S, 2005, NATURWISSENSCHAFTEN, V92, P468, DOI 10.1007/s00114-005-0020-y; Sonnenberg BR, 2019, CURR BIOL, V29, P670, DOI 10.1016/j.cub.2019.01.006; SPENCE KW, 1959, J EXP PSYCHOL, V58, P8, DOI 10.1037/h0045812; Steck K, 2010, ANIM BEHAV, V79, P939, DOI 10.1016/j.anbehav.2010.01.011; Steck K, 2009, FRONT ZOOL, V6, DOI 10.1186/1742-9994-6-5; Su NY, 2017, J ECON ENTOMOL, V110, P1728, DOI 10.1093/jee/tox153; Thornton A, 2012, ANIM BEHAV, V83, P1459, DOI 10.1016/j.anbehav.2012.03.018; TOLMAN EC, 1948, PSYCHOL REV, V55, P189, DOI 10.1037/h0061626; Torres-Contreras H, 2007, ETHOLOGY, V113, P76, DOI 10.1111/j.1439-0310.2006.01302.x; TRANIELLO JFA, 1977, BEHAV ECOL SOCIOBIOL, V2, P61, DOI 10.1007/BF00299289; VanderSal ND, 2008, ANIM COGN, V11, P563, DOI 10.1007/s10071-008-0145-4; Vonshak M., 2009, ISRAEL J ENTOMOL, V39, P35; VOWLES DM, 1965, BRIT J PSYCHOL, V56, P15, DOI 10.1111/j.2044-8295.1965.tb00940.x; Warburton K, 2003, FISH FISH, V4, P203, DOI 10.1046/j.1467-2979.2003.00125.x; Wehner R, 2003, J COMP PHYSIOL A, V189, P579, DOI 10.1007/s00359-003-0431-1; Weiss MR, 2003, ANIM BEHAV, V65, P425, DOI 10.1006/anbe.2003.2084; WETTERER JK, 1994, OECOLOGIA, V98, P235, DOI 10.1007/BF00341478; Wilson EB, 1927, J AM STAT ASSOC, V22, P209, DOI 10.2307/2276774; Wittlinger M, 2007, J EXP BIOL, V210, P198, DOI 10.1242/jeb.02657; Ziegler PE, 1997, J COMP PHYSIOL A, V181, P13, DOI 10.1007/s003590050088	101	5	5	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2020	15	2							e0229709	10.1371/journal.pone.0229709	http://dx.doi.org/10.1371/journal.pone.0229709			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LQ8HR	32109253	Green Published, gold			2022-12-26	WOS:000535239800024
J	Connolly, M; Garfield, BE; Crosby, A; Morrell, NW; Wort, SJ; Kemp, PR				Connolly, Martin; Garfield, Benjamin E.; Crosby, Alexi; Morrell, Nick W.; Wort, Stephen J.; Kemp, Paul R.			miR-1-5p targets TGF-beta R1 and is suppressed in the hypertrophying hearts of rats with pulmonary arterial hypertension	PLOS ONE			English	Article							TGF-BETA; CARDIAC FIBROSIS; MUSCLE-CELLS; EXPRESSION; MICRORNA-1; SMOOTH; ENDOTHELIN-1; DYSFUNCTION; HYPOXIA; ACTIVIN	The microRNA miR-1 is an important regulator of muscle phenotype including cardiac muscle. Down-regulation of miR-1 has been shown to occur in left ventricular hypertrophy but its contribution to right ventricular hypertrophy in pulmonary arterial hypertension are not known. Previous studies have suggested that miR-1 may suppress transforming growth factor-beta (TGF-beta) signalling, an important pro-hypertrophic pathway but only indirect mechanisms of regulation have been identified. We identified the TGF-beta type 1 receptor (TGF beta R1) as a putative miR-1 target. We therefore hypothesized that miR-1 and TGF-beta R1 expression would be inversely correlated in hypertrophying right ventricle of rats with pulmonary arterial hypertension and that miR-1 would inhibit TGF-beta signalling by targeting TGF beta R1 expression. Quantification of miR-1 and TGF-beta R1 in rats treated with monocrotaline to induce pulmonary arterial hypertension showed appropriate changes in miR-1 and TGF-beta R1 expression in the hypertrophying right ventricle. A miR-1-mimic reduced enhanced green fluorescent protein expression from a reporter vector containing the TGF-beta R1 3'-untranslated region and knocked down endogenous TGF-beta R1. Lastly, miR-1 reduced TGF beta activation of a (mothers against decapentaplegic homolog) SMAD2/3-dependent reporter. Taken together, these data suggest that miR-1 targets TGF-beta R1 and reduces TGF-beta signalling, so a reduction in miR-1 expression may increase TGF-beta signalling and contribute to cardiac hypertrophy.	[Connolly, Martin; Garfield, Benjamin E.; Kemp, Paul R.] Imperial Coll London, Natl Heart & Lung Inst, Mol Med, London, England; [Garfield, Benjamin E.; Wort, Stephen J.] Imperial Coll London, Natl Pulm Hypertens Ctr, Royal Brompton & Harefield NHS Trust, London, England; [Garfield, Benjamin E.; Wort, Stephen J.] Imperial Coll London, Natl Heart & Lung Inst, London, England; [Crosby, Alexi; Morrell, Nick W.] Univ Cambridge, Addenbrookes Hosp, Dept Med, Cambridge, England	Imperial College London; Imperial College London; Royal Brompton & Harefield NHS Foundation Trust; Royal Brompton Hospital; Imperial College London; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge	Kemp, PR (corresponding author), Imperial Coll London, Natl Heart & Lung Inst, Mol Med, London, England.	p.kemp@imperial.ac.uk		Connolly, Martin/0000-0002-6156-8244; Morrell, Nicholas/0000-0001-5700-9792	British Heart Foundation (BHF) [FS/14/71/31038]; MRC [MR/K023918/1] Funding Source: UKRI	British Heart Foundation (BHF)(British Heart Foundation); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Funded by Award recipient: Paul Kemp. Grant number: FS/14/71/31038 Funder: British Heart Foundation (BHF). Funder website: https://www.bhf.org.uk/.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bloch SAA, 2015, THORAX, V70, P219, DOI 10.1136/thoraxjnl-2014-206225; Bujak M, 2007, CIRCULATION, V116, P2127, DOI 10.1161/CIRCULATIONAHA.107.704197; Chen YF, 2006, J APPL PHYSIOL, V100, P564, DOI 10.1152/japplphysiol.00595.2005; Connolly M, 2018, J CACHEXIA SARCOPENI, V9, P400, DOI 10.1002/jcsm.12266; Connolly M, 2018, FEBS OPEN BIO, V8, P339, DOI 10.1002/2211-5463.12369; Dobaczewski M, 2011, J MOL CELL CARDIOL, V51, P600, DOI 10.1016/j.yjmcc.2010.10.033; Ellis PD, 2004, J BIOL CHEM, V279, P36660, DOI 10.1074/jbc.M405380200; Farber HW, 2004, NEW ENGL J MED, V351, P1655, DOI 10.1056/NEJMra035488; Favot L, 2005, AM J PATHOL, V167, P1497, DOI 10.1016/S0002-9440(10)61236-9; FOURIE PR, 1992, CARDIOVASC RES, V26, P839, DOI 10.1093/cvr/26.9.839; Garros RF, 2017, AM J RESP CRIT CARE, V196, P1422, DOI 10.1164/rccm.201701-0101OC; Gray MO, 1998, CARDIOVASC RES, V40, P352, DOI 10.1016/S0008-6363(98)00121-7; Hua YN, 2012, J CELL MOL MED, V16, P83, DOI 10.1111/j.1582-4934.2011.01307.x; Jonk LJC, 1998, J BIOL CHEM, V273, P21145, DOI 10.1074/jbc.273.33.21145; Karakikes I, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000078; Koitabashi N, 2011, J CLIN INVEST, V121, P2301, DOI 10.1172/JCI44824; Kumarswamy R, 2012, EUR HEART J, V33, P1067, DOI 10.1093/eurheartj/ehs043; Leask A, 2008, CELL SIGNAL, V20, P1409, DOI 10.1016/j.cellsig.2008.01.006; Lewis A, 2012, THORAX, V67, P26, DOI 10.1136/thoraxjnl-2011-200309; Li Y, 2014, CANCER RES, V74, P6107, DOI 10.1158/0008-5472.CAN-14-0389; Morrell NW, 2001, CIRCULATION, V104, P790, DOI 10.1161/hc3201.094152; Pan ZW, 2012, CIRCULATION, V126, P840, DOI 10.1161/CIRCULATIONAHA.112.094524; Paul R, 2018, J CACHEXIA SARCOPENI, V9, P119, DOI 10.1002/jcsm.12236; Sayed D, 2007, CIRC RES, V100, P416, DOI 10.1161/01.RES.0000257913.42552.23; Simonneau G, 2009, J AM COLL CARDIOL, V54, pS43, DOI [10.1016/j.jacc.2009.04.012, 10.1016/j.jacc.2013.10.029]; Sticht C, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0206239; Sun YT, 2010, J CELL BIOL, V189, P1157, DOI 10.1083/jcb.200912093; Thomas M, 2009, AM J PATHOL, V174, P380, DOI 10.2353/ajpath.2009.080565; Tijsen AJ, 2014, CARDIOVASC RES, V104, P61, DOI 10.1093/cvr/cvu184; Yu XY, 2008, BIOCHEM BIOPH RES CO, V376, P548, DOI 10.1016/j.bbrc.2008.09.025; Zhao X, 2015, CELL PHYSIOL BIOCHEM, V35, P213, DOI 10.1159/000369689	31	6	5	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2020	15	2							e0229409	10.1371/journal.pone.0229409	http://dx.doi.org/10.1371/journal.pone.0229409			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8HR	32109943	gold, Green Published			2022-12-26	WOS:000535239800008
J	Catchpole, T; Nguyen, TD; Gilfoyle, A; Csaky, KG				Catchpole, Timothy; Nguyen, Timothy D.; Gilfoyle, Alexa; Csaky, Karl G.			A profile of circulating vascular progenitor cells in human neovascular age-related macular degeneration	PLOS ONE			English	Article							PERIPHERAL-BLOOD; STEM-CELLS; RESISTANCE; THERAPY; VEGFA; GENE	Background/objective A subset of neovascular age-related macular degeneration (nvAMD) subjects appears to be refractory to the effects of anti-VEGF treatment and require frequent intravitreal injections. The vascular phenotype of the choroidal neovascular (CNV) lesions may contribute to the resistance. Animal studies of CNV lesions have shown that cells originating from bone marrow are capable of forming varying cell types in the lesions. This raised the possibility of a similar cell population in human nvAMD subjects. Materials and methods Blood draws were obtained from subjects with active nvAMD while patients were receiving standard of care anti-VEGF injections. Subjects were classified as refractory or non-refractory to anti-VEGF treatment based on previous number of injections in the preceding 12 months. Peripheral blood mononuclear cells (PBMCs) were isolated and CD34-positive cells purified using magnetic bead sorting. The isolated cells were expanded in StemSpan SFEM media to increase cell numbers. After expansion, the cells were split and plated in either endothelial or mesenchymal promoting conditions. Phenotype analysis was performed via qPCR. Results There was no significant difference in the number of PBMCs and CD34-positive cells between refractory and non-refractory nvAMD subjects. The growth pattern distribution between endothelial and mesenchymal media conditions were very similar between refractory and non-refractory subjects. qPCR and immunostaining demonstrated positive expression of endothelial markers in endothelial media, and markers such as NG2 and aSMA in mesenchymal media. However, analysis of subsequent samples from AMD subjects demonstrated high variability in both the numbers and differentiation properties of this cell population. Conclusions CD34+ cells can be isolated from nvAMD subjects and show both endothelial and pericyte-like characteristics after differentiation in certain media conditions. However, nvAMD subjects show high variability in both numbers of cells and differentiation characteristics in repeat sampling. This variability highlights the importance of taking multiple samples from nvAMD subjects for any clinical trials focused on biomarkers for the disease.	[Catchpole, Timothy; Nguyen, Timothy D.; Gilfoyle, Alexa; Csaky, Karl G.] Retina Fdn Southwest, Dallas, TX 75231 USA; [Csaky, Karl G.] Univ Texas Southwestern Med Ctr Dallas, Dept Ophthalmol, Dallas, TX USA	Retina Foundation of the Southwest; University of Texas System; University of Texas Southwestern Medical Center Dallas	Catchpole, T (corresponding author), Retina Fdn Southwest, Dallas, TX 75231 USA.	tcatch@retinafoundation.org			NEI [R21EY024422]; Harrington Foundation; T. Boone Pickens Foundation	NEI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Harrington Foundation; T. Boone Pickens Foundation	Financial support was provided by NEI grant R21EY024422, the Harrington Foundation and the T. Boone Pickens Foundation for support of Dr. Karl Csaky. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.	Abedi F, 2013, OPHTHALMOLOGY, V120, P115, DOI 10.1016/j.ophtha.2012.10.006; Azam F, 2010, EUR J CANCER, V46, P1323, DOI 10.1016/j.ejca.2010.02.020; BENDER JG, 1991, BLOOD, V77, P2591; Bergers G, 2008, NAT REV CANCER, V8, P592, DOI 10.1038/nrc2442; BEYTH S, 2015, BONE MARROW RES, P84364, DOI DOI 10.1155/2015/914935; Catchpole T, 2016, EXP EYE RES, V148, P45, DOI 10.1016/j.exer.2016.05.025; Espinosa-Heidmann DG, 2003, INVEST OPHTH VIS SCI, V44, P4914, DOI 10.1167/iovs.03-0371; Ferreira LS, 2007, CIRC RES, V101, P286, DOI 10.1161/CIRCRESAHA.107.150201; Francis Peter James, 2011, Trans Am Ophthalmol Soc, V109, P115; Hagstrom SA, 2014, JAMA OPHTHALMOL, V132, P521, DOI 10.1001/jamaophthalmol.2014.109; Helfrich I, 2010, J EXP MED, V207, P491, DOI 10.1084/jem.20091846; Klein R, 2011, ARCH OPHTHALMOL-CHIC, V129, P75, DOI 10.1001/archophthalmol.2010.318; Korbling M, 2001, BLOOD, V98, P2900, DOI 10.1182/blood.V98.10.2900; Llufrio EM, 2018, REDOX BIOL, V16, P381, DOI 10.1016/j.redox.2018.03.004; Martin DF, 2012, OPHTHALMOLOGY, V119, DOI 10.1016/j.ophtha.2012.03.053; Martin DF, 2011, NEW ENGL J MED, V364, P1897, DOI 10.1056/NEJMoa1102673; Sidney LE, 2014, STEM CELLS, V32, P1380, DOI 10.1002/stem.1661; Wei L, 2012, CELL REP, V2, P1151, DOI 10.1016/j.celrep.2012.10.013; Wong T, 2008, OPHTHALMOLOGY, V115, P116, DOI 10.1016/j.ophtha.2007.03.008	19	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2020	15	2							e0229504	10.1371/journal.pone.0229504	http://dx.doi.org/10.1371/journal.pone.0229504			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8GQ	32106279	Green Published, gold			2022-12-26	WOS:000535237000036
J	Luo, SQ; Xiong, DH; Li, J; Li, GD; Wang, YL; Zhang, JM; Bu, XF; Hu, WX; Hu, JP				Luo, Sai-Qun; Xiong, De-Hui; Li, Jiang; Li, Guangdi; Wang, Yali; Zhang, Jia-Ming; Bu, Xiu-Fen; Hu, Wei-Xin; Hu, Jingping			C1orf35 contributes to tumorigenesis by activating c-MYC transcription in multiple myeloma	ONCOGENE			English	Article							BINDING-PROTEIN; CELL-CYCLE; PROGNOSTIC-SIGNIFICANCE; DNA; PROGRESSION; ABNORMALITIES; EXPRESSION; ADDICTION; TRANSLATION; PROMOTER	Multiple myeloma (MM) is a clinically and biologically heterogenous event that accounts for approximately 10% of all hematological malignancies. Chromosome 1 open reading frame 35 (C1orf35) is a gene cloned and identified in our laboratory from a MM cell line (GenBank: AY137773), but little is known about its function. In the current study, we have confirmed that C1orf35 is a candidate oncogene, and it can promote cell cycle progression from G1 to S. Later, we found that C1orf35 is able to affect the cell proliferation by modulating the expression of c-MYC (v-myc myelocytomatosis viral oncogene homolog), and the oncogenic property of C1orf35 can be rescued by c-MYC inhibition. Herein, we found positive association between C1orf35 and c-MYC in MM patients and in MM cell lines. The correlation analysis of the genes coamplified in MM patients from GEO datasets showed a correlation between C1orf35 and c-MYC, and the expression data of different stages of plasma cell neoplasm acquired from GEO datasets showed that the expression of C1orf35 increase with the progression of the disease. This indicates that C1orf35 may play a role in the disease progression. Moreover, C1orf35 can modulate c-MYC expression and rescue c-MYC transcription inhibited by Act D. Finally, we have shown that C1orf35 activates c-MYC transcription by binding to the i-motif of Nuclease hypersensitivity element III1 (NHE III1) in the c-MYC promoter. Not only does our current study advance our knowledge of the pathogenesis and therapeutic landscape of MM, but also of other cancer types and diseases that are initiated with deregulated c-MYC transcription.	[Luo, Sai-Qun; Xiong, De-Hui; Li, Jiang; Zhang, Jia-Ming; Bu, Xiu-Fen; Hu, Wei-Xin; Hu, Jingping] Cent South Univ, Mol Biol Res Ctr, Sch Life Sci, 110 Xiangya Rd, Changsha 410078, Hunan, Peoples R China; [Li, Guangdi; Wang, Yali] Cent South Univ, Xiangya Sch Publ Hlth, Dept Epidemiol & Hlth Stat, 110 Xiangya Rd, Changsha 410078, Hunan, Peoples R China	Central South University; Central South University	Hu, WX; Hu, JP (corresponding author), Cent South Univ, Mol Biol Res Ctr, Sch Life Sci, 110 Xiangya Rd, Changsha 410078, Hunan, Peoples R China.	weixinhu@mail.csu.edu.cn; jingpinghu@csu.edu.cn	Li, Guangdi/AAU-6951-2020	Hu, Jingping/0000-0001-5548-1241; Li, Guangdi/0000-0001-8852-034X	National Natural Science Foundation of China [81372538, 81400819, 81071947, 39880021, 30770906]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported with grants from the National Natural Science Foundation of China (Nos. 81372538, 81400819, 81071947, 39880021 and 30770906).	Agnelli L, 2009, GENE CHROMOSOME CANC, V48, P603, DOI 10.1002/gcc.20668; Arabi A, 2005, NAT CELL BIOL, V7, P303, DOI 10.1038/ncb1225; Armas P, 2008, J CELL BIOCHEM, V103, P1013, DOI 10.1002/jcb.21474; Avet-Loiseau H, 2012, J CLIN ONCOL, V30, P1949, DOI 10.1200/JCO.2011.36.5726; Avet-Loiseau H, 2009, J CLIN ONCOL, V27, P4585, DOI 10.1200/JCO.2008.20.6136; Bretones G, 2015, BBA-GENE REGUL MECH, V1849, P506, DOI 10.1016/j.bbagrm.2014.03.013; Carrasco DR, 2006, CANCER CELL, V9, P313, DOI 10.1016/j.ccr.2006.03.019; Chesi M, 2008, CANCER CELL, V13, P167, DOI 10.1016/j.ccr.2008.01.007; Chng WJ, 2011, LEUKEMIA, V25, P1026, DOI 10.1038/leu.2011.53; Chng WJ, 2007, CANCER RES, V67, P2982, DOI 10.1158/0008-5472.CAN-06-4046; Decaux O, 2008, J CLIN ONCOL, V26, P4798, DOI 10.1200/JCO.2007.13.8545; Dominguez-Sola D, 2007, NATURE, V448, P445, DOI 10.1038/nature05953; DUNCAN R, 1994, GENE DEV, V8, P465, DOI 10.1101/gad.8.4.465; Eddy J, 2006, NUCLEIC ACIDS RES, V34, P3887, DOI 10.1093/nar/gkl529; Geltinger C, 1996, GENE EXPRESSION, V6, P113; Gonzalez V, 2010, ANNU REV PHARMACOL, V50, P111, DOI 10.1146/annurev.pharmtox.48.113006.094649; Grand CL, 2002, MOL CANCER THER, V1, P565; Hanamura I, 2006, BLOOD, V108, P1724, DOI 10.1182/blood-2006-03-009910; Holien T, 2012, BLOOD, V120, P2450, DOI 10.1182/blood-2011-08-371567; Hu JP, 2018, CANCER LETT, V414, P214, DOI 10.1016/j.canlet.2017.11.020; Jovanovic KK, 2018, LEUKEMIA, V32, P1295, DOI 10.1038/s41375-018-0036-x; Kuehl WM, 2012, BLOOD, V120, P2351, DOI 10.1182/blood-2012-08-445262; Kumar SK, 2018, NAT REV CLIN ONCOL, V15, P409, DOI 10.1038/s41571-018-0018-y; Le Baccon P, 2001, GENE CHROMOSOME CANC, V32, P250, DOI 10.1002/gcc.1189; MAJELLO B, 1995, ONCOGENE, V10, P1841; Manier S, 2017, NAT REV CLIN ONCOL, V14, P100, DOI 10.1038/nrclinonc.2016.122; Marzin Y, 2006, ANTICANCER RES, V26, P953; Mateyak MK, 1999, MOL CELL BIOL, V19, P4672; Mathur V, 2004, BIOCHEM BIOPH RES CO, V320, P1220, DOI 10.1016/j.bbrc.2004.06.074; Melton PE, 2019, J HYPERTENS, V37, P997, DOI 10.1097/HJH.0000000000002023; Morgan GJ, 2012, NAT REV CANCER, V12, P335, DOI 10.1038/nrc3257; Neben K, 2013, J CLIN ONCOL, V31, P4325, DOI 10.1200/JCO.2012.48.4923; NOWELL PC, 1976, SCIENCE, V194, P23, DOI 10.1126/science.959840; Pawlyn C, 2017, NAT REV CANCER, V17, P543, DOI 10.1038/nrc.2017.63; Pelengaris S, 2002, NAT REV CANCER, V2, P764, DOI 10.1038/nrc904; POSTEL EH, 1993, SCIENCE, V261, P478, DOI 10.1126/science.8392752; Rajkumar SV, 2009, CURR PROB CANCER, V33, P7, DOI 10.1016/j.currproblcancer.2009.01.001; Sabo A, 2014, NATURE, V511, P488, DOI 10.1038/nature13537; Sawyer JR, 2011, CANCER GENET-NY, V204, P3, DOI 10.1016/j.cancergencyto.2010.11.002; Shaffer AL, 2008, NATURE, V454, P226, DOI 10.1038/nature07064; Shi YJ, 2008, CANCER RES, V68, P10215, DOI 10.1158/0008-5472.CAN-08-1066; Shou YP, 2000, P NATL ACAD SCI USA, V97, P228, DOI 10.1073/pnas.97.1.228; Snead NM, 2013, NUCLEIC ACIDS RES, V41, P6209, DOI 10.1093/nar/gkt200; SOBELL HM, 1985, P NATL ACAD SCI USA, V82, P5328, DOI 10.1073/pnas.82.16.5328; Stine ZE, 2015, CANCER DISCOV, V5, P1024, DOI 10.1158/2159-8290.CD-15-0507; Tian JY, 2003, ACTA BIOCH BIOPH SIN, V35, P143; Wiegering A, 2015, CANCER DISCOV, V5, P768, DOI 10.1158/2159-8290.CD-14-1040; Zeraati M, 2018, NAT CHEM, V10, P631, DOI 10.1038/s41557-018-0046-3	48	9	9	0	14	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 16	2020	39	16					3354	3366		10.1038/s41388-020-1222-7	http://dx.doi.org/10.1038/s41388-020-1222-7		FEB 2020	13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	QF9OJ	32103167				2022-12-26	WOS:000516683100001
J	Machani, MG; Ochomo, E; Amimo, F; Kosgei, J; Munga, S; Zhou, G; Githeko, AK; Yan, GY; Afrane, YA				Machani, Maxwell G.; Ochomo, Eric; Amimo, Fred; Kosgei, Jackline; Munga, Stephen; Zhou, Guofa; Githeko, Andrew K.; Yan, Guiyun; Afrane, Yaw A.			Resting behaviour of malaria vectors in highland and lowland sites of western Kenya: Implication on malaria vector control measures	PLOS ONE			English	Article							INSECTICIDE-TREATED BEDNETS; HUMAN BLOOD INDEX; ANOPHELES-GAMBIAE; PLASMODIUM-FALCIPARUM; PYRETHROID RESISTANCE; MOSQUITOS; ARABIENSIS; POPULATION; IMPACT; IDENTIFICATION	Background Understanding the interactions between increased insecticide resistance and resting behaviour patterns of malaria mosquitoes is important for planning of adequate vector control. This study was designed to investigate the resting behavior, host preference and rates of Plasmodium falciparum infection in relation to insecticide resistance of malaria vectors in different ecologies of western Kenya. Methods Anopheles mosquito collections were carried out during the dry and rainy seasons in Kisian (lowland site) and Bungoma (highland site), both in western Kenya using pyrethrum spray catches (PSC), mechanical aspiration (Prokopack) for indoor collections, clay pots, pit shelter and Prokopack for outdoor collections. WHO tube bioassay was used to determine levels of phenotypic resistance of indoor and outdoor collected mosquitoes to deltamethrin. PCRbased molecular diagnostics were used for mosquito speciation, genotype for knockdown resistance mutations (1014S and 1014F) and to determine specific host blood meal origins. Enzyme-linked Immunosorbent Assay (ELISA) was used to determine mosquito sporozoite infections. Results Anopheles gambiae s.l. was the most predominant species (75%, n = 2706) followed by An. funestus s.l. (25%, n = 860). An. gambiae s.s hereafter (An. gambiae) accounted for 91% (95% CI: 89-93) and An. arabiensis 8% (95% CI: 6-9) in Bungoma, while in Kisian, An. arabiensis composition was 60% (95% CI: 55-66) and An. gambiae 39% (95% CI: 34-44). The resting densities of An. gambiae s.l and An. funestus were higher indoors than outdoor in both sites (An. gambiae s.l; F-1,F- 655 = 41.928, p < 0.0001, An. funestus; F-1,F- 655 = 36.555, p < 0.0001). The mortality rate for indoor and outdoor resting An. gambiae s.l F1 progeny was 37% (95% CI: 34-39) vs 67% (95% CI: 62-69) respectively in Bungoma. In Kisian, the mortality rate was 67% (95% CI: 61-73) vs 76% (95% CI: 71-80) respectively. The mortality rate for F1 progeny of An. funestus resting indoors in Bungoma was 32% (95% CI: 28-35). The 1014S mutation was only detected in indoor resitng An. arabiensis. Similarly, the 1014F mutation was present only in indoor resting An. gambiae. The sporozoite rates were highest in An. funestus followed by An. gambiae, and An. arabiensis resting indoors at 11% (34/311), 8% (47/618) and 4% (1/27) respectively in Bungoma. Overall, in Bungoma, the sporozoite rate for indoor resting mosquitoes was 9% (82/956) and 4% (8/190) for outdoors. In Kisian, the sporozoite rate was 1% (1/112) for indoor resting An. gambiae. None of the outdoor collected mosquitoes in Kisian tested positive for sporozoite infections (n = 73). Conclusion The study reports high indoor resting densities of An. gambiae and An. funestus, insecticide resistance, and persistence of malaria transmission indoors regardless of the use of longlasting insecticidal nets (LLINs). These findings underline the difficulties of controlling malaria vectors resting and biting indoors using the current interventions. Supplemental vector control tools and implementation of sustainable insecticide resistance management strategies are needed in western Kenya.	[Machani, Maxwell G.; Ochomo, Eric; Kosgei, Jackline] Kenya Govt Med Res Ctr, Ctr Global Hlth Res, Entomol Sect, Kisumu, Kenya; [Machani, Maxwell G.; Amimo, Fred] Jaram Oginga Odinga Univ Sci & Technol, Sch Hlth Sci, Bondo, Kenya; [Munga, Stephen; Githeko, Andrew K.] Kenya Govt Med Res Ctr, Ctr Global Hlth Res, Kisumu, Kenya; [Zhou, Guofa; Yan, Guiyun] Univ Calif Irvine, Coll Hlth Sci, Program Publ Hlth, Irvine, CA USA; [Afrane, Yaw A.] Univ Ghana, Med Sch, Dept Med Microbiol, Accra, Ghana	Kenya Medical Research Institute; Kenya Medical Research Institute; University of California System; University of California Irvine; University of Ghana	Afrane, YA (corresponding author), Univ Ghana, Med Sch, Dept Med Microbiol, Accra, Ghana.	yaw_afrane@yahoo.com		Machani, Maxwell/0000-0002-2640-130X; Ochomo, Eric/0000-0002-4042-4970	National Institute of Health [R01 A1123074, U19 AI129326, R01 AI050243, D43 TW001505]	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This study was supported by grants from the National Institute of Health (R01 A1123074, U19 AI129326, R01 AI050243, D43 TW001505). There was no additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afrane YA, 2007, AM J TROP MED HYG, V77, P660, DOI 10.4269/ajtmh.2007.77.660; [Anonymous], PLOS ONE; Bass C, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-111; Bayoh MN, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-380; Bayoh MN, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-62; Bhatt S, 2015, NATURE, V526, P207, DOI 10.1038/nature15535; Bonizzoni M, 2012, PLOS ONE, V7, P9; Cohen JM, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-122; Cohuet A, 2003, AM J TROP MED HYG, V69, P200, DOI 10.4269/ajtmh.2003.69.200; COLLINS FH, 1987, AM J TROP MED HYG, V37, P37, DOI 10.4269/ajtmh.1987.37.37; Davidson JR, 2018, PARASITE VECTOR, V11, DOI 10.1186/s13071-018-3031-1; Degefa T, 2017, MALARIA J, V16, DOI 10.1186/s12936-017-2098-z; Diabate A, 2002, AM J TROP MED HYG, V67, P617, DOI 10.4269/ajtmh.2002.67.617; Durnez L, 2013, ANOPHELES MOSQUITOES - NEW INSIGHTS INTO MALARIA VECTORS, P671, DOI 10.5772/55925; Garrett-Jones C., 1964, Bulletin of the World Health Organization, V30, P241; Gillies M, 1987, PUBL S AFRI CAN I ME, V55, P1; Gimnig JE, 2003, AM J TROP MED HYG, V68, P16, DOI 10.4269/ajtmh.2003.68.16; Hamel MJ, 2011, AM J TROP MED HYG, V85, P597, DOI 10.4269/ajtmh.2011.10-0678; Hemming-Schroeder E, 2018, AM J TROP MED HYG, V98, P704, DOI 10.4269/ajtmh.17-0445; Kabula B, 2014, TROP MED INT HEALTH, V19, P331, DOI 10.1111/tmi.12248; Kawada H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022574; Kent RJ, 2007, AM J TROP MED HYG, V76, P267, DOI 10.4269/ajtmh.2007.76.267; Killeen GF, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1280-z; Killeen GF, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-330; Lindblade KA, 2006, J MED ENTOMOL, V43, P428, DOI 10.1093/jmedent/43.2.428; LINES JD, 1988, PARASITOL TODAY, V4, pS17, DOI 10.1016/0169-4758(88)90083-X; Luc DS, 2016, J VECTOR ECOL, V41, P34, DOI 10.1111/jvec.12191; Lynd A, 2010, MOL BIOL EVOL, V27, P1117, DOI 10.1093/molbev/msq002; Mathias DK, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-10; Mbogo CNM, 1996, MED VET ENTOMOL, V10, P251, DOI 10.1111/j.1365-2915.1996.tb00739.x; McCann RS, 2014, AM J TROP MED HYG, V90, P597, DOI 10.4269/ajtmh.13-0614; Muirhead-Thomson R. C., 1958, Bulletin of the World Health Organization, V19, P1116; Mwangangi JM, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-13; Ndenga B, 2006, J MED ENTOMOL, V43, P200, DOI 10.1603/0022-2585(2006)043[0200:PDOMVI]2.0.CO;2; Ndenga BA, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1115-y; Ndiath MO, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097700; Ochomo E, 2013, MED VET ENTOMOL, V27, P156, DOI 10.1111/j.1365-2915.2012.01039.x; Ochomo E, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-1223-5; Ochomo E, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-310; Ochomo EO, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-368; Odiere M, 2007, J MED ENTOMOL, V44, P14, DOI 10.1603/0022-2585(2007)44[14:SORAGA]2.0.CO;2; Ogola EO, 2018, PARASITE VECTOR, V11, DOI 10.1186/s13071-018-3171-3; Ototo EN, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0763-7; Pappa V, 2011, AM J TROP MED HYG, V84, P298, DOI 10.4269/ajtmh.2011.10-0463; PMI, 2019, KEN MAL OP PLAN FY 2; Ranson H, 2016, TRENDS PARASITOL, V32, P187, DOI 10.1016/j.pt.2015.11.010; Ranson H, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-299; Reid MC, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1162-4; Russell TL, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-56; Russell TL, 2013, MALARIA J, V12; Russell TL, 2011, MALARIA J, V10; SCOTT JA, 1993, AM J TROP MED HYG, V49, P520, DOI 10.4269/ajtmh.1993.49.520; Siegert PY, 2009, J ECON ENTOMOL, V102, P2061, DOI 10.1603/029.102.0607; Takken W, 2002, TROP MED INT HEALTH, V7, P1022, DOI 10.1046/j.1365-3156.2002.00983.x; Tanga MC, 2011, TROP MED INT HEALTH, V16, P447, DOI 10.1111/j.1365-3156.2011.02726.x; Trape JF, 2011, LANCET INFECT DIS, V11, P925, DOI 10.1016/S1473-3099(11)70194-3; van den Bijllaardt W, 2009, ACTA TROP, V111, P197, DOI 10.1016/j.actatropica.2009.04.003; Verhaeghen K, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-16; Wanjala CL, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-1194-6; Wanjala CL, 2015, EMERG INFECT DIS, V21, P2178, DOI 10.3201/eid2112.150814; Wanjala CL, 2015, EMERGING INFECT DIS, V21; WHO, 2018, WORLD MAL REP 2018; WHO, 2019, WORLD MAL REP 2018; WHO, 2013, TEST PROC INS RES MA; WIRTZ RA, 1987, EXP PARASITOL, V63, P166, DOI 10.1016/0014-4894(87)90158-5; World Health Organization, 2017, DEPRESSION	66	10	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2020	15	2							e0224718	10.1371/journal.pone.0224718	http://dx.doi.org/10.1371/journal.pone.0224718			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8EV	32097407	gold, Green Published, Green Submitted			2022-12-26	WOS:000535232000005
J	Jegouzo, SAF; Nelson, C; Hardwick, T; Wong, STA; Lau, NKK; Neoh, GKE; Castellanos-Rueda, R; Huang, ZY; Mignot, B; Hirdaramani, A; Howitt, A; Frewin, K; Shen, Z; Fox, RJ; Wong, R; Ando, M; Emony, L; Zhu, H; Holder, A; Werling, D; Krishnan, N; Robertson, BD; Clements, A; Taylor, ME; Drickamer, K				Jegouzo, Sabine A. F.; Nelson, Conor; Hardwick, Thomas; Wong, S. T. Angel; Lau, Noel Kuan Kiat; Neoh, Gaik Kin Emily; Castellanos-Rueda, Rocio; Huang, Zhiyao; Mignot, Benjamin; Hirdaramani, Aanya; Howitt, Annie; Frewin, Kathryn; Shen, Zheng; Fox, Rhys J.; Wong, Rachel; Ando, Momoko; Emony, Lauren; Zhu, Henderson; Holder, Angela; Werling, Dirk; Krishnan, Nitya; Robertson, Brian D.; Clements, Abigail; Taylor, Maureen E.; Drickamer, Kurt			Mammalian lectin arrays for screening host?microbe interactions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						glycobiology; lectin; carbohydrate-binding protein; carbohydrate function; lipopolysaccharide (LPS); array screening; glycan-binding receptors; innate immune system; ligand binding; pathogen	C-TYPE LECTIN; CARBOHYDRATE-RECOGNITION; MOLECULAR-BASIS; BINDING; RECEPTOR; EXPRESSION; IDENTIFICATION; MECHANISM; LIPOPOLYSACCHARIDES; POLYSACCHARIDE	Many members of the C-type lectin family of glycan-binding receptors have been ascribed roles in the recognition of microorganisms and serve as key receptors in the innate immune response to pathogens. Other mammalian receptors have become targets through which pathogens enter target cells. These receptor roles have often been documented with binding studies involving individual pairs of receptors and microorganisms. To provide a systematic overview of interactions between microbes and the large complement of C-type lectins, here we developed a lectin array and suitable protocols for labeling of microbes that could be used to probe this array. The array contains C-type lectins from cow, chosen as a model organism of agricultural interest for which the relevant pathogen?receptor interactions have not been previously investigated in detail. Screening with yeast cells and various strains of both Gram-positive and -negative bacteria revealed distinct binding patterns, which in some cases could be explained by binding to lipopolysaccharides or capsular polysaccharides, but in other cases they suggested the presence of novel glycan targets on many of the microorganisms. These results are consistent with interactions previously ascribed to the receptors, but they also highlight binding to additional sugar targets that have not previously been recognized. Our findings indicate that mammalian lectin arrays represent unique discovery tools for identifying both novel ligands and new receptor functions.	[Jegouzo, Sabine A. F.; Nelson, Conor; Hardwick, Thomas; Wong, S. T. Angel; Lau, Noel Kuan Kiat; Neoh, Gaik Kin Emily; Castellanos-Rueda, Rocio; Huang, Zhiyao; Mignot, Benjamin; Hirdaramani, Aanya; Howitt, Annie; Frewin, Kathryn; Shen, Zheng; Fox, Rhys J.; Wong, Rachel; Ando, Momoko; Emony, Lauren; Zhu, Henderson; Clements, Abigail; Taylor, Maureen E.; Drickamer, Kurt] Imperial Coll London, Dept Life Sci, London SW7 2AZ, England; [Holder, Angela; Werling, Dirk] Royal Vet Coll, Dept Pathobiol & Populat Sci, Hatfield AL9 7TA, Herts, England; [Krishnan, Nitya; Robertson, Brian D.] Imperial Coll London, Dept Infect Dis, London SW7 2AZ, England; [Clements, Abigail] Imperial Coll London, MRC Ctr Mol Bacteriol & Infect, London SW7 2AZ, England	Imperial College London; University of London; University of London Royal Veterinary College; Imperial College London; Imperial College London	Drickamer, K (corresponding author), Imperial Coll London, Dept Life Sci, London SW7 2AZ, England.; Drickamer, K (corresponding author), Imperial Coll, Dept Life Sci, Sir Ernst Chain Bldg, London SW7 2AZ, England.	k.drickamer@imperial.ac.uk	Werling, Dirk/F-5555-2013	Werling, Dirk/0000-0001-5411-4044; Zhu, Henderson/0000-0002-5547-6669; Lau, Noel Kuan Kiat/0000-0002-9560-504X; Howitt, Annie/0000-0003-0388-0990; Wong, Rachel/0000-0003-0701-4563; Hardwick, Tom/0000-0003-1018-511X; Jegouzo, Sabine/0000-0001-7768-0102; Neoh, Emily/0000-0002-4802-3135; Mignot, Benjamin/0000-0002-0283-3108; Fox, Rhys/0000-0002-7433-0331	Biotechnology and Biological Sciences Research Council [BB/P005659/1, BB/P008461/1]; Bill and Melinda Gates Foundation [37882]; Aeras grant; BBSRC [BB/P005659/1, BB/P008461/1] Funding Source: UKRI; MRC [MR/P028225/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Aeras grant; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by Biotechnology and Biological Sciences Research Council Grants BB/P005659/1 (to K. D. and M. E. T.) and BB/P008461/1 (to D. W.), Bill and Melinda Gates Foundation Grant 37882 (to B. D. R.), and an Aeras grant (to B. D. R.). The authors declare that they have no conflicts of interest with the contents of this article.	Arthur CM, 2015, METHODS MOL BIOL, V1207, P115, DOI 10.1007/978-1-4939-1396-1_8; Blixt O, 2004, P NATL ACAD SCI USA, V101, P17033, DOI 10.1073/pnas.0407902101; Brown S, 2013, ANNU REV MICROBIOL, V67, P313, DOI 10.1146/annurev-micro-092412-155620; Carroll P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009823; Chatterjee D, 2001, CELL MOL LIFE SCI, V58, P2018, DOI 10.1007/PL00000834; Clements A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003817; Coombs PJ, 2005, J BIOL CHEM, V280, P22993, DOI 10.1074/jbc.M504197200; Drickamer K, 2015, CURR OPIN STRUC BIOL, V34, P26, DOI 10.1016/j.sbi.2015.06.003; East L, 2002, J BIOL CHEM, V277, P50469, DOI 10.1074/jbc.M208985200; EISENBERG SP, 1990, NATURE, V343, P341, DOI 10.1038/343341a0; Fadden AJ, 2003, GLYCOBIOLOGY, V13, P529, DOI 10.1093/glycob/cwg068; Feinberg H, 2017, J BIOL CHEM, V292, P13402, DOI 10.1074/jbc.M117.799080; Feinberg H, 2013, J BIOL CHEM, V288, P28457, DOI 10.1074/jbc.M113.497149; Feinberg H, 2011, J MOL BIOL, V405, P1027, DOI 10.1016/j.jmb.2010.11.039; FORNSTEDT N, 1975, FEBS LETT, V57, P187, DOI 10.1016/0014-5793(75)80713-7; Fuller ME, 2000, APPL ENVIRON MICROB, V66, P4486, DOI 10.1128/AEM.66.10.4486-4496.2000; Fulton KM, 2018, EXPERT REV PROTEOMIC, V15, P203, DOI 10.1080/14789450.2018.1435276; Geissner A, 2019, P NATL ACAD SCI USA, V116, P1958, DOI 10.1073/pnas.1800853116; Gibson AJ, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00124; Gjerstorff M, 2004, ANIM GENET, V35, P333, DOI 10.1111/j.1365-2052.2004.01167.x; Guzman E, 2018, FRONT VET SCI, V5, DOI 10.3389/fvets.2018.00307; Hansen S, 2002, J IMMUNOL, V169, P5726, DOI 10.4049/jimmunol.169.10.5726; Heinrichs DE, 1998, MOL MICROBIOL, V30, P221, DOI 10.1046/j.1365-2958.1998.01063.x; Hirabayashi J, 2015, TOP CURR CHEM, V367, P105, DOI 10.1007/128_2014_612; Howard M, 2018, SEMIN IMMUNOPATHOL, V40, P75, DOI 10.1007/s00281-017-0642-0; Huson DH, 2012, SYST BIOL, V61, P1061, DOI 10.1093/sysbio/sys062; Jang S, 2009, J BIOL CHEM, V284, P3956, DOI 10.1074/jbc.M807477200; Killick KE, 2013, CELL MICROBIOL, V15, P1484, DOI 10.1111/cmi.12161; Klein G, 2011, J BIOL CHEM, V286, P42787, DOI 10.1074/jbc.M111.291799; KUHN HM, 1988, FEMS MICROBIOL LETT, V54, P195, DOI 10.1111/j.1574-6968.1988.tb02743.x; Lang R, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00005; Madeira F, 2019, NUCLEIC ACIDS RES, V47, pW636, DOI 10.1093/nar/gkz268; Mavridou DAI, 2016, PLASMID, V87-88, P65, DOI 10.1016/j.plasmid.2016.09.005; Mistretta N, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-39929-1; Ng KKS, 1996, J BIOL CHEM, V271, P663, DOI 10.1074/jbc.271.2.663; Ng S, 2015, J AM CHEM SOC, V137, P5248, DOI 10.1021/ja511237n; Nishiuchi Y, 2000, FEMS IMMUNOL MED MIC, V28, P163, DOI 10.1111/j.1574-695X.2000.tb01472.x; Pant SD, 2014, GENE, V537, P302, DOI 10.1016/j.gene.2013.12.020; Pilobello KT, 2005, CHEMBIOCHEM, V6, P985, DOI 10.1002/cbic.200400403; Plato A, 2013, INT REV IMMUNOL, V32, P134, DOI 10.3109/08830185.2013.777065; Powlesland AS, 2008, J BIOL CHEM, V283, P593, DOI 10.1074/jbc.M706292200; Propster JM, 2015, PROTEIN EXPRES PURIF, V109, P14, DOI 10.1016/j.pep.2015.01.005; Ram S, 2010, CLIN MICROBIOL REV, V23, P740, DOI 10.1128/CMR.00048-09; SCHATZ PJ, 1993, BIO-TECHNOL, V11, P1138, DOI 10.1038/nbt1093-1138; Smith PA, 1998, NUCLEIC ACIDS RES, V26, P1414, DOI 10.1093/nar/26.6.1414; Stambach NS, 2003, GLYCOBIOLOGY, V13, P401, DOI 10.1093/glycob/cwg045; Stowell SR, 2014, NAT CHEM BIOL, V10, P470, DOI [10.1038/nchembio.1525, 10.1038/NCHEMBIO.1525]; Taylor ME, 2019, FEBS J, V286, P1800, DOI 10.1111/febs.14759; TAYLOR ME, 1992, J BIOL CHEM, V267, P1719; Valdivia RH, 2006, METHOD BIOCHEM ANAL, V47, P163; Vinogradov E, 2002, J BIOL CHEM, V277, P25070, DOI 10.1074/jbc.M202683200; Weis WI, 1998, IMMUNOL REV, V163, P19, DOI 10.1111/j.1600-065X.1998.tb01185.x; Whitfield C., 2015, ECOLOGICAL IMPORTANC, P265, DOI DOI 10.1016/B978-0-12-802749-3.00009-8; WIDMALM G, 1993, CARBOHYD RES, V247, P255, DOI 10.1016/0008-6215(93)84258-8; Willcocks S, 2006, VET IMMUNOL IMMUNOP, V113, P234, DOI 10.1016/j.vetimm.2006.04.007; Yamakawa Y, 2008, J LEUKOCYTE BIOL, V83, P1396, DOI 10.1189/jlb.0807523; Yonekawa A, 2014, IMMUNITY, V41, P402, DOI 10.1016/j.immuni.2014.08.005; Young JC, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6887; Zhen L, 2018, FEBS LETT, V592, P3976, DOI 10.1002/1873-3468.13217; Zheng RB, 2017, ACS CHEM BIOL, V12, P2990, DOI 10.1021/acschembio.7b00797	60	5	5	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 3	2020	295	14					4541	4555		10.1074/jbc.RA120.012783	http://dx.doi.org/10.1074/jbc.RA120.012783			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LB2WZ	32094229	Green Published, Green Accepted, hybrid			2022-12-26	WOS:000524499700015
J	Watanabe, Y; Watanabe, K; Fujioka, D; Nakamura, K; Nakamura, T; Uematsu, M; Bachschmid, MM; Matsui, R; Kugiyama, K				Watanabe, Yosuke; Watanabe, Kazuhiro; Fujioka, Daisuke; Nakamura, Kazuto; Nakamura, Takamitsu; Uematsu, Manabu; Bachschmid, Markus M.; Matsui, Reiko; Kugiyama, Kiyotaka			Protein S-glutathionylation stimulate adipogenesis by stabilizing C/EBP beta in 3T3L1 cells	FASEB JOURNAL			English	Article						CCAAT enhancer-binding protein; glutaredoxin-1; reactive oxygen species; S-glutathionylation	ADIPOCYTE DIFFERENTIATION; OXIDATIVE STRESS; MICE LACKING; E3 LIGASE; OBESITY; UBIQUITIN; INHIBITOR; ISCHEMIA; DELETION; CYSTEINE	Reactive oxygen species (ROS) increase during adipogenesis and in obesity. Oxidants react with cysteine residues of proteins to form glutathione (GSH) adducts, S-glutathionylation, that are selectively removed by glutaredoxin-1 (Glrx). We have previously reported that Glrx knockout mice had increased protein S-glutathionylation and developed obesity by an unknown mechanism. In this study, we demonstrated that 3T3L1 adipocytes differentiation increased ROS and protein S-glutathionylation. Glrx ablation elevated protein S-glutathionylation and lipid content in 3T3L1 cells. Glrx replenishment decreased the lipid content of Glrx KO 3T3L1 cells. Glrx KO also increased protein expression and protein S-glutathionylation of the adipogenic transcription factor CCAAT enhancer-binding protein (C/EBP) beta. Protein S-glutathionylation decreased the interaction of C/EBP beta and protein inhibitor of activated STAT (PIAS) 1, a small ubiquitin-related modifier E3 ligase that facilitates C/EBP beta degradation. Experiments with truncated mutant C/EBP beta demonstrated that PIAS1 interacted with the liver-enriched inhibitory protein (LIP) region of C/EBP beta. Furthermore, mass spectrometry analysis identified protein S-glutathionylation of Cys201 and Cys296 in the LIP region of C/EBP beta. The C201S, C296S double-mutant C/EBP beta prevented protein S-glutathionylation and preserved the interaction with PIAS1. In summary, Glrx ablation stimulated 3T3L1 cell differentiation and adipogenesis via increased protein S-glutathionylation of C/EBP beta, stabilizing and increasing C/EBP beta protein levels.	[Watanabe, Yosuke; Watanabe, Kazuhiro; Fujioka, Daisuke; Nakamura, Kazuto; Nakamura, Takamitsu; Uematsu, Manabu; Kugiyama, Kiyotaka] Univ Yamanashi, Dept Internal Med 2, Chuo Ku, Shimokato 1110, Yamanashi 4003898, Japan; [Bachschmid, Markus M.; Matsui, Reiko] Boston Univ, Sch Med, Whitaker Cardiovasc Inst, Dept Med,Vasc Biol Sect, Boston, MA 02118 USA	University of Yamanashi; Boston University	Watanabe, Y (corresponding author), Univ Yamanashi, Dept Internal Med 2, Chuo Ku, Shimokato 1110, Yamanashi 4003898, Japan.	yosuke@yamanashi.ac.jp			NHLBI NIH HHS [R01 HL133013] Funding Source: Medline; NIDDK NIH HHS [R01 DK103750] Funding Source: Medline	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Anathy V, 2018, NAT MED, V24, P1128, DOI 10.1038/s41591-018-0090-y; Berndsen CE, 2014, NAT STRUCT MOL BIOL, V21, P301, DOI 10.1038/nsmb.2780; Carvalho AN, 2016, FEBS LETT, V590, P1455, DOI 10.1002/1873-3468.12177; Chang YC, 2013, EMBO MOL MED, V5, P1165, DOI 10.1002/emmm.201302679; Cho H, 2012, MOL CELL, V46, P495, DOI 10.1016/j.molcel.2012.03.009; Chrestensen CA, 2000, J BIOL CHEM, V275, P26556, DOI 10.1074/jbc.M004097200; Fruh SM, 2017, J AM ASSOC NURSE PRA, V29, pS3, DOI 10.1002/2327-6924.12510; Furukawa S, 2004, J CLIN INVEST, V114, P1752, DOI [10.1172/JCI20042162S, 10.1172/JCI21625]; Guo L, 2015, J BIOL CHEM, V290, P755, DOI 10.1074/jbc.R114.619957; Han CY, 2012, J BIOL CHEM, V287, P10379, DOI 10.1074/jbc.M111.304998; Han YH, 2010, INT J MOL MED, V25, P657, DOI 10.3892/ijmm_00000389; Hausman D B, 2001, Obes Rev, V2, P239, DOI 10.1046/j.1467-789X.2001.00042.x; Herrmann J, 2007, CIRC RES, V100, P1276, DOI 10.1161/01.RES.0000264500.11888.f0; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Kendig EL, 2011, TOXICOL APPL PHARM, V257, P338, DOI 10.1016/j.taap.2011.09.017; Klein EA, 2011, JAMA-J AM MED ASSOC, V306, P1549, DOI 10.1001/jama.2011.1437; Kobayashi T, 2010, CARDIOVASC RES, V85, P785, DOI 10.1093/cvr/cvp342; Lee H, 2009, J BIOL CHEM, V284, P10601, DOI 10.1074/jbc.M808742200; Liu Y, 2013, MOL CELL BIOL, V33, P4606, DOI 10.1128/MCB.00723-13; Luedde T, 2004, HEPATOLOGY, V40, P356, DOI 10.1002/hep.20333; Millward CA, 2007, DIABETES, V56, P161, DOI 10.2337/db06-0310; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Shao D, 2017, ANTIOXID REDOX SIGN, V27, P313, DOI 10.1089/ars.2016.6716; Tanaka T, 1997, EMBO J, V16, P7432, DOI 10.1093/emboj/16.24.7432; Tormos KV, 2011, CELL METAB, V14, P537, DOI 10.1016/j.cmet.2011.08.007; Unamuno X, 2018, EUR J CLIN INVEST, V48, DOI 10.1111/eci.12997; Vigilanza P, 2011, J CELL PHYSIOL, V226, P2016, DOI 10.1002/jcp.22542; Watanabe Y, 2016, CIRC J, V80, P1278, DOI 10.1253/circj.CJ-16-0317; Watanabe Y, 2016, P NATL ACAD SCI USA, V113, P6011, DOI 10.1073/pnas.1524198113; Watanabe Y, 2013, CARDIOVASC RES, V97, P282, DOI 10.1093/cvr/cvs333; Youn JY, 2014, DIABETES, V63, P2344, DOI 10.2337/db13-0719; Zhang YY, 2011, MOL BIOL CELL, V22, P2165, DOI 10.1091/mbc.E10-11-0912	32	10	10	0	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2020	34	4					5827	5837		10.1096/fj.201902575R	http://dx.doi.org/10.1096/fj.201902575R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	LJ5ZA	32141127	Bronze, Green Accepted			2022-12-26	WOS:000530242100067
J	Gil, S; Solano, E; Martinez-Trucharte, F; Martinez-Esain, J; Perez-Bern, AJ; Conesa, JJ; Kamma-Lorger, C; Alsina, M; Sabes, M				Gil, Silvia; Solano, Eduardo; Martinez-Trucharte, Francesc; Martinez-Esain, Jordi; Perez-Bern, Ana J.; Javier Conesa, Jose; Kamma-Lorger, Christina; Alsina, Merce; Sabes, Manel			Multiparametric analysis of the effectiveness of cisplatin on cutaneous squamous carcinoma cells using two different types of adjuvants	PLOS ONE			English	Article							VISUALIZATION; RECOGNITION; TOMOGRAPHY; TRICINE; COMPLEX; DEATH	The objective of this study was to regulate the cytotoxicity of cisplatin (cisPt) minimizing its adverse effects. For this purpose, the lowest cisPt concentration needed to obtain a significant positive response in cutaneous squamous cell carcinoma (cSCC) was explored. Two adjuvant agents as gold nanoparticles (AuNP) and chelating tricine were tested as enhancers in cisPt treatment. Effectiveness of all treatments was assessed by means of biochemical techniques, which offer quantitative data, as well as two microscopy-based techniques that provided qualitative cell imaging. The present work confirms the effectiveness of free cisplatin at very low concentrations. In order to enhance its effectiveness while the side effects were probably diminished, cisPt 3.5 mu M was administered with AuNP 2.5 mM, showing an effectiveness practically equal to that observed with free cisPt. However, the second treatment investigated, based on cisPt 3.5 mu M combined with tricine 50 mM, enhanced drug effectiveness, increasing the percentage of cells dying by apoptosis. This treatment was even better in terms of cell damage than free cisPt at 15 mu M. Images obtained by TEM and cryo-SXT confirmed these results, since a notable number of apoptotic bodies were detected when cisPt was combined with tricine. Thus, tricine was clearly a better adjuvant for cisPt treatments.	[Gil, Silvia; Alsina, Merce] Hosp Clin Barcelona, Barcelona, Spain; [Gil, Silvia; Martinez-Trucharte, Francesc] Hosp Parc Tauli, Barcelona, Spain; [Solano, Eduardo; Perez-Bern, Ana J.; Javier Conesa, Jose; Sabes, Manel] ALBA Synchrotron Light Source, Barcelona, Spain; [Martinez-Esain, Jordi] Univ Autonoma Barcelona, Dept Quim, Bellaterra, Spain; [Kamma-Lorger, Christina] Australian Nucl Sci & Technol Org, Australian Synchrotron, Clayton, Vic, Australia; [Sabes, Manel] Univ Autonoma Barcelona, Fac Med, Unitat Biofis, Barcelona, Spain	University of Barcelona; Hospital Clinic de Barcelona; Autonomous University of Barcelona; Parc Tauli Hospital Universitari; Autonomous University of Barcelona; Australian Nuclear Science & Technology Organisation; Autonomous University of Barcelona; University of Barcelona	Gil, S (corresponding author), Hosp Clin Barcelona, Barcelona, Spain.; Gil, S (corresponding author), Hosp Parc Tauli, Barcelona, Spain.	sgil@tauli.cat	Solano, Eduardo/M-6655-2015; Gil, Silvia/AAB-4008-2020	Solano, Eduardo/0000-0002-2348-2271; Gil, Silvia/0000-0002-2599-3016; Perez-Berna, Ana/0000-0003-4145-532X	Asociacion Espanola Contra el Cancer (Federacio de Barcelona); Institut d'Investigacio i Innovacio Parc Tauli (I3PT); synchrotron ALBA	Asociacion Espanola Contra el Cancer (Federacio de Barcelona); Institut d'Investigacio i Innovacio Parc Tauli (I3PT); synchrotron ALBA	1) S.G., M.A., M.S. received the funding of the Asociacion Espanola Contra el Cancer (Federacio de Barcelona), and the Institut d'Investigacio i Innovacio Parc Tauli (I3PT). https://www.aecc.es/es/sobre-nosotros/donde-estamos/sede-barcelona http://www.tauli.cat/i3pt/The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. 2) S.G., E.S., F.M.-T., J.M.-E., A.J. P.-B., J.J.C., C.K.-L., M.A., M.S. received the funding of synchrotron ALBA to perform part of this work in the Mistral beamline of this light source. Members of the Mistral beamline at ALBA synchrotron helped in the data collection and analysis, as well as in the preparation of the manuscript.	Agulleiro JI, 2011, BIOINFORMATICS, V27, P582, DOI 10.1093/bioinformatics/btq692; Carrascosa JL, 2009, J STRUCT BIOL, V168, P234, DOI 10.1016/j.jsb.2009.07.009; Comenge J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047562; Comenge J, 2010, J CONTROL RELEASE, V148, pE31, DOI 10.1016/j.jconrel.2010.07.041; Darzynkiewicz Z, 1997, CYTOMETRY, V27, P1; Fernandez JJ, 2003, J STRUCT BIOL, V144, P152, DOI 10.1016/j.jsb.2003.09.010; Gil S, 2016, DERMATOL THER, V29, P341, DOI 10.1111/dth.12373; GOOD NE, 1966, BIOCHEMISTRY-US, V5, P467, DOI 10.1021/bi00866a011; Hartmann JT, 2003, EXPERT OPIN PHARMACO, V4, P889, DOI 10.1517/14656566.4.6.889; Jamieson ER, 1999, CHEM REV, V99, P2467, DOI 10.1021/cr980421n; Perez-Berna AJ, 2016, ACS NANO, V10, P6597, DOI 10.1021/acsnano.6b01374; Kartalou M, 2001, MUTAT RES-FUND MOL M, V478, P1, DOI 10.1016/s0027-5107(01)00142-7; Kelland L, 2007, NAT REV CANCER, V7, P573, DOI 10.1038/nrc2167; Keminer O, 1999, BIOPHYS J, V77, P217, DOI 10.1016/S0006-3495(99)76883-9; Kremer JR, 1996, J STRUCT BIOL, V116, P71, DOI 10.1006/jsbi.1996.0013; LARSEN SK, 1995, BIOCONJUGATE CHEM, V6, P635, DOI 10.1021/bc00035a020; Lenaz G, 2004, METHOD ENZYMOL, V382, P3; Liang ZD, 2012, MOL CANCER THER, V11, P2483, DOI 10.1158/1535-7163.MCT-12-0580; Neumaier F, 2017, ACTA PHYSL; Pandey A, 2019, AM J CASE REP, V20, P294, DOI 10.12659/AJCR.913488; Pereiro E, 2009, J SYNCHROTRON RADIAT, P16505; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Rodriguez-Carino C, 2011, J COMP PATHOL, V144, P91, DOI 10.1016/j.jcpa.2010.07.001; Silva MR, 2001, ACTA CRYSTALLOGR C, V57, P9, DOI 10.1107/S0108270100014281; Sorrentino A, 2015, J SYNCHROTRON RADIAT, V22, P1112, DOI 10.1107/S1600577515008632; Tribius S, 2009, STRAHLENTHER ONKOL, V185, P675, DOI 10.1007/s00066-009-1992-x; Wang D, 2005, NAT REV DRUG DISCOV, V4, P307, DOI 10.1038/nrd1691; Zayed ME, 2014, J SAUDI CHEM SOC, V18, P774, DOI 10.1016/j.jscs.2011.08.006; Zong WX, 2006, GENE DEV, V20, P1, DOI 10.1101/gad.1376506	29	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2020	15	3							e0230022	10.1371/journal.pone.0230022	http://dx.doi.org/10.1371/journal.pone.0230022			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8TR	32143211	gold, Green Published			2022-12-26	WOS:000535271600031
J	Bharati, AP; Kashif, M; Chaturvedi, SK; Khan, RH; Ahmad, A				Bharati, Akhilendra Pratap; Kashif, Mohd; Chaturvedi, Sumit Kumar; Khan, Rizwan Hasan; Ahmad, Abrar			An insight into structural plasticity and conformational transitions of transcriptional co-activator Sus1	PLOS ONE			English	Article							NUCLEAR-PORE; FUNCTIONAL COMPONENT; CIRCULAR-DICHROISM; SAGA; COMPLEX; EXPORT; ELONGATION; DEUBIQUITINATION; FLUORESCENCE; SPECIFICITY	RNA biogenesis and mRNA transport are an intricate process for every eukaryotic cell. SAGA, a transcriptional coactivator and TREX-2 are the two major complexes participate in this process. Sus1 is a transcription export factor and part of both the SAGA and the TREX-2 complex. The competitive exchange of Sus1 molecule between SAGA and TREX-2 complex modulates their function which is credited to structural plasticity of Sus1. Here, we portray the biophysical characterization of Sus1 from S. cerevisiae. The recombinant Sus1 is a alpha-helical structure which is stable at various pH conditions. We reported the alpha-helix to beta-sheet transition at the low pH as well as at high pH. Sus1 showed 50% reduction in the fluorescence intensity at pH-2 as compared to native protein. The fluorescence studies demonstrated the unfolding of tertiary structure of the protein with variation in pH as compared to neutral pH. The same results were obtained in the ANS binding and acrylamide quenching studies. Similarly, the secondary structure of the Sus1 was found to be stable till 55% alcohol concentration while tertiary structure was stable up to 20% alcohol concentration. Further increase in the alcohol concentration destabilizes the secondary as well as tertiary structure. The 300 mM concentration of ammonium sulfate also stabilizes the secondary structure of the protein. The structural characterization of this protein is expected to unfold the process of the transportation of the mRNA with cooperation of different proteins.	[Bharati, Akhilendra Pratap] ICAR Natl Bur Agr Important Microorganisms, Mau, Uttar Pradesh, India; [Kashif, Mohd] CSIR NBRI, Ctr Plant Mol Biol Div, Lucknow, Uttar Pradesh, India; [Chaturvedi, Sumit Kumar; Khan, Rizwan Hasan] Aligarh Muslim Univ, Interdisciplinary Biotechnol Unit, Aligarh, Uttar Pradesh, India; [Ahmad, Abrar] King Abdulaziz Univ, Dept Biochem, Fac Sci, Jeddah, Saudi Arabia	Indian Council of Agricultural Research (ICAR); ICAR - National Bureau of Agriculturally Important Microorganisms; Council of Scientific & Industrial Research (CSIR) - India; CSIR - National Botanical Research Institute (NBRI); Aligarh Muslim University; King Abdulaziz University	Kashif, M (corresponding author), CSIR NBRI, Ctr Plant Mol Biol Div, Lucknow, Uttar Pradesh, India.; Ahmad, A (corresponding author), King Abdulaziz Univ, Dept Biochem, Fac Sci, Jeddah, Saudi Arabia.	kashifibu@gmail.com; abrar.ghauri@gmail.com	Chaturvedi, Sumit K/P-5052-2014; Khan, Rizwan Hasan/F-8276-2014; Bharati, Akhiendra Pratap/GWR-1433-2022; Ahmad, Abrar/AAP-9038-2020; Khan, Rizwan/GXZ-5789-2022	Chaturvedi, Sumit K/0000-0003-3600-8883; Khan, Rizwan Hasan/0000-0002-9965-8982; Bharati, Akhiendra Pratap/0000-0001-8711-610X; Ahmad, Abrar/0000-0001-9439-7712; 	Council of Scientific and Industrial Research (CSIR); Indian Council of Agricultural Research (ICAR); Deanship of Scientific Research [DF-709-130-141]; ICAR; CSIR; Deanship of Scientific Research (DSR), King Abdulaziz University	Council of Scientific and Industrial Research (CSIR)(Council of Scientific & Industrial Research (CSIR) - India); Indian Council of Agricultural Research (ICAR)(Indian Council of Agricultural Research (ICAR)); Deanship of Scientific Research; ICAR(Indian Council of Agricultural Research (ICAR)); CSIR(Council of Scientific & Industrial Research (CSIR) - India); Deanship of Scientific Research (DSR), King Abdulaziz University	This work was supported by the Council of Scientific and Industrial Research (CSIR), Indian Council of Agricultural Research (ICAR) and Deanship of Scientific Research (grant no-DF-709-130-141). APB is grateful to ICAR and MK is grateful to CSIR for the financial assistance. AA is grateful to the Deanship of Scientific Research (DSR), King Abdulaziz University for the financial assistance.	Ahmad B, 2006, J BIOCHEM, V140, P501, DOI 10.1093/jb/mvj178; Ahmad E, 2010, BIOCHIMIE, V92, P885, DOI 10.1016/j.biochi.2010.03.023; [Anonymous], 2008, DESIGN, V14, P3267, DOI [10.2174/138161208786404164, DOI 10.2174/138161208786404164]; Bharati AP, 2016, SCI REP-UK, V6, DOI 10.1038/srep31294; Cabal GG, 2006, NATURE, V441, P770, DOI 10.1038/nature04752; CHEN YH, 1972, BIOCHEMISTRY-US, V11, P4120, DOI 10.1021/bi00772a015; Chen YC, 2012, HUM MOL GENET, V21, P394, DOI 10.1093/hmg/ddr474; Cuenca-Bono B, 2011, NUCLEIC ACIDS RES, V39, P8599, DOI 10.1093/nar/gkr496; EFTINK MR, 1987, BIOCHIM BIOPHYS ACTA, V916, P343, DOI 10.1016/0167-4838(87)90179-8; Eick D, 2013, CHEM REV, V113, P8456, DOI 10.1021/cr400071f; Ellisdon AM, 2010, J BIOL CHEM, V285, P3850, DOI 10.1074/jbc.M109.070839; Faza MB, 2009, J CELL BIOL, V184, P833, DOI 10.1083/jcb.200810059; Garcia-Oliver E, 2012, BBA-GENE REGUL MECH, V1819, P555, DOI 10.1016/j.bbagrm.2011.11.011; Gasymov OK, 2007, BBA-PROTEINS PROTEOM, V1774, P403, DOI 10.1016/j.bbapap.2007.01.002; Gonzalez-Aguilera C, 2008, MOL BIOL CELL, V19, P4310, DOI 10.1091/mbc.E08-04-0355; Govind CK, 2007, MOL CELL, V25, P31, DOI 10.1016/j.molcel.2006.11.020; Kohler A, 2008, NAT CELL BIOL, V10, P707, DOI 10.1038/ncb1733; Kohler A, 2006, MOL BIOL CELL, V17, P4228, DOI 10.1091/mbc.E06-02-0098; Kopytova DV, 2010, CELL CYCLE, V9, P479, DOI 10.4161/cc.9.3.10610; Laskowski RA, 2018, PROTEIN SCI, V27, P129, DOI 10.1002/pro.3289; Louis-Jeune C, 2012, PROTEINS, V80, P374, DOI 10.1002/prot.23188; Luna R, 2009, RNA BIOL, V6, P145, DOI 10.4161/rna.6.2.7803; Mohan RD, 2014, CURR OPIN GENET DEV, V26, P96, DOI 10.1016/j.gde.2014.06.008; Moore MJ, 2009, CELL, V136, P688, DOI 10.1016/j.cell.2009.02.001; Morgan MT, 2016, SCIENCE, V351, P725, DOI 10.1126/science.aac5681; Naeem A, 2006, BIOCHEMISTRY-MOSCOW+, V71, P1101, DOI 10.1134/S0006297906100075; Nagai Y, 2008, CURR PHARM DESIGN, V14, P3267, DOI 10.2174/138161208786404164; PAN KM, 1993, P NATL ACAD SCI USA, V90, P10962, DOI 10.1073/pnas.90.23.10962; Pascual-Garcia P, 2008, GENE DEV, V22, P2811, DOI 10.1101/gad.483308; Pascual-Garcia P, 2009, RNA BIOL, V6, P141, DOI 10.4161/rna.6.2.7793; Perales R, 2009, MOL CELL, V36, P178, DOI 10.1016/j.molcel.2009.09.018; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Qadeer A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050633; Rabbani G, 2011, CELL BIOCHEM BIOPHYS, V61, P551, DOI 10.1007/s12013-011-9237-x; Rodriguez-Navarro S, 2004, CELL, V116, P75, DOI 10.1016/S0092-8674(03)01025-0; Salzwedel K, 1999, J VIROL, V73, P2469, DOI 10.1128/JVI.73.3.2469-2480.1999; Sasahara K, 2006, PROTEINS, V63, P127, DOI 10.1002/prot.20782; Singh SK, 2014, J BIOL CHEM, V289, P35225, DOI 10.1074/jbc.M113.507673; Tan JY, 2014, NAT STRUCT MOL BIOL, V21, P955, DOI 10.1038/nsmb.2902; Wang L, 2014, EPIGENOMICS-UK, V6, P329, DOI [10.2217/EPI.14.22, 10.2217/epi.14.22]; Wei Y, 2014, BBA-PROTEINS PROTEOM, V1844, P2331, DOI 10.1016/j.bbapap.2014.10.001	41	4	4	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2020	15	3							e0229216	10.1371/journal.pone.0229216	http://dx.doi.org/10.1371/journal.pone.0229216			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LJ8LF	32134955	gold, Green Published			2022-12-26	WOS:000530412000001
J	Qiao, N; Dai, HJ; Liu, J; Zhu, XP; Li, JT; Zhang, DZ; Liu, YG				Qiao, Ning; Dai, Huijie; Liu, Jie; Zhu, Xiaoping; Li, Jintang; Zhang, Dezhen; Liu, Yongguang			Detection of melon necrotic spot virus by one-step reverse transcription loop-mediated isothermal amplification assay	PLOS ONE			English	Article							PETITS-RUMINANTS VIRUS; RAPID DETECTION; OLPIDIUM-BORNOVANUS; SEED TRANSMISSION; PCR ASSAY; GENE; LAMP	Melon necrotic spot virus (MNSV) can cause significant economic losses due to decreased quality in cucurbit crops. The current study is the first to use reverse transcription loop-mediated isothermal amplification (RT-LAMP) for detection of MNSV. A set of four LAMP primers was designed based on the coat protein gene sequence of MNSV, and a RT-LAMP reaction was successfully performed for 1 h at 62 degrees C. The results of RT-LAMP showed high specificity for MNSV and no cross-reaction with other viruses. Compared to traditional reverse transcription-PCR (RT-PCR), the RT-LAMP assay was 10(3)-fold more sensitive in detecting MNSV. Due to its sensitivity, speed and visual assessment, RT-LAMP is appropriate for detecting MNSV in the laboratory.	[Qiao, Ning; Zhu, Xiaoping] Shandong Agr Univ, Coll Plant Protect, Tai An, Shandong, Peoples R China; [Qiao, Ning; Dai, Huijie; Liu, Jie; Li, Jintang; Zhang, Dezhen; Liu, Yongguang] Weifang Univ Sci & Technol, Facil Hort Lab Univ Shandong, Shouguang, Shandong, Peoples R China	Shandong Agricultural University	Zhu, XP (corresponding author), Shandong Agr Univ, Coll Plant Protect, Tai An, Shandong, Peoples R China.	zhuxp@sdau.edu.cn	Liu, Jie/AAH-5117-2020	Liu, Jie/0000-0002-2103-2816	Program for Applied Agricultural Technology Innovation of Shandong [SD2019ZZ004]; Shandong Provincial Natural Science Foundation, China [ZR2017CM058]; Science and Technology Development Planning Program of Weifang [2017GX076]; Scientific Research Project of Facility Horticulture Laboratory of Universities in Shandong [2018YY002]	Program for Applied Agricultural Technology Innovation of Shandong; Shandong Provincial Natural Science Foundation, China(Natural Science Foundation of Shandong Province); Science and Technology Development Planning Program of Weifang; Scientific Research Project of Facility Horticulture Laboratory of Universities in Shandong	This research has been supported by the following grants: Program for Applied Agricultural Technology Innovation of Shandong (No. SD2019ZZ004), Shandong Provincial Natural Science Foundation, China (No. ZR2017CM058), the Science and Technology Development Planning Program of Weifang (No. 2017GX076), and the Scientific Research Project of Facility Horticulture Laboratory of Universities in Shandong (No. 2018YY002).	Aleandri MP, 2017, J PLANT PATHOL, V99, P169, DOI 10.4454/jpp.v99i1.3787; AVGELIS A, 1985, PHYTOPATHOL Z, V114, P365; Balamurugan V, 2006, VET RES COMMUN, V30, P655, DOI 10.1007/s11259-006-3331-3; Campbell RN, 1996, PHYTOPATHOLOGY, V86, P1294, DOI 10.1094/Phyto-86-1294; CAMPBELL RN, 1995, EUR J PLANT PATHOL, V101, P273, DOI 10.1007/BF01874783; de Cara M, 2008, PLANT DIS, V92, P709, DOI 10.1094/PDIS-92-5-0709; Fallahi S, 2014, DIAGN MICR INFEC DIS, V79, P347, DOI 10.1016/j.diagmicrobio.2014.02.014; Genoves A, 2006, J GEN VIROL, V87, P2371, DOI 10.1099/vir.0.81793-0; GONZALEZGARZA R, 1979, PHYTOPATHOLOGY, V69, P340, DOI 10.1094/Phyto-69-340; Goto M, 2009, BIOTECHNIQUES, V46, P167, DOI 10.2144/000113072; Gu QS, 2008, PLANT PATHOL, V57, P765, DOI 10.1111/j.1365-3059.2008.01847.x; Herrera-Vasquez JA, 2010, PLANT PATHOL, V59, P240, DOI 10.1111/j.1365-3059.2009.02208.x; Herrera-Vasquez JA, 2009, PLANT PATHOL, V58, P436, DOI 10.1111/j.1365-3059.2008.01985.x; Hibi T., 1985, CMIAAB DESCRIPTIONS, V302; Kishi K., 1966, JPN J PHYTOPATHOL, V32, P138, DOI [10.3186/jjphytopath.32.138, DOI 10.3186/JJPHYTOPATH.32.138]; Kwiatek O, 2010, J VIROL METHODS, V165, P168, DOI 10.1016/j.jviromet.2010.01.014; Lai DW, 2018, SAUDI J BIOL SCI, V25, P1577, DOI 10.1016/j.sjbs.2016.02.024; Li JY, 2013, J VIROL METHODS, V193, P583, DOI 10.1016/j.jviromet.2013.07.059; Li L, 2010, J VIROL METHODS, V170, P37, DOI 10.1016/j.jviromet.2010.08.016; Li ZL, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-32473-4; Liu H, 2019, J VIROL METHODS, V265, P53, DOI 10.1016/j.jviromet.2018.12.011; MATSUO K, 1991, Annals of the Phytopathological Society of Japan, V57, P558, DOI 10.3186/jjphytopath.57.558; Misawa Yoshiki, 2007, Journal of Infection and Chemotherapy, V13, P134, DOI 10.1007/s10156-007-0508-9; Mori Y, 2001, BIOCHEM BIOPH RES CO, V289, P150, DOI 10.1006/bbrc.2001.5921; Piepenburg O, 2006, PLOS BIOL, V4, P1115, DOI 10.1371/journal.pbio.0040204; da Silva SJR, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-40960-5; RIVIERE CJ, 1990, J GEN VIROL, V71, P1887, DOI 10.1099/0022-1317-71-9-1887; Ryden K., 1986, Vaxtskyddsnotiser, V50, P130; Shen WT, 2014, J VIROL METHODS, V195, P174, DOI 10.1016/j.jviromet.2013.09.011; Stanghellini ME, 2014, EUR J PLANT PATHOL, V139, P387, DOI 10.1007/s10658-014-0395-8; Tahzima R, 2019, J VIROL METHODS, V265, P91, DOI 10.1016/j.jviromet.2018.12.019; Tomassoli L., 2000, EPPO B, V30, P279, DOI DOI 10.1111/J.1365-2338.2000.TB00895.X; Tomita N, 2008, NAT PROTOC, V3, P877, DOI 10.1038/nprot.2008.57; Tsai LC, 2018, FORENSIC SCI MED PAT, V14, P469, DOI 10.1007/s12024-018-0008-5; Wang JC, 2018, J VIROL METHODS, V260, P56, DOI 10.1016/j.jviromet.2018.07.007; Wang ZY, 2014, J VIROL METHODS, V195, P63, DOI 10.1016/j.jviromet.2013.08.037; Yakoubi S, 2008, PLANT PATHOL, V57, P386, DOI 10.1111/j.1365-3059.2007.01719.x; Yin JY, 2019, J FISH DIS, V42, P817, DOI 10.1111/jfd.12983; Yoneyama T, 2007, J VIROL METHODS, V145, P162, DOI 10.1016/j.jviromet.2007.05.023; Yuan DW, 2013, J VIROL METHODS, V187, P274, DOI 10.1016/j.jviromet.2012.11.020; Zeng R, 2019, MOL CELL PROBE, V43, P84, DOI 10.1016/j.mcp.2018.12.005; Zhang QL, 2013, J VIROL METHODS, V187, P384, DOI 10.1016/j.jviromet.2012.11.005	42	5	5	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2020	15	3							e0230023	10.1371/journal.pone.0230023	http://dx.doi.org/10.1371/journal.pone.0230023			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8RK	32134962	Green Submitted, gold, Green Published			2022-12-26	WOS:000535265600065
J	Renaud, M; Cousins, M; Awuah, KF; Jegede, O; Hale, B; Sousa, JP; Siciliano, SD				Renaud, Mathieu; Cousins, Mark; Awuah, Kobby Fred; Jegede, Olukayode; Hale, Beverley; Sousa, Jose Paulo; Siciliano, Steven Douglas			Metal oxides and annealed metals as alternatives to metal salts for fixed-ratio metal mixture ecotoxicity tests in soil	PLOS ONE			English	Article							FOLSOMIA-CANDIDA COLLEMBOLA; HEAVY-METALS; ENCHYTRAEUS-CRYPTICUS; CONTAMINATED SOILS; COMPETITIVE ADSORPTION; THERMAL-DECOMPOSITION; ZNO NANOPARTICLES; EISENIA-FOETIDA; COPPER TOXICITY; ZINC-OXIDE	In soil metal ecotoxicology research, dosing is usually performed with metal salts, followed by leaching to remove excess salinity. This process also removes some metals, affecting metal mixture ratios as different metals are removed by leaching at different rates. Consequently, alternative dosing methods must be considered for fixed ratio metal mixture research. In this study three different metal mixture dosing methods (nitrate, oxide and annealed metal dosing) were examined for metal concentrations and toxicity. In the nitrate metal dosing method leaching reduced total metal retention and was affected by soil pH and cation exchange capacity (CEC). Acidic soils 3.22 (pH 3.4, CEC 8 meq/100g) and WTRS (pH 4.6, CEC 16 meq/100g) lost more than 75 and 64% of their total metals to leaching respectively while Elora (6.7 pH, CEC 21 meq/100g) and KUBC (pH 5.6, CEC 28 meq/100g) with higher pH and CEC only lost 13.6% and 12.2% total metals respectively. Metal losses were highest for Ni, Zn and Co (46.0%, 63.7% and 48.4% metal loss respectively) whereas Pb and Cu (5.6% and 20.0% metal loss respectively) were mostly retained, affecting mixture ratios. Comparatively, oxide and annealed metal dosing which do not require leaching had higher total metal concentrations, closer to nominal doses and maintained better mixture ratios (percent of nominal concentrations for the oxide metal dosing were Pb = 109.9%, Cu = 84.6%, Ni = 101.9%, Zn = 82.3% and Co = 97.8% and for the annealed metal dosing were Pb = 81.7%, Cu = 80.3%, Ni = 100.5%, Zn = 89.2% and Co = 101.3%). Relative to their total metal concentrations, nitrate metal dosing (lowest metal concentrations) was the most toxic followed by metal oxides dosing while the annealed dosing method was generally non-toxic. Due to the lack of toxicity of the annealed metals and their higher dosing effort, metal oxides, are the most appropriate of the tested dosing methods, for fixed-ratio metal mixtures studies with soil invertebrates.	[Renaud, Mathieu; Sousa, Jose Paulo] Univ Coimbra, Ctr Funct Ecol, Dept Life Sci, Coimbra, Portugal; [Cousins, Mark; Siciliano, Steven Douglas] Univ Saskatchewan, Dept Soil Sci, Saskatoon, SK, Canada; [Awuah, Kobby Fred; Jegede, Olukayode] Univ Saskatchewan, Toxicol Ctr, Saskatoon, SK, Canada; [Hale, Beverley] Univ Guelph, Sch Environm Sci, Guelph, ON, Canada	Universidade de Coimbra; University of Saskatchewan; University of Saskatchewan; University of Guelph	Renaud, M (corresponding author), Univ Coimbra, Ctr Funct Ecol, Dept Life Sci, Coimbra, Portugal.	jeanmathieubr@gmail.com	Sousa, Jose Paulo FA/H-5407-2011; Siciliano, Steven D/G-3370-2011	Sousa, Jose Paulo FA/0000-0001-8045-4296; Awuah, Kobby Fred/0000-0002-7622-0419; Renaud, Mathieu/0000-0001-8751-4722; Siciliano, Steven/0000-0002-8994-3341; Cousins, Mark/0000-0003-1714-8362	Natural Sciences and Engineering Research Council (NSERC); Portuguese Institution "Fundacao para a Ciencia e a Tecnologia (FCT) [SFRH/BD/130442/2017]	Natural Sciences and Engineering Research Council (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Portuguese Institution "Fundacao para a Ciencia e a Tecnologia (FCT)	Funding for this research was provided by a Natural Sciences and Engineering Research Council (NSERC -https://www.nserc-crsng.gc.ca) Strategic Grant to B.H. and S.D.S. and the PhD grant of M. R. (SFRH/BD/130442/2017) by the Portuguese Institution "Fundacao para a Ciencia e a Tecnologia (FCT -https://www.fct.pt).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amorim MJD, 2005, ENVIRON TOXICOL CHEM, V24, P1875, DOI 10.1897/04-505R.1; [Anonymous], SRM2711A; [Anonymous], 1963, J CHEM ENG DATA; [Anonymous], 2016, 16387 ISO; Awuah KF, 2019, CHEMOSPHERE, V232, P366, DOI 10.1016/j.chemosphere.2019.05.213; Baas J, 2007, ENVIRON TOXICOL CHEM, V26, P1320, DOI 10.1897/06-437R.1; Bongers M, 2004, ENVIRON TOXICOL CHEM, V23, P195, DOI 10.1897/02-508; CCME, 2019, SOIL QUAL GUID PROT; Cipullo S, 2018, SCI TOTAL ENVIRON, V615, P708, DOI 10.1016/j.scitotenv.2017.09.321; Criel P, 2008, ENVIRON TOXICOL CHEM, V27, P1748, DOI 10.1897/07-545; Dijkstra JJ, 2004, ENVIRON SCI TECHNOL, V38, P4390, DOI 10.1021/es049885v; ELLIOTT HA, 1986, J ENVIRON QUAL, V15, P214, DOI 10.2134/jeq1986.00472425001500030002x; Fajana HO, 2019, ENVIRON TOXICOL CHEM, V38, P2593, DOI 10.1002/etc.4574; Fountain MT, 2005, ANNU REV ENTOMOL, V50, P201, DOI 10.1146/annurev.ento.50.071803.130331; Gomes PC, 2001, SOIL SCI SOC AM J, V65, P1115, DOI 10.2136/sssaj2001.6541115x; Hamilton JG, 2016, J ENVIRON QUAL, V45, P684, DOI 10.2134/jeq2015.03.0145; He EK, 2019, ENVIRON POLLUT, V245, P510, DOI 10.1016/j.envpol.2018.11.037; He E, 2015, CHEMOSPHERE, V139, P216, DOI 10.1016/j.chemosphere.2015.06.057; He E, 2015, ENVIRON TOXICOL CHEM, V34, P328, DOI 10.1002/etc.2802; Hope RM, 2013, RMISC RMISC RYAN MIS; ISO, 1999, 11267 ISO; Jegede OO, 2019, CHEMOSPHERE, V227, P444, DOI 10.1016/j.chemosphere.2019.04.090; Khalil MA, 1996, PEDOBIOLOGIA, V40, P548; Khalil MA, 1996, APPL SOIL ECOL, V4, P213, DOI 10.1016/S0929-1393(96)00115-1; Kool PL, 2011, ENVIRON POLLUT, V159, P2713, DOI 10.1016/j.envpol.2011.05.021; KORTE NE, 1976, SOIL SCI, V122, P350, DOI 10.1097/00010694-197612000-00006; Li B, 2010, ENVIRON TOXICOL CHEM, V29, P835, DOI 10.1002/etc.108; Lock K, 2004, COMP BIOCHEM PHYS C, V139, P195, DOI 10.1016/j.cca.2004.10.002; Lock K, 2003, CHEMOSPHERE, V53, P851, DOI 10.1016/S0045-6535(03)00593-9; Lock K, 2002, CHEMOSPHERE, V46, P197, DOI 10.1016/S0045-6535(01)00112-6; Lock K, 2002, ECOTOX ENVIRON SAFE, V52, P1, DOI 10.1006/eesa.2002.2155; Lock K, 2006, ENVIRON TOXICOL CHEM, V25, P2006, DOI 10.1897/05-612R.1; Manceau A, 2000, AM J SCI, V300, P289, DOI 10.2475/ajs.300.4.289; McLean JE, 1992, OFF RES DEV; Nikolic R, 2006, J THERM ANAL CALORIM, V86, P423, DOI 10.1007/s10973-005-7237-z; Owojori OJ, 2009, PEDOBIOLOGIA, V52, P351, DOI 10.1016/j.pedobi.2008.12.002; Owojori OJ, 2008, SOIL BIOL BIOCHEM, V40, P2385, DOI 10.1016/j.soilbio.2008.05.019; Owojori OJ, 2012, ENVIRON TOXICOL CHEM, V31, P1639, DOI 10.1002/etc.1857; Pereira CS, 2015, CHEMOSPHERE, V135, P116, DOI 10.1016/j.chemosphere.2015.03.094; Pohlert T., 2014, PAIRWISE MULTIPLE CO; Posthuma L, 1997, ECOTOX ENVIRON SAFE, V38, P108, DOI 10.1006/eesa.1997.1568; Princz JI, 2010, ENVIRON TOXICOL CHEM, V29, P971, DOI 10.1002/etc.98; R Core Team, 2018, R LANG ENV STAT COMP; Ribeiro MJ, 2019, NANOTOXICOLOGY, V13, P751, DOI 10.1080/17435390.2019.1570374; Rombke J, 2003, PEDOBIOLOGIA, V47, P607; Sandifer RD, 1996, CHEMOSPHERE, V33, P2475, DOI 10.1016/S0045-6535(96)00348-7; Sandifer RD, 1997, ECOTOX ENVIRON SAFE, V37, P125, DOI 10.1006/eesa.1997.1536; Schwertfeger DM, 2013, COMMUN SOIL SCI PLAN, V44, P1570, DOI 10.1080/00103624.2012.760576; Smolders E, 2009, ENVIRON TOXICOL CHEM, V28, P1633, DOI 10.1897/08-592.1; Stevens DP, 2003, ENVIRON TOXICOL CHEM, V22, P3017, DOI 10.1897/02-290; TOPPER K, 1990, COMMUN SOIL SCI PLAN, V21, P1437, DOI 10.1080/00103629009368315; US-EPA, 2007, SW846 USEPA; VRATNY F, 1963, J INORG NUCL CHEM, V25, P1129, DOI 10.1016/0022-1902(63)80133-5; Waalewijn-Kool PL, 2013, ENVIRON TOXICOL CHEM, V32, P2349, DOI 10.1002/etc.2302; YONG RN, 1993, CAN GEOTECH J, V30, P821, DOI 10.1139/t93-073; Zhang LL, 2019, SCI TOTAL ENVIRON, V664, P975, DOI 10.1016/j.scitotenv.2019.02.054	56	4	4	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2020	15	3							e0229794	10.1371/journal.pone.0229794	http://dx.doi.org/10.1371/journal.pone.0229794			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8RK	32134972	gold, Green Published			2022-12-26	WOS:000535265600046
J	Xie, J; An, SW; Jin, X; Gui, Y; Huang, CL				Xie, Jian; An, Sung-Wan; Jin, Xin; Gui, Yuan; Huang, Chou-Long			Munc13 mediates klotho-inhibitable diacylglycerol-stimulated exocytotic insertion of pre-docked TRPC6 vesicles	PLOS ONE			English	Article							FUNCTIONAL VARIANT; CHANNELS; RELEASE; MEMBRANE; RECEPTOR; PROTEIN; GENE; ASSOCIATION; CLEAVAGE; DENSITY	alpha-Klotho is a type 1 transmembrane protein that exhibits aging suppression function. The large amino-terminal extracellular domain of alpha -klotho is shed as soluble klotho (sKlotho) and functions as a circulating cardioprotective hormone. Diacylglycerol (DAG)-activated calcium-permeable TRPC6 channel plays a critical role in stress-induced cardiac remodeling. DAG activates TRPC6 by acting directly on the channel to increase its activity and by stimulation of channel exocytosis. sKlotho protects the heart by inhibiting DAG stimulation of TRPC6 exocytosis. How DAG stimulates TRPC6 exocytosis and thereby inhibition by sKlotho are unknown. Using a compound that directly activates TRPC6 without affecting channel exocytosis, we validate that sKlotho selectively blocks DAG stimulation of channel exocytosis. We further show that DAG stimulates exocytosis of TRPC6-containing vesicles pre-docked to the plasma membrane. Mnuc13 family proteins play important roles in the proper assembly of SNARE proteins and priming the vesicle competent for fusion. We show that DAG stimulates TRPC6 exocytosis by targeting to the C1 domain of Munc13-2. The results provide fresh insights into the molecular mechanism by which DAG regulates vesicle fusion and how sKlotho protects the heart against injury.	[Xie, Jian; An, Sung-Wan; Jin, Xin; Gui, Yuan; Huang, Chou-Long] Univ Iowa, Carver Coll Med, Dept Internal Med, Div Nephrol, Iowa City, IA 52242 USA	University of Iowa	Huang, CL (corresponding author), Univ Iowa, Carver Coll Med, Dept Internal Med, Div Nephrol, Iowa City, IA 52242 USA.	chou-long-huang@uiowa.edu		Xie, Jian/0000-0001-9454-1358	NIH of USA [DK109887, DK 100605]; Roy J. Carver Chair in Internal Medicine in the University of Iowa Carver College of Medicine	NIH of USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Roy J. Carver Chair in Internal Medicine in the University of Iowa Carver College of Medicine	The study is supported by grants from NIH of USA (DK109887, DK 100605) and Roy J. Carver Chair in Internal Medicine in the University of Iowa Carver College of Medicine. Funders play no role in study design. There was no additional external funding received for this study	Arking DE, 2005, CIRC RES, V96, P412, DOI 10.1161/01.RES.0000157171.04054.30; Arking DE, 2003, AM J HUM GENET, V72, P1154, DOI 10.1086/375035; Arking DE, 2002, P NATL ACAD SCI USA, V99, P856, DOI 10.1073/pnas.022484299; Bauer M, 2012, EUR PSYCHIAT, V27; Berry AK, 2019, Inhibitors of TRPC6, PCT Publication No. WO2019, Patent No. [161010 A1, 161010]; Cayouette S, 2004, J BIOL CHEM, V279, P7241, DOI 10.1074/jbc.M312042200; Chaudhuri P, 2016, P NATL ACAD SCI USA, V113, P2110, DOI 10.1073/pnas.1600371113; Chen CD, 2007, P NATL ACAD SCI USA, V104, P19796, DOI 10.1073/pnas.0709805104; Dalton G, 2017, P NATL ACAD SCI USA, V114, P752, DOI 10.1073/pnas.1620301114; Dalton GD, 2017, FRONT ENDOCRINOL, V8, DOI 10.3389/fendo.2017.00323; Hofmann T, 1999, NATURE, V397, P259, DOI 10.1038/16711; Imura A, 2004, FEBS LETT, V565, P143, DOI 10.1016/j.febslet.2004.03.090; Kang LJ, 2006, CELL METAB, V3, P463, DOI 10.1016/j.cmet.2006.04.012; Kawano KI, 2002, J BONE MINER RES, V17, P1744, DOI 10.1359/jbmr.2002.17.10.1744; Kuroo M, 1997, NATURE, V390, P45, DOI 10.1038/36285; Kurosu H, 2006, J BIOL CHEM, V281, P6120, DOI 10.1074/jbc.C500457200; Kurosu H, 2005, SCIENCE, V309, P1829, DOI 10.1126/science.1112766; Kuwahara K, 2006, J CLIN INVEST, V116, P3114, DOI 10.1172/JCI27702; Makarewich CA, 2014, CIRC RES, V115, P567, DOI 10.1161/CIRCRESAHA.115.303831; Morishita K, 2001, J NUTR, V131, P3182, DOI 10.1093/jn/131.12.3182; Razzaque MS, 2007, J ENDOCRINOL, V194, P1, DOI 10.1677/JOE-07-0095; SCHIAVO G, 1992, EMBO J, V11, P3577, DOI 10.1002/j.1460-2075.1992.tb05441.x; Sudhof TC, 2012, NEURON, V75, P11, DOI 10.1016/j.neuron.2012.06.012; Urakawa I, 2006, NATURE, V444, P770, DOI 10.1038/nature05315; Wang S, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-018-08028-6; Wu X, 2010, P NATL ACAD SCI USA, V107, P7000, DOI 10.1073/pnas.1001825107; Xie J, 2015, J AM SOC NEPHROL, V26, P1150, DOI 10.1681/ASN.2014040325; Xie J, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2240	28	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2020	15	3							e0229799	10.1371/journal.pone.0229799	http://dx.doi.org/10.1371/journal.pone.0229799			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8RK	32134975	Green Published, Green Submitted, gold			2022-12-26	WOS:000535265600048
J	Encarnacion-Rivera, L; Foltz, S; Hartzell, HC; Choo, H				Encarnacion-Rivera, Lucas; Foltz, Steven; Hartzell, H. Criss; Choo, Hyojung			Myosoft: An automated muscle histology analysis tool using machine learning algorithm utilizing FIJI/ImageJ software	PLOS ONE			English	Article							SKELETAL-MUSCLE; FIBER COMPOSITION; SEGMENTATION; RESISTANCE; EXERCISE; INSIGHTS; MODELS; HEAVY	Skeletal muscle is comprised of a heterogeneous population of muscle fibers which can be classified by their metabolic and contractile properties (fiber "types"). Fiber type is a primary determinant of muscle function along with fiber size (cross-sectional area). The fiber type composition of a muscle responds to physiological changes like exercise and aging and is often altered in disease states. Thus, analysis of fiber size and type in histological muscle preparations is a useful method for quantifying key indicators of muscle function and for measuring responses to a variety of stimuli or stressors. These analyses are near-ubiquitous in the fields of muscle physiology and myopathy, but are most commonly performed manually, which is highly labor- and time-intensive. To offset this obstacle, we developed Myosoft, a novel method to automate morphometric and fiber type analysis in muscle sections stained with fluorescent antibodies. Methods Muscle sections were stained for cell boundary (laminin) and myofiber type (myosin heavy chain isoforms). Myosoft, running in the open access software platform FIJI (ImageJ), was used to analyze myofiber size and type in transverse sections of entire gastrocnemius/soleus muscles. Results Myosoft provides an accurate analysis of hundreds to thousands of muscle fibers within 25 minutes, which is >10-times faster than manual analysis. We demonstrate that Myosoft is capable of handling high-content images even when image or staining quality is suboptimal, which is a marked improvement over currently available and comparable programs. Conclusions Myosoft is a reliable, accurate, high-throughput, and convenient tool to analyze high-content muscle histology. Myosoft is freely available to download from Github at https://github.com/Hyojung-Choo/Myosoft/tree/Myosoft-hub.	[Encarnacion-Rivera, Lucas; Foltz, Steven; Hartzell, H. Criss; Choo, Hyojung] Emory Univ, Sch Med, Dept Cell Biol, Atlanta, GA 30322 USA; [Encarnacion-Rivera, Lucas] Emory Univ, Sch Med, Undergrad Program Neurosci & Behav Biol, Atlanta, GA USA	Emory University; Emory University	Choo, H (corresponding author), Emory Univ, Sch Med, Dept Cell Biol, Atlanta, GA 30322 USA.	hchoo2@emory.edu		Foltz, Steven/0000-0002-9851-3693; Choo, Hyojung/0000-0002-6280-0332	National Institutes of Health [1R01AR071397-03, 1R01AR067786-04, 1R01EY014852-15, 1F32AR074249-01A1, 1R25GM125598-01]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by National Institutes of Health grants 1R01AR071397-03 (to HC), 1R01AR067786-04 and 1R01EY014852-15 (to HCH), 1F32AR074249-01A1 (to SJF), and 1R25GM125598-01 (to LER). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arganda-Carreras I, 2017, BIOINFORMATICS, V33, P2424, DOI 10.1093/bioinformatics/btx180; Bergmeister KD, 2017, JOVE-J VIS EXP, DOI 10.3791/55441; Bergmeister KD, 2016, MUSCLE NERVE, V54, P292, DOI 10.1002/mus.25033; Casiraghi E, 2018, BMC BIOINFORMATICS, V19, P281, DOI 10.1186/s12859-018-2302-3; Casiraghi E, 2017, EUR J HISTOCHEM, V61, P270, DOI 10.4081/ejh.2017.2838; CLARYS JP, 1984, HUM BIOL, V56, P459; Cohen Sarah, 2018, Curr Protoc Cell Biol, V79, pe46, DOI 10.1002/cpcb.46; COSTILL DL, 1976, MED SCI SPORT EXER, V8, P96; COSTILL DL, 1976, J APPL PHYSIOL, V40, P149, DOI 10.1152/jappl.1976.40.2.149; Desgeorges T, 2019, SKELET MUSCLE, V9, DOI 10.1186/s13395-018-0186-6; Fakhry A, 2016, BIOINFORMATICS, V32, P2352, DOI 10.1093/bioinformatics/btw165; Fink W J, 1977, Ann N Y Acad Sci, V301, P323; Fluck M, 2006, J EXP BIOL, V209, P2239, DOI 10.1242/jeb.02149; FORBES RM, 1953, J BIOL CHEM, V203, P359; FREEDMAN D, 1981, Z WAHRSCHEINLICHKEIT, V57, P453, DOI 10.1007/BF01025868; Frontera WR, 2015, CALCIFIED TISSUE INT, V96, P183, DOI 10.1007/s00223-014-9915-y; Gurcan Metin N, 2009, IEEE Rev Biomed Eng, V2, P147, DOI 10.1109/RBME.2009.2034865; Holm L, 2008, J APPL PHYSIOL, V105, P1454, DOI 10.1152/japplphysiol.90538.2008; Jain V, 2010, CURR OPIN NEUROBIOL, V20, P653, DOI 10.1016/j.conb.2010.07.004; KAPUR JN, 1985, COMPUT VISION GRAPH, V29, P273, DOI 10.1016/0734-189X(85)90125-2; Kung TA, 2014, J GERONTOL A-BIOL, V69, P657, DOI 10.1093/gerona/glt135; Lepper C, 2010, GENESIS, V48, P424, DOI 10.1002/dvg.20630; Madabhushi A, 2016, MED IMAGE ANAL, V33, P170, DOI 10.1016/j.media.2016.06.037; Mayeuf-Louchart A, 2018, SKELET MUSCLE, V8, DOI 10.1186/s13395-018-0171-0; McGreevy JW, 2015, DIS MODEL MECH, V8, P195, DOI 10.1242/dmm.018424; Miller MS, 2015, AM J PHYSIOL-CELL PH, V308, pC473, DOI 10.1152/ajpcell.00158.2014; Pette D, 2000, MICROSC RES TECHNIQ, V50, P500, DOI 10.1002/1097-0029(20000915)50:6<500::AID-JEMT7>3.0.CO;2-7; Pette D, 2002, CAN J APPL PHYSIOL, V27, P423, DOI 10.1139/h02-023; Pette D, 1997, Int Rev Cytol, V170, P143, DOI 10.1016/S0074-7696(08)61622-8; Reyes-Fernandez PC, 2019, SKELET MUSCLE, V9, DOI 10.1186/s13395-019-0200-7; Rueden CT, 2017, BMC BIOINFORMATICS, V18, DOI 10.1186/s12859-017-1934-z; Schiaffino S, 2011, PHYSIOL REV, V91, P1447, DOI 10.1152/physrev.00031.2010; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Sirinukunwattana K, 2016, IEEE T MED IMAGING, V35, P1196, DOI 10.1109/TMI.2016.2525803; Smith LR, 2014, SKELET MUSCLE, V4, DOI 10.1186/2044-5040-4-21; Song YF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0116455; Talbot J, 2016, WIRES DEV BIOL, V5, P518, DOI 10.1002/wdev.230; van Ginneken B, 2017, RADIOL PHYS TECHNOL, V10, P23, DOI 10.1007/s12194-017-0394-5; Wen Y, 2018, J APPL PHYSIOL, V124, P40, DOI 10.1152/japplphysiol.00762.2017; Wilson JM, 2012, J STRENGTH COND RES, V26, P1724, DOI 10.1519/JSC.0b013e318234eb6f	40	17	17	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2020	15	3							e0229041	10.1371/journal.pone.0229041	http://dx.doi.org/10.1371/journal.pone.0229041			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	KV5IE	32130242	gold, Green Published, Green Submitted			2022-12-26	WOS:000520515600001
J	Muiru, AN; Charlebois, ED; Balzer, LB; Kwarisiima, D; Elly, A; Black, D; Okiror, S; Kabami, J; Atukunda, M; Snyman, K; Petersen, M; Kamya, M; Havlir, D; Estrella, MM; Hsu, CY				Muiru, Anthony N.; Charlebois, Edwin D.; Balzer, Laura B.; Kwarisiima, Dalsone; Elly, Assurah; Black, Doug; Okiror, Samuel; Kabami, Jane; Atukunda, Mucunguzi; Snyman, Katherine; Petersen, Maya; Kamya, Moses; Havlir, Diane; Estrella, Michelle M.; Hsu, Chi-yuan			The epidemiology of chronic kidney disease (CKD) in rural East Africa: A population-based study	PLOS ONE			English	Article							STAGE RENAL-DISEASE; SUB-SAHARAN-AFRICA; GLOMERULAR-FILTRATION-RATE; SICKLE-CELL TRAIT; DIPSTICK PROTEINURIA; RISK; ASSOCIATION; ALBUMINURIA; HEALTH; INTERVENTION	Background Chronic kidney disease (CKD) may be common among individuals living in sub-Saharan Africa due to the confluence of CKD risk factors and genetic predisposition. Methods We ascertained the prevalence of CKD and its risk factors among a sample of 3,686 participants of a population-based HIV trial in rural Uganda and Kenya. Prevalent CKD was defined as a serum creatinine-based estimated glomerular filtration rate < 60 mL/min/1.73m(2) or proteinuria (urine dipstick >= 1+). We used inverse-weighting to estimate the population prevalence of CKD, and multivariable log-link Poisson models to assess the associations of potential risk factors with CKD. Results The estimated CKD prevalence was 6.8% (95% CI 5.7-8.1%) overall and varied by region, being 12.5% (10.1-15.4%) in eastern Uganda, 3.9% (2.2-6.8%) in southwestern Uganda and 3.7% (2.7-5.1%) in western Kenya. Risk factors associated with greater CKD prevalence included age.60 years (adjusted prevalence ratio [aPR] 3.5 [95% CI 1.9-6.5] compared with age 18-29 years), HIV infection (aPR 1.6 [1.1-2.2]), and residence in eastern Uganda (aPR 3.9 [2.6-5.9]). However, two-thirds of individuals with CKD did not have HIV, diabetes, or hypertension as risk factors. Furthermore, we noted many individuals who did not have proteinuria had dipstick positive leukocyturia or hematuria. Conclusion The prevalence of CKD is appreciable in rural East Africa and there are considerable regional differences. Conventional risk factors appear to only explain a minority of cases, and leukocyturia and hematuria were common, highlighting the need for further research into understanding the nature of CKD in sub-Saharan Africa.	[Muiru, Anthony N.; Charlebois, Edwin D.; Black, Doug; Snyman, Katherine; Havlir, Diane; Estrella, Michelle M.; Hsu, Chi-yuan] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Muiru, Anthony N.; Estrella, Michelle M.] San Francisco VA Med Ctr, Kidney Hlth Res Collaborat, San Francisco, CA 94121 USA; [Balzer, Laura B.] Univ Massachusetts, Amherst, MA 01003 USA; [Kwarisiima, Dalsone; Okiror, Samuel; Kabami, Jane; Atukunda, Mucunguzi] Infect Dis Res Collaborat, Kampala, Uganda; [Elly, Assurah] Kenya Govt Med Res Ctr, Nairobi, Kenya; [Petersen, Maya] Univ Calif Berkeley, Sch Publ Hlth, Berkeley, CA 94720 USA; [Kamya, Moses] Makerere Univ, Kampala, Uganda	University of California System; University of California San Francisco; US Department of Veterans Affairs; Veterans Health Administration (VHA); San Francisco VA Medical Center; University of Massachusetts System; University of Massachusetts Amherst; Kenya Medical Research Institute; University of California System; University of California Berkeley; Makerere University	Muiru, AN (corresponding author), Univ Calif San Francisco, San Francisco, CA 94143 USA.; Muiru, AN (corresponding author), San Francisco VA Med Ctr, Kidney Hlth Res Collaborat, San Francisco, CA 94121 USA.	anthony.muiru@ucsf.edu			NIH [U01AI099959, K24 DK92291]; President's Emergency Plan for AIDS Relief; Bill & Melinda Gates Foundation; Gilead Sciences; University of California, San Francisco [NIH T32DK007219-41S1, R01DK114014-01A1S1]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); President's Emergency Plan for AIDS Relief(United States Agency for International Development (USAID)United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR); Gilead Sciences(Gilead Sciences); University of California, San Francisco(University of California System)	This work was supported by NIH U01AI099959 and in part by the President's Emergency Plan for AIDS Relief, the Bill & Melinda Gates Foundation, and Gilead Sciences. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health, the President's Emergency Plan for AIDS Relief, the Bill & Melinda Gates Foundation, or Gilead. CYH was also supported by NIH K24 DK92291. ANM was supported by University of California, San Francisco, Dean's Diversity award, NIH T32DK007219-41S1 and R01DK114014-01A1S1 diversity supplements. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anand S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072860; Arnlov J, 2005, CIRCULATION, V112, P969, DOI 10.1161/CIRCULATIONAHA.105.538132; Arogundade FA, 2008, AM J KIDNEY DIS, V51, P515, DOI 10.1053/j.ajkd.2007.12.006; Arogundade FA, 2016, CLIN NEPHROL, V86, pS53, DOI 10.5414/CNP86S120; Atun R, 2017, LANCET DIABETES ENDO, V5, P622, DOI 10.1016/S2213-8587(17)30181-X; Balen J, 2010, EMERG THEMES EPIDEMI, V7, DOI 10.1186/1742-7622-7-7; Barros Aluisio J D, 2003, BMC Med Res Methodol, V3, P21, DOI 10.1186/1471-2288-3-21; Bukabau JB, 2019, KIDNEY INT, V95, P1181, DOI 10.1016/j.kint.2018.11.045; Clark WF, 2011, J AM SOC NEPHROL, V22, P1729, DOI 10.1681/ASN.2010111217; Eastwood JB, 2010, NEPHROL DIAL TRANSPL, V25, P2178, DOI 10.1093/ndt/gfp765; Eckardt KU, 2012, KIDNEY INT SUPPL, V2, P7, DOI 10.1038/kisup.2012.8; Fischer RSB, 2018, KIDNEY INT, V93, P681, DOI 10.1016/j.kint.2017.09.012; Genovese G, 2010, SCIENCE, V329, P841, DOI 10.1126/science.1193032; Havlir DV, 2019, NEW ENGL J MED, V381, P219, DOI 10.1056/NEJMoa1809866; Hernan MA, 2006, J EPIDEMIOL COMMUN H, V60, P578, DOI 10.1136/jech.2004.029496; Hillege HL, 2002, CIRCULATION, V106, P1777, DOI 10.1161/01.CIR.0000031732.78052.81; HORVITZ DG, 1952, J AM STAT ASSOC, V47, P663, DOI 10.2307/2280784; Hsu CY, 2009, ARCH INTERN MED, V169, P342, DOI 10.1001/archinternmed.2008.605; Hsu CY, 2003, J AM SOC NEPHROL, V14, P2902, DOI 10.1097/01.ASN.0000091586.46532.B4; Ishani A, 2006, J AM SOC NEPHROL, V17, P1444, DOI 10.1681/ASN.2005091012; Jha V, 2010, NEPHROLOGY, V15, P10, DOI 10.1111/j.1440-1797.2010.01305.x; Johnson RJ, 2019, NEW ENGL J MED, V380, P1843, DOI 10.1056/NEJMra1813869; Kalyesubula R, 2017, BMC NEPHROL, V18, DOI 10.1186/s12882-017-0521-x; Kalyesubula R, 2014, JAIDS-J ACQ IMM DEF, V67, pS68, DOI 10.1097/QAI.0000000000000259; Kasembeli AN, 2015, J AM SOC NEPHROL, V26, P2882, DOI 10.1681/ASN.2014050469; Kasembeli Alex N, 2015, World J Nephrol, V4, P295, DOI 10.5527/wjn.v4.i2.295; Kaze FF, 2015, BMC NEPHROL, V16, DOI 10.1186/s12882-015-0111-8; Kaze FF, 2015, BMC NEPHROL, V16, DOI 10.1186/s12882-015-0102-9; Kwarisiima D, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156309; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Limou S, 2014, ADV CHRONIC KIDNEY D, V21, P426, DOI 10.1053/j.ackd.2014.06.005; Liyanage T, 2015, LANCET, V385, P1975, DOI 10.1016/S0140-6736(14)61601-9; Lunyera J, 2017, KIDNEY INT, V92, P548, DOI 10.1016/j.kint.2017.04.043; Luyckx VA, 2002, AM J KIDNEY DIS, V39, DOI 10.1053/ajkd.2002.31424; Luyckx VA, 2008, NAT CLIN PRACT NEPHR, V4, P664, DOI 10.1038/ncpneph0970; Matsushita K, 2010, LANCET, V375, P2073, DOI 10.1016/S0140-6736(10)60674-5; Mills KT, 2016, CIRCULATION, V134, P441, DOI 10.1161/CIRCULATIONAHA.115.018912; Mushi L, 2015, BMC HEALTH SERV RES, V15, DOI 10.1186/s12913-015-1166-8; Naicker S, 2003, KIDNEY INT, V63, P119, DOI 10.1046/j.1523-1755.63.s83.25.x; Naik RP, 2017, J AM SOC NEPHROL, V28, P2180, DOI 10.1681/ASN.2016101086; Naik RP, 2014, JAMA-J AM MED ASSOC, V312, P2115, DOI 10.1001/jama.2014.15063; Oluyombo R, 2013, West Afr J Med, V32, P85; Picozzi K, 2005, BMJ-BRIT MED J, V331, P1238, DOI 10.1136/bmj.331.7527.1238; SANDLER DP, 1991, ANN INTERN MED, V115, P165, DOI 10.7326/0003-4819-115-3-165; Saran R, 2019, AM J KIDNEY DIS, V73, pSVII; Seck Sidy Mohamed, 2014, Nephrourol Mon, V6, pe19085, DOI 10.5812/numonthly.19085; Stanifer JW, 2015, BMC NEPHROL, V16, DOI 10.1186/s12882-015-0161-y; Stanifer JW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124506; Stanifer JW, 2014, LANCET GLOB HEALTH, V2, pE174, DOI 10.1016/S2214-109X(14)70002-6; Sumaili EK, 2009, NEPHROL DIAL TRANSPL, V24, P117, DOI 10.1093/ndt/gfn469; Thirumurthy H, 2016, AIDS CARE, V28, P90, DOI 10.1080/09540121.2016.1178959; Tishkoff SA, 2009, SCIENCE, V324, P1035, DOI 10.1126/science.1172257; Tsai TL, 2017, KIDNEY INT, V92, P710, DOI 10.1016/j.kint.2017.03.013; Turin TC, 2013, J AM SOC NEPHROL, V24, P1661, DOI 10.1681/ASN.2012111118; United Nations, WORLD URB PROSP 2018; Vos T, 2016, LANCET, V388, P1545, DOI [10.1016/S0140-6736(16)31012-1, 10.1016/S0140-6736(16)31678-6]; Wijkstrom J, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0193056; Wijkstrom J, 2017, AM J KIDNEY DIS, V69, P626, DOI 10.1053/j.ajkd.2016.10.036; Wolf G, 2002, AM J KIDNEY DIS, V39, P1, DOI 10.1053/ajkd.2002.29865; Wyatt CM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069601	60	12	12	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2020	15	3							e0229649	10.1371/journal.pone.0229649	http://dx.doi.org/10.1371/journal.pone.0229649			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8QU	32130245	Green Published, gold			2022-12-26	WOS:000535264000038
J	Ellis, CR; Racz, R; Kruhlak, NL; Kim, MT; Zakharov, AV; Southall, N; Hawkins, EG; Burkhart, K; Strauss, DG; Stavitskaya, L				Ellis, Christopher R.; Racz, Rebecca; Kruhlak, Naomi L.; Kim, Marlene T.; Zakharov, Alexey V.; Southall, Noel; Hawkins, Edward G.; Burkhart, Keith; Strauss, David G.; Stavitskaya, Lidiya			Evaluating kratom alkaloids using PHASE	PLOS ONE			English	Article							MITRAGYNA-SPECIOSA; RECEPTOR; PHARMACOLOGY; ABUSE	Kratom is a botanical substance that is marketed and promoted in the US for pharmaceutical opioid indications despite having no US Food and Drug Administration approved uses. Kratom contains over forty alkaloids including two partial agonists at the mu opioid receptor, mitragynine and 7-hydroxymitragynine, that have been subjected to the FDA's scientific and medical evaluation. However, pharmacological and toxicological data for the remaining alkaloids are limited. Therefore, we applied the Public Health Assessment via Structural Evaluation (PHASE) protocol to generate in silico binding profiles for 25 kratom alkaloids to facilitate the risk evaluation of kratom. PHASE demonstrates that kratom alkaloids share structural features with controlled opioids, indicates that several alkaloids bind to the opioid, adrenergic, and serotonin receptors, and suggests that mitragynine and 7-hydroxymitragynine are the strongest binders at the mu opioid receptor. Subsequently, the in silico binding profiles of a subset of the alkaloids were experimentally verified at the opioid, adrenergic, and serotonin receptors using radioligand binding assays. The verified binding profiles demonstrate the ability of PHASE to identify potential safety signals and provide a tool for prioritizing experimental evaluation of high-risk compounds.	[Ellis, Christopher R.; Racz, Rebecca; Kruhlak, Naomi L.; Kim, Marlene T.; Burkhart, Keith; Strauss, David G.; Stavitskaya, Lidiya] US FDA, Div Appl Regulatory Sci, Off Clin Pharmacol, Off Translat Sci,Ctr Drug Evaluat & Res, Silver Spring, MD 20993 USA; [Zakharov, Alexey V.; Southall, Noel] NIH, Natl Ctr Adv Translat Sci, Rockville, MD USA; [Hawkins, Edward G.] US FDA, Ctr Drug Evaluat & Res, Silver Spring, MD USA	US Food & Drug Administration (FDA); National Institutes of Health (NIH) - USA; NIH National Center for Advancing Translational Sciences (NCATS); US Food & Drug Administration (FDA)	Stavitskaya, L (corresponding author), US FDA, Div Appl Regulatory Sci, Off Clin Pharmacol, Off Translat Sci,Ctr Drug Evaluat & Res, Silver Spring, MD 20993 USA.	Lidiya.Stavitskaya@fda.hhs.gov	Strauss, David G/A-9211-2012; Southall, Noel/H-8991-2012	Southall, Noel/0000-0003-4500-880X; Stavitskaya, Lidiya/0000-0002-6307-2314; Racz, Rebecca/0000-0002-5487-5692	FDA's Safety Research Interest Group; National Institute of Mental Health's Psychoactive Drug Screening Program [HHSN-271-2018-00023-C]; Intramural Research Program, National Center for Advancing Translational Sciences, National Institutes of Health [1ZIATR000058-03]	FDA's Safety Research Interest Group; National Institute of Mental Health's Psychoactive Drug Screening Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Intramural Research Program, National Center for Advancing Translational Sciences, National Institutes of Health	This project was supported by FDA's Safety Research Interest Group and appointment to the Research Participation Programs at the Oak Ridge Institute for Science and Education through an interagency agreement between the Department of Energy and FDA. Binding affinity determinations at the opioid, adrenergic, and serotonin receptors was generously provided by the National Institute of Mental Health's Psychoactive Drug Screening Program, Contract #HHSN-271-2018-00023-C (NIMH PDSP). The NIMH PDSP is Directed by Bryan L. Roth MD, PhD at the University of North Carolina at Chapel Hill and Project Officer Jamie Driscoll at NIMH, Bethesda MD, USA. NCATS work was supported by A.V.Z. and N.S. discloses that this project was funded in part with Intramural Research Program, National Center for Advancing Translational Sciences, National Institutes of Health (1ZIATR000058-03).	Adkins JE, 2011, CURR TOP MED CHEM, V11, P1165; Anwar M, 2016, MMWR-MORBID MORTAL W, V65, P748, DOI 10.15585/mmwr.mm6529a4; Avery BA, 2019, PLANTA MED, V85, P340, DOI 10.1055/a-0770-3683; Besnard J, 2012, NATURE, V492, P215, DOI 10.1038/nature11691; Boyer EW, 2008, ADDICTION, V103, P1048, DOI 10.1111/j.1360-0443.2008.02209.x; Carhart-Harris RL, 2017, J PSYCHOPHARMACOL, V31, P1091, DOI 10.1177/0269881117725915; Case D. A., 2016, AMBER 2016; Cinosi E, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/968786; Clayton CC, 2014, J BIOL CHEM, V289, P33663, DOI 10.1074/jbc.M114.605378; Corbeil CR, 2012, J COMPUT AID MOL DES, V26, P775, DOI 10.1007/s10822-012-9570-1; Ellis CR, 2019, CLIN PHARMACOL THER, V106, P116, DOI 10.1002/cpt.1418; Ellis CR, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0197734; Garcia-Serna R, 2015, CHEM RES TOXICOL, V28, P1875, DOI 10.1021/acs.chemrestox.5b00260; GERBER PR, 1995, J COMPUT AID MOL DES, V9, P251, DOI 10.1007/BF00124456; Grundmann O, 2017, DRUG ALCOHOL DEPEN, V176, P63, DOI 10.1016/j.drugalcdep.2017.03.007; Hassan Z, 2013, NEUROSCI BIOBEHAV R, V37, P138, DOI 10.1016/j.neubiorev.2012.11.012; Hemby SE, 2019, ADDICT BIOL, V24, P874, DOI 10.1111/adb.12639; Huang WJ, 2015, NATURE, V524, P315, DOI 10.1038/nature14886; Jakalian A, 2002, J COMPUT CHEM, V23, P1623, DOI 10.1002/jcc.10128; Kamble SH, 2019, XENOBIOTICA, V49, P1279, DOI 10.1080/00498254.2018.1552819; Keiser MJ, 2007, NAT BIOTECHNOL, V25, P197, DOI 10.1038/nbt1284; Keiser MJ, 2009, NATURE, V462, P175, DOI 10.1038/nature08506; Khan ZP, 1999, ANAESTHESIA, V54, P146, DOI 10.1046/j.1365-2044.1999.00659.x; Kim S, 2016, NUCLEIC ACIDS RES, V44, pD1202, DOI 10.1093/nar/gkv951; Kruegel AC, 2018, NEUROPHARMACOLOGY, V134, P108, DOI 10.1016/j.neuropharm.2017.08.026; Kruegel AC, 2016, J AM CHEM SOC, V138, P6754, DOI 10.1021/jacs.6b00360; Leon F, 2009, NAT PROD COMMUN, V4, P907; Lydecker AG, 2016, J MED TOXICOL, V12, P341, DOI 10.1007/s13181-016-0588-y; Manglik A, 2012, NATURE, V485, P321, DOI 10.1038/nature10954; Matsumoto K, 2004, LIFE SCI, V74, P2143, DOI 10.1016/j.lfs.2003.09.054; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Panczyk K, 2015, CURR PHARM DESIGN, V21, P1723, DOI 10.2174/1381612821666141121114917; Pantsar T, 2018, MOLECULES, V23, DOI 10.3390/molecules23081899; Pfleger KDG, 2006, NAT PROTOC, V1, P337, DOI 10.1038/nprot.2006.52; Prozialeck WC, 2012, J AM OSTEOPATH ASSOC, V112, P792; Roberts M. F., 1998, ALKALOIDS BIOCH ECOL; Roth B. L., 2018, NATL I MENTAL HLTH P; Singh D, 2014, DRUG ALCOHOL DEPEN, V139, P132, DOI 10.1016/j.drugalcdep.2014.03.017; SUWANLERT S, 1975, B NARCOTICS, V27, P21; Tay YL, 2016, TOXICOL APPL PHARM, V305, P22, DOI 10.1016/j.taap.2016.05.022; Varadi A, 2016, J MED CHEM, V59, P8381, DOI 10.1021/acs.jmedchem.6b00748; Vidal D, 2010, MOL INFORM, V29, P543, DOI 10.1002/minf.201000055; Willett P, 1998, J CHEM INF COMP SCI, V38, P983, DOI 10.1021/ci9800211; Williams C, 2006, MOL DIVERS, V10, P311, DOI 10.1007/s11030-006-9039-z; YEADON M, 1988, J PHARM PHARMACOL, V40, P736, DOI 10.1111/j.2042-7158.1988.tb07008.x; Yue K, 2018, PSYCHOPHARMACOLOGY, V235, P2823, DOI 10.1007/s00213-018-4974-9; Yusoff NHM, 2016, ADDICT BIOL, V21, P98, DOI 10.1111/adb.12185	47	23	23	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2020	15	3							e0229646	10.1371/journal.pone.0229646	http://dx.doi.org/10.1371/journal.pone.0229646			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8MS	32126112	Green Published, gold			2022-12-26	WOS:000535253100041
J	Hu, DP; Wang, C; O'Connor, AM				Hu, Dapeng; Wang, Chong; O'Connor, Annette M.			A method of back-calculating the log odds ratio and standard error of the log odds ratio from the reported group-level risk of disease	PLOS ONE			English	Article							EXPLANATION	In clinical trials and observational studies, the effect of an intervention or exposure can be reported as an absolute or relative comparative measure such as risk difference, odds ratio or risk ratio, or at the group level with the estimated risk of disease in each group. For meta-analysis of results with covariate adjustment, the log of the odds ratio (log odds ratio), with its standard error, is a commonly used measure of effect. However, extracting the adjusted log odds ratio from the reported estimates of disease risk in each group is not straightforward. Here, we propose a method to transform the adjusted probability of the event in each group to the log of the odds ratio and obtain the appropriate (approximate) standard error, which can then be used in a meta-analysis. We also use example data to compare our method with two other methods and show that our method is superior in calculating the standard error of the log odds ratio.	[Hu, Dapeng; Wang, Chong] Iowa State Univ, Dept Stat, Ames, IA 50011 USA; [Wang, Chong; O'Connor, Annette M.] Iowa State Univ, Dept Vet Diagnost & Prod Anim Med, Ames, IA 50011 USA	Iowa State University; Iowa State University	Wang, C (corresponding author), Iowa State Univ, Dept Stat, Ames, IA 50011 USA.; Wang, C (corresponding author), Iowa State Univ, Dept Vet Diagnost & Prod Anim Med, Ames, IA 50011 USA.	chwang@iastate.edu	Wang, Chong/AAI-3796-2020; O'Connor, Annette/GRX-1453-2022; O'Connor, A/AFK-8069-2022; O'Connor, A/E-5591-2010	Wang, Chong/0000-0003-4489-4344; O'Connor, Annette/0000-0003-0604-7822; O'Connor, A/0000-0003-0604-7822; O'Connor, A/0000-0003-0604-7822; Hu, Dapeng/0000-0002-7307-1454				BARNDORFFNIELSEN O, 1979, J ROY STAT SOC B MET, V41, P279; Borenstein M, 2009, INTRO META ANAL; DANIELS HE, 1954, ANN MATH STAT, V25, P631, DOI 10.1214/aoms/1177728652; Hedges LV, 2014, STAT METHODS METAANA; Knudson C., 2018, INTRO MODEL FITTING; Macdonald Geraldine, 2012, Cochrane Database Syst Rev, pCD001930, DOI 10.1002/14651858.CD001930.pub3; O'Connor AM, 2016, ZOONOSES PUBLIC HLTH, V63, P662, DOI 10.1111/zph.12315; OCONNOR AM, 2010, PREV VET MED, V93, P11, DOI DOI 10.1111/j.1939-1676.2009.0441.x; Sargeant JM, 2016, PREV VET MED, V134, P188, DOI 10.1016/j.prevetmed.2016.09.005; Sargeant JM, 2010, ZOONOSES PUBLIC HLTH, V57, P105, DOI 10.1111/j.1863-2378.2009.01312.x; Schabenberger O., 2005, SUGI, P196; Schunicht OC, 2002, CAN VET J, V43, P355; White BJ, 2015, J ANIM SCI, V93, P4115, DOI 10.2527/jas.2015-9079; WOLFINGER R, 1993, J STAT COMPUT SIM, V48, P233, DOI 10.1080/00949659308811554	14	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2020	15	3							e0222690	10.1371/journal.pone.0222690	http://dx.doi.org/10.1371/journal.pone.0222690			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8MS	32126072	Green Published, gold, Green Submitted			2022-12-26	WOS:000535253100004
J	Miskiewicz, J; Trela, Z; Burdach, Z; Karcz, W; Balinska-Miskiewicz, W				Miskiewicz, Janusz; Trela, Zenon; Burdach, Zbigniew; Karcz, Waldemar; Balinska-Miskiewicz, Wanda			Long range correlations of the ion current in SV channels. Met(3)PbCl influence study	PLOS ONE			English	Article							FLUCTUATION ANALYSIS; TIME-SERIES; PATCH-CLAMP; LEAD; TRANSPORT; MEMBRANE; TOXICITY; GASOLINE; REMOVAL	The long-range correlations within the current signal time series of the Beta vulgaris vacuolar membrane under the influence of organolead compound (Met(3)PbCl) are investigated. The current time series is transformed into a dwell time series. Then the rescaled range and detrended fluctuations analyses are used. It is shown that the presence of Met(3)PbCl in the solution decreases the mean value of the Hurst exponent and therefore influences the long-range correlations in ionic channel current. This observation is statistically significant. An ion channel model is built and the experimental results reconstructed and analysed.	[Miskiewicz, Janusz] Univ Wroclaw, Inst Theoret Phys, Wroclaw, Poland; [Miskiewicz, Janusz; Trela, Zenon] Wroclaw Univ Environm & Life Sci, Dept Phys & Biophys, Wroclaw, Poland; [Burdach, Zbigniew; Karcz, Waldemar] Univ Silesia, Fac Biol & Environm Protect, Dept Plant Physiol, Katowice, Poland; [Balinska-Miskiewicz, Wanda] Wroclaw Med Univ, Dept & Clin Paediat Allergol & Cardiol 1, Wroclaw, Poland	University of Wroclaw; Wroclaw University of Environmental & Life Sciences; University of Silesia in Katowice; Wroclaw Medical University	Miskiewicz, J (corresponding author), Univ Wroclaw, Inst Theoret Phys, Wroclaw, Poland.; Miskiewicz, J (corresponding author), Wroclaw Univ Environm & Life Sci, Dept Phys & Biophys, Wroclaw, Poland.	janusz.miskiewicz@upwr.edu.pl	Miskiewicz, Janusz/ABB-7691-2021	Miskiewicz, Janusz/0000-0002-3505-7838; Balinska-Miskiewicz, Wanda/0000-0003-3252-2164; Karcz, Waldemar/0000-0001-7630-1553				Allen GJ, 1997, ADV BOT RES, V25, P217, DOI 10.1016/S0065-2296(08)60154-8; ALLEN GJ, 1995, PLANT CELL, V7, P1473; Andreottola G, 2008, J HAZARD MATER, V156, P488, DOI 10.1016/j.jhazmat.2007.12.044; BASSINGTHWAIGHTE JB, 1994, ANN BIOMED ENG, V22, P432, DOI 10.1007/BF02368250; Berg, 2018, RANDOM WALKS BIOL; BERTL A, 1992, SCIENCE, V258, P873, DOI 10.1126/science.1439795; Bragadin M, 2007, J INORG BIOCHEM, V101, P876, DOI 10.1016/j.jinorgbio.2007.01.016; Caccia DC, 1997, PHYSICA A, V246, P609, DOI 10.1016/S0378-4371(97)00363-4; Cairney S, 2002, NEUROSCI BIOBEHAV R, V26, P81, DOI 10.1016/S0149-7634(01)00040-9; Carpaneto A, 1999, FEBS LETT, V442, P129, DOI 10.1016/S0014-5793(98)01642-1; Carruyo I, 2008, BIOL TRACE ELEM RES, V125, P276, DOI 10.1007/s12011-008-8175-y; COYAUD L, 1987, BIOCHIM BIOPHYS ACTA, V902, P263, DOI 10.1016/0005-2736(87)90304-X; Craig PJ, 2003, ORGANOMETALLIC COUMP; Davison AC, 1997, BOOTSTRAP METHODS TH; Day M, 1996, J ANAL APPL PYROL, V37, P49, DOI 10.1016/0165-2370(96)00938-2; Fatmi Z, 2017, INT J ENV RES PUB HE, V14, DOI 10.3390/ijerph14040413; GELLI A, 1993, PLANT PHYSIOL, V102, P1139, DOI 10.1104/pp.102.4.1139; HEDRICH R, 1986, FEBS LETT, V204, P228, DOI 10.1016/0014-5793(86)80817-1; HEDRICH R, 1987, NATURE, V329, P833, DOI 10.1038/329833a0; HURST HE, 1951, T AM SOC CIV ENG, V116, P770; Kepplinger KJF, 2000, J PHYSIOL-LONDON, V529, P119, DOI 10.1111/j.1469-7793.2000.00119.x; Kupper H., 2017, METAL IONS LIFE SCI, V17, P491, DOI DOI 10.1515/9783110434330-015; Lan TH, 2008, CELL BIOL INT, V32, P247, DOI 10.1016/j.cellbi.2007.09.001; Lead I Group ZS, 2019, LEAD ZINC STAT; Lespes G, 2009, J ENVIRON MANAGE, V90, pS60, DOI 10.1016/j.jenvman.2008.07.019; Lippiat Jonathan D., 2008, V491, P141, DOI 10.1007/978-1-59745-526-8_11; Mercik S, 1999, PHYS REV E, V60, P7343, DOI 10.1103/PhysRevE.60.7343; Mercik S, 2001, PHYS REV E, V63, P1; Michalzik B, 2007, WASTE MANAGE, V27, P497, DOI 10.1016/j.wasman.2006.02.018; Miedema H, 2003, J MEMBRANE BIOL, V194, P11, DOI 10.1007/s00232-003-2022-z; Mielniczuk J, 2007, COMPUT STAT DATA AN, V51, P4510, DOI 10.1016/j.csda.2006.07.033; Miller FP, 2010, KERNEL DENSITY ESTIM; Miskiewicz J, 2010, EUR BIOPHYS J BIOPHY, V39, P1397, DOI 10.1007/s00249-010-0594-y; Mitra P, 2017, CRIT REV CL LAB SCI, V54, P506, DOI 10.1080/10408363.2017.1408562; NaitAli A, 2009, ADVANCED BIOSIGNAL PROCESSING, P1; Needleman HL, 2000, ENVIRON RES, V84, P20, DOI 10.1006/enrs.2000.4069; NEHER E, 1976, NATURE, V260, P799, DOI 10.1038/260799a0; Palma, 2006, LONG MEMORY TIME SER; PANTOJA O, 1992, SCIENCE, V255, P1567, DOI 10.1126/science.255.5051.1567; PENG CK, 1994, PHYS REV E, V49, P1685, DOI 10.1103/PhysRevE.49.1685; Peters E.E., 1994, FRACTAL MARKET ANAL; Pottosin II, 2007, J EXP BOT, V58, P1559, DOI 10.1093/jxb/erm035; Ramanan SV, 2005, J MEMBRANE BIOL, V205, P81, DOI 10.1007/s00232-005-0765-4; Schofield K, 2017, INT J ENV RES PUB HE, V14, DOI 10.3390/ijerph14121511; Silbergeld EK, 2003, MUTAT RES-FUND MOL M, V533, P121, DOI 10.1016/j.mrfmmm.2003.07.010; Silverman BW., 1986, DENSITY ESTIMATION S, V26, DOI 10.1201/9781315140919; Siwy Z, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.031907; Siwy Z, 2001, PHYSICA A, V297, P79, DOI 10.1016/S0378-4371(01)00194-7; Sottocornola B, 2006, J BIOL CHEM, V281, P35735, DOI 10.1074/jbc.M603361200; Thomas SV, 2011, J BIOL CHEM, V286, P32074, DOI 10.1074/jbc.M111.278283; Tikhonova LI, 1997, PLANT J, V11, P1059, DOI 10.1046/j.1365-313X.1997.11051059.x; Trela Z, 2012, CR BIOL, V335, P722, DOI 10.1016/j.crvi.2012.11.004; Tylkowski B, 2017, METAL IONS LIFE SCI, V17, P61, DOI 10.1515/9783110434330-004; Vandewalle N., 1997, EC WORKSH BUD HUNG; Wawrzkiewicz A, 2012, EUR BIOPHYS J BIOPHY, V41, P505, DOI 10.1007/s00249-012-0806-8; Weron R, 2002, PHYSICA A, V312, P285, DOI 10.1016/S0378-4371(02)00961-5; White LD, 2007, TOXICOL APPL PHARM, V225, P1, DOI 10.1016/j.taap.2007.08.001	57	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2020	15	3							e0229433	10.1371/journal.pone.0229433	http://dx.doi.org/10.1371/journal.pone.0229433			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8MS	32126096	Green Published, gold			2022-12-26	WOS:000535253100023
J	Tucci, P; Portela, M; Chetto, CR; Gonzalez-Sapienza, G; Marin, M				Tucci, Paula; Portela, Madelon; Rivas Chetto, Carlos; Gonzalez-Sapienza, Gualberto; Marin, Monica			Integrative proteomic and glycoproteomic profiling of Mycobacterium tuberculosis culture filtrate	PLOS ONE			English	Article							VII SECRETION SYSTEM; 45-KILODALTON GLYCOPROTEIN; GLYCOSYLATION SITES; PROTEINS; EXPRESSION; ANTIGEN; IDENTIFICATION; MECHANISMS; VIRULENCE; MANNOSE	Despite being the subject of intensive research, tuberculosis, caused by Mycobacterium tuberculosis, remains at present the leading cause of death from an infectious agent. Secreted and cell wall proteins interact with the host and play important roles in pathogenicity. These proteins are explored as candidate diagnostic markers, potential drug targets or vaccine antigens, and more recently special attention is being given to the role of their post-translational modifications. With the purpose of contributing to the proteomic and glycoproteomic characterization of this important pathogen, we performed a shotgun analysis of culture filtrate proteins of M. tuberculosis based on a liquid nano-HPLC tandem mass spectrometry and a label-free spectral counting normalization approach for protein quantification. We identified 1314 M. tuberculosis proteins in culture filtrate and found that the most abundant proteins belong to the extracellular region or cell wall compartment, and that the functional categories with higher protein abundance factor were virulence, detoxification and adaptation, and cell wall and cell processes. We could identify a group of proteins consistently detected in previous studies, most of which were highly abundant proteins. In culture filtrate, 140 proteins were predicted to contain one of the three types of bacterial N-terminal signal peptides. Besides, various proteins belonging to the ESX secretion systems, and to the PE and PPE families, secreted by the type VII secretion system using nonclassical secretion signals, were also identified. O-glycosylation was identified in 46 proteins, many of them lipoproteins and cell wall associated proteins. Finally, we provide proteomic evidence for 33 novel O-glycosylated proteins, aiding to the glycoproteomic characterization of relevant antigenic membrane and exported proteins. These findings are expected to collaborate with the research on pathogen derived biomarkers, virulence factors and vaccine candidates, and to provide clues to the understanding of the pathogenesis and survival strategies adopted by M. tuberculosis.	[Tucci, Paula; Marin, Monica] Univ Republica, Fac Ciencias, Secc Bioquim, Montevideo, Uruguay; [Portela, Madelon] Inst Pasteur Montevideo, Unidad Bioquim & Proteom Analit, Montevideo, Uruguay; [Portela, Madelon] Univ Repub, Fac Ciencias, Montevideo, Uruguay; [Rivas Chetto, Carlos] Minist Salud Publ, Dept Lab, Comis Honoraria Lucha Antituberculosa & Enfermeda, Ctr Referencia Nacl Micobacterias, Montevideo, Uruguay; [Gonzalez-Sapienza, Gualberto] Univ Republ Uruguay, Fac Quim, DEPBIO, Catedra Inmunol, Montevideo, Uruguay	Universidad de la Republica, Uruguay; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur de Montevideo; Universidad de la Republica, Uruguay; Universidad de la Republica, Uruguay	Tucci, P (corresponding author), Univ Republica, Fac Ciencias, Secc Bioquim, Montevideo, Uruguay.	ptucci@fcien.edu.uy		Gonzalez-Sapienza, Gualberto/0000-0003-1824-0611	Agencia Nacional de Investigacion e Innovacion (ANII) [FMV_3_2013_1_100859]	Agencia Nacional de Investigacion e Innovacion (ANII)	PT was a recipient of a Doctoral Fellowship (Comision Academica de Posgrado https://www.posgrados.udelar.edu.uy/portada. php). PT was supported by Agencia Nacional de Investigacion e Innovacion (ANII https://www.anii.org.uy/apoyos/investigacion/) grant FMV_3_2013_1_100859. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdallah AM, 2007, NAT REV MICROBIOL, V5, P883, DOI 10.1038/nrmicro1773; Albrethsen J, 2013, MOL CELL PROTEOMICS, V12, P1180, DOI 10.1074/mcp.M112.018846; Almagro Armenteros JJ, 2019, NAT BIOTECHNOL; Alonso H, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08489-7; ANDERSEN P, 1991, INFECT IMMUN, V59, P1905, DOI 10.1128/IAI.59.6.1905-1910.1991; Ausubel BR, 1999, CURRENT PROTOCOLS MO; Bando-Campos G, 2019, MICROB CELL FACT, V18, DOI 10.1186/s12934-019-1059-3; Bell C, 2012, J PROTEOME RES, V11, P119, DOI 10.1021/pr2007939; Birhanu AG, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-39654-9; Borud B, 2018, J BACTERIOL, V200, DOI 10.1128/JB.00794-17; Carvalho PC, 2016, NAT PROTOC, V11, P102, DOI 10.1038/nprot.2015.133; Carvalho PC, 2012, PROTEOMICS, V12, P944, DOI 10.1002/pmic.201100529; Chegou NN, 2011, EXPERT REV ANTI-INFE, V9, P457, DOI [10.1586/eri.11.23, 10.1586/ERI.11.23]; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Daffe M., 1999, Tubercle and Lung Disease, V79, P153, DOI 10.1054/tuld.1998.0200; de Fischer JSdG, 2014, J PROTEOMICS, V129, P42; de Souza GA, 2011, J PROTEOMICS, V75, P502, DOI 10.1016/j.jprot.2011.08.016; Dheda K, 2016, LANCET, V387, P1211, DOI 10.1016/S0140-6736(15)00151-8; Diaz-Silvestre H, 2005, MICROB PATHOGENESIS, V39, P97, DOI 10.1016/j.micpath.2005.06.002; DOBOS KM, 1995, INFECT IMMUN, V63, P2846, DOI 10.1128/IAI.63.8.2846-2853.1995; Dobos KM, 1996, J BACTERIOL, V178, P2498, DOI 10.1128/jb.178.9.2498-2506.1996; Eng JK, 2015, J AM SOC MASS SPECTR, V26, P1865, DOI 10.1007/s13361-015-1179-x; Ernst JD, 2018, CELL HOST MICROBE, V24, P34, DOI 10.1016/j.chom.2018.06.004; Forrellad MA, 2013, VIRULENCE, V4, P3, DOI 10.4161/viru.22329; GARBE T, 1993, INFECT IMMUN, V61, P260, DOI 10.1128/IAI.61.1.260-267.1993; Gonzalez-Zamnorano M, 2009, J PROTEOME RES, V8, P721, DOI 10.1021/pr800756a; Hatherill M, 2016, TUBERCULOSIS TUBERCL, P193; Herrmann JL, 2000, FEBS LETT, V473, P358, DOI 10.1016/S0014-5793(00)01553-2; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Huang YS, 2006, BIOCHEM BIOPH RES CO, V342, P618, DOI 10.1016/j.bbrc.2006.01.178; Hulsen T, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-488; Kapopoulou A, 2011, TUBERCULOSIS, V91, P8, DOI 10.1016/j.tube.2010.09.006; Keenan T, 2019, CHARACTERIZATION STR; Khoshnood S, 2018, INT J BIOL MACROMOL, V120, P180, DOI 10.1016/j.ijbiomac.2018.08.037; Korotkova N, 2014, MOL MICROBIOL, V94, P367, DOI 10.1111/mmi.12770; Kovacs-Simon A, 2011, INFECT IMMUN, V79, P548, DOI 10.1128/IAI.00682-10; Kumar A, 2007, P NATL ACAD SCI USA, V104, P11568, DOI 10.1073/pnas.0705054104; Leistikow RL, 2010, J BACTERIOL, V192, P1662, DOI 10.1128/JB.00926-09; Lima A, 2011, J PROTEOMICS, V74, P1720, DOI 10.1016/j.jprot.2011.03.005; Liu CF, 2013, P NATL ACAD SCI USA, V110, P6560, DOI 10.1073/pnas.1219704110; Malen H, 2007, PROTEOMICS, V7, P1702, DOI 10.1002/pmic.200600853; Mattow J, 2003, ELECTROPHORESIS, V24, P3405, DOI 10.1002/elps.200305601; McIlwain S, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-308; Meena LS, 2010, FEBS J, V277, P2416, DOI 10.1111/j.1742-4658.2010.07666.x; Mehaffy C, 2019, TUBERCULOSIS, V115, P1, DOI 10.1016/j.tube.2019.01.001; Michell SL, 2003, J BIOL CHEM, V278, P16423, DOI 10.1074/jbc.M207959200; Nambi S, 2015, CELL HOST MICROBE, V17, P829, DOI 10.1016/j.chom.2015.05.008; Niederweis M, 2010, TRENDS MICROBIOL, V18, P109, DOI 10.1016/j.tim.2009.12.005; Nielsen H, 2017, METHODS MOL BIOL, V1611, P59, DOI 10.1007/978-1-4939-7015-5_6; Oliveros J.C., VENNY INTERACTIVE TO; Parra J, 2017, SCI REP, V7; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Ragas A, 2007, J BIOL CHEM, V282, P5133, DOI 10.1074/jbc.M610183200; Renaux A, 2018, NUCLEIC ACIDS RES, V46, P2699, DOI 10.1093/nar/gky092; Schubert OT, 2015, CELL HOST MICROBE, V18, P96, DOI 10.1016/j.chom.2015.06.001; Shah S, 2016, FRONT CELL INFECT MI, V6, DOI 10.3389/fcimb.2016.00049; Sivaramakrishnan S, 2013, BIOSENSORS-BASEL, V3, P259, DOI 10.3390/bios3030259; Smith GT, 2014, J PROTEOMICS, V97, P296, DOI 10.1016/j.jprot.2013.05.011; Solomonson M, 2015, STRUCTURE, V23, P571, DOI 10.1016/j.str.2015.01.002; Stanley SA, 2003, P NATL ACAD SCI USA, V100, P13001, DOI 10.1073/pnas.2235593100; Steinberg TH, 2009, PROTEIN GEL STAINING, P541; Steingart KR, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001062; Sudha D, 2017, CLIN PROTEOM, V14, DOI 10.1186/s12014-017-9148-y; Tiwari P, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7059; Tucci P, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00549; Tullius MV, 2001, INFECT IMMUN, V69, P6348, DOI 10.1128/IAI.69.10.6348-6363.2001; van Els CACM, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00361; Van Winden VJC, 2019, MICROBIOL SPECTR, V7, DOI 10.1128/microbiolspec.GPP3-0043-2018; VanderVen BC, 2005, SCIENCE, V309, P941, DOI 10.1126/science.1114347; Wang Mu, 2008, Briefings in Functional Genomics & Proteomics, V7, P329, DOI 10.1093/bfgp/eln031; WHO, 2019, GLOB TUB REP; York IA, 2019, BIOSCIENCE REP, V39, DOI 10.1042/BSR20171505; Zhang B, 2007, J PROTEOME RES, V6, P3549, DOI 10.1021/pr070230d; Zybailov B, 2006, J PROTEOME RES, V5, P2339, DOI 10.1021/pr060161n	75	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2020	15	3							e0221837	10.1371/journal.pone.0221837	http://dx.doi.org/10.1371/journal.pone.0221837			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8MS	32126063	Green Published, gold, Green Submitted			2022-12-26	WOS:000535253100003
J	de Souza, BL; Ribeiro-Oliveira, JP; Bravo, JP; Dias, GF; da Silva, EAA				de Souza, Bruna Luiza; Ribeiro-Oliveira, Joao Paulo; Bravo, Juliana Pereira; Dias, Gabriela Fernanda; Amaral da Silva, Edvaldo Aparecido			What happens when the rain is back? A hypothetical model on how germination and post-germination occur in a species from transient seed banks	PLOS ONE			English	Article							ENDO-BETA-MANNANASE; A. ST-HIL.; TOMATO; ENDOSPERM; EXPRESSION; POLYSACCHARIDES; HYDRATION; CLONING; TRAITS; EMBRYO	We hypothesize that by simulating the natural priming in seeds of a species that forms transient seed banks it is possible to clarify molecular aspects of germination that lead to the recruitment of seedlings when the next rainy season begins. We used seeds of Solanum lycocarpum as a biological model. Our findings support the idea that the increment of seed germination kinetics when the rainy season returns is mainly based on the metabolism and embryonic growth, and that the hydropriming, at the end of seed dispersion, increases the germination window time of these seeds by mainly increasing the degradation of galactomannan of the cell wall. This can improve the energy supply (based on carbon metabolism) for seedling growth in post-germination, which improves the seedling's survival chances. From these findings, we promote a hypothetical model about how the priming at the end of the rainy season acts on mRNA synthesis in the germination of seeds from transient banks and the consequence of this priming at the beginning of the following rainy season. This model predicts that besides the Gibberellin and Abscisic Acid balance (content and sensitivity), Auxin would be a key component for the seed-seedling transition in Neotropical areas.	[de Souza, Bruna Luiza; Bravo, Juliana Pereira; Dias, Gabriela Fernanda; Amaral da Silva, Edvaldo Aparecido] Univ Estadual Paulista, Fac Ciencias Agron, Dept Prod & Melhoramento Vegetal, Botucatu, SP, Brazil; [Ribeiro-Oliveira, Joao Paulo] Univ Fed Uberlandia, Inst Ciencias Agr, Uberlandia, MG, Brazil	Universidade Estadual Paulista; Universidade Federal de Uberlandia	da Silva, EAA (corresponding author), Univ Estadual Paulista, Fac Ciencias Agron, Dept Prod & Melhoramento Vegetal, Botucatu, SP, Brazil.; Ribeiro-Oliveira, JP (corresponding author), Univ Fed Uberlandia, Inst Ciencias Agr, Uberlandia, MG, Brazil.	ribeirooliveirajp@gmail.com; amaral.silva@unesp.br	Amaral da Silva, Edvaldo/AAY-4481-2021	Amaral da Silva, Edvaldo/0000-0001-6454-1488	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) [001]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico [309718/2018-0]	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This study was supported by: Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) (Finance code 001) to J.P. Ribeiro-Oliveira and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico 309718/2018-0 to E. A. Amaral da Silva.	Al-Namazi AA, 2017, ECOL EVOL, V7, P2747, DOI 10.1002/ece3.2690; Almeida S.M., 1998, PLANALTINA EMBRAPA C, P464; Anese S, 2011, SEED SCI TECHNOL, V39, P125, DOI 10.15258/sst.2011.39.1.11; Baker HG., 1989, ECOLOGY SOIL SEED BA, P9; Bewley JD, 1997, TRENDS PLANT SCI, V2, P464, DOI 10.1016/S1360-1385(97)01147-3; Bewley JD, 2013, SEEDS PHYSL DEV GERM; BRASIL. Secretaria de Defesa Agropecuaria, 2009, REGR AN SEM; Buckeridge MS, 2010, PLANT PHYSIOL, V154, P1017, DOI 10.1104/pp.110.158642; Buckeridge MS, 2000, PLANT PHYSIOL BIOCH, V38, P141, DOI 10.1016/S0981-9428(00)00162-5; BUCKLAND ST, 1985, J R STAT SOC C-APPL, V34, P296; Chen F, 2001, PLANT PHYSIOL, V127, P928, DOI 10.1104/pp.010259; Chen K, 2013, ENVIRON EXP BOT, V94, P33, DOI 10.1016/j.envexpbot.2012.03.005; Csontos P, 2003, SEED SCI RES, V13, P101, DOI 10.1079/SSR2003129; Damasco G, 2018, FRONT YOUNG MINDS, V6; De Lorenzo G, 2019, PLANT J, V97, P134, DOI 10.1111/tpj.14196; Douh C, 2018, FOREST ECOL MANAG, V409, P766, DOI 10.1016/j.foreco.2017.12.012; EFRON B, 1979, ANN STAT, V7, P1, DOI 10.1214/aos/1176344552; Feurtado JA, 2001, J EXP BOT, V52, P1239, DOI 10.1093/jexbot/52.359.1239; Francoso RD, 2015, NAT CONSERVACAO, V13, P35, DOI 10.1016/j.ncon.2015.04.001; GROOT SPC, 1987, PLANTA, V171, P525, DOI 10.1007/BF00392302; IBM, 2015, SPSS BOOTSTR; Jimenez-Alfaro B, 2016, J VEG SCI, V27, P637, DOI 10.1111/jvs.12375; LABOURIALG, 1970, AN ACAD BRAS CIENC, V42, P235; Labouriau L.G., 1983, GERMINACAO SEMENTES; Lima AT, 2018, S AFR J BOT, V116, P164, DOI 10.1016/j.sajb.2018.03.017; Lima AT, 2017, SEED SCI RES, V27, P292, DOI 10.1017/S0960258517000241; Lutts S., 2016, NEW CHALLENGES SEED, P1, DOI [DOI 10.5772/64420, 10.5772/64420]; MAGUIRE JAMES D., 1962, CROP SCI, V2, P176, DOI 10.2135/cropsci1962.0011183X000200020033x; Minic Z, 2008, PLANTA, V227, P723, DOI 10.1007/s00425-007-0668-y; Miransari M, 2014, ENVIRON EXP BOT, V99, P110, DOI 10.1016/j.envexpbot.2013.11.005; Mo BX, 2002, PLANTA, V215, P141, DOI 10.1007/s00425-001-0725-x; Nonogaki H, 2000, PLANT PHYSIOL, V123, P1235, DOI 10.1104/pp.123.4.1235; Nonogaki H., 2007, Seed development, dormancy and germination, P264, DOI 10.1002/9780470988848.ch11; Ooi MKJ, 2012, SEED SCI RES, V22, pS53, DOI 10.1017/S0960258511000407; Ordonez-Salanueva CA, 2017, PLANT BIOLOGY, V19, P973, DOI 10.1111/plb.12611; Padilla FM, 2006, FRONT ECOL ENVIRON, V4, P196, DOI 10.1890/1540-9295(2006)004[0196:TRONPI]2.0.CO;2; Palubicki W, 2019, J EXP BOT, V70, P3601, DOI 10.1093/jxb/erz210; Paparella S, 2015, PLANT CELL REP, V34, P1281, DOI 10.1007/s00299-015-1784-y; Passos FB, 2014, BRAZ J BOT, V37, P251, DOI 10.1007/s40415-014-0079-9; Penfield S, 2017, J EXP BOT, V68, P819, DOI 10.1093/jxb/erw436; Pereira-Diniz SG, 2006, PLANT ECOL, V183, P337, DOI 10.1007/s11258-005-9044-9; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Pinto LVA, 2007, ANN BOT-LONDON, V100, P1175, DOI 10.1093/aob/mcm211; Quesada CA, 2008, TREE PHYSIOL, V28, P405, DOI 10.1093/treephys/28.3.405; Ranal Marli A., 2006, Braz. J. Bot., V29, P1, DOI 10.1590/S0100-84042006000100002; Ribeiro-Oliveira JP, 2018, ACTA SCI-AGRON, V40, DOI 10.4025/actasciagron.v40i1.35300; Silveira LED, 2019, ANN APPL BIOL, V175, P136, DOI 10.1111/aab.12523; Sitrit Y, 1999, PLANT PHYSIOL, V121, P419, DOI 10.1104/pp.121.2.419; Springthorpe V, 2015, ELIFE, V4, DOI 10.7554/eLife.05557; Steinbrecher T, 2017, J EXP BOT, V68, P765, DOI 10.1093/jxb/erw428; Toorop PE, 1996, PLANTA, V200, P153, DOI 10.1007/BF00208303; Vander Wall SB, 2012, BOT REV, V78, P10, DOI 10.1007/s12229-011-9093-9; Venable D.L., 1989, ECOLOGY SOIL SEED BA, P67; Wolf S, 2009, MOL PLANT, V2, P851, DOI 10.1093/mp/ssp066; Yadav RK, 2018, IJCS, V6, P1588	55	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2020	15	2							e0229215	10.1371/journal.pone.0229215	http://dx.doi.org/10.1371/journal.pone.0229215			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8FM	32101558	Green Published, gold			2022-12-26	WOS:000535233700020
J	Ayyathan, DM; Koganti, P; Marcu-Malina, V; Litmanovitch, T; Trakhtenbrot, L; Emanuelli, A; Apel-Sarid, L; Blank, M				Manikoth Ayyathan, Dhanoop; Koganti, Praveen; Marcu-Malina, Victoria; Litmanovitch, Talia; Trakhtenbrot, Luba; Emanuelli, Andrea; Apel-Sarid, Liat; Blank, Michael			SMURF2 prevents detrimental changes to chromatin, protecting human dermal fibroblasts from chromosomal instability and tumorigenesis	ONCOGENE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; E3 UBIQUITIN LIGASE; PROTEIN STABILITY; DEPENDENT DEGRADATION; SENESCENCE; EXPRESSION; COMPLEX; SMAD7; CELLS; ASSAY	E3 ubiquitin ligases (E3s) play essential roles in the maintenance of tissue homeostasis under normal and stress conditions, as well as in disease states, particularly in cancer. However, the role of E3s in the initiation of human tumors is poorly understood. Previously, we reported that genetic ablation of the HECT-type E3 ubiquitin ligase Smurf2 induces carcinogenesis in mice; but whether and how these findings are pertinent to the inception of human cancer remain unknown. Here we show that SMURF2 is essential to protect human dermal fibroblasts (HDFs) from malignant transformation, and its depletion converts HDFs into tumorigenic entity. This phenomenon was associated with the radical changes in chromatin structural and epigenetic landscape, dysregulated gene expression and cell-cycle control, mesenchymal-to-epithelial transition and impaired DNA damage response. Furthermore, we show that SMURF2-mediated tumor suppression is interlinked with SMURF2's ability to regulate the expression of two central chromatin modifiers-an E3 ubiquitin ligase RNF20 and histone methyltransferase EZH2. Silencing these factors significantly reduced the growth and transformation capabilities of SMURF2-depleted cells. Finally, we demonstrate that SMURF2-compromised HDFs are highly tumorigenic in nude mice. These findings suggest the critical role that SMURF2 plays in preventing malignant alterations, chromosomal instability and cancer.	[Manikoth Ayyathan, Dhanoop; Koganti, Praveen; Emanuelli, Andrea; Blank, Michael] Bar Ilan Univ, Azrieli Fac Med, Lab Mol & Cellular Canc Biol, IL-1311502 Safed, Israel; [Marcu-Malina, Victoria; Litmanovitch, Talia; Trakhtenbrot, Luba] Sheba Med Ctr, Canc Res Ctr, Hematol Lab, Ramat Gan, Israel; [Apel-Sarid, Liat] Galilee Med Ctr, Dept Pathol, IL-22100 Nahariyya, Israel	Bar Ilan University; Chaim Sheba Medical Center; Western Galilee Hospital	Blank, M (corresponding author), Bar Ilan Univ, Azrieli Fac Med, Lab Mol & Cellular Canc Biol, IL-1311502 Safed, Israel.	michael.blank@biu.ac.il	Emanuelli, Andrea/AAJ-8175-2020	Koganti, Praveen/0000-0002-9708-0996; Manikoth Ayyathan, Dhanoop/0000-0001-8214-1381	ICRF [00636]; Marie-Curie FP-7 CIG [612816]; Israel Cancer Association [20160073, 20171153, 20200007]; Dayan Family Foundation	ICRF; Marie-Curie FP-7 CIG; Israel Cancer Association; Dayan Family Foundation	We thank Sandy Boutros Suleiman for helping with some data acquisition/analysis, Gal Levy-Cohen for important administrative support, and Meir Shamay for the helpful discussions during the manuscript preparation. This work was supported by the following grants: ICRF (#00636), Marie-Curie FP-7 CIG (#612816), and Israel Cancer Association (#20160073, #20171153, and #20200007) grants awarded to MB. We are very grateful to Dayan Family Foundation for their continued support of our research.	Abdollahi E, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19082399; Ayyathan DM, 2017, ANAL BIOCHEM, V531, P56, DOI 10.1016/j.ab.2017.05.024; Blank M, 2001, ONCOL RES, V12, P409; Blank M, 2006, J CELL BIOL, V174, P195, DOI 10.1083/jcb.200604022; Blank M, 2012, NAT MED, V18, P227, DOI 10.1038/nm.2596; Bodnar AG, 1998, SCIENCE, V279, P349, DOI 10.1126/science.279.5349.349; Borroni AP, 2018, AGING CELL, V17, DOI 10.1111/acel.12732; Chandhoke AS, 2016, CELL DEATH DIFFER, V23, P876, DOI 10.1038/cdd.2015.152; de Magalhaes JP, 2002, FEBS LETT, V523, P157, DOI 10.1016/S0014-5793(02)02973-3; Du JX, 2011, J BIOL CHEM, V286, P40354, DOI 10.1074/jbc.M111.258707; Emanuelli A, 2019, CANCERS, V11, DOI 10.3390/cancers11040556; Emanuelli A, 2017, CANCER RES, V77, P4217, DOI 10.1158/0008-5472.CAN-16-2828; Franken NAP, 2006, NAT PROTOC, V1, P2315, DOI 10.1038/nprot.2006.339; Fukuchi M, 2001, MOL BIOL CELL, V12, P1431, DOI 10.1091/mbc.12.5.1431; Genna A, 2018, J CELL BIOL, V217, P375, DOI 10.1083/jcb.201702184; Grade Marian, 2015, Recent Results Cancer Res, V200, P115, DOI 10.1007/978-3-319-20291-4_6; Howe B, 2014, JOVE-J VIS EXP, DOI 10.3791/50203; Huang PS, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19051463; Jeong HM, 2014, BBA-MOL CELL RES, V1843, P2005, DOI 10.1016/j.bbamcr.2014.04.023; Johnston ST, 2015, BMC SYST BIOL, V9, DOI 10.1186/s12918-015-0182-y; Jolly MK, 2019, PHARMACOL THERAPEUT, V194, P161, DOI 10.1016/j.pharmthera.2018.09.007; Kavsak P, 2000, MOL CELL, V6, P1365, DOI 10.1016/S1097-2765(00)00134-9; Kim S, 2010, J BIOL CHEM, V285, P36420, DOI 10.1074/jbc.M110.137471; Koganti P, 2018, FRONT ONCOL, V8, DOI 10.3389/fonc.2018.00295; Kong YH, 2011, AGING CELL, V10, P1038, DOI 10.1111/j.1474-9726.2011.00746.x; Kumaravel TS, 2009, CELL BIOL TOXICOL, V25, P53, DOI 10.1007/s10565-007-9043-9; Li Y, 2014, CANCER RES, V74, P6107, DOI 10.1158/0008-5472.CAN-14-0389; Lin X, 2000, J BIOL CHEM, V275, P36818, DOI 10.1074/jbc.C000580200; Liu XP, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-57; McGowan-Jordan J, 2016, INT STANDING COMMITT; Nakao A, 1997, NATURE, V389, P631, DOI 10.1038/39369; Nie J, 2010, J BIOL CHEM, V285, P22816, DOI 10.1074/jbc.M110.126920; Osmundson EC, 2008, J CELL BIOL, V183, P267, DOI 10.1083/jcb.200801049; Padilla-Nash HM, 2006, NAT PROTOC, V1, P3129, DOI 10.1038/nprot.2006.358; Popovic D, 2014, NAT MED, V20, P1242, DOI 10.1038/nm.3739; Ramkumar C, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3598; Ramkumar C, 2012, CANCER RES, V72, P2714, DOI 10.1158/0008-5472.CAN-11-3773; Ray D, 2011, NEOPLASIA, V13, P570, DOI 10.1593/neo.11632; Schaeffer D, 2014, MOL CELL BIOL, V34, P3486, DOI 10.1128/MCB.00694-14; Senft D, 2018, NAT REV CANCER, V18, P69, DOI 10.1038/nrc.2017.105; Shechter D, 2007, NAT PROTOC, V2, P1445, DOI 10.1038/nprot.2007.202; Shukla S, 2014, NEOPLASIA, V16, P115, DOI 10.1593/neo.14184; Spagnol ST, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146244; Williams ED, 2019, NAT REV CANCER, V19, P716, DOI 10.1038/s41568-019-0213-x; Wu QQ, 2009, EXP CELL RES, V315, P2386, DOI 10.1016/j.yexcr.2009.05.019; Yu L, 2019, CANCER LETT, V448, P40, DOI 10.1016/j.canlet.2019.01.039; Yu YL, 2013, EMBO MOL MED, V5, P531, DOI 10.1002/emmm.201201783; Yuan B, 2019, EMBO J, V38, DOI 10.15252/embj.201899945; Zhang H, 2004, GENE DEV, V18, P3028, DOI 10.1101/gad.1253004; Zhang WL, 2015, INT J ONCOL, V47, P1043, DOI 10.3892/ijo.2015.3076; Zou X, 2015, BBA-REV CANCER, V1856, P91, DOI 10.1016/j.bbcan.2015.06.005	51	12	12	1	6	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 16	2020	39	16					3396	3410		10.1038/s41388-020-1226-3	http://dx.doi.org/10.1038/s41388-020-1226-3		FEB 2020	15	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	QF9OJ	32103168				2022-12-26	WOS:000516683200001
J	Konert, T; Everitt, S; La Fontaine, MD; van de Kamer, JB; MacManus, MP; Vogel, WV; Callahan, J; Sonke, JJ				Konert, Tom; Everitt, Sarah; La Fontaine, Matthew D.; van de Kamer, Jeroen B.; MacManus, Michael P.; Vogel, Wouter V.; Callahan, Jason; Sonke, Jan-Jakob			Robust, independent and relevant prognostic F-18-fluorodeoxyglucose positron emission tomography radiomics features in non-small cell lung cancer: Are there any?	PLOS ONE			English	Article							F-18-FDG PET; TEXTURAL FEATURES; TUMOR HETEROGENEITY; 8TH EDITION; SURVIVAL; THERAPY; VOLUME; IMPACT; NSCLC; CHEMORADIOTHERAPY	In locally advanced lung cancer, established baseline clinical variables show limited prognostic accuracy and F-18-fluorodeoxyglucose positron emission tomography (FDG PET) radiomics features may increase accuracy for optimal treatment selection. Their robustness and added value relative to current clinical factors are unknown. Hence, we identify robust and independent PET radiomics features that may have complementary value in predicting survival endpoints. A 4D PET dataset (n = 70) was used for assessing the repeatability (Bland-Altman analysis) and independence of PET radiomics features (Spearman rank: vertical bar rho vertical bar<0.5). Two 3D PET datasets combined (n = 252) were used for training and validation of an elastic net regularized generalized logistic regression model (GLM) based on a selection of clinical and robust independent PET radiomics features (GLM(all)). The fitted model performance was externally validated (n = 40). The performance of GLM(all) (measured with area under the receiver operating characteristic curve, AUC) was highest in predicting 2-year overall survival (0.66 +/- 0.07). No significant improvement was observed for GLM(all) compared to a model containing only PET radiomics features or only clinical variables for any clinical endpoint. External validation of GLM(all) led to AUC values no higher than 0.55 for any clinical endpoint. In this study, robust independent FDG PET radiomics features did not have complementary value in predicting survival endpoints in lung cancer patients. Improving risk stratification and clinical decision making based on clinical variables and PET radiomics features has still been proven difficult in locally advanced lung cancer patients.	[Konert, Tom; Vogel, Wouter V.] Netherlands Canc Inst, Nucl Med Dept, Amsterdam, Netherlands; [Konert, Tom; La Fontaine, Matthew D.; van de Kamer, Jeroen B.; Vogel, Wouter V.; Sonke, Jan-Jakob] Netherlands Canc Inst, Dept Radiat Oncol, Amsterdam, Netherlands; [Everitt, Sarah; MacManus, Michael P.; Callahan, Jason] Peter MacCallum Canc Ctr, Div Radiat Oncol & Canc Imaging, Melbourne, Vic, Australia; [Everitt, Sarah; MacManus, Michael P.] Univ Melbourne, Sir Peter MacCallum Dept Oncol, Melbourne, Vic, Australia	Netherlands Cancer Institute; Netherlands Cancer Institute; Peter Maccallum Cancer Center; Peter Maccallum Cancer Center; University of Melbourne	Sonke, JJ (corresponding author), Netherlands Canc Inst, Dept Radiat Oncol, Amsterdam, Netherlands.	j.sonke@nki.nl	Sonke, Jan-Jakob/D-1575-2017	MacManus, Michael/0000-0002-0900-5815; Sonke, Jan-Jakob/0000-0001-5155-5274	Australian National Health and Medical Research Council [APP1003895]; Victorian Cancer Agency Grant	Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Victorian Cancer Agency Grant	One co-author, SE, received the Australian National Health and Medical Research Council (APP1003895) and Victorian Cancer Agency Grant. Sources: http://www.victoriancanceragency.org.au/https://www.nhmrc.gov.au/The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aerts HJWL, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5006; AMADASUN M, 1989, IEEE T SYST MAN CYB, V19, P1264, DOI 10.1109/21.44046; Antonia SJ, 2018, N ENGL J MED; Auperin A, 2010, J CLIN ONCOL, V28, P2181, DOI 10.1200/JCO.2009.26.2543; Berghmans Thierry, 2011, Ther Adv Med Oncol, V3, P127, DOI 10.1177/1758834011401951; Bertolaccini L, 2017, J THORAC DIS, V9, P924, DOI 10.21037/jtd.2017.03.157; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Brooks FJ, 2014, J NUCL MED, V55, P37, DOI 10.2967/jnumed.112.116715; Buccheri G, 2001, LUNG CANCER, V34, P433, DOI 10.1016/S0169-5002(01)00273-2; Chalkidou A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124165; Chan BA, 2015, TRANSL LUNG CANCER R, V4, P36, DOI 10.3978/j.issn.2218-6751.2014.05.01; Cook GJR, 2015, RADIOLOGY, V276, P883, DOI 10.1148/radiol.2015141309; Cook GJR, 2013, J NUCL MED, V54, P19, DOI 10.2967/jnumed.112.107375; Cremonesi M, 2017, EUR J NUCL MED MOL I, V44, P1915, DOI 10.1007/s00259-017-3762-9; de Jong EEC, 2017, ACTA ONCOL, V56, P1459, DOI 10.1080/0284186X.2017.1346824; Deist TM, 2018, MED PHYS, V45, P3449, DOI 10.1002/mp.12967; Del Gobbo A, 2016, HISTOPATHOLOGY, V68, P746, DOI 10.1111/his.12808; Desseroit MC, 2017, J NUCL MED, V58, P406, DOI 10.2967/jnumed.116.180919; Detterbeck FC, 2017, CHEST, V151, P193, DOI 10.1016/j.chest.2016.10.010; Dingemans AMC, 2011, ANN ONCOL, V22, P559, DOI 10.1093/annonc/mdq391; Everitt S, 2017, INT J RADIAT ONCOL, V99, P947, DOI 10.1016/j.ijrobp.2017.07.035; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Fried DV, 2014, INT J RADIAT ONCOL, V90, P834, DOI 10.1016/j.ijrobp.2014.07.020; Friedman J, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i01; Galloway M., 1975, COMPUTER GRAPHICS IM, V4, P172, DOI DOI 10.1016/S0146-664X(75)80008-6; Gillies RJ, 2016, RADIOLOGY, V278, P563, DOI 10.1148/radiol.2015151169; Grootjans W, 2016, J NUCL MED, V57, P1692, DOI 10.2967/jnumed.116.173112; HARALICK RM, 1973, IEEE T SYST MAN CYB, VSMC3, P610, DOI 10.1109/TSMC.1973.4309314; Hatt M, 2016, ARXIV161207003; Hatt M, 2015, J NUCL MED, V56, P38, DOI 10.2967/jnumed.114.144055; Hosny A, 2018, NAT REV CANCER, V18, P500, DOI 10.1038/s41568-018-0016-5; Hyun SH, 2014, EUR J NUCL MED MOL I, V41, P50, DOI 10.1007/s00259-013-2530-8; Jiang AG, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1403-x; KEYES JW, 1995, J NUCL MED, V36, P1836; Konert T, 2018, J THORAC DIS, V10, pS2508, DOI 10.21037/jtd.2018.07.101; Kruis MF, 2013, INT J RADIAT ONCOL, V87, P394, DOI 10.1016/j.ijrobp.2013.06.007; Lambin P, 2012, EUR J CANCER, V48, P441, DOI 10.1016/j.ejca.2011.11.036; Larue RTHM, 2017, RADIOTHER ONCOL, V125, P147, DOI 10.1016/j.radonc.2017.07.023; Leijenaar RTH, 2015, SCI REP-UK, V5, DOI 10.1038/srep11075; Lovinfosse P, 2016, EUR J NUCL MED MOL I, V43, P1453, DOI 10.1007/s00259-016-3314-8; Mahar AL, 2015, J THORAC ONCOL, V10, P1576, DOI 10.1097/JTO.0000000000000652; Martin B, 2004, BRIT J CANCER, V91, P2018, DOI 10.1038/sj.bjc.6602233; Mileshkin L, 2011, CLIN CANCER RES, V17, P3304, DOI 10.1158/1078-0432.CCR-10-2763; Moon SH, 2013, EUR J NUCL MED MOL I, V40, P1005, DOI 10.1007/s00259-013-2400-4; Murphy A, 2018, BRIT J RADIOL, V91, DOI 10.1259/bjr.20180028; Nakamura H, 2011, ANN THORAC CARDIOVAS, V17, P469, DOI 10.5761/atcs.oa.10.01637; Ohri N, 2016, J NUCL MED, V57, P842, DOI 10.2967/jnumed.115.166934; Orlhac F, 2018, J NUCL MED, V59, P1321, DOI 10.2967/jnumed.117.199935; Orlhac F, 2014, J NUCL MED, V55, P414, DOI 10.2967/jnumed.113.129858; Paesmans M, 2012, BREATHE, V9, P113, DOI 10.1183/20734735.006911; Paesmans M, 2010, J THORAC ONCOL, V5, P612, DOI 10.1097/JTO.0b013e3181d0a4f5; Pallis AG, 2010, CANCER TREAT REV, V36, P436, DOI 10.1016/j.ctrv.2009.12.013; Parmar C, 2015, SCI REP-UK, V5, DOI 10.1038/srep13087; Parmar C, 2015, SCI REP-UK, V5, DOI 10.1038/srep11044; Pavlou M, 2016, STAT MED, V35, P1159, DOI 10.1002/sim.6782; Pyka T, 2015, RADIAT ONCOL, V10, DOI 10.1186/s13014-015-0407-7; Rami-Porta R, 2014, J THORAC ONCOL, V9, P1618, DOI 10.1097/JTO.0000000000000334; Remon J, 2018, CANCER TREAT REV, V64, P21, DOI 10.1016/j.ctrv.2018.02.002; Salavati A, 2017, EUR J NUCL MED MOL I, V44, P1969, DOI 10.1007/s00259-017-3753-x; Shang JJ, 2016, EUR J NUCL MED MOL I, V43, P1945, DOI 10.1007/s00259-016-3420-7; Steels E, 2001, EUR RESPIR J, V18, P705, DOI 10.1183/09031936.01.00062201; Strom HH, 2014, J THORAC ONCOL, V9, P825, DOI 10.1097/JTO.0000000000000184; SUN CJ, 1983, COMPUT VISION GRAPH, V23, P341, DOI 10.1016/0734-189X(83)90032-4; Szyszko TA, 2016, LUNG CANCER, V94, P7, DOI 10.1016/j.lungcan.2016.01.010; Takeda K, 2017, J RADIAT RES, V58, P862, DOI 10.1093/jrr/rrx050; Thibault G, 2014, IEEE T BIO-MED ENG, V61, P630, DOI 10.1109/TBME.2013.2284600; Tong JL, 2011, LUNG CANCER, V74, P155, DOI 10.1016/j.lungcan.2011.04.019; Vaidya M, 2012, RADIOTHER ONCOL, V102, P239, DOI 10.1016/j.radonc.2011.10.014; Vallieres M, 2015, PHYS MED BIOL, V60, P5471, DOI 10.1088/0031-9155/60/14/5471; van Baardwijk A, 2008, RADIOTHER ONCOL, V87, P55, DOI 10.1016/j.radonc.2008.02.002; van Griethuysen JJM, 2017, CANCER RES, V77, pE104, DOI 10.1158/0008-5472.CAN-17-0339; van Velden FHP, 2016, MOL IMAGING BIOL, V18, P788, DOI 10.1007/s11307-016-0940-2; Walraven I, 2016, RADIOTHER ONCOL, V118, P442, DOI 10.1016/j.radonc.2016.02.011; Weiss GJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100244; Wu J, 2016, RADIOLOGY, V281, P270, DOI 10.1148/radiol.2016151829; Yan JH, 2015, J NUCL MED, V56, P1667, DOI 10.2967/jnumed.115.156927; Yip S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115510; Yip SSF, 2017, J NUCL MED, V58, P569, DOI 10.2967/jnumed.116.181826; Yu KH, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12474; Yu ZP, 2017, ONCOTARGET, V8, P4043, DOI 10.18632/oncotarget.14022; Zambelli AE, 2016, F1000RES; Zou H, 2005, J R STAT SOC B, V67, P301, DOI 10.1111/j.1467-9868.2005.00503.x	82	18	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2020	15	2							e0228793	10.1371/journal.pone.0228793	http://dx.doi.org/10.1371/journal.pone.0228793			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8EV	32097418	Green Published, gold			2022-12-26	WOS:000535232000012
J	Brewitz, L; Tumber, A; Schofield, CJ				Brewitz, Lennart; Tumber, Anthony; Schofield, Christopher J.			Kinetic parameters of human aspartate/asparagine??-hydroxylase suggest that it has a possible function in oxygen sensing	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						epigenetics; enzyme kinetics; hypoxia; mass spectrometry (MS); hypoxia-inducible factor (HIF); 2-oxoglutarate; alpha-ketoglutarate; 2OG-dependent dioxygenase; aspartate; asparagine?beta-hydroxylase; AspH; BAH; HAAH; enzyme assays; epidermal growth factor?like domain; epidermal growth factor?like protein 7; EGFL7	HYPOXIA-INDUCIBLE-FACTOR; FACTOR-LIKE DOMAIN; ASPARAGINYL BETA-HYDROXYLASE; HISTONE LYSINE DEMETHYLASES; SITE-DIRECTED MUTAGENESIS; FACTOR-INHIBITING-HIF; GROWTH-FACTOR-DOMAIN; AMINO-ACID-SEQUENCE; EGF-LIKE DOMAIN; HEPATOCELLULAR-CARCINOMA	Human aspartate/asparagine??-hydroxylase (AspH) is a 2-oxoglutarate (2OG)?dependent oxygenase that catalyzes the post-translational hydroxylation of Asp and Asn residues in epidermal growth factor?like domains (EGFDs). Despite its biomedical significance, studies on AspH have long been limited by a lack of assays for its isolated form. Recent structural work has revealed that AspH accepts substrates with a noncanonical EGFD disulfide connectivity (i.e. the Cys 1?2, 3?4, 5?6 disulfide pattern). We developed stable cyclic thioether analogues of the noncanonical EGFD AspH substrates to avoid disulfide shuffling. We monitored their hydroxylation by solid-phase extraction coupled to MS. The extent of recombinant AspH-catalyzed cyclic peptide hydroxylation appears to reflect levels of EGFD hydroxylation observed in vivo, which vary considerably. We applied the assay to determine the kinetic parameters of human AspH with respect to 2OG, Fe(II), l-ascorbic acid, and substrate and found that these parameters are in the typical ranges for 2OG oxygenases. Of note, a relatively high K-m for O-2 suggested that O-2 availability may regulate AspH activity in a biologically relevant manner. We anticipate that the assay will enable the development of selective small-molecule inhibitors for AspH and other human 2OG oxygenases.	[Brewitz, Lennart; Tumber, Anthony; Schofield, Christopher J.] Univ Oxford, Chem Res Lab, 12 Mansfield Rd, Oxford OX1 3TA, England	University of Oxford	Schofield, CJ (corresponding author), Univ Oxford, Chem Res Lab, 12 Mansfield Rd, Oxford OX1 3TA, England.	christopher.schofield@chem.ox.ac.uk		Tumber, Anthony/0000-0003-1958-8353	Wellcome Trust [106244/Z/14/Z]; Cancer Research UK [C8717/A18245]; Biotechnology and Biological Sciences Research Council [BB/J003018/1]; Deutsche Forschungsgemeinschaft [BR 5486/2-1]; BBSRC [BB/L009846/1, BB/J003018/1, BB/L000121/1] Funding Source: UKRI	Wellcome Trust(Wellcome TrustEuropean Commission); Cancer Research UK(Cancer Research UK); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by Wellcome Trust Grant 106244/Z/14/Z, Cancer Research UK Grant C8717/A18245, and Biotechnology and Biological Sciences Research Council Grant BB/J003018/1. This work was also supported by Deutsche Forschungsgemeinschaft Fellowship BR 5486/2-1 (to L. B.) The authors declare that they have no conflicts of interest with the contents of this article.	Barriga HHA, 2018, AM J MED GENET A, V176, P2494, DOI 10.1002/ajmg.a.40508; Aihara A, 2014, HEPATOLOGY, V60, P1302, DOI 10.1002/hep.27275; ARLAUD GJ, 1987, FEBS LETT, V222, P129, DOI 10.1016/0014-5793(87)80205-3; Benita Y, 2009, NUCLEIC ACIDS RES, V37, P4587, DOI 10.1093/nar/gkp425; CAMPBELL ID, 1993, CURR OPIN STRUC BIOL, V3, P385, DOI 10.1016/S0959-440X(05)80111-3; Cascella B, 2012, BIOCHEMISTRY-US, V51, P8699, DOI 10.1021/bi3012466; Chakraborty AA, 2019, SCIENCE, V363, P1217, DOI 10.1126/science.aaw1026; Chen Q, 2005, P NATL ACAD SCI USA, V102, P13604, DOI 10.1073/pnas.0506390102; Chevreux G, 2015, PROTEIN SCI, V24, P1640, DOI 10.1002/pro.2756; Chillakuri CR, 2012, SEMIN CELL DEV BIOL, V23, P421, DOI 10.1016/j.semcdb.2012.01.009; Chowdhury R, 2009, STRUCTURE, V17, P981, DOI 10.1016/j.str.2009.06.002; Cockman ME, 2006, P NATL ACAD SCI USA, V103, P14767, DOI 10.1073/pnas.0606877103; Coleman ML, 2007, J BIOL CHEM, V282, P24027, DOI 10.1074/jbc.M704102200; Copeland R. A., 2004, ENZYMES PRACTICAL IN; Dao JH, 2009, ANAL BIOCHEM, V384, P213, DOI 10.1016/j.ab.2008.09.052; de la Monte SM, 2006, J HEPATOL, V44, P971, DOI 10.1016/j.jhep.2006.01.038; DERIAN CK, 1989, J BIOL CHEM, V264, P6615; Dilley DR, 2013, AOB PLANTS, V5, DOI 10.1093/aobpla/plt031; Dinchuk JE, 2002, J BIOL CHEM, V277, P12970, DOI 10.1074/jbc.M110389200; DRAKENBERG T, 1983, P NATL ACAD SCI-BIOL, V80, P1802, DOI 10.1073/pnas.80.7.1802; Ehrismann D, 2007, BIOCHEM J, V401, P227, DOI 10.1042/BJ20061151; Elvidge GP, 2006, J BIOL CHEM, V281, P15215, DOI 10.1074/jbc.M511408200; Epstein ACR, 2001, CELL, V107, P43, DOI 10.1016/S0092-8674(01)00507-4; FERNLUND P, 1983, J BIOL CHEM, V258, P2509; Fitch MJ, 2004, DEV DYNAM, V230, P316, DOI 10.1002/dvdy.20063; Flashman E, 2010, FEBS J, V277, P4089, DOI 10.1111/j.1742-4658.2010.07804.x; Flashman E, 2010, BIOCHEM J, V427, P135, DOI 10.1042/BJ20091609; Gerken PA, 2017, ANGEW CHEM INT EDIT, V56, P15555, DOI 10.1002/anie.201706788; GLANVILLE RW, 1994, J BIOL CHEM, V269, P26630; GRADY JK, 1988, ANAL BIOCHEM, V173, P111, DOI 10.1016/0003-2697(88)90167-4; GRONKE RS, 1989, P NATL ACAD SCI USA, V86, P3609, DOI 10.1073/pnas.86.10.3609; GRONKE RS, 1990, J BIOL CHEM, V265, P8558; Hancock RL, 2017, ACS CHEM BIOL, V12, P1011, DOI 10.1021/acschembio.6b00958; HARRIS RJ, 1992, J BIOL CHEM, V267, P5102; Hirsila M, 2003, J BIOL CHEM, V278, P30772, DOI 10.1074/jbc.M304982200; Holt-Martyn JP, 2019, MEDCHEMCOMM, V10, P500, DOI 10.1039/c8md00548f; Horton JR, 2010, NAT STRUCT MOL BIOL, V17, P38, DOI 10.1038/nsmb.1753; Huang CK, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150336; Huergo LF, 2015, MICROBIOL MOL BIOL R, V79, P419, DOI 10.1128/MMBR.00038-15; Hutchinson SE, 2012, J BIOMOL SCREEN, V17, P39, DOI 10.1177/1087057111416660; Hynes RO, 2009, SCIENCE, V326, P1216, DOI 10.1126/science.1176009; Ince N, 2000, CANCER RES, V60, P1261; Kaelin WG, 2008, MOL CELL, V30, P393, DOI 10.1016/j.molcel.2008.04.009; KANZAKI T, 1990, CELL, V61, P1051, DOI 10.1016/0092-8674(90)90069-Q; Kawamura A, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14773; Koivunen P, 2004, J BIOL CHEM, V279, P9899, DOI 10.1074/jbc.M312254200; Koivunen P, 2007, J BIOL CHEM, V282, P4524, DOI 10.1074/jbc.M610415200; Koivunen P, 2006, J BIOL CHEM, V281, P28712, DOI 10.1074/jbc.M604628200; KORIOTH F, 1994, GENE, V150, P395, DOI 10.1016/0378-1119(94)90460-X; Koury MJ, 2015, NAT REV NEPHROL, V11, P394, DOI 10.1038/nrneph.2015.82; Lavaissiere L, 1996, J CLIN INVEST, V98, P1313, DOI 10.1172/JCI118918; Lawton M, 2010, OXID MED CELL LONGEV, V3, P347, DOI 10.4161/oxim.3.5.13296; Liu YS, 2015, POSTGRAD MED, V127, P144, DOI 10.1080/00325481.2015.996503; Luo BH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099922; Ma LB, 2017, INT J CLIN EXP PATHO, V10, P5359; McGinnis K, 1996, BIOCHEMISTRY-US, V35, P3957, DOI 10.1021/bi951520n; McKeown SR, 2014, BRIT J RADIOL, V87, DOI 10.1259/bjr.20130676; MCMULLEN BA, 1983, BIOCHEMISTRY-US, V22, P2875, DOI 10.1021/bi00281a016; McNeill LA, 2005, MOL BIOSYST, V1, P321, DOI 10.1039/b511249b; Metzen E, 2003, J CELL SCI, V116, P1319, DOI 10.1242/jcs.00318; Mulji A, 2012, J BIOMOL SCREEN, V17, P108, DOI 10.1177/1087057111418229; MYLLYLA R, 1984, J BIOL CHEM, V259, P5403; Nichol D, 2010, BLOOD, V116, P6133, DOI 10.1182/blood-2010-03-274860; Osipyants AI, 2018, BIOCHIMIE, V147, P46, DOI 10.1016/j.biochi.2017.12.011; Parker LH, 2004, NATURE, V428, P754, DOI 10.1038/nature02416; Patel N, 2014, AM J HUM GENET, V94, P755, DOI 10.1016/j.ajhg.2014.04.002; Pescador N, 2005, BIOCHEM J, V390, P189, DOI 10.1042/BJ20042121; Pfeffer I, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-12711-7; Pollard PJ, 2008, BIOCHEM J, V416, P387, DOI 10.1042/BJ20081238; PRZYSIECKI CT, 1987, P NATL ACAD SCI USA, V84, P7856, DOI 10.1073/pnas.84.22.7856; Rabinowitz MH, 2013, J MED CHEM, V56, P9369, DOI 10.1021/jm400386j; Rose NR, 2011, CHEM SOC REV, V40, P4364, DOI 10.1039/c0cs00203h; Rydzik AM, 2012, CHEMBIOCHEM, V13, P1559, DOI 10.1002/cbic.201200256; Schofield CJ, 2015, 2-OXOGLUTARATE-DEPENDENT OXYGENASES, pV; Schofield CJ, 2004, NAT REV MOL CELL BIO, V5, P343, DOI 10.1038/nrm1366; Seo YS, 2004, BIOCHEM J, V380, P339, DOI 10.1042/BJ20031762; Siggs OM, 2019, OPHTHALMIC GENET, V40, P12, DOI 10.1080/13816810.2018.1561904; Sjakste N, 2005, CNS DRUG REV, V11, P151; STENFLO J, 1991, BLOOD, V78, P1637; STENFLO J, 1989, P NATL ACAD SCI USA, V86, P444, DOI 10.1073/pnas.86.2.444; Sturla LM, 2016, HELIYON, V2, DOI 10.1016/j.heliyon.2016.e00203; Takeda K, 2006, MOL CELL BIOL, V26, P8336, DOI 10.1128/MCB.00425-06; Tarhonskaya H, 2015, J BIOL CHEM, V290, P19726, DOI 10.1074/jbc.M115.653014; THIELENS NM, 1990, BIOCHEMISTRY-US, V29, P3570, DOI 10.1021/bi00466a021; THIM L, 1988, BIOCHEMISTRY-US, V27, P7785, DOI 10.1021/bi00420a030; WANG QP, 1991, J BIOL CHEM, V266, P14004; Westaway SM, 2016, J MED CHEM, V59, P1357, DOI 10.1021/acs.jmedchem.5b01537; Wilkins SE, 2009, INT J BIOCHEM CELL B, V41, P1563, DOI 10.1016/j.biocel.2009.01.005; Wu F, 2009, HEPATOLOGY, V50, P1839, DOI 10.1002/hep.23197; Xue JH, 2019, NATURE, V569, P581, DOI 10.1038/s41586-019-1160-0; Yang H, 2010, ONCOL REP, V24, P1257, DOI 10.3892/or_00000980; Yang M, 2013, ANGEW CHEM INT EDIT, V52, P1700, DOI 10.1002/anie.201208046; Yang M, 2011, J BIOL CHEM, V286, P7648, DOI 10.1074/jbc.M110.193540; Zou QF, 2018, EBIOMEDICINE, V31, P287, DOI 10.1016/j.ebiom.2018.05.004	94	10	10	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 5	2020	295	23					7826	7838		10.1074/jbc.RA119.012202	http://dx.doi.org/10.1074/jbc.RA119.012202			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LZ0QD	32107312	hybrid, Green Published			2022-12-26	WOS:000540935400002
J	Li, WF; Aryal, M; Shu, ST; Smithgall, TE				Li Wing Fai; Aryal, Manish; Shu, Sherry T.; Smithgall, Thomas E.			HIV-1 Nef dimers short-circuit immune receptor signaling by activating Tec-family kinases at the host cell membrane	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						human immunodeficiency virus (HIV); protein kinase; dimerization; signal transduction; protein?protein interaction; T-cell receptor (TCR); infectious disease; bimolecular fluorescence complementation (BiFC); Bruton's tyrosine kinase (BTK); HIV-1 Nef; interleukin-2-inducible kinase (ITK); Tec-family kinase	CRYSTAL-STRUCTURE; SRC; PROTEIN; HCK; TRANSFORMATION; INFECTIVITY; ENDOCYTOSIS; RESISTANCE; SERINC5; COMPLEX	The HIV-1 virulence factor Nef promotes high-titer viral replication, immune escape, and pathogenicity. Nef interacts with interleukin-2?inducible T-cell kinase (Itk) and Bruton's tyrosine kinase (Btk), two Tec-family kinases expressed in HIV-1 target cells (CD4 T cells and macrophages, respectively). Using a cell-based bimolecular fluorescence complementation assay, here we demonstrate that Nef recruits both Itk and Btk to the cell membrane and induces constitutive kinase activation in transfected 293T cells. Nef homodimerization-defective mutants retained their interaction with both kinases but failed to induce activation, supporting a role for Nef homodimer formation in the activation mechanism. HIV-1 infection up-regulates endogenous Itk activity in SupT1 T cells and donor-derived peripheral blood mononuclear cells. However, HIV-1 strains expressing Nef variants with mutations in the dimerization interface replicated poorly and were significantly attenuated in Itk activation. We conclude that direct activation of Itk and Btk by Nef at the membrane in HIV-infected cells may override normal immune receptor control of Tec-family kinase activity to enhance the viral life cycle.	[Li Wing Fai; Aryal, Manish; Shu, Sherry T.; Smithgall, Thomas E.] Univ Pittsburgh, Sch Med, Dept Microbiol & Mol Genet, Bridgeside Point 2,Suite 523,450 Technol Dr, Pittsburgh, PA 15219 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Smithgall, TE (corresponding author), Univ Pittsburgh, Sch Med, Dept Microbiol & Mol Genet, Bridgeside Point 2,Suite 523,450 Technol Dr, Pittsburgh, PA 15219 USA.	tsmithga@pitt.edu			National Institutes of Health [AI057083, AI126617]; China Scholarship Council award through the Tsinghua University School of Medicine	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); China Scholarship Council award through the Tsinghua University School of Medicine	This work was supported by National Institutes of Health Grants AI057083 and AI126617 (to T. E. S.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. This article contains Figs. S1-S4.; Supported by a China Scholarship Council award through the Tsinghua University School of Medicine. Present address: Tsinghua University School of Medicine, Beijing 100084, China.	AIKEN C, 1994, CELL, V76, P853, DOI 10.1016/0092-8674(94)90360-3; Alvarado JJ, 2014, J BIOL CHEM, V289, P28539, DOI 10.1074/jbc.M114.600031; Andreotti AH, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a002287; Arold S, 1997, STRUCTURE, V5, P1361, DOI 10.1016/S0969-2126(97)00286-4; Basmaciogullari S, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00232; Briggs SD, 1997, J BIOL CHEM, V272, P17899, DOI 10.1074/jbc.272.29.17899; Chung JK, 2019, P NATL ACAD SCI USA, V116, P10798, DOI 10.1073/pnas.1819309116; Collette Y, 2000, J BIOL CHEM, V275, P4171, DOI 10.1074/jbc.275.6.4171; Collins KL, 1998, NATURE, V391, P397, DOI 10.1038/34929; Courtney AH, 2018, TRENDS BIOCHEM SCI, V43, P108, DOI 10.1016/j.tibs.2017.11.008; DEACON NJ, 1995, SCIENCE, V270, P988, DOI 10.1126/science.270.5238.988; Devkota S, 2017, BIOCHEMISTRY-US, V56, P2938, DOI 10.1021/acs.biochem.6b01182; Emert-Sedlak L, 2009, ACS CHEM BIOL, V4, P939, DOI 10.1021/cb900195c; Emert-Sedlak LA, 2016, BIOORG MED CHEM LETT, V26, P1480, DOI 10.1016/j.bmcl.2016.01.043; Emert-Sedlak LA, 2013, CHEM BIOL, V20, P82, DOI 10.1016/j.chembiol.2012.11.005; Foster JL, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-84; Gaud G, 2018, NAT REV IMMUNOL, V18, P485, DOI 10.1038/s41577-018-0020-8; Heusinger E, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00198; KESTLER HW, 1991, CELL, V65, P651, DOI 10.1016/0092-8674(91)90097-I; KIRCHHOFF F, 1995, NEW ENGL J MED, V332, P228, DOI 10.1056/NEJM199501263320405; Lee CH, 1996, CELL, V85, P931, DOI 10.1016/S0092-8674(00)81276-3; Lin TA, 2004, BIOCHEMISTRY-US, V43, P11056, DOI 10.1021/bi049428r; Linnemann T, 2002, VIROLOGY, V294, P246, DOI 10.1006/viro.2002.1365; Manninen A, 2000, J BIOL CHEM, V275, P16513, DOI 10.1074/jbc.M910032199; Moarefi I, 1997, NATURE, V385, P650, DOI 10.1038/385650a0; Mohamed AJ, 2009, IMMUNOL REV, V228, P58, DOI 10.1111/j.1600-065X.2008.00741.x; Moroco JA, 2018, J MOL BIOL, V430, P310, DOI 10.1016/j.jmb.2017.12.008; Mujib S, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.93684; Narute PS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032561; Pawlak EN, 2015, BBA-GEN SUBJECTS, V1850, P733, DOI 10.1016/j.bbagen.2015.01.003; Pizzato M, 2007, P NATL ACAD SCI USA, V104, P6812, DOI 10.1073/pnas.0607622104; Poe JA, 2009, J MOL BIOL, V394, P329, DOI 10.1016/j.jmb.2009.09.047; Readinger JA, 2008, P NATL ACAD SCI USA, V105, P6684, DOI 10.1073/pnas.0709659105; Rosa A, 2015, NATURE, V526, P212, DOI 10.1038/nature15399; Roskoski R, 2016, PHARMACOL RES, V113, P395, DOI 10.1016/j.phrs.2016.09.011; Schwartz O, 1996, NAT MED, V2, P338, DOI 10.1038/nm0396-338; Shi HB, 2020, ACS INFECT DIS, V6, P302, DOI 10.1021/acsinfecdis.9b00382; Sloan RD, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-44; Tarafdar S, 2014, J BIOL CHEM, V289, P15718, DOI 10.1074/jbc.M114.572099; Trible RP, 2006, J BIOL CHEM, V281, P27029, DOI 10.1074/jbc.M601128200; Usami Y, 2015, NATURE, V526, P218, DOI 10.1038/nature15400; Veillette M, 2014, J VIROL, V88, P2633, DOI 10.1128/JVI.03230-13; Venzke S, 2006, J VIROL, V80, P11141, DOI 10.1128/JVI.01556-06; Wang TJ, 2017, CLIN CANCER RES, V23, P2506, DOI 10.1158/1078-0432.CCR-16-1996; Wu MS, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0192512; Wu YF, 2019, MBIO, V10, DOI 10.1128/mBio.01071-19	46	8	8	2	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 10	2020	295	15					5163	5174		10.1074/jbc.RA120.012536	http://dx.doi.org/10.1074/jbc.RA120.012536			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LE7FC	32144207	Green Published, hybrid			2022-12-26	WOS:000526887000034
J	Velasquez, CD; Kim, C; Haldiman, T; Kim, C; Herbst, A; Aiken, J; Safar, JG; McKenzie, D				Velasquez, Camilo Duque; Kim, Chae; Haldiman, Tracy; Kim, Chiye; Herbst, Allen; Aiken, Judd; Safar, Jiri G.; McKenzie, Debbie			Chronic wasting disease (CWD) prion strains evolve via adaptive diversification of conformers in hosts expressing prion protein polymorphisms	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						prion; genetic polymorphism; conformational change; oligomer; prion disease; host?pathogen interaction; evolution; host range; strains	CREUTZFELDT-JAKOB-DISEASE; CONFORMATIONAL TRANSITIONS; PRP POLYMORPHISMS; SCRAPIE; DEER; TRANSMISSION; STABILITY; ENCEPHALOPATHY; SUSCEPTIBILITY; INFECTIVITY	Chronic wasting disease (CWD) is caused by an unknown spectrum of prions and has become enzootic in populations of cervid species that express cellular prion protein (PrP (c)) molecules varying in amino acid composition. These PrP (c) polymorphisms can affect prion transmission, disease progression, neuropathology, and emergence of new prion strains, but the mechanistic steps in prion evolution are not understood. Here, using conformation-dependent immunoassay, conformation stability assay, and protein-misfolding cyclic amplification, we monitored the conformational and phenotypic characteristics of CWD prions passaged through deer and transgenic mice expressing different cervid PrP (c) polymorphisms. We observed that transmission through hosts with distinct PrP (c) sequences diversifies the PrPCWD conformations and causes a shift toward oligomers with defined structural organization, replication rate, and host range. When passaged in host environments that restrict prion replication, distinct co-existing PrPCWD conformers underwent competitive selection, stabilizing a new prion strain. Nonadaptive conformers exhibited unstable replication and accumulated only to low levels. These results suggest a continuously evolving diversity of CWD conformers and imply a critical interplay between CWD prion plasticity and PrP (c) polymorphisms during prion strain evolution.	[Velasquez, Camilo Duque; Kim, Chiye; McKenzie, Debbie] Univ Alberta, Dept Biol Sci, Edmonton, AB T6G 2R3, Canada; [Kim, Chae; Haldiman, Tracy; Safar, Jiri G.] Case Western Reserve Univ, Dept Pathol, Cleveland, OH 44106 USA; [Safar, Jiri G.] Case Western Reserve Univ, Dept Neurol, Cleveland, OH 44106 USA; [Herbst, Allen; Aiken, Judd] Univ Alberta, Dept Agr Food & Nutr Sci, Edmonton, AB T6G 2P5, Canada; [Velasquez, Camilo Duque; Kim, Chiye; Herbst, Allen; Aiken, Judd; McKenzie, Debbie] Univ Alberta, Ctr Prions & Prot Folding Dis, Edmonton, AB T6G 2M8, Canada	University of Alberta; Case Western Reserve University; Case Western Reserve University; University of Alberta; University of Alberta	McKenzie, D (corresponding author), Univ Alberta, Dept Biol Sci, Edmonton, AB T6G 2R3, Canada.; McKenzie, D (corresponding author), Univ Alberta, Ctr Prions & Prot Folding Dis, Edmonton, AB T6G 2M8, Canada.	Debbie.McKenzie@ualberta.ca		Herbst, Allen/0000-0001-6601-1245	Alberta Prion Research Institute (APRI) [PEX15023]; Genome Canada; Genome Alberta; APRI; University of Alberta; Natural Sciences and Engineering Research Council of Canada [RGPIN-2017-05539]; Alberta Innovates Biosolutions [FP00204477]; National Institutes of Health [1R01NS103848]	Alberta Prion Research Institute (APRI); Genome Canada(Genome Canada); Genome Alberta; APRI; University of Alberta(University of Alberta); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Alberta Innovates Biosolutions; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by Alberta Prion Research Institute (APRI) Grant PEX15023, Genome Canada, Genome Alberta, APRI, the University of Alberta in support of Systems Biology and Molecular Ecology, Natural Sciences and Engineering Research Council of Canada Grant RGPIN-2017-05539, Alberta Innovates Biosolutions Grant FP00204477, and National Institutes of Health Grant 1R01NS103848. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Angers R, 2014, P NATL ACAD SCI USA, V111, P11169, DOI 10.1073/pnas.1404739111; Angers RC, 2010, SCIENCE, V328, P1154, DOI 10.1126/science.1187107; Asante EA, 2015, NATURE, V522, P478, DOI 10.1038/nature14510; Ayers JI, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001317; Bartz JC, 2000, J VIROL, V74, P5542, DOI 10.1128/JVI.74.12.5542-5547.2000; Benestad SL, 2016, VET RES, V47, DOI 10.1186/s13567-016-0375-4; BESSEN RA, 1992, J VIROL, V66, P2096, DOI 10.1128/JVI.66.4.2096-2101.1992; BRUCE ME, 1993, BRIT MED BULL, V49, P822, DOI 10.1093/oxfordjournals.bmb.a072649; BRUCE ME, 1991, J GEN VIROL, V72, P595, DOI 10.1099/0022-1317-72-3-595; Cali I, 2009, BRAIN, V132, P2643, DOI 10.1093/brain/awp196; Choi YP, 2011, J GEN VIROL, V92, P727, DOI 10.1099/vir.0.026948-0; Choi YP, 2010, J VIROL, V84, P12030, DOI 10.1128/JVI.01057-10; Cinar MU, 2018, VET J, V233, P19, DOI 10.1016/j.tvjl.2017.12.019; Cohen ML, 2015, BRAIN, V138, P1009, DOI 10.1093/brain/awv006; Collinge J, 2016, NATURE, V539, P217, DOI 10.1038/nature20415; Denkers ND, 2013, J VIROL, V87, P1890, DOI 10.1128/JVI.02852-12; Gonzalez L, 2003, J GEN VIROL, V84, P1339, DOI 10.1099/vir.0.18800-0; Haldiman T, 2013, J BIOL CHEM, V288, P29846, DOI 10.1074/jbc.M113.500108; Hannaoui S, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006553; Henderson DM, 2015, J VIROL, V89, P9338, DOI 10.1128/JVI.01118-15; Herbst A, 2017, EMERG INFECT DIS, V23, P1598, DOI [10.3201/eid2309.161474, 10.3201/eid2309.161747]; Hizume M, 2009, J BIOL CHEM, V284, P3603, DOI 10.1074/jbc.M809254200; Jeffrey M, 2006, J COMP PATHOL, V134, P17, DOI 10.1016/j.jcpa.2005.06.005; Johnson CJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035383; Johnson CJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017450; KASCSAK RJ, 1985, J GEN VIROL, V66, P1715, DOI 10.1099/0022-1317-66-8-1715; Kim C, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04584-z; Kim C, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002835; Kim C, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002242; Laferriere F, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003702; Langeveld JPM, 2016, J VIROL, V90, P805, DOI 10.1128/JVI.02316-15; Lau A, 2015, EMBO MOL MED, V7, P339, DOI 10.15252/emmm.201404588; Le Dur A, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14170; Li QY, 2018, J BIOL CHEM, V293, P18494, DOI [10.1074/jbc.RA118.005622, 10.1074/jbc.ra118.005622]; Makarava N, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003759; Mays CE, 2015, J VIROL, V89, P12418, DOI 10.1128/JVI.02142-15; Mays CE, 2014, J CLIN INVEST, V124, P847, DOI 10.1172/JCI72241; Meade-White K, 2007, J VIROL, V81, P4533, DOI 10.1128/JVI.02762-06; Miller MW, 2012, J WILDLIFE DIS, V48, P526, DOI 10.7589/0090-3558-48.2.526; Miller MW, 2003, NATURE, V425, P35, DOI 10.1038/425035a; Moore RA, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005416; Moore SJ, 2018, BMC VET RES, V14, DOI 10.1186/s12917-018-1400-9; Oelschlegel AM, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003158; Otero A, 2019, BMC VET RES, V15, DOI 10.1186/s12917-019-1794-z; Parchi P, 1999, ANN NEUROL, V46, P224, DOI 10.1002/1531-8249(199908)46:2<224::AID-ANA12>3.0.CO;2-W; Peretz D, 2001, PROTEIN SCI, V10, P854, DOI 10.1110/ps.39201; Perucchini M, 2008, J GEN VIROL, V89, P1324, DOI 10.1099/vir.0.83424-0; Pirisinu L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012723; PRUSINER SB, 1990, CELL, V63, P673, DOI 10.1016/0092-8674(90)90134-Z; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Puoti G, 1999, NEUROLOGY, V53, P2173, DOI 10.1212/WNL.53.9.2173; Race B, 2011, J VIROL, V85, P9235, DOI 10.1128/JVI.00790-11; Raymond GJ, 2000, EMBO J, V19, P4425, DOI 10.1093/emboj/19.17.4425; Robinson SJ, 2012, ECOL APPL, V22, P1050, DOI 10.1890/11-0907.1; SAFAR J, 1993, PROTEIN SCI, V2, P2206, DOI 10.1002/pro.5560021220; SAFAR J, 1994, BIOCHEMISTRY-US, V33, P8375, DOI 10.1021/bi00193a027; SAFAR J, 1993, J BIOL CHEM, V268, P20276; Safar J, 1998, NAT MED, V4, P1157, DOI 10.1038/2654; SAFAR J, 1993, BIOPOLYMERS, V33, P1461, DOI 10.1002/bip.360330915; Safar JG, 2005, J VIROL, V79, P10796, DOI 10.1128/JVI.79.16.10796-10806.2005; Safar JG, 2005, J GEN VIROL, V86, P2913, DOI 10.1099/vir.0.80947-0; Safar JG, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004832; Safar JG, 2012, PRION, V6, P108, DOI 10.4161/pri.18666; Silva CJ, 2018, ANAL CHEM, V90, P1255, DOI 10.1021/acs.analchem.7b03985; Silva CJ, 2017, ANAL CHEM, V89, P854, DOI 10.1021/acs.analchem.6b03822; Tixador P, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000859; Tzaban S, 2002, BIOCHEMISTRY-US, V41, P12868, DOI 10.1021/bi025958g; Uro-Coste E, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000029; Velasquez CD, 2015, J VIROL, V89, P12362, DOI 10.1128/JVI.02010-15; Weissmann C, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002582	70	19	19	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 10	2020	295	15					4985	5001		10.1074/jbc.RA120.012546	http://dx.doi.org/10.1074/jbc.RA120.012546			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LE7FC	32111742	Green Published, hybrid			2022-12-26	WOS:000526887000021
J	Massa, D; Baran, M; Bengoechea, JA; Bowie, AG				Massa, Davide; Baran, Marcin; Bengoechea, Jose A.; Bowie, Andrew G.			PYHIN1 regulates pro-inflammatory cytokine induction rather than innate immune DNA sensing in airway epithelial cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						innate immunity; pattern recognition receptor (PRR); DNA viruses; interleukin 6 (IL-6); tumor necrosis factor (TNF); airway epithelial cells; cGAS; DNA sensing; PYHIN proteins; STING	CYCLIC DINUCLEOTIDE; IFI16; SENSOR; AIM2; ADAPTER; GENE; INFLAMMASOMES; REPLICATION; ACTIVATION; INFECTION	Animal cells use pattern-recognition receptors (PRRs) to detect specific pathogens. Pathogen detection mounts an appropriate immune response, including interferon and cytokine induction. The intracellular PRR-signaling pathways that detect DNA viruses have been characterized, particularly in myeloid cells. In these pathways, cGMP-AMP synthase (cGAS) and the pyrin and HIN domain family member (PYHIN) protein interferon-??inducible protein 16 (IFI16) detect DNA and signal via stimulator of interferon genes protein (STING). However, although airway epithelial cells are frontline sentinels in detecting pathogens, information on how they respond to DNA viruses is limited, and the roles of PYHIN proteins in these cells are unknown. Here, we examined expression and activities of cGAS, STING, and PYHINs in human lung epithelial cells. A549 epithelial cells, commonly used for RNA-sensing studies, failed to respond to DNA because they lacked STING expression, and ectopic STING expression restored a cGAS-dependent DNA response in these cells. In contrast, NuLi-1 immortalized human bronchial epithelial cells did express STING, which was activated after DNA stimulation and mediated DNA-dependent gene induction. PYHIN1, which like IFI16 has been proposed to be a viral DNA sensor, was the only PYHIN protein expressed in both airway epithelial cell types. However, rather than having a role in DNA sensing, PYHIN1 induced proinflammatory cytokines in response to interleukin-1 (IL-1) or tumor necrosis factor ? (TNF?) stimulation. Of note, PYHIN1, via its HIN domain, directly induced IL-6 and TNF? transcription, revealing that PYHIN proteins play a role in proinflammatory gene induction in airway epithelial cells.	[Massa, Davide; Baran, Marcin; Bowie, Andrew G.] Trinity Coll Dublin, Sch Biochem & Immunol, Trinity Biomed Sci Inst, Dublin 2, Ireland; [Bengoechea, Jose A.] Queens Univ Belfast, Wellcome Wolfson Inst Expt Med, Belfast BT9 7BL, Antrim, North Ireland	Trinity College Dublin; Queens University Belfast	Bowie, AG (corresponding author), Trinity Coll Dublin, Sch Biochem & Immunol, Trinity Biomed Sci Inst, Dublin 2, Ireland.	agbowie@tcd.ie		Bengoechea, Jose/0000-0002-9677-8751; Bowie, Andrew/0000-0001-5316-4373	Science Foundation Ireland [11/PI/1056, 16/IA/4376]; European Union Seventh Framework Programme Marie Curie Initial Training Networks (FP7-PEOPLE-2012-ITN) [PITN-GA-2012316682]; Marie Curie Career Integration Grant [PCIG13-GA-2013-618162]; Biotechnology and Biological Sciences Research Council (BBSRC) [BB/L007223/1, BB/P020194/1]; BBSRC [BB/P020194/1, BB/L007223/1, BB/P006078/1] Funding Source: UKRI	Science Foundation Ireland(Science Foundation IrelandEuropean Commission); European Union Seventh Framework Programme Marie Curie Initial Training Networks (FP7-PEOPLE-2012-ITN); Marie Curie Career Integration Grant; Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by Science Foundation Ireland Grants 11/PI/1056 and 16/IA/4376 (to A. G. B.) and by the European Union Seventh Framework Programme Marie Curie Initial Training Networks (FP7-PEOPLE-2012-ITN) for the project INBIONET under grant agreement PITN-GA-2012316682 (to D. M.). This work was also supported by Marie Curie Career Integration Grant PCIG13-GA-2013-618162 (U-KARE) and by Biotechnology and Biological Sciences Research Council (BBSRC) Grants BB/L007223/1 and BB/P020194/1 (to J. A. B.). The authors declare that they have no conflicts of interest with the contents of this article.	Ablasser A, 2013, NATURE, V498, P380, DOI 10.1038/nature12306; Almine JF, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14392; Andreoletti G, 2015, INFLAMM BOWEL DIS, V21, P1229, DOI 10.1097/MIB.0000000000000381; Antiochos B, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.120179; BALIS JU, 1984, EXP LUNG RES, V6, P197, DOI 10.3109/01902148409109248; Burckstummer T, 2009, NAT IMMUNOL, V10, P266, DOI 10.1038/ni.1702; Caneparo V, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01180; Chen Q, 2016, NAT IMMUNOL, V17, P1142, DOI 10.1038/ni.3558; Connolly DJ, 2014, BIOCHEM PHARMACOL, V92, P405, DOI 10.1016/j.bcp.2014.08.031; Cooksley C, 2015, MOL IMMUNOL, V68, P476, DOI 10.1016/j.molimm.2015.09.024; Crow MS, 2017, MOL CELL PROTEOMICS, V16, pS200, DOI 10.1074/mcp.M116.064741; Diner BA, 2016, MBIO, V7, DOI 10.1128/mBio.01553-16; Diner BA, 2015, MOL SYST BIOL, V11, DOI 10.15252/msb.20145808; Diner EJ, 2013, CELL REP, V3, P1355, DOI 10.1016/j.celrep.2013.05.009; Ding Y, 2006, MOL CELL BIOL, V26, P1979, DOI 10.1128/MCB.26.5.1979-1996.2006; Ding Y, 2004, ONCOGENE, V23, P4556, DOI 10.1038/sj.onc.1207592; Eisenbarth SC, 2008, NATURE, V453, P1122, DOI 10.1038/nature06939; Fernandes-Alnemri T, 2009, NATURE, V458, P509, DOI 10.1038/nature07710; Gariano GR, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002498; Ghosh S, 2017, J IMMUNOL, V199, P3249, DOI 10.4049/jimmunol.1700823; Girardin SE, 2003, SCIENCE, V300, P1584, DOI 10.1126/science.1084677; HALBERT CL, 1991, J VIROL, V65, P473, DOI 10.1128/JVI.65.1.473-478.1991; Hauenstein AV, 2015, CURR OPIN STRUC BIOL, V31, P75, DOI 10.1016/j.sbi.2015.03.014; Hornung V, 2009, NATURE, V458, P514, DOI 10.1038/nature07725; Hotter D, 2019, CELL HOST MICROBE, V25, P858, DOI 10.1016/j.chom.2019.05.002; Ishikawa H, 2008, NATURE, V455, P674, DOI 10.1038/nature07317; Ishikawa H, 2009, NATURE, V461, P788, DOI 10.1038/nature08476; Jeremiah N, 2014, J CLIN INVEST, V124, P5516, DOI 10.1172/JCI79100; Jin L, 2011, GENES IMMUN, V12, P263, DOI 10.1038/gene.2010.75; Jin TC, 2012, IMMUNITY, V36, P561, DOI 10.1016/j.immuni.2012.02.014; Jonsson KL, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14391; Kantor DB, 2013, HUM GENET, V132, P1039, DOI 10.1007/s00439-013-1310-7; Kim MS, 2014, NATURE, V509, P575, DOI 10.1038/nature13302; Kiyono T, 1998, NATURE, V396, P84, DOI 10.1038/23962; Knipe DM, 2015, VIROLOGY, V479, P153, DOI 10.1016/j.virol.2015.02.009; Konno H, 2018, ONCOGENE, V37, P2037, DOI 10.1038/s41388-017-0120-0; Konno H, 2013, CELL, V155, P688, DOI 10.1016/j.cell.2013.09.049; Li Y, 2017, J INFLAMM-LOND, V14, DOI 10.1186/s12950-017-0159-2; Liao JCC, 2011, STRUCTURE, V19, P418, DOI 10.1016/j.str.2010.12.015; Liu Y, 2014, NEW ENGL J MED, V371, P507, DOI 10.1056/NEJMoa1312625; Lo Cigno I, 2015, J VIROL, V89, P7506, DOI 10.1128/JVI.00013-15; Lukens JR, 2015, IMMUNITY, V42, P654, DOI 10.1016/j.immuni.2015.03.006; Merkl PE, 2019, MBIO, V10, DOI 10.1128/mBio.02621-18; Mishra R, 2016, AM J RESP CELL MOL, V54, P853, DOI 10.1165/rcmb.2014-0437OC; Morrone SR, 2014, P NATL ACAD SCI USA, V111, pE62, DOI 10.1073/pnas.1313577111; Ng KW, 2018, TRENDS IMMUNOL, V39, P44, DOI 10.1016/j.it.2017.07.013; Olagnier D, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05861-7; Orzalli MH, 2013, P NATL ACAD SCI USA, V110, pE4492, DOI 10.1073/pnas.1316194110; Paludan SR, 2011, NAT REV IMMUNOL, V11, P143, DOI 10.1038/nri2937; Schlee M, 2016, NAT REV IMMUNOL, V16, P566, DOI 10.1038/nri.2016.78; Scholl T, 1997, P NATL ACAD SCI USA, V94, P6330, DOI 10.1073/pnas.94.12.6330; Sharma BR, 2019, EUR J IMMUNOL, V49, P1998, DOI 10.1002/eji.201848070; Singh A, 2006, PLOS MED, V3, P1865, DOI 10.1371/journal.pmed.0030420; Sun LJ, 2013, SCIENCE, V339, P786, DOI 10.1126/science.1232458; Tang A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037689; Thompson MR, 2014, J BIOL CHEM, V289, P23568, DOI 10.1074/jbc.M114.554147; Torgerson DG, 2011, NAT GENET, V43, P887, DOI 10.1038/ng.888; Unterholzner L, 2010, NAT IMMUNOL, V11, P997, DOI 10.1038/ni.1932; Vanhove W, 2015, INFLAMM BOWEL DIS, V21, P2673, DOI 10.1097/MIB.0000000000000535; Xia TL, 2016, CELL REP, V14, P282, DOI 10.1016/j.celrep.2015.12.029; Yamaguchi H, 2008, MOL CARCINOGEN, V47, P739, DOI 10.1002/mc.20423; Yoneyama M, 2015, CURR OPIN IMMUNOL, V32, P48, DOI 10.1016/j.coi.2014.12.012; Zabner J, 2003, AM J PHYSIOL-LUNG C, V284, pL844, DOI 10.1152/ajplung.00355.2002; Zhang ZQ, 2011, NAT IMMUNOL, V12, P959, DOI 10.1038/ni.2091; Zhong B, 2008, IMMUNITY, V29, P538, DOI 10.1016/j.immuni.2008.09.003	65	7	8	0	8	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 3	2020	295	14					4438	4450		10.1074/jbc.RA119.011400	http://dx.doi.org/10.1074/jbc.RA119.011400			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LB2WZ	32102850	Green Published, hybrid			2022-12-26	WOS:000524499700007
J	Koivunen, S; Viljakainen, M; Mannisto, T; Gissler, M; Pouta, A; Kaaja, R; Eriksson, J; Laivuori, H; Kajantie, E; Vaarasmaki, M				Koivunen, Sanna; Viljakainen, Matti; Mannisto, Tuija; Gissler, Mika; Pouta, Anneli; Kaaja, Risto; Eriksson, Johan; Laivuori, Hannele; Kajantie, Eero; Vaarasmaki, Marja			Pregnancy outcomes according to the definition of gestational diabetes	PLOS ONE			English	Article							INTERNATIONAL ASSOCIATION; HYPERGLYCEMIA; MELLITUS; CLASSIFICATION; DIAGNOSIS; CRITERIA; QUALITY; RISK	Objective To assess the frequency and perinatal outcomes of gestational diabetes mellitus (GDM) defined by the criteria according to the International Association of Diabetes in Pregnancy Study Group (IADPSG) and the National Institute for Health and Care Excellence (NICE) diagnostic criteria for GDM. Design A retrospective cohort study. Setting Six secondary and tertiary delivery hospitals in Finland in 2009. Population Pregnant women (N = 4,033) and their offspring. Methods We used data on comprehensive screening of pregnant women with a 2-h 75-g oral glucose tolerance test (OGTT), performed between gestational weeks 24 and 40. OGTT glucose concentrations were used to identify women who fulfilled IADPSG and NICE criteria. While cut-offs according to Finnish national criteria partly overlapped with both criteria, a subgroup of IADPSG- or NICE-positive GDM women remained undiagnosed by Finnish criteria and hence non-treated. They were analysed as subgroups and compared to controls who were negative with all cut-offs. Main outcome measures GDM prevalence, birth weight SD score (BWSDS), large for gestational age (LGA) and caesarean section (CS) rates. Results Among the 4,033 women screened for GDM, 1,249 (31.0%) and 529 (13.1%) had GDM according to the IADPSG and NICE criteria, respectively. The LGA rate was similar in both groups. Regardless of the diagnostic criteria, women with GDM had a higher risk of induced delivery and CSs than controls. In IADPSG-positive non-treated women, offspring's BWSDS and CS rate were higher than in controls. Conclusions GDM prevalence was 2.4-fold higher according to the IADPSG compared with the NICE criteria but the LGA rate did not differ. BWSDS and CS rate were increased already with mild untreated hyperglycaemia.	[Koivunen, Sanna; Viljakainen, Matti; Kajantie, Eero; Vaarasmaki, Marja] Oulu Univ Hosp, PEDEGO Res Unit, MRC Oulu, Oulu, Finland; [Koivunen, Sanna; Viljakainen, Matti; Mannisto, Tuija; Kajantie, Eero; Vaarasmaki, Marja] Univ Oulu, Oulu, Finland; [Koivunen, Sanna; Viljakainen, Matti; Kajantie, Eero; Vaarasmaki, Marja] Natl Inst Hlth & Welf, Publ Hlth Promot Unit, Helsinki, Finland; [Koivunen, Sanna; Viljakainen, Matti; Kajantie, Eero; Vaarasmaki, Marja] Natl Inst Hlth & Welf, Publ Hlth Promot Unit, Oulu, Finland; [Mannisto, Tuija] Oulu Univ Hosp, Northern Finland Lab Ctr NordLab, Dept Clin Chem, Oulu, Finland; [Mannisto, Tuija] Oulu Univ Hosp, MRC Oulu, Oulu, Finland; [Gissler, Mika] Natl Inst Hlth & Welf, Informat Dept, Helsinki, Finland; [Gissler, Mika] Karolinska Inst, Dept Neurobiol Care Sci & Soc, Stockholm, Sweden; [Pouta, Anneli] Natl Inst Hlth & Welf, Dept Govt Serv, Helsinki, Finland; [Kaaja, Risto] Univ Tampere, Fac Med & Life Sci, Tampere, Finland; [Eriksson, Johan] Univ Helsinki, Dept Gen Practice, Helsinki, Finland; [Eriksson, Johan] Helsinki Univ Hosp, Folkhalsan Res Ctr, Helsinki, Finland; [Laivuori, Hannele] Tampere Univ Hosp, Dept Obstet & Gynaecol, Helsinki, Finland; [Laivuori, Hannele] Univ Tampere, Fac Med & Life Sci, Helsinki, Finland; [Laivuori, Hannele] Univ Helsinki, Med & Clin Genet, Helsinki, Finland; [Laivuori, Hannele] Helsinki Univ Hosp, Helsinki, Finland; [Laivuori, Hannele] Univ Helsinki, Inst Mol Med Finland, Helsinki Inst Life Sci, Helsinki, Finland; [Kajantie, Eero] Norwegian Univ Sci & Technol, Dept Clin & Mol Med, Trondheim, Norway; [Kajantie, Eero] Helsinki Univ Hosp, Childrens Hosp, Helsinki, Finland; [Kajantie, Eero] Univ Helsinki, Helsinki, Finland	University of Oulu; University of Oulu; Finland National Institute for Health & Welfare; Finland National Institute for Health & Welfare; University of Oulu; University of Oulu; Finland National Institute for Health & Welfare; Karolinska Institutet; Finland National Institute for Health & Welfare; Tampere University; University of Helsinki; Folkhalsan Research Center; University of Helsinki; Helsinki University Central Hospital; Tampere University; Tampere University Hospital; Tampere University; University of Helsinki; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; Norwegian University of Science & Technology (NTNU); University of Helsinki; Helsinki University Central Hospital; University of Helsinki	Koivunen, S (corresponding author), Oulu Univ Hosp, PEDEGO Res Unit, MRC Oulu, Oulu, Finland.; Koivunen, S (corresponding author), Univ Oulu, Oulu, Finland.; Koivunen, S (corresponding author), Natl Inst Hlth & Welf, Publ Hlth Promot Unit, Helsinki, Finland.; Koivunen, S (corresponding author), Natl Inst Hlth & Welf, Publ Hlth Promot Unit, Oulu, Finland.	sanna.koivunen@oulu.fi	; Laivuori, Hannele/F-2953-2011	Etelainen, Sanna/0000-0002-4711-0309; Gissler, Mika/0000-0001-8254-7525; Vaarasmaki, Marja/0000-0002-8234-4434; Laivuori, Hannele/0000-0003-3212-7826	Academy of Finland [127437, 129306, 130326, 134791, 263924, 315690]; European Commission [733280]; Finnish Foundation for Pediatric Research; Juho Vainio Foundation; Novo Nordisk Foundation; Signe and Ane Gyllenberg Foundation; Sigrid Juselius Foundation; Yrjo Jahnsson Foundation; Medical Research Center Oulu; National Graduate School of Clinical Investigation; Pohjois-Suomen terveydenhuollon Tukisaatio; Finnish Medical Foundation	Academy of Finland(Academy of Finland); European Commission(European CommissionEuropean Commission Joint Research Centre); Finnish Foundation for Pediatric Research; Juho Vainio Foundation; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Signe and Ane Gyllenberg Foundation; Sigrid Juselius Foundation(Sigrid Juselius Foundation); Yrjo Jahnsson Foundation; Medical Research Center Oulu; National Graduate School of Clinical Investigation; Pohjois-Suomen terveydenhuollon Tukisaatio; Finnish Medical Foundation	This work was supported by the Academy of Finland (Grants 127437, 129306, 130326, 134791, 263924 and 315690 to Eero Kajantie); the European Commission (Horizon 2020 award 733280) RECAP Research on Children and Adults born preterm to EK); the Finnish Foundation for Pediatric Research (to EK); the Juho Vainio Foundation (to EK and Marja Vaarasmaki); the Novo Nordisk Foundation (to EK and MV); The Signe and Ane Gyllenberg Foundation (to EK); the Sigrid Juselius Foundation (to EK); and the Yrjo Jahnsson Foundation (to EK and MV), Medical Research Center Oulu (Sanna Koivunen); National Graduate School of Clinical Investigation (SK); Pohjois-Suomen terveydenhuollon Tukisaatio (SK) and The Finnish Medical Foundation (SK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal MM, 2014, DIABETES RES CLIN PR, V103, P341, DOI 10.1016/j.diabres.2013.10.012; Amer Diabet Assoc, 2008, DIABETES CARE, V31, pS12, DOI 10.2337/dc08-S012; Bellamy L, 2009, LANCET, V373, P1773, DOI 10.1016/S0140-6736(09)60731-5; Bhatia M, 2018, J CLIN MED, V7, DOI 10.3390/jcm7100376; Black MH, 2010, DIABETES CARE, V33, P2524, DOI 10.2337/dc10-1445; Crowther CA, 2005, NEW ENGL J MED, V352, P2477, DOI 10.1056/NEJMoa042973; Disse E, 2013, DIABETES METAB, V39, P132, DOI 10.1016/j.diabet.2012.09.006; Ethridge JK, 2014, OBSTET GYNECOL, V124, P571, DOI 10.1097/AOG.0000000000000412; Finnish Medical Society Duodecim, 2008, GESTATIONAL DIABETES; Gissler M, 2002, MED INFORM INTERNET, V27, P33, DOI 10.1080/14639230110119234; GISSLER M, 1995, SCAND J SOC MED, V23, P75, DOI 10.1177/140349489502300113; Koivunen S, 2015, EUR J ENDOCRINOL, V173, P623, DOI 10.1530/EJE-15-0294; Landon MB, 2009, NEW ENGL J MED, V361, P1339, DOI 10.1056/NEJMoa0902430; Liao LZ, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2018-023014; Metzger BE, 2008, NEW ENGL J MED, V358, P1991, DOI 10.1056/NEJMoa0707943; Metzger BE, 2010, DIABETES CARE, V33, P676, DOI 10.2337/dc09-1848; National Institute for Health and Care Excellence, NICE GUID 3; Sankilampi U, 2013, ANN MED, V45, P446, DOI 10.3109/07853890.2013.803739; The International Federation of Gynecology and Obstetrics (FIGO), 2015, INT J GYNAECOL OB S3, V131, pS173, DOI 10.1016/S0020-7292(15)30007-2; Vandorsten James P, 2013, NIH Consens State Sci Statements, V29, P1	20	15	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2020	15	3							e0229496	10.1371/journal.pone.0229496	http://dx.doi.org/10.1371/journal.pone.0229496			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8RK	32134959	Green Published, gold			2022-12-26	WOS:000535265600027
J	Vieten, MM; Weich, C				Vieten, Manfred M.; Weich, Christian			The kinematics of cyclic human movement	PLOS ONE			English	Article							DYNAMIC STABILITY; STRATEGIES	Literature mentions two types of models describing cyclic movement-theory and data driven. Theory driven models include anatomical and physiological aspects. They are principally suitable for answering questions about the reasons for movement characteristics, but they are complicated and substantial simplifications do not allow generally valid results. Data driven models allow answering specific questions, but lack the understanding of the general movement characteristic. With this paper we try a compromise without having to rely on anatomy, neurology and muscle function. We hypothesize a general kinematic description of cyclic human motion is possible without having to specify the movement generating processes, and still get the kinematics right. The model proposed consists of a superposition of six contributions-subject's attractor, morphing, short time fluctuation, transient effect, control mechanism and sensor noise, while characterizing numbers and random contributions. We test the model with data from treadmill running and stationary biking. Applying the model in a simulation results in good agreement between measured data and simulation values. We find in all our cases the similarity analysis between measurement and simulation is best for the same subjects-delta(same sub)(run) > 55% and delta(same sub)(bike) > 64%. All comparisons between different subjects are 51% > delta(run) (different sub) and 52% > delta(different sub)(bike). This uniquely allows for the identification of each measurement for the associated simulation. However, even different subject comparisons show good agreement between measurement and simulation results of differences delta(run) = 6.7 +/- 4.7% and delta(bike) = 5.1 +/- 4.5%.	[Vieten, Manfred M.; Weich, Christian] Univ Konstanz, Dept Sport Sci, Constance, Germany	University of Konstanz	Vieten, MM (corresponding author), Univ Konstanz, Dept Sport Sci, Constance, Germany.	Manfred.Vieten@uni-konstanz.de	Vieten, Manfred/GMW-7459-2022	Vieten, Manfred/0000-0002-2745-2344	University of Konstanz	University of Konstanz	AFF-grand "cyclic human motion -2019" of the University of Konstanz. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Zahrani KS, 2008, NEUROSCIENCES, V13, P460; Alligood KT, 1997, CHAOS INTRO DYNAMICA, pxvii; [Anonymous], [No title captured]; Barnes KR, 2015, SPORTS MED, V45, P37, DOI 10.1007/s40279-014-0246-y; Bramble DM, 2004, NATURE, V432, P345, DOI 10.1038/nature03052; Broscheid KC, 2018, GAIT POSTURE, V63, P242, DOI 10.1016/j.gaitpost.2018.05.015; BUCHTHAL F, 1970, ACTA PHYSIOL SCAND, V79, P435, DOI 10.1111/j.1748-1716.1970.tb04744.x; Clermont CA, 2019, J APPL BIOMECH, V35, P401, DOI 10.1123/jab.2018-0453; Clermont CA, 2019, J SPORT SCI, V37, P204, DOI 10.1080/02640414.2018.1488518; Dingwell JB, 2000, CHAOS, V10, P848, DOI 10.1063/1.1324008; Dingwell JB, 2007, J BIOMECH ENG-T ASME, V129, P586, DOI 10.1115/1.2746383; Enders H, 2015, MED SCI SPORT EXER, V47, P1450, DOI 10.1249/MSS.0000000000000564; England SA, 2007, GAIT POSTURE, V25, P172, DOI 10.1016/j.gaitpost.2006.03.003; GERRITSEN KGM, 1995, J BIOMECH, V28, P661, DOI 10.1016/0021-9290(94)00127-P; Hausdorff JM, 1999, J APPL PHYSIOL, V86, P1040, DOI 10.1152/jappl.1999.86.3.1040; HAUSDORFF JM, 1995, J APPL PHYSIOL, V78, P349, DOI 10.1152/jappl.1995.78.1.349; HURMUZLU Y, 1993, J APPL MECH-T ASME, V60, P337, DOI 10.1115/1.2900798; HURMUZLU Y, 1994, J BIOMECH ENG-T ASME, V116, P30, DOI 10.1115/1.2895701; Janssen D, 2008, J NONVERBAL BEHAV, V32, P79, DOI 10.1007/s10919-007-0045-3; Kerscher T., 2010, THESIS, DOI [10.5445/IR/1000019634, DOI 10.5445/IR/1000019634]; Kindermann W., 1987, DTSCH Z SPORTMEDIZIN, V38; Loske S, 2018, SPINE J; NASHNER LM, 1980, J NEUROPHYSIOL, V44, P650, DOI 10.1152/jn.1980.44.4.650; Sehle A, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00279; Sehle A, 2014, J NEUROL, V261, P1752, DOI 10.1007/s00415-014-7415-7; Sehle A, 2011, J NEUROENG REHABIL, V8, DOI 10.1186/1743-0003-8-59; Spitzer F., 2001, PRINCIPLES RANDOM WA, pxii; Strogatz SH, 1994, NONLINEAR DYNAMICS C, pxi; Vieten MM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071824; Vieten MM, 2004, FILTERING KINEMAITC; Weich C, 2019, SPORT BIOMECH, V18, P215, DOI 10.1080/14763141.2017.1391324; WILSON RC, 1989, CLIN SCI, V76, P277, DOI 10.1042/cs0760277	32	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2020	15	3							e0225157	10.1371/journal.pone.0225157	http://dx.doi.org/10.1371/journal.pone.0225157			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8RK	32134925	Green Published, gold, Green Submitted			2022-12-26	WOS:000535265600010
J	Whitney, BM; Guthrie, BL; Srinivasan, S; Tapia, K; Muriuki, EM; Chohan, BH; Wallis, JM; Liu, CZ; McClelland, RS; Fredricks, DN; Roxby, AC				Whitney, Bridget M.; Guthrie, Brandon L.; Srinivasan, Sujatha; Tapia, Kenneth; Muriuki, Eric Munene; Chohan, Bhavna H.; Wallis, Jacqueline M.; Liu, Congzhou; McClelland, R. Scott; Fredricks, David N.; Roxby, Alison C.			Changes in key vaginal bacteria among postpartum African women initiating intramuscular depot-medroxyprogesterone acetate	PLOS ONE			English	Article							HIV ACQUISITION; HORMONAL CONTRACEPTION; MICROBIOME; VAGINOSIS; RISK; RESPONSES; IMPACT	Background The ECHO trial has relieved apprehension about intramuscular depot medroxyprogesterone acetate (DMPA-IM), however it is still important to understand how DMPA-IM affects the vaginal environment. We sought to describe how DMPA-IM initiation influences vaginal bacteria associated with HIV acquisition in postpartum women. Methods Vaginal swabs were collected for Nugent score determination and taxon-specific quantitative PCR of eight bacteria. Enrollment occurred at contraceptive initiation (DMPA-IM or nonhormonal contraception (non-HC)) and repeat vaginal swabs were collected after three months. Generalized estimating equations were used to estimate changes in Nugent score, total bacterial load, and taxa concentrations among contraceptive groups. Results Women who chose DMPA-IM (n = 33) were more likely to be married (97%vs.67%) and have resumed intercourse since delivery (52%vs.29%) compared to women who chose non-HC (n = 21). After three months, significant decreases in the concentrations of Sneathia species, Mycoplasma hominis, and Parvimonas species Type 1 were seen among non-HC users, however concentrations remained stable among DMPA-IM users; contraceptive method was associated with significantly different changes in M. hominis concentration between groups (p = 0.010). Conclusions Our findings suggest that postpartum use of DMPA-IM and non-HC may have differential impacts on the vaginal concentrations of some bacteria that have previously been associated with HIV acquisition.	[Whitney, Bridget M.; Guthrie, Brandon L.; McClelland, R. Scott] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; [Guthrie, Brandon L.; Tapia, Kenneth; Chohan, Bhavna H.; McClelland, R. Scott; Roxby, Alison C.] Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA; [Srinivasan, Sujatha; Wallis, Jacqueline M.; Liu, Congzhou; Fredricks, David N.] Fred Hutchinson Canc Res Ctr, Vaccine & Infect Dis Div, 1124 Columbia St, Seattle, WA 98104 USA; [Muriuki, Eric Munene; Chohan, Bhavna H.] Univ Nairobi, Inst Infect & Trop Dis, Nairobi, Kenya; [McClelland, R. Scott; Roxby, Alison C.] Univ Washington, Dept Med, Seattle, WA USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Fred Hutchinson Cancer Center; University of Nairobi; University of Washington; University of Washington Seattle	Whitney, BM (corresponding author), Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA.	bmw05@uw.edu		Roxby, Alison/0000-0001-9449-8062; Whitney, Bridget/0000-0002-3738-5704; Wallis, Jacqueline/0000-0001-7964-202X	National Institutes of Health [5R21AI129712-02, 1K23HD071788-01A1]; University of Washington Royalty Research Fund [A106982]; University of Washington STD/AIDS Research Training Fellowship Program [National Institutes of Health] [T32 AI07140]; Center for AIDS Research (CFAR) [AI027757]; National Center for Advancing Translational Sciences/National Institutes of Health [UL1 TR002319, KL2 TR002317, TL1 TR002318]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Washington Royalty Research Fund(University of Washington); University of Washington STD/AIDS Research Training Fellowship Program [National Institutes of Health]; Center for AIDS Research (CFAR); National Center for Advancing Translational Sciences/National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This project received financial support from the following sources: National Institutes of Health grants 5R21AI129712-02 (to ACR) and 1K23HD071788-01A1 (to ACR) [https://www.nih.gov]; University of Washington Royalty Research Fund A106982 (to ACR); University of Washington STD/AIDS Research Training Fellowship Program [National Institutes of Health T32 AI07140 (to BMW)] [https://depts.washington.edu/cfas/training/aids-std-training/]; and the Center for AIDS Research (CFAR) AI027757 [http://depts.washington.edu/cfar/?q=home].Study data were collected and managed using REDCap electronic data capture tools hosted at the University of Washington, funded by UL1 TR002319, KL2 TR002317, and TL1 TR002318 from National Center for Advancing Translational Sciences/National Institutes of Health [https://ncats.nih.gov; https://www.nih.gov].The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achilles SL, 2018, AM J OBSTET GYNECOL, V218, DOI 10.1016/j.ajog.2018.02.017; Achilles SL, 2013, AIDS, V27, pS5, DOI 10.1097/QAD.0000000000000058; Ahmed A, 2012, J BACTERIOL, V194, P3922, DOI 10.1128/JB.00056-12; Ahmed K, 2019, LANCET; American College of Obstetricians and Gynecologists CoAHC, 2014, OBSTET GYNECOL, P1398; Anahtar MN, 2015, IMMUNITY, V42, P965, DOI 10.1016/j.immuni.2015.04.019; [Anonymous], 2015, TRENDS CONTRACEPTIVE; [Anonymous], 2018, UNAIDS DAT 2018; Austin PC, 2015, J CLIN EPIDEMIOL, V68, P627, DOI 10.1016/j.jclinepi.2014.12.014; Birse KD, 2017, J INFECT DIS, V215, P590, DOI 10.1093/infdis/jiw590; Brind J, 2015, ISSUES LAW MED, V30, P129; Brooks JP, 2017, CONTRACEPTION, V95, P405, DOI 10.1016/j.contraception.2016.11.006; Brotman RM, 2014, VACCINE, V32, P1543, DOI 10.1016/j.vaccine.2013.10.010; Brotman RM, 2011, J CLIN INVEST, V121, P4610, DOI 10.1172/JCI57172; Chaban B, 2014, MICROBIOME, V2, DOI 10.1186/2049-2618-2-23; Doyle R, 2018, APPL ENVIRON MICROB, V84, DOI 10.1128/AEM.02150-17; Fredricks DN, 2007, J CLIN MICROBIOL, V45, P3270, DOI 10.1128/JCM.01272-07; Fredricks DN, 2009, J CLIN MICROBIOL, V47, P721, DOI 10.1128/JCM.01384-08; Gajer P, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003605; Golob JL, 2017, BMC BIOINFORMATICS, V18, DOI 10.1186/s12859-017-1690-0; Gosmann C, 2017, IMMUNITY, V46, P29, DOI 10.1016/j.immuni.2016.12.013; Hapgood JP, 2020, AIDS RES HUM RETROV, V36, P357, DOI [10.1089/aid.2019.0228, 10.1089/AID.2019.0228]; Hapgood JP, 2018, ENDOCR REV, V39, P36, DOI 10.1210/er.2017-00103; Jespers V, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-12198-6; Khot PD, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-73; Lopes dos Santos Santiago G, 2011, AM J OBSTET GYNECOL, V204, DOI 10.1016/j.ajog.2010.12.061; MacIntyre DA, 2015, SCI REP-UK, V5, DOI 10.1038/srep08988; McClelland RS, 2018, LANCET INFECT DIS, V18, P554, DOI 10.1016/S1473-3099(18)30058-6; Miller L, 2000, OBSTET GYNECOL, V96, P431, DOI 10.1016/S0029-7844(00)00906-6; Mirmonsef P, 2015, MENOPAUSE, V22, P702, DOI 10.1097/GME.0000000000000397; Mirmonsef P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102467; Mishell DR, 1996, J REPROD MED, V41, P381; Morrison CS, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001778; Nanda K, 2016, CONTRACEPTION, V94, P40, DOI 10.1016/j.contraception.2016.03.003; NUGENT RP, 1991, J CLIN MICROBIOL, V29, P297, DOI 10.1128/JCM.29.2.297-301.1991; Passmore J, 2016, INT AIDS C DURB S AF; Polis CB, 2016, AIDS, V30, P2665, DOI 10.1097/QAD.0000000000001228; Ralph LJ, 2015, LANCET INFECT DIS, V15, P181, DOI 10.1016/S1473-3099(14)71052-7; Ravel J, 2011, P NATL ACAD SCI USA, V108, P4680, DOI 10.1073/pnas.1002611107; Roxby AC, 2016, JAIDS-J ACQ IMM DEF, V71, P359, DOI 10.1097/QAI.0000000000000866; Schellenberg JJ, 2017, RES MICROBIOL, V168, P837, DOI 10.1016/j.resmic.2017.02.011; Smith SB, 2017, J PHYSIOL-LONDON, V595, P451, DOI 10.1113/JP271694; Srinivasan S, 2018, VAGINAL MICROBIOTA H; Srinivasan S, 2015, MBIO, V6, DOI 10.1128/mBio.00204-15; Srinivasan S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037818; Srinivasan S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010197; Thomson KA, 2018, J INFECT DIS, V218, P16, DOI 10.1093/infdis/jiy113; van de Wijgert JHHM, 2017, RES MICROBIOL, V168, P859, DOI 10.1016/j.resmic.2017.02.003; van de Wijgert JHHM, 2013, AIDS, V27, P2141, DOI 10.1097/QAD.0b013e32836290b6; Yang LY, 2019, EMERG MICROBES INFEC, V8, P197, DOI 10.1080/22221751.2018.1563458	50	6	6	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2020	15	3							e0229586	10.1371/journal.pone.0229586	http://dx.doi.org/10.1371/journal.pone.0229586			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8RK	32134931	gold, Green Published			2022-12-26	WOS:000535265600032
J	Choi, J; Lee, D; Shim, JH; Kim, KM; Lim, YS; Lee, YS; Lee, HC				Choi, Jonggi; Lee, Danbi; Shim, Ju Hyun; Kim, Kang Mo; Lim, Young-Suk; Lee, Yung Sang; Lee, Han Chu			Evaluation of transarterial chemoembolization refractoriness in patients with hepatocellular carcinoma	PLOS ONE			English	Article							CLINICAL-PRACTICE GUIDELINES; KINKI CRITERIA; MANAGEMENT; SORAFENIB; SUBCLASSIFICATION; VALIDATION; EFFICACY	Background & aim In clinical practice, transarterial chemoembolization (TACE) has been widely used for the treatment of hepatocellular carcinoma (HCC) beyond as well as within guideline recommendations. Here we aimed to verify whether two consecutive non-responses could be an optimal criterion for creating a rule to stop TACE being performed on these patients. Methods This study evaluated 200 patients with HCC beyond the Milan criteria, initially treated with TACE. TACE response was determined using the mRECIST criteria via dynamic CT or MRI. Median follow-up duration was 23.9 months. Results Within the 200 patients analyzed, 183 (91.5%) were male, with a total median age of 59.8 years. The mean size of the largest tumor was 6.8 cm, with 80 (40.0%) patients with >= 4 tumors. After the first TACE procedure, complete response, partial response, stable disease, or progressive disease were observed in 48 (24.0%), 87 (43.5%), 59 (29.5%) and 6 (3.0%) of patients, respectively. 45 (22.5%) patients showed no objective response (OR) following two consecutive TACE sessions. Of these, 28 received a subsequent TACE, with a 10.7% OR rate. Patients without OR showed poorer survival when compared to patients who achieved OR after repeated TACE. Multivariable analysis showed that size of the largest tumor > 5cm and high alpha-fetoprotein of > 200 ng/mL were significant factors associated with failure of OR to two consecutive TACE sessions. Conclusion Patients showing no OR to two consecutive TACE sessions will present a poor OR to subsequent TACE procedures. Early transition to systemic therapy may be advocated in such cases.	[Choi, Jonggi; Lee, Danbi; Shim, Ju Hyun; Kim, Kang Mo; Lim, Young-Suk; Lee, Yung Sang; Lee, Han Chu] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Gastroenterol,Liver Ctr, Seoul, South Korea	University of Ulsan; Asan Medical Center	Lee, HC (corresponding author), Univ Ulsan, Coll Med, Asan Med Ctr, Dept Gastroenterol,Liver Ctr, Seoul, South Korea.	hch@amc.seoul.kr	Choi, Jonggi/L-1521-2019	Lim, Young-Suk/0000-0002-1544-577X; Lee, Han Chu/0000-0002-7631-4124	Bayer	Bayer(Bayer AG)	This study was supported by grants from Bayer. However, Bayer had no role in the study design, data collection, analysis, decision to publish, or preparation of the manuscript. The final decision on content was exclusively retained by the authors.	Arizumi T, 2017, DIGEST DIS, V35, P589, DOI 10.1159/000480208; Arizumi T, 2015, LIVER CANCER, V4, P253, DOI 10.1159/000367743; Arizumi T, 2015, ONCOLOGY-BASEL, V89, P47, DOI 10.1159/000440631; Chung SR, 2015, J VASC INTERV RADIOL, V26, P1130, DOI 10.1016/j.jvir.2015.05.006; European Assoc Study Liver, 2018, J HEPATOL, V69, P182, DOI 10.1016/j.jhep.2018.03.019; Heimbach JK, 2018, HEPATOLOGY, V67, P358, DOI 10.1002/hep.29086; Ikeda M, 2014, J GASTROENTEROL, V49, P932, DOI 10.1007/s00535-013-0853-7; Kim JH, 2018, LIVER INT, V38, P1646, DOI 10.1111/liv.13719; Kim JH, 2017, LIVER INT, V37, P1861, DOI 10.1111/liv.13487; Kudo M, 2016, LIVER INT, V36, P1196, DOI 10.1111/liv.13096; Kudo M, 2015, DIGEST DIS, V33, P751, DOI 10.1159/000439290; Kudo M, 2014, LIVER CANCER, V3, P458, DOI 10.1159/000343875; Lencioni R, 2016, J HEPATOL, V64, P1090, DOI 10.1016/j.jhep.2016.01.012; Lencioni R, 2010, SEMIN LIVER DIS, V30, P52, DOI 10.1055/s-0030-1247132; Llovet JM, 2003, HEPATOLOGY, V37, P429, DOI 10.1053/jhep.2003.50047; Llovet JM, 2002, LANCET, V359, P1734, DOI 10.1016/S0140-6736(02)08649-X; Lo CM, 2002, HEPATOLOGY, V35, P1164, DOI 10.1053/jhep.2002.33156; MATSUI O, 1993, RADIOLOGY, V188, P79, DOI 10.1148/radiology.188.1.8390073; Miyayama S, 2016, J VASC INTERV RADIOL, V27, P1269, DOI 10.1016/j.jvir.2016.04.014; Ogasawara S, 2014, ONCOLOGY-BASEL, V87, P330, DOI 10.1159/000365993; Omata M, 2017, HEPATOL INT, V11, P317, DOI 10.1007/s12072-017-9799-9; Park JW, 2015, LIVER INT, V35, P2155, DOI 10.1111/liv.12818; Peck-Radosavljevic M, 2018, OUTCOMES PATIENTS PT; Shim JH, 2013, J VASC INTERV RADIOL, V24, P316, DOI 10.1016/j.jvir.2012.10.022; Shim JH, 2012, RADIOLOGY, V262, P708, DOI 10.1148/radiol.11110282	25	10	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2020	15	3							e0229696	10.1371/journal.pone.0229696	http://dx.doi.org/10.1371/journal.pone.0229696			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8QU	32130270	Green Published, gold			2022-12-26	WOS:000535264000044
J	Fort-Vanmeerhaeghe, A; Bishop, C; Busca, B; Aguilera-Castells, J; Vicens-Bordas, J; Gonzalo-Skok, O				Fort-Vanmeerhaeghe, Azahara; Bishop, Chris; Busca, Bernat; Aguilera-Castells, Joan; Vicens-Bordas, Jordi; Gonzalo-Skok, Oliver			Inter-limb asymmetries are associated with decrements in physical performance in youth elite team sports athletes	PLOS ONE			English	Article							LOWER-EXTREMITY INJURY; EXCURSION BALANCE TEST; STRENGTH ASYMMETRY; RELIABILITY; DEFICITS; SPRINT; TESTS; LEG; ABILITY; SINGLE	Actually, there is scarce literature looking for the relationship between inter-limb asymmetries and performance in youth elite team sports. The main purpose of this cross-sectional study was to examine the relationships between inter-limb asymmetries and physical performance in youth elite team-sports players. A secondary objective was to evaluate the presence of between-sexes differences in inter-limb asymmetries in elite youth team sports players. Eighty-one young elite team-sports athletes (age: u-14 to u-18) performed the star excursion balance test in the anterior direction (SEBT ANT), a single leg vertical countermovement jump test (SLCMJ), the one leg hop test for distance (OLHT), a 30 m sprint test, and the V-cut test. Inter-limb asymmetries were calculated for SEBT ANT, SLCMJ and OLHT. Pearson r was used to analyse the relationships between inter-limb asymmetries and physical performance. Results showed significant (p < 0.05) but small (r = 0.26) relationships between SLCMJ asymmetries and 30 m sprint time for the total group. Significant negative correlations with small to moderate magnitude of correlation were also found between SLCMJ asymmetries and SLCMJ performance on the lowest performing limb for the total group (p < 0.05; r = -0.26), males (p < 0.01; r = -0.48) and females (p < 0.05; r = -0.30). Moreover, significant negative correlations with moderate and large magnitude were also present between OLHT asymmetries and OLHT performance on the lowest performing limb for the total group (p < 0.01; r = -0.44), males (p < 0.01; r = -0.56) and females (p < 0.01; r = -0.64). No correlations were observed between asymmetries and either the V-cut test or SEBT ANT performance. No correlation were observed between SEBT ANT asymmetries and physical performance. In addition, when comparing asymmetry values between sexes there were no significant differences in vertical (p = 0.06) and horizontal (p = 0.61) jumping tests. However, there were significant differences in asymmetry between sexes in the ANT SEBT (p = 0.04). In conclusion, the current study indicated that jumping asymmetries were associated with decrements in sprint speed and jumping performance. Therefore, assessing inter-limb asymmetries would be recommended to improve training interventions for youth elite team-sports athletes.	[Fort-Vanmeerhaeghe, Azahara; Busca, Bernat; Aguilera-Castells, Joan] Ramon Llull Univ, Fac Psychol Educ Sci & Sport FPCEE Blanquerna, Barcelona, Spain; [Fort-Vanmeerhaeghe, Azahara] Ramon Llull Univ, Sch Hlth Sci FCS Blanquerna, Barcelona, Spain; [Fort-Vanmeerhaeghe, Azahara] Catalan Federat Basketball, Segle XXI Female Basketball Team, Esplugas de Llobregat, Spain; [Bishop, Chris] Middlesex Univ, London Sport Inst, London, England; [Vicens-Bordas, Jordi] Univ Girona, Sch Hlth & Sport Sci EUSES, Salt, Spain; [Gonzalo-Skok, Oliver] Univ San Jorge, Fac Hlth Sci, Zaragoza, Spain	Universitat Ramon Llull; Universitat Ramon Llull; Middlesex University; Universitat de Girona; Universidad San Jorge	Fort-Vanmeerhaeghe, A (corresponding author), Ramon Llull Univ, Fac Psychol Educ Sci & Sport FPCEE Blanquerna, Barcelona, Spain.; Fort-Vanmeerhaeghe, A (corresponding author), Ramon Llull Univ, Sch Hlth Sci FCS Blanquerna, Barcelona, Spain.; Fort-Vanmeerhaeghe, A (corresponding author), Catalan Federat Basketball, Segle XXI Female Basketball Team, Esplugas de Llobregat, Spain.	azaharafv@blanquerna.url.edu	Buscà, Bernat/HDN-9609-2022; Vicens-Bordas, Jordi/AAD-6061-2022	Buscà, Bernat/0000-0002-4831-8224; Aguilera-Castells, Joan/0000-0001-7665-0235; Vicens-Bordas, Jordi/0000-0002-8388-8863; Fort-Vanmeerhaeghe, Azahara/0000-0002-5071-1084; Gonzalo-Skok, Oliver/0000-0002-7679-2062				Atkins SJ, 2016, J STRENGTH COND RES, V30, P1007, DOI 10.1519/JSC.0b013e3182987044; Bailey CA, 2015, INT J SPORT PHYSIOL, V10, P504, DOI 10.1123/ijspp.2014-0379; Bishop C, 2021, J STRENGTH COND RES, V35, P56, DOI 10.1519/JSC.0000000000002544; Bishop C, 2018, STRENGTH COND J, V40, P40, DOI 10.1519/SSC.0000000000000354; Bishop C, 2018, J SPORT SCI, V36, P1135, DOI 10.1080/02640414.2017.1361894; Bishop M, 2019, J IMMUNOTHER CANCER, V7; BOSCO C, 1983, EUR J APPL PHYSIOL O, V50, P273, DOI 10.1007/BF00422166; Carpes FP, 2010, PHYS THER SPORT, V11, P136, DOI 10.1016/j.ptsp.2010.06.005; Cormack SJ, 2008, INTJ SPORT PHYSIOL, V3, P131, DOI 10.1123/ijspp.3.2.131; De Blas X., 2009, ANN M AM COLL SPORTS; de Noronha M, 2006, BRIT J SPORT MED, V40, P824, DOI 10.1136/bjsm.2006.029645; DEBLAS X, 2012, J SPORTS SCI, V8, P334; Dos'Santos T., 2017, J TRAINOL, V6, P35, DOI 10.17338/trainology.6.2_35; Fagan V, 2008, BRIT J SPORT MED, V42, P789, DOI 10.1136/bjsm.2008.046623; Vanmeerhaeghe AF, 2013, APUNTS-MED ESPORT, V48, P109, DOI 10.1016/j.apunts.2013.05.003; Fort-Vanmeerhaeghe A, 2016, STRENGTH COND J, V38, P9, DOI 10.1519/SSC.0000000000000234; Fort-Vanmeerhaeghe A, 2016, STRENGTH COND J, V38, P36, DOI 10.1519/SSC.0000000000000229; Fort-Vanmeerhaeghe A, 2016, J HUM KINET, V50, P135, DOI 10.1515/hukin-2015-0150; Fort-Vanmeerhaeghe A, 2015, PHYS THER SPORT, V16, P317, DOI 10.1016/j.ptsp.2015.01.003; Gonzalo-Skok O, 2015, INT J SPORTS MED, V36, P893, DOI 10.1055/s-0035-1554635; Gonzalo-Skok O, 2019, INT J SPORT PHYSIOL, V14, P1256, DOI 10.1123/ijspp.2018-0920; Gribble PA, 2012, J ATHL TRAINING, V47, P339, DOI 10.4085/1062-6050-47.3.08; Hewett TE, 2006, AM J SPORT MED, V34, P299, DOI 10.1177/0363546505284183; Hewett Timothy E, 2010, N Am J Sports Phys Ther, V5, P234; Hewit JK, 2012, PHYS THER SPORT, V13, P238, DOI 10.1016/j.ptsp.2011.12.003; Hiller CE, 2011, BRIT J SPORT MED, V45, P660, DOI 10.1136/bjsm.2010.077404; Hopkins WG, 2009, MED SCI SPORTS EXERC; Hopkins WG, 2009, MED SCI SPORT EXER, V41, P3, DOI 10.1249/MSS.0b013e31818cb278; Hosea TM, 2000, CLIN ORTHOP RELAT R, P45; Impellizzeri FM, 2007, MED SCI SPORT EXER, V39, P2044, DOI 10.1249/mss.0b013e31814fb55c; Koo TK, 2016, J CHIROPR MED, V15, P155, DOI 10.1016/j.jcm.2016.02.012; Lawson BR, 2006, J STRENGTH COND RES, V20, P608; Lockie RG, 2014, J STRENGTH COND RES, V28, P3557, DOI 10.1519/JSC.0000000000000588; Maloney SJ, 2019, J STRENGTH COND RES, V33, P2579, DOI 10.1519/JSC.0000000000002608; Maloney SJ, 2017, J SPORT SCI, V35, P547, DOI 10.1080/02640414.2016.1179775; Markou S, 2006, EUR J SPORT SCI, V6, P71, DOI 10.1080/17461390500533147; Menzel HJ, 2013, J STRENGTH COND RES, V27, P1370, DOI 10.1519/JSC.0b013e318265a3c8; Meylan C, 2009, J STRENGTH COND RES, V23, P1140, DOI 10.1519/JSC.0b013e318190f9c2; Mirwald RL, 2002, MED SCI SPORT EXER, V34, P689, DOI 10.1097/00005768-200204000-00020; Munro AG, 2010, PHYS THER SPORT, V11, P128, DOI 10.1016/j.ptsp.2010.07.002; Myer GD, 2011, J ORTHOP SPORT PHYS, V41, P377, DOI 10.2519/jospt.2011.3547; NOYES FR, 1991, AM J SPORT MED, V19, P513, DOI 10.1177/036354659101900518; Paterno MV, 2007, CLIN J SPORT MED, V17, P258, DOI 10.1097/JSM.0b013e31804c77ea; Paterno MV, 2010, AM J SPORT MED, V38, P1968, DOI 10.1177/0363546510376053; Plisky PJ, 2006, J ORTHOP SPORT PHYS, V36, P911, DOI 10.2519/jospt.2006.2244; Rahnama N, 2005, ERGONOMICS, V48, P1568, DOI 10.1080/00140130500101585; Read PJ, 2018, PEDIATR EXERC SCI, V30, P168, DOI 10.1123/pes.2017-0081; Romero-Franco N, 2017, EUR J SPORT SCI, V17, P386, DOI 10.1080/17461391.2016.1249031; Schmitt LC, 2012, J ORTHOP SPORT PHYS, V42, P750, DOI 10.2519/jospt.2012.4194; Spencer M, 2005, SPORTS MED, V35, P1025, DOI 10.2165/00007256-200535120-00003; Theoharopoulos A, 2000, J STRENGTH COND RES, V14, P457; Vuurberg G, 2018, BRIT J SPORT MED, V52, P956, DOI 10.1136/bjsports-2017-098106; Webster KE, 2018, J ORTHOP RES, V36, P2696, DOI 10.1002/jor.24043; Young WB, 2002, J SPORT MED PHYS FIT, V42, P282	54	28	28	3	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2020	15	3							e0229440	10.1371/journal.pone.0229440	http://dx.doi.org/10.1371/journal.pone.0229440			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8MS	32126107	gold, Green Published, Green Accepted			2022-12-26	WOS:000535253100024
J	Lin, SF; Tung, SY; Wei, KL; Chen, CH; Hu, TH; Shen, CH; Chang, TS; Chen, WM; Yen, CW; Wang, JH; Hung, CH; Lu, SN				Lin, Sheng Feng; Tung, Shui-Yi; Wei, Kuo-Liang; Chen, Chien-Hung; Hu, Tsung-Hui; Shen, Chien Heng; Chang, Te-Sheng; Chen, Wei-Ming; Yen, Chih-Wei; Wang, Jing-Houng; Hung, Chao-Hung; Lu, Sheng-Nan			Clinical utility of hepatitis C virus core antigen assay in the monitoring of direct-acting antivirals for chronic hepatitis C	PLOS ONE			English	Article							HCV RNA	Background Hepatitis C virus core antigen (HCV Ag) assay has been proposed as a more economical alternative to HCV RNA detection. This study aimed to investigate the clinical utility of HCV Ag assay in the monitoring of direct-acting antivirals (DAAs) for chronic hepatitis C patients. Methods We analyzed serum samples from 110 patients treated with paritaprevir/ritonavir, ombitasvir, and dasabuvir (PrOD) with or without ribavirin. The levels for both HCV Ag and HCV RNA assessed by COBAS TaqMan HCV (CTM) Test or Abbott RealTime HCV (ART) assay were evaluated at baseline, week 2, 4, and 12 during treatment and 12 weeks after completion. Results Baseline HCV Ag levels showed good correlations with HCV viral load (r = 0.879; p< 0.001); whereas the correlation was slightly stronger with CTM test than with ART assay (p = 0.074). The concordance of HCV Ag and HCV RNA undetectability was significantly better in CTM test than in ART assay at week 2 (p = 0.003) and week 4 (p = 0.003). A sustained viral response 12 weeks off therapy (SVR12) was achieved in 108 patients (98%); the HCV Ag assay identified 99% of these patients. Both undetectability of serum HCV Ag and HCV RNA had high positive predictive value at week 2 (98% vs. 100%) and at week 4 (97% vs. 99%) in predicting SVR12. Conclusions HCV Ag assay may be a feasible alternative to HCV RNA for the determination of SVR12 in patients treated with DAAs.	[Lin, Sheng Feng; Tung, Shui-Yi; Wei, Kuo-Liang; Chen, Chien-Hung; Hu, Tsung-Hui; Shen, Chien Heng; Chang, Te-Sheng; Chen, Wei-Ming; Yen, Chih-Wei; Wang, Jing-Houng; Hung, Chao-Hung; Lu, Sheng-Nan] Chiayi Chang Gung Mem Hosp, Div Hepatogastroenterol, Dept Internal Med, Chiayi, Taiwan; [Chen, Chien-Hung; Hu, Tsung-Hui; Wang, Jing-Houng; Hung, Chao-Hung; Lu, Sheng-Nan] Chang Gung Univ, Coll Med, Kaohsiung, Taiwan	Chang Gung Memorial Hospital; Chang Gung University	Hung, CH (corresponding author), Chiayi Chang Gung Mem Hosp, Div Hepatogastroenterol, Dept Internal Med, Chiayi, Taiwan.; Hung, CH (corresponding author), Chang Gung Univ, Coll Med, Kaohsiung, Taiwan.	chh4366@yahoo.com.tw		Chen, Wei-Ming/0000-0002-4949-393X	Chang Gung Memorial Hospital, Taiwan [CMRPG6J00081]	Chang Gung Memorial Hospital, Taiwan(Chang Gung Memorial Hospital)	This study was supported by contract grants CMRPG6J00081 from Chang Gung Memorial Hospital, Taiwan to C-HH. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AASLD-IDSA HCV Guidance Panel, 2018, UPD AASLD IDSA REC T, V67, P1477; Abbott Molecular Inc Package Insert, 2017, ABB REAL TIM HCV; Aghemo A, 2016, CLIN GASTROENTEROL H, V14, P1331, DOI 10.1016/j.cgh.2016.03.035; Blach S, 2017, LANCET GASTROENTEROL, V2, P161, DOI 10.1016/S2468-1253(16)30181-9; Blanchard L, 2017, MICROBIOLOGYOPEN, V6, DOI 10.1002/mbo3.477; Chang C, 2018, KAOHSIUNG J MED SCI, V34, P684, DOI 10.1016/j.kjms.2018.08.002; Chen CH, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-43554-3; Chevaliez S, 2018, ANTIVIR THER, V23, P211, DOI 10.3851/IMP3042; Durante-Mangoni E, 2013, J MED VIROL, V85, P1913, DOI 10.1002/jmv.23672; European Assoc Study Liver, 2018, J HEPATOL, V69, P461, DOI 10.1016/j.jhep.2018.03.026; Freiman JM, 2016, ANN INTERN MED, V165, P345, DOI 10.7326/M16-0065; Heimbach JK, 2018, HEPATOLOGY, V67, P358, DOI 10.1002/hep.29086; Kesli R, 2011, J CLIN MICROBIOL, V49, P4089, DOI 10.1128/JCM.05292-11; Lauer GM, 2001, NEW ENGL J MED, V345, P41, DOI 10.1056/NEJM200107053450107; Nguyen LT, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163900; Loggi E, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0187755; Tillmann HL, 2014, WORLD J GASTROENTERO, V20, P6701, DOI 10.3748/wjg.v20.i22.6701; Vermehren J, 2017, J CLIN VIROL, V89, P51, DOI 10.1016/j.jcv.2017.02.008; Vermehren J, 2012, J CLIN VIROL, V55, P17, DOI 10.1016/j.jcv.2012.05.008; Wang JH, 2019, J FORMOS MED ASS	20	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2020	15	3							e0229994	10.1371/journal.pone.0229994	http://dx.doi.org/10.1371/journal.pone.0229994			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8MS	32126125	gold, Green Published			2022-12-26	WOS:000535253100057
J	Du, F; Li, XW; Feng, WB; Qiao, CY; Chen, J; Jiang, MZ; Qiu, ZY; Qian, MR; Tian, D; Nie, YZ; Fan, DM; Wu, KC; Xia, LM				Du, Feng; Li, Xiaowei; Feng, Weibo; Qiao, Chenyang; Chen, Jie; Jiang, Mingzuo; Qiu, Zhaoyan; Qian, Meirui; Tian, Dean; Nie, Yongzhan; Fan, Daiming; Wu, Kaichun; Xia, Limin			SOX13 promotes colorectal cancer metastasis by transactivating SNAI2 and c-MET	ONCOGENE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; TUMOR-SUPPRESSOR; PANCREATIC-CANCER; EXPRESSION; STEM; CHEMOTHERAPY; PRINCIPLES; CRIZOTINIB; RESISTANCE; REGULATORS	Metastasis is a major cause of high recurrence and poor survival of patients with colorectal cancer (CRC), although the mechanisms associated with this process remain poorly understood. In this study, we report a novel mechanism by which SOX13 promotes CRC metastasis by transactivating SNAI2 and c-MET. SOX13 overexpression was significantly correlated with more aggressive clinicopathological features of CRC and indicated poor prognosis in two independent cohorts of CRC patients (cohort I, n = 363; cohort II, n = 390). Overexpression of SOX13-promoted CRC migration, invasion, and metastasis, whereas SOX13 downregulation caused the opposite effects. Further mechanistic investigation identified SNAI2 and MET as important target genes of SOX13 using serial deletion and site-directed mutagenesis luciferase reporter and chromatin immunoprecipitation (ChIP) assays, as well as functional complementation analyses. In addition, SOX13 was shown to be a direct target of HGF/STAT3 signaling, and the c-MET inhibitor crizotinib blocked the HGF/STAT3/SOX13/c-MET axis, significantly inhibiting SOX13-mediated CRC migration, invasion and metastasis. Moreover, in clinical CRC tissues, SOX13 expression was positively correlated with the expression of SNAI2, c-MET, and HGF. CRC patients with positive coexpression of SOX13/SNAI2, SOX13/c-MET, or HGF/SOX13 exhibited a worse prognosis. In summary, SOX13 is a promising prognostic biomarker in patients with CRC, and blocking the HGF/STAT3/SOX13/c-MET axis with crizotinib could be a new therapeutic strategy to prevent SOX13-mediated CRC metastasis.	[Du, Feng; Tian, Dean; Xia, Limin] Huazhong Univ Sci & Technol, Tongji Hosp, Dept Gastroenterol, Tongji Med Coll, Wuhan 430030, Hubei, Peoples R China; [Du, Feng; Feng, Weibo; Qiao, Chenyang; Chen, Jie; Jiang, Mingzuo; Qian, Meirui; Nie, Yongzhan; Fan, Daiming; Wu, Kaichun; Xia, Limin] Fourth Mil Med Univ, State Key Lab Canc Biol, Natl Clin Res Ctr Digest Dis, Xian 710032, Shaanxi, Peoples R China; [Du, Feng; Feng, Weibo; Qiao, Chenyang; Chen, Jie; Jiang, Mingzuo; Qian, Meirui; Nie, Yongzhan; Fan, Daiming; Wu, Kaichun; Xia, Limin] Fourth Mil Med Univ, Xijing Hosp Digest Dis, Xian 710032, Shaanxi, Peoples R China; [Du, Feng] Chinese People Liberat Army 306th Hosp, Dept Gastroenterol, Beijing, Peoples R China; [Li, Xiaowei] Navy Gen Hosp, Dept Gastroenterol, Beijing 100048, Peoples R China; [Qiu, Zhaoyan] Chinese Peoples Liberat Army Gen Hosp, Dept Gen Surg, Fuxing Rd 28, Beijing 100853, Peoples R China; [Tian, Dean; Xia, Limin] Huazhong Univ Sci & Technol, Tongji Hosp, Inst Liver & Gastrointestinal Dis, Tongji Med Coll, Wuhan 430030, Hubei, Peoples R China	Huazhong University of Science & Technology; Air Force Military Medical University; Air Force Military Medical University; Sixth Medical Center of Chinese PLA General Hospital; Chinese People's Liberation Army General Hospital; Huazhong University of Science & Technology	Xia, LM (corresponding author), Huazhong Univ Sci & Technol, Tongji Hosp, Dept Gastroenterol, Tongji Med Coll, Wuhan 430030, Hubei, Peoples R China.; Xia, LM (corresponding author), Fourth Mil Med Univ, State Key Lab Canc Biol, Natl Clin Res Ctr Digest Dis, Xian 710032, Shaanxi, Peoples R China.; Xia, LM (corresponding author), Fourth Mil Med Univ, Xijing Hosp Digest Dis, Xian 710032, Shaanxi, Peoples R China.; Xia, LM (corresponding author), Huazhong Univ Sci & Technol, Tongji Hosp, Inst Liver & Gastrointestinal Dis, Tongji Med Coll, Wuhan 430030, Hubei, Peoples R China.	xialimin@fmmu.edu.cn			National Key Research and Development Program of China [SQ2017YFSF090132, 2018YFC1312103]; National Natural Science Foundation of China [81972237, 81772623, 81627807, 81430072, 81421003]; National Center for Clinical Research of Digestive Diseases [2015BAI13B07]	National Key Research and Development Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Center for Clinical Research of Digestive Diseases	Research was supported by grants from the National Key Research and Development Program of China 2018YFC1312103 (LX), National Natural Science Foundation of China No. 81972237 (LX), No. 81772623 (LX), No. 81627807 (KW), No.81430072 (DF) and No. 81421003 (KW), National Key Research and Development Program of China SQ2017YFSF090132 (KW), and National Center for Clinical Research of Digestive Diseases 2015BAI13B07 (DF). We also would like to thank Qingling An and Jianhua Dou from the Fourth Military Medical University for providing excellent technical assistance.	Nieto MA, 2016, CELL, V166, P21, DOI 10.1016/j.cell.2016.06.028; Balsas P, 2017, BLOOD, V130, P501, DOI 10.1182/blood-2017-04-776740; Batlle E, 2000, NAT CELL BIOL, V2, P84, DOI 10.1038/35000034; Boumahdi S, 2014, NATURE, V511, P246, DOI 10.1038/nature13305; Du F, 2019, CANCER LETT, V452, P103, DOI 10.1016/j.canlet.2019.03.035; Du F, 2019, CELL DEATH DIS, V10, DOI 10.1038/s41419-019-1481-9; Emaduddin M, 2008, P NATL ACAD SCI USA, V105, P2358, DOI 10.1073/pnas.0712176105; Fakih MG, 2015, J CLIN ONCOL, V33, P1809, DOI 10.1200/JCO.2014.59.7633; Gherardi E, 2012, NAT REV CANCER, V12, P89, DOI 10.1038/nrc3205; Guo WJ, 2012, CELL, V148, P1015, DOI 10.1016/j.cell.2012.02.008; Hu Y, 2018, CLIN EPIGENETICS, V10, DOI 10.1186/s13148-018-0592-y; Huang WJ, 2015, HEPATOLOGY, V61, P1920, DOI 10.1002/hep.27756; Kamachi Y, 2013, DEVELOPMENT, V140, P4129, DOI 10.1242/dev.091793; Lambert AW, 2017, CELL, V168, P670, DOI 10.1016/j.cell.2016.11.037; Larsimont JC, 2015, CELL STEM CELL, V17, P60, DOI 10.1016/j.stem.2015.05.008; Lee SJ, 2018, CLIN COLORECTAL CANC, V17, P165, DOI 10.1016/j.clcc.2018.02.013; Li CW, 2011, GASTROENTEROLOGY, V141, P2218, DOI 10.1053/j.gastro.2011.08.009; Li CX, 2017, P NATL ACAD SCI USA, V114, pE2852, DOI 10.1073/pnas.1618297114; Man CH, 2015, BLOOD, V125, P3928, DOI 10.1182/blood-2014-06-580993; McQuade RM, 2017, CURR MED CHEM, V24, P1537, DOI 10.2174/0929867324666170111152436; Moore AE, 2009, CARCINOGENESIS, V30, P1796, DOI 10.1093/carcin/bgp183; Mu P, 2017, SCIENCE, V355, P84, DOI 10.1126/science.aah4307; Peters S, 2017, NEW ENGL J MED, V377, P829, DOI 10.1056/NEJMoa1704795; Pietrantonio F, 2016, CANCER DISCOV, V6, P963, DOI 10.1158/2159-8290.CD-16-0297; Prior HM, 1996, MOL MED, V2, P405, DOI 10.1007/BF03401900; Sarkar A, 2013, CELL STEM CELL, V12, P15, DOI 10.1016/j.stem.2012.12.007; Shakhova O, 2012, NAT CELL BIOL, V14, P882, DOI 10.1038/ncb2535; Siegel RL, 2018, CA-CANCER J CLIN, V68, P7, DOI 10.3322/caac.21442; Solomon BJ, 2014, NEW ENGL J MED, V371, P2167, DOI [10.1056/NEJMoa1408440, 10.1056/NEJMx150034]; Tchougounova E, 2009, ONCOGENE, V28, P1537, DOI 10.1038/onc.2009.9; Thu KL, 2014, ONCOGENE, V33, P279, DOI 10.1038/onc.2012.595; Tiwari N, 2013, CANCER CELL, V23, P768, DOI 10.1016/j.ccr.2013.04.020; Trusolino L, 2010, NAT REV MOL CELL BIO, V11, P834, DOI 10.1038/nrm3012; Tsao CM, 2012, HEPATOLOGY, V56, P2277, DOI 10.1002/hep.25933; Wegner M, 1999, NUCLEIC ACIDS RES, V27, P1409, DOI 10.1093/nar/27.6.1409; Zarour LR, 2017, CELL MOL GASTROENTER, V3, P163, DOI 10.1016/j.jcmgh.2017.01.006; Zeng ZS, 2008, CANCER LETT, V265, P258, DOI 10.1016/j.canlet.2008.02.049; Zhang R, 2018, EUR REV MED PHARMACO, V22, P6801, DOI 10.26355/eurrev_201810_16146	38	22	22	2	23	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR	2020	39	17					3522	3540		10.1038/s41388-020-1233-4	http://dx.doi.org/10.1038/s41388-020-1233-4		FEB 2020	19	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	LH1YK	32111984				2022-12-26	WOS:000517049100003
J	Allen, TE; Morere, DA				Allen, Thomas E.; Morere, Donna A.			Early visual language skills affect the trajectory of literacy gains over a three-year period of time for preschool aged deaf children who experience signing in the home	PLOS ONE			English	Article							HARD-OF-HEARING; READING-COMPREHENSION; PHONOLOGICAL AWARENESS; ACADEMIC-ACHIEVEMENT; EMERGENT LITERACY; ASL; STUDENTS; WORD; KINDERGARTEN; PREDICTORS	Previous research has established a correlation between literacy skills and sign language skills among deaf children raised in signing families, but little research has examined the impact of early signing skills on the rate of growth of emergent literacy in early childhood. A subset of data was extracted from a larger dataset containing national longitudinal data from a three-year investigation of early literacy development of deaf children who were between the ages of three and six at the outset of the study. Selection criteria for inclusion in this limited sample included: 1) being rated as having little or no access to spoken language and 2) being raised in homes in which signs were regularly used as a means of communication (N = 56). Our purpose was twofold: 1) to examine and describe the trajectories of growth in letter and word identification skill for this sample in relation to the participants' initial ages; and 2) to assess the degree to which the presence or deaf parents in the home (DoD) and the receptive American Sign Language (ASL) skills of the participants impacted both the level of emerging print literacy and its rate of growth over the three year period. We hypothesized that both the presence of a deaf parent in the home and the acquisition of ASL skills, a strong native language, would contribute to both the overall letter and word identification skills and to the rates of growth of this skill over time. Results indicated that having a deaf parent did, indeed, impact emergent literacy attainment, but its effect was rendered nonsignificant when ASL skill was taken into consideration. Possession of stronger ASL skills, whether or not the children had deaf parents, contributed significantly to both the levels and rate of growth. The findings contribute to the body of work that emphasizes the importance early language skills (spoken or signed) to later academic success and dispels the myth that deaf children with deaf parents have exclusive access to the acquisition of these skills.	[Allen, Thomas E.; Morere, Donna A.] Gallaudet Univ, Sci Learning Ctr Visual Language & Visual Learnin, Washington, DC 20002 USA; [Allen, Thomas E.] Gallaudet Univ, PhD Educ Neurosci Program, Washington, DC 20002 USA; [Morere, Donna A.] Gallaudet Univ, Dept Psychol, Washington, DC 20002 USA		Allen, TE (corresponding author), Gallaudet Univ, Sci Learning Ctr Visual Language & Visual Learnin, Washington, DC 20002 USA.; Allen, TE (corresponding author), Gallaudet Univ, PhD Educ Neurosci Program, Washington, DC 20002 USA.	thomas.allen@gallaudet.edu		Allen, Thomas/0000-0002-1545-8853	National Science Foundation Science of Learning Center Program under Gallaudet University [SBE-0541953, SBE-1041725]	National Science Foundation Science of Learning Center Program under Gallaudet University	Support was provided by the National Science Foundation Science of Learning Center Program under Cooperative Agreements with Gallaudet University, SBE-0541953 (TEA, Principal Investigator) and SBE-1041725 (TEA and Laura Ann Petitto, Co-Principal Investigators). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adlof SM, 2010, J LEARN DISABIL-US, V43, P332, DOI 10.1177/0022219410369067; Allen T., 1986, DEAF CHILDREN AM, P161, DOI DOI 10.1177/15257401050270010201; Allen T., 2012, ASSESSING LITERACY D, P231; Allen T, 2014, VL2 EARLY ED LONGITU; Allen TE, 2013, SIGN LANG STUD, V14, P233; Allen TE, 2015, SIGN LANG STUD, V15, P233, DOI 10.1353/sls.2015.0006; Allen TE, 2014, AM ANN DEAF, V159, P346, DOI 10.1353/aad.2014.0030; Andrews J. F., 2016, PSYCHOLOGY, V7, P510, DOI [10.4236/psych.2016.74052, DOI 10.4236/PSYCH.2016.74052]; Chamberlain C, 2008, APPL PSYCHOLINGUIST, V29, P367, DOI 10.1017/S014271640808017X; Colin S, 2007, J CHILD PSYCHOL PSYC, V48, P139, DOI 10.1111/j.1469-7610.2006.01700.x; DeLana M, 2007, AM ANN DEAF, V152, P73, DOI 10.1353/aad.2007.0010; Dickinson DK, 2010, EDUC RESEARCHER, V39, P305, DOI 10.3102/0013189X10370204; Easterbrooks SR, 2008, VOLTA REV, V108, P91; Enns CJ, 2011, J DEAF STUD DEAF EDU, V16, P362, DOI 10.1093/deafed/enr004; Fernald A, 2013, DEVELOPMENTAL SCI, V16, P234, DOI 10.1111/desc.12019; Gallaudet Research Institute, 2011, REG NAT SUMM REP DAT; Goldin-Meadow S, 2014, AM PSYCHOL, V69, P588, DOI 10.1037/a0036886; Hall ML, 2019, DEAF CHILDREN NEED L; Harris M, 1998, J Deaf Stud Deaf Educ, V3, P205; Harris M, 2017, J DEAF STUD DEAF EDU, V22, P233, DOI 10.1093/deafed/enw101; Hoffmeister R, 1997, P DEAF STUD 5 C; Hoffmeister RJ, 2014, COGNITION, V132, P229, DOI 10.1016/j.cognition.2014.03.014; Holmer E, 2016, RES DEV DISABIL, V48, P145, DOI 10.1016/j.ridd.2015.10.008; Hrastinski I, 2016, J DEAF STUD DEAF EDU, V21, P156, DOI 10.1093/deafed/env072; Jaffe L. E., 2009, WOODCOCK JOHNSON 3 A, V11; Kyle FE, 2011, J DEAF STUD DEAF EDU, V16, P289, DOI 10.1093/deafed/enq069; Kyle FE, 2010, J EXP CHILD PSYCHOL, V107, P229, DOI 10.1016/j.jecp.2010.04.011; Lederberg AR, 2019, J DEAF STUD DEAF EDU, V24, P408, DOI 10.1093/deafed/enz011; Lederberg AR, 2013, DEV PSYCHOL, V49, P15, DOI 10.1037/a0029558; Mayberry RI, 2011, J DEAF STUD DEAF EDU, V16, P164, DOI 10.1093/deafed/enq049; MAYBERRY RI, 1991, J MEM LANG, V30, P486, DOI 10.1016/0749-596X(91)90018-F; Mayer C, 2007, J DEAF STUD DEAF EDU, V12, P411, DOI 10.1093/deafed/enm020; McGrew KS, 2014, TECHNICAL MANUAL; McQuarrie L, 2013, SIGN LANG STUD, V14, P80, DOI 10.1353/sls.2013.0028; Moats L., 2009, LANGUAGE ESSENTIALS; Moreno-Perez FJ, 2015, J DEAF STUD DEAF EDU, V20, P374, DOI 10.1093/deafed/env030; National Reading Panel (U.S.) & National Institute of Child Health and Human Development (U.S.) ., 2000, REP NAT READ PAN TEA; Novogrodsky R, 2014, SIGN LANG STUD, V14, P225, DOI 10.1353/sls.2014.0003; Novogrodsky R, 2014, LANG LEARN, V64, P749, DOI 10.1111/lang.12078; Petitto LA, 2016, WIRES COGN SCI, V7, P366, DOI 10.1002/wcs.1404; Petitto LA, 2000, SIGNS OF LANGUAGE REVISITED, P449; Prinz PM, 1998, TOP LANG DISORD, V18, P47; Qi S, 2012, J DEAF STUD DEAF EDU, V17, P1, DOI 10.1093/deafed/enr028; Raver CC, 1996, DEV PSYCHOL, V32, P850, DOI 10.1037/0012-1649.32.5.850; Schrank F. A., 2001, WOODCOCK JOHNSON 3 A, V2; Scott JA, 2017, J DEAF STUD DEAF EDU, V22, P59, DOI 10.1093/deafed/enw065; Singer J.D., 2003, APPL LONGITUDINAL DA, DOI 10.1093/acprof:oso/9780195152968.001.0001; Singleton JL, 1998, TOP LANG DISORD, V18, P16; Stone A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139610; Strong M, 2000, LANGUAGE ACQUISITION BY EYE, P131; Wauters LN, 2006, READ WRIT, V19, P49, DOI 10.1007/s11145-004-5894-0; Wilbur R B, 2000, J Deaf Stud Deaf Educ, V5, P81, DOI 10.1093/deafed/5.1.81; Woodcock R.W., 2001, WOODCOCK JOHNSON 3 N; Woodcock R.W., 2007, INT J NEUROSCI, DOI DOI 10.1080/00207450500535453; Worsfold S, 2018, RES DEV DISABIL, V77, P49, DOI 10.1016/j.ridd.2018.04.007	55	8	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2020	15	2							e0229591	10.1371/journal.pone.0229591	http://dx.doi.org/10.1371/journal.pone.0229591			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LQ8GQ	32106252	Green Published, gold			2022-12-26	WOS:000535237000047
J	Huibers, MHW; Calis, JC; Allain, TJ; Coupland, SE; Phiri, C; Phiri, KS; Swinkels, DW; van Hensbroek, MB; Bates, I				Huibers, Minke H. W.; Calis, Job C.; Allain, Theresa J.; Coupland, Sarah E.; Phiri, Chimota; Phiri, Kamija S.; Swinkels, Dorine W.; van Hensbroek, Michael Boele; Bates, Imelda			A possible role for hepcidin in the detection of iron deficiency in severely anaemic HIV-infected patients in Malawi	PLOS ONE			English	Article							SOLUBLE TRANSFERRIN RECEPTOR; SERUM HEPCIDIN; BONE-MARROW; FERRITIN; SUPPLEMENTATION; INFLAMMATION; MORTALITY; DIAGNOSIS; CHILDREN; ADULTS	Introduction Iron deficiency is a treatable cause of severe anaemia in low-and-middle-income-countries (LMIC). Diagnosing it remains challenging as peripheral blood markers poorly reflect bone-marrow iron deficiency (BM-ID), especially in the context of HIV-infection. Methods Severely anaemic (haemoglobin.70g/l) HIV-infected adults were recruited at Queen Elizabeth Central Hospital, Blantyre, Malawi. BM-ID was evaluated. Accuracy of blood markers (including hepcidin, mean corpuscular volume, mean cellular haemoglobin concentration, serum iron, serum ferritin, soluble transferrin receptor (sTfR), sTfR index, sTfR-ratio) to detect BM-ID was evaluated by ROC area under the curve (AUC(ROC)). Results Seventy-three patients were enrolled and 35 (48.0%) had BM-ID. Although hepcidin and MCV performed best (AUC(ROC) of 0.593 and 0.545 respectively) all markers performed poorly in identifying BM-ID (ROC<0.6). The AUC(ROC) of hepcidin in males was 0.767 (sensitivity 80%, specificity 78%) and in women 0.490 (sensitivity 60%, specificity 61%). Conclusion BM-ID deficiency was common in severely anaemic HIV-infected patients. It is an important and potential treatable contributor to severe anaemia but lack of definitive biomarkers makes it difficult to accurately assess iron status in these patients. Further investigation of the potential of hepcidin is needed, including exploration of the differences in hepcidin results between males and females.	[Huibers, Minke H. W.; Calis, Job C.; van Hensbroek, Michael Boele] Univ Amsterdam, Amsterdam Univ Med Ctr, Emma Childrens Hosp, Global Child Hlth Grp, Amsterdam, Netherlands; [Huibers, Minke H. W.; van Hensbroek, Michael Boele] Amsterdam Inst Global Hlth Dev AIGHD, Amsterdam, Netherlands; [Calis, Job C.] Univ Amsterdam, Amsterdam Univ Med Ctr, Emma Childrens Hosp, Dept Pediat Intens Care, Amsterdam, Netherlands; [Calis, Job C.] Queen Elizabeth Cent Hosp, Coll Med, Dept Paediat, Blantyre, Malawi; [Allain, Theresa J.; Bates, Imelda] Univ Liverpool Liverpool Sch Trop Med, Liverpool, Merseyside, England; [Allain, Theresa J.; Phiri, Chimota] Queen Elizabeth Cent Hosp, Coll Med, Dept Internal Med, Blantyre, Malawi; [Coupland, Sarah E.] Univ Liverpool, Dept Mol & Clin Canc Med, Pathol, Liverpool, Merseyside, England; [Coupland, Sarah E.] Royal Liverpool Univ Hosp, Dept Pathol, Liverpool Clin Labs, Liverpool, Merseyside, England; [Phiri, Kamija S.] Coll Med, Sch Publ Hlth & Family Med, Blantyre, Malawi; [Swinkels, Dorine W.] Radboud Univ Nijmegen, Dept Lab Med, Med Ctr, Nijmegen, Netherlands; [Swinkels, Dorine W.] Hepcidinanal Com, Nijmegen, Netherlands	Emma Children's Hospital; University of Amsterdam; Emma Children's Hospital; University of Amsterdam; University of Malawi; Liverpool School of Tropical Medicine; University of Malawi; University of Liverpool; Royal Liverpool & Broadgreen University Hospitals NHS Trust; Royal Liverpool University Hospital; University of Liverpool; University of Malawi; Radboud University Nijmegen	Huibers, MHW (corresponding author), Univ Amsterdam, Amsterdam Univ Med Ctr, Emma Childrens Hosp, Global Child Hlth Grp, Amsterdam, Netherlands.; Huibers, MHW (corresponding author), Amsterdam Inst Global Hlth Dev AIGHD, Amsterdam, Netherlands.	mhw.huibers@gmail.com		huibers, minke/0000-0003-0310-3067; Boele van Hensbroek, Michael/0000-0003-1907-5427	Wellcome Trust, Liverpool, United Kingdom [WT086559]; Nutricia research foundation [2017-43]; Nutricia research foundation, The Hague, the Netherlands [2017-43]	Wellcome Trust, Liverpool, United Kingdom; Nutricia research foundation(Danone Nutricia); Nutricia research foundation, The Hague, the Netherlands(Danone Nutricia)	This study was funded by the Wellcome Trust fund Project number: WT086559, Liverpool, United Kingdom, which was awarded to Dr. Steve Mckew, who was supervised by IB. Dr. Steve Mckew is not a listed author. Data collection and laboratory testing were paid under this grant. The funder had no additional role in study design, analysis, decision to publish, or preparation of the manuscript. MWHH received the Nutricia research foundation; Project number 2017-43. The Hague, The Netherlands grant. All other authors were funded by there own institutions. DWS is a paid employee of Radboud UMC, which offers hepcidin measurements via Hepcidinanalysis.com at a fee for service basis. Hepcidinanalysis.com' did not play any role in the study design, data collection.; The authors would like to thank all of the study participants, doctors, nurses and support staff of Queens Elizabeth Hospital and the Malawi-Liverpool-Wellcome centre in Blantyre for their participation and cooperation. This study was supported by the Nutricia research foundation Project number 2017-43), The Hague, the Netherlands and the Wellcome Trust (Project number WT086559), Liverpool, United Kingdom. The funders had no role in the study design, data collection and analysis, decision to publish or preparation of the manuscript. Dorine W. Swinkels is an employee of Radboud UMC that offers high quality hepcidin measurements via Hepcidinanalysis.com at a fee for service basis. 'Hepcidinanalysis.com' did not play any role in the study design, or data collection or analysis.	Aguilar R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050584; [Anonymous], 1996, SIGNAL DETECTION THE, P94; Bain BJ, 2001, J CLIN PATHOL, V54, P737, DOI 10.1136/jcp.54.10.737; Bain BJ, 2001, J CLIN PATHOL, V54, P657, DOI 10.1136/jcp.54.9.657; Bates I., 2018, PRACTICAL HEMATOLOGY; Bewick V, 2004, CRIT CARE, V8, P508, DOI 10.1186/cc3000; Butensky E, 2004, J ASSOC NURSE AIDS C, V15, P31, DOI 10.1177/1055329004271125; Calis JCJ, 2008, NEW ENGL J MED, V358, P888, DOI 10.1056/NEJMoa072727; D'Angelo G, 2013, BLOOD RES, V48, P10, DOI 10.5045/br.2013.48.1.10; de Mast Q, 2010, HAEMATOL-HEMATOL J, V95, P1068, DOI 10.3324/haematol.2009.019331; Diepeveen LE, 2018, CLIN CHEM LAB MED; Esan MO, 2013, CLIN INFECT DIS, V57, P1626, DOI 10.1093/cid/cit528; Esan MO, 2012, T ROY SOC TROP MED H, V106, P579, DOI 10.1016/j.trstmh.2012.07.002; FINCH CA, 1982, NEW ENGL J MED, V307, P1702, DOI 10.1056/NEJM198212303072709; Frosch AEP, 2018, AM J TROP MED HYG, V99, P439, DOI 10.4269/ajtmh.18-0208; GALE E, 1963, J CLIN INVEST, V42, P1076, DOI 10.1172/JCI104793; Galesloot TE, 2011, BLOOD, V117, pE218, DOI 10.1182/blood-2011-02-337907; Haider BA, 2019, AM J TROP MED HYG, V100, P1512, DOI 10.4269/ajtmh.18-0096; Hugman A, 2006, CLIN LAB HAEMATOL, V28, P75, DOI 10.1111/j.1365-2257.2006.00768.x; Jonker FAM, 2014, J CLIN PATHOL, V67, P717, DOI 10.1136/jclinpath-2014-202291; Jonker FAM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078964; Kagu M B, 2007, Afr J Med Med Sci, V36, P125; Kassebaum NJ, 2014, LANCET, V384, P2209, DOI 10.1016/S0140-6736(14)62425-9; Klassen M K, 1997, Ann Diagn Pathol, V1, P57, DOI 10.1016/S1092-9134(97)80009-3; Kroot JJC, 2011, CLIN CHEM, V57, P1650, DOI 10.1373/clinchem.2009.140053; Kroot JJC, 2010, CLIN CHEM, V56, P1570, DOI 10.1373/clinchem.2010.149187; Lewis DK, 2007, T ROY SOC TROP MED H, V101, P613, DOI 10.1016/j.trstmh.2006.11.004; Lewis DK, 2005, T ROY SOC TROP MED H, V99, P561, DOI 10.1016/j.trstmh.2005.01.002; Lopez A, 2016, LANCET, V387, P907, DOI 10.1016/S0140-6736(15)60865-0; Marti-Carvajal AJ, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004776.pub3; METZ CE, 1978, SEMIN NUCL MED, V8, P283, DOI 10.1016/S0001-2998(78)80014-2; Ministry of Health Malawi, 2010, TREATMENT AIDS GUIDE; Nel E, 2015, MATERN CHILD NUTR, V11, P221, DOI 10.1111/mcn.12175; Odunukwe NN, 2000, TROP MED INT HEALTH, V5, P582, DOI 10.1046/j.1365-3156.2000.00601.x; Pasricha SR, 2018, BMJ-BRIT MED J, V362, DOI 10.1136/bmj.k3165; Pasricha SR, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008249; Pasricha SR, 2011, HAEMATOL-HEMATOL J, V96, P1099, DOI 10.3324/haematol.2010.037960; Prentice AM, 2012, BLOOD, V119, P1922, DOI 10.1182/blood-2011-11-391219; Rabindrakumar Miruna Sudharshani Kalaimani, 2018, BMC Hematol, V18, P37, DOI 10.1186/s12878-018-0131-2; Rimon E, 2002, ARCH INTERN MED, V162, P445, DOI 10.1001/archinte.162.4.445; Rohner F, 2017, AM J CLIN NUTR, V106, p372S, DOI 10.3945/ajcn.116.142232; Sazawal S, 2006, LANCET, V367, P133, DOI 10.1016/S0140-6736(06)67962-2; Skikne BS, 2011, AM J HEMATOL, V86, P923, DOI 10.1002/ajh.22108; Suchdev PS, 2017, AM J CLIN NUTR, V106, p1626S, DOI 10.3945/ajcn.117.155937; Suominen P, 1997, CLIN CHEM, V43, P1641; Swinkels DW, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002706; van der Vorm LN, 2016, CLIN CHEM, V62, P993, DOI 10.1373/clinchem.2016.256768; Volberding Paul A, 2004, Clin Infect Dis, V38, P1454, DOI 10.1086/383031; Wisaksana R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079904	49	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2020	15	2							e0218694	10.1371/journal.pone.0218694	http://dx.doi.org/10.1371/journal.pone.0218694			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8GQ	32107492	gold, Green Published, Green Accepted			2022-12-26	WOS:000535237000003
J	Kasiri, S; Chen, BZ; Wilson, AN; Reczek, A; Mazambani, S; Gadhvi, J; Noel, E; Marriam, U; Mino, B; Lu, W; Girard, L; Solis, LM; Luby-Phelps, K; Bishop, J; Kim, JW; Kim, J				Kasiri, Sahba; Chen, Baozhi; Wilson, Alexandra N.; Reczek, Annika; Mazambani, Simbarashe; Gadhvi, Jashkaran; Noel, Evan; Marriam, Ummay; Mino, Barbara; Lu, Wei; Girard, Luc; Solis, Luisa M.; Luby-Phelps, Katherine; Bishop, Justin; Kim, Jung-Whan; Kim, James			Stromal Hedgehog pathway activation by IHH suppresses lung adenocarcinoma growth and metastasis by limiting reactive oxygen species	ONCOGENE			English	Article							MITOCHONDRIAL COMPLEX-III; MOTOR-NEURON INDUCTION; SONIC-HEDGEHOG; OXIDATIVE STRESS; FLOOR PLATE; MOUSE MODEL; CANCER; ANGIOGENESIS; PROGRESSION; MUTATIONS	Activation of the Hedgehog (Hh) signaling pathway by mutations within its components drives the growth of several cancers. However, the role of Hh pathway activation in lung cancers has been controversial. Here, we demonstrate that the canonical Hh signaling pathway is activated in lung stroma by Hh ligands secreted from transformed lung epithelia. Genetic deletion of Shh, the primary Hh ligand expressed in the lung, in Kras(G12D/+);Trp53(fl/fl) autochthonous murine lung adenocarcinoma had no effect on survival. Early abrogation of the pathway by an anti-SHH/IHH antibody 5E1 led to significantly worse survival with increased tumor and metastatic burden. Loss of IHH, another Hh ligand, by in vivo CRISPR led to more aggressive tumor growth suggesting that IHH, rather than SHH, activates the pathway in stroma to drive its tumor suppressive effects-a novel role for IHH in the lung. Tumors from mice treated with 5E1 had decreased blood vessel density and increased DNA damage suggestive of reactive oxygen species (ROS) activity. Treatment of Kras(G12D/+);Trp53(fl/fl) mice with 5E1 and N-acetylcysteine, as a ROS scavenger, decreased tumor DNA damage, inhibited tumor growth and prolonged mouse survival. Thus, IHH induces stromal activation of the canonical Hh signaling pathway to suppress tumor growth and metastases, in part, by limiting ROS activity.	[Kasiri, Sahba; Chen, Baozhi; Wilson, Alexandra N.; Reczek, Annika; Noel, Evan; Marriam, Ummay; Girard, Luc; Kim, James] Nancy B & Jake L Hamon Ctr Therapeut Oncol Res, Dallas, TX 75390 USA; [Kasiri, Sahba; Chen, Baozhi; Wilson, Alexandra N.; Reczek, Annika; Noel, Evan; Marriam, Ummay; Girard, Luc; Kim, James] Harold C Simmons Comprehens Canc Ctr, Dallas, TX 75390 USA; [Mazambani, Simbarashe; Gadhvi, Jashkaran; Kim, Jung-Whan] Univ Texas Dallas, Dept Biol Sci, Richardson, TX 75080 USA; [Mino, Barbara; Lu, Wei; Solis, Luisa M.] Univ Texas MD Anderson Canc Ctr, Dept Translat Mol Pathol, Houston, TX 77030 USA; [Luby-Phelps, Katherine] Univ Texas Southwestern Med Ctr Dallas, Dept Cell Biol, Dallas, TX 75390 USA; [Bishop, Justin] Univ Texas Southwestern Med Ctr Dallas, Dept Pathol, Dallas, TX 75390 USA; [Kim, James] Univ Texas Southwestern Med Ctr Dallas, Dept Internal Med, Dallas, TX 75390 USA	University of Texas System; University of Texas Dallas; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Kim, J (corresponding author), Nancy B & Jake L Hamon Ctr Therapeut Oncol Res, Dallas, TX 75390 USA.; Kim, J (corresponding author), Harold C Simmons Comprehens Canc Ctr, Dallas, TX 75390 USA.; Kim, J (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Dept Internal Med, Dallas, TX 75390 USA.	james.kim@utsouthwestern.edu		Luby-Phelps, Katherine/0000-0002-8378-1409; Mazambani, Simbarashe/0000-0002-6554-7889; Gadhvi, Jashkaran/0000-0002-9522-8053	National Cancer Institute [P50CA70907, R01CA196851, R21 CA208746]; National Heart, Lung, and Blood Institute [5T32HL098040]; American Cancer Society [RSG-16-090-01-TBG]; American Lung Association [LCD-400239]; Sidney Kimmel Foundation for Cancer Research [SKF-14-057]; Lung Cancer Research Foundation; Bonnie J. Addario Lung Cancer Foundation	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); American Cancer Society(American Cancer Society); American Lung Association; Sidney Kimmel Foundation for Cancer Research; Lung Cancer Research Foundation; Bonnie J. Addario Lung Cancer Foundation	We thank Dr John D. Minna for valuable discussions, Drs Rolf Brekken and David Wang for their helpful comments on the manuscript, Nicolas Loof, Kim Nguyen, and Terry Shih of the Moody Foundation Flow Cytometry Core Facility for assistance with FACS, and Denise Ramirez of the Whole Brain Microscopy Facility. We also thank John Shelton at UTSW HistoPathology Core and Dr Cheryl Lewis at UTSW Tissue Management Core for assistance with tissue processing and embedding. This work was supported in part by the National Cancer Institute (P50CA70907: JK; R01CA196851: JK; R21 CA208746: J-WK), National Heart, Lung, and Blood Institute (5T32HL098040 to SK), American Cancer Society (RSG-16-090-01-TBG: JK), American Lung Association (LCD-400239: J-WK), Sidney Kimmel Foundation for Cancer Research (SKF-14-057: JK), Lung Cancer Research Foundation (JK) and Bonnie J. Addario Lung Cancer Foundation (J.K.).	Aavikko M, 2012, AM J HUM GENET, V91, P520, DOI 10.1016/j.ajhg.2012.07.015; Administration USFaD, 2015, SON; Administration USFaD, 2018, FDA APPR NEW TREATM; Axelson M, 2013, CLIN CANCER RES, V19, P2289, DOI 10.1158/1078-0432.CCR-12-1956; Bai CB, 2002, DEVELOPMENT, V129, P4753; Barreto DC, 2000, J DENT RES, V79, P1418, DOI 10.1177/00220345000790061101; Belani CP, 2013, J CLIN ONCOL S, V31, P7508, DOI DOI 10.1200/JCO.2013.31.15_SUPPL.7508; Bell EL, 2007, J CELL BIOL, V177, P1029, DOI 10.1083/jcb.200609074; Bermudez O, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063226; Brastianos PK, 2013, NAT GENET, V45, P285, DOI 10.1038/ng.2526; Buglino JA, 2008, J BIOL CHEM, V283, P22076, DOI 10.1074/jbc.M803901200; Byrd N, 2002, DEVELOPMENT, V129, P361; Cancer Genome Atlas Research Network, 2014, Nature, V511, P543, DOI [10.1038/s41586-018-0228-6, 10.1038/nature13385]; Cha YJ, 2017, TRANSL LUNG CANCER R, V6, P508, DOI 10.21037/tlcr.2017.06.10; Chandel NS, 2000, J BIOL CHEM, V275, P25130, DOI 10.1074/jbc.M001914200; Chen JK, 2002, GENE DEV, V16, P2743, DOI 10.1101/gad.1025302; Clark VE, 2013, SCIENCE, V339, P1077, DOI 10.1126/science.1233009; Colnot C, 2005, DEVELOPMENT, V132, P1057, DOI 10.1242/dev.01649; Di Mauro C, 2017, BRIT J CANCER, V116, P1425, DOI 10.1038/bjc.2017.116; DuPage M, 2009, NAT PROTOC, V4, P1064, DOI 10.1038/nprot.2009.95; ECHELARD Y, 1993, CELL, V75, P1417, DOI 10.1016/0092-8674(93)90627-3; Epstein EH, 2008, NAT REV CANCER, V8, P743, DOI 10.1038/nrc2503; Ericson J, 1996, CELL, V87, P661, DOI 10.1016/S0092-8674(00)81386-0; Eser S, 2013, CANCER CELL, V23, P406, DOI 10.1016/j.ccr.2013.01.023; Gerling M, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12321; Guzy RD, 2005, CELL METAB, V1, P401, DOI 10.1016/j.cmet.2005.05.001; Gyorffy B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082241; Jackson EL, 2005, CANCER RES, V65, P10280, DOI 10.1158/0008-5472.CAN-05-2193; Jackson EL, 2001, GENE DEV, V15, P3243, DOI 10.1101/gad.943001; Jonkers J, 2001, NAT GENET, V29, P418, DOI 10.1038/ng747; Justilien V, 2014, CANCER CELL, V25, P139, DOI 10.1016/j.ccr.2014.01.008; Kasiri S, 2017, CANCER RES, V77, P4448, DOI 10.1158/0008-5472.CAN-16-3315; Kim CFB, 2005, CELL, V121, P823, DOI 10.1016/j.cell.2005.03.032; Kugler MC, 2015, AM J RESP CELL MOL, V52, P1, DOI 10.1165/rcmb.2014-0132TR; Lauth M, 2010, NAT STRUCT MOL BIOL, V17, P718, DOI 10.1038/nsmb.1833; Lee JJ, 2016, P NATL ACAD SCI USA, V113, pE7545, DOI 10.1073/pnas.1616447113; Lee JJ, 2014, P NATL ACAD SCI USA, V111, pE3091, DOI 10.1073/pnas.1411679111; Lee SR, 2002, J BIOL CHEM, V277, P20336, DOI 10.1074/jbc.M111899200; Lewis PM, 2001, CELL, V105, P599, DOI 10.1016/S0092-8674(01)00369-5; Li W, 2016, CANCER INVEST, V34, P424, DOI 10.1080/07357907.2016.1227442; Li ZX, 2006, FEBS LETT, V580, P6161, DOI 10.1016/j.febslet.2006.10.016; Liou GY, 2016, CELL REP, V14, P2325, DOI 10.1016/j.celrep.2016.02.029; Maity T, 2005, P NATL ACAD SCI USA, V102, P17026, DOI 10.1073/pnas.0507848102; MARTI E, 1995, DEVELOPMENT, V121, P2537; Mathew E, 2014, CELL REP, V9, P484, DOI 10.1016/j.celrep.2014.09.010; Maun HR, 2010, J BIOL CHEM, V285, P26570, DOI 10.1074/jbc.M110.112284; Morrisey EE, 2010, DEV CELL, V18, P8, DOI 10.1016/j.devcel.2009.12.010; Munchhof MJ, 2012, ACS MED CHEM LETT, V3, P106, DOI 10.1021/ml2002423; Muzumdar MD, 2007, GENESIS, V45, P593, DOI 10.1002/dvg.20335; National Cancer Institute Surveillance E and End Results Program, CANC STAT FACTS LUNG; Paladini RD, 2005, J INVEST DERMATOL, V125, P638, DOI 10.1111/j.0022-202X.2005.23867.x; Pan SF, 2010, ACS MED CHEM LETT, V1, P130, DOI 10.1021/ml1000307; Park KS, 2011, NAT MED, V17, P1504, DOI 10.1038/nm.2473; Po A, 2017, ONCOGENE, V36, P4641, DOI 10.1038/onc.2017.91; Pola R, 2001, NAT MED, V7, P706, DOI 10.1038/89083; Reczek CR, 2017, ANNU REV CANC BIOL, V1, P79, DOI 10.1146/annurev-cancerbio-041916-065808; Rhim AD, 2014, CANCER CELL, V25, P735, DOI 10.1016/j.ccr.2014.04.021; Robarge KD, 2009, BIOORG MED CHEM LETT, V19, P5576, DOI 10.1016/j.bmcl.2009.08.049; ROELINK H, 1995, CELL, V81, P445, DOI 10.1016/0092-8674(95)90397-6; ROELINK H, 1994, CELL, V76, P761, DOI 10.1016/0092-8674(94)90514-2; Sabharwal SS, 2014, NAT REV CANCER, V14, P709, DOI 10.1038/nrc3803; SAFFORD SE, 1994, CANCER RES, V54, P4261; Samudrala P, 2017, PROC SPIE, V10147, DOI 10.1117/12.2258137; Sanchez-Rivera FJ, 2014, NATURE, V516, P428, DOI 10.1038/nature13906; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Shimada Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070995; Shin K, 2014, CANCER CELL, V26, P521, DOI 10.1016/j.ccell.2014.09.001; Shin K, 2014, NAT CELL BIOL, V16, P469, DOI 10.1038/ncb2956; Siegel RL, 2016, CA-CANCER J CLIN, V66, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; STCLAIR DK, 1992, MOL CARCINOGEN, V6, P238, DOI 10.1002/mc.2940060404; Sweeney RT, 2014, NAT GENET, V46, P722, DOI 10.1038/ng.2986; Szczepny A, 2017, ONCOGENE, V36, P5544, DOI 10.1038/onc.2017.173; Taipale J, 2000, NATURE, V406, P1005, DOI 10.1038/35023008; Tanaka T, 2006, CELL CYCLE, V5, P2671, DOI 10.4161/cc.5.22.3472; Theunissen JW, 2009, CANCER RES, V69, P6007, DOI 10.1158/0008-5472.CAN-09-0756; Toftgard R, 2000, CELL MOL LIFE SCI, V57, P1720, DOI 10.1007/PL00000654; Varjosalo M, 2008, GENE DEV, V22, P2454, DOI 10.1101/gad.1693608; Wang LC, 2000, J INVEST DERMATOL, V114, P901, DOI 10.1046/j.1523-1747.2000.00951.x; Weinberg F, 2010, P NATL ACAD SCI USA, V107, P8788, DOI 10.1073/pnas.1003428107; Wiel C, 2019, CELL, V178, P330, DOI 10.1016/j.cell.2019.06.005; Yang ZH, 2017, DIS MODEL MECH, V10, P39, DOI 10.1242/dmm.027417	83	8	8	2	7	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 16	2020	39	16					3258	3275		10.1038/s41388-020-1224-5	http://dx.doi.org/10.1038/s41388-020-1224-5		FEB 2020	18	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	QF9OJ	32108165	Green Accepted, hybrid, Green Submitted, Green Published			2022-12-26	WOS:000516891300002
J	Niizato, T; Sakamoto, K; Mototake, Y; Murakami, H; Tomaru, T; Hoshika, T; Fukushima, T				Niizato, Takayuki; Sakamoto, Kotaro; Mototake, Yoh-ichi; Murakami, Hisashi; Tomaru, Takenori; Hoshika, Tomotaro; Fukushima, Toshiki			Finding continuity and discontinuity in fish schools via integrated information theory	PLOS ONE			English	Article							COLLECTIVE BEHAVIOR; DYNAMICS; SYSTEMS; LEADERSHIP; CONSENSUS; MOTION; FLOCKS; SPEED	Collective behaviours are known to be the result of diverse dynamics and are sometimes likened to living systems. Although many studies have revealed the dynamics of various collective behaviours, their main focus has been on the information processing performed by the collective, not on interactions within the collective. For example, the qualitative difference between three and four elements in a system has rarely been investigated. Tononi et al. proposed integrated information theory (IIT) to measure the degree of consciousness phi. IIT postulates that the amount of information loss caused by the minimum information partition is equivalent to the degree of information integration in the system. This measure is not only useful for estimating the degree of consciousness but can also be applied to more general network systems. Here, we obtained two main results from the application of IIT (in particular, IIT 3.0) to the analysis of real fish schools (Plecoglossus altivelis). First, we observed that the discontinuity on <phi(N)> distributions emerges for a school of four or more fish. This transition was not observed by measuring the mutual information or the sum of the transfer entropy. We also analysed the IIT on Boids simulations with respect to different coupling strengths; however, the results of the Boids model were found to be quite different from those of real fish. Second, we found a correlation between this discontinuity and the emergence of leadership. We discriminate leadership in this paper from its traditional meaning (e.g. defined by transfer entropy) because IIT-induced leadership refers not to group behaviour, as in other methods, but the degree of autonomy (i.e. group integrity). These results suggest that integrated information phi can reveal the emergence of a new type of leadership which cannot be observed using other measures.	[Niizato, Takayuki; Hoshika, Tomotaro; Fukushima, Toshiki] Univ Tsukuba, Fac Engn Informat & Syst, Ibaraki, Japan; [Sakamoto, Kotaro] Univ Tsukuba, Leading Grad Sch Doctoral Program Human Biol, Tsukuba, Ibaraki, Japan; [Mototake, Yoh-ichi] Inst Stat Math, Tachikawa, Tokyo, Japan; [Murakami, Hisashi] Univ Tokyo, Res Ctr Adv Sci & Technol, Tokyo, Japan; [Tomaru, Takenori] Toyohashi Univ Technol, Dept Comp Sci & Engn, Toyohashi, Aichi, Japan	University of Tsukuba; University of Tsukuba; Research Organization of Information & Systems (ROIS); Institute of Statistical Mathematics (ISM) - Japan; University of Tokyo; Toyohashi University of Technology	Niizato, T (corresponding author), Univ Tsukuba, Fac Engn Informat & Syst, Ibaraki, Japan.; Sakamoto, K (corresponding author), Univ Tsukuba, Leading Grad Sch Doctoral Program Human Biol, Tsukuba, Ibaraki, Japan.	t_niizato@yahoo.co.jp; sakamoto@ccs.tsukuba.ac.jp		Sakamoto, Kotaro/0000-0003-0007-3894				Aguilera M, 2018, AGENCY INTEGRATED IN; Aguilera M, 2019, NEURAL NETW; Albantakis L, 2019, ENTROPY-SWITZ, V21, DOI 10.3390/e21050459; Albantakis L, 2015, ENTROPY-SWITZ, V17, P5472, DOI 10.3390/e17085472; Alkire MT, 2008, SCIENCE, V322, P876, DOI 10.1126/science.1149213; Amari S., SPRINGER P MATH STAT, V252; [Anonymous], 1969, GEN SYSTEM THEORY FD; Attanasi A, 2015, J R SOC INTERFACE, V12, DOI 10.1098/rsif.2015.0319; Attanasi A, 2014, PHYS REV LETT, V113, DOI 10.1103/PhysRevLett.113.238102; Attanasi A, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003697; Ay N, 2008, ADV COMPLEX SYST, V11, P17, DOI 10.1142/S0219525908001465; Bak P., 1988, Physical Review A (General Physics), V38, P364, DOI 10.1103/PhysRevA.38.364; Balduzzi D, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000462; Ballerini M, 2008, ANIM BEHAV, V76, P201, DOI 10.1016/j.anbehav.2008.02.004; Barrett AB, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001052; Bazazi S, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002498; Berdahl A, 2013, SCIENCE, V339, P574, DOI 10.1126/science.1225883; Berlow EL, 1999, NATURE, V398, P330, DOI 10.1038/18672; Bialek W, 2014, P NATL ACAD SCI USA, V111, P7212, DOI 10.1073/pnas.1324045111; Bosel T, 2017, CURR OPIN BEHAV SCI, V16, P30, DOI 10.1016/j.cobeha.2017.03.004; Buhl J, 2006, SCIENCE, V312, P1402, DOI 10.1126/science.1125142; Butail S, 2016, PHYS REV E, V93, DOI 10.1103/PhysRevE.93.042411; Cavagna A, 2013, PROCBIOL SCI; Cavagna A, 2010, P NATL ACAD SCI USA, V107, P11865, DOI 10.1073/pnas.1005766107; Christensen WD, 2002, MONIST, V85, P3, DOI 10.5840/monist20028516; Couzin I, 2007, NATURE, V445, P715, DOI 10.1038/445715a; Couzin ID, 2011, SCIENCE, V334, P1578, DOI 10.1126/science.1210280; Couzin ID, 2009, TRENDS COGN SCI, V13, P36, DOI 10.1016/j.tics.2008.10.002; Couzin ID, 2002, J THEOR BIOL, V218, P1, DOI 10.1006/jtbi.2002.3065; Crosato E, 2018, SWARM INTELL-US, V12, P283, DOI 10.1007/s11721-018-0157-x; Dyer JRG, 2009, PHILOS T R SOC B, V364, P781, DOI 10.1098/rstb.2008.0233; Edlund JA, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002236; Engel David M TW, 2018, ARTIF LIFE ROBOT; Erten EY, 2017, ENTROPY-SWITZ, V19, DOI 10.3390/e19050194; Esteban FJ, 2018, PLOS COMPUT BIOL, V14, DOI 10.1371/journal.pcbi.1006154; Farnsworth KD, 2018, BIOLOGY-BASEL, V7, DOI 10.3390/biology7030038; Franks NR, 2003, P ROY SOC B-BIOL SCI, V270, P2457, DOI 10.1098/rspb.2003.2527; Gautrais J, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002678; Gosseries O, 2014, ANNU REV NEUROSCI, V37, P457, DOI 10.1146/annurev-neuro-062012-170339; Gunji YP, 2014, COMPLEX SYST, V23, P55, DOI 10.25088/ComplexSystems.23.1.55; Gunji YP, 2014, BIOSYSTEMS, V123, P99, DOI 10.1016/j.biosystems.2014.05.005; Herbert-Read JE, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2564; Hesse J, 2014, FRONT SYST NEUROSCI, V8, DOI 10.3389/fnsys.2014.00166; HOPFIELD JJ, 1982, P NATL ACAD SCI-BIOL, V79, P2554, DOI 10.1073/pnas.79.8.2554; Ioannou CC, 2012, SCIENCE, V337, P1212, DOI 10.1126/science.1218919; Ishiwata R, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-24777-2; Ito S., 2018, ARXIV181009545; Ito S, 2018, PHYS REV LETT, V121, DOI 10.1103/PhysRevLett.121.030605; James RG, 2016, PHYS REV LETT, V116, DOI 10.1103/PhysRevLett.116.238701; Jia Y VT, 2018, ARXIV181009545; Jolles JW, 2017, CURR BIOL, V27, P2862, DOI 10.1016/j.cub.2017.08.004; Kadoya T, 2015, SCI REP-UK, V5, DOI 10.1038/srep12652; Kanakov O, 2019, PHYS REV E, V99, DOI 10.1103/PhysRevE.99.012418; Katz Y, 2011, P NATL ACAD SCI USA, V108, P18720, DOI 10.1073/pnas.1107583108; Khajehabdollahi S, 2019, BIORXIV160608313; Landi P, 2018, COMPLEXITY STABILITY; LANGTON CG, 1990, PHYSICA D, V42, P12, DOI 10.1016/0167-2789(90)90064-V; Lizier JT, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.026110; Lizier JT, 2012, INFORM SCIENCES, V208, P39, DOI 10.1016/j.ins.2012.04.016; Lynn CW., 2019, NAT PHYS; Marshall W, 2017, PHILOS T R SOC A, V375, DOI 10.1098/rsta.2016.0358; Massimini M., 2005, SCIENCE; Mayner WGP, 2018, PLOS COMPUT BIOL, V14, DOI 10.1371/journal.pcbi.1006343; Mediano P, 2019, ENTROPY; Mediano P.A.M., 2016, ARXIV160608313; Mediano P. A. M., 2019, ARXIV190902297; Mora T, 2016, NAT PHYS, V12, P1153, DOI [10.1038/NPHYS3846, 10.1038/nphys3846]; Mori H, 2018, INFORM INTEGRATION G; Murakami H, 2015, SCI REP-UK, V5, DOI 10.1038/srep10605; Murakami H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097870; Nagy M, 2010, NATURE, V464, P890, DOI 10.1038/nature08891; Niizato T, 2019, PREPRINTS; Niizato T, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0195988; Niizato T, 2017, AIP CONF PROC, V1863, DOI 10.1063/1.4992536; Niizato T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035615; Oizumi M, 2016, P NATL ACAD SCI USA, V113, P14817, DOI 10.1073/pnas.1603583113; Oizumi M, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1004654; Oizumi M, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003588; Olfati-Saber R, 2006, IEEE T AUTOMAT CONTR, V51, P401, DOI 10.1109/TAC.2005.864190; Olfati-Saber R, 2007, P IEEE, V95, P215, DOI 10.1109/JPROC.2006.887293; Ozogany K, 2015, J STAT PHYS, V158, P628, DOI 10.1007/s10955-014-1131-7; Pearl J, 2002, IIE T, V34, P583; Pennington J., 2018, ARXIV180209979 AISTA; Pinkoviezky I, 2018, PHYS REV E, V97, DOI 10.1103/PhysRevE.97.032304; Reynolds C.W., 1987, P 14 ANN C COMPUTER, V21, P25, DOI DOI 10.1145/37402.37406; ROSENBLATT F, 1958, PSYCHOL REV, V65, P386, DOI 10.1037/h0042519; Staniek M, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.158101; Strandburg-Peshkin A, 2013, CURR BIOL, V23, pR709, DOI 10.1016/j.cub.2013.07.059; Sumpter D. J., 2010, COLLECTIVE ANIMAL BE, DOI [10.1515/9781400837106, DOI 10.1515/9781400837106]; Sun J, 2014, PHYSICA D, V267, P49, DOI 10.1016/j.physd.2013.07.001; Tetzlaff C, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1001013; Tomaru T, 2016, ARTIF LIFE ROBOT, V21, P177, DOI 10.1007/s10015-016-0272-y; Tononi G, 2003, BMC NEUROSCI, V4, DOI 10.1186/1471-2202-4-31; Tononi G, 2001, ARCH ITAL BIOL, V139, P367; Tononi G., 2010, ENCY CONSCIOUSNESS; Vicsek T, 2012, PHYS REP, V517, P71, DOI 10.1016/j.physrep.2012.03.004; Wang X.G., 2012, PLOS ONE, V7; Wang X.R., 2011, P 11 EUR C SYNTH SIM; Xiao L., 2018, ARXIV180605393 ICML; Yates CA, 2009, P NATL ACAD SCI USA, V106, P5464, DOI 10.1073/pnas.0811195106; 2011, HDB PHILOS SCI, V10, P1	101	6	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2020	15	2							e0229573	10.1371/journal.pone.0229573	http://dx.doi.org/10.1371/journal.pone.0229573			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8GQ	32107495	Green Published, Green Submitted, gold			2022-12-26	WOS:000535237000043
J	Tsuchiya, K; Sano, T; Tomioka, N; Kohzu, A; Komatsu, K; Shinohara, R; Shimode, S; Toda, T; Imai, A				Tsuchiya, Kenji; Sano, Tomoharu; Tomioka, Noriko; Kohzu, Ayato; Komatsu, Kazuhiro; Shinohara, Ryuichiro; Shimode, Shinji; Toda, Tatsuki; Imai, Akio			Incorporation characteristics of exogenous N-15-labeled thymidine, deoxyadenosine, deoxyguanosine and deoxycytidine into bacterial DNA	PLOS ONE			English	Article							LACTOBACILLUS-ACIDOPHILUS; KINASE-ACTIVITY; WATERS; DEOXYRIBONUCLEOSIDES; EXTRACTS; LEUCINE; GROWTH; FRESH; RNA	Bacterial production has been often estimated from DNA synthesis rates by using tritium-labeled thymidine. Some bacteria species cannot incorporate extracellular thymidine into their DNA, suggesting their biomass production might be overlooked when using the conventional method. In the present study, to evaluate appropriateness of deoxyribonucleosides for evaluating bacterial production of natural bacterial communities from the viewpoint of DNA synthesis, incorporation rates of four deoxyribonucleosides (thymidine, deoxyadenosine, deoxyguanosine and deoxycytidine) labeled by nitrogen stable isotope (N-15) into bacterial DNA were examined in both ocean (Sagami Bay) and freshwater (Lake Kasumigaura) ecosystems in July 2015 and January 2016. In most stations in Sagami Bay and Lake Kasumigaura, we found that incorporation rates of deoxyguanosine were the highest among those of the four deoxyribonucleosides, and the incorporation rate of deoxyguanosine was approximately 2.5 times higher than that of thymidine. Whereas, incorporation rates of deoxyadenosine and deoxycytidine were 0.9 and 0.2 times higher than that of thymidine. These results clearly suggest that the numbers of bacterial species which can incorporate exogenous deoxyguanosine into their DNA are relatively greater as compared to the other deoxyribonucleosides, and measurement of bacterial production using deoxyguanosine more likely reflects larger numbers of bacterial species productions.	[Tsuchiya, Kenji; Toda, Tatsuki] Soka Univ, Fac Sci & Engn, Hachioji, Tokyo, Japan; [Tsuchiya, Kenji; Tomioka, Noriko; Kohzu, Ayato; Komatsu, Kazuhiro; Shinohara, Ryuichiro; Imai, Akio] Natl Inst Environm Studies, Ctr Reg Environm Res, Tsukuba, Ibaraki, Japan; [Sano, Tomoharu] Natl Inst Environm Studies, Ctr Environm Measurement & Anal, Tsukuba, Ibaraki, Japan; [Shimode, Shinji] Yokohama Natl Univ, Grad Sch Environm & Informat Sci, Yokohama, Kanagawa, Japan	Soka University; National Institute for Environmental Studies - Japan; National Institute for Environmental Studies - Japan; Yokohama National University	Tsuchiya, K (corresponding author), Soka Univ, Fac Sci & Engn, Hachioji, Tokyo, Japan.; Tsuchiya, K (corresponding author), Natl Inst Environm Studies, Ctr Reg Environm Res, Tsukuba, Ibaraki, Japan.	ktsuchiya@soka.gr.jp		Tsuchiya, Kenji/0000-0002-6644-1701; Toda, Tatsuki/0000-0001-9279-030X	Japan Society for the Promotion of Science [25550019, 15K21449]; Sasakawa Scientific Research Grant from The Japan Science Society [25-716]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Sasakawa Scientific Research Grant from The Japan Science Society	This work was supported by: Grants-in-Aid for Scientific Research (25550019, 15K21449) of Japan Society for the Promotion of Science; The Sasakawa Scientific Research Grant (25-716) from The Japan Science Society.	BEAN B, 1973, J BACTERIOL, V113, P1356, DOI 10.1128/JB.113.3.1356-1362.1973; BRITTAIN AM, 1990, APPL ENVIRON MICROB, V56, P1245, DOI 10.1128/AEM.56.5.1245-1254.1990; COLE JJ, 1988, MAR ECOL PROG SER, V43, P1, DOI 10.3354/meps043001; Cottrell MT, 2005, ENVIRON MICROBIOL, V7, P1883, DOI 10.1111/j.1462-2920.2005.00762.x; DAVIS MTB, 1976, J BACTERIOL, V126, P1136, DOI 10.1128/JB.126.3.1136-1140.1976; DOUGLAS DJ, 1987, MAR ECOL PROG SER, V36, P91, DOI 10.3354/meps036091; DURHAM JP, 1971, BIOCHIM BIOPHYS ACTA, V228, P9, DOI 10.1016/0005-2787(71)90542-9; Fenchel T, 2008, J EXP MAR BIOL ECOL, V366, P99, DOI 10.1016/j.jembe.2008.07.013; FUHRMAN JA, 1980, APPL ENVIRON MICROB, V39, P1085, DOI 10.1128/AEM.39.6.1085-1095.1980; FUHRMAN JA, 1982, MAR BIOL, V66, P109, DOI 10.1007/BF00397184; GUALERZI CO, 1990, BIOCHEMISTRY-US, V29, P5881, DOI 10.1021/bi00477a001; Imai A, 2003, WATER RES, V37, P4284, DOI 10.1016/S0043-1354(03)00310-5; JEFFREY WH, 1990, APPL ENVIRON MICROB, V56, P1367, DOI 10.1128/AEM.56.5.1367-1372.1990; KARLSTRO.HO, 1970, EUR J BIOCHEM, V17, P68, DOI 10.1111/j.1432-1033.1970.tb01135.x; KIRCHMAN D, 1985, APPL ENVIRON MICROB, V49, P599, DOI 10.1128/AEM.49.3.599-607.1985; Kopf SH, 2016, P NATL ACAD SCI USA, V113, pE110, DOI 10.1073/pnas.1512057112; Mittenhuber G, 2001, J MOL MICROB BIOTECH, V3, P21; Nohara K, 2011, ARCH TOXICOL, V85, P653, DOI 10.1007/s00204-010-0611-z; PEDROSALIO C, 1989, MAR ECOL PROG SER, V55, P83, DOI 10.3354/meps055083; Perez MT, 2010, ENVIRON MICROBIOL, V12, P74, DOI 10.1111/j.1462-2920.2009.02043.x; POWELL JW, 1973, APPL MICROBIOL, V25, P869, DOI 10.1128/AEM.25.6.869-872.1973; REICHARD P, 1988, ANNU REV BIOCHEM, V57, P349, DOI 10.1146/annurev.bi.57.070188.002025; ROBARTS RD, 1993, ADV MICROB ECOL, V13, P371; Tinta T, 2012, FEMS MICROBIOL LETT, V331, P120, DOI 10.1111/j.1574-6968.2012.02565.x; Tsuchiya K, 2019, LIMNOL OCEANOGR, V64, P2441, DOI 10.1002/lno.11196; Tsuchiya K, 2015, J OCEANOGR, V71, P675, DOI 10.1007/s10872-015-0310-8; WACHSMAN JT, 1971, J BACTERIOL, V105, P787, DOI 10.1128/JB.105.3.787-792.1971; WACHSMAN JT, 1973, APPL MICROBIOL, V25, P506, DOI 10.1128/AEM.25.3.506-508.1973; Yu XC, 1997, EMBO J, V16, P5455, DOI 10.1093/emboj/16.17.5455; Zhang Y, 2006, AQUAT MICROB ECOL, V43, P233, DOI 10.3354/ame043233	30	3	3	3	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2020	15	2							e0229740	10.1371/journal.pone.0229740	http://dx.doi.org/10.1371/journal.pone.0229740			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8GQ	32106263	Green Published, gold, Green Submitted			2022-12-26	WOS:000535237000067
J	Saraf, SL; Ghimire, K; Patel, P; Sweiss, K; Gowhari, M; Molokie, RE; Gordeuk, VR; Rondelli, D				Saraf, Santosh L.; Ghimire, Krishna; Patel, Pritesh; Sweiss, Karen; Gowhari, Michel; Molokie, Robert E.; Gordeuk, Victor R.; Rondelli, Damiano			Improved health care utilization and costs in transplanted versus non-transplanted adults with sickle cell disease	PLOS ONE			English	Article							HYDROXYUREA; CHILDREN; HOSPITALIZATION; FREQUENCY; CRISES	Patients with sickle cell disease (SCD) have access to fewer health care resources and therapies compared to other diseases, which contributes to increased morbidity and health care utilization. We compared health care utilization (inpatient hospital days, emergency care visits) and health care-related costs between SCD adults that underwent hematopoietic stem cell transplantation (HSCT) using a nonmyeloblative conditioning regimen versus those referred for HSCT but did not proceed due to lack of an HLA-matched sibling donor, denial by insurance, red blood cell antibodies to the potential donor, or declining further evaluation. Between 8/2011 and 4/2016, 83 SCD patients were referred for allogeneic HSCT and 16 underwent the procedure. The HSCT and non-HSCT groups were similar by age, sex, prior SCD-related therapy and complications. Compared to pre HSCT, significantly fewer inpatient hospital days (median of 1 versus 22 days, P = 0.003) and emergency care visits (median of 1 versus 4 visits, P = 0.04) were observed by the 2nd year post-HSCT. Similar results were observed in comparison to the standard-of-care group (median of 1 versus 12 hospital days, P = 0.002; median of 1 versus 3 emergency visits, P = 0.03). Lower health care costs were observed by the 2nd year post-HSCT (median of $16,281 versus $64,634 pre-HSCT (P = 0.01) and versus $54,082 in the standard-of-care group (P = 0.05). A median reduction of -$20,833/patient/year (IQR, -$67,078-+$4,442/patient/year) in health care costs compared to pre-HSCT was observed in the 2nd year post-HSCT. In conclusion, allogeneic HSCT leads to improvements in health care utilization and costs compared to standard-of-care therapy in high-risk SCD adults.	[Saraf, Santosh L.; Ghimire, Krishna; Patel, Pritesh; Sweiss, Karen; Gowhari, Michel; Molokie, Robert E.; Gordeuk, Victor R.; Rondelli, Damiano] Univ Illinois, Dept Med, Div Hematol & Oncol, Chicago, IL 60607 USA; [Sweiss, Karen] Univ Illinois, Coll Pharm, Dept Pharm Practice, Chicago, IL USA; [Molokie, Robert E.] Jesse Brown VA Med Ctr, Chicago, IL USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; US Department of Veterans Affairs; Veterans Health Administration (VHA); Jesse Brown VA Medical Center	Saraf, SL; Rondelli, D (corresponding author), Univ Illinois, Dept Med, Div Hematol & Oncol, Chicago, IL 60607 USA.	ssaraf@uic.edu; drond@uic.edu		Molokie, Robert/0000-0003-3623-7395				Angelucci E, 2014, HAEMATOLOGICA, V99, P811, DOI 10.3324/haematol.2013.099747; Arnold SD, 2017, HAEMATOLOGICA, V102, P1823, DOI 10.3324/haematol.2017.169581; Arnold SD, 2015, BIOL BLOOD MARROW TR, V21, P1258, DOI 10.1016/j.bbmt.2015.01.010; Ataga KI, 2017, NEW ENGL J MED, V376, P429, DOI 10.1056/NEJMoa1611770; Ballas SK, 2009, AM J HEMATOL, V84, P320, DOI 10.1002/ajh.21443; Benenson Irina, 2017, JBI Database System Rev Implement Rep, V15, P765, DOI 10.11124/JBISRIR-2016-002983; Blinder MA, 2013, PEDIATR BLOOD CANCER, V60, P828, DOI 10.1002/pbc.24459; Bou-Maroun LM, 2018, PEDIATR BLOOD CANCER, V65, DOI 10.1002/pbc.26758; Brousseau DC, 2010, JAMA-J AM MED ASSOC, V303, P1288, DOI 10.1001/jama.2010.378; Carroll CP, 2011, J HOSP MED, V6, P248, DOI 10.1002/jhm.850; CDC, SICKL CELL DIS HLTH; CHARACHE S, 1995, NEW ENGL J MED, V332, P1317, DOI 10.1056/NEJM199505183322001; Gluckman E, 2017, BLOOD, V129, P1548, DOI 10.1182/blood-2016-10-745711; Gluckman E, 2013, HEMATOL-AM SOC HEMAT, P370, DOI 10.1182/asheducation-2013.1.370; Hassell KL, 2010, AM J PREV MED, V38, pS512, DOI 10.1016/j.amepre.2009.12.022; Hsieh MM, 2014, JAMA-J AM MED ASSOC, V312, P48, DOI 10.1001/jama.2014.7192; Kauf TL, 2009, AM J HEMATOL, V84, P323, DOI 10.1002/ajh.21408; Lanzkron S, 2006, AM J HEMATOL, V81, P927, DOI 10.1002/ajh.20703; Lanzkron S, 2018, BLOOD ADV, V2, P2412, DOI 10.1182/bloodadvances.2018018382; Lubeck D, 2019, JAMA NETW OPEN, V2, DOI 10.1001/jamanetworkopen.2019.15374; Modell B, 2008, B WORLD HEALTH ORGAN, V86, P480, DOI 10.2471/BLT.06.036673; Moore RD, 2000, AM J HEMATOL, V64, P26, DOI 10.1002/(SICI)1096-8652(200005)64:1<26::AID-AJH5>3.3.CO;2-6; Pizzo E, 2015, J PUBLIC HEALTH-UK, V37, P529, DOI 10.1093/pubmed/fdu026; Ribeil JA, 2017, NEW ENGL J MED, V376, P848, DOI 10.1056/NEJMoa1609677; Saraf SL, 2016, BIOL BLOOD MARROW TR, V22, P441, DOI 10.1016/j.bbmt.2015.08.036; Stallworth JR, 2010, AM J HEMATOL, V85, P795, DOI 10.1002/ajh.21772; Telen MJ, 2015, BLOOD, V125, P2656, DOI 10.1182/blood-2014-06-583351; Vichinsky E, 2019, NEW ENGL J MED, V381, P509, DOI 10.1056/NEJMoa1903212; Wang WC, 2013, PEDIATRICS, V132, P677, DOI 10.1542/peds.2013-0333; Wolfson JA, 2012, PEDIATR BLOOD CANCER, V58, P66, DOI 10.1002/pbc.22979	30	7	7	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2020	15	2							e0229710	10.1371/journal.pone.0229710	http://dx.doi.org/10.1371/journal.pone.0229710			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8FM	32101564	Green Published, gold			2022-12-26	WOS:000535233700048
J	Teixeira-Santos, J; Ribeiro, ACD; Wiig, O; Pinto, NS; Cantanhede, LG; Sena, L; Mendes-Oliveira, AC				Teixeira-Santos, Juliana; da Cunha Ribeiro, Ana Carolina; Wiig, Oystein; Pinto, Nelson Silva; Cantanhede, Lorrane Gabrielle; Sena, Leonardo; Mendes-Oliveira, Ana Cristina			Environmental factors influencing the abundance of four species of threatened mammals in degraded habitats in the eastern Brazilian Amazon	PLOS ONE			English	Article							PECCARIES TAYASSU-TAJACU; MYRMECOPHAGA-TRIDACTYLA; EVOLUTIONARY PRINCIPLES; TAPIRUS-TERRESTRIS; ACTIVITY PATTERNS; CAMERA-TRAP; FOREST; BIODIVERSITY; DENSITY; RESPONSES	On the latest 60 years the degradation and fragmentation of native habitats have been modifying the landscape in the eastern Brazilian Amazon. The adaptive plasticity of an organism has been crucial for its long-term survival and success in these novel ecosystems. In this study, we investigated the response of four endangered species of large terrestrial mammals to the variations in the quality of their original habitats, in a context of high anthropogenic pressure. The distribution of the Myrmecophaga tridactyla (Giant anteater), Priodontes maximus (Giant armadillo), Tapirus terrestris (Lowland tapir) and Tayassu pecari (White-lipped peccary) in all sampled habitats suggests their tolerance to degradation. However, the survival ability of each species in the different habitats was not the same. Among the four species, T. pecari seems to be the one with the least ability to survive in more altered environments. The positive influence of the anthropogenically altered habitats on abundances of three of the four species studied, as observed at the regeneration areas, can be considered as a potential indication of the ecological trap phenomenon. This study reinforces the importance of the forest remnants for the survival of endangered mammal species, in regions of high anthropogenic pressure, as in the eastern Brazilian Amazon.	[Teixeira-Santos, Juliana; da Cunha Ribeiro, Ana Carolina; Cantanhede, Lorrane Gabrielle; Sena, Leonardo; Mendes-Oliveira, Ana Cristina] Fed Univ Para, Inst Biol Sci, Belem, Para, Brazil; [Wiig, Oystein] Univ Oslo, Nat Hist Museum, Oslo, Norway; [Pinto, Nelson Silva] Ctr Univ UniAraguaia, Goiania, Go, Brazil	Universidade Federal do Para; University of Oslo	Mendes-Oliveira, AC (corresponding author), Fed Univ Para, Inst Biol Sci, Belem, Para, Brazil.	cris.mastozoologia@gmail.com	de Oliveira, Ana Cristina Mendes/I-2680-2012; Wiig, Øystein/AAT-9518-2020; Sena, Leonardo/AAL-6707-2021; Pinto, Nelson Silva/F-4709-2013	Wiig, Øystein/0000-0003-0395-5251; Pinto, Nelson Silva/0000-0001-9189-7068; Teixeira-Santos, Juliana/0000-0003-1085-9380; Ribeiro, Ana Carolina/0000-0003-2821-5233; Mendes Oliveira, Ana Cristina/0000-0002-7863-9678	Biodiversity Research Consortium BrazilNorway (BRC); Hydro Paragominas; Coordenacao de Aperfeicoamento de Pessoal de Ni'vel Superior (CAPES); Conselho Nacional de Desenvolvimento Cienti'fico e Tecnologico CNPq)	Biodiversity Research Consortium BrazilNorway (BRC); Hydro Paragominas; Coordenacao de Aperfeicoamento de Pessoal de Ni'vel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Conselho Nacional de Desenvolvimento Cienti'fico e Tecnologico CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	Biodiversity Research Consortium BrazilNorway (BRC) and Hydro Paragominas supported this research; Coordenacao de Aperfeicoamento de Pessoal de Ni ' vel Superior (CAPES) -Masters Scholarship for Juliana Teixeira Santos and Lorrane Gabrielle Cantanhede; Conselho Nacional de Desenvolvimento Cienti ' fico e Tecnologico CNPq) -Research Productivity Scholarship for Ana Cristina Mendes-Oliveira and Masters Scholarship for Ana Carolina da Cunha Ribeiro. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdi H, 2010, WIRES COMPUT STAT, V2, P433, DOI 10.1002/wics.101; Anacleto TCS, 2014, PRIODONTES MAXIMUS I; Anacleto Teresa Cristina S., 2001, Revista Brasileira de Zoologia, V18, P681; Ardente NC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167266; Aya-Cuero C, 2017, J MAMMAL, V98, P770, DOI 10.1093/jmammal/gyx006; Barlow J, 2007, P NATL ACAD SCI USA, V104, P18555, DOI 10.1073/pnas.0703333104; Barreto GR, 1997, J ZOOL, V241, P279, DOI 10.1111/j.1469-7998.1997.tb01958.x; Barton K., 2016, MUMIN MULTIMODEL INF; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Bolker B., 2017, BBMLE TOOLS GEN MAXI; BRESLOW NE, 1993, J AM STAT ASSOC, V88, P9, DOI 10.1080/01621459.1993.10594284; Broadbent EN, 2008, BIOL CONSERV, V141, P1745, DOI 10.1016/j.biocon.2008.04.024; Brown S., 1994, RESTORATION ECOLOGY, V2, P97, DOI [10.1111/j.1526-100x.1994.tb00047.x, DOI 10.1111/J.1526-100X.1994.TB00047.X]; Burnham K.P., 2002, PRACTICAL INFORM THE, V2nd ed., DOI [DOI 10.1007/B97636, 10.1007/b97636]; Camilo-Alves CD, 2006, BIOTROPICA, V38, P52, DOI 10.1111/j.1744-7429.2006.00106.x; Cheida CC., 2006, MAM FEROS BRASIL, P231; Coelho M, 2014, BIODIVERS CONSERV, V23, P3171, DOI 10.1007/s10531-014-0772-9; Cove MV, 2013, TROP CONSERV SCI, V6, P781, DOI 10.1177/194008291300600606; de Almeida-Rocha JM, 2017, BIOL CONSERV, V215, P30, DOI 10.1016/j.biocon.2017.08.018; de Thoisy B, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-278; Deepayan S., 2008, LATTICE MULTIVARIATE; Defler T., 2019, HIST TERRESTRIAL MAM; Di Blanco Yamil E., 2012, Edentata, V13, P49; EOS (Earth Observing System), 2013, SAT IM PAR REG; Foster VC, 2013, BIOTROPICA, V45, P373, DOI 10.1111/btp.12021; Fragoso JMV, 1997, J ECOL, V85, P519, DOI 10.2307/2960574; Fragoso JMV, 2003, ECOLOGY, V84, P1998, DOI 10.1890/01-0621; Goncalves GR, 2017, J ARID ENVIRON, V140, P6, DOI 10.1016/j.jaridenv.2017.01.004; Hendry AP, 2011, EVOL APPL, V4, P159, DOI 10.1111/j.1752-4571.2010.00165.x; ICMBio [Instituto Chico Mendes de Conservacao da Biodiversidade], 2018, LIVRO VERMELHO FAUNA; IMAZON (Instituto do Homem e Meio Ambiente da Amazonia), 2013, CLASS SHAP IM PAR RE; IUCN, 2020, IUCN RED LIST THREAT; JACKSON DA, 1993, ECOLOGY, V74, P2204, DOI 10.2307/1939574; Jackson ST, 2010, TRENDS ECOL EVOL, V25, P153, DOI 10.1016/j.tree.2009.10.001; Keuroghlian A, 2013, TAYASSU PECARI IUCN; KILTIE RA, 1982, BIOTROPICA, V14, P188, DOI 10.2307/2388025; Kottek M, 2006, METEOROL Z, V15, P259, DOI 10.1127/0941-2948/2006/0130; Krauss J, 2010, ECOL LETT, V13, P597, DOI 10.1111/j.1461-0248.2010.01457.x; Lankau R, 2011, EVOL APPL, V4, P315, DOI 10.1111/j.1752-4571.2010.00171.x; Lapola DM, 2014, NAT CLIM CHANGE, V4, P27, DOI 10.1038/NCLIMATE2056; Lees AC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122432; Gasparini GM, 2014, HIST BIOL, V26, P785, DOI 10.1080/08912963.2013.858247; Marsden SJ, 2002, FOREST ECOL MANAG, V165, P117, DOI 10.1016/S0378-1127(01)00653-3; McNamara JM, 2011, ECOL LETT, V14, P1183, DOI 10.1111/j.1461-0248.2011.01686.x; Meek PD, 2014, BIODIVERS CONSERV, V23, P2321, DOI 10.1007/s10531-014-0712-8; Meek PD, 2012, WILDLIFE RES, V39, P649, DOI 10.1071/WR12138; Mendes-Oliveira AC, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0187650; Merritt DA Jr, 1985, EVOLUTION ECOLOGY AR, P333; MMA, 2013, PLAN AC PREV CONTR D; Montgomery G.G., 1977, P103; Nakagawa S, 2013, METHODS ECOL EVOL, V4, P133, DOI 10.1111/j.2041-210x.2012.00261.x; Novack AJ, 2005, J ZOOL, V267, P167, DOI 10.1017/S0952836905007338; Nowak R.M, 1999, WALKERS MAMMALS WORL, V6th; Nowak RM, 1983, WALKERS MAMMALS WORL; O'Brien TG, 2008, ANIM CONSERV, V11, P179, DOI 10.1111/j.1469-1795.2008.00178.x; Oksanen J., 2020, VEGAN COMMUNITY ECOL; PAGLIA A. P., 2012, OCCASIONAL PAPERS CO, V6; Parera A, 2002, MAMIFEROS ARGENTINA, P1; Parrotta JA, 1999, RESTOR ECOL, V7, P103, DOI 10.1046/j.1526-100X.1999.72001.x; Peck DV, 2006, ENV MONITORING ASSES; Pezzuti JCB, 2009, PAPERS DO NAEA, V236, P1; Pinage ER, 2019, REMOTE SENS-BASEL, V11, DOI 10.3390/rs11060709; Potestio ML, 2009, INT J BEHAV NUTR PHY, V6, DOI 10.1186/1479-5868-6-77; R Core Team, 2021, R LANGUAGE ENV STAT; Reyna-Hurtado R, 2016, BIOTROPICA, V48, P246, DOI 10.1111/btp.12269; Ribeiro SS, 2019, FLORESTA AMBIENTE, V26, DOI 10.1590/2179-8087.081217; Richard E, 2000, MANEJO FAUNA SILVEST, P433; Robertson BA, 2006, ECOLOGY, V87, P1075, DOI 10.1890/0012-9658(2006)87[1075:AFFUET]2.0.CO;2; Robertson BA, 2013, TRENDS ECOL EVOL, V28, P552, DOI 10.1016/j.tree.2013.04.004; Sales LP, 2019, ECOGRAPHY, V42, P1789, DOI 10.1111/ecog.04499; SHAW JH, 1987, BIOTROPICA, V19, P255, DOI 10.2307/2388344; Sih A, 2011, EVOL APPL, V4, P367, DOI 10.1111/j.1752-4571.2010.00166.x; Sonter LJ, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00557-w; Souza CM, 2019, WATER-SUI, V11, DOI 10.3390/w11030566; Thomas CD, 2004, NATURE, V427, P145, DOI 10.1038/nature02121; Tobler MW, 2015, J APPL ECOL, V52, P413, DOI 10.1111/1365-2664.12399; Tobler MW, 2014, ORYX, V48, P410, DOI 10.1017/S0030605312001652; Trolle M, 2008, BIOTROPICA, V40, P211, DOI 10.1111/j.1744-7429.2007.00350.x; UHL C, 1989, BIOTROPICA, V21, P98, DOI 10.2307/2388700; Veloso H. M. P., 1991, CLASSIFICACAO VEGETA; Venables WN., 2002, MODERN APPL STAT S, V4; Vidolin GP, 2011, CIENC FLOREST, V21, P509, DOI 10.5902/198050983808; Wilkie DS, 2011, ANN NY ACAD SCI, V1223, P120, DOI 10.1111/j.1749-6632.2010.05908.x; Willis KJ, 2006, SCIENCE, V314, P1261, DOI 10.1126/science.1122667	84	6	6	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2020	15	2							e0229459	10.1371/journal.pone.0229459	http://dx.doi.org/10.1371/journal.pone.0229459			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8FM	32101578	Green Published, gold			2022-12-26	WOS:000535233700036
J	Yellamilli, A; Ren, Y; McElmurry, RT; Lambert, JP; Gross, P; Mohsin, S; Houser, SR; Elrod, JW; Tolar, J; Garry, DJ; van Berlo, JH				Yellamilli, Amritha; Ren, Yi; McElmurry, Ron T.; Lambert, Jonathan P.; Gross, Polina; Mohsin, Sadia; Houser, Steven R.; Elrod, John W.; Tolar, Jakub; Garry, Daniel J.; van Berlo, Jop H.			Abcg2-expressing side population cells contribute to cardiomyocyte renewal through fusion	FASEB JOURNAL			English	Article						cardiac regeneration; cardiomyocyte proliferation; fusion; side population	BINDING CASSETTE TRANSPORTER; CARDIAC PROGENITOR CELLS; HEMATOPOIETIC STEM-CELLS; MYOCARDIAL-INFARCTION; C-KIT(+) CELLS; HEART-FAILURE; ABCG2; REGENERATION; EXPRESSION; MYOCYTES	The adult mammalian heart has a limited regenerative capacity. Therefore, identification of endogenous cells and mechanisms that contribute to cardiac regeneration is essential for the development of targeted therapies. The side population (SP) phenotype has been used to enrich for stem cells throughout the body; however, SP cells isolated from the heart have been studied exclusively in cell culture or after transplantation, limiting our understanding of their function in vivo. We generated a new Abcg2-driven lineage-tracing mouse model with efficient labeling of SP cells. Labeled SP cells give rise to terminally differentiated cells in bone marrow and intestines. In the heart, labeled SP cells give rise to lineage-traced cardiomyocytes under homeostatic conditions with an increase in this contribution following cardiac injury. Instead of differentiating into cardiomyocytes like proposed cardiac progenitor cells, cardiac SP cells fuse with preexisting cardiomyocytes to stimulate cardiomyocyte cell cycle reentry. Our study is the first to show that fusion between cardiomyocytes and non-cardiomyocytes, identified by the SP phenotype, contribute to endogenous cardiac regeneration by triggering cardiomyocyte cell cycle reentry in the adult mammalian heart.	[Yellamilli, Amritha; Ren, Yi; Garry, Daniel J.; van Berlo, Jop H.] Univ Minnesota, Sch Med, Lillehei Heart Inst, Minneapolis, MN 55455 USA; [Yellamilli, Amritha; van Berlo, Jop H.] Univ Minnesota, Sch Med, Dept Integrat Biol & Physiol, Minneapolis, MN 55455 USA; [Yellamilli, Amritha; McElmurry, Ron T.; Tolar, Jakub; van Berlo, Jop H.] Univ Minnesota, Sch Med, Stem Cell Inst, Minneapolis, MN 55455 USA; [McElmurry, Ron T.; Tolar, Jakub] Univ Minnesota, Sch Med, Dept Pediat, Minneapolis, MN 55455 USA; [Lambert, Jonathan P.; Elrod, John W.] Temple Univ, Lewis Katz Sch Med, Ctr Translat Med, Philadelphia, PA 19122 USA; [Gross, Polina; Mohsin, Sadia; Houser, Steven R.] Temple Univ, Lewis Katz Sch Med, Cardiovasc Res Ctr, Philadelphia, PA 19122 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University	van Berlo, JH (corresponding author), Univ Minnesota, Dept Med, Lillehei Heart Inst, 2231 6th St SE, Minneapolis, MN 55455 USA.	jvanberl@umn.edu	Lambert, Jonathan/P-1766-2018	Lambert, Jonathan/0000-0001-7048-6841; Elrod, John/0000-0003-3925-2224; Tolar, Jakub/0000-0002-0957-4380	National Institutes of Health [HL112852, HL130072]; MSTP [T32GM008244]; Hartwell Foundation; Minnesota Regenerative Medicine Initiative	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MSTP; Hartwell Foundation; Minnesota Regenerative Medicine Initiative	National Institutes of Health, Grant/Award Number: HL112852 and HL130072; MSTP, Grant/Award Number: T32GM008244; The Hartwell Foundation; Minnesota Regenerative Medicine Initiative	Alfakir M, 2012, INT J CARDIOL, V156, P133, DOI 10.1016/j.ijcard.2010.10.025; Alvarez-Dolado M, 2003, NATURE, V425, P968, DOI 10.1038/nature02069; Beltrami AP, 2003, CELL, V114, P763, DOI 10.1016/S0092-8674(03)00687-1; Bergmann O, 2015, CELL, V161, P1566, DOI 10.1016/j.cell.2015.05.026; Bergmann O, 2009, SCIENCE, V324, P98, DOI 10.1126/science.1164680; Bollini S, 2014, STEM CELLS DEV, V23, P1719, DOI 10.1089/scd.2014.0019; Brooks WW, 2009, COMPARATIVE MED, V59, P339; Chen ZM, 2017, CIRCULATION, V136, P2359, DOI 10.1161/CIRCULATIONAHA.117.030137; Chiong M, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.130; Darwich AS, 2014, DRUG METAB DISPOS, V42, P2016, DOI 10.1124/dmd.114.058404; Deb A, 2003, CIRCULATION, V107, P1247, DOI 10.1161/01.CIR.0000061910.39145.F0; Dekaney CM, 2005, GASTROENTEROLOGY, V129, P1567, DOI 10.1053/j.gastro.2005.08.011; Dey D, 2013, CIRC RES, V112, P1253, DOI 10.1161/CIRCRESAHA.112.300779; Epelman S, 2014, IMMUNITY, V40, P91, DOI 10.1016/j.immuni.2013.11.019; Epstein JA, 2019, JAMA CARDIOL, V4, P95, DOI 10.1001/jamacardio.2018.4435; Ergen Aysegul V, 2013, Methods Mol Biol, V946, P151, DOI 10.1007/978-1-62703-128-8_10; Eschenhagen T, 2017, CIRCULATION, V136, P680, DOI 10.1161/CIRCULATIONAHA.117.029343; Fatima S, 2012, STEM CELLS, V30, P210, DOI 10.1002/stem.1002; Fioret BA, 2014, CELL REP, V8, P229, DOI 10.1016/j.celrep.2014.06.004; Garbern JC, 2013, CELL STEM CELL, V12, P689, DOI 10.1016/j.stem.2013.05.008; Golebiewska A, 2011, CELL STEM CELL, V8, P136, DOI 10.1016/j.stem.2011.01.007; Goodell MA, 1996, J EXP MED, V183, P1797, DOI 10.1084/jem.183.4.1797; Gundewar S, 2007, AM J PHYSIOL-HEART C, V293, pH2462, DOI 10.1152/ajpheart.00392.2007; He LJ, 2017, NAT MED, V23, P1488, DOI 10.1038/nm.4437; Hierlihy AM, 2002, FEBS LETT, V530, P239, DOI 10.1016/S0014-5793(02)03477-4; Higashikuni Y, 2010, ARTERIOSCL THROM VAS, V30, P2128, DOI 10.1161/ATVBAHA.110.211755; Hong KU, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096725; Horsey AJ, 2016, BIOCHEM SOC T, V44, P824, DOI 10.1042/BST20160014; Hsieh PCH, 2007, NAT MED, V13, P970, DOI 10.1038/nm1618; Jackson KA, 2001, J CLIN INVEST, V107, P1395, DOI 10.1172/JCI12150; Kretzschmar K, 2018, P NATL ACAD SCI USA, V115, pE12245, DOI 10.1073/pnas.1805829115; Krishnamurthy P, 2006, ANNU REV PHARMACOL, V46, P381, DOI 10.1146/annurev.pharmtox.46.120604.141238; Leach JP, 2017, NATURE, V550, P260, DOI 10.1038/nature24045; Li Y, 2018, CIRCULATION, V138, P793, DOI 10.1161/CIRCULATIONAHA.118.034250; Liang SX, 2010, INT J CARDIOL, V138, P40, DOI 10.1016/j.ijcard.2008.08.032; Liu QZ, 2016, CELL RES, V26, P119, DOI 10.1038/cr.2015.143; Luongo TS, 2017, NATURE, V545, P93, DOI 10.1038/nature22082; Martin CM, 2004, DEV BIOL, V265, P262, DOI 10.1016/j.ydbio.2003.09.028; Matsuura K, 2004, J CELL BIOL, V167, P351, DOI 10.1083/jcb.200312111; Meissner K, 2006, J HISTOCHEM CYTOCHEM, V54, P215, DOI 10.1369/jhc.5A6750.2005; Min YL, 2018, P NATL ACAD SCI USA, V115, pE8430, DOI 10.1073/pnas.1800526115; Mouquet F, 2005, CIRC RES, V97, P1090, DOI 10.1161/01.RES.0000194330.66545.f5; Murry CE, 2004, NATURE, V428, P664, DOI 10.1038/nature02446; Nakada Y, 2017, NATURE, V541, P222, DOI 10.1038/nature20173; Noseda M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7930; Nygren JM, 2004, NAT MED, V10, P494, DOI 10.1038/nm1040; O'Connell Timothy D, 2007, Methods Mol Biol, V357, P271; Oh H, 2003, P NATL ACAD SCI USA, V100, P12313, DOI 10.1073/pnas.2132126100; Okabe K, 2014, CELL, V159, P584, DOI 10.1016/j.cell.2014.09.025; Oyama T, 2007, J CELL BIOL, V176, P329, DOI 10.1083/jcb.200603014; Parsons SA, 2004, J BIOL CHEM, V279, P26192, DOI 10.1074/jbc.M313800200; Pfister O, 2005, CIRC RES, V97, P52, DOI 10.1161/01.RES.0000173297.53793.fa; Pfister O, 2008, CIRC RES, V103, P825, DOI 10.1161/CIRCRESAHA.108.174615; Pfister O, 2010, METHODS MOL BIOL, V660, P53, DOI 10.1007/978-1-60761-705-1_4; Sanganalmath SK, 2013, CIRC RES, V113, P810, DOI 10.1161/CIRCRESAHA.113.300219; Sawamiphak S, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01555-8; Senyo SE, 2013, NATURE, V493, P433, DOI 10.1038/nature11682; Solbach TF, 2008, N-S ARCH PHARMACOL, V377, P231, DOI 10.1007/s00210-008-0279-6; Sultana N, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9701; Tzahor E, 2017, SCIENCE, V356, P1035, DOI 10.1126/science.aam5894; Unno K, 2012, CIRC RES, V110, P1355, DOI 10.1161/CIRCRESAHA.111.243014; van Berlo JH, 2016, CIRC RES, V118, P17, DOI 10.1161/CIRCRESAHA.115.307934; van Berlo JH, 2014, NAT MED, V20, P1386, DOI 10.1038/nm.3764; van Berlo JH, 2014, NATURE, V509, P337, DOI 10.1038/nature13309; van Empel VPM, 2005, CARDIOVASC RES, V67, P21, DOI 10.1016/j.cardiores.2005.04.012; von Furstenberg RJ, 2014, STEM CELL RES, V12, P364, DOI 10.1016/j.scr.2013.10.012; Wallner M, 2016, CIRC RES, V119, P865, DOI 10.1161/CIRCRESAHA.116.308687; Wu JMF, 2015, CIRC RES, V116, P633, DOI 10.1161/CIRCRESAHA.116.304564; Yellamilli A, 2016, FRONT CELL DEV BIOL, V4, DOI 10.3389/fcell.2016.00102; Zhou S, 2002, P NATL ACAD SCI USA, V99, P12339, DOI 10.1073/pnas.192276999; Zhou S, 2001, NAT MED, V7, P1028, DOI 10.1038/nm0901-1028	71	6	6	0	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2020	34	4					5642	5657		10.1096/fj.201902105R	http://dx.doi.org/10.1096/fj.201902105R		FEB 2020	16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	LJ5ZA	32100368	Green Submitted, Green Accepted			2022-12-26	WOS:000517898300001
J	Zhuo, MH; Chen, WB; Shang, SH; Guo, P; Peng, KS; Li, M; Mo, PL; Zhang, YY; Qiu, XF; Li, WG; Yu, CD				Zhuo, Minghui; Chen, Wenbo; Shang, Shaohui; Guo, Peng; Peng, Kesong; Li, Ming; Mo, Pingli; Zhang, Yongyou; Qiu, Xingfeng; Li, Wengang; Yu, Chundong			Inflammation-induced JMJD2D promotes colitis recovery and colon tumorigenesis by activating Hedgehog signaling	ONCOGENE			English	Article							INTESTINAL INFLAMMATION; KAPPA-B; EPITHELIAL-CELLS; RANDOMIZED-TRIAL; ASPIRIN; METASTASIS; INHIBITION; SALICYLATE; VISMODEGIB; DEFICIENT	Histone demethylase JMJD2D can promote gene expression by specifically demethylating H3K9me2/3. The role of JMJD2D in colitis and colitis-associated colorectal cancer (CRC) progression remains unclear. Here, we show that colonic JMJD2D is induced by TNF alpha during dextran sulfate sodium-induced colitis. JMJD2D-deficient mice exhibit more severe colon damage and defective colon regeneration due to impaired Hedgehog signaling activation after colitis. JMJD2D knockdown in CRC cells suppresses Hedgehog signaling, resulting in reduced CRC growth and metastasis. Mechanistically, JMJD2D promotes Hedgehog target gene expression through interacting with Gli2 to reduce H3K9me3 levels at the promoter. Clinically, JMJD2D expression is upregulated and positively correlated with Gli2 expression in human inflammatory bowel disease specimens and CRC specimens. The JMJD2D inhibitor 5-c-8HQ or aspirin synergizes with Hedgehog inhibitor vismodegib to inhibit CRC cell proliferation and tumorigenesis. Collectively, our findings unveil an essential role of JMJD2D in activating the processes of colonic protection, regeneration, and tumorigenesis.	[Zhuo, Minghui; Shang, Shaohui; Guo, Peng; Peng, Kesong; Mo, Pingli; Zhang, Yongyou; Yu, Chundong] Xiamen Univ, Sch Life Sci, Innovat Ctr Cell Biol, State Key Lab Cellular Stress Biol, Xiamen, Peoples R China; [Chen, Wenbo] Xiamen Univ, Dept Cardiol, Affiliated Hosp 1, Xiamen, Peoples R China; [Peng, Kesong] Fudan Univ, Sch Basic Med Sci, Dept Cellular & Genet Med, Shanghai, Peoples R China; [Li, Ming; Li, Wengang] Xiamen Univ, Sch Med, Xiangan Hosp, Dept Hepatobiliary & Pancreat & Organ Transplanta, Xiamen, Peoples R China; [Qiu, Xingfeng] Xiamen Univ, Zhongshan Hosp, Dept Gastrointestinal Surg, Xiamen, Peoples R China	Xiamen University; Xiamen University; Fudan University; Xiamen University; Xiamen University	Yu, CD (corresponding author), Xiamen Univ, Sch Life Sci, Innovat Ctr Cell Biol, State Key Lab Cellular Stress Biol, Xiamen, Peoples R China.; Li, WG (corresponding author), Xiamen Univ, Sch Med, Xiangan Hosp, Dept Hepatobiliary & Pancreat & Organ Transplanta, Xiamen, Peoples R China.; Qiu, XF (corresponding author), Xiamen Univ, Zhongshan Hosp, Dept Gastrointestinal Surg, Xiamen, Peoples R China.	dr.qxf@xmu.edu.cn; lwg11861@163.com; cdyu@xmu.edu.cn		zhang, yongyou/0000-0003-2413-9106	National Natural Science Foundation of China [81970485, 81772942, 81901597]; National Basic Research Program of China (973 Program) [2015CB553800]; National Science and Technology Major Project of China [2017ZX10203206]; Scientific Research Foundation for Advanced Talents, Xiang'an Hospital of Xiamen University [PM20180917008]; Natural Science Foundation of Fujian Province [2017J01268]; National Health and Family Planning Commission's Scientific Research Foundation-Health and Education cooperation foundation [WKJ2016-2-17]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Science and Technology Major Project of China; Scientific Research Foundation for Advanced Talents, Xiang'an Hospital of Xiamen University; Natural Science Foundation of Fujian Province(Natural Science Foundation of Fujian Province); National Health and Family Planning Commission's Scientific Research Foundation-Health and Education cooperation foundation	We thank Shiwen Luo (Nanchang University) for providing Gli2 expression plasmid and Hedgehog signaling reporter 8xGBS, Chenglin Bian for TCGA data analysis, and Lei Huang for technical support. This study was supported by grants from the National Natural Science Foundation of China (no. 81970485 to CY), the National Natural Science Foundation of China (no. 81772942 to CY), the National Basic Research Program of China (973 Program, no. 2015CB553800 to CY), the National Natural Science Foundation of China (no. 81901597 to WC), the National Science and Technology Major Project of China (2017ZX10203206 to WL), the Scientific Research Foundation for Advanced Talents, Xiang'an Hospital of Xiamen University (no. PM20180917008 to WL), the Natural Science Foundation of Fujian Province (2017J01268 to XQ), and the National Health and Family Planning Commission's Scientific Research Foundation-Health and Education cooperation foundation (WKJ2016-2-17 to XQ).	Accari SL, 2015, INT REV CEL MOL BIO, V319, P165, DOI 10.1016/bs.ircmb.2015.07.003; Baron JA, 2003, NEW ENGL J MED, V348, P891, DOI 10.1056/NEJMoa021735; Berlin J, 2013, CLIN CANCER RES, V19, P258, DOI 10.1158/1078-0432.CCR-12-1800; Berry WL, 2013, CANCER RES, V73, P2936, DOI 10.1158/0008-5472.CAN-12-4300; Buller NVJA, 2012, PHYSIOLOGY, V27, P148, DOI 10.1152/physiol.00003.2012; Catenacci DVT, 2015, J CLIN ONCOL, V33, P4284, DOI 10.1200/JCO.2015.62.8719; Chen WB, 2018, INT J BIOL SCI, V14, P2051, DOI 10.7150/ijbs.28576; Dai P, 1999, J BIOL CHEM, V274, P8143, DOI 10.1074/jbc.274.12.8143; Das S, 2016, ONCOGENE, V35, P2645, DOI 10.1038/onc.2015.327; Elinav E, 2013, NAT REV CANCER, V13, P759, DOI 10.1038/nrc3611; Fattahi S, 2018, J CELL PHYSIOL, V233, P5726, DOI 10.1002/jcp.26506; Feagins LA, 2009, NAT REV GASTRO HEPAT, V6, P297, DOI 10.1038/nrgastro.2009.44; Geng H, 2018, GASTROENTEROLOGY, V155, P144, DOI 10.1053/j.gastro.2018.03.058; Greten FR, 2004, CELL, V118, P285, DOI 10.1016/j.cell.2004.07.013; Ikram MS, 2004, J INVEST DERMATOL, V122, P1503, DOI 10.1111/j.0022-202X.2004.22612.x; Jiang J, 2008, DEV CELL, V15, P801, DOI 10.1016/j.devcel.2008.11.010; Kasper M, 2006, EUR J CANCER, V42, P437, DOI 10.1016/j.ejca.2005.08.039; KOPP E, 1994, SCIENCE, V265, P956, DOI 10.1126/science.8052854; Lees CW, 2008, PLOS MED, V5, P1761, DOI 10.1371/journal.pmed.0050239; Markowitz SD, 2009, NEW ENGL J MED, V361, P2449, DOI 10.1056/NEJMra0804588; Mizushima T, 2013, AM J PATHOL, V183, P1936, DOI 10.1016/j.ajpath.2013.08.012; Naito Y, 2003, J GASTROEN HEPATOL, V18, P560, DOI 10.1046/j.1440-1746.2003.03034.x; Onizawa M, 2009, AM J PHYSIOL-GASTR L, V296, pG850, DOI 10.1152/ajpgi.00071.2008; Peng KS, 2019, GASTROENTEROLOGY, V156, P1112, DOI 10.1053/j.gastro.2018.11.036; Pugliese D, 2017, EXPERT REV CLIN IMMU, V13, P223, DOI 10.1080/1744666X.2017.1243468; Ranganathan P, 2013, AM J PHYSIOL-RENAL, V305, pF1422, DOI 10.1152/ajprenal.00319.2013; Regl G, 2004, CANCER RES, V64, P7724, DOI 10.1158/0008-5472.CAN-04-1085; Rominger CM, 2009, J PHARMACOL EXP THER, V329, P995, DOI 10.1124/jpet.109.152090; Sandler RS, 2003, NEW ENGL J MED, V348, P883, DOI 10.1056/NEJMoa021633; Schwitalla S, 2013, CANCER CELL, V23, P93, DOI 10.1016/j.ccr.2012.11.014; Sekulic A, 2017, BMC CANCER, V17, DOI 10.1186/s12885-017-3286-5; Sekulic A, 2012, NEW ENGL J MED, V366, P2171, DOI 10.1056/NEJMoa1113713; Sipos Ferenc, 2002, Orv Hetil, V143, P2485; Terzic J, 2010, GASTROENTEROLOGY, V138, P2101, DOI 10.1053/j.gastro.2010.01.058; Tong ZW, 2015, J BIOL CHEM, V290, P18596, DOI 10.1074/jbc.M115.640490; Ullman TA, 2011, GASTROENTEROLOGY, V140, P1807, DOI 10.1053/j.gastro.2011.01.057; Varnat F, 2009, EMBO MOL MED, V1, P338, DOI 10.1002/emmm.200900039; Wang Y, 2013, LAB INVEST, V93, P1024, DOI 10.1038/labinvest.2013.89; Whetstine JR, 2006, CELL, V125, P467, DOI 10.1016/j.cell.2006.03.028; Wirtz S, 2017, NAT PROTOC, V12, P1295, DOI 10.1038/nprot.2017.044; Xiao YT, 2016, CYTOKINE, V83, P189, DOI 10.1016/j.cyto.2016.04.012; Xu YH, 2007, IMMUNOL CELL BIOL, V85, P633, DOI 10.1038/sj.icb.7100112; Yin MJ, 1998, NATURE, V396, P77, DOI 10.1038/23948; Zhao B, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8166	44	18	17	9	23	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 16	2020	39	16					3336	3353		10.1038/s41388-020-1219-2	http://dx.doi.org/10.1038/s41388-020-1219-2		FEB 2020	18	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	QF9OJ	32094404				2022-12-26	WOS:000515475800001
J	Majumdar, A; Trinh, V; Moore, KJ; Smallwood, CR; Kumar, A; Yang, TH; Scott, DC; Long, NJ; Newton, SM; Klebba, PE				Majumdar, Aritri; Trinh, Vy; Moore, Kyle J.; Smallwood, Chuck R.; Kumar, Ashish; Yang, Taihao; Scott, Daniel C.; Long, Noah J.; Newton, Salete M.; Klebba, Phillip E.			Conformational rearrangements in the N-domain of Escherichia coli FepA during ferric enterobactin transport	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						membrane transport; iron; outer membrane; disulfide; site-directed mutagenesis; siderophore; FepA; fluorescent sensor	LOW-COPY-NUMBER; OUTER-MEMBRANE; CRYSTAL-STRUCTURE; RECEPTOR PROTEIN; PSEUDOMONAS-AERUGINOSA; DEPENDENT TRANSPORT; STRUCTURAL BASIS; IRON TRANSPORT; TONB; CHANNELS	The Escherichia coli outer membrane receptor FepA transports ferric enterobactin (FeEnt) by an energy- and TonB-dependent, but otherwise a mechanistically undetermined process involving its internal 150-residue N-terminal globular domain (N-domain). We genetically introduced pairs of Cys residues in different regions of the FepA tertiary structure, with the potential to form disulfide bonds. These included Cys pairs on adjacent ?-strands of the N-domain (intra-N) and Cys pairs that bridged the external surface of the N-domain to the interior of the C-terminal transmembrane ?-barrel (inter-N?C). We characterized FeEnt uptake by these mutants with siderophore nutrition tests, [Fe-59]Ent binding and uptake experiments, and fluorescence decoy sensor assays. The three methods consistently showed that the intra-N disulfide bonds, which restrict conformational motion within the N-domain, prevented FeEnt uptake, whereas most inter-N?C disulfide bonds did not prevent FeEnt uptake. These outcomes indicate that conformational rearrangements must occur in the N terminus of FepA during FeEnt transport. They also argue against disengagement of the N-domain out of the channel as a rigid body and suggest instead that it remains within the transmembrane pore as FeEnt enters the periplasm.	[Majumdar, Aritri; Kumar, Ashish; Yang, Taihao; Long, Noah J.; Newton, Salete M.; Klebba, Phillip E.] Kansas State Univ, Dept Biochem & Mol Biophys, 141 Chalmers Hall, Manhattan, KS 66506 USA; [Trinh, Vy] Univ Oklahoma, Dept Chem & Biochem, Norman, OK 73019 USA; [Moore, Kyle J.] Cameron Univ, Dept Chem Phys & Engn, Lawton, OK 73505 USA; [Smallwood, Chuck R.] Sandia Natl Labs, POB 5800, Albuquerque, NM 87185 USA; [Scott, Daniel C.] St Jude Childrens Res Hosp, Howard Hughes Med Inst, Memphis, TN 38105 USA	Kansas State University; University of Oklahoma System; University of Oklahoma - Norman; United States Department of Energy (DOE); Sandia National Laboratories; Howard Hughes Medical Institute; St Jude Children's Research Hospital	Klebba, PE (corresponding author), Kansas State Univ, Dept Biochem & Mol Biophys, 141 Chalmers Hall, Manhattan, KS 66506 USA.	peklebba@ksu.edu	Smallwood, Chuck/P-5421-2017	Smallwood, Chuck/0000-0003-2221-5726	National Science Foundation [MCB09522999]; National Institutes of Health [GM53836, AI115187]	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by National Science Foundation Grant MCB09522999 and National Institutes of Health Grants GM53836 and AI115187. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Annamalai R, 2004, J BACTERIOL, V186, P3578, DOI 10.1128/JB.186.11.3578-3589.2004; BARDWELL JCA, 1994, MOL MICROBIOL, V14, P199, DOI 10.1111/j.1365-2958.1994.tb01281.x; Buchanan SK, 1999, NAT STRUCT BIOL, V6, P56; Buckling A, 2007, FEMS MICROBIOL ECOL, V62, P135, DOI 10.1111/j.1574-6941.2007.00388.x; Cao Z, 2002, BIOCHIMIE, V84, P399, DOI 10.1016/S0300-9084(02)01455-4; Cao ZH, 2000, MOL MICROBIOL, V37, P1306, DOI 10.1046/j.1365-2958.2000.02093.x; Cao ZH, 2003, J BIOL CHEM, V278, P1022, DOI 10.1074/jbc.M210360200; Chakravorty S, 2019, J BIOL CHEM, V294, P4682, DOI 10.1074/jbc.RA118.006921; Chimento DP, 2003, NAT STRUCT BIOL, V10, P394, DOI 10.1038/nsb914; Cobessi D, 2005, J MOL BIOL, V352, P893, DOI 10.1016/j.jmb.2005.08.004; Cobessi D, 2005, J MOL BIOL, V347, P121, DOI 10.1016/j.jmb.2005.01.021; Cornelissen CN, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00117; COWAN SW, 1992, NATURE, V358, P727, DOI 10.1038/358727a0; Dhople AM, 1996, MICROBIOS, V87, P77; DIMASI DR, 1973, J BACTERIOL, V115, P506, DOI 10.1128/JB.115.2.506-513.1973; Eisenbeis S, 2008, J BACTERIOL, V190, P5230, DOI 10.1128/JB.00194-08; Ferguson AD, 2002, SCIENCE, V295, P1715, DOI 10.1126/science.1067313; Ferguson AD, 1998, SCIENCE, V282, P2215, DOI 10.1126/science.282.5397.2215; Fetherston JD, 2010, INFECT IMMUN, V78, P2045, DOI 10.1128/IAI.01236-09; FURMAN M, 1994, INFECT IMMUN, V62, P4091, DOI 10.1128/IAI.62.9.4091-4094.1994; Gleiter S, 2008, BBA-MOL CELL RES, V1783, P530, DOI 10.1016/j.bbamcr.2008.02.009; Goldstone D, 2001, P NATL ACAD SCI USA, V98, P9551, DOI 10.1073/pnas.171315498; Gumbart J, 2007, BIOPHYS J, V93, P496, DOI 10.1529/biophysj.107.104158; HANCOCK REW, 1976, FEBS LETT, V65, P208, DOI 10.1016/0014-5793(76)80481-4; HASHIMOTOGOTOH T, 1981, GENE, V16, P227, DOI 10.1016/0378-1119(81)90079-2; HOLLIFIELD WC, 1978, BIOCHEM BIOPH RES CO, V83, P739, DOI 10.1016/0006-291X(78)91051-3; Jordan LD, 2013, P NATL ACAD SCI USA, V110, P11553, DOI 10.1073/pnas.1304243110; Josts I, 2019, ELIFE, V8, DOI 10.7554/eLife.48528; KLEBBA PE, 1982, J BACTERIOL, V149, P880, DOI 10.1128/JB.149.3.880-888.1982; KLEBBA PE, 1994, EMBO J, V13, P4670, DOI 10.1002/j.1460-2075.1994.tb06790.x; Konings AF, 2013, INFECT IMMUN, V81, P2697, DOI 10.1128/IAI.00418-13; Larson JA, 2002, INFECT IMMUN, V70, P1461, DOI 10.1128/IAI.70.3.1461-1467.2002; le Coutret J, 2000, BIOPOLYMERS, V55, P297, DOI 10.1002/1097-0282(2000)55:4<297::AID-BIP1003>3.0.CO;2-H; LIU J, 1994, BIOCHEMISTRY-US, V33, P13274, DOI 10.1021/bi00249a014; Locher KP, 1998, CELL, V95, P771, DOI 10.1016/S0092-8674(00)81700-6; Lohmiller S, 2008, MICROBIOL-SGM, V154, P1748, DOI 10.1099/mic.0.2008/017350-0; LUCKEY M, 1980, BIOCHEM BIOPH RES CO, V93, P166, DOI 10.1016/S0006-291X(80)80261-0; LUCKEY M, 1980, P NATL ACAD SCI-BIOL, V77, P167, DOI 10.1073/pnas.77.1.167; LUGTENBERG B, 1975, FEBS LETT, V58, P254, DOI 10.1016/0014-5793(75)80272-9; Lukacik P, 2012, P NATL ACAD SCI USA, V109, P9857, DOI 10.1073/pnas.1203472109; Ma L, 2007, J BIOL CHEM, V282, P397, DOI 10.1074/jbc.M605333200; Mainathambika BS, 2008, ANNU REV CELL DEV BI, V24, P211, DOI 10.1146/annurev.cellbio.24.110707.175333; Mortensen BL, 2013, FRONT CELL INFECT MI, V3, DOI 10.3389/fcimb.2013.00095; Moynie L, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11508-y; MURPHY CK, 1990, J BACTERIOL, V172, P2736, DOI 10.1128/jb.172.5.2736-2746.1990; Nairn BL, 2017, J BACTERIOL, V199, DOI 10.1128/JB.00889-16; NEIDHARDT FC, 1974, J BACTERIOL, V119, P736, DOI 10.1128/JB.119.3.736-747.1974; Neugebauer H, 2005, J BACTERIOL, V187, P8300, DOI 10.1128/JB.187.24.8300-8311.2005; Newton SM, 2010, J BIOL CHEM, V285, P17488, DOI 10.1074/jbc.M109.100206; Newton SMC, 1999, MOL MICROBIOL, V32, P1153, DOI 10.1046/j.1365-2958.1999.01424.x; NIKAIDO H, 1981, J GEN PHYSIOL, V77, P121, DOI 10.1085/jgp.77.2.121; NIKAIDO H, 1983, J BACTERIOL, V153, P241, DOI 10.1128/JB.153.1.241-252.1983; Nikaido H, 2003, MICROBIOL MOL BIOL R, V67, P593, DOI 10.1128/MMBR.67.4.593-656.2003; NOEL D, 1979, BIOCHEMISTRY-US, V18, P4159, DOI 10.1021/bi00586a017; Noinaj N, 2010, ANNU REV MICROBIOL, V64, P43, DOI 10.1146/annurev.micro.112408.134247; Pawelek PD, 2006, SCIENCE, V312, P1399, DOI 10.1126/science.1128057; Payne MA, 1997, J BIOL CHEM, V272, P21950, DOI 10.1074/jbc.272.35.21950; RUTZ JM, 1992, SCIENCE, V258, P471, DOI 10.1126/science.1411544; Saier MH, 2000, J MEMBRANE BIOL, V175, P165, DOI 10.1007/s00232001065; Schauer K, 2008, TRENDS BIOCHEM SCI, V33, P330, DOI 10.1016/j.tibs.2008.04.012; SCHIRMER T, 1995, SCIENCE, V267, P512, DOI 10.1126/science.7824948; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schoolnik GK, 2002, ADV MICROB PHYSIOL, V46, P1, DOI 10.1016/S0065-2911(02)46001-8; Scott DC, 2001, J BIOL CHEM, V276, P13025, DOI 10.1074/jbc.M011282200; Shultis DD, 2006, SCIENCE, V312, P1396, DOI 10.1126/science.1127694; Smallwood CR, 2014, J GEN PHYSIOL, V144, P69, DOI 10.1085/jgp.201311159; Smallwood CR, 2009, MOL MICROBIOL, V72, P1171, DOI 10.1111/j.1365-2958.2009.06715.x; SMIT J, 1975, J BACTERIOL, V124, P942, DOI 10.1128/JB.124.2.942-958.1975; Smith KD, 2007, INT J BIOCHEM CELL B, V39, P1776, DOI 10.1016/j.biocel.2007.07.003; TAKESHITA S, 1987, GENE, V61, P63, DOI 10.1016/0378-1119(87)90365-9; Tapley TL, 2007, J BIOL CHEM, V282, P10263, DOI 10.1074/jbc.M611541200; Torres AG, 2001, INFECT IMMUN, V69, P6179, DOI 10.1128/IAI.69.10.6179-6185.2001; Torres VJ, 2006, J BACTERIOL, V188, P8421, DOI 10.1128/JB.01335-06; WAYNE R, 1976, J BACTERIOL, V126, P7, DOI 10.1128/JB.126.1.7-12.1976; WEISS MS, 1990, FEBS LETT, V267, P268, DOI 10.1016/0014-5793(90)80942-C; Zhai YF, 2003, BBA-BIOMEMBRANES, V1614, P201, DOI 10.1016/S0005-2736(03)00176-7	76	5	6	0	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 10	2020	295	15					4974	4984		10.1074/jbc.RA119.011850	http://dx.doi.org/10.1074/jbc.RA119.011850			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LE7FC	32098871	hybrid, Green Published			2022-12-26	WOS:000526887000020
J	Ariana, A; Alturki, NA; Hajjar, S; Stumpo, DJ; Tiedje, C; Alnemri, ES; Gaestel, M; Blackshear, PJ; Sad, S				Ariana, Ardeshir; Alturki, Norah A.; Hajjar, Stephanie; Stumpo, Deborah J.; Tiedje, Christopher; Alnemri, Emad S.; Gaestel, Matthias; Blackshear, Perry J.; Sad, Subash			Tristetraprolin regulates necroptosis during tonic Toll-like receptor 4 (TLR4) signaling in murine macrophages	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						inflammation; cell death; Toll-like receptor 4 (TLR4); necrosis; necrotic death; cytokine; tristetraprolin; ZFP36 ring finger protein (ZFP36); necrosome	TUMOR-NECROSIS-FACTOR; CELL-DEATH; TNF-ALPHA; PROGRAMMED NECROSIS; RIPK1; INFLAMMATION; BINDING; PHOSPHORYLATION; INHIBITOR; CASPASE-8	The necrosome is a protein complex required for signaling in cells that results in necroptosis, which is also dependent on tumor necrosis factor receptor (TNF-R) signaling. TNF? promotes necroptosis, and its expression is facilitated by mitogen-activated protein (MAP) kinase?activated protein kinase 2 (MK2) but is inhibited by the RNA-binding protein tristetraprolin (TTP, encoded by the Zfp36 gene). We have stimulated murine macrophages from WT, MyD88(?/?), Trif(?/?), MyD88(?/?)Trif(?/?), MK2(?/?), and Zfp36(?/?) mice with graded doses of lipopolysaccharide (LPS) and various inhibitors to evaluate the role of various genes in Toll-like receptor 4 (TLR4)?induced necroptosis. Necrosome signaling, cytokine production, and cell death were evaluated by immunoblotting, ELISA, and cell death assays, respectively. We observed that during TLR4 signaling, necrosome activation is mediated through the adaptor proteins MyD88 and TRIF, and this is inhibited by MK2. In the absence of MK2-mediated necrosome activation, lipopolysaccharide-induced TNF? expression was drastically reduced, but MK2-deficient cells became highly sensitive to necroptosis even at low TNF? levels. In contrast, during tonic TLR4 signaling, WT cells did not undergo necroptosis, even when MK2 was disabled. Of note, necroptosis occurred only in the absence of TTP and was mediated by the expression of TNF? and activation of JUN N-terminal kinase (JNK). These results reveal that TTP plays an important role in inhibiting TNF?/JNK-induced necrosome signaling and resultant cytotoxicity.	[Ariana, Ardeshir; Alturki, Norah A.; Hajjar, Stephanie; Sad, Subash] Univ Ottawa, Fac Med, Dept Biochem Microbiol & Immunol, Ottawa, ON K1H 8M5, Canada; [Stumpo, Deborah J.] NIEHS, Signal Transduct Lab, Res Triangle Pk, NC 27709 USA; [Tiedje, Christopher; Blackshear, Perry J.] Univ Copenhagen, Dept Cellular & Mol Med, Maersk Tower 7-3,Blegdamsvej 3B, DK-2200 Copenhagen, Denmark; [Tiedje, Christopher; Gaestel, Matthias] Hannover Med Sch, Inst Cell Biochem, D-30623 Hannover, Germany; [Alnemri, Emad S.] Thomas Jefferson Univ, Dept Biochem & Mol Biol, Philadelphia, PA 19107 USA; [Sad, Subash] Univ Ottawa, Ctr Infect Immun & Inflammat, Ottawa, ON K1H 8M5, Canada	University of Ottawa; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); University of Copenhagen; Hannover Medical School; Jefferson University; University of Ottawa	Sad, S (corresponding author), Univ Ottawa, Fac Med, Dept Biochem Microbiol & Immunol, Ottawa, ON K1H 8M5, Canada.; Sad, S (corresponding author), Univ Ottawa, Ctr Infect Immun & Inflammat, Ottawa, ON K1H 8M5, Canada.	subash.sad@uottawa.ca	Gaestel, Matthias/A-6560-2013; Blackshear, Perry/C-6206-2019	Gaestel, Matthias/0000-0002-4944-4652; Tiedje, Christopher/0000-0002-3013-6967; Blackshear, Perry/0000-0002-9561-8529; alturki, Norah/0000-0003-0608-4797; Sad, Subash/0000-0002-2462-7137; Ariana, Ardeshir/0000-0003-2206-9829	Natural Sciences and Engineering Research Council (NSERC) [RGPIN-2017-03836]; Canadian Institutes of Health Research (CIHR) [375862]; Intramural Research Program of the NIEHS, National Institutes of Health	Natural Sciences and Engineering Research Council (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Intramural Research Program of the NIEHS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by Natural Sciences and Engineering Research Council (NSERC) Grant RGPIN-2017-03836 and by Canadian Institutes of Health Research (CIHR) Grant 375862 (to S. S.). This work was also supported by the Intramural Research Program of the NIEHS, National Institutes of Health (to P. J. B. and D. J. S.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Alturki NA, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0672-0; Arthur JSC, 2013, NAT REV IMMUNOL, V13, P679, DOI 10.1038/nri3495; Berger SB, 2014, J IMMUNOL, V192, P5476, DOI 10.4049/jimmunol.1400499; Brodsky IE, 2009, NAT CELL BIOL, V11, P521, DOI 10.1038/ncb0509-521; Brumatti G, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aad3099; Cao MT, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-1189-2; Carballo E, 1998, SCIENCE, V281, P1001, DOI 10.1126/science.281.5379.1001; Carballo E, 2001, J BIOL CHEM, V276, P42580, DOI 10.1074/jbc.M104953200; Cho Y, 2009, CELL, V137, P1112, DOI 10.1016/j.cell.2009.05.037; Christofferson DE, 2010, CURR OPIN CELL BIOL, V22, P263, DOI 10.1016/j.ceb.2009.12.003; Conte D, 2006, MOL CELL BIOL, V26, P699, DOI 10.1128/MCB.26.2.699-708.2006; Declercq W, 2009, CELL, V138, P229, DOI 10.1016/j.cell.2009.07.006; Degterev A, 2005, NAT CHEM BIOL, V1, P112, DOI 10.1038/nchembio711; Dillon CP, 2014, CELL, V157, P1189, DOI 10.1016/j.cell.2014.04.018; Dillon CP, 2012, CELL REPORTS, V1, P401, DOI 10.1016/j.celrep.2012.03.010; Dondelinger Y, 2017, NAT CELL BIOL, V19, P1237, DOI 10.1038/ncb3608; Duprez L, 2011, IMMUNITY, V35, P908, DOI 10.1016/j.immuni.2011.09.020; Eckmann L, 2001, MICROBES INFECT, V3, P1191, DOI 10.1016/S1286-4579(01)01479-4; Festjens N, 2006, BBA-BIOENERGETICS, V1757, P1371, DOI 10.1016/j.bbabio.2006.06.014; Galluzzi L, 2008, CELL, V135, P1161, DOI 10.1016/j.cell.2008.12.004; Geng JF, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00406-w; Gunther C, 2011, NATURE, V477, P335, DOI 10.1038/nature10400; Haneklaus M, 2017, J BIOL CHEM, V292, P6869, DOI 10.1074/jbc.M116.772947; He SD, 2011, P NATL ACAD SCI USA, V108, P20054, DOI 10.1073/pnas.1116302108; Hitomi JI, 2008, CELL, V135, P1311, DOI 10.1016/j.cell.2008.10.044; Hitti E, 2006, MOL CELL BIOL, V26, P2399, DOI 10.1128/MCB.26.6.2399-2407.2006; Hughes MA, 2016, MOL CELL, V61, P834, DOI 10.1016/j.molcel.2016.02.023; Ito Y, 2016, SCIENCE, V353, P603, DOI 10.1126/science.aaf6803; Jaco I, 2017, MOL CELL, V66, P698, DOI 10.1016/j.molcel.2017.05.003; Kaczmarek A, 2013, IMMUNITY, V38, P209, DOI 10.1016/j.immuni.2013.02.003; Kaiser WJ, 2011, NATURE, V471, P368, DOI 10.1038/nature09857; Karunakaran D, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1600224; Kearney CJ, 2014, FEBS J, V281, P4921, DOI 10.1111/febs.13034; Kotlyarov A, 1999, NAT CELL BIOL, V1, P94, DOI 10.1038/10061; Lalaoui N, 2016, CANCER CELL, V29, P145, DOI 10.1016/j.ccell.2016.01.006; Legarda D, 2016, CELL REP, V15, P2449, DOI 10.1016/j.celrep.2016.05.032; McComb S, 2012, CELL DEATH DIFFER, V19, P1791, DOI 10.1038/cdd.2012.59; McComb S, 2014, P NATL ACAD SCI USA, V111, pE3206, DOI 10.1073/pnas.1407068111; McComb S, 2014, J IMMUNOL, V192, P5671, DOI 10.4049/jimmunol.1303380; Menon MB, 2017, NAT CELL BIOL, V19, P1248, DOI 10.1038/ncb3614; Meylan E, 2004, NAT IMMUNOL, V5, P503, DOI 10.1038/ni1061; Najjar M, 2016, IMMUNITY, V45, P46, DOI 10.1016/j.immuni.2016.06.007; Neininger A, 2002, J BIOL CHEM, V277, P3065, DOI 10.1074/jbc.C100685200; Newton K, 2014, SCIENCE, V343, P1357, DOI 10.1126/science.1249361; Oberst A, 2011, NATURE, V471, P363, DOI 10.1038/nature09852; Ofengeim D, 2015, CELL REP, V10, P1836, DOI 10.1016/j.celrep.2015.02.051; Pasparakis M, 2015, NATURE, V517, P311, DOI 10.1038/nature14191; Rijal D, 2018, J BIOL CHEM, V293, P11913, DOI 10.1074/jbc.RA118.003614; Robinson N, 2012, NAT IMMUNOL, V13, P954, DOI 10.1038/ni.2397; Sabio G, 2014, SEMIN IMMUNOL, V26, P237, DOI 10.1016/j.smim.2014.02.009; Selmi T, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1388-5; Shutinoski B, 2016, CELL DEATH DIFFER, V23, P1628, DOI 10.1038/cdd.2016.51; Taylor GA, 1996, IMMUNITY, V4, P445, DOI 10.1016/S1074-7613(00)80411-2; Tenev T, 2011, MOL CELL, V43, P432, DOI 10.1016/j.molcel.2011.06.006; Tiedje C, 2016, NUCLEIC ACIDS RES, V44, P7418, DOI 10.1093/nar/gkw474; Vandenabeele P, 2010, NAT REV MOL CELL BIO, V11, P700, DOI 10.1038/nrm2970; Wang W, 2018, CANCER CELL, V34, P757, DOI 10.1016/j.ccell.2018.10.006	57	5	5	3	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 3	2020	295	14					4661	4672		10.1074/jbc.RA119.011633	http://dx.doi.org/10.1074/jbc.RA119.011633			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LB2WZ	32094226	hybrid, Green Published			2022-12-26	WOS:000524499700024
J	Raz, Y; van den Akker, EB; Roest, T; Riaz, M; van de Rest, O; Suchiman, HED; Lakenberg, N; Stassen, SA; van Putten, M; Feskens, EJM; Reinders, MJT; Goeman, J; Beekman, M; Raz, V; Slagboom, PE				Raz, Yotam; van den Akker, Erik B.; Roest, Tijmen; Riaz, Muhammad; van de Rest, Ondine; Suchiman, H. Eka D.; Lakenberg, Nico; Stassen, Stefanie A.; van Putten, Maaike; Feskens, Edith J. M.; Reinders, Marcel J. T.; Goeman, Jelle; Beekman, Marian; Raz, Vered; Slagboom, Pieternella Eline			A data-driven methodology reveals novel myofiber clusters in older human muscles	FASEB JOURNAL			English	Article						bioinformatics; clustering; fibertyping; human; muscle; muscle health; myofiber; myosin heavy chain; RNA-sequencing; sarcomere	SKELETAL-MUSCLE; SARCOPLASMIC-RETICULUM; PROTEASOMAL ACTIVITY; ISOFORMS; FIBERS; SLOW; MEN	Skeletal muscles control posture, mobility and strength, and influence whole-body metabolism. Muscles are built of different types of myofibers, each having specific metabolic, molecular, and contractile properties. Fiber classification is, therefore, regarded the key for understanding muscle biology, (patho-) physiology. The expression of three myosin heavy chain (MyHC) isoforms, MyHC-1, MyHC-2A, and MyHC-2X, marks myofibers in humans. Typically, myofiber classification is performed by an eye-based histological analysis. This classical approach is insufficient to capture complex fiber classes, expressing more than one MyHC-isoform. We, therefore, developed a methodological procedure for high-throughput characterization of myofibers on the basis of multiple isoforms. The mean fluorescence intensity of the three most abundant MyHC isoforms was measured per myofiber in muscle biopsies of 56 healthy elderly adults, and myofiber classes were identified using computational biology tools. Unsupervised clustering revealed the existence of six distinct myofiber clusters. A comparison with the visual assessment of myofibers using the same images showed that some of these myofiber clusters could not be detected or were frequently misclassified. The presence of these six clusters was reinforced by RNA expressions levels of sarcomeric genes. In addition, one of the clusters, expressing all three MyHC isoforms, correlated with histological measures of muscle health. To conclude, this methodological procedure enables deep characterization of the complex muscle heterogeneity. This study opens opportunities to further investigate myofiber composition in comparative studies.	[Raz, Yotam; van den Akker, Erik B.; Roest, Tijmen; Suchiman, H. Eka D.; Lakenberg, Nico; Beekman, Marian; Slagboom, Pieternella Eline] Leiden Univ, Med Ctr, Sect Mol Epidemiol, NL-2300 RC Leiden, Netherlands; [van den Akker, Erik B.; Reinders, Marcel J. T.] Leiden Univ, Med Ctr, Leiden Computat Biol Ctr, Leiden, Netherlands; [van den Akker, Erik B.; Reinders, Marcel J. T.] Delft Univ Technol, Delft Bioinformat Lab, Delft, Netherlands; [Riaz, Muhammad; van Putten, Maaike; Raz, Vered] Leiden Univ, Med Ctr, Dept Human Genet, Leiden, Netherlands; [van de Rest, Ondine; Feskens, Edith J. M.] Wageningen Univ & Res, Div Human Nutr, Wageningen, Netherlands; [Stassen, Stefanie A.] Leiden Univ, Med Ctr, Sect Gerontol & Geriatr, Leiden, Netherlands; [Goeman, Jelle] Leiden Univ, Med Ctr, Dept Med Stat, Leiden, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Delft University of Technology; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Wageningen University & Research; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	van den Akker, EB (corresponding author), Leiden Univ, Med Ctr, Sect Mol Epidemiol, NL-2300 RC Leiden, Netherlands.	e.b.van_den_akker@lumc.nl	Feskens, Edith/ABI-1446-2020; Goeman, Jelle/AAT-1300-2020; Suchiman, H. Eka D./F-5024-2017	Feskens, Edith/0000-0001-5819-2488; Goeman, Jelle/0000-0003-4283-0259; van Putten, Maaike/0000-0002-0683-8897; Suchiman, H. Eka D./0000-0002-7168-5516; raz, vered/0000-0003-3152-1952	European Union's Seventh Framework Programme [259679]; Netherlands Consortium for Healthy Aging [050-060-810]; Netherlands Genomics Initiative, Netherlands Organization for Scientific Research (NWO); BMRI-NL, a Research Infrastructure financed by the Dutch government [NWO 184.021.007]; French Muscular Dystrophy Association (AFM-Telethon) [21160]; Leiden University Medical Center	European Union's Seventh Framework Programme(European Commission); Netherlands Consortium for Healthy Aging; Netherlands Genomics Initiative, Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); BMRI-NL, a Research Infrastructure financed by the Dutch government; French Muscular Dystrophy Association (AFM-Telethon); Leiden University Medical Center	The research leading to these results has received funding from the European Union's Seventh Framework Programme (FP7/2007-2011) under grant agreement number 259679. This study was supported by the Netherlands Consortium for Healthy Aging (grant 050-060-810), in the framework of the Netherlands Genomics Initiative, Netherlands Organization for Scientific Research (NWO); by BBMRI-NL, a Research Infrastructure financed by the Dutch government (NWO 184.021.007) to PES and EJMF This study was also supported by French Muscular Dystrophy Association (AFM-Telethon), grant 21160 to VR YR received funding from the Leiden University Medical Center, in the framework of the MD/PhD-track.	Andersen JL, 1999, MUSCLE NERVE, V22, P449, DOI 10.1002/(SICI)1097-4598(199904)22:4<449::AID-MUS4>3.3.CO;2-U; Andersen JL, 1999, J APPL PHYSIOL, V86, P455, DOI 10.1152/jappl.1999.86.2.455; Bloemberg D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035273; Bonder MJ, 2017, NAT GENET, V49, P131, DOI 10.1038/ng.3721; BOROSHATFALUDY S, 1986, EUR J APPL PHYSIOL O, V55, P334, DOI 10.1007/BF02343809; Chemello F, 2019, CELL REP, V26, P3784, DOI 10.1016/j.celrep.2019.02.105; Ciciliot S, 2013, INT J BIOCHEM CELL B, V45, P2191, DOI 10.1016/j.biocel.2013.05.016; Engel WK, 2015, BBA-MOL BASIS DIS, V1852, P563, DOI 10.1016/j.bbadis.2014.11.015; ENGEL WK, 1970, ARCH NEUROL-CHICAGO, V22, P97, DOI 10.1001/archneur.1970.00480200003001; Francioli LC, 2014, NAT GENET, V46, P818, DOI 10.1038/ng.3021; Frontera WR, 2000, J APPL PHYSIOL, V88, P1321; Gehlert S, 2012, EUR J APPL PHYSIOL, V112, P2393, DOI 10.1007/s00421-011-2209-4; GIACOMEL.F, 1967, NATURE, V213, P679, DOI 10.1038/213679a0; Giordani L, 2019, MOL CELL, V74, P609, DOI 10.1016/j.molcel.2019.02.026; Gregorevic P, 2008, MUSCLE NERVE, V37, P104, DOI 10.1002/mus.20877; Hu X, 2017, SKELET MUSCLE, V7, DOI 10.1186/s13395-017-0143-9; Kim J, 2014, METHODS MOL BIOL, V1213, P245, DOI 10.1007/978-1-4939-1453-1_20; KLITGAARD H, 1990, ACTA PHYSIOL SCAND, V140, P41, DOI 10.1111/j.1748-1716.1990.tb08974.x; Kragstrup TW, 2011, SCAND J MED SCI SPOR, V21, P749, DOI 10.1111/j.1600-0838.2011.01377.x; LEXELL J, 1995, J GERONTOL A-BIOL, V50, P11; Mackey AL, 2009, MUSCLE NERVE, V40, P455, DOI 10.1002/mus.21369; MARIN P, 1994, DIABETES CARE, V17, P382, DOI 10.2337/diacare.17.5.382; MIDRIO M, 1992, PFLUG ARCH EUR J PHY, V420, P446, DOI 10.1007/BF00374618; Murgia M, 2017, CELL REP, V19, P2396, DOI 10.1016/j.celrep.2017.05.054; Nigro V, 2015, BBA-MOL BASIS DIS, V1852, P585, DOI 10.1016/j.bbadis.2014.07.023; Ogata T, 1997, ANAT REC, V248, P214; Olie CS, 2019, ISCIENCE, V12, P318, DOI 10.1016/j.isci.2019.01.024; Purves-Smith FM, 2014, EXERC SPORT SCI REV, V42, P45, DOI 10.1249/JES.0000000000000012; Raz V, 2019, FASEB J, V33, P4046, DOI 10.1096/fj.201801714R; Raz V, 2018, FASEB J, V32, P1579, DOI 10.1096/fj.201700861R; Raz V, 2017, J CACHEXIA SARCOPENI, V8, P798, DOI 10.1002/jcsm.12211; Raz Y, 2015, FRONT AGING NEUROSCI, V7, DOI 10.3389/fnagi.2015.00236; Riaz M, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006031; Robinson MM, 2017, CELL METAB, V25, P581, DOI 10.1016/j.cmet.2017.02.009; Rowan SL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029082; Sawano S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166080; SCHIAFFINO S, 1994, J APPL PHYSIOL, V77, P493, DOI 10.1152/jappl.1994.77.2.493; Schutte BAM, 2016, SCI REP-UK, V6, DOI 10.1038/srep38980; SIMONEAU JA, 1995, FASEB J, V9, P1091, DOI 10.1096/fasebj.9.11.7649409; Strucksberg KH, 2010, ANAL BIOCHEM, V399, P225, DOI 10.1016/j.ab.2009.12.026; Tiku V, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms16083; Zhernakova DV, 2017, NAT GENET, V49, P139, DOI 10.1038/ng.3737	42	4	4	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2020	34	4					5525	5537		10.1096/fj.201902350R	http://dx.doi.org/10.1096/fj.201902350R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	LJ5ZA	32141137	Green Published, hybrid			2022-12-26	WOS:000530242100046
J	He, ZS; Thorrez, L; Siegfried, G; Meulemans, S; Evrard, S; Tejpar, S; Khatib, AM; Creemers, JWM				He, Zongsheng; Thorrez, Lieven; Siegfried, Geraldine; Meulemans, Sandra; Evrard, Serge; Tejpar, Sabine; Khatib, Abdel-Majid; Creemers, John W. M.			The proprotein convertase furin is a pro-oncogenic driver in KRAS and BRAF driven colorectal cancer	ONCOGENE			English	Article							HUMAN COLON; TUMOR PROGRESSION; GROWTH; EXPRESSION; CELLS; PROLIFERATION; ACTIVATION; RESISTANCE; INHIBITORS; MUTATIONS	Mutations in KRAS and/or BRAF that activate the ERK kinase are frequently found in colorectal cancer (CRC) and drive resistance to targeted therapies. Therefore, the identification of therapeutic targets that affect multiple signaling pathways simultaneously is crucial for improving the treatment of patients with KRAS or BRAF mutations. The proprotein convertase furin activates several oncogenic protein precursors involved in the ERK-MAPK pathway by endoproteolytic cleavage. Here we show that genetic inactivation of furin suppresses tumorigenic growth, proliferation, and migration in KRAS or BRAF mutant CRC cell lines but not in wild-type KRAS and BRAF cells. In a mouse xenograft model, these KRAS or BRAF mutant cells lacking furin displayed reduced growth and angiogenesis, and increased apoptosis. Mechanistically, furin inactivation prevents the processing of various protein pecursors including proIGF1R, proIR, proc-MET, proTGF-beta 1 and NOTCH1 leading to potent and durable ERK-MAPK pathway suppression in KRAS or BRAF mutant cells. Furthermore, we identified genes involved in activating the ERK-MAPK pathway, such as PTGS2, which are downregulated in the KRAS or BRAF mutant cells after furin inactivation but upregulated in wild-type KRAS and BRAF cells. Analysis of human colorectal tumor samples reveals a positive correlation between enhanced furin expression and KRAS or BRAF expression. These results indicate that furin plays an important role in KRAS or BRAF-associated ERK-MAPK pathway activation and tumorigenesis, providing a potential target for personalized treatment.	[He, Zongsheng; Meulemans, Sandra; Creemers, John W. M.] Katholieke Univ Leuven, Dept Human Genet, Lab Biochem Neuroendocrinol, Leuven, Belgium; [Thorrez, Lieven] Katholieke Univ Leuven, Dept Dev & Regenerat, Interdisciplinary Res Facil, Campus Kulak Kortrijk, Kortrijk, Belgium; [Siegfried, Geraldine; Evrard, Serge; Khatib, Abdel-Majid] INSERM, UMR, LAMC, Allee Geoffroy St Hilaire 1029, Pessac, France; [Evrard, Serge] Inst Bergonie, Bordeaux, France; [Tejpar, Sabine] Univ Hosp Leuven, Dept Oncol, Digest Oncol Unit, Leuven, Belgium	KU Leuven; KU Leuven; Institut National de la Sante et de la Recherche Medicale (Inserm); UNICANCER; Institut Bergonie; KU Leuven; University Hospital Leuven	Creemers, JWM (corresponding author), Katholieke Univ Leuven, Dept Human Genet, Lab Biochem Neuroendocrinol, Leuven, Belgium.	john.creemers@kuleuven.be	Thorrez, Lieven/A-2583-2011; KHATIB, Abdel-Majid/A-9948-2015	Thorrez, Lieven/0000-0002-5896-6823; KHATIB, Abdel-Majid/0000-0001-6957-0384; siegfried, geraldine/0000-0002-6346-5206	SIRIC BRIO, France; La Ligue Contre le Cancer, France; FWO Vlaanderen [G.0738.15]; Chinese Government Scholarship [201409110101]	SIRIC BRIO, France; La Ligue Contre le Cancer, France; FWO Vlaanderen(FWO); Chinese Government Scholarship	We would like to thank Maria Francesca Baietti for providing help with the soft agar assay, and Rudra Kashyap for providing help with the wound healing migration assay. We would also like to thank Alvaro Cortes Calabuig for the RNA-seq data analysis. This work was supported in part by SIRIC BRIO and La Ligue Contre le Cancer to AMK, France. We acknowledge grant support from FWO Vlaanderen (Grant nr. G.0738.15) to JC. ZH was supported by a Chinese Government Scholarship (Nr. 201409110101).	Artenstein AW, 2011, NEW ENGL J MED, V365, P2507, DOI 10.1056/NEJMra1106700; Bardelli A, 2013, CANCER DISCOV, V3, P658, DOI 10.1158/2159-8290.CD-12-0558; Bassi DE, 2001, MOL CARCINOGEN, V31, P224, DOI 10.1002/mc.1057; Batlle E, 2019, IMMUNITY, V50, P924, DOI 10.1016/j.immuni.2019.03.024; Benvenuti S, 2007, CANCER RES, V67, P2643, DOI 10.1158/0008-5472.CAN-06-4158; Blommaert E, 2019, P NATL ACAD SCI USA, V116, P9865, DOI 10.1073/pnas.1817815116; Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492; Buck E, 2010, MOL CANCER THER, V9, P2652, DOI 10.1158/1535-7163.MCT-10-0318; Chisanga D, 2016, NUCLEIC ACIDS RES, V44, pD969, DOI 10.1093/nar/gkv1097; Cordova ZM, 2016, ONCOTARGET, V7, P54392, DOI 10.18632/oncotarget.11106; Couture F, 2015, EXPERT OPIN THER PAT, V25, P379, DOI 10.1517/13543776.2014.1000303; Creemers JWM, 2008, FRONT BIOSCI-LANDMRK, V13, P4960, DOI 10.2741/3055; Dahms SO, 2016, SCI REP-UK, V6, DOI 10.1038/srep34303; De Roock W, 2011, LANCET ONCOL, V12, P594, DOI 10.1016/S1470-2045(10)70209-6; Declercq J, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/148651; Duguay SJ, 1998, J BIOL CHEM, V273, P18443, DOI 10.1074/jbc.273.29.18443; Duguay SJ, 1997, J BIOL CHEM, V272, P6663, DOI 10.1074/jbc.272.10.6663; Erdogan B, 2017, BIOCHEM SOC T, V45, P229, DOI 10.1042/BST20160387; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Ghisoli M, 2016, MOL THER, V24, P1478, DOI 10.1038/mt.2016.86; Ginefra P, 2018, CELL REP, V22, P2176, DOI 10.1016/j.celrep.2018.02.005; Grabocka E, 2016, CELL, V167, P1803, DOI 10.1016/j.cell.2016.11.035; Guo SC, 2011, BBA-REV CANCER, V1815, P197, DOI 10.1016/j.bbcan.2010.12.002; Hardes K, 2015, CHEMMEDCHEM, V10, P1218, DOI 10.1002/cmdc.201500103; Henrich S, 2005, J MOL BIOL, V345, P211, DOI 10.1016/j.jmb.2004.10.050; Holderfield M, 2014, NAT REV CANCER, V14, P455, DOI 10.1038/nrc3760; Huang YY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030638; Jaaks P, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161396; Jin M, 2018, PATHOL ONCOL RES, V24, P45, DOI 10.1007/s12253-017-0195-5; Khatib AM, 2001, J BIOL CHEM, V276, P30686, DOI 10.1074/jbc.M101725200; Kopan R, 2009, CELL, V137, P216, DOI 10.1016/j.cell.2009.03.045; Kosumi K, 2019, EUR J CANCER, V111, P82, DOI 10.1016/j.ejca.2019.01.022; Krysan K, 2005, CANCER RES, V65, P6275, DOI 10.1158/0008-5472.CAN-05-0216; Liu DX, 2007, J CLIN ENDOCR METAB, V92, P2264, DOI 10.1210/jc.2006-1613; Liu XL, 2011, AM J CLIN PATHOL, V135, P245, DOI 10.1309/AJCP7FO2VAXIVSTP; Low K, 2019, FEBS J, V286, P4597, DOI 10.1111/febs.14979; Lopez de Cicco R, 2002, Acta Odontol Latinoam, V15, P29; Louagie E, 2008, P NATL ACAD SCI USA, V105, P12319, DOI 10.1073/pnas.0800340105; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Oh J, 2016, GYNECOL ONCOL, V143, P504, DOI 10.1016/j.ygyno.2016.09.018; Page RE, 2007, CELL ONCOL, V29, P289; Ramirez C, 2019, NATURE, V576, P477, DOI 10.1038/s41586-019-1831-x; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Roebroek AJM, 2004, J BIOL CHEM, V279, P53442, DOI 10.1074/jbc.M407152200; Sanchez-Vega F, 2018, CELL, V173, P321, DOI 10.1016/j.cell.2018.03.035; Sarac MS, 2002, INFECT IMMUN, V70, P7136, DOI 10.1128/IAI.70.12.7136-7139.2002; Scamuffa N, 2008, J CLIN INVEST, V118, P352, DOI 10.1172/JCI32040; Scamuffa N, 2014, CARCINOGENESIS, V35, P528, DOI 10.1093/carcin/bgt345; Shimura T, 2020, CARCINOGENESIS, V41, P751, DOI 10.1093/carcin/bgz195; Siegfried G, 2005, ONCOGENE, V24, P6925, DOI 10.1038/sj.onc.1208838; Siegfried G, 2003, J CLIN INVEST, V111, P1723, DOI 10.1172/JCI200317220; Siegfried G, 2020, CANCER LETT, V473, P50, DOI 10.1016/j.canlet.2019.12.027; Susan-Resiga D, 2011, J BIOL CHEM, V286, P22785, DOI 10.1074/jbc.M111.233577; Tang ZF, 2017, NUCLEIC ACIDS RES, V45, pW98, DOI 10.1093/nar/gkx247; Tome M, 2019, CANCER RES, V79, P5008, DOI 10.1158/0008-5472.CAN-19-0086; Tripathi S, 2015, CELL HOST MICROBE, V18, P723, DOI 10.1016/j.chom.2015.11.002; Tsujii M, 1997, P NATL ACAD SCI USA, V94, P3336, DOI 10.1073/pnas.94.7.3336; Ulanet DB, 2010, P NATL ACAD SCI USA, V107, P10791, DOI 10.1073/pnas.0914076107; Van Cutsem E, 2009, NEW ENGL J MED, V360, P1408, DOI 10.1056/NEJMoa0805019; Van Schaeybroeck S, 2014, CELL REP, V7, P1940, DOI 10.1016/j.celrep.2014.05.032; Vartanian S, 2013, J BIOL CHEM, V288, P2403, DOI 10.1074/jbc.M112.394130; Wang D, 2010, ONCOGENE, V29, P781, DOI 10.1038/onc.2009.421; Wang DZ, 2010, NAT REV CANCER, V10, P181, DOI 10.1038/nrc2809; Zhang DX, 2015, CELL REP, V10, P1335, DOI 10.1016/j.celrep.2015.02.006; Zhang YL, 2017, INT J ONCOL, V50, P1352, DOI 10.3892/ijo.2017.3896	65	23	23	1	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR	2020	39	17					3571	3587		10.1038/s41388-020-1238-z	http://dx.doi.org/10.1038/s41388-020-1238-z		MAR 2020	17	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	LH1YK	32139876	Green Published			2022-12-26	WOS:000518240400001
J	Beksisa, J; Getinet, T; Tanie, S; Diribi, J; Hassen, HY				Beksisa, Jemal; Getinet, Tewodros; Tanie, Sisay; Diribi, Jilcha; Hassen, Hamid Yimam			Survival and prognostic determinants of prostate cancer patients in Tikur Anbessa Specialized Hospital, Addis Ababa, Ethiopia: A retrospective cohort study	PLOS ONE			English	Article							MORTALITY	Background Globally, the incidence of prostate cancer is increasing, particularly in low- and middle-income countries. It is the most common cancer among men worldwide, with higher mortality in low and middle-income countries. In Ethiopia, it is the second most common cause of cancer morbidity and mortality among men. Despite a few studies done regarding the disease burden, the evidence is scarce about the survival and prognostic determinants of prostate cancer patients in Ethiopia. Thus, this study assessed the survival and prognostic determinants of patients with prostate cancer. Methods We retrospectively followed patients who were newly diagnosed from 2012 to 2016 at the Oncology Department of Tikur Anbessa Specialized Hospital. We extracted the data from patient charts that were available in the cancer registry using a checklist with the help of oncology nurses. Kaplan-Meier survival analyses with the log-rank test were used to estimate and compare the probability of survival among covariate categories. After checking for assumptions, a multivariable Cox regression analysis was performed to identify prognostic determinants of survival. Results The median survival time was 28 months with an overall 2-, 3- and 5-year survival of 57%, 38.9% and 22%, respectively. The overall survival differs according to the clinical stage (P-value< 0.01), presence or absence of distant metastasis (P<0.01) and androgen deprivation therapy (ADT) (P<0.05). Cancer stage at diagnosis (adjusted hazard ratio (AHR) = 0.309, 95%CI = 0.151-0.633) and ADT (AHR = 3.884, 95%CI = 1.677-8.997) remained significant in the final Cox proportional hazards model. Conclusions The overall 2-, 3- and 5-year survival of prostate cancer patients in Ethiopia is very low. The cancer stage at diagnosis and treatment modalities are significant prognostic determinants of survival. Therefore, early detection through screening and timely initiation of treatment are essential to improve the survival of prostate cancer patients.	[Beksisa, Jemal] St Pauls Hosp, Ethiopian Field Epidemiol Training Program, Millennium Med Coll, Addis Ababa, Ethiopia; [Getinet, Tewodros; Tanie, Sisay] St Pauls Hosp, Dept Publ Hlth, Millennium Med Coll, Addis Ababa, Ethiopia; [Diribi, Jilcha] Tikur Anbessa Hosp, Dept Oncol, Addis Ababa, Ethiopia; [Hassen, Hamid Yimam] Mizan Tepi Univ, Dept Publ Hlth, Mizan Teferi, Ethiopia		Hassen, HY (corresponding author), Mizan Tepi Univ, Dept Publ Hlth, Mizan Teferi, Ethiopia.	albdulhamidy71@gmail.com	Endries, Aman Yesuf/AAN-6871-2021; Hassen, Hamid/A-1105-2019	Hassen, Hamid/0000-0001-6485-4193; Feyisa, Jilcha Diribi/0000-0002-5344-5340	Saint Paul's Hospital Millennium medical college	Saint Paul's Hospital Millennium medical college	JB has received partial financial support from Saint Paul's Hospital Millennium medical college for data collection. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdollah F, 2014, EUR UROL, V65, P554, DOI 10.1016/j.eururo.2013.09.025; American Cancer Society, 2016, PROST CANC WHAT IS P; Chen SL, 2017, SCI REP-UK, V7, DOI 10.1038/srep40003; D'Amico AV, 2002, J CLIN ONCOL, V20, P4567, DOI 10.1200/JCO.2002.03.061; Fadlelmola FM, 2016, INTCLINPATHOL J, V2, P67, DOI [10.15406/icpjl.2016.02.00045, DOI 10.15406/ICPJL.2016.02.00045]; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Fitzmaurice C, 2017, JAMA ONCOL, V3, P524, DOI 10.1001/jamaoncol.2016.5688; Fitzmaurice C, 2015, JAMA ONCOL, V1, P505, DOI 10.1001/jamaoncol.2015.0735; Gravis G, 2015, EUR UROL, V68, P196, DOI 10.1016/j.eururo.2014.09.022; Hassanipour-Azgomi S, 2016, PROSTATE INT, V4, P118, DOI 10.1016/j.prnil.2016.07.001; Hay SI, 2017, LANCET, V390, P1260, DOI 10.1016/S0140-6736(17)32130-X; Ibrahim AG, 2015, CARCINOMA PROSTATE 5, V1, P512; Jemal A, 2012, CANCER-AM CANCER SOC, V118, P4372, DOI 10.1002/cncr.27410; Kwes AS, 2014, DETERMINATION PREDIC, V4, P77; LITTLE RJA, 1992, J AM STAT ASSOC, V87, P1227, DOI 10.2307/2290664; Memirie ST, 2018, J GLOB ONCOL, V4, DOI 10.1200/JGO.17.00175; Migowski A, 2010, REV SAUDE PUBL, V44, P344, DOI 10.1590/S0034-89102010000200016; Mohamed FA, 2017, TUMOR METASTASIS DIL, V5, P275; Naghavi M, 2017, LANCET, V390, P1151, DOI 10.1016/S0140-6736(17)32152-9; Nazim SM, 2015, PAK J MED SCI, V31, P710, DOI 10.12669/pjms.313.7103; Robinson D, 2008, ASPECTS LOCALISED LO; Schymura MJ, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-152; Sugihara T, 2014, JPN J CLIN ONCOL, V44, P1227, DOI 10.1093/jjco/hyu142; Torre LA, 2015, CA-CANCER J CLIN, V65, P87, DOI 10.3322/caac.21262; Wang HT, 2014, DIAGN PATHOL, V9, DOI 10.1186/1746-1596-9-35; Wiyanto Joko, 2017, World J Nucl Med, V16, P266, DOI 10.4103/1450-1147.215498; Wong WW, 2017, CLIN GENITOURIN CANC, V15, pE969, DOI 10.1016/j.clgc.2017.04.016	27	6	7	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2020	15	3							e0229854	10.1371/journal.pone.0229854	http://dx.doi.org/10.1371/journal.pone.0229854			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8RK	32134996	Green Published, gold			2022-12-26	WOS:000535265600052
J	Lahijani, MS; Islam, T; Srinivasan, A; Namilae, S				Lahijani, Mehran Sadeghi; Islam, Tasvirul; Srinivasan, Ashok; Namilae, Sirish			Constrained Linear Movement Model (CALM): Simulation of passenger movement in airplanes	PLOS ONE			English	Article							VALIDATION	Pedestrian dynamics models the walking movement of individuals in a crowd. It has recently been used in the analysis of procedures to reduce the risk of disease spread in airplanes, relying on the SPED model. This is a social force model inspired by molecular dynamics; pedestrians are treated as point particles, and their trajectories are determined in a simulation. A parameter sweep is performed to address uncertainties in human behavior, which requires a large number of simulations. The SPED model's slow speed is a bottleneck to performing a large parameter sweep. This is a severe impediment to delivering real-time results, which are often required in the course of decision meetings, especially during emergencies. We propose a new model, called CALM, to remove this limitation. It is designed to simulate a crowd's movement in constrained linear passageways, such as inside an aircraft. We show that CALM yields realistic results while improving performance by two orders of magnitude over the SPED model.	[Lahijani, Mehran Sadeghi] Florida State Univ, Dept Comp Sci, Tallahassee, FL 32306 USA; [Islam, Tasvirul; Srinivasan, Ashok] Univ West Florida, Dept Comp Sci, Pensacola, FL USA; [Namilae, Sirish] Embry Riddle Aeronaut Univ, Aerosp Engn Dept, Daytona Beach, FL USA	State University System of Florida; Florida State University; State University System of Florida; University of West Florida; Embry-Riddle Aeronautical University	Lahijani, MS (corresponding author), Florida State Univ, Dept Comp Sci, Tallahassee, FL 32306 USA.	sadeghil@cs.fsu.edu		Sadeghi Lahijani, Mehran/0000-0002-0550-3315	National Science Foundation [1640822]	National Science Foundation(National Science Foundation (NSF))	This material is based upon work supported by the National Science Foundation under Grant No. 1640822 awarded to Ashok Srinivasan Initial: A. S. Web page: http://www.cs.fsu.edu/similar to asriniva/home/.	[Anonymous], 1992, STRASSE VERKEHR; Burstedde C, 2001, PHYSICA A, V295, P507, DOI 10.1016/S0378-4371(01)00141-8; Chunduri S, 2018, CLUST CLOUD GRID COM; Garcimartin A, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-11197-x; Helbing D, 2000, NATURE, V407, P487, DOI 10.1038/35035023; HELBING D, 1995, PHYS REV E, V51, P4282, DOI 10.1103/PhysRevE.51.4282; Helbing D., 2009, ENCY COMPLEXITY SYST, P6476, DOI [10.1007/978-0-387-30440-3_382, DOI 10.1007/978-0-387-30440-3_382]; Knepper R. A., 2012, 2012 RO-MAN: The 21st IEEE International Symposium on Robot and Human Interactive Communication, P94, DOI 10.1109/ROMAN.2012.6343737; Lammel G., 2008, P 7 INT C AUT AG MUL; Liao WC, 2017, SIMUL MODEL PRACT TH, V77, P20, DOI 10.1016/j.simpat.2017.05.002; Mehran Ramin, 2009, P IEEE C COMP VIS PA; Moussaid M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010047; Muramatsu M, 1999, PHYSICA A, V267, P487, DOI 10.1016/S0378-4371(99)00018-7; Namilae S, 2017, PHYSICA A, V465, P248, DOI 10.1016/j.physa.2016.08.028; Namilae S, 2017, PHYS REV E, V95, DOI 10.1103/PhysRevE.95.052320; Schadschneider A., 2001, CONDMAT0112117 ARXIV; Seyfried A, 2008, LECT NOTES COMPUT SC, V5191, P563, DOI 10.1007/978-3-540-79992-4_77; Song W, 2016, COLLECTIVE DYNAMIC A, VA11, P1; Srinivasan A, 2016, IEEE ACM INT SYMP, P136, DOI 10.1109/CCGrid.2016.23; Steffen B, 2010, PHYSICA A, V389, P1902, DOI 10.1016/j.physa.2009.12.015; von Sivers I, 2016, SAFETY SCI, V89, P288, DOI 10.1016/j.ssci.2016.07.001; Wald A, 2014, J AIR TRANSP MANAG, V36, P101, DOI 10.1016/j.jairtraman.2014.01.001; Zou Y, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153388	23	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2020	15	3							e0229690	10.1371/journal.pone.0229690	http://dx.doi.org/10.1371/journal.pone.0229690			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8RK	32134966	Green Published, gold, Green Submitted			2022-12-26	WOS:000535265600038
J	Liu, L; Quang, ND; Banu, R; Kumar, H; Tham, YC; Cheng, CY; Wong, TY; Sabanayagam, C				Liu, Lei; Nguyen Duc Quang; Banu, Riswana; Kumar, Himeesh; Yih-Chung Tham; Cheng, Ching-Yu; Wong, Tien Yin; Sabanayagam, Charumathi			Hypertension, blood pressure control and diabetic retinopathy in a large population-based study	PLOS ONE			English	Article							RISK-FACTORS; PULSE PRESSURE; MICROVASCULAR COMPLICATIONS; EYE DISEASES; PREVALENCE; ASSOCIATION; EPIDEMIOLOGY; COHORT; METHODOLOGY; PROGRESSION	Background Clinical trials have shown beneficial effects of blood pressure (BP) control in reducing the risk of diabetic retinopathy (DR). However, association between BP control and DR in population-based studies is not clear. We aimed to examine the association of hypertension and BP control with DR. Methods We analysed data from a population-based cross-sectional study of Chinese, Malay and Indians adults with diabetes and hypertension (2004-2011, n = 2189, aged 40-80 years) in Singapore. DR severity was assessed from retinal photographs and graded for any-and vision-threatening DR (VTDR) using the modified Airlie House classification. Hypertension status was classified into (1) good control: on treatment (SBP < 130 and DBP < 80 mm Hg), (2) moderate control: on treatment, with BP levels other than group 1 and 3, (3) poor control: on treatment (SBP.140 and DBP. 90 mm Hg), (4) untreated hypertension, any BP level. SBP, DBP and pulse pressure (PP) were analyzed as categories and as continuous variables. The association between BP and DR was assessed using multivariable logistic regression models. Results The prevalence of any-DR and VTDR in the study population was 33.8% and 9.0% respectively. Both poorly controlled and untreated hypertension were significantly associated with any-DR with odds ratio (OR) (95% confidence interval [CI]) of 1.97 (1.39-2.83), and 2.01 [1.34-3.05]. Among BP components, SBP and PP were associated with both any-DR and VTDR with OR (95% CI) of 1.45 (1.28-1.65) and 1.61 (1.41-1.84) for any-DR, and 1.44 (1.19-1.76) and 1.67 (1.37-2.06) for VTDR. Conclusion In a population-based sample of Asian adults with diabetes and hypertension, treated but poorly controlled as well as untreated hypertension were significantly associated with anyDR. Among the BP components, higher SBP and PP levels were associated with both anyDR and VTDR. Further longitudinal studies are necessary to confirm our findings.	[Liu, Lei; Nguyen Duc Quang; Banu, Riswana; Yih-Chung Tham; Cheng, Ching-Yu; Wong, Tien Yin; Sabanayagam, Charumathi] Singapore Eye Res Inst, Singapore, Singapore; [Liu, Lei; Nguyen Duc Quang; Banu, Riswana; Yih-Chung Tham; Cheng, Ching-Yu; Wong, Tien Yin; Sabanayagam, Charumathi] Singapore Natl Eye Ctr, Singapore, Singapore; [Liu, Lei] China Med Univ, Dept Ophthalmol, Affiliated Hosp 1, Shenyang, Peoples R China; [Kumar, Himeesh] Alfred Hlth, Melbourne, Vic, Australia; [Yih-Chung Tham; Cheng, Ching-Yu; Wong, Tien Yin; Sabanayagam, Charumathi] Duke NUS Med Sch, Ophthalmol & Visual Sci Acad Clin Program, Singapore, Singapore; [Cheng, Ching-Yu; Wong, Tien Yin; Sabanayagam, Charumathi] Natl Univ Singapore, Yong Loo Lin Sch Med, Singapore, Singapore	National University of Singapore; Singapore National Eye Center; Singapore National Eye Center; China Medical University; National University of Singapore; National University of Singapore	Sabanayagam, C (corresponding author), Singapore Eye Res Inst, Singapore, Singapore.; Sabanayagam, C (corresponding author), Singapore Natl Eye Ctr, Singapore, Singapore.; Sabanayagam, C (corresponding author), Duke NUS Med Sch, Ophthalmol & Visual Sci Acad Clin Program, Singapore, Singapore.; Sabanayagam, C (corresponding author), Natl Univ Singapore, Yong Loo Lin Sch Med, Singapore, Singapore.	charumathi.sabanayagam@seri.com.sg	Cheng, Ching-Yu/Y-2229-2019; Nguyen, Duc Quang/AHC-6430-2022; Wong, Tien Yin/AAC-9724-2020; Chung, Yih/AIF-2414-2022; Sabanayagam, Charumathi/C-1294-2011	Cheng, Ching-Yu/0000-0003-0655-885X; Nguyen, Duc Quang/0000-0001-6919-5211; Wong, Tien Yin/0000-0002-8448-1264; Chung, Yih/0000-0002-6752-797X; Sabanayagam, Charumathi/0000-0002-4042-4719	National Medical Research Council [0796/2003, 0863/2004]; Biomedical Research Council [08/1/35/19/550]	National Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biomedical Research Council(Agency for Science Technology & Research (A*STAR))	This study was supported by the National Medical Research Council Grants No 0796/2003, 0863/2004 and Biomedical Research Council Grant No 08/1/35/19/550. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler AI, 2000, BMJ-BRIT MED J, V321, P412, DOI 10.1136/bmj.321.7258.412; Anderson RJ, 2014, DIABETES CARE, V37, P2782, DOI 10.2337/dc14-0284; [Anonymous], 1991, Ophthalmology, V98, P786; Bunce C, 2008, EYE, V22, P905, DOI 10.1038/sj.eye.6702767; Cockcroft JR, 2005, AM J HYPERTENS, V18, P1463, DOI 10.1016/j.amjhyper.2005.05.009; Cui JD, 2017, ADV MATER SCI ENG, V2017, P1, DOI [10.1155/2017/6786270, DOI 10.1155/2017/6786270]; de Simone G, 2005, HYPERTENSION, V45, P575, DOI 10.1161/01.HYP.0000158268.95012.08; Estacio RO, 2000, DIABETES CARE, V23, pB54; Foong AWP, 2007, OPHTHAL EPIDEMIOL, V14, P25, DOI 10.1080/09286580600878844; Huang OS, 2015, BRIT J OPHTHALMOL, V99, P1614, DOI 10.1136/bjophthalmol-2014-306492; KLEIN R, 1989, ARCH INTERN MED, V149, P2427, DOI 10.1001/archinte.149.11.2427; Klein R, 2002, OPHTHALMOLOGY, V109, P1225, DOI 10.1016/S0161-6420(02)01074-6; Knudsen ST, 2002, AM J HYPERTENS, V15, P244, DOI 10.1016/S0895-7061(01)02281-6; Kramer Caroline Kaercher, 2009, Diabetes Res Clin Pract, V84, pe12, DOI 10.1016/j.diabres.2008.12.016; Lavanya R, 2009, OPHTHAL EPIDEMIOL, V16, P325, DOI 10.3109/09286580903144738; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Liu Y, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2017-016280; Longo-Mbenza B, 2008, INT J DIABETES METAB, V16, P17; Patel A, 2007, LANCET, V370, P829, DOI 10.1016/S0140-6736(07)61303-8; Peralta CA, 2007, HYPERTENSION, V50, P474, DOI 10.1161/HYPERTENSIONAHA.107.088088; Rajalakshmi R, 2014, J DIABETES COMPLICAT, V28, P291, DOI 10.1016/j.jdiacomp.2013.12.008; Raman R, 2012, J DIABETES COMPLICAT, V26, P123, DOI 10.1016/j.jdiacomp.2012.02.001; Rani PK, 2009, J POSTGRAD MED, V55, P92, DOI 10.4103/0022-3859.48787; Rema M, 2007, INDIAN J MED RES, V125, P297; Sabanayagam C, 2013, BMC NEPHROL, V14, DOI 10.1186/1471-2369-14-86; Sasongko MB, 2012, DIABETOLOGIA, V55, P666, DOI 10.1007/s00125-011-2424-x; Schrier RW, 1996, DIABETOLOGIA, V39, P1646, DOI 10.1007/s001250050629; Seow LSE, 2015, J CLIN GERONTOL GERI, V6, P125, DOI 10.1016/j.jcgg.2015.05.002; Shi Y, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175966; Stearne MR, 1998, BMJ-BRIT MED J, V317, P703; Tan GS, 2018, OPHTHALMOLOGY, V125, P529, DOI 10.1016/j.ophtha.2017.10.026; Tseng ST, 2015, INT J CLIN EXP MED, V8, P21507; van Leiden HA, 2002, DIABETES CARE, V25, P1320, DOI 10.2337/diacare.25.8.1320; Wang FH, 2011, ACTA OPHTHALMOL, V89, pE336, DOI 10.1111/j.1755-3768.2010.02062.x; Whelton PK, 2017, J AM COLL CARDIOL, DOI [10.1016/j.jacc.2017.11.006, DOI 10.1016/J.JACC.2017.11.006]; Wolf G, 2002, AM J KIDNEY DIS, V39, P1, DOI 10.1053/ajkd.2002.29865; Wong TY, 2008, OPHTHALMOLOGY, V115, P1869, DOI 10.1016/j.ophtha.2008.05.014; Wong TY, 2006, AM J OPHTHALMOL, V141, P446, DOI 10.1016/j.ajo.2005.08.063; Yau JWY, 2012, DIABETES CARE, V35, P556, DOI 10.2337/dc11-1909; Zhang GH, 2017, BRIT J OPHTHALMOL, V101, P1591, DOI 10.1136/bjophthalmol-2017-310316; Zheng YF, 2012, OPHTHALMOLOGY, V119, P2119, DOI 10.1016/j.ophtha.2012.04.027	41	21	22	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2020	15	3							e0229665	10.1371/journal.pone.0229665	http://dx.doi.org/10.1371/journal.pone.0229665			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8RK	32134944	gold, Green Published			2022-12-26	WOS:000535265600036
J	Murray, MH; Lankau, EW; Kidd, AD; Welch, CN; Ellison, T; Adams, HC; Lipp, EK; Hernandez, SM				Murray, Maureen H.; Lankau, Emily W.; Kidd, Anjelika D.; Welch, Catharine N.; Ellison, Taylor; Adams, Henry C.; Lipp, Erin K.; Hernandez, Sonia M.			Gut microbiome shifts with urbanization and potentially facilitates a zoonotic pathogen in a wading bird	PLOS ONE			English	Article							ENTERICA SEROVAR TYPHIMURIUM; STABLE-ISOTOPES; SALMONELLA; TRANSMISSION; INFLAMMATION; CAPTIVITY; PACKAGE; COMPETE; DISEASE; MICE	Microbial communities in the gastrointestinal tract influence many aspects of host health, including metabolism and susceptibility to pathogen colonization. These relationships and the environmental and individual factors that drive them are relatively unexplored for free-living wildlife. We quantified the relationships between urban habitat use, diet, and age with microbiome composition and diversity for 82 American white ibises (Eudocimus albus) captured along an urban gradient in south Florida and tested whether gut microbial diversity was associated with Salmonella enterica prevalence. Shifts in community composition were significantly associated with urban land cover and, to a lesser extent, diets higher in provisioned food. The diversity of genera was negatively associated with community composition associated with urban land cover, positively associated with age class, and negatively associated with Salmonella shedding. Our results suggest that shifts in both habitat use and diet for urban birds significantly alter gut microbial composition and diversity in ways that may influence health and pathogen susceptibility as species adapt to urban habitats.	[Murray, Maureen H.; Kidd, Anjelika D.; Welch, Catharine N.; Ellison, Taylor; Adams, Henry C.; Hernandez, Sonia M.] Univ Georgia, Warnell Sch Forestry & Nat Resources, Athens, GA 30602 USA; [Murray, Maureen H.; Kidd, Anjelika D.; Hernandez, Sonia M.] Univ Georgia, Southeastern Cooperat Wildlife Dis Study, Athens, GA 30602 USA; [Lankau, Emily W.] Univ Wisconsin, Dept Anim Sci, Madison, WI USA; [Lankau, Emily W.] Ronin Inst, Montclair, NJ USA; [Lipp, Erin K.] Univ Georgia, Dept Environm Hlth Sci, Athens, GA 30602 USA; [Murray, Maureen H.] Lincoln Pk Zoo, Davee Ctr Epidemiol & Endocrinol, Chicago, IL USA; [Murray, Maureen H.] Lincoln Pk Zoo, Urban Wildlife Inst, Chicago, IL USA	University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; University of Wisconsin System; University of Wisconsin Madison; University System of Georgia; University of Georgia	Hernandez, SM (corresponding author), Univ Georgia, Warnell Sch Forestry & Nat Resources, Athens, GA 30602 USA.; Hernandez, SM (corresponding author), Univ Georgia, Southeastern Cooperat Wildlife Dis Study, Athens, GA 30602 USA.	shernz@uga.edu		Lankau, Emily/0000-0002-7094-7780	NSF Ecology and Evolution of Infectious Diseases [DEB-1518611]	NSF Ecology and Evolution of Infectious Diseases	This work was funded by a grant from the NSF Ecology and Evolution of Infectious Diseases (DEB-1518611) to MM, EL, EL, AK, CNW, HCA, TE and SMH. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors thank the University of Wisconsin Biotechnology Center DNA Sequencing Facility for providing microbial community DNA extraction and Illumina sequencing services. The authors also thank Richard Lankau for assistance with bioinformatic processing of microbiome sequences and our collaborators Sonia Altizer, Richard Hall, Jeff Hepinstall-Cymerman, Kristen Navara and Michael J. Yabsley as well as volunteers and additional undergraduate researchers for their help with study design and data collection.	[Anonymous], 2019, R LANG ENV STAT COMP; [Anonymous], 1993, WHITE IBIS WETLAND W; [Anonymous], 2014, J APPL ECOL, DOI [DOI 10.1111/1365-2664.12306, DOI 10.1016/S0167-8809(99)00024-9]; Azcarate-Peril MA, 2018, APPL ENVIRON MICROB, V84, DOI 10.1128/AEM.02526-17; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bradley CA, 2007, TRENDS ECOL EVOL, V22, P95, DOI 10.1016/j.tree.2006.11.001; Brearley G, 2013, BIOL REV, V88, P427, DOI 10.1111/brv.12009; Buffie CG, 2012, INFECT IMMUN, V80, P62, DOI 10.1128/IAI.05496-11; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Carding Simon, 2015, Microbial Ecology in Health and Disease, V26, P26191, DOI 10.3402/mehd.v26.26191; Chalmers RP, 2012, J STAT SOFTW, V48, P1; CONOVER MR, 1991, WILDLIFE SOC B, V19, P36; Coogan SCP, 2017, BEHAV ECOL, V28, P1021, DOI 10.1093/beheco/arx060; Costello EK, 2012, SCIENCE, V336, P1255, DOI 10.1126/science.1224203; CUI YZ, 2017, FRONT MICROBIOL, V8, P24519, DOI DOI 10.3389/FMICB.2017.00001; Delport TC, 2016, APPL ENVIRON MICROB, V82, P3440, DOI 10.1128/AEM.00192-16; DENIRO MJ, 1981, GEOCHIM COSMOCHIM AC, V45, P341, DOI 10.1016/0016-7037(81)90244-1; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Frederick PC, 1997, COLON WATERBIRD, V20, P316, DOI 10.2307/1521699; Fridolfsson AK, 1999, J AVIAN BIOL, V30, P116, DOI 10.2307/3677252; Fuirst M, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0209200; Galbraith JA, 2015, P NATL ACAD SCI USA, V112, pE2648, DOI 10.1073/pnas.1501489112; Ganz HH, 2017, MSYSTEMS, V2, DOI 10.1128/mSystems.00188-16; Hawley DM, 2009, ECOTOXICOLOGY, V18, P499, DOI 10.1007/s10646-009-0307-4; HOBBS RJ, 1992, CONSERV BIOL, V6, P324, DOI 10.1046/j.1523-1739.1992.06030324.x; HOBSON KA, 1993, AUK, V110, P638, DOI 10.2307/4088430; Hollister EB, 2014, GASTROENTEROLOGY, V146, P1449, DOI 10.1053/j.gastro.2014.01.052; HUGHES RA, 2017, FRONT VET SCI, V4, P24519, DOI DOI 10.3389/FVETS.2017.00001; Hyde ER, 2016, MSYSTEMS, V1, DOI 10.1128/mSystems.00046-16; Jahren AH, 2008, P NATL ACAD SCI USA, V105, P17855, DOI 10.1073/pnas.0809870105; Kark S, 2007, J BIOGEOGR, V34, P638, DOI 10.1111/j.1365-2699.2006.01638.x; Kau AL, 2011, NATURE, V474, P327, DOI 10.1038/nature10213; Klindworth A, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks808; Kumari S, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0202993; Lawley TD, 2008, INFECT IMMUN, V76, P403, DOI 10.1128/IAI.01189-07; Lawley TD, 2009, INFECT IMMUN, V77, P3661, DOI 10.1128/IAI.00558-09; Lax S, 2014, SCIENCE, V345, P1048, DOI 10.1126/science.1254529; Luo ZY, 2014, J MICROBIOL METH, V101, P86, DOI 10.1016/j.mimet.2014.03.012; Maeda I, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/438956; McKenna P, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040020; McKenzie VJ, 2017, INTEGR COMP BIOL, V57, P690, DOI 10.1093/icb/icx090; Muegge BD, 2011, SCIENCE, V332, P970, DOI 10.1126/science.1198719; Murray MH, 2019, FRONT ECOL ENVIRON, V17, P575, DOI 10.1002/fee.2126; Murray MH, 2018, PHILOS T R SOC B, V373, DOI 10.1098/rstb.2017.0100; Murray MH, ECOHEALTH; Oakley BB, 2014, FEMS MICROBIOL LETT, V360, P100, DOI 10.1111/1574-6968.12608; Oberski D, 2014, J STAT SOFTW, V57, P1; Pan D, 2014, GUT MICROBES, V5, P108, DOI 10.4161/gmic.26945; Parnell AC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009672; Partecke J, 2007, ECOLOGY, V88, P882, DOI 10.1890/06-1105; Patterson JA, 2003, POULTRY SCI, V82, P627, DOI 10.1093/ps/82.4.627; Pickard JM, 2017, IMMUNOL REV, V279, P70, DOI 10.1111/imr.12567; Price MN, 2009, MOL BIOL EVOL, V26, P1641, DOI 10.1093/molbev/msp077; Puigvehi M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164883; Ruiz G, 2002, CONDOR, V104, P162, DOI 10.1650/0010-5422(2002)104[0162:HPASII]2.0.CO;2; Singh RK, 2017, J TRANSL MED, V15, DOI 10.1186/s12967-017-1175-y; Stecher B, 2007, PLOS BIOL, V5, P2177, DOI 10.1371/journal.pbio.0050244; Teyssier A, 2018, SCI TOTAL ENVIRON, V612, P1276, DOI 10.1016/j.scitotenv.2017.09.035; Thiennimitr P, 2011, P NATL ACAD SCI USA, V108, P17480, DOI 10.1073/pnas.1107857108; Tyakht AV, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3469; Waite DW, 2015, FRONTIERS MICROBIOLO, V6, P1; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Wasimuddin, 2017, MOL ECOL, V26, P5515, DOI 10.1111/mec.14278; Wickham H, 2007, J STAT SOFTW, V21, P1; Xie YW, 2016, SCI REP-UK, V6, DOI 10.1038/srep33350; Yoshimoto S, 2013, NATURE, V499, P97, DOI 10.1038/nature12347; YURDUSEV N, 1989, INFECT IMMUN, V57, P724, DOI 10.1128/IAI.57.3.724-731.1989	67	34	34	7	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2020	15	3							e0220926	10.1371/journal.pone.0220926	http://dx.doi.org/10.1371/journal.pone.0220926			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8RK	32134945	Green Published, gold, Green Submitted			2022-12-26	WOS:000535265600004
J	Seijmonsbergen-Schermers, AE; Zondag, DC; Nieuwenhuijze, M; van den Akker, T; Verhoeven, CJ; Geerts, CC; Schellevis, FG; de Jonge, A				Seijmonsbergen-Schermers, Anna E.; Zondag, Dirkje C.; Nieuwenhuijze, Marianne; van den Akker, Thomas; Verhoeven, Corine J.; Geerts, Caroline C.; Schellevis, Francois G.; de Jonge, Ank			Regional variations in childbirth interventions and their correlations with adverse outcomes, birthplace and care provider: A nationwide explorative study	PLOS ONE			English	Article							LABOR; RISK; MIDWIFERY; MIDWIVES; WOMEN; EPISIOTOMY; EXPERIENCES; RATES	Background Variations in childbirth interventions may indicate inappropriate use. Most variation studies are limited by the lack of adjustments for maternal characteristics and do not investigate variations in adverse outcomes. This study aims to explore regional variations in the Netherlands and their correlations with referral rates, birthplace, interventions, and adverse outcomes, adjusted for maternal characteristics. Methods In this nationwide retrospective cohort study, using a national data register, intervention rates were analysed between twelve regions among single childbirths after 37 weeks' gestation in 2010-2013 (n = 614,730). These were adjusted for maternal characteristics using multivariable logistic regression. Primary outcomes were intrapartum referral, birthplace, and interventions used in midwife- and obstetrician-led care. Correlations both between primary outcomes and between adverse outcomes were calculated with Spearman's rank correlations. Findings Intrapartum referral rates varied between 55-68% (nulliparous) and 20-32% (multiparous women), with a negative correlation with receiving midwife-led care at the onset of labour in two-thirds of the regions. Regions with higher referral rates had higher rates of severe postpartum haemorrhages. Rates of home birth varied between 6-16% (nulliparous) and 16-31% (multiparous), and was negatively correlated with episiotomy and postpartum oxytocin rates. Among midwife-led births, episiotomy rates varied between 14-42% (nulliparous) and 3-13% (multiparous) and in obstetrician-led births from 46-67% and 14-28% respectively. Rates of postpartum oxytocin varied between 59-88% (nulliparous) and 50-85% (multiparous) and artificial rupture of membranes between 43-52% and 54-61% respectively. A north-south gradient was visible with regard to birthplace, episiotomy, and oxytocin. Conclusions Our study suggests that attitudes towards interventions vary, independent of maternal characteristics. Care providers and policy makers need to be aware of reducing unwarranted variation in birthplace, episiotomy and the postpartum use of oxytocin. Further research is needed to identify explanations and explore ways to reduce unwarranted intervention rates.	[Seijmonsbergen-Schermers, Anna E.; Zondag, Dirkje C.; Verhoeven, Corine J.; Geerts, Caroline C.; de Jonge, Ank] Vrije Univ Amsterdam, Amsterdam Publ Hlth Res Inst, Amsterdam UMC, Dept Midwifery Sci,AVAG, Amsterdam, Netherlands; [Nieuwenhuijze, Marianne] Zuyd Univ, Res Ctr Midwifery Sci, Heerlen, Netherlands; [van den Akker, Thomas] Leiden Univ, Dept Obstet, Med Ctr, Leiden, Netherlands; [Verhoeven, Corine J.] Maxima Med Ctr, Dept Obstet & Gynaecol, Veldhoven, Netherlands; [Schellevis, Francois G.] NIVEL Netherlands Inst Hlth Serv Res, Utrecht, Netherlands; [Schellevis, Francois G.] Amsterdam UMC, Dept Gen Practice & Elderly Care Med, Amsterdam Publ Hlth Res Inst, Amsterdam, Netherlands	University of Amsterdam; Vrije Universiteit Amsterdam; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Maxima Medical Center; Netherlands Institute for Health Services Research; University of Amsterdam; Vrije Universiteit Amsterdam	Seijmonsbergen-Schermers, AE (corresponding author), Vrije Univ Amsterdam, Amsterdam Publ Hlth Res Inst, Amsterdam UMC, Dept Midwifery Sci,AVAG, Amsterdam, Netherlands.	a.seijmonsbergen@amsterdamumc.nl	Seijmonsbergen-Schermers, Anna/CAG-6574-2022; de Jonge, Ank/F-6475-2013		AVAG, Amsterdam Public Health Research Institute, Amsterdam UMC	AVAG, Amsterdam Public Health Research Institute, Amsterdam UMC	This study was funded by AVAG, Amsterdam Public Health Research Institute, Amsterdam UMC. There was no external funding for this study. The corresponding author had full access to all the data in the study and had final responsibility for the decision to submit for publication.	Aasheim V, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006672.pub3; Alliman J, 2016, J MIDWIFERY WOM HEAL, V61, P21, DOI 10.1111/jmwh.12356; Amelink-Verburg MP, 2009, BJOG-INT J OBSTET GY, V116, P923, DOI 10.1111/j.1471-0528.2009.02202.x; [Anonymous], 2019, BMJ; [Anonymous], 2016, PER ZORG NED 2015; [Anonymous], 2010, WOR HEALT REP; Australian Institute of Health Welfare, 2019, AUSTR MOTH BAB 2017; Begley CM, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007412.pub3; Blix E, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-179; Blondel B, 2016, ACTA OBSTET GYNECOL, DOI [10.1111/aogs, DOI 10.1111/AOGS]; Brownlee S, 2017, LANCET, V390, P156, DOI 10.1016/S0140-6736(16)32585-5; Chalmers B, 2012, BIRTH-ISS PERINAT C, V39, P203, DOI 10.1111/j.1523-536X.2012.00549.x; Cromi A, 2015, J MATERN-FETAL NEO M, V28, P2201, DOI 10.3109/14767058.2014.982087; de Jong JD, 2003, SOC SCI MED, V57, P1515, DOI 10.1016/S0277-9536(02)00548-8; de Jonge A, 2017, BJOG-INT J OBSTET GY, V124, P1477, DOI 10.1111/1471-0528.14676; Edqvist M, 2017, BIRTH-ISS PERINAT C, V44, P86, DOI 10.1111/birt.12267; EURO-PERISTAT Project with SCPE and EUROCAT, 2013, EURO PERISTAT PROJ S; Fok WY, 2005, ACTA OBSTET GYN SCAN, V84, P166, DOI 10.1111/j.0001-6349.2005.00700.x; Goueslard K, 2018, BMC PREGNANCY CHILDB, V18, DOI 10.1186/s12884-018-1747-8; Healy S, 2016, WOMEN BIRTH, V29, P107, DOI 10.1016/j.wombi.2015.08.010; Hitzert M, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2017-016960; Hitzert M, 2016, MIDWIFERY, V40, P70, DOI 10.1016/j.midw.2016.06.004; Jans SMPJ, 2016, INT J CHILDBIRTH, V6, P173, DOI 10.1891/2156-5287.6.3.173; Jiang H, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000081.pub3; Leal MD, 2014, CAD SAUDE PUBLICA, V30, DOI 10.1590/0102-311X00151513; Lutomski JE, 2012, BMC PREGNANCY CHILDB, V12, DOI 10.1186/1471-2393-12-123; MacDorman MF, 2019, BIRTH-ISS PERINAT C, V46, P279, DOI 10.1111/birt.12411; Martin JA, 2013, NCHS DATA BRIEF, V175, P1; Mead MMP, 2004, MIDWIFERY, V20, P61, DOI 10.1016/S0266-6138(03)00054-8; Meray N, 2007, J CLIN EPIDEMIOL, V60, P883, DOI 10.1016/j.jclinepi.2006.11.021; Miller S, 2016, LANCET, V388, P2176, DOI 10.1016/S0140-6736(16)31472-6; Offerhaus Pien M, 2015, Midwifery, V31, pe69, DOI 10.1016/j.midw.2015.01.005; Offerhaus PM, 2015, BMC PREGNANCY CHILDB, V15, DOI 10.1186/s12884-015-0471-x; Offerhaus PM, 2014, MIDWIFERY, V30, P560, DOI [10.1016/j.midw.2013.06.013, 10.1016/j.midw.2015.01.013]; Office of National Statistics, 2019, OFF NAT STAT STAT B; Page M, 2014, MIDWIFERY, V30, P28, DOI 10.1016/j.midw.2013.01.012; Petersen A, 2013, ARCH GYNECOL OBSTET, V288, P245, DOI 10.1007/s00404-013-2737-8; Poulsen MO, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-008346; Renfrew MJ, 2014, LANCET, V384, P1129, DOI 10.1016/S0140-6736(14)60789-3; Sandall J, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004667.pub4; Sartore A, 2004, OBSTET GYNECOL, V103, P669, DOI 10.1097/01.AOG.0000119223.04441.c9; Schuit E, 2016, J MATERN-FETAL NEO M, V29, P3304, DOI 10.3109/14767058.2015.1124080; Seijmonsbergen-Schermers AE, 2018, BMC PREGNANCY CHILDB, V18, DOI 10.1186/s12884-018-1795-0; Seijmonsbergen-Schermers AE, 2013, BIRTH-ISS PERINAT C, V40, P247, DOI 10.1111/birt.12060; Smyth RMD, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006167.pub4; Stichting Perinatale Registratie Nederland, 2008, PERINATALE ZORG NEDE; Stuurgroep ZWANGERSCHAP EN GEBOORTE, 2009, VEIL ZORG ROND ZWANG; Suzuki S, 2010, AM J OBSTET GYNECOL, V202, DOI 10.1016/j.ajog.2009.08.027; Vogel JP, 2014, CLIN OBSTET GYNECOL, V57, P331, DOI 10.1097/GRF.0000000000000031; Westhoff G, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001808.pub2; World Health Organization (WHO), 1996, CAR NORM BIRTH PRACT; Wu LC, 2013, ARCH GYNECOL OBSTET, V288, P1249, DOI 10.1007/s00404-013-2897-6	52	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2020	15	3							e0229488	10.1371/journal.pone.0229488	http://dx.doi.org/10.1371/journal.pone.0229488			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LQ8RK	32134957	Green Published, gold			2022-12-26	WOS:000535265600025
J	Li, CJ; Ma, RL; Zhang, XH; Ma, JL; Wang, XP; He, J; Zhang, JY; Wang, K; Hu, YH; Pang, HR; Mu, LT; Yan, YZ; Song, YP; Guo, H; Guo, SX				Li, Changjing; Ma, Rulin; Zhang, Xianghui; Ma, Jiaolong; Wang, Xinping; He, Jia; Zhang, Jingyu; Wang, Kui; Hu, Yunhua; Pang, Hongrui; Mu, Lati; Yan, Yizhong; Song, Yanpeng; Guo, Heng; Guo, Shuxia			Risk of coronary heart disease in the rural population in Xinjiang: A nested case-control study in China	PLOS ONE			English	Article							FAMILY-HISTORY	Background and aim Coronary heart disease (CHD) is a chronic complex disease caused by a combination of factors such as lifestyle behaviors and environmental and genetic factors. We conducted this study to evaluate the risk factors affecting the development of CHD in Xinjiang, and to obtain valuable information for formulating appropriate local public health policies. Method We conducted a nested case-control study with 277 confirmed CHD cases and 554 matched controls. The association of the risk factors with the risk of CHD was assessed using the multivariate Cox proportional hazard model. Multiplicative interactions were evaluated by entering interaction terms in the Cox proportional hazard model. The additive interactions among the risk factors were assessed by the index of additive interaction. Results The risk of CHD increased with frequent high-fat food consumption, dyslipidemia, obesity, and family history of CHD after adjustment for drinking, smoking status, hypertension, diabetes, family history of hypertension, and family history of diabetes. We noted consistent interactions between family history of CHD and frequent high-fat food consumption, family history of CHD and obesity, frequent high-fat food consumption and obesity, frequent high-fat food consumption and dyslipidemia, and obesity and dyslipidemia. The risk of CHD events increased with the presence of the aforementioned interactions. Conclusions Frequent high-fat food consumption, family history of CHD, dyslipidemia and obesity were independent risk factors for CHD, and their interactions are important for public health interventions in patients with CHD in Xinjiang.	[Li, Changjing; Ma, Rulin; Zhang, Xianghui; Ma, Jiaolong; Wang, Xinping; He, Jia; Zhang, Jingyu; Wang, Kui; Hu, Yunhua; Pang, Hongrui; Mu, Lati; Yan, Yizhong; Song, Yanpeng; Guo, Heng; Guo, Shuxia] Shihezi Univ, Dept Publ Hlth, Sch Med, Shihezi, Peoples R China; [Guo, Shuxia] Shihezi Univ, Dept Pathol, Sch Med, Shihezi, Peoples R China; [Guo, Shuxia] Shihezi Univ, Minist Educ, Key Lab Xinjiang Endem & Ethn Dis, Shihezi, Peoples R China	Shihezi University; Shihezi University; Shihezi University	Guo, H; Guo, SX (corresponding author), Shihezi Univ, Dept Publ Hlth, Sch Med, Shihezi, Peoples R China.; Guo, SX (corresponding author), Shihezi Univ, Dept Pathol, Sch Med, Shihezi, Peoples R China.; Guo, SX (corresponding author), Shihezi Univ, Minist Educ, Key Lab Xinjiang Endem & Ethn Dis, Shihezi, Peoples R China.	guoheng@shzu.edu.cn; gsxshzu@sina.com	Wang, Xin/AAN-8435-2021	Wang, Xin/0000-0002-4457-7376; Zhang, XiangHui/0000-0002-1829-1681; zhong, yan/0000-0003-1957-5421	National Natural Science Foundation of China [81560551]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study is supported by National Natural Science Foundation of China (No. 81560551).Shuxia Guo received this award.	Chen Chunming, 2004, Biomed Environ Sci, V17 Suppl, P1; Chmurzynska A, 2018, NUTRIENTS, V10, DOI 10.3390/nu10111692; Devaraj S, 2008, METABOLISM, V57, P867, DOI 10.1016/j.metabol.2008.02.016; Ding YS, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/607364; Eckel RH, 2005, LANCET, V365, P1415, DOI 10.1016/S0140-6736(05)66378-7; Fritz J, 2017, J AM HEART ASSOC, V6, DOI 10.1161/JAHA.116.005254; Gomez-Delgado F, 2018, J GERONTOL A-BIOL, V73, P327, DOI 10.1093/gerona/glw194; Gomez-Delgado F, 2015, MOL NUTR FOOD RES, V59, P2556, DOI 10.1002/mnfr.201500375; Harcombe Z, 2017, BRIT J SPORT MED, V51, P1742, DOI 10.1136/bjsports-2016-096550; He Jia, 2013, Zhonghua Liu Xing Bing Xue Za Zhi, V34, P1164; Hirakawa Yoichiro, 2016, Prev Med Rep, V3, P79, DOI 10.1016/j.pmedr.2015.12.012; Hou L, 2015, INT J CLIN EXP MED, V8, P781; Kopin Laurie, 2017, Ann Intern Med, V167, pITC81, DOI 10.7326/AITC201712050; Kwagyan J, 2015, ETHNIC DIS, V25, P208; Leander K, 2001, EPIDEMIOLOGY, V12, P215, DOI 10.1097/00001648-200103000-00014; Libby P, 2002, NATURE, V420, P868, DOI 10.1161/ATVBAHA.108.179705; Lin HC, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2017-016667; Mercanligil SM, 2007, EUR J CLIN NUTR, V61, P212, DOI 10.1038/sj.ejcn.1602518; Michos ED, 2005, AM J CARDIOL, V95, P655, DOI 10.1016/j.amjcard.2004.10.045; Mozaffarian Dariush, 2005, Curr Atheroscler Rep, V7, P435, DOI 10.1007/s11883-005-0060-y; Naghavi M, 2017, LANCET, V390, P1151, DOI 10.1016/S0140-6736(17)32152-9; Nie Z Q, 2016, Zhonghua Liu Xing Bing Xue Za Zhi, V37, P737, DOI 10.3760/cma.j.issn.0254-6450.2016.05.031; Prabhakaran D, 2012, MT SINAI J MED, V79, P721, DOI 10.1002/msj.21348; SLATTERY ML, 1993, INT J SPORTS MED, V14, P93, DOI 10.1055/s-2007-1021152; Stocker R, 2004, PHYSIOL REV, V84, P1381, DOI 10.1152/physrev.00047.2003; Tang X, 2015, INT J STROKE, V10, P388, DOI 10.1111/ijs.12343; Wang ZQ, 2018, GLYCOCONJUGATE J, V35, P443, DOI 10.1007/s10719-018-9831-x; Wolfram G, 2015, ANN NUTR METAB, V67, P141, DOI [10.1159/00043724, 10.1159/000437243]; Zeng X, 2018, CHINESE CIRCULATION, P33; Zhu JR., 2016, CHINESE CIRCULATION, V31, P937, DOI DOI 10.3969/J.ISSN.1000-3614.2016.10.001	30	3	3	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2020	15	3							e0229598	10.1371/journal.pone.0229598	http://dx.doi.org/10.1371/journal.pone.0229598			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8QU	32130248	Green Published, gold			2022-12-26	WOS:000535264000031
J	Tennant, JM; Li, MC; Henderson, DM; Tyer, ML; Denkers, ND; Haley, NJ; Mathiason, CK; Hoover, EA				Tennant, Joanne M.; Li, Manci; Henderson, Davin M.; Tyer, Margaret L.; Denkers, Nathaniel D.; Haley, Nicholas J.; Mathiason, Candace K.; Hoover, Edward A.			Shedding and stability of CWD prion seeding activity in cervid feces	PLOS ONE			English	Article							CHRONIC WASTING DISEASE; INFECTIOUS PRIONS; ENVIRONMENTAL SOURCES; DEER; PROTEIN; TRANSMISSION; AMPLIFICATION; TISSUES; SALIVA; URINE	CWD is an emergent prion disease that now affects cervid species on three continents. CWD is efficiently spread in wild and captive populations, likely through both direct animal contact and environmental contamination. Here, by longitudinally assaying in feces of CWD-exposed white-tailed deer by RT-QuIC, we demonstrate fecal shedding of prion seeding activity months before onset of clinical symptoms and continuing throughout the disease course. We also examine the impact of simulated environmental conditions such as repeated freeze-thaw cycles and desiccation on fecal prion seeding activity. We found that while multiple (n = 7) freeze-thaw cycles substantially decreased fecal seeding activity, desiccation had little to no effect on seeding activity. Finally, we examined whether RT-QuIC testing of landscape fecal deposits could distinguish two premises with substantial known CWD prevalence from one in which no CWD-infected animals had been detected. In the above pilot study, this distinction was possible. We conclude that fecal shedding of CWD prions occurs over much of the disease course, that environmental factors influence prion seeding activity, and that it is feasible to detect fecal prion contamination using RT-QuIC.	[Tennant, Joanne M.; Li, Manci; Henderson, Davin M.; Tyer, Margaret L.; Denkers, Nathaniel D.; Mathiason, Candace K.; Hoover, Edward A.] Colorado State Univ, Coll Vet Med & Biomed Sci, Prion Res Ctr, Ft Collins, CO 80523 USA; [Haley, Nicholas J.] Midwestern Univ, Coll Grad Studies, Glendale, AZ USA	Colorado State University; Midwestern University	Hoover, EA (corresponding author), Colorado State Univ, Coll Vet Med & Biomed Sci, Prion Res Ctr, Ft Collins, CO 80523 USA.	edward.hoover@colostate.edu		Li, Manci/0000-0003-3930-7117; Tyer, Margaret/0000-0002-8128-5655	National Institute of Health (NIH) [PO1-AI077774, RO1-NS061902, RO1-NS076894]; NIH	National Institute of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the National Institute of Health (NIH) grants PO1-AI077774 to EAH, RO1-NS061902 to EAH, and RO1-NS076894 to CKM (https://www.nih.gov/).The NIH grants went towards the provided indoor-adapted, handraised deer for some of these studies. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atarashi R, 2011, PRION, V5, P150, DOI 10.4161/pri.5.3.16893; Benestad SL, 2016, VET RES, V47, DOI 10.1186/s13567-016-0375-4; Cheng YC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166187; Colby DW, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a006833; Cooper SK, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0221654; Davenport KA, 2018, J CLIN MICROBIOL, V56, DOI [10.1128/JCM.00947-18, 10.1128/jcm.00947-18]; Davenport KA, 2018, J CLIN MICROBIOL, V56, DOI 10.1128/JCM.01243-17; Denkers ND, 2016, J GEN VIROL, V97, P2023, DOI 10.1099/jgv.0.000515; Ellis CK, 2019, PRION, V13, P94, DOI 10.1080/19336896.2019.1607462; Gabizon R, 1996, NAT MED, V2, P59, DOI 10.1038/nm0196-59; Haley NJ, 2018, PRION, V12, P93, DOI 10.1080/19336896.2018.1436925; Haley NJ, 2017, PATHOGENS, V6, DOI 10.3390/pathogens6030035; Haley NJ, 2011, J VIROL, V85, P6309, DOI 10.1128/JVI.00425-11; Haley NJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007990; Henderson DM, 2017, J GEN VIROL, V98, P1953, DOI 10.1099/jgv.0.000844; Henderson DM, 2015, J VIROL, V89, P9338, DOI 10.1128/JVI.01118-15; Henderson DM, 2015, J GEN VIROL, V96, P210, DOI 10.1099/vir.0.069906-0; Henderson DM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074377; Hoover CE, 2017, J VIROL; Hoover CE, 2017, J VIROL, V91, DOI 10.1128/JVI.02162-16; Jennelle CS, 2009, J TOXICOL ENV HEAL A, V72, P1018, DOI 10.1080/15287390903084249; Maddison BC, 2010, J VIROL, V84, P11560, DOI 10.1128/JVI.01133-10; Mathiason CK, 2006, SCIENCE, V314, P133, DOI 10.1126/science.1132661; Mathiason CK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005916; Miller MW, 1998, J WILDLIFE DIS, V34, P532, DOI 10.7589/0090-3558-34.3.532; Miller MW, 2003, NATURE, V425, P35, DOI 10.1038/425035a; Miller MW, 2004, EMERG INFECT DIS, V10, P1003, DOI 10.3201/eid1006.040010; Plummer IH, 2017, J GEN VIROL, V98, P1932, DOI 10.1099/jgv.0.000845; PRUSINER SB, 1984, CELL, V38, P127, DOI 10.1016/0092-8674(84)90533-6; Pulford B, 2012, J WILDLIFE DIS, V48, P425, DOI 10.7589/0090-3558-48.2.425; Saa P, 2006, J BIOL CHEM, V281, P35245, DOI 10.1074/jbc.M603964200; Saborio GP, 2001, NATURE, V411, P810, DOI 10.1038/35081095; Safar JG, 2008, J INFECT DIS, V198, P81, DOI 10.1086/588193; Saunders SE, 2008, ENVIRON SCI TECHNOL, V42, P6573, DOI 10.1021/es800590k; Sigurdson CJ, 2008, VET RES, V39, DOI 10.1051/vetres:2008018; Tamguney G, 2009, NATURE, V461, P529, DOI 10.1038/nature08289; Telling GC, 1996, SCIENCE, V274, P2079, DOI 10.1126/science.274.5295.2079; Terry LA, 2011, VET RES, V42, DOI 10.1186/1297-9716-42-65; Vikoren T, 2019, J WILDLIFE DIS; Wilham JM, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001217; Williams E.S., 1992, Revue Scientifique et Technique Office International des Epizooties, V11, P551; Yuan Q, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004638	42	23	23	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2020	15	3							e0227094	10.1371/journal.pone.0227094	http://dx.doi.org/10.1371/journal.pone.0227094			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8MS	32126066	Green Published, gold			2022-12-26	WOS:000535253100006
J	Maclaine, KD; Stebbings, KA; Llano, DA; Rhodes, JS				Maclaine, Kendra D.; Stebbings, Kevin A.; Llano, Daniel A.; Rhodes, Justin S.			Voluntary wheel running has no impact on brain and liver mitochondrial DNA copy number or mutation measures in the PolG mouse model of aging	PLOS ONE			English	Article							HIPPOCAMPAL NEUROGENESIS; CELL-PROLIFERATION; OXIDATIVE STRESS; EXERCISE; RENEWAL	The mitochondrial theory of aging attributes much of the aging process to mitochondrial DNA damage. The polymerase gamma (PolG) mutant mouse was designed to evaluate this theory and thus carries a mutated proofreading region of polymerase gamma (D257A) that exclusively transcribes the mitochondrial genome. As a result, PolGD(257A) mice accumulate mitochondrial DNA (mtDNA) mutations that lead to premature aging, as evidenced by hair loss, weight loss, kyphosis, increased rates of apoptosis, organ damage, and an early death, occurring around 12 months of age. Research has shown that exercise decreases skeletal muscle mtDNA mutations and normalizes protein levels in PolG mice. However, brain mtDNA changes with exercise in PolG mice have not been studied. We found no effects of exercise on mtDNA mutations or copy number in either the brain or liver of PolG mice, despite changes to body mass. Our results suggest that mitochondrial mutations play little role in exercise-brain interactions in the PolG model of accelerated aging. In addition to evaluating the effect of exercise on mtDNA outcomes, we also implemented novel methods for both extracting mtDNA and measuring mtDNA mutations, with aims for improving the efficiency and accuracy of these methods.	[Maclaine, Kendra D.; Stebbings, Kevin A.; Llano, Daniel A.; Rhodes, Justin S.] Univ Illinois, Beckman Inst, Urbana, IL 61801 USA; [Stebbings, Kevin A.; Llano, Daniel A.; Rhodes, Justin S.] Univ Illinois, Neurosci Program, Beckman Inst, Urbana, IL 61801 USA; [Llano, Daniel A.] Univ Illinois, Dept Mol & Integrat Physiol, Urbana, IL USA; [Rhodes, Justin S.] Univ Illinois, Dept Psychol, Champaign, IL 61820 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Rhodes, JS (corresponding author), Univ Illinois, Beckman Inst, Urbana, IL 61801 USA.; Rhodes, JS (corresponding author), Univ Illinois, Neurosci Program, Beckman Inst, Urbana, IL 61801 USA.; Rhodes, JS (corresponding author), Univ Illinois, Dept Psychol, Champaign, IL 61820 USA.	jrhodes@illinois.edu		Llano, Daniel/0000-0003-0933-1837; , Kendra/0000-0003-0750-6365	MCB SROP, Jenner award [AG059103]; Beckman Neurotechnology for Memory and Cognition undergraduate fellowship	MCB SROP, Jenner award; Beckman Neurotechnology for Memory and Cognition undergraduate fellowship	This project was funded by grant AG059103 (to D.A.L.) and MCB SROP, Jenner award and Beckman Neurotechnology for Memory and Cognition undergraduate fellowship (to K.D. M.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bronte V, 2013, IMMUNITY, V39, P806, DOI 10.1016/j.immuni.2013.10.010; Brummelte S, 2010, NEUROSCIENCE, V168, P680, DOI 10.1016/j.neuroscience.2010.04.023; CHENG H, 1974, AM J ANAT, V141, P537, DOI 10.1002/aja.1001410407; Chu HT, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-S7-S5; Clark PJ, 2011, GENES BRAIN BEHAV, V10, P345, DOI 10.1111/j.1601-183X.2010.00674.x; Clark PJ, 2009, HIPPOCAMPUS, V19, P937, DOI 10.1002/hipo.20543; Clark-Matott J, 2015, NEUROBIOL AGING, V36, P2972, DOI 10.1016/j.neurobiolaging.2015.07.020; EDWARDS JL, 1961, AM J PATHOL, V38, P437; Faraci C, 2018, REPRODUCTION, V156, P185, DOI 10.1530/REP-18-0061; Foote K, 2018, AGING CELL, V17, DOI 10.1111/acel.12773; Herbst A, 2016, AGING CELL, V15, P1132, DOI 10.1111/acel.12520; Ibarguchi G, 2006, GENOME, V49, P1438, DOI 10.1139/G06-107; Kaguni LS, 2004, ANNU REV BIOCHEM, V73, P293; Kamakura R, 2016, PHYSIOL REP, V4, DOI 10.14814/phy2.12703; Kramer AF, 2006, J APPL PHYSIOL, V101, P1237, DOI 10.1152/japplphysiol.00500.2006; Kujoth GC, 2005, SCIENCE, V309, P481, DOI 10.1126/science.1112125; Lezi E, 2014, NEUROBIOL AGING, V35, P2574, DOI 10.1016/j.neurobiolaging.2014.05.033; Lezi E, 2013, EXP PHYSIOL, V98, P207, DOI 10.1113/expphysiol.2012.066688; Lightfoot JT, 2004, PHYSIOL GENOMICS, V19, P270, DOI 10.1152/physiolgenomics.00125.2004; Ma H, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0201304; Magami Y, 2002, LIVER, V22, P419, DOI 10.1034/j.1600-0676.2002.01702.x; Malik AN, 2016, MITOCHONDRION, V29, P59, DOI 10.1016/j.mito.2016.05.003; Manouze H, 2019, ENEURO, V6, DOI 10.1523/ENEURO.0179-18.2019; Puente-Maestu L, 2011, THORAX, V66, P121, DOI 10.1136/thx.2010.153031; Quiros PM, 2017, CURR PROTOC MOUSE BI, V7, P47; Quispe-Tintaya W, 2013, BIOTECHNIQUES, V55, P133, DOI 10.2144/000114077; Ross JM, 2019, AGING CELL, V18, DOI 10.1111/acel.13029; Safdar A, 2016, CURR OPIN GENET DEV, V38, P127, DOI 10.1016/j.gde.2016.06.011; Safdar A, 2011, P NATL ACAD SCI USA, V108, P4135, DOI 10.1073/pnas.1019581108; Steiner JL, 2011, J APPL PHYSIOL, V111, P1066, DOI 10.1152/japplphysiol.00343.2011; Svensson M, 2016, NEUROBIOL STRESS, V5, P8, DOI 10.1016/j.ynstr.2016.09.002; Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517; Turner MJ, 2005, PHYSIOL GENOMICS, V22, P76, DOI 10.1152/physiolgenomics.00243.2004; van Praag H, 2005, J NEUROSCI, V25, P8680, DOI 10.1523/JNEUROSCI.1731-05.2005; van Praag H, 1999, NAT NEUROSCI, V2, P266, DOI 10.1038/6368; Zhang P, 2017, GENOMICS, V109, P457, DOI 10.1016/j.ygeno.2017.07.002	36	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2020	15	3							e0226860	10.1371/journal.pone.0226860	http://dx.doi.org/10.1371/journal.pone.0226860			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8JT	32119683	gold, Green Published, Green Submitted			2022-12-26	WOS:000535245300004
J	Nozawa, A; Oshima, H; Togawa, N; Nozaki, T; Murakami, S				Nozawa, Ai; Oshima, Hiroyuki; Togawa, Naoyuki; Nozaki, Takenori; Murakami, Shinya			Development of Oral Care Chip, a novel device for quantitative detection of the oral microbiota associated with periodontal disease	PLOS ONE			English	Article							TAQMAN; PCR; BIOFILMS; ARRAY	Periodontal disease, the most prevalent infectious disease in the world, is caused by biofilms formed in periodontal pockets. No specific bacterial species that can cause periodontitis alone has been found in any study to date. Several periodontopathic bacteria are associated with the progress of periodontal disease. Consequently, it is hypothesized that dysbiosis of subgingival microbiota may be a cause of periodontal disease. This study aimed to investigate the relationship between the subgingival microbiota and the clinical status of periodontal pockets in a quantitative and clinically applicable way with the newly developed Oral Care Chip. The Oral Care Chip is a DNA microarray tool with improved quantitative performance, that can be used in combination with competitive PCR to quantitatively detect 17 species of subgingival bacteria. Cluster analysis based on the similarity of each bacterial quantity was performed on 204 subgingival plaque samples collected from periodontitis patients and healthy volunteers. A significant difference in the number of total bacteria, Treponema denticola, Campylobacter rectus, Fusobacterium nucleatum, and Streptococcus intermedia bacteria in any combination of the three clusters indicated that these bacteria gradually increased in number from the stage before the pocket depth deepened. Conversely, Porphyromonas gingivalis, Tannerella forsythia, Prevotella intermedia, and Streptococcus constellatus, which had significant differences only in limited clusters, were thought to increase in number as the pocket depth deepened, after periodontal pocket formation. Furthermore, in clusters where healthy or mild periodontal disease sites were classified, there was no statistically significant difference in pocket depth, but the number of bacteria gradually increased from the stage before the pocket depth increased. This means that quantitative changes in these bacteria can be a predictor of the progress of periodontal tissue destruction, and this novel microbiological test using the Oral Care Chip could be effective at detecting dysbiosis.	[Nozawa, Ai; Oshima, Hiroyuki; Togawa, Naoyuki] Mitsubishi Chem Corp, Tsurumi R&D Ctr, Yokohama, Kanagawa, Japan; [Nozaki, Takenori] Osaka Univ, Div Interdisciplinary Dent, Dent Hosp, Suita, Osaka, Japan; [Murakami, Shinya] Osaka Univ, Dept Periodontol, Grad Sch Dent, Suita, Osaka, Japan	Mitsubishi Chemical Holdings Corporation; Mitsubishi Chemical; Osaka University; Osaka University	Murakami, S (corresponding author), Osaka Univ, Dept Periodontol, Grad Sch Dent, Suita, Osaka, Japan.	ipshinya@dent.osaka-u.ac.jp			Mitsubishi Chemical Corporation	Mitsubishi Chemical Corporation	A research grant was provided by Mitsubishi Chemical Corporation based on the joint research agreement between Mitsubishi Chemical Corporation and Osaka University. The funder provided support in the form of salaries for authors who belong to Mitsubishi Chemical Company [AN, HO, NT], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Clementi M, 2015, NEW MICROBIOL, V38, P437; Kirst ME, 2015, APPL ENVIRON MICROB, V81, P783, DOI 10.1128/AEM.02712-14; Kolenbrander PE, 2010, NAT REV MICROBIOL, V8, P471, DOI 10.1038/nrmicro2381; Kuboniwa M, 2004, ORAL MICROBIOL IMMUN, V19, P168, DOI 10.1111/j.0902-0055.2004.00135.x; LOE H, 1965, J PERIODONTOL, V36, P177, DOI 10.1902/jop.1965.36.3.177; Maeda H, 2003, FEMS IMMUNOL MED MIC, V39, P81, DOI 10.1016/S0928-8244(03)00224-4; Moritani K, 2015, ORAL DIS, V21, P748, DOI 10.1111/odi.12341; Okuzaki D, 2010, DNA RES, V17, P369, DOI 10.1093/dnares/dsq025; Rafiei Mohammad, 2018, J Dent (Shiraz), V19, P232; Schmalz G, 2016, DIAGN MICR INFEC DIS, V85, P289, DOI 10.1016/j.diagmicrobio.2016.04.003; Shelburne CE, 2000, J MICROBIOL METH, V39, P97, DOI 10.1016/S0167-7012(99)00106-2; Socransky SS, 2002, PERIODONTOL 2000, V28, P12, DOI 10.1034/j.1600-0757.2002.280102.x; Socransky SS, 1998, J CLIN PERIODONTOL, V25, P134, DOI 10.1111/j.1600-051X.1998.tb02419.x; Suzuki N, 2005, CLIN MED RES, V3, P176, DOI 10.3121/cmr.3.3.176; Teles RP, 2006, PERIODONTOL 2000, V42, P180, DOI 10.1111/j.1600-0757.2006.00192.x; Treimo J, 2006, J APPL MICROBIOL, V100, P985, DOI 10.1111/j.1365-2672.2006.02805.x; Yazawa A, 2019, J MICROBIOL METH, V165, DOI 10.1016/j.mimet.2019.105718; Zentilin L, 2007, NAT PROTOC, V2, P2092, DOI 10.1038/nprot.2007.299	18	7	7	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2020	15	2							e0229485	10.1371/journal.pone.0229485	http://dx.doi.org/10.1371/journal.pone.0229485			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8HR	32109938	Green Published, gold			2022-12-26	WOS:000535239800014
J	Booth, BG; Hoefnagels, E; Huysmans, T; Sijbers, J; Keijsers, NLW				Booth, Brian G.; Hoefnagels, Eva; Huysmans, Toon; Sijbers, Jan; Keijsers, Noel L. W.			PAPPI: Personalized analysis of plantar pressure images using statistical modelling and parametric mapping	PLOS ONE			English	Article							FOOT PRESSURE; HALLUX-VALGUS; CLASSIFICATION; GAIT; SYSTEM; INDEX	Quantitative analyses of plantar pressure images typically occur at the group level and under the assumption that individuals within each group display homogeneous pressure patterns. When this assumption does not hold, a personalized analysis technique is required. Yet, existing personalized plantar pressure analysis techniques work at the image level, leading to results that can be unintuitive and difficult to interpret. To address these limitations, we introduce PAPPI: the Personalized Analysis of Plantar Pressure Images. PAPPI is built around the statistical modelling of the relationship between plantar pressures in healthy controls and their demographic characteristics. This statistical model then serves as the healthy baseline to which an individual's real plantar pressures are compared using statistical parametric mapping. As a proof-of-concept, we evaluated PAPPI on a cohort of 50 hallux valgus patients. PAPPI showed that plantar pressures from hallux valgus patients did not have a single, homogeneous pattern, but instead, 5 abnormal pressure patterns were observed in sections of this population. When comparing these patterns to foot pain scores (i.e. Foot Function Index, Manchester-Oxford Foot Questionnaire) and radiographic hallux angle measurements, we observed that patients with increased pressure under metatarsal 1 reported less foot pain than other patients in the cohort, while patients with abnormal pressures in the heel showed more severe hallux valgus angles and more foot pain. Also, incidences of pes planus were higher in our hallux valgus cohort compared to the modelled healthy controls. PAPPI helped to clarify recent discrepancies in group-level plantar pressure studies and showed its unique ability to produce quantitative, interpretable, and personalized analyses for plantar pressure images.	[Booth, Brian G.; Huysmans, Toon; Sijbers, Jan] Univ Antwerp, Dept Phys, Imec Vis Lab, Antwerp, Belgium; [Hoefnagels, Eva] Sint Maartenskliniek, Dept Orthopaed, Woerden, Netherlands; [Huysmans, Toon] Delft Univ Technol, Fac Ind Design Engn, Sect Appl Ergon & Design, Delft, Netherlands; [Keijsers, Noel L. W.] Sint Maartenskliniek, Dept Res, Nijmegen, Netherlands	IMEC; University of Antwerp; Sint Maartens Clinic; Delft University of Technology; Sint Maartens Clinic	Booth, BG (corresponding author), Univ Antwerp, Dept Phys, Imec Vis Lab, Antwerp, Belgium.	brian.booth@uantwerpen.be	Booth, Brian G/AAU-5768-2021; Sijbers, Jan/C-4214-2011	Booth, Brian G/0000-0001-9228-4810; Sijbers, Jan/0000-0003-4225-2487; Huysmans, Toon/0000-0001-7053-6458	European Union's Horizon 2020 research and innovation programme under the Marie Sklodowska-Curie grant [746614]; imec Belgium through ICON grant [150218]	European Union's Horizon 2020 research and innovation programme under the Marie Sklodowska-Curie grant; imec Belgium through ICON grant	B.G.B. received funding from the European Union's Horizon 2020 research and innovation programme under the Marie Sklodowska-Curie grant agreement no. 746614 (https://cordis.europa.eu/project/rcn/209771/factsheet/en).B.G.B., T.H., and J.S. received funding from imec Belgium through ICON grant no. 150218. (https://www.imec-int.com/en/what-weoffer/research-portfolio/footwork).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acharya UR, 2012, J MED SYST, V36, P2483, DOI 10.1007/s10916-011-9715-0; Ramirez-Bautista JA, 2018, BIOCYBERN BIOMED ENG, V38, P342, DOI 10.1016/j.bbe.2018.02.004; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bennetts CJ, 2013, J BIOMECH, V46, P19, DOI 10.1016/j.jbiomech.2012.09.007; Booth B. G., 2011, 2011 IEEE International Conference on Healthcare Informatics, Imaging and Systems Biology, P166, DOI 10.1109/HISB.2011.19; Booth BG, 2019, P 28 C INT SOC BIOM, P1; Booth BG, 2019, J BIOMECH, V87, P161, DOI 10.1016/j.jbiomech.2019.02.008; Booth BG, 2018, GAIT POSTURE, V63, P268, DOI 10.1016/j.gaitpost.2018.04.029; Booth BG, 2016, NEUROIMAGE, V125, P705, DOI 10.1016/j.neuroimage.2015.08.079; Bryant A., 1999, FOOT, V9, P115, DOI DOI 10.1054/F00T.1999.0538; Buldt AK, 2018, GAIT POSTURE, V62, P56, DOI 10.1016/j.gaitpost.2018.02.026; Bus SA, 2005, CLIN BIOMECH, V20, P892, DOI 10.1016/j.clinbiomech.2005.05.004; Castelvecchi D, 2016, NATURE, V537, P20, DOI 10.1038/538020a; CAVANAGH PR, 1987, J BIOMECH, V20, P547, DOI 10.1016/0021-9290(87)90255-7; Deschamps K, 2015, J SPORT MED PHYS FIT, V55, P191; Deschamps K, 2016, GAIT POSTURE, V49, P168, DOI 10.1016/j.gaitpost.2016.07.009; Deschamps K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079924; Galica AM, 2013, J FOOT ANKLE RES, V6, DOI 10.1186/1757-1146-6-42; GIACOMOZZI C., 2011, BIOMECHANICS APPL, P249; Giacomozzi C, 2012, ANN I SUPER SANITA, V48, P259, DOI 10.4415/ANN_12_03_06; Giacomozzi C, 2009, GAIT POSTURE, V29, P220, DOI 10.1016/j.gaitpost.2008.08.004; Guimond A, 2000, COMPUT VIS IMAGE UND, V77, P192, DOI 10.1006/cviu.1999.0815; Han JT, 2011, J PHYS THER SCI, V23, P683, DOI 10.1589/jpts.23.683; Harrell FE, 1996, STAT MED, V15, P361, DOI 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4; Hida T, 2017, J ORTHOP SCI, V22, P1054, DOI 10.1016/j.jos.2017.08.008; Jeon HS, 2008, IEEE ENG MED BIO, P4672, DOI 10.1109/IEMBS.2008.4650255; Keijsers N, 2012, SCI FOOTWEAR, P377; Keijsers NLW, 2013, CLIN BIOMECH, V28, P350, DOI 10.1016/j.clinbiomech.2013.01.012; Keijsers N. L. W., 2014, J FOOT ANKLE RES, V7, pA40, DOI DOI 10.1186/1757-1146-7-S1-A40; Koller U, 2014, J ORTHOP RES, V32, P1688, DOI 10.1002/jor.22707; Kuyvenhoven MM, 2002, J RHEUMATOL, V29, P1023; Liang SY, 2015, SENSORS-BASEL, V15, P29393, DOI 10.3390/s151129393; MASSEY FJ, 1951, J AM STAT ASSOC, V46, P68, DOI 10.2307/2280095; Mayer AR, 2014, HUM BRAIN MAPP, V35, P5457, DOI 10.1002/hbm.22563; Morley D, 2013, BONE JOINT RES, V2, P66, DOI 10.1302/2046-3758.24.2000147; Niemann U, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161326; Pataky TC, 2008, J BIOMECH, V41, P2465, DOI 10.1016/j.jbiomech.2008.05.010; Pataky TC, 2008, J BIOMECH, V41, P2136, DOI 10.1016/j.jbiomech.2008.04.034; Pataky TC, 2015, J BIOMECH, V48, P1277, DOI 10.1016/j.jbiomech.2015.02.051; Pataky TC, 2014, GAIT POSTURE, V40, P255, DOI 10.1016/j.gaitpost.2014.01.023; Pataky TC, 2012, J R SOC INTERFACE, V9, P790, DOI 10.1098/rsif.2011.0430; Pataky TC, 2011, GAIT POSTURE, V33, P418, DOI 10.1016/j.gaitpost.2010.12.015; Pique-Vidal C, 2009, J FOOT ANKLE RES, V2, DOI 10.1186/1757-1146-2-15; Stankovic K, 2016, P 7 INT C 3D BOD SCA, P70, DOI DOI 10.15221/16.070; Styner M, 2000, IEEE T MED IMAGING, V19, P153, DOI 10.1109/42.845174; Telfer S, 2019, GAIT POSTURE, V67, P269, DOI 10.1016/j.gaitpost.2018.10.030; Vercauteren T, 2009, NEUROIMAGE, V45, pS61, DOI 10.1016/j.neuroimage.2008.10.040; Waldecker Ute, 2012, Foot Ankle Surg, V18, P42, DOI 10.1016/j.fas.2011.03.004; Wen JM, 2012, GAIT POSTURE, V36, P344, DOI 10.1016/j.gaitpost.2012.03.030	49	2	3	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2020	15	2							e0229685	10.1371/journal.pone.0229685	http://dx.doi.org/10.1371/journal.pone.0229685			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8GQ	32106256	Green Submitted, Green Published, gold			2022-12-26	WOS:000535237000060
J	Olou, AA; King, RJ; Yu, F; Singh, PK				Olou, Appolinaire A.; King, Ryan J.; Yu, Fang; Singh, Pankaj K.			MUC1 oncoprotein mitigates ER stress via CDA-mediated reprogramming of pyrimidine metabolism	ONCOGENE			English	Article							ENDOPLASMIC-RETICULUM STRESS; UNFOLDED PROTEIN RESPONSE; CYTIDINE DEAMINASE; OXIDATIVE STRESS; GLUCOSE DEPRIVATION; GEMCITABINE RESISTANCE; TUMOR-CELLS; APOPTOSIS; ACTIVATION; CALCIUM	The Mucin 1 (MUC1) protein is overexpressed in various cancers and mediates chemotherapy resistance. However, the mechanism is not fully understood. Given that most chemotherapeutic drugs disrupt ER homeostasis as part of their toxicity, and MUC1 expression is regulated by proteins involved in ER homeostasis, we investigated the link between MUC1 and ER homeostasis. MUC1 knockdown in pancreatic cancer cells enhanced unfolded protein response (UPR) signaling and cell death upon ER stress induction. Transcriptomic analysis revealed alterations in the pyrimidine metabolic pathway and cytidine deaminase (CDA). ChIP and CDA activity assays showed that MUC1 occupied CDA gene promoter upon ER stress induction correlating with increased CDA expression and activity in MUC1-expressing cells as compared with MUC1 knockdown cells. Inhibition of either the CDA or pyrimidine metabolic pathway diminished survival in MUC1-expressing cancer cells upon ER stress induction. Metabolomic analysis demonstrated that MUC1-mediated CDA activity corresponded to deoxycytidine to deoxyuridine metabolic reprogramming upon ER stress induction. The resulting increase in deoxyuridine mitigated ER stress-induced cytotoxicity. In addition, given (1) the established roles of MUC1 in protecting cells against reactive oxygen species (ROS) insults, (2) ER stress-generated ROS further promote ER stress and (3) the emerging anti-oxidant property of deoxyuridine, we further investigated if MUC1 regulated ER stress by a deoxyuridine-mediated modulation of ROS levels. We observed that deoxyuridine could abrogate ROS-induced ER stress to promote cancer cell survival. Taken together, our findings demonstrate a novel MUC1-CDA axis of the adaptive UPR that provides survival advantage upon ER stress induction.	[Olou, Appolinaire A.; King, Ryan J.; Singh, Pankaj K.] Univ Nebraska Med Ctr, Eppley Inst Res Canc & Allied Dis, Omaha, NE 68198 USA; [Yu, Fang; Singh, Pankaj K.] Univ Nebraska Med Ctr, Dept Biostat, Omaha, NE 68198 USA; [Singh, Pankaj K.] Univ Nebraska Med Ctr, Dept Biochem & Mol Biol, Omaha, NE 68198 USA; [Singh, Pankaj K.] Univ Nebraska Med Ctr, Dept Pathol & Microbiol, Omaha, NE 68198 USA; [Singh, Pankaj K.] Univ Nebraska Med Ctr, Dept Genet Cell Biol & Anat, Omaha, NE 68198 USA	University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center	Singh, PK (corresponding author), Univ Nebraska Med Ctr, Eppley Inst Res Canc & Allied Dis, Omaha, NE 68198 USA.; Singh, PK (corresponding author), Univ Nebraska Med Ctr, Dept Biostat, Omaha, NE 68198 USA.; Singh, PK (corresponding author), Univ Nebraska Med Ctr, Dept Biochem & Mol Biol, Omaha, NE 68198 USA.; Singh, PK (corresponding author), Univ Nebraska Med Ctr, Dept Pathol & Microbiol, Omaha, NE 68198 USA.; Singh, PK (corresponding author), Univ Nebraska Med Ctr, Dept Genet Cell Biol & Anat, Omaha, NE 68198 USA.	pankaj.singh@unmc.edu		Singh, Pankaj/0000-0001-8903-0131	National Institutes of Health (NCI) [R01 CA216853, CA163649, CA210439]; Specialized Programs of Research Excellence (SPORE, NCI) [2P50 CA127297]; NCI [P01 CA2117798]; Fred & Pamela Buffett Cancer Center Support Grant (NCI) [P30CA036727];  [R01CA216853-01]	National Institutes of Health (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Specialized Programs of Research Excellence (SPORE, NCI); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Fred & Pamela Buffett Cancer Center Support Grant (NCI); 	This work was supported in part by funding from the National Institutes of Health (R01 CA216853, CA163649, CA210439, NCI) to PKS, the Specialized Programs of Research Excellence (SPORE, 2P50 CA127297, NCI) to PKS, P01 CA2117798 (NCI) to PKS, and a supplement to NIH grant (R01CA216853-01) to AAO. We would also like to acknowledge the Fred & Pamela Buffett Cancer Center Support Grant (P30CA036727, NCI) for supporting shared resources.	Agata N, 2008, CANCER RES, V68, P6136, DOI 10.1158/0008-5472.CAN-08-0464; Alejandro EU, 2015, CELL REP, V13, P2527, DOI 10.1016/j.celrep.2015.11.020; Behrens ME, 2010, ONCOGENE, V29, P5667, DOI 10.1038/onc.2010.327; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Bertolotti A, 2000, NAT CELL BIOL, V2, P326, DOI 10.1038/35014014; Blackburn RV, 1999, FREE RADICAL BIO MED, V26, P419, DOI 10.1016/S0891-5849(98)00217-2; Calfon M, 2002, NATURE, V415, P92, DOI 10.1038/415092a; Castellvi A, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-39722-0; Chabosseau P, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1363; Chaika NV, 2012, P NATL ACAD SCI USA, V109, P13787, DOI 10.1073/pnas.1203339109; Chang QS, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-64; Chevet E, 2013, ONCOGENE, V32, P2499, DOI 10.1038/onc.2012.346; Chung SJ, 2005, J MED CHEM, V48, P658, DOI 10.1021/jm0496279; COHEN RM, 1971, J BIOL CHEM, V246, P7561; Denzel MS, 2014, CELL, V156, P1167, DOI 10.1016/j.cell.2014.01.061; Dickinson DA, 2002, ANN NY ACAD SCI, V973, P488, DOI 10.1111/j.1749-6632.2002.tb04690.x; Dumartin L, 2017, ONCOGENE, V36, P3094, DOI 10.1038/onc.2016.459; Eletto D, 2014, J CELL SCI, V127, P3649, DOI 10.1242/jcs.153643; Fagone P, 2009, J LIPID RES, V50, pS311, DOI 10.1194/jlr.R800049-JLR200; Farooqi AA, 2015, TUMOR BIOL, V36, P5743, DOI 10.1007/s13277-015-3797-0; Feno S, 2019, OXID MED CELL LONGEV, V2019, DOI 10.1155/2019/9324018; Ferrer CM, 2015, MOL CELL ONCOL, V2, DOI 10.4161/23723548.2014.961809; Gebregiworgis T, 2017, J PROTEOME RES, V16, P3536, DOI 10.1021/acs.jproteome.7b00246; Gemble S, 2016, J CELL SCI, V129, P3167, DOI 10.1242/jcs.187781; Goode G, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176820; Guang W, 2009, INT J BIOCHEM CELL B, V41, P1354, DOI 10.1016/j.biocel.2008.12.004; Gunda V, 2017, CLIN CANCER RES, V23, P5881, DOI 10.1158/1078-0432.CCR-17-1151; Hauser J, 2008, P NATL ACAD SCI USA, V105, P1267, DOI 10.1073/pnas.0708220105; Hayakawa Y, 2011, P NATL ACAD SCI USA, V108, P780, DOI 10.1073/pnas.1011418108; Hiraki M, 2016, SCI REP-UK, V6, DOI 10.1038/srep26643; Hui LJ, 2008, J CLIN INVEST, V118, P3943, DOI 10.1172/JCI37156; Ikonen E, 2008, NAT REV MOL CELL BIO, V9, P125, DOI 10.1038/nrm2336; Jing X, 2019, ONCOL REP, V41, P801, DOI 10.3892/or.2018.6887; Juin P, 1998, J BIOL CHEM, V273, P17559, DOI 10.1074/jbc.273.28.17559; Jun HS, 2010, BLOOD, V116, P2783, DOI 10.1182/blood-2009-12-258491; Kannan N, 2014, P NATL ACAD SCI USA, V111, P7789, DOI 10.1073/pnas.1403813111; Kriss CL, 2012, BLOOD, V120, P1027, DOI 10.1182/blood-2011-11-394346; Lau SK, 2004, AM J CLIN PATHOL, V122, P61, DOI 10.1309/9R6673QEC06D86Y4; Lebrecht D, 2008, ARTHRITIS RHEUM-US, V58, P318, DOI 10.1002/art.23235; Lebrecht D, 2007, HEPATOLOGY, V45, P72, DOI 10.1002/hep.21490; Lee AH, 2003, MOL CELL BIOL, V23, P7448, DOI 10.1128/MCB.23.21.7448-7459.2003; Lee YJ, 1998, J BIOL CHEM, V273, P5294, DOI 10.1074/jbc.273.9.5294; Li G, 2009, J CELL BIOL, V186, P783, DOI 10.1083/jcb.200904060; Vu LT, 2017, BIOSCI TRENDS, V11, P243, DOI 10.5582/bst.2017.01049; Ma Q, 2013, ANNU REV PHARMACOL, V53, P401, DOI 10.1146/annurev-pharmtox-011112-140320; Ma YJ, 2002, J MOL BIOL, V318, P1351, DOI 10.1016/S0022-2836(02)00234-6; Rodriguez-Vargas JM, 2012, CELL RES, V22, P1181, DOI 10.1038/cr.2012.70; Marini C, 2016, SCI REP-UK, V6, DOI 10.1038/srep25092; McCullough KD, 2001, MOL CELL BIOL, V21, P1249, DOI 10.1128/MCB.21.4.1249-1259.2001; Mehla K, 2014, BBA-REV CANCER, V1845, P126, DOI 10.1016/j.bbcan.2014.01.001; Menendez D, 2017, MOL CANCER RES, V15, P735, DOI 10.1158/1541-7786.MCR-17-0019; Nath S, 2013, ONCOGENESIS, V2, DOI 10.1038/oncsis.2013.16; Nishitoh H, 2002, GENE DEV, V16, P1345, DOI 10.1101/gad.992302; Norris AM, 2013, ONCOGENE, V32, P3867, DOI 10.1038/onc.2012.394; Oslowski CM, 2011, METHOD ENZYMOL, V490, P71, DOI 10.1016/B978-0-12-385114-7.00004-0; Rahn JJ, 2004, J BIOL CHEM, V279, P29386, DOI 10.1074/jbc.C400010200; Raina D, 2004, J BIOL CHEM, V279, P20607, DOI 10.1074/jbc.M310538200; Rajabi H, 2016, ONCOGENE, V35, P6439, DOI 10.1038/onc.2016.180; Rajabi H, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07850-0; Ren Z, 2017, TOXICOLOGY, V392, P11, DOI 10.1016/j.tox.2017.10.002; Ron D, 2004, J CELL BIOL, V167, P23, DOI 10.1083/jcb.200408117; Ruckemann K, 1998, J BIOL CHEM, V273, P21682, DOI 10.1074/jbc.273.34.21682; Serdjebi C, 2015, EXPERT OPIN DRUG MET, V11, P665, DOI 10.1517/17425255.2015.985648; Sharma AK, 2004, J BIOL CHEM, V279, P35564, DOI 10.1074/jbc.M401037200; Sharma S, 2019, GENOME BIOL, V20, DOI 10.1186/s13059-019-1651-1; Shukla SK, 2017, CANCER CELL, V32, P71, DOI 10.1016/j.ccell.2017.06.004; Singh PK, 2008, J BIOL CHEM, V283, P26985, DOI 10.1074/jbc.M805036200; Singh PK, 2007, CANCER RES, V67, P5201, DOI 10.1158/0008-5472.CAN-06-4647; Singh PK, 2006, TRENDS CELL BIOL, V16, P467, DOI 10.1016/j.tcb.2006.07.006; Song BB, 2008, J CLIN INVEST, V118, P3378, DOI 10.1172/JCI34587; Song M, 2018, NATURE, V562, P423, DOI 10.1038/s41586-018-0597-x; Spitz DR, 2000, ANN NY ACAD SCI, V899, P349, DOI 10.1111/j.1749-6632.2000.tb06199.x; Srinivas US, 2019, REDOX BIOL, V25, DOI 10.1016/j.redox.2018.101084; STOLLER RG, 1978, BIOCHEM PHARMACOL, V27, P53, DOI 10.1016/0006-2952(78)90256-3; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tadros S, 2017, CANCER RES, V77, P5503, DOI 10.1158/0008-5472.CAN-16-3062; Tagde A, 2016, ONCOTARGET, V7, P38974, DOI 10.18632/oncotarget.9777; Thorp E, 2009, CELL METAB, V9, P474, DOI 10.1016/j.cmet.2009.03.003; Urano F, 2000, SCIENCE, V287, P664, DOI 10.1126/science.287.5453.664; Wang L, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184110; Wang MX, 2018, CRIT REV ONCOL HEMAT, V127, P66, DOI 10.1016/j.critrevonc.2018.05.003; Wang M, 2014, NAT REV CANCER, V14, P581, DOI 10.1038/nrc3800; Wei XL, 2005, CANCER CELL, V7, P167, DOI 10.1016/j.ccr.2005.01.008; Weizman N, 2014, ONCOGENE, V33, P3812, DOI 10.1038/onc.2013.357; Yamamori T, 2013, FEBS LETT, V587, P3348, DOI 10.1016/j.febslet.2013.08.030; Yamamoto M, 2019, CANCER RES, V79, P2031, DOI 10.1158/0008-5472.CAN-18-3259; Ye FG, 2015, CANCER RES, V75, P1504, DOI 10.1158/0008-5472.CAN-14-2341; Ye J, 2000, MOL CELL, V6, P1355, DOI 10.1016/S1097-2765(00)00133-7; Yin L, 2003, J BIOL CHEM, V278, P35458, DOI 10.1074/jbc.M301987200; Zeeshan HMA, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17030327; Zeng T, 2015, BIOCHEM BIOPH RES CO, V460, P530, DOI 10.1016/j.bbrc.2015.03.064; Zinszner H, 1998, GENE DEV, V12, P982, DOI 10.1101/gad.12.7.982; Zweitzig DR, 2007, MOL CELL BIOCHEM, V306, P255, DOI 10.1007/s11010-007-9562-y	93	14	15	1	8	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 16	2020	39	16					3381	3395		10.1038/s41388-020-1225-4	http://dx.doi.org/10.1038/s41388-020-1225-4		FEB 2020	15	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	QF9OJ	32103170	Green Accepted			2022-12-26	WOS:000516683200002
J	Placido, A; Ferreira-da-Silva, F; Leite, JRSA; de-los-Santos-Alvarez, N; Delerue-Matos, C				Placido, Alexandra; Ferreira-da-Silva, Frederico; Leite, Jose Roberto S. A.; de-los-Santos-Alvarez, Noemi; Delerue-Matos, Cristina			A convenient renewable surface plasmon resonance chip for relative quantification of genetically modified soybean in food and feed	PLOS ONE			English	Article							MODIFIED ORGANISMS; ELECTROCHEMICAL SENSOR; DNA; HYBRIDIZATION; BIOSENSOR; IMMOBILIZATION; TECHNOLOGY; PROTEINS; KINETICS; CROPS	The cultivation of genetically modified organisms (GMO) continues to expand worldwide. Still, many consumers express concerns about the use of GMO in food or feed, and many countries have legislated on labelling systems to indicate the presence of GMO in commercial products. To deal with the increased number of GMO events and to address related regulations, alternative detection methods for GMO inspection are required. In this work, a genosensor based on Surface Plasmon Resonance under continuous flow was developed for the detection and quantification of a genetically modified soybean (event GTS 40-3-2). In a single chip, the simultaneous detection of the event-specific and the taxon-specific samples were achieved, whose detection limits were 20 pM and 16 pM, respectively. The reproducibility was 1.4%, which supports the use of the chip as a reliable and cost-effective alternative to other DNA-based techniques. The results indicate that the proposed method is a versatile tool for GMO quantification in food and feed samples.	[Placido, Alexandra; Delerue-Matos, Cristina] Inst Politecn Porto, Inst Super Engn Porto, REQUIMTE LAQV, Porto, Portugal; [Ferreira-da-Silva, Frederico] Univ Porto, i3S, Inst Invest & Inovacao Saude, Porto, Portugal; [Ferreira-da-Silva, Frederico] Univ Porto, Inst Biol Mol & Celular, Porto, Portugal; [Leite, Jose Roberto S. A.] Univ Brasilia, Fac Med, Area Morfol, Campus Darcy Ribeiro, Brasilia, DF, Brazil; [de-los-Santos-Alvarez, Noemi] Univ Oviedo, Dept Quim Fis & Analit, Oviedo, Spain	Polytechnic Institute of Porto; Universidade do Porto; i3S - Instituto de Investigacao e Inovacao em Saude, Universidade do Porto; Universidade do Porto; Universidade de Brasilia; University of Oviedo	Placido, A (corresponding author), Inst Politecn Porto, Inst Super Engn Porto, REQUIMTE LAQV, Porto, Portugal.	alexandra.placido@gmail.com	de-los-Santos-Álvarez, Noemí/AAG-1972-2020; Silva, Frederico/K-3820-2013; Placido, Alexandra/L-3085-2014	de-los-Santos-Álvarez, Noemí/0000-0002-5216-6825; Silva, Frederico/0000-0002-8890-4228; Placido, Alexandra/0000-0003-2706-7777	European Union (FEDER funds through COMPETE); National Funds (FCT, Fundacao para a Ciencia e a Tecnologia) [UID/QUI/50006/2013]; FEDER; FCT by POPH-QREN [SFRH/BD/97995/2013]; FSE; MCTES	European Union (FEDER funds through COMPETE); National Funds (FCT, Fundacao para a Ciencia e a Tecnologia); FEDER(European Commission); FCT by POPH-QREN; FSE(European Social Fund (ESF)); MCTES	This work received financial support from the European Union (FEDER funds through COMPETE), National Funds (FCT, Fundacao para a Ciencia e a Tecnologia) through project UID/QUI/50006/2013 and cofinanced by FEDER funds. Alexandra Pla ' cido is grateful for the FCT grant (SFRH/BD/97995/2013) financed by POPH-QREN (subsidized by FSE and MCTES).; .	Arugula MA, 2014, ANAL CHEM, V86, P119, DOI 10.1021/ac402898j; Balaz M, 2005, ANGEW CHEM INT EDIT, V44, P4006, DOI 10.1002/anie.200501149; Blow N, 2009, NAT METHODS, V6, P389, DOI 10.1038/nmeth0509-389; Brand GD, 2017, ARCH BIOCHEM BIOPHYS, V618, P9, DOI 10.1016/j.abb.2017.01.009; Brogioni B, 2014, MEDCHEMCOMM, V5, P1058, DOI 10.1039/c4md00088a; Chu RY, 2014, SCI REP-UK, V4, DOI 10.1038/srep07360; Cottenet G, 2019, FOOD CHEM, V274, P760, DOI 10.1016/j.foodchem.2018.09.050; Davis TM, 2000, ANAL BIOCHEM, V284, P348, DOI 10.1006/abio.2000.4726; Feriotto G, 2002, J AGR FOOD CHEM, V50, P955, DOI 10.1021/jf0109773; Fu CC, 2014, ANAL CHEM, V86, P11494, DOI 10.1021/ac5038736; Gao W, 2019, FOOD CHEM, V279, P246, DOI 10.1016/j.foodchem.2018.12.013; Gonzalez-Fernandez E, 2012, TALANTA, V99, P767, DOI 10.1016/j.talanta.2012.07.019; Gupta R, 2017, APPL ENV SCI ENG SUS, P425, DOI 10.1007/978-981-10-1866-4_14; Hossain MB, 2016, J SENSORS, V2016, DOI 10.1155/2016/6070742; JOHNSSON B, 1991, ANAL BIOCHEM, V198, P268, DOI 10.1016/0003-2697(91)90424-R; Jordan CE, 1997, ANAL CHEM, V69, P4939, DOI 10.1021/ac9709763; Karlsson R, 2006, ANAL BIOCHEM, V349, P136, DOI 10.1016/j.ab.2005.09.034; Keijzers G, 2015, BIOSCIENCE REP, V35, DOI 10.1042/BSR20150058; Kuzuya A, 2017, CHEM COMMUN, V53, P8276, DOI 10.1039/c7cc03991c; KYPR J, 1986, GEN PHYSIOL BIOPHYS, V5, P415; Kypr J, 2009, NUCLEIC ACIDS RES, V37, P1713, DOI 10.1093/nar/gkp026; Liao WC, 2013, BIOSENS BIOELECTRON, V50, P414, DOI 10.1016/j.bios.2013.06.044; LONG GL, 1983, ANAL CHEM, V55, pA712, DOI 10.1021/ac00258a001; Manzanares-Palenzuela CL, 2015, BIOSENS BIOELECTRON, V68, P259, DOI 10.1016/j.bios.2015.01.007; Madeira Alexandra, 2011, Curr Protoc Protein Sci, VChapter 19, DOI 10.1002/0471140864.ps1921s65; Mano J, 2017, FOOD CHEM, V226, P149, DOI 10.1016/j.foodchem.2017.01.064; Marani MM, 2017, GENE, V605, P70, DOI 10.1016/j.gene.2016.12.020; Mariotti E, 2002, ANAL CHIM ACTA, V453, P165, DOI 10.1016/S0003-2670(01)01458-1; Martin-Fernandez B, 2015, ANAL BIOANAL CHEM, V407, P3481, DOI 10.1007/s00216-015-8560-2; Milkani E, 2011, ANAL METHODS-UK, V3, P122, DOI 10.1039/c0ay00492h; Milkani E, 2010, BIOSENS BIOELECTRON, V25, P1217, DOI 10.1016/j.bios.2009.09.010; Miranda-Castro R, 2018, ELECTROANAL, V30, P1229, DOI 10.1002/elan.201800049; Myszyka DG, 1999, J MOL RECOGNIT, V12, P279, DOI 10.1002/(SICI)1099-1352(199909/10)12:5<279::AID-JMR473>3.0.CO;2-3; Nikolic Z, 2014, FOOD CHEM, V145, P1072, DOI 10.1016/j.foodchem.2013.09.017; Owczarzy R, 1997, BIOPOLYMERS, V44, P217, DOI 10.1002/(SICI)1097-0282(1997)44:3<217::AID-BIP3>3.0.CO;2-Y; Palau W, 2013, TALANTA, V114, P211, DOI 10.1016/j.talanta.2013.04.022; Peeters S, 2008, BIOSENS BIOELECTRON, V24, P72, DOI 10.1016/j.bios.2008.03.012; Peterson AW, 2002, J AM CHEM SOC, V124, P14601, DOI 10.1021/ja0279996; Placido A, 2018, BIOSENS BIOELECTRON, V110, P147, DOI 10.1016/j.bios.2018.03.042; SATYANARAYANA S, 1993, BIOCHEMISTRY-US, V32, P2573, DOI 10.1021/bi00061a015; Sedighi A, 2015, NANO RES, V8, P3922, DOI 10.1007/s12274-015-0893-9; Sipova H, 2013, ANAL CHIM ACTA, V773, P9, DOI 10.1016/j.aca.2012.12.040; Takabatake R, 2018, FOOD CHEM, V252, P390, DOI 10.1016/j.foodchem.2017.12.036; Wang RH, 2004, BIOSENS BIOELECTRON, V20, P967, DOI 10.1016/j.bios.2004.06.013; Wang W, 2014, SCI REP-UK, V4, DOI 10.1038/srep06609; Windels P, 2001, EUR FOOD RES TECHNOL, V213, P107, DOI 10.1007/s002170100336; WOODY RW, 1995, METHOD ENZYMOL, V246, P34; Yu F, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh067	48	2	2	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2020	15	2							e0229659	10.1371/journal.pone.0229659	http://dx.doi.org/10.1371/journal.pone.0229659			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8FM	32101588	gold, Green Published, Green Submitted			2022-12-26	WOS:000535233700046
J	Williams, PT				Williams, Paul T.			Quantile-dependent expressivity of postprandial lipemia	PLOS ONE			English	Article							DIETARY-FAT CLEARANCE; EUROPEAN ATHEROSCLEROSIS RESEARCH; APOLIPOPROTEIN-E POLYMORPHISM; BODY-MASS INDEX; APO E PHENOTYPE; TRIGLYCERIDE-RICH LIPOPROTEINS; HIGH-DENSITY-LIPOPROTEIN; LIPASE GENE VARIATION; ACID-BINDING PROTEIN; LIPID-LOWERING DRUGS	Purpose "Quantile-dependent expressivity" describes an effect of the genotype that depends upon the level of the phenotype (e.g., whether a subject's triglycerides are high or low relative to its population distribution). Prior analyses suggest that the effect of a genetic risk score (GRS) on fasting plasma triglyceride levels increases with the percentile of the triglyceride distribution. Postprandial lipemia is well suited for testing quantile-dependent expressivity because it exposes each individual's genotype to substantial increases in their plasma triglyceride concentrations. Ninety-seven published papers were identified that plotted mean triglyceride response vs. time and genotype, which were converted into quantitative data. Separately, for each published graph, standard least-squares regression analysis was used to compare the genotype differences at time t (dependent variable) to average triglyceride concentrations at time t (independent variable) to assess whether the genetic effect size increased in association with higher triglyceride concentrations and whether the phenomenon could explain purported genetic interactions with sex, diet, disease, BMI, and drugs. Results Consistent with the phenomenon, genetic effect sizes increased (P.0.05) with increasing triglyceride concentrations for polymorphisms associated with ABCA1, ANGPTL4, APOA1, APOA2, APOA4, APOA5, APOB, APOC3, APOE, CETP, FABP2, FATP6, GALNT2, GCKR, HL, IL1b, LEPR, LOX-1, LPL, MC4R, MTTP, NPY, SORT1, SULF2, TNFA, TCF7L2, and TM6SF2. The effect size for these polymorphisms showed a progressively increasing dose-response, with intermediate effect sizes at intermediate triglyceride concentrations. Quantile-dependent expressivity provided an alternative interpretation to their interactions with sex, drugs, disease, diet, and age, which have been traditionally ascribed to gene-environment interactions and genetic predictors of drug efficacy (i.e., personalized medicine). Conclusion Quantile-dependent expressivity applies to the majority of genetic variants affecting postprandial triglycerides, which may arise because the impaired functionalities of these variants increase at higher triglyceride concentrations. Purported gene-drug interactions may be the manifestations of quantile-dependent expressivity, rather than genetic predictors of drug efficacy.	[Williams, Paul T.] Lawrence Berkeley Natl Lab, Berkeley, CA 94720 USA	United States Department of Energy (DOE); Lawrence Berkeley National Laboratory	Williams, PT (corresponding author), Lawrence Berkeley Natl Lab, Berkeley, CA 94720 USA.	ptwilliams@lbl.gov		Williams, Paul/0000-0002-4872-4556				Agren JJ, 1998, ARTERIOSCL THROM VAS, V18, P1606, DOI 10.1161/01.ATV.18.10.1606; Anagnostopoulou KK, 2009, LIPIDS HEALTH DIS, V8, DOI 10.1186/1476-511X-8-24; Auinger A, 2012, BRIT J NUTR, V107, P1422, DOI 10.1017/S0007114511004727; Bergeron N, 1996, J CLIN INVEST, V97, P65, DOI 10.1172/JCI118408; Berthier MT, 2001, OBES RES, V9, P668, DOI 10.1038/oby.2001.91; BOERWINKLE E, 1994, AM J HUM GENET, V54, P341; BRENNINKMEIJER BJ, 1987, J LIPID RES, V28, P361; BROWN AJ, 1991, ARTERIOSCLER THROMB, V11, P1737, DOI 10.1161/01.ATV.11.6.1737; Byrne CD, 1996, ATHEROSCLEROSIS, V127, P35, DOI 10.1016/S0021-9150(96)05932-1; CALABRESI L, 1993, ARTERIOSCLER THROMB, V13, P521, DOI 10.1161/01.ATV.13.4.521; Cardona F, 2005, J CLIN ENDOCR METAB, V90, P2972, DOI 10.1210/jc.2004-1912; Cardona F, 2006, CLIN CHEM, V52, P1920, DOI 10.1373/clinchem.2006.069690; Cardona F, 2009, ATHEROSCLEROSIS, V206, P148, DOI 10.1016/j.atherosclerosis.2009.02.024; Carpentier AC, 2012, J CLIN ENDOCR METAB, V97, P1635, DOI 10.1210/jc.2011-3002; Carvalho-Wells AL, 2010, ATHEROSCLEROSIS, V212, P481, DOI 10.1016/j.atherosclerosis.2010.06.036; Clemente-Postigo M, 2010, CLIN BIOCHEM, V43, P1300, DOI 10.1016/j.clinbiochem.2010.08.014; Connors KE, 2014, CIRC-CARDIOVASC GENE, V7, P576, DOI 10.1161/CIRCGENETICS.114.000534; Corella D, 2007, CLIN CHEM, V53, P1144, DOI 10.1373/clinchem.2006.084863; Dallongeville J, 1999, ATHEROSCLEROSIS, V145, P381, DOI 10.1016/S0021-9150(99)00069-6; Dart A, 1997, ATHEROSCLEROSIS, V130, P161, DOI 10.1016/S0021-9150(96)06062-5; Dart AM, 1999, ARTERIOSCL THROM VAS, V19, P2465, DOI 10.1161/01.ATV.19.10.2465; deGoma EM, 2011, VASC MED, V16, P391, DOI 10.1177/1358863X11422251; Delgado-Lista J, 2007, J NUTR, V137, P2024; Delgado-Lista J, 2011, J CLIN ENDOCR METAB, V96, pE816, DOI 10.1210/jc.2010-2455; Delgado-Lista J, 2010, ARTERIOSCL THROM VAS, V30, P1051, DOI 10.1161/ATVBAHA.109.202580; Delgado-Lista J, 2010, J LIPID RES, V51, P63, DOI 10.1194/jlr.M800527-JLR200; Engelbrechtsen L, 2017, SCI REP-UK, V7, DOI 10.1038/srep43128; Erkkila AT, 2007, EUR J CLIN NUTR, V61, P1094, DOI 10.1038/sj.ejcn.1602620; Fernandez-Miranda C, 2001, NUTRITION, V17, P529, DOI 10.1016/S0899-9007(01)00552-4; Ferreira AP, 2013, ATHEROSCLEROSIS, V229, P139, DOI 10.1016/j.atherosclerosis.2013.03.027; Fisher RM, 1999, J LIPID RES, V40, P287; Fontaine-Bisson B, 2007, METABOLISM, V56, P649, DOI 10.1016/j.metabol.2006.12.013; Gambino R, 2007, HEPATOLOGY, V45, P1097, DOI 10.1002/hep.21631; Garelnabi M, 2013, CLIN BIOCHEM, V46, P12, DOI 10.1016/j.clinbiochem.2012.09.007; Geng X, 2018, J LIPID RES, V59, P722, DOI 10.1194/jlr.P080333; Georgopoulos A, 2000, J CLIN ENDOCR METAB, V85, P3155, DOI 10.1210/jc.85.9.3155; Gerdes C, 1997, CIRCULATION, V96, P733; Gertow K, 2003, ATHEROSCLEROSIS, V167, P265, DOI 10.1016/S0021-9150(02)00454-9; Gomez P, 2004, ATHEROSCLEROSIS, V174, P73, DOI 10.1016/j.atherosclerosis.2003.12.038; Gomez-Delgado F, 2014, MOL NUTR FOOD RES, V58, P1519, DOI 10.1002/mnfr.201300723; Guardiola M, 2017, CURR ATHEROSCLER REP, V19, DOI 10.1007/s11883-017-0665-y; Gudnason V, 1999, EUR J CLIN INVEST, V29, P116, DOI 10.1046/j.1365-2362.1999.00412.x; Hassing HC, 2014, OBESITY, V22, P1309, DOI 10.1002/oby.20682; Helwig U, 2007, METABOLISM, V56, P723, DOI 10.1016/j.metabol.2006.11.014; Hockey KJ, 2001, J LIPID RES, V42, P211; Holleboom AG, 2011, CELL METAB, V14, P811, DOI 10.1016/j.cmet.2011.11.005; Hooper AJ, 2007, J CLIN ENDOCR METAB, V92, P1474, DOI 10.1210/jc.2006-1998; Hooper AJ, 2015, J CLIN ENDOCR METAB, V100, pE1484, DOI 10.1210/jc.2015-2731; Humphries SE, 1998, ARTERIOSCL THROM VAS, V18, P526, DOI 10.1161/01.ATV.18.4.526; Inazu A, 2008, ATHEROSCLEROSIS, V196, P953, DOI 10.1016/j.atherosclerosis.2007.02.028; Irvin MR, 2010, CIRC-CARDIOVASC GENE, V3, P462, DOI 10.1161/CIRCGENETICS.110.950667; Jackson KG, 2017, MOL NUTR FOOD RES, V61, DOI 10.1002/mnfr.201600688; Jackson KG, 2016, NUTR J, V15, DOI 10.1186/s12937-016-0190-9; Jackson KG, 2012, MOL NUTR FOOD RES, V56, P1761, DOI 10.1002/mnfr.201200452; Jackson KG, 2012, ATHEROSCLEROSIS, V225, P135, DOI 10.1016/j.atherosclerosis.2012.08.035; Jackson KG, 2012, ATHEROSCLEROSIS, V220, P22, DOI 10.1016/j.atherosclerosis.2011.08.012; Jackson KG, 2010, GENES NUTR, V5, P39, DOI 10.1007/s12263-009-0149-y; Jang Y, 2004, AM J CLIN NUTR, V80, P832; Jansen H, 1999, ARTERIOSCL THROM VAS, V19, P303, DOI 10.1161/01.ATV.19.2.303; Jayewardene AF, 2016, EUR J CLIN NUTR, V70, P1325, DOI 10.1038/ejcn.2016.132; Jean M, 2017, PLOS ONE, V12, DOI [10.1371/journal.pone.0177110, DOI 10.1371/JOURNAL.PONE.0177110]; Jimenez-Gomez Y, 2008, NUTR METAB CARDIOVAS, V18, P173, DOI 10.1016/j.numecd.2006.11.002; Kobayashi J, 2001, ATHEROSCLEROSIS, V154, P539, DOI 10.1016/S0021-9150(00)00464-0; Kolovou G, 2003, J CLIN PATHOL, V56, P937, DOI 10.1136/jcp.56.12.937; Kolovou G, 2007, CLIN CHEM LAB MED, V45, P1190, DOI 10.1515/CCLM.2007.267; Lai CQ, 2007, ARTERIOSCL THROM VAS, V27, P1417, DOI 10.1161/ATVBAHA.107.140103; Lai CQ, 2016, J LIPID RES, V57, P2200, DOI 10.1194/jlr.M069948; Lefevre M, 2005, METABOLISM, V54, P1652, DOI 10.1016/j.metabol.2005.06.015; Liu YJ, 2008, J HUM GENET, V53, P709, DOI 10.1007/s10038-008-0302-2; Lopez-Miranda J, 2004, J CLIN ENDOCR METAB, V89, P4721, DOI 10.1210/jc.2003-031642; LopezMiranda J, 1997, ARTERIOSCL THROM VAS, V17, P1765, DOI 10.1161/01.ATV.17.9.1765; Lundahl B, 2002, ARTERIOSCL THROM VAS, V22, P289, DOI 10.1161/hq0202.102876; Marin C, 2002, AM J CLIN NUTR, V76, P319; Martin S, 2003, BBA-MOL BASIS DIS, V1637, P217, DOI 10.1016/S0925-4439(03)00033-4; Masana L, 2003, CLIN CHEM LAB MED, V41, P517, DOI 10.1515/CCLM.2003.078; Masuda D, 2009, J LIPID RES, V50, P999, DOI 10.1194/jlr.P700032-JLR200; Matikainen N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079473; Mero N, 1999, J LIPID RES, V40, P1663; MIESENBOCK G, 1993, J CLIN INVEST, V91, P448, DOI 10.1172/JCI116222; Mooij HL, 2015, J LIPID RES, V56, P665, DOI 10.1194/jlr.M053504; Moreno JA, 2003, J LIPID RES, V44, P2059, DOI 10.1194/jlr.M300124-JLR200; Moreno R, 2006, ATHEROSCLEROSIS, V189, P163, DOI 10.1016/j.atherosclerosis.2005.11.029; Moreno-Luna R, 2007, J CLIN ENDOCR METAB, V92, P2280, DOI 10.1210/jc.2006-1802; Musso G, 2017, J LIPID RES, V58, P1221, DOI 10.1194/jlr.M075028; Musso G, 2011, AM J CLIN NUTR, V94, P1033, DOI 10.3945/ajcn.111.015610; Musso G, 2009, HEPATOLOGY, V49, P426, DOI 10.1002/hep.22659; Nierman MC, 2005, METABOLISM, V54, P1499, DOI 10.1016/j.metabol.2005.05.016; NIKKILA M, 1994, ATHEROSCLEROSIS, V106, P149, DOI 10.1016/0021-9150(94)90120-1; Noto D, 2009, ATHEROSCLEROSIS, V206, P193, DOI 10.1016/j.atherosclerosis.2009.01.037; O'Hare EA, 2017, HEPATOLOGY, V65, P1526, DOI 10.1002/hep.29021; Olano-Martin E, 2008, J LIPID RES, V49, P945, DOI 10.1194/jlr.M700112-JLR200; Ooi TC, 2017, J CLIN ENDOCR METAB, V102, P3452, DOI 10.1210/jc.2017-00684; Orth M, 1996, BBA-LIPID LIPID MET, V1303, P22, DOI 10.1016/0005-2760(96)00075-6; Ostos MA, 2000, ATHEROSCLEROSIS, V153, P209, DOI 10.1016/S0021-9150(00)00400-7; Ostos MA, 1998, J LIPID RES, V39, P2493; Parnell LD, 2018, CURR OPIN LIPIDOL, V29, P30, DOI 10.1097/MOL.0000000000000469; Parnell LD, 2014, BIODATA MIN, V7, DOI 10.1186/1756-0381-7-21; Perez-Martinez P, 2004, J MOL ENDOCRINOL, V32, P237, DOI 10.1677/jme.0.0320237; Perez-Martinez P, 2008, AM J CLIN NUTR, V87, P744, DOI 10.1093/ajcn/87.3.744; Perez-Martinez P, 2007, LIPIDS, V42, P143, DOI 10.1007/s11745-007-3027-7; Perez-Martinez P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043390; Perez-Martinez P, 2011, BRIT J NUTR, V106, P468, DOI 10.1017/S0007114511002212; Perez-Martinez P, 2009, AM J CLIN NUTR, V89, P391, DOI 10.3945/ajcn.2008.26363; Pimstone SN, 1996, J LIPID RES, V37, P1675; Pollin TI, 2008, SCIENCE, V322, P1702, DOI 10.1126/science.1161524; Pratley RE, 2000, J LIPID RES, V41, P2002; RegisBailly A, 1996, CLIN CHIM ACTA, V253, P127, DOI 10.1016/0009-8981(96)06364-4; Reiber I, 2003, J NUTR BIOCHEM, V14, P394, DOI 10.1016/S0955-2863(03)00061-5; Reznik Y, 1996, METABOLISM, V45, P63, DOI 10.1016/S0026-0495(96)90201-2; Reznik Y, 2002, METABOLISM, V51, P1088, DOI 10.1053/meta.2002.34696; Ribalta J, 2005, CLIN CHEM, V51, P864, DOI 10.1373/clinchem.2004.044347; ROCHE HM, 1995, PROG LIPID RES, V34, P249, DOI 10.1016/0163-7827(95)00012-O; Rubin D, 2008, BRIT J NUTR, V99, P76, DOI 10.1017/S0007114507791857; Saleheen D, 2017, NATURE, V544, P235, DOI 10.1038/nature22034; Schwab US, 2002, EUR J CLIN NUTR, V56, P149, DOI 10.1038/sj.ejcn.1601297; Shatwan IM, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17030397; Shen HQ, 2009, HUM GENET, V126, P567, DOI 10.1007/s00439-009-0700-3; Shen J, 2008, J LIPID RES, V49, P1839, DOI 10.1194/jlr.P700033-JLR200; Smart MC, 2011, NUTR METAB CARDIOVAS, V21, P476, DOI 10.1016/j.numecd.2009.12.004; Smith JA, 2008, EUR J HUM GENET, V16, P603, DOI 10.1038/sj.ejhg.5202003; Staels B, 1998, CIRCULATION, V98, P2088, DOI 10.1161/01.CIR.98.19.2088; Tahvanainen E, 2000, ATHEROSCLEROSIS, V152, P317, DOI 10.1016/S0021-9150(99)00488-8; Talmud PJ, 2008, ARTERIOSCL THROM VAS, V28, P2319, DOI 10.1161/ATVBAHA.108.176917; Talmud PJ, 1998, J LIPID RES, V39, P1189; Tanaka T, 2007, J LIPID RES, V48, P1402, DOI 10.1194/jlr.M700066-JLR200; Tanaka T, 2007, J NUTR, V137, P578, DOI 10.1093/jn/137.3.578; Tilly-Kiesi M, 1998, ATHEROSCLEROSIS, V137, P37, DOI 10.1016/S0021-9150(97)00250-5; van't Hooft FM, 2001, CIRCULATION, V104, P1223, DOI 10.1161/hc3601.095709; Vansant G, 1999, INT J OBESITY, V23, P14, DOI 10.1038/sj.ijo.0800790; Vimaleswaran KS, 2015, NUTR METAB, V12, DOI 10.1186/s12986-015-0002-9; Warodomwichit D, 2009, J NUTR, V139, P439, DOI 10.3945/jn.108.096461; Waterworth DM, 1999, CIRCULATION, V99, P1872, DOI 10.1161/01.CIR.99.14.1872; WEINTRAUB MS, 1987, J CLIN INVEST, V80, P1571, DOI 10.1172/JCI113243; Williams PT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028764; Williams PT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027657; Williams PT., 2020, BEHAV GENETICS; Wojczynski MK, 2015, METABOLISM, V64, P1359, DOI 10.1016/j.metabol.2015.07.001; Wolever TMS, 1997, AM J CLIN NUTR, V66, P584, DOI 10.1093/ajcn/66.3.584; Woo SK, 2003, J HUM GENET, V48, P551, DOI 10.1007/s10038-003-0074-7; Xu CX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056216; Zemankova K, 2017, PHYSIOL RES, V66, P859, DOI 10.33549/physiolres.933552; ZILVERSMIT DB, 1979, CIRCULATION, V60, P473, DOI 10.1161/01.CIR.60.3.473	142	20	20	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2020	15	2							e0229495	10.1371/journal.pone.0229495	http://dx.doi.org/10.1371/journal.pone.0229495			32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8FM	32101585	gold, Green Published, Green Submitted			2022-12-26	WOS:000535233700038
J	Walker, OS; Ragos, R; Wong, MK; Adam, M; Cheung, A; Raha, S				Walker, O'Llenecia S.; Ragos, Rehginald; Wong, Michael K.; Adam, Mohamed; Cheung, Anson; Raha, Sandeep			Reactive oxygen species from mitochondria impacts trophoblast fusion and the production of endocrine hormones by syncytiotrophoblasts	PLOS ONE			English	Article							OXIDATIVE STRESS; PLACENTAL TROPHOBLAST; OXIDASE ACTIVITY; RECEPTOR-GAMMA; CYTOCHROME-C; GROWTH; DIFFERENTIATION; METABOLISM; MORPHOLOGY; LACTOGEN	The placenta, a tissue that is metabolically active and rich in mitochondria, forms a critical interface between the mother and developing fetus. Oxidative stress within this tissue, derived from the dysregulation of reactive oxygen species (ROS), has been linked to a number of adverse fetal outcomes. While such outcomes have been associated with mitochondrial dysfunction, the causal role of mitochondrial dysfunction and mitochondrially generated ROS in altering the process of placentation remains unclear. In this study, mitochondrial complex I activity was attenuated using 10 nM rotenone to induce cellular oxidative stress by increasing mitochondrial ROS production in the BeWo choriocarcinoma cell line. Increased mitochondrial ROS resulted in a significant decrease in the transcripts which encode for proteins associated with fusion (GCM1, ERVW-1, and ERVFRD-1) resulting in a 5-fold decrease in the percentage of BeWo fusion. This outcome was associated with increased indicators of mitochondrial fragmentation, as determined by decreased expression of MFN2 and OPA1 along with an increase in a marker of mitochondrial fission (DRP1). Importantly, increased mitochondrial ROS also resulted in a 5.0-fold reduction of human placental lactogen (PL) and a 4.4-fold reduction of insulin like growth factor 2 (IGF2) transcripts; hormones which play an important role in regulating fetal growth. The pre-treatment of rotenone-exposed cells with 5 mM N-acetyl cysteine (NAC) resulted in the prevention of these ROS mediated changes in BeWo function and supports a central role for mitochondrial ROS signaling in the maintenance and function of the materno-fetal interface.	[Walker, O'Llenecia S.; Ragos, Rehginald; Wong, Michael K.; Adam, Mohamed; Cheung, Anson; Raha, Sandeep] McMaster Univ, Dept Pediat, Hamilton, ON, Canada; [Walker, O'Llenecia S.; Ragos, Rehginald; Wong, Michael K.; Adam, Mohamed; Cheung, Anson; Raha, Sandeep] McMaster Univ, Grad Program Med Sci, Hamilton, ON, Canada	McMaster University; McMaster University	Raha, S (corresponding author), McMaster Univ, Dept Pediat, Hamilton, ON, Canada.	rahas@mcmaster.ca	Raha, Sandeep/AAF-3655-2020	Raha, Sandeep/0000-0001-7307-3292; Cheung, Anson/0000-0002-2324-5962	National Science and Engineering Research Council; McMaster University Medical Sciences Graduate Program; Hamilton Health Sciences High School Summer Bursary Program	National Science and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); McMaster University Medical Sciences Graduate Program; Hamilton Health Sciences High School Summer Bursary Program	This work was supported by funding from the National Science and Engineering Research Council (S.R.) -Discovery grant program. OW was supported by a stipend from the the McMaster University Medical Sciences Graduate Program and A.C. was supported by the Hamilton Health Sciences High School Summer Bursary Program.	Agarwal A, 2005, REPROD BIOL ENDOCRIN, V3, DOI 10.1186/1477-7827-3-28; Al-Hasan YM, 2013, REPROD SCI, V20, P299, DOI 10.1177/1933719112453509; ANTHONY RV, 1995, J ANIM SCI, V73, P1861; Babbar M., 2014, MOL CELL PHARM, V5, P109; Beere HM, 2004, J CELL SCI, V117, P2641, DOI 10.1242/jcs.01284; Boulton SJ, 2015, FASEB J, V29, P346, DOI 10.1096/fj.14-261982; Burton GJ, 2017, PLACENTA, V52, P146, DOI 10.1016/j.placenta.2016.04.001; Carey EAK, 2014, STEM CELLS DEV, V23, P2921, DOI 10.1089/scd.2014.0092; Casanueva E, 2003, J NUTR, V133, p1700S, DOI 10.1093/jn/133.5.1700S; Cassidy-Stone A, 2008, DEV CELL, V14, P193, DOI 10.1016/j.devcel.2007.11.019; Chan DC, 2006, CELL, V125, P1241, DOI 10.1016/j.cell.2006.06.010; Chen HC, 2003, J CELL BIOL, V160, P189, DOI 10.1083/jcb.200211046; Chen H, 2010, ANN NY ACAD SCI, V1201, P21, DOI 10.1111/j.1749-6632.2010.05615.x; Collett Gavin P, 2018, Oncotarget, V9, P6707, DOI 10.18632/oncotarget.24158; Crowe A, 2012, ASSAY DRUG DEV TECHN, V10, P476, DOI 10.1089/adt.2011.441; Dalleau S, 2013, CELL DEATH DIFFER, V20, P1615, DOI 10.1038/cdd.2013.138; Davies S, 2004, MOL HUM REPROD, V10, P935, DOI 10.1093/molehr/gah124; Castillo DD, 2011, J BIOL CHEM, V286, P23911, DOI 10.1074/jbc.M111.252056; Fato R, 2009, BBA-BIOENERGETICS, V1787, P384, DOI 10.1016/j.bbabio.2008.11.003; Ferretti C, 2007, HUM REPROD UPDATE, V13, P121, DOI 10.1093/humupd/dml048; Fogarty NME, 2015, PLACENTA, V36, P796, DOI 10.1016/j.placenta.2015.05.006; Gauster M., 2008, J REPRODUKTIONSMED E, V5, P76; Gude NM, 2004, THROMB RES, V114, P397, DOI 10.1016/j.thromres.2004.06.038; Gupta SK, 2016, AM J REPROD IMMUNOL, V75, P361, DOI 10.1111/aji.12436; Handwerger S, 2000, J PEDIATR ENDOCR MET, V13, P343, DOI 10.1515/JPEM.2000.13.4.343; Holland O, 2017, PLACENTA, V54, P2, DOI 10.1016/j.placenta.2016.12.012; Jauniaux E, 2010, PLACENTAL BED DISORD, P63; Knofler M, 2001, PLACENTA, V22, pS83, DOI 10.1053/plac.2001.0648; Kurjak A., 2015, TXB PERINATAL MED, P1033; Kushnareva Y, 2002, BIOCHEM J, V368, P545, DOI 10.1042/BJ20021121; Lenaz G, 2010, ANTIOXID REDOX SIGN, V12, P961, DOI 10.1089/ars.2009.2704; Li NY, 2003, J BIOL CHEM, V278, P8516, DOI 10.1074/jbc.M210432200; Marchi S, 2014, BBA-BIOENERGETICS, V1837, P461, DOI 10.1016/j.bbabio.2013.10.015; Martinez F, 1997, ENDOCRINOLOGY, V138, P2172, DOI 10.1210/en.138.5.2172; Matsubara S, 1997, PLACENTA, V18, P255, DOI 10.1016/S0143-4004(97)80059-8; Melmed S., 2016, WILLIAMS TXB ENDOCRI, P877; Mokhtari V, 2017, CELL J, V19, P11; MORRISH DW, 1987, J CLIN ENDOCR METAB, V65, P1282, DOI 10.1210/jcem-65-6-1282; Muralimanoharan S, 2012, PLACENTA, V33, P816, DOI 10.1016/j.placenta.2012.07.002; Orendi K, 2010, REPRODUCTION, V140, P759, DOI 10.1530/REP-10-0221; Poidatz D, 2015, FERTIL STERIL, V104, P483, DOI 10.1016/j.fertnstert.2015.05.005; Poidatz D, 2015, MOL HUM REPROD, V21, P206, DOI 10.1093/molehr/gau102; Raha S, 2000, TRENDS BIOCHEM SCI, V25, P502, DOI 10.1016/S0968-0004(00)01674-1; Raha S, 2012, J PREGNANCY, V2012, DOI 10.1155/2012/315203; Thompson LP, 2012, J PREGNANCY, V2012, DOI 10.1155/2012/582748; van der Bliek AM, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a011072; Weinberg SE, 2015, IMMUNITY, V42, P406, DOI 10.1016/j.immuni.2015.02.002; WICE B, 1990, EXP CELL RES, V186, P306, DOI 10.1016/0014-4827(90)90310-7; Wu F, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/293271	49	18	18	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2020	15	2							e0229332	10.1371/journal.pone.0229332	http://dx.doi.org/10.1371/journal.pone.0229332			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8DW	32092105	Green Published, gold			2022-12-26	WOS:000535229300047
J	Wataru, K; Sugiyama, A; Yoneyama, S; Matsubara, M; Fukuda, Y; Parikh, R; Sakurada, Y				Wataru, Kikushima; Sugiyama, Atsushi; Yoneyama, Seigo; Matsubara, Mio; Fukuda, Yoshiko; Parikh, Ravi; Sakurada, Yoichi			Five-year outcomes of photodynamic therapy combined with intravitreal injection of ranibizumab or aflibercept for polypoidal choroidal vasculopathy	PLOS ONE			English	Article							VISUAL PROGNOSIS; LESION SIZE; EFFICACY; VERTEPORFIN; BEVACIZUMAB; THICKNESS; ASSOCIATION; GENOTYPE; SAFETY	We report 5-year visual and anatomical outcomes after combination therapy of photodynamic therapy (PDT) and intravitreal injection of ranibizumab or aflibercept for polypoidal choroidal vasculopathy (PCV) and predictive factors for visual outcomes at 5-year and time to recurrence. Medical charts were retrospectively reviewed for 43 consecutive eyes with PCV treated with combination therapy of PDT and intravitreal injection of ranibizumab(n = 13) or aflibercept(n = 30) and completed 5-year follow-up. The variants of ARMS2 A69S and CFH I62V were genotyped using TaqMan assay. Best corrected visual acuity (BCVA) significantly improved at 5-year (P = 0.01) with 20% reduction of subfoveal choroidal thickness irrespective of presence or absence of recurrence. Visual improvement was associated with baseline shorter greatest linear dimension (GLD) (P = 1.0x10(-4)). Mean time to recurrence was 28.6 +/- 23.1 months (95% CI: 21.5-35.7, Median:18.0) and time to recurrence was associated with G allele (protective allele) of ARMS2 A69S and GLD (P = 4.0x10(-4) and 1.0x10(-2), respectively). Multiple regression analysis revealed that time to recurrence extended by 15.5 months when the G allele of ARMS2 A69S increased by one allele (TT: 15.7 +/- 17.0, TG: 30.8 +/- 23.5, GG: 41.1 +/- 22.6 months). The combination therapy resulted in a favorable visual outcome for PCV during 5-year follow-up.	[Wataru, Kikushima; Sugiyama, Atsushi; Yoneyama, Seigo; Matsubara, Mio; Fukuda, Yoshiko; Sakurada, Yoichi] Univ Yamanashi, Fac Med, Dept Ophthalmol, Kofu, Yamanashi, Japan; [Parikh, Ravi] NYU, Sch Med, New York, NY USA; [Parikh, Ravi] Manhattan Retina & Eye Consultants, New York, NY USA	University of Yamanashi; New York University	Sakurada, Y (corresponding author), Univ Yamanashi, Fac Med, Dept Ophthalmol, Kofu, Yamanashi, Japan.	sakurada@yamanashi.ac.jp		Parikh, Ravi/0000-0003-3369-4224; Sakurada, Yoichi/0000-0002-2894-0454	JSPS (Japan Society for the promotion of Science) KAKENHI [18K16921]	JSPS (Japan Society for the promotion of Science) KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	JSPS (Japan Society for the promotion of Science) KAKENHI Grant Number 18K16921	Chan WM, 2004, OPHTHALMOLOGY, V111, P1576, DOI 10.1016/j.ophtha.2003.12.056; Fukuda Y, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-48494-6; Gomi F, 2008, BRIT J OPHTHALMOL, V92, P70, DOI 10.1136/bjo.2007.122283; Gomi F, 2010, AM J OPHTHALMOL, V150, P48, DOI 10.1016/j.ajo.2010.02.008; Honda S, 2014, OPHTHALMOLOGICA, V232, P92, DOI 10.1159/000360308; Jain P, 2018, INDIAN J OPHTHALMOL, V66, P1119, DOI 10.4103/ijo.IJO_1222_17; Kikushima W, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-16476-1; Kikushima W, 2017, SCI REP-UK, V7, DOI 10.1038/srep44020; Kikushima W, 2017, GRAEF ARCH CLIN EXP, V255, P311, DOI 10.1007/s00417-016-3467-y; Koh A, 2017, JAMA OPHTHALMOL, V135, P1206, DOI 10.1001/jamaophthalmol.2017.4030; Lee YA, 2012, AM J OPHTHALMOL, V154, P872, DOI 10.1016/j.ajo.2012.03.051; Maruko I, 2013, AM J OPHTHALMOL, V156, P548, DOI 10.1016/j.ajo.2013.03.041; Miyata M, 2019, BRIT J OPHTHALMOL, V103, P617, DOI 10.1136/bjophthalmol-2018-311963; Nakai S, 2019, JPN J OPHTHALMOL, V63, P389, DOI 10.1007/s10384-019-00683-6; Nakai S, 2019, JPN J OPHTHALMOL, V63, P100, DOI 10.1007/s10384-018-0636-z; Nishijima K, 2004, AM J OPHTHALMOL, V137, P770, DOI 10.1016/S0002-9394(03)01147-4; Sakai T, 2016, ACTA OPHTHALMOL, V94, pE765, DOI 10.1111/aos.13130; Sakurada Y, 2017, RETINA-J RET VIT DIS, V37, P1866, DOI 10.1097/IAE.0000000000001427; Sakurada Y, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149978; Sakurada Y, 2013, J OCUL PHARMACOL TH, V29, P832, DOI 10.1089/jop.2013.0044; Sakurada Y, 2011, OPHTHALMOLOGY, V118, P1402, DOI 10.1016/j.ophtha.2010.12.010; Sakurada Y, 2010, RETINA-J RET VIT DIS, V30, P1616, DOI 10.1097/IAE.0b013e3181e587e3; Sakurada Y, 2009, RETINA-J RET VIT DIS, V29, P1522, DOI 10.1097/IAE.0b013e3181af0d72; Sato T, 2010, AM J OPHTHALMOL, V149, P947, DOI 10.1016/j.ajo.2009.12.038; SPAIDE RF, 1995, RETINA-J RET VIT DIS, V15, P100, DOI 10.1097/00006982-199515020-00003; Sugiyama A, 2018, OPHTHALMOLOGICA, V239, P52, DOI 10.1159/000480439; Tsujikawa A, 2011, AM J OPHTHALMOL, V151, P961, DOI 10.1016/j.ajo.2011.01.002; Yamashiro K, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09632-0; Yang JY, 2019, BMC OPHTHALMOL, V19, DOI 10.1186/s12886-019-1245-4; YANNUZZI LA, 1990, RETINA-J RET VIT DIS, V10, P1, DOI 10.1097/00006982-199001010-00001; Yoneyama S, 2016, RETINA-J RET VIT DIS, V36, P1535, DOI 10.1097/IAE.0000000000000964	31	10	11	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2020	15	2							e0229231	10.1371/journal.pone.0229231	http://dx.doi.org/10.1371/journal.pone.0229231			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8DW	32092094	Green Published, gold			2022-12-26	WOS:000535229300034
J	Xie, L; Wang, S; Zhou, LY; Li, JS; Gu, JQ; Dawa, EZ; Xu, MQ				Xie Liang; Wang Shu; Zhou Linyong; Li Jianshui; Gu Junqing; Dawa Enzhu; Xu Mingqing			Preoperative nutritional evaluation of patients with hepatic alveolar echinococcosis	PLOS ONE			English	Article							MALNUTRITION; INFECTION; SURGERY	Objective This study is aimed at determining the preoperative nutritional status of patients with hepatic alveolar echinococcosis (HAE), and subsequently establish a concise and reasonable nutritional evaluation indicator. The established evaluation method could be used for clinical preoperative risk assessment and prediction of post-operation recovery. Methods The basic patient information on height, body weight, BMI and hepatic encephalopathy of 93 HAE patients were examined. Subsequently, abdominal ultrasonography, blood coagulation and liver function tests were done on the patients. Liver function was assessed using the Child-Pugh improved grading method while nutritional status was evaluated using the European Nutrition Risk Screening 2002 (NRS 2002) method. Additional parameters including hospitalization time, the hemoglobin (HGB) level on the 3rd day after the operation, and the number of postoperative complications of HAE patients were also recorded. Results The NRS 2002 score was negatively correlated with body weight, body mass index (BMI) and albumin (ALB) (P<0.01), and positively correlated with the transverse and longitudinal diameters of the lesions (P<0.01). A worse grading of liver function was associated with a low ALB and a high NRS 2002 score (P<0.01). Results of the NRS 2002 score indicate that the hospitalization time of the normal nutrition group was significantly shorter than that of the malnourished group (P < 0.05). The HGB level of the control group on the 3rd day after the operation was significantly higher than that of the malnourished group (P < 0.05), and the number of postoperative complications was lower than that of malnutrition group (P < 0.05). Conclusion Malnutrition is common in HAE patients. The nutritional status of HAE patients is related to many clinical factors, such as Child-Pugh classification of liver function, size of the lesion, and ALB among others. Although both BMI and ALB can be used as primary screening indicators for malnutrition in HAE patients, NRS 2002 is more reliable and prudent in judging malnutrition in HAE patients. Therefore, BMI and ALB are more suitable for preoperative risk assessment and prediction of postoperative recovery.	[Xie Liang; Li Jianshui] North Sichuan Med Coll, Affiliated Hosp, Dept Hepatobiliary Surg 2, Nanchong, Peoples R China; [Xie Liang; Li Jianshui] North Sichuan Med Coll, Northeast Sichuan Acute Pancreat Res Ctr, Nanchong, Peoples R China; [Wang Shu; Gu Junqing] North Sichuan Med Coll, Dept Urol Surg, Affiliated Hosp, Nanchong, Peoples R China; [Zhou Linyong; Dawa Enzhu] Peoples Hosp Ganzi Cty, Surg Dept, Kangding, Ganzi Tibetan A, Peoples R China; [Xu Mingqing] Sichuan Univ, West China Hosp, Dept Hepat Surg, Chengdu, Peoples R China	North Sichuan Medical University; North Sichuan Medical University; North Sichuan Medical University; Sichuan University	Xu, MQ (corresponding author), Sichuan Univ, West China Hosp, Dept Hepat Surg, Chengdu, Peoples R China.	xumingqing@scu.edu.cn			project of Sichuan Province health and Family Planning Commission [17PJ106]	project of Sichuan Province health and Family Planning Commission	This research is supported by the project of Sichuan Province health and Family Planning Commission (17PJ106)	Bhutani N, 2018, ANN MED SURG, V36, P99, DOI 10.1016/j.amsu.2018.10.032; Brady M., 2003, COCHRANE DB SYST REV, V4, pCD004423, DOI [10.1002/14651858.CD004423, DOI 10.1002/14651858.CD004423, 10.1002/14651858.cd004423]; Bresnahan KA, 2014, ADV NUTR, V5, P702, DOI 10.3945/an.114.006361; Cederholm T, 2017, CLIN NUTR, V36, P49, DOI 10.1016/j.clnu.2016.09.004; Cederholm T, 2015, CLIN NUTR, V34, P335, DOI 10.1016/j.clnu.2015.03.001; Chinese Expert Group on Enhanced Recovery After Surgery, 2016, CHINESE J SURG, V54, P335; Deshmukh VR, 2017, INDIAN PEDIATR, V54, P1025, DOI 10.1007/s13312-017-1205-0; Hackl C, 2016, WORLD J GASTROENTERO, V22, P2725, DOI 10.3748/wjg.v22.i9.2725; Hertlein L, 2014, EUR J OBSTET GYN R B, V174, P137, DOI 10.1016/j.ejogrb.2013.12.028; Hu J, 2019, J PREV MED CHIN PLA, P9; Kondrup J, 2003, CLIN NUTR, V22, P321, DOI 10.1016/S0261-5614(02)00214-5; Lei JY, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000000514; Li XY, 2016, NUTRITION, V32, P1057, DOI 10.1016/j.nut.2016.02.020; Liu N, 2016, PARENTERAL ENTERAL N, V23, P346; Nunnari G, 2012, WORLD J GASTROENTERO, V18, P1448, DOI 10.3748/wjg.v18.i13.1448; Okumiya K, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-009728; Parsak CK, 2007, ACTA CHIR BELG, V107, P572, DOI 10.1080/00015458.2007.11680128; Puneeta T, 2017, HEPATOLOGY, V65; Salm LA, 2019, FOOD WATERB PARASIT, V15, DOI 10.1016/j.fawpar.2019.e00050; Tunc S, 2013, J PHOTOCH PHOTOBIO B, V120, P59, DOI 10.1016/j.jphotobiol.2013.01.011; van Stijn MFM, 2013, JPEN-PARENTER ENTER, V37, P37, DOI 10.1177/0148607112445900; Weimann A, 2017, CLIN NUTR, V36, P623, DOI 10.1016/j.clnu.2017.02.013; Xu T, 2016, MED J PEKING UNION M, P110; Ya-Min Guo, 2018, Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi, V30, P705, DOI 10.16250/j.32.1374.2018169; Zhang CS, 2012, PLOS ONE, V7, P436, DOI 10.1371/journal.pone.0030127	25	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2020	15	2							e0229396	10.1371/journal.pone.0229396	http://dx.doi.org/10.1371/journal.pone.0229396			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8DW	32092109	Green Published, gold			2022-12-26	WOS:000535229300054
J	Reardon, PN; Jara, KA; Rolland, AD; Smith, DA; Hoang, HTM; Prell, JS; Barbar, EJ				Reardon, Patrick N.; Jara, Kayla A.; Rolland, Amber D.; Smith, Delaney A.; Hoang, Hanh T. M.; Prell, James S.; Barbar, Elisar J.			The dynein light chain 8 (LC8) binds predominantly ?in-register? to a multivalent intrinsically disordered partner	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						intrinsically disordered protein; nuclear magnetic resonance (NMR); analytical ultracentrifugation; protein dynamic; protein assembly; LC8; multivalency; native mass spectrometry	INTERMEDIATE CHAIN; STRUCTURAL BASIS; RECOGNITION; DYNLL1; MOTIF; DIMERIZATION; SYSTEM; ASCIZ; C-13	Dynein light chain 8 (LC8) interacts with intrinsically disordered proteins (IDPs) and influences a wide range of biological processes. It is becoming apparent that among the numerous IDPs that interact with LC8, many contain multiple LC8-binding sites. Although it is established that LC8 forms parallel IDP duplexes with some partners, such as nucleoporin Nup159 and dynein intermediate chain, the molecular details of these interactions and LC8's interactions with other diverse partners remain largely uncharacterized. LC8 dimers could bind in either a paired ?in-register? or a heterogeneous off-register manner to any of the available sites on a multivalent partner. Here, using NMR chemical shift perturbation, analytical ultracentrifugation, and native electrospray ionization MS, we show that LC8 forms a predominantly in-register complex when bound to an IDP domain of the multivalent regulatory protein ASCIZ. Using saturation transfer difference NMR, we demonstrate that at substoichiometric LC8 concentrations, the IDP domain preferentially binds to one of the three LC8 recognition motifs. Further, the differential dynamic behavior for the three sites and the size of the fully bound complex confirmed an in-register complex. Dynamics measurements also revealed that coupling between sites depends on the linker length separating these sites. These results identify linker length and motif specificity as drivers of in-register binding in the multivalent LC8?IDP complex assembly and the degree of compositional and conformational heterogeneity as a promising emerging mechanism for tuning of binding and regulation.	[Reardon, Patrick N.] Oregon State Univ, NMR Facil, Corvallis, OR 97331 USA; [Jara, Kayla A.; Smith, Delaney A.; Hoang, Hanh T. M.; Barbar, Elisar J.] Oregon State Univ, Dept Biochem & Biophys, Corvallis, OR 97331 USA; [Rolland, Amber D.; Prell, James S.] Univ Oregon, Dept Chem & Biochem, Eugene, OR 97403 USA; [Rolland, Amber D.] Univ Oregon, Inst Mol Biol, Eugene, OR 97403 USA; [Prell, James S.] Univ Oregon, Mat Sci Inst, Eugene, OR 97403 USA	Oregon State University; Oregon State University; University of Oregon; University of Oregon; University of Oregon	Barbar, EJ (corresponding author), Dept Biochem & Biophys, 2011 Agr & Life Sci Bldg,2900 SW Campus Way, Corvallis, OR 97331 USA.	Elisar.Barbar@oregonstate.edu	Smith, Delaney/AAD-3412-2021	Rolland, Amber/0000-0002-7905-8250; Jara, Kayla/0000-0003-0406-2957; Barbar, Elisar/0000-0003-4892-5259; Reardon, Patrick/0000-0002-6858-0086	National Science Foundation [1617019]; National Institutes of Health [T32 GM007759]; National Institutes of Health, HEI [1S10OD018518]; M. J. Murdock Charitable Trust [2014162]	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health, HEI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); M. J. Murdock Charitable Trust	This work was supported by National Science Foundation Award 1617019. This work was also supported by a National Institutes of Health Grant T32 GM007759 (to A. D. R.). The Oregon State University NMR Facility is supported in part by the National Institutes of Health, HEI Grant 1S10OD018518 (to E. J. B.) and by M. J. Murdock Charitable Trust Grant 2014162 (to E. J. B.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Barbar E, 2008, BIOCHEMISTRY-US, V47, P503, DOI 10.1021/bi701995m; Benison G, 2007, J MOL BIOL, V371, P457, DOI 10.1016/j.jmb.2007.05.046; Benison G, 2006, J MOL BIOL, V362, P1082, DOI 10.1016/j.jmb.2006.08.006; Benison G, 2009, METHOD ENZYMOL, V455, P237, DOI 10.1016/S0076-6879(08)04209-2; Bodor A, 2014, BIOCHEMISTRY-US, V53, P7107, DOI 10.1021/bi500574z; Clark S, 2018, ELIFE, V7, DOI 10.7554/eLife.36258; Clark S, 2016, BIOCHEMISTRY-US, V55, P199, DOI 10.1021/acs.biochem.5b01099; Clark SA, 2015, FEBS LETT, V589, P2543, DOI 10.1016/j.febslet.2015.07.032; Coggins BE, 2012, J AM CHEM SOC, V134, P18619, DOI 10.1021/ja307445y; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dunsch AK, 2012, J CELL BIOL, V198, P1039, DOI 10.1083/jcb.201202112; Fan JS, 2001, J MOL BIOL, V306, P97, DOI 10.1006/jmbi.2000.4374; Fejtova A, 2009, J CELL BIOL, V185, P341, DOI 10.1083/jcb.200807155; Gaik M, 2015, J CELL BIOL, V208, P283, DOI 10.1083/jcb.201411003; Hall J, 2009, J BIOL CHEM, V284, P33115, DOI 10.1074/jbc.M109.048587; Jespersen N., 2020, TRENDS BIOCH SCI; Jespersen N, 2019, LIFE SCI ALLIANCE, V2, DOI 10.26508/lsa.201900366; Jespersen NE, 2019, J MOL BIOL, V431, P4959, DOI 10.1016/j.jmb.2019.10.011; Johnson Bruce A, 2004, Methods Mol Biol, V278, P313; Jurado S, 2012, J EXP MED, V209, P1629, DOI 10.1084/jem.20120785; Jurado S, 2012, J BIOL CHEM, V287, P3156, DOI 10.1074/jbc.M111.306019; KING SM, 1995, J BIOL CHEM, V270, P11445, DOI 10.1074/jbc.270.19.11445; Krishnamurthy VM, 2007, J AM CHEM SOC, V129, P1312, DOI 10.1021/ja066780e; Laue T.M., 1992, ANAL ULTRACENTRIFUGA, P90; Liang J, 1999, NAT STRUCT BIOL, V6, P735; Lo KWH, 2001, J BIOL CHEM, V276, P14059, DOI 10.1074/jbc.M010320200; Nyarko A, 2013, J BIOL CHEM, V288, P2614, DOI 10.1074/jbc.M112.432831; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Rapali P, 2011, BIOCHEM BIOPH RES CO, V414, P493, DOI 10.1016/j.bbrc.2011.09.093; Rapali P, 2011, FEBS J, V278, P2980, DOI 10.1111/j.1742-4658.2011.08254.x; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Shimada I, 2009, PROG NUCL MAG RES SP, V54, P123, DOI 10.1016/j.pnmrs.2008.07.001; Slevin LK, 2014, J BIOL CHEM, V289, P20727, DOI 10.1074/jbc.M114.576041; Sorensen CS, 2019, P NATL ACAD SCI USA, V116, P23124, DOI 10.1073/pnas.1904813116; Stelter P, 2007, NAT CELL BIOL, V9, P788, DOI 10.1038/ncb1604; Toropova K, 2019, NAT STRUCT MOL BIOL, V26, P823, DOI 10.1038/s41594-019-0286-y; Venters RA, 1996, J MOL BIOL, V264, P1101, DOI 10.1006/jmbi.1996.0699; Wheeler LC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164740; WISHART DS, 1994, J BIOMOL NMR, V4, P171; Wishart DS, 2001, METHOD ENZYMOL, V338, P3; Zaytseva O, 2014, GENETICS, V196, P443, DOI 10.1534/genetics.113.159541	41	8	8	2	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 10	2020	295	15					4912	4922		10.1074/jbc.RA119.011653	http://dx.doi.org/10.1074/jbc.RA119.011653			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LE7FC	32139510	hybrid, Green Published			2022-12-26	WOS:000526887000015
J	Dzansi, G; Tornu, E; Chipps, J				Dzansi, Gladys; Tornu, Eric; Chipps, Jeniffer			Promoters and inhibitors of treatment adherence among HIV/AIDS patients receiving antiretroviral therapy in Ghana: Narratives from an underserved population	PLOS ONE			English	Article							HIV; PEOPLE; BARRIERS; OUTCOMES; CARE	Adherence to antiretroviral therapy (ART) is essential to achieving an improved cluster of differentiation-4 (CD4) count, viral load, and quality of life while preventing drug resistance. Medication adherence among people living with Human Immunodeficiency Virus (HIV) is influenced by different factors. Several studies have identified adherence promoters and inhibitors that emanate from the internal and external environment. We conducted six (6) individual in-depth interviews and three (3) focus group discussions to explore adherence behaviour among patients diagnosed with HIV in a teaching hospital in Accra, Ghana. Participants were drawn from the intervention arm of a mobile phone adherence intervention program. They had been enrolled in the study for at least six (6) months before the interviews are conducted. Results revealed that participants adhered to treatment irrespective of prompts from significant others. Adherence promoters included perception of ART as part of daily routines, benefits of the ART, awareness of regimen, access to food, and transparency. Adherence inhibitors were forgetfulness, secrecy, waiting time, religious beliefs, and sleep. People living with HIV (PLWHIV) have the personal motivation to take medication; however, negative perceptions about HIV must be addressed to ensure optimum adherence behaviour.	[Dzansi, Gladys; Tornu, Eric] Univ Ghana, Coll Hlth Sci, Sch Nursing & Midwifery, Dept Adult Hlth, Legon, Accra, Ghana; [Chipps, Jeniffer] Univ Western Cape, Sch Nursing & Midwifery, Cape Town, South Africa	University of Ghana; University of the Western Cape	Tornu, E (corresponding author), Univ Ghana, Coll Hlth Sci, Sch Nursing & Midwifery, Dept Adult Hlth, Legon, Accra, Ghana.	etornu@ug.edu.gh	DZANSI, GLADYS/AAW-8923-2021; DZANSI, GLADYS/N-2653-2018; DZANSI, GLADYS/GSO-1641-2022	DZANSI, GLADYS/0000-0002-6036-811X; DZANSI, GLADYS/0000-0002-6036-811X; Tornu, Eric/0000-0002-7469-5496				Chib A, 2015, J HEALTH COMMUN, V20, P4, DOI 10.1080/10810730.2013.864735; Chung MH, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000422; Creswell JW, 2009, CAN J U CONTIN ED, P35; Fishbein M, 2011, PREDICTING AND CHANGING BEHAVIOR: THE REASONED ACTION APPROACH, P1; Kalichman SC, 2015, INFECT DIS THER, V4, P79, DOI 10.1007/s40121-015-0057-y; Langebeek N, 2014, BMC MED, V12, DOI [10.1186/s12916-014-0142-1, 10.1186/PREACCEPT-1453408941291432]; Mannheimer S, 2015, CURR INFECT DIS REP, V17, DOI 10.1007/s11908-015-0466-9; Obirikorang C, 2013, ISRN AIDS, V2013; Ortego C, 2012, AIDS CARE, V24, P1519, DOI 10.1080/09540121.2012.672722; Paterson DL, 2000, ANN INTERN MED, V133, P21, DOI 10.7326/0003-4819-133-1-200007040-00004; Portelli MS, 2015, ASIA-PAC J PUBLIC HE, V27, pNP778, DOI 10.1177/1010539512442082; Ruanjahn G, 2010, AIDS CARE, V22, P1555, DOI 10.1080/09540121003759901; Sanjobo N, 2008, SAHARA J-J SOC ASP H, V5, P136, DOI 10.1080/17290376.2008.9724912; Smillie K, 2014, J ASSOC NURSE AIDS C, V25, P614, DOI 10.1016/j.jana.2014.01.008; Starks H, 2008, AIDS CARE, V20, P607, DOI 10.1080/09540120701660379; Tesch R., 1990, QUALITATIVE RES ANAL; Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042; UNAIDS, 2019, GHAN HIV AIDS EST; van Loggerenberg F, 2015, AIDS PATIENT CARE ST, V29, P299, DOI 10.1089/apc.2014.0293; Vu VT, 2011, AIDS CARE, V23, P139, DOI 10.1080/09540121.2010.507741; Wakibi SN, 2011, AIDS RES THER, V8, DOI 10.1186/1742-6405-8-43; World Health Organization, 2003, ADHERENCE LONG TERM; World Health Organization, 2016, CONS GUID US ANT DRU, DOI [10.1016/j.jped.2014.04.007, DOI 10.1016/J.JPED.2014.04.007]	23	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2020	15	3							e0230159	10.1371/journal.pone.0230159	http://dx.doi.org/10.1371/journal.pone.0230159			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LQ8TR	32142549	Green Published, gold			2022-12-26	WOS:000535271600040
J	Dorweiler, JE; Obaoye, JO; Oddo, MJ; Shilati, FM; Scheidemantle, GM; Coleman, TJ; Reilly, JA; Smith, GR; Manogaran, AL				Dorweiler, Jane E.; Obaoye, Joanna O.; Oddo, Mitch J.; Shilati, Francesca M.; Scheidemantle, Grace M.; Coleman, Thomas J.; Reilly, Jacob A.; Smith, Gregory R.; Manogaran, Anita L.			DMSO-mediated curing of several yeast prion variants involves Hsp104 expression and protein solubilization, and is decreased in several autophagy related gene (atg) mutants	PLOS ONE			English	Article							PSI+ PRION; GUANIDINE-HYDROCHLORIDE; SUP35; OVEREXPRESSION; PROPAGATION; PSI(+); ELIMINATION; DETERMINANT; APPEARANCE; GENERATION	Chaperones and autophagy are components of the protein quality control system that contribute to the management of proteins that are misfolded and aggregated. Here, we use yeast prions, which are self-perpetuating aggregating proteins, as a means to understand how these protein quality control systems influence aggregate loss. Chaperones, such as Hsp104, fragment prion aggregates to generate more prion seeds for propagation. While much is known about the role of chaperones, little is known about how other quality control systems contribute to prion propagation. We show that the aprotic solvent dimethyl sulfoxide (DMSO) cures a range of [PSI+] prion variants, which are related to several misfolded aggregated conformations of the Sup35 protein. Our studies show that DMSO-mediated curing is quicker and more efficient than guanidine hydrochloride, a prion curing agent that inactivates the Hsp104 chaperone. Instead, DMSO appears to induce Hsp104 expression. Using the yTRAP system, a recently developed transcriptional reporting system for tracking protein solubility, we found that DMSO also rapidly induces the accumulation of soluble Sup35 protein, suggesting a potential link between Hsp104 expression and disassembly of Sup35 from the prion aggregate. However, DMSO-mediated curing appears to also be associated with other quality control systems. While the induction of autophagy alone does not lead to curing, we found that DMSO-mediated curing is dramatically impaired in autophagy related (atg) gene mutants, suggesting that other factors influence this DMSO mechanism of curing. Our data suggest that DMSO-mediated curing is not simply dependent upon Hsp104 overexpression alone, but may further depend upon other aspects of proteostasis.	[Dorweiler, Jane E.; Obaoye, Joanna O.; Oddo, Mitch J.; Shilati, Francesca M.; Scheidemantle, Grace M.; Reilly, Jacob A.; Manogaran, Anita L.] Marquette Univ, Dept Biol Sci, Milwaukee, WI 53233 USA; [Coleman, Thomas J.; Smith, Gregory R.] Lakeland Univ, Dept Biol, Plymouth, WI USA	Marquette University	Manogaran, AL (corresponding author), Marquette Univ, Dept Biol Sci, Milwaukee, WI 53233 USA.	anita.manogaran@marquette.edu	Dorweiler, Jane/K-3116-2019		National Institutes of Health (NIH) [GM109336]; Marquette University Honors Fellowships; NSF REU Fellowship; Lakeland University Lure Fellowship	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Marquette University Honors Fellowships; NSF REU Fellowship(National Science Foundation (NSF)NSF - Office of the Director (OD)); Lakeland University Lure Fellowship	This work was supported by the National Institutes of Health (NIH) grant GM109336 to A.L. M., Marquette University Honors Fellowships to J. O.O, M.J.O, and F.M.S., the NSF REU Fellowship to G.M.S., and the Lakeland University Lure Fellowship to T.J.C. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvers AL, 2009, AGING CELL, V8, P353, DOI 10.1111/j.1474-9726.2009.00469.x; Bailleul PA, 1999, GENETICS, V153, P81; Bradley ME, 2003, GENETICS, V165, P1675; CHERNOFF YO, 1995, SCIENCE, V268, P880, DOI 10.1126/science.7754373; Cox B, 2003, GENETICS, V165, P23; COX BS, 1988, YEAST, V4, P159, DOI 10.1002/yea.320040302; Derkatch IL, 1997, GENETICS, V147, P507; Derkatch IL, 1996, GENETICS, V144, P1375; Derkatch IL, 2001, CELL, V106, P171, DOI 10.1016/S0092-8674(01)00427-5; Eaglestone SS, 2000, P NATL ACAD SCI USA, V97, P240, DOI 10.1073/pnas.97.1.240; Eisenberg T, 2009, NAT CELL BIOL, V11, P1305, DOI 10.1038/ncb1975; Ferreira PC, 2001, MOL MICROBIOL, V40, P1357, DOI 10.1046/j.1365-2958.2001.02478.x; Glover JR, 1998, CELL, V94, P73, DOI 10.1016/S0092-8674(00)81223-4; Helsen CW, 2012, J BIOL CHEM, V287, P542, DOI 10.1074/jbc.M111.302869; Howie RL, 2019, GENETICS, V212, P757, DOI 10.1534/genetics.119.302237; Huang YW, 2020, CURR GENET, V66, P97, DOI 10.1007/s00294-019-01003-8; Kamada Y, 2003, CURR TOP MICROBIOL, V279, P73; Kang JF, 2016, PROC EUR S-STATE DEV, P154, DOI 10.1109/ESSDERC.2016.7599610; King CY, 2001, J MOL BIOL, V307, P1247, DOI 10.1006/jmbi.2001.4542; Klaips CL, 2014, ELIFE, V3, DOI 10.7554/eLife.04288; Kryndushkin DS, 2003, J BIOL CHEM, V278, P49636, DOI 10.1074/jbc.M307996200; Kumar R, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006324; Labbadia J, 2015, ANNU REV BIOCHEM, V84, P435, DOI 10.1146/annurev-biochem-060614-033955; Lyke DR, 2019, YEAST, V36, P465, DOI 10.1002/yea.3392; Manogaran AL, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001386; Ness F, 2002, MOL CELL BIOL, V22, P5593, DOI 10.1128/MCB.22.15.5593-5605.2002; Ness F, 2017, MOL MICROBIOL, V104, P125, DOI 10.1111/mmi.13617; Newby GA, 2017, CELL, V171, P966, DOI 10.1016/j.cell.2017.09.041; Newnam GP, 2011, J MOL BIOL, V408, P432, DOI 10.1016/j.jmb.2011.02.034; Osherovich LZ, 2001, CELL, V106, P183, DOI 10.1016/S0092-8674(01)00440-8; Park YN, 2014, EUKARYOT CELL, V13, P635, DOI 10.1128/EC.00300-13; Paushkin SV, 1996, EMBO J, V15, P3127, DOI 10.1002/j.1460-2075.1996.tb00675.x; Satpute-Krishnan P, 2007, PLOS BIOL, V5, P251, DOI 10.1371/journal.pbio.0050024; Sharma J, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00135-6; Sharma J, 2013, J MOL BIOL, V425, P3046, DOI 10.1016/j.jmb.2013.06.006; Shorter J, 2004, SCIENCE, V304, P1793, DOI 10.1126/science.1098007; Song YM, 2012, AUTOPHAGY, V8, P1085, DOI 10.4161/auto.20260; Straub M, 1997, J BACTERIOL, V179, P3875, DOI 10.1128/jb.179.12.3875-3883.1997; TAKESHIGE K, 1992, J CELL BIOL, V119, P301, DOI 10.1083/jcb.119.2.301; Tanaka M, 2006, NATURE, V442, P585, DOI 10.1038/nature04922; TSUKADA M, 1993, FEBS LETT, V333, P169, DOI 10.1016/0014-5793(93)80398-E; TUITE MF, 1981, GENETICS, V98, P691; Uptain SM, 2001, EMBO J, V20, P6236, DOI 10.1093/emboj/20.22.6236; Wegrzyn RD, 2001, MOL CELL BIOL, V21, P4656, DOI 10.1128/MCB.21.14.4656-4669.2001; WICKNER RB, 1994, SCIENCE, V264, P566, DOI 10.1126/science.7909170; Zhou P, 1999, EMBO J, V18, P1182, DOI 10.1093/emboj/18.5.1182; Zhou P, 2001, MOL MICROBIOL, V39, P37, DOI 10.1046/j.1365-2958.2001.02224.x	47	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2020	15	3							e0229796	10.1371/journal.pone.0229796	http://dx.doi.org/10.1371/journal.pone.0229796			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8RK	32134970	gold, Green Published			2022-12-26	WOS:000535265600047
J	Rotov, AY; Cherbunin, RV; Anashina, A; Kavokin, KV; Chernetsov, N; Firsov, ML; Astakhova, LA				Rotov, Alexander Yu; Cherbunin, Roman, V; Anashina, Anna; Kavokin, Kirill, V; Chernetsov, Nikita; Firsov, Michael L.; Astakhova, Luba A.			Searching for magnetic compass mechanism in pigeon retinal photoreceptors	PLOS ONE			English	Article							ORIENTATION BEHAVIOR; MIGRATORY BIRDS; MAGNETORECEPTION; LIGHT; RED; WAVELENGTH; FIELD	Migratory birds can detect the direction of the Earth's magnetic field using the magnetic compass sense. However, the sensory basis of the magnetic compass still remains a puzzle. A large body of indirect evidence suggests that magnetic compass in birds is localized in the retina. To confirm this point, an evidence of visual signals modulation by magnetic field (MF) should be obtained. In a previous study we showed that MF inclination impacts the amplitude of ex vivo electroretinogram (ERG) recorded from isolated pigeon retina. Here we present the results of an analysis of putative MF effect on one component of ERG, the photoreceptor's response, isolated from the total ERG by adding sodium aspartate and barium chloride to the perfusion solution. Photoresponses were recorded from isolated retinae of domestic pigeons Columba livia. The retinal samples were placed in MF that was modulated by three pairs of orthogonal Helmholtz coils. Light stimuli (blue and red) were applied under two inclinations of MF, 0 degrees and 90 degrees. In all the experiments, preparations from two parts of retina were used, red field (with dominant red-sensitive cones) and yellow field (with relatively uniform distribution of cone color types). In contrast to the whole retinal ERG, we did not observe any effect of MF inclination on either amplitude or kinetics of pharmacologically isolated photoreceptor responses to blue or red half-saturating flashes. A possible explanations of these results could be that magnetic compass sense is localized in retinal cells other than photoreceptors, or that photoreceptors do participate in magnetoreception, but require some processing of compass information in other retinal layers, so that only whole retina signal can reflect the response to changing MF.	[Rotov, Alexander Yu; Cherbunin, Roman, V; Anashina, Anna; Kavokin, Kirill, V; Chernetsov, Nikita; Firsov, Michael L.; Astakhova, Luba A.] Russian Acad Sci, Sechenov Inst Evolutionary Physiol & Biochem, St Petersburg, Russia	Russian Academy of Sciences; Sechenov Institute of Evolutionary Physiology & Biochemistry	Astakhova, LA (corresponding author), Russian Acad Sci, Sechenov Inst Evolutionary Physiol & Biochem, St Petersburg, Russia.	lubkins@yandex.ru	Chernetsov, Nikita/K-7957-2012; Kavokin, Kirill V/I-7736-2013; Cherbunin, Roman R. V./J-3625-2013	Chernetsov, Nikita/0000-0001-7299-6829; Kavokin, Kirill V/0000-0002-0047-5706; Cherbunin, Roman R. V./0000-0002-8791-6227; Rotov, Alexander/0000-0002-7903-6262; Astakhova, Luba/0000-0003-3162-2446	Russian Science Foundation [16-1410159]; Russian Science Foundation [19-14-13026] Funding Source: Russian Science Foundation	Russian Science Foundation(Russian Science Foundation (RSF)); Russian Science Foundation(Russian Science Foundation (RSF))	This work was supported by grant 16-1410159 from Russian Science Foundation (http://rscf.ru/en/) for all authors. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Astakhova LA, 2019, ZH OBSHCH BIOL, V80, P83, DOI 10.1134/S0044459619020040; BOLNICK DA, 1979, VISION RES, V19, P1117, DOI 10.1016/0042-6989(79)90006-3; Bolte P, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147819; BOWMAKER JK, 1977, VISION RES, V17, P1129, DOI 10.1016/0042-6989(77)90147-X; DONNER K, 1988, ACTA PHYSIOL SCAND, V134, P535, DOI 10.1111/j.1365-201X.1988.tb10632.x; Engels S, 2014, NATURE, V509, P353, DOI 10.1038/nature13290; GALIFRET Y, 1968, Z ZELLFORSCH MIK ANA, V86, P535, DOI 10.1007/BF00324864; Gunther A, 2018, CURR BIOL, V28, P211, DOI 10.1016/j.cub.2017.12.003; Hore PJ, 2016, ANNU REV BIOPHYS, V45, P299, DOI 10.1146/annurev-biophys-032116-094545; Kishkinev D, 2015, CURR BIOL, V25, pR822, DOI 10.1016/j.cub.2015.08.012; Mouritsen H, 2004, P NATL ACAD SCI USA, V101, P14294, DOI 10.1073/pnas.0405968101; Muheim R, 2002, J EXP BIOL, V205, P3845; Munro U, 1997, AUST J ZOOL, V45, P189, DOI 10.1071/ZO96066; Muntz W. R. A., 1972, PHOTOCHEMISTRY VISIO, P529; Niessner C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150377; Niessner C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020091; Pinzon-Rodriguez A, 2017, J EXP BIOL, V220, P1202, DOI 10.1242/jeb.148098; Rappl R, 2000, AUK, V117, P256, DOI 10.1642/0004-8038(2000)117[0256:OBOGWS]2.0.CO;2; Ritz T, 2000, BIOPHYS J, V78, P707, DOI 10.1016/S0006-3495(00)76629-X; Rotov AY, 2018, J EVOL BIOCHEM PHYS+, V54, P498, DOI 10.1134/S00220930180600121; SCHULTEN K, 1978, Z PHYS CHEM NEUE FOL, V111, P1, DOI 10.1524/zpch.1978.111.1.001; Stett A, 2000, VISION RES, V40, P1785, DOI 10.1016/S0042-6989(00)00005-5; Vinberg F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013025; WILTSCHK.W, 1972, SCIENCE, V176, P62, DOI 10.1126/science.176.4030.62; Wiltschko R, 2008, J EXP BIOL, V211, P3344, DOI 10.1242/jeb.020313; Wiltschko R, 2010, J R SOC INTERFACE, V7, pS163, DOI 10.1098/rsif.2009.0367.focus; WILTSCHKO W, 1993, NATURE, V364, P525, DOI 10.1038/364525a0; WINKLER BS, 1972, VISION RES, V12, P1183, DOI 10.1016/0042-6989(72)90106-X; WORTEL JF, 1984, VISION RES, V24, P1107, DOI 10.1016/0042-6989(84)90089-0	29	2	2	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2020	15	3							e0229142	10.1371/journal.pone.0229142	http://dx.doi.org/10.1371/journal.pone.0229142			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8RK	32134934	gold, Green Published			2022-12-26	WOS:000535265600019
J	Dzudie, A; Njume, E; Abanda, M; Aminde, L; Hamadou, B; Dzekem, B; Azabji, M; Doualla, MS; Ngowe, M; Kengne, AP				Dzudie, Anastase; Njume, Epie; Abanda, Martin; Aminde, Leopold; Hamadou, Ba; Dzekem, Bonaventure; Azabji, Marcel; Doualla, Marie Solange; Ngowe, Marcelin; Kengne, Andre P.			Availability, cost and affordability of essential cardiovascular disease medicines in the south west region of Cameroon: Preliminary findings from the Cameroon science for disease study	PLOS ONE			English	Article							SUB-SAHARAN AFRICA; NONCOMMUNICABLE DISEASES; MIDDLE-INCOME	Background More than 80% of premature deaths due to cardiovascular disease (CVD) occur in low-and middle-income countries. However, access to, and affordability of medications remain a challenge in these countries. Objective To assess the availability, cost and affordability of essential cardiovascular medicines in the South West region of Cameroon. Methods In an audit of 63 medicine outlets, twenty-six essential medicines were surveyed using the World Health Organisation (WHO) /Health Action International methodology. Availability, costs and the ratio of the median price to the international reference price were evaluated in public, confessional, private facility medicine outlets, and community pharmacies. Affordability was assessed by calculating the number of days' wages it will cost the lowest-paid unskilled government worker to purchase a month worth of chronic treatment. Findings Availability ranged from 25.3% (public facility outlets) to 49.2% (community pharmacies) for all medicines. This was higher in urban and semi-urban compared to rural outlets. Cost of medicines was highest in community pharmacies and lowest in public facility outlets. Aspirin, digoxin, furosemide, hydrochlorothiazide and nifedipine were affordable (cost a day's wage or less). Medicines for heart failure and dyslipidaemia (beta blockers, angiotensin converting enzyme inhibitors and statins) required 2-5 days and 6-13 days wages respectively for one month of chronic treatment. Conclusion Overall availability of CVD essential medicines was lower than WHO recommendations, and medicines were largely unaffordable. While primary prevention is pivotal, improving availability and affordability of medicines especially for public facilities would provide additional benefit in curbing the CVD burden.	[Dzudie, Anastase; Doualla, Marie Solange; Ngowe, Marcelin] Univ Buea, Fac Hlth Sci, Buea, Cameroon; [Dzudie, Anastase; Njume, Epie; Abanda, Martin; Aminde, Leopold; Dzekem, Bonaventure; Kengne, Andre P.] Clin Res Educ Networking & Consultancy CRENC, Douala, Cameroon; [Dzudie, Anastase; Hamadou, Ba; Azabji, Marcel; Doualla, Marie Solange] Univ Yaounde I, Fac Med & Biomed Sci, Yaounde, Cameroon; [Dzudie, Anastase] Univ Cape Town, Fac Hlth Sci, Dept Med, Cape Town, South Africa; [Njume, Epie] Cameroon Baptist Convent Hlth Serv, Nkwen Bamenda, Cameroon; [Aminde, Leopold] Univ Queensland, Fac Med, Sch Publ Hlth, Brisbane, Qld, Australia; [Kengne, Andre P.] MRC, Noncommunicable Dis Unit, Cape Town, South Africa	University of Yaounde I; University of Cape Town; University of Queensland	Njume, E (corresponding author), Clin Res Educ Networking & Consultancy CRENC, Douala, Cameroon.; Njume, E (corresponding author), Cameroon Baptist Convent Hlth Serv, Nkwen Bamenda, Cameroon.	enjume20181@outlook.com	Kengne, Andre Pascal/ABB-3696-2020	NJUME, EPIE/0000-0002-1788-6958; Kengne, Andre Pascal/0000-0002-5183-131X; DZUDIE, Anastase/0000-0003-4038-4128				Abegunde D., ESSENTIAL MED NONCOM; [Anonymous], 2010, I MED US COMM PREV G; Boutayeb A., 2005, DOUBLE BURDEN COMMUN, DOI DOI 10.1016; Bovet P, 2012, PUB HLTH REV, V33, P397, DOI DOI 10.1007/BF03391643; Cameroon Data Portal, 2015, CAM CENS DAT; Dabare PRL, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-817; Dalal S, 2011, INT J EPIDEMIOL, V40, P885, DOI 10.1093/ije/dyr050; Echouffo-Tcheugui JB, 2011, GLOBALIZATION HEALTH, V7, DOI 10.1186/1744-8603-7-44; Huffman MD, 2014, J AM COLL CARDIOL, V63, P1368, DOI 10.1016/j.jacc.2013.08.1665; Huffman MD, APPL RECOMMEND FIXED; Islam SMS, 2014, GLOBALIZATION HEALTH, V10, DOI 10.1186/s12992-014-0081-9; Jingi AM, 2014, PLOS ONE; Kengne AP, 2013, PROG CARDIOVASC DIS, V56, P302, DOI 10.1016/j.pcad.2013.10.011; Laslett LJ, 2012, J AM COLL CARDIOL, V60, pS1, DOI 10.1016/j.jacc.2012.11.002; Mensah GA, 2015, CARDIOVASC J AFR, V26, pS6, DOI 10.5830/CVJA-2015-036; Muszbek N, 2008, INT J CLIN PRACT, V62, P338, DOI 10.1111/j.1742-1241.2007.01683.x; Pena MSB, 2015, GLOB HEART, V10, P71, DOI 10.1016/j.gheart.2014.12.006; Robertson J, 2015, GLOBALIZATION HEALTH, V11, DOI 10.1186/s12992-015-0105-0; Tchoumi JCT, 2013, CARDIOVASC DIAGN THE, V3, P236, DOI 10.3978/j.issn.2223-3652.2013.12.05; van Mourik MSM, 2010, BMC CARDIOVASC DISOR, V10, DOI 10.1186/1471-2261-10-25; *WHO, 2002, INT MAN CARD RISK RE; WHO, 2015, WHO MODEL LIST ESSEN; World Economic Forum and the Harvard School of Public Health, 2011, GLOB EC BURD NONC DI; World Health Organisation, 2008, INT DRUG PRIC IND GU; World Health Organization, 2014, INT DRUG PRIC IND GU; World Health Organization, GLOB STAT REP NONC D; World Health Organization, 2014, NONC DIS COUNTR PROF; Yusuf S, 2011, LANCET, V378, P1231, DOI 10.1016/S0140-6736(11)61215-4	28	7	7	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2020	15	3							e0229307	10.1371/journal.pone.0229307	http://dx.doi.org/10.1371/journal.pone.0229307			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8QU	32130252	Green Published, gold			2022-12-26	WOS:000535264000020
J	Lemas, DJ; Mack, JA; Schoch, JJ; Cacho, N; Plasencia, E; Rhoton-Vlasak, AS; Neu, J; Thompson, L; Francois, M; Patel, K; Hogan, WR; Lipori, GP; Gurka, MJ				Lemas, Dominick J.; Mack, Jasmine A.; Schoch, Jennifer J.; Cacho, Nicole; Plasencia, Elizabeth; Rhoton-Vlasak, Alice S.; Neu, Josef; Thompson, Lindsay; Francois, Magda; Patel, Keval; Hogan, William R.; Lipori, Gloria P.; Gurka, Matthew J.			Postnatal pediatric systemic antibiotic episodes during the first three years of life are not associated with mode of delivery	PLOS ONE			English	Article							CESAREAN-SECTION; RISK-FACTORS; BIRTH; CHILDHOOD; CHILDREN; OUTCOMES; OBESITY; US; PRESCRIPTIONS; POPULATION	Background Delivery by cesarean section (C-section) is associated with adverse short-term and long-term infant outcomes. Given that antibiotics during early life are prescribed for infant outcomes that are more likely among c-section deliveries, we hypothesized that postnatal antibiotic exposure will be greater among c-section infants compared to vaginally delivered infants. Objective The aim of this paper was to evaluate if mode of infant delivery was associated with patterns of systemic antibiotic exposure in children during their first three years. Methods Pediatric electronic health records from UFHealth, 2011 to 2017 were reviewed. We included singleton, term infants (37-42 weeks gestation) with a birth weight >= 2500 grams, with documented mode of delivery and well visits on record. Infants with a neonatal intensive care unit stay were excluded. Both oral and intravenous antibiotics for a 10-day duration were classified as a single episode. The primary outcome was antibiotic episodes in the first three years of life, and a sub-analysis was performed to compare broad-spectrum versus narrow-spectrum antibiotic exposures. Results The mean number of antibiotic episodes in 4,024 full-term infants was 0.34 (SD = 0.79) and 24.1% of infants had at least one antibiotic episode. Penicillins were the most prescribed antibiotic in children 0-1 years (66.9%) and cephalosporins were the most common antibiotic prescribed for children 1-3 years (56.2%). We did not detect a meaningful or significant rate ratio (RR) between mode of delivery and overall antibiotic episodes 1.14 (95% CI 0.99, 1.31), broad-spectrum episodes 1.19 (95% CI 0.93, 1.52, or narrow-spectrum episodes 1.14 (95% CI 0.97, 1.34). Conclusion Our results do not support the hypothesis that postnatal antibiotic exposure was greater among infants delivered by cesarean section compare to infants delivered vaginally during the first three years of life.	[Lemas, Dominick J.; Mack, Jasmine A.; Francois, Magda; Patel, Keval; Hogan, William R.; Gurka, Matthew J.] Univ Florida, Dept Hlth Outcomes & Biomed Informat, Coll Med, Gainesville, FL 32611 USA; [Schoch, Jennifer J.] Univ Florida, Dept Dermatol, Coll Med, Gainesville, FL USA; [Cacho, Nicole; Neu, Josef; Thompson, Lindsay] Univ Florida, Coll Med, Dept Pediat, Gainesville, FL USA; [Plasencia, Elizabeth; Rhoton-Vlasak, Alice S.] Univ Florida, Coll Med, Dept Obstet & Gynecol, Gainesville, FL 32610 USA; [Lipori, Gloria P.] Univ Florida, Hlth Shands Hosp, Gainesville, FL USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida	Lemas, DJ (corresponding author), Univ Florida, Dept Hlth Outcomes & Biomed Informat, Coll Med, Gainesville, FL 32611 USA.	djlemas@ufl.edu	Cacho, Nicole/AAE-8308-2022; Lemas, Dominick/E-3960-2019	Mack, Jasmine/0000-0001-7343-0579; Lemas, Dominick/0000-0001-5105-2458; Schoch, Jennifer/0000-0003-3381-0096	National Institute of Diabetes and Digestive and Kidney Diseases [K01DK115632]; National Center for Advancing Translational Sciences of the National Institutes of Health under University of Florida Clinical and Translational Science Awards [UL1 TR000064, UL1TR001427]	National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Center for Advancing Translational Sciences of the National Institutes of Health under University of Florida Clinical and Translational Science Awards	The Research reported in this publication was supported by the National Institute of Diabetes and Digestive and Kidney Diseases (K01DK115632), National Center for Advancing Translational Sciences of the National Institutes of Health under University of Florida Clinical and Translational Science Awards UL1 TR000064 and UL1TR001427. All authors -designed research (project conception, development of overall research plan, and study oversight); JAM and MJG analyzed data or performed statistical analysis; DJL, JS, NC, JN -interpreted data findings; DJL wrote paper and had primary responsibility for final content. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agency for Healthcare Research and Quality, 2017, HCUP FAST STATS; Ajslev TA, 2011, INT J OBESITY, V35, P522, DOI 10.1038/ijo.2011.27; Barros FC, 2012, AM J CLIN NUTR, V95, P465, DOI 10.3945/ajcn.111.026401; Block JP, 2018, PEDIATRICS, V142, DOI 10.1542/peds.2018-0290; Chai G, 2012, PEDIATRICS, V130, P23, DOI 10.1542/peds.2011-2879; Cho CE, 2013, AM J OBSTET GYNECOL, V208, P249, DOI 10.1016/j.ajog.2012.08.009; Decker E, 2010, PEDIATRICS, V125, pE1433, DOI 10.1542/peds.2009-2260; Di Martino M, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4905-4; Doan E, 2014, AUST NZ J OBSTET GYN, V54, P340, DOI 10.1111/ajo.12220; Glasgow TS, 2007, PAEDIATR PERINAT EP, V21, P338, DOI 10.1111/j.1365-3016.2007.00811.x; Goldani HAS, 2011, AM J CLIN NUTR, V93, P1344, DOI 10.3945/ajcn.110.010033; Hamilton Brady E, 2016, Natl Vital Stat Rep, V65, P1; Hayward GN, 2016, J ANTIMICROB CHEMOTH, V71, P2612, DOI 10.1093/jac/dkw189; Heerman WJ, 2019, INT J OBESITY, V43, P1202, DOI 10.1038/s41366-018-0316-6; Holstiege J, 2014, BMC PEDIATR, V14, DOI 10.1186/1471-2431-14-174; Huang Xiao-Zhong, 2013, World J Clin Pediatr, V2, P46, DOI 10.5409/wjcp.v2.i4.46; Huh SY, 2012, ARCH DIS CHILD, V97, P610, DOI 10.1136/archdischild-2011-301141; Hyde MJ, 2012, BIOL REV, V87, P229, DOI 10.1111/j.1469-185X.2011.00195.x; Kulas Tomislav, 2013, Med Arch, V67, P460, DOI 10.5455/medarh.2013.67.460-463; Langdon A, 2016, GENOME MED, V8, DOI 10.1186/s13073-016-0294-z; Magnus MC, 2011, AM J EPIDEMIOL, V174, P1275, DOI 10.1093/aje/kwr242; Majeed A, 1999, BRIT J GEN PRACT, V49, P735; Marild K, 2012, GASTROENTEROLOGY, V142, P39, DOI 10.1053/j.gastro.2011.09.047; Marra F, 2006, J ANTIMICROB CHEMOTH, V58, P830, DOI 10.1093/jac/dkl275; Marra F, 2011, BMC PULM MED, V11, DOI 10.1186/1471-2466-11-32; Mercer BM, 1997, JAMA-J AM MED ASSOC, V278, P989, DOI 10.1001/jama.278.12.989; Mesquita DN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066827; Miller JE, 2018, INT J EPIDEMIOL, V47, P561, DOI 10.1093/ije/dyx272; Montoya-Williams D, 2018, NEONATOLOGY, V114, P103, DOI 10.1159/000487102; Montoya-Williams D, 2017, J WOMENS HEALTH, V26, P1285, DOI 10.1089/jwh.2016.6188; Mueller NT, 2015, INT J OBESITY, V39, P665, DOI 10.1038/ijo.2014.180; Mueller NT, 2015, TRENDS MOL MED, V21, P109, DOI 10.1016/j.molmed.2014.12.002; Mukhopadhyay S, 2012, SEMIN PERINATOL, V36, P408, DOI 10.1053/j.semperi.2012.06.002; Natile M, 2014, ITAL J PEDIATR, V40, DOI 10.1186/1824-7288-40-52; Nordahl-Hansen A, 2018, PSYCHIAT RES, V270, P801, DOI 10.1016/j.psychres.2018.10.069; O'Shea TM, 2010, SEMIN PERINATOL, V34, P281, DOI 10.1053/j.semperi.2010.03.008; Pennington AF, 2018, PAEDIATR PERINAT EP, V32, P495, DOI 10.1111/ppe.12510; Persaud RR, 2015, J MATERN-FETAL NEO M, V28, P1190, DOI 10.3109/14767058.2014.947578; Rani S, 2022, SPAT INF RES, V30, P417, DOI 10.1007/s41324-022-00442-9; Rao GG, 1998, DRUGS, V55, P323, DOI 10.2165/00003495-199855030-00001; Resi D, 2003, J ANTIMICROB CHEMOTH, V52, P282, DOI 10.1093/jac/dkg302; Riskin A, 2014, ISR MED ASSOC J, V16, P559; Sarpong EM, 2015, HEALTH SERV RES, V50, P830, DOI 10.1111/1475-6773.12260; Sharma S, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1512-4; Smith N, 2010, INT J PEDIATR OBES, V5, P237, DOI 10.3109/17477160903268308; Tita ATN, 2016, NEW ENGL J MED, V375, P1231, DOI 10.1056/NEJMoa1602044; Tzur T, 2011, J MATERN-FETAL NEO M, V24, P58, DOI 10.3109/14767051003678267; Wang L, 2013, EUR J PEDIATR, V172, P1341, DOI 10.1007/s00431-013-2043-2; Ward E, 2016, AM J OBSTET GYNECOL, V214, DOI 10.1016/j.ajog.2016.02.037; WHO Collaborating Centre for Drug Statistics Methodology, 2019, GUID ATC CLASS DDD A; Wu PS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151705	51	1	1	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2020	15	3							e0229861	10.1371/journal.pone.0229861	http://dx.doi.org/10.1371/journal.pone.0229861			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8QU	32130278	gold, Green Published			2022-12-26	WOS:000535264000053
J	Manyahi, J; Kibwana, U; Mgimba, E; Majigo, M				Manyahi, Joel; Kibwana, Upendo; Mgimba, Edna; Majigo, Mtebe			Multi-drug resistant bacteria predict mortality in bloodstream infection in a tertiary setting in Tanzania	PLOS ONE			English	Article							DAR-ES-SALAAM; ANTIMICROBIAL RESISTANCE; BETA-LACTAMASES	Background Bloodstream infections (BSI) are serious and life-threatening, associated with high mortality and morbidity. In resource-limited settings, there is a paucity of data on predictors of outcome in patients with BSI. This study aimed at examining the predictors of mortality in patients with BSI as well as bacteria causing BSI. Methods and materials This was a cross-sectional study conducted at Muhimbili National Hospital between April and May 2018. Blood culture results from all inpatients at the clinical microbiology laboratory were recorded and clinical information was retrieved retrospectively from the files. Bacteria from positive blood culture were identified and antimicrobial susceptibility was performed. Results The overall prevalence of BSI was, 46/402 (11.4% 95% CI 8.6-15), with a case fatality rate of 37%. There was a significantly high rate of BSI in patients who had died (19.5%) compared to those who survived (9.2%) p = 0.008. Gram-negative bacteria (74%) were the common cause of BSI, with a predominance of Enterobacteriaceae (22), followed by Pseudomonas aeruginosa (11). The majority of bacteria (70.5%) isolated from patients with BSI were Multi-drug resistant (MDR). Forty-six percent of Pseudomonas aeruginosa were resistant to meropenem while 68% (15/22) of Enterobacteriaceae were extended-spectrum beta lactamase producers. Carbapenemase production was detected in 27% (3/11) of Pseudomonas aeruginosa and one Proteus mirabilis. Forty percent of Staphylococcus aureus were methicillin-resistant Staphylococcus aureus. Positive blood culture (aOR 2.24, 95%CI 1.12-4.47, p 0.02) and admission to the intensive care unit (aOR 3.88, 95%CI 1.60-9.41, p = 0.003) were independent factors for mortality in suspected BSI. Isolation of MDR bacteria was an independent predictor for mortality in confirmed BSI (aOR 15.62, 95%CI 1.24-161.38, p = 0.02). Conclusion The prevalence of BSI was 11.4%, with the majority of bacteria in BSI were MDR. Positive blood culture, admission to the ICU and MDR were predictors for mortality.	[Manyahi, Joel; Kibwana, Upendo; Majigo, Mtebe] Muhimbili Univ Hlth & Allied Sci, Dept Microbiol & Immunol, Dar Es Salaam, Tanzania; [Mgimba, Edna] Muhimbili Natl Hosp, Cent Pathol Lab, Dar Es Salaam, Tanzania	Muhimbili University of Health & Allied Sciences	Manyahi, J (corresponding author), Muhimbili Univ Hlth & Allied Sci, Dept Microbiol & Immunol, Dar Es Salaam, Tanzania.	manyahijoel@yahoo.com		Majigo, Mtebe/0000-0003-3726-2816; Manyahi, Joel/0000-0002-1388-3901				Daw Mohamed A, 2017, BMC Res Notes, V10, P170, DOI [10.1186/s13104-017-2389-z, 10.1186/s13104-017-2491-2]; [Anonymous], 2018, M100S20 CLSI S; Blomberg B, 2005, J CLIN MICROBIOL, V43, P745, DOI 10.1128/JCM.43.2.745-749.2005; Blomberg B, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-43; Boyles TH, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1127-1; Christopher A, 2013, ITAL J PEDIATR, V39, DOI 10.1186/1824-7288-39-27; Crichton H, 2018, SAMJ S AFR MED J, V108, P99, DOI [10.7196/SAMJ.2018.v108i2.12601, 10.7196/samj.2018.v108i2.12601, 10.7196/SAMJ.2017.v108i2.12601]; Giske CG, 2011, CLIN MICROBIOL INFEC, V17, P552, DOI 10.1111/j.1469-0691.2010.03294.x; Goyal D, 2019, OPEN FORUM INFECT DI, V6, DOI 10.1093/ofid/ofy357; Kayange N, 2010, BMC PEDIATR, V10, DOI 10.1186/1471-2431-10-39; Laupland KB, 2002, CRIT CARE MED, V30, P2462, DOI 10.1097/00003246-200211000-00010; Lee CC, 2017, CRIT CARE, V21, DOI 10.1186/s13054-017-1696-z; Magiorakos AP, 2012, CLIN MICROBIOL INFEC, V18, P268, DOI 10.1111/j.1469-0691.2011.03570.x; Manyahi Joel, 2014, BMC Res Notes, V7, P500, DOI 10.1186/1756-0500-7-500; Jaramago JM, 2017, REV ESP ANEST REANIM, V64, P490, DOI 10.1016/j.redar.2017.03.007; Moghnieh R, 2015, FRONT CELL INFECT MI, V5, DOI 10.3389/fcimb.2015.00011; Moyo S, 2010, SAMJ S AFR MED J, V100, P835, DOI 10.7196/SAMJ.4186; Moyo S, 2015, ANTIMICROB AGENTS CH, V59, P682, DOI 10.1128/AAC.01436-13; Moyo Sabrina J, 2010, BMC Res Notes, V3, P348, DOI 10.1186/1756-0500-3-348; Negussie Adugna, 2015, Int J Biol Med Res, V6, P4709; Obeng-Nkrumah N, 2016, ANN CLIN MICROB ANTI, V15, DOI 10.1186/s12941-016-0163-z; Scheich S, 2018, ANN HEMATOL, V97, P2225, DOI 10.1007/s00277-018-3423-5; Seboxa T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144944; Seni J, 2019, BMC PEDIATR, V19, DOI 10.1186/s12887-019-1411-0; Sigauque B, 2009, PEDIATR INFECT DIS J, V28, P108, DOI 10.1097/INF.0b013e318187a87d; Smith JNA, 2018, J CLIN GASTROENTEROL, V52, P648, DOI 10.1097/MCG.0000000000000964; Snyder BM, 2019, EPIDEMIOL INFECT, V147, DOI [10.1017/S0950268819000256, 10.1017/s0950268819000256]	27	12	12	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2020	15	3							e0220424	10.1371/journal.pone.0220424	http://dx.doi.org/10.1371/journal.pone.0220424			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8QU	32130227	Green Submitted, gold, Green Published			2022-12-26	WOS:000535264000001
J	Wik, JA; Lundback, P; Poulsen, LL; Haraldsen, G; Skalhegg, BS; Hol, J				Wik, Jonas Aakre; Lundback, Peter; Poulsen, Lars la Cour; Haraldsen, Guttorm; Skalhegg, Bjorn Steen; Hol, Johanna			3PO inhibits inflammatory NF kappa B and stress-activated kinase signaling in primary human endothelial cells independently of its target PFKFB3	PLOS ONE			English	Article							6-PHOSPHOFRUCTO-2-KINASE PFKFB3; PROINFLAMMATORY ACTIVATION; GLYCOLYSIS; INTERLEUKIN-1; TAK1	Inhibition of the key glycolytic activator 6-phosphofructokinase 2/fructose-2,6-bisphosphatase-3 (PFKFB3) by 3-(3-pyridinyl)-1-(4-pyridinyl)-2-propen-1-one (3PO) strongly attenuates pathological angiogenesis in cancer and inflammation. In addition to modulating endothelial proliferation and migration, 3PO also dampens proinflammatory activation of endothelial cells and experimental inflammation in vivo, suggesting a potential for 3PO in the treatment of chronic inflammation. The aim of our study was to explore if the anti-inflammatory action of 3PO in human endothelial cells was mediated by inhibition of PFKFB3 and glycolysis and assess if other means of PFKFB3 inhibition reduced inflammatory activation in a similar manner. We found that 3PO caused a rapid and transient reduction in IL-1 beta- and TNF-induced phosphorylation of both IKK alpha/beta and JNK, thus inhibiting signaling through the NF kappa B and the stress-activated kinase pathways. However, in contrast to 3PO-treatment, neither shRNA-mediated silencing of PFKFB3 nor treatment with the alternative PFKFB3 inhibitor 7,8-dihydroxy-3-(4-hydroxy-phenyl)-chromen-4-one (YN1) prevented cytokineinduced NF kappa B signaling and upregulation of the adhesion molecules VCAM-1 and E-selectin, implying off target effects of 3PO. Collectively, our results suggest that the anti-inflammatory action of 3PO in human endothelial cells is not limited to inhibition of PFKFB3 and cellular glycolysis.	[Wik, Jonas Aakre; Poulsen, Lars la Cour; Haraldsen, Guttorm; Hol, Johanna] Oslo Univ Hosp, Dept Pathol, Rikshosp, Oslo, Norway; [Wik, Jonas Aakre; Lundback, Peter; Haraldsen, Guttorm] Univ Oslo, Inst Clin Med, Dept Pathol, Oslo, Norway; [Wik, Jonas Aakre; Lundback, Peter; Poulsen, Lars la Cour; Haraldsen, Guttorm; Hol, Johanna] Univ Oslo, Fac Med, KG Jebsen Inflammat Res Ctr, Inst Clin Med, Oslo, Norway; [Skalhegg, Bjorn Steen] Univ Oslo, Inst Basic Med Sci, Dept Nutr, Div Mol Nutr, Oslo, Norway; [Hol, Johanna] Norwegian Vet Inst, Sect Immunol & Virol, Oslo, Norway	University of Oslo; National Hospital Norway; University of Oslo; University of Oslo; University of Oslo; Norwegian Veterinary Institute	Hol, J (corresponding author), Oslo Univ Hosp, Dept Pathol, Rikshosp, Oslo, Norway.; Hol, J (corresponding author), Univ Oslo, Fac Med, KG Jebsen Inflammat Res Ctr, Inst Clin Med, Oslo, Norway.; Hol, J (corresponding author), Norwegian Vet Inst, Sect Immunol & Virol, Oslo, Norway.	johanna.hol.fosse@vetinst.no	Hol, Johanna/AAJ-8586-2020; Skålhegg, Bjørn Steen/AAZ-2976-2021	Hol, Johanna/0000-0001-5837-5006; Skålhegg, Bjørn Steen/0000-0002-3481-8084; Wik, Jonas Aakre/0000-0003-3065-5529; la Cour Poulsen, Lars/0000-0001-5406-3945; Haraldsen, Guttorm/0000-0002-0064-9665	South-Eastern Norway Regional Health Authorities [2014032, 2017013]; National Association for Public Health, Norway	South-Eastern Norway Regional Health Authorities; National Association for Public Health, Norway	The study was funded by grants from the South-Eastern Norway Regional Health Authorities (https://www.helse-sorost.no/, 2014032 and 2017013, awarded JH) and the National Association for Public Health, Norway (https://nasjonalforeningen.no, 2016, awarded JH). The funders had no role in study design, data Collection and analysis, decision to publish, or preparation of the manuscript.	Biniecka M, 2016, ANN RHEUM DIS, V75, P2192, DOI 10.1136/annrheumdis-2015-208476; Brooke DG, 2014, BIOORGAN MED CHEM, V22, P1029, DOI 10.1016/j.bmc.2013.12.041; Cantelmo AR, 2016, CANCER CELL, V30, P968, DOI 10.1016/j.ccell.2016.10.006; Clem B, 2008, MOL CANCER THER, V7, P110, DOI 10.1158/1535-7163.MCT-07-0482; Clem BF, 2013, MOL CANCER THER, V12, P1461, DOI 10.1158/1535-7163.MCT-13-0097; Conradi LC, 2017, ANGIOGENESIS, V20, P599, DOI 10.1007/s10456-017-9573-6; De Bock K, 2013, CELL, V154, P651, DOI 10.1016/j.cell.2013.06.037; Dinarello CA, 1996, BLOOD, V87, P2095, DOI 10.1182/blood.V87.6.2095.bloodjournal8762095; EDGELL CJ, 1983, P NATL ACAD SCI-BIOL, V80, P3734, DOI 10.1073/pnas.80.12.3734; Erickson JR, 2013, NATURE, V502, P372, DOI 10.1038/nature12537; Gong YQ, 2017, BIOCHEM BIOPH RES CO, V491, P522, DOI 10.1016/j.bbrc.2017.05.173; Haraldsen G, 1996, J IMMUNOL, V156, P2558; Hart GW, 2011, ANNU REV BIOCHEM, V80, P825, DOI 10.1146/annurev-biochem-060608-102511; Israel A, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000158; JAFFE EA, 1973, J CLIN INVEST, V52, P2745, DOI 10.1172/JCI107470; Jia WZ, 2018, ONCOGENE, V37, P1685, DOI 10.1038/s41388-017-0072-4; Li ZW, 1999, J EXP MED, V189, P1839, DOI 10.1084/jem.189.11.1839; Madge LA, 2001, EXP MOL PATHOL, V70, P317, DOI 10.1006/exmp.2001.2368; Mako V, 2010, CYTOM PART A, V77A, P962, DOI 10.1002/cyto.a.20952; McGarry T, 2017, SCI REP-UK, V7, P1, DOI 10.1038/srep43165; O'Neill LAJ, 2016, NAT REV IMMUNOL, V16, P553, DOI 10.1038/nri.2016.70; Pollheimer J, 2013, ARTERIOSCL THROM VAS, V33, pE47, DOI 10.1161/ATVBAHA.112.253427; Schoors S, 2014, CELL METAB, V19, P37, DOI 10.1016/j.cmet.2013.11.008; Seo M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024179; Shi JH, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01849; Takaesu G, 2001, MOL CELL BIOL, V21, P2475, DOI 10.1128/MCB.21.7.2475-2484.2001; Tawakol A, 2015, ARTERIOSCL THROM VAS, V35, P1463, DOI 10.1161/ATVBAHA.115.305551; VANSCHAFTINGEN E, 1982, EUR J BIOCHEM, V129, P191; Wang C, 2001, NATURE, V412, P346, DOI 10.1038/35085597; Xu YM, 2014, ARTERIOSCL THROM VAS, V34, P1231, DOI 10.1161/ATVBAHA.113.303041; Yalcin A, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.292; Yalcin A, 2009, J BIOL CHEM, V284, P24223, DOI 10.1074/jbc.M109.016816; Zhang RY, 2019, INFLAMMATION, V42, P146, DOI 10.1007/s10753-018-0880-x	33	7	8	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2020	15	3							e0229395	10.1371/journal.pone.0229395	http://dx.doi.org/10.1371/journal.pone.0229395			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8QU	32130250	Green Published, gold			2022-12-26	WOS:000535264000024
J	Alamgir, M; Campbell, MJ; Sloan, S; Engert, J; Word, J; Laurance, WF				Alamgir, Mohammed; Campbell, Mason J.; Sloan, Sean; Engert, Jayden; Word, Jettie; Laurance, William F.			Emerging challenges for sustainable development and forest conservation in Sarawak, Borneo	PLOS ONE			English	Article							CLIMATE-CHANGE; VEGETATION; SHIFTS; AREAS; DAMS	The forests of Borneo-the third largest island on the planet-sustain some of the highest biodiversity and carbon storage in the world. The forests also provide vital ecosystem services and livelihood support for millions of people in the region, including many indigenous communities. The Pan-Borneo Highway and several hydroelectric dams are planned or already under construction in Sarawak, a Malaysian state comprising part of the Borneo. This development seeks to enhance economic growth and regional connectivity, support community access to services, and promote industrial development. However, the implications of the development of highway and dams for forest integrity, biodiversity and ecosystem services remained largely unreported. We assessed these development projects using fine-scale biophysical and environmental data and found several environmental and socioeconomic risks associated with the projects. The highway and hydroelectric dam projects will impact 32 protected areas including numerous key habitats of threatened species such as the proboscis monkey (Nasalis larvatus), Sarawak surili (Presbytis chrysomelas), Bornean orangutans (Pongo pygmaeus) and tufted ground squirrel (Rheithrosciurus macrotis). Under its slated development trajectory, the local and trans-national forest connectivity between Malaysian Borneo and Indonesian Borneo would also be substantially diminished. Nearly similar to 161 km of the Pan-Borneo Highway in Sarawak will traverse forested landscapes and similar to 55 km will traverse carbon-rich peatlands. The 13 hydroelectric dam projects will collectively impact similar to 1.7 million ha of forest in Sarawak. The consequences of planned highway and hydroelectric dams construction will increase the carbon footprint of development in the region. Moreover, many new road segments and hydroelectric dams would be built on steep slopes in high-rainfall zones and forested areas, increasing both construction and ongoing maintenance costs. The projects would also alter livelihood activities of downstream communities, risking their long-term sustainability. Overall, our findings identify major economic, social and environmental risks for several planned road segments in Sarawak-such as those between Telok Melano and Kuching; Sibu and Bintulu; and in the Lambir, Limbang and Lawas regions-and dam projects-such as Tutoh, Limbang, Lawas, Baram, Linau, Ulu Air and Baleh dams. Such projects need to be reviewed to ensure they reflect Borneo's unique environmental and forest ecosystem values, the aspirations of local communities and long-term sustainability of the projects rather than being assessed solely on their short-term economic returns.	[Alamgir, Mohammed; Campbell, Mason J.; Sloan, Sean; Engert, Jayden; Laurance, William F.] James Cook Univ, Coll Sci & Engn, Ctr Trop Environm & Sustainabil Sci, Cairns, Qld, Australia; [Word, Jettie] Earth Isl Inst, Borneo Project, Berkeley, CA USA	James Cook University	Alamgir, M; Laurance, WF (corresponding author), James Cook Univ, Coll Sci & Engn, Ctr Trop Environm & Sustainabil Sci, Cairns, Qld, Australia.	mohammed.alamgir@jcu.edu.au; bill.laurance@jcu.edu.au	Alamgir, Mohammed/G-3757-2014	Alamgir, Mohammed/0000-0001-8888-686X; Engert, Jayden/0000-0002-5558-2058				Aiken SR, 2015, GEOGR ANN B, V97, P69, DOI 10.1111/geob.12066; Alamgir M, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0219408; Alamgir M, 2019, SCI REP-UK, V9, DOI [10.1038/s41598-018-36594-8, 10.1038/s41598-019-51237-2]; Alamgir M, 2017, CURR BIOL, V27, pR1130, DOI 10.1016/j.cub.2017.08.067; [Anonymous], 2019, STAR ONLINE; [Anonymous], 2019, THE SUN DAILY; [Anonymous], 2011, 20111073 US GEOL SUR; [Anonymous], 2019, REUTERS; [Anonymous], 2015, 11 MAL PLAN 11 MAL P; Ansar A, 2016, OXFORD REV ECON POL, V32, P360, DOI 10.1093/oxrep/grw022; Ansar A, 2014, ENERG POLICY, V69, P43, DOI 10.1016/j.enpol.2013.10.069; Asner GP, 2018, BIOL CONSERV, V217, P289, DOI 10.1016/j.biocon.2017.10.020; Benchimol M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129818; Berger BH, 2018, THE DIPLOMAT; Bruno Manser Fonds, 2012, SAR DAM PLANS COMPR; Chen IC, 2011, SCIENCE, V333, P1024, DOI 10.1126/science.1206432; Curran LM, 2004, SCIENCE, V303, P1000, DOI 10.1126/science.1091714; de Bruyn M, 2014, SYST BIOL, V63, P879, DOI 10.1093/sysbio/syu047; Dounias E., 2018, CONVERSATION; Fearnside PM, 2002, WATER AIR SOIL POLL, V133, P69, DOI 10.1023/A:1012971715668; Gaveau DLA, 2019, CONSERV LETT, V12, DOI 10.1111/conl.12622; Gaveau DLA, 2016, SCI REP-UK, V6, DOI 10.1038/srep32017; Gaveau DLA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101654; Gaveau DLA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069887; Gaveau DLA, 2017, DEFORESTATION IND PL; GOM, 2016, NAT POL BIOL DIV 201; GOM, 2017, MAL SUST DEV GOALS V; Gonzalez P, 2010, GLOBAL ECOL BIOGEOGR, V19, P755, DOI 10.1111/j.1466-8238.2010.00558.x; Gumbricht T, 2017, GLOBAL CHANGE BIOL, V23, P3581, DOI 10.1111/gcb.13689; Harun AA, 2017, BORNEO POSTONLINE; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Holmes T., 2013, INDIGENOUS COMMUNITI; Ibisch PL, 2016, SCIENCE, V354, P1423, DOI 10.1126/science.aaf7166; Kitzes J, 2016, AMBIO, V45, P110, DOI 10.1007/s13280-015-0683-3; Kuo L, 2016, AFRICAS BIGGEST HYDR; Larson H, 2019, IUCN RED LIST THREAT, DOI [10.2305/IUCN.UK.2019-2.RLTS.T196326A89803716.en, DOI 10.2305/IUCN.UK.2019-3.RLTS.T5143A17944705.EN]; Laurance W., 2017, DARK LEGACY CHINAS D; Laurance WF, 2013, YALE ENV 360; Laurance WF, 2012, NATURE, V489, P290, DOI 10.1038/nature11318; Lee Tanya, 2014, NO CONSENT PROCEED I; Maisels F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059469; Meijaard E., 2016, IUCN RED LIST THREAT, V2016; Page SE, 2011, GLOBAL CHANGE BIOL, V17, P798, DOI 10.1111/j.1365-2486.2010.02279.x; Pan Borneo Highway, PAN BORN HIGHW STOR; Phan A., 2019, PAN BORNEO HIGHWAY S; Rao M., 2019, MALAYSIAN RESERVE; Regional Corridor Development Authority, 2016, ANN REP 2016; Rijsdijk A, 2007, GEOMORPHOLOGY, V87, P28, DOI 10.1016/j.geomorph.2006.06.040; Runting RK, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7819; Sarawak Forestry Corporation, 2019, NAT PARKS NAT RES LA; Sarawak Forestry Corporation, 2019, NAT PARKS NAT RES GU; Schertow J. A., 2019, INDIGENOUS PEOPLES S; Sidle RC, 2012, NAT GEOSCI, V5, P437, DOI 10.1038/ngeo1512; Sloan S, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0221947; Sloan S, 2019, ENVIRON SCI POLICY, V92, P98, DOI 10.1016/j.envsci.2018.11.011; Sloan S, 2018, LAND USE POLICY, V77, P298, DOI 10.1016/j.landusepol.2018.05.043; Sloan S, 2018, CURR BIOL, V28, pR650, DOI 10.1016/j.cub.2018.04.082; Sloan S, 2014, BIOL CONSERV, V177, P12, DOI 10.1016/j.biocon.2014.05.027; Sovacool BK, 2013, SUSTAIN SCI, V8, P121, DOI 10.1007/s11625-012-0159-3; The Borneo Project, 2019, BORN MEG RISK IND ET; Thomas CD, 2010, DIVERS DISTRIB, V16, P488, DOI 10.1111/j.1472-4642.2010.00642.x; Tryse D., FLOODING BORNEOS RAI; United Nations, 2019, SUSTAINABLE DEV GOAL; Van der Putten WH, 2010, PHILOS T R SOC B, V365, P2025, DOI 10.1098/rstb.2010.0037; Vogt P, 2017, USER GUIDE GUIDOS TO; Vogt P, 2017, EUR J REMOTE SENS, V50, P352, DOI 10.1080/22797254.2017.1330650; Watch GGF, 2019, SAR PROT AR 2019; Wich S, 2011, ORANGUTANS EC SUSTAI; Wiggins EB, 2018, P NATL ACAD SCI USA, V115, P12419, DOI 10.1073/pnas.1806003115; Wong J., 2019, STAR ONLINE; WWF, 2019, BORN SUM 2019; WWF, 10 AS SPEC POACH WIL; Yang JJ, 2014, LANDSC ECOL ENG, V10, P77, DOI 10.1007/s11355-013-0217-8	73	13	13	3	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2020	15	3							e0229614	10.1371/journal.pone.0229614	http://dx.doi.org/10.1371/journal.pone.0229614			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LQ8MS	32126070	Green Published, gold, Green Accepted			2022-12-26	WOS:000535253100039
J	Guillen, D; Schievelbein, M; Patel, K; Jose, D; Ouellet, J				Guillen, Danielle; Schievelbein, Mika; Patel, Kushkumar; Jose, Davis; Ouellet, Jonathan			A simple and affordable kinetic assay of nucleic acids with SYBR Gold gel staining	PLOS ONE			English	Article							HAMMERHEAD RIBOZYMES; BIOCHEMISTRY; RNA; CLEAVAGE; IONS	Labeling substrates or products are paramount in determining enzymatic kinetic parameters. Several options are available; many laboratories use either radioactive or fluorescent labeling because of their high sensitivity. However, those methods have their own drawbacks such as half-life decay, expensive and hazardous. Here, we propose a novel, simple, economical and fast alternative to substrate labeling for studying the kinetics of nucleic acids: post-migration gel staining with SYBR Gold. Cleavage rates similar to the ones reported in the literature for the I-R3 DNA-cleaving DNA enzyme in the presence of zinc chloride are an indication of the quality of the new method. Moreover, the activity of the hammerhead ribozyme was also monitored by our method to illustrate its versatility. This labeling-free method has several advantages such as its ease of use as well as cost effective and versatility with both non-structured and structured RNAs or DNAs.	[Guillen, Danielle; Schievelbein, Mika; Patel, Kushkumar; Jose, Davis; Ouellet, Jonathan] Monmouth Univ, Dept Chem & Phys, West Long Branch, NJ 07764 USA	Monmouth University	Ouellet, J (corresponding author), Monmouth Univ, Dept Chem & Phys, West Long Branch, NJ 07764 USA.	jouellet@monmouth.edu			Monmouth University School of Science Summer Research Program	Monmouth University School of Science Summer Research Program	This project was funded by the Monmouth University School of Science Summer Research Program.	BERTINI I, 1985, J CHEM EDUC, V62, P924, DOI 10.1021/ed062p924; Bertini Ivan, 1994, BIOINORG CHEM, P85; BEVILACQUA PC, 2003, KINETIC ANAL RIBOZYM; Chow CS, 1999, J CHEM EDUC, V76, P651, DOI 10.1021/ed076p651; Davidi D, 2017, CURR OPIN BIOTECH, V46, P81, DOI 10.1016/j.copbio.2017.02.007; Dhamodharan V, 2017, ACS CHEM BIOL, V12, P2940, DOI 10.1021/acschembio.7b00621; ERITJA R, 1986, NUCLEIC ACIDS RES, V14, P5869, DOI 10.1093/nar/14.14.5869; Ferrari D, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf111; Gu HZ, 2013, J AM CHEM SOC, V135, P9121, DOI 10.1021/ja403585e; Jose D, 2009, P NATL ACAD SCI USA, V106, P4231, DOI 10.1073/pnas.0900803106; LEPECQ JB, 1966, ANAL BIOCHEM, V17, P100, DOI 10.1016/0003-2697(66)90012-1; McCall KA, 2000, J NUTR, V130, p1437S, DOI 10.1093/jn/130.5.1437S; MILLIGAN JF, 1987, NUCLEIC ACIDS RES, V15, P8783, DOI 10.1093/nar/15.21.8783; O'Rourke SM, 2018, PROG MOL BIOL TRANSL, V159, P177, DOI 10.1016/bs.pmbts.2018.07.006; Saksmerprome V, 2004, RNA, V10, P1916, DOI 10.1261/rna.7159504; Silverman SK, 2016, TRENDS BIOCHEM SCI, V41, P595, DOI 10.1016/j.tibs.2016.04.010; Singh KK, 1999, RNA, V5, P1348, DOI 10.1017/S1355838299991185; Tuma RS, 1999, ANAL BIOCHEM, V268, P278, DOI 10.1006/abio.1998.3067; Williams LR, 2001, BIOTECH HISTOCHEM, V76, P127, DOI 10.1080/714028140; WILLIAMS RJP, 1987, POLYHEDRON, V6, P61, DOI 10.1016/S0277-5387(00)81239-5; Zingler N, 2014, METHODS MOL BIOL, V1086, P209, DOI 10.1007/978-1-62703-667-2_12	21	0	0	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2020	15	3							e0229527	10.1371/journal.pone.0229527	http://dx.doi.org/10.1371/journal.pone.0229527			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8MS	32126098	Green Published			2022-12-26	WOS:000535253100029
J	Li, Y; Zhang, T; Tian, WJ; Hu, HJ; Xin, ZF; Ma, XJ; Ye, CY; Hang, K; Han, XG; Zhao, J; Li, WX				Li, Yan; Zhang, Ting; Tian, Wenjia; Hu, Hejia; Xin, Zengfeng; Ma, Xiaojing; Ye, Chenyi; Hang, Kai; Han, Xiuguo; Zhao, Jie; Li, Weixu			Loss of TIMP3 expression induces inflammation, matrix degradation, and vascular ingrowth in nucleus pulposus: A new mechanism of intervertebral disc degeneration	FASEB JOURNAL			English	Article						inflammation; matrix degradation; nucleus pulposus; TIMP3; vascular ingrowth	ENDOTHELIAL-CELL PROLIFERATION; AGE-RELATED-CHANGES; TISSUE INHIBITOR; GROWTH; ANGIOGENESIS; RECEPTORS; ENZYMES; INNERVATION; FEATURES; SMAD2/3	Low back pain (LBP) is one of the most common complains in orthopedic outpatient department and intervertebral disc degeneration (IDD) is one of the most important reasons of LBP. The mechanisms of IDD contain a complex biochemical cascade which includes inflammation, vascular ingrowth, and results in degradation of matrix. In our study, we used both in vitro and in vivo models to investigate the relation between tissue inhibitor of metalloproteinase-3 (TIMP3) expression and IDD. Loss of TIMP3 expression was found in degenerative intervertebral disc (IVD), this change of expression was closely related with the dephosphorylation of smad2/3. Overexpression of TIMP3 significantly inhibited the release of TNF-alpha and matrix degradation induced by Lipopolysaccharide. Vascular ingrowth was also suppressed by TIMP3 in the in vitro and in vivo models. Further, animal experiments confirmed that the degeneration of IVD was reduced after overexpression of TIMP3 in nucleus pulposus. Taken together, our results indicated TIMP-3 might play an important role in the pathogenesis of IDD and therefore be a potential therapeutic target in the future.	[Li, Yan; Hu, Hejia; Xin, Zengfeng; Ye, Chenyi; Hang, Kai; Li, Weixu] Zhejiang Univ, Sch Med, Affiliated Hosp 2, Dept Orthoped Surg, 88 Jiefang Rd, Hangzhou 310009, Zhejiang, Peoples R China; [Li, Yan; Hu, Hejia; Xin, Zengfeng; Ye, Chenyi; Hang, Kai; Li, Weixu] Zhejiang Univ, Orthoped Res Inst, Hangzhou, Peoples R China; [Zhang, Ting] Zhejiang Univ, Sch Med, Affiliated Hosp 2, Dept Radiotherapy, Hangzhou, Peoples R China; [Tian, Wenjia] Zhejiang Chinese Med Univ, Affiliated Hosp 1, Dept Endocrinol, Hangzhou, Peoples R China; [Ma, Xiaojing] Zhejiang Univ, Sch Med, Affiliated Hosp 2, Dept Pathol, Hangzhou, Peoples R China; [Han, Xiuguo; Zhao, Jie] Shanghai Jiao Tong Univ, Sch Med, Shanghai Peoples Hosp 9, Shanghai Key Lab Orthopaed Implants,Dept Orthopae, Shanghai, Peoples R China	Zhejiang University; Zhejiang University; Zhejiang University; Zhejiang Chinese Medical University; Zhejiang University; Shanghai Jiao Tong University	Li, WX (corresponding author), Zhejiang Univ, Sch Med, Affiliated Hosp 2, Dept Orthoped Surg, 88 Jiefang Rd, Hangzhou 310009, Zhejiang, Peoples R China.	zrlwx@zju.edu.cn			National Natural Science Foundation of China (NSFC) [81802228]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	National Natural Science Foundation of China (NSFC), Grant/Award Number: 81802228	Andersson GBJ, 1999, LANCET, V354, P581, DOI 10.1016/S0140-6736(99)01312-4; Bachmeier BE, 2007, ANN NY ACAD SCI, V1096, P44, DOI 10.1196/annals.1397.069; Binch ALA, 2014, ARTHRITIS RES THER, V16, DOI 10.1186/s13075-014-0416-1; Boos N, 2002, SPINE, V27, P2631, DOI 10.1097/00007632-200212010-00002; Chen T, 2018, MED SCI MONITOR, V24, P6456, DOI 10.12659/MSM.910636; Chen YY, 2014, ANGIOGENESIS, V17, P207, DOI 10.1007/s10456-013-9389-y; Das AM, 2016, EUR J CANCER, V53, P135, DOI 10.1016/j.ejca.2015.09.014; Das AM, 2014, ANGIOGENESIS, V17, P163, DOI 10.1007/s10456-013-9385-2; DePalma MJ, 2011, PAIN MED, V12, P224, DOI 10.1111/j.1526-4637.2010.01045.x; Ellman MB, 2012, GENE, V505, P283, DOI 10.1016/j.gene.2012.06.004; Freemont AJ, 1997, LANCET, V350, P178, DOI 10.1016/S0140-6736(97)02135-1; Freemont AJ, 2002, J PATHOL, V197, P286, DOI 10.1002/path.1108; Griffith JF, 2007, SPINE, V32, pE708, DOI 10.1097/BRS.0b013e31815a59a0; Hashimoto G, 2001, FEBS LETT, V494, P192, DOI 10.1016/S0014-5793(01)02323-7; Huang M, 2012, J ORTHOP RES, V30, P267, DOI 10.1002/jor.21507; Igarashi T, 2000, SPINE, V25, P2975, DOI 10.1097/00007632-200012010-00003; Johnson WEB, 2002, ARTHRITIS RHEUM-US, V46, P2658, DOI 10.1002/art.10585; KAUPPILA LI, 1995, J BONE JOINT SURG AM, V77A, P26, DOI 10.2106/00004623-199501000-00004; Kepler CK, 2013, SPINE J, V13, P318, DOI 10.1016/j.spinee.2012.12.003; Kwon WK, 2017, OSTEOARTHR CARTILAGE, V25, P1738, DOI 10.1016/j.joca.2017.06.003; Le Maitre CL, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2275; Le Maitre CL, 2004, J PATHOL, V204, P47, DOI 10.1002/path.1608; Lee JM, 2011, J ORTHOP RES, V29, P265, DOI 10.1002/jor.21210; Leivonen SK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057474; Li GJ, 2017, MOL MED REP, V15, P1981, DOI 10.3892/mmr.2017.6240; Li Y, 2016, BIOCHEM BIOPH RES CO, V469, P507, DOI 10.1016/j.bbrc.2015.12.020; Liu Y, 2019, OXID MED CELL LONGEV, V2019, DOI 10.1155/2019/7189854; Mohammed FF, 2004, NAT GENET, V36, P969, DOI 10.1038/ng1413; Pockert AJ, 2009, ARTHRITIS RHEUM-US, V60, P482, DOI 10.1002/art.24291; Qi JH, 2003, NAT MED, V9, P407, DOI 10.1038/nm846; Schafers Maria, 2007, Expert Rev Neurother, V7, P1613, DOI 10.1586/14737175.7.11.1613; SCHWARZER AC, 1995, SPINE, V20, P1878, DOI 10.1097/00007632-199509000-00007; Smookler DS, 2006, J IMMUNOL, V176, P721, DOI 10.4049/jimmunol.176.2.721; Tsuji T, 2007, SPINE, V32, P849, DOI 10.1097/01.brs.0000259804.39881.62; Vos T, 2012, LANCET, V380, P2163, DOI 10.1016/S0140-6736(12)61729-2; WALTENBERGER J, 1994, J BIOL CHEM, V269, P26988; Wang CB, 2014, COGN NEUROSCI-UK, V5, P3, DOI 10.1080/17588928.2013.797388; Wang X, 2014, ARCH BIOCHEM BIOPHYS, V564, P229, DOI 10.1016/j.abb.2014.09.009; Wuertz K, 2013, GLOB SPINE J, V3, P175, DOI 10.1055/s-0033-1347299; Zhu YH, 2017, J CELL MOL MED, V21, P1781, DOI 10.1111/jcmm.13099	40	5	6	0	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2020	34	4					5483	5498		10.1096/fj.201902364RR	http://dx.doi.org/10.1096/fj.201902364RR		FEB 2020	16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	LJ5ZA	32107793	Bronze			2022-12-26	WOS:000517909800001
J	Orsolic, I; Bursac, S; Jurada, D; Hofman, ID; Dembic, Z; Bartek, J; Mihalek, I; Volarevic, S				Orsolic, Ines; Bursac, Sladana; Jurada, Deana; Drmic Hofman, Irena; Dembic, Zlatko; Bartek, Jiri; Mihalek, Ivana; Volarevic, Sinisa			Cancer-associated mutations in the ribosomal protein L5 gene dysregulate the HDM2/p53-mediated ribosome biogenesis checkpoint	ONCOGENE			English	Article							DIAMOND-BLACKFAN ANEMIA; RPL11 GENES; P53; L11; RNA; INHIBITION; IDENTIFICATION; CONSERVATION; DEGRADATION; ACTIVATION	Perturbations in ribosome biogenesis have been associated with cancer. Such aberrations activate p53 through the RPL5/RPL11/5S rRNA complex-mediated inhibition of HDM2. Studies using animal models have suggested that this signaling pathway might constitute an important anticancer barrier. To gain a deeper insight into this issue in humans, here we analyze somatic mutations in RPL5 and RPL11 coding regions, reported in The Cancer Genome Atlas and International Cancer Genome Consortium databases. Using a combined computational and statistical approach, complemented by a range of biochemical and functional analyses in human cancer cell models, we demonstrate the existence of several mechanisms by which RPL5 mutations may impair wild-type p53 upregulation and ribosome biogenesis. Unexpectedly, the same approach provides only modest evidence for a similar role of RPL11, suggesting that RPL5 represents a preferred target during human tumorigenesis in cancers with wild-type p53. Furthermore, we find that several functional cancer-associated RPL5 somatic mutations occur as rare germline variants in general population. Our results shed light on the so-far enigmatic role of cancer-associated mutations in genes encoding ribosomal proteins, with implications for our understanding of the tumor suppressive role of the RPL5/RPL11/5S rRNA complex in human malignancies.	[Orsolic, Ines; Bursac, Sladana; Jurada, Deana; Mihalek, Ivana; Volarevic, Sinisa] Univ Rijeka, Fac Med, Dept Mol Med & Biotechnol, Rijeka 51000, Croatia; [Drmic Hofman, Irena] Univ Split, Sch Med, Dept Med Chem & Biochem, Split 21000, Croatia; [Dembic, Zlatko] Univ Oslo, Fac Dent, Inst Oral Biol, PB 1052 Blindern, N-0316 Oslo, Norway; [Bartek, Jiri] Karolinska Inst, Dept Med Biochem & Biophys, Div Genome Biol, S-17176 Stockholm, Sweden; [Bartek, Jiri] Danish Canc Soc Res, DK-2100 Copenhagen, Denmark	University of Rijeka; University of Split; University of Oslo; Karolinska Institutet; Danish Cancer Society	Mihalek, I; Volarevic, S (corresponding author), Univ Rijeka, Fac Med, Dept Mol Med & Biotechnol, Rijeka 51000, Croatia.; Bartek, J (corresponding author), Karolinska Inst, Dept Med Biochem & Biophys, Div Genome Biol, S-17176 Stockholm, Sweden.; Bartek, J (corresponding author), Danish Canc Soc Res, DK-2100 Copenhagen, Denmark.	jb@cancer.dk; ivana.mihalek@medri.uniri.hr; sinisa.volarevic@medri.uniri.hr	Bursać, Slađana/Q-7894-2018; Volarevic, Sinisa/O-4349-2018; Oršolić, Ines/AGE-5929-2022; Dembic, Zlatko/A-1833-2008	Bursać, Slađana/0000-0002-6478-3409; Volarevic, Sinisa/0000-0003-4893-389X; Oršolić, Ines/0000-0003-4517-7187; Dembic, Zlatko/0000-0002-9970-6497	Croatian Science Foundation [09.01/220, 2079]; Scientific Center of Excellence for Reproductive and Regenerative Medicine [KK.01.1.1.01.0008]; University of Rijeka [uniri-biomed-18-206]; Swedish Cancer Society [170176]; Swedish Research Council [VR-MH 2014-46602-117891-30]; Novo Nordisk Foundation [16854]; Danish National Research Foundation (project CARD) [DNRF125]; Danish Cancer Society [R204-A12617]; Lundbeck Foundation	Croatian Science Foundation; Scientific Center of Excellence for Reproductive and Regenerative Medicine; University of Rijeka; Swedish Cancer Society(Swedish Cancer Society); Swedish Research Council(Swedish Research CouncilEuropean Commission); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Danish National Research Foundation (project CARD); Danish Cancer Society(Danish Cancer Society); Lundbeck Foundation(Lundbeckfonden)	We are grateful to Drs George Thomas and Jonathan Ashwell for critical review of the manuscript and helpful suggestions. We would also like to thank Davor Mihalek for his expert assistance in preparing the supplementary movie as well as Miljana Uzelac and Ivana Matui for their technical help. The authors sincerely thank Dr. Moshe Oren (Weizmann Institute of Science) for providing the pCMV-HA3-HDM1B expression plasmid. The pCHDM1A-HDM2 expression plasmid was kindly provided by Dr. Karen Vousden (Francis Crick Institute). SV laboratory was supported with grants from the Croatian Science Foundation (09.01/220 and 2079 to SV), the Scientific Center of Excellence for Reproductive and Regenerative Medicine (KK.01.1.1.01.0008 to SV), the University of Rijeka (uniri-biomed-18-206 to SV). JB laboratory is funded by grants from the Swedish Cancer Society (grant number: 170176) and the Swedish Research Council (VR-MH 2014-46602-117891-30), the Novo Nordisk Foundation (no. 16854), the Danish National Research Foundation (project CARD: no. DNRF125), the Danish Cancer Society (R204-A12617), and the Lundbeck Foundation.	Ajore R, 2017, EMBO MOL MED, V9, P498, DOI 10.15252/emmm.201606660; ANDERSON DE, 1990, BIOCHEMISTRY-US, V29, P2403, DOI 10.1021/bi00461a025; Anslyn E.V., 2006, MODERN PHYS ORGANIC; Arena G, 2018, CELL DEATH DIFFER, V25, P1533, DOI 10.1038/s41418-018-0156-x; Aspesi A, 2019, NAT REV CANCER, V19, P228, DOI 10.1038/s41568-019-0105-0; Badertscher L, 2015, CELL REP, V13, P2879, DOI 10.1016/j.celrep.2015.11.061; Ben-Shem A, 2011, SCIENCE, V334, P1524, DOI 10.1126/science.1212642; Berman H. M., 2006, INT TABLES CRYSTALLO, P675, DOI DOI 10.1107/97809553602060000722; Bhat KP, 2004, EMBO J, V23, P2402, DOI 10.1038/sj.emboj.7600247; Bohlman Stephen, 2014, Subcell Biochem, V85, P235, DOI 10.1007/978-94-017-9211-0_13; Boria I, 2010, HUM MUTAT, V31, P1269, DOI 10.1002/humu.21383; Bursac S, 2012, P NATL ACAD SCI USA, V109, P20467, DOI 10.1073/pnas.1218535109; Bywater MJ, 2012, CANCER CELL, V22, P51, DOI 10.1016/j.ccr.2012.05.019; Cancer Genome Atlas Research Network, 2013, Nat Genet, V45, P1113, DOI 10.1038/ng.2764; Cmejla R, 2009, HUM MUTAT, V30, P321, DOI 10.1002/humu.20874; Dai MS, 2004, J BIOL CHEM, V279, P44475, DOI 10.1074/jbc.M403722200; De Keersmaecker K, 2013, NAT GENET, V45, P186, DOI 10.1038/ng.2508; Delaporta P, 2014, PEDIATR BLOOD CANCER, V61, P2249, DOI 10.1002/pbc.25183; Donati G, 2013, CELL REP, V4, P87, DOI 10.1016/j.celrep.2013.05.045; Ebert BL, 2008, NATURE, V451, P335, DOI 10.1038/nature06494; Errichiello E, 2017, BLOOD CELL MOL DIS, V64, P38, DOI 10.1016/j.bcmd.2017.03.002; Fancello L, 2017, ONCOTARGET, V8, P14462, DOI 10.18632/oncotarget.14895; Fersht AR, 2002, CELL, V108, P573, DOI 10.1016/S0092-8674(02)00620-7; Ballester EF, 2015, CLIN CASE REP, V3, P392, DOI 10.1002/ccr3.240; Gao J, 2017, RETHINK ASIA INT REL, P1; Gazda HT, 2008, AM J HUM GENET, V83, P769, DOI 10.1016/j.ajhg.2008.11.004; Golomb L, 2014, FEBS LETT, V588, P2571, DOI 10.1016/j.febslet.2014.04.014; Greenman C, 2006, GENETICS, V173, P2187, DOI 10.1534/genetics.105.044677; Halazonetis TD, 2008, SCIENCE, V319, P1352, DOI 10.1126/science.1140735; Hofman IJF, 2017, LEUKEMIA, V31, P1706, DOI 10.1038/leu.2016.370; Hofman IJF, 2017, HAEMATOLOGICA, V102, pE317, DOI 10.3324/haematol.2016.162198; Horn HF, 2008, ONCOGENE, V27, P5774, DOI 10.1038/onc.2008.189; Hunter JD, 2007, COMPUT SCI ENG, V9, P90, DOI 10.1109/MCSE.2007.55; Irving JA, 2000, GENOME RES, V10, P1845, DOI 10.1101/gr.GR-1478R; Kamburov A, 2015, P NATL ACAD SCI USA, V112, pE5486, DOI 10.1073/pnas.1516373112; Karlin S, 1996, J BACTERIOL, V178, P1881, DOI 10.1128/jb.178.7.1881-1894.1996; Kazerounian S, 2016, J CANCER, V7, P32, DOI 10.7150/jca.13292; Lawrence MS, 2014, NATURE, V505, P495, DOI 10.1038/nature12912; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; Lindstrom MS, 2018, ONCOGENE, V37, P2351, DOI 10.1038/s41388-017-0121-z; Liu S, 2017, ONCOGENE, V36, P1374, DOI 10.1038/onc.2016.301; Lohrum MAE, 2003, CANCER CELL, V3, P577, DOI 10.1016/S1535-6108(03)00134-X; Lykke-Andersen S, 2015, NAT REV MOL CELL BIO, V16, P665, DOI 10.1038/nrm4063; Macias E, 2010, CANCER CELL, V18, P231, DOI 10.1016/j.ccr.2010.08.007; Mihalek I, 2003, J MOL BIOL, V331, P263, DOI 10.1016/S0022-2836(03)00663-6; Morgado-Palacin L, 2015, CELL REP, V13, P712, DOI 10.1016/j.celrep.2015.09.038; Narla A, 2010, BLOOD, V115, P3196, DOI 10.1182/blood-2009-10-178129; Nicolas E, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11390; Nishimura K, 2015, CELL REP, V10, P1310, DOI 10.1016/j.celrep.2015.01.055; Noller HF, 2012, CSH PERSPECT BIOL, V4, P1, DOI 10.1101/cshperspect.a003681; Orsolic I, 2016, SEMIN CANCER BIOL, V37-38, P36, DOI 10.1016/j.semcancer.2015.12.004; Pelletier J, 2018, NAT REV CANCER, V18, P51, DOI 10.1038/nrc.2017.104; Pon JR, 2015, ANNU REV PATHOL-MECH, V10, P25, DOI 10.1146/annurev-pathol-012414-040312; Quarello P, 2010, HAEMATOL-HEMATOL J, V95, P206, DOI 10.3324/haematol.2009.011783; Rahman N, 2014, NATURE, V505, P302, DOI 10.1038/nature12981; Sivley RM, 2018, AM J HUM GENET, V102, P415, DOI 10.1016/j.ajhg.2018.01.017; Sloan KE, 2013, CELL REP, V5, P237, DOI 10.1016/j.celrep.2013.08.049; Tafforeau L, 2013, MOL CELL, V51, P539, DOI 10.1016/j.molcel.2013.08.011; Tahmasebi S, 2018, NAT REV MOL CELL BIO, V19, P791, DOI 10.1038/s41580-018-0034-x; Tzoneva G, 2013, NAT MED, V19, P368, DOI 10.1038/nm.3078; Velimezi G, 2013, NAT CELL BIOL, V15, P967, DOI 10.1038/ncb2795; Vlachos A, 2012, BLOOD, V119, P3815, DOI 10.1182/blood-2011-08-375972; Voorhees RM, 2014, CELL, V157, P1632, DOI 10.1016/j.cell.2014.05.024; Zhang J, 2011, DISCRETE DYN NAT SOC, V2011, DOI [10.1155/2011/958381, 10.1093/database/bar026]; Zhang JY, 2007, GENE DEV, V21, P2580, DOI 10.1101/gad.1569307; Zhang YP, 2003, MOL CELL BIOL, V23, P8902, DOI 10.1128/MCB.23.23.8902-8912.2003; Zheng JG, 2015, GENE DEV, V29, P1524, DOI 10.1101/gad.261792.115	67	15	15	2	9	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR	2020	39	17					3443	3457		10.1038/s41388-020-1231-6	http://dx.doi.org/10.1038/s41388-020-1231-6		FEB 2020	15	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	LH1YK	32108164				2022-12-26	WOS:000516891300004
J	Smith, TS; Amstrup, SC; Kirschhoffer, BJ; York, G				Smith, Tom S.; Amstrup, Steven C.; Kirschhoffer, B. J.; York, Geoffrey			Efficacy of aerial forward-looking infrared surveys for detecting polar bear maternal dens	PLOS ONE			English	Article							URSUS-MARITIMUS; HABITAT; SEA	Denned polar bears (Ursus maritimus) are invisible under the snow, therefore winter-time petroleum exploration and development activities in northern Alaska have potential to disturb maternal polar bears and their cubs. Previous research determined forward looking infrared (FLIR) imagery could detect many polar bear maternal dens under the snow, but also identified limitations of FLIR imagery. We evaluated the efficacy of FLIR-surveys conducted by oil-field operators from 2004-2016. Aerial FLIR surveys detected 15 of 33 (45%) and missed 18 (55%) of the dens known to be within surveyed areas. While greater adherence to previously recommended protocols may improve FLIR detection rates, the physical characteristics of polar bear maternal dens, increasing frequencies of weather unsuitable for FLIR detections-caused by global warming, and competing false positives are likely to prevent FLIR surveys from detecting maternal dens reliably enough to afford protections consonant with increasing global threats to polar bear welfare.	[Smith, Tom S.] Brigham Young Univ, Wildlife & Wildlands Conservat Program, Provo, UT 84602 USA; [Amstrup, Steven C.; Kirschhoffer, B. J.; York, Geoffrey] Polar Bears Int, Bozeman, MT USA; [Amstrup, Steven C.] Univ Wyoming, Dept Zool & Physiol, Laramie, WY 82071 USA	Brigham Young University; University of Wyoming	Smith, TS (corresponding author), Brigham Young Univ, Wildlife & Wildlands Conservat Program, Provo, UT 84602 USA.	tom_smith@byu.edu			Polar Bears International	Polar Bears International	We would like to thank anonymous reviewers for their thoughtful comments regarding this manuscript. We would also like to thank the following persons for assisting data collection: S. Partridge, T. D. DeBruyn, J. Wilder, T. Evans, S. Schliebe, C. Perham, R. Shideler, B. Jessop, J. Olson, R. Robinson, W. G. Larson and J. Whiting. Additionally, we thank W. J. Streever, D. Sanzone, and C. Pohl of British Petroleum Exploration (BPX) for their support and assistance, without which this work would not have been possible. Also important was R. Murray and N. Hermon of Alaska Clean Seas, and S. Gogosha and D. Heebner of HilCorp Energy Company who provided invaluable assistance at the Milne Point facility. We extend special thanks to D. Herron and J. Thompson of the BP Thermographics Division for providing access to the FLIR cameras. Polar Bears International (PBI) has played a critical role in supporting this work.	Amstrup SC, 2004, BIOSCIENCE, V54, P337, DOI 10.1641/0006-3568(2004)054[0337:DDPBWF]2.0.CO;2; AMSTRUP SC, 1993, ARCTIC, V46, P246; AMSTRUP SC, 1994, J WILDLIFE MANAGE, V58, P1, DOI 10.2307/3809542; Amstrup SC., 2003, WILD MAMMALS N AM BI, P587; Bromaghin JF, 2015, ECOL APPL, V25, P634, DOI 10.1890/14-1129.1; Durner GM, 2006, ARCTIC, V59, P31; Durner GM, 2003, ARCTIC, V56, P55; Durner GM, 2001, ARCTIC, V54, P115; Fischbach AS, 2007, POLAR BIOL, V30, P1395, DOI 10.1007/s00300-007-0300-4; LARSEN T, 1985, J WILDLIFE MANAGE, V49, P320, DOI 10.2307/3801524; Linnell JDC, 2000, WILDLIFE SOC B, V28, P400; Ovsyanikov N, 1998, URSUS-SERIES, V10, P251; Robinson R, 2014, BIOSCIENCE, V64, P735, DOI 10.1093/biosci/biu095; Rode KD, 2018, J MAMMAL, V99, P16, DOI 10.1093/jmammal/gyx181; Serreze MC, 2012, J GEOPHYS RES-ATMOS, V117, DOI 10.1029/2011JD017421; Smith TS, 2007, ARCTIC, V60, P187; Smith TS, 2013, ARCTIC, V66, P139; U.S. Fish and Wildlife, 2016, POL BEAR URS MAR CON; US Government, 2018, COAST PLAN OIL GAS L; Uspenski SM, 1972, INT C BEAR RES MANAG, V2, P181; York G., 2004, USING FORWARD UNPUB	21	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2020	15	2							e0222744	10.1371/journal.pone.0222744	http://dx.doi.org/10.1371/journal.pone.0222744			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8GQ	32106278	gold, Green Submitted, Green Published			2022-12-26	WOS:000535237000005
J	Horsley, AR; Alrumuh, A; Bianco, B; Bayfield, K; Tomlinson, J; Jones, A; Maitra, A; Cunningham, S; Smith, J; Fullwood, C; Pandyan, A; Gilchrist, FJ				Horsley, Alex R.; Alrumuh, Amnah; Bianco, Brooke; Bayfield, Katie; Tomlinson, Joanne; Jones, Andrew; Maitra, Anirban; Cunningham, Steve; Smith, Jaclyn; Fullwood, Catherine; Pandyan, Anand; Gilchrist, Francis J.			Lung clearance index in healthy volunteers, measured using a novel portable system with a closed circuit wash-in	PLOS ONE			English	Article							MULTIPLE BREATH WASHOUT; INERT-GAS WASHOUT; CYSTIC-FIBROSIS; DISEASE; SPIROMETRY; CHILDREN; IVACAFTOR; VALUES; AGE	Introduction Lung clearance index (LCI) is a sensitive measure of early lung disease, but adoption into clinical practice has been slow. Challenges include the time taken to perform each test. We recently described a closed-circuit inert gas wash-in method that reduces overall testing time by decreasing the time to equilibration. The aim of this study was to define a normative range of LCI in healthy adults and children derived using this method. We were also interested in the feasibility of using this system to measure LCI in a community setting. Methods LCI was assessed in healthy volunteers at three hospital sites and in two local primary schools. Volunteers completed three washout repeats at a single visit using the closed circuit wash-in method (0.2% SF6 wash-in tracer gas to equilibrium, room air washout). Results 160 adult and paediatric subjects successfully completed LCI assessment (95%) (100 in hospital, 60 in primary schools). Median coefficient of variation was 3.4% for LCI repeats and 4.3% for FRC. Mean (SD) LCI for the analysis cohort (n = 53, age 5-39 years) was 6.10 (0.42), making the upper limit of normal LCI 6.8. There was no relationship between LCI and multiple demographic variables. Median (interquartile range) total test time was 18.7 (16.0-22.5) minutes. Conclusion The closed circuit method of LCI measurement can be successfully and reproducibly measured in healthy volunteers, including in out-of-hospital settings. Normal range appears stable up to 39 years. With few subjects older than 40 years, further work is required to define the normal limits above this age.	[Horsley, Alex R.; Jones, Andrew; Smith, Jaclyn] Univ Manchester, Fac Biol Med & Hlth, Div Infect Immun & Resp Med, Manchester, Lancs, England; [Horsley, Alex R.; Bianco, Brooke; Jones, Andrew] Manchester Univ NHS Fdn Trust, Manchester Adult CF Ctr, Manchester, Lancs, England; [Alrumuh, Amnah; Pandyan, Anand; Gilchrist, Francis J.] Keele Univ, Inst Appl Clin Sci, Newcastle Under Lyme, England; [Alrumuh, Amnah; Tomlinson, Joanne; Gilchrist, Francis J.] Univ Hosp North Midlands NHS Trust, Royal Stoke Univ Hosp, Stoke On Trent, Staffs, England; [Bianco, Brooke; Bayfield, Katie] NIHR Manchester Clin Res Facil, Manchester, Lancs, England; [Maitra, Anirban] Manchester Univ NHS Fdn Trust, Royal Manchester Childrens Hosp, Manchester, Lancs, England; [Cunningham, Steve] Univ Edinburgh, Ctr Inflammat Res, Edinburgh, Midlothian, Scotland; [Fullwood, Catherine] Manchester Univ NHS Fdn Trust, Res & Innovat, Manchester, Lancs, England; [Fullwood, Catherine] Univ Manchester, Fac Biol Med & Hlth, Ctr Biostat, Manchester, Lancs, England	University of Manchester; Keele University; Royal Stoke University Hospital; Royal Manchester Children's Hospital; University of Edinburgh; University of Manchester	Horsley, AR (corresponding author), Univ Manchester, Fac Biol Med & Hlth, Div Infect Immun & Resp Med, Manchester, Lancs, England.; Horsley, AR (corresponding author), Manchester Univ NHS Fdn Trust, Manchester Adult CF Ctr, Manchester, Lancs, England.	alexander.horsley@manchester.ac.uk	Maitra, Anirban/AFP-6089-2022; Gilchrist, Francis/F-4198-2014	Smith, Jaclyn/0000-0001-8837-4928; Pandyan, Anand/0000-0002-2180-197X; Fullwood, Catherine/0000-0003-4136-2027; Cunningham, Steve/0000-0001-7342-251X; Horsley, Alex/0000-0003-1828-0058; Bayfield, Katie/0000-0003-3587-4763; Gilchrist, Francis/0000-0002-1947-7621; jones, andrew/0000-0003-3232-1055	National Institute for Health Research [NIHRCS12-013]	National Institute for Health Research(National Institute for Health Research (NIHR))	This study was funded by a National Institute for Health Research (www.nihr.ac.uk) Clinician Scientist award to AH (NIHRCS12-013). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alton EWFW, 2015, LANCET RESP MED, V3, P684, DOI 10.1016/S2213-2600(15)00245-3; Anagnostopoulou P, 2019, EUR RESPIR J, V54, DOI 10.1183/13993003.congress-2019.PA4990; Bayfield KJ, 2019, ERJ OPEN RES, V5, DOI 10.1183/23120541.00234-2018; Bell AS, 2018, INT J CHRONIC OBSTR, V13, P2113, DOI 10.2147/COPD.S164285; Benseler A, 2015, RESPIROLOGY, V20, P459, DOI 10.1111/resp.12470; Davies J, 2013, LANCET RESP MED, V1, P630, DOI 10.1016/S2213-2600(13)70182-6; Engberinkt EO, 2017, EUR RESPIR J, V50, DOI 10.1183/13993003.00433-2017; Fuchs SI, 2009, PEDIATR PULM, V44, P1180, DOI 10.1002/ppul.21093; GOLDMAN HI, 1959, AM REV TUBERC PULM, V79, P457; Guglani L., 2018, J APPL PHYSL; Gustafsson PM, 2008, THORAX, V63, P129, DOI 10.1136/thx.2007.077784; Gustafsson PM, 2003, EUR RESPIR J, V22, P972, DOI 10.1183/09031936.03.00049502; Horsley AR, 2008, THORAX, V63, P135, DOI 10.1136/thx.2007.082628; Horsley A, 2015, RESPIROLOGY, V20, P33, DOI 10.1111/resp.12382; Horsley A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098487; Horsley AR., 2016, ERJ OPEN RES, V2; Htun C, 2018, J APPL PHYSIOL, V125, P1378, DOI 10.1152/japplphysiol.00114.2018; Jensen R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056868; Kane M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185553; Kent L, 2014, J CYST FIBROS, V13, P123, DOI 10.1016/j.jcf.2013.09.005; Kjellberg S, 2016, RESP MED, V117, P92, DOI 10.1016/j.rmed.2016.05.028; Lum S, 2013, EUR RESPIR J, V41, P1371, DOI 10.1183/09031936.00005512; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; O'Neill K, 2020, RESPIROLOGY, V25, P64, DOI 10.1111/resp.13653; Polgar G, 1971, PULMONARY FUNCTION T; Poncin W, 2017, J CYST FIBROS, V16, P258, DOI 10.1016/j.jcf.2016.11.004; Quanjer PH, 2012, EUR RESPIR J, V40, P1324, DOI 10.1183/09031936.00080312; Ratjen F, 2017, LANCET RESP MED, V5, P557, DOI 10.1016/S2213-2600(17)30215-1; Robinson PD, 2018, AM J RESP CRIT CARE, V197, P557, DOI 10.1164/rccm.201801-0074ST; Robinson PD, 2013, EUR RESPIR J, V41, P507, DOI 10.1183/09031936.00069712; Singer F, 2013, PEDIATR PULM, V48, P739, DOI 10.1002/ppul.22651; Singer F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036083; Smith L, 2018, AM J RESP CRIT CARE, V197, P397, DOI 10.1164/rccm.201705-0894LE; Stanojevic S, 2017, AM J RESP CRIT CARE, V195, P1216, DOI 10.1164/rccm.201610-2158OC; Verbanck S, 2016, EUR RESPIR J, V47, P166, DOI 10.1183/13993003.00695-2015; Verbanck S, 2012, THORAX, V67, P789, DOI 10.1136/thoraxjnl-2011-201484	36	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2020	15	2							e0229300	10.1371/journal.pone.0229300	http://dx.doi.org/10.1371/journal.pone.0229300			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8EV	32097445	Green Published, Green Accepted, gold			2022-12-26	WOS:000535232000025
J	Kim, GD; Lee, JH; Song, SM; Kim, SW; Han, JS; Shin, SP; Park, BC; Park, TS				Kim, Gap-Don; Lee, Jeong Hyo; Song, Sumin; Kim, Seo Woo; Han, Ji Seon; Shin, Seung Pyo; Park, Byung-Chul; Park, Tae Sub			Generation of myostatin-knockout chickens mediated by D10A-Cas9 nickase	FASEB JOURNAL			English	Article						chicken; D10A-Cas9; muscle; myostatin; nickase; off-target	EFFICIENT GENERATION; GENE KNOCKOUT; PIGS; HYPERTROPHY; HYPERPLASIA; MUTATIONS; CATTLE; CAS9; MICE	Many studies have been conducted to improve economically important livestock traits such as feed efficiency and muscle growth. Genome editing technologies represent a major advancement for both basic research and agronomic biotechnology development. The clustered regularly interspaced short palindromic repeats (CRISPR)/Cas9 technical platform is a powerful tool used to engineer specific targeted loci. However, the potential occurrence of off-target effects, including the cleavage of unintended targets, limits the practical applications of Cas9-mediated genome editing. In this study, to minimize the off-target effects of this technology, we utilized D10A-Cas9 nickase to generate myostatin-knockout (MSTN KO) chickens via primordial germ cells. D10A-Cas9 nickase (Cas9n)-mediated MSTN KO chickens exhibited significantly larger skeletal muscles in the breast and leg. Degrees of skeletal muscle hypertrophy and hyperplasia induced by myostatin deletion differed by sex and muscle type. The abdominal fat deposition was dramatically lower in MSTN KO chickens than in wild-type chickens. Our results demonstrate that the D10A-Cas9 technical platform can facilitate precise and efficient targeted genome engineering and may broaden the range of applications for genome-edited chickens in practical industrialization and as animal models of human diseases.	[Kim, Gap-Don; Song, Sumin; Kim, Seo Woo; Han, Ji Seon; Park, Byung-Chul; Park, Tae Sub] Seoul Natl Univ, Grad Sch Int Agr Technol, Pyeongchang Gun 25354, Gangwon Do, South Korea; [Kim, Gap-Don; Lee, Jeong Hyo; Shin, Seung Pyo; Park, Byung-Chul; Park, Tae Sub] Seoul Natl Univ, Inst Green Bio Sci & Technol, Pyeongchang Gun, South Korea; [Park, Byung-Chul] Seoul Natl Univ, Res Inst Agr & Life Sci, Seoul, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU)	Park, BC; Park, TS (corresponding author), Seoul Natl Univ, Grad Sch Int Agr Technol, Pyeongchang Gun 25354, Gangwon Do, South Korea.	bcpark@snu.ac.kr; taesubpark@snu.ac.kr		Lee, Jeong Hyo/0000-0002-1848-5347	RDA, Korea [PJ01334801]	RDA, Korea	RDA, Korea, Grant/Award Number: PJ01334801	Bastiaansen JWM, 2018, GENET SEL EVOL, V50, DOI 10.1186/s12711-018-0389-7; Bhattacharya TK, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-44217-z; Carlson DF, 2016, NAT BIOTECHNOL, V34, P479, DOI 10.1038/nbt.3560; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Cui XX, 2011, NAT BIOTECHNOL, V29, P64, DOI 10.1038/nbt.1731; Dimitrov L, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154303; Dou TF, 2018, MOL BIOL REP, V45, P511, DOI 10.1007/s11033-018-4187-7; Gao YP, 2017, GENOME BIOL, V18, DOI 10.1186/s13059-016-1144-4; Hauschild J, 2011, P NATL ACAD SCI USA, V108, P12013, DOI 10.1073/pnas.1106422108; Kang JD, 2017, RSC ADV, V7, P12541, DOI 10.1039/c6ra28579a; Lee JH, 2017, ASIAN AUSTRAL J ANIM, V30, P743, DOI 10.5713/ajas.16.0695; Mali P, 2013, NAT BIOTECHNOL, V31, P833, DOI 10.1038/nbt.2675; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; McPherron AC, 1997, NATURE, V387, P83, DOI 10.1038/387083a0; McPherron AC, 1997, P NATL ACAD SCI USA, V94, P12457, DOI 10.1073/pnas.94.23.12457; Meuwissen T, 2013, ANNU REV ANIM BIOSCI, V1, P221, DOI 10.1146/annurev-animal-031412-103705; Miller JC, 2011, NAT BIOTECHNOL, V29, P143, DOI 10.1038/nbt.1755; Nishi M, 2002, BIOCHEM BIOPH RES CO, V293, P247, DOI 10.1016/S0006-291X(02)00209-7; Oishi I, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-28438-2; Oishi I, 2016, SCI REP-UK, V6, DOI 10.1038/srep23980; Park TS, 2019, FASEB J, V33, P1188, DOI 10.1096/fj.201800784R; Park TS, 2014, P NATL ACAD SCI USA, V111, P12716, DOI 10.1073/pnas.1410555111; Peng H, 2016, SCI REP-UK, V6, DOI 10.1038/srep22000; Ran FA, 2013, CELL, V154, P1380, DOI 10.1016/j.cell.2013.08.021; Shen B, 2014, NAT METHODS, V11, P399, DOI [10.1038/nmeth.2857, 10.1038/NMETH.2857]; Stern CD, 2005, DEV CELL, V8, P9, DOI 10.1016/j.devcel.2004.11.018; Sung YH, 2013, NAT BIOTECHNOL, V31, P23, DOI 10.1038/nbt.2477; Wang KK, 2015, SCI REP-UK, V5, DOI 10.1038/srep16623; Whitworth KM, 2016, NAT BIOTECHNOL, V34, P20, DOI 10.1038/nbt.3434; Zhou XQ, 2015, CELL MOL LIFE SCI, V72, P1175, DOI 10.1007/s00018-014-1744-7; Zhu XL, 2000, FEBS LETT, V474, P71, DOI 10.1016/S0014-5793(00)01570-2	31	29	32	1	13	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2020	34	4					5688	5696		10.1096/fj.201903035R	http://dx.doi.org/10.1096/fj.201903035R		FEB 2020	9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	LJ5ZA	32100378	hybrid			2022-12-26	WOS:000517898700001
J	Laitakari, A; Huttunen, R; Kuvaja, P; Hannuksela, P; Szabo, Z; Heikkila, M; Kerkela, R; Myllyharju, J; Dimova, EY; Serpi, R; Koivunen, P				Laitakari, Anna; Huttunen, Riikka; Kuvaja, Paula; Hannuksela, Pauliina; Szabo, Zoltan; Heikkila, Minna; Kerkela, Risto; Myllyharju, Johanna; Dimova, Elitsa Y.; Serpi, Raisa; Koivunen, Peppi			Systemic long-term inactivation of hypoxia-inducible factor prolyl 4-hydroxylase 2 ameliorates aging-induced changes in mice without affecting their life span	FASEB JOURNAL			English	Article						anemia; HCC; hypoxia response; metabolism	CORONARY-HEART-DISEASE; SERUM URIC-ACID; CELL-PROLIFERATION; ROXADUSTAT FG-4592; ENDOTHELIAL-CELLS; PHD2; ACTIVATION; INHIBITION; MORTALITY; PROTECTS	Hypoxia inactivates hypoxia-inducible factor (HIF) prolyl 4-hydroxylases (HIF-P4Hs), which stabilize HIF and upregulate genes to restore tissue oxygenation. HIF-P4Hs can also be inhibited by small molecules studied in clinical trials for renal anemia. Knowledge of systemic long-term inactivation of HIF-P4Hs is limited but crucial, since HIF overexpression is associated with cancers. We aimed to determine the effects of systemic genetic inhibition of the most abundant isoenzyme HIF prolyl 4-hydroxylase-2 (HIF-P4H-2)/PHD2/EglN1 on life span and tissue homeostasis in aged mice. Our data showed no difference between wild-type and HIF-P4H-2-deficient mice in the average age reached. There were several differences, however, in the primary causes of death and comorbidities, the HIF-P4H-2-deficient mice having less inflammation, liver diseases, including cancer, and myocardial infarctions, and not developing anemia. No increased cancer incidence was observed due to HIF-P4H-2-deficiency. These data suggest that chronic inactivation of HIF-P4H-2 is not harmful but rather improves the quality of life in senescence.	[Laitakari, Anna; Huttunen, Riikka; Hannuksela, Pauliina; Heikkila, Minna; Myllyharju, Johanna; Dimova, Elitsa Y.; Serpi, Raisa; Koivunen, Peppi] Univ Oulu, Oulu Ctr Cell Matrix Res, Fac Biochem & Mol Med, Bioctr Oulu, Aapistie 7C, FIN-90014 Oulu, Finland; [Kuvaja, Paula] Univ Oulu, Oulu Univ Hosp, Med Res Ctr Oulu, Canc & Translat Med Res Unit, Oulu, Finland; [Kuvaja, Paula] Oulu Univ Hosp, Dept Pathol, Oulu, Finland; [Szabo, Zoltan; Kerkela, Risto] Univ Oulu, Dept Pharmacol & Toxicol, Res Unit Biomed, Oulu, Finland	University of Oulu; University of Oulu; University of Oulu; University of Oulu	Koivunen, P (corresponding author), Univ Oulu, Oulu Ctr Cell Matrix Res, Fac Biochem & Mol Med, Bioctr Oulu, Aapistie 7C, FIN-90014 Oulu, Finland.	peppi.koivunen@oulu.fi		Szabo, Zoltan/0000-0003-0778-1113; Serpi, Raisa/0000-0002-8207-4673	Academy of Finland (Suomen Akatemia) [266719, 308009, 296498, 251314]; Sigrid Juseliuksen Saatio (Sigrid Juselius Stiftelse); Finnish Cancer Foundation; Jane ja Aatos Erkon Saatio (JAE); FibroGen (FibroGen Inc.)	Academy of Finland (Suomen Akatemia)(Academy of Finland); Sigrid Juseliuksen Saatio (Sigrid Juselius Stiftelse); Finnish Cancer Foundation; Jane ja Aatos Erkon Saatio (JAE); FibroGen (FibroGen Inc.)	Academy of Finland (Suomen Akatemia), Grant/Award Number: 266719, 308009, 296498 and 251314; Sigrid Juseliuksen Saatio (Sigrid Juselius Stiftelse); Finnish Cancer Foundation; Jane ja Aatos Erkon Saatio (J & AE); FibroGen (FibroGen Inc.)	Acker T, 2005, CANCER CELL, V8, P131, DOI 10.1016/j.ccr.2005.07.003; Amiiants V I, 1997, Klin Med (Mosk), V75, P26; Andersen S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023847; Austad SN, 2016, CELL METAB, V23, P1022, DOI 10.1016/j.cmet.2016.05.019; Bagherniya M, 2018, AGEING RES REV, V47, P183, DOI 10.1016/j.arr.2018.08.004; Blouw B, 2003, CANCER CELL, V4, P133, DOI 10.1016/S1535-6108(03)00194-6; Bogaerts E, 2016, EXCLI J, V15, P687, DOI 10.17179/excli2016-607; Callicott RJ, 2006, COMPARATIVE MED, V56, P17; Carmeliet P, 1998, NATURE, V394, P485, DOI 10.1038/28867; Cawthon RM, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e47; Chang AM, 2003, AM J PHYSIOL-ENDOC M, V284, pE7, DOI 10.1152/ajpendo.00366.2002; Chen N, 2017, NEPHROL DIAL TRANSPL, V32, P1373, DOI 10.1093/ndt/gfx011; Dai ZY, 2016, CIRCULATION, V133, P2447, DOI 10.1161/CIRCULATIONAHA.116.021494; Dhillon S, 2019, DRUGS, V79, P563, DOI 10.1007/s40265-019-01077-1; Di Conza G, 2017, CELL REP, V18, P2836, DOI 10.1016/j.celrep.2017.02.081; Dovell F, 2018, EUR J CANCER PREV, V27, P399, DOI [10.1097/cej.0000000000000440, 10.1097/CEJ.0000000000000440]; Durkin M.E., 2013, BIOPROTOC, V3, pE908, DOI DOI 10.21769/BioProtoc.908; Ezzati M, 2012, J EPIDEMIOL COMMUN H, V66, DOI 10.1136/jech.2010.112938; Faeh D, 2009, CIRCULATION, V120, P495, DOI 10.1161/CIRCULATIONAHA.108.819250; Farese RV, 1996, P NATL ACAD SCI USA, V93, P6393, DOI 10.1073/pnas.93.13.6393; Flamme I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111838; Folgueras AR, 2018, CIRC RES, V123, P905, DOI 10.1161/CIRCRESAHA.118.312204; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Guralnik Jack M, 2005, Hematology Am Soc Hematol Educ Program, P528; Haase VH, 2017, HEMODIAL INT, V21, pS110, DOI 10.1111/hdi.12567; Hawley JA, 2018, CELL METAB, V27, P962, DOI 10.1016/j.cmet.2018.04.014; Hirsila M, 2003, J BIOL CHEM, V278, P30772, DOI 10.1074/jbc.M304982200; Hwang AB, 2012, CURR GENOMICS, V13, P519, DOI 10.2174/138920212803251427; Hyvarinen J, 2010, J BIOL CHEM, V285, P13646, DOI 10.1074/jbc.M109.084855; Kaelin WG, 2008, MOL CELL, V30, P393, DOI 10.1016/j.molcel.2008.04.009; Kaelin William G Jr, 2017, Trans Am Clin Climatol Assoc, V128, P298; Karsikas S, 2016, J MOL MED, V94, P301, DOI 10.1007/s00109-015-1349-0; Kerkela R, 2013, MOL CELL BIOL, V33, P3321, DOI 10.1128/MCB.00432-13; Klotzsche-von Ameln A, 2011, CANCER RES, V71, P3306, DOI 10.1158/0008-5472.CAN-10-3838; Koivunen P, 2018, TRENDS MOL MED, V24, P1021, DOI 10.1016/j.molmed.2018.10.004; Koivunen P, 2016, PHARMACOL RES, V114, P265, DOI 10.1016/j.phrs.2016.11.003; Koivunen P, 2012, NATURE, V483, P485, DOI 10.1038/nature10898; Kozlova N, 2017, ONCOTARGET, V8, P9885, DOI 10.18632/oncotarget.14241; Kuchnio A, 2015, CELL REP, V12, P992, DOI 10.1016/j.celrep.2015.07.010; Laitakari A, 2019, REDOX BIOL, V22, DOI 10.1016/j.redox.2019.101145; Laitala A, 2012, BLOOD, V120, P3336, DOI 10.1182/blood-2012-07-441824; Li Z, 2014, MEDICINE, V93, DOI 10.1097/MD.0000000000000179; Liu ZW, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.00477; Loenarz C, 2011, EMBO REP, V12, P63, DOI 10.1038/embor.2010.170; Lopez-Otin C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039; Mack FA, 2003, CANCER CELL, V3, P75, DOI 10.1016/S1535-6108(02)00240-4; McCay CM, 1935, J NUTR, V10, P63, DOI 10.1093/jn/10.1.63; Minamishima YA, 2008, BLOOD, V111, P3236, DOI 10.1182/blood-2007-10-117812; MIRRAKHIMOV MM, 1991, KARDIOLOGIYA, V31, P8; MKRTCHYAN RI, 1989, KARDIOLOGIYA, V29, P22; Myllyharju J, 2008, ANN MED, V40, P402, DOI 10.1080/07853890801986594; Myllymaki MNM, 2017, MOL CELL BIOL, V37, DOI 10.1128/MCB.00529-16; Nath B, 2011, HEPATOLOGY, V53, P1526, DOI 10.1002/hep.24256; Olson E, 2014, VASC MED, V19, P473, DOI 10.1177/1358863X14557151; Provenzano R, 2016, CLIN J AM SOC NEPHRO, V11, P982, DOI 10.2215/CJN.06890615; Provenzano R, 2016, AM J KIDNEY DIS, V67, P912, DOI 10.1053/j.ajkd.2015.12.020; Rahtu-Korpela L, 2016, ARTERIOSCL THROM VAS, V36, P608, DOI 10.1161/ATVBAHA.115.307136; Rahtu-Korpela L, 2014, DIABETES, V63, P3324, DOI 10.2337/db14-0472; Rankin EB, 2009, MOL CELL BIOL, V29, P4527, DOI 10.1128/MCB.00200-09; Salminen A, 2012, AGING-US, V4, P166, DOI 10.18632/aging.100444; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Schito L, 2016, TRENDS CANCER, V2, P758, DOI 10.1016/j.trecan.2016.10.016; Semenza GL, 2009, PHYSIOLOGY, V24, P97, DOI 10.1152/physiol.00045.2008; Snyder JM, 2016, VET PATHOL, V53, P233, DOI 10.1177/0300985815610391; Song LP, 2008, ONCOGENE, V27, P519, DOI 10.1038/sj.onc.1210670; Strasak AM, 2007, CANCER CAUSE CONTROL, V18, P1021, DOI 10.1007/s10552-007-9043-3; Takeda K, 2008, BLOOD, V111, P3229, DOI 10.1182/blood-2007-09-114561; Tao YF, 2016, INT J BIOCHEM CELL B, V77, P129, DOI 10.1016/j.biocel.2016.05.022; Veniant MM, 1998, J CLIN INVEST, V102, P1559, DOI 10.1172/JCI4164; Voss JD, 2013, INT J OBESITY, V37, P1407, DOI 10.1038/ijo.2013.5; Xie C, 2017, NAT MED, V23, P1298, DOI 10.1038/nm.4412; Yeh TL, 2017, CHEM SCI, V8, P7651, DOI 10.1039/c7sc02103h; Zhao G, 2013, ATHEROSCLEROSIS, V231, P61, DOI 10.1016/j.atherosclerosis.2013.08.023	73	6	6	1	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2020	34	4					5590	5609		10.1096/fj.201902331R	http://dx.doi.org/10.1096/fj.201902331R		FEB 2020	20	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	LJ5ZA	32100354	Green Submitted, Bronze			2022-12-26	WOS:000517899100001
J	Walczyk, A; Kopczynski, J; Gasior-Perczak, D; Palyga, I; Kowalik, A; Chrapek, M; Hejnold, M; Gozdz, S; Kowalska, A				Walczyk, Agnieszka; Kopczynski, Janusz; Gasior-Perczak, Danuta; Palyga, Iwona; Kowalik, Artur; Chrapek, Magdalena; Hejnold, Maria; Gozdz, Stanislaw; Kowalska, Aldona			Histopathology and immunohistochemistry as prognostic factors for poorly differentiated thyroid cancer in a series of Polish patients	PLOS ONE			English	Article							ROUTINE HISTOLOGIC SECTIONS; TURIN PROPOSAL; CARCINOMA; PAPILLARY; MITOSIS; INDEX	Background Poorly differentiated thyroid cancer (PDTC) is a rare but aggressive type of thyroid cancer (TC) and the main cause of death from non-anaplastic follicular cell-derived TC. Although the Turin criteria are well defined, the pathological features that could serve as diagnostic and prognostic factors remain controversial. Materials and methods Forty-nine consecutive PDTC cases were identified in a single cancer center between 2000 and 2018. We analyzed the impact of routine histopathological and immunohistochemical features and several parameters that are not routinely included in pathology reports such as the presence of atypical mitoses, the amount of necrosis, or insulin-like growth factor-II mRNA-binding protein 3 immunostaining on the survival of patients with PDTC. Overall survival (OS) and disease-specific survival (DSS) were calculated using the Kaplan-Meier method. Results Of the 49 PDTC 34 (69.4%) showed the insular pattern of growth. The median of poorly differentiated area was 95% (range, 1-100), and 30 (61.2%) patients had a predominant (> 50%) insular area. The 5-year OS and DSS rates at a median follow-up of 57 months were 60.6% and 64.3%, respectively. Univariate analysis showed that tumor size > 4 cm, presence of atypical mitoses, Ki-67 > 5%, and thyroglobulin (Tg)-negative immunostaining were associated with a higher risk of PDTC-related death. Atypical mitoses and Tg negativity were independent factors of worse DSS in multivariate analysis. Patients with insular and predominant insular areas showed a 3- and 6-fold higher risk of PDTC death when they displayed atypical mitoses. Conclusions In PDTC, the presence of atypical mitoses may be helpful in identifying patients with poorer outcome and worth including in pathology reports, particularly in tumors with a dominant insular pattern of growth. Additionally, the inclusion of Tg immunostaining may be considered in a prognostic context, and not only as a diagnostic feature.	[Walczyk, Agnieszka; Gasior-Perczak, Danuta; Palyga, Iwona; Kowalska, Aldona] Holycross Canc Ctr, Endocrinol Clin, Kielce, Poland; [Walczyk, Agnieszka; Gasior-Perczak, Danuta; Palyga, Iwona; Gozdz, Stanislaw; Kowalska, Aldona] Jan Kochanowski Univ Humanities & Sci, Coll Med, Kielce, Poland; [Kopczynski, Janusz; Hejnold, Maria] Holycross Canc Ctr, Dept Surg Pathol, Kielce, Poland; [Kowalik, Artur] Holycross Canc Ctr, Dept Mol Diagnost, Kielce, Poland; [Chrapek, Magdalena] Jan Kochanowski Univ Humanities & Sci, Fac Nat Sci, Kielce, Poland; [Gozdz, Stanislaw] Holycross Canc Ctr, Clin Oncol Clin, Kielce, Poland	Jan Kochanowski University; Jan Kochanowski University	Walczyk, A (corresponding author), Holycross Canc Ctr, Endocrinol Clin, Kielce, Poland.; Walczyk, A (corresponding author), Jan Kochanowski Univ Humanities & Sci, Coll Med, Kielce, Poland.	a.walczyk@post.pl	KOWALSKA, ALDONA/AAE-9040-2021; Walczyk, Agnieszka/ABC-3334-2020; Gąsior-Perczak, Danuta/AAM-2668-2020; Gozdz, Stanislaw/D-3300-2013; Kowalik, Artur/K-2111-2017	KOWALSKA, ALDONA/0000-0001-5647-5898; Gąsior-Perczak, Danuta/0000-0003-0936-4890; Gozdz, Stanislaw/0000-0001-6902-3807; Kowalik, Artur/0000-0002-3718-999X; Palyga, Iwona/0000-0001-5333-6112; Chrapek, Magdalena/0000-0003-2480-6124; Walczyk, Agnieszka/0000-0002-5083-659X	 [024/RID/2018/19]		Project financed under the program of the Minister of Science and Higher Education called "Regional Initiative of Excellence" in the years, project no 024/RID/2018/19, amount of financing 11 999 000.00 zl.	[Anonymous], AJCC CANC STAGING MA; Asioli S, 2010, MODERN PATHOL, V23, P1269, DOI 10.1038/modpathol.2010.117; Baloch Z, 2018, ENDOCR PATHOL, V29, P91, DOI 10.1007/s12022-018-9532-9; CARCANGIU ML, 1984, AM J SURG PATHOL, V8, P655, DOI 10.1097/00000478-198409000-00005; Cherkaoui GS, 2015, PAN AFR MED J, V21, DOI 10.11604/pamj.2015.21.137.6720; de la Fouchardiere C, 2018, EUR J CANCER, V92, P40, DOI 10.1016/j.ejca.2017.12.027; DeLellis R.A., 2004, WHO CLASSIFICATION T, P73; Dettmer M, 2012, HISTOPATHOLOGY, V60, P1045, DOI 10.1111/j.1365-2559.2012.04188.x; Dettmer M, 2011, AM J SURG PATHOL, V35, P1866, DOI 10.1097/PAS.0b013e31822cf962; Gnemmi V, 2014, HISTOPATHOLOGY, V64, P263, DOI 10.1111/his.12246; Habougit C, 2017, VIRCHOWS ARCH, V470, P639, DOI 10.1007/s00428-017-2109-z; Haugen BR, 2016, THYROID, V26, P1, DOI 10.1089/thy.2015.0020; Hiltzik D, 2006, CANCER-AM CANCER SOC, V106, P1286, DOI 10.1002/cncr.21739; Ibrahimpasic T, 2014, J CLIN ENDOCR METAB, V99, P1245, DOI 10.1210/jc.2013-3842; Ibrahimpasic T, 2019, THYROID, V29, P311, DOI 10.1089/thy.2018.0509; Kakudo K, 2009, PATHOL INT, V59, P359, DOI 10.1111/j.1440-1827.2009.02378.x; Kowalska A, 2016, THYROID, V26, P543, DOI 10.1089/thy.2015.0352; La Vecchia C, 2015, INT J CANCER, V136, P2187, DOI 10.1002/ijc.29251; Lancia I, 2016, J CLIN INVEST, V126, P1052, DOI 10.1172/JCI85271; Matsuda Y, 2016, PANCREATOLOGY, V16, P127, DOI 10.1016/j.pan.2015.10.005; Montgomery E, 2003, CANCER BIOL THER, V2, P248, DOI 10.4161/cbt.2.3.362; Morris LGT, 2013, THYROID, V23, P886, DOI 10.1089/thy.2013.0045; Ohashi R, 2018, J SURG ONCOL, V118, P557, DOI 10.1002/jso.25152; ROSAI J, 1992, ATLAS TUMOR PATHOL, P161; SAKAMOTO A, 1983, CANCER, V52, P1849, DOI 10.1002/1097-0142(19831115)52:10<1849::AID-CNCR2820521015>3.0.CO;2-X; Sanders EM, 2007, WORLD J SURG, V31, P934, DOI 10.1007/s00268-007-9033-3; Setia Namrata, 2014, Surg Pathol Clin, V7, P475, DOI 10.1016/j.path.2014.08.001; Tallini G, 2017, WHO CLASSIFICATION T, P100; Tisell LE, 2003, BRIT J CANCER, V89, P2093, DOI 10.1038/sj.bjc.6601453; Volante M, 2004, CANCER-AM CANCER SOC, V100, P950, DOI 10.1002/cncr.20087; Volante M, 2007, AM J SURG PATHOL, V31, P1256, DOI 10.1097/PAS.0b013e3180309e6a; Volante M, 2016, SEMIN DIAGN PATHOL, V33, P277, DOI 10.1053/j.semdp.2016.05.007; Volante M, 2010, ENDOCR PATHOL, V21, P1, DOI 10.1007/s12022-009-9100-4; Walczyk A, 2019, CLIN ENDOCRINOL, V91, P331, DOI 10.1111/cen.13910; Walczyk A, 2010, ENDOKRYNOL POL, V61, P467; Wojciechowska U, CANC INCIDENCE MORTA	36	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2020	15	2							e0229264	10.1371/journal.pone.0229264	http://dx.doi.org/10.1371/journal.pone.0229264			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8DW	32092093	Green Published, gold			2022-12-26	WOS:000535229300041
J	Levy, DR; Udgata, A; Tourlomousis, P; Symmons, MF; Hopkins, LJ; Bryant, CE; Gay, NJ				Levy, Daniel R.; Udgata, Atul; Tourlomousis, Panagiotis; Symmons, Martyn F.; Hopkins, Lee J.; Bryant, Clare E.; Gay, Nicholas J.			The Parkinson's disease-associated kinase LRRK2 regulates genes required for cell adhesion, polarization, and chemotaxis in activated murine macrophages	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						transcriptomics; Parkinson's disease; macrophage; protein kinase; guanine nucleotide exchange factor (GEF)	NICOTINIC-ACID; EXPRESSION; CHEMOKINES; MUTATION; GPR109A; SYSTEM; TARGET; LIVER; LPS; MYC	Leucine-rich repeat kinase 2 (LRRK2) encodes a complex protein that includes kinase and GTPase domains. Genome-wide association studies have identified dominantLRRK2alleles that predispose their carriers to late-onset idiotypic Parkinson's disease (PD) and also to autoimmune disorders such as Crohn's disease. Considerable evidence indicates that PD initiation and progression involve activation of innate immune functions in microglia, which are brain-resident macrophages. Here we asked whether LRRK2 modifies inflammatory signaling and how this modification might contribute to PD and Crohn's disease. We used RNA-Seq-based high-resolution transcriptomics to compare gene expression in activated primary macrophages derived from WT andLrrk2knockout mice. Remarkably, expression of a single gene, Rap guanine nucleotide exchange factor 3 (Rapgef3), was strongly up-regulated in the absence of LRRK2 and down-regulated in its presence. We observed similar regulation ofRapgef3expression in cells treated with a highly specific inhibitor of LRRK2 protein kinase activity.Rapgef3encodes an exchange protein, activated by cAMP 1 (EPAC-1), a guanine nucleotide exchange factor that activates the small GTPase Rap-1. Rap-1 mediates cell adhesion, polarization, and directional motility, and our results indicate that LRRK2 modulates chemotaxis of microglia and macrophages. Dominant PD-associatedLRRK2alleles may suppress EPAC-1 activity, further restricting motility and preventing efficient migration of microglia to sites of neuronal damage. Functional analysisin vivoin a subclinical infection model also indicated that Lrrk2 subtly modifies the inflammatory response. These results indicate that LRRK2 modulates the expression of genes involved in murine immune cell chemotaxis.	[Levy, Daniel R.; Udgata, Atul; Symmons, Martyn F.; Gay, Nicholas J.] Univ Cambridge, Dept Biochem, Tennis Court Rd, Cambridge CB2 1GA, England; [Tourlomousis, Panagiotis; Hopkins, Lee J.; Bryant, Clare E.] Univ Cambridge, Dept Vet Med, Madingley Rd, Cambridge CB3 0ES, England	University of Cambridge; University of Cambridge	Gay, NJ (corresponding author), Univ Cambridge, Dept Biochem, Tennis Court Rd, Cambridge CB2 1GA, England.	njg11@cam.ac.uk		Levy, Daniel/0000-0002-4660-8615; Bryant, Clare Elizabeth/0000-0002-2924-0038	Wellcome Trust [WT100321/z/12/Z, 108045/Z/15/Z]	Wellcome Trust(Wellcome Trust)	This work was supported by Wellcome Trust Investigator awards WT100321/z/12/Z and 108045/Z/15/Z (to C. E. B. and N. J. G.). The authors declare that they have no conflicts of interest with the contents of this article.	Akagi K, 2008, GENOME RES, V18, P869, DOI 10.1101/gr.075770.107; Akram IG, 2016, TUMOR BIOL, V37, P2461, DOI 10.1007/s13277-015-4089-4; Banerjee U, 2015, GENE, V570, P157, DOI 10.1016/j.gene.2015.06.063; Cascon A, 2012, CANCER RES, V72, P3119, DOI 10.1158/0008-5472.CAN-11-3891; Castano A, 2002, J NEUROCHEM, V81, P150, DOI 10.1046/j.1471-4159.2002.00799.x; Choi I, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9255; Devine MJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022489; Di Fonzo A, 2005, LANCET, V365, P412; Digby JE, 2012, ARTERIOSCL THROM VAS, V32, P669, DOI 10.1161/ATVBAHA.111.241836; Dzamko N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039132; Gardet A, 2010, J IMMUNOL, V185, P5577, DOI 10.4049/jimmunol.1000548; Gilchrist M, 2006, NATURE, V441, P173, DOI 10.1038/nature04768; Gilks WP, 2005, LANCET, V365, P415, DOI 10.1016/S0140-6736(05)17830-1; Gingras S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000808; Greggio E, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-94; Iravani MM, 2005, EUR J NEUROSCI, V22, P317, DOI 10.1111/j.1460-9568.2005.04220.x; Ishiguro H, 2001, ONCOGENE, V20, P5062, DOI 10.1038/sj.onc.1204603; Jang H, 2009, BBA-MOL BASIS DIS, V1792, P714, DOI 10.1016/j.bbadis.2008.08.001; Karin M, 1999, ONCOGENE, V18, P6867, DOI 10.1038/sj.onc.1203219; Linde L, 2007, EUR J HUM GENET, V15, P1156, DOI 10.1038/sj.ejhg.5201889; Liu H, 2012, NAT CELL BIOL, V14, P567, DOI 10.1038/ncb2491; Lorenowicz MJ, 2006, J LEUKOCYTE BIOL, V80, P1542, DOI 10.1189/jlb.0506357; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Luerman GC, 2014, J NEUROCHEM, V128, P561, DOI 10.1111/jnc.12483; Lukasova M, 2011, TRENDS PHARMACOL SCI, V32, P700, DOI 10.1016/j.tips.2011.08.002; Ma B, 2016, HUM MOL GENET, V25, P3515, DOI 10.1093/hmg/ddw194; Marin I, 2008, FASEB J, V22, P3103, DOI 10.1096/fj.08-111310; Mastroeni P, 2000, J EXP MED, V192, P237, DOI 10.1084/jem.192.2.237; Migeotte I, 2002, EUR J IMMUNOL, V32, P494, DOI 10.1002/1521-4141(200202)32:2<494::AID-IMMU494>3.0.CO;2-Y; Mills RD, 2014, HUM MUTAT, V35, P395, DOI 10.1002/humu.22515; Murray PJ, 2011, NAT REV IMMUNOL, V11, P723, DOI 10.1038/nri3073; Nakamura T, 1998, GENES CELLS, V3, P395, DOI 10.1046/j.1365-2443.1998.00198.x; Nichols WC, 2005, LANCET, V365, P410, DOI 10.1016/S0140-6736(05)17828-3; Niehaus I, 2003, OCCUP ENVIRON MED, V60, P378, DOI 10.1136/oem.60.5.378; Parisiadou L, 2009, J NEUROSCI, V29, P13971, DOI 10.1523/JNEUROSCI.3799-09.2009; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Qin LY, 2007, GLIA, V55, P453, DOI 10.1002/glia.20467; Reith AD, 2012, BIOORG MED CHEM LETT, V22, P5625, DOI 10.1016/j.bmcl.2012.06.104; Robichaux WG, 2018, PHYSIOL REV, V98, P919, DOI 10.1152/physrev.00025.2017; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Roy A, 2016, SCI REP-UK, V6, DOI 10.1038/srep22067; Russo I, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0449-7; Spandidos A, 2010, NUCLEIC ACIDS RES, V38, pD792, DOI 10.1093/nar/gkp1005; Thevenet J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021519; Turner MD, 2014, BBA-MOL CELL RES, V1843, P2563, DOI 10.1016/j.bbamcr.2014.05.014; Wakade C, 2014, J NEUROL SCI, V347, P34, DOI 10.1016/j.jns.2014.10.024; Wakade C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109818; Yi L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030404; Yoshimura T, 2011, EXP CELL RES, V317, P674, DOI 10.1016/j.yexcr.2010.10.023; Zandi-Nejad K, 2013, FASEB J, V27, P4366, DOI 10.1096/fj.12-223933; Zlotnik A, 2000, IMMUNITY, V12, P121, DOI 10.1016/S1074-7613(00)80165-X	51	6	6	1	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 31	2020	295	31					10857	10867		10.1074/jbc.RA119.011842	http://dx.doi.org/10.1074/jbc.RA119.011842			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NB3HM	32111741	Green Published, hybrid, Green Submitted			2022-12-26	WOS:000560405600027
J	Zamanian-Daryoush, M; Gogonea, V; DiDonato, AJ; Buffa, JA; Choucair, I; Levison, BS; Hughes, RA; Ellington, AD; Huang, Y; Li, XMS; DiDonato, JA; Hazen, SL				Zamanian-Daryoush, Maryam; Gogonea, Valentin; DiDonato, Anthony J.; Buffa, Jennifer A.; Choucair, Ibrahim; Levison, Bruce S.; Hughes, Randall A.; Ellington, Andrew D.; Huang, Ying; Li, Xinmin S.; DiDonato, Joseph A.; Hazen, Stanley L.			Site-specific 5-hydroxytryptophan incorporation into apolipoprotein A-I impairs cholesterol efflux activity and high-density lipoprotein biogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						apolipoprotein; cholesterol; recombinant protein expression; atherosclerosis; synthetic biology; tryptophan; apolipoprotein A-I dysfunction; genetic code expansion; non-canonical amino acids; orthogonal translation; posttranslational modification; cardiovascular disease; high-density lipoprotein (HDL); coronary artery disease	MYELOPEROXIDASE-CATALYZED OXIDATION; HYPOCHLOROUS ACID; ARTERY WALL; LIPID RAFTS; MOUSE MODEL; APOA-I; HDL; ATHEROSCLEROSIS; DISEASE; ABCA1	Apolipoprotein A-I (apoA-I) is the major protein constituent of high-density lipoprotein (HDL) and a target of myeloperoxidase-dependent oxidation in the artery wall. In atherosclerotic lesions, apoA-I exhibits marked oxidative modifications at multiple sites, including Trp(72). Site-specific mutagenesis studies have suggested, but have not conclusively shown, that oxidative modification of Trp(72) of apoA-I impairs many atheroprotective properties of this lipoprotein. Herein, we used genetic code expansion technology with an engineered Saccharomyces cerevisiae tryptophanyl tRNA-synthetase (Trp-RS):suppressor tRNA pair to insert the noncanonical amino acid 5-hydroxytryptophan (5-OHTrp) at position 72 in recombinant human apoA-I and confirmed site-specific incorporation utilizing MS. In functional characterization studies, 5-OHTrp(72) apoA-I (compared with WT apoA-I) exhibited reduced ABC subfamily A member 1 (ABCA1)-dependent cholesterol acceptor activity in vitro (41.73 ? 6.57% inhibition; p < 0.01). Additionally, 5-OHTrp(72) apoA-I displayed increased activation and stabilization of paraoxonase 1 (PON1) activity (?mol/min/mg) when compared with WT apoA-I and comparable PON1 activation/stabilization compared with reconstituted HDL (WT apoA-I, 1.92 ? 0.04; 5-OHTrp(72) apoA-I, 2.35 ? 0.0; and HDL, 2.33 ? 0.1; p < 0.001, p < 0.001, and p < 0.001, respectively). Following injection into apoA-I?deficient mice, 5-OHTrp(72) apoA-I reached plasma levels comparable with those of native apoA-I yet exhibited significantly reduced (48%; p < 0.01) lipidation and evidence of HDL biogenesis. Collectively, these findings unequivocally reveal that site-specific oxidative modification of apoA-I via 5-OHTrp at Trp(72) impairs cholesterol efflux and the rate-limiting step of HDL biogenesis both in vitro and in vivo.	[Zamanian-Daryoush, Maryam; Gogonea, Valentin; DiDonato, Anthony J.; Buffa, Jennifer A.; Choucair, Ibrahim; Levison, Bruce S.; Huang, Ying; Li, Xinmin S.; DiDonato, Joseph A.; Hazen, Stanley L.] Cleveland Clin, Lerner Res Inst, Dept Cardiovasc & Metab Sci, NC10,9500 Euclid Ave, Cleveland, OH 44195 USA; [Zamanian-Daryoush, Maryam; Gogonea, Valentin; DiDonato, Anthony J.; Buffa, Jennifer A.; Choucair, Ibrahim; Huang, Ying; Li, Xinmin S.; DiDonato, Joseph A.; Hazen, Stanley L.] Cleveland Clin, Ctr Microbiome & Human Hlth, Cleveland, OH 44195 USA; [Hazen, Stanley L.] Cleveland Clin, Heart & Vasc Inst, Cleveland, OH 44195 USA; [Gogonea, Valentin; Choucair, Ibrahim] Cleveland State Univ, Dept Chem, Cleveland, OH 44115 USA; [Hughes, Randall A.] Univ Texas Austin, US Army, Res Lab South, Austin, TX 78712 USA; [Ellington, Andrew D.] Univ Texas Austin, Ctr Syst & Synthet Biol, Austin, TX 78712 USA	Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cleveland Clinic Foundation; University System of Ohio; Cleveland State University; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin	Hazen, SL (corresponding author), Cleveland Clin, Lerner Res Inst, Dept Cardiovasc & Metab Sci, NC10,9500 Euclid Ave, Cleveland, OH 44195 USA.	hazens@ccf.org	Hazen, Stanley L/ABD-5845-2021	Choucair, Ibrahim/0000-0003-3540-2811; Levison, Bruce/0000-0002-1816-368X	National Institutes of Health [R01 HL128300, R01 HL103866, P01 H147823, S10OD016346]; Astra Zeneca; PG; Roche Diagnostics; Pfizer Inc.	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Astra Zeneca(AstraZeneca); PG; Roche Diagnostics; Pfizer Inc.(Pfizer)	This work was supported by National Institutes of Health Grants R01 HL128300, R01 HL103866, and P01 H147823 (to S. L. H.) and S10OD016346 (to J. A. D.). S. L. H. is named as an inventor on pending and issued patents held by the Cleveland Clinic relating to cardiovascular diagnostics or therapeutics. S. L. H. reports having the right to receive royalty payment for inventions or discoveries related to cardiovascular diagnostics from Cleveland Heart Lab, Inc. S. L. H. also reports having been paid as a consultant for P&G and receiving research funds from Astra Zeneca, P&G, Pfizer Inc., and Roche Diagnostics. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aharoni A, 2004, P NATL ACAD SCI USA, V101, P482, DOI 10.1073/pnas.2536901100; Arciello A, 2016, FEBS LETT, V590, P4171, DOI 10.1002/1873-3468.12468; BADIMON JJ, 1990, J CLIN INVEST, V85, P1234, DOI 10.1172/JCI114558; Barter PJ, 2007, NEW ENGL J MED, V357, P2109, DOI 10.1056/NEJMoa0706628; Barter PJ, 2004, CIRC RES, V95, P764, DOI 10.1161/01.RES.0000146094.59640.13; Beck WHJ, 2013, BBA-BIOMEMBRANES, V1828, P1503, DOI 10.1016/j.bbamem.2013.02.009; Bergt C, 2004, P NATL ACAD SCI USA, V101, P13032, DOI 10.1073/pnas.0405292101; Bhattacharyya T, 2008, JAMA-J AM MED ASSOC, V299, P1265, DOI 10.1001/jama.299.11.1265; Black LL, 2015, J IMMUNOL, V195, P4685, DOI 10.4049/jimmunol.1500806; Boden WE, 2011, NEW ENGL J MED, V365, P2255, DOI 10.1056/NEJMoa1107579; Catapano AL, 2014, CARDIOVASC RES, V103, P372, DOI 10.1093/cvr/cvu150; Das M, 2016, J MOL BIOL, V428, P449, DOI 10.1016/j.jmb.2015.10.029; Das M, 2014, FEBS J, V281, P2525, DOI 10.1111/febs.12809; DAUGHERTY A, 1994, J CLIN INVEST, V94, P437, DOI 10.1172/JCI117342; de Souza JA, 2010, J CELL MOL MED, V14, P608, DOI 10.1111/j.1582-4934.2009.00713.x; Di Angelantonio E, 2009, JAMA-J AM MED ASSOC, V302, P1993, DOI 10.1001/jama.2009.1619; DiDonato JA, 2014, J BIOL CHEM, V289, P10276, DOI 10.1074/jbc.M114.556506; DiDonato JA, 2013, CIRCULATION, V128, P1644, DOI 10.1161/CIRCULATIONAHA.113.002624; Duffy D, 2009, NAT REV CARDIOL, V6, P455, DOI 10.1038/nrcardio.2009.94; Ellefson JW, 2014, NAT BIOTECHNOL, V32, P97, DOI 10.1038/nbt.2714; Feig JE, 2014, ANN GLOB HEALTH, V80, P13, DOI 10.1016/j.aogh.2013.12.001; Feig JE, 2014, CIRC RES, V114, P205, DOI 10.1161/CIRCRESAHA.114.300760; Fisher EA, 2012, ARTERIOSCL THROM VAS, V32, P2813, DOI 10.1161/ATVBAHA.112.300133; Fuhrman B, 2010, ATHEROSCLEROSIS, V211, P61, DOI 10.1016/j.atherosclerosis.2010.01.025; Gaddis DE, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03493-5; GORDON T, 1977, AM J MED, V62, P707, DOI 10.1016/0002-9343(77)90874-9; Gross E, 2006, BIOPHYS J, V90, P1362, DOI 10.1529/biophysj.105.075069; Guo L, 2013, J BIOL CHEM, V288, P17947, DOI 10.1074/jbc.M112.442699; Hammill JT, 2007, NAT PROTOC, V2, P2601, DOI 10.1038/nprot.2007.379; Hazen SL, 1997, J CLIN INVEST, V99, P2075, DOI 10.1172/JCI119379; Hewing B, 2014, ARTERIOSCL THROM VAS, V34, P779, DOI 10.1161/ATVBAHA.113.303044; Huang Y, 2014, NAT MED, V20, P193, DOI 10.1038/nm.3459; Huang Y, 2013, J CLIN INVEST, V123, P3815, DOI 10.1172/JCI67478; Italia JS, 2017, NAT CHEM BIOL, V13, P446, DOI 10.1038/nchembio.2312; Kaul S, 2016, J AM HEART ASSOC, V5, DOI 10.1161/JAHA.116.004401; Khera AV, 2011, NEW ENGL J MED, V364, P127, DOI 10.1056/NEJMoa1001689; Kim KD, 2005, BIOCHEM BIOPH RES CO, V338, P1126, DOI 10.1016/j.bbrc.2005.10.065; Kontush A, 2015, HANDB EXP PHARMACOL, V224, P3, DOI 10.1007/978-3-319-09665-0_1; Koyama M, 2009, BIOCHEMISTRY-US, V48, P2529, DOI 10.1021/bi802317v; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lewis GF, 2005, CIRC RES, V96, P1221, DOI 10.1161/01.RES.0000170946.56981.5c; Lewis TL, 2010, J BIOL CHEM, V285, P36958, DOI 10.1074/jbc.M110.127829; Ma J, 2004, ACTA BIOCH BIOPH SIN, V36, P419, DOI 10.1093/abbs/36.6.419; Mamat U, 2015, MICROB CELL FACT, V14, DOI 10.1186/s12934-015-0241-5; Melchior JT, 2017, NAT STRUCT MOL BIOL, V24, P1093, DOI 10.1038/nsmb.3501; Miyake-Stoner SJ, 2010, BIOCHEMISTRY-US, V49, P1667, DOI 10.1021/bi901947r; Navab M, 2011, NAT REV CARDIOL, V8, P222, DOI 10.1038/nrcardio.2010.222; NELSON DP, 1972, ANAL BIOCHEM, V49, P474, DOI 10.1016/0003-2697(72)90451-4; Nissen SE, 2007, NEW ENGL J MED, V356, P1304, DOI 10.1056/NEJMoa070635; Oram JF, 2000, J BIOL CHEM, V275, P34508, DOI 10.1074/jbc.M006738200; Ouimet M, 2019, CIRC RES, V124, P1505, DOI 10.1161/CIRCRESAHA.119.312617; Pedelacq JD, 2006, NAT BIOTECHNOL, V24, P79, DOI 10.1038/nbt1172; Peng DQ, 2008, ARTERIOSCL THROM VAS, V28, P2063, DOI 10.1161/ATVBAHA.108.173815; Pennathur S, 2004, J BIOL CHEM, V279, P42977, DOI 10.1074/jbc.M406762200; PLUMP AS, 1994, P NATL ACAD SCI USA, V91, P9607, DOI 10.1073/pnas.91.20.9607; Pollard RD, 2016, BIOCHEMISTRY-US, V55, P4971, DOI 10.1021/acs.biochem.6b00347; Porter JJ, 2018, OXID MED CELL LONGEV, V2018, DOI 10.1155/2018/7607463; RUBIN EM, 1991, NATURE, V353, P265, DOI 10.1038/353265a0; Shao BH, 2014, CIRC RES, V114, P1733, DOI 10.1161/CIRCRESAHA.114.303454; Shao BH, 2010, J LIPID RES, V51, P1849, DOI 10.1194/jlr.M004085; Shao BH, 2010, CHEM RES TOXICOL, V23, P447, DOI 10.1021/tx9003775; Shao BH, 2006, J BIOL CHEM, V281, P9001, DOI 10.1074/jbc.C600011200; Shao BH, 2005, J BIOL CHEM, V280, P29311, DOI 10.1074/jbc.M504040200; Sorci-Thomas MG, 2012, ARTERIOSCL THROM VAS, V32, P2561, DOI 10.1161/ATVBAHA.112.300135; Sorci-Thomas MG, 2012, J LIPID RES, V53, P1890, DOI 10.1194/jlr.M026674; Stahlman M, 2008, J LIPID RES, V49, P481, DOI 10.1194/jlr.D700025-JLR200; Su F, 2010, P NATL ACAD SCI USA, V107, P19997, DOI 10.1073/pnas.1009010107; Sultana A, 2016, FASEB J, V30, P2324, DOI 10.1096/fj.201500026R; Tang WHW, 2012, ARTERIOSCL THROM VAS, V32, P2803, DOI 10.1161/ATVBAHA.112.253930; Tavori H, 2015, J LIPID RES, V56, P635, DOI 10.1194/jlr.M056408; Thacker SG, 2016, IMMUNOLOGY, V149, P306, DOI 10.1111/imm.12638; Todorovski T, 2011, J PEPT SCI, V17, P256, DOI 10.1002/psc.1322; Umemoto T, 2013, CIRC RES, V112, P1345, DOI 10.1161/CIRCRESAHA.111.300581; Undurti A, 2009, J BIOL CHEM, V284, P30825, DOI 10.1074/jbc.M109.047605; Vizcaino JA, 2014, NAT BIOTECHNOL, V32, P223, DOI 10.1038/nbt.2839; Voight BF, 2012, LANCET, V380, P572, DOI 10.1016/S0140-6736(12)60312-2; Yamada H, 2017, BIOCHEM BIOPH RES CO, V484, P403, DOI 10.1016/j.bbrc.2017.01.138; Zamanian-Daryoush M, 2015, FRONT PHARMACOL, V6, DOI 10.3389/fphar.2015.00265; Zamanian-Daryoush M, 2013, J BIOL CHEM, V288, P21237, DOI 10.1074/jbc.M113.468967; Zhang ZW, 2004, P NATL ACAD SCI USA, V101, P8882, DOI 10.1073/pnas.0307029101; Zheng L, 2005, J BIOL CHEM, V280, P38, DOI 10.1074/jbc.M407019200; Zheng LM, 2004, J CLIN INVEST, V114, P529, DOI 10.1172/JCI200421109; Zhou L, 2016, AMINO ACIDS, V48, P1309, DOI 10.1007/s00726-016-2186-3	83	11	15	0	10	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 10	2020	295	15					4836	4848		10.1074/jbc.RA119.012092	http://dx.doi.org/10.1074/jbc.RA119.012092			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LE7FC	32098873	Green Published, hybrid			2022-12-26	WOS:000526887000008
J	Aistleitner, K; Sieper, T; Sturz, I; Jeske, R; Tritscheller, S; Mantel, S; Tscherne, A; Zange, S; Stoecker, K; Wolfel, R				Aistleitner, Karin; Sieper, Tina; Stuerz, Inga; Jeske, Rimma; Tritscheller, Susanne; Mantel, Sonja; Tscherne, Alina; Zange, Sabine; Stoecker, Kilian; Woelfel, Roman			NOTIFy (non-toxic lyophilized field)-FISH for the identification of biological agents by Fluorescence in situ Hybridization	PLOS ONE			English	Article							16S RIBOSOMAL-RNA; BACILLUS-ANTHRACIS SPORES; RAPID IDENTIFICATION; OLIGONUCLEOTIDE PROBES; VEGETATIVE CELLS; BLOOD CULTURES; FISH; PCR; BACTERIA; DIAGNOSIS	The rapid and reliable diagnostics of highly pathogenic bacteria under restricted field conditions poses one of the major challenges to medical biodefense, especially since false positive or false negative reports might have far-reaching consequences. Fluorescence in situ hybridization (FISH) has the potential to represent a powerful microscopy-based addition to the existing molecular-based diagnostic toolbox. In this study, we developed a set of FISH-probes for the fast, matrix independent and simultaneous detection of thirteen highly pathogenic bacteria in different environmental and clinical sample matrices. Furthermore, we substituted formamide, a routinely used chemical that is toxic and volatile, by non-toxic urea. This will facilitate the application of FISH under resource limited field laboratory conditions. We demonstrate that hybridizations performed with urea show the same specificity and comparable signal intensities for the FISH-probes used in this study. To further simplify the use of FISH in the field, we lyophilized the reagents needed for FISH. The signal intensities obtained with these lyophilized reagents are comparable to freshly prepared reagents even after storage for a month at room temperature. Finally, we show that by the use of non-toxic lyophilized field (NOTIFy)-FISH, specific detection of microorganisms with simple and easily transportable equipment is possible in the field.	[Aistleitner, Karin; Sieper, Tina; Stuerz, Inga; Jeske, Rimma; Tritscheller, Susanne; Mantel, Sonja; Tscherne, Alina; Zange, Sabine; Stoecker, Kilian; Woelfel, Roman] Bundeswehr Inst Microbiol, Munich, Germany	Bundeswehr Institute of Microbiology (IMB)	Stoecker, K (corresponding author), Bundeswehr Inst Microbiol, Munich, Germany.	kilianstoecker@bundeswehr.org	Wölfel, Roman/AAQ-3977-2021	Wölfel, Roman/0000-0002-8756-7821; Stoecker, Kilian/0000-0003-3201-272X; Zange, Sabine/0000-0001-8721-9248; Jeske, Rima/0000-0003-4596-3778				Aistleitner K, 2018, J MED MICROBIOL, V67, P537, DOI 10.1099/jmm.0.000704; AMANN RI, 1990, APPL ENVIRON MICROB, V56, P1919, DOI 10.1128/AEM.56.6.1919-1925.1990; Amann R, 2008, NAT REV MICROBIOL, V6, P339, DOI 10.1038/nrmicro1888; Behnam F, 2012, APPL ENVIRON MICROB, V78, P5138, DOI 10.1128/AEM.00977-12; Bisha B, 2009, APPL ENVIRON MICROB, V75, P1450, DOI 10.1128/AEM.01944-08; Brown AR, 2007, J CLIN MICROBIOL, V45, P1920, DOI 10.1128/JCM.00147-07; Buchbinder S, 2004, INFECTION, V32, P242, DOI 10.1007/s15010-004-2127-z; CHAMBON P, 1968, J BIOL CHEM, V243, P5110; Daims H, 2006, ENVIRON MICROBIOL, V8, P200, DOI 10.1111/j.1462-2920.2005.00880.x; Daims H, 2005, FLUORESCENCE SITU HY, P213; Filion G, 2009, J MICROBIOL METH, V77, P29, DOI 10.1016/j.mimet.2008.12.009; FISCHER K, 1995, SYST APPL MICROBIOL, V18, P265, DOI 10.1016/S0723-2020(11)80397-8; Fontenete S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125494; Frickmann H, 2017, CRIT REV MICROBIOL, V43, P263, DOI 10.3109/1040841X.2016.1169990; Fuchs BM, 2000, APPL ENVIRON MICROB, V66, P3603, DOI 10.1128/AEM.66.8.3603-3607.2000; Gescher DM, 2008, DIAGN MICR INFEC DIS, V60, P99, DOI 10.1016/j.diagmicrobio.2007.07.012; Gosiewski T, 2014, BMC MICROBIOL, V14, DOI 10.1186/s12866-014-0313-4; Hagen RM, 2011, INT J MED MICROBIOL, V301, P585, DOI 10.1016/j.ijmm.2011.04.017; Henriques AO, 2007, ANNU REV MICROBIOL, V61, P555, DOI 10.1146/annurev.micro.61.080706.093224; Hogardt M, 2000, J CLIN MICROBIOL, V38, P818, DOI 10.1128/JCM.38.2.818-825.2000; Hoshino T, 2008, APPL ENVIRON MICROB, V74, P5068, DOI 10.1128/AEM.00208-08; Kempf VAJ, 2000, J CLIN MICROBIOL, V38, P830, DOI 10.1128/JCM.38.2.830-838.2000; Kenny JH, 2008, J MICROBIOL METH, V75, P293, DOI 10.1016/j.mimet.2008.06.021; Koncan R, 2015, EUR J CLIN MICROBIOL, V34, P2097, DOI 10.1007/s10096-015-2458-y; La Cono V, 2003, J MICROBIOL METH, V55, P65, DOI 10.1016/S0167-7012(03)00115-5; Laflamme C, 2009, SYST APPL MICROBIOL, V32, P323, DOI 10.1016/j.syapm.2009.03.003; Lang S, 2004, CLIN MICROBIOL INFEC, V10, P579, DOI 10.1111/j.1198-743X.2004.00821.x; Lawson TS, 2012, LETT APPL MICROBIOL, V54, P263, DOI 10.1111/j.1472-765X.2011.03197.x; Ludwig W, 2004, NUCLEIC ACIDS RES, V32, P1363, DOI 10.1093/nar/gkh293; Machado A, 2015, PEERJ, V3, DOI 10.7717/peerj.780; Mallmann C, 2010, CLIN MICROBIOL INFEC, V16, P767, DOI 10.1111/j.1469-0691.2009.02936.x; MALVAR T, 1994, J BACTERIOL, V176, P4742, DOI 10.1128/JB.176.15.4742-4749.1994; MANZ W, 1992, SYST APPL MICROBIOL, V15, P593, DOI 10.1016/S0723-2020(11)80121-9; Matthiesen SH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040675; Meier H, 1999, SYST APPL MICROBIOL, V22, P186, DOI 10.1016/S0723-2020(99)80065-4; [NATO NATO], 2000, HDB SAMPL ID BIOL CH; Peters RPH, 2006, J CLIN MICROBIOL, V44, P4186, DOI 10.1128/JCM.01085-06; Poppert S, 2005, J CLIN MICROBIOL, V43, P3390, DOI 10.1128/JCM.43.7.3390-3397.2005; Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219; Reller ME, 2007, J CLIN MICROBIOL, V45, P3802, DOI 10.1128/JCM.01127-07; Rohde A, 2017, FOOD MICROBIOL, V62, P39, DOI 10.1016/j.fm.2016.09.013; Rohde A, 2015, FOOD MICROBIOL, V46, P395, DOI 10.1016/j.fm.2014.09.002; Rovery C, 2005, J CLIN MICROBIOL, V43, P163, DOI 10.1128/JCM.43.1.163-167.2005; Schmiedel D, 2014, CLIN MICROBIOL INFEC, V20, pO538, DOI 10.1111/1469-0691.12526; Schramm A, 2002, ENVIRON MICROBIOL, V4, P1462; Simon S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054947; Splettstoesser WD, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-72; Stoecker K, 2010, APPL ENVIRON MICROB, V76, P922, DOI 10.1128/AEM.02456-09; Sunde PT, 2003, MICROBIOL-SGM, V149, P1095, DOI 10.1099/mic.0.26077-0; Thomas P, 2012, CURR MICROBIOL, V64, P130, DOI 10.1007/s00284-011-0040-0; Trebesius K, 1998, J CLIN MICROBIOL, V36, P2557, DOI 10.1128/JCM.36.9.2557-2564.1998; Turingan RS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056093; Valm AM, 2012, SYST APPL MICROBIOL, V35, P496, DOI 10.1016/j.syapm.2012.03.004; Wagner M, 1998, FEMS MICROBIOL LETT, V160, P159, DOI 10.1016/S0378-1097(97)00570-3; Wang DB, 2015, BIOSENS BIOELECTRON, V67, P608, DOI 10.1016/j.bios.2014.09.067; Weerasekara MLMAW, 2013, J MICROBIOL METH, V93, P177, DOI 10.1016/j.mimet.2013.03.007; Wellinghausen N, 2006, J CLIN MICROBIOL, V44, P1828, DOI 10.1128/JCM.44.5.1828-1830.2006; Werner G, 2007, J CLIN MICROBIOL, V45, P3421, DOI 10.1128/JCM.00179-07; Wolfel R., 2015, Eurosurveillance, V20, P21291; Yang S, 2009, J CLIN MICROBIOL, V47, P2252, DOI 10.1128/JCM.00033-09; Yilmaz LS, 2004, APPL ENVIRON MICROB, V70, P7126, DOI 10.1128/AEM.70.12.7126-7139.2004; You Y, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl175	62	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2020	15	3							e0230057	10.1371/journal.pone.0230057	http://dx.doi.org/10.1371/journal.pone.0230057			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8TR	32142548	gold, Green Published			2022-12-26	WOS:000535271600034
J	Jia, RN; Furlong, E; Gao, SA; Santos, LR; Levy, I				Jia, Ruonan; Furlong, Ellen; Gao, Sean; Santos, Laurie R.; Levy, Ifat			Learning about the Ellsberg Paradox reduces, but does not abolish, ambiguity aversion	PLOS ONE			English	Article							DECISION-MAKING; NEURAL REPRESENTATION; MODELING PREFERENCES; COGNITIVE CONTROL; RISK; UNCERTAINTY; PROBABILITY; BEHAVIOR; OPTIMISM; EMOTION	Ambiguity aversion-the tendency to avoid options whose outcome probabilities are unknown-is a ubiquitous phenomenon. While in some cases ambiguity aversion is an adaptive strategy, in many situations it leads to suboptimal decisions, as illustrated by the famous Ellsberg Paradox. Behavioral interventions for reducing ambiguity aversion should therefore be of substantial practical value. Here we test a simple intervention, aimed at reducing ambiguity aversion in an experimental design, where aversion to ambiguity leads to reduced earnings. Participants made a series of choices between a reference lottery with a 50% chance of winning $5, and another lottery, which offered more money, but whose outcome probability was either lower than 50% (risky lottery) or not fully known (ambiguous lottery). Similar to previous studies, participants exhibited both risk and ambiguity aversion in their choices. They then went through one of three interventions. Two groups of participants learned about the Ellsberg Paradox and their own suboptimal choices, either by actively calculating the objective winning probability of the ambiguous lotteries, or by observing these calculations. A control group learned about base-rate neglect, which was irrelevant to the task. Following the intervention, participants again made a series of choices under risk and ambiguity. Participants who learned about the Ellsberg Paradox were more tolerant of ambiguity, yet ambiguity aversion was not completely abolished. At the same time, these participants also exhibited reduced aversion to risk, suggesting inappropriate generalization of learning to an irrelevant decision domain. Our results highlight the challenge for behavioral interventions: generating a strong, yet specific, behavioral change.	[Jia, Ruonan; Levy, Ifat] Yale Univ, Interdept Neurosci Program, New Haven, CT 06520 USA; [Jia, Ruonan; Gao, Sean; Levy, Ifat] Yale Univ, Dept Comparat Med, New Haven, CT 06520 USA; [Furlong, Ellen] Illinois Wesleyan Univ, Dept Psychol, Bloomington, IL 61701 USA; [Santos, Laurie R.; Levy, Ifat] Yale Univ, Dept Psychol, New Haven, CT 06520 USA; [Levy, Ifat] Yale Univ, Dept Neurosci, New Haven, CT 06520 USA	Yale University; Yale University; Illinois Wesleyan University; Yale University; Yale University	Jia, RN; Levy, I (corresponding author), Yale Univ, Interdept Neurosci Program, New Haven, CT 06520 USA.; Jia, RN; Levy, I (corresponding author), Yale Univ, Dept Comparat Med, New Haven, CT 06520 USA.; Levy, I (corresponding author), Yale Univ, Dept Psychol, New Haven, CT 06520 USA.; Levy, I (corresponding author), Yale Univ, Dept Neurosci, New Haven, CT 06520 USA.	ruonan.jia@yale.edu; ifat.levy@yale.edu		Jia, Ruonan/0000-0001-5870-9336	NIH (National Institutes of Health) [R21AG049293]; NIH/NIA (National Institute on Aging) [R56AG058769]; NIH [R21AG049293, R56AG058769]	NIH (National Institutes of Health)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH/NIA (National Institute on Aging); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was partially funded by NIH (National Institutes of Health, https://www.nih.gov/) grant R21AG049293 and NIH/NIA (National Institute on Aging, https://www.nia.nih.gov/) grant R56AG058769 to Ifat Levy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Igor Berman for helping with data collection and pre-processing. The study was funded by NIH grants R21AG049293 and R56AG058769 to IL.	[Anonymous], 2015, HLTH PROT REP, V9, P1, DOI DOI 10.1186/1752-4458-9-1; [Anonymous], 2018, VOX             0919; [Anonymous], 1995, ROGERS REPORT, V7, P1; [Anonymous], 2006, ISMP MED SAF ALERT, V11, P1; Antoniou C, 2015, J BANK FINANC, V58, P57, DOI 10.1016/j.jbankfin.2015.04.009; Arnsten AFT, 2012, J AM ACAD CHILD PSY, V51, P356, DOI 10.1016/j.jaac.2012.01.008; Bach DR, 2011, J NEUROSCI, V31, P4811, DOI 10.1523/JNEUROSCI.1452-10.2011; Bach DR, 2009, J NEUROSCI, V29, P1648, DOI 10.1523/JNEUROSCI.4578-08.2009; Barnett SM, 2002, PSYCHOL BULL, V128, P612, DOI 10.1037//0033-2909.128.4.612; BASSOK M, 1990, J EXP PSYCHOL LEARN, V16, P522, DOI 10.1037/0278-7393.16.3.522; BASSOK M, 1989, J EXP PSYCHOL LEARN, V15, P153, DOI 10.1037/0278-7393.15.1.153; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; BECKER SW, 1964, J POLIT ECON, V72, P62, DOI 10.1086/258854; CAMERER C, 1992, J RISK UNCERTAINTY, V5, P325, DOI 10.1007/BF00122575; Chambers CD, 2009, NEUROSCI BIOBEHAV R, V33, P631, DOI 10.1016/j.neubiorev.2008.08.016; Charness G, 2013, J RISK UNCERTAINTY, V46, P1, DOI 10.1007/s11166-012-9157-1; Chen Z, 2008, ADV CHILD DEV BEHAV, V36, P419, DOI 10.1016/S0065-2407(08)00010-4; COHEN M, 1985, THEOR DECIS, V18, P203, DOI 10.1007/BF00134074; Cokely ET, 2009, JUDGM DECIS MAK, V4, P20; CURLEY SP, 1986, ORGAN BEHAV HUM DEC, V38, P230, DOI 10.1016/0749-5978(86)90018-X; CURLEY SP, 1985, ORGAN BEHAV HUM DEC, V36, P273, DOI 10.1016/0749-5978(85)90016-0; de Bruin WB, 2007, J PERS SOC PSYCHOL, V92, P938, DOI 10.1037/0022-3514.92.5.938; De Rosario-Martinez H., 2015, PHIA POSTHOC INTERAC; Defazio Giovanni, 2013, Tremor Other Hyperkinet Mov (N Y), V3, DOI 10.7916/D8QN65GQ; Derrfuss J, 2005, HUM BRAIN MAPP, V25, P22, DOI 10.1002/hbm.20127; Dimmock SG, 2016, J FINANC ECON, V119, P559, DOI 10.1016/j.jfineco.2016.01.003; ELLSBERG D, 1961, Q J ECON, V75, P643, DOI 10.2307/1884324; FOX CR, 1995, Q J ECON, V110, P585, DOI 10.2307/2946693; Frederick S, 2002, J ECON LIT, V40, P351, DOI 10.1257/002205102320161311; Frisch D., 1988, J BEHAVIORAL DECISIO, V1, P149, DOI [DOI 10.1002/BDM.3960010303, 10.1002/bdm.3960010303]; Gentner D, 1997, AM PSYCHOL, V52, P45, DOI 10.1037/0003-066X.52.1.45; Gentner D, 2003, J EDUC PSYCHOL, V95, P393, DOI 10.1037/0022-0663.95.2.393; GICK ML, 1983, COGNITIVE PSYCHOL, V15, P1, DOI 10.1016/0010-0285(83)90002-6; GICK ML, 1980, COGNITIVE PSYCHOL, V12, P306, DOI 10.1016/0010-0285(80)90013-4; Glimcher PW, 2009, NEUROECONOMICS: DECISION MAKING AND THE BRAIN, P1; Hackman DA, 2009, TRENDS COGN SCI, V13, P65, DOI 10.1016/j.tics.2008.11.003; Hartley CA, 2012, BIOL PSYCHIAT, V72, P113, DOI 10.1016/j.biopsych.2011.12.027; HOGARTH RM, 1990, MANAGE SCI, V36, P780, DOI 10.1287/mnsc.36.7.780; Hsu M, 2005, SCIENCE, V310, P1680, DOI 10.1126/science.1115327; Huettel SA, 2006, NEURON, V49, P765, DOI 10.1016/j.neuron.2006.01.024; Ionescu T, 2012, NEW IDEAS PSYCHOL, V30, P190, DOI 10.1016/j.newideapsych.2011.11.001; KAHNEMAN D, 1979, ECONOMETRICA, V47, P263, DOI 10.2307/1914185; Keck S, 2014, J ECON BEHAV ORGAN, V103, P60, DOI 10.1016/j.jebo.2014.03.026; Knight FH, 2012, RISK UNCERTAINTY PRO; Kuhnen CM, 2017, J FINANC ECON, V124, P349, DOI 10.1016/j.jfineco.2017.03.002; Lerman-Sinkoff DB, 2017, NEUROIMAGE, V163, P41, DOI 10.1016/j.neuroimage.2017.08.081; Levy I, 2012, JOVE-J VIS EXP, DOI 10.3791/3724; Levy I, 2010, J NEUROPHYSIOL, V103, P1036, DOI 10.1152/jn.00853.2009; Li C, 2017, J RISK UNCERTAINTY, V54, P239, DOI 10.1007/s11166-017-9262-2; Liu HH, 2009, J ECON PSYCHOL, V30, P277, DOI 10.1016/j.joep.2009.02.001; MacLeod C, 2012, ANNU REV CLIN PSYCHO, V8, P189, DOI 10.1146/annurev-clinpsy-032511-143052; Muthukrishnan AV, 2009, MANAGE SCI, V55, P1933, DOI 10.1287/mnsc.1090.1087; Oechssler J, 2009, J ECON BEHAV ORGAN, V72, P147, DOI 10.1016/j.jebo.2009.04.018; Opfer JE, 2008, CHILD DEV, V79, P788, DOI 10.1111/j.1467-8624.2008.01158.x; Pinheiro J., 2011, R PACKAGE VERSION, V3, P1; Politi MC, 2007, MED DECIS MAKING, V27, P681, DOI 10.1177/0272989x07307270; Pushkarskaya H, 2015, J PSYCHIATR RES, V69, P166, DOI 10.1016/j.jpsychires.2015.08.011; R Core Team, 2021, R LANGUAGE ENV STAT; REED SK, 1974, COGNITIVE PSYCHOL, V6, P436, DOI 10.1016/0010-0285(74)90020-6; Revelle William, 2020, CRAN; Ritov I., 1990, Journal of Behavioral Decision Making, V3, P263, DOI 10.1002/bdm.3960030404; Ruderman L, 2016, DEPRESS ANXIETY, V33, P606, DOI 10.1002/da.22494; Rustichini A, 2005, SCIENCE, V310, P1624, DOI 10.1126/science.1122179; Senecal N, 2012, JUDGM DECIS MAK, V7, P568; Sharot T, 2011, CURR BIOL, V21, pR941, DOI 10.1016/j.cub.2011.10.030; THALER R, 1981, ECON LETT, V8, P201, DOI 10.1016/0165-1765(81)90067-7; Trautmann ST, 2008, J RISK UNCERTAINTY, V36, P225, DOI 10.1007/s11166-008-9038-9; Tymula A, 2013, P NATL ACAD SCI USA, V110, P17143, DOI 10.1073/pnas.1309909110; Tymula A, 2012, P NATL ACAD SCI USA, V109, P17135, DOI 10.1073/pnas.1207144109; WEBER M, 1987, OR SPEKTRUM, V9, P129, DOI 10.1007/BF01721094; WEINSTEIN ND, 1980, J PERS SOC PSYCHOL, V39, P806, DOI 10.1037/0022-3514.39.5.806; Zizzo DJ, 2010, EXP ECON, V13, P75, DOI 10.1007/s10683-009-9230-z	73	3	3	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2020	15	3							e0228782	10.1371/journal.pone.0228782	http://dx.doi.org/10.1371/journal.pone.0228782			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	KX8DC	32130214	Green Published, gold, Green Submitted			2022-12-26	WOS:000522104600001
J	Subirana, L; Farstey, V; Bertrand, S; Escriva, H				Subirana, Lucie; Farstey, Viviana; Bertrand, Stephanie; Escriva, Hector			Asymmetron lucayanum: How many species are valid?	PLOS ONE			English	Article							MITOCHONDRIAL GENOME; CEPHALOCHORDATA; ALIGNMENT; EVOLUTION; TREE	The cephalochordates amphioxus or lancelets are benthic marine animals representing the earliest divergent evolutionary lineage within chordates. Although amphioxus are present in most of the world's tropical and temperate oceans, only about thirty different species grouped into three different genera, Branchiostoma, Epigonichthys and Asymmetron have been described. In the genus Asymmetron, only two species have been characterized, although for one of them, A. lucayanum, several cryptic lineages exist. In this work we have sequenced and analyzed the mitogenome of an A. lucayanum population previously described in the Red Sea. The phylogenetic study using this complete mitogenome as well as the analysis of COI gene sequences of several individuals of this Red Sea population show that the Red Sea population is a new cryptic species. We propose to call this new species Asymmetron rubrum.	[Subirana, Lucie; Bertrand, Stephanie; Escriva, Hector] Sorbonne Univ, CNRS, Biol Integrat Organismes Marins BIOM, Observ Oceanol, Banyuls Sur Mer, France; [Farstey, Viviana] Interuniv Inst Marine Sci, Elat, Israel	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite	Bertrand, S; Escriva, H (corresponding author), Sorbonne Univ, CNRS, Biol Integrat Organismes Marins BIOM, Observ Oceanol, Banyuls Sur Mer, France.	stephanie.bertrand@obs-banyuls.fr; hescriva@obs-banyuls.fr	Bertrand, Stephanie/D-8482-2014; Escriva, Hector/K-8325-2013	Bertrand, Stephanie/0000-0002-0689-0126; Escriva, Hector/0000-0001-7577-5028; Subirana, Lucie/0000-0002-9942-1125	Centre National de la Recherche Scientifique (CNRS); Agence nationale de la recherche (ANR) [ANR-16-CE12-0008-01]; Institut Universitaire de France; Assemble FP7 EU transnational access grant	Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); Agence nationale de la recherche (ANR)(French National Research Agency (ANR)); Institut Universitaire de France; Assemble FP7 EU transnational access grant	H.E. was supported by the Centre National de la Recherche Scientifique (CNRS) and Agence nationale de la recherche (ANR) grant no. ANR-16-CE12-0008-01 S.B. was supported by the Institut Universitaire de France. H.E. and S.M. travel expenses to the IUI in Eilat were supported by the Assemble FP7 EU transnational access grant The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The laboratory of H.E. was supported by the Centre National de la Recherche Scientifique (CNRS) and Agence nationale de la recherche (ANR) grant no. ANR-16-CE12-0008-01; S.B. was supported by the Institut Universitaire de France. H.E. and S.M. travel expenses to the IUI in Eilat were supported by the Assemble FP7 EU transnational access grant. We also thank the technical staff of the Interuniversity Institute for Marine Sciences in Eilat for their assistance during the collection of the specimens.	Bernt M, 2013, MOL PHYLOGENET EVOL, V69, P313, DOI 10.1016/j.ympev.2012.08.023; Bertrand S, 2014, TREE OF LIFE: EVOLUTION AND CLASSIFICATION OF LIVING ORGANISMS, P461; Bertrand S, 2011, DEVELOPMENT, V138, P4819, DOI 10.1242/dev.066720; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259; Hedges SB, 2015, MOL BIOL EVOL, V32, P835, DOI 10.1093/molbev/msv037; HIGHTON R, 1990, HERPETOLOGICA, V46, P114; Igawa T, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00786-5; Kon T, 2006, MAR BIOL, V149, P875, DOI 10.1007/s00227-006-0271-y; Kon T, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-127; Kumar S, 2018, MOL BIOL EVOL, V35, P1547, DOI 10.1093/molbev/msy096; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Li WY, 2014, ZOOL SCI, V31, P766, DOI 10.2108/zs130213; Mayden R.L., 1997, Systematics Association Special Volume Series, V54, P381; Miller MA, 2015, EVOL BIOINFORM, V11, P43, DOI 10.4137/EBO.S21501; Nohara M, 2005, J MOL EVOL, V60, P526, DOI 10.1007/s00239-004-0238-x; Poss SG, 1996, ISRAEL J ZOOL, V42, pS13; Richardson B. J., 1994, Invertebrate Taxonomy, V8, P1443, DOI 10.1071/IT9941443; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Sievers F, 2014, METHODS MOL BIOL, V1079, P105, DOI 10.1007/978-1-62703-646-7_6; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Steinitz H., 1962, Bulletin Sea Fisheries Research Station Israel, VNo. 30, P35; Tamura K, 2012, P NATL ACAD SCI USA, V109, P19333, DOI 10.1073/pnas.1213199109; THORPE JP, 1982, ANNU REV ECOL SYST, V13, P139, DOI 10.1146/annurev.es.13.110182.001035; WINNEPENNINCKX B, 1993, TRENDS GENET, V9, P407; Zachos FE, 2018, J GENET, V97, P811, DOI 10.1007/s12041-018-0965-1; Zhang QL, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.01833; Zhong J, 2009, MAR BIOL RES, V5, P278, DOI 10.1080/17451000802430817	28	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2020	15	3							e0229119	10.1371/journal.pone.0229119	http://dx.doi.org/10.1371/journal.pone.0229119			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8QU	32130230	Green Published, gold			2022-12-26	WOS:000535264000016
J	Borghese, MFA; Ortiz, MD; Marinoni, RC; Oronel, LH; Palamidessi, M; Yarza, CA; Di Siervi, N; Davio, C; Majowicz, MP				Albertoni Borghese, Maria Florencia; Ortiz, Maria del Carmen; Marinoni, Rocio C.; Oronel, Lucas H.; Palamidessi, Milena; Yarza, Carolina A.; Di Siervi, Nicolas; Davio, Carlos; Majowicz, Monica P.			Inhibition of Endothelin system during the postnatal nephrogenic period in the rat. Its relationship with hypertension and renal disease in adulthood	PLOS ONE			English	Article							DUCT-SPECIFIC KNOCKOUT; VASOPRESSIN REGULATION; BLOOD-PRESSURE; RISK-FACTOR; SODIUM; KIDNEY; SALT; ENAC; RECEPTORS; DYSFUNCTION	The aim of this work was to study the effect of a high sodium (HS) diet on blood pressure and renal function in male adult rats that have been treated with a dual Endothelin receptor antagonist (ERA) during their early postnatal period (day 1 to 20 of life). Male Sprague-Dawley rats were divided in four groups: C-NS: control rats with normosodic diet; ERA(NS): ERA-treated rats with normosodic diet; C-HS: control rats with high sodium diet; ERA(HS): ERA-treated rats with HS diet. Systolic blood pressure (SBP) was recorded before and after the diet and 24-hour metabolic cage studies were performed. AQP2 and alpha-ENac expressions were measured by western blot and real time PCR in the renal medulla. Vasopressin (AVP) pathway was evaluated by measuring V2 receptor and adenylyl cyclase 6 (AC6) expression and cAMP production in the renal medulla. Pre-pro ET-1mRNA was also evaluated in the renal medulla. Only rats that had been treated with an ERA during their postnatal period increased their SBP after consumption of a HS diet, showing an impaired capacity to excrete sodium and water, i.e. developing salt sensitivity. This salt sensitivity would be mediated by an increase in renomedullary expression and activity of AQP2 and alpha-ENaC as a consequence of increased AC6 expression and cAMP production and/or a decreased ET-1 production in the renal medulla. The knowledge of the molecular mechanisms underlying the perinatal programming of salt sensitive hypertension will allow the development of reprogramming strategies in order to avoid this pathology.	[Albertoni Borghese, Maria Florencia; Ortiz, Maria del Carmen; Marinoni, Rocio C.; Oronel, Lucas H.; Palamidessi, Milena; Yarza, Carolina A.; Majowicz, Monica P.] Univ Buenos Aires, Fac Farm & Bioquim, Dept Ciencias Biol, Catedra Biol Celular & Mol, Buenos Aires, DF, Argentina; [Albertoni Borghese, Maria Florencia] Univ Buenos Aires, Fac Farm & Bioquim, Dept Ciencias Biol, Catedra Biol Celular & Mol,CONICET, Buenos Aires, DF, Argentina; [Di Siervi, Nicolas; Davio, Carlos] Univ Buenos Aires, Inst Invest Farmacol ININFA, Fac Farm & Bioquim, CONICET, Buenos Aires, DF, Argentina; [Davio, Carlos] Univ Buenos Aires, Fac Farm & Bioquim, Dept Farmacol, Buenos Aires, DF, Argentina	University of Buenos Aires; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires; University of Buenos Aires	Majowicz, MP (corresponding author), Univ Buenos Aires, Fac Farm & Bioquim, Dept Ciencias Biol, Catedra Biol Celular & Mol, Buenos Aires, DF, Argentina.	mmajow@ffyb.uba.ar		Di Siervi, Nicolas/0000-0002-9035-8174	Universidad de Buenos Aires [UBACYT 20020130200184BA, 20020170100135BA]	Universidad de Buenos Aires(University of Buenos Aires)	This work was supported by Grants UBACYT 20020130200184BA and 20020170100135BA from the Universidad de Buenos Aires to MPM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn D, 2004, J CLIN INVEST, V114, P504, DOI 10.1172/JCI200421064; Borghese MFA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148866; Bankir L, 2010, AM J PHYSIOL-RENAL, V299, pF917, DOI 10.1152/ajprenal.00413.2010; Barni T, 1998, J CRAN GENET DEV BIO, V18, P183; BRENNER BM, 1988, AM J HYPERTENS, V1, P335, DOI 10.1093/ajh/1.4.335; BRENNER BM, 1993, AM J KIDNEY DIS, V21, P66, DOI 10.1016/0272-6386(93)70097-I; Brenner BM, 1997, KIDNEY INT, pS124; Burrell LM, 2013, J AM SOC HYPERTENS, V7, P3, DOI 10.1016/j.jash.2012.11.004; Clouthier DE, 2000, DEV BIOL, V217, P10, DOI 10.1006/dbio.1999.9527; Crestani S, 2014, VASC PHARMACOL, V60, P67, DOI 10.1016/j.vph.2013.12.001; DAVIO CA, 1995, BIOCHEM PHARMACOL, V50, P91, DOI 10.1016/0006-2952(95)00108-C; Ebefors K, 2019, KIDNEY INT, V96, P957, DOI 10.1016/j.kint.2019.05.007; Farjah M, 2004, HYPERTENSION, V43, P282, DOI 10.1161/01.HYP.0000111584.15095.8a; Ge YQ, 2005, AM J PHYSIOL-RENAL, V288, pF912, DOI 10.1152/ajprenal.00432.2004; HOSODA K, 1994, CELL, V79, P1267, DOI 10.1016/0092-8674(94)90017-5; Jensen IS, 2016, ACTA PHYSIOL, V218, P49, DOI 10.1111/apha.12707; Kohan DE, 2006, CURR OPIN NEPHROL HY, V15, P34, DOI 10.1097/01.mnh.0000186852.15889.1a; Kwon TH, 2013, KIDNEY RES CLIN PRAC, V32, P96, DOI 10.1016/j.krcp.2013.07.005; Langley-Evans SC, 2010, MED PRIN PRACT, V19, P87, DOI 10.1159/000273066; Li X, 2014, LIFE SCI, V113, P31, DOI 10.1016/j.lfs.2014.07.027; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Tomat AL, 2011, NUTRITION, V27, P392, DOI 10.1016/j.nut.2010.09.010; Luyckx VA, 2013, LANCET, V382, P273, DOI 10.1016/S0140-6736(13)60311-6; MALKUSCH W, 1995, EXP LUNG RES, V21, P67, DOI 10.3109/01902149509031745; Maynard TM, 2001, SCHIZOPHRENIA BULL, V27, P457, DOI 10.1093/oxfordjournals.schbul.a006887; Mironova E, 2015, ACTA PHYSIOL, V213, P213, DOI 10.1111/apha.12372; OISHI R, 1991, AM J PHYSIOL, V261, pF951, DOI 10.1152/ajprenal.1991.261.6.F951; Pearce D, 2015, CLIN J AM SOC NEPHRO, V10, P135, DOI 10.2215/CJN.05760513; Pratt JH, 2005, J AM SOC NEPHROL, V16, P3154, DOI 10.1681/ASN.2005050460; Puddu M, 2009, AM J NEPHROL, V30, P162, DOI 10.1159/000211324; Qi HY, 2017, DIABETES, V66, P763, DOI 10.2337/db16-0695; Roos KP, 2013, J AM SOC NEPHROL, V24, P218, DOI 10.1681/ASN.2012050449; Roos KP, 2012, AM J PHYSIOL-RENAL, V302, pF78, DOI 10.1152/ajprenal.00397.2011; Roxas B, 2002, BIOCHEM BIOPH RES CO, V296, P755, DOI 10.1016/S0006-291X(02)00896-3; Ruta LAM, 2010, AM J PHYSIOL-RENAL, V298, pF1384, DOI 10.1152/ajprenal.00049.2010; Singh RR, 2015, CURR OPIN PHARMACOL, V21, P53, DOI 10.1016/j.coph.2014.12.010; Snyder PM, 2005, ENDOCRINOLOGY, V146, P5079, DOI 10.1210/en.2005-0894; Sorokin A, 2015, VITAM HORM, V98, P155, DOI 10.1016/bs.vh.2015.01.001; Soundararajan R, 2010, J BIOL CHEM, V285, P30363, DOI 10.1074/jbc.R110.155341; Stockand JD, 2010, KIDNEY INT, V78, P849, DOI 10.1038/ki.2010.276; Strait Kevin A, 2007, BMC Nephrol, V8, P8, DOI 10.1186/1471-2369-8-8; Suganami T, 2003, HYPERTENSION, V42, P1183, DOI 10.1161/01.HYP.0000101689.64849.97; Sun Y, 2011, ACTA PHARMACOL SIN, V32, P789, DOI 10.1038/aps.2011.72; TOMITA K, 1990, J CLIN INVEST, V85, P2014, DOI 10.1172/JCI114667; Yanagisawa H, 1998, DEVELOPMENT, V125, P825; Zaika O, 2013, CURR HYPERTENS REP, V15, P17, DOI 10.1007/s11906-012-0316-1	46	2	2	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2020	15	3							e0229756	10.1371/journal.pone.0229756	http://dx.doi.org/10.1371/journal.pone.0229756			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8MS	32126132	Green Submitted, Green Published, gold			2022-12-26	WOS:000535253100047
J	Khan, A; Valli, E; Lam, H; Scott, DA; Murray, J; Hanssen, KM; Eden, G; Gamble, LD; Pandher, R; Flemming, CL; Allan, S; Osterman, AL; Haber, M; Norris, MD; Fletcher, JI; Yu, DMT				Khan, Aaminah; Valli, Emanuele; Lam, Hayley; Scott, David A.; Murray, Jayne; Hanssen, Kimberley M.; Eden, Georgina; Gamble, Laura D.; Pandher, Rupinder; Flemming, Claudia L.; Allan, Sophie; Osterman, Andrei L.; Haber, Michelle; Norris, Murray D.; Fletcher, Jamie, I; Yu, Denise M. T.			Targeting metabolic activity in high-risk neuroblastoma through Monocarboxylate Transporter 1 (MCT1) inhibition	ONCOGENE			English	Article							CANCER-CELLS; N-MYC; GLYCOLYSIS; HYPOXIA; GROWTH; ACTIVATION; PYRUVATE; GLUTAMINOLYSIS; COMBINATION; METASTASIS	Amplification of the MYCN oncogene occurs in similar to 25% of primary neuroblastomas and is the single most powerful biological marker of poor prognosis in this disease. MYCN transcriptionally regulates a range of biological processes important for cancer, including cell metabolism. The MYCN-regulated metabolic gene SLC16A1, encoding the lactate transporter monocarboxylate transporter 1 (MCT1), is a potential therapeutic target. Treatment of neuroblastoma cells with the MCT1 inhibitor SR13800 increased intracellular lactate levels, disrupted the nicotinamide adenine dinucleotide (NADH/NAD(+)) ratio, and decreased intracellular glutathione levels. Metabolite tracing with 13C-glucose and 13C-glutamine following MCT1 inhibitor treatment revealed increased quantities of tricarboxylic acid (TCA) cycle intermediates and increased oxygen consumption rate. MCT1 inhibition was highly synergistic with vincristine and LDHA inhibition under cell culture conditions, but this combination was ineffective against neuroblastoma xenografts. Posttreatment xenograft tumors had increased synthesis of the MCT1 homolog MCT4/SLC16A, a known resistance factor to MCT1 inhibition. We found that MCT4 was negatively regulated by MYCN in luciferase reporter assays and its synthesis in neuroblastoma cells was increased under hypoxic conditions and following hypoxia-inducible factor (HIF1) induction, suggesting that MCT4 may contribute to resistance to MCT1 inhibitor treatment in hypoxic neuroblastoma tumors. Co-treatment of neuroblastoma cells with inhibitors of MCT1 and LDHA, the enzyme responsible for lactate production, resulted in a large increase in intracellular pyruvate and was highly synergistic in decreasing neuroblastoma cell viability. These results highlight the potential of targeting MCT1 in neuroblastoma in conjunction with strategies that involve disruption of pyruvate homeostasis and indicate possible resistance mechanisms.	[Khan, Aaminah; Valli, Emanuele; Lam, Hayley; Murray, Jayne; Hanssen, Kimberley M.; Eden, Georgina; Gamble, Laura D.; Pandher, Rupinder; Flemming, Claudia L.; Allan, Sophie; Haber, Michelle; Norris, Murray D.; Fletcher, Jamie, I; Yu, Denise M. T.] UNSW Sydney, Childrens Canc Inst, Lowy Canc Res Ctr, Sydney, NSW 2052, Australia; [Khan, Aaminah; Lam, Hayley] UNSW Sydney, Sch Med Sci, Sydney, NSW 2052, Australia; [Valli, Emanuele; Hanssen, Kimberley M.; Fletcher, Jamie, I; Yu, Denise M. T.] UNSW Sydney, Sch Womens & Childrens Hlth, Sydney, NSW 2052, Australia; [Scott, David A.; Osterman, Andrei L.] Sanford Burnham Prebys Med Discovery Inst, Canc Metab Core, La Jolla, CA 92037 USA; [Norris, Murray D.] Univ New South Wales, Ctr Childhood Canc Res, Sydney, NSW, Australia	Children's Cancer Institute; University of New South Wales Sydney; University of New South Wales Sydney; University of New South Wales Sydney; Sanford Burnham Prebys Medical Discovery Institute; University of New South Wales Sydney	Fletcher, JI; Yu, DMT (corresponding author), UNSW Sydney, Childrens Canc Inst, Lowy Canc Res Ctr, Sydney, NSW 2052, Australia.; Fletcher, JI; Yu, DMT (corresponding author), UNSW Sydney, Sch Womens & Childrens Hlth, Sydney, NSW 2052, Australia.	JFletcher@ccia.unsw.edu.au; DYu@ccia.unsw.edu.au	Murray, Jayne/AAM-8115-2021; Valli, Emanuele/ABD-7213-2020	Valli, Emanuele/0000-0002-0928-8624; Fletcher, Jamie/0000-0003-2949-9469; Hanssen, Kimberley/0000-0002-2919-3104; Haber, Michelle/0000-0003-2036-8817; Gamble, Laura D./0000-0001-8496-9705; Murray, Jayne/0000-0002-1861-6570; Scott, David/0000-0002-8668-2449	Balnaves Foundation Young Investigator Grant; National Health and Medical Research Council [APP1016699]; SBP NCI Cancer Center Support Grant [P30 CA030199]	Balnaves Foundation Young Investigator Grant; National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); SBP NCI Cancer Center Support Grant	We thank Donna Lai and Sheng Hua from the Bosch Molecular Biology Facility, University of Sydney for support with Seahorse Analyses, and Alan Truong for technical support. This work was supported by a Balnaves Foundation Young Investigator Grant (DMTY), a National Health and Medical Research Council Program Grant APP1016699 (MH, MDN), and a SBP NCI Cancer Center Support Grant P30 CA030199 (DS, AO).	Benjamin D, 2018, CELL REP, V25, P3047, DOI 10.1016/j.celrep.2018.11.043; Birsoy K, 2013, NAT GENET, V45, P104, DOI 10.1038/ng.2471; Bonuccelli G, 2010, CELL CYCLE, V9, P3506, DOI 10.4161/cc.9.17.12731; Cohn SL, 2009, J CLIN ONCOL, V27, P289, DOI 10.1200/JCO.2008.16.6785; Curtis NJ, 2017, ONCOTARGET, V8, P69219, DOI 10.18632/oncotarget.18215; Doherty JR, 2014, CANCER RES, V74, P908, DOI 10.1158/0008-5472.CAN-13-2034; Fang J, 2006, MOL PHARMACOL, V70, P2108, DOI 10.1124/mol.106.026245; Faubert B, 2017, CELL, V171, P358, DOI 10.1016/j.cell.2017.09.019; Fiaschi T, 2012, CANCER RES, V72, P5130, DOI 10.1158/0008-5472.CAN-12-1949; Fotsis T, 1999, EUR J BIOCHEM, V263, P757, DOI 10.1046/j.1432-1327.1999.00575.x; Galluzzi L, 2013, NAT REV DRUG DISCOV, V12, P829, DOI 10.1038/nrd4145; Gan L, 2016, ONCOGENE, V35, P3037, DOI 10.1038/onc.2015.360; Gherardi S, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00042; Groninger E, 2002, INT J ONCOL, V21, P1339; Halestrap AP, 2012, IUBMB LIFE, V64, P109, DOI 10.1002/iub.572; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Henderson MJ, 2011, J NATL CANCER I, V103, P1236, DOI 10.1093/jnci/djr256; Hong CS, 2016, CELL REP, V14, P1590, DOI 10.1016/j.celrep.2016.01.057; Huang M, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a014415; Jin L, 2016, ONCOGENE, V35, P3619, DOI 10.1038/onc.2015.447; Kocak H, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.84; Le Floch R, 2011, P NATL ACAD SCI USA, V108, P16663, DOI 10.1073/pnas.1106123108; Levy AG, 2012, INVEST NEW DRUG, V30, P191, DOI 10.1007/s10637-010-9551-y; Lin RY, 1998, J BIOL CHEM, V273, P28959, DOI 10.1074/jbc.273.44.28959; Matthay KK, 2016, NAT REV DIS PRIMERS, V2, DOI 10.1038/nrdp.2016.78; Noble RA, 2017, HAEMATOLOGICA, V102, P1247, DOI 10.3324/haematol.2016.163030; Obre E, 2015, INT J BIOCHEM CELL B, V59, P167, DOI 10.1016/j.biocel.2014.12.008; Park JR, 2010, HEMATOL ONCOL CLIN N, V24, P65, DOI 10.1016/j.hoc.2009.11.011; Pelicano H, 2006, ONCOGENE, V25, P4633, DOI 10.1038/sj.onc.1209597; Pertega-Gomes N, 2015, ONCOTARGET, V6, P21675, DOI 10.18632/oncotarget.4328; Polanski R, 2014, CLIN CANCER RES, V20, P926, DOI 10.1158/1078-0432.CCR-13-2270; Qing GL, 2012, CANCER CELL, V22, P631, DOI 10.1016/j.ccr.2012.09.021; Qing GL, 2010, CANCER RES, V70, P10351, DOI 10.1158/0008-5472.CAN-10-0740; Quanz M, 2018, MOL CANCER THER, V17, P2285, DOI 10.1158/1535-7163.MCT-17-1253; Ratnikov B, 2015, ONCOTARGET, V6, P7379, DOI 10.18632/oncotarget.3132; Ren P, 2015, J PATHOL, V235, P90, DOI 10.1002/path.4429; Scott DA, 2011, J BIOL CHEM, V286, P42626, DOI 10.1074/jbc.M111.282046; Sonveaux P, 2008, J CLIN INVEST, V118, P3930, DOI 10.1172/JCI36843; Sounni NE, 2014, CELL METAB, V20, P280, DOI 10.1016/j.cmet.2014.05.022; Sullivan LB, 2016, NAT REV CANCER, V16, P680, DOI 10.1038/nrc.2016.85; Thangaraju M, 2009, BIOCHEM J, V417, P379, DOI 10.1042/BJ20081132; Tu Y, 2013, INT J MOL MED, V31, P113, DOI 10.3892/ijmm.2012.1167; Ullah MS, 2006, J BIOL CHEM, V281, P9030, DOI 10.1074/jbc.M511397200; Valli E, 2012, BBA-GENE REGUL MECH, V1819, P1173, DOI 10.1016/j.bbagrm.2012.08.001; Wagner W, 2015, CELL COMMUN SIGNAL, V13, DOI 10.1186/s12964-015-0114-x; Wise DR, 2008, P NATL ACAD SCI USA, V105, P18782, DOI 10.1073/pnas.0810199105; Xiao DB, 2015, ONCOTARGET, V6, P40655, DOI 10.18632/oncotarget.5821; Xu RH, 2005, CANCER RES, V65, P613; Zhang XL, 2011, MOL CELL BIOCHEM, V358, P287, DOI 10.1007/s11010-011-0979-y; Zhao L, 2004, CLIN CANCER RES, V10, P7994, DOI 10.1158/1078-0432.CCR-04-1087; Zhao YX, 2011, J CEREBR BLOOD F MET, V31, P1412, DOI 10.1038/jcbfm.2010.230	51	14	14	3	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR	2020	39	17					3555	3570		10.1038/s41388-020-1235-2	http://dx.doi.org/10.1038/s41388-020-1235-2		MAR 2020	16	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	LH1YK	32123312	Green Accepted			2022-12-26	WOS:000517738400001
J	Tamura, R; Yoshihara, K; Nakaoka, H; Yachida, N; Yamaguchi, M; Suda, K; Ishiguro, T; Nishino, K; Ichikawa, H; Homma, K; Kikuchi, A; Ueda, Y; Takei, Y; Fujiwara, H; Motoyama, T; Okuda, S; Wakai, T; Inoue, I; Enomoto, T				Tamura, Ryo; Yoshihara, Kosuke; Nakaoka, Hirofumi; Yachida, Nozomi; Yamaguchi, Manako; Suda, Kazuaki; Ishiguro, Tatsuya; Nishino, Koji; Ichikawa, Hiroshi; Homma, Keiichi; Kikuchi, Akira; Ueda, Yutaka; Takei, Yuji; Fujiwara, Hiroyuki; Motoyama, Teiichi; Okuda, Shujiro; Wakai, Toshifumi; Inoue, Ituro; Enomoto, Takayuki			XCL1 expression correlates with CD8-positive T cells infiltration and PD-L1 expression in squamous cell carcinoma arising from mature cystic teratoma of the ovary	ONCOGENE			English	Article							GENOMIC CHARACTERIZATION; HEAD; LYMPHOTACTIN; NIVOLUMAB; RECEPTOR; NUMBER; XCR1	Molecular characteristics of carcinoma arising from mature cystic teratoma of the ovary (MCT) remain unclear due to its rarity. We analyzed RNA-sequencing data of 2322 pan-cancer [1378 squamous cell carcinomas (SCC), 6 adenosquamous carcinomas (ASC), and 938 adenocarcinomas (AC)] including six carcinomas arising from MCT (four SCCs, one ASC, and one AC). Hierarchical clustering and principal component analysis showed that gene expression profiles of carcinomas arising from MCT were different between each histological type and that gene expression profiles of SCCs arising MCT (MCT-SCCs) was apparently similar to those of lung SCCs. By epidermis-associated pathways activity based on gene set enrichment analysis, 1030 SCCs were divided into two groups: epidermis-signature high (head and neck, esophagus, and skin) and low (cervix, lung, and MCT). In addition to pan-SCC transcriptome analysis, cytokeratin profiling based on immunohistochemistry in the independent samples of 21 MCT-SCCs clarified that MCT-SCC dominantly expressed CK18, suggesting the origin of MCT-SCC was columnar epithelium. Subsequently, we investigated differentially expressed genes in MCT-SCCs compared with different SCCs and identified XCL1 was specifically overexpressed in MCT-SCCs. Through immunohistochemistry analysis, we identified XCL1 expression on tumor cells in 13/24 (54%) of MCT-SCCs but not in MCTs. XCL1 expression was also significantly associated with the number of tumor-infiltrating CD8-positive T cells and PD-L1 expression on tumor cells. XCL1 produced by tumor cells may induce PD1/PD-L1 interaction and dysfunction of CD8-positive T cells in tumor microenvironment. XCL1 expression may be a novel biomarker for malignant transformation of MCT into SCC and a biomarker candidate for therapeutic response to an anti-PD1/PD-L1 therapy.	[Tamura, Ryo; Yoshihara, Kosuke; Yachida, Nozomi; Yamaguchi, Manako; Suda, Kazuaki; Ishiguro, Tatsuya; Nishino, Koji; Enomoto, Takayuki] Niigata Univ, Dept Obstet & Gynecol, Grad Sch Med & Dent Sci, Niigata 9518510, Japan; [Nakaoka, Hirofumi; Inoue, Ituro] Natl Inst Genet, Human Genet Lab, Mishima, Shizuoka 4118540, Japan; [Ichikawa, Hiroshi; Wakai, Toshifumi] Niigata Univ, Div Digest & Gen Surg, Grad Sch Med & Dent Sci, Niigata 9518510, Japan; [Homma, Keiichi] Niigata Canc Ctr Hosp, Dept Pathol, Niigata 9518133, Japan; [Kikuchi, Akira] Niigata Canc Ctr Hosp, Dept Gynecol, Niigata 9518133, Japan; [Ueda, Yutaka] Osaka Univ, Dept Obstet & Gynecol, Sch Med, Suita, Osaka 5650871, Japan; [Takei, Yuji; Fujiwara, Hiroyuki] Jichi Med Univ, Dept Obstet & Gynecol, Shimotsuke, Tochigi 3290498, Japan; [Motoyama, Teiichi] Niigata Univ, Dept Mol & Diagnost Pathol, Grad Sch Med & Dent Sci, Niigata 9518510, Japan; [Okuda, Shujiro] Niigata Univ, Div Bioinformat, Grad Sch Med & Dent Sci, Niigata 9518510, Japan	Niigata University; Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan; Niigata University; Osaka University; Jichi Medical University; Niigata University; Niigata University	Yoshihara, K (corresponding author), Niigata Univ, Dept Obstet & Gynecol, Grad Sch Med & Dent Sci, Niigata 9518510, Japan.	yoshikou@med.niigata-u.ac.jp	Takei, Yuji/ABD-2485-2020; Yoshihara, Kosuke/AAU-9874-2020	Yoshihara, Kosuke/0000-0002-2254-3378; Nakaoka, Hirofumi/0000-0002-8454-1159; Ueda, Yutaka/0000-0001-8760-6379; Ishiguro, Tatsuya/0000-0002-6445-4066; Enomoto, Takayuki/0000-0003-4538-5541	JSPS KAKENHI [18K16760, JP16H06267, JP16H06279]; Mochida Grant; Tsukada Grant for Niigata University Medical Research; ROIS (Research Organization of Information and Systems)	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Mochida Grant; Tsukada Grant for Niigata University Medical Research; ROIS (Research Organization of Information and Systems)	We are grateful to Anna Ishida, Junko Kajiwara, Junko Kitayama, and Yumiko Sato for their technical assistance. We also grateful to Yusuke Tanaka, Reisa Kakubari, Mariko Kayamori, and Taeko Hyuga for sample collections. This work was supported in part by JSPS KAKENHI grant number 18K16760 (Grant-in-Aid for Young Scientists for RT), JP16H06267 (Grant-in-Aid for Young Scientists A for KY), JP16H06279 (Grant-in-Aid for Scientific Research on Innovative Areas-Platforms for Advanced Technologies and Research Resources for HN and KY), the Mochida Grant for KY, the Tsukada Grant for Niigata University Medical Research for RT, and "Challenging Exploratory Research Projects for the Future" grant from ROIS (Research Organization of Information and Systems) for HN.	Akazawa M, 2018, INT J GYNECOL CANCER, V28, P1650, DOI 10.1097/IGC.0000000000001375; AMERIGO J, 1979, GYNECOL ONCOL, V8, P277, DOI 10.1016/0090-8258(79)90035-0; Bray NL, 2016, NAT BIOTECHNOL, V34, P888, DOI 10.1038/nbt0816-888d; Burk RD, 2017, NATURE, V543, P378, DOI 10.1038/nature21386; Calinski R.B., 1974, COMMUNICATIONS STAT, V3, P1, DOI [10.1080/03610927408827101, DOI 10.1080/03610927408827101]; Campbell JD, 2018, CELL REP, V23, P194, DOI 10.1016/j.celrep.2018.03.063; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Chakravarty D, 2017, JCO PRECIS ONCOL, V1; Chiang AJ, 2017, J GYNECOL ONCOL, V28, DOI 10.3802/jgo.2017.28.e69; Chitsazzadeh V, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12601; Chung HC, 2019, J CLIN ONCOL, V37, P1470, DOI 10.1200/JCO.18.01265; Cooke SL, 2017, CLIN CANCER RES, V23, P7633, DOI 10.1158/1078-0432.CCR-17-1789; Cristescu R, 2018, SCIENCE, V362, P197, DOI 10.1126/science.aar3593; Ding HY, 2019, CELL REP, V27, P3331, DOI 10.1016/j.celrep.2019.05.043; Dorner BG, 2009, IMMUNITY, V31, P823, DOI 10.1016/j.immuni.2009.08.027; Eifert C, 2017, PERS MED, V14, P309, DOI 10.2217/pme-2017-0011; Ferris RL, 2016, NEW ENGL J MED, V375, P1856, DOI 10.1056/NEJMoa1602252; Forbes SA, 2015, NUCLEIC ACIDS RES, V43, pD805, DOI 10.1093/nar/gku1075; Fruman DA, 2017, CELL, V170, P605, DOI 10.1016/j.cell.2017.07.029; Hackethal A, 2008, LANCET ONCOL, V9, P1173, DOI 10.1016/S1470-2045(08)70306-1; Hammerman PS, 2012, NATURE, V489, P519, DOI 10.1038/nature11404; HIRAKAWA T, 1989, AM J SURG PATHOL, V13, P397, DOI 10.1097/00000478-198905000-00007; Hoadley KA, 2018, CELL, V173, P291, DOI 10.1016/j.cell.2018.03.022; Ichikawa H, 2017, GENOME MED, V9, DOI 10.1186/s13073-017-0484-3; Iwasa A, 2007, HISTOPATHOLOGY, V51, P98, DOI 10.1111/j.1365-2559.2007.02727.x; John T, 2009, ONCOGENE, V28, pS14, DOI 10.1038/onc.2009.197; Keck MK, 2015, CLIN CANCER RES, V21, P870, DOI 10.1158/1078-0432.CCR-14-2481; KELNER GS, 1994, SCIENCE, V266, P1395, DOI 10.1126/science.7973732; Khurram SA, 2010, J PATHOL, V221, P153, DOI 10.1002/path.2695; Kim J, 2017, NATURE, V541, P169, DOI 10.1038/nature20805; Kim M, 2012, MOL CANCER RES, V10, P1419, DOI 10.1158/1541-7786.MCR-12-0361; KRZANOWSKI WJ, 1988, BIOMETRICS, V44, P23, DOI 10.2307/2531893; Kudo T, 2017, LANCET ONCOL, V18, P631, DOI 10.1016/S1470-2045(17)30181-X; Lawrence MS, 2015, NATURE, V517, P576, DOI 10.1038/nature14129; Lei Y, 2012, MICROBES INFECT, V14, P262, DOI 10.1016/j.micinf.2011.10.003; Li BL, 2019, CLIN CANCER RES, V25, P3528, DOI 10.1158/1078-0432.CCR-18-4085; Li F, 2013, CELL, V153, P590, DOI 10.1016/j.cell.2013.03.025; MARCIALROJAS RA, 1958, ARCH PATHOL, V66, P577; Migden MR, 2018, NEW ENGL J MED, V379, P341, DOI 10.1056/NEJMoa1805131; Mori Y, 2003, GYNECOL ONCOL, V90, P338, DOI 10.1016/S0090-8258(03)00259-2; Nicorici, 2014, BIORXIV, DOI [10.1101/011650, DOI 10.1101/011650V1]; Nishiwaki M, 2008, J CLIN MICROBIOL, V46, P1161, DOI 10.1128/JCM.00793-07; O'Malley DP, 2019, MODERN PATHOL, V32, P929, DOI 10.1038/s41379-019-0210-3; Reck M, 2016, NEW ENGL J MED, V375, P1823, DOI 10.1056/NEJMoa1606774; Suda K, 2018, CELL REP, V24, P1777, DOI 10.1016/j.celrep.2018.07.037; Sun JQ, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-219; Tamura R, 2018, ONCOGENESIS, V7, DOI 10.1038/s41389-017-0018-2; Teng MWL, 2015, CANCER RES, V75, P2139, DOI 10.1158/0008-5472.CAN-15-0255; Torres-Garcia W, 2014, BIOINFORMATICS, V30, P2224, DOI 10.1093/bioinformatics/btu169; Yarchoan M, 2017, NEW ENGL J MED, V377, P2500, DOI 10.1056/NEJMc1713444; Zhang L, 2003, NEW ENGL J MED, V348, P203, DOI 10.1056/NEJMoa020177	51	16	17	8	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR	2020	39	17					3541	3554		10.1038/s41388-020-1237-0	http://dx.doi.org/10.1038/s41388-020-1237-0		MAR 2020	14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	LH1YK	32115573	hybrid, Green Published			2022-12-26	WOS:000517359700002
J	Jani, J; Yang, YY; Lusk, MG; Toor, GS				Jani, Jariani; Yang, Yun-Ya; Lusk, Mary G.; Toor, Gurpal S.			Composition of nitrogen in urban residential stormwater runoff: Concentrations, loads, and source characterization of nitrate and organic nitrogen	PLOS ONE			English	Article							ISOTOPIC COMPOSITION; CLIMATE-CHANGE; LEAF-LITTER; 1ST FLUSH; FRESH-WATER; NUTRIENT; MATTER; PRECIPITATION; SYSTEMS; CARBON	Stormwater runoff is a leading cause of nitrogen (N) transport to water bodies and hence one means of water quality deterioration. Stormwater runoff was monitored in an urban residential catchment (drainage area: 3.89 hectares) in Florida, United States to investigate the concentrations, forms, and sources of N. Runoff samples were collected over 22 storm events (May to September 2016) at the end of a stormwater pipe that delivers runoff from the catchment to the stormwater pond. Various N forms such as ammonium (NH4-N), nitrate (NOx-N), dissolved organic nitrogen (DON), and particulate organic nitrogen (PON) were determined and isotopic characterization tools were used to infer sources of NO3-N and PON in collected runoff samples. The DON was the dominant N form in runoff (47%) followed by PON (22%), NOx-N (17%), and NH4-N (14%). Three N forms (NOx-N, NH4-N, and PON) were positively correlated with total rainfall and antecedent dry period, suggesting longer dry periods and higher rainfall amounts are significant drivers for transport of these N forms. Whereas DON was positively correlated to only rainfall intensity indicating that higher intensity rain may flush out DON from soils and cause leaching of DON from particulates present in the residential catchment. We discovered, using stable isotopes of NO3-, a shifting pattern of NO3- sources from atmospheric deposition to inorganic N fertilizers in events with higher and longer duration of rainfall. The stable isotopes of PON confirmed that plant material (oak detritus, grass clippings) were the primary sources of PON in stormwater runoff. Our results demonstrate that practices targeting both inorganic and organic N are needed to control N transport from residential catchments to receiving waters.	[Jani, Jariani] Univ Malaya, Fac Sci, Chem Dept, Kuala Lumpur, Malaysia; [Yang, Yun-Ya; Toor, Gurpal S.] Univ Maryland, Dept Environm Sci & Technol, College Pk, MD 20742 USA; [Lusk, Mary G.] Univ Florida, Gulf Coast Res & Educ Ctr, Wimauma, FL USA	Universiti Malaya; University System of Maryland; University of Maryland College Park; State University System of Florida; University of Florida	Toor, GS (corresponding author), Univ Maryland, Dept Environm Sci & Technol, College Pk, MD 20742 USA.	gstoor@umd.edu	MOHD JANI, SITI JARIANI/ABH-2751-2021; Yang, Yun-Ya/I-6722-2019	MOHD JANI, SITI JARIANI/0000-0002-4783-1640; Yang, Yun-Ya/0000-0002-9919-2457	Florida Department of Environmental Protection	Florida Department of Environmental Protection	GST received funding from Florida Department of Environmental Protection. There is no grant number. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen ST, 2017, WIRES WATER, V4, DOI 10.1002/wat2.1187; Altieri KE, 2012, ATMOS CHEM PHYS, V12, P3557, DOI 10.5194/acp-12-3557-2012; Bardhan P, 2017, BIOGEOSCIENCES, V14, P767, DOI 10.5194/bg-14-767-2017; Bratt AR, 2017, ENVIRON SCI TECHNOL, V51, P3138, DOI 10.1021/acs.est.6b06299; Brezonik PL, 2002, WATER RES, V36, P1743, DOI 10.1016/S0043-1354(01)00375-X; Bronk DA, 2007, BIOGEOSCIENCES, V4, P283, DOI 10.5194/bg-4-283-2007; Buda AR, 2009, ATMOS ENVIRON, V43, P4453, DOI 10.1016/j.atmosenv.2009.06.027; Cao D, 2014, MAR POLLUT BULL, V85, P727, DOI 10.1016/j.marpolbul.2014.05.041; Carey RO, 2012, HORTTECHNOLOGY, V22, P418, DOI 10.21273/HORTTECH.22.4.418; Charbeneau RJ, 1998, WATER ENVIRON RES, V70, P1295, DOI 10.2175/106143098X123679; Coplen T, 2007, DETERMINATION 16O NI; CRAIG H, 1961, SCIENCE, V133, P1702, DOI 10.1126/science.133.3465.1702; Denault C, 2006, J AM WATER RESOUR AS, V42, P685, DOI 10.1111/j.1752-1688.2006.tb04485.x; Derrien M, 2018, SCI TOTAL ENVIRON, V618, P569, DOI 10.1016/j.scitotenv.2017.11.067; Divers MT, 2014, ENVIRON SCI TECHNOL, V48, P10580, DOI 10.1021/es404880j; Duan SW, 2014, BIOGEOCHEMISTRY, V121, P61, DOI 10.1007/s10533-014-0016-9; Felix JD, 2012, ENVIRON SCI TECHNOL, V46, P3528, DOI 10.1021/es203355v; Fields S, 2004, ENVIRON HEALTH PERSP, V112, pA556, DOI 10.1289/ehp.112-a556; Fissore C, 2011, ECOL APPL, V21, P619, DOI 10.1890/10-0386.1; Fork ML, 2018, LIMNOL OCEANOGR LETT, V3, P215, DOI 10.1002/lol2.10066; Gao XL, 2012, MAR POLLUT BULL, V64, P1148, DOI 10.1016/j.marpolbul.2012.03.028; Hagedorn F, 2001, GEODERMA, V100, P173, DOI 10.1016/S0016-7061(00)00085-9; Hale RL, 2014, ENVIRON SCI TECHNOL, V48, P6211, DOI 10.1021/es501039t; Han YG, 2014, GEODERMA, V213, P87, DOI 10.1016/j.geoderma.2013.07.019; Hastings MG, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2003JD003789; Hathaway JM, 2012, WATER AIR SOIL POLL, V223, P5903, DOI 10.1007/s11270-012-1327-x; Hobbie SE, 2017, P NATL ACAD SCI USA, V114, P4177, DOI 10.1073/pnas.1618536114; Hobbie SE, 2014, URBAN ECOSYST, V17, P369, DOI 10.1007/s11252-013-0329-9; Hochmuth G, 2012, URBAN WATER QUALITY; HOERING T, 1957, GEOCHIM COSMOCHIM AC, V12, P97, DOI 10.1016/0016-7037(57)90021-2; Howarth RW, 2006, LIMNOL OCEANOGR, V51, P364, DOI 10.4319/lo.2006.51.1_part_2.0364; Jani J, 2018, WATER RES, V137, P344, DOI 10.1016/j.watres.2018.02.042; Janke BD, 2017, ENVIRON SCI TECHNOL, V51, P9569, DOI 10.1021/acs.est.7b02225; Kaushal SS, 2011, ENVIRON SCI TECHNOL, V45, P8225, DOI 10.1021/es200779e; Kendall C, 2001, HYDROL PROCESS, V15, P1301, DOI 10.1002/hyp.216; Kendall C., 2012, ISOTOPE TRACERS CATC; Kendall C, 2007, ECOL METHOD CONCEPT, P375, DOI 10.1002/9780470691854.ch12; Kojima K, 2011, CHEMOSPHERE, V84, P1716, DOI 10.1016/j.chemosphere.2011.04.071; Langeveld JG, 2013, J HYDROL, V476, P112, DOI 10.1016/j.jhydrol.2012.10.021; Lee JH, 2002, SCI TOTAL ENVIRON, V293, P163, DOI 10.1016/S0048-9697(02)00006-2; Lewis DB, 2007, ECOL APPL, V17, P2347, DOI 10.1890/06-0031.1; Li LQ, 2014, ENVIRON SCI TECHNOL, V48, P3403, DOI 10.1021/es4055302; Li Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130814; Lis G, 2008, ANAL CHEM, V80, P287, DOI 10.1021/ac701716q; Liu HZ, 2012, ENVIRON SCI TECHNOL, V46, P713, DOI 10.1021/es203085y; Lu CY, 2015, J ENVIRON QUAL, V44, P210, DOI 10.2134/jeq2014.06.0247; Lusk MG, 2020, SCI TOTAL ENVIRON, V707, DOI 10.1016/j.scitotenv.2019.135962; Lusk MG, 2018, WATER RES, V131, P52, DOI 10.1016/j.watres.2017.11.040; Lusk MG, 2016, WATER RES, V96, P225, DOI 10.1016/j.watres.2016.03.060; Lusk MG, 2016, ENVIRON SCI TECHNOL, V50, P3391, DOI 10.1021/acs.est.5b05714; Miguntanna NP, 2013, J ENVIRON MANAGE, V120, P61, DOI 10.1016/j.jenvman.2013.02.027; Newcomer TA, 2012, ECOL MONOGR, V82, P449, DOI 10.1890/12-0458.1; Osborne DM, 2013, RAPID COMMUN MASS SP, V27, P851, DOI 10.1002/rcm.6521; Phillips DL, 2005, OECOLOGIA, V144, P520, DOI [10.1007/s00442-004-1816-8, 10.1007/s000442-004-1816-8]; Price RM, 2008, J HYDROL, V358, P193, DOI 10.1016/j.jhydrol.2008.06.003; Sansalone JJ, 1997, J ENVIRON ENG-ASCE, V123, P134, DOI 10.1061/(ASCE)0733-9372(1997)123:2(134); Schiff KC, 2016, WATER-SUI, V8, DOI 10.3390/w8080320; Schiff S, 2011, NY TIMES BK REV, P1; Seitzinger SP, 2002, LIMNOL OCEANOGR, V47, P353, DOI 10.4319/lo.2002.47.2.0353; Selbig WR, 2016, SCI TOTAL ENVIRON, V571, P124, DOI 10.1016/j.scitotenv.2016.07.003; Smith VH, 2006, LIMNOL OCEANOGR, V51, P351, DOI 10.4319/lo.2006.51.1_part_2.0351; Taylor GD, 2005, WATER RES, V39, P1982, DOI 10.1016/j.watres.2005.03.022; Tsai YI, 2004, CHEMOSPHERE, V54, P1171, DOI 10.1016/j.chemosphere.2003.09.021; U.S. EPA, 1993, 3501 UNEPA; United States Environmental Protection Agency, 1993, 3532 USEPA; van Kessel C, 2009, J ENVIRON QUAL, V38, P393, DOI 10.2134/jeq2008.0277; Vaze J, 2003, WATER RESOUR RES, V39, DOI 10.1029/2002WR001786; Wei ZC, 2013, INT J DISTRIB SENS N, DOI 10.1155/2013/282340; Willems P, 2013, J HYDROL, V496, P166, DOI 10.1016/j.jhydrol.2013.05.037; Yang YY, 2018, CURR POLLUT REP, V4, P112, DOI 10.1007/s40726-018-0087-7; Yang YY, 2017, WATER RES, V112, P176, DOI 10.1016/j.watres.2017.01.039; Yang YY, 2016, ENVIRON SCI TECHNOL, V50, P2881, DOI 10.1021/acs.est.5b05353	72	30	31	7	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2020	15	2							e0229715	10.1371/journal.pone.0229715	http://dx.doi.org/10.1371/journal.pone.0229715			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8HR	32109256	Green Published, gold			2022-12-26	WOS:000535239800025
J	Baykal-Kose, S; Acikgoz, E; Yavuz, AS; Geyik, OG; Ate, H; Sezerman, OU; Ozsan, GH; Yuce, Z				Baykal-Kose, Seda; Acikgoz, Eda; Yavuz, Ahmet Sinan; Geyik, Oyku Gonul; Ate, Halil; Sezerman, Osman Ugur; Ozsan, Guner Hayri; Yuce, Zeynep			Adaptive phenotypic modulations lead to therapy resistance in chronic myeloid leukemia cells	PLOS ONE			English	Article							CHRONIC MYELOGENOUS LEUKEMIA; ERYTHROID-DIFFERENTIATION; E-CADHERIN; STEM-CELLS; MESENCHYMAL TRANSITION; MOLECULAR-BIOLOGY; IMATINIB; CANCER; LINE; CHONDROCYTES	Tyrosine kinase inhibitor (TKI) resistance is a major problem in chronic myeloid leukemia (CML). We generated a TKI-resistant K562 sub-population, K562-IR, under selective imatinib-mesylate pressure. K562-IR cells are CD34(-)/CD38(-), BCR-Abl-independent, proliferate slowly, highly adherent and form intact tumor spheroids. Loss of CD45 and other hematopoietic markers reveal these cells have diverged from their hematopoietic origin. CD34 negativity, high expression of E-cadherin and CD44; decreased levels of CD45 and beta-catenin do not fully confer with the leukemic stem cell (LSC) phenotype. Expression analyses reveal that K562-IR cells differentially express tissue/ organ development and differentiation genes. Our data suggest that the observed phenotypic shift is an adaptive process rendering cells under TKI stress to become oncogene independent. Cells develop transcriptional instability in search for a gene expression framework suitable for new environmental stresses, resulting in an adaptive phenotypic shift in which some cells partially display LSC-like properties. With leukemic/cancer stem cell targeted therapies underway, the difference between treating an entity and a spectrum of dynamic cellular states will have conclusive effects on the outcome.	[Baykal-Kose, Seda; Geyik, Oyku Gonul; Yuce, Zeynep] Dokuz Eylul Univ, Fac Med, Dept Med Biol, Izmir, Turkey; [Acikgoz, Eda] Ege Univ, Fac Med, Dept Histol & Embryol, Izmir, Turkey; [Acikgoz, Eda] Yuzuncu Yil Univ, Fac Med, Dept Histol & Embryol, Van, Turkey; [Yavuz, Ahmet Sinan] Sabanci Univ, Fac Engn & Nat Sci, Dept Mol Biol Genet & Bioengn, Istanbul, Turkey; [Ate, Halil; Ozsan, Guner Hayri] Dokuz Eylul Univ, Fac Med, Dept Hematol, Izmir, Turkey; [Sezerman, Osman Ugur] Acibadem Univ, Sch Med, Dept Biostat & Med Informat, Istanbul, Turkey	Dokuz Eylul University; Ege University; Yuzuncu Yil University; Sabanci University; Dokuz Eylul University; Acibadem University	Yuce, Z (corresponding author), Dokuz Eylul Univ, Fac Med, Dept Med Biol, Izmir, Turkey.	zeynep.sercan@deu.edu.tr	SEZERMAN, OSMAN U/X-6441-2018; Acikgoz, eda/W-2171-2017; Baykal Köse, Seda/ABI-4548-2020; Köse, Seda Baykal/ABI-3945-2020; Geyik, Öykü Gönül/AAL-3308-2020	Baykal Köse, Seda/0000-0001-8654-5332; Geyik, Öykü Gönül/0000-0003-3014-1253; Yuce, Zeynep/0000-0002-2762-0942; Acikgoz, Eda/0000-0002-6772-3081; Yavuz, Ahmet Sinan/0000-0003-4069-6105	Dokuz Eylul University Scientific Research Projects [:2012KBSAG092, 2009KBSAG029]	Dokuz Eylul University Scientific Research Projects(Dokuz Eylul University)	Dokuz Eylul University Scientific Research Projects, grants no:2012KBSAG092 and 2009KBSAG029. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas R, 2012, CANCER CHEMOTH PHARM, V69, P221, DOI 10.1007/s00280-011-1688-7; Acikgoz E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141090; ANDERSSON LC, 1979, NATURE, V278, P364, DOI 10.1038/278364a0; Assouline S, 2011, CURR ONCOL, V18, pE71; Bhatia S, 2017, BIOCHEM J, V474, P3269, DOI 10.1042/BCJ20160782; Cano A, 2000, NAT CELL BIOL, V2, P76, DOI 10.1038/35000025; Chorzalska A, 2017, STEM CELLS DEV, V26, P656, DOI 10.1089/scd.2016.0262; Cipolleschi MG, 2013, CURR PHARM DESIGN, V19, P5374, DOI 10.2174/1381612811319300006; Corbin AS, 2011, J CLIN INVEST, V121, P396, DOI 10.1172/JCI35721; Deininger MW, 2008, CLIN CANCER RES, V14, P4027, DOI 10.1158/1078-0432.CCR-07-5015; Deininger MWN, 2003, PHARMACOL REV, V55, P401, DOI 10.1124/pr.55.3.4; Deininger MWN, 2000, BLOOD, V96, P3343, DOI 10.1182/blood.V96.10.3343; GAMBARI R, 1984, CELL DIFFER DEV, V14, P87, DOI 10.1016/0045-6039(84)90033-2; Hertweck MK, 2011, ANN HEMATOL, V90, P493, DOI 10.1007/s00277-011-1161-z; Hochedlinger K, 2009, DEVELOPMENT, V136, P509, DOI 10.1242/dev.020867; Hochhaus A, 2017, NEW ENGL J MED, V376, P917, DOI 10.1056/NEJMoa1609324; Holyoake TL, 2017, BLOOD, V129, P1595, DOI 10.1182/blood-2016-09-696013; Huber MA, 2005, CURR OPIN CELL BIOL, V17, P548, DOI 10.1016/j.ceb.2005.08.001; Hwangbo C, 2016, ONCOGENE, V35, P389, DOI 10.1038/onc.2015.100; Ishiguro T, 2017, CANCER SCI, V108, P283, DOI 10.1111/cas.13155; Jabbour EJ, 2013, CL LYMPH MYELOM LEUK, V13, P515, DOI 10.1016/j.clml.2013.03.018; Jamieson CHM, 2004, NEW ENGL J MED, V351, P657, DOI 10.1056/NEJMoa040258; Jin LQ, 2006, NAT MED, V12, P1167, DOI 10.1038/nm1483; Jolly MK, 2018, BBA-REV CANCER, V1870, P151, DOI 10.1016/j.bbcan.2018.07.001; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Kemper K, 2014, CANCER RES, V74, P5937, DOI 10.1158/0008-5472.CAN-14-1174; Krause DS, 2006, NAT MED, V12, P1175, DOI 10.1038/nm1489; Lee J, 2017, CELL TRANSPLANT, V26, P1673, DOI 10.1177/0963689717724794; Liang W, 2014, UROL ONCOL-SEMIN ORI, V32, P855, DOI 10.1016/j.urolonc.2014.01.005; Lu ZM, 2003, CANCER CELL, V4, P499, DOI 10.1016/S1535-6108(03)00304-0; Mandl EW, 2004, MATRIX BIOL, V23, P231, DOI 10.1016/j.matbio.2004.06.004; Matsuo T, 1997, ACTA MED OKAYAMA, V51, P251; Prieto-Garcia E, 2017, MED ONCOL, V34, DOI 10.1007/s12032-017-0980-8; Puissant A, 2012, J MOL CELL BIOL, V4, P207, DOI 10.1093/jmcb/mjs010; Quintas-Cardama A, 2009, BLOOD, V113, P1619, DOI 10.1182/blood-2008-03-144790; Ren JG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012520; Rovida E, 2014, CELL CYCLE, V13, P3169, DOI 10.4161/15384101.2014.964107; SCARRA GLB, 1986, CANCER RES, V46, P6327; Seton-Rogers S, 2006, NAT REV CANCER, V6, P831, DOI 10.1038/nrc2019; Staal FJT, 2010, J CELL BIOCHEM, V109, P844, DOI 10.1002/jcb.22467; Surani MA, 2007, CELL, V128, P747, DOI 10.1016/j.cell.2007.02.010; Takahashi N, 2012, J HEMATOL ONCOL, V5, DOI 10.1186/1756-8722-5-23; TETTEROO PAT, 1984, LEUKEMIA RES, V8, P197, DOI 10.1016/0145-2126(84)90143-7; TONINI GP, 1987, CANCER RES, V47, P4544; von Bubnoff N, 2003, LEUKEMIA, V17, P829, DOI 10.1038/sj.leu.2402889; Wong SHM, 2018, CRIT REV ONCOL HEMAT, V121, P11, DOI 10.1016/j.critrevonc.2017.11.010; Xin H, 2013, J PHARMACOL SCI, V122, P299, DOI 10.1254/jphs.13025FP; ZANYK MJ, 1988, CYTOMETRY, V9, P374, DOI 10.1002/cyto.990090415; Zhang KD, 2016, RECENT PAT ANTI-CANC, V11, P236, DOI 10.2174/1574892811666160128151437; Zoller M, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00235	50	11	12	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2020	15	2							e0229104	10.1371/journal.pone.0229104	http://dx.doi.org/10.1371/journal.pone.0229104			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8GQ	32106243	Green Published, gold			2022-12-26	WOS:000535237000018
J	Noda, AA; Grillova, L; Mariet, JF; Paiffer, NB; Ruiz, YC; Rodriguez, I; Echevarria, E; Obregon, AM; Lienhard, R; Picardeau, M				Noda, Angel A.; Grillova, Linda; Mariet, Jean-Francois; Paiffer, Nadiezda B.; Ruiz, Yanet C.; Rodriguez, Islay; Echevarria, Eduardo; Obregon, Ana Margarita; Lienhard, Reto; Picardeau, Mathieu			A first insight into the genomic diversity of Leptospira strains isolated from patients in Cuba	PLOS ONE			English	Article								Leptospirosis is a neglected disease causing severe infections in humans and animals. Due in part to misdiagnosis, this infectious disease results in nearly 60,000 deaths per year around the globe. This study represents the first effort to describe the diversity of pathogenic Leptospira in Cuba based on whole-genome sequencing. We have collected nineteen whole-blood samples from patients that were diagnosed as having leptospirosis between 2008 and 2012 in Cuba. In addition, we have enhanced our sample set by three historical strains that were used for the development of a human vaccine in 1990s. The Leptospira strains were grown and serotyped by the microscopic agglutination test, and the draft genomes were generated by NGS (Illumina). Subsequently, the core genomes were analyzed and compared to the genetic data available from other Caribbean islands and countries in Central America. Core genome Multi-locus Sequence Typing (cgMLST) revealed four different core genome clonal groups (cgCGs), with the highest number of samples belonging to L. interrogans, followed by L. borgpetersenii and L. kirschneri. All cgCGs that were found in Cuba have been also identified from multiple origins across the globe, except in neighbor countries and Central America. Serotyping divided the samples into the serogroups Canicola, Ballum and Pomona. The most frequent cgCGs, cgCG28, associated with serogroup Canicola, and cgCG15, associated with serogroup Ballum, have also been identified from samples isolated from dogs, rodents, and pigs; suggesting that these hosts represent the major source of human infection in Cuba. The vaccine strains did not significantly differ from the recent patient isolates. However, the increasing prevalence of samples belonging to the serogroup Ballum combined with the fact that the available vaccine in Cuba represents inactivated Leptospira belonging to serogroups other than Ballum, should be a valuable information for the National and Regional Leptospirosis Control Programs.	[Noda, Angel A.; Rodriguez, Islay; Echevarria, Eduardo; Obregon, Ana Margarita] Inst Trop Med Pedro Kouri, Dept Mycol Bacteriol, Havana, Cuba; [Grillova, Linda; Mariet, Jean-Francois; Picardeau, Mathieu] Inst Pasteur, Biol Spirochetes Unit, Paris, France; [Paiffer, Nadiezda B.; Ruiz, Yanet C.] Finlay Vaccine Inst, Havana, Cuba; [Lienhard, Reto] ADMED Microbiol, La Chaux De Fonds, Switzerland	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Picardeau, M (corresponding author), Inst Pasteur, Biol Spirochetes Unit, Paris, France.	mathieu.picardeau@pasteur.fr	Noda, Angel/ABF-5191-2020	Banos Paiffer, Nadiezda/0000-0001-5866-3307; Grillova, Linda/0000-0003-2371-3161	PTR grant from the Institut Pasteur [PTR30-17]	PTR grant from the Institut Pasteur	This study was funded by a PTR grant (PTR30-17) from the Institut Pasteur to MP. Dr. Reto Lienhard (the employee of the commercial affiliation ADMED Microbiologie) was included in the study design, however ADMED Microbiologie did not financially support this study.	Boonsilp S, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0001954; Bourhy P, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002114; Costa F, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003898; Gonzalez M, 2004, BIOTECNOL APL, V21, P107; Guglielmini J, 2019, PLOS NEGLECT TROP D, V13, DOI 10.1371/journal.pntd.0007374; Letunic I, 2016, NUCLEIC ACIDS RES, V44, pW242, DOI 10.1093/nar/gkw290; Levett PN, 2001, CLIN MICROBIOL REV, V14, P296, DOI 10.1128/CMR.14.2.296-326.2001; Nalam K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012637; Obregon AM, 2018, J VET MED RES, V5, P1144; Obregón Ana Margarita, 2003, Rev Cubana Med Trop, V55, P96; Obregon Ana Margarita, 2007, Rev Cubana Med Trop, V59, P68; Rodriguez Gonzalez Islay, 2007, Rev Cubana Med Trop, V59, P19; Rodriguez Y, 2018, J VET MED RES, V5, P1143; Schneider Maria Cristina, 2017, Rev Panam Salud Publica, V41, pe81, DOI 10.26633/RPSP.2017.81; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Vincent AT, 2019, PLOS NEGLECT TROP D, V13, DOI 10.1371/journal.pntd.0007270; World Health Organization, HUM LEPT GUID DIAGN	17	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2020	15	2							e0229673	10.1371/journal.pone.0229673	http://dx.doi.org/10.1371/journal.pone.0229673			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8GQ	32106244	Green Published, gold			2022-12-26	WOS:000535237000058
J	Fischer, A; Goh, XH; Varney, JLS; Blake, AJ; Takacs, S; Gries, G				Fischer, Andreas; Goh, Xiang Hao; Varney, Jamie-Lynne S.; Blake, Adam J.; Takacs, Stephen; Gries, Gerhard			Multimodal and multifunctional signaling? - Web reduction courtship behavior in a North American population of the false black widow spider	PLOS ONE			English	Article							CHEMICAL COMMUNICATION; SEXUAL CONFLICT; URBAN; MALES; ARCHITECTURE; INTRUSIONS; DIVERSITY; EVOLUTION; DOMINANCE; FEMALES	Males of widow spiders courting on the web of females engage in web-reduction behavior which entails excising a section of the web, bundling it up, and wrapping it with their silk. Males of the false black widow spider, Steatoda grossa, in European populations also produce stridulatory courtship sound which has not yet been studied in their invaded North American range. Working with a North American population of S. grossa, we tested the hypotheses that (1) web reduction by males renders webs less attractive to rival males; (2) deposition of silk by courting males has an inter-sexual (male-female) signal function that enhances their likelihood of copulation; and (3) stridulatory sound is a courtship signal of males. Testing anemotactic attraction of males in Y-tube olfactometer experiments revealed that reduced webs (indicative of a mated female) and intact webs (indicative of a virgin female) were equally attractive to males. Recording courtship behavior of males with either functional (silk-releasing) spinnerets or spinnerets experimentally occluded on the web of virgin females showed that males with functional spinnerets were more likely to copulate with the female they courted. Although males possess the stridulatory apparatus to produce courtship sound, they did not stridulate when courting or copulating on the web of females. Our data support the conclusion that web-reduction behavior of S. grossa males in their invaded North American range has no long-range effect on mate seeking males. Instead, web-reduction behavior has an inter-sexual signaling function that seems to be linked to functional spinnerets of the courting male. The signal produced by a male likely entails a volatile silk-borne pheromone, but may also embody a gauge of his endurance (the amount of time he engages in web reduction causing web vibrations).	[Fischer, Andreas; Goh, Xiang Hao; Varney, Jamie-Lynne S.; Blake, Adam J.; Takacs, Stephen; Gries, Gerhard] Simon Fraser Univ, Dept Biol Sci, Burnaby, BC, Canada	Simon Fraser University	Fischer, A (corresponding author), Simon Fraser Univ, Dept Biol Sci, Burnaby, BC, Canada.	afischer@sfu.ca	Blake, Adam/ABE-5234-2020	Blake, Adam/0000-0002-4143-6981; Fischer, Andreas/0000-0001-5922-8411	Simon Fraser University; McCarthy Bursary of Simon Fraser University; Natural Sciences and Engineering Research Council of Canada NSERC; NSERC -Industrial Research Chair; Scotts Canada Ltd.	Simon Fraser University; McCarthy Bursary of Simon Fraser University; Natural Sciences and Engineering Research Council of Canada NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); NSERC -Industrial Research Chair(Canada Research Chairs); Scotts Canada Ltd.	AF: Graduate Fellowship from Simon Fraser University and the McCarthy Bursary of Simon Fraser University JLSV: Undergraduate Student Research Award from the Natural Sciences and Engineering Research Council of Canada NSERC) GG: NSERC -Industrial Research Chair with Scotts Canada Ltd. as the industrial sponsor The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arbuthnott D, 2009, HEREDITY, V103, P15, DOI 10.1038/hdy.2009.22; Balsby TJS, 2003, BEHAV PROCESS, V63, P149, DOI 10.1016/S0376-6357(03)00052-4; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Blackledge TA, 2007, ANIM BEHAV, V73, P855, DOI 10.1016/j.anbehav.2006.10.014; Bradley R. A., 2012, COMMON SPIDERS N AM; Braun R., 1956, Zeitschrift fuer Wissenschaftliche Zoologie, V159, P255; Cory AL, 2018, ECOL EVOL, V8, P344, DOI 10.1002/ece3.3672; Cory AL, 2016, PEERJ, V4, DOI 10.7717/peerj.1877; Dabelsteen Torben, 1998, Bioacoustics, V9, P89; Davies NB, 2012, INTRO BEHAV ECOLOGY; Derstine NT, 2017, ENTOMOL EXP APPL, V164, P35, DOI 10.1111/eea.12591; DiRienzo N, 2019, BEHAV ECOL SOCIOBIOL, V73, DOI 10.1007/s00265-018-2618-z; Dowling JL, 2012, BEHAV ECOL, V23, P201, DOI 10.1093/beheco/arr176; Dronnet S, 2005, MOL ECOL, V14, P1311, DOI 10.1111/j.1365-294X.2005.02508.x; Fauvelot C, 2009, MAR BIOL, V156, P2313, DOI 10.1007/s00227-009-1259-1; Fischer A, 2019, J ARACHNOL, V47, P1, DOI 10.1636/0161-8202-47.1.1; Fischer A, 2018, ETHOLOGY, V124, P838, DOI 10.1111/eth.12807; Fischer A, 2018, J ECON ENTOMOL, V111, P314, DOI 10.1093/jee/tox339; Galeotti P, 2005, CAN J ZOOL, V83, P1306, DOI 10.1139/Z05-130; Gerhardt U., 1925, Zeitschrift fuer Morphologie und Oekologie der Tiere Berlin, V3, P567, DOI 10.1007/BF00408191; Gerhardt U, 1924, ZOOMORPHOLOGY, P567; Gerhardt V., 1926, Zeitschrift fuer Morphologie und Oekologie der Tiere Berlin, V6, P1; Gwinner-Hanke H, 1970, ETHOLOGY, V27, P649, DOI [10.1111/j.1439-0310.1970.tb01893.x, DOI 10.1111/J.1439-0310.1970.TB01893.X]; Harari AR, 2013, CURR ZOOL, V59, P569, DOI 10.1093/czoolo/59.4.569; Kasumovic MM, 2006, CURR BIOL, V16, pR242, DOI 10.1016/j.cub.2006.03.017; Knoflach B., 2004, Denisia, V12, P161; Laidre ME, 2013, CURR BIOL, V23, pR829, DOI 10.1016/j.cub.2013.07.070; LEE R C P, 1986, Mitteilungen der Schweizerischen Entomologischen Gesellschaft, V59, P337; Levi H. W., 1957, Bulletin of the Museum of Comparative Zoology, V117, P367; Liu J, 2016, MOL PHYLOGENET EVOL, V94, P658, DOI 10.1016/j.ympev.2015.09.023; Luther D, 2010, P R SOC B, V277, P469, DOI 10.1098/rspb.2009.1571; Mateos C, 1999, BEHAV ECOL SOCIOBIOL, V45, P235, DOI 10.1007/s002650050558; Miles MC, 2018, J ANIM ECOL, V87, P1149, DOI 10.1111/1365-2656.12824; Mistal C, 2000, CAN ENTOMOL, V132, P867, DOI 10.4039/Ent132867-6; R Core Team, 2021, R LANGUAGE ENV STAT; ROELOFS WL, 1977, ANNU REV ENTOMOL, V22, P377, DOI 10.1146/annurev.en.22.010177.002113; Schafer MA, 2001, HEREDITY, V86, P94, DOI 10.1046/j.1365-2540.2001.00815.x; Schulte-Hostedde AI, 2005, ECOLOGY, V86, P155, DOI 10.1890/04-0232; Scott C, 2018, J ETHOL, V36, P191, DOI 10.1007/s10164-017-0539-3; Scott C, 2015, ANIM BEHAV, V107, P71, DOI 10.1016/j.anbehav.2015.06.009; Scott C, 2012, CAN ENTOMOL, V144, P672, DOI 10.4039/tce.2012.56; Scott CE, 2018, J ARACHNOL, V46, P173, DOI 10.1636/JoA-S-17-093.1; Segev O, 2003, J ARACHNOL, V31, P379, DOI 10.1636/S01-101; Simmons LW, 1996, P ROY SOC B-BIOL SCI, V263, P1305, DOI 10.1098/rspb.1996.0191; Steiger S, 2012, BEHAV ECOL, V23, P1126, DOI 10.1093/beheco/ars082; Steiger S, 2009, ETHOLOGY, V115, P178, DOI 10.1111/j.1439-0310.2008.01600.x; Umbers KDL, 2015, AM NAT, V185, P417, DOI 10.1086/679614; Van Dyk DA, 2008, BEHAV ECOL, V19, P895, DOI 10.1093/beheco/arn052; Vandergast AG, 2009, J INSECT CONSERV, V13, P329, DOI 10.1007/s10841-008-9176-z; Vasconcelos RO, 2010, ETHOLOGY, V116, P155, DOI 10.1111/j.1439-0310.2009.01722.x; Vibert S, 2014, FRONT ZOOL, V11, DOI 10.1186/1742-9994-11-4; WATSON PJ, 1986, SCIENCE, V233, P219, DOI 10.1126/science.3726530; Welzenberger R, 2018, THESIS; Wyatt TD, 2014, PHEROMONES AND ANIMAL BEHAVIOR: CHEMICAL SIGNALS AND SIGNATURES, 2ND EDITION, P1; Xiao YH, 2010, P ROY SOC B-BIOL SCI, V277, P3009, DOI 10.1098/rspb.2010.0763; Yorzinski JL, 2017, J EXP BIOL, V220, P1146, DOI 10.1242/jeb.150946; Zaspel JM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101975; Zhang SC, 2011, ANIM BEHAV, V82, P1299, DOI 10.1016/j.anbehav.2011.09.010; Zuk M, 2006, BIOL LETTERS, V2, P521, DOI 10.1098/rsbl.2006.0539	59	4	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2020	15	2							e0228988	10.1371/journal.pone.0228988	http://dx.doi.org/10.1371/journal.pone.0228988			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LQ8FM	32101544	gold, Green Published			2022-12-26	WOS:000535233700015
J	Cubillos-Angulo, JM; Fukutani, ER; Cruz, LAB; Arriaga, MB; Lima, JV; Andrade, BB; Queiroz, ATL; Fukutani, KF				Cubillos-Angulo, Juan M.; Fukutani, Eduardo R.; Cruz, Luis A. B.; Arriaga, Maria B.; Lima, Joao Victor; Andrade, Bruno B.; Queiroz, Artur T. L.; Fukutani, Kiyoshi F.			Systems biology analysis of publicly available transcriptomic data reveals a critical link between AKR1B10 gene expression, smoking and occurrence of lung cancer	PLOS ONE			English	Article							HUMAN AIRWAY EPITHELIUM; CIGARETTE-SMOKING; DNA ADDUCTS; NNK; OVEREXPRESSION; SUSCEPTIBILITY; MECHANISMS	Background Cigarette smoking is associated with an increased risk of developing respiratory diseases and various types of cancer. Early identification of such unfavorable outcomes in patients who smoke is critical for optimizing personalized medical care. Methods Here, we perform a comprehensive analysis using Systems Biology tools of publicly available data from a total of 6 transcriptomic studies, which examined different specimens of lung tissue and/or cells of smokers and nonsmokers to identify potential markers associated with lung cancer. Results Expression level of 22 genes was capable of classifying smokers from non-smokers. A machine learning algorithm revealed that AKR1B10 was the most informative gene among the 22 differentially expressed genes (DEGs) accounting for the classification of the clinical groups. AKR1B10 expression was higher in smokers compared to non-smokers in datasets examining small and large airway epithelia, but not in the data from a study of sorted alveolar macrophages. Moreover, AKR1B10 expression was relatively higher in lung cancer specimens compared to matched healthy tissue obtained from nonsmoking individuals. Although the overall accuracy of AKR1B10 expression level in distinction between cancer and healthy lung tissue was 76%, with a specificity of 98%, our results indicated that such marker exhibited low sensitivity, hampering its use for cancer screening such specific setting. Conclusion The systematic analysis of transcriptomic studies performed here revealed a potential critical link between AKR1B10 expression, smoking and occurrence of lung cancer.	[Cubillos-Angulo, Juan M.; Fukutani, Eduardo R.; Cruz, Luis A. B.; Arriaga, Maria B.; Lima, Joao Victor; Andrade, Bruno B.; Queiroz, Artur T. L.; Fukutani, Kiyoshi F.] Fundacao Oswaldo Cruz, Inst Goncalo Moniz, Salvador, BA, Brazil; [Cubillos-Angulo, Juan M.; Arriaga, Maria B.; Andrade, Bruno B.] Univ Fed Bahia, Fac Med, Salvador, BA, Brazil; [Cubillos-Angulo, Juan M.; Cruz, Luis A. B.; Arriaga, Maria B.; Andrade, Bruno B.; Fukutani, Kiyoshi F.] Multinatl Org Network Sponsoring Translat & Epide, Salvador, BA, Brazil; [Cruz, Luis A. B.; Andrade, Bruno B.; Fukutani, Kiyoshi F.] Fac Tecnol & Ciencias, Curso Med, Salvador, BA, Brazil; [Andrade, Bruno B.] Univ Salvador UNIFACS, Laureate Univ, Salvador, BA, Brazil; [Andrade, Bruno B.] Escola Bahiana Med & Saude Publ EBMSP, Salvador, BA, Brazil	Fundacao Oswaldo Cruz; Universidade Federal da Bahia; Universidade Salvador (UNIFACS); Escola Bahiana de Medicina e Saude Publica	Andrade, BB; Queiroz, ATL; Fukutani, KF (corresponding author), Fundacao Oswaldo Cruz, Inst Goncalo Moniz, Salvador, BA, Brazil.; Andrade, BB (corresponding author), Univ Fed Bahia, Fac Med, Salvador, BA, Brazil.; Andrade, BB; Fukutani, KF (corresponding author), Multinatl Org Network Sponsoring Translat & Epide, Salvador, BA, Brazil.; Andrade, BB; Fukutani, KF (corresponding author), Fac Tecnol & Ciencias, Curso Med, Salvador, BA, Brazil.; Andrade, BB (corresponding author), Univ Salvador UNIFACS, Laureate Univ, Salvador, BA, Brazil.; Andrade, BB (corresponding author), Escola Bahiana Med & Saude Publ EBMSP, Salvador, BA, Brazil.	bruno.andrade@fiocruz.br; arturlopo@gmail.com; ferreirafk@gmail.com	Queiroz, Artur/AAT-9330-2021	Andrade, Bruno/0000-0001-6833-3811; Cubillos Angulo, Juan Manuel/0000-0002-3877-5077; Arriaga Gutierrez, Maria Belen/0000-0001-6883-8422; Cruz, Luis/0000-0003-1859-3011	Universidade Salvador; Intramural Program of Fundacao Oswaldo Cruz (FIOCRUZ); Fundacao Jose Silveira; Brazilian National Council for Scientific and Technological Development (CNPq); Programa Nacional de Pos-Doutorado, Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) [001]; NIH [U01AI115940, R01AI069923-08, R01AI20790-02]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - Brasil (CAPES) [001]; Fundacao de Amparo a Pesquisa da Bahia (FAPESB); FIOCRUZ; CNPq; Organization of American States Partnerships Program for Education and Training (OAS-PAEC)	Universidade Salvador; Intramural Program of Fundacao Oswaldo Cruz (FIOCRUZ); Fundacao Jose Silveira; Brazilian National Council for Scientific and Technological Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Programa Nacional de Pos-Doutorado, Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - Brasil (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundacao de Amparo a Pesquisa da Bahia (FAPESB)(Fundacao de Amparo a Pesquisa do Estado da Bahia (FAPESB)); FIOCRUZ; CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Organization of American States Partnerships Program for Education and Training (OAS-PAEC)	This study was supported by Universidade Salvador, the Intramural Program of Fundacao Oswaldo Cruz (FIOCRUZ), Fundacao Jose Silveira and by the Brazilian National Council for Scientific and Technological Development (CNPq). K.F.F. received a fellowship from the Programa Nacional de Pos-Doutorado, Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) (Finance Code 00 1). The work of B.B.A. was supported by grants from the NIH (U01AI115940, R01AI069923-08, R01AI20790-02). B.B.A. and A.T.L.Q. are senior investigators from CNPq. J. M. C.-A. was supported by the Organization of American States Partnerships Program for Education and Training (OAS-PAEC) and his study was financed in part by the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - Brasil (CAPES) - Finance Code 001. M.B.A. received PhD fellowship from Fundacao de Amparo a Pesquisa da Bahia (FAPESB) and FIOCRUZ. L.A.B.C. was supported by a research fellowship from CNPq. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akopyan G, 2006, INT J ONCOL, V29, P745; Badal S, 2014, J APPL TOXICOL, V34, P743, DOI 10.1002/jat.2968; Barnes PJ, 2016, J ALLERGY CLIN IMMUN, V138, P16, DOI 10.1016/j.jaci.2016.05.011; Berndt N, 2011, NAT REV CANCER, V11, P775, DOI 10.1038/nrc3151; Blackford A, 2009, CANCER RES, V69, P3681, DOI 10.1158/0008-5472.CAN-09-0015; Bolstad B, 2018, PREPROCESSCORE COLLE; Buterin T, 2000, CANCER RES, V60, P1849; Carolan BJ, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-111; Chung YT, 2012, MODERN PATHOL, V25, P758, DOI 10.1038/modpathol.2011.191; Cockcroft DW, 2018, SEMIN RESP CRIT CARE, V39, P12, DOI 10.1055/s-0037-1606219; Feldman C, 2013, J INFECTION, V67, P169, DOI 10.1016/j.jinf.2013.05.004; Fukumoto S, 2005, CLIN CANCER RES, V11, P1776, DOI 10.1158/1078-0432.CCR-04-1238; Fukutani KF, 2018, FRONT BIOENG BIOTECH, V5, DOI 10.3389/fbioe.2017.00084; Gallego O, 2007, P NATL ACAD SCI USA, V104, P20764, DOI 10.1073/pnas.0705659105; Gibbons DL, 2014, MOL CANCER RES, V12, P3, DOI 10.1158/1541-7786.MCR-13-0539; Hanzelmann S, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-7; Hamburg MA, 2010, NEW ENGL J MED, V363, P301, DOI 10.1056/NEJMp1006304; Harvey BG, 2007, J MOL MED, V85, P39, DOI 10.1007/s00109-006-0103-z; Hecht SS, 2008, CHEM RES TOXICOL, V21, P160, DOI 10.1021/tx7002068; Jin YT, 2016, CANCER INVEST, V34, P173, DOI 10.3109/07357907.2016.1156689; Johnson WE, 2007, BIOSTATISTICS, V8, P118, DOI 10.1093/biostatistics/kxj037; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kang MW, 2011, J INT MED RES, V39, P78, DOI 10.1177/147323001103900110; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Lee Ken W. K., 2013, Frontiers in Genetics, V4, P132, DOI 10.3389/fgene.2013.00132; Li H, 2005, WORLD J GASTROENTERO, V11, P5757, DOI 10.3748/wjg.v11.i37.5757; Lu TP, 2010, CANCER EPIDEM BIOMAR, V19, P2590, DOI 10.1158/1055-9965.EPI-10-0332; Ma J, 2008, J BIOL CHEM, V283, P3418, DOI 10.1074/jbc.M707650200; Martin HJ, 2009, CHEM-BIOL INTERACT, V178, P145, DOI 10.1016/j.cbi.2008.10.021; Maser E, 2000, CANCER LETT, V148, P135, DOI 10.1016/S0304-3835(99)00323-7; Nakano T, 2012, ONCOL REP, V28, P1727, DOI 10.3892/or.2012.1972; Pavanello S, 2000, MUTAT RES-REV MUTAT, V463, P285, DOI 10.1016/S1383-5742(00)00051-X; Peluso M, 2010, J NUCLEIC ACIDS, V2010, DOI 10.4061/2010/386798; Perricone C, 2016, AUTOIMMUN REV, V15, P354, DOI 10.1016/j.autrev.2016.01.001; Ranjit Sabina, 2018, F1000Res, V7, DOI 10.12688/f1000research.12068.1; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Russo PST, 2018, BMC BIOINFORMATICS, V19, DOI 10.1186/s12859-018-2053-1; Satow R, 2010, CLIN CANCER RES, V16, P2518, DOI 10.1158/1078-0432.CCR-09-2214; Sean D, 2007, BIOINFORMATICS, V23, P1846, DOI 10.1093/bioinformatics/btm254; Shaykhiev R, 2011, CELL MOL LIFE SCI, V68, P877, DOI 10.1007/s00018-010-0500-x; Sohal SS, 2013, EXPERT REV RESP MED, V7, P275, DOI [10.1586/ERS.13.26, 10.1586/ers.13.26]; Sopori M, 2002, NAT REV IMMUNOL, V2, P372, DOI 10.1038/nri803; Stapelfeld C, 2017, CANCER LETT, V405, P120, DOI 10.1016/j.canlet.2017.07.016; Tan Q, 2013, ONCOTARGETS THER, V6, P1471, DOI 10.2147/OTT.S51041; Tilley AE, 2009, AM J RESP CRIT CARE, V179, P457, DOI 10.1164/rccm.200705-795OC; Wang C, 2009, J BIOL CHEM, V284, P26742, DOI 10.1074/jbc.M109.022897; Wang GQ, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-150; Wang R, 2010, CHEST, V138, P1402, DOI 10.1378/chest.09-2634; WHO, 2015, WHO GLOB REP TRENDS; Wickham H., 2016, GGPLOT2 ELEGANT GRAP	50	6	6	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2020	15	2							e0222552	10.1371/journal.pone.0222552	http://dx.doi.org/10.1371/journal.pone.0222552			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8EV	32097409	Green Submitted, Green Published, gold			2022-12-26	WOS:000535232000003
J	Dhal, PK; Kopprio, GA; Gardes, A				Dhal, Paltu Kumar; Kopprio, German A.; Gaerdes, Astrid			Insights on aquatic microbiome of the Indian Sundarbans mangrove areas	PLOS ONE			English	Article							MARINE ACTINOBACTERIA; BACTERIAL COMMUNITY; DIVERSITY; SEDIMENTS; SEQUENCE; BIODIVERSITY; ESTUARINE; DYNAMICS; ECOLOGY; BENGAL	Background Anthropogenic perturbations have strong impact on water quality and ecological health of mangrove areas of Indian Sundarbans. Diversity in microbial community composition is important causes for maintaining the health of the mangrove ecosystem. However, microbial communities of estuarine water in Indian Sundarbans mangrove areas and environmental determinants that contribute to those communities were seldom studied. Methods Nevertheless, this study attempted first to report bacterial and archaeal communities simultaneously in the water from Matla River and Thakuran River of Maipith coastal areas more accurately using 16S rRNA gene-based amplicon approaches. Attempt also been made to assess the capability of the environmental parameters for explaining the variation in microbial community composition. Results Our investigation indicates the dominancy of halophilic marine bacteria from families Flavobacteriaceae and OM1 clade in the water with lower nutrient load collected from costal regions of a small Island of Sundarban Mangroves (ISM). At higher eutrophic conditions, changes in bacterial communities in Open Marine Water (OMW) were detected, where some of the marine hydrocarbons degrading bacteria under families Oceanospirillaceae and Spongiibacteraceae were dominated. While most abundant bacterial family Rhodobacteracea almost equally (18% of the total community) dominated in both sites. Minor variation in the composition of archaeal community was also observed between OMW and ISM. Redundancy analysis indicates a combination of total nitrogen and dissolved inorganic nutrients for OMW and for ISM, salinity and total nitrogen was responsible for explaining the changes in their respective microbial community composition. Conclusions Our study contributes the first conclusive overview on how do multiple environmental/anthropogenic stressors (salinity, pollution, eutrophication, land-use) affect the Sundarban estuary water and consequently the microbial communities in concert. However, systematic approaches with more samples for evaluating the effect of environmental pollutions on mangrove microbial communities are recommended.	[Dhal, Paltu Kumar] Jadavpur Univ, Dept Life Sci & Biotechnol, Kolkata, India; [Kopprio, German A.; Gaerdes, Astrid] Leibniz Ctr Trop Marine Res, Trop Marine Microbiol, Dept Biogeochem & Geol, Bremen, Germany	Jadavpur University; Leibniz Zentrum fur Marine Tropenforschung (ZMT)	Dhal, PK (corresponding author), Jadavpur Univ, Dept Life Sci & Biotechnol, Kolkata, India.	paltuk.dhal@jadavpuruniversity.in	Dhal, Paltu Kumar/AAA-2895-2022	Dhal, Paltu Kumar/0000-0001-5790-3268	Leibniz Zentrumfur Marine Tropenforschung (ZMT), Bremen, Germany	Leibniz Zentrumfur Marine Tropenforschung (ZMT), Bremen, Germany	This work was part of the Joint NAM S&T Centre - ZMT Bremen Fellowship in Tropical Coastal Marine Research that was supported by the Leibniz Zentrumfur Marine Tropenforschung (ZMT), Bremen, Germany	[Anonymous], 1997, WORLD MANGROVE ATLAS; Azman AS, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00856; Balasubramanian R., 2005, INDIA INT J ECOL ENV, V31, P273; Banerjee K, 2017, AMBIO, V46, P492, DOI 10.1007/s13280-016-0839-9; Basak P, 2016, GENOM DATA, V7, P76, DOI 10.1016/j.gdata.2015.11.030; Basak P, 2015, MICROB ECOL, V69, P500, DOI 10.1007/s00248-014-0498-y; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bhattacharyya A, 2015, ARCHAEA, V2015, DOI 10.1155/2015/968582; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Borin S, 2009, RES MICROBIOL, V160, P307, DOI 10.1016/j.resmic.2009.04.005; Buchan A, 2005, APPL ENVIRON MICROB, V71, P5665, DOI 10.1128/AEM.71.10.5665-5677.2005; Campbell AM, 2015, MICROBIOLOGYOPEN, V4, P390, DOI 10.1002/mbo3.245; Chakraborty A, 2015, WORLD J MICROB BIOT, V31, P593, DOI 10.1007/s11274-015-1814-5; Cho JC, 2004, APPL ENVIRON MICROB, V70, P432, DOI 10.1128/AEM.70.1.432-440.2004; Dang HY, 2008, MICROBIOL-SGM, V154, P2084, DOI 10.1099/mic.0.2007/013581-0; Das G.K., 2016, EARTH SCI INDIA, V9, DOI [10.31870/ESI.09.3.2016.9, DOI 10.31870/ESI.09.3.2016.9, 10.31870/esi.09.3.2016.9]; Dhal PK, 2014, J ENVIRON SCI HEAL A, V49, P694, DOI 10.1080/10934529.2014.865458; Doberva M, 2017, FRONT MICROBIOL, V8, P1, DOI 10.3389/fmicb.2017.01152; dos Santos HF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016943; Dupont CL, 2012, ISME J, V6, P1186, DOI 10.1038/ismej.2011.189; Fernandes AD, 2014, MICROBIOME, V2, DOI 10.1186/2049-2618-2-15; Ghosh A, 2010, INDIAN SALINE SYST, V6, P1, DOI [10.1186/1746-1448-6-1, DOI 10.1186/1746-1448-6-1]; Ghosh A, 2019, MICROBIOLOGYOPEN, V8, DOI 10.1002/mbo3.741; Ghosh A, 2018, ENVIRON SCI POLLUT R, V25, P5722, DOI 10.1007/s11356-017-0852-y; Ghosh A, 2017, GENOM DATA, V11, P39, DOI 10.1016/j.gdata.2016.11.017; Giovannoni SJ, 2005, NATURE, V437, P343, DOI 10.1038/nature04158; Gong B, 2019, SCI REP-UK, V9, DOI [10.1038/s41598-019-45804-w, 10.1038/s41598-019-458]; Gopal B, 2006, AQUAT SCI, V68, P338, DOI 10.1007/s00027-006-0868-8; Grasshoff K, 1999, METHODS SEAWATER ANA; Haro-Moreno JM, 2017, ISME J, V11, P1102, DOI 10.1038/ismej.2016.188; Hassenruck C, 2016, FEMS MICROBIOL ECOL, V92, DOI 10.1093/femsec/fiw027; HILL MO, 1973, ECOLOGY, V54, P427, DOI 10.2307/1934352; Ho Adrian, 2017, FEMS MICROBIOLOGY EC, V93; Hoffmann K, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00266; Holguin G, 2006, SCI TOTAL ENVIRON, V363, P260, DOI 10.1016/j.scitotenv.2005.05.026; Hu CC, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.00009; Huggett MJ, 2012, J BACTERIOL, V194, P732, DOI 10.1128/JB.06506-11; Jessen C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062091; Kegle HF, 2018, PEERJ, V6, DOI 10.7717/peerj.4555; Kunda P, 2018, META GENE, V18, P79, DOI 10.1016/j.mgene.2018.08.004; Kuznetsova A, 2017, J STAT SOFTW, V82, P1, DOI 10.18637/jss.v082.i13; Lauro FM, 2009, P NATL ACAD SCI USA, V106, P15527, DOI 10.1073/pnas.0903507106; Lewin GR, 2016, ANNU REV MICROBIOL, V70, P235, DOI 10.1146/annurev-micro-102215-095748; Liu HD, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01098; Mahe F, 2015, PEERJ, V3, DOI 10.7717/peerj.1420; Mallick I, 2018, SCI TOTAL ENVIRON, V610, P1239, DOI 10.1016/j.scitotenv.2017.07.234; Manivasagan P, 2014, ENVIRON TOXICOL PHAR, V38, P172, DOI 10.1016/j.etap.2014.05.014; Martin M, 2011, EMBNET J, V17, P10, DOI [10.14806/ej.17.1.200, 10.10.14806/ej.17.1.200, DOI 10.14806/EJ.17.1.200]; Mizuno CM, 2015, MBIO, V6, DOI 10.1128/mBio.02083-14; Mishra RR, 2012, REV BIOL TROP, V60, P909; Mitra A, 2009, CURR SCI INDIA, V97, P1445; Morris RM, 2012, ENVIRON MICROBIOL, V14, P1133, DOI 10.1111/j.1462-2920.2011.02694.x; Mukherjee D, 2009, ENVIRON GEOL, V58, P1757, DOI 10.1007/s00254-008-1675-4; Ngugi DK, 2018, GENOME ANNOUNCEMENTS, V6, DOI 10.1128/genomeA.00565-18; Nogales B, 2011, FEMS MICROBIOL REV, V35, P275, DOI 10.1111/j.1574-6976.2010.00248.x; Nouioui I, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.02007; Oksanen J, 2022, R PACKAGE VERSION; Parada AE, 2016, ENVIRON MICROBIOL, V18, P1403, DOI 10.1111/1462-2920.13023; Pruesse E, 2012, BIOINFORMATICS, V28, P1823, DOI 10.1093/bioinformatics/bts252; Ribicic D, 2018, MAR POLLUT BULL, V129, P370, DOI 10.1016/j.marpolbul.2018.02.034; Sarkar KS, 2010, WATER QUALITY ANAL C, P258; Sarkar SK, 2004, ENVIRON INT, V30, P1089, DOI 10.1016/j.envint.2004.06.005; Scott JJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009922; Sengupta S, 2015, BMC MICROBIOL, V15, DOI 10.1186/s12866-015-0495-4; Seo JH, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174159; Simon M, 2017, ISME J, V11, P1483, DOI 10.1038/ismej.2016.198; Spring S, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00281; Tanaka D, 2008, ENVIRON TOXICOL, V23, P563, DOI 10.1002/tox.20409; Teeling H, 2012, SCIENCE, V336, P608, DOI 10.1126/science.1218344; Yilmaz P, 2016, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.01524; Zhang JJ, 2014, BIOINFORMATICS, V30, P614, DOI 10.1093/bioinformatics/btt593	71	12	13	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2020	15	2							e0221543	10.1371/journal.pone.0221543	http://dx.doi.org/10.1371/journal.pone.0221543			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8EV	32097429	Green Published, Green Submitted			2022-12-26	WOS:000535232000002
J	Solanki, A; King, D; Thibault, G; Wang, L; Gibbs, SL				Solanki, Allison; King, Diana; Thibault, Guillaume; Wang, Lei; Gibbs, Summer L.			Quantification of fluorophore distribution and therapeutic response in matched in vivo and ex vivo pancreatic cancer model systems	PLOS ONE			English	Article							DRUG-RESISTANCE; GEMCITABINE; DELIVERY	Therapeutic resistance plagues cancer outcomes, challenging treatment particularly in aggressive disease. A unique method to decipher drug interactions with their targets and inform therapy is to employ fluorescence-based screening tools; however, to implement productive screening assays, adequate model systems must be developed. Patient-derived pancreatic cancer models (e.g., cell culture, patient-derived xenograft mouse models, and organoids) have been traditionally utilized to predict personalized therapeutic response. However, cost, long read out times and the inability to fully recapitulate the tumor microenvironment have rendered most models incompatible with clinical decision making for pancreatic ductal adenocarcinoma (PDAC) patients. Tumor explant cultures, where patient tissue can be kept viable for up to weeks, have garnered interest as a platform for delivering personalized therapeutic prediction on a clinically relevant timeline. To fully explore this ex vivo platform, a series of studies were completed to quantitatively compare in vivo models with tumor explants, examining gemcitabine therapeutic efficacy, small molecule uptake and drug-target engagement using a novel fluorescently-labeled gemcitabine conjugate. This initial work shows promise for patient-specific therapeutic selection, where tumor explant drug distribution and response recapitulated the in vivo behavior and could provide a valuable platform for understanding mechanisms of therapeutic response and resistance.	[Solanki, Allison; Wang, Lei; Gibbs, Summer L.] Oregon Hlth & Sci Univ, Dept Biomed Engn, Portland, OR 97201 USA; [King, Diana; Gibbs, Summer L.] Oregon Hlth & Sci Univ, Knight Canc Inst, Portland, OR 97201 USA; [Thibault, Guillaume; Gibbs, Summer L.] Oregon Hlth & Sci Univ, Ctr Spatial Syst Biomed, Portland, OR 97201 USA	Oregon Health & Science University; Oregon Health & Science University; Oregon Health & Science University	Gibbs, SL (corresponding author), Oregon Hlth & Sci Univ, Dept Biomed Engn, Portland, OR 97201 USA.; Gibbs, SL (corresponding author), Oregon Hlth & Sci Univ, Knight Canc Inst, Portland, OR 97201 USA.; Gibbs, SL (corresponding author), Oregon Hlth & Sci Univ, Ctr Spatial Syst Biomed, Portland, OR 97201 USA.	gibbss@ohsu.edu			BrendenColson Center for Pancreatic Care at Oregon Health and Science University	BrendenColson Center for Pancreatic Care at Oregon Health and Science University	This work was funded by the BrendenColson Center for Pancreatic Care at Oregon Health and Science University (S.L.G). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amanam I, 2018, CANCERS, V10, DOI 10.3390/cancers10020036; Baker LA, 2016, TRENDS CANCER, V2, P176, DOI 10.1016/j.trecan.2016.03.004; Biankin AV, 2012, NATURE, V491, P399, DOI 10.1038/nature11547; Chand S, 2016, INT J BIOL SCI, V12, P273, DOI 10.7150/ijbs.14951; Cui JJ, 2012, CURR PHARM DESIGN, V18, P2464, DOI 10.2174/13816128112092464; Davies E, 2015, SCI REP-UK, V5, DOI 10.1038/srep17187; Gerlach MM, 2014, BRIT J CANCER, V110, P479, DOI 10.1038/bjc.2013.700; Gruner BM, 2016, MOL CANCER THER, V15, P1145, DOI 10.1158/1535-7163.MCT-15-0165; Holohan C, 2013, NAT REV CANCER, V13, P714, DOI 10.1038/nrc3599; Jiang XY, 2017, ONCOIMMUNOLOGY, V6, DOI 10.1080/2162402X.2017.1333210; Karekla E, 2017, CANCER RES, V77, P2029, DOI 10.1158/0008-5472.CAN-16-1121; Kramer RM, 2015, CANCER BIOTHER RADIO, V30, P299, DOI 10.1089/cbr.2015.1869; Laquente B, 2008, MOL CANCER THER, V7, P638, DOI 10.1158/1535-7163.MCT-07-2122; Lee JJ, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003231; Liang C, 2017, EXP MOL MED, V49, DOI 10.1038/emm.2017.255; Lim CY, 2018, PANCREATOLOGY, V18, P913, DOI 10.1016/j.pan.2018.09.009; Majumder B, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7169; Marciniak A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078706; Matsuoka T, 2016, WORLD J GASTROENTERO, V22, P776, DOI 10.3748/wjg.v22.i2.776; McGuigan A, 2018, WORLD J GASTROENTERO, V24, P4846, DOI 10.3748/wjg.v24.i43.4846; Meijer TG, 2017, FUTUR SCI OA, V3, DOI 10.4155/fsoa-2017-0003; Naipal KAT, 2016, BMC CANCER, V16, DOI 10.1186/s12885-016-2119-2; Neesse A, 2013, P NATL ACAD SCI USA, V110, P12325, DOI 10.1073/pnas.1300415110; Pulido J, 2014, J MED CHEM, V57, P191, DOI 10.1021/jm401586a; Roife D, 2016, CLIN CANCER RES, V22, P6021, DOI 10.1158/1078-0432.CCR-15-2936; Rosenberg A, 2018, J GASTROINTEST ONCOL, V9, P143, DOI 10.21037/jgo.2018.01.13; Serra J, 1983, IMAGE ANAL MATH MORP; Sparks H, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04820-6; Vaira V, 2010, P NATL ACAD SCI USA, V107, P8352, DOI 10.1073/pnas.0907676107; Waaijer SJH, 2018, J NUCL MED, V59, P726, DOI 10.2967/jnumed.116.188045; Winner KRK, 2016, CANCER RES, V76, P1320, DOI 10.1158/0008-5472.CAN-15-1620; Witkiewicz AK, 2015, ONCOTARGET, V6, P15788, DOI 10.18632/oncotarget.3819	32	2	2	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2020	15	2							e0229407	10.1371/journal.pone.0229407	http://dx.doi.org/10.1371/journal.pone.0229407			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8EV	32097436	Green Submitted, gold, Green Published			2022-12-26	WOS:000535232000029
J	Hall, A; Northstone, K; Iles-Caven, Y; Ellis, G; Gregory, S; Golding, J; Pembrey, M				Hall, Amanda; Northstone, Kate; Iles-Caven, Yasmin; Ellis, Genette; Gregory, Steve; Golding, Jean; Pembrey, Marcus			Intolerance of loud sounds in childhood: Is there an intergenerational association with grandmaternal smoking in pregnancy?	PLOS ONE			English	Article							LINE TRANSGENERATIONAL RESPONSES; DNA METHYLATION; INHERITANCE; CHILDREN; HEALTH; HYPERACUSIS; MECHANISMS; NUTRITION; DISEASES; PARENTS	Recent research using the Avon Longitudinal Study of Parents and Children (ALSPAC) demonstrated an association between maternal grandmother smoking in pregnancy and the autistic traits of impaired social communication and repetitive behaviour in granddaughters but not grandsons, but of paternal grandmother smoking and early development of myopia in the grandchild. Here we investigate whether grandmaternal smoking in pregnancy is associated with intolerance to loud sounds. ALSPAC collected information during the index pregnancy from the study parents on the smoking habits, social and other features of their own parents. Maternal report when the child was aged 6 and 13 included hating loud sounds; at age 11 the child was tested for volume preference for listening to music through headphones. Statistical analysis compared results for grandchildren in relation to whether a parent had been exposed in utero to maternal smoking, adjusted for their grandparents' social and demographic attributes. We hypothesised that there would be sex differences in the effects of grandmaternal prenatal smoking, based on previous intergenerational studies. For 6-year-old children maternal report of intolerance to loud noise was more likely in grandsons if the maternal grandmother had smoked [adjusted odds ratio (AOR) 1.27; 95% confidence interval (CI) 1.03,1.56; P = 0.025], but less likely in girls [AOR 0.82; 95%CI 0.63,1.07] Pinteraction < 0.05. If the paternal grandmother had smoked the grandchildren were less likely to be intolerant, especially girls. The objective measure of choice of volume for music through headphones showed that grandsons of both maternal and paternal smoking grandmothers were less likely to choose high volumes compared with granddaughters (P<0.05). In line with our prior hypothesis of sex differences, we showed that grandsons were more intolerant of loud sounds than granddaughters particularly at age 6, and this was confirmed by objective measures at age 11.	[Hall, Amanda] Aston Univ, Sch Life & Hlth Sci, Birmingham, W Midlands, England; [Northstone, Kate] Univ Bristol, Bristol Med Sch Publ Hlth Sci, Bristol, Avon, England; [Iles-Caven, Yasmin; Ellis, Genette; Gregory, Steve; Golding, Jean; Pembrey, Marcus] Univ Bristol, Ctr Acad Child Hlth, Bristol Med Sch Publ Hlth Sci, Bristol, Avon, England	Aston University; University of Bristol; University of Bristol	Golding, J (corresponding author), Univ Bristol, Ctr Acad Child Hlth, Bristol Med Sch Publ Hlth Sci, Bristol, Avon, England.	jean.golding@bristol.ac.uk	Northstone, Kate/A-8165-2011; Hall, Amanda/AAB-7570-2022	Northstone, Kate/0000-0002-0602-1983; Golding, Jean/0000-0003-2826-3307; Ellis, Genette/0000-0002-7028-2758; Gregory, Steve/0000-0002-1529-9338; Hall, Amanda/0000-0001-8520-6005	Wellcome Trust [102215/2/13/2]; John Templeton Foundation [60828]; UK Medical Research Council [102215/2/13/2]; MRC [MC_PC_19009] Funding Source: UKRI	Wellcome Trust(Wellcome TrustEuropean Commission); John Templeton Foundation; UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The UK Medical Research Council (https://mrc.ukri.org/) and Wellcome Trust (https://wellcome.ac.uk/) (Grant ref: 102215/2/13/2) and the University of Bristol (http://www.bristol.ac.uk/homepage/) provide core support for ALSPAC. This publication is the work of the authors and they will serve as guarantors for the contents of this paper. A comprehensive list of grants funding is available on the ALSPAC website (http://www.bristol.ac.uk/alspac/external/documents/grantacknowledgements.pdf).This research was specifically funded by the John Templeton Foundation (https://www.templeton.org/) (60828: JG and MP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson LM, 2006, NUTRITION, V22, P327, DOI 10.1016/j.nut.2005.09.006; [Anonymous], 2005, UK CONTROL NOISE WOR; [Anonymous], 1990, STAND OCC CLASS 1990; Auerbach BD, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00206; Bak ST, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00287; BARKER DJP, 1990, BRIT MED J, V301, P1111, DOI 10.1136/bmj.301.6761.1111; Birmingham K, 2018, PIONEERING ETHICS LO; Bohacek J, 2015, NAT REV GENET, V16, P641, DOI 10.1038/nrg3964; BOUCHER BJ, 1994, DIABETOLOGIA, V37, P49; Boyd A, 2013, INT J EPIDEMIOL, V42, P111, DOI 10.1093/ije/dys064; Boyle EA, 2017, CELL, V169, P1177, DOI 10.1016/j.cell.2017.05.038; Brendal MA, 2017, J SPEECH LANG HEAR R, V60, P1076, DOI 10.1044/2016_JSLHR-H-16-0024; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Bygren LO, 2001, ACTA BIOTHEOR, V49, P53, DOI 10.1023/A:1010241825519; Champagne FA, 2013, BIOL PSYCHIAT, V73, P2, DOI 10.1016/j.biopsych.2012.10.004; Drake AJ, 2004, J ENDOCRINOL, V180, P1, DOI 10.1677/joe.0.1800001; Dunn GA, 2011, ENDOCRINOLOGY, V152, P2228, DOI 10.1210/en.2010-1461; Elsabbagh M, 2011, J INTELL DISABIL RES, V55, P563, DOI 10.1111/j.1365-2788.2011.01411.x; Fraser A, 2013, INT J EPIDEMIOL, V42, P97, DOI 10.1093/ije/dys066; Fuchsberger C, 2016, NATURE, V536, P41, DOI 10.1038/nature18642; Gapp K, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6466; Gapp K, 2014, NAT NEUROSCI, V17, P667, DOI 10.1038/nn.3695; Gluckman PD, 2008, NEW ENGL J MED, V359, P61, DOI 10.1056/NEJMra0708473; Golding J, 2001, PAEDIATR PERINAT EP, V15, P74; GOLDING J, 2004, EUR J ENDOCRINOL S3, V151; Golding J, 2017, SCI REP-UK, V7, DOI 10.1038/srep46179; Golding J, 2014, AM J HUM BIOL, V26, P731, DOI 10.1002/ajhb.22594; Gomes Erissandra, 2008, Pró-Fono R. Atual. Cient., V20, P279, DOI 10.1590/S0104-56872008000400013; Illum LRH, 2018, J MOL ENDOCRINOL, V60, pR39, DOI 10.1530/JME-17-0189; Jirtle Randy L., 2000, Environmental Health Perspectives, V108, P271, DOI 10.2307/3454445; Joris PX, 2009, JARO-J ASSOC RES OTO, V10, P1, DOI 10.1007/s10162-009-0156-0; Kaati G, 2002, EUR J HUM GENET, V10, P682, DOI 10.1038/sj.ejhg.5200859; Khramtsova EA, 2019, NAT REV GENET, V20, P173, DOI 10.1038/s41576-018-0083-1; Knipper L, 2013, PROG NEUROBIOL, V111, P17, DOI 10.1016/j.pneurobio.2013.08.002; Laubenthal J, 2012, FASEB J, V26, P3946, DOI 10.1096/fj.11-201194; Lodge CJ, 2018, CLIN EXP ALLERGY, V48, P167, DOI 10.1111/cea.13031; Lumey L H, 1992, Paediatr Perinat Epidemiol, V6, P240, DOI 10.1111/j.1365-3016.1992.tb00764.x; Manners MT, 2019, GENES BRAIN BEHAV, V18, DOI 10.1111/gbb.12493; Marouli E, 2017, NATURE, V542, P186, DOI 10.1038/nature21039; Mekhail K, 2018, FRONT GENET, V9, DOI 10.3389/fgene.2018.00095; Mercati O, 2017, MOL PSYCHIATR, V22, P625, DOI 10.1038/mp.2016.61; Miller LL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086781; Miska EA, 2016, SCIENCE, V354, P59, DOI 10.1126/science.aaf4945; Nilsson EE, 2018, ENVIRON EPIGENETICS, V4, DOI 10.1093/eep/dvy016; Northstone K, 2014, EUR J HUM GENET, V22, P1382, DOI 10.1038/ejhg.2014.31; Pembrey M, 2014, J MED GENET, V51, P563, DOI 10.1136/jmedgenet-2014-102577; Pembrey ME, 2010, HUM FERTIL, V13, P268, DOI 10.3109/14647273.2010.524721; Pembrey ME, 2006, EUR J HUM GENET, V14, P159, DOI 10.1038/sj.ejhg.5201538; Petronis A, 2004, BIOL PSYCHIAT, V55, P965, DOI 10.1016/j.biopsych.2004.02.005; Rich SS, 2016, NATURE, V536, P38, DOI 10.1038/nature18906; Rosenhall U, 1999, J AUTISM DEV DISORD, V29, P349, DOI 10.1023/A:1023022709710; Saavedra-Rodriguez L, 2013, BIOL PSYCHIAT, V73, P44, DOI 10.1016/j.biopsych.2012.06.035; Sharma A, 2017, MECH AGEING DEV, V163, P15, DOI 10.1016/j.mad.2016.12.015; Sharma U, 2018, DEV CELL, V46, P481, DOI 10.1016/j.devcel.2018.06.023; Stringer S, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09249-3; Tobi EW, 2009, HUM MOL GENET, V18, P4046, DOI 10.1093/hmg/ddp353; Vagero D, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07617-9; Van Baak TE, 2018, GENOME BIOL, V19, DOI 10.1186/s13059-017-1374-0; van den Berg GJ, 2016, ECON HUM BIOL, V23, P103, DOI 10.1016/j.ehb.2016.07.001; Williamson CM, 2019, SCI REP-UK, V9, DOI [10.1038/s41598-019-43747-w, 10.1038/s41598-019-51678-9]; Wilson US, 2017, J NEUROPHYSIOL, V118, P1164, DOI 10.1152/jn.00142.2017; Yen AMF, 2016, CIRCULATION, V134, P392, DOI 10.1161/CIRCULATIONAHA.116.021511; Zhao LQ, 2003, PHYSIOL BEHAV, V78, P625, DOI 10.1016/S0031-9384(03)00057-X; Zuko A, 2013, EUR J PHARMACOL, V719, P63, DOI 10.1016/j.ejphar.2013.07.016	64	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2020	15	2							e0229323	10.1371/journal.pone.0229323	http://dx.doi.org/10.1371/journal.pone.0229323			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8DW	32092095	Green Published, gold, Green Accepted			2022-12-26	WOS:000535229300046
J	Nakanishi, H; Sawada, T; Kaizaki, Y; Ota, R; Suzuki, H; Yamamoto, E; Aoki, H; Eizuka, M; Hasatani, K; Takahashi, N; Inagaki, S; Ebi, M; Kato, H; Kubota, E; Kataoka, H; Takahashi, S; Tokino, T; Minamoto, T; Sugai, T; Sasaki, Y				Nakanishi, Hiroyoshi; Sawada, Takeshi; Kaizaki, Yasuharu; Ota, Ryosuke; Suzuki, Hiromu; Yamamoto, Eiichiro; Aoki, Hironori; Eizuka, Makoto; Hasatani, Kenkei; Takahashi, Naoki; Inagaki, Satoko; Ebi, Masahide; Kato, Hiroyuki; Kubota, Eiji; Kataoka, Hiromi; Takahashi, Satoru; Tokino, Takashi; Minamoto, Toshinari; Sugai, Tamotsu; Sasaki, Yasushi			Significance of gene mutations in the Wnt signaling pathway in traditional serrated adenomas of the colon and rectum	PLOS ONE			English	Article							ISLAND METHYLATOR PHENOTYPE; MICROSATELLITE INSTABILITY; COLORECTAL-CANCER; NEOPLASTIC PROGRESSION; HELICOBACTER-PYLORI; BRAF MUTATION; BETA-CATENIN; POLYPS; DISTINCT; LESIONS	Recent studies have shown that colorectal serrated lesions, which include sessile serrated adenomas (SSAs) and traditional serrated adenomas (TSAs), are precursors of colorectal cancer. However, the molecular mechanisms underlying the carcinogenesis, particularly in TSAs, remain largely uncharacterized. To clarify their molecular and clinicopathological characteristics, we performed mutation and methylation analyses of cancer-associated genes in 78 serrated lesions, including TSAs, SSAs and microvesicular hyperplastic polyps. Target exon sequence analysis was performed with 39 genes, including genes known to be frequently mutated in colorectal cancers and/or serrated lesions. We also used bisulfite pyrosequencing to assess the methylation status of various cancer-associated genes and marker genes of the CpG island methylator phenotype (CIMP). The prevalence of mutations in genes associated with Wnt signaling was significantly higher in TSAs than SSAs (65% vs. 28%, p < 0.01). Among those, RNF43 mutations were observed in 38% of TSAs and 17% of SSAs. In immunohistochemical studies of 39 serrated lesions, the prevalence of abnormal nuclear beta-catenin accumulation was significantly higher in TSAs (57%) than SSAs (8%) (P = 0.01). SMOC1 methylation was detected in 54% of TSAs but in no SSAs (p < 0.01). Additionally, SMOC1 methylation was more prevalent among TSAs with KRAS mutation (82%) than with BRAF mutation (38%, p = 0.03). Lesions with CIMP-high or RNF43 mutations were detected only in TSAs with BRAF mutation, suggesting two distinct carcinogenic pathways in TSAs. Mutations in genes associated with Wnt signaling play a greater role in the carcinogenesis of TSAs than SSAs.	[Nakanishi, Hiroyoshi; Sawada, Takeshi; Ota, Ryosuke; Minamoto, Toshinari] Kanazawa Univ, Canc Res Inst, Div Translat & Clin Oncol, Kanazawa, Ishikawa, Japan; [Sawada, Takeshi; Kubota, Eiji; Kataoka, Hiromi] Nagoya City Univ, Dept Gastroenterol & Metab, Grad Sch Med Sci, Nagoya, Aichi, Japan; [Kaizaki, Yasuharu] Fukui Prefectural Hosp, Dept Pathol, Fukui, Japan; [Suzuki, Hiromu; Yamamoto, Eiichiro; Aoki, Hironori] Sapporo Med Univ, Dept Mol Biol, Sch Med, Sapporo, Hokkaido, Japan; [Eizuka, Makoto; Sugai, Tamotsu] Iwate Med Univ, Dept Mol Diagnost Pathol, Sch Med, Morioka, Iwate, Japan; [Hasatani, Kenkei] Fukui Prefectural Hosp, Dept Gastroenterol, Fukui, Japan; [Takahashi, Naoki] Saitama Canc Ctr, Dept Gastroenterol, Saitama, Japan; [Inagaki, Satoko] Kanazawa Univ, Dept Adv Res Community Med, Grad Sch Med Sci, Kanazawa, Ishikawa, Japan; [Ebi, Masahide] Aichi Med Univ, Dept Gastroenterol, Nagakute, Aichi, Japan; [Kato, Hiroyuki; Takahashi, Satoru] Nagoya City Univ, Dept Expt Pathol & Tumor Biol, Grad Sch Med Sci, Nagoya, Aichi, Japan; [Tokino, Takashi] Sapporo Med Univ, Res Inst Frontier Med, Dept Med Genome Sci, Sapporo, Hokkaido, Japan; [Sasaki, Yasushi] Sapporo Med Univ, Ctr Med Educ, Dept Liberal Arts & Sci, Div Biol, Sapporo, Hokkaido, Japan	Kanazawa University; Nagoya City University; Sapporo Medical University; Iwate Medical University; Kanazawa University; Aichi Medical University; Nagoya City University; Sapporo Medical University; Sapporo Medical University	Sawada, T (corresponding author), Kanazawa Univ, Canc Res Inst, Div Translat & Clin Oncol, Kanazawa, Ishikawa, Japan.; Sawada, T (corresponding author), Nagoya City Univ, Dept Gastroenterol & Metab, Grad Sch Med Sci, Nagoya, Aichi, Japan.; Sasaki, Y (corresponding author), Sapporo Med Univ, Ctr Med Educ, Dept Liberal Arts & Sci, Div Biol, Sapporo, Hokkaido, Japan.	takeshisawada@icloud.com; yasushi@sapmed.ac.jp	Tokino, Takashi/AAI-9887-2021	KUBOTA, EIJI/0000-0002-6694-8772; Sasaki, Yasushi/0000-0002-3500-8059	JSPS KAKENHI [JP16K09304, JP17K09374, JP19K08367]; Japanese Foundation for Research and Promotion of Endoscopy; Extramural Collaborative Research Grant of Cancer Research Institute, Kanazawa University; Takeda Science Foundation	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Japanese Foundation for Research and Promotion of Endoscopy(Japanese Foundation for Research and Promotion of Endoscopy); Extramural Collaborative Research Grant of Cancer Research Institute, Kanazawa University; Takeda Science Foundation(Takeda Science Foundation (TSF))	This study was supported in part by JSPS KAKENHI Grant Numbers JP16K09304 (TS), JP17K09374 (SI), and JP19K08367 (RO), Grant-in-Aid from the Japanese Foundation for Research and Promotion of Endoscopy (TS), Extramural Collaborative Research Grant of Cancer Research Institute, Kanazawa University (TS), and a Grant-in-Aid from the Takeda Science Foundation (TS). There was no additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoki H, 2018, ONCOTARGET, V9, P4707, DOI 10.18632/oncotarget.23523; Axon A, 2005, ENDOSCOPY, V37, P570, DOI 10.1055/s-2005-861352; Bettington ML, 2015, MODERN PATHOL, V28, P414, DOI 10.1038/modpathol.2014.122; Burnett-Hartman AN, 2013, CANCER RES, V73, P2863, DOI 10.1158/0008-5472.CAN-12-3462; De Sousa E Melo F, 2013, NAT MED, V19, P614, DOI 10.1038/nm.3174; FEARON ER, 1990, CELL, V61, P759, DOI 10.1016/0092-8674(90)90186-I; Fu XS, 2012, J CLIN PATHOL, V65, P675, DOI 10.1136/jclinpath-2011-200602; Gala MK, 2014, GASTROENTEROLOGY, V146, P520, DOI 10.1053/j.gastro.2013.10.045; Giannakis M, 2014, NAT GENET, V46, P1264, DOI 10.1038/ng.3127; Gonzalo DH, 2013, J PATHOL, V230, P420, DOI 10.1002/path.4200; Grady WM, 2008, GASTROENTEROLOGY, V135, P1079, DOI 10.1053/j.gastro.2008.07.076; Grasso C, 2015, J MOL DIAGN, V17, P53, DOI 10.1016/j.jmoldx.2014.09.008; Iino H, 1999, J CLIN PATHOL, V52, P5, DOI 10.1136/jcp.52.1.5; Jiao YF, 2008, ONCOLOGY-BASEL, V74, P127, DOI 10.1159/000151359; Kambara T, 2004, GUT, V53, P1137, DOI 10.1136/gut.2003.037671; Kanth P, 2016, CANCER PREV RES, V9, P456, DOI 10.1158/1940-6207.CAPR-15-0363; Kim KM, 2010, AM J SURG PATHOL, V34, P667, DOI 10.1097/PAS.0b013e3181d40cb2; Kim MJ, 2013, AM J CLIN PATHOL, V140, P898, DOI 10.1309/AJCPDJC9VC5KTYUS; Kimura T, 2012, AM J GASTROENTEROL, V107, P460, DOI 10.1038/ajg.2011.457; Lochhead P, 2014, AM J GASTROENTEROL, V109, P1205, DOI 10.1038/ajg.2014.153; LONGACRE TA, 1990, AM J SURG PATHOL, V14, P524, DOI 10.1097/00000478-199006000-00003; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Nakagaki T, 2017, ONCOTARGET, V8, P59113, DOI 10.18632/oncotarget.19262; O'Brien MJ, 2006, AM J SURG PATHOL, V30, P1491, DOI 10.1097/01.pas.0000213313.36306.85; Ougolkov AV, 2002, GASTROENTEROLOGY, V122, P60, DOI 10.1053/gast.2002.30306; Rosty C, 2013, J GASTROENTEROL, V48, P287, DOI 10.1007/s00535-012-0720-y; Roszik J, 2016, SCI REP-UK, V6, DOI 10.1038/srep19649; Sakai E, 2016, INT J CANCER, V138, P1634, DOI 10.1002/ijc.29903; Sambuudash O, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000005592; Sawada T, 2016, ONCOTARGET, V7, P35106, DOI 10.18632/oncotarget.9044; Sekine S, 2016, J PATHOL, V239, P133, DOI 10.1002/path.4709; Singh RR, 2013, J MOL DIAGN, V15, P607, DOI 10.1016/j.jmoldx.2013.05.003; Snover DC, 2005, AM J CLIN PATHOL, V124, P380, DOI 10.1309/V2EPTPLJRB3FGHJL; Snover DC, 2010, WHO CLASSIFICATION T, P160; Spring KJ, 2006, GASTROENTEROLOGY, V131, P1400, DOI 10.1053/j.gastro.2006.08.038; Suzuki H, 2004, NAT GENET, V36, P417, DOI 10.1038/ng1330; Suzuki H, 2010, CARCINOGENESIS, V31, P342, DOI 10.1093/carcin/bgp179; Tahara T, 2014, GASTROENTEROLOGY, V146, P530, DOI 10.1053/j.gastro.2013.10.060; Torlakovic E, 2003, AM J SURG PATHOL, V27, P65, DOI 10.1097/00000478-200301000-00008; Toyota M, 1999, P NATL ACAD SCI USA, V96, P8681, DOI 10.1073/pnas.96.15.8681; Toyota M, 2008, CANCER RES, V68, P4123, DOI 10.1158/0008-5472.CAN-08-0325; Tsai JH, 2016, AM J SURG PATHOL, V40, P1352, DOI 10.1097/PAS.0000000000000664; Tsai JH, 2014, MODERN PATHOL, V27, P1375, DOI 10.1038/modpathol.2014.35; Wang W, 2019, SEMIN CANCER BIOL, V55, P37, DOI 10.1016/j.semcancer.2018.05.002; Wei R, 2016, SCI REP-UK, V6, DOI 10.1038/srep37358; Weisenberger DJ, 2006, NAT GENET, V38, P787, DOI 10.1038/ng1834; Yachida S, 2009, AM J SURG PATHOL, V33, P1823, DOI 10.1097/PAS.0b013e3181b6da19; Yamamoto E, 2008, CANCER EPIDEM BIOMAR, V17, P2555, DOI 10.1158/1055-9965.EPI-08-0112; Yamamoto E, 2012, AM J PATHOL, V181, P1847, DOI 10.1016/j.ajpath.2012.08.007; Yan HHN, 2017, GUT, V66, P1645, DOI 10.1136/gutjnl-2016-311849; Yang HJ, 2018, GASTRIC CANCER, V21, P237, DOI 10.1007/s10120-017-0741-6	51	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2020	15	2							e0229262	10.1371/journal.pone.0229262	http://dx.doi.org/10.1371/journal.pone.0229262			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8DW	32092099	gold, Green Published, Green Submitted			2022-12-26	WOS:000535229300040
J	Gustafsson, L; Lu, F; Rickard, F; MacArthur, C; Cummins, C; Coker, I; Mane, K; Manneh, K; Wilson, A; Manaseki-Holland, S				Gustafsson, Lotta; Lu, Fides; Rickard, Faith; MacArthur, Christine; Cummins, Carole; Coker, Ivan; Mane, Kebba; Manneh, Kebba; Wilson, Amie; Manaseki-Holland, Semira			The content and completeness of women-held maternity documents before admission for labour: A mixed methods study in Banjul, The Gambia	PLOS ONE			English	Article							HEALTH; INFORMATION; RECORDS; CARE	Background Women-held maternity documents are well established for enabling continuity of maternity care worldwide, with the World Health Organisation (WHO) recommending their use in effective decision-making. We aimed to assess the presence, content and completeness of women-held maternity documents at admission to hospitals in The Gambia, and investigate barriers and facilitators to their completion. Methods We interviewed 250 women on maternity wards of all 3 Banjul hospitals and conducted content analysis of documentation brought by women on admission for their completeness against WHO referrals criteria. Logistic regression models were used to estimate the odds of the minimum criteria being met. Two focus groups and 21 semi-structured interviews (8 doctors, 8 midwives and 5 nurses) were conducted with healthcare practitioners to explore barriers and facilitators to documented clinical information availability on admission. Findings Of the women admitted, all but 10/250 (4%) brought either a maternity card or a structured referral sheet. Of all forms of documentation, women most frequently brought the government-issued maternity card (235/250, 94%); 16% of cards had all 9 minimum criteria completed. Of the 79 referred women, 60% carried standardised referral forms. Only 30% of 97 high-risk women had risk-status recorded. Women were less likely to have documents complete if they were illiterate, had not attended three maternity appointments, or lived more than one hour from hospital. During qualitative interviews, three themes were identified: women as agents for transporting information and documents (e.g. remembering to bring maternity cards); role of individual healthcare professionals' actions (e.g. legibility of handwriting); system and organisational culture (e.g. standardised referral guidelines). Conclusion Women rarely forgot their maternity card, but documents brought at admission were frequently incomplete. This is a missed opportunity to enhance handover and quality of care, especially for high-risk women. National guidelines were recognised by providers as needed for good document keeping and would enhance the women-held maternity documents' contribution to improving both safety and continuity of care.	[Gustafsson, Lotta; Lu, Fides; Rickard, Faith] Univ Birmingham, Med Sch, Birmingham, W Midlands, England; [MacArthur, Christine; Cummins, Carole; Wilson, Amie; Manaseki-Holland, Semira] Univ Birmingham, Birmingham Clin Trials Unit, Inst Appl Hlth Res, Coll Med & Dent Sci, Birmingham, W Midlands, England; [Coker, Ivan; Mane, Kebba] Bundung Maternal & Child Hlth Hosp, Banjul, Gambia; [Manneh, Kebba] Kanifing Gen Hosp, Banjul, Gambia	University of Birmingham; University of Birmingham	Manaseki-Holland, S (corresponding author), Univ Birmingham, Birmingham Clin Trials Unit, Inst Appl Hlth Res, Coll Med & Dent Sci, Birmingham, W Midlands, England.	S.ManasekiHolland@bham.ac.uk	Manaseki-Holland, Semira/AFX-1728-2022; MacArthur, Christine/ABA-8601-2021; Wilson, Amie/HHS-0117-2022	Manaseki-Holland, Semira/0000-0001-5827-8855; MacArthur, Christine/0000-0003-0434-2158; Wilson, Amie/0000-0002-1015-3786; Cummins, Carole/0000-0001-5464-1944	University of Birmingham Intercalation Award: Arthur Thompson Trust	University of Birmingham Intercalation Award: Arthur Thompson Trust	This work recieved funding from the University of Birmingham Intercalation Award: Arthur Thompson Trust Award to LG. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aihara Y., 2006, J INT HLTH, V21, P123, DOI [10.11197/jaih.21.123, DOI 10.11197/JAIH.21.123]; Akhlaq A, 2016, HEALTH POLICY PLANN, V31, P1310, DOI 10.1093/heapol/czw056; Bhuiyan SUNY., 2006, J PUBLIC HLTH DEV, V4, P45; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [DOI 10.1191/1478088706QP063OA, 10.1191/1478088706qp063oa]; Brown HC, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002856.pub3; Carter N, 2014, ONCOL NURS FORUM, V41, P545, DOI 10.1188/14.ONF.545-547; Chatterjee P, 2012, SAMJ S AFR MED J, V102, P138, DOI 10.7196/SAMJ.5672; Global Health Workforce Alliance, 2017, DEP PUBL ENV HLTH; HAMILTON S G, 1956, Practitioner, V176, P79; Harrison D, 1998, S AFR MED J, V88, P1424; Hawley G, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-52; Homer CSE, 1999, AUST NZ J OBSTET GYN, V39, P54, DOI 10.1111/j.1479-828X.1999.tb03445.x; Humphries C, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0207511; JEFFS D, 1994, J PAEDIATR CHILD H, V30, P248, DOI 10.1111/j.1440-1754.1994.tb00627.x; Lovell A, 1987, Paediatr Perinat Epidemiol, V1, P57, DOI 10.1111/j.1365-3016.1987.tb00090.x; Lyndon A, 2011, AM J OBSTET GYNECOL, V205, P91, DOI 10.1016/j.ajog.2011.04.021; Mori R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119772; Osaki K, 2013, GLOBAL HEALTH ACTION, V6, P1, DOI 10.3402/gha.v6i0.20429; SHAH PM, 1993, B WORLD HEALTH ORGAN, V71, P535; Sheikh A., 2018, INT J COMMUNITY MED, V5, P3760, DOI [10.18203/2394-6040.ijcmph20183560, DOI 10.18203/2394-6040.IJCMPH20183560]; The Gambia Bureau of Statistics (GBOS) and ICF International, 2014, GAM DEM HLTH SURV 20; Toohill Jocelyn, 2006, Women Birth, V19, P113, DOI 10.1016/j.wombi.2006.07.003; Turner KE, 2011, ONLINE J PUBLIC HLTH, V3; UN Women, SDG 3 ENS HLTH LIV P; Usman HR, 2011, TROP MED INT HEALTH, V16, P334, DOI 10.1111/j.1365-3156.2010.02698.x; Walraven G, 2000, B WORLD HEALTH ORGAN, V78, P603; WHO, 2022, WHO RECOMMENDATIONS; WHO, 2002, WHO ANT CAR RAND CON; WHO (World Health Organization), 2015, TRENDS MATERNAL MORT; World Health Organisation, 2010, AN SUMM MAT NEWB HLT; World Health Organization, 2018, WHO REC HOM BAS REC; World Health Organization, 2006, PROV EFF ANT CAR; World Health Organization, 2017, MAN COMPL PREGN CHIL; World Health Organization (WHO), 2016, STANDARDS IMPROVING; Yanagisawa S, 2015, HEALTH POLICY PLANN, V30, P1184, DOI 10.1093/heapol/czu133	36	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2020	15	3							e0230063	10.1371/journal.pone.0230063	http://dx.doi.org/10.1371/journal.pone.0230063			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8TR	32142545	gold, Green Published			2022-12-26	WOS:000535271600035
J	Fero, E; Juma, A; Koni, A; Boci, J; Kirandjiski, T; Connor, R; Wareth, G; Koleci, X				Fero, Edi; Juma, Arla; Koni, Anita; Boci, Jonida; Kirandjiski, Toni; Connor, Robert; Wareth, Gamal; Koleci, Xhelil			The seroprevalence of brucellosis and molecular characterization of Brucella species circulating in the beef cattle herds in Albania	PLOS ONE			English	Article							IDENTIFICATION; DIAGNOSIS; INSIGHTS	Background Brucellosis is a ubiquitous zoonotic disease globally. It is endemic among bovines, sheep, and goats in Albania. The national control and eradication programs for brucellosis has been applied on sheep and goat farms as well as large dairy cattle farms, i.e., those with more than ten milking cows. The current study aims at estimating the herd and average individual animal prevalence of brucellosis in the national beef cattle herds, the missing information that was essential to propose the most appropriate control measures for this subpopulation. Rose Bengal Test (RBT), Fluorescence Polarization Assay (FPA), and Enzyme-Linked Immunosorbent Assay (ELISA) were used as serological tests and classical bacteriology for isolation. Results were also used to investigate the difference in sensitivity between the assays used. Methodology In total, 655 animals from 38 beef cattle herds from six southern districts of Albania were sampled. Sera were tested using RBT, FPA, and ELISA. Fifteen positive cows and a bull from eight high-prevalence positive herds were slaughtered, and particular tissue samples were collected for bacteriology. Results The overall herd seroprevalence in the tested beef cattle population was 55%, while the overall average within-herd prevalence (including only positive herds) was 38.3%, 42.7%, and 45.6% determined by the RBT, ELISA, and FPA, respectively. FPA was used for the first time in the diagnosis of bovine brucellosis in Albania, and its sensitivity was higher than RBT and ELISA. Three B. abortus strains were identified, two from the supra-mammary lymph node of two cows and one from the epididymis of a seropositive bull. Conclusion Brucellosis was highly prevalent in beef cattle in the southern part of Albania, and B. abortus was isolated from this subpopulation. To the best of our knowledge, this is the first statistically based survey of bovine brucellosis in beef herds in Albania. Using the FPA in parallel with other serological tests improved overall diagnostic sensitivity. Test and slaughter policy is not a rational approach for the control of brucellosis in beef cattle in Albania, and vaccination is only applicable, including strict control of the movement of animals.	[Fero, Edi; Koni, Anita; Connor, Robert; Koleci, Xhelil] Agr Univ Tirana, Fac Vet Med, Dept Vet Publ Hlth, Tirana, Albania; [Juma, Arla; Boci, Jonida] Food Safety & Vet Inst, Anim Hlth Lab, Tirana, Albania; [Kirandjiski, Toni; Connor, Robert] ISUV, Tirana, Albania; [Wareth, Gamal] Friedrich Loeffler Inst, Inst Bacterial Infect & Zoonoses, Jena, Germany; [Wareth, Gamal] Benha Univ, Fac Vet Med, Toukh, Qalyubia, Egypt	Friedrich Loeffler Institute; Egyptian Knowledge Bank (EKB); Benha University	Koleci, X (corresponding author), Agr Univ Tirana, Fac Vet Med, Dept Vet Publ Hlth, Tirana, Albania.	xhelil.koleci@ubt.edu.al	Wareth, Gamal/AAA-8868-2021	Wareth, Gamal/0000-0001-6259-1932; Koleci, Xhelil/0000-0001-8945-7776	EU EXPANSION (EU) [Europe Aid/128304/C/SER/AL]; [IZSVe EXPANSION] (IZSVe) Consortium, under EU [2009/223-812]	EU EXPANSION (EU); [IZSVe EXPANSION] (IZSVe) Consortium, under EU	This work was supported in part by the [EU EXPANSION] (EU)-funded "Improving of consumer protection against zoonotic diseases (Albania)", project no. Europe Aid/128304/C/SER/AL that was implemented by the [NIRAS IC EXPANSION] (NIRAS IC), Agrotec and [IZSVe EXPANSION] (IZSVe) Consortium, under EU contract number 2009/223-812. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Alton G.G., 1988, TECHNIQUES BRUCELLOS; Awah-Ndukum J, 2018, Vet Med Int, V2018, P3468596, DOI 10.1155/2018/3468596; Bego A, 2013, INT J SCI REIJSR, V4, P1519; Bounaadja L, 2009, VET MICROBIOL, V137, P156, DOI 10.1016/j.vetmic.2008.12.023; Bundle DR, 2017, ACCOUNTS CHEM RES, V50, P2958, DOI 10.1021/acs.accounts.7b00445; de Figueiredo P, 2015, AM J PATHOL, V185, P1505, DOI 10.1016/j.ajpath.2015.03.003; Ducrotoy MJ, 2018, PREV VET MED, V151, P57, DOI 10.1016/j.prevetmed.2018.01.005; Edi Fero AJ, 2018, ALB DAIR CATTL INT C; EUROPEANUNION, 2008, OFFICIAL J EUROPEA L, V352; FENSTERBANK R, 1978, VET REC, V103, P283, DOI 10.1136/vr.103.13.283; Ferro E, 2019, EUROPEAN ACAD RES, VVII, P3696; Foster G, 2007, INT J SYST EVOL MICR, V57, P2688, DOI 10.1099/ijs.0.65269-0; Godfroid J., 2004, Infectious diseases of livestock. Volume Three, P1510; Godfroid J, 2011, PREV VET MED, V102, P118, DOI 10.1016/j.prevetmed.2011.04.007; Kalleshamurthy T, 2019, J MICROBIOL METH, V156, P46, DOI 10.1016/j.mimet.2018.11.023; Kalleshamurthy T, 2018, MICROBIOL IMMUNOL, V62, P694, DOI 10.1111/1348-0421.12654; Lemos TS, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006770; Mai HM, 2012, BMC VET RES, V8, DOI 10.1186/1746-6148-8-144; McGiven J, 2011, REV SCI TECH OIE, V30, P809; Mersinaj K, 2013, ALBANIAN J AGR SCI; Mersini K, 2019, INT J INFECT DIS, V79, P3, DOI 10.1016/j.ijid.2018.11.028; Mutolo MJ, 2012, AM J PHYS ANTHROPOL, V147, P254, DOI 10.1002/ajpa.21643; OIE, 2018, BRUC BRUC AB B MED B; Peck D, 2017, REV SCI TECH OIE, V36, P291, DOI 10.20506/rst.36.1.2629; Project P, 2015, EUROPEAID128304CSERA; Sacchini L, 2019, MICROORGANISMS, V7, DOI 10.3390/microorganisms7100398; Scholz HC, 2008, INT J SYST EVOL MICR, V58, P375, DOI 10.1099/ijs.0.65356-0; Scholz HC, 2016, INT J SYST EVOL MICR, V66, P2090, DOI 10.1099/ijsem.0.000998; Scholz HC, 2010, INT J SYST EVOL MICR, V60, P801, DOI 10.1099/ijs.0.011148-0; Solutions. S, 2013, DAT AN PLAN KAPP COE; Wareth G, 2017, TRANSBOUND EMERG DIS, V64, pE27, DOI 10.1111/tbed.12535; Wareth G., 2019, BRUCELLOSIS MEDITERR; Wareth G, 2020, PATHOGENS, V9, DOI 10.3390/pathogens9020077; Whatmore AM, 2014, INT J SYST EVOL MICR, V64, P4120, DOI 10.1099/ijs.0.065482-0	34	6	7	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2020	15	3							e0229741	10.1371/journal.pone.0229741	http://dx.doi.org/10.1371/journal.pone.0229741			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8RK	32134953	gold, Green Published			2022-12-26	WOS:000535265600041
J	Su, MW; Chang, CK; Lin, CW; Ling, SJ; Hsiung, CN; Chu, HW; Wu, PE; Shen, CY				Su, Ming-Wei; Chang, Chung-ke; Lin, Chien-Wei; Ling, Shiu-Jie; Hsiung, Chia-Ni; Chu, Hou-Wei; Wu, Pei-Ei; Shen, Chen-Yang			Blood multiomics reveal insights into population clusters with low prevalence of diabetes, dyslipidemia and hypertension	PLOS ONE			English	Article							METABOLIC SYNDROME; CHOLESTEROL; DISEASE; MTOR; RISK; LDL	Diabetes, dyslipidemia and hypertension are important metabolic diseases that impose a great burden on many populations worldwide. However, certain population strata have reduced prevalence for all three diseases, but the underlying mechanisms are poorly understood. We sought to identify the phenotypic, genomic and metabolomic characteristics of the low-prevalence population to gain insights into possible innate non-susceptibility against metabolic diseases. We performed k-means cluster analysis of 16,792 subjects using anthropometric and clinical biochemistry data collected by the Taiwan Biobank. Nuclear magnetic resonance spectra-based metabolome analysis was carried out for 217 subjects with normal body mass index, good exercise habits and healthy lifestyles. We found that the gene APOA5 was significantly associated with reduced prevalence of disease, and lesser associations included the genes HIF1A, LIMA1, LPL, MLXIPL, and TRPC4. Blood plasma of subjects belonging to the low disease prevalence cluster exhibited lowered levels of the GlycA inflammation marker, very low-density lipoprotein and low-density lipoprotein cholesterol, triglycerides, valine and leucine compared to controls. Literature mining revealed that these genes and metabolites are biochemically linked, with the linkage between lipoprotein metabolism and inflammation being particularly prominent. The combination of phenomic, genomic and metabolomic analysis may also be applied towards the study of metabolic disease prevalence in other populations.	[Su, Ming-Wei; Chang, Chung-ke; Lin, Chien-Wei; Hsiung, Chia-Ni; Chu, Hou-Wei; Wu, Pei-Ei; Shen, Chen-Yang] Acad Sinica, Inst Biomed Sci, Taipei, Taiwan; [Ling, Shiu-Jie] Wego Private Bilingual Senior High Sch, Taipei, Taiwan; [Hsiung, Chia-Ni] Natl Tsing Hua Univ, Inst Bioinformat & Struct Biol, Hsinchu, Taiwan; [Shen, Chen-Yang] China Med Univ, Coll Publ Hlth, Taichung, Taiwan	Academia Sinica - Taiwan; National Tsing Hua University; China Medical University Taiwan	Shen, CY (corresponding author), Acad Sinica, Inst Biomed Sci, Taipei, Taiwan.; Shen, CY (corresponding author), China Med Univ, Coll Publ Hlth, Taichung, Taiwan.	bmcys@ibms.sinica.edu.tw	Shen, CY/F-6271-2010	Chang, Chung-ke/0000-0002-3864-1896	Institute of Biomedical Sciences, Academia Sinica	Institute of Biomedical Sciences, Academia Sinica(Academia Sinica - Taiwan)	This study was funded by the Institute of Biomedical Sciences, Academia Sinica. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aje TO, 2009, WORLD J CARDIOL, V1, P3, DOI 10.4330/wjc.v1.i1.3; Ananieva EA, 2016, ADV NUTR, V7, p798S, DOI 10.3945/an.115.011221; Babio N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058354; Brinks R, 2015, MATH MED BIOL, V32, P425, DOI 10.1093/imammb/dqu024; Bush WS, 2016, NAT REV GENET, V17, P129, DOI 10.1038/nrg.2015.36; Chen CH, 2016, HUM MOL GENET, V25, P5321, DOI 10.1093/hmg/ddw346; Graham S, 2012, EXP BIOL MED, V237, P111, DOI 10.1258/ebm.2011.011208; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; Grundy SM, 2005, CIRCULATION, V112, P2735, DOI 10.1161/CIRCULATIONAHA.105.169404; Guo Q, 2017, SCI REP-UK, V7, DOI 10.1038/srep43965; Haase CL, 2015, DIABETES, V64, P3328, DOI 10.2337/db14-1603; Horiuchi Y, 2017, CIRCULATION, V136; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Iizuka K, 2008, ENDOCR J, V55, P617, DOI 10.1507/endocrj.K07E-110; Kanbay M, 2016, EUR J INTERN MED, V29, P3, DOI 10.1016/j.ejim.2015.11.026; KEIDING N, 1991, J R STAT SOC A STAT, V154, P371, DOI 10.2307/2983150; Kim WR, 2008, HEPATOLOGY, V47, P1363, DOI 10.1002/hep.22109; Lin CF, 2018, INT J GERONTOL, V12, P2, DOI 10.1016/j.ijge.2018.02.010; Makinen VP, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb4100205; Onat A, 2012, OBESITY, V20, P842, DOI 10.1038/oby.2011.136; Otvos JD, 2015, CLIN CHEM, V61, P714, DOI 10.1373/clinchem.2014.232918; Ovalle F, 2018, NAT MED, V24, P1108, DOI 10.1038/s41591-018-0089-4; Pollex RL, 2006, NAT CLIN PRACT CARD, V3, P482, DOI 10.1038/ncpcardio0638; Psychogios N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016957; Schaap FG, 2004, J BIOL CHEM, V279, P27941, DOI 10.1074/jbc.M403240200; Schofield JD, 2016, DIABETES THER, V7, P203, DOI 10.1007/s13300-016-0167-x; Shen GM, 2012, BIOCHEM J, V441, P675, DOI 10.1042/BJ20111377; Soininen P, 2015, CIRC-CARDIOVASC GENE, V8, P192, DOI 10.1161/CIRCGENETICS.114.000216; Suhre K, 2011, NATURE, V477, P54, DOI 10.1038/nature10354; Taverna M, 2013, ANN INTENSIVE CARE, V3, DOI 10.1186/2110-5820-3-4; Trevino-Villarreal JH, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.99470; Waickman AT, 2012, IMMUNOL REV, V249, P43, DOI 10.1111/j.1600-065X.2012.01152.x; Weatherall M, 2009, EUR RESPIR J, V34, P812, DOI 10.1183/09031936.00174408; WHO, DIAB FACT SHEET; World Health Organization, GLOB HLTH OBS GHO DA; Zarfeshani A, 2014, CLIN EPIGENETICS, V6, DOI 10.1186/1868-7083-6-27; Zhang YY, 2018, SCIENCE, V360, P1087, DOI 10.1126/science.aao6575; Ziberna L, 2016, SCI REP-UK, V6, DOI 10.1038/srep29240	38	4	4	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2020	15	3							e0229922	10.1371/journal.pone.0229922	http://dx.doi.org/10.1371/journal.pone.0229922			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8RK	32134946	gold, Green Published			2022-12-26	WOS:000535265600061
J	Win, SMK; Saito, R; Win, NC; Lasham, D; Kyaw, Y; Lin, N; Thein, KN; Chon, I; Odagiri, T; Thein, W; Kyaw, LL; Tin, OS; Saitoh, A; Tamura, T; Hirokawa, C; Uchida, Y; Saito, T; Watanabe, S; Odagiri, T; Kamata, K; Osada, H; Dapat, C; Watanabe, H; Ti, HH				Win, Su Mon Kyaw; Saito, Reiko; Win, Nay Chi; Lasham, Di Ja; Kyaw, Yadanar; Lin, Nay; Thein, Khin Nyo; Chon, Irina; Odagiri, Takashi; Thein, Win; Kyaw, Latt Latt; Tin, Ommar Swe; Saitoh, Akihiko; Tamura, Tsutomu; Hirokawa, Chika; Uchida, Yuko; Saito, Takehiko; Watanabe, Shinji; Odagiri, Takato; Kamata, Kazuhiro; Osada, Hidekazu; Dapat, Clyde; Watanabe, Hisami; Ti, Htay Htay			Epidemic of influenza A(H1N1)pdm09 analyzed by full genome sequences and the first case of oseltamivir-resistant strain in Myanmar 2017	PLOS ONE			English	Article							VIRUSES; EMERGENCE; INDIA	A community outbreak of human influenza A(H1N1)pdm09 virus strains was observed in Myanmar in 2017. We investigated the circulation patterns, antigenicity, and drug resistance of 2017 influenza A(H1N1)pdm09 viruses from Myanmar and characterized the full genome of influenza virus strains in Myanmar from in-patients and out-patients to assess the pathogenicity of the viruses. Nasopharyngeal swabs were collected from out-patients and inpatients with acute respiratory tract infections in Yangon and Pyinmana City in Myanmar during January-December 2017. A total of 215 out-patients and 18 in-patients infected with A(H1N1)pdm09 were detected by virus isolation and real-time RT-PCR. Among the positive patients, 90.6% were less than 14 years old. Hemagglutination inhibition (HI) antibody titers against A(H1N1)pdm09 viruses in Myanmar were similar to the recommended Japanese influenza vaccine strain for 2017-2018 seasons (A/Singapore/GP1908/2015) and WHO recommended 2017 southern hemisphere vaccine component (A/Michigan/45/2015). Phylogenetic analysis of the hemagglutinin sequence showed that the Myanmar strains belonged to the genetic subclade 6B.1, possessing mutations of S162N and S164T at potential antigenic sites. However, the amino acid mutation at position 222, which may enhance the severity of disease and mortality, was not found. One case with no prior history of oseltamivir treatment possessed H275Y mutated virus in neuraminidase (NA), which confers resistance to oseltamivir and peramivir with elevated IC50 values. The full genome sequence of Myanmar strains showed no difference between samples from in-patients and out-patients, suggesting no additional viral mutations associated with patient severity. Several amino acid changes were observed in PB2, PB1, and M2 of Myanmar strains when compared to the vaccine strain and other Asian strains. However, no mutations associated with pathogenicity were found in the Myanmar strains, suggesting that viral factors cannot explain the underlying reasons of the massive outbreak in Myanmar. This study reported the first detection of an oseltamivir-resistant influenza virus in Myanmar, highlighting the importance of continuous antiviral monitoring and genetic characterization of the influenza virus in Myanmar.	[Win, Su Mon Kyaw; Saito, Reiko; Win, Nay Chi; Lasham, Di Ja; Kamata, Kazuhiro; Osada, Hidekazu; Watanabe, Hisami] Niigata Univ Myanmar IDRC, Infect Dis Res Ctr, Yangon, Yangon Region, Myanmar; [Saito, Reiko; Chon, Irina] Niigata Univ, Grad Sch Med & Dent Sci, Div Int Hlth, Niigata, Niigata, Japan; [Kyaw, Yadanar] Thingangyun Sanpya Gen Hosp, Resp Med Dept, Yangon, Yangon Region, Myanmar; [Lin, Nay] Pyinmana Gen Hosp, Microbiol Sect, Clin Lab, Pyinmana Township, Nay Pyi Taw, Myanmar; [Thein, Khin Nyo] Yankin Children Hosp, Pediat Ward 1, Yangon, Yangon Region, Myanmar; [Odagiri, Takashi] Iwate Med Univ, Dept Microbiol Infect Dis & Immunol, Morioka, Iwate, Japan; [Thein, Win; Kyaw, Latt Latt; Tin, Ommar Swe; Ti, Htay Htay] Minist Hlth & Sports, Natl Hlth Lab, Dept Med Serv, Yangon, Yangon Region, Myanmar; [Saitoh, Akihiko] Niigata Univ, Grad Sch Med & Dent Sci, Dept Pediat, Niigata, Niigata, Japan; [Tamura, Tsutomu; Hirokawa, Chika] Niigata Prefectural Inst Publ Hlth & Environm Sci, Div Virol, Niigata, Niigata, Japan; [Uchida, Yuko; Saito, Takehiko] Natl Agr & Food Res Org NARO, Div Transboundary Anim Dis, Tsukuba, Ibaraki, Japan; [Watanabe, Shinji; Odagiri, Takato] Natl Inst Infect Dis, Influenza Res Ctr, Lab Influenza Virus Surveillance, Sinjuku Ku, Tokyo, Japan; [Kamata, Kazuhiro; Osada, Hidekazu; Watanabe, Hisami] Niigata Univ, Inst Med & Dent, Niigata, Japan; [Dapat, Clyde] Tohoku Univ, Dept Virol, Grad Sch Med, Sendai, Miyagi, Japan	Niigata University; Iwate Medical University; Niigata University; National Agriculture & Food Research Organization - Japan; National Institute of Infectious Diseases (NIID); Niigata University; Tohoku University	Win, SMK (corresponding author), Niigata Univ Myanmar IDRC, Infect Dis Res Ctr, Yangon, Yangon Region, Myanmar.	sumonkyawwin@gmail.com	Saito, Takehiko/AFM-3038-2022; Dapat, Clyde/B-4196-2009	Dapat, Clyde/0000-0002-7616-4680; Kyaw Win, Su Mon/0000-0003-3939-4185	International Development Strategy Program for Infectious Diseases Research (JGRID) of AMED (Japan Medical Research and Development Organization) [15fm0108009h000119fm0108009h0005]; Ministry of Agriculture, Forestry and Fisheries in Japan	International Development Strategy Program for Infectious Diseases Research (JGRID) of AMED (Japan Medical Research and Development Organization); Ministry of Agriculture, Forestry and Fisheries in Japan(Ministry of Agriculture Forestry & Fisheries - Japan)	the International Development Strategy Program for Infectious Diseases Research (JGRID) of AMED (Japan Medical Research and Development Organization) (15fm0108009h000119fm0108009h0005); We are grateful to Dr. Tomomi Ota and the staff of the Chest Medical Unit of Sanpya Hospital, Pyinmana General Hospital, Yankin Children Hospital for sample collection, for the management of the study. We thank Niigata University staff, Mrs. Akemi Watanabe for laboratory assistance, Ms. Saori Nedachi and Ms. Yukie Maruyama for secretarial support and Dr. Yugo Shobugawa for study planning. We also thank Dr. Nobuhiro Takemae in the Ministry of Agriculture, Forestry and Fisheries in Japan for contribution to the analysis, and Drs. Nobuo Nagata, Isamu Sato, Takashi Kawashima, Toshihiro Tanaka, Satoshi Aoki, Naoki, Kodo, Hironori Masaki, Norichika Asoh, Yoshiko Tsuchihashi, Yutaka Shirahige, and Hirotsune Hamabata for collecting influenza viruses in Japan. We would like to thank Editage (www.editage.com) for English language editing.	[Anonymous], 2017, Wkly Epidemiol Rec, V92, P117; [Anonymous], 2016, Wkly Epidemiol Rec, V91, P469; Aung LL ZE, 2017, MYANMAR CLIMATE REPO, V9, P1; Barde PV, 2017, EPIDEMIOL INFECT, V145, P2656, DOI 10.1017/S0950268817001595; Biggerstaff M, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-480; Central Epidemiology Unit-Department of Public Health Ministry of Health and Sports, 2018, INFL ILLN ILI SEV AC; Chon I, 2019, VACCINE-X, V1, DOI 10.1016/j.jvacx.2019.100011; Dapat C, 2013, INFLUENZA OTHER RESP, V7, P766, DOI 10.1111/irv.12030; Dapat C, 2009, INTERVIROLOGY, V52, P310, DOI 10.1159/000237738; Department of Public Health Ministry of Health and Sports Myanmar, 2017, REP RESP ACT PREV ME; Dong GY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119115; European Centre for Disease Prevention and Control, 2019, INFL VIR CHAR SUMM E; Graham M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016087; Gubareva LV, 2017, ANTIVIR RES, V146, P12, DOI 10.1016/j.antiviral.2017.08.004; Htwe KTZ, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0210550; Hurt AC, 2011, EUROSURVEILLANCE, V16, P2; Influenza Virus Research Center-National Institute of Infectious Diseases, INFL VACC STRAINS JA; Influenza Virus Research Center-National Institute of Infectious Diseases, INFL 2016 17 SEAS JA; Influenza Virus Research Center-National Institute of Infectious Diseases, LAB PROT DET INFL VI; Jagadesh A, 2019, VIRUS GENES, V55, P458, DOI 10.1007/s11262-019-01675-x; Kash JC, 2015, AM J PATHOL, V185, P1528, DOI 10.1016/j.ajpath.2014.08.030; Kilander A, 2010, EUROSURVEILLANCE, V15, P6; Lackenby A, 2011, EUROSURVEILLANCE, V16, P10; Liu Y, 2010, J VIROL, V84, P12069, DOI 10.1128/JVI.01639-10; MacIntyre CR, 2018, BMC INFECT DIS, V18, DOI 10.1186/s12879-018-3548-0; Mills CE, 2004, NATURE, V432, P904, DOI 10.1038/nature03063; Mukherjee A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0168464; Nakamura K, 2017, INFLUENZA OTHER RESP, V11, P399, DOI 10.1111/irv.12469; Pandey Salonee, 2018, VirusDisease, V29, P380, DOI 10.1007/s13337-018-0474-0; Ruuskanen O, 2011, LANCET, V377, P1264, DOI 10.1016/S0140-6736(10)61459-6; Sarmah K, 2018, 3 BIOTECH, V8, DOI 10.1007/s13205-018-1427-4; Shao WH, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18081650; Suzuki Y, 2011, J CLIN MICROBIOL, V49, P125, DOI 10.1128/JCM.01401-10; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tandel K, 2018, J MED VIROL, V90, P836, DOI 10.1002/jmv.25013; Tewawong N, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175655; World Health Organization, WEEKLY EPIDEMIOLOGIC, V87, P369; World Health Organization, MAN LAB DIAGN VIR SU; World Health Organization, INFL LAB SURV INF GL; World Health Organization. Influenza Laboratory Surveillance Information, 2017, FLUNET GLOB INFL SUR; Worldwide Influenza Centre-The Francis Crick Institute, FEBR 2017 INT REP; Zaraket H, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00262	42	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2020	15	3							e0229601	10.1371/journal.pone.0229601	http://dx.doi.org/10.1371/journal.pone.0229601			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8QU	32130243	gold, Green Published			2022-12-26	WOS:000535264000032
J	Doring, K; Qaseem, A; Becer, M; Li, JY; Mishra, P; Gao, MJ; Kirchner, P; Sauter, F; Telukunta, KK; Moumbock, AFA; Thomas, P; Gunther, S				Doering, Kersten; Qaseem, Ammar; Becer, Michael; Li, Jianyu; Mishra, Pankaj; Gao, Mingjie; Kirchner, Pascal; Sauter, Florian; Telukunta, Kiran K.; Moumbock, Aurelien F. A.; Thomas, Philippe; Guenther, Stefan			Automated recognition of functional compound-protein relationships in literature	PLOS ONE			English	Article							NETWORKS; DATABASE	Motivation Much effort has been invested in the identification of protein-protein interactions using text mining and machine learning methods. The extraction of functional relationships between chemical compounds and proteins from literature has received much less attention, and no ready-to-use open-source software is so far available for this task. Method We created a new benchmark dataset of 2,613 sentences from abstracts containing annotations of proteins, small molecules, and their relationships. Two kernel methods were applied to classify these relationships as functional or non-functional, named shallow linguistic and all-paths graph kernel. Furthermore, the benefit of interaction verbs in sentences was evaluated. Results The cross-validation of the all-paths graph kernel (AUC value: 84.6%, F1 score: 79.0%) shows slightly better results than the shallow linguistic kernel (AUC value: 82.5%, F1 score: 77.2%) on our benchmark dataset. Both models achieve state-of-the-art performance in the research area of relation extraction. Furthermore, the combination of shallow linguistic and all-paths graph kernel could further increase the overall performance slightly. We used each of the two kernels to identify functional relationships in all PubMed abstracts (29 million) and provide the results, including recorded processing time. Availability The software for the tested kernels, the benchmark, the processed 29 million PubMed abstracts, all evaluation scripts, as well as the scripts for processing the complete PubMed database are freely available at https://github.com/KerstenDoering/CPI-Pipeline.	[Doering, Kersten; Qaseem, Ammar; Becer, Michael; Li, Jianyu; Mishra, Pankaj; Gao, Mingjie; Kirchner, Pascal; Sauter, Florian; Telukunta, Kiran K.; Moumbock, Aurelien F. A.; Guenther, Stefan] Albert Ludwigs Univ Freiburg, Inst Pharmaceut Sci, Freiburg, Germany; [Thomas, Philippe] DFKI Language Technol Lab, Berlin, Germany	University of Freiburg; German Research Center for Artificial Intelligence (DFKI)	Gunther, S (corresponding author), Albert Ludwigs Univ Freiburg, Inst Pharmaceut Sci, Freiburg, Germany.	stefan.guenther@pharmazie.uni-freiburg.de	Moumbock, Aurélien F. A./GXV-1802-2022; Günther, Stefan/AAY-8944-2020; mishra, pankaj/G-9274-2016	Moumbock, Aurélien F. A./0000-0002-6034-2016; Telukunta, Kiran Kumar/0000-0002-3219-9240; mishra, pankaj/0000-0002-3487-6911; Li, Jianyu/0000-0001-5524-692X; Thomas, Philippe/0000-0001-9136-9660	German National Research Foundation (DFG) [Lis45]; German Academic Exchange Service [DAAD] [91653768]; China Scholarship Council [2201908080143]; German National Research Foundation [DFG] [1976]; Baden-Wurttemberg Foundation [BWST_WSF-043]; German Research Center for Artificial Intelligence (DFKI); state of BadenWurttemberg through bwHPC; German Research Foundation (DFG) [INST 37/935-1 FUGG]; Albert Ludwigs University Freiburg	German National Research Foundation (DFG)(German Research Foundation (DFG)); German Academic Exchange Service [DAAD](Deutscher Akademischer Austausch Dienst (DAAD)); China Scholarship Council(China Scholarship Council); German National Research Foundation [DFG](German Research Foundation (DFG)); Baden-Wurttemberg Foundation; German Research Center for Artificial Intelligence (DFKI); state of BadenWurttemberg through bwHPC; German Research Foundation (DFG)(German Research Foundation (DFG)); Albert Ludwigs University Freiburg	KD received funding for this project by the German National Research Foundation (DFG, Lis45). AFAM was funded by a doctoral research grant from the German Academic Exchange Service [DAAD, Award No. 91653768]. MG was funded by China Scholarship Council [Award No. 2201908080143] JL was supported by the German National Research Foundation [DFG, Research Training Group 1976] and funded by the Baden-Wurttemberg Foundation [BWST_WSF-043] PT received funding from the German Research Center for Artificial Intelligence (DFKI). The company DKFI is a non-profit public-private partnership. Calculations were partly performed on a cluster hosted by the High Performance and Cloud Computing Group at the Zentrum fur Datenverarbeitung of the University of Tubingen. The cluster is funded by the state of BadenWurttemberg through bwHPC and the German Research Foundation (DFG) through grant no INST 37/935-1 FUGG. The article processing charge was funded by the German Research Foundation (DFG) and the Albert Ludwigs University Freiburg in the funding programme Open Access Publishing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Airola A, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-S11-S2; Antunes R, 2019, DATABASE-OXFORD, DOI 10.1093/database/baz095; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Corbett P, 2018, DATABASE-OXFORD, DOI 10.1093/database/bay066; Doring K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163794; Dogan RI, 2019, DATABASE-OXFORD, DOI 10.1093/database/bay147; French L, 2012, BIOINFORMATICS, V28, P2963, DOI 10.1093/bioinformatics/bts542; Gartner T, 2003, LECT NOTES ARTIF INT, V2777, P129, DOI 10.1007/978-3-540-45167-9_11; Gaulton A, 2017, NUCLEIC ACIDS RES, V45, pD945, DOI 10.1093/nar/gkw1074; Giuliano C., 2006, P 11 C EUR CHAPT ASS, P401; Gruning BA, 2011, BIOINFORMATICS, V27, P1341, DOI 10.1093/bioinformatics/btr130; Gunther S, 2008, NUCLEIC ACIDS RES, V36, pD919, DOI 10.1093/nar/gkm862; Hettne KM, 2009, BIOINFORMATICS, V25, P2983, DOI 10.1093/bioinformatics/btp535; Jensen LJ, 2006, NAT REV GENET, V7, P119, DOI 10.1038/nrg1768; Kabiljo R, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-233; Kim S, 2019, NUCLEIC ACIDS RES, V47, pD1102, DOI 10.1093/nar/gky1033; Krallinger M, P 6 BIOCREATIVE CHAL, V1, P141; Kunz M, 2016, DATABASE-OXFORD, DOI 10.1093/database/baw041; Least-squares R, 2003, NATO SCI SERIES 3, V190, P131; Lim S, 2018, DATABASE-OXFORD, DOI 10.1093/database/bay060; Marneffe M, P 5 INT C LANG RES E; Peng Y, 2017, BIONLP; Peng YF, 2018, DATABASE-OXFORD, DOI 10.1093/database/bay073; Rebholz-Schuhmann D, 2008, BIOINFORMATICS, V24, P296, DOI 10.1093/bioinformatics/btm557; Rinaldi F, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-S14-S6; Rinaldi F, 2013, DATABASE-OXFORD, DOI 10.1093/database/bas053; Saetre R, 2007, CEUR WORKSHOP P, V319; Saric J, 2006, BIOINFORMATICS, V22, P645, DOI 10.1093/bioinformatics/bti597; Senger C, 2012, BIOINFORMATICS, V28, P709, DOI 10.1093/bioinformatics/bts026; Solt I., 2010, P 2010 I2B2 VA WORKS; Spirin V, 2003, P NATL ACAD SCI USA, V100, P12123, DOI 10.1073/pnas.2032324100; Szklarczyk D, 2017, NUCLEIC ACIDS RES, V45, pD362, DOI 10.1093/nar/gkw937; Szklarczyk D, 2016, NUCLEIC ACIDS RES, V44, pD380, DOI 10.1093/nar/gkv1277; TheUniProtConsortium, 2017, Nucleic Acids Res, V45, pD158, DOI 10.1093/nar/gkw1099; Thomas P., 2013, 2 JOINT C LEX COMP S, V2, P628; Tikk D, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-12; Tikk D, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000837; Wang RX, 2005, J MED CHEM, V48, P4111, DOI 10.1021/jm048957q; Warikoo N, 2018, DATABASE-OXFORD, DOI 10.1093/database/bay108; Wei CH, 2013, NUCLEIC ACIDS RES, V41, pW518, DOI 10.1093/nar/gkt441; Wei CH, 2012, DATABASE-OXFORD, DOI 10.1093/database/bas041; Wishart DS, 2018, NUCLEIC ACIDS RES, V46, pD1074, DOI 10.1093/nar/gkx1037; Zhang YJ, 2018, J BIOMED INFORM, V81, P83, DOI 10.1016/j.jbi.2018.03.011	43	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2020	15	3							e0220925	10.1371/journal.pone.0220925	http://dx.doi.org/10.1371/journal.pone.0220925			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8MS	32126064	Green Submitted, Green Published, gold			2022-12-26	WOS:000535253100002
J	Gao, M; Soriano, SF; Cao, QH; Yang, XS; Lu, GQ				Gao, Ming; Soriano, Sara Fuentes; Cao, Qinghe; Yang, Xinsun; Lu, Guquan			Hexaploid sweetpotato (Ipomoea batatas (L.) Lam.) may not be a true type to either auto- or allopolyploid	PLOS ONE			English	Article							PHYLOGENETIC-RELATIONSHIPS; GENETIC DIVERSITY; WILD RELATIVES; GENOME; CONVOLVULACEAE; RECOMBINATION; EVOLUTIONARY; SEQUENCES; ORIGIN	To better define the sweetpotato polyploidy, we sought to reconstruct phylogenies of its subgenomes based on hybridization networks that could trace reticulate lineages of differentiated homoeolog triplets of multiple single-copy genes. In search of such homoeolog triplets, we distinguished cDNA variants of 811 single-copy Conserved Ortholog Set II (COSII) genes from two sweetpotato clones into variation partitions specified by corresponding homologs from two I. trifida lines, I. tenuissima and I. littoralis using a phylogenetic partition method, and amplicon variants of the COSII-marker regions from 729 of these genes from two sweetpotato clones into putative homoeoallele groups using haplotype tree and the partition methods referenced by corresponding homologs from I. tenuissima. These analyses revealed partly or completely differentiated expressed-homoeologs and homoeologs from a majority of these genes with three important features. 1. Two variation types: the predominant interspecific variations (homoeoalleles), which are non-randomly clustered, differentially interspecifically conserved or sweetpotato-specific, and the minor intraspecific ones (alleles), which are randomly distributed mostly at non-interspecifically variable sites, and usually sweetpotato-specific. 2. A clear differentiation of cDNA variants of many COSII genes into the variation partition specified by I. tenuissima or I. littoralis from that by I. trifida. 3. Three species-homolog-specified and one sweetpotato-specific variation partitions among 293 different COSII cDNAs, and two or three out of the four partitions among cDNA variants of 306 COSII genes. We then constructed hybridization networks from two concatenations of 16 and 4 alignments of 8 homologous COSII cDNA regions each, which included three taxa of expressed homoeologs in a triple-partition combination from the 16 or 4 sweetpotato COSII genes and 5 taxa each of respective cDNA homologs from the three sweetpotato relatives and I. nil, and inferred a species tree embodying both networks. The species tree predicted close-relative origins of three partly differentiated sweetpotato subgenomes.	[Gao, Ming] Prairie View A&M Univ, Cooperat Agr Res Ctr, Prairie View, TX 77446 USA; [Soriano, Sara Fuentes] New Mexico State Univ, Anim & Range Sci Dept, Las Cruces, NM 88003 USA; [Cao, Qinghe] Jingsu Xuzhou Sweetpotato Res Ctr, Xuzhou, Jiangsu, Peoples R China; [Yang, Xinsun] Hubei Acad Agr Sci, Food Crops Inst, Wuhan, Peoples R China; [Lu, Guquan] Zhejiang A&F Univ, Inst Root & Tuber Crops, Hangzhou, Zhejiang, Peoples R China	Texas A&M University System; Prairie View A&M University; New Mexico State University; Hubei Academy of Agricultural Sciences; Zhejiang A&F University	Gao, M (corresponding author), Prairie View A&M Univ, Cooperat Agr Res Ctr, Prairie View, TX 77446 USA.	migao@pvamu.edu		Yang, Xinsun/0000-0003-3942-1112; Gao, Ming/0000-0002-8196-8077	National Institute of Food and Agriculture, US Department of Agriculture [2014-38821-22429]; USDA-ARS, Stoneville, MS.	National Institute of Food and Agriculture, US Department of Agriculture(United States Department of Agriculture (USDA)); USDA-ARS, Stoneville, MS.	This work was supported by the National Institute of Food and Agriculture, US Department of Agriculture (Grant numbers 2014-38821-22429 to MG, et al.). The custom 454-NGS sequencing was partially supported by USDA-ARS, Stoneville, MS.	AUSTIN A, 1988, NEW YORK TIMES BK R, P27; Cifuentes M, 2010, NEW PHYTOL, V186, P29, DOI 10.1111/j.1469-8137.2009.03084.x; Dolezel J, 2007, NAT PROTOC, V2, P2233, DOI 10.1038/nprot.2007.310; Dufresne F, 2014, MOL ECOL, V23, P40, DOI 10.1111/mec.12581; Gaeta RT, 2010, NEW PHYTOL, V186, P18, DOI 10.1111/j.1469-8137.2009.03089.x; Gao M, 2011, EUPHYTICA, V177, P111, DOI 10.1007/s10681-010-0275-z; Hirakawa H, 2015, DNA RES, V22, P171, DOI 10.1093/dnares/dsv002; Huang JC, 2000, THEOR APPL GENET, V100, P1050, DOI 10.1007/s001220051386; Huang JC, 2002, GENET RESOUR CROP EV, V49, P541, DOI 10.1023/A:1021290927362; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Jarret R. L., 1994, Genetic Resources and Crop Evolution, V41, P165, DOI 10.1007/BF00051633; JARRET RL, 1992, J AM SOC HORTIC SCI, V117, P633, DOI 10.21273/JASHS.117.4.633; JONES A, 1965, P AM SOC HORTIC SCI, V86, P527; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Kriegner A, 2003, MOL BREEDING, V11, P169, DOI 10.1023/A:1022870917230; Levin D. A, 2002, OX ECOL EV; MAGOON ML, 1970, THEOR APPL GENET, V40, P360, DOI 10.1007/BF00285415; NISHIYAMA I, 1971, BOT MAG TOKYO, V84, P377; NISHIYAMA I, 1975, EUPHYTICA, V24, P197, DOI 10.1007/BF00147186; Rajapakse S, 2004, MOL PHYLOGENET EVOL, V30, P623, DOI 10.1016/S1055-7903(03)00249-5; Rodriguez P, 2018, CURRENT BIOL; Roullier C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062707; Schafleitner R, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-604; Seehausen O, 2004, TRENDS ECOL EVOL, V19, P198, DOI 10.1016/j.tree.2004.01.003; Sharpe AG, 1995, GENOME, V38, P1112, DOI 10.1139/g95-148; SHIOTANI I, 1989, JPN J BREED, V39, P57; SHIOTANI I, 1987, JPN J BREED, V37, P367; Sochorova J, 2017, ANN BOT-LONDON, V119, P13, DOI 10.1093/aob/mcw187; Soltis PS, 2015, CURR OPIN GENET DEV, V35, P119, DOI 10.1016/j.gde.2015.11.003; Srisuwan S, 2006, PLANT SCI, V171, P424, DOI 10.1016/j.plantsci.2006.05.007; STEBBINS GL, 1947, ADV GENET, V1, P403, DOI 10.1016/S0065-2660(08)60490-3; STEPHENS JC, 1985, MOL BIOL EVOL, V2, P539; Tahara M, 2017, BREEDING SCI, V67, P1, DOI 10.1270/jsbbs.67.1; TING YC, 1957, AM NAT, V91, P197, DOI 10.1086/281978; Ukoskit K, 1997, J AM SOC HORTIC SCI, V122, P822, DOI 10.21273/JASHS.122.6.822; Wei CH, 2015, MOL GENET GENOMICS, V290, P1873, DOI 10.1007/s00438-015-1034-6; Wu FN, 2006, GENETICS, V174, P1407, DOI 10.1534/genetics.106.062455; Yang J, 2017, NAT PLANTS, V3, P696, DOI 10.1038/s41477-017-0002-z	38	8	8	3	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2020	15	3							e0229624	10.1371/journal.pone.0229624	http://dx.doi.org/10.1371/journal.pone.0229624			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8MS	32126067	gold, Green Published			2022-12-26	WOS:000535253100040
J	Kikuchi, H; Odagiri, Y; Ohya, Y; Nakanishi, Y; Shimomitsu, T; Theorell, T; Inoue, S				Kikuchi, Hiroyuki; Odagiri, Yuko; Ohya, Yumiko; Nakanishi, Yutaka; Shimomitsu, Teruichi; Theorell, Tores; Inoue, Shigeru			Association of overtime work hours with various stress responses in 59,021 Japanese workers: Retrospective cross-sectional study	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; JOB-STRESS; MYOCARDIAL-INFARCTION; PSYCHOSOCIAL STRESS; NATIONAL POLICY; RISK; WORKPLACE; OVERWORK; FATIGUE; HEALTH	This study aims to clarify the relationships between length of overtime work and various stress responses using large-scale cross-sectional data of Japanese workers. This study's participants are 59,021 Japanese workers in 117 companies. Data was collected by self-reporting questionnaire. The Brief Job Stress Questionnaire was used to measure stress responses on six scales (i.e. "lack of vigor", "irritability", "fatigue", "anxiety", "depression", and "somatic responses"). Length of overtime work hours were classified as 0-20, 21-30, 31-40, 41-50, 51-60, 61-70, 71-80, and >80 hours/month. Multiple linear regression analyses were used to examine the association of stress responses with overtime while adjusting all possible confounders. In result, workers with longer overtime showed significantly higher "irritability", "fatigue", "anxiety", "depression", and "somatic responses" for both genders (p-for-trend <0.001), however, length of overtime was negatively associated with "lack of vigor" among men (p-for-trend <0.001). Men with 61-80 hours of overtime showed high fatigue with high vigor at the same time. Length of overtime was linearly associated with various stress responses, except for "lack of vigor". Length of overtime shows linear associations with various psychosomatic stress responses. However, "lack of vigor" was not consistently associated with overtime. Male workers with 61-80 hours of monthly overtime were more likely to feel vigorous than workers with shorter overtime. However, potential longterm effects of such extreme overtime should not be underestimated and must be paid attention to.	[Kikuchi, Hiroyuki; Odagiri, Yuko; Ohya, Yumiko; Shimomitsu, Teruichi; Inoue, Shigeru] Tokyo Med Univ, Dept Prevent Med & Publ Hlth, Shinjuku Ku, Tokyo, Japan; [Odagiri, Yuko; Nakanishi, Yutaka; Shimomitsu, Teruichi; Inoue, Shigeru] Publ Hlth Res Fdn, Hlth Promot Ctr, Chiyoda Ku, Tokyo, Japan; [Shimomitsu, Teruichi] Japan Hlth Promot & Fitness Fdn, Minato Ku, Tokyo, Japan; [Theorell, Tores] Stockholm Univ, Stress Res Inst, Stockholm, Sweden	Tokyo Medical University; Stockholm University	Odagiri, Y (corresponding author), Tokyo Med Univ, Dept Prevent Med & Publ Hlth, Shinjuku Ku, Tokyo, Japan.; Odagiri, Y (corresponding author), Publ Hlth Res Fdn, Hlth Promot Ctr, Chiyoda Ku, Tokyo, Japan.	odagiri@tokyo-med.ac.jp		Odagiri, Yuko/0000-0002-7603-4800; Kikuchi, Hiroyuki/0000-0003-0510-1030				[Anonymous], WORK COND EMPL SOC A, DOI [10.1007/BF02691093, 10.1007/s00420-004-0572-8, DOI 10.1007/BF02691093]; [Anonymous], ETH GUID MED HLTH RE; Bannai A, 2014, SCAND J WORK ENV HEA, V40, P5, DOI 10.5271/sjweh.3388; Beckers DGJ, 2004, J OCCUPATIONAL ENV M; Campion WM, 2006, J MARKETING RES, V26, P485; Driesen K, 2010, CHRONOBIOL INT, V27, P1062, DOI 10.3109/07420528.2010.489877; Gonzalez-Roma V, 2006, J VOCAT BEHAV; Hagihara A, 1998, Environ Health Prev Med, V2, P139, DOI 10.1007/BF02931691; HENRY J P, 1992, Integrative Physiological and Behavioral Science, V27, P66, DOI 10.1007/BF02691093; Het S, 2012, PSYCHOSOM MED; Imai T, 2016, J OCCUP HEALTH, V58, P340, DOI 10.1539/joh.15-0260-OA; Iwasaki K, 1998, IND HEALTH, V36, P361, DOI 10.2486/indhealth.36.361; Japanese Ministry of Internal Affairs and Communication, 2016, JAP SURV TIM US LEIS; Kato R, 2014, OCCUP MED-OXFORD, V64, P622, DOI 10.1093/occmed/kqu120; Kawakami N, 2016, J OCCUP HEALTH, V58, P1, DOI 10.1539/joh.15-0001-ER; Kivimaki M, 2015, LANCET, V386, P1739, DOI 10.1016/S0140-6736(15)60295-1; Kristensen TS, 2004, WORK STRESS, V18, P305, DOI 10.1080/02678370412331314005; Kuwahara K, 2019, PREV MED, V121, P18, DOI 10.1016/j.ypmed.2019.02.002; Lee K, 2017, IND HEALTH, V55, P46, DOI 10.2486/indhealth.2015-0173; Mills MJ, 2012, J HAPPINESS STUD, DOI [10.1007/s10902-011-9304-4, DOI 10.1007/S10902-011-9304-4]; Ministry of Health Labour and Welfare of Japan, STRESS CHECK PROGR; Mohren DCL, 2005, INT J BEHAV MED, V12, P11, DOI 10.1207/s15327558ijbm1201_2; Nagashima S, 2007, OCCUP MED-OXFORD, V57, P449, DOI 10.1093/occmed/kqm047; Nakata A, 2017, ONCOTARGET, V8, P53041, DOI 10.18632/oncotarget.18084; Newman DA, 2014, ORGAN RES METHODS, V17, P372, DOI 10.1177/1094428114548590; Nishiyama K, 1997, INT J HEALTH SERV, V27, P625, DOI 10.2190/1JPC-679V-DYNT-HJ6G; North S, 2016, CONT JAPAN, V28; Odagiri Y, 1996, INT J SPORTS MED, V17, P325, DOI 10.1055/s-2007-972855; Osborn DPJ, 2003, INT J GERIATR PSYCHI; Owyang, 2006, REGIONAL EC      APR, P10; Park JS, 2001, IND HEALTH, V39, P244, DOI 10.2486/indhealth.39.244; Preckel D, 2005, INT ARCH OCC ENV HEA, V78, P117, DOI 10.1007/s00420-004-0572-8; Prime Minister of Japan and His Cabinet, 2017, ACT PLAN REAL WORK S, DOI [10.1017/S0033291711000171, DOI 10.1017/S0033291711000171]; Sapp AL, 2010, J OCCUP ENVIRON MED, V52, P740, DOI 10.1097/JOM.0b013e3181e80842; Sato Y, 2009, OCCUP MED CHIC ILL; Schaufeli W, 2002, J HAPPINESS STUD; Sekine M, 2006, SLEEP, V29, P206, DOI 10.1093/sleep/29.2.206; Shields M, 1999, Health Rep, V11, P33; Shimada K, 2010, J OCCUP HEALTH, V52, P335, DOI 10.1539/joh.L9130; Shimomitsu T, 2001, Adv Psychosom Med, V22, P35; Shimomitsu T, 1999, FINAL DEV BRIEF JOB; Shimomitsu T., 1992, EUR J PUBLIC HEALTH, V2, P76, DOI [10.1093/eurpub/2.2.76, DOI 10.1093/EURPUB/2.2.76]; Shirom A., 2011, REV GEN PSYCHOL; Siegrist J, 2004, SOC SCI MED, V58, P1483, DOI 10.1016/S0277-9536(03)00351-4; Sokejima S, 1998, BRIT MED J, V317, P775, DOI 10.1136/bmj.317.7161.775; Stenstrom U, 2005, EUR J CARDIOV PREV R, V12, P568, DOI 10.1097/00149831-200512000-00009; Subramanian S V., 2010, HDB BEHAV MED, P881; Tanaka H, 2019, J EPIDEMIOL COMMUN H, V73, P750, DOI 10.1136/jech-2018-211715; Theorell T, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1954-4; Tsutsumi A, 2001, SCAND J WORK ENV HEA, V27, P146, DOI 10.5271/sjweh.602; Tsutsumi A, 2017, J OCCUP HEALTH, V59, P356, DOI 10.1539/joh.17-0011-BR; Virtanen M, 2011, PSYCHOL MED, V41, P2485, DOI 10.1017/S0033291711000171; Virtanen M, 2018, SCAND J WORK ENV HEA, V44, P239, DOI 10.5271/sjweh.3712; Virtanen M, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.g7772; Virtanen M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030719; Virtanen M, 2010, EUR HEART J, V31, P1737, DOI 10.1093/eurheartj/ehq124; Virtanen M, 2009, SLEEP, V32, P737, DOI 10.1093/sleep/32.6.737; Vrijkotte TGM, 1999, PSYCHOSOM MED, V61, P796, DOI 10.1097/00006842-199911000-00012; Wong K, 2019, INT J ENV RES PUB HE, V16, DOI 10.3390/ijerph16122102; Yamauchi T, 2017, IND HEALTH, V55, P293, DOI 10.2486/indhealth.2016-0198	60	15	15	3	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2020	15	3							e0229506	10.1371/journal.pone.0229506	http://dx.doi.org/10.1371/journal.pone.0229506			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LQ8MS	32126094	Green Published, gold			2022-12-26	WOS:000535253100028
J	Mcgovern, PG; Dinsmore, SJ; Blanchong, JA				Mcgovern, Patrick G.; Dinsmore, Stephen J.; Blanchong, Julie A.			Survival of white-tailed deer fawns in central Iowa	PLOS ONE			English	Article							CAUSE-SPECIFIC MORTALITY; AGE-SPECIFIC SURVIVAL; HOME-RANGE; PREDATION; PATTERNS; BEHAVIOR; RATES; SIZE	Understanding demographic parameters such as survival is important for scientifically sound wildlife management. Survival can vary by region, sex, age-class, habitat, and other factors. White-tailed deer fawn survival is highly variable across the species' range. While recent studies have investigated fawn survival in several Midwestern states, there have been no published estimates from Iowa for 30 years. We radio-collared 48 fawns in central Iowa from 2015-2017 to estimate survival, home range size, and habitat composition and identity causes of mortality. Estimated fawn survival (+/- SE) was similar to other Midwest studies at 30 (0.78 +/- 0.07)) and 60 days (0.69 +/- 0.08), but considerably lower at 7 months (0.31 +/- 0.02). Survival was positively associated with woodland habitat through 30 and 60 days, but not related to habitat at 7 months. Female fawns avoided agricultural habitat in their home ranges. Fawn 95% kernel density home ranges were smaller than in other studies in the Midwest (21.22 +/- 2.74 ha at 30 days, 25.47 +/- 2.87 ha at 60 days, and 30.59 +/- 2.37 ha at 7 months). The large amount of woodland and grassland (> 90%) in our study area meant that fawns did not have to travel far to find suitable cover, which may explain their small home ranges. We recorded 21 mortalities, the leading cause of which was disease (n = 9; 56% epizootic hemorrhagic disease [EHD]) followed by suspected predation (4) and harvest (3). The mortality associated with an outbreak of EHD in 2016, all of which occurred after 60 days post-capture, is the most likely explanation for our low survival estimate at 7 months. While predation, usually early in life, is the leading cause of mortality in most studies, sporadic diseases like EHD can be a major source of mortality in older fawns in some years.	[Mcgovern, Patrick G.; Dinsmore, Stephen J.; Blanchong, Julie A.] Iowa State Univ, Dept Nat Resource Ecol & Management, Ames, IA 50011 USA; [Mcgovern, Patrick G.] Purdue Univ, Dept Forestry & Nat Resources, W Lafayette, IN 47907 USA	Iowa State University; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Blanchong, JA (corresponding author), Iowa State Univ, Dept Nat Resource Ecol & Management, Ames, IA 50011 USA.	julieb@iastate.edu		McGovern, Patrick/0000-0002-4433-4948	Iowa State University Presidential Wildlife Initiative; Hatch Act fund [IOW05434, IOWA5438]; State of Iowa fund [IOW05434, IOWA5438]; Iowa Agriculture and Home Economics Experiment Station, Ames, Iowa Project [IOWA5438, IOWA5434]	Iowa State University Presidential Wildlife Initiative; Hatch Act fund; State of Iowa fund; Iowa Agriculture and Home Economics Experiment Station, Ames, Iowa Project	The Iowa State University Presidential Wildlife Initiative provided funding for this research to JAB and SJD. This paper is a product of the Iowa Agriculture and Home Economics Experiment Station, Ames, Iowa. Project No.'s IOW05434 (JAB) and IOWA5438 (SJD) are sponsored by Hatch Act and State of Iowa funds. Funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank the Iowa Department of Natural Resources, the Mid-Iowa Council of the Boy Scouts of America, the Iowa Wildlife Center, D. Adams, B. Dodd, S. McClure and G. Shull for allowing us access to their properties. Thank you to technicians S. George, A. Hebein, M. Huggins, J. Kemner, K. Weber, and H. Wolfe, as well as numerous volunteers. Thank you to J. Koenigsfeld and A. Bartlett for assistance in reporting newborn fawns and to M. Yaeger for conducting necropsies. Thank you to the reviewers whose comments improved the manuscript. This paper is a product of the Iowa Agriculture and Home Economics Experiment Station, Ames, Iowa Project No.'s IOWA5434 and IOWA5438.	[Anonymous], 2009, IOWA LANDCOVER DATA; Brinkman TJ, 2004, WILDLIFE SOC B, V32, P726, DOI 10.2193/0091-7648(2004)032[0726:SOWDIA]2.0.CO;2; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Carstensen M, 2009, J WILDLIFE MANAGE, V73, P175, DOI 10.2193/2006-107; Chitwood MC, 2017, WILDLIFE BIOL, DOI 10.2981/wlb.00250; Davidson W.R., 2006, FIELD MANUAL WILDLIF; DelGiudice GD, 2002, J WILDLIFE MANAGE, V66, P698, DOI 10.2307/3803136; Delgiudice GD, 2006, J WILDLIFE MANAGE, V70, P1556, DOI 10.2193/0022-541X(2006)70[1556:ALASAO]2.0.CO;2; Diefenbach DR, 2003, WILDLIFE SOC B, V31, P756; Downing RL, 1969, J WILDLIFE MANAGE; EBERSOLE JP, 1980, AM NAT, V115, P492, DOI 10.1086/283576; Etter DR, 2002, J WILDLIFE MANAGE, V66, P500, DOI 10.2307/3803183; Evelsizer V., 2017, TRENDS IOWA WILDLIFE, P62; FISCHER JR, 1995, J WILDLIFE DIS, V31, P30, DOI 10.7589/0090-3558-31.1.30; Gaillard JM, 1998, TRENDS ECOL EVOL, V13, P58, DOI 10.1016/S0169-5347(97)01237-8; Gilbert SL, 2014, METHODS ECOL EVOL, V5, P992, DOI 10.1111/2041-210X.12234; Gingery TM, 2018, J WILDLIFE MANAGE, V82, P1003, DOI 10.1002/jwmg.21456; Grovenburg TW, 2012, J WILDLIFE MANAGE, V76, P632, DOI 10.1002/jwmg.288; Grovenburg TW, 2011, J WILDLIFE MANAGE, V75, P213, DOI 10.1002/jwmg.20; Gulsby WD, 2017, J WILDLIFE MANAGE, V81, P601, DOI 10.1002/jwmg.21240; Harms T., 2018, TRENDS IOWA WILDLIFE, P1; Harms T., 2017, TRENDS IOWA WILDLIFE, P1; Hasapes SK, 2017, WILDLIFE SOC B, V41, P499, DOI 10.1002/wsb.782; Hiller TL, 2008, AM MIDL NAT, V159, P403, DOI 10.1674/0003-0031(2008)159[403:SASUOF]2.0.CO;2; HUEGEL CN, 1985, WILDLIFE SOC B, V13, P287; HUEGEL CN, 1985, J WILDLIFE MANAGE, V49, P377, DOI 10.2307/3801536; JACKSON RM, 1972, ECOLOGY, V53, P262, DOI 10.2307/1934080; JOHNSON DH, 1980, ECOLOGY, V61, P65, DOI 10.2307/1937156; JOHNSON-GROH C L, 1985, Proceedings of the Iowa Academy of Science, V92, P129; JONES RH, 1977, J WILDLIFE DIS, V13, P2, DOI 10.7589/0090-3558-13.1.2; Kenward RE, 1999, J ANIM ECOL, V68, P1020, DOI 10.1046/j.1365-2656.1999.00347.x; Kernohan Brian J., 2001, P125, DOI 10.1016/B978-012497781-5/50006-2; Kilgo JC, 2014, J WILDLIFE MANAGE, V78, P1261, DOI 10.1002/jwmg.764; KUNKEL KE, 1994, CAN J ZOOL, V72, P1557, DOI 10.1139/z94-207; Lendrum PE, 2018, LANDSCAPE ECOL, V33, P157, DOI 10.1007/s10980-017-0590-z; Lent P.C., 1974, IUCN Publs (New Series), VNo. 24, P14; LENTH RV, 1981, TECHNOMETRICS, V23, P149, DOI 10.2307/1268030; Manly B.F.J., 2002, RESOURCE SELECTION A; McNew LB, 2012, J WILDLIFE MANAGE, V76, P987, DOI 10.1002/jwmg.369; Norton A., 2016, TRENDS IOWA WILDLIFE, P9; Piccolo BP, 2010, CAN J ZOOL, V88, P487, DOI 10.1139/Z10-026; Porath W. R., 1980, WHITE TAILED DEER PO, P55; Burroughs JP, 2006, J WILDLIFE MANAGE, V70, P743, DOI 10.2193/0022-541X(2006)70[743:CMASOW]2.0.CO;2; Rettie WJ, 1999, CAN J ZOOL, V77, P1175, DOI 10.1139/cjz-77-8-1175; Rodgers Arthur R., 2001, P79, DOI 10.1016/B978-012497781-5/50005-0; Rohm JH, 2007, J WILDLIFE MANAGE, V71, P851, DOI 10.2193/2006-027; SCHWEDE G, 1994, J MAMMAL, V75, P438, DOI 10.2307/1382565; Seaman DE, 1999, J WILDLIFE MANAGE, V63, P739, DOI 10.2307/3802664; SHACKELL NL, 1994, CAN J FISH AQUAT SCI, V51, P642, DOI 10.1139/f94-065; Sikes RS, 2016, J MAMMAL, V97, P663, DOI 10.1093/jmammal/gyw078; VERME LJ, 1977, J WILDLIFE MANAGE, V41, P700, DOI 10.2307/3799992; Vreeland JK, 2004, WILDLIFE SOC B, V32, P542, DOI 10.2193/0091-7648(2004)32[542:SRMCAH]2.0.CO;2; Warbington CH, 2017, J WILDLIFE MANAGE, V81, P824, DOI 10.1002/jwmg.21260; White GC, 1999, BIRD STUDY, V46, P120, DOI 10.1080/00063659909477239	54	1	1	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2020	15	3							e0229242	10.1371/journal.pone.0229242	http://dx.doi.org/10.1371/journal.pone.0229242			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8MS	32126101	Green Published, gold			2022-12-26	WOS:000535253100019
J	Ma, F; Gu, X; Liu, JQ; Mo, LH; Yang, G; Geng, XR; Liu, ZQ; Liu, ZG; Yang, PC				Ma, Fei; Gu, Xia; Liu, Jiang-Qi; Mo, Li-Hua; Yang, Gui; Geng, Xiao-Rui; Liu, Zhi-Qiang; Liu, Zhi-Gang; Yang, Ping-Chang			Inhibition of livin overcomes radioresistance in nasopharyngeal carcinoma cells	PLOS ONE			English	Article							APOPTOSIS; RADIATION; CANCER; EXPRESSION; SURVIVIN; PROTEINS	Background and aims Radiotherapy is one of the major remedies for the treatment of cancer, including nasopharyngeal carcinoma (NPC). Radioresistance occurs very often in target cells that is a large drawback in cancer treated with radiotherapy. Livin involves the over-growth of cancer cells. This study aims to investigate the role of livin in the radioresistance formation in NPC cells. Methods NPC cell lines were exposed to small doses of irradiation to establish a cell model of radioresistance, in which the role of livin in the development of radioresistance was evaluated. Results The expression of livin was observed in NPC cells, which was significantly increased after exposing to small doses of irradiation. A negative correlation was detected between livin and Fas expression in NPC cells. Livin formed a complex with heat shock factor-1 (HSF1, the transcription factor of Fas) in NPC cells after irradiation, which sped up ubiquitination of HSF1. Livin was involved in suppressing Fas expression in NPC cells with radioresistance. Exposure to livin inhibitors prevented radioresistance development and overcame the established radioresistance in NPC cells. Conclusions Livin expression in NPC cells plays a critical role in the development of radioresistance. Depletion of livin increases the sensitiveness of NPC cells to irradiation. Target therapy against livin may have the translational potential for the treatment of NPC.	[Ma, Fei] Southern Med Univ, Affiliated Shenzhen Matern & Child Healthcare Hos, Dept Tradit Chinese Med, Shenzhen, Peoples R China; [Ma, Fei; Gu, Xia; Mo, Li-Hua; Liu, Zhi-Gang; Yang, Ping-Chang] Shenzhen Univ, Sch Med, Res Ctr Allergy & Immunol, Shenzhen, Peoples R China; [Gu, Xia] Xinan Med Univ, Affiliated Hosp, Dept Respirol, Luzhou, Peoples R China; [Liu, Jiang-Qi; Geng, Xiao-Rui; Liu, Zhi-Qiang] Longgang ENT Hosp, Dept Allergy, Shenzhen, Peoples R China; [Liu, Jiang-Qi; Geng, Xiao-Rui; Liu, Zhi-Qiang] Inst ENT, Shenzhen Key Lab ENT, Shenzhen, Peoples R China; [Yang, Gui] Longgang Cent Hosp, Dept Otolaryngol, Shenzhen, Peoples R China; [Yang, Ping-Chang] Guangdong Prov Key Lab Reg Immun & Dis, Shenzhen, Peoples R China	Southern Medical University - China; Shenzhen University	Liu, ZG; Yang, PC (corresponding author), Shenzhen Univ, Sch Med, Res Ctr Allergy & Immunol, Shenzhen, Peoples R China.; Yang, PC (corresponding author), Guangdong Prov Key Lab Reg Immun & Dis, Shenzhen, Peoples R China.	lzg@szu.edu.cn; pcy2356@szu.edu.cn			National Nature and Science Foundation of China [81870706, 31570932, 81700888, 81701589]; Guangdong Provincial Key Laboratory of Regional Immunity and Diseases [2019B030301009]; Shenzhen Science, Technology and Innovation Committee [JCYJ20170307162827158, KQTD20170331145453160]	National Nature and Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangdong Provincial Key Laboratory of Regional Immunity and Diseases; Shenzhen Science, Technology and Innovation Committee	This study was supported by grants from the National Nature and Science Foundation of China (81870706, 31570932, 81700888, 81701589), Guangdong Provincial Key Laboratory of Regional Immunity and Diseases (2019B030301009) and the Shenzhen Science, Technology and Innovation Committee (JCYJ20170307162827158, KQTD20170331145453160). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bohli M, 2019, EUR ANN OTORHINOLARY, V136, P409, DOI 10.1016/j.anorl.2019.04.005; Bold RJ, 1997, SURG ONCOL, V6, P133, DOI 10.1016/S0960-7404(97)00015-7; Chen NN, 2016, NEUROCHEM RES, V41, P3052, DOI 10.1007/s11064-016-2024-8; Chen W, 2015, CANCER BIOL MED, V12, P23, DOI 10.7497/j.issn.2095-3941.2014.0015; Chou CH, 2012, CELL CYCLE, V11, P532, DOI 10.4161/cc.11.3.19051; Crnkovic-Mertens I, 2010, CELL MOL LIFE SCI, V67, P1895, DOI 10.1007/s00018-010-0300-3; E SM, 2010, MOL CELLS, V29, P527, DOI 10.1007/s10059-010-0065-4; El-Sehemy A, 2016, NITRIC OXIDE-BIOL CH, V54, P30, DOI 10.1016/j.niox.2016.02.002; Elmore S, 2007, TOXICOL PATHOL, V35, P495, DOI 10.1080/01926230701320337; Fukumoto M, 2014, PATHOL INT, V64, P251, DOI 10.1111/pin.12170; Gao B, 2015, INT J MOL MED, V36, P1282, DOI 10.3892/ijmm.2015.2358; Garcia-Aranda M, 2017, ANTI-CANCER DRUG, V28, P702, DOI 10.1097/CAD.0000000000000507; Hartman ML, 2013, CANCER LETT, V331, P24, DOI 10.1016/j.canlet.2013.01.010; Hein AL, 2014, INT J ONCOL, V45, P1813, DOI 10.3892/ijo.2014.2614; Holliday EB, 2016, CHIN CLIN ONCOL, V5, DOI 10.21037/cco.2016.03.05; Hollmann G, 2016, AQUAT TOXICOL, V173, P1, DOI 10.1016/j.aquatox.2015.12.025; Joiner MC, 1996, MUTAT RES-FUND MOL M, V358, P171, DOI 10.1016/S0027-5107(96)00118-2; Kalungi S, 2013, APMIS, V121, P239, DOI 10.1111/j.1600-0463.2012.02962.x; Kamran SC, 2015, SURG ONCOL CLIN N AM, V24, P547, DOI 10.1016/j.soc.2015.03.008; Liu AH, 2016, CANCER RADIOTHER, V20, P384, DOI 10.1016/j.canrad.2016.05.013; Malik A, 2016, ANAL CELL PATHOL, V2016, DOI 10.1155/2016/6146595; Petersson F, 2015, SEMIN DIAGN PATHOL, V32, P54, DOI 10.1053/j.semdp.2015.02.021; Pfeffer CM, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19020448; Shimura T, 2017, INT J RADIAT BIOL, V93, P381, DOI 10.1080/09553002.2016.1257832; Wu YK, 2018, MEDICINE, V97, DOI 10.1097/MD.0000000000011922; Xiang YQ, 2006, LARYNGOSCOPE, V116, P126, DOI 10.1097/01.mlg.0000187392.87904.35; Yan B, 2011, MOL CELL BIOCHEM, V357, P39, DOI 10.1007/s11010-011-0873-7; Zhang J, 2017, ONCOL REP, V38, P2471, DOI 10.3892/or.2017.5897	28	4	4	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2020	15	3							e0229272	10.1371/journal.pone.0229272	http://dx.doi.org/10.1371/journal.pone.0229272			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8JT	32119704	Green Published, Green Submitted, gold			2022-12-26	WOS:000535245300020
J	Williamson, T; Ryser, MD; Abdelgadir, J; Lemmon, M; Barks, MC; Zakare, R; Ubel, PA				Williamson, Theresa; Ryser, Marc D.; Abdelgadir, Jihad; Lemmon, Monica; Barks, Mary Carol; Zakare, Rasheedat; Ubel, Peter A.			Surgical decision making in the setting of severe traumatic brain injury: A survey of neurosurgeons	PLOS ONE			English	Article							DECOMPRESSIVE CRANIECTOMY; PROGNOSTIC MODELS; VALIDATION; RECOVERY	Background Surgical decision-making in severe traumatic brain injury (TBI) is complex. Neurosurgeons weigh risks and benefits of interventions that have the potential to both maximize the chance of recovery and prolong suffering. Inaccurate prognostication can lead to over- or underestimation of outcomes and influence treatment recommendations. Objective To evaluate the impact of evidence-based risk estimates on neurosurgeon treatment recommendations and prognostic beliefs in severe TBI. Methods In a survey-based randomized experiment, a total of 139 neurosurgeons were presented with two hypothetical patient with severe TBI and subdural hematoma; the intervention group received additional evidence-based risk estimates for each patient. The main outcome was neurosurgeon treatment recommendation of non-surgical management. Secondary outcomes included prediction of functional recovery at six months. Results In the first patient scenario, 22% of neurosurgeons recommended non-surgical management and provision of evidence-based risk estimates increased the propensity to recommend non-surgical treatment (odds ratio [OR]: 2.81, 95% CI: 1.21-6.98; p = 0.02). Neurosurgeon prognostic beliefs of 6-month functional recovery were variable in both control (median 20%, IQR: 10%-40%) and intervention (30% IQR: 10%-50%) groups and neurosurgeons were less likely to recommend non-surgical management when they believed prognosis was favorable (odds ratio [OR] per percentage point increase in 6-month functional recovery: 0.97, 95% confidence interval [CI]: 0.95-0.99). The results for the second patient scenario were qualitatively similar. Conclusions Our findings show that the provision of evidence-based risk predictions can influence neurosurgeon treatment recommendations and prognostication, but the effect is modest and there remains large variability in neurosurgeon prognostication.	[Williamson, Theresa; Abdelgadir, Jihad] Duke Univ, Med Ctr, Dept Neurosurg, Durham, NC 27708 USA; [Ryser, Marc D.] Duke Univ, Dept Populat Hlth Sci, Med Ctr, Durham, NC USA; [Ryser, Marc D.; Zakare, Rasheedat; Ubel, Peter A.] Duke Univ, Duke Sch Med, Durham, NC USA; [Ryser, Marc D.] Duke Univ, Dept Math, Durham, NC USA; [Lemmon, Monica] Duke Univ, Dept Pediat, Med Ctr, Durham, NC USA; [Lemmon, Monica] Duke Margolis Ctr Hlth Policy, Durham, NC USA; [Barks, Mary Carol; Ubel, Peter A.] Duke Univ, Fuqua Sch Business, Durham, NC 27706 USA	Duke University; Duke University; Duke University; Duke University; Duke University; Duke University	Williamson, T (corresponding author), Duke Univ, Med Ctr, Dept Neurosurg, Durham, NC 27708 USA.	theresa.williamson@duke.edu		Barks, Mary/0000-0002-3060-5524; williamson, theresa/0000-0002-5036-8597				BARON RM, 1986, J PERS SOC PSYCHOL, V51, P1173, DOI 10.1037/0022-3514.51.6.1173; Collaborators M.C.T., 2008, ONLINE 1; Corso P, 2015, INJURY PREV, V21, P432, DOI [10.1136/ip.2005.010983rep, 10.1136/injuryprev-2015-041862]; Giacino J.T., 2018, NEUROLOGY; Han JL, 2014, J NEUROTRAUM, V31, P1146, DOI 10.1089/neu.2013.3003; Ho KM, 2011, J TRAUMA, V71, P1637, DOI 10.1097/TA.0b013e31823a08f1; Ho KM, 2011, CRIT CARE MED, V39, P2495, DOI 10.1097/CCM.0b013e318225764e; KAUFMAN HH, 1986, NEUROSURGERY, V18, P689, DOI 10.1227/00006123-198606000-00002; Kwok A., 2011, INTENSITY VARIATION, V15; Letsinger J, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183552; Lilley E., 2017, JAMA SURG; Livingston DH, 2009, J TRAUMA, V67, P341, DOI 10.1097/TA.0b013e3181a5cc34; Livingston DH, 2005, J TRAUMA, V59, P1298, DOI 10.1097/01.ta.0000196002.03681.18; Maas AIR, 2007, J NEUROTRAUM, V24, P232, DOI 10.1089/neu.2006.0024; Masel BE, 2010, J NEUROTRAUM, V27, P1529, DOI 10.1089/neu.2010.1358; MCFARLAND SG, 1981, PUBLIC OPIN QUART, V45, P208, DOI 10.1086/268651; Nakase-Richardson R, 2012, J NEUROTRAUM, V29, P59, DOI 10.1089/neu.2011.1829; Peabody JW, 2000, JAMA-J AM MED ASSOC, V283, P1715, DOI 10.1001/jama.283.13.1715; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; Seifert J, 2007, J EPIDEMIOL COMMUN H, V61, DOI [10.1136/jech.2007.059717, DOI 10.1136/JECH.2007.059717]; Souter M., 2015, NEUROCRITICAL CARE; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Wabi R, 2018, J NEUROSURG, P1	23	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2020	15	3							e0228947	10.1371/journal.pone.0228947	http://dx.doi.org/10.1371/journal.pone.0228947			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LQ8JT	32119677	gold, Green Published			2022-12-26	WOS:000535245300012
J	Li, F; Li, ZM; Han, Q; Cheng, YR; Ji, WX; Yang, Y; Lu, S; Xia, WL				Li, Fan; Li, Ziming; Han, Qing; Cheng, Yirui; Ji, Wenxiang; Yang, Ying; Lu, Shun; Xia, Weiliang			Enhanced autocrine FGF19/FGFR4 signaling drives the progression of lung squamous cell carcinoma, which responds to mTOR inhibitor AZD2104	ONCOGENE			English	Article							TUMOR PROGRESSION; FGF19 CONTRIBUTES; BETA-KLOTHO; CANCER; GROWTH; FGFR4; PROMOTES; TARGET; IDENTIFICATION; EXPRESSION	Lung cancer occurrence and associated mortality ranks top in all countries. Despite the rapid development of targeted and immune therapies, many patients experience relapse within a few years. It is urgent to uncover the mechanisms that drive lung cancer progression and identify novel molecular targets. Our group has previously identified FGF19 as a prognostic marker and potential driver gene of lung squamous cell carcinomas (LSQ) in Chinese smoking patients. However, the underlying mechanism of how FGF19 promotes the progression of LSQ remains unclear. In this study, we characterized and confirmed that FGF19 serves as an oncogenic driver in LSQ development and progression, and reported that the amplification and high expression of FGF19 in LSQ was significantly associated with poor overall and progression-free survival. A higher serum level of FGF19 was found in lung cancer patients, which could also serve as a novel diagnostic index to screen lung cancer. Overproduction of FGF19 in LSQ cells markedly promoted cell growth, progression and metastasis, while downregulating FGF19 effectively inhibited LSQ progression in vitro and in vivo. Moreover, downregulating the receptor FGFR4 was also effective to suppress the growth and migration of LSQ cells. Since FGF19 could be induced by smoking or endoplasmic reticulum stress, to tackle the more malignant FGF19-overproducing LSQ, we reported for the first time that inhibiting mTOR pathway by using AZD2014 was effective and feasible. These findings have offered a new strategy by using anti-FGF19/FGFR4 therapy or mTOR-based therapy in FGF19-driven LSQ.	[Li, Fan; Han, Qing; Cheng, Yirui; Xia, Weiliang] Shanghai Jiao Tong Univ, State Key Lab Oncogenes & Related Genes, Renji Med Clin Stem Cell Res Ctr 10, Ren Ji Hosp,Sch Med, Shanghai, Peoples R China; [Li, Fan; Han, Qing; Cheng, Yirui; Xia, Weiliang] Shanghai Jiao Tong Univ, Sch Biomed Engn, Shanghai, Peoples R China; [Li, Ziming; Ji, Wenxiang; Yang, Ying; Lu, Shun] Shanghai Jiao Tong Univ, Shanghai Chest Hosp, Shanghai Lung Canc Ctr, Shanghai, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University	Xia, WL (corresponding author), Shanghai Jiao Tong Univ, State Key Lab Oncogenes & Related Genes, Renji Med Clin Stem Cell Res Ctr 10, Ren Ji Hosp,Sch Med, Shanghai, Peoples R China.; Xia, WL (corresponding author), Shanghai Jiao Tong Univ, Sch Biomed Engn, Shanghai, Peoples R China.	wlxia@sjtu.edu.cn	XIA, WEILIANG/AEA-0835-2022; li, fan/AAY-5915-2020; Lu, Shun/ABF-8341-2021; Li, Fan/GRX-7461-2022	XIA, WEILIANG/0000-0002-0256-4219; 	National Natural Science Foundation of China [81773115]; National Key Grant of China [2016YFC0906400]; Medical-Engineering Joint Funds from Shanghai Jiao Tong University [YG2017MS52, YG2017MS81]; Shanghai Science and Technology Commission guidance projects [18411968200]; Shanghai Chest Hospital Project of Collaborative Innovation [YJXT20190209]; Shanghai Youth Top Talent Project	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Grant of China; Medical-Engineering Joint Funds from Shanghai Jiao Tong University; Shanghai Science and Technology Commission guidance projects; Shanghai Chest Hospital Project of Collaborative Innovation; Shanghai Youth Top Talent Project	This work is financially supported, in whole or in part, by National Natural Science Foundation of China (81773115), National Key Grant of China (2016YFC0906400) and Medical-Engineering Joint Funds from Shanghai Jiao Tong University (YG2017MS52, YG2017MS81), Shanghai Science and Technology Commission guidance projects (18411968200), Shanghai Chest Hospital Project of Collaborative Innovation (YJXT20190209) and Shanghai Youth Top Talent Project.	Aldhahrani Adil, 2017, ERJ Open Res, V3, DOI 10.1183/23120541.00107-2016; Beck JT, 2014, CANCER TREAT REV, V40, P980, DOI 10.1016/j.ctrv.2014.06.006; Chen WQ, 2016, CA-CANCER J CLIN, V66, P115, DOI 10.3322/caac.21338; Desnoyers L, 2008, ONCOGENE, V27, P85, DOI 10.1038/sj.onc.1210623; Feng S, 2013, CANCER RES, V73, P2551, DOI 10.1158/0008-5472.CAN-12-4108; Gao LX, 2019, ONCOGENE, V38, P2394, DOI 10.1038/s41388-018-0591-7; Greenman C, 2007, NATURE, V446, P153, DOI 10.1038/nature05610; Guichard SM, 2015, MOL CANCER THER, V14, P2508, DOI 10.1158/1535-7163.MCT-15-0365; Gyorffy B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082241; Hagel M, 2015, CANCER DISCOV, V5, P424, DOI 10.1158/2159-8290.CD-14-1029; Ji WX, 2016, ONCOTARGET, V7, P15118, DOI 10.18632/oncotarget.7701; Joshi JJ, 2017, CANCER RES, V77, P6999, DOI 10.1158/0008-5472.CAN-17-1865; Koole K, 2015, PATHOBIOLOGY, V82, P280, DOI 10.1159/000439536; Lang LW, 2019, CURR CANCER DRUG TAR, V19, P17, DOI 10.2174/1568009618666180319091731; Lewis DR, 2014, CANCER-AM CANCER SOC, V120, P2883, DOI 10.1002/cncr.28749; Li F, 2019, THERANOSTICS, V9, P7474, DOI 10.7150/thno.35582; Lin BC, 2007, J BIOL CHEM, V282, P27277, DOI 10.1074/jbc.M704244200; Lin YN, 2019, BIOMED PHARMACOTHER, V118, DOI 10.1016/j.biopha.2019.109249; Luo YD, 2010, J BIOL CHEM, V285, P30069, DOI 10.1074/jbc.M110.148288; Massafra V, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171185; Nagamatsu H, 2015, PROSTATE, V75, P1092, DOI 10.1002/pros.22994; Pelaez-Garcia A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063695; Piotrowska Z, 2018, CANCER DISCOV, V8, P1529, DOI 10.1158/2159-8290.CD-18-1022; Powers CJ, 2000, ENDOCR-RELAT CANCER, V7, P165, DOI 10.1677/erc.0.0070165; Raja A, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8060536; Sawey ET, 2011, CANCER CELL, V19, P347, DOI 10.1016/j.ccr.2011.01.040; Siegel RL, 2016, CA-CANCER J CLIN, V66, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; Singleton KR, 2015, CANCER RES, V75, P4398, DOI 10.1158/0008-5472.CAN-15-0509; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tan Q, 2016, ONCOTARGET, V7, P18394, DOI 10.18632/oncotarget.7817; Teng Y, 2017, CANCER RES, V77, P6215, DOI 10.1158/0008-5472.CAN-17-2039; Tiong KH, 2016, ONCOTARGET, V7, P57633, DOI 10.18632/oncotarget.9328; Turunen SP, 2019, CELL DEATH DIFFER, V26, P2577, DOI 10.1038/s41418-019-0321-x; Wan ZY, 2016, HEPATOLOGY, V64, P1289, DOI 10.1002/hep.28639; Wang S, 2016, ONCOL RES, V23, P197, DOI 10.3727/096504016X14537290676919; Yoo C, 2017, ONCOTARGET, V8, P38592, DOI 10.18632/oncotarget.16951; Zhang XC, 2017, THORAC CANCER, V8, P655, DOI 10.1111/1759-7714.12504; Zhang XL, 2016, OTOLARYNG HEAD NECK, V154, P52, DOI 10.1177/0194599815609534; Zhao HK, 2016, ONCOTARGET, V7, P13575, DOI 10.18632/oncotarget.6185; Zhou M, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15433	40	15	15	0	8	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR	2020	39	17					3507	3521		10.1038/s41388-020-1227-2	http://dx.doi.org/10.1038/s41388-020-1227-2		FEB 2020	15	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	LH1YK	32111983	Green Published, hybrid			2022-12-26	WOS:000517049100002
J	Pecanha, PM; Gomes, SC; Pone, SM; Pone, MVD; Vasconcelos, Z; Zin, A; Vilibor, RHH; Costa, RP; Meio, MDBB; Nielsen-Saines, K; Brasil, P; Brickley, E; Moreira, MEL				Pecanha, Pedro Massaroni; Gomes Junior, Saint Clair; Pone, Sheila Moura; da Silva Pone, Marcos Vinicius; Vasconcelos, Zilton; Zin, Andrea; Hasue Vilibor, Renata Hydee; Costa, Roozemeria Pereira; Barbosa Baker Meio, Maria Dalva; Nielsen-Saines, Karin; Brasil, Patricia; Brickley, Elizabeth; Lopes Moreira, Maria Elisabeth			Neurodevelopment of children exposed intra-uterus by Zika virus: A case series	PLOS ONE			English	Article							HEAD GROWTH; PRETERM INFANTS; INFECTION; BRAIN; STANDARDS; WEIGHT; BRAZIL; NEEDS	The main goal of this manuscript was to investigate the neurodevelopment of children exposed by Zika virus in the intrauterine period who are asymptomatic at birth. Newborns with documented Zika virus exposure during the intrauterine period who were asymptomatic at birth were followed in the first two years of life for neurodevelopment using Bayley III test. Children were classified as having normal or delayed neurodevelopment for age based on most recent Bayley III evaluation results. Eighty-four infants were included in the study. The first Bayley III evaluation was performed at a mean chronological age of 9.7 +/- 3.1 month; 13 children (15%) had a delay in one of the three domains, distributed as follow: 10 (12%) in the language domain and 3 (3.5%) in the motor domain. The most recent Bayley III evaluation was performed at a mean age 15.3 +/- 3.1 months; 42 children (50%) had a delay in one of the three domains: 4 (5%) in cognition, 31 (37%) in language, and 20 (24%) in motor performance. There were no statistical differences in Gender, Gestational Age, Birth Weight and Head Circurference at birth between children with normal and delayed neurodevelopment for age. A very high proportion of children exposed ZIKV during pregnancy who were asymptomatic at birth demonstrated a delay in neurodevelopment, mainly in the language domain, the first two years of life.	[Pecanha, Pedro Massaroni; Gomes Junior, Saint Clair; Pone, Sheila Moura; da Silva Pone, Marcos Vinicius; Vasconcelos, Zilton; Zin, Andrea; Costa, Roozemeria Pereira; Barbosa Baker Meio, Maria Dalva; Lopes Moreira, Maria Elisabeth] Inst Fernandes Figueira Fiocruz, Rio De Janeiro, Brazil; [Hasue Vilibor, Renata Hydee] Univ Sao Paulo, Sao Paulo, Brazil; [Nielsen-Saines, Karin] UCLA, Los Angeles, CA USA; [Brasil, Patricia] Inst Nacl Infectol Fiocruz, Rio De Janeiro, Brazil; [Brickley, Elizabeth] London Sch Hyg & Trop Med, London, England	Fundacao Oswaldo Cruz; Universidade de Sao Paulo; University of California System; University of California Los Angeles; University of London; London School of Hygiene & Tropical Medicine	Moreira, MEL (corresponding author), Inst Fernandes Figueira Fiocruz, Rio De Janeiro, Brazil.	bebethiff@gmail.com	Gomes, Clair/F-7579-2012; Brasil, Patricia/P-3536-2014; Hasue, Renata Hydee/B-2328-2013; Pone, Marcos/ABF-2743-2022; Brickley, Elizabeth/U-3625-2017	Gomes, Clair/0000-0002-1554-943X; Hasue, Renata Hydee/0000-0002-7717-6042; Pone, Marcos/0000-0002-5152-2242; Massaroni Pecanha, Pedro/0000-0002-4151-5508; Brickley, Elizabeth/0000-0003-0280-2288; Brasil, Patricia/0000-0001-9555-7976	European Union [734584]; Wellcome Trust [205377/Z/16/Z]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico CNPq [441098/2016-9]; Faperj [E-26/202.979/2017]; PIP2/IFF/Fiocruz [IFF-002Fio1628]; NIH/NIAID [RO1-AI140718]	European Union(European Commission); Wellcome Trust(Wellcome TrustEuropean Commission); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Faperj(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); PIP2/IFF/Fiocruz; NIH/NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The author(s) received specific fundings for this work -European Union's Horizon 2020 Research and Innovation Programme under ZikaPLAN 734584 Maria Elisabeth lopes Moreira - Wellcome Trust 205377/Z/16/Z Dr Elizabeth Brickley - Conselho Nacional de Desenvolvimento Cientifico e Tecnologico CNPq 441098/2016-9 Maria Elisabeth lopes Moreira - Faperj E-26/202.979/2017 Maria Elisabeth lopes Moreira - PIP2/IFF/Fiocruz IFF-002Fio1628 Maria Elisabeth lopes Moreira - NIH/NIAID - RO1-AI140718.	Adu-Afarwuah S, 2017, ANN NY ACAD SCI, V1392, P18, DOI 10.1111/nyas.13328; BALLARD JL, 1979, J PEDIATR-US, V95, P769, DOI 10.1016/S0022-3476(79)80734-9; Bayley N., 2019, BAYLEY SCALES INFANT; Brasil. Ministerio da Saude. Secretaria de Vigilancia em Saude. Secretaria de Atenc Saude, 2016, GUID EARL STIM INF 3; Britto PR, 2017, LANCET, V389, P91, DOI 10.1016/S0140-6736(16)31390-3; Broussard CS, 2018, PEDIATRICS, V141, pS146, DOI 10.1542/peds.2017-2038C; Chan JFW, 2016, J INFECTION, V72, P507, DOI 10.1016/j.jinf.2016.02.011; Cheong JLY, 2008, PEDIATRICS, V121, pE1534, DOI 10.1542/peds.2007-2671; Chimelli L, 2018, J NEUROPATH EXP NEUR, V77, P193, DOI 10.1093/jnen/nlx116; Cooke RWI, 2006, ARCH DIS CHILD-FETAL, V91, pF17, DOI 10.1136/adc.2005.077438; Coplan J., 1983, ELM SCALE EARLY LANG; Countryeconomy.com, 2018, BRAZ NAT MIN WAG NMW; Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296; de Onis M, 2006, ACTA PAEDIATR, V95, P76, DOI 10.1080/08035320500495548; de Paiva GS, 2010, SAO PAULO MED J, V128, P276, DOI 10.1590/S1516-31802010000500007; Dubowitz L, 2005, MENT RETARD DEV D R, V11, P52, DOI 10.1002/mrdd.20048; Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297; Franca GVA, 2016, LANCET, V388, P891, DOI 10.1016/S0140-6736(16)30902-3; Gale CR, 2006, PEDIATRICS, V118, P1486, DOI 10.1542/peds.2005-2629; Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116; Gilberti LDP, 1999, AN 6 C GOIAN PED GOI; Gulland A, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i657; Kuban KCK, 2009, J PEDIATR-US, V155, P344, DOI 10.1016/j.jpeds.2009.04.002; Martines RB, 2016, MMWR-MORBID MORTAL W, V65, P159, DOI 10.15585/mmwr.mm6506e1; Martinot AJ, 2018, CELL, V173, P1111, DOI 10.1016/j.cell.2018.03.019; Miranda DD, 2016, AM J PUBLIC HEALTH, V106, P598, DOI 10.2105/AJPH.2016.303115; Moore CA, 2017, JAMA PEDIATR, V171, P288, DOI 10.1001/jamapediatrics.2016.3982; Neubauer V, 2013, ACTA PAEDIATR, V102, P883, DOI 10.1111/apa.12319; OECD, 2018, ED GLANC 2018; Paul AM, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.02028; Pessoa A, 2018, PEDIATRICS, V141, pS167, DOI 10.1542/peds.2017-2038F; Raghuram K, 2017, PEDIATRICS, V140, DOI 10.1542/peds.2017-0216; Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338; Saad T, 2018, CHILD NERV SYST, V34, P73, DOI 10.1007/s00381-017-3634-4; Maria-Mengel MR, 2007, REV LAT-AM ENFERM, V15, P837, DOI 10.1590/S0104-11692007000700019; Soriano-Arandes A, 2018, EXPERT REV ANTI-INFE, V16, P243, DOI 10.1080/14787210.2018.1438265; Villar J, 2014, LANCET, V384, P857, DOI 10.1016/S0140-6736(14)60932-6; Waldorf KMA, 2018, NAT MED; Waldorf KMA, 2013, REPRODUCTION, V146, pR151, DOI 10.1530/REP-13-0232; Wheeler AC, 2018, PEDIATRICS, V141, pS154, DOI [10.1542/peds.2017-2038D, 10.1542/peds.2017-2038d]; Wu YH, 2018, CELL REP, V25, P1537, DOI 10.1016/j.celrep.2018.10.025	41	29	30	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2020	15	2							e0229434	10.1371/journal.pone.0229434	http://dx.doi.org/10.1371/journal.pone.0229434			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8HR	32109947	gold, Green Published			2022-12-26	WOS:000535239800011
J	Trilla-Fuertes, L; Miranda, N; Castellano, D; Lopez-Vacas, R; Tello, CAF; de Velasco, G; Villacampa, F; Lopez-Camacho, E; Prado-Vazquez, G; Zapater-Moros, A; Espinosa, E; Vara, JAF; Pinto, A; Gamez-Pozo, A				Trilla-Fuertes, Lucia; Miranda, Natalia; Castellano, Daniel; Lopez-Vacas, Rocio; Farfan Tello, Carlos A.; de Velasco, Guillermo; Villacampa, Felipe; Lopez-Camacho, Elena; Prado-Vazquez, Guillermo; Zapater-Moros, Andrea; Espinosa, Enrique; Fresno Vara, Juan Angel; Pinto, Alvaro; Gamez-Pozo, Angelo			miRNA profiling in renal carcinoma suggest the existence of a group of pro-angionenic tumors in localized clear cell renal carcinoma	PLOS ONE			English	Article							COMPREHENSIVE MOLECULAR CHARACTERIZATION; MICRORNA EXPRESSION; MANAGEMENT; CLASSIFICATION; NEPHRECTOMY; SUNITINIB; THERAPY; MIR-126; SYSTEM	Renal cell carcinoma comprises a variety of entities, the most common being the clear-cell, papillary and chromophobe subtypes. These subtypes are related to different clinical evolution; however, most therapies have been developed for clear-cell carcinoma and there is not a specific treatment based on different subtypes. In this study, one hundred and sixty-four paraffin samples from primary nephrectomies for localized tumors were analyzed. MiRNAs were isolated and measured by microRNA arrays. Significance Analysis of Microarrays and Consensus Cluster algorithm were used to characterize different renal subtypes. The analyses showed that chromophobe renal tumors are a homogeneous group characterized by an overexpression of miR 1229, miR 10a, miR 182, miR 1208, miR 222, miR 221, miR 891b, miR 629-5p and miR 221-5p. On the other hand, clear cell renal carcinomas presented two different groups inside this histological subtype, with differences in miRNAs that regulate focal adhesion, transcription, apoptosis and angiogenesis processes. Specifically, one of the defined groups had an overexpression of proangiogenic microRNAs miR185, miR126 and miR130a. In conclusion, differences in miRNA expression profiles between histological renal subtypes were established. In addition, clear cell renal carcinomas had different expression of proangiogenic miRNAs. With the emergence of antiangiogenic drugs, these differences could be used as therapeutic targets in the future or as a selection method for tailoring personalized treatments.	[Trilla-Fuertes, Lucia; Lopez-Camacho, Elena; Prado-Vazquez, Guillermo; Zapater-Moros, Andrea; Fresno Vara, Juan Angel; Gamez-Pozo, Angelo] Biomed Mol Med SL, Madrid, Spain; [Miranda, Natalia] Hosp Univ 12 Octubre, Urol Serv, Madrid, Spain; [Castellano, Daniel; Farfan Tello, Carlos A.; de Velasco, Guillermo] Hosp Univ 12 Octubre, Med Oncol Serv, Madrid, Spain; [Lopez-Vacas, Rocio; Prado-Vazquez, Guillermo; Zapater-Moros, Andrea; Fresno Vara, Juan Angel; Gamez-Pozo, Angelo] Hosp Univ La Paz IdiPAZ, Mol Oncol & Pathol Lab, Madrid, Spain; [Farfan Tello, Carlos A.] Clin Int SA, Lima, Peru; [Villacampa, Felipe] Clin Univ Navarra, Urol Dept, Madrid, Spain; [Zapater-Moros, Andrea; Espinosa, Enrique; Fresno Vara, Juan Angel] ISCIII, Biomed Res Networking Ctr Oncol CIBERONC, Madrid, Spain; [Espinosa, Enrique; Pinto, Alvaro] La Paz Univ Hosp IdiPAZ, Med Oncol Serv, Madrid, Spain	Hospital Universitario 12 de Octubre; Hospital Universitario 12 de Octubre; Hospital Universitario La Paz; University of Navarra; Instituto de Salud Carlos III; Hospital Universitario La Paz	Gamez-Pozo, A (corresponding author), Biomed Mol Med SL, Madrid, Spain.; Gamez-Pozo, A (corresponding author), Hosp Univ La Paz IdiPAZ, Mol Oncol & Pathol Lab, Madrid, Spain.; Pinto, A (corresponding author), La Paz Univ Hosp IdiPAZ, Med Oncol Serv, Madrid, Spain.	alvaropintomarin@gmail.com; angelogamez@gmail.com	Vara, Juan Ángel Fresno/Y-9928-2019; Trilla, Lucia/AAG-8392-2019; Gamez-Pozo, Angelo/N-2506-2014	Vara, Juan Ángel Fresno/0000-0003-1527-1252; Trilla, Lucia/0000-0002-4452-3474; Gamez-Pozo, Angelo/0000-0002-8931-0624; Villacampa, Felipe/0000-0001-6779-6945; Espinosa Arranz, Enrique/0000-0001-6562-7902	FEDER program, "Una forma de hacer Europa" [PI07/1302]; Spanish Economy and Competitiveness Ministry [PTQ2018-009760, DI-15-07614]; Consejeria de Educacion e Investigacion de la Comunidad de Madrid [IND2018/BMD-9262]; Consejeria de Educacion, Juventud y Deporte of Comunidad de Madrid [IND2017/BMD7783]; Instituto de Salud Carlos III, Spanish Economy and Competitiveness Ministry, Spain	FEDER program, "Una forma de hacer Europa"; Spanish Economy and Competitiveness Ministry(Spanish Government); Consejeria de Educacion e Investigacion de la Comunidad de Madrid; Consejeria de Educacion, Juventud y Deporte of Comunidad de Madrid; Instituto de Salud Carlos III, Spanish Economy and Competitiveness Ministry, Spain	This study was supported by Instituto de Salud Carlos III, Spanish Economy and Competitiveness Ministry, Spain and co-funded by the FEDER program, "Una forma de hacer Europa" (PI07/1302). LT-F is supported by the Spanish Economy and Competitiveness Ministry (DI-15-07614). AZ-M is supported by Consejeria de Educacion e Investigacion de la Comunidad de Madrid (IND2018/BMD-9262). GP-V is supported by Consejeria de Educacion, Juventud y Deporte of Comunidad de Madrid (IND2017/BMD7783). EL-C is supported by the Spanish Economy and Competitiveness Ministry (PTQ2018-009760).The funders had no role in the study design, data collection and analysis, decision to publish or preparation of the manuscript.	Bex A, 2017, ANN ONCOL, V28, P682, DOI 10.1093/annonc/mdx014; Chen EY, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-128; Chen Y, 2008, BLOOD, V111, P1217, DOI 10.1182/blood-2007-07-104133; Dweep H, 2011, J BIOMED INFORM, V44, P839, DOI 10.1016/j.jbi.2011.05.002; Fish JE, 2008, DEV CELL, V15, P272, DOI 10.1016/j.devcel.2008.07.008; Gamez-Pozo A, 2015, CANCER RES, V75, P2243, DOI 10.1158/0008-5472.CAN-14-1937; Gamez-Pozo A, 2012, NEOPLASIA, V14, P1144, DOI 10.1593/neo.12734; Garzon R, 2009, ANNU REV MED, V60, P167, DOI 10.1146/annurev.med.59.053006.104707; Gross-Goupil M, 2018, ANN ONCOL, V29, P2371, DOI 10.1093/annonc/mdy454; Harris TA, 2008, P NATL ACAD SCI USA, V105, P1516, DOI 10.1073/pnas.0707493105; Janowitz T, 2013, SEMIN ONCOL, V40, P482, DOI 10.1053/j.seminoncol.2013.05.004; Janzen NK, 2003, UROL CLIN N AM, V30, P843, DOI 10.1016/S0094-0143(03)00056-9; Johnson WE, 2007, BIOSTATISTICS, V8, P118, DOI 10.1093/biostatistics/kxj037; Kakimoto Y, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163125; Khella HWZ, 2015, AM J PATHOL, V185, P693, DOI 10.1016/j.ajpath.2014.11.017; Lawrence NJ, 2018, KIDNEY CANCER, V2, P123, DOI 10.3233/KCA-180038; Linehan WM, 2016, NEW ENGL J MED, V374, P135, DOI 10.1056/NEJMoa1505917; Lopez-Romero Pedro, 2010, BMC Res Notes, V3, P18, DOI 10.1186/1756-0500-3-18; Ma X, 2015, UROL ONCOL-SEMIN ORI, V33, DOI 10.1016/j.urolonc.2015.01.003; Moch H, 2016, EUR UROL, V70, P93, DOI 10.1016/j.eururo.2016.02.029; Monti S, 2003, MACH LEARN, V52, P91, DOI 10.1023/A:1023949509487; Motzer RJ, 2017, J CLIN ONCOL, V35, P3916, DOI 10.1200/JCO.2017.73.5324; Powers MP, 2011, DIAGN MOL PATHOL, V20, P63, DOI 10.1097/PDM.0b013e3181efe2a9; Ricketts CJ, 2018, CELL REP, V23, P313, DOI [10.1016/j.celrep.2018.03.075, 10.1016/j.celrep.2018.06.032]; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Si WG, 2019, CLIN EPIGENETICS, V11, DOI 10.1186/s13148-018-0587-8; Siegel RL, 2016, CA-CANCER J CLIN, V66, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; Silva-Santos RM, 2013, BRIT J CANCER, V109, P2646, DOI 10.1038/bjc.2013.552; Staehler M, 2018, ANN ONCOL, V29, P2098, DOI 10.1093/annonc/mdy329; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Wang WT, 2014, J HEMATOL ONCOL, V7, DOI 10.1186/1756-8722-7-6; Youssef YM, 2011, EUR UROL, V59, P721, DOI 10.1016/j.eururo.2011.01.004; Yuan HX, 2014, TUMOR BIOL, V35, P12757, DOI 10.1007/s13277-014-2602-9	33	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2020	15	2							e0229075	10.1371/journal.pone.0229075	http://dx.doi.org/10.1371/journal.pone.0229075			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8HR	32109249	gold, Green Published, Green Submitted			2022-12-26	WOS:000535239800005
J	Churchill, GC; Strupp, M; Galione, A; Platt, FM				Churchill, Grant C.; Strupp, Michael; Galione, Antony; Platt, Frances M.			Unexpected differences in the pharmacokinetics of N-acetyl-DL-leucine enantiomers after oral dosing and their clinical relevance	PLOS ONE			English	Article							AMINO-ACIDS; METABOLISM; RAT; PERMEABILITY; ABSORPTION; TRANSPORT; MEMBRANES; CHIRALITY	The enantiomers of many chiral drugs not only exhibit different pharmacological effects in regard to targets that dictate therapeutic and toxic effects, but are also handled differently in the body due to pharmacokinetic effects. We investigated the pharmacokinetics of the enantiomers of N-acetyl-leucine after administration of the racemate (N-acetyl-DL-leucine) or purified, pharmacologically active L-enantiomer (N-acetyl-L-leucine). The results suggest that during chronic administration of the racemate, the D-enantiomer would accumulate, which could have negative effects. Compounds were administered orally to mice. Plasma and tissue samples were collected at predetermined time points (0.25 to 8 h), quantified with liquid chromatography/mass spectrometry, and pharmacokinetic constants were calculated using a noncompartmental model. When administered as the racemate, both the maximum plasma concentration (C-max) and the area under the plasma drug concentration over time curve (AUC) were much greater for the D-enantiomer relative to the L-enantiomer. When administered as the L-enantiomer, the dose proportionality was greater than unity compared to the racemate, suggesting saturable processes affecting uptake and/or metabolism. Elimination (k(e) and T-1/2) was similar for both enantiomers. These results are most readily explained by inhibition of uptake at an intestinal carrier of the L-enantiomer by the D-enantiomer, and by first-pass metabolism of the L-, but not D-enantiomer, likely by deacetylation. In brain and muscle, N-acetyl-L-leucine levels were lower than N-acetyl-D-leucine, consistent with rapid conversion into L-leucine and utilization by normal leucine metabolism. In summary, the enantiomers of N-acetyl-leucine exhibit large, unexpected differences in pharmacokinetics due to both unique handling and/or inhibition of uptake and metabolism of the Lenantiomer by the D-enantiomer. Taken together, these results have clinical implications supporting the use of N-acetyl-L-leucine instead of the racemate or N-acetyl-D-leucine, and support the research and development of only N-acetyl-L-leucine.	[Churchill, Grant C.; Galione, Antony; Platt, Frances M.] Univ Oxford, Dept Pharmacol, Oxford, England; [Strupp, Michael] Ludwig Maximilians Univ Hosp Munich, German Ctr Vertigo & Balance Disorders, Dept Neurol, Munich, Germany	University of Oxford; University of Munich	Churchill, GC (corresponding author), Univ Oxford, Dept Pharmacol, Oxford, England.	grant.churchill@pharm.ox.ac.uk		Strupp, Michael/0000-0002-9544-2279; Churchill, Grant/0000-0001-9591-9391; Galione, Antony/0000-0002-4132-7646	IntraBio	IntraBio	This study was financially supported by IntraBio (https://intrabio.com).The authors (GCC, MS, AG and FMP) were paid for consultancy work for IntraBio. Authors, acting in their capacity as consultants for IntraBio, played roles in study design, data collection and analysis, decision to publish, or preparation of the manuscript. FMP is also a Royal Society Wolfson Research Merit Award holder and a Wellcome Trust Investigator in Science.	[Anonymous], 1992, Chirality, V4, P338; ARIENS EJ, 1986, TRENDS PHARMACOL SCI, V7, P200, DOI 10.1016/0165-6147(86)90313-5; ARIENS EJ, 1984, EUR J CLIN PHARMACOL, V26, P663, DOI 10.1007/BF00541922; Benard P, 2001, EUR J DRUG METAB PH, V26, P71, DOI 10.1007/BF03190379; BIRNBAUM SM, 1952, J BIOL CHEM, V194, P455; BLOCH K, 1947, J BIOL CHEM, V169, P467; BLOCH K, 1946, J BIOL CHEM, V164, P483; Bremova T, 2015, NEUROLOGY, V85, P1368, DOI 10.1212/WNL.0000000000002041; Brocks DR, 2006, BIOPHARM DRUG DISPOS, V27, P387, DOI 10.1002/bdd.517; Camenisch G, 1996, Pharm Acta Helv, V71, P309, DOI 10.1016/S0031-6865(96)00031-3; CHAKRABARTI AC, 1994, AMINO ACIDS, V6, P213, DOI 10.1007/BF00813743; Chen WG, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-17225-0; Cortina-Borja M, 2018, ORPHANET J RARE DIS, V13, DOI 10.1186/s13023-018-0880-9; Eriksson T, 2001, EUR J CLIN PHARMACOL, V57, P365, DOI 10.1007/s002280100320; Feil K, 2017, BMC NEUROL, V17, DOI 10.1186/s12883-016-0786-x; Ferber-Viart C, 2009, AUDIOL NEURO-OTOL, V14, P17, DOI 10.1159/000148206; Gabrielsson J., 2016, PHARMACOKINETIC PHAR; Gunther L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120891; Hasegawa H, 2000, DRUG METAB DISPOS, V28, P920; Kalla R, 2019, CURR NEUROPHARMACOL, V17, P7, DOI 10.2174/1570159X16666180905093535; Khoronenkova SV, 2008, BIOCHEMISTRY-MOSCOW+, V73, P1511, DOI 10.1134/S0006297908130105; Kiela PR, 2016, BEST PRACT RES CL GA, V30, P145, DOI 10.1016/j.bpg.2016.02.007; KREBS HANS ADOLF, 1935, BIOCHEM JOUR, V29, P1620; Krehbiel C. R., 2003, Amino acids in animal nutrition, P41, DOI 10.1079/9780851996547.0041; Lee AJ, 2015, AMINO ACIDS, V47, P917, DOI 10.1007/s00726-015-1920-6; Lees P, 2012, J VET PHARMACOL THER, V35, P17, DOI 10.1111/j.1365-2885.2012.01367.x; Martignoni M, 2006, EXPERT OPIN DRUG MET, V2, P875, DOI 10.1517/17425255.2.6.875; MATTHEWS DE, 1980, AM J PHYSIOL, V238, pE473, DOI 10.1152/ajpendo.1980.238.5.E473; Missner A, 2009, CHEMPHYSCHEM, V10, P1405, DOI 10.1002/cphc.200900270; MUNCK BG, 1985, J MEMBRANE BIOL, V83, P15, DOI 10.1007/BF01868734; MUNCK LK, 1994, PHYSIOL RES, V43, P335; Nair Anroop B, 2016, J Basic Clin Pharm, V7, P27, DOI 10.4103/0976-0105.177703; Neuzil E., 2002, B SOC PHARM BORDEAUX, V141, P15; PAULING L, 1977, P ROY SOC LOND A MAT, V356, P433, DOI 10.1098/rspa.1977.0143; Platt F, 2016, J NEUROL, V263, P1239, DOI 10.1007/s00415-016-8048-9; Schniepp Roman, 2016, Cerebellum Ataxias, V3, P8, DOI 10.1186/s40673-016-0046-2; Schoser B, 2019, EUR J NEUROL; STILLWELL W, 1976, BIOSYSTEMS, V8, P111, DOI 10.1016/0303-2647(76)90014-9; Strupp M, 2019, J NEUROL, V266, P525, DOI 10.1007/s00415-018-9155-6; Strupp M, 2013, J NEUROL, V260, P2556, DOI 10.1007/s00415-013-7016-x; TESTA B, 1986, TRENDS PHARMACOL SCI, V7, P60, DOI 10.1016/0165-6147(86)90255-5; Tighilet B, 2015, EUR J PHARMACOL, V769, P342, DOI 10.1016/j.ejphar.2015.11.041; Vibert N, 2001, EUR J NEUROSCI, V13, P735, DOI 10.1046/j.0953-816x.2000.01447.x; WALLE T, 1986, TRENDS PHARMACOL SCI, V7, P155, DOI 10.1016/0165-6147(86)90294-4; WHALER BC, 1955, J PHYSIOL-LONDON, V130, P278, DOI 10.1113/jphysiol.1955.sp005410; Zhang G, 2019, RACEMIZATION REVERSE	46	10	10	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2020	15	2							e0229585	10.1371/journal.pone.0229585	http://dx.doi.org/10.1371/journal.pone.0229585			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8GQ	32108176	Green Published, Green Submitted, gold			2022-12-26	WOS:000535237000046
J	Girard, M; Hu, D; Pradervand, N; Neuenschwander, S; Bee, G				Girard, M.; Hu, D.; Pradervand, N.; Neuenschwander, S.; Bee, G.			Chestnut extract but not sodium salicylate decreases the severity of diarrhea and enterotoxigenic Escherichia coli F4 shedding in artificially infected piglets	PLOS ONE			English	Article							ANTIBACTERIAL ACTIVITIES; ANTIMICROBIAL ACTIVITY; ANTIBIOTIC-RESISTANCE; ETEC; PERFORMANCE; PIG; POLYPHENOLS; ADHESION; TANNINS; GROWTH	The development of alternatives to antibiotics is crucial to limiting the incidence of antimicrobial resistance, especially in prophylactic and metaphylactic use to control post-weaning diarrhea (PWD). Feed additives, including bioactive compounds, could be a promising alternative. This study aimed to test two bioactive compounds, sodium salicylate (SA) and a chestnut extract (CE) containing hydrolysable tannins, on the occurrence of PWD. At weaning, 72 piglets were assigned to four treatments that combined two factors: CE supplementation (with 2% of CE (CE+) or without (CE-)) and SA supplementation (with 35 mg/kg BW of SA (SA+) or without (SA-)). Then, 4 days after weaning, all piglets were infected with a suspension at 108 CFU/ml of enterotoxigenic Escherichia coli (ETEC F4ac). Each piglet had free access to an electrolyte solution containing, or not, SA. This SA supplementation was administered for 5 days (i.e., from the day of infection (day 0) to 4 days post-infection (day 4). During the 2 weeks post-infection, supplementation with SA had no effect (P > 0.05) on growth performances nor on fecal scores. A significant SA x time interaction (P < 0.01) for fecal scores and the percentage of diarrhea indicated that piglets with SA did not recover faster and did have a second episode of diarrhea. In contrast to SA treatment, inclusion of CE increased (P < 0.05) growth performances and feed intake. In the first week post-infection, CE decreased (P < 0.001) the overall fecal scores, the percentage of piglets with diarrhea, the days in diarrhea, and ETEC shedding in the feces. There was a SAxCE interaction (P < 0.05) for ETEC shedding, suggesting a negative effect of combining SA with CE. This study highlighted that, in contrast to SA, CE could represent a promising alternative to antibiotics immediately after weaning for improving growth performance and reducing PWD.	[Girard, M.; Pradervand, N.; Bee, G.] Agroscope, Fribourg, Switzerland; [Hu, D.; Neuenschwander, S.] Swiss Fed Inst Technol, Inst Agr Sci, Zurich, Switzerland	Swiss Federal Research Station Agroscope; Swiss Federal Institutes of Technology Domain; ETH Zurich	Bee, G (corresponding author), Agroscope, Fribourg, Switzerland.	giuseppe.bee@agroscope.admin.ch	; Bee, Giuseppe/E-6139-2013	Girard, Marion/0000-0003-1819-3800; Bee, Giuseppe/0000-0002-6397-7543; Neuenschwander, Stefan/0000-0002-8348-261X				Agroscope, 2017, FUT NAHRW SCHWEIN; Al-Zoreky NS, 2009, INT J FOOD MICROBIOL, V134, P244, DOI 10.1016/j.ijfoodmicro.2009.07.002; Biagi G, 2010, ARCH ANIM NUTR, V64, P121, DOI 10.1080/17450390903461584; Boerlin P, 2005, APPL ENVIRON MICROB, V71, P6753, DOI 10.1128/AEM.71.11.6753-6761.2005; Brand P, 2017, SCHWEIZ ARCH TIERH, V159, P373, DOI 10.17236/sat00120; Brus M., 2013, Bulgarian Journal of Agricultural Science, V19, P841; Carstensen B., 2008, INT J BIOSTAT, V4, P16, DOI DOI 10.2202/1557-4679.1107; CEDERLUND H, 1993, J ANTIMICROB CHEMOTH, V32, P355, DOI 10.1093/jac/32.3.355; Coddens A, 2017, VET MICROBIOL, V202, P64, DOI 10.1016/j.vetmic.2017.01.019; COHEN SP, 1993, J BACTERIOL, V175, P7856, DOI 10.1128/JB.175.24.7856-7862.1993; Espin JC, 2007, J AGR FOOD CHEM, V55, P10476, DOI 10.1021/jf0723864; Fairbrother JM, 2012, DIS SWINE, P723; Fairbrother John M., 2005, Animal Health Research Reviews, V6, P17, DOI 10.1079/AHR2005105; Girard M, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0197878; Graziani R, 2006, EPC 2006, P328; Hu D, 2019, ANIM GENET, V50, P136, DOI 10.1111/age.12770; Kim JC, 2016, J ANIM SCI BIOTECHNO, V7, DOI 10.1186/s40104-016-0118-4; Lee CY, 2017, J ANIM PHYSIOL AN N, V101, P88, DOI 10.1111/jpn.12513; Lindsay BR, 2014, FEMS MICROBIOL LETT, V352, P25, DOI 10.1111/1574-6968.12362; Liu YT, 2006, BIOTECHNOL BIOENG, V93, P297, DOI 10.1002/bit.20675; MA D, 1995, MOL MICROBIOL, V16, P45, DOI 10.1111/j.1365-2958.1995.tb02390.x; Min BR, 2008, SCI RES ESSAYS, V3, P66; Min BR, 2007, J FOOD PROTECT, V70, P543, DOI 10.4315/0362-028X-70.3.543; Molist F, 2011, BRIT J NUTR, V105, P1592, DOI 10.1017/S0007114510004575; Morinaga N, 2005, J BIOL CHEM, V280, P23303, DOI 10.1074/JBC.M502093200; Myrie SB, 2008, J ANIM SCI, V86, P609, DOI 10.2527/jas.2006-793; Nagy B, 1999, VET RES, V30, P259; Nataro JP, 1998, CLIN MICROBIOL REV, V11, P403; Nepomuceno RC, 2016, CIENC AGROTEC, V40, P205, DOI 10.1590/1413-70542016402043315; Price CTD, 2000, INT J BIOCHEM CELL B, V32, P1029, DOI 10.1016/S1357-2725(00)00042-X; RASKIN I, 1992, PLANT PHYSIOL, V99, P799, DOI 10.1104/pp.99.3.799; Rodea GE, 2017, FRONT CELL INFECT MI, V7, DOI 10.3389/fcimb.2017.00187; Ropiak HM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170768; Schubnell F, 2016, PARASITOL INT, V65, P618, DOI 10.1016/j.parint.2016.09.005; Thomas Pious, 2015, Biotechnol Rep (Amst), V8, P45, DOI 10.1016/j.btre.2015.08.003; Valle Demetrio L. Jr., 2015, Asian Pacific Journal of Tropical Biomedicine, V5, P532, DOI 10.1016/j.apjtb.2015.04.005; Van der Klis JD, 2012, 28 FFDNA C ADV AN NU; Verhelst R, 2014, LIVEST SCI, V160, P138, DOI 10.1016/j.livsci.2013.11.026; Verhelst R, 2010, LIVEST SCI, V133, P101, DOI 10.1016/j.livsci.2010.06.035; WISE CM, 1983, AM J VET RES, V44, P2221; XU ZR, 1990, J ANIM SCI, V68, P1639	41	11	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2020	15	2							e0214267	10.1371/journal.pone.0214267	http://dx.doi.org/10.1371/journal.pone.0214267			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8GQ	32106264	Green Published, gold			2022-12-26	WOS:000535237000001
J	Gonzalez, C; Silva-Ramirez, AS; Navarro-Tovar, G; Barrios-Capuchino, JJ; Rocha-Uribe, A				Gonzalez, Carmen; Sonia Silva-Ramirez, Ana; Navarro-Tovar, Gabriela; Jesus Barrios-Capuchino, Juan; Rocha-Uribe, Alejandro			Effect of the double bond conjugation on the vascular physiology and nitric oxide production of isomers of eicosapentaenoic and docosahexaenoic acids prepared from shark oil	PLOS ONE			English	Article							POLYUNSATURATED FATTY-ACIDS; CARDIOVASCULAR-DISEASE; FISH CONSUMPTION; HEART-RATE; IN-VITRO; MECHANISMS; GROWTH; SUPPLEMENTATION; ETHYL; TONE	A collection of evidence suggests that conjugation of double bonds of eicosapentaenoic (EPA) and docosahexaenoic (DHA) acids, omega-3 polyunsaturated fatty acids (n-3 PUFAs), increases their anticarcinogenic activity; however, the effect of such conjugation on vascular tone activity remains unknown. We propose that the mixture of conjugated PUFAs exerts higher vasorelaxation activity than the corresponding mixture of nonconjugated PUFAs. The vascular response to different concentrations of conjugated and nonconjugated isomers of EPA and DHA, among other fatty acids (FAs) naturally present in shark oil, and the role of nitric oxide (NO) as a vasorelaxant agent were investigated. Both conjugated EPA (CEPA) and conjugated DHA (CDHA) were prepared by alkaline isomerization of all PUFAs contained in shark oil. Different concentrations of conjugated and nonconjugated PUFAs were placed in contact with precontracted aortic rings of Wistar rats to assess their effect on vascular tone. All tested samples exerted a vasorelaxant effect. Compared to nonconjugated PUFAs, conjugated isomers exhibited an increase in the dilatation of the aortic rings (P < 0.001) in a dose-dependent manner (P < 0.001). In addition, nonconjugated PUFAs produced nitric oxide (NO) in a dose-dependent manner, while conjugated PUFAs did not, suggesting that their dilatation mechanism is not totally dependent on NO.	[Gonzalez, Carmen; Sonia Silva-Ramirez, Ana; Navarro-Tovar, Gabriela; Jesus Barrios-Capuchino, Juan; Rocha-Uribe, Alejandro] Univ Autonoma San Luis Potosi, Fac Ciencias Quim, San Luis Potosi, San Luis Potosi, Mexico; [Gonzalez, Carmen; Navarro-Tovar, Gabriela] Univ Autonoma San Luis Potosi, Ctr Invest Ciencias Salud & Biomed CICSaB, San Luis Potosi, San Luis Potosi, Mexico; [Navarro-Tovar, Gabriela] Consejo Nacl Ciencia & Technol, Mexico City, DF, Mexico	Universidad Autonoma de San Luis Potosi; Universidad Autonoma de San Luis Potosi	Rocha-Uribe, A (corresponding author), Univ Autonoma San Luis Potosi, Fac Ciencias Quim, San Luis Potosi, San Luis Potosi, Mexico.	arochau@uaslp.mx			Fondo de Apoyo a la Investigacion de la Universidad Autonoma de San Luis Potosi [C08FAI-10-26.62]	Fondo de Apoyo a la Investigacion de la Universidad Autonoma de San Luis Potosi	Alejandro Rocha-Uribe was supported by the grant by Fondo de Apoyo a la Investigacion de la Universidad Autonoma de San Luis Potosi (C08FAI-10-26.62). http://www.uaslp.mx/InvestigacionyPosgrado/Paginas/FAI/inicio.aspx.	Abdelhamid AS, 2018, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003177.pub3; Flores-Martinez IA, 2017, J MAR BIOL ASSOC UK, V97, P337, DOI 10.1017/S0025315416000424; AOCS, 1998, CD325CD758 AOCS; Arrowsmith S., 2018, JOVE-J VIS EXP, V131, P56639; BANG HO, 1976, ACTA MED SCAND, V200, P69; Binienda Z. K., 2013, Food and Nutrition Sciences, V4, P6; Braeckman RA, 2014, CLIN PHARM DRUG DEV, V3, P101, DOI 10.1002/cpdd.84; Calder PC, 2004, CLIN SCI, V107, P1, DOI 10.1042/CS20040119; Calnek DS, 2000, CURR ORG CHEM, V4, P1111, DOI 10.2174/1385272003375888; Chan WK, 2000, CARDIOVASC RES, V46, P180, DOI 10.1016/S0008-6363(99)00423-X; Christensen JH, 1997, AM J CARDIOL, V79, P1670, DOI 10.1016/S0002-9149(97)00220-8; Contreras GA, 2012, J DAIRY SCI, V95, P5011, DOI 10.3168/jds.2012-5382; Daci A, 2017, PROSTAG OTH LIPID M, V133, P29, DOI 10.1016/j.prostaglandins.2017.08.007; Danbara N, 2004, NUTR CANCER, V50, P71, DOI 10.1207/s15327914nc5001_10; Davidson MH, 2006, AM J CARDIOL, V98, p27I, DOI 10.1016/j.amjcard.2005.12.024; DECATERINA R, 1994, ARTERIOSCLER THROMB, V14, P1829, DOI 10.1161/01.ATV.14.11.1829; Deckelbaum RJ, 2006, AM J CLIN NUTR, V83, p1520S, DOI 10.1093/ajcn/83.6.1520S; Dong L, 2016, J BIOL CHEM, V291, P4069, DOI 10.1074/jbc.M115.698001; DYERBERG J, 1978, LANCET, V2, P117, DOI 10.1016/s0140-6736(78)91505-2; Engler MB, 2000, BRIT J PHARMACOL, V131, P1793, DOI 10.1038/sj.bjp.0703754; Gonzalez C, 2004, ENDOCRINOLOGY, V145, P5714, DOI 10.1210/en.2004-0647; Gonzalez C, 2015, ACTA PHARMACOL SIN, V36, P572, DOI 10.1038/aps.2014.159; Gortan Cappellari G, 2013, J NUTR BIOCHEM, V24, P371, DOI 10.1016/j.jnutbio.2012.07.012; Gousset-Dupont A, 2007, PROSTAG LEUKOTR ESS, V76, P131, DOI 10.1016/j.plefa.2006.11.005; Gurpinar T, 2012, SWISS MED WKLY, V142, DOI 10.4414/smw.2012.13558; Harris WS, 2006, CURR OPIN LIPIDOL, V17, P387, DOI 10.1097/01.mol.0000236363.63840.16; Khan F, 2003, CARDIOVASC RES, V59, P955, DOI 10.1016/S0008-6363(03)00395-X; Kris-Etherton PM, 2004, NUTR REV, V62, P414, DOI 10.1111/j.1753-4887.2004.tb00013.x; KROMHOUT D, 1985, NEW ENGL J MED, V312, P1205, DOI 10.1056/NEJM198505093121901; LAWSON LD, 1988, BIOCHEM BIOPH RES CO, V152, P328, DOI 10.1016/S0006-291X(88)80718-6; LAWSON LD, 1988, BIOCHEM BIOPH RES CO, V156, P960, DOI 10.1016/S0006-291X(88)80937-9; Li QR, 2005, J LIPID RES, V46, P1904, DOI 10.1194/jlr.M500033-JLR200; Libinaki R, 2017, NUTRIENTS, V9, DOI 10.3390/nu9091042; Limbu R, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0192484; Linder M, 2010, OCL OILS FAT CROP LI, V17, P194, DOI 10.1051/ocl.2010.0328; Massaro M, 2008, PROSTAG LEUKOTR ESS, V79, P109, DOI 10.1016/j.plefa.2008.09.009; Matsumoto Noriko, 2001, Tohoku Journal of Agricultural Research, V52, P1; McLennan P, 1996, EUR J PHARMACOL, V300, P83, DOI 10.1016/0014-2999(95)00861-6; Miranda KM, 2001, NITRIC OXIDE-BIOL CH, V5, P62, DOI 10.1006/niox.2000.0319; Mori TA, 1999, HYPERTENSION, V34, P253, DOI 10.1161/01.HYP.34.2.253; Mori TA, 2000, CIRCULATION, V102, P1264, DOI 10.1161/01.CIR.102.11.1264; MOULDS RFW, 1983, GEN PHARMACOL, V14, P47, DOI 10.1016/0306-3623(83)90062-9; Mozaffarian D, 2011, J AM COLL CARDIOL, V58, P2047, DOI 10.1016/j.jacc.2011.06.063; Mullen A, 2010, J NUTR BIOCHEM, V21, P444, DOI 10.1016/j.jnutbio.2009.02.008; Navarro-Garcia G., 2000, Journal of Food Composition and Analysis, V13, P791, DOI 10.1006/jfca.2000.0928; Omura M, 2001, FEBS LETT, V487, P361, DOI 10.1016/S0014-5793(00)02351-6; Raphael W, 2013, INT J MOL SCI, V14, P21167, DOI 10.3390/ijms141021167; Rocha-Uribe A, 2004, J AM OIL CHEM SOC, V81, P685, DOI 10.1007/s11746-004-962-z; Sato K, 2014, PHARMACOLOGY, V93, P229, DOI 10.1159/000360543; SHIMOKAWA H, 1987, CIRCULATION, V76, P898, DOI 10.1161/01.CIR.76.4.898; Singh TU, 2010, EUR J PHARMACOL, V636, P108, DOI 10.1016/j.ejphar.2010.02.041; Siscovick DS, 2017, CIRCULATION, V135, pe867, DOI 10.1161/CIR.0000000000000482; Skulas-Ray AC, 2019, CIRCULATION, V140, pE673, DOI 10.1161/CIR.0000000000000709; Spector AA, 1992, ENDOTHELIAL CELL DYS, p[507, 524]; Tagawa H, 1999, J CARDIOVASC PHARM, V33, P633, DOI 10.1097/00005344-199904000-00017; Takenouchi Y, 2018, LIPIDS HEALTH DIS, V17, DOI 10.1186/s12944-018-0770-0; Tsujita-Kyutoku M, 2004, BREAST CANCER RES, V6, pR291, DOI 10.1186/bcr789; Tsuzuki T, 2005, LIPIDS, V40, P1117, DOI 10.1007/s11745-005-1475-0; Tsuzuki T, 2005, LIPIDS, V40, P147, DOI 10.1007/s11745-005-1369-1; Tsuzuki T, 2004, J NUTR, V134, P1162, DOI 10.1093/jn/134.5.1162; Tsuzuki T, 2007, BIOSCI BIOTECH BIOCH, V71, P1902, DOI 10.1271/bbb.70114; Wiest EF, 2017, TOXICOL SCI, V156, P300, DOI 10.1093/toxsci/kfw255; Yamagata K, 2017, LIPIDS HEALTH DIS, V16, DOI 10.1186/s12944-017-0514-6; Yonezawa Y, 2007, INT J MOL SCI, V8, P1206, DOI 10.3390/i8121206	64	0	0	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2020	15	2							e0229435	10.1371/journal.pone.0229435	http://dx.doi.org/10.1371/journal.pone.0229435			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8GQ	32107491	Green Published, Green Submitted, gold			2022-12-26	WOS:000535237000031
J	Hashmat, D; Shoaib, MH; Ali, FR; Siddiqui, F				Hashmat, Durriya; Shoaib, Muhammad Harris; Ali, Fatima Ramzan; Siddiqui, Fahad			Lornoxicam controlled release transdermal gel patch: Design, characterization and optimization using co-solvents as penetration enhancers	PLOS ONE			English	Article							NANOSTRUCTURED LIPID CARRIERS; DRUG-DELIVERY SYSTEM; IN-VITRO EVALUATION; SKIN PERMEATION; FORMULATION DESIGN; PROPYLENE-GLYCOL; VIVO; HYDROCHLORIDE; NANOPARTICLES; TESTOSTERONE	The aim of the current study was to develop membrane-based transdermal patches of lornoxicam gel using oleic acid (OA)and propylene glycol (PG) as penetration enhancers to improve drug delivery across the skin and to evaluate in vivo analgesic and anti-inflammatory activity. For this purpose, nine formulations were developed in accordance with 32 factorial design using Design Expert (R) 11. The concentration of propylene glycol (X-1) and oleic acid (X-2) were selected as independent variable whereas Q(10) (Y-1), flux (Y-2) and lag time (Y-3) were considered as the response variables. The impact of drug loading, surface area, gel concentration, membrane variation and agitation speed on drug release and permeation was also studied. The skin sensitivity reaction, analgesic activity and anti-inflammatory action of the optimized patch were also determined in Albino Wistar rats. Stability studies were performed for three months at three different temperature conditions. The result suggests that a membrane-based system with controlled zero-order drug releaseof 95.8 +/- 1.121% for 10 h exhibiting flux of 126.51 +/- 1.19 mu g/cm(2)/h and lag time of 0.908 +/- 0.57h was optimized with the desired analgesic and anti-inflammatory effect can be obtained by using propylene glycol and oleic acid co-solvents as a penetration enhancer. The patch was also found stable at 4 degrees C for a period of 6.44 months. Formulation F9 comprising of 10% PG and 3% OA was selected as an optimized formulation. The study demonstrates that the fabricated transdermal system of lornoxicam can deliver the drug through the skin in a controlled manner with desired analgesic and anti-inflammatory activity and can be considered as a suitable alternative of the oral route.	[Hashmat, Durriya; Shoaib, Muhammad Harris; Ali, Fatima Ramzan; Siddiqui, Fahad] Univ Karachi, Fac Pharm & Pharmaceut Sci, Dept Pharmaceut, Karachi, Pakistan	University of Karachi	Shoaib, MH (corresponding author), Univ Karachi, Fac Pharm & Pharmaceut Sci, Dept Pharmaceut, Karachi, Pakistan.	harrisshoaib2000@yahoo.com	Hashmat, Durriya/ABD-7845-2021; 张, 张鑫月/AAP-1001-2020; Shoaib, Muhammad/AAR-8933-2020	Shoaib, Muhammad/0000-0002-3639-0026				Aboofazeli R, 2002, DRUG DELIV, V9, P239, DOI 10.1080/10717540260397855; Aggarwal G, 2013, PHARM DEV TECHNOL, V18, P916, DOI 10.3109/10837450.2011.609993; Ahad A, 2014, EXPERT OPIN DRUG DEL, V11, P1149, DOI 10.1517/17425247.2014.914027; Ahmed MO, 2011, PROF DRUG SUB EXCIP, V36, P205, DOI 10.1016/B978-0-12-387667-6.00006-3; Al-Achi A, 2013, INTEGRATED PHARMACEU; Al-Suwayeh SA, 2014, SCI WORLD J, DOI 10.1155/2014/127495; Allen L, 2013, ANSELS PHARM DOSAGE; Alves MP, 2007, INT J PHARMACEUT, V341, P215, DOI 10.1016/j.ijpharm.2007.03.031; [Anonymous], 2011, ASIAN J PHARM CLIN R; Arellano A, 1999, EUR J PHARM SCI, V7, P129, DOI 10.1016/S0928-0987(98)00010-4; Baker AK, 2002, PHARMACOL BIOCHEM BE, V74, P73, DOI 10.1016/S0091-3057(02)00961-9; Baker R., 1987, CONTROLLED RELEASE B; Baviskar D.T., 2013, J PHARM SCI TECHNOL, V67, P9, DOI DOI 10.5731/pdajpst.2013.00898; Beetge E, 2000, INT J PHARMACEUT, V193, P261, DOI 10.1016/S0378-5173(99)00340-3; Benecke AG, 1991, STORAGE STABLE TRANS; BENTLEY GA, 1983, BRIT J PHARMACOL, V79, P125, DOI 10.1111/j.1476-5381.1983.tb10504.x; Bowen JL, 2006, INT J PHARMACEUT, V307, P251, DOI 10.1016/j.ijpharm.2005.10.014; Chaisson D., 1995, DISSOLUTION TECHNOLO, V2, P7; Chaudhary H, 2013, INT J BIOL MACROMOL, V55, P246, DOI 10.1016/j.ijbiomac.2013.01.015; Costa P, 2001, EUR J PHARM SCI, V13, P123, DOI 10.1016/S0928-0987(01)00095-1; Costa P, 2003, DRUG DEV IND PHARM, V29, P89, DOI 10.1081/DDC-120016687; Dave BS, 2004, AAPS PHARMSCITECH, V5, DOI 10.1208/pt050234; Devi VK, 2003, DRUG DEV IND PHARM, V29, P495, DOI 10.1081/DDC-120018638; Draize JH, 1944, J PHARMACOL EXP THER, V82, P377; El Nabarawi MA, 2013, INT J PHARM PHARM SC, V5, P242; El Nabarawy NA, 2014, DEV EC TRANSDERMAL P; Gonullu U, 2015, ACTA PHARMACEUT, V65, P1, DOI 10.1515/acph-2015-0009; GREENBERGER JS, 2014, J PHARM, V4, P10925, DOI DOI 10.3389/FONC.2014.00024; Gwak HS, 2004, DRUG DEV IND PHARM, V30, P187, DOI 10.1081/DDC-120028714; Gwak HS, 2001, ARCH PHARM RES, V24, P578, DOI 10.1007/BF02975169; Hai NT, 2008, INT J PHARMACEUT, V357, P55, DOI 10.1016/j.ijpharm.2008.01.024; Hwang BY, 1997, J CONTROL RELEASE, V49, P177, DOI 10.1016/S0168-3659(97)00073-4; Kalia YN, 2001, ADV DRUG DELIVER REV, V48, P159, DOI 10.1016/S0169-409X(01)00113-2; Karande P, 2009, BBA-BIOMEMBRANES, V1788, P2362, DOI 10.1016/j.bbamem.2009.08.015; Kim MK, 2001, INT J PHARM, V219, P51, DOI 10.1016/S0378-5173(01)00631-7; Kumar R, 2007, TROP J PHARM RES, V6, P633; Mittal A, 2009, PHARM DEV TECHNOL, V14, P422, DOI 10.1080/10837450902748388; Morris Christopher J, 2003, Methods Mol Biol, V225, P115; Mundada MS, 2013, INDIAN J PHARM EDUC, V47, P168; Palei NN, 2017, J DRUG DELIV SCI TEC, V39, P490, DOI 10.1016/j.jddst.2017.05.001; Panigrahi L, 2005, AAPS PHARMSCITECH, V6; Park CW, 2012, INT J PHARMACEUT, V436, P32, DOI 10.1016/j.ijpharm.2012.06.057; Patel J., 2011, INT J DRUG DEV RES, V3, P156; Pichayakorn W, 2013, CHEM ENG RES DES, V91, P520, DOI 10.1016/j.cherd.2012.09.011; Prausnitz MR, 2004, NAT REV DRUG DISCOV, V3, P115, DOI 10.1038/nrd1304; Prodduturi S, 2009, PHARM RES-DORD, V26, P1344, DOI 10.1007/s11095-009-9843-0; Radhofer-Welte S, 2000, DRUG TODAY, V36, P55, DOI 10.1358/dot.2000.36.1.566627; Shahzad Y, 2013, INT J BIOL MACROMOL, V61, P26, DOI 10.1016/j.ijbiomac.2013.06.049; Sheikh NA, 2017, MATH PROBL ENG, V2017, DOI 10.1155/2017/9402964; Shin SC, 2002, EUR J PHARM BIOPHARM, V54, P201, DOI 10.1016/S0939-6411(02)00051-6; Singh B, 2006, INT J PHARM, V325, P15, DOI 10.1016/j.ijpharm.2006.06.007; SMITH WL, 1991, BIOCHIM BIOPHYS ACTA, V1083, P1, DOI 10.1016/0005-2760(91)90119-3; THACHARODI D, 1995, BIOMATERIALS, V16, P145, DOI 10.1016/0142-9612(95)98278-M; Venkatraman S, 1998, BIOMATERIALS, V19, P1119, DOI 10.1016/S0142-9612(98)00020-9; Walters KA, 1993, PHARM SKIN PENETRATI; Wang MY, 2005, INT J PHARMACEUT, V290, P25, DOI 10.1016/j.ijpharm.2004.10.027; Welin-Berger K, 2001, EUR J PHARM SCI, V13, P309, DOI 10.1016/S0928-0987(01)00118-X; Williams AC, 2012, ADV DRUG DELIVER REV, V64, P128, DOI 10.1016/j.addr.2012.09.032; WINTER CA, 1962, P SOC EXP BIOL MED, V111, P544; Wissing SA, 2002, J CONTROL RELEASE, V81, P225, DOI 10.1016/S0168-3659(02)00056-1; Yang Z, 2013, INT J PHARMACEUT, V447, P231, DOI 10.1016/j.ijpharm.2013.02.048; Yener G, 2010, CHEM PHARM BULL, V58, P1466, DOI 10.1248/cpb.58.1466; Zhan XP, 2015, BRAZ J PHARM SCI, V51, P373, DOI 10.1590/S1984-82502015000200015; Zhang Y, 2010, AAPS J, V12, P263, DOI 10.1208/s12248-010-9185-1; Zhang YX, 2014, ASIAN J PHARM SCI, V9, P251, DOI 10.1016/j.ajps.2014.07.007; Zhao H, 2002, DRUG DEV IND PHARM, V28, P1125, DOI 10.1081/DDC-120014579	66	10	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2020	15	2							e0228908	10.1371/journal.pone.0228908	http://dx.doi.org/10.1371/journal.pone.0228908			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8GQ	32107483	gold, Green Published			2022-12-26	WOS:000535237000015
J	Lawanprasert, A; Guinan, CA; Langford, EA; Hawkins, CE; Sloand, JN; Fescemyer, HW; Aronson, MR; Halle, JA; Marden, JH; Medina, SH				Lawanprasert, Atip; Guinan, Caitlin A.; Langford, Erica A.; Hawkins, Carly E.; Sloand, Janna N.; Fescemyer, Howard W.; Aronson, Matthew R.; Halle, Jacob A.; Marden, James H.; Medina, Scott H.			Discovery of antitumor lectins from rainforest tree root transcriptomes	PLOS ONE			English	Article							PLANT-LECTINS; PROTEIN GLYCOSYLATION; N-GLYCANS; MANNOSE; APOPTOSIS; RESISTANCE; PATHOGENS; BIOMARKER; PATHWAYS; MUCINS	Glycans are multi-branched sugars that are displayed from lipids and proteins. Through their diverse polysaccharide structures they can potentiate a myriad of cellular signaling pathways involved in development, growth, immuno-communication and survival. Not surprisingly, disruption of glycan synthesis is fundamental to various human diseases; including cancer, where aberrant glycosylation drives malignancy. Here, we report the discovery of a novel mannose-binding lectin, ML6, which selectively recognizes and binds to these irregular tumor-specific glycans to elicit potent and rapid cancer cell death. This lectin was engineered from gene models identified in a tropical rainforest tree root transcriptome and is unusual in its six canonical mannose binding domains (QxDxNxVxY), each with a unique amino acid sequence. Remarkably, ML6 displays antitumor activity that is > 10(5) times more potent than standard chemotherapeutics, while being almost completely inactive towards non-transformed, healthy cells. This activity, in combination with results from glycan binding studies, suggests ML6 differentiates healthy and malignant cells by exploiting divergent glycosylation pathways that yield naive and incomplete cell surface glycans in tumors. Thus, ML6 and other high-valence lectins may serve as novel biochemical tools to elucidate the glycomic signature of different human tumors and aid in the rational design of carbohydrate-directed therapies. Further, understanding how nature evolves proteins, like ML6, to combat the changing defenses of competing microorganisms may allow for fundamental advances in the way we approach combinatorial therapies to fight therapeutic resistance in cancer.	[Lawanprasert, Atip; Sloand, Janna N.; Aronson, Matthew R.; Halle, Jacob A.; Medina, Scott H.] Penn State Univ, Dept Biomed Engn, University Pk, PA 16802 USA; [Guinan, Caitlin A.; Langford, Erica A.; Hawkins, Carly E.; Fescemyer, Howard W.; Marden, James H.] Penn State Univ, Dept Biol, University Pk, PA 16802 USA; [Marden, James H.] Penn State Univ, Huck Inst Life Sci, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Medina, SH (corresponding author), Penn State Univ, Dept Biomed Engn, University Pk, PA 16802 USA.; Marden, JH (corresponding author), Penn State Univ, Dept Biol, University Pk, PA 16802 USA.; Marden, JH (corresponding author), Penn State Univ, Huck Inst Life Sci, University Pk, PA 16802 USA.	jhm10@psu.edu; shm126@psu.edu		Aronson, Matthew/0000-0002-8871-8265; Hawkins, Carly/0000-0003-0133-6764	NSF [DEB1120476, DEB-1457571]; Charles E. Kaufman Foundation -New Initiative Award [KA201791785]	NSF(National Science Foundation (NSF)); Charles E. Kaufman Foundation -New Initiative Award	The ML6 sequence was obtained and characterized using support from NSF DEB1120476 and DEB-1457571, from material covered under export permits and a materials transfer agreement from Panama. This work was generously supported by a Charles E. Kaufman Foundation -New Initiative Award (KA201791785). There was no additional external funding received for this study.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnaud J, 2013, ACS CHEM BIOL, V8, P1918, DOI 10.1021/cb400254b; Azarkan M, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-29439-x; Bafna S, 2010, ONCOGENE, V29, P2893, DOI 10.1038/onc.2010.87; Barre A, 2001, BIOCHIMIE, V83, P645, DOI 10.1016/S0300-9084(01)01315-3; Barton C, 2014, ANTIMICROB AGENTS CH, V58, P120, DOI 10.1128/AAC.01407-13; Benkert P, 2011, BIOINFORMATICS, V27, P343, DOI 10.1093/bioinformatics/btq662; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; [陈虹 Chen Hong], 2014, [低温工程, Cryogenics], P1; Chen ZH, 2017, GASTROENTEROLOGY, V153, P1120, DOI 10.1053/j.gastro.2016.12.036; Chugh S, 2015, BBA-REV CANCER, V1856, P211, DOI 10.1016/j.bbcan.2015.08.003; De Hoff PL, 2009, MOL GENET GENOMICS, V282, P1, DOI 10.1007/s00438-009-0460-8; De-la-Pena C, 2012, CURR PROTEOMICS, V9, P103, DOI 10.2174/157016412800786194; Drake PM, 2010, CLIN CHEM, V56, P223, DOI 10.1373/clinchem.2009.136333; Franz H, 2013, ADV LECTIN RES; Fu LL, 2011, INT J BIOCHEM CELL B, V43, P1442, DOI 10.1016/j.biocel.2011.07.004; Garcia-Guzman G, 2014, NEW PHYTOL, V201, P1106, DOI 10.1111/nph.12562; Guo J, 2014, MOLECULES, V19, P20073, DOI 10.3390/molecules191220073; Hossler P, 2009, GLYCOBIOLOGY, V19, P936, DOI 10.1093/glycob/cwp079; Ishikawa K, 2017, CELL CHEM BIOL, V24, P149, DOI 10.1016/j.chembiol.2016.12.009; Jiang QL, 2015, CELL PROLIFERAT, V48, P17, DOI 10.1111/cpr.12155; Karasaki Y, 2001, FOOD RES INT, V34, P7, DOI 10.1016/S0963-9969(00)00122-8; Kasanmoentalib ES, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-016-0770-9; Krijger JJ, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-722; Kufe DW, 2009, NAT REV CANCER, V9, P874, DOI 10.1038/nrc2761; Kurosu M, 2018, J MOL PHARM ORG PROC, V6, P141; Lannoo N, 2015, PLANT SCI, V239, P67, DOI 10.1016/j.plantsci.2015.06.023; Li YF, 2015, SCI REP-UK, V5, DOI 10.1038/srep16556; Liu B, 2010, CANCER LETT, V287, P1, DOI 10.1016/j.canlet.2009.05.013; Liu B, 2009, ARCH BIOCHEM BIOPHYS, V482, P1, DOI 10.1016/j.abb.2008.12.003; Liu Z, 2012, APPL BIOCHEM BIOTECH, V168, P629, DOI 10.1007/s12010-012-9805-6; Liu ZY, 2010, APPL BIOCHEM BIOTECH, V162, P134, DOI 10.1007/s12010-009-8694-9; Marden JH, 2017, MOL ECOL, V26, P2498, DOI 10.1111/mec.13999; Mathesius U, 2009, J PROTEOMICS, V72, P353, DOI 10.1016/j.jprot.2008.12.006; Michelow IC, 2011, J INFECT DIS, V203, P175, DOI 10.1093/infdis/jiq025; Nilsson Carol L., 2007, P1; Nizet V, 2017, ESSENTIALS GLYCOBIOL, V3rd; Oliveira-Ferrer L, 2017, SEMIN CANCER BIOL, V44, P141, DOI 10.1016/j.semcancer.2017.03.002; Parret AHA, 2005, APPL ENVIRON MICROB, V71, P5197, DOI 10.1128/AEM.71.9.5197-5207.2005; Peng H, 2009, PEPTIDES, V30, P1805, DOI 10.1016/j.peptides.2009.06.027; Pinho SS, 2015, NAT REV CANCER, V15, P540, DOI 10.1038/nrc3982; Remmert M, 2012, NAT METHODS, V9, P173, DOI [10.1038/NMETH.1818, 10.1038/nmeth.1818]; ROSEN S, 1992, J GEN MICROBIOL, V138, P2663, DOI 10.1099/00221287-138-12-2663; St Swierzko A, 2014, CANCER IMMUNOL IMMUN, V63, P1129, DOI 10.1007/s00262-014-1579-y; Stergiopoulos I, 2009, ANNU REV PHYTOPATHOL, V47, P233, DOI 10.1146/annurev.phyto.112408.132637; Taniguchi N, 2015, ADV CANCER RES, V126, P11, DOI 10.1016/bs.acr.2014.11.001; Tedersoo L, 2014, SCIENCE, V346, P1078, DOI 10.1126/science.1256688; VANDAMME EJM, 1987, FEBS LETT, V215, P140, DOI 10.1016/0014-5793(87)80129-1; Varki A., 2017, BIOL FUNCTIONS GLYCA; Varki A, 2012, ANN NY ACAD SCI, V1253, P16, DOI 10.1111/j.1749-6632.2012.06517.x; Wang Q, 2015, METHODS MOL BIOL, V1321, P287, DOI 10.1007/978-1-4939-2760-9_20; Wingfield PT, 2015, CURR PROTOC PROTEIN, V80; Xu XF, 2011, BIOTECHNOL ADV, V29, P667, DOI 10.1016/j.biotechadv.2011.05.003	52	2	2	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2020	15	2							e0229467	10.1371/journal.pone.0229467	http://dx.doi.org/10.1371/journal.pone.0229467			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8EV	32097449	gold, Green Published			2022-12-26	WOS:000535232000031
J	Shen, L; Viljoen, A; Villaume, S; Joe, M; Halloum, I; Chene, L; Mery, A; Fabre, E; Takegawa, K; Lowary, TL; Vincent, SP; Kremer, L; Guerardel, Y; Mariller, C				Shen, Lin; Viljoen, Albertus; Villaume, Sydney; Joe, Maju; Halloum, Iman; Chene, Loic; Mery, Alexandre; Fabre, Emeline; Takegawa, Kaoru; Lowary, Todd L.; Vincent, Stephane P.; Kremer, Laurent; Guerardel, Yann; Mariller, Christophe			The endogenous galactofuranosidase GlfH1 hydrolyzes mycobacterial arabinogalactan	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Mycobacterium tuberculosis; mycobacteria; polysaccharide; glycosidase; galactofuranose; arabinogalactan; catabolism; cell envelope; galactofuranosidase; Rv3096	SUBSTRATE-SPECIFICITY; TUBERCULOSIS; KINETICS; INSIGHTS; CALCIUM	Despite impressive progress made over the past 20 years in our understanding of mycolylarabinogalactan-peptidoglycan (mAGP) biogenesis, the mechanisms by which the tubercle bacillus Mycobacterium tuberculosis adapts its cell wall structure and composition to various environmental conditions, especially during infection, remain poorly understood. Being the central portion of the mAGP complex, arabinogalactan (AG) is believed to be the constituent of the mycobacterial cell envelope that undergoes the least structural changes, but no reports exist supporting this assumption. Herein, using recombinantly expressed mycobacterial protein, bioinformatics analyses, and kinetic and biochemical assays, we demonstrate that the AG can be remodeled by a mycobacterial endogenous enzyme. In particular, we found that the mycobacterial GlfH1 (Rv3096) protein exhibits exo-?-d-galactofuranose hydrolase activity and is capable of hydrolyzing the galactan chain of AG by recurrent cleavage of the terminal ?-(1,5) and ?-(1,6)-Galf linkages. The characterization of this galactosidase represents a first step toward understanding the remodeling of mycobacterial AG.	[Shen, Lin; Mery, Alexandre; Fabre, Emeline; Guerardel, Yann; Mariller, Christophe] Univ Lille, CNRS, UMR8576, UGSF, F-59000 Lille, France; [Viljoen, Albertus; Halloum, Iman; Kremer, Laurent] UM, CNRS, UMR9004, IRIM, 1919 Route Mende, F-34293 Montpellier 5, France; [Villaume, Sydney; Chene, Loic; Vincent, Stephane P.] Univ Namur, Lab Chim Bioorgan CBO, Rue Bruxelles 61, B-5000 Namur, Belgium; [Joe, Maju; Lowary, Todd L.] Univ Alberta, Alberta Glyc Ctr, Edmonton, AB T6G 2G2, Canada; [Joe, Maju; Lowary, Todd L.] Univ Alberta, Dept Chem, Edmonton, AB T6G 2G2, Canada; [Takegawa, Kaoru] Kyushu Univ, Fac Agr, Dept Biosci & Biotechnol, Nishi Ku, 744 Motooka, Fukuoka 8190395, Japan; [Kremer, Laurent] INSERM, Inst Rech Infectiol Montpellier, F-34293 Montpellier, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Lille - ISITE; Universite de Lille; Centre National de la Recherche Scientifique (CNRS); University of Namur; University of Alberta; University of Alberta; Kyushu University; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier	Mariller, C (corresponding author), Univ Lille, CNRS, UMR8576, UGSF, F-59000 Lille, France.	christophe.mariller@univ-lille.fr	Viljoen, Albertus/O-6794-2019; Lowary, Todd L/F-9608-2019; Kremer, Laurent/M-4935-2017	Viljoen, Albertus/0000-0001-8949-7401; Lowary, Todd L/0000-0002-8331-8211; Kremer, Laurent/0000-0002-6604-4458; Guerardel, Yann/0000-0003-4967-9512; CHENE, Loic P./0000-0002-7574-3816; JOE, MAJU/0000-0003-0664-5275	Centre National de La Recherche Scientifique (CNRS); Agence Nationale de la Recherche (project MyCat) [ANR-15-CE18-0007-01]; Fondation pour la Recherche Medicale (FRM) [DEQ20150331719]	Centre National de La Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); Agence Nationale de la Recherche (project MyCat)(French National Research Agency (ANR)); Fondation pour la Recherche Medicale (FRM)(Fondation pour la Recherche Medicale)	This work was supported by the Centre National de La Recherche Scientifique (CNRS), the Agence Nationale de la Recherche (project MyCat) Grant ANR-15-CE18-0007-01 (to L. S., Y. G., and C. M.), and the Fondation pour la Recherche Medicale (FRM) Grant DEQ20150331719 (to I. H. and L. K.). The authors declare that they have no conflicts of interest with the contents of this article.	Alderwick LJ, 2015, CSH PERSPECT MED, V5, DOI 10.1101/cshperspect.a021113; ANGYAL SJ, 1984, ADV CARBOHYD CHEM BI, V42, P15, DOI 10.1016/S0065-2318(08)60122-5; [Anonymous], 2015, REACTION PATHWAYS ME, DOI DOI 10.1007/978-981-287-688-1; [Anonymous], [No title captured]; Armenteros JJA, 2019, NAT BIOTECHNOL, V37, P420, DOI 10.1038/s41587-019-0036-z; Besra GS, 1998, METH MOL B, V101, P91, DOI 10.1385/0-89603-471-2:91; Bhamidi S, 2011, J BIOL CHEM, V286, P23168, DOI 10.1074/jbc.M110.210534; Bordoni A, 2008, CARBOHYD RES, V343, P1863, DOI 10.1016/j.carres.2008.02.019; Carrere-Kremer S, 2015, MOL MICROBIOL, V96, P1085, DOI 10.1111/mmi.12992; CIUCANU I, 1984, CARBOHYD RES, V131, P209, DOI 10.1016/0008-6215(84)85242-8; Daffe M, 2015, TUBERCULOSIS, V95, pS155, DOI 10.1016/j.tube.2015.02.024; de Sanctis D, 2010, FEBS J, V277, P4562, DOI 10.1111/j.1742-4658.2010.07870.x; Dias FMV, 2004, J BIOL CHEM, V279, P25517, DOI 10.1074/jbc.M401647200; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Ferrer M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038134; Goncalves AMD, 2012, ACTA CRYSTALLOGR D, V68, P1468, DOI 10.1107/S0907444912034646; Goodsmith N, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004645; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Gupta RS, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.00067; Hilge M, 1998, STRUCTURE, V6, P1433, DOI 10.1016/S0969-2126(98)00142-7; Hong X, 2004, BIOMACROMOLECULES, V5, P1052, DOI 10.1021/bm034514c; Joe M, 2016, CAN J CHEM, V94, P976, DOI 10.1139/cjc-2016-0416; Kaur Devinder, 2009, Adv Appl Microbiol, V69, P23, DOI 10.1016/S0065-2164(09)69002-X; Kieser KJ, 2014, NAT REV MICROBIOL, V12, P550, DOI 10.1038/nrmicro3299; Lee REB, 2005, GLYCOBIOLOGY, V15, P139, DOI 10.1093/glycob/cwh150; LIVINGSTONE G, 1977, J SOLUTION CHEM, V6, P203, DOI 10.1007/BF00646739; MargollesClark E, 1996, APPL ENVIRON MICROB, V62, P3840, DOI 10.1128/AEM.62.10.3840-3846.1996; Marino C, 2017, FUTUR SCI OA, V3, DOI 10.4155/fsoa-2017-0030; Matsunaga E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137230; Mishra KC, 2008, INFECT IMMUN, V76, P127, DOI 10.1128/IAI.00410-07; Moynihan PJ, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10586-2; Naumoff DG, 1999, FEBS LETT, V448, P177, DOI 10.1016/S0014-5793(99)00369-5; Okonechnikov K, 2012, BIOINFORMATICS, V28, P1166, DOI 10.1093/bioinformatics/bts091; Okuyama M, 2014, FEBS LETT, V588, P3213, DOI 10.1016/j.febslet.2014.07.002; Ota R, 2019, CARBOHYD RES, V473, P99, DOI 10.1016/j.carres.2019.01.005; Puffal J, 2018, PATHOG DIS, V76, DOI 10.1093/femspd/fty027; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; Rombouts Y, 2012, J BIOL CHEM, V287, P11060, DOI 10.1074/jbc.M111.327387; Saha BC, 2000, BIOTECHNOL ADV, V18, P403, DOI 10.1016/S0734-9750(00)00044-6; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sambandamurthy VK, 2002, NAT MED, V8, P1171, DOI 10.1038/nm765; Santucci P, 2019, FEBS J, V286, P3164, DOI 10.1111/febs.14864; Santucci P, 2018, INFECT IMMUN, V86, DOI 10.1128/IAI.00394-18; STOVER CK, 1991, NATURE, V351, P456, DOI 10.1038/351456a0; Tefsen B, 2012, BIOL CHEM, V393, P767, DOI 10.1515/hsz-2012-0134; van Kessel JC, 2007, NAT METHODS, V4, P147, DOI 10.1038/nmeth996; VARELA O, 1986, CARBOHYD RES, V155, P247, DOI 10.1016/S0008-6215(00)90153-8; Wadood A, 2018, INT J BIOL MACROMOL, V111, P82, DOI 10.1016/j.ijbiomac.2017.12.148; Wheat WH, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003405; Wu M, 2015, SCIENCE, V350, DOI 10.1126/science.aac5992; Xin Y, 1999, BBA-GEN SUBJECTS, V1473, P267, DOI 10.1016/S0304-4165(99)00204-4; Zhou P, 2014, ACTA CRYSTALLOGR D, V70, P2970, DOI 10.1107/S1399004714019762	52	7	7	2	10	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 10	2020	295	15					5110	5123		10.1074/jbc.RA119.011817	http://dx.doi.org/10.1074/jbc.RA119.011817			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LE7FC	32107309	hybrid, Green Published			2022-12-26	WOS:000526887000030
J	Chang, E; Kim, JH; Bang, JH; Park, WB; Kim, ES; Park, SW; Oh, MD				Chang, Euijin; Kim, Jeong-Han; Bang, Ji Hwan; Park, Wan Beom; Kim, Eu Suk; Park, Sang Won; Oh, Myoung-don			Application of the severe fever with thrombocytopenia syndrome prediction score: Differentiation of febrile diseases using basic laboratory parameters	PLOS ONE			English	Article							C-REACTIVE PROTEIN; RISK; DEATH	Background The prolonged manifestation of concurrent leukopenia, thrombocytopenia and normal C-reactive protein (CRP) (named as SFTS prediction score) in febrile diseases is not usual and may be used to make an initial differential diagnosis, which is a characteristic finding of severe fever with thrombocytopenia syndrome (SFTS). Methods The dynamics of SFTS prediction scores was investigated in SFTS patients. The study subjects for the comparison were febrile patients aged >= 16 years with SFTS scores of 2 (S2) or 3 (S3) who visited an emergency room for a 4-year study period. The dynamic distribution of S2 and S3 at presentation with regards to onset of illness, the characteristics of responsible diseases and the predictability of SFTS in both groups were described. Results In 104 patients with SFTS, the daily proportion of S2 or S3 ranged from 58.3 to 100% from day (D) 1 to D12 after the onset of illness. The S2 subtype of 'leukopenia plus thrombocytopenia' and S3 represented 72.7-100% of all scores. In contrast, for the 130 patients in the febrile cohort, 73.8% of evaluations were distributed between D1 and D4 after the onset of illness, and 68.8% of patients had the S2 subtype of 'leukopenia plus normal CRP'. Upper respiratory infection was the most frequent (50.0%) cause of diseases. Pneumonia (13.8%) and urosepsis (6.2%) initially presented with either S2 with normal CRP or S3 but had poor prognosis. The presence of S2 or S3 predicted SFTS with sensitivity and specificity of 0.85 (0.42-0.99; 95% CI) and 0.98 (0.98-0.98; 95% CI), respectively. Conclusion The temporal distribution and composition of S2 or S3 were unique in several febrile diseases including SFTS, and the SFTS prediction score may be useful for differentiating febrile diseases in primary care settings of SFTS endemic areas.	[Chang, Euijin; Kim, Jeong-Han; Bang, Ji Hwan; Park, Sang Won] Boramae Med Ctr, Dept Internal Med, Seoul, South Korea; [Kim, Jeong-Han; Park, Wan Beom; Park, Sang Won; Oh, Myoung-don] Seoul Natl Univ, Dept Internal Med, Coll Med, Seoul, South Korea; [Kim, Eu Suk] Seoul Natl Univ, Bundang Hosp, Dept Internal Med, Seongnam, South Korea	Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University (SNU)	Park, SW (corresponding author), Boramae Med Ctr, Dept Internal Med, Seoul, South Korea.; Park, SW (corresponding author), Seoul Natl Univ, Dept Internal Med, Coll Med, Seoul, South Korea.	hswon1@snu.ac.kr	Park, Wan Beom/GLU-9886-2022; Park, Wan Beom/AGO-0374-2022	Park, Wan Beom/0000-0003-0022-9625; Kim, Eu Suk/0000-0001-7132-0157	Korea Centers for Disease Control and Prevention [2015-E24001-00]	Korea Centers for Disease Control and Prevention	This work was supported by a grant from the Korea Centers for Disease Control and Prevention (www.cdc.go.kr; grant numbers 2015-E24001-00, MdO). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	CASTELL JV, 1990, HEPATOLOGY, V12, P1179, DOI 10.1002/hep.1840120517; Chen CC, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/936062; Choi SJ, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005264; Gai ZT, 2012, J INFECT DIS, V206, P1095, DOI 10.1093/infdis/jis472; Jin C, 2012, P NATL ACAD SCI USA, V109, P10053, DOI 10.1073/pnas.1120246109; Kalayanarooj Siripen, 2011, Trop Med Health, V39, P83, DOI 10.2149/tmh.2011-S10; Kotepui M, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-218; Liu Q, 2014, LANCET INFECT DIS, V14, P763, DOI 10.1016/S1473-3099(14)70718-2; McKenzie FE, 2005, J INFECT DIS, V192, P323, DOI 10.1086/431152; Nanri A, 2007, ASIAN PAC J CANCER P, V8, P167; Park SW, 2019, BMC INFECT DIS, V19, DOI 10.1186/s12879-019-3773-1; Paul Rudrajit, 2012, Adv Biomed Res, V1, P41, DOI 10.4103/2277-9175.100140; Ridker PM, 2009, CLIN CHEM, V55, P209, DOI 10.1373/clinchem.2008.119214; Shin J, 2015, EMERG INFECT DIS, V21, P1704, DOI 10.3201/eid2110.141928; Shin SY, 2016, YONSEI MED J, V57, P1286, DOI 10.3349/ymj.2016.57.5.1286; Wright WF, 2015, MANDELL DOUGLAS BENN, P721	16	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2020	15	3							e0229920	10.1371/journal.pone.0229920	http://dx.doi.org/10.1371/journal.pone.0229920			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8RK	32134948	Green Published, gold			2022-12-26	WOS:000535265600060
J	Song, GQ; Han, X; Wiersma, AT; Zong, XJ; Awale, HE; Kelly, JD				Song, Guo-qing; Han, Xue; Wiersma, Andrew T.; Zong, Xiaojuan; Awale, Halima E.; Kelly, James D.			Induction of competent cells for Agrobacterium tumefaciens-mediated stable transformation of common bean (Phaseolus vulgaris L.)	PLOS ONE			English	Article							GOLDEN-MOSAIC-VIRUS; BAR GENE; BIOTECHNOLOGY; REGENERATION; RESISTANCE; VARIETIES; SEED	Stable transformation of common bean (Phaseolus vulgaris L.) has been successful, to date, only using biolistic-mediated transformation and shoot regeneration from meristem-containing embryo axes. In this study, using precultured embryo axes, and optimal co-cultivation conditions resulted in a successful transformation of the common bean cultivar Ola-the using Agrobacterium tumefaciens strain EHA105. Plant regeneration through somatic embryogenesis was attained through the preculture of embryo axes for 12 weeks using induced competent cells for A. tumefaciens-mediated gene delivery. Using A. tumefaciens at a low optical density (OD) of 0.1 at a wavelength of 600 nm for infection and 4-day co-cultivation, compared to OD600 of 0.5, increased the survival rate of the inoculated explants from 23% to 45%. Selection using 0.5 mg L-1 glufosinate (GS) was effective to identify transformed cells when the bialaphos resistance (bar) gene under the constitutive 35S promoter was used as a selectable marker. After an 18-week selection period, 1.5% -2.5% inoculated explants, in three experiments with a total of 600 explants, produced GS-resistant plants through somatic embryogenesis. The expression of bar was confirmed in first- and second-generation seedlings of the two lines through reverse polymerase chain reaction. Presence of the bar gene was verified through genome sequencing of two selected transgenic lines. The induction of regenerable, competent cells is key for the successful transformation, and the protocols described may be useful for future transformation of additional Phaseolus germplasm.	[Song, Guo-qing; Han, Xue; Zong, Xiaojuan] Michigan State Univ, Dept Hort, Plant Biotechnol Resource & Outreach Ctr, E Lansing, MI 48824 USA; [Wiersma, Andrew T.; Awale, Halima E.; Kelly, James D.] Michigan State Univ, Dept Plant Soil & Microbial Sci, E Lansing, MI 48824 USA	Michigan State University; Michigan State University	Song, GQ (corresponding author), Michigan State Univ, Dept Hort, Plant Biotechnol Resource & Outreach Ctr, E Lansing, MI 48824 USA.	songg@msu.edu		Wiersma, Andrew/0000-0001-6656-646X				ARAGAO FJL, 1992, PLANT MOL BIOL, V20, P357, DOI 10.1007/BF00014508; Assefa T, 2019, MOL BREEDING, V39, DOI 10.1007/s11032-018-0920-0; Balsamo GM, 2015, J AGR FOOD CHEM, V63, P10569, DOI 10.1021/acs.jafc.5b04659; Barraza A, 2018, PLANT SCI, V274, P45, DOI 10.1016/j.plantsci.2018.05.006; Bett B, 2019, FRONT PLANT SCI, V10, DOI 10.3389/fpls.2019.00219; Bonfim K, 2007, MOL PLANT MICROBE IN, V20, P717, DOI 10.1094/MPMI-20-6-0717; Broughton WJ, 2003, PLANT SOIL, V252, P55, DOI 10.1023/A:1024146710611; Christou P, 1997, FIELD CROP RES, V53, P83, DOI 10.1016/S0378-4290(97)00024-5; Collado R, 2015, SCI HORTIC-AMSTERDAM, V195, P89, DOI 10.1016/j.scienta.2015.06.046; Dita MA, 2006, EUPHYTICA, V147, P1, DOI 10.1007/s10681-006-6156-9; Faria JC, 2006, PLANT SCI, V171, P565, DOI 10.1016/j.plantsci.2006.06.010; Hacisalihoglu G, 2013, J PLANT NUTR, V36, P772, DOI 10.1080/01904167.2012.754041; Hayat I, 2014, CRIT REV FOOD SCI, V54, P580, DOI 10.1080/10408398.2011.596639; Hnatuszko-Konka K, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-42723-8; Hnatuszko-Konka K, 2014, BIOTECHNOL ADV, V32, P1205, DOI 10.1016/j.biotechadv.2014.06.001; HOOD EE, 1993, TRANSGENIC RES, V2, P208, DOI 10.1007/BF01977351; Kamfwa K, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172141; Kelly JD, 2018, BURL DODDS AGR SCI, V36, P3, DOI 10.19103/AS.2017.0023.18; Kelly JD, 2018, BIOTECHNOLOGIES CROP, P211, DOI [10.1007/978-3-319-94746-4_10, DOI 10.1007/978-3-319-94746-4_10]; Kim JW, 1996, PLANT SCI, V117, P131, DOI 10.1016/0168-9452(96)04403-2; Lima Aragao F.J., 2014, BMC P, V8, pO24, DOI DOI 10.1186/1753-6561-8-S4-024; Liu ZC, 2005, MOL BREEDING, V16, P189, DOI 10.1007/s11032-005-6616-2; Loskutov AV, 2008, IN VITRO CELL DEV-PL, V44, P239, DOI 10.1007/s11627-008-9116-3; McGinnis S, 2004, NUCLEIC ACIDS RES, V32, pW20, DOI 10.1093/nar/gkh435; Miao ZM, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00063; Mukeshimana G, 2013, PLANT BIOTECHNOL REP, V7, P59, DOI 10.1007/s11816-012-0237-0; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Paz MM, 2006, PLANT CELL REP, V25, P206, DOI 10.1007/s00299-005-0048-7; Quintero-Jimenez A, 2010, PLANT CELL TISS ORG, V102, P381, DOI 10.1007/s11240-010-9744-2; Raatz B, 2019, GENETIC RESOURCES CR, V66, P16; Rivera NGR, 2016, PLANT BIOTECHNOL J, V14, P2021, DOI 10.1111/pbi.12561; Rivera A, 2018, FRONT PLANT SCI, V9, DOI 10.3389/fpls.2018.01642; Schmutz J, 2014, NAT GENET, V46, P707, DOI 10.1038/ng.3008; Simpson JT, 2009, GENOME RES, V19, P1117, DOI 10.1101/gr.089532.108; Somers DA, 2003, PLANT PHYSIOL, V131, P892, DOI 10.1104/pp.102.017681; Song GQ, 2008, J AM SOC HORTIC SCI, V133, P605, DOI 10.21273/JASHS.133.4.605; Song GQ, 2018, PLANT SCI, V276, P22, DOI 10.1016/j.plantsci.2018.07.018; Song GQ, 2018, BMC PLANT BIOL, V18, DOI 10.1186/s12870-018-1311-8; Souza TLPO, 2018, CROP SCI, V58, P579, DOI 10.2135/cropsci2017.06.0355; Svetleva D, 2003, EUPHYTICA, V131, P189, DOI 10.1023/A:1023983831582; Veltcheva M, 2005, SCI HORTIC-AMSTERDAM, V107, P2, DOI 10.1016/j.scienta.2005.07.005; VERVLIET G, 1975, J GEN VIROL, V26, P33, DOI 10.1099/0022-1317-26-1-33; Solis-Ramose LY, 2019, REV BIOL TROP, V67, P83	43	5	5	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2020	15	3							e0229909	10.1371/journal.pone.0229909	http://dx.doi.org/10.1371/journal.pone.0229909			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8RK	32134988	gold, Green Published			2022-12-26	WOS:000535265600059
J	Chan, VF; Singer, S; Naidoo, KS				Chan, Ving Fai; Singer, Susanne; Naidoo, Kovin Shunmugan			Disability-related-distress in primary school learners with vision impairment due to uncorrected refractive error in KwaZulu-Natal Province, South Africa - a qualitative study	PLOS ONE			English	Article							CHILDREN; PREVALENCE; RESILIENCE; PEOPLE; ADULTS; LIFE	Background Uncorrected refractive error (URE) is a major cause of vision impairment among children that impacts negatively on their lives including distresses. We aim to understand the disability-related distress among vision-impaired children due to URE in rural and semi-rural South Africa using qualitative techniques. Methods Structured focus groups of children (aged 5-12 years old) with normal vision and vision impairment due to URE from four schools in Pinetown, KwaZulu Natal, South Africa, were performed (four mixed-gender group discussions and eight single gender group discussions). We recruited the study participants after the children underwent standardised vision screening. Criterion sampling was used when selecting study participants. The interviews were transcribed to identify meaning units and broken down to condensed meaning units, which were then grouped into megathemes. Themes were then generated. Results Thirteen children with normal vision and 63 children with vision impairment due to URE participated in the twelve focus group discussions with 36 boys (47%) and 40 girls (53%). Twelve themes were generated. The megathemes were Loss of Self Confidence (number of themes (n) = 3), Loss of self-worth (n = 3), Loss of interconnection/interaction with community (n = 2), Humiliation (n = 2) and Discrimination (n = 2). Conclusions We found that vision impairment due to URE can cause distress in different domains in children's life and further grouped them into different themes. The themes will be used for the development of a tool to assess disability-related distress among children with vision impairment due to URE. We also recommend that distresses caused by URE should be taken into consideration when designing eye care programmes for children.	[Chan, Ving Fai] Queens Univ Belfast, Sch Med Dent & Biomed Med, Ctr Publ Hlth, Belfast, Antrim, North Ireland; [Chan, Ving Fai] Univ KwaZulu Natal, Durban, South Africa; [Singer, Susanne] Johannes Gutenberg Univ Mainz, Inst Med Biostat Epidemiol & Informat IMBEI, Div Epidemiol & Hlth Serv Res, Univ Med Ctr, Mainz, Germany; [Naidoo, Kovin Shunmugan] Univ KwaZulu Natal, African Vis Res Inst, Durban, South Africa; [Naidoo, Kovin Shunmugan] Univ New South Wales, Sch Optometry, Sydney, NSW, Australia	Queens University Belfast; University of Kwazulu Natal; Johannes Gutenberg University of Mainz; University of Kwazulu Natal; University of New South Wales Sydney	Chan, VF (corresponding author), Queens Univ Belfast, Sch Med Dent & Biomed Med, Ctr Publ Hlth, Belfast, Antrim, North Ireland.; Chan, VF (corresponding author), Univ KwaZulu Natal, Durban, South Africa.	v.chan@qub.ac.uk	Singer, Susanne/GPT-4385-2022	Singer, Susanne/0000-0001-5784-7964; Chan, Ving Fai/0000-0002-4968-7953	University of KwaZulu Natal, College of Health Sciences	University of KwaZulu Natal, College of Health Sciences	VF CHAN, University of KwaZulu Natal, College of Health Sciences, PhD Scholarship Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2014, CENSUS 2011 PROFILE; [Anonymous], 2011, WORLD REP DIS; Appleton PL, 1997, J PEDIATR PSYCHOL, V22, P707, DOI 10.1093/jpepsy/22.5.707; Bourne RRA, 2017, LANCET GLOB HEALTH, V5, pE888, DOI 10.1016/S2214-109X(17)30293-0; Bourne RRA, 2013, LANCET GLOB HEALTH, V1, pE339, DOI 10.1016/S2214-109X(13)70113-X; BROWN M, 1987, ARCH PHYS MED REHAB, V68, P828; Caldwell L.L., 2009, CANADIAN J COMMUNITY, V9, P111, DOI [DOI 10.7870/CJCMH-1990-0022, 10.7870/cjcmh-1990-0022]; Chadha RK, 2011, BRIT J OPHTHALMOL, V95, P642, DOI 10.1136/bjo.2010.182386; Day S., 1997, NORMAL ABNORMAL VISU; Dear M, 1997, ENVIRON PLANN D, V15, P455, DOI 10.1068/d150455; Dias L, 2002, OPTOMETRY VISION SCI, V79, P688, DOI 10.1097/00006324-200211000-00006; DiLorenzo TM, 1998, PREV MED, V27, P470, DOI 10.1006/pmed.1998.0307; Doll B., 1996, SCH PSYCH REV; Dunn, 1994, PHYS OCCUPATIONAL TH, V13, P1, DOI DOI 10.1080/J006V13N03_01; EORTC Quality of Life Group, 2011, GUIDELINES DEV QUEST; Felce D, 1996, EXPLORING CURRENT CO; FRASER BC, 1980, CHILD CARE HLTH DEV, V6, P83, DOI 10.1111/j.1365-2214.1980.tb00800.x; GARTON AF, 1991, J ADOLESCENCE, V14, P305, DOI 10.1016/0140-1971(91)90023-K; Holden BA, 2008, ARCH OPHTHALMOL-CHIC, V126, P1731, DOI 10.1001/archopht.126.12.1731; Holt Louise., 2004, CHILDRENS GEOGRAPHIE, V2, P219, DOI [DOI 10.1080/14733280410001720520, 10.1080/14733280410001720520]; Irwin LG, 2005, QUAL HEALTH RES, V15, P821, DOI 10.1177/1049732304273862; Irwin S., 2001, DISABILITY LIFE COUR, P15, DOI DOI 10.1017/CBO9780511520914.004; James A, 2000, RES CHILDREN PERSPEC, P201; Kempen AH, 2004, ARCH OPHTHALMOL-CHIC, V122, P495; KINNEY WB, 1992, ARCH PHYS MED REHAB, V73, P863; Kitchin R, 1998, DISABIL SOC, V13, P343, DOI 10.1080/09687599826678; Lightfoot J, 1999, CHILD CARE HLTH DEV, V25, P267, DOI 10.1046/j.1365-2214.1999.00112.x; Lockwood A. D, 1991, LEISURE OPTIONS AUST, V1, P7; Ma XC, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g5740; Margalit M., 1981, ISR J PSYCHIAT RELAT; McNay L., 2013, FOUCAULT CRITICAL IN; Merrett F., 1990, POSITIVE TEACHING PR; Miller T., 2006, SOCIAL SKILLS CHILDR; Patterson J, 1996, ARCH PEDIAT ADOL MED, V150, P692, DOI 10.1001/archpedi.1996.02170320038006; Raphael D., 1996, INT J DISABIL DEV ED, V43, P25, DOI [10.1080/0156655960430103, DOI 10.1080/0156655960430103]; ROCHLEVECQ AC, 2008, INVEST OPHTH VIS SCI, V49, P1427; RUTTER M, 1987, AM J ORTHOPSYCHIAT, V57, P316, DOI 10.1111/j.1939-0025.1987.tb03541.x; Saw SM, 2007, OPHTHAL PHYSL OPT, V27, P126, DOI 10.1111/j.1475-1313.2006.00455.x; Schalock RL, 1990, QUALITY LIFE PERSPEC, V29; SELIGMAN ME, 1972, ANNU REV MED, V23, P407, DOI 10.1146/annurev.me.23.020172.002203; Shashidhar S, 2009, INDIAN J PEDIATR, V76, P495, DOI 10.1007/s12098-009-0091-4; Shrestha GS., 2011, J OPTOM, V4, P49, DOI [10.1016/S1888-4296(11)70041-3, DOI 10.1016/S1888-4296(11)70041-3]; Swain SD, 2008, J MARKETING RES, V45, P116, DOI 10.1509/jmkr.45.1.116; Taub D. E., 2000, Journal of Sport & Social Issues, V24, P395, DOI 10.1177/0193723500244007; Taylor WC, 1998, AM J PREV MED, V15, P334, DOI 10.1016/S0749-3797(98)00081-6; Terry RL, 1997, OPTOMETRY VISION SCI, V74, P1044, DOI 10.1097/00006324-199712000-00027; Waldron NL, 2010, J EDUC PSYCHOL CONS, V20, P58, DOI 10.1080/10474410903535364; WALLANDER JL, 1989, AM J COMMUN PSYCHOL, V17, P185, DOI 10.1007/BF00931007; WERNER EE, 1994, J DEV BEHAV PEDIATR, V15, P131; Wilson C., 2012, GUIDE INTERVIEWING C; Young IM, 2011, IDEAL COMMUNITY POLI	51	8	8	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2020	15	3							e0229108	10.1371/journal.pone.0229108	http://dx.doi.org/10.1371/journal.pone.0229108			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LQ8MS	32126114	Green Published, gold			2022-12-26	WOS:000535253100015
J	Diamond-Smith, N; Onyango, GO; Wawire, S; Ayodo, G				Diamond-Smith, Nadia; Onyango, George O.; Wawire, Salome; Ayodo, George			Knowledge of menstruation and fertility among adults in rural Western Kenya: Gaps and opportunities for support	PLOS ONE			English	Article							PREGNANCY; DETERMINANTS; PERCEPTIONS; RISKS	An understanding of menstruation and its relationship to fertility can help women know the gestational age of any pregnancies, and thus identify preterm births. It can also help women avoid unintended pregnancies. However, little is known about women, and especially men's, menstruation and fertility knowledge, outside of research on adolescent girls and stigma, and in low and middle income countries (LMIC). Additionally, little is known about practices surrounding the tracking of menstruation and fertility, and how, if at all, women would like to be supported in this. This research is the first phase in adapting a support tool for women in a LMIC, using an implementation science approach to understand relevant cultural needs. We explored women and men's understanding of the relationship between menstruation and fertility, and their interest in support tools, through in-depth qualitative interviews in rural western Kenya. We interviewed 45 adult men, adult women and adolescent women all who had children in 2018. We found high levels of misinformation about menstruation and fertility, with most respondents not knowing the correct times when a woman could become pregnant. Common sources of knowledge included friends/family and school. Few women got information from health providers, even when they were at a facility already for care. There were mixed feelings from women about wanting support from male partners regarding tracking menstruation. While women were interested in a tool that could help them track their menstruation and pregnancies, they had privacy concerns about a mobile health app approach and preferred simpler calendar based tools. This study provides evidence for the high need for correct menstruation information among both men and women, and not only for adolescents. It also suggests that despite the international health community's enthusiasm for mobile health solutions, that approach might not be most appropriate for this topic and setting.	[Diamond-Smith, Nadia] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Onyango, George O.; Ayodo, George] Jaramogi Oginga Odinga Univ Sci & Technol, Bondo, Kenya	University of California System; University of California San Francisco; Jaramogi Oginga Odinga University of Science & Technology	Diamond-Smith, N (corresponding author), Univ Calif San Francisco, San Francisco, CA 94143 USA.	nadia.diamond-smith@ucsf.edu		Diamond-Smith, Nadia/0000-0002-8711-3029	Preterm Birth Initiative at the University of California, San Francisco through Bill and Melinda Gates Foundation	Preterm Birth Initiative at the University of California, San Francisco through Bill and Melinda Gates Foundation	This grant was funded by the Preterm Birth Initiative at the University of California, San Francisco through a larger grant from the Bill and Melinda Gates Foundation. NDS and GO received the grant. The funder did not play a role in the study design, data collection or analysis, decision to publish or preparation of the manuscript.; The authors would like to acknowledge the generous support of the Preterm Birth Initiative at the University of California, San Francisco, funded through the Bill and Melinda Gates Foundation. We would also like to thank Nicole Santos and the rest of the Preterm Birth Initiative team at UCSF for their support. Finally, we would like to thank the participants of the interviews for their time and sharing their experiences.	AJAYI AA, 1991, STUD FAMILY PLANN, V22, P205, DOI 10.2307/1966477; [Anonymous], 2013, ATL TI 7; Blencowe H, 2012, LANCET, V379, P2162, DOI 10.1016/S0140-6736(12)60820-4; Chandra-Mouli V, 2017, REPROD HEALTH, V14, DOI 10.1186/s12978-017-0293-6; Cho JY, 2014, QUAL REP, V19, DOI 10.7838/jsebs.2014.19.1.001; Crichton J, 2012, J ADOLESCENCE, V35, P21, DOI 10.1016/j.adolescence.2011.06.008; Godia PM, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-476; Hennegan J, 2019, PLOS MED, V16, DOI 10.1371/journal.pmed.1002803; Kabagenyi A, 2014, REPROD HEALTH, V11, DOI 10.1186/1742-4755-11-21; Kazi Abdul Momin, 2017, JMIR Public Health Surveill, V3, pe5, DOI 10.2196/publichealth.5386; Kenya National Bureau of Statistics (KNBS) and ICF Macro, 2014, KEN DEM HLTH SURV; Kinaro J. W., 2013, Health, V5, P14, DOI 10.4236/health.2013.51003; Kwambai TK, 2013, BMC PREGNANCY CHILDB, V13, DOI 10.1186/1471-2393-13-134; Magadi MA, 2009, J BIOSOC SCI, V41, P409, DOI 10.1017/S0021932008003210; Marchant T, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001292; Mason L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079132; McMahon SA, 2011, BMC INT HEALTH HUM R, V11, DOI 10.1186/1472-698X-11-7; Moglia ML, 2016, OBSTET GYNECOL, V127, P1153, DOI 10.1097/AOG.0000000000001444; Moster D, 2008, NEW ENGL J MED, V359, P262, DOI 10.1056/NEJMoa0706475; Nzioka C, 2001, REPROD HEALTH MATTER, V9, P108, DOI 10.1016/S0968-8080(01)90014-X; Phillips-Howard PA, 2015, J WOMENS HEALTH, V24, P801, DOI 10.1089/jwh.2014.5031; Varga C A, 2001, Afr J Reprod Health, V5, P175, DOI 10.2307/3583334; Wambui T, 2009, INT NURS REV, V56, P340, DOI 10.1111/j.1466-7657.2009.00726.x; Were M, 2007, ECON HUM BIOL, V5, P322, DOI 10.1016/j.ehb.2007.03.005; Wilson KM, 2011, PREV CHRONIC DIS, V8	25	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2020	15	3							e0229871	10.1371/journal.pone.0229871	http://dx.doi.org/10.1371/journal.pone.0229871			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LQ8MS	32126117	Green Published, gold			2022-12-26	WOS:000535253100056
J	Ursino, M; Magosso, E; Lopane, G; Calandra-Buonaura, G; Cortelli, P; Contin, M				Ursino, Mauro; Magosso, Elisa; Lopane, Giovanna; Calandra-Buonaura, Giovanna; Cortelli, Pietro; Contin, Manuela			Mathematical modeling and parameter estimation of levodopa motor response in patients with parkinson disease	PLOS ONE			English	Article							BASAL GANGLIA; SYNAPTIC PLASTICITY; NEUROCOMPUTATIONAL MODELS; COGNITIVE DEFICITS; FRONTAL-CORTEX; ORAL LEVODOPA; DOPAMINE; NEURONS; INHIBITION; MODULATION	Parkinson disease (PD) is characterized by a clear beneficial motor response to levodopa (LD) treatment. However, with disease progression and longer LD exposure, drug-related motor fluctuations usually occur. Recognition of the individual relationship between LD concentration and its effect may be difficult, due to the complexity and variability of the mechanisms involved. This work proposes an innovative procedure for the automatic estimation of LD pharmacokinetics and pharmacodynamics parameters, by a biologically-inspired mathematical model. An original issue, compared with previous similar studies, is that the model comprises not only a compartmental description of LD pharmacokinetics in plasma and its effect on the striatal neurons, but also a neurocomputational model of basal ganglia action selection. Parameter estimation was achieved on 26 patients (13 with stable and 13 with fluctuating LD response) to mimic plasma LD concentration and alternate finger tapping frequency along four hours after LD administration, automatically minimizing a cost function of the difference between simulated and clinical data points. Results show that individual data can be satisfactorily simulated in all patients and that significant differences exist in the estimated parameters between the two groups. Specifically, the drug removal rate from the effect compartment, and the Hill coefficient of the concentration-effect relationship were significantly higher in the fluctuating than in the stable group. The model, with individualized parameters, may be used to reach a deeper comprehension of the PD mechanisms, mimic the effect of medication, and, based on the predicted neural responses, plan the correct management and design innovative therapeutic procedures.	[Ursino, Mauro; Magosso, Elisa] Univ Bologna, Dept Elect Elect & Informat Engn, Cesena, Italy; [Lopane, Giovanna; Calandra-Buonaura, Giovanna; Cortelli, Pietro; Contin, Manuela] Ist Sci Neurol Bologna, IRCCS, Bologna, Italy; [Lopane, Giovanna; Calandra-Buonaura, Giovanna; Cortelli, Pietro; Contin, Manuela] Univ Bologna, Dept Biomed & Neuromotor Sci, Bologna, Italy	University of Bologna; IRCCS Istituto delle Scienze Neurologiche di Bologna (ISNB); University of Bologna	Ursino, M (corresponding author), Univ Bologna, Dept Elect Elect & Informat Engn, Cesena, Italy.	mauro.ursino@unibo.it	Ursino, Mauro/AAE-7389-2020; Buonaura, Giovanna Calandra/K-5281-2016; Cortelli, Pietro/K-6063-2016	Ursino, Mauro/0000-0002-0911-0308; Buonaura, Giovanna Calandra/0000-0002-9447-3532; Lopane, Giovanna/0000-0002-3383-0516				Aquino CC, 2015, MOVEMENT DISORD, V30, P80, DOI 10.1002/mds.26125; Bagetta V, 2010, BIOCHEM SOC T, V38, P493, DOI 10.1042/BST0380493; Baston C, 2016, 2016 IEEE 2ND INTERNATIONAL FORUM ON RESEARCH AND TECHNOLOGIES FOR SOCIETY AND INDUSTRY LEVERAGING A BETTER TOMORROW (RTSI), P190; Baston C, 2016, FRONT HUM NEUROSCI, V10, DOI 10.3389/fnhum.2016.00280; Baston C, 2015, COMPUT INTEL NEUROSC, V2015, DOI 10.1155/2015/187417; Baston C, 2015, IEEE ENG MED BIO, P6505, DOI 10.1109/EMBC.2015.7319883; Beeler JA, 2012, CELL REP, V2, P1747, DOI 10.1016/j.celrep.2012.11.014; Beeler JA, 2011, BRAIN RES, V1423, P96, DOI 10.1016/j.brainres.2011.09.040; Brown JW, 2004, NEURAL NETWORKS, V17, P471, DOI 10.1016/j.neunet.2003.08.006; Calabresi P, 1997, J NEUROSCI, V17, P4536; Calabresi P, 2009, BRAIN, V132, P285, DOI 10.1093/brain/awn340; Chan PLS, 2004, J PHARMACOKINET PHAR, V31, P243, DOI 10.1023/B:JOPA.0000039566.75368.59; Cohen MX, 2009, BEHAV BRAIN RES, V199, P141, DOI 10.1016/j.bbr.2008.09.029; CONTIN M, 1993, NEUROLOGY, V43, P367, DOI 10.1212/WNL.43.2.367; CONTIN M, 1990, CLIN NEUROPHARMACOL, V13, P19, DOI 10.1097/00002826-199002000-00002; Contin M, 2001, THER DRUG MONIT, V23, P621, DOI 10.1097/00007691-200112000-00005; CONTIN M, 1994, NEUROLOGY, V44, P1287, DOI 10.1212/WNL.44.7.1287; Contin M, 2010, J NEUROL, V257, pS253, DOI 10.1007/s00415-010-5728-8; Frank MJ, 2001, COGN AFFECT BEHAV NE, V1, P137, DOI 10.3758/CABN.1.2.137; Frank MJ, 2005, J COGNITIVE NEUROSCI, V17, P51, DOI 10.1162/0898929052880093; Goodfellow I., 2016, DEEP LEARNING, DOI DOI 10.4258/HIR.2016.22.4.351; Homann CN, 2000, MOVEMENT DISORD, V15, P641, DOI 10.1002/1531-8257(200007)15:4<641::AID-MDS1007>3.0.CO;2-2; KEENER J., 2009, MATH PHYSL CELLULAR; MELAMED E, 1980, ANN NEUROL, V8, P558, DOI 10.1002/ana.410080603; Miller R., 2007, THEORY BASAL GANGLIA; Mink JW, 1996, PROG NEUROBIOL, V50, P381, DOI 10.1016/S0301-0082(96)00042-1; Moustafa AA, 2008, J NEUROSCI, V28, P12294, DOI 10.1523/JNEUROSCI.3116-08.2008; Nambu A, 2000, J NEUROPHYSIOL, V84, P289, DOI 10.1152/jn.2000.84.1.289; NELDER JA, 1965, COMPUT J, V7, P308, DOI 10.1093/comjnl/7.4.308; Oldenburg IA, 2011, CURR OPIN NEUROBIOL, V21, P425, DOI 10.1016/j.conb.2011.04.004; Postuma RB, 2015, MOVEMENT DISORD, V30, P1591, DOI 10.1002/mds.26424; Reynolds JNJ, 2001, NATURE, V413, P67, DOI 10.1038/35092560; Reynolds JNJ, 2002, NEURAL NETWORKS, V15, P507, DOI 10.1016/S0893-6080(02)00045-X; Roesch MR, 2007, NAT NEUROSCI, V10, P1615, DOI 10.1038/nn2013; Samejima K, 2005, SCIENCE, V310, P1337, DOI 10.1126/science.1115270; Schroll H, 2014, EUR J NEUROSCI, V39, P688, DOI 10.1111/ejn.12434; SHEINER LB, 1979, CLIN PHARMACOL THER, V25, P358; Shen WX, 2008, SCIENCE, V321, P848, DOI 10.1126/science.1160575; Tavares ALT, 2005, MOVEMENT DISORD, V20, P1286, DOI 10.1002/mds.20556; Tomlinson CL, 2010, MOVEMENT DISORD, V25, P2649, DOI 10.1002/mds.23429; Ursino M, 2018, EUR J NEUROSCI, V47, P1563, DOI 10.1111/ejn.13960; Wiecki TV, 2010, PROG BRAIN RES, V183, P275, DOI 10.1016/S0079-6123(10)83014-6; Zhuang Xiao-Xi, 2012, Shengli Xuebao, V64, P543	43	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2020	15	3							e0229729	10.1371/journal.pone.0229729	http://dx.doi.org/10.1371/journal.pone.0229729			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8MS	32126124	Green Published, gold			2022-12-26	WOS:000535253100044
J	Orimoto, A; Kyakumoto, S; Eitsuka, T; Nakagawa, K; Kiyono, T; Fukuda, T				Orimoto, Ai; Kyakumoto, Seiko; Eitsuka, Takahiro; Nakagawa, Kiyotaka; Kiyono, Tohru; Fukuda, Tomokazu			Efficient immortalization of human dental pulp stem cells with expression of cell cycle regulators with the intact chromosomal condition	PLOS ONE			English	Article							DEPENDENT KINASE 4; PRAIRIE VOLE; ESTABLISHMENT; FIBROBLASTS; TRANSFORMATION; KARYOTYPE; ANTIGEN; TISSUE; LINES; TOOL	Clinical studies have recently demonstrated that autologous transplantation of mobilized dental pulp stem cells is a safe and efficacious potential therapy for pulp regeneration. However, some limitations need to be addressed, such as the high cost of the safety and quality control tests for isolated individual dental pulp cell products before transplantation. Therefore, more efficient in vitro culturing of human dental pulp stem cells might be useful for providing low cost and high reliability testing for pulp regeneration therapy. In this study, we established a novel immortalized dental pulp stem cell line by co-expressing a mutant cyclin-dependent kinase 4 (CDK4(R24C)), Cyclin D1, and telomerase reverse transcriptase (TERT). The established cell line maintained its original diploid chromosomes and stemness characteristics and exhibited an enhanced proliferation rate. In addition, we showed the immortalized human dental pulp stem cells still keeps their osteogenic and adipogenic differentiation abilities under appropriate culture conditions even though the cell proliferation was accelerated. Taken together, our established cell lines could serve as a useful in vitro tool for pulp regeneration therapy, and can contribute to reproducibility and ease of cell handling, thereby saving time and costs associated with safety and quality control tests.	[Orimoto, Ai; Fukuda, Tomokazu] Iwate Univ, Grad Sch Sci & Engn, Morioka, Iwate, Japan; [Kyakumoto, Seiko] Iwate Med Univ, Dept Biochem, Div Cellular Biosignal Sci, Morioka, Iwate, Japan; [Eitsuka, Takahiro; Nakagawa, Kiyotaka] Tohoku Univ, Grad Sch Agr Sci, Sendai, Miyagi, Japan; [Kiyono, Tohru] Natl Canc Ctr, Div Carcinogenesis & Prevent, Res Inst, Tokyo, Japan; [Fukuda, Tomokazu] Iwate Univ, Soft Path Engn Res Ctr SPERC, Morioka, Iwate, Japan	Iwate University; Iwate Medical University; Tohoku University; National Cancer Center - Japan; Iwate University	Orimoto, A; Fukuda, T (corresponding author), Iwate Univ, Grad Sch Sci & Engn, Morioka, Iwate, Japan.; Kiyono, T (corresponding author), Natl Canc Ctr, Div Carcinogenesis & Prevent, Res Inst, Tokyo, Japan.; Fukuda, T (corresponding author), Iwate Univ, Soft Path Engn Res Ctr SPERC, Morioka, Iwate, Japan.	aiorimoto@gmail.com; tkiyono@ncc.go.jp; tomofukuda009@gmail.com						Alcorta DA, 1996, P NATL ACAD SCI USA, V93, P13742, DOI 10.1073/pnas.93.24.13742; Cordeiro MM, 2008, J ENDODONT, V34, P962, DOI 10.1016/j.joen.2008.04.009; Donai K, 2014, J BIOTECHNOL, V176, P50, DOI 10.1016/j.jbiotec.2014.02.017; El-Ayachi I, 2016, DATA BRIEF, V6, P696, DOI 10.1016/j.dib.2016.01.009; Fukuda T, 2019, FRONT GENET, V10, DOI 10.3389/fgene.2019.00587; Fukuda T, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-27271-x; Fukuda T, 2016, CYTOTECHNOLOGY, V68, P1937, DOI 10.1007/s10616-016-0004-0; Fukuda T, 2012, BIOSCI BIOTECH BIOCH, V76, P1372, DOI 10.1271/bbb.120155; Galler KM, 2006, EUR J ORAL SCI, DOI [10.1111/j.1600-0722.2006, DOI 10.1111/J.1600-0722.2006]; Gouko R, 2018, CYTOTECHNOLOGY, V70, P1619, DOI 10.1007/s10616-018-0254-0; Gronthos S, 2000, P NATL ACAD SCI USA, V97, P13625, DOI 10.1073/pnas.240309797; Huang GTJ, 2010, TISSUE ENG PT A, V16, P605, DOI [10.1089/ten.tea.2009.0518, 10.1089/ten.TEA.2009.0518]; Inada E, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20194904; Kamata N, 2004, J ORAL PATHOL MED, V33, P417, DOI 10.1111/j.1600-0714.2004.00228.x; Katayama M, 2017, J REPROD DEVELOP, V63, P311, DOI 10.1262/jrd.2016-164; Katayama M, 2016, EXP ANIM TOKYO, V65, P87, DOI 10.1538/expanim.15-0061; Kitagawa M, 2007, ARCH ORAL BIOL, V52, P727, DOI 10.1016/j.archoralbio.2007.02.006; Kiyono T, 1998, NATURE, V396, P84, DOI 10.1038/23962; Kuroda K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143473; Kuroda K, 2015, J CELL BIOCHEM, V116, P205, DOI 10.1002/jcb.24963; LEVINE AJ, 1990, VIROLOGY, V177, P419, DOI 10.1016/0042-6822(90)90505-L; Nakashima M, 2017, J ENDODONT, V43, pS82, DOI 10.1016/j.joen.2017.06.014; Nakashima M, 2017, STEM CELL RES THER, V8, DOI 10.1186/s13287-017-0506-5; Neve A, 2013, J CELL PHYSIOL, V228, P1149, DOI 10.1002/jcp.24278; Paino F, 2017, CLIN SCI, V131, P699, DOI 10.1042/CS20170047; Ramirez RD, 2001, GENE DEV, V15, P398, DOI 10.1101/gad.859201; RAY FA, 1990, J CELL BIOCHEM, V42, P13, DOI 10.1002/jcb.240420103; Sasaki R, 2009, CARCINOGENESIS, V30, P423, DOI 10.1093/carcin/bgp007; Shiomi K, 2011, GENE THER, V18, P857, DOI 10.1038/gt.2011.44; STEWART N, 1991, VIROLOGY, V180, P49, DOI 10.1016/0042-6822(91)90008-Y; Tani T, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0221364; Tirino V, 2011, STEM CELL REV REP, V7, P608, DOI 10.1007/s12015-011-9235-9; Xuan K, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aaf3227	33	13	13	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2020	15	3							e0229996	10.1371/journal.pone.0229996	http://dx.doi.org/10.1371/journal.pone.0229996			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8JT	32119713	Green Published, gold			2022-12-26	WOS:000535245300045
J	Davies, CE; Briones-Fourzan, P; Barradas-Ortiz, C; Negrete-Soto, F; Moo-Cocom, G; Lozano-Alvarez, E				Davies, Charlotte E.; Briones-Fourzan, Patricia; Barradas-Ortiz, Cecilia; Negrete-Soto, Fernando; Moo-Cocom, Gema; Lozano-Alvarez, Enrique			Do ecological characteristics drive the prevalence of Panulirus argus virus 1 (PaV1) in juvenile Caribbean spiny lobsters in a tropical reef lagoon?	PLOS ONE			English	Article							THALASSIA-TESTUDINUM; DISEASE; DIVERSITY; DYNAMICS; MARINE; SEASONALITY; CRUSTACEANS; POPULATION; ECOSYSTEMS; SEAGRASSES	PaV1 is a pathogenic virus found only to infect Caribbean spiny lobsters Panulirus argus, a major fishing resource. P. argus is a benthic mesopredator and has a complex life history, with several ontogenetic habitat changes. Habitat characteristics and species diversity of surrounding communities may have implications for disease dynamics. This is of more concern for juvenile lobsters, which are more susceptible to PaV1 and are far less mobile than adult lobsters. We targeted a population of juvenile P. argus in a reef lagoon in Mexico, where PaV1 was first observed in 2001. Prevalence has been since irregularly assessed, but in 2016 we began a more systematic assessment, with two sampling periods per year (June and November) in three different zones of the reef lagoon. To examine the relationship between PaV1 prevalence and potential ecological determinants, we assessed habitat complexity, cover of different substrates, and invertebrate community composition in all zones during the first four sampling periods (June and November 2016 and 2017). Habitat complexity and percent cover of some substrates varied with zone and sampling period. This was the case for seagrass and macroalgae, which nevertheless were the dominant substrates. The invertebrate community composition varied with sampling period, but not with zone. Probability of infection decreased with increasing lobster size, consistent with previous studies, but was not affected by zone (i.e., variations in ecological characteristics did not appear to be sufficiently large so as to influence prevalence of PaV1). This result possibly reflects the dominance of marine vegetation and suggests that lobsters can be sampled throughout the reef lagoon to assess PaV1 prevalence. Prevalence was higher in only one of seven sampling periods (November 2017), suggesting that the pathogen has leveled off to an enzootic level.	[Davies, Charlotte E.; Briones-Fourzan, Patricia; Barradas-Ortiz, Cecilia; Negrete-Soto, Fernando; Moo-Cocom, Gema; Lozano-Alvarez, Enrique] Univ Nacl Autonoma Mexico, Inst Ciencias Mar & Limnol, Unidad Acad Sistemas Arrecifales, Puerto Morelos, Quintana Roo, Mexico; [Davies, Charlotte E.] Swansea Univ, Coll Sci, Dept Biosci, Singleton Pk, Swansea, W Glam, Wales	Universidad Nacional Autonoma de Mexico; Swansea University	Briones-Fourzan, P (corresponding author), Univ Nacl Autonoma Mexico, Inst Ciencias Mar & Limnol, Unidad Acad Sistemas Arrecifales, Puerto Morelos, Quintana Roo, Mexico.	briones@cmarl.unam.mx	Davies, Charlotte E/L-2182-2015; Fourzán, Patricia Briones/AAD-4736-2020	Briones-Fourzan, Patricia/0000-0003-4096-1415; Davies, Charlotte Eve/0000-0002-5853-1934	Universidad Nacional Autonoma de Mexico-Direccion General de Asuntos del Personal Academico-Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica (UNAM-DGAPA-PAPIIT) [IN-206117]; DGAPA	Universidad Nacional Autonoma de Mexico-Direccion General de Asuntos del Personal Academico-Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica (UNAM-DGAPA-PAPIIT); DGAPA	This project was funded by Universidad Nacional Autonoma de Mexico-Direccion General de Asuntos del Personal Academico-Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica (UNAM-DGAPA-PAPIIT, http://dgapa.unam.mx/), Project IN-206117 granted to P.B.F., and a postdoctoral scholarship 2016-2018 also granted by DGAPA to C.E.D. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez E, 2008, DIS AQUAT ORGAN, V80, P95, DOI [10.3354/dao01921, DOI 10.3354/DAO01921]; Alvarez LJ, 2011, ECOSPHERE, V2, DOI [10.1890/ES11-00104.1, 10.1890/ES11-00185.1]; Anderson JR, 2013, MAR ECOL PROG SER, V474, P191, DOI 10.3354/meps10091; Beevers ND, 2012, DIS AQUAT ORGAN, V100, P95, DOI 10.3354/dao02473; Behringer DC, 2006, NATURE, V441, P421, DOI 10.1038/441421a; Behringer DC, 2011, DIS AQUAT ORGAN, V94, P153, DOI 10.3354/dao02326; Briones-Fourzan P, 2003, MAR BIOL, V142, P855, DOI 10.1007/s00227-003-1013-z; Briones-Fourzan P, 2001, B MAR SCI, V68, P207; Briones-Fourzan P, 2001, MAR ECOL PROG SER, V221, P221, DOI 10.3354/meps221221; Briones-Fourzan P, 2008, LIMNOL OCEANOGR, V53, P970, DOI 10.4319/lo.2008.53.3.0970; Briones-Fourzan P, 2007, OECOLOGIA, V151, P401, DOI 10.1007/s00442-006-0595-9; Briones-Fourzan Patricia, 2019, Frontiers in Marine Science, V5, P516; Briones-Fourzan P, 2013, LOBSTERS: BIOLOGY, MANAGEMENT, AQUACULTURE AND FISHERIES, 2ND EDITION, P186; Briones-Fourzan P, 2012, DIS AQUAT ORGAN, V100, P135, DOI 10.3354/dao02465; Butler MJ, 2008, DIS AQUAT ORGAN, V79, P173, DOI 10.3354/dao01899; Butler MJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126374; Candia-Zulbaran RI, 2019, DIS AQUAT ORGAN, V137, P47, DOI 10.3354/dao03427; Candia-Zulbaran RI, 2015, ICES J MAR SCI, V72, P164, DOI 10.1093/icesjms/fsu249; Candia-Zulbaran RI, 2012, DIS AQUAT ORGAN, V100, P125, DOI 10.3354/dao02452; Candia-Zulbaran RI, 2020, THESIS; Clark AS, 2018, DIS AQUAT ORGAN, V129, P193, DOI 10.3354/dao03242; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; Clarke KR., 2001, CHANGE MARINE COMMUN, V2; Cox C, 1997, MAR FRESHWATER RES, V48, P671, DOI 10.1071/MF97198; Davies CE, 2019, MAR BIOL, V166, DOI 10.1007/s00227-019-3563-8; Ehrhardt N, 2011, MARE PUBL SER, P157; Elzinga C.L., 1998, 17301 BUR LAND MAN; Enriquez S, 2005, OECOLOGIA, V145, P235, DOI 10.1007/s00442-005-0111-7; GERBA CP, 1984, ADV APPL MICROBIOL, V30, P133, DOI 10.1016/S0065-2164(08)70054-6; Gonzalez-Gomez R, 2018, PEERJ, V6, DOI 10.7717/peerj.4922; Gratwicke B, 2005, J FISH BIOL, V66, P650, DOI 10.1111/j.0022-1112.2005.00629.x; Hamilton KM, 2009, ICES J MAR SCI, V66, P1837, DOI 10.1093/icesjms/fsp152; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Hernandez A, 2005, ARCH VIROL, V150, P2357, DOI 10.1007/s00705-005-0584-z; Herrnkind W.F., 1980, P349; Huchin-Mian JP, 2008, DIS AQUAT ORGAN, V79, P153, DOI 10.3354/dao01898; Jordan-Dahlgren E, 1993, LATIN AM CORAL REEFS, P131; Kannan RRR, 2010, ASIAN PAC J TROP MED, V3, P890, DOI 10.1016/S1995-7645(10)60214-3; Keesing F, 2006, ECOL LETT, V9, P485, DOI 10.1111/j.1461-0248.2006.00885.x; Lafferty KD, 2003, ECOL LETT, V6, P654, DOI 10.1046/j.1461-0248.2003.00480.x; Lamb JB, 2017, SCIENCE, V355, P731, DOI 10.1126/science.aal1956; Lozano-Alvarez E, 2018, B MAR SCI, V94, P657, DOI 10.5343/bms.2017.1128; Lozano-Alvarez E, 2017, J SEA RES, V128, P84, DOI 10.1016/j.seares.2017.08.010; Lozano-Alvarez E, 2015, DIS AQUAT ORGAN, V117, P165, DOI 10.3354/dao02935; Ma HW, 2009, J INVERTEBR PATHOL, V101, P112, DOI 10.1016/j.jip.2009.04.002; Montgomery-Fullerton MM, 2007, DIS AQUAT ORGAN, V76, P1, DOI 10.3354/dao076001; Morris EK, 2014, ECOL EVOL, V4, P3514, DOI 10.1002/ece3.1155; Moss J, 2013, DIS AQUAT ORGAN, V104, P129, DOI 10.3354/dao02589; Moss J, 2012, AQUAT BIOL, V14, P223, DOI 10.3354/ab00395; Mydlarz LD, 2006, ANNU REV ECOL EVOL S, V37, P251, DOI 10.1146/annurev.ecolsys.37.091305.110103; Newcombe RG, 1998, STAT MED, V17, P873, DOI 10.1002/(SICI)1097-0258(19980430)17:8<873::AID-SIM779>3.0.CO;2-I; Ostfeld RS, 2012, ANNU REV ECOL EVOL S, V43, P157, DOI 10.1146/annurev-ecolsys-102710-145022; Huchin-Mian JP, 2013, DIS AQUAT ORGAN, V107, P87, DOI 10.3354/dao02676; Peinado-Guevara LI, 2006, AQUACULTURE, V251, P33, DOI 10.1016/j.aquaculture.2005.05.022; Peterson CH, 2004, MAR ECOL PROG SER, V268, P81, DOI 10.3354/meps268081; Quinn GP, 2003, EXPT DESIGN DATA ANA; Rodriguez-Martinez RE, 2019, MAR POLLUT BULL, V146, P201, DOI 10.1016/j.marpolbul.2019.06.015; Rodriguez-Martinez RE, 2010, REV BIOL TROP, V58, P23; Ruiz-Renteria F, 1998, COAST REG SM ISL PA, P57; Rutherford A., 2001, INTRO ANOVA ANCOVA G; SCOFFIN TP, 1970, J SEDIMENT PETROL, V40, P249; Shields JD, 2011, J INVERTEBR PATHOL, V106, P79, DOI 10.1016/j.jip.2010.09.015; Shields JD, 2004, DIS AQUAT ORGAN, V59, P109, DOI 10.3354/dao059109; Small HJ, 2011, J INVERTEBR PATHOL, V106, P153, DOI 10.1016/j.jip.2010.09.016; Stentiford GD, 2009, AQUACULTURE, V291, P1, DOI 10.1016/j.aquaculture.2009.02.042; Swinton J., 2002, P83; TABERLET P, 2018, ENV DNA BIOD RES MON, pNIL6; van Tussenbroek BI, 1998, AQUAT BOT, V61, P69, DOI 10.1016/S0304-3770(98)00058-8; van Tussenbroek BI, 2017, MAR POLLUT BULL, V122, P272, DOI 10.1016/j.marpolbul.2017.06.057; van Tussenbroek BI, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090600; van Tussenbroek BI, 2011, HIDROBIOLOGICA, V21, P293; VANTUSSENBROEK BI, 1995, MAR BIOL, V122, P33, DOI 10.1007/BF00349275; Wang MQ, 2019, SCIENCE, V365, P83, DOI 10.1126/science.aaw7912; Warton DI, 2011, ECOLOGY, V92, P3, DOI 10.1890/10-0340.1; Zarco-Perello S, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-43037-5	75	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2020	15	2							e0229827	10.1371/journal.pone.0229827	http://dx.doi.org/10.1371/journal.pone.0229827			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8HR	32109265	Green Published, gold			2022-12-26	WOS:000535239800026
J	Han, JYS; Kinoshita, J; Bisetto, S; Bell, BA; Nowak, RA; Peachey, NS; Philp, NJ				Han, John Y. S.; Kinoshita, Junzo; Bisetto, Sara; Bell, Brent A.; Nowak, Romana A.; Peachey, Neal S.; Philp, Nancy J.			Role of monocarboxylate transporters in regulating metabolic homeostasis in the outer retina: Insight gained from cell-specific Bsg deletion	FASEB JOURNAL			English	Article						basigin; lactate; monocarboxylate transporters; photoreceptors; retina; RPE	PIGMENT EPITHELIUM; PLASMA-MEMBRANE; MCT3 GENE; EXPRESSION; CONE; ROD; PHOTORECEPTORS; BASIGIN; LACTATE; DEGENERATION	The neural retina metabolizes glucose through aerobic glycolysis generating large amounts of lactate. Lactate flux into and out of cells is regulated by proton-coupled monocarboxylate transporters (MCTs), which are encoded by members of the Slc16a family. MCT1, MCT3, and MCT4 are expressed in the retina and require association with the accessory protein basigin, encoded by Bsg, for maturation and trafficking to the plasma membrane. Bsg(-/-) mice have severely reduced electroretinograms (ERGs) and progressive photoreceptor degeneration, which is presumed to be driven by metabolic dysfunction resulting from loss of MCTs. To understand the basis of the Bsg(-/-) phenotype, we generated mice with conditional deletion of Bsg in rods (Rod Delta Bsg), cones (Cone increment Bsg), or retinal pigment epithelial cells (RPE Delta Bsg). Rod Delta Bsg mice showed a progressive loss of photoreceptors, while Cone Delta Bsg mice did not display a degenerative phenotype. The RPE Delta Bsg mice developed a distinct phenotype characterized by severely reduced ERG responses as early as 4 weeks of age. The loss of lactate transporters from the RPE most closely resembled the phenotype of the Bsg(-/-) mouse, suggesting that the regulation of lactate levels in the RPE and the subretinal space is essential for the viability and function of photoreceptors.	[Han, John Y. S.; Bisetto, Sara; Philp, Nancy J.] Thomas Jefferson Univ, Dept Pathol Anat & Cell Biol, 1020 Locust St, Philadelphia, PA 19107 USA; [Kinoshita, Junzo; Peachey, Neal S.] Cleveland Clin, Cole Eye Inst, Cleveland, OH 44106 USA; [Bell, Brent A.] Univ Penn, Dept Ophthalmol, Philadelphia, PA 19104 USA; [Nowak, Romana A.] Univ Illinois, Anim Sci, Urbana, IL USA; [Peachey, Neal S.] Louis Stokes Cleveland VA Med Ctr, Cleveland, OH USA; [Peachey, Neal S.] Case Western Reserve Univ, Cleveland Clin, Lerner Coll Med, Dept Ophthalmol, Cleveland, OH 44106 USA; [Kinoshita, Junzo] Daiichi Sankyo Co Ltd, Med Safety Res Labs, Tokyo, Japan	Jefferson University; Cleveland Clinic Foundation; University of Pennsylvania; University of Illinois System; University of Illinois Urbana-Champaign; US Department of Veterans Affairs; Veterans Health Administration (VHA); Case Western Reserve University; Louis Stokes Cleveland Veterans Affairs Medical Center; Case Western Reserve University; Cleveland Clinic Foundation; Daiichi Sankyo Company Limited	Philp, NJ (corresponding author), Thomas Jefferson Univ, Dept Pathol Anat & Cell Biol, 1020 Locust St, Philadelphia, PA 19107 USA.; Peachey, NS (corresponding author), Louis Stokes Cleveland VA Med Ctr, Res Serv 151, 10701 East Blvd, Cleveland, OH 44106 USA.	neal.peachey@va.gov; Nancy.Philp@jefferson.edu	Peachey, Neal/G-5533-2010	Peachey, Neal/0000-0002-4419-7226; Philp, Nancy/0000-0001-7028-0448; Han, John/0000-0003-4200-5128	HHS \ NIH \ National Eye Institute (NEI) [R01 EY12042, P30 EY025585]; U.S. Department of Veterans Affairs (VA) [I01 BX002340]; HHS \ NIH \ National Institute on Alcohol Abuse and Alcoholism (NIAAA) [T32AA007463]	HHS \ NIH \ National Eye Institute (NEI); U.S. Department of Veterans Affairs (VA)(US Department of Veterans Affairs); HHS \ NIH \ National Institute on Alcohol Abuse and Alcoholism (NIAAA)	HHS vertical bar NIH vertical bar National Eye Institute (NEI), Grant/Award Number: R01 EY12042; HHS vertical bar NIH vertical bar National Eye Institute (NEI), Grant/Award Number: P30 EY025585; U.S. Department of Veterans Affairs (VA), Grant/Award Number: I01 BX002340; HHS vertical bar NIH vertical bar National Institute on Alcohol Abuse and Alcoholism (NIAAA), Grant/Award Number: T32AA007463	Adijanto J, 2014, EXP EYE RES, V126, P77, DOI 10.1016/j.exer.2014.01.015; Adijanto J, 2012, CURR TOP MEMBR, V70, P275, DOI 10.1016/B978-0-12-394316-3.00009-0; Ait-Ali N, 2015, CELL, V161, P817, DOI 10.1016/j.cell.2015.03.023; Akimoto M, 2004, INVEST OPHTH VIS SCI, V45, P42, DOI 10.1167/iovs.03-0804; Bell BA, 2019, EXP EYE RES, V185, DOI 10.1016/j.exer.2019.05.012; Bell BA, 2015, EXP EYE RES, V135, P192, DOI 10.1016/j.exer.2015.04.009; Bell BA, 2014, EXP EYE RES, V127, P280, DOI 10.1016/j.exer.2014.01.001; Bisetto S, 2019, ISCIENCE, V22, P507, DOI 10.1016/j.isci.2019.11.041; Bisetto S, 2018, FRONT ONCOL, V8, DOI 10.3389/fonc.2018.00324; BRETON ME, 1994, INVEST OPHTH VIS SCI, V35, P295; Caceres PS, 2020, CURR OPIN CELL BIOL, V62, P37, DOI 10.1016/j.ceb.2019.08.001; Castorino JJ, 2011, TRAFFIC, V12, P483, DOI 10.1111/j.1600-0854.2010.01155.x; Chang B, 2002, VISION RES, V42, P517, DOI 10.1016/S0042-6989(01)00146-8; Chang B, 2006, INVEST OPHTH VIS SCI, V47, P5017, DOI 10.1167/iovs.05-1468; Chen M, 2016, AGING CELL, V15, P436, DOI 10.1111/acel.12447; Chinchore Y, 2017, ELIFE, V6, DOI 10.7554/eLife.25946; Contreras-Baeza Y, 2019, J BIOL CHEM, V294, P20135, DOI 10.1074/jbc.RA119.009093; Daniele LL, 2008, AM J PHYSIOL-CELL PH, V295, pC451, DOI 10.1152/ajpcell.00124.2008; Du JH, 2016, J BIOL CHEM, V291, P4698, DOI 10.1074/jbc.M115.698985; Fisel P, 2018, CTS-CLIN TRANSL SCI, V11, P352, DOI 10.1111/cts.12551; Flynn E, 2014, INVEST OPHTH VIS SCI, V55, P5643, DOI 10.1167/iovs.14-14136; FULTON AB, 1978, VISION RES, V18, P785, DOI 10.1016/0042-6989(78)90118-9; Gallagher SM, 2007, CANCER RES, V67, P4182, DOI 10.1158/0008-5472.CAN-06-3184; Gao XR, 2019, HUM MOL GENET, V28, P1162, DOI 10.1093/hmg/ddy422; Goto Y, 1995, DOC OPHTHALMOL, V91, P147, DOI 10.1007/BF01203694; Hamann S, 2003, EXP EYE RES, V76, P493, DOI 10.1016/S0014-4835(02)00329-9; Hood Donald C., 1996, Documenta Ophthalmologica, V92, P253, DOI 10.1007/BF02584080; Hoppe G, 2016, P NATL ACAD SCI USA, V113, pE2516, DOI 10.1073/pnas.1523005113; Hori K, 2000, INVEST OPHTH VIS SCI, V41, P3128; Iacovelli J, 2011, INVEST OPHTH VIS SCI, V52, P1378, DOI 10.1167/iovs.10-6347; Iommarini L, 2017, FRONT ONCOL, V7, DOI 10.3389/fonc.2017.00286; Issa PC, 2013, INVEST OPHTH VIS SCI, V54, P5602, DOI 10.1167/iovs.13-11688; Jeon CJ, 1998, J NEUROSCI, V18, P8936; Joyal JS, 2018, PROG RETIN EYE RES, V64, P131, DOI 10.1016/j.preteyeres.2017.11.002; Kanow MA, 2017, ELIFE, V6, DOI 10.7554/eLife.28899; Kim JW, 2016, DEV CELL, V37, P520, DOI 10.1016/j.devcel.2016.05.023; Kirk P, 2000, EMBO J, V19, P3896, DOI 10.1093/emboj/19.15.3896; Kurihara T, 2016, ELIFE, V5, DOI 10.7554/eLife.14319; Kurihara T, 2012, J CLIN INVEST, V122, P4213, DOI 10.1172/JCI65157; Lee YJ, 2012, NATURE, V487, P443, DOI 10.1038/nature11314; Leveillard T, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20030762; Li S, 2005, GENESIS, V41, P73, DOI 10.1002/gene.20097; Lindsay KJ, 2014, P NATL ACAD SCI USA, V111, P15579, DOI 10.1073/pnas.1412441111; Macosko EZ, 2015, CELL, V161, P1202, DOI 10.1016/j.cell.2015.05.002; Muramatsu T, 2016, J BIOCHEM, V159, P481, DOI 10.1093/jb/mvv127; Ochrietor JD, 2003, INVEST OPHTH VIS SCI, V44, P4086, DOI 10.1167/iovs.02-0995; Ochrietor JD, 2002, VISION RES, V42, P447, DOI 10.1016/S0042-6989(01)00236-X; Peachey NS, 2018, ADV EXP MED BIOL, V1074, P375, DOI 10.1007/978-3-319-75402-4_46; PEACHEY NS, 1989, VISION RES, V29, P263, DOI 10.1016/0042-6989(89)90075-8; Perkins GA, 2003, MOL VIS, V9, P60; Petit L, 2018, CELL REP, V23, P2629, DOI 10.1016/j.celrep.2018.04.111; Philp NJ, 2003, INVEST OPHTH VIS SCI, V44, P1716, DOI 10.1167/iovs.02-0287; Philp NJ, 2003, INVEST OPHTH VIS SCI, V44, P1305, DOI 10.1167/iovs.02-0552; Philp NJ, 2001, AM J PHYSIOL-CELL PH, V280, pC1319, DOI 10.1152/ajpcell.2001.280.5.C1319; Philp NJ, 1998, AM J PHYSIOL, V274, P1824; POITRYYAMATE CL, 1995, J NEUROSCI, V15, P5179; Rajala A, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0712-9; Rajala A, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0296-4; Rosafio K, 2016, NEUROSCIENCE, V317, P108, DOI 10.1016/j.neuroscience.2015.12.052; Rosell A, 2014, P NATL ACAD SCI USA, V111, P2966, DOI 10.1073/pnas.1323779111; Schmidt N, 2017, NEURON, V96, P827, DOI 10.1016/j.neuron.2017.09.038; Silagi ES, 2019, J BONE MINER RES, P1; Swarup A, 2019, AM J PHYSIOL-CELL PH, V316, pC121, DOI 10.1152/ajpcell.00410.2018; Tanner LB, 2018, CELL SYST, V7, P49, DOI 10.1016/j.cels.2018.06.003; Ullah MS, 2006, J BIOL CHEM, V281, P9030, DOI 10.1074/jbc.M511397200; Wei H, 2016, EXP EYE RES, V145, P450, DOI 10.1016/j.exer.2015.09.015; Wilson DF, 2015, AM J PHYSIOL-ENDOC M, V308, pE506, DOI 10.1152/ajpendo.00544.2014; Wubben TJ, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-18098-z; Xu XP, 2000, EXP NEUROL, V163, P207, DOI 10.1006/exnr.2000.7370; Yoon H, 1999, GENOMICS, V60, P366, DOI 10.1006/geno.1999.5926; Yu DY, 2006, INVEST OPHTH VIS SCI, V47, P1109, DOI 10.1167/iovs.05-1118; Zhao C, 2011, J CLIN INVEST, V121, P369, DOI 10.1172/JCI44303	72	11	11	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2020	34	4					5401	5419		10.1096/fj.201902961R	http://dx.doi.org/10.1096/fj.201902961R		FEB 2020	19	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	LJ5ZA	32112484	Bronze, Green Accepted			2022-12-26	WOS:000517912600001
J	Wagner, FH; Sanchez, A; Aidar, MPM; Rochelle, ALC; Tarabalka, Y; Fonseca, MG; Phillips, OL; Gloor, E; Aragao, LEOC				Wagner, Fabien H.; Sanchez, Alber; Aidar, Marcos P. M.; Rochelle, Andre L. C.; Tarabalka, Yuliya; Fonseca, Marisa G.; Phillips, Oliver L.; Gloor, Emanuel; Aragao, Luiz E. O. C.			Mapping Atlantic rainforest degradation and regeneration history with indicator species using convolutional network	PLOS ONE			English	Article								The Atlantic rainforest of Brazil is one of the global terrestrial hotspots of biodiversity. Despite having undergone large scale deforestation, forest cover has shown signs of increases in the last decades. Here, to understand the degradation and regeneration history of Atlantic rainforest remnants near Sao Paulo, we combine a unique dataset of very high resolution images from Worldview-2 and Worldview-3 (0.5 and 0.3m spatial resolution, respectively), georeferenced aerial photographs from 1962 and use a deep learning method called U-net to map (i) the forest cover and changes and (ii) two pioneer tree species, Cecropia hololeuca and Tibouchina pulchra. For Tibouchina pulchra, all the individuals were mapped in February, when the trees undergo mass-flowering with purple and pink blossoms. Additionally, elevation data at 30m spatial resolution from NASA Shuttle Radar Topography Mission (SRTM) and annual mean climate variables (Terraclimate datasets at similar to 4km of spatial resolution) were used to analyse the forest and species distributions. We found that natural forests are currently more frequently found on south-facing slopes, likely because of geomorphology and past land use, and that Tibouchina is restricted to the wetter part of the region (southern part), which annually receives at least 1600 mm of precipitation. Tibouchina pulchra was found to clearly indicate forest regeneration as almost all individuals were found within or adjacent to forests regrown after 1962. By contrast, Cecropia hololeuca was found to indicate older disturbed forests, with all individuals almost exclusively found in forest fragments already present in 1962. At the regional scale, using the dominance maps of both species, we show that at least 4.3% of the current region's natural forests have regrown after 1962 (Tibouchina dominated, similar to 4757 ha) and that similar to 9% of the old natural forests have experienced significant disturbance (Cecropia dominated).	[Wagner, Fabien H.; Sanchez, Alber; Fonseca, Marisa G.; Aragao, Luiz E. O. C.] Natl Inst Space Res INPE, Remote Sensing Div, Sao Jose Dos Campos, SP, Brazil; [Wagner, Fabien H.] Fdn Sci Technol & Space Applicat FUNCATE, Geoproc Div, Sao Jose Dos Campos, SP, Brazil; [Aidar, Marcos P. M.] Inst Bot, Dept Plant Physiol & Biochem, Sao Paulo, Brazil; [Rochelle, Andre L. C.] Natl Inst Space Res INPE, Ctr Earth Syst Sci, Sao Jose Dos Campos, SP, Brazil; [Tarabalka, Yuliya] Inria Sophia Antipolis, Sophia Antipolis, France; [Tarabalka, Yuliya] Luxcarta Technol, Parc Activite Argile, Mouans Sartoux, France; [Phillips, Oliver L.; Gloor, Emanuel] Univ Leeds, Sch Geog, Ecol & Global Change, Leeds, W Yorkshire, England; [Aragao, Luiz E. O. C.] Univ Exeter, Coll Life & Environm Sci, Exeter, Devon, England	Instituto Nacional de Pesquisas Espaciais (INPE); Instituto de Botanica - Sao Paulo; Instituto Nacional de Pesquisas Espaciais (INPE); University of Leeds; University of Exeter	Wagner, FH (corresponding author), Natl Inst Space Res INPE, Remote Sensing Div, Sao Jose Dos Campos, SP, Brazil.; Wagner, FH (corresponding author), Fdn Sci Technol & Space Applicat FUNCATE, Geoproc Div, Sao Jose Dos Campos, SP, Brazil.	wagner.h.fabien@gmail.com	Sanchez, Alber/AAQ-4055-2021; Phillips, Oliver/A-1523-2011; Wagner, Fabien FW/B-8364-2013; Aidar, Marcos Pereira Marinho/B-2212-2013	Sanchez, Alber/0000-0001-7966-2880; Phillips, Oliver/0000-0002-8993-6168; Wagner, Fabien FW/0000-0002-9623-1182; Aidar, Marcos Pereira Marinho/0000-0001-5728-6749	Sao Paulo Research Foundation (FAPESP) [2015/50484-0]; U.K. Natural Environment Research Council (NERC) [NE/N012542/1]; FAPESP [2013/50533-5, 2016/17652-9, 2016/03397-7]; ECOFOR Project, BIOTA-FAPESP [2012/51872-5]; State of Sao Paulo Research Foundation/FAPESP within the BIOTA/FAPESP Program - The Biodiversity Virtual Institute [2012/51872-5]; British Natural Environment Research Council/NERC [NE/K016431/1]; French National Research Agency (ANR) [ANR-17CE23-0009]; CNPq [305054/2016-3]; Amazon Fund; Foundation for Science, Technology and Space Applications (FUNCATE) [17.2.0536.1]; NERC; Capes; ANR; Luxcarta Technology; NERC [NE/N012542/1, NE/K016431/1] Funding Source: UKRI	Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); U.K. Natural Environment Research Council (NERC)(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); ECOFOR Project, BIOTA-FAPESP; State of Sao Paulo Research Foundation/FAPESP within the BIOTA/FAPESP Program - The Biodiversity Virtual Institute; British Natural Environment Research Council/NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); French National Research Agency (ANR)(French National Research Agency (ANR)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Amazon Fund; Foundation for Science, Technology and Space Applications (FUNCATE); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Capes(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); ANR(French National Research Agency (ANR)); Luxcarta Technology; NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	The research leading to these results received funding from the project BIO-RED `Biomes of Brazil -Resilience, Recovery, and Diversity', which is supported by the Sao Paulo Research Foundation (FAPESP, 2015/50484-0) and the U.K. Natural Environment Research Council (NERC, NE/N012542/1). F.H.W. has been funded by FAPESP (grant 2016/17652-9). A.S. acknowledges the support of the FAPESP (grant 2016/03397-7). M.P.M.A. has been funded by ECOFOR Project, BIOTA-FAPESP (grant number 2012/51872-5). A.L.C.R. has been funded by supported by the State of Sao Paulo Research Foundation/FAPESP as part of the project ECOFOR (Process number 2012/51872-5) within the BIOTA/FAPESP Program - The Biodiversity Virtual Institute (www.biota.org.br) and co-supported by the British Natural Environment Research Council/NERC (NE/K016431/1). M.G.F acknowledges the support of Capes through a postdoctoral fellowship. Y.T. has been funded by the project EPITOME ANR-17CE23-0009 of the French National Research Agency (ANR). L.E.O.C.A. thank the support of FAPESP (grant 2013/50533-5) and CNPq (grant 305054/2016-3). We also thank the Amazon Fund through the financial collaboration of the Brazilian Development Bank (BNDES) and the Foundation for Science, Technology and Space Applications (FUNCATE) no. 17.2.0536.1 (Environmental Monitoring of Brazilian Biomes). The funders (FAPESP, NERC, Capes, ANR and Luxcarta Technology) provided support in the form of salaries for authors F.W., A.S., Y.T. and M.G.F., but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the `author contributions' section.	Abadi M., 2016, TENSORFLOW LARGE SCA; Abatzoglou JT, 2018, SCI DATA, V5, DOI 10.1038/sdata.2017.191; Allaire J, 2016, KERAS R INTERFACE TO; Brito VLG, 2012, PLANT SYST EVOL, V298, P1271, DOI 10.1007/s00606-012-0633-5; Brown M, 2003, NINTH IEEE INTERNATIONAL CONFERENCE ON COMPUTER VISION, VOLS I AND II, PROCEEDINGS, P1218; Brown M, 2007, INT J COMPUT VISION, V74, P59, DOI 10.1007/s11263-006-0002-3; Couteron P, 2006, LANDSCAPE ECOL, V21, P555, DOI 10.1007/s10980-005-2166-6; Dean W., 1997, BROADAX FIREBRAND; Diaz S, 2006, PLOS BIOL, V4, P1300, DOI 10.1371/journal.pbio.0040277; DICE LR, 1945, ECOLOGY, V26, P297, DOI 10.2307/1932409; Draper FC, 2019, ECOLOGY, V100, DOI 10.1002/ecy.2636; ESRI, 2018, ARCGIS DESKT 10 4 GE; Farr TG, 2007, REV GEOPHYS, V45, DOI 10.1029/2005RG000183; Feret JB, 2014, ECOL APPL, V24, P1289, DOI 10.1890/13-1824.1; Franco-Rosselli Pilar, 1997, Caldasia, V19, P285; Furian S, 1999, CATENA, V38, P65, DOI 10.1016/S0341-8162(99)00015-6; Grizonnet M., 2017, OPEN GEOSPAT DATA SO, V2, P15, DOI [10.1186/s40965-017-0031-6, DOI 10.1186/S40965-017-0031-6]; Hanson MA, 2012, SCIENCE, V335, P851, DOI [10.1126/science.1244693, 10.1126/science.1215904]; He KS, 2015, REMOTE SENS ECOL CON, V1, P4, DOI 10.1002/rse2.7; HORN BKP, 1981, P IEEE, V69, P14, DOI 10.1109/PROC.1981.11918; Huang B, 2018, IEEE INT GEOSC REM S; INPE, 2017, ATL REM FLOR MAL ATL; Joly CA, 2014, NEW PHYTOL, V204, P459, DOI 10.1111/nph.12989; Joly CA, 2010, SCIENCE, V328, P1358, DOI 10.1126/science.1188639; Kwok R, 2018, NATURE, V556, P137, DOI 10.1038/d41586-018-03924-9; Laurance WF, 2009, BIOL CONSERV, V142, P1137, DOI 10.1016/j.biocon.2008.10.011; LEITAOFILHO H.F., 1993, ECOLOGIA MATA ATLANT; Lorenzi H., 1992, ARVORESA BRASILEIRAS, P4; Mesquita RCG, 2001, J ECOL, V89, P528, DOI 10.1046/j.1365-2745.2001.00583.x; Mutanga O, 2019, AFR J ECOL, V57, P314, DOI 10.1111/aje.12604; Pettorelli N, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0190; QGIS Development Team, 2009, QGIS GEOGR INF SYST; RCore Team, 2020, R LANG ENV STAT COMP; Ribeiro MC, 2009, BIOL CONSERV, V142, P1141, DOI 10.1016/j.biocon.2009.02.021; Rodrigues RR, 2011, FOREST ECOL MANAG, V261, P1605, DOI 10.1016/j.foreco.2010.07.005; Ronneberger O., 2015, U NET CONVOLUTIONAL; Sampaio A., 1975, EUCALIPTO ECOLOGIAS, P5; Sanchez-Azofeifa A, 2011, SENSORS-BASEL, V11, P3831, DOI 10.3390/s110403831; Scarano FR, 1995, BRAZIL J TROP ECOL, V11, P147, DOI DOI 10.1017/S0266467400008518; Silva AL, 2018, REMOTE SENS-BASEL, V10, DOI 10.3390/rs10070996; SSC, 2012, UN C BIOL DIV COP11; Strassburg BBN, 2016, BIOTROPICA, V48, P890, DOI 10.1111/btp.12393; Tabarelli M., 1999, Revista Brasileira de Biologia, V59, P239, DOI 10.1590/S0034-71081999000200008; Turner W, 2014, SCIENCE, V346, P301, DOI 10.1126/science.1256014; Viana M. B, 2004, EUCALIPTO EFEITOS AM; Wagner FH, 2019, REMOTE SENSING ECOLO; Werneck FPdL, 1985, MEMORIA FUNDAC FAZEN, P57; Wieland LM, 2011, TROP CONSERV SCI, V4, P300, DOI 10.1177/194008291100400308; Wilson MFJ, 2007, MAR GEOD, V30, P3, DOI 10.1080/01490410701295962; World Resources Institute, 2005, MILL EC ASS EC HUM W; ZIMMERMAN JK, 1994, J ECOL, V82, P911, DOI 10.2307/2261454	51	17	18	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2020	15	2							e0229448	10.1371/journal.pone.0229448	http://dx.doi.org/10.1371/journal.pone.0229448			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8HR	32109946	Green Published, Green Submitted, gold			2022-12-26	WOS:000535239800013
J	Zhu, TF; Corraze, G; Plagnes-Juan, E; Skiba-Cassy, S				Zhu, Tengfei; Corraze, Genevieve; Plagnes-Juan, Elisabeth; Skiba-Cassy, Sandrine			Cholesterol metabolism regulation mediated by SREBP-2, LXR alpha and miR-33a in rainbow trout (Oncorhynchus mykiss) both in vivo and in vitro	PLOS ONE			English	Article							PLANT PROTEIN-SOURCES; SALMON SALMO-SALAR; DIETARY FISH-OIL; NUCLEAR RECEPTOR LXR; EUROPEAN SEA-BASS; TOTAL REPLACEMENT; LIPID-METABOLISM; GENE-EXPRESSION; TRANSCRIPTION FACTORS; MEAL REPLACEMENT	Cholesterol metabolism is greatly affected in fish fed plant-based diet. The regulation of cholesterol metabolism is mediated by both transcriptional factors such as sterol regulatory element-binding proteins (SREBPs) and liver X receptors (LXRs), and posttranscriptional factors including miRNAs. In mammals, SREBP-2 and LXR alpha are involved in the transcriptional regulation of cholesterol synthesis and elimination, respectively. In mammals, miR-33a is reported to directly target genes involved in cholesterol catabolism. The present study aims to investigate the regulation of cholesterol metabolism by SREBP-2 and LXR alpha and miR-33a in rainbow trout using in vivo and in vitro approaches. In vivo, juvenile rainbow trout of similar to 72 g initial body weight were fed a total plant-based diet (V) or a marine diet (M) containing fishmeal and fish oil. In vitro, primary cell culture hepatocytes were stimulated by graded concentrations of 25-hydroxycholesterol (25-HC). The hepatic expression of cholesterol synthetic genes, srebp-2 and miR-33a as well as miR-33a level in plasma were increased in fish fed the plant-based diet, reversely, their expression in hepatocytes were inhibited with the increasing 25-HC in vitro. However, lxr alpha was not affected neither in vivo nor in vitro. Our results suggest that SREBP-2 and miR-33a synergistically enhance the expression of cholesterol synthetic genes but do not support the involvement of LXR alpha in the regulation of cholesterol elimination. As plasma level of miR-33a appears as potential indicator of cholesterol synthetic capacities, this study also highlights circulating miRNAs as promising noninvasive biomarker in aquaculture.	[Zhu, Tengfei; Corraze, Genevieve; Plagnes-Juan, Elisabeth; Skiba-Cassy, Sandrine] Univ Pau & Pays Adour, INRA, E2S UPPA, UMR 1419,Nutr Metab Aquaculture, St Pee Sur Nivelle, France	INRAE; Universite de Pau et des Pays de l'Adour	Skiba-Cassy, S (corresponding author), Univ Pau & Pays Adour, INRA, E2S UPPA, UMR 1419,Nutr Metab Aquaculture, St Pee Sur Nivelle, France.	sandrine.skiba@inra.fr			China Scholarship Council (CSC) [201406330071]	China Scholarship Council (CSC)(China Scholarship Council)	T. Zhu gratefully acknowledges the financial assistance provided by the China Scholarship Council (CSC, File No. 201406330071) for his doctoral fellowship.	Adams CM, 2004, J BIOL CHEM, V279, P52772, DOI 10.1074/jbc.M410302200; Al-Hasani H, 2005, BEST PRACT RES CL EN, V19, P589, DOI 10.1016/j.beem.2005.07.005; Ali AA, 2004, J NUTR BIOCHEM, V15, P583, DOI 10.1016/j.jnutbio.2004.04.005; Allen RM, 2012, EMBO MOL MED, V4, P882, DOI 10.1002/emmm.201201228; AOAC, 2000, OFFICIAL METHODS ANA; Auboeuf D, 1997, DIABETES, V46, P1319, DOI 10.2337/diabetes.46.8.1319; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bell J. Gordon, 2008, P185, DOI 10.1007/978-1-4020-6810-2_6; Brown DA, 1998, ANNU REV CELL DEV BI, V14, P111, DOI 10.1146/annurev.cellbio.14.1.111; CHAPMAN MJ, 1980, J LIPID RES, V21, P789; Chawla A, 2001, SCIENCE, V294, P1866, DOI 10.1126/science.294.5548.1866; Corsten MF, 2010, CIRC-CARDIOVASC GENE, V3, P499, DOI 10.1161/CIRCGENETICS.110.957415; Costet P, 2000, J BIOL CHEM, V275, P28240; Dweep H, 2011, J BIOMED INFORM, V44, P839, DOI 10.1016/j.jbi.2011.05.002; Eberle D, 2004, BIOCHIMIE, V86, P839, DOI 10.1016/j.biochi.2004.09.018; Esau C, 2006, CELL METAB, V3, P87, DOI 10.1016/j.cmet.2006.01.005; Etheridge A, 2011, MUTAT RES-FUND MOL M, V717, P85, DOI 10.1016/j.mrfmmm.2011.03.004; EZEASOR DN, 1981, J FISH BIOL, V18, P527, DOI 10.1111/j.1095-8649.1981.tb03794.x; Fange R, 1979, DIGESTION FISH PHYSL, P162; FAO, 2016, CONTR FOOD SEC NUTR; Ferraris M, 2002, AQUAT TOXICOL, V59, P283, DOI 10.1016/S0166-445X(02)00007-3; Fox J, 2016, RCMDR R COMMANDER R; Friedman M, 1996, J AGR FOOD CHEM, V44, P6, DOI 10.1021/jf9400167; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Geay F, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-522; Gomez-Requeni P, 2004, AQUACULTURE, V232, P493, DOI 10.1016/S0044-8486(03)00532-5; Gu M, 2014, BRIT J NUTR, V111, P432, DOI 10.1017/S0007114513002717; HENDERSON RJ, 1987, PROG LIPID RES, V26, P281, DOI 10.1016/0163-7827(87)90002-6; Holick MF, 2007, NEW ENGL J MED, V357, P266, DOI 10.1056/NEJMra070553; Horton JD, 2002, J CLIN INVEST, V109, P1125, DOI 10.1172/JCI200215593; Iliopoulos D, 2010, J LIPID RES, V51, P1513, DOI 10.1194/jlr.M004812; Inui M, 2010, NAT REV MOL CELL BIO, V11, P252, DOI 10.1038/nrm2868; Ivey KN, 2010, CELL STEM CELL, V7, P36, DOI 10.1016/j.stem.2010.06.012; Janowski BA, 1999, P NATL ACAD SCI USA, V96, P266, DOI 10.1073/pnas.96.1.266; Janowski BA, 1996, NATURE, V383, P728, DOI 10.1038/383728a0; JOHNSON KA, 1994, J LIPID RES, V35, P2241; Jordal AEO, 2007, AQUACULT NUTR, V13, P114, DOI 10.1111/j.1365-2095.2007.00455.x; Kang MH, 2013, ARTERIOSCL THROM VAS, V33, P2724, DOI 10.1161/ATVBAHA.113.302004; Kaushik SJ, 2004, AQUACULTURE, V230, P391, DOI 10.1016/S0044-8486(03)00422-8; KAUSHIK SJ, 1995, AQUACULTURE, V133, P257, DOI 10.1016/0044-8486(94)00403-B; Kortner TM, 2013, BRIT J NUTR, V109, P593, DOI 10.1017/S0007114512002024; Krutzfeldt J, 2006, CELL METAB, V4, P9, DOI 10.1016/j.cmet.2006.05.009; Kumar V, 2011, FOOD CHEM TOXICOL, V49, P2144, DOI 10.1016/j.fct.2011.05.029; Laterza OF, 2009, CLIN CHEM, V55, P1977, DOI 10.1373/clinchem.2009.131797; Leaver MJ, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-299; Lee SH, 2007, NUTR RES, V27, P505, DOI 10.1016/j.nutres.2007.05.003; Lehmann JM, 1997, J BIOL CHEM, V272, P3137, DOI 10.1074/jbc.272.6.3137; Li TG, 2013, HEPATOLOGY, V58, P1111, DOI 10.1002/hep.26427; Ma YJ, 2008, AM J PHYSIOL-ENDOC M, V295, pE1369, DOI 10.1152/ajpendo.90555.2008; Marquart TJ, 2010, P NATL ACAD SCI USA, V107, P12228, DOI 10.1073/pnas.1005191107; Mennigen JA, 2013, J EXP BIOL, V216, P1597, DOI 10.1242/jeb.082248; Mommsen Thomas P., 1994, Biochemistry and Molecular Biology of Fishes, V3, P355; Morais S, 2011, BRIT J NUTR, V106, P1457, DOI 10.1017/S0007114511001954; Najafi-Shoushtari SH, 2010, SCIENCE, V328, P1566, DOI 10.1126/science.1189123; National Research Council, 2011, NUTR REQ FISH SHRIMP; Panserat S, 2009, AQUACULTURE, V294, P123, DOI 10.1016/j.aquaculture.2009.05.013; Rasal KD, 2016, REV FISH BIOL FISHER, V26, P199, DOI 10.1007/s11160-016-9421-6; Regost C, 1999, AQUACULTURE, V180, P99, DOI 10.1016/S0044-8486(99)00026-5; Repa JJ, 2000, ANNU REV CELL DEV BI, V16, P459, DOI 10.1146/annurev.cellbio.16.1.459; Repa JJ, 2002, J BIOL CHEM, V277, P18793, DOI 10.1074/jbc.M109927200; Repa JJ, 2000, SCIENCE, V289, P1524, DOI 10.1126/science.289.5484.1524; Richard N, 2006, BRIT J NUTR, V96, P299, DOI 10.1079/BJN20061821; Robaina L, 1999, AQUACULTURE, V179, P45, DOI 10.1016/S0044-8486(99)00151-9; Russell DW, 2003, ANNU REV BIOCHEM, V72, P137, DOI 10.1146/annurev.biochem.72.121801.161712; SASTRY K V, 1976, Zeitschrift fuer Mikroskopisch-Anatomische Forschung (Leipzig), V90, P1032; Schroepfer GJ, 2000, PHYSIOL REV, V80, P361, DOI 10.1152/physrev.2000.80.1.361; Segner H, 1998, COMP BIOCHEM PHYS A, V120, P71, DOI 10.1016/S1095-6433(98)10012-0; Seiliez I, 2011, AM J PHYSIOL-REG I, V300, pR733, DOI 10.1152/ajpregu.00579.2010; Shimano H, 2001, PROG LIPID RES, V40, P439, DOI 10.1016/S0163-7827(01)00010-8; Sitja-Bobadilla A, 2005, AQUACULTURE, V249, P387, DOI 10.1016/j.aquaculture.2005.03.031; Soifer HS, 2007, MOL THER, V15, P2070, DOI 10.1038/sj.mt.6300311; Su ZY, 2015, ONCOTARGET, V6, P8474, DOI 10.18632/oncotarget.3523; SUGANO M, 1990, J NUTR, V120, P977, DOI 10.1093/jn/120.9.977; Tabas I, 2002, J CLIN INVEST, V110, P583, DOI 10.1172/JCI200216381; Tay J W, 2017, BMC Res Notes, V10, P312, DOI 10.1186/s13104-017-2636-3; Tocher DR, 2008, AQUACULTURE, V280, P21, DOI 10.1016/j.aquaculture.2008.04.034; Vanstone CA, 2002, AM J CLIN NUTR, V76, P1272, DOI 10.1093/ajcn/76.6.1272; Venou B, 2006, AQUACULTURE, V261, P343, DOI 10.1016/j.aquaculture.2006.07.030; Wang YH, 2015, NAT REV MOL CELL BIO, V16, P678, DOI 10.1038/nrm4074; Wienholds E, 2005, FEBS LETT, V579, P5911, DOI 10.1016/j.febslet.2005.07.070; Yekta S, 2004, SCIENCE, V304, P594, DOI 10.1126/science.1097434; Yu LQ, 2003, J BIOL CHEM, V278, P15565, DOI 10.1074/jbc.M301311200; Zhang Y, 2001, J BIOL CHEM, V276, P43018, DOI 10.1074/jbc.M107823200; Zhu TF, 2018, AM J PHYSIOL-REG I, V314, pR58, DOI 10.1152/ajpregu.00179.2017	86	9	9	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2020	15	2							e0223813	10.1371/journal.pone.0223813	http://dx.doi.org/10.1371/journal.pone.0223813			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8HR	32109243	Green Published, gold			2022-12-26	WOS:000535239800001
J	Li, XH; Vance, GM; Cartwright, J; Cao, JP; Wilson, RA; Castro-Borges, W				Li, Xiao-Hong; Vance, Gillian M.; Cartwright, Jared; Cao, Jian-Ping; Wilson, R. Alan; Castro-Borges, William			Mapping the epitopes of Schistosoma japonicum esophageal gland proteins for incorporation into vaccine constructs	PLOS ONE			English	Article							PROTEOMIC ANALYSIS; MANSONI INFECTION; TEGUMENT SURFACE; PROTECTION; BABOONS	Background The development of a schistosome vaccine has proved challenging but we have suggested that characterisation of the self-cure mechanism in rhesus macaques might provide a route to an effective product. The schistosome esophagus is a complex structure where blood processing is initiated by secretions from anterior and posterior glands, achieved by a mixture of similar to 40 unique proteins. The mechanism of self-cure in macaques involves cessation of feeding, after which worms slowly starve to death. Antibody coats the esophagus lumen and disrupts the secretory processes from the glands, potentially making their secretions ideal vaccine targets. Methodology/Principal findings We have designed three peptide arrays comprising overlapping 15-mer peptides encompassing 32 esophageal gland proteins, and screened them for reactivity against 22-week infection serum from macaques versus permissive rabbit and mouse hosts. There was considerable intra- and inter-species variation in response and no obvious unique target was associated with self-cure status, which suggests that self-cure is achieved by antibodies reacting with multiple targets. Some immuno-dominant sequences/regions were evident across species, notably including: MEGs 4.1C, 4.2, and 11 (Array 1); MEG-12 and Aspartyl protease (Array 2); a Tetraspanin 1 loop and MEG-n2 (Array 3). Responses to MEGs 8.1C and 8.2C were largely confined to macaques. As proof of principle, three synthetic genes were designed, comprising several key targets from each array. One of these was expressed as a recombinant protein and used to vaccinate rabbits. Higher antibody titres were obtained to the majority of reactive regions than those elicited after prolonged infection. Conclusions/Significance It is feasible to test simultaneously the additive potential of multiple esophageal proteins to induce protection by combining their most reactive regions in artificial constructs that can be used to vaccinate suitable hosts. The efficacy of the approach to disrupt esophageal function now needs to be tested by a parasite challenge.	[Li, Xiao-Hong; Cao, Jian-Ping] Chinese Ctr Dis Control & Prevent, Natl Inst Parasit Dis, Shanghai, Peoples R China; [Vance, Gillian M.; Wilson, R. Alan] Univ York, Ctr Immunol & Infect, Dept Biol, York, N Yorkshire, England; [Cartwright, Jared] Univ York, Dept Biol, Prot Prod Lab, York, N Yorkshire, England; [Castro-Borges, William] Univ Fed Ouro Preto, Dept Ciencias Biol, Campus Morro Cruzeiro, Ouro Preto, MG, Brazil	Chinese Center for Disease Control & Prevention; National Institute of Parasitic Diseases, Chinese Center for Disease Control & Prevention; University of York - UK; University of York - UK; Universidade Federal de Ouro Preto	Cao, JP (corresponding author), Chinese Ctr Dis Control & Prevent, Natl Inst Parasit Dis, Shanghai, Peoples R China.; Wilson, RA (corresponding author), Univ York, Ctr Immunol & Infect, Dept Biol, York, N Yorkshire, England.	caojp@yahoo.com; alan.wilson@york.ac.uk	Castro-Borges, William/GLR-8712-2022; Cao, Jianping/AFL-5468-2022	Cao, Jianping/0000-0002-1974-0047; Wilson, Alan/0000-0002-7210-0321	funds for Natural Science Foundation of Shanghai [15ZR1444300]; CAPES [170/2012]; Newton Fund grant, through the BBSRC/Fapemig joint initiative [APQ-00829-15]	funds for Natural Science Foundation of Shanghai; CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Newton Fund grant, through the BBSRC/Fapemig joint initiative(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	XHL received funds for Natural Science Foundation of Shanghai (Grant No. 15ZR1444300. http://www.stcsm.gov.cn/sj/app.htm).WCB received funds from CAPES (Special Visiting Reseacher Program) Grant 170/2012, that enabled RAW to work in his laboratory (http://www.capes.gov.br) and a Newton Fund grant, APQ-00829-15, through the BBSRC/Fapemig joint initiative, held with Dr. Peter Ashton, University of York and Prof. R Beynon, Liverpool University (http://www.newtonfund.ac.uk).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Braschi S, 2006, PROTEOMICS, V6, P1471, DOI 10.1002/pmic.200500368; Braschi S, 2006, MOL CELL PROTEOMICS, V5, P347, DOI 10.1074/mcp.M500287-MCP200; Buus S, 2012, MOL CELL PROTEOMICS, V11, P1790, DOI 10.1074/mcp.M112.020800; Castro-Borges W, 2011, J PROTEOMICS, V74, P1519, DOI 10.1016/j.jprot.2011.06.011; Castro-Borges W, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000993; CHEEVER AW, 1972, B WORLD HEALTH ORGAN, V46, P301; Colley DG, 2017, INFECT DIS POVERTY, V6, DOI 10.1186/s40249-017-0275-5; Coulson PS, 1997, ADV PARASIT, V39, P271, DOI 10.1016/S0065-308X(08)60048-2; Curwen RS, 2006, MOL CELL PROTEOMICS, V5, P835, DOI 10.1074/mcp.M500313-MCP200; Fenwick A, 2017, T ROY SOC TROP MED H, V111, P191, DOI 10.1093/trstmh/trx036; Fogg MJ, 2008, BIOCHEM SOC T, V36, P771, DOI 10.1042/BST0360771; Gaze S, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004033; Guan J, 2017, VIRUSES-BASEL, V9, DOI 10.3390/v9120374; Hall SL, 2011, MOL BIOCHEM PARASIT, V179, P18, DOI 10.1016/j.molbiopara.2011.05.002; He YX, 1990, SCHISTOSOME BIOL CON, P198; Hewitson JP, 2014, EXPERT REV VACCINES, V13, P473, DOI 10.1586/14760584.2014.893195; Hotez PJ, 2019, TRENDS PARASITOL, V35, P104, DOI 10.1016/j.pt.2018.10.005; Hotez PJ, 2016, ANNU REV MED, V67, P405, DOI 10.1146/annurev-med-051214-024241; Li XH, 2016, SCHISTOSOMA BIOL PAT, P523; Li XH, 2014, PARASITE VECTOR, V7, DOI 10.1186/s13071-014-0565-8; Li XH, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006235; Li XH, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003925; Li XH, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002337; LIU C, 1950, B JOHNS HOPKINS HOSP, V86, P215; MELENEY HE, 1954, EXP PARASITOL, V3, P128, DOI 10.1016/0014-4894(54)90003-X; Mulvenna J, 2010, INT J PARASITOL, V40, P543, DOI 10.1016/j.ijpara.2009.10.002; Naik AS, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175349; Ogongo P, 2018, PARASITOLOGY, V145, P1355, DOI 10.1017/S0031182018000240; Ortu G, 2017, AM J TROP MED HYG, V96, P664, DOI 10.4269/ajtmh.16-0671; Pearson MS, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00213; Philippsen GS, 2015, GENOME BIOL EVOL, V7, P431, DOI 10.1093/gbe/evu287; Riveau G, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006968; Siddiqui AA, 2017, TRENDS PARASITOL, V33, P194, DOI 10.1016/j.pt.2016.10.010; SMITHERS SR, 1965, PARASITOLOGY, V55, P701, DOI 10.1017/S003118200008625X; Stylianou A, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-017-2227-0; Tajiri K, 2015, WORLD J GASTROENTERO, V21, P7074, DOI 10.3748/wjg.v21.i23.7074; van Grootveld R, 2018, EUR J CLIN MICROBIOL, V37, P1709, DOI 10.1007/s10096-018-3303-x; Verity CK, 2001, PARASITOLOGY, V122, P415, DOI 10.1017/S0031182001007521; VOGEL H, 1953, Z Tropenmed Parasitol, V4, P418; Wilson RA, 2017, EMERG TOP LIFE SCI, V1, P641, DOI 10.1042/ETLS20170094; Wilson RA, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1369-9; Wilson RA, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004272; Wilson RA, 2012, PARASITOLOGY, V139, P1178, DOI 10.1017/S0031182012000339; Wilson RA, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000290; Zhang WD, 2018, ANN NY ACAD SCI, V1425, P38, DOI 10.1111/nyas.13942; Zhang WD, 2010, J INFECT DIS, V201, P1105, DOI 10.1086/651147	46	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2020	15	2							e0229542	10.1371/journal.pone.0229542	http://dx.doi.org/10.1371/journal.pone.0229542			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8GQ	32107503	Green Published, gold			2022-12-26	WOS:000535237000040
J	Maestre, L; Garcia-Garcia, JF; Jimenez, S; Reyes-Garcia, AI; Garcia-Gonzalez, A; Montes-Moreno, S; Arribas, AJ; Gonzalez-Garcia, P; Caleiras, E; Banham, AH; Piris, MA; Roncador, G				Maestre, Lorena; Fernando Garcia-Garcia, Juan; Jimenez, Scherezade; Isabel Reyes-Garcia, Ana; Garcia-Gonzalez, Alvaro; Montes-Moreno, Santiago; Arribas, Alberto J.; Gonzalez-Garcia, Patricia; Caleiras, Eduardo; Banham, Alison H.; Angel Piris, Miguel; Roncador, Giovanna			High-mobility group box (TOX) antibody a useful tool for the identification of B and T cell subpopulations	PLOS ONE			English	Article							C-MYC; LYMPHOMA; EXPRESSION; MARKER	Thymocyte selection-associated high-mobility group box (TOX) is a DNA-binding factor that is able to regulate transcription by modifying local chromatin structure and modulating the formation of multi-protein complexes. TOX has multiple roles in the development of the adaptive immune system including development of CD4 T cells, NK cells and lymph node organogenesis. However very few antibodies recognizing this molecule have been reported and no extensive study of the expression of TOX in reactive and neoplastic lymphoid tissue has been performed to date. In the present study, we have investigated TOX expression in normal and neoplastic lymphoid tissues using a novel rat monoclonal antibody that recognizes its target molecule in paraffin-embedded tissue sections. A large series of normal tissues and B- and T-cell lymphomas was studied, using whole sections and tissue microarrays. We found that the majority of precursor B/T lymphoblastic, follicular and diffuse large B-cell lymphomas, nodular lymphocyte-predominant Hodgkin lymphomas and angioimmunoblastic T-cell lymphomas strongly expressed the TOX protein. Burkitt and mantle cell lymphomas showed TOX expression in a small percentage of cases. TOX was not found in the majority of chronic lymphocytic leukemia, myelomas, marginal zone lymphomas and classical Hodgkin lymphomas. In conclusion, we describe for the first time the expression of TOX in normal and neoplastic lymphoid tissues. The co-expression of TOX and PD-1 identified in normal and neoplastic T cells is consistent with recent studies identifying TOX as a critical regulator of T-cell exhaustion and a potential immunotherapy target. Its differential expression may be of diagnostic relevance in the differential diagnosis of follicular lymphoma, the identification of the phenotype of diffuse large B-cell lymphoma and the recognition of peripheral T-cell lymphoma with a follicular helper T phenotype.	[Maestre, Lorena; Jimenez, Scherezade; Isabel Reyes-Garcia, Ana; Garcia-Gonzalez, Alvaro; Roncador, Giovanna] CNIO, Monoclonal Antibodies Core Unit, Madrid, Spain; [Fernando Garcia-Garcia, Juan] MD Anderson Canc Ctr Madrid, Dept Pathol, Madrid, Spain; [Montes-Moreno, Santiago] Hosp Univ Marques de Valdecilla, Pathol Dept, Santander, Spain; [Arribas, Alberto J.] Univ Svizzera Italiana, Inst Oncol Res, Bellinzona, Switzerland; [Gonzalez-Garcia, Patricia; Caleiras, Eduardo] CNIO, Histopathol Core Unit, Madrid, Spain; [Banham, Alison H.] Univ Oxford, Radcliffe Dept Med, Nuffield Div Clin Lab Sci, Oxford, England; [Angel Piris, Miguel] Fdn Jimenez Diaz, CIBERONC, Dept Pathol, Madrid, Spain	Centro Nacional de Investigaciones Oncologicas (CNIO); University of Texas System; UTMD Anderson Cancer Center; Hospital Universitario Marques de Valdecilla (HUMV); Institute of Oncology Research (IOR); Universita della Svizzera Italiana; Centro Nacional de Investigaciones Oncologicas (CNIO); University of Oxford; CIBER - Centro de Investigacion Biomedica en Red; CIBERONC	Roncador, G (corresponding author), CNIO, Monoclonal Antibodies Core Unit, Madrid, Spain.	groncador@cnio.es	Montes-Moreno, Santiago/E-7008-2011; Maestre, Lorena/L-1352-2014	Montes-Moreno, Santiago/0000-0002-3565-8262; Maestre, Lorena/0000-0001-8743-0422; Piris, Miguel A/0000-0001-5839-3634; Caleiras, Eduardo/0000-0001-8768-3630	Plan Nacional de I+D+I; Fondo Europeo de Desarrollo Regional (FEDER); Programs of R&D activities among research groups of the Community of Madrid in Biomedicine [B2017/BMD-3778]; ISCIII-Subdireccion General de Evaluacion;  [CIBERONC -CB16/12/00291]	Plan Nacional de I+D+I; Fondo Europeo de Desarrollo Regional (FEDER)(European Commission); Programs of R&D activities among research groups of the Community of Madrid in Biomedicine; ISCIII-Subdireccion General de Evaluacion; 	This work was supported by grants from the Plan Nacional de I+D+I, co-financed by the ISCIII-Subdireccion General de Evaluacion and the Fondo Europeo de Desarrollo Regional (FEDER), CIBERONC -CB16/12/00291 (MAP), and Programs of R&D activities among research groups of the Community of Madrid in Biomedicine (B2017/BMD-3778) (MAP, GR, JFGG). All funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfei F, 2019, NATURE, V571, P265, DOI 10.1038/s41586-019-1326-9; Aliahmad P, 2008, J EXP MED, V205, P245, DOI 10.1084/jem.20071944; Aliahmad P, 2010, NAT IMMUNOL, V11, P945, DOI 10.1038/ni.1930; Arribas AJ, 2013, MODERN PATHOL, V26, P889, DOI 10.1038/modpathol.2012.220; Arribas Alberto J, 2012, Blood, V119, pe9, DOI 10.1182/blood-2011-02-339556; Braggio E, 2015, CLIN CANCER RES, V21, P3986, DOI 10.1158/1078-0432.CCR-14-2116; Bustin M, 1999, MOL CELL BIOL, V19, P5237; Chang CC, 2003, ARCH PATHOL LAB MED, V127, P208; Cheng Jing, 2008, Chinese Journal of Pathology, V37, P384; Davis RE, 2001, J EXP MED, V194, P1861, DOI 10.1084/jem.194.12.1861; Dulmage BO, 2015, ONCOTARGET; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Hans CP, 2004, BLOOD, V103, P275, DOI 10.1182/blood-2003-05-1545; Huang YS, 2015, BLOOD, V125, P1435, DOI 10.1182/blood-2014-05-571778; Huang YS, 2014, ONCOTARGET, V5, P4418, DOI 10.18632/oncotarget.2031; Kanellis G, 2009, LEUKEMIA, V23, P1847, DOI 10.1038/leu.2009.108; Khan O, 2019, NATURE, V571, P211, DOI 10.1038/s41586-019-1325-x; Li XM, 2017, PATHOL RES PRACT, V213, P659, DOI 10.1016/j.prp.2017.02.012; Mandelbaum J, 2010, CANCER CELL, V18, P568, DOI 10.1016/j.ccr.2010.10.030; Montes-Moreno S, 2008, BLOOD, V111, P351, DOI 10.1182/blood-2007-06-094151; Morimura S, 2014, ARCH DERMATOL RES, V306, P843, DOI 10.1007/s00403-014-1501-7; Natkunam Y, 2007, BLOOD, V109, P1636, DOI 10.1182/blood-2006-08-039024; O'Flaherty E, 2003, BMC GENOMICS, V4, DOI 10.1186/1471-2164-4-13; Reimand J, 2019, NAT PROTOC, V14, P482, DOI 10.1038/s41596-018-0103-9; Schmitz R, 2018, NEW ENGL J MED, V378, P1396, DOI 10.1056/NEJMoa1801445; Schrader AMR, 2016, BRIT J DERMATOL, V175, P382, DOI 10.1111/bjd.14508; Schrader AMR, 2016, ARCH DERMATOL RES, V308, P423, DOI 10.1007/s00403-016-1654-7; Scott AC, 2019, NATURE, V571, P270, DOI 10.1038/s41586-019-1324-y; Seo H, 2019, P NATL ACAD SCI USA, V116, P12410, DOI 10.1073/pnas.1905675116; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tessema TB, 2012, ECO MONT, V4, P13, DOI 10.1553/eco.mont-4-2s13; Torres-Ruiz R, 2017, STEM CELL REP, V8, P1408, DOI 10.1016/j.stemcr.2017.04.014; Wang XC, 2019, J HEPATOL, V71, P731, DOI 10.1016/j.jhep.2019.05.015; Wilkinson B, 2002, NAT IMMUNOL, V3, P272, DOI 10.1038/ni767; Yao C, 2019, NAT IMMUNOL, V20, P890, DOI 10.1038/s41590-019-0403-4; Yun S, 2011, IMMUNOL LETT, V136, P29, DOI 10.1016/j.imlet.2010.11.008	36	6	6	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2020	15	2							e0229743	10.1371/journal.pone.0229743	http://dx.doi.org/10.1371/journal.pone.0229743			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8GQ	32106280	gold, Green Published			2022-12-26	WOS:000535237000068
J	Taylor, HB; Kurtz, HD				Taylor, Harrison B.; Kurtz, Harry D., Jr.			Microbial community structure shows differing levels of temporal stability in intertidal beach sands of the grand strand region of South Carolina	PLOS ONE			English	Article							BACTERIAL DIVERSITY; SEQUENCE DATA; ABUNDANCE; SEDIMENT; WATER; PHYTOPLANKTON; DISTURBANCE; DYNAMICS; BASIN; CYCLE	Studies of microbial community structure in intertidal and supratidal beach sands along the California and Gulf of Mexico coasts have begun to reveal geographical patterns in microbial diversity through the use of next generation sequencing technology. Only a few studies have targeted communities along the Eastern seaboard, leaving a variety of microbial ecosystems uncharacterized. In this study, we examine the microbial community structure within three South Carolina beaches along the Grand Strand via sequencing of the V4 region of the 16S rRNA gene to discern relationships between diversity and temporal or regional factors. Gammaproteobacteria, Planctomycetes, Acidobacteria, and Actinobacteria dominated the composition of these beaches. Diversity analyses revealed that highly diverse communities were similar in overall composition and diversity but showed different levels of community structure stability over time. The community structure in Pawleys Island sands showed no significant change over time, while Garden City experienced significant shifts between each sampling date. Community structure also differed between beaches and, to a lesser degree, sampling date. These data provide evidence of the high microbial diversity within these beach sands and suggest that even though beaches of the same geographic region can show similarity in composition and diversity at a particular timepoint, the nature of their community structure and underlying diversity may differ comparatively and over time.	[Taylor, Harrison B.; Kurtz, Harry D., Jr.] Clemson Univ, Dept Biol Sci, Clemson, SC 29634 USA; [Taylor, Harrison B.] Med Univ South Carolina, Dept Microbiol & Immunol, Charleston, SC 29425 USA	Clemson University; Medical University of South Carolina	Kurtz, HD (corresponding author), Clemson Univ, Dept Biol Sci, Clemson, SC 29634 USA.	hkurtz@clemson.edu	Taylor, Harrison/ABH-2548-2020	Taylor, Harrison/0000-0002-0369-789X	Creative Inquiry Program at Clemson University; Department of Biological Sciences at Clemson University	Creative Inquiry Program at Clemson University; Department of Biological Sciences at Clemson University	We would like to thank the Creative Inquiry Program and the Department of Biological Sciences at Clemson University for financially supporting this work.	Abarca E, 2013, WATER RESOUR RES, V49, P2473, DOI 10.1002/wrcr.20075; Ager D, 2010, ENVIRON MICROBIOL, V12, P670, DOI 10.1111/j.1462-2920.2009.02107.x; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; AZOV Y, 1986, J PLANKTON RES, V8, P41, DOI 10.1093/plankt/8.1.41; Boer SI, 2009, ISME J, V3, P780, DOI 10.1038/ismej.2009.29; Boehm AB, 2014, APPL ENVIRON MICROB, V80, P3943, DOI 10.1128/AEM.00513-14; Bolyen E, 2018, PEERJ PREPRINTS; Boras JA, 2015, ESTUAR COAST SHELF S, V154, P102, DOI 10.1016/j.ecss.2014.12.039; Campbell BJ, 2011, P NATL ACAD SCI USA, V108, P12776, DOI 10.1073/pnas.1101405108; Clarke A, 1996, LIMNOL OCEANOGR, V41, P1281, DOI 10.4319/lo.1996.41.6.1281; Crossett K., 2013, NATL COASTAL POPULAT; Cui HL, 2013, APPL ENVIRON MICROB, V79, P3601, DOI 10.1128/AEM.00135-13; DEFLAUN MF, 1983, LIMNOL OCEANOGR, V28, P873, DOI 10.4319/lo.1983.28.5.0873; Delgado-Baquerizo M, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10541; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; EXCOFFIER L, 1992, GENETICS, V131, P479; FAITH DP, 1992, BIOL CONSERV, V61, P1, DOI 10.1016/0006-3207(92)91201-3; Feng BW, 2009, FEMS MICROBIOL ECOL, V70, P236, DOI 10.1111/j.1574-6941.2009.00772.x; Feng F, 2010, FEMS MICROBIOL ECOL, V74, P214, DOI 10.1111/j.1574-6941.2010.00921.x; Finlay BJ, 1997, OIKOS, V80, P209, DOI 10.2307/3546587; Gerhardt P., 1994, METHODS GEN MOL BACT; Gilbert JA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015545; Gobet A, 2014, ENVIRON MICROBIOL, V16, P2672, DOI 10.1111/1462-2920.12308; Gobet A, 2012, ISME J, V6, P542, DOI 10.1038/ismej.2011.132; Graham EB, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00214; Griffiths BS, 2000, OIKOS, V90, P279, DOI 10.1034/j.1600-0706.2000.900208.x; Grote J, 2012, P NATL ACAD SCI USA, V109, P506, DOI 10.1073/pnas.1111262109; Halliday E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090815; Han YC, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00989; Hansen M, 2015, ISME J, V9, P696, DOI 10.1038/ismej.2014.173; Hu AY, 2019, MICROORGANISMS, V7, DOI 10.3390/microorganisms7120598; Ivanova EP, 2004, SYST APPL MICROBIOL, V27, P301, DOI 10.1078/0723-2020-00269; Jochum LM, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.02038; Kartal B, 2006, J BIOTECHNOL, V126, P546, DOI 10.1016/j.jbiotec.2006.05.012; Kindt R., 2005, WORLD; Kostka JE, 2011, APPL ENVIRON MICROB, V77, P7962, DOI 10.1128/AEM.05402-11; Kozich JJ, 2013, APPL ENVIRON MICROB, V79, P5112, DOI 10.1128/AEM.01043-13; Ladau J, 2013, ISME J, V7, P1669, DOI 10.1038/ismej.2013.37; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; MAGURRAN A. E., 2004, MEASURING BIOLOGICAL; Musat N, 2006, SYST APPL MICROBIOL, V29, P333, DOI 10.1016/j.syapm.2005.12.006; Mussmann M, 2017, ISME J, V11, P1276, DOI 10.1038/ismej.2016.185; Newton RJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074265; Office for Coastal Management, 2018, NOAA REP US OC GREAT; Probandt D, 2018, ISME J, V12, P623, DOI 10.1038/ismej.2017.197; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; R Studio Team, 2015, RSTUDIO INT DEV R; Rogers DR, 2010, APPL ENVIRON MICROB, V76, P7938, DOI 10.1128/AEM.02056-09; Romao D, 2017, MAR POLLUT BULL, V119, P351, DOI 10.1016/j.marpolbul.2017.04.036; Schloss PD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027310; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Silveira CB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076321; Staley C, 2016, APPL ENVIRON MICROB, V69, P6447; Whitman RL, 2014, REV ENVIRON SCI BIO, V13, P329, DOI 10.1007/s11157-014-9340-8; Yamahara KM, 2012, APPL ENVIRON MICROB, V78, P1733, DOI 10.1128/AEM.06185-11; Yannarell AC, 2007, ENVIRON MICROBIOL, V9, P576, DOI 10.1111/j.1462-2920.2006.01173.x; Yue JC, 2005, COMMUN STAT-THEOR M, V34, P2123, DOI 10.1080/STA-200066418	57	1	1	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2020	15	2							e0229387	10.1371/journal.pone.0229387	http://dx.doi.org/10.1371/journal.pone.0229387			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8GQ	32106250	Green Published, Green Submitted, gold			2022-12-26	WOS:000535237000028
J	Valberg, SJ; Matsui, AKB; Firshman, AM; Bookbinder, L; Katzman, SA; Finno, CJ				Valberg, Stephanie J.; Matsui, Amanda K. Borer; Firshman, Anna M.; Bookbinder, Lauren; Katzman, Scott A.; Finno, Carrie J.			3 Dimensional photonic scans for measuring body volume and muscle mass in the standing horse	PLOS ONE			English	Article							GENERALIZED EQUATIONS; FAT	Reasons for performing study Although muscle mass strongly influences performance, there is currently no effective means to measure the 3-dimensional muscle mass of horses. We evaluated a 3-dimensional (3D) scanning methodology for its ability to quantify torso and hindquarter volumes as a proxy for regional muscle mass in horses. Objectives Determine the repeatability of 3D scanning volume (V) measurements and their correlation to body weight, estimated body volume and muscle/fat ultrasound (US) depth. Methods Handheld 3D photonic scans were performed on 16 Quarter Horses of known body weight 56 days apart (n = 32 scans) with each scan performed in duplicate (n = 32 replicates). Tail head fat, gluteal and longissimus dorsi muscle depths were measured using US. Processed scans were cropped to isolate hindquarter (above hock, caudal to tuber coxae) and torso (hindquarter plus dorsal thoracolumbar region) segments and algorithms used to calculate V. Torso and hindquarter volume were correlated with body weight and US using Pearson's correlation and with estimated torso volume (50% body weight / body density) with BlandAltman analysis. Results Scans took 2 min with < 3.5% error for duplicate scans. Torso volume (R = 0.90, P< 0.001) and hindquarter volume (R = 0.82, P< 0.001) strongly correlated with body weight and estimated BV (R = 0.91) with low bias. Torso volume moderately correlated to mean muscle US depth (R = 0.4, P< 0.05) and tail head fat (R = 0.42, P< 0.01). Mean muscle US depth moderately correlated to body weight (R = 0.50, P< 0.01). Main limitations 3D Scans determine body volume not muscle volume. Conclusions The hand-held 3D scan provided a rapid repeatable assessment of torso and hindquarter volume strongly correlated to body weight and estimated volume. Superimposition of regional scans and volume measures could provide a practical means to follow muscle development when tail head fat depth remain constant.	[Valberg, Stephanie J.; Matsui, Amanda K. Borer; Bookbinder, Lauren] Michigan State Univ, McPhail Equine Performance Ctr, Dept Large Anim Clin Sci, E Lansing, MI 48824 USA; [Firshman, Anna M.] Univ Minnesota, Coll Vet Med, Dept Vet Populat Med, St Paul, MN 55108 USA; [Katzman, Scott A.] Univ Calif Davis, Dept Surg & Radiol Sci, Davis, CA 95616 USA; [Finno, Carrie J.] Univ Calif Davis, Dept Populat Hlth & Reprod, Davis, CA 95616 USA	Michigan State University; University of Minnesota System; University of Minnesota Twin Cities; University of California System; University of California Davis; University of California System; University of California Davis	Valberg, SJ (corresponding author), Michigan State Univ, McPhail Equine Performance Ctr, Dept Large Anim Clin Sci, E Lansing, MI 48824 USA.	valbergs@cvm.msu.edu		Valberg, Stephanie/0000-0001-5978-7010	Endowment of the Mary Anne McPhail Dressage Chair in Equine Sports Medicine; Michigan State University; Freeman Fund for Equine Research; University of California Center for Equine Health	Endowment of the Mary Anne McPhail Dressage Chair in Equine Sports Medicine; Michigan State University; Freeman Fund for Equine Research; University of California Center for Equine Health	Endowment of the Mary Anne McPhail Dressage Chair in Equine Sports Medicine (SJV), Michigan State University, Freeman Fund for Equine Research, Michigan State University (SJV) and University of California Center for Equine Health (CJF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler C, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180201; BROZEK J, 1963, ANN NY ACAD SCI, V110, P113, DOI 10.1111/j.1749-6632.1963.tb17079.x; Dugdale AHA, 2011, EQUINE VET J, V43, P552, DOI 10.1111/j.2042-3306.2010.00330.x; Graham-Thiers PM, 2005, J ANIM SCI, V83, P2783; Gunn H. M., 1987, Equine exercise physiology 2., P253; JACKSON A, 1978, MED SCI SPORT EXER, V10, P47; JACKSON AS, 1978, BRIT J NUTR, V40, P497, DOI 10.1079/BJN19780152; Kane R.A., 1987, P 10 EQ NUTR PHYS S, P127; Karlsson A, 2015, J MAGN RESON IMAGING, V41, P1558, DOI 10.1002/jmri.24726; Kearns CF, 2002, VET J, V164, P224, DOI 10.1053/tvjl.2001.0702; Lee SY, 2008, CURR OPIN CLIN NUTR, V11, P566, DOI 10.1097/MCO.0b013e32830b5f23; Lindner A, 2010, J EQUINE VET SCI, V30, P635, DOI 10.1016/j.jevs.2010.10.007; Pandis P, 2017, P I MECH ENG H, V231, P1064, DOI 10.1177/0954411917727031; Payne RC, 2005, J ANAT, V206, P557, DOI 10.1111/j.1469-7580.2005.00420.x; Schranz N, 2012, J SPORT SCI, V30, P1241, DOI 10.1080/02640414.2012.696204; Valberg S.J.B., 2018, COMP EXERCISE PHYSL, V14, pS25; Wells JCK, 2008, INT J OBESITY, V32, P232, DOI 10.1038/sj.ijo.0803727; WESTERVELT RG, 1976, J ANIM SCI, V43, P781, DOI 10.2527/jas1976.434781x	18	3	3	4	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2020	15	2							e0229656	10.1371/journal.pone.0229656	http://dx.doi.org/10.1371/journal.pone.0229656			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8GQ	32106234	Green Published, Green Submitted, gold			2022-12-26	WOS:000535237000055
J	Yoshida, Y; Takaku, Y; Nakamoto, Y; Takayanagi, N; Yanagisawa, T; Takizawa, H; Kurashima, K				Yoshida, Yuki; Takaku, Yotaro; Nakamoto, Yasuo; Takayanagi, Noboru; Yanagisawa, Tsutomu; Takizawa, Hajime; Kurashima, Kazuyoshi			Changes in airway diameter and mucus plugs in patients with asthma exacerbation	PLOS ONE			English	Article							FLOW LIMITATION; DIMENSIONS; DISEASE; DYSFUNCTION; PATHOLOGY; SPUTUM	Background Airway obstruction due to decreased airway diameter and increased incidence of mucus plugs has not been directly observed in asthma exacerbation. We studied the changes in the inner diameter of the airway (Din) and the frequency of mucus plugs by airway generation in patients with asthma exacerbation. We compared these patients to those in a stable phase using high-resolution computed tomography (HRCT). Methods and findings Thirteen patients with asthma were studied by HRCT during asthma exacerbation and in a stable period. The HRCT study was performed on patients who could safely hold their breath for a short while in a supine position 1 hour after initial treatment for asthma exacerbation. Using a curved multiplanar reconstruction (MPR) software, we reconstructed the longitudinal airway images and the images exactly perpendicular to the airway axis to measure the Din and mucus plugs from the second-(segmental) to sixth-generation bronchi in all segments of the lungs.The ratios of Din (exacerbation/stable) were 0.91(P = 0.016), 0.88 (P = 0.002), 0.83 (P = 0.001), 0.80 (P = 0.001), and 0.87 (NS) in the second-, third-, fourth-, fifth-, and sixth-generation bronchi, respectively. The percentages of airway obstruction due to mucus plugs were notably higher in the fourth-and fifth-generation bronchi (17.9%/18.1% in stable phase and 43.2%/45.9% in the exacerbation phase, respectively) than in the other generations of bronchi. Conclusions Among the bronchi examined, the fourth-and fifth-generation bronchi were significantly obstructed during asthma exacerbation compared with the stable phase in terms of a decreased airway diameter and mucus plugs.	[Yoshida, Yuki; Takaku, Yotaro; Nakamoto, Yasuo; Takayanagi, Noboru; Yanagisawa, Tsutomu; Kurashima, Kazuyoshi] Saitama Cardiovasc & Resp Ctr, Dept Resp Med, Kumagaya, Saitama, Japan; [Yoshida, Yuki; Takizawa, Hajime] Kyorin Univ, Dept Resp Med, Sch Med, Mitaka, Tokyo, Japan	Kyorin University	Takaku, Y (corresponding author), Saitama Cardiovasc & Resp Ctr, Dept Resp Med, Kumagaya, Saitama, Japan.	takaku.yotaro@pref.saitama.lg.jp						[Anonymous], 1995, AM J RESP CRIT CARE, V152, P1107, DOI 10.1164/ajrccm.152.3.7663792; Choi S, 2017, J ALLERGY CLIN IMMUN, V140, P690, DOI 10.1016/j.jaci.2016.11.053; de Jong PA, 2005, EUR RESPIR J, V26, P140, DOI 10.1183/09031936.05.00007105; DeBoer EM, 2017, J ALLERGY CLIN IMMUN, V139, P21, DOI 10.1016/j.jaci.2016.11.004; Dunican EM, 2018, J CLIN INVEST, V128, P997, DOI 10.1172/JCI95693; DUNNILL MS, 1960, J CLIN PATHOL, V13, P27, DOI 10.1136/jcp.13.1.27; ENHORNING G, 1995, AM J RESP CRIT CARE, V151, P554, DOI 10.1164/ajrccm.151.2.7842219; ENHORNING G, 1993, J APPL PHYSIOL, V74, P2922, DOI 10.1152/jappl.1993.74.6.2922; Fahy JV, 2010, NEW ENGL J MED, V363, P2233, DOI 10.1056/NEJMra0910061; Hasegawa M, 2006, AM J RESP CRIT CARE, V173, P1309, DOI 10.1164/rccm.200601-037OC; HEROLD CJ, 1991, RADIOLOGY, V181, P369, DOI 10.1148/radiology.181.2.1924774; Huber HL, 1922, ARCH INTERN MED, V30, P689, DOI 10.1001/archinte.1922.00110120002001; Innes AL, 2009, AM J RESP CRIT CARE, V180, P203, DOI 10.1164/rccm.200807-1056OC; Japan Lung Cancer Society, 1999, GEN RUL CLIN PATH RE; KAMINSKY DA, 1995, AM J RESP CRIT CARE, V152, P1784, DOI 10.1164/ajrccm.152.6.8520737; Kraft M, 2001, AM J RESP CRIT CARE, V163, P1551, DOI 10.1164/ajrccm.163.7.2008013; Kurashima K, 1997, AM J RESP CRIT CARE, V155, P1254, DOI 10.1164/ajrccm.155.4.9105063; Kurashima K, 2013, INT J CHRONIC OBSTR, V8, P523, DOI 10.2147/COPD.S52637; Kurashima K, 2012, RESPIROLOGY, V17, P79, DOI 10.1111/j.1440-1843.2011.02052.x; Lavorini F, 2017, CHEST, V151, P1345, DOI 10.1016/j.chest.2016.07.035; LIU M, 1995, CLIN EXP ALLERGY, V25, P1053, DOI 10.1111/j.1365-2222.1995.tb03251.x; MACKLEM PT, 1970, RESP PHYSIOL, V8, P191, DOI 10.1016/0034-5687(70)90015-0; Montaudon M, 2009, RADIOLOGY, V253, P844, DOI 10.1148/radiol.2533090303; Murphy JFA., 2018, IR MED J, V93, P135; Okazawa M, 1996, AM J RESP CRIT CARE, V154, P1557, DOI 10.1164/ajrccm.154.5.8912780; Shim SS, 2018, J ALLERGY CLIN IMMUN, V142, P1773, DOI 10.1016/j.jaci.2017.12.1004; Shimizu K, 2010, RESP MED, V104, P1809, DOI 10.1016/j.rmed.2010.06.013; 't Veen JCCMI, 2000, AM J RESP CRIT CARE, V161, P1902; Usmani OS, 2016, RESP MED, V116, P19, DOI 10.1016/j.rmed.2016.05.006; Usmani OS, 2015, CURR OPIN PULM MED, V21, P55, DOI 10.1097/MCP.0000000000000115; Usmani OS, 2014, ALLERGY ASTHMA IMMUN, V6, P376, DOI 10.4168/aair.2014.6.5.376; Weibel E.R., 1963, MORPHOMETRY HUMAN LU, P4	32	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2020	15	2							e0229238	10.1371/journal.pone.0229238	http://dx.doi.org/10.1371/journal.pone.0229238			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8GQ	32106233	Green Published, gold			2022-12-26	WOS:000535237000023
J	Petro, B; Kojouharova, P; Gaal, ZA; Nagy, B; Csizmadia, P; Czigler, I				Petro, Bela; Kojouharova, Petia; Gaal, Zsofia Anna; Nagy, Boglarka; Csizmadia, Petra; Czigler, Istvan			The effect of hand motion and object orientation on the automatic detection of orientation: A visual mismatch negativity study	PLOS ONE			English	Article							CORTICAL DYNAMICS; SUPPRESSION; PERCEPTION; COMPONENTS; CORTEX; ERPS	We investigated the effects of voluntary hand movements and continuously present objects on the automatic detection of deviant stimuli in a passive oddball paradigm. The visual mismatch negativity (vMMN) component of event-related potentials (ERPs) was measured as the index of automatic deviant detection. The stimuli were textures consisting of parallel, oblique bars with frequent (standard) and infrequent (deviant) orientation. Traditional vMMN was measured by the difference between ERPs to frequent (standard) and infrequent (deviant) textures. Additionally, we measured 'genuine' vMMN by comparing the ERPs to deviant and control textures in the equal probability procedure. Compatible and incompatible hand movement directions to the standard texture had no influence on 'traditional' vMMN and elicited no 'genuine' vMMN. However, the deviant texture elicited 'genuine' vMMN if the orientation of a continuously present rectangle was different from the standard (and identical to the deviant) texture orientation. Our results suggest that the direction of voluntary hand movement and the orientation of task-irrelevant visual patterns do not acquire common memory representation, but a continuously present object contributes to the detection of sequential regularity violation.	[Petro, Bela] Eotvos Lorand Univ, Doctoral Sch Psychol, Budapest, Hungary; [Petro, Bela; Czigler, Istvan] Eotvos Lorand Univ, Inst Psychol, Budapest, Hungary; [Petro, Bela; Kojouharova, Petia; Gaal, Zsofia Anna; Nagy, Boglarka; Csizmadia, Petra; Czigler, Istvan] Inst Cognit Neurosci & Psychol, Res Ctr Nat Sci, Budapest, Hungary; [Nagy, Boglarka; Csizmadia, Petra] Budapest Univ Technol & Econ, Fac Nat Sci, Dept Cognit Sci, Budapest, Hungary	Eotvos Lorand University; Eotvos Lorand University; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Research Centre for Natural Sciences; Budapest University of Technology & Economics	Petro, B (corresponding author), Eotvos Lorand Univ, Doctoral Sch Psychol, Budapest, Hungary.; Petro, B (corresponding author), Eotvos Lorand Univ, Inst Psychol, Budapest, Hungary.; Petro, B (corresponding author), Inst Cognit Neurosci & Psychol, Res Ctr Nat Sci, Budapest, Hungary.	petro.bela@ttk.hu	; Kojouharova, Petia/I-6995-2017	Csizmadia, Petra/0000-0002-7317-6379; Petro, Bela/0000-0001-9939-1678; Kojouharova, Petia/0000-0001-6315-4822	Hungarian Research Found (NKFIH) [119587]	Hungarian Research Found (NKFIH)	Funding was provided by the Hungarian Research Found (NKFIH), Grant 119587 to IC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Astikainen P, 2008, EUR J NEUROSCI, V28, P2319, DOI 10.1111/j.1460-9568.2008.06510.x; Baess P, 2011, PSYCHOPHYSIOLOGY, V48, P1276, DOI 10.1111/j.1469-8986.2011.01196.x; Csifcsak G, 2019, PSYCHOPHYSIOLOGY, V56, DOI 10.1111/psyp.13289; Czigler I, 2006, NEUROSCI LETT, V401, P178, DOI 10.1016/j.neulet.2006.03.018; Czigler I, 2007, J PSYCHOPHYSIOL, V21, P224, DOI 10.1027/0269-8803.21.34.224; Czigler I, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0209130; Czigler I, 2010, NEUROPSYCHOLOGIA, V48, P1277, DOI 10.1016/j.neuropsychologia.2009.12.029; Di Russo F, 2002, HUM BRAIN MAPP, V15, P95, DOI 10.1002/hbm.10010; DUNCAN J, 1984, J EXP PSYCHOL GEN, V113, P501, DOI 10.1037/0096-3445.113.4.501; File D, 2017, ATTEN PERCEPT PSYCHO, V79, P2153, DOI 10.3758/s13414-017-1373-y; File K, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15030443; Friston KJ, 2009, PHILOS T R SOC B, V364, P1211, DOI 10.1098/rstb.2008.0300; Garrido MI, 2009, CLIN NEUROPHYSIOL, V120, P453, DOI 10.1016/j.clinph.2008.11.029; Hommel B, 2001, BEHAV BRAIN SCI, V24, P849, DOI 10.1017/S0140525X01000103; Horvath J, 2013, BIOL PSYCHOL, V93, P81, DOI 10.1016/j.biopsycho.2012.12.008; Horvath J, 2012, J COGNITIVE NEUROSCI, V24, P1919, DOI 10.1162/jocn_a_00215; Jacobsen T, 2001, PSYCHOPHYSIOLOGY, V38, P723, DOI 10.1017/S0048577201000993; JEFFREYS DA, 1972, EXP BRAIN RES, V16, P1; Jonides J., 1981, ATTENTION PERFORM, P243; Kimura M, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00267; Kimura M, 2011, NEUROREPORT, V22, P669, DOI 10.1097/WNR.0b013e32834973ba; Kimura M, 2010, NEUROSCI LETT, V485, P198, DOI 10.1016/j.neulet.2010.09.011; Kimura M, 2009, PSYCHOPHYSIOLOGY, V46, P402, DOI 10.1111/j.1469-8986.2008.00767.x; Koivisto M, 2017, NEUROIMAGE, V158, P308, DOI 10.1016/j.neuroimage.2017.07.011; Kojouharova P, 2019, EXP BRAIN RES, V237, P1179, DOI 10.1007/s00221-019-05494-2; Luck SJ, 2014, INTRODUCTION TO THE EVENT-RELATED POTENTIAL TECHNIQUE, 2ND EDITION, P1; Miall RC, 1996, NEURAL NETWORKS, V9, P1265, DOI 10.1016/S0893-6080(96)00035-4; Muller HJ, 2003, J EXP PSYCHOL HUMAN, V29, P1021, DOI 10.1037/0096-1523.29.5.1021; Naatanen R, 2005, PSYCHOPHYSIOLOGY, V42, P25, DOI 10.1111/j.1469-8986.2005.00256.x; O'Shea RP, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00038; Prinz W, 1997, EUR J COGN PSYCHOL, V9, P129, DOI 10.1080/713752551; Ruhnau P, 2012, CLIN NEUROPHYSIOL, V123, P507, DOI 10.1016/j.clinph.2011.07.035; Stefanics G, 2016, FRONT HUM NEUROSCI, V10, DOI 10.3389/fnhum.2016.00013; Stefanics G, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00666; Sulykos I, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0188929; Sulykos I, 2011, BRAIN RES, V1398, P64, DOI 10.1016/j.brainres.2011.05.009; Summerfield C, 2008, NAT NEUROSCI, V11, P1004, DOI 10.1038/nn.2163; Susac A, 2014, BRAIN TOPOGR, V27, P648, DOI 10.1007/s10548-013-0340-8; Takacs E, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00591; Urakawa T, 2010, PSYCHOPHYSIOLOGY, V47, P905, DOI 10.1111/j.1469-8986.2010.00987.x; Urakawa T, 2010, NEUROIMAGE, V52, P302, DOI 10.1016/j.neuroimage.2010.03.071; van Loon AM, 2016, CEREB CORTEX, V26, P1986, DOI 10.1093/cercor/bhv018; Ventura MI, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-58; Wykowska A, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00379	44	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2020	15	2							e0229223	10.1371/journal.pone.0229223	http://dx.doi.org/10.1371/journal.pone.0229223			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LQ8FM	32101573	Green Published, gold			2022-12-26	WOS:000535233700021
J	Meng, XD; Huang, X; Deng, W; Li, JP; Li, T				Meng, Xiandong; Huang, Xia; Deng, Wei; Li, Jiping; Li, Tao			Serum uric acid a depression biomarker	PLOS ONE			English	Article							BIPOLAR DISORDER; MOOD DISORDERS; DISEASE; STRESS; LEVEL	Objective We aimed to investigate the difference in serum uric acid(SUA)levels between subtypes of depression and normal population, and whether SUA can be used to identify bipolar disorder depressive episode and major depressive disorder and predict the length of hospital stay. Methods 1543 depression patients and 1515 healthy controls were obtained according to the entry and exclusion criteria from one mental health center of a tertiary hospital in southwestern China. The diagnosis and classification of depression was in accordance with ICD-10. The SUA value was derived from fasting plasma samples analysis. The level of SUA of all the participants was quantified using Roche cobas8000-c702-MSB automatic biochemical analyzer. Data were analyzed by SPSS18.0 statistical software package. Results Overall, the level of SUA in patients with depression was lower than that in normal control. Specifically, males' SUA levels were in the interval of [240, 323.3) and [323.3, 406.6), and women were in the [160, 233.3] levels. The SUA level of bipolar disorder depressive episode was higher compared to major depressive disorder level. Interestingly, male patients who were hospitalized for two weeks had higher SUA than those who were hospitalized for three weeks or four weeks. Conclusions Our results suggest that the length of hospital stay may be associated with SUA, and when it is difficult to make a differential diagnosis of bipolar disorder depressive episode and major depressive disorder, the level of SUA may be considered. The adjustment of SUA as a method for treating depression needs to be carefully assessed.	[Meng, Xiandong; Huang, Xia; Deng, Wei; Li, Tao] Sichuan Univ, West China Hosp, Mental Hlth Ctr, Chengdu, Sichuan, Peoples R China; [Li, Jiping] Sichuan Univ, West China Hosp, Nursing Dept, Chengdu, Sichuan, Peoples R China	Sichuan University; Sichuan University	Li, JP (corresponding author), Sichuan Univ, West China Hosp, Nursing Dept, Chengdu, Sichuan, Peoples R China.	jp-li@163.com		, XianDong/0000-0003-3270-9666	Ministry of Science and Technology of People's Republic of China (National key research and development plan) [2016YFC0904300]	Ministry of Science and Technology of People's Republic of China (National key research and development plan)	Financial support for this research was from Ministry of Science and Technology of People's Republic of China (National key research and development plan). Name of the project is study on the precise diagnosis and treatment model of schizophrenia based on multi-omics map, and the item number is 2016YFC0904300. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMES BN, 1981, P NATL ACAD SCI-BIOL, V78, P6858, DOI 10.1073/pnas.78.11.6858; Andreadou E, 2009, CLIN NEUROL NEUROSUR, V111, P724, DOI 10.1016/j.clineuro.2009.06.012; Auinger P, 2010, MOVEMENT DISORD, V25, P224, DOI 10.1002/mds.22907; Bartoli F, 2016, J PSYCHIATR RES, V81, P133, DOI 10.1016/j.jpsychires.2016.07.007; BECKER BF, 1993, FREE RADICAL BIO MED, V14, P615, DOI 10.1016/0891-5849(93)90143-I; Black CN, 2018, J AFFECT DISORDERS, V225, P684, DOI 10.1016/j.jad.2017.09.003; Bromet E, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-90; Chaudhari K, 2010, INDIAN J CLIN BIOCHE, V25, P77, DOI 10.1007/s12291-010-0016-z; Costello EJ, 2006, J CHILD PSYCHOL PSYC, V47, P1263, DOI 10.1111/j.1469-7610.2006.01682.x; Drulovic J, 2001, J NEUROL, V248, P121, DOI 10.1007/s004150170246; El Ridi R, 2017, J ADV RES, V8, P487, DOI 10.1016/j.jare.2017.03.003; Fang J, 2009, P AMER CONTR CONF, P1970, DOI 10.1109/ACC.2009.5160383; Fang Pu, 2013, Brain Disord Ther, V2, P109; Glantzounis GK, 2005, CURR PHARM DESIGN, V11, P4145, DOI 10.2174/138161205774913255; Hink HU, 2002, COLD SPRING HARB SYM, V67, P483, DOI 10.1101/sqb.2002.67.483; Kesebir S, 2013, J BIOL REG HOMEOS AG, V27, P981; Kutzing MK, 2008, J PHARMACOL EXP THER, V324, P1, DOI 10.1124/jpet.107.129031; Lin SD, 2006, J CHIN MED ASSOC, V69, P512, DOI [DOI 10.1016/S1726-4901(09)70320-X, 10.1016/s1726-4901(09)70320-x]; Lupien SJ, 2009, NAT REV NEUROSCI, V10, P434, DOI 10.1038/nrn2639; Maes M, 2011, NEUROENDOCRINOL LETT, V32, P7; Maes M, 2010, J AFFECT DISORDERS, V125, P287, DOI 10.1016/j.jad.2009.12.014; Maiuolo J, 2016, INT J CARDIOL, V213, P8, DOI 10.1016/j.ijcard.2015.08.109; Miller Gary E., 2019, CURRENT PSYCHIAT, V18, P16; Miller Gary E., 2019, CURRENT PSYCHIAT, V18, P10; Ortiz R, 2015, PROG NEURO-PSYCHOPH, V57, P117, DOI 10.1016/j.pnpbp.2014.10.016; Pacher P, 2007, PHYSIOL REV, V87, P315, DOI 10.1152/physrev.00029.2006; Pan MQ, 2013, NEUROIMMUNOMODULAT, V20, P19, DOI 10.1159/000342483; Piccinelli M, 2000, BRIT J PSYCHIAT, V177, P486, DOI 10.1192/bjp.177.6.486; Piotr Gatecki, 2009, PHARM REPORTS, V61, P436, DOI [10.1016/s1734-1140(09)70084-2, DOI 10.1016/S1734-1140(09)70084-2]; Shankar A, 2006, J HUM HYPERTENS, V20, P937, DOI 10.1038/sj.jhh.1002095; Smith-Nielsen J, 2018, BMC PSYCHIATRY, V18, DOI 10.1186/s12888-018-1965-7; Tao R, 2015, J AFFECT DISORDERS, V174, P464, DOI 10.1016/j.jad.2014.12.031; Ustun TB, 2004, BRIT J PSYCHIAT, V184, P386, DOI 10.1192/bjp.184.5.386; Wen SL, 2012, CLIN BIOCHEM, V45, P49, DOI 10.1016/j.clinbiochem.2011.10.010; WHO, 2012, DEPR WHAT IS DEPR; Wiener C, 2014, EUR PSYCHIAT, V29, P58, DOI 10.1016/j.eurpsy.2013.05.006; Zarate CA, 2008, MT SINAI J MED, V75, P226, DOI 10.1002/msj.20042	37	12	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2020	15	3							e0229626	10.1371/journal.pone.0229626	http://dx.doi.org/10.1371/journal.pone.0229626			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LQ8QU	32130258	Green Published, gold			2022-12-26	WOS:000535264000035
J	Mo, R; Gamboa, M; Watanabe, K; Wang, GQ; Li, WH; Yang, D; Muranyi, D				Mo, RaoRao; Gamboa, Maribet; Watanabe, Kozo; Wang, GuoQuan; Li, WeiHai; Yang, Ding; Muranyi, David			A remarkable new genus and species of Nemourinae (Plecoptera, Nemouridae) from Sichuan, China, with systematic notes on the related genera	PLOS ONE			English	Article							PROVINCE	A remarkable new genus and species of Nemourinae, Sinonemura balangshana gen. et sp. n., is described from Balang Mountains, Sichuan, southwestern China. The description is based on morphology and molecular data. The Nemourinae genera related to the new taxon are re-evaluated on the basis of comparative functional morphology of male epiproct. Notes on the Asian distribution of the Nemourinae are also given.	[Mo, RaoRao; Wang, GuoQuan] Guangxi Univ, Agr Coll, Guangxi Key Lab Agr Environm & Agr Prod Safety, Nanning, Guangxi, Peoples R China; [Mo, RaoRao; Li, WeiHai] Henan Inst Sci & Technol, Dept Plant Protect, Xinxiang, Henan, Peoples R China; [Gamboa, Maribet; Watanabe, Kozo] Ehime Univ, Dept Civil & Environm Engn, Matsuyama, Ehime, Japan; [Yang, Ding] China Agr Univ, Dept Entomol, Beijing, Peoples R China; [Muranyi, David] Eszterhazy Karoly Univ, Dept Zool, Eger, Hungary; [Muranyi, David] Hungarian Nat Hist Museum, Dept Zool, Budapest, Hungary	Guangxi University; Henan Institute of Science & Technology; Ehime University; China Agricultural University	Wang, GQ (corresponding author), Guangxi Univ, Agr Coll, Guangxi Key Lab Agr Environm & Agr Prod Safety, Nanning, Guangxi, Peoples R China.; Li, WH (corresponding author), Henan Inst Sci & Technol, Dept Plant Protect, Xinxiang, Henan, Peoples R China.; Muranyi, D (corresponding author), Eszterhazy Karoly Univ, Dept Zool, Eger, Hungary.; Muranyi, D (corresponding author), Hungarian Nat Hist Museum, Dept Zool, Budapest, Hungary.	wangguoquan0@163.com; lwh7969@163.com; d.muranyi@gmail.com	Gamboa, Maribet/AAT-7556-2020; Watanabe, Kozo/F-7388-2010	Gamboa, Maribet/0000-0003-3744-1339; Watanabe, Kozo/0000-0002-7062-595X; Muranyi, David/0000-0002-3907-5590	National Natural Science Foundation of China [31372251]; Aid Program for Science and Technology Innovative Research Team in Higher Educational Institutions of Henan Province [17IRTSTHN18]; Landmark Innovative	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Aid Program for Science and Technology Innovative Research Team in Higher Educational Institutions of Henan Province; Landmark Innovative	The National Natural Science Foundation of China (http://www.nsfc.gov.cn/english/site_1/, No. 31372251), the Aid Program for Science and Technology Innovative Research Team in Higher Educational Institutions of Henan Province (No. 17IRTSTHN18), and the Landmark Innovative	Baumann R.W., 1975, Smithsonian Contributions to Zoology, VNo. 211, P1; Chen L, 2008, PROG NAT SCI, V18, P833, DOI 10.1016/j.pnsc.2008.02.004; Chen ZT, 2018, ZOOTAXA, V4407, P293, DOI 10.11646/zootaxa.4407.2.11; Chen ZT, 2018, ZOOTAXA, V4375, P59, DOI 10.11646/zootaxa.4375.1.2; Chen ZT, 2017, ZOOTAXA, V4254, P294, DOI 10.11646/zootaxa.4254.2.10; CHU YANTING T., 1928, CHINA JOUR, V8, P332; DeWalt R.E., 2019, PLECOPTERA SPECIES F; Du YZ, 2008, ENTOMOL NEWS, V119, P67, DOI 10.3157/0013-872X(2008)119[67:FNSOTG]2.0.CO;2; Errochdi S, 2014, ZOOTAXA, V3838, P46, DOI 10.11646/zootaxa.3838.1.2; Gamboa M, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0210269; Illies J., 1966, KATALOG REZENTEN PLE, V82, P1; JEWETT S G JR, 1975, Oriental Insects, V9, P1; JEWETT STANLEY G., 1958, PROC NATL ACAD SCI INDIA SECT B, V28, P320; KAWAI T, 1968, PAC INSECTS, V10, P241; Kempny P., 1898, VERHANDLUNGEN ZOOLOG, V48, P37; Klapalek F., 1907, WISSENSCHAFTLICHE ER, V10, P59, DOI [10.2307/199584, DOI 10.2307/199584]; Klapalek Fr. H., 1912, Entomologische Mitteilungen Berlin, V1; Li W, 2008, AQUAT INSECT, V30, P205, DOI 10.1080/01650420802334038; Li WH, 2007, ZOOTAXA, P65; Li WH, 2012, ZOOTAXA, P63, DOI 10.11646/zootaxa.3427.1.6; Li WH, 2013, ZOOTAXA, V3746, P473, DOI 10.11646/zootaxa.3746.3.6; Li Weihai, 2008, Illiesia, V4, P205; Li Weihai, 2008, Fauna and Taxonomy of Insects in Henan, V6, P11; Li WH, 2006, ZOOTAXA, P53, DOI 10.11646/zootaxa.1137.1.3; Li WH, 2005, ZOOTAXA, P59; LI WH, 2008, ZOOTAXA 0606, P61; Needham J. G., 1925, Thomas Say Foundation Ent Soc Amer La Fayette Indiana, V2, P1; Ping C., 1928, PALAEONTOL SIN SER B, V13, P5; Qian YH, 2018, ZOOTAXA, V4375, P281, DOI 10.11646/zootaxa.4375.2.8; Retzius A.J., 1783, CAROLI GEER GENERA S, P120; Ricker W.E., 1952, INDIANA U PUBLICATIO, V18, P1; Ris F., 1902, Mitteilungen der Schweizerischen Entomologischen Gesellschaft, Vx, P378; Shimizu T, 1997, AQUAT INSECT, V19, P193, DOI 10.1080/01650429709361656; Shimizu Takao, 2001, P393; Shimizu Takao, 1998, Japanese Journal of Systematic Entomology, V4, P227; SIVEC I, 1981, Aquatic Insects, V3, P79, DOI 10.1080/01650428109361050; Sivec Ignac, 2010, Illiesia, V6, P277; Sivec Ignac, 2009, Illiesia, V5, P199; Ueno M., 1941, KONTY TOKYO, V15, P21; Wang HL, 2013, ZOOTAXA, V3637, P561, DOI 10.11646/zootaxa.3637.5.4; Wang Zhi-Jie, 2006, Illiesia, V2, P50; Wu C.F., 1973, Acta Entomologica Sinica, V16, P97; Wu C. F., 1926, China Journal of Science and Arts, V6, P331; Wu C. F., 1940, Peking Natural History Bulletin, V14, P153; Wu C.F., 1949, PEKING NATURAL HIST, V17, P251; Wu CF, 1938, PLECOPTERORUM SINENS; Wu Chenfu F., 1962, Acta Entomologica Sinica Peking suppl, V11, P139; WU CHENFU F., 1935, PEKING NAT HIST BULL, V9, P227; WU CHENFU F., 1929, CHINA JOUR, V10, P200; Yang D, 2018, PLECOPTERA SPECIES C, V2; Yang D., 2015, FAUNA SINICA INSECTA, V58; Zhi-Jie W, 2008, ZOOTAXA, P18, DOI 10.11646/zootaxa.1879.1.2; Zhiltzova LA, 2001, RUSSIAN ENTOMOLOGICA, V11, P2; Zhiltzova LA, 2003, FAUNA RUSSIA NEIGHBO; Zhu Fang, 2003, Acta Zootaxonomica Sinica, V28, P474; Zwick P., 1973, Das Tierreich, VNo. 94, P1; ZWICK P, 1982, AQUAT INSECT, V4, P39, DOI 10.1080/01650428209361077; Zwick P., 1980, Entomologica Basiliensia, V5, P59; Zwick P., 1977, ENTOMOLOGICA BASILEN, V2, P85; Zwick Peter, 2011, Illiesia, V7, P148; Zwick Peter, 2010, Illiesia, V6, P75	61	1	1	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2020	15	3							e0229120	10.1371/journal.pone.0229120	http://dx.doi.org/10.1371/journal.pone.0229120			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8QU	32130246	Green Published, gold			2022-12-26	WOS:000535264000017
J	Chen, ZL; Haus, JM; Chen, L; Wu, SC; Urao, N; Koh, TJ; Minshall, RD				Chen, Zhenlong; Haus, Jacob M.; Chen, Lin; Wu, Stephanie C.; Urao, Norifumi; Koh, Timothy J.; Minshall, Richard D.			CCL28-induced CCR10/eNOS interaction in angiogenesis and skin wound healing	FASEB JOURNAL			English	Article						angiogenesis; CCL28; CCR10; eNOS; wound healing	NITRIC-OXIDE SYNTHASE; ENDOTHELIAL GROWTH-FACTOR; ACTIVATION; CELLS; ENOS; RECEPTOR; BINDING; CCL28; IDENTIFICATION; CONTRIBUTES	Chemokines and their receptors play important roles in vascular homeostasis, development, and angiogenesis. Little is known regarding the molecular signaling mechanisms activated by CCL28 chemokine via its primary receptor CCR10 in endothelial cells (ECs). Here, we test the hypothesis that CCL28/CCR10 signaling plays an important role in regulating skin wound angiogenesis through endothelial nitric oxide synthase (eNOS)-dependent Src, PI3K, and MAPK signaling. We observed nitric oxide (NO) production in human primary ECs stimulated with exogenous CCL28, which also induced direct binding of CCR10 and eNOS resulting in inhibition of eNOS activity. Knockdown of CCR10 with siRNA lead to reduced eNOS expression and tube formation suggesting the involvement of CCR10 in EC angiogenesis. Based on this interaction, we engineered a myristoylated 7 amino acid CCR10-binding domain (Myr-CBD7) peptide and showed that this can block eNOS interaction with CCR10, but not with calmodulin, resulting in upregulation of eNOS activity. Importantly, topical administration of Myr-CBD7 peptide on mouse dermal wounds not only blocked CCR10-eNOS interaction, but also enhanced expression of eNOS, CD31, and IL-4 with reduction of CCL28 and IL-6 levels associated with improved wound healing. These results point to a potential therapeutic strategy to upregulate NO bioavailability, enhance angiogenesis, and improve wound healing by disrupting CCL28-activated CCR10-eNOS interaction.	[Chen, Zhenlong; Minshall, Richard D.] Univ Illinois, Dept Anesthesiol, 835 S Wolcott Ave M-C 868, Chicago, IL 60612 USA; [Haus, Jacob M.; Urao, Norifumi; Koh, Timothy J.] Univ Illinois, Dept Kinesiol & Nutr, Chicago, IL USA; [Chen, Lin] Univ Illinois, Dept Periodont, Chicago, IL USA; [Chen, Lin; Urao, Norifumi; Koh, Timothy J.] Univ Illinois, Ctr Wound Healing & Tissue Regenerat, Chicago, IL USA; [Wu, Stephanie C.] Rosalind Franklin Univ Med & Sci, Dr William M Scholl Coll Podiatr Med, CLEAR, N Chicago, IL USA; [Minshall, Richard D.] Univ Illinois, Dept Pharmacol, 835 S Wolcott Ave M-C 868, Chicago, IL 60612 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Rosalind Franklin University Medical & Science; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Chen, ZL; Minshall, RD (corresponding author), Univ Illinois, Dept Anesthesiol, 835 S Wolcott Ave M-C 868, Chicago, IL 60612 USA.; Minshall, RD (corresponding author), Univ Illinois, Dept Pharmacol, 835 S Wolcott Ave M-C 868, Chicago, IL 60612 USA.	zlchen@uic.edu; rminsh@uic.edu	Chen, Zhenlong/AAQ-9578-2021; Chen, Lin/AAW-8207-2020	Chen, Lin/0000-0001-8530-2363; Koh, Timothy/0000-0001-6549-7060	National Institutes of Health [P01 HL60678, R01 HL125356, R01 HL083298, UL1 RR029879]; American Diabetes Association [1-14-JF-32]; University of Illinois at Chicago Chancellor's Translational Research Initiative	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association(American Diabetes Association); University of Illinois at Chicago Chancellor's Translational Research Initiative	This work was supported in part by National Institutes of Health grants P01 HL60678, R01 HL125356 and R01 HL083298, and UL1 RR029879, American Diabetes Association grant 1-14-JF-32, and the University of Illinois at Chicago Chancellor's Translational Research Initiative. Myr-CBD peptides are protected under United States Patent and Trademark Office (USPTO) application number 62879717.	Alkaitis Matthew S, 2012, Curr Heart Fail Rep, V9, P200, DOI 10.1007/s11897-012-0097-5; Baig MS, 2015, J EXP MED, V212, P1725, DOI 10.1084/jem.20140654; Balaji S, 2015, ADV WOUND CARE, V4, P660, DOI 10.1089/wound.2014.0564; BARBUL A, 1990, SURGERY, V108, P331; Blanchet X, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00175; Bonnefoy-Berard N, 2004, BBA-MOL CELL RES, V1644, P159, DOI 10.1016/j.bbamcr.2003.10.014; BREDT DS, 1990, NATURE, V347, P768, DOI 10.1038/347768a0; Bunemann E, 2018, EUR J MED RES, V23, DOI 10.1186/s40001-017-0299-0; Cao S, 2001, J BIOL CHEM, V276, P14249, DOI 10.1074/jbc.M006258200; Chen ZL, 2018, MOL BIOL CELL, V29, P1190, DOI 10.1091/mbc.E17-01-0049; Chen ZL, 2015, ANN RHEUM DIS, V74, P1898, DOI 10.1136/annrheumdis-2013-204530; Chen Z, 2013, J IMMUNOL, V190, P5256, DOI 10.4049/jimmunol.1201675; Chen ZL, 2012, MOL BIOL CELL, V23, P1388, DOI 10.1091/mbc.E11-09-0811; Chignalia AZ, 2015, AM J PATHOL, V185, P1251, DOI 10.1016/j.ajpath.2015.01.022; Curnock AP, 2002, IMMUNOLOGY, V105, P125, DOI 10.1046/j.1365-2567.2002.01345.x; Daff S, 2010, NITRIC OXIDE-BIOL CH, V23, P1, DOI 10.1016/j.niox.2010.03.001; Facciabene A, 2011, NATURE, V475, P226, DOI 10.1038/nature10169; Fernandez A, 2001, J NATL CANCER I, V93, P208, DOI 10.1093/jnci/93.3.208; Forstermann U, 2006, CIRCULATION, V113, P1708, DOI 10.1161/CIRCULATIONAHA.105.602532; Galvez BG, 2005, J BIOL CHEM, V280, P1292, DOI 10.1074/jbc.M408673200; Garcia-Cardena G, 1998, NATURE, V392, P821, DOI 10.1038/33934; Gosain A, 2004, WORLD J SURG, V28, P321, DOI 10.1007/s00268-003-7397-6; GOSINK EC, 1993, AM J PHYSIOL, V265, pC1620, DOI 10.1152/ajpcell.1993.265.6.C1620; Heiss C, 2015, ANTIOXID REDOX SIGN, V22, P1230, DOI 10.1089/ars.2014.6158; Jayathilaka G, 2007, J BIOMOL TECH, V18, P46; Jetten N, 2014, ANGIOGENESIS, V17, P109, DOI 10.1007/s10456-013-9381-6; KIRK SJ, 1993, SURGERY, V114, P155; Kobayashi K, 2014, ARTERIOSCL THROM VAS, V34, P1716, DOI 10.1161/ATVBAHA.114.303890; Koh TJ, 2011, EXPERT REV MOL MED, V13, DOI 10.1017/S1462399411001943; Kroncke KD, 1998, CLIN EXP IMMUNOL, V113, P147; Lee PC, 1999, AM J PHYSIOL-HEART C, V277, pH1600, DOI 10.1152/ajpheart.1999.277.4.H1600; Lee SJ, 2006, AM J PHYSIOL-HEART C, V291, pH2836, DOI 10.1152/ajpheart.00113.2006; Li Q, 2015, J HYPERTENS, V33, P1128, DOI 10.1097/HJH.0000000000000587; Liu ZJ, 2008, ANTIOXID REDOX SIGN, V10, P1869, DOI 10.1089/ars.2008.2121; Mahmoud AM, 2016, PHYSIOL REP, V4, DOI 10.14814/phy2.12895; MARCHESE A, 1994, GENOMICS, V23, P609, DOI 10.1006/geno.1994.1549; Masckauchan T. Nestor H., 2005, Angiogenesis, V8, P43, DOI 10.1007/s10456-005-5612-9; Mathieu D, 2006, Int J Low Extrem Wounds, V5, P233, DOI 10.1177/1534734606294450; Mirza R, 2009, AM J PATHOL, V175, P2454, DOI 10.2353/ajpath.2009.090248; Moncada S., 2006, V176, P213; Murad F, 2004, BIOSCIENCE REP, V24, P452, DOI 10.1007/s10540-005-2741-8; Murohara T, 1998, J CLIN INVEST, V101, P2567, DOI 10.1172/JCI1560; Namba T, 2003, CIRCULATION, V108, P2250, DOI 10.1161/01.CIR.0000093190.53478.78; NATHAN C, 1992, FASEB J, V6, P3051, DOI 10.1096/fasebj.6.12.1381691; Novak ML, 2013, J LEUKOCYTE BIOL, V93, P875, DOI 10.1189/jlb.1012512; Pan JL, 2000, J IMMUNOL, V165, P2943, DOI 10.4049/jimmunol.165.6.2943; Papapetropoulos A, 1997, J CLIN INVEST, V100, P3131, DOI 10.1172/JCI119868; Petrai I, 2008, INT J BIOCHEM CELL B, V40, P1764, DOI 10.1016/j.biocel.2008.01.008; Rees PA, 2015, ADV WOUND CARE, V4, P687, DOI 10.1089/wound.2014.0568; Ribatti D, 2009, ANGIOGENESIS, V12, P101, DOI 10.1007/s10456-008-9125-1; Ridiandries A, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19103217; Ridiandries A, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17111856; Risau W, 1997, NATURE, V386, P671, DOI 10.1038/386671a0; Schaffer MR, 1996, J SURG RES, V63, P237, DOI 10.1006/jsre.1996.0254; Stallmeyer B, 2002, NITRIC OXIDE-BIOL CH, V6, P168, DOI 10.1006/niox.2001.0407; Stamatovic SM, 2006, J IMMUNOL, V177, P2651, DOI 10.4049/jimmunol.177.4.2651; Su YC, 2014, CURR PHARM DESIGN, V20, P3514, DOI 10.2174/13816128113196660752; Takahashi S, 2003, J BIOL CHEM, V278, P9339, DOI 10.1074/jbc.M212651200; Thomas GD, 2001, JAMA-J AM MED ASSOC, V285, P2055, DOI 10.1001/jama.285.16.2055; VENEMA RC, 1995, J BIOL CHEM, V270, P14705, DOI 10.1074/jbc.270.24.14705; Venema RC, 1996, J BIOL CHEM, V271, P6435, DOI 10.1074/jbc.271.11.6435; Wang W, 2000, J BIOL CHEM, V275, P22313, DOI 10.1074/jbc.M001461200; White GE, 2013, PHARMACOL REV, V65, P47, DOI 10.1124/pr.111.005074; Wietecha MS, 2013, ADV WOUND CARE, V2, P81, DOI 10.1089/wound.2011.0348; Witte MB, 2002, BRIT J SURG, V89, P1594, DOI 10.1046/j.1365-2168.2002.02263.x; Witte MB, 2000, NITRIC OXIDE-BIOL CH, V4, P572, DOI 10.1006/niox.2000.0307; Xiong N, 2012, PROTEIN CELL, V3, P571, DOI 10.1007/s13238-012-2927-3; Yang JY, 2018, EXP CELL RES, V363, P262, DOI 10.1016/j.yexcr.2018.01.016; Yu J, 2005, P NATL ACAD SCI USA, V102, P10999, DOI 10.1073/pnas.0501444102; Zhao Y, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146451	70	3	4	0	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2020	34	4					5838	5850		10.1096/fj.201902060R	http://dx.doi.org/10.1096/fj.201902060R		MAR 2020	13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	LJ5ZA	32124475	Bronze, Green Accepted			2022-12-26	WOS:000517934400001
J	Simard, J; Marschang, RE; Leineweber, C; Hellebuyck, T				Simard, Jules; Marschang, Rachel E.; Leineweber, Christoph; Hellebuyck, Tom			Prevalence of inclusion body disease and associated comorbidity in captive collections of boid and pythonid snakes in Belgium	PLOS ONE			English	Article							BOA-CONSTRICTOR-CONSTRICTOR; LYMPHOBLASTIC LYMPHOMA; ARENAVIRUSES; IDENTIFICATION; RETROVIRUSES	Inclusion body disease (IBD) is caused by reptarenaviruses and constitutes one of the most notorious viral diseases in snakes. Although central nervous system disease and various other clinical signs have been attributed to IBD in boid and pythonid snakes, studies that unambiguously reveal the clinical course of natural IBD and reptarenavirus infection are scarce. In the present study, the prevalence of IBD and reptarenaviruses in captive snake collections and the correlation of IBD and reptarenavirus infection with the clinical status of the sampled snakes were investigated. In three IBD positive collections, long-term follow-up during a three- to seven-year period was performed. A total of 292 snakes (178 boas and 114 pythons) from 40 collections in Belgium were sampled. In each snake, blood and buffy coat smears were evaluated for the presence of IBD inclusion bodies (IB) and whole blood was tested for reptarenavirus RNA by RT-PCR. Of all tested snakes, 16.5% (48/292) were positive for IBD of which all were boa constrictors (34.0%; 48/141) and 17.1% (50/292) were reptarenavirus RT-PCR positive. The presence of IB could not be demonstrated in any of the tested pythons, while 5.3% (6/114) were reptarenavirus positive. In contrast to pythons, the presence of IB in peripheral blood cells in boa constrictors is strongly correlated with reptarenavirus detection by RT-PCR (P<0.0001). Although boa constrictors often show persistent subclinical infection, long-term follow-up indicated that a considerable number (22.2%; 6/27) of IBD/reptarenavirus positive boas eventually develop IBD associated comorbidities.	[Simard, Jules; Hellebuyck, Tom] Univ Ghent, Dept Pathol Bacteriol & Avian Dis Exot Compan Ani, Div Poultry, Merelbeke, Belgium; [Marschang, Rachel E.; Leineweber, Christoph] Laboklin GmbH & Co KG, Bad Kissingen, Germany	Ghent University; LABOKLIN GmbH & Co. KG	Simard, J (corresponding author), Univ Ghent, Dept Pathol Bacteriol & Avian Dis Exot Compan Ani, Div Poultry, Merelbeke, Belgium.	Jules.Simard@UGent.be		Simard, Jules/0000-0003-4815-2831				Aqrawi T, 2015, TIERAERZTL PRAX K H, V43, P239, DOI 10.15654/TPK-140743; Bodewes R, 2013, J GEN VIROL, V94, P1206, DOI 10.1099/vir.0.051995-0; Chang L, 2016, VET J, V218, P13, DOI 10.1016/j.tvjl.2016.10.006; Chang LW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082916; Chang LW, 2010, J EXOT PET MED, V19, P216, DOI 10.1053/j.jepm.2010.07.014; Dietz J, 2020, J ZOO WILD MED; Funk RS, 2019, MADERS REPTILE AMPHI, P1249; Hellebuyck T, 2015, J VET DIAGN INVEST, V27, P245, DOI 10.1177/1040638714562825; Hepojoki J, 2015, J VIROL, V89, P8657, DOI 10.1128/JVI.01112-15; Hepojoki J, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1007415; Hepojoki J, 2015, J VIROL, V89, P1119, DOI 10.1128/JVI.03119-14; Hetzel U, 2013, J VIROL, V87, P10918, DOI 10.1128/JVI.01123-13; Huder JB, 2002, J VIROL, V76, P7607, DOI 10.1128/JVI.76.15.7607-7615.2002; Hyndman TH, 2019, AUST VET J, V97, P93, DOI 10.1111/avj.12792; International Committee on Taxonomy of Viruses (ICTV), VIR TAX 2018B REL; Jacobson E.R., 2007, INFECT DIS PATHOLOGY, DOI [10.1201/9781420004038, DOI 10.1201/9781420004038]; Jacobson ER, 2001, AM J VET RES, V62, P217, DOI 10.2460/ajvr.2001.62.217; Keller S, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006179; Korzyukov Y, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158417; Meyer B, 2016, J VIROL, V90, P3810, DOI 10.1128/JVI.03049-15; Pees M, 2010, VET REC, V166, P422, DOI 10.1136/vr.b4819; Schilliger Lionel, 2014, Journal of Herpetological Medicine and Surgery, V24, P11, DOI 10.5818/1529-9651-24.1.11; Schilliger L, 2011, J VET DIAGN INVEST, V23, P159, DOI 10.1177/104063871102300131; SCHUMACHER J, 1994, J ZOO WILDLIFE MED, V25, P511; Stenglein MD, 2017, J VIROL, V91, DOI 10.1128/JVI.00451-17; Stenglein MD, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004900; Stenglein MD, 2012, MBIO, V3, DOI 10.1128/mBio.00180-12; West G, 2001, J ZOO WILDLIFE MED, V32, P360, DOI 10.1638/1042-7260(2001)032[0360:MIABSP]2.0.CO;2; Windbichler K, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0221863; Wozniak E, 2000, VET PATHOL, V37, P449, DOI 10.1354/vp.37-5-449	30	4	4	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2020	15	3							e0229667	10.1371/journal.pone.0229667	http://dx.doi.org/10.1371/journal.pone.0229667			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8JT	32119716	Green Published, gold			2022-12-26	WOS:000535245300035
J	Korb, D; Schmitz, T; Seco, A; Goffinet, F; Deneux-Tharaux, C				Korb, Diane; Schmitz, Thomas; Seco, Aurelien; Goffinet, Francois; Deneux-Tharaux, Catherine		JUmeaux MODe dAccouchement JUMODA; Grp Rech Obstet Gynecologie GROG	Risk factors and high-risk subgroups of severe acute maternal morbidity in twin pregnancy: A population-based study	PLOS ONE			English	Article							CESAREAN DELIVERY; FRANCE	Objective To determine risk factors of severe acute maternal morbidity in women with twin pregnancies and identify subgroups at high risk. Methods In a prospective, population-based study of twin deliveries, the JUMODA cohort, all women with twin pregnancies at or after 22 weeks of gestation were recruited in 176 French hospitals. Severe acute maternal morbidity was a composite criterion. We determined its risk factors by multilevel multivariate Poisson regression modeling and identified high-risk subgroups by classification and regression tree (CART) analysis, in two steps: first considering only characteristics known at the beginning of pregnancy and then adding factors arising during its course. Results Among the 8,823 women with twin pregnancies, 542 (6.1%, 95% confidence interval (CI) 5.6-6.6) developed severe acute maternal morbidity. Risk factors for severe maternal morbidity identified at the beginning of pregnancy were maternal birth in sub-Saharan Africa (adjusted relative risk (aRR) 1.6, 95% CI 1.1-2.3), preexisting insulin-treated diabetes (aRR 2.2, 95% CI 1.1-4.4), nulliparity (aRR 1.6, 95% CI 1.3-2.0), IVF with autologous oocytes (aRR, 1.3, 95% CI, 1.0-1.6), and oocyte donation (aRR 2.0, 95% CI 1.4-2.8); CART analysis identified nulliparous women with oocyte donation as the subgroup at highest risk (SAMM rate: 14.7%, 95% CI, 10.3-19.1). At the end of pregnancy, additional risk factors identified were placenta praevia (aRR 3.5, 95% CI 2.3-5.3), non-severe preeclampsia (aRR 2.5, 95% CI 1.9-3.2), and macrosomia for either twin (aRR 1.7, 95% CI 1.3-2.1); CART analysis identified women with both oocyte donation and non-severe preeclampsia (SAMM rate: 28.9%, 95% CI, 19.9-37.9) and sub-Saharan nulliparous women with non-severe preeclampsia (SAMM rate: 26.9%, 95% CI, 9.9-43.9) as the two subgroups at highest risk. Conclusion In woman with twin pregnancy, rates of severe acute maternal morbidity vary between subgroups from 4.6% to 14.7% and from 3.8% to 28.9% at the beginning and at the end of pregnancy respectively, depending on the combined presence of risk factors.	[Korb, Diane; Schmitz, Thomas; Seco, Aurelien; Goffinet, Francois; Deneux-Tharaux, Catherine] Univ Paris, Epidemiol & Stat Res Ctr CRESS, INRA, INSERM, Paris, France; [Korb, Diane; Schmitz, Thomas] Robert Debre Hosp, AP HP, Dept Obstet & Gynecol, Paris, France; [Seco, Aurelien] AP HP, Clin Res Unit Paris Descartes Necker Cochin, Paris, France; [Goffinet, Francois] Cochin Hosp, AP HP, Port Royal Matern Unit, Paris, France	INRAE; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite	Korb, D (corresponding author), Univ Paris, Epidemiol & Stat Res Ctr CRESS, INRA, INSERM, Paris, France.; Korb, D (corresponding author), Robert Debre Hosp, AP HP, Dept Obstet & Gynecol, Paris, France.	diane.korb@inserm.fr			French Ministry of Health (Programme Hospitalier de Recherche Clinique) [AOM2012]	French Ministry of Health (Programme Hospitalier de Recherche Clinique)	Thomas Schmitz was supported by a grant from the French Ministry of Health (Programme Hospitalier de Recherche Clinique, AOM2012). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Zirqi I, 2008, BJOG-INT J OBSTET GY, V115, P1265, DOI 10.1111/j.1471-0528.2008.01859.x; Bamberg C, 2012, FERTIL STERIL, V98, DOI 10.1016/j.fertnstert.2012.04.009; Blondel B, 2017, J GYNECOL OBSTET HUM, V46, P701, DOI 10.1016/j.jogoh.2017.09.002; Creanga AA, 2015, AM J OBSTET GYNECOL, V213, DOI 10.1016/j.ajog.2015.05.002; Creanga AA, 2014, AM J OBSTET GYNECOL, V210, DOI 10.1016/j.ajog.2013.11.039; Fong FM, 2014, AM J EPIDEMIOL, V180, P335, DOI 10.1093/aje/kwu151; Grobman WA, 2006, AM J OBSTET GYNECOL, V194, P888, DOI 10.1016/j.ajog.2005.09.002; Guilbaud L, 2017, FERTIL STERIL, V107, DOI 10.1016/j.fertnstert.2017.01.019; Gyamfi-Bannerman C, 2018, AM J OBSTET GYNECOL, V219, DOI 10.1016/j.ajog.2018.04.052; Hitti J, 2018, AM J OBSTET GYNECOL, V219, DOI 10.1016/j.ajog.2018.07.002; Howell EA, 2016, AM J OBSTET GYNECOL, V215, P143, DOI 10.1016/j.ajog.2016.05.007; Howell EA, 2016, AM J OBSTET GYNECOL, V214, DOI 10.1016/j.ajog.2015.08.019; Korb D, 2019, CAN MED ASSOC J, V191, pE352, DOI 10.1503/cmaj.181067; Kramer MS, 2011, J OBSTET GYNAECOL CA, V33, P810, DOI 10.1016/S1701-2163(16)34984-2; Lisonkova S, 2014, OBSTET GYNECOL, V124, P771, DOI 10.1097/AOG.0000000000000472; Luke B, 2017, AM J OBSTET GYNECOL, V217, DOI 10.1016/j.ajog.2017.04.025; Madar H, 2019, OBSTET GYNECOL, V133, P1141, DOI 10.1097/AOG.0000000000003261; Marshall RJ, 2001, J CLIN EPIDEMIOL, V54, P603, DOI 10.1016/S0895-4356(00)00344-9; Martin AS, 2016, OBSTET GYNECOL, V127, P59, DOI 10.1097/AOG.0000000000001197; Martin Joyce A, 2018, Natl Vital Stat Rep, V67, P1; Sauvegrain P, 2017, BJOG-INT J OBSTET GY, V124, P1858, DOI 10.1111/1471-0528.14658; Say L, 2009, BEST PRACT RES CL OB, V23, P287, DOI 10.1016/j.bpobgyn.2009.01.007; Schmitz T, 2017, OBSTET GYNECOL, V129, P986, DOI 10.1097/AOG.0000000000002048; Snowden JM, 2016, OBESITY, V24, P1590, DOI 10.1002/oby.21532; Urquia ML, 2015, EUR J PUBLIC HEALTH, V25, P620, DOI 10.1093/eurpub/cku230; Waterstone M, 2001, BMJ-BRIT MED J, V322, P1089, DOI 10.1136/bmj.322.7294.1089; Witteveen T, 2016, AM J OBSTET GYNECOL, V214, DOI 10.1016/j.ajog.2015.11.003; Zwart JJ, 2008, BJOG-INT J OBSTET GY, V115, P842, DOI 10.1111/j.1471-0528.2008.01713.x	28	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2020	15	2							e0229612	10.1371/journal.pone.0229612	http://dx.doi.org/10.1371/journal.pone.0229612			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8HR	32109258	Green Published, gold			2022-12-26	WOS:000535239800018
J	Zhang, FH; Zhang, L; Li, YL				Zhang, Fuhai; Zhang, Lei; Li, Yulong			Investigation of gap-graded soils' seepage internal stability with the concept of void filling ratio	PLOS ONE			English	Article							SUFFUSION; EROSION	Gap-graded soils from mountain areas are often used as subgrade filling materials, but problems associated with the gap-graded soils such as large permeability, poor uniformity, and poor seepage stability have to be solved. This article proposes a new terminology "void filling ratio" to study the seepage internal stability of gap-graded soils as subgrade filling materials. Laboratory seepage tests were performed to investigate the effects of compaction degrees of coarse grains, void filling ratios, and clay contents on the internal stability. Laboratory model tests were also performed to verify the findings from the laboratory seepage tests. It was found that the internal stability increased with increase of the void filling ratios, confirmed by both laboratory seepage tests and slope model tests. The increases of both void filling ratio and the clay content were able to change the type of internal instability from piping to the transitional type of internal instability. In laboratory model tests, surface areas lost more fine particles than the deeper area did in the models, but when the void filling ratio was increased, the amount of lost fine particles was significantly reduced. Finally, it was confirmed that void filling ratio was able to effectively describe the internal stability of gap-graded soils subject to different levels of hydraulic gradient.	[Zhang, Fuhai] Hohai Univ, Geotech Res Inst, Minist Educ Geomech & Embankment Engn, Key Lab, Nanjing, Peoples R China; [Zhang, Lei] Oregon State Univ, Sch Civil & Construct Engn, Corvallis, OR 97331 USA; [Li, Yulong] Tianjin Inst Geotech Invest Surveying, Tianjin, Peoples R China	Hohai University; Oregon State University	Li, YL (corresponding author), Tianjin Inst Geotech Invest Surveying, Tianjin, Peoples R China.	zhanglei@oregonstate.edu			National Natural Science Foundation of China [51778211]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	F. Z. received financial support from the National Natural Science Foundation of China (NSFC No. 51778211) Link: http://www.nsfc.gov.cn/english/site_1/index.html.	Chang DS, 2013, SOILS FOUND, V53, P569, DOI 10.1016/j.sandf.2013.06.008; [樊恒辉 FAN Henghui], 2007, [长安大学学报. 自然科学版, Journal of Chang'An University. Natural Science Edition], V27, P76; Fell R., 2007, INTERNAL EROSION DAM, P9; Hama N. A., 2017, EPJ WEB C, V140, P10011; Hama NA, 2019, EUR J ENVIRON CIV EN, V23, P1368, DOI 10.1080/19648189.2017.1347526; Indraratna B, 2011, J GEOTECH GEOENVIRON, V137, P550, DOI 10.1061/(ASCE)GT.1943-5606.0000447; Israr J, 2017, J GEOTECH GEOENVIRON, V143, DOI 10.1061/(ASCE)GT.1943-5606.0001661; Istomina V. S., 1957, SEEPAGE INSTABILITY; Ke L, 2012, SOILS FOUND, V52, P698, DOI 10.1016/j.sandf.2012.07.010; KENNEY TC, 1985, CAN GEOTECH J, V22, P215, DOI 10.1139/t85-029; Ma D, 2019, ENG FRACT MECH, V220, DOI 10.1016/j.engfracmech.2019.106640; Ma D, 2019, TUNN UNDERGR SP TECH, V91, DOI 10.1016/j.tust.2019.102993; Ma D, 2019, ENVIRON SCI POLLUT R, V26, P19719, DOI 10.1007/s11356-019-05311-x; Mehdizadeh A., 2018, P 9 INT C SCOUR ER T, P19; Mehdizadeh A, 2018, INT J GEOMECH, V18, DOI [10.1061/(asce)gm.1943-5622.0001085, 10.1061/(ASCE)GM.1943-5622.0001085]; Rochim A, 2017, J GEOTECH GEOENVIRON, V143, DOI [10.1061/(asce)gt.1943-5606.0001673, 10.1061/(ASCE)GT.1943-5606.0001673]; SCHULER U, 1995, RES DEV FIELD DAMS, P145; Taylor HF, 2019, GEOTECHNIQUE, V69, P274, DOI 10.1680/jgeot.17.T.051; Tomlinson SS, 2000, CAN GEOTECH J, V37, P1, DOI 10.1139/cgj-37-1-1; Wan CF, 2008, J GEOTECH GEOENVIRON, V134, P401, DOI 10.1061/(ASCE)1090-0241(2008)134:3(401); Xie QY, 2018, PROCESSES, V6, DOI 10.3390/pr6070092; Yang J, 2020, ARCH COMPUT METHOD E, V27, P673, DOI 10.1007/s11831-019-09330-2; Zhong CH, 2018, J GEOTECH GEOENVIRON, V144, DOI 10.1061/(ASCE)GT.1943-5606.0001935; Zhou Z., 2006, ROCK SOIL MECHNICS, V27, P665	24	3	3	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2020	15	2							e0229559	10.1371/journal.pone.0229559	http://dx.doi.org/10.1371/journal.pone.0229559			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8HR	32109942	Green Published, gold			2022-12-26	WOS:000535239800015
J	Evers, C; Ostheimer, C; Sieker, F; Vordermark, D; Medenwald, D				Evers, Christoph; Ostheimer, Christian; Sieker, Frank; Vordermark, Dirk; Medenwald, Daniel			Benefit from surgery with additional radiotherapy in N1 head and neck cancer at the time of IMRT: A population-based study on recent developments	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; MODULATED RADIATION-THERAPY; NODE-POSITIVE HEAD; HUMAN-PAPILLOMAVIRUS; POSTOPERATIVE RADIOTHERAPY; ADJUVANT RADIOTHERAPY; OROPHARYNGEAL CANCER; UNITED-STATES; ORAL-CAVITY; SURVIVAL	Background Currently, the role of adjuvant irradiation in head and neck cancer (HNC) patients with N1-lymph node status is not clarified. Objectives To assess the population-based effect of recent developments in radiotherapy such as intensity-modulated radiotherapy (IMRT) in relation to overall survival (OS) together with surgery in N1 HNC patients. Materials and methods We used 9,318 HNC cases with pT1/2 N0/1 disease from German cancer registries. Time of diagnosis ranged from January 2000 to December 2014, which we divided into three periods: (low [LIA] vs intermediate [IA] vs high [HIA] IMRT availability period) based on usage of IMRT in Germany. For each period, we examined a possible association between treatment (surgery vs. surgery and radiotherapy) in terms of OS. Statistical analyses included Kaplan-Meier and multivariate Cox regression (models adjusted for HPV-related cancer site). Results Temporal analysis revealed increasing usage of IMRT in Germany. In patients with N1 tumours, a comparison of patients treated with and without radiotherapy during the HIA period showed a superiority of the combined treatment as opposed to surgery alone (HR 0.54, 95%CI: 0.35-0.85, p = 0.003). The survival analyses related to treatments in terms of period underlined the superiority of surgery plus radiotherapy between periods IA and HIA (p = 0.03). Conclusion The advent of IMRT, additional radiotherapy may present a survival advantage in patients with N1 HNC when combined with surgery.	[Evers, Christoph] Martin Luther Univ Halle Wittenberg, Med Fac, Saale, Saxony Anhalt, Germany; [Evers, Christoph] Univ Hosp Leipzig, Dept Radiat Oncol, Leipzig, Saxony, Germany; [Ostheimer, Christian; Sieker, Frank; Vordermark, Dirk; Medenwald, Daniel] Martin Luther Univ Halle Wittenberg, Dept Radiat Oncol, Saale, Saxony Anhalt, Germany; [Medenwald, Daniel] Martin Luther Univ Halle Wittenberg, Inst Med Epidemiol, Saale, Saxony Anhalt, Germany	Martin Luther University Halle Wittenberg; Leipzig University; Martin Luther University Halle Wittenberg; Martin Luther University Halle Wittenberg	Evers, C (corresponding author), Martin Luther Univ Halle Wittenberg, Med Fac, Saale, Saxony Anhalt, Germany.; Evers, C (corresponding author), Univ Hosp Leipzig, Dept Radiat Oncol, Leipzig, Saxony, Germany.	Christoph.evers@uk-halle.de		Evers, Christoph/0000-0002-7115-474X	Publishing Fund of Martin Luther University Halle-Wittenberg	Publishing Fund of Martin Luther University Halle-Wittenberg	The study was funded by the Publishing Fund of Martin Luther University Halle-Wittenberg The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ang KK, 2010, NEW ENGL J MED, V363, P24, DOI 10.1056/NEJMoa0912217; Ang KK, 2001, INT J RADIAT ONCOL, V51, P571, DOI 10.1016/S0360-3016(01)01690-X; Barry CP, 2017, HEAD NECK-J SCI SPEC, V39, P1399, DOI 10.1002/hed.24780; Benard VB, 2008, CANCER-AM CANCER SOC, V113, P2910, DOI 10.1002/cncr.23742; Boero IJ, 2016, J CLIN ONCOL, V34, P684, DOI 10.1200/JCO.2015.63.9898; Chaturvedi AK, 2008, J CLIN ONCOL, V26, P612, DOI 10.1200/JCO.2007.14.1713; Chaturvedi AK, 2011, J CLIN ONCOL, V29, P4294, DOI 10.1200/JCO.2011.36.4596; Chen MM, 2016, JAMA OTOLARYNGOL, V142, P1224, DOI 10.1001/jamaoto.2016.3519; Edge SB, 2010, ANN SURG ONCOL, V17, P1471, DOI 10.1245/s10434-010-0985-4; Fritz A, 2000, INT CLASSIFICATION D; Greene Frederick L, 2002, Bull Am Coll Surg, V87, P13; Gregoire V, 2007, ONCOLOGIST, V12, P555, DOI 10.1634/theoncologist.12-5-555; Hager B, 2015, RADIOTHER ONCOL, V115, P90, DOI 10.1016/j.radonc.2015.02.024; Ingarfield K, 2019, FRONT ONCOL, V8, DOI 10.3389/fonc.2018.00673; Jackel MC, 2008, HEAD NECK-J SCI SPEC, V30, P875, DOI 10.1002/hed.20794; Jansen L, 2018, ORAL ONCOL, V76, P8, DOI 10.1016/j.oraloncology.2017.11.015; Kao J, 2008, INT J RADIAT ONCOL, V71, P362, DOI 10.1016/j.ijrobp.2007.09.058; Lavaf A, 2008, CANCER-AM CANCER SOC, V112, P535, DOI 10.1002/cncr.23206; Liebig C, 2009, CANCER-AM CANCER SOC, V115, P3379, DOI 10.1002/cncr.24396; Marta GN, 2014, RADIOTHER ONCOL, V110, P9, DOI 10.1016/j.radonc.2013.11.010; Merlotti A, 2014, RADIAT ONCOL, V9, DOI 10.1186/s13014-014-0264-9; Moergel M, 2011, STRAHLENTHER ONKOL, V187, P337, DOI 10.1007/s00066-011-2206-x; Mohan R, 2000, INT J RADIAT ONCOL, V46, P619, DOI 10.1016/S0360-3016(99)00438-1; Nguyen NTA, 2018, CURR TREAT OPTION ON, V19, DOI 10.1007/s11864-018-0554-9; Nutting CM, 2011, LANCET ONCOL, V12, P127, DOI 10.1016/S1470-2045(10)70290-4; Ostheimer C, 2019, J CANCER RES CLIN, V145, P2813, DOI 10.1007/s00432-019-03013-y; Pagedar NA, 2017, CANCER CAUSE CONTROL, V28, P1085, DOI 10.1007/s10552-017-0938-3; Pfister DG SS, 2018, NCCN GUIDELINES HEAD; Pollom EL, 2017, INT J RADIAT ONCOL, V98, P177, DOI 10.1016/j.ijrobp.2017.01.006; Rathod S, 2013, ORAL ONCOL, V49, P634, DOI 10.1016/j.oraloncology.2013.02.013; Roman BR, 2017, J SURG ONCOL, V116, P351, DOI 10.1002/jso.24674; Schmitd LB, 2018, J DENT RES, V97, P742, DOI 10.1177/0022034518756297; Schmitz S, 2009, EUR ARCH OTO-RHINO-L, V266, P437, DOI 10.1007/s00405-008-0767-9; Shrime MG, 2010, ARCH OTOLARYNGOL, V136, P225, DOI 10.1001/archoto.2010.22; Stein AP, 2015, CANCER J, V21, P138, DOI 10.1097/PPO.0000000000000115; Studer G, 2006, RADIAT ONCOL, V1, DOI 10.1186/1748-717X-1-7; Tinhofer I, 2015, EUR J CANCER, V51, P514, DOI 10.1016/j.ejca.2014.12.018; VOKES EE, 1993, NEW ENGL J MED, V328, P184, DOI 10.1056/NEJM199301213280306; Ward MC, 2016, JAMA OTOLARYNGOL, V142, P1164, DOI 10.1001/jamaoto.2016.1876; Ward MC, 2017, ESSENTIALS CLIN RAD; World Health Organization, 2004, INT STAT CLASS DIS R; Yao M, 2005, INT J RADIAT ONCOL, V63, P410, DOI 10.1016/j.ijrobp.2005.02.025	42	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2020	15	2							e0229266	10.1371/journal.pone.0229266	http://dx.doi.org/10.1371/journal.pone.0229266			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8FM	32101560	gold, Green Published			2022-12-26	WOS:000535233700022
J	Glinge, C; Engstrom, T; Midgley, SE; Tanck, MWT; Madsen, JEH; Pedersen, F; Jacobsen, MR; Lodder, EM; Al-Hussainy, NR; Stampe, NK; Trebbien, R; Kober, L; Gerds, T; Torp-Pedersen, C; Fischer, TK; Bezzina, CR; Tfelt-Hansen, J; Jabbari, R				Glinge, Charlotte; Engstrom, Thomas; Midgley, Sofie E.; Tanck, Michael W. T.; Madsen, Jeppe Ekstrand Halkjaer; Pedersen, Frants; Jacobsen, Mia Ravn; Lodder, Elisabeth M.; Al-Hussainy, Nour R.; Stampe, Niels Kjaer; Trebbien, Ramona; Kober, Lars; Gerds, Thomas; Torp-Pedersen, Christian; Fischer, Thea Kolsen; Bezzina, Connie R.; Tfelt-Hansen, Jacob; Jabbari, Reza			Seasonality of ventricular fibrillation at first myocardial infarction and association with viral exposure	PLOS ONE			English	Article							SUDDEN CARDIAC DEATH; CARDIOVASCULAR-DISEASE; ADENOVIRUS RECEPTOR; INFLUENZA EPIDEMICS; NATIONWIDE; SYMPTOMS; PREVENTION; CONDUCTION; COXSACKIE; INFECTION	Aims To investigate seasonality and association of increased enterovirus and influenza activity in the community with ventricular fibrillation (VF) risk during first ST-elevation myocardial infarction (STEMI). Methods This study comprised all consecutive patients with first STEMI (n = 4,659; aged 18-80 years) admitted to the invasive catheterization laboratory between 2010-2016, at Copenhagen University Hospital, Rigshospitalet, covering eastern Denmark (2.6 million inhabitants, 45% of the Danish population). Hospital admission, prescription, and vital status data were assessed using Danish nationwide registries. We utilized monthly/weekly surveillance data for enterovirus and influenza from the Danish National Microbiology Database (2010-2016) that receives copies of laboratory tests from all Danish departments of clinical microbiology. Results Of the 4,659 consecutively enrolled STEMI patients, 581 (12%) had VF before primary percutaneous coronary intervention. In a subset (n = 807), we found that VF patients experienced more generalized fatigue and flu-like symptoms within 7 days before STEMI compared with the patients without VF (OR 3.39, 95% CI 1.76-6.54). During the study period, 2,704 individuals were diagnosed with enterovirus and 19,742 with influenza. No significant association between enterovirus and VF (OR 1.00, 95% CI 0.99-1.02), influenza and VF (OR 1.00, 95% CI 1.00-1.00), or week number and VF (p-value 0.94 for enterovirus and 0.89 for influenza) was found. Conclusion We found no clear seasonality of VF during first STEMI. Even though VF patients had experienced more generalized fatigue and flu-like symptoms within 7 days before STEMI compared with patients without VF, no relationship was found between enterovirus or influenza exposure and occurrence of VF.	[Glinge, Charlotte; Engstrom, Thomas; Madsen, Jeppe Ekstrand Halkjaer; Pedersen, Frants; Jacobsen, Mia Ravn; Al-Hussainy, Nour R.; Stampe, Niels Kjaer; Kober, Lars; Tfelt-Hansen, Jacob; Jabbari, Reza] Copenhagen Univ Hosp, Rigshosp, Heart Ctr, Dept Cardiol, Copenhagen, Denmark; [Glinge, Charlotte; Lodder, Elisabeth M.; Bezzina, Connie R.] Univ Amsterdam, Heart Ctr, Dept Clin & Expt Cardiol, Amsterdam UMC,Amsterdam Cardiovasc Sci, Amsterdam, Netherlands; [Engstrom, Thomas] Lund Univ, Dept Cardiol, Lund, Sweden; [Midgley, Sofie E.; Trebbien, Ramona; Fischer, Thea Kolsen] Statens Serum Inst, Dept Virus & Microbiol Special Diagnost, Div Infect Dis Preparedness, Copenhagen, Denmark; [Tanck, Michael W. T.] Univ Amsterdam, Dept Clin Epidemiol Biostat & Bioinformat, Amsterdam UMC, Amsterdam Publ Hlth APH, Amsterdam, Netherlands; [Madsen, Jeppe Ekstrand Halkjaer; Gerds, Thomas] Univ Copenhagen, Fac Med Sci, Sect Biostat, Copenhagen, Denmark; [Torp-Pedersen, Christian] Nordsjaellands Hosp, Dept Clin Invest & Cardiol, Hillerod, Denmark; [Torp-Pedersen, Christian] Aalborg Univ Hosp, Dept Cardiol, Aalborg, Denmark; [Fischer, Thea Kolsen] Univ Southern Denmark, Clin Inst, Dept Infect Dis, Odense, Denmark; [Fischer, Thea Kolsen] Univ Southern Denmark, Clin Inst, Dept Global Hlth, Odense, Denmark; [Tfelt-Hansen, Jacob] Univ Copenhagen, Fac Med Sci, Dept Forens Med, Copenhagen, Denmark; [Jabbari, Reza] Brigham & Womens Hosp, Int External Collab Sponsored Staff, Div Prevent Med, 75 Francis St, Boston, MA 02115 USA	Rigshospitalet; University of Copenhagen; University of Amsterdam; Lund University; Statens Serum Institut; University of Amsterdam; University of Copenhagen; Aalborg University; Aalborg University Hospital; University of Southern Denmark; University of Southern Denmark; University of Copenhagen; Harvard University; Brigham & Women's Hospital	Glinge, C (corresponding author), Copenhagen Univ Hosp, Rigshosp, Heart Ctr, Dept Cardiol, Copenhagen, Denmark.; Glinge, C (corresponding author), Univ Amsterdam, Heart Ctr, Dept Clin & Expt Cardiol, Amsterdam UMC,Amsterdam Cardiovasc Sci, Amsterdam, Netherlands.	cglinge@gmail.com	Tfelt-Hansen, Jacob/AAU-8691-2020; Al-Hussainy, Nour/AFL-8193-2022; Jabbari, Reza/AAM-6649-2021; Al-Hussainy, Nour/AAG-8173-2022; Fischer, Thea K/AAH-9892-2019; Glinge, Charlotte/C-4983-2018	Tfelt-Hansen, Jacob/0000-0003-3895-9316; Al-Hussainy, Nour/0000-0002-9118-206X; Jabbari, Reza/0000-0002-9432-0632; Al-Hussainy, Nour/0000-0002-9118-206X; Fischer, Thea K/0000-0003-4812-980X; Madsen, Jeppe Ekstrand Halkjaer/0000-0002-7327-3224; Kober, Lars/0000-0002-6635-1466; Glinge, Charlotte/0000-0003-0406-256X; Gerds, Thomas Alexander/0000-0002-5955-816X; Trebbien, Ramona/0000-0003-2352-5726; Bezzina, Connie/0000-0002-0633-3514; Tanck, Michael/0000-0001-9828-4459; Stampe, Niels Kjaer/0000-0003-2510-1046; Ravn Jacobsen, Mia/0000-0002-3990-4176	Novo Nordisk Foundation, Copenhagen, Denmark [NNFOC140011573]; Copenhagen University Hospital; Rigshospitalets Forskningspuljer, Rigshospitalet, Copenhagen, Denmark; ESC Research Grant	Novo Nordisk Foundation, Copenhagen, Denmark(Novo Nordisk Foundation); Copenhagen University Hospital; Rigshospitalets Forskningspuljer, Rigshospitalet, Copenhagen, Denmark; ESC Research Grant	This study was supported by funding from the Novo Nordisk Foundation (number NNFOC140011573), Copenhagen, Denmark, and C. Glinge was funded by the Copenhagen University Hospital, Rigshospitalets Forskningspuljer, Rigshospitalet, Copenhagen, Denmark, and the ESC Research Grant. The funders were not involved in any aspects of the study or the decision to submit for publication.	Andreoletti L, 2007, J AM COLL CARDIOL, V50, P2207, DOI 10.1016/j.jacc.2007.07.080; [Anonymous], 2019, R LANG ENV STAT COMP; Arking DE, 2004, CIRC RES, V94, P712, DOI 10.1161/01.RES.0000123861.16082.95; Arntz HR, 2000, EUR HEART J, V21, P315, DOI 10.1053/euhj.1999.1739; Bagai A, 2013, CIRCULATION, V128, P2595, DOI 10.1161/CIRCULATIONAHA.113.004164; Barnes M, 2015, HEART, V101, P1738, DOI 10.1136/heartjnl-2015-307691; Bezzina CR, 2010, NAT GENET, V42, P688, DOI 10.1038/ng.623; BOWLES NE, 1986, LANCET, V1, P1120; Bugert P, 2011, CLIN CHEM LAB MED, V49, P1237, DOI 10.1515/CCLM.2011.190; Chang TY, 2016, HEART RHYTHM, V13, P1189, DOI 10.1016/j.hrthm.2016.01.026; Chugh SS, 2010, NAT REV CARDIOL, V7, P318, DOI 10.1038/nrcardio.2010.52; Clar C, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005050.pub3; Condell O, 2016, EURO SURVEILL B EUR, V21; Corrales-Medina VF, 2010, LANCET INFECT DIS, V10, P83, DOI 10.1016/S1473-3099(09)70331-7; Deo R, 2012, CIRCULATION, V125, P620, DOI 10.1161/CIRCULATIONAHA.111.023838; Feldman AM, 2000, NEW ENGL J MED, V343, P1388, DOI 10.1056/NEJM200011093431908; Gaist D, 1997, DAN MED BULL, V44, P445; Gerber Y, 2006, J AM COLL CARDIOL, V48, P287, DOI 10.1016/j.jacc.2006.02.065; Glinge C, 2015, J CARDIOVASC ELECTR, V26, P761, DOI 10.1111/jce.12674; Herlitz J, 2002, RESUSCITATION, V54, P133, DOI 10.1016/S0300-9572(02)00097-7; Jabbari R, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170193; Jabbari R, 2015, AM J CARDIOL, V116, P678, DOI 10.1016/j.amjcard.2015.05.037; Jabbari R, 2015, J AM HEART ASSOC, V4, DOI 10.1161/JAHA.114.001399; Jabbari R, 2013, HEART, V99, P938, DOI 10.1136/heartjnl-2012-303534; Kildemoes HW, 2011, SCAND J PUBLIC HEALT, V39, P38, DOI 10.1177/1403494810394717; Klein RM, 2002, SCAND J INFECT DIS, V34, P746, DOI 10.1080/00365540110076949; Kwong JC, 2018, NEW ENGL J MED, V378, P345, DOI 10.1056/NEJMoa1702090; Lim BK, 2008, J CLIN INVEST, V118, P2758, DOI 10.1172/JCI34777; Lisewski U, 2008, J EXP MED, V205, P2369, DOI 10.1084/jem.20080897; MacIntyre CR, 2016, HEART, V102, P1953, DOI 10.1136/heartjnl-2016-309983; Madjid M, 2007, EUR HEART J, V28, P1205, DOI 10.1093/eurheartj/ehm035; Marijon E, 2016, ANN INTERN MED, V164, P23, DOI 10.7326/M14-2342; Marsman RFJ, 2014, J AM COLL CARDIOL, V63, P549, DOI 10.1016/j.jacc.2013.10.062; Modin D, 2019, CIRCULATION, V139, P575, DOI 10.1161/CIRCULATIONAHA.118.036788; Nguyen JL, 2016, JAMA CARDIOL, V1, P274, DOI 10.1001/jamacardio.2016.0433; Onozuka D, 2018, INT J CARDIOL, V263, P158, DOI 10.1016/j.ijcard.2018.02.028; Pedersen CB, 2011, SCAND J PUBLIC HEALT, V39, P22, DOI 10.1177/1403494810387965; Priori SG, 2015, EUR HEART J, V36, P2757, DOI 10.1093/eurheartj/ehv445; Ryti NRI, 2017, SCI REP-UK, V7, DOI 10.1038/srep41060; Schmidt M, 2015, CLIN EPIDEMIOL, V7, P449, DOI 10.2147/CLEP.S91125; Straus SMJM, 2004, J CLIN EPIDEMIOL, V57, P98, DOI 10.1016/S0895-4356(03)00210-5; Tse G, 2016, FRONT PHYSIOL, V7, DOI 10.3389/fphys.2016.00308; Warren-Gash C, 2011, J INFECT DIS, V203, P1710, DOI 10.1093/infdis/jir171; Warren-Gash C, 2009, LANCET INFECT DIS, V9, P601, DOI 10.1016/S1473-3099(09)70233-6; Weerasinghe DP, 2002, HEART, V88, P30, DOI 10.1136/heart.88.1.30; Wellens HJJ, 2014, EUR HEART J, V35, P1642, DOI 10.1093/eurheartj/ehu176; Winkel BG, 2011, EUR HEART J, V32, P983, DOI 10.1093/eurheartj/ehq428	47	3	3	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2020	15	2							e0226936	10.1371/journal.pone.0226936	http://dx.doi.org/10.1371/journal.pone.0226936			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8FM	32101559	Green Published, gold			2022-12-26	WOS:000535233700005
J	Jain, R; Bronkema, SM; Yakah, W; Rowntree, JE; Bitler, CA; Fenton, JI				Jain, Raghav; Bronkema, Sara M.; Yakah, William; Rowntree, Jason E.; Bitler, Chad A.; Fenton, Jenifer, I			Seasonal differences exist in the polyunsaturated fatty acid, mineral and antioxidant content of US grass-finished beef	PLOS ONE			English	Article							CONJUGATED LINOLEIC-ACID; ANIMAL PERFORMANCE; INTRAMUSCULAR FAT; VITAMIN-E; PASTURE; MEAT; HEALTH; CONCENTRATE; CATTLE; STABILITY	There is increased consumer interest in grass-finished beef (GFB) with retail sales reaching $272 million in 2016. GFB contains higher omega-3 fatty acid levels compared to grain-finished beef, but variations in fatty acid (FA), mineral, and antioxidant content by producers and season is poorly documented. Hence, GFB samples from cattle finished in both fall and spring were obtained from four producers representing several US sub-regions. FAs were extracted using microwave-assisted extraction, derivatized to methyl-esters, and quantified using gas chromatography-mass spectrometry. Mineral content was quantified using coupled plasma mass-spectrometry and antioxidants were quantified via UV-absorption. Overall, total omega-3 FA content was greater in beef from cattle finished in the spring (13.4 mg/100g beef) than the fall (10.3; P<0.001). Additionally, alpha-tocopherol was present in greater amounts in spring-finished beef (259 vs. 223 ug/100g beef, P<0.001) as was the micromineral selenium (18.2 vs. 17.3ug/100g beef, P = 0.008). Despite using the same feed in fall and spring, cattle from producer 4 had higher total omega-3, omega-6, and total polyunsaturated fatty acids in spring compared to fall (P<0.010). These results suggest there are seasonal differences in omega-3 and omega-6 fatty acids, minerals and antioxidants in grass-finished beef independent of finishing diet.	[Jain, Raghav; Yakah, William; Fenton, Jenifer, I] Michigan State Univ, Dept Food Sci & Human Nutr, E Lansing, MI 48824 USA; [Bronkema, Sara M.; Rowntree, Jason E.] Michigan State Univ, Dept Anim Sci, E Lansing, MI 48824 USA; [Bitler, Chad A.] Greenacres Fdn, Cincinnati, OH USA	Michigan State University; Michigan State University	Fenton, JI (corresponding author), Michigan State Univ, Dept Food Sci & Human Nutr, E Lansing, MI 48824 USA.	imigjeni@msu.edu	Yakah, William/AAR-6932-2021	Yakah, William/0000-0003-3264-5404; Jain, Raghav/0000-0002-1284-6762; Fenton, Jenifer/0000-0002-8875-3239	Greenacres foundation	Greenacres foundation	This research is funded by Greenacres foundation.	Akil M, 2015, BRATISL MED J, V116, P233, DOI 10.4149/BLL_2015_045; Alfaia CPM, 2009, FOOD CHEM, V114, P939, DOI 10.1016/j.foodchem.2008.10.041; Ballet N., 2000, VITAMINS FORAGES; Baumgard LH, 2013, ANNU REV ANIM BIOSCI, V1, P311, DOI 10.1146/annurev-animal-031412-103644; Bradford HL, 2016, J ANIM SCI, V94, P4369, DOI 10.2527/jas.2016-0683; Bronkema S.M., 2019, MEAT MUSCLE BIOL, V3, P116, DOI [10.22175/mmb2018.10.0034, DOI 10.22175/MMB2018.10.0034]; Chail A, 2016, J ANIM SCI, V94, P2184, DOI 10.2527/jas.2015-0241; Cheung R., 2017, BACK GRASS MARKET PO; Daley CA, 2010, NUTR J, V9, DOI 10.1186/1475-2891-9-10; Descalzo AM, 2005, MEAT SCI, V70, P35, DOI 10.1016/j.meatsci.2004.11.018; Dewhurst RJ, 2006, ANIM FEED SCI TECH, V131, P168, DOI 10.1016/j.anifeedsci.2006.04.016; Dierking RM, 2010, CROP SCI, V50, P391, DOI 10.2135/cropsci2008.12.0741; Domaradzki P, 2016, BIOL TRACE ELEM RES, V171, P328, DOI 10.1007/s12011-015-0549-3; Duckett SK, 2013, J ANIM SCI, V91, P1454, DOI 10.2527/jas.2012-5914; Dumont B, 2007, ANIMAL, V1, P1042, DOI 10.1017/S1751731107000250; Fernandez ML, 2005, J NUTR, V135, P2075, DOI 10.1093/jn/135.9.2075; French P, 2000, J ANIM SCI, V78, P2849; Fuke G, 2017, CRIT REV FOOD SCI, V57, P1, DOI 10.1080/10408398.2012.716800; Candela CG, 2011, NUTR HOSP, V26, P323, DOI [10.1590/S0212-16112011000200013, 10.3305/nh.2011.26.2.5117]; Husted KS, 2016, MEDICINA-LITHUANIA, V52, P139, DOI 10.1016/j.medici.2016.05.003; Insani EM, 2008, MEAT SCI, V79, P444, DOI 10.1016/j.meatsci.2007.10.017; Jain R, 2018, J NUTR BIOCHEM, V59, P1, DOI 10.1016/j.jnutbio.2018.02.015; KILCHER MR, 1981, J RANGE MANAGE, V34, P363, DOI 10.2307/3897904; Leheska JM, 2008, J ANIM SCI, V86, P3575, DOI 10.2527/jas.2007-0565; Locke A, 2018, AM FAM PHYSICIAN, V97, P721; Martin SS, 2012, MED CLIN N AM, V96, P13, DOI 10.1016/j.mcna.2012.01.009; Mirzad AN, 2018, J VET MED SCI, V80, P20, DOI 10.1292/jvms.17-0321; Palmquist Donald L, 2005, Adv Food Nutr Res, V50, P179, DOI 10.1016/S1043-4526(05)50006-8; Patterson E, 2012, J NUTR METAB, V2012, DOI 10.1155/2012/539426; Pestana JM, 2012, MEAT SCI, V90, P819, DOI 10.1016/j.meatsci.2011.11.023; Ponnampalam EN, 2018, REV SCI TECH OIE, V37, P57, DOI 10.20506/rst.37.1.2740; Preston RL, 1999, BEEF, P1; Provenza FD, 2019, FRONT NUTR, V6, DOI 10.3389/fnut.2019.00026; ROBERTS AHC, 1987, NEW ZEAL J EXP AGR, V15, P283, DOI 10.1080/03015521.1987.10425573; Sales-Campos H, 2013, MINI-REV MED CHEM, V13, P201; Schmidt JR, 2013, J ANIM SCI, V91, P4451, DOI 10.2527/jas.2012-5405; Scollan N, 2006, FATTY ACID COMPOSITI, P23; Scollan N, 2006, MEAT SCI, V74, P17, DOI 10.1016/j.meatsci.2006.05.002; Silva-Ramirez AS, 2018, EUR J LIPID SCI TECH, V120, DOI 10.1002/ejlt.201700454; Simopoulos AP, 2002, BIOMED PHARMACOTHER, V56, P365, DOI 10.1016/S0753-3322(02)00253-6; Sobczuk-Szul M, 2013, ASIAN AUSTRAL J ANIM, V26, P275, DOI 10.5713/ajas.2012.12371; Steiner J.L., 2015, SO PLAINS ASSESSMENT; Tinggi U, 2008, SELENIUM ITS ROLE AN; Tume RK, 2004, AUST J EXP AGR, V44, P663, DOI 10.1071/EA02152; Turner KE, 2002, J ANIM SCI, V80, P2513; Umberger WJ, 2009, AUST J AGR RESOUR EC, V53, P603, DOI 10.1111/j.1467-8489.2009.00466.x; USDA, 1999, USDA NUTR DAT STAND; USDA, 2016, USDA AGR MARK SERV G; Uzhova I, 2018, EUR J CLIN NUTR; Wang XP, 2012, LIPIDS HEALTH DIS, V11, DOI 10.1186/1476-511X-11-25; Whigham LD, 2007, AM J CLIN NUTR, V85, P1203; Wood JD, 2007, BRIT GRASSL SOC OCC; Yang A, 2002, MEAT SCI, V60, P41, DOI 10.1016/S0309-1740(01)00103-6; Yoshihara Y, 2013, AGROFOREST SYST, V87, P901, DOI 10.1007/s10457-013-9606-0	54	7	7	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2020	15	2							e0229340	10.1371/journal.pone.0229340	http://dx.doi.org/10.1371/journal.pone.0229340			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8FM	32101561	gold, Green Published			2022-12-26	WOS:000535233700027
J	Orimbo, EO; Oyugi, E; Dulacha, D; Obonyo, M; Hussein, A; Githuku, J; Owiny, M; Gura, Z				Orimbo, Erick Otieno; Oyugi, Elvis; Dulacha, Diba; Obonyo, Mark; Hussein, Abubakar; Githuku, Jane; Owiny, Maurice; Gura, Zeinab			Knowledge, attitude and practices on cholera in an arid county, Kenya, 2018: A mixed-methods approach	PLOS ONE			English	Article								Background Cholera remains a public health problem in Kenya despite increased efforts to create awareness. Assessment of knowledge, attitude and practice (KAP) in the community is essential for the planning and implementation of preventive measures. We assessed cholera KAP in a community in Isiolo County, Kenya. Methods This cross-sectional study involved a mixed-methods approach utilizing a questionnaire survey and focus group discussions (FGDs). Using multistage sampling with household as the secondary sampling unit, interviewers administered structured questionnaires to one respondent aged.18 years old per household. We created knowledge score by allotting one point for each correct response, considered any total score. median score as high knowledge score, calculated descriptive statistics and used multivariate logistic regression to examine factors associated with high knowledge score. In FGDs, we randomly selected the participants aged.18 years and had lived in Isiolo for > 1 year, conducted the FGDs using an interview guide and used content analysis to identify salient emerging themes. Results We interviewed 428 participants (median age = 30 years; Q1 = 25, Q3 = 38) comprising 372 (86.9%) females. Of the 425/428 (99.3%) who had heard about cholera, 311/425 (73.2%) knew that it is communicable. Although 273/428 (63.8%) respondents knew the importance of treating drinking water, only 216/421 (51.3%) treated drinking water. Those with good defecation practice were 209/428 (48.8%). Respondents with high knowledge score were 227/ 428 (53.0%). Positive attitude (aOR = 2.88, 95% C.I = 1.34-6.20), treating drinking water (aOR = 2.21, 95% C.I = 1.47-3.33), age < 36 years (aOR = 1.75, 95% C.I = 1.11-2.74) and formal education (aOR = 1.71, 95% C.I = 1.08-2.68) were independently associated with high knowledge score. FGDs showed poor latrine coverage, inadequate water treatment and socio-cultural beliefs as barriers to cholera prevention and control. Conclusions There was a high knowledge score on cholera with gaps in preventive practices. We recommend targeted health education to the old and uneducated persons and general strengthening of health education in the community.	[Orimbo, Erick Otieno; Oyugi, Elvis; Dulacha, Diba; Obonyo, Mark; Hussein, Abubakar; Githuku, Jane; Owiny, Maurice; Gura, Zeinab] Minist Hlth, Field Epidemiol & Lab Training FELTP Kenya, Nairobi, Kenya; [Orimbo, Erick Otieno] Cty Govt Migori, Migori, Kenya; [Hussein, Abubakar] Cty Govt Isiolo, Dept Hlth, Isiolo, Kenya		Orimbo, EO (corresponding author), Minist Hlth, Field Epidemiol & Lab Training FELTP Kenya, Nairobi, Kenya.; Orimbo, EO (corresponding author), Cty Govt Migori, Migori, Kenya.	erickorimbo@gmail.com		Orimbo, Erick/0000-0001-7546-7754	Kenya Field Epidemiology and Laboratory Training Program	Kenya Field Epidemiology and Laboratory Training Program	The field work for this study was funded by the Kenya Field Epidemiology and Laboratory Training Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali M, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003832; Ali M, 2012, B WORLD HEALTH ORGAN, V90, P209, DOI 10.2471/BLT.11.093427; CDC, 2016, CHOL VIBR CHOL INF; Clemens JD, 2017, SEMINAR CHOLERA; Cochran WG., 1963, SAMPLING TECHNIQUES; Date K, 2013, J INFECT DIS, V208, pS62, DOI 10.1093/infdis/jit198; Isiolo County Government, 2013, COUNT INT DEV PLAN 2; Kenya National Bureau of Statistics (KNBS), 2009, 2009 POP CENS REP; Kenya Red Cross Society, 2016, CHOL RESP FOC SIAYA; Lantagne D, 2018, J INFECT DIS, V218, pS147, DOI 10.1093/infdis/jiy488; Leus T., 2006, AADAA BORAANAA DICT; Mandal S, 2011, ASIAN PAC J TROP MED, V4, P573, DOI 10.1016/S1995-7645(11)60149-1; Ministry of Health, KEN HLTH INF SYST; Ministry of Health Kenya, 2009, AR YOUR HANDS CLEAN; Mohamed AA, 2012, EMERG INFECT DIS, V18, P925, DOI 10.3201/eid1806.111774; Mpazi V, 2005, KNOWLEDGE ATTITUDES; Rabbi SE, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-89; Shikanga OT, 2009, AM J TROP MED HYG, V81, P1085, DOI 10.4269/ajtmh.2009.09-0400; Wahed T, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-242; World Health Organization, 2017, CHOL FACT SHEET; World Health Organization, 2017, CHOL KEN	21	4	5	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2020	15	2							e0229437	10.1371/journal.pone.0229437	http://dx.doi.org/10.1371/journal.pone.0229437			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8FM	32101587	Green Published, gold			2022-12-26	WOS:000535233700033
J	Wang, KH; Vorontsova, I; Hoshino, M; Uesugi, K; Yagi, N; Hall, JE; Schilling, TF; Pierscionek, BK				Wang, Kehao; Vorontsova, Irene; Hoshino, Masato; Uesugi, Kentaro; Yagi, Naoto; Hall, James E.; Schilling, Thomas F.; Pierscionek, Barbara K.			Optical development in the zebrafish eye lens	FASEB JOURNAL			English	Article						eye lens; ocular development; vision; zebrafish	GRADIENT REFRACTIVE-INDEX; AFRICAN CICHLID FISH; CRYSTALLINE LENS; SPHERICAL-ABERRATION; ZONES; SHAPE; QUALITY; GROWTH; MOUSE	The optics of the eye is the key to a functioning visual system. The exact nature of the correlation between ocular optics and eye development is not known because of the paucity of knowledge about the growth of a key optical element, the eye lens. The sophisticated optics of the lens and its gradient of refractive index provide the superior optical quality that the eye needs and which, it is thought, has a major influence on the development of proper visual function. The nature of a gradient refractive index lens, however, renders accurate measurements of its development difficult to make and has been the reason why the influence of lens growth on visual function remains largely unknown. Novel imaging techniques have made it possible to investigate growth of the eye lens in the zebrafish. This study shows measurements using X-ray Talbot interferometry of three-dimensional gradient index profiles in eye lenses of zebrafish from late larval to adult stages. The zebrafish lens shows evidence of a gradient of refractive index from the earliest stages measured and its growth suggests an apparent coincidence between periods of rapid increase in refractive index in the lens nucleus and increased expression of a particular crystallin protein group.	[Wang, Kehao; Pierscionek, Barbara K.] Nottingham Trent Univ, Sch Sci & Technol, Nottingham NG11 8NS, England; [Vorontsova, Irene; Hall, James E.] Univ Calif Irvine, Dept Physiol & Biophys, Irvine, CA 92717 USA; [Vorontsova, Irene; Schilling, Thomas F.] Univ Calif Irvine, Dept Dev & Cell Biol, Irvine, CA 92717 USA; [Hoshino, Masato; Uesugi, Kentaro; Yagi, Naoto] Japan Synchrotron Radiat Res Inst Spring 8, Sayo, Hyogo, Japan; [Pierscionek, Barbara K.] Staffordshire Univ, Sch Life Sci & Educ, Stafford, England	Nottingham Trent University; University of California System; University of California Irvine; University of California System; University of California Irvine; Japan Synchrotron Radiation Research Institute; Staffordshire University	Pierscionek, BK (corresponding author), Nottingham Trent Univ, Sch Sci & Technol, Nottingham NG11 8NS, England.	barbara.pierscionek@staffs.ac.uk	Pierscionek, Barbara/AAK-5760-2021		SPring-8 synchrotron [2016A1096, 2017A1197, 2018A1105]; Royal Society [IE160996]; Fight for Sight UK [1319/1320]; National Institutes of Health [R01 EY05661]; Zeiss Meditec AG	SPring-8 synchrotron; Royal Society(Royal Society of London); Fight for Sight UK; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Zeiss Meditec AG	SPring-8 synchrotron, Grant/Award Number: 2016A1096, 2017A1197 and 2018A1105; Royal Society, Grant/Award Number: IE160996; Zeiss Meditec AG; Fight for Sight UK, Grant/Award Number: 1319/1320; National Institutes of Health, Grant/Award Number: R01 EY05661	AXELROD D, 1988, VISION RES, V28, P57, DOI 10.1016/S0042-6989(88)80006-3; Bahrami M, 2014, EXP EYE RES, V124, P93, DOI 10.1016/j.exer.2014.05.009; BARER R, 1954, Q J MICROSC SCI, V95, P399; Bassnett S, 2017, PROG RETIN EYE RES, V60, P181, DOI 10.1016/j.preteyeres.2017.04.001; Birkenfeld J, 2014, INVEST OPHTH VIS SCI, V55, P2599, DOI 10.1167/iovs.14-14201; Birkenfeld J, 2013, VISION RES, V86, P27, DOI 10.1016/j.visres.2013.04.004; CAMPBELL MCW, 1984, VISION RES, V24, P409, DOI 10.1016/0042-6989(84)90039-7; Collery RF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110699; Easter SS, 1996, DEV BIOL, V180, P646; FAGERHOLM PP, 1981, EXP EYE RES, V33, P615, DOI 10.1016/S0014-4835(81)80101-7; FERNALD RD, 1983, NATURE, V301, P618, DOI 10.1038/301618a0; Garner LF, 2001, VISION RES, V41, P973, DOI 10.1016/S0042-6989(01)00011-6; Greiling TMS, 2008, SEMIN CELL DEV BIOL, V19, P94, DOI 10.1016/j.semcdb.2007.10.011; Greiling TMS, 2012, INT REV CEL MOL BIO, V296, P1, DOI 10.1016/B978-0-12-394307-1.00001-1; Hoshino M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025140; Hoshino M, 2010, AIP CONF PROC, V1266, P57, DOI 10.1063/1.3478199; Jackson JM, 2016, SCI REP-UK, V6, DOI 10.1038/srep33585; Jagger WS, 1996, VISION RES, V36, P2623, DOI 10.1016/0042-6989(95)00328-2; Jones CE, 2004, MAGN RESON IMAGING, V22, P211, DOI 10.1016/j.mri.2003.07.005; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; KORETZ JF, 1994, VISION RES, V34, P2955, DOI 10.1016/0042-6989(94)90267-4; Kozlowski TM, 2019, VISION RES, V162, P29, DOI 10.1016/j.visres.2019.06.008; Kozlowski TM, 2019, EXP EYE RES, V181, P1, DOI 10.1016/j.exer.2018.12.013; Kroger RHH, 2001, VISION RES, V41, P549, DOI 10.1016/S0042-6989(00)00283-2; KROGER RHH, 1994, VISION RES, V34, P1815, DOI 10.1016/0042-6989(94)90306-9; Lim JC, 2009, INVEST OPHTH VIS SCI, V50, P4304, DOI 10.1167/iovs.09-3435; Momose A, 2005, JPN J APPL PHYS 1, V44, P6355, DOI 10.1143/JJAP.44.6355; Momose A, 2003, JPN J APPL PHYS 2, V42, pL866, DOI 10.1143/JJAP.42.L866; PIERSCIONEK B, 1987, VISION RES, V27, P1539, DOI 10.1016/0042-6989(87)90162-3; Pierscionek B K, 1995, J Am Optom Assoc, V66, P739; Pierscionek B, 2015, ONCOTARGET, V6, P30532, DOI 10.18632/oncotarget.5762; Pierscionek BK, 2012, PROG RETIN EYE RES, V31, P332, DOI 10.1016/j.preteyeres.2012.03.001; Pierscionek BK, 2003, EXP EYE RES, V77, P639, DOI 10.1016/S0014-4835(03)00221-5; PIERSCIONEK BK, 1989, VISION RES, V29, P1759, DOI 10.1016/0042-6989(89)90158-2; Schilling Thomas F., 2002, P59; SIVAK JG, 1983, INVEST OPHTH VIS SCI, V24, P1162; Soules KA, 2005, BMC DEV BIOL, V5, DOI 10.1186/1471-213X-5-12; Vendra VPR, 2016, BBA-GEN SUBJECTS, V1860, P333, DOI 10.1016/j.bbagen.2015.06.007; Verma Y, 2007, APPL PHYS B-LASERS O, V87, P607, DOI 10.1007/s00340-007-2689-4; Vihtelic TS, 2005, MOL VIS, V11, P1083; Vorontsova I, 2019, JOVE-J VIS EXP, DOI 10.3791/59528; Vorontsova I, 2018, INVEST OPHTH VIS SCI, V59, P2869, DOI 10.1167/iovs.18-24044; Wages P, 2013, MOL VIS, V19, P408; Westerfield M, 2000, ZEBRAFISH BOOK GUIDE	44	9	9	2	10	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2020	34	4					5552	5562		10.1096/fj.201902607R	http://dx.doi.org/10.1096/fj.201902607R		FEB 2020	11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	LJ5ZA	32103543	Green Submitted, hybrid			2022-12-26	WOS:000517906400001
J	Talmazov, G; Veilleux, N; Abdulmajeed, A; Bencharit, S				Talmazov, Georgi; Veilleux, Nathan; Abdulmajeed, Aous; Bencharit, Sompop			Finite element analysis of a one-piece zirconia implant in anterior single tooth implant applications	PLOS ONE			English	Article							STRESS-DISTRIBUTION; DENTAL IMPLANTS; BITE FORCES; BONE; TITANIUM; DIAMETER; PROSTHESIS; PARAMETERS; PLACEMENT; ABUTMENTS	This study evaluated the von Mises stress (MPa) and equivalent strain occurring around monolithic yttria-zirconia (Zir) implant using three clinically simulated finite element analysis (FEA) models for a missing maxillary central incisor. Two unidentified patients' cone-beam computed tomography (CBCT) datasets with and without right maxillary central incisor were used to create the FEA models. Three different FEA models were made with bone structures that represent a healed socket (HS), reduced bone width edentulous site (RB), and immediate extraction socket with graft (EG). A one-piece abutment-implant fixture mimicking Straumann Standard Plus tissue level RN 4.1 x 11.8mm, for titanium alloy (Ti) and Zir were modeled. 178 N oblique load and 200 N vertical load were used to simulate occlusal loading. Von Mises stress and equivalent strain values for around each implant model were measured. Within the HS and RB models the labial-cervical region in the cortical bone exhibited highest stress, with Zir having statistically significant lower stress-strain means than Ti in both labial and palatal aspects. For the EG model the labial-cervical area had no statistically significant difference between Ti and Zir; however, Zir performed better than Ti against the graft. FEA models suggest that Ti, a more elastic material than Zir, contributes to the transduction of more overall forces to the socket compared to Zir. Thus, compared to Ti implants, Zir implants may be less prone to peri-implant bone overloading and subsequent bone loss in high stress areas especially in the labial-cervical region of the cortical bone. Zir implants respond to occlusal loading differently than Ti implants. Zir implants may be more favorable in non-grafted edentulous or immediate extraction with grafting.	[Talmazov, Georgi; Abdulmajeed, Aous; Bencharit, Sompop] Virginia Commonwealth Univ, Sch Dent, Dept Gen Practice, Richmond, VA 23284 USA; [Veilleux, Nathan; Bencharit, Sompop] Virginia Commonwealth Univ, Coll Engn, Dept Biomed Engn, Richmond, VA 23284 USA; [Bencharit, Sompop] Commonwealth Univ, Sch Dent, Dept Oral & Maxillofacial Surg, Richmond, VA 23284 USA	Virginia Commonwealth University; Virginia Commonwealth University; Virginia Commonwealth University	Bencharit, S (corresponding author), Virginia Commonwealth Univ, Sch Dent, Dept Gen Practice, Richmond, VA 23284 USA.; Bencharit, S (corresponding author), Virginia Commonwealth Univ, Coll Engn, Dept Biomed Engn, Richmond, VA 23284 USA.; Bencharit, S (corresponding author), Commonwealth Univ, Sch Dent, Dept Oral & Maxillofacial Surg, Richmond, VA 23284 USA.	sbencharit@vcu.edu		Bencharit, Sompop/0000-0003-1209-9362				Akin J.E., 2010, FINITE ELEMENT ANAL; Andreiotelli M, 2009, CLIN ORAL IMPLAN RES, V20, P32, DOI 10.1111/j.1600-0501.2009.01785.x; Balkaya MC, 2014, IMPLANT DENT, P1; Bencharit S, 2018, J ORAL MAXIL SURG, V76, P1431, DOI 10.1016/j.joms.2018.02.010; Bencharit S, 2015, J PROSTHET DENT, V113, P262, DOI 10.1016/j.prosdent.2014.09.022; Radaelli MTB, 2018, J PROSTHET DENT, V120, P565, DOI 10.1016/j.prosdent.2017.12.023; Brodt MD, 1998, J ORTHOPAED RES, V16, P43, DOI 10.1002/jor.1100160108; Bryington Matthew, 2014, Dent Clin North Am, V58, P193, DOI 10.1016/j.cden.2013.09.009; Bujtar P, 2014, BR J ORAL MAXILLOFAC, V52, pe71; Caglar A, 2011, INT J ORAL MAX IMPL, V26, P961; Chun HJ, 2005, J ORAL REHABIL, V32, P193, DOI 10.1111/j.1365-2842.2004.01407.x; Chun HJ, 2002, J ORAL REHABIL, V29, P565, DOI 10.1046/j.1365-2842.2002.00891.x; Degerliyurt K, 2010, ORAL SURG ORAL MED O, V110, pE1, DOI 10.1016/j.tripleo.2010.03.029; Denry I, 2008, DENT MATER, V24, P299, DOI 10.1016/j.dental.2007.05.007; Depprich R, 2014, CLIN IMPLANT DENT R, V16, P124, DOI 10.1111/j.1708-8208.2012.00454.x; Dragomir-Daescu D, 2011, ANN BIOMED ENG, V39, P742, DOI 10.1007/s10439-010-0196-y; Edelmann AR, 2016, J ORAL IMPLANTOL, V42, P233, DOI [10.1563/AAID-JOI-D-15-00056, 10.1563/aaid-joi-D-15-00056]; El-Anwar Mohamed I, 2017, Eur J Dent, V11, P186, DOI 10.4103/1305-7456.208432; Ferrario VF, 2004, J DENT, V32, P451, DOI 10.1016/j.jdent.2004.02.009; Ferrario VF, 2004, J ORAL REHABIL, V31, P18, DOI 10.1046/j.0305-182X.2003.01179.x; Gayer D, 2016, PROC SPIE, V9914, DOI 10.1117/12.2233268; Geng JP, 2001, J PROSTHET DENT, V85, P585, DOI 10.1067/mpr.2001.115251; Gluckman H, 2018, J PROSTHET DENT, V120, P50, DOI 10.1016/j.prosdent.2017.09.005; Grassi FR, 2015, INT J ORAL MAX IMPL, V30, P671, DOI 10.11607/jomi.3831; Hashim D, 2016, CLIN ORAL INVEST, V20, P1403, DOI 10.1007/s00784-016-1853-9; Himmlova L, 2004, J PROSTHET DENT, V91, P20, DOI 10.1016/j.prosdent.2003.08.008; Holmgren E P, 1998, J Oral Implantol, V24, P80, DOI 10.1563/1548-1336(1998)024<0080:EPOODI>2.3.CO;2; Hosseini B, 2015, J ORAL IMPLANTOL, V41, pE202, DOI 10.1563/aaid-joi-D-14-00075; HR Ali S, 2017, CURRENT TRENDS BIOME, P8, DOI [10.19080/ctbeb.2017.08.555732, DOI 10.19080/CTBEB.2017.08.555732]; Hsu M-L, 2010, FINITE ELEMENT ANAL, P44; Huynh-Ba G, 2010, CLIN ORAL IMPLAN RES, V21, P37, DOI 10.1111/j.1600-0501.2009.01870.x; Karl M, 2017, INT J ORAL MAX IMPL, V32, P971, DOI 10.11607/jomi.5592; Koopaie Maryam, 2016, Med J Islam Repub Iran, V30, P461; Kwon Byung-Gon, 2006, Implant Dent, V15, P254, DOI 10.1097/01.id.0000219864.33618.8b; Lee KS, 2017, INT J PROSTHODONT, V30, P581, DOI 10.11607/ijp.5369; Liddelow G, 2011, AUST DENT J, V56, P417, DOI 10.1111/j.1834-7819.2011.01367.x; Marcian P, 2018, COMPUT BIOL MED, V96, P157, DOI 10.1016/j.compbiomed.2018.03.012; Papavasiliou G, 1996, J PROSTHET DENT, V76, P633, DOI 10.1016/S0022-3913(96)90442-4; Pellizzer EP, 2018, MAT SCI ENG C-MATER, V90, P645, DOI 10.1016/j.msec.2018.05.012; Perez-Pevida E, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/1850401; Petrie CS, 2005, CLIN ORAL IMPLAN RES, V16, P486, DOI 10.1111/j.1600-0501.2005.01132.x; Pianykh OS, 2009, DIGITAL IMAGING COMM, p[3, 363]; Piconi C, 1999, BIOMATERIALS, V20, P1, DOI 10.1016/S0142-9612(98)00010-6; Sanon C, 2015, DENT MATER, V31, P15, DOI 10.1016/j.dental.2014.09.002; Scarano A, 2004, J PERIODONTOL, V75, P292, DOI 10.1902/jop.2004.75.2.292; Schropp L, 2003, INT J PERIODONT REST, V23, P313; Schrotenboer J, 2009, IMPLANT DENT, V18, P260, DOI 10.1097/ID.0b013e31819e8c1d; Sevimay M, 2005, J PROSTHET DENT, V93, P227, DOI 10.1016/j.prosdent.2004.12.019; Shih R., 2016, INTRO FINITE ELEMENT; Spradley JP, 2017, AM J PHYS ANTHROPOL, V163, P94, DOI 10.1002/ajpa.23188; Ubhi K., 2007, DENT NURSING, V3, P336; Wang W, 2009, 2009 WRI WORLD CONGRESS ON SOFTWARE ENGINEERING, VOL 1, PROCEEDINGS, P108, DOI 10.1109/WCSE.2009.110; Winter W, 2013, J ORAL IMPLANTOL, V39, P23, DOI 10.1563/AAID-JOI-D-11-00221; Zhang Y, 2017, IEEE T MED IMAGING, V36, P641, DOI 10.1109/TMI.2016.2623745	54	10	11	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2020	15	2							e0229360	10.1371/journal.pone.0229360	http://dx.doi.org/10.1371/journal.pone.0229360			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8DW	32092128	Green Published, gold			2022-12-26	WOS:000535229300051
J	Tan, WN; Murphy, VJ; Charron, A; van Twest, S; Sharp, M; Constantinou, A; Parker, MW; Crismani, W; Bythell-Douglas, R; Deans, AJ				Tan, Winnie; Murphy, Vincent J.; Charron, Aude; van Twest, Sylvie; Sharp, Michael; Constantinou, Angelos; Parker, Michael W.; Crismani, Wayne; Bythell-Douglas, Rohan; Deans, Andrew J.			Preparation and purification of mono-ubiquitinated proteins using Avi-tagged ubiquitin	PLOS ONE			English	Article							DNA-REPAIR; PCNA; LIGASE; BRCA1-BARD1; COMPLEX; FANCD2; DAMAGE; BRCA1; EXPRESSION; BINDING	Site-specific conjugation of ubiquitin onto a range of DNA repair proteins regulates their critical functions in the DNA damage response. Biochemical and structural characterization of these functions are limited by an absence of tools for the purification of DNA repair proteins in purely the ubiquitinated form. To overcome this barrier, we designed a ubiquitin fusion protein that is N-terminally biotinylated and can be conjugated by E3 RING ligases onto various substrates. Biotin affinity purification of modified proteins, followed by cleavage of the affinity tag leads to release of natively-mono-ubiquitinated substrates. As proof-of-principle, we applied this method to several substrates of mono-ubiquitination in the Fanconi anemia (FA)-BRCA pathway of DNA interstrand crosslink repair. These include the FANCI: FANCD2 complex, the PCNA trimer and BRCA1 modified nucleosomes. This method provides a simple approach to study the role of mono-ubiquitination in DNA repair or any other mono-ubiquitination signaling pathways.	[Tan, Winnie; Murphy, Vincent J.; Charron, Aude; van Twest, Sylvie; Sharp, Michael; Crismani, Wayne; Bythell-Douglas, Rohan; Deans, Andrew J.] St Vincents Inst Med Res, Genome Stabil Unit, Fitzroy, Vic, Australia; [Tan, Winnie; Crismani, Wayne; Bythell-Douglas, Rohan; Deans, Andrew J.] Univ Melbourne, St Vincents Hlth, Dept Med, Melbourne, Vic, Australia; [Charron, Aude] Natl Grad Sch Chem Montpellier ENSCM, Montpellier, France; [Constantinou, Angelos] Univ Montpellier, CNRS, Inst Human Genet IGH, Montpellier, France; [Parker, Michael W.] St Vincents Inst Med Res, Struct Biol Unit, Fitzroy, Vic, Australia; [Parker, Michael W.] Univ Melbourne, Bio21 Inst, Parkville, Vic, Australia	St. Vincent's Institute of Medical Research; University of Melbourne; Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier; St. Vincent's Institute of Medical Research; University of Melbourne	Deans, AJ (corresponding author), St Vincents Inst Med Res, Genome Stabil Unit, Fitzroy, Vic, Australia.; Deans, AJ (corresponding author), Univ Melbourne, St Vincents Hlth, Dept Med, Melbourne, Vic, Australia.	adeans@svi.edu.au	Deans, Andrew/U-3515-2019; Parker, Michael W/F-9069-2013	Deans, Andrew/0000-0002-5271-4422; Parker, Michael W/0000-0002-3101-1138; Crismani, Associate Professor Wayne/0000-0003-0143-8293; Sharp, Michael/0000-0002-1019-3729; Murphy, Vincent/0000-0003-2791-303X; Charron, Aude/0000-0002-8196-6047; Tan, Winnie/0000-0003-3229-4157	National Health and Medical Research Council, Australia [GNT1123100, GNT1156343]; Maddie Riewoldt's Vision [SVIMRV2017G]; Victoria government IOS program; University of Melbourne; National Breast Cancer Foundation; NHMRC [GNT1129757]; Maddie Riewoldt's Vision Fellow [WC-MRV2016]	National Health and Medical Research Council, Australia(National Health and Medical Research Council (NHMRC) of Australia); Maddie Riewoldt's Vision; Victoria government IOS program; University of Melbourne(University of Melbourne); National Breast Cancer Foundation; NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Maddie Riewoldt's Vision Fellow	This work was supported by a grant from the National Health and Medical Research Council, Australia (GNT1123100 to A.J.D. and GNT1156343 to WC), Maddie Riewoldt's Vision (SVIMRV2017G) and the Victoria government IOS program. WT is recipient of a research training scholarship from the University of Melbourne, R. B-D is funded by the National Breast Cancer Foundation, W.C is an NHMRC Career Development Fellow (GNT1129757) and Maddie Riewoldt's Vision Fellow (WC-MRV2016) and AJD is a Victorian Cancer Agency mid-career fellow. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arkinson C, 2018, LIFE SCI ALLIANCE, V1, DOI 10.26508/lsa.201800162; Berger I, 2004, NAT BIOTECHNOL, V22, P1583, DOI 10.1038/nbt1036; Brzovic PS, 2006, MOL CELL, V21, P873, DOI 10.1016/j.molcel.2006.02.008; Chaugule VK, 2020, NAT CHEM BIOL, V16, P291, DOI 10.1038/s41589-019-0426-z; Chaugule VK, 2019, METHOD ENZYMOL, V618, P73, DOI 10.1016/bs.mie.2018.12.021; Chen JJ, 2010, NAT CHEM BIOL, V6, P270, DOI [10.1038/NCHEMBIO.316, 10.1038/nchembio.316]; de Oca RM, 2005, BLOOD, V105, P1003, DOI 10.1182/blood-2003-11-3997; Deans AJ, 2011, NAT REV CANCER, V11, P467, DOI 10.1038/nrc3088; Densham RM, 2016, NAT STRUCT MOL BIOL, V23, P647, DOI 10.1038/nsmb.3236; Eger S, 2011, CHEMBIOCHEM, V12, P2807, DOI 10.1002/cbic.201100444; Gao Y, 2016, MOL CELL PROTEOMICS, V15, P1381, DOI [10.1074/mcp.O115.051839, 10.1074/mcp.O115.051839 ]; Geng LY, 2010, J CELL BIOL, V191, P249, DOI 10.1083/jcb.201005101; Gilberto S, 2017, J CELL BIOL, V216, P2259, DOI 10.1083/jcb.201703170; Graslund S, 2017, METHODS MOL BIOL, V1586, P337, DOI 10.1007/978-1-4939-6887-9_22; Harper S, 2011, METHODS MOL BIOL, V681, P259, DOI 10.1007/978-1-60761-913-0_14; Hashizume R, 2001, J BIOL CHEM, V276, P14537, DOI 10.1074/jbc.C000881200; Hibbert RG, 2012, J BIOL CHEM, V287, P39216, DOI 10.1074/jbc.M112.389890; Hibbert RG, 2011, P NATL ACAD SCI USA, V108, P5590, DOI 10.1073/pnas.1017516108; Hishiki A, 2009, J BIOL CHEM, V284, P10552, DOI 10.1074/jbc.M809745200; Hoege C, 2002, NATURE, V419, P135, DOI 10.1038/nature00991; Howlett NG, 2009, J BIOL CHEM, V284, P28935, DOI 10.1074/jbc.M109.016352; Huber LJ, 2001, MOL CELL BIOL, V21, P4005, DOI 10.1128/MCB.21.12.4005-4015.2001; Joo W, 2011, SCIENCE, V333, P312, DOI 10.1126/science.1205805; Kalb R, 2014, CELL REP, V8, P999, DOI 10.1016/j.celrep.2014.07.025; Kilic S, 2018, CHEM SCI, V9, P3704, DOI 10.1039/c8sc00681d; Kim DI, 2016, MOL BIOL CELL, V27, P1188, DOI 10.1091/mbc.E15-12-0844; Klein D. D., 2014, CELL, V54, P460, DOI DOI 10.1016/j.molcel.2014.03.015; Lau WCY, 2015, SCI REP-UK, V5, DOI 10.1038/srep15759; Lecker SH, 2006, J AM SOC NEPHROL, V17, P1807, DOI 10.1681/ASN.2006010083; Li W, 2008, CELL MOL LIFE SCI, V65, P2397, DOI 10.1007/s00018-008-8090-6; Li ZP, 2011, APPL MICROBIOL BIOT, V91, P1203, DOI 10.1007/s00253-011-3407-z; Lowary PT, 1998, J MOL BIOL, V276, P19, DOI 10.1006/jmbi.1997.1494; Ludwig C, 2010, PROTEIN EXPRES PURIF, V71, P54, DOI 10.1016/j.pep.2009.12.001; MacKay C, 2010, CELL, V142, P65, DOI 10.1016/j.cell.2010.06.021; Rajendra E, 2014, MOL CELL, V54, P858, DOI 10.1016/j.molcel.2014.05.001; Raran-Kurussi S, 2016, ANAL BIOCHEM, V504, P30, DOI 10.1016/j.ab.2016.04.006; Schwertman P, 2013, ANAL BIOCHEM, V440, P227, DOI 10.1016/j.ab.2013.05.020; Stewart MD, 2018, P NATL ACAD SCI USA, V115, P1316, DOI 10.1073/pnas.1715467115; Swuec P, 2017, CELL REP, V18, P611, DOI 10.1016/j.celrep.2016.11.013; Tan W, 2019, BIORXIV, DOI [10.1101/862805, DOI 10.1101/862805]; Tan WN, 2017, EXP HEMATOL, V50, P27, DOI 10.1016/j.exphem.2017.03.001; Teixeira LK, 2013, ANNU REV BIOCHEM, V82, P387, DOI 10.1146/annurev-biochem-060410-105307; Thakur S, 1997, MOL CELL BIOL, V17, P444, DOI 10.1128/MCB.17.1.444; Uckelmann M, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02653-3; van Twest S, 2017, MOL CELL, V65, P247, DOI 10.1016/j.molcel.2016.11.005; VIJAYKUMAR S, 1987, J MOL BIOL, V194, P531, DOI 10.1016/0022-2836(87)90679-6; Wang AT, 2011, GENE DEV, V25, P1859, DOI 10.1101/gad.15699211; Wang YF, 2016, CANCER RES, V76, P2778, DOI 10.1158/0008-5472.CAN-16-0186; Zhao WX, 2017, NATURE, V550, P360, DOI 10.1038/nature24060	49	7	7	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2020	15	2							e0229000	10.1371/journal.pone.0229000	http://dx.doi.org/10.1371/journal.pone.0229000			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8DW	32092106	gold, Green Submitted, Green Published			2022-12-26	WOS:000535229300019
J	Wu, SX; Mipam, T; Xu, CF; Zhao, WS; Shah, MA; Yi, CP; Luo, H; Cai, X; Zhong, JC				Wu, Shixin; Mipam, TserangDonko; Xu, Chuanfei; Zhao, Wangsheng; Shah, Mujahid Ali; Yi, Chuanping; Luo, Hui; Cai, Xin; Zhong, Jincheng			Testis transcriptome profiling identified genes involved in spermatogenic arrest of cattleyak	PLOS ONE			English	Article							MESSENGER-RNA EXPRESSION; PROMOTER METHYLATION; MOLECULAR-BASIS; PROTEIN; COMPLEX; SEQUENCE; LOCALIZATION; MAINTENANCE; DYNAMICS; MITOSIS	Background Cattleyak are the hybrid offspring between cattle and yak and combine yak hardiness with cattle productivity. Much attempt has been made to examine the mechanisms of male sterility caused by spermatogenic arrest, but yet there is no research systematically and precisely elucidated testis gene expression profiling between cattleyak and yak. Methods To explore the higher resolution comparative transcriptome map between the testes of yak and cattleyak, and further analyze the mRNA expression dynamics of spermatogenic arrest in cattleyak. We characterized the comparative transcriptome profile from the testes of yak and cattleyak using high-throughput sequencing. Then we used quantitative analysis to validate several differentially expressed genes (DEGs) in testicular tissue and spermatogenic cells. Results Testis transcriptome profiling identified 6477 DEGs (2919 upregulated and 3558 downregulated) between cattleyak and yak. Further analysis revealed that the marker genes and apoptosis regulatory genes for undifferentiated spermatogonia were upregulated, while the genes for differentiation maintenance were downregulated in cattleyak. A majority of DEGs associated with mitotic checkpoint, and cell cycle progression were downregulated in cattleyak during spermatogonial mitosis. Furthermore, almost all DEGs related to synaptonemal complex assembly, and meiotic progression presented no sign of expression in cattleyak. Even worse, dozens of genes involved in acrosome formation, and flagellar development were dominantly downregulated in cattleyak. Conclusion DEGs indicated that spermatogenic arrest of cattleyak may originate from the differentiation stage of spermatogonial stem cells and be aggravated during spermatogonial mitosis and spermatocyte meiosis, which contributes to the scarcely presented sperms in cattleyak.	[Wu, Shixin; Mipam, TserangDonko; Cai, Xin; Zhong, Jincheng] Southwest Minzu Univ, Key Lab Qinghai Tibetan Plateau Anim Genet Resour, Sichuan Prov & Minist Educ, Chengdu, Peoples R China; [Xu, Chuanfei; Zhao, Wangsheng; Shah, Mujahid Ali; Yi, Chuanping; Luo, Hui] Southwest Univ Sci & Technol, Sch Life Sci & Engn, Mianyang, Sichuan, Peoples R China	Southwest Minzu University; Southwest University of Science & Technology - China	Cai, X; Zhong, JC (corresponding author), Southwest Minzu Univ, Key Lab Qinghai Tibetan Plateau Anim Genet Resour, Sichuan Prov & Minist Educ, Chengdu, Peoples R China.	caixin2323@126.com; zhongjincheng518@126.com	Shah, Mujahid Ali/AAG-7045-2020	Shah, Mujahid Ali/0000-0001-5727-7164	National Natural Science Foundation of China [31572396, 31601946]; Key Project of Sichuan Provincial Education Department [16ZA0134]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Project of Sichuan Provincial Education Department	This work was supported by the grants from the National Natural Science Foundation of China (31572396 to X.C.; 31601946 to W.S.) and the Key Project of Sichuan Provincial Education Department (16ZA0134 to X.C.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aloisio GM, 2014, J CLIN INVEST, V124, P3929, DOI 10.1172/JCI75943; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Ansorge HL, 2009, J BIOL CHEM, V284, P8427, DOI 10.1074/jbc.M805582200; Ayad NG, 2003, CELL, V113, P101, DOI 10.1016/S0092-8674(03)00232-0; Baleato RM, 2008, AM J PATHOL, V173, P927, DOI 10.2353/ajpath.2008.071149; Bao JQ, 2012, HISTOCHEM CELL BIOL, V137, P377, DOI 10.1007/s00418-011-0897-9; Bengtsson E, 2002, J BIOL CHEM, V277, P15061, DOI 10.1074/jbc.M108285200; Benjamini Y, 2001, ANN STAT, V29, P1165; Bhogaraju S, 2013, SCIENCE, V341, P1009, DOI 10.1126/science.1240985; Cai X, 2017, THERIOGENOLOGY, V88, P28, DOI 10.1016/j.theriogenology.2016.09.047; Costa Y, 2005, J CELL SCI, V118, P2755, DOI 10.1242/jcs.02402; Costoya JA, 2004, NAT GENET, V36, P653, DOI 10.1038/ng1367; Dawe HR, 2005, J CELL SCI, V118, P5421, DOI 10.1242/jcs.02659; de Vries FAT, 2005, GENE DEV, V19, P1376, DOI 10.1101/gad.329705; Dzhindzhev NS, 2010, NATURE, V467, P714, DOI 10.1038/nature09445; Elsik CG, 2009, SCIENCE, V324, P522, DOI 10.1126/science.1169588; Gyamera-Acheampong C, 2006, BIOL REPROD, V74, P666, DOI 10.1095/biolreprod.105.046821; Hao JX, 2014, BIOCHEM BIOPH RES CO, V444, P537, DOI 10.1016/j.bbrc.2014.01.080; He ZP, 2005, REPRODUCTION, V130, P333, DOI 10.1530/rep.1.00694; Hu O.M, 2000, J SW NATL COLL, V26, P61; Huang ZH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071213; Jang CY, 2008, J CELL BIOL, V181, P255, DOI 10.1083/jcb.200711032; Kumagai A, 2010, CELL, V140, P349, DOI 10.1016/j.cell.2009.12.049; Kuo YC, 2015, J CELL SCI, V128, P923, DOI 10.1242/jcs.158998; Larsson M, 2000, EUR J CELL BIOL, V79, P718, DOI 10.1078/0171-9335-00097; Lee CY, 2015, CELL REP, V11, P551, DOI 10.1016/j.celrep.2015.03.045; Li BJ, 2015, GENE, V573, P50, DOI 10.1016/j.gene.2015.07.021; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li Xian, 2010, Scientia Agricultura Sinica, V43, P3221; Li YC, 2015, MOL REPROD DEV, V82, P787, DOI 10.1002/mrd.22523; Libby BJ, 2003, P NATL ACAD SCI USA, V100, P15706, DOI 10.1073/pnas.2432067100; Liu Y, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005090; Lu J, 2014, ANIMAL HUSBANDRY VET, V46, P61; Luo H, 2013, BMC GENET, V14, DOI 10.1186/1471-2156-14-58; Luo MC, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3788; Manning AL, 2007, MOL BIOL CELL, V18, P2970, DOI 10.1091/mbc.E07-02-0110; Meng XJ, 2000, SCIENCE, V287, P1489, DOI 10.1126/science.287.5457.1489; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Naaby-Hansen S, 2002, DEV BIOL, V242, P236, DOI 10.1006/dbio.2001.0527; Naughton CK, 2006, BIOL REPROD, V74, P314, DOI 10.1095/biolreprod.105.047365; Nomikos M, 2012, BIOESSAYS, V34, P126, DOI 10.1002/bies.201100127; Oatley JM, 2006, P NATL ACAD SCI USA, V103, P9524, DOI 10.1073/pnas.0603332103; Perrault I, 2012, AM J HUM GENET, V90, P864, DOI 10.1016/j.ajhg.2012.03.006; Pilecki B, 2016, J BIOL CHEM, V291, P1103, DOI 10.1074/jbc.M115.681775; Prieto I, 2001, NAT CELL BIOL, V3, P761, DOI 10.1038/35087082; Qi HY, 2007, P NATL ACAD SCI USA, V104, P1219, DOI 10.1073/pnas.0610286104; Rape M, 2004, NATURE, V432, P588, DOI 10.1038/nature03023; Robinson MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-r25; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Seo S, 2010, P NATL ACAD SCI USA, V107, P1488, DOI 10.1073/pnas.0910268107; Shah MA, 2018, ANIM REPROD SCI, V193, P182, DOI 10.1016/j.anireprosci.2018.04.067; Shimasaki S, 2010, ZOOL SCI, V27, P755, DOI 10.2108/zsj.27.755; Song HW, 2014, SEMIN CELL DEV BIOL, V30, P14, DOI 10.1016/j.semcdb.2014.02.005; Sun YQ, 2018, J CELL PHYSIOL, V233, P1887, DOI 10.1002/jcp.26013; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; van Bragt MPA, 2008, REPRODUCTION, V136, P33, DOI 10.1530/REP-07-0536; Vasudevan A, 2010, HIPPOCAMPUS, V20, P608, DOI 10.1002/hipo.20660; Wandke C, 2012, J CELL BIOL, V198, P847, DOI 10.1083/jcb.201110060; Wang JN, 2012, J BIOL CHEM, V287, P25501, DOI 10.1074/jbc.M112.350397; Wang S, 2012, REPROD DOMEST ANIM, V47, P455, DOI 10.1111/j.1439-0531.2011.01902.x; Yan P, 2014, MOL BIOL REP, V41, P7255, DOI 10.1007/s11033-014-3611-x; Zheng XD, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11874; [周阳 Zhou Yang], 2013, [中国农业科学, Scientia Agricultura Sinica], V46, P630; Zhu JY, 2015, CELL CYCLE, V14, P1809, DOI 10.1080/15384101.2015.1036210; Zimin AV, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-4-r42	67	16	16	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2020	15	2							e0229503	10.1371/journal.pone.0229503	http://dx.doi.org/10.1371/journal.pone.0229503			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8DW	32092127	Green Published, gold			2022-12-26	WOS:000535229300061
J	Abbadi, A; Loftis, J; Wang, AM; Yu, MJ; Wang, Y; Shakya, S; Li, XX; Maytin, E; Hascall, V				Abbadi, Amina; Loftis, Jacqueline; Wang Aimin; Yu Minjia; Wang Yan; Shakya, Sajina; Li Xiaoxia; Maytin, Edward; Hascall, Vincent			Heparin inhibits proinflammatory and promotes anti-inflammatory macrophage polarization under hyperglycemic stress	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						macrophage; monocyte; hyaluronan; inflammation; heparin	ALTERNATIVE ACTIVATION; ENDOPLASMIC-RETICULUM; HYALURONAN STRUCTURES; MESANGIAL CELLS; MONOCYTE; EXPRESSION; MECHANISM; ADHESIVE; MATRIX	Monocytes are rapidly recruited to sites of diabetic complications and differentiate into macrophages. Previously, we showed that rat kidney mesangial cells dividing during hyperglycemic stress abnormally synthesize hyaluronan (HA) in intracellular compartments. This initiates a stress response, resulting in an extracellular HA matrix after division that recruits inflammatory cells. Cell?cell communication among macrophages that are recruited into the glomeruli and the damaged rat mesangial cells leads to diabetic nephropathy, fibrosis, and proteinurea, which are inhibited in heparin-treated diabetic rats. In this study, we found that murine bone marrow?derived macrophages (BMDMs) and a human leukemic cell line, U937 cells, dividing in hyperglycemia also accumulate intracellular HA and that heparin inhibits the HA accumulation. Both cell types expressed increased levels of proinflammatory markers: inducible nitric-oxide synthase and tumor necrosis factor-?, when cultured under hyperglycemic stress, which was inhibited by heparin. Furthermore, the abnormal intracellular HA was also observed in peripheral blood monocytes derived from three different hyperglycemic diabetic mouse models: streptozotocin-treated, high-fat fed, and Ins2Akita. Moreover, peripheral blood monocytes in humans with type 2 diabetes and poorly controlled blood glucose levels (hemoglobin A1c (HbA1c) levels of >7) also had intracellular HA, whereas those with HbA1c of <7, did not. Of note, heparin increased the anti-inflammatory markers arginase 1 and interleukin-10 in murine BMDMs. We conclude that heparin treatment of high glucose?exposed dividing BMDMs promotes an anti-inflammatory tissue-repair phenotype in these cells.	[Abbadi, Amina; Loftis, Jacqueline; Wang Aimin; Wang Yan; Shakya, Sajina; Maytin, Edward; Hascall, Vincent] Cleveland Clin, Lerner Res Inst, Dept Biomed Engn, Cleveland, OH 44195 USA; [Yu Minjia; Li Xiaoxia] Cleveland Clin, Lerner Res Inst, Dept Inflammat & Immun, Cleveland, OH 44195 USA; [Yu Minjia] Harvard Med Sch, Mt Auburn Hosp, Cambridge, MA 02472 USA	Cleveland Clinic Foundation; Cleveland Clinic Foundation; Harvard University; Mount Auburn Hospital	Hascall, V (corresponding author), Cleveland Clin, Lerner Res Inst, Dept Biomed Engn, Cleveland, OH 44195 USA.	hascalv@ccf.org		Shakya, Sajina/0000-0002-9400-4250	NHLBI, National Institutes of Health [P01HL107147, 1K12HL141952]	NHLBI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by Grants P01HL107147 and 1K12HL141952 from the NHLBI, National Institutes of Health. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ahyi ANN, 2009, J IMMUNOL, V183, P1598, DOI 10.4049/jimmunol.0803302; Bhattacharjee A, 2013, FREE RADICAL BIO MED, V54, P1, DOI 10.1016/j.freeradbiomed.2012.10.553; Calabro A, 2000, GLYCOBIOLOGY, V10, P273, DOI 10.1093/glycob/10.3.273; Cipolletta C, 2005, DIABETES, V54, P2779, DOI 10.2337/diabetes.54.9.2779; de la Motte CA, 2003, AM J PATHOL, V163, P121, DOI 10.1016/S0002-9440(10)63636-X; Eguchi J, 2013, DIABETES, V62, P3394, DOI 10.2337/db12-1327; El Chartouni C, 2010, IMMUNOBIOLOGY, V215, P821, DOI 10.1016/j.imbio.2010.05.031; Forbes JM, 2013, PHYSIOL REV, V93, P137, DOI 10.1152/physrev.00045.2011; Gerhardt T, 2015, CARDIOVASC RES, V107, P321, DOI 10.1093/cvr/cvv147; Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733; Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978; Gordon S, 2010, IMMUNITY, V32, P593, DOI 10.1016/j.immuni.2010.05.007; Gurley SB, 2006, AM J PHYSIOL-RENAL, V290, pF214, DOI 10.1152/ajprenal.00204.2005; Honma K, 2005, P NATL ACAD SCI USA, V102, P16001, DOI 10.1073/pnas.0504226102; Italiani P, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00514; Jaguin M, 2013, CELL IMMUNOL, V281, P51, DOI 10.1016/j.cellimm.2013.01.010; Lawrence T, 2011, NAT REV IMMUNOL, V11, P750, DOI 10.1038/nri3088; Liu LP, 2004, ATHEROSCLEROSIS, V175, P39, DOI 10.1016/j.atherosclerosis.2004.01.044; Mathews CE, 2002, TRANSPLANTATION, V73, P1333, DOI 10.1097/00007890-200204270-00024; Mills CD, 2001, CRIT REV IMMUNOL, V21, P399, DOI 10.1615/critrevimmunol.v21.i5.10; Mills CD, 2000, J IMMUNOL, V164, P6166, DOI 10.4049/jimmunol.164.12.6166; Mills CD, 2012, CRIT REV IMMUNOL, V32, P463, DOI 10.1615/CritRevImmunol.v32.i6.10; Murray PJ, 2014, IMMUNITY, V41, P14, DOI 10.1016/j.immuni.2014.06.008; Oyadomari S, 2002, J CLIN INVEST, V109, P525, DOI 10.1172/JCI200214550; Parsa R, 2012, DIABETES, V61, P2881, DOI 10.2337/db11-1635; Ron D, 2002, J CLIN INVEST, V109, P443, DOI 10.1172/JC1200215020; Sica A, 2015, CELL MOL LIFE SCI, V72, P4111, DOI 10.1007/s00018-015-1995-y; Stempin CC, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/683485; SUNDSTROM C, 1976, INT J CANCER, V17, P565, DOI 10.1002/ijc.2910170504; Szablewski L, 2017, BIOL CHEM, V398, P411, DOI 10.1515/hsz-2016-0196; Szkudelski T, 2001, PHYSIOL RES, V50, P537; Wang AM, 2014, J BIOL CHEM, V289, P11410, DOI 10.1074/jbc.M113.541458; Wang AM, 2014, J BIOL CHEM, V289, P9418, DOI 10.1074/jbc.M113.541441; Wang AM, 2011, FEBS J, V278, P1412, DOI 10.1111/j.1742-4658.2011.08069.x; Wang AM, 2004, J BIOL CHEM, V279, P10279, DOI 10.1074/jbc.M312045200; Wang J, 1999, J CLIN INVEST, V103, P27, DOI 10.1172/JCI4431; Yoshioka M, 1997, DIABETES, V46, P887, DOI 10.2337/diabetes.46.5.887; Zhang Xia, 2008, Curr Protoc Immunol, VChapter 14, DOI 10.1002/0471142735.im1401s83	38	8	8	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 10	2020	295	15					4849	4857		10.1074/jbc.RA119.012419	http://dx.doi.org/10.1074/jbc.RA119.012419			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LE7FC	32107314	hybrid, Green Published			2022-12-26	WOS:000526887000009
J	Sander, M; Wu, ZD; Strasburger, CJ				Sander, Max; Wu Zida; Strasburger, Christian J.			Short stature explained by dimerization of human growth hormone induced by a p.C53S point mutation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						growth hormone; disulfide; dimerization; pituitary gland; protein folding; c; 705G>C; cysteine; GH-C53S; growth hormone deficiency	FULL-LENGTH RECEPTOR; DISULFIDE BONDS; ENDOPLASMIC-RETICULUM; EXTRACELLULAR DOMAIN; PITUITARY; PROLACTIN; SERUM; HGH; GH; ACTIVATION	A homozygous mutation in growth hormone 1 (GH1) was recently identified in an individual with growth failure. This mutation, c.705G>C, causes replacement of cysteine at position 53 of the 191-amino-acid sequence of 22 kDa human GH (hGH) with serine (p.C53S). This hGH molecule (hereafter referred to as GH-C53S) lacks the disulfide bond between p.Cys-53 and p.Cys-165, which is highly conserved among species. It has been reported previously that monomeric GH-C53S has reduced bioactivity compared with WT GH (GH-WT) because of its decreased ability to bind and activate the GH receptor in vitro. In this study, we discovered that substitution of p.Cys-53 in hGH significantly increased formation of hGH dimers in pituitary cells. We expressed His-tagged hGH variants in the cytoplasm of genetically modified Rosetta-gami B DE3 Escherichia coli cells, facilitating high-yield production. We observed that the bioactivity of monomeric GH-C53S is 25.2% of that of GH-WT and that dimeric GH-C53S?His has no significant bioactivity in cell proliferation assays. We also found that the expression of GH-C53S in pituitary cells deviates from that of GH-WT. GH-C53S was exclusively stained in the Golgi apparatus, and no secretory granules formed for this variant, impairing its stimulated release. In summary, the unpaired Cys-165 in GH-C53S forms a disulfide bond linking two hGH molecules in pituitary cells. We conclude that the GH-C53S dimer is inactive and responsible for the growth failure in the affected individual.	[Sander, Max; Wu Zida; Strasburger, Christian J.] Univ Med Berlin, Dept Endocrinol Diabet & Nutr Med, Campus Charite Mitte,Charitepl 1, D-10117 Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Sander, M (corresponding author), Charite Univ Med Berlin, Dept Endocrinol Diabet & Nutr Med, Sauerbruchweg 5, D-10117 Berlin, Germany.	max.sander@charite.de			Deutsche Forschungsgemeinschaft	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by a research fellowship of the Deutsche Forschungsgemeinschaft-funded Graduate College 1208 "Hormonal Regulation of Energy Metabolism, Body Weight, and Growth" (to M. S.). The authors declare that they have no conflicts of interest with the contents of this article.	Abkevich VI, 2000, J MOL BIOL, V300, P975, DOI 10.1006/jmbi.2000.3893; Anderson LL, 2012, EXP BIOL MED, V237, P126, DOI 10.1258/ebm.2011.011306; Ariyasu D, 2013, ENDOCRINOLOGY, V154, P3228, DOI 10.1210/en.2013-1249; BANCROFT FC, 1973, ENDOCRINOLOGY, V92, P1014, DOI 10.1210/endo-92-4-1014; BANCROFT FC, 1973, EXP CELL RES, V79, P275, DOI 10.1016/0014-4827(73)90445-X; BAUMANN G, 1986, ENDOCRINOLOGY, V119, P1497, DOI 10.1210/endo-119-4-1497; Bessette PH, 1999, P NATL ACAD SCI USA, V96, P13703, DOI 10.1073/pnas.96.24.13703; Besson A, 2005, J CLIN ENDOCR METAB, V90, P2493, DOI 10.1210/jc.2004-1838; BEWLEY TA, 1969, BIOCHEMISTRY-US, V8, P4701, DOI 10.1021/bi00840a007; Brown RJ, 2005, NAT STRUCT MOL BIOL, V12, P814, DOI 10.1038/nsmb977; Bustamante JJ, 2009, PROTEOMICS, V9, P3474, DOI 10.1002/pmic.200800989; CHEN XZ, 1992, MOL ENDOCRINOL, V6, P598, DOI 10.1210/me.6.4.598; CUNNINGHAM BC, 1991, SCIENCE, V253, P545, DOI 10.1126/science.1907025; CUNNINGHAM BC, 1991, SCIENCE, V254, P821, DOI 10.1126/science.1948064; CUNNINGHAM BC, 1989, SCIENCE, V244, P1081, DOI 10.1126/science.2471267; Dannies PS, 2002, MOL GENET METAB, V76, P6, DOI 10.1016/S1096-7192(02)00011-2; DATTANI MT, 1995, J CLIN ENDOCR METAB, V80, P2675, DOI 10.1210/jc.80.9.2675; DEFELIPPIS MR, 1993, BIOCHEMISTRY-US, V32, P1555, DOI 10.1021/bi00057a021; DEVOS AM, 1992, SCIENCE, V255, P306, DOI 10.1126/science.1549776; DIXON JS, 1966, SCIENCE, V154, P785, DOI 10.1126/science.154.3750.785; DUDEN R, 1991, CELL, V64, P649, DOI 10.1016/0092-8674(91)90248-W; Forsyth IA, 2002, J MAMMARY GLAND BIOL, V7, P291, DOI 10.1023/A:1022804817104; Gertler A, 1996, J BIOL CHEM, V271, P24482, DOI 10.1074/jbc.271.40.24482; GRAF L, 1976, FEBS LETT, V66, P233, DOI 10.1016/0014-5793(76)80511-X; Haro LS, 1996, BIOCHEM BIOPH RES CO, V228, P549, DOI 10.1006/bbrc.1996.1697; Jensen MR, 2008, PROTEINS, V73, P161, DOI 10.1002/prot.22039; KOPCHICK JJ, 1990, J REPROD FERTIL, P25; KOWARSKI AA, 1978, J CLIN ENDOCR METAB, V47, P461, DOI 10.1210/jcem-47-2-461; LEWIS UJ, 1977, J BIOL CHEM, V252, P3697; MOORE HPH, 1985, J CELL BIOL, V101, P1773, DOI 10.1083/jcb.101.5.1773; NECESSARY PC, 1985, MOL CELL ENDOCRINOL, V39, P247, DOI 10.1016/0303-7207(85)90068-1; NIALL HD, 1971, P NATL ACAD SCI USA, V68, P866, DOI 10.1073/pnas.68.4.866; Pearce KH, 1999, BIOCHEMISTRY-US, V38, P81, DOI 10.1021/bi9817008; Petkovic V, 2012, ENDOCR DEV, V23, P96, DOI 10.1159/000341763; Riemer J, 2009, SCIENCE, V324, P1284, DOI 10.1126/science.1170653; Ross RJM, 1997, MOL ENDOCRINOL, V11, P265, DOI 10.1210/me.11.3.265; Rowland JE, 2002, CLIN ENDOCRINOL, V56, P475, DOI 10.1046/j.1365-2265.2002.01507.x; Rowlinson SW, 1998, J BIOL CHEM, V273, P5307, DOI 10.1074/jbc.273.9.5307; Sockolosky JT, 2013, PROTEIN EXPRES PURIF, V87, P129, DOI 10.1016/j.pep.2012.11.002; St-Amand Jonny, 2011, Front Endocrinol (Lausanne), V2, P111, DOI 10.3389/fendo.2011.00111; Strasburger CJ, 1996, J CLIN ENDOCR METAB, V81, P2613, DOI 10.1210/jc.81.7.2613; Szymanski CM, 2005, NAT REV MICROBIOL, V3, P225, DOI 10.1038/nrmicro1100; Walsh STR, 2003, PROTEIN SCI, V12, P1960, DOI 10.1110/ps.03133903; Wang JH, 2005, HUM GENE THER, V16, P571, DOI 10.1089/hum.2005.16.571; Waters Michael J, 2014, JAKSTAT, V3, pe29569, DOI 10.4161/jkst.29569; Woycechowsky KJ, 2000, CURR OPIN CHEM BIOL, V4, P533, DOI 10.1016/S1367-5931(00)00128-9; Wu MM, 2001, J BIOL CHEM, V276, P33027, DOI 10.1074/jbc.M103917200	47	2	1	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 10	2020	295	15					4893	4901		10.1074/jbc.RA119.009101	http://dx.doi.org/10.1074/jbc.RA119.009101			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LE7FC	32132170	Green Published, hybrid			2022-12-26	WOS:000526887000013
J	Chin, HG; Esteve, PO; Ruse, C; Lee, J; Schaus, SE; Pradhan, S; Hansen, U				Chin, Hang Gyeong; Esteve, Pierre-Olivier; Ruse, Cristian; Lee, Jiyoung; Schaus, Scott E.; Pradhan, Sriharsa; Hansen, Ulla			The microtubule-associated histone methyltransferase SET8, facilitated by transcription factor LSF, methylates ?-tubulin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						tubulin; posttranslational modification (PTM); protein methylation; cytoskeleton; cancer; lysine methyltransferase 5A (KMT5A); mammalian cells; SET8; transcription factor CP2 (TFCP2); transcription factor LSF	LATE SV40 FACTOR; SMALL-MOLECULE INHIBITORS; POSTTRANSLATIONAL MODIFICATIONS; GENE-EXPRESSION; CELL-CYCLE; C-MYC; PR-SET7; H4; DNA; RESISTANCE	Microtubules are cytoskeletal structures critical for mitosis, cell motility, and protein and organelle transport and are a validated target for anticancer drugs. However, how tubulins are regulated and recruited to support these distinct cellular processes is incompletely understood. Posttranslational modifications of tubulins are proposed to regulate microtubule function and dynamics. Although many of these modifications have been investigated, only one prior study reports tubulin methylation and an enzyme responsible for this methylation. Here we used in vitro radiolabeling, MS, and immunoblotting approaches to monitor protein methylation and immunoprecipitation, immunofluorescence, and pulldown approaches to measure protein?protein interactions. We demonstrate that N-lysine methyltransferase 5A (KMT5A or SET8/PR-Set7), which methylates lysine 20 in histone H4, bound ?-tubulin and methylated it at a specific lysine residue, Lys(311). Furthermore, late SV40 factor (LSF)/CP2, a known transcription factor, bound both ?-tubulin and SET8 and enhanced SET8-mediated ?-tubulin methylation in vitro. In addition, we found that the ability of LSF to facilitate this methylation is countered by factor quinolinone inhibitor 1 (FQI1), a specific small-molecule inhibitor of LSF. These findings suggest the general model that microtubule-associated proteins, including transcription factors, recruit or stimulate protein-modifying enzymes to target tubulins. Moreover, our results point to dual functions for SET8 and LSF not only in chromatin regulation but also in cytoskeletal modification.	[Chin, Hang Gyeong; Esteve, Pierre-Olivier; Ruse, Cristian; Pradhan, Sriharsa] New England Biolabs Inc, Ipswich, MA 01938 USA; [Chin, Hang Gyeong; Hansen, Ulla] Boston Univ, Grad Sch Arts & Sci, MCBB Grad Program, Boston, MA 02215 USA; [Schaus, Scott E.] Boston Univ, Ctr Mol Discovery, Boston, MA 02215 USA; [Hansen, Ulla] Boston Univ, Dept Biol, 5 Cummington Mall, Boston, MA 02215 USA; [Lee, Jiyoung] Korea Res Inst Biosci & Biotechnol, Biol Resource Ctr, Jeongeup Si 56212, Jeollabuk Do, South Korea	New England Biolabs; Boston University; Boston University; Boston University; Korea Research Institute of Bioscience & Biotechnology (KRIBB)	Hansen, U (corresponding author), Boston Univ, Dept Biol, 5 Cummington Mall, Boston, MA 02215 USA.	uhansen@bu.edu		Hansen, Ulla/0000-0001-9803-4185	New England Biolabs, Inc.; National Institutes of Health [R01 GM078240, R24 GM111625]; Boston University; Johnson & Johnson Clinical Innovation Award through Boston University	New England Biolabs, Inc.; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Boston University; Johnson & Johnson Clinical Innovation Award through Boston University	Supported by New England Biolabs, Inc.; Supported by National Institutes of Health Grants R01 GM078240 and R24 GM111625.; Supported by Ignition Awards from Boston University and a Johnson & Johnson Clinical Innovation Award through Boston University.	Abbas T, 2010, MOL CELL, V40, P9, DOI 10.1016/j.molcel.2010.09.014; ALEXANDROVA N, 1995, MOL CELL BIOL, V15, P5188; ANDREWS NC, 1991, NUCLEIC ACIDS RES, V19, P2499, DOI 10.1093/nar/19.9.2499; Brownell JE, 1996, CELL, V84, P843, DOI 10.1016/S0092-8674(00)81063-6; Centore RC, 2010, MOL CELL, V40, P22, DOI 10.1016/j.molcel.2010.09.015; Chen XY, 2019, CELL DEATH DIS, V10, DOI 10.1038/s41419-019-1541-1; Chin HG, 2016, ONCOTARGET, V7, P83627, DOI 10.18632/oncotarget.13271; Dillon SC, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-8-227; Dong CM, 2000, MOL CELL, V5, P27, DOI 10.1016/S1097-2765(00)80400-1; Esteve PO, 2006, GENE DEV, V20, P3089, DOI 10.1101/gad.1463706; Fan RH, 2011, WORLD J GASTROENTERO, V17, P3420, DOI 10.3748/wjg.v17.i29.3420; Fang J, 2002, CURR BIOL, V12, P1086, DOI 10.1016/S0960-9822(02)00924-7; Giannakakou P, 2000, NAT CELL BIOL, V2, P709, DOI 10.1038/35036335; Grant TJ, 2012, P NATL ACAD SCI USA, V109, P4503, DOI 10.1073/pnas.1121601109; Gu YJ, 2015, ONCOTARGET, V6, P33658, DOI 10.18632/oncotarget.5603; Hansen U, 2009, CELL CYCLE, V8, P2146, DOI 10.4161/cc.8.14.9089; Hassig CA, 1997, CURR OPIN CHEM BIOL, V1, P300, DOI 10.1016/S1367-5931(97)80066-X; Houston SI, 2008, J BIOL CHEM, V283, P19478, DOI 10.1074/jbc.M710579200; Huen MSY, 2008, J BIOL CHEM, V283, P11073, DOI 10.1074/jbc.C700242200; Ikegami K, 2006, J BIOL CHEM, V281, P30707, DOI 10.1074/jbc.M603984200; Janke C, 2005, SCIENCE, V308, P1758, DOI 10.1126/science.1113010; Janke C, 2017, CURR BIOL, V27, pR1287, DOI 10.1016/j.cub.2017.10.044; Janke C, 2014, J CELL BIOL, V206, P461, DOI 10.1083/jcb.201406055; Jorgensen S, 2007, J CELL BIOL, V179, P1337, DOI 10.1083/jcb.200706150; Karachentsev D, 2005, GENE DEV, V19, P431, DOI 10.1101/gad.1263005; Kim JS, 2017, ONCOTARGET, V8, P24389, DOI 10.18632/oncotarget.15462; Komlodi-Pasztor E, 2012, CLIN CANCER RES, V18, P51, DOI 10.1158/1078-0432.CCR-11-0999; Kotarba G, 2018, CANCER LETT, V420, P72, DOI 10.1016/j.canlet.2018.01.078; Laursen Lucas, 2014, Nature, V516, pS2, DOI 10.1038/516S2a; Lee J, 2010, MOL CELL, V40, P345, DOI 10.1016/j.molcel.2010.10.033; Lu CH, 2013, DIGEST DIS SCI, V58, P2713, DOI 10.1007/s10620-013-2692-z; MAXWELL SA, 1991, CELL GROWTH DIFFER, V2, P115; McKay DJ, 2015, DEV CELL, V32, P373, DOI 10.1016/j.devcel.2014.12.025; Milite C, 2016, CLIN EPIGENETICS, V8, DOI 10.1186/s13148-016-0268-4; Niklinski J, 2000, MOL CELL BIOL, V20, P5276, DOI 10.1128/MCB.20.14.5276-5284.2000; Nishioka K, 2002, MOL CELL, V9, P1201, DOI 10.1016/S1097-2765(02)00548-8; Oda H, 2010, MOL CELL, V40, P364, DOI 10.1016/j.molcel.2010.10.011; Oda H, 2009, MOL CELL BIOL, V29, P2278, DOI 10.1128/MCB.01768-08; Park IY, 2016, CELL, V166, P950, DOI 10.1016/j.cell.2016.07.005; Perez-Riverol Y, 2019, NUCLEIC ACIDS RES, V47, pD442, DOI 10.1093/nar/gky1106; Powell CMH, 2000, EMBO J, V19, P4665, DOI 10.1093/emboj/19.17.4665; Rajasekaran D, 2015, ONCOTARGET, V6, P26266, DOI 10.18632/oncotarget.4656; Rice JC, 2002, GENE DEV, V16, P2225, DOI 10.1101/gad.1014902; Sakaguchi A, 2007, J CELL BIOL, V176, P155, DOI 10.1083/jcb.200607178; Seol HS, 2016, CANCER LETT, V372, P24, DOI 10.1016/j.canlet.2015.12.005; Shi XB, 2007, MOL CELL, V27, P636, DOI 10.1016/j.molcel.2007.07.012; Song YY, 2015, TRENDS CELL BIOL, V25, P125, DOI 10.1016/j.tcb.2014.10.004; Stanton RA, 2011, MED RES REV, V31, P443, DOI 10.1002/med.20242; Struhl K, 1999, CELL, V98, P1, DOI 10.1016/S0092-8674(00)80599-1; Takawa M, 2012, CANCER RES, V72, P3217, DOI 10.1158/0008-5472.CAN-11-3701; Tardat M, 2007, J CELL BIOL, V179, P1413, DOI 10.1083/jcb.200706179; Tardat M, 2010, NAT CELL BIOL, V12, P1086, DOI 10.1038/ncb2113; Taunton J, 1996, SCIENCE, V272, P408, DOI 10.1126/science.272.5260.408; Thul PJ, 2017, SCIENCE, V356, DOI 10.1126/science.aal3321; Verhey KJ, 2007, CELL CYCLE, V6, P2152, DOI 10.4161/cc.6.17.4633; Willoughby J. L. S., 2019, LSF SMALL MOL INHIBI, DOI [10.1101/665570, DOI 10.1101/665570]; Wloga D, 2010, J CELL SCI, V123, P3447, DOI 10.1242/jcs.063727; Wu SM, 2011, CELL CYCLE, V10, P68, DOI 10.4161/cc.10.1.14363; Wu SM, 2010, GENE DEV, V24, P2531, DOI 10.1101/gad.1984210; Xu ZJ, 2017, SCIENCE, V356, P328, DOI 10.1126/science.aai8764; Yin Y, 2008, CELL CYCLE, V7, P1423, DOI 10.4161/cc.7.10.5867; Yoo BK, 2010, P NATL ACAD SCI USA, V107, P8357, DOI 10.1073/pnas.1000374107; Zhang HF, 2019, NUCLEIC ACIDS RES, V47, P9053, DOI 10.1093/nar/gkz626; Zhang X, 2017, CELL REP, V21, P1227, DOI 10.1016/j.celrep.2017.10.017; Ziegelbauer J, 2001, MOL CELL, V8, P339, DOI 10.1016/S1097-2765(01)00313-6	65	13	13	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 3	2020	295	14					4748	4759		10.1074/jbc.RA119.010951	http://dx.doi.org/10.1074/jbc.RA119.010951			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LB2WZ	32111740	Green Published, hybrid, Green Submitted			2022-12-26	WOS:000524499700031
J	Zhao, J; Sun, Y; Lin, H; Chou, FJ; Xiao, Y; Jin, RA; Cai, XJ; Chang, CS				Zhao, Jie; Sun, Yin; Lin, Hui; Chou, Fuju; Xiao, Yao; Jin, Ren'an; Cai, Xiujun; Chang, Chawnshang			Olaparib and enzalutamide synergistically suppress HCC progression via the AR-mediated miR-146a-5p/BRCA1 signaling	FASEB JOURNAL			English	Article						androgen receptor; enzalutamide; hepatocellular carcinoma; olaparib; synergistic effect	UNRESECTABLE HEPATOCELLULAR-CARCINOMA; PROSTATE-CANCER; ANTIANDROGEN THERAPY; DNA-DAMAGE; REPAIR; SORAFENIB; MIR-146A; GENES; PATHOGENESIS; INHIBITION	Hepatocellular carcinoma (HCC) is one of most common cancers worldwide, however, the treatment for advanced HCC remains unsatisfactory. We focused on the function of the androgen receptor (AR) in HCC and tried to find new treatment strategy based on antiandrogen enzalutamide (Enz). Here, we found that olaparib, a FDA-approved PARP inhibitor, could enhance the cytotoxicity in HCC cells with a lower BRCA1 expression, and suppressing the AR with either Enz or AR-shRNA could further increase the olaparib sensitivity to better suppress the HCC cell growth via a synergistic mechanism that may involve suppressing the expression of BRCA1 and other DNA damage response (DDR) genes. Mechanism studies revealed that Enz/AR signaling might transcriptionally regulate the miR-146a-5p expression via binding to the Androgen Response Elements on its 5 ' promoter region, which could then lead to suppress the homologous recombination-related BRCA1 expression via direct binding to the mRNA 3 ' UTR. Preclinical studies using an in vivo mouse model also demonstrated that combining Enz plus olaparib led to better suppression of the HCC progression. Together, these in vitro/in vivo data suggest that combining Enz and olaparib may help in the development of a novel therapy to better suppress the HCC progression.	[Zhao, Jie; Lin, Hui; Jin, Ren'an; Cai, Xiujun] Zhejiang Univ, Sch Med, Sir Run Run Shaw Hosp, Dept Gen Surg,Innovat Ctr Minimally Invas Tech &, Hangzhou 310016, Peoples R China; [Zhao, Jie; Lin, Hui; Jin, Ren'an; Cai, Xiujun] Zhejiang Univ, Sch Med, Sir Run Run Shaw Hosp, Dept Urol,Innovat Ctr Minimally Invas Tech & Devi, Hangzhou, Peoples R China; [Zhao, Jie; Sun, Yin; Chou, Fuju; Xiao, Yao; Jin, Ren'an; Chang, Chawnshang] Univ Rochester, Med Ctr, Dept Pathol, George Whipple Lab Canc Res, Rochester, NY 14642 USA; [Zhao, Jie; Sun, Yin; Chou, Fuju; Xiao, Yao; Jin, Ren'an; Chang, Chawnshang] Univ Rochester, Med Ctr, Dept Urol, George Whipple Lab Canc Res, Rochester, NY 14642 USA; [Zhao, Jie; Sun, Yin; Chou, Fuju; Xiao, Yao; Jin, Ren'an; Chang, Chawnshang] Univ Rochester, Med Ctr, Wilmot Canc Inst, Rochester, NY 14642 USA; [Chang, Chawnshang] China Med Univ Hosp, Sex Hormone Res Ctr, Taichung, Taiwan	Zhejiang University; Zhejiang University; University of Rochester; University of Rochester; University of Rochester; China Medical University Taiwan; China Medical University Hospital - Taiwan	Cai, XJ (corresponding author), Zhejiang Univ, Sch Med, Sir Run Run Shaw Hosp, Dept Gen Surg,Innovat Ctr Minimally Invas Tech &, Hangzhou 310016, Peoples R China.; Chang, CS (corresponding author), Univ Rochester, Med Ctr, Dept Pathol, George Whipple Lab Canc Res, Rochester, NY 14642 USA.; Chang, CS (corresponding author), Univ Rochester, Med Ctr, Dept Urol, George Whipple Lab Canc Res, Rochester, NY 14642 USA.; Chang, CS (corresponding author), Univ Rochester, Med Ctr, Wilmot Canc Inst, Rochester, NY 14642 USA.	srrsh_cxj@zju.edu.cn; chang@urmc.rochester.edu	Xiao, Yao/AEX-1775-2022	Xiao, Yao/0000-0002-4638-4148; Chang, Chawnshang/0000-0001-8510-3516	NCI NIH HHS [R01 CA156700] Funding Source: Medline	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Asim M, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00393-y; Bandiera S, 2016, J VIROL, V90, P6387, DOI 10.1128/JVI.00619-16; Beer TM, 2014, NEW ENGL J MED, V371, P424, DOI 10.1056/NEJMoa1405095; Brechot C, 2004, GASTROENTEROLOGY, V127, pS56, DOI 10.1053/j.gastro.2004.09.016; Chen CF, 2010, HEPATOLOGY, V52, P1690, DOI 10.1002/hep.23847; CHOU TC, 1994, JNCI-J NATL CANCER I, V86, P1517, DOI 10.1093/jnci/86.20.1517; Cui YJ, 2016, ONCOL RES, V23, P275, DOI 10.3727/096504016X14562725373798; Di Maio M, 2006, ANN NY ACAD SCI, V1089, P252, DOI 10.1196/annals.1386.007; El-Amm J, 2013, CLIN MED INSIGHTS-ON, V7, P235, DOI 10.4137/CMO.S11670; El-Serag HB, 2007, GASTROENTEROLOGY, V132, P2557, DOI 10.1053/j.gastro.2007.04.061; Farazi PA, 2006, NAT REV CANCER, V6, P674, DOI 10.1038/nrc1934; Fautrel A, 2005, J HEPATOL, V43, P288, DOI 10.1016/j.jhep.2005.02.020; Fong PC, 2009, NEW ENGL J MED, V361, P123, DOI 10.1056/NEJMoa0900212; Fujimoto A, 2012, NAT GENET, V44, P760, DOI 10.1038/ng.2291; Garcia AI, 2011, EMBO MOL MED, V3, P279, DOI 10.1002/emmm.201100136; Grimaldi C, 1998, J CLIN ONCOL, V16, P411, DOI 10.1200/JCO.1998.16.2.411; GUPTA S, 1988, J CLIN GASTROENTEROL, V10, P651, DOI 10.1097/00004836-198812000-00016; Hu QM, 2018, ONCOL REP, V39, P3015, DOI 10.3892/or.2018.6391; Huang J, 2012, NAT GENET, V44, P1117, DOI 10.1038/ng.2391; Kudo M, 2018, LANCET, V391, P1163, DOI 10.1016/S0140-6736(18)30207-1; Lacona JR, 2019, WIRES RNA, V10, DOI 10.1002/wrna.1533; Li Y., 2010, CANCER RES, V70, P5703, DOI [10.1158/1538-7445.AM10-5703, DOI 10.1158/1538-7445.AM10-5703]; Li YL, 2016, ONCOTARGET, V7, P59287, DOI 10.18632/oncotarget.11040; Llovet JM, 2008, NEW ENGL J MED, V359, P378, DOI 10.1056/NEJMoa0708857; Llovet JM, 2015, NAT REV CLIN ONCOL, V12, P408, DOI [10.1038/nrclinonc.2015.103, 10.1038/nrclinonc.2015.121]; Ma CL, 2008, GASTROENTEROLOGY, V135, P947, DOI 10.1053/j.gastro.2008.05.046; Mateo J, 2015, NEW ENGL J MED, V373, P1697, DOI 10.1056/NEJMoa1506859; Olive PL, 2006, NAT PROTOC, V1, P23, DOI 10.1038/nprot.2006.5; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Pierce AJ, 1999, GENE DEV, V13, P2633, DOI 10.1101/gad.13.20.2633; Polkinghorn WR, 2013, CANCER DISCOV, V3, P1245, DOI 10.1158/2159-8290.CD-13-0172; Robson M, 2017, NEW ENGL J MED, V377, P523, DOI 10.1056/NEJMoa1706450; Rouleau M, 2010, NAT REV CANCER, V10, P293, DOI 10.1038/nrc2812; Sasaki H, 2016, CLIN GENITOURIN CANC, V14, pE493, DOI 10.1016/j.clgc.2016.04.002; Scher HI, 2012, NEW ENGL J MED, V367, P1187, DOI 10.1056/NEJMoa1207506; Sun Q, 2014, PROSTATE, V74, P1613, DOI 10.1002/pros.22878; Tangkijvanich P, 2004, WORLD J GASTROENTERO, V10, P1547, DOI 10.3748/wjg.v10.i11.1547; Wang C, 2016, BRIT J CANCER, V115, P1548, DOI 10.1038/bjc.2016.367; Warde P, 2011, LANCET, V378, P2104, DOI 10.1016/S0140-6736(11)61095-7; Wu MH, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001143; Xu JJ, 2016, EBIOMEDICINE, V12, P55, DOI 10.1016/j.ebiom.2016.07.013; Yang SF, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/153867	42	6	7	2	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2020	34	4					5877	5891		10.1096/fj.201903045RR	http://dx.doi.org/10.1096/fj.201903045RR			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	LJ5ZA	32134529	Green Submitted, Green Accepted, Bronze			2022-12-26	WOS:000530242100071
J	Boukari, W; Wei, CY; Tang, LH; Hincapie, M; Naranjo, M; Nuessly, G; Beuzelin, J; Sood, S; Rott, P				Boukari, Wardatou; Wei, Chunyan; Tang, Lihua; Hincapie, Martha; Naranjo, Moramay; Nuessly, Gregg; Beuzelin, Julien; Sood, Sushma; Rott, Philippe			Lack of transmission of Sugarcane yellow leaf virus in Florida from Columbus grass and sugarcane to sugarcane with aphids or mites	PLOS ONE			English	Article							1ST REPORT; RESISTANCE; INFECTION; VECTOR; IMPACT; SCYLV; YIELD; LUTEOVIRUS; EFFICIENCY; GENOTYPES	Sugarcane yellow leaf virus (SCYLV), the causal agent of yellow leaf disease, naturally infects at least three plant species in Florida: sugarcane (Saccharum spp.), the weed Columbus grass (Sorghum almum) and cultivated sorghum (S. bicolor). All three hosts are also colonized by the sugarcane aphid (Melanaphis sacchari), the main vector of SCYLV worldwide. To understand the high incidence of SCYLV observed in sugarcane commercial fields and in germplasm collections, we investigated the transmission efficiency of SCYLV from sugarcane and Columbus grass to sugarcane using the sugarcane aphid and a spider mite (Oligonychus grypus) that also tested positive for SCYLV in Florida. Healthy and SCYLV-infected leaf pieces of sugarcane and Columbus grass carrying viruliferous aphids or spider mites were transferred to virus-free plants of the yellow leaf susceptible sugarcane cultivar CP96-1252. Three- and 6-months post inoculation, the 108 aphid-inoculated plants of Columbus grass and the 90 mite-inoculated plants of sugarcane tested negative for SCYLV by tissue blot immunoassay (TBIA) or reverse transcription polymerase chain reaction (RT-PCR). Similar results were obtained for 162 aphid-inoculated plants of sugarcane, except for two plants that tested positive for SCYLV by TBIA and RT-PCR. In two field experiments planted with SCYLV-free and virus-infected sugarcane (cultivar CP96-1252), only 18-28% of healthy plants became infected during a 24- to 28-month period. SCYLV prevalence in these field experiments did not differ between aphicide treated and untreated plots. Incidence of M. sacchari haplotypes in the Everglades agricultural area also indicated that the predominant haplotype that is currently colonizing sugarcane was not a vector of SCYLV in Florida. Lack of virus transmission by the spider mite suggested that this arthropod only acquired the virus when feeding on infected plants but was unable to transmit SCYLV. The current vector of SCYLV in Florida remains to be identified.	[Boukari, Wardatou; Wei, Chunyan; Tang, Lihua; Hincapie, Martha; Rott, Philippe] Univ Florida, Everglades Res & Educ Ctr, Dept Plant Pathol, Belle Glade, FL 33430 USA; [Wei, Chunyan; Tang, Lihua] Guangxi Univ, Coll Agr, State Key Lab Conservat & Utilizat Subtrop Agrobi, Nanning, Peoples R China; [Naranjo, Moramay] Florida Crystals Corp, Belle Glade, FL USA; [Nuessly, Gregg; Beuzelin, Julien] Univ Florida, Everglades Res & Educ Ctr, Dept Entomol & Nematol, Belle Glade, FL 33430 USA; [Sood, Sushma] USDA ARS, Sugarcane Field Stn, Canal Point, FL USA; [Rott, Philippe] CIRAD, UMR BGPI, Montpellier, France; [Rott, Philippe] Univ Montpellier, BGPI, CIRAD, INRAE,SupAgro, Montpellier, France	State University System of Florida; University of Florida; Guangxi University; State University System of Florida; University of Florida; United States Department of Agriculture (USDA); CIRAD; CIRAD; INRAE; Institut Agro; Montpellier SupAgro; Universite de Montpellier	Rott, P (corresponding author), Univ Florida, Everglades Res & Educ Ctr, Dept Plant Pathol, Belle Glade, FL 33430 USA.; Rott, P (corresponding author), CIRAD, UMR BGPI, Montpellier, France.; Rott, P (corresponding author), Univ Montpellier, BGPI, CIRAD, INRAE,SupAgro, Montpellier, France.	philippe.rott@cirad.fr	Boukari, Warda/AAH-5747-2021		Florida Sugar Cane League [00107475, F000057, 660684]; Florida Crystals Corporation; US Sugar Corporation; Sugar Cane Growers Cooperative of Florida	Florida Sugar Cane League; Florida Crystals Corporation; US Sugar Corporation; Sugar Cane Growers Cooperative of Florida	This work was funded by Project #00107475 (PR), Fund #F000057 (PR), and Fund #660684 (PR) from the Florida Sugar Cane League (http://floridasugarcaneleague.org/), including Florida Crystals Corporation (https://www.floridacrystals.com/), US Sugar Corporation (https://www.ussugar.com/), and the Sugar Cane Growers Cooperative of Florida (https://www.scgc.org/).The funders provided support in the form of salaries for authors [MH, MN, PR, WB], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu Ahmad Y, 2007, PLANT DIS, V91, P253, DOI 10.1094/PDIS-91-3-0253; Abu Ahmad Y, 2006, PLANT DIS, V90, P1156, DOI 10.1094/PD-90-1156; Ahmad YA, 2006, ARCH VIROL, V151, P1355, DOI 10.1007/s00705-005-0712-9; Armstrong JS, 2015, J ECON ENTOMOL, V108, P576, DOI 10.1093/jee/tou065; Bayer Crop Science, 2015, SIV 200 SL LAB; Bouallegue M, 2014, PLANT DIS, V98, P1016, DOI 10.1094/PDIS-12-13-1269-PDN; Boukari W, 2019, PLANT DIS, V103, P2367, DOI 10.1094/PDIS-01-19-0199-RE; Chaudhary R, 2014, P NATL ACAD SCI USA, V111, P8919, DOI 10.1073/pnas.1407687111; Chinnaraja C., 2015, VirusDisease, V26, P237, DOI 10.1007/s13337-015-0267-7; Cilia M, 2011, J VIROL, V85, P2148, DOI 10.1128/JVI.01504-10; Comstock J. C., 2004, Journal - American Society of Sugar Cane Technologists, V24, P31; Comstock J. C., 2001, Sugar Tech, V3, P128, DOI 10.1007/BF02956805; Delgado HVE, 2016, PLANT DIS, V100, P1027, DOI 10.1094/PDIS-10-15-1158-PDN; Elzinga DA, 2014, MOL PLANT MICROBE IN, V27, P747, DOI 10.1094/MPMI-01-14-0018-R; FAO (Food and Agriculture Organization of the United Nations), 2018, CAT CROPS US BIOEN F; Filloux D, 2018, PLANT DIS, V102, P2317, DOI 10.1094/PDIS-04-18-0581-RE; Girard J. C, 2010, P INT SOC SUGAR CANE, V27, P1123; Graham JH, 2011, PLANT DIS, V95, P725, DOI 10.1094/PDIS-09-10-0653; Gray S, 2014, ADV VIRUS RES, V89, P141, DOI 10.1016/B978-0-12-800172-1.00004-5; Grisham M. P., 2009, Sugar Cane International, V27, P91; Grisham MP, 2002, J AM SOC SUGAR CANE, V22, P125; Hall D. G., 2005, Journal - American Society of Sugar Cane Technologists, V25, P143; Heuze V, FEEDIPEDIA PROGRAM I, V14, P30; Hull R., 2014, PLANT VIROLOGY; Jimenez-Martinez ES, 2004, J ECON ENTOMOL, V97, P1790, DOI 10.1603/0022-0493-97.6.1790; Kaloshian I, 2005, ANNU REV PHYTOPATHOL, V43, P491, DOI 10.1146/annurev.phyto.43.040204.135944; Klingler J, 1998, ENTOMOL EXP APPL, V86, P79, DOI 10.1023/A:1003153410049; Lehrer AT, 2007, PLANT PATHOL, V56, P711, DOI 10.1111/j.1365-3059.2007.01557.x; Lehrer AT, 2009, J GEN PLANT PATHOL, V75, P288, DOI 10.1007/s10327-009-0172-2; Lehrer AT, 2001, INTERNATIONAL SOCIETY OF SUGAR CANE TECHNOLOGISTS, VOL II, PROCEEDINGS, P439; LIN NS, 1990, PHYTOPATHOLOGY, V80, P824, DOI 10.1094/Phyto-80-824; Lockhart B, 2000, GUIDE SUGARCANE DIS, P291; Martin B, 2003, ANN APPL BIOL, V142, P245, DOI 10.1111/j.1744-7348.2003.tb00247.x; McAllister CD, 2008, PLANT DIS, V92, P607, DOI 10.1094/PDIS-92-4-0607; Naidu R.A., 2001, P PLANT VIR SUB SAH, P233; Nibouche S, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0196124; Nuessly GS, 2019, MISCELLANEOUS INSECT, P1; Paray NB, 2011, SUGAR TECH, V13, P77, DOI 10.1007/s12355-010-0058-9; Pengelly S.D., 2005, TROPICAL FORAGES; Rassaby L, 2003, EUR J PLANT PATHOL, V109, P459, DOI 10.1023/A:1024211823306; Rott P., 2008, Sugar Cane International, V26, P18; Rott P., 2000, GUIDE SUGARCANE DIS; Rott PC., 2016, P INT SOC SUGAR CANE, V29, P595; SAS Institute Inc, 2017, SAS STAT 14 3 US GUI; Scagliusi SM, 2000, PHYTOPATHOLOGY, V90, P120, DOI 10.1094/PHYTO.2000.90.2.120; Schenck S, 2000, PLANT DIS, V84, P1085, DOI 10.1094/PDIS.2000.84.10.1085; Schenck S, 1997, SUGAR CANE, V4, P5; Schenck S, 2001, HAWAII AGR RES CTR P, V68, P1; Schenck S, 1991, P HAWAIIAN SUGAR TEC, V50, P45; Vallad GE, 2004, CROP SCI, V44, P1920, DOI 10.2135/cropsci2004.1920; VANDENHEUVEL JFJM, 1994, J GEN VIROL, V75, P2559, DOI 10.1099/0022-1317-75-10-2559; VanWeelden M., 2019, Sugar Journal, V82, P12; Vega J, 1997, PLANT DIS, V81, P21, DOI 10.1094/PDIS.1997.81.1.21; Viswanathan R, 2014, ACTA PHYSIOL PLANT, V36, P1805, DOI 10.1007/s11738-014-1554-4; Voinnet O, 2001, TRENDS GENET, V17, P449, DOI 10.1016/S0168-9525(01)02367-8; Wei C, 2016, PLANT DIS, V100, P1798, DOI 10.1094/PDIS-02-16-0183-PDN; Zhou GuoHui, 2006, Scientia Agricultura Sinica, V39, P2023; Zhu YJ, 2010, EUR J PLANT PATHOL, V127, P263, DOI 10.1007/s10658-010-9591-3	58	6	6	3	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2020	15	3							e0230066	10.1371/journal.pone.0230066	http://dx.doi.org/10.1371/journal.pone.0230066			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8TR	32142559	gold, Green Published			2022-12-26	WOS:000535271600036
J	Denomme, MM; Parks, JC; McCallie, BR; McCubbin, NI; Schoolcraft, WB; Katz-Jaffe, MG				Denomme, Michelle M.; Parks, Jason C.; McCallie, Blair R.; McCubbin, Nathan, I; Schoolcraft, William B.; Katz-Jaffe, Mandy G.			Advanced paternal age directly impacts mouse embryonic placental imprinting	PLOS ONE			English	Article							GENE-EXPRESSION; DELAYED FATHERHOOD; DNA METHYLATION; NETWORK; OUTCOMES; MICE	The placental epigenome plays a critical role in regulating mammalian growth and development. Alterations to placental methylation, often observed at imprinted genes, can lead to adverse pregnancy complications such as intrauterine growth restriction and preterm birth. Similar associations have been observed in offspring derived from advanced paternal age fathers. As parental age at time of conception continues to rise, the impact of advanced paternal age on these reproductive outcomes is a growing concern, but limited information is available on the molecular mechanisms affected in utero. This longitudinal murine research study thus investigated the impact of paternal aging on genomic imprinting in viable F1 embryonic portions of the placentas derived from the same paternal males when they were young (4-6 months) and when they aged (11-15 months). The use of a controlled out-bred mouse model enabled analysis of offspring throughout the natural lifetime of the same paternal males and excluded confounding factors like female age or infertility. Firstly, paternal age significantly impacted embryonic placental weight, fetal weight and length. Targeted bisulfite sequencing was utilized to examine imprinted methylation at the Kcnq1ot1 imprinting control region, with significant hypermethylation observed upon natural paternal aging. Quantitative real-time PCR assessed imprinted gene expression levels at various imprinting clusters, resulting in transcript level alterations attributable to advanced paternal age. In summary, our results demonstrate a paternal age effect with dysregulation at numerous imprinted loci, providing a mechanism for future adverse placental and offspring health conditions.	[Denomme, Michelle M.; Parks, Jason C.; McCallie, Blair R.; McCubbin, Nathan, I; Katz-Jaffe, Mandy G.] Fertil Labs Colorado, Lone Tree, CO 80124 USA; [Schoolcraft, William B.; Katz-Jaffe, Mandy G.] Colorado Ctr Reprod Med, Lone Tree, CO 80124 USA		Katz-Jaffe, MG (corresponding author), Fertil Labs Colorado, Lone Tree, CO 80124 USA.; Katz-Jaffe, MG (corresponding author), Colorado Ctr Reprod Med, Lone Tree, CO 80124 USA.	MKatz-Jaffe@ColoCRM.com		McCallie, Blair/0000-0002-6142-032X; Denomme, Michelle/0000-0001-7876-0462				Al Adhami H, 2015, GENOME RES, V25, P353, DOI 10.1101/gr.175919.114; Alio AP, 2012, AM J MENS HEALTH, V6, P427, DOI 10.1177/1557988312440718; Atsem S, 2016, HUM MOL GENET, V25, P4996, DOI 10.1093/hmg/ddw328; Azzi S, 2014, HUM MUTAT, V35, P1211, DOI 10.1002/humu.22623; Bartolomei MS, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a002592; Brandt JS, 2019, PRENATAL DIAG, V39, P81, DOI 10.1002/pd.5402; Coan PM, 2005, PLACENTA, V26, pS10, DOI 10.1016/j.placenta.2004.12.009; Denomme MM, 2018, FERTIL STERIL, V110, P419, DOI 10.1016/j.fertnstert.2018.04.004; Denomme MM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156980; Gabory A, 2009, DEVELOPMENT, V136, P3413, DOI 10.1242/dev.036061; Garcia-Palomares S, 2009, BIOL REPROD, V80, P337, DOI 10.1095/biolreprod.108.072066; Garcia-Palomares S, 2009, BIOL REPROD, V80, P343, DOI 10.1095/biolreprod.108.073395; Jenkins TG, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004458; Katz-Jaffe MG, 2013, FERTIL STERIL, V100, P262, DOI 10.1016/j.fertnstert.2013.03.021; Khandwala YS, 2018, BMJ-BRIT MED J, V363, DOI 10.1136/bmj.k4372; Kimura R, 2018, ADV EXP MED BIOL, V1012, P75, DOI 10.1007/978-981-10-5526-3_8; Kobayashi N, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167127; Larman MG, 2011, HUM REPROD, V26, P2672, DOI 10.1093/humrep/der238; Leenen FAD, 2016, CLIN EPIGENETICS, V8, DOI 10.1186/s13148-016-0256-8; Ly L, 2017, MOL HUM REPROD, V23, P461, DOI 10.1093/molehr/gax029; Mackay Deborah J. G., 2015, BioMolecular Concepts, V6, P47, DOI 10.1515/bmc-2014-0037; Mancini-DiNardo D, 2003, HUM MOL GENET, V12, P283, DOI 10.1093/hmg/ddg024; Milekic MH, 2015, MOL PSYCHIATR, V20, P995, DOI 10.1038/mp.2014.84; Mitchell M, 2017, MOL REPROD DEV, V84, P316, DOI 10.1002/mrd.22784; Monnier P, 2013, P NATL ACAD SCI USA, V110, P20693, DOI 10.1073/pnas.1310201110; Oh-McGinnis R, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-50; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Quenneville S, 2011, MOL CELL, V44, P361, DOI 10.1016/j.molcel.2011.08.032; Sanchez-Delgado M, 2016, TRENDS GENET, V32, P444, DOI 10.1016/j.tig.2016.05.001; Smith RG, 2013, MOL PSYCHIATR, V18, P635, DOI 10.1038/mp.2012.88; Sood R, 2006, P NATL ACAD SCI USA, V103, P5478, DOI 10.1073/pnas.0508035103; Tilley SK, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0193271; Toure DM, 2016, J MATERN-FETAL NEO M, V29, P3542, DOI 10.3109/14767058.2016.1138465; Varrault A, 2006, DEV CELL, V11, P711, DOI 10.1016/j.devcel.2006.09.003	34	11	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2020	15	3							e0229904	10.1371/journal.pone.0229904	http://dx.doi.org/10.1371/journal.pone.0229904			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8TR	32142542	Green Submitted, Green Published, gold			2022-12-26	WOS:000535271600025
J	Shinojima, A; Sawa, M; Mori, R; Sekiryu, T; Oshima, Y; Kato, A; Hara, C; Saito, M; Sugano, Y; Ashikari, M; Hirano, Y; Asato, H; Nakamure, M; Matsune, K; Kuno, N; Kimure, E; Nishiyama, T; Yuzawa, M; Ishibashi, T; Ogura, Y; Lida, T; Gomi, F; Yasukawa, T				Shinojima, Ari; Sawa, Miki; Mori, Ryusaburo; Sekiryu, Tetsuju; Oshima, Yuji; Kato, Aki; Hara, Chikako; Saito, Masaaki; Sugano, Yukinori; Ashikari, Masayuki; Hirano, Yoshio; Asato, Hitomi; Nakamure, Mayumi; Matsune, Kiyoshi; Kuno, Noriyuki; Kimure, Erika; Nishiyama, Takeshi; Yuzawa, Mitsuko; Ishibashi, Tatsuro; Ogura, Yuichiro; Lida, Tomohiro; Gomi, Fumi; Yasukawa, Tsutomu			Five-year follow-up of fundus autofluorescence and retinal sensitivity in the fellow eye in exudative age-related macular degeneration in Japan	PLOS ONE			English	Article							VISUAL FUNCTION; 2ND EYE; MICROPERIMETRY; RISK	Purpose To assess the 5-year change in abnormal fundus autofluorescence (FAF) patterns and retinal sensitivity in the fellow eye of Japanese patients with unilateral exudative age-related macular degeneration (AMD). Methods Patients with unilateral exudative AMD who developed abnormal FAF in the fellow eyes were enrolled. FAF imaging and microperimetry were performed at baseline and follow-ups. FAF findings were classified into 8 patterns based on the International Fundus Autofluorescence Classification Group to assess retinal sensitivity. Forty-five points covering the central 12 degrees on microperimetry were superimposed onto the FAF images. Each point was classified depending on the distance from the abnormal FAF. "Close" was defined as the portion within 1 degree from the border of any abnormal FAF, and "Distant" was defined as the portion over 1 degree from the border of abnormal FAF. To investigate the association between the retinal sensitivity and distance from the abnormal FAF, hierarchical linear mixed-effect models were used with the distance, time and time squared from baseline months), and angle (degrees) as fixed effects. Differences among patients, eyes, and test point locations were considered successively nested random effects. Results We studied 66 fellow eyes with abnormal FAF. Twenty-seven eyes were followed-up during the 5 years. In the 13 of 27 eyes (48%), the abnormal FAF patterns had changed during the 5 years. We found retinal sensitivity was associated significantly with the distance from the abnormal FAF ("Distant": p< 0.001, time2 from baseline: p< 0.001, angle: p< 0.001). The mean retinal sensitivity of the "Close" tended to deteriorate after the third year and eventually showed the similar sensitivity as the portion within the abnormal FAF. Conclusion FAF patterns can change about half during the 5 years and the retinal sensitivity near abnormal FAF tends to deteriorate after the third year.	[Shinojima, Ari; Mori, Ryusaburo; Yuzawa, Mitsuko] Nihon Univ, Dept Visual Sci, Div Ophthalmol, Sch Med, Tokyo, Japan; [Shinojima, Ari] Keio Univ, Dept Ophthalmol, Sch Med, Tokyo, Japan; [Sawa, Miki; Hara, Chikako; Gomi, Fumi] Osaka Univ, Dept Ophthalmol, Grad Sch Med, Suita, Osaka, Japan; [Sekiryu, Tetsuju; Saito, Masaaki; Sugano, Yukinori; Lida, Tomohiro] Fukushima Med Univ, Dept Ophthalmol, Sch Med, Fukushima, Japan; [Oshima, Yuji; Asato, Hitomi; Ishibashi, Tatsuro] Kyushu Univ, Grad Sch Med Sci, Dept Ophthalmol, Fukuoka, Japan; [Kato, Aki; Ashikari, Masayuki; Hirano, Yoshio; Ogura, Yuichiro; Yasukawa, Tsutomu] Nagoya City Univ, Dept Ophthalmol & Visual Sci, Grad Sch Med Sci, Nagoya, Aichi, Japan; [Saito, Masaaki] Akita Univ, Grad Sch Med, Dept Ophthalmol, Akita, Japan; [Saito, Masaaki] Akita Univ, Fac Med, Akita, Japan; [Nakamure, Mayumi; Matsune, Kiyoshi; Kuno, Noriyuki; Kimure, Erika] Santen Pharmaceut Co Ltd, Ikoma, Japan; [Kuno, Noriyuki] Japan Innovat Therapeut Inc, Nagoya, Aichi, Japan; [Nishiyama, Takeshi] Aichi Med Univ, Dept Publ Hlth, Sch Med, Nagakute, Aichi, Japan; [Lida, Tomohiro] Tokyo Womens Med Univ, Dept Ophthalmol, Tokyo, Japan; [Gomi, Fumi] Hyogo Coll Med, Dept Ophthalmol, Nishinomiya, Hyogo, Japan	Nihon University; Keio University; Osaka University; Fukushima Medical University; Kyushu University; Nagoya City University; Akita University; Akita University; Santen Pharmaceutical Co Ltd; Aichi Medical University; Tokyo Women's Medical University; Hyogo College of Medicine	Yasukawa, T (corresponding author), Nagoya City Univ, Dept Ophthalmol & Visual Sci, Grad Sch Med Sci, Nagoya, Aichi, Japan.	yasukawa@med.nagoya-cu.ac.jp	Saito, Masaaki/ABI-2783-2020; Shinojima, Ari/AAR-4442-2021	Saito, Masaaki/0000-0003-1494-6350; Shinojima, Ari/0000-0003-2322-0332; Hirano, Yoshio/0000-0002-9173-0839; Gomi, Fumi/0000-0003-0807-8817	Santen Pharmaceutical Co., Ltd.; JSPS KAKENHI [JP19K18893]	Santen Pharmaceutical Co., Ltd.; JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	Santen Pharmaceutical Co., Ltd. provided support in the form of honoraria for speaking and/or organizing at meetings (AS, MS, RM, TS, Yuji Oshima, TI, Yuichiro Ogura, FG, TY), but did not have any additional role in the study design, data analysis, decision to publish, or preparation of the manuscript. Santen Pharmaceutical Co., Ltd. provided support in the form of salaries for authors [MN, KM, NK, and EK], but did not have any additional role in the study design, data analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the `author contributions' section. This work was also supported by JSPS KAKENHI Grant Number JP19K18893.	American Academy of Ophthalmology, 2015, AG REL MAC DEG PPP U; Bindewald A, 2005, INVEST OPHTH VIS SCI, V46, P3309, DOI 10.1167/iovs.04-0430; Birtel J, 2019, AM J OPHTHALMOL, V199, P19, DOI 10.1016/j.ajo.2018.10.021; Brandl C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167181; Cassels NK, 2018, SURV OPHTHALMOL, V63, P40, DOI 10.1016/j.survophthal.2017.05.007; Einbock W, 2005, GRAEF ARCH CLIN EXP, V243, P300, DOI 10.1007/s00417-004-1027-3; Hariri AH, 2016, AM J OPHTHALMOL, V168, P122, DOI 10.1016/j.ajo.2016.05.007; Kassoff A, 2001, ARCH OPHTHALMOL-CHIC, V119, P1417, DOI 10.1001/archopht.119.10.1417; Kiziltunc PB, 2018, TURK OFTALMOL DERG, V48, P304, DOI 10.4274/tjo.69260; Maguire MG, 1997, ARCH OPHTHALMOL-CHIC, V115, P741; Midena E, 2007, BRIT J OPHTHALMOL, V91, P1499, DOI 10.1136/bjo.2007.119685; Midena E, 2010, OPHTHALMOLOGY, V117, P1571, DOI 10.1016/j.ophtha.2009.12.044; Nomura Y, 2019, GRAEF ARCH CLIN EXP, V257, P1591, DOI 10.1007/s00417-019-04332-z; Ozdemir H, 2008, EYE, V22, P204, DOI 10.1038/sj.eye.6702563; Ozdemir H, 2008, EUR J OPHTHALMOL, V18, P799, DOI 10.1177/112067210801800522; Parisi V, 2007, RETINA-J RET VIT DIS, V27, P879, DOI 10.1097/IAE.0b013e318042d6aa; Rim TH, 2017, BRIT J OPHTHALMOL, V101, P1367, DOI 10.1136/bjophthalmol-2016-309952; Rohrschneider K, 2005, AM J OPHTHALMOL, V139, P125, DOI 10.1016/j.ajo.2004.08.060; Schmitz-Valckenberg S, 2008, RETINA-J RET VIT DIS, V28, P385, DOI 10.1097/IAE.0b013e318164a907; Shinojima A, 2016, OPHTHALMOLOGICA, V235, P208, DOI 10.1159/000444885; Springer C, 2005, OPHTHALMOLOGY, V112, P848, DOI 10.1016/j.ophtha.2004.11.051; Swaroop A, 2009, ANNU REV GENOM HUM G, V10, P19, DOI 10.1146/annurev.genom.9.081307.164350; The Royal College of Ophthalmologists, AG REL MAC DEG GUID; Uyama M, 2000, BRIT J OPHTHALMOL, V84, P1018, DOI 10.1136/bjo.84.9.1018; Vingolo EM, 2017, EUR J OPHTHALMOL, V27, P352, DOI 10.5301/ejo.5000904; VONRUCKMANN A, 1995, BRIT J OPHTHALMOL, V79, P407, DOI 10.1136/bjo.79.5.407; Whitmore SS, 2015, PROG RETIN EYE RES, V45, P1, DOI 10.1016/j.preteyeres.2014.11.005; Yasukawa T, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0213161; 2001, AM J OPHTHALMOL, V132, P668, DOI DOI 10.1016/S0002-9394(01)01218-1	29	1	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2020	15	3							e0229694	10.1371/journal.pone.0229694	http://dx.doi.org/10.1371/journal.pone.0229694			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8TR	32142523	Green Published, gold			2022-12-26	WOS:000535271600016
J	Gunning, MN; Meun, C; van Rijn, BB; Daan, NMP; van Lennep, JER; Appelman, Y; Boersma, E; Hofstra, L; Fauser, CGKM; Rueda-Ochoa, OL; Ikram, MA; Kavousi, M; Lambalk, CB; Eijkemans, MJC; Laven, JSE; Fauser, BCJM				Gunning, Marlise N.; Meun, Cindy; van Rijn, Bas B.; Daan, Nadine M. P.; van Lennep, Jeanine E. Roeters; Appelman, Yolande; Boersma, Eric; Hofstra, Leonard; Fauser, Clemens G. K. M.; Rueda-Ochoa, Oscar L.; Ikram, Mohammad A.; Kavousi, Maryam; Lambalk, Cornelis B.; Eijkemans, Marinus J. C.; Laven, Joop S. E.; Fauser, Bart C. J. M.		CREW Consortium	The cardiovascular risk profile of middle age women previously diagnosed with premature ovarian insufficiency: A case-control study	PLOS ONE			English	Article							CAUSE-SPECIFIC MORTALITY; PULSE-WAVE VELOCITY; INTIMA-MEDIA THICKNESS; CORONARY-HEART-DISEASE; MYOCARDIAL-INFARCTION; PREMENOPAUSAL WOMEN; ARTERIAL STIFFNESS; METABOLIC SYNDROME; NATURAL MENOPAUSE; BLOOD-PRESSURE	Background Cardiovascular disease (CVD) is the leading cause of death in women worldwide. The cardiovascular risk profile deteriorates after women enter menopause. By definition, women diagnosed with premature ovarian insufficiency (POI) experience menopause before 40 years of age, which may render these women even more susceptible to develop CVD later in life. However, prospective long-term follow up data of well phenotyped women with POI are scarce. In the current study we compare the CVD profile and risk of middle aged women previously diagnosed with POI, to a population based reference group matched for age and BMI. Methods and findings We compared 123 women (age 49.0 (+/- 4.3) years) and diagnosed with POI 8.1 (IQR: 6.89.6) years earlier, with 123 population controls (age 49.4 (+/- 3.9) years). All women underwent an extensive standardized cardiovascular screening. We assessed CVD risk factors including waist circumference, BMI, blood pressure, lipid profile, pulse wave velocity (PWV), and the prevalence of diabetes mellitus, metabolic syndrome (MetS) and carotid intima media thickness (cIMT), in both women with POI and controls. We calculated the 10-year CVD Framingham Risk Score (FRS) and the American Heart Association's suggested cardiovascular health score (CHS). Waist circumference (90.0 (IQR: 83.0-98.0) versus 80.7 (IQR: 75.1-86.8), p < 0.01), waist-to-hip ratio (0.90 (IQR: 0.85-0.93) versus 0.79 (IQR: 0.75-0.83), p < 0.01), systolic blood pressure (124 (IQR 112-135) versus 120 (IQR109131), p < 0.04) and diastolic blood pressure (81 (IQR: 76-89) versus 78 (IQR: 71-86), p < 0.01), prevalence of hypertension (45 (37%) versus 21 (17%), p < 0.01) and MetS (19 (16%) versus 4 (3%), p < 0.01) were all significantly increased in women with POI compared to healthy controls. Other risk factors, however, such as lipids, glucose levels and prevalence of diabetes were similar comparing women with POI versus controls. The arterial stiffness assessed by PWV was also similar in both populations (8.1 (IQR: 7.1-9.4) versus 7.9 (IQR: 7.1-8.4), p = 0.21). In addition, cIMT was lower in women with POI compared to controls (550 mu m (500-615) versus 684 mu m (618-737), p < 0.01). The calculated 10-year CVD risk was 5.9% (IQR: 3.7-10.6) versus 6.0% (IQR: 3.9-9.0) (p = 0.31) and current CHS was 6.1 (1.9) versus 6.5 (1.6) (p = 0.07), respectively in POI versus controls. Conclusions Middle age women with POI presented with more unfavorable cardiovascular risk factors (increased waist circumference and a higher prevalence of hypertension and MetS) compared to age and BMI matched population controls. In contrast, the current study reveals a lower cIMT and similar 10-year cardiovascular disease risk and cardiovascular health score. In summary, neither signs of premature atherosclerosis nor a worse cardiovascular disease risk or health score were observed among middle age women with POI compared to population controls. Longer-term follow-up studies of women of more advanced age are warranted to establish whether women with POI are truly at increased risk of developing CVD events later in life.	[Gunning, Marlise N.; Daan, Nadine M. P.; Eijkemans, Marinus J. C.; Fauser, Bart C. J. M.] Univ Utrecht, Univ Med Ctr Utrecht, Dept Reprod Med & Gynecol, Utrecht, Netherlands; [Meun, Cindy; Laven, Joop S. E.] Erasmus MC, Dept Obstet & Gynecol, Div Reprod Endocrinol & Infertil, Rotterdam, South Holland, Netherlands; [van Rijn, Bas B.] Univ Med Ctr Utrecht, Wilhelmina Childrens Hosp, Dept Obstet, Birth Ctr, Utrecht, Netherlands; [van Rijn, Bas B.] Erasmus MC, Dept Obstet & Gynecol, Div Obstet & Fetal Med, Rotterdam, Netherlands; [van Lennep, Jeanine E. Roeters] Erasmus MC, Dept Internal Med, Rotterdam, South Holland, Netherlands; [Appelman, Yolande; Hofstra, Leonard] Vrije Univ Amsterdam, Dept Cardiol, Amsterdam UMC, Amsterdam, North Holland, Netherlands; [Boersma, Eric] Cardiovasc Res Sch COEUR, Rotterdam, South Holland, Netherlands; [Boersma, Eric; Rueda-Ochoa, Oscar L.; Ikram, Mohammad A.; Kavousi, Maryam] Erasmus MC, Dept Epidemiol, Rotterdam, South Holland, Netherlands; [Boersma, Eric] Erasmus MC, Dept Cardiol, Rotterdam, South Holland, Netherlands; [Hofstra, Leonard; Fauser, Clemens G. K. M.] Cardiol Ctr Netherlands, Utrecht, Netherlands; [Rueda-Ochoa, Oscar L.] Univ Ind Santander, Sch Med, Santander, Colombia; [Ikram, Mohammad A.] Erasmus MC, Dept Neurol, Rotterdam, South Holland, Netherlands; [Lambalk, Cornelis B.] Amsterdam Univ Med Ctr Locat VUmc, Dept Obstet & Gynecol, Amsterdam, North Holland, Netherlands; [Eijkemans, Marinus J. C.] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center; Erasmus University Rotterdam; Erasmus MC; Utrecht University; Utrecht University Medical Center; Wilhelmina Kinderziekenhuis; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; University of Amsterdam; Vrije Universiteit Amsterdam; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Universidad Industrial de Santander; Erasmus University Rotterdam; Erasmus MC; Utrecht University; Utrecht University Medical Center	Gunning, MN (corresponding author), Univ Utrecht, Univ Med Ctr Utrecht, Dept Reprod Med & Gynecol, Utrecht, Netherlands.	m.n.gunning@umcutrecht.nl	Kavousi, Maryam/F-1174-2018; Ikram, M. Arfan/AAM-5225-2021; van Rijn, Bas/ABZ-1080-2022	Kavousi, Maryam/0000-0001-5976-6519; van Rijn, Bas/0000-0003-1305-3825; Rueda-Ochoa, Oscar L./0000-0003-2684-9005; Lambalk, Cornelis/0000-0003-3947-5129; Ikram, Mohammad Arfan/0000-0003-0372-8585	Dutch Heart Foundation [2013T083]	Dutch Heart Foundation(Netherlands Heart Foundation)	The current study was funded only by the Dutch Heart Foundation (grant number 2013T083). https://www.hartstichting.nl/Research conducted by M.N.G. and C.M. were funded by this grant. This funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. We declare complete independence of funders.	Aksoy MNM, 2017, SCAND CARDIOVASC J, V51, P95, DOI 10.1080/14017431.2017.1285044; Alexander CM, 2003, DIABETES, V52, P1210, DOI 10.2337/diabetes.52.5.1210; Amagai Y, 2006, J EPIDEMIOL, V16, P161, DOI 10.2188/jea.16.161; [Anonymous], 2017, Circulation, V136, pe196, DOI 10.1161/CIR.0000000000000530; Appiah D, 2015, AM J EPIDEMIOL, V182, P991, DOI 10.1093/aje/kwv162; ASMAR R, 1995, HYPERTENSION, V26, P485, DOI 10.1161/01.HYP.26.3.485; Atsma F, 2006, MENOPAUSE, V13, P265, DOI 10.1097/01.gme.0000218683.97338.ea; Bos S, 2017, ATHEROSCLEROSIS, V256, P62, DOI 10.1016/j.atherosclerosis.2016.12.005; Bots ML, 1997, CIRCULATION, V96, P1432, DOI 10.1161/01.CIR.96.5.1432; de Almeida DMB, 2011, MENOPAUSE, V18, P262, DOI 10.1097/gme.0b013e3181f4318d; Christ JP, 2018, FERTIL STERIL, V109, P594, DOI 10.1016/j.fertnstert.2017.11.035; Cruickshank K, 2002, CIRCULATION, V106, P2085, DOI 10.1161/01.CIR.0000033824.02722.F7; Cui R, 2006, J EPIDEMIOL, V16, P177, DOI 10.2188/jea.16.177; D'Agostino RB, 2008, CIRCULATION, V117, P743, DOI 10.1161/CIRCULATIONAHA.107.699579; Daan NMP, 2015, HUM REPROD, V30, P2376, DOI 10.1093/humrep/dev195; Daan NMP, 2016, J CLIN ENDOCR METAB, V101, P3306, DOI 10.1210/jc.2016-1141; Daan NMP, 2014, FERTIL STERIL, V102, DOI 10.1016/j.fertnstert.2014.08.001; De Vos M, 2010, LANCET, V376, P911, DOI 10.1016/S0140-6736(10)60355-8; Douglas PS, 1996, NEW ENGL J MED, V334, P1311, DOI 10.1056/NEJM199605163342007; Gameiro CM, 2010, MATURITAS, V67, P316, DOI 10.1016/j.maturitas.2010.08.003; Graham I, 2007, EUR HEART J, V28, P2375, DOI 10.1093/eurheartj/ehm316; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; Hippisley-Cox J, 2008, BMJ-BRIT MED J, V336, P1475, DOI 10.1136/bmj.39609.449676.25; Hippisley-Cox J, 2007, BMJ-BRIT MED J, V335, P136, DOI 10.1136/bmj.39261.471806.55; HOFMAN A, 1991, EUR J EPIDEMIOL, V7, P403, DOI 10.1007/BF00145007; Hong JS, 2007, MATURITAS, V56, P411, DOI 10.1016/j.maturitas.2006.11.004; Horvath IG, 2010, J HYPERTENS, V28, P2068, DOI 10.1097/HJH.0b013e32833c8a1a; Ikram MA, 2017, EUR J EPIDEMIOL, V32, P807, DOI 10.1007/s10654-017-0321-4; Janse F, 2010, MENOPAUSE, V17, P758, DOI 10.1097/gme.0b013e3181cf8521; Khatibi A, 2007, CLIMACTERIC, V10, P386, DOI 10.1080/13697130701377265; Knauff EAH, 2008, MENOPAUSE, V15, P919, DOI 10.1097/gme.0b013e31816b4509; Kok HS, 2006, J AM COLL CARDIOL, V47, P1976, DOI 10.1016/j.jacc.2005.12.066; Laven JSE, 2016, MATURITAS, V92, P15, DOI 10.1016/j.maturitas.2016.07.006; Laven JSE, 2016, SEMIN REPROD MED, V34, P193, DOI 10.1055/s-0036-1585407; Leening MJG, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g5992; Li S, 2013, MATURITAS, V75, P246, DOI 10.1016/j.maturitas.2013.04.003; Lloyd-Jones DM, 2010, CIRCULATION, V121, P586, DOI 10.1161/CIRCULATIONAHA.109.192703; Lorenz MW, 2007, CIRCULATION, V115, P459, DOI 10.1161/CIRCULATIONAHA.106.628875; Mattace-Raso FUS, 2006, CIRCULATION, V113, P657, DOI 10.1161/CIRCULATIONAHA.105.555235; Mieres JH, 2005, CIRCULATION, V111, P682, DOI 10.1161/01.CIR.0000155233.67287.60; Mitchell GF, 2010, CIRCULATION, V121, P505, DOI 10.1161/CIRCULATIONAHA.109.886655; Moreau KL, 2012, J CLIN ENDOCR METAB, V97, P4692, DOI 10.1210/jc.2012-2244; Mozaffarian D, 2015, CIRCULATION, V131, pE29, DOI 10.1161/CIR.0000000000000152; Muka T, 2016, JAMA CARDIOL, V1, P767, DOI 10.1001/jamacardio.2016.2415; Muntner P, 2014, JAMA-J AM MED ASSOC, V311, P1406, DOI 10.1001/jama.2014.2630; Nelson Lawrence M, 2009, N Engl J Med, V360, P606, DOI 10.1056/NEJMcp0808697; Ninomiya JK, 2004, CIRCULATION, V109, P42, DOI 10.1161/01.CIR.0000108926.04022.0C; Ossewaarde ME, 2005, EPIDEMIOLOGY, V16, P556, DOI 10.1097/01.ede.0000165392.35273.d4; Perez-Lopez FR, 2009, FERTIL STERIL, V92, P1171, DOI 10.1016/j.fertnstert.2009.06.032; Popat VB, 2009, J CLIN ENDOCR METAB, V94, P2277, DOI 10.1210/jc.2008-1878; Reckelhoff JF, 2004, HYPERTENSION, V43, P918, DOI 10.1161/01.HYP.0000124670.03674.15; Ridker PM, 2007, JAMA-J AM MED ASSOC, V297, P611, DOI 10.1001/jama.297.6.611; Rivera CM, 2009, MENOPAUSE, V16, P15, DOI 10.1097/gme.0b013e31818888f7; Rocca WA, 2006, LANCET ONCOL, V7, P821, DOI 10.1016/S1470-2045(06)70869-5; Rocca WA, 2016, MAYO CLIN PROC, V91, P1577, DOI 10.1016/j.mayocp.2016.08.002; Seals DR, 2000, J PHYSIOL-LONDON, V528, P407, DOI 10.1111/j.1469-7793.2000.00407.x; Shaw LJ, 2018, EUR HEART J, V39, P3727, DOI 10.1093/eurheartj/ehy534; Stanaway JD, 2018, LANCET, V392, P1923, DOI 10.1016/s0140-6736(18)32225-6; Stolk L, 2012, NAT GENET, V44, P260, DOI 10.1038/ng.1051; Sullivan SD, 2016, FERTIL STERIL, V106, P1588, DOI 10.1016/j.fertnstert.2016.09.046; Tao XY, 2016, CLIMACTERIC, V19, P27, DOI 10.3109/13697137.2015.1094784; Tom SE, 2012, J WOMENS HEALTH, V21, P10, DOI 10.1089/jwh.2011.2745; Vaidya D, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d5170; Valkenburg O, 2008, J CLIN ENDOCR METAB, V93, P470, DOI 10.1210/jc.2007-1756; van Lennep JER, 2016, EUR J PREV CARDIOL, V23, P178, DOI 10.1177/2047487314556004; Webber L, 2016, HUM REPROD, V31, P926, DOI 10.1093/humrep/dew027; WIINBERG N, 1995, AM J HYPERTENS, V8, P978, DOI 10.1016/0895-7061(95)00216-2; Wu XY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089597; Yanes LL, 2011, AM J HYPERTENS, V24, P740, DOI 10.1038/ajh.2011.71; Zoet GA, 2017, BMC WOMENS HEALTH, V17, DOI 10.1186/s12905-017-0415-x	70	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2020	15	3							e0229576	10.1371/journal.pone.0229576	http://dx.doi.org/10.1371/journal.pone.0229576			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8RK	32134933	Green Published, gold			2022-12-26	WOS:000535265600031
J	Manning, AD; Cunningham, RB; Tongway, D; Lindenmayer, DB				Manning, Adrian D.; Cunningham, Ross B.; Tongway, David; Lindenmayer, David B.			Woodlands and woody debris: Understanding structure and composition to inform restoration	PLOS ONE			English	Article							SPECIES-DIVERSITY; EUCALYPT WOODLAND; MULLIGANS FLAT; ECOLOGY; VEGETATION; GOOROOYARROO; BIODIVERSITY; PATTERNS; RESERVES; VOLUMES	Simplification of stand structure of forests and woodlands through human-induced modification is a serious threat to biodiversity. Restoring lost habitat complexity and heterogeneity, such as woody debris, requires an understanding of the relationships between different elements that contribute to stand structure. In this study, we examine the structure and composition of a critically endangered box-gum grassy woodland in south-eastern Australia and relationships with woody debris loads. We found that: (1) despite modification by humans and differing susceptibility to dieback, the two dominant tree species, Blakeley's red gum, Eucalyptus blakelyi and yellow box, E. melliodora, occurred in similar proportions irrespective of vegetation density; (2) E. blakelyi had the largest number of stems and basal area, but while E. melliodora had fewer stems, it had a similar basal area to E. blakelyi. E. melliodora also showed fewer signs of dieback than E. blakelyi with between 40-50% trees in good condition compared to 2% for the latter species; (3) woody debris loads were low compared to other studies in woodland, but there were levels of heterogeneity indicating `natural' accumulation was occurring; (4) tree basal area and woody debris loads had a 1:1 relationship across all sites and vegetation densities. Overall, our study indicated that ecosystem recovery was taking place (i.e. with many young trees), but there were fewer large trees that are known to supply most woody debris. Our findings highlight the slow accumulation of this critical resource because the volumes were lower than expected. Based on our results, we recommend: (1) aiming for approximately a 50:50 ratio of yellow box to Blakely's red gum basal area in woodland restoration projects; (2) to accelerate the recovery of woodland structure, addition of woody debris should be added at a minimum ratio of 1:1 to standing basal area (i.e. a basal area of 5.99 m(2) requires a minimum volume of 3.11 m(3)) (3) managing for both volume and heterogeneity of woody debris loads; (4) preserving large diameter trees to harness proportionally higher woody debris and litter inputs.	[Manning, Adrian D.; Cunningham, Ross B.; Tongway, David; Lindenmayer, David B.] Australian Natl Univ, Fenner Sch Environm & Soc, Canberra, ACT, Australia	Australian National University	Manning, AD (corresponding author), Australian Natl Univ, Fenner Sch Environm & Soc, Canberra, ACT, Australia.	adrian.manning@anu.edu.au	Manning, Adrian/AAX-7288-2021; Manning, Adrian/AAG-2949-2019	Manning, Adrian/0000-0003-0989-9203; 	Australian Research Council [LP0561817, LP110100126, FT100100358]; ACT Government as part of an Australian Research Council Linkage Grant [LP0561817, LP110100126]	Australian Research Council(Australian Research Council); ACT Government as part of an Australian Research Council Linkage Grant(Australian Research Council)	This work was supported by: DL, LP0561817 Australian Research Council, https://www.arc.gov.au/; AM, LP110100126 Australian Research Council, https://www.arc.gov.au/; AM, FT100100358 Australian Research Council, https://www.arc.gov.au/.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Thanks to: Meredith Cosgrove, Chris Davey, Steve Holliday, Brett Howland, Paul Killey, Nicki Munro, Karl Newport, Jenny Newport for assistance with field surveys; Christine Donnelly for assistance with statistical analysis; Saul Cunningham, Joern Fischer, Phil Gibbons, Iain Gordon, Chris McElhinny (now deceased), Sue McIntyre, David Shorthouse and Jeff Wood for providing advice to the project; Sue McIntyre for provision of literature; all the ACT Government staff that have assisted in all aspects of this project. Fieldwork was covered by ACT project licence LT2005201 and LT2009347. Funding and in-kind logistic support for this project was provided by the ACT Government as part of an Australian Research Council Linkage Grant (LP0561817; LP110100126). ADM was supported by an Australian Research Council Future Fellowship (FT100100358).The authors thank Phil Gibbons for comments on an earlier draft of this manuscript.	Barton PS, 2011, J APPL ECOL, V48, P943, DOI 10.1111/j.1365-2664.2011.01994.x; Barton PS, 2010, J BIOGEOGR, V37, P1927, DOI 10.1111/j.1365-2699.2010.02349.x; Barton PS, 2009, BIOL CONSERV, V142, P1701, DOI 10.1016/j.biocon.2009.03.005; Beadle N., 1981, VEGETATION AUSTR; Benson J. S., 1997, Cunninghamia, V5, P285; Bradstock RA., 2002, FLAMMABLE AUSTR FIRE; Brooker MIH., 1999, FIELD GUIDE EUCALYPT; Brown JS, 1999, J MAMMAL, V80, P385, DOI 10.2307/1383287; CATLING PC, 1995, WILDLIFE RES, V22, P271, DOI 10.1071/WR9950271; CODY ML, 1981, BIOSCIENCE, V31, P107, DOI 10.2307/1308252; Department of the Environment and Heritage, 2006, EPBC POL STAT 3 5 WH; Fischer J, 2004, J APPL ECOL, V41, P32, DOI 10.1111/j.1365-2664.2004.00869.x; Fischer J, 2009, P NATL ACAD SCI USA, V106, P10386, DOI 10.1073/pnas.0900110106; Galway N. W., 2006, INTRO MIXED MODELLIN; Gibbons P, 2008, BIOL CONSERV, V141, P2483, DOI 10.1016/j.biocon.2008.07.009; HARMON ME, 1986, ADV ECOL RES, V15, P133, DOI 10.1016/S0065-2504(08)60121-X; Hobbs R.J., 2000, TEMPERATE EUCALYPT W; Hoekstra JM, 2005, ECOL LETT, V8, P23, DOI 10.1111/j.1461-0248.2004.00686.x; HOLMES RT, 1981, OECOLOGIA, V48, P31, DOI 10.1007/BF00346985; Ikin K, 2015, LANDSCAPE ECOL, V30, P1387, DOI 10.1007/s10980-015-0193-5; Kenward MG, 1997, BIOMETRICS, V53, P983, DOI 10.2307/2533558; Killey P, 2010, AUSTRAL ECOL, V35, P956, DOI 10.1111/j.1442-9993.2010.02107.x; LANDSBERG J, 1983, AUST J ECOL, V8, P27, DOI 10.1111/j.1442-9993.1983.tb01516.x; Laundre JW, 2001, CAN J ZOOL, V79, P1401, DOI 10.1139/cjz-79-8-1401; Lima SL, 1998, BIOSCIENCE, V48, P25, DOI 10.2307/1313225; Lindenmayer DB, 2007, EMU, V107, P135, DOI 10.1071/MU06040; Lindenmayer D, 2012, BIOL CONSERV, V152, P62, DOI 10.1016/j.biocon.2012.02.026; Lunt ID, 2005, J BIOGEOGR, V32, P1859, DOI 10.1111/j.1365-2699.2005.01296.x; Lunt ID, 2010, MANAGING EXTENSIVE A; Mac Nally R, 2001, BIOL CONSERV, V99, P191, DOI 10.1016/S0006-3207(00)00180-4; MACARTHUR R, 1961, ECOLOGY, V42, P594, DOI 10.2307/1932254; MACARTHUR R, 1962, AM NAT, V96, P167, DOI 10.1086/282219; Manning A.D., 2011, Australian Zoologist, V35, P633; Manning AD, 2004, BIOL CONSERV, V120, P363, DOI 10.1016/j.biocon.2004.03.008; Manning AD, 2006, BIOL CONSERV, V132, P311, DOI 10.1016/j.biocon.2006.04.023; Manning AD, 2013, BIOL CONSERV, V157, P204, DOI 10.1016/j.biocon.2012.06.028; Manning Adrian D., 2007, Ecological Management & Restoration, V8, P221, DOI 10.1111/j.1442-8903.2007.00371.x; McIntyre S., 2010, Cunninghamia, V11, P319; NSW Scientific Committee, 2002, WHIT BOX YELL BOX BA; PIANKA ER, 1967, ECOLOGY, V48, P333, DOI 10.2307/1932670; Price JN, 2008, AUSTRAL ECOL, V33, P278, DOI 10.1111/j.1442-9993.2007.01815.x; Rackham O, 2003, ANCIENT WOODLAND ITS; Reid N, 2000, TEMPERATE EUCALYPT WOODLANDS IN AUSTRALIA, P127; Shorthouse David J., 2012, Ecological Management & Restoration, V13, P112, DOI 10.1111/j.1442-8903.2012.00654.x; Threlfall CG, 2019, AUSTRAL ECOL, V44, P138, DOI 10.1111/aec.12661; VANWAGNER CE, 1968, FOREST SCI, V14, P20; Waddell K., 2002, ECOL INDICATORS, V1, P139; WARREN W. G., 1964, FOREST SCI, V10, P267; Yates CJ, 1997, AUST J BOT, V45, P949, DOI 10.1071/BT96091	49	1	1	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2020	15	3							e0224258	10.1371/journal.pone.0224258	http://dx.doi.org/10.1371/journal.pone.0224258			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8RK	32134939	Green Published, gold			2022-12-26	WOS:000535265600008
J	Zhong, YW; Wu, XL				Zhong, Youwen; Wu, Xiaoling			Effects of cost-benefit analysis under back propagation neural network on financial benefit evaluation of investment projects	PLOS ONE			English	Article							PREDICTION	To determine the influence of the weight of the economic effectiveness evaluation criteria of the major investments of listed enterprises, and provide new management ideas for the development of the follow-up enterprises, firstly, the financial benefit evaluation system of investment projects is analyzed and constructed, and the specific evaluation process is analyzed. Then, on this basis, the evaluation index is refined; the basic structure of BP neural network (BPNN) is introduced, and genetic algorithm is used to improve BP neural network. The cost-benefit analysis model is constructed based on the improved BPNN. The listed company A is taken as an example to analyze its development data in recent years, and then the data of 10 listed companies are taken as the research object. Matlab simulation software is used to train and verify the improved BPNN model, analyze and predict the weight value of the financial benefit index of the investment projects of these 10 companies, and then determine the index to improve the financial benefit of the investment projects. Under the analysis of the development data of listed company A in the past 10 years, it is found that the indicators of the listed company's profitability per share, debt risk operation ability, development, and growth ability in the past 10 years are in relatively stable state. The principal component analysis of its 20 secondary sub-indexes is conducted based on the four primary indicators: profitability, debt risk, operational capacity, and development and growth. A total of eight principal components including return on equity (ROE), return on assets (ROA), (total asset turnover) TATO, turnover of account receivable (AR), asset-liability ratio, interest protection multiple, income growth rate, and year-on-year rate of increase for complete assets are extracted. The average error between the final output value, the actual value, and the expected value is 0.0304 and 0.0169, respectively. The weight coefficient of the monetary benefits evaluation indicator of investment items is calculated, and the computed results show that year-on-year rate of increase for complete assets, TOTA, ROA, turnover of total capital, and ROE are important indexes in the financial benefit evaluation of investment projects. It indicates that to improve the financial benefit of investment projects of listed enterprises, it is necessary to enhance the year-over-year growth degree of total properties and ROA.	[Zhong, Youwen] Xi An Jiao Tong Univ, Sch Econ & Finance, Xian, Shaanxi, Peoples R China; [Wu, Xiaoling] Xi An Jiao Tong Univ, Dept Obstet & Gynecol, Affiliated Hosp 2, Xian, Shaanxi, Peoples R China	Xi'an Jiaotong University; Xi'an Jiaotong University	Zhong, YW (corresponding author), Xi An Jiao Tong Univ, Sch Econ & Finance, Xian, Shaanxi, Peoples R China.	ovens2020@126.com		Zhong, Youwen/0000-0002-4627-5849				Aljarah I, 2018, SOFT COMPUT, V22, P1, DOI 10.1007/s00500-016-2442-1; Bril A R, 2017, AKTUAL PROBL EKON AC; Chen TD, 2018, J DISCRET MATH SCI C, V21, P869, DOI 10.1080/09720529.2018.1480277; Cooremans C, 2019, J CLEAN PROD, V230, P264, DOI 10.1016/j.jclepro.2019.04.333; Du WH, 2019, MULTIMED TOOLS APPL, V78, P30271, DOI 10.1007/s11042-018-6872-x; Esch M, 2019, BUS STRATEG ENVIRON, V28, P599, DOI 10.1002/bse.2267; Friedman SA, 2018, HEALTH SERV RES, V53, P366, DOI 10.1111/1475-6773.12614; Guan HJ, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0192366; Harjanti W., 2019, ARCH BUSINESS RES AB, V7, P164; Hocine B., 2017, J ED PRACTICE, V8, P89; Jiang Q., 2019, IEEE ACCESS, V7; Kaewunruen S, 2019, J CLEAN PROD, V212, P1008, DOI 10.1016/j.jclepro.2018.11.271; Kulczycka J, 2016, CLEAN TECHNOL ENVIR, V18, P829, DOI 10.1007/s10098-015-1059-x; Li JC, 2018, PHYSICA A, V495, P1, DOI 10.1016/j.physa.2017.12.018; Liu Y., 2017, INT J ADV MANUF TECH, V88, P1, DOI DOI 10.1007/S00170-016-9622-0; Long JB, 2019, T INDIAN I METALS, V72, P2443, DOI 10.1007/s12666-019-01696-y; Nastos PT, 2013, ATMOS RES, V119, P153, DOI 10.1016/j.atmosres.2011.07.020; Pimentel V, 2019, COMPUT IND ENG, V137, DOI 10.1016/j.cie.2019.106073; [任宏 Ren Hong], 2015, [系统工程理论与实践, Systems Engineering-Theory & Practice], V35, P1474; Strouhal J, 2018, J COMPETITIVENESS, V10, P144, DOI 10.7441/joc.2018.01.09; Tu Y., 2018, CLUSTER COMPUT, P1; [王金峰 Wang Jinfeng], 2017, [农业工程学报, Transactions of the Chinese Society of Agricultural Engineering], V33, P116; Zheng D, 2018, CONSTR BUILD MATER, V158, P614, DOI 10.1016/j.conbuildmat.2017.10.056; Ziyadin S, 2019, SUSTAINABILITY-BASEL, V11, DOI 10.3390/su11092544	24	10	10	3	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2020	15	3							e0229739	10.1371/journal.pone.0229739	http://dx.doi.org/10.1371/journal.pone.0229739			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8RK	32134951	Green Published, gold			2022-12-26	WOS:000535265600040
J	Guedes, JVM; Aquino, JA; Castro, TLB; de Morais, FA; Baldoni, AO; Belo, VS; Otoni, A				Marques Guedes, Joao Victor; Aquino, Jessica Azevedo; Castro, Tassia Lima Bernardino; de Morais, Flavio Augusto; Baldoni, Andre Oliveira; Belo, Vinicius Silva; Otoni, Alba			Omeprazole use and risk of chronic kidney disease evolution	PLOS ONE			English	Article							PROTON PUMP INHIBITORS; SEX; HYPOMAGNESEMIA; ASSOCIATION; PROGRESSION; EQUATION; STAGE	Rationale, aims and objectives In recent years, the use of proton pump inhibitors (PPI), especially omeprazole, has been associated with development of chronic kidney disease (CKD). These drugs are widely used worldwide. Although some studies have found an association between the use of PPI and the onset of acute renal failure and CKD. This study aims to analyze the association between the continuous use of omeprazole and the progression of CKD in adult and elderly individuals. Method A retrospective cohort study was conducted with patients followed up at a nephrology clinic in Brazil, in 2016 and 2017. Information about clinical and sociodemographic data, health behaviors, and medication use were collected from all patients diagnosed with CKD through consultation of medical charts and the Brazilian health information system (SIS). The participants were allocated into two groups: users and non-users of omeprazole, and the progression of CKD was then evaluated for each group. In the bivariate analysis, the Mann-Whitney U test to compare the quantitative variables between groups, and the Pearson/Fisher two-tailed chi-square test to compare the categorical variables were applied. Multivariate analysis was performed using Cox regression. Results A total of 199 CKD patients were attended in the polyclinic, and of these, 42.7% were omeprazole users. There was a higher percentage of CKD progression in users (70.6%) compared to non-users (10.5%). The hazard ratio was 7.34 (CI: 3.94-13.71), indicating a higher risk of progression to worse stages of CKD in omeprazole users than in non-users. As for the other variables, no statistically significant difference was found between groups (p > 0.05). Conclusion An association between omeprazole use and progression of CKD stage was identified, showing a higher risk of disease evolution among omeprazole users.	[Marques Guedes, Joao Victor; Aquino, Jessica Azevedo; Castro, Tassia Lima Bernardino; Baldoni, Andre Oliveira; Belo, Vinicius Silva; Otoni, Alba] Fed Univ Sao Joao Del Rei UFSJ, Dept Hlth Sci, Divinopolis, MG, Brazil; [de Morais, Flavio Augusto] Ambulatory Municipal Polyclin Divinopolis, Dept Nephrol, Divinopolis, MG, Brazil	Universidade Federal de Sao Joao del-Rei	Guedes, JVM (corresponding author), Fed Univ Sao Joao Del Rei UFSJ, Dept Hlth Sci, Divinopolis, MG, Brazil.	jvmg92@gmail.com	Belo, Vinícius Silva/AAP-6532-2020; AO BALDONI, AO BALDONI/B-3219-2016; Baldoni, André Oliveira/AAO-2675-2021	Belo, Vinícius Silva/0000-0003-0183-1175; AO BALDONI, AO BALDONI/0000-0001-6379-0415; 				Ahrens D, 2012, INT J CLIN PRACT, V66, P767, DOI 10.1111/j.1742-1241.2012.02973.x; Alcantara Montero A, 2017, SEMERGEN, V43, P29, DOI [10.1016/j.semerg.2016.03.020, DOI 10.1016/J.SEMERG.2016.03.020]; ALTURA B M, 1985, Magnesium, V4, P226; [Anonymous], 2016, LANCET ONCOL, V17, P1, DOI 10.1016/S1470-2045(15)00568-9; [Anonymous], 2017, CENS DIAL 2017; [Anonymous], 2014, J ELECT MAT, V1, P1; Bailey JNC, 2016, BIOCOMPUT-PAC SYM, P285; Bandeira VAC, 2013, REV BRAS CIENC ENVEL, V10, P181, DOI [10.5335/rbceh.2013.2753, DOI 10.5335/RBCEH.2013.2753]; Barreto Fellype Carvalho, 2014, Braz. J. Nephrol., V36, P221, DOI 10.5935/0101-2800.20140033; Batuwitage BT, 2007, POSTGRAD MED J, V83, P66, DOI 10.1136/pgmj.2006.051151; Bolignano D, 2014, AGEING RES REV, V14, P65, DOI 10.1016/j.arr.2014.02.003; Carvalho M. H. C., 2001, REV BRAS HIPERTENS, V8, P76; Chen K, 2016, REPROD SCI, V23, P200, DOI 10.1177/1933719115597760; Cheungpasitporn W, 2015, RENAL FAILURE, V37, P1237, DOI 10.3109/0886022X.2015.1057800; Chou YH, 2017, J FORMOS MED ASSOC, V116, P652, DOI 10.1016/j.jfma.2017.04.026; Cobo G, 2016, CLIN SCI, V130, P1147, DOI 10.1042/CS20160047; Barcellos RCD, 2015, CAD SAUDE PUBLICA, V31, P1565, DOI 10.1590/0102-311X00150814; Denic A, 2016, ADV CHRONIC KIDNEY D, V23, P19, DOI 10.1053/j.ackd.2015.08.004; Dhodi DK, 2014, INT J BASIC CLIN PHA, V3, P591, DOI [10.5455/2319-2003.ijbcp20140826, DOI 10.5455/2319-2003.IJBCP20140826]; Ely Luísa Scheer, 2015, Rev. bras. geriatr. gerontol., V18, P475, DOI 10.1590/1809-9823.2015.14141; Euser AM, 2009, NEPHRON CLIN PRACT, V113, pC214, DOI 10.1159/000235241; Fagundes Raquel Aparecida Bandeira, 2018, Braz. J. Nephrol., V40, P278, DOI [10.1590/2175-8239-JBN-3931, 10.1590/2175-8239-jbn-3931]; Fisher AA, 2001, DRUG SAFETY, V24, P39, DOI 10.2165/00002018-200124010-00004; Gau JT, 2012, PHARMACOEPIDEM DR S, V21, P553, DOI 10.1002/pds.3224; Ribeiro RDHM, 2008, ACTA PAUL ENFERM, V21, P207, DOI 10.1590/S0103-21002008000500013; Hilliard LM, 2013, CURR HYPERTENS REP, V15, P71, DOI 10.1007/s11906-012-0319-y; Kamal F, 2018, J CLIN GASTROENTEROL, V52, P468, DOI 10.1097/MCG.0000000000001035; Kim S, 2015, AM J THER, V22, P14, DOI 10.1097/MJT.0b013e31829c4c71; Klatte DCF, 2017, GASTROENTEROLOGY, V153, P702, DOI 10.1053/j.gastro.2017.05.046; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Lazarus B, 2016, JAMA INTERN MED, V176, P238, DOI 10.1001/jamainternmed.2015.7193; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Levin A, 2013, KIDNEY INT SUPPL, V3, P5, DOI 10.1038/kisup.2012.77; Lotufo PA, 2016, SAO PAULO MED J, V134, P1, DOI 10.1590/1516-3180.2016.13411512; Malachias Mvb, 2016, Arq Bras Cardiol, V107, P1, DOI 10.5935/abc.20160151; Markovits N, 2014, J CLIN PHARMACOL, V54, P889, DOI 10.1002/jcph.316; Mascarenhas CHM, 2010, ESPAC SAUDE, V12, P30; Melgaco SSC., 2010, MEDICINA, V43, P382; Moledina DG, 2016, J AM SOC NEPHROL, V27, P2926, DOI 10.1681/ASN.2016020192; Montenegro MF, 2017, HYPERTENSION, V69, P23, DOI 10.1161/HYPERTENSIONAHA.116.08081; Mota P. M., 2010, Revista de Ciencias Farmaceuticas Basica e Aplicada, V31, P157; MUNGER K, 1988, AM J PHYSIOL, V254, pF223, DOI 10.1152/ajprenal.1988.254.2.F223; Nast CC, 2017, ADV CHRONIC KIDNEY D, V24, P72, DOI 10.1053/j.ackd.2016.11.016; Peng YC, 2016, MEDICINE, V95, DOI [10.1097/MD.0000000000002911, 10.1097/MD.0000000000003363]; Pinto-Sanchez MI, 2017, COCHRANE DB SYST REV, V3, DOI [10.1002/14651858.CD011194.pub2, DOI 10.1002/14651858.CD011194.PUB2]; Pioneer Network, 2011, TOOLS CHANGE, V1, P1; Qiu TT, 2018, J GASTROEN HEPATOL, V33, P1566, DOI 10.1111/jgh.14157; Radcliff S, 2015, J AM GERIATR SOC, V63, P2227, DOI 10.1111/jgs.13702; Raghavan R, 2017, ADV CHRONIC KIDNEY D, V24, P64, DOI 10.1053/j.ackd.2016.11.004; Saini HK, 2006, AM J PHYSIOL-HEART C, V290, pH373, DOI 10.1152/ajpheart.00613.2005; Schoenfeld AJ, 2016, JAMA INTERN MED, V176, P172, DOI 10.1001/jamainternmed.2015.7927; Sontia B, 2007, ARCH BIOCHEM BIOPHYS, V458, P33, DOI 10.1016/j.abb.2006.05.005; The National Collaborating Centre For Chronic Conditions, 2008, CHRON KIDN DIS NAT C, V73, P3; Van Zanten SV, 2008, GERIATRICS AGING, V11, P363; Veronese FV, 2014, CLIN CHEM LAB MED, V52, P1747, DOI 10.1515/cclm-2014-0052; Wijarnpreecha K, 2017, DIGEST DIS SCI, V62, P2821, DOI 10.1007/s10620-017-4725-5; Xie Y, 2017, KIDNEY INT, V91, P1482, DOI 10.1016/j.kint.2016.12.021; Xie Y, 2016, J AM SOC NEPHROL, V27, P3153, DOI 10.1681/ASN.2015121377; Zanocco JA, 2012, ESTIMATIVAS TAXA FIL; Zhang YE, 2018, CURR OPIN CELL BIOL, V51, P1, DOI 10.1016/j.ceb.2017.10.001; Zipursky J, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001736	61	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2020	15	3							e0229344	10.1371/journal.pone.0229344	http://dx.doi.org/10.1371/journal.pone.0229344			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	KY9JD	32130255	Green Published, gold			2022-12-26	WOS:000522889900001
J	Thach, TQ; Mahirah, D; Dunleavy, G; Zhang, YC; Nazeha, N; Rykov, Y; Nah, A; Roberts, AC; Christopoulos, GI; Soh, CK; Car, J				Thuan-Quoc Thach; Mahirah, Dhiya; Dunleavy, Gerard; Zhang, Yichi; Nazeha, Nuraini; Rykov, Yuri; Nah, Audrey; Roberts, Adam Charles; Christopoulos, George, I; Soh, Chee-Kiong; Car, Josip			Association between shift work and poor sleep quality in an Asian multi-ethnic working population: A cross-sectional study	PLOS ONE			English	Article							BODY-MASS INDEX; CIRCADIAN-RHYTHMS; OF-LIFE; DURATION; PREVALENCE; OBESITY; METAANALYSIS; COMPONENTS; DISTRESS; DISEASE	Background We aimed to examine the association between shift work and sleep quality in a diverse occupational type. Methods This was a cross-sectional study of self-reported sleep quality in 424 workers aged >= 21 using the Pittsburgh Sleep Quality Index (PSQI). We divided workers into two categories based on their PSQI score: (a) <= 5 (good sleep quality) and (b) >5 (poor sleep quality). We used multiple logistic regressions to assess the association between shift work and sleep quality adjusted for potential confounders. Results The mean age was 39.2 (SD = 11.3) years, with shift workers being older than their counterparts. Most workers were of Chinese ethnicity (63.9%). Males were significantly more likely to undertake shift work than females (89% v 11%, p-value<0.001), but it should be noted that the majority of workers was male (78.8%) in this sample of workers. Shift workers had a 198% increased odds of poor sleep quality compared to non-shift workers (OR = 2.98; 95% CI:1.53-5.81). Conclusion Shift work was significantly and independently associated with increased odds of poor sleep quality in this sample of workers. The present findings may inform employment guidelines and help develop workplace health promotion interventions aimed at improving sleep quality among workers and ultimately lead to a healthier workforce.	[Thuan-Quoc Thach; Mahirah, Dhiya; Dunleavy, Gerard; Zhang, Yichi; Nazeha, Nuraini; Rykov, Yuri; Nah, Audrey; Car, Josip] Nanyang Technol Univ, Ctr Populat Hlth Sci, Lee Kong Chian Sch Med, Singapore, Singapore; [Roberts, Adam Charles] Nanyang Technol Univ, Sch Mech & Aerosp Engn, Singapore, Singapore; [Christopoulos, George, I] Nanyang Technol Univ, Coll Business, Nanyang Business Sch, Div Strategy Management & Org, Singapore, Singapore; [Soh, Chee-Kiong] Nanyang Technol Univ, Coll Engn, Sch Civil & Environm Engn, Singapore, Singapore	Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Thach, TQ (corresponding author), Nanyang Technol Univ, Ctr Populat Hlth Sci, Lee Kong Chian Sch Med, Singapore, Singapore.	thuanquoc.thach@ntu.edu.sg	Rykov, Yuri G./C-2201-2016; Thach, Thuan-Quoc/C-4416-2009; Soh, Chee Kiong/GSM-9641-2022; Christopoulos, Georgios/AAI-4401-2021; Car, Josip/H-6755-2015	Rykov, Yuri G./0000-0002-9966-7117; Thach, Thuan-Quoc/0000-0003-3404-3888; Soh, Chee Kiong/0000-0001-7995-8171; Christopoulos, Georgios/0000-0003-2492-653X; , Dhiya Mahirah/0000-0001-9947-1328; Car, Josip/0000-0001-8969-371X	Singapore Ministry of National Development; National Research Foundation, Prime Minister's Office under the Land and Liveability National Innovation Challenge (L2 NIC) Research Programme (L2 NIC Award) [L2NICCFP1-20132]	Singapore Ministry of National Development(Ministry of National Development, Singapore); National Research Foundation, Prime Minister's Office under the Land and Liveability National Innovation Challenge (L2 NIC) Research Programme (L2 NIC Award)	This research is supported in part by the Singapore Ministry of National Development and the National Research Foundation, Prime Minister's Office under the Land and Liveability National Innovation Challenge (L2 NIC) Research Programme (L2 NIC Award No. L2NICCFP1-20132). Any opinions, findings, and conclusions or recommendations expressed in this material are those of the author(s) and do not reflect the views of the Singapore Ministry of National Development and National Research Foundation, Prime Minister's Office, Singapore.	Akerstedt T, 2009, SLEEP MED CLIN, V4, P257, DOI 10.1016/j.jsmc.2009.03.001; Ali T, 2013, WORLD J GASTROENTERO, V19, P9231, DOI 10.3748/wjg.v19.i48.9231; Bonzini M, 2011, BJOG-INT J OBSTET GY, V118, P1429, DOI 10.1111/j.1471-0528.2011.03066.x; Bray MS, 2007, OBES REV, V8, P169, DOI 10.1111/j.1467-789X.2006.00277.x; Bull FC, 2009, J PHYS ACT HEALTH, V6, P790, DOI 10.1123/jpah.6.6.790; Buscemi N, 2005, Evid Rep Technol Assess (Summ), P1; Buysse DJ, 2008, SLEEP, V31, P473, DOI 10.1093/sleep/31.4.473; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Cappuccio FP, 2008, SLEEP, V31, P619, DOI 10.1093/sleep/31.5.619; Chan O. Y., 1993, Singapore Medical Journal, V34, P33; Chiang GSH, 2018, PRIM HEALTH CARE RES, V19, P610, DOI 10.1017/S146342361800018X; Drake CL, 2004, SLEEP, V27, P1453, DOI 10.1093/sleep/27.8.1453; Dunleavy G, 2019, EPIDEMIOLOGY HLTH; Ford DE, 1989, JAMA, V262; Goldberg DP, 1997, PSYCHOL MED, V27, P191, DOI 10.1017/S0033291796004242; Gooley Joshua J., 2018, Neurobiology of Sleep and Circadian Rhythms, V4, P34, DOI 10.1016/j.nbscr.2017.11.001; Huth JJ, 2013, J PEDIATR NURS, V28, pE64, DOI 10.1016/j.pedn.2013.02.032; Itani O, 2011, SLEEP MED, V12, P341, DOI 10.1016/j.sleep.2010.09.007; Jehan Shazia, 2017, Sleep Med Disord, V1; Kageyama T, 2001, J Hum Ergol (Tokyo), V30, P149; Kecklund G, 2016, BMJ-BRIT MED J, V355, DOI 10.1136/bmj.i5210; Knutson A, 2010, SCAND J WORK ENV HEA, V36, P85, DOI 10.5271/sjweh.2897; Knutsson A, 2014, CHRONOBIOL INT, V31, P1146, DOI 10.3109/07420528.2014.957308; Koh HWL, 2015, SLEEP BREATH, V19, P1147, DOI 10.1007/s11325-015-1130-1; Laposky AD, 2008, FEBS LETT, V582, P142, DOI 10.1016/j.febslet.2007.06.079; Leger D, 2002, SLEEP, V25, P625; Lin PC, 2012, INT ARCH OCC ENV HEA, V85, P877, DOI 10.1007/s00420-011-0730-8; Ljosa CH, 2011, SCAND J WORK ENV HEA, V37, P551, DOI 10.5271/sjweh.3191; McFarlane SI, 2017, SLEEP MED DISORDERS, V1; McMenamin TM, 2007, MON LABOR REV, V130, P3; Ministry of Manpower, 2019, SUMM TABL LAB FORC S; Mollayeva T, 2016, SLEEP MED REV, V25, P52, DOI 10.1016/j.smrv.2015.01.009; Nena E, 2018, INDIAN J OCCUP ENVIR, V22, P29, DOI 10.4103/ijoem.IJOEM_4_18; Nielsen LS, 2011, OBES REV, V12, P78, DOI 10.1111/j.1467-789X.2010.00724.x; Paoli P., 2000, 3 EUROPEAN SURVEY WO; Pi-Sunyer FX, 1998, OBES RES, V6, p51S; Puttonen S, 2010, SCAND J WORK ENV HEA, V36, P96, DOI 10.5271/sjweh.2894; Ramey SL, 2012, WORKPLACE HEALTH SAF, V60, P215, DOI 10.3928/21650799-20120416-22; Rezaei M, 2018, SLEEP SCI, V11, P274, DOI 10.5935/1984-0063.20180043; Roth T, 2005, J CLIN PSYCHIAT, V66, P10; Roth T, 2007, J CLIN SLEEP MED, V3, P595; Simpson N, 2007, NUTR REV, V65, pS244, DOI [10.1111/j.1753-4887.2007.tb00371.x, 10.1301/nr.2007.dec.S244-S252]; Soric M, 2013, COLLEGIUM ANTROPOL, V37, P379; Suwazono Y, 2008, OBESITY, V16, P1887, DOI 10.1038/oby.2008.298; TARQUINI B, 1986, INT ARCH OCC ENV HEA, V58, P99, DOI 10.1007/BF00380760; Travis R.C., 2016, JNCI-J NATL CANCER I, V108, P12; van Amelsvoort LGMP, 1999, INT J OBESITY, V23, P973, DOI 10.1038/sj.ijo.0801028; van Drongelen A, 2011, SCAND J WORK ENV HEA, V37, P263, DOI 10.5271/sjweh.3143; Wang XS, 2011, OCCUP MED-OXFORD, V61, P78, DOI 10.1093/occmed/kqr001; World Health Organization, 2010, IARC MONOGRAPHS EVAL, V98; Wu YL, 2014, SLEEP MED, V15, P1456, DOI 10.1016/j.sleep.2014.07.018; Zuo H, 2009, METABOLISM, V58, P1102, DOI 10.1016/j.metabol.2009.04.008	52	5	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2020	15	3							e0229693	10.1371/journal.pone.0229693	http://dx.doi.org/10.1371/journal.pone.0229693			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LQ8QU	32130268	Green Published, gold			2022-12-26	WOS:000535264000043
J	Carnero, E; Bragard, J; Urrestarazu, E; Rivas, E; Polo, V; Larrosa, JM; Anton, V; Pelaez, A; Moreno-Montanes, J				Carnero, Elena; Bragard, Jean; Urrestarazu, Elena; Rivas, Estefania; Polo, Vicente; Manuel Larrosa, Jose; Anton, Vanesa; Pelaez, Antonio; Moreno-Montanes, Javier			Continuous intraocular pressure monitoring in patients with obstructive sleep apnea syndrome using a contact lens sensor	PLOS ONE			English	Article							ANGIOTENSIN-CONVERTING ENZYME; NORMAL-TENSION GLAUCOMA; OPTIC-NERVE HEAD; VISUAL-FIELD PROGRESSION; OPEN-ANGLE GLAUCOMA; FIXED COMBINATION; HEALTHY-SUBJECTS; CHRONIC MODELS; PREVALENCE; RISK	Purpose To analyse nocturnal intraocular pressure (IOP) fluctuations in patients with obstructive sleep apnea syndrome (OSAS) using a contact lens sensor (CLS) and to identify associations between the OSAS parameters determined by polysomnographic study (PSG) and IOP changes. Method Prospective, observational study. Twenty participants suspected of having OSAS were recruited. During PSG study, IOP was monitored using a CLS placed in the eye of the patient. The patients were classified according to the apnea-hypopnea index (AHI) in two categories, severe (> 30) or mild/moderate (< 30) OSAS. We evaluated several parameters determined by the IOP curves, including nocturnal elevations (acrophase) and plateau times in acrophase (PTs) defined by mathematical and visual methods. Results The IOP curves exhibited a nocturnal acrophase followed by PTs of varying extents at which the IOP remained higher than daytime measurement with small variations. We found significant differences in the length of the PTs in patients with severe OSAS compared to those with mild/moderate disease (P = 0.032/P = 0.028). We found a positive correlation between PTs and OSAS severity measured by the total number of apneic events (r = 0.681/ 0.751 P = 0.004/0.001) and AHI (r = 0.674/0.710, P = 0.004/0.002). Respiratory-related arousal and oxygen saturation also were associated significantly with the IOP PT length. Conclusions Periods of nocturnal IOP elevation lasted longer in severe OSAS patients than those with mild/moderate OSAS and correlate with the severity of the disease. The length of the nocturnal PT is also associated to respiratory parameters altered in patients with OSAS.	[Carnero, Elena; Anton, Vanesa; Moreno-Montanes, Javier] Univ Navarra, Clin Univ Navarra, Dept Ophthalmol, Pamplona, Spain; [Bragard, Jean; Pelaez, Antonio] Univ Navarra, Dept Phys & Appl Math, Pamplona, Spain; [Urrestarazu, Elena; Rivas, Estefania] Univ Navarra, Clin Univ Navarra, Dept Neurophysiol, Sleep Disorders Unit, Pamplona, Spain; [Polo, Vicente; Manuel Larrosa, Jose] Univ Zaragoza, Hosp Miguel Servet, Dept Ophthalmol, Zaragoza, Spain	University of Navarra; University of Navarra; University of Navarra; Miguel Servet University Hospital; University of Zaragoza	Moreno-Montanes, J (corresponding author), Univ Navarra, Clin Univ Navarra, Dept Ophthalmol, Pamplona, Spain.	jmoreno@unav.es	; BRAGARD, Jean/C-8086-2012	Moreno-Montanes, Javier/0000-0002-6623-6783; Polo Llorens, Vicente/0000-0002-1402-3129; BRAGARD, Jean/0000-0003-3450-9609; Carnero, Elena/0000-0001-9828-2197	Instituto de Salud Carlos III, "Red tematica de Investigacion Cooperativa,OftaRed: Patologia ocular del envejecimiento, calidad visual y calidad de vida" [RD07/0063]; Universidad de Navarra [PIUNA 2016-2018]; Instituto de Salud Carlos III, "Red tematica de Investigacion Cooperativa. OftaRed: Patologia ocular del envejecimiento, calidad visual y calidad de vida" [RD07/0063]; Plan de Investigacion Universidad de Navarra, 2016-2018	Instituto de Salud Carlos III, "Red tematica de Investigacion Cooperativa,OftaRed: Patologia ocular del envejecimiento, calidad visual y calidad de vida"; Universidad de Navarra; Instituto de Salud Carlos III, "Red tematica de Investigacion Cooperativa. OftaRed: Patologia ocular del envejecimiento, calidad visual y calidad de vida"; Plan de Investigacion Universidad de Navarra, 2016-2018	This work was supported by: EC, JM-M, Project number RD07/0063, Instituto de Salud Carlos III, "Red tematica de Investigacion Cooperativa,OftaRed: Patologia ocular del envejecimiento, calidad visual y calidad de vida", www.isciii.es/; EC, JM-M, Project number PIUNA 2016-2018, Universidad de Navarra, https://www.unav.edu/web/investigacion/piuna.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was supported in part by Instituto de Salud Carlos III, "Red tematica de Investigacion Cooperativa, Proyecto RD07/0063. OftaRed: Patologia ocular del envejecimiento, calidad visual y calidad de vida" and Plan de Investigacion Universidad de Navarra, 2016-2018. We would like to thank Ms. Maria Carmen Sanz for her help at the Sleep Disorder Unit.	Agarwal R, 2014, EUR J PHARMACOL, V730, P8, DOI 10.1016/j.ejphar.2014.02.021; Agnifili L, 2015, ACTA OPHTHALMOL, V93, pE14, DOI 10.1111/aos.12408; Aptel F, 2016, PROG RETIN EYE RES, V55, P108, DOI 10.1016/j.preteyeres.2016.07.002; Aptel F, 2014, JAMA OPHTHALMOL, V132, P1232, DOI 10.1001/jamaophthalmol.2014.1761; Barcelo A, 2001, EUR RESPIR J, V17, P728, DOI 10.1183/09031936.01.17407280; Barkana Y, 2006, ARCH OPHTHALMOL-CHIC, V124, P793, DOI 10.1001/archopht.124.6.793; Bergea B, 1999, OPHTHALMOLOGY, V106, P997, DOI 10.1016/S0161-6420(99)00523-0; Bilgin G, 2014, BMC OPHTHALMOL, V14, DOI 10.1186/1471-2415-14-27; BUGUET A, 1994, AM J OPHTHALMOL, V117, P342, DOI 10.1016/S0002-9394(14)73143-5; Burgoyne CF, 2005, PROG RETIN EYE RES, V24, P39, DOI 10.1016/j.preteyeres.2004.06.001; Caprioli J, 2007, ARCH OPHTHALMOL-CHIC, V125, P1124, DOI 10.1001/archopht.125.8.1124; Casas P, RETINAL OPTIC NERVE, DOI [10.1007/s00417-013-2268-9, DOI 10.1007/S00417-013-2268-9]; Choi HJ, 2015, MOL VIS, V21; Cook C, 2012, CAN J OPHTHALMOL, V47, P223, DOI 10.1016/j.jcjo.2012.02.003; Costagliola C, 2000, EXP EYE RES, V71, P167, DOI 10.1006/exer.2000.0866; Costagliola C, EUR J OPHTHALMOL, V5, P19; Cullinane AB, 2002, BRIT J OPHTHALMOL, V86, P676, DOI 10.1136/bjo.86.6.676; De Smedt S, 2012, J GLAUCOMA, V21, P539, DOI 10.1097/IJG.0b013e31821dac43; Dikopf MS, 2017, EXPERT OPIN PHARMACO, V18, P885, DOI 10.1080/14656566.2017.1328498; Dong RF, 2018, J STROKE CEREBROVASC, V27, P1471, DOI 10.1016/j.jstrokecerebrovasdis.2017.12.048; Downs JC, 2011, EXP EYE RES, V93, P133, DOI 10.1016/j.exer.2010.08.004; Epstein LJ, 2009, J CLIN SLEEP MED, V5, P263; Faridi O, 2012, CLIN EXP OPHTHALMOL, V40, P408, DOI 10.1111/j.1442-9071.2012.02768.x; Foster Paul J, 2002, Semin Ophthalmol, V17, P50; Gallice M, 2017, INVEST OPHTH VIS SCI, V58, P5460, DOI 10.1167/iovs.17-21855; Gisler C, 2015, TRANSL VIS SCI TECHN, V4, DOI 10.1167/tvst.4.1.4; Goldblum D, 2000, KLIN MONATSBL AUGENH, V216, P246, DOI 10.1055/s-2000-10553; Heijl A, 2002, ARCH OPHTHALMOL-CHIC, V120, P1268, DOI 10.1001/archopht.120.10.1268; Hollo G, 2015, EXPERT OPIN DRUG SAF, V14, P609, DOI 10.1517/14740338.2015.1010507; Huseyinoglu N, OPTIC DISC RETINAL N, DOI [10.1007/s11325-013-0854-z, DOI 10.1007/S11325-013-0854-Z]; Inoue T, 2001, CURR EYE RES, V23, P139, DOI 10.1076/ceyr.23.2.139.5470; Ittoop SM, 2016, ADV THER, V33, P1679, DOI 10.1007/s12325-016-0388-4; Kida T, 2008, AM J OPHTHALMOL, V146, P567, DOI 10.1016/j.ajo.2008.05.026; Konczak J, 1999, MOTOR CONTROL, V3, P394, DOI 10.1123/mcj.3.4.394; Konstas AG, 2017, ADV THER, V34, P221, DOI 10.1007/s12325-016-0448-9; Lee TE, 2015, AM J OPHTHALMOL, V160, P929, DOI 10.1016/j.ajo.2015.07.030; Leonardi M, 2009, ACTA OPHTHALMOL, V87, P433, DOI 10.1111/j.1755-3768.2008.01404.x; Lin CC, 2013, OPHTHALMOLOGY, V120, P1559, DOI 10.1016/j.ophtha.2013.01.006; Lin PW, 2011, J GLAUCOMA, V20, P553, DOI 10.1097/IJG.0b013e3181f3eb81; Liu JHK, 1998, INVEST OPHTH VIS SCI, V39, P2707; Malihi M, 2012, OPHTHALMOLOGY, V119, P987, DOI 10.1016/j.ophtha.2011.11.024; Mansouri K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125530; Mansouri K, 2012, INVEST OPHTH VIS SCI, V53, P8050, DOI 10.1167/iovs.12-10569; Masaki T, 2008, J VIROL, V82, P7964, DOI 10.1128/JVI.00826-08; McMonnies CW, 2014, CLIN EXP OPTOM, V97, P221, DOI 10.1111/cxo.12108; Mehta A, 2010, CAN J PHYSIOL PHARM, V88, P595, DOI [10.1139/Y10-026, 10.1139/y10-026]; Moghimi S, 2013, SLEEP MED, V14, P53, DOI 10.1016/j.sleep.2012.07.004; Mojon DS, 1999, OPHTHALMOLOGY, V106, P1009, DOI 10.1016/S0161-6420(99)00525-4; Mottet B, 2013, JAMA OPHTHALMOL, V131, P1507, DOI 10.1001/jamaophthalmol.2013.5297; Muraki I, 2018, J DIABETES INVEST, V9, P991, DOI 10.1111/jdi.12823; Nouri-Mahdavi K, 2004, INVEST OPHTH VIS SCI, V45, P4346, DOI 10.1167/iovs.04-0204; Nouri-Mahdavi K, 2004, OPHTHALMOLOGY, V111, P1627, DOI 10.1016/j.ophtha.2004.02.017; Nowak MS, 2011, ARCH MED SCI, V7, P332, DOI 10.5114/aoms.2011.22087; Ohana EB, 2010, EUR ANN OTORHINOLARY, V127, P159, DOI 10.1016/j.anorl.2010.07.003; Pavlatos E, 2018, INVEST OPHTH VIS SCI, V59, P3779, DOI 10.1167/iovs.18-24462; Pavlatos E, 2016, J BIOMECH ENG-T ASME, V138, DOI 10.1115/1.4032124; Quigley HA, 2006, BRIT J OPHTHALMOL, V90, P262, DOI 10.1136/bjo.2005.081224; Sergi M, 2007, J GLAUCOMA, V16, P42, DOI 10.1097/01.ijg.0000243472.51461.24; Shah GB, 2000, J CARDIOVASC PHARM, V36, P169, DOI 10.1097/00005344-200008000-00005; Shi YH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0115625; Shinmei Y, 2016, INVEST OPHTH VIS SCI, V57, P2824, DOI 10.1167/iovs.16-19220; Sutherland K, 2018, EXPERT REV RESP MED, V12, P293, DOI 10.1080/17476348.2018.1439743; Udugama IA, 2017, 2017 3RD INTERNATIONAL MORATUWA ENGINEERING RESEARCH CONFERENCE (MERCON), P23, DOI 10.1109/MERCon.2017.7980450; VanHaeringen NJ, 1996, BRIT J OPHTHALMOL, V80, P99, DOI 10.1136/bjo.80.2.99; Wang RF, 2005, EXP EYE RES, V80, P629, DOI 10.1016/j.exer.2004.11.012	65	3	3	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2020	15	3							e0229856	10.1371/journal.pone.0229856	http://dx.doi.org/10.1371/journal.pone.0229856			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8MS	32126130	Green Published, gold			2022-12-26	WOS:000535253100055
J	da Cruz, AB; Maia, MM; Pereira, ID; Taniwaki, NN; Namiyama, GM; Telles, JPM; Vidal, JE; Spegiorin, LCJF; de Mattos, CCB; de Mattos, LC; Meira-Strejevitch, CD; Pereira-Chioccola, VL				da Cruz, Allecineia Bispo; Maia, Marta Marques; Pereira, Ingrid de Siqueira; Taniwaki, Noemi Nosomi; Namiyama, Gislene Mitsue; Marochi Telles, Joao Paulo; Vidal, Jose Ernesto; Junqueira Franco Spegiorin, Ligia Cosentino; Brandao de Mattos, Cinara Cassia; de Mattos, Luiz Carlos; Meira-Strejevitch, Cristina da Silva; Pereira-Chioccola, Vera Lucia			Human extracellular vesicles and correlation with two clinical forms of toxoplasmosis	PLOS ONE			English	Article							CEREBRAL TOXOPLASMOSIS; CONGENITAL TOXOPLASMOSIS; OCULAR TOXOPLASMOSIS; CEREBROSPINAL-FLUID; IMMUNE-RESPONSES; GONDII INFECTION; HIGH PREVALENCE; SAO-PAULO; EXOSOMES; HIV	Aim This study analyzed microvesicles and exosomes, called as extracellular vesicles (EVs) excreted in serum and cerebrospinal fluid (CSF) from patients with cerebral or gestational toxoplasmosis. Methods Clinical samples from 83 individuals were divided into four groups. Group I, 20 sera from healthy individuals and pregnant women (seronegative for toxoplasmosis); group II, 21 sera from seropositive patients for toxoplasmosis (cerebral or gestational forms); group III, 26 CSF samples from patients with cerebral toxoplasmosis/HIV co-infection (CT/HIV) (seropositive for toxoplasmosis); and group IV, 16 CSF samples from seronegative patients for toxoplasmosis, but with HIV infection and other opportunistic infections (OI/HIV). Serum and CSF samples were ultracentrifuged to recover EVs. Next, vesicle size and concentration were characterized by Nanoparticle Tracking Analysis (NTA). Results Concentrations of serum-derived EVs from toxoplasmosis patients (mean: 2.4 x 10(10) EVs/mL) were statically higher than of non-infected individuals (mean: 5.9 x 10(9) EVs/mL). Concentrations of CSF-derived EVs were almost similar in both groups. CT/HIV (mean: 2.9 x 10(9) EVs/mL) and OI/HIV (mean: 4.8 x 10(9) EVs/mL). Analyses by NTA confirmed that CSF-derived EVs and serum-derived EVs had size and shape similar to microvesicles and exosomes. The mean size of EVs was similar in serum and CSF. Thus, the concentration, and not size was able distinguish patients with toxoplasmosis than healthy individuals. Presence of exosomes was also confirmed by transmission electron microscopy and evidence of tetraspanins CD63 and CD9 in immunoblotting. Relative expressions of miR-146a-5p, miR-155-5p, miR-21-5p, miR-29c-3p and miR-125b-5p were estimated in exosomal miRNA extracted of EVs. Serum-derived EVs from group II (cerebral and gestational toxoplasmosis) up-expressed miR-125b-5p and miR-146a-5p. CSF-derived EVs from CT/HIV patients) up-expressed miR-155-5p and miR-21-5p and were unable to express miR-29c-3p. Conclusion These data suggest the participation of EVs and exosomal miRNAs in unbalance of immune response as elevation of TNF-alpha, IL-6; and downregulation of IFN-gamma in cerebral and gestational forms of toxoplasmosis.	[da Cruz, Allecineia Bispo; Maia, Marta Marques; Pereira, Ingrid de Siqueira; Meira-Strejevitch, Cristina da Silva; Pereira-Chioccola, Vera Lucia] Adolfo Lutz Inst, Ctr Parasitol & Micol, Sao Paulo, Brazil; [Taniwaki, Noemi Nosomi; Namiyama, Gislene Mitsue] Adolfo Lutz Inst, Nucleo Microscopia Eletron, Sao Paulo, Brazil; [Marochi Telles, Joao Paulo; Vidal, Jose Ernesto] Inst Infectol Emilio Ribas, Sao Paulo, Brazil; [Vidal, Jose Ernesto] Univ Sao Paulo, Hosp Clin, Fac Med, Sao Paulo, Brazil; [Vidal, Jose Ernesto] Univ Sao Paulo, Inst Med Trop, Lab Invest Med LIM 49, Sao Paulo, Brazil; [Junqueira Franco Spegiorin, Ligia Cosentino; Brandao de Mattos, Cinara Cassia; de Mattos, Luiz Carlos] Hosp Base, Sao Jose Do Rio Preto, Brazil; [Junqueira Franco Spegiorin, Ligia Cosentino] Fac Med Sao Jose Do Rio Preto, Sao Jose Do Rio Preto, Brazil	Instituto Adolfo Lutz; Instituto Adolfo Lutz; Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo; Faculdade de Medicina de Sao Jose do Rio Preto (FAMERP)	Pereira-Chioccola, VL (corresponding author), Adolfo Lutz Inst, Ctr Parasitol & Micol, Sao Paulo, Brazil.	pchioccola@gmail.com	BRANDÃO, CINARA/B-3650-2008; Meira-Strejevitch, Cristina Silva/L-8914-2016; DE MATTOS, LUIZ CARLOS/F-6739-2010; Pereira-Chioccola, Vera Lucia/F-2452-2014	BRANDÃO, CINARA/0000-0002-4836-3113; Meira-Strejevitch, Cristina Silva/0000-0002-2070-8087; DE MATTOS, LUIZ CARLOS/0000-0002-8572-8177; Pereira-Chioccola, Vera Lucia/0000-0003-3317-195X	FAPESP [2018/04709-8]; CAPES; CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico) [302327/2018-5]	FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This study was supported by grants from the FAPESP -2018/04709-8, ABC, MMMand ISP were supported by scholarship from CAPES; VLPC, from CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnolo ' gico) 302327/2018-5.	Akers JC, 2013, J NEURO-ONCOL, V113, P1, DOI 10.1007/s11060-013-1084-8; Alexander M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8321; Aline F, 2004, INFECT IMMUN, V72, P4127, DOI 10.1128/IAI.72.7.4127-4137.2004; Alvarez-Erviti L, 2011, NAT BIOTECHNOL, V29, P341, DOI 10.1038/nbt.1807; Amado T, 2015, EUR J IMMUNOL, V45, P1584, DOI 10.1002/eji.201545487; Murata FHA, 2016, REV SOC BRAS MED TRO, V49, P512, DOI 10.1590/0037-8682-0046-2016; Arroyo JD, 2011, P NATL ACAD SCI USA, V108, P5003, DOI 10.1073/pnas.1019055108; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Beauvillain C, 2007, MICROBES INFECT, V9, P1614, DOI 10.1016/j.micinf.2007.07.002; Bhatnagar S, 2007, BLOOD, V110, P3234, DOI 10.1182/blood-2007-03-079152; Bossi P, 2004, LANCET, V364, P579, DOI 10.1016/S0140-6736(04)16841-4; Camilo LM, 2017, BRAZ J INFECT DIS, V21, P638, DOI 10.1016/j.bjid.2017.07.003; Carruthers VB, 2002, ACTA TROP, V81, P111, DOI 10.1016/S0001-706X(01)00201-7; Cocucci E, 2009, TRENDS CELL BIOL, V19, P43, DOI 10.1016/j.tcb.2008.11.003; Costa-Silva TA, 2012, ACTA TROP, V124, P203, DOI 10.1016/j.actatropica.2012.08.013; Daryani A, 2003, VET PARASITOL, V113, P123, DOI 10.1016/S0304-4017(03)00044-X; Delabranche X, 2012, MED MALADIES INFECT, V42, P335, DOI 10.1016/j.medmal.2012.05.011; Dlugonska Henryka, 2016, Annals of Parasitology, V62, P169, DOI 10.17420/ap6203.50; Goncalves MAD, 2010, BRAZ J INFECT DIS, V14, P601, DOI 10.1590/S1413-86702010000600009; Dubey JP, 2012, PARASITOLOGY, V139, P1375, DOI 10.1017/S0031182012000765; Dubey JP, 1998, INT J PARASITOL, V28, P1019, DOI 10.1016/S0020-7519(98)00023-X; Elbez-Rubinstein A, 2009, J INFECT DIS, V199, P280, DOI 10.1086/595793; ExoCarta, EX PROT RNA LIP DAT; Ferreira AIC, 2014, EPIDEMIOL INFECT, V142, P142, DOI 10.1017/S0950268813000526; Fleming A, 2014, PATHOG DIS, V71, P107, DOI 10.1111/2049-632X.12135; GLASNER PD, 1992, AM J OPHTHALMOL, V114, P136, DOI 10.1016/S0002-9394(14)73976-5; Hernandez AV, 2017, HIV MED, V18, P115, DOI 10.1111/hiv.12402; Hill Dolores E., 2005, Animal Health Research Reviews, V6, P41, DOI 10.1079/AHR2005100; Kalra H, 2013, PROTEOMICS, V13, P3354, DOI 10.1002/pmic.201300282; Kim MJ, 2016, KOREAN J PARASITOL, V54, P147, DOI 10.3347/kjp.2016.54.2.147; Lakhter AJ, 2018, DIABETOLOGIA, V61, P1124, DOI 10.1007/s00125-018-4559-5; Li YW, 2018, INT J NANOMED, V13, P467, DOI 10.2147/IJN.S151110; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Ma F, 2011, NAT IMMUNOL, V12, P861, DOI 10.1038/ni.2073; Maia MM, 2017, PARASITE IMMUNOL, V39, DOI 10.1111/pim.12462; Mathivanan S, 2010, J PROTEOMICS, V73, P1907, DOI 10.1016/j.jprot.2010.06.006; Matsumoto J, 2017, ACTA NEUROPATHOL COM, V5, DOI 10.1186/s40478-017-0470-4; Meira CS, 2008, J MED MICROBIOL, V57, P845, DOI 10.1099/jmm.0.47687-0; Meira CS, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00492; Meira CS, 2011, DIAGN MICR INFEC DIS, V71, P279, DOI 10.1016/j.diagmicrobio.2011.07.008; Montoya JG, 2004, LANCET, V363, P1965, DOI 10.1016/S0140-6736(04)16412-X; Nematian SE, 2018, J CLIN ENDOCR METAB, V103, P64, DOI 10.1210/jc.2017-01199; Olariu TR, 2011, PEDIATR INFECT DIS J, V30, P1056, DOI 10.1097/INF.0b013e3182343096; Pereira-Chioccola VL, 2009, FUTURE MICROBIOL, V4, P1363, DOI [10.2217/fmb.09.89, 10.2217/FMB.09.89]; Pope SM, 2013, J EXTRACELL VESICLES, V2, DOI 10.3402/jev.v2i0.22484; Previato Mariana, 2015, BMC Res Notes, V8, P746, DOI 10.1186/s13104-015-1650-6; Prigione I, 2000, J IMMUNOL, V164, P3741, DOI 10.4049/jimmunol.164.7.3741; Rappa G, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20051114; Schwab A, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.01132; Shi M, 2019, PROG NEUROBIOL, V175, P96, DOI 10.1016/j.pneurobio.2019.01.005; Silva VO, 2018, PARASITE IMMUNOL, V40, DOI 10.1111/pim.12571; Spaull R, 2019, INT J DEV NEUROSCI, V73, P59, DOI 10.1016/j.ijdevneu.2019.01.004; Steiner DF, 2011, IMMUNITY, V35, P169, DOI 10.1016/j.immuni.2011.07.009; Street JM, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-5; Thery C, 2009, NAT REV IMMUNOL, V9, P581, DOI 10.1038/nri2567; Verma P, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01274; Vidal JE, 2005, AIDS PATIENT CARE ST, V19, P626, DOI 10.1089/apc.2005.19.626; Vidal JE, 2013, BRAZ J INFECT DIS, V17, P379, DOI 10.1016/j.bjid.2012.10.030; Wowk PF, 2017, PROTEOMICS, V17, DOI 10.1002/pmic.201600477; Yang LL, 2012, J EXP MED, V209, P1655, DOI 10.1084/jem.20112218; Yang XX, 2019, J CONTROL RELEASE; Yu X, 2006, CANCER RES, V66, P4795, DOI 10.1158/0008-5472.CAN-05-4579	62	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2020	15	3							0229602	10.1371/journal.pone.0229602	http://dx.doi.org/10.1371/journal.pone.0229602			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8MS	32126572	Green Published, gold			2022-12-26	WOS:000535253100035
J	Kunze, PE; Perrault, JR; Chang, YM; Manire, CA; Clark, S; Stacy, NI				Kunze, Patricia E.; Perrault, Justin R.; Chang, Yu-Mei; Manire, Charles A.; Clark, Samantha; Stacy, Nicole I.			Pre-/analytical factors affecting whole blood and plasma glucose concentrations in loggerhead sea turtles (Caretta caretta)	PLOS ONE			English	Article							STORAGE-TEMPERATURE; BIOCHEMICAL VARIABLES; METERS; GLUCOMETER; VALUES; ANALYTES; JUVENILE; TIME; HEMATOCRIT; GUIDELINES	Blood glucose is vital for many physiological pathways and can be quantified by clinical chemistry analyzers and in-house point-of-care (POC) devices. Pre-analytical and analytical factors can influence blood glucose measurements. This project aimed to investigate preanalytical factors on whole blood and plasma glucose measurements in loggerhead sea turtles (Caretta caretta) by evaluating the effects of storage (refrigeration) up to 48h after sampling and of packed cell volume (PCV) on whole blood glucose analysis by POC glucometer (time series n = 13); and by evaluating the effects of storage (room temperature and refrigeration) on plasma glucose concentrations using a dry slide chemistry analyzer (DCA) at various conditions: immediate processing and delayed plasma separation from erythrocytes at 24h and 48h (time series n = 14). The POC glucometer had overall strong agreement with the DCA (CCC = 0.76, r = 0.84, C-b = 0.90), but consistently overestimated glucose concentrations (mean difference: +0.4 mmol/L). The POC glucometer results decreased significantly over time, resulting in a substantial decline within the first 2h (0.41 +/- 0.47 mmol/L; 8 +/- 9%) that could potentially alter clinical decisions, thereby highlighting the need for immediate analysis using this method. The effects of PCV on glucose could not be assessed, as the statistical significance was associated with one outlier. Storage method significantly affected plasma glucose measurements using DCA, with room temperature samples resulting in rapid decreases of 3.57 +/- 0.89 mmol/L (77 +/- 9%) over the first 48h, while refrigerated samples provided consistent plasma glucose results over the same time period (decrease of 0.26 +/- 0.23 mmol/L; 6 +/- 5%). The results from this study provide new insights into optimal blood sample handling and processing for glucose analysis in sea turtles, show the suitability of the POC glucometer as a rapid diagnostic test, and confirm the reliability of plasma glucose measurements using refrigeration. These findings emphasize the need to consider pre-/analytical factors when interpreting blood glucose results from loggerhead sea turtles.	[Kunze, Patricia E.; Chang, Yu-Mei] Univ London, Royal Vet Coll, London, England; [Kunze, Patricia E.] Zool Soc London, Inst Zool, London, England; [Perrault, Justin R.; Manire, Charles A.; Clark, Samantha] Loggerhead Marinelife Ctr, Juno Beach, FL USA; [Stacy, Nicole I.] Univ Florida, Coll Vet Med, Dept Comparat Diagnost & Populat Med, Gainesville, FL 32611 USA; [Stacy, Nicole I.] Univ Florida, Coll Vet Med, Aquat Amphibian & Reptile Pathol Program, Gainesville, FL USA	University of London; University of London Royal Veterinary College; Zoological Society of London; State University System of Florida; University of Florida; State University System of Florida; University of Florida	Stacy, NI (corresponding author), Univ Florida, Coll Vet Med, Dept Comparat Diagnost & Populat Med, Gainesville, FL 32611 USA.; Stacy, NI (corresponding author), Univ Florida, Coll Vet Med, Aquat Amphibian & Reptile Pathol Program, Gainesville, FL USA.	stacyn@ufl.edu		Perrault, Justin/0000-0002-5046-6701; Stacy, Nicole/0000-0003-4258-4414; Kunze, Patricia Edith/0000-0002-1728-0614	Aquatic Animal Health Program, University of Florida, Gainesville, Florida, USA	Aquatic Animal Health Program, University of Florida, Gainesville, Florida, USA	Funding for chemistry analysis was provided by the Aquatic Animal Health Program, University of Florida, Gainesville, Florida, USA. The funders had no role in support in the form of salaries for authors, study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberghina Daniela, 2015, Comparative Clinical Pathology, V24, P193, DOI 10.1007/s00580-014-1923-9; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Bennett KA, 2017, CONSERV PHYSIOL, V5, DOI 10.1093/conphys/cox013; Blanco A, 2017, MED BIOCH, P573, DOI [10.1016/B978-0-12-803550-4.00026-4, DOI 10.1016/B978-0-12-803550-4.00026-4]; Blanco A., 2017, MED BIOCH, P283; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Bonnet X, 2016, J COMP PHYSIOL B, V186, P787, DOI 10.1007/s00360-016-0993-1; Burnett RW, 2001, CLIN CHIM ACTA, V307, P205; Carey R, 2016, CLIN BIOCHEM, V49, P1406, DOI 10.1016/j.clinbiochem.2016.05.017; Casal AB, 2009, VET CLIN PATH, V38, P213, DOI 10.1111/j.1939-165X.2008.00106.x; Casale P., 2017, CARETTA CARETTA, DOI [10.2305/IUCN.UK.2017-2.RLTS.T3897A119333622.en, DOI 10.2305/IUCN.UK.2017-2.RLTS.T3897A119333622.EN, 10.2305/IUCN.UK.20172.RLTS.T3897A119333622.en]; CHAN AYW, 1989, CLIN CHEM, V35, P315; Collicutt NB, 2015, VET CLIN PATH, V44, P120, DOI 10.1111/vcp.12217; Cray C, 2009, J AM ASSOC LAB ANIM, V48, P202; Dai KS, 2004, CLIN CHIM ACTA, V349, P135, DOI 10.1016/j.cccn.2004.06.010; Deem SL, 2009, J WILDLIFE DIS, V45, P41, DOI 10.7589/0090-3558-45.1.41; Delgado C, 2011, J WILDLIFE DIS, V47, P523, DOI 10.7589/0090-3558-47.3.523; Divers SJ., 2019, MADERS REPTILE AMPHI, V3rd ed., P649, DOI DOI 10.1016/B978-0-323-48253-0.00067-2; Dobromylskyj MJ, 2010, VET REC, V167, P438, DOI 10.1136/vr.c4260; Eisenhawer E, 2008, J ZOO WILDLIFE MED, V39, P208, DOI 10.1638/2007-0166R.1; Eshar D, 2018, AM J VET RES, V79, P852, DOI 10.2460/ajvr.79.8.852; Fleming K. A., 2019, THESIS; Frye FL, 1991, BIOMEDICAL SURG ASPE, P209; Gerber KL, 2016, VET CLIN PATH, V45, P10, DOI 10.1111/vcp.12310; GUPPY M, 1992, VOX SANG, V62, P70, DOI 10.1111/j.1423-0410.1992.tb01173.x; Hackett ES, 2010, J VET INTERN MED, V24, P617, DOI 10.1111/j.1939-1676.2010.0481.x; Harr KE, 2005, VET CLIN PATH, V34, P383, DOI 10.1111/j.1939-165X.2005.tb00065.x; Harr KE, 2013, VET CLIN PATH, V42, P424, DOI 10.1111/vcp.12101; Harvey JW, 2008, CLINICAL BIOCHEMISTRY OF DOMESTIC ANIMALS, 6TH EDITION, P173, DOI 10.1016/B978-0-12-370491-7.00007-6; Heatley JJ., 2019, MADERS REPTILE AMPHI, V3rd ed, P319; Hollis AR, 2008, J VET INTERN MED, V22, P1189, DOI 10.1111/j.1939-1676.2008.0148.x; Hoppes SM, 2015, J AVIAN MED SURG, V29, P200, DOI 10.1647/2014-033; Innis CJ, 2019, CHELONIAN CONSERV BI, V18, P3, DOI 10.2744/CCB-1335.1; Janssen K, 2010, ACTA CLIN BELG, V65, P311, DOI 10.1179/acb.2010.068; Kakizoe Y, 2007, J ZOO WILDLIFE MED, V38, P77, DOI 10.1638/05-096.1; Kuznetsova A, 2017, J STAT SOFTW, V82, P1, DOI 10.18637/jss.v082.i13; LIN LI, 1989, BIOMETRICS, V45, P255, DOI 10.2307/2532051; LIN LIK, 1992, BIOMETRICS, V48, P599, DOI 10.2307/2532314; Lippi G, 2018, CLIN CHEM LAB MED, V56, P2125, DOI 10.1515/cclm-2018-0523; MAGNANI M, 1980, COMP BIOCHEM PHYS B, V67, P139, DOI 10.1016/0305-0491(80)90282-5; National Marine Fisheries Services (NMFS) United States Fish and Wildlife Service (USFWS), 2011, FED REGISTER, P58868; NIKINMAA M, 1994, ACTA PHYSIOL SCAND, V152, P183, DOI 10.1111/j.1748-1716.1994.tb09798.x; Paul AEH, 2011, AM J VET RES, V72, P1204, DOI 10.2460/ajvr.72.9.1204; Perrault JR, 2018, J WILDLIFE DIS, V54, P196, DOI 10.7589/2017-08-198; R Core Team, 2021, R LANGUAGE ENV STAT; Reynolds B, 2006, VET CLIN PATH, V35, P339, DOI 10.1111/j.1939-165X.2006.tb00144.x; Rousselet E, 2013, J ZOO WILDLIFE MED, V44, P859, DOI 10.1638/2012-0162R1.1; Sarkar D, 2008, USE R, P1; Selleri P, 2014, JAVMA-J AM VET MED A, V245, P87, DOI 10.2460/javma.245.1.87; Stacy NI, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0200355; Stacy NI, 2018, CONSERV PHYSIOL, V6, DOI 10.1093/conphys/coy006; Stoot LJ, 2014, CONSERV PHYSIOL, V2, DOI 10.1093/conphys/cou011; Tang ZP, 2000, ARCH PATHOL LAB MED, V124, P1135; van den Berg SAA, 2015, SCI REP-UK, V5, DOI 10.1038/srep08875; Wess G, 2000, J AM VET MED ASSOC, V216, P203, DOI 10.2460/javma.2000.216.203; Wess G, 2000, AM J VET RES, V61, P1587, DOI 10.2460/ajvr.2000.61.1587	56	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2020	15	3							e0229800	10.1371/journal.pone.0229800	http://dx.doi.org/10.1371/journal.pone.0229800			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8MS	32126109	Green Published, Green Accepted, gold			2022-12-26	WOS:000535253100053
J	Luvsansharav, UO; Wakhungu, J; Grass, J; Oneko, M; Nguyen, V; Bigogo, G; Ogola, E; Audi, A; Onyango, D; Hamel, MJ; Montgomery, JM; Fields, PI; Mahon, BE				Luvsansharav, Ulzii-Orshikh; Wakhungu, James; Grass, Julian; Oneko, Martina; Von Nguyen; Bigogo, Godfrey; Ogola, Eric; Audi, Allan; Onyango, Dickens; Hamel, Mary J.; Montgomery, Joel M.; Fields, Patricia I.; Mahon, Barbara E.			Exploration of risk factors for ceftriaxone resistance in invasive non-typhoidal Salmonella infections in western Kenya	PLOS ONE			English	Article							DISEASE; ENTEROBACTERIACEAE; EPIDEMIOLOGY; PREVALENCE; CHILDREN; SPREAD; GENE	Multidrug-resistant non-typhoidal Salmonella (NTS) infection has emerged as a prominent cause of invasive infections in Africa. We investigated the prevalence of ceftriaxone-resistant invasive NTS infections, conducted exploratory analysis of risk factors for resistance, and described antimicrobial use in western Kenya. We conducted a secondary analysis of existing laboratory, epidemiology, and clinical data from three independent projects, a malaria vaccine trial, a central nervous system (CNS) study, and the International Emerging Infections Program morbidity surveillance (surveillance program) during 2009-2014. We calculated odds ratios (OR) with 95% confidence intervals (CI) for ceftriaxone-resistant NTS infections compared with ceftriaxone-susceptible infections. We surveyed hospitals, pharmacies, and animal drug retailers about the availability and use of antimicrobials. In total, 286 invasive NTS infections were identified in the three projects; 43 NTS isolates were ceftriaxone-resistant. The absolute prevalence of ceftriaxone resistance varied among these methodologically diverse projects, with 18% (16/90) of isolates resistant to ceftriaxone in the vaccine trial, 89% (16/18) in the CNS study, and 6% (11/178) in the surveillance program. Invasive ceftriaxone-resistant infections increased over time. Most ceftriaxone-resistant isolates were co-resistant to multiple other antimicrobials. Having an HIV-positive mother (OR = 3.7; CI = 1.2-11.4) and taking trimethoprim-sulfamethoxazole for the current illness (OR = 9.6, CI = 1.2-78.9) were significantly associated with acquiring ceftriaxone-resistant invasive NTS infection. Ceftriaxone and other antibiotics were widely prescribed; multiple issues related to prescription practices and misuse were identified. In summary, ceftriaxone-resistant invasive NTS infection is increasing and limiting treatment options for serious infections. Efforts are ongoing to address the urgent need for improved microbiologic diagnostic capacity and an antimicrobial surveillance system in Kenya.	[Luvsansharav, Ulzii-Orshikh; Von Nguyen] Ctr Dis Control & Prevent, Epidem Intelligence Serv, Epidemiol Workforce Branch, Div Sci Educ & Profess Dev, Atlanta, GA 30333 USA; [Luvsansharav, Ulzii-Orshikh; Grass, Julian; Von Nguyen; Fields, Patricia I.; Mahon, Barbara E.] Ctr Dis Control & Prevent, Enter Dis Epidemiol Branch, Div Foodborne Waterborne & Environm Dis, Natl Ctr Emerging Zoonot Infect Dis, Atlanta, GA 30333 USA; [Wakhungu, James] Minist Hlth, Field Epidemiol & Lab Training Program, Nairobi, Kenya; [Oneko, Martina; Bigogo, Godfrey; Ogola, Eric; Audi, Allan] Kenya Govt Med Res Ctr, Ctr Global Hlth Res, Nairobi, Kenya; [Onyango, Dickens] Minist Hlth, Nairobi, Kenya; [Hamel, Mary J.] Ctr Dis Control & Prevent, Malaria Branch, Div Parasit Dis & Malaria, 4770 Buford Highway,Mail Stop F-12, Atlanta, GA USA; [Montgomery, Joel M.] Ctr Dis Control & Prevent, Div Global Hlth Protect, Nairobi, Kenya	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Kenya Medical Research Institute; Centers for Disease Control & Prevention - USA	Luvsansharav, UO (corresponding author), Ctr Dis Control & Prevent, Epidem Intelligence Serv, Epidemiol Workforce Branch, Div Sci Educ & Profess Dev, Atlanta, GA 30333 USA.; Luvsansharav, UO (corresponding author), Ctr Dis Control & Prevent, Enter Dis Epidemiol Branch, Div Foodborne Waterborne & Environm Dis, Natl Ctr Emerging Zoonot Infect Dis, Atlanta, GA 30333 USA.	xde7@cdc.gov		Onyango, Dickens/0000-0002-1634-0531; Ogola, Eric/0000-0003-3343-6735				Arcilla MS, 2017, LANCET INFECT DIS, V17, P78, DOI 10.1016/S1473-3099(16)30319-X; Clinical and Laboratory Standards Institute, 2017, PERFORMANCE STANDARD; Crump JA, 2015, CLIN MICROBIOL REV, V28, P901, DOI 10.1128/CMR.00002-15; Feasey NA, 2012, LANCET, V379, P2489, DOI 10.1016/S0140-6736(11)61752-2; Feikin DR, 2010, INT J EPIDEMIOL, V39, P450, DOI 10.1093/ije/dyp374; Global Antibiotic Resistance Partnership-Kenya Working Group, 2011, SIT AN REC ANT US RE; Hunsperger E, 2019, BMC PUBLIC HEALTH, V19, DOI 10.1186/s12889-019-6770-9; Kariuki S, 2015, CLIN INFECT DIS, V61, pS317, DOI 10.1093/cid/civ711; Kariuki S, 2015, ANTIMICROB AGENTS CH, V59, P3133, DOI 10.1128/AAC.00078-15; Kenya MoH, 2008, NAT MAN MAN HIV REL; Laxminarayan R, 2013, LANCET INFECT DIS, V13, P1057, DOI 10.1016/S1473-3099(13)70318-9; Liakopoulos A, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.00293; Mahon BE, 2016, MICROBIOL SPECTR, V4, DOI 10.1128/microbiolspec.EI10-0015-2016; Marks F, 2017, LANCET GLOB HEALTH, V5, pE310, DOI 10.1016/S2214-109X(17)30022-0; Morpeth SC, 2009, CLIN INFECT DIS, V49, P606, DOI 10.1086/603553; Odhiambo F, 2014, PAN AFR MED J, V19, DOI 10.11604/pamj.2014.19.332.5159; Okoro CK, 2012, NAT GENET, V44, P1215, DOI 10.1038/ng.2423; Okoth Caleb, 2018, Hosp Pract (1995), V46, P128, DOI 10.1080/21548331.2018.1464872; Oneko M, 2015, CLIN INFECT DIS, V61, pS310, DOI 10.1093/cid/civ674; Onyango CO, 2017, J CLIN MICROBIOL, V55, P2035, DOI [10.1128/JCM.02469-16, 10.1128/jcm.02469-16]; Reddy EA, 2010, LANCET INFECT DIS, V10, P417, DOI 10.1016/S1473-3099(10)70072-4; Strockbine NA., 2015, MANUAL CLIN MICROBIO, P685, DOI DOI 10.1128/9781555817381.CH37; Tagg KA, 2019, J ANTIMICROB CHEMOTH, V74, P38, DOI 10.1093/jac/dky373; Uche Ifeanyi Valentine, 2017, PLoS Negl Trop Dis, V11, pe0005118, DOI 10.1371/journal.pntd.0005118; van den Bunt G, 2017, J ANTIMICROB CHEMOTH, V72, P589, DOI 10.1093/jac/dkw443; Verani JR, 2015, CLIN INFECT DIS, V61, pS302, DOI 10.1093/cid/civ728	26	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2020	15	3							e0229581	10.1371/journal.pone.0229581	http://dx.doi.org/10.1371/journal.pone.0229581			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8MS	32126103	Green Published, gold			2022-12-26	WOS:000535253100032
J	Kierzek, E; Kierzek, R				Kierzek, Elzbieta; Kierzek, Ryszard			Conscious uncoupling of riboswitch functions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Editorial Material								Riboswitches alter gene expression in response to ligand binding, coupling sensing and regulatory functions to help bacteria respond to their environment. The structural determinants of ligand binding in the prequeuosine (7-aminomethyl-7-deazaguanine, preQ(1)) bacterial riboswitches have been studied, but the functional consequences of structural perturbations are less known. A new article combining biophysical and cell-based readouts of 15 mutants of the preQ(1)-II riboswitch from Lactobacillus rhamnosus demonstrates that ligand binding does not ensure successful gene regulation, providing new insights into these shapeshifting sequences.	[Kierzek, Elzbieta; Kierzek, Ryszard] Polish Acad Sci, Inst Bioorgan Chem, Noskowskiego 12-14, PL-61704 Poznan, Poland	Polish Academy of Sciences	Kierzek, R (corresponding author), Polish Acad Sci, Inst Bioorgan Chem, Noskowskiego 12-14, PL-61704 Poznan, Poland.	rkierzek@ibch.poznan.pl		Kierzek, Ryszard/0000-0002-7644-0016; Kierzek, Elzbieta/0000-0002-5563-003X				Batey RT, 2012, Q REV BIOPHYS, V45, P345, DOI 10.1017/S0033583512000078; Deigan KE, 2011, ACCOUNTS CHEM RES, V44, P1329, DOI 10.1021/ar200039b; Dutta D, 2020, J BIOL CHEM, V295, P2555, DOI 10.1074/jbc.RA119.010755; Eichhorn CD, 2014, BBA-GENE REGUL MECH, V1839, P939, DOI 10.1016/j.bbagrm.2014.04.019; GRUNDY FJ, 1993, CELL, V74, P475, DOI 10.1016/0092-8674(93)80049-K; Kang MJ, 2014, P NATL ACAD SCI USA, V111, pE663, DOI 10.1073/pnas.1400126111; Liberman JA, 2013, NAT CHEM BIOL, V9, P353, DOI 10.1038/nchembio.1231	7	3	3	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 28	2020	295	9					2568	2569		10.1074/jbc.H120.012787	http://dx.doi.org/10.1074/jbc.H120.012787			2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KU8NN	32111719	hybrid, Green Published			2022-12-26	WOS:000519969100003
J	Vergeer, M; Engel, SA				Vergeer, Mark; Engel, Stephen A.			Control of visual adaptation depends upon task	PLOS ONE			English	Article							COLOR CONSTANCY; GRATINGS	The visual system optimizes its functioning for a given environment through processes collectively called adaptation. It is currently unknown, however, whether adaptation is affected by the particular task the observer performs within that environment. Two experiments tested whether this is the case. Observers adapted to high contrast grating patterns, and the decay of adaptation was measured using a version of the tilt-aftereffect, while they performed two different secondary tasks. One task involved judging the luminance of a small circular spot at fixation, and was expected to be unaffected by adaptation. The other secondary task involved judging a low contrast grating, and adaptation was expected to make this task difficult by reducing the visibility of the grating. Identical displays containing both a fixation spot and a grating were used for both tasks. Tilt-aftereffects were smaller when subjects concurrently performed the grating task than when they performed the fixation task. These results suggest that the control of adaptation, in this case its decay, is sensitive to the nature of the task the observer is performing. Adaptation may attempt to optimize vision with respect to many different criteria simultaneously; task is likely one of the criteria included in this process.	[Vergeer, Mark; Engel, Stephen A.] Univ Minnesota, Dept Psychol, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities	Engel, SA (corresponding author), Univ Minnesota, Dept Psychol, Minneapolis, MN 55455 USA.	engel@umn.edu			US National Science Foundation [BCS1558308]	US National Science Foundation(National Science Foundation (NSF))	SAE received BCS1558308 from the US National Science Foundation, who did not play a role in the study design.	Abrams AB, 2007, NEURAL COMPUT, V19, P2610, DOI 10.1162/neco.2007.19.10.2610; Barbot A, 2017, PSYCHOL SCI, V28, P285, DOI 10.1177/0956797616679634; Barlow H. B., 1990, THEORY FUNCTIONAL RO; BARLOW HB, 1976, VISION RES, V16, P1043, DOI 10.1016/0042-6989(76)90241-8; Barlow HB, 1989, COMPUTING NEURON, P54; Bartlett LK, 2019, NEUROSCI BIOBEHAV R, V96, P290, DOI 10.1016/j.neubiorev.2018.10.010; BLAKEMORE C, 1969, J PHYSIOL-LONDON, V203, P237, DOI 10.1113/jphysiol.1969.sp008862; Brenner N, 2000, NEURON, V26, P695, DOI 10.1016/S0896-6273(00)81205-2; Clifford CWG, 2007, VISION RES, V47, P3125, DOI 10.1016/j.visres.2007.08.023; Dhruv NT, 2014, NEURON, V81, P529, DOI 10.1016/j.neuron.2013.11.025; Engel SA, 2016, VISION RES, V125, P41, DOI 10.1016/j.visres.2016.05.003; Gibson JJ, 1937, J EXP PSYCHOL, V20, P453, DOI 10.1037/h0059826; Keller AJ, 2017, ELIFE, V6, DOI 10.7554/eLife.21589; Kohn A, 2007, J NEUROPHYSIOL, V97, P3155, DOI 10.1152/jn.00086.2007; Mather G., 1998, MOTION AFTEREFFECT M; McGovern DP, 2012, J NEUROSCI, V32, P13621, DOI 10.1523/JNEUROSCI.1363-12.2012; Meese TS, 1996, VISION RES, V36, P1421, DOI 10.1016/0042-6989(95)00212-X; Morgan MJ, 2019, Q J EXP PSYCHOL, V72, P2848, DOI 10.1177/1747021819864552; Patterson CA, 2014, NEURON, V81, P674, DOI 10.1016/j.neuron.2013.11.022; Peirce JW, 2007, J NEUROSCI METH, V162, P8, DOI 10.1016/j.jneumeth.2006.11.017; Peirce JW, 2009, FRONT NEUROINFORM, V2, DOI 10.3389/neuro.11.010.2008; Scolari M, 2009, J NEUROSCI, V29, P11933, DOI 10.1523/JNEUROSCI.5642-08.2009; Verghese P, 2012, J NEUROSCI, V32, P16379, DOI 10.1523/JNEUROSCI.1174-12.2012; Wainwright MJ, 1999, VISION RES, V39, P3960, DOI 10.1016/S0042-6989(99)00101-7; WEBSTER MA, 1995, NATURE, V373, P694, DOI 10.1038/373694a0; Webster MA, 2015, ANNU REV VIS SCI, V1, P547, DOI 10.1146/annurev-vision-082114-035509; Wissig SC, 2013, J VISION, V13, DOI 10.1167/13.2.6; Yehezkel O, 2010, VISION RES, V50, P1550, DOI 10.1016/j.visres.2010.05.014; Zhang P, 2009, CURR BIOL, V19, P1956, DOI 10.1016/j.cub.2009.10.018	29	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2020	15	2							e0229343	10.1371/journal.pone.0229343	http://dx.doi.org/10.1371/journal.pone.0229343			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8GQ	32106238	gold, Green Published			2022-12-26	WOS:000535237000026
J	Burr, PC; Avery, JL; Street, GM; Strickland, BK; Dorr, BS				Burr, Paul C.; Avery, Jimmy L.; Street, Garrett M.; Strickland, Bronson K.; Dorr, Brian S.			Fine scale characteristics of catfish aquaculture ponds influencing piscivorous avian species foraging use in the Mississippi Delta	PLOS ONE			English	Article							DOUBLE-CRESTED CORMORANTS; CHANNEL CATFISH; ICTALURUS-PUNCTATUS; PHALACROCORAX-AURITUS; SITE-OCCUPANCY; LETHAL CONTROL; UNITED-STATES; WADING BIRDS; IMPACT; FACILITIES	Piscivorous avian species are the main source of catfish depredation at aquaculture facilities in Mississippi, resulting in the economic loss of millions of dollars every year. Most notable of these avian species are the double-crested cormorant (Phalacrocorax auritus), great blue heron (Ardea herodias), and great egret (A. alba). Understanding why these species select specific ponds can increase management efficiency directed at avian dispersal and provide insight into their decision making with respect to foraging behavior. We collected species presence data on catfish ponds by flying 35 surveys from October through April of 2015-2017, during which an average of 973 catfish ponds were observed each year. We collected data associated with each pond's physical surroundings and contents and used occupancy modeling to determine their influence on avian occupancy probability. We also collected data associated with stocking practices and catfish health on a subset of ponds, and constructed resource selection functions to model their influence on avian presence. Pond area was positively related to occupancy probability of each species. Cormorant occupancy increased as pond distance from forest cover and activity centers, such as workshops and offices, increased. Distance to nearest activity center was positively related to egret occupancy, while distance to nearest forested area was negative. Ponds containing diseased catfish had an increased probability of use by both herons and egrets. In general, cormorants and egrets showed greater probability of use on the periphery of pond clusters. The abundance of catfish was positively related to cormorant and heron presence. Specific pond contents and characteristics influenced presence of each avian species in different ways, including fish species cultured, production methods, pond systems, and fish types. Many pond selection relationships were species-specific, illustrating inherent differences in their foraging ecology. Consequently, specific management actions aimed to reduce avian presence will depend on the targeted species.	[Burr, Paul C.; Street, Garrett M.; Strickland, Bronson K.] Mississippi State Univ, Dept Wildlife Fisheries & Aquaculture, Mississippi State, MS 39762 USA; [Avery, Jimmy L.] Mississippi State Univ, Natl Warmwater Aquaculture Ctr, Stoneville, MS USA; [Dorr, Brian S.] USDA, Mississippi Field Stn, Natl Wildlife Res Ctr, Wildlife Serv Anim & Plant Hlth Inspect Serv, Mississippi State, MS USA; [Burr, Paul C.] Coll Forest Resources, Dept Wildlife Fisheries & Aquaculture, Mississippi State, MS 39762 USA	Mississippi State University; Mississippi State University; Mississippi State University; United States Department of Agriculture (USDA); Mississippi State University	Burr, PC (corresponding author), Mississippi State Univ, Dept Wildlife Fisheries & Aquaculture, Mississippi State, MS 39762 USA.; Burr, PC (corresponding author), Coll Forest Resources, Dept Wildlife Fisheries & Aquaculture, Mississippi State, MS 39762 USA.	pcb124@msstate.edu	Dorr, Brian/AAX-9033-2020	Dorr, Brian/0000-0001-6857-8560; Burr, Paul/0000-0001-5289-0373	United States Department of Agriculture, Animal and Plant Health Inspection Service, Wildlife Services, National Wildlife Research Center [14-7428-1045(CA), 15-7428-1141(CA), 16-74281247(CA), 17-7428-1247(CA), 18-7428-1247 (CA)]; National Wildlife Research Center	United States Department of Agriculture, Animal and Plant Health Inspection Service, Wildlife Services, National Wildlife Research Center(United States Department of Agriculture (USDA)); National Wildlife Research Center(United States Department of Agriculture (USDA))	This research was funded by the United States Department of Agriculture, Animal and Plant Health Inspection Service, Wildlife Services, National Wildlife Research Center (https://www.aphis.usda.gov/aphis/ourfocus/wildlifedamage/programs/nwrc) Cooperative Service Agreements: 14-7428-1045(CA), 15-7428-1141(CA), 16-74281247(CA), 17-7428-1247(CA), and 18-7428-1247 (CA) awarded to BKS. Co-author Brian S. Dorr is a Research Biologist for the funder National Wildlife Research Center and played a role in study design, data collection and analysis, and manuscript preparation.	Bailey LL, 2014, METHODS ECOL EVOL, V5, P1269, DOI 10.1111/2041-210X.12100; Bailey LL, 2004, ECOL APPL, V14, P692, DOI 10.1890/03-5012; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Belant JL, 2000, WILDLIFE SOC B, V28, P379; Blackwell BF, 2000, N AM J AQUACULT, V62, P300, DOI 10.1577/1548-8454(2000)062&lt;0300:LCOPBA&gt;2.0.CO;2; Burnham K.P., 2002, PRACTICAL INFORM THE, V2nd ed., DOI [DOI 10.1007/B97636, 10.1007/b97636]; Conover M., 2000, RESOLVING HUMAN WILD; Crum NJ, 2017, J WILDLIFE MANAGE, V81, P521, DOI 10.1002/jwmg.21207; Dorr B, 2004, WATERBIRDS, V27, P147, DOI 10.1675/1524-4695(2004)027[0147:DCMIRT]2.0.CO;2; Dorr B., 2003, P 10 WILDL DAM MAN C, P52, DOI DOI 10.1007/S13398-014-0173-7.2; Dorr B. S., 2006, THESIS; Dorr B. S., 2014, BIRDS N AM; Dorr BS, 2008, J WILDLIFE MANAGE, V72, P1634, DOI 10.2193/2007-308; Dorr BS, 2012, J WORLD AQUACULT SOC, V43, P502, DOI 10.1111/j.1749-7345.2012.00586.x; Dunham R, 2012, SO REGIONAL AQUACULT, V190, P1; Fiske IJ, 2011, J STAT SOFTW, V43, P1; Fleury BE, 1995, AUK, V112, P613; Fuller AK, 2016, J WILDLIFE MANAGE, V80, P794, DOI 10.1002/jwmg.21077; Glahn J. F., 2002, HUMAN CONFLICTS WILD, P138; Glahn JF, 1999, J WORLD AQUACULT SOC, V30, P107, DOI 10.1111/j.1749-7345.1999.tb00323.x; Glahn JF, 2000, N AM J AQUACULT, V62, P149, DOI 10.1577/1548-8454(2000)062<0149:CGBHPO>2.0.CO;2; Glahn JF, 1995, COLON WATERBIRD, V18, P158, DOI 10.2307/1521536; Glahn JF, 1995, COLON WATERBIRD, V18, P168, DOI 10.2307/1521537; Glahn JF, 2002, J WILDLIFE MANAGE, V66, P194, DOI 10.2307/3802885; Glahn JF, 2000, PROC VERTEBR PEST C, P44; Glahn JF, 2002, J WORLD AQUACULT SOC, V33, P85, DOI 10.1111/j.1749-7345.2002.tb00482.x; Glahn JF, 2004, DEV AQUAC FISH SCI, V34, P503; Gorenzel WP, 1994, PREVENTION CONTROL W; Gosser A. L., 1997, BERRYMAN I PUBLICATI, V13; JOHNSON DH, 1980, ECOLOGY, V61, P65, DOI 10.2307/1937156; Johnson K, 2014, J WORLD AQUACULT SOC, V45, P279, DOI 10.1111/jwas.12117; Li MH, 2004, J APPL AQUAC, V15, P1045, DOI [10.1300/J028v15n03, DOI 10.1300/J028V15N03]; Linden DW, 2017, J APPL ECOL, V54, P2043, DOI 10.1111/1365-2664.12883; MacKenzie D. I., 2006, OCCUPANCY ESTIMATION; MacKenzie DI, 2004, J AGR BIOL ENVIR ST, V9, P300, DOI 10.1198/108571104X3361; Manly B., 2007, RESOURCE SELECTION A; Mccrimmon Jr D. A., 2011, BIRDS N AM ONLINE; Mott DF, 1995, COLON WATERBIRD, V18, P176, DOI 10.2307/1521538; National Agriculture Statistics Service (NASS), 2018, CATF PROD, P1; Peterman WE, 2013, J NAT CONSERV, V21, P114, DOI 10.1016/j.jnc.2012.11.005; R Core Team, 2021, R LANGUAGE ENV STAT; Reinhold D. S., 1997, USDA NATL WILDLIFE R, V10, P99; Royle JA, 2003, ECOLOGY, V84, P777, DOI 10.1890/0012-9658(2003)084[0777:EAFRPA]2.0.CO;2; Schielzeth H, 2010, METHODS ECOL EVOL, V1, P103, DOI 10.1111/j.2041-210X.2010.00012.x; Stickley Allen R. Jr., 1992, Journal of the World Aquaculture Society, V23, P192, DOI 10.1111/j.1749-7345.1992.tb00768.x; Stickley Allen R. Jr., 1995, Journal of the World Aquaculture Society, V26, P194, DOI 10.1111/j.1749-7345.1995.tb00244.x; Tucker C.S., 2010, GLOB AQUACULT ADVOCA, V13, P64; Tucker C.S., 2004, BIOL CULTURE CHANNEL; US Department of Agriculture (USDA), 2010, REF CATF HLTH PROD P; US Department of Agriculture (USDA), 2003, CATF 2003 1; US Department of Agriculture (USDA), 2010, CATF 2010 3; USDA, 2010, CATF 2010 2; Vennesland RG, 2011, BIRDS N AM ONLINE; Vilsack T, 2014, US DEP AGR, V1, P685; Vilsack T, 2014, 2012 CENSUS AQUACULT; Werner SJ, 2006, J WORLD AQUACULT SOC, V37, P121, DOI 10.1111/j.1749-7345.2006.00015.x; Werner SJ, 2005, J WORLD AQUACULT SOC, V36, P354, DOI 10.1111/j.1749-7345.2005.tb00339.x; Wires LR, 2001, TATUS DOUBLE CRESTED; Wywialowski AP, 1999, J WORLD AQUACULT SOC, V30, P461, DOI 10.1111/j.1749-7345.1999.tb00994.x; Zuur Alain F., 2009, P1	60	2	2	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2020	15	2							e0229402	10.1371/journal.pone.0229402	http://dx.doi.org/10.1371/journal.pone.0229402			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8FM	32101563	Green Published, gold			2022-12-26	WOS:000535233700031
J	Karaba, AH; Figueroa, A; Massaccesi, G; Botto, S; DeFilippis, VR; Cox, AL				Karaba, Andrew H.; Figueroa, Alexis; Massaccesi, Guido; Botto, Sara; DeFilippis, Victor R.; Cox, Andrea L.			Herpes simplex virus type 1 inflammasome activation in proinflammatory human macrophages is dependent on NLRP3, ASC, and caspase-1	PLOS ONE			English	Article							HUMAN MONOCYTES; 1 INFECTION; DNA; RECOGNITION; IFI16; DIFFERENTIATION; INTERLEUKIN-1; DEGRADATION; MECHANISM; CYTOKINES	The proinflammatory cytokines interleukin (IL)-1 beta and IL-18 are products of activation of the inflammasome, an innate sensing system, and important in the pathogenesis of herpes simplex virus type 1 (HSV-1). The release of IL-18 and IL-1 beta from monocytes/macrophages is critical for protection from HSV-1 based on animal models of encephalitis and genital infection, yet if and how HSV-1 activates inflammasomes in human macrophages is unknown. To investigate this, we utilized both primary human monocyte derived macrophages and human monocytic cell lines (THP-1 cells) with various inflammasome components knocked-out. We found that HSV-1 activates inflammasome signaling in proinflammatory primary human macrophages, but not in resting macrophages. Additionally, HSV-1 inflammasome activation in THP-1 cells is dependent on nucleotide-binding domain and leucine-rich repeat-containing receptor 3 (NLRP3), apoptosis-associated speck-like molecule containing a caspase recruitment domain (ASC), and caspase-1, but not on absent in melanoma 2 (AIM2), or gamma interferon-inducible protein 16 (IFI16). In contrast, HSV-1 activates non-canonical inflammasome signaling in proinflammatory macrophages that results in IL-1 beta, but not IL-18, release that is independent of NLRP3, ASC, and caspase-1. Ultraviolet irradiation of HSV-1 enhanced inflammasome activation, demonstrating that viral replication suppresses inflammasome activation. These results confirm that HSV-1 is capable of activating the inflammasome in human macrophages through an NLRP3 dependent process and that the virus has evolved an NLRP3 specific mechanism to inhibit inflammasome activation in macrophages.	[Karaba, Andrew H.; Figueroa, Alexis; Massaccesi, Guido; Cox, Andrea L.] Johns Hopkins Univ, Sch Med, Dept Med, Div Infect Dis, Baltimore, MD 21205 USA; [Botto, Sara; DeFilippis, Victor R.] Oregon Hlth & Sci Univ, Vaccine & Gene Therapy Inst, Portland, OR 97201 USA	Johns Hopkins University; Oregon Health & Science University	Cox, AL (corresponding author), Johns Hopkins Univ, Sch Med, Dept Med, Div Infect Dis, Baltimore, MD 21205 USA.	acox@jhmi.edu	Karaba, Andrew/AAS-9303-2021	Cox, Andrea/0000-0002-9331-2462; Massaccesi, Guido/0000-0002-4528-0937; Figueroa, Alexis/0000-0002-6549-3489	National Institute of Allergy and Infectious Diseases [U19AI088791, R01AI108403]; National Institute of Health [T32 AI007291-27]; U.S. Health Resources and Services Administration, Bureau of Health Workforce, Health Careers Opportunity Program [D18HP29037]	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); U.S. Health Resources and Services Administration, Bureau of Health Workforce, Health Careers Opportunity Program	This work was supported by the National Institute of Allergy and Infectious Diseases U19AI088791 and R01AI108403. AHK was supported by the National Institute of Health T32 AI007291-27. AF was supported, in part, by grant D18HP29037 from the U.S. Health Resources and Services Administration, Bureau of Health Workforce, Health Careers Opportunity Program. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afonina IS, 2015, IMMUNITY, V42, P991, DOI 10.1016/j.immuni.2015.06.003; Almine JF, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14392; Awad F, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175336; Beyer M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045466; Botto S, 2019, MBIO, V10, DOI 10.1128/mBio.02510-18; Broz P, 2016, NAT REV IMMUNOL, V16, P407, DOI 10.1038/nri.2016.58; Brubaker SW, 2015, ANNU REV IMMUNOL, V33, P257, DOI 10.1146/annurev-immunol-032414-112240; Chan AH, 2020, J EXP MED, V217, DOI 10.1084/jem.20190314; Chattergoon MA, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004082; Chen IY, 2015, TRENDS MICROBIOL, V23, P55, DOI 10.1016/j.tim.2014.09.007; Chen W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084953; Connolly SA, 2011, NAT REV MICROBIOL, V9, P369, DOI 10.1038/nrmicro2548; Coulon PG, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01631; da Costa LS, 2019, CELL DEATH DIS, V10, DOI 10.1038/s41419-019-1579-0; de Castro-Jorge LA, 2019, PLOS PATHOG, V15, DOI 10.1371/journal.ppat.1007934; Dinarello CA, 2018, IMMUNOL REV, V281, P8, DOI 10.1111/imr.12621; Doitsh G, 2014, NATURE, V505, P509, DOI 10.1038/nature12940; Dutta D, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005030; Ellermann-Eriksen S, 2005, VIROL J, V2, DOI 10.1186/1743-422X-2-59; Fields BN, 2013, FIELDS VIROLOGY; Frank D, 2019, CELL DEATH DIFFER, V26, P99, DOI 10.1038/s41418-018-0212-6; Gaidt MM, 2017, CELL, V171, P1110, DOI 10.1016/j.cell.2017.09.039; Gaidt MM, 2016, IMMUNITY, V44, P833, DOI 10.1016/j.immuni.2016.01.012; Gerrick KY, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0208602; GHIASI H, 1995, J VIROL, V69, P334, DOI 10.1128/JVI.69.1.334-340.1995; Gimenez F, 2016, J LEUKOCYTE BIOL, V99, P647, DOI 10.1189/jlb.3HI0715-321R; Hashimoto S, 1997, BLOOD, V89, P315, DOI 10.1182/blood.V89.1.315.315_315_321; He Y, 2016, TRENDS BIOCHEM SCI, V41, P1012, DOI 10.1016/j.tibs.2016.09.002; Hoeksema MA, 2015, J IMMUNOL, V194, P3909, DOI 10.4049/jimmunol.1402077; Horan KA, 2013, J IMMUNOL, V190, P2311, DOI 10.4049/jimmunol.1202749; Johnson KE, 2013, J VIROL, V87, P5005, DOI 10.1128/JVI.00082-13; Karaba AH, 2011, J VIROL, V85, P10041, DOI 10.1128/JVI.05445-11; Kuriakose T, 2017, MOL IMMUNOL, V86, P56, DOI 10.1016/j.molimm.2017.01.023; Labzin LI, 2019, EMBO J, V38, DOI 10.15252/embj.2018101365; Lee AJ, 2017, J EXP MED, V214, P1153, DOI 10.1084/jem.20160880; Lee DH, 2017, J VIROL, V91, DOI 10.1128/JVI.00578-17; Lupfer C, 2015, CURR OPIN VIROL, V12, P38, DOI 10.1016/j.coviro.2015.02.007; Man SM, 2017, IMMUNOL REV, V277, P61, DOI 10.1111/imr.12534; Mantovani A, 2019, IMMUNITY, V50, P778, DOI 10.1016/j.immuni.2019.03.012; Mariathasan S, 2006, NATURE, V440, P228, DOI 10.1038/nature04515; Martinez FO, 2006, J IMMUNOL, V177, P7303, DOI 10.4049/jimmunol.177.10.7303; Maruzuru Y, 2018, CELL HOST MICROBE, V23, P254, DOI 10.1016/j.chom.2017.12.014; Melchjorsen J, 2010, J VIROL, V84, P11350, DOI 10.1128/JVI.01106-10; Miettinen JJ, 2012, J VIROL, V86, P12770, DOI 10.1128/JVI.01545-12; Murray PJ, 2017, ANNU REV PHYSIOL, V79, P541, DOI 10.1146/annurev-physiol-022516-034339; Muruve DA, 2008, NATURE, V452, P103, DOI 10.1038/nature06664; Orzalli MH, 2012, P NATL ACAD SCI USA, V109, pE3008, DOI 10.1073/pnas.1211302109; Rathinam VAK, 2010, NAT IMMUNOL, V11, P395, DOI 10.1038/ni.1864; Sergerie Y, 2007, J INFECT DIS, V196, P853, DOI 10.1086/520094; Strittmatter GE, 2016, J INVEST DERMATOL, V136, P610, DOI 10.1016/j.jid.2015.12.022; Swanson KV, 2017, J EXP MED, V214, P3611, DOI 10.1084/jem.20171749; Tognarelli EI, 2019, FRONT CELL INFECT MI, V9, DOI 10.3389/fcimb.2019.00127; Tyrkalska SD, 2019, IMMUNITY, V51, P50, DOI 10.1016/j.immuni.2019.05.005; Voet S, 2019, EMBO MOL MED, V11, DOI 10.15252/emmm.201810248; Wu MF, 2013, J BIOMED SCI, V20, DOI 10.1186/1423-0127-20-36; Yasuda K, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20030649	56	16	20	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2020	15	2							e0229570	10.1371/journal.pone.0229570	http://dx.doi.org/10.1371/journal.pone.0229570			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	KT6HE	32101570	Green Submitted, gold, Green Published			2022-12-26	WOS:000519114200001
J	Tola, HH; Holakouie-Naieni, K; Mansournia, MA; Yaseri, M; Tesfaye, E; Mahamed, Z; Sisay, MM				Tola, Habteyes Hailu; Holakouie-Naieni, Kourosh; Mansournia, Mohammad Ali; Yaseri, Mehdi; Tesfaye, Ephrem; Mahamed, Zemedu; Sisay, Million Molla			Low enrollment and high treatment success in children with drug-resistant tuberculosis in Ethiopia: A ten years national retrospective cohort study	PLOS ONE			English	Article							TREATMENT OUTCOMES; CHILDHOOD TUBERCULOSIS; CLINICAL-FEATURES; SOUTH-AFRICA; MDR-TB; MANAGEMENT; BURDEN	Background Limited evidence exists on the treatment outcome and factors that are associated with the duration from the initiation of treatment to death or treatment failure in children with drug resistant tuberculosis (DR-TB). Thus, we aimed to determine the proportion of treatment enrollment, status of treatment outcome and determine factors that are associated with the duration from treatment initiation to death or treatment failure in children treated for DR-TB in Ethiopia. Methods We conducted a retrospective cohort study in children younger than 15 years old who were treated for DR-TB from February 2009 to February 2019 in Ethiopia. We collected data on socio-demographic and clinical characteristics from clinical charts, registration books and laboratory result reports on 155 children. Proportion of enrollment to the treatment was calculated by dividing the total number of children who were receiving the treatment by the total number of DR-TB patients treated during the specified years. We used Cox proportional hazard models to determine factors that were associated with the duration from the beginning of the treatment to death or treatment failure. Data was analyzed using STATA version 14. Results Of the 3,478 DR-TB patients enrolled into the treatment and fulfilling our inclusion criteria during the past ten years, 155 (4.5%) were children. Of the 155 children, 75 (48.4%) completed the treatment and 51 (32.9%) were cured. Furthermore, 18 (11.6%) children were died, seven (4.5%) lost to follow up and treatment of four (2.6%) children was failed. The overall treatment success was 126 (81.3%). Age younger than 5 years old [Adjusted Hazard Ratio (AHR) = 3.2, 95%CI (1.2-8.3)], HIV sero-reactivity [AHR = 5.3, 95%CI (1.8-14.9)] and being anemic [AHR = 4.3, 95%CI (1.8-10.3)] were significantly associated with the duration from the enrollment into the treatment to death or treatment failure. Conclusion In this study, the proportion of children enrolled into DR-TB treatment was lower than the proportion of adults enrolled to the treatment (4.5% in children versus 95.5% in adults) in last ten years. Our findings also suggest that children with DR-TB can be successfully treated with standardized long term regimen. Further prospective cohort study is required to investigate factors contributing to death or treatment failure.	[Tola, Habteyes Hailu; Holakouie-Naieni, Kourosh; Mansournia, Mohammad Ali; Yaseri, Mehdi] Univ Tehran Med Sci, Sch Publ Hlth, Dept Epidemiol & Biostat, Tehran, Iran; [Tola, Habteyes Hailu; Tesfaye, Ephrem; Mahamed, Zemedu] Ethiopian Publ Hlth Inst, TB HIV Res Directorate, Addis Ababa, Ethiopia; [Sisay, Million Molla] St Peters Specialized Hosp, Res & Evidence Generat Directorate, Addis Ababa, Ethiopia	Tehran University of Medical Sciences	Holakouie-Naieni, K (corresponding author), Univ Tehran Med Sci, Sch Publ Hlth, Dept Epidemiol & Biostat, Tehran, Iran.	holakoik@hotmail.com	; Yaseri, Mehdi/I-1645-2018; Doosti-Irani, Amin/Q-1260-2016	Molla, Million/0000-0002-2021-8440; Yaseri, Mehdi/0000-0002-4066-873X; Tola, Habteyes Hailu/0000-0002-2889-956X; Doosti-Irani, Amin/0000-0003-0623-7503	Tehran University of Medical Sciences and Ethiopian Public Health Institute	Tehran University of Medical Sciences and Ethiopian Public Health Institute	This work was supported by Tehran University of Medical Sciences and Ethiopian Public Health Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad N, 2018, LANCET, V392, P821, DOI 10.1016/S0140-6736(18)31644-1; Alene KA, 2017, TROP MED INT HEALTH, V22, P351, DOI 10.1111/tmi.12826; Chiang SS, 2016, CLIN INFECT DIS, V63, P1063, DOI 10.1093/cid/ciw489; Curry RJ, 2016, ENEURO, V3, DOI 10.1523/ENEURO.0309-16.2016; Dodd PJ, 2017, LANCET GLOB HEALTH, V5, pE898, DOI [10.1016/S2214-109X(17)30289-9, 10.1016/s2214-109x(17)30289-9]; Dodd PJ, 2014, LANCET GLOB HEALTH, V2, pE453, DOI 10.1016/S2214-109X(14)70245-1; Drobac PC, 2006, PEDIATRICS, V117, P2022, DOI 10.1542/peds.2005-2235; Ettehad D, 2012, LANCET INFECT DIS, V12, P449, DOI 10.1016/S1473-3099(12)70033-6; Fairlie L, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-28; Federal Democratic Republic of Ethiopia Ministry of Health, 2012, GUID PROGR MAN DRUG; Federal Democratic Republic of Ethiopia Ministry of Health, 2018, GUID MAN FF TB DR TB, P1; Feja K, 2008, PEDIATR INFECT DIS J, V27, P907, DOI 10.1097/INF.0b013e3181783aca; Gegia M, 2013, INT J TUBERC LUNG D, V17, P624, DOI 10.5588/ijtld.12.0792; Hall EW, 2017, PEDIATR INFECT DIS J, V36, pE322, DOI 10.1097/INF.0000000000001691; Harausz EP, 2018, PLOS MED, V15, DOI 10.1371/journal.pmed.1002591; Hicks RM, 2014, INT J TUBERC LUNG D, V18, P1074, DOI 10.5588/ijtld.14.0231; Jenkins H E, 2018, Int J Tuberc Lung Dis, V22, P3, DOI 10.5588/ijtld.17.0357; Kibret KT, 2017, INFECT DIS POVERTY, V6, DOI 10.1186/s40249-016-0214-x; Marais BJ, 2018, LANCET GLOB HEALTH, V6, pE1260, DOI 10.1016/S2214-109X(18)30449-2; Meressa D, 2015, THORAX, V70, P1181, DOI 10.1136/thoraxjnl-2015-207374; Moore BK, 2015, INT J TUBERC LUNG D, V19, P663, DOI 10.5588/ijtld.14.0879; Qamar F, 2016, INT J INFECT DIS, V45, P14, DOI 10.1016/j.ijid.2016.02.066; Roy RB, 2012, CURR OPIN INFECT DIS, V25, P250, DOI 10.1097/QCO.0b013e3283529af9; Sandgren A, 2012, EUR RESPIR J, V40, P294, DOI 10.1183/09031936.00187711; Schaaf HS, 2003, ARCH DIS CHILD, V88, P1106, DOI 10.1136/adc.88.12.1106; Seddon JA, 2014, THORAX, V69, P471, DOI 10.1136/thoraxjnl-2013-203900; Seddon JA, 2012, LANCET INFECT DIS, V12, P469, DOI 10.1016/S1473-3099(11)70366-8; Seddon JA, 2012, CLIN INFECT DIS, V54, P157, DOI 10.1093/cid/cir772; Simon AK, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2014.3085; Smith Kim Connelly, 2005, Expert Rev Anti Infect Ther, V3, P995, DOI 10.1586/14787210.3.6.995; The World Health Organization, 2019, WHO CONSOLIDATED GUI; Thomas TA, 2010, INT J TUBERC LUNG D, V14, P1244; World Health Organization, 2011, VITAMIN MINERAL NUTR; World Health Organization (WHO), 2018, GLOBAL TUBERCULOSIS, P35; World Health Organization(WHO), 2014, GUID NAT TUB PROGR M, V2nd; Zumla A, 2012, J INFECT DIS, V205, pS228, DOI 10.1093/infdis/jir858	36	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2020	15	2							e0229284	10.1371/journal.pone.0229284	http://dx.doi.org/10.1371/journal.pone.0229284			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8FM	32101580	Green Published, gold			2022-12-26	WOS:000535233700024
J	Lim, JM; Duong, MC; Hsu, LY; Tam, CC				Lim, Jane Mingjie; Duong, Minh Cam; Hsu, Li Yang; Tam, Clarence C.			Determinants influencing antibiotic use in Singapore's small-scale aquaculture sectors: A qualitative study	PLOS ONE			English	Article								Singapore's Antimicrobial Resistance (AMR) national strategic action plan includes inappropriate use of antimicrobials in food-producing animals as a specific priority. Although the use of antibiotics and other drugs are monitored by regulatory bodies, food fish farmers are allowed to buy and administer antimicrobials without a veterinary prescription. We conducted a qualitative study of Singaporean food fish farmers to understand patterns and determinants of antibiotic use, their knowledge of antibiotic resistance, as well as perceptions of on-farm infection prevention and control measures. During the interview, participants were asked about their farming processes, farm infrastructure, antibiotic use and any disease prevention measures. Thematic analysis of participants' interviews showed that antibiotic for growth promotion and infection prevention was uncommon among local food fish farmers. The following three main themes influenced participants' decisions to use antibiotics in their practice: 1) individual factors, 2) local regulatory factors as well as 3) marketrelated factors. Individual factors included their personal experience and knowledge both with antibiotics as well as with alternate options. In terms of local regulatory factors, we found that regular oversight was a strong deterrent in antibiotic use. Last, at the market level, the relatively high price of antibiotics in Singapore coupled with stiff competition was a strong disincentive for participants to use antibiotics in their farming practice. These factors were also influential in their relationships with local regulatory bodies as well as their counterparts. Although industries differ significantly across countries, lessons learnt from Singapore's food fish farming demonstrate the importance of an environment where multidimensional factors come together to discourage the irrational use of antibiotics in food animal production. In addition, our results allow greater insight into food fish farmers' perspectives on infection control and form a basis from which further research work can be undertaken.	[Lim, Jane Mingjie; Duong, Minh Cam; Hsu, Li Yang; Tam, Clarence C.] Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, Singapore, Singapore; [Lim, Jane Mingjie; Duong, Minh Cam; Hsu, Li Yang; Tam, Clarence C.] Natl Univ Hlth Syst NUHS, Singapore, Singapore; [Tam, Clarence C.] London Sch Hyg & Trop Med, London, England	National University of Singapore; National University of Singapore; University of London; London School of Hygiene & Tropical Medicine	Tam, CC (corresponding author), Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, Singapore, Singapore.; Tam, CC (corresponding author), Natl Univ Hlth Syst NUHS, Singapore, Singapore.; Tam, CC (corresponding author), London Sch Hyg & Trop Med, London, England.	clarence.tam@nus.edu.sg		Lim, Jane M/0000-0001-9017-4714; Tam, Clarence/0000-0003-1697-286X				[Anonymous], 2018, ANTIMICROBIAL USE EN; [Anonymous], 2017, NATL STRATEGIC ACTIO; Pham DK, 2015, ECOHEALTH, V12, P480, DOI 10.1007/s10393-014-1006-z; Defoirdt T, 2011, CURR OPIN MICROBIOL, V14, P251, DOI 10.1016/j.mib.2011.03.004; Fisheries F, 2017, GLOBAL AQUACULTURE P; Heuer H, 2009, ENVIRON MICROBIOL, V11, P937, DOI 10.1111/j.1462-2920.2008.01819.x; Holmstrom K, 2003, INT J FOOD SCI TECH, V38, P255, DOI 10.1046/j.1365-2621.2003.00671.x; Otto P, 2013, FAO OIE WHO TRIPARTI; Sapkota A, 2008, ENVIRON INT, V34, P1215, DOI 10.1016/j.envint.2008.04.009; Watts JEM, 2017, MAR DRUGS, V15, DOI 10.3390/md15060158; World Health Organization, 2012, GLOB ACT PLAN CONTR	11	4	4	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2020	15	2							e0228701	10.1371/journal.pone.0228701	http://dx.doi.org/10.1371/journal.pone.0228701			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8EV	32097422	Green Published, gold			2022-12-26	WOS:000535232000010
J	Lee, JH; Lee, DH				Lee, Jae Hee; Lee, Duk Hee			Types and clinical outcomes of chemical ingestion in emergency departments in South Korea (2011-2016)	PLOS ONE			English	Article								Objective This study aims to provide basic data on the types and frequency of chemical ingestions and the clinical outcomes of chemical ingestion injury. Methods This study retrospectively analyzed the data obtained from the Emergency Department-Based Injury In-depth Surveillance of the Korea Centers for Disease Control and Prevention (South Korea) from 2011 to 2016. Patients ingesting chemicals aged >= 18 years were included, but those ingesting unknown chemical substances or with unknown clinical outcomes were excluded. Results This study included 2,712 (47.2% were men and 52.8% were women, mean age, 47.05 years) patients ingesting chemicals. Unintentional and intentional ingestions were reported in 1,673 (61.7%) and 1,039 (38.3%), respectively. The most commonly ingested chemical substances were hypochlorites, detergents, ethanol, and acetic acid. In the unintentional ingestion group, the most common chemicals upon admission were hypochlorites (74), glacial acetic acid (60), and detergent (33). The admission rates were 60% for glacial acetic acid, 58.3% ethylene glycol, and 30.4% other alkali agents. In the intentional ingestion group, the most common chemicals upon admission were hypochlorites (242), glacial acetic acid (79), ethylene glycol (42), and detergent (41). The admission rates were 91.9% for glacial acetic acid, 87.5% ethylene glycol, 85.7% potassium cyanide, and 81.4% hydrochloric acid. In total, 79 deaths (10 unintentional ingestions, 69 intentional ingestion) were reported, and glacial acetic acid had an odds ratio of 9.299 for mortality. Conclusion We compared the intentional and unintentional ingestion groups, and analyzed the factors affecting hospital admission and mortality in each group. The types and clinical outcomes of chemical ingestion varied depending on the purpose of chemical ingestion. The findings are considered beneficial in establishing treatment policies for patients ingesting chemicals.	[Lee, Jae Hee; Lee, Duk Hee] Ewha Womans Univ, Dept Emergency Med, Seoul, South Korea	Ewha Womans University	Lee, DH (corresponding author), Ewha Womans Univ, Dept Emergency Med, Seoul, South Korea.	ewhain78@gmail.com		Lee, Duk Hee/0000-0001-5992-5284; Lee, Jae Hee/0000-0002-3864-6929	National Research Foundation of Korea (NRF) - Korea government (MSIT) [2018R1C1B5046096]; Research of Korea Centers for Disease Control and Prevention (Emergency Department-Based Injury In-depth Surveillance)	National Research Foundation of Korea (NRF) - Korea government (MSIT); Research of Korea Centers for Disease Control and Prevention (Emergency Department-Based Injury In-depth Surveillance)	This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Korea government (MSIT) (No. 2018R1C1B5046096), and a fund by Research of Korea Centers for Disease Control and Prevention (Emergency Department-Based Injury In-depth Surveillance). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akcay M, 2014, PEDIATR DENT, V36, P316; 이재석, 2015, [Fire Science and Engineering, 한국화재소방학회 논문지], V29, P73, DOI 10.7731/KIFSE.2015.29.5.073; Choi G.Y., 2012, J KOREAN SOC CLIN TO, V10, P91; Choi S, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15061162; Doles William, 2015, Hosp Pharm, V50, P304, DOI 10.1310/hpj5004-304; Duncan MA, 2010, J MED TOXICOL, V6, P461, DOI 10.1007/s13181-010-0114-6; Gummin DD, 2018, CLIN TOXICOL, V56, P1213, DOI 10.1080/15563650.2018.1533727; Kyong Y, 2004, J KOREAN SOC CLIN TO, V2, P23; Lee Tae-Hyung, 2018, 한국안전학회지, V33, P54; Lee Tae-Hyung, 2017, [Fire Science and Engineering, 한국화재소방학회 논문지], V31, P81, DOI 10.7731/KIFSE.2017.31.1.081; Ling SLY, 2018, EUR J EMERG MED, V25, P134, DOI 10.1097/MEJ.0000000000000430; Guitian PP, 2011, MED CLIN-BARCELONA, V136, P149, DOI 10.1016/j.medcli.2010.04.033; Rietjens SJ, 2014, NETH J MED, V72, P73; Tan HH, 2014, OCCUP MED-OXFORD, V64, P113, DOI 10.1093/occmed/kqt158; Tomassoni AJ, 2015, EMERG MED CLIN N AM, V33, P13, DOI 10.1016/j.emc.2014.09.004	15	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2020	15	3							e0229939	10.1371/journal.pone.0229939	http://dx.doi.org/10.1371/journal.pone.0229939			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8QU	32130274	Green Published, gold			2022-12-26	WOS:000535264000056
J	Fakhri, O; Devlin, JM; Browning, GF; Vaz, PK; Thilakarathne, D; Lee, SW; Hartley, CA				Fakhri, Omid; Devlin, Joanne M.; Browning, Glenn F.; Vaz, Paola K.; Thilakarathne, Dulari; Lee, Sang-Won; Hartley, Carol A.			Genomic recombination between infectious laryngotracheitis vaccine strains occurs under a broad range of infection conditions in vitro and in ovo	PLOS ONE			English	Article							HERPES-SIMPLEX-VIRUS; PSEUDORABIES VIRUS; GLYCOPROTEIN-G; SEQUENCE; ALPHAHERPESVIRUSES; EFFICACY; DISEASE; CELLS; EGGS	Gallid alphaherpesvirus 1 causes infectious laryngotracheitis (ILT) in farmed poultry worldwide. Intertypic recombination between vaccine strains of this virus has generated novel and virulent isolates in field conditions. In this study, in vitro and in ovo systems were co-infected and superinfected under different conditions with two genomically distinct and commonly used ILTV vaccines. The progeny virus populations were examined for the frequency and pattern of recombination events using multi-locus high-resolution melting curve analysis of polymerase chain reaction products. A varied level of recombination (0 to 58.9%) was detected, depending on the infection system (in ovo or in vitro), viral load, the composition of the inoculum mixture, and the timing and order of infection. Full genome analysis of selected recombinants with different in vitro phenotypes identified alterations in coding and non-coding regions. The ability of ILTV vaccines to maintain their capacity to recombine under such varied conditions highlights the significance of recombination in the evolution of this virus and demonstrates the capacity of ILTV vaccines to play a role in the emergence of recombinant viruses.	[Fakhri, Omid; Devlin, Joanne M.; Browning, Glenn F.; Vaz, Paola K.; Thilakarathne, Dulari; Lee, Sang-Won; Hartley, Carol A.] Univ Melbourne, Fac Vet & Agr Sci, Asia Pacific Ctr Anim Hlth, Parkville, Vic, Australia; [Lee, Sang-Won] Konkuk Univ, Coll Vet Med, Seoul, South Korea	University of Melbourne; Konkuk University	Fakhri, O (corresponding author), Univ Melbourne, Fac Vet & Agr Sci, Asia Pacific Ctr Anim Hlth, Parkville, Vic, Australia.	omid.fakhri@unimelb.edu.au	Fakhri, Omid/Z-4995-2019; Vaz, Paola/D-8713-2015	Fakhri, Omid/0000-0002-2448-8501; Vaz, Paola/0000-0001-6877-7383; Hartley, Carol/0000-0001-6174-7341	Australian Research Council [DE140100735]	Australian Research Council(Australian Research Council)	SWL received a Discovery Early Career Research Award (DECRA) from the Australian Research Council, award number DE140100735	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; Agnew-Crumpton R, 2016, INFECT GENET EVOL, V43, P67, DOI 10.1016/j.meegid.2016.05.023; ATHERTON SS, 1982, VIROLOGY, V120, P18, DOI 10.1016/0042-6822(82)90003-4; Bensink Z, 1999, VET MICROBIOL, V68, P131, DOI 10.1016/S0378-1135(99)00069-3; CAMPADELLIFIUME G, 1990, J VIROL, V64, P6070, DOI 10.1128/JVI.64.12.6070-6079.1990; CAMPADELLIFIUME G, 1988, J VIROL, V62, P159, DOI 10.1128/JVI.62.1.159-167.1988; Condit R. C., 2013, FIELDS VIROLOGY, P21; Criddle A, 2016, J VIROL, V90, P4049, DOI 10.1128/JVI.00089-16; Davison S, 2006, AVIAN DIS, V50, P50, DOI 10.1637/7398-062105R.1; Devlin JM, 2006, J GEN VIROL, V87, P2839, DOI 10.1099/vir.0.82194-0; Devlin JM, 2007, VACCINE, V25, P3561, DOI 10.1016/j.vaccine.2007.01.080; Dufour-Zavala L, 2008, AVIAN DIS, V52, P1, DOI 10.1637/8018-051007-Review; Esaki M, 2013, AVIAN DIS, V57, P192, DOI 10.1637/10383-092412-Reg.1; Fakhri O, 2018, ARCH VIROLOGY; Fulton RM, 2000, AVIAN DIS, V44, P8, DOI 10.2307/1592502; Garcia M, 2017, VET MICROBIOL, V206, P157, DOI 10.1016/j.vetmic.2016.12.023; GARCIA OG, 2013, DIS POULTRY, P161; GENTRY RF, 1963, AVIAN DIS, V7, P31, DOI 10.2307/1587986; GLAZENBURG KL, 1994, VIRUS RES, V34, P115, DOI 10.1016/0168-1702(94)90094-9; Johnson DI, 2010, AVIAN DIS, V54, P1251, DOI 10.1637/9401-052310-Reg.1; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Kirkpatrick NC, 2006, AVIAN DIS, V50, P28, DOI 10.1637/7414-072205R.1; Lee SW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120282; Lee SW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055121; Lee SW, 2012, SCIENCE, V337, P188, DOI 10.1126/science.1217134; Lole KS, 1999, J VIROL, V73, P152, DOI 10.1128/JVI.73.1.152-160.1999; Loncoman CA, 2018, VACCINE, V36, P5709, DOI 10.1016/j.vaccine.2018.08.012; Loncoman CA, 2017, APPL ENVIRON MICROB, V83, DOI [10.1128/AEM.01532-17, 10.1128/aem.01532-17]; Loncoman CA, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174590; LUKERT PD, 1965, AVIAN DIS, V9, P308, DOI 10.2307/1588016; Luo YZ, 2014, VET MICROBIOL, V174, P107, DOI 10.1016/j.vetmic.2014.09.003; Mahmoudian A, 2012, COMP IMMUNOL MICROB, V35, P103, DOI 10.1016/j.cimid.2011.11.001; Mahmoudian A, 2011, AVIAN PATHOL, V40, P237, DOI 10.1080/03079457.2011.553582; Martin DP, 2015, VIRUS EVOL, V1, DOI 10.1093/ve/vev003; Meurens F, 2004, J VIROL, V78, P9828, DOI 10.1128/JVI.78.18.9828-9836.2004; Meurens F, 2004, J VIROL, V78, P3872, DOI 10.1128/JVI.78.8.3872-3879.2004; Mundt A, 2011, J GEN VIROL, V92, P2586, DOI 10.1099/vir.0.031443-0; Muylkens B, 2009, J VIROL, V83, P3127, DOI 10.1128/JVI.02474-08; SAKAOKA H, 1994, J GEN VIROL, V75, P513, DOI 10.1099/0022-1317-75-3-513; Schneiders GH, 2018, AVIAN DIS; Slomka M, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18112316; Stiles KM, 2008, VIROLOGY, V373, P98, DOI 10.1016/j.virol.2007.11.012; Thilakarathne DS, 2020, J VIROL METHODS, V277, DOI 10.1016/j.jviromet.2019.113797; Thiry E, 2005, REV MED VIROL, V15, P89, DOI 10.1002/rmv.451; Ye C, 2016, VIROLOGY, V491, P56, DOI 10.1016/j.virol.2016.01.016	46	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2020	15	3							e0229082	10.1371/journal.pone.0229082	http://dx.doi.org/10.1371/journal.pone.0229082			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8JT	32119681	Green Published, gold			2022-12-26	WOS:000535245300014
J	Tan, ZY; Zhang, H				Tan, Zhaoyuan; Zhang, Hui			Niche-processes induced differences in plant growth, carbon balance, stress resistance, and regeneration affect community assembly over succession	PLOS ONE			English	Article							SEED MASS; FUNCTIONAL DIVERSITY; TRAITS; GERMINATION; GRADIENT; ECOLOGY; DISTRIBUTIONS; REPRODUCTION; MAINTENANCE; PERFORMANCE	The relationship between plant traits and species relative abundance along environmental gradients can provide important insights on the determinants of community structure. Here we bring extensive data on six key traits (specific leaf area (SLA), seed mass, seed germination rate, height, leaf proline content and photosynthesis rate) to test trait-abundance relationships in a successional chronosequence of subalpine meadow plant communities. Our results show that in late-successional meadows, abundant species had higher values for seed mass, seed germination rate, and SLA, but had lower values for height, photosynthesis rate, and leaf proline content than rarer species. The opposite patterns of trait-abundance relationships were observed for early-successional meadows. Observations of strong trait convergence and divergence in these successional communities lend greater support for niche processes compared to neutral community assembly. We conclude that species' niches that determine plant growth (plant height and photosynthesis rate), carbon balance (SLA, photosynthesis rate), regeneration (seed mass and seed germination rate), and abiotic stress resistance (leaf proline content) under different environmental conditions have strong influence on species relative abundance in these sub-alpine meadow communities during succession.	[Tan, Zhaoyuan; Zhang, Hui] Hainan Univ, Coll Forestry, Wuzhishan Natl Long Term Forest Ecosyst Monitorin, Haikou, Hainan, Peoples R China; [Tan, Zhaoyuan; Zhang, Hui] Hainan Univ, Coll Forestry, Minist Educ, Key Lab Genet & Germplasm Innovat Trop Special Fo, Haikou, Hainan, Peoples R China	Hainan University; Hainan University	Zhang, H (corresponding author), Hainan Univ, Coll Forestry, Wuzhishan Natl Long Term Forest Ecosyst Monitorin, Haikou, Hainan, Peoples R China.; Zhang, H (corresponding author), Hainan Univ, Coll Forestry, Minist Educ, Key Lab Genet & Germplasm Innovat Trop Special Fo, Haikou, Hainan, Peoples R China.	zhanghuitianxia@163.com			Hainan University (KYQD) [(ZR) 1876]	Hainan University (KYQD)	This work was funded by the start-up fund from Hainan University (KYQD (ZR) 1876). Z. Y.T. and H.Z. designed research; Z.Y.T. and H.Z. performed research; H.Z. analysed data; Z.Y.T. and H.Z. wrote the paper.	Adler PB, 2014, P NATL ACAD SCI USA, V111, P10019, DOI 10.1073/pnas.1410430111; Baraloto C, 2005, J ECOL, V93, P1156, DOI 10.1111/j.1365-2745.2005.01041.x; Bhaskar R, 2014, FUNCT ECOL, V28, P1256, DOI 10.1111/1365-2435.12257; Botta-Dukat Z, 2018, COMMUNITY ECOL, V19, P77, DOI 10.1556/168.2018.19.1.8; Botta-Dukat Z, 2016, METHODS ECOL EVOL, V7, P114, DOI 10.1111/2041-210X.12450; Castro J, 1999, NEW PHYTOL, V144, P153, DOI 10.1046/j.1469-8137.1999.00495.x; CHOE HS, 1988, OECOLOGIA, V76, P158, DOI 10.1007/BF00379615; Chu CJ, 2007, ANN BOT-LONDON, V100, P807, DOI 10.1093/aob/mcm166; COHEN D, 1966, J THEOR BIOL, V12, P119, DOI 10.1016/0022-5193(66)90188-3; COMINS HN, 1980, J THEOR BIOL, V82, P205, DOI 10.1016/0022-5193(80)90099-5; Cornwell WK, 2010, J ECOL, V98, P814, DOI 10.1111/j.1365-2745.2010.01662.x; Cornwell WK, 2009, ECOL MONOGR, V79, P109, DOI 10.1890/07-1134.1; de Bello F, 2012, GLOBAL ECOL BIOGEOGR, V21, P312, DOI 10.1111/j.1466-8238.2011.00682.x; FENNER M, 1983, NEW PHYTOL, V95, P697, DOI 10.1111/j.1469-8137.1983.tb03533.x; Garnier E, 2004, ECOLOGY, V85, P2630, DOI 10.1890/03-0799; Gleason HA, 1927, ECOLOGY, V8, P299, DOI 10.2307/1929332; GLEESON SK, 1990, ECOLOGY, V71, P1144, DOI 10.2307/1937382; Gotelli NJ, 2002, ECOLOGY, V83, P2091, DOI 10.2307/3072040; Gravel D, 2006, ECOL LETT, V9, P399, DOI 10.1111/j.1461-0248.2006.00884.x; Hodgson JG, 1999, OIKOS, V85, P282, DOI 10.2307/3546494; Hubbell SP, 2005, FUNCT ECOL, V19, P166, DOI 10.1111/j.0269-8463.2005.00965.x; Hubbell Stephen P., 2001, V32, pi; Kembel SW, 2010, BIOINFORMATICS, V26, P1463, DOI 10.1093/bioinformatics/btq166; Klein JA, 2004, ECOL LETT, V7, P1170, DOI 10.1111/j.1461-0248.2004.00677.x; Kraft NJB, 2008, SCIENCE, V322, P580, DOI 10.1126/science.1160662; Lavorel S, 2002, FUNCT ECOL, V16, P545, DOI 10.1046/j.1365-2435.2002.00664.x; leps, 2006, QUANT INT FUNCT DIV; Levine JM, 2009, NATURE, V461, P254, DOI 10.1038/nature08251; Liu XJ, 2013, FUNCT ECOL, V27, P264, DOI 10.1111/1365-2435.12018; McGill BJ, 2006, TRENDS ECOL EVOL, V21, P178, DOI 10.1016/j.tree.2006.02.002; McGill BJ, 2007, ECOL LETT, V10, P995, DOI 10.1111/j.1461-0248.2007.01094.x; Mittler R, 2010, ANNU REV PLANT BIOL, V61, P443, DOI 10.1146/annurev-arplant-042809-112116; Muller-Landau HC, 2010, P NATL ACAD SCI USA, V107, P4242, DOI 10.1073/pnas.0911637107; Norden N, 2009, FUNCT ECOL, V23, P203, DOI 10.1111/j.1365-2435.2008.01477.x; Pearson TRH, 2002, ECOLOGY, V83, P2798, DOI 10.1890/0012-9658(2002)083[2798:GEONPI]2.0.CO;2; Poorter L, 2006, ECOLOGY, V87, P1733, DOI 10.1890/0012-9658(2006)87[1733:LTAGPO]2.0.CO;2; Prach K, 2011, TRENDS ECOL EVOL, V26, P119, DOI 10.1016/j.tree.2010.12.007; REES M, 1994, AM NAT, V144, P43, DOI 10.1086/285660; Shipley B, 2006, SCIENCE, V314, P812, DOI 10.1126/science.1131344; Szabados L, 2010, TRENDS PLANT SCI, V15, P89, DOI 10.1016/j.tplants.2009.11.009; TILMAN D, 1994, ECOLOGY, V75, P2, DOI 10.2307/1939377; Walker LR, 2010, J ECOL, V98, P725, DOI 10.1111/j.1365-2745.2010.01664.x; WHITTAKER RH, 1979, AM NAT, V113, P185, DOI 10.1086/283378; Zhang HG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038111; Zhang H, 2018, OECOLOGIA, V188, P547, DOI 10.1007/s00442-018-4230-3; Zhang H, 2013, OIKOS, V122, P952, DOI 10.1111/j.1600-0706.2012.20828.x	46	1	1	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2020	15	2							e0229443	10.1371/journal.pone.0229443	http://dx.doi.org/10.1371/journal.pone.0229443			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8HR	32109939	gold, Green Published			2022-12-26	WOS:000535239800012
J	Tejedor, J; Gutierrez-Carmona, FJ				Tejedor, Jaime; Gutierrez-Carmona, Francisco J.			Botulinum toxin in the treatment of partially accommodative esotropia with high AC/A ratio	PLOS ONE			English	Article							PULLEY POSTERIOR FIXATION; DEFINING REAL CHANGE; CONVERGENCE; SURGERY	Purpose To study the outcome of botulinum toxin (BTX) treatment (group 1) in partially accommodative esotropia with high accommodative convergence/accommodation (AC/A) ratio, in comparison with bilateral medial rectus muscles recessions and posterior fixation (group 2). Methods In a retrospective comparative study, children aged 3-8 years old treated between 2011 and 2016, with partially accommodative esotropia with high AC/A ratio, deviation at distance of 10 prism diopters or more, and at least 1 year of follow-up, were included. Visual acuity, alternate prism and cover test, stereoacuity, biomicroscopy, and cycloplegic retinoscopy were carried out at initial, baseline visit, 6 months and 1 year after BTX injection or surgery. Main outcome variables were deviation at distance and near, improvement in stereoacuity, and percentage of success. We used multiple regression or proportional odds analysis to control for potential confounding variables. Results Of 95 patients, 84 were eligible, 48 children in group 1 and 36 in group 2. Deviation and stereoacuity were similar in the two groups at 6 months, but significantly better in the BTX group at 1 year (median distance deviation 0 prism diopters vs 5 prism diopters, p<0.01), although differences were not clinically relevant. Percentage of success was also significantly better only at 1 year (93% vs 72%, p = 0.01). Change in distance-near disparity was not significantly different in the two groups in the period of study. Conclusions Botulinum toxin could be superior to, or as effective as surgery, at middle term, in the treatment of partially accommodative esotropia with high AC/A ratio.	[Tejedor, Jaime; Gutierrez-Carmona, Francisco J.] Hosp Ramon & Cajal, Dept Ophthalmol, Madrid, Spain; [Tejedor, Jaime] Univ Autonoma Madrid, Dept Neurosci, Madrid, Spain; [Gutierrez-Carmona, Francisco J.] Univ Alfonso X El Sabio, Madrid, Spain	Hospital Universitario Ramon y Cajal; Autonomous University of Madrid; Universidad Alfonso X el Sabio (UAX)	Tejedor, J (corresponding author), Hosp Ramon & Cajal, Dept Ophthalmol, Madrid, Spain.; Tejedor, J (corresponding author), Univ Autonoma Madrid, Dept Neurosci, Madrid, Spain.	jaime.tejedor@telefonica.net	Tejedor, Jaime/G-7728-2015	Tejedor Fraile, Jaime/0000-0001-5507-5622	 [MINECO UAMA13-4E2192]		JT received grant MINECO UAMA13-4E2192 The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Adams WE, 2009, OPHTHALMOLOGY, V116, P281, DOI 10.1016/j.ophtha.2008.09.012; American Academy of Ophthalmology, 2014, PED OPHTH STRAB BAS; Clark RA, 2004, AM J OPHTHALMOL, V137, P1026, DOI 10.1016/j.ajo.2004.01.012; DEMER JL, 1995, INVEST OPHTH VIS SCI, V36, P1125; Holmes JM, 2008, AM J OPHTHALMOL, V145, P381, DOI 10.1016/j.ajo.2007.09.012; KUSHNER BJ, 1987, ARCH OPHTHALMOL-CHIC, V105, P815; Kushner BJ, 2001, ARCH OPHTHALMOL-CHIC, V119, P1150, DOI 10.1001/archopht.119.8.1150; Lee HJ, 2017, J AAPOS, V21, P190, DOI 10.1016/j.jaapos.2017.05.009; LEITCH RJ, 1990, BRIT J OPHTHALMOL, V74, P278, DOI 10.1136/bjo.74.5.278; Wabulembo G, 2012, STRABISMUS, V20, P115, DOI 10.3109/09273972.2012.711795; WRIGHT KW, 1993, J PEDIATR OPHTHALMOL, V30, P167	11	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2020	15	2							e0229267	10.1371/journal.pone.0229267	http://dx.doi.org/10.1371/journal.pone.0229267			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8HR	32109950	Green Published, gold			2022-12-26	WOS:000535239800007
J	Liu, YQ; Tang, L; Wang, C; Li, JT				Liu, Yanqing; Tang, Li; Wang, Can; Li, Jinting			NAA and 6-BA promote accumulation of oleanolic acid by JA regulation in Achyranthes bidentata Bl	PLOS ONE			English	Article							TRANSCRIPTIONAL REGULATION; GINSENOSIDE BIOSYNTHESIS; TRITERPENOID SAPONIN; TRANSPORT	Application of plant growth regulators has become one of the most important means of improving yield and quality of medicinal plants. To understand the molecular basis of phytohormone-regulated oleanolic acid metabolism, RNA-seq was used to analyze global gene expression in Achyranthes bidentata treated with 2.0 mg/L 1-naphthaleneacetic acid (NAA) and 1.0 mg/L 6-benzyladenine (6-BA). Compared with untreated controls, the expression levels of 20,896 genes were significantly altered with phytohormone treatment. We found that 13071 (62.5%) unigenes were up-regulated, and a lot of differentially expressed genes involved in hormone or terpenoid biosynthesis, or transcription factors were significantly upregulated. These results suggest that oleanolic acid biosynthesis induced by NAA and 6-BA occurs due to the expression of key genes involved in jasmonic acid signal transduction. This study is the first to analyze the production and hormonal regulation of medicinal A. bidentata metabolites at the molecular level. The results herein contribute to a better understanding of the regulation of oleanane-type triterpenoid saponins accumulation and define strategies to improve the yield of these useful metabolites.	[Liu, Yanqing; Tang, Li; Wang, Can; Li, Jinting] Henan Normal Univ, Coll Life Sci, Xinxiang, Henan, Peoples R China; [Li, Jinting] Engn Lab Biotechnol Green Med Plant Henan Prov, Xinxiang, Henan, Peoples R China	Henan Normal University	Li, JT (corresponding author), Henan Normal Univ, Coll Life Sci, Xinxiang, Henan, Peoples R China.; Li, JT (corresponding author), Engn Lab Biotechnol Green Med Plant Henan Prov, Xinxiang, Henan, Peoples R China.	Ljt66882004@126.com			National Nature Science Foundation of China [81274076]; Key Projects of Henan Province Colleges and Universities [17A180026]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Projects of Henan Province Colleges and Universities	The National Nature Science Foundation of China (81274076) and the Key Projects of Henan Province Colleges and Universities (17A180026).	Afrin S, 2015, SCI BULL, V60, P1062, DOI 10.1007/s11434-015-0813-0; Alsoufi ASM, 2019, PHYTOCHEM LETT, V31, P5, DOI 10.1016/j.phytol.2019.02.030; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Botta B, 2005, TRENDS PHARMACOL SCI, V26, P606, DOI 10.1016/j.tips.2005.09.012; Boyle EI, 2004, BIOINFORMATICS, V20, P3710, DOI 10.1093/bioinformatics/bth456; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Cao HZ, 2015, INT J MOL SCI, V16, P3035, DOI 10.3390/ijms16023035; Carelli M, 2011, PLANT CELL, V23, P3070, DOI 10.1105/tpc.111.087312; Chen J, 2015, BMC GENOMICS, V16, DOI 10.1186/1471-2164-16-S7-S15; Chen QC, 2016, INT J GENOMICS, V2016, DOI 10.1155/2016/7840914; Chen QH, 2009, IMMUNOPHARM IMMUNOT, V31, P253, DOI 10.1080/08923970802439795; Cheng Jian, 2014, Zhongguo Zhong Yao Za Zhi, V39, P1502; Fukushima EO, 2011, PLANT CELL PHYSIOL, V52, P2050, DOI 10.1093/pcp/pcr146; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Han JY, 2013, PLANT CELL PHYSIOL, V54, P2034, DOI 10.1093/pcp/pct141; Han SB, 2005, ARCH PHARM RES, V28, P902, DOI 10.1007/BF02973875; Han X, 2017, J JIANGHAN U, V45, P323; Heide L, 2009, CURR OPIN CHEM BIOL, V13, P171, DOI 10.1016/j.cbpa.2009.02.020; Hwang HS, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1357-z; Karp PD, 2016, BRIEF BIOINFORM, V17, P877, DOI 10.1093/bib/bbv079; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Li JT, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01860; Li JT, 2009, J INTEGR PLANT BIOL, V51, P122, DOI 10.1111/j.1744-7909.2008.00764.x; [李金亭 LI Jinting], 2006, [中草药, Chinese Traditional and Herbal Drugs], V37, P952; Li JT, 2015, GUIHAIA, V35; Li J, 2016, PROG SOLID STATE CH, V44, P107, DOI 10.1016/j.progsolidstchem.2016.11.001; Li JX, 2005, PLANTA MED, V71, P673, DOI 10.1055/s-2005-871275; Liao YL, 2016, PLANT MOL BIOL REP, V34, P566, DOI 10.1007/s11105-015-0947-x; Lichtenthaler H., 1983, BIOCHEM SOC T, V11, P591, DOI [10.1042/bst0110591, 10.1042/BST0110591, DOI 10.1042/BST0110591]; Liu TT, 2017, BIORESOURCE TECHNOL, V232, P44, DOI 10.1016/j.biortech.2017.02.004; [吕桂珍 Lv Guizhen], 2013, [河南农业大学学报, Journal of Henan Agricultural University], V47, P256; Ma CH, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00673; Ma L, 2016, CENTRAL S PHARM, V14, P834; Mazumdar AB, 2016, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.01199; Memelink J, 2009, PHYTOCHEMISTRY, V70, P1560, DOI 10.1016/j.phytochem.2009.09.004; Mertens J, 2016, PLANT CELL PHYSIOL, V57, P2564, DOI 10.1093/pcp/pcw168; Mertens J, 2016, PLANT PHYSIOL, V170, P194, DOI 10.1104/pp.15.01645; Miettinen K, 2018, NUCLEIC ACIDS RES, V46, pD586, DOI 10.1093/nar/gkx925; Miettinen K, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14153; Patra B, 2013, BBA-GENE REGUL MECH, V1829, P1236, DOI 10.1016/j.bbagrm.2013.09.006; Pollier J, 2012, PHYTOCHEMISTRY, V77, P10, DOI 10.1016/j.phytochem.2011.12.022; Powell C, 2010, AUTOIMMUN REV, V9, P721, DOI 10.1016/j.autrev.2010.06.007; Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219; Rai A, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00481; Sage RF, 2007, AM J BOT, V94, P1992, DOI 10.3732/ajb.94.12.1992; Sun JQ, 2009, PLANT CELL, V21, P1495, DOI 10.1105/tpc.108.064303; Wang J, 2016, SCI REP-UK, V6, DOI 10.1038/srep37263; Wasternack C, 2013, ANN BOT-LONDON, V111, P1021, DOI 10.1093/aob/mct067; [徐立新 Xu Lixin], 2010, [吉林大学学报. 工学版, Journal of Jilin University. Engineering and Technology Edition], V40, P1619; Zhan CS, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01094; ZHANG JX, 1995, PLANT PHYSIOL BIOCH, V33, P567; Zhang SP, 2015, BIOCHEM BIOPH RES CO, V466, P450, DOI 10.1016/j.bbrc.2015.09.048; Zheng Y, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-453	55	0	1	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2020	15	2							e0229490	10.1371/journal.pone.0229490	http://dx.doi.org/10.1371/journal.pone.0229490			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8GQ	32107496	Green Published, gold			2022-12-26	WOS:000535237000034
J	Hohmann, T; Kessler, J; Vordermark, D; Dehghani, F				Hohmann, Tim; Kessler, Jacqueline; Vordermark, Dirk; Dehghani, Faramarz			Evaluation of machine learning models for automatic detection of DNA double strand breaks after irradiation using a gamma H2AX foci assay	PLOS ONE			English	Article							HISTONE H2AX; DOSE-RESPONSE; HIGH-LET; RADIATION; REPAIR; QUANTIFICATION; DAMAGE; PROTEINS	Ionizing radiation induces amongst other the most critical type of DNA damage: double-strand breaks (DSBs). Efficient repair of such damage is crucial for cell survival and genomic stability. The analysis of DSB associated foci assays is often performed manually or with automatic systems. Manual evaluation is time consuming and subjective, while most automatic approaches are prone to changes in experimental conditions or to image artefacts. Here, we examined multiple machine learning models, namely a multi-layer perceptron classifier (MLP), linear support vector machine classifier (SVM), complement naive bayes classifier (cNB) and random forest classifier (RF), to correctly classify gamma H2AX foci in manually labeled images containing multiple types of artefacts. All models yielded reasonable agreements to the manual rating on the training images (Matthews correlation coefficient > 0.4). Afterwards, the best performing models were applied on images obtained under different experimental conditions. Thereby, the MLP model produced the best results with an F1 Score > 0.9. As a consequence, we have demonstrated that the used approach is sufficient to mimic manual counting and is robust against image artefacts and changes in experimental conditions.	[Hohmann, Tim; Dehghani, Faramarz] Martin Luther Univ Halle Wittenberg, Inst Anat & Cell Biol, Halle, Germany; [Kessler, Jacqueline; Vordermark, Dirk] Martin Luther Univ Halle Wittenberg, Dept Radiotherapy, Halle, Germany	Martin Luther University Halle Wittenberg; Martin Luther University Halle Wittenberg	Hohmann, T (corresponding author), Martin Luther Univ Halle Wittenberg, Inst Anat & Cell Biol, Halle, Germany.	tim.hohmann@medizin.uni-halle.de			German Research Foundation (DFG)	German Research Foundation (DFG)(German Research Foundation (DFG))	T.H. received funding from the German Research Foundation (DFG) for Open Access Publishing.; We acknowledge the financial support within the funding program Open Access Publishing by the German Research Foundation (DFG).	Boker W, 2006, RADIAT RES, V165, P113, DOI 10.1667/RR3486.1; Brand M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127142; Cai ZL, 2009, INT J RADIAT BIOL, V85, P262, DOI 10.1080/09553000902748757; Carpenter AE, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r100; Costes SV, 2006, RADIAT RES, V165, P505, DOI 10.1667/RR3538.1; Herbert AD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114749; Hohmann T, 2018, HISTOL HISTOPATHOL, V33, P475, DOI 10.14670/HH-11-945; Hohmann T, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18092001; Hou YN, 2009, RADIAT RES, V171, P360, DOI 10.1667/RR1349.1; Ivashkevich AN, 2011, MUTAT RES-FUND MOL M, V711, P49, DOI 10.1016/j.mrfmmm.2010.12.015; Jucha A, 2010, MUTAT RES-GEN TOX EN, V696, P16, DOI 10.1016/j.mrgentox.2009.12.004; Kessler J, 2015, RADIOTHER ONCOL, V116, P381, DOI 10.1016/j.radonc.2015.08.007; Leatherbarrow EL, 2006, INT J RADIAT BIOL, V82, P111, DOI 10.1080/09553000600599783; Lengert N, 2018, SCI REP, V8, P1, DOI [10.1038/s41598-017-17765-5, DOI 10.1038/S41598-017-17765-5]; MacPhail SH, 2003, INT J RADIAT BIOL, V79, P351, DOI 10.1080/0955300032000093128; Mahrhofer H, 2006, INT J RADIAT ONCOL, V64, P573, DOI 10.1016/j.ijrobp.2005.09.037; Markova E, 2007, INT J RADIAT BIOL, V83, P319, DOI 10.1080/09553000601170469; MATTHEWS BW, 1975, BIOCHIM BIOPHYS ACTA, V405, P442, DOI 10.1016/0005-2795(75)90109-9; McVean Andrew, 2012, Genome Integr, V3, P1, DOI 10.1186/2041-9414-3-1; Nagy Z, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1005791; Neumaier T, 2012, P NATL ACAD SCI USA, V109, P443, DOI 10.1073/pnas.1117849108; Powers D. M, 2011, ARXIV201016061; Qvarnstrom OF, 2004, RADIOTHER ONCOL, V72, P311, DOI 10.1016/j.radonc.2004.07.009; Riballo E, 2004, MOL CELL, V16, P715, DOI 10.1016/j.molcel.2004.10.029; Roch-Lefevre S, 2010, RADIAT RES, V174, P185, DOI 10.1667/RR1775.1; Rodrigue A, 2006, EMBO J, V25, P222, DOI 10.1038/sj.emboj.7600914; Rogakou EP, 1999, J CELL BIOL, V146, P905, DOI 10.1083/jcb.146.5.905; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; Rothkamm K, 2013, MUTAT RES-GEN TOX EN, V756, P170, DOI 10.1016/j.mrgentox.2013.04.012; Runge R, 2012, INT J RADIAT BIOL, V88, P439, DOI 10.3109/09553002.2012.658468; Sancar A, 2004, ANNU REV BIOCHEM, V73, P39, DOI 10.1146/annurev.biochem.73.011303.073723; Sedelnikova OA, 2002, RADIAT RES, V158, P486, DOI 10.1667/0033-7587(2002)158[0486:QDOIID]2.0.CO;2; Suzuki K, 2003, ONCOGENE, V22, P6988, DOI 10.1038/sj.onc.1206881; van Gent DC, 2001, NAT REV GENET, V2, P196, DOI 10.1038/35056049; Vandevoorde C, 2015, EUR RADIOL, V25, P800, DOI 10.1007/s00330-014-3463-8; Weichsel J, 2010, CYTOM PART A, V77A, P52, DOI 10.1002/cyto.a.20818	36	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2020	15	2							e0229620	10.1371/journal.pone.0229620	http://dx.doi.org/10.1371/journal.pone.0229620			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8FM	32101565	gold, Green Published			2022-12-26	WOS:000535233700045
J	Takashima, Y; Kawaguchi, A; Lwadate, Y; Hondoh, H; Fukai, J; Kajiwara, K; Hayano, A; Yamanaka, R				Takashima, Yasuo; Kawaguchi, Atsushi; Lwadate, Yasuo; Hondoh, Hiroaki; Fukai, Junya; Kajiwara, Koji; Hayano, Azusa; Yamanaka, Ryuya			miR-101, miR-548b, miR-554, and miR-1202 are reliable prognosis predictors of the miRNAs associated with cancer immunity in primary central nervous system lymphoma	PLOS ONE			English	Article							HEPATOCELLULAR-CARCINOMA; PRIMARY CNS; RNA INTERFERENCE; PD-1 BLOCKADE; EXPRESSION; MICRORNA; BIOMARKERS; GENE; NIVOLUMAB; LIGANDS	MicroRNAs (miRNAs) inhibit protein function by silencing the translation of target mRNAs. However, in primary central nervous system lymphoma (PCNSL), the expression and functions of miRNAs are inadequately known. Here, we examined the expression of 847 miRNAs in 40 PCNSL patients with a microarray and investigated for the miRNA predictors associated with cancer immunity-related genes such as T helper cell type 1/2 (Th-1/Th-2) and regulatory T cell (T-reg) status, and stimulatory and inhibitory checkpoint genes, for prognosis prediction in PCNSL. The aim of this study is to find promising prognosis markers based on the miRNA expression in PCNSL. We detected 334 miRNAs related to 66 cancer immunity-related genes in the microarray profiling. Variable importance measured by the random survival forest analysis and Cox proportional hazards regression model elucidated that 11 miRNAs successfully constitute the survival formulae dividing the Kaplan-Meier curve of the respective PCNSL subgroups. On the other hand, univariate analysis shortlisted 23 miRNAs for overall survival times, with four miRNAs clearly dividing the survival curves-miR-101/548b/554/1202. These miRNAs regulated Th-1/Th-2 status, T-reg cell status, and immune checkpoints. The miRNAs were also associated with gene ontology terms as Ras/MAP-kinase, ubiquitin ligase, PRC2 and acetylation, CDK, and phosphorylation, and several diseases including acquired immunodeficiency syndrome, glioma, and those related to blood and hippocampus with statistical significance. In conclusion, the results demonstrated that the four miRNAs comprising miR-101/548b/554/1202 associated with cancer immunity can be a useful prognostic marker in PCNSL and would help us understand target pathways for PCNSL treatments.	[Takashima, Yasuo; Hayano, Azusa; Yamanaka, Ryuya] Kyoto Prefectural Univ Med, Grad Sch Med Sci, Lab Mol Target Therapy Canc, Kyoto, Japan; [Kawaguchi, Atsushi] Saga Univ, Fac Med, Ctr Comprehens Community Med, Saga, Japan; [Lwadate, Yasuo] Chiba Univ, Grad Sch Med Sci, Dept Neurosurg, Chiba, Japan; [Hondoh, Hiroaki] Toyama Prefectural Cent Hosp, Dept Neurosurg, Toyama, Japan; [Fukai, Junya] Wakayama Med Univ, Dept Neurol Surg, Sch Med, Wakayama, Japan; [Kajiwara, Koji] Yamaguchi Univ, Grad Sch Med Sci, Dept Neurosurg, Ube, Yamaguchi, Japan	Kyoto Prefectural University of Medicine; Saga University; Chiba University; Wakayama Medical University; Yamaguchi University	Yamanaka, R (corresponding author), Kyoto Prefectural Univ Med, Grad Sch Med Sci, Lab Mol Target Therapy Canc, Kyoto, Japan.	ryaman@koto.kpu-m.ac.jp		Yamanaka, Ryuya/0000-0003-2941-7996; Takashima, Yasuo/0000-0001-8876-6673	MEXT KAKENHI [16H05441, 18K09001]	MEXT KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	The study was supported the MEXT KAKENHI Grant Numbers 16H05441 and 18K09001. There was no additional external funding received for this study.	Ahmadvand M, 2018, LEUKEMIA RES, V70, P45, DOI 10.1016/j.leukres.2018.05.006; [Anonymous], 2016, PRIMARY CENTRAL NERV; Ansell SM, 2015, NEW ENGL J MED, V372, P311, DOI 10.1056/NEJMoa1411087; Ansell SM, 2009, CLIN CANCER RES, V15, P6446, DOI 10.1158/1078-0432.CCR-09-1339; Baraniskin A, 2018, J NEURO-ONCOL, V137, P463, DOI 10.1007/s11060-018-2749-0; Batlevi CL, 2016, NAT REV CLIN ONCOL, V13, P25, DOI 10.1038/nrclinonc.2015.187; Berghoff AS, 2014, CLIN NEUROPATHOL, V33, P42, DOI 10.5414/NP300698; Chen H, 2017, ONCOL REP, V37, P3493, DOI 10.3892/or.2017.5596; Cho H, 2017, ONCOTARGET, V8, P87317, DOI 10.18632/oncotarget.20264; Du B, 2017, BIOMED PHARMACOTHER, V96, P1246, DOI 10.1016/j.biopha.2017.11.090; Fang C, 2012, ANN HEMATOL, V91, P553, DOI 10.1007/s00277-011-1350-9; Fischer L, 2011, NEURO-ONCOLOGY, V13, P1090, DOI 10.1093/neuonc/nor107; Giza DE, 2015, ADV EXP MED BIOL, V889, P23, DOI 10.1007/978-3-319-23730-5_2; Hayano A, 2017, ANTICANCER RES, V37, P5655, DOI 10.21873/anticanres.12001; Huang YQ, 2019, CANCER MANAG RES, V11, P2739, DOI 10.2147/CMAR.S197744; Illerhaus G, 2018, BLOOD, V132, P681, DOI 10.1182/blood-2018-01-791558; Iwadate Y, 2014, J NEURO-ONCOL, V117, P261, DOI 10.1007/s11060-014-1379-4; Kawaguchi A, 2012, CLIN CANCER RES, V18, P5672, DOI 10.1158/1078-0432.CCR-12-0596; Khare D, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0187722; Leivonen SK, 2017, BLOOD CANCER J, V7, DOI 10.1038/s41408-017-0033-8; Lin CZ, 2020, LASER MED SCI, V35, P1085, DOI 10.1007/s10103-019-02892-4; Lopez JP, 2014, NAT MED, V20, P764, DOI 10.1038/nm.3582; Louis DN, 2016, ACTA NEUROPATHOL, V131, P803, DOI 10.1007/s00401-016-1545-1; Ma C, 2017, J CLIN EXP HEMATOP, V57, P21, DOI 10.3960/jslrt.17006; Miyasato Y, 2018, J CLIN EXP HEMATOP, V58, P95, DOI 10.3960/jslrt.18001; Moss EG, 2001, CURR BIOL, V11, pR772, DOI 10.1016/S0960-9822(01)00467-5; Nayak L, 2017, BLOOD, V129, P3071, DOI 10.1182/blood-2017-01-764209; Ni XF, 2018, NEOPLASMA, V65, P881, DOI 10.4149/neo_2018_171206N803; Pan Y, 2016, NEUROREPORT, P27; Pillar N, 2017, ONCOTARGET, V8, P86020, DOI 10.18632/oncotarget.20902; Qiu HL, 2019, EXP THER MED, V18, P2332, DOI 10.3892/etm.2019.7812; Quan Y, 2017, TUMOR BIOL, V39, DOI 10.1177/1010428317697565; Rao P, 2013, FRONT MOL NEUROSCI, V6, DOI 10.3389/fnmol.2013.00039; Ricard D, 2012, LANCET, V379, P1984, DOI 10.1016/S0140-6736(11)61346-9; Roehle A, 2008, BRIT J HAEMATOL, V142, P732, DOI 10.1111/j.1365-2141.2008.07237.x; Roth P, 2015, EUR J CANCER, V51, P382, DOI 10.1016/j.ejca.2014.10.028; Saffari M, 2019, UROL J, V16, P267, DOI 10.22037/uj.v0i0.4564; Shalaby T, 2015, INT J MOL SCI, V16, P29103, DOI 10.3390/ijms161226150; Sharma P, 2017, CELL, V168, P707, DOI 10.1016/j.cell.2017.01.017; Shi YF, 2015, BIOMED PHARMACOTHER, V75, P111, DOI 10.1016/j.biopha.2015.07.027; Tabara H, 1999, CELL, V99, P123, DOI 10.1016/S0092-8674(00)81644-X; Takashima Y, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0216825; Takashima Y, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0210400; Takashima Y, 2018, CANCER SCI, V109, P3543, DOI 10.1111/cas.13798; Takashima Yasuo, 2018, Oncotarget, V9, P27471, DOI 10.18632/oncotarget.25463; Takashima Yasuo, 2018, Oncotarget, V9, P19065, DOI 10.18632/oncotarget.24897; Takashima Y, 2016, HEPATOLOGY, V64, P245, DOI 10.1002/hep.28548; Thyagarajan A, 2018, J PHARMACOL EXP THER, V364, P1, DOI 10.1124/jpet.117.242636; Ultimo S, 2018, J CELL PHYSIOL, V233, P5642, DOI 10.1002/jcp.26290; Wei D, 2015, MOL NEUROBIOL, V51, P1452, DOI 10.1007/s12035-014-8822-6; Whelan JT, 2012, J CELL PHYSIOL, V227, P1235, DOI 10.1002/jcp.22899; Yamada S, 2014, HEPATOL RES, V44, P837, DOI 10.1111/hepr.12192; Yao YL, 2015, CNS NEUROSCI THER, V21, P40, DOI 10.1111/cns.12321; Yun ZN, 2019, CANCER MANAG RES, V11, P5821, DOI 10.2147/CMAR.S198615	54	9	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2020	15	2							e0229577	10.1371/journal.pone.0229577	http://dx.doi.org/10.1371/journal.pone.0229577			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8FM	32101576	gold, Green Submitted, Green Published			2022-12-26	WOS:000535233700043
J	Yang, T; Li, RZ; Liang, N; Li, J; Yang, Y; Huang, Q; Li, YD; Cao, W; Wang, Q; Zhang, HX				Yang, Tao; Li, Renzhi; Liang, Ning; Li, Jing; Yang, Yi; Huang, Qian; Li, Yuedan; Cao, Wei; Wang, Qian; Zhang, Hongxin			The application of key feature extraction algorithm based on Gabor wavelet transformation in the diagnosis of lumbar intervertebral disc degenerative changes	PLOS ONE			English	Article								Objective Based on the theoretical basis of Gabor wavelet transformation, the application effects of feature extraction algorithm in Magnetic Resonance Imaging (MRI) and the role of feature extraction algorithm in the diagnosis of lumbar vertebra degenerative diseases were explored. Method The structure of lumbar vertebra and degenerative changes were respectively introduced to clarify the onset mechanism and pathological changes of lumbar vertebra degenerative changes. Most importantly, the theoretical basis of Gabor wavelet transformation and the extraction effect of feature information in lumbar vertebra MRI images were introduced. The differentiation effects of feature information extraction algorithm on annulus fibrosus and nucleus pulposus were analyzed. In this study, the data of lumbar spine MRI was randomly selected from the Wenzhou Lumbar Spine Research Database as research objects. A total of 130 discs were successfully fitted, and 109 images were graded by a doctor after observation, which was compared with the results of the artificial diagnosis. Through the comparison with the results of observation and diagnosis by professional doctors, the accuracy of feature extraction algorithm based on Gabor wavelet transformation in the diagnosis of lumbar vertebra degenerative changes was analyzed. Results 1. Compared with the results of the manual diagnosis, the accuracy of the classification method was 88.3%. In addition, the specificity (SPE), accuracy (ACC), and sensitivity (SEN) of the classification method were respectively 89.5%, 92.4%, and 87.6%. 2. The mutual information method and the KLT algorithm were utilized for vertebral body tracking. The maximum mutual information method was more effective in the case of fewer image sequences; however, with the increase of image frames, the accumulation of errors would make the tracking effects of images get worse. Based on the KLT algorithm, the enhanced vertebral boundary information was selected; the soft tissues showed in the obtained images were smooth, the boundary information of vertebral body was enhanced, and the results were more accurate. Conclusion The feature extraction algorithm based on Gabor wavelet transformation could easily and quickly realize the localization of the lumbar intervertebral disc, and the accuracy of the results was ensured. In addition, from the aspect of vertebral body tracking, the tracking effects based on the KLT algorithm were better and faster than those based on the maximum mutual information method.	[Yang, Tao; Yang, Yi; Cao, Wei; Zhang, Hongxin] Fourth Mil Med Univ, Tangdu Hosp, Dept Pain Treatment, Xian, Peoples R China; [Li, Renzhi] Chinese Peoples Liberat Army, Troops 31638, Kunming, Yunnan, Peoples R China; [Li, Renzhi] 75th Grp Army Hosp, Dept Radiol, Dali, Peoples R China; [Liang, Ning] 75th Grp Army Hosp, Dept Gen Surg, Dali, Peoples R China; [Li, Jing] Xi An Jiao Tong Univ, Coll & Hosp Stomatol, Xian, Peoples R China; [Huang, Qian] 75th Grp Army Hosp, Dept Obstet & Gynecol, Dali, Peoples R China; [Li, Yuedan] Gen Hosp Cent Theater Command, Dept Pharm, Wuhan, Peoples R China; [Wang, Qian] Zhengzhou Univ, Dept Anorectal Surg, Affiliated Hosp 1, Zhengzhou, Peoples R China	Air Force Military Medical University; Xi'an Jiaotong University; Zhengzhou University	Zhang, HX (corresponding author), Fourth Mil Med Univ, Tangdu Hosp, Dept Pain Treatment, Xian, Peoples R China.; Wang, Q (corresponding author), Zhengzhou Univ, Dept Anorectal Surg, Affiliated Hosp 1, Zhengzhou, Peoples R China.	1211072068@qq.com; zhhxtdjr@163.com			National Natural Science Foundation of China [81572304, 81600478]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (grants 81572304, 81600478).	Bates NM, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-23604-y; Duran S, 2017, CAN ASSOC RADIOL J, V68, P210, DOI 10.1016/j.carj.2016.11.002; Griffith JF, 2007, SPINE, V32, pE708, DOI 10.1097/BRS.0b013e31815a59a0; Gu T, 2017, J ORTHOP RES, V35, P1311, DOI 10.1002/jor.22995; Jinho L, 2017, EVID-BASED COMPL ALT, V2017, P1; Koichiro M, 2018, BMC MUSCULOSKEL DIS, V19, P164, DOI [10.1186/s12891-018-2086-7, DOI 10.1186/S12891-018-2086-7]; Li H, 2017, J ORTHOP SURG RES, V12, DOI 10.1186/s13018-017-0669-x; Liang J., 2016, P SIVP, V10, P1441; Ou X, 2016, INT J COSMETIC SCI, V38, P607, DOI 10.1111/ics.12332; Paholpak P, 2018, EUR J RADIOL, V98, P193, DOI 10.1016/j.ejrad.2017.11.023; Rodriguez-Soto Ana E., 2017, ERGONOMICS, V60, P1; Shokri E, 2018, CHIROPR MAN THER, V26, DOI 10.1186/s12998-018-0185-z; Soltani Bozchalooi I, 2018, J SOUND VIBRATION, V420, P393; Sun Zheng-Ming, 2017, Nan Fang Yi Ke Da Xue Xue Bao, V37, P983; Tetsuhiro I, 2018, ASIAN SPINE J, V12, P317, DOI [10.4184/asj.2018.12.2.317, DOI 10.4184/ASJ.2018.12.2.317]; Torrents-Barrena J, 2016, J EXP THEOR ARTIF IN, V28, P295, DOI 10.1080/0952813X.2015.1024491; Tschugg A, 2017, NEUROSURG REV, V40, P597, DOI 10.1007/s10143-017-0811-6; Ul Haq I, 2016, IEEE ENG MED BIO, P3883, DOI 10.1109/EMBC.2016.7591576; Wang CY, 2016, MAR POLLUT BULL, V104, P322, DOI 10.1016/j.marpolbul.2016.01.001; Wang D, 2017, J SOUND VIB, V395, P393, DOI 10.1016/j.jsv.2017.02.013; Wang J Q, 2017, SPINE, V43, P1; Wang W, 2017, EXP THER MED, V14, P2078, DOI 10.3892/etm.2017.4786; Xiao L, 2017, MED SCI MONITOR, V23, P4932, DOI 10.12659/MSM.904315; Xiong XQ, 2018, AM J TRANSL RES, V10, P444	24	7	7	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2020	15	2							e0227894	10.1371/journal.pone.0227894	http://dx.doi.org/10.1371/journal.pone.0227894			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8FM	32101549	Green Published, gold			2022-12-26	WOS:000535233700008
J	Suemoto, CK; Gibbons, LE; Thacker, EL; Jackson, JD; Satizabal, CL; Bettcher, BM; Launer, L; Phillips, C; White, LR; Power, MC				Suemoto, Claudia K.; Gibbons, Laura E.; Thacker, Evan L.; Jackson, Jonathan D.; Satizabal, Claudia L.; Bettcher, Brianne M.; Launer, Lenore; Phillips, Caroline; White, Lon R.; Power, Melinda C.			Incident prolonged QT interval in midlife and late-life cognitive performance	PLOS ONE			English	Article							VASCULAR RISK-FACTORS; MARGINAL STRUCTURAL MODELS; MINI-MENTAL STATE; BODY-MASS INDEX; ALZHEIMERS-DISEASE; BLOOD-PRESSURE; HEART-RATE; DEMENTIA; IMPAIRMENT; STROKE	Background Measures of cardiac ventricular electrophysiology have been associated with cognitive performance in cross-sectional studies. We sought to evaluate the association of worsening ventricular repolarization in midlife, as measured by incident prolonged QT interval, with cognitive decline in late life. Methods Midlife QT interval was assessed by electrocardiography during three study visits from 1965/68 to 1971/74 in a cohort of Japanese American men aged 46-68 at Exam 1 from the Honolulu Heart Study. We defined incident prolonged QT as the QT interval in the upper quartile at Exam 2 or 3 after QT interval in lower three quartiles at Exam 1. Cognitive performance was assessed at least once using the Cognitive Abilities Screening Instrument (CASI), scored using item response theory (CASI-IRT), during four subsequent visits from 1991/93 to 1999/2000 among 2,511 of the 4,737 men in the Honolulu-Asia Aging Study otherwise eligible for inclusion in analyses. We used marginal structural modeling to determine the association of incident prolonged QT with cognitive decline, using weighting to account for confounding and attrition. Results Incident prolonged QT interval in midlife was not associated with late-life CASI-IRT at cognitive baseline (estimated difference in CASI-IRT: 0.04; 95% CI: -0.28, 0.35; p = 0.81), or change in CASI-IRT over time (estimated difference in annual change in CASI-IRT: -0.002; 95%CI: -0.013, 0.010; p = 0.79). Findings were consistent across sensitivity analyses. Conclusions Although many midlife cardiovascular risk factors and cardiac structure and function measures are associated with late-life cognitive decline, incident prolonged QT interval in midlife was not associated with late-life cognitive performance or cognitive decline.	[Suemoto, Claudia K.] Univ Sao Paulo, Div Geriatr, Med Sch, Sao Paulo, Brazil; [Gibbons, Laura E.] Univ Washington, Harborview Med Ctr, 325 9Th Ave, Seattle, WA 98104 USA; [Thacker, Evan L.] Brigham Young Univ, Dept Publ Hlth, Provo, UT 84602 USA; [Jackson, Jonathan D.] Harvard Med Sch, Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02115 USA; [Satizabal, Claudia L.] Boston Univ, Sch Med, Dept Neurol, Boston, MA 02118 USA; [Satizabal, Claudia L.] UT Hlth San Antonio, San Antonio, TX USA; [Bettcher, Brianne M.] Univ Colorado, Anschutz Sch Med, Rocky Mt Alzheimers Dis Ctr, Dept Neurosurg & Neurol, Aurora, CO USA; [Launer, Lenore; Phillips, Caroline] NIA, Bethesda, MD 20892 USA; [White, Lon R.] Univ Hawaii, John A Burns Sch Med, Dept Med, Honolulu, HI 96822 USA; [White, Lon R.] Univ Hawaii, John A Burns Sch Med, Dept Geriatr, Honolulu, HI 96822 USA; [Power, Melinda C.] George Washington Univ, Milken Inst Publ Hlth, Dept Epidemiol & Biostat, Washington, DC USA	Universidade de Sao Paulo; Harborview Medical Center; University of Washington; University of Washington Seattle; Brigham Young University; Harvard University; Harvard Medical School; Massachusetts General Hospital; Boston University; University of Texas System; University of Texas Health San Antonio; University of Colorado System; University of Colorado Anschutz Medical Campus; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); University of Hawaii System; University of Hawaii System; George Washington University	Suemoto, CK (corresponding author), Univ Sao Paulo, Div Geriatr, Med Sch, Sao Paulo, Brazil.	cksuemoto@usp.br	Suemoto, Claudia K/C-7218-2012	Suemoto, Claudia K/0000-0002-5942-4778	NIH [R13 AG030995, P01 AG036694-08S1, P50 AG05136]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	These analyses were conceived and begun by a working group at the 2016 Conference on Advanced Psychometric Methods in Cognitive Aging funded by the NIH (R13 AG030995) to Dan Mungus (PI). JDJ was supported by P01 AG036694-08S1 to Sperling, LEG was supported by P50 AG05136 to Grabowski from NIH.	Alzheimer's A., 2017, ALZHEIMERS DEMENT, V13, P325, DOI DOI 10.1016/J.JALZ.2017.02.001; Anstey KJ, 2011, OBES REV, V12, pe426, DOI 10.1111/j.1467-789X.2010.00825.x; Cole SR, 2008, AM J EPIDEMIOL, V168, P656, DOI 10.1093/aje/kwn164; Coppola L, 2013, INT J GERIATR PSYCH, V28, P632, DOI 10.1002/gps.3870; Crane PK, 2008, J CLIN EPIDEMIOL, V61, P1018, DOI 10.1016/j.jclinepi.2007.11.011; De Ponti F, 2000, LANCET, V356, P75, DOI 10.1016/S0140-6736(05)73412-7; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Fumagalli S, 2016, INT J CARDIOL, V219, P212, DOI 10.1016/j.ijcard.2016.06.001; Furuang L, 2013, BMC GERIATR, V13, DOI 10.1186/1471-2318-13-45; Gibbons LE, 2009, INT PSYCHOGERIATR, V21, P129, DOI 10.1017/S1041610208007862; Gorelick PB, 2011, STROKE, V42, P2672, DOI 10.1161/STR.0b013e3182299496; Hasegawa K., 1983, AGING EIGHTIES, P207; Hernan MA, 2000, EPIDEMIOLOGY, V11, P561, DOI 10.1097/00001648-200009000-00012; Hoth KF, 2010, J CARDIOPULM REHABIL, V30, P401, DOI 10.1097/HCR.0b013e3181e1739a; Iadecola C, 2003, STROKE, V34, P335, DOI 10.1161/01.STR.0000054050.51530.76; Ishikawa J, 2015, HYPERTENSION, V65, P554, DOI 10.1161/HYPERTENSIONAHA.114.04722; Jefferson AL, 2011, AM J CARDIOL, V108, P1346, DOI 10.1016/j.amjcard.2011.06.056; Kimm H, 2011, ARCH GERONTOL GERIAT, V52, pE117, DOI 10.1016/j.archger.2010.09.004; Kivipelto M, 2001, BMJ-BRIT MED J, V322, P1447, DOI 10.1136/bmj.322.7300.1447; Kivipelto M, 2005, ARCH NEUROL-CHICAGO, V62, P1556, DOI 10.1001/archneur.62.10.1556; Kochanek K. D., 2014, MORTALITY US 2013; LAUNER LJ, 1995, JAMA-J AM MED ASSOC, V274, P1846, DOI 10.1001/jama.274.23.1846; LEPESCHKIN E, 1952, CIRCULATION, V6, P378, DOI 10.1161/01.CIR.6.3.378; Lucas BP, 2010, AM J CARDIOL, V106, P1169, DOI 10.1016/j.amjcard.2010.06.031; Murray CJL, 2013, JAMA-J AM MED ASSOC, V310, P591, DOI 10.1001/jama.2013.13805; Nachimuthu S, 2012, THER ADV DRUG SAF, V3, P241, DOI 10.1177/2042098612454283; Ninomiya T, 2011, HYPERTENSION, V58, P22, DOI 10.1161/HYPERTENSIONAHA.110.163055; O'Neal WT, 2015, CLIN RES CARDIOL, V104, P743, DOI 10.1007/s00392-015-0838-z; Petrovitch H, 2005, ANN NEUROL, V57, P98, DOI 10.1002/ana.20318; Power MC, 2013, EPIDEMIOLOGY, V24, P886, DOI 10.1097/EDE.0b013e3182a7121c; Rautaharju PM, 2002, J CARDIOVASC ELECTR, V13, P1211, DOI 10.1046/j.1540-8167.2002.01211.x; Robins JM, 2000, EPIDEMIOLOGY, V11, P550, DOI 10.1097/00001648-200009000-00011; Rubin DB, 2004, MULTIPLE IMPUTATION; SAGIE A, 1992, AM J CARDIOL, V70, P797, DOI 10.1016/0002-9149(92)90562-D; Sperling R, 2014, NEURON, V84, P608, DOI 10.1016/j.neuron.2014.10.038; Suemoto CK, 2015, INT J OBESITY, V39, P1383, DOI 10.1038/ijo.2015.83; Tchetgen EJT, 2012, EPIDEMIOLOGY, V23, P644, DOI 10.1097/EDE.0b013e31825727b5; Teng E L, 1994, Int Psychogeriatr, V6, P45, DOI 10.1017/S1041610294001602; TENG EL, 1987, J CLIN PSYCHIAT, V48, P314; Tolppanen AM, 2012, J ALZHEIMERS DIS, V32, P531, DOI 10.3233/JAD-2012-120802; Weuve J, 2012, EPIDEMIOLOGY, V23, P119, DOI 10.1097/EDE.0b013e318230e861; White IR, 2011, STAT MED, V30, P377, DOI 10.1002/sim.4067; Whitmer RA, 2005, NEUROLOGY, V64, P277, DOI 10.1212/01.WNL.0000149519.47454.F2; Zulli R, 2005, J AM GERIATR SOC, V53, P2135, DOI 10.1111/j.1532-5415.2005.00508.x; Zulli R, 2008, CLIN NEUROL NEUROSUR, V110, P791, DOI 10.1016/j.clineuro.2008.05.002	45	2	2	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2020	15	2							e0229519	10.1371/journal.pone.0229519	http://dx.doi.org/10.1371/journal.pone.0229519			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LQ8EV	32097438	Green Published, gold			2022-12-26	WOS:000535232000032
J	Arnetz, BB; Sudan, S; Arnetz, JE; Yamin, JB; Lumley, MA; Beck, JS; Stemmer, PM; Burghardt, P; Counts, SE; Jamil, H				Arnetz, Bengt B.; Sudan, Sukhesh; Arnetz, Judith E.; Yamin, Jolin B.; Lumley, Mark A.; Beck, John S.; Stemmer, Paul M.; Burghardt, Paul; Counts, Scott E.; Jamil, Hikmet			Dysfunctional neuroplasticity in newly arrived Middle Eastern refugees in the US: Association with environmental exposures and mental health symptoms	PLOS ONE			English	Article							POSTTRAUMATIC-STRESS-DISORDER; HARVARD TRAUMA QUESTIONNAIRE; IRAQI REFUGEES; BODY-WEIGHT; ANXIETY; DISPLACEMENT; CONFLICT; PTSD; NEUROTROPHINS; PLASTICITY	Background Psychological war trauma among displaced refugees is an established risk factor for mental health disorders, especially post-traumatic stress disorder (PTSD). Persons with trauma-induced disorders have heightened neuroplastic restructuring of limbic brain circuits (e.g., amygdala and hippocampus), which are critical factors in the pathophysiology of PTSD. Civilians in war are exposed to both psychological trauma and environmental hazards, such as metals. Little is known about the possible mental health impact from such environmental exposures, alone or in combination with trauma. It is of special interest to determine whether war exposures contribute to dysfunctional neuroplasticity; that is, an adverse outcome from sustained stress contributing to mental health disorders. The current study examined Middle Eastern refugees in the United States to determine the relationships among pre-displacement trauma and environmental exposures, brain derived neurotrophic growth factor (BDNF) and nerve growth factor (NGF)-two neurotrophins reported to mediate neuroplasticity responses to stress-related exposures-and mental health. Methods Middle Eastern refugees (n = 64; 33 men, 31 women) from Syria (n = 40) or Iraq (n = 24) were assessed 1 month after arrival to Michigan, US. Participants were interviewed in Arabic using a semi-structured survey to assess pre-displacement trauma and environmental exposure, PTSD, depression, anxiety, and self-rated mental health. Whole blood was collected, and concentrations of six heavy metals as well as BDNF and NGF levels were determined. Because these two neurotrophins have similar functions in neuroplasticity, we combined them to create a neuroplasticity index. Linear regression tested whether psychosocial trauma, environmental exposures and biomarkers were associated with mental health symptoms. Findings The neuroplasticity index was associated with PTSD (standardized beta, beta = 0.25, p < 0.05), depression (0.26, < 0.05) and anxiety (0.32, < 0.01) after controlling for pre-displacement trauma exposures. In addition, pre-displacement environmental exposure was associated with PTSD (0.28, < 0.05) and anxiety (0.32, < 0.05). Syrian refugees and female gender were associated with higher scores on depression (0.25, < 0.05; 0.30, < 0.05) and anxiety scales (0.35, < 0.01; 0.27, < 0.05), and worse on self-rated mental health (0.32, < 0.05; 0.34, < 0.05). In bivariate analysis, the neuroplasticity index was related to blood lead levels (r = 0.40; p < 0.01). Conclusions The current study confirms the adverse effects of war trauma on mental health. Higher levels of biomarkers of neuroplasticity correlated with worse mental health and higher blood lead levels. Higher neurotrophin levels in refugees might indicate dysfunctional neuroplasticity with increased consolidation of adverse war memories in the limbic system. Such a process may contribute to psychiatric symptoms. Further research is needed to clarify the pathobiological mechanisms linking war trauma and environmental exposures to adverse mental health.	[Arnetz, Bengt B.; Sudan, Sukhesh; Arnetz, Judith E.; Counts, Scott E.; Jamil, Hikmet] Michigan State Univ, Coll Human Med, Dept Family Med, Grand Rapids, MI 49503 USA; [Yamin, Jolin B.; Lumley, Mark A.] Wayne State Univ, Dept Psychol, 71 W Warren Ave, Detroit, MI 48202 USA; [Beck, John S.; Counts, Scott E.] Dept Translat Neurosci, Grand Rapids, MI USA; [Stemmer, Paul M.] Wayne State Univ, Inst Environm Hlth Sci, Detroit, MI USA; [Burghardt, Paul] Wayne State Univ, Dept Nutr & Food Sci, Detroit, MI 48202 USA	Michigan State University; Michigan State University College of Human Medicine; Wayne State University; Wayne State University; Wayne State University	Arnetz, BB (corresponding author), Michigan State Univ, Coll Human Med, Dept Family Med, Grand Rapids, MI 49503 USA.	arnetzbe@msu.edu	Sudan, Sukhesh/P-5844-2019; Arnetz, Bengt/G-1685-2011	Sudan, Sukhesh/0000-0002-6435-7848; Stemmer, Paul/0000-0003-3315-9846; Arnetz, Bengt/0000-0001-7173-4333	National Institute of Mental Health/National Institute of health [NIMH/NIH R01MH085793]; National Institute of environmental Health Sciences/National Institute of Health [NIEHS/NIH P30ES020957]; National Institute on Aging/National Institute of Health [NIA/NIH P01014449]	National Institute of Mental Health/National Institute of health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institute of environmental Health Sciences/National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); National Institute on Aging/National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	BA -NIMH/NIH R01MH085793 (National Institute of Mental Health/National Institute of health; https://urldefense.com/v3/__https://www.nimh.nih.gov/index.shtml__;!!HXCxUKc! hZZI7yglrK-DsE2aI5M2reRjmTrnyp8_ntSV3vu k8K0t0OjJI43sPaK42a-HVRQ$), NIEHS/NIH P30ES020957 (National Institute of environmental Health Sciences/National Institute of Health; https://urldefense.com/v3/__https://www.niehs.nih.gov/index.cfm__;!!HXCxUKc!hZZI7yglrK-DsE2aI5M2 reRjmTrnyp8_ntSV3vuk8K0t0OjJI43sPaK4 kLxB0Q0$) SEC -NIA/NIH P01014449 (National Institute on Aging/National Institute of Health; https://urldefense.com/v3/__https://www.nia.nih.gov/__;!!HXCxUKc!hZZI7yglrK-DsE2aI5M2re RjmTrnyp8_ntSV3vuk8K0t0OjJI43sPaK4QMyfUsI $) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andero R, 2012, GENES BRAIN BEHAV, V11, P503, DOI 10.1111/j.1601-183X.2012.00801.x; Arnetz BB, 2020, J ASTHMA, V57, P28, DOI 10.1080/02770903.2018.1545856; Arnetz BB, 2014, J IMMIGR MINOR HEALT, V16, P1055, DOI 10.1007/s10903-014-9995-9; Arnetz J, 2013, J NERV MENT DIS, V201, P167, DOI 10.1097/NMD.0b013e3182848afe; Averill LA, 2019, DEPRESS ANXIETY, V36, P834, DOI 10.1002/da.22912; BECK AT, 1988, J CONSULT CLIN PSYCH, V56, P893, DOI 10.1037/0022-006X.56.6.893; Blanchard EB, 1996, BEHAV RES THER, V34, P669, DOI 10.1016/0005-7967(96)00033-2; Blin A., 2018, WAR RELIG EUROPE MED; Brydges NM, 2018, TRANSL PSYCHIAT, V8, DOI 10.1038/s41398-018-0322-4; Chao MV, 2003, NAT REV NEUROSCI, V4, P299, DOI 10.1038/nrn1078; Clukay CJ, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0219385; D'Ilio S, 2006, ANAL CHIM ACTA, V579, P202, DOI 10.1016/j.aca.2006.07.027; Dhalimi Abir, 2018, Stigma Health, V3, P325, DOI 10.1037/sah0000068; Enrico Alleva LA, 1989, INT J COMP PSYCHOL, V2, P202; Georgiadou E, 2017, INT J ENV RES PUB HE, V14, DOI 10.3390/ijerph14060612; Gibon J, 2017, NEUROSCIENTIST, V23, P587, DOI 10.1177/1073858417697037; Halperin D, 2017, PSYCHIAT QUART, V88, P213, DOI 10.1007/s11126-016-9451-1; He M, 2018, CURR PHARM DESIGN, V24, P4051, DOI 10.2174/1381612824666181120094749; Hill JL, 2016, CURR OPIN NEUROBIOL, V36, P59, DOI 10.1016/j.conb.2015.10.001; Jamil H., 1991, US ARMY MED DEP J, V2013, P58; Jamil Hikmet, 2015, Iraqi J Med Sci, V13, P108; Jamil Hikmet, 2011, US Army Med Dep J, P87; Jen KLC, 2015, J IMMIGR MINOR HEALT, V17, P1468, DOI 10.1007/s10903-014-0127-3; Jen KLC, 2018, J IMMIGR MINOR HEALT, V20, P283, DOI 10.1007/s10903-017-0565-9; Keefe KM, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18030548; Koponen E, 2004, MOL CELL NEUROSCI, V26, P166, DOI 10.1016/j.mcn.2004.01.006; Leal G, 2014, NEUROPHARMACOLOGY, V76, P639, DOI 10.1016/j.neuropharm.2013.04.005; LeMaster JW, 2018, AM J ORTHOPSYCHIAT, V88, P38, DOI 10.1037/ort0000240; Liu IYC, 2004, J NEUROSCI, V24, P7958, DOI 10.1523/JNEUROSCI.1948-04.2004; Mahan AL, 2012, TRENDS NEUROSCI, V35, P24, DOI 10.1016/j.tins.2011.06.007; McLaughlin KA, 2019, PSYCHOL MED, V49, P2215, DOI 10.1017/S0033291718003082; Miller KE, 2017, EPIDEMIOL PSYCH SCI, V26, P129, DOI 10.1017/S2045796016000172; Mowafi H, 2011, GLOB PUBLIC HEALTH, V6, P472, DOI 10.1080/17441692.2011.570358; Rakesh G, 2019, MOL PSYCHIATR, V24, P1268, DOI 10.1038/s41380-019-0383-7; Resnick B, 2019, INT J ORTHOP TRAUMA, V34, P36, DOI 10.1016/j.ijotn.2019.03.005; Schur RR, 2019, EUR NEUROPSYCHOPHARM, V29, P405, DOI 10.1016/j.euroneuro.2018.12.009; Sheerin CM, 2019, BRAIN SCI, V9, DOI 10.3390/brainsci9060146; Shoeb M, 2007, INT J SOC PSYCHIATR, V53, P447, DOI 10.1177/0020764007078362; Silbermann Michael, 2016, J Glob Oncol, V2, P422, DOI 10.1200/JGO.2016.005173; SPILLANTINI MG, 1989, P NATL ACAD SCI USA, V86, P8555, DOI 10.1073/pnas.86.21.8555; Wright AM, 2017, J IMMIGR MINOR HEALT, V19, P98, DOI 10.1007/s10903-015-0340-8; Wright AM, 2016, SCAND J PSYCHOL, V57, P564, DOI 10.1111/sjop.12320; Yee BK, 2007, J NEURAL TRANSM, V114, P431, DOI 10.1007/s00702-006-0548-9; Yuan N, 2019, TRANSL PSYCHIAT, V9, DOI 10.1038/s41398-019-0570-y; Zhang L, 2014, MOL PSYCHIATR, V19, P8, DOI 10.1038/mp.2012.180; Zhang L, 2016, WORLD J PSYCHIATR, V6, P1, DOI 10.5498/wjp.v6.i1.1; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	47	5	5	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2020	15	3							e0230030	10.1371/journal.pone.0230030	http://dx.doi.org/10.1371/journal.pone.0230030			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LQ8TR	32142533	Green Published, gold			2022-12-26	WOS:000535271600033
J	Balazik, M; Barber, M; Altman, S; Reine, K; Katzenmeyer, A; Bunch, A; Garman, G				Balazik, Matthew; Barber, Michael; Altman, Safra; Reine, Kevin; Katzenmeyer, Alan; Bunch, Aaron; Garman, Greg			Dredging activity and associated sound have negligible effects on adult Atlantic sturgeon migration to spawning habitat in a large coastal river	PLOS ONE			English	Article								Dredging is considered a major threat/impedance to anadromous fish migrating to spawning habitat. Due to the perceived threat caused by dredging, environmental windows that restrict dredge operations are enforced within many rivers along the east coast. However, it is generally unknown how anadromous fish react to encountering an active dredge during spawning migrations. Atlantic sturgeon (ATS) are an endangered, anadromous species along the Atlantic slope of North America. To determine if and how an active dredge may affect ATS spawning migration, a Vemco Positioning System array was deployed around an active hydraulic-cutterhead dredge that adult ATS must traverse to reach spawning habitat in the James River, VA. Telemetry data showed that all ATS that entered the study area survived. ATS that migrated upstream during dredge operations (N = 103) traversed the dredge area and continued upstream to spawning habitat. Many ATS made multiple trips through the study area during dredge operations. There was no noticeable difference in swim behavior regardless of whether the dredge was absent or working within the study area. We suggest that dredging in the lower James River does not create a barrier for adult ATS migrating to spawning habitat or cause adults to significantly modify swim behavior. This is the first study to utilize fine-scale telemetry data to describe how an organism moves in relation to an active dredge. This methodology could be used to describe dredge-sturgeon interactions on different life stages and in other locations and could be expanded to other aquatic organisms of concern.	[Balazik, Matthew; Altman, Safra; Reine, Kevin; Katzenmeyer, Alan] US Army Corps Engineers, Engineer Res & Dev Ctr, Vicksburg, MS 39183 USA; [Balazik, Matthew; Barber, Michael; Garman, Greg] Virginia Commonwealth Univ, Rice Rivers Ctr, Charles City, VA 23284 USA; [Bunch, Aaron] Virginia Dept Game & Inland Fisheries, Charles City, VA USA	United States Department of Defense; United States Army; U.S. Army Corps of Engineers; U.S. Army Engineer Research & Development Center (ERDC)	Balazik, M (corresponding author), US Army Corps Engineers, Engineer Res & Dev Ctr, Vicksburg, MS 39183 USA.; Balazik, M (corresponding author), Virginia Commonwealth Univ, Rice Rivers Ctr, Charles City, VA 23284 USA.	Matthew.T.Balazik@usace.army.mil		Bunch, Aaron/0000-0002-1855-5616	National Oceanic and Atmospheric Administration, Virginia Department of Game and Inland Fisheries [NA13NMF4720037]; Engineer Research and Develop Center [DOERFY17-10]	National Oceanic and Atmospheric Administration, Virginia Department of Game and Inland Fisheries; Engineer Research and Develop Center	This study was funded by: grant #NA13NMF4720037 National Oceanic and Atmospheric Administration, Virginia Department of Game and Inland Fisheries to MTB and GCG and grant #DOERFY17-10 Engineer Research and Develop Center to MTB and SF. The funders provided a role in the preparation of the manuscript. The funders had no additional role in study design, data collection and analysis, or decision to publish.	[Anonymous], 2015, ANIM BIOTELEM; ASSRT (Atlantic Sturgeon Status Review Team), 2007, STAT REV ATL STURG A; Balazik MT, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179661; Balazik MT, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128234; Balazik MT, 2015, N AM J FISH MANAGE, V35, P398, DOI 10.1080/02755947.2015.1011358; Balazik MT, 2012, T AM FISH SOC, V141, P1465, DOI 10.1080/00028487.2012.703157; Collins MR, 2000, T AM FISH SOC, V129, P982, DOI 10.1577/1548-8659(2000)129&lt;0982:HUABCO&gt;2.3.CO;2; Farrae DJ, 2017, CONSERV GENET, V18, P813, DOI 10.1007/s10592-017-0929-7; GETIS A, 1992, GEOGR ANAL, V24, P189, DOI 10.1111/j.1538-4632.1992.tb00261.x; McLean MF, 2014, MAR ECOL PROG SER, V496, P59, DOI 10.3354/meps10555; NOAA (National Oceanic and Atmospheric Administration), 2012, FED REGISTER, V77, P5880; NOAA (National Oceanic and Atmospheric Administration), 2012, FED REGISTER, V77, P5914; R Core Team, 2018, R LANG ENV STAT COMP; Reine K, TR1412 ERDCEL; ROY R, 2014, J BIOMED SCI, V21, P22580, DOI DOI 10.1186/2050-3385-2-1; Smith JA, 2015, T AM FISH SOC, V144, P48, DOI 10.1080/00028487.2014.965344; Vine JR, 2019, N AM J FISH MANAGE, V39, P939, DOI 10.1002/nafm.10326	17	4	4	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2020	15	3							e0230029	10.1371/journal.pone.0230029	http://dx.doi.org/10.1371/journal.pone.0230029			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8TR	32142543	Green Published, gold			2022-12-26	WOS:000535271600032
J	Yount, KM; Cheong, YF; Grose, RG; Hayford, SR				Yount, Kathryn M.; Cheong, Yuk Fai; Grose, Rose Grace; Hayford, Sarah R.			Community gender systems and a daughter's risk of female genital mutilation/cutting: Multilevel findings from Egypt	PLOS ONE			English	Article							CONTEXT; RESOURCES; VIOLENCE; MINYA; WOMEN; DISCONTINUATION; CONSEQUENCES; CIRCUMCISION; CONFORMITY; MORTALITY	We tested a feminist social-ecological model to understand community influences on daughters' experience of female genital mutilation/cutting (FGMC) in Egypt, where over 90% of women ages 15-49 are cut. FGMC has potential adverse effects on demographic and health outcomes and has been defined as a human-rights violation. However, an integrated multilevel-level framework is lacking. We theorized that a more favorable community-level gender system, including stronger gender norms opposing FGMC and expanded extra-familial opportunities for women in the village or neighborhood, would be associated with a daughter's lower risk of FGMC and would strengthen the negative association of a mother's opposition to FGMC with her daughter's risk of cutting. Using a national sample of 14,171 mother-daughter dyads from the 2014 Egypt Demographic and Health Survey, we estimated multilevel discrete-time hazard models to test these relationships. Community gender norms opposing FGMC had significant direct, negative associations with the hazard that a daughter was cut, but women's opportunities outside the family did not. Maternal opposition to FGMC was negatively associated with cutting a daughter, and these associations were stronger where community opposition to FGMC and opportunities for women were greater. Results provided good support for a gender-systems framework of the multilevel influences on FGMC. Integrated, multilevel interventions that address gender norms about FGMC and structural opportunities for women in the community, as well as beliefs about the practice among the mothers of at-risk daughters, may be needed for sustainable declines in the practice.	[Yount, Kathryn M.] Emory Univ, Hubert Dept Global Hlth, Atlanta, GA 30322 USA; [Yount, Kathryn M.] Emory Univ, Dept Sociol, Atlanta, GA 30322 USA; [Cheong, Yuk Fai] Emory Univ, Dept Psychol, Atlanta, GA 30322 USA; [Grose, Rose Grace] Univ Northern Colorado, Colorado Sch Publ Hlth, Dept Community Hlth Educ, Greeley, CO USA; [Hayford, Sarah R.] Ohio State Univ, Dept Sociol, Columbus, OH 43210 USA	Emory University; Emory University; Emory University; Colorado School of Public Health; University of Northern Colorado; University System of Ohio; Ohio State University	Yount, KM (corresponding author), Emory Univ, Hubert Dept Global Hlth, Atlanta, GA 30322 USA.; Yount, KM (corresponding author), Emory Univ, Dept Sociol, Atlanta, GA 30322 USA.	kyount@emory.edu	Cheong, Yuk/AAQ-4604-2021	Yount, Kathryn/0000-0003-1917-1574	Eunice Kennedy Shriver National Institute for Child Health and Human Development [1R21HD086762-01/02]; National Center on HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention; Health Resources and Service Administration of the Health Policy Leadership Fellowship in the Satcher Health Leadership Institute at Morehouse School of Medicine; Ohio State University's Institute for Population Research [P2c-HD058484]	Eunice Kennedy Shriver National Institute for Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Center on HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention; Health Resources and Service Administration of the Health Policy Leadership Fellowship in the Satcher Health Leadership Institute at Morehouse School of Medicine; Ohio State University's Institute for Population Research	KY, SH, RG, YC, and LJH received support from research grant 1R21HD086762-01/02 (PIs KY and SH) from the Eunice Kennedy Shriver National Institute for Child Health and Human Development (https://www.nichd.nih.gov/).RG also received support from the National Center on HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention; Health Resources and Service Administration in support of the Health Policy Leadership Fellowship in the Satcher Health Leadership Institute at Morehouse School of Medicine (http://satcherinstitute.org/division-ofhealth-policy/health-policy-leadership-fellowship-program/).SH also received additional support from the Ohio State University's Institute for Population Research (P2c-HD058484) (https://ipr.osu.edu/).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alkhalaileh D, 2017, CULTURE HLTH SEXUALI, P1; Almroth L, 2005, LANCET, V366, P385, DOI 10.1016/S0140-6736(05)67023-7; Andro A, 2016, POPULATION, V71, P225; [Anonymous], 1996, EGYPT DEMOGRAPHIC HL; [Anonymous], 2010, DYNAMICS SOCIAL CHAN; Assaad R., 2017, EC RES FORUM WORKING; Aubel J., 2010, DIALOGUE PROMOTE CHA; Barber JS, 2000, SOCIOL METHODOL, V30, P201, DOI 10.1111/0081-1750.00079; Battle JD, 2017, INT J SEX HEALTH, V29, P173, DOI 10.1080/19317611.2016.1265036; Berg R., 2012, CAMPBELL SYSTEMATIC, V9, P1, DOI DOI 10.4073/CSR.2012.9; Berg RC, 2014, OBSTET GYNECOL INT, V2014, DOI 10.1155/2014/542859; BERG RC, 2013, OBSTET GYNECOL INT, V2013, DOI DOI 10.1155/2013/496564; Berg RC, 2012, SEX RES SOC POLICY, V9, P41, DOI 10.1007/s13178-011-0048-z; Bicchieri C., 2017, NORMS WILD DIAGNOSE, DOI DOI 10.1093/ACPROF:OSO/9780190622046.001.0001; Bicchieri C, 2014, JERUSALEM PHILOS Q, V63; Bicchieri C., 2014, SOCIAL NORMS PERSPEC; BODDY J, 1982, AM ETHNOL, V9, P682, DOI 10.1525/ae.1982.9.4.02a00040; Boddy J, 2016, HAU-J ETHNOGR THEORY, V6, P41, DOI 10.14318/hau6.2.008; Boudet AM, 2013, DEVELOPMENT; Boyle EH, 2002, INT SOCIOL, V17, P5, DOI 10.1177/0268580902017001001; BRADLEY K, 1993, GENDER SOC, V7, P347, DOI 10.1177/089124393007003003; Browning CR, 2004, DEMOGRAPHY, V41, P697, DOI 10.1353/dem.2004.0029; Center for Development and Population Activities-Egypt, 1999, POS DEV APPR FEM GEN; Chao FQ, 2019, P NATL ACAD SCI USA, V116, P9303, DOI 10.1073/pnas.1812593116; Cislaghi B, 2019, HEALTH PROMOT INT, V34, P616, DOI 10.1093/heapro/day017; Dalal Koustuv, 2010, J Inj Violence Res, V2, P41, DOI 10.5249/jivr.v2i1.33; Diop NJ, 2009, STUD FAMILY PLANN, V40, P307, DOI 10.1111/j.1728-4465.2009.00213.x; El-Gibaly O, 2002, SOC SCI MED, V54, P205, DOI 10.1016/S0277-9536(01)00020-X; El-Zanaty F, 1993, EGYPT DEMOGRAPHIC HL; El-Zanaty F., 2001, EGYPT DEMOGRAPHIC HL; El-Zanaty F. H., 2004, EGYPT INTERIM DEMOGR; Fahmy A, 2010, REPROD HEALTH MATTER, V18, P181, DOI 10.1016/S0968-8080(10)36535-9; Gage AJ, 2006, INT J GYNECOL OBSTET, V92, P92, DOI 10.1016/j.ijgo.2005.09.019; Grose RG, 2019, J HEALTH SOC BEHAV, V60, P84, DOI 10.1177/0022146518821870; Gruenbaum E, 2005, CULT HEALTH SEX, V7, P429, DOI 10.1080/13691050500262953; Guilmoto CZ, 2018, LANCET GLOB HEALTH, V6, pE650, DOI [10.1016/S2214-109X(18)30184-0, 10.1016/s2214-109x(18)30184-0]; Haghighat Elhum, 2013, J INT WOMENS STUDIES, V14, P273; Hayford SR, 2011, J SCI STUD RELIG, V50, P252, DOI 10.1111/j.1468-5906.2011.01566.x; Hayford SR, 2005, J HEALTH SOC BEHAV, V46, P121, DOI 10.1177/002214650504600201; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Jackson EF, 2003, STUD FAMILY PLANN, V34, P200, DOI 10.1111/j.1728-4465.2003.00200.x; Kabeer N, 1999, DEV CHANGE, V30, P435, DOI 10.1111/1467-7660.00125; Kandiyoti D, 1988, GENDER SOC, V2, P274, DOI 10.1177/089124388002003004; Kline R. B, 2015, PRINCIPLES PRACTICE, DOI DOI 10.1111/j.1467-8721.2009.01598.x; Klouman E, 2005, TROP MED INT HEALTH, V10, P105, DOI 10.1111/j.1365-3156.2004.01350.x; Kravdal O, 2006, DEMOGR RES, V15, P1, DOI 10.4054/DemRes.2006.15.1; Lei L, 2017, SOC SCI MED, V179, P172, DOI 10.1016/j.socscimed.2017.02.028; Leonard L., 2000, QUAL INQ, V6, P212, DOI [10.1177/107780040000600203, DOI 10.1177/107780040000600203]; LESTHAEGHE R, 1983, POPUL DEV REV, V9, P411, DOI 10.2307/1973316; Liang MJ, 2019, J ADOLESCENT HEALTH, V65, pS3, DOI 10.1016/j.jadohealth.2019.09.015; Macintyre S, 2002, SOC SCI MED, V55, P125, DOI 10.1016/S0277-9536(01)00214-3; Mackie G, 1996, AM SOCIOL REV, V61, P999, DOI 10.2307/2096305; Mackie G, 2003, MED ANTHROPOL Q, V17, P135, DOI 10.1525/maq.2003.17.2.135; Mackie G., 2000, FEMALE CIRCUMCISION, P253; Mackie G, 2009, SPECIAL SERIES SOCIA, V6, P2009; Mackie G., 2015, WHAT ARE SOCIAL NORM; Marcus R., 2014, CHANGING DISCRIMINAT; Ministry of Health and Population [Egypt] El-Zanaty and Associates ICF International. Egypt Demographic and Health Survey, 2014, EG DEM HLTH SURV 201; Moghadam V.M., 2007, PATRIARCHY EMPOWERME; Palloni A, 2001, DIFFUSION PROCESSES AND FERTILITY TRANSITION: SELECTED PERSPECTIVES, P66; Pankhurst A., 2016, INTERPLAY COMMUNITY; Preacher KJ, 2006, J EDUC BEHAV STAT, V31, P437, DOI 10.3102/10769986031004437; Rasheed SM, 2011, INT J GYNAECOL OBSTE, V114; Reardon SF, 2002, MULTIVAR BEHAV RES, V37, P297, DOI 10.1207/S15327906MBR3703_1; Alcaraz MR, 2014, INT NURS REV, V61, P25, DOI 10.1111/inr.12070; REILLY T, 1995, SOCIOL METHOD RES, V23, P421, DOI 10.1177/0049124195023004002; Sagna ML, 2014, CULT HEALTH SEX, V16, P603, DOI 10.1080/13691058.2014.896474; Shell-Duncan B, 2016, EVIDENCE END FGM C R; Shell-Duncan B, 2011, SOC SCI MED, V73, P1275, DOI 10.1016/j.socscimed.2011.07.022; StataCorp, 2015, STAT STAT SOFTW REL; Steiger JH, 2007, PERS INDIV DIFFER, V42, P893, DOI 10.1016/j.paid.2006.09.017; Stephenson R, 2014, J HEALTH POPUL NUTR, V32, P161; Stewart CH, 2010, MULTILEVEL MODELLING; Tostan, 1999, END FEM GEN CUTT KOL; UNICEF, 2016, FEMALE GENITAL MUTIL; UNICEF, 2013, FEM GEN MUT CUTT STA; United Nations (UN), 2015, TRANSF OUR WORLD 203; Van Rossem R, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2203-6; Westreich D, 2013, AM J EPIDEMIOL, V177, P292, DOI 10.1093/aje/kws412; Wickrama KAS, 2003, J MARRIAGE FAM, V65, P850, DOI 10.1111/j.1741-3737.2003.00850.x; Wodon Q, 2017, DEV PRACT, V27, P708, DOI 10.1080/09614524.2017.1330401; World Health Organization, 2008, EL FEM GEN MUT INT S; Yodanis CL, 2004, J INTERPERS VIOLENCE, V19, P655, DOI 10.1177/0886260504263868; Yoder PS, 2013, STUD FAMILY PLANN, V44, P189, DOI 10.1111/j.1728-4465.2013.00352.x; Yount KM, 2007, STUD FAMILY PLANN, V38, P73, DOI 10.1111/j.1728-4465.2007.00119.x; Yount KM, 2004, ADV GEND RES, V8, P199, DOI 10.1016/S1529-2126(04)08007-5; Yount KM, 2018, WORLD DEV, V102, P124, DOI 10.1016/j.worlddev.2017.09.013; Yount KM, 2016, DEMOGRAPHY, V53, P1821, DOI 10.1007/s13524-016-0520-8; Yount KM, 2016, SOC INDIC RES, V128, P1171, DOI 10.1007/s11205-015-1074-7; Yount KM, 2005, J MARRIAGE FAM, V67, P579, DOI 10.1111/j.1741-3737.2005.00155.x; Yount KM, 2005, J MARRIAGE FAM, V67, P410, DOI 10.1111/j.0022-2445.2005.00125.x; Yount KM, 2004, SOC FORCES, V82, P1063, DOI 10.1353/sof.2004.0062; Yount KM, 2001, POP STUD-J DEMOG, V55, P291, DOI 10.1080/00324720127703; Yount KM, 2002, J HEALTH SOC BEHAV, V43, P336, DOI 10.2307/3090208; 2014, GLOB STAT REP VIOL, P1	95	4	4	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2020	15	3							e0229917	10.1371/journal.pone.0229917	http://dx.doi.org/10.1371/journal.pone.0229917			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LQ8TR	32142530	Green Submitted, Green Published, gold			2022-12-26	WOS:000535271600027
J	Cassar, R; Shiramizu, V; DeBruine, LM; Jones, BC				Cassar, Rachel; Shiramizu, Victor; DeBruine, Lisa M.; Jones, Benedict C.			No evidence that partnered and unpartnered gay men differ in their preferences for male facial masculinity	PLOS ONE			English	Article							HOMOSEXUAL-MEN; SEXUAL-DIMORPHISM	Women's preferences for masculine characteristics in men's faces have been extensively studied. By contrast, little is known about how gay men respond to masculine facial characteristics. One area of disagreement in the emerging literature on this topic is the association between gay men's partnership status and masculinity preference. One study found that partnered gay men showed stronger preferences for masculine faces than did single gay men, while another study found that partnered gay men showed weaker preferences for masculine faces than did single gay men. We re-examined this issue in a sample of 618 gay men, finding no significant difference between partnered and single gay men's masculinity preferences. Together with the mixed previous findings, our null result suggests that the effect of partnership status on gay men's face preferences is not robust.	[Cassar, Rachel; Shiramizu, Victor; DeBruine, Lisa M.; Jones, Benedict C.] Univ Glasgow, Inst Neurosci & Psychol, Glasgow, Lanark, Scotland	University of Glasgow	Cassar, R (corresponding author), Univ Glasgow, Inst Neurosci & Psychol, Glasgow, Lanark, Scotland.	Rachel.Cassar@glasgow.ac.uk	Shiramizu, Victor/GPP-0919-2022; DeBruine, Lisa M/A-6990-2008; Jones, Benedict/A-7850-2008	DeBruine, Lisa M/0000-0002-7523-5539; Jones, Benedict/0000-0001-7777-0220	European Research Council	European Research Council(European Research Council (ERC)European Commission)	European Research Council award to LMD (KINSHIP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barr DJ, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00328; Barr DJ, 2013, J MEM LANG, V68, P255, DOI 10.1016/j.jml.2012.11.001; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Boothroyd LG, 2007, PERS INDIV DIFFER, V43, P1161, DOI 10.1016/j.paid.2007.03.008; Buss D. M., 2016, EVOLUTION DESIRE; Glassenberg AN, 2010, ARCH SEX BEHAV, V39, P1289, DOI 10.1007/s10508-009-9559-6; Holzleitner IJ, 2017, ADAPT HUM BEHAV PHYS, V3, P304, DOI 10.1007/s40750-017-0070-3; Jones AL, 2019, SYMMETRY-BASEL, V11, DOI 10.3390/sym11020279; Jones BC, 2018, PSYCHOL SCI, V29, P996, DOI 10.1177/0956797618760197; Kuznetsova A, 2017, J STAT SOFTW, V82, P1, DOI 10.18637/jss.v082.i13; Little AC, 2002, P ROY SOC B-BIOL SCI, V269, P1095, DOI 10.1098/rspb.2002.1984; Little AC, 2014, BRIT J PSYCHOL, V105, P364, DOI 10.1111/bjop.12043; Marcinkowska UM, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0210162; Perrett DI, 1998, NATURE, V394, P884, DOI 10.1038/29772; Tiddeman B, 2001, IEEE COMPUT GRAPH, V21, P42, DOI 10.1109/38.946630; Valentova J, 2013, PERCEPTION, V42, P187, DOI 10.1068/p6909; Welling LLM, 2013, ARCH SEX BEHAV, V42, P785, DOI 10.1007/s10508-012-0059-8; Zhang J, 2018, PERS INDIV DIFFER, V134, P137, DOI 10.1016/j.paid.2018.06.009; Zheng LJ, 2019, PERS INDIV DIFFER, V138, P243, DOI 10.1016/j.paid.2018.10.012; Zheng LJ, 2013, ARCH SEX BEHAV, V42, P1223, DOI 10.1007/s10508-012-0057-x	20	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2020	15	3							e0229133	10.1371/journal.pone.0229133	http://dx.doi.org/10.1371/journal.pone.0229133			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LQ8RK	32134936	Green Published, Green Accepted, gold, Green Submitted			2022-12-26	WOS:000535265600018
J	Ibrahim, AEC; van Dolleweerd, CJ; Drake, PMW; Ma, JKC				Ibrahim, Ahmad E. C.; van Dolleweerd, Craig J.; Drake, Pascal M. W.; Ma, Julian K-C			Development of a minigenome cassette for Lettuce necrotic yellows virus: A first step in rescuing a plant cytorhabdovirus	PLOS ONE			English	Article							VESICULAR STOMATITIS-VIRUS; ESCHERICHIA-COLI; RABIES VIRUS; INTRON-INSERTION; INFECTIOUS CDNA; COPY-NUMBER; GENOMIC RNA; EXPRESSION; GENE; TOBACCO	Rhabdoviruses are enveloped negative-sense RNA viruses that have numerous biotechnological applications. However, recovering plant rhabdoviruses from cDNA remains difficult due to technical difficulties such as the need for concurrent in planta expression of the viral genome together with the viral nucleoprotein (N), phosphoprotein (P) and RNA-dependent RNA polymerase (L) and viral genome instability in E. coli. Here, we developed a negative-sense minigenome cassette for Lettuce necrotic yellows virus (LNYV). We introduced introns into the unstable viral ORF and employed Agrobacterium tumefaciens to co-infiltrate Nicotiana with the genes for the N, P, and L proteins together with the minigenome cassette. The minigenome cassette included the Discosoma sp. red fluorescent protein gene (DsRed) cloned in the negative-sense between the viral trailer and leader sequences which were placed between hammerhead and hepatitis delta ribozymes. In planta DsRed expression was demonstrated by western blotting while the appropriate splicing of introduced introns was confirmed by sequencing of RT-PCR product.	[Ibrahim, Ahmad E. C.; van Dolleweerd, Craig J.; Drake, Pascal M. W.; Ma, Julian K-C] St Georges Univ London, Inst Infect & Immun, London, England	St Georges University London	Drake, PMW (corresponding author), St Georges Univ London, Inst Infect & Immun, London, England.	pdrake@sgul.ac.uk		Drake, Pascal/0000-0002-6181-0600	Wellcome Trust [WT093092MA]; Hotung Charitable Settlement; ERC award [ERC-2010-ADG_20100317]	Wellcome Trust(Wellcome TrustEuropean Commission); Hotung Charitable Settlement; ERC award	This work was supported by a Wellcome Trust grant (JM) (Grant number WT093092MA, https://wellcome.ac.uk), the Hotung Charitable Settlement (JM) and an ERC award (JM) (Grant number ERC-2010-ADG_20100317, https://erc.europa.eu/).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews LB, 2005, BIOTECHNOL PROGR, V21, P946, DOI 10.1021/bp049569k; Borniego MB, 2016, VIROLOGY, V498, P172, DOI 10.1016/j.virol.2016.08.027; BRINSTER RL, 1988, P NATL ACAD SCI USA, V85, P836, DOI 10.1073/pnas.85.3.836; Buschmann C, 2000, PHOTOSYNTHETICA, V38, P483, DOI 10.1023/A:1012440903014; CHAMBERS TC, 1965, VIROLOGY, V27, P320, DOI 10.1016/0042-6822(65)90111-X; CONZELMANN KK, 1994, J VIROL, V68, P713, DOI 10.1128/JVI.68.2.713-719.1994; CROWLEY NC, 1967, VIROLOGY, V31, P107, DOI 10.1016/0042-6822(67)90013-X; CUNNINGHAM TP, 1993, GENE, V124, P93, DOI 10.1016/0378-1119(93)90766-V; Dadami E, 2013, FEBS LETT, V587, P706, DOI 10.1016/j.febslet.2013.01.045; Dietzgen RG., 2007, PLANT VIRUSES, V1, P85; ECKES P, 1986, MOL GEN GENET, V205, P14, DOI 10.1007/BF02428027; ECKNER R, 1991, EMBO J, V10, P3513, DOI 10.1002/j.1460-2075.1991.tb04915.x; Fakhfakh H, 1996, J GEN VIROL, V77, P519, DOI 10.1099/0022-1317-77-3-519; Ganesan U, 2013, J VIROL, V87, P10598, DOI 10.1128/JVI.01397-13; Ghanem A, 2012, EUR J CELL BIOL, V91, P10, DOI 10.1016/j.ejcb.2011.01.008; Gillman JD, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-155; Jackson AO, 2005, ANNU REV PHYTOPATHOL, V43, P623, DOI 10.1146/annurev.phyto.43.011205.141136; Johansen IE, 1996, P NATL ACAD SCI USA, V93, P12400, DOI 10.1073/pnas.93.22.12400; Kato A, 1996, GENES CELLS, V1, P569, DOI 10.1046/j.1365-2443.1996.d01-261.x; Kato Y, 2001, J BIOL CHEM, V276, P15378, DOI 10.1074/jbc.M010570200; KEENE JD, 1981, P NATL ACAD SCI-BIOL, V78, P6191, DOI 10.1073/pnas.78.10.6191; Kerstetter RA, 1997, DEVELOPMENT, V124, P3045; Lauretti F, 2016, HUM VACC IMMUNOTHER, V12, P2327, DOI 10.1080/21645515.2016.1183857; Le Mercier P, 2002, J VIROL, V76, P2024, DOI 10.1128/JVI.76.4.2024-2027.2002; Li DS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018197; Li Xiao-juan, 2005, Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi, V19, P12; LOPILATO J, 1986, MOL GEN GENET, V205, P285, DOI 10.1007/BF00430440; Matsumoto K, 1998, EMBO J, V17, P2107, DOI 10.1093/emboj/17.7.2107; Mishin VP, 2001, VIRUS RES, V81, P113, DOI 10.1016/S0168-1702(01)00371-9; Neumann G, 2002, J GEN VIROL, V83, P2635, DOI 10.1099/0022-1317-83-11-2635; PATTNAIK AK, 1992, CELL, V69, P1011, DOI 10.1016/0092-8674(92)90619-N; Paul M, 2014, MABS-AUSTIN, V6, P1585, DOI 10.4161/mabs.36336; PERROTTA AT, 1990, NUCLEIC ACIDS RES, V18, P6821, DOI 10.1093/nar/18.23.6821; Pfaller CK, 2015, VIROLOGY, V479, P331, DOI 10.1016/j.virol.2015.01.029; Pineau E, 2017, NEW PHYTOL, V215, P173, DOI 10.1111/nph.14590; Polo S, 1997, J VIROL, V71, P5366, DOI 10.1128/JVI.71.7.5366-5374.1997; Pu SY, 2011, J VIROL, V85, P2927, DOI 10.1128/JVI.01986-10; Rayson S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031917; Rosano GL, 2014, RECOMBINANT PROTEIN, P7; Rossi SL, 2005, VIROLOGY, V331, P457, DOI 10.1016/j.virol.2004.10.046; Sack M, 2015, PLANT BIOTECHNOL J, V13, P1094, DOI 10.1111/pbi.12438; Safronetz D, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003736; SANDER L, 1995, PLANT MOL BIOL, V27, P165, DOI 10.1007/BF00019188; SCHNELL MJ, 1994, EMBO J, V13, P4195, DOI 10.1002/j.1460-2075.1994.tb06739.x; Schnell MJ, 1996, P NATL ACAD SCI USA, V93, P11359, DOI 10.1073/pnas.93.21.11359; Schoberer J, 2009, TRAFFIC, V10, P101, DOI 10.1111/j.1600-0854.2008.00841.x; Stillman EA, 1997, J VIROL, V71, P2127, DOI 10.1128/JVI.71.3.2127-2137.1997; STUBBS LL, 1963, AUST J AGR RES, V14, P439, DOI 10.1071/AR9630439; Suzuki R, 2007, VIROLOGY, V362, P374, DOI 10.1016/j.virol.2006.11.026; SWARD R J, 1990, Australasian Plant Pathology, V19, P46, DOI 10.1071/APP9900046; TURPEN TH, 1993, J VIROL METHODS, V42, P227, DOI 10.1016/0166-0934(93)90035-P; van Dolleweerd CJ, 2014, J INFECT DIS, V210, P200, DOI 10.1093/infdis/jiu085; Wang HF, 2007, BIOCHEM BIOPH RES CO, V354, P203, DOI 10.1016/j.bbrc.2006.12.184; Wang Q, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005223; WETZEL T, 1994, VIROLOGY, V200, P401, DOI 10.1006/viro.1994.1204; Whelan SPJ, 1999, J VIROL, V73, P297, DOI 10.1128/JVI.73.1.297-306.1999; WHELAN SPJ, 1995, P NATL ACAD SCI USA, V92, P8388, DOI 10.1073/pnas.92.18.8388; WOLANSKI BS, 1971, VIROLOGY, V44, P582, DOI 10.1016/0042-6822(71)90372-2; Yamshchikov V, 2001, VIROLOGY, V281, P272, DOI 10.1006/viro.2000.0793; Yang SJ, 1998, ARCH VIROL, V143, P2443, DOI 10.1007/s007050050474; Yun T, 2015, J VIROL, V89, P1242, DOI 10.1128/JVI.02583-14	61	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2020	15	3							e0229877	10.1371/journal.pone.0229877	http://dx.doi.org/10.1371/journal.pone.0229877			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8RK	32134974	Green Published, gold, Green Accepted			2022-12-26	WOS:000535265600056
J	Welter, BH; Walters, HA; Temesvari, LA				Welter, Brenda H.; Walters, Heather A.; Temesvari, Lesly A.			Reduced expression of a rhomboid protease, EhROM1, correlates with changes in the submembrane distribution and size of the Gal/GalNAc lectin subunits in the human protozoan parasite, Entamoeba histolytica	PLOS ONE			English	Article							INTEGRIN-LIKE MOLECULE; UNIQUE RAB GTPASE; LIPID RAFTS; GAMMA-SECRETASE; MEMBRANE; LOCALIZATION; PROTEOLYSIS; ADHERENCE; ADHESINS; INVASION	Entamoeba histolytica is a food- and waterborne parasite that causes amebic dysentery and amoebic liver abscesses. Adhesion is one of the most important virulence functions as it facilitates motility, colonization of host, destruction of host tissue, and uptake of nutrients by the parasite. The parasite cell surface adhesin, the Gal/GalNAc lectin, facilitates parasitehost interaction by binding to galactose or N-acetylgalactosamine residues on host components. It is composed of heavy (Hgl), intermediate (Igl), and light (Lgl) subunits. Igl is constitutively localized to lipid rafts (cholesterol-rich membrane domains), whereas Hgl and Lgl transiently associate with rafts. When all three subunits are localized to rafts, galactose-sensitive adhesion is enhanced. Thus, submembrane location may regulate the function of this adhesion. Rhomboid proteases are a conserved family of intramembrane proteases that also participate in the regulation of parasite-host interactions. In E. histolytica, one rhomboid protease, EhROM1, cleaves Hgl as a substrate, and knockdown of its expression inhibits parasite-host interactions. Since rhomboid proteases are found within membranes, it is not surprising that lipid composition regulates their activity and enzyme-substrate binding. Given the importance of the lipid environment for both rhomboid proteases and the Gal/GalNAc lectin, we sought to gain insight into the relationship between rhomboid proteases and submembrane location of the lectin in E. histolytica. We demonstrated that EhROM1, itself, is enriched in highly buoyant triton-insoluble membranes reminiscent of rafts. Reducing rhomboid protease activity, either pharmacologically or genetically, correlated with an enrichment of Hgl and Lgl in rafts. In a mutant cell line with reduced EhROM1 expression, there was also a significant augmentation of the level of all three Gal/GalNAc subunits on the cell surface and an increase in the molecular weight of Hgl and Lgl. Overall, the study provides insight into the molecular mechanisms governing parasite-host adhesion for this pathogen.	[Welter, Brenda H.; Walters, Heather A.; Temesvari, Lesly A.] Clemson Univ, Dept Biol Sci, Clemson, SC 29634 USA; [Welter, Brenda H.; Walters, Heather A.; Temesvari, Lesly A.] Clemson Univ, Eukaryot Pathogens Innovat Ctr EPIC, Clemson, SC 29634 USA	Clemson University; Clemson University	Temesvari, LA (corresponding author), Clemson Univ, Dept Biol Sci, Clemson, SC 29634 USA.; Temesvari, LA (corresponding author), Clemson Univ, Eukaryot Pathogens Innovat Ctr EPIC, Clemson, SC 29634 USA.	LTEMESV@clemson.edu		Temesvari, Lesly/0000-0002-4154-8158	National Institute of General Medical Sciences Grant [GM109094]	National Institute of General Medical Sciences Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by a National Institute of General Medical Sciences Grant (https://www.nigms.nih.gov): GM109094 (LAT). The funding agency had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This content is solely the responsibility of the authors and does not necessarily represent the views of the National Institute of General Medical Sciences or the National Institutes of Health.	Adrain C, 2011, EMBO REP, V12, P421, DOI 10.1038/embor.2011.50; Garcia MA, 2015, MOLECULES, V20, P2802, DOI 10.3390/molecules20022802; Baker RP, 2006, PLOS PATHOG, V2, P922, DOI 10.1371/journal.ppat.0020113; Baxt LA, 2008, GENE DEV, V22, P1636, DOI 10.1101/gad.1667708; Baxt LA, 2010, EUKARYOT CELL, V9, P1283, DOI 10.1128/EC.00015-10; Brossier F, 2005, P NATL ACAD SCI USA, V102, P4146, DOI 10.1073/pnas.0407918102; Brossier F, 2008, EUKARYOT CELL, V7, P664, DOI 10.1128/EC.00331-07; Buguliskis JS, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000858; CHADEE K, 1987, J CLIN INVEST, V80, P1245, DOI 10.1172/JCI113199; DIAMOND LS, 1978, T ROY SOC TROP MED H, V72, P431, DOI 10.1016/0035-9203(78)90144-X; Dickey SW, 2013, CELL, V155, P1270, DOI 10.1016/j.cell.2013.10.053; Dodson JM, 1999, J INFECT DIS, V179, P460, DOI 10.1086/314610; Dowse TJ, 2005, INT J PARASITOL, V35, P747, DOI 10.1016/j.ijpara.2005.04.001; Ejigiri I, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002725; Ghosh S, 2019, CURR CLIN MICROBIOL, V6, P51, DOI 10.1007/s40588-019-0113-6; Goldston AM, 2012, EUKARYOT CELL, V11, P743, DOI 10.1128/EC.00054-12; Grebmer K., 2015, UNICEF WHO 2015 UPDA; Ha Y, 2013, J BIOL CHEM, V288, P15430, DOI 10.1074/jbc.R112.422378; Koushik AB, 2013, INFECT IMMUN, V81, P2145, DOI 10.1128/IAI.00040-13; Laughlin RC, 2004, INFECT IMMUN, V72, P5349, DOI 10.1128/IAI.72.9.5349-5357.2004; Leon-Coria A, 2020, GUT MICROBES, V11, P118, DOI 10.1080/19490976.2019.1614363; Leon-Coria A, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1007466; Lohi O, 2004, CURR BIOL, V14, P236, DOI 10.1016/j.cub.2004.01.025; Maegawa S, 2005, BIOCHEMISTRY-US, V44, P13543, DOI 10.1021/bi051363k; Maegawa S, 2007, MOL MICROBIOL, V64, P435, DOI 10.1111/j.1365-2958.2007.05679.x; Mittal K, 2008, EXP PARASITOL, V120, P127, DOI 10.1016/j.exppara.2008.06.003; Moin SM, 2012, ELIFE, V1, DOI 10.7554/eLife.00173; O'Donnell RA, 2006, J CELL BIOL, V174, P1023, DOI 10.1083/jcb.200604136; Parente J, 2014, J BIOL CHEM, V289, P11304, DOI 10.1074/jbc.M113.546531; Paschkowsky S, 2018, J BIOL CHEM, V293, P15556, DOI 10.1074/jbc.RA118.002640; Pike LJ, 2003, J LIPID RES, V44, P655, DOI 10.1194/jlr.R200021-JLR200; POWERS JC, 1994, METHOD ENZYMOL, V244, P442; Rastew E, 2015, EXP PARASITOL, V154, P33, DOI 10.1016/j.exppara.2015.04.004; Riestra AM, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005294; Rugarabamu G, 2015, MOL MICROBIOL, V97, P244, DOI 10.1111/mmi.13021; SALATA RA, 1987, PARASITE IMMUNOL, V9, P249, DOI 10.1111/j.1365-3024.1987.tb00504.x; SALATA RA, 1986, J INFECT DIS, V154, P19, DOI 10.1093/infdis/154.1.19; Sheiner L, 2008, TRAFFIC, V9, P665, DOI 10.1111/j.1600-0854.2008.00736.x; Sibley LD, 2013, BBA-BIOMEMBRANES, V1828, P2908, DOI 10.1016/j.bbamem.2013.04.017; Srinivasan P, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000262; Talamas-Lara D, 2015, EXP CELL RES, V337, P226, DOI 10.1016/j.yexcr.2015.07.030; Talamas-Rohana P, 1998, J EUKARYOT MICROBIOL, V45, P356, DOI 10.1111/j.1550-7408.1998.tb04549.x; TALAMASROHANA P, 1994, T ROY SOC TROP MED H, V88, P596, DOI 10.1016/0035-9203(94)90179-1; Urban S, 2005, P NATL ACAD SCI USA, V102, P1883, DOI 10.1073/pnas.0408306102; Urban S, 2014, CELL REP, V8, P1241, DOI 10.1016/j.celrep.2014.07.039; Urban S, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-10-231; Vetrivel KS, 2005, J BIOL CHEM, V280, P25892, DOI 10.1074/jbc.M503570200; Vines RR, 1998, MOL BIOL CELL, V9, P2069, DOI 10.1091/mbc.9.8.2069; Welter BH, 2006, EXP PARASITOL, V113, P91, DOI 10.1016/j.exppara.2005.12.012; Welter BH, 2009, EUKARYOT CELL, V8, P1014, DOI 10.1128/EC.00030-09; Welter BH, 2005, MOL BIOCHEM PARASIT, V140, P161, DOI 10.1016/j.molbiopara.2004.12.011; Welter BH, 2011, INT J PARASITOL, V41, P1409, DOI 10.1016/j.ijpara.2011.10.003; WU FS, 1984, ANAL BIOCHEM, V139, P100, DOI 10.1016/0003-2697(84)90394-4	53	3	3	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2020	15	3							e0219870	10.1371/journal.pone.0219870	http://dx.doi.org/10.1371/journal.pone.0219870			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8RK	32134930	Green Published, gold, Green Submitted			2022-12-26	WOS:000535265600003
J	Weuring, WJ; Singh, S; Volkers, L; Rook, MB; van't Slot, RH; Bosma, M; Inserra, M; Vetter, I; Verhoeven-Duif, NM; Braun, KPJ; Rivara, M; Koeleman, BPC				Weuring, Wout J.; Singh, Sakshi; Volkers, Linda; Rook, Martin B.; van't Slot, Ruben H.; Bosma, Marjolein; Inserra, Marco; Vetter, Irina; Verhoeven-Duif, Nanda M.; Braun, Kees P. J.; Rivara, Mirko; Koeleman, Bobby P. C.			NaV1.1 and NaV1.6 selective compounds reduce the behavior phenotype and epileptiform activity in a novel zebrafish model for Dravet Syndrome	PLOS ONE			English	Article							SEVERE MYOCLONIC EPILEPSY; NA(V)1.1 CHANNELS; MOUSE MODEL; SCN1A; SCN8A	Dravet syndrome is caused by dominant loss-of-function mutations in SCN1A which cause reduced activity of Nav1.1 leading to lack of neuronal inhibition. On the other hand, gain-offunction mutations in SCN8A can lead to a severe epileptic encephalopathy subtype by over activating NaV1.6 channels. These observations suggest that Nav1.1 and Na(v)1.6 represent two opposing sides of the neuronal balance between inhibition and activation. Here, we hypothesize that Dravet syndrome may be treated by either enhancing Nav1.1 or reducing Nav1.6 activity. To test this hypothesis we generated and characterized a novel DS zebrafish model and tested new compounds that selectively activate or inhibit the human Na(V)1.1 or Na(V)1.6 channel respectively. We used CRISPR/Cas9 to generate two separate Scn1Lab knockout lines as an alternative to previous zebrafish models generated by random mutagenesis or morpholino oligomers. Using an optimized locomotor assay, spontaneous burst movements were detected that were unique to Scn1Lab knockouts and disappear when introducing human SCN1A mRNA. Besides the behavioral phenotype, Scn1Lab knockouts show sudden, electrical discharges in the brain that indicate epileptic seizures in zebrafish. Scn1Lab knockouts showed increased sensitivity to the GABA antagonist pentylenetetrazole and a reduction in whole organism GABA levels. Drug screenings further validated a Dravet syndrome phenotype. We tested the Na(V)1.1 activator AA43279 and two novel Na(V)1.6 inhibitors MV1369 and MV1312 in the Scn1Lab knockouts. Both type of compounds significantly reduced the number of spontaneous burst movements and seizure activity. Our results show that selective inhibition of Na(V)1.6 could be just as efficient as selective activation of Na(V)1.1 and these approaches could prove to be novel potential treatment strategies for Dravet syndrome and other (genetic) epilepsies. Compounds tested in zebrafish however, should always be further validated in other model systems for efficacy in mammals and to screen for potential side effects.	[Weuring, Wout J.; Singh, Sakshi; van't Slot, Ruben H.; Bosma, Marjolein; Verhoeven-Duif, Nanda M.; Koeleman, Bobby P. C.] Univ Utrecht, Univ Med Ctr Utrecht, UMC Utrecht Brain Ctr, Dept Genet,Ctr Mol Med, Utrecht, Netherlands; [Volkers, Linda] Univ Med Ctr Leiden, Dept Cardiol, Lab Expt Cardiol, Leiden, Netherlands; [Rook, Martin B.] Univ Med Ctr Utrecht, Dept Med Physiol, Utrecht, Netherlands; [Inserra, Marco; Vetter, Irina] Univ Queensland, Ctr Pain Res, Brisbane, Qld, Australia; [Inserra, Marco; Vetter, Irina] Univ Queensland, Sch Pharm, Brisbane, Qld, Australia; [Braun, Kees P. J.] Univ Med Ctr Utrecht, Dept Neurol, Utrecht, Netherlands; [Rivara, Mirko] Univ Parma, Food & Drug Dept, Parma, Italy	Utrecht University; Utrecht University Medical Center; Leiden University; Leiden University Medical Center (LUMC); Utrecht University; Utrecht University Medical Center; University of Queensland; University of Queensland; Utrecht University; Utrecht University Medical Center; University of Parma	Koeleman, BPC (corresponding author), Univ Utrecht, Univ Med Ctr Utrecht, UMC Utrecht Brain Ctr, Dept Genet,Ctr Mol Med, Utrecht, Netherlands.	b.p.c.koeleman@umcutrecht.nl	; RIVARA, Mirko/R-3505-2017; Vetter, Irina/A-6035-2010	Weuring, Wout/0000-0002-7439-5653; RIVARA, Mirko/0000-0001-6809-0020; Vetter, Irina/0000-0002-3594-9588	Vrienden WKZ fund [1616091]	Vrienden WKZ fund	W.W, S.S., K.P.J.B. and B.P.C.K. were funded by Vrienden WKZ fund 1616091 (Ming); The authors would like to thank Prof. Dr. J. Bakkers and Dr. F. Tessadori (Hubrecht Institute Utrecht, the Netherlands) for help and advice during the project. Compound AA43279 was a kind gift from Dr. T. Benned-Jensen (H.Lundbeck A/S Copenhagen). The authors would like to thank Prof. P. de Witte (K.U. Leuven, Belgium), Dr. A. Zdebik (U.C. Londen, England) and Dr. T.P. de Boer (UMC Utrecht) for their advice on the electrophysiology setup.	Afrikanova Tatiana, 2013, PLoS One, V8, pe54166, DOI 10.1371/journal.pone.0054166; Baraban SC, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3410; Boerma RS, 2016, NEUROTHERAPEUTICS, V13, P192, DOI 10.1007/s13311-015-0372-8; Chen TH, 2011, AQUAT TOXICOL, V102, P162, DOI 10.1016/j.aquatox.2011.01.010; de Bruijn Ewart, 2009, V546, P3, DOI 10.1007/978-1-60327-977-2_1; de Witte P, 2017, BRAIN, V140, DOI 10.1093/brain/awx090; Depienne C, 2009, J MED GENET, V46, P183, DOI 10.1136/jmg.2008.062323; Eimon PM, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02404-4; El-Brolosy MA, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1006780; Escayg A, 2010, EPILEPSIA, V51, P1650, DOI 10.1111/j.1528-1167.2010.02640.x; Escoubas P, 2002, MOL PHARMACOL, V62, P48, DOI 10.1124/mol.62.1.48; Frederiksen K, 2017, EUR J NEUROSCI, V46, P1887, DOI 10.1111/ejn.13626; Gagnon JA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098186; Griffin A, 2017, BRAIN, V140, P669, DOI 10.1093/brain/aww342; Han S, 2012, P NATL ACAD SCI USA, V109, pE368, DOI 10.1073/pnas.1115729109; Hawkins NA, 2017, ANN CLIN TRANSL NEUR, V4, P326, DOI 10.1002/acn3.413; Kandel ER, PRINCIPLES NEURAL SC, V46, P913; Kantae V, 2016, ZEBRAFISH, V13, P504, DOI 10.1089/zeb.2016.1313; Labun K, 2016, NUCLEIC ACIDS RES, V44, pW272, DOI 10.1093/nar/gkw398; Lawson ND, 2016, TRENDS CELL BIOL, V26, P77, DOI 10.1016/j.tcb.2015.11.005; Lorincz A, 2008, J NEUROSCI, V28, P14329, DOI 10.1523/JNEUROSCI.4833-08.2008; Martin MS, 2007, HUM MOL GENET, V16, P2892, DOI 10.1093/hmg/ddm248; Meng H, 2015, HUM MUTAT, V36, P573, DOI 10.1002/humu.22782; Moller RS, 2016, NEUROTHERAPEUTICS, V13, P190, DOI 10.1007/s13311-015-0403-5; Novak AE, 2006, DEV DYNAM, V235; Parihar R, 2013, J HUM GENET, V58, P573, DOI 10.1038/jhg.2013.77; Richards KL, 2018, P NATL ACAD SCI USA, V115, pE8077, DOI 10.1073/pnas.1804764115; Rosker C, 2007, AM J PHYSIOL-CELL PH, V293, pC783, DOI 10.1152/ajpcell.00070.2007; Schoonjans AS, 2015, THER ADV NEUROL DISO, V8, P328, DOI 10.1177/1756285615607726; Stemmer M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124633; Volkers L, 2011, EUR J NEUROSCI, V34, P1268, DOI 10.1111/j.1460-9568.2011.07826.x; Wang JP, 2017, BMC MED GENET, V18, DOI 10.1186/s12881-017-0460-1; Westerfield M., 1993, ZEBRAFISH BOOK GUIDE; Wirrell EC, 2016, CAN J NEUROL SCI, V43, pS13, DOI 10.1017/cjn.2016.249; Ye MY, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-017-17344-8; Yu FH, 2006, NAT NEUROSCI, V9, P1142, DOI 10.1038/nn1754; Zhang YF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125898	37	16	16	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2020	15	3							e0219106	10.1371/journal.pone.0219106	http://dx.doi.org/10.1371/journal.pone.0219106			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8RK	32134913	Green Published, gold			2022-12-26	WOS:000535265600002
J	Arpagaus, A; Franzeck, FC; Sikalengo, G; Ndege, R; Mnzava, D; Rohacek, M; Hella, J; Reither, K; Battegay, M; Glass, TR; Paris, DH; Bani, F; Rajab, ON; Weisser, M				Arpagaus, Armon; Franzeck, Fabian Christoph; Sikalengo, George; Ndege, Robert; Mnzava, Dorcas; Rohacek, Martin; Hella, Jerry; Reither, Klaus; Battegay, Manuel; Glass, Tracy Renee; Paris, Daniel Henry; Bani, Farida; Rajab, Omary Ngome; Weisser, Maja		KIULARCO Study Grp	Extrapulmonary tuberculosis in HIV-infected patients in rural Tanzania: The prospective Kilombero and Ulanga antiretroviral cohort	PLOS ONE			English	Article							MILIARY TUBERCULOSIS; RAPID DIAGNOSIS; XPERT MTB/RIF; PREVALENCE; MORTALITY; THERAPY; ADULTS	Background In sub-Saharan Africa, diagnosis and management of extrapulmonary tuberculosis (EPTB) in people living with HIV (PLHIV) remains a major challenge. This study aimed to characterize the epidemiology and risk factors for poor outcome of extrapulmonary tuberculosis in people living with HIV (PLHIV) in a rural setting in Tanzania. Methods We included PLHIV >18 years of age enrolled into the Kilombero and Ulanga antiretroviral cohort (KIULARCO) from 2013 to 2017. We assessed the diagnosis of tuberculosis by integrating prospectively collected clinical and microbiological data. We calculated prevalence- and incidence rates and used Cox regression analysis to evaluate the association of risk factors in extrapulmonary tuberculosis (EPTB) with a combined endpoint of lost to follow-up (LTFU) and death. Results We included 3,129 subjects (64.5% female) with a median age of 38 years (interquartile range [IQR] 31-46) and a median CD4+ cell count of 229/mu l (IQR 94-421) at baseline. During the median follow-up of 1.25 years (IQR 0.46-2.85), 574 (18.4%) subjects were diagnosed with tuberculosis, whereof 175 (30.5%) had an extrapulmonary manifestation. Microbiological evidence by Acid-Fast-Bacillus stain (AFB-stain) or Xpert (R) MTB/RIF was present in 178/483 (36.9%) patients with pulmonary and in 28/175 (16.0%) of patients with extrapulmonary manifestations, respectively. Incidence density rates for pulmonary Tuberculosis (PTB and EPTB were 17.9/1000 person-years (py) (95% CI 14.2-22.6) and 5.8/1000 py (95% CI 4.0-8.5), respectively. The combined endpoint of death and LTFU was observed in 1058 (33.8%) patients, most frequently in the subgroup of EPTB (47.2%). Patients with EPTB had a higher rate of the composite outcome of death/LTFU after TB diagnosis than with PTB [HR 1.63, (1.14-2.31); p = 0.006]. The adjusted hazard ratios [HR (95% CI)] for death/LTFU in EPTB patients were significantly increased for patients aged >45 years [HR 1.95, (1.15-3.3); p = 0.013], whereas ART use was protective [HR 0.15, (0.08-0.27); p<0.001]. Conclusions Extrapulmonary tuberculosis was a frequent manifestation in this cohort of PLHIV. The diagnosis of EPTB in the absence of histopathology and mycobacterial culture remains challenging even with availability of Xpert (R) MTB/RIF. Patients with EPTB had increased rates of mortality and LTFU despite early recognition of the disease after enrollment.	[Arpagaus, Armon; Rohacek, Martin; Hella, Jerry; Reither, Klaus; Glass, Tracy Renee; Paris, Daniel Henry; Weisser, Maja] Univ Basel, Swiss Trop & Publ Hlth Inst, Basel, Switzerland; [Arpagaus, Armon; Rohacek, Martin; Hella, Jerry; Reither, Klaus; Glass, Tracy Renee; Paris, Daniel Henry] Univ Basel, Basel, Switzerland; [Franzeck, Fabian Christoph; Battegay, Manuel; Weisser, Maja] Univ Basel, Univ Hosp Basel, Div Infect Dis & Hosp Epidemiol, Basel, Switzerland; [Sikalengo, George; Ndege, Robert; Mnzava, Dorcas; Rohacek, Martin; Hella, Jerry; Bani, Farida; Rajab, Omary Ngome; Weisser, Maja] Ifakara Hlth Inst, Ifakara, Tanzania; [Sikalengo, George; Ndege, Robert] St Francis Referral Hosp, Ifakara, Tanzania	University of Basel; Swiss Tropical & Public Health Institute; University of Basel; University of Basel; Ifakara Health Institute	Weisser, M (corresponding author), Univ Basel, Swiss Trop & Publ Hlth Inst, Basel, Switzerland.; Weisser, M (corresponding author), Univ Basel, Univ Hosp Basel, Div Infect Dis & Hosp Epidemiol, Basel, Switzerland.; Weisser, M (corresponding author), Ifakara Hlth Inst, Ifakara, Tanzania.	m.weisser@unibas.ch	Glass, Tracy R/D-5046-2017; Hella, Jerry/I-6738-2017	Glass, Tracy R/0000-0001-7075-9803; Reither, Klaus/0000-0001-6195-8237; Hella, Jerry/0000-0003-2392-8592; Ndege, Robert/0000-0002-1253-8970	Freie Akademische Gesellschaft Basel; Government of the Canton of Basel, Switzerland; Swiss Tropical & Public Health Institute; Ifakara Health Institute; University Hospital Basel; Government of Tanzania; United States Agency for International Development through TUNAJALIDeloitte/USAID Boresha Afya; Freiwillige Akademische Gesellschaft Basel	Freie Akademische Gesellschaft Basel; Government of the Canton of Basel, Switzerland; Swiss Tropical & Public Health Institute; Ifakara Health Institute; University Hospital Basel; Government of Tanzania; United States Agency for International Development through TUNAJALIDeloitte/USAID Boresha Afya; Freiwillige Akademische Gesellschaft Basel(General Electric)	This research was supported by grants from the Freie Akademische Gesellschaft Basel (https://fag-basel.ch).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank the Government of the Canton of Basel, Switzerland, the Swiss Tropical & Public Health Institute, the Ifakara Health Institute, the University Hospital Basel, the Government of Tanzania, and the United States Agency for International Development through TUNAJALIDeloitte/USAID Boresha Afya for support of the CDCI. Furthermore, we thank the "Freiwillige Akademische Gesellschaft Basel" for the financial support.	Ade S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095603; Ahmedov S, 2013, PRINCIPLES RECOMMEND; Albrecht S, 2019, AIDS, V33, P1031, DOI 10.1097/QAD.0000000000002171; Alemie GA, 2014, COMMON TYPES TUBERCU; Alemie GA, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-319; Anderson L., 2018, GLOBAL TUBERCULOSIS; Apers L, 2007, IMPROVING DIAGNOSIS; Barber DL, 2012, NAT REV MICROBIOL, V10, P150, DOI 10.1038/nrmicro2712; Blakemore R, 2010, J CLIN MICROBIOL, V48, P2495, DOI 10.1128/JCM.00128-10; Boehme CC, 2010, NEW ENGL J MED, V363, P1005, DOI 10.1056/NEJMoa0907847; Chakravorty S, 2017, MBIO, V8, DOI [10.1128/mBio.00812-17, 10.1128/mbio.00812-17]; Chammartin F, 2018, CLIN INFECT DIS, V67, P1643, DOI 10.1093/cid/ciy347; Di Tanna GL, 2019, LANCET GLOB HEALTH, V7, pE191, DOI [10.1016/S2214-109X(18)30458-3, 10.1016/s2214-109x(18)30458-3]; Essen Lv, 2018, CHARACTERIZATION ADV; Fanosie A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150646; Govender K, 2017, PAN AFR MED J, V26, DOI 10.11604/pamj.2017.26.126.11000; Gui XW, 2014, INT J CLIN EXP MED, V7, P3126; Gupta RK, 2015, AIDS, V29, P1987, DOI 10.1097/QAD.0000000000000802; Haas AD, 2018, J INT AIDS SOC, V21, DOI 10.1002/jia2.25084; Haraka F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123275; Hoogendoorn JC, 2017, EPIDEMIOL INFECT, V145, P2500, DOI 10.1017/S095026881700156X; Houston AM., 2014, MEDICINE, V42, P18; KIM JH, 1990, REV INFECT DIS, V12, P583; Kohli M, 2018, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD012768.pub2; Letang Emilio, 2017, Swiss Med Wkly, V147, pw14485, DOI 10.4414/smw.2017.14485; MAARTENS G, 1990, AM J MED, V89, P291, DOI 10.1016/0002-9343(90)90340-J; Mhalu G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138413; Ministry of Health and Social Welfare National AIDS Control Programme, 2012, NAT GUID MAN HIV AID; Ministry of Health and Social Welfare T, 2005, NAT GUID CLIN MAN HI; Ministry of Health and Social Welfare T, 2015, NAT GUID MAN HIV AID; Mohammed H, 2018, HIV AIDS-RES PALLIAT, V10, P225, DOI 10.2147/HIV.S176587; Narendran G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063541; Narita M, 1998, AM J RESP CRIT CARE, V158, P157, DOI 10.1164/ajrccm.158.1.9712001; Ndege R, 2019, OPEN FORUM INFECT DI, V6, DOI 10.1093/ofid/ofz154; Ohene SA, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0209650; Pandie S, 2014, BMC MED, V12, DOI 10.1186/1741-7015-12-101; Porcel JM, 2008, RESP MED, V102, P1159, DOI 10.1016/j.rmed.2008.03.001; Qian X, 2018, EMERG MICROBES INFEC, V7, DOI 10.1038/s41426-018-0106-1; RICHTER C, 1991, TROP GEOGR MED, V43, P375; SAHN SA, 1974, AM J MED, V56, P495, DOI 10.1016/0002-9343(74)90482-3; Shah M, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD011420.pub2; Shanmuganathan A, 2013, J CLIN DIAGN RES, V7, P1644, DOI 10.7860/JCDR/2013/6363.3301; Sharma SK, 2004, INDIAN J MED RES, V120, P316; Sikalengo G, 2018, INFECT DIS POVERTY, V7, DOI 10.1186/s40249-018-0404-9; Tatar D, 2016, IRAN J PUBLIC HEALTH, V45, P305; Theron G, 2014, SCI REP-UK, V4, DOI 10.1038/srep05658; Theron G, 2014, LANCET INFECT DIS, V14, P527, DOI 10.1016/S1473-3099(13)70360-8; Tortoli E, 2012, EUR RESPIR J, V40, P442, DOI 10.1183/09031936.00176311; Tweya H, 2019, J INT AIDS SOC, V22, DOI 10.1002/jia2.25240; UNAIDS, 2018, UNAIDS DAT 2018; Vanobberghen F, 2017, 16 EUR AIDS C MIL; Vanobberghen F, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180983; Weber SF, 2018, AM J TROP MED HYG, V98, P266, DOI 10.4269/ajtmh.17-0486; World Health Organization, 2016, INT STAT CLASS DIS R, V10th; Zeka AN, 2011, J CLIN MICROBIOL, V49, P4138, DOI 10.1128/JCM.05434-11; Zurcher K, 2019, J INT AIDS SOC, V22, DOI 10.1002/jia2.25392	56	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2020	15	3							e0229875	10.1371/journal.pone.0229875	http://dx.doi.org/10.1371/journal.pone.0229875			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8QU	32130279	Green Published, gold, Green Accepted			2022-12-26	WOS:000535264000054
J	Boiche, J; Escalera, MY; Chanal, J				Boiche, Julie; Escalera, Marc Yanguez; Chanal, Julien			Students physical activity assessed by accelerometers and motivation for physical education during class: Should we consider lessons as a whole or only active periods?	PLOS ONE			English	Article							SELF-DETERMINED MOTIVATION; SCHOOL; SCALE	Background This study explores the links between measures of motivation based on Self-Determination Theory, and physical activity (PA) indicators assessed with accelerometers during physical education lessons. Methods Questionnaires about motivation and psychological needs on the context of physical education were completed by 319 middle high school students, up to 5 times within a 2-year period; they were equipped with an accelerometer and videotaped during a physical education lesson. PA-related indicators were computed considering the entire duration of the lessons (strategy 1), but also retaining only active times during the lesson (strategy 2). Results When the first strategy was used very few correlations emerged between motivation constructs and PA-related indicators. On the other hand, the second strategy was more effective to detect the link between motivation and students activity during class-time, in particular with sedentary time, moderate and vigorous PA. Conclusions This study shed light on the importance of considering how the sequences of PA sessions should be coded, in order to link psychological phenomena with PA levels, as well as to provide a meaningful support for motivational hypotheses.	[Boiche, Julie] Univ Paul Valery Montpellier 3, Univ Montpellier, EPSYLON, EA 4556, Montpellier, France; [Escalera, Marc Yanguez; Chanal, Julien] Univ Geneva, Fac Psychol, Geneva, Switzerland; [Escalera, Marc Yanguez; Chanal, Julien] Distance Learning Univ, Brig, Switzerland	Universite de Montpellier; Universite Paul-Valery; University of Geneva	Boiche, J (corresponding author), Univ Paul Valery Montpellier 3, Univ Montpellier, EPSYLON, EA 4556, Montpellier, France.; Chanal, J (corresponding author), Univ Geneva, Fac Psychol, Geneva, Switzerland.; Chanal, J (corresponding author), Distance Learning Univ, Brig, Switzerland.	Julie.boiche@umontpellier.fr; Julien.chanal@unige.ch		Chanal, Julien/0000-0002-9670-1340	Swiss National Science Foundation [SNF 100014_132010/1]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	JC was supported by a research grant from the Swiss National Science Foundation (SNF 100014_132010/1)(http://www.snf.ch/en/Pages/default.aspx).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Assor A, 2009, J EDUC PSYCHOL, V101, P482, DOI 10.1037/a0014236; Bryan C.L., 2012, J SPORT BEHAV, V35, P267; Chanal J, 2019, PSYCHOL SPORT EXERC, V43, P233, DOI 10.1016/j.psychsport.2019.03.006; Cheval B, 2016, PREV MED, V87, P170, DOI 10.1016/j.ypmed.2016.02.043; Dohrn IM, 2018, CLIN EPIDEMIOL, V10, P179, DOI 10.2147/CLEP.S151613; Erwin HE, 2013, J TEACH PHYS EDUC, V32, P321, DOI 10.1123/jtpe.32.3.321; Gagne M, 2015, EUR J WORK ORGAN PSY, V24, P178, DOI 10.1080/1359432X.2013.877892; Gao Z, 2013, J SPORT HEALTH SCI, V2, P146, DOI 10.1016/j.jshs.2013.01.005; Gillet N, 2008, CAN J BEHAV SCI, V40, P230, DOI 10.1037/a0013201; Guay F, 2008, CAN PSYCHOL, V49, P233, DOI 10.1037/a0012758; Hollis JL, 2017, INT J BEHAV NUTR PHY, P14; Johnson CE, 2017, J TEACH PHYS EDUC, V36, P398, DOI 10.1123/jtpe.2016-0172; Li FZ, 1999, J APPL SPORT PSYCHOL, V11, P97, DOI 10.1080/10413209908402953; Lonsdale C, 2009, PREV MED, V48, P69, DOI 10.1016/j.ypmed.2008.09.013; Markland D, 2004, J SPORT EXERCISE PSY, V26, P191, DOI 10.1123/jsep.26.2.191; Owen KB, 2014, PREV MED, V67, P270, DOI 10.1016/j.ypmed.2014.07.033; Owen KB, 2013, J ADOLESCENT HEALTH, V53, P420, DOI 10.1016/j.jadohealth.2013.05.007; Pelletier LG, 2007, PSYCHOL SPORT EXERC, V8, P615, DOI 10.1016/j.psychsport.2007.03.006; Ryan RM, 2000, AM PSYCHOL, V55, P68, DOI 10.1037/0003-066X.55.1.68; Sebire SJ, 2013, INT J BEHAV NUTR PHY, V10, DOI 10.1186/1479-5868-10-111; Shephard RJ, 2003, BRIT J SPORT MED, V37, P197, DOI 10.1136/bjsm.37.3.197; Teixeira PJ, 2012, THE INTERNATIONAL JO, P30, DOI DOI 10.1186/1479-5868-9-30; Van den Berghe L, 2014, PHYS EDUC SPORT PEDA, V19, P97, DOI 10.1080/17408989.2012.732563; WHO, 2014, GLOBAL STATUS REPORT ON VIOLENCE PREVENTION 2014, P1	24	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2020	15	3							e0229046	10.1371/journal.pone.0229046	http://dx.doi.org/10.1371/journal.pone.0229046			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LQ8MS	32126099	gold, Green Published			2022-12-26	WOS:000535253100012
J	Yang, JC; Roman-Urrestarazu, A; Brayne, C				Yang, Justin C.; Roman-Urrestarazu, Andres; Brayne, Carol			Responses among substance abuse treatment providers to the opioid epidemic in the USA: Variations in buprenorphine and methadone treatment by geography, operational, and payment characteristics, 2007-16	PLOS ONE			English	Article							MEDICATION-ASSISTED TREATMENT; UNITED-STATES; USE DISORDERS; PRESCRIBE BUPRENORPHINE; CARE; BARRIERS; PROGRAMS; NEED	Objective To identify the geographic, organisational, and payment correlates of buprenorphine and methadone treatment among substance abuse treatment (SAT) providers. Methods Secondary analyses of the National Survey of Substance Abuse Treatment Services (NSSATS) from 2007-16 were conducted. We provide bivariate descriptive statistics regarding substance abuse treatment services which offered buprenorphine and methadone treatment from 2007-16. Using multiple logistic regression, we regressed geographic, organisational, and payment correlates on buprenorphine and methadone treatment. Results Buprenorphine is increasingly offered at SAT facilities though uptake remains comparatively low outside of the northeast. SAT facilities run by tribal governments or Indian Health Service which offer buprenorphine remain low compared to privately operated SAT facilities (AOR = 0.528). The odds of offering buprenorphine among facilities offering free or no charge treatment (AOR = 0.838) or a sliding fee scale (AOR = 0.464) was lower. SAT facilities accepting Medicaid payments showed higher odds of offering methadone treatment (AOR = 2.035). Conclusions Greater attention towards the disparities in provision of opioid agonist therapies is warranted, especially towards the reasons why uptake has been moderate among civilian providers. Additionally, the care needs of Native Americans facing opioid-related use disorders bears further scrutiny.	[Yang, Justin C.; Roman-Urrestarazu, Andres; Brayne, Carol] Univ Cambridge, Cambridge Inst Publ Hlth, Cambridge, England; [Yang, Justin C.] UCL, Fac Brain Sci, Div Psychiat, Dept Epidemiol & Appl Clin Res, London, England	University of Cambridge; University of London; University College London	Yang, JC (corresponding author), Univ Cambridge, Cambridge Inst Publ Hlth, Cambridge, England.; Yang, JC (corresponding author), UCL, Fac Brain Sci, Div Psychiat, Dept Epidemiol & Appl Clin Res, London, England.	justin.yang@ucl.ac.uk	Roman-Urrestarazu, Andres/U-9224-2018; Yang, Justin Christopher/H-1780-2018	Roman-Urrestarazu, Andres/0000-0002-2405-9432; Yang, Justin Christopher/0000-0003-2881-4906; Brayne, Carol/0000-0001-5307-663X				AJTJoP, 2005, TRENDS ABUSE OXYCONT, V6, P662; [Anonymous], 2013, STAT STAT SOFTW REL; Blum K, 2016, SUBST USE MISUSE, V51, P1674, DOI 10.1080/10826084.2016.1200097; Brady KT, 2016, AM J PSYCHIAT, V173, P18, DOI 10.1176/appi.ajp.2015.15020262; Cantor J, 2017, J SUBST ABUSE TREAT, V81, P59, DOI 10.1016/j.jsat.2017.07.005; Chen LY, 2013, J ADDICT MED, V7, P325, DOI 10.1097/ADM.0b013e31829b7afe; Choi NG, 2014, DRUG ALCOHOL DEPEN, V145, P113, DOI 10.1016/j.drugalcdep.2014.10.004; Clark RE, 2011, HEALTH AFFAIR, V30, P1425, DOI 10.1377/hlthaff.2010.0532; Duncan Laura G, 2015, J Addict Med Ther Sci, V1, P31; Fullerton CA, 2014, PSYCHIAT SERV, V65, P146, DOI 10.1176/appi.ps.201300235; Huhn AS, 2017, J SUBST ABUSE TREAT, V78, P1, DOI 10.1016/j.jsat.2017.04.005; Jones CM, 2015, AM J PUBLIC HEALTH, V105, pE55, DOI 10.2105/AJPH.2015.302664; Kampman K, 2015, J ADDICT MED, V9, P358, DOI 10.1097/ADM.0000000000000166; Knudsen HK, 2017, DRUG ALCOHOL DEPEN, V173, pS55, DOI 10.1016/j.drugalcdep.2016.08.642; Knudsen HK, 2015, DRUG ALCOHOL DEPEN, V157, P36, DOI 10.1016/j.drugalcdep.2015.09.032; Knudsen HK, 2015, J STUD ALCOHOL DRUGS, V76, P644, DOI 10.15288/jsad.2015.76.644; Kolodny A, 2015, ANNU REV PUBL HEALTH, V36, P559, DOI 10.1146/annurev-publhealth-031914-122957; Kresina T., 2009, J DRUG POLICY ANAL, V2, DOI [DOI 10.2202/1941-2851.1007, 10.2202/1941-2851.1007]; Lofwall MR, 2012, DRUG ALCOHOL DEPEN, V126, P379, DOI 10.1016/j.drugalcdep.2012.05.025; Meyer R, 2014, POPUL HEALTH MANAG, V17, P372, DOI 10.1089/pop.2013.0098; Momper SL, 2012, FAM SOC, V93, P312, DOI 10.1606/1044-3894.4242; Paulozzi LJ, 2006, AM J PREV MED, V31, P506, DOI 10.1016/j.amepre.2006.08.017; Pergolizzi JV, 2018, J PAIN RES, V11, P301, DOI 10.2147/JPR.S127602; Quinn PD, 2017, PAIN, V158, P140, DOI 10.1097/j.pain.0000000000000730; Rieckmann T, 2017, PSYCHIAT SERV, V68, P1136, DOI 10.1176/appi.ps.201600397; Rieckmann T, 2016, J SUBST ABUSE TREAT, V68, P46, DOI 10.1016/j.jsat.2016.05.007; Rieckmann TR, 2011, J SUBST ABUSE TREAT, V41, P374, DOI 10.1016/j.jsat.2011.05.005; Rosenblatt RA, 2015, ANN FAM MED, V13, P23, DOI 10.1370/afm.1735; Rudd RA, 2016, MMWR-MORBID MORTAL W, V65, P1445, DOI 10.15585/mmwr.mm655051e1; Short VL, 2018, J SUBST ABUSE TREAT, V89, P67, DOI 10.1016/j.jsat.2018.04.003; Stein BD, 2015, MILBANK Q, V93, P561, DOI 10.1111/1468-0009.12137; Substance Abuse and Mental Health Services Administration, 2016, LEARN 8 DIM WELLN; Substance Abuse and Mental Health Services Administration, 2011, NAT SURV SUBST AB TR; Thomas CP, 2014, PSYCHIAT SERV, V65, P158, DOI 10.1176/appi.ps.201300256; United States Department of Health and Human Services, 2015, NAT SURV SUBST AB TR; United States Department of Health and Human Services, 2014, NAT SURV SUBST AB TR; United States Department of Health and Human Services, 2013, NAT SURV SUBST AB TR; United States Department of Health and Human Services, 2010, NAT SURV SUBST AB TR; United States Department of Health and Human Services, 2012, NAT SURV SUBST AB TR; United States Department of Health and Human Services, 2008, NAT SURV SUBST AB TR; United States Department of Health and Human Services, 2007, NAT SURV SUBST AB TR; United States Department of Health and Human Services, 2009, NAT SURV SUBST AB TR; Vadivelu N, 2018, CURR PAIN HEADACHE R, V22, DOI 10.1007/s11916-018-0679-3; Vivolo-Kantor AM, 2018, MMWR-MORBID MORTAL W, V67, P279, DOI 10.15585/mmwr.mm6709e1	44	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2020	15	3							e0229787	10.1371/journal.pone.0229787	http://dx.doi.org/10.1371/journal.pone.0229787			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LQ8MS	32126120	Green Published, gold			2022-12-26	WOS:000535253100052
J	Campbell, AD; Wang, YQ				Campbell, Anthony Daniel; Wang, Yeqiao			Salt marsh monitoring along the mid-Atlantic coast by Google Earth Engine enabled time series	PLOS ONE			English	Article							SPARTINA-ALTERNIFLORA; TIDAL MARSH; BIOMASS ALLOCATION; CLIMATE-CHANGE; RIVER DELTA; DIE-OFF; WETLANDS; MODEL; PERSISTENCE; RESTORATION	Salt marshes provide a bulwark against sea-level rise (SLR), an interface between aquatic and terrestrial habitats, important nursery grounds for many species, a buffer against extreme storm impacts, and vast blue carbon repositories. However, salt marshes are at risk of loss from a variety of stressors such as SLR, nutrient enrichment, sediment deficits, herbivory, and anthropogenic disturbances. Determining the dynamics of salt marsh change with remote sensing requires high temporal resolution due to the spectral variability caused by disturbance, tides, and seasonality. Time series analysis of salt marshes can broaden our understanding of these changing environments. This study analyzed aboveground green biomass (AGB) in seven mid-Atlantic Hydrological Unit Code 8 (HUC-8) watersheds. The study revealed that the Eastern Lower Delmarva watershed had the highest average loss and the largest net reduction in salt marsh AGB from 1999-2018. The study developed a method that used Google Earth Engine (GEE) enabled time series of the Landsat archive for regional analysis of salt marsh change and identified at-risk watersheds and salt marshes providing insight into the resilience and management of these ecosystems. The time series were filtered by cloud cover and the Tidal Marsh Inundation Index (TMII). The combination of GEE enabled Landsat time series, and TMII filtering demonstrated a promising method for historic assessment and continued monitoring of salt marsh dynamics.	[Campbell, Anthony Daniel; Wang, Yeqiao] Univ Rhode Isl, Dept Nat Resources Sci, Kingston, RI 02881 USA; [Campbell, Anthony Daniel] Yale Sch Forestry & Environm Studies, New Haven, CT USA	University of Rhode Island; Yale University	Wang, YQ (corresponding author), Univ Rhode Isl, Dept Nat Resources Sci, Kingston, RI 02881 USA.	yqwang@uri.edu			National Park Service [NPS_P14AC00230]; Environmental Data Center at the University of Rhode Island; NASA RI Space Grant; NSF [BSR-8702333-06, DEB-9211772, DEB-9411974, DEB-0080381, DEB-0621014, DEB-1237733]	National Park Service; Environmental Data Center at the University of Rhode Island; NASA RI Space Grant; NSF(National Science Foundation (NSF))	Y.W received funding from the National Park Service as part of grant number: NPS_P14AC00230. The funding organization website can be found at https://www.nps.gov/index.htm.Y.W.also received publication support from the Environmental Data Center at the University of Rhode Island funding organizations website can be found at https://www.edc.uri.edu/.A.D.C.received support from the NASA RI Space Grant. Funding organization website can be found at https://www.brown.edu/initiatives/ri-spacegrant/.A.D.C.also received data access to in situ biomass estimates from the Virginia Coast Reserve Long-Term Ecological Research with support of NSF Grants BSR-8702333-06, DEB-9211772, DEB-9411974, DEB-0080381, DEB-0621014 and DEB-1237733. The organizations website can be found at https://www.vcrlter.virginia.edu/home2/.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alizad K, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0205176; ANDERSON GL, 1993, REMOTE SENS ENVIRON, V45, P165, DOI 10.1016/0034-4257(93)90040-5; Anisfeld SC, 2017, GLOBAL CHANGE BIOL, V23, P755, DOI 10.1111/gcb.13398; Armitage AR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125404; Basu S, 2007, KNOWL INF SYST, V11, P137, DOI 10.1007/s10115-006-0026-6; Boon JD, 2012, J COASTAL RES, V28, P1437, DOI 10.2112/JCOASTRES-D-12-00102.1; Byrd K, 2017, US GEOLOG SURV DATA, V10; Byrd KB, 2018, ISPRS J PHOTOGRAMM, V139, P255, DOI 10.1016/j.isprsjprs.2018.03.019; Byrd KB, 2014, REMOTE SENS ENVIRON, V149, P166, DOI 10.1016/j.rse.2014.04.003; Cahoon DR, ESTUARIES COASTS, P1; Cameron Engineering and Associates, 2015, NEW ENGLAND INTERSTA, V1, P207; Campbell A, 2018, IEEE T GEOSCI REMOTE, V56, P5169, DOI 10.1109/TGRS.2018.2810503; Campbell A, 2017, REMOTE SENS-BASEL, V9, DOI 10.3390/rs9020131; Christian R, 2014, END YEAR BIOMASS MAR; Cleveland R.B., 1990, J OFF STAT, V6, P3; Corman SS, 2012, J COASTAL RES, V28, P874, DOI 10.2112/JCOASTRES-D-11-00012.1; Cowardin L.M., 1979, CLASSIFICATION WETLA; Crawford JT, 2015, WETLANDS, V35, P13, DOI 10.1007/s13157-014-0588-0; Crosby SC, 2017, ESTUAR COAST, V40, P213, DOI 10.1007/s12237-016-0142-9; Crosby SC, 2016, ESTUAR COAST SHELF S, V181, P93, DOI 10.1016/j.ecss.2016.08.018; Crosby SC, 2015, AM J BOT, V102, P669, DOI 10.3732/ajb.1400534; Crotty SM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183058; DAME RF, 1986, MAR ECOL PROG SER, V32, P71, DOI 10.3354/meps032071; Davranche A, 2010, REMOTE SENS ENVIRON, V114, P552, DOI 10.1016/j.rse.2009.10.009; Deaton CD, 2017, GEOLOGY, V45, P123, DOI 10.1130/G38459.1; Deegan LA, 2012, NATURE, V490, P388, DOI 10.1038/nature11533; DeVries B, 2015, REMOTE SENS ENVIRON, V161, P107, DOI 10.1016/j.rse.2015.02.012; Dong JW, 2015, REMOTE SENS ENVIRON, V160, P99, DOI 10.1016/j.rse.2015.01.004; DUNN OJ, 1964, TECHNOMETRICS, V6, P241, DOI 10.2307/1266041; Elsey-Quirk T, 2011, WETLANDS, V31, P87, DOI 10.1007/s13157-010-0139-2; Estel S, 2015, REMOTE SENS ENVIRON, V163, P312, DOI 10.1016/j.rse.2015.03.028; Fu BL, 2017, ECOL INDIC, V73, P105, DOI 10.1016/j.ecolind.2016.09.029; Fu P, 2016, REMOTE SENS ENVIRON, V175, P205, DOI 10.1016/j.rse.2015.12.040; Geraldi NR, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0055100, 10.1371/journal.pone.0069244]; Hird JN, 2017, REMOTE SENS-BASEL, V9, DOI 10.3390/rs9121315; Holdredge C, 2009, CONSERV BIOL, V23, P672, DOI 10.1111/j.1523-1739.2008.01137.x; JENSEN JR, 1993, PHOTOGRAMM ENG REM S, V59, P1039; Jin YW, 2016, OCEAN COAST MANAGE, V123, P44, DOI 10.1016/j.ocecoaman.2016.01.013; Kayastha N, 2012, WETLANDS, V32, P1149, DOI 10.1007/s13157-012-0345-1; KEARNEY MS, 1991, J COASTAL RES, V7, P403; Kirwan ML, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL045489; Klemas V, 2011, J COASTAL RES, V27, P418, DOI 10.2112/JCOASTRES-D-10-00174.1; KRUSKAL WH, 1952, J AM STAT ASSOC, V47, P583, DOI 10.1080/01621459.1952.10483441; Liu MY, 2018, REMOTE SENS-BASEL, V10, DOI 10.3390/rs10121933; Mariotti G, 2013, P NATL ACAD SCI USA, V110, P5353, DOI 10.1073/pnas.1219600110; Matthews JW, 2016, WETLANDS, V36, P1155, DOI 10.1007/s13157-016-0836-6; MCKEE KL, 1988, ESTUARIES, V11, P143, DOI 10.2307/1351966; Morris JT, 2002, ECOLOGY, V83, P2869, DOI 10.1890/0012-9658(2002)083[2869:ROCWTR]2.0.CO;2; Mudd SM, 2004, COAST ESTUAR STUD, V59, P165; Najjar RG, 2000, CLIMATE RES, V14, P219, DOI 10.3354/cr014219; Nelson JL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038558; O'Connell JL, 2017, REMOTE SENS ENVIRON, V201, P34, DOI 10.1016/j.rse.2017.08.008; O'Donnell JPR, 2016, REMOTE SENS-BASEL, V8, DOI 10.3390/rs8060477; Pasquarella VJ, 2016, REMOTE SENS ECOL CON, V2, P152, DOI 10.1002/rse2.24; Raposa KB, 2017, ESTUAR COAST, V40, P640, DOI 10.1007/s12237-015-0018-4; Roman CT, 2017, ESTUAR COAST, V40, P711, DOI 10.1007/s12237-016-0149-2; Roy DP, 2016, REMOTE SENS ENVIRON, V185, P57, DOI 10.1016/j.rse.2015.12.024; Saintilan N, 2014, GLOBAL CHANGE BIOL, V20, P147, DOI 10.1111/gcb.12341; Schepers L, 2017, LIMNOL OCEANOGR, V62, P137, DOI 10.1002/lno.10381; Schile LM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088760; Schuerch M, 2018, NATURE, V561, P231, DOI 10.1038/s41586-018-0476-5; Silliman BR, 2001, ECOLOGY, V82, P2830, DOI 10.1890/0012-9658(2001)082[2830:TDCOSA]2.0.CO;2; Simas T, 2001, ECOL MODEL, V139, P1, DOI 10.1016/S0304-3800(01)00226-5; Snedden GA, 2015, ECOL ENG, V81, P133, DOI 10.1016/j.ecoleng.2015.04.035; Stedman S.M., 2013, STATUS TRENDS WETLAN; Sweet W., 2017, NOAA TECHNICAL REPOR, DOI 10.7289/v5/tr-nos-coops-083; Taylor S.J., 2017, FORECASTING SCALE; U.S. Geological Society, 2013, 100 MET RES IMP SURF; Verbesselt J, 2010, REMOTE SENS ENVIRON, V114, P106, DOI 10.1016/j.rse.2009.08.014; Vogelmann JE, 2016, REMOTE SENS ENVIRON, V185, P258, DOI 10.1016/j.rse.2016.02.060; Wang YQ, 2018, NPSNCBNNRR20181717; Watson EB, 2017, ESTUAR COAST, V40, P617, DOI [10.1007/s12237-016-0166-1, 10.1007/s12237-016-0069-1]; Weatherall P, 2015, EARTH SPACE SCI, V2, P331, DOI 10.1002/2015EA000107; Weston NB, 2014, ESTUAR COAST, V37, P1, DOI 10.1007/s12237-013-9654-8; Yuan Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053843; Zhao B, 2009, ECOL INDIC, V9, P346, DOI 10.1016/j.ecolind.2008.05.009; Zhu Z, 2016, REMOTE SENS ENVIRON, V185, P243, DOI 10.1016/j.rse.2016.03.036	77	22	23	8	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2020	15	2							e0229605	10.1371/journal.pone.0229605	http://dx.doi.org/10.1371/journal.pone.0229605			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8HR	32109951	Green Published, gold			2022-12-26	WOS:000535239800016
J	Cheng, FY; Su, SY; Zhu, XF; Jia, X; Tian, HM; Zhai, XG; Guan, W; Zhou, YJ				Cheng, Fangyun; Su, Shengyan; Zhu, Xiaofei; Jia, Xin; Tian, Haimeng; Zhai, Xuguang; Guan, Wei; Zhou, Yajun			Leptin promotes methionine adenosyltransferase 2A expression in hepatic stellate cells by the downregulation of E2F-4 via the beta-catenin pathway	FASEB JOURNAL			English	Article						hyperleptinemia; liver fibrosis; methylation; obesity; signaling transduction	BINDING PROTEIN-1C EXPRESSION; GAMMA GENE-EXPRESSION; LIVER FIBROSIS; IN-VIVO; INHIBITION; ACTIVATION; CONTRIBUTES; INDUCTION; PHENOTYPE; MEDIATE	Most obese patients develop hyperleptinaemia. Leptin, mainly produced by adipocytes, demonstrates a promotional role in liver fibrosis. Hepatic stellate cell (HSC) activation, a key step in liver fibrogenesis, requires global reprogramming of gene expression. The remodeling of DNA methylation is a mechanism of the epigenetic regulation of gene expression. The biosynthesis of S-adenosylmethionine, a principle biological methyl donor, is catalyzed by methionine adenosyltransferase (MAT) such as MATII which has been shown to promote HSC activation in vitro. This study was mainly aimed to determine the effect of leptin on MAT2A expression (the catalytic subunit of MATII) in HSCs. Results showed that MAT2A knockdown reduced leptin-induced HSC activation and liver fibrosis in the leptin-deficient mouse model. Leptin promoted MAT2A expression in HSCs and increased MAT2A promoter activity. The axis of the beta-catenin pathway/E2F-4 mediated the effect of leptin on MAT2A expression. Leptin-induced beta-catenin signaling reduced E2F-4 expression and thus abated E2F-4 binding to MAT2A promoter at a site around -2779 bp, leading to an increase in the MAT2A promoter activity. These data might shed more light on the mechanisms responsible for liver fibrogenesis in obese patients with hyperleptinaemia.	[Cheng, Fangyun; Su, Shengyan; Jia, Xin; Tian, Haimeng; Zhai, Xuguang; Zhou, Yajun] Nantong Univ, Coll Med, Dept Biochem & Mol Biol, Qi Xiou Rd 19, Nantong 226001, Jiangsu, Peoples R China; [Zhu, Xiaofei; Guan, Wei] Nantong Univ, Sch Pharm, Dept Pharmacol, Nantong, Peoples R China	Nantong University; Nantong University	Zhou, YJ (corresponding author), Nantong Univ, Coll Med, Dept Biochem & Mol Biol, Qi Xiou Rd 19, Nantong 226001, Jiangsu, Peoples R China.	zhouyajun6464@hotmail.com			National Natural Science Foundation of China (NSFC) [81570553]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	National Natural Science Foundation of China (NSFC), Grant/Award Number: 81570553	Akhmetshina A, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1734; Aleffi S, 2005, HEPATOLOGY, V42, P1339, DOI 10.1002/hep.20965; Cai SP, 2016, MOL IMMUNOL, V80, P58, DOI 10.1016/j.molimm.2016.11.002; Cao Q, 2007, J HEPATOL, V46, P124, DOI 10.1016/j.jhep.2006.07.027; Choi SS, 2010, J BIOL CHEM, V285, P36551, DOI 10.1074/jbc.M110.168542; Elinav E, 2009, HEPATOLOGY, V49, P278, DOI 10.1002/hep.22584; Galli A, 2002, GASTROENTEROLOGY, V122, P1924, DOI 10.1053/gast.2002.33666; Hernandez-Gea V, 2011, ANNU REV PATHOL-MECH, V6, P425, DOI 10.1146/annurev-pathol-011110-130246; Honda H, 2002, HEPATOLOGY, V36, P12, DOI 10.1053/jhep.2002.33684; Hsu J, 2016, CELL CYCLE, V15, P3183, DOI 10.1080/15384101.2016.1234551; Jia XW, 2011, CELL BIOL INT, V35, P697, DOI 10.1042/CBI20100298; Lee BK, 2011, NUCLEIC ACIDS RES, V39, P3558, DOI 10.1093/nar/gkq1313; Liuzzi A, 1999, INT J OBESITY, V23, P1066, DOI 10.1038/sj.ijo.0801036; Mato JM, 2007, HEPATOLOGY, V45, P1306, DOI 10.1002/hep.21650; McCullough AJ, 1999, HEPATOLOGY, V29, P1328, DOI 10.1002/hep.510290451; Page A, 2016, J HEPATOL, V64, P661, DOI 10.1016/j.jhep.2015.11.024; Petrov N, 2012, STEM CELLS DEV, V21, P589, DOI 10.1089/scd.2011.0048; Qiao HW, 2016, BBA-MOL BASIS DIS, V1862, P2186, DOI 10.1016/j.bbadis.2016.09.001; Ramani K, 2008, HEPATOLOGY, V47, P521, DOI 10.1002/hep.22064; Ramani K, 2010, HEPATOLOGY, V51, P986, DOI 10.1002/hep.23411; Ratziu V, 2000, GASTROENTEROLOGY, V118, P1117, DOI 10.1016/S0016-5085(00)70364-7; Rezvani M, 2016, CELL STEM CELL, V18, P809, DOI 10.1016/j.stem.2016.05.005; Stefanovic A, 2008, DIABETES RES CLIN PR, V79, P156, DOI 10.1016/j.diabres.2007.07.019; Tomasi ML, 2013, EXP CELL RES, V319, P1902, DOI 10.1016/j.yexcr.2013.04.005; Tsukamoto H, 2005, ALCOHOL CLIN EXP RES, V29, p132S, DOI 10.1097/01.alc.0000189279.92602.f0; Yan KF, 2012, MOL MED, V18, P10, DOI 10.2119/molmed.2011.00243; Yochum GS, 2007, J BIOL CHEM, V282, P871, DOI 10.1074/jbc.M609391200; Zhai XG, 2013, BRIT J PHARMACOL, V169, P197, DOI 10.1111/bph.12114; Zhang W, 2013, INT J BIOCHEM CELL B, V45, P736, DOI 10.1016/j.biocel.2012.12.019; Zhang X, 2019, INT C COMP SUPP COOP, P10, DOI 10.1109/CSCWD.2019.8791924; Zhou Q, 2014, BBA-MOL BASIS DIS, V1842, P2367, DOI 10.1016/j.bbadis.2014.10.001; Zhou YJ, 2010, MOL CELL ENDOCRINOL, V323, P193, DOI 10.1016/j.mce.2010.03.005; Zhou YJ, 2009, MOL CELL BIOCHEM, V325, P131, DOI 10.1007/s11010-009-0027-3	33	9	12	2	10	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2020	34	4					5578	5589		10.1096/fj.201903021RR	http://dx.doi.org/10.1096/fj.201903021RR		FEB 2020	12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	LJ5ZA	32108965				2022-12-26	WOS:000517910100001
J	Chen, J; Zhang, YL; Chen, C; Zhang, Y; Zhou, W; Sang, YX				Chen, Jia; Zhang, Yalun; Chen, Chen; Zhang, Yan; Zhou, Wei; Sang, Yaxin			Identification and quantification of cassava starch adulteration in different food starches by droplet digital PCR	PLOS ONE			English	Article							REAL-TIME PCR; PORK; QUANTITATION	We report a rapid and accurate quantitative detection method using droplet digital PCR (ddPCR) technology to identify cassava adulteration in starch products. The ddPCR analysis showed that the weight of cassava (M) and cassava-extracted DNA content had a significant linear relationship-the correlation coefficient was R-2 = 0.995, and the maximum coefficient of variation of replicates was 7.48%. The DNA content and DNA copy number (C) measured by ddPCR also had a linear relationship with R-2 = 0.992; the maximum coefficient of variation of replicates was 8.85%. The range of cassava ddPCR DNA content was 25 ng/mu L, and the formula M = (C + 32.409)/350.579 was obtained by converting DNA content into the median signal. The accuracy and application potential of the method were verified using the constructed adulteration model.	[Chen, Jia; Sang, Yaxin] Hebei Agr Univ, Coll Food Sci & Technol, Baoding, Hebei, Peoples R China; [Zhang, Yalun; Chen, Chen; Zhang, Yan; Zhou, Wei] Hebei Food Inspect & Res Inst, Hebei Food Safety Key Lab, Shijiazhuang, Hebei, Peoples R China	Hebei Agricultural University	Sang, YX (corresponding author), Hebei Agr Univ, Coll Food Sci & Technol, Baoding, Hebei, Peoples R China.; Zhou, W (corresponding author), Hebei Food Inspect & Res Inst, Hebei Food Safety Key Lab, Shijiazhuang, Hebei, Peoples R China.	zhouwei0311@163.com; sangyaxin@sina.com	Zhang, Yan/GZA-4648-2022	Zhang, Yan/0000-0002-2947-1629; Yaxin, Sang/0000-0003-1071-8297; Zhou, Wei/0000-0003-1763-714X	South China Agricultural University [2017YFC1601700]	South China Agricultural University	This work was supported by South China Agricultural University [grant number 2017YFC1601700].	Ali ME, 2012, MEAT SCI, V91, P454, DOI 10.1016/j.meatsci.2012.02.031; Bharuthram A, 2014, INFECT GENET EVOL, V25, P28, DOI 10.1016/j.meegid.2014.03.028; Bhat S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039181; Blaya J, 2016, PEST MANAG SCI, V72, P747, DOI 10.1002/ps.4048; Brunetto GS, 2014, J NEUROVIROL, V20, P341, DOI 10.1007/s13365-014-0249-3; Burd A, 2011, REGENERATIVE MEDICINE USING PREGNANCY-SPECIFIC BIOLOGICAL SUBSTANCES, P3, DOI 10.1007/978-1-84882-718-9_1; Calvo JH, 2002, J AGR FOOD CHEM, V50, P5265, DOI 10.1021/jf0201576; Chacon J, 2008, MOL PHYLOGENET EVOL, V49, P260, DOI 10.1016/j.ympev.2008.07.015; Drabkova L, 2004, J MOL EVOL, V59, P1, DOI 10.1007/s00239-004-2598-7; Han JM, 2015, CHINA ECON REV, V36, P325, DOI 10.1016/j.chieco.2015.07.003; Jia QZ, 2015, 2015 2ND INTERNATIONAL CONFERENCE ON MECHATRONIC SYSTEMS AND MATERIALS APPLICATION (ICMSMA 2015), P38; Koppel R, 2011, EUR FOOD RES TECHNOL, V232, P151, DOI 10.1007/s00217-010-1371-y; Pinheiro LB, 2012, ANAL CHEM, V84, P1003, DOI 10.1021/ac202578x; Pohl G, 2004, EXPERT REV MOL DIAGN, V4, P41, DOI 10.1586/14737159.4.1.41; Rodriguez MA, 2005, MEAT SCI, V70, P113, DOI 10.1016/j.meatsci.2004.12.005; Strain MC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055943; SYKES PJ, 1992, BIOTECHNIQUES, V13, P444; Vogelstein B, 1999, P NATL ACAD SCI USA, V96, P9236, DOI 10.1073/pnas.96.16.9236; Xu ZQ, 2005, CHINA QUALITY SUPERV, V8, P45, DOI [10.3969/j.issn.1008-1607.2005.08.025, DOI 10.3969/J.ISSN.1008-1607.2005.08.025]; Zhang Y, 2016, PLOS ONE, V11, DOI [10.1371/journal.pone.0168604, 10.1371/journal.pone.0146784]	20	3	3	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2020	15	2							e0228624	10.1371/journal.pone.0228624	http://dx.doi.org/10.1371/journal.pone.0228624			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8FM	32101546	Green Published, gold			2022-12-26	WOS:000535233700010
J	Labrie, G; Gagnon, AE; Vanasse, A; Latraverse, A; Tremblay, G				Labrie, Genevieve; Gagnon, Annie-Eve; Vanasse, Anne; Latraverse, Alexis; Tremblay, Gilles			Impacts of neonicotinoid seed treatments on soil-dwelling pest populations and agronomic parameters in corn and soybean in Quebec (Canada)	PLOS ONE			English	Article							WIREWORMS COLEOPTERA-ELATERIDAE; SYSTEMIC INSECTICIDES; ENVIRONMENTAL RISKS; AGRIOTES SPP.; COVER CROP; MANAGEMENT; FIPRONIL; GROWTH; APHID; MAIZE	Agricultural soil pests, including wireworms (Coleoptera: Elateridae), are managed primarily with pesticides applied directly to seeds before sowing. Seeds coated with neonicotinoids have been used widely in Quebec (Canada) for several years. To assess the agronomic and economic value of neonicotinoid seed treatments in soybeans and corn in Quebec, trials were conducted from 2012 to 2016 in 84 fields across seven regions in Quebec. We evaluated the effect of neonicotinoid seed treatments on soil pest densities, crop damage and yield. The results showed that 92.6% of corn fields and 69.0% of soybean fields had less than 1 wireworm per bait trap. However, no significant differences in plant stand or yield were observed between treated and untreated corn or soybeans during the study. This study shows that neonicotinoid seed treatments in field crops in Quebec are useful in less than 5% of cases, given the very low level of pest-associated pressure and damage, and that they should not be used prophylactically. Integrated pest management (IPM) strategies need to be developed for soil insect pests to offer effective alternative solutions to producers.	[Labrie, Genevieve; Gagnon, Annie-Eve; Latraverse, Alexis; Tremblay, Gilles] Ctr Rech Grains Inc CEROM, St Mathieu De Beloeil, PQ, Canada; [Vanasse, Anne] Univ Laval, Dept Phytol, Quebec City, PQ, Canada; [Labrie, Genevieve] Ctr Rech Agroalimentaire Mirabel CRAM, Mirabel, PQ, Canada; [Gagnon, Annie-Eve] Agr & Agri Food Canada, Res & Dev Ctr, St Jean, PQ, Canada; [Tremblay, Gilles] Minist Agr Pecheries & Alimentat Quebec, St Hyacinthe, PQ, Canada	Laval University; Agriculture & Agri Food Canada	Labrie, G (corresponding author), Ctr Rech Grains Inc CEROM, St Mathieu De Beloeil, PQ, Canada.; Labrie, G (corresponding author), Ctr Rech Agroalimentaire Mirabel CRAM, Mirabel, PQ, Canada.	glabrie@cram-mirabel.com		Labrie, Genevieve/0000-0002-0163-8896	Ministere de l'Agriculture, des Pecheries et de l'Alimentation du Quebec [PV 3.22014-003, PV3.2-2014-020, CERO-1-LUT-111582]	Ministere de l'Agriculture, des Pecheries et de l'Alimentation du Quebec	Labrie, G. The 5 years studies in corn and soybean have been possible by funding from the program Prime-Vert Volet 11.1 and Volet 3.2 of the Ministere de l'Agriculture, des Pecheries et de l'Alimentation du Quebec project number PV 3.22014-003, PV3.2-2014-020, CERO-1-LUT-111582. The funders did not play any role in the study design, data collection, analysis, decision to publish or preparation of the manuscript.	Afifi M, 2015, PEST MANAG SCI, V71, P505, DOI 10.1002/ps.3789; Alford AM, 2018, J ECON ENTOMOL, V111, P689, DOI 10.1093/jee/tox379; Alford A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173836; Barsics Fanny, 2013, Insects, V4, P117, DOI 10.3390/insects4010117; Barton K, 2019, R PACKAGE VERSION, V1, P6, DOI DOI 10.1016/J.AGEE.2019.04.009; Barzman M, 2015, AGRON SUSTAIN DEV, V35, P1199, DOI 10.1007/s13593-015-0327-9; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Becker EC, 1956, CANADIAN ENTOMOLO S1, V88, P1, DOI [DOI 10.4039/ENTM8801FV, 10.4039/entm8801fv]; Becker EC, 1991, IMMATURE INSECTS, P409; Benefer CM, 2013, J PEST SCI, V86, P19, DOI 10.1007/s10340-012-0454-x; Bohner H, 2009, INCREASING PROFITS P; Bolker BM, 2009, TRENDS ECOL EVOL, V24, P127, DOI 10.1016/j.tree.2008.10.008; Bonmatin JM, 2015, ENVIRON SCI POLLUT R, V22, P35, DOI 10.1007/s11356-014-3332-7; Bousquet Y, 2013, ZOOKEYS, P1, DOI 10.3897/zookeys.360.4742; Cataneo AC, 2011, SOYBEAN PHYSL BIOCH, P231; Chabert A., 1992, PHYTOMA, V436, P26; Chagnon M, 2015, ENVIRON SCI POLLUT R, V22, P119, DOI 10.1007/s11356-014-3277-x; Chretien F, 2017, ENVIRON POLLUT, V224, P255, DOI 10.1016/j.envpol.2017.02.002; Cox WJ, 2007, CROP SCI, V47, P2482, DOI 10.2135/cropsci2006.12.0810; Cox WJ, 2011, AGRON J, V103, P1366, DOI 10.2134/agronj2011.0129; Cox WJ, 2008, AGRON J, V100, P1662, DOI 10.2134/agronj2008.0015; Douglas MR, 2016, PEERJ, V4, DOI 10.7717/peerj.2776; Douglas MR, 2015, ENVIRON SCI TECHNOL, V49, P5088, DOI 10.1021/es506141g; Elbert A, 2008, PEST MANAG SCI, V64, P1099, DOI 10.1002/ps.1616; Fleischer SJ, 1999, VEG GAZ, V3, P1; Ford KA, 2010, P NATL ACAD SCI USA, V107, P17527, DOI 10.1073/pnas.1013020107; FUNDERBURK JE, 1984, ENVIRON ENTOMOL, V13, P105, DOI 10.1093/ee/13.1.105; Furlan L, 2021, ENVIRON SCI POLLUT R, V28, P11798, DOI 10.1007/s11356-017-1052-5; Furlan L, 2014, J PEST SCI, V87, P609, DOI 10.1007/s10340-014-0583-5; Gibbons D, 2015, ENVIRON SCI POLLUT R, V22, P103, DOI 10.1007/s11356-014-3180-5; Giroux I, 2015, PRESENCE PESTICIDES; Giroux I, 2018, ETAT SITUATION PRESE; Giroux I, 2016, PORTRAIT PRESENCE PE; Glen R., 1950, SMITHSONIAN MISCELLA, V111, P1; Glen Robert, 1943, CANADIAN JOUR RES SECT D ZOOL SCI, V21, P358; Goulson D, 2013, J APPL ECOL, V50, P977, DOI 10.1111/1365-2664.12111; HALL DG, 1993, FLA ENTOMOL, V76, P155, DOI 10.2307/3496022; HAMMOND RB, 1993, CROP PROT, V12, P539, DOI 10.1016/0261-2194(93)90096-2; HAMMOND RB, 1984, ENVIRON ENTOMOL, V13, P1302, DOI 10.1093/ee/13.5.1302; HAMMOND RB, 1990, ENVIRON ENTOMOL, V19, P510, DOI 10.1093/ee/19.3.510; Health Canada, 2018, HLTH CAN CONS PLAN P; Hesler LS, 2018, J INTEGR PEST MANAG, V9, DOI 10.1093/jipm/pmx028; HIGLEY LG, 1984, ENVIRON ENTOMOL, V13, P1436, DOI 10.1093/ee/13.5.1436; Hladik ML, 2018, ENVIRON SCI TECHNOL, V52, P3329, DOI 10.1021/acs.est.7b06388; Isaacs J., 2016, NEW WIREWORM TRAP DE; Jeschke P, 2011, J AGR FOOD CHEM, V59, P2897, DOI 10.1021/jf101303g; Johnson P. J., 2002, AM BEETLES, V2, P160, DOI DOI 10.1201/9781420041231; Jordan TA, 2012, CROP PROT, V39, P57, DOI 10.1016/j.cropro.2012.04.006; Kabaluk JT, 2007, PHYTOPROTECTION, V88, P51, DOI 10.7202/018055ar; Kabaluk JT, 2007, AGRON J, V99, P1377, DOI 10.2134/agronj2007.0017N; KAHLER AL, 1985, AGRON J, V77, P769, DOI 10.2134/agronj1985.00021962007700050023x; Krupke CH, 2017, J APPL ECOL, V54, P1449, DOI 10.1111/1365-2664.12924; Krupke CH, 2017, PEST MANAG SCI, V73, P2184, DOI 10.1002/ps.4602; Kuhar T. P., 2003, Pesticide Outlook, V14, P265, DOI 10.1039/b314851n; Labrie G, 2014, CERO1LUT111582; Labrie G, 2017, PV322015002 MIN AGR; LAFRANCE J, 1968, CAN ENTOMOL, V100, P801, DOI 10.4039/Ent100801-8; LAFRANCE J., 1964, Phytoprotection, V45, P83; LAFRANCE J., 1963, CANADIAN ENTOMOL, V95, P873; LEVESQUE C, 1993, COLEOPTS BULL, V47, P269; Lindroth E, 2009, J ECON ENTOMOL, V102, P743, DOI 10.1603/029.102.0235; Macedo WR, 2011, PESTIC BIOCHEM PHYS, V100, P299, DOI 10.1016/j.pestbp.2011.05.003; Magalhaes LC, 2009, J ECON ENTOMOL, V102, P187, DOI 10.1603/029.102.0127; Main AR, 2016, AGR ECOSYST ENVIRON, V215, P76, DOI 10.1016/j.agee.2015.09.011; Main AR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092821; Maisonhaute JE, 2016, J ECON ENTOMOL, V109, P1465, DOI 10.1093/jee/tow048; McCarville MT, 2013, J ECON ENTOMOL, V106, P1302, DOI 10.1603/EC12495; Ministere du Developpement durable de l'Environnement et de la Lutte contre les changements climatiques (MDDELCC), 2015, STRAT QUEB PEST 2015; Mourtzinis S, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-47442-8; Myers C., 2014, BENEFITS NEONICOTINO; Noronha C, 2017, PROCEDURE USING ROTA; North JH, 2018, J ECON ENTOMOL, V111, P187, DOI 10.1093/jee/tox278; North JH, 2016, J ECON ENTOMOL, V109, P1156, DOI 10.1093/jee/tow035; Paquet-Walsh A, 2019, SCI TOTAL ENVIRON, V685, P690, DOI 10.1016/j.scitotenv.2019.05.113; Parker WE, 2001, AGR FOREST ENTOMOL, V3, P85, DOI 10.1046/j.1461-9563.2001.00094.x; Penn HJ, 2017, PEST MANAG SCI, V73, P1625, DOI 10.1002/ps.4499; Pinheiro J, 2000, MIXED EFFECTS MODELS; Pisa LW, 2015, ENVIRON SCI POLLUT R, V22, P68, DOI 10.1007/s11356-014-3471-x; Pons X, 2002, CROP PROT, V21, P943, DOI 10.1016/S0261-2194(02)00069-8; R Core Team, R LANG ENV STAT COMP; Reddy GVP, 2014, J INVERTEBR PATHOL, V120, P43, DOI 10.1016/j.jip.2014.05.005; Reisig DD, 2012, J ECON ENTOMOL, V105, P884, DOI 10.1603/EC11429; Riley TJ, 1981, PICTORIAL FIELD KEY; Saguez J, 2017, ENVIRON ENTOMOL, V46, P814, DOI 10.1093/ee/nvx116; Samson-Robert O, 2017, PEERJ, V5, DOI 10.7717/peerj.3670; Samson-Robert O, 2015, SCI REP-UK, V5, DOI 10.1038/srep12636; Samson-Robert O, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108443; Schaafsma A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118139; Seagraves MP, 2012, J PEST SCI, V85, P125, DOI 10.1007/s10340-011-0374-1; Sharma A, 2019, J APPL ENTOMOL, V143, P460, DOI 10.1111/jen.12601; Simon-Delso N, 2015, ENVIRON SCI POLLUT R, V22, P5, DOI 10.1007/s11356-014-3470-y; Stehr F. W., 1991, IMMATURE INSECTS, V2; Tomizawa M, 2005, ANNU REV PHARMACOL, V45, P247, DOI 10.1146/annurev.pharmtox.45.120403.095930; Traugott M, 2015, ANNU REV ENTOMOL, V60, P313, DOI 10.1146/annurev-ento-010814-021035; Tsvetkov N, 2017, SCIENCE, V356, P1395, DOI 10.1126/science.aam7470; Valenciano JB, 2004, FIELD CROP RES, V85, P103, DOI 10.1016/S0378-4290(03)00155-2; van der Sluijs JP, 2015, ENVIRON SCI POLLUT R, V22, P148, DOI 10.1007/s11356-014-3229-5; van Herk WG, 2015, J PEST SCI, V88, P717, DOI 10.1007/s10340-015-0697-4; van Herk Willem G., 2014, Biological Survey of Canada Monograph Series, V6, P87; Vasileiadis VP, 2011, AGR SYST, V104, P533, DOI 10.1016/j.agsy.2011.04.002; Vernon RS, 2016, J PEST SCI, V89, P375, DOI 10.1007/s10340-015-0707-6; Vernon RS, 2009, J ECON ENTOMOL, V102, P2126, DOI 10.1603/029.102.0616; Wang X, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0199525; Wang XL, 2016, AGR WATER MANAGE, V166, P77, DOI 10.1016/j.agwat.2015.12.007; Whale J., 2002, AM VEG GROW, V3, P1; Wilde G, 2004, J AGR URBAN ENTOMOL, V21, P75; Wood TJ, 2017, ENVIRON SCI POLLUT R, V22, P119; Zuur A, 2009, MIXED EFFECTS MODELS; Zuur Alain F., 2009, P1	109	25	27	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2020	15	2							e0229136	10.1371/journal.pone.0229136	http://dx.doi.org/10.1371/journal.pone.0229136			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8FM	32101547	Green Published, gold			2022-12-26	WOS:000535233700019
J	Bachorec, E; Horacek, I; Hulva, P; Konecny, A; Lucan, RK; Jedlicka, P; Shohdi, WM; Rerucha, S; Abi-Said, M; Bartonicka, T				Bachorec, Erik; Horacek, Ivan; Hulva, Pavel; Konecny, Adam; Lucan, Radek K.; Jedlicka, Petr; Shohdi, Wael M.; Rerucha, Simon; Abi-Said, Mounir; Bartonicka, Tomas			Spatial networks differ when food supply changes: Foraging strategy of Egyptian fruit bats	PLOS ONE			English	Article							FEMALE BECHSTEINS BATS; ROUSETTUS-AEGYPTIACUS; INFORMATION-TRANSFER; SOCIAL NETWORKS; HABITAT USE; POPULATION; RELATEDNESS; EVOLUTION; DYNAMICS; ECOLOGY	Animals are faced with a range of ecological constraints that shape their behavioural decisions. Habitat features that affect resource abundance will also have an impact, especially as regards spatial distribution, which will in turn affect associations between the animals. Here we utilised a network approach, using spatial and genetic data, to describe patterns in use of space (foraging sites) by free-ranging Egyptian fruit bats (Rousettus aegyptiacus) at the Dakhla Oasis in Egypt. We observed a decrease in home range size during spring, when food availability was lowest, which was reflected by differences in space sharing networks. Our data showed that when food was abundant, space sharing networks were less connected and more related individuals shared more foraging sites. In comparison, when food was scarce the bats had few possibilities to decide where and with whom to forage. Overall, both networks had high mean degree, suggesting communal knowledge of predictable food distribution.	[Bachorec, Erik; Konecny, Adam; Bartonicka, Tomas] Masaryk Univ, Dept Bot & Zool, Brno, Czech Republic; [Horacek, Ivan; Hulva, Pavel; Lucan, Radek K.] Charles Univ Prague, Dept Zool, Prague, Czech Republic; [Jedlicka, Petr; Rerucha, Simon] Czech Acad Sci ISI, Inst Sci Instruments, Brno, Czech Republic; [Shohdi, Wael M.] Nat Conservat Egypt, Giza, Egypt; [Abi-Said, Mounir] Lebanese Univ, Fac Sci 2, Dept Earth & Life Sci, Fanar, Lebanon	Masaryk University Brno; Charles University Prague; Czech Academy of Sciences; Institute of Scientific Instruments of the Czech Academy of Sciences; Lebanese University	Bachorec, E (corresponding author), Masaryk Univ, Dept Bot & Zool, Brno, Czech Republic.	ebachorec@gmail.com	Bartonička, Tomáš/J-2756-2014; Rerucha, Simon/D-6924-2012; Bachorec, Erik/GXZ-9303-2022; M. Shohdi, Wael/H-6506-2013	Rerucha, Simon/0000-0002-2026-5159; Bachorec, Erik/0000-0002-5791-5338; M. Shohdi, Wael/0000-0002-3755-3982	Grant Agency of the Academy of Sciences of the Czech Republic [IAA601110905]; Grant Agency of the Czech Republic [206/09/0888]; Charles University Research Centre program [204069]; Masaryk University, Brno, Czech Republic [MUNI/A/1078/2017]; Research aims of the Academy of Sciences of the Czech Republic [RVO 68081766]	Grant Agency of the Academy of Sciences of the Czech Republic(Czech Academy of SciencesGrant Agency of the Czech Republic); Grant Agency of the Czech Republic(Grant Agency of the Czech Republic); Charles University Research Centre program; Masaryk University, Brno, Czech Republic(Czech Republic Government); Research aims of the Academy of Sciences of the Czech Republic	This work received support from: Grant Agency of the Academy of Sciences of the Czech Republic (#IAA601110905); Grant Agency of the Czech Republic (#206/09/0888); Charles University Research Centre program (#204069); Masaryk University, Brno, Czech Republic (#MUNI/A/1078/2017); Research aims of the Academy of Sciences of the Czech Republic (# RVO 68081766). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams ES, 2001, ANNU REV ECOL SYST, V32, P277, DOI 10.1146/annurev.ecolsys.32.081501.114034; Andrianaivoarivelo AR, 2009, CONSERV GENET, V10, P1025, DOI 10.1007/s10592-008-9679-x; Aplin LM, 2013, ECOL LETT, V16, P1365, DOI 10.1111/ele.12181; Aplin LM, 2012, P ROY SOC B-BIOL SCI, V279, P4199, DOI 10.1098/rspb.2012.1591; Bartolommei P, 2016, HYSTRIX, V27, DOI 10.4404/hystrix-27.2-11876; Bastian M., 2009, INT AAAI C WEBL SOC, V8, P361, DOI DOI 10.13140/2.1.1341.1520; Benda Petr, 2011, Vespertilio, V15, P3; Blouin MS, 2003, TRENDS ECOL EVOL, V18, P503, DOI 10.1016/S0169-5347(03)00225-8; Bonnell TR, 2017, ROY SOC OPEN SCI, V4, DOI 10.1098/rsos.170148; Bonnie KE, 2007, ANIM BEHAV, V74, P171, DOI 10.1016/j.anbehav.2006.12.009; Boogert NJ, 2008, ANIM BEHAV, V75, P1509, DOI 10.1016/j.anbehav.2007.09.033; Borgatti S.P., 2002, UCINET 6 WINDOWS SOF; BOUTIN S, 1990, CAN J ZOOL, V68, P203, DOI 10.1139/z90-031; Brown J.L., 1970, ANNU REV ECOL SYST, V1, P239; Centeno-Cuadros A, 2017, MOL ECOL, V26, P6224, DOI 10.1111/mec.14365; Chaverri G, 2010, BEHAV ECOL SOCIOBIOL, V64, P1619, DOI 10.1007/s00265-010-0975-3; CLUTTONBROCK TH, 1977, J ZOOL, V183, P1, DOI 10.1111/j.1469-7998.1977.tb04171.x; CoussiKorbel S, 1995, ANIM BEHAV, V50, P1441, DOI 10.1016/0003-3472(95)80001-8; Croft DP, 2008, EXPLORING ANIMAL SOCIAL NETWORKS, P1; Cvikel N, 2015, CURR BIOL, V25, P206, DOI 10.1016/j.cub.2014.11.010; Dechmann DKN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009012; Dekker D, 2007, PSYCHOMETRIKA, V72, P563, DOI 10.1007/s11336-007-9016-1; Dickens WT, 2003, NATURE NURTURE COMPL; Drewe JA, 2009, BEHAV ECOL SOCIOBIOL, V63, P1295, DOI 10.1007/s00265-009-0782-x; Egert-Berg K, 2018, CURR BIOL, V28, P3667, DOI 10.1016/j.cub.2018.09.064; EMLEN ST, 1977, SCIENCE, V197, P215, DOI 10.1126/science.327542; Emsens WJ, 2013, BIOTROPICA, V45, P88, DOI 10.1111/j.1744-7429.2012.00888.x; ESRI. Environmental Systems Research Institute (ESRI), 2018, ARCGIS REL 10 6; Ewer RF., 1967, ETHOLOGY MAMMALS; Farine DR, 2016, SCI REP-UK, V6, DOI 10.1038/srep27704; Farine DR, 2015, J ANIM ECOL, V84, P1144, DOI 10.1111/1365-2656.12418; Farine DR, 2015, ANIM BEHAV, V104, pE1, DOI 10.1016/j.anbehav.2014.11.019; Frank SA, 2003, EVOLUTION, V57, P693; Galef BG, 2005, BIOSCIENCE, V55, P489, DOI 10.1641/0006-3568(2005)055[0489:SLIAES]2.0.CO;2; Galef BG, 2001, ANIM BEHAV, V61, P3, DOI 10.1006/anbe.2000.1557; Gannon WL, 2007, J MAMMAL, V88, P809, DOI 10.1644/06-MAMM-F-185R1.1; Geoffroy ES-H., 1810, ANN MUSEUM DHISTOIRE, V15, P86; GETZ LOWELL L., 1961, JOUR MAMMOL, V42, P24, DOI 10.2307/1377237; GOULD JL, 1987, SCI AM, V256, P74, DOI 10.1038/scientificamerican0187-74; Greville LJ, 2018, J MAMMAL, V99, P974, DOI 10.1093/jmammal/gyy050; Guimaraes PR, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.042901; Harten L, 2018, SCI ADV, V4, DOI 10.1126/sciadv.1603293; He P, 2019, BEHAV ECOL SOCIOBIOL, V73, DOI 10.1007/s00265-018-2602-7; Herrera LG, 2008, J MAMMAL, V89, P1184, DOI 10.1644/07-MAMM-A-263.1; Hirsch BT, 2013, ANIM BEHAV, V85, P463, DOI 10.1016/j.anbehav.2012.12.011; Hoppitt W., 2013, SOCIAL LEARNING INTR, DOI DOI 10.23943/PRINCETON/9780691150703.001.0001/UPSO-9780691150703; Hua PY, 2006, MOL ECOL NOTES, V6, P939, DOI 10.1111/j.1471-8286.2006.01407.x; Hulva P, 2012, MOL ECOL, V21, P6104, DOI 10.1111/mec.12078; Ismael H, 2015, PRESENT ENV SUST DEV, V9, P47, DOI 10.1515/pesd-2015-0024; Itani J., 1973, PRECULTURAL PRIMATE, P26; JANSON C, 1985, BEHAV ECOL SOCIOBIOL, V18, P125, DOI 10.1007/BF00299041; Johnson JS, 2013, ACTA CHIROPTEROL, V15, P1, DOI 10.3161/150811013X667821; Judd TM, 1996, ANIM BEHAV, V52, P957, DOI 10.1006/anbe.1996.0244; Kalinowski ST, 2006, MOL ECOL NOTES, V6, P576, DOI 10.1111/j.1471-8286.2006.01256.x; Kauhala K, 2002, ANN ZOOL FENN, V39, P317; Kerth G, 2001, BEHAV ECOL SOCIOBIOL, V50, P283, DOI 10.1007/s002650100352; Kerth G, 2003, P ROY SOC B-BIOL SCI, V270, P511, DOI 10.1098/rspb.2002.2267; Kerth G, 2011, P ROY SOC B-BIOL SCI, V278, P2761, DOI 10.1098/rspb.2010.2718; Korine C, 1999, BIOL CONSERV, V88, P301, DOI 10.1016/S0006-3207(98)00126-8; Krause J, 2002, LIVING GROUPS; Kunz TH, 2009, ECOLOGICAL BEHAV MET; Kwiecinski Gary G., 1999, Mammalian Species, V611, P1; Laidre ME, 2010, P ROY SOC B-BIOL SCI, V277, P1361, DOI 10.1098/rspb.2009.1580; Laland KN, 2004, LEARN BEHAV, V32, P4; Lucan RK, 2016, J MAMMAL, V97, P815, DOI 10.1093/jmammal/gyw014; Lucan RK, 2014, J MAMMAL, V95, P1036, DOI 10.1644/14-MAMM-A-035; Lusseau D, 2006, J ANIM ECOL, V75, P14, DOI 10.1111/j.1365-2656.2005.01013.x; Lusseau D, 2008, ANIM BEHAV, V75, P1809, DOI 10.1016/j.anbehav.2007.10.029; Manno TG, 2008, ANIM BEHAV, V75, P1221, DOI 10.1016/j.anbehav.2007.09.025; Melber M, 2013, ETHOLOGY, V119, P793, DOI 10.1111/eth.12123; Morrell LJ, 2008, ANIM BEHAV, V76, P855, DOI 10.1016/j.anbehav.2008.02.015; Mourier J, 2012, ANIM BEHAV, V83, P389, DOI 10.1016/j.anbehav.2011.11.008; Mueller T, 2013, SCIENCE, V341, P999, DOI 10.1126/science.1237139; MUTERE F A, 1968, Acta Tropica, V25, P97; NICOL CJ, 1994, APPL ANIM BEHAV SCI, V40, P31, DOI 10.1016/0168-1591(94)90085-X; Patriquin KJ, 2010, BEHAV ECOL SOCIOBIOL, V64, P899, DOI 10.1007/s00265-010-0905-4; Peel MC, 2007, HYDROL EARTH SYST SC, V11, P1633, DOI 10.5194/hess-11-1633-2007; Reader SM, 2003, ANIM BEHAV, V66, P729, DOI 10.1006/anbe.2003.2252; Rerucha S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116785; Rossiter SJ, 2002, BEHAV ECOL SOCIOBIOL, V51, P510, DOI 10.1007/s00265-002-0467-1; Rozin P., 2015, EVOLUTIONARY PSYCHOL; Sapolsky RM, 2005, SCIENCE, V308, P648, DOI 10.1126/science.1106477; Silk JB, 2010, CURR BIOL, V20, P1359, DOI 10.1016/j.cub.2010.05.067; Thurfjell H, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178082; van Noordwijk MA, 1999, PRIMATES, V40, P105, DOI 10.1007/BF02557705; WARD P, 1973, IBIS, V115, P517, DOI 10.1111/j.1474-919X.1973.tb01990.x; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Whitehead H, 1999, ADV STUD BEHAV, V28, P33, DOI 10.1016/S0065-3454(08)60215-6; Whitehead H, 2008, ANAL ANIMAL SOC QUAN; Wilkinson GS, 2019, BEHAV ECOL SOCIOBIOL, V73, DOI 10.1007/s00265-018-2608-1; WILKINSON GS, 1992, ANIM BEHAV, V44, P501, DOI 10.1016/0003-3472(92)90059-I; Wilkinson GS, 1998, ANIM BEHAV, V55, P337, DOI 10.1006/anbe.1997.0557; Wiszniewski J, 2009, ANIM BEHAV, V77, P1449, DOI 10.1016/j.anbehav.2009.02.025; WORTON BJ, 1989, ECOLOGY, V70, P164, DOI 10.2307/1938423; Wright GS, 2011, ANIM BEHAV, V82, P1075, DOI 10.1016/j.anbehav.2011.07.044	95	8	8	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2020	15	2							e0229110	10.1371/journal.pone.0229110	http://dx.doi.org/10.1371/journal.pone.0229110			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8EV	32097434	gold, Green Published, Green Submitted			2022-12-26	WOS:000535232000018
J	Moon, JH; Chung, CK; Kim, CH; Lee, CH; Park, SB; Heo, W				Moon, Jung Hyeon; Chung, Chun Kee; Kim, Chi Heon; Lee, Chang-Hyun; Park, Sung Bae; Heo, Won			Longitudinal change of cervical artificial disc motion following replacement	PLOS ONE			English	Article							ADJACENT SEGMENT DEGENERATION; HETEROTOPIC OSSIFICATION; FUSION; ARTHROPLASTY; DISEASE; RADICULOPATHY; DISKECTOMY; RANGE; SPINE	We reviewed charts and radiologic studies of 30 patients operated upon by ADR with MobiC (R) in single level since 2006. All patients had healthy cervical facet joints (less than or equal to grade 1 according to grading systems for cervical facet joint degeneration) preoperatively. We assessed clinical outcomes with NDI and VAS on neck and arm over follow-up and also measured ROM at implanted segment on dynamic radiographs during follow-up. The mean follow-up period was 42.4 +/- 15.9 months. We then assessed the linearity of changes in ROM at implanted segment through linear mixed model. All patients showed significantly improved clinical outcomes. ROMs at implanted segment were maintained at slightly increased levels until 24 months postoperatively (P = 0.529). However, after 24 months, ROMs at implanted segment decreased significantly until last follow-up (P = 0.001). In addition, the decreasing pattern after 24 months showed a regular regression (P = 0.001). This decline was correlated with decline of extension angle at implanted segment. Based on this regular regression, we estimated that ROMs at implanted segments would be less than 2 degrees at 10.24 years postoperatively. Even though implanted segment maintains its motion for some length of time, we could assume that an artificial disc would have limited life expectancy correlated with the decline of extension angle.	[Moon, Jung Hyeon] Dongguk Univ, Dept Neurosurg, Ilsan Hosp, Ilsan, South Korea; [Chung, Chun Kee; Kim, Chi Heon; Lee, Chang-Hyun] Seoul Natl Univ, Dept Neurosurg, Coll Med, Seoul, South Korea; [Chung, Chun Kee; Kim, Chi Heon] Seoul Natl Univ, Neurosci Res Inst, Med Res Ctr, Seoul, South Korea; [Chung, Chun Kee; Kim, Chi Heon] Seoul Natl Univ Hosp, Clin Res Inst, Seoul, South Korea; [Chung, Chun Kee] Seoul Natl Univ, Dept Brain & Cognit Sci, Coll Nat Sci, Seoul, South Korea; [Park, Sung Bae] Seoul Natl Univ, Dept Neurosurg, Boramae Med Ctr, Seoul, South Korea; [Heo, Won] Gyeongsang Natinoal Univ, Dept Neurosurg, Changwon Hosp, Chang Won, South Korea	Dongguk University; NHIS Ilsan Hospital; Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University (SNU); Seoul National University Hospital	Chung, CK (corresponding author), Seoul Natl Univ, Dept Neurosurg, Coll Med, Seoul, South Korea.; Chung, CK (corresponding author), Seoul Natl Univ, Neurosci Res Inst, Med Res Ctr, Seoul, South Korea.; Chung, CK (corresponding author), Seoul Natl Univ Hosp, Clin Res Inst, Seoul, South Korea.; Chung, CK (corresponding author), Seoul Natl Univ, Dept Brain & Cognit Sci, Coll Nat Sci, Seoul, South Korea.	chungc@snu.ac.kr	Chung, Chun Kee/J-5650-2012	Chung, Chun Kee/0000-0003-3485-2327	Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) - Ministry of Health & Welfare, Republic of Korea [HC15C1320]	Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) - Ministry of Health & Welfare, Republic of Korea	This research was supported by a grant of the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health & Welfare, Republic of Korea (grant number: HC15C1320).	Ahn PG, 2009, J NEUROSURG-SPINE, V11, P688, DOI 10.3171/2009.7.SPINE0946; BOHLMAN HH, 1993, J BONE JOINT SURG AM, V75A, P1298, DOI 10.2106/00004623-199309000-00005; Burkus JK, 2010, J NEUROSURG-SPINE, V13, P308, DOI 10.3171/2010.3.SPINE09513; Cannada LK, 2003, SPINE, V28, P46, DOI 10.1097/00007632-200301010-00012; Cot P, 1997, SPINE, V22, P859; Cunningham BW, 2003, SPINE, V28, pS110, DOI 10.1097/01.BRS.0000092209.27573.90; Davis RJ, 2013, J NEUROSURG-SPINE, V19, P532, DOI 10.3171/2013.6.SPINE12527; Goffin J, 2004, J SPINAL DISORD TECH, V17, P79, DOI 10.1097/00024720-200404000-00001; Goffin J, 2010, J NEUROSURG-SPINE, V12, P261, DOI 10.3171/2009.9.SPINE09129; Harrison DE, 2000, SPINE, V25, P2072, DOI 10.1097/00007632-200008150-00011; Helgeson MD, 2013, SPINE J, V13, P342, DOI 10.1016/j.spinee.2012.12.009; Hilibrand AS, 1999, J BONE JOINT SURG AM, V81A, P519, DOI 10.2106/00004623-199904000-00009; KELLGREN JH, 1957, ANN RHEUM DIS, V16, P494, DOI 10.1136/ard.16.4.494; Lee SE, 2012, J NEUROSURG-SPINE, V16, P31, DOI 10.3171/2011.8.SPINE11303; LIND B, 1989, ARCH PHYS MED REHAB, V70, P692; Matsumoto M, 2010, SPINE, V35, P36, DOI 10.1097/BRS.0b013e3181b8a80d; McAfee PC, 2003, J SPINAL DISORD TECH, V16, P384, DOI 10.1097/00024720-200308000-00010; Nabhan A, 2007, J LONG TERM EFFECTS, V17; Park DK, 2011, SPINE, V36, P721, DOI 10.1097/BRS.0b013e3181df10fc; Richards O, 2012, BRIT J NEUROSURG, V26, P2, DOI 10.3109/02688697.2011.595846; Robertson JT, 2005, J NEUROSURG-SPINE, V3, P417, DOI 10.3171/spi.2005.3.6.0417; Sasso RC, 2007, SPINE, V32, P2933, DOI 10.1097/BRS.0b013e31815d0034; Tian W, 2010, CHINESE MED J-PEKING, V123, P2969, DOI 10.3760/cma.j.issn.0366-6999.2010.21.003; Tu TH, 2011, J NEUROSURG-SPINE, V14, P457, DOI 10.3171/2010.11.SPINE10444; Walraevens J, 2010, NEUROSURGERY, V67, P679, DOI 10.1227/01.NEU.0000377039.89725.F3	25	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2020	15	2							e0228628	10.1371/journal.pone.0228628	http://dx.doi.org/10.1371/journal.pone.0228628			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8EV	32097419	Green Published, gold			2022-12-26	WOS:000535232000009
J	Rokke, GB; Hohmann-Marriott, MF; Almaas, E				Rokke, Gunvor Bjerkelund; Hohmann-Marriott, Martin Frank; Almaas, Eivind			An adjustable algal chloroplast plug-and-play model for genome-scale metabolic models	PLOS ONE			English	Article							CYCLIC ELECTRON-TRANSPORT; PLASTID TERMINAL OXIDASE; PHOTOSYSTEM-I; AMINO-ACID; PROFILES; PATHWAYS; RECONSTRUCTION; BIOSYNTHESIS; MICROALGAE; FLOW	The chloroplast is a central part of plant cells, as this is the organelle where the photosynthesis, fixation of inorganic carbon, and other key functions related to fatty acid synthesis and amino acid synthesis occur. Since this organelle should be an integral part of any genome-scale metabolic model for a microalgae or a higher plant, it is of great interest to generate a detailed and standardized chloroplast model. Additionally, we see the need for a novel type of sub-model template, or organelle model, which could be incorporated into a larger, less specific genome-scale metabolic model, while allowing for minor differences between chloroplast-containing organisms. The result of this work is the very first standardized chloroplast model, iGR774, consisting of 788 reactions, 764 metabolites, and 774 genes. The model is currently able to run in three different modes, mimicking the chloroplast metabolism of three photosynthetic microalgae-Nannochloropsis gaditana, Chlamydomonas reinhardtii and Phaeodactylum tricornutum. In addition to developing the chloroplast metabolic network reconstruction, we have developed multiple software tools for working with this novel type of sub-model in the COBRA Toolbox for MATLAB, including tools for connecting the chloroplast model to a genome-scale metabolic reconstruction in need of a chloroplast, for switching the model between running in different organism modes, and for expanding it by introducing more reactions either related to one of the current organisms included in the model, or to a new organism.	[Rokke, Gunvor Bjerkelund; Hohmann-Marriott, Martin Frank; Almaas, Eivind] Norwegian Univ Sci & Technol, Dept Biotechnol & Food Sci, Trondheim, Norway; [Almaas, Eivind] Norwegian Univ Sci & Technol, KG Jebsen Ctr Genet Epidemiol, Trondheim, Norway	Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU)	Almaas, E (corresponding author), Norwegian Univ Sci & Technol, Dept Biotechnol & Food Sci, Trondheim, Norway.; Almaas, E (corresponding author), Norwegian Univ Sci & Technol, KG Jebsen Ctr Genet Epidemiol, Trondheim, Norway.	eivind.almaas@ntnu.no		Hohmann-Marriott, Martin/0000-0002-2957-7052; Bjerkelund Rokke, Gunvor/0000-0003-0193-2072				Agren R, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002980; Allen JF, 2011, TRENDS PLANT SCI, V16, P645, DOI 10.1016/j.tplants.2011.10.004; Alric J, 2017, CURR OPIN PLANT BIOL, V37, P78, DOI 10.1016/j.pbi.2017.03.014; ARAO T, 1987, PHYTOCHEMISTRY, V26, P2573, DOI 10.1016/S0031-9422(00)83880-7; Arnold A, 2011, TRENDS PLANT SCI, V16, P676, DOI 10.1016/j.tplants.2011.09.004; Boudiere L, 2014, BBA-BIOENERGETICS, V1837, P470, DOI 10.1016/j.bbabio.2013.09.007; Boyle NR, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-4; Bromke MA, 2013, METABOLITES, V3, P294, DOI 10.3390/metabo3020294; BROWN MR, 1991, J EXP MAR BIOL ECOL, V145, P79, DOI 10.1016/0022-0981(91)90007-J; Brunk E, 2018, NAT BIOTECHNOL, V36, P272, DOI 10.1038/nbt.4072; Carol P, 2001, TRENDS PLANT SCI, V6, P31, DOI 10.1016/S1360-1385(00)01811-2; EICHENBERGER W, 1986, PHYSIOL PLANTARUM, V66, P589, DOI 10.1111/j.1399-3054.1986.tb05584.x; Erb TJ, 2018, CURR OPIN BIOTECH, V49, P100, DOI 10.1016/j.copbio.2017.07.017; Fan JL, 2011, FEBS LETT, V585, P1985, DOI 10.1016/j.febslet.2011.05.018; Finazzi G, 2002, EMBO REP, V3, P280, DOI 10.1093/embo-reports/kvf047; Heber U, 2002, PHOTOSYNTH RES, V73, P223, DOI 10.1023/A:1020459416987; Heydarizadeh P, 2013, MAR DRUGS, V11, P3425, DOI 10.3390/md11093425; Imam S, 2015, PLANT J, V84, P1239, DOI 10.1111/tpj.13059; Iwai M, 2010, NATURE, V464, P1210, DOI 10.1038/nature08885; Johnson GN, 2011, BBA-BIOENERGETICS, V1807, P384, DOI 10.1016/j.bbabio.2010.11.009; Kuntz M, 2004, PLANTA, V218, P896, DOI 10.1007/s00425-004-1217-6; Levering J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155038; Li J, 2014, PLANT CELL, V26, P1645, DOI 10.1105/tpc.113.121418; Loira N, 2017, BMC SYST BIOL, V11, DOI 10.1186/s12918-017-0441-1; Lubian LM, 2000, J APPL PHYCOL, V12, P249, DOI 10.1023/A:1008170915932; Machado D, 2018, NUCLEIC ACIDS RES, V46, P7542, DOI 10.1093/nar/gky537; Martyushenko N, 2019, BMC BIOINFORMATICS, V20, DOI 10.1186/s12859-019-2615-x; Muhlroth A, 2013, MAR DRUGS, V11, P4662, DOI 10.3390/md11114662; Overbeek R, 2014, NUCLEIC ACIDS RES, V42, pD206, DOI 10.1093/nar/gkt1226; Rebolloso-Fuentes MM, 2001, J FOOD BIOCHEM, V25, P57, DOI 10.1111/j.1745-4514.2001.tb00724.x; Reyes-Prieto A, 2012, SCI REP-UK, V2, DOI 10.1038/srep00955; Schellenberger J, 2011, NAT PROTOC, V6, P1290, DOI 10.1038/nprot.2011.308; Schulze T, 2013, MOL PLANT, V6, P931, DOI 10.1093/mp/sss137; Shah A, 2017, ALGAL RES, V26, P354, DOI 10.1016/j.algal.2017.08.014; Shikanai T, 2007, ANNU REV PLANT BIOL, V58, P199, DOI 10.1146/annurev.arplant.58.091406.110525; Shikanai T, 2014, CURR OPIN BIOTECH, V26, P25, DOI 10.1016/j.copbio.2013.08.012; Suh SS, 2015, ASIAN PAC J TROP MED, V8, P191, DOI 10.1016/S1995-7645(14)60313-8; Terashima M, 2011, CURR GENET, V57, P151, DOI 10.1007/s00294-011-0339-1; Thiele I, 2013, NAT BIOTECHNOL, V31, P419, DOI 10.1038/nbt.2488; Tikhonov AN, 2014, BIOSYSTEMS, V121, P1, DOI 10.1016/j.biosystems.2014.04.007; Tonon T, 2002, PHYTOCHEMISTRY, V61, P15, DOI 10.1016/S0031-9422(02)00201-7; Ufaz S, 2008, PLANT PHYSIOL, V147, P954, DOI 10.1104/pp.108.118091; Vieler A, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003064; Xiao Y, 2013, BIORESOURCE TECHNOL, V130, P731, DOI 10.1016/j.biortech.2012.11.116	44	2	2	5	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2020	15	2							e0229408	10.1371/journal.pone.0229408	http://dx.doi.org/10.1371/journal.pone.0229408			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8DW	32092117	Green Published, gold			2022-12-26	WOS:000535229300055
J	Gorisse, L; Li, ZG; Wagner, CD; Worthylake, DK; Zappacosta, F; Hedman, AC; Annan, RS; Sacks, DB				Gorisse, Laetitia; Li, Zhigang; Wagner, Craig D.; Worthylake, David K.; Zappacosta, Francesca; Hedman, Andrew C.; Annan, Roland S.; Sacks, David B.			Ubiquitination of the scaffold protein IQGAP1 diminishes its interaction with and activation of the Rho GTPase CDC42	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						scaffold protein; ubiquitylation (ubiquitination); CDC42; cell signaling; Ras-related C3 botulinum toxin substrate 1 (Rac1); GAP-related domain; IQGAP1; small GTPase	RAC1; BINDING; IDENTIFICATION; CALMODULIN; PROMOTES; ADHESION; DOMAIN; PHOSPHORYLATION; CONJUGATION; PROTEASOME	IQ motif-containing GTPase-activating protein 1 (IQGAP1) is a scaffold protein that interacts with numerous binding partners and thereby regulates fundamental biological processes. The functions of IQGAP1 are modulated by several mechanisms, including protein binding, self-association, subcellular localization, and phosphorylation. Proteome-wide screens have indicated that IQGAP1 is ubiquitinated, but the possible effects of this post-translational modification on its function are unknown. Here we characterized and evaluated the function of IQGAP1 ubiquitination. Using MS-based analysis in HEK293 cells, we identified six lysine residues (Lys-556, -1155, -1230, -1465, -1475, and -1528) as ubiquitination sites in IQGAP1. To elucidate the biological consequences of IQGAP1 ubiquitination, we converted each of these lysines to arginine and found that replacing two of these residues, Lys-1155 and Lys-1230, in the GAP-related domain of IQGAP1 (termed IQGAP1 GRD-2K) reduces its ubiquitination. Moreover, IQGAP1 GRD-2K bound a significantly greater proportion of the two Rho GTPases cell division cycle 42 (CDC42) and Rac family small GTPase 1 (RAC1) than did WT IQGAP1. Consistent with this observation, reconstitution of IQGAP1-null cells with IQGAP1 GRD-2K significantly increased the amount of active CDC42 and enhanced cell migration significantly more than WT IQGAP1. Our results reveal that ubiquitination of the CDC42 regulator IQGAP1 alters its ability to bind to and activate this GTPase, leading to physiological effects. Collectively, these findings expand our view of the role of ubiquitination in cell signaling and provide additional insight into CDC42 regulation.	[Gorisse, Laetitia; Li, Zhigang; Hedman, Andrew C.; Sacks, David B.] NIH, Dept Lab Med, Bldg 10, Bethesda, MD 20892 USA; [Wagner, Craig D.; Zappacosta, Francesca; Annan, Roland S.] GlaxoSmithKline, Discovery Analyt, Collegeville, PA 19426 USA; [Worthylake, David K.] Louisiana State Univ Hlth Sci, Dept Biochem & Mol Biol, New Orleans, LA 70112 USA	National Institutes of Health (NIH) - USA; GlaxoSmithKline; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans	Sacks, DB (corresponding author), 10 Ctr Dr,10-2C306, Bethesda, MD 20892 USA.	david.sacks2@nih.gov		Sacks, David/0000-0003-3100-0735	National Institutes of Health Intramural Research Program	National Institutes of Health Intramural Research Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the National Institutes of Health Intramural Research Program. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Baker R, 2013, NAT STRUCT MOL BIOL, V20, P46, DOI 10.1038/nsmb.2430; Bardwell AJ, 2017, J BIOL CHEM, V292, P8750, DOI 10.1074/jbc.M116.767087; Bishop AL, 2000, BIOCHEM J, V348, P241, DOI 10.1042/0264-6021:3480241; BOURNE HR, 1990, NATURE, V348, P125, DOI 10.1038/348125a0; Briggs MW, 2003, EMBO REP, V4, P571, DOI 10.1038/sj.embor.embor867; Brown MD, 2007, J BIOL CHEM, V282, P30265, DOI 10.1074/jbc.M702537200; Brown MD, 2006, TRENDS CELL BIOL, V16, P242, DOI 10.1016/j.tcb.2006.03.002; Cerikan B, 2016, DEV CELL, V39, P28, DOI 10.1016/j.devcel.2016.08.020; Chen ZJJ, 2009, MOL CELL, V33, P275, DOI 10.1016/j.molcel.2009.01.014; Choi S, 2016, NAT CELL BIOL, V18, P1324, DOI 10.1038/ncb3441; DeLano W.L., 2002, CCP4 NEWSL PROTEIN C, V40, P82; Dise RS, 2008, AM J PHYSIOL-GASTR L, V294, pG276, DOI 10.1152/ajpgi.00340.2007; Durfee LA, 2010, MOL CELL, V38, P722, DOI 10.1016/j.molcel.2010.05.002; Hart MJ, 1996, EMBO J, V15, P2997, DOI 10.1002/j.1460-2075.1996.tb00663.x; Hedman AC, 2015, EMBO REP, V16, P427, DOI 10.15252/embr.201439834; Ho YD, 1999, J BIOL CHEM, V274, P464, DOI 10.1074/jbc.274.1.464; HOCHSTRASSER M, 1995, CURR OPIN CELL BIOL, V7, P215, DOI 10.1016/0955-0674(95)80031-X; Hochstrasser M, 2009, NATURE, V458, P422, DOI 10.1038/nature07958; Hodge RG, 2016, NAT REV MOL CELL BIO, V17, P496, DOI 10.1038/nrm.2016.67; Hornbeck PV, 2015, NUCLEIC ACIDS RES, V43, pD512, DOI 10.1093/nar/gku1267; Itoh RE, 2008, J CELL SCI, V121, P2635, DOI 10.1242/jcs.028647; Jadeski L, 2008, J BIOL CHEM, V283, P1008, DOI 10.1074/jbc.M708466200; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kim W, 2011, MOL CELL, V44, P325, DOI 10.1016/j.molcel.2011.08.025; Komander D, 2012, ANNU REV BIOCHEM, V81, P203, DOI 10.1146/annurev-biochem-060310-170328; Kurella VB, 2009, J BIOL CHEM, V284, P14857, DOI 10.1074/jbc.M808974200; Kuroda S, 1996, J BIOL CHEM, V271, P23363, DOI 10.1074/jbc.271.38.23363; Kuroda S, 1998, SCIENCE, V281, P832, DOI 10.1126/science.281.5378.832; LeCour L, 2016, STRUCTURE, V24, P1499, DOI 10.1016/j.str.2016.06.016; Li L, 2006, J BIOL CHEM, V281, P1978, DOI 10.1074/jbc.M508545200; Li ZG, 2005, J BIOL CHEM, V280, P13871, DOI 10.1074/jbc.M413482200; Li ZG, 2003, J BIOL CHEM, V278, P4347, DOI 10.1074/jbc.M208579200; Liang ZW, 2017, CANCER LETT, V411, P90, DOI 10.1016/j.canlet.2017.09.046; Liu BP, 2000, MOL CELL BIOL, V20, P7160, DOI 10.1128/MCB.20.19.7160-7169.2000; Liu L, 2019, FRONT PHARMACOL, V10, DOI 10.3389/fphar.2019.00370; Lovell SC, 2000, PROTEINS, V40, P389, DOI 10.1002/1097-0134(20000815)40:3<389::AID-PROT50>3.0.CO;2-2; Mataraza JM, 2003, J BIOL CHEM, V278, P41237, DOI 10.1074/jbc.M304838200; Mataraza JM, 2003, BIOCHEM BIOPH RES CO, V305, P315, DOI 10.1016/S0006-291X(03)00759-9; Mateer SC, 2003, CELL MOTIL CYTOSKEL, V55, P147, DOI 10.1002/cm.10118; McNulty DE, 2011, J BIOL CHEM, V286, P15010, DOI 10.1074/jbc.M111.227694; Mukhopadhyay D, 2007, SCIENCE, V315, P201, DOI 10.1126/science.1127085; Nobes CD, 1999, J CELL BIOL, V144, P1235, DOI 10.1083/jcb.144.6.1235; Noritake J, 2005, J CELL SCI, V118, P2085, DOI 10.1242/jcs.02379; Nouri K, 2016, J BIOL CHEM, V291, P26364, DOI 10.1074/jbc.M116.752121; Oshikawa K, 2012, J PROTEOME RES, V11, P796, DOI 10.1021/pr200668y; Osman MA, 2010, THESCIENTIFICWORLDJO, V10, P944, DOI 10.1100/tsw.2010.85; Owen D, 2008, J BIOL CHEM, V283, P1692, DOI 10.1074/jbc.M707257200; Ozdemir ES, 2018, J BIOL CHEM, V293, P3685, DOI 10.1074/jbc.RA117.001596; Pan CW, 2017, EMBO J, V36, P995, DOI 10.15252/embj.201695534; Ren JG, 2005, J BIOL CHEM, V280, P34548, DOI 10.1074/jbc.M507321200; Ren JG, 2007, P NATL ACAD SCI USA, V104, P10465, DOI 10.1073/pnas.0611308104; Ridley AJ, 2015, CURR OPIN CELL BIOL, V36, P103, DOI 10.1016/j.ceb.2015.08.005; Roy M, 2005, MOL CELL BIOL, V25, P7940, DOI 10.1128/MCB.25.18.7940-7952.2005; Sasaki AT, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001518; Sayedyahossein S, 2016, J BIOL CHEM, V291, P19261, DOI 10.1074/jbc.M116.732529; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Shin D, 2017, ELIFE, V6, DOI 10.7554/eLife.29154; Shin KJ, 2006, P NATL ACAD SCI USA, V103, P13759, DOI 10.1073/pnas.0606179103; Sinha S, 2008, CELL SIGNAL, V20, P1927, DOI 10.1016/j.cellsig.2008.05.002; Smith JM, 2015, TRENDS CELL BIOL, V25, P171, DOI 10.1016/j.tcb.2014.12.005; Swart-Mataraza JM, 2002, J BIOL CHEM, V277, P24753, DOI 10.1074/jbc.M111165200; Tu S, 2003, J BIOL CHEM, V278, P49293, DOI 10.1074/jbc.M307021200; Tu S, 2001, J BIOL CHEM, V276, P19656, DOI 10.1074/jbc.M009838200; Udeshi ND, 2012, MOL CELL PROTEOMICS, V11, P148, DOI 10.1074/mcp.M111.016857; Vetterkind S, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09434-4; Wagner SA, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.013284; Waterhouse A, 2018, NUCLEIC ACIDS RES, V46, pW296, DOI 10.1093/nar/gky427; White CD, 2012, CELL SIGNAL, V24, P826, DOI 10.1016/j.cellsig.2011.12.005; Zhang BL, 1997, J BIOL CHEM, V272, P21999, DOI 10.1074/jbc.272.35.21999	70	7	7	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 10	2020	295	15					4822	4835		10.1074/jbc.RA119.011491	http://dx.doi.org/10.1074/jbc.RA119.011491			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LE7FC	32094223	Green Published, hybrid			2022-12-26	WOS:000526887000007
J	Peng, FX; Zhou, Y; Wang, J; Guo, BQ; Wei, Y; Deng, H; Wu, ZH; Zhang, C; Shi, KT; Li, Y; Wang, X; Shore, P; Zhao, SS; Deng, WS				Peng, Feixia; Zhou, Ying; Wang, Juan; Guo, Baoqiang; Wei, Yun; Deng, Huan; Wu, Zihui; Zhang, Cheng; Shi, Kaituo; Li, Yuan; Wang, Xin; Shore, Paul; Zhao, Shasha; Deng, Wensheng			The transcription factor Sp1 modulates RNA polymerase III gene transcription by controlling BRF1 and GTF3C2 expression in human cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						specificity protein 1 (Sp1); RNA polymerase III; transcription; filamin; cancer; TFIIB-related factor 1 (BRF1); gene transcription; TFIIB-related factor 1 (BRF1); filamin A (FLNA)	O-GLYCOSYLATION; I-RECEPTOR; CANCER; PHOSPHORYLATION; INHIBITION; PROTEIN; MITHRAMYCIN; ACTIVATION; FILAMIN; P300	Specificity protein 1 (Sp1) is an important transcription factor implicated in numerous cellular processes. However, whether Sp1 is involved in the regulation of RNA polymerase III (Pol III)-directed gene transcription in human cells remains unknown. Here, we first show that filamin A (FLNA) represses Sp1 expression as well as expression of TFIIB-related factor 1 (BRF1) and general transcription factor III C subunit 2 (GTF3C2) in HeLa, 293T, and SaOS2 cell lines stably expressing FLNA-silencing shRNAs. Both BRF1 promoter 4 (BRF1P4) and GTF3C2 promoter 2 (GTF3C2P2) contain putative Sp1-binding sites, suggesting that Sp1 affects Pol III gene transcription by regulating BRF1 and GTF3C2 expression. We demonstrate that Sp1 knockdown inhibits Pol III gene transcription, BRF1 and GTF3C2 expression, and the proliferation of 293T and HeLa cells, whereas Sp1 overexpression enhances these activities. We obtained a comparable result in a cell line in which both FLNA and Sp1 were depleted. These results indicate that Sp1 is involved in the regulation of Pol III gene transcription independently of FLNA expression. Reporter gene assays showed that alteration of Sp1 expression affects BRF1P4 and GTF3C2P2 activation, suggesting that Sp1 modulates Pol III?mediated gene transcription by controlling BRF1 and GTF3C2 gene expression. Further analysis revealed that Sp1 interacts with and thereby promotes the occupancies of TATA box?binding protein, TFIIA?, and p300 at both BRF1P4 and GTF3C2P2. These findings indicate that Sp1 controls Pol III?directed transcription and shed light on how Sp1 regulates cancer cell proliferation.	[Peng, Feixia; Zhou, Ying; Wang, Juan; Wei, Yun; Deng, Huan; Wu, Zihui; Zhang, Cheng; Shi, Kaituo; Li, Yuan; Zhao, Shasha; Deng, Wensheng] Wuhan Univ Sci & Technol, Coll Life Sci & Hlth, Wuhan 430065, Peoples R China; [Guo, Baoqiang] Manchester Metropolitan Univ, Fac Sci & Engn, Ctr Biosci, Manchester M1 5GD, Lancs, England; [Wang, Xin; Shore, Paul] Univ Manchester, Fac Biol Med & Hlth, Manchester M13 9PL, Lancs, England	Wuhan University of Science & Technology; Manchester Metropolitan University; University of Manchester	Zhao, SS; Deng, WS (corresponding author), Wuhan Univ Sci & Technol, Coll Life Sci & Hlth, Wuhan 430065, Peoples R China.; Shore, P (corresponding author), Univ Manchester, Fac Biol Med & Hlth, Manchester M13 9PL, Lancs, England.	Paul.Shore@manchester.ac.uk; zhaoshasha@wust.edu.cn; dengwensheng@wust.edu.cn		Shore, Paul/0000-0002-1832-5976	Natural Science Foundation of China [31271395, 31671357]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by Natural Science Foundation of China Projects 31271395 and 31671357 (to W. D.). The authors declare that they have no conflicts of interest with the contents of this article.	Abramovitch S, 2003, FEBS LETT, V541, P149, DOI 10.1016/S0014-5793(03)00315-6; Barski A, 2010, NAT STRUCT MOL BIOL, V17, P629, DOI 10.1038/nsmb.1806; Beishline K, 2015, FEBS J, V282, P224, DOI 10.1111/febs.13148; Bywater MJ, 2012, CANCER CELL, V22, P51, DOI 10.1016/j.ccr.2012.05.019; Cabarcas S, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-47; Choi J, 2017, P NATL ACAD SCI USA, V114, P13691, DOI 10.1073/pnas.1719592115; Chu SJ, 2012, GENE, V508, P1, DOI 10.1016/j.gene.2012.07.022; Deng WS, 2012, P NATL ACAD SCI USA, V109, P1524, DOI 10.1073/pnas.1107879109; Derenzini M, 2017, ACTA HISTOCHEM, V119, P190, DOI 10.1016/j.acthis.2017.01.009; Dieci G, 2013, BBA-GENE REGUL MECH, V1829, P296, DOI 10.1016/j.bbagrm.2012.09.010; Fica SM, 2013, NATURE, V503, P229, DOI 10.1038/nature12734; Gomez-Roman N, 2003, NATURE, V421, P290, DOI 10.1038/nature01327; Grewal SS, 2015, BBA-GENE REGUL MECH, V1849, P898, DOI 10.1016/j.bbagrm.2014.12.005; Han I, 1997, MOL CELL BIOL, V17, P2550, DOI 10.1128/MCB.17.5.2550; Holmqvist PH, 2013, TRANSCR-AUSTIN, V4, P18, DOI 10.4161/trns.22601; Hung JJ, 2006, MOL CELL BIOL, V26, P1770, DOI 10.1128/MCB.26.5.1770-1785.2006; Jiang YX, 2004, CLIN EXP METASTAS, V21, P755, DOI 10.1007/s10585-005-1198-2; Kim HS, 2009, J BIOL CHEM, V284, P15475, DOI 10.1074/jbc.M808734200; Lei Junxia, 2017, Liver Res, V1, P112, DOI 10.1016/j.livres.2017.08.005; LESCURE A, 1992, J MOL BIOL, V228, P387, DOI 10.1016/0022-2836(92)90828-8; Li L, 2004, BIOCHEM CELL BIOL, V82, P460, DOI 10.1139/O04-045; Luster TA, 2000, MOL REPROD DEV, V57, P4, DOI 10.1002/1098-2795(200009)57:1<4::AID-MRD3>3.0.CO;2-I; Majumdar G, 2006, J BIOL CHEM, V281, P3642, DOI 10.1074/jbc.M511223200; Marshall L, 2008, NAT REV CANCER, V8, P911, DOI 10.1038/nrc2539; Mauger E, 2004, BIOCHEM SOC T, V32, P976, DOI 10.1042/BST0320976; Moir RD, 2013, BBA-GENE REGUL MECH, V1829, P361, DOI 10.1016/j.bbagrm.2012.11.001; Ohlsson C, 1998, ENDOCRINOLOGY, V139, P1101, DOI 10.1210/en.139.3.1101; Park JL, 2017, EPIGENOMICS-UK, V9, P171, DOI 10.2217/epi-2016-0108; Peltonen K, 2014, CANCER CELL, V25, P77, DOI 10.1016/j.ccr.2013.12.009; Previdi S, 2010, GYNECOL ONCOL, V118, P182, DOI 10.1016/j.ygyno.2010.03.020; Salvatori L, 2003, ONCOGENE, V22, P4875, DOI 10.1038/sj.onc.1206784; Sankpal UT, 2012, CURR MED CHEM, V19, P3779; Spengler ML, 2006, J BIOL CHEM, V281, P5567, DOI 10.1074/jbc.M600035200; Sriskanthadevan-Pirahas S, 2018, PLOS GENET, V14, DOI 10.1371/journal.pgen.1007202; Tapias A, 2008, CELL CYCLE, V7, P2856, DOI 10.4161/cc.7.18.6671; Thomas MC, 2006, CRIT REV BIOCHEM MOL, V41, P105, DOI 10.1080/10409230600648736; Torigoe T, 2003, NUCLEIC ACIDS RES, V31, P4523, DOI 10.1093/nar/gkg487; Turowski TW, 2016, BIOCHEM SOC T, V44, P1367, DOI 10.1042/BST20160062; Vizcaino C, 2015, PHARMACOL THERAPEUT, V152, P111, DOI 10.1016/j.pharmthera.2015.05.008; Waby JS, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-275; Wang J, 2016, J BIOL CHEM, V291, P25239, DOI 10.1074/jbc.M116.735886; Wang LW, 2003, CLIN CANCER RES, V9, P6371; Wang YT, 2011, J MOL BIOL, V414, P1, DOI 10.1016/j.jmb.2011.09.027; White RJ, 2004, ONCOGENE, V23, P3208, DOI 10.1038/sj.onc.1207547; Winter AG, 2000, P NATL ACAD SCI USA, V97, P12619, DOI 10.1073/pnas.230224097; Yuan P, 2007, CANCER-AM CANCER SOC, V110, P2682, DOI 10.1002/cncr.23092; Zhong Q, 2016, ONCOTARGET, V7, P6243, DOI 10.18632/oncotarget.6668	47	7	7	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 3	2020	295	14					4617	4630		10.1074/jbc.RA119.011555	http://dx.doi.org/10.1074/jbc.RA119.011555			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LB2WZ	32115405	hybrid, Green Published			2022-12-26	WOS:000524499700021
J	Spiegel, S				Spiegel, Sarah			Sphingosine-1-phosphate: From insipid lipid to a key regulator	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Biographical-Item						sphingosine 1-phosphate (S1P); sphingosine kinase (SphK); sphingolipid; S1PR; sphingolipid metabolites	PROTEIN-COUPLED RECEPTOR; PHOSPHATIDIC-ACID LEVELS; PROGRAMMED CELL-DEATH; SPHINGOSINE 1-PHOSPHATE; CHOLERA-TOXIN; B-SUBUNIT; FLUORESCENT GANGLIOSIDES; MOLECULAR-CLONING; FUNCTIONAL-CHARACTERIZATION; KINASE	It is a great honor to be asked to write a ?Reflections? article by one of the true icons of biochemistry, Herb Tabor. I felt humbled, especially since it follows many written by biochemists I admire and whose contributions have shaped major advances in biochemistry and molecular biology in the last century. Here I present my personal reflections on my adventure with the bioactive sphingolipid metabolite sphingosine-1-phosphate intertwined with those of my family life as a wife, mother, and grandmother. These reflections brought back many memories of events in my early career that played significant roles in determining the path I have taken for more than 40 years and that brought much fun and satisfaction into my life. It has been an exciting journey so far, with many surprises along the way, that still continues.	[Spiegel, Sarah] Virginia Commonwealth Univ, Sch Med, Dept Biochem & Mol Biol, Richmond, VA 23298 USA; [Spiegel, Sarah] Virginia Commonwealth Univ, Sch Med, Massey Canc Ctr, Richmond, VA 23298 USA	Virginia Commonwealth University; Virginia Commonwealth University	Spiegel, S (corresponding author), Virginia Commonwealth Univ, Sch Med, Dept Biochem & Mol Biol, Richmond, VA 23298 USA.; Spiegel, S (corresponding author), Virginia Commonwealth Univ, Sch Med, Massey Canc Ctr, Richmond, VA 23298 USA.	sarah.spiegel@vcuhealth.org		Spiegel, Sarah/0000-0003-0751-2634	National Institutes of Health [R01GM043880]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by National Institutes of Health Grant R01GM043880 (to S. S.). The author declares that she has no conflicts of interest with the contents of this article. The content is solely the responsibility of the author and does not necessarily represent the official views of the National Institutes of Health.	Alvarez SE, 2010, NATURE, V465, P1084, DOI 10.1038/nature09128; BARTON NW, 1990, P NATL ACAD SCI USA, V87, P1913, DOI 10.1073/pnas.87.5.1913; Bektas M, 2005, J CELL BIOL, V169, P801, DOI 10.1083/jcb.200407123; BUCKLEY NE, 1990, EXP CELL RES, V189, P13, DOI 10.1016/0014-4827(90)90250-E; Comi G, 2017, J NEUROL, V264, P2436, DOI 10.1007/s00415-017-8642-5; Cuvillier O, 1996, NATURE, V381, P800, DOI 10.1038/381800a0; Cuvillier O, 1998, J BIOL CHEM, V273, P2910, DOI 10.1074/jbc.273.5.2910; DESAI NN, 1992, J BIOL CHEM, V267, P23122; DIXON SJ, 1987, J CELL BIOL, V105, P1153, DOI 10.1083/jcb.105.3.1153; Donoviel MS, 2015, FASEB J, V29, P5018, DOI 10.1096/fj.15-274936; Edsall LC, 1997, J NEUROSCI, V17, P6952; Edsall LC, 1999, ANAL BIOCHEM, V272, P80, DOI 10.1006/abio.1999.4157; GOODEMOTE KA, 1995, J BIOL CHEM, V270, P10272, DOI 10.1074/jbc.270.17.10272; Grenald SA, 2017, PAIN, V158, P1733, DOI 10.1097/j.pain.0000000000000965; Hait NC, 2015, ONCOGENESIS, V4, DOI 10.1038/oncsis.2015.16; Hait NC, 2014, NAT NEUROSCI, V17, P971, DOI 10.1038/nn.3728; Hait NC, 2009, SCIENCE, V325, P1254, DOI 10.1126/science.1176709; HANNUN YA, 1989, SCIENCE, V243, P500, DOI 10.1126/science.2643164; Harikumar KB, 2014, NAT IMMUNOL, V15, P231, DOI 10.1038/ni.2810; Hecht JH, 1996, J CELL BIOL, V135, P1071, DOI 10.1083/jcb.135.4.1071; Himmelfarb J, 2002, KIDNEY INT, V62, P1524, DOI 10.1046/j.1523-1755.2002.00600.x; HLA T, 1990, J BIOL CHEM, V265, P9308; Hobson JP, 2001, SCIENCE, V291, P1800, DOI 10.1126/science.1057559; Jolly PS, 2004, J EXP MED, V199, P959, DOI 10.1084/jem.20030680; Kapitonov D, 2009, CANCER RES, V69, P6915, DOI 10.1158/0008-5472.CAN-09-0664; Kawahara A, 2009, SCIENCE, V323, P524, DOI 10.1126/science.1167449; Kleuser B, 1998, CANCER RES, V58, P1817; Kohama T, 1998, J BIOL CHEM, V273, P23722, DOI 10.1074/jbc.273.37.23722; Kunkel GT, 2013, NAT REV DRUG DISCOV, V12, P688, DOI 10.1038/nrd4099; Le Stunff H, 2002, J BIOL CHEM, V277, P8920, DOI 10.1074/jbc.M109968200; Lee MJ, 1998, SCIENCE, V279, P1552, DOI 10.1126/science.279.5356.1552; Liang J, 2013, CANCER CELL, V23, P107, DOI 10.1016/j.ccr.2012.11.013; Liu CH, 1999, MOL BIOL CELL, V10, P1179, DOI 10.1091/mbc.10.4.1179; Liu H, 2000, J BIOL CHEM, V275, P19513, DOI 10.1074/jbc.M002759200; Liu YJ, 2000, J CLIN INVEST, V106, P951, DOI 10.1172/JCI10905; Maceyka M, 2005, J BIOL CHEM, V280, P37118, DOI 10.1074/jbc.M502207200; Maceyka M, 2014, NATURE, V510, P58, DOI 10.1038/nature13475; Maceyka M, 2009, J LIPID RES, V50, pS272, DOI 10.1194/jlr.R800065-JLR200; Maczis MA, 2018, J LIPID RES, V59, P2297, DOI 10.1194/jlr.M085191; Malek RL, 2001, J BIOL CHEM, V276, P5692, DOI 10.1074/jbc.M003964200; Mandala S, 2002, SCIENCE, V296, P346, DOI 10.1126/science.1070238; Mandala SM, 2000, P NATL ACAD SCI USA, V97, P7859, DOI 10.1073/pnas.120146897; Mandala SM, 1998, P NATL ACAD SCI USA, V95, P150, DOI 10.1073/pnas.95.1.150; Matloubian M, 2004, NATURE, V427, P355, DOI 10.1038/nature02284; Milstien S, 2006, CANCER CELL, V9, P148, DOI 10.1016/j.ccr.2006.02.025; Nagahashi M, 2018, CANCER RES, V78, P1713, DOI 10.1158/0008-5472.CAN-17-1423; Nagahashi M, 2013, FASEB J, V27, P1001, DOI 10.1096/fj.12-219618; Nava VE, 2002, EXP CELL RES, V281, P115, DOI 10.1006/excr.2002.5658; Olivera A, 1998, J BIOL CHEM, V273, P12576, DOI 10.1074/jbc.273.20.12576; OLIVERA A, 1993, NATURE, V365, P557, DOI 10.1038/365557a0; Olivera A, 2003, J BIOL CHEM, V278, P46452, DOI 10.1074/jbc.M308749200; Paugh SW, 2008, BLOOD, V112, P1382, DOI 10.1182/blood-2008-02-138958; Price MM, 2013, J ALLERGY CLIN IMMUN, V131, P501, DOI 10.1016/j.jaci.2012.07.014; REBOIS RV, 1983, P NATL ACAD SCI-BIOL, V80, P1275, DOI 10.1073/pnas.80.5.1275; Rosenfeldt HM, 2001, FASEB J, V15, P2649, DOI 10.1096/fj.01-0523com; Singh Sandeep K., 2020, Advances in Biological Regulation, V75, P100670, DOI 10.1016/j.jbior.2019.100670; SPIEGEL S, 1989, J BIOL CHEM, V264, P6766; SPIEGEL S, 1989, J BIOL CHEM, V264, P16512; SPIEGEL S, 1985, J CELL BIOL, V100, P721, DOI 10.1083/jcb.100.3.721; Spiegel S, 2003, NAT REV MOL CELL BIO, V4, P397, DOI 10.1038/nrm1103; SPIEGEL S, 1987, P NATL ACAD SCI USA, V84, P141, DOI 10.1073/pnas.84.1.141; SPIEGEL S, 1984, J CELL BIOL, V99, P699, DOI 10.1083/jcb.99.2.699; SPIEGEL S, 1990, J CELL BIOCHEM, V42, P143, DOI 10.1002/jcb.240420305; SPIEGEL S, 1979, P NATL ACAD SCI USA, V76, P5277, DOI 10.1073/pnas.76.10.5277; SPIEGEL S, 1985, SCIENCE, V230, P1285, DOI 10.1126/science.2999979; SPIEGEL S, 1984, J CELL BIOL, V99, P1575, DOI 10.1083/jcb.99.5.1575; SPIEGEL S, 1986, J CELL BIOL, V102, P1898, DOI 10.1083/jcb.102.5.1898; Spiegel S, 2011, NAT REV IMMUNOL, V11, P403, DOI 10.1038/nri2974; Stockstill K, 2018, J EXP MED, V215, P1301, DOI 10.1084/jem.20170584; STOFFEL W, 1970, H-S Z PHYSIOL CHEM, V351, P1041, DOI 10.1515/bchm2.1970.351.2.1041; STOFFEL W, 1970, H-S Z PHYSIOL CHEM, V351, P635, DOI 10.1515/bchm2.1970.351.1.635; Takabe K, 2008, PHARMACOL REV, V60, P181, DOI 10.1124/pr.107.07113; Takabe K, 2010, J BIOL CHEM, V285, P10477, DOI 10.1074/jbc.M109.064162; Thudichum J.L.W., 1884, TREATISE CHEM CONSTI; Toman RE, 2004, J CELL BIOL, V166, P381, DOI 10.1083/jcb.200402016; Van Brocklyn JR, 2000, BLOOD, V95, P2624; Van Brocklyn JR, 1999, J BIOL CHEM, V274, P4626, DOI 10.1074/jbc.274.8.4626; Van Brocklyn JR, 1998, J CELL BIOL, V142, P229, DOI 10.1083/jcb.142.1.229; van der Weyden L, 2017, NATURE, V541, P233, DOI 10.1038/nature20792; Wang F, 1999, J BIOL CHEM, V274, P35343, DOI 10.1074/jbc.274.50.35343; ZHANG H, 1990, J BIOL CHEM, V265, P76; ZHANG H, 1991, J CELL BIOL, V114, P155, DOI 10.1083/jcb.114.1.155; ZHANG H, 1990, J BIOL CHEM, V265, P21309	83	9	9	2	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 6	2020	295	10					3371	3384		10.1074/jbc.X120.012838	http://dx.doi.org/10.1074/jbc.X120.012838			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KU3GL	32144147	Green Published, hybrid			2022-12-26	WOS:000519597300038
J	Adikari, A; de Silva, D; Ranasinghe, WKB; Bandaragoda, T; Alahakoon, O; Persad, R; Lawrentschuk, N; Alahakoon, D; Bolton, D				Adikari, Achini; de Silva, Daswin; Ranasinghe, Weranja K. B.; Bandaragoda, Tharindu; Alahakoon, Oshadi; Persad, Raj; Lawrentschuk, Nathan; Alahakoon, Damminda; Bolton, Damien			Can online support groups address psychological morbidity of cancer patients? An artificial intelligence based investigation of prostate cancer trajectories	PLOS ONE			English	Article							QUALITY-OF-LIFE; SOCIAL SUPPORT; ERECTILE DYSFUNCTION; EMOTIONAL SUPPORT; DISTRESS; MEN; FRAMEWORK; CARE	Background Online Cancer Support Groups (OCSG) are becoming an increasingly vital source of information, experiences and empowerment for patients with cancer. Despite significant contributions to physical, psychological and emotional wellbeing of patients, OCSG are yet to be formally recognised and used in multidisciplinary cancer support programs. This study highlights the opportunity of using Artificial Intelligence (AI) in OCSG to address psychological morbidity, with supporting empirical evidence from prostate cancer (PCa) patients. Methods A validated framework of AI techniques and Natural Language Processing (NLP) methods, was used to investigate PCa patient activities based on conversations in ten international OCSG (18,496 patients-277,805 conversations). The specific focus was on activities that indicate psychological morbidity; the reasons for joining OCSG, deep emotions and the variation from joining through to milestones in the cancer trajectory. Comparative analyses were conducted using t-tests, One-way ANOVA and Tukey-Kramer post-hoc analysis. Findings PCa patients joined OCSG at four key phases of psychological distress; diagnosis, treatment, side-effects, and recurrence, the majority group was `treatment' (61.72%). The four groups varied in expression of the intense emotional burden of cancer. The `side-effects' group expressed increased negative emotions during the first month compared to other groups (p< 0.01). A comparison of pre-treatment vs post-treatment emotions showed that joining pre-treatment had significantly lower negative emotions after 12-months compared to post-treatment (p< 0.05). Long-term deep emotion analysis reveals that all groups except 'recurrence' improved in emotional wellbeing. Conclusion This is the first empirical study of psychological morbidity and deep emotions expressed by men with a new diagnosis of cancer, using AI. PCa patients joining pre-treatment had improved emotions, and long-term participation in OCSG led to an increase in emotional wellbeing, indicating a decrease in psychological distress. It is opportune to further investigate AI in OCSG for early psychological intervention as an adjunct to conventional intervention programs.	[Adikari, Achini; de Silva, Daswin; Ranasinghe, Weranja K. B.; Bandaragoda, Tharindu; Alahakoon, Damminda] La Trobe Univ, Res Ctr Data Analyt & Cognit, Bundoora, Vic, Australia; [Ranasinghe, Weranja K. B.] Univ Texas Houston, MD Anderson Canc Ctr, 1515 Holcombe Blvd, Houston, TX 77030 USA; [Alahakoon, Oshadi] Victoria Univ, Coll Engn & Sci, Heidelberg, Vic, Australia; [Persad, Raj] NHS Trust, North Bristol, England; [Lawrentschuk, Nathan; Bolton, Damien] Univ Melbourne, Dept Surg, Melbourne, Vic, Australia; [Lawrentschuk, Nathan; Bolton, Damien] Austin Hosp, Olivia Newton John Canc Ctr, Melbourne, Vic, Australia; [Lawrentschuk, Nathan] Epworth Healthcare, EJ Whitten Prostate Canc Res Ctr, Melbourne, Vic, Australia; [Lawrentschuk, Nathan] Peter MacCallum Canc Ctr, Div Canc Surg, Melbourne, Vic, Australia	La Trobe University; University of Texas System; University of Texas Health Science Center Houston; UTMD Anderson Cancer Center; Victoria University; University of Melbourne; Florey Institute of Neuroscience & Mental Health; La Trobe University; Olivia Newton-John Cancer Research Institute; Peter Maccallum Cancer Center	Ranasinghe, WKB (corresponding author), La Trobe Univ, Res Ctr Data Analyt & Cognit, Bundoora, Vic, Australia.; Ranasinghe, WKB (corresponding author), Univ Texas Houston, MD Anderson Canc Ctr, 1515 Holcombe Blvd, Houston, TX 77030 USA.	weranja@gmail.com	Lawrentschuk, Nathan/AAL-8610-2021; des, d/GVU-7765-2022; Ranasinghe, Weranja/HHS-8150-2022; Ranasinghe, Weranja/AAV-5678-2021	Lawrentschuk, Nathan/0000-0001-8553-5618; Ranasinghe, Weranja/0000-0002-4006-0388; Bandaragoda, Tharindu/0000-0001-5047-3496; Adikari, Achini/0000-0001-5112-5063				Alahakoon D, 2000, IEEE T NEURAL NETWOR, V11, P601, DOI 10.1109/72.846732; Bandaragoda T, 2018, ANN SURG ONCOL, P1; Bandaragoda TR, 2017, J ASSOC INF SCI TECH, V68, P2394, DOI 10.1002/asi.23896; Bandaragoda TR, 2018, J ASS INF SCI TECHNO; Barak A, 2008, COMPUT HUM BEHAV, V24, P1867, DOI 10.1016/j.chb.2008.02.004; Blei DM, 2003, J MACH LEARN RES, V3, P993, DOI 10.1162/jmlr.2003.3.4-5.993; Broom A, 2005, J SOCIOL, V41, P87, DOI 10.1177/1440783305050965; Castelein S, 2008, ACTA PSYCHIAT SCAND, V118, P64, DOI 10.1111/j.1600-0447.2008.01216.x; COHEN S, 1985, PSYCHOL BULL, V98, P310, DOI 10.1037/0033-2909.98.2.310; Council I of M and NR, 2005, CANC PATIENT CANC SU; Courtens AM, 1996, CANCER NURS, V19, P162, DOI 10.1097/00002820-199606000-00002; De Silva D, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0205855; Foster C, 2011, BRIT J CANCER, V105, pS21, DOI 10.1038/bjc.2011.419; Gustafson DH, 2001, J GEN INTERN MED, V16, P435, DOI 10.1046/j.1525-1497.2001.016007435.x; Haglind E, 2015, EUR UROL, V68, P216, DOI 10.1016/j.eururo.2015.02.029; Harrison JD, 2009, SUPPORT CARE CANCER, V17, P1117, DOI 10.1007/s00520-009-0615-5; Hoch D, 2005, PLOS MED; Hoybye MT, 2010, SUPPORT CARE CANCER, V18, P553, DOI 10.1007/s00520-009-0683-6; Huber J, 2011, BJU INT, V107, P1570, DOI 10.1111/j.1464-410X.2010.09859.x; Lieberman MA, 2003, CANCER, V97, P920, DOI 10.1002/cncr.11145; Manning CD, 2014, PROCEEDINGS OF 52ND ANNUAL MEETING OF THE ASSOCIATION FOR COMPUTATIONAL LINGUISTICS: SYSTEM DEMONSTRATIONS, P55, DOI 10.3115/v1/p14-5010; Mehrotra S, 2010, IEEE INT CON MULTI, P1, DOI 10.1109/ICME.2010.5582531; Nanton V, 2018, BJU INT, V121, P494, DOI 10.1111/bju.14114; Nelson CJ, 2011, J SEX MED, V8, P560, DOI 10.1111/j.1743-6109.2010.02127.x; Oba A, 2017, JPN J CLIN ONCOL, V47, P735, DOI 10.1093/jjco/hyx066; Punnen S, 2013, BJU INT, V112, pE67, DOI 10.1111/bju.12209; Ranasinghe W, 2018, J UROLOGY, V199, pE133; Ranasinghe W, 2017, BJU INT, V120, P59, DOI 10.1111/bju.14036; Seale C, 2006, SOC SCI MED, V62, P2577, DOI 10.1016/j.socscimed.2005.11.016; Sillence E, 2014, HEALTH EXPECT, V17, P244, DOI 10.1111/j.1369-7625.2011.00745.x; Sinfield P, 2008, PATIENT EDUC COUNS, V73, P91, DOI 10.1016/j.pec.2008.05.001; Slevin ML, 1996, BRIT J CANCER, V74, P1275, DOI 10.1038/bjc.1996.529; Soatario M, RADIOL ONCOL, P11; Tang K, 2017, ONCOTARGET, V8, P32237, DOI 10.18632/oncotarget.13332; van Uden-Kraan CF, 2008, QUAL HEALTH RES, V18, P405, DOI 10.1177/1049732307313429; Watts S, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-003901; Weber BA, 2004, PSYCHO-ONCOL, V13, P47, DOI 10.1002/pon.718; Weis J, 2003, SUPPORT CARE CANCER, V11, P763, DOI 10.1007/s00520-003-0536-7; Wright K, 2002, J APPL COMMUN RES, V30, P195, DOI 10.1080/00909880216586; Yaxley JW, 2016, LANCET, V388, P1057, DOI 10.1016/S0140-6736(16)30592-X; Zakowski SG, 2003, BRIT J HEALTH PSYCH, V8, P271, DOI 10.1348/135910703322370851; Ziegler L, 2011, J PAIN SYMPTOM MANAG, V41, P619, DOI 10.1016/j.jpainsymman.2010.06.024	42	9	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2020	15	3							e0229361	10.1371/journal.pone.0229361	http://dx.doi.org/10.1371/journal.pone.0229361			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LQ8QU	32130256	Green Published, gold			2022-12-26	WOS:000535264000022
J	Knudsen, JS; Baggesen, LM; Lajer, M; Nurkanovic, L; Ustyugova, A; Sorensen, HT; Thomsen, RW				Knudsen, Jakob S.; Baggesen, Lisbeth M.; Lajer, Maria; Nurkanovic, Larisa; Ustyugova, Anastasia; Sorensen, Henrik T.; Thomsen, Reimar W.			Changes in SGLT2i and GLP-1RA real-world initiator profiles following cardiovascular outcome trials: A Danish nationwide population-based study	PLOS ONE			English	Article							LIRAGLUTIDE; PREVALENCE; DENMARK; DISEASE; TRENDS; RISK	Background We investigated changes in clinical characteristics of SGLT2i and GLP-1RA real-world initiators in Denmark before/after landmark cardiovascular outcome trials. Methods We compared first-time SGLT2i (25,070) and GLP-1RA (14,671) initiators to initiators of DPP-4i (n = 34,079), a class without proven cardiovascular benefits. We used linked population-based healthcare data to examine initiation incidence, medication patterns, and preexisting atherosclerotic cardiovascular disease (ASCVD) during 2014-2017. Results Nationwide incidence of SGLT2i initiators increased 3.6-fold (53/100,000 to 172/100,000 per year) vs. a 1.5-fold increase for GLP-1RA. DPP-4i initiation remained stable. From the end of 2015, SGLT2i was increasingly used as 2nd-line therapy, while medication patterns were much more stable for GLP-1RA. Among SGLT2i users, ASCVD increased slightly from 28% to 30%; age- and gender-adj. prevalence ratio (aPR) = 1.03 (95% CI:0.97-1.10). In contrast, among GLP-1RA initiators, baseline ASCVD declined from 29% to 27% (aPR: 0.90 (95% CI:0.84-0.97)), and in DPP-4i initiators from 31% to 29% (aPR: 0.91 (95% CI:0.88-0.96)). Conclusions Following the EMPA-REG OUTCOME trial in 2015, SGLT2i have become increasingly used as 2nd-line treatment in everyday clinical practice, with only minor increases in patient proportions with ASCVD. For GLP-1RA, we observed more stable therapy lines and slightly decreasing ASCVD in new users despite the LEADER trial.	[Knudsen, Jakob S.; Baggesen, Lisbeth M.; Sorensen, Henrik T.; Thomsen, Reimar W.] Aarhus Univ Hosp, Dept Clin Epidemiol, Aarhus, Denmark; [Lajer, Maria] Boehringer Ingelheim GmbH & Co KG, Copenhagen, Denmark; [Nurkanovic, Larisa] Boehringer Ingelheim GmbH & Co KG, Amsterdam, Netherlands; [Ustyugova, Anastasia] Boehringer Ingelheim Int GmbH, Ingelheim, Germany	Aarhus University; Boehringer Ingelheim; Boehringer Ingelheim; Boehringer Ingelheim	Knudsen, JS (corresponding author), Aarhus Univ Hosp, Dept Clin Epidemiol, Aarhus, Denmark.	jsk@clin.au.dk		Toft Sorensen, Henrik/0000-0003-4299-7040; Schollhammer Knudsen, Jakob/0000-0002-3772-4497; Thomsen, Reimar/0000-0001-9135-3474	Boehringer Ingelheim	Boehringer Ingelheim(Boehringer Ingelheim)	This work was supported by an institutional research grant from Boehringer Ingelheim to Aarhus University. While Boehringer Ingelheim was involved in the study's concept, it was designed and conducted by the coauthors from Aarhus University. The funder provided support in the form of salaries for authors ML, LN, and AU, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	[Anonymous], 2019, DIABETES CARE, V42, pS1, DOI [10.2337/dc19-Sint01, 10.2337/dc19-SINT01]; Bailey CJ, 2019, DIABETES OBES METAB, V21, P3, DOI 10.1111/dom.13492; Bork CS, 2017, DAN MED J, V64; Carstensen B, 2018, P 54 ANN M EUR ASS S; Cavallari I, 2019, DIABETES-METAB RES, V35, DOI 10.1002/dmrr.3124; Christensen DH, 2016, CLIN EPIDEMIOL, V8, P381, DOI 10.2147/CLEP.S113211; Dalsgaard NB, 2018, DIABETES OBES METAB, V20, P508, DOI 10.1111/dom.13128; Danish Society for General Practice and Danish Endocrine Society, 2018, PHARM TREATM TYP 2 D; Davies MJ, 2018, DIABETOLOGIA, V61, P2461, DOI 10.1007/s00125-018-4729-5; Gedebjerg A, 2018, J DIABETES COMPLICAT, V32, P34, DOI 10.1016/j.jdiacomp.2017.09.010; Grann Anne Fia, 2011, Clin Epidemiol, V3, P133, DOI 10.2147/CLEP.S17901; Green JB, 2017, NEW ENGL J MED, V373, P232; Horsdal HT, 2008, DIABETOLOGIA, V51, P567, DOI 10.1007/s00125-008-0947-6; Inzucchi SE, 2015, DIABETES CARE, V38, P140, DOI 10.2337/dc14-2441; Leegaard A, 2011, DIABETES CARE, V34, P2530, DOI 10.2337/dc11-0902; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Marso SP, 2016, NEW ENGL J MED, V375, P311, DOI 10.1056/NEJMoa1603827; Montvida O, 2018, DIABETES CARE, V41, P69, DOI 10.2337/dc17-1414; Mor A, 2017, AM J EPIDEMIOL, V186, P227, DOI 10.1093/aje/kwx049; Neal B, 2017, NEW ENGL J MED, V377, P644, DOI 10.1056/NEJMoa1611925; Nilsson M, 2018, BASIC CLIN PHARMACOL, V122, P606, DOI 10.1111/bcpt.12961; Piepoli MF, 2016, ATHEROSCLEROSIS, V252, P207, DOI [10.1177/2047487316653709, 10.1016/j.atherosclerosis.2016.05.037]; Pottegard A, 2017, INT J EPIDEMIOL, V46, P798, DOI 10.1093/ije/dyw213; Pottegard A, 2014, EUR J CLIN PHARMACOL, V70, P205, DOI 10.1007/s00228-013-1595-4; Radholm K, 2018, DIABETES RES CLIN PR, V140, P118, DOI 10.1016/j.diabres.2018.03.027; Rungby J, 2017, CARDIOVASC ENDOCRINO, V6, P145, DOI 10.1097/XCE.0000000000000135; Scheen AJ, 2018, CIRC RES, V122, P1439, DOI 10.1161/CIRCRESAHA.117.311588; Schmidt M, 2015, CLIN EPIDEMIOL, V7, P449, DOI 10.2147/CLEP.S91125; Schmidt M, 2014, EUR J EPIDEMIOL, V29, P541, DOI 10.1007/s10654-014-9930-3; Sposito AC, 2018, CARDIOVASC DIABETOL, V17, DOI 10.1186/s12933-018-0800-2; Sundboll J, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-012832; Thomsen RW, 2017, NEPHROL DIAL TRANSPL, V33, P1; Thygesen SK, 2011, BMC MED RES METHODOL, V11, DOI 10.1186/1471-2288-11-83; Zinman B, 2015, NEW ENGL J MED, V373, P2117, DOI 10.1056/NEJMoa1504720	34	17	17	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2020	15	3							e0229621	10.1371/journal.pone.0229621	http://dx.doi.org/10.1371/journal.pone.0229621			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8QU	32130249	Green Published, gold			2022-12-26	WOS:000535264000034
J	Kia, B; Mendes, A; Parnami, A; George, R; Mobley, K; Ditto, WL				Kia, Behnam; Mendes, Allen; Parnami, Akshay; George, Robin; Mobley, Kenneth; Ditto, William L.			Nonlinear dynamics based machine learning: Utilizing dynamics-based flexibility of nonlinear circuits to implement different functions	PLOS ONE			English	Article							COMPUTATION; BRAIN; CHAOS; EDGE	The core element of machine learning is a flexible, universal function approximator that can be trained and fit into the data. One of the main challenges in modern machine learning is to understand the role of nonlinearity and complexity in these universal function approximators. In this research, we focus on nonlinear complex systems, and show their capability in representation and learning of different functions. Complex nonlinear dynamics and chaos naturally yield an almost infinite diversity of dynamical behaviors and functions. Physical, biological and engineered systems can utilize this diversity to implement adaptive, robust behaviors and operations. A nonlinear dynamical system can be considered as an embodiment of a collection of different possible behaviors or functions, from which different behaviors or functions can be chosen as a response to different conditions or problems. This process of selection can be manual in the sense that one can manually pick and choose the right function through directly setting parameters. Alternatively, we can automate the process and allow the system itself learn how to do it. This creates an approach to machine learning, wherein the nonlinear dynamics represents and embodies different possible functions, and it learns through training how to pick the right function from this function space. We report on how we utilized nonlinear dynamics and chaos to design and fabricate nonlinear dynamics based, morphable hardware in silicon as a physical embodiment for different possible functions. We demonstrate how this flexible, morphable hardware learns through learning and searching algorithms such as genetic algorithm to implement different desired functions. In this approach, we combine two powerful natural and biological phenomenon, Darwinian evolution and nonlinear dynamics and chaos, as a dynamics-oriented approach to designing intelligent, adaptive systems with applications. Nonlinear dynamics embodies different functions at the hardware level, while an evolutionary method is utilized in order to find the parameters to implement the right function.	[Kia, Behnam; Mendes, Allen; Parnami, Akshay; George, Robin; Ditto, William L.] North Carolina State Univ, Dept Phys, Nonlinear Artificial Intelligence Lab, Raleigh, NC 27695 USA; [Mobley, Kenneth] First Pass Engn, Castle Rock, CO USA	University of North Carolina; North Carolina State University	Ditto, WL (corresponding author), North Carolina State Univ, Dept Phys, Nonlinear Artificial Intelligence Lab, Raleigh, NC 27695 USA.	wditto@ncsu.edu	Ditto, William/AAK-9827-2020	Ditto, William/0000-0002-7416-8012	ONR [N00014-16-1-3056]	ONR(Office of Naval Research)	This research was supported by an ONR Grant N00014-16-1-3056 to WD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The funder (First Pass Engineering) provided support in the form of salaries for authors [K.M.], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the `author contributions' section.	Avrim Blum, 1989, ADV NEURAL INFORM PR; Berger TW, 2012, IEEE T NEUR SYS REH, V20, P198, DOI 10.1109/TNSRE.2012.2189133; BERGER TW, 1994, NEURAL NETWORKS, V7, P1031, DOI 10.1016/S0893-6080(05)80158-3; Bertschinger N, 2004, NEURAL COMPUT, V16, P1413, DOI 10.1162/089976604323057443; Eiben AE, 2015, NATURE, V521, P476, DOI 10.1038/nature14544; Gauthier Daniel J., 2018, PHYS REV LETT, V120; Haddow PC, 2000, IEEE C EVOL COMPUTAT, P553, DOI 10.1109/CEC.2000.870345; Hastad John, 1986, P 18 ANN ACM S THEOR; HORNIK K, 1991, NEURAL NETWORKS, V4, P251, DOI 10.1016/0893-6080(91)90009-T; Ian Goodfellow, 2016, DEEP LEARNING, V1; Indiveri G, 2011, FRONT NEUROSCI-SWITZ, V5, DOI 10.3389/fnins.2011.00073; Keymeulen D, 2000, IEEE T RELIAB, V49, P305, DOI 10.1109/24.914547; Kia B, 2017, NASA ESA CONF, P200, DOI 10.1109/AHS.2017.8046379; Kia B, 2017, IEEE T CIRCUITS-II, V64, P715, DOI 10.1109/TCSII.2016.2611442; Kia B, 2017, PHILOS T R SOC A, V375, DOI 10.1098/rsta.2016.0222; Kia B, 2016, IEEE T CIRCUITS-II, V63, P944, DOI 10.1109/TCSII.2016.2538358; Kia B, 2015, FRONT COMPUT NEUROSC, V9, DOI 10.3389/fncom.2015.00049; Krizhevsky A., 2012, ADV NEURAL INF PROCE; LANGTON CG, 1990, PHYSICA D, V42, P12, DOI 10.1016/0167-2789(90)90064-V; LeCun Y, 2015, NATURE, V521, P436, DOI 10.1038/nature14539; MCKENNA TM, 1994, NEUROSCIENCE, V60, P587, DOI 10.1016/0306-4522(94)90489-8; Rabinovich MI, 2010, PHYS-USP+, V53, P357, DOI 10.3367/UFNe.0180.201004b.0371; Rocke P, 2008, LECT NOTES COMPUT SC, V5216, P118; Song D, 2007, IEEE T BIO-MED ENG, V54, P1053, DOI 10.1109/TBME.2007.891948; Stomeo E, 2006, AHS 2006: FIRST NASA/ESA CONFERENCE ON ADAPTIVE HARDWARE AND SYSTEMS, PROCEEDINGS, P179	25	0	0	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2020	15	3							e0228534	10.1371/journal.pone.0228534	http://dx.doi.org/10.1371/journal.pone.0228534			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8MS	32126089	Green Published, gold			2022-12-26	WOS:000535253100009
J	Ruggeri, J; Ferlazzo, G; Boniotti, MB; Capucci, L; Guarneri, F; Barbieri, I; Alborali, GL; Amadori, M				Ruggeri, Jessica; Ferlazzo, Gianluca; Boniotti, Maria Beatrice; Capucci, Lorenzo; Guarneri, Flavia; Barbieri, Ilaria; Alborali, Giovanni Loris; Amadori, Massimo			Characterization of the IgA response to PRRS virus in pig oral fluids	PLOS ONE			English	Article							RESPIRATORY SYNDROME VIRUS; PASSIVE TRANSFER; SWINE; NEUTRALIZATION; PROTECTION; ANTIBODIES; INFECTION	Porcine Reproductive and Respiratory Syndrome (PRRS) is a complex model of host/virus relationship. Disease control measures often includes "acclimatization", i.e. the exposure of PRRS-naive gilts and sows to PRRSV-infected pigs and premises before the breeding period. In this respect, we had repeatedly observed an association between PRRSV-specific IgA responses in oral fluids (OF) of gilts and block of PRRSV spread. Therefore, we set out to investigate in vitro the inhibition of PRRSV replication by OF samples with different titers of PRRSV-specific IgA and IgG antibody, using Real-time RT PCR. PRRSV yield reduction in monocyte-derived macrophages was associated with the IgA content in OF samples, whereas the IgG-rich samples were sometimes associated with antibody-dependent enhancement (ADE) of replication. Accordingly, we could discriminate between ADEpositive and ADE-negative PRRSV strains. Next, we separated Ig isotypes in OF samples of PRRSV-infected pigs by means of protein A and size exclusion chromatography. The above results were confirmed by using separated Ig isotypes. Both dimeric and monomeric IgA were associated with the strongest reduction of PRRSV replication. The treatment of pig macrophages with separated OF antibodies before PRRSV infection was also associated with PRRSV yield reduction, along with clear changes of both CD163 and CD169 surface expression. Our results point at a role of mucosal IgA in the control of PRRSV replication by extra- and/or intracellular interaction with PRRSV, as well as by induction of signals leading to a reduced susceptibility of macrophages to PRRSV infection.	[Ruggeri, Jessica; Ferlazzo, Gianluca; Guarneri, Flavia; Amadori, Massimo] Ist Zooprofilatt Sperimentale Lombardia & Emilia, Lab Anim Welf Clin Chem & Vet Immunol, Brescia, Italy; [Boniotti, Maria Beatrice; Barbieri, Ilaria] Ist Zooprofilatt Sperimentale Lombardia & Emilia, Genom Dept, Brescia, Italy; [Capucci, Lorenzo] Ist Zooprofilatt Sperimentale Lombardia & Emilia, Virol Dept, Brescia, Italy; [Alborali, Giovanni Loris] Ist Zooprofilatt Sperimentale Lombardia & Emilia, Diagnost Lab, Brescia, Italy; [Ruggeri, Jessica] ATS Brescia, Vet Serv, Viale Duca Abruzzi, Brescia, Italy; [Ferlazzo, Gianluca] Veronesi Holding, Pellegrina Extent Serv, Quinto Di Valpantena, Italy	IZS Lombardia e Emilia; IZS Lombardia e Emilia; IZS Lombardia e Emilia; IZS Lombardia e Emilia	Amadori, M (corresponding author), Ist Zooprofilatt Sperimentale Lombardia & Emilia, Lab Anim Welf Clin Chem & Vet Immunol, Brescia, Italy.	m_amadori@fastwebnet.it	Guarneri, Flavia/GON-5193-2022; Boniotti, Maria Beatrice/AAD-1762-2022; Amadori, Massimo/J-2511-2014	Boniotti, Maria Beatrice/0000-0001-6252-9848; Capucci, Lorenzo/0000-0002-1830-3929; Amadori, Massimo/0000-0002-7562-0322; Guarneri, Flavia/0000-0003-2206-6089	Italian Ministry of Health [PRC 2015018]	Italian Ministry of Health(Ministry of Health, Italy)	This study was funded by Italian Ministry of Health, Grant PRC 2015018	Ben Mkaddem S, 2014, CURR TOP MICROBIOL, V382, P221, DOI 10.1007/978-3-319-07911-0_10; Busquets N, 2010, VET RES, V41, DOI 10.1051/vetres/2010046; CHEN TR, 1977, EXP CELL RES, V104, P255, DOI 10.1016/0014-4827(77)90089-1; Corzo CA, 2010, VIRUS RES, V154, P185, DOI 10.1016/j.virusres.2010.08.016; Crisci E, 2019, VET SCI, V6, DOI 10.3390/vetsci6010026; Dea S, 2000, ARCH VIROL, V145, P659, DOI 10.1007/s007050050662; Diaz I, 2012, VET RES, V43, DOI 10.1186/1297-9716-43-30; Drigo M, 2018, VET IMMUNOL IMMUNOP, V200, P32, DOI 10.1016/j.vetimm.2018.04.007; Holtkamp DJ, 2011, TIERAERZTL PRAX G N, V39, P101; Karniychuk UU, 2010, BMC VET RES, V6, DOI 10.1186/1746-6148-6-30; Kittawornrat A, 2013, BMC VET RES, V9, DOI 10.1186/1746-6148-9-61; Klinge KL, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-177; Labarque GG, 2000, J GEN VIROL, V81, P1327, DOI 10.1099/0022-1317-81-5-1327; Lopez OJ, 2007, CLIN VACCINE IMMUNOL, V14, P269, DOI 10.1128/CVI.00304-06; Mateu E, 2008, VET J, V177, P345, DOI 10.1016/j.tvjl.2007.05.022; MAZANEC MB, 1992, P NATL ACAD SCI USA, V89, P6901, DOI 10.1073/pnas.89.15.6901; Morgan SB, 2013, VET MICROBIOL, V163, P13, DOI 10.1016/j.vetmic.2012.11.024; Nelsen CJ, 1999, J VIROL, V73, P270, DOI 10.1128/JVI.73.1.270-280.1999; Osorio FA, 2002, VIROLOGY, V302, P9, DOI 10.1006/viro.2002.1612; Petry DB, 2005, J ANIM SCI, V83, P1494; ROWLAND RRR, 1994, J GEN VIROL, V75, P1071, DOI 10.1099/0022-1317-75-5-1071; Singleton H, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00832; Stadejek T, 2006, J GEN VIROL, V87, P1835, DOI 10.1099/vir.0.81782-0; Wang ZP, 1996, AM J RESP CRIT CARE, V154, P1261, DOI 10.1164/ajrccm.154.5.8912733; Welch SKW, 2010, VIRUS RES, V154, P98, DOI 10.1016/j.virusres.2010.07.018; YOON IJ, 1994, J VET DIAGN INVEST, V6, P289; Yoon KJ, 1997, VET MICROBIOL, V55, P277, DOI 10.1016/S0378-1135(96)01338-7; Zimmerman J, 2006, PORCINE REPRODUCTIVE, P387	28	7	7	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2020	15	3							e0229065	10.1371/journal.pone.0229065	http://dx.doi.org/10.1371/journal.pone.0229065			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8MS	32126095	gold, Green Submitted, Green Published			2022-12-26	WOS:000535253100013
J	Che, GH; Gao, H; Hu, QB; Xie, HC; Zhang, YF				Che, Guanghua; Gao, Hang; Hu, Qibo; Xie, Hongchang; Zhang, Yunfeng			Angiotensin II promotes podocyte injury by activating Arf6-Erk1/2-Nox4 signaling pathway	PLOS ONE			English	Article							NADPH OXIDASES; MECHANISMS; NEPHRIN; ROLES; ARF6	Angiotensin II (Ang II) is a key contributor to glomerular disease by predominantly resulting in podocyte injury, whereas the underlying molecular mechanisms has not been fully understood. This study aimed to investigate if and how ADP-ribosylation factor 6 (Arf6), a small GTP-binding protein, involves Ang II-induced cellular injury in cultured human podocytes. Cellular injury was evaluated with caspase 3 activity, reactive oxygen species (ROS) level and TUNEL assay. Arf6 activity was measured using an Arf6-GTP Pull-Down Assay. Ang II significantly enhanced Arf6 expressions accompanied by increase of Arf6-GTP. The TUNEL-positive cells as well as activated caspase 3, NADPH oxidase 4 protein (Nox4) and ROS levels were dramatically increased in Ang II-treated podocytes, which was prevented by secinH3, an Arf6 activity inhibitor. Induction of ROS by Ang II was inhibited in podocytes with Nox4 knockdown. Ang II-induced elevation of Nox4 and ROS was prevented by Arf6 knockdown. Phpspho-Erk1/2Thr202/Tyr204 levels were upregulated remarkably following Ang II treatment, and Erk inhibitor LY3214996 significantly downregulated Nox4 expression. In addition, Ang II decreased CD2AP expression. Overexpression of CD2AP prevented Ang IIinduced upregulation of Arf6-GTP. Our data demonstrated that Ang II promotes ROS production and podocytes injury through activation of Arf6-Erk1/2-Nox4 signaling. We also provided evidence that Ang II activates Arf6 by degradation of CD2AP.	[Che, Guanghua; Hu, Qibo; Xie, Hongchang; Zhang, Yunfeng] Jilin Univ, Hosp 2, Dept Pediat, Changchun, Peoples R China; [Gao, Hang] Jilin Univ, Norman Bethune Coll Med, Key Lab Pathobiol, Minist Educ, Changchun, Peoples R China	Jilin University; Jilin University	Zhang, YF (corresponding author), Jilin Univ, Hosp 2, Dept Pediat, Changchun, Peoples R China.	yunfengzhang11@126.com						Anderson M, 2014, J CELL PHYSIOL, V229, P434, DOI 10.1002/jcp.24461; Bedard K, 2007, PHYSIOL REV, V87, P245, DOI 10.1152/physrev.00044.2005; Bourmoum M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148097; Campbell KN, 2011, CURR DIABETES REV, V7, P3, DOI 10.2174/157339911794273973; Cao XR, 2019, OXID MED CELL LONGEV, V2019, DOI 10.1155/2019/4546975; Cardoso VG, 2018, BMC NEPHROL, V19, DOI 10.1186/s12882-018-0968-4; Chen YM, 2015, BMC NEPHROL, V16, DOI 10.1186/s12882-015-0090-9; Das R, 2014, AM J PHYSIOL-RENAL, V306, pF155, DOI 10.1152/ajprenal.00438.2013; Eid AA, 2010, J BIOL CHEM, V285, P37503, DOI 10.1074/jbc.M110.136796; Eid AA, 2009, DIABETES, V58, P1201, DOI 10.2337/db08-1536; Gao N, 2017, CHEM-BIOL INTERACT, V277, P110, DOI 10.1016/j.cbi.2017.09.010; George B, 2012, J CLIN INVEST, V122, P674, DOI 10.1172/JCI60070; Gorin Y, 2004, BIOCHEM J, V381, P231, DOI 10.1042/BJ20031614; Hafner M, 2006, NATURE, V444, P941, DOI 10.1038/nature05415; Hsu HH, 2008, J MOL MED, V86, P1379, DOI 10.1007/s00109-008-0399-y; Ikeda S, 2005, CIRC RES, V96, P467, DOI 10.1161/01.RES.0000158286.51045.16; Inoue K, 2019, J AM SOC NEPHROL, V30, P2307, DOI 10.1681/ASN.2019010053; Johnson RI, 2011, MOL BIOL CELL, V22, P4513, DOI 10.1091/mbc.E11-04-0305; Kang JS, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-44194-3; Lal MA, 2018, FRONT ENDOCRINOL, V9, DOI 10.3389/fendo.2018.00409; Li R, 2017, LIFE SCI, V182, P80, DOI 10.1016/j.lfs.2017.06.008; Lin JS, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184575; Marquez E, 2015, AM J PHYSIOL-RENAL, V308, pF1, DOI 10.1152/ajprenal.00531.2013; Martin CE, 2018, FRONT ENDOCRINOL, V9, DOI 10.3389/fendo.2018.00302; Porter AG, 1999, CELL DEATH DIFFER, V6, P99, DOI 10.1038/sj.cdd.4400476; Redza-Dutordoir M, 2016, BBA-MOL CELL RES, V1863, P2977, DOI 10.1016/j.bbamcr.2016.09.012; Ren ZL, 2012, CELL SIGNAL, V24, P443, DOI 10.1016/j.cellsig.2011.09.022; Ruster C, 2013, SEMIN NEPHROL, V33, P44, DOI 10.1016/j.semnephrol.2012.12.002; Saleem MA, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V133630; Schafer DA, 2000, TRAFFIC, V1, P892; Scott RP, 2015, J CELL BIOL, V209, P199, DOI 10.1083/jcb.201410017; Sedeek M, 2010, AM J PHYSIOL-RENAL, V299, pF1348, DOI 10.1152/ajprenal.00028.2010; Sedeek M, 2013, J AM SOC NEPHROL, V24, P1512, DOI 10.1681/ASN.2012111112; Sun Y, 2015, J RECEPT SIG TRANSD, V35, P600, DOI 10.3109/10799893.2015.1030412; Vriz S, 2014, CURR TOP DEV BIOL, V108, P121, DOI 10.1016/B978-0-12-391498-9.00002-4; Zhang JC, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.01447; Zhao M, 2018, KIDNEY DIS-BASEL, V4, P83, DOI 10.1159/000488242; Zou JR, 2019, MOL MED REP, V19, P759, DOI 10.3892/mmr.2018.9712	38	13	13	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2020	15	3							e0229747	10.1371/journal.pone.0229747	http://dx.doi.org/10.1371/journal.pone.0229747			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8JT	32119711	gold, Green Published			2022-12-26	WOS:000535245300038
J	Khokhar, JS; King, J; King, IP; Young, SD; Foulkes, MJ; De Silva, J; Weerasinghe, M; Mossa, A; Griffiths, S; Riche, AB; Hawkesford, M; Shewry, P; Broadley, MR				Khokhar, Jaswant S.; King, Julie; King, Ian P.; Young, Scott D.; Foulkes, Michael J.; De Silva, Jayalath; Weerasinghe, Minuka; Mossa, Abdul; Griffiths, Simon; Riche, Andrew B.; Hawkesford, Malcolm; Shewry, Peter; Broadley, Martin R.			Novel sources of variation in grain Zinc (Zn) concentration in bread wheat germplasm derived from Watkins landraces	PLOS ONE			English	Article							IRON CONCENTRATIONS; LOW-INCOME; BIOFORTIFICATION; LOCALIZATION; DEFICIENCY; NUTRITION; RESOURCE; CALCIUM; HEALTH; FOODS	A diverse panel of 245 wheat genotypes, derived from crosses between landraces from the Watkins collection representing global diversity in the early 20th century and the modern wheat cultivar Paragon, was grown at two field sites in the UK in 2015-16 and the concentrations of zinc and iron determined in wholegrain using inductively coupled plasma-mass spectrometry (ICP-MS). Zinc concentrations in wholegrain varied from 24-49 mg kg(-1) and were correlated with iron concentration (r = 0.64) and grain protein content (r = 0.14). However, the correlation with yield was low (r = -0.16) indicating little yield dilution. A sub-set of 24 wheat lines were selected from 245 wheat genotypes and characterised for Zn and Fe concentrations in wholegrain and white flour over two sites and years. White flours from 24 selected lines contained 8-15 mg kg(-1) of zinc, which was positively correlated with the wholegrain Zn concentration (r = 0.79, averaged across sites and years). This demonstrates the potential to exploit the diversity in landraces to increase the concentration of Zn in wholegrain and flour of modern high yielding bread wheat cultivars.	[Khokhar, Jaswant S.; King, Julie; King, Ian P.; Young, Scott D.; Foulkes, Michael J.; De Silva, Jayalath; Weerasinghe, Minuka; Mossa, Abdul; Broadley, Martin R.] Univ Nottingham, Sch Biosci, Sutton Bonington Campus, Loughborough, Leics, England; [Griffiths, Simon] John Innes Ctr, Crop Genet, Norwich, Norfolk, England; [Riche, Andrew B.; Hawkesford, Malcolm; Shewry, Peter] Rothamsted Res, Plant Sci, Harpenden, Herts, England	University of Nottingham; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Rothamsted Research	Khokhar, JS (corresponding author), Univ Nottingham, Sch Biosci, Sutton Bonington Campus, Loughborough, Leics, England.	Jaswant.Singh1@nottingham.ac.uk	Hawkesford, Malcolm/AAE-1522-2022; broadley, martin r/E-9081-2011; Khokhar, Jaswant/ABG-8288-2020; Broadley, Martin/AAW-4638-2021	broadley, martin r/0000-0003-3964-7226; Khokhar, Jaswant/0000-0003-4870-6208; Broadley, Martin/0000-0003-3964-7226; Hawkesford, Malcolm/0000-0001-8759-3969; Mossa, Abdul Wahab/0000-0002-9540-2023	Indian Department of Biotechnology [BT/IN/UK-VNC/43/KV/2015-16]; Biotechnology and Biological Sciences Research Council (BBSRC) (UK) [BB/N013360/1]; Designing Future Wheat strategic programme [BB/P016855/1]; Biotechnology and Biological Sciences Research Council under the Sustainable Crop Production Research for International Development (SCPRID) programme [BB/J011827/1]; Newton-Bhabha Fund Project "Indo-UK Centre for the improvement of nitrogen use efficiency in wheat" (INEW); Biotechnology and Biological Sciences Research Council (BBSRC) of the UK; BBSRC [BBS/E/C/000I0250, BB/N013360/1, BBS/E/C/000I0220, BB/J011827/1] Funding Source: UKRI	Indian Department of Biotechnology; Biotechnology and Biological Sciences Research Council (BBSRC) (UK)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Designing Future Wheat strategic programme; Biotechnology and Biological Sciences Research Council under the Sustainable Crop Production Research for International Development (SCPRID) programme(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Newton-Bhabha Fund Project "Indo-UK Centre for the improvement of nitrogen use efficiency in wheat" (INEW); Biotechnology and Biological Sciences Research Council (BBSRC) of the UK(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the Newton-Bhabha Fund Project "Indo-UK Centre for the improvement of nitrogen use efficiency in wheat" (INEW) co-funded by the Indian Department of Biotechnology (BT/IN/UK-VNC/43/KV/2015-16) and the Biotechnology and Biological Sciences Research Council (BBSRC) [grant number BB/N013360/1] (UK); Rothamsted Research and the John Innes Centre receive grant-aided support from the Biotechnology and Biological Sciences Research Council (BBSRC) of the UK and the work forms part of the Designing Future Wheat strategic programme (BB/P016855/1) and, the Biotechnology and Biological Sciences Research Council [grant number BB/J011827/1], under the Sustainable Crop Production Research for International Development (SCPRID) programme.	AACCI American Association of Cereal Chemists, 2000, 665001 AACCI; Ajiboye B, 2015, PLANT SOIL, V392, P357, DOI 10.1007/s11104-015-2467-8; Badakhshan H., 2013, International Journal of Agriculture and Crop Sciences (IJACS), V6, P57; Black RE, 2003, LANCET, V361, P2226, DOI 10.1016/S0140-6736(03)13779-8; Borg S, 2009, PLANT SOIL, V325, P15, DOI 10.1007/s11104-009-0046-6; Bouis HE, 2017, GLOB FOOD SECUR-AGR, V12, P49, DOI 10.1016/j.gfs.2017.01.009; Cakmak I, 2004, SOIL SCI PLANT NUTR, V50, P1047, DOI 10.1080/00380768.2004.10408573; Cakmak I, 2018, EUR J SOIL SCI, V69, P172, DOI 10.1111/ejss.12437; Cakmak I, 2010, J AGR FOOD CHEM, V58, P9092, DOI 10.1021/jf101197h; CATALDO DA, 1975, COMMUN SOIL SCI PLAN, V6, P71, DOI 10.1080/00103627509366547; Chen XW, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-04992-z; Dotlacil L, 2010, CZECH J GENET PLANT, V46, pS70, DOI 10.17221/1519-CJGPB; Eagling T, 2014, J AGR FOOD CHEM, V62, P708, DOI 10.1021/jf403331p; Gibson RS, 2010, FOOD NUTR BULL, V31, pS134, DOI 10.1177/15648265100312S206; Gupta RK, 2015, J FOOD SCI TECH MYS, V52, P676, DOI 10.1007/s13197-013-0978-y; Guzman C, 2014, J CEREAL SCI, V60, P617, DOI 10.1016/j.jcs.2014.07.006; Hess SY, 2009, FOOD NUTR BULL, V30, pS60, DOI 10.1177/15648265090301S105; Joy EJM, 2015, PLANT SOIL, V389, P1, DOI 10.1007/s11104-015-2430-8; Khokhar JS, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179208; Khokhar JS, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0192026; Kjeldahl J., 1883, CHEM NEWS, V1240, P101; Kumssa DB, 2015, SCI REP-UK, V5, DOI 10.1038/srep10974; Lockyer S, 2018, NUTR BULL, V43, P416, DOI 10.1111/nbu.12348; Morgounov A, 2007, EUPHYTICA, V155, P193, DOI 10.1007/s10681-006-9321-2; Oury FX, 2006, EUR J AGRON, V25, P177, DOI 10.1016/j.eja.2006.04.011; Ozturk L, 2006, PHYSIOL PLANTARUM, V128, P144, DOI 10.1111/j.1399-3054.2006.00737.x; Pandey A, 2016, SPRINGERPLUS, V5, DOI 10.1186/s40064-016-3586-2; Pena-Bautista RJ, 2017, CEREAL FOOD WORLD, V62, P231, DOI 10.1094/CFW-62-5-0231; Roberts C, 2018, NATL DIET NUTROTION; Sazawal S, 2018, NUTR J, V17, DOI 10.1186/s12937-018-0391-5; Singh R, 2017, IND STUD BUS ECON, P177, DOI 10.1007/978-981-10-3123-6_9; Srinivasa J, 2014, THEOR APPL GENET, V127, P1643, DOI 10.1007/s00122-014-2327-6; Stein AJ, 2007, PUBLIC HEALTH NUTR, V10, P492, DOI 10.1017/S1368980007223857; Stomph TJ, 2011, ANN BOT-LONDON, V107, P927, DOI 10.1093/aob/mcr040; Szira F, 2014, CEREAL RES COMMUN, V42, P293, DOI 10.1556/CRC.2013.0059; Thomas CL, 2016, BMC PLANT BIOL, V16, DOI 10.1186/s12870-016-0902-5; Velu G, 2012, FIELD CROP RES, V137, P261, DOI 10.1016/j.fcr.2012.07.018; Velu G, 2017, PLANT SOIL, V411, P81, DOI 10.1007/s11104-016-3025-8; Wingen LU, 2017, GENETICS, V205, P1657, DOI 10.1534/genetics.116.194688; Wingen LU, 2014, THEOR APPL GENET, V127, P1831, DOI 10.1007/s00122-014-2344-5; Zhang YQ, 2010, J AGR FOOD CHEM, V58, P12268, DOI 10.1021/jf103039k	41	19	20	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2020	15	2							e0229107	10.1371/journal.pone.0229107	http://dx.doi.org/10.1371/journal.pone.0229107			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8HR	32109944	Green Published, gold, Green Submitted			2022-12-26	WOS:000535239800006
J	Simpson, KMJ; Mor, SM; Ward, MP; Collins, J; Flint, J; Hill-Cawthorne, GA; Ghany, MA				Simpson, Kelly M. J.; Mor, Siobhan M.; Ward, Michael P.; Collins, Julie; Flint, James; Hill-Cawthorne, Grant A.; Ghany, Moataz Abd El			Genomic characterisation of Salmonella enterica serovar Wangata isolates obtained from different sources reveals low genomic diversity	PLOS ONE			English	Article							TRANSMISSION; TYPHIMURIUM; RESISTANCE; VIRULENCE; OUTBREAK	Salmonella enterica serovar Wangata is an important pathogen in New South Wales (NSW), Australia. The incidence of S. Wangata is increasing and transmission is suspected to be via a non-food source. A recent outbreak investigation of sources of S. Wangata recovered isolates from humans, domestic animals, wildlife and the environment. Here, we extend that investigation by characterising and describing the genomic determinates of these isolates. We found that Australian S. Wangata isolates from different sources exhibited similar virulence and antimicrobial resistance gene profiles. There were no major genomic differences between isolates obtained from different geographical regions within Australia or from different host species. In addition, we found evidence (low number of SNPs and identical virulence gene profiles) suggestive of an international transmission event between Australia and the United Kingdom. This study supports the hypothesis that S. Wangata is shared between different hosts in NSW, Australia and provides strong justification for the continued use of genomic surveillance of Salmonella.	[Simpson, Kelly M. J.; Mor, Siobhan M.; Ward, Michael P.] Univ Sydney, Fac Sci, Sch Vet Sci, Sydney, NSW, Australia; [Mor, Siobhan M.; Hill-Cawthorne, Grant A.; Ghany, Moataz Abd El] Univ Sydney, Westmead Inst Med Res, Marie Bashir Inst Infect Dis & Biosecur, Westmead, NSW, Australia; [Mor, Siobhan M.] Univ Liverpool, Fac Hlth & Life Sci, Inst Infect & Global Hlth, Liverpool, Merseyside, England; [Collins, Julie; Flint, James] Hunter New England Populat Hlth, Wallsend, NSW, Australia; [Collins, Julie] Australian Natl Univ, Natl Ctr Epidemiol & Populat Hlth, Canberra, ACT, Australia; [Hill-Cawthorne, Grant A.] Univ Sydney, Sch Publ Hlth, Sydney Med Sch, Sydney, NSW, Australia; [Ghany, Moataz Abd El] Univ Sydney, Westmead Inst Med Res, Sydney, NSW, Australia	University of Sydney; University of Sydney; Westmead Institute for Medical Research; University of Liverpool; Australian National University; University of Sydney; University of Sydney; Westmead Institute for Medical Research	Simpson, KMJ (corresponding author), Univ Sydney, Fac Sci, Sch Vet Sci, Sydney, NSW, Australia.	ksim8161@uni.sydney.edu.au	Ward, Michael Patrick/GRX-1851-2022; Ward, Michael/C-5758-2009; Ward, Michael Patrick/W-1897-2019; Hill-Cawthorne, Grant/B-8039-2009	Ward, Michael Patrick/0000-0002-9921-4986; Ward, Michael/0000-0002-9921-4986; Hill-Cawthorne, Grant/0000-0002-3828-5473; Mor, Siobhan/0000-0003-0121-2016	NSW Public Health Pathogen Genomics Consortium; CIDM-PH; NSW Health; Marie Bashir Institute for Infectious Diseases and Biosecurity, The University of Sydney	NSW Public Health Pathogen Genomics Consortium; CIDM-PH; NSW Health; Marie Bashir Institute for Infectious Diseases and Biosecurity, The University of Sydney	This project was supported by funding from the NSW Public Health Pathogen Genomics Consortium, CIDM-PH, NSW Health and seed funding from the Marie Bashir Institute for Infectious Diseases and Biosecurity, The University of Sydney.	Abd El Ghany M, 2016, J CLIN MICROBIOL, V54, P2014, DOI 10.1128/JCM.00052-16; Abraham S, 2014, INT J ANTIMICROB AG, V43, P126, DOI 10.1016/j.ijantimicag.2013.10.014; Achtman M, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002776; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Arndt D, 2016, NUCLEIC ACIDS RES, V44, pW16, DOI 10.1093/nar/gkw387; Astridge K, 2015, COMMUN DIS INTELL, V39, pE236; Australian Commission on Safety and Quality in Health Care (ACSQHC), 2017, AURA 2017 2 AUSTR RE; Berger CN, 2010, ENVIRON MICROBIOL, V12, P2385, DOI 10.1111/j.1462-2920.2010.02297.x; Bloomfield SJ, 2017, EMERG INFECT DIS, V23, P906, DOI 10.3201/eid2306.161934; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Carver T, 2008, BIOINFORMATICS, V24, P2672, DOI 10.1093/bioinformatics/btn529; Collins J, 2019, EPIDEMIOL INFECT, V147, DOI [10.1017/S0950268819000475, 10.1017/s0950268819000475]; Dolejska M., 2016, J ANTIMICROB CHEMOTH; Farrant JL, 1997, MOL MICROBIOL, V25, P785, DOI 10.1046/j.1365-2958.1997.5151877.x; Figueroa-Bossi N, 1999, MOL MICROBIOL, V33, P167, DOI 10.1046/j.1365-2958.1999.01461.x; Fitzgerald T., 2015, THESIS; Fu SZ, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-06079-1; Grimont P. A. D., 2007, ANTIGENIC FORMULAE S; Hayward MR, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-365; Jia BF, 2017, NUCLEIC ACIDS RES, V45, pD566, DOI 10.1093/nar/gkw1004; Langridge G. C., 2012, ECOSAL PLUS, V5; Langridge GC, 2015, P NATL ACAD SCI USA, V112, P863, DOI 10.1073/pnas.1416707112; Larsen MV, 2012, J CLIN MICROBIOL, V50, P1355, DOI 10.1128/JCM.06094-11; LEEKITCHAROENPHON, 2012, BMC GENOMICS, V13, DOI DOI 10.1186/1471-2164-13-88; Marcus SL, 2000, MICROBES INFECT, V2, P145, DOI 10.1016/S1286-4579(00)00273-2; Mather AE, 2016, APPL ENVIRON MICROB, V82, P6728, DOI 10.1128/AEM.01660-16; Mohammed M, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2628-x; Nicholson FA, 2005, BIORESOURCE TECHNOL, V96, P135, DOI 10.1016/j.biortech.2004.02.030; NNDSS, 2019, SALM PUBL DAT SET; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Retamal P, 2017, POLAR BIOL, V40, P2531, DOI 10.1007/s00300-017-2163-7; Sanderson KE, 2013, SALMONELLA IN DOMESTIC ANIMALS, 2ND EDITION, P1, DOI 10.1079/9781845939021.0001; Seemann T, 2014, BIOINFORMATICS, V30, P2068, DOI 10.1093/bioinformatics/btu153; Staff M, 2012, EMERG INFECT DIS, V18, P1159, DOI 10.3201/eid1807.111443; Thomas M, 2017, GUT PATHOG, V9, DOI 10.1186/s13099-017-0213-x; Toro M, 2016, APPL ENVIRON MICROB, V82, P6223, DOI 10.1128/AEM.01760-16; Unicomb LE, 2006, CLIN INFECT DIS, V42, P1368, DOI 10.1086/503426; Webber MA, 2003, J ANTIMICROB CHEMOTH, V51, P9, DOI 10.1093/jac/dkg050; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Zhang SK, 2015, J CLIN MICROBIOL, V53, P1685, DOI 10.1128/JCM.00323-15	40	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2020	15	2							e0229697	10.1371/journal.pone.0229697	http://dx.doi.org/10.1371/journal.pone.0229697			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8HR	32109266	Green Published, gold			2022-12-26	WOS:000535239800022
J	Wettstadt, S; Filloux, A				Wettstadt, Sarah; Filloux, Alain			Manipulating the type VI secretion system spike to shuttle passenger proteins	PLOS ONE			English	Article							BACTERIAL TYPE VI; SUICIDE VECTOR; EFFECTOR TSE1; IDENTIFICATION; DELIVERY; COMPLEX; STRAIN; TOXIN; GENE; VGRG	The type VI secretion system (T6SS) is a contractile injection apparatus that translocates a spike loaded with various effectors directly into eukaryotic or prokaryotic target cells. Pseudomonas aeruginosa can load either one of its three T6SSs with a variety of toxic bullets using different but specific modes. The T6SS spike, which punctures the bacterial cell envelope allowing effector transport, consists of a torch-like VgrG trimer on which sits a PAAR protein sharpening the VgrG tip. VgrG itself sits on the Hcp tube and all elements, packed into a T6SS sheath, are propelled out of the cell and into target cells. On occasion, effectors are covalent extensions of VgrG, PAAR or Hcp proteins, which are then coined "evolved" components as opposed to canonical. Here, we show how various passenger domains could be fused to the C terminus of a canonical VgrG, VgrG1a from P. aeruginosa, and be sent into the bacterial culture supernatant. There is no restriction on the passenger type, although the efficacy may vary greatly, since we used either an unrelated T6SS protein, beta-lactamase, a covalent extension of an "evolved" VgrG, VgrG2b, or a Hcp-dependent T6SS toxin, Tse2. Our data further highlights an exceptional modularity/flexibility for loading the T6SS nano-weapon. Refining the parameters to optimize delivery of passenger proteins of interest would have attractive medical and industrial applications. This may for example involve engineering the T6SS as a delivery system to shuttle toxins into either bacterial pathogens or tumour cells which would be an original approach in the fight against antimicrobial resistant bacteria or cancer.	[Wettstadt, Sarah; Filloux, Alain] Imperial Coll London, MRC Ctr Mol Bacteriol & Infect, Dept Life Sci, London, England; [Wettstadt, Sarah] CSIC, Dept Environm Protect, Estn Expt Zaidin, Granada, Spain	Imperial College London; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Experimental del Zaidin (EEZ)	Filloux, A (corresponding author), Imperial Coll London, MRC Ctr Mol Bacteriol & Infect, Dept Life Sci, London, England.	a.filloux@imperial.ac.uk	Wettstadt, Sarah/X-1224-2019	Wettstadt, Sarah/0000-0003-0248-0469	MRC [MR/K001930/1, MR/N023250/1]; BBSRC [BB/I019871/1]; Imperial College President's Scholarship; MRC [MR/P028225/1] Funding Source: UKRI	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Imperial College President's Scholarship; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	AF work on T6SS was supported by the MRC grants MR/K001930/1 and MR/N023250/1 and the BBSRC grant BB/I019871/1. SW was supported by the Imperial College President's Scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the of the manuscript.	Allsopp LP, 2017, P NATL ACAD SCI USA, V114, P7707, DOI 10.1073/pnas.1700286114; Becher A, 2000, BIOTECHNIQUES, V29, P948, DOI 10.2144/00295bm04; Bondage DD, 2016, P NATL ACAD SCI USA, V113, pE3931, DOI 10.1073/pnas.1600428113; Broms JE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050473; Brooks TM, 2013, J BIOL CHEM, V288, P7618, DOI 10.1074/jbc.M112.436725; Brunet YR, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005545; Brunet YR, 2014, EMBO REP, V15, P315, DOI 10.1002/embr.201337936; Busby JN, 2013, NATURE, V501, P547, DOI 10.1038/nature12465; Charpentier X, 2004, J BACTERIOL, V186, P5486, DOI 10.1128/JB.186.16.5486-5495.2004; Cianfanelli FR, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005735; Ding JJ, 2012, J BIOL CHEM, V287, P26911, DOI 10.1074/jbc.M112.368043; Diniz JA, 2015, J BACTERIOL, V197, P2350, DOI 10.1128/JB.00199-15; Durand E, 2015, NATURE, V523, P555, DOI 10.1038/nature14667; Durand E, 2014, TRENDS MICROBIOL, V22, P498, DOI 10.1016/j.tim.2014.06.004; Durand E, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.390153; Durand E, 2012, J BIOL CHEM, V287, P14157, DOI 10.1074/jbc.M111.338731; FIGURSKI DH, 1979, P NATL ACAD SCI USA, V76, P1648, DOI 10.1073/pnas.76.4.1648; Flaugnatti N, 2016, MOL MICROBIOL, V99, P1099, DOI 10.1111/mmi.13292; Hachani A, 2014, J BIOL CHEM, V289, P17872, DOI 10.1074/jbc.M114.563429; Hachani A, 2013, JOVE-J VIS EXP, DOI 10.3791/50103; Hachani A, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.193045; HERRERO M, 1990, J BACTERIOL, V172, P6557, DOI 10.1128/jb.172.11.6557-6567.1990; Ho BT, 2017, P NATL ACAD SCI USA, V114, P9427, DOI 10.1073/pnas.1711219114; Jiang F, 2014, CELL HOST MICROBE, V15, P600, DOI 10.1016/j.chom.2014.04.010; Jiang N, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06201-5; Jones C, 2014, J BACTERIOL, V196, P800, DOI 10.1128/JB.00863-13; Kanamaru S, 2002, NATURE, V415, P553, DOI 10.1038/415553a; KANIGA K, 1991, GENE, V109, P137, DOI 10.1016/0378-1119(91)90599-7; Koskiniemia S, 2013, RHS PROTEINS DIVERSE; Leiman PG, 2009, P NATL ACAD SCI USA, V106, P4154, DOI 10.1073/pnas.0813360106; Liang XY, 2015, P NATL ACAD SCI USA, V112, P9106, DOI 10.1073/pnas.1505317112; Lossi NS, 2013, J BIOL CHEM, V288, P7536, DOI 10.1074/jbc.M112.439273; Lossi NS, 2012, MOL MICROBIOL, V86, P437, DOI 10.1111/j.1365-2958.2012.08204.x; Ma AT, 2009, CELL HOST MICROBE, V5, P234, DOI 10.1016/j.chom.2009.02.005; Ma JL, 2017, ENVIRON MICROBIOL, V19, P345, DOI 10.1111/1462-2920.13621; MILLER VL, 1988, J BACTERIOL, V170, P2575, DOI 10.1128/JB.170.6.2575-2583.1988; Moscoso JA, 2011, ENVIRON MICROBIOL, V13, P3128, DOI 10.1111/j.1462-2920.2011.02595.x; Pissaridou P, 2018, P NATL ACAD SCI USA, V115, P12519, DOI 10.1073/pnas.1814181115; Planamente S, 2016, EMBO J, V35, P1613, DOI 10.15252/embj.201694024; Pukatzki S, 2006, P NATL ACAD SCI USA, V103, P1528, DOI 10.1073/pnas.0510322103; Pukatzki S, 2007, P NATL ACAD SCI USA, V104, P15508, DOI 10.1073/pnas.0706532104; Quentin D, 2018, NAT MICROBIOL, V3, P1142, DOI 10.1038/s41564-018-0238-z; Robb CS, 2016, STRUCTURE, V24, P277, DOI 10.1016/j.str.2015.11.012; Russell AB, 2011, NATURE, V475, P343, DOI 10.1038/nature10244; Salih O, 2018, STRUCTURE, V26, P329, DOI 10.1016/j.str.2017.12.005; Sana TG, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006325; Sana TG, 2015, MBIO, V6, DOI 10.1128/mBio.00712-15; Schroeder GN, 2010, J BACTERIOL, V192, P6001, DOI 10.1128/JB.00778-10; Shi L, 2016, AMB EXPRESS, V6, DOI 10.1186/s13568-016-0226-8; Shneider MM, 2013, NATURE, V500, P350, DOI 10.1038/nature12453; Silverman JM, 2013, MOL CELL, V51, P584, DOI 10.1016/j.molcel.2013.07.025; Suarez G, 2010, J BACTERIOL, V192, P155, DOI 10.1128/JB.01260-09; Toesca IJ, 2014, INFECT IMMUN, V82, P1436, DOI 10.1128/IAI.01367-13; Unterweger D, 2015, EMBO J, V34, P2198, DOI 10.15252/embj.201591163; Vasseur P, 2005, MICROBIOL-SGM, V151, P985, DOI 10.1099/mic.0.27410-0; Ventre I, 2006, P NATL ACAD SCI USA, V103, P171, DOI 10.1073/pnas.0507407103; Vettiger A, 2016, CELL, V167, P99, DOI 10.1016/j.cell.2016.08.023; Walker BJ, 2017, EXPERT REV MOL MED, V19, DOI 10.1017/erm.2017.7; Wang TY, 2013, ACTA CRYSTALLOGR D, V69, P1889, DOI 10.1107/S090744491301576X; Wettstadt S, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.01718; Whitney JC, 2015, CELL, V163, P607, DOI 10.1016/j.cell.2015.09.027; Wood TE, 2019, CELL REPORTS; Wood TE, 2019, MICROBIOL-SGM, V165, P1203, DOI 10.1099/mic.0.000842; Zhang H, 2012, FEBS LETT, V586, P3193, DOI 10.1016/j.febslet.2012.06.036	64	9	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2020	15	2							e0228941	10.1371/journal.pone.0228941	http://dx.doi.org/10.1371/journal.pone.0228941			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8FM	32101557	gold, Green Published			2022-12-26	WOS:000535233700014
J	Ferland, DJ; Garver, H; Contreras, GA; Fink, GD; Watts, SW				Ferland, David J.; Garver, Hannah; Contreras, G. Andres; Fink, Gregory D.; Watts, Stephanie W.			Chemerin contributes to in vivo adipogenesis in a location-specific manner	PLOS ONE			English	Article							ADIPOSE-TISSUE; METABOLIC SYNDROME; SERUM CHEMERIN; OBESITY; ADIPOKINE; RECEPTOR; INFLAMMATION; POPULATION; MARKERS; CELLS	Since chemerin's identification as an adipokine, it has been associated with a number of human diseases including diabetes and obesity. However, the basic scientific foundation for these clinical determinations is still lacking. Fibroblastic mouse 3T3 cells are unable to develop lipid droplets if chemerin is not present. Thus, we hypothesized that an in vivo rat model chemerin knockout (KO; an advancement from the previously mentioned in vitro cultures) would have limited accumulation of lipid in adipocytes compared to their wild-type (WT) counterparts. Female WT/KO rats (Sprague Dawley background) were fed a low-fat diet starting at 8 weeks of age with weekly body weight and food consumption monitoring. At 25 weeks of age, adipose tissue depots were dissected and flash frozen for PCR analysis or fixed with paraformaldehyde for histology. Over the 17 weeks of experimentation, WT and KO animals did not have differences in total body weight or food consumption but KO animals had a significantly reduced amount of visceral fat compared to WT animals (via microCT at 8 and 25 weeks). Histology of retroperitoneal and mesenteric depots demonstrated a significant leftward shift in adipocyte size in the mesenteric but not the retroperitoneal depot of the KO compared to WT animals. Similarly, in the mesenteric fat of the KO rat, gene expression of adiponectin, fatty acid synthase, perilipin, and leptin were significantly reduced compared to mesenteric fat of WT animals and retroperitoneal fat of both WT and KO animals. Adiponectin was highlighted by a protein-protein interaction network as being important for the physiological effects of chemerin removal. These data are the first, to our knowledge, to demonstrate chemerin's adipokine potential in vivo and identify it as fat depot location-specific.	[Ferland, David J.; Garver, Hannah; Fink, Gregory D.; Watts, Stephanie W.] Michigan State Univ, Dept Pharmacol & Toxicol, E Lansing, MI 48824 USA; [Contreras, G. Andres] Michigan State Univ, Dept Large Anim Clin Sci, E Lansing, MI 48824 USA	Michigan State University; Michigan State University	Ferland, DJ (corresponding author), Michigan State Univ, Dept Pharmacol & Toxicol, E Lansing, MI 48824 USA.	ferlandd@msu.edu	Contreras, Andres/I-8282-2019	Contreras, Andres/0000-0003-4969-2178; Ferland, David/0000-0002-8780-5383	American Heart Association [19TPA34850014]; National Institutes of Health (National Heart, Lung, and Blood Institute) [HL143937]	American Heart Association(American Heart Association); National Institutes of Health (National Heart, Lung, and Blood Institute)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	American Heart Association 19TPA34850014 to SWW (https://professional.heart.org/professional/ResearchPrograms/ApplicationInformation/ScientistPrincipalinvestigators/UCM_316962_ForScientists.jsp).National Institutes of Health (National Heart, Lung, and Blood Institute) HL143937 to DJF (https://www.nhlbi.nih.gov/).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti KGMM, 2009, CIRCULATION, V120, P1640, DOI 10.1161/CIRCULATIONAHA.109.192644; Andersen J, 2001, ASIS MONOGR, P1; Bartness TJ, 2014, FRONT NEUROENDOCRIN, V35, P473, DOI 10.1016/j.yfrne.2014.04.001; Berndt J, 2007, DIABETOLOGIA, V50, P1472, DOI 10.1007/s00125-007-0689-x; Annette B, 2017, BBA-MOL BASIS DIS, V1863, P1026, DOI 10.1016/j.bbadis.2017.01.016; Bozaoglu K, 2007, ENDOCRINOLOGY, V148, P4687, DOI 10.1210/en.2007-0175; Brunner KT, 2019, CURR OBES REP, V8, P220, DOI 10.1007/s13679-019-00345-1; Cash JL, 2008, J EXP MED, V205, P767, DOI 10.1084/jem.20071601; Chu SH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034710; Dong BK, 2011, INTERNAL MED, V50, P1093, DOI 10.2169/internalmedicine.50.5025; Engin AB, 2017, ADV EXP MED BIOL, V960, pV, DOI 10.1007/978-3-319-48382-5_1; Ernst MC, 2010, TRENDS ENDOCRIN MET, V21, P660, DOI 10.1016/j.tem.2010.08.001; Ferland DJ, 2017, VASC PHARMACOL, V88, P30, DOI 10.1016/j.vph.2016.11.009; Gateva A, 2018, HORM MOL BIOL CLIN I, V34, DOI 10.1515/hmbci-2017-0031; Goralski KB, 2007, J BIOL CHEM, V282, P28175, DOI 10.1074/jbc.M700793200; GREENBERG AS, 1991, J BIOL CHEM, V266, P11341; Gu P, 2014, CLIN EXP HYPERTENS, V36, P326, DOI 10.3109/10641963.2013.827697; Hansen LB, 2013, DAN MED J, V60; Henry SL, 2012, CLIN EXP PHARMACOL P, V39, P799, DOI 10.1111/j.1440-1681.2011.05579.x; Kaur J, 2010, BIOCHEM BIOPH RES CO, V391, P1762, DOI 10.1016/j.bbrc.2009.12.150; Kotchen TA, 2010, AM J HYPERTENS, V23, P1170, DOI 10.1038/ajh.2010.172; Lorincz H, 2014, CLIN ENDOCRINOL, V81, P370, DOI 10.1111/cen.12363; Muruganandan S, 2011, J BIOL CHEM, V286, P23982, DOI 10.1074/jbc.M111.220491; Ouwens DM, 2012, ARCH PHYSIOL BIOCHEM, V118, P135, DOI 10.3109/13813455.2012.654800; Roh SG, 2007, BIOCHEM BIOPH RES CO, V362, P1013, DOI 10.1016/j.bbrc.2007.08.104; Sell H, 2010, J CLIN ENDOCR METAB, V95, P2892, DOI 10.1210/jc.2009-2374; Sell H, 2009, DIABETES, V58, P2731, DOI 10.2337/db09-0277; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Shin HY, 2012, CLIN ENDOCRINOL, V77, P47, DOI 10.1111/j.1365-2265.2011.04217.x; Spyrou N, 2018, CURR OBES REP; Stejskal D, 2008, BIOMED PAP, V152, P217, DOI 10.5507/bp.2008.033; Stern JH, 2016, CELL METAB, V23, P770, DOI 10.1016/j.cmet.2016.04.011; Suzuki M, 2001, IEE CONF PUBL, P1, DOI 10.1049/cp:20010570; Watts SW, 2018, FASEB J, V32, P6596, DOI 10.1096/fj.201800479; Wilson PWF, 2002, ARCH INTERN MED, V162, P1867, DOI 10.1001/archinte.162.16.1867; Wittamer V, 2004, J BIOL CHEM, V279, P9956, DOI 10.1074/jbc.M313016200; Wittamer V, 2003, J EXP MED, V198, P977, DOI 10.1084/jem.20030382; Zabel BA, 2005, J BIOL CHEM, V280, P34661, DOI 10.1074/jbc.M504868200; Zylla S, 2017, OBESITY, V25, P468, DOI 10.1002/oby.21735	39	15	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2020	15	2							e0229251	10.1371/journal.pone.0229251	http://dx.doi.org/10.1371/journal.pone.0229251			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8DW	32092101	Green Published, gold			2022-12-26	WOS:000535229300036
J	Gordon, CJ; Tchesnokov, EP; Feng, JY; Porter, DP; Gotte, M				Gordon, Calvin J.; Tchesnokov, Egor P.; Feng, Joy Y.; Porter, Danielle P.; Gotte, Matthias			The antiviral compound remdesivir potently inhibits RNA-dependent RNA polymerase from Middle East respiratory syndrome coronavirus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						plus-stranded RNA virus; viral polymerase; drug development; enzyme inhibitor; nucleoside; nucleotide analog; coronavirus; positive-sense RNA virus; Ebola virus (EBOV); Middle East respiratory syndrome coronavirus (MERS?CoV); SARS?CoV-2; remdesivir; antiviral drug; RNA chain termination; RNA-dependent RNA polymerase (RdRp); viral replicase	EBOLA-VIRUS; GS-5734; REPLICATION; EXCISION	Antiviral drugs for managing infections with human coronaviruses are not yet approved, posing a serious challenge to current global efforts aimed at containing the outbreak of severe acute respiratory syndrome?coronavirus 2 (CoV-2). Remdesivir (RDV) is an investigational compound with a broad spectrum of antiviral activities against RNA viruses, including severe acute respiratory syndrome?CoV and Middle East respiratory syndrome (MERS?CoV). RDV is a nucleotide analog inhibitor of RNA-dependent RNA polymerases (RdRps). Here, we co-expressed the MERS?CoV nonstructural proteins nsp5, nsp7, nsp8, and nsp12 (RdRp) in insect cells as a part a polyprotein to study the mechanism of inhibition of MERS?CoV RdRp by RDV. We initially demonstrated that nsp8 and nsp12 form an active complex. The triphosphate form of the inhibitor (RDV-TP) competes with its natural counterpart ATP. Of note, the selectivity value for RDV-TP obtained here with a steady-state approach suggests that it is more efficiently incorporated than ATP and two other nucleotide analogs. Once incorporated at position i, the inhibitor caused RNA synthesis arrest at position i + 3. Hence, the likely mechanism of action is delayed RNA chain termination. The additional three nucleotides may protect the inhibitor from excision by the viral 3??5? exonuclease activity. Together, these results help to explain the high potency of RDV against RNA viruses in cell-based assays.	[Gordon, Calvin J.; Tchesnokov, Egor P.; Gotte, Matthias] Univ Alberta, Dept Med Microbiol & Immunol, Edmonton, AB T6G 2E1, Canada; [Gotte, Matthias] Univ Alberta, Li Ka Shing Inst Virol, Edmonton, AB T6G 2E1, Canada; [Feng, Joy Y.; Porter, Danielle P.] Gilead Sci Inc, 353 Lakeside Dr, Foster City, CA 94404 USA	University of Alberta; University of Alberta; Gilead Sciences	Gotte, M (corresponding author), Univ Alberta, Dept Med Microbiol & Immunol, Edmonton, AB T6G 2E1, Canada.	gotte@ualberta.ca		Gordon, Calvin/0000-0002-8259-6201	Canadian Institutes of Health Research [159507]; Alberta Ministry of Economic Development, Trade and Tourism by the Major Innovation Fund Program for the AMR-One Health Consortium; Gilead Sciences	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Alberta Ministry of Economic Development, Trade and Tourism by the Major Innovation Fund Program for the AMR-One Health Consortium; Gilead Sciences(Gilead Sciences)	This study was supported by Canadian Institutes of Health Research Grant 159507 (to M. G.) and a grant from the Alberta Ministry of Economic Development, Trade and Tourism by the Major Innovation Fund Program for the AMR-One Health Consortium (to M. G.). M. G. has previously received funding from Gilead Sciences in support for the study of EBOV RdRp inhibition by RDV.	Agostini ML, 2018, MBIO, V9, DOI 10.1128/mBio.00221-18; Arabi YM, 2020, TRIALS, V21, DOI 10.1186/s13063-019-3846-x; Berger I, 2004, NAT BIOTECHNOL, V22, P1583, DOI 10.1038/nbt1036; Bieniossek Christoph, 2008, Curr Protoc Protein Sci, VChapter 5, DOI 10.1002/0471140864.ps0520s51; Brown AJ, 2019, ANTIVIR RES, V169, DOI 10.1016/j.antiviral.2019.104541; de Wilde AH, 2014, ANTIMICROB AGENTS CH, V58, P4875, DOI 10.1128/AAC.03011-14; de Wit E, 2020, P NATL ACAD SCI USA, V117, P6771, DOI 10.1073/pnas.1922083117; Deval J, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004995; Dulin D, 2017, CELL REP, V21, P1063, DOI 10.1016/j.celrep.2017.10.005; Ferron F, 2018, P NATL ACAD SCI USA, V115, pE162, DOI 10.1073/pnas.1718806115; Imbert I, 2006, EMBO J, V25, P4933, DOI 10.1038/sj.emboj.7601368; Jordan PC, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1006889; Kirchdoerfer RN, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10280-3; Lo MK, 2017, SCI REP-UK, V7, DOI 10.1038/srep43395; Muhlberger E, 1999, J VIROL, V73, P2333; Mulangu S, 2019, NEW ENGL J MED, V381, P2293, DOI 10.1056/NEJMoa1910993; Noton SL, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002980; POCH O, 1989, EMBO J, V8, P3867, DOI 10.1002/j.1460-2075.1989.tb08565.x; Sheahan TP, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-019-13940-6; Sheahan TP, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aal3653; Siegel D, 2017, J MED CHEM, V60, P1648, DOI 10.1021/acs.jmedchem.6b01594; Subissi L, 2014, P NATL ACAD SCI USA, V111, pE3900, DOI 10.1073/pnas.1323705111; Tchesnokov EP, 2019, VIRUSES-BASEL, V11, DOI 10.3390/v11040326; Tchesnokov EP, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22328-3; Tchesnokov EP, 2008, J BIOL CHEM, V283, P34218, DOI 10.1074/jbc.M806797200; Warren TK, 2016, NATURE, V531, P381, DOI 10.1038/nature17180	26	469	485	7	104	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 10	2020	295	15					4773	4779		10.1074/jbc.AC120.013056	http://dx.doi.org/10.1074/jbc.AC120.013056			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LE7FC	32094225	hybrid, Green Published			2022-12-26	WOS:000526887000002
J	Du, H; Wang, PC; Wu, J; He, XM; Wang, YS				Du, Hua; Wang, Pengcheng; Wu, Jun; He, Xiaomei; Wang, Yinsheng			The roles of polymerases ? and ? in replicative bypass of O-6- and N-2-alkyl-2?-deoxyguanosine lesions in human cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						DNA damage; DNA polymerase; DNA replication; MS; mutagenesis; mutagenesis mechanism; DNA alkylation; polymerase ?; polymerase ?	TRANSLESION DNA-SYNTHESIS; ERROR-FREE BYPASS; SOMATIC HYPERMUTATION; THYMINE GLYCOL; POL-ZETA; DAMAGE; O-6-ALKYLGUANINE; REPAIR; THETA; ETA	Exogenous and endogenous chemicals can react with DNA to produce DNA lesions that may block DNA replication. Not much is known about the roles of polymerase (Pol) ? and Pol ? in translesion synthesis (TLS) in cells. Here we examined the functions of these two polymerases in bypassing major-groove O-6-alkyl-2?-deoxyguanosine (O-6-alkyl-dG) and minor-groove N-2-alkyl-dG lesions in human cells, where the alkyl groups are ethyl, n-butyl (nBu), and, for O-6-alkyl-dG, pyridyloxobutyl. We found that Pol ? and Pol ? promote TLS across major-groove O-6-alkyl-dG lesions. O-6-alkyl-dG lesions mainly induced G?A mutations that were modulated by the two TLS polymerases and the structures of the alkyl groups. Simultaneous ablation of Pol ? and Pol ? resulted in diminished mutation frequencies for all three O-6-alkyl-dG lesions. Depletion of Pol ? alone reduced mutations only for O-6-nBu-dG, and sole loss of Pol ? attenuated the mutation rates for O-6-nBu-dG and O-6-pyridyloxobutyl-dG. Replication across the two N-2-alkyl-dG lesions was error-free, and Pol ? and Pol ? were dispensable for their replicative bypass. Together, our results provide critical knowledge about the involvement of Pol ? and Pol ? in bypassing alkylated guanine lesions in human cells.	[Du, Hua; Wang, Pengcheng; Wu, Jun; He, Xiaomei; Wang, Yinsheng] Univ Calif Riverside, Dept Chem, Riverside, CA 92521 USA	University of California System; University of California Riverside	Wang, YS (corresponding author), Univ Calif Riverside, Dept Chem, Riverside, CA 92521 USA.	Yinsheng.Wang@ucr.edu	Wang, Yin/HCI-9352-2022		National Institutes of Health [R01 ES029749]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by National Institutes of Health Grant R01 ES029749 (to Y. W.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Acharya N, 2008, P NATL ACAD SCI USA, V105, P17724, DOI 10.1073/pnas.0809844105; Arana ME, 2008, NUCLEIC ACIDS RES, V36, P3847, DOI 10.1093/nar/gkn310; Arana ME, 2007, DNA REPAIR, V6, P213, DOI 10.1016/j.dnarep.2006.09.012; Bauer NC, 2015, NUCLEIC ACIDS RES, V43, P10083, DOI 10.1093/nar/gkv1136; Burns JA, 2010, NUCLEIC ACIDS RES, V38, P8178, DOI 10.1093/nar/gkq706; Chan SH, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001005; Choi JY, 2006, J BIOL CHEM, V281, P38244, DOI 10.1074/jbc.M608369200; Choi JY, 2006, J BIOL CHEM, V281, P21062, DOI 10.1074/jbc.M602246200; Du H, 2019, J BIOL CHEM, V294, P11144, DOI 10.1074/jbc.RA119.009054; Du H, 2018, J BIOL CHEM, V293, P11100, DOI 10.1074/jbc.RA118.003477; Friedberg EC, 2003, NATURE, V421, P436, DOI 10.1038/nature01408; Gan GN, 2008, CELL RES, V18, P174, DOI 10.1038/cr.2007.117; Goodman MF, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a010363; Gowda ASP, 2016, CHEM RES TOXICOL, V29, P1894, DOI 10.1021/acs.chemrestox.6b00318; Haracska L, 2001, MOL CELL, V8, P407, DOI 10.1016/S1097-2765(01)00319-7; Hendel A, 2008, DNA REPAIR, V7, P1636, DOI 10.1016/j.dnarep.2008.06.008; Hoeijmakers JHJ, 2009, NEW ENGL J MED, V361, P1475, DOI 10.1056/NEJMra0804615; JANSEN JG, 1995, CANCER RES, V55, P1875; Johnson SJ, 2004, CELL, V116, P803, DOI 10.1016/S0092-8674(04)00252-1; Kent T, 2015, NAT STRUCT MOL BIOL, V22, P230, DOI 10.1038/nsmb.2961; Kryston TB, 2011, MUTAT RES-FUND MOL M, V711, P193, DOI 10.1016/j.mrfmmm.2010.12.016; Lee YS, 2014, P NATL ACAD SCI USA, V111, P2954, DOI 10.1073/pnas.1324001111; Li ZQ, 2002, MUTAT RES-FUND MOL M, V510, P71, DOI 10.1016/S0027-5107(02)00253-1; Liu S, 2015, CHEM SOC REV, V44, P7829, DOI 10.1039/c5cs00316d; Masuda K, 2005, P NATL ACAD SCI USA, V102, P13986, DOI 10.1073/pnas.0505636102; Masuda K, 2007, J BIOL CHEM, V282, P17387, DOI 10.1074/jbc.M611849200; Minko IG, 2008, CHEM RES TOXICOL, V21, P1983, DOI 10.1021/tx800174a; Moldovan GL, 2010, MOL CELL BIOL, V30, P1088, DOI 10.1128/MCB.01124-09; Ohashi E, 2000, GENE DEV, V14, P1589; Pages V, 2002, ONCOGENE, V21, P8957, DOI 10.1038/sj.onc.1206006; PARTHASARATHY R, 1986, CARCINOGENESIS, V7, P221, DOI 10.1093/carcin/7.2.221; Pauly GT, 2002, CHEM RES TOXICOL, V15, P165, DOI 10.1021/tx0101245; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Sale JE, 2012, NAT REV MOL CELL BIO, V13, P141, DOI 10.1038/nrm3289; Seki M, 2004, EMBO J, V23, P4484, DOI 10.1038/sj.emboj.7600424; Seki M, 2008, DNA REPAIR, V7, P119, DOI 10.1016/j.dnarep.2007.08.005; Shachar S, 2009, EMBO J, V28, P383, DOI 10.1038/emboj.2008.281; Shrivastav N, 2010, CARCINOGENESIS, V31, P59, DOI 10.1093/carcin/bgp262; SWANN PF, 1990, MUTAT RES, V233, P81, DOI 10.1016/0027-5107(90)90153-U; Takata K, 2006, J BIOL CHEM, V281, P23445, DOI 10.1074/jbc.M604317200; Tamae D, 2011, BIOCHEMISTRY-US, V50, P2321, DOI 10.1021/bi101933p; Washington MT, 2000, P NATL ACAD SCI USA, V97, P3094, DOI 10.1073/pnas.050491997; Waters LS, 2009, MICROBIOL MOL BIOL R, V73, P134, DOI 10.1128/MMBR.00034-08; Wu J, 2019, ACS CHEM BIOL, V14, P1708, DOI 10.1021/acschembio.9b00129; Wu J, 2018, J BIOL CHEM, V293, P8638, DOI 10.1074/jbc.RA118.003133; Wu J, 2016, NUCLEIC ACIDS RES, V44, P9256, DOI 10.1093/nar/gkw662; Yamanaka K, 2010, CHEM RES TOXICOL, V23, P689, DOI 10.1021/tx900449u; Yang W, 2018, ANNU REV BIOCHEM, V87, P239, DOI 10.1146/annurev-biochem-062917-012405; Yoon JH, 2019, CELL, V176, P1295, DOI 10.1016/j.cell.2019.01.023; Yoon JH, 2014, J BIOL CHEM, V289, P13177, DOI 10.1074/jbc.M114.556977; Yoon JH, 2010, P NATL ACAD SCI USA, V107, P14116, DOI 10.1073/pnas.1007795107; You CJ, 2013, J BIOL CHEM, V288, P28548, DOI 10.1074/jbc.M113.480459; Yuan BF, 2011, J BIOL CHEM, V286, P17503, DOI 10.1074/jbc.M111.232835; Yuan BF, 2010, ACS CHEM BIOL, V5, P1021, DOI 10.1021/cb100214b; Ziv O, 2009, P NATL ACAD SCI USA, V106, P11552, DOI 10.1073/pnas.0812548106	55	6	5	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 3	2020	295	14					4556	4562		10.1074/jbc.RA120.012830	http://dx.doi.org/10.1074/jbc.RA120.012830			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LB2WZ	32098870	Green Published, hybrid			2022-12-26	WOS:000524499700016
J	Yarawsky, AE; Johns, SL; Schuck, P; Herr, AB				Yarawsky, Alexander E.; Johns, Stefanie L.; Schuck, Peter; Herr, Andrew B.			The biofilm adhesion protein Aap from Staphylococcus epidermidis forms zinc-dependent amyloid fibers	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						amyloid; analytical ultracentrifugation; bacterial pathogenesis; biofilm; biophysics; circular dichroism (CD); confocal microscopy; fibril; infection; spectroscopy	ACCUMULATION-ASSOCIATED PROTEIN; SEDIMENTATION-VELOCITY ANALYSIS; ANALYTICAL ULTRACENTRIFUGATION; INTERCELLULAR-ADHESION; SHAPE-DISTRIBUTIONS; CIRCULAR-DICHROISM; SELF-ASSOCIATION; FIBRILS; BINDING; PEPTIDE	The skin-colonizing commensal bacterium Staphylococcus epidermidis is a leading cause of hospital-acquired and device-related infections. Its pathogenicity in humans is largely due to its propensity to form biofilms, surface-adherent bacterial accumulations that are remarkably resistant to chemical and physical stresses. Accumulation-associated protein (Aap) from S. epidermidis has been shown to be necessary and sufficient for mature biofilm formation and catheter infection. Aap contains up to 17 tandem B-repeat domains, capable of zinc-dependent assembly into twisted, rope-like intercellular filaments in the biofilm. Using microscopic and biophysical techniques, we show here that Aap B-repeat constructs assemble further into zinc-dependent functional amyloid fibers. We observed such amyloid fibers by confocal microscopy during both early and late stages of S. epidermidis biofilm formation, and we confirmed that extracellular fibrils from these biofilms contain Aap. Unlike what has been observed for amyloidogenic biofilm proteins from other bacteria, which typically use chaperones or initiator proteins to initiate amyloid assembly, our findings indicate that Aap from S. epidermidis requires Zn2+ as a catalyst that drives amyloid fiber formation, similar to many mammalian amyloid-forming proteins that require metals for assembly. This work provides detailed insights into S. epidermidis biofilm formation and architecture that improve our understanding of persistent staphylococcal infections.	[Yarawsky, Alexander E.; Johns, Stefanie L.] Univ Cincinnati, Coll Med, Grad Program Mol Genet Biochem & Microbiol, Cincinnati, OH 45267 USA; [Herr, Andrew B.] Univ Cincinnati, Coll Med, Dept Pediat, Cincinnati, OH 45229 USA; [Yarawsky, Alexander E.; Herr, Andrew B.] Cincinnati Childrens Hosp Med Ctr, Div Immunobiol, Cincinnati, OH 45229 USA; [Herr, Andrew B.] Cincinnati Childrens Hosp Med Ctr, Div Infect Dis, Cincinnati, OH 45229 USA; [Schuck, Peter] Natl Inst Biomed Imaging & Bioengn, Dynam Macromol Assembly Sect, Lab Cellular Imaging & Bioengn, NIH, Bethesda, MD 20814 USA; [Johns, Stefanie L.] Enable Inject Inc, Cincinnati, OH 45241 USA	University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; National Institutes of Health (NIH) - USA; NIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)	Herr, AB (corresponding author), Univ Cincinnati, Coll Med, Dept Pediat, Cincinnati, OH 45229 USA.; Herr, AB (corresponding author), Cincinnati Childrens Hosp Med Ctr, Div Immunobiol, Cincinnati, OH 45229 USA.; Herr, AB (corresponding author), Cincinnati Childrens Hosp Med Ctr, Div Infect Dis, Cincinnati, OH 45229 USA.	andrew.herr@cchmc.org	Schuck, Peter/AAA-6888-2020; Herr, Andrew/R-3049-2019	Schuck, Peter/0000-0002-8859-6966; Herr, Andrew/0000-0002-3598-3399; Yarawsky, Alexander/0000-0002-5973-5058	National Institutes of Health NIGMS [R01 GM094363]; NIAID [U19 AI070235]; Cincinnati Children's Hospital Research Foundation; National Institutes of Health Intramural Research Program of the National Institute of Biomedical Imaging and Bioengineering	National Institutes of Health NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Cincinnati Children's Hospital Research Foundation; National Institutes of Health Intramural Research Program of the National Institute of Biomedical Imaging and Bioengineering	This work was supported by National Institutes of Health NIGMS Grant R01 GM094363 (to A. B. H.) and NIAID Grant U19 AI070235 (to A. B. H.), by Cincinnati Children's Hospital Research Foundation (to A. B. H.), and in part by the National Institutes of Health Intramural Research Program of the National Institute of Biomedical Imaging and Bioengineering (to P. S.). A. B. H. serves as a Scientific Advisory Board member for Hoth Therapeutics, Inc., holds equity in Hoth Therapeutics and Chelexa BioSciences, LLC, and was a co-inventor on three patents broadly related to the subject matter of this work. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adlard PA, 2006, J ALZHEIMERS DIS, V10, P145; Andersen CB, 2010, J MOL BIOL, V397, P932, DOI 10.1016/j.jmb.2010.02.012; Banner MA, 2007, J BACTERIOL, V189, P2793, DOI 10.1128/JB.00952-06; Biancalana M, 2010, BBA-PROTEINS PROTEOM, V1804, P1405, DOI 10.1016/j.bbapap.2010.04.001; Binger KJ, 2008, J MOL BIOL, V376, P1116, DOI 10.1016/j.jmb.2007.12.055; Blancas-Mejia LM, 2015, J BIOL CHEM, V290, P4953, DOI 10.1074/jbc.M114.615401; Brown PH, 2006, BIOPHYS J, V90, P4651, DOI 10.1529/biophysj.106.081372; BUSH AI, 1994, SCIENCE, V265, P1464, DOI 10.1126/science.8073293; Calabrese MF, 2008, NAT STRUCT MOL BIOL, V15, P965, DOI 10.1038/nsmb.1483; Cardo D, 2004, AM J INFECT CONTROL, V32, P470, DOI 10.1016/j.ajic.2004.10.001; Chapman MR, 2002, SCIENCE, V295, P851, DOI 10.1126/science.1067484; Chaton CT, 2017, PROTEIN SCI, V26, P1964, DOI 10.1002/pro.3232; Chaton CT, 2015, METHOD ENZYMOL, V562, P187, DOI 10.1016/bs.mie.2015.04.004; Chi LLP, 2011, METHODS MOL BIOL, V752, P179, DOI 10.1007/978-1-60327-223-0_12; COLLINSON SK, 1991, J BACTERIOL, V173, P4773, DOI 10.1128/jb.173.15.4773-4781.1991; Conrady DG, 2013, P NATL ACAD SCI USA, V110, pE202, DOI 10.1073/pnas.1208134110; Conrady DG, 2008, P NATL ACAD SCI USA, V105, P19456, DOI 10.1073/pnas.0807717105; Corrigan RM, 2007, MICROBIOL-SGM, V153, P2435, DOI 10.1099/mic.0.2007/006676-0; Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318; Damo SM, 2013, P NATL ACAD SCI USA, V110, P3841, DOI 10.1073/pnas.1220341110; Decker R, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004735; Demeler B, 2004, ANAL BIOCHEM, V335, P279, DOI 10.1016/j.ab.2004.08.039; Demeler B, 2009, METHOD ENZYMOL, V454, P87, DOI 10.1016/S0076-6879(08)03804-4; Dong JJ, 2006, J AM CHEM SOC, V128, P3540, DOI 10.1021/ja055973j; Dueholm MS, 2015, J BIOL CHEM, V290, P20590, DOI 10.1074/jbc.M115.654780; Dueholm MS, 2010, MOL MICROBIOL, V77, P1009, DOI 10.1111/j.1365-2958.2010.07269.x; Eakin CM, 2002, BIOCHEMISTRY-US, V41, P10646, DOI 10.1021/bi025944a; Edgeworth JA, 2010, P NATL ACAD SCI USA, V107, P14402, DOI 10.1073/pnas.1004036107; Faller P, 2009, CHEMBIOCHEM, V10, P2837, DOI 10.1002/cbic.200900321; Fedunova D, 2013, GEN PHYSIOL BIOPHYS, V32, P215, DOI 10.4149/gpb_2013020; Fey PD, 2010, CURR OPIN MICROBIOL, V13, P610, DOI 10.1016/j.mib.2010.09.007; Fey PD, 2010, FUTURE MICROBIOL, V5, P917, DOI 10.2217/FMB.10.56; Formosa-Dague C, 2016, P NATL ACAD SCI USA, V113, P410, DOI 10.1073/pnas.1519265113; Fowler DM, 2007, TRENDS BIOCHEM SCI, V32, P217, DOI 10.1016/j.tibs.2007.03.003; Geoghegan JA, 2010, J BACTERIOL, V192, P5663, DOI 10.1128/JB.00628-10; Gill SR, 2005, J BACTERIOL, V187, P2426, DOI 10.1128/JB.187.7.2426-2438.2005; Gruszka DT, 2012, P NATL ACAD SCI USA, V109, pE1011, DOI 10.1073/pnas.1119456109; Hammer ND, 2007, P NATL ACAD SCI USA, V104, P12494, DOI 10.1073/pnas.0703310104; Herr AB, 2011, METHOD ENZYMOL, P101, DOI 10.1016/B978-0-12-381268-1.00005-7; Howie AJ, 2009, MICRON, V40, P285, DOI 10.1016/j.micron.2008.10.002; Hussain M, 1997, INFECT IMMUN, V65, P519, DOI 10.1128/IAI.65.2.519-524.1997; Izano EA, 2008, APPL ENVIRON MICROB, V74, P470, DOI 10.1128/AEM.02073-07; Jabbouri S, 2010, FEMS IMMUNOL MED MIC, V59, P280, DOI 10.1111/j.1574-695X.2010.00695.x; Jobling MF, 2001, BIOCHEMISTRY-US, V40, P8073, DOI 10.1021/bi0029088; Kayed R, 2007, MOL NEURODEGENER, V2, DOI 10.1186/1750-1326-2-18; Kodali R, 2010, J MOL BIOL, V401, P503, DOI 10.1016/j.jmb.2010.06.023; Kogan G, 2006, FEMS MICROBIOL LETT, V255, P11, DOI 10.1111/j.1574-6968.2005.00043.x; Kristian SA, 2008, J INFECT DIS, V197, P1028, DOI 10.1086/528992; Larsen P, 2007, ENVIRON MICROBIOL, V9, P3077, DOI 10.1111/j.1462-2920.2007.01418.x; Lashuel HA, 1998, BIOCHEMISTRY-US, V37, P17851, DOI 10.1021/bi981876+; Laue T.M., 1992, ANAL ULTRACENTRIFUGA, P90; Lembre P, 2014, PROTEIN PEPTIDE LETT, V21, P75; LEVINE H, 1993, PROTEIN SCI, V2, P404, DOI 10.1002/pro.5560020312; Liu C, 2011, J AM CHEM SOC, V133, P6736, DOI 10.1021/ja200222n; Macchi F, 2012, INT J MOL SCI, V13, P3801, DOI 10.3390/ijms13033801; Macintosh RL, 2009, J BACTERIOL, V191, P7007, DOI 10.1128/JB.00764-09; Mack D, 1996, J INFECT DIS, V174, P881, DOI 10.1093/infdis/174.4.881; MacRaild CA, 2003, BIOPHYS J, V84, P2562, DOI 10.1016/S0006-3495(03)75061-9; Morris K, 2010, CHEM SOC REV, V39, P3445, DOI 10.1039/b919453n; Nagel-Steger L, 2010, EUR BIOPHYS J BIOPHY, V39, P415, DOI 10.1007/s00249-009-0416-2; NAIKI H, 1989, ANAL BIOCHEM, V177, P244, DOI 10.1016/0003-2697(89)90046-8; Navarro S, 2016, EUR J MED CHEM, V121, P785, DOI 10.1016/j.ejmech.2015.10.044; Nelson R, 2005, NATURE, V435, P773, DOI 10.1038/nature03680; Nenninger AA, 2009, P NATL ACAD SCI USA, V106, P900, DOI 10.1073/pnas.0812143106; O'Nuallain B, 2006, METHOD ENZYMOL, V413, P34, DOI 10.1016/S0076-6879(06)13003-7; Otto M, 2009, NAT REV MICROBIOL, V7, P555, DOI 10.1038/nrmicro2182; Paharik AE, 2017, MOL MICROBIOL, V103, P860, DOI 10.1111/mmi.13594; Pedersen JS, 2008, PROTEIN SCI, V17, P2, DOI 10.1110/ps.073127808; Pedersen JS, 2006, J MOL BIOL, V355, P501, DOI 10.1016/j.jmb.2005.09.100; Plakoutsi G, 2005, J MOL BIOL, V351, P910, DOI 10.1016/j.jmb.2005.06.043; Rogers KL, 2009, INFECT DIS CLIN N AM, V23, P73, DOI 10.1016/j.idc.2008.10.001; Rohde H, 2005, MOL MICROBIOL, V55, P1883, DOI 10.1111/j.1365-2958.2005.04515.x; Rohde H, 2007, BIOMATERIALS, V28, P1711, DOI 10.1016/j.biomaterials.2006.11.046; Romero D, 2011, MOL MICROBIOL, V80, P1155, DOI 10.1111/j.1365-2958.2011.07653.x; Romero D, 2010, P NATL ACAD SCI USA, V107, P2230, DOI 10.1073/pnas.0910560107; Ryan TM, 2010, J MOL BIOL, V399, P731, DOI 10.1016/j.jmb.2010.04.042; Sadovskaya I, 2005, INFECT IMMUN, V73, P3007, DOI 10.1128/IAI.73.5.3007-3017.2005; Sawaya MR, 2007, NATURE, V447, P453, DOI 10.1038/nature05695; Schaeffer CR, 2015, INFECT IMMUN, V83, P214, DOI 10.1128/IAI.02177-14; Schuck P, 2002, BIOPHYS J, V82, P1096, DOI 10.1016/S0006-3495(02)75469-6; Shelton CL, 2017, BIOCHEM J, V474, P427, DOI 10.1042/BCJ20160675; Shewmaker F, 2009, J BIOL CHEM, V284, P25065, DOI 10.1074/jbc.M109.007054; Sikorski P, 2003, STRUCTURE, V11, P915, DOI 10.1016/S0969-2126(03)00149-7; Smith DP, 2010, P NATL ACAD SCI USA, V107, P6794, DOI 10.1073/pnas.0913046107; SPURLINO JC, 1991, J BIOL CHEM, V266, P5202; Sun DQ, 2005, CLIN DIAGN LAB IMMUN, V12, P93, DOI 10.1128/CDLI.12.1.93-100.2005; Sunde M, 1997, ADV PROTEIN CHEM, V50, P123, DOI 10.1016/S0065-3233(08)60320-4; Taglialegna A, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005711; Talmard C, 2009, J BIOL INORG CHEM, V14, P449, DOI 10.1007/s00775-008-0461-9; Tormo MA, 2005, MICROBIOL-SGM, V151, P2465, DOI 10.1099/mic.0.27865-0; Tougu V, 2009, J NEUROCHEM, V110, P1784, DOI 10.1111/j.1471-4159.2009.06269.x; Uckay I, 2009, ANN MED, V41, P109, DOI 10.1080/07853890802337045; VANHOLDE KE, 1978, BIOPOLYMERS, V17, P1387, DOI 10.1002/bip.1978.360170602; VASSAR PS, 1959, ARCH PATHOL, V68, P487; von Eiff C, 2002, LANCET INFECT DIS, V2, P677, DOI 10.1016/S1473-3099(02)00438-3; Wang Y, 2018, J BIOL CHEM, V293, P14296, DOI 10.1074/jbc.RA118.002448; Whitmore L, 2004, NUCLEIC ACIDS RES, V32, pW668, DOI 10.1093/nar/gkh371; Wisplinghoff H, 2004, CLIN INFECT DIS, V39, P309, DOI 10.1086/421946; Wolfe LS, 2010, P NATL ACAD SCI USA, V107, P16863, DOI 10.1073/pnas.1002867107; Yarawsky AE, 2017, J MOL BIOL, V429, P261, DOI 10.1016/j.jmb.2016.11.017; Zhang R, 2009, P NATL ACAD SCI USA, V106, P4653, DOI 10.1073/pnas.0901085106; Zhao Ran, 2016, Biophys Rev, V8, P445, DOI 10.1007/s12551-016-0233-7	102	21	21	2	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 3	2020	295	14					4411	4427		10.1074/jbc.RA119.010874	http://dx.doi.org/10.1074/jbc.RA119.010874			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LB2WZ	32102851	hybrid, Green Published			2022-12-26	WOS:000524499700005
J	Yang, LL; Dai, JJ; Gao, QP; Yuan, GZ; Liu, J; Sun, Y; Sun, YX; Wang, L; Qian, C; Zhu, BJ; Liu, CL; Wei, GQ				Yang, Liangli; Dai, Junjun; Gao, Qiuping; Yuan, Guozhen; Liu, Jiang; Sun, Yu; Sun, Yuxuan; Wang, Lei; Qian, Cen; Zhu, Baojian; Liu, Chaoliang; Wei, Guoqing			Characterization of the complete mitochondrial genome of Orthaga olivacea Warre (Lepidoptera Pyralidae) and comparison with other Lepidopteran insects	PLOS ONE			English	Article							TRANSFER-RNA GENES; PHYLOGENETIC ANALYSIS; COMPLETE MITOGENOME; EVOLUTIONARY GENOMICS; POPULATION-GENETICS; NUCLEOTIDE-SEQUENCE; CONTROL REGION; DNA; MOTH; ORGANIZATION	Orthaga olivacea Warre (Lepidoptera: Pyralidae) is an important agricultural pest of camphor trees (Cinnamomum camphora). To further supplement the known genome-level features of related species, the complete mitochondrial genome of Orthaga olivacea is amplified, sequenced, annotated, analyzed, and compared with 58 other species of Lepidopteran. The complete sequence is 15,174 bp, containing 13 protein-coding genes (PCGs), 22 transfer RNA (tRNA) genes, 2 ribosomal RNA (rRNA) genes, and a putative control region. Base composition is biased toward adenine and thymine (79.02% A+T) and A+T skew are slightly negative. Twelve of the 13 PCGs use typical ATN start codons. The exception is cytochrome oxidase 1 (cox1) that utilizes a CGA initiation codon. Nine PCGs have standard termination codon (TAA); others have incomplete stop codons, a single T or TA nucleotide. All the tRNA genes have the typical clover-leaf secondary structure, except for trnS(AGN), in which dihydrouridine (DHU) arm fails to form a stable stem-loop structure. The A+T-rich region (293 bp) contains a typical Lepidopter motifs 'ATAGA' followed by a 17 bp poly-T stretch, and a microsatellite-like (AT)(13) repeat. Codon usage analysis revealed that Asn, Ile, Leu2, Lys, Tyr and Phe were the most frequently used amino acids, while Cys was the least utilized. Phylogenetic analysis suggested that among sequenced lepidopteran mitochondrial genomes, Orthaga olivacea Warre was most closely related to Hypsopygia regina, and confirmed that Orthaga olivacea Warre belongs to the Pyralidae family.	[Yang, Liangli; Gao, Qiuping; Yuan, Guozhen; Liu, Jiang; Sun, Yu; Sun, Yuxuan; Wang, Lei; Qian, Cen; Zhu, Baojian; Liu, Chaoliang; Wei, Guoqing] Anhui Agr Univ, Sch Life Sci, Hefei, Peoples R China; [Dai, Junjun] Anhui Acad Agr Sci, Sericulture Res Inst, Hefei, Peoples R China	Anhui Agricultural University; Anhui Academy of Agricultural Sciences	Wei, GQ (corresponding author), Anhui Agr Univ, Sch Life Sci, Hefei, Peoples R China.	weiguoqing@ahau.edu.cn	Zhu, Baojian/ABG-4522-2021		National Natural Science Foundation of China [31472147]; earmarked fund for Anhui International Joint Research and Development Center of Sericulture Resources Utilization [2017R0101]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); earmarked fund for Anhui International Joint Research and Development Center of Sericulture Resources Utilization	GQW was supported by the grant from the National Natural Science Foundation of China (31472147) the earmarked fund for Anhui International Joint Research and Development Center of Sericulture Resources Utilization (2017R0101). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Baeity H, 2019, MITOCHONDRIAL DNA B, V4, P413, DOI 10.1080/23802359.2018.1547158; Ali MB, 2017, MITOCHONDRIAL DNA B, V2, P344, DOI 10.1080/23802359.2017.1334525; AVISE JC, 1987, ANNU REV ECOL SYST, V18, P489, DOI 10.1146/annurev.es.18.110187.002421; Bae JS, 2004, MOL PHYLOGENET EVOL, V32, P978, DOI 10.1016/j.ympev.2004.03.009; Benson G, 1999, NUCLEIC ACIDS RES, V27, P573, DOI 10.1093/nar/27.2.573; Boore JL, 1999, NUCLEIC ACIDS RES, V27, P1767, DOI 10.1093/nar/27.8.1767; Cameron SL, 2008, GENE, V408, P112, DOI 10.1016/j.gene.2007.10.023; Cameron SL, 2014, SYST ENTOMOL, V39, P400, DOI 10.1111/syen.12071; Cameron SL, 2014, ANNU REV ENTOMOL, V59, P95, DOI 10.1146/annurev-ento-011613-162007; Cao SS, 2014, GENE, V548, P270, DOI 10.1016/j.gene.2014.07.045; Chai HN, 2012, INT J BIOL SCI, V8, P561, DOI 10.7150/ijbs.3540; Chang Z, 2016, MITOCHONDRIAL DNA A, V27, P4561, DOI 10.3109/19401736.2015.1101564; Chen HL, 1994, J ZHEJIANG FORESTRY, V11, P218; Chen Mei, 2012, Zoological Research, V33, P191, DOI 10.3724/SP.J.1141.2012.02191; Chen S, 2016, MITOCHONDRIAL DNA B, V1, P638, DOI 10.1080/23802359.2016.1214551; CLARY DO, 1985, J MOL EVOL, V22, P252, DOI 10.1007/BF02099755; Coates BS, 2005, INT J BIOL SCI, V1, P13; Coates BS, 2004, J INSECT SCI, V4, DOI 10.1093/jis/4.1.35; Dai LS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132951; Dong WW, 2016, GENE, V577, P37, DOI 10.1016/j.gene.2015.11.020; Dowton M, 2002, INVERTEBR SYST, V16, P345, DOI 10.1071/IS02003; Flook PK, 1995, J MOL EVOL, V41, P928, DOI 10.1007/BF00173173; FORSTEN A, 1991, ANN ZOOL FENN, V28, P301; Gong YJ, 2013, MITOCHONDR DNA, V24, P391, DOI 10.3109/19401736.2013.763241; Gong YJ, 2012, MOL BIOL REP, V39, P2893, DOI 10.1007/s11033-011-1049-y; Hao JS, 2012, COMP FUNCT GENOM, DOI 10.1155/2012/328049; HAYASAKA K, 1988, MOL BIOL EVOL, V5, P626; He SL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129355; Jiang ST, 2009, INT J BIOL SCI, V5, P351; Junqueira ACM, 2004, GENE, V339, P7, DOI 10.1016/j.gene.2004.06.031; Kim MJ, 2013, MITOCHONDR DNA, V24, P622, DOI 10.3109/19401736.2013.772155; Kim MJ, 2010, AFR J BIOTECHNOL, V9, P735; Kim SR, 2009, MOL BIOL REP, V36, P1871, DOI 10.1007/s11033-008-9393-2; Kong WQ, 2015, J INSECT SCI, V15, DOI 10.1093/jisesa/iev032; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Li WW, 2011, DNA CELL BIOL, V30, P3, DOI 10.1089/dna.2010.1058; Liao F, 2010, INT J BIOL SCI, V6, P172; Liu LT, 2008, JOUANAL JILIN AGR U, V30, P24; Liu QY, 2018, MITOCHONDRIAL DNA B, V3, P189, DOI 10.1080/23802359.2018.1436993; Liu QN, 2016, MITOCHONDRIAL DNA A, V27, P122, DOI 10.3109/19401736.2013.873934; Liu SX, 2014, GENE, V547, P136, DOI 10.1016/j.gene.2014.06.044; Liu YQ, ACTA BIOCH BIOPHYSIC, V40, P693; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Lu HD, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0069950, 10.1371/journal.pone.0072410]; McKnight ML, 1997, MOL BIOL EVOL, V14, P1167, DOI 10.1093/oxfordjournals.molbev.a025726; Miya M, 2001, MOL BIOL EVOL, V18, P1993, DOI 10.1093/oxfordjournals.molbev.a003741; OJALA D, 1980, CELL, V22, P393, DOI 10.1016/0092-8674(80)90350-5; Oliveira MT, 2007, J MOL EVOL, V64, P519, DOI 10.1007/s00239-006-0099-6; Ort BS, 2007, GENETICS, V177, P1087, DOI 10.1534/genetics.107.072934; Pan MH, 2008, SCI CHINA SER C, V51, P693, DOI 10.1007/s11427-008-0097-6; Park J.S., 2013, MITOCHONDR DNA, V26, P247, DOI DOI 10.3109/; Park JS, 2014, MITOCHONDR DNA, V25, P275, DOI 10.3109/19401736.2013.800504; Park JS, 2012, J ASIA-PAC ENTOMOL, V15, P331, DOI 10.1016/j.aspen.2012.01.002; PERNA NT, 1995, J MOL EVOL, V41, P353, DOI 10.1007/BF01215182; RAND DM, 1993, J MOL EVOL, V37, P281, DOI 10.1007/BF00175505; Saccone C, 1999, GENE, V238, P195, DOI 10.1016/S0378-1119(99)00270-X; Saito S, 2005, GENETICS, V171, P1695, DOI 10.1534/genetics.105.046243; Salvato P, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-331; Sheffield NC, 2008, MOL BIOL EVOL, V25, P2499, DOI 10.1093/molbev/msn198; Sun QQ, 2012, GENET MOL RES, V11, P4213, DOI 10.4238/2012.September.10.2; Sun YX, 2016, SCI REP-UK, V6, DOI 10.1038/srep39153; Taanman JW, 1999, BBA-BIOENERGETICS, V1410, P103, DOI 10.1016/S0005-2728(98)00161-3; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tang M, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku917; Wang J, 2016, MITOCHONDRIAL DNA A, V27, P1821, DOI 10.3109/19401736.2014.971241; Wei SJ, 2013, DNA CELL BIOL, V32, P173, DOI 10.1089/dna.2012.1942; Wei Shu-Jun, 2008, Chinese Bulletin of Entomology, V45, P562; WICH G, 1986, NUCLEIC ACIDS RES, V14, P2459, DOI 10.1093/nar/14.6.2459; WOLSTENHOLME DR, 1992, INT REV CYTOL, V141, P173, DOI 10.1016/S0074-7696(08)62066-5; Wu QL, 2015, MITOCHONDR DNA, V26, P139, DOI 10.3109/19401736.2013.815175; Wu QL, 2013, MITOCHONDR DNA, V24, P105, DOI 10.3109/19401736.2012.726621; Wu YP, 2012, DNA CELL BIOL, V31, P1508, DOI 10.1089/dna.2012.1642; Wu YP, 2012, J INSECT SCI, V12, DOI 10.1673/031.012.7201; Xing LX, 2014, MITOCHONDR DNA, V25, P122, DOI 10.3109/19401736.2013.800506; Yang ML, 2017, MITOCHONDRIAL DNA B, V2, P275, DOI 10.1080/23802359.2017.1325338; Yang XS, 2015, MOL PHYLOGENET EVOL, V85, P230, DOI 10.1016/j.ympev.2015.02.005; Ye F, 2016, MITOCHONDRIAL DNA A, V27, P28, DOI 10.3109/19401736.2013.869678; Ye F, 2015, MITOCHONDR DNA, V26, P853, DOI 10.3109/19401736.2013.861427; Ye F, 2013, AQUAT INSECT, V35, P71, DOI 10.1080/01650424.2014.948456; Yin J, 2011, MITOCHONDR DNA, V22, P41, DOI 10.3109/19401736.2011.605126; Yin JA, 2010, MITOCHONDR DNA, V21, P160, DOI 10.3109/19401736.2010.503242; Zhang DX, 1997, BIOCHEM SYST ECOL, V25, P99, DOI 10.1016/S0305-1978(96)00042-7; Zhang M, 2012, MOL BIOL REP, V39, P6529, DOI 10.1007/s11033-012-1481-7; Zhang NianHuan, 2004, Journal of Zhejiang Forestry Science and Technology, V24, P24; Zhao JL, 2011, MOL BIOL REP, V38, P3757, DOI 10.1007/s11033-010-0491-6; Zheng N, 2018, INT J BIOL MACROMOL, V113, P961, DOI 10.1016/j.ijbiomac.2018.02.110; Zhu BJ, 2013, GENE, V527, P283, DOI 10.1016/j.gene.2013.06.035; Zhu WB, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0194672; Zou Y, 2016, MITOCHONDRIAL DNA A, V27, P740, DOI 10.3109/19401736.2014.913167	89	5	5	4	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2020	15	3							e0227831	10.1371/journal.pone.0227831	http://dx.doi.org/10.1371/journal.pone.0227831			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8TR	32142522	Green Published, gold			2022-12-26	WOS:000535271600003
J	Fahsbender, E; da-Costa, AC; Gill, DE; Milagres, FAD; Brustulin, R; Monteiro, FJC; Rego, MOD; Ribeiro, ESD; Sabino, EC; Delwart, E				Fahsbender, Elizabeth; da-Costa, Antonio Charlys; Gill, Danielle Elise; Milagres, Flavio Augusto de Padua; Brustulin, Rafael; Monteiro, Fred Julio Costa; Rego, Marlisson Octavio da Silva; Ribeiro, Edcelha Soares D'Athaide; Sabino, Ester Cerdeira; Delwart, Eric			Plasma virome of 781 Brazilians with unexplained symptoms of arbovirus infection include a novel parvovirus and densovirus	PLOS ONE			English	Article							MERKEL CELL POLYOMAVIRUS; VIRAL NUCLEIC-ACIDS; HUMAN PEGIVIRUS 2; BLOOD-DONORS; DNA VIRUSES; GEMYCIRCULARVIRUS; GENERATION	Plasma from patients with dengue-like symptoms was collected in 2013 to 2016 from the Brazilian states of Tocantins and Amapa. 781 samples testing negative for IgM against Dengue, Zika, and Chikungunya viruses and for flaviviruses, alphaviruses and enteroviruses RNA using RT-PCRs were analyzed using viral metagenomics. Viral particles-associated nucleic acids were enriched, randomly amplified, and deep sequenced in 102 mini-pools generating over 2 billion reads. Sequence data was analyzed for the presence of known and novel eukaryotic viral reads. Anelloviruses were detected in 80%, human pegivirus 1 in 19%, and parvovirus B19 in 17% of plasma pools. HIV and enteroviruses were detected in two pools each. Previously uncharacterized viral genomes were also identified, and their presence in single plasma samples confirmed by PCR. Chapparvovirus and ambidensovirus genomes, both in the Parvoviridae family, were partially characterized showing 33% and 34% identity in their NS1 sequences to their closest relative. Molecular surveillance using pre-existing plasma from febrile patients provides a readily scalable approach for the detection of novel, potentially emerging, viruses.	[Fahsbender, Elizabeth; Delwart, Eric] Vitalant Res Inst, San Francisco, CA 94118 USA; [Fahsbender, Elizabeth; Delwart, Eric] Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94110 USA; [da-Costa, Antonio Charlys; Gill, Danielle Elise; Sabino, Ester Cerdeira] Univ Sao Paulo, Sch Med, Infect Dis, Sao Paulo, Brazil; [da-Costa, Antonio Charlys; Gill, Danielle Elise; Sabino, Ester Cerdeira] Univ Sao Paulo, Inst Trop Med, Infect Dis, Sao Paulo, Brazil; [Milagres, Flavio Augusto de Padua; Brustulin, Rafael] Hlth Tocantins, Publ Hlth Lab State LACEN TO, Palmas, TO, Brazil; [Milagres, Flavio Augusto de Padua; Brustulin, Rafael] Fed Univ Tocantins, Palmas, Tocantins, Brazil; [Monteiro, Fred Julio Costa; Rego, Marlisson Octavio da Silva; Ribeiro, Edcelha Soares D'Athaide] Hlth Amapa, Publ Hlth Lab State LACEN AP, Macapa, AP, Brazil	Vitalant; Vitalant Research Institute; University of California System; University of California San Francisco; Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade Federal do Tocantins (UFT)	Delwart, E (corresponding author), Vitalant Res Inst, San Francisco, CA 94118 USA.; Delwart, E (corresponding author), Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94110 USA.	edelwart@vitalant.org	Sabino, Ester C/F-7750-2010; da-Costa, Antonio Charlys/G-1548-2010	Sabino, Ester C/0000-0003-2623-5126; da-Costa, Antonio Charlys/0000-0001-5516-5177; Julio Costa Monteiro, Fred/0000-0002-1989-7810; Milagres, Flavio/0000-0002-6889-8772	Vitalant Research Institute; Grifols Diagnostic Solutions Inc.; FAPESP [2017/00021-9, 2016/01735-2]; CNPq [400354/2016-0]	Vitalant Research Institute; Grifols Diagnostic Solutions Inc.; FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This study was partially supported by Vitalant Research Institute, an unrestricted research grant from Grifols Diagnostic Solutions Inc., FAPESP #2016/01735-2 and CNPq #400354/2016-0. Antonio Charlys da-Costa is funded by FAPESP #2017/00021-9. The specific roles of this author are articulated in the 'author contributions' section. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asplund M, 2019, CLIN MICROBIOL INFEC, V25, P1277, DOI 10.1016/j.cmi.2019.04.028; Baker KS, 2013, VIROLOGY, V441, P95, DOI 10.1016/j.virol.2013.03.014; Berg MG, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005325; Brito F, 2018, VOX SANG, V113, P601, DOI 10.1111/vox.12695; Chiu CY, 2019, NAT REV GENET, V20, P341, DOI 10.1038/s41576-019-0113-7; Chivero ET, 2015, J GEN VIROL, V96, P1521, DOI 10.1099/vir.0.000086; Chong R, 2019, J VIROL, V93, DOI [10.1128/jvi.00205-19, 10.1128/JVI.00205-19]; Coller KE, 2020, EMERG INFECT DIS, V26, P265, DOI 10.3201/eid2602.190434; Coller KE, 2016, J CLIN MICROBIOL, V54, P2023, DOI 10.1128/JCM.00515-16; Cordey S, 2019, EMERG MICROBES INFEC, V8, P613, DOI 10.1080/22221751.2019.1603791; Cordey S, 2018, EMERG MICROBES INFEC, V7, DOI 10.1038/s41426-018-0025-1; de Souza WM, 2017, J GEN VIROL, V98, P225, DOI 10.1099/jgv.0.000671; de Villiers EM, 2009, J GEN VIROL, V90, P1999, DOI 10.1099/vir.0.011478-0; Deng XT, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv002; Di Paola N, 2019, CLIN INFECT DIS, V68, P810, DOI 10.1093/cid/ciy630; Du J, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.02815; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; El-Far M, 2004, VIRUS RES, V99, P17, DOI 10.1016/j.virusres.2003.09.010; FAHSBENDER E, 2019, VIRUSES-BASEL, V11, DOI DOI 10.3390/V11050398; Fukumoto H, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-84; Furuta RA, 2015, TRANSFUSION, V55, P1889, DOI 10.1111/trf.13057; Giry C, 2017, BMC MICROBIOL, V17, DOI 10.1186/s12866-017-1080-9; Grard G, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002924; Hewson I, 2014, P NATL ACAD SCI USA, V111, P17278, DOI 10.1073/pnas.1416625111; Holmes EC, 2019, CLIN MICROBIOL INFEC, V25, P1167, DOI 10.1016/j.cmi.2019.06.019; Jerome H, 2019, J INFECTION, V79, P383, DOI 10.1016/j.jinf.2019.08.003; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; Jones MS, 2005, J VIROL, V79, P8230, DOI 10.1128/JVI.79.13.8230-8236.2005; JOUSSET FX, 1993, VIRUS RES, V29, P99, DOI 10.1016/0168-1702(93)90052-O; Kapoor A, 2015, MBIO, V6, DOI 10.1128/mBio.01466-15; Kapusinszky B, 2017, J VIROL, V91, DOI 10.1128/JVI.00952-17; Krupovic M, 2016, ARCH VIROL, V161, P2633, DOI 10.1007/s00705-016-2943-3; Lamberto I, 2014, GENOME ANNOUNCEMENTS, V2, DOI 10.1128/genomeA.00848-14; Lau P, 2017, TRANSFUSION, V57, P1787, DOI 10.1111/trf.14148; Laubscher F, 2019, MICROBIOL RESOUR ANN, V8, DOI 10.1128/MRA.00764-19; Li L, 2015, J VIROL METHODS, V213, P139, DOI 10.1016/j.jviromet.2014.12.002; Lima DA, 2019, VIRUS RES, V261, P9, DOI 10.1016/j.virusres.2018.12.005; Liu S, 2016, P NATL ACAD SCI USA, V113, P12803, DOI 10.1073/pnas.1608013113; Liu SY, 2018, CELL, V175, P347, DOI 10.1016/j.cell.2018.08.016; Liu XP, 2020, VIROLOGY, V539, P80, DOI 10.1016/j.virol.2019.10.013; Macera L, 2019, NEW MICROBIOL, V42, P118; Moustafa A, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006292; Naccache SN, 2013, J VIROL, V87, P11966, DOI 10.1128/JVI.02323-13; Ngoi CN, 2017, J GEN VIROL, V98, P517, DOI 10.1099/jgv.0.000762; Ngoi CN, 2016, J GEN VIROL, V97, P3359, DOI 10.1099/jgv.0.000644; Anh NT, 2019, J CLIN MICROBIOL, V57, DOI 10.1128/JCM.00386-19; Anh NT, 2018, EMERG INFECT DIS, V24, P2063, DOI 10.3201/eid2411.180668; Palinski RM, 2016, VIRUS GENES, V52, P564, DOI 10.1007/s11262-016-1322-1; Pancaldi C, 2011, BLOOD, V117, P7099, DOI 10.1182/blood-2010-09-310557; Patel P, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-58; PENZES JJ, 2019, VIRUSES-BASEL, V11, DOI DOI 10.3390/V11060525; Ramesh A, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0218318; Reuter G, 2014, ARCH VIROL, V159, P2161, DOI 10.1007/s00705-014-2025-3; Roediger B, 2018, CELL, V175, P530, DOI 10.1016/j.cell.2018.08.013; Sauvage V, 2016, BLOOD TRANSFUS-ITALY, V14, P400, DOI 10.2450/2016.0160-15; Sawaswong V, 2019, VIRUSES-BASEL, V11, DOI 10.3390/v11100971; Schowalter RM, 2010, CELL HOST MICROBE, V7, P509, DOI 10.1016/j.chom.2010.05.006; Shui JW, 2019, J GEN VIROL, V100, P968, DOI 10.1099/jgv.0.001266; Somasekar S, 2017, CLIN INFECT DIS, V65, P1477, DOI 10.1093/cid/cix596; Spandole S, 2015, ARCH VIROL, V160, P893, DOI 10.1007/s00705-015-2363-9; Sridhar S, 2019, OPEN FORUM INFECT DI, V6, DOI 10.1093/ofid/ofz329; Stremlau MH, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003631; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tijssen P, 2016, J INVERTEBR PATHOL, V140, P83, DOI 10.1016/j.jip.2016.09.005; Phan TG, 2018, VIRUS GENES, V54, P33, DOI 10.1007/s11262-017-1514-3; Phan TG, 2016, ARCH VIROL, V161, P3231, DOI 10.1007/s00705-016-3002-9; Phan TG, 2015, VIROLOGY, V482, P98, DOI 10.1016/j.virol.2015.03.011; Uch R, 2015, EMERG INFECT DIS, V21, P2096, DOI 10.3201/eid2111.150486; Wang Y, 2019, ARCH VIROL, V164, P3, DOI 10.1007/s00705-018-4037-x; Williams SH, 2018, MSPHERE, V3, DOI 10.1128/mSphere.00311-18; Williams SH, 2018, MBIO, V9, DOI [10.1128/mBio.01354-17, 10.1128/mbio.01354-17]; Wylie KM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0027735; Xie JT, 2011, VIROLOGY, V418, P49, DOI 10.1016/j.virol.2011.07.008; Yang SX, 2016, VIROL J, V13, DOI 10.1186/s12985-016-0589-0; Yang WT, 2016, INFECT GENET EVOL, V41, P107, DOI 10.1016/j.meegid.2016.03.035; Yinda CK, 2018, VIRUS EVOL, V4, DOI 10.1093/ve/vey008; Yozwiak NL, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001485; Zhang SY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102724; Zhang W, 2016, TRANSFUSION, V56, P2248, DOI 10.1111/trf.13692	79	11	11	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2020	15	3							e0229993	10.1371/journal.pone.0229993	http://dx.doi.org/10.1371/journal.pone.0229993			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	KX8CZ	32134963	Green Published, gold			2022-12-26	WOS:000522104300001
J	Liu, RC; Zou, XP; Wang, Y; Long, Q; Pei, Y				Liu, Ruochen; Zou, Xiuping; Wang, You; Long, Qin; Pei, Yan			A 100 bp GAGA motif-containing sequence in AGAMOUS second intron is able to suppress the activity of CaMV35S enhancer in vegetative tissues	PLOS ONE			English	Article							FLORAL HOMEOTIC GENE; MOSAIC-VIRUS S-35; REGULATORY ELEMENTS; NEGATIVE REGULATION; PROMOTER SEQUENCES; TRANSCRIPTION; EXPRESSION; ARABIDOPSIS; CIS; DNA	Flower-specific promoters enable genetic manipulation of floral organs to improve crop yield and quality without affecting vegetative growth. However, the identification of strong tissue-specific promoters is a challenge. In addition, information on cis elements that is able to repress gene expression in vegetative tissues remains limited. Here, we report that fusing a 35S enhancer to the stamen- and carpel-specific NtAGIP1 promoter derived from the tobacco AGAMOUS second intron (AGI) can significantly increase the promoter activity. Interestingly, although the activity of the new promoter extends to sepals and pedicles, it does not cross the boundary of the reproductive organs. Serial deletion of the AGI and chromatin immunoprecipitation (ChIP) assay reveal a 100-bp fragment that contains a conserved GAGA factor binding motif contributes to the flower specificity by mediating histone H3 lysine 27 trimethylation (H3K27me3) modification of the promoter. Furthermore, this fragment shows significant suppressive effect on the activity of the 35S enhancer in vegetative tissues, consequently, resulting in a significant increase of the activity of 35S enhancer: AGI chimeric promoter without sacrifice of its specificity in inflorescence.	[Liu, Ruochen; Zou, Xiuping; Wang, You; Long, Qin; Pei, Yan] Southwest Univ, Chongqing Key Lab Applicat & Safety Control Genet, Chongqing, Peoples R China; [Liu, Ruochen; Zou, Xiuping; Wang, You; Long, Qin; Pei, Yan] Southwest Univ, Biotechnol Res Ctr, Chongqing, Peoples R China	Southwest University - China; Southwest University - China	Pei, Y (corresponding author), Southwest Univ, Chongqing Key Lab Applicat & Safety Control Genet, Chongqing, Peoples R China.	peiyan3@swu.edu.cn			Chinese Ministry of Science and Technology of China [2016YFD0100505]	Chinese Ministry of Science and Technology of China	This research was supported by the Chinese Ministry of Science and Technology of China (Grant 2016YFD0100505). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azuma M, 2016, PLANT BIOTECHNOL J, V14, P354, DOI 10.1111/pbi.12389; BANERJI J, 1981, CELL, V27, P299, DOI 10.1016/0092-8674(81)90413-X; BENFEY PN, 1990, SCIENCE, V250, P959, DOI 10.1126/science.250.4983.959; BOWMAN JL, 1991, DEVELOPMENT, V112, P1; BOWMAN JL, 1989, PLANT CELL, V1, P37, DOI 10.1105/tpc.1.1.37; Busch MA, 1999, SCIENCE, V285, P585, DOI 10.1126/science.285.5427.585; Christensen AH, 1996, TRANSGENIC RES, V5, P213, DOI 10.1007/BF01969712; Conner J, 2000, P NATL ACAD SCI USA, V97, P12902, DOI 10.1073/pnas.230352397; Deng WW, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-593; Deyholos MK, 2000, PLANT CELL, V12, P1799, DOI 10.1105/tpc.12.10.1799; Dong HQ, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20184551; DREWS GN, 1991, CELL, V65, P991, DOI 10.1016/0092-8674(91)90551-9; Du LJ, 2014, PLANT MOL BIOL REP, V32, P234, DOI 10.1007/s11105-013-0646-4; FANG RX, 1989, PLANT CELL, V1, P141, DOI 10.1105/tpc.1.1.141; Fath S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017596; Goodrich J, 1997, NATURE, V386, P44, DOI 10.1038/386044a0; GUILLEY H, 1982, CELL, V30, P763, DOI 10.1016/0092-8674(82)90281-1; Hecker A, 2015, PLANT PHYSIOL, V168, P130, DOI 10.1104/pp.15.00409; Hong RL, 2003, PLANT CELL, V15, P1296, DOI 10.1105/tpc.009548; HORSCH RB, 1985, SCIENCE, V227, P1229, DOI 10.1126/science.227.4691.1229; JEFFERSON RA, 1987, EMBO J, V6, P3901; Kassis JA, 2013, ADV GENET, V81, P83, DOI 10.1016/B978-0-12-407677-8.00003-8; Katsumoto Y, 2007, PLANT CELL PHYSIOL, V48, P1589, DOI 10.1093/pcp/pcm131; KAY R, 1987, SCIENCE, V236, P1299, DOI 10.1126/science.236.4806.1299; Konermann S, 2015, NATURE, V517, P583, DOI 10.1038/nature14136; Krogan NT, 2012, DEVELOPMENT, V139, P4180, DOI 10.1242/dev.085407; Kruger NJ, 2009, SPRINGER PROTOC HAND, P17, DOI 10.1007/978-1-59745-198-7_4; Li W, 2016, PLANT BIOTECHNOL J, V14, P2276, DOI 10.1111/pbi.12581; Liu WS, 2016, CURR OPIN BIOTECH, V37, P36, DOI 10.1016/j.copbio.2015.10.001; Liu YL, 2011, PLANT CELL REP, V30, P2187, DOI 10.1007/s00299-011-1124-9; Mozgova I, 2015, ANNU REV PLANT BIOL, V66, P269, DOI 10.1146/annurev-arplant-043014-115627; ODELL JT, 1985, NATURE, V313, P810, DOI 10.1038/313810a0; ODELL JT, 1988, PLANT MOL BIOL, V10, P263, DOI 10.1007/BF00027403; Ong CT, 2011, NAT REV GENET, V12, P283, DOI 10.1038/nrg2957; Paine JA, 2005, NAT BIOTECHNOL, V23, P482, DOI 10.1038/nbt1082; Plett JM, 2010, PLANT J, V64, P419, DOI 10.1111/j.1365-313X.2010.04343.x; Pu L, 2015, TRENDS GENET, V31, P252, DOI 10.1016/j.tig.2015.03.004; SANDERS PR, 1987, NUCLEIC ACIDS RES, V15, P1543, DOI 10.1093/nar/15.4.1543; Schubert D, 2006, EMBO J, V25, P4638, DOI 10.1038/sj.emboj.7601311; Seger M, 2015, PLANTA, V241, P69, DOI 10.1007/s00425-014-2165-4; Sieburth LE, 1997, PLANT CELL, V9, P355, DOI 10.1105/tpc.9.3.355; Simon JA, 2013, MOL CELL, V49, P808, DOI 10.1016/j.molcel.2013.02.013; Singer SD, 2010, PLANT MOL BIOL, V74, P293, DOI 10.1007/s11103-010-9673-9; Wu HW, 2018, NEW PHYTOL, V219, P1480, DOI 10.1111/nph.15231; Xiao J, 2017, NAT GENET, V49, P1546, DOI 10.1038/ng.3937; Yang YZ, 2010, PLANTA, V231, P1159, DOI 10.1007/s00425-010-1120-2; YANOFSKY MF, 1990, NATURE, V346, P35, DOI 10.1038/346035a0; Zhang M, 2011, NAT BIOTECHNOL, V29, P453, DOI 10.1038/nbt.1843; ZHANG WG, 1991, PLANT CELL, V3, P1155, DOI 10.1105/tpc.3.11.1155; Zheng XL, 2007, PLANT CELL REP, V26, P1195, DOI 10.1007/s00299-007-0307-x	50	2	2	3	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2020	15	3							e0230203	10.1371/journal.pone.0230203	http://dx.doi.org/10.1371/journal.pone.0230203			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8RK	32134990	gold, Green Published			2022-12-26	WOS:000535265600070
J	Yokoi, H; Take, Y; Uchida, R; Magome, T; Shimomura, K; Mae, T; Okamoto, T; Hanai, T; Chong, Y; Sato, S; Hikida, M; Nakata, K				Yokoi, Hiroyuki; Take, Yasuhiro; Uchida, Ryohei; Magome, Takuya; Shimomura, Kazunori; Mae, Tatsuo; Okamoto, Tomoko; Hanai, Tatsuhiro; Chong, Yang; Sato, Seira; Hikida, Minami; Nakata, Ken			Vibration acceleration promotes endochondral formation during fracture healing through cellular chondrogenic differentiation	PLOS ONE			English	Article							WHOLE-BODY VIBRATION; HIGH-FREQUENCY VIBRATION; LOW-MAGNITUDE; POSTURAL CONTROL; CALLUS FORMATION; BONE REPAIR; EXPRESSION; ULTRASOUND; STRENGTH; WOMEN	Vibration acceleration through whole body vibration has been reported to promote fracture healing. However, the mechanism responsible for this effect remains unclear. Purpose of this study was to determine whether vibration acceleration directly affects cells around the fracture site and promotes endochondral ossification. Four-week-old female Wistar Hannover rats were divided into two groups (vibration [V group] and control [C group]). The eighth ribs on both sides were cut vertically using scissors. From postoperative day 3 to 11, vibration acceleration using Power Plate (R) (30 Hz, low amplitude [30-Low], 10 min/day) was applied in the V group. Mature calluses appeared earlier in the V group than in the C group by histological analysis. The GAG content in the fracture callus on day 6 was significantly higher in the V group than in the C group. The mRNA expressions of SOX-9, aggrecan, and Col-II in the fracture callus on day 6 and Col-X on day 9 were significantly higher in the V group than in the C group. For in vitro analysis, four different conditions of vibration acceleration (30 or 50 Hz with low or high amplitude [30-Low, 30-High, 50-Low, and 50-High], 10 min/day) were applied to a prechondrogenic cell (ATDC5) and an undifferentiated cell (C3H10T1/2). There was no significant difference in cell proliferation between the control and any of the four vibration conditions for both cell lines. For both cell lines, alcian blue staining was greater under 30-Low and 50-Low conditions than under control as well as 30-High and 50-High conditions on days 7 and 14. Vibration acceleration under 30-L condition upregulated chondrogenic gene expressions of SOX-9, aggrecan, Col-II, and Col-X. Low-amplitude vibration acceleration can promote endochondral ossification in the fracture healing in vivo and chondrogenic differentiation in vitro.	[Yokoi, Hiroyuki; Take, Yasuhiro; Magome, Takuya; Shimomura, Kazunori; Okamoto, Tomoko; Hanai, Tatsuhiro; Chong, Yang; Sato, Seira; Hikida, Minami; Nakata, Ken] Osaka Univ, Grad Sch Med, Med Sports & Performing Arts, Osaka, Japan; [Yokoi, Hiroyuki; Take, Yasuhiro; Shimomura, Kazunori; Mae, Tatsuo; Sato, Seira; Nakata, Ken] Osaka Univ, Grad Sch Med, Dept Orthoped Surg, Osaka, Japan; [Uchida, Ryohei] Yukioka Hosp, Dept Sports Med, Osaka, Japan	Osaka University; Osaka University	Nakata, K (corresponding author), Osaka Univ, Grad Sch Med, Med Sports & Performing Arts, Osaka, Japan.; Nakata, K (corresponding author), Osaka Univ, Grad Sch Med, Dept Orthoped Surg, Osaka, Japan.	ken-nakata@umin.ac.jp	Uchida, Ryohei/AAW-7733-2021; Take, Yasuhiro/AAO-2266-2021		PROTEA JAPAN Company, Limited [J167701901]; Department of Medicine for Sports and Performing Arts, Osaka University Graduate School of Medicine	PROTEA JAPAN Company, Limited; Department of Medicine for Sports and Performing Arts, Osaka University Graduate School of Medicine	Support was provided by PROTEA JAPAN Company, Limited [http://www.protea.co.jp], grant number J167701901. The initial of author who received the funding is K.N (Department of Medicine for Sports and Performing Arts, Osaka University Graduate School of Medicine). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alentorn-Geli E, 2008, J ALTERN COMPLEM MED, V14, P975, DOI 10.1089/acm.2008.0050; Andreassen TT, 1999, J BONE MINER RES, V14, P960, DOI 10.1359/jbmr.1999.14.6.960; Azuma Y, 2001, J BONE MINER RES, V16, P671, DOI 10.1359/jbmr.2001.16.4.671; Bacabac RG, 2006, FASEB J, V20, P858, DOI 10.1096/fj.05-4966.com; Bassett C A, 1982, Instr Course Lect, V31, P88; Bautmans Ivan, 2005, BMC Geriatr, V5, P17, DOI 10.1186/1471-2318-5-17; Bogaerts A, 2007, GAIT POSTURE, V26, P309, DOI 10.1016/j.gaitpost.2006.09.078; Bogaerts A, 2011, GAIT POSTURE, V33, P466, DOI 10.1016/j.gaitpost.2010.12.027; BRIGHTON CT, 1995, CLIN ORTHOP RELAT R, P223; Cardinale M, 2010, BRIT J SPORT MED, V44, P284, DOI 10.1136/bjsm.2007.043232; Cheung WH, 2012, ULTRASOUND MED BIOL, V38, P2120, DOI 10.1016/j.ultrasmedbio.2012.07.025; Chow DHK, 2011, J ORTHOP RES, V29, P746, DOI 10.1002/jor.21303; Chow SKH, 2016, OSTEOPOROSIS INT, V27, P2989, DOI 10.1007/s00198-016-3619-2; Chung SL, 2014, J ORTHOP RES, V32, P1572, DOI 10.1002/jor.22715; Dabbs NC, 2010, J STRENGTH COND RES, V24, P2296, DOI 10.1519/JSC.0b013e3181eccde5; DEBASTIANI G, 1984, J BONE JOINT SURG BR, V66, P538, DOI 10.1302/0301-620X.66B4.6746689; Delecluse C, 2003, MED SCI SPORT EXER, V35, P1033, DOI 10.1249/01.MSS.0000069752.96438.B0; EGGER EL, 1993, J TRAUMA, V34, P185, DOI 10.1097/00005373-199302000-00001; Figueroa A, 2011, EUR J APPL PHYSIOL, V111, P1261, DOI 10.1007/s00421-010-1746-6; Fjeldstad C, 2009, MATURITAS, V63, P79, DOI 10.1016/j.maturitas.2009.03.013; Gluhak-Heinrich J, 2003, J BONE MINER RES, V18, P807, DOI 10.1359/jbmr.2003.18.5.807; GOODSHIP AE, 1985, J BONE JOINT SURG BR, V67, P650, DOI 10.1302/0301-620X.67B4.4030869; Goodship AE, 2009, J ORTHOP RES, V27, P922, DOI 10.1002/jor.20824; Guo Y, 2012, BIOMED ENG ONLINE, V11, DOI 10.1186/1475-925X-11-80; HASHIMOTO J, 1989, BONE, V10, P453, DOI 10.1016/8756-3282(89)90078-1; HECKMAN JD, 1994, J BONE JOINT SURG AM, V76A, P26, DOI 10.2106/00004623-199401000-00004; Holzer G, 1999, CLIN ORTHOP RELAT R, P258, DOI 10.1097/00003086-199909000-00033; Joosen M, 2008, INT J OCCUP MED ENV, V21, P237, DOI 10.2478/v10001-008-0025-9; Kawaguchi H, 2001, J CLIN ENDOCR METAB, V86, P875, DOI 10.1210/jc.86.2.875; Komrakova M, 2013, CALCIFIED TISSUE INT, V92, P509, DOI 10.1007/s00223-013-9706-x; Kristiansen TK, 1997, J BONE JOINT SURG AM, V79A, P961, DOI 10.2106/00004623-199707000-00002; Leung KS, 2009, J ORTHOP RES, V27, P458, DOI 10.1002/jor.20753; Maredziak M, 2017, CELL MOL BIOENG, V10, P549, DOI 10.1007/s12195-017-0501-z; Marycz K, 2016, PEERJ, V4, DOI 10.7717/peerj.1637; Matsushita T, 1998, ACTA ORTHOP SCAND, V69, P95, DOI 10.3109/17453679809002365; Meinyk M, 2008, INT J SPORTS MED, V29, P839, DOI 10.1055/s-2008-1038405; Moezy A, 2008, BRIT J SPORT MED, V42, DOI 10.1136/bjsm.2007.038554; Motokawa M, 2005, J DENT RES, V84, P422, DOI 10.1177/154405910508400505; Murao H, 2013, J BONE MINER METAB, V31, P390, DOI 10.1007/s00774-013-0429-x; Nakajima A, 2003, BONE, V32, pS224; Ness LL, 2009, RESTOR NEUROL NEUROS, V27, P621, DOI 10.3233/RNN-2009-0487; NOORDEEN MHH, 1995, J BONE JOINT SURG BR, V77B, P645, DOI 10.1302/0301-620X.77B4.7615614; Ota T, 2016, CYTOTECHNOLOGY, V68, P2287, DOI 10.1007/s10616-016-0023-x; Padilla F, 2014, ULTRASONICS, V54, P1125, DOI 10.1016/j.ultras.2014.01.004; RAABCULLEN DM, 1994, CALCIFIED TISSUE INT, V55, P473, DOI 10.1007/BF00298562; Radomsky ML, 1999, J ORTHOP RES, V17, P607, DOI 10.1002/jor.1100170422; Schindeler A, 2008, SEMIN CELL DEV BIOL, V19, P459, DOI 10.1016/j.semcdb.2008.07.004; Shi HF, 2010, BONE, V46, P1299, DOI 10.1016/j.bone.2009.11.028; Slatkovska L, 2010, OSTEOPOROSIS INT, V21, P1969, DOI 10.1007/s00198-010-1228-z; Stockl S, 2013, CELL PHYSIOL BIOCHEM, V31, P703, DOI 10.1159/000350089; Stuermer EK, 2014, BONE, V64, P187, DOI 10.1016/j.bone.2014.04.008; Stuermer EK, 2010, CALCIFIED TISSUE INT, V87, P168, DOI 10.1007/s00223-010-9381-0; Tanaka SM, 2003, J BIOMECH, V36, P73, DOI 10.1016/S0021-9290(02)00245-2; Uchida R, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172614; Verschueren SMP, 2004, J BONE MINER RES, V19, P352, DOI 10.1359/JBMR.0301245; Vissers D, 2010, OBESITY FACTS, V3, P93, DOI 10.1159/000301785; Wang J, 2017, EUR CELLS MATER, V34, P108, DOI 10.22203/eCM.v034a08; Wang JB, 2017, BMC MUSCULOSKEL DIS, V18, DOI 10.1186/s12891-017-1579-0; Wehrle E, 2015, DIS MODEL MECH, V8, P93, DOI 10.1242/dmm.018622; Wehrle E, 2014, J ORTHOP RES, V32, P1006, DOI 10.1002/jor.22629; Wei FY, 2016, EUR CELLS MATER, V31, P341, DOI 10.22203/eCM.v031a22; Westerhuis RJ, 2005, INJURY, V36, P1405, DOI 10.1016/j.injury.2005.02.047; Yu SB, 2012, BMC MUSCULOSKEL DIS, V13, DOI 10.1186/1471-2474-13-190; Zhao Q, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172954	64	2	2	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2020	15	3							e0229127	10.1371/journal.pone.0229127	http://dx.doi.org/10.1371/journal.pone.0229127			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8RK	32134943	gold, Green Published			2022-12-26	WOS:000535265600017
J	Lin, CY; Wu, MY; Tseng, CN; Chang, YS; Liu, YC; Lu, CH; Tsai, FC				Lin, Chun-Yu; Wu, Meng-Yu; Tseng, Chi-Nan; Chang, Yu-Sheng; Liu, Yuan-Chang; Lu, Cheng-Hui; Tsai, Feng-Chun			Surgical rescues for critical hemopericardium complicated by acute type A aortic dissection: Emergent subxiphoid pericardiotomy or cardiopulmonary bypass first?	PLOS ONE			English	Article							CEREBRAL PERFUSION; TASK-FORCE; SURGERY; ASSOCIATION; CANNULATION; GUIDELINES; MANAGEMENT; DIAGNOSIS; SOCIETY	Background Hemopericardium is a common and hazardous complication of acute type A aortic dissection (ATAAD). This retrospective study aimed to clarify the short-term and mid-term outcomes in patients who underwent surgical rescues for hemopericardium complicated by ATAAD. Methods Between January 2007 and March 2019, 586 consecutive patients underwent ATAAD repair at our institution. According to preoperative computed tomography, hemopericardium was found in 191 patients (32.6%), 150 were stabilized with medical treatment, and 41 underwent surgical rescues for critical hemodynamics. The 41 patients were classified into groups according to their rescue procedures: emergent subxiphoid pericardiotomy (E-SXP group, n = 26, 63.4%) or emergent cardiopulmonary bypass (E-CPB group, n = 15, 36.6%). Clinical features, surgical information, postoperative complications, and 3-year survival were analyzed and compared. Results Demographics, comorbidities and aortic repair procedures were generally homogenous between the two groups, except for sex. The average systolic blood pressure was 62.4 +/- 13.3 mmHg and 67.1 +/- 13.1 mmHg in the E-SXP and E-CPB groups, respectively. A total of 29.3% of patients underwent cardiopulmonary resuscitation (CPR) before surgical rescues. The in-hospital mortality was similar (30.8% versus 33.3%, P = 0.865) in the two groups. Multivariate analysis revealed that preoperative CPR was an in-hospital predictor of mortality. For patients who survived to discharge, 3-year cumulative survival rates were 87.8% +/- 8.1% and 60.0% +/- 19.7% in the E-SXP and E-CPB groups, respectively (P = 0.170). Conclusions Patients who underwent surgical rescues for ATAAD-complicated hemopericardium are at a high risk of in-hospital mortality. The two rescue procedures revealed similar short-term and mid-term outcomes.	[Lin, Chun-Yu; Wu, Meng-Yu; Tseng, Chi-Nan; Chang, Yu-Sheng; Liu, Yuan-Chang; Lu, Cheng-Hui; Tsai, Feng-Chun] Chang Gung Univ, Coll Med, Dept Med, Taoyuan, Taiwan; [Lin, Chun-Yu; Wu, Meng-Yu; Tseng, Chi-Nan; Chang, Yu-Sheng; Tsai, Feng-Chun] Chang Gung Mem Hosp, Linkou Med Ctr, Dept Cardiothorac & Vasc Surg, Taoyuan, Taiwan; [Liu, Yuan-Chang] Chang Gung Mem Hosp, Linkou Med Ctr, Dept Med Imaging & Intervent, Taoyuan, Taiwan; [Lu, Cheng-Hui] Chang Gung Mem Hosp, Linkou Med Ctr, Dept Cardiol, Taoyuan, Taiwan	Chang Gung University; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital	Lin, CY (corresponding author), Chang Gung Univ, Coll Med, Dept Med, Taoyuan, Taiwan.; Lin, CY (corresponding author), Chang Gung Mem Hosp, Linkou Med Ctr, Dept Cardiothorac & Vasc Surg, Taoyuan, Taiwan.	B9002078@cgmh.org.tw		Lin, Chun-Yu/0000-0002-0069-3690				Adler Y, 2015, EUR HEART J, V36, P2921, DOI 10.1093/eurheartj/ehv318; Adnet F, 2017, RESUSCITATION, V111, P74, DOI 10.1016/j.resuscitation.2016.11.024; Apaydin AZ, 2002, ANN THORAC SURG, V74, P2034, DOI 10.1016/S0003-4975(02)04096-1; Bayegan K, 2001, EUR J CARDIO-THORAC, V20, P1194, DOI 10.1016/S1010-7940(01)01017-X; Buonocore M, 2016, EUR J CARDIO-THORAC, V50, P652, DOI 10.1093/ejcts/ezw152; EUGENE J, 1981, CLIN CARDIOL, V4, P356, DOI 10.1002/clc.4960040610; Gilon D, 2009, AM J CARDIOL, V103, P1029, DOI 10.1016/j.amjcard.2008.12.013; Hagan PG, 2000, JAMA-J AM MED ASSOC, V283, P897, DOI 10.1001/jama.283.7.897; Hiratzka LF, 2010, CIRCULATION, V121, pE266, DOI 10.1161/CIR.0b013e3181d4739e; Lin CY, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0211900; Lin CY, 2018, MEDICINE, V97, DOI 10.1097/MD.0000000000012165; Long SM, 2003, ANN THORAC SURG, V75, P520, DOI 10.1016/S0003-4975(02)04536-8; Maisch B, 2004, EUR HEART J, V25, P587, DOI 10.1016/j.ehj.2004.02.002; Murai T, 2001, Keio J Med, V50, P175; Perreas K, 2016, ANN THORAC SURG, V101, P146, DOI 10.1016/j.athoracsur.2015.06.029; Rahimi-Barfeh A, 2016, ANN THORAC SURG, V101, P1753, DOI 10.1016/j.athoracsur.2015.10.043; ROBICSEK F, 1985, J CARDIOVASC SURG, V26, P36; SANTOS GH, 1977, ANN THORAC SURG, V23, P467, DOI 10.1016/S0003-4975(10)64168-9; TEMECK BK, 1994, ANN THORAC SURG, V57, P1015, DOI 10.1016/0003-4975(94)90227-5; Troughton RW, 2004, LANCET, V363, P717, DOI 10.1016/S0140-6736(04)15648-1; Tsukube T, 2017, E J CARDIOL PRACT, V15, P18; Wong DR, 2010, ANN THORAC SURG, V90, P731, DOI 10.1016/j.athoracsur.2010.04.059	22	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2020	15	3							e0229648	10.1371/journal.pone.0229648	http://dx.doi.org/10.1371/journal.pone.0229648			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8JT	32119707	gold, Green Published			2022-12-26	WOS:000535245300034
J	Monte, ER; Wilding, A; Leubolt, G; Kerbs, P; Bagnoli, JW; Hartmann, L; Hiddemann, W; Chen-Wichmann, L; Krebs, S; Blum, H; Cusan, M; Vick, B; Jeremias, I; Enard, W; Theurich, S; Wichmann, C; Greif, PA				Redondo Monte, Enric; Wilding, Anja; Leubolt, Georg; Kerbs, Paul; Bagnoli, Johannes W.; Hartmann, Luise; Hiddemann, Wolfgang; Chen-Wichmann, Linping; Krebs, Stefan; Blum, Helmut; Cusan, Monica; Vick, Binje; Jeremias, Irmela; Enard, Wolfgang; Theurich, Sebastian; Wichmann, Christian; Greif, Philipp A.			ZBTB7A prevents RUNX1-RUNX1T1-dependent clonal expansion of human hematopoietic stem and progenitor cells	ONCOGENE			English	Article							AML1-ETO; MUTATIONS; LEUKEMIA; FATE; REPRESSION; LRF	ZBTB7A is frequently mutated in acute myeloid leukemia (AML) with t(8;21) translocation. However, the oncogenic collaboration between mutated ZBTB7A and the RUNX1-RUNX1T1 fusion gene in AML t(8;21) remains unclear. Here, we investigate the role of ZBTB7A and its mutations in the context of normal and malignant hematopoiesis. We demonstrate that clinically relevant ZBTB7A mutations in AML t(8;21) lead to loss of function and result in perturbed myeloid differentiation with block of the granulocytic lineage in favor of monocytic commitment. In addition, loss of ZBTB7A increases glycolysis and hence sensitizes leukemic blasts to metabolic inhibition with 2-deoxy-d-glucose. We observed that ectopic expression of wild-type ZBTB7A prevents RUNX1-RUNX1T1-mediated clonal expansion of human CD34+ cells, whereas the outgrowth of progenitors is enabled by ZBTB7A mutation. Finally, ZBTB7A expression in t(8;21) cells lead to a cell cycle arrest that could be mimicked by inhibition of glycolysis. Our findings suggest that loss of ZBTB7A may facilitate the onset of AML t(8;21), and that RUNX1-RUNX1T1-rearranged leukemia might be treated with glycolytic inhibitors.	[Redondo Monte, Enric; Wilding, Anja; Leubolt, Georg; Kerbs, Paul; Hartmann, Luise; Hiddemann, Wolfgang; Cusan, Monica; Theurich, Sebastian; Greif, Philipp A.] Ludwig Maximilians Univ Munchen, Univ Hosp, Dept Med 3, D-81377 Munich, Germany; [Redondo Monte, Enric; Wilding, Anja; Leubolt, Georg; Kerbs, Paul; Hartmann, Luise; Hiddemann, Wolfgang; Greif, Philipp A.] German Canc Consortium DKTK, Partner Site Munich, D-81377 Munich, Germany; [Redondo Monte, Enric; Wilding, Anja; Leubolt, Georg; Kerbs, Paul; Hartmann, Luise; Hiddemann, Wolfgang; Greif, Philipp A.] German Canc Res Ctr, D-69121 Heidelberg, Germany; [Bagnoli, Johannes W.; Enard, Wolfgang] Ludwig Maximilians Univ Munchen, Dept Biol 2, Anthropol & Human Genom, D-82152 Martinsried, Germany; [Chen-Wichmann, Linping; Wichmann, Christian] Ludwig Maximilians Univ Munchen, Univ Hosp, Dept Transfus Med Cell Therapeut & Hemostasis, D-81377 Munich, Germany; [Krebs, Stefan; Blum, Helmut] Ludwig Maximilians Univ Munchen, Lab Funct Genome Anal, Gene Ctr, D-81377 Munich, Germany; [Vick, Binje; Jeremias, Irmela] Helmholtz Ctr Munich, Res Unit Apoptosis Hematopoiet Stem Cells, D-81377 Munich, Germany; [Theurich, Sebastian] Ludwig Maximilians Univ Munchen, Gene Ctr, Canc & Immunometab Res Grp, D-81377 Munich, Germany	University of Munich; Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); University of Munich; University of Munich; University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Munich	Greif, PA (corresponding author), Ludwig Maximilians Univ Munchen, Univ Hosp, Dept Med 3, D-81377 Munich, Germany.; Greif, PA (corresponding author), German Canc Consortium DKTK, Partner Site Munich, D-81377 Munich, Germany.; Greif, PA (corresponding author), German Canc Res Ctr, D-69121 Heidelberg, Germany.	pgreif@med.lmu.de	Theurich, Sebastian/C-9995-2018; Wichmann, Christian/H-2491-2017; Theurich, Sebastian/AAB-2855-2022; Jeremias, Irmela/Q-5934-2019	Theurich, Sebastian/0000-0001-5706-8258; Jeremias, Irmela/0000-0003-1773-7677; Vick, Binje/0000-0003-1956-2778; Bagnoli, Johannes/0000-0003-0393-6157; Redondo Monte, Enric/0000-0002-3588-223X; Kerbs, Paul/0000-0001-5525-1374	German Research Foundation (DFG) within the Collaborative Research Centre [(SFB) 1243]; Wilhelm Sander-Stiftung [2014.162.2]; Munich Clinician Scientist Program (MCSP) Advanced Track; Projekt DEAL	German Research Foundation (DFG) within the Collaborative Research Centre(German Research Foundation (DFG)); Wilhelm Sander-Stiftung; Munich Clinician Scientist Program (MCSP) Advanced Track; Projekt DEAL	This study was supported by the German Research Foundation (DFG) within the Collaborative Research Centre (SFB) 1243 "Cancer Evolution" (Projects A05, A08, A14, and Z02). PAG and CW acknowledge support by the Wilhelm Sander-Stiftung (Forderantrag Nr. 2014.162.2). PAG received funds from the Munich Clinician Scientist Program (MCSP) Advanced Track. Open access funding provided by Projekt DEAL.	BENZ EJ, 1980, P NATL ACAD SCI-BIOL, V77, P3509, DOI 10.1073/pnas.77.6.3509; Burel SA, 2001, MOL CELL BIOL, V21, P5577, DOI 10.1128/MCB.21.16.5577-5590.2001; Christen F, 2019, BLOOD, V133, P1140, DOI 10.1182/blood-2018-05-852822; COLLINS SJ, 1987, BLOOD, V70, P1233; de Guzman CG, 2002, MOL CELL BIOL, V22, P5506, DOI 10.1128/MCB.22.15.5506-5517.2002; Druker BJ, 2001, NEW ENGL J MED, V344, P1031, DOI 10.1056/NEJM200104053441401; Faber ZJ, 2016, NAT GENET, V48, P1551, DOI 10.1038/ng.3709; Hartmann L, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11733; HUANG ME, 1988, BLOOD, V72, P567, DOI 10.1182/blood.V72.2.567.567; Isa A, 2018, KLIN PADIATR, V230, P165; Kawashima N, 2019, ANN HEMATOL, V98, P83, DOI 10.1007/s00277-018-3492-5; Lavallee VP, 2016, BLOOD, V127, P2498, DOI 10.1182/blood-2016-03-703868; Lee SU, 2013, BLOOD, V121, P918, DOI 10.1182/blood-2012-03-418103; Liu XS, 2016, ONCOGENE, V35, P3071, DOI 10.1038/onc.2015.371; Liu XS, 2014, GENE DEV, V28, P1917, DOI 10.1101/gad.245910.114; Lunardi A, 2013, BLOOD, V121, P2845, DOI 10.1182/blood-2012-11-292037; Maeda T, 2007, SCIENCE, V316, P860, DOI 10.1126/science.1140881; Maeda T, 2009, DEV CELL, V17, P527, DOI 10.1016/j.devcel.2009.09.005; MARTIN SJ, 1990, CLIN EXP IMMUNOL, V79, P448; Mulloy JC, 2002, BLOOD, V99, P15, DOI 10.1182/blood.V99.1.15; Opatz S, 2020, LEUKEMIA, V34, P1553, DOI 10.1038/s41375-019-0697-0; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Rhoades KL, 2000, BLOOD, V96, P2108; ROWLEY JD, 1973, ANN GENET-PARIS, V16, P109; Schwieger M, 2002, J EXP MED, V196, P1227, DOI 10.1084/jem.20020824; Suganuma K, 2010, LEUKEMIA LYMPHOMA, V51, P2112, DOI 10.3109/10428194.2010.512966; Vick B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120925; Westendorf JJ, 1998, MOL CELL BIOL, V18, P322, DOI 10.1128/MCB.18.1.322; Wichmann C, 2015, LEUKEMIA, V29, P279, DOI 10.1038/leu.2014.179; Yan JS, 2017, LEUKEMIA LYMPHOMA, V58, P1985, DOI 10.1080/10428194.2016.1272690; Yeh JRJ, 2008, DEVELOPMENT, V135, P401, DOI 10.1242/dev.008904; Yuan YZ, 2001, P NATL ACAD SCI USA, V98, P10398, DOI 10.1073/pnas.171321298	32	10	10	2	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR	2020	39	15					3195	3205		10.1038/s41388-020-1209-4	http://dx.doi.org/10.1038/s41388-020-1209-4		MAR 2020	11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	LB8NS	32115572	Green Published, hybrid			2022-12-26	WOS:000517359700001
J	Ashrafi, M; Xu, Y; Muhamadali, H; White, I; Wilkinson, M; Hollywood, K; Baguneid, M; Goodacre, R; Bayat, A				Ashrafi, Mohammed; Xu, Yun; Muhamadali, Howbeer; White, Iain; Wilkinson, Maxim; Hollywood, Katherine; Baguneid, Mohamed; Goodacre, Royston; Bayat, Ardeshir			A microbiome and metabolomic signature of phases of cutaneous healing identified by profiling sequential acute wounds of human skin: An exploratory study	PLOS ONE			English	Article							GAS CHROMATOGRAPHY/MASS SPECTROMETRY; OPTICAL COHERENCE TOMOGRAPHY; TEMPORAL STABILITY; BIOMARKERS; DIVERSITY; APOPTOSIS; PLASMA; IMPACT; SERUM; TOOL	Profiling skin microbiome and metabolome has been utilised to gain further insight into wound healing processes. The aims of this multi-part temporal study in 11 volunteers were to analytically profile the dynamic wound tissue and headspace metabolome and sequence microbial communities in acute wound healing at days 0, 7, 14, 21 and 28, and to investigate their relationship to wound healing, using non-invasive quantitative devices. Metabolites were obtained using tissue extraction, sorbent and polydimethylsiloxane patches and analysed using GCMS. PCA of wound tissue metabolome clearly separated time points with 10 metabolites of 346 being involved in separation. Analysis of variance-simultaneous component analysis identified a statistical difference between the wound headspace metabolome, sites (P = 0.0024) and time points (P<0.0001), with 10 out of the 129 metabolites measured involved with this separation between sites and time points. A reciprocal relationship between Staphylococcus spp. and Propionibacterium spp. was observed at day 21 (P<0.05) with a statistical correlation between collagen and Propionibacterium (r = 0.417; P = 0.038) and Staphylococcus (r = -0.434; P = 0.03). Procrustes analysis showed a statistically significant similarity between wound headspace and tissue metabolome with non-invasive wound devices. This exploratory study demonstrates the temporal and dynamic nature of acute wound metabolome and microbiome presenting a novel class of biomarkers that correspond to wound healing, with further confirmatory studies now necessary.	[Ashrafi, Mohammed; Bayat, Ardeshir] Univ Manchester, NIHR Manchester Biomed Res Ctr BRC, Div Musculoskeletal & Dermatol Sci, Plast & Reconstruct Surg Res, Manchester, Lancs, England; [Ashrafi, Mohammed; Baguneid, Mohamed; Bayat, Ardeshir] Manchester Univ NHS Fdn Trust, Wythenshawe Hosp, Manchester, Lancs, England; [Ashrafi, Mohammed; Bayat, Ardeshir] Univ Manchester, Sch Mat, Bioengn Grp, Manchester, Lancs, England; [Xu, Yun; Muhamadali, Howbeer; White, Iain; Wilkinson, Maxim; Goodacre, Royston] Univ Manchester, Sch Chem, Manchester Inst Biotechnol, Manchester, Lancs, England; [Xu, Yun; Muhamadali, Howbeer; Goodacre, Royston] Univ Liverpool, Inst Integrat Biol, Dept Biochem, Liverpool, Merseyside, England; [White, Iain] Univ Nova Gorica, Lab Environm & Life Sci, Nova Gorica, Slovenia; [Hollywood, Katherine] Univ Manchester, Manchester Ctr Synthet Biol Fine & Special Chem S, Manchester Inst Biotechnol, Manchester, Lancs, England	University of Manchester; Wythenshawe Hospital NHS Foundation Trust; Wythenshawe Hospital; University of Manchester; University of Manchester; University of Liverpool; University of Nova Gorica; University of Manchester	Bayat, A (corresponding author), Univ Manchester, NIHR Manchester Biomed Res Ctr BRC, Div Musculoskeletal & Dermatol Sci, Plast & Reconstruct Surg Res, Manchester, Lancs, England.; Bayat, A (corresponding author), Manchester Univ NHS Fdn Trust, Wythenshawe Hosp, Manchester, Lancs, England.; Bayat, A (corresponding author), Univ Manchester, Sch Mat, Bioengn Grp, Manchester, Lancs, England.	ardeshir.bayat@manchester.ac.uk	White, Iain/AAY-8452-2021; Xu, Yun/ABG-2114-2021	White, Iain/0000-0001-9040-0048; Xu, Yun/0000-0003-3228-5111; Baguneid, Mohamed/0000-0002-3819-4993; Wilkinson, Max/0000-0002-4924-612X	NIHR Manchester Biomedical Research Centre	NIHR Manchester Biomedical Research Centre(National Institute for Health Research (NIHR))	AB and MA acknowledge the support of the NIHR Manchester Biomedical Research Centre.	AlRabiah H, 2014, ANALYST, V139, P4193, DOI 10.1039/c4an00176a; Ammons MCB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126735; BIRCHER A, 1994, CONTACT DERMATITIS, V30, P65, DOI 10.1111/j.1600-0536.1994.tb00565.x; Bouslimani A, 2015, P NATL ACAD SCI USA, V112, pE2120, DOI 10.1073/pnas.1424409112; Byrd AL, 2018, NAT REV MICROBIOL, V16, P143, DOI 10.1038/nrmicro.2017.157; Cobb MJ, 2010, GASTROINTEST ENDOSC, V71, P223, DOI 10.1016/j.gie.2009.07.005; Dame ZT, 2015, METABOLOMICS, V11, P1864, DOI 10.1007/s11306-015-0840-5; Deonarine K, 2007, J TRANSL MED, V5, DOI 10.1186/1479-5876-5-11; Di Cagno R, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-219; Domingo-Almenara X, 2016, ANAL CHEM, V88, P9821, DOI 10.1021/acs.analchem.6b02927; Domingo-Almenara X, 2015, J CHROMATOGR A, V1409, P226, DOI 10.1016/j.chroma.2015.07.044; Dunn WB, 2011, NAT PROTOC, V6, P1060, DOI 10.1038/nprot.2011.335; Dunn WB, 2011, CHEM SOC REV, V40, P387, DOI 10.1039/b906712b; Feezor RJ, 2004, PHYSIOL GENOMICS, V16, P341, DOI 10.1152/physiolgenomics.00101.2003; Fluhr JW, 2008, BRIT J DERMATOL, V159, P23, DOI 10.1111/j.1365-2133.2008.08643.x; Fonder MA, 2008, J AM ACAD DERMATOL, V58, P185, DOI 10.1016/j.jaad.2007.08.048; Gambichler T, 2005, J DERMATOL SCI, V40, P85, DOI 10.1016/j.jdermsci.2005.07.006; Greaves NS, 2014, BRIT J DERMATOL, V170, P840, DOI 10.1111/bjd.12786; Greenhalgh DG, 1998, INT J BIOCHEM CELL B, V30, P1019, DOI 10.1016/S1357-2725(98)00058-2; Grice EA, 2008, GENOME RES, V18, P1043, DOI 10.1101/gr.075549.107; Gromski PS, 2015, ANAL CHIM ACTA, V879, P10, DOI 10.1016/j.aca.2015.02.012; Guo S, 2010, J DENT RES, V89, P219, DOI 10.1177/0022034509359125; Hannigan GD, 2015, MBIO, V6, DOI 10.1128/mBio.01578-15; Huang TH, 2018, MAR DRUGS, V16, DOI 10.3390/md16080256; Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234; Junka A, 2017, J PHARMACEUT BIOMED, V137, P13, DOI 10.1016/j.jpba.2017.01.018; Kalkhof S, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/934848; Kimball BA, 2016, BIOANALYSIS, V8, P1987, DOI 10.4155/bio-2016-0203; Kossi J, 1999, EUR SURG RES, V31, P74, DOI 10.1159/000008623; Lin HW, 2013, CNS NEUROL DISORD-DR, V12, P316, DOI 10.2174/1871527311312030005; Loesche M, 2017, J INVEST DERMATOL, V137, P237, DOI 10.1016/j.jid.2016.08.009; Mamas M, 2011, ARCH TOXICOL, V85, P5, DOI 10.1007/s00204-010-0609-6; McCusker MM, 2010, CLIN DERMATOL, V28, P440, DOI 10.1016/j.clindermatol.2010.03.020; Mechin MC, 2016, J DERMATOL SCI, V81, P101, DOI 10.1016/j.jdermsci.2015.11.006; Meisel JS, 2018, MICROBIOME, V6, DOI 10.1186/s40168-018-0404-9; Mishima E, 2017, KIDNEY INT, V92, P634, DOI 10.1016/j.kint.2017.02.011; Moncrieff M, 2002, BRIT J DERMATOL, V146, P448, DOI 10.1046/j.1365-2133.2002.04569.x; Nussbaum SR, 2018, VALUE HEALTH, V21, P27, DOI 10.1016/j.jval.2017.07.007; Oh J, 2016, CELL, V165, P854, DOI 10.1016/j.cell.2016.04.008; Oh J, 2014, NATURE, V514, P59, DOI 10.1038/nature13786; OKADA M, 1994, SURG TODAY, V24, P347, DOI 10.1007/BF02348566; Pastar I, 2018, EXP DERMATOL; Penhallow K, 2005, J Wound Care, V14, P123; Peres-Neto PR, 2001, OECOLOGIA, V129, P169, DOI 10.1007/s004420100720; Pyo JS, 2008, J CHROMATOGR B, V876, P170, DOI 10.1016/j.jchromb.2008.10.031; R Core Team, 2013, R LANG ENV STAT COMP; Riazanskaia S, 2008, ANALYST, V133, P1020, DOI 10.1039/b802515k; Richmond NA, 2013, WOUND REPAIR REGEN, V21, P789, DOI 10.1111/wrr.12099; Rodrigues HG, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165115; Samy RP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0080199; Scales BS, 2013, J PATHOL, V229, P323, DOI 10.1002/path.4118; Smilde AK, 2005, BIOINFORMATICS, V21, P3043, DOI 10.1093/bioinformatics/bti476; Sood RF, 2015, WOUND REPAIR REGEN, V23, P423, DOI 10.1111/wrr.12299; Steinritz D, 2014, CHEM-BIOL INTERACT, V219, P143, DOI 10.1016/j.cbi.2014.05.015; Sumner LW, 2007, METABOLOMICS, V3, P211, DOI 10.1007/s11306-007-0082-2; Sun RL, 2020, SCI TOTAL ENVIRON, V705, DOI 10.1016/j.scitotenv.2019.135879; Talib WH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124384; Thomas AN, 2010, WOUND REPAIR REGEN, V18, P391, DOI 10.1111/j.1524-475X.2010.00592.x; Trivedi DK, 2017, NEW HORIZ TRANSL MED, V3, P294, DOI 10.1016/j.nhtm.2017.06.001; Ud-Din S, 2016, EXP DERMATOL, V25, P579, DOI 10.1111/exd.13027; van Oort PMP, 2017, BMC PULM MED, V17, DOI 10.1186/s12890-016-0353-7; Vulimiri SV, 2011, REPRODUCTIVE AND DEVELOPMENTAL TOXICOLOGY, P303, DOI 10.1016/B978-0-12-382032-7.10023-2; Wedge DC, 2011, ANAL CHEM, V83, P6689, DOI 10.1021/ac2012224; Welzel J, 2004, BRIT J DERMATOL, V150, P220, DOI 10.1111/j.1365-2133.2004.05810.x; Wollenberg MS, 2014, MBIO, V5, DOI 10.1128/mBio.01286-14	65	12	12	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2020	15	2							e0229545	10.1371/journal.pone.0229545	http://dx.doi.org/10.1371/journal.pone.0229545			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8GQ	32106276	Green Published, gold			2022-12-26	WOS:000535237000041
J	Hu, W; He, MF; Li, LP				Hu, Wei; He, Meifang; Li, Liangping			HLA class I restricted epitopes prediction of common tumor antigens in white and East Asian populations: Implication on antigen selection for cancer vaccine design	PLOS ONE			English	Article							PD-1 BLOCKADE; CELL; LANDSCAPE; NEOANTIGENS	Tumor antigens processed and presented by human leukocyte antigen (HLA) Class I alleles are important targets in tumor immunotherapies. Clinical trials showed that presence of CD8 + T cells specific to tumor associated antigens (TAAs) and tumor neoantigens is one of the main factors resulting in tumor regression. Affinity prediction of tumor antigen epitopes to HLA is an important reference index for peptide selection, which is highly individualized. In this study, we selected 6 CTAs (cancer-testis antigens) commonly used in cancer immunotherapy and top 95 hot mutations from the Cancer Genome Atlas for analyzing potential epitopes with high affinities to the common HLA class I molecules in white and East Asian population, respectively. The results showed that the overall difference in CTAs epitope prediction is small between the two populations. Meanwhile, there is a linear relationship between the CTAs peptide length and the relative overall epitope occurrence. However, the difference is bigger for epitopes prediction of missense mutations between the two populations. It is worth noting that, both in the two populations, the single point mutations with the highest incidences have the lowest epitope occurrences while the mutations with the highest epitope occurrences are with low mutation incidences. This may be the result of long-term selection by the host immunosurveillance. Frameshift/inframe indel mutation neoantigens are between CTAs and spot mutation neoantigens in the relationship between peptide length and predicted epitope number. Our results help provide clues for tumor antigen and epitope selection in cancer vaccine design.	[Hu, Wei] Sun Yat Sen Univ, Affiliated Hosp 1, Clin Trials Unit, Guangzhou, Peoples R China; [Hu, Wei; Li, Liangping] Jinan Univ, Affiliated Hosp 1, Inst Clin Oncol, Guangzhou, Peoples R China; [He, Meifang] Sun Yat Sen Univ, Affiliated Hosp 1, Lab Gen Surg, Guangzhou, Peoples R China	Sun Yat Sen University; Jinan University; Sun Yat Sen University	Li, LP (corresponding author), Jinan Univ, Affiliated Hosp 1, Inst Clin Oncol, Guangzhou, Peoples R China.; He, MF (corresponding author), Sun Yat Sen Univ, Affiliated Hosp 1, Lab Gen Surg, Guangzhou, Peoples R China.	hmf410@163.com; liangping_li@jnu.edu.cn			National Natural Science Foundation of China [81472824, 81502464]; National Key R&D Program of China [2016YFC1303404]; Guangdong Province Science and the Technology Project [2015A020211009, 201604020133]; Natural Science Foundation of Guangdong Province [2016A030310186]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key R&D Program of China; Guangdong Province Science and the Technology Project; Natural Science Foundation of Guangdong Province(National Natural Science Foundation of Guangdong Province)	This study was supported by the National Natural Science Foundation of China (No. 81472824) to LL, the National Key R&D Program of China (No. 2016YFC1303404) to LL, the Guangdong Province Science and the Technology Project (No. 2015A020211009) to LL, the Guangzhou Science and Technology Project (No. 201604020133) to LL, the National Natural Science Foundation of China (No. 81502464) to MH and the Natural Science Foundation of Guangdong Province (No. 2016A030310186) to MH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreatta M, 2016, BIOINFORMATICS, V32, P511, DOI 10.1093/bioinformatics/btv639; Forni G, 2015, J INFECT DEV COUNTR, V9, P600, DOI 10.3855/jidc.7201; Gjerstorff MF, 2015, ONCOTARGET, V6, P15772, DOI 10.18632/oncotarget.4694; Gordeeva O, 2018, SEMIN CANCER BIOL, V53, P75, DOI 10.1016/j.semcancer.2018.08.006; Hilf N, 2019, NATURE, V565, P240, DOI 10.1038/s41586-018-0810-y; Klebanoff CA, 2018, J EXP MED, V215, P5, DOI 10.1084/jem.20172188; Maiers M, 2007, HUM IMMUNOL, V68, P779, DOI 10.1016/j.humimm.2007.04.005; Ott PA, 2017, NATURE, V547, P217, DOI 10.1038/nature22991; Parkhurst M, 2017, CLIN CANCER RES, V23, P2491, DOI 10.1158/1078-0432.CCR-16-2680; Rizvi NA, 2015, SCIENCE, V348, P124, DOI 10.1126/science.aaa1348; Sahin U, 2017, NATURE, V547, P222, DOI 10.1038/nature23003; Schooten E, 2018, CANCER TREAT REV, V67, P54, DOI 10.1016/j.ctrv.2018.04.009; Srivastava PK, 2015, CANCER IMMUNOL RES, V3, P969, DOI 10.1158/2326-6066.CIR-15-0134; Stevanovic S, 2017, SCIENCE, V356, P200, DOI 10.1126/science.aak9510; Stronen E, 2016, SCIENCE, V352, P1337, DOI 10.1126/science.aaf2288; Thomas R, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00947; Tran E, 2016, NEW ENGL J MED, V375, P2255, DOI 10.1056/NEJMoa1609279; Tumeh PC, 2014, NATURE, V515, P568, DOI 10.1038/nature13954; Verdegaal EME, 2016, NATURE, V536, P91, DOI 10.1038/nature18945; Yee C, 2017, CANCER J, V23, P144, DOI 10.1097/PPO.0000000000000255; Zhang JX, 2019, TECHNOL CANCER RES T, V18, DOI 10.1177/1533033819831068	21	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2020	15	2							e0229327	10.1371/journal.pone.0229327	http://dx.doi.org/10.1371/journal.pone.0229327			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LP5GA	32106223	gold, Green Published			2022-12-26	WOS:000534344700001
J	Rachmansah, A; Norris, D; Gibbs, JP				Rachmansah, Angga; Norris, Darren; Gibbs, James P.			Population dynamics and biological feasibility of sustainable harvesting as a conservation strategy for tropical and temperate freshwater turtles	PLOS ONE			English	Article							LIFE-HISTORY TRAITS; INDIGENOUS HARVEST; BODY-SIZE; GEOGRAPHIC-VARIATION; SPECIES RICHNESS; PIG PREDATION; MANAGEMENT; MATURITY; PATTERNS; GROWTH	Background Conservation strategies are urgently needed for tropical turtles that are increasingly threatened by unsustainable exploitation. Studies conducted exclusively in temperate zones have revealed that typical turtle life history traits (including delayed sexual maturity and high adult survivorship) make sustainable harvest programs an unviable strategy for turtle conservation. However, most turtles are tropical in distribution and the tropics have higher, more constant and more extended ambient temperature regimes that, in general, are more favorable for population growth. Methods To estimate the capacity of temperate and tropical turtles to sustain harvest, we synthesized life-history traits from 165 predominantly freshwater turtle species in 12 families (Caretto-chelydae, Chelidae, Chelydridae, Dermatemydidae, Emydidae, Geoemydidae, Kinosternidae, Pelomedusidae, Platysternidae, Podocnemididae, Staurotypidae and Trionychidae). The influence of climate variables and latitude on turtle life-history traits (clutch size, clutch frequency, age at sexual maturity, and annual adult survival) were examined using Generalized Additive Models. The biological feasibility of sustainable harvest in temperate and tropical species was evaluated using a sensitivity analysis of population growth rates obtained from stage-structured matrix population models. Results Turtles at low latitudes (tropical zones) exhibit smaller clutch sizes, higher clutch frequency, and earlier age at sexual maturity than those at high latitudes (temperate zones). Adult survival increased weakly with latitude and declined significantly with increasing bioclimatic temperature (mean temperature of warmest quarter). A modeling synthesis of these data indicates that the interplay of life-history traits does not create higher harvest opportunity in adults of tropical species. Yet, we found potential for sustainable exploitation of eggs in tropical species. Conclusions Sustainable harvest as a conservation strategy for tropical turtles appears to be as biologically problematic as in temperature zones and likely only possible if the focus is on limited harvest of eggs. Further studies are urgently needed to understand how the predicted population surplus in early life stages can be most effectively incorporated into conservation programs for tropical turtles.	[Rachmansah, Angga; Gibbs, James P.] SUNY Coll Environm Sci & Forestry, Dept Environm & Forest Biol, New York, NY USA; [Norris, Darren] Univ Fed Amapa, Ecol & Conservat Amazonian Vertebrates Res Grp, Macapa, Amapa, Brazil; [Norris, Darren] Univ Fed Amapa, Postgrad Programme Trop Biodivers, Macapa, Amapa, Brazil; [Rachmansah, Angga] Fauna Flora Int Indonesia Programme, Jakarta, Indonesia	State University of New York (SUNY) System; State University of New York (SUNY) College of Environmental Science & Forestry; Fundacao Universidade Federal do Amapa; Fundacao Universidade Federal do Amapa	Norris, D (corresponding author), Univ Fed Amapa, Ecol & Conservat Amazonian Vertebrates Res Grp, Macapa, Amapa, Brazil.; Norris, D (corresponding author), Univ Fed Amapa, Postgrad Programme Trop Biodivers, Macapa, Amapa, Brazil.	dnorris75@gmail.com	Norris, Darren/J-5182-2012	Norris, Darren/0000-0003-0015-8214; Rachmansah, Angga/0000-0001-9851-754X	United States Agency for International Development [AID-OAA-A11-00012]	United States Agency for International Development(United States Agency for International Development (USAID))	This work was supported by the United States Agency for International Development (AID-OAA-A11-00012). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altrichter M, 2006, BIODIVERS CONSERV, V15, P2719, DOI 10.1007/s10531-005-0307-5; AlvarezBuylla ER, 1996, ANNU REV ECOL SYST, V27, P387, DOI 10.1146/annurev.ecolsys.27.1.387; Angielczyk KD, 2015, J EXP ZOOL PART B, V324, P270, DOI 10.1002/jez.b.22602; [Anonymous], R PACKAGE VERSION 3; Ashton KG, 2003, EVOLUTION, V57, P1151, DOI 10.1111/j.0014-3820.2003.tb00324.x; Benton TG, 2006, P R SOC B, V273, P1173, DOI 10.1098/rspb.2006.3495; Benton TG, 1999, TRENDS ECOL EVOL, V14, P467, DOI 10.1016/S0169-5347(99)01724-3; Blamires SJ, 2005, WILDLIFE RES, V32, P339, DOI 10.1071/WR04083; BURKE VJ, 1994, AM MIDL NAT, V131, P190, DOI 10.2307/2426622; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Campos-Silva JV, 2018, NAT SUSTAIN, V1, P650, DOI 10.1038/s41893-018-0170-5; Caswell H, 1989, MATRIX POPULATION MO; Congdon J.D., 1990, LIFE HIST ECOLOGY SL; CONGDON JD, 1993, CONSERV BIOL, V7, P826, DOI 10.1046/j.1523-1739.1993.740826.x; CONGDON JD, 1994, AM ZOOL, V34, P397; CONGDON JD, 1986, AM MIDL NAT, V115, P165, DOI 10.2307/2425846; Crawley M.J., 2007, R BOOK; CROUSE DT, 1987, ECOLOGY, V68, P1412, DOI 10.2307/1939225; DOROFF AM, 1990, COPEIA, P387, DOI 10.2307/1446344; Dunham A.E., 1990, P135; Eisemberg CC, 2011, BIOL CONSERV, V144, P2282, DOI 10.1016/j.biocon.2011.06.005; Fick SE, 2017, INT J CLIMATOL, V37, P4302, DOI 10.1002/joc.5086; FITZGERALD A, 1994, CONSERV BIOL, V8, P12, DOI 10.1046/j.1523-1739.1994.08010012.x; Fordham DA, 2008, J APPL ECOL, V45, P52, DOI 10.1111/j.1365-2664.2007.01414.x; Fordham DA, 2007, J ANIM ECOL, V76, P1231, DOI 10.1111/j.1365-2656.2007.01298.x; GALBRAITH DA, 1989, COPEIA, P896, DOI 10.2307/1445975; Gamble T, 2004, WILDLIFE SOC B, V32, P1269, DOI 10.2193/0091-7648(2004)032[1269:COHANP]2.0.CO;2; Gibbons JW, 2000, BIOSCIENCE, V50, P653, DOI 10.1641/0006-3568(2000)050[0653:TGDORD]2.0.CO;2; GIBBONS JW, 1981, AM NAT, V117, P841, DOI 10.1086/283774; Gibbs JP, 2000, TURTLE CONSERVATION, P207; Gilbert SF, 2008, BIOL TURTLES STRUCTU; Harju E, 2018, AMBIO, V47, P327, DOI 10.1007/s13280-017-0943-5; He FZ, 2018, DIVERS DISTRIB, V24, P1395, DOI 10.1111/ddi.12780; Heppell SS, 1998, COPEIA, P367, DOI 10.2307/1447430; Hutchings JA, 2012, ECOL APPL, V22, P1061, DOI 10.1890/11-1313.1; Iverson J.B., 1992, HERPETOL MONOGR, V6, P25, DOI [10.2307/1466960, DOI 10.2307/1466960]; IVERSON JB, 1993, CAN J ZOOL, V71, P2448, DOI 10.1139/z93-341; IVERSON JB, 1992, HERPETOL J, V2, P77; Iverson JB, 1997, HERPETOLOGICA, V53, P96; IVERSON JB, 1982, OECOLOGIA, V55, P69, DOI 10.1007/BF00386720; IVERSON JB, 1991, CAN J ZOOL, V69, P385, DOI 10.1139/z91-060; Jackson DC, 2000, NEWS PHYSIOL SCI, V15, P181; Jonsson B, 2001, FUNCT ECOL, V15, P310, DOI 10.1046/j.1365-2435.2001.00528.x; Kendall BE, 2019, ECOL MODEL, V406, P33, DOI 10.1016/j.ecolmodel.2019.03.011; KLEMENS MW, 1995, BIODIVERS CONSERV, V4, P281, DOI 10.1007/BF00055974; LEFKOVITCH LP, 1965, BIOMETRICS, V21, P1, DOI 10.2307/2528348; Lovich JE, 2018, BIOSCIENCE, V68, P771, DOI 10.1093/biosci/biy095; Macip-Rios R, 2017, EVOL ECOL RES, V18, P539; Macip-Rios R, 2011, HERPETOL J, V21, P235; Mali I, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139053; Mali I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086478; Manly BFJ., 2018, RANDOMIZATION BOOTST; Martin TE, 2000, SCIENCE, V287, P1482, DOI 10.1126/science.287.5457.1482; McNamara JM, 2008, AM NAT, V172, P331, DOI 10.1086/589886; McNeely J. A., 1990, CONSERVING WORLDS BI; Mena P, 2000, BIOL RESOURCE MANAGE, P57; Milner-Gulland EJ, 2003, TRENDS ECOL EVOL, V18, P351, DOI 10.1016/S0169-5347(03)00123-X; Mittermeier RA, 1978, S AM RIVER TURTLES S, V14, P222, DOI [10.1017/S0030605300015532, DOI 10.1017/S0030605300015532]; Moll D, 2004, ECOLOGY EXPLOITATION; Moll EO, 2000, TURLTE CONSERVATION; <monospace>R</monospace>Development Core Team, 2019, R LANG ENV STAT COMP; Rodrigues JFM, 2017, ECOGRAPHY, V40, P1402, DOI 10.1111/ecog.02649; Norris D, 2019, BIOL CONSERV, V233, P51, DOI 10.1016/j.biocon.2019.02.022; Norris D, 2018, PEERJ, V6, DOI 10.7717/peerj.4856; OBBARD ME, 1980, HERPETOLOGICA, V36, P158; Pavitt A., 2017, TECHNICAL REPORT PRE; Pedersen EJ, 2019, PEERJ, V7, DOI 10.7717/peerj.6876; Pike DA, 2008, ECOLOGY, V89, P607, DOI 10.1890/06-2162.1; Pimbert M, 1998, COMMUNITIES AND CONSERVATION, P58; Quintana I, 2019, J ZOOL, V309, P94, DOI 10.1111/jzo.12689; Rhodin AGJ, 2018, CHELONIAN CONSERV BI, V17, P135, DOI 10.2744/CCB-1348.1; Robinson JG, 1999, J WILDLIFE MANAGE, V63, P1, DOI 10.2307/3802482; Robinson JG, 1990, HUNTING SUSTAINABILI; Saha A, 2018, J HERPETOL, V52, P259, DOI 10.1670/17-076; Salguero-Gomez R, 2016, J ANIM ECOL, V85, P371, DOI 10.1111/1365-2656.12482; Santilli J, 2018, BIOL J LINN SOC, V124, P381, DOI 10.1093/biolinnean/bly054; Santos-Fita D, 2012, J ETHNOBIOL ETHNOMED, V8, DOI 10.1186/1746-4269-8-38; SHINE R, 1995, OIKOS, V72, P343, DOI 10.2307/3546119; SIMBERLOFF D, 1988, ANNU REV ECOL SYST, V19, P473, DOI 10.1146/annurev.ecolsys.19.1.473; Spencer RJ, 2017, CONSERV BIOL, V31, P1340, DOI 10.1111/cobi.12930; Spencer RJ, 2005, CONSERV BIOL, V19, P845, DOI 10.1111/j.1523-1739.2005.00487.x; Spencer RJ, 2002, AUST J ZOOL, V50, P477, DOI 10.1071/ZO01066; Stearns S.C., 1992, pi; STEARNS SC, 1977, ANNU REV ECOL SYST, V8, P145, DOI 10.1146/annurev.es.08.110177.001045; Storey KB, 2017, PHYSIOL REV, V97, P623, DOI 10.1152/physrev.00016.2016; Stott I, 2016, R PACKAGE VERSION 0; Stubben C, 2007, J STAT SOFTW, V22, P1, DOI 10.18637/jss.v022.i11; Sunday JM, 2011, P ROY SOC B-BIOL SCI, V278, P1823, DOI 10.1098/rspb.2010.1295; Sung YH, 2013, CONSERV BIOL, V27, P1421, DOI 10.1111/cobi.12102; Thorbjarnarson J, 2000, TURTLE CONSERVATION, P33; TINKLE DW, 1961, ECOLOGY, V42, P68, DOI 10.2307/1933268; Tokolyi J, 2014, BIOL J LINN SOC, V111, P719, DOI 10.1111/bij.12238; Townsend WR, 2000, HUNTING SUSTAINABILL; Turtle Taxonomy Working Group, 2017, Chelonian Research Monographs, V7, P1; Webb Grahame J. W., 2002, Pacific Conservation Biology, V8, P12; Wood S.N., 2017, GEN ADDITIVE MODELS; Wood SN, 2013, BIOMETRIKA, V100, P1005, DOI 10.1093/biomet/ast038; Wood SN, 2011, J R STAT SOC B, V73, P3, DOI 10.1111/j.1467-9868.2010.00749.x; Zimmer-Shaffer SA, 2014, CHELONIAN CONSERV BI, V13, P227, DOI 10.2744/CCB-1109.1; Zug G. R., 2001, HERPETOLOGY, P57; Zuur A.F., 2007, ANAL ECOLOGICAL DATA	101	9	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2020	15	2							e0229689	10.1371/journal.pone.0229689	http://dx.doi.org/10.1371/journal.pone.0229689			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8GQ	32106260	Green Published, gold, Green Submitted			2022-12-26	WOS:000535237000061
J	Belter, A; Barciszewski, J; Barciszewska, AM				Belter, Agnieszka; Barciszewski, Jakub; Barciszewska, Anna-Maria			Revealing the epigenetic effect of temozolomide on glioblastoma cell lines in therapeutic conditions	PLOS ONE			English	Article							CEREBROSPINAL-FLUID PHARMACOKINETICS; NEWLY-DIAGNOSED GLIOBLASTOMA; MGMT PROMOTER METHYLATION; BASE EXCISION-REPAIR; RANDOMIZED PHASE-III; DNA METHYLATION; ADJUVANT TEMOZOLOMIDE; OXIDATIVE STRESS; HYPOMETHYLATION; RADIOTHERAPY	Temozolomide (TMZ) is a drug of choice in glioblastoma treatment. Its therapeutic applications expand also beyond high grade gliomas. However, a significant number of recurrences and resistance to the drug is observed. The key factor in each chemotherapy is to achieve the therapeutic doses of a drug at the pathologic site. Nonetheless, the rate of temozolomide penetration from blood to cerebrospinal fluid is only 20-30%, and even smaller into brain intestinum. That makes a challenge for the therapeutic regimens to obtain effective drug concentrations with minimal toxicity and minor side effects. The aim of our research was to explore a novel epigenetic mechanism of temozolomide action in therapeutic conditions. We analyzed the epigenetic effects of TMZ influence on different glioblastoma cell lines in therapeutically achieved TMZ concentrations through total changes of the level of 5-methylcytosine in DNA, the main epigenetic marker. That was done with classical approach of radioactive nucleotide post-labelling and separation on thin-layer chromatography. In the range of therapeutically achieved temozolomide concentrations we observed total DNA hypomethylation. The significant hypermethylating effect was visible after reaching TMZ concentrations of 10-50 mu M (depending on the cell line). Longer exposure time promoted DNA hypomethylation. The demethylated state of the glioblastoma cell lines was overcome by repeated TMZ applications, where dosedependent increase in DNA 5-methylcytosine contents was observed. Those effects were not seen in non-cancerous cell line. The increase of DNA methylation resulting in global gene silencing and consecutive down regulation of gene expression after TMZ treatment may explain better glioblastoma patients' survival.	[Belter, Agnieszka; Barciszewski, Jakub] Polish Acad Sci, Inst Bioorgan Chem, Poznan, Poland; [Barciszewska, Anna-Maria] Poznan Univ Med Sci, Chair & Dept Neurosurg & Neurotraumatol, Intraoperat Imaging Unit, Poznan, Poland; [Barciszewska, Anna-Maria] Heliodor Swiecicki Clin Hosp, Dept Neurosurg & Neurotraumatol, Poznan, Poland	Polish Academy of Sciences; Institute of Bioorganic Chemistry of the Polish Academy of Sciences; Poznan University of Medical Sciences	Barciszewska, AM (corresponding author), Poznan Univ Med Sci, Chair & Dept Neurosurg & Neurotraumatol, Intraoperat Imaging Unit, Poznan, Poland.; Barciszewska, AM (corresponding author), Heliodor Swiecicki Clin Hosp, Dept Neurosurg & Neurotraumatol, Poznan, Poland.	abarcisz@man.poznan.pl	Barciszewska, Anna-Maria/J-5978-2018	Barciszewska, Anna-Maria/0000-0002-7179-1474; Belter, Agnieszka/0000-0001-7082-4986				Bady P, 2018, ACTA NEUROPATHOL, V135, P601, DOI 10.1007/s00401-018-1810-6; Barciszewska AM, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8091065; Barciszewska AM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136669; Barciszewska AM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092599; Barciszewska MZ, 2007, BIOGERONTOLOGY, V8, P673, DOI 10.1007/s10522-007-9109-3; Bei R, 2010, RECENT PAT ANTI-CANC, V5, P172, DOI 10.2174/157489210791760526; Bignami M, 2000, MUTAT RES-REV MUTAT, V462, P71, DOI 10.1016/S1383-5742(00)00016-8; Carmo A, 2011, ONCOL LETT, V2, P1165, DOI 10.3892/ol.2011.406; Carpenter BL, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-06351-4; Chen CC, 2013, J BIOL CHEM, V288, P9084, DOI 10.1074/jbc.M112.445585; Chu LX, 2018, DRUG DELIV, V25, P1634, DOI 10.1080/10717544.2018.1494226; Dawson MA, 2012, CELL, V150, P12, DOI 10.1016/j.cell.2012.06.013; DENNY BJ, 1994, BIOCHEMISTRY-US, V33, P9045, DOI 10.1021/bi00197a003; Ehrlich M, 2013, ADV EXP MED BIOL, V754, P31, DOI 10.1007/978-1-4419-9967-2_2; Feng ES, 2017, EUR NEUROL, V77, P201, DOI 10.1159/000455842; Ferrer-Font L, 2017, NMR BIOMED, V30, DOI 10.1002/nbm.3748; Franco R, 2008, CANCER LETT, V266, P6, DOI 10.1016/j.canlet.2008.02.026; Fukui T, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20051254; Garcia-Carpizo V, 2011, J MOL ENDOCRINOL, V47, pE75, DOI 10.1530/JME-11-0059; Gilbert MR, 2013, J CLIN ONCOL, V31, P4085, DOI 10.1200/JCO.2013.49.6968; Goldstein M, 2015, ANNU REV MED, V66, P129, DOI 10.1146/annurev-med-081313-121208; Good CR, 2018, CANCER RES, V78, P4126, DOI 10.1158/0008-5472.CAN-17-2082; Harder BG, 2018, FRONT ONCOL, V8, DOI 10.3389/fonc.2018.00462; Hegi ME, 2005, NEW ENGL J MED, V352, P997, DOI 10.1056/NEJMoa043331; Hsieh SYP, 2017, HONG KONG MED J, V23, P594, DOI 10.12809/hkmj165002; Jakubowicz-Gil J, 2013, TUMOR BIOL, V34, P2367, DOI 10.1007/s13277-013-0785-0; Kong DS, 2010, NEURO-ONCOLOGY, V12, P289, DOI 10.1093/neuonc/nop030; Koukourakis GV, 2009, MOLECULES, V14, P1561, DOI 10.3390/molecules14041561; League-Pascual JC, 2017, J NEURO-ONCOL, V132, P401, DOI 10.1007/s11060-017-2388-x; Li RH, 2015, JCPSP-J COLL PHYSICI, V25, P680, DOI 09.2015/JCPSP.680688; Liu L, 1999, CLIN CANCER RES, V5, P2908; Lopez-Moyado IF, 2019, P NATL ACAD SCI USA, V116, P16933, DOI 10.1073/pnas.1903059116; Mainprize T, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-018-36340-0; Milkovic L, 2014, CURR PHARM DESIGN, V20, P6529, DOI 10.2174/1381612820666140826152822; Nachbichler SB, 2017, STRAHLENTHER ONKOL, V193, P890, DOI 10.1007/s00066-017-1110-4; Nair Anroop B, 2016, J Basic Clin Pharm, V7, P27, DOI 10.4103/0976-0105.177703; Nam JY, 2017, J ONCOL PRACT, V13, P629, DOI 10.1200/JOP.2017.025536; Newlands ES, 1997, CANCER TREAT REV, V23, P35, DOI 10.1016/S0305-7372(97)90019-0; Nordling-David MM, 2017, J CONTROL RELEASE, V261, P138, DOI 10.1016/j.jconrel.2017.06.028; Nyce JW, 1997, MUTAT RES-REV MUTAT, V386, P153, DOI 10.1016/S1383-5742(96)00051-8; O'Regan CJ, 2018, J NEURO-ONCOL, V137, P233, DOI 10.1007/s11060-017-2722-3; Omuro A, 2013, NEURO-ONCOLOGY, V15, P242, DOI 10.1093/neuonc/nos295; Ostermann S, 2004, CLIN CANCER RES, V10, P3728, DOI 10.1158/1078-0432.CCR-03-0807; Patel M, 2003, J NEURO-ONCOL, V61, P203, DOI 10.1023/A:1022592913323; Perri F, 2017, CRIT REV ONCOL HEMAT, V111, P166, DOI 10.1016/j.critrevonc.2017.01.020; Pfeifer GP, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19041166; Portnow J, 2009, CLIN CANCER RES, V15, P7092, DOI 10.1158/1078-0432.CCR-09-1349; Rai R, 2016, BIOORG MED CHEM LETT, V26, P5103, DOI 10.1016/j.bmcl.2016.08.064; Robertson KD, 2005, NAT REV GENET, V6, P597, DOI 10.1038/nrg1655; Roos WP, 2007, ONCOGENE, V26, P186, DOI 10.1038/sj.onc.1209785; Skardelly M, 2017, ONCOLOGIST, V22, P570, DOI 10.1634/theoncologist.2016-0347; Smolarek I, 2010, MED SCI MONITOR, V16, pCR149; Strobel H, 2019, BIOMEDICINES, V7, DOI 10.3390/biomedicines7030069; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Stupp R, 2009, LANCET ONCOL, V10, P459, DOI 10.1016/S1470-2045(09)70025-7; Teng FF, 2017, RADIOTHER ONCOL, V125, P89, DOI 10.1016/j.radonc.2017.08.006; Tentori L, 2002, CURR MED CHEM, V9, P1285, DOI 10.2174/0929867023369916; Trivedi RN, 2005, CANCER RES, V65, P6394, DOI 10.1158/0008-5472.CAN-05-0715; Turner BM, 2009, PHILOS T R SOC B, V364, P3403, DOI 10.1098/rstb.2009.0125; Unnikrishnan A, 2018, ANN NY ACAD SCI, V1418, P69, DOI 10.1111/nyas.13533; van den Bent MJ, 2011, CLIN CANCER RES, V17, P7148, DOI 10.1158/1078-0432.CCR-11-1274; Van Tongelen A, 2017, CANCER LETT, V396, P130, DOI 10.1016/j.canlet.2017.03.029; Vineis P, 2017, FASEB J, V31, P2241, DOI 10.1096/fj.201601059RR; Voso MT, 2014, HAEMATOLOGICA, V99, P613, DOI 10.3324/haematol.2013.099549; Wachsman JT, 1997, MUTAT RES-FUND MOL M, V375, P1, DOI 10.1016/S0027-5107(97)00003-1; WANG Y, 2017, MEDICINE, V96, DOI DOI 10.1097/MD; Weller M, 2015, CLIN CANCER RES, V21, P2057, DOI 10.1158/1078-0432.CCR-14-2737; Wick W, 2009, NEURO-ONCOLOGY, V11, P69, DOI 10.1215/15228517-2008-078; Zhou QY, 2007, J PHARMACOL EXP THER, V321, P265, DOI 10.1124/jpet.106.118265; Zukiel R, 2004, MOL CANCER RES, V2, P196	70	9	9	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2020	15	2							e0229534	10.1371/journal.pone.0229534	http://dx.doi.org/10.1371/journal.pone.0229534			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8FM	32101575	Green Published, gold, Green Submitted			2022-12-26	WOS:000535233700041
J	Chen, S; Shiesh, SC; Lee, GB; Chen, C				Chen, Shi; Shiesh, Shu-Chu; Lee, Gwo-Bin; Chen, Chihchen			Two-step magnetic bead-based (2MBB) techniques for immunocapture of extracellular vesicles and quantification of microRNAs for cardiovascular diseases: A pilot study	PLOS ONE			English	Article							CIRCULATING MICRORNAS; BIOMARKERS; EXOSOMES; MARKERS	Extracellular vesicles (EVs) have attracted increasing attention because of their potential roles in various biological processes and medical applications. However, isolation of EVs is technically challenging mainly due to their small and heterogeneous size and contaminants that are often co-isolated. We have thus designed a two-step magnetic bead-based (2MBB) method for isolation a subset of EVs as well as their microRNAs from samples of a limited amount. The process involves utilizing magnetic beads coated with capture molecules that recognize EV surface markers, such as CD63. Captured EVs could be eluted from beads or lyzed directly for subsequent analysis. In this study, we used a second set of magnetic beads coated with complementary oligonucleotides to isolate EV-associated microRNAs (EV-miRNAs). The efficiencies of 2MBB processes were assessed by reverse transcription-polymerase chain reaction (RT-PCR) with spiked-in exogenous cel-miR-238 molecules. Experimental results demonstrated the high efficiency in EV enrichment (74 +/- 7%, n = 4) and miRNA extraction (91 +/- 4%, n = 4). Transmission electron micrographs (TEM) and nanoparticle tracking analysis (NTA) show that captured EVs enriched by 2MBB method could be released and achieved a higher purity than the differential ultracentrifugation (DUC) method (p < 0.001, n = 3). As a pilot study, EV-miR126-3p and total circulating cell-free miR126-3p (cf-miR126-3p) in eight clinical plasma samples were measured and compared with the level of protein markers. Compared to cf-miR126-3p, a significant increase in correlations between EV-miR126-3p and cardiac troponin I (cTnI) and N-terminal propeptide of B-type natriuretic peptide (NTproBNP) was detected. Furthermore, EV-miR126-3p levels in plasma samples from healthy volunteers (n = 18) and high-risk cardiovascular disease (CVD) patients (n = 10) were significantly different (p = 0.006), suggesting EV-miR126 may be a potential biomarker for cardiovascular diseases. 2MBB technique is easy, versatile, and provides an efficient means for enriching EVs and EV-associated nucleic acid molecules.	[Chen, Shi; Lee, Gwo-Bin; Chen, Chihchen] Natl Tsing Hua Univ, Inst NanoEngn & MicroSyst, Hsinchu, Taiwan; [Shiesh, Shu-Chu] Natl Cheng Kung Univ, Dept Med Lab Sci & Biotechnol, Tainan, Taiwan; [Lee, Gwo-Bin; Chen, Chihchen] Natl Tsing Hua Univ, Dept Power Mech Engn, Hsinchu, Taiwan; [Lee, Gwo-Bin] Natl Tsing Hua Univ, Inst Biomed Engn, Hsinchu, Taiwan	National Tsing Hua University; National Cheng Kung University; National Tsing Hua University; National Tsing Hua University	Chen, C (corresponding author), Natl Tsing Hua Univ, Inst NanoEngn & MicroSyst, Hsinchu, Taiwan.; Chen, C (corresponding author), Natl Tsing Hua Univ, Dept Power Mech Engn, Hsinchu, Taiwan.	chihchen@mx.nthu.edu.tw	Chen, Chihchen/AAF-5703-2020	Chen, Chihchen/0000-0002-2195-4802	Ministry of Science and Technology of Taiwan [MOST 1062221-E-007-003, MOST 106-2628-E007-010-MY3]	Ministry of Science and Technology of Taiwan(Ministry of Science and Technology, Taiwan)	This study was supported by grants from the Ministry of Science and Technology of Taiwan (https://www.most.gov.tw/?l=en): MOST 1062221-E-007-003 (CC) and MOST 106-2628-E007-010-MY3 (CC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.	Arroyo JD, 2011, P NATL ACAD SCI USA, V108, P5003, DOI 10.1073/pnas.1019055108; Brzozowski JS, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-27180-z; Chen ZX, 2018, ANATOL J CARDIOL, V19, P140, DOI 10.14744/AnatolJCardiol.2017.8124; Cheng L, 2018, BMC MICROBIOL, V18, DOI 10.1186/s12866-018-1159-y; Chiang CY, 2019, J BIOMED SCI, V26, DOI 10.1186/s12929-019-0502-4; Chim SSC, 2008, CLIN CHEM, V54, P482, DOI 10.1373/clinchem.2007.097972; Console L, 2019, CLIN CHIM ACTA, V488, P165, DOI 10.1016/j.cca.2018.11.009; Contreras-Naranjo JC, 2017, LAB CHIP, V17, P3558, DOI 10.1039/c7lc00592j; Coumans FAW, 2017, CIRC RES, V120, P1632, DOI 10.1161/CIRCRESAHA.117.309417; Crescitelli R, 2013, J EXTRACELL VESICLES, V2, DOI 10.3402/jev.v2i0.20677; Danielson Kirsty M, 2014, Exosomes Microvesicles, V2, DOI 10.5772/58390; Duprez DA, 2011, AIDS, V25, P651, DOI 10.1097/QAD.0b013e32834404a1; Fang SM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175050; Gould SJ, 2013, J EXTRACELL VESICLES, V2, DOI 10.3402/jev.v2i0.20389; Jansen F, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.114.001249; Jiang Y, 2014, SCI REP-UK, V4, DOI 10.1038/srep05026; Kowal J, 2016, P NATL ACAD SCI USA, V113, pE968, DOI 10.1073/pnas.1521230113; Lamparski HG, 2002, J IMMUNOL METHODS, V270, P211, DOI 10.1016/S0022-1759(02)00330-7; Lane RE, 2018, CLIN TRANSL MED, V7, DOI 10.1186/s40169-018-0192-7; Lasser C, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-9; Lim W, 2006, ARCH INTERN MED, V166, P2446, DOI 10.1001/archinte.166.22.2446; Linares R, 2015, J EXTRACELL VESICLES, V4, DOI 10.3402/jev.v4.29509; Long GW, 2012, INT J BIOL SCI, V8, P811, DOI 10.7150/ijbs.4439; Mateescu B, 2017, J EXTRACELL VESICLES, V6, DOI 10.1080/20013078.2017.1286095; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Nakai W, 2016, SCI REP-UK, V6, DOI 10.1038/srep33935; Navickas R, 2016, CARDIOVASC RES, V111, P322, DOI 10.1093/cvr/cvw174; Njock MS, 2017, TRENDS ENDOCRIN MET, V28, P237, DOI 10.1016/j.tem.2016.11.009; Ponikowski P, 2016, EUR HEART J, V37, P2129, DOI 10.1093/eurheartj/ehw128; Raj DAA, 2012, KIDNEY INT, V81, P1263, DOI 10.1038/ki.2012.25; Ramirez MI, 2018, NANOSCALE, V10, P881, DOI 10.1039/c7nr08360b; Raposo G, 1996, J EXP MED, V183, P1161, DOI 10.1084/jem.183.3.1161; Ratajczak J, 2006, LEUKEMIA, V20, P847, DOI 10.1038/sj.leu.2404132; Sarangadharan I, 2018, ECS J SOLID STATE SC, V7, pQ3032, DOI 10.1149/2.0061807jss; Taylor DD, 2008, GYNECOL ONCOL, V110, P13, DOI 10.1016/j.ygyno.2008.04.033; Thery C, 2018, J EXTRACELL VESICLES, V7, DOI 10.1080/20013078.2018.1535750; Thorsteinsdottir I, 2016, CLIN CHEM, V62, P623, DOI 10.1373/clinchem.2015.250811; Turchinovich A, 2015, FRONT MOL BIOSCI, V2, DOI 10.3389/fmolb.2015.00011; Turchinovich A, 2011, NUCLEIC ACIDS RES, V39, P7223, DOI 10.1093/nar/gkr254; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; Wagner J, 2013, ARTERIOSCL THROM VAS, V33, P1392, DOI 10.1161/ATVBAHA.112.300741; Witwer KW, 2015, CLIN CHEM, V61, P56, DOI 10.1373/clinchem.2014.221341; Witwer KW, 2013, J EXTRACELL VESICLES, V2, DOI 10.3402/jev.v2i0.20360; Yanez-Mo M, 2015, J EXTRACELL VESICLES, V4, DOI 10.3402/jev.v4.27066	44	17	17	4	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2020	15	2							e0229610	10.1371/journal.pone.0229610	http://dx.doi.org/10.1371/journal.pone.0229610			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8FM	32101583	Green Published, gold			2022-12-26	WOS:000535233700044
J	Li, S; Lavrijsen, M; Bakker, A; Magierowski, M; Magierowska, K; Liu, PY; Wang, WH; Peppelenbosch, MP; Smits, R				Li, Shan; Lavrijsen, Marla; Bakker, Aron; Magierowski, Marcin; Magierowska, Katarzyna; Liu, Pengyu; Wang, Wenhui; Peppelenbosch, Maikel P.; Smits, Ron			Commonly observed RNF43 mutations retain functionality in attenuating Wnt/beta-catenin signaling and unlikely confer Wnt-dependency onto colorectal cancers	ONCOGENE			English	Article							COMPREHENSIVE MOLECULAR CHARACTERIZATION; TUMOR-SUPPRESSOR RNF43; FINGER PROTEIN 43; RECURRENT MUTATIONS; RECEPTOR TURNOVER; GENOMIC LANDSCAPE; CARCINOMA; NEOPLASMS; SUBTYPES; PROMOTES	Cancer-associated RNF43 mutations lead to activation of beta-catenin signaling through aberrantly increasing Wnt-receptor levels at the membrane. Importantly, inactivating RNF43 mutations have been suggested to render cancer cells sensitive to Wnt-based therapeutics. However, the extent to which RNF43 mutations lead to impaired regulation of Wnt/beta-catenin signaling has been poorly investigated. Here, we observed that tumors with a functional mismatch repair system show a predominant 5 '-location of truncating RNF43 mutations, suggesting C-terminal truncations such as the most commonly reported p.G659fs mutation, do not affect beta-catenin signaling. In accordance, expressing C-terminal truncation mutants and wild-type RNF43, showed equal effects on beta-catenin signaling, Wnt-receptor turnover, and DVL-binding. We confirmed these observations at endogenous levels by CRISPR-Cas9-mediated knockout of G659fs RNF43 expression in KM12 cells and generating comparable mutations in HEK293T cells. We could not confirm previous reports linking RNF43 to p53 and E-cadherin breakdown. Our data also suggest that only colorectal cancer cells harboring N-terminal mutations of RNF43 convey Wnt-dependency onto the tumor cells. Results of this study have potentially important clinical implications indicating that Wnt-based therapeutics should be applied cautiously in cancer patients harboring RNF43 mutations.	[Li, Shan; Lavrijsen, Marla; Bakker, Aron; Magierowski, Marcin; Magierowska, Katarzyna; Liu, Pengyu; Wang, Wenhui; Peppelenbosch, Maikel P.; Smits, Ron] Erasmus MC, Univ Med Ctr, Dept Gastroenterol & Hepatol, Rotterdam, Netherlands; [Li, Shan] Army Med Univ, Daping Hosp, Dept Hepatobiliary Surg, Chongqing, Peoples R China; [Magierowski, Marcin; Magierowska, Katarzyna] Jagiellonian Univ, Med Coll, Dept Physiol, Krakow, Poland; [Wang, Wenhui] China Pharmaceut Univ, Dept Pharmacol, State Key Lab Nat Med, Nanjing, Peoples R China	Erasmus University Rotterdam; Erasmus MC; Army Medical University; Jagiellonian University; Collegium Medicum Jagiellonian University; China Pharmaceutical University	Smits, R (corresponding author), Erasmus MC, Univ Med Ctr, Dept Gastroenterol & Hepatol, Rotterdam, Netherlands.	m.j.m.smits@erasmusmc.nl	; Li, Shan/GSN-4678-2022	Magierowski, Marcin/0000-0003-0175-5600; liu, pengyu/0000-0001-6600-6139; Peppelenbosch, Maikel/0000-0001-9112-6028; Li, Shan/0000-0003-4446-2218	China Scholarship Council [201408060053, 201408220029]; Erasmus MC Grant; National Science Center Poland [UMO-2015/16/T/NZ4/00176]	China Scholarship Council(China Scholarship Council); Erasmus MC Grant; National Science Center Poland(National Science Centre, Poland)	We wish to thank Dr Louis Vermeulen (AMC, Amsterdam, The Netherlands) for providing us with several of the cell lines used in this study. We are grateful to Dr Erik A.C. Wiemer and Dr Robbert J. Rottier (Erasmus MC, Rotterdam, The Netherlands) for providing us, respectively with H1299 and A549 cell lines. We gratefully acknowledge Dr Aart G. Jochemsen (LUMC, Leiden, The Netherlands) for helpful discussion on p53-related works and providing us the p53-related plasmids. We thank Dr Markus Gerhard (Technische Universitat Munchen, Munich, Germany) for kindly providing HA-tagged RNF43 plasmid. We thank Natascha Nieuwenhuijze (Erasmus MC, Rotterdam, The Netherlands) for help with confocal microscopy. We would like to thank Dr Feng Cong (Novartis Institutes for Biomedical Research, Cambridge, MA, USA) for kindly giving us positive responses and the detailed protocol of surface SNAP-labeling experiments. This work was supported by the China Scholarship Council PhD fellowship (grant numbers 201408060053 to SL and 201408220029 to PL); and an Erasmus MC Grant; MM received financial support from National Science Center Poland (UMO-2015/16/T/NZ4/00176).	Ashkenazy H, 2016, NUCLEIC ACIDS RES, V44, pW344, DOI 10.1093/nar/gkw408; Bailey P, 2016, NATURE, V531, P47, DOI 10.1038/nature16965; Bass AJ, 2014, NATURE, V513, P202, DOI 10.1038/nature13480; Behm-Ansmant I, 2007, FEBS LETT, V581, P2845, DOI 10.1016/j.febslet.2007.05.027; Carmon KS, 2014, P NATL ACAD SCI USA, V111, pE1221, DOI 10.1073/pnas.1323106111; Carmon KS, 2011, P NATL ACAD SCI USA, V108, P11452, DOI 10.1073/pnas.1106083108; Eto T, 2018, J PATHOL, V245, P445, DOI 10.1002/path.5098; Forbes SA, 2015, NUCLEIC ACIDS RES, V43, pD805, DOI 10.1093/nar/gku1075; Fujii M, 2016, CELL STEM CELL, V18, P827, DOI 10.1016/j.stem.2016.04.003; Getz G, 2013, NATURE, V497, P67, DOI 10.1038/nature12113; Giannakis M, 2016, CELL REP, V15, P857, DOI 10.1016/j.celrep.2016.03.075; Giannakis M, 2014, NAT GENET, V46, P1264, DOI 10.1038/ng.3127; Gibson WJ, 2016, NAT GENET, V48, P848, DOI 10.1038/ng.3602; Gonzalez-Sancho JM, 2004, MOL CELL BIOL, V24, P4757, DOI 10.1128/MCB.24.11.4757-4768.2004; Hao HX, 2016, CANCERS, V8, DOI 10.3390/cancers8060054; Hao HX, 2012, NATURE, V485, P195, DOI 10.1038/nature11019; Hashimoto T, 2017, AM J SURG PATHOL, V41, P1188, DOI 10.1097/PAS.0000000000000877; Haupt Y, 1997, NATURE, V387, P296, DOI 10.1038/387296a0; Jiang XM, 2015, MOL CELL, V58, P522, DOI 10.1016/j.molcel.2015.03.015; Jiang XM, 2013, P NATL ACAD SCI USA, V110, P12649, DOI 10.1073/pnas.1307218110; Jiao YC, 2014, J PATHOL, V232, P428, DOI 10.1002/path.4310; Koo BK, 2015, P NATL ACAD SCI USA, V112, P7548, DOI 10.1073/pnas.1508113112; Koo BK, 2012, NATURE, V488, P665, DOI 10.1038/nature11308; Lee HJ, 2015, ELIFE, V4, DOI 10.7554/eLife.08142; Loregger A, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.aac6757; Madan B, 2016, ONCOGENE, V35, P2197, DOI 10.1038/onc.2015.280; Mazzoni SM, 2014, CANCER LETT, V355, P1, DOI 10.1016/j.canlet.2014.09.018; Min BH, 2016, J PATHOL, V240, P304, DOI 10.1002/path.4777; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Nailwal H, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.131; Neumeyer V, 2019, CARCINOGENESIS, V40, P551, DOI 10.1093/carcin/bgy152; Niu L, 2015, CELL PHYSIOL BIOCHEM, V36, P1835, DOI 10.1159/000430154; Picco G, 2017, EMBO MOL MED, V9, P293, DOI 10.15252/emmm.201606773; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Ryland GL, 2015, GENOME MED, V7, DOI 10.1186/s13073-015-0210-y; Ryland GL, 2013, J PATHOL, V229, P469, DOI 10.1002/path.4134; Sakamoto H, 2015, MODERN PATHOL, V28, P261, DOI 10.1038/modpathol.2014.98; Sekine S, 2016, J PATHOL, V239, P133, DOI 10.1002/path.4709; Seshagiri S, 2012, NATURE, V488, P660, DOI 10.1038/nature11282; Shinada K, 2011, BIOCHEM BIOPH RES CO, V404, P143, DOI 10.1016/j.bbrc.2010.11.082; Soumerai TE, 2018, CLIN CANCER RES, V24, P5939, DOI 10.1158/1078-0432.CCR-18-0412; Steinhart Z, 2017, NAT MED, V23, P60, DOI 10.1038/nm.4219; Tsai JH, 2017, HISTOPATHOLOGY, V70, P756, DOI 10.1111/his.13125; Tsukiyama T, 2015, MOL CELL BIOL, V35, P2007, DOI 10.1128/MCB.00159-15; van de Wetering M, 2015, CELL, V161, P933, DOI 10.1016/j.cell.2015.03.053; Vanderwalde A, 2018, CANCER MED-US, V7, P746, DOI 10.1002/cam4.1372; Waddell N, 2015, NATURE, V518, P495, DOI 10.1038/nature14169; Wang K, 2014, NAT GENET, V46, P573, DOI 10.1038/ng.2983; Wang K, 2011, NAT GENET, V43, P1219, DOI 10.1038/ng.982; Wang WH, 2016, NEOPLASIA, V18, P711, DOI 10.1016/j.neo.2016.10.004; Witkiewicz AK, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7744; Wu J, 2011, P NATL ACAD SCI USA, V108, P21188, DOI 10.1073/pnas.1118046108; Xie HY, 2015, INT J CLIN EXP PATHO, V8, P14995; Xie Y, 2013, EMBO REP, V14, P1120, DOI 10.1038/embor.2013.167; Xing CY, 2013, MOL CANCER THER, V12, P94, DOI 10.1158/1535-7163.MCT-12-0672; Yaeger R, 2018, CANCER CELL, V33, P125, DOI 10.1016/j.ccell.2017.12.004; Yan HHN, 2017, GUT, V66, P1645, DOI 10.1136/gutjnl-2016-311849; Zebisch M, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3787; Zhang YF, 2019, BMC CANCER, V19, DOI 10.1186/s12885-019-5880-1; Zou Y, 2013, GENE, V531, P112, DOI 10.1016/j.gene.2013.08.054	60	19	20	2	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR	2020	39	17					3458	3472		10.1038/s41388-020-1232-5	http://dx.doi.org/10.1038/s41388-020-1232-5		FEB 2020	15	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	LH1YK	32103169	Green Submitted			2022-12-26	WOS:000516683200003
J	Silva, B; Hidalgo, S; Campusano, JM				Silva, Bryon; Hidalgo, Sergio; Campusano, Jorge M.			Dop1R1, a type 1 dopaminergic receptor expressed in Mushroom Bodies, modulates Drosophila larval locomotion	PLOS ONE			English	Article							CENTRAL COMPLEX; SLEEP-DEPRIVATION; NEURONS; BODY; D1; SYSTEM; MODEL; TRANSPORTER; OCTOPAMINE; SEROTONIN	As in vertebrates, dopaminergic neural systems are key regulators of motor programs in insects, including the fly Drosophila melanogaster. Dopaminergic systems innervate the Mushroom Bodies (MB), an important association area in the insect brain primarily associated to olfactory learning and memory, but that has been also implicated with the execution of motor programs. The main objectives of this work is to assess the idea that dopaminergic systems contribute to the execution of motor programs in Drosophila larvae, and then, to evaluate the contribution of specific dopaminergic receptors expressed in MB to these programs. Our results show that animals bearing a mutation in the dopamine transporter show reduced locomotion, while mutants for the dopaminergic biosynthetic enzymes or the dopamine receptor Dop1R1 exhibit increased locomotion. Pan-neuronal expression of an RNAi for the Dop1R1 confirmed these results. Further studies show that animals expressing the RNAi for Dop1R1 in the entire MB neuronal population or only in the MB gamma-lobe forming neurons, exhibit an increased motor output, as well. Interestingly, our results also suggest that other dopaminergic receptors do not contribute to larval motor behavior. Thus, our data support the proposition that CNS dopamine systems innervating MB neurons modulate larval locomotion and that Dop1R1 mediates this effect.	[Silva, Bryon; Hidalgo, Sergio; Campusano, Jorge M.] Pontificia Univ Catolica Chile, Fac Ciencias Biol, Dept Biol Celular & Mol, Lab Neurogenet Conducta, Santiago, Chile; [Silva, Bryon] PSL Res Univ, ESPCI Paris, CNRS, Brain Plastic Unit,Genes & Dynam Memory Syst, Paris, France; [Hidalgo, Sergio] Univ Bristol, Fac Life Sci, Sch Physiol Pharmacol & Neurosci, Bristol, Avon, England; [Campusano, Jorge M.] Pontificia Univ Catolica Chile, Ctr Interdisciplinario Neurociencias, Santiago, Chile	Pontificia Universidad Catolica de Chile; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; Ecole Superieure de Physique et de Chimie Industrielles de la Ville de Paris (ESPCI); University of Bristol; Pontificia Universidad Catolica de Chile	Campusano, JM (corresponding author), Pontificia Univ Catolica Chile, Fac Ciencias Biol, Dept Biol Celular & Mol, Lab Neurogenet Conducta, Santiago, Chile.; Campusano, JM (corresponding author), Pontificia Univ Catolica Chile, Ctr Interdisciplinario Neurociencias, Santiago, Chile.	jcampusano@bio.puc.cl	Campusano, Jorge M/A-1592-2014; Campusano, Jorge M/CAF-8833-2022	Campusano, Jorge M/0000-0001-5254-8340; Campusano, Jorge M/0000-0001-5254-8340; Hidalgo, Sergio/0000-0002-2604-156X; Silva, Bryon/0000-0001-5871-8099	Grants Fondo Nacional de Desarrollo Cienti'fico y Tecnologico [1141233]; PUC-VRI [P-1805]	Grants Fondo Nacional de Desarrollo Cienti'fico y Tecnologico; PUC-VRI	This work was funded by Grants Fondo Nacional de Desarrollo Cienti ' fico y Tecnologico 1141233 (Dr Jorge M Campusano) and PUC-VRI P-1805 (Dr Jorge M Campusano). Funders had no role on this work.	Andretic R, 2008, P NATL ACAD SCI USA, V105, P20392, DOI 10.1073/pnas.0806776105; Berry JA, 2012, NEURON, V74, P530, DOI 10.1016/j.neuron.2012.04.007; Blenau W, 2011, ARTHROPOD STRUCT DEV, V40, P381, DOI 10.1016/j.asd.2011.01.004; Chang HY, 2006, MOL PSYCHIATR, V11, P99, DOI 10.1038/sj.mp.4001742; Crittenden JR, 1998, LEARN MEMORY, V5, P38; Draper I, 2007, DEV NEUROBIOL, V67, P378, DOI 10.1002/dneu.20355; Dubnau J, 2001, NATURE, V411, P476, DOI 10.1038/35078077; Duffy JB, 2002, GENESIS, V34, P1, DOI 10.1002/gene.10150; Fuenzalida-Uribe N, 2016, NICOTINIC ACETYLCHOL; Fuenzalida-Uribe N, 2013, J NEUROCHEM, V125, P281, DOI 10.1111/jnc.12161; Graybiel AM, 2000, CURR BIOL, V10, pR509, DOI 10.1016/S0960-9822(00)00593-5; Han KA, 1996, NEURON, V16, P1127, DOI 10.1016/S0896-6273(00)80139-7; Hardie SL, 2007, DEV NEUROBIOL, V67, P1396, DOI 10.1002/dneu.20459; Helfrich-Forster C, 2002, J NEUROGENET, V16, P73, DOI 10.1080/01677060290024592; Hidalgo S, 2017, ACS CHEM NEUROSCI, V8, P2168, DOI 10.1021/acschemneuro.7b00089; Huser A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047518; Inagaki HK, 2012, CELL, V148, P583, DOI 10.1016/j.cell.2011.12.022; Isabel G, 2004, SCIENCE, V304, P1024, DOI 10.1126/science.1094932; Kahsai L, 2012, NEUROSCIENCE, V208, P11, DOI 10.1016/j.neuroscience.2012.02.007; Kim YC, 2007, GENES BRAIN BEHAV, V6, P201, DOI 10.1111/j.1601-183X.2006.00241.x; Kim YC, 2003, GENE EXPR PATTERNS, V3, P237, DOI 10.1016/S1567-133X(02)00098-4; Klein MO, 2019, CELL MOL NEUROBIOL, V39, P31, DOI 10.1007/s10571-018-0632-3; Kong EC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009954; Lebestky T, 2009, NEURON, V64, P522, DOI 10.1016/j.neuron.2009.09.031; Lee T, 1999, DEVELOPMENT, V126, P4065; Liu QL, 2012, CURR BIOL, V22, P2114, DOI 10.1016/j.cub.2012.09.008; Martin JR, 1998, LEARN MEMORY, V5, P179; McGuire SE, 2005, PROG NEUROBIOL, V76, P328, DOI 10.1016/j.pneurobio.2005.09.003; McGuire SE, 2001, SCIENCE, V293, P1330, DOI 10.1126/science.1062622; Meder D, 2018, NEUROIMAGE; Molina-Mateo D, 2017, BBA-MOL BASIS DIS, V1863, P2882, DOI 10.1016/j.bbadis.2017.07.013; Monastirioti M, 1999, MICROSC RES TECHNIQ, V45, P106, DOI 10.1002/(SICI)1097-0029(19990415)45:2<106::AID-JEMT5>3.3.CO;2-V; Moncalvo VGR, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-66; Neckameyer WS, 2012, BMC NEUROSCI, V13, DOI 10.1186/1471-2202-13-26; Neckameyer WS, 1996, DEV BIOL, V176, P209, DOI 10.1006/dbio.1996.0128; Nishi A, 2011, FRONT NEUROANAT, V5, DOI 10.3389/fnana.2011.00043; Pauls D, 2010, J NEUROSCI, V30, P10655, DOI 10.1523/JNEUROSCI.1281-10.2010; Pech U, 2013, J COMP NEUROL, V521, P3992, DOI 10.1002/cne.23388; Riemensperger T, 2013, CELL REP, V5, P952, DOI 10.1016/j.celrep.2013.10.032; Riemensperger T, 2011, P NATL ACAD SCI USA, V108, P834, DOI 10.1073/pnas.1010930108; Scantlebury N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010652; Selcho M, 2012, J COMP NEUROL, V520, P3764, DOI 10.1002/cne.23152; Selcho M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005897; Seugnet L, 2008, CURR BIOL, V18, P1110, DOI 10.1016/j.cub.2008.07.028; Seugnet L, 2011, SLEEP, V34, P137, DOI 10.1093/sleep/34.2.137; Seugnet L, 2009, SLEEP, V32, P984, DOI 10.1093/sleep/32.8.984; Silva B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089641; Srivastava DP, 2005, J NEUROSCI, V25, P6145, DOI 10.1523/JNEUROSCI.1005-05.2005; STRAUSS R, 1993, J NEUROSCI, V13, P1852, DOI 10.1523/jneurosci.13-05-01852.1993; Strauss R, 2002, CURR OPIN NEUROBIOL, V12, P633, DOI 10.1016/S0959-4388(02)00385-9; Sun J, 2018, FRONT SYST NEUROSCI, V12, DOI 10.3389/fnsys.2018.00006; Surmeier DJ, 2007, TRENDS NEUROSCI, V30, P228, DOI 10.1016/j.tins.2007.03.008; Suster ML, 2003, J NEUROBIOL, V55, P233, DOI 10.1002/neu.10202; Varnam CJ, 1996, J NEUROGENET, V11, P99, DOI 10.3109/01677069609107065; Vickrey TL, 2013, ACS CHEM NEUROSCI, V4, P832, DOI 10.1021/cn400019q; Vickrey TL, 2011, ACS CHEM NEUROSCI, V2, P723, DOI 10.1021/cn200057k; Wiemerslage L, 2013, J NEUROCHEM, V126, P529, DOI 10.1111/jnc.12228; Xiong Y, 2010, FLY, V4, P194, DOI 10.4161/fly.12668; Zhang W, 2007, EUR J NEUROSCI, V26, P2405, DOI 10.1111/j.1460-9568.2007.05862.x	59	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2020	15	2							e0229671	10.1371/journal.pone.0229671	http://dx.doi.org/10.1371/journal.pone.0229671			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8FM	32101569	gold, Green Published			2022-12-26	WOS:000535233700047
J	Tzou, PL; Pond, SLK; Avila-Rios, S; Holmes, SP; Kantor, R; Shafer, RW				Tzou, Philip L.; Pond, Sergei L. Kosakovsky; Avila-Rios, Santiago; Holmes, Susan P.; Kantor, Rami; Shafer, Robert W.			Analysis of unusual and signature APOBEC-mutations in HIV-1 pol next-generation sequences	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; RESISTANCE; PROTEASE	Introduction At low mutation-detection thresholds, next generation sequencing (NGS) for HIV-1 genotypic resistance testing is susceptible to artifactual detection of mutations arising from PCR error and APOBEC-mediated G- to-A hypermutation. Methods We analyzed published HIV-1 pol Illumina NGS data to characterize the distribution of mutations at eight NGS mutation detection thresholds: 20%, 10%, 5%, 2%, 1%, 0.5%, 0.2%, and 0.1%. At each threshold, we determined proportions of amino acid mutations that were unusual (defined as having a prevalence < 0.01% in HIV-1 group M sequences) or signature APOBEC mutations. Results Eight studies, containing 855 samples, in the NCBI Sequence Read Archive were analyzed. As detection thresholds were lowered, there was a progressive increase in the proportion of positions with usual and unusual mutations and in the proportion of all mutations that were unusual. The median proportion of positions with an unusual mutation increased gradually from 0% at the 20% threshold to 0.3% at the 1% threshold and then exponentially to 1.3% (0.5% threshold), 6.9% (0.2% threshold), and 23.2% (0.1% threshold). In two of three studies with available plasma HIV-1 RNA levels, the proportion of positions with unusual mutations was negatively associated with virus levels. Although the complete set of signature APOBEC mutations was much smaller than that of unusual mutations, the former outnumbered the latter in one-sixth of samples at the 0.5%, 1%, and 2% thresholds. Conclusions The marked increase in the proportion of positions with unusual mutations at thresholds below 1% and in samples with lower virus loads suggests that, at low thresholds, many unusual mutations are artifactual, reflecting PCR error or G-to-A hypermutation. Profiling the numbers of unusual and signature APOBEC pol mutations at different NGS mutation detection thresholds may be useful to avoid selecting a threshold that is too low and poses an unacceptable risk of identifying artifactual mutations.	[Tzou, Philip L.; Shafer, Robert W.] Stanford Univ, Dept Med, Div Infect Dis, Stanford, CA 94305 USA; [Pond, Sergei L. Kosakovsky] Temple Univ, Inst Genom & Evolutionary Med, Philadelphia, PA 19122 USA; [Avila-Rios, Santiago] Natl Inst Resp Dis, Ctr Res Infect Dis, Mexico City, DF, Mexico; [Holmes, Susan P.] Stanford Univ, Dept Stat, Stanford, CA 94305 USA; [Kantor, Rami] Brown Univ, Dept Med, Div Infect Dis, Providence, RI 02912 USA	Stanford University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Stanford University; Brown University	Tzou, PL; Shafer, RW (corresponding author), Stanford Univ, Dept Med, Div Infect Dis, Stanford, CA 94305 USA.	philiptz@stanford.edu; rshafer@stanford.edu	Pond, Sergei LK/G-9830-2012; Avila-Rios, Santiago/AAB-4383-2020	Pond, Sergei LK/0000-0003-4817-4029; Holmes, Susan/0000-0002-2208-8168; Tzou, Philip Lei/0000-0002-2876-1552	National Institutes of Health [NIH/NIAID R24AI136618]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	RK is supported by a grant from the National Institutes of Health (NIH/NIAID P30AI042853). PLT and RWS are also supported by a grant from the National Institutes of Health (NIH/NIAID R24AI136618) (https://www.niaid.nih.gov/).The funder doesn't play any role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abram ME, 2010, J VIROL, V84, P9864, DOI 10.1128/JVI.00915-10; Avila-Rios S, 2016, LANCET HIV, V3, pE579, DOI 10.1016/S2352-3018(16)30119-9; Avila-Rios S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164156; Babrzadeh F, 2013, J ANTIMICROB CHEMOTH, V68, P414, DOI 10.1093/jac/dks409; Bruner KM, 2016, NAT MED, V22, P1043, DOI 10.1038/nm.4156; Clutter DS, 2017, J INFECT DIS, V216, P387, DOI 10.1093/infdis/jix338; Dalmat RR, 2018, J CLIN MICROBIOL, V56, DOI 10.1128/JCM.01443-18; Dauwe K, 2016, J CLIN MICROBIOL, V54, P1605, DOI 10.1128/JCM.00030-16; Delviks-Frankenberry KA, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005646; Gianella S, 2011, J VIROL, V85, P8359, DOI 10.1128/JVI.02582-10; Huber M, 2017, J VIROL METHODS, V240, P7, DOI 10.1016/j.jviromet.2016.11.008; Jabara CB, 2011, P NATL ACAD SCI USA, V108, P20166, DOI 10.1073/pnas.1110064108; Jair K, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0214820; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Learn GH, 1996, J VIROL, V70, P5720, DOI 10.1128/JVI.70.8.5720-5730.1996; Macalalad AR, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002417; Mansky LM, 1996, AIDS RES HUM RETROV, V12, P307, DOI 10.1089/aid.1996.12.307; Moscona R, 2017, J INT AIDS SOC, V20, DOI 10.7448/IAS.20.1.21846; Nguyen T, 2018, J ANTIMICROB CHEMOTH, V73, P2485, DOI 10.1093/jac/dky198; Noguera-Julian M, 2016, CLIN MICROBIOL INFEC, V22, P191, DOI 10.1016/j.cmi.2015.10.004; Noguera-Julian M, 2017, J INFECT DIS, V216, pS829, DOI 10.1093/infdis/jix397; Ode H, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.01258; Orton RJ, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1456-x; Raymond S, 2018, CLIN INFECT DIS, V66, P1588, DOI 10.1093/cid/cix1070; Rhee SY, 2016, J VIROL, V90, P6058, DOI 10.1128/JVI.00495-16; Rose PP, 2000, BIOINFORMATICS, V16, P400, DOI 10.1093/bioinformatics/16.4.400; Taylor T, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-45328-3; Telele NF, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-25888-6; Tzou PL, 2018, J CLIN MICROBIOL, V56, DOI [10.1128/JCM.00105-18, 10.1128/jcm.00105-18]; Tzou PL, 2019, AIDS RES HUM RETROV, V35, P924, DOI [10.1089/aid.2018.0289, 10.1089/AID.2018.0289]; Varghese V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010992; Zanini F, 2017, VIRUS EVOL, V3, DOI 10.1093/ve/vex003	32	12	12	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2020	15	2							e0225352	10.1371/journal.pone.0225352	http://dx.doi.org/10.1371/journal.pone.0225352			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8FM	32102090	gold, Green Submitted, Green Published			2022-12-26	WOS:000535233700004
J	Dondina, O; Orioli, V; Torretta, E; Merli, F; Bani, L; Meriggi, A				Dondina, Olivia; Orioli, Valerio; Torretta, Elisa; Merli, Federico; Bani, Luciano; Meriggi, Alberto			Combining ensemble models and connectivity analyses to predict wolf expected dispersal routes through a lowland corridor	PLOS ONE			English	Article							SPECIES DISTRIBUTION MODELS; CANIS-LUPUS POPULATIONS; HABITAT SELECTION; WOLVES; LANDSCAPE; APENNINES; EVOLUTION; GENETICS; ECOLOGY; ISLAND	The Italian wolf (Canis lupus italicus) population has remained isolated South of the Alps for the last few thousand years. After a strong decline, the species has recolonized the Apennines and the Western Alps, while it is currently struggling to colonize the Eastern Alps. Recently, the species was detected in a lowland park connecting the Northern Apennines to the Central Alps. If the park was able to sustain a net wolf dispersal flow, this could significantly boost the connection with the Eastern Alps and the Dinaric-Balkan population. We investigated the suitability of the park as a functional ecological corridor for the wolf through the unhospitable lowland of Northern Italy. We collected wolf occurrence data in two study areas. We modeled species distribution running a separate ensemble model for each study area and then merging the output of the models to obtain an integrated suitability map. We used this map to identify corridors for the wolf adopting a factorial least-cost path and a cumulative resistant kernel approach. The connectivity models showed that only two corridors exist in the lowland areas between the Northern Apennines and the Central Alps. The Western corridor is a blind route, while the eastern corridor passes through the park and has a continuous course. However, the models also revealed a scarce resilience of corridor connectivity in the passageways between the park and the Apennines and the Prealps, which suggests that urgent management actions are necessary to ensure the future functionality of this important corridor.	[Dondina, Olivia; Orioli, Valerio; Merli, Federico; Bani, Luciano] Univ Milano Bicocca, Dept Earth & Environm Sci, Milan, Italy; [Torretta, Elisa; Meriggi, Alberto] Univ Pavia, Dept Earth & Environm Sci, Pavia, Italy	University of Milano-Bicocca; University of Pavia	Dondina, O (corresponding author), Univ Milano Bicocca, Dept Earth & Environm Sci, Milan, Italy.	olivia.dondina@unimib.it	Bani, Luciano/M-9522-2016	Bani, Luciano/0000-0001-5795-9499; Dondina, Olivia/0000-0001-8097-1971				Abrahms B, 2017, J APPL ECOL, V54, P412, DOI 10.1111/1365-2664.12714; [Anonymous], R LANG ENV STAT COMP, DOI DOI 10.1080/02705060.2017.1422558; Araujo MB, 2007, TRENDS ECOL EVOL, V22, P42, DOI 10.1016/j.tree.2006.09.010; Bani L, 2018, CONSERV GENET, V19, P283, DOI 10.1007/s10592-017-0999-6; Bani L, 2017, CONSERV GENET, V18, P261, DOI 10.1007/s10592-016-0898-2; Bani L, 2015, ECOL EVOL, V5, P3472, DOI 10.1002/ece3.1617; Barabesi L, 2011, ENVIRONMETRICS, V22, P271, DOI 10.1002/env.1046; Boitani L., 1982, P158; Boitani L., 2000, NATURE ENV, V113; Boitani Luigi, 2003, P317; Bosso L, 2018, INT J WILDLAND FIRE, V27, P756, DOI [10.1071/WF18072, 10.1071/wf18072]; Breitenmoser U, 1998, BIOL CONSERV, V83, P279, DOI 10.1016/S0006-3207(97)00084-0; Cayuela L, 2004, APPL GEOGR, V24, P199, DOI 10.1016/j.apgeog.2004.04.003; Chapron G, 2014, SCIENCE, V346, P1517, DOI 10.1126/science.1257553; Chiatante G, 2017, HYSTRIX, V28, P247, DOI 10.4404/hystrix-00005-2017; Cushman Samuel A., 2014, Diversity-Basel, V6, P844; Cushman SA, 2013, MOV ECOL, V1, DOI 10.1186/2051-3933-1-12; Cushman SA, 2013, BIODIVERS CONSERV, V22, P2583, DOI 10.1007/s10531-013-0541-1; Cushman SA, 2009, CONSERV BIOL, V23, P368, DOI 10.1111/j.1523-1739.2008.01111.x; Delibes M, 2001, AM NAT, V158, P277, DOI 10.1086/321319; Dondina O, 2018, LANDSCAPE ECOL, V33, P1741, DOI 10.1007/s10980-018-0698-9; Dondina O, 2018, LANDSCAPE ECOL, V33, P275, DOI 10.1007/s10980-017-0600-1; Dondina O, 2017, J BIOGEOGR, V44, P1041, DOI 10.1111/jbi.12827; Eggermann J, 2011, MAMM BIOL, V76, P217, DOI 10.1016/j.mambio.2010.10.010; Fabbri E, 2014, MAMM BIOL, V79, P138, DOI 10.1016/j.mambio.2013.10.002; Fabbri E, 2007, MOL ECOL, V16, P1661, DOI 10.1111/j.1365-294X.2007.03262.x; Fernandes RF, 2019, J NAT CONSERV, V49, P85, DOI 10.1016/j.jnc.2019.04.001; Fois M, 2018, ENVIRON CONSERV, V45, P11, DOI 10.1017/S0376892917000108; Galaverni M, 2016, MAMMAL RES, V61, P13, DOI 10.1007/s13364-015-0247-8; Genovesi P, 2002, PIANO AZIONE NAZL CO; Gilroy JJ, 2015, SCIENCE, V347, P381, DOI 10.1126/science.347.6220.382-a; Hedrick PW, 2010, CONSERV GENET, V11, P615, DOI 10.1007/s10592-009-9999-5; Hindrikson M, 2017, BIOL REV, V92, P1601, DOI 10.1111/brv.12298; Imbert C, 2016, BIOL CONSERV, V195, P156, DOI 10.1016/j.biocon.2016.01.003; Jedrzejewski W, 2005, ACTA THERIOL, V50, P417, DOI 10.1007/BF03192636; Jedrzejewski W, 2004, DIVERS DISTRIB, V10, P225, DOI 10.1111/j.1366-9516.2004.00073.x; Kaartinen S, 2005, ANN ZOOL FENN, V42, P523; Kabir M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0187027; Khosravi R, 2018, DIVERS DISTRIB, V24, P193, DOI 10.1111/ddi.12672; Landguth EL, 2012, ECOGRAPHY, V35, P9, DOI 10.1111/j.1600-0587.2011.07149.x; Leonard JA, 2014, EVOL ECOL RES, V16, P461; Linnell John D.C., 2011, P12; Lowe WH, 2010, MOL ECOL, V19, P3038, DOI 10.1111/j.1365-294X.2010.04688.x; Lucchini V, 2004, MOL ECOL, V13, P523, DOI 10.1046/j.1365-294X.2004.02077.x; Maiorano L, 2019, BIOL CONSERV, V237, P19, DOI 10.1016/j.biocon.2019.06.014; Marmion M, 2009, DIVERS DISTRIB, V15, P59, DOI 10.1111/j.1472-4642.2008.00491.x; Marucco F, 12NATIT00080 LIFE; Marucco F, 2012, HYSTRIX, V23, P5, DOI 10.4404/hystrix-23.1-4584; Massolo A, 1998, ECOGRAPHY, V21, P97, DOI 10.1111/j.1600-0587.1998.tb00663.x; Sanchez MCM, 2014, INT J GEOGR INF SCI, V28, P1531, DOI 10.1080/13658816.2013.776684; Mateo-Sanchez MC, 2015, LANDSCAPE ECOL, V30, P1405, DOI 10.1007/s10980-015-0194-4; Mateo-Sanchez MC, 2015, ECOSPHERE, V6, DOI 10.1890/ES14-00387.1; Mcrae BH, 2008, ECOLOGY, V89, P2712, DOI 10.1890/07-1861.1; MERIGGI A, 1991, ACTA THERIOL, V36, P141, DOI 10.4098/AT.arch.91-11; Mohammadi S, 2019, ECOL INFORM, V52, P7, DOI 10.1016/j.ecoinf.2019.04.003; Pilot M, 2014, HEREDITY, V112, P428, DOI 10.1038/hdy.2013.122; Pinto N, 2009, LANDSCAPE ECOL, V24, P253, DOI 10.1007/s10980-008-9303-y; Randi E, 2011, MAMMAL REV, V41, P99, DOI 10.1111/j.1365-2907.2010.00176.x; Ripple WJ, 2014, SCIENCE, V343, P151, DOI 10.1126/science.1241484; Rodriguez-Freire M, 2008, ENVIRON MODEL ASSESS, V13, P35, DOI 10.1007/s10666-006-9078-y; Rodriguez-Soto C, 2011, DIVERS DISTRIB, V17, P350, DOI 10.1111/j.1472-4642.2010.00740.x; Sastre N, 2011, CONSERV GENET, V12, P701, DOI 10.1007/s10592-010-0177-6; Scherrer D, 2019, DIVERS DISTRIB, V25, P770, DOI 10.1111/ddi.12893; Schlaepfer MA, 2002, TRENDS ECOL EVOL, V17, P474, DOI 10.1016/S0169-5347(02)02580-6; Shahnaseri G, 2019, LANDSCAPE ECOL, V34, P1263, DOI 10.1007/s10980-019-00831-w; Stronen AV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076454; Thuiller W., 2016, R PACKAGE VERSION, V21, P788; Thuiller W, 2009, ECOGRAPHY, V32, P369, DOI 10.1111/j.1600-0587.2008.05742.x; Wan HY, 2019, LANDSCAPE ECOL, V34, P503, DOI 10.1007/s10980-019-00788-w; Zeller KA, 2012, LANDSCAPE ECOL, V27, P777, DOI 10.1007/s10980-012-9737-0; Ziolkowska E, 2016, LANDSCAPE ECOL, V31, P1863, DOI 10.1007/s10980-016-0368-8	71	12	12	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2020	15	2							e0229261	10.1371/journal.pone.0229261	http://dx.doi.org/10.1371/journal.pone.0229261			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8DW	32092115	Green Published, gold			2022-12-26	WOS:000535229300039
J	Nunes, AF; Monteiro, PL; Nunes, AS				Nunes, Amelia Fernandes; Monteiro, Pedro Lourenco; Nunes, Antonio Santos			Factor structure of the convergence insufficiency symptom survey questionnaire	PLOS ONE			English	Article							EXPLORATORY FACTOR-ANALYSIS; VISUAL SYMPTOMS; READING SPEED; CHILDREN; PREVALENCE; ACCOMMODATION; RELIABILITY; ASTHENOPIA; VALIDITY	The purpose of this study is to analyze the factorial structure of the Convergence Insufficiency Symptom Survey questionnaire with 15 items, in order to identify latent dimensions that can contribute to a more focused implementation. The questionnaire was self-administered in paper by 183 university students, in the age span of 18 to 30. Both Kaiser-Meyer-Olkin measure and Bartlett's sphericity test were performed to ensure the validity of the factorization. In order to analyze the principal components, factors which obtained eigenvalues greater than 1 were chosen. The extraction of factors was performed after computing a Promax rotation and a Kaiser criterion. In each extracted factor, the internal consistency was used to prove its reliability. Bartlett's sphericity test was statistically significant (p < 0.001), and the Both Kaiser-Meyer-Olkin test was 0.89, confirming the factorization of this instrument. Exploratory factor analysis followed by a Promax rotation and scree plots graphic, extracted three factors that explained 62.1% of the total variance. The composition of each factor suggests the following meanings: Factor 1 (somatic sensation) includes 8 of 15 items; Factor 2 (impaired vision) includes 3 of 15 items; Factor 3 (cognitive performance) includes 4 of 15 items. Cronbach's alpha coefficient demonstrated good internal consistency (alpha>0.75) in three dimensions. The multivariate statistical analysis of the Convergence Insufficiency Symptom Survey revealed a three-factor structure, so new forms of questionnaire analysis can be designed in order to obtain gains in the management of a symptomatic patient, using 3 subscores, one for each factor, instead of a total score. The factorial structure of the questionnaire can be used with a high level of confidence in future investigations, which aim to assess which dimensions are most affected in each type of visual changes and develop more targeted therapeutic performances.	[Nunes, Amelia Fernandes; Monteiro, Pedro Lourenco; Nunes, Antonio Santos] Univ Beira Interior, Covilha, Portugal; [Nunes, Amelia Fernandes; Monteiro, Pedro Lourenco] Hlth Sci Res Ctr CICS UBI, UBIMed, Covilha, Portugal; [Nunes, Antonio Santos] Res Unit Business Sci NECE, Covilha, Portugal	Universidade da Beira Interior	Nunes, AF (corresponding author), Univ Beira Interior, Covilha, Portugal.; Nunes, AF (corresponding author), Hlth Sci Res Ctr CICS UBI, UBIMed, Covilha, Portugal.	amnunes@ubi.pt		Nunes, Amelia/0000-0002-5001-3534				Aakre Bente Monica, 2007, Cont Lens Anterior Eye, V30, P174, DOI 10.1016/j.clae.2007.01.001; Barnhardt C, 2012, OPTOMETRY VISION SCI, V89, P1512, DOI 10.1097/OPX.0b013e318269c8f9; Borsting EJ, 2003, OPTOMETRY VISION SCI, V80, P832, DOI 10.1097/00006324-200312000-00014; Borsting E, 2008, OPTOMETRY VISION SCI, V85, P992, DOI 10.1097/OPX.0b013e31818883cd; Clark TY, 2015, AM J OPHTHALMOL, V160, P905, DOI 10.1016/j.ajo.2015.08.008; Conlon EG, 1999, VIS COGN, V6, P637, DOI 10.1080/135062899394885; Davis AL, 2016, J OPHTHALMOL, V2016, DOI 10.1155/2016/6963976; Gaskin CJ, 2014, INT J NURS STUD, V51, P511, DOI 10.1016/j.ijnurstu.2013.10.005; Han CC, 2013, INT J OPHTHALMOL-CHI, V6, P718, DOI 10.3980/j.issn.2222-3959.2013.05.31; Horwood AM, 2014, BRIT J OPHTHALMOL, V98, P679, DOI 10.1136/bjophthalmol-2013-304533; Ip JM, 2006, AM J OPHTHALMOL, V142, P495, DOI 10.1016/j.ajo.2006.03.047; Izquierdo I, 2014, PSICOTHEMA, V26, P395, DOI 10.7334/psicothema2013.349; Lambooij M, 2010, J SOC INF DISPLAY, V18, P931, DOI 10.1889/JSID18.11.931; Marran LF, 2006, OPTOMETRY VISION SCI, V83, P281, DOI 10.1097/01.opx.0000216097.78951.7b; Munshi S, 2017, INT J CLIN PRACT, V71, DOI 10.1111/ijcp.12962; Onsman A., 2010, AUSTRALASIAN J PARAM, V8, P1, DOI DOI 10.33151/AJP.8.3.93; Palomo-Alvarez C, 2013, GRAEF ARCH CLIN EXP, V251, P945, DOI 10.1007/s00417-012-2162-x; Portello JK, 2012, OPHTHAL PHYSL OPT, V32, P375, DOI 10.1111/j.1475-1313.2012.00925.x; Quaid P, 2013, GRAEF ARCH CLIN EXP, V251, P169, DOI 10.1007/s00417-012-2135-0; Rouse MW, 2004, OPHTHAL PHYSL OPT, V24, P384, DOI 10.1111/j.1475-1313.2004.00202.x; Schellini S, 2016, INT J OPHTHALMOL-CHI, V9, P1657, DOI 10.18240/ijo.2016.11.20; Sheedy JE, 2007, J MOD OPTIC, V54, P1333, DOI 10.1080/09500340600855460; Sterner B, 2006, OPHTHAL PHYSL OPT, V26, P148, DOI 10.1111/j.1475-1313.2006.00364.x; Tavares C, 2014, ARQ BRAS OFTALMOL, V77, P21, DOI 10.5935/0004-2749.20140007; Tosha C, 2009, OPHTHAL PHYSL OPT, V29, P625, DOI 10.1111/j.1475-1313.2009.00687.x; Vilela MAP, 2015, J PEDIAT-BRAZIL, V91, P320, DOI [10.1016/j.jped.2014.10.008, 10.1016/j.jpedp.2015.05.005]; von Noorden G, 2002, BINOCULAR VISION OCU, P150; Zou KH, 2014, PATIENT REPORTED OUT, P66	28	4	4	3	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2020	15	2							e0229511	10.1371/journal.pone.0229511	http://dx.doi.org/10.1371/journal.pone.0229511			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LQ8DW	32092119	Green Published, gold			2022-12-26	WOS:000535229300063
J	Zhou, J; Teo, M; Ho, V; Brannan, JD				Zhou, Jerry; Teo, Ming; Ho, Vincent; Brannan, John D.			Prevalence and effects of gastro-oesophageal reflux during spirometry in subjects undergoing reflux assessment	PLOS ONE			English	Article							ESOPHAGEAL SPHINCTER PRESSURE; ASTHMA; BRONCHOCONSTRICTION; ASSOCIATION; MECHANISMS; SYMPTOMS	Variability during spirometry can persist despite control of technical and personal factors. We postulate spirometry induces gastro-oesophageal reflux (GOR), which may cause variability and affect results of spirometry. Fifty-eight (58) subjects undergoing GOR investigation with oesophageal manometry and 24hr pH monitoring were recruited. Oesophageal dysmotility and GOR were assessed as part of clinical care. Subjects performed 2 sets of spirometry separated by a 10-minute rest period. The assessment of GOR during spirometry procedure (defined by a lower oesophageal pH<4) started from the first set of spirometry and concluded when the second set of spirometry was completed. We calculated variability (%) of FEV1, FVC and PEFR within each set as well as changes over 10-minutes. Twenty-six subjects (45%) recorded GOR during assessment. Of these, 23 subjects recorded GOR during the 10-minute rest period. Four subjects had GOR recorded only during spirometry tests. We did not find variability of spirometry parameters between the groups with and without GOR during spirometry procedure. However, in subjects with GOR, we found small but significant reductions of PEFR (0.5L/s, 8%, p<0.001) and FEV1 (84 mL, 3%, p = 0.048) in the second set of spirometry compared to the first spirometry set. This pilot study demonstrates that GOR can occur during and following spirometry. Presence of GOR during spirometry in this patient population caused small decreases in PEFR and FEV1 when it is repeated 10-minutes later however not increase variability in a single series of measurements.	[Zhou, Jerry; Ho, Vincent] Western Sydney Univ, Sch Med, Campbelltown, NSW, Australia; [Teo, Ming] Blacktown Hosp, Dept Resp Med, Blacktown, NSW, Australia; [Brannan, John D.] John Hunter Hosp, Dept Resp & Sleep Med, New Lambton, NSW, Australia	University of Sydney; Western Sydney University; Blacktown & Mount Druitt Hospital; John Hunter Hospital	Zhou, J (corresponding author), Western Sydney Univ, Sch Med, Campbelltown, NSW, Australia.	j.zhou@westernsydney.edu.au		Ho, Vincent/0000-0003-3127-2933; Brannan, John/0000-0001-7243-7998				[Anonymous], 1991, AM REV RESPIR DIS, V144, P1202, DOI 10.1164/ajrccm/144.5.1202; Barnes PJ, 2001, RESP PHYSIOL, V125, P145, DOI 10.1016/S0034-5687(00)00210-3; BLABER LC, 1985, BRIT J PHARMACOL, V86, P723, DOI 10.1111/j.1476-5381.1985.tb08951.x; BOYLE JT, 1985, GASTROENTEROLOGY, V88, P723, DOI 10.1016/0016-5085(85)90143-X; BOYLE JT, 1985, AM REV RESPIR DIS, V131, pS16; Bredenoord AJ, 2012, NEUROGASTROENT MOTIL, V24, P57, DOI 10.1111/j.1365-2982.2011.01834.x; EMPEY DW, 1972, BRIT MED J, V3, P503, DOI 10.1136/bmj.3.5825.503; Field SK, 1996, CHEST, V109, P316, DOI 10.1378/chest.109.2.316; Fox MR, 2008, GUT, V57, DOI 10.1136/gut.2007.127993; HARDING SM, 1995, CHEST, V108, P1220, DOI 10.1378/chest.108.5.1220; HIRSHMAN CA, 1983, J APPL PHYSIOL, V54, P1101, DOI 10.1152/jappl.1983.54.4.1101; JACK CIA, 1995, THORAX, V50, P201, DOI 10.1136/thx.50.2.201; JAMIESON JR, 1992, AM J GASTROENTEROL, V87, P1102; Lavorini F, 2011, CHEST, V140, P690, DOI 10.1378/chest.10-1084; Liu S, 2017, COMPUT MATH METHOD M, V2017, DOI 10.1155/2017/9239074; MANSFIELD LE, 1981, ANN ALLERGY, V47, P431; MANSFIELD LE, 1978, ANN ALLERGY, V41, P224; MANSFIELD LE, 1978, AM REV RESPIR DIS, V117, P72; MAYS EE, 1976, JAMA-J AM MED ASSOC, V236, P2626, DOI 10.1001/jama.236.23.2626; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; Mokhlesi B, 2001, CHEST, V119, P1043, DOI 10.1378/chest.119.4.1043; MOOTE DW, 1986, J ALLERGY CLIN IMMUN, V78, P619, DOI 10.1016/0091-6749(86)90079-5; Ricciardolo FLM, 1999, AM J RESP CRIT CARE, V159, P557, DOI 10.1164/ajrccm.159.2.9804022; Ricciardolo FLM, 2001, AM J MED, V111, P18, DOI 10.1016/S0002-9343(01)00816-6; Richter JE, 1997, AM J MED, V103, p130S, DOI 10.1016/S0002-9343(97)00338-0; UTELL MJ, 1983, AM REV RESPIR DIS, V128, P444, DOI 10.1164/arrd.1983.128.3.444; WELCH RW, 1982, GASTROENTEROLOGY, V83, P590	27	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2020	15	2							e0229250	10.1371/journal.pone.0229250	http://dx.doi.org/10.1371/journal.pone.0229250			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ8DW	32092097	Green Published, gold			2022-12-26	WOS:000535229300035
